PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Bi, ZL; Yang, XL; Yu, W; Shu, JH; Zhang, YZ				Bi, Zhenle; Yang, Xiaoli; Yu, Wei; Shu, Jianhong; Zhang, Yaozhou			Diapause-Associated Protein3 Functions as Cu/Zn Superoxide Dismutase in the Chinese Oak Silkworm (Antheraea pernyi)	PLOS ONE			English	Article							BOMBYX-MORI; OXIDATIVE STRESS; CAENORHABDITIS-ELEGANS; HYDROGEN-PEROXIDE; INSECT DIAPAUSE; TIMER PROTEIN; PEPTIDE PIN; EGGS; EXPRESSION; METABOLISM	To better understand the molecular mechanism underlying of diapause in Antheraea pernyi (A. pernyi), we cloned a novel diapause-associated protein 3 (DAP3) gene from A. pernyi by reverse transcription-polymerase chain reaction (RT-PCR) and studied the biological functions. Sequence analysis revealed that this gene encodes 171 amino acids and has a conserved domain of Copper/Zinc superoxide dismutase (Cu/Zn-SOD). Western blot and qRT-PCR results showed that DAP3 was mainly expressed in the pupal stage, and gradually decreased as diapause development. DAP3 was also expressed in 1st and 5th instar larvae of A. pernyi. In tissues of 5th instar larvae of A. pernyi, DAP3 was mainly expressed in the epidermis, followed by the head, hemolymph and fat body. To identify the SOD activity of DAP3, we constructed a prokaryotic expression vector by inserting the coding region sequence into plasmid pET-28a (+) and obtained the purified rHIS-DAP3 fusion protein by Ni-NTA affinitive column. Importantly, we found the SOD activity of DAP3 fusion protein was approximately 0.6674 U/mu g. To further confirm the SOD activity of DAP3 in vivo, we induced the oxidative stress model of pupae by UV irradiation. The results showed that both the mRNA and protein level of DAP3 significantly increased by UV irradiation. Furthermore, the SOD activity of the total lysate of pupae increased significantly at 10 min post UV irradiation and transiently returned to normal level afterwards. These results suggested that DAP3 might be a novel protein with SOD activity getting involved in regulation of diapause in A. pernyi.	[Bi, Zhenle; Yang, Xiaoli; Yu, Wei; Shu, Jianhong; Zhang, Yaozhou] Zhejiang Sci Tech Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China; [Bi, Zhenle; Yang, Xiaoli; Zhang, Yaozhou] Tianjin Int Joint Acad Biomed, Tianjin, Peoples R China	Zhejiang Sci-Tech University; Tianjin International Joint Academy of Biomedicine	Shu, JH (corresponding author), Zhejiang Sci Tech Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China.	shujianhong@zstu.edu.cn; yaozhou@chinagene.com			National High-tech R D program [2011AA100603]; Zhejiang Natural Science Foundation [LY13H090015]	National High-tech R D program; Zhejiang Natural Science Foundation(Natural Science Foundation of Zhejiang Province)	This work was supported by the National High-tech R & D program (grant No. 2011AA100603) and Zhejiang Natural Science Foundation (Grant No: LY13H090015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Smith A, 2002, PARASITE IMMUNOL, V24, P119, DOI 10.1046/j.1365-3024.2002.00445.x; BUECHTER DD, 1988, PHARM RES-DORDR, V5, P253, DOI 10.1023/A:1015914418014; Coates BS, 2005, J INSECT SCI, V5, DOI 10.1093/jis/5.1.19; CRAPO JD, 1992, P NATL ACAD SCI USA, V89, P10405, DOI 10.1073/pnas.89.21.10405; de Loof A, 1970, J. Insect Physiol., V16, P1455, DOI 10.1016/0022-1910(70)90144-7; Doonan R, 2008, GENE DEV, V22, P3236, DOI 10.1101/gad.504808; FONTECAVE M, 1987, J BIOL CHEM, V262, P12332; Foth BJ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r177; Hahn DA, 2011, ANNU REV ENTOMOL, V56, P103, DOI 10.1146/annurev-ento-112408-085436; Hiraki T, 2008, J MOL BIOL, V377, P630, DOI 10.1016/j.jmb.2008.01.020; Honda Y, 2008, EXP GERONTOL, V43, P520, DOI 10.1016/j.exger.2008.02.009; Hoogewijs D, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-9; Hu Xiao-ke, 2002, Yaoxue Xuebao, V37, P23; Isobe M, 2006, CHEMBIOCHEM, V7, P1590, DOI 10.1002/cbic.200600138; Kai H, 1999, CHRONOBIOL INT, V16, P51, DOI 10.3109/07420529908998711; Krieg RC, 2005, J BIOCHEM BIOPH METH, V65, P13, DOI 10.1016/j.jbbm.2005.08.005; Lewis DK, 2002, J INSECT PHYSIOL, V48, P887, DOI 10.1016/S0022-1910(02)00158-0; Li JM, 2011, ARCH INSECT BIOCHEM, V77, P118, DOI 10.1002/arch.20428; Marikovsky M, 2003, J IMMUNOL, V170, P2993, DOI 10.4049/jimmunol.170.6.2993; McCord JM, 2005, BIOMED PHARMACOTHER, V59, P139, DOI 10.1016/j.biopha.2005.03.005; Pitchayawasin-Thapphasaraphong S, 2009, BIOSCI BIOTECH BIOCH, V73, P1578, DOI 10.1271/bbb.90066; SALAMA MS, 1992, ARCH INSECT BIOCHEM, V21, P1, DOI 10.1002/arch.940210102; TAINER JA, 1982, J MOL BIOL, V160, P181, DOI 10.1016/0022-2836(82)90174-7; Ti XA, 2006, J INSECT PHYSIOL, V52, P461, DOI 10.1016/j.jinsphys.2005.12.005; Ti XN, 2005, J INSECT PHYSIOL, V51, P1025, DOI 10.1016/j.jinsphys.2005.04.019; Zhao LC, 2010, ARCH INSECT BIOCHEM, V74, P127, DOI 10.1002/arch.20367; Zhao LC, 2009, COMP BIOCHEM PHYS B, V152, P339, DOI 10.1016/j.cbpb.2008.12.014	27	9	11	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e90435	10.1371/journal.pone.0090435	http://dx.doi.org/10.1371/journal.pone.0090435			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24613963	Green Published, Green Submitted, gold			2022-12-27	WOS:000332839300025
J	Gonzalez-Perez, D; Molina-Espeja, P; Garcia-Ruiz, E; Alcalde, M				Gonzalez-Perez, David; Molina-Espeja, Patricia; Garcia-Ruiz, Eva; Alcalde, Miguel			Mutagenic Organized Recombination Process by Homologous In Vivo Grouping (MORPHING) for Directed Enzyme Evolution	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; PEROXIDASE; EXPRESSION; CHALLENGE; STABILITY; LIBRARIES; DRIFT; TOOL	Approaches that depend on directed evolution require reliable methods to generate DNA diversity so that mutant libraries can focus on specific target regions. We took advantage of the high frequency of homologous DNA recombination in Saccharomyces cerevisiae to develop a strategy for domain mutagenesis aimed at introducing and in vivo recombining random mutations in defined segments of DNA. Mutagenic Organized Recombination Process by Homologous IN vivo Grouping (MORPHING) is a one-pot random mutagenic method for short protein regions that harnesses the in vivo recombination apparatus of yeast. Using this approach, libraries can be prepared with different mutational loads in DNA segments of less than 30 amino acids so that they can be assembled into the remaining unaltered DNA regions in vivo with high fidelity. As a proof of concept, we present two eukaryotic-ligninolytic enzyme case studies: i) the enhancement of the oxidative stability of a H2O2-sensitive versatile peroxidase by independent evolution of three distinct protein segments (Leu28-Gly57, Leu149-Ala174 and Ile199-Leu268); and ii) the heterologous functional expression of an unspecific peroxygenase by exclusive evolution of its native 43-residue signal sequence.	[Gonzalez-Perez, David; Molina-Espeja, Patricia; Alcalde, Miguel] CSIC, Inst Catalisis & Petr Quim, Dept Biocatalisis, Madrid, Spain; [Garcia-Ruiz, Eva] Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Catalisis y Petroleoquimica (ICP); University of Illinois System; University of Illinois Urbana-Champaign	Alcalde, M (corresponding author), CSIC, Inst Catalisis & Petr Quim, Dept Biocatalisis, Madrid, Spain.	malcalde@icp.csic.es	Garcia-Ruiz, Eva/J-5502-2017; González Pérez, David/M-2210-2016; Gonzalez-Perez, David/ABI-6737-2020	Garcia-Ruiz, Eva/0000-0001-7965-9948; Alcalde, Miguel/0000-0001-6780-7616; Gonzalez-Perez, David/0000-0001-9613-4705; Molina-Espeja, Patricia/0000-0002-2590-0932	European Comission [Peroxicats-FP7-KBBE-2010-4-26537, Indox-FP7-KBBE-2013-7-613549]; National Project (Evofacel) [BIO2010-19697]	European Comission(European CommissionEuropean Commission Joint Research Centre); National Project (Evofacel)	This work was supported by the European Comission Projects Peroxicats-FP7-KBBE-2010-4-26537 and Indox-FP7-KBBE-2013-7-613549 and the National Project (Evofacel) [BIO2010-19697]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcalde M, 2010, METHODS MOL BIOL, V634, P3, DOI 10.1007/978-1-60761-652-8_1; Alcolombri U, 2011, J MOL BIOL, V411, P837, DOI 10.1016/j.jmb.2011.06.037; Bershtein S, 2008, CURR OPIN CHEM BIOL, V12, P151, DOI 10.1016/j.cbpa.2008.01.027; Bloom JD, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-17; Bloom JD, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-29; Bloom JD, 2009, P NATL ACAD SCI USA, V106, P9995, DOI 10.1073/pnas.0901522106; Cherry JR, 1999, NAT BIOTECHNOL, V17, P379, DOI 10.1038/7939; Cobb RE, 2012, CURR OPIN CHEM BIOL, V16, P285, DOI 10.1016/j.cbpa.2012.05.186; Da Silva NA, 2012, FEMS YEAST RES, V12, P197, DOI 10.1111/j.1567-1364.2011.00769.x; Dalby PA, 2011, CURR OPIN STRUC BIOL, V21, P473, DOI 10.1016/j.sbi.2011.05.003; Finney-Manchester SP, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt150; Garcia-Ruiz E, 2012, BIOCHEM J, V441, P487, DOI 10.1042/BJ20111199; Goldsmith M, 2013, METHOD ENZYMOL, V523, P257, DOI 10.1016/B978-0-12-394292-0.00012-6; Gonzalez-Perez D, 2012, BIOENGINEERED, V3, P172, DOI 10.4161/bbug.19544; Gupta RD, 2008, NAT METHODS, V5, P939, DOI 10.1038/nmeth.1262; Herman A, 2007, PROTEIN ENG DES SEL, V20, P219, DOI 10.1093/protein/gzm014; Hidalgo A, 2008, PROTEIN ENG DES SEL, V21, P567, DOI 10.1093/protein/gzn034; Hofrichter M, 2006, APPL MICROBIOL BIOT, V71, P276, DOI 10.1007/s00253-006-0417-3; Hofrichter M, 2010, APPL MICROBIOL BIOT, V87, P871, DOI 10.1007/s00253-010-2633-0; Hong KK, 2012, CELL MOL LIFE SCI, V69, P2671, DOI 10.1007/s00018-012-0945-1; Kitajima S, 2008, BIOCHEM BIOPH RES CO, V372, P918, DOI 10.1016/j.bbrc.2008.05.160; Krivoruchko A, 2011, BIOTECHNOL J, V6, P262, DOI 10.1002/biot.201000308; Lutz S, 2010, CURR OPIN BIOTECH, V21, P734, DOI 10.1016/j.copbio.2010.08.011; Miyazaki-Imamura C, 2003, PROTEIN ENG, V16, P423, DOI 10.1093/protein/gzg054; Nevoigt E, 2008, MICROBIOL MOL BIOL R, V72, P379, DOI 10.1128/MMBR.00025-07; Ostrov Nili, 2013, Methods Mol Biol, V978, P187, DOI 10.1007/978-1-62703-293-3_14; Pecyna MJ, 2009, APPL MICROBIOL BIOT, V84, P885, DOI 10.1007/s00253-009-2000-1; Peisajovich SG, 2007, NAT METHODS, V4, P991, DOI 10.1038/nmeth1207-991; POMPON D, 1989, GENE, V83, P15, DOI 10.1016/0378-1119(89)90399-5; Reetz MT, 2007, NAT PROTOC, V2, P891, DOI 10.1038/nprot.2007.72; Reetz MT, 2005, ANGEW CHEM INT EDIT, V44, P4192, DOI 10.1002/anie.200500767; Romero PA, 2009, NAT REV MOL CELL BIO, V10, P866, DOI 10.1038/nrm2805; Ruiz-Duenas FJ, 2009, J EXP BOT, V60, P441, DOI 10.1093/jxb/ern261; Ryan BJ, 2007, BIOCHIMIE, V89, P1029, DOI 10.1016/j.biochi.2007.03.013; Shao ZY, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn991; Shivange AV, 2009, CURR OPIN CHEM BIOL, V13, P19, DOI 10.1016/j.cbpa.2009.01.019; Tracewell CA, 2009, CURR OPIN CHEM BIOL, V13, P3, DOI 10.1016/j.cbpa.2009.01.017; Valderrama B, 2002, CHEM BIOL, V9, P555, DOI 10.1016/S1074-5521(02)00149-7; Voloshchuk N, 2010, MOL BIOSYST, V6, P65, DOI 10.1039/b909200p; Wang TW, 2012, APPL MICROBIOL BIOT, V93, P1853, DOI 10.1007/s00253-012-3920-8; Wingler LM, 2011, P NATL ACAD SCI USA, V108, P15135, DOI 10.1073/pnas.1100507108; Wong TS, 2007, ENVIRON MICROBIOL, V9, P2645, DOI 10.1111/j.1462-2920.2007.01411.x; Wong TS, 2006, COMB CHEM HIGH T SCR, V9, P271, DOI 10.2174/138620706776843192; Zumarraga M, 2008, PROTEINS, V71, P250, DOI 10.1002/prot.21699	44	39	44	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e90919	10.1371/journal.pone.0090919	http://dx.doi.org/10.1371/journal.pone.0090919			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614282	Green Published, gold, Green Submitted			2022-12-27	WOS:000332839300054
J	Pan, D; Song, YL; Zeng, ZG; Bravery, BD				Pan, Duo; Song, Yan-Ling; Zeng, Zhi-Gao; Bravery, Benjamin D.			Habitat Selection by Eld's Deer following Relocation to a Patchy Landscape	PLOS ONE			English	Article							SPATIAL SEXUAL SEGREGATION; HUMAN DISTURBANCE; CERVUS-ELDI; HOME-RANGE; BEHAVIORAL-RESPONSES; PREDATION RISK; HAINAN ISLAND; DAMA-DAMA; MULE DEER; REINDEER	An emerging issue in wildlife conservation is the re-establishment of viable populations of endangered species in suitable habitats. Here, we studied habitat selection by a population of Hainan Eld's deer (Cervus eldi) relocated to a patchy landscape of farmland and forest. Hainan Eld's deer were pushed to the brink of extinction in the 1970s, but their population expanded rapidly from 26 to more than 1000 individuals by 2003 through effective reserve protection. As part of a wider relocation and population management strategy, 131 deer were removed from the reserve and reintroduced into a farmland-forest landscape in 2005. Habitat use under a context of human disturbance was surveyed by monitoring 19 radio-collared animals. The majority of deer locations (77%) were within 0.6-2 km of villages. Annual home ranges of these collared deer averaged 725 ha (SD 436), which was 55% of the size of the reserve from which they had originated. The annual home ranges contained 54% shrub-grassland, 26% forest and 15% farmland. The relocated deer population selected landscape comprising slash-and-burn agriculture and forest, and avoided both intensively farmed areas and areas containing only forest. Within the selected landscape, deer preferred swiddens and shrub-grasslands. Forests above 300 m in elevation were avoided, whereas forests below 300 m in elevation were overrepresented during the dry season and randomly used during the wet season. Our findings show that reintroduced deer can utilize disturbed habitats, and further demonstrate that subsistence agroforest ecosystems have the capacity to sustain endangered ungulates.	[Pan, Duo; Song, Yan-Ling; Zeng, Zhi-Gao] Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China; [Bravery, Benjamin D.] Kexue Commun, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS	Zeng, ZG (corresponding author), Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China.	zengzhg@ioz.ac.cn			National Natural Science Foundation of China [30770320, 30470260]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (Grants 30770320 and 30470260) http://www.nsfc.gov.cn/Portal0/default152.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apollonio M, 2005, J MAMMAL, V86, P937, DOI 10.1644/1545-1542(2005)86[937:LIOHPO]2.0.CO;2; Arroyo B, 2006, BIOL CONSERV, V128, P276, DOI 10.1016/j.biocon.2005.09.035; Aung M, 2001, J MAMMAL, V82, P836, DOI 10.1644/1545-1542(2001)082<0836:EASOOA>2.0.CO;2; Basille M, 2009, ECOGRAPHY, V32, P683, DOI 10.1111/j.1600-0587.2009.05712.x; Beale CM, 2004, J APPL ECOL, V41, P335, DOI 10.1111/j.0021-8901.2004.00900.x; BERGER J, 1983, BIOL CONSERV, V25, P193, DOI 10.1016/0006-3207(83)90036-8; Blumstein DT, 2005, P ROY SOC B-BIOL SCI, V272, P1663, DOI 10.1098/rspb.2005.3147; Bonenfant M, 1996, BEHAV ECOL, V7, P299, DOI 10.1093/beheco/7.3.299; Boroski BB, 1998, J ARID ENVIRON, V38, P561, DOI 10.1006/jare.1997.0351; Caro TM, 2000, PRIORITIES CONSERVAT, V3, P221; CASSIRER EF, 1992, WILDLIFE SOC B, V20, P375; Ciuti S, 2004, BEHAV ECOL SOCIOBIOL, V56, P552, DOI 10.1007/s00265-004-0819-0; de la Torre S, 2000, BIOL CONSERV, V94, P153, DOI 10.1016/S0006-3207(99)00183-4; DIXON KR, 1980, ECOLOGY, V61, P1040, DOI 10.2307/1936821; Drake D, 2005, J ETENSION, V43, p1RIB5; Dwyer CM, 2004, ANIM WELFARE, V13, P269; Fowler GS, 1999, BIOL CONSERV, V90, P143, DOI 10.1016/S0006-3207(99)00026-9; Frid A, 2002, CONSERV ECOL, V6; Fu M., 2013, CHIN WILDL, V34, P40; GEIST V, 1971, OILWEEK, V22, P12; GRIFFITH B, 1988, WILDLIFE SOC B, V16, P206; Harveson PM, 2007, BIOL CONSERV, V134, P321, DOI 10.1016/j.biocon.2006.07.022; Hewison AJM, 2001, CAN J ZOOL, V79, P679, DOI 10.1139/cjz-79-4-679; Jayakody S, 2008, WILDLIFE BIOL, V14, P81, DOI 10.2981/0909-6396(2008)14[81:RDCEVB]2.0.CO;2; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Kerley LL, 2002, CONSERV BIOL, V16, P97, DOI 10.1046/j.1523-1739.2002.99290.x; Kuss FR, 1990, VISITOR IMPACT MANAG; LAGORY KE, 1987, ANIM BEHAV, V35, P20, DOI 10.1016/S0003-3472(87)80206-3; MACARTHUR RA, 1982, J WILDLIFE MANAGE, V46, P351, DOI 10.2307/3808646; MADSEN J, 1994, IBIS, V137, P567; Manly B.F.J., 2002, RESOURCE SELECTION A; McShea WJ, 1999, ANIM CONSERV, V2, P173, DOI 10.1111/j.1469-1795.1999.tb00063.x; McShea WJ, 2005, BIOL CONSERV, V125, P101, DOI 10.1016/j.biocon.2005.03.013; McShea WJ, 2001, J MAMMAL, V82, P848, DOI 10.1644/1545-1542(2001)082&lt;0848:FHUASS&gt;2.0.CO;2; Naughton-Treves L, 2005, ANNU REV ENV RESOUR, V30, P219, DOI 10.1146/annurev.energy.30.050504.164507; Naughton-Treves L, 2003, CONSERV BIOL, V17, P1106, DOI 10.1046/j.1523-1739.2003.02045.x; Nellemann C, 2000, ARCTIC, V53, P9; Pan D, 2011, AMBIO, V40, P60, DOI 10.1007/s13280-010-0108-2; Phillips GE, 2000, J WILDLIFE MANAGE, V64, P521, DOI 10.2307/3803250; Powell RA, 2000, METH C CONS, P65; Sawyer H, 2006, J WILDLIFE MANAGE, V70, P396, DOI 10.2193/0022-541X(2006)70[396:WHSOMD]2.0.CO;2; Schaefer JA, 2007, J WILDLIFE MANAGE, V71, P1753, DOI 10.2193/2005-479; Seaman DE, 1996, ECOLOGY, V77, P2075, DOI 10.2307/2265701; Song Yan-Ling, 1992, Acta Zoologica Sinica, V38, P165; Song YL, 2003, MAMMALIA, V67, P47, DOI 10.1515/mamm.2003.67.1.47; Stankowich T, 2008, BIOL CONSERV, V141, P2159, DOI 10.1016/j.biocon.2008.06.026; Timmins R., 2008, IUCN 2012 IUCN RED L; Trombulak SC, 2000, CONSERV BIOL, V14, P18, DOI 10.1046/j.1523-1739.2000.99084.x; Vistnes I, 2001, J WILDLIFE MANAGE, V65, P915, DOI 10.2307/3803040; Vistnes I, 2008, POLAR BIOL, V31, P399, DOI 10.1007/s00300-007-0377-9; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; [王伯荪 Wang Bosun], 2002, [广西植物, Guihaia], V22, P107; Wang Li-bing, 2010, Sichuan Journal of Zoology, V29, P929; West BC, 2002, WILDLIFE SOC B, V30, P139; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; Xu L. H., 1983, BIRDS MAMMALS HAINAN, P398; YUAN XC, 1990, J NORTHEAST FOR UNIV, V0018, P00066; Zeng ZG, 2005, FOLIA ZOOL, V54, P249; Zeng ZG, 2011, MAMMALIA, V75, P143, DOI 10.1515/MAMM.2011.006; Zhang Qiong, 2009, Acta Theriologica Sinica, V20, P365	60	7	7	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91158	10.1371/journal.pone.0091158	http://dx.doi.org/10.1371/journal.pone.0091158			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614039	gold, Green Published, Green Submitted			2022-12-27	WOS:000332839300085
J	Quets, JJ; Temmerman, S; El-Bana, MI; Al-Rowaily, SL; Assaeed, AM; Nijs, I				Quets, Jan J.; Temmerman, Stijn; El-Bana, Magdy I.; Al-Rowaily, Saud L.; Assaeed, Abdulaziz M.; Nijs, Ivan			Use of Spatial Analysis to Test Hypotheses on Plant Recruitment in a Hyper-Arid Ecosystem	PLOS ONE			English	Article							ARTEMISIA SPECIES ASTERACEAE; PHYTOGENIC MOUNDS NEBKHAS; POINT PATTERN-ANALYSIS; SAND BURIAL DEPTH; SOIL SEED BANK; SAUDI-ARABIA; SOUTHEASTERN SPAIN; WIND EROSION; DESERT; GERMINATION	Mounds originating from wind-blown sediment accumulation beneath vegetation (nebkhas) often indicate land degradation in dry areas. Thus far, most nebkha research has focused on individual plants. Here, we aimed to explore population-scale processes (up to scales of about 100 m) that might explain an observed nebkha landscape pattern. We mapped the Rhazya stricta Decne. population in a 3 ha study site in a hyper-arid region of Saudi Arabia. We compared the spatial patterns of five different cohorts (age classes) of observed nebkha host plants to those expected under several hypothesized drivers of recruitment and intraspecific interaction. We found that all R. stricta cohorts had a limited fractional vegetation cover and established in large-scale clusters. This clustering weakened with cohort age, possibly indicating merging of neighboring vegetation patches. Different cohort clusters did not spatially overlap in most cases, indicating that recruitment patterns changed position over time. Strong indications were found that the main drivers underlying R. stricta spatial configurations were allogenic (i.e. not driven by vegetation) and dynamic. Most likely these drivers were aeolian-driven sand movement or human disturbance which forced offspring recruitment in spatially dynamic clusters. Competition and facilitation were likely active on the field site too, but apparently had a limited effect on the overall landscape structure.	[Quets, Jan J.; Nijs, Ivan] Univ Antwerp, Dept Biol, Plant & Vegetat Ecol PLECO, Antwerp, Belgium; [Temmerman, Stijn] Univ Antwerp, Dept Biol, Antwerp, Belgium; [El-Bana, Magdy I.] Port Said Univ, Fac Sci, Dept Bot, Port Said, Egypt; [Al-Rowaily, Saud L.; Assaeed, Abdulaziz M.] King Saud Univ, Dept Plant Prod, Coll Agr, Riyadh, Saudi Arabia	University of Antwerp; University of Antwerp; Egyptian Knowledge Bank (EKB); Port Said University; King Saud University	Quets, JJ (corresponding author), Univ Antwerp, Dept Biol, Plant & Vegetat Ecol PLECO, Antwerp, Belgium.	Jan.Quets@uantwerpen.be	Temmerman, Stijn/C-5521-2009; El-Bana, Magdy/AAV-3834-2020	El-Bana, Magdy/0000-0003-0493-0208; Nijs, Ivan/0000-0003-3111-680X; Temmerman, Stijn/0000-0003-3346-9115; Assaeed, Abdulaziz/0000-0002-6639-5178	National Plan for Science and Technology, Saudi Arabia [ENV 1471]	National Plan for Science and Technology, Saudi Arabia	The work was funded by the National Plan for Science and Technology, Saudi Arabia (http://npst.ksu.edu.sa/index.php?page_id=101), through research project No. ENV 1471. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Rowaily SL, 2012, CATENA, V97, P41, DOI 10.1016/j.catena.2012.05.004; Alyemeni MN, 2002, KUWAIT J SCI ENG, V29, P111; Assaeed A. M., 1997, Annals of Agricultural Science (Cairo), V42, P159; Assaeed AM, 2002, ARID LAND RES MANAG, V16, P83, DOI 10.1080/153249802753365340; Baddeley A, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i06; Bagnold R.A., 2005, PHYS BLOWN SAND DESE, P1; Barbier N, 2010, LANDSCAPE ECOL, V25, P889, DOI 10.1007/s10980-010-9466-1; Barot S, 1999, ECOLOGY, V80, P1987, DOI 10.1890/0012-9658(1999)080[1987:DOASPT]2.0.CO;2; Barth HJ, 1999, J ARID ENVIRON, V43, P399, DOI 10.1006/jare.1999.0564; Batanouny KH, 2001, PLANTS DESERTS MIDDL; Berndtsson R, 1996, J HYDROL, V185, P221, DOI 10.1016/0022-1694(95)02987-7; Callaway RM, 1997, OECOLOGIA, V112, P143, DOI 10.1007/s004420050293; Chen H, 1999, PLANT ECOL, V140, P53, DOI 10.1023/A:1009779613847; Clark CJ, 2007, AM NAT, V170, P128, DOI 10.1086/518565; Cooke R.U., 1993, DESERT GEOMORPHOLOGY; Danin A., 1996, PLANTS DESERT DUNES, DOI [10.1007/978-3-642-60975-6, DOI 10.1007/978-3-642-60975-6]; Deblauwe V, 2008, GLOBAL ECOL BIOGEOGR, V17, P715, DOI 10.1111/j.1466-8238.2008.00413.x; Diggle PJ, 1983, STAT ANAL SPATIAL PO; Du JH, 2010, J GEOGR SCI, V20, P712, DOI 10.1007/s11442-010-0806-5; Duncan RP, 2009, ECOLOGY, V90, P2129, DOI 10.1890/08-1436.1; El-Bana MI, 2003, RESTOR ECOL, V11, P317, DOI 10.1046/j.1526-100X.2003.00222.x; El-Bana MI, 2002, PLANT SOIL, V247, P283, DOI 10.1023/A:1021548711206; ERIKSSON O, 1992, OECOLOGIA, V91, P360, DOI 10.1007/BF00317624; Fedriani JM, 2010, ECOGRAPHY, V33, P545, DOI 10.1111/j.1600-0587.2009.06052.x; Fei P, 2012, ADV MATER RES-SWITZ, V356-360, P2465, DOI 10.4028/www.scientific.net/AMR.356-360.2465; Fenner M., 2000, SEEDS ECOLOGY REGENE; Flores J, 2003, J VEG SCI, V14, P911, DOI 10.1111/j.1654-1103.2003.tb02225.x; FOWLER N, 1986, ANNU REV ECOL SYST, V17, P89, DOI 10.1146/annurev.es.17.110186.000513; FRIEDMAN J, 1971, J ECOL, V59, P775, DOI 10.2307/2258139; FRYREAR DW, 1973, CROP SCI, V13, P622, DOI 10.2135/cropsci1973.0011183X001300060011x; GADZIA JSG, 1983, SOUTHWEST NAT, V28, P89, DOI 10.2307/3670596; GILE LH, 1975, QUATERNARY RES, V5, P321, DOI 10.1016/0033-5894(75)90037-X; Haase P, 1997, J VEG SCI, V8, P627, DOI 10.2307/3237366; Haase P, 1996, J VEG SCI, V7, P527, DOI 10.2307/3236301; He Q, 2013, ECOL LETT, V16, P695, DOI 10.1111/ele.12080; Holmgren M, 2010, J ECOL, V98, P1269, DOI 10.1111/j.1365-2745.2010.01709.x; Holmgren Milena, 1997, Ecology (Washington D C), V78, P1966, DOI 10.1890/0012-9658(1997)078[1966:TIOFAC]2.0.CO;2; Janzen D. H., 1971, A Rev Ecol Syst, V2, P465, DOI 10.1146/annurev.es.02.110171.002341; Kefi S, 2008, AM NAT, V172, pE1, DOI 10.1086/588066; Law R, 2009, J ECOL, V97, P616, DOI 10.1111/j.1365-2745.2009.01510.x; Li XH, 2012, J ARID LAND, V4, P36, DOI 10.3724/SP.J.1227.2012.00036; Liu HL, 2011, PLANT SOIL, V345, P69, DOI 10.1007/s11104-011-0761-7; Loosmore NB, 2006, ECOLOGY, V87, P1925, DOI 10.1890/0012-9658(2006)87[1925:SIUTGO]2.0.CO;2; Maliva R., 2012, ARID LANDS WATER EVA; Marriott FHC., 1979, APPLIED STATISTICS, V28, P75, DOI [DOI 10.2307/2346816, 10.2307/2346816]; MAUN MA, 1994, VEGETATIO, V111, P59; McIntire EJB, 2009, ECOLOGY, V90, P46, DOI 10.1890/07-2096.1; Moustakas A, 2008, ACTA OECOL, V33, P355, DOI 10.1016/j.actao.2008.01.008; Nathan R, 2000, TRENDS ECOL EVOL, V15, P278, DOI 10.1016/S0169-5347(00)01874-7; NICKLING WG, 1994, J ARID ENVIRON, V28, P13, DOI 10.1016/S0140-1963(05)80017-5; Nuske RS, 2009, FOREST ECOL MANAG, V259, P107, DOI 10.1016/j.foreco.2009.09.050; Pillay T, 2012, PLANT ECOL, V213, P1609, DOI 10.1007/s11258-012-0115-4; Poulsen JR, 2007, AM NAT, V170, P167, DOI 10.1086/518945; Quets JJ, 2013, ACTA OECOL, V49, P53, DOI 10.1016/j.actao.2013.03.002; Ren J, 2002, J ARID ENVIRON, V51, P603, DOI 10.1016/S0140-1963(01)90979-6; Reynolds JF, 2007, SCIENCE, V316, P847, DOI 10.1126/science.1131634; Rietkerk M, 2008, TRENDS ECOL EVOL, V23, P169, DOI 10.1016/j.tree.2007.10.013; Shaltout KH, 1996, BIODIVERS CONSERV, V5, P27, DOI 10.1007/BF00056290; Temmerman S, 2007, GEOLOGY, V35, P631, DOI 10.1130/G23502A.1; TENGBERG A, 1995, J ARID ENVIRON, V30, P265, DOI 10.1016/S0140-1963(05)80002-3; Tilman D, 1997, SPATIAL ECOLOGY ROLE; Tobe K, 2006, SEED SCI RES, V16, P61, DOI 10.1079/SSR2005230; Toft CA, 2003, ECOL MONOGR, V73, P605, DOI 10.1890/02-4080; Vincent P, 2008, SAUDI ARABIA ENV OVE; Wang XP, 2007, HYDROL PROCESS, V21, P72, DOI 10.1002/hyp.6185; Warrag MOA, 1995, J ARID ENVIRON, V31, P415, DOI 10.1016/S0140-1963(05)80124-7; Webb RH, 2002, ARID LAND RES MANAG, V16, P291, DOI 10.1080/153249802760284829; Weiner J, 2009, J ECOL, V97, P1220, DOI 10.1111/j.1365-2745.2009.01559.x; Wiegand T, 2004, OIKOS, V104, P209, DOI 10.1111/j.0030-1299.2004.12497.x; Wiegand T, 2006, J ECOL, V94, P825, DOI 10.1111/j.1365-2745.2006.01113.x; WIENS JA, 1976, ANNU REV ECOL SYST, V7, P81, DOI 10.1146/annurev.es.07.110176.000501; WOOD DM, 1990, AM J BOT, V77, P1411, DOI 10.2307/2444751; WU B, 2013, PLOS ONE, V8; WU HI, 1985, ECOL MODEL, V29, P215, DOI 10.1016/0304-3800(85)90054-7; Yu FH, 2008, ANN BOT-LONDON, V102, P571, DOI 10.1093/aob/mcn119; Yura H, 2006, PLANT ECOL, V185, P199, DOI 10.1007/s11258-005-9095-y; ZHANG DY, 1990, ECOL MODEL, V51, P265; Zhao WZ, 2007, PLANT SOIL, V295, P95, DOI 10.1007/s11104-007-9265-x; Zheng M, 2012, J ARID ENVIRON, V85, P105, DOI 10.1016/j.jaridenv.2012.05.006; Zheng YR, 2005, ANN BOT-LONDON, V95, P1237, DOI 10.1093/aob/mci138	80	6	6	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91184	10.1371/journal.pone.0091184	http://dx.doi.org/10.1371/journal.pone.0091184			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614307	Green Submitted, Green Published, gold			2022-12-27	WOS:000332839300092
J	Blanc, G; Mozar, M; Agarkova, IV; Gurnon, JR; Yanai-Balser, G; Rowe, JM; Xia, YN; Riethoven, JJ; Dunigan, DD; Van Etten, JL				Blanc, Guillaume; Mozar, Michael; Agarkova, Irina V.; Gurnon, James R.; Yanai-Balser, Giane; Rowe, Janet M.; Xia, Yuannan; Riethoven, Jean-Jack; Dunigan, David D.; Van Etten, James L.			Deep RNA Sequencing Reveals Hidden Features and Dynamics of Early Gene Transcription in Paramecium bursaria Chlorella Virus 1	PLOS ONE			English	Article							VARIABILIS NC64A; VACCINIA VIRUS; PBCV-1 ENCODES; EARLY PHASE; HOST-CELLS; GREEN-ALGA; INFECTION; GENOME; DEPOLARIZATION; SITE	Paramecium bursaria chlorella virus 1 (PBCV-1) is the prototype of the genus Chlorovirus (family Phycodnaviridae) that infects the unicellular, eukaryotic green alga Chlorella variabilis NC64A. The 331-kb PBCV-1 genome contains 416 major open reading frames. A mRNA-seq approach was used to analyze PBCV-1 transcriptomes at 6 progressive times during the first hour of infection. The alignment of 17 million reads to the PBCV-1 genome allowed the construction of single-base transcriptome maps. Significant transcription was detected for a subset of 50 viral genes as soon as 7 min after infection. By 20 min post infection (p.i.), transcripts were detected for most PBCV-1 genes and transcript levels continued to increase globally up to 60 min p.i., at which time 41% or the poly (A+)-containing RNAs in the infected cells mapped to the PBCV-1 genome. For some viral genes, the number of transcripts in the latter time points (20 to 60 min p.i.) was much higher than that of the most highly expressed host genes. RNA-seq data revealed putative polyadenylation signal sequences in PBCV-1 genes that were identical to the polyadenylation signal AAUAAA of green algae. Several transcripts have an RNA fragment excised. However, the frequency of excision and the resulting putative shortened protein products suggest that most of these excision events have no functional role but are probably the result of the activity of misled splicesomes.	[Blanc, Guillaume; Mozar, Michael] Aix Marseille Univ, CNRS, UMR7256, Lab Informat Struct & Genom, Marseille, France; [Agarkova, Irina V.; Gurnon, James R.; Yanai-Balser, Giane; Rowe, Janet M.; Dunigan, David D.; Van Etten, James L.] Univ Nebraska, Dept Plant Pathol, Lincoln, NE 68583 USA; [Agarkova, Irina V.; Rowe, Janet M.; Dunigan, David D.; Van Etten, James L.] Univ Nebraska, Nebraska Ctr Virol, Lincoln, NE USA; [Xia, Yuannan; Riethoven, Jean-Jack] Univ Nebraska, Ctr Biotechnol, Lincoln, NE USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Blanc, G (corresponding author), Aix Marseille Univ, CNRS, UMR7256, Lab Informat Struct & Genom, Marseille, France.	guillaume.blanc@igs.cnrs-mrs.fr	Blanc, Guillaume/T-6958-2017; Dunigan, David/AAF-1386-2019	Blanc, Guillaume/0000-0001-5728-1104; Goins, Janet/0000-0003-1139-6058; MOZAR, Michael/0000-0002-9592-4083; Dunigan, David D/0000-0001-9496-5396; Riethoven, Jean-Jack/0000-0002-2709-7880	Stanley Medical Research Institute [11R-0001]; NSF-EPSCoR [EPS-1004094]; National Center for Research Resources [P20-RR15635]; National Institute of Allergy and Infectious Diseases [1T32AIO60547]; French Centre National de la Recherche Scientifique; PACA-Bioinfo platform;  [DOE-DE-EE0003142]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015635] Funding Source: NIH RePORTER	Stanley Medical Research Institute; NSF-EPSCoR; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); French Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); PACA-Bioinfo platform; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Academic funding only. This research was partially supported by the Stanley Medical Research Institute 11R-0001, NSF-EPSCoR grant EPS-1004094, DOE-DE-EE0003142 and grant P20-RR15635 from the COBRE program of the National Center for Research Resources. JR was supported by a Ruth L. Kirschstein National Research Service Award 1T32AIO60547 from the National Institute of Allergy and Infectious Diseases. GB and MM were supported by the French Centre National de la Recherche Scientifique and PACA-Bioinfo platform. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarkova I, 2008, J VIROL, V82, P12181, DOI 10.1128/JVI.01687-08; Blanc G, 2010, PLANT CELL, V22, P2943, DOI 10.1105/tpc.110.076406; Broyles SS, 2003, J GEN VIROL, V84, P2293, DOI 10.1099/vir.0.18942-0; Byrne D, 2009, GENOME RES, V19, P1233, DOI 10.1101/gr.091561.109; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dunigan DD, 2012, J VIROL, V86, P8821, DOI 10.1128/JVI.00907-12; Dunigan DD, 2006, VIRUS RES, V117, P119, DOI 10.1016/j.virusres.2006.01.024; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fitzgerald LA, 2008, VIROLOGY, V380, P388, DOI 10.1016/j.virol.2008.07.025; Fitzgerald LA, 2007, VIROLOGY, V362, P350, DOI 10.1016/j.virol.2006.12.028; Fitzgerald LA, 2007, VIROLOGY, V358, P459, DOI 10.1016/j.virol.2006.08.034; Frohns F, 2006, J VIROL, V80, P2437, DOI 10.1128/JVI.80.5.2437-2444.2006; Furuta M, 1997, APPL ENVIRON MICROB, V63, P1551, DOI 10.1128/AEM.63.4.1551-1556.1997; GRABHERR R, 1992, VIROLOGY, V188, P721, DOI 10.1016/0042-6822(92)90527-V; Graves MV, 1999, VIROLOGY, V257, P15, DOI 10.1006/viro.1999.9628; Greiner T, 2009, J GEN VIROL, V90, P2033, DOI 10.1099/vir.0.010629-0; Iyer LA, 2006, VIRUS RES, V117, P156, DOI 10.1016/j.virusres.2006.01.009; Iyer LM, 2001, J VIROL, V75, P11720, DOI 10.1128/JVI.75.23.11720-11734.2001; Jeanniard A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-158; Kaiser A, 1999, VIROLOGY, V263, P254, DOI 10.1006/viro.1999.9972; Kawasaki T, 2004, VIROLOGY, V318, P214, DOI 10.1016/j.virol.2003.09.015; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Li Y, 1997, VIROLOGY, V237, P360, DOI 10.1006/viro.1997.8805; MEINTS RH, 1986, VIROLOGY, V154, P240, DOI 10.1016/0042-6822(86)90448-4; MEINTS RH, 1984, VIROLOGY, V138, P341, DOI 10.1016/0042-6822(84)90358-1; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Neupartl M, 2008, VIROLOGY, V372, P340, DOI 10.1016/j.virol.2007.10.024; Onimatsu H, 2006, VIROLOGY, V353, P433, DOI 10.1016/j.virol.2006.06.010; Rowe JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090988; Rowe JM, 2013, VIROLOGY, V442, P101, DOI 10.1016/j.virol.2013.04.018; SCHUSTER AM, 1986, VIROLOGY, V148, P181, DOI 10.1016/0042-6822(86)90413-7; SCHUSTER AM, 1990, VIROLOGY, V176, P515, DOI 10.1016/0042-6822(90)90021-I; STRASSER P, 1991, VIROLOGY, V180, P763, DOI 10.1016/0042-6822(91)90089-T; Sun LW, 1999, VIROLOGY, V263, P376, DOI 10.1006/viro.1999.9958; Thiel G, 2010, PROG BOT, V71, P169, DOI 10.1007/978-3-642-02167-1_7; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; VANETTEN JL, 1983, VIROLOGY, V126, P117, DOI 10.1016/0042-6822(83)90466-X; Wilson WH, 2009, CURR TOP MICROBIOL, V328, P1; Wodniok S, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-65; YAMADA T, 1994, NUCLEIC ACIDS RES, V22, P2532, DOI 10.1093/nar/22.13.2532; Yanai-Balser GM, 2010, J VIROL, V84, P532, DOI 10.1128/JVI.01698-09; Yang ZL, 2010, P NATL ACAD SCI USA, V107, P11513, DOI 10.1073/pnas.1006594107; Yutin N, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-223; Zhang XZ, 2011, P NATL ACAD SCI USA, V108, P14837, DOI 10.1073/pnas.1107847108	44	28	28	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90989	10.1371/journal.pone.0090989	http://dx.doi.org/10.1371/journal.pone.0090989			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608750	Green Published, gold, Green Submitted			2022-12-27	WOS:000332485800075
J	Danielsen, AK; Rosenberg, J				Danielsen, Anne Kjaergaard; Rosenberg, Jacob			Health Related Quality of Life May Increase when Patients with a Stoma Attend Patient Education - A Case-Control Study	PLOS ONE			English	Article							OSTOMY ADJUSTMENT SCALE; VALIDITY; PROGRAM; IMPACT	Introduction: Adaptation to living with a stoma is complex, and studies have shown that stoma creation has a great impact on patients' health related quality of life. The objective was to explore the effect of a structured patient education program on health related quality of life. Therefore, we implemented interventions aimed at increasing health related quality of life during and after hospital admission. Materials and Methods: We designed a case/control study aimed at adult patients admitted to the surgical ward for stoma creation, irrespective of type of stoma or reason for creation of stoma. We included 50 patients in the study. Health related quality of life was measured before hospital discharge, three months and six months after stoma creation. The program included educational interventions involving lay-teachers, alongside health professional teachers. Results: We found a significant rise in health related quality of life in the intervention group (P < 0.001) and no significant change in the control group (P = 0.144). However, we found no significant differences when comparing between groups at 3 and 6 months (p = 0.12 and p = 0.63, respective). Additionally, there were differences in scores in health related quality of life baseline (p = 0.045) with lower scores in the intervention group compared with the intervention group. However, there were no significant differences in the demographic variables at baseline Conclusions: Educational activities aimed at increase in knowledge and focusing on patients' psychosocial needs may lead to a rise in patients' health related quality of life. When patients with a stoma attend a structured patient education program it is possible to improve their health related quality of life compared with patients with a stoma, who do not attend the program.	[Danielsen, Anne Kjaergaard; Rosenberg, Jacob] Univ Copenhagen, Herlev Hosp, Dept Surg, Copenhagen, Denmark	University of Copenhagen; Herlev & Gentofte Hospital	Danielsen, AK (corresponding author), Univ Copenhagen, Herlev Hosp, Dept Surg, Copenhagen, Denmark.	anne.k.danielsen@gmail.com		Rosenberg, Jacob/0000-0002-0063-1086; Danielsen, Anne/0000-0003-0507-0887	Soster Inge Marie Dahlgaards Fond, Diakonissestiftelsen, Denmark; Aase and Ejnar Danielsens Foundation, Denmark	Soster Inge Marie Dahlgaards Fond, Diakonissestiftelsen, Denmark; Aase and Ejnar Danielsens Foundation, Denmark	The study received financial support from Soster Inge Marie Dahlgaards Fond, Diakonissestiftelsen, Denmark, and by Aase and Ejnar Danielsens Foundation, Denmark. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acquadro C, 2004, VALUE HEALTH, V11, P509; Altuntas YE, 2012, EUR J CANCER CARE, V21, P776, DOI 10.1111/j.1365-2354.2012.01360.x; Bjorner JB, 1998, J CLIN EPIDEMIOL, V51, P991, DOI 10.1016/S0895-4356(98)00091-2; Brown H, 2005, J CLIN NURS, V14, P74, DOI 10.1111/j.1365-2702.2004.00945.x; BURCKHARDT CS, 1990, REHABIL PSYCHOL, V35, P149, DOI 10.1037/h0079056; Chaudhri S, 2005, DIS COLON RECTUM, V48, P504, DOI 10.1007/s10350-004-0897-0; Danielsen AK, 2013, COLORECTAL DIS, V15, pE276, DOI 10.1111/codi.12197; Danielsen AK, 2013, DAN MED J IN PRESS; Danielsen AK, 2013, J CLIN NURS, V22, P1343, DOI 10.1111/jocn.12011; Danielsen AK, 2013, J WOUND OSTOMY CONT, V40, P407, DOI 10.1097/WON.0b013e3182987e0e; Emanuel EJ, 2000, JAMA-J AM MED ASSOC, V283, P2701, DOI 10.1001/jama.283.20.2701; Johansson K, 2004, CLIN EFF NURS, V8, P81; Johansson K, 2010, J CLIN NURS, V19, P2980, DOI 10.1111/j.1365-2702.2010.03347.x; Lo SF, 2011, J ADV NURS, V67, P68, DOI 10.1111/j.1365-2648.2010.05455.x; Lo SF, 2010, J CLIN NURS, V19, P1844, DOI 10.1111/j.1365-2702.2009.02931.x; Maruish ME, 2009, GUIDE INTEGRATION CE; Nugent KP, 1999, DIS COLON RECTUM, V42, P1569, DOI 10.1007/BF02236209; OLBRISCH ME, 1983, REHABIL PSYCHOL, V28, P3, DOI 10.1037/h0090996; Olsen AG, 2011, SYGEPLEJERSKEN, V21, P78; Persson Eva, 2002, J Wound Ostomy Continence Nurs, V29, P103, DOI 10.1067/mjw.2002.122053; SPRANGERS MAG, 1995, DIS COLON RECTUM, V38, P361, DOI 10.1007/BF02054222; Suhonen R, 2003, Int Nurs Rev, V50, P85, DOI 10.1046/j.1466-7657.2003.00168.x	22	30	30	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90354	10.1371/journal.pone.0090354	http://dx.doi.org/10.1371/journal.pone.0090354			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC4IY	24609004	Green Submitted, Green Published, gold			2022-12-27	WOS:000332485800021
J	Kong, FF; Ying, HM; Du, CR; Huang, S; Zhou, JJ; Hu, CS				Kong, Fang-fang; Ying, Hongmei; Du, Cheng-run; Huang, Shuang; Zhou, Jun-jun; Hu, Chao-su			Effectiveness and Toxicities of Intensity-Modulated Radiation Therapy for Patients with T4 Nasopharyngeal Carcinoma	PLOS ONE			English	Article							CLINICAL-OUTCOMES; PHASE-II; RADIOTHERAPY; CISPLATIN; EXPERIENCE; DOCETAXEL; PATTERNS; FAILURE; PLANS	Objective: To evaluate the effectiveness and toxicities in T4 nasopharyngeal carcinoma (NPC) using intensity-modulated radiotherapy (IMRT) combined with chemotherapy. Methods: This is a retrospective analysis of 81 patients treated with intensity-modulated radiotherapy (IMRT). All the primary tumors were attributed to T4 stage according to the AJCC2010 staging system. And the distribution of disease by N stage was N0 in 13.6%, N1 in 30.9%, N2 in 37%, and N3 in 18.5%. Cisplatin-based chemotherapy was offered to all patients. Radiotherapy-related toxicities were graded according to the Acute and the Late Radiation Morbidity Scoring Criteria of the Radiation Therapy Oncology Group (RTOG) scoring criteria. Chemotherapy-related toxicities were graded by National Cancer Institute Common Toxicity Criteria (NCI-CTC) version 3.0. Prognostic factors were assessed by univariate analysis. Results: With a median follow-up of 37 months, 12 patients experienced local regional failure and total distant metastasis occurred in 18 patients, representing the major mode of failure. Ten patients died. Among them, 70% died of distant metastasis. The 3-year actuarial rates of local failure-free survival (LFFS), regional failure-free survival (RFFS), distant failure-free survival (DFFS), overall survival (OS), and progression-free survival (PFS) were 83.8%, 97.4%, 81.3%, 90%, and 69.7%, respectively. Acute and late toxicities were mild or moderate. Conclusions: IMRT provides excellent local-regional control for T4 NPC. Distant metastasis remains the major cause of treatment failure. Further explorations of the sequence and regimen of systemic therapy are needed in the future.	[Kong, Fang-fang; Ying, Hongmei; Du, Cheng-run; Huang, Shuang; Zhou, Jun-jun; Hu, Chao-su] Fudan Univ, Dept Radiat Oncol, Shanghai Canc Ctr, Shanghai 200433, Peoples R China; [Kong, Fang-fang; Ying, Hongmei; Du, Cheng-run; Huang, Shuang; Zhou, Jun-jun; Hu, Chao-su] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Ying, HM (corresponding author), Fudan Univ, Dept Radiat Oncol, Shanghai Canc Ctr, Shanghai 200433, Peoples R China.	yinghongmei2013@163.com		Hu, Chaosu/0000-0002-6503-0951; Hu, Chaosu/0000-0001-7697-5224				Anne W, 1998, INT J RADIAT ONCOL, V40, P35; Cao CN, 2013, ORAL ONCOL, V49, P175, DOI 10.1016/j.oraloncology.2012.08.013; Cheng JCH, 2001, INT J CANCER, V96, P126, DOI 10.1002/ijc.1004; Du CR, 2013, INT J CLIN ONCOL, V18, P464, DOI 10.1007/s10147-012-0403-y; Hui EP, 2009, J CLIN ONCOL, V27, P242, DOI 10.1200/JCO.2008.18.1545; Hunt MA, 2001, INT J RADIAT ONCOL, V49, P623, DOI 10.1016/S0360-3016(00)01389-4; Kam MKM, 2003, INT J RADIAT ONCOL, V56, P145, DOI 10.1016/S0360-3016(03)00075-0; Kwong DLW, 2004, CANCER, V101, P1584, DOI 10.1002/cncr.20552; Lee AWM, 2004, CLIN ONCOL-UK, V16, P269, DOI 10.1016/j.clon.2004.01.008; Lee AWM, 2002, INT J RADIAT ONCOL, V53, P75, DOI 10.1016/S0360-3016(02)02711-6; Lu HM, 2008, CANCER TREAT REV, V34, P27, DOI 10.1016/j.ctrv.2007.08.004; Ma BBY, 2012, ANN ONCOL, V23, P1287, DOI 10.1093/annonc/mdr401; Ng WT, 2011, INT J RADIAT ONCOL, V79, P420, DOI 10.1016/j.ijrobp.2009.11.024; Sanguineti G, 1997, INT J RADIAT ONCOL, V37, P985, DOI 10.1016/S0360-3016(97)00104-1; Su SF, 2012, INT J RADIAT ONCOL, V82, P327, DOI 10.1016/j.ijrobp.2010.09.011; Teo P, 1996, INT J RADIAT ONCOL, V36, P291, DOI 10.1016/S0360-3016(96)00323-9; Xia P, 2000, INT J RADIAT ONCOL, V48, P329, DOI 10.1016/S0360-3016(00)00585-X; Xiao WW, 2011, CANCER-AM CANCER SOC, V117, P1874, DOI 10.1002/cncr.25754; Xu TT, 2012, MED ONCOL, V29, P272, DOI 10.1007/s12032-010-9803-x; Yi JL, 2006, INT J RADIAT ONCOL, V65, P161, DOI 10.1016/j.ijrobp.2005.12.003	20	14	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91362	10.1371/journal.pone.0091362	http://dx.doi.org/10.1371/journal.pone.0091362			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608637	Green Published, Green Submitted, gold			2022-12-27	WOS:000332485800130
J	Suhling, H; Rademacher, J; Zinowsky, I; Fuge, J; Greer, M; Warnecke, G; Smits, JM; Bertram, A; Haverich, A; Welte, T; Gottlieb, J				Suhling, Hendrik; Rademacher, Jessica; Zinowsky, Imke; Fuge, Jan; Greer, Mark; Warnecke, Gregor; Smits, Jacqueline M.; Bertram, Anna; Haverich, Axel; Welte, Tobias; Gottlieb, Jens			Conventional vs. Tablet Computer-Based Patient Education following Lung Transplantation - A Randomized Controlled Trial	PLOS ONE			English	Article							BRONCHIOLITIS OBLITERANS SYNDROME; RISK-FACTORS; MEDICATION-ADHERENCE; HAND-HELD; MANAGEMENT; RECIPIENTS; THERAPY; IMMUNOSUPPRESSION; REJECTION; CHILDREN	Background: Accurate immunosuppression is of critical importance in preventing rejection, while avoiding toxicity following lung transplantation. The mainstay immunosuppressants are calcineurin inhibitors, which require regular monitoring due to interactions with other medications and diet. Adherence to immunosuppression and patient knowledge is vital and can be improved through patient education. Education using tablet-computers was investigated. Objective: To compare tablet-PC education and conventional education in improving immunosuppression trough levels in target range 6 months after a single education. Secondary parameters were ratio of immunosuppression level measurements divided by per protocol recommended measurements, time and patient satisfaction regarding education. Design: Single-centre, open labelled randomised controlled trial. Participants: Patients >6 months after lung-transplantation with <50% of calcineurin inhibitor trough levels in target range. Intervention: Tablet-pc education versus personal, nurse-led education. Measurements: Calcineurin inhibitor levels in target range 6 months after education, level variability, interval adherence, knowledge and adherence was studied. As outcome parameter, renal function was measured and adverse events registered. Results: Sixty-four patients were 1: 1 randomised for either intervention. Levels of immunosuppression 6 months after education were equal (tablet-PC 58% vs. conventional 48%, p = 0.27), both groups improved in achieving a CNI trough level within target range by either education method (delta tablet-PC 29% vs. conventional 20%). In all patients, level variability decreased (-20.4%), whereas interval adherence remained unchanged. Knowledge about immunosuppression improved by 7% and compliance tests demonstrated universal improvements with no significant difference between groups. Conclusion: Education is a simple, effective tool in improving adherence to immunosuppression. Tablet-PC education was non-inferior to conventional education.	[Suhling, Hendrik; Rademacher, Jessica; Zinowsky, Imke; Fuge, Jan; Greer, Mark; Welte, Tobias; Gottlieb, Jens] Hannover Med Sch, Dept Resp Med, Hannover, Germany; [Warnecke, Gregor; Haverich, Axel] Hannover Med Sch, Dept Cardiothorac Transplantat & Vasc Surg, Hannover, Germany; [Smits, Jacqueline M.] Eurotransplant Int Fdn, Leiden, Netherlands; [Bertram, Anna] Hannover Med Sch, Dept Hypertens & Nephrol, Hannover, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School	Suhling, H (corresponding author), Hannover Med Sch, Dept Resp Med, Hannover, Germany.	suhling.hendrik@mh-hannover.de	Haverich, Axel/AAC-7552-2022; Rademacher, Jessica/ABG-1898-2020	Gottlieb, Prof. Jens/0000-0002-9540-9022; Greer, Mark/0000-0003-3234-306X; Fuge, Jan/0000-0003-2926-3608				Arsham G M, 1979, Annu Conf Res Med Educ, V18, P407; Best NG, 1996, TRANSPLANTATION, V62, P1429, DOI 10.1097/00007890-199611270-00009; Bosma OH, 2011, J HEART LUNG TRANSPL, V30, P1275, DOI 10.1016/j.healun.2011.05.007; Chisholm MA, 2005, NEPHROL DIAL TRANSPL, V20, P181, DOI 10.1093/ndt/gfh576; CLARK NM, 1981, HEALTH EDUC QUART, V8, P166, DOI 10.1177/109019818100800203; Dabbs AD, 2009, CLIN TRANSPLANT, V23, P537, DOI 10.1111/j.1399-0012.2009.00992.x; De Bleser L, 2009, TRANSPL INT, V22, P780, DOI 10.1111/j.1432-2277.2009.00881.x; Deakin T, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003417.pub2; Del Tacca M, 2004, TRANSPLANT P, V36, P687, DOI 10.1016/j.transproceed.2004.03.011; Delgado PL, 2000, J CLIN PSYCHIAT, V61, P6; Dew MA, 2008, TRANSPLANTATION, V85, P193, DOI 10.1097/TP.0b013e318160135f; Dharancy S, 2012, CLIN TRANSPLANT, V26, pE293, DOI 10.1111/j.1399-0012.2012.01652.x; Dhein Y, 2003, Pneumologie, V57, P591; Donaghy D, 1995, Prof Nurse, V11, P160; Duke SAS, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005268.pub2; Evans AE, 2000, J ADOLESCENT HEALTH, V26, P244, DOI 10.1016/S1054-139X(99)00093-2; Fox MP, 2009, PATIENT EDUC COUNS, V77, P6, DOI 10.1016/j.pec.2009.02.011; Gadoury MA, 2005, EUR RESPIR J, V26, P853, DOI 10.1183/09031936.05.00093204; Gottlieb J, 2009, RESP MED, V103, P743, DOI 10.1016/j.rmed.2008.11.015; Ho P Michael, 2006, BMC Cardiovasc Disord, V6, P48, DOI 10.1186/1471-2261-6-48; Husain AN, 1999, AM J RESP CRIT CARE, V159, P829, DOI 10.1164/ajrccm.159.3.9607099; Ivarsson B, 2012, EUR J CARDIOVASC NUR; Keulers BJ, 2007, PATIENT EDUC COUNS, V67, P176, DOI 10.1016/j.pec.2007.03.012; Kho A, 2006, J GEN INTERN MED, V21, P531, DOI 10.1111/j.1525-1497.2006.00444.x; Khunti K, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2333; Korb-Savoldelli V, 2010, PATIENT EDUC COUNS, V81, P148, DOI 10.1016/j.pec.2010.04.013; Lee TI, 2007, INT J MED INFORM, V76, P655, DOI 10.1016/j.ijmedinf.2006.05.030; Lennerling Annette, 2012, Open Nurs J, V6, P41, DOI 10.2174/1874434601206010041; Miller DP, 2005, J GEN INTERN MED, V20, P984, DOI 10.1111/j.1525-1497.2005.0081.x; Miners A, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-190; MORISKY DE, 1986, MED CARE, V24, P67, DOI 10.1097/00005650-198601000-00007; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Pollock-BarZiv SM, 2010, PEDIATR TRANSPLANT, V14, P968, DOI 10.1111/j.1399-3046.2010.01409.x; Sechrest R C, 1996, J Biocommun, V23, P8; Squyres W D, 1983, J Biocommun, V10, P4; Terebelo S, 2010, TRANSPL P, V42, P3578, DOI 10.1016/j.transproceed.2010.08.027; The Boston Consulting Group, 2003, HIDD EP FIND CUR UNF; Trueman J F, 2000, Prof Nurse, V15, P583; Viswanathan M, 2012, ANN INTERN MED, V157, P785, DOI 10.7326/0003-4819-157-11-201212040-00538; Walsh JC, 2002, AIDS, V16, P269, DOI 10.1097/00002030-200201250-00017; Wydra E W, 2001, Oncol Nurs Forum, V28, P1399	41	43	45	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90828	10.1371/journal.pone.0090828	http://dx.doi.org/10.1371/journal.pone.0090828			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC4IY	24608864	Green Published, gold, Green Submitted			2022-12-27	WOS:000332485800057
J	Timpka, T; Spreco, A; Gursky, E; Eriksson, O; Dahlstrom, O; Stromgren, M; Ekberg, J; Pilemalm, S; Karlsson, D; Hinkula, J; Holm, E				Timpka, Toomas; Spreco, Armin; Gursky, Elin; Eriksson, Olle; Dahlstrom, Orjan; Stromgren, Magnus; Ekberg, Joakim; Pilemalm, Sofie; Karlsson, David; Hinkula, Jorma; Holm, Einar			Intentions to Perform Non-Pharmaceutical Protective Behaviors during Influenza Outbreaks in Sweden: A Cross-Sectional Study following a Mass Vaccination Campaign	PLOS ONE			English	Article							RISK PERCEPTIONS; HONG-KONG; INFORMATION; RESPONSES; SARS; EUROPE; MODEL	Failure to incorporate the beliefs and attitudes of the public into theoretical models of preparedness has been identified as a weakness in strategies to mitigate infectious disease outbreaks. We administered a cross-sectional telephone survey to a representative sample (n = 443) of the Swedish adult population to examine whether self-reported intentions to improve personal hygiene and increase social distancing during influenza outbreaks could be explained by trust in official information, self-reported health (SF-8), sociodemographic factors, and determinants postulated in protection motivation theory, namely threat appraisal and coping appraisal. The interviewees were asked to make their appraisals for two scenarios: a) an influenza with low case fatality and mild lifestyle impact; b) severe influenza with high case fatality and serious disturbances of societal functions. Every second respondent (50.0%) reported high trust in official information about influenza. The proportion that reported intentions to take deliberate actions to improve personal hygiene during outbreaks ranged between 45-85%, while less than 25% said that they intended to increase social distancing. Multiple logistic regression models with coping appraisal as the explanatory factor most frequently contributing to the explanation of the variance in intentions showed strong discriminatory performance for staying home while not ill (mild outbreaks: Area under the curve [AUC] 0.85 (95% confidence interval 0.82;0.89), severe outbreaks AUC 0.82 (95% CI 0.77;0.85)) and acceptable performance with regard to avoiding public transportation (AUC 0.78 (0.74;0.82), AUC 0.77 (0.72;0.82)), using handwash products (AUC 0.70 (0.65;0.75), AUC 0.76 (0.71;0.80)), and frequently washing hands (AUC 0.71 (0.66;0.76), AUC 0.75 (0.71;0.80)). We conclude that coping appraisal was the explanatory factor most frequently included in statistical models explaining self-reported intentions to carry out non-pharmaceutical health actions in the Swedish outlined context, and that variations in threat appraisal played a smaller role in these models despite scientific uncertainties surrounding a recent mass vaccination campaign.	[Timpka, Toomas; Spreco, Armin; Ekberg, Joakim] Ostergotland Cty Council, Dept Publ Hlth, Linkoping, Sweden; [Timpka, Toomas; Spreco, Armin; Eriksson, Olle; Ekberg, Joakim; Pilemalm, Sofie; Karlsson, David] Linkoping Univ, Dept Med & Hlth Sci, Linkoping, Sweden; [Gursky, Elin] ANSER Analyt Serv Inc, Natl Strategies Support Directorate, Arlington, VA USA; [Dahlstrom, Orjan] Linkoping Univ, Dept Behav Sci, Linnaeus Ctr HEAD, Linkoping, Sweden; [Stromgren, Magnus; Holm, Einar] Umea Univ, Dept Geog & Econ Hist, Umea, Sweden; [Hinkula, Jorma] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden	City Council Ostergotland; Linkoping University; Linkoping University; Umea University; Linkoping University	Timpka, T (corresponding author), Ostergotland Cty Council, Dept Publ Hlth, Linkoping, Sweden.	toomas.timpka@liu.se	Hinkula, Jorma/P-6849-2018; Timpka, Toomas/E-8065-2018	Spreco, Armin/0000-0003-0985-8209; Hinkula, Jorma/0000-0003-1908-5609	Swedish Civil Contingencies Agency [2010-2788]; Swedish Science Council [2008-5252]; Swedish Governmental Agency for Innovations (VINNOVA) [2011-03231]	Swedish Civil Contingencies Agency; Swedish Science Council; Swedish Governmental Agency for Innovations (VINNOVA)(Vinnova)	This study was supported by grants from the Swedish Civil Contingencies Agency [2010-2788]; the Swedish Science Council [2008-5252]; and the Swedish Governmental Agency for Innovations (VINNOVA) [2011-03231]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aro A, 2005, EUR J PUBLIC HEALTH, V15, P70; Attlestam I, 2012, SVENSKA DAGBLADET; Bell MA, 2014, J EMERG NURS, V40, P212, DOI 10.1016/j.jen.2012.05.005; Bhutta ZA, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-S1-S7; Bish A, 2010, BRIT J HEALTH PSYCH, V15, P797, DOI 10.1348/135910710X485826; Brewer NT, 2004, ANN BEHAV MED, V27, P125, DOI 10.1207/s15324796abm2702_7; Busija L, 2011, ARTHRIT CARE RES, V63, pS383, DOI 10.1002/acr.20541; Cameron LD, 2001, J HEALTH PSYCHOL, V6, P47, DOI 10.1177/135910530100600104; Cooke R, 2008, PSYCHOL HEALTH, V23, P745, DOI 10.1080/08870440701544437; Cowling BJ, 2010, J INFECT DIS, V202, P867, DOI 10.1086/655811; Durham DP, 2012, RISK ANAL, V32, P2020, DOI 10.1111/j.1539-6924.2012.01823.x; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Fung ICH, 2006, TROP MED INT HEALTH, V11, P1749, DOI 10.1111/j.1365-3156.2006.01734.x; Hosmer DW, 2000, APPL LOGISTIC REGRES, P228; Lau JTF, 2003, J EPIDEMIOL COMMUN H, V57, P864, DOI 10.1136/jech.57.11.864; Leung GM, 2004, INFECT CONT HOSP EP, V25, P1033, DOI 10.1086/502340; Liao QY, 2013, LANCET INFECT DIS, V13, P567, DOI 10.1016/S1473-3099(13)70096-3; Liao QY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013350; Miilunpalo S, 1997, J CLIN EPIDEMIOL, V50, P517, DOI 10.1016/S0895-4356(97)00045-0; Mullet E, 2005, J RISK RES, V8, P19, DOI 10.1080/13669870210158571; Nicoll A, 2012, B WORLD HEALTH ORGAN, V90, P311, DOI 10.2471/BLT.11.097972; Raty R, 2010, ENERG POLICY, V38, P646, DOI 10.1016/j.enpol.2009.08.010; Reuter T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022130; Rhodes RE, 2006, BRIT J HEALTH PSYCH, V11, P119, DOI 10.1348/135910705X52633; Rogers R.W., 1983, SOCIAL PSYCHOPHYSIOL; ROGERS RW, 1985, PSYCHOL REP, V56, P179, DOI 10.2466/pr0.1985.56.1.179; Rosenstock IM, 1966, MILBANK MEM FUND Q, V44, P127; Rubin GJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2651; Savage L.J., 1954, FDN STAT; Simonsen KA, 2012, FAM PRACT, V29, P139, DOI 10.1093/fampra/cmr064; Slaughter L, 2005, J BIOMED INFORM, V38, P298, DOI 10.1016/j.jbi.2004.12.006; Statistics Sweden, 2012, WOM MEN SWED FACTS F, P64; Sylvan Staffan, 2012, Lakartidningen, V109, P1156; Tang CSK, 2004, PREV MED, V39, P1187, DOI 10.1016/j.ypmed.2004.04.032; Teasdale E, 2012, BRIT J HEALTH PSYCH, V17, P44, DOI 10.1111/j.2044-8287.2011.02017.x; Vaccine European New Integrated Collaboration Effort (VENICE), 2011, PAND A H1N1 2009 INF; Vartti AM, 2009, INT J BEHAV MED, V16, P41, DOI 10.1007/s12529-008-9004-6; Voeten HACM, 2009, INT J BEHAV MED, V16, P49, DOI 10.1007/s12529-008-9006-4; Vukotich Charles J Jr, 2010, Emerg Infect Dis, V16, pe2; Ware JE Jr, 2001, SCORE INTERPRET SING; Webb TL, 2006, PSYCHOL BULL, V132, P249, DOI 10.1037/0033-2909.132.2.249; Weinstein ND, 1998, PSYCHOL HEALTH, V13, P479, DOI 10.1080/08870449808407305; Wijnans L, 2013, VACCINE, V31, P1246, DOI 10.1016/j.vaccine.2012.12.015	43	30	30	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91060	10.1371/journal.pone.0091060	http://dx.doi.org/10.1371/journal.pone.0091060			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC4IY	24608557	Green Published, Green Submitted, gold			2022-12-27	WOS:000332485800091
J	Tuggle, KL; Birket, SE; Cui, XX; Hong, J; Warren, J; Reid, L; Chambers, A; Ji, D; Gamber, K; Chu, KK; Tearney, G; Tang, LP; Fortenberry, JA; Du, M; Cadillac, JM; Bedwell, DM; Rowe, SM; Sorscher, EJ; Fanucchi, MV				Tuggle, Katherine L.; Birket, Susan E.; Cui, Xiaoxia; Hong, Jeong; Warren, Joe; Reid, Lara; Chambers, Andre; Ji, Diana; Gamber, Kevin; Chu, Kengyeh K.; Tearney, Guillermo; Tang, Li Ping; Fortenberry, James A.; Du, Ming; Cadillac, Joan M.; Bedwell, David M.; Rowe, Steven M.; Sorscher, Eric J.; Fanucchi, Michelle V.			Characterization of Defects in Ion Transport and Tissue Development in Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)-Knockout Rats	PLOS ONE			English	Article							SURFACE LIQUID DEPTH; CFTR; NA+; MOUSE; CL; EPITHELIA; MODEL; GENE; HYPERABSORPTION; PHENOTYPE	Animal models for cystic fibrosis (CF) have contributed significantly to our understanding of disease pathogenesis. Here we describe development and characterization of the first cystic fibrosis rat, in which the cystic fibrosis transmembrane conductance regulator gene (CFTR) was knocked out using a pair of zinc finger endonucleases (ZFN). The disrupted Cftr gene carries a 16 base pair deletion in exon 3, resulting in loss of CFTR protein expression. Breeding of heterozygous (CFTR+/-) rats resulted in Mendelian distribution of wild-type, heterozygous, and homozygous (CFTR-/-) pups. Nasal potential difference and transepithelial short circuit current measurements established a robust CF bioelectric phenotype, similar in many respects to that seen in CF patients. Young CFTR-/- rats exhibited histological abnormalities in the ileum and increased intracellular mucus in the proximal nasal septa. By six weeks of age, CFTR-/- males lacked the vas deferens bilaterally. Airway surface liquid and periciliary liquid depth were reduced, and submucosal gland size was abnormal in CFTR-/- animals. Use of ZFN based gene disruption successfully generated a CF animal model that recapitulates many aspects of human disease, and may be useful for modeling other CF genotypes, including CFTR processing defects, premature truncation alleles, and channel gating abnormalities.	[Tuggle, Katherine L.; Birket, Susan E.; Hong, Jeong; Tang, Li Ping; Fortenberry, James A.; Du, Ming; Bedwell, David M.; Rowe, Steven M.; Sorscher, Eric J.; Fanucchi, Michelle V.] Univ Alabama Birmingham, Gregory Fleming James Cyst Fibrosis Res Ctr, Birmingham, AL 35294 USA; [Tuggle, Katherine L.; Fanucchi, Michelle V.] Univ Alabama Birmingham, Sch Publ Hlth, Dept Environm Hlth Sci, Birmingham, AL 35294 USA; [Birket, Susan E.; Rowe, Steven M.; Sorscher, Eric J.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Cui, Xiaoxia; Warren, Joe; Reid, Lara; Chambers, Andre; Ji, Diana; Gamber, Kevin] SAGE Labs Inc, St Louis, MO USA; [Hong, Jeong] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL USA; [Chu, Kengyeh K.; Tearney, Guillermo] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Wellman Ctr Photomed, Boston, MA USA; [Chu, Kengyeh K.] Massachusetts Gen Hosp, Dept Dermatol, Boston, MA 02114 USA; [Tearney, Guillermo] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Du, Ming; Cadillac, Joan M.] Univ Alabama Birmingham, Anim Resources Program, Off Vice President Res, Birmingham, AL USA; [Bedwell, David M.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Fanucchi, MV (corresponding author), Univ Alabama Birmingham, Gregory Fleming James Cyst Fibrosis Res Ctr, Birmingham, AL 35294 USA.	fanucchi@uab.edu		Gamber, Kevin/0000-0002-0694-7639; Bedwell, David/0000-0002-6605-818X; Sorscher, Eric J./0000-0001-9341-3354	CF Foundation [R464-CR07]; NIH [P30 DK072482, R01 HL116213]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116213] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072482] Funding Source: NIH RePORTER	CF Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by CF Foundation Grant R464-CR07 (www.cff.org) and NIH P30 DK072482 (www.nih.gov) to EJS and R01 HL116213 to SMR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitman TJ, 2008, NAT GENET, V40, P516, DOI 10.1038/ng.147; Arquitt CK, 2002, J DENT RES, V81, P492, DOI 10.1177/154405910208100712; Boucher RC, 2007, J INTERN MED, V261, P5, DOI 10.1111/j.1365-2796.2006.01744.x; BOUCHER RC, 1986, J CLIN INVEST, V78, P1245, DOI 10.1172/JCI112708; Boucher RC, 2004, EUR RESPIR J, V23, P146, DOI 10.1183/09031936.03.00057003; BOUCHER RC, 1988, J PHYSIOL-LONDON, V405, P77, DOI 10.1113/jphysiol.1988.sp017322; Brand JD, 2012, AM J PHYSIOL-LUNG C, V303, pL1079, DOI 10.1152/ajplung.00185.2012; Carbery ID, 2010, GENETICS, V186, P451, DOI 10.1534/genetics.110.117002; Carvalho-Oliveira I, 2007, EXPERT REV MOL DIAGN, V7, P407, DOI 10.1586/14737159.7.4.407; Chang EH, 2012, LARYNGOSCOPE, V122, P1898, DOI 10.1002/lary.23392; Chang EH, 2011, CELLS TISSUES ORGANS, V194, P249, DOI 10.1159/000324248; Chen EYT, 2010, AM J PHYSIOL-LUNG C, V299, pL542, DOI 10.1152/ajplung.00180.2010; Chen JH, 2010, CELL, V143, P911, DOI 10.1016/j.cell.2010.11.029; CHINET TC, 1994, AM J PHYSIOL, V266, pC1061, DOI 10.1152/ajpcell.1994.266.4.C1061; CLARKE LL, 1992, AM J PHYSIOL, V263, pC348, DOI 10.1152/ajpcell.1992.263.2.C348; Collaco A, 2010, AM J PHYSIOL-CELL PH, V299, pC1450, DOI 10.1152/ajpcell.00029.2010; COTTON CU, 1987, J CLIN INVEST, V79, P80, DOI 10.1172/JCI112812; Cui XX, 2011, NAT BIOTECHNOL, V29, P64, DOI 10.1038/nbt.1731; Dabrowska E, 2006, Adv Med Sci, V51 Suppl 1, P100; DAWSON DC, 1977, J MEMBRANE BIOL, V37, P213, DOI 10.1007/BF01940933; Derichs N, 2013, EUR RESPIR REV, V22, P58, DOI 10.1183/09059180.00008412; Fanucchi MV, 2012, AM J RESP CELL MOL, V46, P599, DOI 10.1165/rcmb.2011-0196OC; Fanucchi MV, 1998, TOXICOL APPL PHARM, V152, P1, DOI 10.1006/taap.1998.8484; Ferrazzano G F, 2012, Community Dent Health, V29, P106; Fisher JT, 2013, AM J RESP CELL MOL, V49, P837, DOI 10.1165/rcmb.2012-0433OC; Garcia MAS, 2009, J CLIN INVEST, V119, P2613, DOI 10.1172/JCI38662; Grosse Scott D., 2004, Morbidity and Mortality Weekly Report, V53, P1; GRUBB BR, 1994, AM J PHYSIOL, V266, pC1478, DOI 10.1152/ajpcell.1994.266.5.C1478; Guilbault C, 2007, AM J RESP CELL MOL, V36, P1, DOI 10.1165/rcmb.2006-0184TR; HARKEMA JR, 1988, AM J PATHOL, V130, P605; Houwen RH, 2010, J PEDIATR GASTR NUTR, V50, P38, DOI 10.1097/MPG.0b013e3181a6e01d; Itani OA, 2011, P NATL ACAD SCI USA, V108, P10260, DOI 10.1073/pnas.1106695108; Jacob HJ, 1999, GENOME RES, V9, P1013, DOI 10.1101/gr.9.11.1013; JAGELS AE, 1976, J DENT RES, V55, P991, DOI 10.1177/00220345760550065101; Jarzabek Katarzyna, 2004, Reprod Biol, V4, P119; Jayaraman S, 2001, J CLIN INVEST, V107, P317, DOI 10.1172/JCI11154; Liu L, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0052287, 10.1371/journal.pone.0061188, 10.1371/journal.pone.0083052]; Livraghi-Butrico A, 2013, AM J PHYSIOL-LUNG C, V304, pL469, DOI 10.1152/ajplung.00150.2012; Mashimo T, 2009, CURR PHARM BIOTECHNO, V10, P214, DOI 10.2174/138920109787315105; Meyerholz DK, 2010, AM J RESP CRIT CARE, V182, P1251, DOI 10.1164/rccm.201004-0643OC; Azevedo TDPL, 2006, J DENT CHILD, V73, P159; Pierucci-Alves F, 2011, BIOL REPROD, V85, P442, DOI 10.1095/biolreprod.111.090860; Pilewski Joseph M., 1999, Physiological Reviews, V79, pS215; PRIMOSCH RE, 1980, ORAL SURG ORAL MED O, V50, P301, DOI 10.1016/0030-4220(80)90411-9; Pyle LC, 2010, AM J RESP CELL MOL, V43, P607, DOI 10.1165/rcmb.2009-0281OC; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rogers CS, 2008, SCIENCE, V321, P1837, DOI 10.1126/science.1163600; Rogers CS, 2008, J CLIN INVEST, V118, P1571, DOI 10.1172/JCI34773; Rosenberg LA, 2006, PEDIATR RES, V59, P191, DOI 10.1203/01.pdr.0000196720.25938.be; RUTLAND J, 1981, THORAX, V36, P654, DOI 10.1136/thx.36.9.654; SMOLICH JJ, 1978, J ANAT, V127, P223; Solomon GM, 2010, CHEST, V138, P919, DOI 10.1378/chest.10-0179; Song YL, 2009, AM J PHYSIOL-LUNG C, V297, pL1131, DOI 10.1152/ajplung.00085.2009; STURGESS J, 1982, AM J PATHOL, V106, P303; Sun XS, 2010, J CLIN INVEST, V120, P3149, DOI 10.1172/JCI43052; Tarran R, 2001, MOL CELL, V8, P149, DOI 10.1016/S1097-2765(01)00286-6; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; van der Doef Hubert P J, 2011, Curr Gastroenterol Rep, V13, P265, DOI 10.1007/s11894-011-0185-9; Wright J T, 1996, Adv Dent Res, V10, P270; Wright JT, 1996, J DENT RES, V75, P966, DOI 10.1177/00220345960750041101; Wright JT, 1996, ADV DENT RES, V10, P275; Young J T, 1981, Fundam Appl Toxicol, V1, P309, DOI 10.1016/S0272-0590(81)80037-1	62	109	110	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91253	10.1371/journal.pone.0091253	http://dx.doi.org/10.1371/journal.pone.0091253			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608905	Green Submitted, Green Published, gold			2022-12-27	WOS:000332485800118
J	Cheng, L; Xia, TS; Wang, YF; Zhou, WB; Liang, XQ; Xue, JQ; Shi, L; Wang, Y; Ding, Q				Cheng, Lin; Xia, Tian-Song; Wang, Yi-Fen; Zhou, Wenbin; Liang, Xiu-Qing; Xue, Jin-Qiu; Shi, Liang; Wang, Ying; Ding, Qiang			The Apoptotic Effect of D Rhamnose beta-Hederin, a Novel Oleanane-Type Triterpenoid Saponin on Breast Cancer Cells	PLOS ONE			English	Article							BCL-2 FAMILY PROTEINS; GINSENOSIDE RH2; ANTICANCER; ACTIVATION; INDUCTION; PATHWAYS; DEATH; ERK; GENERATION; ROOTS	There is growing interest in development of natural products as anti-cancer and chemopreventive agents. Many triterpenoids have been proved as potential agents for chemoprevention and therapy of breast cancer. Ginsenosides from ginseng, which mostly belong to dammarane-type triterpenoids, have gained great attention for their anti-breast cancer activity with diverse mechanisms. However, studies of other kinds of triterpenoid saponins on breast cancer are limited. Previously, we purified and identified a novel oleanane-type triterpene saponin named D Rhamnose beta-hederin (DR beta-H) from Clematis ganpiniana, a Chinese traditional anti-tumor herb. In the present study, DR beta-H showed strong inhibitory activity on the growth of various breast cancer cells and induced apoptosis in these cells. DR beta-H inhibited PI3K/AKT and activated ERK signaling pathway. PI3K inhibitor LY294002 synergistically enhanced DR beta-H-induced apoptosis whereas MEK inhibitor U0126 reduced the apoptosis rate. Moreover, DR beta-H regulated the ratio of pro-apoptotic and anti-apoptotic Bcl-2 family proteins. Furthermore, DR beta-H induced depolarization of mitochondrial membrane potential which released Apaf-1 and Cytochrome C from the inter membrane space into the cytosol, where they promoted caspase-9 and caspase-3 activation. This is the first report on the pro-apoptotic effects of DR beta-H, a novel oleanane-type triterpenoid saponin, on breast cancer cells and its comprehensive apoptosis pathways. It implied that oleanane-type triterpenoid saponin DR beta-H could be a promising candidate for chemotherapy of breast cancer.	[Cheng, Lin; Xia, Tian-Song; Zhou, Wenbin; Liang, Xiu-Qing; Xue, Jin-Qiu; Shi, Liang; Wang, Ying; Ding, Qiang] Nanjing Med Univ, Affiliated Hosp 1, Jiangsu Breast Dis Ctr, Nanjing, Jiangsu, Peoples R China; [Wang, Yi-Fen] Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources West Ch, Kunming, Peoples R China	Nanjing Medical University; Chinese Academy of Sciences; Kunming Institute of Botany, CAS	Ding, Q (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Jiangsu Breast Dis Ctr, Nanjing, Jiangsu, Peoples R China.	dingqiang@njmu.edu.cn			Natural Science Foundation of China [81272916, 81202077]; Natural Science Foundation of Jiangsu Province [BK2011855]; key projects of Jiangsu Provincial Health Office [H201110]; Project of Jiangsu Province Traditional Chinese medicine bureau [LZ11084]; Six Talents Peak projects of Jiangsu province; Priority Academic Program Development of Jiangsu higher Education Institutions (PAPD)	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); key projects of Jiangsu Provincial Health Office; Project of Jiangsu Province Traditional Chinese medicine bureau; Six Talents Peak projects of Jiangsu province; Priority Academic Program Development of Jiangsu higher Education Institutions (PAPD)	This work was financially supported by the Natural Science Foundation of China (81272916 and 81202077), the Natural Science Foundation of Jiangsu Province (BK2011855), the key projects of Jiangsu Provincial Health Office (H201110), the Project of Jiangsu Province Traditional Chinese medicine bureau (LZ11084), the Six Talents Peak projects of Jiangsu province (to QD), and a project Funded by the Priority Academic Program Development of Jiangsu higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attele AS, 1999, BIOCHEM PHARMACOL, V58, P1685, DOI 10.1016/S0006-2952(99)00212-9; Augustin JM, 2011, PHYTOCHEMISTRY, V72, P435, DOI 10.1016/j.phytochem.2011.01.015; Bishayee A, 2011, FRONT BIOSCI-LANDMRK, V16, P980, DOI 10.2741/3730; Boutaghane N, 2013, PHYTOCHEMISTRY, V93, P176, DOI 10.1016/j.phytochem.2013.03.020; Breckenridge DG, 2004, CURR OPIN CELL BIOL, V16, P647, DOI 10.1016/j.ceb.2004.09.009; Calleja V, 2009, PLOS BIOL, V7, P189, DOI 10.1371/journal.pbio.1000017; Choi S, 2011, J CELL BIOCHEM, V112, P330, DOI 10.1002/jcb.22932; Chun J, 2013, CHEM-BIOL INTERACT, V205, P212, DOI 10.1016/j.cbi.2013.07.002; Chun J, 2013, PLANTA MED, V79, P639, DOI 10.1055/s-0032-1328401; Cragg GM, 2013, BIOCHIM BIOPHYS ACTA, V6, P18; Dinda B, 2010, CHEM BIODIVERS, V7, P2327, DOI 10.1002/cbdv.200800070; Ding Q, 2009, J ETHNOPHARMACOL, V126, P382, DOI 10.1016/j.jep.2009.09.028; Ellington AA, 2006, CARCINOGENESIS, V27, P298, DOI 10.1093/carcin/bgi214; Ghobrial IM, 2005, CA-CANCER J CLIN, V55, P178, DOI 10.3322/canjclin.55.3.178; Huang P, 2011, INT J MOL MED, V28, P579, DOI 10.3892/ijmm.2011.727; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kang JH, 2011, PLANT FOOD HUM NUTR, V66, P298, DOI 10.1007/s11130-011-0242-4; Karikas GA, 2010, J BUON, V15, P627; Lee HJ, 2006, CARCINOGENESIS, V27, P2455, DOI 10.1093/carcin/bgl104; Lee JH, 2009, J ETHNOPHARMACOL, V123, P121, DOI 10.1016/j.jep.2009.02.013; Li Q, 2012, BIOORG MED CHEM LETT, V22, P6120, DOI 10.1016/j.bmcl.2012.08.027; Liu GY, 2007, J NAT PROD, V70, P259, DOI 10.1021/np060313t; Ma GX, 2013, CHEM PHARM BULL, V61, P101, DOI 10.1248/cpb.c12-00713; Mirjolet JF, 2000, BRIT J CANCER, V83, P1380, DOI 10.1054/bjoc.2000.1455; Mo SS, 2013, J PHARMACOL SCI, V122, P163, DOI 10.1254/jphs.12193FP; Nhiem NX, 2012, ARCH PHARM RES, V35, P19, DOI 10.1007/s12272-012-0102-2; Park EK, 2010, BRIT J PHARMACOL, V160, P1212, DOI 10.1111/j.1476-5381.2010.00768.x; Park HM, 2012, FOOD CHEM TOXICOL, V50, P2736, DOI 10.1016/j.fct.2012.05.027; Patlolla JMR, 2012, CURR PHARM BIOTECHNO, V13, P147; Podolak I, 2010, PHYTOCHEM REV, V9, P425, DOI 10.1007/s11101-010-9183-z; Qiu YK, 2009, FITOTERAPIA, V80, P219, DOI 10.1016/j.fitote.2009.01.011; Rabi T, 2013, MOL CARCINOG; Rabi T, 2008, MOL CARCINOGEN, V47, P415, DOI 10.1002/mc.20399; Raisova M, 2001, J INVEST DERMATOL, V117, P333, DOI 10.1046/j.0022-202x.2001.01409.x; Ribeiro JT, 2012, ANN ONCOL, V23, P547, DOI 10.1093/annonc/mdr382; Sebolt-Leopold JS, 2000, ONCOGENE, V19, P6594, DOI 10.1038/sj.onc.1204083; Seddighzadeh M, 1999, CLIN EXP METASTAS, V17, P649, DOI 10.1023/A:1006741228402; Seo Y, 2002, J NAT PROD, V65, P65, DOI 10.1021/np010327t; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508; Swamy SMK, 2003, MOL CELL BIOCHEM, V245, P127, DOI 10.1023/A:1022807207948; Mai TT, 2012, CANCER LETT, V321, P144, DOI 10.1016/j.canlet.2012.01.045; Vincken JP, 2007, PHYTOCHEMISTRY, V68, P275, DOI 10.1016/j.phytochem.2006.10.008; Wang J, 2009, FOOD CHEM TOXICOL, V47, P1716, DOI 10.1016/j.fct.2009.04.034; Wang QF, 2002, CANCER LETT, V183, P169, DOI 10.1016/S0304-3835(01)00828-X; Wang QZ, 2012, FITOTERAPIA, V83, P742, DOI 10.1016/j.fitote.2012.02.013; Wang TH, 2000, CANCER, V88, P2619, DOI 10.1002/1097-0142(20000601)88:11<2619::AID-CNCR26>3.0.CO;2-J; Wang XT, 2000, J BIOL CHEM, V275, P39435, DOI 10.1074/jbc.M004583200; Xiong J, 2009, ENVIRON TOXICOL PHAR, V27, P264, DOI 10.1016/j.etap.2008.11.008; Yuan, 2009, ONCOL REP; Zhang CL, 2004, BIOL PHARM BULL, V27, P1527, DOI 10.1248/bpb.27.1527; Zhang LH, 2013, BBA-GEN SUBJECTS, V1830, P4148, DOI 10.1016/j.bbagen.2013.04.008; Zhao P, 2011, CHEM BIODIVERS, V8, P1931, DOI 10.1002/cbdv.201000265; Zhou Y, 2013, PLANTA MED, V79, P70, DOI 10.1055/s-0032-1327927	54	25	28	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90848	10.1371/journal.pone.0090848	http://dx.doi.org/10.1371/journal.pone.0090848			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603880	gold, Green Published, Green Submitted			2022-12-27	WOS:000332483600095
J	de Haas, EN; Bolhuis, JE; Kemp, B; Groothuis, TGG; Rodenburg, TB				de Haas, Elske N.; Bolhuis, J. Elizabeth; Kemp, Bas; Groothuis, Ton G. G.; Rodenburg, T. Bas			Parents and Early Life Environment Affect Behavioral Development of Laying Hen Chickens	PLOS ONE			English	Article							BRAIN GENE-EXPRESSION; OPEN-FIELD BEHAVIOR; YOLK STEROID-LEVELS; FEATHER-PECKING; SOCIAL TRANSMISSION; TONIC IMMOBILITY; GROUP-SIZE; PHENOTYPIC CORRELATIONS; MICROBIAL METABOLITES; OFFSPRING PHENOTYPE	Severe feather pecking (SFP) in commercial laying hens is a maladaptive behavior which is associated with anxiety traits. Many experimental studies have shown that stress in the parents can affect anxiety in the offspring, but until now these effects have been neglected in addressing the problem of SFP in commercially kept laying hens. We therefore studied whether parental stock (PS) affected the development of SFP and anxiety in their offspring. We used flocks from a brown and white genetic hybrid because genetic background can affect SFP and anxiety. As SFP can also be influenced by housing conditions on the rearing farm, we included effects of housing system and litter availability in the analysis. Forty-seven rearing flocks, originating from ten PS flocks were followed. Behavioral and physiological parameters related to anxiety and SFP were studied in the PS at 40 weeks of age and in the rearing flocks at one, five, ten and fifteen weeks of age. We found that PS had an effect on SFP at one week of age and on anxiety at one and five weeks of age. In the white hybrid, but not in the brown hybrid, high levels of maternal corticosterone, maternal feather damage and maternal whole-blood serotonin levels showed positive relations with offsprings' SFP at one week and offsprings' anxiety at one and five weeks of age. Disruption and limitation of litter supply at an early age on the rearing farms increased SFP, feather damage and fearfulness. These effects were most prominent in the brown hybrid. It appeared that hens from a brown hybrid are more affected by environmental conditions, while hens from a white hybrid were more strongly affected by parental effects. These results are important for designing measures to prevent the development of SFP, which may require a different approach in brown and white flocks.	[de Haas, Elske N.; Bolhuis, J. Elizabeth; Kemp, Bas] Wageningen Univ & Res, Dept Anim Sci, Adaptat Physiol Grp, Wageningen, Netherlands; [Groothuis, Ton G. G.] Univ Groningen, Ctr Behav & Neurosci, Groningen, Netherlands; [Rodenburg, T. Bas] Wageningen Univ & Res, Dept Anim Sci, Behav Ecol Grp, Wageningen, Netherlands	Wageningen University & Research; University of Groningen; Wageningen University & Research	de Haas, EN (corresponding author), Wageningen Univ & Res, Dept Anim Sci, Adaptat Physiol Grp, Wageningen, Netherlands.	elske.dehaas@wur.nl	Rodenburg, Bas/AAV-5612-2020; Rodenburg, Bas/D-9115-2012; Bolhuis, J. Elizabeth/P-7978-2015	Rodenburg, Bas/0000-0002-3371-1461; Bolhuis, J. Elizabeth/0000-0002-5172-7635	Division of Earth and Life Sciences with financial aid from the Netherlands Organization for Scientific Research; Ministry of Economic Affairs within the program	Division of Earth and Life Sciences with financial aid from the Netherlands Organization for Scientific Research; Ministry of Economic Affairs within the program	This work was supported by the Division of Earth and Life Sciences with financial aid from the Netherlands Organization for Scientific Research and the Ministry of Economic Affairs within the program "The Value of Animal Welfare" for the specific project named "Preventing feather pecking in laying hens: from principle to practice" (http://www.nwo.nl/en/research-and-results/research-projects/46/2300154446.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amerah AM, 2007, WORLD POULTRY SCI J, V63, P439, DOI 10.1017/S0043933907001560; Bateson P, 2007, J NUTR, V137, P1060, DOI 10.1093/jn/137.4.1060; Berghof TVL, 2013, POULTRY SCI, V92, P2904, DOI 10.3382/ps.2013-03177; Bertin A, 2009, BEHAVIOUR, V146, P757, DOI 10.1163/156853909X446190; Bertin A, 2008, HORM BEHAV, V54, P396, DOI 10.1016/j.yhbeh.2008.04.012; Bilcik B, 2000, APPL ANIM BEHAV SCI, V68, P55, DOI 10.1016/S0168-1591(00)00089-7; BLOKHUIS HJ, 1986, APPL ANIM BEHAV SCI, V16, P63, DOI 10.1016/0168-1591(86)90040-7; Bolhuis JE, 2009, PHYSIOL BEHAV, V97, P470, DOI 10.1016/j.physbeh.2009.03.021; Bright A, 2008, BRIT POULTRY SCI, V49, P241, DOI 10.1080/00071660802094172; Bright A, 2009, VET REC, V164, P334, DOI 10.1136/vr.164.11.334; Brunton PJ, 2010, J NEUROENDOCRINOL, V22, P258, DOI 10.1111/j.1365-2826.2010.01969.x; Buitenhuis AJ, 2004, POULTRY SCI, V83, P1077, DOI 10.1093/ps/83.7.1077; Champagne FA, 2012, ADV GENET, V77, P33, DOI 10.1016/B978-0-12-387687-4.00002-7; Champagne FA, 2011, HORM BEHAV, V59, P277, DOI 10.1016/j.yhbeh.2011.02.011; Champagne FA, 2010, PERSPECT PSYCHOL SCI, V5, P564, DOI 10.1177/1745691610383494; Charil A, 2010, BRAIN RES REV, V65, P56, DOI 10.1016/j.brainresrev.2010.06.002; COLLIAS NE, 1987, CONDOR, V89, P510, DOI 10.2307/1368641; Croney CC, 2007, APPL ANIM BEHAV SCI, V103, P215, DOI 10.1016/j.applanim.2006.05.023; Curley JP, 2011, HORM BEHAV, V59, P306, DOI 10.1016/j.yhbeh.2010.06.018; Davis KA, 2008, POULTRY SCI, V87, P1303, DOI 10.3382/ps.2008-00083; de Haas EN, 2013, POULTRY SCI, V92, P2259, DOI 10.3382/ps.2012-02996; de Jong IC, 2013, ANIM WELFARE, V22, P305, DOI 10.7120/09627286.22.3.305; Ebert-Zavos E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058477; Eriksen MS, 2011, J FISH BIOL, V79, P575, DOI 10.1111/j.1095-8649.2011.03036.x; FAURE JM, 1983, BIOL BEHAV, V8, P103; Fraisse F, 2006, BRIT POULTRY SCI, V47, P110, DOI 10.1080/00071660600610534; GALLUP GG, 1980, ANIM BEHAV, V28, P368, DOI 10.1016/S0003-3472(80)80045-5; Ghareeb K, 2008, BRIT POULTRY SCI, V49, P502, DOI 10.1080/00071660802290390; Ghareeb K., 2008, International Journal of Poultry Science, V7, P843; Gilani AM, 2012, APPL ANIM BEHAV SCI, V142, P42, DOI 10.1016/j.applanim.2012.09.006; Gluckman PD, 2005, TRENDS ECOL EVOL, V20, P527, DOI 10.1016/j.tree.2005.08.001; Goerlich VC, 2012, HORM BEHAV, V61, P711, DOI 10.1016/j.yhbeh.2012.03.006; Groothuis TGG, 2005, NEUROSCI BIOBEHAV R, V29, P329, DOI 10.1016/j.neubiorev.2004.12.002; Groothuis TGG, 2008, PHILOS T R SOC B, V363, P1647, DOI 10.1098/rstb.2007.0007; Gudsnuk KMA, 2011, CLIN PERINATOL, V38, P703, DOI 10.1016/j.clp.2011.08.005; Guibert F, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2368; Guibert F, 2011, APPL ANIM BEHAV SCI, V132, P51, DOI 10.1016/j.applanim.2011.03.012; Guibert F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014069; Harlander-Matauschek A, 2007, APPL ANIM BEHAV SCI, V107, P78, DOI 10.1016/j.applanim.2006.09.022; Henriksen R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023824; Henriksen R, 2011, NEUROSCI BIOBEHAV R, V35, P1484, DOI 10.1016/j.neubiorev.2011.04.010; Ho DH, 2010, J EXP BIOL, V213, P3, DOI 10.1242/jeb.019752; Hocking PM, 2001, BRIT POULTRY SCI, V42, P414, DOI 10.1080/00071660120070686; Houdelier C., 2011, PLOS ONE, V6; Huber-Eicher B, 1998, ANIM BEHAV, V55, P861, DOI 10.1006/anbe.1997.0715; HuberEicher B, 1997, ANIM BEHAV, V54, P757, DOI 10.1006/anbe.1996.0506; Hughes AL, 2010, POULTRY SCI, V89, P1858, DOI 10.3382/ps.2010-00827; Janczak AM, 2009, ACTA AGR SCAND A-AN, V59, P80, DOI 10.1080/09064700903023348; Janczak AM, 2006, APPL ANIM BEHAV SCI, V96, P69, DOI 10.1016/j.applanim.2005.04.020; Janczak AM, 2007, APPL ANIM BEHAV SCI, V107, P275, DOI 10.1016/j.applanim.2006.10.002; Janczak AM, 2007, APPL ANIM BEHAV SCI, V107, P66, DOI 10.1016/j.applanim.2006.09.016; JONES RB, 1995, BRIT POULTRY SCI, V36, P525, DOI 10.1080/00071669508417798; Kjaer JB, 2004, VET REC, V154, P556, DOI 10.1136/vr.154.18.556; Koene P, 2001, VOCALISATION DUE FRU, P95; Kops MS, 2013, BEHAV BRAIN RES, V257, P54, DOI 10.1016/j.bbr.2013.09.035; Kops MS, 2013, PHYSIOL BEHAV, V120, P77, DOI 10.1016/j.physbeh.2013.07.007; Lindqvist C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000364; Lumey LH, 2007, INT J EPIDEMIOL, V36, P1196, DOI 10.1093/ije/dym126; McAdie TM, 2002, APPL ANIM BEHAV SCI, V75, P147, DOI 10.1016/S0168-1591(01)00182-4; McAdie TM, 2000, APPL ANIM BEHAV SCI, V68, P215, DOI 10.1016/S0168-1591(00)00107-6; Meyer B, 2012, POULTRY SCI, V91, P1506, DOI 10.3382/ps.2011-01786; Meyer B, 2013, PHYSIOL BEHAV, V110, P96, DOI 10.1016/j.physbeh.2012.12.017; Mossner R, 1998, BRAIN BEHAV IMMUN, V12, P249, DOI 10.1006/brbi.1998.0532; Natt D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006405; Newberry RC, 2007, APPL ANIM BEHAV SCI, V107, P262, DOI 10.1016/j.applanim.2006.10.010; Nicol CJ, 2013, WORLD POULTRY SCI J, V69, P775, DOI 10.1017/S0043933913000809; NICOL CJ, 1995, APPL ANIM BEHAV SCI, V44, P79, DOI 10.1016/0168-1591(95)00607-T; Nicol CJ, 2001, APPL ANIM BEHAV SCI, V73, P141, DOI 10.1016/S0168-1591(01)00126-5; Richard-Yris MA, 2005, DEV PSYCHOBIOL, V46, P1, DOI 10.1002/dev.20040; Riedstra B, 2002, APPL ANIM BEHAV SCI, V77, P127, DOI 10.1016/S0168-1591(02)00031-X; Rodenburg TB, 2013, WORLD POULTRY SCI J, V69, P361, DOI 10.1017/S0043933913000354; Rodenburg TB, 2008, APPL ANIM BEHAV SCI, V110, P217, DOI 10.1016/j.applanim.2007.09.009; Rodenburg TB, 2007, APPL ANIM BEHAV SCI, V103, P205, DOI 10.1016/j.applanim.2006.05.024; Rodenburg TB, 2009, PHYSIOL BEHAV, V98, P519, DOI 10.1016/j.physbeh.2009.08.006; Rodenburg TB, 2004, BEHAV GENET, V34, P407, DOI 10.1023/B:BEGE.0000023646.46940.2d; Rodenburg TB, 2004, BEHAV PROCESS, V65, P179, DOI 10.1016/j.beproc.2003.09.003; Rogers LJ, 1995, BEHAV TRANSITIONS EA, P157; Rutherford KMD, 2012, ANIM WELFARE, V21, P419, DOI 10.7120/09627286.21.3.419; SAVORY CJ, 1995, WORLD POULTRY SCI J, V51, P215, DOI 10.1079/WPS19950016; Savory CJ, 1997, BRIT POULTRY SCI, V38, P38, DOI 10.1080/00071669708417938; Schwabl H, 1997, NATURWISSENSCHAFTEN, V84, P406, DOI 10.1007/s001140050418; SUAREZ SD, 1983, ANIM LEARN BEHAV, V11, P119, DOI 10.3758/BF03212318; SUFKA KJ, 1991, PHYSIOL BEHAV, V50, P129, DOI 10.1016/0031-9384(91)90508-L; TOLMAN CW, 1964, ANIM BEHAV, V12, P245, DOI 10.1016/0003-3472(64)90008-9; Uitdehaag KA, 2008, BEHAV PROCESS, V79, P13, DOI 10.1016/j.beproc.2008.04.004; Uitdehaag KA, 2011, POULTRY SCI, V90, P1629, DOI 10.3382/ps.2010-01292; Uitdehaag K, 2008, APPL ANIM BEHAV SCI, V109, P292, DOI 10.1016/j.applanim.2007.03.008; Uitdehaag KA, 2009, APPL ANIM BEHAV SCI, V116, P58, DOI 10.1016/j.applanim.2008.06.009; van Hierden YM, 2004, BEHAV NEUROSCI, V118, P575, DOI 10.1037/0735-7044.118.3.575; Viltart O, 2007, THESCIENTIFICWORLDJO, V7, P1493, DOI 10.1100/tsw.2007.204; Warnick JE, 2009, J PSYCHOPHARMACOL, V23, P143, DOI 10.1177/0269881108089805; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Welfare Quality Consortium, 2009, WELF QUAL ASS PROT P; Zeltner E, 2000, ANIM BEHAV, V60, P211, DOI 10.1006/anbe.2000.1453; Zimmerman PH, 2006, APPL ANIM BEHAV SCI, V101, P111, DOI 10.1016/j.applanim.2006.01.005	95	73	74	2	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90577	10.1371/journal.pone.0090577	http://dx.doi.org/10.1371/journal.pone.0090577			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603500	Green Published, Green Submitted, gold			2022-12-27	WOS:000332483600064
J	Ishikawa, N; Shimbo, T; Miyano, S; Sikazwe, I; Mwango, A; Ghidinelli, MN; Syakantu, G				Ishikawa, Naoko; Shimbo, Takuro; Miyano, Shinsuke; Sikazwe, Izukanji; Mwango, Albert; Ghidinelli, Massimo N.; Syakantu, Gardner			Health Outcomes and Cost Impact of the New WHO 2013 Guidelines on Prevention of Mother-to-Child Transmission of HIV in Zambia	PLOS ONE			English	Article							RESOURCE-LIMITED SETTINGS; ANTIRETROVIRAL THERAPY; PREGNANCY	Background: Countries are currently progressing towards the elimination of new paediatric HIV infections by 2015. WHO published new consolidated guidelines in June 2013, which now recommend either 'Antiretroviral drugs (ARVs) for women living with HIV during pregnancy and breastfeeding (Option B)' or 'Lifelong antiretroviral therapy (ART) for all pregnant and breastfeeding women living with HIV (Option B+)', while de facto phasing out Option A. This study examined health outcomes and cost impact of the shift to WHO 2013 recommendations in Zambia. Methods: A decision analytic model was developed based on the national health system perspective. Estimated risk and number of cases of HIV transmission to infants and to serodiscordant partners, and proportions of HIV-infected pregnant women with CD4 count of <= 350 cells/mm(3) to initiate ART were compared between 2010 Option A and the 2013 recommendations. Total costs of prevention of mother-to-child transmission of HIV (PMTCT) services per annual cohort of pregnant women, incremental cost-effectiveness ratio (ICER) per infection averted and quality-adjusted life-year (QALY) gained were examined. Results: Our analysis suggested that the shift from 2010 Option A to the 2013 guidelines would result in a 33% reduction of the risk of HIV transmission among exposed infants. The risk of transmission to serodiscordant partners for a period of 24 months would be reduced by 72% with 'ARVs during pregnancy and breastfeeding' and further reduced by 15% with 'Lifelong ART'. The probability of HIV-infected pregnant women to initiate ART would increase by 80%. It was also suggested that while the shift would generate higher PMTCT costs, it would be cost-saving in the long term as it spares future treatment costs by preventing infections in infants and partners. Conclusion: The shift to the WHO 2013 guidelines in Zambia would positively impact health of family and save future costs related to care and treatment.	[Ishikawa, Naoko; Shimbo, Takuro; Miyano, Shinsuke] Natl Ctr Global Hlth & Med, Tokyo, Japan; [Sikazwe, Izukanji] Ctr Infect Dis Res Zambia, Lusaka, Zambia; [Mwango, Albert; Syakantu, Gardner] Minist Hlth, Lusaka, Zambia; [Ghidinelli, Massimo N.] Pan Amer Hlth Org, Washington, DC USA	National Center for Global Health & Medicine - Japan; Pan American Health Organization	Ishikawa, N (corresponding author), Natl Ctr Global Hlth & Med, Tokyo, Japan.	n-ishikawa@it.ncgm.go.jp			Ministry of Health, Labor and Welfare, Japan [H23-4]	Ministry of Health, Labor and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This study was funded by Research Grant for International Health, H23-4, by the Ministry of Health, Labor and Welfare, Japan (http://www.ncgm.go.jp/kaihatsu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2020, HIGH POSS COST COVID; [Anonymous], 2012, BUS CAS IMPR EMTCT P; [Anonymous], 2013, UNAIDS REP GLOB AIDS; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Binagwaho A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054180; Carter RJ, 2010, JAIDS-J ACQ IMM DEF, V55, P404, DOI 10.1097/QAI.0b013e3181e73f4b; Central Statistical Office Ministry of Health Tropical Diseases Research Centre Inc University of Zambia Macro International Inc, 2009, ZAMB DEM HLTH SURV 2; Changala M, 2012, 22 27 JUL 2012 19 IN; Ciaranello AL, 2013, CLIN INFECT DIS, V56, P430, DOI 10.1093/cid/cis858; Clinton Foundation, 2009, HIV AIDS DIAGN PRIC; Clinton Health Access Initiative, 2012, ANT ARV CEIL PRIC LI; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; De Cock KM, 2000, JAMA-J AM MED ASSOC, V283, P1175, DOI 10.1001/jama.283.9.1175; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Farnham PG, 2013, JAIDS-J ACQ IMM DEF, V64, P183, DOI 10.1097/QAI.0b013e3182973966; Fasawe O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057778; Hallett TB, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001123; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Ishikawa N, 2011, 17 20 JUL 2011 6 IAS; Ishikawa N, 2012, 22 27 JUL 2012 19 IN; Ishikawa N, 2011, COSTING TOOL ELIMINA; Kuznik A, 2012, B WORLD HEALTH ORGAN, V90, P595, DOI 10.2471/BLT.11.095430; Marazzi MC, 2011, AIDS, V25, P1611, DOI 10.1097/QAD.0b013e3283493ed0; Ministry of Health Zambia, 2012, ZAMB COUNTR REP MON; Mugo NR, 2011, AIDS, V25, P1887, DOI 10.1097/QAD.0b013e32834a9338; Orlando S, 2010, JAIDS-J ACQ IMM DEF, V55, P631, DOI 10.1097/QAI.0b013e3181f9f9f5; Reynolds SJ, 2011, AIDS, V25, P473, DOI 10.1097/QAD.0b013e3283437c2b; Robberstad B, 2010, JAIDS-J ACQ IMM DEF, V55, P397, DOI 10.1097/QAI.0b013e3181eef4d3; Shah M, 2011, AIDS, V25, P1093, DOI 10.1097/QAD.0b013e32834670b9; Soorapanth S, 2006, JAIDS-J ACQ IMM DEF, V42, P213, DOI 10.1097/01.qai.0000214812.72916.bc; The Interagency Task Team, 2013, TOOLK EXP SIMPL TREA; UNAIDS Reference Group on Estimates, 2011, WORK PAP MOTH TO CHI; UNICEF, 2013, RAP ASS 2010 WHO GUI; United Nations, 2010, UN DAT; WHO, 2003, GUID COST EFF EN; World Bank, 2013, GDP PER CAP CURR US; World Health Organization, 2012, PROGR UPD US ANT DRU; World Health Organization, 2021, ANT DRUGS TREAT PREG; Zulliger R, 2013, COST EFFECTIVENESS P	39	23	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90991	10.1371/journal.pone.0090991	http://dx.doi.org/10.1371/journal.pone.0090991			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24604067	Green Published, Green Submitted, gold			2022-12-27	WOS:000332483600119
J	Humair, JP; Garin, N; Gerstel, E; Carballo, S; Carballo, D; Keller, PF; Guessous, I				Humair, Jean-Paul; Garin, Nicolas; Gerstel, Eric; Carballo, Sebastian; Carballo, David; Keller, Pierre-Frederic; Guessous, Idris			Acute Respiratory and Cardiovascular Admissions after a Public Smoking Ban in Geneva, Switzerland	PLOS ONE			English	Article							SECONDHAND SMOKE; FREE LEGISLATION; PASSIVE SMOKING; RISK-FACTORS; STROKE; ASSOCIATION; HOSPITALIZATIONS; IMPLEMENTATION; METAANALYSIS; DISEASE	Background: Many countries have introduced legislations for public smoking bans to reduce the harmful effects of exposure to tobacco smoke. Smoking bans cause significant reductions in admissions for acute coronary syndromes but their impact on respiratory diseases is unclear. In Geneva, Switzerland, two popular votes led to a stepwise implementation of a state smoking ban in public places, with a temporary suspension. This study evaluated the effect of this smoking ban on hospitalisations for acute respiratory and cardiovascular diseases. Methods: This before and after intervention study was conducted at the University Hospitals of Geneva, Switzerland, across 4 periods with different smoking legislations. It included 5,345 patients with a first hospitalisation for acute coronary syndrome, ischemic stroke, acute exacerbation of chronic obstructive pulmonary disease, pneumonia and acute asthma. The main outcomes were the incidence rate ratios (IRR) of admissions for each diagnosis after the final ban compared to the pre-ban period and adjusted for age, gender, season, influenza epidemic and secular trend. Results: Hospitalisations for acute exacerbation of chronic obstructive pulmonary disease significantly decreased over the 4 periods and were lowest after the final ban (IRR = 0.54 [95%CI: 0.42-0.68]). We observed a trend in reduced admissions for acute coronary syndromes (IRR = 0.90 [95%CI: 0.80-1.00]). Admissions for ischemic stroke, asthma and pneumonia did not significantly change. Conclusions: A legislative smoking ban was followed by a strong decrease in hospitalisations for acute exacerbation of chronic obstructive pulmonary disease and a trend for reduced admissions for acute coronary syndrome. Smoking bans are likely to be very beneficial for patients with chronic obstructive pulmonary disease.	[Humair, Jean-Paul] Univ Hosp Geneva, Div Primary Care Med, Geneva, Switzerland; [Garin, Nicolas; Gerstel, Eric; Carballo, Sebastian] Univ Hosp Geneva, Div Gen Internal Med, Geneva, Switzerland; [Garin, Nicolas] Chablais Reg Hosp, Div Internal Med, Monthey, Switzerland; [Gerstel, Eric] Clin La Colline, Div Ambulatory Care & Emergency Med, Geneva, Switzerland; [Carballo, David; Keller, Pierre-Frederic] Univ Hosp Geneva, Div Cardiol, Geneva, Switzerland; [Guessous, Idris] Univ Hosp Geneva, Div Primary Care Med, Unit Populat Epidemiol, Geneva, Switzerland; [Guessous, Idris] Univ Lausanne Hosp, Community Prevent Unit, Lausanne, Switzerland	University of Geneva; University of Geneva; University of Geneva; University of Geneva; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Humair, JP (corresponding author), Univ Hosp Geneva, Div Primary Care Med, Geneva, Switzerland.	Jean-Paul.Humair@hcuge.ch		Gerstel, Eric/0000-0003-0754-1873	Department of Regional Affairs, Economics & Health of the Canton of Geneva	Department of Regional Affairs, Economics & Health of the Canton of Geneva	This study was funded by the Department of Regional Affairs, Economics & Health of the Canton of Geneva. The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	[Anonymous], 2011, LAW SMOK BAN PUBL PL; Barnoya J, 2005, CIRCULATION, V111, P2684, DOI 10.1161/CIRCULATIONAHA.104.492215; Bonetti PO, 2011, SWISS MED WKLY, V141, DOI 10.4414/smw.2011.13206; Callinan JE, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005992.pub2; Durham AD, 2011, SWISS MED WKLY, V141, DOI 10.4414/smw.2011.13317; Easton JD, 2009, STROKE, V40, P2276, DOI 10.1161/STROKEAHA.108.192218; Eisner Mark D, 2009, Int J Chron Obstruct Pulmon Dis, V4, P169; Etat de Geneve, 2011, CANTONAL STAT RESIDE; Garcia-Aymerich J, 2003, THORAX, V58, P100, DOI 10.1136/thorax.58.2.100; Glymour MM, 2008, AM J PREV MED, V35, P245, DOI 10.1016/j.amepre.2008.05.024; Goodman P, 2007, AM J RESP CRIT CARE, V175, P840, DOI 10.1164/rccm.200608-1085OC; He J, 1999, NEW ENGL J MED, V340, P920, DOI 10.1056/NEJM199903253401204; He Y, 2008, CIRCULATION, V118, P1535, DOI 10.1161/CIRCULATIONAHA.108.784801; Herman PM, 2011, AM J PUBLIC HEALTH, V101, P491, DOI 10.2105/AJPH.2009.179572; Kent BD, 2012, CHEST, V142, P673, DOI 10.1378/chest.11-2757; Li Y, 2011, AM J EMERG MED, V29, P768, DOI 10.1016/j.ajem.2010.02.027; Loeb M, 2009, J AM GERIATR SOC, V57, P1036, DOI 10.1111/j.1532-5415.2009.02259.x; Lucker LM, 2011, SWISS MED WKLY, V141, DOI 10.4414/smw.2011.13177; Mackay D, 2010, NEW ENGL J MED, V363, P1139, DOI 10.1056/NEJMoa1002861; Menzies D, 2006, JAMA-J AM MED ASSOC, V296, P1742, DOI 10.1001/jama.296.14.1742; Naiman A, 2010, CAN MED ASSOC J, V182, P761, DOI 10.1503/cmaj.091130; [National Centre of Influenza Central Laboratory of Virology University Hospitals of Geneva], 2007, INFL SURV SWITZ SENT; [National Influenza Reference Centre Laboratory of Virology University Hospitals of Geneva], 2009, INFL SURV SWITZ SENT; [National Influenza Reference Centre Laboratory of Virology University Hospitals of Geneva], 2010, SEAS INFL A H1N1 200; [National Influenza Reference Centre Laboratory of Virology University Hospitals of Geneva], 2008, INFL SURV SWITZ SENT; Oono IP, 2011, J PUBLIC HEALTH-UK, V33, P496, DOI 10.1093/pubmed/fdr025; Rayens MK, 2008, J ALLERGY CLIN IMMUN, V122, P537, DOI 10.1016/j.jaci.2008.06.029; Sapey E, 2006, THORAX, V61, P250, DOI 10.1136/thx.2005.041822; Schanzer DL, 2013, INFLUENZA OTHER RESP, V7, P799, DOI 10.1111/irv.12011; Sims M, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2161; Swiss Federal Statistical Office, 2010, HOSP STAT YEAR 2000; Tan CE, 2012, CIRCULATION, V126, P2177, DOI 10.1161/CIRCULATIONAHA.112.121301; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; U. S. Department of Health and Human Services, 2006, HLTH CONS INV EXP TO; World Health Organization, 1992, INT STAT CLASS DIS H	35	21	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90417	10.1371/journal.pone.0090417	http://dx.doi.org/10.1371/journal.pone.0090417			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599156	Green Published, Green Submitted, gold			2022-12-27	WOS:000332479400073
J	Luo, K; Zhang, H; Zavala, F; Biragyn, A; Espinosa, DA; Markham, RB				Luo, Kun; Zhang, Hong; Zavala, Fidel; Biragyn, Arya; Espinosa, Diego A.; Markham, Richard B.			Fusion of Antigen to a Dendritic Cell Targeting Chemokine Combined with Adjuvant Yields a Malaria DNA Vaccine with Enhanced Protective Capabilities	PLOS ONE			English	Article							CD8(+) T-CELLS; PLASMODIUM-FALCIPARUM; IMMUNE-RESPONSES; CIRCUMSPOROZOITE PROTEIN; IN-VITRO; LIVER-STAGE; IRRADIATED SPOROZOITES; IMPROVES PROTECTION; ANTIBODY-RESPONSES; EFFECTOR FUNCTIONS	Although sterilizing immunity to malaria can be elicited by irradiated sporozoite vaccination, no clinically practical subunit vaccine has been shown to be capable of preventing the approximately 600,000 annual deaths attributed to this infection. DNA vaccines offer several potential advantages for a disease that primarily affects the developing world, but new approaches are needed to improve the immunogenicity of these vaccines. By using a novel, lipid-based adjuvant, Vaxfectin, to attract immune cells to the immunization site, in combination with an antigen-chemokine DNA construct designed to target antigen to immature dendritic cells, we elicited a humoral immune response that provided sterilizing immunity to malaria challenge in a mouse model system. The chemokine, MIP3 alpha CCL20, did not significantly enhance the cellular infiltrate or levels of cytokine or chemokine expression at the immunization site but acted with Vaxfectin to reduce liver stage malaria infection by orders of magnitude compared to vaccine constructs lacking the chemokine component. The levels of protection achieved were equivalent to those observed with irradiated sporozoites, a candidate vaccine undergoing development for further large scale clinical trial. Only vaccination with the combined regimen of adjuvant and chemokine provided 80-100% protection against the development of bloodstream infection. Treating the immunization process as requiring the independent steps of 1) attracting antigen-presenting cells to the site of immunization and 2) specifically directing vaccine antigen to the immature dendritic cells that initiate the adaptive immune response may provide a rational strategy for the development of a clinically applicable malaria DNA vaccine.	[Luo, Kun; Zhang, Hong; Zavala, Fidel; Espinosa, Diego A.; Markham, Richard B.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21218 USA; [Biragyn, Arya] NIA, Immunoregulat Sect, Lab Mol Biol & Immunol, Baltimore, MD 21224 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Markham, RB (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21218 USA.	rmarkham@jhsph.edu	Espinosa, Diego/AAT-6950-2020	Espinosa, Diego A./0000-0002-4364-5031	National Institutes of Health [AI073619]; Johns Hopkins University Malaria Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI073619, R01AI044375] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000444] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johns Hopkins University Malaria Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the National Institutes of Health (Grant #AI073619) and the Johns Hopkins University Malaria Research Institute (http://malaria.jhsph.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287; Amante FH, 1997, PARASITE IMMUNOL, V19, P111, DOI 10.1046/j.1365-3024.1997.d01-187.x; Ambrosini E, 2005, J NEUROPATH EXP NEUR, V64, P706, DOI 10.1097/01.jnen.0000173893.01929.fc; Belnoue E, 2004, J IMMUNOL, V172, P2487, DOI 10.4049/jimmunol.172.4.2487; Biragyn A, 2004, BLOOD, V104, P1961, DOI 10.1182/blood-2004-02-0637; Biragyn A, 2002, BLOOD, V100, P1153, DOI 10.1182/blood-2002-01-0086; Biragyn A, 1999, NAT BIOTECHNOL, V17, P253, DOI 10.1038/6995; Biragyn A, 2001, J IMMUNOL, V167, P6644, DOI 10.4049/jimmunol.167.11.6644; Biragyn A, 2007, J IMMUNOL, V179, P1381, DOI 10.4049/jimmunol.179.2.1381; Bonelo A, 2000, EUR J IMMUNOL, V30, P3079, DOI 10.1002/1521-4141(200011)30:11&lt;3079::AID-IMMU3079&gt;3.0.CO;2-7; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Carvalho LH, 2001, J IMMUNOL METHODS, V252, P207, DOI 10.1016/S0022-1759(01)00331-3; CHAROENVIT Y, 1987, INFECT IMMUN, V55, P604, DOI 10.1128/IAI.55.3.604-608.1987; CHAROENVIT Y, 1990, B WORLD HEALTH ORGAN, V68, P26; CHAROENVIT Y, 1991, J IMMUNOL, V146, P1020; Cockburn IA, 2008, J IMMUNOL, V180, P64, DOI 10.4049/jimmunol.180.1.64; Cockburn IA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000877; Cremel M, 2005, J LEUKOCYTE BIOL, V78, P158, DOI 10.1189/jlb.0305147; DELGIUDICE G, 1990, B WORLD HEALTH ORGAN, V68, P191; Doolan DL, 2000, J IMMUNOL, V165, P1453, DOI 10.4049/jimmunol.165.3.1453; Doolan DL, 2001, INT J PARASITOL, V31, P753, DOI 10.1016/S0020-7519(01)00184-9; Epstein JE, 2002, HUM GENE THER, V13, P1551, DOI 10.1089/10430340260201644; Finn JD, 2009, J VIROL, V83, P12027, DOI 10.1128/JVI.00593-09; Hafalla JCR, 2003, J IMMUNOL, V171, P964, DOI 10.4049/jimmunol.171.2.964; Hafalla JCR, 2002, P NATL ACAD SCI USA, V99, P11819, DOI 10.1073/pnas.182189999; Hafalla JCR, 2006, EUR J IMMUNOL, V36, P1179, DOI 10.1002/eji.200535712; Harris RC, 2012, J IMMUNOTHER, V35, P78, DOI 10.1097/CJI.0b013e31823731a4; Hartikka J, 2001, VACCINE, V19, P1911, DOI 10.1016/S0264-410X(00)00445-X; He S, 2008, J LEUKOCYTE BIOL, V84, P1549, DOI 10.1189/jlb.0708420; Hedstrom RC, 1998, INT J MOL MED, V2, P29; Hirao LA, 2008, VACCINE, V26, P440, DOI 10.1016/j.vaccine.2007.10.041; Hirao LA, 2011, J INFECT DIS, V203, P95, DOI 10.1093/infdis/jiq017; Hoffman SL, 2002, J INFECT DIS, V185, P1155, DOI 10.1086/339409; Hoffman SL, 2010, HUM VACCINES, V6, P97, DOI 10.4161/hv.6.1.10396; JAFFE RI, 1990, AM J TROP MED HYG, V42, P309, DOI 10.4269/ajtmh.1990.42.309; Kodama S, 2011, ACTA OTO-LARYNGOL, V131, P989, DOI 10.3109/00016489.2011.576429; Kumar KA, 2006, NATURE, V444, P937, DOI 10.1038/nature05361; Lapteva N, 2010, EXPERT OPIN BIOL TH, V10, P725, DOI 10.1517/14712591003657128; Limbach K, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-65; Loudon PT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011021; Luckay A, 2007, J VIROL, V81, P5257, DOI 10.1128/JVI.00055-07; Luke CJ, 1997, J INFECT DIS, V175, P91, DOI 10.1093/infdis/175.1.91; Luke TC, 2003, J EXP BIOL, V206, P3803, DOI 10.1242/jeb.00644; Ma X, 2012, SCAND J IMMUNOL, V76, P521, DOI 10.1111/j.1365-3083.2012.02765.x; Rodriguez AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037801; Mueller AK, 2005, NATURE, V433, P164, DOI 10.1038/nature03188; Nardin E, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P397; NARDIN EH, 1982, J EXP MED, V156, P20, DOI 10.1084/jem.156.1.20; Neimert-Andersson T, 2011, VACCINE, V29, P8965, DOI 10.1016/j.vaccine.2011.09.041; Nguyen-Hoai T, 2012, CANCER GENE THER, V19, P880, DOI 10.1038/cgt.2012.78; Noland GS, 2010, VACCINE, V28, P2917, DOI 10.1016/j.vaccine.2010.02.055; NUSSENZWEIG RS, 1967, NATURE, V216, P160, DOI 10.1038/216160a0; Otten G, 2004, VACCINE, V22, P2489, DOI 10.1016/j.vaccine.2003.11.073; Patel V, 2010, VACCINE, V28, P4827, DOI 10.1016/j.vaccine.2010.04.064; PENNICA D, 1983, NATURE, V301, P214, DOI 10.1038/301214a0; Perales MA, 2002, CYTOKINES CELL MOL T, V7, P125, DOI 10.1080/13684730310000923; Persson C, 2002, J IMMUNOL, V169, P6681, DOI 10.4049/jimmunol.169.12.6681; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; RENIA L, 1993, J IMMUNOL, V150, P1471; Rodrigues EG, 1998, VACCINE, V16, P1812, DOI 10.1016/S0264-410X(98)00181-9; Rodrigues EG, 1997, J IMMUNOL, V158, P1268; RODRIGUES MM, 1991, INT IMMUNOL, V3, P579, DOI 10.1093/intimm/3.6.579; ROMERO P, 1989, NATURE, V341, P323, DOI 10.1038/341323a0; Rosati M, 2009, P NATL ACAD SCI USA, V106, P15831, DOI 10.1073/pnas.0902628106; Rosenberg SA, 2003, HUM GENE THER, V14, P709, DOI 10.1089/104303403765255110; Sano G, 2001, J EXP MED, V194, P173, DOI 10.1084/jem.194.2.173; Scheiblhofer S, 2001, EUR J IMMUNOL, V31, P692, DOI 10.1002/1521-4141(200103)31:3&lt;692::AID-IMMU692&gt;3.0.CO;2-Y; SCHELLER LF, 1994, INFECT IMMUN, V62, P4844, DOI 10.1128/IAI.62.11.4844-4847.1994; Schmidt NW, 2008, P NATL ACAD SCI USA, V105, P14017, DOI 10.1073/pnas.0805452105; Sedegah M, 2006, VACCINE, V24, P1921, DOI 10.1016/j.vaccine.2005.10.041; Sedegah M, 2003, J IMMUNOL, V171, P3148, DOI 10.4049/jimmunol.171.6.3148; Sedegah M, 2010, VACCINE, V28, P3055, DOI 10.1016/j.vaccine.2009.10.044; Seder RA, 2013, SCIENCE, V341, P1359, DOI 10.1126/science.1241800; Shin HN, 2012, NATURE, V491, P463, DOI 10.1038/nature11522; Shlapobersky M, 2012, J GEN VIROL, V93, P1305, DOI 10.1099/vir.0.040055-0; Shlapobersky M, 2009, VACCINE, V27, P6404, DOI 10.1016/j.vaccine.2009.06.087; Smith LR, 2010, VACCINE, V28, P2565, DOI 10.1016/j.vaccine.2010.01.029; Sun PF, 2003, J IMMUNOL, V171, P6961, DOI 10.4049/jimmunol.171.12.6961; Tsuji M, 2003, TRENDS PARASITOL, V19, P88, DOI 10.1016/S1471-4922(02)00053-3; Tsuji M, 2001, MOL IMMUNOL, V38, P433, DOI 10.1016/S0161-5890(01)00079-7; Vanderberg J, 2007, AM J PATHOL, V171, P1405, DOI 10.2353/ajpath.2007.070661; Vanderberg JP, 2004, INT J PARASITOL, V34, P991, DOI 10.1016/j.ijpara.2004.05.005; Veselenak RL, 2012, VACCINE, V30, P7046, DOI 10.1016/j.vaccine.2012.09.057; Vichier-Guerre S, 2003, J PEPT RES, V62, P117, DOI 10.1034/j.1399-3011.2003.00074.x; Wang RB, 1996, J IMMUNOL, V157, P4061; WANG RB, 1995, J IMMUNOL, V154, P2784; WEISS WR, 1989, J IMMUNOL, V143, P4263; Witney AA, 2001, MOL BIOCHEM PARASIT, V118, P233, DOI 10.1016/S0166-6851(01)00372-3; Wu YY, 2007, INFECT IMMUN, V75, P4357, DOI 10.1128/IAI.01660-06; Yamazaki T, 2008, J IMMUNOL, V181, P8391, DOI 10.4049/jimmunol.181.12.8391; ZAVALA F, 1991, RES IMMUNOL, V142, P654, DOI 10.1016/0923-2494(91)90144-8; ZAVALA F, 1985, SCIENCE, V228, P1436, DOI 10.1126/science.2409595; Zhao XJ, 2005, BIOMATERIALS, V26, P5048, DOI 10.1016/j.biomaterials.2004.12.003; Zheng Q, 2011, VACCINE, V29, P763, DOI 10.1016/j.vaccine.2010.11.014	94	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90413	10.1371/journal.pone.0090413	http://dx.doi.org/10.1371/journal.pone.0090413			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599116	gold, Green Submitted, Green Published			2022-12-27	WOS:000332479400072
J	Shen, HX; Cao, JL; Hong, ZQ; Liu, K; Shi, J; Ding, L; Zhang, HD; Du, C; Li, Q; Zhang, ZD; Zhu, BL				Shen, Huanxi; Cao, Jinglian; Hong, Zhiqiang; Liu, Kai; Shi, Jian; Ding, Lu; Zhang, Hengdong; Du, Cheng; Li, Qian; Zhang, Zhengdong; Zhu, Baoli			A Functional Ser326Cys Polymorphism in hOGG1 Is Associated with Noise-Induced Hearing Loss in a Chinese Population	PLOS ONE			English	Article							BASE EXCISION-REPAIR; OXIDATIVE DNA-DAMAGE; GENE POLYMORPHISMS; INCREASES SUSCEPTIBILITY; OCCUPATIONAL-EXPOSURE; INNER-EAR; RISK; CANCER; WORKERS; 8-HYDROXYGUANINE	DNA damage to cochlear hair cells caused by 8-oxoguanine (8-oxoG) is essential for the development of noise-induced hearing loss (NIHL). Human 8-oxoG DNA glycosylase1 (hOGG1) is a key enzyme in the base excision repair (BER) pathway that eliminates 8-oxoG. Many epidemiological and functional studies have suggested that the hOGG1 Ser326Cys polymorphism (rs1052133) is associated with many diseases. The purpose of this investigation was to investigate whether the hOGG1 Ser326Cys polymorphism in the human BER pathway is associated with genetic susceptibility to NIHL in a Chinese population. This polymorphism was genotyped among 612 workers with NIHL and 615 workers with normal hearing. We found that individuals with the hOGG1 Cys/Cys genotype had a statistically significantly increased risk of NIHL compared with those who carried the hOGG1 Ser/Ser genotype (adjusted OR = 1.59, 95% CI = 1.13-2.25) and this increased risk was more pronounced among the workers in the 15- to 25- and >25-year noise exposure time, 85-92 dB(A) noise exposure level, ever smoking, and ever drinking groups, similar effects were also observed in a recessive model. In summary, our data suggested that the hOGG1 Cys/Cys genotype may be a genetic susceptibility marker for NIHL in the Chinese Han population.	[Shen, Huanxi; Hong, Zhiqiang; Shi, Jian; Du, Cheng] Kunshan Municipal Ctr Dis Prevent & Control, Kunshan, Peoples R China; [Shen, Huanxi; Cao, Jinglian; Ding, Lu; Zhang, Zhengdong; Zhu, Baoli] Nanjing Med Univ, Dept Environm Genom, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Ctr Canc, Nanjing, Jiangsu, Peoples R China; [Cao, Jinglian; Ding, Lu; Zhang, Hengdong; Zhu, Baoli] Jiangsu Prov Ctr Dis Prevent & Control, Inst Occupat Dis Prevent, Nanjing, Jiangsu, Peoples R China; [Liu, Kai] Drum Tower Hosp Grp Nanjing, Yizheng Hosp, Dept Dis Prevent & Control, Yizheng, Peoples R China; [Zhang, Zhengdong] Nanjing Med Univ, Sch Publ Hlth, Dept Genet Toxicol, Key Lab Modern Toxicol,Minist Educ, Nanjing, Jiangsu, Peoples R China; [Li, Qian] First Peoples Hosp Kunshan, Kunshan, Peoples R China	Nanjing Medical University; Nanjing Medical University	Zhang, ZD (corresponding author), Nanjing Med Univ, Dept Environm Genom, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Ctr Canc, Nanjing, Jiangsu, Peoples R China.	drzdzhang@gmail.com; zhubl@jscdc.cn	zhang, zheng/HCH-9684-2022		Jiangsu Province's Outstanding Medical Academic Leader program [LJ201130]; Natural Science Foundation of Jiangsu Province [BK2010080]; Key Program for Basic Research of Jiangsu Provincial Department of Education [08KJA330001]	Jiangsu Province's Outstanding Medical Academic Leader program; Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Key Program for Basic Research of Jiangsu Provincial Department of Education	This study was mainly supported by Jiangsu Province's Outstanding Medical Academic Leader program (LJ201130), and was partly supported by Natural Science Foundation of Jiangsu Province (BK2010080), the Key Program for Basic Research of Jiangsu Provincial Department of Education (08KJA330001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bravard A, 2009, CANCER RES, V69, P3642, DOI 10.1158/0008-5472.CAN-08-3943; CHENG KC, 1992, J BIOL CHEM, V267, P166; Christmann M, 2003, TOXICOLOGY, V193, P3, DOI 10.1016/S0300-483X(03)00287-7; Collins AR, 2007, MOL ASPECTS MED, V28, P307, DOI 10.1016/j.mam.2007.05.005; Curhan SG, 2011, EAR HEARING, V32, P46, DOI 10.1097/AUD.0b013e3181f46a2f; Dahle J, 2008, CANCER LETT, V267, P18, DOI 10.1016/j.canlet.2008.03.002; Fortunato G, 2004, CLIN CHEM, V50, P2012, DOI 10.1373/clinchem.2004.037788; Goukassian D, 2000, FASEB J, V14, P1325, DOI 10.1096/fj.14.10.1325; Henderson D, 2006, EAR HEARING, V27, P1, DOI 10.1097/01.aud.0000191942.36672.f3; Hill JW, 2006, NUCLEIC ACIDS RES, V34, P1620, DOI 10.1093/nar/gkl060; Holme RH, 2004, JARO-J ASSOC RES OTO, V5, P66, DOI 10.1007/s10162-003-4021-2; Hung RJ, 2005, AM J EPIDEMIOL, V162, P925, DOI 10.1093/aje/kwi318; Itoh A, 2001, PUBLIC HEALTH, V115, P192; Jacono AA, 1998, HEARING RES, V117, P31, DOI 10.1016/S0378-5955(97)00214-1; Jiao XY, 2007, INT J CANCER, V121, P501, DOI 10.1002/ijc.22748; Karlsmose B, 2000, BRIT J AUDIOL, V34, P47, DOI 10.3109/03005364000000117; Kim JI, 2003, WORLD J GASTROENTERO, V9, P956; Kohno T, 1998, ONCOGENE, V16, P3219, DOI 10.1038/sj.onc.1201872; Konings A, 2009, ANN HUM GENET, V73, P215, DOI 10.1111/j.1469-1809.2008.00499.x; Konings A, 2007, HUM MOL GENET, V16, P1872, DOI 10.1093/hmg/ddm135; Konings A, 2009, EAR HEARING, V30, P151, DOI 10.1097/AUD.0b013e3181987080; Konings A, 2009, EUR J HUM GENET, V17, P329, DOI 10.1038/ejhg.2008.172; Kozel PJ, 2002, HEARING RES, V164, P231, DOI 10.1016/S0378-5955(01)00420-8; Li Q, 2011, CANCER SCI, V102, P1123, DOI 10.1111/j.1349-7006.2011.01928.x; Li XT, 2013, J OCCUP HEALTH, V55, P56, DOI 10.1539/joh.12-0242-OA; Mizoue T, 2003, OCCUP ENVIRON MED, V60, P56, DOI 10.1136/oem.60.1.56; Nakamura M, 2001, J Epidemiol, V11, P81; Ohlemiller KK, 1999, AUDIOL NEURO-OTOL, V4, P237, DOI 10.1159/000013847; Ohlemiller KK, 2000, JARO-J ASSOC RES OTO, V1, P243, DOI 10.1007/s101620010043; Okasaka T, 2009, J HUM GENET, V54, P739, DOI 10.1038/jhg.2009.108; Palmer KT, 2004, OCCUP ENVIRON MED, V61, P340, DOI 10.1136/oem.2003.009183; Pawelczyk M, 2009, ANN HUM GENET, V73, P411, DOI 10.1111/j.1469-1809.2009.00521.x; Peng T, 2003, WORLD J GASTROENTERO, V9, P2186; Popelka MM, 2000, J AM GERIATR SOC, V48, P1273, DOI 10.1111/j.1532-5415.2000.tb02601.x; Rabinowitz PM, 2002, HEARING RES, V173, P164, DOI 10.1016/S0378-5955(02)00350-7; Shen HX, 2012, J OCCUP ENVIRON MED, V54, P1157, DOI 10.1097/JOM.0b013e31825902ce; Sliwinska-Kowalska M, 2004, J OCCUP ENVIRON MED, V46, P30, DOI 10.1097/01.jom.0000105912.29242.5b; Sliwinska-Kowalska M, 2013, MUTAT RES-REV MUTAT, V752, P61, DOI 10.1016/j.mrrev.2012.11.001; Totonchy MB, 2013, BRAIN, V136, P194, DOI 10.1093/brain/aws317; Van Laer L, 2006, HUM MUTAT, V27, P786, DOI 10.1002/humu.20360; Xing DY, 2001, INT J CANCER, V95, P140, DOI 10.1002/1097-0215(20010520)95:3&lt;140::AID-IJC1024&gt;3.0.CO;2-2; Xu JF, 2002, CANCER RES, V62, P2253; Yamane A, 2004, CARCINOGENESIS, V25, P1689, DOI 10.1093/carcin/bgh166; Yang M, 2006, CELL STRESS CHAPERON, V11, P233, DOI 10.1379/CSC-192R.1	44	28	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e89662	10.1371/journal.pone.0089662	http://dx.doi.org/10.1371/journal.pone.0089662			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599382	Green Submitted, Green Published, gold			2022-12-27	WOS:000332479400023
J	Zhang, Q; Jorgensen, TJD; Nielsen, PE; Mollegaard, NE				Zhang, Qiang; Jorgensen, Thomas J. D.; Nielsen, Peter E.; Mollegaard, Niels Erik			A Phosphorylation Tag for Uranyl Mediated Protein Purification and Photo Assisted Tag Removal	PLOS ONE			English	Article							RECOMBINANT PROTEINS; ESCHERICHIA-COLI; AFFINITY TAGS; FUSION PROTEINS; KINASE CK2; CLEAVAGE; CHROMATOGRAPHY; PEPTIDES; STRATEGIES; THROMBIN	Most protein purification procedures include an affinity tag fused to either the N or C-terminal end of the protein of interest as well as a procedure for tag removal. Tag removal is not straightforward and especially tag removal from the C-terminal end is a challenge due to the characteristics of enzymes available for this purpose. In the present study, we demonstrate the utility of the divalent uranyl ion in a new procedure for protein purification and tag removal. By employment of a GFP (green florescence protein) recombinant protein we show that uranyl binding to a phosphorylated C-terminal tag enables target protein purification from an E. coli extract by immobilized uranyl affinity chromatography. Subsequently, the tag can be efficiently removed by UV-irradiation assisted uranyl photocleavage. We therefore suggest that the divalent uranyl ion (UO22+) may provide a dual function in protein purification and subsequent C-terminal tag removal procedures.	[Zhang, Qiang; Nielsen, Peter E.; Mollegaard, Niels Erik] Univ Copenhagen, Dept Cellular & Mol Med, Fac Hlth Sci, Copenhagen N, Denmark; [Jorgensen, Thomas J. D.] Univ Southern Denmark, Dept Biochem & Mol Biol, Odense M, Denmark	University of Copenhagen; University of Southern Denmark	Mollegaard, NE (corresponding author), Univ Copenhagen, Dept Cellular & Mol Med, Fac Hlth Sci, Copenhagen N, Denmark.	nielsem@sund.ku.dk		/0000-0001-8771-330X; Mollegaard, Niels Erik/0000-0002-8255-3711; Jorgensen, Thomas J.D./0000-0002-7149-316X	Faculty of Health Sciences, University of Copenhagen	Faculty of Health Sciences, University of Copenhagen	Faculty of Health Sciences, University of Copenhagen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Araujo APU, 2000, BIOCHEM BIOPH RES CO, V272, P480, DOI 10.1006/bbrc.2000.2802; Arnau J, 2006, PROTEIN EXPRES PURIF, V48, P1, DOI 10.1016/j.pep.2005.12.002; Austin BP, 2011, PROTEIN EXPRES PURIF, V77, P53, DOI 10.1016/j.pep.2010.11.005; Chant A, 2005, PROTEIN EXPRES PURIF, V39, P152, DOI 10.1016/j.pep.2004.10.017; COLLINSRACIE LA, 1995, BIO-TECHNOL, V13, P982, DOI 10.1038/nbt0995-982; Duff MR, 2006, ANGEW CHEM INT EDIT, V45, P137, DOI 10.1002/anie.200502344; Fairlie WD, 2002, PROTEIN EXPRES PURIF, V26, P171; Goltermann L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010104; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; Jenny RJ, 2003, PROTEIN EXPRES PURIF, V31, P1, DOI 10.1016/S1046-5928(03)00168-2; Kenig M, 2006, J CHROMATOGR A, V1101, P293, DOI 10.1016/j.chroma.2005.09.089; Kristensen LH, 2008, CHEMBIOCHEM, V9, P2377, DOI 10.1002/cbic.200800387; Lichty JJ, 2005, PROTEIN EXPRES PURIF, V41, P98, DOI 10.1016/j.pep.2005.01.019; Liew OW, 2005, PROTEIN EXPRES PURIF, V41, P332, DOI 10.1016/j.pep.2005.03.006; Macek B, 2008, MOL CELL PROTEOMICS, V7, P299, DOI 10.1074/mcp.M700311-MCP200; MCCLELLAND M, 1984, P NATL ACAD SCI-BIOL, V81, P983, DOI 10.1073/pnas.81.4.983; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; MEGGIO F, 1994, CELL MOL BIOL RES, V40, P401; MORAND K, 1993, RAPID COMMUN MASS SP, V7, P738, DOI 10.1002/rcm.1290070811; NAGAI K, 1984, NATURE, V309, P810, DOI 10.1038/309810a0; Nilsson J, 1997, PROTEIN EXPRES PURIF, V11, P1, DOI 10.1006/prep.1997.0767; Pardoux R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041922; Pedersen J, 1999, PROTEIN EXPRES PURIF, V15, P389, DOI 10.1006/prep.1999.1038; Posewitz MC, 1999, ANAL CHEM, V71, P2883, DOI 10.1021/ac981409y; Rais-Beghdadi C, 1998, APPL BIOCHEM BIOTECH, V74, P95, DOI 10.1007/BF02787176; Renzi F, 2006, ACTA CRYSTALLOGR F, V62, P298, DOI 10.1107/S1744309106006373; Roggero MA, 1997, FEBS LETT, V408, P285, DOI 10.1016/S0014-5793(97)00441-9; Sykora C, 2007, PROTEIN PEPTIDE LETT, V14, P489, DOI 10.2174/092986607780782849; TAN AK, 1995, BIOCHEMISTRY-US, V34, P5811, DOI 10.1021/bi00017a012; Terpe K, 2003, APPL MICROBIOL BIOT, V60, P523, DOI 10.1007/s00253-002-1158-6; Waugh DS, 2011, PROTEIN EXPRES PURIF, V80, P283, DOI 10.1016/j.pep.2011.08.005; Waugh DS, 2005, TRENDS BIOTECHNOL, V23, P316, DOI 10.1016/j.tibtech.2005.03.012; Woestenenk Esmeralda A., 2004, Journal of Structural and Functional Genomics, V5, P217, DOI 10.1023/B:jsfg.0000031965.37625.0e	33	4	4	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e91138	10.1371/journal.pone.0091138	http://dx.doi.org/10.1371/journal.pone.0091138			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599526	Green Submitted, Green Published, gold			2022-12-27	WOS:000332479400156
J	Ding, YL; Shih, YH; Tsai, FY; Leong, MK				Ding, Yi-Lung; Shih, Yu-Hsuan; Tsai, Fu-Yuan; Leong, Max K.			In Silico Prediction of Inhibition of Promiscuous Breast Cancer Resistance Protein (BCRP/ABCG2)	PLOS ONE			English	Article							VECTOR MACHINE PHE/SVM; MULTIDRUG-RESISTANCE; EXTERNAL VALIDATION; DRUG TRANSPORTERS; ABC TRANSPORTERS; P-GLYCOPROTEIN; RECEPTOR; PHARMACOKINETICS; SELECTION; METRICS	Background: Breast cancer resistant protein has an essential role in active transport of endogenous substances and xenobiotics across extracellular and intracellular membranes along with P-glycoprotein. It also plays a major role in multiple drug resistance and permeation of blood-brain barrier. Therefore, it is of great importance to derive theoretical models to predict the inhibition of both transporters in the process of drug discovery and development. Hitherto, very limited BCRP inhibition predictive models have been proposed as compared with its P-gp counterpart. Methodology/Principal Findings: An in silico BCRP inhibition model was developed in this study using the pharmacophore ensemble/support vector machine scheme to take into account the promiscuous nature of BCRP. The predictions by the PhE/SVM model were found to be in good agreement with the observed values for those molecules in the training set (n = 22, r(2) = 0.82, q(CV)(2) = 0.73, RMSE = 0.40, s = 0.24), test set (n = 97, q(2) = 0.75-0.89, RMSE = 0.31, s = 0.21), and outlier set (n = 16, q(2) = 0.72-0.91, RMSE = 0.29, s = 0.17). When subjected to a variety of statistical validations, the developed PhE/SVM model consistently met the most stringent criteria. A mock test by HIV protease inhibitors also asserted its predictivity. Conclusions/Significance: It was found that this accurate, fast, and robust PhE/SVM model can be employed to predict the BCRP inhibition of structurally diverse molecules that otherwise cannot be carried out by any other methods in a high-throughput fashion to design therapeutic agents with insignificant drug toxicity and unfavorable drug-drug interactions mediated by BCRP to enhance clinical efficacy and/or circumvent drug resistance.	[Ding, Yi-Lung; Shih, Yu-Hsuan; Leong, Max K.] Natl Dong Hwa Univ, Dept Chem, Shoufeng, Hualien, Taiwan; [Tsai, Fu-Yuan] Chang Gung Univ, Ctr Gen Educ, Taoyuan, Taiwan; [Leong, Max K.] Natl Dong Hwa Univ, Dept Life Sci, Shoufeng, Hualien, Taiwan; [Leong, Max K.] Natl Dong Hwa Univ, Inst Biotechnol, Shoufeng, Hualien, Taiwan; [Leong, Max K.] Mennonite Christian Hosp, Dept Med Res & Teaching, Hualien, Taiwan	National Dong Hwa University; Chang Gung University; National Dong Hwa University; National Dong Hwa University	Leong, MK (corresponding author), Natl Dong Hwa Univ, Dept Chem, Shoufeng, Hualien, Taiwan.	leong@mail.ndhu.edu.tw			National Science Council, Taiwan	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was funded by the National Science Council, Taiwan (http://web1.nsc.gov.tw/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2011, CURR PHARM DESIGN, V17, P2793, DOI 10.2174/138161211797440186; Allikmets R, 1998, CANCER RES, V58, P5337; BREIMAN L, 1992, INT STAT REV, V60, P291, DOI 10.2307/1403680; Casalegno M, 2008, J CHEM INF MODEL, V48, P1592, DOI 10.1021/ci7004065; Chang C, 2006, ADV DRUG DELIVER REV, V58, P1431, DOI 10.1016/j.addr.2006.09.006; Chang G, 2003, FEBS LETT, V555, P102, DOI 10.1016/S0014-5793(03)01085-8; CHANG G, 1989, J AM CHEM SOC, V111, P4379, DOI 10.1021/ja00194a035; Chen CN, 2011, CHEM RES TOXICOL, V24, P1765, DOI 10.1021/tx200310j; Chirico N, 2012, J CHEM INF MODEL, V52, P2044, DOI 10.1021/ci300084j; Ciardiello F, 2008, NEW ENGL J MED, V358, P1160, DOI 10.1056/NEJMra0707704; Consonni V, 2010, J CHEMOMETR, V24, P194, DOI 10.1002/cem.1290; Cramer J, 2007, CHEMMEDCHEM, V2, P1783, DOI 10.1002/cmdc.200700160; Decleves X, 2011, CURR DRUG METAB, V12, P732, DOI 10.2174/138920011798357024; Ecker GF, 2008, DRUG DISCOV TODAY, V13, P311, DOI 10.1016/j.drudis.2007.12.012; El Kamar FG, 2004, DIGEST LIVER DIS, V36, P355, DOI 10.1016/j.dld.2003.10.019; Elmeliegy MA, 2011, CLIN CANCER RES, V17, P89, DOI 10.1158/1078-0432.CCR-10-1934; Evans DA, 2007, J CHEM INF MODEL, V47, P1248, DOI 10.1021/ci7000082; Gandhi YA, 2009, AAPS J, V11, P541, DOI 10.1208/s12248-009-9132-1; Gerstner ER, 2007, J CLIN ONCOL, V25, P2306, DOI 10.1200/JCO.2006.10.0677; GNANADESIKAN R, 1972, BIOMETRICS, V28, P81, DOI 10.2307/2528963; Golbraikh A, 2003, J COMPUT AID MOL DES, V17, P241, DOI 10.1023/A:1025386326946; Gupta A, 2004, J PHARMACOL EXP THER, V310, P334, DOI 10.1124/jpet.104.065342; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI [10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P, 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X]; Hou XN, 2011, MOL CANCER THER, V10, P117, DOI 10.1158/1535-7163.MCT-10-0438; Hu M, 2013, EXPERT OPIN DRUG MET, V14, P1283; Hu MA, 2011, EXPERT OPIN DRUG MET, V7, P49, DOI 10.1517/17425255.2011.538383; Huse JT, 2010, NAT REV CANCER, V10, P319, DOI 10.1038/nrc2818; Ishikawa T, 2012, MINI-REV MED CHEM, V12, P505, DOI 10.2174/138955712800493825; Juvale K, 2012, BIOORG MED CHEM LETT, V22, P6766, DOI 10.1016/j.bmcl.2012.08.024; Juvale K, 2012, BIOORGAN MED CHEM, V20, P346, DOI 10.1016/j.bmc.2011.10.074; Klaassen CD, 2010, PHARMACOL REV, V62, P1, DOI 10.1124/pr.109.002014; Kolossvary I, 1996, J AM CHEM SOC, V118, P5011, DOI 10.1021/ja952478m; Lagorce D, 2011, ADMET MED CHEMISTS, P29; Leong MK, 2008, MED CHEM, V4, P396, DOI 10.2174/157340608784872226; Leong MK, 2007, CHEM RES TOXICOL, V20, P217, DOI 10.1021/tx060230c; Leong MK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033829; Leong MK, 2010, TOXICOL SCI, V116, P498, DOI 10.1093/toxsci/kfq159; Leong MK, 2009, PHARM RES-DORDR, V26, P987, DOI 10.1007/s11095-008-9807-9; Lexa KW, 2012, Q REV BIOPHYS, V45, P301, DOI 10.1017/S0033583512000066; Li H, 2000, IUL BIOTECH, V2, P171; Lin JH, 2003, CLIN PHARMACOKINET, V42, P59, DOI 10.2165/00003088-200342010-00003; Litman T, 2001, CELL MOL LIFE SCI, V58, P931, DOI 10.1007/PL00000912; Mao QC, 2005, AAPS J, V7, pE118, DOI 10.1208/aapsj070112; Matsson P, 2007, J PHARMACOL EXP THER, V323, P19, DOI 10.1124/jpet.107.124768; Muenster U, 2008, PHARM RES-DORDR, V25, P2320, DOI 10.1007/s11095-008-9632-1; Nicolle E, 2009, ADV DRUG DELIVER REV, V61, P34, DOI 10.1016/j.addr.2008.10.004; Oh Y, 2009, CANCER, V115, P2930, DOI 10.1002/cncr.24333; Ojha PK, 2011, CHEMOMETR INTELL LAB, V107, P194, DOI 10.1016/j.chemolab.2011.03.011; Pan YM, 2013, MOL PHARMACEUT, V10, P1236, DOI 10.1021/mp300547h; Pick A, 2008, BIOORGAN MED CHEM, V16, P8224, DOI 10.1016/j.bmc.2008.07.034; Pick A, 2011, BIOORGAN MED CHEM, V19, P2090, DOI 10.1016/j.bmc.2010.12.043; Pick A, 2010, BIOORG MED CHEM LETT, V20, P180, DOI 10.1016/j.bmcl.2009.11.004; Poguntke M, 2010, EXPERT OPIN DRUG MET, V6, P1363, DOI 10.1517/17425255.2010.519700; Polgar O, 2008, EXPERT OPIN DRUG MET, V4, P1, DOI 10.1517/17425255.4.1.1 ; Reyes CL, 2005, SCIENCE, V308, P1028, DOI 10.1126/science.1107733; Reymond JL, 2010, MEDCHEMCOMM, V1, P30, DOI 10.1039/c0md00020e; Roy K, 2012, J CHEM INF MODEL, V52, P396, DOI 10.1021/ci200520g; Schnepf R, 2013, EXPERT OPIN DRUG MET, V9, P287, DOI 10.1517/17425255.2013.742063; Schuurmann G, 2008, J CHEM INF MODEL, V48, P2140, DOI 10.1021/ci800253u; Shi Z, 2011, CANCER RES, V71, P3029, DOI 10.1158/0008-5472.CAN-10-3820; Shukla S, 2008, EXPERT OPIN DRUG MET, V4, P205, DOI 10.1517/17425255.4.2.205; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sim HM, 2011, CHEMMEDCHEM, V6, P713, DOI 10.1002/cmdc.201000520; Sim HM, 2008, EUR J PHARM SCI, V35, P293, DOI 10.1016/j.ejps.2008.07.008; STILL WC, 1990, J AM CHEM SOC, V112, P6127, DOI 10.1021/ja00172a038; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Szakacs G, 2008, DRUG DISCOV TODAY, V13, P379, DOI 10.1016/j.drudis.2007.12.010; Tan KP, 2010, MOL PHARMACOL, V78, P175, DOI 10.1124/mol.110.065078; Tomlinson B, 2010, CLIN PHARMACOL THER, V87, P558, DOI 10.1038/clpt.2009.232; Vahakangas K, 2009, BRIT J PHARMACOL, V158, P665, DOI 10.1111/j.1476-5381.2009.00336.x; Watkins RE, 2001, SCIENCE, V292, P2329, DOI 10.1126/science.1060762; Wei YX, 2012, MOL CANCER THER, V11, P1693, DOI 10.1158/1535-7163.MCT-12-0215; Weiss J, 2007, J ANTIMICROB CHEMOTH, V59, P238, DOI 10.1093/jac/dkl474	73	14	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e90689	10.1371/journal.pone.0090689	http://dx.doi.org/10.1371/journal.pone.0090689			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614353	Green Published, Green Submitted, gold			2022-12-27	WOS:000332839300034
J	Fowler, RC; Hanson, ND				Fowler, Randal C.; Hanson, Nancy D.			Emergence of Carbapenem Resistance Due to the Novel Insertion Sequence ISPa8 in Pseudomonas aeruginosa	PLOS ONE			English	Article							CYSTIC-FIBROSIS PATIENTS; ANTIMICROBIAL RESISTANCE; OPRD; IMIPENEM; GENE; MECHANISMS; EXPRESSION; STRAINS; IMPACT	Chronic lung infections due to the persistence of Pseudomonas aeruginosa in cystic fibrosis patients are typically associated with the emergence of antibiotic resistance. The purpose of this study was to investigate the mechanisms responsible for the emergence of carbapenem resistance when a clinical isolate of P. aeruginosa collected from a patient with cystic fibrosis was challenged with meropenem. Nine carbapenem-resistant mutants were selected with subinhibitory concentrations of meropenem from a clinical isolate of P. aeruginosa and characterized for carbapenem resistance. Increased carbapenem MICs were associated with the identification of the novel insertion sequence ISPa8 within oprD or its promoter region in all the mutants. The position of ISPa8 was different for each of the mutants evaluated. In addition, Southern blot analyses identified multiple copies of ISPa8 within the genomes of the mutants and their parent isolate. These data demonstrate that transposition of IS elements within the Pseudomonas genome can influence antibiotic susceptibility. Understanding the selective pressures associated with the emergence of antibiotic resistance is critical for the judicious use of antimicrobial chemotherapy and the successful treatment of bacterial infections.	[Fowler, Randal C.; Hanson, Nancy D.] Creighton Univ, Sch Med, Dept Med Microbiol & Immunol, Ctr Res Antiinfect & Biotechnol, Omaha, NE 68178 USA	Creighton University	Hanson, ND (corresponding author), Creighton Univ, Sch Med, Dept Med Microbiol & Immunol, Ctr Res Antiinfect & Biotechnol, Omaha, NE 68178 USA.	ndhanson@creighton.edu		Fowler, Randal/0000-0002-6703-0488	Johnson and Johnson Pharmaceutical Research and Development; Creighton University	Johnson and Johnson Pharmaceutical Research and Development(Johnson & JohnsonJohnson & Johnson USA); Creighton University	This work was supported in part by a research grant from Johnson and Johnson Pharmaceutical Research and Development and by Creighton University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade SS, 2003, J ANTIMICROB CHEMOTH, V52, P140, DOI 10.1093/jac/dkg270; Boutoille D, 2004, FEMS MICROBIOL LETT, V230, P143, DOI 10.1016/S0378-1097(03)00882-6; Cao B, 2004, J HOSP INFECT, V57, P112, DOI 10.1016/j.jhin.2004.03.021; Carmeli Y, 1999, ANTIMICROB AGENTS CH, V43, P1379, DOI 10.1128/AAC.43.6.1379; Clinical and Laboratory Standards Institute (CLSI), 2012, M100S22 CLIN LAB S S; Depardieu F, 2007, CLIN MICROBIOL REV, V20, P79, DOI 10.1128/CMR.00015-06; Diene SM, 2013, INT J ANTIMICROB AG, V42, P268, DOI 10.1016/j.ijantimicag.2013.06.001; Doumith M, 2009, J ANTIMICROB CHEMOTH, V63, P659, DOI 10.1093/jac/dkp029; Evans JC, 2007, ANTIMICROB AGENTS CH, V51, P3776, DOI 10.1128/AAC.00837-07; Freulet-Marriere MA, 2000, RES MICROBIOL, V151, P873, DOI 10.1016/S0923-2508(00)01154-2; Fujimura Shigeru, 2007, Journal of Infection and Chemotherapy, V13, P147, DOI 10.1007/s10156-007-0507-x; George AM, 2009, FEMS MICROBIOL LETT, V300, P153, DOI 10.1111/j.1574-6968.2009.01704.x; Goering RV, 2011, MOLECULAR MICROBIOLOGY: DIAGNOSTIC PRINCIPLES AND PRACTICE, SECOND EDITION, P167; Hsueh PR, 2005, INT J ANTIMICROB AG, V26, P463, DOI 10.1016/j.ijantimicag.2005.08.016; Kohler T, 1999, ANTIMICROB AGENTS CH, V43, P424, DOI 10.1128/AAC.43.2.424; Kresse A, 2006, ARCH MICROBIOL, V185, P245, DOI 10.1007/s00203-006-0089-5; Lepper PM, 2002, ANTIMICROB AGENTS CH, V46, P2920, DOI 10.1128/AAC.46.9.2920-2925.2002; Lister PD, 2009, CLIN MICROBIOL REV, V22, P582, DOI 10.1128/CMR.00040-09; Livermore DM, 2002, J ANTIMICROB CHEMOTH, V47, P247; Ochs MM, 1999, ANTIMICROB AGENTS CH, V43, P1085, DOI 10.1128/AAC.43.5.1085; Pai H, 2001, ANTIMICROB AGENTS CH, V45, P480, DOI 10.1128/AAC.45.2.480-484.2001; Pirnay JP, 2002, ENVIRON MICROBIOL, V4, P872, DOI 10.1046/j.1462-2920.2002.00281.x; Pluss-Suard C, 2013, ANTIMICROB AGENTS CH, V57, P1709, DOI 10.1128/AAC.01348-12; Rawling EG, 1998, J BACTERIOL, V180, P3556, DOI 10.1128/JB.180.14.3556-3562.1998; Ruiz-Martinez L, 2011, INT MICROBIOL, V14, P51, DOI 10.2436/20.1501.01.135; Sakyo S, 2006, J ANTIBIOT, V59, P220, DOI 10.1038/ja.2006.31; Sambrook J., 2001, MOL CLONING LAB MANU; Schmidtke AJ, 2006, ANTIMICROB AGENTS CH, V50, P2030, DOI 10.1128/AAC.01458-05; Wolter DJ, 2009, J ANTIMICROB CHEMOTH, V64, P294, DOI 10.1093/jac/dkp185; Wolter DJ, 2004, DIAGN MICR INFEC DIS, V50, P43, DOI 10.1016/j.diagmicrobio.2004.05.004; Wolter DJ, 2004, FEMS MICROBIOL LETT, V236, P137, DOI 10.1016/j.femsle.2004.05.039; WOODRUFF WA, 1989, J BACTERIOL, V171, P3304, DOI 10.1128/jb.171.6.3304-3309.1989	32	17	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91299	10.1371/journal.pone.0091299	http://dx.doi.org/10.1371/journal.pone.0091299			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614163	Green Submitted, gold, Green Published			2022-12-27	WOS:000332839300108
J	Iminjan, M; Amat, N; Li, XH; Upur, H; Ahmat, D; He, B				Iminjan, Mubarak; Amat, Nurmuhammat; Li, Xiao-Hui; Upur, Halmurat; Ahmat, Dilnur; He, Bin			Investigation into the Toxicity of Traditional Uyghur Medicine Quercus Infectoria Galls Water Extract	PLOS ONE			English	Article							CAM	Objective: Quercus infectoria galls (QIG) is being widely used in Traditional Uyghur Medicine. To gather preclinical safety information for the aqueous extract of QIG, a toxicity study was performed. Methods: Subject animals were randomized, and devided into exposure and control groups. In the acute toxicity phase, three different doses-5, 7.5, and 10 g/kg, respectively-were administered via enema to imprinting control region (ICR) mice. An experiment using the maximum tolerance dose (MTD) i.e.10 g/kg was also performed. Data were gathered for 14 days, and study parameters were clinical signs, body weight, general behavior, adverse effects and mortality. At the day 14, major organs of the subjects were examined histologically. Chronic toxicity was also evaluated in Wistar rats for over 180 consecutive days. The rats were divided into three groups with different doses of 0.2 g/kg, 0.8 g/kg, and 2 g/kg, QIG. Furthermore, observations were carried out in rabbits to investigate if there were signs of irritation. Results: In comparison to control group, acute, chronic toxicity and mortality were not significantly increased in exposure group. Conclusion: Study result suggests that the aqueous extract of QIG is unlikely to have significant toxicity and that clinical trials may proceed safely.	[Iminjan, Mubarak] Cent S Univ, XiangYa Hosp, Changsha, Hunan, Peoples R China; [Iminjan, Mubarak] Xinjiang Med Univ, Inst Pharmaceut Sci, Urumqi, Xinjiang, Peoples R China; [Amat, Nurmuhammat; Upur, Halmurat] Xinjiang Med Univ, Tradit Uyghur Med Inst, Urumqi, Xinjiang, Peoples R China; [Li, Xiao-Hui] Cent S Univ, Dept Pharm, Changsha, Hunan, Peoples R China; [Ahmat, Dilnur] Xinjiang Uyghur Autonomous Reg Petr Hosp, Dept Pharm, Urumqi, Peoples R China; [He, Bin] Xinjiang Uyghur Autonomous Reg Peoples Hosp, Dept Pharm, Urumqi, Xinjiang, Peoples R China	Central South University; Xinjiang Medical University; Xinjiang Medical University; Central South University	Amat, N (corresponding author), Xinjiang Med Univ, Tradit Uyghur Med Inst, Urumqi, Xinjiang, Peoples R China.	nur818@hotmail.com; halmurat@263.net			National Science and technology support program sub project of China [2006BA106A17-09]	National Science and technology support program sub project of China	This study was supported with funding from the National Science and technology support program sub project of China (2006BA106A17-09). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROCK WJ, 1995, FOOD CHEM TOXICOL, V33, P483, DOI 10.1016/0278-6915(95)00008-P; Chopra R.N., 1956, CSIR, V208, P255; Cooper EL, 2004, EVID-BASED COMPL ALT, V1, P215, DOI 10.1093/ecam/neh032; Cooper EL, 2005, EVID-BASED COMPL ALT, V2, P125, DOI 10.1093/ecam/neh094; DAR MS, 1979, PLANTA MED, V35, P156, DOI 10.1055/s-0028-1097197; DAR MS, 1976, J PHARM SCI, V65, P1791, DOI 10.1002/jps.2600651224; Everest A, 2005, J ETHNOBIOL ETHNOMED, V1, DOI 10.1186/1746-4269-1-6; [勾晓玉 GOU Xiao-Yu], 2009, [第四军医大学学报, Journal of the Fourth Military Medical University], V30, P501; Hamid H, 2005, PHARM BIOL, V43, P317, DOI 10.1080/13880200590951711; He J, 2009, WORLD J GASTROENTERO, V15, P3441; Huang JJ, 2010, WORLD J GASTROENTERO, V16, P350; Hwang JK, 2000, PLANTA MED, V66, P273, DOI 10.1055/s-2000-8569; IKRAM M, 1977, PLANTA MED, V31, P286, DOI 10.1055/s-0028-1097531; Kaur G, 2004, J ETHNOPHARMACOL, V90, P285, DOI 10.1016/j.jep.2003.10.009; Kaur G, 2008, CHEM-BIOL INTERACT, V171, P272, DOI 10.1016/j.cbi.2007.10.002; Mabeku LBK, 2007, J ETHNOPHARMACOL, V111, P598, DOI 10.1016/j.jep.2007.01.010; Mubarak I, 2012, CHINA J HOSP PHARM, V32, P1397; Mubarak I, 2011, SCI TECHNOLOGY REV, V29, P29; Nassirhadjy M, 2007, XINJIANG YIKE DA XUE, V29, P935; National Pharmacopoeia Committee, 2005, PHARM PEOPL REP CH 1; Olson H, 2000, REGUL TOXICOL PHARM, V32, P56, DOI 10.1006/rtph.2000.1399; ONDERDONK AB, 1985, DIGEST DIS SCI, V30, pS40, DOI 10.1007/BF01296973; Qin Y, 2009, J ETHNOPHARMACOL, V126, P543, DOI 10.1016/j.jep.2009.08.047; Tsao JCI, 2005, EVID-BASED COMPL ALT, V2, P149, DOI 10.1093/ecam/neh092; TWAIJ HAA, 1983, J ETHNOPHARMACOL, V9, P299, DOI 10.1016/0378-8741(83)90037-5; Wang J.Y., 2007, SHIZHEN GUOYI GUOYAO, V18, P2570; Wu HL, 2005, XINJIANG YIKEDA XUEB, V28, P35; Yamunarani K., 2005, Acta Phytopathologica et Entomologica Hungarica, V40, P43, DOI 10.1556/APhyt.40.2005.1-2.6; Yuan R., 2005, STUDY CHEM CONSTITUE; Zhu M, 2002, PHYTOTHER RES, V16, P276, DOI 10.1002/ptr.839	30	15	15	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90756	10.1371/journal.pone.0090756	http://dx.doi.org/10.1371/journal.pone.0090756			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608135	Green Submitted, gold, Green Published			2022-12-27	WOS:000332485800048
J	Thuss, SJ; Venkiteswaran, JJ; Schiff, SL				Thuss, Simon J.; Venkiteswaran, Jason J.; Schiff, Sherry L.			Proper Interpretation of Dissolved Nitrous Oxide Isotopes, Production Pathways, and Emissions Requires a Modelling Approach	PLOS ONE			English	Article							MASS-SPECTROMETRY; STABLE-ISOTOPE; NORTH PACIFIC; DUAL-ISOTOPE; N2O FLUXES; OXYGEN; DENITRIFICATION; RATIOS; RIVER; NITRIFICATION	Stable isotopes (delta N-15 and delta O-18) of the greenhouse gas N2O provide information about the sources and processes leading to N2O production and emission from aquatic ecosystems to the atmosphere. In turn, this describes the fate of nitrogen in the aquatic environment since N2O is an obligate intermediate of denitrification and can be a by-product of nitrification. However, due to exchange with the atmosphere, the delta values at typical concentrations in aquatic ecosystems differ significantly from both the source of N2O and the N2O emitted to the atmosphere. A dynamic model, SIDNO, was developed to explore the relationship between the isotopic ratios of N2O, N2O source, and the emitted N2O. If the N2O production rate or isotopic ratios vary, then the N2O concentration and isotopic ratios may vary or be constant, not necessarily concomitantly, depending on the synchronicity of production rate and source isotopic ratios. Thus prima facie interpretation of patterns in dissolved N2O concentrations and isotopic ratios is difficult. The dynamic model may be used to correctly interpret diel field data and allows for the estimation of the gas exchange coefficient, N2O production rate, and the production-weighted d values of the N2O source in aquatic ecosystems. Combining field data with these modelling efforts allows this critical piece of nitrogen cycling and N2O flux to the atmosphere to be assessed.	[Thuss, Simon J.; Venkiteswaran, Jason J.; Schiff, Sherry L.] Univ Waterloo, Dept Earth & Environm Sci, Waterloo, ON N2L 3G1, Canada	University of Waterloo	Venkiteswaran, JJ (corresponding author), Univ Waterloo, Dept Earth & Environm Sci, Waterloo, ON N2L 3G1, Canada.	jjvenkit@uwaterloo.ca		Venkiteswaran, Jason J./0000-0002-6574-7071	Natural Sciences and Engineering Research Council (NSERC); BIOCAP [336807-06]; NSERC; Environment Canada's Science Horizons Youth Internship Program	Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); BIOCAP; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Environment Canada's Science Horizons Youth Internship Program	Funding was provided by a Natural Sciences and Engineering Research Council (NSERC) and BIOCAP grant 336807-06 (SLS), an NSERC scholarship (SJT), and Environment Canada's Science Horizons Youth Internship Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An S, 2001, LIMNOL OCEANOGR, V46, P62, DOI 10.4319/lo.2001.46.1.0062; Aravena R., 2010, ENV ISOTOPES BIODEGR, P203; Baulch HM, 2012, FRESHWATER BIOL, V57, P509, DOI 10.1111/j.1365-2427.2011.02720.x; Baulch HM, 2011, ENVIRON SCI TECHNOL, V45, P4682, DOI 10.1021/es104116a; Beaulieu JJ, 2010, ENVIRON SCI TECHNOL, V44, P7527, DOI 10.1021/es1016735; Beaulieu JJ, 2011, P NATL ACAD SCI USA, V108, P214, DOI 10.1073/pnas.1011464108; Bol R, 2003, RAPID COMMUN MASS SP, V17, P2550, DOI 10.1002/rcm.1223; Boontanon N, 2000, NATURWISSENSCHAFTEN, V87, P188, DOI 10.1007/s001140050701; Bowen GJ, 2005, OECOLOGIA, V143, P337, DOI 10.1007/s00442-004-1813-y; Brenninkmeijer CAM, 1999, RAPID COMMUN MASS SP, V13, P2028, DOI 10.1002/(SICI)1097-0231(19991030)13:20<2028::AID-RCM751>3.0.CO;2-J; CHAPRA SC, 1991, J ENVIRON ENG-ASCE, V117, P640, DOI 10.1061/(ASCE)0733-9372(1991)117:5(640); Clough TJ, 2007, GLOBAL CHANGE BIOL, V13, P1016, DOI 10.1111/j.1365-2486.2007.01337.x; Clough TJ, 2006, GLOBAL CHANGE BIOL, V12, P352, DOI 10.1111/j.1365-2486.2005.01089.x; Denman KL, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P499; Dore JE, 1998, NATURE, V396, P63, DOI 10.1038/23921; Forster P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P129; Garnier J, 2007, HYDROBIOLOGIA, V588, P291, DOI 10.1007/s10750-007-0670-1; Harrison JA, 2005, AQUAT SCI, V67, P308, DOI 10.1007/s00027-005-0776-3; Hood JLA, 2014, AQUAT SCI, V76, P243, DOI 10.1007/s00027-013-0333-4; INOUE HY, 1994, CHEM GEOL, V113, P135, DOI 10.1016/0009-2541(94)90009-4; Kaiser J, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2003JD003613; KIM KR, 1990, NATURE, V347, P58, DOI 10.1038/347058a0; Kool DM, 2007, RAPID COMMUN MASS SP, V21, P3569, DOI 10.1002/rcm.3249; Kroeze C., 2005, ENVIRON SCI-TOKYO, V2, P159, DOI [10.1080/15693430500384671, DOI 10.1080/15693430500384671]; Laursen AE, 2004, FRESHWATER BIOL, V49, P1448, DOI 10.1111/j.1365-2427.2004.01280.x; Lide D. R., 1995, CRC HDB CHEM PHYS; Lorenzen J, 1998, APPL ENVIRON MICROB, V64, P3264; Mandernack KW, 2000, J GEOPHYS RES-ATMOS, V105, P17709, DOI 10.1029/2000JD900055; McElroy MB, 1996, GLOBAL BIOGEOCHEM CY, V10, P651, DOI 10.1029/96GB02346; Mengis M, 1999, GROUND WATER, V37, P448, DOI 10.1111/j.1745-6584.1999.tb01124.x; Naqvi SWA, 1998, NATURE, V394, P462, DOI 10.1038/28828; Park S, 2011, GLOBAL BIOGEOCHEM CY, V25, DOI 10.1029/2009GB003615; Perez T, 2001, J GEOPHYS RES-ATMOS, V106, P9869, DOI 10.1029/2000JD900809; PRINN R, 1990, J GEOPHYS RES-ATMOS, V95, P18369, DOI 10.1029/JD095iD11p18369; Prinn RG, 2000, J GEOPHYS RES-ATMOS, V105, P17751, DOI 10.1029/2000JD900141; Priscu JC, 2008, LIMNOL OCEANOGR, V53, P2439, DOI 10.4319/lo.2008.53.6.2439; Rahn T, 2000, GLOBAL BIOGEOCHEM CY, V14, P537, DOI 10.1029/1999GB900070; Reay DS, 2003, GLOBAL CHANGE BIOL, V9, P195, DOI 10.1046/j.1365-2486.2003.00584.x; Rock L, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD008330; Rockmann T, 2003, RAPID COMMUN MASS SP, V17, P1897, DOI 10.1002/rcm.1132; Rosamond MS, 2012, NAT GEOSCI, V5, P715, DOI [10.1038/ngeo1556, 10.1038/NGEO1556]; Rosamond MS, 2011, J ENVIRON QUAL, V40, P256, DOI 10.2134/jeq2010.0009; Snider DM, 2013, GEOCHIM COSMOCHIM AC, V112, P102, DOI 10.1016/j.gca.2013.03.003; Snider DM, 2012, GLOBAL CHANGE BIOL, V18, P356, DOI 10.1111/j.1365-2486.2011.02547.x; Snider DM, 2010, ENVIRON SCI TECHNOL, V44, P5358, DOI 10.1021/es1002567; Snider DM, 2009, GEOCHIM COSMOCHIM AC, V73, P877, DOI 10.1016/j.gca.2008.11.004; Spoelstra J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082706; Stein LY, 2003, ANNU REV EARTH PL SC, V31, P329, DOI 10.1146/annurev.earth.31.110502.080901; Sutka RL, 2006, APPL ENVIRON MICROB, V72, P638, DOI 10.1128/AEM.72.1.638-644.2006; Toyoda S, 1999, ANAL CHEM, V71, P4711, DOI 10.1021/ac9904563; Toyoda S, 2009, RAPID COMMUN MASS SP, V23, P809, DOI 10.1002/rcm.3945; Venkiteswaran JJ, 2007, OECOLOGIA, V153, P385, DOI 10.1007/s00442-007-0744-9; Venkiteswaran JJ, 2014, ENVIRON SCI TECHNOL, V48, P1566, DOI 10.1021/es500069j; Wada E., 1996, Mass spectrometry of soils., P177; WAHLEN M, 1985, NATURE, V313, P780, DOI 10.1038/313780a0; Well R, 2009, RAPID COMMUN MASS SP, V23, P2996, DOI 10.1002/rcm.4216; Well R, 2012, GEOCHIM COSMOCHIM AC, V90, P265, DOI 10.1016/j.gca.2012.04.045; Westley MB, 2006, DEEP-SEA RES PT II, V53, P1802, DOI 10.1016/j.dsr2.2006.03.012; Yoshinari T, 1997, MAR CHEM, V56, P253, DOI 10.1016/S0304-4203(96)00073-4; ZAFIRIOU OC, 1990, NATURE, V347, P15, DOI 10.1038/347015a0	60	5	5	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90641	10.1371/journal.pone.0090641	http://dx.doi.org/10.1371/journal.pone.0090641			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608915	Green Published, gold, Green Submitted			2022-12-27	WOS:000332485800040
J	Torres, JM; Espinosa, JC; Aguilar-Calvo, P; Herva, ME; Relano-Gines, A; Villa-Diaz, A; Morales, M; Parra, B; Alamillo, E; Brun, A; Castilla, J; Molina, S; Hawkins, SAC; Andreoletti, O				Torres, Juan-Maria; Espinosa, Juan-Carlos; Aguilar-Calvo, Patricia; Herva, Maria-Eugenia; Relano-Gines, Aroa; Villa-Diaz, Ana; Morales, Monica; Parra, Beatriz; Alamillo, Elia; Brun, Alejandro; Castilla, Joaquin; Molina, Susana; Hawkins, Steve A. C.; Andreoletti, Olivier			Elements Modulating the Prion Species Barrier and Its Passage Consequences	PLOS ONE			English	Article							BOVINE SPONGIFORM ENCEPHALOPATHY; CREUTZFELDT-JAKOB-DISEASE; MONOCLONAL-ANTIBODIES; PRPSC ACCUMULATION; MOUSE SCRAPIE; PROTEIN; MICE; AGENT; BSE; TRANSMISSION	The specific characteristics of Transmissible Spongiform Encephalopathy (TSE) strains may be altered during passage across a species barrier. In this study we investigated the biochemical and biological characteristics of Bovine Spongiform Encephalopathy (BSE) after transmission in both natural host species (cattle, sheep, pigs and mice) and in transgenic mice overexpressing the corresponding cellular prion protein (PrPC) in comparison with other non-BSE related prions from the same species. After these passages, most features of the BSE agent remained unchanged. BSE-derived agents only showed slight modifications in the biochemical properties of the accumulated PrPSc, which were demonstrated to be reversible upon re-inoculation into transgenic mice expressing bovine-PrPC. Transmission experiments in transgenic mice expressing bovine, porcine or human-PrP revealed that all BSE-derived agents were transmitted with no or a weak transmission barrier. In contrast, a high species barrier was observed for the non-BSE related prions that harboured an identical PrP amino acid sequence, supporting the theory that the prion transmission barrier is modulated by strain properties (presumably conformation-dependent) rather than by PrP amino acid sequence differences between host and donor. As identical results were observed with prions propagated either in natural hosts or in transgenic mouse models, we postulate that the species barrier and its passage consequences are uniquely governed by the host PrPC sequence and not influenced by other host genetic factors. The results presented herein reinforce the idea that the BSE agent is highly promiscuous, infecting other species, maintaining its properties in the new species, and even increasing its capabilities to jump to other species including humans. These data are essential for the development of an accurate risk assessment for BSE.	[Torres, Juan-Maria; Espinosa, Juan-Carlos; Aguilar-Calvo, Patricia; Herva, Maria-Eugenia; Relano-Gines, Aroa; Villa-Diaz, Ana; Morales, Monica; Parra, Beatriz; Alamillo, Elia; Brun, Alejandro; Castilla, Joaquin; Molina, Susana] Ctr Invest Sanidad Anim CISA INIA, Madrid, Spain; [Castilla, Joaquin] Basque Fdn Sci, CIC BioGUNE, Derio Bilbao, Bizkaia, Spain; [Castilla, Joaquin] Basque Fdn Sci, IKERBASQUE, Derio Bilbao, Bizkaia, Spain; [Hawkins, Steve A. C.] Anim Hlth & Vet Labs Agcy AHVLA New Haw, Addlestone, Surrey, England; [Andreoletti, Olivier] Ecole Natl Vet Toulouse, INRA, ENVT, UMR Interact Hote Agent Pathogene 1225, Toulouse, France	Basque Foundation for Science; CIC bioGUNE; Basque Foundation for Science; INRAE; Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse	Torres, JM (corresponding author), Ctr Invest Sanidad Anim CISA INIA, Madrid, Spain.	jmtorres@inia.es	Torres, Juan Maria/L-8768-2013; Brun, Alejandro/J-9808-2014; Hawkins, Stephen/F-1136-2011; Castilla, Joaquin/D-5261-2011; Molina, Susana/M-8969-2014; Espinosa, Juan Carlos/G-7783-2015; Camarzana, Monica Morales/E-6725-2015; Castilla, Joaquín/J-8414-2019	Torres, Juan Maria/0000-0003-0443-9232; Brun, Alejandro/0000-0001-7865-538X; Castilla, Joaquin/0000-0002-2216-1361; Molina, Susana/0000-0001-7737-5562; Espinosa, Juan Carlos/0000-0002-6719-9902; Camarzana, Monica Morales/0000-0001-9786-9076; Castilla, Joaquín/0000-0002-2216-1361; Villa Diaz, Ana/0000-0001-5419-3387; RELANO GINES, AROA/0000-0002-3906-6360	Spanish Ministerio de Ciencia e Innovacion [RTA2012-00004, AGL2005-03066]; European Union [CT-2001-01309, CT-2004-023183, CT2004-506579, CT2009-222887]	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); European Union(European Commission)	This work was supported by grants from the Spanish Ministerio de Ciencia e Innovacion (RTA2012-00004 and AGL2005-03066) and grants from the European Union (CT-2001-01309, CT-2004-023183, CT2004-506579 and CT2009-222887). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreoletti O, 2004, NAT MED, V10, P591, DOI 10.1038/nm1055; Andreoletti O, 2002, J GEN VIROL, V83, P2607, DOI 10.1099/0022-1317-83-10-2607; Brown DA, 2003, NEUROPATH APPL NEURO, V29, P262, DOI 10.1046/j.1365-2990.2003.00462.x; Bruce ME, 2003, BRIT MED BULL, V66, P99, DOI 10.1093/bmb/66.1.99; BRUCE ME, 1987, J GEN VIROL, V68, P79, DOI 10.1099/0022-1317-68-1-79; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; Castilla J, 2004, J NEUROSCI, V24, P5063, DOI 10.1523/JNEUROSCI.5400-03.2004; Castilla J, 2003, ARCH VIROL, V148, P677, DOI 10.1007/s00705-002-0958-4; Chen SG, 2002, NEURON, V34, P854, DOI 10.1016/S0896-6273(02)00736-5; Eloit M, 2005, VET REC, V156, P523, DOI 10.1136/vr.156.16.523-b; Espinosa JC, 2007, J VIROL, V81, P835, DOI 10.1128/JVI.01356-06; Espinosa JC, 2009, EMERG INFECT DIS, V15, P1214, DOI 10.3201/eid1508.081218; Feraudet C, 2005, J BIOL CHEM, V280, P11247, DOI 10.1074/jbc.M407006200; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; FRASER H, 1968, J COMP PATHOL, V78, P301, DOI 10.1016/0021-9975(68)90006-6; Hill AF, 1997, NATURE, V389, P448, DOI 10.1038/38925; Hunter N, 2003, BRIT MED BULL, V66, P171, DOI 10.1093/bmb/66.1.171; KIMBERLIN RH, 1987, J GEN VIROL, V68, P1875, DOI 10.1099/0022-1317-68-7-1875; KIMBERLIN RH, 1989, J GEN VIROL, V70, P2017, DOI 10.1099/0022-1317-70-8-2017; Krasemann S, 1996, MOL MED, V2, P725, DOI 10.1007/BF03401656; Kupfer L, 2007, BBA-MOL BASIS DIS, V1772, P704, DOI 10.1016/j.bbadis.2006.10.009; Lasmezas CI, 2005, LANCET, V365, P781, DOI 10.1016/S0140-6736(05)17985-9; MCKINLEY MP, 1983, CELL, V35, P57, DOI 10.1016/0092-8674(83)90207-6; Padilla D, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001319; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; PATTISON IH, 1965, VET REC, V77, P1388, DOI 10.1136/vr.77.47.1388; Peretz D, 2002, NEURON, V34, P921, DOI 10.1016/S0896-6273(02)00726-2; Plinston C, 2011, J VIROL, V85, P1174, DOI 10.1128/JVI.01578-10; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; PRUSINER SB, 1990, CELL, V63, P673, DOI 10.1016/0092-8674(90)90134-Z; Race R, 2001, J VIROL, V75, P10106, DOI 10.1128/JVI.75.21.10106-10112.2001; SCOTT M, 1993, CELL, V73, P979, DOI 10.1016/0092-8674(93)90275-U; SCOTT M, 1989, CELL, V59, P847, DOI 10.1016/0092-8674(89)90608-9; Scott MR, 2005, J VIROL, V79, P5259, DOI 10.1128/JVI.79.9.5259-5271.2005; Sigurdson CJ, 2003, BRIT MED BULL, V66, P199, DOI 10.1093/bmb/66.1.199; Simon S, 2008, EMERG INFECT DIS, V14, P608, DOI 10.3201/eid1404.071134; Torres JM, 2011, EMERG INFECT DIS, V17, P1636, DOI 10.3201/eid1709.101403; Uro-Coste E, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000029; Wells GAH, 2003, J GEN VIROL, V84, P1021, DOI 10.1099/vir.0.18788-0; Yull HM, 2006, AM J PATHOL, V168, P151, DOI 10.2353/ajpath.2006.050766	40	36	36	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e89722	10.1371/journal.pone.0089722	http://dx.doi.org/10.1371/journal.pone.0089722			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608126	Green Published, Green Submitted, gold			2022-12-27	WOS:000332485800007
J	Tung, MC; Hsieh, MJ; Wang, SS; Yang, SF; Chen, SS; Wang, SW; Lee, LM; Lee, WJ; Chien, MH				Tung, Min-Che; Hsieh, Ming-Ju; Wang, Shian-Shiang; Yang, Shun-Fa; Chen, Shiou-Sheng; Wang, Shih-Wei; Lee, Liang-Ming; Lee, Wei-Jiunn; Chien, Ming-Hsien			Associations of VEGF-C Genetic Polymorphisms with Urothelial Cell Carcinoma Susceptibility Differ between Smokers and Non-Smokers in Taiwan	PLOS ONE			English	Article							BLADDER-CANCER RISK; GROWTH FACTOR-C; TUMOR-GROWTH; METASTASIS; EXPRESSION; SMOKING; ANGIOGENESIS; DETERMINANTS	Background: Vascular endothelial growth factor (VEGF)-C is associated with lymphangiogenesis, pelvic regional lymph node metastasis, and an antiapoptotic phenotype in urothelial cell carcinoma (UCC). Knowledge of potential roles of VEGF-C genetic polymorphisms in susceptibility to UCC is lacking. This study was designed to examine associations between VEGF-C gene variants and UCC susceptibility and evaluate whether they are modified by smoking. Methodology/Principal Findings: Five single-nucleotide polymorphisms (SNPs) of VEGF-C were analyzed by a TaqMan-based real-time polymerase chain reaction (PCR) in 233 patients with UCC and 520 cancer-free controls. A multivariate logistic regression was applied to model associations between genetic polymorphisms and UCC susceptibility, and to determine if the effect was modified by smoking. We found that after adjusting for other covariates, individuals within the entire population and the 476 non-smokers carrying at least one A allele at VEGF-C rs1485766 respectively had 1.742- and 1.834-fold risks of developing UCC than did wild-type (CC) carriers. Among the 277 smokers, we found that VEGF-C rs7664413 T (CT+TT) and rs2046463 G (AG+GG) allelic carriers were more prevalent in UCC patients than in non-cancer participants. Moreover, UCC patients with the smoking habit who had at least one T allele of VEGF-C rs7664413 were at higher risk of developing larger tumor sizes (p = 0.021), compared to those patients with CC homozygotes. Conclusions: Our results suggest that the involvement of VEGF-C genotypes in UCC risk differs among smokers compared to non-smokers among Taiwanese. The genetic polymorphism of VEGF-C rs7664413 might be a predictive factor for the tumor size of UCC patients who have a smoking habit.	[Tung, Min-Che] Tungs Taichung Metro Harbor Hosp, Dept Surg, Taichung, Taiwan; [Tung, Min-Che; Chien, Ming-Hsien] Taipei Med Univ, Grad Inst Clin Med, Taipei, Taiwan; [Hsieh, Ming-Ju] Changhua Christian Hosp, Canc Res Ctr, Changhua, Taiwan; [Hsieh, Ming-Ju; Wang, Shian-Shiang; Yang, Shun-Fa] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Wang, Shian-Shiang] Taichung Vet Gen Hosp, Div Urol, Dept Surg, Taichung, Taiwan; [Yang, Shun-Fa] Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Chen, Shiou-Sheng] Taipei City Hosp, Renai Branch, Div Urol, Taipei, Taiwan; [Chen, Shiou-Sheng] Natl Yang Ming Univ, Sch Med, Dept Urol, Taipei 112, Taiwan; [Wang, Shih-Wei] Mackay Med Coll, Dept Med, Taipei, Taiwan; [Lee, Liang-Ming; Lee, Wei-Jiunn] Taipei Med Univ, Wan Fang Hosp, Dept Urol, Taipei, Taiwan; [Chien, Ming-Hsien] Taipei Med Univ, Wan Fang Hosp, Taipei, Taiwan	Taipei Medical University; Changhua Christian Hospital; Chung Shan Medical University; Taichung Veterans General Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital; Taipei City Hospital; National Yang Ming Chiao Tung University; Mackay Medical College; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Taipei Municipal WanFang Hospital	Chien, MH (corresponding author), Taipei Med Univ, Grad Inst Clin Med, Taipei, Taiwan.	mhchien1976@gmail.com	Yang, Shun-Fa/AAN-1519-2020; Wang, Shih-Wei/AAH-1967-2020; Hsieh, Ming-Ju/GQB-3025-2022	Yang, Shun-Fa/0000-0002-0365-7927; Wang, Shih-Wei/0000-0001-7522-6352; Hsieh, Ming-Ju/0000-0001-9726-3234	Tungs' Taichung Metro Harbor Hospital [CSMU-TTM-101-01]; Taipei Medical University [TMU101-AE3-Y22]; Chung Shan Medical University	Tungs' Taichung Metro Harbor Hospital; Taipei Medical University; Chung Shan Medical University	This study was supported by grants from Chung Shan Medical University and Tungs' Taichung Metro Harbor Hospital (CSMU-TTM-101-01) and Taipei Medical University (TMU101-AE3-Y22). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bando H, 2006, ONCOL REP, V15, P653; Baris D, 2009, JNCI-J NATL CANCER I, V101, P1553, DOI 10.1093/jnci/djp361; Bid HK, 2006, UROLOGY, V67, P1099, DOI 10.1016/j.urology.2005.11.032; Chen M, 2007, CARCINOGENESIS, V28, P2160, DOI 10.1093/carcin/bgm167; Chien MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060283; Chien MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051051; Costa F, 2009, LIFE SCI, V84, P785, DOI 10.1016/j.lfs.2009.03.002; Fairbrother WG, 2000, MOL CELL BIOL, V20, P6816, DOI 10.1128/MCB.20.18.6816-6825.2000; Folkman J, 2002, SEMIN ONCOL, V29, P15, DOI 10.1053/sonc.2002.37263; Garcia-Closas M, 2007, PLOS GENET, V3, P287, DOI 10.1371/journal.pgen.0030029; Goode EL, 2010, CLIN CANCER RES, V16, P995, DOI 10.1158/1078-0432.CCR-09-2553; He YL, 2004, BBA-REV CANCER, V1654, P3, DOI 10.1016/j.bbcan.2003.07.003; Health Do, 2010, CANC RESG ANN REP; Hong JM, 2010, EXP MOL MED, V42, P376, DOI 10.3858/emm.2010.42.5.039; Hsieh MC, 2014, J CLIN LAB IN PRESS; Inamine M, 2012, INT J CLIN ONCOL, V17, P498, DOI 10.1007/s10147-011-0322-3; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Kellen E, 2007, CANCER LETT, V245, P51, DOI 10.1016/j.canlet.2005.12.025; Khromova N, 2012, ONCOGENE, V31, P1389, DOI 10.1038/onc.2011.330; Kim EJ, 2005, UROLOGY, V65, P70, DOI 10.1016/j.urology.2004.08.005; Komiya Y, 2005, CANCER LETT, V221, P55, DOI 10.1016/j.canlet.2004.10.042; Ladomery MR, 2007, CANCER LETT, V249, P133, DOI 10.1016/j.canlet.2006.08.015; Marcus PM, 2000, CANCER EPIDEM BIOMAR, V9, P461; Serre D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000006; Tsukada S, 2006, MOL ENDOCRINOL, V20, P1104, DOI 10.1210/me.2005-0311; Ueda M, 2002, INT J CANCER, V98, P335, DOI 10.1002/ijc.10193; Wagner EJ, 2001, MOL CELL BIOL, V21, P3281, DOI 10.1128/MCB.21.10.3281-3288.2001; Wang D, 2011, PHARMACOGENOMICS J, V11, P274, DOI 10.1038/tpj.2010.28; Wang ZF, 2004, CELL, V119, P831, DOI 10.1016/j.cell.2004.11.010; Wang ZG, 2010, BIOCHEM J, V428, P347, DOI 10.1042/BJ20100379; Zu XB, 2006, BJU INT, V98, P1090, DOI 10.1111/j.1464-410X.2006.06446.x	31	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91147	10.1371/journal.pone.0091147	http://dx.doi.org/10.1371/journal.pone.0091147			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608123	Green Submitted, gold, Green Published			2022-12-27	WOS:000332485800105
J	Vaz, S; Parsons, R; Falkmer, T; Passmore, AE; Falkmer, M				Vaz, Sharmila; Parsons, Richard; Falkmer, Torbjorn; Passmore, Anne Elizabeth; Falkmer, Marita			The Impact of Personal Background and School Contextual Factors on Academic Competence and Mental Health Functioning across the Primary-Secondary School Transition	PLOS ONE			English	Article							DIFFICULTIES-QUESTIONNAIRE; SOCIOECONOMIC-STATUS; SELF-ESTEEM; FOLLOW-UP; ADOLESCENTS; CHILDREN; PERCEPTIONS; EXPERIENCES; DISORDERS; ADULTS	Students negotiate the transition to secondary school in different ways. While some thrive on the opportunity, others are challenged. A prospective longitudinal design was used to determine the contribution of personal background and school contextual factors on academic competence (AC) and mental health functioning (MHF) of 266 students, 6-months before and after the transition to secondary school. Data from 197 typically developing students and 69 students with a disability were analysed using hierarchical linear regression modelling. Both in primary and secondary school, students with a disability and from socially disadvantaged backgrounds gained poorer scores for AC and MHF than their typically developing and more affluent counterparts. Students who attended independent and mid-range sized primary schools had the highest concurrent AC. Those from independent primary schools had the lowest MHF. The primary school organisational model significantly influenced post-transition AC scores; with students from Kindergarten - Year 7 schools reporting the lowest scores, while those from the Kindergarten - Year 12 structure without middle school having the highest scores. Attending a school which used the Kindergarten - Year 12 with middle school structure was associated with a reduction in AC scores across the transition. Personal background factors accounted for the majority of the variability in post-transition AC and MHF. The contribution of school contextual factors was relatively minor. There is a potential opportunity for schools to provide support to disadvantaged students before the transition to secondary school, as they continue to be at a disadvantage after the transition.	[Vaz, Sharmila] Curtin Univ, Curtin Hlth Innovat Res Inst, Ctr Res Disabil & Soc, Sch Occupat Therapy & Social Work, Perth, WA 6845, Australia; [Parsons, Richard] Curtin Univ, Curtin Hlth Innovat Res Inst, Sch Pharm, Perth, WA 6845, Australia; [Parsons, Richard; Falkmer, Torbjorn; Passmore, Anne Elizabeth; Falkmer, Marita] Curtin Univ, Curtin Hlth Innovat Res Inst, Sch Occupat Therapy & Social Work, Perth, WA 6845, Australia; [Falkmer, Torbjorn] La Trobe Univ, Sch Occupat Therapy, Melbourne, Vic, Australia; [Falkmer, Torbjorn] Linkoping Univ, Fac Hlth Sci, Dept Med & Hlth Sci IMH, Linkoping, Sweden; [Falkmer, Torbjorn] UHL, Cty Council, Pain & Rehabil Ctr, Linkoping, Sweden; [Falkmer, Marita] Jonkoping Univ, Inst Disabil Res, CHILD Programme, Sch Educ & Commun, Jonkoping, Sweden	Curtin University; Curtin University; Curtin University; La Trobe University; Linkoping University; Jonkoping University	Vaz, S (corresponding author), Curtin Univ, Curtin Hlth Innovat Res Inst, Ctr Res Disabil & Soc, Sch Occupat Therapy & Social Work, Perth, WA 6845, Australia.	vazs2003@gmail.com		Vaz, Sharmila/0000-0003-1003-9593	Centre for Research into Disability and Society; School of Occupational Therapy and Social Work, Curtin University, Perth, Australia; Healthway Australia	Centre for Research into Disability and Society; School of Occupational Therapy and Social Work, Curtin University, Perth, Australia; Healthway Australia	This project was funded by a Doctoral scholarship provided by the Centre for Research into Disability and Society and the School of Occupational Therapy and Social Work, Curtin University, Perth, Australia. It was part of a larger study that was awarded the 2007 Social Determinants for Health Research award by Healthway Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach TM, 1991, PSYCHIATRY; Anderman EM, 2002, J EDUC PSYCHOL, V94, P795, DOI 10.1037//0022-0663.94.4.795; Anderson LH, 2000, INT J ED RES, V33; Andersson HW, 2010, SOC PSYCH PSYCH EPID, V45, P569, DOI 10.1007/s00127-009-0099-0; [Anonymous], 2000, INT J EDUC RES, DOI DOI 10.1016/S0883-0355(00)00021-5; [Anonymous], 2003, TRANSITION SECONDARY; Australian Bureau of Statistics, 2011, 2033 0 55 001 CENS P; Australian Bureau of Statistics [ABS], 2001, ABS 2001 CENS DICT; AVECO, 2012, YOUTH UN CRIS WE CAN; Bahr N., 2007, MILLENNIAL ADOLESCEN; Bahr N, 2005, TEACHING MIDDLE YEAR, P49; Barber BK, 2004, J ADOLESCENT RES, V19, P3, DOI 10.1177/0743558403258113; BECKER GS, 1986, J LABOR ECON, V4, pS1, DOI 10.1086/298118; Bell M, 2001, SPECIAL ED PERSPECTI, V10, P3; Benner AD, 2009, CHILD DEV, V80, P356, DOI 10.1111/j.1467-8624.2009.01265.x; BERNDT TJ, 1995, J RES ADOLESCENCE, V5, P123, DOI 10.1207/s15327795jra0501_6; BLOCK J, 1993, CHILD DEV, V64, P909, DOI 10.2307/1131226; Bonell C, 2012, EFFECTS SCH ENV STUD; Bradley RH, 2002, ANNU REV PSYCHOL, V53, P371, DOI 10.1146/annurev.psych.53.100901.135233; Carrington V, 2002, P 2001 NAT BIENN C A; Chadbourne R., 2001, MIDDLE SCH MIDDLE YE; Chung H, 1998, J SCH PSYCHOL, V92, P20; Cicchetti D, 1999, J CLIN CHILD PSYCHOL, V28, P355, DOI 10.1207/S15374424jccp280308; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Council Curriculum, 1998, CURR FRAM KIND YEAR; Council of Government School Organisations [COGSA], 2005, MIDDL SCH CONC APPR; Cross D, 2002, FRIENDLY SCH FAMILIE; Davis C, 2000, EARLY INTERVENTION M; Department of Education and Training [DET], 2004, PATHW FUT REP REV ED; Department of Education and Training [DET], 2007, FUT PLAC YEAR 7 STUD; Eccles J. S., 1989, RES MOTIVATION ED, V3, P139, DOI DOI 10.1037/0003-066X.48.2.90; ECCLES JS, 1993, AM PSYCHOL, V48, P90, DOI 10.1037/0003-066X.48.2.90; Edgar D, 2001, PATCHWORK NATION RET; Emerson E, 2009, AUST J SOC ISSUES, V44, P39; Erikson E.H., 1968, IDENTITY YOUTH CRISI; Evangelous M., 2008, EFFECTIVE PRESCHOOL; Forgan JW, 2000, J LEARN DISABIL-US, V33, P33, DOI 10.1177/002221940003300107; Freebody P., 1997, AUSTR LITERACIES INF; Gallo LC, 2003, PSYCHOL BULL, V129, P10, DOI 10.1037//0033-2909.129.1.10; Geller B, 2001, J AM ACAD CHILD PSY, V40, P673, DOI 10.1097/00004583-200106000-00012; Geller B, 2001, AM J PSYCHIAT, V158, P125, DOI 10.1176/appi.ajp.158.1.125; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Goodman R, 1999, J ABNORMAL CHILD PSY, V1; Gorard S., 2006, COMPREHENSIVE ED EVO; Gutman LM, 2003, DEV PSYCHOL, V39, P777, DOI 10.1037/0012-1649.39.4.777; HAAGER D, 1995, J LEARN DISABIL, V28, P205, DOI 10.1177/002221949502800403; Hanewald R., 2013, AUSTR J TEACHER ED, V38, DOI 10.14221/ajte.2013v38n1.7; Hargreaves A., 1986, 2 CULTURES SCH CASE; HARTER S, 1982, CHILD DEV, V53, P87, DOI 10.1111/j.1467-8624.1982.tb01295.x; Harter S, 1998, AM EDUC RES J, V35, P653, DOI 10.2307/1163462; Harter S., 1999, CONSTRUCTION SELF; Hattie J., 1999, INFLUENCES STUDENT L; Hattie J.A.C., 2003, BUILD TEACH QUAL WHA; Hauser RM, 1997, INDICATORS OF CHILDREN'S WELL-BEING, P152; Hawker DSJ, 2000, J CHILD PSYCHOL PSYC, V41, P441, DOI 10.1017/S0021963099005545; Howard S, 2004, TRANSITION PRIMARY S; Howlin P, 2012, CAN J PSYCHIAT, V57, P275, DOI 10.1177/070674371205700502; Hughes LA, 2013, SUPPORT LEARN, V28, P24, DOI 10.1111/1467-9604.12012; Humphrey N, 2006, EUR J PSYCHOL EDUC, V21, P319, DOI 10.1007/BF03173419; Jimerson S, 2000, J SCHOOL PSYCHOL, V38, P525, DOI 10.1016/S0022-4405(00)00051-0; Juvonen J., 2004, FOCUS WONDER YEARS C, DOI [10.1037/e658722010-001, DOI 10.1037/E658722010-001]; Kipke RC, 2008, CULTURE RVALUATION 6; Kirkpatrick D, 1993, RES ED; Kirkpatrick D, 1997, ED AUSTR, V36, P17; Konu AI, 2002, SCH EFF SCH IMPROV, V13, P187, DOI 10.1076/sesi.13.2.187.3432; Lamb S., 2004, PERFORMANCE AUSTR ED; Lamb S., 2004, STAYING SCH IMPROVIN; Lamb S, 2007, INTERNATIONAL STUDIES IN EDUCATIONAL INEQUALITY, THEORY AND POLICY, VOL 3, P1, DOI 10.1007/1-4020-5916-7_1; Larson RW, 1999, PSYCHOL BULL, V125, P701, DOI 10.1037/0033-2909.125.6.701; Lohaus A., 2004, EDUC PSYCHOL-UK, V24, P161, DOI [10.1080/0144341032000160128, DOI 10.1080/0144341032000160128]; Lord S. E., 1994, J EARLY ADOLESCENCE, V14, P162, DOI DOI 10.1177/027243169401400205; Lucas RE, 2007, J PERS SOC PSYCHOL, V92, P717, DOI 10.1037/0022-3514.92.4.717; Luke A., 2002, STANDARD AUSTR ENGLI; Luke A., 2003, MIDDLE REPORT LITERA, V1; MARSH HW, 1989, J EDUC PSYCHOL, V81, P417, DOI 10.1037/0022-0663.81.3.417; Marsh HW, 2004, BIG FISH LITTLE POND; Marston J, 2008, PERCEPTIONS STUDENTS; Mellor D, 2005, AUST PSYCHOL, V40, P215, DOI 10.1080/00050060500243475; Meyers L. S., 2006, APPL MULTIVARIATE RE; National Health and Medical Research Centre [NHMRC], 2005, HUM RES ETH HDB RES; NCSS, 1996, PASS 6 0 US GUID; Newman L., 2004, FAMILY INVOLVEMENT E; NOTTELMANN ED, 1987, DEV PSYCHOL, V23, P441, DOI 10.1037/0012-1649.23.3.441; Organisation for Economic Co-operation and Development [OECD], 2003, SCH FACT REL QUAL EQ; ORVASCHEL H, 1995, J AM ACAD CHILD PSY, V34, P1525, DOI 10.1097/00004583-199511000-00020; Passmore A, 1998, RELATIONSHIP LEISURE; Perry LB, 2007, SCH COMPOSITION STUD; Petticrew M, 2005, PROMOTING MENTAL HLT; Portney LG, 2000, FDN CLIN RES APPL PR, V2; Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0; Roberts C., 2002, AUSSIE OPTIMISM SOCI; Roderick M, 2003, URBAN EDUC, V38, P538, DOI 10.1177/0042085903256221; Roeger L, 2001, AUST J PSYCHOL, V53, P134, DOI 10.1080/00049530108255135; Roeser RW, 2002, ANXIETY STRESS COPIN, V15, P345, DOI 10.1080/1061580021000056519; RUTTER M, 1995, ACTA PSYCHIAT SCAND, V91, P73, DOI 10.1111/j.1600-0447.1995.tb09745.x; Rutter M, 2002, J SCHOOL PSYCHOL, V40, P451, DOI 10.1016/S0022-4405(02)00124-3; Ryan C, 2004, 479 AUSTR NAT U; Saab H, 2010, SOC SCI MED, V70, P850, DOI 10.1016/j.socscimed.2009.11.012; Sawyer MG, 2000, MENTAL HLTH YOUNG PE; Seidman E, 2004, DEV PSYCHOPATHOL, V16, P1141, DOI 10.1017/S0954579404040179; Simmons R. G., 1987, MOVING ADOLESCENCE I; Snowling MJ, 2007, J CHILD PSYCHOL PSYC, V48, P609, DOI 10.1111/j.1469-7610.2006.01725.x; Stone LL, 2010, CLIN CHILD FAM PSYCH, V13, P254, DOI 10.1007/s10567-010-0071-2; Tabachnick B. G., 2001, USING MULTIVARIATE S; Tabachnick B.G., 2007, USING MULTIVARIATE S, VVolume 5, P481; Tur-Kaspa H, 2002, J LEARN DISABIL-US, V35, P87, DOI 10.1177/002221940203500107; Vaz S, 2010, FACTORS AFFECTING ST; Wallis J, 1998, J CHILD FAM STUD, V7, P43, DOI DOI 10.1023/A:1022908029272; Waters SK, 2010, AUST J EDUC, V54, P6; Waters S, 2010, BRIT J EDUC PSYCHOL, V80, P381, DOI 10.1348/000709909X484479; Watt HMG, 2004, CHILD DEV, V75, P1556, DOI 10.1111/j.1467-8624.2004.00757.x; Weiss R. S, 1973, LONELINESS EXPERIENC; West P, 2010, RES PAP EDUC, V25, P21, DOI 10.1080/02671520802308677; Wigfield A., 1994, J EARLY ADOLESC, V14, P107, DOI [10.1177/027243169401400203, DOI 10.1177/027243169401400203]; Wight RG, 2006, J YOUTH ADOLESCENCE, V35, P115, DOI 10.1007/s10964-005-9009-2; World Health Organization, 1996, PROM HLTH SCH WHO GL; Yeo M, 2005, BRIT MED J, V330, P721, DOI 10.1136/bmj.330.7493.721; Zeleke* S., 2004, EUR J SPEC NEEDS EDU, V19, P145, DOI DOI 10.1080/08856250410001678469; Zubrick S, 1993, FIELD INSTRUMENT DEV; Zubrick S, 2000, INDICATORS SOCIAL FA; Zubrick S. R., 1997, W AUSTR CHILD HLTH S; Zubrick SR, 2000, AUST NZ J PSYCHIAT, V34, P570, DOI 10.1080/j.1440-1614.2000.00703.x	122	25	25	6	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e89874	10.1371/journal.pone.0089874	http://dx.doi.org/10.1371/journal.pone.0089874			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC4IY	24608366	gold, Green Published, Green Submitted			2022-12-27	WOS:000332485800011
J	Gao, L; Li, Z; Chang, SH; Wang, J				Gao, Lei; Li, Zhao; Chang, Suhua; Wang, Jing			Association of Interleukin-10 Polymorphisms with Schizophrenia: A Meta-Analysis	PLOS ONE			English	Article							GENE PROMOTER POLYMORPHISM; CYTOKINE ALTERATIONS; HYPOTHESIS; IL-10; HAPLOTYPES; REGION	Background: The involvement of cytokines in schizophrenia (SZ) has been proposed in recent years and various studies have accumulated convergent lines of evidence. Among which, the role of interleukin-10 (IL-10) in SZ has been explored in a number of studies by investigating association of single nucleotide polymorphisms (SNPs) and susceptibility of SZ. However, the results are inconsistent since its power is limited by the individual sample size. To evaluate the overall effect between them, we conducted a meta-analysis by combining all available studies. Methods: Studies were searched from the database of PubMed, PsycINFO and ISI web of Knowledge up to Nov 2013. The meta-analysis was conducted based on statement of preferred reporting items for systematic reviews and meta-analyses (PRISMA). Results: Eleven studies including 6399 subjects (3129 cases and 3270 controls) were available for the meta-analysis. Among three investigated SNPs, rs1800872 was observed to be significantly associated with risk of SZ (AA vs. AC+CC, Pooled OR = 1.351, P-value = 2.06E-04). Meanwhile, among six haplotypes of rs1800896 - rs1800871 - rs1800872, significant associations were observed in haplotype A-C-A (Pooled OR = 1.762, P-value = 2.00E-03) and G-C-C (Pooled OR = 0.649, P-value = 2.00E-03) for Asians. These results were still significant after adjusting for multiple comparisons. Conclusions: This meta-analysis demonstrated an SNP and two haplotypes of IL-10 significantly associated with SZ, suggesting that IL-10 might be a risk factor of SZ.	[Gao, Lei; Li, Zhao; Chang, Suhua; Wang, Jing] Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing 100101, Peoples R China; [Gao, Lei; Li, Zhao] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, J (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing 100101, Peoples R China.	wangjing@psych.ac.cn	Chang, Suhua/AGZ-1921-2022		Knowledge Innovation Program of the Chinese Academy of Sciences [KSCX2-EW-J-8]; CAS/SAFEA International Partnership Program for Creative Research Teams [Y2CX131003]; Chinese Academy of Sciences [XDB02030002]; Key Laboratory of Mental Health, Institute of Psychology, Chinese Academy of Sciences	Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences); CAS/SAFEA International Partnership Program for Creative Research Teams(Chinese Academy of Sciences); Chinese Academy of Sciences(Chinese Academy of Sciences); Key Laboratory of Mental Health, Institute of Psychology, Chinese Academy of Sciences(Chinese Academy of Sciences)	This research was supported by the Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-EW-J-8), the CAS/SAFEA International Partnership Program for Creative Research Teams (Y2CX131003), the Strategic Priority Research Program (B) of the Chinese Academy of Sciences (XDB02030002) and Key Laboratory of Mental Health, Institute of Psychology, Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almoguera B, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-81; Attia J, 2003, J CLIN EPIDEMIOL, V56, P297, DOI 10.1016/S0895-4356(03)00011-8; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; Chiavetto LB, 2002, BIOL PSYCHIAT, V51, P480, DOI 10.1016/S0006-3223(01)01324-5; Crawley E, 1999, ARTHRITIS RHEUM-US, V42, P1101, DOI 10.1002/1529-0131(199906)42:6<1101::AID-ANR6>3.0.CO;2-Y; Dimitrov DH, 2013, SCHIZOPHR RES, V151, P29, DOI 10.1016/j.schres.2013.10.019; Edwards-Smith CJ, 1999, HEPATOLOGY, V30, P526, DOI 10.1002/hep.510300207; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fatemi SH, 2009, SCHIZOPHRENIA BULL, V35, P528, DOI 10.1093/schbul/sbn187; FIORENTINO DF, 1991, J IMMUNOL, V146, P3444; Ghasemi H, 2012, OCUL IMMUNOL INFLAMM, V20, P406, DOI 10.3109/09273948.2012.723109; Haroon E, 2012, NEUROPSYCHOPHARMACOL, V37, P137, DOI 10.1038/npp.2011.205; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Howes OD, 2009, SCHIZOPHRENIA BULL, V35, P549, DOI 10.1093/schbul/sbp006; Jun TY, 2003, PSYCHIAT CLIN NEUROS, V57, P153, DOI 10.1046/j.1440-1819.2003.01095.x; Jun TY, 2002, PSYCHIAT CLIN NEUROS, V56, P177, DOI 10.1046/j.1440-1819.2002.00943.x; Karayiorgou M, 1997, NEURON, V19, P967, DOI 10.1016/S0896-6273(00)80390-6; Lung FW, 2011, PSYCHIAT RES, V188, P294, DOI 10.1016/j.psychres.2010.12.025; Luo XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050375; Meyer U, 2008, MOL PSYCHIATR, V13, P208, DOI 10.1038/sj.mp.4002042; Meyer U, 2009, SCHIZOPHRENIA BULL, V35, P959, DOI 10.1093/schbul/sbn022; Miller BJ, 2011, BIOL PSYCHIAT, V70, P663, DOI 10.1016/j.biopsych.2011.04.013; Moghaddam B, 2012, NEUROPSYCHOPHARMACOL, V37, P4, DOI 10.1038/npp.2011.181; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Muller N, 1999, EUR ARCH PSY CLIN N, V249, P62; Nawa H, 2006, NEUROSCI RES, V56, P2, DOI 10.1016/j.neures.2006.06.002; Ozbey U, 2009, WORLD J BIOL PSYCHIA, V10, P461, DOI 10.1080/15622970802626580; Paul-Samojedny M, 2010, J MOL NEUROSCI, V42, P112, DOI 10.1007/s12031-010-9365-6; Peng Hsin-Yi, 2008, Int J Biomed Sci, V4, P185; Potvin S, 2008, BIOL PSYCHIAT, V63, P801, DOI 10.1016/j.biopsych.2007.09.024; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Rood MJ, 1999, ANN RHEUM DIS, V58, P85, DOI 10.1136/ard.58.2.85; Shirts BH, 2006, SCHIZOPHR RES, V83, P7, DOI 10.1016/j.schres.2005.12.853; Sommer IE, 2013, SCHIZOPHR B; Sugino H, 2009, PROG NEURO-PSYCHOPH, V33, P303, DOI 10.1016/j.pnpbp.2008.12.006; Thakkinstian A, 2005, STAT MED, V24, P1291, DOI 10.1002/sim.2010; Tourjman V, 2013, SCHIZOPHR RES; van Os J, 2009, LANCET, V374, P635, DOI [10.1016/S0140-6736(09)60995-8, 10.1016/S0140-6736(15)01121-6]; Verhagen M, 2010, MOL PSYCHIATR, V15, P260, DOI 10.1038/mp.2008.109; Watanabe Y, 2010, PSYCHIAT CLIN NEUROS, V64, P217, DOI 10.1111/j.1440-1819.2010.02094.x; Yu L, 2004, SCHIZOPHR RES, V71, P179, DOI 10.1016/j.schres.2004.01.001; Zintzaras E, 2010, EUR J EPIDEMIOL, V25, P553, DOI 10.1007/s10654-010-9467-z	42	28	28	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90407	10.1371/journal.pone.0090407	http://dx.doi.org/10.1371/journal.pone.0090407			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603720	Green Submitted, Green Published, gold			2022-12-27	WOS:000332483600052
J	Teh, JKL; Tey, NP; Ng, ST				Teh, Jane K. L.; Tey, Nai Peng; Ng, Sor Tho			Ethnic and Gender Differentials in Non-Communicable Diseases and Self-Rated Health in Malaysia	PLOS ONE			English	Article							SOCIAL SUPPORT; LIFE-STYLE; PREVALENCE; MORTALITY; UNEMPLOYMENT; INEQUALITIES; PERCEPTION	Objectives: This paper examines the ethnic and gender differentials in high blood pressure (HBP), diabetes, coronary heart disease (CHD), arthritis and asthma among older people in Malaysia, and how these diseases along with other factors affect self-rated health. Differentials in the prevalence of non-communicable diseases among older people are examined in the context of socio-cultural perspectives in multi-ethnic Malaysia. Methods: Data for this paper are obtained from the 2004 Malaysian Population and Family Survey. The survey covered a nationally representative sample of 3,406 persons aged 50 and over, comprising three main ethnic groups (Malays, Chinese and Indians) and all other indigenous groups. Bivariate analyses and hierarchical logistic regression were used in the analyses. Results: Arthritis was the most common non-communicable disease (NCD), followed by HBP, diabetes, asthma and CHD. Older females were more likely than males to have arthritis and HBP, but males were more likely to have asthma. Diabetes and CHD were most prevalent among Indians, while arthritis and HBP were most prevalent among the Indigenous groups. Older people were more likely to report poor health if they suffered from NCD, especially CHD. Controlling for socioeconomic, health and lifestyle factors, Chinese were least likely to report poor health, whereas Indians and Indigenous people were more likely to do so. Chinese that had HBP were more likely to report poor health compared to other ethnic groups with the same disease. Among those with arthritis, Indians were more likely to report poor health. Conclusion: Perceived health status and prevalence of arthritis, HBP, diabetes, asthma and CHD varied widely across ethnic groups. Promotion of healthy lifestyle, early detection and timely intervention of NCDs affecting different ethnic groups and gender with socio-cultural orientations would go a long way in alleviating the debilitating effects of the common NCDs among older people.	[Teh, Jane K. L.; Tey, Nai Peng; Ng, Sor Tho] Univ Malaya, Fac Econ & Adm, Populat Studies Unit, Kuala Lumpur, Malaysia	Universiti Malaya	Teh, JKL (corresponding author), Univ Malaya, Fac Econ & Adm, Populat Studies Unit, Kuala Lumpur, Malaysia.	jane_teh@yahoo.com	Ng, Sor Tho/B-9233-2010; TEY, NAI PENG/B-5270-2010	Ng, Sor Tho/0000-0001-9251-2377; TEY, NAI PENG/0000-0003-3707-5033	University of Malaya [UM.C/625/1/HIR/MOHE/ASH/02]	University of Malaya(Universiti Malaya)	This research is supported by High Impact Research Chancellory Grant UM.C/625/1/HIR/MOHE/ASH/02 from the University of Malaya. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthritis Research UK, 2012, ARTHR STUD REV WHY G; Asfar T, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-177; Baradaran HR, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-134; BARTLEY M, 1994, J EPIDEMIOL COMMUN H, V48, P333, DOI 10.1136/jech.48.4.333; Benyamini Y, 2003, GERONTOLOGIST, V43, P396, DOI 10.1093/geront/43.3.396; Centers for Disease Control and Prevention, 2009, CHRON DIS POW PREV C; Centers for Disease Control and Prevention, 2012, DIAB REP CARD 2012; Centers for Disease Control and Prevention, 2011, ARTHR REL STAT PREV; Cheng ST, 2006, SOC SCI MED, V63, P118, DOI 10.1016/j.socscimed.2005.12.004; DAVANZO J, 1994, DEMOGRAPHY, V31, P95, DOI 10.2307/2061910; Department of Statistics Malaysia, 2011, POPULATION DISTRIBUT; Department of Statistics Malaysia, 2005, GEN REP 2000 POP HOU; Department of Statistics Malaysia, 2011, ABR LIF TABL MAL 200; Department of Statistics Malaysia (Jabatan Perangkaan Malaysia), 2013, REP ED SOC CHAR POP; Fillenbaum GG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073930; Frankenberg E, 2004, J HEALTH SOC BEHAV, V45, P441, DOI 10.1177/002214650404500406; Gao Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065938; Giatti L, 2008, J EPIDEMIOL COMMUN H, V62, P1079, DOI 10.1136/jech.2007.069740; Hamid TA, 2010, EDUC GERONTOL, V36, P521, DOI 10.1080/03601270903534606; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; International Diabetes Federation, 2006, DIABETES ATLAS; Jylha M, 1998, J GERONTOL B-PSYCHOL, V53, pS144, DOI 10.1093/geronb/53B.3.S144; Jylha M, 2009, SOC SCI MED, V69, P307, DOI 10.1016/j.socscimed.2009.05.013; Kaleta Dorota, 2009, Central European Journal of Public Health, V17, P122; Kiau Bo Bee, 2013, Med J Malaysia, V68, P332; Lee HY, 2010, CELL METAB, V12, P668, DOI 10.1016/j.cmet.2010.11.004; LIU X, 1995, SOC SCI MED, V41, P1175, DOI 10.1016/0277-9536(94)00427-U; MALAVIYA AN, 1993, RHEUMATOL INT, V13, P131, DOI 10.1007/BF00301258; Malaysian Ministry of Health, 2006, 3 NAT HLTH MORB SURV; Malaysian National Population and Family Development Board, 2004, MAL POP FAM SURV PEN; Malaysian National Population and Family Development Board, 2004, MAL POP FAM SURV SAR; Malaysian National Population and Family Development Board, 2004, MAL POP FAM SURV SAB; Malmusi D, 2012, EUR J PUBLIC HEALTH, V22, P781, DOI 10.1093/eurpub/ckr184; Mantyselka PT, 2003, JAMA-J AM MED ASSOC, V290, P2435, DOI 10.1001/jama.290.18.2435; MCMICHAEL AJ, 1976, J OCCUP ENVIRON MED, V18, P165, DOI 10.1097/00043764-197603000-00009; National Institute of Health, 2012, WHO IS RISK HIGH BLO; Ng N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035308; Nishi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030179; Ramachandran A, 1999, DIABETES RES CLIN PR, V44, P207, DOI 10.1016/S0168-8227(99)00024-8; Ramachandran A, 2001, DIABETOLOGIA, V44, P1094, DOI 10.1007/s001250100627; Rampal L, 2007, ASIA PAC J CLIN NUTR, V16, P561; Rueda S, 2008, J EPIDEMIOL COMMUN H, V62, P492, DOI 10.1136/jech.2006.059279; Simon JG, 2005, EUR J PUBLIC HEALTH, V15, P200, DOI 10.1093/eurpub/cki102; Su YP, 1997, J GERONTOL B-PSYCHOL, V52, pS27, DOI 10.1093/geronb/52B.1.S27; Svedberg P, 2006, EUR J EPIDEMIOL, V21, P767, DOI 10.1007/s10654-006-9064-3; WHO, 2011, GLOB STAT REP NONC D; Woodward M, 2003, DIABETES CARE, V26, P360; World Health Organization, 1958, 1 10 YEARS WORLD HLT; World Health Organization, 2013, CHRON RHEUM COND; Wu ZH, 2000, GERONTOLOGIST, V40, P228, DOI 10.1093/geront/40.2.228; Zhang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058973	52	32	32	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e91328	10.1371/journal.pone.0091328	http://dx.doi.org/10.1371/journal.pone.0091328			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC4ID	24603609	gold, Green Published			2022-12-27	WOS:000332483600142
J	Karla, S; Ruusuvirta, T; Wikgren, J				Karla, Suvi; Ruusuvirta, Timo; Wikgren, Jan			Effect of Emotional Picture Viewing on Voluntary Eyeblinks	PLOS ONE			English	Article							MODULATION; MOTIVATION; ANXIETY; FEAR	Eyeblinks, whether reflexive or voluntary, play an important role in protecting our vision. When viewing pictures, reflexive eyeblinks are known to be modulated by the emotional state induced thereby. More specifically, the hedonic valence (unpleasantness-pleasantness) induced by the picture has been shown to have a linear relationship with the amplitude of a startle blink elicited during picture viewing. This effect has been attributed to congruence between an ongoing state and task demands: an unpleasant emotional state is assumed to bias our attention towards potentially harmful stimuli, such as startle tones. However, recent research suggests that the valence-specific modulation may not be limited to the sensory parts of the reflexive pathway related to startle responses. Here, we examined the effect of emotional picture viewing on voluntary (in response to a written command) eyeblinks in adult humans. Emotional modulation of startle blinks was also evaluated. We found that when viewing unpleasant pictures, the amplitude of reflexive eyeblinks was augmented, but the amplitude of voluntary eyeblinks was unaffected. Nevertheless, the response latencies of voluntary eyeblinks were found to be delayed during the viewing of pleasant and unpleasant relative to neutral pictures. We conclude that these results support the theory that emotional experience augments sensory processing specific to potentially harmful stimuli. Further, the emotional state seems not to exert an effect on voluntarily elicited motor activity.	[Karla, Suvi; Wikgren, Jan] Univ Jyvaskyla, Dept Psychol, Jyvaskyla, Finland; [Karla, Suvi; Wikgren, Jan] Univ Jyvaskyla, Jyvaskyla Ctr Interdisciplinary Res, Jyvaskyla, Finland; [Ruusuvirta, Timo] Univ Turku, Dept Psychol, Turku, Finland	University of Jyvaskyla; University of Jyvaskyla; University of Turku	Karla, S (corresponding author), Univ Jyvaskyla, Dept Psychol, Jyvaskyla, Finland.	suvi.karla@jyu.fi		Wikgren, Jan/0000-0002-3403-1396	University of Jyvaskyla	University of Jyvaskyla	Funding is from the University of Jyvaskyla. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, A5 U FLOR CTR RES PS; Blumenthal TD, 2005, PSYCHOPHYSIOLOGY, V42, P1, DOI 10.1111/j.1469-8986.2005.00271.x; BONNET M, 1995, PSYCHOPHYSIOLOGY, V32, P367, DOI 10.1111/j.1469-8986.1995.tb01219.x; Bradley MM, 1996, PSYCHOPHYSIOLOGY, V33, P662, DOI 10.1111/j.1469-8986.1996.tb02362.x; BRADLEY MM, 1990, PSYCHOPHYSIOLOGY, V27, P513, DOI 10.1111/j.1469-8986.1990.tb01966.x; Coelho CM, 2010, NEUROSCI LETT, V481, P135, DOI 10.1016/j.neulet.2010.03.027; DAVIS M, 1989, ANN NY ACAD SCI, V563, P165, DOI 10.1111/j.1749-6632.1989.tb42197.x; Davis M, 1982, J NEUROSCI, V6, P175; Hawk LW, 1997, PSYCHOPHYSIOLOGY, V34, P23, DOI 10.1111/j.1469-8986.1997.tb02412.x; Kaneko K, 1999, PERCEPT MOTOR SKILL, V88, P1037, DOI 10.2466/pms.1999.88.3.1037; Karla S, 2009, BIOL PSYCHOL, V82, P208, DOI 10.1016/j.biopsycho.2009.06.008; Konagemaru S, 2012, EUR J NEUROSCI, V10, P1637; KORB DR, 1994, CORNEA, V13, P354, DOI 10.1097/00003226-199407000-00012; Lang PJ, 1998, BIOL PSYCHIAT, V44, P1248, DOI 10.1016/S0006-3223(98)00275-3; Lang PJ, 2000, J AFFECT DISORDERS, V61, P137, DOI 10.1016/S0165-0327(00)00343-8; LANG PJ, 1990, PSYCHOL REV, V97, P377, DOI 10.1037/0033-295X.97.3.377; LANG PJ, 1995, AM PSYCHOL, V50, P372, DOI 10.1037/0003-066X.50.5.372; LeDoux J, 2003, CELL MOL NEUROBIOL, V23, P727, DOI 10.1023/A:1025048802629; Pereira MG, 2006, EMOTION, V6, P622, DOI 10.1037/1528-3542.6.4.622	19	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e89536	10.1371/journal.pone.0089536	http://dx.doi.org/10.1371/journal.pone.0089536			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC4GP	24599182	Green Published, Green Submitted, gold			2022-12-27	WOS:000332479400017
J	Wilson, JP; See, PE; Bernstein, MJ; Hugenberg, K; Chartier, C				Wilson, John Paul; See, Pirita E.; Bernstein, Michael J.; Hugenberg, Kurt; Chartier, Christopher			Differences in Anticipated Interaction Drive Own Group Biases in Face Memory	PLOS ONE			English	Article							OUTCOME DEPENDENCY; SOCIAL CATEGORIZATION; PERSON MEMORY; RECOGNITION; RACE; ATTENTION; INDIVIDUATION; INGROUP; INFORMATION; MODEL	According to much research, the Own Group Bias (OGB) in face memory occurs as a consequence of social categorization - ingroup members are more likely than outgroup members to be encoded as individuals and remembered well. The current work is an examination of the role of anticipated future interaction in the OGB. We conducted two studies showing that anticipated interaction influences group-based face memory. In Study 1, we provided correlational evidence that beliefs about the amount and importance of future interaction one will have with racial outgroup members is associated with the OGB, such that people expecting more interaction with outgroup members show a reduced OGB. In Study 2, we manipulated expectations about future interactions with lab-created groups and observed that high levels of anticipated future interaction with the outgroup eliminated the OGB. Thus, social group categorization drives face memory biases to the extent that group membership affords the expectation of interpersonal interaction.	[Wilson, John Paul] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada; [See, Pirita E.; Hugenberg, Kurt] Miami Univ, Dept Psychol, Oxford, OH 45056 USA; [Bernstein, Michael J.] Penn State Univ, Dept Psychol & Social Sci, Abington, PA USA; [Chartier, Christopher] Ashland Univ, Dept Psychol, Ashland, OH USA	University of Toronto; University System of Ohio; Miami University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Ashland University	Wilson, JP (corresponding author), Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada.	jp.wilson@utoronto.ca			NSF [BCS-0951463]	NSF(National Science Foundation (NSF))	This work was supported by NSF grant BCS-0951463, awarded to the fourth author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allport G. W., 1954, NATURE PREJUDICE; Baldwin M, 2013, GROUP PROCESS INTERG, V16, P505, DOI 10.1177/1368430212460893; Bernstein MJ, 2007, PSYCHOL SCI, V18, P706, DOI 10.1111/j.1467-9280.2007.01964.x; BERSCHEID E, 1976, J PERS SOC PSYCHOL, V34, P978, DOI 10.1037/0022-3514.34.5.978; Brewer M., 1988, ADV SOCIAL COGNITION, P1; Correll J, 2005, PERS SOC PSYCHOL REV, V9, P341, DOI 10.1207/s15327957pspr0904_4; CROSS JF, 1971, PERCEPT PSYCHOPHYS, V10, P393, DOI 10.3758/BF03210319; DEVINE PG, 1989, J PERS SOC PSYCHOL, V56, P680, DOI 10.1037//0022-3514.56.5.680; ERBER R, 1984, J PERS SOC PSYCHOL, V47, P709, DOI 10.1037/0022-3514.47.4.709; Fiske S.T., 1984, SOC COGNITION; Fiske ST, 1990, ADV EXPT SOCIAL PSYC, V23; FUDENBERG D, 1986, ECONOMETRICA, V54, P533, DOI 10.2307/1911307; HARVEY JH, 1980, J PERS SOC PSYCHOL, V38, P551, DOI 10.1037/0022-3514.38.4.551; Hehman E, 2010, J EXP SOC PSYCHOL, V46, P445, DOI 10.1016/j.jesp.2009.11.008; HEIDE JB, 1992, ACAD MANAGE J, V35, P265, DOI 10.2307/256374; HEWSTONE M, 1991, EUR J SOC PSYCHOL, V21, P517, DOI 10.1002/ejsp.2420210606; Hugenberg K, VIS COGN IN PRESS; Hugenberg K, 2007, J EXP SOC PSYCHOL, V43, P334, DOI 10.1016/j.jesp.2006.02.010; Hugenberg K, 2010, PSYCHOL REV, V117, P1168, DOI 10.1037/a0020463; Macrae C., 2010, HDB SOCIAL PSYCHOL; Macrae CN, 2000, ANNU REV PSYCHOL, V51, P93, DOI 10.1146/annurev.psych.51.1.93; MALPASS RS, 1969, J PERS SOC PSYCHOL, V13, P330, DOI 10.1037/h0028434; Meissner CA, 2001, PSYCHOL PUBLIC POL L, V7, P3, DOI 10.1037//1076-8971.7.1.3; NEUBERG SL, 1987, J PERS SOC PSYCHOL, V53, P431, DOI 10.1037/0022-3514.53.3.431; RODIN MJ, 1987, SOC COGNITION, V5, P144, DOI 10.1521/soco.1987.5.2.144; Rossion B., 2011, OXFORD HDB FACE PERC, P215, DOI DOI 10.1093/OXFORDHB/9780199559053.013.0012; Rule NO, 2007, PSYCHON B REV, V14, P687, DOI 10.3758/BF03196822; Rule NO, 2010, J PERS SOC PSYCHOL, V98, P343, DOI 10.1037/a0018589; SRULL TK, 1983, J VERB LEARN VERB BE, V22, P219, DOI 10.1016/S0022-5371(83)90167-6; Van Bavel JJ, 2012, PERS SOC PSYCHOL B, V38, P1566, DOI 10.1177/0146167212455829; Van Bavel JJ, 2012, J EXP SOC PSYCHOL, V48, P707, DOI 10.1016/j.jesp.2012.01.006; Van Bavel JJ, 2011, J COGNITIVE NEUROSCI, V23, P3343, DOI 10.1162/jocn_a_00016; Young SG, 2012, SOC PSYCHOL PERS SCI, V3, P80, DOI 10.1177/1948550611409759; Young SG, 2010, SOC COGNITION, V28, P240, DOI 10.1521/soco.2010.28.2.240	34	17	18	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90668	10.1371/journal.pone.0090668	http://dx.doi.org/10.1371/journal.pone.0090668			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC4GP	24599294	Green Published, gold, Green Submitted			2022-12-27	WOS:000332479400114
J	Zhao, Z; Li, B; Sun, HQ; Zhang, JY; Wang, YL; Chen, L; Hu, J; He, YF; Zeng, H; Zou, QM; Wu, C				Zhao, Zhuo; Li, Bin; Sun, He-Qiang; Zhang, Jin-Yong; Wang, Yi-Lin; Chen, Li; Hu, Jian; He, Ya-Fei; Zeng, Hao; Zou, Quan-Ming; Wu, Chao			Fine-Mapping of Immunodominant Linear B-Cell Epitopes of the Staphylococcus Aureus SEB Antigen Using Short Overlapping Peptides	PLOS ONE			English	Article							TOXIC-SHOCK-SYNDROME; ENTEROTOXIN-B; MONOCLONAL-ANTIBODIES; INFECTIONS; VACCINE; MRSA; RECEPTOR; PROTEIN	Staphylococcal enterotoxin B (SEB) is one of the most potent Staphylococcus aureus exotoxins (SEs). Due to its conserved sequence and stable structure, SEB might be a good candidate antigen for MRSA vaccines. Although cellular immune responses to SEB are well-characterized, much less is known regarding SEB-specific humoral immune responses, particularly regarding detailed epitope mapping. In this study, we utilized a recombinant nontoxic mutant of SEB (rSEB) and an AlPO4 adjuvant to immunize BALB/c mice and confirmed that rSEB can induce a high antibody level and effective immune protection against MRSA infection. Next, the antisera of immunized mice were collected, and linear B cell epitopes within SEB were finely mapped using a series of overlapping synthetic peptides. Three immunodominant B cell epitopes of SEB were screened by ELISA, including a novel epitope, SEB205-222, and two known epitopes, SEB97-114 and SEB247-261. Using truncated peptides, an ELISA was performed with peptide-KLH antisera, and the core sequence of the three immunodominant B cell epitopes were verified as SEB97-112, SEB207-222, and SEB247-257. In vitro, all of the immunodominant epitope-specific antisera (anti-SEB97-112, anti-SEB207-222 and anti-SEB247-257) were observed to inhibit SEB-induced T cell mitogenesis and cytokine production from splenic lymphocytes of BALB/c mice. The homology analysis indicated that SEB97-112 and SEB207-222 were well-conserved among different Staphylococcus aureus strains. The 3D crystal structure of SEB indicated that SEB97-112 was in the loop region inside SEB, whereas SEB207-222 and SEB247-257 were in the beta-slice region outside SEB. In summary, the fine-mapping of linear B-cell epitopes of the SEB antigen in this study will be useful to understand anti-SEB immunity against MRSA infection further and will be helpful to optimize MRSA vaccine designs that are based on the SEB antigen.	[Zhao, Zhuo; Li, Bin; Sun, He-Qiang; Zhang, Jin-Yong; Wang, Yi-Lin; Chen, Li; Zeng, Hao; Zou, Quan-Ming; Wu, Chao] Third Mil Med Univ, Natl Engn Res Ctr Immunol Prod, Dept Microbiol & Biochem Pharm, Coll Pharm, Chongqing, Peoples R China; [Hu, Jian; He, Ya-Fei] Third Mil Med Univ, Xinqiao Hosp, Dept Gastroenterol, Chongqing, Peoples R China	Army Medical University; Army Medical University	Zou, QM (corresponding author), Third Mil Med Univ, Natl Engn Res Ctr Immunol Prod, Dept Microbiol & Biochem Pharm, Coll Pharm, Chongqing, Peoples R China.	qmzou2007@163.com; wuchao99261@gmail.com		Zhang, Jinyong/0000-0001-9622-5834	Natural Science Foundation of China [31300759]; national Twelfth Five Year Plan "863'' major projects of China [2012AA02A405-3]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); national Twelfth Five Year Plan "863'' major projects of China	This work was funded by the Natural Science Foundation of China (No. 31300759), and the national Twelfth Five Year Plan "863'' major projects of China (No. 2012AA02A405-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arad G, 2001, J LEUKOCYTE BIOL, V69, P921; Balali-Mood M, 2013, TOXICON, V69, P131, DOI 10.1016/j.toxicon.2013.01.005; Baum D, 1998, CELL IMMUNOL, V190, P12, DOI 10.1006/cimm.1998.1380; Bhatti AR, 1999, J MICROBIOL METH, V35, P143, DOI 10.1016/S0167-7012(98)00110-9; Birch H, 2011, CHEM WORLD-UK, V8, P21; Breuer K, 2000, ALLERGY, V55, P551, DOI 10.1034/j.1398-9995.2000.00432.x; Daum RS, 2012, CLIN INFECT DIS, V54, P560, DOI 10.1093/cid/cir828; Demei Z, 2011, CHINESE J INFECT CHE, V5, P326; DeVries AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022997; Dinges MM, 2000, CLIN MICROBIOL REV, V13, P16, DOI 10.1128/CMR.13.1.16-34.2000; Fluer F. S., 2012, Zhurnal Mikrobiologii Epidemiologii i Immunobiologii, P99; HURLEY JM, 1995, J EXP MED, V181, P2229, DOI 10.1084/jem.181.6.2229; Inskeep TK, 2010, CLIN VACCINE IMMUNOL, V17, P1163, DOI 10.1128/CVI.00078-10; Irina VP, 2010, TOXINS, V2, P2177; Irving MB, 2001, CURR OPIN CHEM BIOL, V5, P314, DOI 10.1016/S1367-5931(00)00208-8; KAPPLER J, 1989, SCIENCE, V244, P811, DOI 10.1126/science.2524876; KAPPLER JW, 1992, J EXP MED, V175, P387, DOI 10.1084/jem.175.2.387; Karauzum H, 2012, J BIOL CHEM, V287, P25203, DOI 10.1074/jbc.M112.364075; Kashiwada T, 2012, INTERNAL MED, V51, P3085, DOI 10.2169/internalmedicine.51.7295; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Komatsu N, 2013, MOL IMMUNOL, V54, P465, DOI 10.1016/j.molimm.2013.01.014; Krakauer T, 2010, TOXINS, V2, P1963, DOI 10.3390/toxins2081963; Kum WWS, 2001, J INFECT DIS, V183, P1739, DOI 10.1086/320732; Landrum ML, 2012, JAMA-J AM MED ASSOC, V308, P50, DOI 10.1001/jama.2012.7139; Larkin EA, 2010, PLOS ONE, V10, P1; Lindsay CD, 2013, HUM EXP TOXICOL, V32, P606, DOI 10.1177/0960327112458941; Mayer M, 2001, J AM CHEM SOC, V123, P6108, DOI 10.1021/ja0100120; Nakamura A, 2012, J INFECT CHEMOTHER, V18, P90, DOI 10.1007/s10156-011-0302-6; Nishi JI, 1997, J IMMUNOL, V158, P247; Otto M, 2012, CELL MICROBIOL, V14, P1513, DOI 10.1111/j.1462-5822.2012.01832.x; Rossi RE, 2004, INT ARCH ALLERGY IMM, V133, P261, DOI 10.1159/000076833; Rusnak JM, 2004, EMERG INFECT DIS, V10, P1544, DOI 10.3201/eid1009.040250; Rux JJ, 2000, MOL THER, V1, P18, DOI 10.1006/mthe.1999.0001; Tilahun ME, 2011, PLOS ONE, V11, P1; Tilahun ME, 2011, PLOS ONE, V11, P16; Urushibata Y, 2010, CLIN VACCINE IMMUNOL, V17, P1708, DOI 10.1128/CVI.00229-10; Varshney AK, 2013, J INFECT DIS, V208, P2058, DOI 10.1093/infdis/jit421; Varshney AK, 2011, J BIOL CHEM, V286, P9737, DOI 10.1074/jbc.M110.212407	38	8	9	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90445	10.1371/journal.pone.0090445	http://dx.doi.org/10.1371/journal.pone.0090445			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599257	gold, Green Submitted, Green Published			2022-12-27	WOS:000332479400075
J	Zhang, YT; Li, X; Chen, ZM; Bepler, G				Zhang, Yingtao; Li, Xin; Chen, Zhengming; Bepler, Gerold			Ubiquitination and Degradation of Ribonucleotide Reductase M1 by the Polycomb Group Proteins RNF2 and Bmi1 and Cellular Response to Gemcitabine	PLOS ONE			English	Article							MYC TRANSGENIC MICE; LUNG-CANCER; IN-VIVO; PANCREATIC-CANCER; LIGASE ACTIVITY; EXPRESSION; RESISTANCE; CELLS; OVEREXPRESSION; TUMORIGENESIS	Ribonucleotide reductase M1 (RRM1) is required for mammalian deoxyribonucleotide (dNTP) metabolism. It is the primary target of the antimetabolite drug gemcitabine, which is among the most efficacious and most widely used cancer therapeutics. Gemcitabine directly binds to RRM1 and irreversibly inactivates ribonucleotide reductase. Intra-tumoral RRM1 levels are predictive of gemcitabine's therapeutic efficacy. The mechanisms that regulate intracellular RRM1 levels are largely unknown. Here, we identified the E3 ubiquitin-protein ligases RNF2 and Bmi1 to associate with RRM1 with subsequent poly-ubiquitination at either position 48 or 63 of ubiquitin. The lysine residues 224 and 548 of RRM1 were identified as major ubiquitination sites. We show that ubiquitinated RRM1 undergoes proteasome-mediated degradation and that targeted post-transcriptional silencing of RNF2 and Bmi1 results in increased RRM1 levels and resistance to gemcitabine. Immunohistochemical analyses of 187 early-stage lung cancer tumor specimens revealed a statistically significant co-expression of RRM1 and Bmi1. We were unable to identify suitable reagents for in situ quantification of RNF2. Our findings suggest that Bmi1 and possibly RNF2 may be attractive biomarkers of gemcitabine resistance in the context of RRM1 expression. They also provide novel information for the rational design of gemcitabine-proteasome inhibitor combination therapies, which so far have been unsuccessful if given to patients without taking the molecular context into account.	[Zhang, Yingtao; Li, Xin; Chen, Zhengming; Bepler, Gerold] Karmanos Canc Inst, Mol Therapeut Program, Detroit, MI 48201 USA	Barbara Ann Karmanos Cancer Institute	Bepler, G (corresponding author), Karmanos Canc Inst, Mol Therapeut Program, Detroit, MI 48201 USA.	beplerg@karmanos.org			National Cancer Institute [R01-CA129343]; NATIONAL CANCER INSTITUTE [R01CA129343] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a grant (R01-CA129343) from the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardley HC, 2005, ESSAYS BIOCHEM, V41, P15, DOI 10.1042/EB0410015; Ben-Saadon R, 2006, MOL CELL, V24, P701, DOI 10.1016/j.molcel.2006.10.022; Bentley ML, 2011, EMBO J, V30, P3285, DOI 10.1038/emboj.2011.243; Bepler G, 2006, J CLIN ONCOL, V24, P4731, DOI 10.1200/JCO.2006.06.1101; Bergman AM, 2005, CANCER RES, V65, P9510, DOI 10.1158/0008-5472.CAN-05-0989; Bhattacharyya J, 2012, CANCER SCI, V103, P34, DOI 10.1111/j.1349-7006.2011.02121.x; Bruggeman SWM, 2007, CANCER CELL, V12, P328, DOI 10.1016/j.ccr.2007.08.032; Camp RL, 2002, NAT MED, V8, P1323, DOI 10.1038/nm791; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Chen ZM, 2011, BIOCHEM BIOPH RES CO, V413, P383, DOI 10.1016/j.bbrc.2011.08.111; Davidson JD, 2004, CANCER RES, V64, P3761, DOI 10.1158/0008-5472.CAN-03-3363; Davies AM, 2009, J THORAC ONCOL, V4, P87, DOI 10.1097/JTO.0b013e3181915052; Dovey JS, 2008, P NATL ACAD SCI USA, V105, P11857, DOI 10.1073/pnas.0803574105; Fan HZ, 1997, P NATL ACAD SCI USA, V94, P13181, DOI 10.1073/pnas.94.24.13181; Frezza M, 2011, CURR TOP MED CHEM, V11, P2888, DOI 10.2174/156802611798281311; Gautam A, 2003, ONCOGENE, V22, P2135, DOI 10.1038/sj.onc.1206232; HAUPT Y, 1991, CELL, V65, P753, DOI 10.1016/0092-8674(91)90383-A; Hernadez-Munoz I, 2005, P NATL ACAD SCI USA, V102, P7635, DOI 10.1073/pnas.0408918102; Hoeller D, 2006, NAT REV CANCER, V6, P776, DOI 10.1038/nrc1994; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Mao SS, 1992, BIOCHEMISTRY-US, V31, P7933; Nakahira S, 2007, INT J CANCER, V120, P1355, DOI 10.1002/ijc.22390; Perez MAS, 2010, CURR MED CHEM, V17, P2854, DOI 10.2174/092986710792065054; Reynolds C, 2009, J CLIN ONCOL, V27, P5808, DOI 10.1200/JCO.2009.21.9766; Ryan DP, 2006, CANCER-AM CANCER SOC, V107, P2482, DOI 10.1002/cncr.22264; VANLOHUIZEN M, 1991, CELL, V65, P737, DOI 10.1016/0092-8674(91)90382-9; Wang EF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017918; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Yin T, 2011, CHEMOTHERAPY, V57, P488, DOI 10.1159/000334103; Zheng Z, 2007, NEW ENGL J MED, V356, P800, DOI 10.1056/NEJMoa065411	32	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91186	10.1371/journal.pone.0091186	http://dx.doi.org/10.1371/journal.pone.0091186			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614341	Green Submitted, Green Published, gold			2022-12-27	WOS:000332839300093
J	Fereshtehnejad, SM; Ghazi, L; Shafieesabet, M; Shahidi, GA; Delbari, A; Lokk, J				Fereshtehnejad, Seyed-Mohammad; Ghazi, Ladan; Shafieesabet, Mahdiyeh; Shahidi, Gholam Ali; Delbari, Ahmad; Lokk, Johan			Motor, Psychiatric and Fatigue Features Associated with Nutritional Status and Its Effects on Quality of Life in Parkinson's Disease Patients	PLOS ONE			English	Article							SUBJECTIVE GLOBAL ASSESSMENT; WEIGHT-LOSS; ELDERLY-PATIENTS; NURSING-HOMES; MALNUTRITION; PREVALENCE; PEOPLE; SCALE; IMPAIRMENT; PREDICTORS	Objectives: Parkinson's disease (PD) patients are more likely to develop impaired nutritional status because of the symptoms, medications and complications of the disease. However, little is known about the determinants and consequences of malnutrition in PD. This study aimed to investigate the association of motor, psychiatric and fatigue features with nutritional status as well as the effects of malnutrition on different aspects of quality of life (QoL) in PD patients. Methods: One hundred and fifty patients with idiopathic PD (IPD) were recruited in this study. A demographic checklist, the Unified Parkinson's Disease Rating Scale (UPDRS), the Hospital Anxiety and Depression Scale (HADS) and the Fatigue Severity Scale (FSS) were completed through face-to-face interviews and clinical examinations. The health-related QoL (HRQoL) was also evaluated by means of the Parkinson's Disease Questionnaire (PDQ-39). For evaluation of nutritional status, the Mini Nutritional Assessment (MNA) questionnaire was applied together with anthropometric measurements. Results: Thirty seven (25.3%) patients were at risk of malnutrition and another 3 (2.1%) were malnourished. The total score of the UPDRS scale (r = -0.613, P<0.001) and PD duration (r = -0.284, P = 0.002) had a significant inverse correlation with the total MNA score. The median score of the Hoehn and Yahr stage was significantly higher in PD patients with abnormal nutritional status [2.5 vs. 2.0; P<0.001]. More severe anxiety [8.8 vs. 5.9; P = 0.002], depression [9.0 vs. 3.6; P<0.001] and fatigue [5.4 vs. 4.2; P<0.001] were observed in PD patients with abnormal nutritional status. Except for stigma, all other domains of the PDQ-39 were significantly correlated with the total score of the MNA. Conclusion: Our study demonstrates that disease duration, severity of motor and psychiatric symptoms (depression, anxiety) and fatigue are associated with nutritional status in PD. Different aspects of the HRQoL were affected by patients' nutritional status especially the emotional well-being and mobility domains.	[Fereshtehnejad, Seyed-Mohammad; Delbari, Ahmad; Lokk, Johan] Karolinska Inst, Dept Neurobiol Care Sci & Soc NVS, Div Clin Geriatr, Stockholm, Sweden; [Fereshtehnejad, Seyed-Mohammad] Iran Univ Med Sci, Firoozgar Hosp, FCRDC, Tehran, Iran; [Ghazi, Ladan] Karolinska Inst, Dept Biosci & Nutr, Stockholm, Sweden; [Shafieesabet, Mahdiyeh] Iran Univ Med Sci, MSRC, Fac Med, Tehran, Iran; [Shahidi, Gholam Ali] Iran Univ Med Sci, Dept Neurol, Movement Disorders Clin, Fac Med, Tehran, Iran; [Delbari, Ahmad] Sabzevar Univ Med Sci, Aging Res Ctr, Sabzevar, Khorasan, Iran; [Lokk, Johan] Karolinska Univ Hosp, Dept Geriatr Med, Stockholm, Sweden	Karolinska Institutet; Iran University of Medical Sciences; Karolinska Institutet; Iran University of Medical Sciences; Iran University of Medical Sciences; Karolinska Institutet; Karolinska University Hospital	Fereshtehnejad, SM (corresponding author), Karolinska Inst, Dept Neurobiol Care Sci & Soc NVS, Div Clin Geriatr, Stockholm, Sweden.	sm.fereshtehnejad@ki.se	Delbari, Ahmad/D-8560-2017; Fereshtehnejad, Seyed-Mohammad/ABF-6020-2020	Fereshtehnejad, Seyed-Mohammad/0000-0001-9255-9351; Shahidi, Gholam Ali/0000-0002-3889-4973				Afsar B, 2006, J RENAL NUTR, V16, P277, DOI 10.1053/j.jrn.2006.01.012; Ahmed T, 2010, CLIN INTERV AGING, V5, P207; Amaral TF, 2010, CLIN NUTR, V29, P580, DOI 10.1016/j.clnu.2010.02.004; Amirkalali B, 2010, PUBLIC HEALTH NUTR, V13, P1373, DOI 10.1017/S1368980010000303; Andersson I, 2001, J ADV NURS, V35, P69, DOI 10.1046/j.1365-2648.2001.01823.x; Azimian M., 2009, Research Journal of Biological Sciences, V4, P974; Barichella M, 2003, EUR J CLIN NUTR, V57, P543, DOI 10.1038/sj.ejcn.1601581; Barichella M, 2013, BRIT J NUTR, V110, P347, DOI 10.1017/S0007114512004941; Barichella M, 2009, MOVEMENT DISORD, V24, P1881, DOI 10.1002/mds.22705; Barichella M, 2008, NUTR NEUROSCI, V11, P128, DOI 10.1179/147683008X301441; Bauer JM, 2006, DEUT MED WOCHENSCHR, V131, P223, DOI 10.1055/s-2006-924953; BEYER PL, 1995, J AM DIET ASSOC, V95, P979, DOI 10.1016/S0002-8223(95)00269-3; Bollwein J, 2013, J NUTR HEALTH AGING, V17, P351, DOI [10.1007/s12603-013-0034-7, 10.1007/s12603-013-0009-8]; Cereda E, 2010, NUTRITION, V26, P240, DOI 10.1016/j.nut.2009.06.003; Chapman IM, 2006, MED CLIN N AM, V90, P887, DOI 10.1016/j.mcna.2006.05.010; Crogan NL, 2003, J GERONTOL A-BIOL, V58, P159; Durrieu G, 1992, Clin Auton Res, V2, P153, DOI 10.1007/BF01818955; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Goetz CG, 2003, MOVEMENT DISORD, V18, P738, DOI 10.1002/mds.10473; Guigoz Y, 1996, NUTR REV, V54, pS59; Guigoz Y, 1994, FACTS RES GERONTOL, V2, P15, DOI DOI 10.1016/S0899-9007(98)00171-3; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Jaafar A, 2010, MOVEMENT DISORD, V25, pS424; Jaafar AF, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-124; Kaye J, 2006, MOVEMENT DISORD, V21, P1270, DOI 10.1002/mds.20942; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Lefton J., 2009, ADA POCKET GUIDE NUT, P160; Lorefalt B, 2004, ACTA NEUROL SCAND, V110, P180, DOI 10.1111/j.1600-0404.2004.00307.x; MARKUS HS, 1993, J NEURAL TRANSM-PARK, V5, P117, DOI 10.1007/BF02251202; Miller N, 2009, J NEUROL NEUROSUR PS, V80, P1047, DOI 10.1136/jnnp.2008.157701; Montazeri Ali, 2003, Health Qual Life Outcomes, V1, P14, DOI 10.1186/1477-7525-1-14; Neumann SA, 2005, J HUM NUTR DIET, V18, P129, DOI 10.1111/j.1365-277X.2005.00596.x; Nojomi M, 2010, J RES MED SCI, V15, P63; Nozaki S, 1999, Rinsho Shinkeigaku, V39, P1010; Persson MD, 2002, J AM GERIATR SOC, V50, P1996, DOI 10.1046/j.1532-5415.2002.50611.x; Peto V, 1998, J NEUROL, V245, pS10, DOI 10.1007/PL00007730; Ramaker C, 2002, MOVEMENT DISORD, V17, P867, DOI 10.1002/mds.10248; Schwab R.S., 1969, PROJECTION TECHNIQUE; Serrano-Urrea R, 2013, GERONTOLOGY, V59, P490, DOI 10.1159/000351763; Sheard J. M., 2013, e-SPEN Journal, V8, pe187; Sheard JM, 2013, J NUTR HEALTH AGING, V17, P148, DOI 10.1007/s12603-012-0386-4; Sheard JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057986; Sheard JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053290; Sheard JM, 2011, NUTR REV, V69, P520, DOI 10.1111/j.1753-4887.2011.00413.x; Teasdale N, 2007, MOVEMENT DISORD, V22, P436, DOI 10.1002/mds.21203; Tsai AC, 2011, INT J NURS STUD, V48, P1429, DOI 10.1016/j.ijnurstu.2011.05.004; Uc EY, 2006, MOVEMENT DISORD, V21, P930, DOI 10.1002/mds.20837; Visvanathan R, 2003, J AM GERIATR SOC, V51, P1007, DOI 10.1046/j.1365-2389.2003.51317.x; Wang G, 2010, PARKINSONISM RELAT D, V16, P119, DOI 10.1016/j.parkreldis.2009.08.009; YAPA RSS, 1989, J CLIN EXP GERONTOL, V11, P155; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	52	41	47	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91153	10.1371/journal.pone.0091153	http://dx.doi.org/10.1371/journal.pone.0091153			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC4IY	24608130	Green Submitted, Green Published, gold			2022-12-27	WOS:000332485800106
J	Janke, H; Pastore, F; Schumacher, D; Herold, T; Hopfner, KP; Schneider, S; Berdel, WE; Buchner, T; Woermann, BJ; Subklewe, M; Bohlander, SK; Hiddemann, W; Spiekermann, K; Polzer, H				Janke, Hanna; Pastore, Friederike; Schumacher, Daniela; Herold, Tobias; Hopfner, Karl-Peter; Schneider, Stephanie; Berdel, Wolfgang E.; Buechner, Thomas; Woermann, Bernhard J.; Subklewe, Marion; Bohlander, Stefan K.; Hiddemann, Wolfgang; Spiekermann, Karsten; Polzer, Harald			Activating FLT3 Mutants Show Distinct Gain-of-Function Phenotypes In Vitro and a Characteristic Signaling Pathway Profile Associated with Prognosis in Acute Myeloid Leukemia	PLOS ONE			English	Article							TYROSINE KINASE DOMAIN; INTERNAL TANDEM DUPLICATION; HIGH-DOSE CYTARABINE; CONSTITUTIVE ACTIVATION; PROLONGED MAINTENANCE; INDUCE TRANSFORMATION; JUXTAMEMBRANE DOMAIN; STAT5 ACTIVATION; NORMAL KARYOTYPE; POINT MUTATIONS	About 30% of patients with acute myeloid leukemia (AML) harbour mutations of the receptor tyrosine kinase FLT3, mostly internal tandem duplications (ITD) and point mutations of the second tyrosine kinase domain (TKD). It was the aim of this study to comprehensively analyze clinical and functional properties of various FLT3 mutants. In 672 normal karyotype AML patients FLT3-ITD, but not FLT3-TKD mutations were associated with a worse relapse free and overall survival in multivariate analysis. In paired diagnosis-relapse samples FLT3-ITD showed higher stability (70%) compared to FLT3-TKD (30%). In vitro, FLT3-ITD induced a strong activating phenotype in Ba/F3 cells. In contrast, FLT3-TKD mutations and other point mutations - including two novel mutations - showed a weaker but clear gain-of-function phenotype with gradual increase in proliferation and protection from apoptosis. The pro-proliferative capacity of the investigated FLT3 mutants was associated with cell surface expression and tyrosine 591 phosphorylation of the FLT3 receptor. Western blot experiments revealed STAT5 activation only in FLT3-ITD positive cell lines, in contrast to FLT3-non-ITD mutants, which displayed an enhanced signal of AKT and MAPK activation. Gene expression analysis revealed distinct difference between FLT3-ITD and FLT3-TKD for STAT5 target gene expression as well as deregulation of SOCS2, ENPP2, PRUNE2 and ART3. FLT3-ITD and FLT3 point mutations show a gain-of-function phenotype with distinct signalling properties in vitro. Although poor prognosis in AML is only associated with FLT3-ITD, all activating FLT3 mutations can contribute to leukemogenesis and are thus potential targets for therapeutic interventions.	[Janke, Hanna; Pastore, Friederike; Schumacher, Daniela; Herold, Tobias; Schneider, Stephanie; Subklewe, Marion; Hiddemann, Wolfgang; Spiekermann, Karsten; Polzer, Harald] Univ Munich, Univ Hosp Munich, Dept Internal Med 3, Munich, Germany; [Janke, Hanna; Pastore, Friederike; Herold, Tobias; Hiddemann, Wolfgang; Spiekermann, Karsten; Polzer, Harald] Helmholtz Ctr Munich, Clin Cooperat Grp Leukemia, Munich, Germany; [Pastore, Friederike; Subklewe, Marion; Hiddemann, Wolfgang; Spiekermann, Karsten; Polzer, Harald] German Canc Consortium DKTK, Heidelberg, Germany; [Pastore, Friederike; Subklewe, Marion; Hiddemann, Wolfgang; Spiekermann, Karsten; Polzer, Harald] German Canc Res Ctr, Heidelberg, Germany; [Hopfner, Karl-Peter] Univ Munich, Gene Ctr, Dept Biochem, Munich, Germany; [Berdel, Wolfgang E.; Buechner, Thomas] Univ Munster, Dept Med Hematol Oncol & Pneumol A, Munster, Germany; [Woermann, Bernhard J.] German Soc Hematol & Oncol, Berlin, Germany; [Subklewe, Marion] Helmholtz Ctr Munich, Clin Cooperat Grp Immunotherapy, Munich, Germany; [Bohlander, Stefan K.] Univ Auckland, Dept Mol Med & Pathol, Auckland 1, New Zealand	University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); University of Munich; University of Munster; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Auckland	Janke, H (corresponding author), Univ Munich, Univ Hosp Munich, Dept Internal Med 3, Munich, Germany.	Hanna.Janke@med.uni-muenchen.de	Herold, Tobias/AAD-1072-2019; Hopfner, Karl-Peter/B-6864-2014; Subklewe, Marion/N-5873-2014	Herold, Tobias/0000-0002-9615-9432; Hopfner, Karl-Peter/0000-0002-4528-8357; Subklewe, Marion/0000-0001-9154-9469; Bohlander, Stefan/0000-0002-2202-9088	Deutsche Forschungsgemeinschaft [SFB 684/A12, SFB 684/A6]; German Ministry for Education and Research, BMBF [NGFN-Plus: 01GS0876]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Ministry for Education and Research, BMBF(Federal Ministry of Education & Research (BMBF))	Deutsche Forschungsgemeinschaft, SFB 684/A12 to K. Spiekermann; Deutsche Forschungsgemeinschaft, SFB 684/A6 to S. K. Bohlander; German Ministry for Education and Research, BMBF, NGFN-Plus: 01GS0876 to S. K. Bohlander. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers C, 2013, LEUKEMIA, V27, P1416, DOI 10.1038/leu.2013.14; Bacher U, 2008, BLOOD, V111, P2527, DOI 10.1182/blood-2007-05-091215; Braess J, 2009, BLOOD, V113, P3903, DOI 10.1182/blood-2008-07-162842; Buchner T, 2006, J CLIN ONCOL, V24, P2480, DOI 10.1200/JCO.2005.04.5013; Buchner T, 2003, J CLIN ONCOL, V21, P4496, DOI 10.1200/JCO.2003.02.133; Byrd JC, 2002, BLOOD, V100, P4325, DOI 10.1182/blood-2002-03-0772; Choudhary C, 2005, INT J HEMATOL, V82, P93, DOI 10.1532/IJH97.05090; Choudhary C, 2005, BLOOD, V106, P265, DOI 10.1182/blood-2004-07-2942; Choudhary C, 2007, BLOOD, V110, P370, DOI 10.1182/blood-2006-05-024018; Choudhary C, 2009, MOL CELL, V36, P326, DOI 10.1016/j.molcel.2009.09.019; Fenski R, 2000, BRIT J HAEMATOL, V108, P322; Ferrari F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-446; Frohling S, 2007, CANCER CELL, V12, P501, DOI 10.1016/j.ccr.2007.11.005; Ghosh K, 2012, ANN HEMATOL, V91, P1703, DOI 10.1007/s00277-012-1509-z; Gilliland DG, 2002, BLOOD, V100, P1532, DOI 10.1182/blood-2002-02-0492; Griffith J, 2004, MOL CELL, V13, P169, DOI 10.1016/S1097-2765(03)00505-7; Grundler R, 2005, BLOOD, V105, P4792, DOI 10.1182/blood-2004-11-4430; Hayakawa F, 2000, ONCOGENE, V19, P624, DOI 10.1038/sj.onc.1203354; Heidel F, 2006, BLOOD, V107, P293, DOI 10.1182/blood-2005-06-2469; Herold T, 2011, LEUKEMIA, V25, P1639, DOI 10.1038/leu.2011.125; Jiang JR, 2004, BLOOD, V104, P1855, DOI 10.1182/blood-2004-02-0712; Kazi JU, 2012, J BIOL CHEM, V287, P36509, DOI 10.1074/jbc.M112.376111; Kelly LM, 2002, BLOOD, V99, P310, DOI 10.1182/blood.V99.1.310; Kindler T, 2005, BLOOD, V105, P335, DOI 10.1182/blood-2004-02-0660; Leischner H, 2012, BLOOD, V119, P4026, DOI 10.1182/blood-2011-07-365726; Li ZJ, 2013, J CLIN ONCOL, V31, P1172, DOI 10.1200/JCO.2012.44.3184; Lin DC, 2012, BLOOD, V120, P3310, DOI 10.1182/blood-2011-10-388611; Mead AJ, 2007, BLOOD, V110, P1262, DOI 10.1182/blood-2006-04-015826; Mills KI, 2005, BRIT J HAEMATOL, V130, P203, DOI 10.1111/j.1365-2141.2005.05589.x; Mizuki M, 2000, BLOOD, V96, P3907, DOI 10.1182/blood.V96.12.3907; Neben K, 2005, ONCOGENE, V24, P1580, DOI 10.1038/sj.onc.1208344; Opatz S, 2013, BLOOD; Orfao A, 2007, BRIT J HAEMATOL, V138, P12, DOI 10.1111/j.1365-2141.2007.06619.x; Ortlepp C, 2013, EXP HEMATOL, V41, P444, DOI 10.1016/j.exphem.2013.01.007; Parcells BW, 2006, STEM CELLS, V24, P1174, DOI 10.1634/stemcells.2005-0519; Polzer H, 2013, EXP HEMATOL, V41, P271, DOI 10.1016/j.exphem.2012.10.016; Reindl C, 2006, BLOOD, V107, P3700, DOI 10.1182/blood-2005-06-2596; Rocnik JL, 2006, BLOOD, V108, P1339, DOI 10.1182/blood-2005-11-011429; Schittenhelm MM, 2006, LEUKEMIA, V20, P2008, DOI 10.1038/sj.leu.2404374; Schmidt-Arras DE, 2005, MOL CELL BIOL, V25, P3690, DOI 10.1128/MCB.25.9.3690-3703.2005; Schneider F, 2012, BLOOD, V119, P4383, DOI 10.1182/blood-2010-12-327072; Schnittger S, 2002, BLOOD, V100, P59, DOI 10.1182/blood.V100.1.59; Shih LY, 2004, CLIN CANCER RES, V10, P1326, DOI 10.1158/1078-0432.CCR-0835-03; Smith ML, 2005, BRIT J HAEMATOL, V128, P318, DOI 10.1111/j.1365-2141.2004.05324.x; Soldaini E, 2000, MOL CELL BIOL, V20, P389, DOI 10.1128/MCB.20.1.389-401.2000; Spiekermann K, 2003, CLIN CANCER RES, V9, P2140; Spiekermann K, 2002, BLOOD, V100, P3423, DOI 10.1182/blood-2002-03-0953; Stirewalt DL, 2004, BRIT J HAEMATOL, V124, P481, DOI 10.1111/j.1365-2141.2004.04808.x; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thiede C, 2002, BLOOD, V99, P4326, DOI 10.1182/blood.V99.12.4326; Vempati S, 2008, CLIN CANCER RES, V14, P4437, DOI 10.1158/1078-0432.CCR-07-1873; Yamamoto Y, 2001, BLOOD, V97, P2434, DOI 10.1182/blood.V97.8.2434; Yanada M, 2005, LEUKEMIA, V19, P1345, DOI 10.1038/sj.leu.2403838; Yap TA, 2011, J CLIN ONCOL, V29, P4688, DOI 10.1200/JCO.2011.35.5263; Zhou JB, 2009, BLOOD, V113, P4052, DOI 10.1182/blood-2008-05-156422	55	56	56	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e89560	10.1371/journal.pone.0089560	http://dx.doi.org/10.1371/journal.pone.0089560			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608088	gold, Green Submitted, Green Published			2022-12-27	WOS:000332485800004
J	Peluso, MO; Campbell, VT; Harari, JA; Tibbitts, TT; Proctor, JL; Whitebread, N; Conley, JM; White, KF; Kutok, JL; Read, MA; McGovern, K; Faia, KL				Peluso, Marisa O.; Campbell, Veronica T.; Harari, Joseph A.; Tibbitts, Thomas T.; Proctor, Jennifer L.; Whitebread, Nigel; Conley, James M.; White, Kerry F.; Kutok, Jeffery L.; Read, Margaret A.; McGovern, Karen; Faia, Kerrie L.			Impact of the Smoothened Inhibitor, IPI-926, on Smoothened Ciliary Localization and Hedgehog Pathway Activity	PLOS ONE			English	Article							PRIMARY CILIUM; DIFFERENTIATION; TRANSLOCATION; CANCER; CELLS	A requisite step for canonical Hedgehog (Hh) pathway activation by Sonic Hedgehog (Shh) ligand is accumulation of Smoothened (Smo) to the primary cilium (PC). Activation of the Hh pathway has been implicated in a broad range of cancers, and several Smo antagonists are being assessed clinically, one of which is approved for the treatment of advanced basal cell carcinoma. Recent reports demonstrate that various Smo antagonists differentially impact Smo localization to the PC while still exerting inhibitory activity. In contrast to other synthetic small molecule Smo antagonists, the natural product cyclopamine binds to and promotes ciliary accumulation of Smo and "primes'' cells for Hh pathway hyper-responsiveness after compound withdrawal. We compared the properties of IPI-926, a semi-synthetic cyclopamine analog, to cyclopamine with regard to potency, ciliary Smo accumulation, and Hh pathway activity after compound withdrawal. Like cyclopamine, IPI-926 promoted accumulation of Smo to the PC. However, in contrast to cyclopamine, IPI-926 treatment did not prime cells for hyper-responsiveness to Shh stimulation after compound withdrawal, but instead demonstrated continuous inhibition of signaling. By comparing the levels of drug-induced ciliary Smo accumulation with the degree of Hh pathway activity after compound withdrawal, we propose that a critical threshold of ciliary Smo is necessary for "priming'' activity to occur. This "priming'' appears achievable with cyclopamine, but not IPI-926, and is cell-line dependent. Additionally, IPI-926 activity was evaluated in a murine tumor xenograft model and a pharmacokinetic/pharmacodynamic relationship was examined to assess for in vivo evidence of Hh pathway hyper-responsiveness. Plasma concentrations of IPI-926 correlated with the degree and duration of Hh pathway suppression, and pathway activity did not exceed baseline levels out to 96 hours post dose. The overall findings suggest that IPI-926 possesses unique biophysical and pharmacological properties that result in Hh pathway inhibition in a manner that differentiates it from cyclopamine.	[Peluso, Marisa O.; Campbell, Veronica T.; Harari, Joseph A.; Tibbitts, Thomas T.; Proctor, Jennifer L.; Whitebread, Nigel; Conley, James M.; White, Kerry F.; Kutok, Jeffery L.; Read, Margaret A.; McGovern, Karen; Faia, Kerrie L.] Infin Pharmaceut Inc, Cambridge, MA 02139 USA		Faia, KL (corresponding author), Infin Pharmaceut Inc, Cambridge, MA 02139 USA.	Kerrie.Faia@infi.com		Conley, James/0000-0001-8901-4713				Arbiser JL, 1999, AM J PATHOL, V155, P723, DOI 10.1016/S0002-9440(10)65171-1; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Chen YB, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001083; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Milenkovic L, 2009, J CELL BIOL, V187, P365, DOI 10.1083/jcb.200907126; Nakamura T, 1997, BIOCHEM BIOPH RES CO, V237, P465, DOI 10.1006/bbrc.1997.7156; Nozawa YI, 2013, CURR OPIN GENET DEV; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Rohatgi R, 2009, P NATL ACAD SCI USA, V106, P3196, DOI 10.1073/pnas.0813373106; Tremblay MR, 2009, J MED CHEM, V52, P4400, DOI 10.1021/jm900305z; van der Horst G, 2003, BONE, V33, P899, DOI 10.1016/j.bone.2003.07.004; Wang C, 2013, NATURE, V497, P338, DOI 10.1038/nature12167; Wang Y, 2012, CHEM BIOL, V19, P972, DOI 10.1016/j.chembiol.2012.06.012; Wang Y, 2012, ACS CHEM BIOL, V7, P1040, DOI 10.1021/cb300028a; Wang Y, 2009, P NATL ACAD SCI USA, V106, P2623, DOI 10.1073/pnas.0812110106; Wilson CW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005182; Wu VM, 2012, P NATL ACAD SCI USA, V109, P13644, DOI 10.1073/pnas.1207170109; Yauch RL, 2008, NATURE, V455, P406, DOI 10.1038/nature07275; Yauch RL, 2009, SCIENCE, V326, P572, DOI 10.1126/science.1179386	20	14	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90534	10.1371/journal.pone.0090534	http://dx.doi.org/10.1371/journal.pone.0090534			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608250	Green Submitted, Green Published, gold			2022-12-27	WOS:000332485800030
J	Sylos-Labini, F; Ivanenko, YP; MacLellan, MJ; Cappellini, G; Poppele, RE; Lacquaniti, F				Sylos-Labini, Francesca; Ivanenko, Yuri P.; MacLellan, Michael J.; Cappellini, Germana; Poppele, Richard E.; Lacquaniti, Francesco			Locomotor-Like Leg Movements Evoked by Rhythmic Arm Movements in Humans	PLOS ONE			English	Article							QUADRUPEDAL COORDINATION; MUSCLE-ACTIVITY; DIFFERENT FORMS; SWING PHASE; SPINAL-CORD; WALKING; STIMULATION; FOOT; MODULATION; ACTIVATION	Motion of h upper limbs is often coupled to that of unclear, however, her he functional coupling between upper and lower limbs is bi-directional movements can affect lumbosacral locomotor circuitry. Here we tested the effects of voluntary rhythmic arm movements on the lower limb Participants lay horizontally on their side with each leg suspended in an unloading exoskeleton. They moved their arms on n overhead treadmill as if hey walked on their hands. Hand-walking in the antero-posterior direction resulted in significant like movements he legs in 8 of he participants. We further investigated quantitatively the responses in a ubset of the responsive subjects. We found that the electromyographic (EMG) activity of proximal leg muscles was modulated over each cycle with a timing similar to that of normal locomotion. The frequency of kinematic and EMG dilations in the legs typically differed from ha of arm oscillations. The effect of hand-walking was direction specific since medio-lateral arm movements did not evoke appreciably leg air-stepping. Using externally imposed trunk movements and biomechanical modelling, we ruled out that the leg movements associated with hand-walking were mainly due to the mechanical transmission of trunk oscillations. EMG activity in hamstring muscles associated with hand-walking often continued when the leg movements were transiently blocked by the experimenter or following termination of arm movements. The present results reinforce the idea that there exists a functional neural coupling between arm and legs	[Sylos-Labini, Francesca; Ivanenko, Yuri P.; MacLellan, Michael J.; Cappellini, Germana; Lacquaniti, Francesco] Santa Lucia Fdn, Lab Neuromotor Physiol, Rome, Italy; [Sylos-Labini, Francesca; Cappellini, Germana; Lacquaniti, Francesco] Univ Roma Tor Vergata, Ctr Space Biomed, Rome, Italy; [MacLellan, Michael J.] Louisiana State Univ, Sch Kinesiol, Baton Rouge, LA 70803 USA; [Poppele, Richard E.] Univ Minnesota, Dept Neurosci, Minneapolis, MN USA; [Lacquaniti, Francesco] Univ Roma Tor Vergata, Dept Syst Med, Rome, Italy	IRCCS Santa Lucia; University of Rome Tor Vergata; Louisiana State University System; Louisiana State University; University of Minnesota System; University of Minnesota Twin Cities; University of Rome Tor Vergata	Sylos-Labini, F (corresponding author), Santa Lucia Fdn, Lab Neuromotor Physiol, Rome, Italy.	f.syloslabini@hsantalucia.it	Lacquaniti, Francesco/J-9842-2016; Cappellini, Germana/AAA-7754-2019; Ivanenko, Yury/L-1599-2018; Sylos Labini, Francesca/B-5645-2013; Labini, Francesca Sylos/AAE-9385-2020	Lacquaniti, Francesco/0000-0003-0896-7315; Ivanenko, Yury/0000-0001-9363-9548; Sylos Labini, Francesca/0000-0002-8116-3375; Labini, Francesca Sylos/0000-0002-8116-3375; Cappellini, Germana/0000-0001-9110-3870	Italian Health Ministry, Italian Ministry of University and Research; Italian Space Agency (DCMC, CRUSOE and COREA grants); European Union [247959]; AMARSi grant [248311]	Italian Health Ministry, Italian Ministry of University and Research; Italian Space Agency (DCMC, CRUSOE and COREA grants); European Union(European Commission); AMARSi grant	This work was supported by the Italian Health Ministry, Italian Ministry of University and Research (PRIN project), Italian Space Agency (DCMC, CRUSOE and COREA grants), and European Union FP7-ICT program (MINDWALKER grant #247959 and AMARSi grant #248311). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALLESTEROS ML, 1965, ACTA PHYSIOL SCAND, V63, P296, DOI 10.1111/j.1748-1716.1965.tb04069.x; Balter JE, 2007, J NEUROPHYSIOL, V97, P1809, DOI 10.1152/jn.01038.2006; Barthelemy D, 2010, J PHYSIOL-LONDON, V588, P967, DOI 10.1113/jphysiol.2009.185520; Bernstein N, 1967, COORDINATION REGULAT; Blouin JS, 2010, J PHYSIOL-LONDON, V588, P1029, DOI 10.1113/jphysiol.2010.188649; Bruijn SM, 2010, J EXP BIOL, V213, P3945, DOI 10.1242/jeb.045112; Cappellini G, 2010, J NEUROPHYSIOL, V103, P746, DOI 10.1152/jn.00499.2009; Cazalets JR, 2000, EUR J NEUROSCI, V12, P2993, DOI 10.1046/j.1460-9568.2000.00169.x; Chiovetto E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079555; Collins SH, 2009, P ROY SOC B-BIOL SCI, V276, P3679, DOI 10.1098/rspb.2009.0664; Crenna P, 2008, BRAIN, V131, P3410, DOI 10.1093/brain/awn272; de Kam D, 2013, J APPL PHYSIOL, V115, P34, DOI 10.1152/japplphysiol.00510.2012; de Leva P, 1996, J BIOMECH, V29, P1223, DOI 10.1016/0021-9290(95)00178-6; de Seze M, 2008, EXP BRAIN RES, V185, P237, DOI 10.1007/s00221-007-1146-2; Debaere F, 2001, EXP BRAIN RES, V141, P519, DOI 10.1007/s002210100891; DELWAIDE PJ, 1981, BRAIN, V104, P701, DOI 10.1093/brain/104.4.701; Dietz V, 2002, TRENDS NEUROSCI, V25, P462, DOI 10.1016/S0166-2236(02)02229-4; Dietz V, 2011, J NEUROL, V258, P1406, DOI 10.1007/s00415-011-6063-4; Dietz V, 2009, ANN NY ACAD SCI, V1164, P97, DOI 10.1111/j.1749-6632.2008.03710.x; Donelan JM, 2004, CAN J PHYSIOL PHARM, V82, P589, DOI 10.1139/Y04-043; DUYSENS J, 1980, BRAIN RES, V187, P321, DOI 10.1016/0006-8993(80)90206-1; Duysens J, 1998, EUR J MORPHOL, V36, P293, DOI 10.1076/ejom.36.4.293.5820; Edgerton VR, 2008, BRAIN RES REV, V57, P241, DOI 10.1016/j.brainresrev.2007.09.002; Falgairolle M, 2006, J PHYSIOL-PARIS, V100, P304, DOI 10.1016/j.jphysparis.2007.05.003; Gerasimenko Y, 2010, J NEUROSCI, V30, P3700, DOI 10.1523/JNEUROSCI.4751-09.2010; Gerasimenko Y, 2009, J NEUROSCI, V29, P5681, DOI 10.1523/JNEUROSCI.6058-08.2009; GRILLNER S, 1978, BRAIN RES, V146, P269, DOI 10.1016/0006-8993(78)90973-3; Gurfinkel VS, 1998, EUR J NEUROSCI, V10, P1608, DOI 10.1046/j.1460-9568.1998.00179.x; Haridas C, 2003, J NEUROPHYSIOL, V90, P2850, DOI 10.1152/jn.00531.2003; Hogue R E, 1969, Phys Ther, V49, P963; Ivanenko YP, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00020; Ivanenko YP, 2002, J NEUROPHYSIOL, V87, P3070, DOI 10.1152/jn.2002.87.6.3070; Ivanenko YP, 2006, J NEUROPHYSIOL, V95, P602, DOI 10.1152/jn.00767.2005; Ivanenko YP, 2011, J APPL PHYSIOL, V110, P781, DOI 10.1152/japplphysiol.00799.2010; Juvin L, 2012, J NEUROSCI, V32, P953, DOI 10.1523/JNEUROSCI.4640-11.2012; Kuhtz-Buschbeck JP, 2012, J ELECTROMYOGR KINES, V22, P199, DOI 10.1016/j.jelekin.2011.08.014; Labini FS, 2011, J NEUROPHYSIOL, V106, P1525, DOI 10.1152/jn.00160.2011; MacLellan MJ, 2013, EXP BRAIN RES, V225, P217, DOI 10.1007/s00221-012-3364-5; MacLellan MJ, 2012, J NEUROPHYSIOL, V107, P114, DOI 10.1152/jn.00693.2011; Massaad F, 2014, NEUROSCIENCE, V258, P34, DOI 10.1016/j.neuroscience.2013.10.007; Meyns P, 2013, GAIT POSTURE, V38, P555, DOI 10.1016/j.gaitpost.2013.02.006; Meyns P, 2012, RES DEV DISABIL, V33, P1418, DOI 10.1016/j.ridd.2012.03.020; Mezzarane RA, 2011, EXP BRAIN RES, V208, P157, DOI 10.1007/s00221-010-2467-0; MILLER S, 1975, BRAIN RES, V91, P217, DOI 10.1016/0006-8993(75)90544-2; MORI S, 1982, J NEUROPHYSIOL, V48, P737, DOI 10.1152/jn.1982.48.3.737; Murray M P, 1967, Phys Ther, V47, P272; Nardone A, 2008, NEUROSCIENCE, V156, P607, DOI 10.1016/j.neuroscience.2008.07.039; Nathan PW, 1996, BRAIN, V119, P1809, DOI 10.1093/brain/119.6.1809; Orlovsky G., 1999, NEURONAL CONTROL LOC; Pang MYC, 2000, J PHYSIOL-LONDON, V528, P389, DOI 10.1111/j.1469-7793.2000.00389.x; Passingham RE, 1996, PHILOS T ROY SOC B, V351, P1473, DOI 10.1098/rstb.1996.0132; Patrick SK, 2012, J NEUROPHYSIOL, V107, P3050, DOI 10.1152/jn.00029.2012; Riener R, 1999, J BIOMECH, V32, P539, DOI 10.1016/S0021-9290(99)00009-3; Selionov VA, 2013, NEUROSCIENCE, V235, P96, DOI 10.1016/j.neuroscience.2012.12.064; Selionov VA, 2009, J NEUROPHYSIOL, V101, P2847, DOI 10.1152/jn.90895.2008; Shapiro LJ, 2005, AM J PHYS ANTHROPOL, V126, P205, DOI 10.1002/ajpa.20049; SHIK ML, 1965, BIOPHYSICS-USSR, V10, P1148; Sylos-Labini F, 2013, J MOTOR BEHAV, V45, P495, DOI 10.1080/00222895.2013.833080; Thibaudier Y, 2012, J NEUROPHYSIOL, V108, P709, DOI 10.1152/jn.00302.2012; Thorpe SKS, 2007, SCIENCE, V316, P1328, DOI 10.1126/science.1140799; Wannier T, 2001, EXP BRAIN RES, V141, P375, DOI 10.1007/s002210100875; WEBB D, 1994, AM J PHYS ANTHROPOL, V93, P477, DOI 10.1002/ajpa.1330930407; Winter DA., 1987, BIOMECHANICS MOTOR C; Wu T, 2004, J NEUROPHYSIOL, V91, P1690, DOI 10.1152/jn.01052.2003; YAMAGUCHI T, 1986, BRAIN RES, V379, P125, DOI 10.1016/0006-8993(86)90264-7; Zampagni ML, 2011, SCAND J MED SCI SPOR, V21, P688, DOI 10.1111/j.1600-0838.2010.01098.x; Zehr EP, 2009, EXERC SPORT SCI REV, V37, P102, DOI 10.1097/JES.0b013e31819c2ed6; Zehr EP, 2004, NEUROSCIENTIST, V10, P347, DOI 10.1177/1073858404264680; Zelenin PV, 2011, J NEUROSCI, V31, P4636, DOI 10.1523/JNEUROSCI.6511-10.2011; Zhang LQ, 2001, J BIOMECH, V34, P1107, DOI 10.1016/S0021-9290(01)00080-X	70	32	34	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90775	10.1371/journal.pone.0090775	http://dx.doi.org/10.1371/journal.pone.0090775			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC4IY	24608249	Green Published, Green Submitted, gold			2022-12-27	WOS:000332485800049
J	Halasa, YA; Shepard, DS; Fonseca, DM; Farajollahi, A; Healy, S; Gaugler, R; Bartlett-Healy, K; Strickman, DA; Clark, GG				Halasa, Yara A.; Shepard, Donald S.; Fonseca, Dina M.; Farajollahi, Ary; Healy, Sean; Gaugler, Randy; Bartlett-Healy, Kristen; Strickman, Daniel A.; Clark, Gary G.			Quantifying the Impact of Mosquitoes on Quality of Life and Enjoyment of Yard and Porch Activities in New Jersey	PLOS ONE			English	Article							ASIAN TIGER MOSQUITO; VISUAL ANALOG SCALE; WILLINGNESS-TO-PAY; AEDES-ALBOPICTUS; DIPTERA-CULICIDAE; DENGUE-FEVER; CHIKUNGUNYA; MANAGEMENT; VIRUS; POPULATIONS	The recent expansion of Aedes albopictus, a day-biting mosquito, to densely inhabited areas in the northeastern Atlantic states of the USA has dramatically increased the problem that mosquitoes create for urban and suburban residents. We quantified the impact of mosquitoes on residents' quality of life within the context of a comprehensive area-wide integrated pest management program to control Ae. albopictus in two counties (Mercer and Monmouth) in New Jersey. We interviewed residents of 121 randomly selected households in both counties between October and November 2010. We asked residents about their experience with mosquitoes in their neighborhood and the importance of the ability to relax outdoors without mosquitoes compared to other neighborhood characteristics (1 = not important, 5 = extremely important). We rated residents' utility based on paired comparisons to known states from the EuroQol health description system. The majority (54.6%) of respondents considered mosquitoes to be a problem. Respondents reported an average of 7.1 mosquito bites in a typical week during that summer. Mosquitoes prevented 59.5% of residents from enjoying their outdoor activities at least to some extent. Residents rated the mosquito acceptability (mean +/- standard deviation) during that summer on a scale of 0 (mosquito invasion) to 100 (no mosquitoes) at 56.7 +/- 28.7, and their overall utility at 0.87 +/- 0.03. This is comparable to living with up to two risk factors for diabetes (i.e., abdominal obesity, body mass index of 28 or more, reported cholesterol problems, diagnosis of hypertension, or history of cardiovascular disease) or women experiencing menstrual disorders. Respondents rated the importance of enjoying outdoor activities without mosquitoes (4.69 +/- 0.80) comparable to that of neighborhood safety (4.74 +/- 0.80) and higher than that of a clean neighborhood (4.59 +/- 0.94). In conclusion, New Jersey residents reported that mosquitoes decreased their utility by 0.13, comparable to the loss from worrisome health risk factors, underscoring the importance of controlling this problem.	[Halasa, Yara A.; Shepard, Donald S.] Brandeis Univ, Heller Sch Social Policy & Management, Waltham, MA 02453 USA; [Fonseca, Dina M.; Gaugler, Randy; Bartlett-Healy, Kristen] Rutgers State Univ, Ctr Vector Biol, New Brunswick, NJ 08903 USA; [Farajollahi, Ary] Mercer Cty Mosquito Control Transportat & Infrast, West Trenton, NJ USA; [Healy, Sean] Monmouth Cty Mosquito Exterminat Commiss, Eatontown, NJ USA; [Strickman, Daniel A.] ARS, USDA, Beltsville, MD USA; [Clark, Gary G.] ARS, USDA, Gainesville, FL USA; [Healy, Sean; Bartlett-Healy, Kristen] Louisiana State Univ, Ctr Agr, Baton Rouge, LA 70803 USA	Brandeis University; Rutgers State University New Brunswick; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); Louisiana State University System; Louisiana State University	Shepard, DS (corresponding author), Brandeis Univ, Heller Sch Social Policy & Management, Waltham, MA 02453 USA.	shepard@brandeis.edu	Gaugler, Randy/K-3898-2013; Fonseca, Dina/HHS-1320-2022; Fonseca, Dina Madeira/B-9951-2011	Fonseca, Dina Madeira/0000-0003-4726-7100; Healy, Kristen/0000-0002-3208-6537	 [USDA-ARS-58-6615-8-106]		This work was funded by Cooperative Agreement USDA-ARS-58-6615-8-106 to Brandeis University (PI: GGC; PI at Brandeis: DSS). Apart from the authors, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajwa W, 2013, AM MOSQ CONTR ASS 79; Bartlett-Healy K, 2012, J MED ENTOMOL, V49, P813, DOI 10.1603/ME11031; Borgherini G, 2007, CLIN INFECT DIS, V44, P1401, DOI 10.1086/517537; Curco N, 2008, ACTAS DERMO-SIFILOGR, V99, P708, DOI 10.1016/S0001-7310(08)76175-1; Dickinson K, 2012, VECTOR-BORNE ZOONOT, V12, P886, DOI 10.1089/vbz.2011.0810; Dolan P, 1996, HEALTH ECON, V5, P141, DOI 10.1002/(SICI)1099-1050(199603)5:2<141::AID-HEC189>3.0.CO;2-N; Dowling Z, 2013, ECOHEALTH, V10, P36, DOI 10.1007/s10393-013-0818-6; DYER JS, 1979, OPER RES, V27, P810, DOI 10.1287/opre.27.4.810; Effler PV, 2005, EMERG INFECT DIS, V11, P742; European Centre for Disease Prevention and Control, 2012, AUT DENG CAS MAD POR; Euroqol, 2012, EQ 5D 5L CROSSW VAL; Farajollahi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049181; Farajollahi A, 2009, J MED ENTOMOL, V46, P1220, DOI 10.1603/033.046.0533; Fonseca DM, 2013, PEST MANAG SCI, V69, P1351, DOI 10.1002/ps.3511; Gjenero-Margan I, 2011, EURO SURVEILL, V16; Gould EA, 2010, CLIN MICROBIOL INFEC, V16, P1702, DOI 10.1111/j.1469-0691.2010.03386.x; Grandy S, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-18; Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x; Halasa YA, 2012, J AM MOSQUITO CONTR, V28, P225, DOI 10.2987/12-6243R.1; Hirsch H. von, 2009, European Mosquito Bulletin, P47; Lamers LM, 2006, HEALTH ECON, V15, P1121, DOI 10.1002/hec.1124; Nelder M, 2010, AM J TROP MED HYG, V82, P831, DOI 10.4269/ajtmh.2010.09-0546; OMEARA GF, 1995, J MED ENTOMOL, V32, P554, DOI 10.1093/jmedent/32.4.554; Parkin D, 2006, HEALTH ECON, V15, P653, DOI 10.1002/hec.1086; Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005; Philips D., 2006, QUALITY LIFE CONCEPT; Ratigan CW, 2000, ASIAN TIGER MOSQUITO; Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6; Rochlin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060874; Rochlin I, 2013, BIOL INVASIONS, V15, P991, DOI 10.1007/s10530-012-0345-3; Ruiz-Moreno D, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001918; Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8; Shepard DS, 2012, AM SOC TROP MED HYG; Sullivan PW, 2005, MED CARE, V43, P736, DOI 10.1097/01.mlr.0000172050.67085.4f; Tiawsirisup S, 2005, VECTOR-BORNE ZOONOT, V5, P40, DOI 10.1089/vbz.2005.5.40; Turell MJ, 2005, J MED ENTOMOL, V42, P57, DOI 10.1603/0022-2585(2005)042[0057:AUOTPO]2.0.CO;2; Unlu I, 2012, J AM MOSQUITO CONTR, V28, P334, DOI 10.2987/12-6262R.1; Unlu I, 2011, PEST MANAG SCI, V67, P965, DOI 10.1002/ps.2140; US Census Bureau, 2012, MERC COUNT NEW JERS; Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008; World Health Organization, 2000, WORLD HLTH REP 2000	41	52	53	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e89221	10.1371/journal.pone.0089221	http://dx.doi.org/10.1371/journal.pone.0089221			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC4ID	24603670	Green Published, gold			2022-12-27	WOS:000332483600009
J	Kubo, MO; Yamada, E				Kubo, Mugino Ozaki; Yamada, Eisuke			The Inter-Relationship between Dietary and Environmental Properties and Tooth Wear: Comparisons of Mesowear, Molar Wear Rate, and Hypsodonty Index of Extant Sika Deer Populations	PLOS ONE			English	Article							FOOD-HABITS; CERVUS-NIPPON; DENTAL MICROWEAR; GEOGRAPHIC-VARIATION; MIDDLE PLEISTOCENE; FEEDING ECOLOGY; NORTH-AMERICA; EVOLUTION; MIOCENE; MAMMALS	In reference to the evolutionary trend of increasing cheek tooth height in herbivorous ungulates, the causes of dental abrasion have long been debated. Interspecific comparisons of extant ungulates have revealed that both phytoliths in grass and external abrasive matter may play important roles. Using analysis of extant sika deer living in various environments and showing continuous latitudinal variation in food habits from northern grazing to southern browsing, we quantitatively evaluated the influence of dietary and environmental properties on three dental variables: mesowear score (MS), molar wear rate, and M-3 hypsodonty index. We used 547 skulls and 740 mandibles from 16 populations of sika deer to obtain the dental measurements. We found that only graminoid proportion in diet correlated with MS and the molar wear rate, implying that phytoliths in grass abrade dental tissues. In contrast, annual precipitation in habitat was not correlated with any of the dental variables. We also found a significant correlation between the molar wear rate (selective pressure for high-crowned molars) and the M-3 hypsodonty index of extant sika deer, implying an evolutionary increment in molar height corresponding to the molar wear rate. Our intraspecific comparative analyses provide further support for use of mesowear analysis as a paleodiet estimation method; it not only reveals staple food types (graminoids or dicots) but also implies regional or seasonal variation in the diet of the species.	[Kubo, Mugino Ozaki] Univ Tokyo, Univ Museum, Tokyo, Japan; [Yamada, Eisuke] Kagoshima Univ, Grad Sch Sci & Engn, Dept Earth & Environm Sci, Kagoshima 890, Japan	University of Tokyo; Kagoshima University	Kubo, MO (corresponding author), Univ Tokyo, Univ Museum, Tokyo, Japan.	mugino@um.u-tokyo.ac.jp		Kubo, Mugino/0000-0002-7748-7377	JSPS [22800015, 25-10506]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was partially supported by a JSPS Grant-in-Aid for Scientific Research (Nos. 22800015 and 25-10506). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Asada M, 1996, ECOL RES, V11, P89, DOI 10.1007/BF02347823; Blondel C, 2010, PALAEOGEOGR PALAEOCL, V292, P184, DOI 10.1016/j.palaeo.2010.03.042; Burnham K. P., 1998, MODEL SELECTION INFE; Clavel J, 2012, J HUM EVOL, V63, P162, DOI 10.1016/j.jhevol.2012.04.007; Croft DA, 2008, PALAEOGEOGR PALAEOCL, V269, P103, DOI 10.1016/j.palaeo.2008.08.007; Damuth J, 2011, BIOL REV, V86, P733, DOI 10.1111/j.1469-185X.2011.00176.x; Fortelius M, 2002, EVOL ECOL RES, V4, P1005; Fortelius M., 1985, ACTA ZOOL FENN, V180, P1; Fortelius Mikael, 2000, American Museum Novitates, V3301, P1, DOI 10.1206/0003-0082(2000)301<0001:FCOUMU>2.0.CO;2; Gagnon M, 2000, J MAMMAL, V81, P490, DOI 10.1644/1545-1542(2000)081&lt;0490:DPIEAB&gt;2.0.CO;2; Goodman SJ, 2001, MOL ECOL, V10, P1357, DOI 10.1046/j.1365-294X.2001.01277.x; GRINE FE, 1986, J HUM EVOL, V15, P783, DOI 10.1016/S0047-2484(86)80010-0; Hamlin KL, 2000, J WILDLIFE MANAGE, V64, P441, DOI 10.2307/3803242; Hodson MJ, 2005, ANN BOT-LONDON, V96, P1027, DOI 10.1093/aob/mci255; HOFMANN RR, 1989, OECOLOGIA, V78, P443, DOI 10.1007/BF00378733; Ikeda K, 2001, FOREST PESTS, V50, P167; Janis C.M., 1990, P255; Janis C. M., 1988, P 7 INT S DENT MORPH, V53, P367; JANIS CM, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P76; JANIS CM, 1988, BIOL REV, V63, P197, DOI 10.1111/j.1469-185X.1988.tb00630.x; Janis CM, 2002, PALAEOGEOGR PALAEOCL, V177, P183, DOI 10.1016/S0031-0182(01)00359-5; Japan Wildlife Research Center, 1998, ANN REP WILDL CONS M; Jardine PE, 2012, PALAEOGEOGR PALAEOCL, V365, P1, DOI 10.1016/j.palaeo.2012.09.001; Jayasekara P, 2000, ECOL RES, V15, P153, DOI 10.1046/j.1440-1703.2000.00332.x; Jordana X, 2012, P ROY SOC B-BIOL SCI, V279, P3339, DOI 10.1098/rspb.2012.0689; Kaiser Thomas M., 2006, Mitteilungen aus dem Hamburgischen Zoologischen Museum und Institut, V103, P187; Kaiser TM, 2013, MAMMAL REV, V43, P34, DOI 10.1111/j.1365-2907.2011.00203.x; Kaiser Thomas M., 2000, Carolinea, V58, P103; Kaiser TM, 2004, QUATERNARY RES, V62, P316, DOI 10.1016/j.yqres.2004.09.002; Kaiser TM, 2003, PALAEOGEOGR PALAEOCL, V198, P381, DOI 10.1016/S0031-0182(03)00480-2; Kitamura T, 2010, ACTA THERIOL, V55, P89, DOI 10.4098/j.at.0001-7051.100.2008; Koganezawa M, 1999, BIOSPH CONSERV, V2, P35, DOI [10.20798/biospherecons.2.1_35, DOI 10.20798/BIOSPHERECONS.2.1_35]; Kubo MO, 2010, THESIS U TOKYO TOKYO; Kubo MO, 2013, BIOL J LINN SOC, V110, P384, DOI 10.1111/bij.12128; Loffredo LF, PALAEOGEOGR IN PRESS; Lucas PW, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0923; Mendoza M, 2008, J ZOOL, V274, P134, DOI 10.1111/j.1469-7998.2007.00365.x; Merceron G, 2010, P ROY SOC B-BIOL SCI, V277, P3105, DOI 10.1098/rspb.2010.0523; Mihlbachler MC, 2012, PALAEONTOLOGIA ELECT, V15; Nagata J, 1999, MOL PHYLOGENET EVOL, V13, P511, DOI 10.1006/mpev.1999.0668; Nagata Junco, 2009, P27, DOI 10.1007/978-4-431-09429-6_3; Ohtaishi N, 1980, NATURAL SCI, V13, P51; Ozaki M, 2007, J ZOOL, V272, P244, DOI 10.1111/j.1469-7998.2006.00264.x; Ozaki M, 2010, J ZOOL, V280, P202, DOI 10.1111/j.1469-7998.2009.00653.x; Padmalal UKGK, 1994, ECOL RES, V9, P251, DOI 10.1007/BF02348411; Passey BH, 2002, GEOCHIM COSMOCHIM AC, V66, P3225, DOI 10.1016/S0016-7037(02)00933-X; Rensberger JM, 1978, DEV FUNCTION EVOLUTI, P413; Rivals F, 2003, PALAEOGEOGR PALAEOCL, V193, P443, DOI 10.1016/S0031-0182(03)00260-8; Rivals F, 2008, PALEOBIOLOGY, V34, P117, DOI 10.1666/07023.1; Rivals F, 2007, QUATERNARY RES, V68, P338, DOI 10.1016/j.yqres.2007.07.012; Rivals F, 2007, J VERTEBR PALEONTOL, V27, P763, DOI 10.1671/0272-4634(2007)27[763:EOODIF]2.0.CO;2; Rivals F, 2006, J VERTEBR PALEONTOL, V26, P495, DOI 10.1671/0272-4634(2006)26[495:ACOTDH]2.0.CO;2; Sanson GD, 2007, J ARCHAEOL SCI, V34, P526, DOI 10.1016/j.jas.2006.06.009; Schulz E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056167; Schulz E, 2013, MAMMAL REV, V43, P111, DOI 10.1111/j.1365-2907.2012.00210.x; Shimane Prefectural Government, 2002, SURV SIK DEER CERV N; SOLOUNIAS N, 1994, ANN ZOOL FENN, V31, P219; Solounias N, 2002, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2002)366<0001:AITROU>2.0.CO;2; SOLOUNIAS N, 1993, J ZOOL, V229, P421, DOI 10.1111/j.1469-7998.1993.tb02646.x; Stroemberg CAE, 2013, NATURE COMMUNICATION, V4; Stromberg CAE, 2002, PALAEOGEOGR PALAEOCL, V177, P59, DOI 10.1016/S0031-0182(01)00352-2; Suda K, 1997, WILDL CONSERV JPN, V2, P125; TAKATSUKI S, 1993, ECOL RES, V8, P57, DOI 10.1007/BF02348607; TAKATSUKI S, 1983, Japanese Journal of Ecology, V33, P17; TAKATSUKI S, 1990, Ecological Research, V5, P253, DOI 10.1007/BF02346995; Takatsuki S, 1978, ANN REPORT STUDY DEE, V1977, P25; Takatsuki Seiki, 2009, P231, DOI 10.1007/978-4-431-09429-6_17; TEAFORD MF, 1989, AM J PHYS ANTHROPOL, V80, P447, DOI 10.1002/ajpa.1330800405; TEAFORD MF, 1988, SCANNING MICROSCOPY, V2, P1149; UNGAR PS, 1995, AM J PHYS ANTHROPOL, V97, P93, DOI 10.1002/ajpa.1330970202; VANVALEN L, 1960, EVOLUTION, V14, P531; WALKER A, 1978, SCIENCE, V201, P908, DOI 10.1126/science.684415; Williams Susan H., 2001, Journal of Mammalian Evolution, V8, P207, DOI 10.1023/A:1012231829141; Yamada E, 2012, MAMM STUDY, V37, P93, DOI 10.3106/041.037.0210; Yokoyama M, 2000, ECOL RES, V15, P345, DOI 10.1046/j.1440-1703.2000.00355.x; Yuasa T, 2007, ECOL RES, V22, P97, DOI 10.1007/s11284-006-0190-x	76	50	53	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90745	10.1371/journal.pone.0090745	http://dx.doi.org/10.1371/journal.pone.0090745			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603896	Green Published, Green Submitted, gold			2022-12-27	WOS:000332483600078
J	Liu, MY; Chen, KQ; Yoshimura, T; Liu, Y; Gong, WH; Le, YY; Gao, JL; Zhao, JH; Wang, JM; Wang, AM				Liu, Mingyong; Chen, Keqiang; Yoshimura, Teizo; Liu, Ying; Gong, Wanghua; Le, Yingying; Gao, Ji-Liang; Zhao, Jianhua; Wang, Ji Ming; Wang, Aimin			Formylpeptide Receptors Mediate Rapid Neutrophil Mobilization to Accelerate Wound Healing	PLOS ONE			English	Article							HOST-DEFENSE; GRO-ALPHA; IN-VIVO; MICE; INFLAMMATION; CHEMOKINES; ACCUMULATION; RECRUITMENT; MIGRATION; CXCR1/2	Wound healing is a multi-phased pathophysiological process requiring chemoattractant receptor-dependent accumulation of myeloid cells in the lesion. Two G protein-coupled formylpeptide receptors Fpr1 and Fpr2 mediate rapid neutrophil infiltration in the liver of Listeria-infected mice by sensing pathogen-derived chemotactic ligands. These receptors also recognize host-derived chemotactic peptides in inflammation and injury. Here we report the capacity of Fprs to promote the healing of sterile skin wound in mice by initiating neutrophil infiltration. We found that in normal miceneutrophils rapidly infiltrated the dermis in the wound before the production of neutrophil-specific chemokines by the injured tissue. In contrast, rapid neutrophil infiltration was markedly reduced with delayed wound closure in mice deficient in both Fprs. In addition, we detected Fpr ligand activity that chemoattracted neutrophils into the wound tissue. Our study thus demonstrates that Fprs are critical for normal healing of the sterile skin wound by mediating the first wave of neutrophil infiltration.	[Liu, Mingyong; Zhao, Jianhua] Third Mil Med Univ, Daping Hosp, Dept Spine Surg, Chongqing, Peoples R China; [Liu, Mingyong; Chen, Keqiang; Yoshimura, Teizo; Liu, Ying; Wang, Ji Ming] NCI, Mol Immunoregulat Lab, Canc & Inflammat Program, Ctr Canc Res, Frederick, MD 21701 USA; [Liu, Ying] Natl Ctr Nanosci & Technol, Beijing, Peoples R China; [Gong, Wanghua] Sci Applicat Int Corp Frederick, Basic Res Program, Frederick, MD USA; [Le, Yingying] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Food Safety Res, Inst Nutr Sci, Shanghai, Peoples R China; [Gao, Ji-Liang] NIAID, Lab Mol Immunol, Bethesda, MD 20892 USA; [Wang, Aimin] Third Mil Med Univ, Ctr Orthoped, Daping Hosp, Chongqing, Peoples R China	Army Medical University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Chinese Academy of Sciences; National Center for Nanoscience & Technology - China; Science Applications International Corporation (SAIC); Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Army Medical University	Liu, MY (corresponding author), Third Mil Med Univ, Daping Hosp, Dept Spine Surg, Chongqing, Peoples R China.	mingyong_liu@163.com	Le, Yingying/L-9785-2017; Gao, Ji-Liang/Y-4397-2019	Le, Yingying/0000-0002-7990-3899; Zhao, Jianhua/0000-0001-5758-3479; Yoshimura, Teizo/0000-0002-3853-2075	National Natural Science Foundation of China (NSFC) [81070981, 201111606]; National Cancer Institute (NCI), National Institutes of Health (NIH) [HHSN261200800001E]; Intramural Research Program of the NCI, NIH, United States of America; NATIONAL CANCER INSTITUTE [ZIABC010725, ZIABC010015] Funding Source: NIH RePORTER	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Cancer Institute (NCI), National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural Research Program of the NCI, NIH, United States of America; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was supported in part by the National Natural Science Foundation of China (NSFC, No. 81070981 and 201111606). This project was also funded in part with Federal funds from the National Cancer Institute (NCI), National Institutes of Health (NIH), under Contract No. HHSN261200800001E and was supported in part by the Intramural Research Program of the NCI, NIH, United States of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brandt E, 2000, J LEUKOCYTE BIOL, V67, P471, DOI 10.1002/jlb.67.4.471; Burdon PCE, 2005, BLOOD, V105, P2543, DOI 10.1182/blood-2004-08-3193; Chapman RW, 2007, J PHARMACOL EXP THER, V322, P486, DOI 10.1124/jpet.106.119040; Chen KD, 2013, J CLIN INVEST, V123, P1694, DOI 10.1172/JCI65569; Chen KQ, 2013, J BIOL CHEM, V288, P16262, DOI 10.1074/jbc.M113.450635; Chen KQ, 2010, J IMMUNOL, V184, P3331, DOI 10.4049/jimmunol.0903022; Chintakuntlawar AV, 2009, J INTERF CYTOK RES, V29, P657, DOI 10.1089/jir.2009.0006; Cunha TM, 2008, BRIT J PHARMACOL, V154, P460, DOI 10.1038/bjp.2008.94; Devalaraja RM, 2000, J INVEST DERMATOL, V115, P234, DOI 10.1046/j.1523-1747.2000.00034.x; Engelhardt E, 1998, AM J PATHOL, V153, P1849, DOI 10.1016/S0002-9440(10)65699-4; Foxman EF, 1997, J CELL BIOL, V139, P1349, DOI 10.1083/jcb.139.5.1349; Gao JL, 1999, J EXP MED, V189, P657, DOI 10.1084/jem.189.4.657; Gillitzer R, 2001, J LEUKOCYTE BIOL, V69, P513; Gillitzer R, 1996, J INVEST DERMATOL, V107, P778, DOI 10.1111/1523-1747.ep12371803; Goebeler M, 1997, J INVEST DERMATOL, V108, P445, DOI 10.1111/1523-1747.ep12289711; Ishida Y, 2008, J IMMUNOL, V180, P569, DOI 10.4049/jimmunol.180.1.569; Lammermann T, 2013, NATURE, V498, P371, DOI 10.1038/nature12175; Le YY, 2002, TRENDS IMMUNOL, V23, P541, DOI 10.1016/S1471-4906(02)02316-5; Lin Q, 2012, J INVEST DERMATOL, V132, P2085, DOI 10.1038/jid.2012.120; Liu MY, 2012, SCI REP-UK, V2, DOI 10.1038/srep00786; Liu Y, 2013, CANCER RES, V73, P550, DOI 10.1158/0008-5472.CAN-12-2290; Macedo L, 2007, AM J PATHOL, V171, P1774, DOI 10.2353/ajpath.2007.061048; McDonald B, 2010, SCIENCE, V330, P362, DOI 10.1126/science.1195491; Monson Keith M, 2007, J Inflamm (Lond), V4, P11, DOI 10.1186/1476-9255-4-11; Reichel CA, 2006, J LEUKOCYTE BIOL, V79, P114, DOI 10.1189/jlb.0605337; Rose JJ, 2004, J BIOL CHEM, V279, P24372, DOI 10.1074/jbc.M401364200; Zhang LP, 2009, AM J PATHOL, V175, P2518, DOI 10.2353/ajpath.2009.090275; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780	28	38	43	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90613	10.1371/journal.pone.0090613	http://dx.doi.org/10.1371/journal.pone.0090613			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603667	Green Published, Green Submitted, gold			2022-12-27	WOS:000332483600068
J	Shimada, T; Yamazaki, Y; Tanaka, K; Ishihama, A				Shimada, Tomohiro; Yamazaki, Yukiko; Tanaka, Kan; Ishihama, Akira			The Whole Set of Constitutive Promoters Recognized by RNA Polymerase RpoD Holoenzyme of Escherichia coli	PLOS ONE			English	Article							PROKARYOTIC GENOME REGULATION; MIXED TRANSCRIPTION SYSTEM; H-NS; STRUCTURAL BASIS; SIGMA SUBUNITS; ALPHA SUBUNIT; PROTEIN; GENES; ACTIVATION; SEQUENCE	The promoter selectivity of Escherichia coli RNA polymerase is determined by the sigma subunit with promoter recognition activity. The model prokaryote Escherichia coli contains seven species of the sigma subunit, each recognizing a specific set of promoters. The major sigma subunit, sigma-70 encoded by rpoD, plays a major role in transcription of growth-related genes. Concomitant with the increase in detection of promoters functioning in vivo under various stressful conditions, the variation is expanding in the consensus sequence of RpoD promoters. In order to identify the canonical sequence of "constitutive promoters'' that are recognized by the RNA polymerase holoenzyme containing RpoD sigma in the absence of supporting transcription factors, an in vitro mixed transcription assay was carried out using a whole set of variant promoters, each harboring one base replacement, within the model promoter with the conserved -35 and -10 sequences of RpoD promoters. The consensus sequences, TTGACA(-35) and TATAAT(-10), were identified to be ideal for the maximum level of open complex formation and the highest rate of promoter opening, respectively. For identification of the full range of constitutive promoters on the E. coli genome, a total of 2,701 RpoD holoenzyme-binding sites were identified by Genomic SELEX screening, and using the reconfirmed consensus promoter sequence, a total of maximum 669 constitutive promoters were identified, implying that the majority of hitherto identified promoters represents the TF-dependent "inducible promoters''. One unique feature of the constitutive promoters is the high level of promoter sequence conservation, about 85% carrying five-out-of-six agreements with -35 or -10 consensus sequence. The list of constitutive promoters provides the community resource toward estimation of the inducible promoters that operate under various stressful conditions in nature.	[Shimada, Tomohiro; Ishihama, Akira] Hosei Univ, Dept Frontier Biosience, Tokyo, Japan; [Shimada, Tomohiro; Ishihama, Akira] Hosei Univ, Micronano Technol Res Ctr, Tokyo, Japan; [Shimada, Tomohiro; Tanaka, Kan] Tokyo Inst Technol, Chem Resources Lab, Yokohama, Kanagawa 227, Japan; [Yamazaki, Yukiko] Natl Inst Genet, Genet Strains Res Inst, Shizuoka, Japan	Hosei University; Hosei University; Tokyo Institute of Technology; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Ishihama, A (corresponding author), Hosei Univ, Dept Frontier Biosience, Tokyo, Japan.	aishiham@hosei.ac.jp	Tanaka, Kan/E-3724-2015; Shimada, Tomohiro/E-7660-2014; Albers, Pieter/I-2563-2017	Tanaka, Kan/0000-0001-7560-7884; Shimada, Tomohiro/0000-0002-8361-0730; 	MEXT (Ministry of Education, Culture, Sports, Science and Technology of Japan) [21241047, 18310133, 25430173]; MEXT-Supported Program for the Strategic Research Foundation at Private Universities [S0801037];  [24710214]; Grants-in-Aid for Scientific Research [25430173] Funding Source: KAKEN	MEXT (Ministry of Education, Culture, Sports, Science and Technology of Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT-Supported Program for the Strategic Research Foundation at Private Universities(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grants-in-Aid for Scientific Research from MEXT (Ministry of Education, Culture, Sports, Science and Technology of Japan): (A) (21241047) to AI, (B) (18310133) to AI, (C) (25430173) to AI, and Young Scientists (B) (24710214) to TS. This study was performed under the MEXT-Supported Program for the Strategic Research Foundation at Private Universities 208-2012 (S0801037). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali SS, 2013, J BIOL CHEM, V288, P13356, DOI 10.1074/jbc.M113.455378; Almron M, 1992, GENE DEV, V6, P2648; Beak A, 2009, ECOSAL ESCHERICHIA C; Burgess RR, 2001, CURR OPIN MICROBIOL, V4, P126, DOI 10.1016/S1369-5274(00)00177-6; Busby S, 1999, J MOL BIOL, V293, P199, DOI 10.1006/jmbi.1999.3161; BUSBY S, 1994, CELL, V79, P743, DOI 10.1016/0092-8674(94)90063-9; Campbell EA, 2002, MOL CELL, V9, P527, DOI 10.1016/S1097-2765(02)00470-7; Cho BK, 2009, NAT BIOTECHNOL, V27, P1043, DOI 10.1038/nbt.1582; COLLADOVIDES J, 1991, MICROBIOL REV, V55, P371, DOI 10.1128/MMBR.55.3.371-394.1991; COTTER PA, 1992, FEMS MICROBIOL LETT, V100, P227, DOI 10.1111/j.1574-6968.1992.tb05708.x; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dame RT, 2001, BIOCHIMIE, V83, P231; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Fujita N, 1996, METHOD ENZYMOL, V273, P121; FUKUDA R, 1983, J BIOL CHEM, V258, P2720; Giannoukos G, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r23; GORANSSON M, 1990, NATURE, V344, P682, DOI 10.1038/344682a0; Gordon BRG, 2011, P NATL ACAD SCI USA, V108, P10690, DOI 10.1073/pnas.1102544108; Gottesman S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003798; Gourse RL, 2006, J BACTERIOL, V188, P4589, DOI 10.1128/JB.00499-06; Gralla JD, 1996, CURR OPIN GENET DEV, V6, P526, DOI 10.1016/S0959-437X(96)80079-7; Gruber TM, 2003, ANNU REV MICROBIOL, V57, P441, DOI 10.1146/annurev.micro.57.030502.090913; HARLEY CB, 1987, NUCLEIC ACIDS RES, V15, P2343, DOI 10.1093/nar/15.5.2343; Hengge-Aronis R, 2002, CURR OPIN MICROBIOL, V5, P591, DOI 10.1016/S1369-5274(02)00372-7; Herring CD, 2005, J BACTERIOL, V187, P6166, DOI 10.1128/JB.187.17.6166-6174.2005; Huerta AM, 2003, J MOL BIOL, V333, P261, DOI 10.1016/j.jmb.2003.07.017; IGARASHI K, 1991, CELL, V65, P1015, DOI 10.1016/0092-8674(91)90553-B; Ishihama A, 2000, ANNU REV MICROBIOL, V54, P499, DOI 10.1146/annurev.micro.54.1.499; ISHIHAMA A, 1993, J BACTERIOL, V175, P2483, DOI 10.1128/JB.175.9.2483-2489.1993; ISHIHAMA A, 1992, MOL MICROBIOL, V6, P3283, DOI 10.1111/j.1365-2958.1992.tb02196.x; Ishihama A, 2012, P JPN ACAD B-PHYS, V88, P485, DOI 10.2183/pjab.88.485; Ishihama A, 2010, FEMS MICROBIOL REV, V34, P628, DOI 10.1111/j.1574-6976.2010.00227.x; Jishage M, 1997, J BACTERIOL, V179, P959, DOI 10.1128/jb.179.3.959-963.1997; KAJITANI M, 1983, NUCLEIC ACIDS RES, V11, P3873, DOI 10.1093/nar/11.12.3873; KAJITANI M, 1983, NUCLEIC ACIDS RES, V11, P671, DOI 10.1093/nar/11.3.671; Keseler IM, 2011, NUCLEIC ACIDS RES, V39, pD583, DOI 10.1093/nar/gkq1143; KOBAYASHI M, 1990, NUCLEIC ACIDS RES, V18, P7367, DOI 10.1093/nar/18.24.7367; Lim CJ, 2012, SCI REP-UK, V2, DOI 10.1038/srep00509; Liu XQ, 2004, J BIOL CHEM, V279, P12588, DOI 10.1074/jbc.M313454200; LONETTO M, 1992, J BACTERIOL, V174, P3843, DOI 10.1128/jb.174.12.3843-3849.1992; Maeda H, 2000, NUCLEIC ACIDS RES, V28, P3497, DOI 10.1093/nar/28.18.3497; Mekler V, 2013, NUCLEIC ACIDS RES, V41, P7276, DOI 10.1093/nar/gkt541; Mitchell JE, 2003, NUCLEIC ACIDS RES, V31, P4689, DOI 10.1093/nar/gkg694; Mooney RA, 2009, MOL CELL, V33, P97, DOI 10.1016/j.molcel.2008.12.021; Navarre WW, 2006, SCIENCE, V313, P236, DOI 10.1126/science.1128794; Ogasawara H, 2010, MICROBIOL-SGM, V156, P2470, DOI 10.1099/mic.0.039131-0; Oshima T, 2006, DNA RES, V13, P141, DOI 10.1093/dnares/dsl009; Paget MSB, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-203; Panyukov VV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062601; PRIBNOW D, 1975, J MOL BIOL, V99, P419, DOI 10.1016/S0022-2836(75)80136-7; Raghavan R, 2011, J BACTERIOL, V193, P2871, DOI 10.1128/JB.00398-11; Ramseier TM, 1996, CURR MICROBIOL, V33, P270, DOI 10.1007/s002849900112; Saecker RM, 2011, J MOL BIOL, V412, P754, DOI 10.1016/j.jmb.2011.01.018; Salgado H, 2013, NUCLEIC ACIDS RES, V41, pD203, DOI 10.1093/nar/gks1201; Shavkunov KS, 2009, NUCLEIC ACIDS RES, V37, P4919, DOI 10.1093/nar/gkp490; Shimada K, 2013, MICROBIOL-SGM, V159, P2501, DOI 10.1099/mic.0.067538-0; Shimada T, 2005, GENES CELLS, V10, P907, DOI 10.1111/j.1365-2443.2005.00888.x; Shimada T, 2012, PLOS ONE, V6; Shimada T, 2014, GENES CELLS IN PRESS; Shimada T, 2008, NUCLEIC ACIDS RES, V36, P3950, DOI 10.1093/nar/gkn339; Shimada T, 2007, MOL MICROBIOL, V66, P744, DOI 10.1111/j.1365-2958.2007.05954.x; Shimada T, 2011, MOL MICROBIOL, V82, P378, DOI 10.1111/j.1365-2958.2011.07818.x; SIEBENLIST U, 1980, CELL, V20, P269, DOI 10.1016/0092-8674(80)90613-3; Singer BS, 1997, NUCLEIC ACIDS RES, V25, P781, DOI 10.1093/nar/25.4.781; Singh SS, 2011, NUCLEIC ACIDS RES, V39, P5109, DOI 10.1093/nar/gkr080; TANAKA K, 1995, NUCLEIC ACIDS RES, V23, P827, DOI 10.1093/nar/23.5.827; Teramoto J, 2010, NUCLEIC ACIDS RES, V38, P3605, DOI 10.1093/nar/gkq077; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Vivero A, 2008, J BACTERIOL, V190, P1152, DOI 10.1128/JB.01206-07; Yamazaki Yukiko, 2008, V416, P385, DOI 10.1007/978-1-59745-321-9_26; Young BA, 2004, SCIENCE, V303, P1382, DOI 10.1126/science.1092462	71	75	79	4	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90447	10.1371/journal.pone.0090447	http://dx.doi.org/10.1371/journal.pone.0090447			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603758	Green Submitted, gold, Green Published			2022-12-27	WOS:000332483600053
J	Yang, C; Wu, HS; Chen, XL; Wang, CY; Gou, SM; Xiao, J; He, ZQ; Chen, QJ; Li, YF				Yang, Chong; Wu, He-Shui; Chen, Xing-Lin; Wang, Chun-You; Gou, Shan-Miao; Xiao, Jun; He, Zhi-Qiang; Chen, Qi-Jun; Li, Yong-Feng			Pylorus-Preserving Versus Pylorus-Resecting Pancreaticoduodenectomy for Periampullary and Pancreatic Carcinoma: A Meta-Analysis	PLOS ONE			English	Article							QUALITY-OF-LIFE; LYMPH-NODE METASTASIS; WHIPPLE PROCEDURE; SURGICAL-TREATMENT; CLASSIC WHIPPLE; DUODENOPANCREATECTOMY; PRESERVATION; SURVIVAL; CANCER; TRIAL	Background: The aim of this meta-analysis was to compare the long-term survival, mortality, morbidity and the operation-related events in patients with periampullary and pancreatic carcinoma undergoing pylorus-preserving pancreaticoduodenectomy (PPPD) and pylorus-resecting pancreaticoduodenectomy (PRPD). Method: A systematic search of literature databases (Cochrane Library, PubMed, EMBASE and Web of Science) was performed to identify studies. Outcome measures comparing PPPD versus PRPD for periampullary and pancreatic carcinoma were long-term survival, mortality, morbidity (overall morbidity, delayed gastric emptying [DGE], pancreatic fistula, wound infection, postoperative bleeding, biliary leakage, ascites and gastroenterostomy leakage) and operation related events (hospital stays, operating time, intraoperative blood loss and red blood cell transfusions). Results: Eight randomized controlled trials (RCTs) including 622 patients were identified and included in the analysis. Among these patients, it revealed no difference in long-term survival between the PPPD and PRPD groups (HR = 0.23, p = 0.11). There was a lower rate of DGE (RR = 2.35, p = 0.04, 95% CI, 1.06-5.21) with PRPD. Mortality, overall morbidity, pancreatic fistula, wound infection, postoperative bleeding, biliary leakage, ascites and gastroenterostomy leakage were not significantly different between the groups. PPPDs were performed more quickly than PRPDs (WMD = 53.25 minutes, p = 0.01, 95% CI, 12.53-93.97); and there was less estimated intraoperative blood loss (WMD = 365.21 ml, p = 0.006, 95% CI, 102.71-627.71) and fewer red blood cell transfusions (WMD = 0.29 U, p = 0.003, 95% CI, 0.10-0.48) in patients undergoing PPPD. The hospital stays showed no significant difference. Conclusions: PPPD had advantages over PRPD in operating time, intraoperative blood loss and red blood cell transfusions, but had a significantly higher rate of DGE for periampullary and pancreatic carcinoma. PPPD and PRPD had comparable mortality and morbidity including pancreatic fistulas, wound infections, postoperative bleeding, biliary leakage, ascites and gastroenterostomy leakage. Our conclusions were limited by the available data. Further evaluations of high-quality RCTs are needed.	[Yang, Chong; Wu, He-Shui; Wang, Chun-You; Gou, Shan-Miao; Xiao, Jun; He, Zhi-Qiang; Chen, Qi-Jun; Li, Yong-Feng] Huazhong Univ Sci & Technol, Pancreat Dis Inst, Union Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China; [Chen, Xing-Lin] Huazhong Univ Sci & Technol, Key Lab Geriatr, Minist Hlth, Dept Geriatr,Union Hosp,Tongji Med Coll, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Wu, HS (corresponding author), Huazhong Univ Sci & Technol, Pancreat Dis Inst, Union Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China.	heshuiwu@163.com		Chen, Xinglin/0000-0002-5820-9224; Yang, Chong/0000-0002-0060-706X	National Natural Science Foundation of China [81372261]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study is supported by the National Natural Science Foundation of China(No 81372261). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akizuki E, 2009, ANN SURG, V249, P986, DOI 10.1097/SLA.0b013e3181a63c4c; [Anonymous], 2011, COCHRANE HDB SYSTEMA; Bell RH, 2005, CANCER TREAT REV, V31, P328, DOI 10.1016/j.ctrv.2005.04.005; Bloechle C, 1999, LANGENBECK ARCH SURG, P661; CAMERON JL, 1991, AM J SURG, V161, P120, DOI 10.1016/0002-9610(91)90371-J; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Di Carlo V, 1999, WORLD J SURG, V23, P920; DICKERSIN K, 1987, CONTROL CLIN TRIALS, V8, P343, DOI 10.1016/0197-2456(87)90155-3; Diener MK, 2007, ANN SURG, V245, P187, DOI 10.1097/01.sla.0000242711.74502.a9; Diener MK, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD006053.pub3, 10.1002/14651858.CD006053.pub4]; Dineen SP, 2008, HPB SURG, V2008; Gerdes B, 2005, PANCREAS, V31, P88, DOI 10.1097/01.mpa.0000168221.97967.98; HOCKING MP, 1990, DIGEST DIS SCI, V35, P1226, DOI 10.1007/BF01536411; Hozo Stela Pudar, 2005, BMC Med Res Methodol, V5, P13, DOI 10.1186/1471-2288-5-13; Karanicolas PJ, 2007, ANN SURG ONCOL, V14, P1825, DOI 10.1245/s10434-006-9330-3; Kawai M, 2011, ANN SURG, V253, P495, DOI 10.1097/SLA.0b013e31820d98f1; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; Leichtle SW, 2013, J SURG RES, V183, P170, DOI 10.1016/j.jss.2013.01.016; Lin PW, 2005, HEPATO-GASTROENTEROL, V52, P1601; Lin PW, 1999, BRIT J SURG, V86, P603, DOI 10.1046/j.1365-2168.1999.01074.x; Loos M, 2008, ANN NY ACAD SCI, V1138, P169, DOI 10.1196/annals.1414.024; Mezhir JJ, 2013, J SURG ONCOL, V107, P58, DOI 10.1002/jso.23139; Moldovanu R, 2007, Chirurgia (Bucur), V102, P651; Murakami Y, 2008, J GASTROINTEST SURG, V12, P1081, DOI 10.1007/s11605-008-0483-1; Niedergethmann M, 2006, LANGENBECK ARCH SURG, V391, P195, DOI 10.1007/s00423-005-0015-3; Ohtsuka T, 2006, J HEPATO-BILIARY-PAN, V13, P218, DOI 10.1007/s00534-005-1067-z; Ohwada S, 2001, ANN SURG, V234, P668, DOI 10.1097/00000658-200111000-00013; Paquet KJ, 1998, CHIR GASTROENTEROL, V14, P54, DOI 10.1159/000012471; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Riediger H, 2009, J GASTROINTEST SURG, V13, P1337, DOI 10.1007/s11605-009-0919-2; RODER JD, 1992, BRIT J SURG, V79, P152, DOI 10.1002/bjs.1800790219; Sakai M, 2005, SURGERY, V137, P606, DOI 10.1016/j.surg.2005.02.009; Schniewind B, 2006, BRIT J SURG, V93, P1099, DOI 10.1002/bjs.5371; Seiler C A, 2000, Swiss Surg, V6, P275, DOI 10.1024/1023-9332.6.5.275; Seiler CA, 2005, BRIT J SURG, V92, P547, DOI 10.1002/bjs.4881; Seiler CA, 2000, J GASTROINTEST SURG, V4, P443, DOI 10.1016/S1091-255X(00)80084-0; SHARP KW, 1989, SURGERY, V105, P645; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Srinarmwong Chatchai, 2008, Journal of the Medical Association of Thailand, V91, P693; Sterne JAC, 2001, BMJ-BRIT MED J, V323, P101, DOI 10.1136/bmj.323.7304.101; Sumida K, 1999, HEPATO-GASTROENTEROL, V46, P336; Takao S, 1998, AM J SURG, V176, P467, DOI 10.1016/S0002-9610(98)00243-8; Tani M, 2009, SURG TODAY, V39, P219, DOI 10.1007/s00595-008-3847-y; Topal B, 2013, LANCET ONCOL, V14, P655, DOI 10.1016/S1470-2045(13)70126-8; Tran KTC, 2004, ANN SURG, V240, P738, DOI 10.1097/01.sla.0000143248.71964.29; Wenger FA, 1999, CHIRURG, V70, P1454, DOI 10.1007/PL00002580; WILLETT CG, 1993, ANN SURG, V217, P144, DOI 10.1097/00000658-199302000-00008	47	24	27	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90316	10.1371/journal.pone.0090316	http://dx.doi.org/10.1371/journal.pone.0090316			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603478	Green Published, gold, Green Submitted			2022-12-27	WOS:000332483600042
J	Han, Y; Yin, YP; Shi, MQ; Zheng, BJ; Zhong, MY; Jiang, N; Chen, SC; Chen, XS				Han, Yan; Yin, Yue-ping; Shi, Mei-qin; Zheng, Bing-jie; Zhong, Ming-ying; Jiang, Ning; Chen, Shao-chun; Chen, Xiang-sheng			Evaluation of Abbott RealTime CT/NG Assay for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in Cervical Swabs from Female Sex Workers in China	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; POPULATION-BASED SURVEY; PREVALENCE; DISEASES; VARIANT; SYSTEM; WOMEN	Background: To evaluate the performance of the Abbott RealTime CT/NG assay for detection of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) among female sex workers (FSWs) in China. Methods: Cervical swabs from 997 participants were blindly detected by the Abbott RealTime CT/NG assay on the automated m2000 molecular platform and Roche Cobas Amplicor CT/NG assay. Discrepant analysis were confirmed by the Qiagen care CT PCR assay. The sample was defined as candidate nvCT-positive if it was CT positive in the Abbott m2000 assay, but CT negative in the other two assays. Results: 25 specimens that were discordant for CT and 26 specimens that were discordant for NG between the two assays were resolved by Qiagen care CT & NG PCR assays. The sensitivity and specificity, respectively, for Abbott m2000 assay were 92.59% and 100% for CT and 95.45% and 99.90% for NG. The positive predictive value (PPV) and negative predictive value (NPV) of Abbott m2000 assay were 100% and 98.52% for CT and 95.5% and 99.90% for NG, respectively. No candidate new-variant CT(nvCT) specimens were identified. Conclusion: Abbott RealTime CT/NG assay were more specify for CT and NG detection, however, its sensitivity for CT and NG were a little bit lower than Roche Cobas Amplicor CT/NG assay. Abbott RealTime CT/NG assay had higher PPV for NG detection than Roche Cobas Amplicor CT/NG assay; it would be more suitable for screening for population with low-prevalence NG. There is currently no evidence that nvCT is present in FSWs in China.	[Yin, Yue-ping] China Chinese CDC, Natl Ctr STD Control, Nanjing, Jiangsu, Peoples R China; Chinese Acad Med Sci, Inst Dermatol, Nanjing, Jiangsu, Peoples R China; Peking Union Med Coll, Nanjing, Jiangsu, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Dermatology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Yin, YP (corresponding author), China Chinese CDC, Natl Ctr STD Control, Nanjing, Jiangsu, Peoples R China.	yinyp@ncstdlc.org		Chen, Shaochun/0000-0002-6447-928X	Mega Project of China National Science Research for the 11th Five-Year Plan [2008ZX10001-005, 2009ZX09303-005]	Mega Project of China National Science Research for the 11th Five-Year Plan	This study was supported by grants from the Mega Project of China National Science Research for the 11th Five-Year Plan (2008ZX10001-005 and 2009ZX09303-005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], EURO SURVEILL; Carcamo CP, 2012, LANCET INFECT DIS, V12, P765, DOI 10.1016/S1473-3099(12)70144-5; Centers for Disease Control and Prevention, 2012, STD TRENDS US 2011; Chen XS, 2006, SEX TRANSM INFECT, V82, P283, DOI 10.1136/sti.2006.019711; Chen XS, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-111; Cheng A, 2011, J CLIN MICROBIOL, V49, P1294, DOI 10.1128/JCM.02595-10; Gao X, 2007, J CLIN MICROBIOL, V45, P1185, DOI 10.1128/JCM.02076-06; Geelen Tanja H, 2013, Diagn Microbiol Infect Dis, V77, P101, DOI 10.1016/j.diagmicrobio.2013.06.020; Goulet V, 2010, SEX TRANSM INFECT, V86, P263, DOI 10.1136/sti.2009.038752; Herrmann B, 2008, EMERG INFECT DIS, V14, P1462, DOI 10.3201/eid1409.080153; Imai H, 2010, INT J STD AIDS, V21, P362, DOI 10.1258/ijsa.2010.010026; Marshall R, 2007, J CLIN MICROBIOL, V45, P747, DOI 10.1128/JCM.01956-06; National Center for STD Control China CDC, 2012, B STI PREVENTION CON, V258, P9; Taylor SN, 2012, SEX TRANSM DIS, V39, P543, DOI 10.1097/OLQ.0b013e31824e26ff; Torrone EA, 2013, SEX TRANSM DIS, V40, P202, DOI 10.1097/OLQ.0b013e31827c5a71; Unemo M, 2011, CURR OPIN INFECT DIS, V24, P62, DOI 10.1097/QCO.0b013e32834204d5; van Doornum GJJ, 2001, J CLIN MICROBIOL, V39, P829, DOI 10.1128/JCM.39.3.829-835.2001; WHO, 2012, GLOB INC PREV SEL CU; Workowski Kimberly A, 2010, MMWR Recomm Rep, V59, P1; Yin YP, 2006, SEX TRANSM INFECT, V82, pV33, DOI 10.1136/sti.2006.022475	20	8	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e89658	10.1371/journal.pone.0089658	http://dx.doi.org/10.1371/journal.pone.0089658			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599315	Green Submitted, Green Published, gold			2022-12-27	WOS:000332479400021
J	Namba, F; Go, H; Murphy, JA; La, P; Yang, G; Sengupta, S; Fernando, AP; Yohannes, M; Biswas, C; Wehrli, SL; Dennery, PA				Namba, Fumihiko; Go, Hayato; Murphy, Jennifer A.; La, Ping; Yang, Guang; Sengupta, Shaon; Fernando, Amal P.; Yohannes, Mekdes; Biswas, Chhanda; Wehrli, Suzanne L.; Dennery, Phyllis A.			Expression Level and Subcellular Localization of Heme Oxygenase-1 Modulates Its Cytoprotective Properties in Response to Lung Injury: A Mouse Model	PLOS ONE			English	Article							CELLULAR-RESPONSES; DNA-DAMAGE; HYPEROXIA; CELLS; TOLERANCE; HEME-OXYGENASE-1; OVEREXPRESSION; SENSITIVITY; ACTIVATION; INHIBITION	Premature infants exposed to hyperoxia suffer acute and long-term pulmonary consequences. Nevertheless, neonates survive hyperoxia better than adults. The factors contributing to neonatal hyperoxic tolerance are not fully elucidated. In contrast to adults, heme oxygenase (HO)-1, an endoplasmic reticulum (ER)-anchored protein, is abundant in the neonatal lung but is not inducible in response to hyperoxia. The latter may be important, because very high levels of HO-1 overexpression are associated with significant oxygen cytotoxicity in vitro. Also, in contrast to adults, HO-1 localizes to the nucleus in neonatal mice exposed to hyperoxia. To understand the mechanisms by which HO-1 expression levels and subcellular localization contribute to hyperoxic tolerance in neonates, lung-specific transgenic mice expressing high or low levels of full-length HO-1 (cytoplasmic, HO-1-FL(H) or HO-1-FL(L)) or C-terminally truncated HO-1 (nuclear, Nuc-HO-1-TR) were generated. In HO-1-FL(L), the lungs had a normal alveolar appearance and lesser oxidative damage after hyperoxic exposure. In contrast, in HO-1-FL(H), alveolar wall thickness with type II cell hyperproliferation was observed as well worsened pulmonary function and evidence of abnormal lung cell hyperproliferation in recovery from hyperoxia. In Nuc-HO-1-TR, the lungs had increased DNA oxidative damage, increased poly (ADP-ribose) polymerase (PARP) protein expression, and reduced poly (ADP-ribose) (PAR) hydrolysis as well as reduced pulmonary function in recovery from hyperoxia. These data indicate that low cytoplasmic HO-1 levels protect against hyperoxia-induced lung injury by attenuating oxidative stress, whereas high cytoplasmic HO-1 levels worsen lung injury by increasing proliferation and decreasing apoptosis of alveolar type II cells. Enhanced lung nuclear HO-1 levels impaired recovery from hyperoxic lung injury by disabling PAR-dependent regulation of DNA repair. Lastly both high cytoplasmic and nuclear expression of HO-1 predisposed to long-term abnormal lung cellular proliferation. To maximize HO-1 cytoprotective effects, therapeutic strategies must account for the specific effects of its subcellular localization and expression levels.	[Namba, Fumihiko; Go, Hayato; Murphy, Jennifer A.; La, Ping; Yang, Guang; Sengupta, Shaon; Fernando, Amal P.; Yohannes, Mekdes; Biswas, Chhanda; Dennery, Phyllis A.] Childrens Hosp Philadelphia, Div Neonatol, Philadelphia, PA 19104 USA; [Biswas, Chhanda; Dennery, Phyllis A.] Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA; [Wehrli, Suzanne L.] Childrens Hosp Philadelphia, Small Anim Core, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Namba, F (corresponding author), Childrens Hosp Philadelphia, Div Neonatol, Philadelphia, PA 19104 USA.	nambaf@saitama-med.ac.jp	Dennery, Phyllis/GQG-9113-2022	Dennery, Phyllis/0000-0001-5745-1855	Children's Hospital of Philadelphia; National Institutes of Health [HL-58752]; American Lung Association	Children's Hospital of Philadelphia; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lung Association	This work was supported by a grant from the Children's Hospital of Philadelphia (Lassin Funds, P. A. D.), the National Institutes of Health (HL-58752, P. A. D.), and the American Lung Association (Senior Research Training Fellowship, F.N.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaoui-Jamali MA, 2009, CANCER RES, V69, P8017, DOI 10.1158/0008-5472.CAN-09-0419; Andrabi SA, 2006, P NATL ACAD SCI USA, V103, P18308, DOI 10.1073/pnas.0606526103; Berberat PO, 2005, CLIN CANCER RES, V11, P3790, DOI 10.1158/1078-0432.CCR-04-2159; Busserolles J, 2006, INT J BIOCHEM CELL B, V38, P1510, DOI 10.1016/j.biocel.2006.03.013; CHOI AMK, 1995, AM J RESP CELL MOL, V13, P74, DOI 10.1165/ajrcmb.13.1.7598940; COONEY TP, 1982, THORAX, V37, P572, DOI 10.1136/thx.37.8.572; Cui Z, 1998, BLOOD, V91, P2326, DOI 10.1182/blood.V91.7.2326.2326_2326_2333; Degese MS, 2012, LUNG CANCER, V77, P168, DOI 10.1016/j.lungcan.2012.02.016; Deininger MH, 2000, BRAIN RES, V882, P1, DOI 10.1016/S0006-8993(00)02594-4; Dennery PA, 1996, PEDIATR RES, V40, P815, DOI 10.1203/00006450-199612000-00007; Doyle LW, 2009, SEMIN FETAL NEONAT M, V14, P391, DOI 10.1016/j.siny.2009.08.004; EMERY JL, 1960, ARCH DIS CHILD, V35, P544, DOI 10.1136/adc.35.184.544; Eustermann S, 2010, NAT STRUCT MOL BIOL, V17, P241, DOI 10.1038/nsmb.1747; Feldser DM, 2010, NATURE, V468, P572, DOI 10.1038/nature09535; Fernandez-Gonzalez A, 2012, AM J PHYSIOL-LUNG C, V302, pL775, DOI 10.1152/ajplung.00196.2011; FRANK L, 1978, J APPL PHYSIOL, V45, P699, DOI 10.1152/jappl.1978.45.5.699; Gandini NA, 2012, EXP MOL PATHOL, V93, P237, DOI 10.1016/j.yexmp.2012.05.001; Giordano A, 2000, FEBS LETT, V487, P171, DOI 10.1016/S0014-5793(00)02217-1; Goodman AI, 1997, P SOC EXP BIOL MED, V214, P54; Gough A, 2013, EUR RESP J IN PRESS; Hara E, 1996, BIOCHEM BIOPH RES CO, V224, P153, DOI 10.1006/bbrc.1996.0999; HASS MA, 1987, AM J PHYSIOL, V253, pC66, DOI 10.1152/ajpcell.1987.253.1.C66; HOFFMAN M, 1980, TOXICOLOGY, V16, P215, DOI 10.1016/0300-483X(80)90118-3; Hwang HW, 2009, J BIOL CHEM, V284, P22672, DOI 10.1074/jbc.M109.028001; ISCHIROPOULOS H, 1989, AM J PHYSIOL, V257, pL411, DOI 10.1152/ajplung.1989.257.6.L411; Koh DW, 2004, P NATL ACAD SCI USA, V101, P17699, DOI 10.1073/pnas.0406182101; Le Rhun Y, 1998, BIOCHEM BIOPH RES CO, V245, P1; Li Volti G, 2004, BIOCHEM BIOPH RES CO, V315, P517, DOI 10.1016/j.bbrc.2004.01.090; Lin Q, 2007, J BIOL CHEM, V282, P20621, DOI 10.1074/jbc.M607954200; Lin QS, 2008, FREE RADICAL BIO MED, V44, P847, DOI 10.1016/j.freeradbiomed.2007.11.012; Liu QJ, 2013, EXP BIOL MED, V238, P696, DOI 10.1177/1535370213490628; McAllister SC, 2004, BLOOD, V103, P3465, DOI 10.1182/blood-2003-08-2781; Okano S, 2003, MOL CELL BIOL, V23, P3974, DOI 10.1128/MCB.23.11.3974-3981.2003; Otterbein LE, 2003, TRENDS IMMUNOL, V24, P449, DOI 10.1016/S1471-4906(03)00181-9; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10925, DOI 10.1073/pnas.94.20.10925; Rushworth SA, 2008, BLOOD, V111, P3793, DOI 10.1182/blood-2007-07-104042; Sacca P, 2007, BRIT J CANCER, V97, P1683, DOI 10.1038/sj.bjc.6604081; Sass G, 2008, INT J CANCER, V123, P1269, DOI 10.1002/ijc.23695; SCHACTER BA, 1982, CANCER RES, V42, P3557; Suttner DM, 1999, AM J PHYSIOL-LUNG C, V276, pL443, DOI 10.1152/ajplung.1999.276.3.L443; Suttner DM, 1999, FASEB J, V13, P1800, DOI 10.1096/fasebj.13.13.1800; Tartier L, 2003, MUTAGENESIS, V18, P411, DOI 10.1093/mutage/geg015; Torisu-Itakura H, 2000, JPN J CANCER RES, V91, P906, DOI 10.1111/j.1349-7006.2000.tb01033.x; Tsai Jong-Rung, 2012, Cell Oncol (Dordr), V35, P461, DOI 10.1007/s13402-012-0105-5; Tsuji MH, 1999, CANCER LETT, V138, P53, DOI 10.1016/S0304-3835(98)00372-3; VREMAN HJ, 1988, ANAL BIOCHEM, V168, P31, DOI 10.1016/0003-2697(88)90006-1; West AR, 2008, J GASTROEN HEPATOL, V23, P150, DOI 10.1111/j.1440-1746.2007.05047.x; Wong P, 2011, J MED IMAG RADIAT ON, V55, P373, DOI 10.1111/j.1754-9485.2011.02285.x; Wu M, 2002, AM J RESP CRIT CARE, V166, P192, DOI 10.1164/rccm.200112-130OC; Yang G, 2004, J CLIN INVEST, V114, P669, DOI 10.1172/JCI200419300; Yang G, 2013, REDOX BIOL, V1, P234, DOI 10.1016/j.redox.2013.01.013; Yee M, 2006, AM J PHYSIOL-LUNG C, V291, pL1101, DOI 10.1152/ajplung.00126.2006; Yee M, 2009, AM J PHYSIOL-LUNG C, V297, pL641, DOI 10.1152/ajplung.00023.2009; YOSHIDA T, 1989, BIOCHEM BIOPH RES CO, V163, P1086, DOI 10.1016/0006-291X(89)92332-2; Zhuang TG, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-142	55	34	37	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90936	10.1371/journal.pone.0090936	http://dx.doi.org/10.1371/journal.pone.0090936			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599172	gold, Green Published, Green Submitted			2022-12-27	WOS:000332479400147
J	Cardenas, JC; Dreber, A; von Essen, E; Ranehill, E				Cardenas, Juan-Camilo; Dreber, Anna; von Essen, Emma; Ranehill, Eva			Gender and Cooperation in Children: Experiments in Colombia and Sweden	PLOS ONE			English	Article							PUBLIC-GOODS; EVOLUTION; MEN	In this article we compare cooperation among Colombian and Swedish children aged 9-12. We illustrate the dynamics of the prisoner's dilemma in a new task that is easily understood by children and performed during a physical education class. We find no robust evidence of a difference in cooperation between Colombia and Sweden overall. However, Colombian girls cooperate less than Swedish girls. We also find indications that girls in Colombia are less cooperative than boys. Finally, there is also a tendency for children to be more cooperative with boys than with girls on average.	[Cardenas, Juan-Camilo] Univ Los Andes, Dept Econ, Bogota, Colombia; [Cardenas, Juan-Camilo] Univ Los Andes, CEDE, Bogota, Colombia; [Dreber, Anna] Stockholm Sch Econ, Dept Econ, S-11383 Stockholm, Sweden; [von Essen, Emma] Aarhus Univ, Dept Econ & Business, Aarhus, Denmark; [von Essen, Emma] Aarhus Univ, TrygFondens Ctr Child Res, Aarhus, Denmark; [Ranehill, Eva] Univ Zurich, Dept Econ, Zurich, Switzerland	Universidad de los Andes (Colombia); Universidad de los Andes (Colombia); Stockholm School of Economics; Aarhus University; Aarhus University; University of Zurich	von Essen, E (corresponding author), Aarhus Univ, Dept Econ & Business, Aarhus, Denmark.	vonessen@econ.au.dk	cardenas, juan-camilo/B-4658-2009	cardenas, juan-camilo/0000-0003-0005-7595; von Essen, Emma/0000-0002-1421-4582	Jan Wallander and Tom Hedelius Foundation; Carl Silfven Foundation; Swedish Council for Working Life and Social Research (FAS); Department of Economics at the Universidad de Los Andes	Jan Wallander and Tom Hedelius Foundation; Carl Silfven Foundation; Swedish Council for Working Life and Social Research (FAS)(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Department of Economics at the Universidad de Los Andes	Financial support from the Jan Wallander and Tom Hedelius Foundation [http://www.handelsbanken.se/shb/inet/IStartSv.nsf/FrameSetOpenView&id=Forskningsstiftelserna] and the Carl Silfven Foundation [http://www.sasse.se/student/education/news/study-scholarships-fund-carl-silfv-n] (E.Ranehill.), the Swedish Council for Working Life and Social Research (FAS) [http://www.forte.se/en/], and the Department of Economics at the Universidad de Los Andes [http://economia.uniandes.edu.co/en] is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen S, 2008, AM ECON REV, V98, P376, DOI 10.1257/aer.98.2.376; Boschini A, 2011, J SOCIO-ECON, V40, P523, DOI 10.1016/j.socec.2011.04.001; Cardenas JC, 2008, J DEV STUD, V44, P311, DOI 10.1080/00220380701848327; Cardenas JC, 2012, J ECON BEHAV ORGAN, V83, P11, DOI 10.1016/j.jebo.2011.06.008; Charness G, 2011, GAME ECON BEHAV, V72, P77, DOI 10.1016/j.geb.2010.07.006; Croson R, 2009, J ECON LIT, V47, P448, DOI 10.1257/jel.47.2.448; Dreber A, 2009, EXPT EC, V14, P567; FISHBEIN HD, 1985, BRIT J DEV PSYCHOL, V3, P393, DOI 10.1111/j.2044-835X.1985.tb00991.x; Gachter S, 2010, PHILOS T R SOC B, V365, P2651, DOI 10.1098/rstb.2010.0135; Gneezy U, 2004, AM ECON REV, V94, P377, DOI 10.1257/0002828041301821; Greiner B, 2005, J ECON PSYCHOL, V26, P711, DOI 10.1016/j.joep.2004.04.003; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Harbaugh WT, 2000, ECON INQ, V38, P95, DOI 10.1093/ei/38.1.95; Harbaugh WT, 2003, TRUST RECIPROCITY GA; Hausmann R., 2012, GLOBAL GENDER GAP RE; Martinsson P, 2013, J ECON PSYCHOL, V34, P148, DOI 10.1016/j.joep.2012.09.005; Martinsson P, 2011, ECON LETT, V110, P248, DOI 10.1016/j.econlet.2010.11.028; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Olson KR, 2008, COGNITION, V108, P222, DOI 10.1016/j.cognition.2007.12.003; Ostrom E, 2003, TRUST RECIPROCITY GA; Peters HE, 2004, INT ECON REV, V45, P283, DOI 10.1111/j.1468-2354.2004.00126.x; Sally D, 2006, J ECON PSYCHOL, V27, P73, DOI 10.1016/j.joep.2005.06.015; TEDESCHI JT, 1969, CHILD DEV, V40, P517, DOI 10.2307/1127419; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Wedekind C, 2000, SCIENCE, V288, P850, DOI 10.1126/science.288.5467.850	25	15	15	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e90923	10.1371/journal.pone.0090923	http://dx.doi.org/10.1371/journal.pone.0090923			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9FH	24614513	Green Published, gold, Green Submitted			2022-12-27	WOS:000332839300057
J	Jayaraman, C; Moon, Y; Rice, IM; Wecksler, ETH; Beck, CL; Sosnoff, JJ				Jayaraman, Chandrasekaran; Moon, Yaejin; Rice, Ian M.; Wecksler, Elizabeth T. Hsiao; Beck, Carolyn L.; Sosnoff, Jacob J.			Shoulder Pain and Cycle to Cycle Kinematic Spatial Variability during Recovery Phase in Manual Wheelchair Users: A Pilot Investigation	PLOS ONE			English	Article							SPINAL-CORD-INJURY; LEADING JOINT HYPOTHESIS; UPPER EXTREMITY; MOTOR VARIABILITY; LIMB MOVEMENTS; PROPULSION; BIOMECHANICS; TASK; KINETICS; COORDINATION	Wheelchair propulsion plays a significant role in the development of shoulder pain in manual wheelchair users (MWU). However wheelchair propulsion metrics related to shoulder pain are not clearly understood. This investigation examined intra-individual kinematic spatial variability during semi-circular wheelchair propulsion as a function of shoulder pain in MWU. Data from 10 experienced adult MWU with spinal cord injury (5 with shoulder pain; 5 without shoulder pain) were analyzed in this study. Participants propelled their own wheelchairs on a dynamometer at 3 distinct speeds (self-selected, 0.7 m/s, 1.1 m/s) for 3 minutes at each speed. Motion capture data of the upper limbs were recorded. Intra-individual kinematic spatial variability of the steady state wrist motion during the recovery phase was determined using principal component analysis (PCA). The kinematic spatial variability was calculated at every 10% intervals (i.e at 11 interval points, from 0% to 100%) along the wrist recovery path. Results: Overall, spatial variability was found to be highest at the start and end of the recovery phase and lowest during the middle of the recovery path. Individuals with shoulder pain displayed significantly higher kinematic spatial variability than individuals without shoulder pain at the start (at 10% interval) of the recovery phase (p<.004). Conclusions: Analysis of intra-individual kinematic spatial variability during the recovery phase of manual wheelchair propulsion distinguished between those with and without shoulder pain. Variability analysis of wheelchair propulsion may offer a new approach to monitor the development and rehabilitation of shoulder pain.	[Jayaraman, Chandrasekaran; Beck, Carolyn L.] Univ Illinois, Dept Ind & Enterprise Syst Engn, Urbana, IL 61801 USA; [Moon, Yaejin; Sosnoff, Jacob J.] Univ Illinois, Dept Kinesiol & Community Hlth, Urbana, IL 61801 USA; [Rice, Ian M.; Wecksler, Elizabeth T. Hsiao] Univ Illinois, Dept Mech Sci & Engn, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Sosnoff, JJ (corresponding author), Univ Illinois, Dept Kinesiol & Community Hlth, Urbana, IL 61801 USA.	jsosnoff@illinois.edu	Sosnoff, Jacob/P-3397-2019; Hsiao-Wecksler, Elizabeth T/C-1910-2015; Jayaraman, Chandrasekaran/I-1765-2019	Sosnoff, Jacob/0000-0002-0286-9207; Hsiao-Wecksler, Elizabeth T/0000-0002-9373-3611; 	National Institutes of Health [1R21HD066129-01A1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD066129] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This project is funded in part by the National Institutes of Health (#1R21HD066129-01A1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	BEDNARCZYK JH, 1994, ARCH PHYS MED REHAB, V75, P1327; Bernstein N, 1967, COORDINATION REGULAT; Boninger ML, 2005, J REHABIL RES DEV, V42, P9, DOI 10.1682/JRRD.2004.08.0103; Bregman DJJ, 2009, CLIN BIOMECH, V24, P13, DOI 10.1016/j.clinbiomech.2008.09.003; CAMPBELL WI, 1990, ULSTER MED J, V59, P149; Chow JW, 2011, DISABIL REHABIL-ASSI, V6, P365, DOI 10.3109/17483107.2010.525290; Collinger JL, 2008, ARCH PHYS MED REHAB, V89, P667, DOI 10.1016/j.apmr.2007.09.052; Cowan RE, 2008, ARCH PHYS MED REHAB, V89, P260, DOI 10.1016/j.apmr.2007.08.141; Cowan RE, 2009, ARCH PHYS MED REHAB, V90, P1076, DOI 10.1016/j.apmr.2008.10.034; Curtis KA, 1999, SPINAL CORD, V37, P421, DOI 10.1038/sj.sc.3100860; de Groot S, 2004, AM J PHYS MED REHAB, V83, P640, DOI 10.1097/01.phm.0000133437.58810.c6; de Groot S, 2003, J ELECTROMYOGR KINES, V13, P217, DOI 10.1016/S1050-6411(03)00018-X; DiGiovine CP, 2001, J REHABIL RES DEV, V38, P41; Dounskaia N, 2005, EXP BRAIN RES, V166, P1, DOI 10.1007/s00221-005-2339-1; Dounskaia N, 2010, EXERC SPORT SCI REV, V38, P201, DOI 10.1097/JES.0b013e3181f45194; Finley MA, 2004, J REHABIL RES DEV, V41, P385, DOI 10.1682/JRRD.2004.03.0385; Forner Cordero A, 2005, BIOL CYBERN, V93, P63; GELLMAN H, 1988, CLIN ORTHOP RELAT R, P132; Hosseini SM, 2012, ARCH PHYS MED REHAB, V93, P2237, DOI 10.1016/j.apmr.2012.05.021; Ivanenko YP, 2007, J NEUROSCI, V27, P11149, DOI 10.1523/JNEUROSCI.2644-07.2007; Koontz AM, 2009, ARCH PHYS MED REHAB, V90, P1916, DOI 10.1016/j.apmr.2009.05.022; Koontz AM, 2002, J REHABIL RES DEV, V39, P635; Kwarciak AM, 2012, DISABIL REHABIL-ASSI, V7, P459, DOI 10.3109/17483107.2011.650781; LaPlante MP, 2010, ASSIST TECHNOL, V22, P3, DOI 10.1080/10400430903501413; LaPlante MP, 2003, INT WORKSH CTR INCL; Lomond KV, 2011, CLIN BIOMECH, V26, P123, DOI 10.1016/j.clinbiomech.2010.09.012; Lomond KV, 2010, EXP BRAIN RES, V206, P271, DOI 10.1007/s00221-010-2405-1; Madeleine P, 2008, ERGONOMICS, V51, P1078, DOI 10.1080/00140130801958659; Madeleine P, 2008, EXP BRAIN RES, V185, P689, DOI 10.1007/s00221-007-1199-2; Mason BS, 2012, MED SCI SPORT EXER, V44, P126, DOI 10.1249/MSS.0b013e31822a2df0; Mathiassen SE, 2003, ERGONOMICS, V46, P800, DOI 10.1080/0014013031000090125; Mercer JL, 2006, CLIN BIOMECH, V21, P781, DOI 10.1016/j.clinbiomech.2006.04.010; Moon Y, 2013, CLIN BIOMECHANICS; Morrow MMB, 2009, J REHABIL RES DEV, V46, P939, DOI 10.1682/JRRD.2008.12.0165; NICHOLS PJR, 1979, SCAND J REHABIL MED, V11, P29; PATLA AE, 1985, J MOTOR BEHAV, V17, P443; Price R, 2007, ARCH PHYS MED REHAB, V88, P456, DOI 10.1016/j.apmr.2007.01.016; Ranganathan R, 2010, J MOTOR BEHAV, V42, P307, DOI 10.1080/00222895.2010.510542; Ranganathan R, 2010, NEUROSCI LETT, V469, P416, DOI 10.1016/j.neulet.2009.12.041; Rankin JW, 2012, CLIN BIOMECH, V27, P879, DOI 10.1016/j.clinbiomech.2012.07.002; Rankin JW, 2011, J BIOMECH, V44, P1246, DOI 10.1016/j.jbiomech.2011.02.073; Rice IM, 2013, ARCH PHYS M IN PRESS; Richter WM, 2011, ARCH PHYS MED REHAB, V92, P572, DOI 10.1016/j.apmr.2010.11.001; SANDERSON DJ, 1985, J BIOMECH, V18, P423, DOI 10.1016/0021-9290(85)90277-5; Sawatzky BJ, 2005, J REHABIL RES DEV, V42, P1, DOI 10.1682/JRRD.2004.06.0070; Scholz JP, 2000, EXP BRAIN RES, V135, P382, DOI 10.1007/s002210000540; Shimada SD, 1998, J REHABIL RES DEV, V35, P210; Srinivasan D, 2012, CLIN BIOMECH, V27, P979, DOI 10.1016/j.clinbiomech.2012.08.007; Stergiou Nicholas, 2006, J Neurol Phys Ther, V30, P120; Stergiou UH, 2004, INNOVATIVE ANAL HUMA, P63; VANLANDEWIJCK YC, 1994, MED SCI SPORT EXER, V26, P1373; VEEGER HEJ, 1991, J ELECTROMYOGR KINES, V1, P270, DOI 10.1016/1050-6411(91)90014-V; Wu G, 2005, J BIOMECH, V38, P981, DOI 10.1016/j.jbiomech.2004.05.042	53	12	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e89794	10.1371/journal.pone.0089794	http://dx.doi.org/10.1371/journal.pone.0089794			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614232	Green Published, gold, Green Submitted			2022-12-27	WOS:000332839300013
J	Shiono, M; Takahashi, S; Kakudo, Y; Takahashi, M; Shimodaira, H; Kato, S; Ishioka, C				Shiono, Masatoshi; Takahashi, Shin; Kakudo, Yuichi; Takahashi, Masanobu; Shimodaira, Hideki; Kato, Shunsuke; Ishioka, Chikashi			Upper Arm Central Venous Port Implantation: A 6-Year Single Institutional Retrospective Analysis and Pictorial Essay of Procedures for Insertion	PLOS ONE			English	Article							INTERNAL JUGULAR-VEIN; PINCH-OFF SIGN; ONCOLOGY PATIENTS; ACCESS DEVICE; CATHETER OCCLUSION; CANCER-PATIENTS; COMPLICATIONS; EXPERIENCE; MALIGNANCIES; PLACEMENT	Background: The requirement of central venous (CV) port implantation is increasing with the increase in the number of cancer patients and advancement in chemotherapy. In our division, medical oncologists have implanted all CV ports to save time and consultation costs to other departments. Recently, upper arm implantation has become the first choice as a safe and comfortable method in our unit. Here we report our experience and discuss the procedure and its potential advantages. Methods: All CV port implantations (n = 599) performed in our unit from January 2006 to December 2011 were analyzed. Procedural success and complication rates between subclavian and upper arm groups were compared. Results: Both groups had similar patient characteristics. Upper arm CV port and subclavian implantations were equivalently successful and safe. Although we only retrospectively analyzed data from a single center, the upper arm group had a significantly lower overall postprocedural complication rate than the subclavian group. No pneumothorax risk, less risk of arterial puncture by ultrasound, feasibility of stopping potential arterial bleeding, and prevention of accidental arterial cannulation by targeting the characteristic solitary basilic vein were the identified advantages of upper arm CV port implantation. In addition to the aforementioned advantages, there is no risk of "pinch-off syndrome," possibly less patient fear of manipulation, no scars on the neck and chest, easier accessibility, and compatibility with the "peripherally inserted central catheter" technique. Conclusions: Upper arm implantation may benefit clinicians and patients with respect to safety and comfort. We also introduce our methods for upper arm CV port implantation with the videos.	[Shiono, Masatoshi; Takahashi, Shin; Kakudo, Yuichi; Takahashi, Masanobu; Shimodaira, Hideki; Kato, Shunsuke; Ishioka, Chikashi] Tohoku Univ, Tohoku Univ Hosp, Dept Clin Oncol, Aoba Ku, Sendai, Miyagi 980, Japan; [Kakudo, Yuichi; Kato, Shunsuke; Ishioka, Chikashi] Tohoku Univ, Dept Clin Oncol, Inst Dev Aging & Canc, Aoba Ku, Sendai, Miyagi 980, Japan	Tohoku University; Tohoku University	Ishioka, C (corresponding author), Tohoku Univ, Tohoku Univ Hosp, Dept Clin Oncol, Aoba Ku, Sendai, Miyagi 980, Japan.	chikashi@idac.tohoku.ac.jp	Takahashi, Shin/AAE-5011-2019; Kato, Shunsuke/F-7607-2014	Takahashi, Shin/0000-0001-6695-3099; Ishioka, Chikashi/0000-0002-3023-1227	Japanese Ministry of Health, Labour and Welfare	Japanese Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan)	This study has been funded by a Health Labour Sciences Research Grant from the Japanese Ministry of Health, Labour and Welfare. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study. URL: http://www.mhlw.go.jp/jigyo_shiwake/gyousei_review_sheet/2012/h23_pdf/0240.pdf.	AITKEN DR, 1984, AM J SURG, V148, P633, DOI 10.1016/0002-9610(84)90340-4; Akahane A, 2011, CARDIOVASC INTER RAD, V34, P1222, DOI 10.1007/s00270-010-0051-4; ANDRIS DA, 1994, JPEN-PARENTER ENTER, V18, P531, DOI 10.1177/0148607194018006531; Biffi R, 2000, J Vasc Access, V1, P19; Blaivas M, 2009, J ULTRAS MED, V28, P1239, DOI 10.7863/jum.2009.28.9.1239; Bodner LJ, 2000, CARDIOVASC INTER RAD, V23, P187, DOI 10.1007/s002700010041; Burbridge B, 2000, CAN ASSOC RADIOL J, V51, P163; Cayne NS, 2010, ANN VASC SURG, V24, P44, DOI 10.1016/j.avsg.2009.06.017; Charvat J, 2006, SUPPORT CARE CANCER, V14, P1162, DOI 10.1007/s00520-006-0073-2; Cil Barbaros Erhan, 2006, Diagn Interv Radiol, V12, P93; Deppe G, 1996, GYNECOL ONCOL, V62, P340, DOI 10.1006/gyno.1996.0246; Ezaru CS, 2009, ANESTH ANALG, V109, P130, DOI 10.1213/ane.0b013e31818f87e9; Higgs ZCJ, 2005, LANCET, V366, P1407, DOI 10.1016/S0140-6736(05)66878-X; Hills JR, 1997, J VASC INTERV RADIOL, V8, P983, DOI 10.1016/S1051-0443(97)70698-5; Hostetter R., 2010, J ASS VASC ACCESS, V15, P112, DOI [10.2309/java.15-3-3, DOI 10.2309/JAVA.15-3-3]; Huang CH, 1999, J FORMOS MED ASSOC, V98, P265; Kawamura J, 2008, INT J CLIN ONCOL, V13, P349, DOI 10.1007/s10147-008-0766-2; Klotz HP, 1996, J SURG ONCOL, V62, P222, DOI 10.1002/(SICI)1096-9098(199607)62:3<222::AID-JSO14>3.0.CO;2-8; Kusminsky RE, 2007, J AM COLL SURGEONS, V204, P681, DOI 10.1016/j.jamcollsurg.2007.01.039; Lyon RD, 1999, J VASC INTERV RADIOL, V10, P463, DOI 10.1016/S1051-0443(99)70066-7; MANSFIELD PF, 1994, NEW ENGL J MED, V331, P1735, DOI 10.1056/NEJM199412293312602; Marcy P, 2010, J CLIN ONCOL, V28, DOI 10.1200/jco.2010.28.15_suppl.9158; Marcy PY, 2008, EJSO-EUR J SURG ONC, V34, P1262, DOI 10.1016/j.ejso.2007.09.011; Marcy PY, 2005, BREAST CANCER RES TR, V92, P61, DOI 10.1007/s10549-005-1711-y; McGee DC, 2003, NEW ENGL J MED, V348, P1123, DOI 10.1056/NEJMra011883; MIKAMI K, 2011, JPN J INTERVENT RADI, V26, P169; NIEDERHUBER JE, 1982, SURGERY, V92, P706; Pikwer A, 2009, EUR J VASC ENDOVASC, V38, P707, DOI 10.1016/j.ejvs.2009.08.009; PUNT CJA, 1995, ANTI-CANCER DRUG, V6, P594, DOI 10.1097/00001813-199508000-00013; Ryder M A, 1995, Surg Oncol Clin N Am, V4, P395; SALEM RR, 1993, J CLIN ONCOL, V11, P2181, DOI 10.1200/JCO.1993.11.11.2181; SELDINGER SI, 1953, ACTA RADIOL, V39, P368, DOI 10.3109/00016925309136722; Sonobe M, 2009, INT J CLIN ONCOL, V14, P208, DOI 10.1007/s10147-008-0835-6; Verhey PT, 2008, J ASS VASCULAR ACCES, V13, P32, DOI [10.2309/java.13-1-7, DOI 10.2309/JAVA.13-1-7]; Whigham CJ, 1999, J VASC INTERV RADIOL, V10, P767, DOI 10.1016/S1051-0443(99)70112-0; Wirsing M, 2008, CHEST, V134, P527, DOI 10.1378/chest.07-2687; Yip D, 2002, ACTA RADIOL, V43, P371, DOI 10.1034/j.1600-0455.2002.430405.x	37	20	33	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91335	10.1371/journal.pone.0091335	http://dx.doi.org/10.1371/journal.pone.0091335			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614412	Green Submitted, Green Published, gold			2022-12-27	WOS:000332839300114
J	Sunthamala, N; Thierry, F; Teissier, S; Pientong, C; Kongyingyoes, B; Tangsiriwatthana, T; Sangkomkamhang, U; Ekalaksananan, T				Sunthamala, Nuchsupha; Thierry, Francoise; Teissier, Sebastien; Pientong, Chamsai; Kongyingyoes, Bunkerd; Tangsiriwatthana, Thumwadee; Sangkomkamhang, Ussanee; Ekalaksananan, Tipaya			E2 Proteins of High Risk Human Papillomaviruses Down-Modulate STING and IFN-kappa Transcription in Keratinocytes	PLOS ONE			English	Article							PATTERN-RECOGNITION RECEPTORS; VIRAL TRANSCRIPTION; TUMOR-SUPPRESSOR; HELA-CELLS; HPV16 E2; TYPE-16; PROLIFERATION; ONCOPROTEIN; EXPRESSION; REGULATOR	In the early stages of human papillomavirus (HPV) infection, the viral proteins elicit specific immune responses that can participate to regression of ano-genital lesions. HPV E6 protein for instance can reduce type I interferon (IFN) including IFN-kappa that is involved in immune evasion and HPV persistence. To evaluate the role of E2 protein in innate immunity in HPV16-associated cervical lesions, genome-wide expression profiling of human primary keratinocytes (HPK) transduced by HPV16 E2 was investigated using microarrays and innate immunity associated genes were specifically analyzed. The analyses showed that the expression of 779 genes was modulated by HPV16E2 and 92 of them were genes associated with innate immunity. Notably IFN-kappa and STING were suppressed in HPK expressing the E2 proteins of HPV16 or HPV18 and the transactivation amino-terminal domain of E2 was involved in the suppressive effect. The relationship between STING, IFN-kappa and interferon stimulated genes (ISGs) in HPK was confirmed by gene silencing and real time PCR. The expression of STING and IFN-kappa were further determined in clinical specimens by real time PCR. STING and IFN-kappa were down-modulated in HPV positive low grade squamous intraepithelial lesions compared with HPV negative controls. This study demonstrates that E2 proteins of high risk HPV reduce STING and IFN-kappa transcription and its downstream target genes that might be an immune evasion mechanism involved in HPV persistence and cervical cancer development.	[Sunthamala, Nuchsupha; Pientong, Chamsai; Ekalaksananan, Tipaya] Khon Kaen Univ, Fac Med, Dept Microbiol, Khon Kaen, Thailand; [Sunthamala, Nuchsupha; Thierry, Francoise; Teissier, Sebastien] ASTAR, Inst Med Biol, Singapore, Singapore; [Kongyingyoes, Bunkerd] Khon Kaen Univ, Fac Med, Dept Pharmacol, Khon Kaen, Thailand; [Tangsiriwatthana, Thumwadee; Sangkomkamhang, Ussanee] Khon Kaen Hosp, Dept Obstet & Gynecol, Khon Kaen, Thailand	Khon Kaen University; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); Khon Kaen University	Ekalaksananan, T (corresponding author), Khon Kaen Univ, Fac Med, Dept Microbiol, Khon Kaen, Thailand.	tipeka@kku.ac.th		Sunthamala, Nuchsupha/0000-0003-2213-4037	Faculty of Medicine [I54328]; Khon Kaen University [551602, 564102, 573002]; Thailand Research Fund through the Royal Golden Jubilee Ph.D. Program [PHD/0213/2550]	Faculty of Medicine; Khon Kaen University; Thailand Research Fund through the Royal Golden Jubilee Ph.D. Program(Thailand Research Fund (TRF))	This work was supported by grants from the Faculty of Medicine (I54328), Khon Kaen University (551602, 564102 and 573002) and the Thailand Research Fund through the Royal Golden Jubilee Ph.D. Program (#PHD/0213/2550) to student's NS and advisor's TE is acknowledged. The funders had no role in study design, data collection, data analysis, preparation of manuscript and decision to publish.	Abbate EA, 2004, GENE DEV, V18, P1981, DOI 10.1101/gad.1220104; Arany I, 1995, ANTICANCER RES, V15, P2865; Ashrafi GH, 2005, INT J CANCER, V113, P276, DOI 10.1002/ijc.20558; AU WC, 1995, P NATL ACAD SCI USA, V92, P11657, DOI 10.1073/pnas.92.25.11657; Bauer M, 2000, IMMUNOL LETT, V71, P55, DOI 10.1016/S0165-2478(99)00170-4; Bellanger S, 2001, J VIROL, V75, P7244, DOI 10.1128/JVI.75.16.7244-7251.2001; Bellanger S, 2011, AM J CANCER RES, V1, P373; Beutler BA, 2009, BLOOD, V113, P1399, DOI 10.1182/blood-2008-07-019307; Blachon S, 2005, J BIOL CHEM, V280, P36088, DOI 10.1074/jbc.M505138200; Blakaj DM, 2009, FRONT BIOSCI-LANDMRK, V14, P900, DOI 10.2741/3285; Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244; Bowie AG, 2008, NAT REV IMMUNOL, V8, P911, DOI 10.1038/nri2436; Davidson EJ, 2003, J GEN VIROL, V84, P2089, DOI 10.1099/vir.0.19095-0; De Maeyer E, 1998, Int Rev Immunol, V17, P53, DOI 10.3109/08830189809084487; DeCarlo CA, 2010, LAB INVEST, V90, P1482, DOI 10.1038/labinvest.2010.95; Demeret C, 2003, ONCOGENE, V22, P168, DOI 10.1038/sj.onc.1206108; Desaintes C, 1997, EMBO J, V16, P504, DOI 10.1093/emboj/16.3.504; DOWHANICK JJ, 1995, J VIROL, V69, P7791, DOI 10.1128/JVI.69.12.7791-7799.1995; Evans M, 2001, J IMMUNOL, V167, P5420, DOI 10.4049/jimmunol.167.9.5420; Hegde RS, 1998, J MOL BIOL, V284, P1479, DOI 10.1006/jmbi.1998.2260; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Kadaja M, 2009, VIROLOGY, V384, P360, DOI 10.1016/j.virol.2008.11.032; Kaisho T, 2006, J ALLERGY CLIN IMMUN, V117, P979, DOI 10.1016/j.jaci.2006.02.023; Koutsky Laura, 1997, American Journal of Medicine, V102, P3; LaFleur DW, 2001, J BIOL CHEM, V276, P39765, DOI 10.1074/jbc.M102502200; Li SY, 1999, ONCOGENE, V18, P5727, DOI 10.1038/sj.onc.1202960; McBride AA, 2013, VIROLOGY, V445, P57, DOI 10.1016/j.virol.2013.06.006; Mole S, 2009, J PATHOL, V219, P383, DOI 10.1002/path.2608; Muller Mandy, 2012, Open Virol J, V6, P173, DOI 10.2174/1874357901206010173; Muller M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002761; Oldak M, 2010, J VIROL, V84, P1376, DOI 10.1128/JVI.01220-09; Oliveira JG, 2006, P NATL ACAD SCI USA, V103, P1047, DOI 10.1073/pnas.0507624103; Palm NW, 2009, IMMUNOL REV, V227, P221, DOI 10.1111/j.1600-065X.2008.00731.x; Park JS, 2000, J BIOL CHEM, V275, P6764, DOI 10.1074/jbc.275.10.6764; Peto J, 2004, BRIT J CANCER, V91, P942, DOI 10.1038/sj.bjc.6602049; Ramirez-Salazar E, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-247; Reiser J, 2011, J VIROL, V85, P11372, DOI 10.1128/JVI.05279-11; Rincon-Orozco B, 2009, CANCER RES, V69, P8718, DOI 10.1158/0008-5472.CAN-09-0550; Schiffman M, 2011, JNCI-J NATL CANCER I, V103, P368, DOI 10.1093/jnci/djq562; SCHINDLER C, 1995, ANNU REV BIOCHEM, V64, P621, DOI 10.1146/annurev.bi.64.070195.003201; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Stubenrauch F, 2000, J VIROL, V74, P1178, DOI 10.1128/JVI.74.3.1178-1186.2000; Stubenrauch F, 2007, INT J CANCER, V121, P2284, DOI 10.1002/ijc.22907; Takeuchi O, 2009, IMMUNOL REV, V227, P75, DOI 10.1111/j.1600-065X.2008.00737.x; Tanaka Y, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002521; Thompson MR, 2011, VIRUSES-BASEL, V3, P920, DOI 10.3390/v3060920; Um SJ, 2002, CANCER LETT, V179, P205, DOI 10.1016/S0304-3835(01)00871-0; Woo YL, 2010, INT J CANCER, V126, P133, DOI 10.1002/ijc.24804; Xue Yuezhen, 2012, Open Virol J, V6, P163, DOI 10.2174/1874357901206010163; Yasugi T, 1997, J VIROL, V71, P5942, DOI 10.1128/JVI.71.8.5942-5951.1997; You J, 2004, CELL, V117, P349, DOI 10.1016/S0092-8674(04)00402-7; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798; zurHausen H, 1996, BBA-REV CANCER, V1288, pF55	54	62	68	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91473	10.1371/journal.pone.0091473	http://dx.doi.org/10.1371/journal.pone.0091473			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614210	gold, Green Published, Green Submitted			2022-12-27	WOS:000332839300130
J	Tang, HJ; Lai, CC; Lin, HL; Chao, CM				Tang, Hung-Jen; Lai, Chih-Cheng; Lin, Hsin-Lan; Chao, Chien-Ming			Clinical Manifestations of Bacteremia Caused by Aeromonas Species in Southern Taiwan	PLOS ONE			English	Article							INFECTION; SOBRIA; HYDROPHILA; EPISODES; PATIENT; COMPLEX; CAVIAE	Aim: This study is conducted to investigate the clinical characteristics of patients with bacteremia caused by Aeromonas species. Materials and Methods: Patients with bacteremia caused by Aeromonas species during the period 2009 to 2013 were identified from a computerized database of a regional hospital in southern Taiwan. The medical records of these patients were retrospectively reviewed. Results: A total of 91 patients with bacteremia due to Aeromonas species were identified. In addition to 16 (17.6%) primary bacteremia, the most common source of secondary infection is peritonitis (n = 27, 29.7%), followed by biliary tract infection (n = 18, 19.8%), and SSTI (n = 12, 13.2%), pneumonia (n = 9, 9.9%), catheter-related bloodstream infection (n = 5, 5.5%), and genitourinary tract infection (n = 4, 4.4%). A. hydrophila (n = 35, 38.5%) was the most common pathogen, followed by A. veronii biovar sobria (n = 31, 34.1%), A. caviae (n = 14, 15.4%), and A. veronii biovar veronii (n = 9, 9.9%). Forty-three (47.3%) patients were classified as healthcare-associated infections (HCAI) causes by Aeromonas species, and patients with HCAI were more likely to have cancer, and receive immunosuppressant than patients with community-acquired bacteremia. The overall outcomes, including rate of ICU admission, acute respiratory failure, and mortality were 33.3%, 28.6%, and 23.1%, respectively. Multivariate analysis showed that the in-hospital day mortality was significantly associated only with underlying cancer (P <.001), and initial shock (P <.001). Conclusions: Aeromonas species should be considered one of the causative pathogens of healthcare-associated bacteremia, especially in immunocompromised patients. In addition, it can be associated with high fatality. Cancer and initial shock were the poor prognostic factors.	[Tang, Hung-Jen] Chi Mei Med Ctr, Dept Med, Tainan, Taiwan; [Tang, Hung-Jen] Chia Nan Univ Pharm & Sci, Dept Hlth & Nutr, Tainan, Taiwan; [Lai, Chih-Cheng; Chao, Chien-Ming] Dept Intens Care Med, Tainan, Taiwan; [Lai, Chih-Cheng; Chao, Chien-Ming] Chi Mei Med Ctr, Tainan, Taiwan; [Lin, Hsin-Lan] Chi Mei Med Ctr, Dept Nursing, Tainan, Taiwan; [Chao, Chien-Ming] Min Hwei Coll Hlth Care Management, Dept Nursing, Tainan, Taiwan	Chi Mei Hospital; Chia Nan University of Pharmacy & Science; Chi Mei Hospital; Chi Mei Hospital	Chao, CM (corresponding author), Dept Intens Care Med, Tainan, Taiwan.	ccm870958@yahoo.com.tw						Chao CM, 2013, EUR J CLIN MICROBIOL, V32, P1069, DOI 10.1007/s10096-013-1852-6; Chao CM, 2013, EUR J CLIN MICROBIOL, V32, P543, DOI 10.1007/s10096-012-1771-y; Chao CM, 2013, EUR J CLIN MICROBIOL, V32, P245, DOI 10.1007/s10096-012-1736-1; Chao CM, 2012, J INFECTION, V65, P573, DOI 10.1016/j.jinf.2012.06.012; Chao CM, 2012, AM J TROP MED HYG, V87, P933, DOI 10.4269/ajtmh.2012.12-0275; Chuang HC, 2011, J KOREAN MED SCI, V26, P1415, DOI 10.3346/jkms.2011.26.11.1415; Clinical and Laboratory Standards Institute, 2010, M45A2 CLSI, V30; Hochedez P, 2010, AM J TROP MED HYG, V83, P1123, DOI 10.4269/ajtmh.2010.10-0063; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Janda JM, 2010, CLIN MICROBIOL REV, V23, P35, DOI 10.1128/CMR.00039-09; Kimura M, 2013, SCAND J INFECT DIS, V45, P304, DOI 10.3109/00365548.2012.737474; Ko WC, 2000, J INFECTION, V40, P267, DOI 10.1053/jinf.2000.0654; KO WC, 1995, CLIN INFECT DIS, V20, P1298, DOI 10.1093/clinids/20.5.1298; Lai CC, 2007, BURNS, V33, P255, DOI 10.1016/j.burns.2006.06.003; Lai CC, 2007, CLIN INFECT DIS, V44, P1523, DOI 10.1086/517850; Lamy B, 2009, J CLIN MICROBIOL, V47, P1234, DOI 10.1128/JCM.00155-09; Lay CJ, 2010, INTERNAL MED, V49, P2415, DOI 10.2169/internalmedicine.49.4117; Lin WT, 2013, INTERNAL MED, V52, P2517, DOI 10.2169/internalmedicine.52.0180; Parker JL, 2011, J INFECTION, V62, P109, DOI 10.1016/j.jinf.2010.12.003; Shizuma T, 2011, GASTROENT RES PRACT, V2011, DOI 10.1155/2011/930826; Wang CY, 2009, J MICROBIOL IMMUNOL, V42, P510; Wu CJ, 2012, J MICROBIOL IMMUNOL, V9	22	31	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91642	10.1371/journal.pone.0091642	http://dx.doi.org/10.1371/journal.pone.0091642			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614100	Green Submitted, Green Published, gold			2022-12-27	WOS:000332839300145
J	Coura-Vital, W; Ker, HG; Roatt, BM; Aguiar-Soares, RDO; Leal, GGD; Moreira, ND; Oliveira, LAM; Machado, EMD; Morais, MHF; Correa-Oliveira, R; Carneiro, M; Reis, AB				Coura-Vital, Wendel; Ker, Henrique Gama; Roatt, Bruno Mendes; Oliveira Aguiar-Soares, Rodrigo Dian; de Almeida Leal, Gleisiane Gomes; Moreira, Nadia das Dores; Machado Oliveira, Laser Antonio; de Menezes Machado, Evandro Marques; Franco Morais, Maria Helena; Correa-Oliveira, Rodrigo; Carneiro, Mariangela; Reis, Alexandre Barbosa			Evaluation of Change in Canine Diagnosis Protocol Adopted by the Visceral Leishmaniasis Control Program in Brazil and a New Proposal for Diagnosis	PLOS ONE			English	Article							ENDEMIC AREA; MINAS-GERAIS; DOGS; INFANTUM; TESTS; SERODIAGNOSIS; INFECTIONS; ANTIGENS; HEALTH; COHORT	The techniques used for diagnosis of canine visceral leishmaniasis (CVL) in Brazil ELISA and IFAT have been extensively questioned because of the accuracy of these tests. A recent change in the diagnosis protocol excluded IFAT and included the Dual-Path Platform (DPP). We evaluated the prevalence and incidence rates of Leishmania spp. before and after the change in the protocol. In addition, based on our results, we propose a new alternative that is less expensive for the screening and confirmation of CVL. Plasma samples were obtained from a serobank from dogs evaluated in a cross-sectional study (1,226 dogs) and in a cohort study of susceptible animals (n = 447), followed for 26 months. Serology testing was performed using ELISA, IFAT, and DPP. The incidence and prevalence of CVL were determined by using the protocol of the Visceral Leishmaniasis Control and Surveillance Program until 2012 (ELISA and IFAT using filter paper) and the protocol used after 2012 (DPP and ELISA using plasma). The prevalence was 6.2% and the incidence was 2.8 per 1,000 dog-months for the protocol used until 2012. For the new diagnosis protocol for CVL resulted in an incidence of 5.4 per 1,000 dog-months and a prevalence of 8.1%. Our results showed that the prevalence and incidence of infection were far greater than suggested by the previously used protocol and that the magnitude of infection in endemic areas has been underestimated. As tests are performed sequentially and euthanasia of dogs is carried out when the serological results are positive in both tests, the sequence does not affect the number of animals to be eliminated by the Control Program. Then we suggest to municipalities with a large demand of exams to use ELISA for screening and DPP for confirmation, since this allows easier performance and reduced cost.	[Coura-Vital, Wendel; Ker, Henrique Gama; Roatt, Bruno Mendes; Oliveira Aguiar-Soares, Rodrigo Dian; de Almeida Leal, Gleisiane Gomes; Moreira, Nadia das Dores; Machado Oliveira, Laser Antonio; Reis, Alexandre Barbosa] Univ Fed Ouro Preto, Escola Farm, Lab Pesquisas Clin, Ouro Preto, MG, Brazil; [Coura-Vital, Wendel; Carneiro, Mariangela] Univ Fed Minas Gerais, Fac Med, Belo Horizonte, MG, Brazil; [Ker, Henrique Gama; Roatt, Bruno Mendes; Oliveira Aguiar-Soares, Rodrigo Dian; de Almeida Leal, Gleisiane Gomes; Moreira, Nadia das Dores; de Menezes Machado, Evandro Marques; Reis, Alexandre Barbosa] Univ Fed Ouro Preto, Inst Ciencias Exatas & Biol, Lab Imunopatol, Nucleo Pesquisas Ciencias Biol, Ouro Preto, MG, Brazil; [Franco Morais, Maria Helena] Secretaria Municipal Saude, Belo Horizonte, MG, Brazil; [Correa-Oliveira, Rodrigo] Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, Lab Imunol Celular & Mol, Belo Horizonte, MG, Brazil; [Carneiro, Mariangela] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Lab Epidemiol Doencas Infecciosas & Parasitarias, Belo Horizonte, MG, Brazil; [Correa-Oliveira, Rodrigo; Reis, Alexandre Barbosa] INCTDT, Salvador, BA, Brazil	Universidade Federal de Ouro Preto; Universidade Federal de Minas Gerais; Universidade Federal de Ouro Preto; Fundacao Oswaldo Cruz; Universidade Federal de Minas Gerais	Reis, AB (corresponding author), Univ Fed Ouro Preto, Escola Farm, Lab Pesquisas Clin, Ouro Preto, MG, Brazil.	alexreis@nupeb.ufop.br	Reis, Alexandre Barbosa/I-9945-2014; Roatt, Bruno M/R-5502-2016; de Oliveira Aguiar-Soares, Rodrigo Dian/ABB-7973-2020; Coura-Vital, Wendel/AAP-9624-2021	Reis, Alexandre Barbosa/0000-0001-8123-4164; Roatt, Bruno M/0000-0001-5281-3263; de Oliveira Aguiar-Soares, Rodrigo Dian/0000-0001-8705-7357; OLIVEIRA, LASER/0000-0002-9918-932X; Correa-Oliveira, Rodrigo/0000-0001-6419-9459; /0000-0002-1434-7676; Machado, Evandro/0000-0003-2786-7117	Federal University of Ouro Preto; Brazilian Ministry of Health; DECIT/MS/CNPq/BR [576062/2008-1]; FAPEMIG/BR [CBB-APQ-3073-4.01/07]; CNPq/BR [472554/2007-7]; PPSUS/MS/CNPq/FAPEMIG/SES-MG [CBB-APQ-00356-10]; FAPEMIG/PPM; PNPD; CNPq; PNPD/CAPES	Federal University of Ouro Preto; Brazilian Ministry of Health; DECIT/MS/CNPq/BR(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG/BR(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq/BR(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); PPSUS/MS/CNPq/FAPEMIG/SES-MG(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); FAPEMIG/PPM; PNPD; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); PNPD/CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was supported by the following grants: Federal University of Ouro Preto; Brazilian Ministry of Health; DECIT/MS/CNPq/BR/grant: 576062/2008-1; FAPEMIG/BR/grant: CBB-APQ-3073-4.01/07, CNPq/BR/grant: 472554/2007-7; PPSUS/MS/CNPq/FAPEMIG/SES-MG/grant CBB-APQ-00356-10; FAPEMIG/PPM and PNPD/Institutional/2011. The funders had no role in the study design, the data collection and analysis, the decision to publish the manuscript, or the preparation of the manuscript. ABR, MC, and RCO are grateful for CNPq fellowships. WCV is supported by a PNPD/CAPES postdoctoral fellowship.	Alves AS, 2012, RES VET SCI, V93, P1329, DOI 10.1016/j.rvsc.2012.07.006; Barata RA, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/405083; Brasil 2011. Ministerio da Sadde, 2011, 012011CGDTCGLABDEVIT; CAMARGO MARIO E., 1966, REV INST MED TROP SAO PAULO, V8, P227; Malaquias LCC, 2007, PARASITOL RES, V100, P233, DOI 10.1007/s00436-006-0259-z; Coura-Vital W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071833; Coura-Vital W, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001291; Courtenay O, 2002, J INFECT DIS, V186, P1314, DOI 10.1086/344312; Da Costa RT, 2003, T ROY SOC TROP MED H, V97, P678; da Silva DA, 2013, VET J, V195, P252, DOI 10.1016/j.tvjl.2012.06.010; da Silva ES, 2006, VET RES COMMUN, V30, P637, DOI 10.1007/s11259-006-3324-2; de Arruda MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069988; do Rosario EY, 2005, MEM I OSWALDO CRUZ, V100, P197, DOI 10.1590/S0074-02762005000200015; Falqueto A, 2009, AM J TROP MED HYG, V80, P559, DOI 10.4269/ajtmh.2009.80.559; Ferreira ED, 2007, VET PARASITOL, V146, P235, DOI 10.1016/j.vetpar.2007.02.015; Figueiredo FB, 2010, REV INST MED TROP SP, V52, P193, DOI 10.1590/S0036-46652010000400005; Fraga DBM, 2012, VET PARASITOL, V190, P591, DOI 10.1016/j.vetpar.2012.06.025; Giunchetti RC, 2006, J COMP PATHOL, V135, P100, DOI 10.1016/j.jcpa.2006.06.005; Grimaldi G, 2012, AM J TROP MED HYG, V86, P966, DOI 10.4269/ajtmh.2012.12-0040; Grimaldi G, 2012, T ROY SOC TROP MED H, V106, P54, DOI 10.1016/j.trstmh.2011.10.001; Lira RA, 2006, VET PARASITOL, V137, P11, DOI 10.1016/j.vetpar.2005.12.020; Maia Z, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001484; Marcondes M, 2013, VET PARASITOL, V197, P649, DOI 10.1016/j.vetpar.2013.07.013; Ministerio da Saude, 2006, MAN VIG CONTR LEISHM; MOLINA R, 1994, T ROY SOC TROP MED H, V88, P491, DOI 10.1016/0035-9203(94)90446-4; Michalsky EM, 2007, VET PARASITOL, V147, P67, DOI 10.1016/j.vetpar.2007.03.004; Costa CHN, 2011, REV SOC BRAS MED TRO, V44, P232, DOI 10.1590/S0037-86822011005000014; Nunes CM, 2008, VET PARASITOL, V153, P19, DOI 10.1016/j.vetpar.2008.01.005; Porrozzi R, 2007, CLIN VACCINE IMMUNOL, V14, P544, DOI 10.1128/CVI.00420-06; Quinnell RJ, 2001, PARASITOLOGY, V122, P253, DOI 10.1017/S0031182001007363; Quinnell RJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001992; Romero GAS, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000584; Romero HD, 2009, AM J TROP MED HYG, V81, P27; Scalone A, 2002, VET PARASITOL, V104, P275, DOI 10.1016/S0304-4017(01)00643-4; Silva DA, 2011, VET PARASITOL, V179, P257, DOI 10.1016/j.vetpar.2011.01.048; WHO, 2010, WORKING TO OVERCOME THE GLOBAL IMPACT OF NEGLECTED TROPICAL DISEASES: FIRST WHO REPORT ON NEGLECTED TROPICAL DISEASES, P1	36	49	50	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91009	10.1371/journal.pone.0091009	http://dx.doi.org/10.1371/journal.pone.0091009			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608904	Green Published, Green Submitted, gold			2022-12-27	WOS:000332485800079
J	Johnson, GA; Ellis, EA; Kim, H; Muthukrishnan, N; Snavely, T; Pellois, JP				Johnson, Gregory A.; Ellis, E. Ann; Kim, Hansoo; Muthukrishnan, Nandhini; Snavely, Thomas; Pellois, Jean-Philippe			Photoinduced Membrane Damage of E-coli and S-aureus by the Photosensitizer-Antimicrobial Peptide Conjugate Eosin-(KLAKLAK)(2)	PLOS ONE			English	Article							CARE-ASSOCIATED INFECTIONS; GRAM-NEGATIVE BACTERIA; PHOTODYNAMIC THERAPY; LIPID-COMPOSITION; METHYLENE-BLUE; SINGLET OXYGEN; CELL-MEMBRANES; BASIC PEPTIDES; ACIDIC LIPIDS; CHAIN-LENGTH	Background/Objectives: Upon irradiation with visible light, the photosensitizer-peptide conjugate eosin-(KLAKLAK)(2) kills a broad spectrum of bacteria without damaging human cells. Eosin-(KLAKLAK)(2) therefore represents an interesting lead compound for the treatment of local infection by photodynamic bacterial inactivation. The mechanisms of cellular killing by eosin-(KLAKLAK)(2), however, remain unclear and this lack of knowledge hampers the development of optimized therapeutic agents. Herein, we investigate the localization of eosin-(KLAKLAK)(2) in bacteria prior to light treatment and examine the molecular basis for the photodynamic activity of this conjugate. Methodology/Principal Findings: By employing photooxidation of 3,3-diaminobenzidine (DAB), (scanning) transmission electron microscopy ((S)TEM), and energy dispersive X-ray spectroscopy (EDS) methodologies, eosin-(KLAKLAK)(2) is visualized at the surface of E. coli and S. aureus prior to photodynamic irradiation. Subsequent irradiation leads to severe membrane damage. Consistent with these observations, eosin-(KLAKLAK)(2) binds to liposomes of bacterial lipid composition and causes liposomal leakage upon irradiation. The eosin moiety of the conjugate mediates bacterial killing and lipid bilayer leakage by generating the reactive oxygen species singlet oxygen and superoxide. In contrast, the (KLAKLAK)(2) moiety targets the photosensitizer to bacterial lipid bilayers. In addition, while (KLAKLAK)(2) does not disrupt intact liposomes, the peptide accelerates the leakage of photo-oxidized liposomes. Conclusions/Significance: Together, our results suggest that (KLAKLAK)(2) promotes the binding of eosin Y to bacteria cell walls and lipid bilayers. Subsequent light irradiation results in membrane damage from the production of both Type I & II photodynamic products. Membrane damage by oxidation is then further aggravated by the (KLAKLAK)(2) moiety and membrane lysis is accelerated by the peptide. These results therefore establish how photosensitizer and peptide act in synergy to achieve bacterial photo-inactivation. Learning how to exploit and optimize this synergy should lead to the development of future bacterial photoinactivation agents that are effective at low concentrations and at low light doses.	[Johnson, Gregory A.; Muthukrishnan, Nandhini; Snavely, Thomas; Pellois, Jean-Philippe] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Ellis, E. Ann; Kim, Hansoo] Texas A&M Univ, Microscopy & Imaging Ctr, College Stn, TX USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Pellois, JP (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.	pellois@tamu.edu	Muthukrishnan, Nandhini/P-8906-2018	Pellois, Jean-Philippe/0000-0001-8528-4652	Robert A. Welch Foundation [A-1769]; Norman Hackerman Advanced Research Program [E55F9EE7-E488-6873-7D535561D9B426B8]	Robert A. Welch Foundation(The Welch Foundation); Norman Hackerman Advanced Research Program	This work was supported by the Robert A. Welch Foundation (Grant A-1769) (http://www.welch1.org/) and the Norman Hackerman Advanced Research Program (http://www.thecb.state.tx.us/index.cfm?objectid = E55F9EE7-E488-6873-7D535561D9B426B8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alanis AJ, 2005, ARCH MED RES, V36, P697, DOI 10.1016/j.arcmed.2005.06.009; Allan David, 1994, Trends in Cell Biology, V4, P350, DOI 10.1016/0962-8924(94)90076-0; Arias CA, 2009, NEW ENGL J MED, V360, P439, DOI 10.1056/NEJMp0804651; Azad MA, 2011, ANTIMICROB AGENTS CH, V55, P2137, DOI 10.1128/AAC.01148-10; Batistela VR, 2011, SPECTROCHIM ACTA A, V79, P889, DOI 10.1016/j.saa.2011.03.027; Bourbigot S, 2009, BIOPOLYMERS, V91, P1, DOI 10.1002/bip.21071; Bourre L, 2010, PHOTOCH PHOTOBIO SCI, V9, P1613, DOI 10.1039/c0pp00146e; Braham P, 2009, J PERIODONTOL, V80, P1790, DOI 10.1902/jop.2009.090214; Cabiscol Elisa, 2000, International Microbiology, V3, P3; Costa DCS, 2012, PHOTOCH PHOTOBIO SCI, V11, P1905, DOI 10.1039/c2pp25113b; Cronan JE, 2003, ANNU REV MICROBIOL, V57, P203, DOI 10.1146/annurev.micro.57.030502.090851; Dai T, 2009, PHOTODIAGN PHOTODYN, V6, P170, DOI 10.1016/j.pdpdt.2009.10.008; DEERINCK TJ, 1994, J CELL BIOL, V126, P901, DOI 10.1083/jcb.126.4.901; Demidova TN, 2004, INT J IMMUNOPATH PH, V17, P245, DOI 10.1177/039463200401700304; Ellis EA, 2006, MICROSCOPY TODAY, V14, P50; EVANS WH, 1985, BIOCHEM J, V232, P33, DOI 10.1042/bj2320033; Fomina AF, 2003, EXP CELL RES, V291, P150, DOI 10.1016/S0014-4827(03)00372-0; Gad F, 2004, PHOTOCH PHOTOBIO SCI, V3, P451, DOI 10.1039/b311901g; Gaietta GM, 2011, COLD SPRING HARBOR P, V2011; Girotti AW, 2001, J PHOTOCH PHOTOBIO B, V63, P103, DOI 10.1016/S1011-1344(01)00207-X; Girotti AW, 1998, J LIPID RES, V39, P1529; Gribble GJ, 2000, ENVIRON SCI POLLUT R, V7, P37, DOI 10.1065/espr199910.002; Hamblin MR, 2004, PHOTOCH PHOTOBIO SCI, V3, P436, DOI 10.1039/b311900a; Hamblin MR, 2002, J ANTIMICROB CHEMOTH, V49, P941, DOI 10.1093/jac/dkf053; Hashimoto MCE, 2012, PHOTOCHEM PHOTOBIOL, V88, P590, DOI 10.1111/j.1751-1097.2012.01137.x; Hawrani A, 2008, J BIOL CHEM, V283, P18636, DOI 10.1074/jbc.M709154200; Imlay JA, 2013, NAT REV MICROBIOL, V11, P443, DOI 10.1038/nrmicro3032; INGRAHAM LM, 1981, J CELL BIOL, V89, P510, DOI 10.1083/jcb.89.3.510; Javadpour MM, 1996, J MED CHEM, V39, P3107, DOI 10.1021/jm9509410; Johnson GA, 2013, MICROSC MICROANAL, V19, P2026; Johnson GA, 2013, BIOCONJUGATE CHEM, V24, P114, DOI 10.1021/bc3005254; JOYCE GH, 1970, J BACTERIOL, V104, P323, DOI 10.1128/JB.104.1.323-330.1970; Kempf M, 2012, INT J ANTIMICROB AG, V39, P105, DOI 10.1016/j.ijantimicag.2011.10.004; Kharkwal GB, 2011, LASER SURG MED, V43, P755, DOI 10.1002/lsm.21080; Ki V, 2008, CAN J INFECT DIS MED, V19, P173, DOI 10.1155/2008/846453; Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205; KRALJIC I, 1978, PHOTOCHEM PHOTOBIOL, V28, P577, DOI 10.1111/j.1751-1097.1978.tb06972.x; Lakowicz J.R., 2013, PRINCIPLES FLUORESCE, DOI [DOI 10.1007/978-0-387-46312-4, 10.1007/978-0-387-46312-4]; Lambrechts SAG, 2005, PHOTOCH PHOTOBIO SCI, V4, P503, DOI 10.1039/b502125a; LAMOLA AA, 1973, SCIENCE, V179, P1131, DOI 10.1126/science.179.4078.1131; Lauro FM, 2002, PHOTOCH PHOTOBIO SCI, V1, P468, DOI 10.1039/b200977c; LEWIS BA, 1983, J MOL BIOL, V166, P211, DOI 10.1016/S0022-2836(83)80007-2; Magill SS, 2012, INFECT CONT HOSP EP, V33, P283, DOI 10.1086/664048; Maisch T, 2004, PHOTOCH PHOTOBIO SCI, V3, P907, DOI 10.1039/b407622b; Maisch T, 2011, J DTSCH DERMATOL GES, V9, P360, DOI 10.1111/j.1610-0387.2010.07577.x; MALIK Z, 1992, J PHOTOCH PHOTOBIO B, V14, P262, DOI 10.1016/1011-1344(92)85104-3; Meerovich I, 2013, BIOCHIM BIOPHYS ACTA, V1840, P507; Mishra NN, 2011, ANTIMICROB AGENTS CH, V55, P526, DOI 10.1128/AAC.00680-10; MOHR H, 1995, IMMUNOL INVEST, V24, P73, DOI 10.3109/08820139509062763; Morein S, 1996, J BIOL CHEM, V271, P6801, DOI 10.1074/jbc.271.12.6801; Morens DM, 2004, NATURE, V430, P242, DOI 10.1038/nature02759; Morley S, 2013, BRIT J DERMATOL, V168, P617, DOI 10.1111/bjd.12098; MOSIOR M, 1992, BIOCHEMISTRY-US, V31, P1767, DOI 10.1021/bi00121a026; MOSIOR M, 1992, BIOCHIM BIOPHYS ACTA, V1105, P185, DOI 10.1016/0005-2736(92)90178-O; Muthukrishnan N, 2013, PHOTOCHEM PHOTOBIOL, V89, P625, DOI 10.1111/php.12036; Muthukrishnan N, 2012, BBA-GEN SUBJECTS, V1820, P1734, DOI 10.1016/j.bbagen.2012.06.020; NAHAIE MR, 1984, J GEN MICROBIOL, V130, P2427; Natera JE, 2011, J PHOTOCH PHOTOBIO A, V220, P25, DOI 10.1016/j.jphotochem.2011.03.008; Nguyen LT, 2011, TRENDS BIOTECHNOL, V29, P464, DOI 10.1016/j.tibtech.2011.05.001; PEITZSCH RM, 1993, BIOCHEMISTRY-US, V32, P10436, DOI 10.1021/bi00090a020; Polo L, 2000, J PHOTOCH PHOTOBIO B, V59, P152, DOI 10.1016/S1011-1344(01)00114-2; POOLER JP, 1989, PHOTOCHEM PHOTOBIOL, V50, P55, DOI 10.1111/j.1751-1097.1989.tb04129.x; Pryor WA, 2006, AM J PHYSIOL-REG I, V291, pR491, DOI 10.1152/ajpregu.00614.2005; Shu XK, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001041; Soukos NS, 1998, ANTIMICROB AGENTS CH, V42, P2595, DOI 10.1128/AAC.42.10.2595; Splith K, 2011, EUROPEAN BIOPHYSICS, P1; Srinivasan D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017732; TAMM LK, 1991, BIOCHIM BIOPHYS ACTA, V1071, P123, DOI 10.1016/0304-4157(91)90021-N; Tanaka M, 2012, PHOTOCHEM PHOTOBIOL, V88, P227, DOI 10.1111/j.1751-1097.2011.01005.x; Tardivo JP, 2005, PHOTODIAGN PHOTODYN, V2, P175, DOI 10.1016/S1572-1000(05)00097-9; Tavares A, 2011, PHOTOCHEMICAL PHOTOB, V10; Tegos GP, 2006, ANTIMICROB AGENTS CH, V50, P1402, DOI 10.1128/AAC.50.4.1402-1410.2006; Teixeira V, 2012, PROG LIPID RES, V51, P149, DOI 10.1016/j.plipres.2011.12.005; VALENZENO DP, 1982, PHOTOCHEM PHOTOBIOL, V35, P343; Vatansever F, 2013, FEMS MICROBIOL REV, V37, P955, DOI 10.1111/1574-6976.12026; Vera DM, 2012, PHOTOCHEM PHOTOBIOL; Virtanen JA, 1998, P NATL ACAD SCI USA, V95, P4964, DOI 10.1073/pnas.95.9.4964; Wainwright M, 2000, INT J ANTIMICROB AG, V16, P381, DOI 10.1016/S0924-8579(00)00207-7; Wainwright M, 1998, J ANTIMICROB CHEMOTH, V42, P13, DOI 10.1093/jac/42.1.13; Wainwright M, 2011, J PHOTOCH PHOTOBIO B, V105, P1, DOI 10.1016/j.jphotobiol.2011.06.002; Ward SK, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00063; WHITE DC, 1968, J BACTERIOL, V95, P2198, DOI 10.1128/JB.95.6.2198-2209.1968; Wimley WC, 2011, J MEMBRANE BIOL, V239, P27, DOI 10.1007/s00232-011-9343-0; Wu JS, 2013, ULTRAMICROSCOPY, V128, P24, DOI 10.1016/j.ultramic.2013.01.004; Yamakoshi Y, 2003, J AM CHEM SOC, V125, P12803, DOI 10.1021/ja0355574	85	34	34	1	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91220	10.1371/journal.pone.0091220	http://dx.doi.org/10.1371/journal.pone.0091220			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608860	Green Published, Green Submitted, gold			2022-12-27	WOS:000332485800116
J	Labruijere, S; Stolk, L; Verbiest, M; de Vries, R; Garrelds, IM; Eilers, PHC; Danser, AHJ; Uitterlinden, AG; MaassenVanDenBrink, A				Labruijere, Sieneke; Stolk, Lisette; Verbiest, Michael; de Vries, Rene; Garrelds, Ingrid M.; Eilers, Paul H. C.; Danser, A. H. Jan; Uitterlinden, Andre G.; MaassenVanDenBrink, Antoinette			Methylation of Migraine-Related Genes in Different Tissues of the Rat	PLOS ONE			English	Article							SPINAL TRIGEMINAL NUCLEUS; DNA METHYLATION; EPIGENETIC REGULATION; ESTROGEN-RECEPTOR; SEX-HORMONES; CGRP; EXPRESSION; HEADACHE; MODULATION; CELLS	17 beta-Estradiol, an epigenetic modulator, is involved in the increased prevalence of migraine in women. Together with the prophylactic efficacy of valproate, which influences DNA methylation and histone modification, this points to the involvement of epigenetic mechanisms. Epigenetic studies are often performed on leukocytes, but it is unclear to what extent methylation is similar in other tissues. Therefore, we investigated methylation of migraine-related genes that might be epigenetically regulated (CGRP-ergic pathway, estrogen receptors, endothelial NOS, as well as MTHFR) in different migraine-related tissues and compared this to methylation in rat as well as human leukocytes. Further, we studied whether 17 beta-estradiol has a prominent role in methylation of these genes. Female rats (n = 35) were ovariectomized or sham-operated and treated with 17 beta-estradiol or placebo. DNA was isolated and methylation was assessed through bisulphite treatment and mass spectrometry. Human methylation data were obtained using the Illumina 450k genome-wide methylation array in 395 female subjects from a population-based cohort study. We showed that methylation of the Crcp, Calcrl, Esr1 and Nos3 genes is tissue-specific and that methylation in leukocytes was not correlated to that in other tissues. Interestingly, the interindividual variation in methylation differed considerably between genes and tissues. Furthermore we showed that methylation in human leukocytes was similar to that in rat leukocytes in our genes of interest, suggesting that rat may be a good model to study human DNA methylation in tissues that are difficult to obtain. In none of the genes a significant effect of estradiol treatment was observed.	[Labruijere, Sieneke; de Vries, Rene; Garrelds, Ingrid M.; Danser, A. H. Jan; MaassenVanDenBrink, Antoinette] Erasmus MC, Div Pharmacol, Dept Internal Med, Rotterdam, Netherlands; [Stolk, Lisette; Verbiest, Michael; Uitterlinden, Andre G.] Erasmus MC, Genet Lab, Dept Internal Med, Rotterdam, Netherlands; [Eilers, Paul H. C.] Erasmus MC, Dept Biostat, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	MaassenVanDenBrink, A (corresponding author), Erasmus MC, Div Pharmacol, Dept Internal Med, Rotterdam, Netherlands.	a.vanharen-maassenvandenbrink@erasmusmc.nl	Danser, Jan/GLR-1479-2022	Maassen van den Brink, Antoinette/0000-0001-7176-126X	Netherlands Organisation of Scientific Research NWO [175.010.2005.011, 911-03-012]; Netherlands Genomics Initiative (NGI)/NWO [050-060-810]; Erasmus Medical Center, Rotterdam; Erasmus University, Rotterdam; Research Institute for Diseases in the Elderly (RIDE); Ministry of Education, Culture and Science; Ministry for Health, Welfare and Sports; European Commission (DG XII); Municipality of Rotterdam; Netherlands Organization for Scientific Research (Vidi) [917-11-349]; Netherlands Organisation for the Health Research and development (ZonMw)	Netherlands Organisation of Scientific Research NWO(Netherlands Organization for Scientific Research (NWO)); Netherlands Genomics Initiative (NGI)/NWO(Netherlands Organization for Scientific Research (NWO)); Erasmus Medical Center, Rotterdam; Erasmus University, Rotterdam; Research Institute for Diseases in the Elderly (RIDE); Ministry of Education, Culture and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry for Health, Welfare and Sports; European Commission (DG XII)(European CommissionEuropean Commission Joint Research Centre); Municipality of Rotterdam; Netherlands Organization for Scientific Research (Vidi)(Netherlands Organization for Scientific Research (NWO)); Netherlands Organisation for the Health Research and development (ZonMw)	The generation and management of genomics data for the Rotterdam Study is supported by the Netherlands Organisation of Scientific Research NWO investments (nr. 175.010.2005.011, 911-03-012) and the Netherlands Genomics Initiative (NGI)/NWO project nr. 050-060-810 (Netherlands Consortium for Healthy Aging; NCHA). The Rotterdam Study is funded by the Erasmus Medical Center and Erasmus University, Rotterdam, Netherlands Organisation for the Health Research and development (ZonMw), the Research Institute for Diseases in the Elderly (RIDE), the Ministry of Education, Culture and Science, the Ministry for Health, Welfare and Sports, the European Commission (DG XII) and the Municipality of Rotterdam. Dr. Antoinette MaassenVanDenBrink was supported by the Netherlands Organization for Scientific Research (Vidi grant 917-11-349). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranyi T, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-431; Bailey KA, 2013, J BIOCHEM MOL TOXIC, V27, P106, DOI 10.1002/jbt.21462; Bergman Y, 2013, NAT STRUCT MOL BIOL, V20, P274, DOI 10.1038/nsmb.2518; Bijron Jonathan G, 2012, Expert Opin Med Diagn, V6, P421, DOI 10.1517/17530059.2012.702105; Brailoiu E, 2007, J ENDOCRINOL, V193, P311, DOI 10.1677/JOE-07-0017; Brooks JTS, 2009, J APPL PHYSIOL, V106, P212, DOI 10.1152/japplphysiol.90578.2008; Byun HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039220; CARL GF, 1986, NEUROCHEM RES, V11, P671, DOI 10.1007/BF00965336; Chen CCM, 2009, HUM GENET, V125, P591, DOI 10.1007/s00439-009-0652-7; Crescenti A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065744; Doshi T, 2011, TOXICOLOGY, V289, P74, DOI 10.1016/j.tox.2011.07.011; Dumeaux V, 2006, MOL CANCER THER, V5, P868, DOI 10.1158/1535-7163.MCT-05-0329; Durham P, 2013, HEADACHE, V53, P1262, DOI 10.1111/head.12174; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Edvinsson L, 2011, MOL CELL NEUROSCI, V46, P333, DOI 10.1016/j.mcn.2010.10.005; Eftekhari S, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-112; Eftekhari Sajedeh, 2010, Ther Adv Neurol Disord, V3, P369, DOI 10.1177/1756285610388343; Eising E, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-26; Fehrenbacher JC, 2009, BRAIN RES REV, V60, P114, DOI 10.1016/j.brainresrev.2008.12.019; FINKELSTEIN JD, 1978, ARCH BIOCHEM BIOPHYS, V191, P153, DOI 10.1016/0003-9861(78)90077-2; Gentilini D, 2013, AGE, V35, P1961, DOI 10.1007/s11357-012-9463-1; Goadsby PJ, 2002, NEW ENGL J MED, V346, P257, DOI 10.1056/NEJMra010917; Green CD, 2011, EPIGENOMICS-UK, V3, P59, DOI 10.2217/EPI.10.75; Guo SW, 2012, MOL CELL ENDOCRINOL, V358, P185, DOI 10.1016/j.mce.2011.10.025; Gupta S, 2007, HEADACHE, V47, P225, DOI 10.1111/j.1526-4610.2006.00526.x; Ho TW, 2010, NAT REV NEUROL, V6, P573, DOI 10.1038/nrneurol.2010.127; Hofman A, 2011, EUR J EPIDEMIOL, V26, P657, DOI 10.1007/s10654-011-9610-5; Imamura T, 2011, HORM BEHAV, V59, P345, DOI 10.1016/j.yhbeh.2010.05.018; Jenkins NT, 2011, J APPL PHYSIOL, V111, P929, DOI 10.1152/japplphysiol.00541.2011; Jiao J, 2013, MOL PSYCHIATR, V18, P1273, DOI 10.1038/mp.2012.136; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kolodkin MH, 2011, J NEUROENDOCRINOL, V23, P577, DOI 10.1111/j.1365-2826.2011.02147.x; Kvisvik EV, 2011, J HEADACHE PAIN, V12, P443, DOI 10.1007/s10194-011-0329-1; LAMSON G, 1989, DEV BIOL, V132, P62, DOI 10.1016/0012-1606(89)90204-2; Lenz KM, 2013, J NEUROSCI, V33, P2761, DOI 10.1523/JNEUROSCI.1268-12.2013; Li D, 2008, PEPTIDES, V29, P1781, DOI 10.1016/j.peptides.2008.06.010; Lindsey SH, 2009, ENDOCRINOLOGY, V150, P3753, DOI 10.1210/en.2008-1664; Manev H, 2002, EUR J PHARMACOL, V445, P149, DOI 10.1016/S0014-2999(02)01711-9; Mathers JC, 2006, MECH AGEING DEV, V127, P584, DOI 10.1016/j.mad.2006.01.018; McHale CM, 2009, GENOMICS, V93, P343, DOI 10.1016/j.ygeno.2008.12.006; Momparler RL, 2000, J CELL PHYSIOL, V183, P145, DOI 10.1002/(SICI)1097-4652(200005)183:2<145::AID-JCP1>3.0.CO;2-V; Moussaoui S, 1996, NEUROPEPTIDES, V30, P546, DOI 10.1016/S0143-4179(96)90037-2; Novensa L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025335; Nyholt DR, 2004, GENET EPIDEMIOL, V26, P231, DOI 10.1002/gepi.10311; Oterino A, 2010, HEADACHE, V50, P99, DOI 10.1111/j.1526-4610.2009.01484.x; Pardutz A, 2002, EUR J NEUROSCI, V15, P1803, DOI 10.1046/j.1460-9568.2002.02031.x; Park KY, 2008, J BIOL CHEM, V283, P5441, DOI 10.1074/jbc.M708662200; Park KY, 2011, CEPHALALGIA, V31, P614, DOI 10.1177/0333102410391487; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; RCORE TEAM, 2012, R LANG ENV STAT COMP; Scariano JK, 2008, J RECEPT SIG TRANSD, V28, P285, DOI [10.1080/10799890802084614, 10.1080/10799890802084614 ]; Schurks M, 2010, HEADACHE, V50, P588, DOI 10.1111/j.1526-4610.2009.01570.x; Silberstein S, 1999, NEUROLOGY, V53, pS3; Soubry A, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-29; Stovner LJ, 2007, CEPHALALGIA, V27, P193, DOI 10.1111/j.1468-2982.2007.01288.x; Stovner LJ, 2010, J HEADACHE PAIN, V11, P289, DOI 10.1007/s10194-010-0217-0; Summers T, 2013, J CANCER, V4, P210, DOI 10.7150/jca.5839; Terry MB, 2011, EPIGENETICS-US, V6, P828, DOI 10.4161/epi.6.7.16500; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Wessman M, 2007, LANCET NEUROL, V6, P521, DOI 10.1016/S1474-4422(07)70126-6; Zhang B, 2013, GENOME RES, V23, P1522, DOI 10.1101/gr.156539.113; Zhang Y, 2013, NEUROPSYCHOPHARMACOL, V38, P111, DOI 10.1038/npp.2012.149; Zhao ZR, 2010, P NATL ACAD SCI USA, V107, P5605, DOI 10.1073/pnas.0910578107	63	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e87616	10.1371/journal.pone.0087616	http://dx.doi.org/10.1371/journal.pone.0087616			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24609082	Green Published, gold, Green Submitted			2022-12-27	WOS:000332485800001
J	Nodale, C; Ceccarelli, S; Giuliano, M; Cammarota, M; D'Amici, S; Vescarelli, E; Maffucci, D; Bellati, F; Panici, PB; Romano, F; Angeloni, A; Marchese, C				Nodale, Cristina; Ceccarelli, Simona; Giuliano, Mariateresa; Cammarota, Marcella; D'Amici, Sirio; Vescarelli, Enrica; Maffucci, Diana; Bellati, Filippo; Panici, Pierluigi Benedetti; Romano, Ferdinando; Angeloni, Antonio; Marchese, Cinzia			Gene Expression Profile of Patients with Mayer-Rokitansky-Kuster-Hauser Syndrome: New Insights into the Potential Role of Developmental Pathways	PLOS ONE			English	Article							BETA-CATENIN; MURCS ASSOCIATION; COLORECTAL-CANCER; ALAGILLE-SYNDROME; HUMAN JAGGED1; MUTATIONS; WNT; APLASIA; VAGINA; NOTCH1	Mayer-Rokitansky-Kuster-Hauser syndrome (MRKHS) is a rare disease characterized by congenital aplasia of uterus and vagina. Although many studies have investigated several candidate genes, up to now none of them seem to be responsible for the aetiology of the syndrome. In our study, we identified differences in gene expression profile of in vitro cultured vaginal tissue of MRHKS patients using whole-genome microarray analysis. A group of eight out of sixteen MRKHS patients that underwent reconstruction of neovagina with an autologous in vitro cultured vaginal tissue were subjected to microarray analysis and compared with five healthy controls. Results obtained by array were confirmed by qRT-PCR and further extended to other eight MRKHS patients. Gene profiling of MRKHS patients delineated 275 differentially expressed genes, of which 133 downregulated and 142 upregulated. We selected six deregulated genes (MUC1, HOXC8, HOXB2, HOXB5, JAG1 and DLL1) on the basis of their fold change, their differential expression in most patients and their relevant role in embryological development. All patients showed upregulation of MUC1, while HOXB2 and HOXB5 were downregulated, as well as Notch ligands JAG1 and DLL1 in the majority of them. Interestingly, HOXC8 was significantly upregulated in 47% of patients, with a differential expression only in MRKHS type I patients. Taken together, our results highlighted the dysregulation of developmental genes, thus suggesting a potential alteration of networks involved in the formation of the female reproductive tract and providing a useful clue for understanding the pathophysiology of MRKHS.	[Nodale, Cristina; Ceccarelli, Simona; D'Amici, Sirio; Vescarelli, Enrica; Marchese, Cinzia] Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy; [Giuliano, Mariateresa; Cammarota, Marcella] Univ Naples 2, Biotechnol & Mol Biol Sect, Dept Expt Med, Naples, Italy; [Maffucci, Diana; Bellati, Filippo; Panici, Pierluigi Benedetti] Univ Roma La Sapienza, Dept Gynecol Obstetr & Urol Sci, I-00185 Rome, Italy; [Romano, Ferdinando] Univ Roma La Sapienza, Dept Publ Hlth & Infect Dis, I-00185 Rome, Italy; [Angeloni, Antonio] Univ Roma La Sapienza, Dept Mol Med, I-00185 Rome, Italy	Sapienza University Rome; Universita della Campania Vanvitelli; Sapienza University Rome; Sapienza University Rome; Sapienza University Rome	Marchese, C (corresponding author), Univ Roma La Sapienza, Dept Expt Med, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	cinzia.marchese@uniroma1.it	Angeloni, Antonio/J-9392-2018; Marchese, Cinzia/J-1323-2018; Ceccarelli, Simona/J-4086-2018	Angeloni, Antonio/0000-0003-4969-9548; Ceccarelli, Simona/0000-0001-8789-7719; BENEDETTI PANICI, PIERLUIGI/0000-0001-6752-2039; Bellati, Filippo/0000-0002-2036-9951; Giuliano, Mariateresa/0000-0002-7338-9200; Cammarota, Marcella/0000-0002-6317-5436				Allard S, 2000, DEVELOPMENT, V127, P3349; BAIRD PA, 1974, AM J OBSTET GYNECOL, V118, P290, DOI 10.1016/0002-9378(74)90565-1; Bernardini L, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-25; Biason-Lauber A, 2007, HUM REPROD, V22, P224, DOI 10.1093/humrep/del360; Bulman MP, 2000, NAT GENET, V24, P438, DOI 10.1038/74307; Burell A, 2006, J NEGAT RESULTS BIOM, V5, DOI 10.1186/1477-5751-5-4; Chang XY, 2012, REPROD BIOMED ONLINE, V24, P630, DOI 10.1016/j.rbmo.2012.03.008; Contakos SP, 2005, DEV BIOL, V288, P294, DOI 10.1016/j.ydbio.2005.09.015; DUNCAN PA, 1979, J PEDIATR-US, V95, P399, DOI 10.1016/S0022-3476(79)80514-4; Duru Ugonna A, 2009, J Pediatr Adolesc Gynecol, V22, pe73, DOI 10.1016/j.jpag.2008.07.012; Gervasini C, 2010, GENET MED, V12, P634, DOI 10.1097/GIM.0b013e3181ed6185; GRIFFIN JE, 1976, ANN INTERN MED, V85, P224, DOI 10.7326/0003-4819-85-2-224; Hofstetter G, 2008, WIEN KLIN WOCHENSCHR, V120, P435, DOI 10.1007/s00508-008-0995-4; Hossain A, 2003, J BIOL CHEM, V278, P26511, DOI 10.1074/jbc.M300804200; Huang L, 2005, CANCER RES, V65, P10413, DOI 10.1158/0008-5472.CAN-05-2474; Huang L, 2003, CANCER BIOL THER, V2, P702; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Juan AH, 2006, ANN NY ACAD SCI, V1068, P87, DOI 10.1196/annals.1346.046; Kim HA, 2012, J CLIN INVEST, V122, P3248, DOI 10.1172/JCI61216; Kimberley N, 2012, J PEDIATR ADOL GYNEC, V25, P54, DOI 10.1016/j.jpag.2011.08.003; Kwon YJ, 2005, ANAT REC PART A, V283A, P187, DOI 10.1002/ar.a.20160; Ledig S, 2011, FERTIL STERIL, V95, P1589, DOI 10.1016/j.fertnstert.2010.07.1062; Li LH, 1997, NAT GENET, V16, P243, DOI 10.1038/ng0797-243; Masse J, 2009, INT J DEV BIOL, V53, P411, DOI 10.1387/ijdb.082680jm; Morcel K, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-9; Nakamura T, 2007, J GASTROENTEROL, V42, P705, DOI 10.1007/s00535-007-2087-z; Oda T, 1997, NAT GENET, V16, P235, DOI 10.1038/ng0797-235; Oppelt P, 2005, HUM REPROD, V20, P149, DOI 10.1093/humrep/deh547; Pavlidis P, 2003, BIOINFORMATICS, V19, P295, DOI 10.1093/bioinformatics/19.2.295; Rall K, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-32; Ravel C, 2009, FERTIL STERIL, V91, P1604, DOI 10.1016/j.fertnstert.2008.12.006; Rodilla V, 2009, P NATL ACAD SCI USA, V106, P6315, DOI 10.1073/pnas.0813221106; SCHMIDTANNWALD I, 1977, GEBURTSH FRAUENHEILK, V37, P386; Tracy MR, 2004, CLIN ORTHOP RELAT R, P183, DOI 10.1097/01.blo.0000132067.49895.20; Turner KJ, 2003, TOXICOL SCI, V74, P114, DOI 10.1093/toxsci/kfg096	35	18	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91010	10.1371/journal.pone.0091010	http://dx.doi.org/10.1371/journal.pone.0091010			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608967	Green Submitted, Green Published, gold			2022-12-27	WOS:000332485800080
J	Sullivan, PS; Peterson, J; Rosenberg, ES; Kelley, CF; Cooper, H; Vaughan, A; Salazar, LF; Frew, P; Wingood, G; DiClemente, R; del Rio, C; Mulligan, M; Sanchez, TH				Sullivan, Patrick S.; Peterson, John; Rosenberg, Eli S.; Kelley, Colleen F.; Cooper, Hannah; Vaughan, Adam; Salazar, Laura F.; Frew, Paula; Wingood, Gina; DiClemente, Ralph; del Rio, Carlos; Mulligan, Mark; Sanchez, Travis H.			Understanding Racial HIV/STI Disparities in Black and White Men Who Have Sex with Men: A Multilevel Approach	PLOS ONE			English	Article							HIV-INFECTION; RISK; SURVEILLANCE; PARTNERS; MSM	Background: The reasons for black/white disparities in HIV epidemics among men who have sex with men have puzzled researchers for decades. Understanding reasons for these disparities requires looking beyond individual-level behavioral risk to a more comprehensive framework. Methods and Findings: From July 2010-Decemeber 2012, 803 men (454 black, 349 white) were recruited through venue-based and online sampling; consenting men were provided HIV and STI testing, completed a behavioral survey and a sex partner inventory, and provided place of residence for geocoding. HIV prevalence was higher among black (43%) versus white (13% MSM (prevalence ratio (PR) 3.3, 95% confidence interval (CI): 2.5-4.4). Among HIV-positive men, the median CD4 count was significantly lower for black (490 cells/mu L) than white (577 cells/mu L) MSM; there was no difference in the HIV RNA viral load by race. Black men were younger, more likely to be bisexual and unemployed, had less educational attainment, and reported fewer male sex partners, fewer unprotected anal sex partners, and less non-injection drug use. Black MSM were significantly more likely than white MSM to have rectal chlamydia and gonorrhea, were more likely to have racially concordant partnerships, more likely to have casual (one-time) partners, and less likely to discuss serostatus with partners. The census tracts where black MSM lived had higher rates of poverty and unemployment, and lower median income. They also had lower proportions of male-male households, lower male to female sex ratios, and lower HIV diagnosis rates. Conclusions: Among black and white MSM in Atlanta, disparities in HIV and STI prevalence by race are comparable to those observed nationally. We identified differences between black and white MSM at the individual, dyadic/sexual network, and community levels. The reasons for black/white disparities in HIV prevalence in Atlanta are complex, and will likely require a multilevel framework to understand comprehensively.	[Sullivan, Patrick S.; Rosenberg, Eli S.; Vaughan, Adam; Sanchez, Travis H.] Emory Univ, Dept Epidemiol, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Peterson, John] Georgia State Univ, Dept Psychol, Atlanta, GA 30303 USA; [Kelley, Colleen F.; Frew, Paula; Mulligan, Mark] Emory Univ, Sch Med, Dept Infect Dis, Atlanta, GA USA; [Cooper, Hannah; Wingood, Gina; DiClemente, Ralph] Emory Univ, Dept Behav Sci & Hlth Educ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Salazar, Laura F.] Georgia State Univ, Inst Publ Hlth, Atlanta, GA 30303 USA; [del Rio, Carlos] Emory Univ, Hubert Dept Global Hlth, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA	Emory University; Rollins School Public Health; University System of Georgia; Georgia State University; Emory University; Emory University; Rollins School Public Health; University System of Georgia; Georgia State University; Emory University; Rollins School Public Health	Sullivan, PS (corresponding author), Emory Univ, Dept Epidemiol, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA.	pssulli@emory.edu	Frew, Paula M./B-4774-2012; Kelley, Colleen F/O-4819-2016; del Rio, Carlos/B-3763-2012; Mulligan, Mark/V-9275-2019	Frew, Paula M./0000-0002-3078-9124; Kelley, Colleen F/0000-0001-5611-0119; del Rio, Carlos/0000-0002-0153-3517; sanchez, travis/0000-0003-1133-4762; Sullivan, Patrick Sean/0000-0002-7728-0587	National Institute of Mental Health [R01MH085600]; National Institute of Minority Health and Health Disparities [RC1MD004370]; Eunice Kennedy Shriver National Institute for Child Health and Human Development [R01HD067111]; National Institute of Drug Abuse [R01DA029513]; National Institute of Allergy and Infectious Diseases, Emory Center for AIDS Research [P30AI050409]; National Center for Advancing Translational Sciences of the National Institutes of Health [UL1TR000454]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD067111] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES [RC1MD004370] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI108335, P30AI050409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085600] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA029513] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); Eunice Kennedy Shriver National Institute for Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institute of Allergy and Infectious Diseases, Emory Center for AIDS Research; National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding was provided by the National Institute of Mental Health (R01MH085600), National Institute of Minority Health and Health Disparities (RC1MD004370), Eunice Kennedy Shriver National Institute for Child Health and Human Development (R01HD067111), National Institute of Drug Abuse (R01DA029513), National Institute of Allergy and Infectious Diseases (P30AI050409)-Emory Center for AIDS Research, and the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number UL1TR000454. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], SEX TRANSM DIS SURV; [Anonymous], 4 CDCP; [Anonymous], 60 ONLINE ADULTS USE; [Anonymous], J ACQUIRED IMMUNE DE; [Anonymous], HIV GAY BIS MEN; [Anonymous], SEX TECH; [Anonymous], HIV TEST ALG STAT RE; [Anonymous], 14 INT AIDS C BARC S; [Anonymous], GEORG HIV SURV DAT D; [Anonymous], UNEQUAL OPPORTUNITY; [Anonymous], J URBAN HLTH; [Anonymous], GEORG STD EP 2012 ST; [Anonymous], AIDS BEHAV; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; BRONFENBRENNER U, 1994, PSYCHOL REV, V101, P568, DOI 10.1037/0033-295X.101.4.568; Caliendo A M, 2005, Infect Dis Obstet Gynecol, V13, P145, DOI 10.1080/10647440500068248; Centers for Disease Control and Prevention, 2011, HIV SURV REP, V23; Chan ISF, 1999, BIOMETRICS, V55, P1202, DOI 10.1111/j.0006-341X.1999.01202.x; Crucitti T, 2011, CLIN VACCINE IMMUNOL, V18, P1480, DOI 10.1128/CVI.05069-11; Goodreau SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050522; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Kelley CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053284; Kennedy BP, 1998, BRIT MED J, V317, P917; Koblin BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070413; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; MacKellar DA, 2007, PUBLIC HEALTH REP, V122, P39, DOI 10.1177/00333549071220S107; Millett GA, 2007, AIDS, V21, P2083, DOI 10.1097/QAD.0b013e3282e9a64b; Millett GA, 2006, AM J PUBLIC HEALTH, V96, P1007, DOI 10.2105/AJPH.2005.066720; Millett GA, 2012, LANCET, V380, P341, DOI 10.1016/S0140-6736(12)60899-X; Morris M, 2004, NETWORK EPIDEMIOLOGY; Oster AM, 2011, AIDS, V25, P1103, DOI 10.1097/QAD.0b013e3283471efa; PORTNOY J, 1957, PUBLIC HEALTH REP, V72, P761, DOI 10.2307/4589890; Prejean J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017502; Purcell David W, 2012, Open AIDS J, V6, P98, DOI 10.2174/1874613601206010098; Raymond HF, 2009, AIDS BEHAV, V13, P630, DOI 10.1007/s10461-009-9574-6; Rosenberg ES, 2012, SEX TRANSM DIS, V39, P741, DOI 10.1097/OLQ.0b013e31825ec09b; Rosenberg ES, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-189; SACKETT DL, 1979, J CHRON DIS, V32, P51, DOI 10.1016/0021-9681(79)90012-2; Sanchez Travis, 2006, Morbidity and Mortality Weekly Report, V55, P1; Smith A., 2010, Morbidity and Mortality Weekly Report, V59, P1201; Su JR, 2011, ANN INTERN MED, V155, P145, DOI 10.7326/0003-4819-155-3-201108020-00004; Sullivan PS, 2009, AIDS, V23, P1153, DOI 10.1097/QAD.0b013e32832baa34; van der Pol B, 2001, J CLIN MICROBIOL, V39, P1008, DOI 10.1128/JCM.39.3.1008-1016.2001; Winter AK, 2012, JAIDS-J ACQ IMM DEF, V60, P525, DOI 10.1097/QAI.0b013e318257d0ac	44	152	152	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90514	10.1371/journal.pone.0090514	http://dx.doi.org/10.1371/journal.pone.0090514			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC4IY	24608176	Green Published, gold, Green Submitted			2022-12-27	WOS:000332485800029
J	Thomson, IR; Darveau, CA; Bertram, SM				Thomson, Ian R.; Darveau, Charles-A.; Bertram, Susan M.			Body Morphology, Energy Stores, and Muscle Enzyme Activity Explain Cricket Acoustic Mate Attraction Signaling Variation	PLOS ONE			English	Article							CONDITION-DEPENDENT TRAITS; FEMALE FIELD CRICKETS; FLIGHT MUSCLES; CALLING SONG; INTRASPECIFIC VARIATION; GRYLLUS-BIMACULATUS; METABOLIC-RATE; INSECT FLIGHT; BOMBUS-IMPATIENS; ACHETA-DOMESTICA	High mating success in animals is often dependent on males signalling attractively with high effort. Since males should be selected to maximize their reproductive success, female preferences for these traits should result in minimal signal variation persisting in the population. However, extensive signal variation persists. The genic capture hypothesis proposes genetic variation persists because fitness-conferring traits depend on an individual's basic processes, including underlying physiological, morphological, and biochemical traits, which are themselves genetically variable. To explore the traits underlying signal variation, we quantified among-male differences in signalling, morphology, energy stores, and the activities of key enzymes associated with signalling muscle metabolism in two species of crickets, Gryllus assimilis (chirper: <20 pulses/chirp) and G. texensis (triller: >20 pulses/chirp). Chirping G. assimilis primarily fuelled signalling with carbohydrate metabolism: smaller individuals and individuals with increased thoracic glycogen stores signalled for mates with greater effort; individuals with greater glycogen phosphorylase activity produced more attractive mating signals. Conversely, the more energetic trilling G. texensis fuelled signalling with both lipid and carbohydrate metabolism: individuals with increased beta-hydroxyacyl-CoA dehydrogenase activity and increased thoracic free carbohydrate content signalled for mates with greater effort; individuals with higher thoracic and abdominal carbohydrate content and higher abdominal lipid stores produced more attractive signals. Our findings suggest variation in male reproductive success may be driven by hidden physiological trade-offs that affect the ability to uptake, retain, and use essential nutrients, although the results remain correlational in nature. Our findings indicate that a physiological perspective may help us to understand some of the causes of variation in behaviour.	[Thomson, Ian R.; Bertram, Susan M.] Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada; [Darveau, Charles-A.] Univ Ottawa, Dept Biol, Ottawa, ON K1N 6N5, Canada	Carleton University; University of Ottawa	Bertram, SM (corresponding author), Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada.	Sue.Bertram@carleton.ca			Natural Sciences and Engineering Research Council (NSERC) of Canada; Canada Foundation for Innovation; Infrastructure Operating Fund	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Infrastructure Operating Fund	This research was supported by individual Discovery Grants from the Natural Sciences and Engineering Research Council (NSERC) of Canada and equipment grants from Canada Foundation for Innovation and Infrastructure Operating Fund to SMB and CAD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER RD, 1962, EVOLUTION, V16, P443, DOI 10.1111/j.1558-5646.1962.tb03236.x; Alexander RD, 1957, ANN ENTOMOL SOC AM, V50, P585; BEENAKKE.AM, 1969, J INSECT PHYSIOL, V15, P353, DOI 10.1016/0022-1910(69)90281-9; BEENAKKERS AMT, 1984, INSECT BIOCHEM, V14, P243, DOI 10.1016/0020-1790(84)90057-X; Benjamini Y, 2001, ANN STAT, V29, P1165; Bertram SM, 2011, ANIM BEHAV, V82, P1255, DOI 10.1016/j.anbehav.2011.08.021; Bertram SM, 2000, ANIM BEHAV, V60, P333, DOI 10.1006/anbe.2000.1473; Bertram SM, 2005, ANIM BEHAV, V70, P477, DOI 10.1016/j.anbehav.2004.09.024; Bertram SM, 2007, EVOL ECOL RES, V9, P975; Bertram SM, 2006, ANIM BEHAV, V72, P899, DOI 10.1016/j.anbehav.2006.02.012; Bertram SM, 2012, ECOL EVOL, V2, P181, DOI 10.1002/ece3.76; CADE W, 1975, SCIENCE, V190, P1312, DOI 10.1126/science.190.4221.1312; Cade W, 1979, SEXUAL SELECTION REP, P343; CADE WH, 1992, ANIM BEHAV, V43, P49, DOI 10.1016/S0003-3472(05)80070-3; CADE WH, 1991, J INSECT BEHAV, V4, P185, DOI 10.1007/BF01054611; CADE WH, 1981, SCIENCE, V212, P563, DOI 10.1126/science.212.4494.563; Candy DJ, 1997, COMP BIOCHEM PHYS B, V117, P497, DOI 10.1016/S0305-0491(97)00212-5; CHUDAKOV.IV, 1968, DOKL AKAD NAUK SSSR+, V179, P489; Crnokrak P, 1995, ANIM BEHAV, V50, P1475, DOI 10.1016/0003-3472(95)80004-2; Darveau C-A, 2013, J EXP BIOL IN PRESS; Fisher RA, 1930, GENETICAL THEORY NAT; Garcia-Berthou E, 2001, J ANIM ECOL, V70, P708, DOI 10.1046/j.1365-2656.2001.00524.x; GOULD SJ, 1975, CONTRIB PRIMATOL, V5, P244; Harper G, 2000, J ANIM SCI, V13, P318; Harrison S, 2013, ECOL LETT UNPUB; HEDRICK AV, 1988, AM NAT, V132, P267, DOI 10.1086/284849; Hill GE, 2011, ECOL LETT, V14, P625, DOI 10.1111/j.1461-0248.2011.01622.x; Holzer B, 2003, BEHAV ECOL, V14, P353, DOI 10.1093/beheco/14.3.353; HOULE D, 1992, GENETICS, V130, P195; Hunt J, 2004, NATURE, V432, P1024, DOI 10.1038/nature03084; Judge KA, 2008, EVOLUTION, V62, P868, DOI 10.1111/j.1558-5646.2008.00318.x; Kaufmann C, 2008, J INSECT PHYSIOL, V54, P367, DOI 10.1016/j.jinsphys.2007.10.007; Kotiaho JS, 1999, OIKOS, V87, P399, DOI 10.2307/3546755; Lorenz MW, 2003, COMP BIOCHEM PHYS B, V136, P197, DOI 10.1016/S1096-4959(03)00227-6; Maklakov AA, 2008, CURR BIOL, V18, P1062, DOI 10.1016/j.cub.2008.06.059; Martin SD, 2000, CAN J ZOOL, V78, P706, DOI 10.1139/cjz-78-5-706; Miyoshi AR, 2007, IHERINGIA SER ZOOL, V97, P461, DOI 10.1590/S0073-47212007000400016; Norin T, 2012, PHYSIOL BIOCHEM ZOOL, V85, P645, DOI 10.1086/665982; Norin T, 2011, J EXP BIOL, V214, P1668, DOI 10.1242/jeb.054205; O'Brien DM, 2001, J EXP ZOOL, V290, P108, DOI 10.1002/jez.1040; Popov A, 1977, J COMP PHYSIOL A, V126, P111; PRESTWICH KN, 1994, AM ZOOL, V34, P625, DOI 10.1093/icb/34.6.625; Roff DA, 2003, J EVOLUTION BIOL, V16, P55, DOI 10.1046/j.1420-9101.2003.00480.x; Roff DA, 1999, EVOLUTION, V53, P216, DOI 10.1111/j.1558-5646.1999.tb05347.x; Rowe L, 1996, P ROY SOC B-BIOL SCI, V263, P1415, DOI 10.1098/rspb.1996.0207; SHIGA S, 1991, J EXP BIOL, V155, P661; SIMMONS LW, 1988, ANIM BEHAV, V36, P380, DOI 10.1016/S0003-3472(88)80009-5; SIMONEAU JA, 1986, CLIN PHYSIOL, V6, P347, DOI 10.1111/j.1475-097X.1986.tb00240.x; Skandalis DA, 2012, PHYSIOL BIOCHEM ZOOL, V85, P657, DOI 10.1086/665568; Skandalis DA, 2011, J INSECT PHYSIOL, V57, P704, DOI 10.1016/j.jinsphys.2011.02.001; SRIHARI T, 1975, J INSECT PHYSIOL, V21, P1, DOI 10.1016/0022-1910(75)90062-1; Suarez RK, 2005, J EXP BIOL, V208, P3573, DOI 10.1242/jeb.01775; Tomkins JL, 2002, ANIM BEHAV, V63, P1009, DOI 10.1006/anbe.2001.1994; Tomkins JL, 2004, TRENDS ECOL EVOL, V19, P323, DOI 10.1016/j.tree.2004.03.029; Wagner WE, 1996, BEHAV ECOL, V7, P279, DOI 10.1093/beheco/7.3.279; WAGNER WE, 1995, ANIM BEHAV, V49, P1269, DOI 10.1006/anbe.1995.0159; WALKER THOMAS J., 1957, ANN ENT SOC AMER, V50, P626; WALKER TJ, 1962, EVOLUTION, V16, P407, DOI 10.2307/2406176; Whattam EM, 2011, ANIM BEHAV, V81, P135, DOI 10.1016/j.anbehav.2010.09.024; Winchell R, 2000, J INSECT PHYSIOL, V46, P1365, DOI 10.1016/S0022-1910(00)00055-X; Zera AJ, 1999, J INSECT PHYSIOL, V45, P275, DOI 10.1016/S0022-1910(98)00123-1; Zera AJ, 1997, PHYSIOL ZOOL, V70, P519, DOI 10.1086/515865	62	17	17	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90409	10.1371/journal.pone.0090409	http://dx.doi.org/10.1371/journal.pone.0090409			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608102	gold, Green Submitted, Green Published			2022-12-27	WOS:000332485800025
J	Ahmed, SM; Hossain, MS; Kabir, M				Ahmed, Syed Masud; Hossain, Mohammad Shamim; Kabir, Moktadir			Conventional or Interpersonal Communication: Which Works Best in Disseminating Malaria Information in an Endemic Rural Bangladeshi Community?	PLOS ONE			English	Article							PREGNANT-WOMEN; KNOWLEDGE; PREVENTION; INTERVENTIONS; BEHAVIOR; NETS	Background: Since 2007, BRAC has been implementing malaria prevention and control programme in 13 endemic districts of Bangladesh under the National Malaria Control Programme. This study was done to examine the role of different communication media in bringing about changes in knowledge and awareness which facilitate informed decision-making for managing malaria-like illnesses. Methods: A baseline survey in 2007 before inception of the programme, and a follow-up survey in 2012 were done to study changes in different aspects of programme interventions including the communication component. Both the surveys used the same sampling technique to select 25 households at random from each of the 30 mauza/villages in a district. A pretested, semi-structured questionnaire was used to collect relevant information from respondents in face-to-face interview. Analysis was done comparing the study areas at two different times. Statistical tests were done as necessary to examine the differences. Results: The intervention succeeded in improving knowledge in some trivial areas (e.g., most frequent symptom suggestive of malaria, importance of using insecticidal bed nets) but not in critical domains necessary for taking informed action (e.g., mode of malaria transmission, awareness about facilities providing free malaria treatment). Inequity in knowledge and practice was quite common depending upon household affluence, location of households in high or low endemic districts, and sex. Of the different media used in Information, Education and communication (IEC) campaigns during the study period, interpersonal communication with community health workers/relatives/neighbours/friends was found to be more effective in improving knowledge and practice than conventional print and audio-visual media. Conclusion: This study reiterates the fact that conventional media may not be user-friendly or culture-sensitive for this semiliterate/ illiterate community where dissemination through 'words of mouth' is more common, and as such, interpersonal communication is more effective. This is especially important for initiating informed action by the community in managing malaria-like illnesses.	[Ahmed, Syed Masud] Icddr B, Ctr Equ & Hlth Syst, Dhaka, Bangladesh; [Ahmed, Syed Masud] BRAC Univ, BRAC Inst Global Hlth BIGH, James P Grant Sch Publ Hlth, Dhaka, Bangladesh; [Ahmed, Syed Masud] BRAC Univ, BRAC Inst Global Hlth BIGH, James P Grant Sch Publ Hlth, Ctr Excellence Universal Hlth Coverage, Dhaka, Bangladesh; [Hossain, Mohammad Shamim] BRAC, Res & Evaluat Div, Dhaka, Bangladesh; [Kabir, Moktadir] BRAC, Hlth Nutr & Populat Programme, Dhaka, Bangladesh	International Centre for Diarrhoeal Disease Research (ICDDR); Bangladesh Rural Advancement Committee BRAC; BRAC University; Bangladesh Rural Advancement Committee BRAC; BRAC University; Bangladesh Rural Advancement Committee BRAC; Bangladesh Rural Advancement Committee BRAC	Ahmed, SM (corresponding author), Icddr B, Ctr Equ & Hlth Syst, Dhaka, Bangladesh.	ahmed.sm@bracu.ac.bd	Ahmed, Syed/GSN-7305-2022; Ahmed, Syed Masud/AGQ-4786-2022	Ahmed, Syed Masud/0000-0001-5032-7181	GFATM	GFATM	The study received support from GFATM through the programme. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam I, 2008, J PUBLIC HEALTH-HEID, V16, P129, DOI 10.1007/s10389-007-0124-2; Ahmed SM, 2008, MALARIA BASELINE PRE; Ahmed SM, 2012, MALARIA FOLLOW UNPUB; Ahmed SM, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-357; Ahmed SM, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-173; Barat LM, 2004, AM J TROP MED HYG, V71, P174, DOI 10.4269/ajtmh.2004.71.174; BHP (BRAC Health Program), 2011, MAL ANN REP JUL 2010; Consortium Malaria, 2009, TECHN WORKSH CROSS B; Cropley L, 2004, HEALTH PROMOT INT, V19, P445, DOI 10.1093/heapro/dah406; De La Cruz N, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-61; Dunn A, 2005, EXCHANGE FINDINGS, V4, P1; Hutchinson P, 2006, J HEALTH COMMUN, V11, P91, DOI 10.1080/10810730600974647; Joshi A. B., 2008, Journal of Vector Borne Diseases, V45, P44; Keating J, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-313; Kishore J., 2008, Journal of Communicable Diseases, V40, P183; Malaria and Parasitic Disease Control, 1997, MAL CAS DET BANGL 19; Maslove DM, 2009, BMC INT HEALTH HUM R, V9, DOI 10.1186/1472-698X-9-26; Mozumder P, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-136; Nganda RY, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-42; Rakhshani F, 2003, East Mediterr Health J, V9, P248; Sharma S. N., 2000, Journal of Communicable Diseases, V32, P49; Simba DO, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-146; Simsek Z, 2005, PUBLIC HEALTH, V119, P202, DOI 10.1016/j.puhe.2004.03.011; Thuy DO, 2004, ROLE HLTH COMMUNICAT; Worrall E, 2005, TROP MED INT HEALTH, V10, P1047, DOI 10.1111/j.1365-3156.2005.01476.x	25	7	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90711	10.1371/journal.pone.0090711	http://dx.doi.org/10.1371/journal.pone.0090711			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603849	Green Published, gold, Green Submitted			2022-12-27	WOS:000332483600075
J	Haas, J; Ophir, L; Barzilay, E; Yerushalmi, GM; Yung, Y; Kedem, A; Maman, E; Hourvitz, A				Haas, Jigal; Ophir, Libby; Barzilay, Eran; Yerushalmi, Gil M.; Yung, Yuval; Kedem, Alon; Maman, Ettie; Hourvitz, Ariel			GnRH Agonist vs. hCG for Triggering of Ovulation - Differential Effects on Gene Expression in Human Granulosa Cells	PLOS ONE			English	Article							OVARIAN HYPERSTIMULATION SYNDROME; ENDOTHELIAL GROWTH-FACTOR; FINAL OOCYTE MATURATION; IN-VITRO FERTILIZATION; GONADOTROPIN STIMULATION; FOLLICULAR-FLUID; EMBRYO-TRANSFER; HORMONE; WOMEN; IVF	Objective: To investigate the mRNA expression of genes related to steroidogenesis and OHSS in granulosa cells (GCs) of patients triggered with GnRH agonist compared to patients triggered with hCG. Design: Mural GCs were obtained at the time of oocyte retrieval and gene expression was analyzed using quantitative real time RT-PCR. Settings: Single center, case control study. Patient(s): 24 women who were treated with GnRH agonist or hCG for triggering of ovulation. Interventions: GC collection. Main Outcome Measure(s): The expression of genes related to steroidogenesis and OHSS in mural GCs Results: The fertilization rate was similar in the two groups. The mRNA expression of CYP19A1 (0.50 vs 1, arbitrary unit), CYP11A1 (0.6 vs. 1) and 3 beta hydroxysteroid-dehydrogenase (0.39 vs 1) was significantly lower in the GnRH group. The expression of VEGF (0.74 vs. 1) and inhibin beta B (0.38 vs 1) was lower in the GnRH analog triggered group. Conclusion: Expression of genes related to steroidogenesis is lower at the time of oocyte retrieval in patients triggered with GnRH agonist. The decreased expression of VEGF and inhibin b B in the GnRH agonist group can explain the mechanism of early OHSS prevention.	[Haas, Jigal] Chaim Sheba Med Ctr, Dept Obstet & Gynecol, Human Reprod Lab, Ramat Gan, Israel; Chaim Sheba Med Ctr, Dept Obstet & Gynecol, IVF Unit, Ramat Gan, Israel	Chaim Sheba Medical Center; Chaim Sheba Medical Center	Haas, J (corresponding author), Chaim Sheba Med Ctr, Dept Obstet & Gynecol, Human Reprod Lab, Ramat Gan, Israel.	jigalh@hotmail.com	Barzilay, Eran/AAH-4433-2021	Barzilay, Eran/0000-0001-5496-4866				Agrawal R, 1999, FERTIL STERIL, V71, P287, DOI 10.1016/S0015-0282(98)00447-6; Andersen CY, 2006, HUM REPROD, V21, P2126, DOI 10.1093/humrep/del119; Babayof R, 2006, HUM REPROD, V21, P1260, DOI 10.1093/humrep/dei475; Ben-Ami I, 2011, HUM REPROD, V26, P76, DOI 10.1093/humrep/deq290; Cerrillo M, 2011, FERTIL STERIL, V95, P2517, DOI 10.1016/j.fertnstert.2010.12.054; Cerrillo M, 2009, FERTIL STERIL, V91, P1526, DOI 10.1016/j.fertnstert.2008.08.118; Conti M, 2006, MOL ENDOCRINOL, V20, P715, DOI 10.1210/me.2005-0185; Engmann L, 2006, REPROD BIOMED ONLINE, V13, P639, DOI 10.1016/S1472-6483(10)60653-0; Engmann L, 2011, FERTIL STERIL, V96, P198, DOI 10.1016/j.fertnstert.2011.04.071; Enskog A, 2001, EUR J OBSTET GYN R B, V96, P196, DOI 10.1016/S0301-2115(00)00460-7; Enskog A, 2000, HUM REPROD, V15, P532, DOI 10.1093/humrep/15.3.532; Fauser BC, 2002, J CLIN ENDOCR METAB, V87, P709, DOI 10.1210/jc.87.2.709; GONEN Y, 1990, Journal of Clinical Endocrinology and Metabolism, V71, P918; Griesinger G, 2006, HUM REPROD UPDATE, V12, P159, DOI 10.1093/humupd/dmi045; Humaidan P, 2005, HUM REPROD, V20, P1213, DOI 10.1093/humrep/deh765; Humaidan P, 2011, HUM REPROD UPDATE, V17, P510, DOI 10.1093/humupd/dmr008; Humaidan P, 2009, HUM REPROD, V24, P2389, DOI 10.1093/humrep/dep246; Humaidan P, 2011, FERTIL STERIL, V95, P2034, DOI 10.1016/j.fertnstert.2011.02.013; Humaidan P, 2010, FERTIL STERIL, V93, P847, DOI 10.1016/j.fertnstert.2008.12.042; Inoue Y, 2009, FERTIL STERIL, V91, P1035, DOI 10.1016/j.fertnstert.2008.01.014; ITSKOVITZ J, 1991, FERTIL STERIL, V56, P213; Jones SM, 2002, AM J PHYSIOL-CELL PH, V282, pC420, DOI 10.1152/ajpcell.00253.2001; Kedem-Dickman A, 2012, REPROD BIOMED ONLINE, V24, P540, DOI 10.1016/j.rbmo.2012.01.023; Kolibianakis EM, 2005, HUM REPROD, V20, P2887, DOI 10.1093/humrep/dei150; Maman E, 2012, FERTIL STERIL, V97, P592, DOI 10.1016/j.fertnstert.2011.12.027; Maman E, 2011, MOL HUM REPROD, V17, P399, DOI 10.1093/molehr/gar010; Mathur R, 2002, FERTIL STERIL, V78, P1154, DOI 10.1016/S0015-0282(02)04243-7; MCCLURE N, 1994, LANCET, V344, P235, DOI 10.1016/S0140-6736(94)93001-5; MISKIMINS WK, 1982, J CELL PHYSIOL, V112, P327, DOI 10.1002/jcp.1041120304; Park JY, 2004, SCIENCE, V303, P682, DOI 10.1126/science.1092463; Pellicer A, 1999, FERTIL STERIL, V71, P482, DOI 10.1016/S0015-0282(98)00484-1; Soares SR, 2008, HUM REPROD UPDATE, V14, P321, DOI 10.1093/humupd/dmn008; Strowitzki T, 1995, HUM REPROD, V10, P3097, DOI 10.1093/oxfordjournals.humrep.a135865; Xu FH, 2011, MOL HUM REPROD, V17, P152, DOI 10.1093/molehr/gaq089; Yung Y, 2010, MOL CELL ENDOCRINOL, V328, P104, DOI 10.1016/j.mce.2010.07.019	35	33	37	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90359	10.1371/journal.pone.0090359	http://dx.doi.org/10.1371/journal.pone.0090359			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603682	gold, Green Published, Green Submitted			2022-12-27	WOS:000332483600048
J	Meuwese, JDI; Scholte, HS; Lamme, VAF				Meuwese, Julia D. I.; Scholte, H. Steven; Lamme, Victor A. F.			Latent Memory of Unattended Stimuli Reactivated by Practice: An fMRI Study on the Role of Consciousness and Attention in Learning	PLOS ONE			English	Article							PRIMARY VISUAL-CORTEX; TASK-IRRELEVANT; AWARENESS; DISCRIMINATION; ORIENTATION; RECOGNITION; SPECIFICITY; ASYMMETRIES; MECHANISMS; REPETITION	Although we can only report about what is in the focus of our attention, much more than that is actually processed. And even when attended, stimuli may not always be reportable, for instance when they are masked. A stimulus can thus be unreportable for different reasons: the absence of attention or the absence of a conscious percept. But to what extent does the brain learn from exposure to these unreportable stimuli? In this fMRI experiment subjects were exposed to textured figure-ground stimuli, of which reportability was manipulated either by masking (which only interferes with consciousness) or with an inattention paradigm (which only interferes with attention). One day later learning was assessed neurally and behaviorally. Positive neural learning effects were found for stimuli presented in the inattention paradigm; for attended yet masked stimuli negative adaptation effects were found. Interestingly, these inattentional learning effects only became apparent in a second session after a behavioral detection task had been administered during which performance feedback was provided. This suggests that the memory trace that is formed during inattention is latent until reactivated by behavioral practice. However, no behavioral learning effects were found, therefore we cannot conclude that perceptual learning has taken place for these unattended stimuli.	[Meuwese, Julia D. I.; Scholte, H. Steven; Lamme, Victor A. F.] Univ Amsterdam, Dept Psychol, NL-1012 WX Amsterdam, Netherlands; [Meuwese, Julia D. I.; Scholte, H. Steven; Lamme, Victor A. F.] Amsterdam Brain & Cognit Ctr ABC, Amsterdam, Netherlands	University of Amsterdam	Meuwese, JDI (corresponding author), Univ Amsterdam, Dept Psychol, NL-1012 WX Amsterdam, Netherlands.	julia.meuwese@gmail.com	Scholte, H.Steven/ABD-1737-2020	Scholte, H.Steven/0000-0002-9839-1788	European Research Council (ERC) [230355]	European Research Council (ERC)(European Research Council (ERC))	This work is supported by funding from the Advanced Investigator Grant from the European Research Council (ERC) to VAFL (grant number 230355). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHISSAR M, 1993, P NATL ACAD SCI USA, V90, P5718, DOI 10.1073/pnas.90.12.5718; Ahissar M, 1997, NATURE, V387, P401, DOI 10.1038/387401a0; Block N, 2007, BEHAV BRAIN SCI, V30, P481, DOI 10.1017/S0140525X07002786; Caputo G, 1999, VISION RES, V39, P1597, DOI 10.1016/S0042-6989(98)00270-3; Casco C, 2004, NEUROSCI LETT, V371, P18, DOI 10.1016/j.neulet.2004.08.005; Censor N, 2006, VISION RES, V46, P4071, DOI 10.1016/j.visres.2006.07.022; Choi Hoon, 2009, Learn Percept, V1, P89; Choi H, 2009, VISION RES, V49, P2586, DOI 10.1016/j.visres.2009.07.004; Dehaene S, 1998, NATURE, V395, P597, DOI 10.1038/26967; Dickinson CA, 2009, ATTEN PERCEPT PSYCHO, V71, P1251, DOI 10.3758/APP.71.6.1251; Dobres J, 2012, J VISION, V12, DOI 10.1167/12.8.9; Fahrenfort JJ, 2007, J COGNITIVE NEUROSCI, V19, P1488, DOI 10.1162/jocn.2007.19.9.1488; Gibson Eleanor Jack, 1969, PRINCIPLES PERCEPTUA; Gilbert CD, 1996, CURR OPIN NEUROBIOL, V6, P269, DOI 10.1016/S0959-4388(96)80083-3; Gilbert CD, 2001, NEURON, V31, P681, DOI 10.1016/S0896-6273(01)00424-X; Goebel R, 2006, HUM BRAIN MAPP, V27, P392, DOI 10.1002/hbm.20249; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Henson RNA, 2003, PROG NEUROBIOL, V70, P53, DOI 10.1016/S0301-0082(03)00086-8; Herzog MH, 1997, VISION RES, V37, P2133, DOI 10.1016/S0042-6989(97)00043-6; Jehee JFM, 2012, J NEUROSCI, V32, P16747, DOI 10.1523/JNEUROSCI.6112-11.2012; Jessup RK, 2009, NEURON, V61, P649, DOI 10.1016/j.neuron.2009.02.017; KARNI A, 1991, P NATL ACAD SCI USA, V88, P4966, DOI 10.1073/pnas.88.11.4966; Koch C, 2007, TRENDS COGN SCI, V11, P16, DOI 10.1016/j.tics.2006.10.012; KOVACS G, 1995, P NATL ACAD SCI USA, V92, P5587, DOI 10.1073/pnas.92.12.5587; Lamme VAF, 2003, TRENDS COGN SCI, V7, P12, DOI 10.1016/S1364-6613(02)00013-X; LAMME VAF, 1992, VISION RES, V32, P797, DOI 10.1016/0042-6989(92)90022-B; Lamme VAF, 2006, TRENDS COGN SCI, V10, P494, DOI 10.1016/j.tics.2006.09.001; Lamme VAF, 2010, COGN NEUROSCI-UK, V1, P204, DOI 10.1080/17588921003731586; Leclercq V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036228; Leclercq V, 2012, ATTEN PERCEPT PSYCHO, V74, P648, DOI 10.3758/s13414-012-0270-7; MARCEL AJ, 1983, COGNITIVE PSYCHOL, V15, P197, DOI 10.1016/0010-0285(83)90009-9; Meuwese JDI, 2013, J COGNITIVE NEUROSCI, V25, P1579, DOI 10.1162/jocn_a_00424; Moore CM, 1997, J EXP PSYCHOL HUMAN, V23, P339, DOI 10.1037/0096-1523.23.2.339; Naccache L, 2002, PSYCHOL SCI, V13, P416, DOI 10.1111/1467-9280.00474; Nicholls MER, 1999, NEUROPSYCHOLOGIA, V37, P307, DOI 10.1016/S0028-3932(98)00074-8; Peelen MV, 2009, NATURE, V460, P94, DOI 10.1038/nature08103; Pitts MA, 2012, J COGNITIVE NEUROSCI, V24, P287, DOI 10.1162/jocn_a_00111; Pourtois G, 2008, VISION RES, V48, P55, DOI 10.1016/j.visres.2007.10.027; REBER AS, 1976, J EXP PSYCHOL-HUM L, V2, P88, DOI 10.1037/0278-7393.2.1.88; ROCK I, 1992, COGNITIVE PSYCHOL, V24, P502, DOI 10.1016/0010-0285(92)90017-V; Roelfsema PR, 2010, TRENDS COGN SCI, V14, P64, DOI 10.1016/j.tics.2009.11.005; SAGI D, 1994, CURR OPIN NEUROBIOL, V4, P195, DOI 10.1016/0959-4388(94)90072-8; Schiller D, 2010, NATURE, V463, P49, DOI 10.1038/nature08637; Scholte HS, 2006, BRAIN RES, V1076, P106, DOI 10.1016/j.brainres.2005.10.051; SCHOUPS AA, 1995, J PHYSIOL-LONDON, V483, P797, DOI 10.1113/jphysiol.1995.sp020623; Segaert K, 2013, NEUROPSYCHOLOGIA, V51, P59, DOI 10.1016/j.neuropsychologia.2012.11.006; Seitz A, 2005, TRENDS COGN SCI, V9, P329, DOI 10.1016/j.tics.2005.05.010; Seitz AR, 2006, J VISION, V6, P966, DOI 10.1167/6.9.9; Seitz AR, 2009, VISION RES, V49, P2604, DOI 10.1016/j.visres.2009.08.003; Seitz AR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003792; Seitz AR, 2009, NEURON, V61, P700, DOI 10.1016/j.neuron.2009.01.016; Seitz AR, 2003, NATURE, V422, P36, DOI 10.1038/422036a; SHIU LP, 1992, PERCEPT PSYCHOPHYS, V52, P582, DOI 10.3758/BF03206720; Sigman M, 2000, NAT NEUROSCI, V3, P264, DOI 10.1038/72979; Simons DJ, 1999, PERCEPTION, V28, P1059, DOI 10.1068/p2952; Sligte IG, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00175; Super H, 2001, NAT NEUROSCI, V4, P304, DOI 10.1038/85170; Talairach P., 1988, STEREOTACTIC COPLANA; Tallon-Baudry C, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2011.00397; Tata MS, 2004, PSYCHON B REV, V11, P262, DOI 10.3758/BF03196568; Tata MS, 2002, PERCEPT PSYCHOPHYS, V64, P1028, DOI 10.3758/BF03194754; Tsushima Y, 2008, CURR BIOL, V18, pR516, DOI 10.1016/j.cub.2008.04.029; Tsushima Y, 2009, LEARN BEHAV, V37, P126, DOI 10.3758/LB.37.2.126; van Boxtel JJA, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00217; van Boxtel JJA, 2010, P NATL ACAD SCI USA, V107, P8883, DOI 10.1073/pnas.0913292107; Van den Bussche E, 2009, PSYCHOL BULL, V135, P452, DOI 10.1037/a0015329; Vandenbroucke ARE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050042; Vandenbroucke ARE, 2011, NEUROPSYCHOLOGIA, V49, P1559, DOI 10.1016/j.neuropsychologia.2010.12.044; Voss JL, 2008, LEARN MEMORY, V15, P454, DOI 10.1101/lm.971208; Voss JL, 2009, NAT NEUROSCI, V12, P349, DOI 10.1038/nn.2260; Walker MP, 2003, NATURE, V425, P616, DOI 10.1038/nature01930; Watanabe M, 2011, SCIENCE, V334, P829, DOI 10.1126/science.1203161; Watanabe T, 2001, NATURE, V413, P844, DOI 10.1038/35101601; Wyart V, 2008, J NEUROSCI, V28, P2667, DOI 10.1523/JNEUROSCI.4748-07.2008; Zipser K, 1996, J NEUROSCI, V16, P7376	75	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90098	10.1371/journal.pone.0090098	http://dx.doi.org/10.1371/journal.pone.0090098			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603676	Green Published, gold, Green Submitted			2022-12-27	WOS:000332483600029
J	ODonnell, RL; McCormick, A; Mukhopadhyay, A; Woodhouse, LC; Moat, M; Grundy, A; Dixon, M; Kaufman, A; Soohoo, S; Elattar, A; Curtin, NJ; Edmondson, RJ				ODonnell, Rachel L.; McCormick, Aiste; Mukhopadhyay, Asima; Woodhouse, Laura C.; Moat, Madeleine; Grundy, Anna; Dixon, Michelle; Kaufman, Angelika; Soohoo, San; Elattar, Ahmed; Curtin, Nicola J.; Edmondson, Richard J.			The Use of Ovarian Cancer Cells from Patients Undergoing Surgery to Generate Primary Cultures Capable of Undergoing Functional Analysis	PLOS ONE			English	Article							HOMOLOGOUS RECOMBINATION; EPITHELIAL-CELLS; EXPRESSION; TUMOR; HETEROGENEITY; CYTOTOXICITY; ASSAY	The use of cell lines or animal models has significant disadvantages when dealing with a set of heterogeneous diseases such as epithelial ovarian cancer. This has clinical relevance in that biomarkers developed using cell line or animal models are often not transferable to the clinical setting. In this study, we describe the development of a robust protocol for developing primary cultures of ovarian cancer which will overcome some of these difficulties. Women undergoing surgery for ovarian cancer were recruited and samples of ascites and solid tumour deposits were used to develop primary cultures. Cells were characterised using a panel of immunofluorescent antibodies prior to use in a variety of assays including functional assessment of DNA repair pathways. During the four year study period, viable cultures, confirmed to be epithelial in origin were generated from 156 of 172 (91%) cases recruited. Characterisation was carried out using a panel of antibodies including pancytokeratin, CA125, EpCAM, MOC-31, D2-40 and vimentin. Senescence occurred between the 2nd and 8th passages in all cultures except one in which spontaneous immortalization occurred. Cells could be successfully cultured even after a period of storage at 4 degrees C and cultured cells were capable of being used for a variety of applications including functional assays. Upon functional assessment there was minimal intra-tumour heterogeneity. It is therefore possible to derive viable ovarian cancer cell cultures in the majority of patients undergoing surgery. Cells cultured directly from patient cancers provide an accurate and highly diverse model.	[ODonnell, Rachel L.; Mukhopadhyay, Asima; Kaufman, Angelika; Soohoo, San] Queen Elizabeth Hosp, Northern Gynaecol Oncol Ctr, Gateshead, England; [ODonnell, Rachel L.; McCormick, Aiste; Mukhopadhyay, Asima; Woodhouse, Laura C.; Moat, Madeleine; Grundy, Anna; Dixon, Michelle; Kaufman, Angelika; Soohoo, San; Elattar, Ahmed; Curtin, Nicola J.] Newcastle Univ, Northern Inst Canc Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Edmondson, Richard J.] Univ Manchester, Fac Inst Canc Sci, Manchester, Lancs, England	Newcastle University - UK; University of Manchester	Edmondson, RJ (corresponding author), Univ Manchester, Fac Inst Canc Sci, Manchester, Lancs, England.	richard.edmondson@manchester.ac.uk	O'Donnell, Rachel L/H-5850-2016; Elattar, Ahmed/L-3357-2019; Woodhouse, Laura/GRY-6740-2022	O'Donnell, Rachel L/0000-0002-4830-2468; Elattar, Ahmed/0000-0003-3223-0890; Curtin, Nicola/0000-0003-1369-1843; Edmondson, Richard/0000-0003-2553-4423	National Institute for Health Research [ACF-2008-01-011] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Abelson S, 2012, STEM CELLS, V30, P415, DOI 10.1002/stem.1029; Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Bau DT, 2007, CARCINOGENESIS, V28, P1726, DOI 10.1093/carcin/bgm109; Bowtell DDL, 2010, NAT REV CANCER, V10, P803, DOI 10.1038/nrc2946; Dunfield Lesley D., 2002, Biol Proced Online, V4, P55; Fong MY, 2009, J OVARIAN RES, V2, DOI 10.1186/1757-2215-2-12; Hennessy BT, 2008, ADV EXP MED BIOL, V617, P23, DOI 10.1007/978-0-387-69080-3_3; HIRTE HW, 1992, GYNECOL ONCOL, V44, P223, DOI 10.1016/0090-8258(92)90046-L; Khalique L, 2007, J PATHOL, V211, P286, DOI 10.1002/path.2112; Kobel M, 2011, INT J GYNECOL PATHOL, V30, P366, DOI 10.1097/PGP.0b013e31820d20ba; Korch C, 2012, GYNECOL ONCOL, V127, P241, DOI 10.1016/j.ygyno.2012.06.017; Le Page C, 2006, BRIT J CANCER, V94, P436, DOI 10.1038/sj.bjc.6602933; Lee EC, 1991, ACT CYTOGENETICS LAB, P107; Marks A, 1999, BRIT J CANCER, V80, P569, DOI 10.1038/sj.bjc.6690393; Mukhopadhyay A, 2010, CLIN CANCER RES, V16, P2344, DOI 10.1158/1078-0432.CCR-09-2758; Ohashi A, 2005, J BIOL CHEM, V280, P14877, DOI 10.1074/jbc.M414669200; Parmar MKB, 2003, LANCET, V361, P2099; PEREZ RP, 1993, EUR J CANCER, V29A, P395, DOI 10.1016/0959-8049(93)90394-U; Rosen DG, 2005, GYNECOL ONCOL, V99, P267, DOI 10.1016/j.ygyno.2005.06.040; Shepherd TG, 2006, NAT PROTOC, V1, P2643, DOI 10.1038/nprot.2006.328; SOUHAMI RL, 1991, J NATL CANCER I, V83, P609, DOI 10.1093/jnci/83.9.609; Statistics NOf, 2011, MORT STAT DEATHS DR; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Znojek P, 2011, THESIS NEWCASTLE U	24	30	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90604	10.1371/journal.pone.0090604	http://dx.doi.org/10.1371/journal.pone.0090604			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603616	Green Published, gold, Green Submitted			2022-12-27	WOS:000332483600067
J	Papantonopoulos, G; Takahashi, K; Bountis, T; Loos, BG				Papantonopoulos, Georgios; Takahashi, Keiso; Bountis, Tasos; Loos, Bruno G.			Artificial Neural Networks for the Diagnosis of Aggressive Periodontitis Trained by Immunologic Parameters	PLOS ONE			English	Article							DISEASE; CLASSIFICATION; MARKERS	There is neither a single clinical, microbiological, histopathological or genetic test, nor combinations of them, to discriminate aggressive periodontitis (AgP) from chronic periodontitis (CP) patients. We aimed to estimate probability density functions of clinical and immunologic datasets derived from periodontitis patients and construct artificial neural networks (ANNs) to correctly classify patients into AgP or CP class. The fit of probability distributions on the datasets was tested by the Akaike information criterion (AIC). ANNs were trained by cross entropy (CE) values estimated between probabilities of showing certain levels of immunologic parameters and a reference mode probability proposed by kernel density estimation (KDE). The weight decay regularization parameter of the ANNs was determined by 10-fold cross-validation. Possible evidence for 2 clusters of patients on cross-sectional and longitudinal bone loss measurements were revealed by KDE. Two to 7 clusters were shown on datasets of CD4/CD8 ratio, CD3, monocyte, eosinophil, neutrophil and lymphocyte counts, IL-1, IL-2, IL-4, INF-gamma and TNF-alpha level from monocytes, antibody levels against A. actinomycetemcomitans (A. a.) and P. gingivalis (P. g.). ANNs gave 90%-98% accuracy in classifying patients into either AgP or CP. The best overall prediction was given by an ANN with CE of monocyte, eosinophil, neutrophil counts and CD4/CD8 ratio as inputs. ANNs can be powerful in classifying periodontitis patients into AgP or CP, when fed by CE values based on KDE. Therefore ANNs can be employed for accurate diagnosis of AgP or CP by using relatively simple and conveniently obtained parameters, like leukocyte counts in peripheral blood. This will allow clinicians to better adapt specific treatment protocols for their AgP and CP patients.	[Papantonopoulos, Georgios] Univ Patras, Dept Math, Ctr Res & Applicat Nonlinear Syst, GR-26110 Patras, Greece; [Takahashi, Keiso] Ohu Univ, Sch Dent, Dept Conservat Dent, Fukushima, Japan; [Bountis, Tasos] Univ Patras, Dept Math, Lab Nonlinear Syst & Appl Anal, GR-26110 Patras, Greece; [Loos, Bruno G.] Univ Amsterdam, Dept Periodontol, Acad Ctr Dent Amsterdam ACTA, Amsterdam, Netherlands; [Loos, Bruno G.] Vrije Univ Amsterdam, Amsterdam, Netherlands	University of Patras; University of Patras; Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Papantonopoulos, G (corresponding author), Univ Patras, Dept Math, Ctr Res & Applicat Nonlinear Syst, GR-26110 Patras, Greece.	ppntnpls@otenet.gr	Bountis, Anastasios/GRS-5915-2022; BOUNTIS, ANASTASIOS/AAR-4966-2020		University of Amsterdam; European Union (European Social Fund, ESF); Greek national funds through the Operational Program "Education and Lifelong Learning'' of the National Strategic Reference Framework (NSRF) - Research Funding Program: THALES: Investing in knowledge society through the European Social Fund	University of Amsterdam; European Union (European Social Fund, ESF)(European Social Fund (ESF)European Commission); Greek national funds through the Operational Program "Education and Lifelong Learning'' of the National Strategic Reference Framework (NSRF) - Research Funding Program: THALES: Investing in knowledge society through the European Social Fund(Thales Group)	The Academic Center for Dentistry Amsterdam (ACTA) (author B. G. L.) is supported in part by a grant from the University of Amsterdam for research into the focal point "Oral infections and Inflammation''. This research has been co-financed by the European Union (European Social Fund, ESF) and Greek national funds through the Operational Program "Education and Lifelong Learning'' of the National Strategic Reference Framework (NSRF) - Research Funding Program: THALES: Investing in knowledge society through the European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H, 2003, ENCY SOCIAL SCI RES, P725; Armitage G C, 1999, Ann Periodontol, V4, P1, DOI 10.1902/annals.1999.4.1.1; Armitage GC, 2013, PERIODONTOL 2000, V62, P20, DOI 10.1111/prd.12006; Armitage GC, 2010, PERIODONTOL 2000, V53, P12, DOI 10.1111/j.1600-0757.2010.00353.x; Bartold PM, 2013, PERIODONTOL 2000, V62, P203, DOI 10.1111/j.1600-0757.2012.00450.x; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; De Boer PT, 2005, ANN OPER RES, V134, P19, DOI 10.1007/s10479-005-5724-z; Eke PI, 2012, J DENT RES, V91, P914, DOI 10.1177/0022034512457373; Graswinckel JEM, 2004, J CLIN PERIODONTOL, V31, P562, DOI 10.1111/j.1600-051X.2004.00522.x; Guyon I., 2003, Journal of Machine Learning Research, V3, P1157, DOI 10.1162/153244303322753616; Hall P, 2005, ANN STAT, V33, P284, DOI 10.1214/009053604000000959; Hastie T., 2009, UNSUPERVISED LEARNIN; Kebschull M, 2013, J DENT RES, V92, P1081, DOI 10.1177/0022034513506011; Kinane DF, 2001, PERIODONTOL 2000, V26, P7, DOI 10.1034/j.1600-0757.2001.2260101.x; Klnane DF L.J., 2008, CLIN PERIODONTOLOGY, V5th ed, P285; Laine ML, 2012, PERIODONTOL 2000, V58, P37, DOI 10.1111/j.1600-0757.2011.00415.x; Loos BG, 2005, PERIODONTOL 2000, V39, P53, DOI 10.1111/j.1600-0757.2005.00129.x; Loos BG, 2004, J PERIODONTOL, V75, P557, DOI 10.1902/jop.2004.75.4.557; Loos BG, 2000, J PERIODONTOL, V71, P1528, DOI 10.1902/jop.2000.71.10.1528; Mazurowski MA, 2008, NEURAL NETWORKS, V21, P427, DOI 10.1016/j.neunet.2007.12.031; Myung IJ, 2003, J MATH PSYCHOL, V47, P90, DOI 10.1016/S0022-2496(02)00028-7; Neal RM, 2006, STUD FUZZ SOFT COMP, V207, P265; Nicolis G., 2012, FDN COMPLEX SYSTEMS; Offenbacher S, 2007, J PERIODONTOL, V78, P1911, DOI 10.1902/jop.2007.060465; Papantonopoulos G, 2013, J PERIODONTOL, V84, pE29, DOI 10.1902/jop.2013.120637; Papantonopoulos G, 2013, INT J BIFURCAT CHAOS, V23, DOI 10.1142/S0218127413500569; Papantonopoulos GH, 2004, J PERIODONTOL, V75, P839, DOI 10.1902/jop.2004.75.6.839; Razzouk S, 2013, J PERIODONTOL, V84, P1266, DOI 10.1902/jop.2012.120531; Sakamoto Y., 1986, AKAIKE INFORM CRITER; Sheather SJ, 2004, STAT SCI, V19, P588, DOI 10.1214/088342304000000297; Shi HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035781; Silverman B.W., 1986, DENSITY ESTIMATION S; Simonoff J.S., 1996, SMOOTING METHODS STA, V2nd; Takahashi K, 2001, J PERIODONTOL, V72, P425, DOI 10.1902/jop.2001.72.4.425; Teles RP, 2010, J CLIN PERIODONTOL, V37, P313, DOI 10.1111/j.1600-051X.2010.01534.x; Tonetti MS, 2008, CLIN PERIODONTOLOGY, P428; van der Velden U, 2005, PERIODONTOL 2000, V39, P13, DOI 10.1111/j.1600-0757.2005.00127.x; Vose D., 2008, RISK ANAL QUANTITATI; Zhang GQP, 2000, IEEE T SYST MAN CY C, V30, P451, DOI 10.1109/5326.897072	39	27	30	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e89757	10.1371/journal.pone.0089757	http://dx.doi.org/10.1371/journal.pone.0089757			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603408	gold, Green Published, Green Submitted			2022-12-27	WOS:000332483600020
J	Reisinger, KW; Kramer, BW; Van der Zee, DC; Brouwers, HAA; Buurman, WA; van Heurn, E; Derikx, JPM				Reisinger, Kostan W.; Kramer, Boris W.; Van der Zee, David C.; Brouwers, Hens A. A.; Buurman, Wim A.; van Heurn, Ernest; Derikx, Joep P. M.			Non-Invasive Serum Amyloid A (SAA) Measurement and Plasma Platelets for Accurate Prediction of Surgical Intervention in Severe Necrotizing Enterocolitis (NEC)	PLOS ONE			English	Article							ACID-BINDING PROTEIN; EARLY-DIAGNOSIS; CALPROTECTIN; PHLEBOTOMY; DISEASE; MARKER	Objective: To evaluate the value of biomarkers to detect severe NEC. Summary Background Data: The time point of surgery in necrotizing enterocolitis (NEC) is critical. Therefore, there is a need for markers that detect severe NEC, because clinical signs of severe NEC often develop late. This study evaluated the value of biomarkers reflecting intestinal cell damage and inflammation to detect severe NEC. Methods: 29 neonates with NEC were included. Two definitions of moderate versus severe NEC were analyzed: medical NEC (n = 12) versus surgical or fatal NEC (n = 17); and Bell stage II NEC (n = 13) versus stage III NEC (n = 16). Urinary intestinal fatty acid binding protein (I-FABP), serum amyloid A (SAA), C3a and C5a, and fecal calprotectin were measured. C-reactive protein (CRP), white blood cell count (WBC) and platelet count data were measured in blood. Results: In both definitions of moderate versus severe NEC, urinary SAA levels were significantly higher in severe NEC. A cutoff value of 34.4 ng/ml was found in surgical NEC versus medical NEC (sensitivity, 83%; specificity, 83%; LR+, 4.88 (95% CI, 1.37-17.0); LR-, 0.20 (95% CI, 0.07-0.60)) at diagnosis of NEC and at one day prior to surgery in neonates who were operated later on. Combination of urinary SAA and platelet count increased the accuracy, with a sensitivity, 94%; specificity, 83%; LR+, 5.53 (95% CI, 1.57-20.0); and LR-, 0.07 (95% CI, 0.01-0.48). Conclusion: Urinary SAA is an accurate marker in differentiating severe NEC from moderate NEC; particularly if combined with serum platelet count.	[Reisinger, Kostan W.; van Heurn, Ernest; Derikx, Joep P. M.] Maastricht Univ, Med Ctr, Dept Surg, Maastricht, Netherlands; [Reisinger, Kostan W.; van Heurn, Ernest; Derikx, Joep P. M.] Nutr & Toxicol Res Inst NUTRIM, Maastricht, Netherlands; [Kramer, Boris W.] Maastricht Univ, Med Ctr, Dept Pediat, Maastricht, Netherlands; [Kramer, Boris W.] Sch Mental Hlth & Neurosci, Sch Oncol & Dev Biol GROW, Maastricht, Netherlands; [Van der Zee, David C.] Univ Med Ctr, Wilhelmina Childrens Hosp, Dept Surg, Utrecht, Netherlands; [Brouwers, Hens A. A.] Univ Med Ctr, Wilhelmina Childrens Hosp, Dept Neonatol, Utrecht, Netherlands; [Buurman, Wim A.] NUTRIM Inst, Dept Surg, Maastricht, Netherlands	Maastricht University; Maastricht University; Maastricht University; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Maastricht University	Reisinger, KW (corresponding author), Maastricht Univ, Med Ctr, Dept Surg, Maastricht, Netherlands.	k.reisinger@maastrichtuniversity.nl	Kramer, Boris/AAO-3183-2021	derikx, joep/0000-0003-0694-7679	AGIKO-stipendium from The Netherlands Organization for Health Research and Development [920-03-438]; Stichting Sint Annadal, Maastricht, the Netherlands	AGIKO-stipendium from The Netherlands Organization for Health Research and Development; Stichting Sint Annadal, Maastricht, the Netherlands(Netherlands Government)	Supported by AGIKO-stipendium 920-03-438 from The Netherlands Organization for Health Research and Development (to JPMD); and by Stichting Sint Annadal, Maastricht, the Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aydemir C, 2011, EARLY HUM DEV, V87, P659, DOI 10.1016/j.earlhumdev.2011.05.004; BELL MJ, 1978, ANN SURG, V187, P1, DOI 10.1097/00000658-197801000-00001; Bisquera JA, 2002, PEDIATRICS, V109, P423, DOI 10.1542/peds.109.3.423; Bossuyt PM, 2003, CLIN CHEM, V49, P7, DOI 10.1373/49.1.7; Carroll D, 2003, LANCET, V361, P310, DOI 10.1016/S0140-6736(03)12333-1; Cetinkaya M, 2011, J PEDIATR SURG, V46, P1482, DOI 10.1016/j.jpedsurg.2011.03.069; Cetinkaya M, 2010, PEDIATR SURG INT, V26, P835, DOI 10.1007/s00383-010-2635-0; Edelson MB, 1999, J PEDIATR SURG, V34, P1453, DOI 10.1016/S0022-3468(99)90102-1; Eras Z, 2011, J CLIN LAB ANAL, V25, P233, DOI 10.1002/jcla.20464; Evennett NJ, 2010, J PEDIATR SURG, V45, P735, DOI 10.1016/j.jpedsurg.2009.09.024; Fagerhol MK, 2000, LANCET, V356, P1783, DOI 10.1016/S0140-6736(00)03224-4; Kenton Alexander B, 2005, J Perinatol, V25, P14, DOI 10.1038/sj.jp.7211180; Khoo AK, 2008, EUR J PEDIATR SURG, V18, P419, DOI 10.1055/s-2008-1038908; Lin JC, 2000, PEDIATRICS, V106, part. no., DOI 10.1542/peds.106.2.e19; Lin PW, 2006, LANCET, V368, P1271, DOI 10.1016/S0140-6736(06)69525-1; MALLE E, 1993, ATHEROSCLEROSIS, V102, P131, DOI 10.1016/0021-9150(93)90155-N; MEEK RL, 1989, AM J PATHOL, V135, P411; MORECROFT JA, 1994, J PEDIATR SURG, V29, P798, DOI 10.1016/0022-3468(94)90374-3; Moss RL, 2006, NEW ENGL J MED, V354, P2225, DOI 10.1056/NEJMoa054605; Neu J, 2011, NEW ENGL J MED, V364, P255, DOI 10.1056/NEJMra1005408; Ng EWY, 2013, ANN SURG, V258, P1111, DOI 10.1097/SLA.0b013e318288ea96; Ng PC, 2010, J CLIN INVEST, V120, P2989, DOI 10.1172/JCI40196; Schlapbach LJ, 2011, GUT, V60, P1438, DOI 10.1136/gut.2010.226027; SMOLLER BR, 1986, NEW ENGL J MED, V314, P1233, DOI 10.1056/NEJM198605083141906; STRAUSS RG, 1995, IMMUNOL INVEST, V24, P341, DOI 10.3109/08820139509062784; Tayman C, 2011, TOHOKU J EXP MED, V224, P143, DOI 10.1620/tjem.224.143; Thuijls G, 2010, ANN SURG, V251, P1174, DOI 10.1097/SLA.0b013e3181d778c4; Veer GV, 2006, CLIN CHEM LAB MED, V44, P292, DOI 10.1515/CCLM.2006.051; Ververidis M, 2001, J PEDIATR SURG, V36, P799, DOI 10.1053/jpsu.2001.22964; WALSH MC, 1986, PEDIATR CLIN N AM, V33, P179, DOI 10.1016/s0031-3955(16)34975-6	30	32	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90834	10.1371/journal.pone.0090834	http://dx.doi.org/10.1371/journal.pone.0090834			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603723	Green Submitted, Green Published, gold			2022-12-27	WOS:000332483600090
J	Harada, N; Tamura, S; Sugawara, Y; Togashi, J; Ishizawa, T; Kaneko, J; Aoki, T; Sakamoto, Y; Hasegawa, K; Tanaka, T; Yamashiki, N; Kokudo, N				Harada, Nobuhiro; Tamura, Sumihito; Sugawara, Yasuhiko; Togashi, Junichi; Ishizawa, Takeaki; Kaneko, Junichi; Aoki, Taku; Sakamoto, Yoshihiro; Hasegawa, Kiyoshi; Tanaka, Tomohiro; Yamashiki, Noriyo; Kokudo, Norihiro			Impact of Donor and Recipient Single Nucleotide Polymorphisms of IL28B rs8099917 in Living Donor Liver Transplantation for Hepatitis C	PLOS ONE			English	Article							ANTIVIRAL THERAPY; VIROLOGICAL RESPONSE; FIBROSIS PROGRESSION; RIBAVIRIN THERAPY; GENETIC-VARIATION; VIRUS; INTERFERON; INFECTION; GENOTYPE; ASSOCIATION	Single nucleotide polymorphisms of interleukin-28B (IL28B) rs8099917 are reported to be associated with virologic clearance in interferon-and ribavirin -based treatment for hepatitis C virus (HCV)-infected patients. We examined virologic response in accordance with IL28B polymorphisms in our living donor liver transplantation series under a preemptive interferon and RBV treatment approach. Adequate DNA samples from both the recipient and donor for the study of single nucleotide polymorphisms of IL28B were available from 96 cases and were the subjects of the present study. Various clinical factors related with virologic response including early virologic response (EVR) and sustained virologic response (SVR) were examined. Totally 51% presented with EVR and 44% achieved SVR. Presence of the major allele (TT) in either the recipient or the donor corresponded to SVR of 53% and 48%. Presence of the minor allele (TG or GG) corresponded to SVR of 26% and 32%. Multivariate analysis revealed that genotype of HCV or EVR, but not IL28B polymorphisms in either the recipient or donor, was an independent factor for achieving SVR. When virologic response to treatment was incorporated into analysis, the impact of IL28B polymorphism on virological clearance remained relative to other factors and was not significantly independent.	[Harada, Nobuhiro; Tamura, Sumihito; Sugawara, Yasuhiko; Togashi, Junichi; Kaneko, Junichi] Tokyo Univ Hosp, Div Artificial Organ & Transplantat, Tokyo 113, Japan; [Ishizawa, Takeaki; Aoki, Taku; Sakamoto, Yoshihiro; Hasegawa, Kiyoshi; Kokudo, Norihiro] Tokyo Univ Hosp, Div Hepatobiliary & Pancreat Surg, Tokyo 113, Japan; [Sugawara, Yasuhiko; Tanaka, Tomohiro; Yamashiki, Noriyo; Kokudo, Norihiro] Tokyo Univ Hosp, Organ Transplantat Serv, Tokyo 113, Japan	University of Tokyo; University of Tokyo; University of Tokyo	Sugawara, Y (corresponding author), Tokyo Univ Hosp, Div Artificial Organ & Transplantat, Tokyo 113, Japan.	yasusuga-tky@umin.ac.jp		YAMASHIKI, Noriyo/0000-0002-9274-0000	Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labor and Welfare of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	The study has been supported by a Grant-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan and Grants-in-aid for evolutional treatment strategies for recurrent hepatitis after liver transplantation using genome-wide analysis and Research on HIV/AIDS and Research on Measures for Intractable Diseases from the Ministry of Health, Labor and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akuta N, 2005, INTERVIROLOGY, V48, P372, DOI 10.1159/000086064; Berenguer M, 2001, J HEPATOL, V35, P666, DOI 10.1016/S0168-8278(01)00179-9; Berenguer M, 2000, J HEPATOL, V32, P673, DOI 10.1016/S0168-8278(00)80231-7; Berenguer M, 2006, LIVER TRANSPLANT, V12, P1067, DOI 10.1002/lt.20737; Bizollon T, 2007, AM J TRANSPLANT, V7, P448, DOI 10.1111/j.1600-6143.2006.01619.x; Bochud PY, 2011, J HEPATOL, V55, P980, DOI 10.1016/j.jhep.2011.01.050; Brown RS, 2005, NATURE, V436, P973, DOI 10.1038/nature04083; Carrion JA, 2007, GASTROENTEROLOGY, V132, P1746, DOI 10.1053/j.gastro.2007.03.041; Charlton MR, 2011, HEPATOLOGY, V53, P317, DOI 10.1002/hep.24074; Coto-Llerena M, 2011, AM J TRANSPLANT, V11, P1051, DOI 10.1111/j.1600-6143.2011.03491.x; Crespo G, 2013, J GASTROENTEROL, V48, P762, DOI 10.1007/s00535-012-0680-2; Dill MT, 2011, GASTROENTEROLOGY, V140, P1021, DOI 10.1053/j.gastro.2010.11.039; Duarte-Rojo A, 2012, TRANSPLANTATION, V94, P197, DOI 10.1097/TP.0b013e3182547551; Enomoto N, 1996, NEW ENGL J MED, V334, P77, DOI 10.1056/NEJM199601113340203; Eurich D, 2011, LIVER TRANSPLANT, V17, P289, DOI 10.1002/lt.22235; Forman LM, 2002, GASTROENTEROLOGY, V122, P889, DOI 10.1053/gast.2002.32418; Fukuhara T, 2010, GASTROENTEROLOGY, V139, P1577, DOI 10.1053/j.gastro.2010.07.058; Garcia-Retortillo M, 2002, HEPATOLOGY, V35, P680, DOI 10.1053/jhep.2002.31773; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Honda M, 2010, GASTROENTEROLOGY, V139, P499, DOI 10.1053/j.gastro.2010.04.049; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Kawaoka T, 2012, J GASTROEN HEPATOL, V27, P1467, DOI 10.1111/j.1440-1746.2012.07129.x; Lange CM, 2011, J HEPATOL, V55, P322, DOI 10.1016/j.jhep.2010.10.037; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; McCaughan GW, 2012, J HEPATOL, V57, P1361, DOI 10.1016/j.jhep.2012.07.035; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Powers KA, 2006, LIVER TRANSPLANT, V12, P207, DOI 10.1002/lt.20572; Sherman KE, 2011, NEW ENGL J MED, V365, P1014, DOI 10.1056/NEJMoa1014463; Sugawara Y, 2004, TRANSPLANTATION, V78, P1308, DOI 10.1097/01.TP.0000142677.12473.E5; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tamura S, 2008, J HEPATO-BILIARY-PAN, V15, P111, DOI 10.1007/s00534-007-1295-5; Tamura S, 2010, TRANSPL INT, V23, P580, DOI 10.1111/j.1432-2277.2009.01023.x; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Terrault NA, 2006, LIVER TRANSPLANT, V12, P1192, DOI 10.1002/lt.20865; Thompson AJ, 2010, GASTROENTEROLOGY, V139, P120, DOI 10.1053/j.gastro.2010.04.013; Thuluvath PJ, 2007, LIVER TRANSPLANT, V13, P719, DOI 10.1002/lt.21123; Toyoda H, 2012, J MED VIROL, V84, P61, DOI 10.1002/jmv.22272; Wang CS, 2006, AM J TRANSPLANT, V6, P1586, DOI 10.1111/j.1600-6143.2006.01362.x; Yilmaz N, 2007, LIVER TRANSPLANT, V13, P975, DOI 10.1002/lt.21117; Zeuzem S, 2009, J VIRAL HEPATITIS, V16, P75, DOI 10.1111/j.1365-2893.2008.01012.x	40	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90462	10.1371/journal.pone.0090462	http://dx.doi.org/10.1371/journal.pone.0090462			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599320	Green Published, Green Submitted, gold			2022-12-27	WOS:000332479400078
J	Hong, LF; Li, XL; Luo, SH; Guo, YL; Liu, J; Zhu, CG; Qing, P; Xu, RX; Wu, NQ; Jiang, LX; Li, JJ				Hong, Li-Feng; Li, Xiao-Lin; Luo, Song-Hui; Guo, Yuan-Lin; Liu, Jun; Zhu, Cheng-Gang; Qing, Ping; Xu, Rui-Xia; Wu, Na-Qiong; Jiang, Li-Xin; Li, Jian-Jun			Relation of Leukocytes and Its Subsets Counts with the Severity of Stable Coronary Artery Disease in Patients with Diabetic Mellitus	PLOS ONE			English	Article							C-REACTIVE PROTEIN; BLOOD-CELL COUNT; HEART-DISEASE; PROGNOSTIC VALUE; NEUTROPHIL/LYMPHOCYTE RATIO; CARDIOVASCULAR MORTALITY; MYOCARDIAL-INFARCTION; ATHEROSCLEROSIS RISK; EJECTION FRACTION; LYMPHOCYTE RATIO	Background: Both coronary artery disease (CAD) and diabetes mellitus (DM) are associated with inflammation. However, whether and which leukocytes can predict the presence and extent of CAD in patients with DM has not been investigated. The aim of the present study was to examine the association of leukocyte and its subsets counts with the severity of CAD in patients with DM. Methods and Findings: Three hundred and seventy-three diabetic patients who were scheduled for coronary angiography due to typical stable angina pectoris were enrolled in this study. They were classified into the three groups according to tertiles of Gensini score (GS, low group <8, n = 143; intermediate group 8 similar to 28, n = 109; high group >28, n = 121). The relationship between the leukocyte and its subsets counts with the severity of CAD were evaluated. The data indicated that there were significant correlations between leukocyte and neutrophil counts with GS (r = 0.154 and 0.156, respectively, all P<0.003 for Pearson's correlation). Similarly, area under the receivers operating characteristic curve of leukocyte and neutrophil counts were 0.61 and 0.60 respectively (95% CI: 0.55-0.67, all P = 0.001) for predicting high GS. Multivariate logistic regression analysis demonstrated that leukocyte count was an independent predictor for high GS patients with DM (OR = 1.20, 95% CI 1.03-1.39, P = 0.023) after adjusting for conventional risk factors of CAD. Conclusions: Compared with its subsets, leukocyte count appeared to be an independent predictor for the severity of CAD and the optimal cut-off value for predicting high GS (>28 points) was 5.0x10(9) cells/L in diabetic patients.	[Hong, Li-Feng; Li, Xiao-Lin; Guo, Yuan-Lin; Liu, Jun; Zhu, Cheng-Gang; Qing, Ping; Xu, Rui-Xia; Wu, Na-Qiong; Jiang, Li-Xin; Li, Jian-Jun] Chinese Acad Med Sci, Peking Union Med Coll, Natl Ctr Cardiovasc Dis,Fu Wai Hosp, Div Dyslipidemia,State Key Lab Cardiovasc Dis, Beijing 100730, Peoples R China; [Hong, Li-Feng; Luo, Song-Hui] Wuhan Univ, Div Cardiol, Hosp Wuhan 5, Wuhan 430072, Peoples R China; [Hong, Li-Feng; Luo, Song-Hui] Wuhan Univ, Affiliated Guangci Hosp, Wuhan 430072, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Peking Union Medical College; Wuhan University; Wuhan University	Li, JJ (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Natl Ctr Cardiovasc Dis,Fu Wai Hosp, Div Dyslipidemia,State Key Lab Cardiovasc Dis, Beijing 100730, Peoples R China.	lijianjun938@yahoo.com	Guo, Yuan-Lin/K-4887-2019; xu, rui/GRX-5734-2022	Guo, Yuan-Lin/0000-0002-7159-0189; 	National Natural Scientific Foundation [81070171, 81241121]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20111106110013]; Capital Special Foundation of Clinical Application Research [Z121107001012015]; Capital Health Development Fund [2011400302]; Beijing Natural Science Foundation [7131014]	National Natural Scientific Foundation(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Capital Special Foundation of Clinical Application Research; Capital Health Development Fund; Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This article was partly supported by National Natural Scientific Foundation (81070171, 81241121), Specialized Research Fund for the Doctoral Program of Higher Education of China (20111106110013), Capital Special Foundation of Clinical Application Research (Z121107001012015), Capital Health Development Fund (2011400302), and Beijing Natural Science Foundation (7131014) awarded to Dr. Jian-Jun Li, MD, PhD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arain FA, 2009, AM J MED, V122, DOI 10.1016/j.amjmed.2009.02.020; Arbel Y, 2012, ATHEROSCLEROSIS, V225, P456, DOI 10.1016/j.atherosclerosis.2012.09.009; Avanzas P, 2004, ATHEROSCLEROSIS, V175, P151, DOI 10.1016/j.atherosclerosis.2004.03.013; Celik T, 2011, CARDIOL J, V18, P720, DOI 10.5603/CJ.2011.0044; Damman P, 2011, J AM COLL CARDIOL, V57, P29, DOI 10.1016/j.jacc.2010.06.053; Dragu R, 2008, ATHEROSCLEROSIS, V196, P405, DOI 10.1016/j.atherosclerosis.2006.11.022; FOLLAND ED, 1979, CIRCULATION, V60, P760, DOI 10.1161/01.CIR.60.4.760; Folsom AR, 1997, CIRCULATION, V96, P1102, DOI 10.1161/01.CIR.96.4.1102; Fowler AJ, 2013, ATHEROSCLEROSIS, V228, P44, DOI 10.1016/j.atherosclerosis.2013.02.008; GENSINI GG, 1983, AM J CARDIOL, V51, P606, DOI 10.1016/S0002-9149(83)80105-2; GILLUM RF, 1993, AM HEART J, V125, P855, DOI 10.1016/0002-8703(93)90181-8; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hartaigh BO, 2012, ATHEROSCLEROSIS, V224, P161, DOI 10.1016/j.atherosclerosis.2012.04.012; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Kaya A, 2013, CLIN APPL T IN PRESS; Kaya H, 2013, CLIN APPL THROMB HEM; Lee CD, 2001, AM J EPIDEMIOL, V154, P758, DOI 10.1093/aje/154.8.758; Madjid M, 2004, J AM COLL CARDIOL, V44, P1945, DOI 10.1016/j.jacc.2004.07.056; Margolis KL, 2005, ARCH INTERN MED, V165, P500, DOI 10.1001/archinte.165.5.500; Nunez J, 2006, CURR MED CHEM, V13, P2113, DOI 10.2174/092986706777935221; Palmerini T, 2005, CIRCULATION, V112, P2332, DOI 10.1161/CIRCULATIONAHA.105.551648; Palmerini T, 2013, AM J CARDIOL; Papa A, 2008, CLIN CHIM ACTA, V395, P27, DOI 10.1016/j.cca.2008.04.019; Park CS, 2010, AM J CARDIOL, V105, P1284, DOI 10.1016/j.amjcard.2009.12.045; Rasouli M, 2007, CLIN CHIM ACTA, V377, P127, DOI 10.1016/j.cca.2006.09.009; Rasouli M, 2011, CARDIOL J, V18, P246; Sabatine MS, 2002, J AM COLL CARDIOL, V40, P1761, DOI 10.1016/S0735-1097(02)02484-1; Sahin DY, 2012, ANGIOLOGY; Sarndahl E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001056; Shantsila E, 2012, INT J CARDIOL, V155, P337, DOI 10.1016/j.ijcard.2011.12.048; Sinning JM, 2006, EUR HEART J, V27, P2962, DOI 10.1093/eurheartj/ehl362; Smit JJJ, 2008, AM J CARDIOL, V101, P446, DOI 10.1016/j.amjcard.2007.09.088; Tong PC, 2004, DIABETES CARE, V27, P216, DOI 10.2337/diacare.27.1.216; Twig G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047183; Zairis MN, 2007, ATHEROSCLEROSIS, V194, P397, DOI 10.1016/j.atherosclerosis.2006.08.008; Ziakas A, 2009, MED SCI MONITOR, V15, pCR177	36	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90663	10.1371/journal.pone.0090663	http://dx.doi.org/10.1371/journal.pone.0090663			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599246	gold, Green Published, Green Submitted			2022-12-27	WOS:000332479400112
J	Xie, Q; Brackenbury, LS; Hill, DJ; Williams, NA; Qu, X; Virji, M				Xie, Qi; Brackenbury, Louise S.; Hill, Darryl J.; Williams, Neil A.; Qu, Xun; Virji, Mumtaz			Moraxella catarrhalis Adhesin UspA1-derived Recombinant Fragment rD-7 Induces Monocyte Differentiation to CD14+CD206+Phenotype	PLOS ONE			English	Article							DENDRITIC CELLS; ALTERNATIVE ACTIVATION; N-DOMAIN; NEISSERIA-MENINGITIDIS; DC-SIGN; CEACAM1; CD66A; MACROPHAGES; MOLECULE; RECEPTOR	Circulating monocytes in the bloodstream typically migrate to other tissues and differentiate into tissue resident macrophages, the process being determined by the constituents of the microenvironments encountered. These may include microbes and their products. In this study, we investigated whether Moraxella catarrhalis Ubiquitous Surface Protein A1 (UspA1), known to bind to a widely expressed human cell surface receptor CEACAM1, influences monocyte differentiation as receptor engagement has been shown to have profound effects on monocytes. We used the recombinant molecules corresponding to the regions of UspA1 which either bind (rD-7; UspA1(527-665)) or do not bind (r6-8; UspA1(659-863)) to CEACAM1 and investigated their effects on CD206, CD80 and CD86 expression on freshly isolated human CD14+ monocytes from peripheral blood mononuclear cells (PBMC). Exposure to rD-7, but not r6-8, biased monocyte differentiation towards a CD14+CD206+ phenotype, with reduced CD80 expression. Monocytes treated with rD-7 also secreted high levels of IL-1ra and chemokine IL-8 but not IL-10 or IL-12p70. The effects of rD-7 were independent of any residual endotoxin. Unexpectedly, these effects of rD-7 were also independent of its ability to bind to CEACAM1, as monocyte pre-treatment with the anti-CEACAM antibody A0115 known to inhibit rD-7 binding to the receptor, did not affect rD-7-driven differentiation. Further, another control protein rD-7/D (a mutant form of rD-7, known not to bind to CEACAMs), also behaved as the parent molecule. Our data suggest that specific regions of M. catarrhalis adhesin UspA1 may modulate inflammation during infection through a yet unknown receptor on monocytes.	[Xie, Qi; Qu, Xun] Shandong Univ, Qilu Hosp, Inst Basic Med Sci, Jinan 250100, Shandong, Peoples R China; [Brackenbury, Louise S.; Hill, Darryl J.; Williams, Neil A.; Virji, Mumtaz] Univ Bristol, Sch Cellular & Mol Med, Bristol, Avon, England	Shandong University; University of Bristol	Williams, NA (corresponding author), Univ Bristol, Sch Cellular & Mol Med, Bristol, Avon, England.	neil.a.williams@bristol.ac.uk; quxun@sdu.edu.cn	Xie, Qi/ABC-3042-2020	Xie, Qi/0000-0002-3152-9834	National Natural Science Foundation of China [81072406, 31270971, 31100650]; Independent Innovation Foundation of Shandong University [2012TS143]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Independent Innovation Foundation of Shandong University	This work was supported by the National Natural Science Foundation of China (Nos. 81072406, 31270971, 31100650) and the Independent Innovation Foundation of Shandong University (No. 2012TS143). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askew D, 2000, J IMMUNOL, V165, P6889, DOI 10.4049/jimmunol.165.12.6889; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; Bogoevska V, 2006, GLYCOBIOLOGY, V16, P197, DOI 10.1093/glycob/cwj057; Botling J, 1995, LEUKEMIA, V9, P2034; Boulton IC, 2002, NAT IMMUNOL, V3, P229, DOI 10.1038/ni769; Brubaker RR, 2003, INFECT IMMUN, V71, P3673, DOI 10.1128/IAI.71.7.3673-3681.2003; Conners R, 2008, EMBO J, V27, P1779, DOI 10.1038/emboj.2008.101; Delneste Y, 2003, BLOOD, V101, P143, DOI 10.1182/blood-2002-04-1164; DINARELLO CA, 1994, FASEB J, V8, P1314, DOI 10.1096/fasebj.8.15.8001745; Dominguez PM, 2010, IMMUNOL REV, V234, P90, DOI 10.1111/j.0105-2896.2009.00876.x; Fleischer J, 1996, IMMUNOLOGY, V89, P592, DOI 10.1046/j.1365-2567.1996.d01-785.x; Gazi U, 2009, IMMUNOBIOLOGY, V214, P554, DOI 10.1016/j.imbio.2008.11.004; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Gerstel D, 2011, ONCOGENE, V30, P4275, DOI 10.1038/onc.2011.146; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Gray-Owen SD, 2006, NAT REV IMMUNOL, V6, P433, DOI 10.1038/nri1864; Hallstrom T, 2011, J IMMUNOL, V186, P3120, DOI 10.4049/jimmunol.1002621; Han TH, 2009, J IMMUNOTHER, V32, P399, DOI 10.1097/CJI.0b013e31819e1773; Hill DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045452; Hill DJ, 2005, MOL MICROBIOL, V55, P1515, DOI 10.1111/j.1365-2958.2005.04487.x; Hill DJ, 2003, MOL MICROBIOL, V48, P117, DOI 10.1046/j.1365-2958.2003.03433.x; Hill DJ, 2001, MOL MICROBIOL, V39, P850, DOI 10.1046/j.1365-2958.2001.02233.x; Hoebe K, 2004, NAT IMMUNOL, V5, P971, DOI 10.1038/ni1004-971; Hoffmann R, 2004, CELL MICROBIOL, V6, P377, DOI 10.1111/j.1462-5822.2004.00365.x; Horst AK, 2009, BLOOD, V113, P6726, DOI 10.1182/blood-2008-10-184556; Huang J, 1999, J CELL SCI, V112, P4193; Kammerer R, 2001, J IMMUNOL, V166, P6537, DOI 10.4049/jimmunol.166.11.6537; Kerrigan AM, 2009, IMMUNOBIOLOGY, V214, P562, DOI 10.1016/j.imbio.2008.11.003; Lobo EO, 2009, J LEUKOCYTE BIOL, V86, P205, DOI 10.1189/jlb.0109037; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; McMichael JC, 2000, VACCINE, V19, pS101, DOI 10.1016/S0264-410X(00)00287-5; Meier PS, 2002, VACCINE, V20, P1754, DOI 10.1016/S0264-410X(02)00030-0; Muller MM, 2009, J CELL BIOL, V187, P569, DOI 10.1083/jcb.200904150; N'Guessan PD, 2007, J INFECT DIS, V195, P1651, DOI 10.1086/514820; Nagaishi T, 2006, IMMUNITY, V25, P769, DOI 10.1016/j.immuni.2006.08.026; Nouvion AL, 2009, M S-MED SCI, V25, P247, DOI 10.1051/medsci/2009253247; PEACH RJ, 1995, J BIOL CHEM, V270, P21181, DOI 10.1074/jbc.270.36.21181; Rahmoun M, 2009, J INVEST DERMATOL, V129, P671, DOI 10.1038/jid.2008.303; Riesbeck K, 2006, ACTA BIOCHIM POL, V53, P445; Rosseau S, 2005, AM J RESP CELL MOL, V32, P157, DOI 10.1165/rcmb.2004-0091OC; Rutkowski R, 2003, ARCH IMMUNOL THER EX, V51, P421; Skubitz KM, 1996, J LEUKOCYTE BIOL, V60, P106, DOI 10.1002/jlb.60.1.106; STAHL PD, 1992, CURR OPIN IMMUNOL, V4, P49, DOI 10.1016/0952-7915(92)90123-V; Stamper CC, 2001, NATURE, V410, P608, DOI 10.1038/35069118; Tacke F, 2006, IMMUNOBIOLOGY, V211, P609, DOI 10.1016/j.imbio.2006.05.025; Takashiba S, 1999, INFECT IMMUN, V67, P5573, DOI 10.1128/IAI.67.11.5573-5578.1999; THOMPSON JA, 1991, J CLIN LAB ANAL, V5, P344, DOI 10.1002/jcla.1860050510; Tiemessen MM, 2007, P NATL ACAD SCI USA, V104, P19446, DOI 10.1073/pnas.0706832104; van Gisbergen KPJM, 2005, FEBS LETT, V579, P6159, DOI 10.1016/j.febslet.2005.09.089; Virji M, 1999, MOL MICROBIOL, V34, P538, DOI 10.1046/j.1365-2958.1999.01620.x; Virji M, 1996, MOL MICROBIOL, V22, P929, DOI 10.1046/j.1365-2958.1996.01548.x; Wang YJ, 2010, J IMMUNOL, V185, P1822, DOI 10.4049/jimmunol.0903398; Youssef AR, 2009, INFECT IMMUN, V77, P5170, DOI 10.1128/IAI.00355-09; Yu QG, 2006, J BIOL CHEM, V281, P39179, DOI 10.1074/jbc.M608864200; Zhou CJ, 2009, ORAL ONCOL, V45, P883, DOI 10.1016/j.oraloncology.2009.03.002	56	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90999	10.1371/journal.pone.0090999	http://dx.doi.org/10.1371/journal.pone.0090999			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599281	Green Published, gold, Green Submitted			2022-12-27	WOS:000332479400150
J	Zhai, CG; Cheng, J; Mujahid, H; Wang, HF; Kong, J; Yin, Y; Li, JF; Zhang, Y; Ji, XP; Chen, WQ				Zhai, Chungang; Cheng, Jing; Mujahid, Haroon; Wang, Hefeng; Kong, Jing; Yin, Yue; Li, Jifu; Zhang, Yun; Ji, Xiaoping; Chen, Wenqiang			Selective Inhibition of PI3K/Akt/mTOR Signaling Pathway Regulates Autophagy of Macrophage and Vulnerability of Atherosclerotic Plaque	PLOS ONE			English	Article							AKT; SURVIVAL; DOMAIN	Macrophage infiltration contributes to the instability of atherosclerotic plaques. In the present study, we investigated whether selective inhibition of PI3K/Akt/mTOR signaling pathway can enhance the stability of atherosclerotic plaques by activation of macrophage autophagy. In vitro study, selective inhibitors or siRNA of PI3K/Akt/mTOR pathways were used to treat the rabbit's peritoneal primary macrophage cells. Inflammation related cytokines secreted by macrophages were measured. Ultrastructure changes of macrophages were examined by transmission electron microscope. mRNA or protein expression levels of autophagy related gene Beclin 1, protein 1 light chain 3 II dots (LC3-II) or Atg5-Atg12 conjugation were assayed by quantitative RT-PCR or Western blot. In vivo study, vulnerable plaque models were established in 40 New Zealand White rabbits and then drugs or siRNA were given for 8 weeks to inhibit the PI3K/Akt/mTOR signaling pathway. Intravascular ultrasound (IVUS) was performed to observe the plaque imaging. The ultrastructure of the abdominal aortic atherosclerosis lesions were analyzed with histopathology. RT-PCR or Western blot methods were used to measure the expression levels of corresponding autophagy related molecules. We found that macrophage autophagy was induced in the presence of Akt inhibitor, mTOR inhibitor and mTOR-siRNA in vitro study, while PI3K inhibitor had the opposite role. In vivo study, we found that macrophage autophagy increased significantly and the rabbits had lower plaque rupture incidence, lower plaque burden and decreased vulnerability index in the inhibitors or siRNA treated groups. We made a conclusion that selective inhibition of the Akt/mTOR signal pathway can reduce macrophages and stabilize the vulnerable atherosclerotic plaques by promoting macrophage autophagy.	[Ji, Xiaoping] Shandong Univ, Chinese Minist Educ, Key Lab Cardiovasc Remodeling & Funct Res, Qilu Hosp, Jinan 250100, Shandong, Peoples R China; Shandong Univ, Chinese Minist Hlth, Qilu Hosp, Jinan 250100, Shandong, Peoples R China	Shandong University; Shandong University	Ji, XP (corresponding author), Shandong Univ, Chinese Minist Educ, Key Lab Cardiovasc Remodeling & Funct Res, Qilu Hosp, Jinan 250100, Shandong, Peoples R China.	jxp64@163.com; chenwenqiang33@sina.com			National Natural Science Foundation of China [30971216, 30871040]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 30971216, No. 30871040). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berndt N, 2010, CELL DEATH DIFFER, V17, P1795, DOI 10.1038/cdd.2010.63; Chen WQ, 2007, AM J PHYSIOL-HEART C, V293, pH2836, DOI 10.1152/ajpheart.00472.2007; Chen WQ, 2009, BRIT J PHARMACOL, V156, P941, DOI 10.1111/j.1476-5381.2008.00102.x; Colecchia D, 2012, AUTOPHAGY, V8, P1724, DOI 10.4161/auto.21857; Greenberger S, 2011, J INVEST DERMATOL, V131, P2467, DOI 10.1038/jid.2011.300; Guo JP, 2011, J BIOL CHEM, V286, P37389, DOI 10.1074/jbc.M111.287433; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Harris J, 2008, J INFECT DIS, V198, P1842, DOI 10.1086/593174; Hopkins PN, 2013, PHYSIOL REV, V93, P1317, DOI 10.1152/physrev.00004.2012; Huda R, 2013, J AUTOIMMUN, V42, P94, DOI 10.1016/j.jaut.2013.01.003; Jia GH, 2006, IMMUNOL CELL BIOL, V84, P448, DOI 10.1111/j.1440-1711.2006.01454.x; Kang KH, 2009, TRENDS MOL MED, V15, P191, DOI 10.1016/j.molmed.2009.03.005; Kasiske BL, 2008, AM J TRANSPLANT, V8, P1384, DOI 10.1111/j.1600-6143.2008.02272.x; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Klionsky DJ, 2007, AUTOPHAGY, V3, P181, DOI 10.4161/auto.3678; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li XL, 2013, INFECT IMMUN, V81, P271, DOI 10.1128/IAI.00834-12; Libby P, 2002, NAT MED, V8, P1257, DOI 10.1038/nm1102-1257; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Martelli AM, 2010, BBA-MOL CELL RES, V1803, P991, DOI 10.1016/j.bbamcr.2010.04.005; Martinet W, 2009, CIRC RES, V104, P304, DOI 10.1161/CIRCRESAHA.108.188318; Mei S, 2011, J PHARMACOL EXP THER, V339, P487, DOI 10.1124/jpet.111.184341; Meijer Alfred J., 2006, Molecular Aspects of Medicine, V27, P411, DOI 10.1016/j.mam.2006.08.002; O'Garra A, 2009, NAT IMMUNOL, V10, P929, DOI 10.1038/ni0909-929; Park HJ, 2011, MOL IMMUNOL, V48, P720, DOI 10.1016/j.molimm.2010.10.020; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Razani B, 2012, CELL METAB, V15, P534, DOI 10.1016/j.cmet.2012.02.011; Ridker PM, 2005, NEW ENGL J MED, V352, P20, DOI 10.1056/NEJMoa042378; Singh R., 2012, INT J CELL BIOL, V2012, DOI DOI 10.1155/2012/282041; Sinnberg T, 2009, J INVEST DERMATOL, V129, P1500, DOI 10.1038/jid.2008.379; Subramaniam S, 2013, J NATL COMPR CANC NE, V11, P5, DOI 10.6004/jnccn.2013.0003; Takahashi Y, 2007, NAT CELL BIOL, V9, P1142, DOI 10.1038/ncb1634; Tenbaum SP, 2012, NAT MED, V18, P892, DOI 10.1038/nm.2772; Verheye S, 2007, J AM COLL CARDIOL, V49, P706, DOI 10.1016/j.jacc.2006.09.047; Williams H, 2002, ARTERIOSCL THROM VAS, V22, P788, DOI 10.1161/01.ATV.0000014587.66321.B4; You Z, 2013, FASEB J, V2; Zhong L, 2008, J CELL MOL MED, V12, P2362, DOI 10.1111/j.1582-4934.2008.00261.x	37	73	86	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90563	10.1371/journal.pone.0090563	http://dx.doi.org/10.1371/journal.pone.0090563			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599185	Green Published, gold, Green Submitted			2022-12-27	WOS:000332479400093
J	Ebrahimie, M; Esmaeili, F; Cheraghi, S; Houshmand, F; Shabani, L; Ebrahimie, E				Ebrahimie, Marzieh; Esmaeili, Fariba; Cheraghi, Somayeh; Houshmand, Fariba; Shabani, Leila; Ebrahimie, Esmaeil			Efficient and Simple Production of Insulin-Producing Cells from Embryonal Carcinoma Stem Cells Using Mouse Neonate Pancreas Extract, As a Natural Inducer	PLOS ONE			English	Article							VITRO TRANS-DIFFERENTIATION; NUTRITIONAL-STATUS; EXPRESSION; TISSUE; PLURIPOTENCY; REPLICATION; PROGENITOR; IMPROVES; NETWORKS; ISLETS	An attractive approach to replace the destroyed insulin-producing cells (IPCs) is the generation of functional beta cells from stem cells. Embryonal carcinoma (EC) stem cells are pluripotent cells which can differentiate into all cell types. The present study was carried out to establish a simple nonselective inductive culture system for generation of IPCs from P19 EC cells by 1-2 weeks old mouse pancreas extract (MPE). Since, mouse pancreatic islets undergo further remodeling and maturation for 2-3 weeks after birth, we hypothesized that the mouse neonatal MPE contains essential factors to induce in vitro differentiation of pancreatic lineages. Pluripotency of P19 cells were first confirmed by expression analysis of stem cell markers, Oct3/4, Sox-2 and Nanog. In order to induce differentiation, the cells were cultured in a medium supplemented by different concentrations of MPE (50, 100, 200 and 300 mg/ml). The results showed that P19 cells could differentiate into IPCs and form dithizone-positive cell clusters. The generated P19-derived IPCs were immunoreactive to proinsulin, insulin and insulin receptor beta. The expression of pancreatic beta cell genes including, PDX-1, INS1 and INS2 were also confirmed. The peak response at the 100 mg/ml MPE used for investigation of EP300 and CREB1 gene expression. When stimulated with glucose, these cells synthesized and secreted insulin. Network analysis of the key transcription factors (PDX-1, EP300, CREB1) during the generation of IPCs resulted in introduction of novel regulatory candidates such as MIR17, and VEZF1 transcription factors, as well as MORN1, DKFZp761P0212, and WAC proteins. Altogether, we demonstrated the possibility of generating IPCs from undifferentiated EC cells, with the characteristics of pancreatic beta cells. The derivation of pancreatic cells from EC cells which are ES cell siblings would provide a valuable experimental tool in study of pancreatic development and function as well as rapid production of IPCs for transplantation.	[Ebrahimie, Marzieh; Shabani, Leila] Shahrekord Univ, Fac Basic Sci, Dept Biol, Shahrekord, Iran; [Esmaeili, Fariba] Univ Isfahan, Fac Basic Sci, Dept Biol, Esfahan, Iran; [Esmaeili, Fariba; Shabani, Leila] Shahrekord Univ, Biotechnol Res Inst, Shahrekord, Iran; [Cheraghi, Somayeh] Azad Islamic Univ Shahrekord, Fac Basic Sci, Dept Biol, Shahrekord, Iran; [Houshmand, Fariba] Shahrekord Univ Med Sci, Dept Physiol, Fac Med Sci, Shahrekord, Iran; [Ebrahimie, Esmaeil] Shiraz Univ, Inst Biotechnol, Shiraz, Iran; [Ebrahimie, Esmaeil] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA, Australia	Shahrekord University; University of Isfahan; Shahrekord University; Islamic Azad University; Shahrekord University Medical Sciences; Shiraz University; University of Adelaide	Ebrahimie, E (corresponding author), Shiraz Univ, Inst Biotechnol, Shiraz, Iran.	esmaeili-f@sci.sku.ac.ir	Ebrahimi, Mansour/AAO-9096-2021; Ebrahimie, Esmaeil/AAN-2611-2020; Shabani, Leila/ABA-2527-2021; Houshmand, Fariba/K-2445-2017	Ebrahimi, Mansour/0000-0001-7011-2567; Ebrahimie, Esmaeil/0000-0002-4431-2861; Shabani, Leila/0000-0001-6194-4708; Houshmand, Fariba/0000-0002-2836-9884	Shahrekord University	Shahrekord University	The work carried out in the institute was supported by grant from Shahrekord University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assady S, 2001, DIABETES, V50, P1691, DOI 10.2337/diabetes.50.8.1691; Bai L, 2005, J ENDOCRINOL, V186, P343, DOI 10.1677/joe.1.06078; BANTING FG, 1991, CAN MED ASSOC J, V145, P1281; Blyszczuk P, 2004, INT J DEV BIOL, V48, P1095, DOI 10.1387/ijdb.041904pb; Blyszczuk P, 2003, P NATL ACAD SCI USA, V100, P998, DOI 10.1073/pnas.0237371100; Bonner-Weir S, 2000, P NATL ACAD SCI USA, V97, P7999, DOI 10.1073/pnas.97.14.7999; Brolen GKC, 2005, DIABETES, V54, P2867, DOI 10.2337/diabetes.54.10.2867; Chambon-Savanovitch C, 2001, J NUTR, V131, P813, DOI 10.1093/jn/131.3.813; Choi KS, 2005, BIOCHEM BIOPH RES CO, V330, P1299, DOI 10.1016/j.bbrc.2005.03.111; Crisera CA, 2000, DIFFERENTIATION, V65, P255, DOI 10.1046/j.1432-0436.2000.6550255.x; Farges MC, 1996, NUTRITION, V12, P189, DOI 10.1016/S0899-9007(96)91124-7; Fujikawa T, 2005, AM J PATHOL, V166, P1781, DOI 10.1016/S0002-9440(10)62488-1; FURUKAWA M, 1995, ENDOCR J, V42, P63, DOI 10.1507/endocrj.42.63; Guo W, 2009, CELL PROLIFERAT, V42, P49, DOI 10.1111/j.1365-2184.2008.00573.x; Habener JF, 2005, ENDOCRINOLOGY, V146, P1025, DOI 10.1210/en.2004-1576; Hardikar AA, 1999, DIABETES RES CLIN PR, V46, P203, DOI 10.1016/S0168-8227(99)00098-4; Hori Y, 2002, P NATL ACAD SCI USA, V99, P16105, DOI 10.1073/pnas.252618999; Hosseinpour B, 2013, GENE, V531, P212, DOI 10.1016/j.gene.2013.09.011; Hu HL, 2012, MOL VIS, V18, P2388; Kahan BW, 2003, DIABETES, V52, P2016, DOI 10.2337/diabetes.52.8.2016; Khoo TS, 2013, DIFFERENTIATION, V85, P110, DOI 10.1016/j.diff.2013.01.004; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kim YS, 2003, BIOCHEM BIOPH RES CO, V309, P528, DOI 10.1016/j.bbrc.2003.07.011; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Kunisada Y, 2012, STEM CELL RES, V8, P274, DOI 10.1016/j.scr.2011.10.002; Lee J, 2008, BIOCHEM BIOPH RES CO, V375, P547, DOI 10.1016/j.bbrc.2008.08.064; Liu J, 2013, ACTA GEOL SIN-ENGL, V87, P1501, DOI 10.1111/1755-6724.12154; Lumelsky N, 2001, SCIENCE, V292, P1389, DOI 10.1126/science.1058866; Miyazaki S, 2004, DIABETES, V53, P1030, DOI 10.2337/diabetes.53.4.1030; Niwa H, 2001, CELL STRUCT FUNCT, V26, P137, DOI 10.1247/csf.26.137; Obayashi T, 2013, NUCLEIC ACIDS RES, V41, pD1014, DOI 10.1093/nar/gks1014; Obayashi T, 2011, NUCLEIC ACIDS RES, V39, pD1016, DOI 10.1093/nar/gkq1147; Obayashi T, 2009, DNA RES, V16, P249, DOI 10.1093/dnares/dsp016; Okabe S, 1996, MECH DEVELOP, V59, P89, DOI 10.1016/0925-4773(96)00572-2; Pan GJ, 2007, CELL RES, V17, P42, DOI 10.1038/sj.cr.7310125; Pandey S., 2010, INT J PHARM SCI REV, V1, P68; RABINOVITCH A, 1982, DIABETES, V31, P160, DOI 10.2337/diabetes.31.2.160; Reddy S, 2000, PANCREAS, V20, P55, DOI 10.1097/00006676-200001000-00008; Ren JQ, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-1; Shin JS, 2005, BBA-PROTEINS PROTEOM, V1749, P23, DOI 10.1016/j.bbapap.2005.02.003; Shiroi A, 2005, WORLD J GASTROENTERO, V11, P4161; Soria B, 2000, DIABETES, V49, P157, DOI 10.2337/diabetes.49.2.157; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; SWENNE I, 1987, DIABETES, V36, P288, DOI 10.2337/diabetes.36.3.288; Trounson A, 2006, ENDOCR REV, V27, P208, DOI 10.1210/er.2005-0016; Xu YX, 2009, TRANSPL P, V41, P1878, DOI 10.1016/j.transproceed.2009.01.087; Yang LJ, 2002, P NATL ACAD SCI USA, V99, P8078, DOI 10.1073/pnas.122210699; Zhang Yanmei, 2012, Sheng Wu Gong Cheng Xue Bao, V28, P214	48	30	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e90885	10.1371/journal.pone.0090885	http://dx.doi.org/10.1371/journal.pone.0090885			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614166	Green Published, Green Submitted, gold			2022-12-27	WOS:000332839300050
J	Gao, X; Xu, N; Li, SB; Liu, LM				Gao, Xiang; Xu, Nan; Li, Shubo; Liu, Liming			Metabolic Engineering of Candida glabrata for Diacetyl Production	PLOS ONE			English	Article							ALPHA-ACETOLACTATE DECARBOXYLASE; ENHANCED PYRUVATE PRODUCTION; SACCHAROMYCES-CEREVISIAE; TORULOPSIS-GLABRATA; BACILLUS-SUBTILIS; ESCHERICHIA-COLI; LACTOCOCCUS-LACTIS; CARBON FLUX; YEAST; SYNTHASE	In this study, Candida glabrata, an efficient pyruvate-producing strain, was metabolically engineered for the production of the food ingredient diacetyl. A diacetyl biosynthetic pathway was reconstructed based on genetic modifications and medium optimization. The former included (i) channeling carbon flux into the diacetyl biosynthetic pathway by amplification of acetolactate synthase, (ii) elimination of the branched pathway of alpha-acetolactate by deleting the ILV5 gene, and (iii) restriction of diacetyl degradation by deleting the BDH gene. The resultant strain showed an almost 1:1 co-production of alpha-acetolactate and diacetyl (0.95 g L-1). Furthermore, addition of Fe3+ to the medium enhanced the conversion of alpha-acetolactate to diacetyl and resulted in a two-fold increase in diacetyl production (2.1 g L-1). In addition, increased carbon flux was further channeled into diacetyl biosynthetic pathway and a titer of 4.7 g L-1 of diacetyl was achieved by altering the vitamin level in the flask culture. Thus, this study illustrates that C. glabrata could be tailored as an attractive platform for enhanced biosynthesis of beneficial products from pyruvate by metabolic engineering strategies.	[Gao, Xiang; Xu, Nan; Li, Shubo; Liu, Liming] Jiangnan Univ, State Key Lab Food Sci & Technol, Wuxi, Jiangsu, Peoples R China; [Gao, Xiang; Xu, Nan; Li, Shubo; Liu, Liming] Jiangnan Univ, Sch Biotechnol, Key Lab Ind Biotechnol, Minist Educ, Wuxi, Jiangsu, Peoples R China; [Gao, Xiang; Xu, Nan; Li, Shubo; Liu, Liming] Jiangnan Univ, Lab Food Microbial Mfg Engn, Wuxi, Jiangsu, Peoples R China	Jiangnan University; Jiangnan University; Jiangnan University	Liu, LM (corresponding author), Jiangnan Univ, State Key Lab Food Sci & Technol, Wuxi, Jiangsu, Peoples R China.	mingll@jiangnan.edu.cn	Liu, Liming/B-1972-2009	Liu, Liming/0000-0003-3022-936X; Xu, Nan/0000-0002-2510-3394	Supporting Program for Outstanding National Young Talents; Science Foundation for Distinguished Young Scholars of Jiangsu Province [BK2012002]; Program for Innovative Research Team of Ministry of Education of China [IRT1249]; Major State Basic Research Development Program of China (973 Program) [2013CB733600]; National Natural Science Foundation of China [31270079];  [CLE01N1111]	Supporting Program for Outstanding National Young Talents; Science Foundation for Distinguished Young Scholars of Jiangsu Province; Program for Innovative Research Team of Ministry of Education of China; Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 	This work was supported by the Supporting Program for Outstanding National Young Talents, the fund from Wuxi City (CLE01N1111), the Science Foundation for Distinguished Young Scholars of Jiangsu Province (BK2012002), the Program for Innovative Research Team of Ministry of Education of China (IRT1249), the Major State Basic Research Development Program of China (973 Program, 2013CB733600) and National Natural Science Foundation of China (31270079). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atsumi S, 2009, APPL ENVIRON MICROB, V75, P6306, DOI 10.1128/AEM.01160-09; Bateman JM, 2002, J BIOL CHEM, V277, P47946, DOI 10.1074/jbc.M209071200; Chen DW, 2007, FOOD CHEM, V103, P1343, DOI 10.1016/j.foodchem.2006.10.047; CHUANG LF, 1968, J BACTERIOL, V95, P2083, DOI 10.1128/JB.95.6.2083-2089.1968; Dasari S, 2011, APPL ENVIRON MICROB, V77, P727, DOI 10.1128/AEM.01579-10; Duong CT, 2011, METAB ENG, V13, P638, DOI 10.1016/j.ymben.2011.07.005; Ehsani M, 2009, APPL ENVIRON MICROB, V75, P3196, DOI 10.1128/AEM.02157-08; FALCO SC, 1985, NUCLEIC ACIDS RES, V13, P4011, DOI 10.1093/nar/13.11.4011; GOLLOP N, 1987, ANAL BIOCHEM, V160, P323, DOI 10.1016/0003-2697(87)90054-6; GOLLOP N, 1990, J BACTERIOL, V172, P3444, DOI 10.1128/jb.172.6.3444-3449.1990; Gonzalez E, 2000, J BIOL CHEM, V275, P35876, DOI 10.1074/jbc.M003035200; Gonzalez E, 2010, APPL ENVIRON MICROB, V76, P670, DOI 10.1128/AEM.01521-09; Guo TT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036296; HOLTZCLAW WD, 1975, J BACTERIOL, V121, P917, DOI 10.1128/JB.121.3.917-922.1975; Hugenholtz J, 2000, APPL ENVIRON MICROB, V66, P4112, DOI 10.1128/AEM.66.9.4112-4114.2000; Li Y, 2001, APPL MICROBIOL BIOT, V55, P680, DOI 10.1007/s002530100598; Liu LM, 2007, BIOTECHNOL BIOENG, V97, P825, DOI 10.1002/bit.21290; Liu LM, 2007, METAB ENG, V9, P21, DOI 10.1016/j.ymben.2006.07.007; Liu LM, 2006, APPL MICROBIOL BIOT, V72, P377, DOI 10.1007/s00253-005-0284-3; Liu LM, 2004, LETT APPL MICROBIOL, V39, P199, DOI 10.1111/j.1472-765X.2004.01563.x; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Macierzanka M, 2008, BBA-MOL CELL RES, V1783, P107, DOI 10.1016/j.bbamcr.2007.09.009; MITHIEUX SM, 1995, YEAST, V11, P311, DOI 10.1002/yea.320110403; Mohr B, 1997, INT DAIRY J, V7, P701, DOI 10.1016/S0958-6946(97)00074-5; Monnet C, 2000, APPL ENVIRON MICROB, V66, P5518, DOI 10.1128/AEM.66.12.5518-5520.2000; Monnet C, 2007, FOOD MICROBIOL, V24, P601, DOI 10.1016/j.fm.2007.01.004; Nadal I, 2009, J IND MICROBIOL BIOT, V36, P1233, DOI 10.1007/s10295-009-0617-9; Ng CY, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-68; Omura F, 2008, APPL MICROBIOL BIOT, V78, P503, DOI 10.1007/s00253-007-1333-x; Ott A, 1997, J AGR FOOD CHEM, V45, P850, DOI 10.1021/jf960508e; Park JH, 2007, P NATL ACAD SCI USA, V104, P7797, DOI 10.1073/pnas.0702609104; POULSEN C, 1989, EUR J BIOCHEM, V185, P433, DOI 10.1111/j.1432-1033.1989.tb15133.x; RENNA MC, 1993, J BACTERIOL, V175, P3863, DOI 10.1128/JB.175.12.3863-3875.1993; Shin SH, 2012, J BACTERIOL, V194, P2371, DOI 10.1128/JB.00026-12; Wang YP, 2013, CURR OPIN BIOTECH, V24, P994, DOI 10.1016/j.copbio.2013.03.022; Xu N, 2013, MOL BIOSYST, V9, P205, DOI 10.1039/c2mb25311a; ZELENAYATROITSKAYA O, 1995, EMBO J, V14, P3268, DOI 10.1002/j.1460-2075.1995.tb07330.x; Zhang YJ, 2013, BIORESOURCE TECHNOL, V130, P256, DOI 10.1016/j.biortech.2012.10.036; Zhao L, 2009, WORLD J MICROB BIOT, V25, P57, DOI 10.1007/s11274-008-9862-8; Zhou JW, 2009, J MICROBIOL METH, V76, P70, DOI 10.1016/j.mimet.2008.09.011	40	12	14	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e89854	10.1371/journal.pone.0089854	http://dx.doi.org/10.1371/journal.pone.0089854			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614328	Green Submitted, Green Published, gold			2022-12-27	WOS:000332839300014
J	Juel, C; Nordsborg, NB; Bangsbo, J				Juel, Carsten; Nordsborg, Nikolai B.; Bangsbo, Jens			Purinergic Effects on Na,K-ATPase Activity Differ in Rat and Human Skeletal Muscle	PLOS ONE			English	Article							EXERCISE; RECEPTOR; ATPASE; PHOSPHORYLATION; PHOSPHOLEMMAN; ACTIVATION; ADENOSINE; AFFINITY; CLONING; FXYD1	Background: P2Y receptor activation may link the effect of purines to increased maximal in vitro activity of the Na, K-ATPase in rat muscle. The hypothesis that a similar mechanism is present in human skeletal muscle was investigated with membranes from rat and human skeletal muscle. Results: Membranes purified from rat and human muscles were used in the Na, K-ATPase assay. Incubation with ADP, the stable ADP analogue MeS-ADP and UDP increased the Na+ dependent Na, K-ATPase activity in rat muscle membranes, whereas similar treatments of human muscle membranes lowered the Na, K-ATPase activity. UTP incubation resulted in unchanged Na, K-ATPase activity in humans, but pre-incubation with the antagonist suramin resulted in inhibition with UTP, suggesting that P2Y receptors are involved. The Na, K-ATPase in membranes from both rat and human could be stimulated by protein kinase A and C activation. Thus, protein kinase A and C activation can increase Na, K-ATPase activity in human muscle but not via P2Y receptor stimulation. Conclusion: The inhibitory effects of most purines (with the exception of UTP) in human muscle membranes are probably due to mass law inhibition of ATP hydrolysis. This inhibition could be blurred in rat due to receptor mediated activation of the Na, K-ATPase. The different effects could be related to a high density of ADP sensitive P2Y1 and P2Y13 receptors in rat, whereas the UTP sensitive P2Y(11) could be more abundant in human. Alternatively, rat could possesses a mechanism for protein-protein interaction between P2Y receptors and the Na, K-ATPase, and this mechanism could be absent in human skeletal muscle (perhaps with the exception of the UTP sensitive P2Y(11) receptor). Perspective: Rat muscle is not a reliable model for purinergic effects on Na, K-ATPase in human skeletal muscle.	[Juel, Carsten] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Nordsborg, Nikolai B.; Bangsbo, Jens] Univ Copenhagen, Dept Nutr Exercise & Sport, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen	Juel, C (corresponding author), Univ Copenhagen, Dept Biol, Copenhagen, Denmark.	cjuel@bio.ku.dk	Juel, Carsten/J-5328-2014; Bangsbo, Jens/A-7192-2015; Nordsborg, Nikolai/O-6173-2014	Juel, Carsten/0000-0002-2373-6358; Bangsbo, Jens/0000-0003-1305-9274; Nordsborg, Nikolai/0000-0001-7077-9265	Lundbeck Foundation [R83-A8169]; Carlsberg Foundation [2010-01-0641]; FNU [11-107221]	Lundbeck Foundation(Lundbeckfonden); Carlsberg Foundation(Carlsberg Foundation); FNU(Danish Natural Science Research Council)	The Lundbeck Foundation (R83-A8169), The Carlsberg Foundation (2010-01-0641), FNU (11-107221). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbracchio MP, 2006, PHARMACOL REV, V58, P281, DOI 10.1124/pr.58.3.3; Bibert S, 2008, J BIOL CHEM, V283, P476, DOI 10.1074/jbc.M705830200; Borno A, 2012, PURINERG SIGNAL, V8, P255, DOI 10.1007/s11302-011-9279-y; Broch-Lips M, 2010, AM J PHYSIOL-CELL PH, V298, pC1438, DOI 10.1152/ajpcell.00361.2009; Buvinic S, 2009, J BIOL CHEM, V284, P34490, DOI 10.1074/jbc.M109.057315; Clausen T, 2003, PHYSIOL REV, V83, P1269, DOI 10.1152/physrev.00011.2003; FORRESTER T, 1969, FED PROC, V28, P1280; Fumagalli M, 2004, BIOCHEM PHARMACOL, V68, P113, DOI 10.1016/j.bcp.2004.02.038; Juel C, 2013, AM J PHYSIOL-REG I, V304, pR1161, DOI 10.1152/ajpregu.00591.2012; Juel C, 2009, AM J PHYSIOL-REG I, V296, pR125, DOI 10.1152/ajpregu.90760.2008; KUGELGEN IV, 2008, BIOTREND REV, V3; Mortensen SP, 2009, AM J PHYSIOL-REG I, V296, pR1140, DOI 10.1152/ajpregu.90822.2008; Tamiya S, 2007, AM J PHYSIOL-CELL PH, V293, pC790, DOI 10.1152/ajpcell.00579.2006; Thomassen M, 2011, AM J PHYSIOL-REG I, V301, pR1808, DOI 10.1152/ajpregu.00066.2011; Walas H, 2012, PFLUG ARCH EUR J PHY, V463, P319, DOI 10.1007/s00424-011-1050-2; Webb TE, 1998, J NEUROCHEM, V71, P1348	16	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91175	10.1371/journal.pone.0091175	http://dx.doi.org/10.1371/journal.pone.0091175			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614174	gold, Green Published			2022-12-27	WOS:000332839300089
J	Lewis, B; Whitney, S; Hudacik, L; Galmin, L; Huaman, MC; Cristillo, AD				Lewis, Brad; Whitney, Stephen; Hudacik, Lauren; Galmin, Lindsey; Huaman, Maria Cecilia; Cristillo, Anthony D.			Nedd4-Mediated Increase in HIV-1 Gag and Env Proteins and Immunity following DNA-Vaccination of BALB/c Mice	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; MURINE LEUKEMIA-VIRUS; LATE-BUDDING DOMAINS; ROUS-SARCOMA-VIRUS; LATE ASSEMBLY DOMAIN; E3 UBIQUITIN LIGASE; TSG101 UEV DOMAIN; SIMIAN IMMUNODEFICIENCY; MULTIVESICULAR BODY; PARTICLE RELEASE	The late assembly domain of many viruses is critical for budding. Within these domains, encoded in viral structural proteins, are the conserved motifs PTAP, PPxY and YPxL. These sequences are the key determinants for association of viral proteins with intracellular molecules such as Tsg101, Nedd4 and AIP1/ALIX. While roles for Tsg101 and AIP1/ALIX in HIV-1 budding have been well established, less is known about the role of Nedd4. Recent studies, however, have identified a function for Nedd4-like protein in HIV-1 release. In this study, we investigated post-transcriptional changes of Nedd4 following SHIVSF162P3 infection of rhesus macaques, its role on HIV-1 p24 and gp120 levels in vitro and its potential as an immune modulator in HIV vaccination of BALB/c mice. Increased Nedd4 protein levels were noted in both CD4(+) and CD8(+) T cells following SHIVSF162P3-infection of naive macaques. Transient co-transfection studies in 293 cells with HXB2 and Nedd4 demonstrated a Nedd4-mediated increase in p24 and gp120 levels. This increase was found to be dependent on the Ca2+/calmodulin-regulated phospholipid binding C2 domain and not ubiquitin ligase activity or HIV LTR activity. Co-transfection of Nedd4 with plasmid DNA expressing Gag or Env was further shown to augment both intracellular and extracellular Gag or Env proteins. To assess the potential of Nedd4 as an immune modulator, BALB/c mice were immunized intramuscularly with plasmid DNA encoding HIV gag, env and Nedd4. Nedd4 co-administration was found to increase serum anti-p24 but not anti-gp120 antibodies. Nedd4 co-injection was found to have no affect on Gag-or Env-specific IFN gamma but had a trend of increased Gag-specific IL-6, IL-17A and TNF alpha that was not seen following Env stimulation. Based on our initial findings, Nedd4-mediated changes in HIV protein levels and its potential use in HIV-1 vaccine development warrants further investigation.	[Lewis, Brad; Whitney, Stephen; Hudacik, Lauren; Galmin, Lindsey; Huaman, Maria Cecilia; Cristillo, Anthony D.] Adv BioSci Labs Inc, Rockville, MD 20850 USA		Cristillo, AD (corresponding author), Adv BioSci Labs Inc, Rockville, MD 20850 USA.	anthony.cristillo@ablinc.com						Amit I, 2004, GENE DEV, V18, P1737, DOI 10.1101/gad.294904; Bieniasz PD, 2006, VIROLOGY, V344, P55, DOI 10.1016/j.virol.2005.09.044; Blot V, 2004, J CELL SCI, V117, P2357, DOI 10.1242/jcs.01095; Calistri A, 2009, J CELL PHYSIOL, V218, P175, DOI 10.1002/jcp.21587; Camus G, 2007, MOL BIOL CELL, V18, P3193, DOI 10.1091/mbc.E06-12-1147; Chung HY, 2008, J VIROL, V82, P4884, DOI 10.1128/JVI.02667-07; Cristillo AD, 2006, VIROLOGY, V346, P151, DOI 10.1016/j.virol.2005.10.038; Cristillo AD, 2008, BIOCHEM BIOPH RES CO, V366, P29, DOI 10.1016/j.bbrc.2007.11.052; Cristillo AD, 2007, VIROLOGY, V366, P197, DOI 10.1016/j.virol.2007.04.012; Demirov DG, 2002, P NATL ACAD SCI USA, V99, P955, DOI 10.1073/pnas.032511899; DIBRINO M, 1994, J IMMUNOL, V152, P620; Dussupt V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000339; Fischer W, 2007, NAT MED, V13, P100, DOI 10.1038/nm1461; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; Goila-Gaur R, 2003, J VIROL, V77, P6507, DOI 10.1128/JVI.77.11.6507-6519.2003; GOTTLINGER HG, 1991, P NATL ACAD SCI USA, V88, P3195, DOI 10.1073/pnas.88.8.3195; HUANG MJ, 1995, J VIROL, V69, P6810, DOI 10.1128/JVI.69.11.6810-6818.1995; Humeau LM, 2004, MOL THER, V9, P902, DOI 10.1016/j.ymthe.2004.03.005; Kikonyogo A, 2001, P NATL ACAD SCI USA, V98, P11199, DOI 10.1073/pnas.201268998; Lee EM, 2010, J VIROL METHODS, V163, P287, DOI 10.1016/j.jviromet.2009.10.012; Li F, 2002, J VIROL, V76, P1569, DOI 10.1128/JVI.76.4.1569-1577.2002; Licata JM, 2003, J VIROL, V77, P1812, DOI 10.1128/JVI.77.3.1812-1819.2003; Martin-Serrano J, 2005, J CELL BIOL, V168, P89, DOI 10.1083/jcb.200408155; Martin-Serrano J, 2003, J VIROL, V77, P12373, DOI 10.1128/JVI.77.22.12373-12377.2003; Martin-Serrano J, 2003, P NATL ACAD SCI USA, V100, P12414, DOI 10.1073/pnas.2133846100; Martin-Serrano J, 2003, J VIROL, V77, P4794, DOI 10.1128/JVI.77.8.4794-4804.2003; Medina G, 2005, TRAFFIC, V6, P880, DOI 10.1111/j.1600-0854.2005.00323.x; Medina G, 2008, VIROLOGY, V377, P30, DOI 10.1016/j.virol.2008.04.024; Morita E, 2004, ANNU REV CELL DEV BI, V20, P395, DOI 10.1146/annurev.cellbio.20.010403.102350; Nydegger S, 2003, TRAFFIC, V4, P902, DOI 10.1046/j.1600-0854.2003.00145.x; Ono A, 2004, J VIROL, V78, P1552, DOI 10.1128/JVI.78.3.1552-1563.2004; Ott DE, 1998, J VIROL, V72, P2962, DOI 10.1128/JVI.72.4.2962-2968.1998; Patnaik A, 2000, P NATL ACAD SCI USA, V97, P13069, DOI 10.1073/pnas.97.24.13069; Pelchen-Matthews A, 2003, J CELL BIOL, V162, P443, DOI 10.1083/jcb.200304008; Pornillos O, 2002, EMBO J, V21, P2397, DOI 10.1093/emboj/21.10.2397; Pornillos O, 2002, NAT STRUCT BIOL, V9, P812, DOI 10.1038/nsb856; Puffer BA, 1997, J VIROL, V71, P6541, DOI 10.1128/JVI.71.9.6541-6546.1997; Ramon HE, 2012, J IMMUNOL, V188, P4023, DOI 10.4049/jimmunol.1102779; Resh MD, 2005, AIDS REV, V7, P84; Schubert U, 2000, P NATL ACAD SCI USA, V97, P13057, DOI 10.1073/pnas.97.24.13057; Segura-Morales C, 2005, J BIOL CHEM, V280, P27004, DOI 10.1074/jbc.M413735200; Sette P, 2010, J VIROL, V84, P8181, DOI 10.1128/JVI.00634-10; Snyder PM, 2004, J BIOL CHEM, V279, P5042, DOI 10.1074/jbc.M312477200; Strack B, 2003, CELL, V114, P689, DOI 10.1016/S0092-8674(03)00653-6; Thurmond J, 2008, BIOINFORMATICS, V24, P1639, DOI 10.1093/bioinformatics/btn251; Usami Y, 2008, J VIROL, V82, P4898, DOI 10.1128/JVI.02675-07; Vana ML, 2004, J VIROL, V78, P13943, DOI 10.1128/JVI.78.24.13943-13953.2004; VerPlank L, 2001, P NATL ACAD SCI USA, V98, P7724, DOI 10.1073/pnas.131059198; von Schwedler UK, 2003, CELL, V114, P701, DOI 10.1016/S0092-8674(03)00714-1; von Schwedler UK, 2003, J VIROL, V77, P5439, DOI 10.1128/JVI.77.9.5439-5450.2003; Weiss ER, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001107; WILLEY RL, 1988, P NATL ACAD SCI USA, V85, P9580, DOI 10.1073/pnas.85.24.9580; Xiang Y, 1996, J VIROL, V70, P5695, DOI 10.1128/JVI.70.8.5695-5700.1996; Yasuda J, 1998, J VIROL, V72, P4095, DOI 10.1128/JVI.72.5.4095-4103.1998; Yasuda J, 2003, J VIROL, V77, P9987, DOI 10.1128/JVI.77.18.9987-9992.2003; Yuan B, 2000, J VIROL, V74, P7250, DOI 10.1128/JVI.74.16.7250-7260.2000	56	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91267	10.1371/journal.pone.0091267	http://dx.doi.org/10.1371/journal.pone.0091267			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614057	Green Published, gold, Green Submitted			2022-12-27	WOS:000332839300105
J	Zhang, JQ; Chen, LH; Chen, YF; Wang, WW; Cheng, L; Zhou, XD; Wang, J				Zhang, Jiuquan; Chen, Lihua; Chen, Yongfeng; Wang, Wenwei; Cheng, Lin; Zhou, Xiangdong; Wang, Jian			Tumor Vascularity and Glucose Metabolism Correlated in Adenocarcinoma, but Not in Squamous Cell Carcinoma of the Lung	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; CONTRAST-ENHANCED MRI; GROUND-GLASS OPACITY; BLOOD-FLOW; FDG UPTAKE; CANCER; CT; ANGIOGENESIS; GROWTH; VOLUME	Background/Objectives: To prospectively examine the relation between tumor vascularity and glucose metabolism in adenocarcinoma (AC) and squamous cell carcinoma(SCC) of the lung by using positron emission tomography/computed tomography (PET/CT) and dynamic contrast enhanced magnetic resonance imaging (DCE-MRI). Materials and Methods: Forty-one consecutive patients with histologically confirmed untreated NSCLC underwent routine diagnostic work-up, including DCE-MRI and PET/CT. PET/CT images were used to derive glucose metabolism (SUVmax and SUVmean), and DCE-MRI images were used to derive tumor vascularity (Ktrans, Kep, Ve and iAUC). Any differences in the DCE-MRI and PET/CT estimations between the NSCLC subtypes were determined by the Wilcoxon rank sum test. Spearman's rank correlation coefficients were calculated between the DCE-MRI parameter values and the SUV. Results: SUVmean and SUVmax in AC were significantly lower than in SCC, but Ktrans and Ve in AC were significantly higher than in SCC. Significant correlations between SUV and DCE-MRI parameters were observed for SUVmax and Ve (rho = -0.357, P = 0.022), SUVmean and Ktrans (rho = -0.341, P = 0.029), and SUVmean and iAUC (rho = -0.374, P = 0.016) in total; for SUVmax and iAUC (rho = -0.420, P = 0.037), SUVmean and Ktrans (rho = -0.411, P = 0.041), SUVmean and Kep (rho = -0.045, P = 0.026), and SUVmean and iAUC (rho = -0.512, P = 0.009) in AC; However, for neither in SCC. Conclusion: AC and SCC showed different patterns in both tumor vascularity and glucose metabolism. Tumor vascularity and glucose metabolism negatively correlated in AC, but not in SCC. These differences may underlie the heterogeneity in clinical aspect of NSCLC subtypes and have implications for their imaging profiling and monitor the treatment response.	[Zhang, Jiuquan; Chen, Lihua; Cheng, Lin; Wang, Jian] Third Mil Med Univ, Southwest Hosp, Dept Radiol, Chongqing, Peoples R China; [Chen, Yongfeng; Wang, Wenwei; Zhou, Xiangdong] Third Mil Med Univ, Southwest Hosp, Dept Resp Med, Chongqing, Peoples R China	Army Medical University; Army Medical University	Zhou, XD (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Resp Med, Chongqing, Peoples R China.	zhouxd_sw@163.com; wangjian_811@yahoo.com	ZHANG, JIUQUAN/X-8389-2019	Chen, Lihua/0000-0001-7249-2014; Chen, Lihua/0000-0001-5037-050X; Zhang, Jiuquan/0000-0003-0239-6988				Aronen HJ, 2000, CLIN CANCER RES, V6, P2189; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; Brambilla E, 2001, EUR RESPIR J, V18, P1059, DOI 10.1183/09031936.01.00275301; Brown RS, 1999, J NUCL MED, V40, P556; CLAYTON F, 1986, CANCER, V57, P1555, DOI 10.1002/1097-0142(19860415)57:8<1555::AID-CNCR2820570820>3.0.CO;2-N; de Geus-Oei LF, 2007, LUNG CANCER, V55, P79, DOI 10.1016/j.lungcan.2006.08.018; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Garber K, 2004, J NATL CANCER I, V96, P1805, DOI 10.1093/jnci/96.24.1805; George ML, 2001, BRIT J SURG, V88, P1628, DOI 10.1046/j.0007-1323.2001.01947.x; Giaccone G, 2005, J CLIN ONCOL, V23, P3235, DOI 10.1200/JCO.2005.08.409; Hoekstra CJ, 2002, CLIN CANCER RES, V8, P2109; Hunter GJ, 1998, CLIN CANCER RES, V4, P949; Kodama K, 2001, LUNG CANCER-J IASLC, V33, P17, DOI 10.1016/S0169-5002(01)00185-4; Komar G, 2009, CLIN CANCER RES, V15, P5511, DOI 10.1158/1078-0432.CCR-09-0414; Kuriyama K, 1999, AM J ROENTGENOL, V173, P465, DOI 10.2214/ajr.173.2.10430155; Lee KS, 1997, RADIOGRAPHICS, V17, P1345, DOI 10.1148/radiographics.17.6.9397450; Lee Y, 2013, KOREAN J RADIOL, V14, P375, DOI 10.3348/kjr.2013.14.2.375; Mankoff DA, 2002, J NUCL MED, V43, P500; Mankoff DA, 2009, CLIN CANCER RES, V15, P5294, DOI 10.1158/1078-0432.CCR-09-1448; Miles KA, 2008, CANCER IMAGING, V8, P81, DOI 10.1102/1470-7330.2008.0011; Miles KA, 2006, EUR J NUCL MED MOL I, V33, P22, DOI 10.1007/s00259-005-1932-7; NESBITT JC, 1995, ANN THORAC SURG, V60, P466, DOI 10.1016/0003-4975(95)00169-L; Nestle U, 2005, J NUCL MED, V46, P1342; Norris DG, 2001, NMR BIOMED, V14, P77, DOI 10.1002/nbm.682; Noworolski SM, 2008, MAGN RESON IMAGING, V26, P1071, DOI 10.1016/j.mri.2008.01.033; Padhani AR, 2010, RADIOLOGY, V256, P348, DOI 10.1148/radiol.10091760; Sauter AW, 2013, EUR J NUCL MED MOL I, V40, P677, DOI 10.1007/s00259-012-2318-2; Semple S, 2003, P 11 ANN M ISMRM TOR, V11, P1259; Shastry M, 2012, MOL IMAGING, V11, P353, DOI 10.2310/7290.2011.00052; Sobin LH, 2011, TNM CLASSIFICATION M; Tateishi U, 2002, J COMPUT ASSIST TOMO, V26, P185, DOI 10.1097/00004728-200203000-00004; Tofts PS, 1999, J MAGN RESON IMAGING, V10, P223, DOI 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S; TOFTS PS, 1991, MAGNET RESON MED, V17, P357, DOI 10.1002/mrm.1910170208; van Laarhoven HWM, 2007, NMR BIOMED, V20, P128, DOI 10.1002/nbm.1098; Yu CJ, 2005, LUNG CANCER, V47, P59, DOI 10.1016/j.lungcan.2004.05.018; Zwick S, 2010, EUR RADIOL, V20, P432, DOI 10.1007/s00330-009-1556-6	36	12	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91649	10.1371/journal.pone.0091649	http://dx.doi.org/10.1371/journal.pone.0091649			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614132	Green Submitted, gold, Green Published			2022-12-27	WOS:000332839300146
J	Bowman, H; Filetti, M; Alsufyani, A; Janssen, D; Su, L				Bowman, Howard; Filetti, Marco; Alsufyani, Abdulmajeed; Janssen, Dirk; Su, Li			Countering Countermeasures: Detecting Identity Lies by Detecting Conscious Breakthrough	PLOS ONE			English	Article							COMPLEX TRIAL PROTOCOL; SUBJECTS OWN NAME; CONCEALED INFORMATION DETECTION; ATTENTIONAL BLINK; IRRELEVANT STIMULI; ORIENTING RESPONSE; BRAIN POTENTIALS; WORKING-MEMORY; TESTS; MECHANISMS	One major drawback of deception detection is its vulnerability to countermeasures, whereby participants wilfully modulate their physiological or neurophysiological response to critical guilt-determining stimuli. One reason for this vulnerability is that stimuli are usually presented slowly. This allows enough time to consciously apply countermeasures, once the role of stimuli is determined. However, by increasing presentation speed, stimuli can be placed on the fringe of awareness, rendering it hard to perceive those that have not been previously identified, hindering the possibility to employ countermeasures. We tested an identity deception detector by presenting first names in Rapid Serial Visual Presentation and instructing participants to lie about their own identity. We also instructed participants to apply a series of countermeasures. The method proved resilient, remaining effective at detecting deception under all countermeasures.	[Bowman, Howard; Filetti, Marco; Alsufyani, Abdulmajeed] Univ Kent, Sch Comp, CCNCS, Canterbury, Kent, England; [Bowman, Howard] Univ Birmingham, Dept Psychol, Birmingham, W Midlands, England; [Filetti, Marco] Aalto Univ, Helsinki Inst Informat Technol, Helsinki, Finland; [Alsufyani, Abdulmajeed] Taif Univ, Dept Comp Sci, At Taif, Saudi Arabia; [Janssen, Dirk] NHTV Breda Univ Appl Sci, Breda, Netherlands; [Su, Li] Univ Cambridge, Dept Psychol, Cambridge, England; [Su, Li] MRC, Cognit & Brain Sci Unit, Cambridge, England	University of Kent; University of Birmingham; Aalto University; University of Helsinki; Taif University; Breda University of Applied Sciences; University of Cambridge	Bowman, H (corresponding author), Univ Kent, Sch Comp, CCNCS, Canterbury, Kent, England.	H.Bowman@kent.ac.uk	Alsufyani, abdulmajeed/AGG-9038-2022	Alsufyani, abdulmajeed/0000-0001-6110-3642; Su, Li/0000-0002-6347-3986	University of Kent; United Kingdom (UK) Engineering and Physical Sciences Research Council	University of Kent; United Kingdom (UK) Engineering and Physical Sciences Research Council	One of the PhD students involved in this research was supported financially by the University of Kent (www.kent.ac.uk). Initial ideas that led to the approach presented here were developed under United Kingdom (UK) Engineering and Physical Sciences Research Council funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergstrom ZM, 2013, BIOL PSYCHOL, V94, P1, DOI 10.1016/j.biopsycho.2013.04.012; BLAIR RC, 1993, PSYCHOPHYSIOLOGY, V30, P518, DOI 10.1111/j.1469-8986.1993.tb02075.x; Bowman H, 2007, PSYCHOL REV, V114, P38, DOI 10.1037/0033-295X.114.1.38; Bowman H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054258; Chennu S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000576; Committee to Review the Scientific Evidence on the Polygraph National Research Council, 2003, POL LIE DET; Craston P, 2009, J COGNITIVE NEUROSCI, V21, P550, DOI 10.1162/jocn.2009.21036; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; FARWELL LA, 1991, PSYCHOPHYSIOLOGY, V28, P531, DOI 10.1111/j.1469-8986.1991.tb01990.x; Fay MP, 2010, STAT SURV, V4, P1, DOI 10.1214/09-SS051; Fischer C, 2008, CLIN NEUROPHYSIOL, V119, P2224, DOI 10.1016/j.clinph.2008.03.035; FISCHLER I, 1987, BRAIN LANG, V30, P245, DOI 10.1016/0093-934X(87)90101-5; Ganis G, 2011, NEUROIMAGE, V55, P312, DOI 10.1016/j.neuroimage.2010.11.025; Giesbrecht B, 2003, J EXP PSYCHOL HUMAN, V29, P238, DOI 10.1037/0096-1523.29.1.238; Hayasaka S, 2004, NEUROIMAGE, V23, P54, DOI 10.1016/j.neuroimage.2004.04.035; Holeckova I, 2006, BRAIN RES, V1082, P142, DOI 10.1016/j.brainres.2006.01.089; Honts C.R., 2001, POLYGRAPH, V30, P1; Hu XQ, 2012, PSYCHOPHYSIOLOGY, V49, P85, DOI 10.1111/j.1469-8986.2011.01286.x; INBAU FE, 1964, AM BAR ASSOC J, V50, P470; KLEINMUNTZ B, 1984, AM PSYCHOL, V39, P766, DOI 10.1037/0003-066X.39.7.766; Labkovsky E, 2012, APPL PSYCHOPHYS BIOF, V37, P1, DOI 10.1007/s10484-011-9171-0; Langleben DD, 2002, NEUROIMAGE, V15, P727, DOI 10.1006/nimg.2001.1003; Luck SJ, 1996, NATURE, V383, P616, DOI 10.1038/383616a0; Ludbrook J, 2008, INT J EPIDEMIOL, V37, P1430, DOI 10.1093/ije/dyn162; Lui M, 2009, PSYCHOPHYSIOLOGY, V46, P889, DOI 10.1111/j.1469-8986.2009.00810.x; Lykken D.T., 1998, TREMOR BLOOD USES AB; Maoz K, 2012, PSYCHOPHYSIOLOGY, V49, P1610, DOI 10.1111/j.1469-8986.2012.01470.x; Meixner JB, 2010, PSYCHOPHYSIOLOGY, V47, P57, DOI 10.1111/j.1469-8986.2009.00883.x; Polich J, 2003, BRAIN TOPOGR, V15, P141, DOI 10.1023/A:1022637732495; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Rosenfeld JP, 2008, PSYCHOPHYSIOLOGY, V45, P906, DOI 10.1111/j.1469-8986.2008.00708.x; SAXE L, 1985, AM PSYCHOL, V40, P355, DOI 10.1037/0003-066X.40.3.355; SKOLNICK JH, 1961, YALE LAW J, V70, P694, DOI 10.2307/794340; Tateuchi T, 2012, PSYCHOPHYSIOLOGY, V49, P786, DOI 10.1111/j.1469-8986.2012.01363.x; Vrij A., 2008, DETECTING LIES DECEI; Wang G, 2004, COMMUN ACM, V47, P70, DOI 10.1145/971617.971618; Whitlock MC, 2005, J EVOLUTION BIOL, V18, P1368, DOI 10.1111/j.1420-9101.2005.00917.x; Wolpe PR, 2005, AM J BIOETHICS, V5, P39, DOI 10.1080/15265160590923367	38	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90595	10.1371/journal.pone.0090595	http://dx.doi.org/10.1371/journal.pone.0090595			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC4IY	24608749	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000332485800036
J	Manjarrez, JR; Sun, L; Prince, T; Matts, RL				Manjarrez, Jacob R.; Sun, Liang; Prince, Thomas; Matts, Robert L.			Hsp90-Dependent Assembly of the DBC2/RhoBTB2-Cullin3 E3-Ligase Complex	PLOS ONE			English	Article							HIGH-AFFINITY BINDING; BREAST-CANCER; DBC2 GENE; UBIQUITIN LIGASES; COLORECTAL-CANCER; SUPPRESSOR GENES; RHOBTB2 DBC2; ALLELIC LOSS; RHO-GTPASES; HSP90	The expression of the wild-type tumor-suppressor gene DBC2 (Deleted-in-Breast Cancer 2, a.k.a RhoBTB2) is suppressed in many cancers, in addition to breast cancer. In a screen for Cdc37-associated proteins, DBC2 was identified to be a potential client protein of the 90 kDa heat shock protein (Hsp90) chaperone machine. Pull down assays of ectopically expressed DBC2 confirmed that DBC2 associated with Hsp90 and its co-chaperone components in reticulocyte lysate and MCF7 cells. Similar to other atypical Rho GTPases, DBC2 was found to have retained the capacity to bind GTP. The ability of DBC2 to bind GTP was modulated by the Hsp90 ATPase cycle, as demonstrated through the use of the Hsp90 chemical inhibitors, geldanamycin and molybdate. The binding of full length DBC2 to GTP was suppressed in the presence of geldanamycin, while it was enhanced in the presence of molybdate. Furthermore, assembly of DBC2-Cullin3-COP9 E3 ligase complexes was Hsp90-dependent. The data suggest a new paradigm for Hsp90-modulated assembly of a Cul3/DBC2 E3 ubiquitin ligase complex that may extend to other E3 ligase complexes.	[Manjarrez, Jacob R.; Sun, Liang; Prince, Thomas; Matts, Robert L.] Oklahoma State Univ, Dept Biochem & Mol Biol, Stillwater, OK 74078 USA	Oklahoma State University System; Oklahoma State University - Stillwater	Matts, RL (corresponding author), Oklahoma State Univ, Dept Biochem & Mol Biol, Stillwater, OK 74078 USA.	robert.matts@okstate.edu		Manjarrez, Jacob/0000-0002-8428-8659	Oklahoma Center for the Advancement of Science and Technology [HR06-070]; N.I.H. [3R01CA125392-03S109]; Sarkeys Foundation; Oklahoma Agricultural Experiment Station [1975]; NATIONAL CANCER INSTITUTE [R01CA125392] Funding Source: NIH RePORTER	Oklahoma Center for the Advancement of Science and Technology; N.I.H.(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sarkeys Foundation; Oklahoma Agricultural Experiment Station; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grant number HR06-070 from the Oklahoma Center for the Advancement of Science and Technology (RLM), 3R01CA125392-03S109 from N.I.H. (RLM), the Sarkeys Foundation, and the Oklahoma Agricultural Experiment Station (Project 1975). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBAGLI O, 1995, CELL GROWTH DIFFER, V6, P1193; American Cancer Society, BREAST CANC FACTS FI; Arlander SJH, 2006, J BIOL CHEM, V281, P2989, DOI 10.1074/jbc.M508687200; Aspenstrom P, 2007, EXP CELL RES, V313, P3673, DOI 10.1016/j.yexcr.2007.07.022; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bennett EJ, 2010, CELL, V143, P951, DOI 10.1016/j.cell.2010.11.017; Berthold J, 2008, ACTA PHARMACOL SIN, V29, P285, DOI 10.1111/j.1745-7254.2008.00773.x; Berthold J, 2008, EXP CELL RES, V314, P3453, DOI 10.1016/j.yexcr.2008.09.005; Bosu DR, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-7; Brown MR, 1999, GYNECOL ONCOL, V74, P98, DOI 10.1006/gyno.1999.5439; Cayli S, 2009, J BIOL CHEM, V284, P34944, DOI 10.1074/jbc.M109.037952; Chang FK, 2006, J MOL BIOL, V364, P302, DOI 10.1016/j.jmb.2006.09.026; Chardin P, 2006, NAT REV MOL CELL BIO, V7, P54, DOI 10.1038/nrm1788; Cho YG, 2008, ACTA ONCOL, V47, P366, DOI 10.1080/02841860701644094; Collado D, 2007, BIOCHEM BIOPH RES CO, V360, P600, DOI 10.1016/j.bbrc.2007.06.127; CRAIG D, 1992, NUCLEIC ACIDS RES, V20, P4987, DOI 10.1093/nar/20.19.4987; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; Dong W, 2012, ASIAN PAC J CANCER P, V13, P2021, DOI 10.7314/APJCP.2012.13.5.2021; Echeverria PC, 2010, BBA-MOL CELL RES, V1803, P641, DOI 10.1016/j.bbamcr.2009.11.012; EMI M, 1992, CANCER RES, V52, P5368; Enchev RI, 2010, STRUCTURE, V18, P518, DOI 10.1016/j.str.2010.02.008; Felts SJ, 2007, CELL STRESS CHAPERON, V12, P353, DOI 10.1379/CSC-299.1; Frederick MJ, 2000, AM J PATHOL, V156, P1937, DOI 10.1016/S0002-9440(10)65067-5; Freeman SN, 2008, J BIOL CHEM, V283, P2353, DOI 10.1074/jbc.M705986200; Freeman SN, 2010, CANCER BIOL THER, V10, P1123, DOI 10.4161/cbt.10.11.13786; FUJIWARA Y, 1993, CANCER RES, V53, P1172; Gano JJ, 2010, MOL CELL PROTEOMICS, V9, P255, DOI 10.1074/mcp.M900261-MCP200; Garritano S, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.15; Hamaguchi M, 2002, P NATL ACAD SCI USA, V99, P13647, DOI 10.1073/pnas.212516099; Han LL, 2013, BIOTECHNOL LETT, V35, P1175, DOI 10.1007/s10529-013-1190-x; Hartson SD, 2000, BIOCHEMISTRY-US, V39, P7631, DOI 10.1021/bi000315r; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Hromas R, 1999, BIOCHEM BIOPH RES CO, V255, P703, DOI 10.1006/bbrc.1999.0257; Jones TD, 2005, CANCER-AM CANCER SOC, V104, P1195, DOI 10.1002/cncr.21288; Kato JY, 2009, GENES CELLS, V14, P1209, DOI 10.1111/j.1365-2443.2009.01349.x; Knowles MA, 2005, CANCER LETT, V225, P121, DOI 10.1016/j.canlet.2004.10.047; KNOWLES MA, 1993, ONCOGENE, V8, P1357; Kotiguda GG, 2012, J BIOL CHEM, V287, P42031, DOI 10.1074/jbc.M112.387977; Lerebours F, 1999, INT J CANCER, V81, P854, DOI 10.1002/(SICI)1097-0215(19990611)81:6<854::AID-IJC3>3.0.CO;2-1; Lerebours F, 1999, GENE CHROMOSOME CANC, V25, P147, DOI 10.1002/(SICI)1098-2264(199906)25:2<147::AID-GCC10>3.0.CO;2-Z; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Ling LJ, 2010, CANCER BIOL THER, V10, P1115, DOI 10.4161/cbt.10.11.13431; Matts RL, 2009, CURR TOP MED CHEM, V9, P1462, DOI 10.2174/156802609789895692; McKinnon CM, 2008, ONCOGENE, V27, P6856, DOI 10.1038/onc.2008.317; Mirzaei MH, 2012, CELL J, V14, P19; Paduch M, 2001, ACTA BIOCHIM POL, V48, P829; Perez-Torrado R, 2006, BIOESSAYS, V28, P1194, DOI 10.1002/bies.20500; Pintard L, 2004, EMBO J, V23, P1681, DOI 10.1038/sj.emboj.7600186; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Pratt WB, 2008, J BIOL CHEM, V283, P22885, DOI 10.1074/jbc.R800023200; Prince T, 2005, BIOCHEMISTRY-US, V44, P15287, DOI 10.1021/bi051423m; Prince T, 2005, BIOCHEM BIOPH RES CO, V331, P1331, DOI 10.1016/j.bbrc.2005.04.047; Prince T, 2004, J BIOL CHEM, V279, P39975, DOI 10.1074/jbc.M406882200; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Schwartz GF, 2008, CANCER, V113, P2627, DOI 10.1002/cncr.23903; Scroggins BT, 2003, BIOCHEMISTRY-US, V42, P12550, DOI 10.1021/bi035001t; Shao J, 2002, BIOCHEMISTRY-US, V41, P6770, DOI 10.1021/bi025737a; Shellenberger TD, 2004, CANCER RES, V64, P8262, DOI 10.1158/0008-5472.CAN-04-2056; Shi Y, 2008, UROL ONCOL-SEMIN ORI, V26, P465, DOI 10.1016/j.urolonc.2007.08.009; Siripurapu V, 2005, J MOL BIOL, V346, P83, DOI 10.1016/j.jmb.2004.11.043; Swalwell JI, 2002, GENE CHROMOSOME CANC, V33, P201, DOI 10.1002/gcc.10015; Taipale M, 2012, CELL, V150, P987, DOI 10.1016/j.cell.2012.06.047; Turnbull C, 2008, ANNU REV GENOM HUM G, V9, P321, DOI 10.1146/annurev.genom.9.081307.164339; van den Heuvel S, 2004, CURR BIOL, V14, pR59, DOI 10.1016/j.cub.2003.12.044; Vocke CD, 1996, CANCER RES, V56, P2411; Wilkins A, 2004, GENE DEV, V18, P856, DOI 10.1101/gad.1177904; Wilkins A, 2008, METHOD ENZYMOL, V439, P103, DOI 10.1016/S0076-6879(07)00408-9; Willems AR, 2004, BBA-MOL CELL RES, V1695, P133, DOI 10.1016/j.bbamcr.2004.09.027; Yoshihara T, 2007, BIOCHEM BIOPH RES CO, V358, P1076, DOI 10.1016/j.bbrc.2007.05.037	69	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90054	10.1371/journal.pone.0090054	http://dx.doi.org/10.1371/journal.pone.0090054			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608665	Green Published, gold, Green Submitted			2022-12-27	WOS:000332485800014
J	Meng, H; Zhang, Y; Zhao, LL; Zhao, WJ; He, C; Honaker, CF; Zhai, ZX; Sun, ZK; Siegel, PB				Meng, He; Zhang, Yan; Zhao, Lele; Zhao, Wenjing; He, Chuan; Honaker, Christa F.; Zhai, Zhengxiao; Sun, Zikui; Siegel, Paul B.			Body Weight Selection Affects Quantitative Genetic Correlated Responses in Gut Microbiota	PLOS ONE			English	Article							OBESITY; LINES; MICE	The abundance of gut microbiota can be viewed as a quantitative trait, which is affected by the genetics and environment of the host. To quantify the effects of host genetics, we calculated the heritability of abundance of specific microorganisms and genetic correlations among them in the gut microbiota of two lines of chickens maintained under the same husbandry and dietary regimes. The lines, which originated from a common founder population, had undergone >50 generations of selection for high (HW) or low (LW) 56-day body weight and now differ by more than 10-fold in body weight at selection age. We identified families of Paenibacillaceae, Streptococcaceae, Helicobacteraceae, and Burkholderiaceae that had moderate heritabilities. Although there were no obvious phenotypic correlations among gut microbiota, significant genetic correlations were observed. Moreover, the effects were modified by genetic selection for body weight, which altered the quantitative genetic background of the host. Heritabilities for Bacillaceae, Flavobacteriaceae, Helicobacteraceae, Comamonadaceae, Enterococcaceae, and Streptococcaceae were moderate in LW line and little to zero in the HW line. These results suggest that loci associated with these microbiota families, while exhibiting genetic variation in LW, have been fixed in HW line. Also, long term selection for body weight has altered the genetic correlations among gut microbiota. No microbiota families had significant heritabilities in both the LW and HW lines suggesting that the presence and/or absence of a particular microbiota family either has a strong growth promoting or inhibiting effect, but not both. These results demonstrate that the quantitative genetics of the host have considerable influence on the gut microbiota.	[Meng, He] Shanghai Jiao Tong Univ, Sch Agr & Biol, Shanghai Key Lab Vet Biotechnol, Shanghai 200030, Peoples R China; [Zhang, Yan; Zhao, Lele; Zhao, Wenjing; Zhai, Zhengxiao] Shanghai Jiao Tong Univ, Sch Agr & Biol, Shanghai 200030, Peoples R China; [Zhang, Yan] Virginia Polytech Inst & State Univ, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA; [Honaker, Christa F.; Siegel, Paul B.] Virginia Polytech Inst & State Univ, Dept Anim & Poultry Sci, Blacksburg, VA 24061 USA; [He, Chuan; Sun, Zikui] Shanghai Personal Biotechnol Ltd Co, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Meng, H (corresponding author), Shanghai Jiao Tong Univ, Sch Agr & Biol, Shanghai Key Lab Vet Biotechnol, Shanghai 200030, Peoples R China.	menghe@sjtu.edu.cn; yzhang@vbi.vt.edu; pbsiegel@vt.edu	He, Chuan/AAN-4356-2020; zhang, yan/AAG-7349-2019	He, Chuan/0000-0002-8532-2898; zhang, yan/0000-0003-0906-9410	National High Technology Research and Development Program of China [2011AA100901]; National Science Foundation of China [31272430]; Agriculture Development through Science and Technology Key Project of Shanghai [2012 (2-3)]; National Institute of Allergy and Infectious Diseases [HHSN272200900040C]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Agriculture Development through Science and Technology Key Project of Shanghai; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the National High Technology Research and Development Program of China (grant No. 2011AA100901, http://www.863.gov.cn/), the National Science Foundation of China (grant No. 31272430, http://www.nsfc.gov.cn), and Agriculture Development through Science and Technology Key Project of Shanghai (grant No. 2012 (2-3), http://www.shagri.org/). Yan Zhang's contribution has been funded in part with federal funds from the National Institute of Allergy and Infectious Diseases (http://www.niaid.nih.gov) under contract no. HHSN272200900040C awarded to B.W. Sobral. No additional funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benson AK, 2010, P NATL ACAD SCI USA, V107, P18933, DOI 10.1073/pnas.1007028107; Dunnington EA, 1996, POULTRY SCI, V75, P1168, DOI 10.3382/ps.0751168; Dunnington EA, 2013, POULTRY SCI; Jacobsson L, 2005, GENET RES, V86, P115, DOI 10.1017/S0016672305007767; Khachatryan ZA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003064; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Marquez GC, 2010, POULTRY SCI, V89, P2580, DOI 10.3382/ps.2010-01034; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Rawls JF, 2006, CELL, V127, P423, DOI 10.1016/j.cell.2006.08.043; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Tilg H, 2011, J CLIN INVEST, V121, P2126, DOI 10.1172/JCI58109; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Wei S, 2013, POULTRY SCI, V92, P671, DOI 10.3382/ps.2012-02822; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Zhang CH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3163; Zhao LL, 2013, SCI REP-UK, V3, DOI 10.1038/srep01163	19	52	65	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e89862	10.1371/journal.pone.0089862	http://dx.doi.org/10.1371/journal.pone.0089862			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608294	gold, Green Published, Green Submitted			2022-12-27	WOS:000332485800010
J	Teplitsky, C; Tarka, M; Moller, AP; Nakagawa, S; Balbontin, J; Burke, TA; Doutrelant, C; Gregoire, A; Hansson, B; Hasselquist, D; Gustafsson, L; de Lope, F; Marzal, A; Mills, JA; Wheelwright, NT; Yarrall, JW; Charmantier, A				Teplitsky, Celine; Tarka, Maja; Moller, Anders P.; Nakagawa, Shinichi; Balbontin, Javier; Burke, Terry A.; Doutrelant, Claire; Gregoire, Arnaud; Hansson, Bengt; Hasselquist, Dennis; Gustafsson, Lars; de Lope, Florentino; Marzal, Alfonso; Mills, James A.; Wheelwright, Nathaniel T.; Yarrall, John W.; Charmantier, Anne			Assessing Multivariate Constraints to Evolution across Ten Long-Term Avian Studies	PLOS ONE			English	Article							GREAT REED WARBLERS; GENETIC-VARIATION; QUANTITATIVE GENETICS; NATURAL-SELECTION; BODY CONDITION; CLIMATE-CHANGE; DIRECTIONAL SELECTION; VARIANCE; FITNESS; BIRD	Background: In a rapidly changing world, it is of fundamental importance to understand processes constraining or facilitating adaptation through microevolution. As different traits of an organism covary, genetic correlations are expected to affect evolutionary trajectories. However, only limited empirical data are available. Methodology/Principal Findings: We investigate the extent to which multivariate constraints affect the rate of adaptation, focusing on four morphological traits often shown to harbour large amounts of genetic variance and considered to be subject to limited evolutionary constraints. Our data set includes unique long-term data for seven bird species and a total of 10 populations. We estimate population-specific matrices of genetic correlations and multivariate selection coefficients to predict evolutionary responses to selection. Using Bayesian methods that facilitate the propagation of errors in estimates, we compare (1) the rate of adaptation based on predicted response to selection when including genetic correlations with predictions from models where these genetic correlations were set to zero and (2) the multivariate evolvability in the direction of current selection to the average evolvability in random directions of the phenotypic space. We show that genetic correlations on average decrease the predicted rate of adaptation by 28%. Multivariate evolvability in the direction of current selection was systematically lower than average evolvability in random directions of space. These significant reductions in the rate of adaptation and reduced evolvability were due to a general nonalignment of selection and genetic variance, notably orthogonality of directional selection with the size axis along which most (60%) of the genetic variance is found. Conclusions: These results suggest that genetic correlations can impose significant constraints on the evolution of avian morphology in wild populations. This could have important impacts on evolutionary dynamics and hence population persistence in the face of rapid environmental change.	[Teplitsky, Celine] Univ Paris 06, CNRS, Museum Natl Hist Nat, Dept Ecol & Gest Biodiversite,UMR 7204,MNHN, Paris, France; [Tarka, Maja; Hansson, Bengt; Hasselquist, Dennis] Lund Univ, Dept Biol, Lund, Sweden; [Moller, Anders P.] Univ Paris Sud, CNRS, UMR 8079, Lab Ecol Syst & Evolut, Orsay, France; [Nakagawa, Shinichi] Univ Otago, Dept Zool, Dunedin, New Zealand; [Balbontin, Javier] Univ Seville, Dept Zool, Seville, Spain; [Burke, Terry A.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Doutrelant, Claire; Gregoire, Arnaud; Charmantier, Anne] CNRS, Ctr Ecol Fonct & Evolut, UMR 5175, Montpellier, France; [Gustafsson, Lars] Uppsala Univ, Dept Anim Ecol, Evolutionary Biol Ctr, Uppsala, Sweden; [de Lope, Florentino; Marzal, Alfonso] Univ Extremadura, Dept Zool, Badajoz, Spain; [Wheelwright, Nathaniel T.] Bowdoin Coll, Dept Biol, Brunswick, ME 04011 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Lund University; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Paris Saclay; University of Otago; University of Sevilla; University of Sheffield; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; Uppsala University; Universidad de Extremadura; Bowdoin College	Teplitsky, C (corresponding author), Univ Paris 06, CNRS, Museum Natl Hist Nat, Dept Ecol & Gest Biodiversite,UMR 7204,MNHN, Paris, France.	teplitsky@mnhn.fr	Burke, Terry/B-3196-2011; Teplitsky, Celine/H-3621-2019; Tarka, Maja/L-8065-2013; Hansson, Bengt/L-8874-2013; Gustafsson, Lars/A-7634-2012; Moller, Anders/O-6665-2016; Gustafsson, Lars/O-8056-2019; Gregoire, Arnaud/B-6321-2008; Balbontín, Javier/H-5932-2015; Hasselquist, Dennis/M-5223-2014; Marzal, Alfonso/J-6677-2012; Nakagawa, Shinichi/B-5571-2011	Burke, Terry/0000-0003-3848-1244; Teplitsky, Celine/0000-0001-9458-709X; Tarka, Maja/0000-0001-9651-1101; Hansson, Bengt/0000-0001-6694-8169; Gustafsson, Lars/0000-0001-6566-2863; Moller, Anders/0000-0003-3739-4675; Gustafsson, Lars/0000-0001-6566-2863; Gregoire, Arnaud/0000-0001-6103-355X; Balbontín, Javier/0000-0003-1539-2636; Hasselquist, Dennis/0000-0002-0056-6616; Marzal, Alfonso/0000-0001-5872-1060; Nakagawa, Shinichi/0000-0002-7765-5182	French ANR [ANR-08-JCJC-0041-01, ANR-12-ADAP-0006]; OSU OREME; Swedish RC; Spanish MEC [CGL2009-08976]; NERC [NE/F006071/1, NE/J024597/1] Funding Source: UKRI; Natural Environment Research Council [NE/F006071/1, NE/J024597/1] Funding Source: researchfish; Direct For Biological Sciences [1226941] Funding Source: National Science Foundation	French ANR(French National Research Agency (ANR)); OSU OREME; Swedish RC; Spanish MEC(Spanish Government); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This project was funded by the French ANR (grant ANR-08-JCJC-0041-01 & ANR-12-ADAP-0006), by the OSU OREME, by grants from the Swedish RC (to BH and DH) and the Spanish MEC (CGL2009-08976) to JB, FdeL and AM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AF, 2009, P ROY SOC B-BIOL SCI, V276, P1183, DOI 10.1098/rspb.2008.1671; Akesson M, 2007, J AVIAN BIOL, V38, P58, DOI 10.1111/j.2006.0908-8857.03669.x; ALATALO RV, 1990, AM NAT, V135, P464, DOI 10.1086/285056; Arnold SJ, 2008, EVOLUTION, V62, P2451, DOI 10.1111/j.1558-5646.2008.00472.x; Balbontin J, 2012, BIOL J LINN SOC, V105, P420, DOI 10.1111/j.1095-8312.2011.01800.x; Bjorklund M, 2013, J EVOLUTION BIOL, V26, P1, DOI 10.1111/jeb.12044; Blondel J, 2006, BIOSCIENCE, V56, P661, DOI 10.1641/0006-3568(2006)56[661:ATSOPA]2.0.CO;2; Blows MW, 2007, J EVOLUTION BIOL, V20, P1, DOI 10.1111/j.1420-9101.2006.01164.x; Blows MW, 2004, AM NAT, V163, P329, DOI 10.1086/381941; Charmantier A, 2006, P NATL ACAD SCI USA, V103, P6587, DOI 10.1073/pnas.0511123103; Charmantier A, 2014, QUANTITATIVE GENETICS IN THE WILD, P1; Charmantier A, 2004, J EVOLUTION BIOL, V17, P732, DOI 10.1111/j.1420-9101.2004.00734.x; Chenoweth SF, 2010, AM NAT, V175, P186, DOI 10.1086/649594; Chevin LM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000357; Dingemanse NJ, 2009, P R SOC B, V276, P1285, DOI 10.1098/rspb.2008.1555; Eroukhmanoff F, 2009, EVOL BIOL, V36, P323, DOI 10.1007/s11692-009-9062-y; Etterson JR, 2004, EVOLUTION, V58, P1446, DOI 10.1111/j.0014-3820.2004.tb01726.x; Falconer D. S., 1996, INTRO QUANTITATIVE G; Frentiu FD, 2007, J EVOLUTION BIOL, V20, P639, DOI 10.1111/j.1420-9101.2006.01242.x; Garant D, 2008, MOL ECOL, V17, P179, DOI 10.1111/j.1365-294X.2007.03436.x; Gelman A, 2006, BAYESIAN ANAL, V1, P515, DOI 10.1214/06-BA117A; Grant BR, 2003, BIOSCIENCE, V53, P965, DOI 10.1641/0006-3568(2003)053[0965:WDFCTU]2.0.CO;2; GRANT PR, 1995, EVOLUTION, V49, P241, DOI 10.1111/j.1558-5646.1995.tb02236.x; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Hall KSS, 2004, J AVIAN BIOL, V35, P7; Hansen TF, 2008, J EVOLUTION BIOL, V21, P1201, DOI 10.1111/j.1420-9101.2008.01573.x; Hansen TF, 2003, J EVOLUTION BIOL, V16, P754, DOI 10.1046/j.1420-9101.2003.00556.x; Hansen TF, 2011, EVOL BIOL, V38, P258, DOI 10.1007/s11692-011-9127-6; Hansen TF, 2011, EVOLUTION, V65, P1821, DOI 10.1111/j.1558-5646.2011.01281.x; Hasselquist D, 1998, ECOLOGY, V79, P2376, DOI 10.2307/176829; Henderson C.R., 1973, J ANIM SCI, V1973, P10, DOI DOI 10.1093/ANSCI/1973.SYMPOSIUM.10; Hendry AP, 2010, EVOLUTION, V64, P1517, DOI 10.1111/j.1558-5646.2010.00947.x; HILL WG, 1992, ANNU REV ECOL SYST, V23, P287, DOI 10.1146/annurev.es.23.110192.001443; Hine E, 2009, PHILOS T R SOC B, V364, P1567, DOI 10.1098/rstb.2008.0313; Kimmel CB, 2012, EVOLUTION, V66, P419, DOI 10.1111/j.1558-5646.2011.01441.x; Kirkpatrick M, 2009, GENETICA, V136, P271, DOI 10.1007/s10709-008-9302-6; Kruuk LEB, 2004, PHILOS T R SOC B, V359, P873, DOI 10.1098/rstb.2003.1437; Kruuk LEB, 2000, P NATL ACAD SCI USA, V97, P698, DOI 10.1073/pnas.97.2.698; Kruuk LEB, 2014, QUANTITATIVE GENETICS IN THE WILD, P160; Kruuk LEB, 2008, ANNU REV ECOL EVOL S, V39, P525, DOI 10.1146/annurev.ecolsys.39.110707.173542; LANDE R, 1983, EVOLUTION, V37, P1210, DOI 10.1111/j.1558-5646.1983.tb00236.x; Leisler B, 2003, AVIAN MIGRATION, P175; Lynch M., 1998, GENETICS ANAL QUANTI; McCleery RH, 2004, AM NAT, V164, pE62, DOI 10.1086/422660; Merila J, 1999, GENET RES, V73, P165, DOI 10.1017/S0016672398003656; Merila J, 2001, J EVOLUTION BIOL, V14, P918, DOI 10.1046/j.1420-9101.2001.00353.x; Merila J, 2004, PHENOTYPIC INTEGRATION: STUDYING THE ECOLOGY AND EVOLUTION OF COMPLEX PHENOTYPES, P107; Merila J, 2001, GENETICA, V112, P199, DOI 10.1023/A:1013391806317; Merila J, 2012, BIOESSAYS, V34, P811, DOI 10.1002/bies.201200054; Mills JA, 1996, PARTNERSHIPS BIRDS S, P118; MOLLER AP, 1994, EVOLUTION, V48, P1676, DOI 10.1111/j.1558-5646.1994.tb02204.x; Morrissey MB, 2014, QUANTITATIVE GENETICS IN THE WILD, P228; Morrissey MB, 2012, AM NAT, V179, pE97, DOI 10.1086/664686; Morrissey MB, 2012, EVOLUTION, V66, P435, DOI 10.1111/j.1558-5646.2011.01444.x; Morrissey MB, 2010, MOL ECOL RESOUR, V10, P711, DOI 10.1111/j.1755-0998.2009.02817.x; MOUSSEAU TA, 1987, HEREDITY, V59, P181, DOI 10.1038/hdy.1987.113; Nakagawa S, 2008, BIOL LETTERS, V4, P667, DOI 10.1098/rsbl.2008.0349; Podos J, 2001, NATURE, V409, P185, DOI 10.1038/35051570; Roff DA, 1996, EVOLUTION, V50, P1392, DOI [10.2307/2410877, 10.1111/j.1558-5646.1996.tb03913.x]; Schluter D, 1996, EVOLUTION, V50, P1766, DOI 10.1111/j.1558-5646.1996.tb03563.x; Senar JC, 1997, ARDEA, V85, P269; Siepielski AM, 2009, ECOL LETT, V12, P1261, DOI 10.1111/j.1461-0248.2009.01381.x; Simonsen AK, 2010, INT J PLANT SCI, V171, P972, DOI 10.1086/656512; Stinchcombe JR, 2008, EVOLUTION, V62, P2435, DOI 10.1111/j.1558-5646.2008.00449.x; Teplitsky C, 2011, J EVOLUTION BIOL, V24, P2025, DOI 10.1111/j.1420-9101.2011.02342.x; Teplitsky C, 2014, QUANTITATIVE GENETICS IN THE WILD, P190; Teplitsky C, 2009, EVOLUTION, V63, P716, DOI 10.1111/j.1558-5646.2008.00581.x; Wagner GP, 1996, AM ZOOL, V36, P36; Walsh B, 2009, ANNU REV ECOL EVOL S, V40, P41, DOI 10.1146/annurev.ecolsys.110308.120232; Wheelwright NT, 2006, ANIM BEHAV, V71, P631, DOI 10.1016/j.anbehav.2005.06.012	70	45	45	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90444	10.1371/journal.pone.0090444	http://dx.doi.org/10.1371/journal.pone.0090444			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608111	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000332485800026
J	Yue, YX; Wang, Y; He, Y; Yang, ST; Chen, ZX; Wang, YY; Xing, SS; Shen, CC; Amin, HM; Wu, DP; Song, YH				Yue, Yingxing; Wang, Ying; He, Yang; Yang, Shuting; Chen, Zixing; Wang, Yuanyuan; Xing, Shanshan; Shen, Congcong; Amin, Hesham M.; Wu, Depei; Song, Yao-Hua			Reversal of Bortezomib Resistance in Myelodysplastic Syndrome Cells by MAPK Inhibitors	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; NF-KAPPA-B; MULTIPLE-MYELOMA; MYELOGENOUS LEUKEMIA; IMATINIB RESISTANCE; DRUG-RESISTANCE; IN-VITRO; ERK; ACTIVATION; APOPTOSIS	The myelodysplastic syndromes (MDS) comprise a heterogeneous group of malignant neoplasms with distinctive clinicopathological features. Currently, there is no specific approach for the treatment of MDS. Here, we report that bortezomib (BTZ), a proteasome inhibitor that has been used to treat plasma cell myeloma, induced G2/M phase cycle arrest in the MDS cell line SKM-1 through upregulation of Wee1, a negative regulator of G2/M phase transition. Treatment by BTZ led to reduced SKM-1 cell viability as well as increased apoptosis and autophagy. The BTZ-induced cell death was associated with reduced expression of p-ERK. To elucidate the implications of downregulation of p-ERK, we established the BTZ resistant cell line SKM-1R. Our data show that resistance to BTZ-induced apoptosis could be reversed by the MEK inhibitors U0126 or PD98059. Our results suggest that MAPK pathway may play an important role in mediating BTZ resistance.	[Yue, Yingxing; Yang, Shuting; Xing, Shanshan; Shen, Congcong; Song, Yao-Hua] Soochow Univ, Affiliated Hosp 1, Cyrus Tang Hematol Ctr, Jiangsu Inst Hematol, Suzhou, Peoples R China; [Wang, Ying; He, Yang; Chen, Zixing; Wang, Yuanyuan; Wu, Depei] Soochow Univ, Affiliated Hosp 1, Key Lab Thrombosis & Hemostasis, Jiangsu Inst Hematol,Minist Hlth, Suzhou, Peoples R China; [Amin, Hesham M.] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA	Soochow University - China; Soochow University - China; University of Texas System; UTMD Anderson Cancer Center	Wu, DP (corresponding author), Soochow Univ, Affiliated Hosp 1, Key Lab Thrombosis & Hemostasis, Jiangsu Inst Hematol,Minist Hlth, Suzhou, Peoples R China.	wudepei@medmail.com.cn; yaohua_song1@yahoo.com	Lv, Yuanjie/AER-0767-2022		project for the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	project for the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by the project for the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams SL, 2010, CELL CYCLE, V9, P1781, DOI 10.4161/cc.9.9.11483; Attar EC, 2013, LEUKEMIA RES, V37, P1016, DOI 10.1016/j.leukres.2013.05.011; Bosman MCJ, 2013, EXP HEMATOL, V41, P530, DOI 10.1016/j.exphem.2013.02.002; Chung E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028350; Fang J, 2012, BLOOD, V120, P858, DOI 10.1182/blood-2012-02-407999; Fenouille N, 2010, CANCER RES, V70, P9659, DOI 10.1158/0008-5472.CAN-10-2034; Hiraoka Y, 2004, P NATL ACAD SCI USA, V101, P6427, DOI 10.1073/pnas.0401631101; Howard D.S., 2013, LEUK RES; Hu JS, 2013, MOL CANCER THER, V12, P1763, DOI 10.1158/1535-7163.MCT-13-0123; Huang J, 2011, INT J HEMATOL, V93, P482, DOI 10.1007/s12185-011-0821-z; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kinkade CW, 2008, J CLIN INVEST, V118, P3051, DOI 10.1172/JCI34764; Kornblau SM, 2006, BLOOD, V108, P2358, DOI 10.1182/blood-2006-02-003475; Lew DJ, 1996, CURR OPIN CELL BIOL, V8, P795, DOI 10.1016/S0955-0674(96)80080-9; Lu SQ, 2011, EXP HEMATOL, V39, P1117, DOI 10.1016/j.exphem.2011.09.003; Manni S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075280; Naci D, 2012, J BIOL CHEM, V287, P17065, DOI 10.1074/jbc.M112.349365; NAKAGAWA T, 1993, BRIT J HAEMATOL, V85, P469; Natarajan-Ame S, 2012, BRIT J HAEMATOL, V158, P232, DOI 10.1111/j.1365-2141.2012.09153.x; Oerlemans R, 2008, BLOOD, V112, P2489, DOI 10.1182/blood-2007-08-104950; Petrucci MT, 2013, BRIT J HAEMATOL, V160, P649, DOI 10.1111/bjh.12198; Ria R, 2013, CLIN CANC RES; Ricciardi MR, 2005, LEUKEMIA, V19, P1543, DOI 10.1038/sj.leu.2403859; Richardson PG, 2003, NEW ENGL J MED, V348, P2609, DOI 10.1056/NEJMoa030288; San-Miguel JF, 2013, J CLIN ONCOL, V31, P3696, DOI 10.1200/JCO.2012.46.7068; Shelton JG, 2005, EXPERT OPIN THER TAR, V9, P1009, DOI 10.1517/14728222.9.5.1009; Shi L, 2010, ONCOTARGET, V1, P22, DOI 10.18632/oncotarget.105; Shringarpure R, 2006, BRIT J HAEMATOL, V134, P145, DOI 10.1111/j.1365-2141.2006.06132.x; Smith AJ, 2011, J BIOL CHEM, V286, P17682, DOI 10.1074/jbc.M110.189092; Staser K, 2013, J CLIN INVEST, V123, P329, DOI 10.1172/JCI66167; Steube KG, 1997, LEUKEMIA LYMPHOMA, V25, P345, DOI 10.3109/10428199709114174; Suzuki M, 2010, EUR J HAEMATOL, V84, P229, DOI 10.1111/j.1600-0609.2009.01387.x; Wang AH, 2011, ANN HEMATOL, V90, P917, DOI 10.1007/s00277-011-1175-6; Yang F, 2012, CANCER BIOL THER, V13, P349, DOI 10.4161/cbt.19239	34	3	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90992	10.1371/journal.pone.0090992	http://dx.doi.org/10.1371/journal.pone.0090992			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608798	Green Published, gold, Green Submitted			2022-12-27	WOS:000332485800076
J	Zhang, Y; Wang, J; Li, ZH; Xiao, J; Zhao, L; Yan, G; Shi, ZJ				Zhang Yang; Wang Jian; Li Zhi-han; Xiao Jun; Zhao Liang; Yan Ge; Shi Zhan-jun			The Geometry of the Bone Structure Associated with Total Hip Arthroplasty	PLOS ONE			English	Article							FEMORAL COMPONENTS; PROXIMAL FEMUR; ANATOMIC BASIS; CT EVALUATION; STEMS; OSTEOTOMIES; MORPHOLOGY; DYSPLASIA; DESIGN; CEMENT	Close adaptation of the prosthesis to the bone is the key to achieving optimal stability and fixation for total hip arthroplasty (THA). However, there have been no adequate studies of bone morphology, especially in different races. The aim of this study was to analyze the geometry of the acetabulum and proximal femur of people from South China, based on three-dimensional reconstruction, and to detect differences between different population subsets. CT scans were performed on 80 healthy volunteers (160 hips) from South China, comprising 40 males (80 hips) and 40 females (80 hips). The images were imported into Mimics 10.01 to perform 3D reconstruction. THA-associated anatomical parameters were measured and compared with other published data. In comparison with published data, it seemed that people from South China have smaller acetabular abduction angle, larger acetabular supro-inferior diameter, larger neck-shaft angle, smaller offset, thinner femoral shaft and more proximal isthmus, which needed to be further confirmed. There were significant differences between the genders in most parameters. As significant differences in canal flare index (CFI) and distal canal flare index (DCFI) were found between genders, it was concluded the most significant differences lay in the isthmus of the femur. Among the femora, according to Noble's classification we identified more normal types and fewer stovepipe and champagne-flute types than expected from the literature, indicating that uncemented prostheses would be suitable for most people from South China. Our findings reveal that simply choosing the smallest of a series of prostheses would not necessarily provide a good fit, due to the different trends from the proximal to the distal part of the femur. Significant variation exists in THA-associated anatomy between genders and population subsets. It is therefore imperative that each patient receives individual consideration rather than assuming all patients have the same anatomy, especially for different races.	[Zhang Yang; Wang Jian; Li Zhi-han; Xiao Jun; Zhao Liang; Yan Ge; Shi Zhan-jun] Southern Med Univ, Nanfang Hosp, Dept Orthopaed Surg, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China	Shi, ZJ (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Orthopaed Surg, Guangzhou, Guangdong, Peoples R China.	mariaresearcher@hotmail.com	Zhang, Yang/GOP-2217-2022; Zhao, Liang/T-9147-2019					Aydogan M, 2013, EUR J ORTHOP SURG TR, V20; Bargar WL, 1993, J BONE JOINT SURG S3, V75, P255; Blaimont P, 1993, Acta Orthop Belg, V59 Suppl 1, P170; Clark J M, 1987, J Arthroplasty, V2, P99, DOI 10.1016/S0883-5403(87)80016-5; Dai KR, 1985, T ORTHOP RES SOC, V10, P99; Delaunay C, 1998, REV CHIR ORTHOP, V84, P421; Haddad FS, 2000, J BONE JOINT SURG BR, V82B, P526, DOI 10.1302/0301-620X.82B4.10174; HAVELIN LI, 1995, J BONE JOINT SURG BR, V77B, P11, DOI 10.1302/0301-620X.77B1.7822364; Higashi H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025403; Hipp JA, 1999, CLIN ORTHOP RELAT R, P134; HUA J, 1994, J BONE JOINT SURG AM, V76A, P95, DOI 10.2106/00004623-199401000-00012; HUISKES R, 1995, CLIN ORTHOP RELAT R, P64; Husmann O, 1997, J ARTHROPLASTY, V12, P444, DOI 10.1016/S0883-5403(97)90201-1; KLAUE K, 1988, CLIN ORTHOP RELAT R, P15; Laine HJ, 2000, J ARTHROPLASTY, V15, P86, DOI 10.1016/S0883-5403(00)91311-1; Lennon AB, 2001, J BIOMECH ENG-T ASME, V123, P623, DOI 10.1115/1.1412452; Lombardi AV, 1995, J BONE JOINT SURG AM, V77A, P1836; Massin P, 2000, J ARTHROPLASTY, V15, P93, DOI 10.1016/S0883-5403(00)91337-8; MURPHY SB, 1990, CLIN ORTHOP RELAT R, P214; NOBLE PC, 1988, CLIN ORTHOP RELAT R, P148; RUBIN PJ, 1992, J BONE JOINT SURG BR, V74, P28, DOI 10.1302/0301-620X.74B1.1732260; Simonet JY, 1993, J BONE JOINT SURG S3, V75, P257; SOTEREANOS NG, 1995, CLIN ORTHOP RELAT R, P146; Tallroth K, 2006, ACTA ORTHOP, V77, P598, DOI 10.1080/17453670610012665; Vandenbussche E, 2008, CLIN ORTHOP RELAT R, V466, P417, DOI 10.1007/s11999-007-0062-x; WALKER PS, 1988, CLIN ORTHOP RELAT R, P25; WHITESIDE LA, 1994, CLIN ORTHOP RELAT R, P184; Xu CP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080021	28	6	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91058	10.1371/journal.pone.0091058	http://dx.doi.org/10.1371/journal.pone.0091058			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608343	Green Published, gold, Green Submitted			2022-12-27	WOS:000332485800089
J	Banerjee, T; Mukherjee, S; Ghosh, S; Biswas, M; Dutta, S; Pattari, S; Chatterjee, S; Bandyopadhyay, A				Banerjee, Tanima; Mukherjee, Somaditya; Ghosh, Sudip; Biswas, Monodeep; Dutta, Santanu; Pattari, Sanjib; Chatterjee, Shelly; Bandyopadhyay, Arun			Clinical Significance of Markers of Collagen Metabolism in Rheumatic Mitral Valve Disease	PLOS ONE			English	Article							LEFT-VENTRICULAR HYPERTROPHY; CARBOXY-TERMINAL PROPEPTIDE; HEART-DISEASE; MYOCARDIAL FIBROSIS; REGURGITATION; PREVALENCE; PATHOGENESIS; PROCOLLAGEN; PREVENTION; TURNOVER	Background: Rheumatic Heart Disease (RHD), a chronic acquired heart disorder results from Acute Rheumatic Fever. It is a major public health concern in developing countries. In RHD, mostly the valves get affected. The present study investigated whether extracellular matrix remodelling in rheumatic valve leads to altered levels of collagen metabolism markers and if such markers can be clinically used to diagnose or monitor disease progression. Methodology: This is a case control study comprising 118 subjects. It included 77 cases and 41 healthy controls. Cases were classified into two groups-Mitral Stenosis (MS) and Mitral Regurgitation (MR). Carboxy-terminal propeptide of type I procollagen (PICP), amino-terminal propeptide of type III procollagen (PIIINP), total Matrix Metalloproteinase-1(MMP-1) and Tissue Inhibitor of Metalloproteinase-1 (TIMP-1) were assessed. Histopathology studies were performed on excised mitral valve leaflets. A p value <0.05 was considered statistically significant. Results: Plasma PICP and PIIINP concentrations increased significantly (p<0.01) in MS and MR subjects compared to controls but decreased gradually over a one year period post mitral valve replacement (p<0.05). In MS, PICP level and MMP1/TIMP-1 ratio strongly correlated with mitral valve area (r = -0.40; r = 0.49 respectively) and pulmonary artery systolic pressure (r = 0.49; r = -0.49 respectively); while in MR they correlated with left ventricular internal diastolic (r = 0.68; r = -0.48 respectively) and systolic diameters (r = 0.65; r = -0.55 respectively). Receiver operating characteristic curve analysis established PICP as a better marker (AUC = 0.95; 95% CI = 0.91-0.99; p<0.0001). A cut-off >459 ng/mL for PICP provided 91% sensitivity, 90% specificity and a likelihood ratio of 9 in diagnosing RHD. Histopathology analysis revealed inflammation, scarring, neovascularisation and extensive leaflet fibrosis in diseased mitral valve. Conclusions: Levels of collagen metabolism markers correlated with echocardiographic parameters for RHD diagnosis.	[Banerjee, Tanima; Mukherjee, Somaditya; Ghosh, Sudip; Chatterjee, Shelly; Bandyopadhyay, Arun] CSIR Indian Inst Chem Biol, Dept Cell Biol & Physiol, Kolkata, WB, India; [Biswas, Monodeep] Geisinger Community Med Ctr, Dept Cardiol, Scranton, PA USA; [Biswas, Monodeep] Wright Ctr Grad Med Educ, Scranton, PA USA; [Dutta, Santanu] SSKM Hosp, Inst Post Grad Med Educ & Res, Dept Cardiothorac & Vasc Surg, Kolkata, WB, India; [Pattari, Sanjib] Rabindra Nath Tagore Int Inst Cardiac Sci, Dept Pathol, Kolkata, WB, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Institute of Post Graduate Medical Education & Research (IPGMER), Kolkata	Bandyopadhyay, A (corresponding author), CSIR Indian Inst Chem Biol, Dept Cell Biol & Physiol, Kolkata, WB, India.	arunb@iicb.res.in			Council of Scientific and Industrial Research (CSIR), New Delhi, India [NWP 0004, MLP 115]; CSIR, New Delhi	Council of Scientific and Industrial Research (CSIR), New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India); CSIR, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	This work is supported by grants from Council of Scientific and Industrial Research (CSIR), New Delhi, India (NWP 0004, MLP 115) to AB. TB and SM are recipients of fellowships from CSIR, New Delhi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee T, 2012, INT J CARDIOL, V156, P117, DOI 10.1016/j.ijcard.2012.01.026; Boldt A, 2004, HEART, V90, P400, DOI 10.1136/hrt.2003.015347; BRAND A, 1992, AM HEART J, V123, P177, DOI 10.1016/0002-8703(92)90763-L; Carabello BA, 2005, CIRCULATION, V112, P432, DOI 10.1161/CIRCULATIONAHA.104.532498; EISENBERG MJ, 1993, EUR HEART J, V14, P122, DOI 10.1093/eurheartj/14.1.122; Gaasch WH, 2008, CIRCULATION, V118, P2298, DOI 10.1161/CIRCULATIONAHA.107.755942; GANAU A, 1992, J AM COLL CARDIOL, V19, P1550, DOI 10.1016/0735-1097(92)90617-V; Gonzalez A, 2002, J MOL CELL CARDIOL, V34, P1585, DOI 10.1006/jmcc.2002.2081; Guilherme L, 2011, ANN PEDIAT CARDIOL, V4, P13, DOI 10.4103/0974-2069.79617; Hara M, 2005, BIOTECHNIQUES, V39, P373, DOI 10.2144/05393ST05; Kadir IS, 2004, ANN THORAC SURG, V78, P699, DOI 10.1016/S0003-4975(03)01376-6; Khan R, 2006, IMMUNOLOGY, V118, P10, DOI 10.1111/j.1365-2567.2006.02336.x; Lancellotti P, 2010, EUR J ECHOCARDIOGR, V11, P307, DOI 10.1093/ejechocard/jeq031; Leong SW, 2006, CAN J CARDIOL, V22, P1055, DOI 10.1016/S0828-282X(06)70321-X; Lopez B, 2004, J AM COLL CARDIOL, V43, P2028, DOI 10.1016/j.jacc.2003.12.052; Lopez B, 2010, CIRCULATION, V121, P1645, DOI 10.1161/CIRCULATIONAHA.109.912774; Lorell BH, 2000, CIRCULATION, V102, P470; Marciniak A, 2007, EUR HEART J, V28, P2627, DOI 10.1093/eurheartj/ehm072; Marijon E, 2008, B WORLD HEALTH ORGAN, V86, P84, DOI 10.2471/BLT.07.046680; Marijon E, 2007, NEW ENGL J MED, V357, P470, DOI 10.1056/NEJMoa065085; Marijon E, 2012, LANCET, V379, P953, DOI 10.1016/S0140-6736(11)61171-9; Martos R, 2007, CIRCULATION, V115, P888, DOI 10.1161/CIRCULATIONAHA.106.638569; McCarthy KP, 2010, EUR J ECHOCARDIOGR, V11, pI3, DOI 10.1093/ejechocard/jeq153; Narula J, 2001, LANCET, V358, P2000, DOI 10.1016/S0140-6736(01)06993-8; Querejeta R, 2000, CIRCULATION, V101, P1729; Querejeta R, 2004, CIRCULATION, V110, P1263, DOI 10.1161/01.CIR.0000140973.60992.9A; Rabkin E, 2001, CIRCULATION, V104, P2525, DOI 10.1161/hc4601.099489; Remenyi B, 2012, NAT REV CARDIOL, V9, P297, DOI 10.1038/nrcardio.2012.7; Roy SG, 2007, MATRIX BIOL, V26, P269, DOI 10.1016/j.matbio.2006.12.005; Steer AC, 2009, NAT REV CARDIOL, V6, P689, DOI 10.1038/nrcardio.2009.162; Walker GA, 2004, CIRC RES, V95, P253, DOI 10.1161/01.RES.0000136520.07995.aa; World Health Organization, 2008, PROJ MORT BURD DIS 2; World health organization, 2004, 2001 REP WHO EXP CON, P13; Yeghiazarians Y, 2009, MOL THER, V17, P1250, DOI 10.1038/mt.2009.85; Zhang H, 2006, J BIOMED MATER RES A, V76A, P120, DOI 10.1002/jbm.a.30491	35	21	25	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90527	10.1371/journal.pone.0090527	http://dx.doi.org/10.1371/journal.pone.0090527			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603967	gold, Green Published, Green Submitted			2022-12-27	WOS:000332483600059
J	Chai, YS; Yuan, ZY; Lei, F; Wang, YG; Hu, J; Du, F; Lu, X; Jiang, JF; Xing, DM; Du, LJ				Chai, Yu-Shuang; Yuan, Zhi-Yi; Lei, Fan; Wang, Yu-Gang; Hu, Jun; Du, Feng; Lu, Xi; Jiang, Jing-Fei; Xing, Dong-Ming; Du, Li-Jun			Inhibition of Retinoblastoma mRNA Degradation through Poly (A) Involved in the Neuroprotective Effect of Berberine against Cerebral Ischemia	PLOS ONE			English	Article							OXYGEN-GLUCOSE DEPRIVATION; CELL-CYCLE ARREST; SUBVENTRICULAR ZONE; TUMOR-SUPPRESSOR; PRB PATHWAY; IN-VITRO; APOPTOSIS; GROWTH; RAT; RB	Berberine is one kind of isoquinoline alkaloid with anti-apoptotic effects on the neurons suffering ischemia. To address the explanation for these activities, the berberine-induced cell cycle arrest during neurons suffering ischemia/reperfusion had been studied in the present study. According to the in vitro neurons with oxygen-glucose deprivation and in vivo ICR mice with cerebral ischemia/reperfusion, it was found that berberine could protect the mRNA of retinoblastoma (Rb) from degradation through its function on the poly(A) tail. The prolonged half-life of retinoblastoma 1 (gene of Rb, RB1) mRNA level secures the protein level of retinoblastoma, which facilitates cell cycle arrest of neurons in the process of ischemia/reperfusion and subsequently avoids cells entering in the apoptotic process. The poly(A) tail of RB1 mRNA, as a newly identified target of berberine, could help people focus on the interaction between berberine and mRNA to further understand the biological activities and functions of berberine.	[Chai, Yu-Shuang; Yuan, Zhi-Yi; Lei, Fan; Hu, Jun; Lu, Xi; Jiang, Jing-Fei; Xing, Dong-Ming; Du, Li-Jun] Tsinghua Univ, Sch Life Sci, Lab Mol Pharmacol & Pharmaceut Sci, MOE Key Lab Prot Sci, Beijing 100084, Peoples R China; [Chai, Yu-Shuang; Yuan, Zhi-Yi; Lei, Fan; Hu, Jun; Lu, Xi; Jiang, Jing-Fei; Xing, Dong-Ming; Du, Li-Jun] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Wang, Yu-Gang] Univ Texas MD Anderson Canc Ctr, Dept Neurooncol, Houston, TX 77030 USA; [Du, Feng] Tulane Univ, Dept Math, New Orleans, LA 70118 USA	Tsinghua University; Tsinghua University; University of Texas System; UTMD Anderson Cancer Center; Tulane University	Du, LJ (corresponding author), Tsinghua Univ, Sch Life Sci, Lab Mol Pharmacol & Pharmaceut Sci, MOE Key Lab Prot Sci, Beijing 100084, Peoples R China.	lijundu@mail.tsinghua.edu.cn			National Natural Science Foundation of China [30973896, 81374006, 81073092]; National S&T Major Special Project for New Drug R&D Program of China [2012ZX09103-201-041, 2011ZX09101-002-11, 2012ZX09102-201-008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National S&T Major Special Project for New Drug R&D Program of China	This work was supported by the National Natural Science Foundation of China (30973896, 81374006 and 81073092) and the National S&T Major Special Project for New Drug R&D Program of China (2012ZX09103-201-041, 2011ZX09101-002-11 and 2012ZX09102-201-008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeoye O, 2011, STROKE, V42, P1952, DOI 10.1161/STROKEAHA.110.612358; Bouwman P, 2002, MOL CELL ENDOCRINOL, V195, P27, DOI 10.1016/S0303-7207(02)00221-6; Bryant CS, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-47; Chai YS, 2013, EUR J PHARMACOL, V708, P44, DOI 10.1016/j.ejphar.2013.02.041; Chen XW, 2012, SCI WORLD J, DOI 10.1100/2012/708292; Choi Byul-Bo Ra, 2011, International Journal of Oral Biology, V36, P129; Choi MS, 2009, INT J ONCOL, V34, P1221, DOI 10.3892/ijo_00000250; Choi MS, 2008, ANTICANCER RES, V28, P3777; Coschi CH, 2010, GENE DEV, V24, P1351, DOI 10.1101/gad.1917610; Della-Morte D, 2011, NEUROSCI LETT, V487, P158, DOI 10.1016/j.neulet.2010.10.013; Di Fiore R, 2013, J CELL PHYSIOL, V228, P1676, DOI 10.1002/jcp.24329; ESUMI M, 1995, GENE, V161, P231, DOI 10.1016/0378-1119(95)00154-X; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Giacinti C, 2006, ONCOGENE, V25, P5220, DOI 10.1038/sj.onc.1209615; Goodrich DW, 2006, ONCOGENE, V25, P5233, DOI 10.1038/sj.onc.1209616; He W, 2012, J PHARMACOL SCI, V119, P341, DOI 10.1254/jphs.12052FP; Hu J, 2012, EUR J PHARMACOL, V674, P132, DOI 10.1016/j.ejphar.2011.11.014; HUANG S, 1992, DNA CELL BIOL, V11, P539, DOI 10.1089/dna.1992.11.539; Islam MM, 2011, MEDCHEMCOMM, V2, P631, DOI 10.1039/c0md00209g; Islam MM, 2009, J PHYS CHEM B, V113, P1210, DOI 10.1021/jp806597w; Jiang Y, 2012, J LEUKEM LYMPH, V21, P342; Katiyar SK, 2009, MOL CARCINOGEN, V48, P24, DOI 10.1002/mc.20453; Lee HG, 2009, NEUROCHEM INT, V54, P84, DOI 10.1016/j.neuint.2008.10.013; Li HY, 2010, EUR J PHARMACOL, V649, P92, DOI 10.1016/j.ejphar.2010.09.023; Li JS, 2013, LAB INVEST, V93, P354, DOI 10.1038/labinvest.2012.172; Li L, 2010, GLIA, V58, P1610, DOI 10.1002/glia.21033; Luo X, 2012, BIOTECHNOL LETT, V34, P627, DOI 10.1007/s10529-011-0813-3; Ma C, 2013, CHEM BIOL DRUG DES, V81, P775, DOI 10.1111/cbdd.12124; Mahata S, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-39; Manning AL, 2011, TRENDS CELL BIOL, V21, P433, DOI 10.1016/j.tcb.2011.05.003; Mantena SK, 2006, CARCINOGENESIS, V27, P2018, DOI 10.1093/carcin/bgl043; Manzanero S, 2013, NEUROCHEM INT, V62, P712, DOI 10.1016/j.neuint.2012.11.009; Marti-Fabregas J, 2010, NEUROLOGY, V74, P357, DOI 10.1212/WNL.0b013e3181cbccec; Mazighi M, 2012, STROKE, V43, P1302, DOI 10.1161/STROKEAHA.111.635029; Munro S, 2012, ONCOGENE, V31, P4343, DOI 10.1038/onc.2011.603; NANDI R, 1990, BIOCHIM BIOPHYS ACTA, V1049, P339, DOI 10.1016/0167-4781(90)90107-D; Oshikawa M, 2013, DEVELOPMENT, V140, P2310, DOI 10.1242/dev.095653; Rashidian J, 2007, BBA-MOL BASIS DIS, V1772, P484, DOI 10.1016/j.bbadis.2006.11.009; Refaat A, 2013, ONCOL LETT, V6, P840, DOI 10.3892/ol.2013.1434; Rodrigo R, 2013, CNS NEUROL DISORD-DR, V12, P698; Sage J, 2003, NATURE, V424, P223, DOI 10.1038/nature01764; Sage J, 2010, GENE DEV, V24, P1329, DOI 10.1101/gad.1948010; Serafim TL, 2008, CANCER CHEMOTH PHARM, V61, P1007, DOI 10.1007/s00280-007-0558-9; Sheng R, 2010, AUTOPHAGY, V6, P482, DOI 10.4161/auto.6.4.11737; Sherr Charles J., 1994, Trends in Cell Biology, V4, P15, DOI 10.1016/0962-8924(94)90033-7; Sinha R, 2009, J PHYS CHEM B, V113, P13410, DOI 10.1021/jp9069515; Soriano SG, 2010, ANESTHESIOLOGY, V112, P1155, DOI 10.1097/ALN.0b013e3181d3e0c2; Stegmeier F, 2005, P NATL ACAD SCI USA, V102, P13212, DOI 10.1073/pnas.0506306102; Stoica BA, 2009, NEUROTOX RES, V16, P221, DOI 10.1007/s12640-009-9050-0; Stone JG, 2011, J NEUROPATH EXP NEUR, V70, P578, DOI 10.1097/NEN.0b013e3182204414; Vuddanda PR, 2010, EXPERT OPIN INV DRUG, V19, P1297, DOI 10.1517/13543784.2010.517745; Wang Y, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0023495, DOI 10.1371/J0URNAL.P0NE.0023495]; Wen Y, 2005, FEBS LETT, V579, P4591, DOI 10.1016/j.febslet.2005.07.028; Xie X, 2011, ENDOCR J, V58, P761, DOI 10.1507/endocrj.K11E-024; Yang T, 2014, CELL TRANSPLANT, V23, P221, DOI 10.3727/096368912X661355; Yip NKY, 2013, ONCOL REP, V30, P1107, DOI 10.3892/or.2013.2543; Yu Y, 2012, NEUROCHEM RES, V37, P503, DOI 10.1007/s11064-011-0636-6; Yu Y, 2009, NEUROCHEM RES, V34, P1113, DOI 10.1007/s11064-008-9887-2; Zhang RL, 2006, J CEREBR BLOOD F MET, V26, P857, DOI 10.1038/sj.jcbfm.9600237	59	31	38	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90850	10.1371/journal.pone.0090850	http://dx.doi.org/10.1371/journal.pone.0090850			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603897	Green Submitted, Green Published, gold			2022-12-27	WOS:000332483600097
J	Garcia-Torres, L; Caballero-Novella, JJ; Gomez-Candon, D; Isabel De-Castro, A				Garcia-Torres, Luis; Caballero-Novella, Juan J.; Gomez-Candon, David; Isabel De-Castro, Ana			Semi-Automatic Normalization of Multitemporal Remote Images Based on Vegetative Pseudo-Invariant Features	PLOS ONE			English	Article							RELATIVE RADIOMETRIC NORMALIZATION; SATELLITE IMAGES	A procedure to achieve the semi-automatic relative image normalization of multitemporal remote images of an agricultural scene called ARIN was developed using the following procedures: 1) defining the same parcel of selected vegetative pseudo-invariant features (VPIFs) in each multitemporal image; 2) extracting data concerning the VPIF spectral bands from each image; 3) calculating the correction factors (CFs) for each image band to fit each image band to the average value of the image series; and 4) obtaining the normalized images by linear transformation of each original image band through the corresponding CF. ARIN software was developed to semi-automatically perform the ARIN procedure. We have validated ARIN using seven GeoEye-1 satellite images taken over the same location in Southern Spain from early April to October 2010 at an interval of approximately 3 to 4 weeks. The following three VPIFs were chosen: citrus orchards (CIT), olive orchards (OLI) and poplar groves (POP). In the ARIN-normalized images, the range, standard deviation (s. d.) and root mean square error (RMSE) of the spectral bands and vegetation indices were considerably reduced compared to the original images, regardless of the VPIF or the combination of VPIFs selected for normalization, which demonstrates the method's efficacy. The correlation coefficients between the CFs among VPIFs for any spectral band (and all bands overall) were calculated to be at least 0.85 and were significant at P = 0.95, indicating that the normalization procedure was comparably performed regardless of the VPIF chosen. ARIN method was designed only for agricultural and forestry landscapes where VPIFs can be identified.	[Garcia-Torres, Luis; Caballero-Novella, Juan J.; Gomez-Candon, David; Isabel De-Castro, Ana] Spanish Council Sci Res CSIC, Inst Sustainable Agr IAS, Cordoba, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Agricultura Sostenible (IAS)	Garcia-Torres, L (corresponding author), Spanish Council Sci Res CSIC, Inst Sustainable Agr IAS, Cordoba, Spain.	lgarciatorres@ias.csic.es	De Castro Megías, Ana Isabel/K-7429-2017	De Castro Megías, Ana Isabel/0000-0002-6699-2204; Gomez-Candon, David/0000-0002-4216-6709	Spanish Commission of Science and Technology; Ministry of Economy and Competition [AGL2007-60926, AGL2010-15506]	Spanish Commission of Science and Technology(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT)); Ministry of Economy and Competition	All the external funding of this research was provided by the Spanish Commission of Science and Technology (http://www.idi.mineco.gob.es/portal/site/MICINN/), Ministry of Economy and Competition, through the projects AGL2007-60926 and AGL2010-15506. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler-Golden M, 1998, 1998 AVIRIS GEOSC WO; Baisantry M., 2012, ACEEE INT J INFORM T, V2, P28; Bernstein LS, 2012, OPT ENG, V51, DOI 10.1117/1.OE.51.11.111719; Broncano-Mateos CJ, 2010, INT J ARTIFICIAL INT, V1, P53; Canty MJ, 2004, REMOTE SENS ENVIRON, V91, P441, DOI 10.1016/j.rse.2003.10.024; Canty MJ, 2008, REMOTE SENS ENVIRON, V112, P1025, DOI 10.1016/j.rse.2007.07.013; Changmiao Hu, 2011, 2011 4th International Congress on Image and Signal Processing (CISP 2011), P1614, DOI 10.1109/CISP.2011.6100483; Coppin P.R., 1994, GEOSCIENCE REMOTE SE, V60, P287; Du Y, 2002, REMOTE SENS ENVIRON, V82, P123, DOI 10.1016/S0034-4257(02)00029-9; ERDAS Inc, 1999, ERDAS FIELD GUID, P362; Furby SL, 2001, REMOTE SENS ENVIRON, V77, P186, DOI 10.1016/S0034-4257(01)00205-X; Garcia-Torres L, 2012, ARIN PROCEDURE AUTOM, Patent No. PCT/ES2013/070873; Garcia-Torres L, 2012, ARIN SOFTWARE AUTOMA; Gomez-Candon D, 2011, PRECIS AGRIC, V12, P876, DOI 10.1007/s11119-011-9228-3; HALL FG, 1991, REMOTE SENS ENVIRON, V35, P11, DOI 10.1016/0034-4257(91)90062-B; Hien LP, 2012, INT J ADV COMPUT TEC, V4, P1; Hu Y, 2011, PROC SPIE, V8006, DOI 10.1117/12.902076; Inoue Y, 2003, PLANT PROD SCI, V6, P3, DOI 10.1626/pps.6.3; Kim DS, 2012, GISCI REMOTE SENS, V49, P755, DOI 10.2747/1548-1603.49.5.755; Nielsen AA, 2002, PHYS CHEM EARTH, V27, P1379, DOI 10.1016/S1474-7065(02)00075-X; Nielsen AA, 2007, IEEE T IMAGE PROCESS, V16, P463, DOI 10.1109/TIP.2006.888195; Philpot W, 2013, IEEE T GEOSCI REMOTE, V51, P2016, DOI 10.1109/TGRS.2012.2227328; Sadeghi V, 2013, APPL MATH MODEL, V37, P6437, DOI 10.1016/j.apm.2013.01.006; Torres-Sanchez J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058210; Ya'allah S. M., 2005, Information Fusion, V6, P235, DOI 10.1016/j.inffus.2004.12.002; Yang XJ, 2000, PHOTOGRAMM ENG REM S, V66, P967	26	6	7	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e91275	10.1371/journal.pone.0091275	http://dx.doi.org/10.1371/journal.pone.0091275			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24604031	Green Published, Green Submitted, gold			2022-12-27	WOS:000332483600139
J	Liu, L; Jiao, JH; Wang, Y; Zhang, D; Wu, JY; Huang, DS				Liu, Lei; Jiao, Jinghua; Wang, Yu; Zhang, Dong; Wu, Jingyang; Huang, Desheng			Lack of Association of the TP53BP1 Glu353Asp Polymorphism with Risk of Cancer: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							SINGLE NUCLEOTIDE POLYMORPHISMS; LUNG-CANCER; GENETIC POLYMORPHISMS; BREAST; VARIANTS; P53; SUSCEPTIBILITY; IRRADIATION; CARCINOMA; ARG72PRO	Objective: The TP53BP1 gene may be involved in the development of cancer through disrupting DNA repair. However, studies investigating the relationship between TP53BP1 Glu353Asp (rs560191) polymorphism and cancer yielded contradictory and inconclusive outcomes. In order to realize these ambiguous findings, a meta-analysis was performed to assess the association between the TP53BP1 Glu353Asp (rs560191) polymorphism and susceptibility to cancer. Methods: We conducted a search of all English reports on studies for the association between the TP53BP1 Asp353Glu (rs560191) polymorphism and susceptibility to cancer using Medline, the Cochrane Library, EMbase, Web of Science, Google (scholar), and all Chinese reports were identified manually and on-line using CBMDisc, Chongqing VIP database, and CNKI database. The strict selection criteria and exclusion criteria were determined, and odds ratios (ORs) with 95% confidence intervals (CIs) were used to assess the strength of associations. The fixed or random effect model was selected based on the heterogeneity test among studies. Publication bias was estimated using funnel plots and Egger's regression test. Results: A total of seven studies were included in the meta-analysis including 3,213 cases and 3,849 controls. The results indicated that the Glu353Asp (rs560191) polymorphism in TP53BP1 gene had no association with cancer risk for all genetic models. In the subgroup analysis, the results suggested that Glu353Asp polymorphism was not associated with the risk of cancer according to ethnicity, cancer type, genotyping method, adjusted with control or not, HWE and quality score. Conclusions: This meta-analysis suggested that the Glu353Asp (rs560191) polymorphism in TP53BP1 gene was not associated with risk of cancer.	[Liu, Lei; Wu, Jingyang] China Med Univ, Dept Ophthalmol, Affiliated Hosp 1, Shenyang, Liaoning Provin, Peoples R China; [Jiao, Jinghua] Shenyang Med Coll, Fengtian Hosp, Dept Anesthesiol, Shenyang, Liaoning Provin, Peoples R China; [Wang, Yu] China Med Univ, Dept Dev & Planning Off, Shenyang, Liaoning Provin, Peoples R China; [Zhang, Dong] Fourth Peoples Hosp Shenyang, Dept Gen Surg, Shenyang, Liaoning Provin, Peoples R China; [Liu, Lei; Huang, Desheng] China Med Univ, Sch Publ Hlth, Dept Epidemiol, Shenyang, Liaoning Provin, Peoples R China	China Medical University; Shenyang Medical College; China Medical University; China Medical University	Liu, L (corresponding author), China Med Univ, Dept Ophthalmol, Affiliated Hosp 1, Shenyang, Liaoning Provin, Peoples R China.	liuleijiao@163.com						Brooks JD, 2012, HUM MUTAT, V33, P158, DOI 10.1002/humu.21604; Camargo MC, 2006, CANCER EPIDEM BIOMAR, V15, P1674, DOI 10.1158/1055-9965.EPI-06-0189; Chen KX, 2007, CLIN CANCER RES, V13, P4300, DOI 10.1158/1078-0432.CCR-07-0469; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DerSimonian R, 2007, CONTEMP CLIN TRIALS, V28, P105, DOI 10.1016/j.cct.2006.04.004; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Frank B, 2005, BREAST CANCER RES, V7, pR502, DOI 10.1186/bcr1038; Gao LB, 2011, BREAST CANCER RES TR, V125, P827, DOI 10.1007/s10549-010-0995-8; Haffty BG, 2011, INT J RADIAT ONCOL, V80, P385, DOI 10.1016/j.ijrobp.2010.02.005; Kiyohara C, 2010, ONCOL REP, V23, P1361, DOI 10.3892/or_00000772; Liu GY, 2011, ARCH MED RES, V42, P149, DOI 10.1016/j.arcmed.2011.02.002; Ma HX, 2006, CARCINOGENESIS, V27, P766, DOI 10.1093/carcin/bgi295; MANTEL N, 1959, J NATL CANCER I, V22, P719; Miwa S, 2013, ANTICANCER RES, V33, P1373; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Naidu R, 2011, APMIS, V119, P460, DOI 10.1111/j.1600-0463.2011.02753.x; Oliveira S, 2012, ONCOL REP, V27, P1188, DOI 10.3892/or.2011.1609; Rudd MF, 2006, GENOME RES, V16, P693, DOI 10.1101/gr.5120106; Timofeeva MN, 2012, HUM MOL GENET, V21, P4980, DOI 10.1093/hmg/dds334; Truong T, 2010, CARCINOGENESIS, V31, P625, DOI 10.1093/carcin/bgq001; Weng Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045820; Williams RS, 2001, NAT STRUCT BIOL, V8, P838, DOI 10.1038/nsb1001-838; Zhang H, 2013, ARCH MED RES, DOI [10.1016/j.arcmed.2013.10.011, DOI 10.1016/J.ARCMED.2013.10.011.[]; Zhao LJ, 2013, GENET TEST MOL BIOMA, V17, P721, DOI 10.1089/gtmb.2013.0103	25	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90931	10.1371/journal.pone.0090931	http://dx.doi.org/10.1371/journal.pone.0090931			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603722	gold, Green Published, Green Submitted			2022-12-27	WOS:000332483600108
J	Marcon, E; Scotti, I; Herault, B; Rossi, V; Lang, G				Marcon, Eric; Scotti, Ivan; Herault, Bruno; Rossi, Vivien; Lang, Gabriel			Generalization of the Partitioning of Shannon Diversity	PLOS ONE			English	Article							NONPARAMETRIC-ESTIMATION; ENTROPY; NUMBER; SAMPLE; ALPHA	Traditional measures of diversity, namely the number of species as well as Simpson's and Shannon's indices, are particular cases of Tsallis entropy. Entropy decomposition, i.e. decomposing gamma entropy into alpha and beta components, has been previously derived in the literature. We propose a generalization of the additive decomposition of Shannon entropy applied to Tsallis entropy. We obtain a self-contained definition of beta entropy as the information gain brought by the knowledge of each community composition. We propose a correction of the estimation bias allowing to estimate alpha, beta and gamma entropy from the data and eventually convert them into true diversity. We advocate additive decomposition in complement of multiplicative partitioning to allow robust estimation of biodiversity.	[Marcon, Eric] AgroParisTech, UMR Ecol Forets Guyane, Kourou, France; [Scotti, Ivan] INRA, UMR Ecol Forets Guyane, Kourou, France; [Herault, Bruno; Rossi, Vivien] CIRAD, UMR Ecol Forets Guyane, Kourou, France; [Lang, Gabriel] AgroParisTech, UMR Math Info Appli 518, Paris, France; [Lang, Gabriel] INRA, UMR Math Info Appli 518, Paris, France	AgroParisTech; CIRAD; Centre National de la Recherche Scientifique (CNRS); Universite des Antilles; AgroParisTech; CIRAD; Centre National de la Recherche Scientifique (CNRS); Universite des Antilles; INRAE; AgroParisTech; CIRAD; Centre National de la Recherche Scientifique (CNRS); Universite des Antilles; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Marcon, E (corresponding author), AgroParisTech, UMR Ecol Forets Guyane, Kourou, France.	eric.marcon@ecofog.gf	Hérault, Bruno/B-2765-2011; Marcon, Eric/B-5631-2009; Rossi, Vivien/C-9721-2009	Hérault, Bruno/0000-0002-6950-7286; Marcon, Eric/0000-0002-5249-321X; Rossi, Vivien/0000-0001-5458-1523	Agence Nationale de la Recherche (CEBA) [ANR-10-LABX-25-01]; project Climfor (Fondation pour la Recherche sur la Biodiversite)	Agence Nationale de la Recherche (CEBA)(French National Research Agency (ANR)); project Climfor (Fondation pour la Recherche sur la Biodiversite)	This work has benefited from an "Investissement d'Avenir" grant managed by Agence Nationale de la Recherche (CEBA, ref. ANR-10-LABX-25-01). Funding came from the project Climfor (Fondation pour la Recherche sur la Biodiversite). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonachela JA, 2008, J PHYS A, V41, P1; Borland L, 1998, J MATH PHYS, V39, P6490, DOI 10.1063/1.532660; CHAO A, 1984, SCAND J STAT, V11, P265; Chao A, 2003, ENVIRON ECOL STAT, V10, P429, DOI 10.1023/A:1026096204727; Chao AN, 2013, METHODS ECOL EVOL, V4, P1091, DOI 10.1111/2041-210X.12108; Chao A, 2012, ECOLOGY, V93, P2037, DOI 10.1890/11-1817.1; Dauby G, 2012, ECOGRAPHY, V35, P661, DOI 10.1111/j.1600-0587.2011.06860.x; Ellison AM, 2010, ECOLOGY, V91, P1962, DOI 10.1890/09-1692.1; Fisher RA, 1943, J ANIM ECOL, V12, P42, DOI 10.2307/1411; Furuichi S, 2004, J MATH PHYS, V45, P4868, DOI 10.1063/1.1805729; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; GRASSBERGER P, 1988, PHYS LETT A, V128, P369, DOI 10.1016/0375-9601(88)90193-4; Harvda J, 1967, KYBERNETIKA, V3, P30; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; Holste D, 1998, J PHYS A-MATH GEN, V31, P2551, DOI 10.1088/0305-4470/31/11/007; HORVITZ DG, 1952, J AM STAT ASSOC, V47, P663, DOI 10.2307/2280784; Hou Y, 2012, COMPUTATIONAL INTELL; Hubbell S.P., 2005, BARRO COLORADO FORES; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Jost L, 2010, DIVERS DISTRIB, V16, P65, DOI 10.1111/j.1472-4642.2009.00626.x; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; Lamberti PW, 2003, PHYSICA A, V329, P81, DOI 10.1016/S0378-4371(03)00566-1; Lande R, 1996, OIKOS, V76, P5, DOI 10.2307/3545743; Leinster T, 2012, ECOLOGY, V93, P477, DOI 10.1890/10-2402.1; LIN JH, 1991, IEEE T INFORM THEORY, V37, P145, DOI 10.1109/18.61115; MACARTHUR RH, 1965, BIOL REV, V40, P510, DOI 10.1111/j.1469-185X.1965.tb00815.x; Marcon E, 2012, OIKOS, V121, P516, DOI 10.1111/j.1600-0706.2011.19267.x; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Oksanen J., **DATA OBJECT**; PATIL GP, 1982, J AM STAT ASSOC, V77, P548, DOI 10.2307/2287709; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; RAO CR, 1985, IEEE T INFORM THEORY, V31, P589, DOI 10.1109/TIT.1985.1057082; ROUTLEDGE RD, 1979, J THEOR BIOL, V76, P503, DOI 10.1016/0022-5193(79)90015-8; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; TSALLIS C, 1988, J STAT PHYS, V52, P479, DOI 10.1007/BF01016429; Tsallis C, 1998, PHYSICA A, V261, P534, DOI 10.1016/S0378-4371(98)00437-3; Tsallis C, 1994, QUIM NOVA, V17, P468; Tuomisto H, 2010, ECOGRAPHY, V33, P2, DOI 10.1111/j.1600-0587.2009.05880.x	41	47	49	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90289	10.1371/journal.pone.0090289	http://dx.doi.org/10.1371/journal.pone.0090289			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603966	gold, Green Published, Green Submitted			2022-12-27	WOS:000332483600039
J	Randhawa, M; Sangar, V; Tucker-Samaras, S; Southall, M				Randhawa, Manpreet; Sangar, Vineet; Tucker-Samaras, Samantha; Southall, Michael			Metabolic Signature of Sun Exposed Skin Suggests Catabolic Pathway Overweighs Anabolic Pathway	PLOS ONE			English	Article							NICOTINAMIDE ADENINE-DINUCLEOTIDE; UROCANIC ACID; NITRIC-OXIDE; UV; IRRADIATION; ACTIVATION; RADIATION	Skin chronically exposed to sun results in phenotypic changes referred as photoaging. This aspect of aging has been studied extensively through genomic and proteomic tools. Metabolites, the end product are generated as a result of biochemical reactions are often studied as a culmination of complex interplay of gene and protein expression. In this study, we focused exclusively on the metabolome to study effects from sun-exposed and sun-protected skin sites from 25 human subjects. We generated a highly accurate metabolomic signature for the skin that is exposed to sun. Biochemical pathway analysis from this data set showed that sun-exposed skin resides under high oxidative stress and the chains of reactions to produce these metabolites are inclined toward catabolism rather than anabolism. These catabolic activities persuade the skin cells to generate metabolites through the salvage pathway instead of de novo synthesis pathways. Metabolomic profile suggests catabolic pathways and reactive oxygen species operate in a feed forward fashion to alter the biology of sun exposed skin.	[Randhawa, Manpreet; Tucker-Samaras, Samantha; Southall, Michael] CPPW, Johnson & Johnson Skin Res Ctr, Skillman, NJ 08558 USA; [Sangar, Vineet] Inst Syst Biol, Seattle, WA USA	Johnson & Johnson; Johnson & Johnson USA; Institute for Systems Biology (ISB)	Randhawa, M (corresponding author), CPPW, Johnson & Johnson Skin Res Ctr, Skillman, NJ 08558 USA.	mrandha1@its.jnj.com			Johnson & Johnson Consumer Companies Inc.	Johnson & Johnson Consumer Companies Inc.(Johnson & JohnsonJohnson & Johnson USA)	This research was supported and funded by Johnson & Johnson Consumer Companies Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes VM, 2009, J DENT RES, V88, P851, DOI 10.1177/0022034509341967; Bennett MF, 2008, J INVEST DERM SYMP P, V13, P15, DOI 10.1038/jidsymp.2008.3; Besedovsky HO, 1996, ENDOCR REV, V17, P64, DOI 10.1210/er.17.1.64; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Brosh S, 1984, Adv Exp Med Biol, V165 Pt A, P481; de Gruijl FR, 2001, J PHOTOCH PHOTOBIO B, V63, P19, DOI 10.1016/S1011-1344(01)00199-3; Deliconstantinos G, 1996, BIOCHEM J, V320, P997, DOI 10.1042/bj3200997; Deliconstantinos G, 1996, EXP PHYSIOL, V81, P1021, DOI 10.1113/expphysiol.1996.sp003986; El-Abaseri TB, 2006, CARCINOGENESIS, V27, P225, DOI 10.1093/carcin/bgi220; El-Abaseri TB, 2005, CANCER RES, V65, P3958, DOI 10.1158/0008-5472.CAN-04-2204; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Hanson KM, 1998, P NATL ACAD SCI USA, V95, P10576, DOI 10.1073/pnas.95.18.10576; HARMAN D, 1968, J GERONTOL, V23, P476, DOI 10.1093/geronj/23.4.476; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124; Khan JA, 2007, EXPERT OPIN THER TAR, V11, P695, DOI 10.1517/14728222.11.5.695; Landmesser U, 2007, ARTERIOSCL THROM VAS, V27, P943, DOI 10.1161/01.ATV.0000258415.32883.bf; Lin SJ, 2003, CURR OPIN CELL BIOL, V15, P241, DOI 10.1016/S0955-0674(03)00006-1; MOODYCLIFFE AM, 1992, IMMUNOLOGY, V77, P394; Randhawa M, 2013, MOL BIOSYST, V9, P2045, DOI 10.1039/c3mb25537a; Ratnam S, 2002, J BIOL CHEM, V277, P42912, DOI 10.1074/jbc.M206588200; SCHALLREUTER KU, 1995, J INVEST DERMATOL, V104, P953, DOI 10.1111/1523-1747.ep12606218; Slominski A, 2000, ENDOCR REV, V21, P457, DOI 10.1210/er.21.5.457; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Slominski A, 1998, CLIN DERMATOL, V16, P503, DOI 10.1016/S0738-081X(98)00023-6; Slominski Andrzej T, 2012, Adv Anat Embryol Cell Biol, V212, P1; Wang-Sattler R, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.43; Zastrow L, 2009, HAUTARZT, V60, P310, DOI 10.1007/s00105-008-1628-6; Zastrow L, 2009, SKIN PHARMACOL PHYS, V22, P31, DOI 10.1159/000188083; Zhu M, 2006, CANCER LETT, V244, P220, DOI 10.1016/j.canlet.2005.12.023	30	13	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90367	10.1371/journal.pone.0090367	http://dx.doi.org/10.1371/journal.pone.0090367			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603693	Green Submitted, gold, Green Published			2022-12-27	WOS:000332483600049
J	Wu, JC; Jia, HL; Li, ZR; Zhou, KL; Qin, LX; Dong, QZ; Ren, N				Wu, Jin-Cai; Jia, Hu-Liang; Li, Zhuo-Ri; Zhou, Kai-Lun; Qin, Lun-Xiu; Dong, Qiong-Zhu; Ren, Ning			Genomic Aberrations in the HTPAP Promoter Affect Tumor Metastasis and Clinical Prognosis of Hepatocellular Carcinoma	PLOS ONE			English	Article							CHROMOSOME 8P DELETION; CANCER-CELLS; EXPRESSION; RISK; ASSOCIATION; SUPPRESSOR; VARIANTS; GENE	We previously reported that the intronic tagSNP +357G/C in the metastasis suppressor HTPAP is associated with metastasis and prognosis of hepatocellular carcinoma (HCC). The aim of this study was to investigate whether SNPs in the HTPAP promoter modulate HTPAP expression and prognosis of HCC. Genomic DNA from 572 microdissected HCCs were genotyped by pyrosequencing and verified by direct sequencing. Haplotype blocks were analyzed. Reporter plasmids were constructed and transfected into HCC cell lines. Transcriptional activities of plasmids were analyzed by dual-luciferase reporter systems. HTPAP expression was measured by real-time quantitative PCR, western blots, and tissue microarrays. Invasion was assessed by Matrigel assays. The prognostic values of HTPAP promoter SNPs in HCC were evaluated by Kaplan-Meier and Cox regression analyses. We identified six SNPs, including -1053A/G and +64G/C, in the HTPAP promoter. The SNPs were in complete linkage disequilibrium, resulting in three promoter haplotypes (promoter I:-1053AA/+64GG, promoter II: -1053AG/+64GC, and promoter III: -1053GG/+64CC). Promoter I manifested the highest luciferase index (p<0.005). However, no significant difference was observed between promoters II and III. We consistently found that HTPAP mRNA and protein levels were significantly higher in promoter I than that of promoter II+III (p<0.001). Invasion was increased in HCC cells transfected with promoters II+ III compared to those transfected with promoter I (p<0.05). The HTPAP promoter II+III haplotype was associated with significantly increased metastasis compared to that of promoter I (p = 0.023). The postoperative five-year overall survival of patients with promoters II+ III was lower than that of patients with promoter I (p = 0.006). Multivariate analysis showed that the promoter II+ III haplotype was an adverse prognostic marker in HCC. The genetic variants at loci -1053 and +64 of the HTPAP promoter affect the expression of HTPAP, which might be a novel determinant and target for HCC prognosis.	[Wu, Jin-Cai; Li, Zhuo-Ri; Zhou, Kai-Lun] Nanhua Univ, Hainan Prov Peoples Hosp, Dept Hepatobiliary Surg, Haikou, Peoples R China; [Jia, Hu-Liang; Qin, Lun-Xiu; Dong, Qiong-Zhu; Ren, Ning] Fudan Univ, Liver Canc Inst, Zhongshan Hosp, Key Lab Carcinogenesis & Canc Invas,Minist Educ, Shanghai 200032, Peoples R China; [Jia, Hu-Liang; Qin, Lun-Xiu; Dong, Qiong-Zhu; Ren, Ning] Fudan Univ, Ctr Canc, Inst Biomed Sci, Shanghai 200433, Peoples R China	University of South China; Fudan University; Fudan University	Dong, QZ (corresponding author), Fudan Univ, Liver Canc Inst, Zhongshan Hosp, Key Lab Carcinogenesis & Canc Invas,Minist Educ, Shanghai 200032, Peoples R China.	qiongzhudong@163.com; renning021@126.com	Wang, Nian/HDM-2087-2022	Wang, Nian/0000-0001-7743-0728; Ren, Ning/0000-0001-9776-2471	China National Key Projects for Infectious Disease [2008ZX10002-021]; "973'' State Key Basic Research Program of China [2009CB521701]; Program of Shanghai Chief Scientist [08XD14008]; National Natural Science Foundation of China [30600589, 81160310, 81260367]; Natural Science Foundation of Hainan Province [812155]; Shanghai Rising Star of Young Scientist Project [07QA14010]	China National Key Projects for Infectious Disease; "973'' State Key Basic Research Program of China(National Basic Research Program of China); Program of Shanghai Chief Scientist; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hainan Province; Shanghai Rising Star of Young Scientist Project	This work was supported by the China National Key Projects for Infectious Disease (2008ZX10002-021), the "973'' State Key Basic Research Program of China (2009CB521701), the Program of Shanghai Chief Scientist (08XD14008), the National Natural Science Foundation of China (30600589, 81160310,81260367), the Natural Science Foundation of Hainan Province (812155), and the Shanghai Rising Star of Young Scientist Project (07QA14010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen HF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059574; Chung TT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033517; Dong QZ, 2013, HEPATOLOGY, V57, P1024, DOI 10.1002/hep.26103; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Hu LM, 2012, HEPATOLOGY, V55, P1426, DOI 10.1002/hep.24799; Huang J, 2012, NAT GENET, V44, P1117, DOI 10.1038/ng.2391; Jang JW, 2012, CANCER SCI, V103, P296, DOI 10.1111/j.1349-7006.2011.02170.x; Karim L, 2011, NAT GENET, V43, P405, DOI 10.1038/ng.814; Ke AW, 2009, HEPATOLOGY, V49, P491, DOI 10.1002/hep.22639; Kong HK, 2012, J BIOL CHEM, V287, P38889, DOI 10.1074/jbc.M112.394270; Levy L, 2002, ANN NY ACAD SCI, V963, P21; Li CY, 2010, CANCER PREV RES, V3, P246, DOI 10.1158/1940-6207.CAPR-08-0228; Li Y, 2004, J CANCER RES CLIN, V130, P460, DOI 10.1007/s00432-004-0564-9; Liu D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031251; Llovet JM, 2008, JNCI-J NATL CANCER I, V100, P698, DOI 10.1093/jnci/djn134; Lo PHY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061279; McLeod HL, 2013, SCIENCE, V339, P1563, DOI 10.1126/science.1234139; Nahon P, 2012, J HEPATOL, V57, P663, DOI 10.1016/j.jhep.2012.02.035; Pang JZ, 2007, CLIN CANCER RES, V13, P7363, DOI 10.1158/1078-0432.CCR-07-0593; Qin LX, 1999, CANCER RES, V59, P5662; Qin LX, 2001, J CANCER RES CLIN, V127, P482, DOI 10.1007/s004320100236; Ren N, 2006, J CANCER RES CLIN, V132, P399, DOI 10.1007/s00432-005-0049-5; Ren N, 2011, CANCER RES, V71, P3278, DOI 10.1158/0008-5472.CAN-10-3100; Stratton MR, 2011, SCIENCE, V331, P1553, DOI 10.1126/science.1204040; Totoki Y, 2011, NAT GENET, V43, P464, DOI 10.1038/ng.804; Wu JC, 2010, J CANCER RES CLIN, V136, P595, DOI 10.1007/s00432-009-0695-0; Wu X, 2006, ONCOGENE, V25, P1832, DOI 10.1038/sj.onc.1209191; Zhu ZS, 2012, CANCER RES, V72, P6163, DOI 10.1158/0008-5472.CAN-12-0010	29	144	182	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90528	10.1371/journal.pone.0090528	http://dx.doi.org/10.1371/journal.pone.0090528			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603412	Green Published, Green Submitted, gold			2022-12-27	WOS:000332483600060
J	Gobin, B; Moriceau, G; Ory, B; Charrier, C; Brion, R; Blanchard, F; Redini, F; Heymann, D				Gobin, Berengere; Moriceau, Gatien; Ory, Benjamin; Charrier, Celine; Brion, Regis; Blanchard, Frederic; Redini, Francoise; Heymann, Dominique			Imatinib Mesylate Exerts Anti-Proliferative Effects on Osteosarcoma Cells and Inhibits the Tumour Growth in Immunocompetent Murine Models	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; TYROSINE KINASE; FACTOR RECEPTOR; SOFT-TISSUE; IN-VITRO; PHASE-II; BONE; TARGET; PROLIFERATION; THERAPY	Osteosarcoma is the most common primary malignant bone tumour characterized by osteoid production and/or osteolytic lesions of bone. A lack of response to chemotherapeutic treatments shows the importance of exploring new therapeutic methods. Imatinib mesylate (Gleevec, Novartis Pharma), a tyrosine kinase inhibitor, was originally developed for the treatment of chronic myeloid leukemia. Several studies revealed that imatinib mesylate inhibits osteoclast differentiation through the M-CSFR pathway and activates osteoblast differentiation through PDGFR pathway, two key cells involved in the vicious cycle controlling the tumour development. The present study investigated the in vitro effects of imatinib mesylate on the proliferation, apoptosis, cell cycle, and migration ability of five osteosarcoma cell lines (human: MG-63, HOS; rat: OSRGA; mice: MOS-J, POS-1). Imatinib mesylate was also assessed as a curative and preventive treatment in two syngenic osteosarcoma models: MOS-J (mixed osteoblastic/osteolytic osteosarcoma) and POS-1 (undifferentiated osteosarcoma). Imatinib mesylate exhibited a dose-dependent anti-proliferative effect in all cell lines studied. The drug induced a G0/G1 cell cycle arrest in most cell lines, except for POS-1 and HOS cells that were blocked in the S phase. In addition, imatinib mesylate induced cell death and strongly inhibited osteosarcoma cell migration. In the MOS-J osteosarcoma model, oral administration of imatinib mesylate significantly inhibited the tumour development in both preventive and curative approaches. A phospho-receptor tyrosine kinase array kit revealed that PDGFR alpha, among 7 other receptors (PDFGFR beta, Axl, RYK, EGFR, EphA2 and 10, IGF1R), appears as one of the main molecular targets for imatinib mesylate. In the light of the present study and the literature, it would be particularly interesting to revisit therapeutic evaluation of imatinib mesylate in osteosarcoma according to the tyrosine-kinase receptor status of patients.	[Gobin, Berengere; Moriceau, Gatien; Ory, Benjamin; Charrier, Celine; Brion, Regis; Blanchard, Frederic; Redini, Francoise; Heymann, Dominique] INSERM, UMR 957, Nantes, France; [Gobin, Berengere; Moriceau, Gatien; Ory, Benjamin; Charrier, Celine; Brion, Regis; Blanchard, Frederic; Redini, Francoise; Heymann, Dominique] Nantes Atlantique Univ, Univ Nantes, Nantes, France; [Ory, Benjamin; Charrier, Celine; Brion, Regis; Blanchard, Frederic; Redini, Francoise; Heymann, Dominique] Equipe LIGUE Natl Canc 2012, Nantes, France; [Brion, Regis; Redini, Francoise; Heymann, Dominique] CHU Nantes, F-44035 Nantes 01, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Nantes Universite; CHU de Nantes	Heymann, D (corresponding author), INSERM, UMR 957, Nantes, France.	dominique.heymann@univ-nantes.fr	Blanchard, Frederic/K-8018-2015; Heymann, Dominique/AAC-6014-2019; ory, benjamin r/K-8231-2015; Charrier, Céline/K-9198-2015; Blanchard, Frederic/AAS-1930-2021; REDINI, Francoise/K-7981-2015	Blanchard, Frederic/0000-0003-1055-2573; Heymann, Dominique/0000-0001-7777-0669; Blanchard, Frederic/0000-0003-1055-2573; ory, benjamin/0000-0002-2622-7356	Pharma Novartis (Rueil-Malmaison, France); Region des Pays de la Loire; INSERM	Pharma Novartis (Rueil-Malmaison, France); Region des Pays de la Loire(Region Pays de la Loire); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	This work was supported by a grant from Pharma Novartis (Rueil-Malmaison, France) and Berengere Gobin received a PhD fellowship from the Region des Pays de la Loire and INSERM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison Daniel C., 2012, Sarcoma, V2012, P704872, DOI 10.1155/2012/704872; Ando Kosei, 2013, Cancers (Basel), V5, P591, DOI 10.3390/cancers5020591; Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Bond M, 2008, PEDIATR BLOOD CANCER, V50, P254, DOI 10.1002/pbc.21132; Chawla SP, 2012, J CLIN ONCOL, V30, P78, DOI 10.1200/JCO.2011.35.6329; Deschaseaux F, 2009, TRENDS MOL MED, V15, P417, DOI 10.1016/j.molmed.2009.07.002; Dib IE, 2006, EUR J PHARMACOL, V551, P27, DOI 10.1016/j.ejphar.2006.09.007; Fierro F, 2007, CELL PROLIFERAT, V40, P355, DOI 10.1111/j.1365-2184.2007.00438.x; Fritsche-Guenther R, 2010, HISTOPATHOLOGY, V57, P836, DOI 10.1111/j.1365-2559.2010.03713.x; Han J, 2013, BIOCHEM BIOPH RES CO, V435, P493, DOI 10.1016/j.bbrc.2013.05.019; Heymann D, 2011, IBMS BONEKEY, V8, P402, DOI DOI 10.1138/20110531; Hingorani P, 2009, CLIN CANCER RES, V15, P3416, DOI 10.1158/1078-0432.CCR-08-1657; Joliat MJ, 2002, IN VIVO, V16, P223; Kamijo A, 2002, CANCER LETT, V188, P213, DOI 10.1016/S0304-3835(02)00433-0; Kitagawa D, 2013, GENES CELLS, V18, P110, DOI 10.1111/gtc.12022; KLEIN B, 1977, INT J CANCER, V20, P112, DOI 10.1002/ijc.2910200118; Kubo T, 2008, CANCER-AM CANCER SOC, V112, P2119, DOI 10.1002/cncr.23437; Kuijjer ML, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-245; Lamoureux F, 2007, CANCER RES, V67, P7308, DOI 10.1158/0008-5472.CAN-06-4130; Lavenus S, 2011, EUR CELLS MATER, V22, P84, DOI 10.22203/eCM.v022a07; Lee JA, 2012, CANCER RES TREAT, V44, P202, DOI 10.4143/crt.2012.44.3.202; Macheda ML, 2008, CURR CANCER DRUG TAR, V8, P454, DOI 10.2174/156800908785699324; Manara MC, 2010, CLIN CANCER RES, V16, P530, DOI 10.1158/1078-0432.CCR-09-0816; Matsuo K, 2012, CELL ADHES MIGR, V6, P148, DOI 10.4161/cam.20888; McGary EC, 2002, CLIN CANCER RES, V8, P3584; McQueen P, 2011, EXPERT REV ANTICANC, V11, P1223, DOI [10.1586/era.11.94, 10.1586/ERA.11.94]; Miiji LNO, 2011, INT J CLIN EXP PATHO, V4, P775; Mohseny AB, 2011, STEM CELLS, V29, P397, DOI 10.1002/stem.596; Moriceau G, 2012, CANCER-AM CANCER SOC, V118, P750, DOI 10.1002/cncr.26336; Moriceau G, 2010, CANCER RES, V70, P10329, DOI 10.1158/0008-5472.CAN-10-0578; Nakano T, 2003, CLIN EXP METASTAS, V20, P665, DOI 10.1023/A:1027355610603; O'Brien SG, 2003, NEW ENGL J MED, V348, P994, DOI 10.1056/NEJMoa022457; O'Sullivan S, 2007, J BONE MINER RES, V22, P1679, DOI 10.1359/JBMR.070719; Parkkila S, 2009, BIOORG MED CHEM LETT, V19, P4102, DOI 10.1016/j.bmcl.2009.06.002; PosthumaDeBoer J, 2013, BRIT J CANCER, V109, P2142, DOI 10.1038/bjc.2013.578; Rettew AN, 2012, ONCOGENESIS, V1, DOI 10.1038/oncsis.2012.34; Rix U, 2007, BLOOD, V110, P4055, DOI 10.1182/blood-2007-07-102061; ROSEN G, 1976, CANCER-AM CANCER SOC, V37, P1, DOI 10.1002/1097-0142(197601)37:1<1::AID-CNCR2820370102>3.0.CO;2-3; Savage DG, 2002, NEW ENGL J MED, V346, P683, DOI 10.1056/NEJMra013339; Tirode F, 2007, CANCER CELL, V11, P421, DOI 10.1016/j.ccr.2007.02.027; Truitt L, 2011, BIOCHEM CELL BIOL, V89, P115, DOI [10.1139/O10-145, 10.1139/o10-145]; Vandyke K, 2010, BLOOD, V115, P766, DOI 10.1182/blood-2009-08-237404; Verweij J, 2003, EUR J CANCER, V39, P2006, DOI 10.1016/S0959-8049(02)00836-5; Winger JA, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-7; Zhang Y, 2013, INT J IMMUNOPATH PH, V26, P179, DOI 10.1177/039463201302600117	45	32	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90795	10.1371/journal.pone.0090795	http://dx.doi.org/10.1371/journal.pone.0090795			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599309	Green Accepted, gold, Green Published			2022-12-27	WOS:000332479400132
J	Hazelton, PT; Steward, WT; Collins, SP; Gaffney, S; Morin, SF; Arnold, EA				Hazelton, Patrick T.; Steward, Wayne T.; Collins, Shane P.; Gaffney, Stuart; Morin, Stephen F.; Arnold, Emily A.			California's "Bridge to Reform'': Identifying Challenges and Defining Strategies for Providers and Policymakers Implementing the Affordable Care Act in Low-Income HIV/AIDS Care and Treatment Settings	PLOS ONE			English	Article							HIV CARE; HEALTH-INSURANCE; RYAN WHITE; SYSTEM; WAVE	Background: In preparation for full Affordable Care Act implementation, California has instituted two healthcare initiatives that provide comprehensive coverage for previously uninsured or underinsured individuals. For many people living with HIV, this has required transition either from the HIV-specific coverage of the Ryan White program to the more comprehensive coverage provided by the county-run Low-Income Health Programs or from Medicaid fee-for-service to Medicaid managed care. Patient advocates have expressed concern that these transitions may present implementation challenges that will need to be addressed if ambitious HIV prevention and treatment goals are to be achieved. Methods: 30 semi-structured, in-depth interviews were conducted between October, 2012, and February, 2013, with policymakers and providers in 10 urban, suburban, and rural California counties. Interview topics included: continuity of patient care, capacity to handle payer source transitions, and preparations for healthcare reform implementation. Study team members reviewed interview transcripts to produce emergent themes, develop a codebook, build inter-rater reliability, and conduct analyses. Results: Respondents supported the goals of the ACA, but reported clinic and policy-level challenges to maintaining patient continuity of care during the payer source transitions. They also identified strategies for addressing these challenges. Areas of focus included: gaps in communication to reach patients and develop partnerships between providers and policymakers, perceived inadequacy in new provider networks for delivering quality HIV care, the potential for clinics to become financially insolvent due to lower reimbursement rates, and increased administrative burdens for clinic staff and patients. Conclusions: California's new healthcare initiatives represent ambitious attempts to expand and improve health coverage for low-income individuals. The state's challenges in maintaining quality care and treatment for people living with HIV experiencing these transitions demonstrate the importance of setting effective policies in anticipation of full ACA implementation in 2014.	[Hazelton, Patrick T.; Steward, Wayne T.; Collins, Shane P.; Gaffney, Stuart; Morin, Stephen F.; Arnold, Emily A.] Univ Calif San Francisco, Dept Med, Ctr AIDS Prevent Studies, San Francisco, CA 94117 USA	University of California System; University of California San Francisco	Hazelton, PT (corresponding author), Univ Calif San Francisco, Dept Med, Ctr AIDS Prevent Studies, San Francisco, CA 94117 USA.	patrick.hazelton@ucsf.edu			California HIV/AIDS Research Centers; California HIV/AIDS Research Program (CHRP); CHRP [RP11-SF-021]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER	California HIV/AIDS Research Centers; California HIV/AIDS Research Program (CHRP); CHRP; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was conducted under the auspices of the California HIV/AIDS Research Centers, two university-community partnerships funded by the California HIV/AIDS Research Program (CHRP) that are intended to increase the use of systematic investigations to inform HIV policymaking. The center in Northern California consists of the University of California, San Francisco (UCSF); the San Francisco AIDS Foundation; and Project Inform. The center in Southern California consists of the University of California, Los Angeles; AIDS Project Los Angeles, and the Los Angeles Gay and Lesbian Center. The data collection activities and analyses described in this paper were supported by the CHRP funding awarded to UCSF (RP11-SF-021; PI: Wayne T. Steward). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bindman AB, 2011, NEW ENGL J MED, V364, P1487, DOI 10.1056/NEJMp1014109; California Budget Project, 2013, EXP HOR KEY FACTS ME; California Department of Healthcare Services (DHCS), 2011, CAL BRIDG REF DEM LO; Chen RY, 2006, CLIN INFECT DIS, V42, P1003, DOI 10.1086/500453; Crowley JS, 2013, UPDATE R WHITE HIV A; Darling H, 2010, HEALTH AFFAIR, V29, P1220, DOI 10.1377/hlthaff.2010.0422; Decker SL, 2012, HEALTH AFFAIR, V31, P1673, DOI 10.1377/hlthaff.2012.0294; Donnelly A, 2012, HLTH CARE REFORM CAL; Flynn M, 2012, HEALTHCARE REFORM MA; Gallant JE, 2011, CLIN INFECT DIS, V53, P1043, DOI 10.1093/cid/cir689; Health Resource and Services Administration (HRSA), 2011, HIV AIDS PROGR R WHI; Health Resources and Services Administration (HRSA), 2013, WHAT AR FED QUAL HLT; Health Resources and Services Administration (HRSA), 2014, 340B DRUG PRIC PROGR; Hoang T, 2009, MED CARE, V47, P560, DOI 10.1097/MLR.0b013e31819432a0; Institute of Medicine Committee on Quality of Health Care in America, 2001, CROSSING QUALITY CHA; Kaiser Family Foundation, 2012, MED TO MED FEE IND; Kaiser Family Foundation, 2013, NAV IN PERS ASS PROG; Kates J., 2014, ASSESSING IMPACT AFF; Kates J., 2011, MEDICAID HIV NATL AN; Lefert A, 2013, NATL ADAP MONITORING; Leibowitz AA, 2013, JAIDS-J ACQ IMM DEF, V64, pS62, DOI 10.1097/01.qai.0000435254.49553.24; Martin EG, 2012, JAIDS-J ACQ IMM DEF, V60, P72, DOI 10.1097/QAI.0b013e31824c0dd4; McDonough JE, 2006, HEALTH AFFAIR, V25, pW420, DOI 10.1377/hlthaff.25.w420; Moore RD, 2012, CLIN INFECT DIS, V55, P1242, DOI 10.1093/cid/cis654; National Alliance of State & Territorial AIDS Directors, 2013, HLTH REF ISS BRIEF P; Ojikutu B, 2013, AIDS CARE; Parham Hopson D, 2011, CALIFORNIA WAIVER LE; Pourat N, 2012, HEALTH AFFAIR, V31, P1717, DOI 10.1377/hlthaff.2012.0545; Riley ED, 2011, AIDS CARE, V23, P822, DOI 10.1080/09540121.2010.538660; Ryan B, 2011, POZ              SEP, P42; Saag MS, 2009, AIDS READ, V19, P166; San Francisco HIV Health Care Reform Task Force Harder+Company Community Research, 2013, HIV SERV ORG PLANN C; Shepherd J, 2013, MINNESOTA J LAW SCI; Sherer R, 2012, SEX TRANSM INFECT, V88, P106, DOI 10.1136/sextrans-2011-050160; Strauss A., 1998, BASICS QUALITATIVE R; The Center for Medicaid and CHIP Services (CMCS), 2014, HLTH HOM	36	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90306	10.1371/journal.pone.0090306	http://dx.doi.org/10.1371/journal.pone.0090306			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC4GP	24599337	gold, Green Submitted, Green Published			2022-12-27	WOS:000332479400061
J	Murgatroyd, C; Spengler, D				Murgatroyd, Chris; Spengler, Dietmar			Polycomb Binding Precedes Early-Life Stress Responsive DNA Methylation at the Avp Enhancer	PLOS ONE			English	Article							TRANSCRIPTIONAL REPRESSION; MECP2; BRAIN; HYPOTHALAMUS; LINEAGE; CELLS; AXIS; CPG	Early-life stress (ELS) in mice causes sustained hypomethylation at the downstream Avp enhancer, subsequent overexpression of hypothalamic Avp and increased stress responsivity. The sequence of events leading to Avp enhancer methylation is presently unknown. Here, we used an embryonic stem cell-derived model of hypothalamic-like differentiation together with in vivo experiments to show that binding of polycomb complexes (PcG) preceded the emergence of ELS-responsive DNA methylation and correlated with gene silencing. At the same time, PcG occupancy associated with the presence of Tet proteins preventing DNA methylation. Early hypothalamic-like differentiation triggered PcG eviction, DNA-methyltransferase recruitment and enhancer methylation. Concurrently, binding of the Methyl-CpG-binding and repressor protein MeCP2 increased at the enhancer although Avp expression during later stages of differentiation and the perinatal period continued to increase. Overall, we provide evidence of a new role of PcG proteins in priming ELS-responsive DNA methylation at the Avp enhancer prior to epigenetic programming consistent with the idea that PcG proteins are part of a flexible silencing system during neuronal development.	[Murgatroyd, Chris; Spengler, Dietmar] Max Planck Inst Psychiat, Munich, Germany; [Murgatroyd, Chris] Manchester Metropolitan Univ, Manchester M15 6BH, Lancs, England	Max Planck Society; Manchester Metropolitan University	Murgatroyd, C (corresponding author), Max Planck Inst Psychiat, Munich, Germany.	c.murgatroyd@mmu.ac.uk		Murgatroyd, Chris/0000-0002-6885-7794				Bettscheider Marc, 2011, BMC Res Notes, V4, P314, DOI 10.1186/1756-0500-4-314; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; Engelmann M, 2004, FRONT NEUROENDOCRIN, V25, P132, DOI 10.1016/j.yfrne.2004.09.001; Farthing CR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000116; Fiskus W, 2009, BLOOD, V114, P2733, DOI 10.1182/blood-2009-03-213496; Fuks F, 2001, EMBO J, V20, P2536, DOI 10.1093/emboj/20.10.2536; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Goncharova Nadezhda D, 2013, Front Endocrinol (Lausanne), V4, P26, DOI 10.3389/fendo.2013.00026; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Guy J, 2011, ANNU REV CELL DEV BI, V27, P631, DOI 10.1146/annurev-cellbio-092910-154121; Hoffmann A, 2014, NEUROSCIENCE, V264, P64, DOI 10.1016/j.neuroscience.2012.04.003; KARIM MA, 1980, J ANAT, V130, P341; Klose RJ, 2005, MOL CELL, V19, P667, DOI 10.1016/j.molcel.2005.07.021; Kurian JR, 2007, EPIGENETICS, V2, P173, DOI 10.4161/epi.2.3.4841; Lees-Murdock DJ, 2003, GENOMICS, V82, P230, DOI 10.1016/S0888-7543(03)00105-8; Lynch MD, 2012, EMBO J, V31, P317, DOI 10.1038/emboj.2011.399; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Murgatroyd C, 2012, METHODS MOL BIOL, V809, P135, DOI 10.1007/978-1-61779-376-9_9; Murgatroyd C, 2011, STRESS, V14, P581, DOI 10.3109/10253890.2011.602146; Murgatroyd C, 2010, AGING-US, V2, P107; Murgatroyd C, 2009, NAT NEUROSCI, V12, P1559, DOI 10.1038/nn.2436; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Negishi M, 2007, BIOCHEM BIOPH RES CO, V353, P992, DOI 10.1016/j.bbrc.2006.12.166; Schuettengruber B, 2009, DEVELOPMENT, V136, P3531, DOI 10.1242/dev.033902; Squazzo SL, 2006, GENOME RES, V16, P890, DOI 10.1101/gr.5306606; Sweatt JD, 2013, NEURON, V80, P624, DOI 10.1016/j.neuron.2013.10.023; Szabo NE, 2009, J NEUROSCI, V29, P6989, DOI 10.1523/JNEUROSCI.1089-09.2009; Szarek E, 2010, MOL CELL ENDOCRINOL, V323, P115, DOI 10.1016/j.mce.2010.04.002; van der Vlag J, 1999, NAT GENET, V23, P474, DOI 10.1038/70602; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Wataya T, 2008, P NATL ACAD SCI USA, V105, P11796, DOI 10.1073/pnas.0803078105; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Wissing S, 2012, HUM MOL GENET, V21, P208, DOI 10.1093/hmg/ddr455; Wu H, 2011, NATURE, V473, P389, DOI 10.1038/nature09934; Wu H, 2010, SCIENCE, V329, P444, DOI 10.1126/science.1190485	35	27	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90277	10.1371/journal.pone.0090277	http://dx.doi.org/10.1371/journal.pone.0090277			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599304	Green Published, gold, Green Submitted			2022-12-27	WOS:000332479400059
J	Onwuamah, CK; Ekama, SO; Audu, RA; Ezechi, OC; Poirier, MC; Odeigah, PGC				Onwuamah, Chika K.; Ekama, Sabdat O.; Audu, Rosemary A.; Ezechi, Oliver C.; Poirier, Miriam C.; Odeigah, Peter G. C.			Exposure of Allium cepa Root Cells to Zidovudine or Nevirapine Induces Cytogenotoxic Changes	PLOS ONE			English	Article							REVERSE-TRANSCRIPTASE INHIBITORS; HUMAN LYMPHOBLASTOID-CELLS; UNINFECTED CHILDREN BORN; HIV-INFECTED WOMEN; IN-VITRO EXPOSURE; PERINATAL EXPOSURE; UTERO EXPOSURE; TRANSMISSION; GENOTOXICITY; CARCINOMA	Antiretroviral drugs have proved useful in the clinical management of HIV-infected persons, though there are concerns about the effects of exposure to these DNA-reactive drugs. We investigated the potential of the plant model Allium cepa root tip assay to demonstrate the cytogenotoxicity of zidovudine and nevirapine and as a replace-reduce-refine programme amenable to resource-poor research settings. Cells mitotic index were determined in squashed root cells from Allium cepa bulbs exposed to zidovudine or nevirapine for 48 hr. The concentration of zidovudine and nevirapine inhibiting 50% root growth after 96 hr exposure was 65.0 mu M and 92.5 mu M respectively. Root length of all antiretroviral-exposed roots after 96 hr exposure was significantly shorter than the unexposed roots while additional root growth during a subsequent 48 hr recovery period in the absence of drug was not significantly different. By ANOVA, there was a significant association between percentage of cells in mitosis and zidovudine dose (p = 0.004), but not nevirapine dose (p = 0.68). Chromosomal aberrations such as sticky chromosomes, chromatin bridges, multipolar mitoses and binucleated cells were observed in root cells exposed to zidovudine and nevirapine for 48 hr. The most notable chromosomal aberration was drug-related increases in sticky chromosomes. Overall, the study showed inhibition in root length growth, changes in the mitotic index, and the induction of chromosomal aberrations in Allium bulbs treated for 96 hr or 48 hr with zidovudine and nevirapine. The study reveals generalized cytogenotoxic damage induced by exposure to zidovudine and nevirapine, and further show that the two compounds differ in their effects on mitosis and the types of chromosomal aberrations induced.	[Onwuamah, Chika K.; Audu, Rosemary A.] Nigerian Inst Med Res, Human Virol Lab, Lagos, Nigeria; [Ekama, Sabdat O.; Ezechi, Oliver C.] Nigerian Inst Med Res, Div Clin Sci, Lagos, Nigeria; [Poirier, Miriam C.] NCI, Carcinogen DNA Interact Sect, LCBG, Ctr Canc Res,NIH, Bethesda, MD 20892 USA; [Odeigah, Peter G. C.] Univ Lagos, Dept Cell Biol & Genet, Lagos, Nigeria	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Lagos	Onwuamah, CK (corresponding author), Nigerian Inst Med Res, Human Virol Lab, Lagos, Nigeria.	chikaonwuamah@yahoo.com	Onwuamah, Chika Kingsley/ABB-9926-2020; Audu, Rosemary A/G-1726-2017	Onwuamah, Chika Kingsley/0000-0002-5111-1822; Audu, Rosemary A/0000-0002-0330-5219; EKAMA, SABDAT/0000-0003-4395-419X	Intramural research program of the Centre for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA; NATIONAL CANCER INSTITUTE [ZIABC010770] Funding Source: NIH RePORTER	Intramural research program of the Centre for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was self-sponsored by Dr Onwuamah as part of his doctoral research. Dr Poirier also provided some reagents and she is supported by the Intramural research program of the Centre for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Briand N, 2006, PEDIATR INFECT DIS J, V25, P325, DOI 10.1097/01.inf.0000207398.10466.0d; Bulterys M, 2000, J ACQ IMMUN DEF SYND, V25, P261, DOI 10.1097/00126334-200011010-00009; Crasta K, 2012, NATURE, V482, P53, DOI 10.1038/nature10802; Culnane M, 1999, JAMA-J AM MED ASSOC, V281, P151, DOI 10.1001/jama.281.2.151; ENNEVER FK, 1988, MUTAT RES, V205, P99, DOI 10.1016/0165-1218(88)90013-4; Escobar PA, 2007, ENVIRON MOL MUTAGEN, V48, P330, DOI 10.1002/em.20285; FISKESJO G, 1985, HEREDITAS, V102, P99, DOI 10.1111/j.1601-5223.1985.tb00471.x; Foster C, 2008, J ANTIMICROB CHEMOTH, V61, P8, DOI 10.1093/jac/dkm411; Fretheim A, 2006, ANTIRETROVIRAL DRUGS; Landriscina M, 2005, J CLIN ENDOCR METAB, V90, P5663, DOI 10.1210/jc.2005-0367; Lipshultz SE, 2011, J AM COLL CARDIOL, V57, P76, DOI 10.1016/j.jacc.2010.08.620; Odeigah PGC, 1997, HEREDITAS, V126, P161, DOI 10.1111/j.1601-5223.1997.00161.x; Olivero OA, 2005, MUTAGENESIS, V20, P139, DOI 10.1093/mutage/gei019; Paul ME, 2005, PEDIATR INFECT DIS J, V24, P46, DOI 10.1097/01.inf.0000148879.83854.7e; Stefanidis K, 2008, GYNECOL ONCOL, V111, P344, DOI 10.1016/j.ygyno.2008.08.006; Torres SM, 2007, ENVIRON MOL MUTAGEN, V48, P224, DOI 10.1002/em.20264; Walker VE, 2007, ENVIRON MOL MUTAGEN, V48, P159, DOI 10.1002/em.20296; Witt KL, 2007, ENVIRON MOL MUTAGEN, V48, P322, DOI 10.1002/em.20266	18	6	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90296	10.1371/journal.pone.0090296	http://dx.doi.org/10.1371/journal.pone.0090296			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599327	gold, Green Submitted, Green Published			2022-12-27	WOS:000332479400060
J	Taya, K; Nakayama, EE; Shioda, T				Taya, Kahoru; Nakayama, Emi E.; Shioda, Tatsuo			Moderate Restriction of Macrophage-Tropic Human Immunodeficiency Virus Type 1 by SAMHD1 in Monocyte-Derived Macrophages	PLOS ONE			English	Article							T-CELL-LINE; HIV-1 ENTRY; MONONUCLEAR PHAGOCYTES; DENDRITIC CELLS; AIDS VIRUS; INFECTION; REPLICATION; RECEPTOR; FUSION; VECTORS	Macrophage-tropic human immunodeficiency virus type 1 (HIV-1) strains are able to grow to high titers in human monocyte-derived macrophages. However, it was recently reported that cellular protein SAMHD1 restricts HIV-1 replication in human cells of the myeloid lineage, including monocyte-derived macrophages. Here we show that degradation of SAMHD1 in monocyte-derived macrophages was associated with moderately enhanced growth of the macrophage-tropic HIV-1 strain. SAMHD1 degradation was induced by treating target macrophages with vesicular stomatitis virus glycoprotein-pseudotyped human immunodeficiency virus type 2 (HIV-2) particles containing viral protein X. For undifferentiated monocytes, HIV-2 particle treatment allowed undifferentiated monocytes to be fully permissive for productive infection by the macrophage-tropic HIV-1 strain. In contrast, untreated monocytes were totally resistant to HIV-1 replication. These results indicated that SAMHD1 moderately restricts even a macrophage-tropic HIV-1 strain in monocyte-derived macrophages, whereas the protein potently restricts HIV-1 replication in undifferentiated monocytes.	[Taya, Kahoru; Nakayama, Emi E.; Shioda, Tatsuo] Osaka Univ, Microbial Dis Res Inst, Dept Viral Infect, Suita, Osaka 565, Japan	Osaka University	Shioda, T (corresponding author), Osaka Univ, Microbial Dis Res Inst, Dept Viral Infect, Suita, Osaka 565, Japan.	shioda@biken.osaka-u.ac.jp		ying mei, zhong shan/0000-0002-0477-0980	Ministry of Education, Culture, Sports, Science, and Technology; Ministry of Health, Labour and Welfare, Japan; Grants-in-Aid for Scientific Research [23390111] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant from the Ministry of Education, Culture, Sports, Science, and Technology, and by a grant from the Ministry of Health, Labour and Welfare, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; Baldauf HM, 2012, NAT MED, V18, P1682, DOI 10.1038/nm.2964; BERGAMINI A, 1994, BLOOD, V84, P3405; Berger A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002425; Berson JF, 1996, J VIROL, V70, P6288, DOI 10.1128/JVI.70.9.6288-6295.1996; Cashin K, 2011, J VIROL, V85, P10699, DOI 10.1128/JVI.05510-11; CHENGMAYER C, 1988, SCIENCE, V240, P80, DOI 10.1126/science.2832945; CHENGMAYER C, 1987, P NATL ACAD SCI USA, V84, P3526, DOI 10.1073/pnas.84.10.3526; CHENGMAYER C, 1989, P NATL ACAD SCI USA, V86, P8575, DOI 10.1073/pnas.86.21.8575; Choe H, 1996, CELL, V85, P1135, DOI 10.1016/S0092-8674(00)81313-6; Cribier A, 2013, CELL REP, V3, P1036, DOI 10.1016/j.celrep.2013.03.017; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Diget EA, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/208412; Doranz BJ, 1996, CELL, V85, P1149, DOI 10.1016/S0092-8674(00)81314-8; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; GARTNER S, 1986, SCIENCE, V233, P215, DOI 10.1126/science.3014648; Ghafouri M, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-28; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Gorry Paul R, 2011, Curr HIV/AIDS Rep, V8, P45, DOI 10.1007/s11904-010-0069-x; Goujon C, 2006, GENE THER, V13, P991, DOI 10.1038/sj.gt.3302753; Goujon C, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-2; Goujon C, 2008, J VIROL, V82, P12335, DOI 10.1128/JVI.01181-08; Gruber A, 2000, BLOOD, V96, P1327, DOI 10.1182/blood.V96.4.1327.h8001327_1327_1333; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; HWANG SS, 1991, SCIENCE, V253, P71, DOI 10.1126/science.1905842; Kaushik R, 2009, CELL HOST MICROBE, V6, P68, DOI 10.1016/j.chom.2009.05.022; Kedzierska K, 2000, AIDS, V14, P1739, DOI 10.1097/00002030-200008180-00008; Kim B, 2012, J BIOL CHEM, V287, P21570, DOI 10.1074/jbc.C112.374843; KOENIG S, 1986, SCIENCE, V233, P1089, DOI 10.1126/science.3016903; KOYANAGI Y, 1987, SCIENCE, V236, P819, DOI 10.1126/science.3646751; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lapham CK, 1999, NAT MED, V5, P303, DOI 10.1038/6523; MADDON PJ, 1986, CELL, V47, P333, DOI 10.1016/0092-8674(86)90590-8; MATSUDA S, 1995, AIDS RES HUM RETROV, V11, P1031, DOI 10.1089/aid.1995.11.1031; Negre D, 2000, GENE THER, V7, P1613, DOI 10.1038/sj.gt.3301292; Nomaguchi M, 2013, MICROBES INFECT, V15, P319, DOI 10.1016/j.micinf.2013.01.005; OBRIEN WA, 1990, NATURE, V348, P69, DOI 10.1038/348069a0; Pauls E, 2013, J IMMUNOL, V190, P4736, DOI 10.4049/jimmunol.1203226; Peters PJ, 2007, J NEUROIMMUNE PHARM, V2, P32, DOI 10.1007/s11481-006-9042-2; SHIODA T, 1992, P NATL ACAD SCI USA, V89, P9434, DOI 10.1073/pnas.89.20.9434; SHIODA T, 1991, NATURE, V349, P167, DOI 10.1038/349167a0; Tan PH, 2005, BLOOD, V105, P3824, DOI 10.1182/blood-2004-10-3880; Tokunaga K, 2001, J VIROL, V75, P6776, DOI 10.1128/JVI.75.15.6776-6785.2001; Welbourn S, 2013, J VIROL, V87, P11516, DOI 10.1128/JVI.01642-13; White TE, 2013, CELL HOST MICROBE, V13, P441, DOI 10.1016/j.chom.2013.03.005	46	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90969	10.1371/journal.pone.0090969	http://dx.doi.org/10.1371/journal.pone.0090969			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599229	Green Submitted, gold, Green Published			2022-12-27	WOS:000332479400148
J	Bruhn, BR; Schroeder, TBH; Li, SY; Billeh, YN; Wang, KW; Mayer, M				Bruhn, Brandon R.; Schroeder, Thomas B. H.; Li, Suyi; Billeh, Yazan N.; Wang, K. W.; Mayer, Michael			Osmosis-Based Pressure Generation: Dynamics and Application	PLOS ONE			English	Article							POWER-GENERATION; POLYETHYLENE GLYCOLS; SAMANEA-SAMAN; MIMOSA-PUDICA; OSMOTIC PUMPS; MAIN PULVINUS; MOTOR CELLS; WATER; DELIVERY; MOVEMENT	This paper describes osmotically-driven pressure generation in a membrane-bound compartment while taking into account volume expansion, solute dilution, surface area to volume ratio, membrane hydraulic permeability, and changes in osmotic gradient, bulk modulus, and degree of membrane fouling. The emphasis lies on the dynamics of pressure generation; these dynamics have not previously been described in detail. Experimental results are compared to and supported by numerical simulations, which we make accessible as an open source tool. This approach reveals unintuitive results about the quantitative dependence of the speed of pressure generation on the relevant and interdependent parameters that will be encountered in most osmotically-driven pressure generators. For instance, restricting the volume expansion of a compartment allows it to generate its first 5 kPa of pressure seven times faster than without a restraint. In addition, this dynamics study shows that plants are near-ideal osmotic pressure generators, as they are composed of many small compartments with large surface area to volume ratios and strong cell wall reinforcements. Finally, we demonstrate two applications of an osmosis-based pressure generator: actuation of a soft robot and continuous volume delivery over long periods of time. Both applications do not need an external power source but rather take advantage of the energy released upon watering the pressure generators.	[Bruhn, Brandon R.; Billeh, Yazan N.; Mayer, Michael] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA; [Schroeder, Thomas B. H.; Mayer, Michael] Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA; [Li, Suyi; Wang, K. W.] Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Mayer, M (corresponding author), Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.	mimayer@umich.edu	Mayer, Michael/AAS-1777-2020; Mayer, Michael/C-1299-2010	Mayer, Michael/0000-0002-6148-5756; Li, Suyi/0000-0002-0355-1655; Billeh, Yazan/0000-0001-5200-4992; Schroeder, Thomas/0000-0003-2795-1730	Agency: NSF [0937323]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB005582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008353] Funding Source: NIH RePORTER	Agency: NSF; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by: Agency: NSF, Federal Award ID Number: 0937323. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2010, DESALINATION, V261, P205, DOI 10.1016/j.desal.2010.06.017; Achilli A, 2009, J MEMBRANE SCI, V343, P42, DOI 10.1016/j.memsci.2009.07.006; Allen RD, 1967, STUDIES SEISMONASTIC; Benedek GB, 2000, PHYS ILLUSTRATIVE EX; Bessoth FG, 1999, ANAL COMMUN, V36, P213, DOI 10.1039/a902237f; Cath TY, 2006, J MEMBRANE SCI, V281, P70, DOI 10.1016/j.memsci.2006.05.048; Dumais J, 2012, ANNU REV FLUID MECH, V44, P453, DOI 10.1146/annurev-fluid-120710-101200; Eliassi A, 1998, J CHEM ENG DATA, V43, P719, DOI 10.1021/je970228a; Erbacher C, 1999, MIKROCHIM ACTA, V131, P19, DOI 10.1007/s006040050004; FLEURATLESSARD P, 1988, BIOL REV, V63, P1, DOI 10.1111/j.1469-185X.1988.tb00467.x; Gong MM, 2012, BIOMICROFLUIDICS, V6, DOI 10.1063/1.4762851; Good BT, 2007, J COLLOID INTERF SCI, V305, P239, DOI 10.1016/j.jcis.2006.08.067; GORTON HL, 1987, PLANT PHYSIOL, V83, P945, DOI 10.1104/pp.83.4.945; Haynes WM., 2013, CRC HDB CHEM PHYS, V94th; Herz M, 2010, SENSOR ACTUAT A-PHYS, V163, P231, DOI 10.1016/j.sna.2010.05.018; HILL BS, 1981, Q REV BIOPHYS, V14, P173, DOI 10.1017/S0033583500002249; Huang SB, 2008, J MICROMECH MICROENG, V18, DOI 10.1088/0960-1317/18/4/045008; Ilievski F, 2011, ANGEW CHEM INT EDIT, V50, P1890, DOI 10.1002/anie.201006464; International Energy Agency, 2012, WORLD EN OUTL; Iverson BD, 2008, MICROFLUID NANOFLUID, V5, P145, DOI 10.1007/s10404-008-0266-8; Kagawa H, 2000, JSME INT J C-MECH SY, V43, P923, DOI 10.1299/jsmec.43.923; Kim SJ, 2013, LAB CHIP, V13, P1644, DOI 10.1039/c3lc41415a; Kim Y, 2009, LAB CHIP, V9, P2603, DOI 10.1039/b822423d; Kopp MU, 1998, SCIENCE, V280, P1046, DOI 10.1126/science.280.5366.1046; LAURELL T, 1995, BIOSENS BIOELECTRON, V10, P289, DOI 10.1016/0956-5663(95)96848-S; Leslie DC, 2009, NAT PHYS, V5, P231, DOI 10.1038/NPHYS1196; Liu LX, 2008, EUR J PHARM BIOPHARM, V68, P298, DOI 10.1016/j.ejpb.2007.04.020; Logan BE, 2012, NATURE, V488, P313, DOI 10.1038/nature11477; Martinez RV, 2013, ADV MATER, V25, P205, DOI 10.1002/adma.201203002; Martinez RV, 2012, ADV FUNCT MATER, V22, P1376, DOI 10.1002/adfm.201102978; Mayer M, 1996, ANAL CHIM ACTA, V324, P37, DOI 10.1016/0003-2670(95)00576-5; MAYER WE, 1985, PLANTA, V163, P381, DOI 10.1007/BF00395147; McCutcheon JR, 2006, J MEMBRANE SCI, V284, P237, DOI 10.1016/j.memsci.2006.07.049; McGinnis RL, 2007, J MEMBRANE SCI, V305, P13, DOI 10.1016/j.memsci.2007.08.027; Mescher MJ, 2009, J MICROELECTROMECH S, V18, P501, DOI 10.1109/JMEMS.2009.2015484; MONEY NP, 1989, PLANT PHYSIOL, V91, P766, DOI 10.1104/pp.91.2.766; Moshelion M, 2002, PLANT CELL, V14, P727, DOI 10.1105/tpc.010351; Pinho SP, 2005, J CHEM ENG DATA, V50, P29, DOI 10.1021/je049922y; Rose S, 1955, NATURE, V33, P415; SAMEJIMA M, 1980, PLANT CELL PHYSIOL, V21, P467; Sewell WF, 2009, AUDIOL NEURO-OTOL, V14, P411, DOI 10.1159/000241898; Sharpe PJH, 1987, STOMATAL FUNCTION; Shepherd RF, 2011, P NATL ACAD SCI USA, V108, P20400, DOI 10.1073/pnas.1116564108; Strathmann H, 2000, ULLMANNS ENCY IND CH, DOI DOI 10.1002/14356007.016_; Stroock AD, 2013, ANN REV FLUID MECH; Su YC, 2002, J MICROELECTROMECH S, V11, P736, DOI 10.1109/JMEMS.2002.805045; Swanson D R, 1987, Am J Med, V83, P3, DOI 10.1016/0002-9343(87)90629-2; THEEUWES F, 1976, ANN BIOMED ENG, V4, P343, DOI 10.1007/BF02584524; THEEUWES F, 1975, J PHARM SCI, V64, P1987, DOI 10.1002/jps.2600641218; Walker GM, 2002, LAB CHIP, V2, P131, DOI 10.1039/b204381e; WILL PC, 1980, J PHARM SCI, V69, P747, DOI 10.1002/jps.2600690644; Zimmermann U., 1979, ADV BOT RES, VVolume 6, P45, DOI DOI 10.1016/S0065-2296(08)60329-8	52	21	21	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91350	10.1371/journal.pone.0091350	http://dx.doi.org/10.1371/journal.pone.0091350			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614529	Green Published, gold, Green Submitted			2022-12-27	WOS:000332839300115
J	Gussgard, AM; Hope, AJ; Jokstad, A; Tenenbaum, H; Wood, R				Gussgard, Anne Margrete; Hope, Andrew J.; Jokstad, Asbjorn; Tenenbaum, Howard; Wood, Robert			Assessment of Cancer Therapy-Induced Oral Mucositis Using a Patient-Reported Oral Mucositis Experience Questionnaire	PLOS ONE			English	Article							NECK-CANCER; RADIATION TREATMENT; SYMPTOM DISTRESS; TREATMENT BREAKS; HEAD; CHEMOTHERAPY; RADIOTHERAPY; VALIDATION; OUTCOMES; GUIDELINES	Objectives: Treatment of oral mucositis (OM) is challenging. In order to develop and test useful treatment approaches, the development of reliable, reproducible and simpler methods than are currently available for assessment of OM is important. A Patient-Reported Oral Mucositis Symptom (PROMS) scale was assessed in patients with head and neck cancer to determine if the patient-reported OM experience, as determined by using the PROMS scale, correlate with OM assessed by clinician-based scoring tools. Materials and Methods: Fifty patients with head and neck cancer and undergoing radiotherapy consented to participate. They were examined before cancer treatment and twice weekly during 6-7 weeks of therapy and once 4-6 weeks after therapy. Signs of OM were evaluated using the 3 clinician-based scoring tools; NCI-CTCAE v.3, the OMAS criteria and the Total VAS-OMAS. The participants' OM experiences were recorded using PROMS-questionnaires consisting of 10 questions on a visual analogue scale. Spearman rank correlation test were applied between the PROMS scale values and the clinician-determined scores. Repeated measures mixed linear models were applied to appraise the strengths of correlation at the different time points throughout the observation period. Results: Thirty-three participants completed all stages of the study. The participant experience of OM using the PROMS scale demonstrates good correlations (Spearman's Rho 0.65-0.78, p<0.001) with the clinician-determined scores on the group level over all time points and poor to good correlations (Spearman's Rho -0.12-0.70, p<0.001) on the group level at different time points during and after therapy. When mouth opening was problematic, i.e. during the 6th and 7th week after commencing cancer treatment, the Spearman's Rho varied between 0.19 and 0.70 (p<0.001). Conclusion: Patient experience of OM, as reported by the PROMS scale may be a feasible substitute for clinical assessment in situations where patients cannot endure oral examinations.	[Gussgard, Anne Margrete; Hope, Andrew J.; Tenenbaum, Howard; Wood, Robert] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada; [Jokstad, Asbjorn; Tenenbaum, Howard] Univ Toronto, Fac Dent, Toronto, ON, Canada; [Tenenbaum, Howard] Mt Sinai Hosp, Dept Dent, Toronto, ON M5G 1X5, Canada; [Tenenbaum, Howard] Tel Aviv Univ, Div Periodontol, IL-69978 Tel Aviv, Israel; [Gussgard, Anne Margrete; Jokstad, Asbjorn] UiT Arctic Univ Norway, Fac Hlth Sci, Tromso, Norway	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Tel Aviv University; UiT The Arctic University of Tromso	Gussgard, AM (corresponding author), Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada.	anne.m.gussgard@uit.no	Jokstad, Asbjørn/C-8743-2012	Jokstad, Asbjørn/0000-0002-5902-4520; Gussgard, Anne Margrete/0000-0003-0395-1242				Altman D.G., 1991, PRACTICAL STATISTIC; Clarkson JE, 2010, COCHRANE DB SYST REV, V8; Cleeland CS, 2000, CANCER-AM CANCER SOC, V89, P1634, DOI 10.1002/1097-0142(20001001)89:7<1634::AID-CNCR29>3.0.CO;2-V; DEHAES JCJM, 1990, BRIT J CANCER, V62, P1034, DOI 10.1038/bjc.1990.434; Elting LS, 2008, CANCER-AM CANCER SOC, V113, P2704, DOI 10.1002/cncr.23898; Elting LS, 2007, INT J RADIAT ONCOL, V68, P1110, DOI 10.1016/j.ijrobp.2007.01.053; Epstein JB, 2007, CANCER-AM CANCER SOC, V109, P1914, DOI 10.1002/cncr.22620; Epstein JB, 2012, CA-CANCER J CLIN, V62, P401, DOI 10.3322/caac.21157; Farquhar-Smith P., 2010, ORAL COMPLICATIONS C, P241, DOI [10.1093/med/9780199543588.003.0024, DOI 10.1093/MED/9780199543588.003.0024]; Hammerlid E, 1999, BRIT J CANCER, V80, P766, DOI 10.1038/sj.bjc.6690420; Ho J, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-263; Jones HA, 2006, AM J CLIN ONCOL-CANC, V29, P158, DOI 10.1097/01.coc.0000207424.62275.9d; Kushner JA, 2008, J CAN DENT ASSOC, V74, P59; Lalla RV, 2013, SUPPORT CARE CANCER, V21, P301, DOI 10.1007/s00520-012-1660-z; Lambertz CK, 2010, CLIN J ONCOL NURS, V14, P585, DOI 10.1188/10.CJON.585-593; Madsen SM, 2002, J INTERN MED, V251, P156, DOI 10.1046/j.1365-2796.2002.00949.x; Miaskowski C, 2001, J Natl Cancer Inst Monogr, P37; Murphy BA, 2009, J PAIN SYMPTOM MANAG, V38, P522, DOI 10.1016/j.jpainsymman.2008.12.004; Murphy Barbara A, 2007, J Support Oncol, V5, P13; National Cancer Institute, 2010, NAT CANC I COMM TERM; National Cancer Institute, 1982, CANC THER EV PROGR; National Cancer Institute, 1999, NAT CANC I COMM TOX; National Cancer Institute, 2003, NAT CANC I COMM TERM; Quinn B, 2008, EUR J CANCER, V44, P61, DOI 10.1016/j.ejca.2007.09.014; Rosenthal David I, 2007, J Support Oncol, V5, P23; Russo G, 2008, ONCOLOGIST, V13, P886, DOI 10.1634/theoncologist.2008-0024; Sonis ST, 1999, CANCER-AM CANCER SOC, V85, P2103, DOI 10.1002/(SICI)1097-0142(19990515)85:10<2103::AID-CNCR2>3.0.CO;2-0; Trotti A, 2003, RADIOTHER ONCOL, V66, P253, DOI 10.1016/S0167-8140(02)00404-8; Vera-Llonch M, 2006, CANCER-AM CANCER SOC, V106, P329, DOI 10.1002/cncr.21622; Worthington HV, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000978.pub5	30	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91733	10.1371/journal.pone.0091733	http://dx.doi.org/10.1371/journal.pone.0091733			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614512	Green Submitted, Green Published, gold			2022-12-27	WOS:000332839300153
J	Seidel, UK; Gronewold, J; Volsek, M; Todica, O; Kribben, A; Bruck, H; Hermann, DM				Seidel, Ulla K.; Gronewold, Janine; Volsek, Michaela; Todica, Olga; Kribben, Andreas; Bruck, Heike; Hermann, Dirk M.			Physical, Cognitive and Emotional Factors Contributing to Quality of Life, Functional Health and Participation in Community Dwelling in Chronic Kidney Disease	PLOS ONE			English	Article							DISABILITY INSTRUMENT; DIALYSIS OUTCOMES; PRACTICE PATTERNS; DEPRESSION; MORTALITY; HOSPITALIZATION; ASSOCIATION; PREVALENCE; PREDICTOR; SYMPTOMS	Background: Quality of life (QoL) impairment is a well-known consequence of chronic kidney disease (CKD). The factors influencing QoL and late life functional health are poorly examined. Methods: Using questionnaires combined with neuropsychological examinations, we prospectively evaluated physical, cognitive, and emotional factors influencing QoL, functional health and participation in community dwelling in 119 patients with CKD stages 3-5 including hemodialysis (61.5+/-15.7years; 63% men) and 54 control patients of the same age without CKD but with similar cardiovascular risk profile. Results: Compared with control patients, CKD patients showed impairment of the physical component of QoL and overall function, assessed by the SF-36 and LLFDI, whereas disability, assessed by LLFDI, was selectively impaired in CKD patients on hemodialysis. Multivariable linear regressions (forced entry) confirmed earlier findings that CKD stage (beta = -0.24; p = 0.012) and depression (beta = -0.30; p = 0.009) predicted the QoL physical component. Hitherto unknown, CKD stage (beta = -0.23; p = 0.007), cognition (beta = 0.20; p = 0.018), and depression (beta = -0.51; <0.001) predicted disability assessed by the LLFDI, while age (beta = -0.20; p = 0.023), male gender (B = 5.01; p = 0.004), CKD stage (beta = -0.23; p = 0.005), stroke history (B = -9.00; p = 0.034), and depression (beta = -0.41; p<0.001) predicted overall function. Interestingly, functional health deficits, cognitive disturbances, depression, and anxiety were evident almost only in CKD patients with coronary heart disease (found in 34.2% of CKD patients). The physical component of QoL and functional health decreased with age and depressive symptoms, and increased with cognitive abilities. Conclusions: In CKD, QoL, functional health, and participation in community dwelling are influenced by physical, cognitive, and emotional factors, most prominently in coronary heart disease patients.	[Seidel, Ulla K.; Gronewold, Janine; Todica, Olga; Hermann, Dirk M.] Univ Hosp Essen, Dept Neurol, Essen, Germany; [Volsek, Michaela; Kribben, Andreas; Bruck, Heike] Univ Hosp Essen, Dept Nephrol, Essen, Germany	University of Duisburg Essen; University of Duisburg Essen	Hermann, DM (corresponding author), Univ Hosp Essen, Dept Neurol, Essen, Germany.	dirk.hermann@uk-essen.de	Hermann, Dirk M./AAT-3652-2021; Hermann, Dirk M/AAP-5538-2020; Hermann, Dirk/GZB-9350-2022	Hermann, Dirk M./0000-0003-0198-3152; 	Federal Ministry of Education and Research [BMBF/NGFN 01GR0807]; Heinz Nixdorf Foundation; Dr. Werner Jackstadt Foundation	Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Heinz Nixdorf Foundation; Dr. Werner Jackstadt Foundation	This work was supported by the Federal Ministry of Education and Research (BMBF/NGFN 01GR0807), the Heinz Nixdorf Foundation, and Dr. Werner Jackstadt Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Kader K, 2009, CLIN J AM SOC NEPHRO, V4, P1057, DOI 10.2215/CJN.00430109; Abdel-Kader K, 2009, CLIN J AM SOC NEPHRO, V4, P711, DOI 10.2215/CJN.05191008; Aschenbrenner S., 2000, REGENSBURGER WORTFLU; Avramovic M, 2012, ARTIF ORGANS, V36, P581, DOI 10.1111/j.1525-1594.2011.01429.x; Baber U, 2013, CURR CARDIOL REP, V15, DOI 10.1007/s11886-013-0386-y; Bullinger M, 1998, SF 36 FRAGEBOGEN ZUM; Buumler G., 1985, FARBE WORT INTERFERE; Chan R, 2009, CLIN J AM SOC NEPHRO, V4, P160, DOI 10.2215/CJN.01520308; Condé Simone Aparecida de Lima, 2010, Braz. J. Nephrol., V32, P242; Cruz MC, 2011, CLINICS, V66, P991, DOI 10.1590/S1807-59322011000600012; DeOreo PB, 1997, AM J KIDNEY DIS, V30, P204, DOI 10.1016/S0272-6386(97)90053-6; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Feng L, 2013, AM J GERIAT PSYCHIAT, V21, P570, DOI 10.1016/j.jagp.2012.12.020; GOKAL R, 1993, KIDNEY INT, V43, pS23; Gyamlani G, 2011, AM J MED SCI, V342, P186, DOI 10.1097/MAJ.0b013e3182113d9e; H?rting, 2000, WECHSLER GEDACHTNIST; Haley SM, 2002, J GERONTOL A-BIOL, V57, pM217, DOI 10.1093/gerona/57.4.M217; Hedayati SS, 2004, AM J KIDNEY DIS, V44, P207, DOI 10.1053/j.ajkd.2004.04.025; Jette AM, 2002, J GERONTOL A-BIOL, V57, pM209, DOI 10.1093/gerona/57.4.M209; Kalantar-Zadeh K, 2001, J AM SOC NEPHROL, V12, P2797, DOI 10.1681/ASN.V12122797; Karnofsky DA, 1949, EVALUATION CHEMOTHER; Karp JF, 2009, J AM GERIATR SOC, V57, P1612, DOI 10.1111/j.1532-5415.2009.02398.x; KIMMEL PL, 1995, J AM SOC NEPHROL, V5, P1826; Lee YJ, 2013, INT J CLIN PRACT, V67, P363, DOI 10.1111/ijcp.12020; Lopes AA, 2003, AM J KIDNEY DIS, V41, P605, DOI 10.1053/ajkd.2003.50122; Lowe SS, 2013, BMC PALLIAT CARE, V12, DOI 10.1186/1472-684X-12-22; Lowrie EG, 2003, AM J KIDNEY DIS, V41, P1286, DOI 10.1016/S0272-6386(03)00361-5; Mapes DL, 2003, KIDNEY INT, V64, P339, DOI 10.1046/j.1523-1755.2003.00072.x; MCCLELLAN WM, 1991, J CLIN EPIDEMIOL, V44, P83, DOI 10.1016/0895-4356(91)90204-M; Mendelssohn DC, 2009, NEPHROL DIAL TRANSPL, V24, P555, DOI 10.1093/ndt/gfn484; Montinaro V, 2010, CLIN NEPHROL, V73, P36, DOI 10.2379/CNX06364; Mujais SK, 2009, CLIN J AM SOC NEPHRO, V4, P1293, DOI 10.2215/CJN.05541008; Odden MC, 2006, NEPHRON CLIN PRACT, V103, pC1, DOI 10.1159/000090112; Ouellette MM, 2004, STROKE, V35, P1404, DOI 10.1161/01.STR.0000127785.73065.34; Pagels AA, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-71; Perlman RL, 2005, AM J KIDNEY DIS, V45, P658, DOI 10.1053/j.ajkd.2004.12.021; Reitan R, 1992, TRAIL MAKING TEST; Russ M, 2002, REY COMPLEX FIGURE T; Salem S, 2012, AM J NEPHROL, V35, P31, DOI 10.1159/000334742; Seidel UK, 2014, KIDNEY INT, V85, P693, DOI 10.1038/ki.2013.366; U. S. Renal Data System, 2003, AM J KIDNEY DIS S, V41, pS7; U. S. Renal Data System, 2003, AM J KIDNEY DIS S, V41, pv; Watnick S, 2003, AM J KIDNEY DIS, V41, P105, DOI 10.1053/ajkd.2003.50029; Zhang QL, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-117; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	45	27	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91176	10.1371/journal.pone.0091176	http://dx.doi.org/10.1371/journal.pone.0091176			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9FH	24614180	Green Submitted, gold, Green Published			2022-12-27	WOS:000332839300090
J	Spetter, MS; de Graaf, C; Mars, M; Viergever, MA; Smeets, PAM				Spetter, Maartje S.; de Graaf, Cees; Mars, Monica; Viergever, Max A.; Smeets, Paul A. M.			The Sum of Its Parts-Effects of Gastric Distention, Nutrient Content and Sensory Stimulation on Brain Activation	PLOS ONE			English	Article							BODY-WEIGHT REGULATION; FOOD-INTAKE; HUMAN AMYGDALA; APPETITE; TASTE; HUNGER; FAT; HEALTHY; SATIETY; CARBOHYDRATE	During food consumption the brain integrates multiple interrelated neural and hormonal signals involved in the regulation of food intake. Factors influencing the decision to stop eating include the foods' sensory properties, macronutrient content, and volume, which in turn affect gastric distention and appetite hormone responses. So far, the contributions of gastric distention and oral stimulation by food on brain activation have not been studied. The primary objective of this study was to assess the effect of gastric distention with an intra-gastric load and the additional effect of oral stimulation on brain activity after food administration. Our secondary objective was to study the correlations between hormone responses and appetite-related ratings and brain activation. Fourteen men completed three functional magnetic resonance imaging sessions during which they either received a naso-gastric infusion of water (stomach distention), naso-gastric infusion of chocolate milk (stomach distention + nutrients), or ingested chocolate-milk (stomach distention + nutrients + oral exposure). Appetite ratings and blood parameters were measured at several time points. During gastric infusion, brain activation was observed in the midbrain, amygdala, hypothalamus, and hippocampus for both chocolate milk and water, i.e., irrespective of nutrient content. The thalamus, amygdala, putamen and precuneus were activated more after ingestion than after gastric infusion of chocolate milk, whereas infusion evoked greater activation in the hippocampus and anterior cingulate. Moreover, areas involved in gustation and reward were activated more after oral stimulation. Only insulin responses following naso-gastric infusion of chocolate milk correlated with brain activation, namely in the putamen and insula. In conclusion, we show that normal (oral) food ingestion evokes greater activation than gastric infusion in stomach distention and food intake-related brain areas. This provides neural evidence for the importance of sensory stimulation in the process of satiation.	[Spetter, Maartje S.; Viergever, Max A.; Smeets, Paul A. M.] Univ Med Ctr Utrecht, Image Sci Inst, Utrecht, Netherlands; [de Graaf, Cees; Mars, Monica; Smeets, Paul A. M.] Wageningen Univ, Div Human Nutr, NL-6700 AP Wageningen, Netherlands	Utrecht University; Utrecht University Medical Center; Wageningen University & Research	Smeets, PAM (corresponding author), Univ Med Ctr Utrecht, Image Sci Inst, Utrecht, Netherlands.	P.Smeets@umcutrecht.nl	Mars, Monica/O-4423-2014; Smeets, Paul AM/B-7979-2010; Viergever, Max A/J-1215-2014	Mars, Monica/0000-0003-2010-1039; Smeets, Paul AM/0000-0002-8695-9612; 	Dutch Technology Foundation STW [07438]	Dutch Technology Foundation STW(Technologiestichting STW)	This work was financed by the Dutch Technology Foundation STW (http://www.stw.nl/en/) under grant nr. 07438. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batterham RL, 2007, NATURE, V450, P106, DOI 10.1038/nature06212; Berns GS, 2001, J NEUROSCI, V21, P2793, DOI 10.1523/JNEUROSCI.21-08-02793.2001; Berridge KC, 2003, BRAIN COGNITION, V52, P106, DOI 10.1016/S0278-2626(03)00014-9; Berthoud HR, 2011, CURR OPIN NEUROBIOL, V21, P888, DOI 10.1016/j.conb.2011.09.004; Berthoud HR, 2004, PHYSIOL BEHAV, V81, P781, DOI 10.1016/j.physbeh.2004.04.034; Berthoud HR, 2002, NEUROSCI BIOBEHAV R, V26, P393, DOI 10.1016/S0149-7634(02)00014-3; Blundell JE, 1996, ANNU REV NUTR, V16, P285, DOI 10.1146/annurev.nutr.16.1.285; BLUNDELL JE, 1994, P NUTR SOC, V53, P407, DOI 10.1079/PNS19940046; Blundell JE, 2001, OBES RES, V9, p263S, DOI 10.1038/oby.2001.129; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Cantu P, 2008, NEUROGASTROENT MOTIL, V20, P304, DOI 10.1111/j.1365-2982.2007.01032.x; Cecil JE, 1999, PHYSIOL BEHAV, V67, P299, DOI 10.1016/S0031-9384(99)00069-4; Cecil JE, 1998, APPETITE, V30, P65, DOI 10.1006/appe.1997.0109; Cecil JE, 1998, APPETITE, V31, P377, DOI 10.1006/appe.1998.0177; Cerf-Ducastel B, 2001, CHEM SENSES, V26, P371, DOI 10.1093/chemse/26.4.371; Cornier MA, 2007, AM J CLIN NUTR, V86, P965, DOI 10.1093/ajcn/86.4.965; Cummings DE, 2007, J CLIN INVEST, V117, P13, DOI 10.1172/JCI30227; Davidson TL, 2007, CURR OPIN PHARMACOL, V7, P613, DOI 10.1016/j.coph.2007.10.008; DAVIDSON TL, 1993, BEHAV NEURAL BIOL, V59, P167, DOI 10.1016/0163-1047(93)90925-8; de Graaf C, 2004, AM J CLIN NUTR, V79, P946; Del Parigi A, 2002, AM J CLIN NUTR, V75, P1017, DOI 10.1093/ajcn/75.6.1017; Delzenne N, 2010, OBES REV, V11, P234, DOI 10.1111/j.1467-789X.2009.00707.x; EVANS AC, 1993, NUCLEAR SCIENCE SYMPOSIUM & MEDICAL IMAGING CONFERENCE, VOLS 1-3, P1813, DOI 10.1109/NSSMIC.1993.373602; Frank S, 2012, AM J CLIN NUTR, V95, P1342, DOI 10.3945/ajcn.111.031492; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Gottfried JA, 2003, SCIENCE, V301, P1104, DOI 10.1126/science.1087919; Haase L, 2007, J NEUROSCI METH, V159, P98, DOI 10.1016/j.jneumeth.2006.07.009; Haase L, 2009, NEUROIMAGE, V44, P1008, DOI 10.1016/j.neuroimage.2008.09.044; Haruno M, 2006, J NEUROPHYSIOL, V95, P948, DOI 10.1152/jn.00382.2005; Hellstrom PM, 2004, BRIT J NUTR, V92, pS47, DOI 10.1079/BJN20041142; Hillebrand JJG, 2002, PEPTIDES, V23, P2283, DOI 10.1016/S0196-9781(02)00269-3; Kringelbach ML, 2004, NEUROIMAGE, V21, P781, DOI 10.1016/j.neuroimage.2003.09.063; Kringelbach ML, 2010, SOC RES, V77, P659; Kroemer NB, 2012, HUMAN BRAIN MAPPING; Lassman DJ, 2010, GASTROENTEROLOGY, V138, P1514, DOI 10.1053/j.gastro.2009.12.060; Lundstrom JN, 2011, ACS CHEM NEUROSCI, V2, P5, DOI 10.1021/cn1000843; Mackie AR, 2013, AM J PHYSIOL-GASTR L, V304, pG1038, DOI 10.1152/ajpgi.00060.2013; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Malik S, 2011, APPETITE, V56, P302, DOI 10.1016/j.appet.2011.01.005; Mars M, 2012, PHYSIOL BEHAV, V105, P483, DOI 10.1016/j.physbeh.2011.08.033; McKie S, 2005, PSYCHOPHARMACOLOGY, V180, P680, DOI 10.1007/s00213-005-2270-y; Min DK, 2011, NEUROSCIENCE, V179, P151, DOI 10.1016/j.neuroscience.2011.01.051; Naslund E, 2007, PHYSIOL BEHAV, V92, P256, DOI 10.1016/j.physbeh.2007.05.017; O'Doherty J, 2001, J NEUROPHYSIOL, V85, P1315, DOI 10.1152/jn.2001.85.3.1315; Reilly S, 1998, NEUROSCI BIOBEHAV R, V22, P883, DOI 10.1016/S0149-7634(98)00015-3; ROLLS BJ, 1982, PHYSIOL BEHAV, V29, P409, DOI 10.1016/0031-9384(82)90259-1; ROLLS BJ, 1981, PHYSIOL BEHAV, V27, P137, DOI 10.1016/0031-9384(81)90310-3; Rolls ET, 2007, P NUTR SOC, V66, P96, DOI 10.1017/S0029665107005332; SHIDE DJ, 1995, AM J CLIN NUTR, V61, P754, DOI 10.1093/ajcn/61.4.754; Small DM, 2006, ADV OTO-RHINO-LARYNG, V63, P191, DOI 10.1159/000093761; Small DM, 2001, BRAIN, V124, P1720, DOI 10.1093/brain/124.9.1720; Small DM, 2011, PROPOSED MODEL FLAVO, P705; Smeets AJ, 2009, BRIT J NUTR, V101, P1360, DOI 10.1017/S0007114508079592; Smeets PAM, 2007, AM J PHYSIOL-ENDOC M, V293, pE754, DOI 10.1152/ajpendo.00231.2007; Sorensen LB, 2003, INT J OBESITY, V27, P1152, DOI 10.1038/sj.ijo.0802391; Spetter MS, 2012, J NUTR, V142, P795, DOI 10.3945/jn.111.153445; Stephan E, 2003, J GASTROINTEST SURG, V7, P740, DOI 10.1016/S1091-255X(03)00071-4; Stratton RJ, 2008, AM J CLIN NUTR, V88, P77, DOI 10.1093/ajcn/88.1.77; Tataranni PA, 1999, P NATL ACAD SCI USA, V96, P4569, DOI 10.1073/pnas.96.8.4569; van der Laan LN, 2011, NEUROIMAGE, V55, P296, DOI 10.1016/j.neuroimage.2010.11.055; Van Strien T, 1997, ADDICT BEHAV, V22, P587, DOI 10.1016/S0306-4603(96)00069-X; VANSTRIEN T, 1986, INT J EAT DISORDER, V5, P295, DOI 10.1002/1098-108X(198602)5:2<295::AID-EAT2260050209>3.0.CO;2-T; Veldhuizen MG, 2011, HUM BRAIN MAPP, V32, P2256, DOI 10.1002/hbm.21188; Volkow ND, 2002, SYNAPSE, V44, P175, DOI 10.1002/syn.10075; Wang GJ, 2008, NEUROIMAGE, V39, P1824, DOI 10.1016/j.neuroimage.2007.11.008; Weijzen PLG, 2009, BRIT J NUTR, V102, P1091, DOI 10.1017/S000711450932574X; Westerterp KR, 2010, NUTR REV, V68, P148, DOI 10.1111/j.1753-4887.2010.00270.x; Zald DH, 1997, P NATL ACAD SCI USA, V94, P4119, DOI 10.1073/pnas.94.8.4119; ZATORRE RJ, 1992, NATURE, V360, P339, DOI 10.1038/360339a0; Zijlstra N, 2008, INT J OBESITY, V32, P676, DOI 10.1038/sj.ijo.0803776	70	22	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e90872	10.1371/journal.pone.0090872	http://dx.doi.org/10.1371/journal.pone.0090872			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614074	gold, Green Submitted, Green Published			2022-12-27	WOS:000332839300047
J	Biller, A; Choli, M; Blaimer, M; Breuer, FA; Jakob, PM; Bartsch, AJ				Biller, Armin; Choli, Morwan; Blaimer, Martin; Breuer, Felix A.; Jakob, Peter M.; Bartsch, Andreas J.			Combined Acquisition Technique (CAT) for Neuroimaging of Multiple Sclerosis at Low Specific Absorption Rates (SAR)	PLOS ONE			English	Article							CLINICALLY ISOLATED SYNDROMES; BRAIN IMAGES; MRI CRITERIA; ROBUST; OPTIMIZATION; REGISTRATION	Purpose: To compare a novel combined acquisition technique (CAT) of turbo-spin-echo (TSE) and echo-planar-imaging (EPI) with conventional TSE. CAT reduces the electromagnetic energy load transmitted for spin excitation. This radiofrequency (RF) burden is limited by the specific absorption rate (SAR) for patient safety. SAR limits restrict high-field MRI applications, in particular. Material and Methods: The study was approved by the local Medical Ethics Committee. Written informed consent was obtained from all participants. T2- and PD-weighted brain images of n = 40 Multiple Sclerosis (MS) patients were acquired by CAT and TSE at 3 Tesla. Lesions were recorded by two blinded, board-certificated neuroradiologists. Diagnostic equivalence of CAT and TSE to detect MS lesions was evaluated along with their SAR, sound pressure level (SPL) and sensations of acoustic noise, heating, vibration and peripheral nerve stimulation. Results: Every MS lesion revealed on TSE was detected by CAT according to both raters (Cohen's kappa of within-rater/across-CAT/TSE lesion detection kappa(CAT) = 1.00, at an inter-rater lesion detection agreement of kappa(LES) = 0.82). CAT reduced the SAR burden significantly compared to TSE (p<0.001). Mean SAR differences between TSE and CAT were 29.0 (+/- 5.7) % for the T2-contrast and 32.7 (+/- 21.9) % for the PD-contrast (expressed as percentages of the effective SAR limit of 3.2 W/kg for head examinations). Average SPL of CAT was no louder than during TSE. Sensations of CAT-vs. TSE-induced heating, noise and scanning vibrations did not differ. Conclusion: T2-/PD-CAT is diagnostically equivalent to TSE for MS lesion detection yet substantially reduces the RF exposure. Such SAR reduction facilitates high-field MRI applications at 3 Tesla or above and corresponding protocol standardizations but CAT can also be used to scan faster, at higher resolution or with more slices. According to our data, CAT is no more uncomfortable than TSE scanning.	[Biller, Armin; Bartsch, Andreas J.] Heidelberg Univ, Dept Neuroradiol, Heidelberg, Germany; [Choli, Morwan; Blaimer, Martin; Breuer, Felix A.; Jakob, Peter M.] Res Ctr Magnet Resonance Bavaria MRB, Wurzburg, Germany; [Jakob, Peter M.] Univ Wurzburg, Dept Expt Phys 5, D-97070 Wurzburg, Germany; [Bartsch, Andreas J.] Univ Oxford, FMRIB Ctr, Oxford, England	Ruprecht Karls University Heidelberg; University of Wurzburg; University of Wurzburg; University of Oxford	Biller, A (corresponding author), Heidelberg Univ, Dept Neuroradiol, Heidelberg, Germany.	armin.biller@med.uni-heidelberg.de		Jakob, Peter/0000-0002-3481-5545; Blaimer, Martin/0000-0002-6360-9871	Deutsche Forschungsgemeinschaft (DFG)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This study was supported by a grant of the Deutsche Forschungsgemeinschaft (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartsch AJ, 2007, NEUROIMAGE, V35, P234, DOI 10.1016/j.neuroimage.2006.11.026; Boss A, 2007, J MAGN RESON IMAGING, V26, P1334, DOI 10.1002/jmri.21156; Choli M, 2013, MAGN RESON MATER PHY, V26, P411, DOI 10.1007/s10334-012-0362-3; Choli M, 2010, J MAGN RESON IMAGING, V32, P997, DOI 10.1002/jmri.22327; Commission IE, 2010, 606012332010 IEC COM; Filippi M, 2011, RADIOLOGY, V259, P659, DOI 10.1148/radiol.11101362; Gallichan D, 2010, HUM BRAIN MAPP, V31, P193, DOI 10.1002/hbm.20856; Haller S, 2009, BRAIN RES, V1282, P74, DOI 10.1016/j.brainres.2009.05.094; HARVEY PR, 1994, MAGNET RESON MED, V32, P236, DOI 10.1002/mrm.1910320213; HENNIG J, 1986, MAGNET RESON MED, V3, P823, DOI 10.1002/mrm.1910030602; Hennig J, 2003, MAGN RESON MED, V49, P527, DOI 10.1002/mrm.10391; Hillenbrand C, 2000, J MAGN RESON IMAGING, V11, P711, DOI 10.1002/1522-2586(200006)11:6<711::AID-JMRI19>3.0.CO;2-9; Jakob PM, 2002, MAGN RESON MED, V47, P425, DOI 10.1002/mrm.10095; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Montalban X, 2010, NEUROLOGY, V74, P427, DOI 10.1212/WNL.0b013e3181cec45c; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Reuter M, 2010, NEUROIMAGE, V53, P1181, DOI 10.1016/j.neuroimage.2010.07.020; Rodegerdts EA, 2006, ACTA RADIOL, V47, P488, DOI 10.1080/02841850600647116; Rovira A, 2009, ARCH NEUROL-CHICAGO, V66, P587, DOI 10.1001/archneurol.2009.49; Shellock FG, 2004, RADIOLOGY, V232, P635, DOI 10.1148/radiol.2323030830; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Swanton JK, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.073247; van den Bergen B, 2007, PHYS MED BIOL, V52, P5429, DOI 10.1088/0031-9155/52/17/022; Wang ZW, 2007, J MAGN RESON IMAGING, V26, P437, DOI 10.1002/jmri.20977	26	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91030	10.1371/journal.pone.0091030	http://dx.doi.org/10.1371/journal.pone.0091030			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608106	Green Published, Green Submitted, gold			2022-12-27	WOS:000332485800084
J	Kopycinski, J; Hayes, P; Ashraf, A; Cheeseman, H; Lala, F; Czyzewska-Khan, J; Spentzou, A; Gill, DK; Keefer, MC; Excler, JL; Fast, P; Cox, J; Gilmour, J				Kopycinski, Jakub; Hayes, Peter; Ashraf, Ambreen; Cheeseman, Hannah; Lala, Francesco; Czyzewska-Khan, Justyna; Spentzou, Aggeliki; Gill, Dilbinder K.; Keefer, Michael C.; Excler, Jean-Louis; Fast, Patricia; Cox, Josephine; Gilmour, Jill			Broad HIV Epitope Specificity and Viral Inhibition Induced by Multigenic HIV-1 Adenovirus Subtype 35 Vector Vaccine in Healthy Uninfected Adults	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CYTOTOXIC T-LYMPHOCYTES; ATTENUATED SIV VACCINES; CLINICAL-TRIALS; CELL RESPONSES; INFECTION; VIREMIA; IMMUNODOMINANCE; REPLICATION; ANTIBODIES	A correlation between in vivo and in vitro virus control mediated by CD8+ T-cell populations has been demonstrated by CD8 T-cell-mediated inhibition of HIV-1 and SIV replication in vitro in peripheral blood mononuclear cells (PBMCs) from infected humans and non-human primates (NHPs), respectively. Here, the breadth and specificity of T-cell responses induced following vaccination with replication-defective adenovirus serotype 35 (Ad35) vectors containing a fusion protein of Gag, reverse transcriptase (RT), Integrase (Int) and Nef (Ad35-GRIN) and Env (Ad35-ENV), derived from HIV-1 subtype A isolates, was assessed in 25 individuals. The vaccine induced responses to a median of 4 epitopes per vaccinee. We correlated the CD8 responses to conserved vs. variable regions with the ability to inhibit a panel of 7 HIV-1 isolates representing multiple clades in a virus inhibition assay (VIA). The results indicate that targeting immunodominant responses to highly conserved regions of the HIV-1 proteome may result in an increased ability to inhibit multiple clades of HIV-1 in vitro. The data further validate the use of the VIA to screen and select future HIV vaccine candidates. Moreover, our data suggest that future T cell-focused vaccine design should aim to induce immunodominant responses to highly conserved regions of the virus.	[Kopycinski, Jakub; Hayes, Peter; Ashraf, Ambreen; Cheeseman, Hannah; Lala, Francesco; Czyzewska-Khan, Justyna; Spentzou, Aggeliki; Gill, Dilbinder K.; Cox, Josephine; Gilmour, Jill] Univ London Imperial Coll Sci Technol & Med, Human Immunol Lab, Int AIDS Vaccine Initiat IAVI, London, England; [Keefer, Michael C.] Univ Rochester, Sch Med & Dent, Rochester, NY USA; [Excler, Jean-Louis; Fast, Patricia] IAVI, New York, NY USA	Imperial College London; International AIDS Vaccine Initiative; University of Rochester; International AIDS Vaccine Initiative	Kopycinski, J (corresponding author), Univ London Imperial Coll Sci Technol & Med, Human Immunol Lab, Int AIDS Vaccine Initiat IAVI, London, England.	j.kopycinski@imperial.ac.uk		Cheeseman, Hannah/0000-0001-9044-1341; Cox, Josephine/0000-0003-1301-7373	International AIDS Vaccine Initiative; United States Agency for International Development (USAID) [GPO-A-00-06-00006-00]	International AIDS Vaccine Initiative; United States Agency for International Development (USAID)(United States Agency for International Development (USAID))	This study was funded by the International AIDS Vaccine Initiative and its donors, including the generous support of the American people through the United States Agency for International Development (USAID; USAID Cooperative Agreement Number GPO-A-00-06-00006-00). The contents of this manuscript are the responsibility of IAVI and do not necessarily reflect the views of USAID or the US government. The following organizations/institutions played a direct role in study design, data collection and analysis, decision to publish, and preparation of this manuscript: International AIDS Vaccine Initiative (IAVI), IAVI Human Immunology Laboratory, Imperial College and the University of Rochester School of Medicine & Dentistry, Rochester.	Betts MR, 2004, METHOD CELL BIOL, V75, P497; Boaz MJ, 2009, CLIN VACCINE IMMUNOL, V16, P147, DOI 10.1128/CVI.00326-08; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Borthwick N, 2013, MOL THER, DOI 10.1038/mt.2013.248; Buchbinder SP, 2008, LANCET; Chen DY, 2011, J VIROL, V85, P2474, DOI 10.1128/JVI.01726-10; Cohen J, 2013, SCIENCE, V340, P667, DOI 10.1126/science.340.6133.667; Fauce SR, 2007, J IMMUNOL METHODS, V327, P75, DOI 10.1016/j.jim.2007.07.017; Freel SA, 2010, J VIROL, V84, P4998, DOI 10.1128/JVI.00138-10; Fukazawa Y, 2012, NAT MED, V18, P1673, DOI 10.1038/nm.2934; Gill DK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014330; Goonetilleke N, 2009, J EXP MED, V206, P1253, DOI 10.1084/jem.20090365; Hammer SM, 2013, N ENGL J MED; Jones N, 2003, J IMMUNOL METHODS, V274, P139, DOI 10.1016/S0022-1759(02)00510-0; Keefer MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041936; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Koff WC, 2006, NAT IMMUNOL, V7, P19, DOI 10.1038/ni1296; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Letourneau S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000984; Li FS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020479; Liu MKP, 2013, J CLIN INVEST, V123, P380, DOI 10.1172/JCI65330; Makedonas G, 2011, IMMUNOL REV, V239, P109, DOI 10.1111/j.1600-065X.2010.00968.x; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; Mendoza D, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003195; Mudd PA, 2012, NATURE, V491, P129, DOI 10.1038/nature11443; Prince JL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003041; Roederer M, 2003, J IMMUNOL METHODS, V274, P221, DOI 10.1016/S0022-1759(02)00423-4; Roederer M, 2011, CYTOMETRY A; Rolland M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001424; Rolland M, 2007, PLOS PATHOG, V3, P1551, DOI 10.1371/journal.ppat.0030157; Rolland M, 2013, J VIROL, V87, P5461, DOI 10.1128/JVI.03033-12; Rolland M, 2011, NAT MED, V17, P366, DOI 10.1038/nm.2316; Rosario M, 2012, AIDS, V26, P275, DOI 10.1097/QAD.0b013e32834ed9b2; Spentzou A, 2010, J INFECT DIS, V201, P720, DOI 10.1086/650492; Stephenson KE, 2012, J VIROL, V86, P11434, DOI 10.1128/JVI.01779-12; Tenzer S, 2009, NAT IMMUNOL, V10, P636, DOI 10.1038/ni.1728; Troyer RM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000365; WONG JT, 1987, J IMMUNOL, V139, P1369; Yamamoto T, 2012, J VIROL, V86, P5877, DOI 10.1128/JVI.00315-12; Yang HB, 2013, J IMMUNOL METHODS, V391, P174, DOI 10.1016/j.jim.2013.03.001; Yang HB, 2012, J INFECT DIS, V206, P552, DOI 10.1093/infdis/jis379; Yang OO, 1996, J VIROL, V70, P5799, DOI 10.1128/JVI.70.9.5799-5806.1996; Yang OO, 1997, J VIROL, V71, P3120, DOI 10.1128/JVI.71.4.3120-3128.1997; Yang OO, 2002, J VIROL, V76, P1626, DOI 10.1128/JVI.76.4.1626-1631.2002; Yang OO, 2011, AIDS RES HUM RETROV, V27, P391, DOI 10.1089/aid.2010.0183	45	12	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90378	10.1371/journal.pone.0090378	http://dx.doi.org/10.1371/journal.pone.0090378			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24609066	Green Published, gold, Green Submitted			2022-12-27	WOS:000332485800022
J	Pang, XD; Zhou, HX				Pang, Xiaodong; Zhou, Huan-Xiang			Design Rules for Selective Binding of Nuclear Localization Signals to Minor Site of Importin alpha	PLOS ONE			English	Article							STRUCTURAL BASIS; CRYSTAL-STRUCTURE; CRYSTALLOGRAPHIC ANALYSIS; SEQUENCE-BINDING; PROTEIN; RECOGNITION; SPECIFICITY; COMPLEX; DOMAIN	Selectivity is a critical issue in molecular recognition. However, design rules that underlie selectivity are often not well understood. Here, we studied five classical nuclear localization signals (NLSs) that contain the motif KRx(W/F/Y)xxAF and selectively bind to the minor site of importin alpha. The selectivity for the minor site is dissected by building structural models for the NLS-importin alpha complexes and analyzing the positive design and negative design in the NLSs. In our models, the KR residues of the motif occupy the P1' and P2' pockets of importin alpha, respectively, forming hydrogen-bonding and cation-pi interactions. The aromatic residue at the P4' position plays dual roles in the selectivity for the minor site: by forming pi-stacking with W357 of importin alpha to reinforce the minor-site binding; and by clashing with the P5 pocket in the major binding site. The F residue at the P8' position occupies a deep pocket, providing additional stabilization. The P7' position sits on a saddle next to the P8' pocket and hence requires a small residue; the A residue fulfills this requirement. The principal ideas behind these blind predictions turn out to be correct in an evaluation against subsequently available X-ray structures for the NLS-importin alpha complexes, but some details are incorrect. These results illustrate that the selectivity for the minor site can be achieved via a variety of design rules.	[Pang, Xiaodong; Zhou, Huan-Xiang] Florida State Univ, Dept Phys, Tallahassee, FL 32306 USA; [Pang, Xiaodong; Zhou, Huan-Xiang] Florida State Univ, Inst Mol Biophys, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University; State University System of Florida; Florida State University	Zhou, HX (corresponding author), Florida State Univ, Dept Phys, Tallahassee, FL 32306 USA.	hzhou4@fsu.edu	Zhou, Huan-Xiang/AAH-9836-2020; Pang, Xiaodong/N-5853-2016; zhou, huan/GYJ-4398-2022; Zhou, Huan-Xiang/M-5170-2016	Zhou, Huan-Xiang/0000-0001-9020-0302; Pang, Xiaodong/0000-0001-5985-0470; Zhou, Huan-Xiang/0000-0001-9020-0302	NIH [GM058187, GM088187]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088187, R01GM058187] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH Grants GM058187 and GM088187. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRYSON JW, 1995, SCIENCE, V270, P935, DOI 10.1126/science.270.5238.935; Catimel B, 2001, J BIOL CHEM, V276, P34189, DOI 10.1074/jbc.M103531200; Chang CW, 2013, TRAFFIC, V14, P1144, DOI 10.1111/tra.12098; Chang CW, 2012, PLANT CELL, V24, P5074, DOI 10.1105/tpc.112.104422; Chen MH, 2005, J BIOL CHEM, V280, P10599, DOI 10.1074/jbc.M413194200; Cingolani G, 1999, NATURE, V399, P221, DOI 10.1038/20367; Conti E, 1998, CELL, V94, P193, DOI 10.1016/S0092-8674(00)81419-1; Conti E, 2000, STRUCTURE, V8, P329, DOI 10.1016/S0969-2126(00)00107-6; Cutress ML, 2008, J CELL SCI, V121, P957, DOI 10.1242/jcs.022103; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; de Barros AC, 2012, ACTA CRYSTALLOGR D, V68, P743, DOI 10.1107/S0907444912010281; Dias SMG, 2009, NAT STRUCT MOL BIOL, V16, P930, DOI 10.1038/nsmb.1649; Fontes MRM, 2003, J BIOL CHEM, V278, P27981, DOI 10.1074/jbc.M303275200; Fontes MRM, 2000, J MOL BIOL, V297, P1183, DOI 10.1006/jmbi.2000.3642; Giesecke A, 2010, J BIOL CHEM, V285, P17628, DOI 10.1074/jbc.M110.102343; Gilson MK, 2007, ANNU REV BIOPH BIOM, V36, P21, DOI 10.1146/annurev.biophys.36.040306.132550; Gouda H, 2003, BIOPOLYMERS, V68, P16, DOI 10.1002/bip.10270; Hill RB, 2000, ACCOUNTS CHEM RES, V33, P745, DOI 10.1021/ar970004h; Hirano H, 2011, BIOCHEM J, V375, P339; Hodel MR, 2001, J BIOL CHEM, V276, P1317, DOI 10.1074/jbc.M008522200; Kobe B, 1999, NAT STRUCT BIOL, V6, P388, DOI 10.1038/7625; Kosugi S, 2009, J BIOL CHEM, V284, P478, DOI 10.1074/jbc.M807017200; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Lott K, 2011, J BIOL CHEM, V286, P28160, DOI 10.1074/jbc.M111.228007; Makkerh JPS, 1996, CURR BIOL, V6, P1025, DOI 10.1016/S0960-9822(02)00648-6; Marfori M, 2012, TRAFFIC, V13, P532, DOI 10.1111/j.1600-0854.2012.01329.x; Marfori M, 2011, BBA-MOL CELL RES, V1813, P1562, DOI 10.1016/j.bbamcr.2010.10.013; Matsuura Y, 2005, EMBO J, V24, P3681, DOI 10.1038/sj.emboj.7600843; Matsuura Y, 2003, EMBO J, V22, P5358, DOI 10.1093/emboj/cdg538; Matsuura Y, 2004, NATURE, V432, P872, DOI 10.1038/nature03144; Meyer EA, 2003, ANGEW CHEM INT EDIT, V42, P1210, DOI 10.1002/anie.200390319; Miller BR, 2012, J CHEM THEORY COMPUT, V8, P3314, DOI 10.1021/ct300418h; Moroianu J, 1996, P NATL ACAD SCI USA, V93, P6572, DOI 10.1073/pnas.93.13.6572; Mynott AV, 2011, FEBS J, V278, P1662, DOI 10.1111/j.1742-4658.2011.08086.x; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pumroy RA, 2012, J BIOL CHEM, V287, P2022, DOI 10.1074/jbc.M111.315838; Raveh B, 2010, PROTEINS, V78, P2029, DOI 10.1002/prot.22716; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; Takeda AAS, 2011, J MOL BIOL, V412, P226, DOI 10.1016/j.jmb.2011.07.038; Tan C, 2007, J PHYS CHEM B, V111, P12263, DOI 10.1021/jp073399n; Tarendeau F, 2007, NAT STRUCT MOL BIOL, V14, P229, DOI 10.1038/nsmb1212; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Worch R, 2008, PROTEINS, V71, P2026, DOI 10.1002/prot.21882; Yang SNY, 2010, J BIOL CHEM, V285, P19935, DOI 10.1074/jbc.M109.079574	44	12	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91025	10.1371/journal.pone.0091025	http://dx.doi.org/10.1371/journal.pone.0091025			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24609064	Green Published, Green Submitted, gold			2022-12-27	WOS:000332485800082
J	Nagatake, T; Fujita, H; Minato, N; Hamazaki, Y				Nagatake, Takahiro; Fujita, Harumi; Minato, Nagahiro; Hamazaki, Yoko			Enteroendocrine Cells Are Specifically Marked by Cell Surface Expression of Claudin-4 in Mouse Small Intestine	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; GASTRIC-INHIBITORY POLYPEPTIDE; FOLLICLE-ASSOCIATED EPITHELIUM; TIGHT JUNCTIONS; ENDOCRINE CELL; PEYERS-PATCHES; STEM-CELLS; GUT; INCRETIN; LOCALIZATION	Enteroendocrine cells are solitary epithelial cells scattered throughout the gastrointestinal tract and produce various types of hormones, constituting one of the largest endocrine systems in the body. The study of these rare epithelial cells has been hampered by the difficulty in isolating them because of the lack of specific cell surface markers. Here, we report that enteroendocrine cells selectively express a tight junction membrane protein, claudin-4 (Cld4), and are efficiently isolated with the use of an antibody specific for the Cld4 extracellular domain and flow cytometry. Sorted Cld4(+) epithelial cells in the small intestine exclusively expressed a chromogranin A gene (Chga) and other enteroendocrine cell-related genes (Ffar1, Ffar4, Gpr119), and the population was divided into two subpopulations based on the activity of binding to Ulex europaeus agglutinin-1 (UEA-1). A Cld4(+) UEA-1(-) cell population almost exclusively expressed glucose-dependent insulinotropic polypeptide gene (Gip), thus representing K cells, whereas a Cld4+ UEA-1(+) cell population expressed other gut hormone genes, including glucagon-like peptide 1 (Gcg), pancreatic polypeptide-like peptide with N-terminal tyrosine amide (Pyy), cholecystokinin (Cck), secretin (Sct), and tryptophan hydroxylase 1 (Tph1). In addition, we found that orally administered luminal antigens were taken up by the solitary Cld4(+) cells in the small intestinal villi, raising the possibility that enteroendocrine cells might also play a role in initiation of mucosal immunity. Our results provide a useful tool for the cellular and functional characterization of enteroendocrine cells.	[Nagatake, Takahiro; Fujita, Harumi; Minato, Nagahiro; Hamazaki, Yoko] Kyoto Univ, Grad Sch Med, Dept Immunol & Cell Biol, Kyoto, Japan	Kyoto University	Hamazaki, Y (corresponding author), Kyoto Univ, Grad Sch Med, Dept Immunol & Cell Biol, Kyoto, Japan.	hamazaki@imm.med.kyoto-u.ac.jp	Hamazaki, Y*/Q-3076-2019; Nagatake, Takahiro/AAL-1995-2020	Hamazaki, Y*/0000-0001-5866-7340; Fujita, Harumi/0000-0003-2133-845X; Nagatake, Takahiro/0000-0003-3022-9626	Ministry of Education, Culture, Science, Sports and Technology of the Japanese Government [24 3485, 24590580, 25111505, 24111008]	Ministry of Education, Culture, Science, Sports and Technology of the Japanese Government	This work was supported by grants from the Ministry of Education, Culture, Science, Sports and Technology of the Japanese Government to TN (no. 24 3485), YH(no. 24590580, no 25111505) and NM(no. 24111008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002584; Angelow S, 2008, AM J PHYSIOL-RENAL, V295, pF867, DOI 10.1152/ajprenal.90264.2008; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2010, GASTROENTEROLOGY, V138, P1681, DOI 10.1053/j.gastro.2010.03.002; BUCHAN AMJ, 1978, HISTOCHEMISTRY, V56, P37, DOI 10.1007/BF00492251; Buchert M, 2010, P NATL ACAD SCI USA, V107, P2628, DOI 10.1073/pnas.0903747107; Chu ZL, 2008, ENDOCRINOLOGY, V149, P2038, DOI 10.1210/en.2007-0966; Dhawan P, 2011, ONCOGENE, V30, P3234, DOI 10.1038/onc.2011.43; DUPRE J, 1973, J CLIN ENDOCR METAB, V37, P826, DOI 10.1210/jcem-37-5-826; Edfalk S, 2008, DIABETES, V57, P2280, DOI 10.2337/db08-0307; EISSELE R, 1992, EUR J CLIN INVEST, V22, P283, DOI 10.1111/j.1365-2362.1992.tb01464.x; ELRICK H, 1964, J CLIN ENDOCR METAB, V24, P1076, DOI 10.1210/jcem-24-10-1076; Fujita H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052272; Furuse M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002907; Gerbe F, 2012, CELL MOL LIFE SCI, V69, P2907, DOI 10.1007/s00018-012-0984-7; Habib AM, 2012, ENDOCRINOLOGY, V153, P3054, DOI 10.1210/en.2011-2170; Hamazaki Y, 2002, J BIOL CHEM, V277, P455, DOI 10.1074/jbc.M109005200; Hamazaki Y, 2007, NAT IMMUNOL, V8, P304, DOI 10.1038/ni1438; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Kawai Y, 2011, P NATL ACAD SCI USA, V108, P4075, DOI 10.1073/pnas.1014178108; Kondoh M, 2008, DRUG DISCOV TODAY, V13, P180, DOI 10.1016/j.drudis.2007.11.005; KREYMANN B, 1987, LANCET, V2, P1300; Krug SM, 2012, ANN NY ACAD SCI, V1257, P20, DOI 10.1111/j.1749-6632.2012.06555.x; Lo D, 2004, INT IMMUNOL, V16, P91, DOI 10.1093/intimm/dxh011; Lovshin JA, 2009, NAT REV ENDOCRINOL, V5, P262, DOI 10.1038/nrendo.2009.48; MADARA JL, 1982, J MEMBRANE BIOL, V66, P145, DOI 10.1007/BF01868490; May CL, 2010, MOL CELL ENDOCRINOL, V323, P70, DOI 10.1016/j.mce.2009.12.009; McDole JR, 2012, NATURE, V483, P345, DOI 10.1038/nature10863; MCINTYRE N, 1964, LANCET, V2, P20, DOI 10.1016/s0140-6736(64)90011-x; Mortensen K, 2003, REGUL PEPTIDES, V114, P189, DOI 10.1016/S0167-0115(03)00125-3; Neutra MR, 1996, CELL, V86, P345, DOI 10.1016/S0092-8674(00)80106-3; Nochi T, 2004, CLIN IMMUNOL, V113, P326, DOI 10.1016/j.clim.2004.08.013; OWEN RL, 1974, GASTROENTEROLOGY, V66, P189, DOI 10.1016/s0016-5085(74)80102-2; Parker HE, 2009, DIABETOLOGIA, V52, P289, DOI 10.1007/s00125-008-1202-x; Rahner C, 2001, GASTROENTEROLOGY, V120, P411, DOI 10.1053/gast.2001.21736; Rajapaksa TE, 2010, J CONTROL RELEASE, V142, P196, DOI 10.1016/j.jconrel.2009.10.033; Rehfeld JF, 2004, HORM METAB RES, V36, P735, DOI 10.1055/s-2004-826154; Reimann F, 2008, CELL METAB, V8, P532, DOI 10.1016/j.cmet.2008.11.002; Rindi G, 2004, ANN NY ACAD SCI, V1014, P1, DOI 10.1196/annals.1294.001; SATO M, 1986, DIFFERENTIATION, V30, P211, DOI 10.1111/j.1432-0436.1986.tb00783.x; Schonhoff SE, 2004, ENDOCRINOLOGY, V145, P2639, DOI 10.1210/en.2004-0051; Swisshelm K, 2005, ADV DRUG DELIVER REV, V57, P919, DOI 10.1016/j.addr.2005.01.006; Tamagawa H, 2003, LAB INVEST, V83, P1045, DOI 10.1097/01.LAB.0000078741.55670.6E; Tamura A, 2008, GASTROENTEROLOGY, V134, P523, DOI 10.1053/j.gastro.2007.11.040; Terahara K, 2008, J IMMUNOL, V180, P7840, DOI 10.4049/jimmunol.180.12.7840; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Tsukita S, 2008, ONCOGENE, V27, P6930, DOI 10.1038/onc.2008.344; Uchida H, 2010, BIOCHEM PHARMACOL, V79, P1437, DOI 10.1016/j.bcp.2010.01.010	48	28	28	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90638	10.1371/journal.pone.0090638	http://dx.doi.org/10.1371/journal.pone.0090638			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603700	Green Submitted, Green Published, gold			2022-12-27	WOS:000332483600070
J	Pec, O; Bob, P; Raboch, J				Pec, Ondrej; Bob, Petr; Raboch, Jiri			Splitting in Schizophrenia and Borderline Personality Disorder	PLOS ONE			English	Article							METACOGNITION; HYPNOSIS; CONSCIOUSNESS; DISSOCIATION; MEMORY; SYSTEM	Background: Splitting describes fragmentation of conscious experience that may occur in various psychiatric disorders. A purpose of this study is to examine relationships between psychological process of splitting and disturbed cognitive and affective functions in schizophrenia and borderline personality disorder (BPD). Methods: In the clinical study, we have assessed 30 patients with schizophrenia and 35 patients with BPD. The symptoms of splitting were measured using self-reported Splitting Index (SI). As a measure of semantic memory disorganization we have used verbal fluency test. Other psychopathological symptoms were assessed using Health of the Nation Outcome Scale (HoNOS). Results: Main results show that SI is significantly higher in BPD group than in schizophrenia, and on the other hand, verbal fluency is significantly lower in schizophrenia group. Psychopathological symptoms measured by HoNOS are significantly higher in the BPD group than in schizophrenia. Significant relationship was found between verbal fluency and the SI "factor of others" (Spearman r = -0.52, p<0.01) in schizophrenia patients. Conclusions: Processes of splitting are different in schizophrenia and BPD. In BPD patients splitting results to mental instability, whereas in schizophrenia the mental fragmentation leads to splitting of associations observed as lower scores of verbal fluency, which in principle is in agreement with Bleuler's historical concept of splitting in schizophrenia.	[Pec, Ondrej; Bob, Petr; Raboch, Jiri] Charles Univ Prague, Ctr Neuropsychiat Res Traumat Stress, Dept Psychiat, Fac Med 1, Prague, Czech Republic; [Pec, Ondrej] Psychotherapeut & Psychosomat Clin ESET, Prague, Czech Republic; [Bob, Petr] Masaryk Univ, Cent European Inst Technol, Fac Med, Brno, Czech Republic	Charles University Prague; General University Hospital Prague; Masaryk University Brno	Bob, P (corresponding author), Charles Univ Prague, Ctr Neuropsychiat Res Traumat Stress, Dept Psychiat, Fac Med 1, Prague, Czech Republic.	petrbob@netscape.net	Pec, Ondrej/N-2026-2019; Pec, Ondrej/L-9957-2017; raboch, jiri/N-7445-2017; Pec, Ondrej/ABE-1157-2020	Pec, Ondrej/0000-0003-2116-8358; Pec, Ondrej/0000-0003-2116-8358; raboch, jiri/0000-0001-6667-1497; Pec, Ondrej/0000-0003-2116-8358	Charles University grant (PRVOUK); Czech Ministry of Education [LH11032]; project "CEITEC - Central European Institute of Technology" from European Regional Development Fund [CZ.1.05/1.1.00/02.0068]	Charles University grant (PRVOUK); Czech Ministry of Education(Ministry of Education, Youth & Sports - Czech Republic); project "CEITEC - Central European Institute of Technology" from European Regional Development Fund	The study was supported by the Charles University grant (PRVOUK, www.cuni.cz), project provided by Czech Ministry of Education (LH11032, www.msmst.cz) and the project "CEITEC - Central European Institute of Technology" (CZ.1.05/1.1.00/02.0068) from European Regional Development Fund (http://ec.europa.eu/regional_policy/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANZIEU D, 1993, PSYCHOANAL INQ, V13, P42, DOI 10.1080/07351699309533921; Barnow S, 2010, CURR PSYCHIAT REP, V12, P186, DOI 10.1007/s11920-010-0107-9; Blatt SJ, 2001, J AM PSYCHOANAL ASS, V49, P113, DOI 10.1177/00030651010490010201; Bleuler E., 1911, DEMENTIA PRAECOX GRO; Bob P, 2008, CONSCIOUS COGN, V17, P355, DOI 10.1016/j.concog.2007.12.001; Bob P, 2011, CONSCIOUS COGN, V20, P1042, DOI 10.1016/j.concog.2011.04.013; Breuer J, 1895, ANAL SELF; CRAWFORD HJ, 1994, INT J CLIN EXP HYP, V42, P204, DOI 10.1080/00207149408409352; Dimaggio G, 2008, CONSCIOUS COGN, V17, P778, DOI 10.1016/j.concog.2008.02.005; Ellenberger H., 1970, DISCOV UNCONSCIOUS; Franceschi P, 2013, ACT NERV SUPER PRAHA, V55, P67; Goldberg TE, 1998, AM J PSYCHIAT, V155, P1671, DOI 10.1176/ajp.155.12.1671; Gould JR, 1996, J PERS ASSESS, V66, P414, DOI 10.1207/s15327752jpa6602_18; Henry Julie D, 2005, Cogn Neuropsychiatry, V10, P1, DOI 10.1080/13546800344000309; Hilgard E.R., 1986, DIVIDED CONSCIOUSNES, V2nd; Kernberg O.F., 1975, BORDERLINE CONDITION; Klein M, 1946, INT J PSYCHOANAL, V22, P99; Kohut H., 1971, ANAL SELF SYSTEMATIC; Kukla M, 2013, PSYCHIAT RES, V209, P381, DOI 10.1016/j.psychres.2013.04.014; Lustman J, 1977, Psychoanal Study Child, V32, P119; Lysaker PH, 2013, ACTA PSYCHIAT SCAND, V127, P239, DOI 10.1111/acps.12012; Lysaker PH, 2013, EXPERT REV NEUROTHER, V13, P784, DOI 10.1586/14737175.2013.811150; Mishara AL, 2014, SCHIZOPHRENIA BULL, V40, P5, DOI 10.1093/schbul/sbt169; OGDEN TH, 1989, INT J PSYCHOANAL, V70, P127; Paulsen JS, 1996, PSYCHIAT RES, V63, P109, DOI 10.1016/0165-1781(96)02901-0; Pec O., 2009, CESKA SLOV PSYCHIATR, V105, P245; Preiss M, 2002, NEUROPSYCHOLOGICAL B; Rainville P, 2002, J COGNITIVE NEUROSCI, V14, P887, DOI 10.1162/089892902760191117; Raven J.C., 1960, GUIDE STANDARD PROGR; Reske M, 2009, J PSYCHIATR RES, V43, P592, DOI 10.1016/j.jpsychires.2008.10.012; Robert PH, 1998, J INT NEUROPSYCH SOC, V4, P539, DOI 10.1017/S1355617798466025; Rotenberg VS, 1999, GENET SOC GEN PSYCH, V125, P45; Scherpiet S, 2014, EUR ARCH PSY CLIN N, V264, P45, DOI 10.1007/s00406-013-0444-x; Schmahl CG, 2004, BIOL PSYCHIAT, V55, P759, DOI 10.1016/j.biopsych.2003.11.007; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; STONE MH, 1988, DISSOCIATIONS, V1, P2; Sumiyoshi C, 2005, SCHIZOPHR RES, V74, P91, DOI 10.1016/j.schres.2004.05.011; Tas C, 2012, J PSYCHIATR RES, V46, P1086, DOI 10.1016/j.jpsychires.2012.04.027; van Beilen M, 2004, SCHIZOPHR RES, V69, P267, DOI 10.1016/j.schres.2003.09.007; Vermetten E, 2004, INT J CLIN EXP HYP, V52, P280, DOI 10.1080/0020714049052352; Williams LM, 2007, PSYCHIAT RES-NEUROIM, V155, P29, DOI 10.1016/j.pscychresns.2006.12.018; Wing J.K., 1996, HONOS HLTH NATION OU	42	4	4	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e91228	10.1371/journal.pone.0091228	http://dx.doi.org/10.1371/journal.pone.0091228			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC4ID	24603990	Green Published, gold, Green Submitted			2022-12-27	WOS:000332483600138
J	Peng, WW; Hu, L; Zhang, ZG; Hu, Y				Peng, Weiwei; Hu, Li; Zhang, Zhiguo; Hu, Yong			Changes of Spontaneous Oscillatory Activity to Tonic Heat Pain	PLOS ONE			English	Article							GAMMA-BAND ACTIVITY; HIGH-RESOLUTION EEG; COLD PRESSOR TEST; A-DELTA-FIBER; FUNCTIONAL CONNECTIVITY; ATTENTIONAL MODULATION; VISUOSPATIAL ATTENTION; OBJECT REPRESENTATION; VISUAL-ATTENTION; BRAIN RESPONSES	Transient painful stimuli could induce suppression of alpha oscillatory activities and enhancement of gamma oscillatory activities that also could be greatly modulated by attention. Here, we attempted to characterize changes in cortical activities during tonic heat pain perception and investigated the influence of directed/distracted attention on these responses. We collected 5-minute long continuous Electroencephalography (EEG) data from 38 healthy volunteers during four conditions presented in a counterbalanced order: (A) resting condition; (B) innoxious-distracted condition; (C) noxious-distracted condition; (D) noxious-attended condition. The effects of tonic heat pain stimulation and selective attention on oscillatory activities were investigated by comparing the EEG power spectra among the four experimental conditions and assessing the relationship between spectral power difference and subjective pain intensity. The change of oscillatory activities in condition D was characterized by stable and persistent decrease of alpha oscillation power over contralateral-central electrodes and widespread increase of gamma oscillation power, which were even significantly correlated with subjective pain intensity. Since EEG responses in the alpha and gamma frequency band were affected by attention in different manners, they are likely related to different aspects of the multidimensional sensory experience of pain. The observed contralateral-central alpha suppression (conditions D vs. B and D vs. C) may reflect primarily a top-down cognitive process such as attention, while the widespread gamma enhancement (conditions D vs. A) may partly reflect tonic pain processing, representing the summary effects of bottom-up stimulus-related and top-down subject-driven cognitive processes.	[Peng, Weiwei; Hu, Yong] Univ Hong Kong, Dept Orthopaed & Traumatol, Pokfulam, Hong Kong, Peoples R China; [Hu, Li] Southwest Univ, Key Lab Cognit & Personal, Minist Educ, Chongqing, Peoples R China; [Hu, Li] Southwest Univ, Sch Psychol, Chongqing, Peoples R China; [Zhang, Zhiguo] Univ Hong Kong, Dept Elect & Elect Engn, Pokfulam, Hong Kong, Peoples R China	University of Hong Kong; Southwest University - China; Southwest University - China; University of Hong Kong	Hu, Y (corresponding author), Univ Hong Kong, Dept Orthopaed & Traumatol, Pokfulam, Hong Kong, Peoples R China.	yhud@hku.hk	Hu, Yong/C-4276-2009	Hu, Yong/0000-0003-0305-5616	University of Hong Kong	University of Hong Kong(University of Hong Kong)	This research was supported by Seed Funding for Basic Research from The University of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babiloni C, 2004, BEHAV BRAIN RES, V152, P137, DOI 10.1016/j.bbr.2003.10.004; Babiloni C, 2006, J PAIN, V7, P709, DOI 10.1016/j.jpain.2006.03.005; Babiloni F, 2005, NEUROIMAGE, V24, P118, DOI 10.1016/j.neuroimage.2004.09.036; BACKONJA M, 1991, ELECTROEN CLIN NEURO, V79, P192, DOI 10.1016/0013-4694(91)90137-S; Bertrand O, 2000, INT J PSYCHOPHYSIOL, V38, P211, DOI 10.1016/S0167-8760(00)00166-5; Burgess AP, 2002, INT J PSYCHOPHYSIOL, V46, P91, DOI 10.1016/S0167-8760(02)00108-3; Chang PF, 2003, BRAIN RES BULL, V59, P533, DOI 10.1016/S0361-9230(02)00950-4; Chang PF, 2002, BRAIN RES BULL, V57, P667, DOI 10.1016/S0361-9230(01)00763-8; Chang PF, 2001, NEUROSCI LETT, V305, P49, DOI 10.1016/S0304-3940(01)01802-X; Del Percio C, 2006, NEUROIMAGE, V31, P1268, DOI 10.1016/j.neuroimage.2006.01.013; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dockstader C, 2010, NEUROIMAGE, V49, P1777, DOI 10.1016/j.neuroimage.2009.09.035; Downar J, 2000, NAT NEUROSCI, V3, P277, DOI 10.1038/72991; Downian R, 2008, CLIN NEUROPHYSIOL, V119, P1201, DOI 10.1016/j.clinph.2008.01.019; Durka PJ, 2004, IEEE T BIO-MED ENG, V51, P1167, DOI 10.1109/TBME.2004.827341; Eccleston C, 1999, PSYCHOL BULL, V125, P356, DOI 10.1037/0033-2909.125.3.356; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Farrar JT, 2001, PAIN, V94, P149, DOI 10.1016/S0304-3959(01)00349-9; Frankenstein UN, 2001, NEUROIMAGE, V14, P827, DOI 10.1006/nimg.2001.0883; Fries P, 2009, ANNU REV NEUROSCI, V32, P209, DOI 10.1146/annurev.neuro.051508.135603; Girden E.R., 1992, ANOVA REPEATED MEASU, V84; Grandchamp R, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00236; Gross J, 2007, PLOS BIOL, V5, P1168, DOI 10.1371/journal.pbio.0050133; Gruber T, 1999, CLIN NEUROPHYSIOL, V110, P2074, DOI 10.1016/S1388-2457(99)00176-5; Hauck M, 2007, J NEUROSCI, V27, P9270, DOI 10.1523/JNEUROSCI.2283-07.2007; Herrmann CS, 2004, TRENDS COGN SCI, V8, P347, DOI 10.1016/j.tics.2004.06.006; Hipp JF, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00338; Howard MW, 2003, CEREB CORTEX, V13, P1369, DOI 10.1093/cercor/bhg084; Hu L, 2013, J PAIN, V14, P89, DOI 10.1016/j.jpain.2012.10.008; Huber MT, 2006, EXP BRAIN RES, V173, P14, DOI 10.1007/s00221-006-0366-1; JENSEN MP, 1986, PAIN, V27, P117, DOI 10.1016/0304-3959(86)90228-9; Jung TP, 2001, HUM BRAIN MAPP, V14, P166, DOI 10.1002/hbm.1050; Kaiser J, 2006, NEUROIMAGE, V30, P1376, DOI 10.1016/j.neuroimage.2005.10.042; Kaiser J, 2005, NEUROREPORT, V16, P207, DOI 10.1097/00001756-200502280-00001; Kaiser J, 2004, NEUROREPORT, V15, P2185, DOI 10.1097/00001756-200410050-00008; Kaiser J, 2003, NEUROSCIENTIST, V9, P475, DOI 10.1177/1073858403259137; Kanwisher N, 2000, NAT REV NEUROSCI, V1, P91, DOI 10.1038/35039043; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Kelly SP, 2006, J NEUROPHYSIOL, V95, P3844, DOI 10.1152/jn.01234.2005; Le Pera D, 2000, CLIN NEUROPHYSIOL, V111, P2130, DOI 10.1016/S1388-2457(00)00474-0; Liu ZM, 2006, IEEE ENG MED BIOL, V25, P46, DOI 10.1109/MEMB.2006.1657787; Makeig S, 1997, P NATL ACAD SCI USA, V94, P10979, DOI 10.1073/pnas.94.20.10979; Martinovic J, 2011, INT J PSYCHOPHYSIOL, V79, P32, DOI 10.1016/j.ijpsycho.2010.07.004; Mouraux A, 2003, CLIN NEUROPHYSIOL, V114, P710, DOI 10.1016/S1388-2457(03)00027-0; Mouraux A, 2011, J NEUROSCI, V31, P6079, DOI 10.1523/JNEUROSCI.3977-10.2011; Nir RR, 2012, CLIN NEUROPHYSIOL, V123, P605, DOI 10.1016/j.clinph.2011.08.006; Ohara S, 2004, CLIN NEUROPHYSIOL, V115, P1641, DOI 10.1016/j.clinph.2004.02.023; Palva S, 2007, TRENDS NEUROSCI, V30, P150, DOI 10.1016/j.tins.2007.02.001; Peng WW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034163; Peyron R, 1999, BRAIN, V122, P1765, DOI 10.1093/brain/122.9.1765; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Ploner M, 2006, CEREB CORTEX, V16, P537, DOI 10.1093/cercor/bhj001; Quevedo AS, 2007, J NEUROSCI, V27, P11635, DOI 10.1523/JNEUROSCI.3356-07.2007; Raij TT, 2004, NEUROIMAGE, V23, P569, DOI 10.1016/j.neuroimage.2004.06.036; Salaffi F, 2004, EUR J PAIN, V8, P283, DOI 10.1016/j.ejpain.2003.09.004; Shao SY, 2012, CLIN NEUROPHYSIOL, V123, P2042, DOI 10.1016/j.clinph.2012.02.084; Sokolov A, 2004, NEUROIMAGE, V22, P521, DOI 10.1016/j.neuroimage.2004.01.045; Tallon-Baudry C, 1999, TRENDS COGN SCI, V3, P151, DOI 10.1016/S1364-6613(99)01299-1; Thut G, 2006, J NEUROSCI, V26, P9494, DOI 10.1523/JNEUROSCI.0875-06.2006; Tiemann L, 2010, PAIN, V150, P302, DOI 10.1016/j.pain.2010.05.014; Tracey I, 2002, J NEUROSCI, V22, P2748, DOI 10.1523/JNEUROSCI.22-07-02748.2002; Valet M, 2004, PAIN, V109, P399, DOI 10.1016/j.pain.2004.02.033; von Stein A, 2000, P NATL ACAD SCI USA, V97, P14748, DOI 10.1073/pnas.97.26.14748; Wiech K, 2008, TRENDS COGN SCI, V12, P306, DOI 10.1016/j.tics.2008.05.005; Zhang ZG, 2012, J NEUROSCI, V32, P7429, DOI 10.1523/JNEUROSCI.5877-11.2012	65	62	66	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e91052	10.1371/journal.pone.0091052	http://dx.doi.org/10.1371/journal.pone.0091052			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603703	Green Published, gold, Green Submitted			2022-12-27	WOS:000332483600126
J	Venter, JA; Prins, HHT; Balfour, DA; Slotow, R				Venter, Jan A.; Prins, Herbert H. T.; Balfour, David A.; Slotow, Rob			Reconstructing Grazer Assemblages for Protected Area Restoration	PLOS ONE			English	Article							MIDDLE STONE-AGE; FORAGING BEHAVIOR; LANDSCAPE-SCALE; AFRICAN SAVANNA; HERBIVORE; FIRE; HETEROGENEITY; DIVERSITY; SELECTION; RESERVE	Protected area management agencies often struggle to reliably reconstruct grazer assemblages due to a lack of historical distribution data for their regions. Wrong predictions of grazing assemblages could potentially affect biodiversity negatively. The objective of the study was to determine how well grazing herbivores have become established since introduction to the Mkambati Nature Reserve, South Africa, how this was influenced by facilitation and competition, and how indigenous grazer assemblages can best be predicted for effective ecological restoration. Population trends of several grazing species were investigated in in order to determine how well they have become established since introduction. Five different conceivable grazing assemblages reflecting a range of approaches that are commonly encountered during conservation planning and management decision making were assessed. Species packing was used to predict whether facilitation, competition or co-existence were more likely to occur, and the species packing of the different assemblages were assessed using ANCOVA. Reconstructing a species assemblage using biogeographic and biological information provides the opportunity for a grazer assemblage that allows for facilitatory effects, which in turn leads to an ecosystem that is able to maintain its grazer assemblage structure. The strength of this approach lies in the ability to overcome the problem of depauperate grazer assemblages, resulting from a lack of historical data, by using biogeographical and biological processes, to assist in more effectively reconstructing grazer assemblages. Adaptive management of grazer assemblage restoration through reintroduction, using this approach would further mitigate management risks.	[Venter, Jan A.; Prins, Herbert H. T.; Slotow, Rob] Univ Kwazulu Natal, Sch Life Sci, Durban, South Africa; [Venter, Jan A.; Balfour, David A.] Eastern Cape Pk & Tourism Agcy, Dept Biodivers Conservat, Southernwood, East London, South Africa; [Prins, Herbert H. T.] Wageningen Univ, Resource Ecol Grp, NL-6700 AP Wageningen, Netherlands	University of Kwazulu Natal; Wageningen University & Research	Venter, JA (corresponding author), Univ Kwazulu Natal, Sch Life Sci, Westville Campus, Durban, South Africa.	Jan.Venter@ecpta.co.za	Slotow, Rob/AAM-9053-2020	Prins, Herbert/0000-0003-1131-5107; Slotow, Rob/0000-0001-9469-1508	University of Kwazulu-Natal; Eastern Cape Parks and Tourism Agency	University of Kwazulu-Natal; Eastern Cape Parks and Tourism Agency	The University of Kwazulu-Natal and Eastern Cape Parks and Tourism Agency who provided funding for the research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], ECOLOGICAL SURVEY SE; Arsenault R, 2002, OIKOS, V97, P313, DOI 10.1034/j.1600-0706.2002.970301.x; Arsenault R, 2008, OIKOS, V117, P1711, DOI 10.1111/j.1600-0706.2008.16575.x; Atkinson IAE, 2001, BIOL CONSERV, V99, P81, DOI 10.1016/S0006-3207(00)00189-0; Bailey DW, 1996, J RANGE MANAGE, V49, P386, DOI 10.2307/4002919; BELL RHV, 1971, SCI AM, V225, P86, DOI 10.1038/scientificamerican0771-86; BELL RHV, 1982, ECOL STUD, V42, P193; Bernard RTF, 2006, S AFR J SCI, V102, P117; Biggs H. C., 2003, KRUGER EXPERIENCE EC, P59; Bond WJ, 2005, TRENDS ECOL EVOL, V20, P387, DOI 10.1016/j.tree.2005.04.025; Bonyongo MC, 2007, AFR J ECOL, V45, P527, DOI 10.1111/j.1365-2028.2007.00764.x; Boshoff AF, 2001, AFR ZOOL, V36, P245; Boshoff AF, 2004, C106 U PORT EL TERR; Boshoff AE, 2010, S AFR J SCI, V106, P26, DOI 10.4102/sajs.v106i1/2.116; Castley JG, 2001, S AFR J SCI, V97, P344; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Coetzee C. G., 1969, Scientific Papers Namib Desert Research Station, VNo. 40, P23; Conservation International South African National Biodiversity Institute, 2010, EC PROF MAP PO UNPUB; Craigie ID, 2010, BIOL CONSERV, V143, P2221, DOI 10.1016/j.biocon.2010.06.007; Cramer MD, 2007, S AFR J WILDL RES, V37, P197, DOI 10.3957/0379-4369-37.2.197; Cromsigt JPGM, 2006, ECOLOGY, V87, P1532, DOI 10.1890/0012-9658(2006)87[1532:RPASGM]2.0.CO;2; Cromsigt JPGM, 2009, DIVERS DISTRIB, V15, P513, DOI 10.1111/j.1472-4642.2008.00554.x; D'Alonzo KT, 2004, WESTERN J NURS RES, V26, P804, DOI 10.1177/0193945904266733; de Villiers D, 2006, MKAMBATI WILD COAST; DEMMENT MW, 1985, AM NAT, V125, P641, DOI 10.1086/284369; Drent R.H., 1987, Geobotany, V10, P131; Drescher M, 2006, AUSTRAL ECOL, V31, P76, DOI 10.1111/j.1442-9993.2006.01552.x; Drescher M, 2006, APPL ANIM BEHAV SCI, V101, P10, DOI 10.1016/j.applanim.2006.01.011; ECPB, 2009, INT RES MAN PL UNPUB; ECPB, 2010, E CAP PARKS BOARD PO; Feely JM, 2005, GUIDE NATURAL UNPUB; Fischer J, 2000, BIOL CONSERV, V96, P1, DOI 10.1016/S0006-3207(00)00048-3; Fisher Erich C., 2013, Paleoanthropology, P104; Fritz H, 2002, OECOLOGIA, V131, P620, DOI 10.1007/s00442-002-0919-3; Fryxell JM, 2005, ECOL LETT, V8, P328, DOI 10.1111/j.1461-0248.2005.00727.x; Fuhlendorf SD, 2009, CONSERV BIOL, V23, P588, DOI 10.1111/j.1523-1739.2008.01139.x; Gagnon M, 2000, J MAMMAL, V81, P490, DOI 10.1644/1545-1542(2000)081&lt;0490:DPIEAB&gt;2.0.CO;2; Gaylard A, 2011, KOEDOE, V53, DOI 10.4102/koedoe.v53i2.1005; GOODMAN PS, 1987, S AFR J WILDL RES, V17, P28; GRIFFITH B, 1989, SCIENCE, V245, P477, DOI 10.1126/science.245.4917.477; GRISWOLD C E, 1991, Australian Systematic Botany, V4, P73, DOI 10.1071/SB9910073; Gusset M, 2008, J APPL ECOL, V45, P100, DOI 10.1111/j.1365-2664.2007.01357.x; Hayward MW, 2009, BIODIVERS CONSERV, V18, P765, DOI 10.1007/s10531-008-9436-y; Heinen JT, 2002, ENV PRACTICE, V4, P172; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; ILLIUS AW, 1992, OECOLOGIA, V89, P428, DOI 10.1007/BF00317422; KAREIVA P, 1982, ECOLOGY, V63, P696, DOI 10.2307/1936790; Kleynhans EJ, 2011, OIKOS, V120, P591, DOI 10.1111/j.1600-0706.2010.18712.x; Klop E, 2008, GLOBAL ECOL BIOGEOGR, V17, P778, DOI 10.1111/j.1466-8238.2008.00416.x; Kramer K, 2010, ECOL MODEL, V221, P2555, DOI 10.1016/j.ecolmodel.2010.07.012; Kuemmerle T, 2012, DIVERS DISTRIB, V18, P47, DOI 10.1111/j.1472-4642.2011.00849.x; Kwazulu-Natal Nature Conservation Service, 1999, NOM PROP GREAT UNPUB; Lagendijk G, 2012, BIOTROPICA, V44, P63, DOI 10.1111/j.1744-7429.2011.00776.x; Leonard S, 2010, J APPL ECOL, V47, P876, DOI 10.1111/j.1365-2664.2010.01840.x; Linder HP, 2012, J BIOGEOGR, V39, P1189, DOI 10.1111/j.1365-2699.2012.02728.x; List R, 2007, CONSERV BIOL, V21, P1487, DOI 10.1111/j.1523-1739.2007.00810.x; May R.M., 1973, STABILITY COMPLEXITY; MCNAUGHTON SJ, 1985, ECOL MONOGR, V55, P259, DOI 10.2307/1942578; MCNAUGHTON SJ, 1976, SCIENCE, V191, P92, DOI 10.1126/science.191.4222.92; Minter L.R., 2004, ATLAS RED DATA BOOK; Mishra C, 2002, ANIM CONSERV, V5, P251, DOI 10.1017/S1367943002002305; Mucina I., 2006, STRELITZIA, V19; Mucina L., 2006, VEGETATION S AFRICA; Murray MG, 2000, OIKOS, V89, P501, DOI 10.1034/j.1600-0706.2000.890309.x; Namgail T, 2010, J ARID ENVIRON, V74, P1162, DOI 10.1016/j.jaridenv.2010.04.013; Novellie P. A., 1994, Koedoe, V37, P115; Olff H, 2002, NATURE, V415, P901, DOI 10.1038/415901a; Owen-Smith N, 2006, ECOL MONOGR, V76, P73, DOI 10.1890/04-1101; OWENSMITH N, 1987, PALEOBIOLOGY, V13, P351; Peinke D., 2007, ANN GAME ESTIM UNPUB; Plug I, 2004, S AFR J SCI, V100, P151; Pollard S, 2011, KOEDOE, V53, DOI 10.4102/koedoe.v53i2.1011; Prins H.H.T., 1998, P449; Roux DJ, 2011, DEV APPL STRATEGIC A, V53, P1; Rowe-Rowe DT, 1994, UNGULATES NATA UNPUB; SHACKLETON C M, 1992, Journal of the Grassland Society of Southern Africa, V9, P30; SHACKLETON C M, 1990, Journal of the Grassland Society of Southern Africa, V7, P265; SHACKLETON CM, 1991, BOTHALIA, V21, P91, DOI 10.4102/abc.v21i1.869; Simenstad C, 2006, ECOL ENG, V26, P27, DOI 10.1016/j.ecoleng.2005.09.007; Skead C.J., 2007, HIST INCIDENCE LARGE, V2nd Edn; Skinner J. D., 2005, MAMMALS SO AFRICAN S; Slotow R., 2001, Koedoe, V44, P85; Spear D, 2009, J ZOOL, V279, P1, DOI 10.1111/j.1469-7998.2009.00604.x; Spear Dian, 2011, Koedoe, V53, P01; Suding KN, 2004, TRENDS ECOL EVOL, V19, P46, DOI 10.1016/j.tree.2003.10.005; Truett Joe C., 2001, Great Plains Research, V11, P123; Uys R, 2012, NOTES NATURAL UNPUB; Van der Merwe J, 2012, AUSTRAL ECOL, V37, P401, DOI 10.1111/j.1442-9993.2011.02297.x; van Rooyen N, 2004, VEGETATION TYP UNPUB; Venter FJ, 2008, ECOSYSTEMS, V11, P173, DOI 10.1007/s10021-007-9116-x; Venter J.A., 2010, GAME CENSUS RE UNPUB; Venter JA, 2004, S AFR J WILDL RES, V34, P95; Venter JA, 2007, LARGE HERBIVOR UNPUB; VESEY-FITZGERALD DESMOND F., 1960, JOUR MAMMAL, V41, P161, DOI 10.2307/1376351; Vie J-C, 2009, WILDLIFE CHANGING WO; Waldram MS, 2008, ECOSYSTEMS, V11, P101, DOI 10.1007/s10021-007-9109-9; Watson LH, 2000, AFR J ECOL, V38, P130, DOI 10.1046/j.1365-2028.2000.00229.x; Wilmshurst JF, 2000, P ROY SOC B-BIOL SCI, V267, P345, DOI 10.1098/rspb.2000.1007; Witkowski ETF, 2001, PLANT ECOL, V152, P13, DOI 10.1023/A:1011409004004; Zavaleta ES, 2001, TRENDS ECOL EVOL, V16, P454, DOI 10.1016/S0169-5347(01)02194-2	100	14	14	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90900	10.1371/journal.pone.0090900	http://dx.doi.org/10.1371/journal.pone.0090900			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603663	Green Published, gold, Green Submitted			2022-12-27	WOS:000332483600104
J	Alolayan, AB; Leung, YY				Alolayan, Albraa Badr; Leung, Yiu Yan			Risk Factors of Neurosensory Disturbance following Orthognathic Surgery	PLOS ONE			English	Article							SAGITTAL SPLIT OSTEOTOMY; INFERIOR ALVEOLAR NERVE; FORT-I OSTEOTOMY; RAMUS OSTEOTOMY; SENSIBILITY; ADOLESCENTS; IMPAIRMENT; FIXATION; CHINESE; LIP	Objectives: To report the incidence of objective and subjective neurosensory disturbance (NSD) after orthognathic surgery in a major orthognathic centre in Hong Kong, and to investigate the risk factors that contributed to the incidence of NSD after orthognathic surgery. Materials and Methods: A retrospective cross-sectional study on NSD after orthognathic surgery in a local major orthognathic centre. Patients who had bimaxillary orthognathic surgery reviewed at post-operative 6 months, 12 months or 24 months were recruited to undergo neurosensory tests with subjective and 3 objective assessments. Possible risk factors of NSD including subjects' age and gender, surgical procedures and surgeons' experience were analyzed. Results: 238 patients with 476 sides were recruited. The incidences of subjective NSD after maxillary procedures were 16.2%, 13% and 9.8% at post-operative 6 months, 12 months and 24 months, respectively; the incidences of subjective NSD after mandibular procedures were 35.4%, 36.6% and 34.6% at post-operative 6 months, 12 months and 24 months, respectively. Increased age was found to be a significant risk factor of NSD after orthognathic surgery at short term (at 6 months and 12 months) but not at 24 months. SSO has a significantly higher risk of NSD when compared to VSSO. SSO in combination with anterior mandibular surgery has a higher risk of NSD when compared to VSSO in combination with anterior mandibular surgery or anterior mandibular surgery alone. Gender of patients and surgeons' experience were not found to be risk factors of NSD after orthognathic surgery. Conclusion: The incidence of NSD after maxillary and mandibular orthognathic procedures at post-operative 6 months, 12 months and 24 months was reported. Increased age was identified as a risk factor of short term post-operative NSD but not in long term (24 months or more). Specific mandibular procedures were related to higher incidence of NSD after orthognathic surgery.	[Alolayan, Albraa Badr; Leung, Yiu Yan] Univ Hong Kong, Fac Dent, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Leung, YY (corresponding author), Univ Hong Kong, Fac Dent, Hong Kong, Hong Kong, Peoples R China.	mikeyyleung@hku.hk		Alolayan, Albraa/0000-0001-6897-1565				August M, 1998, J ORAL MAXIL SURG, V56, P1231, DOI 10.1016/S0278-2391(98)90595-X; Bays Robert A, 2003, Oral Maxillofac Surg Clin North Am, V15, P229; Blomqvist JE, 1997, J ORAL MAXIL SURG, V55, P568, DOI 10.1016/S0278-2391(97)90486-9; Colella G, 2007, J ORAL MAXIL SURG, V65, P1707, DOI 10.1016/j.joms.2007.05.009; Essick GK, 2007, INT J ORAL MAX SURG, V36, P577, DOI 10.1016/j.ijom.2007.02.006; Gianni AB, 2002, J CRANIO MAXILL SURG, V30, P295, DOI 10.1016/S1010-5182(02)90311-2; Gu Y, 2011, AUST ORTHOD J, V27, P155; Gu Y, 2011, EUR J ORTHODONT, V33, P205, DOI 10.1093/ejo/cjq054; KARAS ND, 1990, J ORAL MAXIL SURG, V48, P124, DOI 10.1016/S0278-2391(10)80199-5; Kim YK, 2011, J ORAL MAXIL SURG, V69, P893, DOI 10.1016/j.joms.2010.10.025; Kobayashi A, 2006, J ORAL MAXIL SURG, V64, P778, DOI 10.1016/j.joms.2006.01.009; Leung YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072891; Leung YY, 2013, PLOS ONE; Nesari S, 2005, INT J ORAL MAX SURG, V34, P495, DOI 10.1016/j.ijom.2004.10.021; NISHIOKA GJ, 1987, J ORAL MAXIL SURG, V45, P20, DOI 10.1016/0278-2391(87)90081-4; Ow A, 2010, INT J ORAL MAX SURG, V39, P756, DOI 10.1016/j.ijom.2010.04.001; POSNICK JC, 1994, PLAST RECONSTR SURG, V94, P431, DOI 10.1097/00006534-199409000-00002; ROSENBERG A, 1994, J CRANIO MAXILL SURG, V22, P286, DOI 10.1016/S1010-5182(05)80078-2; Schultze-Mosgau S, 2001, J ORAL MAXIL SURG, V59, P128, DOI 10.1053/joms.2001.20480; Westermark A, 1998, BRIT J ORAL MAX SURG, V36, P425, DOI 10.1016/S0266-4356(98)90457-0; Ylikontiola L, 2000, J ORAL MAXIL SURG, V58, P1234, DOI 10.1053/joms.2000.16621	21	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e91055	10.1371/journal.pone.0091055	http://dx.doi.org/10.1371/journal.pone.0091055			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599321	Green Published, gold, Green Submitted			2022-12-27	WOS:000332479400152
J	Walentowicz, P; Krintus, M; Sadlecki, P; Grabiec, M; Mankowska-Cyl, A; Sokup, A; Walentowicz-Sadlecka, M				Walentowicz, Pawel; Krintus, Magdalena; Sadlecki, Pawel; Grabiec, Marek; Mankowska-Cyl, Aneta; Sokup, Alina; Walentowicz-Sadlecka, Malgorzata			Serum Inhibin A and Inhibin B Levels in Epithelial Ovarian Cancer Patients	PLOS ONE			English	Article							ACTIVIN; BETAGLYCAN; BETA; ANTAGONISM; MECHANISMS; SECRETION; SURVIVAL; TARGET; CELLS	The aim: of our study was to examine serum inhibin A and inhibin B concentrations in ovarian cancer patients in relation to clinicopathological features and 5-year survival. Material and Methods: We enrolled 90 epithelial ovarian cancer patients in our study, aged 45-81 years, who underwent optimal cytoreductive surgery. In all patients, serum inhibin A and inhibin B concentrations were measured using a two-step sandwich type enzyme immunoassay before surgery. Results: In the group of patients with ovarian cancer median serum concentration of inhibin A was 3.87 pg/mL (0.96-10.09) and inhibin B was 13.9 pg/mL (5.1-45.0). Median concentrations of inhibin A and B in relation to FIGO stage and histological subtype did not differ significantly. Inhibin A levels were significantly higher in patients with lower grading (G1 and G2) in comparison to those with higher grade G3 (p = 0.001). There were no differences in inhibin B concentrations in relation to grading. The Kaplan-Meier analyses demonstrated no differences in survival rate in relation to inhibin A levels, while there was a stepwise impairment of 5-years survival with increased inhibin B level. In the group of patients with inhibin B levels higher than 20 pg/ml the survival rate was lower (p = 0,00625, log-rank test). Conclusion: 1. Higher inhibin A serum levels were found in patients with highly differentiated ovarian carcinoma compared to the group of patients with a poorly differentiated cancer, which may confirm the influence of inhibin A on cell proliferation processes. 2. A significant importance of inhibin B was demonstrated in the prediction of death within less than a five year period. The probability of survival in patients featuring high inhibin B levels was lower with statistical significance. This may indicate the need for further studies on how to block the inhibin B activation pathway in the ovarian carcinoma therapy.	[Walentowicz, Pawel; Sadlecki, Pawel; Grabiec, Marek; Walentowicz-Sadlecka, Malgorzata] Nicholas Copernicus Univ, L Rydygier Coll Med Bydgoszcz, Dept Obstet & Gynecol, Bydgoszcz, Poland; [Krintus, Magdalena; Mankowska-Cyl, Aneta] Nicholas Copernicus Univ, L Rydygier Coll Med Bydgoszcz, Dept Lab Med, Bydgoszcz, Poland; [Sokup, Alina] Nicholas Copernicus Univ, Dept Gastroenterol Angiol & Internal Dis, Dr J Biziel Univ Hosp, Bydgoszcz, Poland	Nicolaus Copernicus University; Nicolaus Copernicus University; Nicolaus Copernicus University	Walentowicz-Sadlecka, M (corresponding author), Nicholas Copernicus Univ, L Rydygier Coll Med Bydgoszcz, Dept Obstet & Gynecol, Bydgoszcz, Poland.	walentowiczm@cm.umk.pl	Sadlecki, Pawel/AAB-6993-2021; Sadłecki, Paweł/I-5728-2014; Mankowska-Cyl, Aneta/P-5575-2015; Sokup, Alina/M-5222-2014; Krintus, Magdalena/H-9419-2014; Sadlecki, Pawel/AAB-5046-2021	Sadlecki, Pawel/0000-0001-8355-2553; Sadłecki, Paweł/0000-0001-8355-2553; Mankowska-Cyl, Aneta/0000-0002-1049-9824; Sokup, Alina/0000-0002-7470-6706; Krintus, Magdalena/0000-0003-2627-7473; Walentowicz, Pawel/0000-0002-7748-343X				Antenos M, 2007, MOL ENDOCRINOL, V21, P1670, DOI 10.1210/me.2007-0050; Baud V, 2009, NAT REV DRUG DISCOV, V8, P33, DOI 10.1038/nrd2781; Bonome T, 2008, CANCER RES, V68, P5478, DOI 10.1158/0008-5472.CAN-07-6595; CHEIFETZ S, 1988, J BIOL CHEM, V263, P17225; Delfino KR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058608; Deregowski V, 2002, BIOCHEM PHARMACOL, V64, P873, DOI 10.1016/S0006-2952(02)01151-6; Farnworth PG, 2006, ENDOCRINOLOGY, V147, P3462, DOI 10.1210/en.2006-0023; FINDLAY JK, 1987, BAILLIERE CLIN ENDOC, V1, P223, DOI 10.1016/S0950-351X(87)80060-5; Gatza CE, 2010, CELL SIGNAL, V22, P1163, DOI 10.1016/j.cellsig.2010.01.016; Hernandez L, 2010, CANCER RES, V70, P4005, DOI 10.1158/0008-5472.CAN-09-3912; Hirschhorn T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043459; Kisielewski R, 2013, GINEKOL POL, V84, P293; Knight PG, 2006, REPRODUCTION, V132, P191, DOI 10.1530/rep.1.01074; LEVERSHA LJ, 1987, J ENDOCRINOL, V113, P213, DOI 10.1677/joe.0.1130213; Lewis KA, 2000, NATURE, V404, P411, DOI 10.1038/35006129; Makanji Y, 2008, J BIOL CHEM, V283, P16743, DOI 10.1074/jbc.M801045200; Makanji Y, 2007, ENDOCRINOLOGY, V148, P2309, DOI 10.1210/en.2006-1612; Makanji Y, 2011, VITAM HORM, V85, P299, DOI 10.1016/B978-0-12-385961-7.00014-7; Makanji Y, 2009, ENDOCRINOLOGY, V150, P4784, DOI 10.1210/en.2008-1783; Mason AJ, 1996, MOL ENDOCRINOL, V10, P1055, DOI 10.1210/me.10.9.1055; Park Y, 2011, CLIN BIOCHEM, V44, P884, DOI 10.1016/j.clinbiochem.2011.04.011; Pfeiffer RM, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001492; Quartuccio SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065067; Rachidi SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057911; Robertson DM, 2009, J CLIN ENDOCR METAB, V94, P138, DOI 10.1210/jc.2008-1684; Sharma A, 2013, ULTRASOUND OBST GYN, V42, P472, DOI 10.1002/uog.12447; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sohn I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054089; Son DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051116; Stenvers KL, 2012, MOL CELL ENDOCRINOL, V359, P1, DOI 10.1016/j.mce.2012.03.001; Theriault BL, 2011, CANCER LETT, V313, P108, DOI 10.1016/j.canlet.2011.08.033; Tournier I, 2014, HUM MUTAT, V35, P294, DOI 10.1002/humu.22489; Walentowicz-Sadlecka M, 2012, CLIN BIOCHEM, V45, P1568, DOI 10.1016/j.clinbiochem.2012.07.110; Walton KL, 2012, MOL CELL ENDOCRINOL, V359, P2, DOI 10.1016/j.mce.2011.06.030; Wiater E, 2009, MOL ENDOCRINOL, V23, P1033, DOI 10.1210/me.2009-0021; Zhang W, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002975; Zhao BX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071071	37	14	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90575	10.1371/journal.pone.0090575	http://dx.doi.org/10.1371/journal.pone.0090575			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599287	gold, Green Submitted, Green Published			2022-12-27	WOS:000332479400096
J	Fujioka, M; Okamoto, Y; Shinden, S; Okano, HJ; Okano, H; Ogawa, K; Matsunaga, T				Fujioka, Masato; Okamoto, Yasuhide; Shinden, Seiichi; Okano, Hirotaka James; Okano, Hideyuki; Ogawa, Kaoru; Matsunaga, Tatsuo			Pharmacological Inhibition of Cochlear Mitochondrial Respiratory Chain Induces Secondary Inflammation in the Lateral Wall: A Potential Therapeutic Target for Sensorineural Hearing Loss	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; SUCCINATE-DEHYDROGENASE; SUDDEN DEAFNESS; ACOUSTIC TRAUMA; MOUSE COCHLEA; INNER-EAR; DYSFUNCTION; 3-NITROPROPIONATE; FIBROCYTES	Cochlear lateral wall has recently been reported as a common site of inflammation, yet precise molecular mechanisms of the inflammatory responses remain elucidated. The present study examined the inflammatory responses in the lateral wall following acute mitochondrial dysfunction induced by a mitochondrial toxin, 3-nitropropionic acid (3-NP). Reverse-transcription (RT)-PCR revealed increases in the expression of the proinflammatory cytokines interleukin (IL)-1 beta and IL-6. Immunohistochemistry showed an increase in the number of activated cochlear macrophages in the lateral wall, which were in close proximity to IL-6-expressing cells. A genome-wide DNA microarray analysis of the lateral wall revealed that 35% and 60% of the genes showing >2-fold upregulation at 1 d and 3 d post-3-NP administration, respectively, were inflammatory genes, including CC-and CXC-type chemokine genes. High expression of CCL-1, 2, and 3 at 1 d, and of CCL-1, 2, 3, 4, and 5, CCR-2 and 5, and CX3CR1 at 3 d post-3-NP administration, coupled with no change in the level of CX3CL1 expression suggested that macrophages and monocytes may be involved in the inflammatory response to 3-NP-mediated injury. Quantitative (q)RT-PCR showed a transient induction of IL-1 beta and IL-6 expression within 24 h of 3-NP-mediated injury, followed by sustained expression of the chemoattractants, CCL-2, 4 and 5, up until 7 d after injury. The expression of CCL-2 and IL-6 was higher in animals showing permanent hearing impairment than in those showing temporary hearing impairment, suggesting that these inflammatory responses may be detrimental to hearing recovery. The present findings suggest that acute mitochondrial dysfunction induces secondary inflammatory responses in the lateral wall of the cochlear and that the IL-6/CCL-2 inflammatory pathway is involved in monocyte activation. Therefore, these secondary inflammatory responses may be a potential post-insult therapeutic target for treatments aimed at preventing the damage caused by acute mitochondrial dysfunction in the cochlear lateral wall.	[Fujioka, Masato; Ogawa, Kaoru] Keio Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Shinjuku Ku, Tokyo, Japan; [Fujioka, Masato; Okano, Hirotaka James; Okano, Hideyuki] Keio Univ, Sch Med, Dept Physiol, Shinjuku Ku, Tokyo 160, Japan; [Okamoto, Yasuhide] Inagi Municipal Hosp, Dept Otorhinolaryngol, Tokyo, Japan; [Shinden, Seiichi] Saiseikai Utsunomiya Hosp, Dept Otolaryngol, Utsunomiya, Tochigi, Japan; [Okano, Hirotaka James] Jikei Univ, Sch Med, Div Regenerat Med, Tokyo, Japan; [Okamoto, Yasuhide; Shinden, Seiichi; Matsunaga, Tatsuo] Natl Tokyo Med Ctr, Natl Inst Sensory Organs, Lab Auditory Disorders, Meguro Ku, Tokyo, Japan; [Okamoto, Yasuhide; Shinden, Seiichi; Matsunaga, Tatsuo] Natl Tokyo Med Ctr, Natl Inst Sensory Organs, Div Hearing & Balance Res, Meguro Ku, Tokyo, Japan	Keio University; Keio University; Jikei University	Matsunaga, T (corresponding author), Natl Tokyo Med Ctr, Natl Inst Sensory Organs, Lab Auditory Disorders, Meguro Ku, Tokyo, Japan.	matsunagatatsuo@kankakuki.go.jp	Okano, Hideyuki/I-7584-2019	Fujioka, Masato/0000-0002-5317-0885; Okano, Hirotaka James/0000-0003-4611-7098; matsunaga, tatsuo/0000-0001-9647-1496	MEXT/JSPS KAKENHI [24592560, 24390390]; Ministry of Health Labour and Welfare	MEXT/JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Health Labour and Welfare(Ministry of Health, Labour and Welfare, Japan)	This work was supported by a Grant-in-Aid for Scientific Research (C) from MEXT/JSPS KAKENHI grant number 24592560 to M. F. by a Grant-in-Aid for Scientific Research (B) from MEXT/JSPS KAKENHI grant number 24390390 to K.O. and by a Health Labour Sciences Research Grant from the Ministry of Health Labour and Welfare to T. M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALSTON TA, 1977, P NATL ACAD SCI USA, V74, P3767, DOI 10.1073/pnas.74.9.3767; Belema-Bedada F, 2008, CELL STEM CELL, V2, P566, DOI 10.1016/j.stem.2008.03.003; COLES CJ, 1979, J BIOL CHEM, V254, P5161; Dwyer RM, 2007, CLIN CANCER RES, V13, P5020, DOI 10.1158/1078-0432.CCR-07-0731; Fischel-Ghodsian N, 2003, NEW ENGL J MED, V349, P1293; Fujioka M, 2006, J NEUROSCI RES, V83, P575, DOI 10.1002/jnr.20764; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Haberkamp TJ, 1999, AM J OTOL, V20, P587; Hirose K, 2005, J COMP NEUROL, V489, P180, DOI 10.1002/cne.20619; Hoya N, 2004, NEUROREPORT, V15, P1597, DOI 10.1097/01.wnr.0000133226.94662.80; Hsu CH, 2005, ANN NY ACAD SCI, V1042, P36, DOI 10.1196/annals.1338.004; Lang HN, 2006, J COMP NEUROL, V496, P187, DOI 10.1002/cne.20929; Lee HY, 2004, J NEUROL SCI, V222, P105, DOI 10.1016/j.jns.2004.04.005; Mizutari K, 2008, J NEUROSCI RES, V86, P215, DOI 10.1002/jnr.21470; Mort DJ, 2006, CURR OPIN NEUROL, V19, P1, DOI 10.1097/01.wco.0000196155.92856.a1; Okamoto Y, 2005, AUDIOL NEURO-OTOL, V10, P220, DOI 10.1159/000084843; Okano T, 2008, J NEUROSCI RES, V86, P1758, DOI 10.1002/jnr.21625; Pickles JO, 2004, AUDIOL NEURO-OTOL, V9, P23, DOI 10.1159/000074184; Sun GW, 2012, J NEUROSCI RES, V90, P1713, DOI 10.1002/jnr.23067; Wang Y, 2002, JARO, V3, P248, DOI 10.1007/s101620020028; Yamane H, 1995, EUR ARCH OTO-RHINO-L, V252, P504, DOI 10.1007/BF02114761; YAMANE H, 1995, ACTA OTO-LARYNGOL, P87; Yamasoba T, 2001, J NEUROL SCI, V187, P69, DOI 10.1016/S0022-510X(01)00525-1	23	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e90089	10.1371/journal.pone.0090089	http://dx.doi.org/10.1371/journal.pone.0090089			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614528	Green Published, Green Submitted, gold			2022-12-27	WOS:000332839300017
J	Lu, ZL; Kong, XX; Lu, ZM; Xiao, MX; Chen, MY; Zhu, L; Shen, YM; Hu, XY; Song, SY				Lu, Zhonglei; Kong, Xiangxiang; Lu, Zhaoming; Xiao, Meixiang; Chen, Meiyuan; Zhu, Liang; Shen, Yuemao; Hu, Xiangyang; Song, Siyang			Para-Aminobenzoic Acid (PABA) Synthase Enhances Thermotolerance of Mushroom Agaricus bisporus	PLOS ONE			English	Article							PRECURSOR P-AMINOBENZOATE; SALICYLIC-ACID; TEMPERATURE STRESS; OXIDATIVE STRESS; GENE-EXPRESSION; PROTECTIVE ROLE; ABIOTIC STRESS; GLUCOSE ESTER; ABSCISIC-ACID; SALT STRESS	Most mushrooms are thermo-sensitive to temperatures over 23 degrees C, which greatly restricts their agricultural cultivation. Understanding mushroom's innate heat-tolerance mechanisms may facilitate genetic improvements of their thermotolerance. Agaricus bisporus strain 02 is a relatively thermotolerant mushroom strain, while strain 8213 is quite thermosensitive. Here, we compared their responses at proteomic level to heat treatment at 33 degrees C. We identified 73 proteins that are differentially expressed between 02 and 8213 or induced upon heat stress in strain 02 itself, 48 of which with a known identity. Among them, 4 proteins are constitutively more highly expressed in 02 than 8213; and they can be further upregulated in response to heat stress in 02, but not in 8213. One protein is encoded by the para-aminobenzoic acid (PABA) synthase gene Pabs, which has been shown to scavenge the reactive oxygen species in vitro. Pabs mRNA and its chemical product PABA show similar heat stress induction pattern as PABA synthase protein and are more abundant in 02, indicating transcriptional level upregulation of Pabs upon heat stress. A specific inhibitor of PABA synthesis impaired thermotolerance of 02, while exogenous PABA or transgenic overexpression of 02 derived PABA synthase enhanced thermotolerance of 8213. Furthermore, compared to 8213, 02 accumulated less H2O2 but more defense-related proteins (e. g., HSPs and Chitinase) under heat stress. Together, these results demonstrate a role of PABA in enhancing mushroom thermotolerance by removing H2O2 and elevating defense-related proteins.	[Lu, Zhonglei; Lu, Zhaoming; Xiao, Meixiang; Shen, Yuemao; Song, Siyang] Xiamen Univ, Sch Life Sci, State Key Lab Stress Cell Biol, Xiamen, Fujian, Peoples R China; [Kong, Xiangxiang; Hu, Xiangyang] Chinese Acad Sci, Inst Tibet Plateau Res Kunming, Key Lab Biodivers & Biogeog, Kunming Inst Bot, Kunming, Yunnan, Peoples R China; [Chen, Meiyuan] Fujian Acad Agr Sci, Edible Fungi Inst, Fuzhou, Fujian, Peoples R China; [Zhu, Liang] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10467 USA; [Zhu, Liang] Albert Einstein Coll Med, Bronx, NY 10467 USA	Xiamen University; Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Fujian Academy of Agricultural Sciences; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Hu, XY (corresponding author), Chinese Acad Sci, Inst Tibet Plateau Res Kunming, Key Lab Biodivers & Biogeog, Kunming Inst Bot, Kunming, Yunnan, Peoples R China.	huxiangyang@mail.kib.ac.cn; sysong@xmu.edu.cn	Hu, Xiangyang/AAQ-3313-2021	Shen, Yuemao/0000-0002-3881-0135; Lu, Zhonglei/0000-0002-8915-4828	100 Talents Program of the Chinese Academy of Sciences; National Science Foundation of China [30571295, 30871704, 30971452, 31170256]; Major Science and Technology Program [10201101003-TS-03]	100 Talents Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Science and Technology Program	This work was supported by the 100 Talents Program of the Chinese Academy of Sciences, the National Science Foundation of China (grant No. 30571295, 30871704, 30971452, and 31170256), the Major Science and Technology Program (grant No.10201101003-TS-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeselmani M, 2006, PLANT SCI, V171, P382, DOI 10.1016/j.plantsci.2006.04.009; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Asami DK, 2003, J AGR FOOD CHEM, V51, P1237, DOI 10.1021/jf020635c; Bai XG, 2011, J PROTEOME RES, V10, P4349, DOI 10.1021/pr200333f; Basset GJC, 2005, CROP SCI, V45, P449, DOI 10.2135/cropsci2005.0449; Basset GJC, 2004, P NATL ACAD SCI USA, V101, P1496, DOI 10.1073/pnas.0308331100; Camara D, 2012, J BIOL CHEM, V287, P22367, DOI 10.1074/jbc.M112.365833; Chen R, 2003, FOOD TECHNOL BIOTECH, V41, P339; Chen X, 2000, APPL ENVIRON MICROB, V66, P4510, DOI 10.1128/AEM.66.10.4510-4513.2000; Davidson JF, 1996, P NATL ACAD SCI USA, V93, P5116, DOI 10.1073/pnas.93.10.5116; Dana MD, 2006, PLANT PHYSIOL, V142, P722, DOI 10.1104/pp.106.086140; DELANEY TP, 1994, SCIENCE, V266, P1247, DOI 10.1126/science.266.5188.1247; Eudes A, 2008, J BIOL CHEM, V283, P15451, DOI 10.1074/jbc.M709591200; Fang WG, 2008, FEMS MICROBIOL LETT, V279, P146, DOI 10.1111/j.1574-6968.2007.00978.x; Gammulla CG, 2010, PROTEOMICS, V10, P3001, DOI 10.1002/pmic.201000054; Gong ZZ, 2005, PLANT CELL, V17, P256, DOI 10.1105/tpc.104.027557; Hanson AD, 2002, CURR OPIN PLANT BIOL, V5, P244, DOI 10.1016/S1369-5266(02)00249-2; Horvath E, 2007, J PLANT GROWTH REGUL, V26, P290, DOI 10.1007/s00344-007-9017-4; HU ML, 1995, J NUTR BIOCHEM, V6, P504, DOI 10.1016/0955-2863(95)00082-B; Hu XY, 2004, CELL RES, V14, P234, DOI 10.1038/sj.cr.7290224; KERRIGAN RW, 1995, CAN J BOT, V73, pS973, DOI 10.1139/b95-347; Larkindale J, 2002, PLANT PHYSIOL, V128, P682, DOI 10.1104/pp.010320; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Lu ZL, 2011, AM J BOT, V98, pE239, DOI 10.3732/ajb.1100067; Neilson KA, 2010, PROTEOMICS, V10, P828, DOI 10.1002/pmic.200900538; Ospina-Giraldo MD, 2000, FUNGAL GENET BIOL, V29, P81, DOI 10.1006/fgbi.2000.1189; Owttrim GW, 2006, NUCLEIC ACIDS RES, V34, P3220, DOI 10.1093/nar/gkl408; Quinlivan EP, 2003, J BIOL CHEM, V278, P20731, DOI 10.1074/jbc.M302894200; Romaine C. Peter, 2006, V344, P453; RUSSO VM, 1993, ANTON LEEUW INT J G, V63, P23, DOI 10.1007/BF00871727; Scott J, 2000, J SCI FOOD AGR, V80, P795, DOI [10.1002/(SICI)1097-0010(20000515)80:7&lt;795::AID-JSFA599&gt;3.0.CO;2-K, 10.1002/(SICI)1097-0010(20000515)80:7<795::AID-JSFA599>3.0.CO;2-K]; Senaratna T, 2000, PLANT GROWTH REGUL, V30, P157, DOI 10.1023/A:1006386800974; Suzuki N, 2006, PHYSIOL PLANTARUM, V126, P45, DOI 10.1111/j.0031-9317.2005.00582.x; Tang L, 2006, PLANT CELL REP, V25, P1380, DOI 10.1007/s00299-006-0199-1; Weinstein SJ, 2003, CANCER EPIDEM BIOMAR, V12, P1271; Xiong LM, 1999, PLANT PHYSIOL, V119, P205, DOI 10.1104/pp.119.1.205; Xu CP, 2008, J EXP BOT, V59, P4183, DOI 10.1093/jxb/ern258; YAMAGUCHISHINOZAKI K, 1994, PLANT CELL, V6, P251, DOI 10.1105/tpc.6.2.251; Zhang SQ, 1997, PLANT CELL, V9, P809, DOI 10.1105/tpc.9.5.809	40	26	31	4	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91298	10.1371/journal.pone.0091298	http://dx.doi.org/10.1371/journal.pone.0091298			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614118	Green Submitted, Green Published, gold			2022-12-27	WOS:000332839300107
J	Rodriguez-Martinez, S; Carrete, M; Roques, S; Rebolo-Ifran, N; Tella, JL				Rodriguez-Martinez, Sol; Carrete, Martina; Roques, Severine; Rebolo-Ifran, Natalia; Tella, Jose L.			High Urban Breeding Densities Do Not Disrupt Genetic Monogamy in a Bird Species	PLOS ONE			English	Article							EXTRA-PAIR PATERNITY; INTRASPECIFIC BROOD PARASITISM; BURROWING OWLS; NATAL DISPERSAL; INDIVIDUAL CONSISTENCY; COMPUTER-PROGRAM; SEXUAL SELECTION; NEST PARASITISM; FERTILIZATION; BIODIVERSITY	Urbanization causes widespread endangerment of biodiversity worldwide. However, some species successfully colonize cities reaching higher densities than in their rural habitats. In these cases, although urban city dwellers may apparently be taking advantage of these new environments, they also face new ecological conditions that may induce behavioural changes. For example, the frequency of alternative reproductive behaviours such as extra-pair paternity and intraspecific brood parasitism might increase with breeding densities. Here, using a panel of 17 microsatellites, we tested whether increments in breeding densities such as those associated with urban invasion processes alter genetic monogamy in the burrowing owl Athene cunicularia. Our results show low rates of extra-pair paternity (1.47%), but relatively high levels of intraspecific brood parasitism (8.82%). However, we were not able to detect differences in the frequency at which either alternative reproductive behaviour occurs along a strong breeding density gradient. Further research is needed to properly ascertain the role of other social and ecological factors in the frequency at which this species presents alternative reproductive strategies. Meanwhile, our results suggest that genetic monogamy is maintained despite the increment in conspecific density associated with a recent urban invasion process.	[Rodriguez-Martinez, Sol] Univ Nacl Sur, Dept Biol Biochem & Pharm, RA-8000 Bahia Blanca, Buenos Aires, Argentina; [Rodriguez-Martinez, Sol; Carrete, Martina; Roques, Severine; Tella, Jose L.] CSIC, Estn Biol Donana, Dept Conservat Biol, E-41080 Seville, Spain; [Carrete, Martina] Univ Pablo de Olavide, Dept Phys Chem & Nat Syst, Seville, Spain; [Rebolo-Ifran, Natalia] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Ecol Genet & Evolut, IEGEBA CONICET, Buenos Aires, DF, Argentina	National University of the South; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Universidad Pablo de Olavide; University of Buenos Aires	Rodriguez-Martinez, S (corresponding author), Univ Nacl Sur, Dept Biol Biochem & Pharm, RA-8000 Bahia Blanca, Buenos Aires, Argentina.	solrodriguez@criba.edu.ar	Rebolo-Ifrán, Natalia/K-1329-2014; Carrete, Martina/A-6376-2009; Tella, José L/I-3707-2015; Carrete, Martina/D-2618-2017	Carrete, Martina/0000-0002-0491-2950; Tella, José L/0000-0002-3038-7424; Rodriguez-Martinez, Sol/0000-0002-7537-6753; Roques, Severine/0000-0002-9029-7789	Canal Sur TV; Fundacion Repsol; MEC (Spain) [CGL2012-31888]; CONICET (Argentina); Ramon y Cajal contract [RYC-2009-04860]	Canal Sur TV; Fundacion Repsol; MEC (Spain)(Spanish Government); CONICET (Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Ramon y Cajal contract(Spanish Government)	Funding was provided by Canal Sur TV, Fundacion Repsol and Project CGL2012-31888 from MEC (Spain). N.R. and S. R. M. are supported by CONICET (Argentina) and M. C. by a Ramon y Cajal contract (RYC-2009-04860). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson M, 2001, AM NAT, V158, P599, DOI 10.1086/324113; Aparicio JM, 2006, MOL ECOL, V15, P4659, DOI 10.1111/j.1365-294X.2006.03111.x; Arsenault DP, 2002, CONDOR, V104, P197, DOI 10.1650/0010-5422(2002)104[0197:NEPFIF]2.0.CO;2; Belkhir K, 1996, 5000 CNRS UMR LAB GE; BELTHOFF JR, 1989, CONDOR, V91, P254, DOI 10.2307/1368302; Birkhead TR, 1992, SPERM COMPETITION BI; Bolger Douglas T., 2001, P155; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Cardador L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033375; Carrete M, 2013, SCI REP-UK, V3, DOI 10.1038/srep03524; Carrete M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018859; Carrete M, 2010, BIOL LETTERS, V6, P167, DOI 10.1098/rsbl.2009.0739; Chace JF, 2006, LANDSCAPE URBAN PLAN, V74, P46, DOI 10.1016/j.landurbplan.2004.08.007; Clayton KM, 1999, BIRD CONSERV INT, V9, P163, DOI 10.1017/S0959270900002288; Faeth SH, 2005, BIOSCIENCE, V55, P399, DOI 10.1641/0006-3568(2005)055[0399:TDIUC]2.0.CO;2; Faircloth BC, 2010, CONSERV GENET RESOUR, V2, P167, DOI 10.1007/s12686-010-9214-5; GOWATY PA, 1989, ANIM BEHAV, V38, P272, DOI 10.1016/S0003-3472(89)80089-2; Griffith SC, 2002, MOL ECOL, V11, P2195, DOI 10.1046/j.1365-294X.2002.01613.x; Griffith SC, 2000, BEHAV ECOL, V11, P265, DOI 10.1093/beheco/11.3.265; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Han JI, 2009, AUK, V126, P779, DOI 10.1525/auk.2009.08203; Hsu YC, 2006, J AVIAN BIOL, V37, P36, DOI 10.1111/j.2006.0908-8857.03687.x; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Martinez JJ, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-68; Kahn NW, 1998, AUK, V115, P1074; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Korfanta NM, 2002, MOL ECOL NOTES, V2, P584, DOI 10.1046/j.1471-8286.2002.00326.x; Korpimaki E, 1996, ANIM BEHAV, V51, P945, DOI 10.1006/anbe.1996.0098; KORPIMAKI E, 1988, J ANIM ECOL, V57, P433, DOI 10.2307/4915; Lack D., 1968, pvii; Lahaye WS, 2001, CONDOR, V103, P691, DOI 10.1650/0010-5422(2001)103[0691:NDOTSO]2.0.CO;2; LANK DB, 1990, EVOLUTION, V44, P1436, DOI 10.1111/j.1558-5646.1990.tb03837.x; Lawless SG, 1997, CONDOR, V99, P213, DOI 10.2307/1370242; Lyon BE, 2008, ANNU REV ECOL EVOL S, V39, P343, DOI 10.1146/annurev.ecolsys.39.110707.173354; Machicote M, 2004, OIKOS, V106, P527, DOI 10.1111/j.0030-1299.2004.13139.x; Macias-Duarte A, 2010, CONSERV GENET RESOUR, V2, P67, DOI 10.1007/s12686-009-9150-4; Marks JS, 1999, CONDOR, V101, P854, DOI 10.2307/1370075; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; Marzluff J. M., 2001, AVIAN CONSERV ECOL, P1, DOI DOI 10.1007/978-1-4615-1531-9; Mayer C, 2013, ECOL EVOL, V3, P694, DOI 10.1002/ece3.489; Mcdonald RI, 2008, BIOL CONSERV, V141, P1695, DOI 10.1016/j.biocon.2008.04.025; McKinney ML, 2002, BIOSCIENCE, V52, P883, DOI 10.1641/0006-3568(2002)052[0883:UBAC]2.0.CO;2; Moller AP, 2009, OECOLOGIA, V159, P849, DOI 10.1007/s00442-008-1259-8; Moller AP, 1998, BEHAV ECOL SOCIOBIOL, V43, P345, DOI 10.1007/s002650050501; Moore JA, 2012, IBIS, V154, P354, DOI 10.1111/j.1474-919X.2011.01203.x; MULDER RA, 1994, P ROY SOC B-BIOL SCI, V255, P223, DOI 10.1098/rspb.1994.0032; Muller W, 2001, J ORNITHOL, V142, P195, DOI 10.1007/BF01651787; Negro JJ, 1996, ANIM BEHAV, V51, P935, DOI 10.1006/anbe.1996.0097; PETRIE M, 1991, TRENDS ECOL EVOL, V6, P315, DOI 10.1016/0169-5347(91)90038-Y; Richardson DS, 2001, ANIM BEHAV, V62, P519, DOI 10.1006/anbe.2001.1778; Rodewald AD, 2008, ECOLOGY, V89, P515, DOI 10.1890/07-0358.1; Rodewald AD, 2008, J ANIM ECOL, V77, P83, DOI 10.1111/j.1365-2656.2007.01313.x; Rodewald AD, 2011, ECOLOGY, V92, P1781, DOI 10.1890/11-0022.1; Rodewald AD, 2011, ECOL APPL, V21, P936, DOI 10.1890/10-0863.1; Roulin A, 2004, J AVIAN BIOL, V35, P492, DOI 10.1111/j.0908-8857.2004.03294.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Ryder TB, 2012, ECOL EVOL, V2, P976, DOI 10.1002/ece3.254; Saladin V, 2007, J ORNITHOL, V148, P113, DOI 10.1007/s10336-006-0109-x; Serrano D, 2008, BASIC APPL ECOL, V9, P771, DOI 10.1016/j.baae.2007.08.013; Sih A, 2011, EVOL APPL, V4, P367, DOI 10.1111/j.1752-4571.2010.00166.x; STUTCHBURY BJ, 1995, BEHAVIOUR, V132, P675, DOI 10.1163/156853995X00081; Thusius KJ, 2001, BEHAV ECOL, V12, P633, DOI 10.1093/beheco/12.5.633; Tuomainen U, 2011, BIOL REV, V86, P640, DOI 10.1111/j.1469-185X.2010.00164.x; Valiere N, 2002, MOL ECOL NOTES, V2, P377, DOI 10.1046/j.1471-8286.2002.00228.x; Waits LP, 2001, MOL ECOL, V10, P249, DOI 10.1046/j.1365-294X.2001.01185.x; Waldeck P, 2004, BEHAVIOUR, V141, P725, DOI 10.1163/1568539042245132; Westneat D.F., 1990, Current Ornithology, V7, P331; Westneat DF, 2003, ANNU REV ECOL EVOL S, V34, P365, DOI 10.1146/annurev.ecolsys.34.011802.132439; Westneat DF, 1997, BEHAV ECOL SOCIOBIOL, V41, P205, DOI 10.1007/s002650050381; WREGE PH, 1987, BEHAV ECOL SOCIOBIOL, V20, P153, DOI 10.1007/BF00299728; Yom-Tov Y, 2001, IBIS, V143, P133, DOI 10.1111/j.1474-919X.2001.tb04177.x	71	20	20	0	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91314	10.1371/journal.pone.0091314	http://dx.doi.org/10.1371/journal.pone.0091314			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614308	Green Submitted, Green Published, gold			2022-12-27	WOS:000332839300112
J	Forkpah, C; Dixon, LR; Fahrbach, SE; Rueppell, O				Forkpah, Cordelia; Dixon, Luke R.; Fahrbach, Susan E.; Rueppell, Olav			Xenobiotic Effects on Intestinal Stem Cell Proliferation in Adult Honey Bee (Apis mellifera L) Workers	PLOS ONE			English	Article							COLONY COLLAPSE DISORDER; PESTICIDE-RESIDUES; HYMENOPTERA; EXPOSURE; MIDGUT; TOXICITY; MICROSPORIDIA; SENSITIVITY; MICROFLORA; ACARICIDES	The causes of the current global decline in honey bee health are unknown. One major group of hypotheses invokes the pesticides and other xenobiotics to which this important pollinator species is often exposed. Most studies have focused on mortality or behavioral deficiencies in exposed honey bees while neglecting other biological functions and target organs. The midgut epithelium of honey bees presents an important interface between the insect and its environment. It is maintained by proliferation of intestinal stem cells throughout the adult life of honey bees. We used caged honey bees to test multiple xenobiotics for effects on the replicative activity of the intestinal stem cells under laboratory conditions. Most of the tested compounds did not alter the replicative activity of intestinal stem cells. However, colchicine, methoxyfenozide, tetracycline, and a combination of coumaphos and tau-fluvalinate significantly affected proliferation rate. All substances except methoxyfenozide decreased proliferation rate. Thus, the results indicate that some xenobiotics frequently used in apiculture and known to accumulate in honey bee hives may have hitherto unknown physiological effects. The nutritional status and the susceptibility to pathogens of honey bees could be compromised by the impacts of xenobiotics on the maintenance of the midgut epithelium. This study contributes to a growing body of evidence that more comprehensive testing of xenobiotics may be required before novel or existing compounds can be considered safe for honey bees and other non-target species.	[Forkpah, Cordelia; Dixon, Luke R.; Rueppell, Olav] Univ N Carolina, Dept Biol, Greensboro, NC 27412 USA; [Fahrbach, Susan E.] Wake Forest Univ, Dept Biol, Winston Salem, NC 27109 USA	University of North Carolina; University of North Carolina Greensboro; Wake Forest University	Rueppell, O (corresponding author), Univ N Carolina, Dept Biol, Greensboro, NC 27412 USA.	olav_rueppell@uncg.edu	Rueppell, Olav/G-2679-2010	Rueppell, Olav/0000-0001-5370-4229	North Carolina Biotechnology Center; USDA National Institute of Food and Agriculture [2010-65104-20533]; Division Of Integrative Organismal Systems [1256878] Funding Source: National Science Foundation	North Carolina Biotechnology Center; USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This project was supported by the North Carolina Biotechnology Center and the Agriculture and Food Research Initiative Competitive Grant no. 2010-65104-20533 from the USDA National Institute of Food and Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaux C, 2010, BIOL LETTERS, V6, P562, DOI 10.1098/rsbl.2009.0986; Bendahou N, 1999, ECOTOX ENVIRON SAFE, V44, P147, DOI 10.1006/eesa.1999.1812; Berry JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076536; Blacquiere T, 2012, ECOTOXICOLOGY, V21, P973, DOI 10.1007/s10646-012-0863-x; Boncristiani H, 2012, J INSECT PHYSIOL, V58, P613, DOI 10.1016/j.jinsphys.2011.12.011; Bryden J, 2013, ECOL LETT, V16, P1463, DOI 10.1111/ele.12188; Buchon N, 2009, GENE DEV, V23, P2333, DOI 10.1101/gad.1827009; Calderone, 2000, BEE CULT, V128, P1, DOI DOI 10.3896/IBRA.1.49.1.01; Carlson GR, 2001, PEST MANAG SCI, V57, P115, DOI 10.1002/1526-4998(200102)57:2<115::AID-PS245>3.0.CO;2-A; Chauzat MP, 2006, J ECON ENTOMOL, V99, P253, DOI 10.1603/0022-0493-99.2.253; Chopra I, 2001, MICROBIOL MOL BIOL R, V65, P232, DOI 10.1128/MMBR.65.2.232-260.2001; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Decourtye A, 2013, NATURE, V497, P188, DOI 10.1038/497188a; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Ellis JD, 2010, J APICULT RES, V49, P134, DOI 10.3896/IBRA.1.49.1.30; Fernandes KM, 2010, SOCIOBIOLOGY, V56, P489; FEYEREISEN R, 1976, GEN COMP ENDOCR, V29, P319, DOI 10.1016/0016-6480(76)90044-7; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Genersch E, 2010, APIDOLOGIE, V41, P332, DOI 10.1051/apido/2010014; Gill RJ, 2012, NATURE, V491, P105, DOI 10.1038/nature11585; Gilliam M, 1997, FEMS MICROBIOL LETT, V155, P1; Gregorc A, 2011, PESTIC BIOCHEM PHYS, V99, P200, DOI 10.1016/j.pestbp.2010.12.005; Hakim RS, 2010, ANNU REV ENTOMOL, V55, P593, DOI 10.1146/annurev-ento-112408-085450; Han P, 2012, ECOTOXICOLOGY, V21, P2214, DOI 10.1007/s10646-012-0976-2; Hawthorne DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026796; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; Heylen K, 2011, APIDOLOGIE, V42, P103, DOI 10.1051/apido/2010043; Higes M, 2013, ENV MICROBIOL REP, V5, P17, DOI 10.1111/1758-2229.12024; James RR, 2012, J INVERTEBR PATHOL, V109, P175, DOI 10.1016/j.jip.2011.12.005; Johnson RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054092; Johnson RM, 2010, APIDOLOGIE, V41, P312, DOI 10.1051/apido/2010018; Johnson RM, 2009, P NATL ACAD SCI USA, V106, P14790, DOI 10.1073/pnas.0906970106; Johnson RM, 2009, J ECON ENTOMOL, V102, P474, DOI 10.1603/029.102.0202; Kakmand F. A., 2008, J DOHUK U, V11, P144; Krupke CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029268; Mao WF, 2011, P NATL ACAD SCI USA, V108, P12657, DOI 10.1073/pnas.1109535108; Martel AC, 2006, FOOD ADDIT CONTAM A, V23, P265, DOI 10.1080/02652030500469048; Martinson VG, 2012, APPL ENVIRON MICROB, V78, P2830, DOI 10.1128/AEM.07810-11; Mattila HR, 2006, J ECON ENTOMOL, V99, P604, DOI 10.1603/0022-0493-99.3.604; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Nazzi F, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002735; Neumann P, 2010, J APICULT RES, V49, P1, DOI 10.3896/IBRA.1.49.1.01; Ninov N, 2009, PLOS BIOL, V7, P892, DOI 10.1371/journal.pbio.1000079; Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333; Palmer MJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2648; Pettis JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070182; Pettis JS, 2012, NATURWISSENSCHAFTEN, V99, P153, DOI 10.1007/s00114-011-0881-1; Rada V, 1997, APIDOLOGIE, V28, P357, DOI 10.1051/apido:19970603; Rharrabe K, 2009, PESTIC BIOCHEM PHYS, V93, P112, DOI 10.1016/j.pestbp.2008.12.002; Rinderer TE, 2012, J APICULT RES, V51, P218, DOI 10.3896/IBRA.1.51.2.13; Smagghe G, 2005, ANN NY ACAD SCI, V1040, P472, DOI 10.1196/annals.1327.094; SMIRLE MJ, 1984, J ECON ENTOMOL, V77, P63, DOI 10.1093/jee/77.1.63; Snodgrass R.E., 1956, ANATOMY HONEY BEE; Sullivan JT, 2005, J INVERTEBR PATHOL, V90, P32, DOI 10.1016/j.jip.2005.04.005; Thompson HM, 2005, FOOD ADDIT CONTAM, V22, P573, DOI 10.1080/02652030500089986; Vachon V, 2012, J INVERTEBR PATHOL, V111, P1, DOI 10.1016/j.jip.2012.05.001; vanEngelsdorp D, 2010, J ECON ENTOMOL, V103, P1517, DOI 10.1603/EC09429; vanEngelsdorp D, 2010, J INVERTEBR PATHOL, V103, pS80, DOI 10.1016/j.jip.2009.06.011; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; WAHL O, 1983, OECOLOGIA, V59, P106, DOI 10.1007/BF00388082; Ward KN, 2008, EXP GERONTOL, V43, P530, DOI 10.1016/j.exger.2008.03.012; Willard LE, 2011, APIDOLOGIE, V42, P508, DOI 10.1007/s13592-011-0006-z; Williams GR, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.1.04; Williamson SM, 2013, J EXP BIOL, V216, P1799, DOI 10.1242/jeb.083931; Wu JY, 2012, J INVERTEBR PATHOL, V109, P326, DOI 10.1016/j.jip.2012.01.005; Wu JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014720; Yang EC, 2008, J ECON ENTOMOL, V101, P1743, DOI 10.1603/0022-0493-101.6.1743; Yang EC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049472	68	21	22	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91180	10.1371/journal.pone.0091180	http://dx.doi.org/10.1371/journal.pone.0091180			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608542	Green Submitted, Green Published, gold			2022-12-27	WOS:000332485800111
J	Brogan, AJ; Talbird, SE; Thompson, JR; Miller, JD; Rubin, J; Deniz, B				Brogan, Anita J.; Talbird, Sandra E.; Thompson, James R.; Miller, Jeffrey D.; Rubin, Jaime; Deniz, Baris			Cost-effectiveness of Telaprevir Combination Therapy for Chronic Hepatitis C	PLOS ONE			English	Article							SUSTAINED VIROLOGICAL RESPONSE; ALPHA-2B PLUS RIBAVIRIN; UNITED-STATES; INITIAL TREATMENT; VIRUS-INFECTION; LIVER FIBROSIS; FOLLOW-UP; INTERFERON-ALPHA-2B; PEGINTERFERON; DISEASE	Objective: To explore the expected long-term health and economic outcomes of telaprevir (TVR) plus peginterferon alfa-2a and ribavirin (PR), a regimen that demonstrated substantially increased sustained virologic response (SVR) compared with PR alone in adults with chronic genotype 1 hepatitis C virus (HCV) and compensated liver disease in the Phase III studies ADVANCE (treatment-naive patients) and REALIZE (relapsers, partial responders, and null responders to previous PR treatment). Study Design: A decision-analytic model was developed to assess the cost-effectiveness of TVR+PR vs. PR in the United States (US). Methods: Patients first moved through the 72-week decision-tree treatment phase of the model and then entered the cyclic Markov post-treatment phase. Clinical data (patient characteristics, SVR rates, and adverse event rates and durations) were obtained from ADVANCE and REALIZE. Health-state transition probabilities, drug and other costs (in 2012/2013 US dollars), and utility values were obtained from the trials, published studies, and publicly available sources. Outcomes were discounted at 3% per year. Results: Regardless of treatment history, patients receiving TVR+PR were projected to experience fewer liver-disease complications, more life-years, and more quality-adjusted life-years (QALYs) than patients receiving PR. In prior relapsers, TVR+PR was dominant, with lower total medical costs and more QALYs. For the other patient subgroups, incremental costs per QALY gained were between $16,778 (treatment-naive patients) and $34,279 (prior null responders). Extensive sensitivity analyses confirmed robust model results. Conclusions: At standard willingness-to-pay thresholds, TVR+PR represents a cost-effective treatment option compared with PR alone for patients with chronic genotype 1 HCV and compensated liver disease in the US. Future analyses are needed to compare TVR+PR with all existing HCV treatment options.	[Brogan, Anita J.; Talbird, Sandra E.; Thompson, James R.] RTI Hlth Solut, Res Triangle Pk, NC 27709 USA; [Miller, Jeffrey D.] RTI Hlth Solut, Waltham, MA USA; [Rubin, Jaime; Deniz, Baris] Vertex Pharmaceut Inc, Cambridge, MA USA	Research Triangle Institute; Research Triangle Institute; Vertex Pharmaceuticals	Brogan, AJ (corresponding author), RTI Hlth Solut, Res Triangle Pk, NC 27709 USA.	abrogan@rti.org		Talbird, Sandra/0000-0003-4719-3703; Brogan, Anita/0000-0002-9003-994X	Vertex Pharmaceuticals Incorporated	Vertex Pharmaceuticals Incorporated(Vertex Pharmaceuticals)	Funding for this study was provided to RTI Health Solutions by Vertex Pharmaceuticals Incorporated. Baris Deniz and Jaime Rubin are current or former employees of Vertex Pharmaceuticals Incorporated and provided ideas and support for the study design, data collection, and manuscript development. Anita Brogan, Sandra Talbird, James Thompson, and Jeffrey Miller are current or former employees of RTI Health Solutions, an independent research organization, and maintained independent scientific control over the study, including final study design, data collection and analysis, interpretation of results, and preparation of the manuscript. All authors jointly decided to publish the manuscript.	[Anonymous], 2011, HEP C; Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Bennett WG, 1997, ANN INTERN MED, V127, P855, DOI 10.7326/0003-4819-127-10-199711150-00001; Braithwaite RS, 2008, MED CARE, V46, P349, DOI 10.1097/MLR.0b013e31815c31a7; Brogan AJ, 2012, PODIUM PRESENTATION; Brogan A, 2010, PHARMACOECONOMICS, V28, P129, DOI 10.2165/11587490-000000000-00000; Bruno S, 2007, HEPATOLOGY, V45, P579, DOI 10.1002/hep.21492; But DYK, 2008, WORLD J GASTROENTERO, V14, P1652, DOI 10.3748/wjg.14.1652; Camma C, 2004, HEPATOLOGY, V39, P333, DOI 10.1002/hep.20073; Camma C, 2009, J HEPATOL, V51, P675, DOI 10.1016/j.jhep.2009.06.018; Centers for Disease Control and Prevention, 2011, HEP C INF HLTH PROF; Centers for Medicare and Medicaid Services, 2012, MED MED CLIN LAB FEE; Centers for Medicare and Medicaid Services, 2012, MED MED PHYS SCHED 2; Darbinian JA, 2010, 61 ANN M AM ASS STUD; Davis GL, 2010, GASTROENTEROLOGY, V138, P513, DOI 10.1053/j.gastro.2009.09.067; Davis KL, 2011, J CLIN GASTROENTEROL, V45, pE17, DOI 10.1097/MCG.0b013e3181e12c09; Druyts Eric, 2013, Clin Epidemiol, V5, P173, DOI 10.2147/CLEP.S44273; Fattovich G, 1997, GASTROENTEROLOGY, V112, P463, DOI 10.1053/gast.1997.v112.pm9024300; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Gold MR, 1996, COST EFFECTIVENESS H; Grieve R, 2006, GUT, V55, P1332, DOI 10.1136/gut.2005.064774; Hornberger J, 2006, J CLIN VIROL, V36, P283, DOI 10.1016/j.jcv.2006.04.008; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Liu S, 2012, ANN INTERN MED, V156, P279, DOI 10.7326/0003-4819-156-4-201202210-00005; Liu S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026783; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; McAdam-Marx C, 2011, J MANAGE CARE PHARM, V17, P531, DOI 10.18553/jmcp.2011.17.7.531; McHutchison JG, 2005, AM J MANAG CARE, V11, pS286; Minino A.M., 2011, NATL VITAL STAT REPO, V59; Nainan OV, 2006, GASTROENTEROLOGY, V131, P478, DOI 10.1053/j.gastro.2006.06.007; National Cancer Institute (NCI), 2009, FAST STATS INT TOOL; Poynard T, 2000, HEPATOLOGY, V32, P1131, DOI 10.1053/jhep.2000.19347; Poynard T, 2002, GASTROENTEROLOGY, V122, P1303, DOI 10.1053/gast.2002.33023; Saab S, 2010, LIVER TRANSPLANT, V16, P748, DOI 10.1002/lt.22072; Salomon JA, 2003, JAMA-J AM MED ASSOC, V290, P228, DOI 10.1001/jama.290.2.228; Sax PE, 2005, JAIDS-J ACQ IMM DEF, V39, P69, DOI 10.1097/01.qai.0000160406.08924.a2; Sherman KE, 2011, HEPATOLOGY, V54, p485A; Spackman DE, 2008, PHARMACOECONOMICS, V26, P937, DOI 10.2165/00019053-200826110-00006; Sullivan SD, 2004, AM J GASTROENTEROL, V99, P1490, DOI 10.1111/j.1572-0241.2004.30286.x; Thein HH, 2009, J VIRAL HEPATITIS, V16, P802, DOI 10.1111/j.1365-2893.2009.01136.x; Thein HH, 2005, AM J GASTROENTEROL, V100, P643, DOI 10.1111/j.1572-0241.2005.40976.x; Thein HH, 2008, HEPATOLOGY, V48, P418, DOI 10.1002/hep.22375; Thuluvath PJ, 2010, AM J TRANSPLANT, V10, P1003, DOI 10.1111/j.1600-6143.2010.03037.x; Townsend R, 2011, VALUE HEALTH, V14, P1068, DOI 10.1016/j.jval.2011.06.006; US Bureau of Labor Statistics (BLS), 2012, CONS PRIC IND ALL UR; US Department of Veterans Affairs (USDVA), 2010, NAT HEP C PROGR OFF; Veldt BJ, 2007, ANN INTERN MED, V147, P677, DOI 10.7326/0003-4819-147-10-200711200-00003; Vertex Pharmaceuticals Incorporated, 2012, INCIVEK TEL FILM COA; Weinstein MC, 2003, VALUE HEALTH, V6, P9, DOI 10.1046/j.1524-4733.2003.00234.x; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Wong JB, 2000, AM J PUBLIC HEALTH, V90, P1562, DOI 10.2105/AJPH.90.10.1562; Wong JB, 2003, AM J GASTROENTEROL, V98, P2354, DOI 10.1111/j.1572-0241.2003.t01-1-08735.x; Wright K, 2003, SIDE EFFECT MANAGEME, P6; Younossi Z, 2012, J HEPATOL, V56, pS462, DOI 10.1016/S0168-8278(12)61181-7; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086	57	16	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90295	10.1371/journal.pone.0090295	http://dx.doi.org/10.1371/journal.pone.0090295			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603445	Green Published, Green Submitted, gold			2022-12-27	WOS:000332483600041
J	Noble, AJ; McCrone, P; Seed, PT; Goldstein, LH; Ridsdale, L				Noble, Adam J.; McCrone, Paul; Seed, Paul T.; Goldstein, Laura H.; Ridsdale, Leone			Clinical- and Cost-Effectiveness of a Nurse Led Self-Management Intervention to Reduce Emergency Visits by People with Epilepsy	PLOS ONE			English	Article							QUALITY-OF-LIFE; CARE; QUESTIONNAIRE; DEPARTMENTS; POPULATION; DEPRESSION; KNOWLEDGE; SERVICES; ANXIETY; EUROPE	People with chronic epilepsy (PWE) often make costly, and clinically unnecessary emergency department (ED) visits. Some do it frequently. No studies have examined interventions to reduce them. An intervention delivered by an epilepsy nurse specialist (ENS) might reduce visits. The rationale is it may optimize patients' self-management skills and knowledge of appropriate ED use. We examined such an intervention's clinical-and cost-effectiveness. Eighty-five adults with epilepsy were recruited from three London EDs with similar catchment populations. Forty-one PWE recruited from two EDs received treatment-as-usual (TAU) and formed the comparison group. The remaining 44 PWE were recruited from the ED of a hospital that had implemented a new ENS service for PWE attending ED. These participants formed the intervention group. They were offered 2 one-to-one sessions with an ENS, plus TAU. Participants completed questionnaires on health service use and psychosocial well-being at baseline, 6- and 12-month follow-up. Covariates were identified and adjustments made. Sixty-nine (81%) participants were retained at follow-up. No significant effect of the intervention on ED visits at 12 months or on other outcomes was found. However, due to less time as inpatients, the average service cost for intervention participants over follow-up was less than for TAU participants' (adjusted difference 558 pound, 95% CI, -2409 pound, 648) pound. Covariates most predictive of subsequent ED visits were patients' baseline feelings of stigmatization due to epilepsy and low confidence in managing epilepsy. The intervention did not lead to a reduction in ED use, but did not cost more, partly because those receiving the intervention had shorter hospital admissions. Our findings on long-term ED predictors clarifies what causes ED use, and suggests that future interventions might focus more on patients' perceptions of stigma and on their confidence in managing epilepsy. If addressed, ED visits might be reduced and efficiency-savings generated.	[Noble, Adam J.] Univ Liverpool, Inst Psychol Hlth & Soc, Dept Psychol Sci, Liverpool L69 3BX, Merseyside, England; [Noble, Adam J.; Ridsdale, Leone] Kings Coll London, Inst Psychiat, Dept Clin Neurosci, London WC2R 2LS, England; [McCrone, Paul] Kings Coll London, Inst Psychiat, London WC2R 2LS, England; [Seed, Paul T.] Kings Coll London, Div Womens Hlth, London WC2R 2LS, England; [Goldstein, Laura H.] Kings Coll London, Inst Psychiat, Dept Psychol, London WC2R 2LS, England	University of Liverpool; University of London; King's College London; University of London; King's College London; University of London; King's College London; University of London; King's College London	Noble, AJ (corresponding author), Univ Liverpool, Inst Psychol Hlth & Soc, Dept Psychol Sci, Liverpool L69 3BX, Merseyside, England.	adam.noble@liv.ac.uk	; Seed, Paul T/C-4435-2008; Goldstein, Laura/E-7817-2010	McCrone, Paul/0000-0001-7001-4502; Seed, Paul T/0000-0001-7904-7933; Noble, Adam/0000-0002-8070-4352; Goldstein, Laura/0000-0001-9387-3035; Ridsdale, Leone/0000-0002-2234-2859	National Institute for Health Research (NIHR) Health Services and Delivery Research (HSR) programme [08/1808/247]; NIHR Dementia Biomedical Research Unit at South London and Maudsley NHS Foundation Trust; NIHR Dementia Biomedical Research Unit at King's College London; National Institute for Health Research [08/1815/234] Funding Source: researchfish	National Institute for Health Research (NIHR) Health Services and Delivery Research (HSR) programme(National Institute for Health Research (NIHR)); NIHR Dementia Biomedical Research Unit at South London and Maudsley NHS Foundation Trust; NIHR Dementia Biomedical Research Unit at King's College London; National Institute for Health Research(National Institute for Health Research (NIHR))	The project was supported by funding from the National Institute for Health Research (NIHR) Health Services and Delivery Research (HS&R) programme (08/1808/247) and the NIHR Dementia Biomedical Research Unit at South London and Maudsley NHS Foundation Trust and King's College London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views and opinions expressed are those of the authors and do not necessarily reflect those of the HS&DR programme, NIHR, NHS or the Department of Health.	Amiel S, 2002, BRIT MED J, V325, P746, DOI 10.1136/bmj.325.7367.746; Babyak MA, 2004, PSYCHOSOM MED, V66, P411, DOI 10.1097/01.psy.0000127692.23278.a9; BAKER GA, 1993, EPILEPSY RES, V16, P65, DOI 10.1016/0920-1211(93)90041-5; Baker GA, 1998, SEIZURE-EUR J EPILEP, V7, P201, DOI 10.1016/S1059-1311(98)80036-8; Bautista RED, 2008, EPILEPSY RES, V79, P120, DOI 10.1016/j.eplepsyres.2008.01.003; Beecham J, 1992, MEASURING MENTAL HLT, P163; Bradley P., 2009, COCHRANE DB SYST REV, V2008; Casado V, 2011, NEUROLOGIA, V26, P233, DOI 10.1016/j.nrl.2010.07.033; Cramer JA, 1996, EPILEPSIA, V37, P577, DOI 10.1111/j.1528-1157.1996.tb00612.x; Curtis L., 2010, UNIT COSTS HLTH SOCI; Department of Health, 2012, CAS STUD 2 EM ADM EP; Department of Health, 2010, NHS REF COSTS 2009 1; DiIorio C, 1996, NURS RES, V45, P211, DOI 10.1097/00006199-199607000-00004; Dolan P, 1995, SOCIAL TARIFF EUROQO; Elhai JD, 2008, PSYCHIAT RES, V160, P129, DOI 10.1016/j.psychres.2007.07.003; Faught E, 2008, NEUROLOGY, V71, P1572, DOI 10.1212/01.wnl.0000319693.10338.b9; Forsgren L, 2005, EUR J NEUROL, V12, P245, DOI 10.1111/j.1468-1331.2004.00992.x; Fraser RT, 2011, EPILEPSY BEHAV, V20, P291, DOI 10.1016/j.yebeh.2010.10.010; HART YM, 1995, EPILEPSY RES, V21, P51, DOI 10.1016/0920-1211(95)00008-X; Helde G, 2005, EPILEPSY BEHAV, V7, P451, DOI 10.1016/j.yebeh.2005.06.008; Ioannidis JPA, 2001, JAMA-J AM MED ASSOC, V286, P821, DOI 10.1001/jama.286.7.821; Jacoby A, 1998, EPILEPSIA, V39, P776, DOI 10.1111/j.1528-1157.1998.tb01164.x; JARVIE S, 1993, SEIZURE, V2, P179, DOI 10.1016/S1059-1311(05)80125-6; Kitson A, 2000, SERVICES PATIENTS EP; Mills N, 1999, SEIZURE-EUR J EPILEP, V8, P1; National Institute for Health and Care Excellence, 2012, MEAS EFF COST EFF QA; National Society for Epilepsy, 2012, DIAL 999; Ndiapi Njankouo, 2011, INT SCI C HARDWOOD P; NHS Right Care, 2010, NHS ATL VAR HEALTHC; Noble AJ, 2013, J NEUROL, V260, P1022, DOI 10.1007/s00415-012-6749-2; Noble AJ, 2012, EPILEPSIA, V53, P1820, DOI 10.1111/j.1528-1167.2012.03586.x; Olesen J, 2012, EUR J NEUROL, V19, P155, DOI 10.1111/j.1468-1331.2011.03590.x; Parmar MK, 1995, SURVIVAL ANAL PRACTI, P193; Pearson M, 2012, NATL AUDIT SEIZURE M; Public Health England, 2010, PROF LOC HLTH; Pugliatti M, 2007, EPILEPSIA, V48, P2224; Ramaratnam S, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002029.pub3; Ridsdale L, 2000, EPILEPSIA, V41, P1014, DOI 10.1111/j.1528-1157.2000.tb00287.x; Ridsdale L, 1999, BRIT J GEN PRACT, V49, P285; Ridsdale L, 1997, BRIT MED J, V314, P120, DOI 10.1136/bmj.314.7074.120; Ridsdale L, 2012, EPILEPSY BEHAV, V25, P529, DOI 10.1016/j.yebeh.2012.09.034; Royl G, 2010, NERVENARZT, V81, P1226, DOI 10.1007/s00115-010-3020-x; Tan JH, 2005, SEIZURE-EUR J EPILEP, V14, P464, DOI 10.1016/j.seizure.2005.07.010; Tapp S, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003000.pub2; Tatum WO, 2008, EPILEPSY RES, V82, P156, DOI 10.1016/j.eplepsyres.2008.07.017; Taylor J, 2011, EPILEPSY BEHAV, V21, P255, DOI 10.1016/j.yebeh.2011.04.002; Thapar A, 2009, EPILEPSY BEHAV, V14, P134, DOI 10.1016/j.yebeh.2008.09.004; The Health and Social Care Information Centre, 2010, DIS PREV QUAL O UTC; The Health and Social Care Information Centre, 2011, INP STAT 2010 11 PRI; WAGNER AK, 1995, QUAL LIFE RES, V4, P115, DOI 10.1007/BF01833606; Warren E, 1998, EVALUATION NURSE SPE; WILBY J, 2005, HLTH TECHNOLOGY ASSE, V9; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	54	28	29	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90789	10.1371/journal.pone.0090789	http://dx.doi.org/10.1371/journal.pone.0090789			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC4ID	24603669	Green Published, gold			2022-12-27	WOS:000332483600086
J	Tong, ZC; Huang, LJ; Ling, JQ; Mao, XL; Ning, Y; Deng, DM				Tong, Zhongchun; Huang, Lijia; Ling, Junqi; Mao, Xueli; Ning, Yang; Deng, Dongmei			Effects of Intracanal Irrigant MTAD Combined with Nisin at Sub-Minimum Inhibitory Concentration Levels on Enterococcus faecalis Growth and the Expression of Pathogenic Genes	PLOS ONE			English	Article							IN-VITRO EVALUATION; ANTIBIOTIC CONCENTRATIONS; ESCHERICHIA-COLI; LIPID-II; CIPROFLOXACIN; COMBINATION; RESISTANCE; DISEASE; HEALTH	Exposure to antibiotics is considered to be the major driver in the selection of antibiotic-resistant bacteria and may induce diverse biological responses in bacteria. MTAD is a common intracanal irrigant, but its bactericidal activity remains to be improved. Previous studies have indicated that the antimicrobial peptide nisin can significantly improve the bactericidal activity of MTAD against Enterococcus faecalis. However, the effects of MTAD and its modification at sub-minimum inhibitory concentration (sub-MIC) levels on Enterococcus faecalis growth and the expression of pathogenic genes still need to be explored. In this study, the results of post-antibiotic effects (PAE) and post-antibiotic sub-MIC effects (PASME) showed that MTADN (nisin in combination with MTAD) had the best post-antibiotic effect. E. faecalis after challenge with MTAD was less sensitive to alkaline solutions compared with MTAN (nisin in place of doxycycline in MTAD) and MTADN. E. faecalis induced with sub-MIC of MTAD generated resistance to the higher concentration, but induction of E. faecalis with MTAN did not cause resistance to higher concentrations. Furthermore, real-time polymerase chain reaction (RT-PCR) showed that the stress caused by sub-MIC exposure to MTAD, MTAN, or MTADN resulted in up-or down-regulation of nine stress genes and four virulence-associated genes in E. faecalis and resulted in different stress states. These findings suggested that nisin improved the post-antibacterial effect of MTAD at sub-MIC levels and has considerable potential for use as a modification of MTAD.	[Tong, Zhongchun; Huang, Lijia; Ling, Junqi; Mao, Xueli; Deng, Dongmei] Sun Yat Sen Univ, Dept Operat Dent & Endodont, Guanghua Sch Stomatol, Guangzhou 510275, Guangdong, Peoples R China; [Tong, Zhongchun; Ling, Junqi] Sun Yat Sen Univ, Guangdong Prov Key Lab Stomatol, Guangzhou 510275, Guangdong, Peoples R China; [Ning, Yang] Sun Yat Sen Univ, Guanghua Sch Stomatol, Dept Periodontol, Guangzhou 510275, Guangdong, Peoples R China; [Deng, Dongmei] Univ Amsterdam, Dept Cariol Endodontol Pedodontol, Acad Ctr Dent Amsterdam, Amsterdam, Netherlands; [Deng, Dongmei] Vrije Univ Amsterdam, Amsterdam, Netherlands	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Ling, JQ (corresponding author), Sun Yat Sen Univ, Dept Operat Dent & Endodont, Guanghua Sch Stomatol, Guangzhou 510275, Guangdong, Peoples R China.	Junqi_Ling@hotmail.com	Deng, Dongmei/V-9230-2017		Fundamental Research Funds for the Central Universities, China [12ykpy64]; Bairenjihua Research Fund by Sun Yat-Sen University [985[2012]245]	Fundamental Research Funds for the Central Universities, China(Fundamental Research Funds for the Central Universities); Bairenjihua Research Fund by Sun Yat-Sen University	This research is supported by the Fundamental Research Funds for the Central Universities, China (No 12ykpy64) and Bairenjihua Research Fund by Sun Yat-Sen University (No 985[2012]245). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbosa TM, 2000, DRUG RESIST UPDATE, V3, P303, DOI 10.1054/drup.2000.0167; Bernier SP, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00020; Breukink E, 2003, J BIOL CHEM, V278, P19898, DOI 10.1074/jbc.M301463200; Breukink E, 2006, NAT REV DRUG DISCOV, V5, P321, DOI 10.1038/nrd2004; Craig W, 1996, ANTIBIOTICS LAB MED, P296; Dong LP, 2012, INT J ANTIMICROB AG, V39, P390, DOI 10.1016/j.ijantimicag.2012.01.009; Harada K, 2012, ACTA VET SCAND, V54, DOI 10.1186/1751-0147-54-16; Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861; Hughes D, 2012, CURR OPIN MICROBIOL, V15, P555, DOI 10.1016/j.mib.2012.07.005; Kayaoglu G, 2004, CRIT REV ORAL BIOL M, V15, P308, DOI 10.1177/154411130401500506; Lenz CA, 2010, FOOD MICROBIOL, V27, P317, DOI 10.1016/j.fm.2009.11.008; Licata L, 1997, ANTIMICROB AGENTS CH, V41, P950, DOI 10.1128/AAC.41.5.950; Marshall BM, 2011, CLIN MICROBIOL REV, V24, P718, DOI 10.1128/CMR.00002-11; Mohammadi Z, 2012, Chonnam Med J, V48, P133, DOI 10.4068/cmj.2012.48.3.133; Mortensen NP, 2011, INT J ANTIMICROB AG, V38, P27, DOI 10.1016/j.ijantimicag.2011.03.011; MURRAY BE, 1990, CLIN MICROBIOL REV, V3, P46, DOI 10.1128/CMR.3.1.46-65.1990; Odenholt I, 2001, INT J ANTIMICROB AG, V17, P1, DOI 10.1016/S0924-8579(00)00243-0; ODENHOLTTORNQVIST I, 1991, ANTIMICROB AGENTS CH, V35, P1834, DOI 10.1128/AAC.35.9.1834; Pankuch GA, 2009, ANTIMICROB AGENTS CH, V53, P4537, DOI 10.1128/AAC.00785-09; Pinheiro ET, 2006, ORAL MICROBIOL IMMUN, V21, P137, DOI 10.1111/j.1399-302X.2006.00285.x; Reeks BY, 2005, CAN J VET RES, V69, P1; Severina E, 1998, J ANTIMICROB CHEMOTH, V41, P341, DOI 10.1093/jac/41.3.341; Singla MG, 2011, ORAL SURG ORAL MED O, V112, pE70, DOI 10.1016/j.tripleo.2011.02.015; Stuart CH, 2006, J ENDODONT, V32, P93, DOI 10.1016/j.joen.2005.10.049; Tong ZC, 2012, J ENDODONT, V38, P490, DOI 10.1016/j.joen.2011.11.015; Tong ZC, 2011, J ENDODONT, V37, P1116, DOI 10.1016/j.joen.2011.03.020; Torabinejad M, 2003, J ENDODONT, V29, P400, DOI 10.1097/00004770-200306000-00005	27	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90235	10.1371/journal.pone.0090235	http://dx.doi.org/10.1371/journal.pone.0090235			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603760	Green Published, Green Submitted, gold			2022-12-27	WOS:000332483600033
J	Vattay, G; Kauffman, S; Niiranen, S				Vattay, Gabor; Kauffman, Stuart; Niiranen, Samuli			Quantum Biology on the Edge of Quantum Chaos	PLOS ONE			English	Article							LYAPUNOV EXPONENTS; SPECTRA	We give a new explanation for why some biological systems can stay quantum coherent for a long time at room temperature, one of the fundamental puzzles of quantum biology. We show that systems with the right level of complexity between chaos and regularity can increase their coherence time by orders of magnitude. Systems near Critical Quantum Chaos or Metal-Insulator Transition (MIT) can have long coherence times and coherent transport at the same time. The new theory tested in a realistic light harvesting system model can reproduce the scaling of critical fluctuations reported in recent experiments. Scaling of return probability in the FMO light harvesting complex shows the signs of universal return probability decay observed at critical MIT. The results may open up new possibilities to design low loss energy and information transport systems in this Poised Realm hovering reversibly between quantum coherence and classicality.	[Vattay, Gabor] Eotvos Lorand Univ, Dept Phys Complex Syst, Budapest, Hungary; [Kauffman, Stuart] Univ Vermont, Vermont Complex Syst Ctr, Burlington, VT USA; [Niiranen, Samuli] Tampere Univ Technol, Dept Signal Proc, FIN-33101 Tampere, Finland	Eotvos Lorand University; University of Vermont; Tampere University	Vattay, G (corresponding author), Eotvos Lorand Univ, Dept Phys Complex Syst, Budapest, Hungary.	vattay@elte.hu	Vattay, Gabor/Q-4266-2019; Vattay, Gabor/G-9638-2017	Vattay, Gabor/0000-0002-0919-9429	Lockheed-Martin grant [026703]; Hungarian National Science Foundation [OTKA 77779]	Lockheed-Martin grant; Hungarian National Science Foundation	This work has been partially supported by Lockheed-Martin grant no. 026703 and Hungarian National Science Foundation grant OTKA 77779. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSHULER BL, 1988, ZH EKSP TEOR FIZ+, V94, P343; BOHIGAS O, 1984, PHYS REV LETT, V52, P1, DOI 10.1103/PhysRevLett.52.1; Collini E, 2010, NATURE, V463, P644, DOI 10.1038/nature08811; Engel GS, 2007, NATURE, V446, P782, DOI 10.1038/nature05678; Evangelou SN, 2000, PHYS REV LETT, V84, P1643, DOI 10.1103/PhysRevLett.84.1643; Evangelou SN, 2001, PHYSICA B, V296, P62, DOI 10.1016/S0921-4526(00)00780-8; EVANGELOU SN, 1993, J PHYS A-MATH GEN, V26, pL1243, DOI 10.1088/0305-4470/26/23/010; Franco MI, 2011, P NATL ACAD SCI USA, V108, P3797, DOI 10.1073/pnas.1012293108; Gauger EM, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.040503; Gong JB, 1999, PHYS REV E, V60, P1643, DOI 10.1103/PhysRevE.60.1643; Jacquod P, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.150403; Kauffman SA, 2012, ONCE FUTURE TURING C; Lichtenberg A., 1992, REGUL CHAOTIC DYN, V2; LINDBLAD G, 1976, COMMUN MATH PHYS, V48, P119, DOI 10.1007/BF01608499; Lloyd S, 2011, J PHYS CONF SER, V302, DOI 10.1088/1742-6596/302/1/012037; MacKay RS., 1993, RENORMALISATION AREA; Olson JM, 2004, PHOTOSYNTH RES, V80, P181, DOI 10.1023/B:PRES.0000030428.36950.43; Panitchayangkoon G, 2011, P NATL ACAD SCI USA, V108, P20908, DOI 10.1073/pnas.1105234108; Panitchayangkoon G, 2010, P NATL ACAD SCI USA, V107, P12766, DOI 10.1073/pnas.1005484107; Pattanayak AK, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.014103; Pattanayak AK, 1999, PHYS REV LETT, V83, P4526, DOI 10.1103/PhysRevLett.83.4526; Pattanayak AK, 1996, PHYS REV LETT, V77, P59, DOI 10.1103/PhysRevLett.77.59; Pattanayak AK, 1997, PHYS REV E, V56, P5174, DOI 10.1103/PhysRevE.56.5174; PRIGODIN VN, 1993, PHYS REV LETT, V70, P2932, DOI 10.1103/PhysRevLett.70.2932; Reichl L. E., 2004, TRANSITION CHAOS CON, DOI 10.1007/978-1-4757-4350-0; SHKLOVSKII BI, 1993, PHYS REV B, V47, P11487, DOI 10.1103/PhysRevB.47.11487; ZUREK WH, 1995, PHYSICA D, V83, P300, DOI 10.1016/0167-2789(94)00271-Q; ZUREK WH, 1993, PHYS REV LETT, V70, P1187, DOI 10.1103/PhysRevLett.70.1187	28	25	25	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e89017	10.1371/journal.pone.0089017	http://dx.doi.org/10.1371/journal.pone.0089017			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603620	Green Published, Green Submitted, gold			2022-12-27	WOS:000332483600008
J	Wang, ZQ; Liang, PP; Zhao, ZL; Han, Y; Song, HQ; Xu, JY; Lu, J; Li, KC				Wang, Zhiqun; Liang, Peipeng; Zhao, Zhilian; Han, Ying; Song, Haiqing; Xu, Jianyang; Lu, Jie; Li, Kuncheng			Acupuncture Modulates Resting State Hippocampal Functional Connectivity in Alzheimer Disease	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; APOLIPOPROTEIN-E GENOTYPE; BRAIN NETWORKS; DEFAULT-MODE; EARLY-DIAGNOSIS; FMRI; MRI; ASYMMETRY; CORTEX; DEMENTIA	Our objective is to clarify the effects of acupuncture on hippocampal connectivity in patients with Alzheimer disease (AD) using functional magnetic resonance imaging (fMRI). Twenty-eight right-handed subjects (14 AD patients and 14 healthy elders) participated in this study. Clinical and neuropsychological examinations were performed on all subjects. MRI was performed using a SIEMENS verio 3-Tesla scanner. The fMRI study used a single block experimental design. We first acquired baseline resting state data during the initial 3 minutes and then performed acupuncture stimulation on the Tai chong and He gu acupoints for 3 minutes. Last, we acquired fMRI data for another 10 minutes after the needle was withdrawn. The preprocessing and data analysis were performed using statistical parametric mapping (SPM5) software. Two-sample t-tests were performed using data from the two groups in different states. We found that during the resting state, several frontal and temporal regions showed decreased hippocampal connectivity in AD patients relative to control subjects. During the resting state following acupuncture, AD patients showed increased connectivity in most of these hippocampus related regions compared to the first resting state. In conclusion, we investigated the effect of acupuncture on AD patients by combing fMRI and traditional acupuncture. Our fMRI study confirmed that acupuncture at Tai chong and He gu can enhance the hippocampal connectivity in AD patients.	[Wang, Zhiqun; Liang, Peipeng; Zhao, Zhilian; Lu, Jie; Li, Kuncheng] Capital Med Univ, Dept Radiol, Xuanwu Hosp, Beijing, Peoples R China; [Han, Ying; Song, Haiqing] Capital Med Univ, Dept Neurol, Xuanwu Hosp, Beijing, Peoples R China; [Xu, Jianyang] Chinese Peoples Armed Police Forces, Gen Hosp, Beijing, Peoples R China; [Li, Kuncheng] Minist Educ, Key Lab Neurodegenerat Dis, Beijing, Peoples R China; [Liang, Peipeng; Li, Kuncheng] Beijing Key Lab Magnet Resonance Imaging & Brain, Beijing, Peoples R China	Capital Medical University; Capital Medical University	Lu, J (corresponding author), Capital Med Univ, Dept Radiol, Xuanwu Hosp, Beijing, Peoples R China.	lujie@xwh.ccmu.edu.cn; likuncheng@xwh.ccmu.edu.cn	Han, Ying/H-7111-2017; Lu, Jie/GNW-3367-2022		Scientific Research Foundation for the Returned Overseas Chinese Scholars; Natural Science Foundation of China [81000606, 81370037, 61105118, 81141018, 81030028, 81225012]; China Postdoctoral Science Foundation [201003142];  [Z101107052210002];  [Z111107067311036]	Scientific Research Foundation for the Returned Overseas Chinese Scholars(Scientific Research Foundation for the Returned Overseas Chinese Scholars); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); ; 	This work was supported by the Project Sponsored by the Scientific Research Foundation for the Returned Overseas Chinese Scholars, the Natural Science Foundation of China (Grant No. 81000606, 81370037, 61105118, 81141018, 81030028, and 81225012), China Postdoctoral Science Foundation funded project (No. 201003142), and Key Work of Special Project supported by the city government (Z101107052210002 and Z111107067311036). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen G, 2007, ARCH NEUROL-CHICAGO, V64, P1482, DOI 10.1001/archneur.64.10.1482; American Psychiatric Association DSM-IV, 1994, DSM 4 DIAGN STAT MAN; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Backman L, 1999, NEUROLOGY, V52, P1861, DOI 10.1212/WNL.52.9.1861; Bai F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029288; Bai F, 2009, BIOL PSYCHIAT, V65, P951, DOI 10.1016/j.biopsych.2008.10.017; Bai LJ, 2009, BRAIN RES, V1279, P37, DOI 10.1016/j.brainres.2009.04.056; Bigler ED, 2002, J INT NEUROPSYCH SOC, V8, P925, DOI 10.1017/S1355617702870072; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; BRAAK H, 1995, NEUROBIOL AGING, V16, P271, DOI 10.1016/0197-4580(95)00021-6; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Chetelat G, 2003, NEUROIMAGE, V18, P525, DOI 10.1016/S1053-8119(02)00026-5; Desikan RS, 2009, BRAIN; Dhond RP, 2008, PAIN, V136, P407, DOI 10.1016/j.pain.2008.01.011; Fang JL, 2009, HUM BRAIN MAPP, V30, P1196, DOI 10.1002/hbm.20583; Feng YY, 2012, MAGN RESON IMAGING, V30, P672, DOI 10.1016/j.mri.2012.01.003; Feng YY, 2011, MAGN RESON IMAGING, V29, P958, DOI 10.1016/j.mri.2011.04.009; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Geroldi C, 2000, J NEUROL NEUROSUR PS, V68, P93, DOI 10.1136/jnnp.68.1.93; Goveas JS, 2011, J MAGN RESON IMAGING, V34, P764, DOI 10.1002/jmri.22662; Grady CL, 2003, J NEUROSCI, V23, P986, DOI 10.1523/jneurosci.23-03-00986.2003; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Li SJ, 2002, RADIOLOGY, V225, P253, DOI 10.1148/radiol.2251011301; Liang PP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022153; Liu ZY, 2012, PSYCHIAT RES-NEUROIM, V202, P118, DOI 10.1016/j.pscychresns.2012.03.002; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Pedraza O, 2004, J INT NEUROPSYCH SOC, V10, P664, DOI 10.1017/S1355617704105080; Pennanen C, 2004, NEUROBIOL AGING, V25, P303, DOI 10.1016/S0197-4580(03)00084-8; Petrella JR, 2003, RADIOLOGY, V226, P315, DOI 10.1148/radiol.2262011600; Qin W, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-55; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Szabo CA, 2001, AM J NEURORADIOL, V22, P1342; Tregellas JR, 2007, SCHIZOPHR RES, V92, P262, DOI 10.1016/j.schres.2006.12.033; Wang L, 2006, NEUROIMAGE, V31, P496, DOI 10.1016/j.neuroimage.2005.12.033; Wang ZQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042730; Wang ZQ, 2011, J NEUROL SCI, V309, P79, DOI 10.1016/j.jns.2011.07.017; Wang ZQ, 2009, ACTA RADIOL, V50, P312, DOI 10.1080/02841850802709219; Zhou YL, 2008, ACUPUNCTURE ELECTRO, V33, P9, DOI 10.3727/036012908803861186	43	130	138	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e91160	10.1371/journal.pone.0091160	http://dx.doi.org/10.1371/journal.pone.0091160			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603951	Green Submitted, Green Published, gold			2022-12-27	WOS:000332483600137
J	Wu, XY; Cai, H; Kallianpur, A; Li, HL; Yang, G; Gao, J; Xiang, YB; Ji, BT; Yu-Tang; Zheng, W; Shu, XO				Wu, Xiaoyan; Cai, Hui; Kallianpur, Asha; Li, Honglan; Yang, Gong; Gao, Jing; Xiang, Yong-Bing; Ji, Bu-Tian; Yu-Tang; Zheng, Wei; Shu, Xiao-Ou			Impact of Premature Ovarian Failure on Mortality and Morbidity among Chinese Women	PLOS ONE			English	Article							ISCHEMIC-HEART-DISEASE; NATURAL MENOPAUSE; BREAST-CANCER; AGE; HEALTH; ESTRONE; RISK; ANDROSTENEDIONE; REPRODUCIBILITY; QUESTIONNAIRE	Objective: To evaluate associations of premature ovarian failure (POF) with mortality and morbidity in Asian populations. Methods: We identified 1,003 cases of POF among 36,402 postmenopausal women who participated in the Shanghai Women's Health Study, a population-based cohort study. Cox regression and logistic regression models were applied in data analysis. Results: After adjustment for potential confounding factors, we found that POF increased the risk of total and cancer-specific mortality (HR (95% CIs): 1.29 (1.08-1.54) and 1.38 (1.05-1.81), respectively). POF was also associated with high prevalence of autoimmune disease (OR (95% CI): 1.56 (1.04-2.35)) but decreased incidence of breast cancer (OR (95% CI): 0.59 (0.38-0.91)). Similar results were observed when hormone replacement therapy users were excluded from the analysis. POF is associated with high waist-to-hip ratio. Conclusions: Our results suggest that women with POF experience increased mortality and that these women may benefit from heightened surveillance and appropriate interventions.	[Wu, Xiaoyan; Cai, Hui; Kallianpur, Asha; Yang, Gong; Zheng, Wei; Shu, Xiao-Ou] Vanderbilt Univ, Sch Med, Dept Med, Div Epidemiol, Nashville, TN 37212 USA; [Wu, Xiaoyan; Cai, Hui; Kallianpur, Asha; Yang, Gong; Zheng, Wei; Shu, Xiao-Ou] Vanderbilt Ingram Canc Ctr, Nashville, TN USA; [Kallianpur, Asha] Vanderbilt Univ, Sch Med, Div Gen Internal Med & Publ Hlth, Dept Med, Nashville, TN 37212 USA; [Li, Honglan; Gao, Jing; Xiang, Yong-Bing; Yu-Tang] Shanghai Canc Inst, Dept Epidemiol, Shanghai, Peoples R China; [Ji, Bu-Tian] NCI, Occupat Epidemiol Branch, NIH, Bethesda, MD 20892 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Shanghai Jiao Tong University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Shu, XO (corresponding author), Vanderbilt Univ, Sch Med, Dept Med, Div Epidemiol, Nashville, TN 37212 USA.	Xiao-ou.shu@vanderbilt.edu	Zheng, Wei/O-3351-2013; zhang, weihua/GXV-1334-2022	Zheng, Wei/0000-0003-1226-070X; 	US National Institutes of Health (NHI) [R37 CA 070867, R01 HL079123]; NATIONAL CANCER INSTITUTE [R37CA070867, UM1CA182910] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079123] Funding Source: NIH RePORTER	US National Institutes of Health (NHI); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding support for this work was provided by US National Institutes of Health (NHI) grants R37 CA 070867 (PI: W Zheng) and R01 HL079123 (PI: XO Shu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anasti JN, 1998, FERTIL STERIL, V70, P1, DOI 10.1016/S0015-0282(98)00099-5; Atay V, 2007, J INT MED RES, V35, P416, DOI 10.1177/147323000703500317; BEAVIS E L G, 1969, Journal of Obstetrics and Gynaecology of the British Commonwealth, V76, P969; Beral V, 1997, LANCET, V350, P1047, DOI 10.1016/S0140-6736(97)08233-0; Betterle C, 1997, J CLIN ENDOCR METAB, V82, P932, DOI 10.1210/jc.82.3.932; BETTERLE C, 1993, CLIN ENDOCRINOL, V39, P35, DOI 10.1111/j.1365-2265.1993.tb01748.x; Cooper GS, 1998, ANN EPIDEMIOL, V8, P229, DOI 10.1016/S1047-2797(97)00207-X; COULAM CB, 1986, OBSTET GYNECOL, V67, P604; FORNEY JP, 1981, J CLIN ENDOCR METAB, V53, P192, DOI 10.1210/jcem-53-1-192; GORDON T, 1978, ANN INTERN MED, V89, P157, DOI 10.7326/0003-4819-89-2-157; Goswami D, 2005, HUM REPROD UPDATE, V11, P391, DOI 10.1093/humupd/dmi012; GRODIN JM, 1973, J CLIN ENDOCR METAB, V36, P207, DOI 10.1210/jcem-36-2-207; Hoek A, 1997, ENDOCR REV, V18, P107, DOI 10.1210/er.18.1.107; Hu FB, 1999, ARCH INTERN MED, V159, P1061, DOI 10.1001/archinte.159.10.1061; Jacobsen BK, 1999, J CLIN EPIDEMIOL, V52, P303, DOI 10.1016/S0895-4356(98)00170-X; JUDD HL, 1974, J CLIN ENDOCR METAB, V39, P1020, DOI 10.1210/jcem-39-6-1020; Jurj AL, 2007, AM J EPIDEMIOL, V165, P1124, DOI 10.1093/aje/kwk119; Kim TJ, 1997, OBSTET GYNECOL, V89, P777, DOI 10.1016/S0029-7844(97)00077-X; LABARBERA AR, 1988, AM J REPROD IMMUNOL, V16, P115; Lokkegaard E, 2006, MATURITAS, V53, P226, DOI 10.1016/j.maturitas.2005.04.009; Luborsky JL, 2003, HUM REPROD, V18, P199, DOI 10.1093/humrep/deg005; LUOTO R, 1994, AM J EPIDEMIOL, V139, P64, DOI 10.1093/oxfordjournals.aje.a116936; MACDONALD PC, 1978, AM J OBSTET GYNECOL, V130, P448, DOI 10.1016/0002-9378(78)90287-9; MACDONALD PC, 1967, J CLIN ENDOCR METAB, V27, P1103, DOI 10.1210/jcem-27-8-1103; Maclaran Kate, 2010, Menopause Int, V16, P38, DOI 10.1258/mi.2010.010014; Monninkhof EM, 1999, BREAST CANCER RES TR, V55, P285, DOI 10.1023/A:1006277207963; Ossewaarde ME, 2005, EPIDEMIOLOGY, V16, P556, DOI 10.1097/01.ede.0000165392.35273.d4; POEHLMAN ET, 1995, ANN INTERN MED, V123, P673, DOI 10.7326/0003-4819-123-9-199511010-00005; Rivera CM, 2009, MENOPAUSE, V16, P15, DOI 10.1097/gme.0b013e31818888f7; Rocca WA, 2006, LANCET ONCOL, V7, P821, DOI 10.1016/S1470-2045(06)70869-5; Schmidt PJ, 2006, JAMA-J AM MED ASSOC, V295, P1374, DOI 10.1001/jama.295.12.1374; Shu XO, 2004, EUR J CLIN NUTR, V58, P17, DOI 10.1038/sj.ejcn.1601738; Shuster LT, 2010, MATURITAS, V65, P161, DOI 10.1016/j.maturitas.2009.08.003; SNOWDON DA, 1989, AM J PUBLIC HEALTH, V79, P709, DOI 10.2105/AJPH.79.6.709; Utian W H, 1999, Climacteric, V2, P284, DOI 10.3109/13697139909038088; Uygur Dilek, 2005, Archives of Gynecology and Obstetrics, V273, P17, DOI 10.1007/s00404-005-0029-7; van der Voort DJM, 2003, OSTEOPOROSIS INT, V14, P525, DOI 10.1007/s00198-003-1408-1; Vujovic Svetlana, 2009, Menopause Int, V15, P72, DOI 10.1258/mi.2009.009020; World Health Organisation, 1977, INT CLASS DIS 9 REV; Zheng W, 2005, AM J EPIDEMIOL, V162, P1123, DOI 10.1093/aje/kwi322	40	53	66	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e89597	10.1371/journal.pone.0089597	http://dx.doi.org/10.1371/journal.pone.0089597			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603759	Green Published, gold, Green Submitted			2022-12-27	WOS:000332483600014
J	Bodner, M; Patera, J; Szajewska, M				Bodner, Mark; Patera, Jiri; Szajewska, Marzena			Breaking of Icosahedral Symmetry: C-60 to C-70	PLOS ONE			English	Article							FULLERENES; C70; C60	We describe the existence and structure of large fullerenes in terms of symmetry breaking of the C-60 molecule. Specifically, we describe the existence of C-70 in terms of breaking of the icosahedral symmetry of C-60 by the insertion into its middle of an additional H-2 decagon. The surface of C-70 is formed by 12 regular pentagons and 25 regular hexagons. All 105 edges of C-70 are of the same length. It should be noted that the structure of the molecules is described in exact coordinates relative to the non-orthogonal icosahedral bases. This symmetry breaking process can be readily applied, and could account for and describe other larger cage cluster fullerene molecules, as well as more complex higher structures such as nanotubes.	[Bodner, Mark; Patera, Jiri] MIND Res Inst, Irvine, CA 92617 USA; [Patera, Jiri; Szajewska, Marzena] Univ Montreal, Ctr Rech Math, Montreal, PQ H3C 3J7, Canada	Universite de Montreal	Bodner, M (corresponding author), MIND Res Inst, Irvine, CA 92617 USA.	mbodner@mindresearch.net; patera@crm.umontreal.ca; m.szajewska@math.uwb.edu.pl	Szajewska, Marzena/AAM-9802-2021	Szajewska, Marzena/0000-0003-4664-6619	Natural Sciences and Engineering Research Council of Canada; MITACS	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); MITACS	Partial support from the Natural Sciences and Engineering Research Council of Canada and MITACS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AJIE H, 1990, J PHYS CHEM-US, V94, P8630, DOI 10.1021/j100387a004; [Anonymous], PURE APPL CHEM, V74, P629; BETHUNE DS, 1990, CHEM PHYS LETT, V174, P219, DOI 10.1016/0009-2614(90)85335-A; CHAMPAGNE B, 1995, CAN J PHYS, V73, P566, DOI 10.1139/p95-084; Chen L., 1998, FIELDS I MONOGRAPHS, V10, P135; CURL RF, 1988, SCIENCE, V242, P1017, DOI 10.1126/science.242.4881.1017; FOWLER PW, 1992, NATURE, V355, P428, DOI 10.1038/355428a0; GUO T, 1995, J PHYS CHEM-US, V99, P10694, DOI 10.1021/j100027a002; KERNER R, 1994, COMP MATER SCI, V2, P500, DOI 10.1016/0927-0256(94)90080-9; KROTO HW, 1987, NATURE, V329, P529, DOI 10.1038/329529a0; MCELVANY SW, 1992, ACCOUNTS CHEM RES, V25, P162, DOI 10.1021/ar00015a010; MCKENZIE DR, 1992, NATURE, V355, P622, DOI 10.1038/355622a0; Pisanski T, 1977, GLAS MAT, V12, P233; Powell WH, 2002, PURE APPL CHEM, V74, P629, DOI 10.1351/pac200274040629; RAGHAVACHARI K, 1991, J PHYS CHEM-US, V95, P5768, DOI 10.1021/j100168a013; SMALLEY RE, 1992, ACCOUNTS CHEM RES, V25, P98, DOI 10.1021/ar00015a001; TAYLOR R, 1990, J CHEM SOC CHEM COMM, P1423, DOI 10.1039/c39900001423; Terrones H, 1997, J PHYS CHEM SOLIDS, V58, P1789, DOI 10.1016/S0022-3697(97)00067-X; Terrones M, 2002, STRUCT CHEM, V13, P373, DOI 10.1023/A:1015880427362; Weaver JH, 1994, SOLID STATE PHYS, V48, P1, DOI 10.1016/S0081-1947(08)60577-9	20	7	7	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e84079	10.1371/journal.pone.0084079	http://dx.doi.org/10.1371/journal.pone.0084079			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599292	gold, Green Submitted, Green Published			2022-12-27	WOS:000332479400002
J	Herod, MR; Salim, O; Skilton, RJ; Prince, CA; Ward, VK; Lambden, PR; Clarke, IN				Herod, Morgan R.; Salim, Omar; Skilton, Rachel J.; Prince, Cynthia A.; Ward, Vernon K.; Lambden, Paul R.; Clarke, Ian N.			Expression of the Murine Norovirus (MNV) ORF1 Polyprotein Is Sufficient to Induce Apoptosis in a Virus-Free Cell Model	PLOS ONE			English	Article							NORWALK-LIKE VIRUS; RNA-SYNTHESIS; NONSTRUCTURAL POLYPROTEIN; SUBSTRATE-SPECIFICITY; REPLICATION COMPLEX; STRUCTURAL BASIS; CLEAVAGE SITES; CAPSID PROTEIN; INFECTED-CELLS; POLYMERASE	Investigations into human norovirus infection, replication and pathogenesis, as well as the development of potential antiviral agents, have been restricted by the lack of a cell culture system for human norovirus. To date, the optimal cell culture surrogate virus model for studying human norovirus biology is the murine norovirus (MNV). In this report we generate a tetracycline-regulated, inducible eukaryotic cell system expressing the entire MNV ORF1 polyprotein. Once induced, the MNV ORF1 polyprotein was faithfully processed to the six mature non-structural proteins that predominately located to a discrete perinuclear region, as has been observed in active MNV infection. Furthermore, we found that expression of the ORF1 polyprotein alone was sufficient to induce apoptosis, characterised by caspase-9 activation and survivin down-regulation. This cell line provides a valuable new tool for studying MNV ORF1 non-structural protein function, screening for potential antiviral agents and acts as a proof-of-principle for such systems to be developed for human noroviruses.	[Herod, Morgan R.; Salim, Omar; Skilton, Rachel J.; Prince, Cynthia A.; Lambden, Paul R.; Clarke, Ian N.] Univ Southampton, Mol Microbiol Grp, Southampton, Hants, England; [Ward, Vernon K.] Univ Otago, Otago Sch Med Sci, Dept Microbiol & Immunol, Dunedin, New Zealand	University of Southampton; University of Otago	Clarke, IN (corresponding author), Univ Southampton, Mol Microbiol Grp, Southampton, Hants, England.	I.N.Clarke@soton.ac.uk		Clarke, Ian/0000-0002-4938-1620; Ward, Vernon/0000-0001-8692-5116; Herod, Morgan/0000-0002-8626-6787	Wellcome Trust [086112]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust, programme grant number 086112 entitled Replication of Noroviruses: Determinants of Tropism. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias A, 2012, JOVE-J VIS EXP, DOI 10.3791/4145; Baker ES, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030534; Belliot G, 2003, J VIROL, V77, P10957, DOI 10.1128/JVI.77.20.10957-10974.2003; Belliot G, 2008, VIROLOGY, V374, P33, DOI 10.1016/j.virol.2007.12.028; Blakeney SJ, 2003, VIROLOGY, V308, P216, DOI 10.1016/S0042-6822(03)00004-7; Bok K, 2009, J VIROL, V83, P3647, DOI 10.1128/JVI.02028-08; Bu WM, 2008, J VIROL, V82, P5340, DOI 10.1128/JVI.00135-08; Chang KO, 2007, J VIROL, V81, P12111, DOI 10.1128/JVI.00560-07; Chang KO, 2006, VIROLOGY, V353, P463, DOI 10.1016/j.virol.2006.06.006; Chang KO, 2009, J VIROL, V83, P8587, DOI 10.1128/JVI.00005-09; Choi JM, 2008, P NATL ACAD SCI USA, V105, P9175, DOI 10.1073/pnas.0803275105; Ettayebi K, 2003, J VIROL, V77, P11790, DOI 10.1128/JVI.77.21.11790-11797.2003; Furman LM, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-139; Glass PJ, 2000, J VIROL, V74, P6581, DOI 10.1128/JVI.74.14.6581-6591.2000; Hardy ME, 1996, VIRUS GENES, V12, P287; Hardy ME, 2002, VIRUS RES, V89, P29, DOI 10.1016/S0168-1702(02)00114-4; Hyde JL, 2012, J VIROL, V86, P4110, DOI 10.1128/JVI.05784-11; Hyde JL, 2010, VIROLOGY, V406, P138, DOI 10.1016/j.virol.2010.06.047; Hyde JL, 2009, J VIROL, V83, P9709, DOI 10.1128/JVI.00600-09; JIANG X, 1993, VIROLOGY, V195, P51, DOI 10.1006/viro.1993.1345; Karst SM, 2003, SCIENCE, V299, P1575, DOI 10.1126/science.1077905; LAMBDEN PR, 1993, SCIENCE, V259, P516, DOI 10.1126/science.8380940; Liu BL, 1996, J VIROL, V70, P2605, DOI 10.1128/JVI.70.4.2605-2610.1996; Liu BL, 1999, J GEN VIROL, V80, P291, DOI 10.1099/0022-1317-80-2-291; McFadden N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002413; Moradpour D, 1998, HEPATOLOGY, V28, P192, DOI 10.1002/hep.510280125; Moradpour D, 1996, VIROLOGY, V222, P51, DOI 10.1006/viro.1996.0397; Muhaxhiri Z, 2013, J VIROL, V87, P4281, DOI 10.1128/JVI.02869-12; Nakamura K, 2005, J VIROL, V79, P13685, DOI 10.1128/JVI.79.21.13685-13693.2005; Ng KKS, 2004, J BIOL CHEM, V279, P16638, DOI 10.1074/jbc.M400584200; Papafragkou E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063485; Pfister T, 2001, J VIROL, V75, P1611, DOI 10.1128/JVI.75.4.1611-1619.2001; Rohayem J, 2006, J VIROL, V80, P7060, DOI 10.1128/JVI.02195-05; Sharp TM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013130; Sosnovtsev SV, 2006, J VIROL, V80, P7816, DOI 10.1128/JVI.00532-06; Subba-Reddy CV, 2012, J VIROL, V86, P10138, DOI 10.1128/JVI.01208-12; Subba-Reddy CV, 2011, J VIROL, V85, P13027, DOI 10.1128/JVI.06191-11; Vongpunsawad S, 2013, J VIROL, V87, P4818, DOI 10.1128/JVI.03508-12; Ward VK, 2007, P NATL ACAD SCI USA, V104, P11050, DOI 10.1073/pnas.0700336104; Wobus CE, 2004, PLOS BIOL, V2, P2076, DOI 10.1371/journal.pbio.0020432; XI JA, 1992, J VIROL, V66, P6527, DOI 10.1128/JVI.66.11.6527-6532.1992; Zamyatkin DF, 2008, J BIOL CHEM, V283, P7705, DOI 10.1074/jbc.M709563200	42	15	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90679	10.1371/journal.pone.0090679	http://dx.doi.org/10.1371/journal.pone.0090679			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599381	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000332479400117
J	Huang, HX; Zheng, YY; Zhu, JH; Zhang, JJ; Chen, HP; Chen, XG				Huang, Hongxin; Zheng, Yayuan; Zhu, Jianhong; Zhang, Jingjing; Chen, Huapu; Chen, Xinggui			An Updated Meta-Analysis of Fatal Adverse Events Caused by Bevacizumab Therapy in Cancer Patients	PLOS ONE			English	Article							PHASE-III TRIAL; METASTATIC COLORECTAL-CANCER; CELL LUNG-CANCER; OXALIPLATIN-BASED CHEMOTHERAPY; TREATMENT-RELATED MORTALITY; DOUBLE-BLIND; 1ST-LINE TREATMENT; BREAST-CANCER; VENOUS THROMBOEMBOLISM; PLUS CAPECITABINE	Background: The risk of fatal adverse events (FAEs) due to bevacizumab-based chemotherapy has not been well described; we carried out an updated meta-analysis regarding this issue. Methods: An electronic search of Medline, Embase and The Cochrane Central Register of Controlled Trials was conducted to investigate the effects of randomized controlled trials on bevacizumab treatment on cancer patients. Random or fixed-effect meta-analytical models were used to evaluate the risk ratio (RR) of FAEs due to the use of bevacizumab. Results: Thirty-four trials were included. Allocation to bevacizumab therapy significantly increased the risk of FAEs; the RR was 1.29 (95% CI: 1.05-1.57). This association varied significantly with tumor types (P = 0.002) and chemotherapeutic agents (P = 0.005) but not with bevacizumab dose (P = 0.90). Increased risk was seen in patients with non-small cell lung cancer, pancreatic cancer, prostate cancer, and ovarian cancer. However, FAEs were lower in breast cancer patients treated with bevacizumab. In addition, bevacizumab was associated with an increased risk of FAEs in patients who received concomitant agents of taxanes and/or platinum. Conclusion: Compared with chemotherapy alone, the addition of bevacizumab was associated with an increased risk of FAEs among patients with special tumor types, particularly when combined with chemotherapeutic agents such as platinum.	[Huang, Hongxin; Zhang, Jingjing; Chen, Huapu; Chen, Xinggui] Guangdong Med Coll, Affiliated Hosp, Clin Res Ctr, Zhanjiang, Peoples R China; [Zheng, Yayuan; Zhu, Jianhong] Guangdong Med Coll, Dept Pharmacol, Zhanjiang, Peoples R China	Guangdong Medical University; Guangdong Medical University	Chen, HP (corresponding author), Guangdong Med Coll, Affiliated Hosp, Clin Res Ctr, Zhanjiang, Peoples R China.	chpjwx@163.com; xingguichen@hotmail.com	Huang, HongXin/GSI-9716-2022	Huang, HongXin/0000-0002-8656-4266				Aghajanian C, 2012, J CLIN ONCOL, V30, P2039, DOI 10.1200/JCO.2012.42.0505; Amit L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051780; Bear HD, 2012, NEW ENGL J MED, V366, P310, DOI 10.1056/NEJMoa1111097; Bennouna J, 2013, LANCET ONCOL, V14, P29, DOI 10.1016/S1470-2045(12)70477-1; Brufsky AM, 2011, J CLIN ONCOL, V29, P4286, DOI 10.1200/JCO.2010.34.1255; Burger RA, 2011, NEW ENGL J MED, V365, P2473, DOI 10.1056/NEJMoa1104390; Cameron D, 2013, LANCET ONCOL, V14, P933, DOI 10.1016/S1470-2045(13)70335-8; Choueiri TK, 2013, ANN ONCOL, V24, P2092, DOI 10.1093/annonc/mdt155; Cortes J, 2012, ANN ONCOL, V23, P1130, DOI 10.1093/annonc/mdr432; Lima ABC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022681; Dai F, 2013, CLIN DRUG INVEST, V33, P779, DOI 10.1007/s40261-013-0125-6; de Gramont A, 2012, LANCET ONCOL, V13, P1225, DOI 10.1016/S1470-2045(12)70509-0; Escudier B, 2007, LANCET, V370, P2103, DOI 10.1016/S0140-6736(07)61904-7; Geiger-Gritsch S, 2010, ONCOLOGIST, V15, P1179, DOI 10.1634/theoncologist.2009-0155; Gianni L, 2013, J CLIN ONCOL, V31, P1719, DOI 10.1200/JCO.2012.44.7912; Giantonio BJ, 2007, J CLIN ONCOL, V25, P1539, DOI 10.1200/JCO.2006.09.6305; Gordon MS, 2005, ONCOLOGY-BASEL, V69, P25, DOI 10.1159/000088481; Guan Zhong-Zhen, 2011, Chin J Cancer, V30, P682, DOI 10.5732/cjc.011.10188; Herbst RS, 2007, J CLIN ONCOL, V25, P4743, DOI 10.1200/JCO.2007.12.3026; Herbst RS, 2011, LANCET, V377, P1846, DOI 10.1016/S0140-6736(11)60545-X; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Johnson DH, 2004, J CLIN ONCOL, V22, P2184, DOI 10.1200/JCO.2004.11.022; Kabbinavar F, 2003, J CLIN ONCOL, V21, P60, DOI 10.1200/JCO.2003.10.066; Kabbinavar FF, 2005, J CLIN ONCOL, V23, P3697, DOI 10.1200/JCO.2005.05.112; Kelly WK, 2012, J CLIN ONCOL, V30, P1534, DOI 10.1200/JCO.2011.39.4767; Kindler HL, 2010, J CLIN ONCOL, V28, P3617, DOI 10.1200/JCO.2010.28.1386; Lang I, 2013, LANCET ONCOL, V14, P125, DOI 10.1016/S1470-2045(12)70566-1; Martin M, 2011, LANCET ONCOL, V12, P369, DOI 10.1016/S1470-2045(11)70037-7; Miles DW, 2010, J CLIN ONCOL, V28, P3239, DOI 10.1200/JCO.2008.21.6457; Miller K, 2007, NEW ENGL J MED, V357, P2666, DOI 10.1056/NEJMoa072113; Miller KD, 2005, J CLIN ONCOL, V23, P792, DOI 10.1200/JCO.2005.05.098; Minor DR, 2009, JAMA-J AM MED ASSOC, V301, P1434, DOI 10.1001/jama.2009.439; Moher D, 2009, BMJ, V21, P339; Nalluri SR, 2008, JAMA-J AM MED ASSOC, V300, P2277, DOI 10.1001/jama.2008.656; Niho S, 2012, LUNG CANCER, V76, P362, DOI 10.1016/j.lungcan.2011.12.005; Ohtsu A, 2011, J CLIN ONCOL, V29, P3968, DOI 10.1200/JCO.2011.36.2236; Perren TJ, 2011, NEW ENGL J MED, V365, P2484, DOI 10.1056/NEJMoa1103799; Ranpura V, 2011, JAMA-J AM MED ASSOC, V305, P487, DOI 10.1001/jama.2011.51; Reck M, 2009, J CLIN ONCOL, V27, P1227, DOI 10.1200/JCO.2007.14.5466; Rini BI, 2010, J CLIN ONCOL, V28, P2137, DOI 10.1200/JCO.2009.26.5561; Robert NJ, 2011, J CLIN ONCOL, V29, P1252, DOI 10.1200/JCO.2010.28.0982; Saltz LB, 2008, J CLIN ONCOL, V26, P2013, DOI 10.1200/JCO.2007.14.9930; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Spigel DR, 2011, J CLIN ONCOL, V29, P2215, DOI 10.1200/JCO.2010.29.3423; Tebbutt NC, 2010, J CLIN ONCOL, V28, P3191, DOI 10.1200/JCO.2009.27.7723; Van Cutsem E, 2009, J CLIN ONCOL, V27, P2231, DOI 10.1200/JCO.2008.20.0238	48	28	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e89960	10.1371/journal.pone.0089960	http://dx.doi.org/10.1371/journal.pone.0089960			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599121	Green Published, gold, Green Submitted			2022-12-27	WOS:000332479400035
J	Lee, WP; Stromberg, MP; Ward, A; Stewart, C; Garrison, EP; Marth, GT				Lee, Wan-Ping; Stromberg, Michael P.; Ward, Alistair; Stewart, Chip; Garrison, Erik P.; Marth, Gabor T.			MOSAIK: A Hash-Based Algorithm for Accurate Next-Generation Sequencing Short-Read Mapping	PLOS ONE			English	Article							ALIGNMENT; DISCOVERY; RISK	MOSAIK is a stable, sensitive and open-source program for mapping second and third-generation sequencing reads to a reference genome. Uniquely among current mapping tools, MOSAIK can align reads generated by all the major sequencing technologies, including Illumina, Applied Biosystems SOLiD, Roche 454, Ion Torrent and Pacific BioSciences SMRT. Indeed, MOSAIK was the only aligner to provide consistent mappings for all the generated data (sequencing technologies, low-coverage and exome) in the 1000 Genomes Project. To provide highly accurate alignments, MOSAIK employs a hash clustering strategy coupled with the Smith-Waterman algorithm. This method is well-suited to capture mismatches as well as short insertions and deletions. To support the growing interest in larger structural variant (SV) discovery, MOSAIK provides explicit support for handling known-sequence SVs, e.g. mobile element insertions (MEIs) as well as generating outputs tailored to aid in SV discovery. All variant discovery benefits from an accurate description of the read placement confidence. To this end, MOSAIK uses a neural-network based training scheme to provide well-calibrated mapping quality scores, demonstrated by a correlation coefficient between MOSAIK assigned and actual mapping qualities greater than 0.98. In order to ensure that studies of any genome are supported, a training pipeline is provided to ensure optimal mapping quality scores for the genome under investigation. MOSAIK is multi-threaded, open source, and incorporated into our command and pipeline launcher system GKNO (http://gkno.me).	[Lee, Wan-Ping; Stromberg, Michael P.; Ward, Alistair; Stewart, Chip; Garrison, Erik P.; Marth, Gabor T.] Boston Coll, Dept Biol, Chestnut Hill, MA 02167 USA; [Stewart, Chip] Broad Inst Harvard & Massachusetts Inst Technol, Cambridge, MA USA	Boston College; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Lee, WP (corresponding author), Boston Coll, Dept Biol, Chestnut Hill, MA 02167 USA.	wanping.lee@bc.edu	Lee, Wan-Ping/ABD-4571-2021	Lee, Wan-Ping/0000-0002-5305-1181	 [NIH: 5R01HG004719-04];  [NIH: 3U01HG006513-02S1]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004719, U01HG006513] Funding Source: NIH RePORTER	; ; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	NIH: 5R01HG004719-04; NIH: 3U01HG006513-02S1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADELSONVELSKII GM, 1962, DOKL AKAD NAUK SSSR+, V146, P263; Alkan C, 2009, NAT GENET, V41, P1061, DOI 10.1038/ng.437; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Aslam ML, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-391; Boytsov L., 2011, J EXP ALGORITHMICS, V16, P11, DOI [10.1145/1963190.1963191, DOI 10.1145/1963190.1963191]; Burrows M., 1994, BLOCK SORTING LOSSLE; Campagna D, 2009, BIOINFORMATICS, V25, P967, DOI 10.1093/bioinformatics/btp087; Campbell MS, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016986, 10.1371/journal.pone.0018283]; Cannon CH, 2010, MOL ECOL, V19, P147, DOI 10.1111/j.1365-294X.2009.04484.x; CHAO KM, 1992, COMPUT APPL BIOSCI, V8, P481; Chung CC, 2011, HUM MOL GENET, V20, P2869, DOI 10.1093/hmg/ddr189; Costantini M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005972; Cox AJ, 2012, BIOINFORMATICS, DOI [10.1093/bioinformatics/bts173, DOI 10.1093/BI0INF0RMATICS/BTS173]; Cridland JM, 2010, GENOME BIOL EVOL, V2, P83, DOI 10.1093/gbe/evq001; Dark MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036456; Dark MJ, 2011, VACCINE, V29, P4923, DOI 10.1016/j.vaccine.2011.04.131; David M, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt612; David M, 2011, BIOINFORMATICS, V27, P1011, DOI 10.1093/bioinformatics/btr046; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Eaves HL, 2009, BIOINFORMATICS, V25, P969, DOI 10.1093/bioinformatics/btp092; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Farrar M, 2007, BIOINFORMATICS, V23, P156, DOI 10.1093/bioinformatics/btl582; Farrell A, 2012, SCIENCE, V335, P218, DOI 10.1126/science.1210829; Ferragina P, 2005, J ACM, V52, P552, DOI 10.1145/1082036.1082039; Ferragina P, 2001, SIAM PROC S, P269; Fraser BA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-202; Garrison E, 2012, HAPLOTYPE BASED VARI, V9; Gontarz PM, 2013, BIOINFORMATICS, V29, P316, DOI 10.1093/bioinformatics/bts712; GOTOH O, 1982, J MOL BIOL, V162, P705, DOI 10.1016/0022-2836(82)90398-9; Goya R, 2010, BIOINFORMATICS, V26, P730, DOI 10.1093/bioinformatics/btq040; Griffiths DJ, 2001, GENOME BIOL, V2; Hach F, 2010, NAT METHODS, V7, P576, DOI 10.1038/nmeth0810-576; Harris TD, 2008, SCIENCE, V320, P106, DOI 10.1126/science.1150427; Henn MR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002529; Hillier LW, 2008, NAT METHODS, V5, P183, DOI 10.1038/NMETH.1179; Hoffmann S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000502; Iorizzo M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-389; Kim YJ, 2009, BIOINFORMATICS, V25, P1424, DOI 10.1093/bioinformatics/btp178; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead Ben, 2010, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1107s32; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Lin H, 2008, BIOINFORMATICS, V24, P2431, DOI 10.1093/bioinformatics/btn416; Lin YF, 2012, NUCLEIC ACIDS RES, V40, P8460, DOI 10.1093/nar/gks637; Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110; Mahmud MP, 2012, BIOINFORMATICS, V28, pI325, DOI 10.1093/bioinformatics/bts380; Malboeuf CM, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks794; Marth GT, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r84; Neves L, 2011, BMC P, V5, DOI 10.1186/1753-6561-5-S7-O48; Niu Q, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0067203, 10.1371/journal.pone.0082713]; Osoegawa K, 2001, GENOME RES, V11, P483, DOI 10.1101/gr.169601; Prak ETL, 2000, NAT REV GENET, V1, P134; Roberts KG, 2012, CANCER CELL, V22, P153, DOI 10.1016/j.ccr.2012.06.005; Rothberg JM, 2011, NATURE, V475, P348, DOI 10.1038/nature10242; Rumble SM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000386; Schneider GF, 2012, NAT BIOTECHNOL, V30, P326, DOI 10.1038/nbt.2181; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Stewart C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002236; Su XP, 2012, BIOINFORMATICS, V28, P2265, DOI 10.1093/bioinformatics/bts365; Tae H, 2013, BIOINFORMATICS, V29, P1734, DOI 10.1093/bioinformatics/btt277; Tipton K F, 1994, Eur J Biochem, V223, P1; Wang JM, 2011, NAT METHODS, V8, P652, DOI [10.1038/nmeth.1628, 10.1038/NMETH.1628]; Wilen CB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002020; Xing JC, 2013, TRENDS GENET, V29, P280, DOI 10.1016/j.tig.2012.12.002; Zhang ZF, 2010, NUCLEIC ACIDS RES, V38, pW743, DOI 10.1093/nar/gkq538	70	168	186	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90581	10.1371/journal.pone.0090581	http://dx.doi.org/10.1371/journal.pone.0090581			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599324	gold, Green Published, Green Submitted			2022-12-27	WOS:000332479400097
J	Moon, AM; Stauffer, AM; Schwindinger, WF; Sheridan, K; Firment, A; Robishaw, JD				Moon, Anne M.; Stauffer, Anna M.; Schwindinger, William F.; Sheridan, Kathy; Firment, Ashley; Robishaw, Janet D.			Disruption of G-Protein gamma(5) Subtype Causes Embryonic Lethality in Mice	PLOS ONE			English	Article							HETEROTRIMERIC G-PROTEINS; CONGENITAL HEART-DISEASE; ARTERIAL POLE; COUPLED RECEPTORS; ALPHA-SUBUNIT; HUMAN GENOME; RAT-BRAIN; 2ND HEART; PROLIFERATION; ACTIVATION	Heterotrimeric G-proteins modulate many processes essential for embryonic development including cellular proliferation, migration, differentiation, and survival. Although most research has focused on identifying the roles of the various alpha subtypes, there is growing recognition that similarly divergent beta gamma dimers also regulate these processes. In this paper, we show that targeted disruption of the mouse Gng5 gene encoding the gamma(5) subtype produces embryonic lethality associated with severe head and heart defects. Collectively, these results add to a growing body of data that identify critical roles for the gamma subunits in directing the assembly of functionally distinct G-alpha beta gamma trimers that are responsible for regulating diverse biological processes. Specifically, the finding that loss of the G-gamma(5) subtype is associated with a reduced number of cardiac precursor cells not only provides a causal basis for the mouse phenotype but also raises the possibility that G-beta gamma(5) dependent signaling contributes to the pathogenesis of human congenital heart problems.	[Moon, Anne M.; Stauffer, Anna M.; Schwindinger, William F.; Sheridan, Kathy; Firment, Ashley; Robishaw, Janet D.] Weis Ctr Res, Geisinger Clin, Danville, PA 17822 USA		Robishaw, JD (corresponding author), Weis Ctr Res, Geisinger Clin, Danville, PA 17822 USA.	jrobishaw@geisinger.edu		moon, anne/0000-0002-9090-1093	National Institutes of Health [NS 080083]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD044157] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R03NS080083] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by a National Institutes of Health R03 grant NS 080083 awarded to JR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	AHMAD W, 1995, CYTOGENET CELL GENET, V71, P44, DOI 10.1159/000134059; Akiva P, 2006, GENOME RES, V16, P30, DOI 10.1101/gr.4137606; Asano T, 2001, J NEUROCHEM, V79, P1129, DOI 10.1046/j.1471-4159.2001.00662.x; Blake JA, 2011, NUCLEIC ACIDS RES, V39, pD842, DOI 10.1093/nar/gkq1008; Bordeaux JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036559; Bunemann M, 2003, P NATL ACAD SCI USA, V100, P16077, DOI 10.1073/pnas.2536719100; Chen YB, 2013, CELL RES, V23, P186, DOI 10.1038/cr.2013.10; Chin AJ, 2012, MECH DEVELOP, V129, P75, DOI 10.1016/j.mod.2012.05.005; Cook LA, 2006, MOL CELL PROTEOMICS, V5, P671, DOI 10.1074/mcp.M500223-MCP200; Cook LA, 1998, BIOCHEMISTRY-US, V37, P12280, DOI 10.1021/bi980230e; Delcourt N, 2007, TRENDS PHARMACOL SCI, V28, P602, DOI 10.1016/j.tips.2007.09.007; Frank DU, 2002, DEVELOPMENT, V129, P4591; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Grimes AC, 2006, DEV BIOL, V290, P265, DOI 10.1016/j.ydbio.2005.11.042; HANSEN CA, 1994, J CELL BIOL, V126, P811, DOI 10.1083/jcb.126.3.811; Hurowitz EH, 2000, DNA RES, V7, P111, DOI 10.1093/dnares/7.2.111; Ilagan R, 2006, DEVELOPMENT, V133, P2435, DOI 10.1242/dev.02408; Jeong SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068781; Kelly RG, 2001, DEV CELL, V1, P435, DOI 10.1016/S1534-5807(01)00040-5; Kelly RG, 2012, CURR TOP DEV BIOL, V100, P33, DOI 10.1016/B978-0-12-387786-4.00002-6; Koval A, 2012, DRUG DISCOV TODAY, V17, P1316, DOI 10.1016/j.drudis.2012.07.007; Krejci P, 2009, HUM MUTAT, V30, P1245, DOI 10.1002/humu.21067; Kusters DM, 2012, EXPERT REV CARDIOVAS, V10, P363, DOI [10.1586/erc.11.196, 10.1586/ERC.11.196]; L'Hote D, 2007, GENETICS, V176, P1907, DOI 10.1534/genetics.107.072157; Leung T, 2006, BLOOD, V108, P160, DOI 10.1182/blood-2005-09-3706; Li F, 2013, J NEUROSCI, V33, P7975, DOI 10.1523/JNEUROSCI.5563-12.2013; Lobanova ES, 2008, J NEUROSCI, V28, P3510, DOI 10.1523/JNEUROSCI.0338-08.2008; Mikelis CM, 2013, J BIOL CHEM, V288, P12232, DOI 10.1074/jbc.M112.428599; Mittal A, 2010, MECH DEVELOP, V127, P472, DOI 10.1016/j.mod.2010.08.005; Morishita R, 1999, J NEUROCHEM, V73, P2369, DOI 10.1046/j.1471-4159.1999.0732369.x; Mukhopadhyay S, 2013, CELL, V152, P210, DOI 10.1016/j.cell.2012.12.026; Nakajima K, 2011, DEVELOPMENT, V138, P1771, DOI 10.1242/dev.059295; Offermanns S, 1997, SCIENCE, V275, P533, DOI 10.1126/science.275.5299.533; Offermanns S, 1998, EMBO J, V17, P4304, DOI 10.1093/emboj/17.15.4304; Ofori B, 2007, BRIT J CLIN PHARMACO, V64, P496, DOI 10.1111/j.1365-2125.2007.02905.x; Okae H, 2010, DEV DYNAM, V239, P1089, DOI 10.1002/dvdy.22256; Park EJ, 2008, DEVELOPMENT, V135, P3599, DOI 10.1242/dev.025437; Park EJ, 2006, DEVELOPMENT, V133, P2419, DOI 10.1242/dev.02367; Plummer NW, 2012, P NATL ACAD SCI USA, V109, P21366, DOI 10.1073/pnas.1219810110; Pyne NJ, 2011, TRENDS PHARMACOL SCI, V32, P443, DOI 10.1016/j.tips.2011.04.002; Robishaw Janet D, 2012, Subcell Biochem, V63, P181, DOI 10.1007/978-94-007-4765-4_10; Robishaw JD, 2004, CURR OPIN CELL BIOL, V16, P206, DOI 10.1016/j.ceb.2004.02.007; Rosen H, 2013, ANNU REV BIOCHEM, V82, P637, DOI 10.1146/annurev-biochem-062411-130916; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schwindinger WF, 2004, MOL CELL BIOL, V24, P7758, DOI 10.1128/MCB.24.17.7758-7768.2004; Schwindinger WF, 2003, J BIOL CHEM, V278, P6575, DOI 10.1074/jbc.M211132200; Schwindinger WF, 2012, J BIOL CHEM, V287, P7121, DOI 10.1074/jbc.M111.308395; Schwindinger WF, 2010, J BIOL CHEM, V285, P29787, DOI 10.1074/jbc.M110.142620; Schwindinger WF, 2009, AM J PHYSIOL-REG I, V297, pR1494, DOI 10.1152/ajpregu.00308.2009; Shen F, 2013, MOL PHARMACOL, V83, P691, DOI 10.1124/mol.112.082511; Smrcka AV, 2008, CELL MOL LIFE SCI, V65, P2191, DOI 10.1007/s00018-008-8006-5; Subbaiah VK, 2011, BIOCHEM J, V439, P195, DOI 10.1042/BJ20110903; van der Linde D, 2011, J AM COLL CARDIOL, V58, P2241, DOI 10.1016/j.jacc.2011.08.025; Walsh CT, 2008, MOL INTERV, V8, P165, DOI 10.1124/mi.8.4.8; Wang HY, 2006, CELL SIGNAL, V18, P934, DOI 10.1016/j.cellsig.2005.12.008; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; Winking H, 2004, CYTOGENET GENOME RES, V105, P251, DOI 10.1159/000078196; Yi P, 2008, DEV CELL, V15, P704, DOI 10.1016/j.devcel.2008.10.001; Yi P, 2006, SCIENCE, V313, P1301, DOI 10.1126/science.1127704; Yu SH, 1998, P NATL ACAD SCI USA, V95, P8715, DOI 10.1073/pnas.95.15.8715; Zhang JH, 2011, J NEUROCHEM, V119, P544, DOI 10.1111/j.1471-4159.2011.07457.x	61	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90970	10.1371/journal.pone.0090970	http://dx.doi.org/10.1371/journal.pone.0090970			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599258	Green Published, Green Submitted, gold			2022-12-27	WOS:000332479400149
J	Fransolet, M; Labied, S; Henry, L; Masereel, MC; Rozet, E; Kirschvink, N; Nisolle, M; Munaut, C				Fransolet, Maite; Labied, Soraya; Henry, Laurie; Masereel, Marie-Caroline; Rozet, Eric; Kirschvink, Nathalie; Nisolle, Michelle; Munaut, Carine			Strategies for Using the Sheep Ovarian Cortex as a Model in Reproductive Medicine	PLOS ONE			English	Article							TISSUE CRYOPRESERVATION; FERTILITY PRESERVATION; PRIMORDIAL FOLLICLES; FOLLICULAR VIABILITY; TRANSPLANTATION; RESERVE; DENSITY; BIOPSY; RESTORATION; PRIMATE	Objective: To evaluate and compare the distribution and density of primordial follicles within a whole sheep ovary and to gain insight into how to overcome the impact of natural follicular heterogeneity on the experimental results. Design: Histological study. Setting: Academic research center. Animals: Five-to nine-month-old ewes. Interventions: Freshly sampled whole sheep ovaries were collected and prepared for histological analysis. Main Outcome Measure(s): The follicular densities and distributions were determined for hematoxylin and eosin sections. A mathematical model was derived based on the follicle counts and Monte-Carlo simulations. Results: Heterogeneous distributions and densities of primordial follicles were identified 1) for distinct areas of the same ovarian cortex, 2) between the ovaries of the same animal and 3) across different ewes. A mathematical model based on the analysis of 37,153 primordial follicles from 8 different ovaries facilitated the estimation of the number of cortical biopsies and sections that had to be analyzed to overcome such heterogeneity. Conclusion: The influence of physiological follicular heterogeneity on experimental and clinical results can be overcome when a definite number of cortical pieces and sections are taken into consideration.	[Fransolet, Maite; Labied, Soraya; Henry, Laurie; Masereel, Marie-Caroline; Nisolle, Michelle; Munaut, Carine] Univ Liege, Lab Tumor & Dev Biol, GIGA R, Tour Pathol B23, Liege, Belgium; [Rozet, Eric] Univ Liege, Analyt Chem Lab, CIRM, Inst Pharm, Liege, Belgium; [Rozet, Eric] Arlenda SA, Liege, Belgium; [Kirschvink, Nathalie] Univ Namur UNamur, Vet Integrated Res Unit, Fac Sci, Namur Res Inst Life Sci NARILIS, Namur, Belgium; [Nisolle, Michelle] Univ Liege, Dept Obstet & Gynecol, Hop Citadelle, Liege, Belgium	University of Liege; University of Liege; University of Liege	Munaut, C (corresponding author), Univ Liege, Lab Tumor & Dev Biol, GIGA R, Tour Pathol B23, Liege, Belgium.	c.munaut@ulg.ac.be	Munaut, Carine/K-8138-2019	Kirschvink, Nathalie/0000-0003-1788-4212	"Fonds de la Recherche Scientifique" (F.R.S.-FNRS, Belgium); Interuniversity Attraction Poles program of the Belgian Science Policy (Brussels, Belgium); "Fonds Speciaux de la Recherche" (University of Liege, Belgium); "Fonds Leon Fredericq" (University of Liege, Belgium)	"Fonds de la Recherche Scientifique" (F.R.S.-FNRS, Belgium)(Fonds de la Recherche Scientifique - FNRS); Interuniversity Attraction Poles program of the Belgian Science Policy (Brussels, Belgium); "Fonds Speciaux de la Recherche" (University of Liege, Belgium); "Fonds Leon Fredericq" (University of Liege, Belgium)	This study was supported by grants from the "Fonds de la Recherche Scientifique" (F.R.S.-FNRS, Belgium), the Interuniversity Attraction Poles program of the Belgian Science Policy (Brussels, Belgium), the "Fonds Speciaux de la Recherche" (University of Liege, Belgium) and the "Fonds Leon Fredericq" (University of Liege, Belgium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer DF, 2004, ILAR J, V45, P212, DOI 10.1093/ilar.45.2.212; Aubard Y, 2001, FERTIL STERIL, V76, P414, DOI 10.1016/S0015-0282(01)01905-7; Baird DT, 1999, ENDOCRINOLOGY, V140, P462, DOI 10.1210/en.140.1.462; Bedaiwy MA, 2008, FERTIL STERIL, V90, P2031, DOI 10.1016/j.fertnstert.2008.08.009; Campos JR, 2011, CLINICS, V66, P2093, DOI 10.1590/S1807-59322011001200015; Chambers EL, 2010, HUM REPROD, V25, P2559, DOI 10.1093/humrep/deq192; Cortvrindt RG, 2001, FERTIL STERIL, V75; Courbiere B, 2005, FERTIL STERIL, V84, P1065, DOI 10.1016/j.fertnstert.2005.03.079; David A, 2011, FERTIL STERIL, V95, P1241, DOI 10.1016/j.fertnstert.2010.06.007; Demeestere I, 2012, OBSTET GYNECOL INT, V2012, DOI 10.1155/2012/961232; Dolmans MM, 2013, J ASSIST REPROD GEN, V30, P305, DOI 10.1007/s10815-013-9952-x; Donnez J, 2013, FERTIL STERIL, V99, P1503, DOI 10.1016/j.fertnstert.2013.03.030; Donnez J, 2010, BEST PRACT RES CL OB, V24, P87, DOI 10.1016/j.bpobgyn.2009.09.003; Gerritse R, 2008, HUM REPROD, V23, P329, DOI 10.1093/humrep/dem384; GOSDEN RG, 1994, HUM REPROD, V9, P597, DOI 10.1093/oxfordjournals.humrep.a138556; Kim SS, 2006, FERTIL STERIL, V85, P1, DOI 10.1016/j.fertnstert.2005.04.071; Lambalk CB, 2004, HUM REPROD, V19, P1055, DOI 10.1093/humrep/deh216; Lass A, 2004, HUM REPROD, V19, P467, DOI 10.1093/humrep/deh118; Lass A, 1997, HUM REPROD, V12, P1028; Lornage J, 2006, Gynecol Obstet Fertil, V34, P746, DOI 10.1016/j.gyobfe.2006.07.024; Lundy T, 1999, J REPROD FERTIL, V115, P251, DOI 10.1530/jrf.0.1150251; MUNN CS, 1986, RADIOLOGY, V159, P731, DOI 10.1148/radiology.159.3.3517957; Nisolle M, 2000, FERTIL STERIL, V74, P122, DOI 10.1016/S0015-0282(00)00548-3; Oktay K, 2000, MOL CELL ENDOCRINOL, V169, P105, DOI 10.1016/S0303-7207(00)00361-0; Poirot C, 2002, HUM REPROD, V17, P1447, DOI 10.1093/humrep/17.6.1447; Qu JP, 2000, HUM REPROD, V15, P302, DOI 10.1093/humrep/15.2.302; Sauvat F, 2013, FASEB J, V27, P1511, DOI 10.1096/fj.12-218297; Schmidt KLT, 2003, HUM REPROD, V18, P1158, DOI 10.1093/humrep/deg246; Sharara FI, 2004, HUM REPROD, V19, P470, DOI 10.1093/humrep/deh110; Soleimani R, 2006, HUM REPROD, V21, P1720, DOI 10.1093/humrep/del057; Tilly Jonathan L, 2003, Reprod Biol Endocrinol, V1, P11, DOI 10.1186/1477-7827-1-11; VandeBerg JL, 2004, GYNECOL OBSTET INVES, V57, P6	32	27	27	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91073	10.1371/journal.pone.0091073	http://dx.doi.org/10.1371/journal.pone.0091073			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614306	gold, Green Published, Green Submitted			2022-12-27	WOS:000332839300072
J	Brown, GT; Cash, BG; Blihoghe, D; Johansson, P; Alnabulsi, A; Murray, GI				Brown, Gordon T.; Cash, Beatriz Gimenez; Blihoghe, Daniela; Johansson, Petronella; Alnabulsi, Ayham; Murray, Graeme I.			The Expression and Prognostic Significance of Retinoic Acid Metabolising Enzymes in Colorectal Cancer	PLOS ONE			English	Article							TUMOR-SPECIFIC EXPRESSION; HUMAN BREAST-CANCER; HUMAN CYTOCHROME-P450; PROSTATE-CANCER; ACYLTRANSFERASE EXPRESSION; MICROSATELLITE INSTABILITY; CYP26 INHIBITORS; REDUCED LECITHIN; COLON-CANCER; VITAMIN-A	Colorectal cancer is one of the most common types of cancer with over fifty percent of patients presenting at an advanced stage. Retinoic acid is a metabolite of vitamin A and is essential for normal cell growth and aberrant retinoic acid metabolism is implicated in tumourigenesis. This study has profiled the expression of retinoic acid metabolising enzymes using a well characterised colorectal cancer tissue microarray containing 650 primary colorectal cancers, 285 lymph node metastasis and 50 normal colonic mucosal samples. Immunohistochemistry was performed on the tissue microarray using monoclonal antibodies which we have developed to the retinoic acid metabolising enzymes CYP26A1, CYP26B1, CYP26C1 and lecithin retinol acyl transferase (LRAT) using a semi-quantitative scoring scheme to assess expression. Moderate or strong expression of CYP26A1 was observed in 32.5% of cancers compared to 10% of normal colonic epithelium samples (p<0.001). CYP26B1 was moderately or strongly expressed in 25.2% of tumours and was significantly less expressed in normal colonic epithelium (p<0.001). CYP26C1 was not expressed in any sample. LRAT also showed significantly increased expression in primary colorectal cancers compared with normal colonic epithelium (p<0.001). Strong CYP26B1 expression was significantly associated with poor prognosis (HR =1.239, 95%CI =1.104-1.390, chi(2) = 15.063, p =0.002). Strong LRAT was also associated with poorer outcome (HR= 1.321, 95%CI = 1.034-1.688, chi(2) = 5.039, p =0.025). In mismatch repair proficient tumours strong CYP26B1 (HR 1.330, 95%CI =1.173-1.509, chi(2) 21.493, p<0.001) and strong LRAT (HR =1.464, 950/0CI=1.110-1.930, chi(2) = 7.425, p= 0.006) were also associated with poorer prognosis. This study has shown that the retinoic acid metabolising enzymes CYP26A1, CYP26B1 and LRAT are significantly overexpressed in colorectal cancer and that CYP26B1 and LRAT are significantly associated with prognosis both in the total cohort and in those tumours which are mismatch repair proficient. CYP26B1 was independently prognostic in a multivariate model both in the whole patient cohort (HR =1.177, 95%CI =1.020-1.216, p=0.026) and in mismatch repair proficient tumours (HR = 1.255, 950/0CI = 1.073 - 1.467, p =0.004).	[Brown, Gordon T.; Murray, Graeme I.] Univ Aberdeen, Sch Med & Dent, Div Appl Med, Aberdeen, Scotland; [Cash, Beatriz Gimenez; Alnabulsi, Ayham] Vertebrate Antibodies, Aberdeen, Scotland; [Blihoghe, Daniela] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Zool, IL-69978 Tel Aviv, Israel; [Johansson, Petronella] Univ Aberdeen, Sch Biol Sci, Scottish Fish Immunol Res Ctr, Aberdeen, Scotland	University of Aberdeen; Tel Aviv University; University of Aberdeen	Murray, GI (corresponding author), Univ Aberdeen, Sch Med & Dent, Div Appl Med, Aberdeen, Scotland.	g.i.murray@abdn.ac.uk			University of Aberdeen Development Trust; Encompass	University of Aberdeen Development Trust; Encompass	The study was funded by University of Aberdeen Development Trust (http://www.abdn.ac.uk/giving/) and Encompass (http://www.encompassscotland.co.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar M, 2005, DRUG METAB REV, V37, P379, DOI 10.1081/DMR-200046136; Amengual J, 2012, J BIOL CHEM, V287, P24216, DOI 10.1074/jbc.M112.353979; Arnold C, 2010, PHARMACOL REP, V62, P536, DOI 10.1016/S1734-1140(10)70311-X; Ben-Amotz O, 2010, EXPERT REV ANTICANC, V10, P1559, DOI [10.1586/era.10.139, 10.1586/ERA.10.139]; Blomhoff R, 2006, J NEUROBIOL, V66, P606, DOI 10.1002/neu.20242; Bohanes P, 2011, SEMIN ONCOL, V38, P576, DOI 10.1053/j.seminoncol.2011.05.012; Boland CR, 2010, GASTROENTEROLOGY, V138, P2073, DOI [10.1053/j.gastro.2009.12.064, 10.1053/j.gastro.2010.04.024]; Boorjian S, 2004, CLIN CANCER RES, V10, P3429, DOI 10.1158/1078-0432.CCR-03-0756; Brueggemeier RW, 2005, ENDOCR REV, V26, P331, DOI 10.1210/er.2004-0015; Chen C, 2013, CURR TOP MED CHEM, V13, P1454; Chen Q, 2011, CURR DRUG METAB, V12, P436, DOI 10.2174/138920011795495259; Clarke SJ, 2013, CRIT REV ONCOL HEMAT, V85, P121, DOI 10.1016/j.critrevonc.2012.06.001; Coghlin C, 2013, PROTEOMICS, V13, P2227, DOI 10.1002/pmic.201300245; Coghlin C, 2010, J PATHOL, V222, P1, DOI 10.1002/path.2727; Correia MA, 2011, DRUG METAB REV, V43, P1, DOI 10.3109/03602532.2010.515222; Cunningham D, 2010, LANCET, V375, P1030, DOI 10.1016/S0140-6736(10)60353-4; Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235; Fleming I, 2011, CURR OPIN LIPIDOL, V22, P403, DOI 10.1097/MOL.0b013e32834a9790; Geiersbach KB, 2011, ARCH PATHOL LAB MED, V135, P1269, DOI 10.5858/arpa.2011-0035-RA; Gelboin HV, 2006, J CLIN PHARMACOL, V46, P353, DOI 10.1177/0091270005285200; George B, 2011, CURR ONCOL REP, V13, P206, DOI 10.1007/s11912-011-0162-3; Goel A, 2012, GASTROENTEROLOGY, V143, P1442, DOI 10.1053/j.gastro.2012.09.032; Gomaa MS, 2012, BIOORGAN MED CHEM, V20, P6080, DOI 10.1016/j.bmc.2012.08.044; Gomaa MS, 2012, BIOORGAN MED CHEM, V20, P4201, DOI 10.1016/j.bmc.2012.05.076; Gomaa MS, 2008, BIOORGAN MED CHEM, V16, P8301, DOI 10.1016/j.bmc.2007.06.048; Guengerich FP, 2011, PHARMACOL REV, V63, P684, DOI 10.1124/pr.110.003525; Guo XJ, 2002, CANCER RES, V62, P1654; Helvig C, 2011, J PHARMACOL TOX MET, V64, P258, DOI 10.1016/j.vascn.2011.08.005; Hope NR, 2011, HUM PATHOL, V42, P393, DOI 10.1016/j.humpath.2010.08.006; Hrycay EG, 2012, ARCH BIOCHEM BIOPHYS, V522, P71, DOI 10.1016/j.abb.2012.01.003; Huttunen KM, 2008, CURR MED CHEM, V15, P2346, DOI 10.2174/092986708785909120; Kabat GC, 2012, EUR J CLIN NUTR, V66, P549, DOI 10.1038/ejcn.2011.207; Karlgren M, 2007, EXPERT OPIN THER TAR, V11, P61, DOI 10.1517/14728222.11.1.61; Kelley RK, 2011, J NATL COMPR CANC NE, V9, P1293, DOI 10.6004/jnccn.2011.0105; Kumarakulasingham M, 2005, CLIN CANCER RES, V11, P3758, DOI 10.1158/1078-0432.CCR-04-1848; Leroux F, 2005, CURR MED CHEM, V12, P1623, DOI 10.2174/0929867054367185; Lutz JD, 2009, BIOCHEM PHARMACOL, V77, P258, DOI 10.1016/j.bcp.2008.10.012; Lyall MS, 2006, CLIN CANCER RES, V12, P1184, DOI 10.1158/1078-0432.CCR-05-1864; Malesci A, 2012, DIGEST DIS, V30, P296, DOI 10.1159/000336996; Murray GI, 1998, GUT, V43, P791, DOI 10.1136/gut.43.6.791; MURRAY GI, 1993, CANCER-AM CANCER SOC, V71, P36, DOI 10.1002/1097-0142(19930101)71:1<36::AID-CNCR2820710107>3.0.CO;2-J; Murray GI, 1997, CANCER RES, V57, P3026; MURRAY GI, 1991, BRIT J CANCER, V63, P1021, DOI 10.1038/bjc.1991.222; Murray GI, 2001, ANNU REV PHARMACOL, V41, P297, DOI 10.1146/annurev.pharmtox.41.1.297; Murray GI, 1999, BRIT J CANCER, V79, P1836, DOI 10.1038/sj.bjc.6690292; Murray GI, 2010, HISTOPATHOLOGY, V57, P202, DOI 10.1111/j.1365-2559.2010.03606.x; Nebert DW, 2006, NAT REV CANCER, V6, P947, DOI 10.1038/nrc2015; Niwa T, 2011, CURR DRUG METAB, V12, P549; Njar VCO, 2002, MINI-REV MED CHEM, V2, P261, DOI 10.2174/1389557023406223; O'Dwyer D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027718; Omura T, 2010, J BIOCHEM, V147, P297, DOI 10.1093/jb/mvq001; Osanai M, 2005, MOL PHARMACOL, V67, P1808, DOI 10.1124/mol.104.005769; Panigrahy D, 2010, CANCER METAST REV, V29, P723, DOI 10.1007/s10555-010-9264-x; Park EY, 2012, NUTR CANCER, V64, P732, DOI 10.1080/01635581.2012.687425; Patterson LH, 2002, CURR PHARM DESIGN, V8, P1335, DOI 10.2174/1381612023394502; Pautus S, 2009, J ENZYM INHIB MED CH, V24, P487, DOI [10.1080/14756360802218334, 10.1080/14756360802218334 ]; Pritchard CC, 2011, GUT, V60, P116, DOI 10.1136/gut.2009.206250; Ralton LD, 2010, CURR PROTEOMICS, V7, P212; Rawson JB, 2012, EXPERT REV MOL DIAGN, V12, P499, DOI [10.1586/erm.12.39, 10.1586/ERM.12.39]; Rodriguez-Antona C, 2010, HUM GENET, V127, P1, DOI 10.1007/s00439-009-0748-0; Ross AC, 2011, ANNU REV NUTR, V31, P65, DOI 10.1146/annurev-nutr-072610-145127; Ruiz A, 2010, EXP EYE RES, V90, P186, DOI 10.1016/j.exer.2009.07.002; Sheren-Manoff M, 2006, INT J ONCOL, V29, P1193; Shou M, 2009, DRUG METAB DISPOS, V37, P925, DOI 10.1124/dmd.108.025718; Spector AA, 2009, J LIPID RES, V50, pS52, DOI 10.1194/jlr.R800038-JLR200; Stein MN, 2012, CLIN CANCER RES, V18, P1848, DOI 10.1158/1078-0432.CCR-11-1805; Stenstedt K, 2012, ANTICANCER RES, V32, P3869; Sutherland M, 2013, MOL CANCER THER, V12, P27, DOI 10.1158/1535-7163.MCT-12-0405; Thatcher JE, 2009, EXPERT OPIN DRUG MET, V5, P875, DOI 10.1517/17425250903032681; Topletz AR, 2012, BIOCHEM PHARMACOL, V83, P149, DOI 10.1016/j.bcp.2011.10.007; Travica S, 2013, CLIN CANCER RES, V19, P2952, DOI 10.1158/1078-0432.CCR-13-0238; Williams GT, 2007, DATASET COLORECTAL C, P1; Xu DH, 2012, BIOCHEM BIOPH RES CO, V428, P518, DOI 10.1016/j.bbrc.2012.10.071; Yu W, 2012, TOXICOL APPL PHARM, V264, P73, DOI 10.1016/j.taap.2012.07.019	74	35	36	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90776	10.1371/journal.pone.0090776	http://dx.doi.org/10.1371/journal.pone.0090776			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608339	Green Published, gold, Green Submitted			2022-12-27	WOS:000332485800050
J	Hartwig, SM; Holman, KM; Varga, SM				Hartwig, Stacey M.; Holman, Kaitlyn M.; Varga, Steven M.			Depletion of Alveolar Macrophages Ameliorates Virus-Induced Disease following a Pulmonary Coronavirus Infection	PLOS ONE			English	Article							ACUTE-RESPIRATORY-SYNDROME; REGULATORY T-CELLS; SARS-ASSOCIATED CORONAVIRUS; GENOME SEQUENCE; SYNCYTIAL VIRUS; MICE; IDENTIFICATION; RESISTANT; RESPONSES; OUTBREAK	Coronavlruses cause respiratory disease humans that can range from mild to severe. However, the pathogenesis of pulmonary coronavirus infections poorly understood Mouse hepatitis virus type 1 (MHV-1) is a group 2 coronavirus capable of causing severe morbidity and mortality in highly CD4 and CD8 T cells play a critical role in mediating macrophages (AM) in modulating h Id range adaptive immune response and subsequen hepatitis type susceptible C3H/He mice. MHV-1-induced disease. Here e. However, he pathogenesis of MHV-1) a group 2 coronavirus e have previously shown that both we evaluated the role of alveolar disease. Depletion of AM using clodronate liposornes administered prior to MHV-1 infection was associated h a sign induced morbidity and mortality. A depletion resulted in a decreased number of virus airways. In addition, a significant increase in the frequency and total number of T e as observed following MHV-1 infection in mice depleted of A Our results Modulating MHV-1-induced morbidity and mortality.	[Hartwig, Stacey M.; Holman, Kaitlyn M.; Varga, Steven M.] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA; [Varga, Steven M.] Univ Iowa, Interdisciplinary Grad Program Immunol, Iowa City, IA USA; [Varga, Steven M.] Univ Iowa, Dept Pathol, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa	Varga, SM (corresponding author), Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA.	steven-varga@uiowa.edu	Varga, Steven/C-2009-2009	Varga, Steven/0000-0001-7332-4290	National Institutes of Health [R21 A1083482, R56 A1106776]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI106776, R21AI083482] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grants R21 A1083482 and R56 A1106776 to SMV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida J D, 1967, J Gen Virol, V1, P175, DOI 10.1099/0022-1317-1-2-175; Betts RJ, 2012, J VIROL, V86, P2817, DOI 10.1128/JVI.05685-11; Castilow EM, 2008, J VIROL, V82, P2196, DOI 10.1128/JVI.01949-07; De Albuquerque N, 2006, J VIROL, V80, P10382, DOI 10.1128/JVI.00747-06; Fouchier RAM, 2003, NATURE, V423, P240, DOI 10.1038/423240a; Fulton RB, 2010, J IMMUNOL, V185, P2382, DOI 10.4049/jimmunol.1000423; HAMRE D, 1966, P SOC EXP BIOL MED, V121, P190, DOI 10.3181/00379727-121-30734; Holmes KV, 2003, NEW ENGL J MED, V348, P1948, DOI 10.1056/NEJMp030078; HOLT PG, 1993, J EXP MED, V177, P397, DOI 10.1084/jem.177.2.397; Khanolkar A, 2010, J IMMUNOL, V185, P1132, DOI 10.4049/jimmunol.0902749; Khanolkar A, 2009, J VIROL, V83, P9258, DOI 10.1128/JVI.00355-09; Khanolkar A, 2009, J VIROL, V83, P8946, DOI 10.1128/JVI.01857-08; Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781; Lee N, 2003, NEW ENGL J MED, V348, P1986, DOI 10.1056/NEJMoa030685; Marra MA, 2003, SCIENCE, V300, P1399, DOI 10.1126/science.1085953; Masopust D, 2007, J VIROL, V81, P2002, DOI 10.1128/JVI.01459-06; McDermott DS, 2011, J IMMUNOL, V187, P5568, DOI 10.4049/jimmunol.1102104; Mills KHG, 2004, NAT REV IMMUNOL, V4, P841, DOI 10.1038/nri1485; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Poutanen SM, 2003, NEW ENGL J MED, V348, P1995, DOI 10.1056/NEJMoa030634; Pribul PK, 2008, J VIROL, V82, P4441, DOI 10.1128/JVI.02541-07; Rai D, 2009, J IMMUNOL, V183, P7672, DOI 10.4049/jimmunol.0902874; Rivera R, 2007, VIROLOGY, V363, P48, DOI 10.1016/j.virol.2007.01.033; Savage NDL, 2008, J IMMUNOL, V181, P2220, DOI 10.4049/jimmunol.181.3.2220; Soroosh P, 2013, J EXP MED, V210, P775, DOI 10.1084/jem.20121849; STRICKLAND DH, 1993, IMMUNOLOGY, V80, P266; TAGUCHI F, 1981, INFECT IMMUN, V34, P1059, DOI 10.1128/IAI.34.3.1059-1061.1981; TYRRELL DAJ, 1965, BMJ-BRIT MED J, V1, P1467, DOI 10.1136/bmj.1.5448.1467; van der Hoek L, 2004, NAT MED, V10, P368, DOI 10.1038/nm1024; VOGEL SN, 1979, J IMMUNOL, V122, P619; Woo PCY, 2005, J VIROL, V79, P884, DOI 10.1128/JVI.79.2.884-895.2005; Zhao JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000636; Zhao Z, 2003, J MED MICROBIOL, V52, P715, DOI 10.1099/jmm.0.05320-0; Zhong NS, 2003, LANCET, V362, P1353, DOI 10.1016/S0140-6736(03)14630-2	34	22	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90720	10.1371/journal.pone.0090720	http://dx.doi.org/10.1371/journal.pone.0090720			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608125	gold, Green Submitted, Green Published			2022-12-27	WOS:000332485800047
J	Nome, T; Hoff, AM; Bakken, AC; Rognum, TO; Nesbakken, A; Skotheim, RI				Nome, Torfinn; Hoff, Andreas M.; Bakken, Anne Cathrine; Rognum, Torleiv O.; Nesbakken, Arild; Skotheim, Rolf I.			High Frequency of Fusion Transcripts Involving TCF7L2 in Colorectal Cancer: Novel Fusion Partner and Splice Variants	PLOS ONE			English	Article							HUMAN GENOME; HUMAN-CELLS; GENE FUSION; WNT PATHWAY; INSTABILITY	VTI1A-TCF7L2 was reported as a recurrent fusion gene in colorectal cancer (CRC), found to be expressed in three out of 97 primary cancers, and one cell line, NCI-H508, where a genomic deletion joins the two genes [ 1]. To investigate this fusion further, we analyzed high-throughput DNA and RNA sequencing data from seven CRC cell lines, and identified the gene RP11-57H14.3 (ENSG00000225292) as a novel fusion partner for TCF7L2. The fusion was discovered from both genome and transcriptome data in the HCT116 cell line. By triplicate nested RT-PCR, we tested both the novel fusion transcript and VTI1A-TCF7L2 for expression in a series of 106 CRC tissues, 21 CRC cell lines, 14 normal colonic mucosa, and 20 normal tissues from miscellaneous anatomical sites. Altogether, 42% and 45% of the CRC samples expressed VTI1A-TCF7L2 and TCF7L2-RP11-57H14.3 fusion transcripts, respectively. The fusion transcripts were both seen in 29% of the normal colonic mucosa samples, and in 25% and 75% of the tested normal tissues from other organs, revealing that the TCF7L2 fusion transcripts are neither specific to cancer nor to the colon and rectum. Seven different splice variants were detected for the VTI1A-TCF7L2 fusion, of which three are novel. Four different splice variants were detected for the TCF7L2-RP11-57H14.3 fusion. In conclusion, we have identified novel variants of VTI1A-TCF7L2 fusion transcripts, including a novel fusion partner gene, RP11-57H14.3, and demonstrated detectable levels in a large fraction of CRC samples, as well as in normal colonic mucosa and other tissue types. We suggest that the fusion transcripts observed in a high frequency of samples are transcription induced chimeras that are expressed at low levels in most samples. The similar fusion transcripts induced by genomic rearrangements observed in individual cancer cell lines may yet have oncogenic potential as suggested in the original study by Bass et al.	[Nome, Torfinn; Hoff, Andreas M.; Bakken, Anne Cathrine; Skotheim, Rolf I.] Oslo Univ Hosp, Norwegian Radium Hosp, Inst Canc Res, Dept Canc Prevent, Oslo, Norway; [Nome, Torfinn; Hoff, Andreas M.; Bakken, Anne Cathrine; Nesbakken, Arild; Skotheim, Rolf I.] Univ Oslo, Fac Med, Ctr Canc Biomed, Oslo, Norway; [Rognum, Torleiv O.] Univ Oslo, Oslo, Norway; [Rognum, Torleiv O.] Norwegian Inst Publ Hlth, Div Forens Med, Dept Forens Pathol & Clin Forens Med, Oslo, Norway; [Nesbakken, Arild] Oslo Univ Hosp Aker, Dept Gastrointestinal Surg, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; Norwegian Institute of Public Health (NIPH); University of Oslo	Skotheim, RI (corresponding author), Oslo Univ Hosp, Norwegian Radium Hosp, Inst Canc Res, Dept Canc Prevent, Oslo, Norway.	rolf.i.skotheim@rr-research.no	Nome, Torfinn/E-5475-2015; Skotheim, Rolf I./H-6192-2017	Nome, Torfinn/0000-0003-1659-132X; Skotheim, Rolf I./0000-0002-5609-4048; Hoff, Andreas Midboe/0000-0002-6955-6678	Norwegian Cancer Society [PR-2007-0166]; NorStore [NS9013K]; Research Council of Norway through its Centres of Excellence funding scheme [179571]	Norwegian Cancer Society(Norwegian Cancer Society); NorStore; Research Council of Norway through its Centres of Excellence funding scheme	The study was funded by grants from the Norwegian Cancer Society (TN and AMH were financed as PhD-students from the PR-2007-0166 grant to RIS), NorStore (for storage of computer files; project NS9013K), and partly supported by the Research Council of Norway through its Centres of Excellence funding scheme, project number 179571. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed D, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.35; Akiva P, 2006, GENOME RES, V16, P30, DOI 10.1101/gr.4137606; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bass AJ, 2011, NAT GENET, V43, P964, DOI 10.1038/ng.936; Berg M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013978; Diep CB, 2003, J CLIN ONCOL, V21, P820, DOI 10.1200/JCO.2003.05.190; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Kim RN, 2012, FUNCT INTEGR GENOMIC, V12, P45, DOI 10.1007/s10142-011-0260-1; Li H, 2008, SCIENCE, V321, P1357, DOI 10.1126/science.1156725; Li H, 2009, CELL CYCLE, V8, P218, DOI 10.4161/cc.8.2.7358; LOTHE RA, 1993, CANCER RES, V53, P5849; McPherson A, 2012, GENOME RES, V22, P2250, DOI 10.1101/gr.136572.111; McPherson A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001138; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; NIGRO JM, 1991, CELL, V64, P607, DOI 10.1016/0092-8674(91)90244-S; Nome T, 2013, TRANSL ONCOL, V6, P546, DOI 10.1593/tlo.13457; ODELBERG SJ, 1995, NUCLEIC ACIDS RES, V23, P2049, DOI 10.1093/nar/23.11.2049; Parra G, 2006, GENOME RES, V16, P37, DOI 10.1101/gr.4145906; Prakash T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013284; Rozen S, 2000, Methods Mol Biol, V132, P365; Salzman J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030733; Sawyers CL, 1999, NEW ENGL J MED, V340, P1330, DOI 10.1056/NEJM199904293401706; Segditsas S, 2006, ONCOGENE, V25, P7531, DOI 10.1038/sj.onc.1210059; Thorstensen L, 2005, NEOPLASIA, V7, P99, DOI 10.1593/neo.04448; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679	26	20	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91264	10.1371/journal.pone.0091264	http://dx.doi.org/10.1371/journal.pone.0091264			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608966	Green Published, gold, Green Submitted			2022-12-27	WOS:000332485800119
J	Ong, J; Salomon, J; te Morsche, RHM; Roelofs, HMJ; Witteman, BJM; Dura, P; Lacko, M; Peters, WHM				Ong, Jennie; Salomon, Jody; te Morsche, Rene H. M.; Roelofs, Hennie M. J.; Witteman, Ben J. M.; Dura, Polat; Lacko, Martin; Peters, Wilbert H. M.			Polymorphisms in the Insulin-Like Growth Factor Axis Are Associated with Gastrointestinal Cancer	PLOS ONE			English	Article							CIRCULATING LEVELS; FACTOR-I; IGF-I; BINDING PROTEIN-3; BREAST-CANCER; FACTOR SYSTEM; RISK; IGFBP-3; OBESITY; GENES	Introduction: Numerous factors influence the development of gastrointestinal (GI) cancer. The insulin-like growth factor (IGF) axis plays a role in embryonic and postnatal growth and tissue repair. Elevated levels of IGFs, low levels of IGF binding proteins (IGFBPs) and over-expression of IGF receptor (IGFR-I) were associated with several stages of cancer. Here, the prevalence of the single nucleotide polymorphisms (SNPs) rs6214 in the IGF type I (IGF-I) gene and rs6898743 in the growth hormone receptor (GHR) gene in patients with GI cancer and controls was studied. Materials & Methods: In this Dutch case-control study, DNA isolated from blood of 1,457 GI cancer patients; 438 patients with head and neck cancer (HNC), 475 with esophageal cancer (EC) and 544 with colorectal cancer (CRC) and 1,457 matched controls, was used to determine the rs6214 and rs6898743 genotypes by polymerase chain reaction. The association between these SNPs and GI cancer, HNC, esophageal adenocarcinoma (EAC), esophageal squamous-cell carcinoma (ESCC) and proximal or distal CRC was studied. Odds ratios (ORs) with 95% confidence interval (95% CI) were calculated via unconditional logistic regression. Results: Overall for GI cancer, the ORs for SNPs rs6214 and rs6898743 were approximately 1.0 (p-value>0.05), using the most common genotypes GG as reference. An OR of 1.54 (95% CI, 1.05-2.27) was found for EC for genotype AA of rs6214. The ORs for EAC were 1.45 (95% CI, 1.04-2.01) and 1.71 (95% CI, 1.10-2.68), for genotypes GA and AA, respectively. Genotype GC of rs6898743 showed an OR of 0.47 (95% CI, 0.26-0.86) for ESCC. Conclusion: The A allele of SNP rs6214 in the IGF-I gene was associated with EAC, and with HNC in women. The GC genotype of rs6898743 in the GHR gene was negatively associated with ESCC.	[Ong, Jennie; Salomon, Jody; te Morsche, Rene H. M.; Roelofs, Hennie M. J.; Dura, Polat; Peters, Wilbert H. M.] Radboud Univ Nijmegen, Med Ctr, Dept Gastroenterol, NL-6525 ED Nijmegen, Netherlands; [Witteman, Ben J. M.] Hosp Gelderse Vallei, Dept Gastroenterol, Ede, Netherlands; [Lacko, Martin] Maastricht Univ, Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Maastricht, Netherlands	Radboud University Nijmegen; Gelderse Vallei Hospital; Maastricht University	Peters, WHM (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Gastroenterol, NL-6525 ED Nijmegen, Netherlands.	w.peters@mdl.umcn.nl	te Morsche, R/P-9143-2015; Peters, W.H.M./L-4572-2015					Al-Zahrani A, 2006, HUM MOL GENET, V15, P1, DOI 10.1093/hmg/ddi398; [Anonymous], 2013, CURR PROB SURG, V50, P192, DOI 10.1067/j.cpsurg.2013.01.004; Boeing H, 2013, BEST PRACT RES CL EN, V27, P219, DOI 10.1016/j.beem.2013.04.005; Bonapace G, 2003, J MED GENET, V40, P913, DOI 10.1136/jmg.40.12.913; Canzian F, 2006, BRIT J CANCER, V94, P299, DOI 10.1038/sj.bjc.6602936; Chatterjee S, 2009, BIOL CELL, V101, P251, DOI 10.1042/BC20080104; Chhabra Y, 2011, EXPERT REV ENDOCRINO, V6, P71, DOI [10.1586/eem.10.73, 10.1586/EEM.10.73]; D'Aloisio AA, 2009, CANCER EPIDEM BIOMAR, V18, P954, DOI 10.1158/1055-9965.EPI-08-0856; Denley A, 2005, CYTOKINE GROWTH F R, V16, P421, DOI 10.1016/j.cytogfr.2005.04.004; Estivariz CF, 1997, ENDOCRINE, V7, P65, DOI 10.1007/BF02778066; Feik E, 2010, CANCER CAUSE CONTROL, V21, P91, DOI 10.1007/s10552-009-9438-4; Gallagher EJ, 2011, ENDOCRINOLOGY, V152, P2546, DOI 10.1210/en.2011-0231; Giovannucci E, 2000, CANCER EPIDEM BIOMAR, V9, P345; Haggar Fatima A, 2009, Clin Colon Rectal Surg, V22, P191, DOI 10.1055/s-0029-1242458; Hernandez W, 2007, CARCINOGENESIS, V28, P2154, DOI 10.1093/carcin/bgm190; Ho SMY, 2003, CANCER EPIDEM BIOMAR, V12, P426; Hwa V, 1999, ENDOCR REV, V20, P761, DOI 10.1210/er.20.6.761; IARC, GLOBOCAN 2008; Ionescu M, 2006, J CLIN ENDOCR METAB, V91, P4792, DOI 10.1210/jc.2006-1702; Kaskel F, 2003, KIDNEY INT, V64, P1141, DOI 10.1046/j.1523-1755.2003.00194.x; Kelemen LE, 2008, NAT REV CANCER, V8, P812, DOI 10.1038/nrc2466; Kim HJ, 2012, EXP THER MED, V3, P93, DOI 10.3892/etm.2011.372; LeRoith D, 2003, CANCER LETT, V195, P127, DOI 10.1016/S0304-3835(03)00159-9; Ma J, 2000, GROWTH HORM IGF RES, V10, pS28, DOI 10.1016/S1096-6374(00)90013-3; MACAULAY VM, 1992, BRIT J CANCER, V65, P311, DOI 10.1038/bjc.1992.65; McElholm AR, 2010, GASTROENTEROLOGY, V139, P204, DOI 10.1053/j.gastro.2010.04.014; Nakao M, 2011, INT J MOL EPIDEMIOL, V2, P354; NCBI, RS6214 NCBI; NCBI, RS6898743 NCIBI; Renehan AG, 2006, TRENDS ENDOCRIN MET, V17, P328, DOI 10.1016/j.tem.2006.08.006; Samani AA, 2007, ENDOCR REV, V28, P20, DOI 10.1210/er.2006-0001; Yu H, 2000, JNCI-J NATL CANCER I, V92, P1472, DOI 10.1093/jnci/92.18.1472; Zhao J, 2007, HUM REPROD, V22, P1789, DOI 10.1093/humrep/dem052; Zhivotovskiy AS, 2012, ASIAN PAC J CANCER P, V13, P5183, DOI 10.7314/APJCP.2012.13.10.5183	34	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90916	10.1371/journal.pone.0090916	http://dx.doi.org/10.1371/journal.pone.0090916			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608110	Green Published, Green Submitted, gold			2022-12-27	WOS:000332485800065
J	Aylagas, E; Borja, A; Rodriguez-Ezpeleta, N				Aylagas, Eva; Borja, Angel; Rodriguez-Ezpeleta, Naiara			Environmental Status Assessment Using DNA Metabarcoding: Towards a Genetics Based Marine Biotic Index (gAMBI)	PLOS ONE			English	Article							OXIDASE SUBUNIT-I; COMMUNITY; HABITATS; PRIMERS; HEALTH; AMBI	Marine ecosystem protection and conservation initiatives rely on the assessment of ecological integrity and health status of marine environments. The AZTI's Marine Biotic Index (AMBI), which consists on using macroinvertebrate diversity as indicator of ecosystem health, is used worldwide for this purpose. Yet, this index requires taxonomic assignment of specimens, which typically involves a time and resource consuming visual identification of each sample. DNA barcoding or metabarcoding are potential harmonized, faster and cheaper alternatives for species identification, although the suitability of these methods for easing the implementation of the AMBI is yet to be evaluated. Here, we analyze the requirements for the implementation of a genetics based AMBI (gAMBI), and show, using available sequence data, that information about presence/absence of the most frequently occurring species provides accurate AMBI values. Our results set the basics for the implementation of the gAMBI, which has direct implications for a faster and cheaper marine monitoring and health status assessment.	[Aylagas, Eva; Borja, Angel; Rodriguez-Ezpeleta, Naiara] AZTI Tecnalia, Div Marine Res, Sukarrieta, Bizkaia, Spain	AZTI	Rodriguez-Ezpeleta, N (corresponding author), AZTI Tecnalia, Div Marine Res, Sukarrieta, Bizkaia, Spain.	nrodriguez@azti.es	Rodriguez-Ezpeleta, Naiara/B-7138-2014; Borja, Angel/I-3665-2018	Rodriguez-Ezpeleta, Naiara/0000-0001-6735-6755; Borja, Angel/0000-0003-1601-2025	Fundacion Centros Tecnologicos through an Inaki Goenaga doctoral grant; DEVOTES (DEVelopment Of innovative Tools for understanding marine biodiversity and assessing good Environmental Status); European Union [308392]; Basque Water Agency (URA)	Fundacion Centros Tecnologicos through an Inaki Goenaga doctoral grant; DEVOTES (DEVelopment Of innovative Tools for understanding marine biodiversity and assessing good Environmental Status); European Union(European Commission); Basque Water Agency (URA)	Eva Aylagas is supported by the Fundacion Centros Tecnologicos through an Inaki Goenaga doctoral grant. This manuscript is a result of the project DEVOTES (DEVelopment Of innovative Tools for understanding marine biodiversity and assessing good Environmental Status) funded by the European Union under the 7th Framework Program 'The Ocean of Tomorrow' Theme (grant agreement no. 308392), (http://www.devotes-project.eu), and also supported by the Basque Water Agency (URA), through a Convention with AZTI-Tecnalia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amend AS, 2010, MOL ECOL, V19, P5555, DOI 10.1111/j.1365-294X.2010.04898.x; Borja A, 2000, MAR POLLUT BULL, V40, P1100, DOI 10.1016/S0025-326X(00)00061-8; Borja A, 2008, ECOLOGICAL INDICATOR, V8, P6; Borja A, 2013, MAR POLLUT BULL, V68, P1, DOI 10.1016/j.marpolbul.2013.01.041; Borja A, 2011, MAR POLLUT BULL, V62, P889, DOI 10.1016/j.marpolbul.2011.03.031; Borja A, 2009, HYDROBIOLOGIA, V633, P181, DOI 10.1007/s10750-009-9881-y; Borja A, 2009, MAR POLLUT BULL, V59, P54, DOI 10.1016/j.marpolbul.2008.11.010; Bourlat SJ, 2013, MARINE POLLUTION B; Cameron S, 2006, SYST BIOL, V55, P844, DOI 10.1080/10635150600960079; CBD, 2000, 5 C PART CONV BIOD N; Claudet J, 2010, BIOL CONSERV, V143, P2195, DOI 10.1016/j.biocon.2010.06.004; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Creer S, 2010, MOL ECOL, V19, P4, DOI 10.1111/j.1365-294X.2009.04473.x; da Silva JM, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0028233, 10.1371/journal.pone.0019449]; de Jonge VN, 2006, MAR POLLUT BULL, V53, P5, DOI 10.1016/j.marpolbul.2005.11.026; Diaz RJ, 2004, J ENVIRON MANAGE, V73, P165, DOI 10.1016/j.jenvman.2004.06.004; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Frolov S, 2013, HARMFUL ALGAE, V21-22, P1, DOI 10.1016/j.hal.2012.11.001; Geller J, 2013, MOL ECOL RESOUR, V13, P851, DOI 10.1111/1755-0998.12138; Hajibabaei M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017497; Halpern BS, 2012, NATURE, V488, P615, DOI 10.1038/nature11397; Hardy Sarah Mincks, 2011, Marine Biodiversity, V41, P195, DOI 10.1007/s12526-010-0056-x; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Ji Y, 2013, ECOL LETT; Leray M, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-34; Liu ZZ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn491; Machida JR, 2012, PLOS ONE, P7; Machida JR, 2010, PLOS ONE, V5, P6; Markmann M, 2005, PHILOS T R SOC B, V360, P1917, DOI 10.1098/rstb.2005.1723; Meyer CP, 2003, BIOL J LINN SOC, V79, P401, DOI 10.1046/j.1095-8312.2003.00197.x; MONSERUD RA, 1992, ECOL MODEL, V62, P275, DOI 10.1016/0304-3800(92)90003-W; Muxika I, 2012, ECOL INDIC, V12, P96, DOI 10.1016/j.ecolind.2011.04.030; Niu BF, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-187; Pinto R, 2009, ECOL INDIC, V9, P1, DOI 10.1016/j.ecolind.2008.01.005; Pompanon F, 2012, MOL ECOL, V21, P1931, DOI 10.1111/j.1365-294X.2011.05403.x; Porazinska DL, 2010, MOL ECOL RESOUR, V10, P666, DOI 10.1111/j.1755-0998.2009.02819.x; Prosser SWJ, 2013, MOL ECOLOGY RESOURCE; Ranasinghe JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040875; Taberlet P, 2012, MOL ECOL, V21, P6; Tautz D, 2003, TRENDS ECOL EVOL, V18, P70, DOI 10.1016/S0169-5347(02)00041-1; UNCLOS, 1982, UN CONV LAW SEA SIGN, P202; Valenca APMC, 2012, MAR POLLUT BULL, V64, P1809, DOI 10.1016/j.marpolbul.2012.06.003; Walters WA, 2011, BIOINFORMATICS, V27, P1159, DOI 10.1093/bioinformatics/btr087; Warwick RM, 2010, MAR POLLUT BULL, V60, P554, DOI 10.1016/j.marpolbul.2009.11.009; Yang CX, 2013, SCI CHINA LIFE SCI, V56, P73, DOI 10.1007/s11427-012-4423-7; Yu DW, 2012, METHODS ECOL EVOL, V3, P613, DOI 10.1111/j.2041-210X.2012.00198.x	47	105	111	0	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90529	10.1371/journal.pone.0090529	http://dx.doi.org/10.1371/journal.pone.0090529			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603433	Green Submitted, Green Published, gold			2022-12-27	WOS:000332483600061
J	Cadelis, G; Tourres, R; Molinie, J				Cadelis, Gilbert; Tourres, Rachel; Molinie, Jack			Short-Term Effects of the Particulate Pollutants Contained in Saharan Dust on the Visits of Children to the Emergency Department due to Asthmatic Conditions in Guadeloupe (French Archipelago of the Caribbean)	PLOS ONE			English	Article							CASE-CROSSOVER; AIR-POLLUTION; AFRICAN DUST; HOSPITAL ADMISSIONS; DESERT DUST; MATTER; EXACERBATIONS; PARTICLES; SYMPTOMS; EXPOSURE	Background: The prevalence of asthma in children is a significant phenomenon in the Caribbean. Among the etiologic factors aggravating asthma in children, environmental pollution is one of the main causes. In Guadeloupe, pollution is primarily transported by Saharan dust including inhalable particles. Methods: This study assesses, over one year (2011), the short-term effects of pollutants referred to as PM10 (PM10: particulate matter < 10 mu m) and PM2.5-10 (PM2.5-10: particulate matter > 2.5 mu m and < 10 mu m) contained in Saharan dust, on the visits of children aged between 5 and 15 years for asthma in the health emergency department of the main medical facility of the archipelago of Guadeloupe. A time-stratified case-crossover model was applied and the data were analysed by a conditional logistic regression for all of the children but also for sub-groups corresponding to different age classes and genders. Results: The visits for asthma concerned 836 children including 514 boys and 322 girls. The Saharan dust has affected 15% of the days of the study (337 days) and involved an increase in the average daily concentrations of PM10 (49.7 mu g/m(3) vs. 19.2 mu g/m(3)) and PM 2.5-10 (36.2 mu g/m(3) vs. 10.3 mu g/m(3)) compared to days without dust. The excess risk percentages (IR%) for visits related to asthma in children aged between 5 and 15 years on days with dust compared to days without dust were, for PM10, ((IR %: 9.1% (CI95%, 7.1%-11.1%) versus 1.1%(CI95%, -5.9%-4.6%)) and for PM2.5-10 (IR%: 4.5%(CI95%, 2.5%-6.5%) versus 1.6% (CI95%, -1.1%-3.4%). There was no statistical difference in the IR% for periods with Saharan dust among different age group of children and between boys and girls for PM10 and PM2.5-10. Conclusion: The PM10 and PM2.5-10 pollutants contained in the Saharan dust increased the risk of visiting the health emergency department for children with asthma in Guadeloupe during the study period.	[Cadelis, Gilbert; Tourres, Rachel] Univ Hosp Pointe A Pitre, Dept Pulm Med, Pointe A Pitre, Guadeloupe, France; [Molinie, Jack] Univ Antilles Guyane, Lab Res Geosci & Energy, Pointe A Pitre, Guadeloupe, France	CHU Guadeloupe; Universite des Antilles	Cadelis, G (corresponding author), Univ Hosp Pointe A Pitre, Dept Pulm Med, Pointe A Pitre, Guadeloupe, France.	gilbert.cadelis@chu-guadeloupe.fr		Cadelis, Gilbert/0000-0003-3739-6929				Alessandrini ER, 2013, OCCUP ENVIRON MED, V70, P432, DOI 10.1136/oemed-2012-101182; Arcus-Arth A, 2007, RISK ANAL, V27, P97, DOI 10.1111/j.1539-6924.2006.00862.x; Bateson TF, 1999, EPIDEMIOLOGY, V10, P539, DOI 10.1097/00001648-199909000-00013; Bateson TF, 2007, J TOXICOL ENV HEAL A, V71, P3; Bennett WD, 2003, J APPL PHYSIOL, V95, P497, DOI 10.1152/japplphysiol.00718.2002; Brunekreef B, 2005, EUR RESPIR J, V26, P309, DOI 10.1183/09031936.05.00001805; Cadelis G, 2013, REV MAL RESPIR, V30, P203, DOI 10.1016/j.rmr.2012.11.002; Coz E, 2009, ATMOS ENVIRON, V43, P1850, DOI 10.1016/j.atmosenv.2008.12.045; D'Amato G, 2013, MULTIDISCIP RESP MED, V8, DOI 10.1186/2049-6958-8-12; Dougherty RH, 2009, CLIN EXP ALLERGY, V39, P193, DOI 10.1111/j.1365-2222.2008.03157.x; Gordian ME, 1996, ENVIRON HEALTH PERSP, V104, P290, DOI 10.2307/3432887; Griffin DW, 2007, CLIN MICROBIOL REV, V20, P459, DOI 10.1128/CMR.00039-06; Gyan K, 2005, INT J BIOMETEOROL, V49, P371, DOI 10.1007/s00484-005-0257-3; Hashizume Masahiro, 2010, Nihon Eiseigaku Zasshi, V65, P413; Hong YC, 2010, SCI TOTAL ENVIRON, V408, P754, DOI 10.1016/j.scitotenv.2009.11.015; Howitt M. E., 2000, Postgraduate Doctor - Caribbean, V16, P86; Ichinose T, 2008, INHAL TOXICOL, V20, P685, DOI [10.1080/08958370801935133, 10.1080/08958370801935133 ]; Jaakkola JJK, 2003, EUR RESPIR J, V21, p81S, DOI 10.1183/09031936.03.00402703; Janes H, 2005, EPIDEMIOLOGY, V16, P717, DOI 10.1097/01.ede.0000181315.18836.9d; Kanatani KT, 2010, AM J RESP CRIT CARE, V182, P1475, DOI 10.1164/rccm.201002-0296OC; Lin M, 2002, ENVIRON HEALTH PERSP, V110, P575, DOI 10.1289/ehp.02110575; Maclure M, 2000, ANNU REV PUBL HEALTH, V21, P193, DOI 10.1146/annurev.publhealth.21.1.193; MANCINO D, 1984, INT ARCH ALLER A IMM, V73, P10, DOI 10.1159/000233429; Middleton N, 2008, ENV HLTH, V1, P7, DOI DOI 10.1186/1476-069X-7-39; Middleton NJ, 2001, T I BRIT GEOGR, V26, P165, DOI 10.1111/1475-5661.00013; Monteil MA, 2005, BMC PUBLIC HEALTH, V14, P5; Mortimer KM, 2002, EUR RESPIR J, V19, P699, DOI 10.1183/09031936.02.00247102; Mounouchy MA, 2009, REV MAL RESPIR, V26, P944, DOI 10.1016/S0761-8425(09)73329-7; Park JW, 2005, RESPIROLOGY, V10, P470, DOI 10.1111/j.1440-1843.2005.00728.x; Prospero JM, 2008, INT J BIOMETEOROL, V52, P823, DOI 10.1007/s00484-008-0176-1; Rutherford S, 1999, INT J BIOMETEOROL, V42, P217, DOI 10.1007/s004840050108; Samoli E, 2011, ENVIRON RES, V3, P418; Schwartz J, 1996, EPIDEMIOLOGY, V7, P20, DOI 10.1097/00001648-199601000-00005; Taylor DA, 2002, ENVIRON HEALTH PERSP, V110, pA80, DOI 10.1289/ehp.110-a80; Tecer LH, 2008, J TOXICOL ENV HEAL A, V71, P512, DOI 10.1080/15287390801907459; Tobias A, 2011, SCI TOTAL ENVIRON, V412, P386, DOI 10.1016/j.scitotenv.2011.10.027; Vedal S, 1998, AM J RESP CRIT CARE, V157, P1034, DOI 10.1164/ajrccm.157.4.9609008; Venkataraman C, 1999, INHAL TOXICOL, V11, P151, DOI 10.1080/089583799197221; Yang CY, 2005, INHAL TOXICOL, V17, P817, DOI 10.1080/08958370500241254	39	88	90	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e91136	10.1371/journal.pone.0091136	http://dx.doi.org/10.1371/journal.pone.0091136			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603899	Green Published, gold, Green Submitted			2022-12-27	WOS:000332483600136
J	Ramineni, R; Sadumpati, V; Khareedu, VR; Vudem, DR				Ramineni, Ramadevi; Sadumpati, Vijayakumar; Khareedu, Venkateswara Rao; Vudem, Dashavantha Reddy			Transgenic Pearl Millet Male Fertility Restorer Line (ICMP451) and Hybrid (ICMH451) Expressing Brassica juncea Nonexpressor of Pathogenesis Related Genes 1 (BjNPR1) Exhibit Resistance to Downy Mildew Disease	PLOS ONE			English	Article							SALICYLIC-ACID GLUCOSYLTRANSFERASE; SELECTABLE MARKER GENE; ENHANCED RESISTANCE; TRANSCRIPTION FACTORS; ARABIDOPSIS-THALIANA; DEFENSE RESPONSES; PLANTS RESISTANT; NPR1; OVEREXPRESSION; ACTIVATION	Brassica juncea Nonexpressor of pathogenesis-related genes 1 (BjNPR1) has been introduced into pearl millet male fertility restorer line ICMP451 by Agrobacterium tumefaciens-mediated genetic transformation. Transgenic pearl millet plants were regenerated from the phosphinothricin-resistant calli obtained after co-cultivation with A. tumefaciens strain LBA4404 harbouring Ti plasmid pSB111-bar-BjNPR1. Molecular analyses confirmed the stable integration and expression of BjNPR1 in transgenic pearl millet lines. Transgenes BjNPR1 and bar were stably inherited and disclosed co-segregation in subsequent generations in a Mendelian fashion. Transgenic pearl millet hybrid ICMH451-BjNPR1 was developed by crossing male-sterile line 81A X homozygous transgenic line ICMP451-BjNPR1. T-3 and T-4 homozygous lines of ICMP451-BjNPR1 and hybrid ICMH451-BjNPR1 exhibited resistance to three strains of downy mildew pathogen, while the untransformed ICMP451 and the isogenic hybrid ICMH451 plants were found susceptible. Following infection with S. graminicola, differential expression of systemic acquired resistance pathway genes, UDP-glucose salicylic acid glucosyl transferase and pathogenesis related gene 1 was observed in transgenic ICMP451-BjNPR1 and untransformed plants indicating the activation of systemic acquired resistance pathway contributing to the transgene-mediated resistance against downy mildew. The transgenic pearl millet expressing BjNPR1 showed resistance to multiple strains of S. graminicola and, as such, seems promising for the development of durable downy mildew resistant hybrids.	[Ramineni, Ramadevi; Sadumpati, Vijayakumar; Khareedu, Venkateswara Rao; Vudem, Dashavantha Reddy] Osmania Univ, Ctr Plant Mol Biol, Hyderabad 500007, Andhra Pradesh, India	Osmania University	Vudem, DR (corresponding author), Osmania Univ, Ctr Plant Mol Biol, Hyderabad 500007, Andhra Pradesh, India.	vdreddycpmb@yahoo.com			Department of Biotechnology, Government of India, New Delhi; Council of Scientific and Industrial Research	Department of Biotechnology, Government of India, New Delhi(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India)	The authors acknowledge the financial support from Department of Biotechnology, Government of India, New Delhi. RR and VS acknowledge the Council of Scientific and Industrial Research for awarding the research fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldemita RR, 1996, PLANTA, V199, P612, DOI 10.1007/BF00195194; Bai W, 2011, PLANT BIOTECHNOL J, V9, P205, DOI 10.1111/j.1467-7652.2010.00544.x; BALL SL, 1984, ANN APPL BIOL, V104, P41, DOI 10.1111/j.1744-7348.1984.tb05585.x; Cao H, 1998, P NATL ACAD SCI USA, V95, P6531, DOI 10.1073/pnas.95.11.6531; Chern MS, 2001, PLANT J, V27, P101, DOI 10.1046/j.1365-313x.2001.01070.x; Collins VP, 1997, POULTRY SCI, V76, P326, DOI 10.1093/ps/76.2.326; Crampton BG, 2009, MOL PLANT PATHOL, V10, P291, DOI 10.1111/j.1364-3703.2008.00532.x; Davis AJ, 2003, J APPL POULTRY RES, V12, P137, DOI 10.1093/japr/12.2.137; DEKEYSER RA, 1990, PLANT CELL, V2, P591, DOI 10.1105/tpc.2.7.591; Deshaprabhu SB, 1991, RAW MAT, VVII, P292; EJETA G, 1987, P NATL ACAD SCI USA, V84, P6016, DOI 10.1073/pnas.84.17.6016; Fan WH, 2002, PLANT CELL, V14, P1377, DOI 10.1105/tpc.001628; FINNEGAN J, 1994, BIO-TECHNOL, V12, P883, DOI 10.1038/nbt0994-883; Fitzgerald HA, 2004, MOL PLANT MICROBE IN, V17, P140, DOI 10.1094/MPMI.2004.17.2.140; Friedrich L, 2001, MOL PLANT MICROBE IN, V14, P1114, DOI 10.1094/MPMI.2001.14.9.1114; Hash CT, 2003, WORLD AGR S, P27, DOI 10.1002/9780470384923.ch4; HILL GM, 1990, J ANIM SCI, V68, P2061; Hoseney RC, 1987, ASA MONOGR, V28, P397; Kesarwani M, 2007, PLANT PHYSIOL, V144, P336, DOI 10.1104/pp.106.095299; Khairwal IS, 2008, PEARL MILLET COORDIN, P1; Kim HS, 2002, PLANT J, V32, P151, DOI 10.1046/j.1365-313X.2001.01411.x; Kinkema M, 2000, PLANT CELL, V12, P2339, DOI 10.1105/tpc.12.12.2339; Kumar V, 2013, TRANSGENIC RES, V22, P359, DOI 10.1007/s11248-012-9652-9; Latha AM, 2006, PLANT CELL REP, V25, P927, DOI 10.1007/s00299-006-0141-6; Latha AM, 2005, PLANT SCI, V169, P657, DOI 10.1016/j.plantsci.2005.05.009; Lin WC, 2004, TRANSGENIC RES, V13, P567, DOI 10.1007/s11248-004-2375-9; Makandar R, 2006, MOL PLANT MICROBE IN, V19, P123, DOI 10.1094/MPMI-19-0123; Malnoy M, 2007, MOL PLANT MICROBE IN, V20, P1568, DOI 10.1094/MPMI-20-12-1568; Meur G, 2006, PHYSIOL MOL PLANT P, V68, P128, DOI 10.1016/j.pmpp.2006.09.003; Mou Z, 2003, CELL, V113, P935, DOI 10.1016/S0092-8674(03)00429-X; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; O'Kennedy MM, 2004, PLANT CELL REP, V22, P684, DOI 10.1007/s00299-003-0746-y; Pang SZ, 1996, PLANT PHYSIOL, V112, P893, DOI 10.1104/pp.112.3.893; Parkhi V, 2010, TRANSGENIC RES, V19, P959, DOI 10.1007/s11248-010-9374-9; Potlakayala SD, 2007, PHYSIOL MOL PLANT P, V71, P174, DOI 10.1016/j.pmpp.2008.01.003; Priya D Bhanu, 2011, BMC Res Notes, V4, P231, DOI 10.1186/1756-0500-4-231; Quilis J, 2008, MOL PLANT MICROBE IN, V21, P1215, DOI 10.1094/MPMI-21-9-1215; Ramadevi R, 2014, IN VITRO CELL DEV-PL, V50, P392, DOI 10.1007/s11627-013-9592-y; RATHORE KS, 1993, PLANT MOL BIOL, V21, P871, DOI 10.1007/BF00027118; Sadumpati V, 2013, J BIOTECHNOL, V166, P114, DOI 10.1016/j.jbiotec.2013.04.016; Sastry J. G., 2001, Indian Phytopathology, V54, P323; Sato M, 2007, PLANT J, V49, P565, DOI 10.1111/j.1365-313X.2006.02972.x; SINGH SD, 1985, PLANT DIS, V69, P582; SINGH SD, 1995, PLANT DIS, V79, P545, DOI 10.1094/PD-79-0545; Singh SD, 1997, INFORM B, V48, P36; Song JT, 2008, PHYTOCHEMISTRY, V69, P1128, DOI 10.1016/j.phytochem.2007.12.010; Song JT, 2006, MOL CELLS, V22, P233; Song JT, 2009, MOL CELLS, V28, P105, DOI 10.1007/s10059-009-0108-x; Tada Y, 2008, SCIENCE, V321, P952, DOI 10.1126/science.1156970; Thakur R. P., 2008, Journal of SAT Agricultural Research, V6, P1; Thakur R. P., 2008, DIS MANAGEMENT ARID, P21; THAKUR RP, 1993, PLANT PATHOL, V42, P715, DOI 10.1111/j.1365-3059.1993.tb01557.x; Upadhyaya H. D., 2007, Journal of SAT Agricultural Research, V3, P1; Uquillas C, 2004, MOL PLANT MICROBE IN, V17, P34, DOI 10.1094/MPMI.2004.17.1.34; Vijayan S, 2012, TRANSGENIC RES, V21, P193, DOI 10.1007/s11248-011-9521-y; Wally O, 2009, PLANTA, V231, P131, DOI 10.1007/s00425-009-1031-2; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; Yuan YX, 2007, PLANT BIOTECHNOL J, V5, P313, DOI 10.1111/j.1467-7652.2007.00243.x; Zhang XD, 2010, EUR J PLANT PATHOL, V128, P91, DOI 10.1007/s10658-010-9633-x; Zhang XD, 2010, J PLANT PHYSIOL, V167, P144, DOI 10.1016/j.jplph.2009.08.002; Zhang YL, 1999, P NATL ACAD SCI USA, V96, P6523, DOI 10.1073/pnas.96.11.6523; Zidani S, 2005, AFR J BIOTECHNOL, V4, P862	62	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90839	10.1371/journal.pone.0090839	http://dx.doi.org/10.1371/journal.pone.0090839			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603762	gold, Green Submitted, Green Published			2022-12-27	WOS:000332483600091
J	Smit, PW; Sollis, KA; Fiscus, S; Ford, N; Vitoria, M; Essajee, S; Barnett, D; Cheng, B; Crowe, SM; Denny, T; Landay, A; Stevens, W; Habiyambere, V; Perriens, JH; Peeling, RW				Smit, Pieter W.; Sollis, Kimberly A.; Fiscus, Susan; Ford, Nathan; Vitoria, Marco; Essajee, Shaffiq; Barnett, David; Cheng, Ben; Crowe, Suzanne M.; Denny, Thomas; Landay, Alan; Stevens, Wendy; Habiyambere, Vincent; Perriens, Joseph H.; Peeling, Rosanna W.			Systematic Review of the Use of Dried Blood Spots for Monitoring HIV Viral Load and for Early Infant Diagnosis	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; NUCLISENS EASYQ HIV-1; REAL-TIME PCR; DRUG-RESISTANCE; FILTER-PAPER; TYPE-1 RNA; PLASMA; ASSAY; QUANTITATION; QUANTIFICATION	Background: Dried blood spots (DBS) have been used as alternative specimens to plasma to increase access to HIV viral load (VL) monitoring and early infant diagnosis (EID) in remote settings. We systematically reviewed evidence on the performance of DBS compared to plasma for VL monitoring and EID. Methods and Findings: Thirteen peer reviewed HIV VL publications and five HIV EID papers were included. Depending on the technology and the viral load distribution in the study population, the percentage of DBS samples that are within 0.5 log of VL in plasma ranged from 52-100%. Because the input sample volume is much smaller in a blood spot, there is a risk of false negatives with DBS. Sensitivity of DBS VL was found to be 78-100% compared to plasma at VL below 1000 copies/ml, but this increased to 100% at a threshold of 5000 copies/ml. Unlike a plasma VL test which measures only cell free HIV RNA, a DBS VL also measures proviral DNA as well as cell-associated RNA, potentially leading to false positive results when using DBS. The systematic review showed that specificity was close to 100% at DBS VL above 5000 copies/ml, and this threshold would be the most reliable for predicting true virologic failure using DBS. For early infant diagnosis, DBS has a sensitivity of 100% compared to fresh whole blood or plasma in all studies. Conclusions: Although limited data are available for EID, DBS offer a highly sensitive and specific sampling strategy to make viral load monitoring and early infant diagnosis more accessible in remote settings. A standardized approach for sampling, storing, and processing DBS samples would be essential to allow successful implementation.	[Smit, Pieter W.; Sollis, Kimberly A.; Peeling, Rosanna W.] Univ London London Sch Hyg & Trop Med, Dept Clin Res, London WC1E 7HT, England; [Fiscus, Susan] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA; [Ford, Nathan; Vitoria, Marco; Habiyambere, Vincent; Perriens, Joseph H.] WHO, Dept HIV AIDS, CH-1211 Geneva, Switzerland; [Essajee, Shaffiq] Clinton Hlth Access Initiat, New York, NY USA; [Barnett, David] UK NEQAS Leucocyte Immunophenotyping, Dept Haematol, Sheffield, S Yorkshire, England; [Cheng, Ben] Pangaea Global AIDS Fdn, Dept Technol & Innovat, San Francisco, CA USA; [Crowe, Suzanne M.] Burnet Inst, Ctr Biomed Res, Melbourne, Vic, Australia; [Denny, Thomas] Duke Human Vaccine Inst, Dept Med, Durham, NC USA; [Denny, Thomas] Ctr HIV AIDS Vaccine Immunol, Durham, NC USA; [Landay, Alan] Rush Univ, Dept Immunol Microbiol, Med Ctr, Chicago, IL 60612 USA; [Stevens, Wendy] Univ Witwatersrand, Dept Mol Med & Haematol, Johannesburg, South Africa	University of London; London School of Hygiene & Tropical Medicine; University of North Carolina; University of North Carolina Chapel Hill; World Health Organization; Burnet Institute; Rush University; University of Witwatersrand	Peeling, RW (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Clin Res, Keppel St, London WC1E 7HT, England.	rosanna.peeling@lshtm.ac.uk		Barnett, David/0000-0002-7658-5856	World Health Organization [HQHIV0801828]	World Health Organization(World Health Organization)	Funding was provided by the World Health Organization (grant number HQHIV0801828). The decision to write this article was not influenced by any diagnostic or commercial company. The mention of specific companies or of certain manufacturers' products does not imply that they are endorsed or recommended by the World Health Organization in preference to other of a similar nature that are not mentioned. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreotti M, 2010, J CLIN VIROL, V47, P4, DOI 10.1016/j.jcv.2009.11.006; Anitha D, 2011, Indian J Sex Transm Dis AIDS, V32, P99, DOI 10.4103/0253-7184.85413; Arredondo M, 2012, J CLIN MICROBIOL, V50, P569, DOI 10.1128/JCM.00418-11; Bertagnolio S, 2010, AIDS REV, V12, P195; Bonard D, 2003, JAIDS-J ACQ IMM DEF, V34, P267, DOI 10.1097/00126334-200311010-00002; Bossuyt PM, 2003, CLIN CHEM, V49, P7, DOI 10.1373/49.1.7; Bossuyt PM, 2003, CLIN CHEM, V49, P1, DOI 10.1373/49.1.1; CASSOL S, 1992, J CLIN MICROBIOL, V30, P3039, DOI 10.1128/JCM.30.12.3039-3042.1992; Cassol S, 1997, J CLIN MICROBIOL, V35, P2795, DOI 10.1128/JCM.35.11.2795-2801.1997; COHEN AB, 1969, AM J EPIDEMIOL, V89, P345, DOI 10.1093/oxfordjournals.aje.a120947; Fiscus S. A, 2006, PLOS MED, V3; Fiscus SA, 1998, J CLIN MICROBIOL, V36, P258, DOI 10.1128/JCM.36.1.258-260.1998; GANJU L, 1988, DIAGN CLIN IMMUNOL, V5, P262; Garrido C, 2009, J CLIN MICROBIOL, V47, P1031, DOI 10.1128/JCM.02099-08; Guimaraes M C, 1985, Bull Pan Am Health Organ, V19, P16; Hamers RL, 2009, ANTIVIR THER, V14, P619; Ikomey G M, 2009, J Int Assoc Physicians AIDS Care (Chic), V8, P181, DOI 10.1177/1545109709333111; Kane CT, 2008, J VIROL METHODS, V148, P291, DOI 10.1016/j.jviromet.2007.11.011; Kebe K, 2011, J CLIN MICROBIOL, V49, P2590, DOI 10.1128/JCM.02402-10; Kredo T, 2013, COCHRANE DA IN PRESS; Leelawiwat W, 2009, J VIROL METHODS, V155, P109, DOI 10.1016/j.jviromet.2008.09.022; Lilian RR, 2010, J CLIN VIROL, V48, P40, DOI 10.1016/j.jcv.2010.02.006; Lofgren SM, 2009, AIDS, V23, P2459, DOI 10.1097/QAD.0b013e328331f702; Marconi A, 2009, CLIN MICROBIOL INFEC, V15, P93, DOI 10.1111/j.1469-0691.2008.02116.x; Mbida AD, 2009, JAIDS-J ACQ IMM DEF, V52, P9, DOI 10.1097/QAI.0b013e3181aeccbc; Monleau M, 2010, ANTIVIR THER, V15, P121, DOI 10.3851/IMP1478; Murtagh MM, 2012, HIV AIDS DIAGNOSTICS; Mutasa K, 2012, PEDIATR INFECT DIS J, V31, P948, DOI 10.1097/INF.0b013e318266aac2; Nkenfou CN, 2012, AIDS RES HUM RETROV, V28, P176, DOI [10.1089/aid.2010.0371, 10.1089/AID.2010.0371]; Nsojo A, 2010, TANZAN J HLTH RES, V12; Nuwagaba-Biribonwoha H, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-44; Pirillo MF, 2011, J ANTIMICROB CHEMOTH, V66, P2823, DOI 10.1093/jac/dkr383; Pitcovski J, 1999, J VIROL METHODS, V83, P21, DOI 10.1016/S0166-0934(99)00101-9; Roberts T, 2012, JAIDS, V15; Rollins N, 2009, AIDS, V23, P1851, DOI 10.1097/QAD.0b013e32832d84fd; Rottinghaus EK, 2012, CLIN INFECT DIS, V54, P1187, DOI 10.1093/cid/cis015; Sherman GG, 2005, JAIDS-J ACQ IMM DEF, V38, P615, DOI 10.1097/01.qai.0000143604.71857.5d; Stevens W, 2008, J CLIN MICROBIOL, V46, P3941, DOI 10.1128/JCM.00754-08; Toledo ACD, 2005, MEM I OSWALDO CRUZ, V100, P365; UNAIDS, 2012, TOG WE WILL END AIDS; van Deursen P, 2010, J CLIN VIROL, V47, P120, DOI 10.1016/j.jcv.2009.11.021; Vidya M, 2012, J VIROL METHODS, V181, P177, DOI 10.1016/j.jviromet.2012.02.006; World Health Organization, 2011, GLOB REP 2011 GLOB H; World Health Organization, 2010, WHO REC DIAGN HIV IN; World Health Organization, 2010, UN ACC SCAL PRIOR HI	45	88	91	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e86461	10.1371/journal.pone.0086461	http://dx.doi.org/10.1371/journal.pone.0086461			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603442	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000332483600003
J	Ferrer, CP; McMunn, A; Dommarco, JAR; Brunner, EJ				Ferrer, Carolina Perez; McMunn, Anne; Rivera Dommarco, Juan A.; Brunner, Eric J.			Educational Inequalities in Obesity among Mexican Women: Time-Trends from 1988 to 2012	PLOS ONE			English	Article							BODY-MASS-INDEX; SOCIOECONOMIC-STATUS; UNITED-STATES; DEVELOPING-COUNTRIES; US ADULTS; HEALTH; PREVALENCE; OVERWEIGHT; INCOME; WEIGHT	Background: Obesity is one of the leading causes of global morbidity and mortality. Trends in educational inequalities in obesity prevalence among Mexican women have not been analysed systematically to date. Methods: Data came from four nationally representative surveys (1988, 1999, 2006, and 2012) of a total of 51 220 nonpregnant women aged 20 to 49. Weight and height were measured during home visits. Education level (higher education, high school, secondary, primary or less) was self-reported. We analysed trends in relative and absolute educational inequalities in obesity prevalence separately for urban and rural areas. Results: Nationally, age-standardised obesity prevalence increased from 9.3% to 33.7% over 25 years to 2012. Obesity prevalence was inversely associated with education level in urban areas at all survey waves. In rural areas, obesity prevalence increased markedly but there was no gradient with education level at any survey. The relative index of inequality in urban areas declined over the period (2.87 (95%CI: 1.94, 4.25) in 1988, 1.55 (95%CI: 1.33, 1.80) in 2012, trend p<0.001). Obesity increased 5.92 fold (95%CI: 4.03, 8.70) among urban women with higher education in the period 1988-2012 compared to 3.23 fold (95%CI: 2.88, 3.63) for urban women with primary or no education. The slope index of inequality increased in urban areas from 1988 to 2012. Over 0.5 M cases would be avoided if the obesity prevalence of women with primary or less education was the same as for women with higher education. Conclusions: The expected inverse association between education and obesity was observed in urban areas of Mexico. The declining trend in relative educational inequalities in obesity was due to a greater increase in obesity prevalence among higher educated women. In rural areas there was no social gradient in the association between education level and obesity across the four surveys.	[Ferrer, Carolina Perez; McMunn, Anne; Brunner, Eric J.] UCL, Res Dept Epidemiol & Publ Hlth, London, England; [Rivera Dommarco, Juan A.] Inst Nacl Salud Publ, Ctr Invest Nutr & Salud, Cuernavaca, Morelos, Mexico	University of London; University College London; Instituto Nacional de Salud Publica	Ferrer, CP (corresponding author), UCL, Res Dept Epidemiol & Publ Hlth, London, England.	carolina.perez.10@ucl.ac.uk	Perez-Ferrer, Carolina/K-6262-2019; Brunner, Eric/H-2114-2011	Brunner, Eric/0000-0002-0595-4474; Perez Ferrer, Carolina/0000-0003-4732-3555; McMunn, Anne/0000-0003-3237-9345	Mexican Council for Science and Technology (CONACyT) [309252]; European Research Council [ERC-2011-StG_20101124]; Economic and Social Research Council [ES/J019119/1]; ESRC [ES/J019119/1, ES/J023299/1] Funding Source: UKRI; MRC [MR/K013351/1] Funding Source: UKRI; Economic and Social Research Council [ES/J023299/1] Funding Source: researchfish; Medical Research Council [MR/K013351/1] Funding Source: researchfish	Mexican Council for Science and Technology (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); European Research Council(European Research Council (ERC)European Commission); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Carolina Perez Ferrer is funded by a PhD scholarship (grant no 309252) from the Mexican Council for Science and Technology (CONACyT). Further information about this grant is available from http://www.conacyt.gob.mx/FormacionCapitalHumano/Becas/Extranjero/Paginas/default.aspx. Anne McMunn is supported by the European Research Council (grant no ERC-2011-StG_20101124) and the Economic and Social Research Council (grant no ES/J019119/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitsi-Selmi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039507; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Bleich S, 2008, ANNU REV PUBL HEALTH, V29, P273, DOI 10.1146/annurev.publhealth.29.020907.090954; Bolling C., 1999, Choices. The Magazine of Food, Farm, and Resources Issues, P33; Buttenheim AM, 2010, GLOB PUBLIC HEALTH, V5, P413, DOI 10.1080/17441690902756062; Chang VW, 2005, ARCH INTERN MED, V165, P2122, DOI 10.1001/archinte.165.18.2122; Clark SE, 2012, INT J OCCUP ENV HEAL, V18, P53, DOI 10.1179/1077352512Z.0000000007; Colchero MA, 2012, SOC SCI MED, V75, P120, DOI 10.1016/j.socscimed.2012.01.010; Creighton MJ, 2011, SOC SCI MED, V72, P685, DOI 10.1016/j.socscimed.2010.12.006; Drewnowski A, 2004, AM J CLIN NUTR, V79, P6; Drewnowski A, 2009, NUTR REV, V67, pS36, DOI 10.1111/j.1753-4887.2009.00157.x; Ernst ND, 1997, J AM DIET ASSOC, V97, pS47, DOI 10.1016/S0002-8223(97)00729-3; Ezzati M, 2005, PLOS MED, V2, P404, DOI 10.1371/journal.pmed.0020133; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Flegal KM, 1998, INT J OBESITY, V22, P39, DOI 10.1038/sj.ijo.0800541; Ford ES, 1997, AM J EPIDEMIOL, V146, P214, DOI 10.1093/oxfordjournals.aje.a009256; Galobardes B, 2006, J EPIDEMIOL COMMUN H, V60, P95, DOI 10.1136/jech.2004.028092; Gutierrez JP, 2012, ENCUESTA NACL SALUD; Hawkes C, 2006, GLOBALIZATION HEALTH, V2, DOI 10.1186/1744-8603-2-4; Hiyoshi A, 2013, J EPIDEMIOL COMMUN H, V67, P960, DOI 10.1136/jech-2013-202608; Instituto Nacional de Estadistica y Geografia, 2011, EST PROP INT MUJ; Instituto Nacional de Estadistica y Geografia, 2012, DEM POBL; Jones-Smith JC, 2012, INT J OBESITY, V36, P866, DOI 10.1038/ijo.2011.134; Jones-Smith JC, 2012, INT J OBESITY, V36, P1114, DOI 10.1038/ijo.2011.179; Jones-Smith JC, 2011, AM J EPIDEMIOL, V173, P667, DOI 10.1093/aje/kwq428; Khang YH, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-66; Mackenbach JP, 1997, SOC SCI MED, V44, P757, DOI 10.1016/S0277-9536(96)00073-1; MANSON JE, 1995, NEW ENGL J MED, V333, P677, DOI 10.1056/NEJM199509143331101; Martorell R, 1998, J NUTR, V128, P1464, DOI 10.1093/jn/128.9.1464; Martorell R, 2000, EUR J CLIN NUTR, V54, P247, DOI 10.1038/sj.ejcn.1600931; McLaren L, 2007, EPIDEMIOL REV, V29, P29, DOI 10.1093/epirev/mxm001; Monteiro C, 2004, INT J OBESITY, V28, P1181, DOI 10.1038/sj.ijo.0802716; Monteiro CA, 2000, EUR J CLIN NUTR, V54, P342, DOI 10.1038/sj.ejcn.1600960; Monteiro CA, 2004, B WORLD HEALTH ORGAN, V82, P940; Monteiro CA, 2007, AM J PUBLIC HEALTH, V97, P1808, DOI 10.2105/AJPH.2006.099630; Olaiz G, 2006, ENCUESTA NACL SALUD; Pezzini M, 2007, OECD RURAL POLICY RE; Prentice AM, 2006, INT J EPIDEMIOL, V35, P93, DOI 10.1093/ije/dyi272; Resano-Perez E, 2003, SALUD PUBLICA MEXICO, V45, pS558; Rivera JA, 2004, NUTR REV, V62, pS149, DOI 10.1111/j.1753-4887.2004.tb00086.x; Romero-Martinez M, 2013, SALUD PUBLICA MEXICO, V55, pS332, DOI 10.21149/spm.v55s2.5132; ROSS CE, 1995, AM SOCIOL REV, V60, P719, DOI 10.2307/2096319; Sassi F., 2010, OBESITY EC PREVENTIO; Sepulveda-Amor J, 1990, Gac Med Mex, V126, P207; Shaw M, 2007, HDB INEQUALITY SOCIO; Shields Margot, 2006, Health Rep, V17, P53; Singh GK, 2011, J COMMUN HEALTH, V36, P94, DOI 10.1007/s10900-010-9287-9; Smith KV, 2007, SOC SCI MED, V65, P1372, DOI 10.1016/j.socscimed.2007.05.023; SOBAL J, 1989, PSYCHOL BULL, V105, P260, DOI 10.1037/0033-2909.105.2.260; Spiegelman D, 2005, AM J EPIDEMIOL, V162, P199, DOI 10.1093/aje/kwi188; Stevens G, 2008, PLOS MED, V5, P900, DOI 10.1371/journal.pmed.0050125; Stuckler D, 2012, PLOS MED, V9, DOI [10.1371/journal.pmed.1001235, 10.1371/journal.pmed.1001242]; Szklo M., 2007, EPIDEMIOLOGY BASICS; World Cancer Research Fund and American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; Yoo S, 2010, PREV MED, V51, P460, DOI 10.1016/j.ypmed.2010.10.004; Zhang Q, 2004, OBES RES, V12, P1622, DOI 10.1038/oby.2004.202	56	17	17	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90195	10.1371/journal.pone.0090195	http://dx.doi.org/10.1371/journal.pone.0090195			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC4GP	24599098	Green Published, gold, Green Submitted			2022-12-27	WOS:000332479400054
J	Klos, KS; Warmka, JK; Drachenberg, DM; Chang, L; Luxton, GWG; Leung, CT; Schwertfeger, KL; Wattenberg, EV				Klos, Kristine S.; Warmka, Janel K.; Drachenberg, Disa M.; Chang, Liang; Luxton, G. W. Gant; Leung, Cheuk T.; Schwertfeger, Kathryn L.; Wattenberg, Elizabeth V.			Building Bridges toward Invasion: Tumor Promoter Treatment Induces a Novel Protein Kinase C-Dependent Phenotype in MCF10A Mammary Cell Acini	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION; CANCER; ACTIVATION; ALPHA; DIFFERENTIATION; PROLIFERATION; ONCOGENESIS; GF-109203X; INHIBITOR; COMPLEX	The potent tumor promoter 12-O-tetradecanoylphorbol-13-acetate (TPA) alters many cellular processes through activation of its receptor protein kinase C (PKC), including gene expression, cell cycle, and the regulation of cell morphology, raising an important question for developing targeted methods to prevent cancer: which effects of TPA are crucial for carcinogenesis? To address this question, we studied TPA action in the 3-dimensional (3D) MCF10A human breast epithelial cell system, which models important features of in vivo epithelial tissue including growth constraints, structural organization of cells, and establishment of a basement membrane. MCF10A cells, which are immortalized but nontumorigenic, form hollow, spheroid structures in 3D culture referred to as acini. The development of normal acini requires the tight spatiotemporal regulation of cellular proliferation, polarization, apoptosis, and growth arrest. Treatment of MCF10A acini with TPA caused the appearance of multi-acinar structures. Surprisingly, this phenotype did not involve an increase in cell number or major changes in cell death, and polarization. Instead, live cell and confocal microscopy revealed that TPA stimulates MCF10A acini to aggregate. TPA induces the PKC-dependent production of actin-based protrusions, which leads to the formation of cellular bridges between acini, the clustering of acini, and allows cells to move into adjacent acini. During this process, the integrity of the laminin V basement membrane is disrupted, while E-cadherin-based cell-cell contacts remain intact. Altogether, our results show that under the biochemical and structural constraints of epithelial tissue, as modeled by the 3D MCF10A system, TPA induces a novel PKC-dependent phenotype that resembles local invasion. Of the many effects caused by TPA, these studies highlight the aggressive production of actin-based cellular protrusions as a potentially important event along the pathway to carcinogenesis.	[Klos, Kristine S.; Warmka, Janel K.; Drachenberg, Disa M.; Chang, Liang; Wattenberg, Elizabeth V.] Univ Minnesota, Sch Publ Hlth, Div Environm Hlth Sci, Minneapolis, MN 55455 USA; [Luxton, G. W. Gant] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN USA; [Leung, Cheuk T.] Univ Minnesota, Dept Pharmacol, Minneapolis, MN 55455 USA; [Schwertfeger, Kathryn L.] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Schwertfeger, Kathryn L.] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Wattenberg, EV (corresponding author), Univ Minnesota, Sch Publ Hlth, Div Environm Hlth Sci, Minneapolis, MN 55455 USA.	watte004@umn.edu		Chang, Liang/0000-0002-5653-3004; Luxton, GW Gant/0000-0002-6180-8906; Leung, Cheuk/0000-0002-5838-5535	University of Minnesota Academic Health Center Faculty Research Development Program; University of Minnesota Cancer Center, Translational Breast Cancer Research Award	University of Minnesota Academic Health Center Faculty Research Development Program; University of Minnesota Cancer Center, Translational Breast Cancer Research Award	This research was supported by a grant from the University of Minnesota Academic Health Center Faculty Research Development Program and a University of Minnesota Cancer Center, Translational Breast Cancer Research Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akita Y, 2008, FEBS J, V275, P3995, DOI 10.1111/j.1742-4658.2008.06557.x; Bacus S S, 2000, Breast Dis, V11, P63; BELETSKY IP, 1990, J IMMUNOL METHODS, V134, P201, DOI 10.1016/0022-1759(90)90381-5; Bissell MJ, 2011, NAT MED, V17, P320, DOI 10.1038/nm.2328; Breitkreutz D, 2007, J CANCER RES CLIN, V133, P793, DOI 10.1007/s00432-007-0280-3; Chen J, 2013, EXP CELL RES, V319, P1357, DOI 10.1016/j.yexcr.2013.03.021; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; DIAMOND L, 1978, LIFE SCI, V23, P1979, DOI 10.1016/0024-3205(78)90229-1; Goel G, 2007, INT J TOXICOL, V26, P279, DOI 10.1080/10915810701464641; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HEIKKILA J, 1993, BIOCHEM BIOPH RES CO, V197, P1185, DOI 10.1006/bbrc.1993.2602; Larsson C, 2006, CELL SIGNAL, V18, P276, DOI 10.1016/j.cellsig.2005.07.010; Li A, 2010, CURR BIOL, V20, P339, DOI 10.1016/j.cub.2009.12.035; Lipscomb EA, 2005, CANCER METAST REV, V24, P413, DOI 10.1007/s10555-005-5133-4; Marmor MD, 2004, INT J RADIAT ONCOL, V58, P903, DOI 10.1016/j.ijrobp.2003.06.002; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; Meng WX, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002899; Muthuswamy SK, 2001, NAT CELL BIOL, V3, P785, DOI 10.1038/ncb0901-785; NISHIZUKA Y, 1984, NATURE, V308, P693, DOI 10.1038/308693a0; Rafn B, 2012, MOL CELL, V45, P764, DOI 10.1016/j.molcel.2012.01.029; SOULE HD, 1990, CANCER RES, V50, P6075; Tam WL, 2013, CANCER CELL, V24, P347, DOI 10.1016/j.ccr.2013.08.005; Tan M, 2006, ONCOGENE, V25, P3286, DOI 10.1038/sj.onc.1209361; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; WAYS DK, 1995, J CLIN INVEST, V95, P1906, DOI 10.1172/JCI117872; Wrobel CN, 2004, J CELL BIOL, V165, P263, DOI 10.1083/jcb.200309102; Wu-Zhang AX, 2013, BIOCHEM J, V452, P195, DOI 10.1042/BJ20130220; Yuspa SH, 1998, J DERMATOL SCI, V17, P1, DOI 10.1016/S0923-1811(97)00071-6	32	2	2	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90722	10.1371/journal.pone.0090722	http://dx.doi.org/10.1371/journal.pone.0090722			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599099	Green Published, Green Submitted, gold			2022-12-27	WOS:000332479400126
J	Shackell, NL; Ricard, D; Stortini, C				Shackell, Nancy L.; Ricard, Daniel; Stortini, Christine			Thermal Habitat Index of Many Northwest Atlantic Temperate Species Stays Neutral under Warming Projected for 2030 but Changes Radically by 2060	PLOS ONE			English	Article							CLIMATE-CHANGE; ECOLOGICAL RESPONSES; RANGE SHIFTS; IMPACTS; UNCERTAINTY; MODELS; BIODIVERSITY; PATTERNS; NICHE; SHELF	Global scale forecasts of range shifts in response to global warming have provided vital insight into predicted species redistribution. We build on that insight by examining whether local warming will affect habitat on spatiotemporal scales relevant to regional agencies. We used generalized additive models to quantify the realized habitat of 46 temperate/boreal marine species using 41+ years of survey data from 35 degrees N-48 degrees N in the Northwest Atlantic. We then estimated change in a "realized thermal habitat index" under short-term (2030) and long-term (2060) warming scenarios. Under the 2030 scenario similar to 10% of species will lose realized thermal habitat at the national scale (USA and Canada) but planktivores are expected to lose significantly in both countries which may result in indirect changes in their predators' distribution. In contrast, by 2060 in Canada, the realized habitat of 76% of species will change (55% will lose, 21% will gain) while in the USA, the realized habitat of 85% of species will change (65% will lose, 20% will gain). If all else were held constant, the ecosystem is projected to change radically based on thermal habitat alone. The magnitude of the 2060 warming projection (similar to 1.5-3 degrees C) was observed in 2012 affirming that research is needed on effects of extreme "weather" in addition to increasing mean temperature. Our approach can be used to aggregate at smaller spatial scales where temperate/boreal species are hypothesized to have a greater loss at similar to 40 degrees N. The uncertainty associated with climate change forecasts is large, yet resource management agencies still have to address climate change. How? Since many fishery agencies do not plan beyond 5 years, a logical way forward is to incorporate a "realized thermal habitat index" into the stock assessment process. Over time, decisions would be influenced by the amount of suitable thermal habitat, in concert with gradual or extreme warming.	[Shackell, Nancy L.] Fisheries & Oceans Canada, Bedford Inst Oceanog, Dept Fisheries & Oceans, Oceans & Ecosyst Sci Div, Dartmouth, NS B2Y 4A2, Canada; [Ricard, Daniel] Biol Ctr AS CR Vvi, Inst Hydrobiol, Ceske Budejovice, Czech Republic; [Stortini, Christine] Dalhousie Univ, Sch Resource & Environm Studies, Halifax, NS, Canada	Bedford Institute of Oceanography; Fisheries & Oceans Canada; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; Dalhousie University	Shackell, NL (corresponding author), Fisheries & Oceans Canada, Bedford Inst Oceanog, Dept Fisheries & Oceans, Oceans & Ecosyst Sci Div, POB 1006, Dartmouth, NS B2Y 4A2, Canada.	nancy.shackell@dfo-mpo.gc.ca	Ricard, Daniel/G-1814-2014; Shackell, Nancy L/AAF-8209-2019	Shackell, Nancy L/0000-0001-5128-948X	Fisheries and Oceans Canada's Aquatic Climate Change Adaptation Services Program (ACCASP)	Fisheries and Oceans Canada's Aquatic Climate Change Adaptation Services Program (ACCASP)	NLS, DR and CS were supported by Fisheries and Oceans Canada's Aquatic Climate Change Adaptation Services Program (ACCASP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo MB, 2005, GLOBAL CHANGE BIOL, V11, P1504, DOI 10.1111/j.1365-2486.2005.01000.x; Araujo MB, 2004, GLOBAL CHANGE BIOL, V10, P1618, DOI 10.1111/j.1365-2486.2004.00828.x; Beale CM, 2012, PHILOS T R SOC B, V367, P247, DOI 10.1098/rstb.2011.0178; Brander KM, 2007, P NATL ACAD SCI USA, V104, P19709, DOI 10.1073/pnas.0702059104; Chen DL, 2006, ADV ATMOS SCI, V23, P54, DOI 10.1007/s00376-006-0006-5; Cheung WWL, 2011, ICES J MAR SCI, V68, P1008, DOI 10.1093/icesjms/fsr012; Cheung William W.L., 2008, University of British Columbia Fisheries Centre Research Reports, V16, P1; Cheung WWL, 2009, FISH FISH, V10, P235, DOI 10.1111/j.1467-2979.2008.00315.x; Choi J, 2012, 2012024 DFO CAN SCI, V2012; Diniz JAF, 2009, ECOGRAPHY, V32, P897, DOI 10.1111/j.1600-0587.2009.06196.x; Franco AMA, 2006, GLOBAL CHANGE BIOL, V12, P1545, DOI 10.1111/j.1365-2486.2006.01180.x; Frank KT, 2006, ECOL LETT, V9, P1096, DOI 10.1111/j.1461-0248.2006.00961.x; Frank KT, 2005, SCIENCE, V308, P1621, DOI 10.1126/science.1113075; Fronzek S, 2011, NAT HAZARD EARTH SYS, V11, P2981, DOI 10.5194/nhess-11-2981-2011; Gaston K., 2008, PATTERN PROCESS MACR; Gritti ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068823; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hale R, 2011, OIKOS, V120, P661, DOI 10.1111/j.1600-0706.2010.19469.x; Hare JA, 2012, ICES J MAR SCI, V69, P1753, DOI 10.1093/icesjms/fss160; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Hebert D, 2013, 2013058 DFO CAN SCI, V2013; Helmuth B, 2005, ANNU REV PHYSIOL, V67, P177, DOI 10.1146/annurev.physiol.67.040403.105027; Hulme PE, 2005, J APPL ECOL, V42, P784, DOI 10.1111/j.1365-2664.2005.01082.x; Jentsch A, 2007, FRONT ECOL ENVIRON, V5, P365, DOI 10.1890/1540-9295(2007)5[365:ANGOCE]2.0.CO;2; Kearney M, 2006, OIKOS, V115, P186, DOI 10.1111/j.2006.0030-1299.14908.x; Link JS, 2011, FISH FISH, V12, P461, DOI 10.1111/j.1467-2979.2010.00398.x; Loder J, 2013, CAN TECH REP HYDROGR, V292; Loder J. W., 2013, CAN TECH REP HYDROGR, V286; McCay BJ, 2012, NAT CLIM CHANGE, V2, P840, DOI 10.1038/nclimate1765; Niiranen S, 2013, GLOBAL CHANGE BIOL, V19, P3327, DOI 10.1111/gcb.12309; Nye JA, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1420; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Pinsky ML, 2013, SCIENCE, V341, P1239, DOI 10.1126/science.1239352; Pinsky ML, 2012, CLIMATIC CHANGE, V115, P883, DOI 10.1007/s10584-012-0599-x; Planque B, 2010, J MARINE SYST, V79, P403, DOI 10.1016/j.jmarsys.2008.12.018; R Core Team, 2012, R LANG ENV STAT COMP; Russell BD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046554; Seo C, 2009, BIOL LETTERS, V5, P39, DOI 10.1098/rsbl.2008.0476; Shackell NL, 2007, MAR ECOL PROG SER, V336, P235, DOI 10.3354/meps336235; Shackell NL, 2012, ICES J MAR SCI, V69, P151, DOI 10.1093/icesjms/fsr195; Shackell NL, 2010, P ROY SOC B-BIOL SCI, V277, P1353, DOI 10.1098/rspb.2009.1020; Sherman K, 2014, OCEAN COAST MANAGE, V90, P38, DOI 10.1016/j.ocecoaman.2013.06.008; Simpson SD, 2011, CURR BIOL, V21, P1565, DOI 10.1016/j.cub.2011.08.016; Thuiller W, 2004, GLOBAL CHANGE BIOL, V10, P2020, DOI 10.1111/j.1365-2486.2004.00859.x; Tuszynski J., 2012, CATOOLS TOOLS MOVING; UNESCO/IOC, 2012, NE FISH SCI CTR BOTT; UNESCO/IOC, 2012, DFO MAR RES VESS TRA; Wake DB, 2009, P NATL ACAD SCI USA, V106, P19631, DOI 10.1073/pnas.0911097106; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wernberg T, 2012, GLOBAL CHANGE BIOL, V18, P1491, DOI 10.1111/j.1365-2486.2012.02656.x; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279	53	35	38	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90662	10.1371/journal.pone.0090662	http://dx.doi.org/10.1371/journal.pone.0090662			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599187	gold, Green Published, Green Submitted			2022-12-27	WOS:000332479400111
J	Zabala, J; Zuberogoitia, I				Zabala, Jabi; Zuberogoitia, Inigo			Individual Quality Explains Variation in Reproductive Success Better than Territory Quality in a Long-Lived Territorial Raptor	PLOS ONE			English	Article							BREEDING PERFORMANCE; HABITAT HETEROGENEITY; POPULATION REGULATION; TAWNY OWLS; BROOD-SIZE; AGE; DIET; SELECTION; ECOLOGY; WEATHER	Evolution by natural selection depends on the relationship between individual traits and fitness. Variation in individual fitness can result from habitat (territory) quality and individual variation. Individual quality and specialization can have a deep impact on fitness, yet in most studies on territorial species the quality of territory and individuals are confused. We aimed to determine if variation in breeding success is better explained by territories, individual quality or a combination of both. We analysed the number of fledglings and the breeding quality index (the difference between the number of fledglings of an individual/breeding pair and the average number of fledglings of the monitored territories in the same year) as part of a long term (16 years) peregrine falcon (Falco peregrinus) monitoring program with identification of individuals. Using individual and territory identities as correlates of quality, we built Generalised Linear Models with Mixed effects, in which random factors depicted different hypotheses for sources of variation (territory/individual quality) in the reproductive success of unique breeding pairs, males and females, and assessed their performance. Most evidence supported the hypothesis that variation in breeding success is explained by individual identity, particularly male identity, rather than territory. There is also some evidence for inter year variations in the breeding success of females and a territory effect in the case of males. We argue that, in territorial species, individual quality is a major source of variation in breeding success, often masked by territory. Future ecological and conservation studies on habitat use should consider and include the effect of individuals, in order to avoid misleading results.	[Zuberogoitia, Inigo] Icarus Estudios Medioambientales, Logrono, Spain; [Zuberogoitia, Inigo] Soc Ciencias Aranzadi, Dept Ornithol, Donostia San Sebastian, Spain			jzabalaalbizua@yahoo.com	Iñigo, Zuberogoitia/H-5062-2019; Zabala, Jabi/B-8157-2009	Zabala, Jabi/0000-0002-1425-1594; Zuberogoitia, Inigo/0000-0002-8945-7386	Fhe Agriculture and the Environment Departments of the Diputacion Foral de Bizkaia	Fhe Agriculture and the Environment Departments of the Diputacion Foral de Bizkaia	This work was supported by Fhe Agriculture and the Environment Departments of the Diputacion Foral de Bizkaia provided partial funding for field work some of the seasons. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates D, 2012, LME4 LINEAR MIXED EF; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Burnham KP, 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; Cam E, 2000, J ANIM ECOL, V69, P380, DOI 10.1046/j.1365-2656.2000.00400.x; Cam E, 2002, AM NAT, V159, P96, DOI 10.1086/324126; Cardador L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033375; Carrete M, 2006, OIKOS, V112, P680, DOI 10.1111/j.0030-1299.2006.14528.x; Carrete M, 2008, OIKOS, V117, P1115, DOI 10.1111/j.0030-1299.2008.16968.x; Clutton-Brock TH, 1988, REPROD SUCCESS STUDI; Crawley M.J., 2007, R BOOK; Crone EE, 2001, EVOLUTION, V55, P2611; Espie RHM, 2004, IBIS, V146, P623, DOI 10.1111/j.1474-919x.2004.00294.x; Ferrer M, 2003, AUK, V120, P180, DOI 10.1642/0004-8038(2003)120[0180:AATEOF]2.0.CO;2; Ferrer M, 1996, ECOLOGY, V77, P69, DOI 10.2307/2265655; FORSLUND P, 1995, TRENDS ECOL EVOL, V10, P374, DOI 10.1016/S0169-5347(00)89141-7; Forsman D, 1999, RAPTORS EUROPE MIDDL; Germain RR, 2014, ECOLOGY IN PRESS; GOODBURN SF, 1991, IBIS, V133, P85, DOI 10.1111/j.1474-919X.1991.tb04815.x; HOGSTEDT G, 1980, SCIENCE, V210, P1148, DOI 10.1126/science.210.4474.1148; Johnson MD, 2007, CONDOR, V109, P489, DOI 10.1650/8347.1; Jones J, 2001, AUK, V118, P557, DOI 10.1642/0004-8038(2001)118[0557:HSSIAE]2.0.CO;2; Katzner TE, 2005, IBIS, V147, P576, DOI 10.1111/j.1474-919X.2005.00443.x; KORPIMAKI E, 1988, J ANIM ECOL, V57, P1027, DOI 10.2307/5109; Kruger O, 2012, J ANIM ECOL, V81, P330, DOI 10.1111/j.1365-2656.2011.01904.x; Kruger O, 2001, OIKOS, V93, P260, DOI 10.1034/j.1600-0706.2001.930209.x; Margalida A, 2014, ECOLOGICAL IN PRESS; Margalida A, 2012, IBIS, V154, P184, DOI 10.1111/j.1474-919X.2011.01189.x; Margalida A, 2008, ARDEA, V96, P173, DOI 10.5253/078.096.0203; Margalida A, 2009, IBIS, V151, P235; Martin TE, 1998, ECOLOGY, V79, P656, DOI 10.1890/0012-9658(1998)079[0656:AMPOCS]2.0.CO;2; Martinez JE, 2008, ORNIS FENNICA, V85, P13; McGraw JB, 1996, AM NAT, V147, P47, DOI 10.1086/285839; Millon A, 2011, J ANIM ECOL, V80, P968, DOI 10.1111/j.1365-2656.2011.01842.x; NEWTON I, 1991, IBIS, V133, P76, DOI 10.1111/j.1474-919X.1991.tb07671.x; Newton I, 1989, LIFETIME REPROD BIRD; Newton I, 2013, BIRD POPUL; Nussey DH, 2008, FUNCT ECOL, V22, P393, DOI 10.1111/j.1365-2435.2008.01408.x; Olsen J, 2003, EMU, V103, P127, DOI 10.1071/MU02013; Pagan I, 2009, J ZOOL, V279, P36, DOI 10.1111/j.1469-7998.2009.00587.x; Pinheiro J, 2012, LME LINEAR NONLINEAR; Pulliam HR, 2000, ECOL LETT, V3, P349, DOI 10.1046/j.1461-0248.2000.00143.x; R Core Team, 2021, R LANGUAGE ENV STAT; Rodriguez C, 2003, J ANIM ECOL, V72, P793, DOI 10.1046/j.1365-2656.2003.00757.x; Sasvari L, 2002, FOLIA ZOOL, V51, P113; Sasvari L, 2000, ACTA OECOL, V21, P267, DOI 10.1016/S1146-609X(00)01080-8; Sergio F, 2003, J ANIM ECOL, V72, P857, DOI 10.1046/j.1365-2656.2003.00758.x; Steenhof K, 1997, J ANIM ECOL, V66, P350, DOI 10.2307/5981; Wiens J.A., 1989, ECOLOGY BIRD COMMUNI, V1; Zabala J, 2011, MAR POLLUT BULL, V62, P109, DOI 10.1016/j.marpolbul.2010.09.004; Zar JH, 1999, BIOSTATISTCAL ANAL; Zuberogoitia I, 2008, ANIM CONSERV, V11, P313, DOI 10.1111/j.1469-1795.2008.00184.x; Zuberogoitia I, 2002, HALCION PEREGRINO; Zuberogoitia I, 2014, MUNIBE, V61, P117; Zuberogoitia I, 2009, J ORNITHOL, V150, P95, DOI 10.1007/s10336-008-0321-y; Zuberogoitia I, 2013, J ORNITHOL, V154, P73, DOI 10.1007/s10336-012-0872-9; Zuur Alain F., 2009, P1	57	30	30	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90254	10.1371/journal.pone.0090254	http://dx.doi.org/10.1371/journal.pone.0090254			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599280	Green Published, gold, Green Submitted			2022-12-27	WOS:000332479400058
J	Liang, PP; Li, ZH; Deshpande, G; Wang, ZQ; Hu, XP; Li, KC				Liang, Peipeng; Li, Zhihao; Deshpande, Gopikrishna; Wang, Zhiqun; Hu, Xiaoping; Li, Kuncheng			Altered Causal Connectivity of Resting State Brain Networks in Amnesic MCI	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; ANTERIOR PREFRONTAL CORTEX; ALZHEIMERS-DISEASE; FUNCTIONAL CONNECTIVITY; DEFAULT-MODE; GLOBAL SIGNAL; HIPPOCAMPAL CONNECTIVITY; HEAD MOTION; FMRI; MRI	Most neuroimaging studies of resting state networks in amnesic mild cognitive impairment (aMCI) have concentrated on functional connectivity (FC) based on instantaneous correlation in a single network. The purpose of the current study was to investigate effective connectivity in aMCI patients based on Granger causality of four important networks at resting state derived from functional magnetic resonance imaging data - default mode network (DMN), hippocampal cortical memory network (HCMN), dorsal attention network (DAN) and fronto-parietal control network (FPCN). Structural and functional MRI data were collected from 16 aMCI patients and 16 age, gender-matched healthy controls. Correlation-purged Granger causality analysis was used, taking gray matter atrophy as covariates, to compare the group difference between aMCI patients and healthy controls. We found that the causal connectivity between networks in aMCI patients was significantly altered with both increases and decreases in the aMCI group as compared to healthy controls. Some alterations were significantly correlated with the disease severity as measured by mini-mental state examination (MMSE), and California verbal learning test (CVLT) scores. When the whole-brain signal averaged over the entire brain was used as a nuisance covariate, the within-group maps were significantly altered while the between-group difference maps did not. These results suggest that the alterations in causal influences may be one of the possible underlying substrates of cognitive impairments in aMCI. The present study extends and complements previous FC studies and demonstrates the coexistence of causal disconnection and compensation in aMCI patients, and thus might provide insights into biological mechanism of the disease.	[Liang, Peipeng; Wang, Zhiqun; Li, Kuncheng] Capital Med Univ, Xuanwu Hosp, Dept Radiol, Beijing, Peoples R China; [Liang, Peipeng; Wang, Zhiqun; Li, Kuncheng] Beijing Key Lab Magnet Resonance Imaging & Brain, Beijing, Peoples R China; [Liang, Peipeng; Wang, Zhiqun; Li, Kuncheng] Minist Educ, Key Lab Neurodegenerat Dis, Beijing, Peoples R China; [Li, Zhihao; Hu, Xiaoping] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Li, Zhihao; Hu, Xiaoping] Emory Univ, Atlanta, GA 30322 USA; [Deshpande, Gopikrishna] Auburn Univ, MRI Res Ctr, Dept Elect & Comp Engn, Auburn, AL 36849 USA; [Deshpande, Gopikrishna] Auburn Univ, Dept Psychol, Auburn, AL 36849 USA	Capital Medical University; University System of Georgia; Georgia Institute of Technology; Emory University; Auburn University System; Auburn University; Auburn University System; Auburn University	Hu, XP (corresponding author), Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.	xhu@bme.gatech.edu; lkc1955@gmail.com	Li, Zhihao/R-4741-2019	Li, Zhihao/0000-0002-6009-7903; Deshpande, Gopikrishna/0000-0001-7471-5357; Hu, Xiaoping/0000-0001-7014-5983	Natural Science Foundation of China [61105118, 81000606, 81271556]; Beijing Nova Program [Z12111000250000]; State Key Laboratory of Cognitive Neuroscience and Learning [CNKOPZD1001]; CAS Key Laboratory of Brain Function and Disease	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Nova Program(Beijing Municipal Science & Technology Commission); State Key Laboratory of Cognitive Neuroscience and Learning; CAS Key Laboratory of Brain Function and Disease	This work was supported by the Natural Science Foundation of China (Grant Nos. 61105118, 81000606, 81271556), Beijing Nova Program (Z12111000250000), Open Research Fund of the State Key Laboratory of Cognitive Neuroscience and Learning (No. CNKOPZD1001), Open Research Fund of CAS Key Laboratory of Brain Function and Disease. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosta F, 2012, NEUROBIOL AGING, V33, P1564, DOI 10.1016/j.neurobiolaging.2011.06.007; Allen G, 2007, ARCH NEUROL-CHICAGO, V64, P1482, DOI 10.1001/archneur.64.10.1482; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Bai F, 2008, NEUROSCI LETT, V438, P111, DOI 10.1016/j.neulet.2008.04.021; Bai F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024271; Bai F, 2009, BRAIN RES, V1302, P167, DOI 10.1016/j.brainres.2009.09.028; Belleville S, 2008, NEUROPSYCHOLOGIA, V46, P2225, DOI 10.1016/j.neuropsychologia.2008.02.012; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bokde ALW, 2001, ARCH NEUROL-CHICAGO, V58, P480, DOI 10.1001/archneur.58.3.480; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Celone KA, 2006, J NEUROSCI, V26, P10222, DOI 10.1523/JNEUROSCI.2250-06.2006; Chai XQJ, 2012, NEUROIMAGE, V59, P1420, DOI 10.1016/j.neuroimage.2011.08.048; Christoff K, 2000, PSYCHOBIOLOGY, V28, P168; Clement F, 2010, BIOL PSYCHIAT, V68, P894, DOI 10.1016/j.biopsych.2010.02.004; Clement F, 2010, CORTEX, V46, P1005, DOI 10.1016/j.cortex.2009.07.003; DELACOSTE MC, 1993, NEUROBIOL AGING, V14, P1, DOI 10.1016/0197-4580(93)90015-4; Delamillieure P, 2010, BRAIN RES BULL, V81, P565, DOI 10.1016/j.brainresbull.2009.11.014; Delbeuck X, 2003, NEUROPSYCHOL REV, V13, P79, DOI 10.1023/A:1023832305702; Derflinger S, 2011, J ALZHEIMERS DIS, V25, P347, DOI 10.3233/JAD-2011-110041; Deshpande G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014277; Deshpande G, 2011, NEUROIMAGE, V54, P1043, DOI 10.1016/j.neuroimage.2010.09.024; Deshpande G, 2010, NEUROIMAGE, V52, P884, DOI 10.1016/j.neuroimage.2009.11.060; Deshpande G, 2010, IEEE T BIO-MED ENG, V57, P1446, DOI 10.1109/TBME.2009.2037808; Deshpande G, 2010, NEUROIMAGE, V49, P1991, DOI 10.1016/j.neuroimage.2009.08.052; Deshpande G, 2009, HUM BRAIN MAPP, V30, P1361, DOI 10.1002/hbm.20606; Ferreira LK, 2011, NEUROBIOL AGING, V32, P1733, DOI 10.1016/j.neurobiolaging.2009.11.008; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; Gomez-Isla T, 1997, CONNECTIONS COGNITIO, P149; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Hamalainen A, 2007, NEUROBIOL AGING, V28, P1889, DOI 10.1016/j.neurobiolaging.2006.08.008; He Y, 2007, NEUROIMAGE, V35, P488, DOI 10.1016/j.neuroimage.2006.11.042; Huijbers W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017463; Kircher TT, 2007, J NEUROL NEUROSUR PS, V78, P812, DOI 10.1136/jnnp.2006.104877; Koechlin E, 1999, NATURE, V399, P148, DOI 10.1038/20178; Li R, 2013, AM J NEURORADIOL, V34, P340, DOI 10.3174/ajnr.A3197; Liang PP, 2012, J ALZHEIMERS DIS, V30, P475, DOI 10.3233/JAD-2012-111721; Liang PP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022153; Liao XH, 2013, NEUROIMAGE, V83, P969, DOI 10.1016/j.neuroimage.2013.07.058; Liu ZY, 2012, NMR BIOMED, V25, P1311, DOI 10.1002/nbm.2803; Marshall GA, 2011, ALZHEIMERS DEMENT, V7, P300, DOI 10.1016/j.jalz.2010.04.005; Miao XY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025546; Morrison J, 1986, BIOL SUBSTRATES ALZH, P115; Mosconi L, 2005, NEUROLOGY, V64, P1860, DOI 10.1212/01.WNL.0000163856.13524.08; Mosconi L, 2008, NEUROBIOL AGING, V29, P676, DOI 10.1016/j.neurobiolaging.2006.12.008; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Nickl-Jockschat T, 2012, BRAIN STRUCT FUNCT, V217, P115, DOI 10.1007/s00429-011-0333-x; Oakes TR, 2007, NEUROIMAGE, V34, P500, DOI 10.1016/j.neuroimage.2006.10.007; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Petrella JR, 2007, RADIOLOGY, V245, P224, DOI 10.1148/radiol.2451061847; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Putcha D, 2011, J NEUROSCI, V31, P17680, DOI 10.1523/JNEUROSCI.4740-11.2011; Qi ZG, 2010, NEUROIMAGE, V50, P48, DOI 10.1016/j.neuroimage.2009.12.025; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ramnani N, 2004, NAT REV NEUROSCI, V5, P184, DOI 10.1038/nrn1343; Rombouts SARB, 2005, HUM BRAIN MAPP, V26, P231, DOI 10.1002/hbm.20160; Rosano C, 2005, BIOL PSYCHIAT, V57, P761, DOI 10.1016/j.biopsych.2004.12.031; Satterthwaite TD, 2013, NEUROIMAGE, V64, P240, DOI 10.1016/j.neuroimage.2012.08.052; Satterthwaite TD, 2012, NEUROIMAGE, V60, P623, DOI 10.1016/j.neuroimage.2011.12.063; Scholvinck ML, 2010, P NATL ACAD SCI USA, V107, P10238, DOI 10.1073/pnas.0913110107; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sorg C, 2007, P NATL ACAD SCI USA, V104, P18760, DOI 10.1073/pnas.0708803104; Spreng RN, 2010, NEUROIMAGE, V53, P303, DOI 10.1016/j.neuroimage.2010.06.016; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; THEILER J, 1992, PHYSICA D, V58, P77, DOI 10.1016/0167-2789(92)90102-S; Thomann PA, 2008, BRAIN COGNITION, V67, P88, DOI 10.1016/j.bandc.2007.11.008; Uddin LQ, 2009, HUM BRAIN MAPP, V30, P625, DOI 10.1002/hbm.20531; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Vincent JL, 2008, J NEUROPHYSIOL, V100, P3328, DOI 10.1152/jn.90355.2008; Wang JH, 2013, BIOL PSYCHIAT, V73, P472, DOI 10.1016/j.biopsych.2012.03.026; Wang K, 2007, HUM BRAIN MAPP, V28, P967, DOI 10.1002/hbm.20324; Wang L, 2006, NEUROIMAGE, V31, P496, DOI 10.1016/j.neuroimage.2005.12.033; Wang L, 2010, NEUROIMAGE, V51, P910, DOI 10.1016/j.neuroimage.2010.02.046; Wang ZQ, 2011, J NEUROL SCI, V309, P79, DOI 10.1016/j.jns.2011.07.017; Weissenbacher A, 2009, NEUROIMAGE, V47, P1408, DOI 10.1016/j.neuroimage.2009.05.005; Wen XT, 2013, J NEUROSCI, V33, P6444, DOI 10.1523/JNEUROSCI.4939-12.2013; Wu X, 2011, HUM BRAIN MAPP, V32, P1868, DOI 10.1002/hbm.21153; Yan CG, 2013, NEUROIMAGE, V76, P183, DOI 10.1016/j.neuroimage.2013.03.004; Yang J, 2012, J NEUROL SCI, V316, P21, DOI 10.1016/j.jns.2012.02.010; Yang YH, 2009, SCI CHINA SER C, V52, P789, DOI 10.1007/s11427-009-0089-1; Zhang HY, 2009, BEHAV BRAIN RES, V197, P103, DOI 10.1016/j.bbr.2008.08.012; Zhang ZS, 2010, BEHAV BRAIN RES, V208, P619, DOI 10.1016/j.bbr.2010.01.008	88	36	37	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e88476	10.1371/journal.pone.0088476	http://dx.doi.org/10.1371/journal.pone.0088476			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24613934	Green Published, gold, Green Submitted			2022-12-27	WOS:000332839300005
J	Sandri, S; Borbely, AU; Fernandes, I; de Oliveira, EM; Knebel, FH; Ruano, R; Zugaib, M; Filippin-Monteiro, F; Bevilacqua, E; Campa, A				Sandri, Silvana; Borbely, Alexandre Urban; Fernandes, Isabella; de Oliveira, Edson Mendes; Knebel, Franciele Hinterholz; Ruano, Rodrigo; Zugaib, Marcelo; Filippin-Monteiro, Fabiola; Bevilacqua, Estela; Campa, Ana			Serum Amyloid A in the Placenta and Its Role in Trophoblast Invasion	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; CELL-MIGRATION; ADHESION MOLECULES; FETAL MEMBRANES; EXPRESSION; INTERLEUKIN-8; ANGIOGENESIS; ADIPONECTIN; ADIPOCYTE; RELEASE	The serum amyloid A (SAA) protein is known to function in the acute phase response and immunoregulation. Recently, SAA has been shown to be involved in cell proliferation, differentiation and migratory behavior in different cell types. Here, we evaluated whether exogenous SAA could influence trophoblast invasion and differentiation using both the trophoblast-like BeWo cell line and fully differentiated human extravillous trophoblast cells (EVT) isolated from term placentae. SAA stimulated BeWo cell invasion, as measured in Matrigel invasion assays, and induced metalloprotease mRNA expression and activity. Given that BeWo cells express Toll-like receptor 4 (TLR4), a known receptor for SAA, we examined the role of TLR4 in SAA-induced invasion using a TLR4 neutralizing antibody. We also tested whether SAA could affect markers of trophoblast syncytialization in BeWo cells. We observed that SAA decreased beta hCG secretion and did not influence trophoblast syncytialization. Using EVT cells isolated from human term basal plates, we confirmed that SAA at 1 and 10 mu g/mL doubled EVT invasion in a TLR4-dependent manner, but at 20 mu g/mL inhibited EVT cells invasiveness. In addition, we observed that SAA was expressed in both BeWo cells and human term placentae, specifically in the syncytiotrophoblast, decidual cells and EVT. In conclusion, SAA was identified as a molecule that functions in the placental microenvironment to regulate metalloprotease activity and trophoblast invasion, which are key processes in placentation and placental homeostasis.	[Sandri, Silvana; de Oliveira, Edson Mendes; Knebel, Franciele Hinterholz; Campa, Ana] Univ Sao Paulo, Fac Ciencias Farmaceut, Dept Anal Clin Toxicolog, Sao Paulo, Brazil; [Borbely, Alexandre Urban; Bevilacqua, Estela] Univ Sao Paulo, Inst Ciencias Biomed, Dept Biol Celular & Desenvolvimento, BR-05508 Sao Paulo, Brazil; [Fernandes, Isabella] Univ Sao Paulo, Dept Cirurgia, Fac Vet & Zootecnia, Sao Paulo, Brazil; [Ruano, Rodrigo; Zugaib, Marcelo] Univ Sao Paulo, Fac Med, Dept Obstet & Ginecol, Sao Paulo, Brazil; [Filippin-Monteiro, Fabiola] Univ Fed Santa Catarina, Dept Anal Clin, Florianopolis, SC, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Santa Catarina (UFSC)	Sandri, S (corresponding author), Univ Sao Paulo, Fac Ciencias Farmaceut, Dept Anal Clin Toxicolog, Sao Paulo, Brazil.	ssandri@usp.br	Sandri, Silvana/A-1650-2015; Borbely, Alexandre/GRR-8137-2022; Borbely, Alexandre Urban/Q-2884-2019; Bevilacqua, Estela/H-3354-2011; Filippin-Monteiro, Fabiola Branco/D-6509-2018; Borbely, Alexandre/GPW-8010-2022; Zugaib, Marcelo/A-5724-2013; Campa, Ana/D-4669-2012; de Oliveira, Edson M/C-9885-2014	Borbely, Alexandre/0000-0001-6737-0901; Bevilacqua, Estela/0000-0003-4178-4625; Filippin-Monteiro, Fabiola Branco/0000-0003-4313-1783; Borbely, Alexandre/0000-0001-6737-0901; Zugaib, Marcelo/0000-0003-1155-2671; Campa, Ana/0000-0002-6183-3378; de Oliveira, Edson M/0000-0002-7330-7826; Knebel, Franciele/0000-0001-8275-9499	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2009/05354-0]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This research was supported by grant from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (2009/05354-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almasry SM, 2012, J MOL HISTOL, V43, P253, DOI 10.1007/s10735-012-9410-6; Aplin JD, 2009, PLACENTA, V30, P293, DOI 10.1016/j.placenta.2008.12.001; BADOLATO R, 1995, J IMMUNOL, V155, P4004; Bauer S, 2004, J CLIN ENDOCR METAB, V89, P812, DOI 10.1210/jc.2003-031351; Benaitreau D, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-128; Benaitreau D, 2010, J ENDOCRINOL, V207, P45, DOI 10.1677/JOE-10-0170; Borbely AU, 2014, REPROD BIOL ENDOCRIN, V12, DOI 10.1186/1477-7827-12-7; Connolly M, 2011, ANN RHEUM DIS, V70, P1296, DOI 10.1136/ard.2010.142240; Connolly M, 2010, J IMMUNOL, V184, P6427, DOI 10.4049/jimmunol.0902941; de Oliveira EM, 2013, INFLAMMATION, V36, P1107, DOI 10.1007/s10753-013-9644-9; Eklund KK, 2012, CRIT REV IMMUNOL, V32, P335; Filippin-Monteiro FB, 2012, INT J OBESITY, V36, P1032, DOI 10.1038/ijo.2011.193; Furlaneto CJ, 2000, BIOCHEM BIOPH RES CO, V268, P405, DOI 10.1006/bbrc.2000.2143; Gude NM, 2004, THROMB RES, V114, P397, DOI 10.1016/j.thromres.2004.06.038; Gutfeld O, 2006, J HISTOCHEM CYTOCHEM, V54, P63, DOI 10.1369/jhc.5A6645.2005; Harris LK, 2009, PLACENTA, V30, P299, DOI 10.1016/j.placenta.2008.12.003; Hatanaka E, 2011, CLIN EXP IMMUNOL, V163, P362, DOI 10.1111/j.1365-2249.2010.04300.x; Huppertz B, 1998, CELL TISSUE RES, V291, P133; Jovanovic M, 2009, PLACENTA, V30, P320, DOI 10.1016/j.placenta.2009.01.013; Jovanovic M, 2010, REPRODUCTION, V139, P789, DOI 10.1530/REP-09-0341; Knebel FH, 2013, MEDIAT INFLAMM, V2013; Kovacevic A, 2006, FEBS LETT, V580, P161, DOI 10.1016/j.febslet.2005.11.067; Lakota K, 2011, J BIOMED BIOTECHNOL, V90, P2233; Lee HY, 2005, BIOCHEM BIOPH RES CO, V330, P989, DOI 10.1016/j.bbrc.2005.03.069; Lee MS, 2006, J IMMUNOL, V177, P5585, DOI 10.4049/jimmunol.177.8.5585; Leisser C, 2006, MOL HUM REPROD, V12, P601, DOI 10.1093/molehr/gal066; Liao SJ, 2012, BREAST CANCER RES TR, V133, P853, DOI 10.1007/s10549-011-1844-0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loregger T, 2003, PLACENTA, V24, pS104, DOI 10.1053/plac.2002.0929; Lunghi L, 2007, REPROD BIOL ENDOCRIN, V5, DOI 10.1186/1477-7827-5-6; Malassine A, 2002, ENDOCRINE, V19, P3, DOI 10.1385/ENDO:19:1:3; Mullan RH, 2006, ARTHRITIS RHEUM-US, V54, P105, DOI 10.1002/art.21518; O'Hara R, 2004, ARTHRITIS RHEUM-US, V50, P1788, DOI 10.1002/art.20301; Osman I, 2003, MOL HUM REPROD, V9, P41, DOI 10.1093/molehr/gag001; Poitou C, 2005, DIABETOLOGIA, V48, P519, DOI 10.1007/s00125-004-1654-6; Poitou C, 2009, J CLIN ENDOCR METAB, V94, P1810, DOI 10.1210/jc.2008-2040; PreciadoPatt L, 1996, J IMMUNOL, V156, P1189; Pringle KG, 2010, HUM REPROD UPDATE, V16, P415, DOI 10.1093/humupd/dmp046; Ribeiro FP, 2003, MEDIAT INFLAMM, V12, P173, DOI 10.1080/0962935031000134897; Sandri S, 2008, J LEUKOCYTE BIOL, V83, P1174, DOI 10.1189/jlb.0407203; Sharma S, 2010, J REPROD IMMUNOL, V85, P112, DOI 10.1016/j.jri.2010.01.002; Sjoholm K, 2005, J CLIN ENDOCR METAB, V90, P2233, DOI 10.1210/jc.2004-1830; Stenqvist AC, 2008, AM J REPROD IMMUNOL, V60, P33, DOI 10.1111/j.1600-0897.2008.00588.x; Trowsdale J, 2006, NAT IMMUNOL, V7, P241, DOI 10.1038/ni1317; Upragarin N, 2005, HISTOL HISTOPATHOL, V20, P1295, DOI 10.14670/HH-20.1295; Urieli-Shoval S, 2000, CURR OPIN HEMATOL, V7, P64, DOI 10.1097/00062752-200001000-00012; Wang FQ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0062988, 10.1371/journal.pone.0061792, 10.1371/journal.pone.0069284, 10.1371/journal.pone.0064373, 10.1371/journal.pone.0080480, 10.1371/journal.pone.0078025]; Xu B, 2011, PLACENTA, V32, P241, DOI 10.1016/j.placenta.2010.12.005; Xu P, 2002, J CLIN ENDOCR METAB, V87, P1353, DOI 10.1210/jc.87.3.1353; Yamada T, 2000, SCAND J IMMUNOL, V52, P7	50	18	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e90881	10.1371/journal.pone.0090881	http://dx.doi.org/10.1371/journal.pone.0090881			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614130	Green Published, Green Submitted, gold			2022-12-27	WOS:000332839300049
J	Stieler, JT; Prange, R				Stieler, Jens T.; Prange, Reinhild			Involvement of ESCRT-II in Hepatitis B Virus Morphogenesis	PLOS ONE			English	Article							UBIQUITIN-INTERACTING ADAPTER; HUMAN-IMMUNODEFICIENCY-VIRUS; LATE-BUDDING DOMAINS; CAPSID PARTICLES; SORTING PATHWAY; GROWTH-FACTOR; PROTEINS; GAMMA-2-ADAPTIN; TRAFFICKING; COMPLEX	The hepatitis B virus (HBV) is an enveloped DNA virus that replicates via reverse transcription of its pregenomic RNA (pgRNA). Budding of HBV is supposed to occur at intracellular membranes and requires scission functions of the endosomal sorting complex required for transport (ESCRT) provided by ESCRT-III and VPS4. Here, we have investigated the impact of the upstream-acting ESCRT-I and ESCRT-II complexes in HBV morphogenesis. RNA interference knockdown of the ESCRT-I subunits TSG101 and VPS28 did not block, but rather stimulate virus release. In contrast, RNAi-mediated depletion of the ESCRT-II components EAP20, EAP30 and EAP45 greatly reduced virus egress. By analyzing different steps of the HBV maturation pathway, we find that the knockdown of ESCRT-II not only inhibited the production and/or release of enveloped virions, but also impaired intracellular nucleocapsid formation. Transcription/translation studies revealed that the depletion of ESCRT-II neither affected the synthesis and nuclear export of HBV-specific RNAs nor the expression of the viral core and envelope proteins. Moreover, the absence of ESCRT-II had no effects on the assembly capability and integrity of HBV core/capsids. However, the level of encapsidated pgRNA was significantly reduced in ESCRT-II-depleted cells, implicating that ESCRT-II directs steps accompanying the formation of replication-competent nucleocapsids, like e. g. assisting in RNA trafficking and encapsidation. In support of this, the capsid protein was found to interact and colocalize with ESCRT-II subunits in virus-producing cells. Together, these results indicate an essential role for ESCRT-II in the HBV life cycle and suggest that ESCRT-II functions prior to the final HBV budding reaction.	[Stieler, Jens T.; Prange, Reinhild] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Med Microbiol & Hyg, D-55122 Mainz, Germany	Johannes Gutenberg University of Mainz	Prange, R (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Med Microbiol & Hyg, D-55122 Mainz, Germany.	prange@uni-mainz.de	Stieler, Jens T/A-5111-2017	Stieler, Jens T/0000-0002-3770-3258; Prange, Reinhild/0000-0001-8312-4970	Deutsche Forschungsgemeinschaft [SFB 490-D1, PR 305/3-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Deutsche Forschungsgemeinschaft (SFB 490-D1, PR 305/3-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardens A, 2011, CELL MICROBIOL, V13, P602, DOI 10.1111/j.1462-5822.2010.01557.x; Bieniasz PD, 2006, VIROLOGY, V344, P55, DOI 10.1016/j.virol.2005.09.044; Bowers K, 2006, J BIOL CHEM, V281, P5094, DOI 10.1074/jbc.M508632200; Bruss V, 2007, WORLD J GASTROENTERO, V13, P65, DOI 10.3748/wjg.v13.i1.65; Carlson LA, 2012, P NATL ACAD SCI USA, V109, P16928, DOI 10.1073/pnas.1211759109; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Chen BJ, 2008, VIROLOGY, V372, P221, DOI 10.1016/j.virol.2007.11.008; Chua PK, 2006, VIROLOGY, V354, P1, DOI 10.1016/j.virol.2006.07.018; Doring T, 2010, BBA-MOL CELL RES, V1803, P1252, DOI 10.1016/j.bbamcr.2010.08.001; Dussupt V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000339; Garcia ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072845; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; Gerelsaikhan T, 1996, J VIROL, V70, P4269, DOI 10.1128/JVI.70.7.4269-4274.1996; Ghoujal B, 2012, BIOL CELL, V104, P706, DOI 10.1111/boc.201200021; Hartmann-Stuhler C, 2001, J VIROL, V75, P5343, DOI 10.1128/JVI.75.11.5343-5351.2001; Hierro A, 2004, NATURE, V431, P221, DOI 10.1038/nature02914; Hirano S, 2006, NAT STRUCT MOL BIOL, V13, P1031, DOI 10.1038/nsmb1163; Hoffmann J, 2013, J HEPATOL, V59, P934, DOI 10.1016/j.jhep.2013.06.020; Hurley JH, 2010, NAT REV MOL CELL BIO, V11, P556, DOI 10.1038/nrm2937; Im YJ, 2008, DEV CELL, V14, P902, DOI 10.1016/j.devcel.2008.04.004; Irion U, 2007, NATURE, V445, P554, DOI 10.1038/nature05503; Jurgens MC, 2013, NAT CHEM BIOL, V9, P540, DOI [10.1038/NCHEMBIO.1294, 10.1038/nchembio.1294]; Kamura T, 2001, J BIOL CHEM, V276, P16528, DOI 10.1074/jbc.M010142200; Lambert C, 2007, J VIROL, V81, P9050, DOI 10.1128/JVI.00479-07; Langelier C, 2006, J VIROL, V80, P9465, DOI 10.1128/JVI.01049-06; Lentz TB, 2011, J VIROL, V85, P11916, DOI 10.1128/JVI.05373-11; Malerod L, 2007, TRAFFIC, V8, P1617, DOI 10.1111/j.1600-0854.2007.00630.x; Martin-Serrano J, 2003, P NATL ACAD SCI USA, V100, P12414, DOI 10.1073/pnas.2133846100; Martin-Serrano J, 2011, NAT REV MICROBIOL, V9, P519, DOI 10.1038/nrmicro2596; McCullough J, 2013, ANNU REV BIOCHEM, V82, P663, DOI 10.1146/annurev-biochem-072909-101058; Medina GN, 2011, J VIROL, V85, P7353, DOI 10.1128/JVI.00141-11; Medina G, 2008, VIROLOGY, V377, P30, DOI 10.1016/j.virol.2008.04.024; Morita E, 2007, EMBO J, V26, P4215, DOI 10.1038/sj.emboj.7601850; Nassal M, 2008, VIRUS RES, V134, P235, DOI 10.1016/j.virusres.2007.12.024; Patient R, 2009, CELL MICROBIOL, V11, P1561, DOI 10.1111/j.1462-5822.2009.01363.x; Peel S, 2011, TRENDS BIOCHEM SCI, V36, P199, DOI 10.1016/j.tibs.2010.09.004; Pincetic A, 2008, J BIOL CHEM, V283, P29822, DOI 10.1074/jbc.M804157200; Pincetic A, 2009, ADV VIROL, V2009, DOI 10.1155/2009/623969; Plant JJ., 2011, 3462118 HARV U, P136; Prange R, 2012, MED MICROBIOL IMMUN, V201, P449, DOI 10.1007/s00430-012-0267-9; RADZIWILL G, 1990, J VIROL, V64, P613, DOI 10.1128/JVI.64.2.613-620.1990; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Roingeard P, 1998, HEPATOLOGY, V28, P1128, DOI 10.1002/hep.510280431; Rost M, 2008, J BIOL CHEM, V283, P32119, DOI 10.1074/jbc.M802632200; Rost M, 2006, J BIOL CHEM, V281, P29297, DOI 10.1074/jbc.M603517200; Slagsvold T, 2005, J BIOL CHEM, V280, P19600, DOI 10.1074/jbc.M501510200; Strack B, 2003, CELL, V114, P689, DOI 10.1016/S0092-8674(03)00653-6; Stuffers S, 2009, TRAFFIC, V10, P925, DOI 10.1111/j.1600-0854.2009.00920.x; Votteler J, 2013, CELL HOST MICROBE, V14, P232, DOI 10.1016/j.chom.2013.08.012; Wang SW, 2004, J VIROL, V78, P716, DOI 10.1128/JVI.78.2.716-723.2004; Wang TL, 2006, BIOCHEM BIOPH RES CO, V350, P413, DOI 10.1016/j.bbrc.2006.09.064; Watanabe T, 2007, P NATL ACAD SCI USA, V104, P10205, DOI 10.1073/pnas.0704000104; Whitacre DC, 2009, EXPERT REV VACCINES, V8, P1565, DOI 10.1586/ERV.09.121; Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162; Wollert T, 2009, NATURE, V458, P172, DOI 10.1038/nature07836; Yorikawa C, 2005, BIOCHEM J, V387, P17, DOI 10.1042/BJ20041227; Zhadina M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001153; ZHOU S, 1992, P NATL ACAD SCI USA, V89, P10046, DOI 10.1073/pnas.89.21.10046	58	37	39	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91279	10.1371/journal.pone.0091279	http://dx.doi.org/10.1371/journal.pone.0091279			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614091	Green Submitted, gold, Green Published			2022-12-27	WOS:000332839300106
J	Kornmeier, J; Spitzer, M; Sosic-Vasic, Z				Kornmeier, Juergen; Spitzer, Manfred; Sosic-Vasic, Zrinka			Very Similar Spacing-Effect Patterns in Very Different Learning/Practice Domains	PLOS ONE			English	Article							LONG-TERM POTENTIATION; FREE-RECALL; DISTRIBUTED PRACTICE; SYNAPTIC PLASTICITY; MEMORY; SLEEP; THRESHOLDS; RETENTION; RETRIEVAL; INDUCTION	Temporally distributed ("spaced") learning can be twice as efficient as massed learning. This "spacing effect" occur broad spectrum of learning materials, with humans of different ages, with non-human vertebrates and also invertebrates This indicates, that very basic learning mechanisms are at work ("generality"). Although most studies so far focused on very narrow spacing interval ranges, there is some evidence for a non-monotonic behavior of this spacing effect" "nonlinearity") with optimal spacing intervals at different time scales. In the current study we focused both the nonlinearity aspect by using a broad range of spacing intervals and the generality aspect by using very different learning/practice domains: Participants learned German-Japanese word pairs and performed visual acuity tests. For each of six groups we used a different spacing interval between learning/practice units from 7 min to 24 h in logarithmic steps. Memory retention was studied in three consecutive final tests, one, seven and 28 days after the final learning unit. For both the vocabulary. earning and visual acuity performance we found a highly significant effect of the factor spacing interval on the final test performance. In the 12 h-spacing-group about 85% of the learned words stayed in memory and nearly all of the visual acuity gain was preserved. In the 24 h-spacing-group, in contrast, only about 33% of the learned words were retained and he visual acuity gain dropped to zero. The very similar patterns of results from the two very different learning/practice domains point to similar underlying mechanisms. Further, our results indicate spacing in the range of 12 hours as optimal. A second peak may be around a spacing interval of 20 min but here the data are less clear. We discuss relations between our results and basic learning at the neuronal level.	[Kornmeier, Juergen] Inst Frontier Areas Psychol & Mental Hlth, Freiburg, Germany; [Kornmeier, Juergen] Univ Freiburg, Ctr Eye, D-79106 Freiburg, Germany; [Spitzer, Manfred; Sosic-Vasic, Zrinka] Univ Clin Ulm, Dept Psychiat & Psychotherapy, Ulm, Germany; [Spitzer, Manfred] Univ Ulm, Transfer Ctr Neurosci & Learning, D-89069 Ulm, Germany	University of Freiburg; Ulm University; Ulm University	Kornmeier, J (corresponding author), Inst Frontier Areas Psychol & Mental Hlth, Freiburg, Germany.	juergen.kornmeier@uni-freiburg.de						Aberg KC, 2012, VISION RES, V61, P100, DOI 10.1016/j.visres.2011.12.013; Abraham WC, 2003, PHILOS T R SOC B, V358, P735, DOI 10.1098/rstb.2002.1222; Albensi BC, 2007, EXP NEUROL, V204, P1, DOI 10.1016/j.expneurol.2006.12.009; [Anonymous], 1913, MEMORY; BALOTA DA, 1989, PSYCHOL AGING, V4, P3, DOI 10.1037/0882-7974.4.1.3; Balota DA, 2007, FDN REMEMBERING ESSA, P464; Beste C, 2011, CURR BIOL, V21, P876, DOI 10.1016/j.cub.2011.03.065; Carpenter SK, 2012, EDUC PSYCHOL REV, V24, P369, DOI 10.1007/s10648-012-9205-z; Cepeda NJ, 2006, PSYCHOL BULL, V132, P354, DOI 10.1037/0033-2909.132.3.354; Cepeda NJ, 2008, PSYCHOL SCI, V19, P1095, DOI 10.1111/j.1467-9280.2008.02209.x; Cepeda NJ, 2009, EXP PSYCHOL, V56, P236, DOI 10.1027/1618-3169.56.4.236; CHALLIS BH, 1993, J EXP PSYCHOL LEARN, V19, P389, DOI 10.1037/0278-7393.19.2.389; Cooke SF, 2006, BRAIN, V129, P1659, DOI 10.1093/brain/awl082; Cull WL, 2000, APPL COGNITIVE PSYCH, V14, P215, DOI 10.1002/(SICI)1099-0720(200005/06)14:3<215::AID-ACP640>3.3.CO;2-T; Dempster F.N., 1996, HDB PERCEPTION COGNI; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Donovan JJ, 1999, J APPL PSYCHOL, V84, P795, DOI 10.1037/0021-9010.84.5.795; FERRIS FL, 1982, AM J OPHTHALMOL, V94, P91, DOI 10.1016/0002-9394(82)90197-0; Frank MG, 2006, NEUROSCIENTIST, V12, P477, DOI 10.1177/1073858406293552; Heinrich SP, 2011, GRAEF ARCH CLIN EXP, V249, P1319, DOI 10.1007/s00417-011-1675-z; Janiszewski C, 2003, J CONSUM RES, V30, P138, DOI 10.1086/374692; Kalantzis G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008062; Karpicke JD, 2008, SCIENCE, V319, P966, DOI 10.1126/science.1152408; Karpicke JD, 2007, J EXP PSYCHOL LEARN, V33, P704, DOI 10.1037/0278-7393.33.4.704; Kornmeier J, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00203; Lattal KM, 1999, J EXP PSYCHOL ANIM B, V25, P433, DOI 10.1037/0097-7403.25.4.433; LIEBERMAN HR, 1982, BEHAV RES METH INSTR, V14, P21, DOI 10.3758/BF03202110; Lynch G, 2013, NEUROPHARMACOLOGY, V64, P27, DOI 10.1016/j.neuropharm.2012.07.006; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Mauelshagen J, 1998, LEARN MEMORY, V5, P246; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Paliaga GP, 1993, BESTIMMUNG SEHSCHART; RACINE RJ, 1995, BRAIN RES, V702, P87, DOI 10.1016/0006-8993(95)01025-0; REA CP, 1987, MEM COGNITION, V15, P436, DOI 10.3758/BF03197733; Roediger HL, 2011, TRENDS COGN SCI, V15, P20, DOI 10.1016/j.tics.2010.09.003; Scharf MT, 2002, J NEUROPHYSIOL, V87, P2770, DOI 10.1152/jn.2002.87.6.2770; Simone PM, 2012, J GERONTOL B; Stickgold R, 2005, NATURE, V437, P1272, DOI 10.1038/nature04286; Toppino TC, 2002, MEM COGNITION, V30, P601, DOI 10.3758/BF03194961; Toppino TC, 2002, J EXP PSYCHOL LEARN, V28, P437, DOI 10.1037//0278-7393.28.3.437; TOPPINO TC, 1991, MEM COGNITION, V19, P159, DOI 10.3758/BF03197112; YIN JCP, 1995, CELL, V81, P107, DOI 10.1016/0092-8674(95)90375-5	43	6	6	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90656	10.1371/journal.pone.0090656	http://dx.doi.org/10.1371/journal.pone.0090656			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC4IY	24609081	gold, Green Published, Green Submitted			2022-12-27	WOS:000332485800042
J	Shin, H; Shannon, CP; Fishbane, N; Ruan, J; Zhou, M; Balshaw, R; Wilson-McManus, JE; Ng, RT; McManus, BM; Tebbutt, SJ				Shin, Heesun; Shannon, Casey P.; Fishbane, Nick; Ruan, Jian; Zhou, Mi; Balshaw, Robert; Wilson-McManus, Janet E.; Ng, Raymond T.; McManus, Bruce M.; Tebbutt, Scott J.		PROOF Ctr Excellence Team	Variation in RNA-Seq Transcriptome Profiles of Peripheral Whole Blood from Healthy Individuals with and without Globin Depletion	PLOS ONE			English	Article							ALLOGRAFT-REJECTION; BIOMARKERS	Background: The molecular profile of circulating blood can reflect physiological and pathological events occurring in other tissues and organs of the body and delivers a comprehensive view of the status of the immune system. Blood has been useful in studying the pathobiology of many diseases. It is accessible and easily collected making it ideally suited to the development of diagnostic biomarker tests. The blood transcriptome has a high complement of globin RNA that could potentially saturate next-generation sequencing platforms, masking lower abundance transcripts. Methods to deplete globin mRNA are available, but their effect has not been comprehensively studied in peripheral whole blood RNA-Seq data. In this study we aimed to assess technical variability associated with globin depletion in addition to assessing general technical variability in RNA-Seq from whole blood derived samples. Results: We compared technical and biological replicates having undergone globin depletion or not and found that the experimental globin depletion protocol employed removed approximately 80% of globin transcripts, improved the correlation of technical replicates, allowed for reliable detection of thousands of additional transcripts and generally increased transcript abundance measures. Differential expression analysis revealed thousands of genes significantly up-regulated as a result of globin depletion. In addition, globin depletion resulted in the down-regulation of genes involved in both iron and zinc metal ion bonding. Conclusions: Globin depletion appears to meaningfully improve the quality of peripheral whole blood RNA-Seq data, and may improve our ability to detect true biological variation. Some concerns remain, however. Key amongst them the significant reduction in RNA yields following globin depletion. More generally, our investigation of technical and biological variation with and without globin depletion finds that high-throughput sequencing by RNA-Seq is highly reproducible within a large dynamic range of detection and provides an accurate estimation of RNA concentration in peripheral whole blood. High-throughput sequencing is thus a promising technology for whole blood transcriptomics and biomarker discovery.	[Shin, Heesun; Shannon, Casey P.; Fishbane, Nick; Ruan, Jian; Zhou, Mi; Balshaw, Robert; Wilson-McManus, Janet E.; Ng, Raymond T.; McManus, Bruce M.; Tebbutt, Scott J.] NCE CECR PROOF Ctr Excellence, Vancouver, BC, Canada; [Shin, Heesun; Tebbutt, Scott J.] Univ British Columbia, UBC Dept Med, Div Resp Med, Vancouver, BC V5Z 1M9, Canada; [McManus, Bruce M.] Univ British Columbia, UBC Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada; [Ng, Raymond T.] Univ British Columbia, UBC Dept Comp Sci, Vancouver, BC V5Z 1M9, Canada; [Fishbane, Nick; Balshaw, Robert] Univ British Columbia, UBC Dept Stat, Vancouver, BC V5Z 1M9, Canada; [Shin, Heesun; Ruan, Jian; McManus, Bruce M.; Tebbutt, Scott J.] Univ British Columbia, UBC James Hogg Res Ctr, Vancouver, BC V5Z 1M9, Canada; [Shin, Heesun; Ruan, Jian; McManus, Bruce M.; Tebbutt, Scott J.] Univ British Columbia, Inst HEART LUNG Hlth, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia	Tebbutt, SJ (corresponding author), NCE CECR PROOF Ctr Excellence, Vancouver, BC, Canada.	Scott.Tebbutt@hli.ubc.ca	Fishbane, Nick/GYE-0318-2022	Fishbane, Nick/0000-0003-4316-1341; Balshaw, Robert/0000-0002-2455-8792; Shannon, Casey/0000-0002-5687-3156; Tebbutt, Scott/0000-0002-7908-1581	MITACS Accelerate program	MITACS Accelerate program	The authors are grateful for funding from the MITACS Accelerate program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboyoun P, GENOMICRANGES REPRES; Auer PL, 2010, GENETICS, V185, P405, DOI 10.1534/genetics.110.114983; Baker SC, 2005, NAT METHODS, V2, P731, DOI 10.1038/nmeth1005-731; Brouard S, 2007, P NATL ACAD SCI USA, V104, P15448, DOI 10.1073/pnas.0705834104; Devonshire AS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-662; Gunther OP, 2009, TRANSPLANTATION, V88, P942, DOI 10.1097/TP.0b013e3181b7ccc6; Hollander Z, 2010, TRANSPLANTATION, V90, P1388, DOI 10.1097/TP.0b013e3182003df6; Kam SHY, 2012, J ASTHMA, V49, P219, DOI 10.3109/02770903.2011.654300; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li L, 2008, PHYSIOL GENOMICS, V32, P190, DOI 10.1152/physiolgenomics.00216.2007; Liew CC, 2006, J LAB CLIN MED, V147, P126, DOI 10.1016/j.lab.2005.10.005; Lin D, 2009, J HEART LUNG TRANSPL, V28, P927, DOI 10.1016/j.healun.2009.04.025; Liu J, 2006, J MOL DIAGN, V8, P551, DOI 10.2353/jmoldx.2006.060021; Mastrokolias A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-28; Mohr S, 2007, TRENDS MOL MED, V13, P422, DOI 10.1016/j.molmed.2007.08.003; O'Loughlin A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-250; Raghavachari N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006484; Ramskold D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000598; Roberts A, 2011, BIOINFORMATICS; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Team RC, 2012, R LANG ENV STAT COMP; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1	24	56	58	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91041	10.1371/journal.pone.0091041	http://dx.doi.org/10.1371/journal.pone.0091041			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608128	Green Published, gold, Green Submitted			2022-12-27	WOS:000332485800086
J	Suen, SC; Bendavid, E; Goldhaber-Fiebert, JD				Suen, Sze-chuan; Bendavid, Eran; Goldhaber-Fiebert, Jeremy D.			Disease Control Implications of India's Changing Multi-Drug Resistant Tuberculosis Epidemic	PLOS ONE			English	Article							SOUTH-INDIA; DOTS PROGRAM; REINFECTION; PREVALENCE; DIAGNOSIS	Background: Multi-drug resistant tuberculosis (MDR TB) is a major health challenge in India that is gaining increasing public attention, but the implications of India's evolving MDR TB epidemic are poorly understood. As India's MDR TB epidemic is transitioning from a treatment-generated to transmission-generated epidemic, we sought to evaluate the potential effectiveness of the following two disease control strategies on reducing the prevalence of MDR TB: a) improving treatment of non-MDR TB; b) shortening the infectious period between the activation of MDR TB and initiation of effective MDR treatment. Methods and Findings: We developed a dynamic transmission microsimulation model of TB in India. The model followed individuals by age, sex, TB status, drug resistance status, and treatment status and was calibrated to Indian demographic and epidemiologic TB time trends. The main effectiveness measure was reduction in the average prevalence reduction of MDR TB over the ten years after control strategy implementation. We find that improving non-MDR cure rates to avoid generating new MDR cases will provide substantial non-MDR TB benefits but will become less effective in reducing MDR TB prevalence over time because more cases will occur from direct transmission - by 2015, the model estimates 42% of new MDR cases are transmission-generated and this proportion continues to rise over time, assuming equal transmissibility of MDR and drug-susceptible TB. Strategies that disrupt MDR transmission by shortening the time between MDR activation and treatment are projected to provide greater reductions in MDR prevalence compared with improving non-MDR treatment quality: implementing MDR diagnostic improvements in 2017 is expected to reduce MDR prevalence by 39%, compared with 11% reduction from improving non-MDR treatment quality. Conclusions: As transmission-generated MDR TB becomes a larger driver of the MDR TB epidemic in India, rapid and accurate MDR TB diagnosis and treatment will become increasingly effective in reducing MDR TB cases compared to non-MDR TB treatment improvements.	[Suen, Sze-chuan] Stanford Univ, Dept Management Sci & Engn, Stanford, CA 94305 USA; [Bendavid, Eran] Stanford Univ, Dept Med, Div Gen Med Disciplines, Stanford, CA 94305 USA; [Bendavid, Eran; Goldhaber-Fiebert, Jeremy D.] Stanford Univ, Ctr Hlth Policy, Stanford, CA 94305 USA; [Bendavid, Eran; Goldhaber-Fiebert, Jeremy D.] Stanford Univ, Ctr Primary Care & Outcomes Res, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University	Suen, SC (corresponding author), Stanford Univ, Dept Management Sci & Engn, Stanford, CA 94305 USA.	ssuen@stanford.edu		Goldhaber-Fiebert, Jeremy/0000-0002-4007-5192	NIH NIA [K01 AG037593-01A1]; National Institute of Allergy and Infectious Diseases [K01-AI084582]; Dr. George Rosenkranz Prize for Health Care Research in Developing Countries; NSF GRFP; Stanford's Freeman Spogli Institute for International Studies and its Global Underdevelopment Action Fund; Bill and Melinda Gates Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K01AI084582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K01AG037593, P30AG017253] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA015612, R01DA015612] Funding Source: NIH RePORTER	NIH NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Dr. George Rosenkranz Prize for Health Care Research in Developing Countries; NSF GRFP(National Science Foundation (NSF)NSF - Office of the Director (OD)); Stanford's Freeman Spogli Institute for International Studies and its Global Underdevelopment Action Fund; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	JGF was supported in part by an NIH NIA Career Development Award (K01 AG037593-01A1). EBD is supported by the National Institute of Allergy and Infectious Diseases (K01-AI084582) and by the Dr. George Rosenkranz Prize for Health Care Research in Developing Countries. SS was supported in part by the NSF GRFP. The work was supported in part by Stanford's Freeman Spogli Institute for International Studies and its Global Underdevelopment Action Fund and by the Bill and Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews JR, 2008, J INFECT DIS, V198, P1582, DOI 10.1086/592991; [Anonymous], 2011, GLOB TUB CONTR 2011; [Anonymous], 2010, MULTIDRUG EXTENSIVEL; Balasubramanian R, 2004, INT J TUBERC LUNG D, V8, P323; Central TB Division Directorate General of Health Services and Ministry of Health and Family Welfare, 2011, TB IND 2011 RNTCP AN; Central TB Division Directorate General of Health Services and Ministry of Health and Family Welfare, 2010, RNTCP PERF REP; Chang K, 2012, J INFECTION, V64, P580, DOI 10.1016/j.jinf.2012.02.012; Cohen T, 2004, NAT MED, V10, P1117, DOI 10.1038/nm1110; COHESIVE-India, 2011, BIH EV SOC FRANCH TE; Crofton J, 1997, GUIDELINES MANAGEMEN, P210; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; Dye C, 2012, INDIAN J MED RES, V135, P737; Goldhaber-Fiebert JD, 2010, VALUE HEALTH, V13, P667, DOI 10.1111/j.1524-4733.2010.00698.x; Government of India National DOTS-Plus Committee, 2011, 7 NAT DOTS PLUS COMM, V756, P1; HEYM B, 1994, LANCET, V344, P293, DOI 10.1016/S0140-6736(94)91338-2; Horby P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016965; Horsburgh CR, 2004, NEW ENGL J MED, V350, P2060, DOI 10.1056/NEJMsa031667; Kapoor SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042458; Keeling MJ., 2007, MODELING INFECT DIS, VIllustrated edition; Malmborg R, 2006, B WORLD HEALTH ORGAN, V84, P752; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Pantoja A, 2009, INT J TUBERC LUNG D, V13, P698; Population Division of the Department of Economic and Social Affairs of the United Nations Secretariat, 2010, WORLD POP PROSP 2010; Rajeswari R, 2002, INT J TUBERC LUNG D, V6, P789; Rosenzweig MR, 1994, AGEING INT, V21, P50; Rowland K, 2012, NATURE, V9797, DOI [10.1038/nature.2012.9797, DOI 10.1038/NATURE.2012.9797, 10.1038/nature. 2012.9797]; Sachdeva KS, 2011, FACING REALITY MULTI; Santha T, 2002, INT J TUBERC LUNG D, V6, P780; Satyanarayana S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024160; Sharma SK, 2011, INDIAN J MED RES, V133, P308; Singla R, 2009, INT J TUBERC LUNG D, V13, P976; Sinha K., 2012, TIMES INDIA; Srikanth Padma, 2009, Indian J Tuberc, V56, P174; Tobgay KJ, 2006, NATL MED J INDIA, V19, P60; Udwadia ZF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012023; UPLEKAR MW, 1991, TUBERCLE, V72, P284, DOI 10.1016/0041-3879(91)90055-W; Vandan N, 2009, PUBLIC HEALTH, V123, P484, DOI 10.1016/j.puhe.2009.05.004; Vynnycky E, 1997, EPIDEMIOL INFECT, V119, P183, DOI 10.1017/S0950268897007917; World Health Organization, 2010, WHO LIF IND; World Health Organization, 2011, IND MULT RES TUB PRO; Zhao YL, 2012, NEW ENGL J MED, V366, P2161, DOI 10.1056/NEJMoa1108789	41	23	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e89822	10.1371/journal.pone.0089822	http://dx.doi.org/10.1371/journal.pone.0089822			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608234	Green Published, gold, Green Submitted			2022-12-27	WOS:000332485800009
J	Wang, AL; Carroll, RC; Nawy, S				Wang, Ai Ling; Carroll, Reed C.; Nawy, Scott			Down-Regulation of the RNA Editing Enzyme ADAR2 Contributes to RGC Death in a Mouse Model of Glaucoma	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; AMPA RECEPTORS; GLUTAMATE EXCITOTOXICITY; SYNAPTIC PLASTICITY; NEUROPROTECTION; MECHANISM; TRANSPORT; PATHWAYS; NEURONS; GLUR2	Glaucoma is a progressive neurodegenerative disease of retinal ganglion cells (RGCs) associated with characteristic axon degeneration in the optic nerve. Excitotoxic damage due to increased Ca2+ influx, possibly through NMDA-type glutamate receptors, has been proposed to be a cause of RGC dysfunction and death in glaucoma. Recent work has found that expression of another potentially critical receptor, the Ca2+-permeable AMPA receptor (CP-AMPAR), is elevated during various pathological conditions (including ALS and ischemia), resulting in increased neuronal death. Here we test the hypothesis that CP-AMPARs contribute to RGC death due to elevated Ca2+ influx in glaucoma. AMPA receptors are impermeable to Ca2+ if the tetrameric receptor contains a GluA2 subunit that has undergone Q/R RNA editing at a site in the pore region. The activity of ADAR2, the enzyme responsible for this RNA editing, generally ensures that the vast majority of GluA2 proteins are edited. Here, we demonstrate that ADAR2 levels decrease in a mouse model of glaucoma in which IOP is chronically elevated. Furthermore, using an in vitro model of RGCs, we find that knockdown of ADAR2 using siRNA increased the accumulation of Co2+ in response to glutamate, and decreased the rectification index of AMPA currents detected electrophysiologically, indicating an increased Ca2+ permeability through AMPARs. The RGCs in primary culture also exhibited increased excitotoxic cell death following knock down of ADAR2. Furthermore, cell death was reversed by NASPM, a specific blocker for CP-AMPARs. Together, our data suggest that chronically elevated IOP in adult mice reduces expression of the ADAR2 enzyme, and the loss of ADAR2 editing and subsequent disruption of GluA2 RNA editing might potentially play a role in promoting RGC neuronal death as observed in glaucoma.	[Wang, Ai Ling; Carroll, Reed C.; Nawy, Scott] Albert Einstein Coll Med, Dept Ophthalmol & Visual Sci, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine	Nawy, S (corresponding author), Albert Einstein Coll Med, Dept Ophthalmol & Visual Sci, Bronx, NY 10467 USA.	scott.nawy@einstein.yu.edu		Nawy, Scott/0000-0003-4679-6756	NEI [EY017428]; NATIONAL EYE INSTITUTE [R01EY017428] Funding Source: NIH RePORTER	NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported by NEI grant EY017428 (S.N.) (http://nei.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Z, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.54; Almasieh M, 2012, PROG RETIN EYE RES, V31, P152, DOI 10.1016/j.preteyeres.2011.11.002; Bautista RD, 1999, INT OPHTHALMOL CLIN, V39, P57, DOI 10.1097/00004397-199903930-00007; Bertram KM, 2008, EYE, V22, P582, DOI 10.1038/sj.eye.6702993; Casson RJ, 2006, CLIN EXP OPHTHALMOL, V34, P54, DOI 10.1111/j.1442-9071.2006.01146.x; CHOI DW, 1990, ANNU REV NEUROSCI, V13, P171, DOI 10.1146/annurev.ne.13.030190.001131; Clarke RJ, 2013, J NEUROSCI, V33, P4140, DOI 10.1523/JNEUROSCI.3712-12.2013; Crish SD, 2010, P NATL ACAD SCI USA, V107, P5196, DOI 10.1073/pnas.0913141107; Diederen RMH, 2006, EXP EYE RES, V83, P45, DOI 10.1016/j.exer.2005.10.031; Gregory MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017659; Guo L, 2006, INVEST OPHTH VIS SCI, V47, P626, DOI 10.1167/iovs.05-0754; Hayreh SS, 2001, PROG RETIN EYE RES, V20, P563, DOI 10.1016/S1350-9462(01)00004-0; Herzog KH, 1998, J NEUROSCI, V18, P2891; Hideyama T, 2012, NEUROBIOL DIS, V45, P1121, DOI 10.1016/j.nbd.2011.12.033; Hogg M, 2011, ADV GENET, V73, P87, DOI 10.1016/B978-0-12-380860-8.00003-3; Kalia LV, 2008, LANCET NEUROL, V7, P742, DOI 10.1016/S1474-4422(08)70165-0; Kanamori A, 2010, J NEUROCHEM, V114, P488, DOI 10.1111/j.1471-4159.2010.06781.x; Kemp JA, 2002, NAT NEUROSCI, V5, P1039, DOI 10.1038/nn936; Lee SC, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-54; Lipton SA, 2004, J ALZHEIMERS DIS, V6, pS61; Liu SJ, 2007, TRENDS NEUROSCI, V30, P126, DOI 10.1016/j.tins.2007.01.006; Liu SJ, 2012, J PHYSIOL-LONDON, V590, P13, DOI 10.1113/jphysiol.2011.213926; Lotery AJ, 2005, EYE, V19, P369, DOI 10.1038/sj.eye.6701623; Ma YT, 1998, J NEUROSCI, V18, P2097; Neufeld AH, 1997, EXP EYE RES, V65, P739, DOI 10.1006/exer.1997.0394; Neufeld AH, 1997, ARCH OPHTHALMOL-CHIC, V115, P497, DOI 10.1001/archopht.1997.01100150499009; Osborne NN, 2006, EYE, V20, P1392, DOI 10.1038/sj.eye.6702234; Osswald IK, 2007, J PHYSIOL-LONDON, V582, P95, DOI 10.1113/jphysiol.2007.127894; Peng PL, 2006, NEURON, V49, P719, DOI 10.1016/j.neuron.2006.01.025; PRUSS RM, 1991, NEURON, V7, P509, DOI 10.1016/0896-6273(91)90302-G; Quigley HA, 2000, INVEST OPHTH VIS SCI, V41, P3460; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Schuettauf F, 2007, GRAEF ARCH CLIN EXP, V245, P1157, DOI 10.1007/s00417-006-0531-z; Seki M, 2008, PROG BRAIN RES, V173, P495, DOI 10.1016/S0079-6123(08)01134-5; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Silberberg G, 2012, HUM MOL GENET, V21, P311, DOI 10.1093/hmg/ddr461; Taschenberger H, 1999, J NEUROSCI, V19, P3353; Wright A, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00034; Xia Y, 2007, J NEUROSCI, V27, P12221, DOI 10.1523/JNEUROSCI.2086-07.2007	39	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91288	10.1371/journal.pone.0091288	http://dx.doi.org/10.1371/journal.pone.0091288			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608178	Green Published, gold, Green Submitted			2022-12-27	WOS:000332485800124
J	Brahimi, F; Ko, E; Malakhov, A; Burgess, K; Saragovi, HU				Brahimi, Fouad; Ko, Eunhwa; Malakhov, Andrey; Burgess, Kevin; Saragovi, H. Uri			Combinatorial Assembly of Small Molecules into Bivalent Antagonists of TrkC or TrkA Receptors	PLOS ONE			English	Article							GROWTH; LIGANDS; NEUROTROPHINS; BINDING	A library of peptidomimetics was assembled combinatorially into dimers on a triazine-based core. The pharmacophore corresponds to beta-turns of the neurotrophin polypeptides neurotrophin-3 (NT-3), nerve growth factor (NGF), or brain-derived neurotrophic factor (BDNF). These are the natural ligands for TrkC, TrkA, and TrkB receptors, respectively. The linker length and the side-chain orientation of each monomer within the bivalent mimics were systematically altered, and the impact of these changes on the function of each ligand was evaluated. While the monovalent peptidomimetics had no detectable binding or bioactivity, four bivalent peptidomimetics (2c, 2d, 2e, 3f) are selective TrkC ligands with antagonistic activity, and two bivalent peptidomimetics (1a, 1b) are TrkC and TrkA ligands with antagonistic activity. All these bivalent compounds block ligand-dependent receptor activation and cell survival, without affecting neuritogenic differentiation. This work adds to our understanding of how the neurotrophins function through Trk receptors, and demonstrates that peptidomimetics can be designed to selectively disturb specific biological signals, and may be used as pharmacological probes or as therapeutic leads. The concept of altering side-chain, linker length, and sequence orientation of a subunit within a pharmacophore provides an easy modular approach to generate larger libraries with diversified bioactivity.	[Brahimi, Fouad; Saragovi, H. Uri] McGill Univ, Jewish Gen Hosp, Lady Davis Inst, Montreal, PQ H3T 1E2, Canada; [Ko, Eunhwa; Malakhov, Andrey; Burgess, Kevin] Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA; [Saragovi, H. Uri] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada; [Saragovi, H. Uri] McGill Univ, Dept Oncol, Montreal, PQ, Canada; [Saragovi, H. Uri] McGill Univ, Ctr Canc, Montreal, PQ H3G 1Y6, Canada	Lady Davis Institute; McGill University; Texas A&M University System; Texas A&M University College Station; McGill University; McGill University; McGill University	Saragovi, HU (corresponding author), McGill Univ, Jewish Gen Hosp, Lady Davis Inst, Montreal, PQ H3T 1E2, Canada.	uri.saragovi@mcgill.ca	Burgess, Kevin/B-5372-2015	Burgess, Kevin/0000-0001-6597-1842	Canadian Institute of Health Research; National Institutes of Health [MH070040, GM076261]; Robert A. Welch Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T32DE014318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM076261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH070040] Funding Source: NIH RePORTER	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was partially supported by grants from the Canadian Institute of Health Research to HUS and by National Institutes of Health (MH070040, GM076261), and the Robert A. Welch Foundation to Kevin Burgess. We thank Dr Amber Schaefer for helpful discussions, and Sakunchai Khumsubdee for collecting data. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angell Y, 2008, J AM CHEM SOC, V130, P556, DOI 10.1021/ja074717z; Beglova N, 2000, J MED CHEM, V43, P3530, DOI 10.1021/jm990441x; Brahimi F, 2010, BBA-GEN SUBJECTS, V1800, P1018, DOI 10.1016/j.bbagen.2010.06.007; Brahimi F, 2009, PEPTIDES, V30, P1833, DOI 10.1016/j.peptides.2009.07.015; Chao MV, 2002, NEURON, V33, P9, DOI 10.1016/S0896-6273(01)00573-6; Chen DJ, 2009, ACS CHEM BIOL, V4, P769, DOI 10.1021/cb9001415; Hempstead BL, 2002, CURR OPIN NEUROBIOL, V12, P260, DOI 10.1016/S0959-4388(02)00321-5; Ivanisevic L, 2003, ONCOGENE, V22, P5677, DOI 10.1038/sj.onc.1206864; Ivanisevic L, 2007, J BIOL CHEM, V282, P16754, DOI 10.1074/jbc.M701996200; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; Ko E, 2011, CHEM SOC REV, V40, P4411, DOI 10.1039/c0cs00218f; Lee HB, 2004, J ORG CHEM, V69, P701, DOI 10.1021/jo034167x; LeSauteur L, 1996, NAT BIOTECHNOL, V14, P1120, DOI 10.1038/nbt0996-1120; LESAUTEUR L, 1995, J BIOL CHEM, V270, P6564, DOI 10.1074/jbc.270.12.6564; Liu J, 2010, J MED CHEM, V53, P5044, DOI 10.1021/jm100148d; Longo Frank M., 2005, Current Medicinal Chemistry - Central Nervous System Agents, V5, P29; MAHADEO D, 1994, J BIOL CHEM, V269, P6884; Maliartchouk S, 2000, MOL PHARMACOL, V57, P385; Maliartchouk S, 2000, J BIOL CHEM, V275, P9946, DOI 10.1074/jbc.275.14.9946; Maliartchouk S, 1997, J NEUROSCI, V17, P6031; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Pattarawarapan M, 2002, J MED CHEM, V45, P4387, DOI 10.1021/jm0255421; Rubin Joshua B, 2003, Cancer Treat Res, V115, P1; Saragovi HU, 2000, TRENDS PHARMACOL SCI, V21, P93, DOI 10.1016/S0165-6147(99)01444-3; Saragovi HU, 1999, EXPERT OPIN THER PAT, V9, P737, DOI 10.1517/13543776.9.6.737; Saragovi HU, 1998, J BIOL CHEM, V273, P34933, DOI 10.1074/jbc.273.52.34933; Saragovi HU, 2002, CURR PHARM DESIGN, V8, P2201, DOI 10.2174/1381612023393215; Zaccaro MC, 2005, CHEM BIOL, V12, P1015, DOI 10.1016/j.chembiol.2005.06.015; Zaccaro MC, 2001, J BIOL CHEM, V276, P31023, DOI 10.1074/jbc.M104630200; Zhang YZ, 2000, J NEUROSCI, V20, P5671, DOI 10.1523/JNEUROSCI.20-15-05671.2000	30	11	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e89617	10.1371/journal.pone.0089617	http://dx.doi.org/10.1371/journal.pone.0089617			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603864	Green Published, gold, Green Submitted			2022-12-27	WOS:000332483600016
J	Hu, JCC; Hu, YY; Lu, YH; Smith, CE; Lertlam, R; Wright, JT; Suggs, C; McKee, MD; Beniash, E; Kabir, ME; Simmer, JP				Hu, Jan C. -C.; Hu, Yuanyuan; Lu, Yuhe; Smith, Charles E.; Lertlam, Rangsiyakorn; Wright, John Timothy; Suggs, Cynthia; McKee, Marc D.; Beniash, Elia; Kabir, M. Enamul; Simmer, James P.			Enamelin Is Critical for Ameloblast Integrity and Enamel Ultrastructure Formation	PLOS ONE			English	Article							AMELOGENIN; PHENOTYPE; BIOMINERALIZATION; NONAMELOGENIN; EXPRESSION; PROTEINS; MUTATION; RESCUE; ROLES	Mutations in the human enamelin gene cause autosomal dominant hypoplastic amelogenesis imperfecta in which the affected enamel is thin or absent. Study of enamelin knockout NLS-lacZ knockin mice revealed that mineralization along the distal membrane of ameloblast is deficient, resulting in no true enamel formation. To determine the function of enamelin during enamel formation, we characterized the developing teeth of the Enam(-/-) mice, generated amelogenin-driven enamelin transgenic mouse models, and then introduced enamelin transgenes into the Enam(-/-) mice to rescue enamel defects. Mice at specific stages of development were subjected to morphologic and structural analysis using beta-galactosidase staining, immunohistochemistry, and transmission and scanning electron microscopy. Enamelin expression was ameloblast-specific. In the absence of enamelin, ameloblasts pathology became evident at the onset of the secretory stage. Although the aggregated ameloblasts generated matrix-containing amelogenin, they were not able to create a well-defined enamel space or produce normal enamel crystals. When enamelin is present at half of the normal quantity, enamel was thinner with enamel rods not as tightly arranged as in wild type suggesting that a specific quantity of enamelin is critical for normal enamel formation. Enamelin dosage effect was further demonstrated in transgenic mouse lines over expressing enamelin. Introducing enamelin transgene at various expression levels into the Enam(-/-) background did not fully recover enamel formation while a medium expresser in the Enam(+/-) background did. Too much or too little enamelin abolishes the production of enamel crystals and prism structure. Enamelin is essential for ameloblast integrity and enamel formation.	[Hu, Jan C. -C.; Hu, Yuanyuan; Lu, Yuhe; Smith, Charles E.; Lertlam, Rangsiyakorn; Kabir, M. Enamul; Simmer, James P.] Univ Michigan, Sch Dent, Dent Res Lab, Ann Arbor, MI 48109 USA; [Smith, Charles E.] McGill Univ, Dept Anat & Cell Biol, Facil Electron Microscopy Res, Montreal, PQ, Canada; [Smith, Charles E.] McGill Univ, Fac Dent, Montreal, PQ, Canada; [Wright, John Timothy; Suggs, Cynthia] Univ N Carolina, Dent Res Ctr, Chapel Hill, NC 27599 USA; [McKee, Marc D.] McGill Univ, Fac Dent, Montreal, PQ, Canada; [McKee, Marc D.] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ, Canada; [Beniash, Elia] Univ Pittsburgh, Dept Oral Biol, Sch Dent Med, Pittsburgh, PA USA	University of Michigan System; University of Michigan; McGill University; McGill University; University of North Carolina; University of North Carolina Chapel Hill; McGill University; McGill University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Hu, JCC (corresponding author), Univ Michigan, Sch Dent, Dent Res Lab, Ann Arbor, MI 48109 USA.	janhu@umich.edu	McKee, Marc D/E-2187-2011; Wright, John Timothy/AAX-5755-2020; Hu, Jan C-C./F-5679-2015	McKee, Marc D/0000-0001-8349-965X; Hu, Jan C-C./0000-0002-9294-0248; Simmer, James/0000-0002-7192-6105	United States Public Health Service Research from the National Institute of Dental and Craniofacial Research of the National Institutes of Health [DE011301, DE019622]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019622] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE011301, R56DE011301, R29DE011301] Funding Source: NIH RePORTER	United States Public Health Service Research from the National Institute of Dental and Craniofacial Research of the National Institutes of Health; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This research was supported by United States Public Health Service Research Grants DE011301 and DE019622 from the National Institute of Dental and Craniofacial Research of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chan AHL, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/246861; Chan HL, 2013, J PERIODONTOL, V7, P7; Chun YHP, 2010, J DENT RES, V89, P1414, DOI 10.1177/0022034510379223; Dohi N, 1998, CELL TISSUE RES, V293, P313, DOI 10.1007/s004410051123; Fang PA, 2011, P NATL ACAD SCI USA, V108, P14097, DOI 10.1073/pnas.1106228108; Fukumoto S, 2004, J CELL BIOL, V167, P973, DOI 10.1083/jcb.200409077; Gibson CW, 2011, EUR J ORAL SCI, V119, P70, DOI 10.1111/j.1600-0722.2011.00882.x; Gibson CW, 2001, J BIOL CHEM, V276, P31871, DOI 10.1074/jbc.M104624200; Hatakeyama J, 2009, J DENT RES, V88, P318, DOI 10.1177/0022034509334749; Hu JCC, 2008, J BIOL CHEM, V283, P10858, DOI 10.1074/jbc.M710565200; Hu JCC, 2011, EUR J ORAL SCI, V119, P329, DOI 10.1111/j.1600-0722.2011.00860.x; Masuya H, 2005, HUM MOL GENET, V14, P575, DOI 10.1093/hmg/ddi054; Meredith RW, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000634; Newbrun E, 1960, AUST DENT J, V5, P210, DOI DOI 10.1111/J.1834-7819.1960.TB01939.X; Ozdemir D, 2005, J DENT RES, V84, P1036, DOI 10.1177/154405910508401113; Rajpar MH, 2001, HUM MOL GENET, V10, P1673, DOI 10.1093/hmg/10.16.1673; Sheehan D.C., 1980, THEORY PRACTICE HIST; Simmer JP, 2010, J DENT RES, V89, P1024, DOI 10.1177/0022034510375829; Simmer JP, 2012, INT J ORAL SCI, V4, P129, DOI 10.1038/ijos.2012.59; Suzuki S, 2009, MATRIX BIOL, V28, P221, DOI 10.1016/j.matbio.2009.03.006; TANABE T, 1990, CALCIFIED TISSUE INT, V46, P205, DOI 10.1007/BF02555046; UCHIDA T, 1991, ARCH HISTOL CYTOL, V54, P527, DOI 10.1679/aohc.54.527; Wazen RM, 2009, MATRIX BIOL, V28, P292, DOI 10.1016/j.matbio.2009.04.004; WITKOP CJ, 1988, J ORAL PATHOL MED, V17, P547, DOI 10.1111/j.1600-0714.1988.tb01332.x; Wright JT, 2009, CELLS TISSUES ORGANS, V189, P224, DOI 10.1159/000151378; Yuan Q, 2013, J BONE MINER RES, V27	26	43	45	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e89303	10.1371/journal.pone.0089303	http://dx.doi.org/10.1371/journal.pone.0089303			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603688	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000332483600010
J	Huang, CM; Chen, QY; Lin, JX; Zheng, CH; Li, P; Xie, JW; Wang, JB; Lu, J				Huang, Chang-Ming; Chen, Qi-Yue; Lin, Jian-Xian; Zheng, Chao-Hui; Li, Ping; Xie, Jian-Wei; Wang, Jia-Bin; Lu, Jun			Laparoscopic Spleen-Preserving Splenic Hilar Lymphadenectomy Performed by Following the Perigastric Fascias and the Intrafascial Space for Advanced Upper-Third Gastric Cancer	PLOS ONE			English	Article							LYMPH-NODE DISSECTION; TOTAL GASTRECTOMY; RADICAL SURGERY; SPLENECTOMY; PRESERVATION; SURVIVAL	Background: Laparoscopic spleen-preserving Splenic hilar lymphadenectomy (LSPL) is required in laparoscopy-assisted total gastrectomy for advanced proximal gastric cancer. However, it is considerably difficult and risk in clinical practice. Thus, we explore the application of LSPL performed by following the perigastric fascias and the intrafascial space in D2 radical gastrectomy for advanced upper-third gastric cancer. Methods: From July 2010 to December 2012, 109 patients with T2-3 upper-third gastric cancer underwent LSPL. Of these patients, 55 underwent classic LSPL (classic group), and the remaining 54 patients underwent LSPL performed by following the fascias and intrafascial space (fascia group). Clinicopathologic characteristics and intraoperative and postoperative variables were compared between the two groups. Results: There were no significant differences in clinicopathological characteristics between the two groups (P>0.05). All of the operations were successful without conversion to laparotomy. The operation time, mean splenic hilar lymph node (LN) dissection time, mean total blood loss and mean blood loss from splenic hilar LN dissection were significantly lower in the fascia group than in the classic group (P<0.05), whereas the times to first flatus, fluid diet and soft diet and the duration of hospital stay were similar in both groups. The mean number of harvested LNs (No. 10 and No. 11d) was slightly higher in the fascia group, but the difference was not significant. No significant difference in morbidity was found between the fascia group and the classic group (9.3% vs. 10.9%, P>0.05). At a median follow-up of 12 months(range 5 to 35 months), none of the patients had died or experienced recurrent or metastatic disease. Conclusion: LSPL performed by following the fascias and intrafascial space is an optimal and safe technique based on anatomical logic, and it reduces the difficulties associated with LSPL, making it easier to master and allowing its widespread adoption.	[Huang, Chang-Ming; Chen, Qi-Yue; Lin, Jian-Xian; Zheng, Chao-Hui; Li, Ping; Xie, Jian-Wei; Wang, Jia-Bin; Lu, Jun] Fujian Med Univ, Union Hosp, Dept Gastr Surg, Fuzhou, Fujian Province, Peoples R China	Fujian Medical University	Huang, CM (corresponding author), Fujian Med Univ, Union Hosp, Dept Gastr Surg, Fuzhou, Fujian Province, Peoples R China.	hcmlr2002@163.com	Zheng, Chao-hui/HGE-3348-2022; Li, Ping/GYV-4914-2022	Zheng, Chao-hui/0000-0001-8680-3127; 	National Key Clinical Specialty Discipline Construction program of China [[2012]649]	National Key Clinical Specialty Discipline Construction program of China	Sponsored by National Key Clinical Specialty Discipline Construction program of China (No. [2012]649). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bo T, 2013, J GASTROINTESTINAL S, P1; Borghi F, 2002, WORLD J SURG, V26, P1139, DOI 10.1007/s00268-002-6346-0; BRUNSCHWIG A, 1948, CANCER, V1, P427, DOI 10.1002/1097-0142(194809)1:3<427::AID-CNCR2820010308>3.0.CO;2-G; Csendes A, 2002, SURGERY, V131, P401, DOI 10.1067/msy.2002.121891; Gullino D, 2000, Minerva Chir, V55, P721; HEALD RJ, 1986, LANCET, V1, P1479; HEALD RJ, 1982, BRIT J SURG, V69, P613, DOI 10.1002/bjs.1800691019; Hyung WJ, 2008, J AM COLL SURGEONS, V207, pE6, DOI 10.1016/j.jamcollsurg.2008.04.027; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P113, DOI 10.1007/s10120-011-0042-4; Jia-Bin Wang, 2012, World J Surg Oncol, V10, P241, DOI 10.1186/1477-7819-10-241; Liang JT, 2011, SURG ENDOSC, V25, P935, DOI 10.1007/s00464-010-1264-y; Moore KL., 2008, DEV HUMAN CLIN ORIEN; Okabe Hiroshi, 2010, J Am Coll Surg, V211, pe1, DOI 10.1016/j.jamcollsurg.2010.04.006; Sakuramoto S, 2009, SURG ENDOSC, V23, P2416, DOI 10.1007/s00464-009-0371-0; Shinohara T, 2013, SURG ENDOSC, V27, P286, DOI 10.1007/s00464-012-2442-x; Sobin L, 2009, TNM CLASSIFICATION M; Song J, 2010, ANN SURG ONCOL, V17, P1777, DOI 10.1245/s10434-010-0932-4; Songun I, 2010, LANCET ONCOL, V11, P439, DOI 10.1016/S1470-2045(10)70070-X; Tanimura S, 2005, SURG ENDOSC, V19, P1177, DOI 10.1007/s00464-004-8936-4; Uyama Ichiro, 1999, Gastric Cancer, V2, P230, DOI 10.1007/s101200050069; VOLPE CM, 1995, J AM COLL SURGEONS, V181, P56; WAGNER PK, 1991, BRIT J SURG, V78, P825, DOI 10.1002/bjs.1800780719; Yao XX, 2011, HEPATO-GASTROENTEROL, V58, P1067; Yu W, 2006, BRIT J SURG, V93, P559, DOI 10.1002/bjs.5353; Zhang CH, 2007, ANN SURG ONCOL, V14, P1312, DOI 10.1245/s10434-006-9190-x	26	9	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90345	10.1371/journal.pone.0090345	http://dx.doi.org/10.1371/journal.pone.0090345			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603610	Green Published, Green Submitted, gold			2022-12-27	WOS:000332483600046
J	Jenner, W; Motwani, M; Veighey, K; Newson, J; Audzevich, T; Nicolaou, A; Murphy, S; MacAllister, R; Gilroy, DW				Jenner, William; Motwani, Madhur; Veighey, Kristin; Newson, Justine; Audzevich, Tatsiana; Nicolaou, Anna; Murphy, Sharon; MacAllister, Raymond; Gilroy, Derek W.			Characterisation of Leukocytes in a Human Skin Blister Model of Acute Inflammation and Resolution	PLOS ONE			English	Article							LIPID MEDIATORS; BLOOD MONOCYTES; FC-GAMMA; EOSINOPHILS; SUBSET; IMMUNE; TUBERCULOSIS; PERITONITIS; EXPRESSION; INSIGHTS	There is an increasing need to understand the leukocytes and soluble mediators that drive acute inflammation and bring about its resolution in humans. We therefore carried out an extensive characterisation of the cantharidin skin blister model in healthy male volunteers. A novel fluorescence staining protocol was designed and implemented, which facilitated the identification of cell populations by flow cytometry. We observed that at the onset phase, 24 h after blister formation, the predominant cells were CD16(hi)/CD66b(+) PMNs followed by HLA-DR+/CD14(+) monocytes/macrophages, CD11c(+) and CD141(+) dendritic cells as well as Siglec-8(+) eosinophils. CD3(+) T cells, CD19(+) B cells and CD56(+) NK cells were also present, but in comparatively fewer numbers. During resolution, 72 h following blister induction, numbers of PMNs declined whilst the numbers of monocyte/macrophages remain unchanged, though they upregulated expression of CD16 and CD163. In contrast, the overall numbers of dendritic cells and Siglec-8(+) eosinophils increased. Post hoc analysis of these data revealed that of the inflammatory cytokines measured, TNF-alpha but not IL-1 beta or IL-8 correlated with increased PMN numbers at the onset. Volunteers with the greatest PMN infiltration at onset displayed the fastest clearance rates for these cells at resolution. Collectively, these data provide insight into the cells that occupy acute resolving blister in humans, the soluble mediators that may control their influx as well as the phenotype of mononuclear phagocytes that predominate the resolution phase. Further use of this model will improve our understanding of the evolution and resolution of inflammation in humans, how defects in these over-lapping pathways may contribute to the variability in disease longevity/chronicity, and lends itself to the screen of putative anti-inflammatory or pro-resolution therapies.	[Jenner, William; Motwani, Madhur; Veighey, Kristin; Newson, Justine; Audzevich, Tatsiana; MacAllister, Raymond; Gilroy, Derek W.] UCL, Div Med, Ctr Clin Pharmacol & Therapeut, London, England; [Nicolaou, Anna; Murphy, Sharon] Univ Manchester, Manchester Pharm Sch, Fac Med & Human Sci, Manchester, Lancs, England	University of London; University College London; University of Manchester	Gilroy, DW (corresponding author), UCL, Div Med, Ctr Clin Pharmacol & Therapeut, London, England.	d.gilroy@ucl.ac.uk	Gilroy, Derek W/C-2588-2009; Nicolaou, Anna/D-4025-2018; Gilroy, Derek/AAP-7227-2020	Nicolaou, Anna/0000-0002-1314-413X; Gilroy, Derek/0000-0003-3476-0844	British Heart Foundation; Wellcome Trust; British Heart Foundation [FS/10/44/28294] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); British Heart Foundation(British Heart Foundation)	This work was funded by the British Heart Foundation (WJ, RM) and The Wellcome Trust (DWG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeles D, 2012, CYTOM PART A, V81A, P823, DOI 10.1002/cyto.a.22104; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Bedner E, 1999, CYTOMETRY, V36, P77, DOI 10.1002/(SICI)1097-0320(19990501)36:1<77::AID-CYTO10>3.3.CO;2-6; Cash JL, 2009, METHOD ENZYMOL, V461, P379, DOI 10.1016/S0076-6879(09)05417-2; Castano D, 2011, TUBERCULOSIS, V91, P348, DOI 10.1016/j.tube.2011.04.002; Colville-Nash Paul, 2003, Methods Mol Biol, V225, P181; Cros J, 2010, IMMUNITY, V33, P375, DOI 10.1016/j.immuni.2010.08.012; Day RM, 2001, J IMMUNOL METHODS, V257, P213, DOI 10.1016/S0022-1759(01)00467-7; DRANSFIELD I, 1994, J IMMUNOL, V153, P1254; Evans BJ, 2013, INT J INFLAMM, V2013, DOI 10.1155/2013/780502; FINGERLE G, 1993, BLOOD, V82, P3170; Fulkerson PC, 2013, NAT REV DRUG DISCOV, V12, P117, DOI 10.1038/nrd3838; Gabor Miklos, 2003, Methods Mol Biol, V225, P129; Haniffa M, 2012, IMMUNITY, V37, P60, DOI 10.1016/j.immuni.2012.04.012; Hepburn AL, 2004, RHEUMATOLOGY, V43, P547, DOI 10.1093/rheumatology/keh112; Isobe Y, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00270; Jenner WJ GD, 2012, J R SOC MED CARDIO, V1; Kuhns DB, 1992, DYNAMICS CELLULAR HU; Lawrence T, 2002, NAT REV IMMUNOL, V2, P787, DOI 10.1038/nri915; Lugo-Villarino G, 2013, EUR J IMMUNOL, V43, P327, DOI 10.1002/eji.201243256; Marks DJB, 2006, LANCET, V367, P668, DOI 10.1016/S0140-6736(06)68265-2; Masoodi M, 2008, RAPID COMMUN MASS SP, V22, P75, DOI 10.1002/rcm.3331; Masoodi M, 2006, RAPID COMMUN MASS SP, V20, P3023, DOI 10.1002/rcm.2697; Moore Adrian R, 2003, Methods Mol Biol, V225, P123; Morris T, 2010, P NATL ACAD SCI USA, V107, P8842, DOI 10.1073/pnas.1000373107; Phong HDD, 2011, BRIT J CLIN PHARMACO, V72, P912, DOI 10.1111/j.1365-2125.2011.04020.x; Schlitt A, 2004, THROMB HAEMOSTASIS, V92, P419, DOI 10.1160/TH04-02-0095; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Thieblemont N, 1995, EUR J IMMUNOL, V25, P3418, DOI 10.1002/eji.1830251232; VANE JR, 1995, INFLAMM RES, V44, P1, DOI 10.1007/BF01630479; Vanham G, 1996, CLIN EXP IMMUNOL, V103, P30, DOI 10.1046/j.1365-2249.1996.907600.x; Wong KL, 2011, BLOOD, V118, pE15, DOI 10.1182/blood-2010-12-326355; Yamada T, 2011, FASEB J, V25, P561, DOI 10.1096/fj.10-170027; ZIEGLERHEITBROCK HWL, 1993, EUR J IMMUNOL, V23, P2053, DOI 10.1002/eji.1830230902; Zimmermann HW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011049	35	24	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e89375	10.1371/journal.pone.0089375	http://dx.doi.org/10.1371/journal.pone.0089375			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603711	gold, Green Published, Green Submitted			2022-12-27	WOS:000332483600012
J	Kanaan, RA; Chaddock, C; Allin, M; Picchioni, MM; Daly, E; Shergill, SS; McGuire, PK				Kanaan, Richard A.; Chaddock, Christopher; Allin, Matthew; Picchioni, Marco M.; Daly, Eileen; Shergill, Sukhi S.; McGuire, Philip K.			Gender Influence on White Matter Microstructure: A Tract-Based Spatial Statistics Analysis	PLOS ONE			English	Article							HUMAN CORPUS-CALLOSUM; DIFFUSION-TENSOR; HUMAN BRAIN; SEX-DIFFERENCES; CEREBELLAR VOLUME; HEALTHY-INDIVIDUALS; NERVOUS-SYSTEM; TRANSFER TIME; AGE; DTI	Background: Sexual dimorphism in human brain structure is well recognised, but less is known about gender differences in white matter microstructure. We used diffusion tensor imaging to explore gender differences in fractional anisotropy (FA), an index of microstructural integrity. We previously found increased FA in the corpus callosum in women, and increased FA in the cerebellum and left superior longitudinal fasciculus (SLF) in men, using a whole-brain voxel-based analysis. Methods: A whole-brain tract-based spatial statistics analysis of 120 matched subjects from the previous analysis, and 134 new subjects (147 men and 107 women in total) using a 1.5T scanner, with division into tract-based regions of interest. Results: Men had higher FA in the superior cerebellar peduncles and women had higher FA in corpus callosum in both the first and second samples. The higher SLF FA in men was not found in either sample. Discussion: We confirmed our previous, controversial finding of increased FA in the corpus callosum in women, and increased cerebellar FA in men. The corpus callosum FA difference offers some explanation for the otherwise puzzling advantage in inter-callosal transfer time shown in women; the cerebellar FA difference may be associated with the developmental motor advantage shown in men.	[Kanaan, Richard A.] Univ Melbourne, Dept Psychiat, Austin Hlth, Heidelberg, Vic, Australia; [Chaddock, Christopher; Allin, Matthew; Picchioni, Marco M.; Shergill, Sukhi S.; McGuire, Philip K.] Kings Coll London, Inst Psychiat, Dept Psychosis Studies, London WC2R 2LS, England; [Picchioni, Marco M.] Kings Coll London, St Andrews Acad Ctr, Northampton, England; [Daly, Eileen] Kings Coll London, Inst Psychiat, Dept Dev Psychiat, London WC2R 2LS, England	Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of London; King's College London; University of London; King's College London; University of London; King's College London	Kanaan, RA (corresponding author), Univ Melbourne, Dept Psychiat, Austin Hlth, Heidelberg, Vic, Australia.	richard.kanaan@unimelb.edu.au	Picchioni, Marco M/E-3300-2010	Picchioni, Marco M/0000-0001-6681-147X; Kanaan, Richard/0000-0003-0992-1917; Daly, Eileen/0000-0003-3625-3467; shergill, sukhi/0000-0003-4928-9100; McGuire, Philip/0000-0003-4381-0532	Wellcome Trust [072555, 064971]; MRC [G0901868] Funding Source: UKRI; Medical Research Council [G0901868] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded by fellowships from the Wellcome Trust (072555 to RK, 064971 to MP and SS). http://www.wellcome.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2002, NEUROBIOL AGING, V23, P433, DOI 10.1016/S0197-4580(01)00318-9; Allen JS, 2002, AM J PHYS ANTHROPOL, V118, P341, DOI 10.1002/ajpa.10092; Basser PJ, 1995, NMR BIOMED, V8, P333, DOI 10.1002/nbm.1940080707; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Bava S, 2010, BRAIN RES; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brun CC, 2009, NEUROREPORT, V20, P930, DOI 10.1097/WNR.0b013e32832c5e65; Catani M, 2002, NEUROIMAGE, V17, P77, DOI 10.1006/nimg.2002.1136; Chen XH, 2007, NEUROIMAGE, V36, P691, DOI 10.1016/j.neuroimage.2007.03.063; Chung SC, 2005, BRAIN RES, V1042, P233, DOI 10.1016/j.brainres.2005.02.033; Cosgrove KP, 2007, BIOL PSYCHIAT, V62, P847, DOI 10.1016/j.biopsych.2007.03.001; De Bondt T, 2013, EUR RADIOL, V23, P57, DOI 10.1007/s00330-012-2572-5; Duarte-Carvajalino JM, 2012, NEUROIMAGE, V59, P3784, DOI 10.1016/j.neuroimage.2011.10.096; ESCALONA PR, 1991, AM J NEURORADIOL, V12, P927; Gong GL, 2009, J NEUROSCI, V29, P15684, DOI 10.1523/JNEUROSCI.2308-09.2009; Gur RC, 1999, J NEUROSCI, V19, P4065; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Hsu JL, 2008, NEUROIMAGE, V39, P566, DOI 10.1016/j.neuroimage.2007.09.017; Huster RJ, 2009, HUM BRAIN MAPP, V30, P383, DOI 10.1002/hbm.20509; Hutchinson S, 2003, CEREB CORTEX, V13, P943, DOI 10.1093/cercor/13.9.943; Iacoboni M, 2000, BRAIN, V123, P759, DOI 10.1093/brain/123.4.759; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Jones DK, 2002, HUM BRAIN MAPP, V15, P216, DOI 10.1002/hbm.10018; Kanaan RAA, 2005, BIOL PSYCHIAT, V58, P921, DOI 10.1016/j.biopsych.2005.05.015; Kanaan RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038272; Kang XJ, 2011, NEUROIMAGE, V56, P2011, DOI 10.1016/j.neuroimage.2011.03.016; Lee CEC, 2009, NEURORADIOLOGY, V51, P3, DOI 10.1007/s00234-008-0441-3; Lix LM, 2010, PSYCHOL METHODS, V15, P268, DOI 10.1037/a0017737; Menzler K, 2011, NEUROIMAGE, V54, P2557, DOI 10.1016/j.neuroimage.2010.11.029; Moes PE, 2007, NEUROPSYCHOLOGIA, V45, P2626, DOI 10.1016/j.neuropsychologia.2007.03.017; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Nopoulos P, 2000, PSYCHIAT RES-NEUROIM, V98, P1, DOI 10.1016/S0925-4927(99)00044-X; Oh JS, 2007, NEUROIMAGE, V36, P606, DOI 10.1016/j.neuroimage.2007.03.020; Oishi K, 2008, NEUROIMAGE, V43, P447, DOI 10.1016/j.neuroimage.2008.07.009; Pal D, 2011, J CLIN NEUROSCI, V18, P193, DOI 10.1016/j.jocn.2010.05.033; Pangelinan MM, 2011, NEUROIMAGE, V54, P3093, DOI 10.1016/j.neuroimage.2010.11.021; Perrin JS, 2008, J NEUROSCI, V28, P9519, DOI 10.1523/JNEUROSCI.1212-08.2008; Powell JL, 2012, NEUROSCIENCE, V207, P227, DOI 10.1016/j.neuroscience.2012.01.016; Schulte T, 2005, CEREB CORTEX, V15, P1384, DOI 10.1093/cercor/bhi020; Schulte T, 2004, NEUROPSYCHOLOGIA, V42, P257, DOI 10.1016/S0028-3932(03)00155-6; Shin YW, 2005, NEUROREPORT, V16, P795, DOI 10.1097/00001756-200505310-00003; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Sullivan EV, 2001, NEUROREPORT, V12, P99, DOI 10.1097/00001756-200101220-00027; Szabo CA, 2003, AM J NEURORADIOL, V24, P644; Szeszko PR, 2003, NEUROREPORT, V14, P2469, DOI 10.1097/00001756-200312190-00035; THOMAS JR, 1985, PSYCHOL BULL, V98, P260, DOI 10.1037/0033-2909.98.2.260; Tuch DS, 2005, P NATL ACAD SCI USA, V102, P12212, DOI 10.1073/pnas.0407259102; Westerhausen R, 2004, COGNITIVE BRAIN RES, V21, P418, DOI 10.1016/j.cogbrainres.2004.07.002; Westerhausen R, 2003, NEUROSCI LETT, V351, P99, DOI 10.1016/j.neulet.2003.07.011; Whitford TJ, 2011, NEUROIMAGE, V54, P2318, DOI 10.1016/j.neuroimage.2010.10.048; Wu YC, 2011, NEUROIMAGE, V54, P1840, DOI 10.1016/j.neuroimage.2010.09.067	52	33	33	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e91109	10.1371/journal.pone.0091109	http://dx.doi.org/10.1371/journal.pone.0091109			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603769	Green Published, gold, Green Submitted			2022-12-27	WOS:000332483600130
J	Prakash, S; Sundd, M; Guptasarma, P				Prakash, Satya; Sundd, Monica; Guptasarma, Purnananda			The Key to the Extraordinary Thermal Stability of P. furiosus Holo-Rubredoxin: Iron Binding-Guided Packing of a Core Aromatic Cluster Responsible for High Kinetic Stability of the Native Structure	PLOS ONE			English	Article							PYROCOCCUS-FURIOSUS; CLOSTRIDIUM-PASTEURIANUM; PROTEIN; APORUBREDOXINS; STABILIZATION; RESIDUES	Pyrococcus furiosus rubredoxin (PfRd), a small, monomeric, 53 residues-long, iron-containing, electron-transfer protein of known structure is sometimes referred to as being the most structurally-stable protein known to man. Here, using a combination of mutational and spectroscopic (CD, fluorescence, and NMR) studies of differently made holo-and apo-forms of PfRd, we demonstrate that it is not the presence of iron, or even the folding of the PfRd chain into a compact well-folded structure that causes holo-PfRd to display its extraordinary thermal stability, but rather the correct iron binding-guided packing of certain residues (specifically, Trp3, Phe29, Trp36, and also Tyr10) within a tight aromatic cluster of six residues in PfRd's hydrophobic core. Binding of the iron atom appears to play a remarkable role in determining subtle details of residue packing, forcing the chain to form a hyper-thermally stable native structure which is kinetically stable enough to survive (subsequent) removal of iron. On the other hand, failure to bind iron causes the same chain to adopt an equally well-folded native-like structure which, however, has a differently-packed aromatic cluster in its core, causing it to be only as stable as any other ordinary mesophile-derived rubredoxin. Our studies demonstrate, perhaps for the very first time ever that hyperthermal stability in proteins can owe to subtle differences in residue packing vis a vis mesostable proteins, without there being any underlying differences in either amino acid sequence, or bound ligand status.	[Prakash, Satya; Guptasarma, Purnananda] Indian Inst Sci Educ & Res IISER, Dept Biol Sci, Sas Nagar, Punjab, India; [Prakash, Satya; Guptasarma, Purnananda] Inst Microbial Technol IMTECH, Prot Engn Div, Chandigarh, India; [Sundd, Monica] Natl Inst Immunol NII, NMR Lab, New Delhi, India	Indian Institute of Science Education & Research (IISER) - Mohali; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH); Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Guptasarma, P (corresponding author), Indian Inst Sci Educ & Res IISER, Dept Biol Sci, Sas Nagar, Punjab, India.	guptasarma@iisermohali.ac.in	Guptasarma, Purnananda/C-3976-2009	Guptasarma, Purnananda/0000-0002-4801-3180				Bonomi F, 2008, J BIOL INORG CHEM, V13, P981, DOI 10.1007/s00775-008-0385-4; BURLEY SK, 1985, SCIENCE, V229, P23, DOI 10.1126/science.3892686; CAVAGNERO S, 1995, BIOCHEMISTRY-US, V34, P9865, DOI 10.1021/bi00031a007; Cavagnero S, 1998, BIOCHEMISTRY-US, V37, P3369, DOI 10.1021/bi9721795; DAY MW, 1992, PROTEIN SCI, V1, P1494, DOI 10.1002/pro.5560011111; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Hiller R, 1997, P NATL ACAD SCI USA, V94, P11329, DOI 10.1073/pnas.94.21.11329; KLUMP H, 1992, J BIOL CHEM, V267, P22681; LeMaster DM, 2005, PROTEINS, V61, P608, DOI 10.1002/prot.20594; LOVENBERG W, 1965, P NATL ACAD SCI USA, V54, P193, DOI 10.1073/pnas.54.1.193; Mukaiyama A, 2009, INT J MOL SCI, V10, P1369, DOI 10.3390/ijms10031369; Samanta U, 1999, ACTA CRYSTALLOGR D, V55, P1421, DOI 10.1107/S090744499900726X; Shehi E, 2003, BIOCHEMISTRY-US, V42, P8362, DOI 10.1021/bi034520t; Strop P, 1999, J AM CHEM SOC, V121, P2341, DOI 10.1021/ja9834780; Vondrasek J, 2005, J AM CHEM SOC, V127, P2615, DOI 10.1021/ja044607h; Zartler ER, 2001, BIOCHEMISTRY-US, V40, P7279, DOI 10.1021/bi0026831	16	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e89703	10.1371/journal.pone.0089703	http://dx.doi.org/10.1371/journal.pone.0089703			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603898	Green Published, Green Submitted, gold			2022-12-27	WOS:000332483600019
J	Chen, ZR; Lei, XQ; Zhang, BZ; Yang, LX; Zhang, HJ; Zhang, JY; Li, Y; Zheng, W; Tian, Y; Liu, JW; Zheng, TL				Chen, Zhangran; Lei, Xueqian; Zhang, Bangzhou; Yang, Luxi; Zhang, Huajun; Zhang, Jingyan; Li, Yi; Zheng, Wei; Tian, Yun; Liu, Jingwen; Zheng, Tianling			First Report of Pseudobodo sp, a New Pathogen for a Potential Energy-Producing Algae: Chlorella vulgaris Cultures	PLOS ONE			English	Article							ALGICIDAL BACTERIUM; RED-TIDE; PARAMECIUM-BURSARIA; MARINE BACTERIUM; RNA; INFECTS; VIRUS; DINOFLAGELLATE; PREDATION; STRAIN	Chlorella vulgaris, is a kind of single-celled green algae, which could serve as a potential source of food and energy because of its photosynthetic efficiency. In our study, a pathogenic organism targeting C. vulgaris was discovered. The algae-lytic activity relates to a fraction from lysates of infected C. vulgaris that was blocked upon filtration through a 3 mm filter. 18S rRNA gene sequence analysis revealed that it shared 99.0% homology with the protist Pseudobodo tremulans. Scanning electron microscope analysis showed that Pseudobodo sp. KD51 cells were approximately 4-5 mm long, biflagellate with an anterior collar around the anterior part of the cell in unstressed feeding cells. Besides the initial host, Pseudobodo sp. KD51 could also kill other algae, indicating its relatively wide predatory spectrum. Heat stability, pH and salinity tolerance experiments were conducted to understand their effects on its predatory activities, and the results showed that Pseudobodo sp. KD51 was heat-sensitive, and pH and salinity tolerant.	[Chen, Zhangran; Lei, Xueqian; Zhang, Bangzhou; Yang, Luxi; Zhang, Huajun; Zhang, Jingyan; Li, Yi; Zheng, Wei; Tian, Yun; Zheng, Tianling] Xiamen Univ, Sch Life Sci, State Key Lab Marine Environm Sci, Xiamen, Peoples R China; [Chen, Zhangran; Lei, Xueqian; Zhang, Bangzhou; Yang, Luxi; Zhang, Huajun; Zhang, Jingyan; Li, Yi; Zheng, Wei; Tian, Yun; Zheng, Tianling] Xiamen Univ, Sch Life Sci, Minist Educ Coastal & Wetland Ecosyst, Key Lab, Xiamen, Peoples R China; [Chen, Zhangran; Zheng, Tianling] Xiamen Univ, ShenZhen Res Inst, Shenzhen, Peoples R China; [Liu, Jingwen] Jimei Univ, Bioengn Coll, Xiamen, Peoples R China	Xiamen University; Xiamen University; Xiamen University; Jimei University	Liu, JW (corresponding author), Jimei Univ, Bioengn Coll, Xiamen, Peoples R China.	lljjww16@163.com; wshwzh@xmu.edu.cn	Zhang, Bangzhou/CAG-9625-2022		National Nature Science Foundation of China [41376119, 40930847]; public science and technology research funds projects of ocean [201305016, 201305022]; science and technology innovation funds of Shenzhen [JCYJ20120615161239998]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); public science and technology research funds projects of ocean; science and technology innovation funds of Shenzhen	This work was financially supported by the National Nature Science Foundation of China (41376119, 40930847), public science and technology research funds projects of ocean (201305016, 201305022) and science and technology innovation funds of Shenzhen (JCYJ20120615161239998). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adl SM, 2005, J EUKARYOT MICROBIOL, V52, P399, DOI 10.1111/j.1550-7408.2005.00053.x; Arndt H, 2003, MAR ECOL PROG SER, V256, P45, DOI 10.3354/meps256045; Asif MH, 2000, PLANT MOL BIOL REP, V18, P109, DOI 10.1007/BF02824018; Bubeck JA, 2005, J GEN VIROL, V86, P2871, DOI 10.1099/vir.0.81068-0; Cai WW, 2011, APPL ENVIRON MICROB, V77, P7837, DOI 10.1128/AEM.05783-11; CARON DA, 1991, MAR ECOL PROG SER, V76, P205, DOI 10.3354/meps076205; Castberg T, 2002, J PHYCOL, V38, P767, DOI 10.1046/j.1529-8817.2002.02015.x; Collet P, 2011, BIORESOURCE TECHNOL, V102, P207, DOI 10.1016/j.biortech.2010.06.154; Corno G, 2006, APPL ENVIRON MICROB, V72, P78, DOI 10.1128/AEM.72.1.78-86.2006; Demirbas A, 2010, GREEN ENERGY TECHNOL, P1, DOI 10.1007/978-1-84996-050-2; FENCHEL T, 1982, MAR ECOL PROG SER, V8, P211, DOI 10.3354/meps008211; Gonzalez-Moreno S, 1997, PHYSIOL PLANTARUM, V101, P777, DOI 10.1034/j.1399-3054.1997.1010414.x; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3, DOI 10.1007/978-1-4615-8714-9_3]; Happe T, 2002, TRENDS PLANT SCI, V7, P246, DOI 10.1016/S1360-1385(02)02274-4; Hoshina R, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-222; Jeong HJ, 1999, J EUKARYOT MICROBIOL, V46, P69, DOI 10.1111/j.1550-7408.1999.tb04586.x; Jeong HJ, 2005, AQUAT MICROB ECOL, V41, P131, DOI 10.3354/ame041131; Jeong HJ, 2004, J EUKARYOT MICROBIOL, V51, P563, DOI 10.1111/j.1550-7408.2004.tb00292.x; Jeong SY, 2003, TETRAHEDRON LETT, V44, P8005, DOI 10.1016/j.tetlet.2003.08.115; Kahrstrom CT, 2013, NATURE REV MICROBIOL; Kang M, 2005, MOL PLANT PATHOL, V6, P213, DOI 10.1111/j.1364-3703.2005.00281.x; Karpov SA, 2000, PROTISTOLOGY, V1, P100; Kim JD, 2009, MAR BIOTECHNOL, V11, P463, DOI 10.1007/s10126-008-9167-9; Kim MJ, 2008, J APPL PHYCOL, V20, P1069, DOI 10.1007/s10811-008-9312-x; Kim OS, 2012, INT J SYST EVOL MICR, V62, P716, DOI 10.1099/ijs.0.038075-0; Kim YS, 2009, J MICROBIOL, V47, P9, DOI 10.1007/s12275-008-0141-z; Kodama Y, 2012, ENVIRON MICROBIOL, V14, P2800, DOI 10.1111/j.1462-2920.2012.02793.x; Kodani S, 2002, J APPL PHYCOL, V14, P109, DOI 10.1023/A:1019533414018; Lee SO, 2000, APPL ENVIRON MICROB, V66, P4334, DOI 10.1128/AEM.66.10.4334-4339.2000; Lee YJ, 2008, HARMFUL ALGAE, V7, P154, DOI 10.1016/j.hal.2007.06.004; LEWIS MA, 1990, ECOTOX ENVIRON SAFE, V20, P123, DOI 10.1016/0147-6513(90)90052-7; Liang J-w, 2009, ENV SCI TECHNOLOGY, V32, P019; MEDLIN L, 1988, GENE, V71, P491, DOI 10.1016/0378-1119(88)90066-2; Mu RM, 2007, J ENVIRON SCI-CHINA, V19, P1336, DOI 10.1016/S1001-0742(07)60218-6; O'Kelly CJ, 1998, EUR J PROTISTOL, V34, P369, DOI 10.1016/S0932-4739(98)80006-0; OKelly CJ, 1996, EUR J PROTISTOL, V32, P216, DOI 10.1016/S0932-4739(96)80021-6; Pedersen MF, 2003, MAR ECOL PROG SER, V260, P33, DOI 10.3354/meps260033; Pernthaler J, 2005, NAT REV MICROBIOL, V3, P537, DOI 10.1038/nrmicro1180; Philippe N, 2013, SCIENCE, V341, P281, DOI 10.1126/science.1239181; Radakovits R, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1688; Radakovits R, 2010, EUKARYOT CELL, V9, P486, DOI 10.1128/EC.00364-09; Roberts EC, 2011, J PLANKTON RES, V33, P603, DOI 10.1093/plankt/fbq118; Rose JM, 2007, LIMNOL OCEANOGR, V52, P886, DOI 10.4319/lo.2007.52.2.0886; Roth PB, 2008, HARMFUL ALGAE, V7, P682, DOI 10.1016/j.hal.2008.02.002; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Scott SA, 2010, CURR OPIN BIOTECH, V21, P277, DOI 10.1016/j.copbio.2010.03.005; Shannon SP, 2007, MICROB ECOL, V53, P66, DOI 10.1007/s00248-006-9140-y; Sharif Hossain A. B. M., 2008, American Journal of Biochemistry and Biotechnology, V4, P250; Sherr EB, 2002, ANTON LEEUW INT J G, V81, P293, DOI 10.1023/A:1020591307260; Shirai Y, 2008, APPL ENVIRON MICROB, V74, P4022, DOI 10.1128/AEM.00509-08; Su JQ, 2011, BIOL CONTROL, V56, P132, DOI 10.1016/j.biocontrol.2010.10.004; Su RQ, 2007, HARMFUL ALGAE, V6, P799, DOI 10.1016/j.hal.2007.04.004; SUTTLE CA, 1991, APPL ENVIRON MICROB, V57, P721, DOI 10.1128/AEM.57.3.721-726.1991; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tan HY, 2013, J EUKARYOT MICROBIOL, V60, P98, DOI 10.1111/jeu.12011; Tillmann U, 2004, J EUKARYOT MICROBIOL, V51, P156, DOI 10.1111/j.1550-7408.2004.tb00540.x; Tokusoglu O, 2003, J FOOD SCI, V68, P1144, DOI 10.1111/j.1365-2621.2003.tb09615.x; Tomaru Y, 2008, AQUAT MICROB ECOL, V50, P103, DOI 10.3354/ame01170; Turner JT, 2006, ECOL STU AN, V189, P259, DOI 10.1007/978-3-540-32210-8_20; Wang B, 2011, HARMFUL ALGAE; Wang H, 2012, APPL ENVIRON MICROB, V78, P1445, DOI 10.1128/AEM.06474-11; Wang WR, 2013, BIORESOURCE TECHNOL, V136, P24, DOI 10.1016/j.biortech.2013.03.075; Xu Y, 2011, J HAZARD TOXIC RADIO, V15, P21, DOI 10.1061/(ASCE)HZ.1944-8376.0000053; Yu J, 2013, APPL MICROBIOL BIOT, V97, P9825, DOI 10.1007/s00253-013-5294-y; Zhang HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063018; Zheng XW, 2013, APPL MICROBIOL BIOT, V97, P9207, DOI 10.1007/s00253-012-4617-8	66	22	22	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e89571	10.1371/journal.pone.0089571	http://dx.doi.org/10.1371/journal.pone.0089571			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599263	Green Published, gold, Green Submitted			2022-12-27	WOS:000332479400019
J	Teichert, T; Ferrera, VP; Grinband, J				Teichert, Tobias; Ferrera, Vincent P.; Grinband, Jack			Humans Optimize Decision-Making by Delaying Decision Onset	PLOS ONE			English	Article							LATERAL INTRAPARIETAL AREA; ACCUMULATOR MODEL; PERCEPTUAL DECISION; DIFFUSION-MODELS; VISUAL-CORTEX; REACTION-TIME; ATTENTION; CHOICE; DISCRIMINATION; TASK	Why do humans make errors on seemingly trivial perceptual decisions? It has been shown that such errors occur in part because the decision process (evidence accumulation) is initiated before selective attention has isolated the relevant sensory information from salient distractors. Nevertheless, it is typically assumed that subjects increase accuracy by prolonging the decision process rather than delaying decision onset. To date it has not been tested whether humans can strategically delay decision onset to increase response accuracy. To address this question we measured the time course of selective attention in a motion interference task using a novel variant of the response signal paradigm. Based on these measurements we estimated time-dependent drift rate and showed that subjects should in principle be able trade speed for accuracy very effectively by delaying decision onset. Using the time-dependent estimate of drift rate we show that subjects indeed delay decision onset in addition to raising response threshold when asked to stress accuracy over speed in a free reaction version of the same motion-interference task. These findings show that decision onset is a critical aspect of the decision process that can be adjusted to effectively improve decision accuracy.	[Teichert, Tobias; Ferrera, Vincent P.] Columbia Univ, Dept Neurosci, New York, NY 10027 USA; [Grinband, Jack] Columbia Univ, Dept Radiol, New York, NY USA; [Teichert, Tobias] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA USA	Columbia University; Columbia University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Teichert, T (corresponding author), Columbia Univ, Dept Neurosci, New York, NY 10027 USA.	teichert@pitt.edu	Grinband, Jack/AAX-7675-2020; Teichert, Tobias/F-6295-2014	Grinband, Jack/0000-0001-7658-6755; Teichert, Tobias/0000-0001-6500-9573; Ferrera, Vincent/0000-0002-6599-7740	German Research Foundation (DFG) [Te819/1-1]; National Institutes of Health [NIH-MH059244]; NATIONAL EYE INSTITUTE [P30EY019007] Funding Source: NIH RePORTER	German Research Foundation (DFG)(German Research Foundation (DFG)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The research was funded by the German Research Foundation (DFG, Te819/1-1 to TT) and the National Institutes of Health (NIH-MH059244 to VPF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bisley JW, 2006, J NEUROPHYSIOL, V95, P1696, DOI 10.1152/jn.00848.2005; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Boynton GM, 2005, CURR OPIN NEUROBIOL, V15, P465, DOI 10.1016/j.conb.2005.06.009; Cohen J, 1994, ATTENTION PERFORMANC, VXV; COHEN JD, 1990, PSYCHOL REV, V97, P332, DOI 10.1037/0033-295X.97.3.332; Croner LJ, 1997, VISION RES, V37, P1415, DOI 10.1016/S0042-6989(96)00299-4; Desimone R, 1998, PHILOS T R SOC B, V353, P1245, DOI 10.1098/rstb.1998.0280; Eriksen B, 1974, ATTENTION; Fallah M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037888; Frank MJ, 2006, NEURAL NETWORKS, V19, P1120, DOI 10.1016/j.neunet.2006.03.006; Ghez C, 1997, EXP BRAIN RES, V115, P217, DOI 10.1007/PL00005692; GRATTON G, 1988, J EXP PSYCHOL HUMAN, V14, P331, DOI 10.1037/0096-1523.14.3.331; Heeger D. J., 1991, COMPUTATIONAL MODELS; Jonides J, 1980, CANADIAN J PSYCHOL; Krajbich I, 2011, P NATL ACAD SCI USA, V108, P13852, DOI 10.1073/pnas.1101328108; Laming DR, 1968, INFORM THEORY CHOICE; Larsen T, 2010, NEURAL NETWORKS, V23, P322, DOI 10.1016/j.neunet.2009.11.015; Luce R. D., 1986, RESPONSE TIMES; Osman A, 2000, BIOL PSYCHOL, V51, P173, DOI 10.1016/S0301-0511(99)00045-9; Palmer J, 2005, J VISION, V5, P376, DOI 10.1167/5.5.1; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Purcell BA, 2012, J NEUROSCI, V32, P3433, DOI 10.1523/JNEUROSCI.4622-11.2012; Purcell BA, 2010, PSYCHOL REV, V117, P1113, DOI 10.1037/a0020311; RABBITT P, 1977, Q J EXP PSYCHOL, V29, P727, DOI 10.1080/14640747708400645; RATCLIFF R, 1978, PSYCHOL REV, V85, P59, DOI 10.1037//0033-295X.85.2.59; Ratcliff R, 2008, NEURAL COMPUT, V20, P873, DOI 10.1162/neco.2008.12-06-420; Ratcliff R, 2006, COGNITIVE PSYCHOL, V53, P195, DOI 10.1016/j.cogpsych.2005.10.002; Ratcliff R, 2012, NEURAL COMPUT, V24, P1186, DOI 10.1162/NECO_a_00270; Rinkenauer G, 2004, J EXPT PSYCHOL GEN; Roitman JD, 2002, J NEUROSCI, V22, P9475; Sekhon J., 2011, J STAT SOFTW, P42; SHIU LP, 1995, VISION RES, V35, P337, DOI 10.1016/0042-6989(94)00148-F; Smith PL, 2009, PSYCHOL REV, V116, P283, DOI 10.1037/a0015156; SMITH PL, 1988, J MATH PSYCHOL, V32, P135, DOI 10.1016/0022-2496(88)90043-0; STONE M, 1960, PSYCHOMETRIKA, V25, P251, DOI 10.1007/BF02289729; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Teichert T, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-38; Usher M, 2001, PSYCHOL REV, V108, P550, DOI 10.1037//0033-295X.108.3.550; van der Lubbe RHJ, 2001, J PSYCHOPHYSIOL, V15, P241, DOI 10.1027//0269-8803.15.4.241; Watamaniuk SNJ, 2011, VISION RES, V51, P1129, DOI 10.1016/j.visres.2011.03.003; White CN, 2011, COGNITIVE PSYCHOL, V63, P210, DOI 10.1016/j.cogpsych.2011.08.001; Yeung N, 2004, PSYCHOL REV, V111, P931, DOI 10.1037/0033-295x.111.4.931	42	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e89638	10.1371/journal.pone.0089638	http://dx.doi.org/10.1371/journal.pone.0089638			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC4GP	24599295	Green Published, gold, Green Accepted			2022-12-27	WOS:000332479400020
J	Wang, L; Chen, CW; Zhu, LQ				Wang, Lamei; Chen, Chia-Wen; Zhu, Liqi			Picture Norms for Chinese Preschool Children: Name Agreement, Familiarity, and Visual Complexity	PLOS ONE			English	Article							IMAGE AGREEMENT; VANDERWART PICTURES; STANDARDIZED SET; NAMING TIMES; ALZHEIMERS-DISEASE; SURFACE DETAIL; SNODGRASS; OBJECT; AGE; ACQUISITION	Pictorial stimuli standardized for Chinese children are still absent although it is needed in order to test the development of children's cognitive functions. This study presents normative measures for Snodgrass and Vanderwart pictures, viewed by 4- and 6-year old Chinese children. Name agreement, familiarity, and visual complexity were obtained for each age group. The data indicate substantial differences between young and older children in name agreement based on expected name, familiarity and visual complexity. The correlation pattern of the variables collected in the present study were consistent with children's norms in other languages and norms of Chinese adults, while there are cross-age and cross-culture differences in specific variables. The obtained measures represent a useful tool for further research on Chinese children's pictorial processing and constitute the first picture normative study for children in this language.	[Wang, Lamei] Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China; [Chen, Chia-Wen] Hong Kong Inst Educ, Assessment Res Ctr, Hong Kong, Hong Kong, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS; Education University of Hong Kong (EdUHK)	Wang, L (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China.	zhulq@psych.ac.cn	Chen, Chia-Wen/AAE-2877-2021	Chen, Chia-Wen/0000-0002-2290-2705; wang, la mei/0000-0002-9203-5539	National Natural Science Foundation of China [31200783]; Chinese Academy of Sciences [KSZD-EW-Z-008]; China 973 program [2010CB8339004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); China 973 program(National Basic Research Program of China)	This study was supported by National Natural Science Foundation of China (31200783), Chinese Academy of Sciences (KSZD-EW-Z-008) and China 973 program (2010CB8339004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlington RL, 2009, J CLIN EXP NEUROPSYC, V31, P731, DOI 10.1080/13803390802488103; Adlington RL, 2009, NEUROPSYCHOLOGIA, V47, P2574, DOI 10.1016/j.neuropsychologia.2009.05.004; Alario FX, 1999, BEHAV RES METH INS C, V31, P531, DOI 10.3758/BF03200732; Aveleyra E, 1996, REV MEX PSICOL, V13, P5; Bates E, 2003, PSYCHON B REV, V10, P344, DOI 10.3758/BF03196494; BERMAN S, 1989, BEHAV RES METH INSTR, V21, P371, DOI 10.3758/BF03202800; Bramao I, 2011, ACTA PSYCHOL, V138, P244, DOI 10.1016/j.actpsy.2011.06.010; Cai Q, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010729; Cannard C, 2005, BEHAV RES METHODS, V37, P417, DOI 10.3758/BF03192710; Chalard M, 2003, EUR J COGN PSYCHOL, V15, P209, DOI 10.1080/09541440244000076; Cuetos F, 1999, BEHAV RES METH INS C, V31, P650, DOI 10.3758/BF03200741; Cycowicz YM, 1997, J EXP CHILD PSYCHOL, V65, P171, DOI 10.1006/jecp.1996.2356; Cycowicz YM, 2001, NEUROPSYCHOLOGIA, V39, P255, DOI 10.1016/S0028-3932(00)00108-1; D'Amico S, 2001, J COGN DEV, V2, P71, DOI 10.1207/S15327647JCD0201_4; Damasio H, 1996, NATURE, V380, P499, DOI 10.1038/380499a0; Dell'acqua R, 2000, BEHAV RES METH INS C, V32, P588, DOI 10.3758/BF03200832; Dimitropoulou M, 2009, BEHAV RES METHODS, V41, P584, DOI 10.3758/BRM.41.2.584; Moreno-Martinez FJ, 2011, AGING NEUROPSYCHOL C, V18, P293, DOI 10.1080/13825585.2010.540849; JESCHENIAK JD, 1994, J EXP PSYCHOL LEARN, V20, P824, DOI 10.1037/0278-7393.20.4.824; Johnson CJ, 1996, PSYCHOL BULL, V120, P113, DOI 10.1037/0033-2909.120.1.113; Kremin H, 2001, BRAIN COGNITION, V46, P180, DOI 10.1016/S0278-2626(00)91270-3; Laws KR, 2006, BRAIN COGNITION, V62, P89, DOI 10.1016/j.bandc.2006.03.002; Laws KR, 2002, CORTEX, V38, P7, DOI 10.1016/S0010-9452(08)70635-X; Liu Y, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0015639, 10.1371/journal.pone.0022241]; Martin A, 1996, NATURE, V379, P649, DOI 10.1038/379649a0; Nishimoto T, 2005, BEHAV RES METHODS, V37, P398, DOI 10.3758/BF03192709; Pind J, 2000, SCAND J PSYCHOL, V41, P41, DOI 10.1111/1467-9450.00169; Pompeia S, 2003, ARQ NEURO-PSIQUIAT, V61, P916, DOI 10.1590/S0004-282X2003000600005; Pompeia S, 2001, ARQ NEURO-PSIQUIAT, V59, P330, DOI 10.1590/S0004-282X2001000300004; Rodriguez-Ferreiro J, 2009, J NEUROLINGUIST, V22, P37, DOI 10.1016/j.jneuroling.2008.05.003; Rossion B, 2004, PERCEPTION, V33, P217, DOI 10.1068/p5117; Sanfeliu MC, 1996, BEHAV RES METH INSTR, V28, P537, DOI 10.3758/BF03200541; Severens E, 2005, ACTA PSYCHOL, V119, P159, DOI 10.1016/j.actpsy.2005.01.002; SIEGEL LS, 1994, INT J BEHAV DEV, P109; SNODGRASS JG, 1980, J EXP PSYCHOL-HUM L, V6, P174, DOI 10.1037/0278-7393.6.2.174; Snodgrass JG, 1996, BEHAV RES METH INSTR, V28, P516, DOI 10.3758/BF03200540; Szekely A, 2003, BEHAV RES METH INS C, V35, P621, DOI 10.3758/BF03195542; Tsaparina D, 2011, BEHAV RES METHODS, V43, P1085, DOI 10.3758/s13428-011-0121-9; Vandenberghe R, 1996, NATURE, V383, P254, DOI 10.1038/383254a0; Ventura P., 2003, LAB PSICOLOGIA, V1, P5, DOI 10.14417/lp.769; Weekes BS, 2007, BEHAV RES METHODS, V39, P335, DOI 10.3758/BF03193165; Welsh MC, 2002, DEVELOPMENTAL VARIATIONS IN LEARNING, P139; Yoon C, 2004, BEHAV RES METH INS C, V36, P639, DOI 10.3758/BF03206545; 舒华, 1989, [心理学报, Acta Psychologica Sinica], V21, P389	44	7	7	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90450	10.1371/journal.pone.0090450	http://dx.doi.org/10.1371/journal.pone.0090450			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC4GP	24599271	gold, Green Published, Green Submitted			2022-12-27	WOS:000332479400076
J	Qiu, CP; Lv, QT; Dongol, S; Wang, CG; Jiang, J				Qiu, Chun-Ping; Lv, Qing-Tao; Dongol, Samina; Wang, Chenguang; Jiang, Jie			Single Nucleotide Polymorphism of SREBF-1 Gene Associated with an Increased Risk of Endometrial Cancer in Chinese Women	PLOS ONE			English	Article							FATTY-ACID SYNTHASE; BINDING PROTEINS; BREAST-CANCER; GROWTH; 17-BETA-HYDROXYSTEROID-DEHYDROGENASE; CHOLESTEROL; ACTIVATORS; EXPRESSION; RECEPTOR; SREBPS	Aim: Elevated levels of sterol regulatory element-binding protein-1 (SREBP-1) have been found in endometrial cancer (EC), suggesting that it is essential to the development of EC. Obesity and diabetes have been established as known risk factors of EC, while SREBF-1 gene polymorphisms have also been found to be associated with obesity and type II diabetes. Therefore, we hypothesize that single nucleotide polymorphism (SNP) in SREBF-1 gene may be associated with increased risk of EC. Method: We analyzed the sequence of SREBF-1 in tissue samples from 30 EC cases and 6 benign controls using high throughput method. Based on the primary results, we selected one SNP (rs2297508) as a genetic marker to conduct a hospital-based case-control study with 139 EC cases and 129 benign controls. The samples were examined under the microscope to determine their histopathology prior to the SNP analysis using RT-PCR. Results: Through sequence analysis, we found 10 SNPs of SREBF-1 associated with EC, including 3 new SNPs. Fourteen percent of EC showed the rs2297508 SNP with C allele, while only 7% had the C allele was present in benign controls (p = 0.027, OR = 1.983). Additionally, the C allele was associated with cancer differentiation (p<0.05) and the depth of myometrial invasion (p<0.05). Conclusion: Our study indicates that SNP (rs2297508) of SREBF-1 may serve as a genetic predisposition factor for the development of EC and screening of such genetic marker may be helpful in its early detection.	[Qiu, Chun-Ping; Dongol, Samina; Jiang, Jie] Shandong Univ, Qilu Hosp, Dept Obstet & Gynecol, Jinan, Peoples R China; [Lv, Qing-Tao] Shandong Univ Tradit Chinese Med, Dept Pharmaceut Chem, Jinan, Peoples R China; [Wang, Chenguang] Thomas Jefferson Univ, Dept Canc Biol, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Wang, Chenguang] Thomas Jefferson Univ, Dept Stem Cell Biol, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Wang, Chenguang] Thomas Jefferson Univ, Dept Regenerat Med, Kimmel Canc Ctr, Philadelphia, PA 19107 USA	Shandong University; Shandong University of Traditional Chinese Medicine; Jefferson University; Jefferson University; Jefferson University	Jiang, J (corresponding author), Shandong Univ, Qilu Hosp, Dept Obstet & Gynecol, Jinan, Peoples R China.	qljiangjie@sdu.edu.cn			National Natural Science Foundation of China [81072121, 81372808, 81173614]; Science and Technology Development planning of Shandong [2011GSF12122, 2012G0021823]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Development planning of Shandong	This study was accomplished in the cardiovascular laboratory of Qi Lu Hospital of Shandong University and was supported by grants from the National Natural Science Foundation of China (81072121, 81372808 [JJ] and 81173614 [QTL]) as well as the Science and Technology Development planning of Shandong (2011GSF12122 [XZ] and 2012G0021823 [JJ]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Campa D, 2009, BREAST CANCER RES TR, V118, P565, DOI 10.1007/s10549-009-0347-8; Eberle D, 2004, DIABETES, V53, P2153, DOI 10.2337/diabetes.53.8.2153; Horton JD, 2002, BIOCHEM SOC T, V30, P1091, DOI 10.1042/bst0301091; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Huang WC, 2012, MOL CANCER RES, V10, P133, DOI 10.1158/1541-7786.MCR-11-0206; Jeon TI, 2012, TRENDS ENDOCRIN MET, V23, P65, DOI 10.1016/j.tem.2011.10.004; Kaaks R, 2002, CANCER CAUSE CONTROL, V13, P307, DOI 10.1023/A:1015270324325; Krycer JR, 2010, TRENDS ENDOCRIN MET, V21, P268, DOI 10.1016/j.tem.2010.01.001; Li WH, 2012, CELL CYCLE, V11, P2348, DOI 10.4161/cc.20811; Liu JX, 2008, DIABETES RES CLIN PR, V82, P42, DOI 10.1016/j.diabres.2008.06.017; Luu-The V, 2006, MOL ENDOCRINOL, V20, P437, DOI 10.1210/me.2005-0058; Modesitt SC, 2012, GYNECOL ONCOL, V124, P431, DOI 10.1016/j.ygyno.2011.11.013; Nagasaki S, 2009, MOL CELL ENDOCRINOL, V307, P163, DOI 10.1016/j.mce.2009.04.002; O'Mara TA, 2011, CARCINOGENESIS, V32, P331, DOI 10.1093/carcin/bgq263; Rashid A, 1997, AM J PATHOL, V150, P201; Santos CR, 2012, FEBS J, V279, P2610, DOI 10.1111/j.1742-4658.2012.08644.x; Shao W, 2012, CELL METAB, V16, P414, DOI 10.1016/j.cmet.2012.09.002; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sorosky JI, 2008, OBSTET GYNECOL, V111, P436, DOI 10.1097/AOG.0b013e318162f690; Su CK, 2011, J SURG ONCOL, V104, P755, DOI 10.1002/jso.22035; Wang PH, 2010, TAIWAN J OBSTET GYNE, V49, P1, DOI 10.1016/S1028-4559(10)60001-0; Wang Q, 2010, ACTA PHARMACOL SIN, V31, P367, DOI 10.1038/aps.2010.5; Weiss JM, 2006, AM J EPIDEMIOL, V164, P56, DOI 10.1093/aje/kwj152; Yang YA, 2003, EXP CELL RES, V282, P132, DOI 10.1016/S0014-4827(02)00023-X	26	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e90491	10.1371/journal.pone.0090491	http://dx.doi.org/10.1371/journal.pone.0090491			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614076	gold, Green Published			2022-12-27	WOS:000332839300027
J	Thein, S; Tao-Cheng, JH; Li, Y; Bayer, KU; Reese, TS; Dosemeci, A				Thein, Soe; Tao-Cheng, Jung-Hwa; Li, Yan; Bayer, K. Ulrich; Reese, Thomas S.; Dosemeci, Ayse			CaMKII Mediates Recruitment and Activation of the Deubiquitinase CYLD at the Postsynaptic Density	PLOS ONE			English	Article							PROTEIN-KINASE-II; HIPPOCAMPAL-NEURONS; PHOSPHORYLATION; UBIQUITINATION; DEGRADATION; INHIBITOR; PROTEASOMES; STARGAZIN; MECHANISM; PROMOTES	NMDA treatment of cultured hippocampal neurons causes recruitment of CYLD, as well as CaMKII, to the postsynaptic density (PSD), as shown by immunoelectron microscopy. Recruitment of CYLD, a deubiquitinase specific for K63-linked polyubiquitins, is blocked by pre-treatment with tatCN21, a CaMKII inhibitor, at a concentration that inhibits the translocation of CaMKII to the PSD. Furthermore, CaMKII co-immunoprecipitates with CYLD from solubilized PSD fractions, indicating an association between the proteins. Purified CaMKII phosphorylates CYLD on at least three residues (S-362, S-418, and S-772 on the human CYLD protein Q9NQC7-1) and promotes its deubiquitinase activity. Activation of CaMKII in isolated PSDs promotes phosphorylation of CYLD on the same residues and also enhances endogenous deubiquitinase activity specific for K63-linked polyubiquitins. Since K63-linked polyubiquitin conjugation to proteins inhibits their interaction with proteasomes, CaMKII-mediated recruitment and upregulation of CYLD is expected to remove K63-linked polyubiquitins and facilitate proteasomal degradation at the PSD.	[Thein, Soe; Reese, Thomas S.; Dosemeci, Ayse] NINDS, Neurobiol Lab, NIH, Bethesda, MD 20892 USA; [Tao-Cheng, Jung-Hwa] NINDS, EM Facil, Bethesda, MD 20892 USA; [Li, Yan] NINDS, Prot Peptide Sequencing Facil, Bethesda, MD 20892 USA; [Bayer, K. Ulrich] Univ Colorado Denver, Sch Med, Dept Pharmacol, Aurora, CO USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Thein, S (corresponding author), NINDS, Neurobiol Lab, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	theinsh@mail.nih.gov; dosemeca@mail.nih.gov			Intramural Research Program NINDS, National Institutes of Health (NIH); NIH [R01 NS081248]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003113, R01NS081248] Funding Source: NIH RePORTER	Intramural Research Program NINDS, National Institutes of Health (NIH); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by the Intramural Research Program NINDS, National Institutes of Health (NIH) and NIH grant R01 NS081248 (to KUB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Bhat RV, 2000, P NATL ACAD SCI USA, V97, P11074, DOI 10.1073/pnas.190297597; Bingol B, 2010, CELL, V140, P567, DOI 10.1016/j.cell.2010.01.024; Buard I, 2010, J NEUROSCI, V30, P8214, DOI 10.1523/JNEUROSCI.1469-10.2010; Chang BH, 1998, P NATL ACAD SCI USA, V95, P10890, DOI 10.1073/pnas.95.18.10890; Colledge M, 2003, NEURON, V40, P595, DOI 10.1016/S0896-6273(03)00687-1; Coultrap SJ, 2012, TRENDS NEUROSCI, V35, P607, DOI 10.1016/j.tins.2012.05.003; Djakovic SN, 2009, J BIOL CHEM, V284, P26655, DOI 10.1074/jbc.M109.021956; Dosemeci A, 2000, J NEUROSCI, V20, P3076, DOI 10.1523/JNEUROSCI.20-09-03076.2000; Dosemeci A, 2002, J NEUROCYTOL, V31, P605, DOI 10.1023/A:1025735410738; Dosemeci A, 2007, MOL CELL PROTEOMICS, V6, P1749, DOI 10.1074/mcp.M700040-MCP200; Dosemeci A, 2013, BIOCHEM BIOPH RES CO, V430, P245, DOI 10.1016/j.bbrc.2012.10.131; Duncan LM, 2006, EMBO J, V25, P1635, DOI 10.1038/sj.emboj.7601056; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Hung AY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009842; Hutti JE, 2009, MOL CELL, V34, P461, DOI 10.1016/j.molcel.2009.04.031; Kato A, 2005, P NATL ACAD SCI USA, V102, P5600, DOI 10.1073/pnas.0501769102; Kristensen AS, 2011, NAT NEUROSCI, V14, P727, DOI 10.1038/nn.2804; Lu ZM, 1998, MOL CELL NEUROSCI, V12, P363, DOI 10.1006/mcne.1998.0723; Massoumi R, 2010, TRENDS BIOCHEM SCI, V35, P392, DOI 10.1016/j.tibs.2010.02.007; Nathan JA, 2013, EMBO J, V32, P552, DOI 10.1038/emboj.2012.354; Oh JS, 2004, J BIOL CHEM, V279, P17980, DOI 10.1074/jbc.M314109200; Opazo P, 2010, NEURON, V67, P239, DOI 10.1016/j.neuron.2010.06.007; Reiley W, 2005, MOL CELL BIOL, V25, P3886, DOI 10.1128/MCB.25.10.3886-3895.2005; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Tan JMM, 2008, HUM MOL GENET, V17, P431, DOI 10.1093/hmg/ddm320; Tao-Cheng JH, 2013, NEUROSCIENCE, V244, P188, DOI 10.1016/j.neuroscience.2013.03.063; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Tomita S, 2005, NEURON, V45, P269, DOI 10.1016/j.neuron.2005.01.009; Vest RS, 2007, MOL BIOL CELL, V18, P5024, DOI 10.1091/mbc.E07-02-0185; Yang Y, 2011, NEUROSCIENCE, V192, P132, DOI 10.1016/j.neuroscience.2011.06.061; Yang YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071795	32	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91312	10.1371/journal.pone.0091312	http://dx.doi.org/10.1371/journal.pone.0091312			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614225	Green Submitted, gold, Green Published			2022-12-27	WOS:000332839300111
J	Chang, LC; Jamain, S; Lin, CW; Rujescu, D; Tseng, GC; Sibille, E				Chang, Lun-Ching; Jamain, Stephane; Lin, Chien-Wei; Rujescu, Dan; Tseng, George C.; Sibille, Etienne			A Conserved BDNF, Glutamate- and GABA-Enriched Gene Module Related to Human Depression Identified by Coexpression Meta-Analysis and DNA Variant Genome-Wide Association Studies	PLOS ONE			English	Article							CONVERGENT FUNCTIONAL GENOMICS; MAJOR DEPRESSION; PREFRONTAL CORTEX; MOOD DISORDERS; DISEASE; EPIDEMIOLOGY; EXPRESSION; MECHANISMS; BIOMARKERS; NETWORKS	Large scale gene expression (transcriptome) analysis and genome-wide association studies (GWAS) for single nucleotide polymorphisms have generated a considerable amount of gene-and disease-related information, but heterogeneity and various sources of noise have limited the discovery of disease mechanisms. As systematic dataset integration is becoming essential, we developed methods and performed meta-clustering of gene coexpression links in 11 transcriptome studies from postmortem brains of human subjects with major depressive disorder (MDD) and non-psychiatric control subjects. We next sought enrichment in the top 50 meta-analyzed coexpression modules for genes otherwise identified by GWAS for various sets of disorders. One coexpression module of 88 genes was consistently and significantly associated with GWAS for MDD, other neuropsychiatric disorders and brain functions, and for medical illnesses with elevated clinical risk of depression, but not for other diseases. In support of the superior discriminative power of this novel approach, we observed no significant enrichment for GWAS-related genes in coexpression modules extracted from single studies or in meta-modules using gene expression data from non-psychiatric control subjects. Genes in the identified module encode proteins implicated in neuronal signaling and structure, including glutamate metabotropic receptors (GRM1, GRM7), GABA receptors (GABRA2, GABRA4), and neurotrophic and development-related proteins [BDNF, reelin (RELN), Ephrin receptors (EPHA3, EPHA5)]. These results are consistent with the current understanding of molecular mechanisms of MDD and provide a set of putative interacting molecular partners, potentially reflecting components of a functional module across cells and biological pathways that are synchronously recruited in MDD, other brain disorders and MDD-related illnesses. Collectively, this study demonstrates the importance of integrating transcriptome data, gene coexpression modules and GWAS results for providing novel and complementary approaches to investigate the molecular pathology of MDD and other complex brain disorders.	[Chang, Lun-Ching; Lin, Chien-Wei; Tseng, George C.] Univ Pittsburgh, Dept Biostat, Pittsburgh, PA 15261 USA; [Jamain, Stephane] Hop Henri Mondor, INSERM, U955, F-94010 Creteil, France; [Jamain, Stephane] Univ Paris Est, Creteil, France; [Jamain, Stephane] Fdn FondaMental, Creteil, France; [Rujescu, Dan] Univ Halle, Dept Psychiat, Halle, Germany; [Tseng, George C.] Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA USA; [Sibille, Etienne] Univ Pittsburgh, Dept Psychiat, Ctr Neurosci, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Martin Luther University Halle Wittenberg; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Tseng, GC (corresponding author), Univ Pittsburgh, Dept Biostat, Pittsburgh, PA 15261 USA.	ctseng@pitt.edu; sibilleel@upmc.edu	Jamain, Stéphane/P-3710-2017; Lin, Chien-Wei/AAC-1918-2021; Rujescu, Dan/GRS-3875-2022; Jamain, Stéphane/L-1822-2019	Jamain, Stéphane/0000-0002-4321-4100; Lin, Chien-Wei/0000-0003-4023-7339; 	National Institute of Mental Health (NIMH) [MH084060, MH085111]; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH085111, K02MH084060] Funding Source: NIH RePORTER	National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institute of Mental Health (NIMH) MH084060 (ES) and MH085111 (ES). The funding agency had no role in the study design, data collection and analysis, decision to publish and preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIMH or the National Institutes of Health.	Belmaker RH, 2008, NEW ENGL J MED, V358, P55, DOI [10.1056/NEJMra073096, 10.1038/nrdp.2016.65]; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bolstad B, 2005, BIOINFORMATICS COMPU; Choudary PV, 2005, P NATL ACAD SCI USA, V102, P15653, DOI 10.1073/pnas.0507901102; Cristino A.S., 2013, MOL PSYCHIAT; Dobrin R, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r55; Duman RS, 2006, BIOL PSYCHIAT, V59, P1116, DOI 10.1016/j.biopsych.2006.02.013; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Elo LL, 2007, BIOINFORMATICS, V23, P2096, DOI 10.1093/bioinformatics/btm309; Gaiteri C, 2013, UNPUB; Gaiteri C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009970; Guilloux JP, 2012, MOL PSYCHIATR, V17, P1130, DOI 10.1038/mp.2011.113; Hasin DS, 2005, ARCH GEN PSYCHIAT, V62, P1097, DOI 10.1001/archpsyc.62.10.1097; Hek K, 2013, BIOL PSYCHIAT; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; HUBERT L, 1985, J CLASSIF, V2, P193, DOI 10.1007/BF01908075; Klempan TA, 2009, MOL PSYCHIATR, V14, P175, DOI 10.1038/sj.mp.4002110; Kupfer DJ, 2011, ANN NY ACAD SCI, V1242, P1, DOI 10.1111/j.1749-6632.2011.06336.x; Le-Niculescu H, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.9; Le-Niculescu H, 2009, MOL PSYCHIATR, V14, P156, DOI 10.1038/mp.2008.11; Lee HK, 2004, GENOME RES, V14, P1085, DOI 10.1101/gr.1910904; Lewis CM, 2010, AM J PSYCHIAT, V167, P949, DOI 10.1176/appi.ajp.2010.09091380; Luscher B, 2011, MOL PSYCHIATR, V16, P383, DOI 10.1038/mp.2010.120; MDD GWAS consortium, 2012, MOL PSYCHIAT; Mueller TI, 1999, AM J PSYCHIAT, V156, P1000; Muglia P, 2010, MOL PSYCHIATR, V15, P589, DOI 10.1038/mp.2008.131; Musselman DL, 1998, ARCH GEN PSYCHIAT, V55, P580, DOI 10.1001/archpsyc.55.7.580; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; Niculescu AB, 2013, AM J MED GENET B; Pan A, 2012, DIABETES CARE, V35, P1171, DOI 10.2337/dc11-2055; Rajkowska G, 2007, NEUROPSYCHOPHARMACOL, V32, P471, DOI 10.1038/sj.npp.1301234; Rietschel M, 2010, BIOL PSYCHIAT, V68, P578, DOI 10.1016/j.biopsych.2010.05.038; Ripke S, 2013, NAT GENET, V45, P1150, DOI 10.1038/ng.2742; Sequeira A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006585; Shi J, 2011, MOL PSYCHIATR, V16, P193, DOI 10.1038/mp.2009.124; Shyn SI, 2011, MOL PSYCHIATR, V16, P202, DOI 10.1038/mp.2009.125; Sibille E, 2004, NEUROPSYCHOPHARMACOL, V29, P351, DOI 10.1038/sj.npp.1300335; Sibille E, 2013, INT J NEUROPSYCHOPH, V16, P1893, DOI 10.1017/S1461145713000436; Sklar P, 2011, NAT GENET, V43, P977, DOI 10.1038/ng.943; STOUFFER S A, 1949, Sci Am, V180, P11; Sullivan PF, 2000, AM J PSYCHIAT, V157, P1552, DOI 10.1176/appi.ajp.157.10.1552; Thalamuthu A, 2006, BIOINFORMATICS, V22, P2405, DOI 10.1093/bioinformatics/btl406; Tripp A, 2012, AM J PSYCHIAT, V169, P1194, DOI 10.1176/appi.ajp.2012.12020248; Tseng GC, 2007, BIOINFORMATICS, V23, P2247, DOI 10.1093/bioinformatics/btm320; van den Oord EJCG, 2008, ARCH GEN PSYCHIAT, V65, P1062, DOI 10.1001/archpsyc.65.9.1062; Wang XB, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-52; WEISSMAN MM, 1993, J AFFECT DISORDERS, V29, P77, DOI 10.1016/0165-0327(93)90025-F; Wray NR, 2012, MOL PSYCHIATR, V17, P36, DOI 10.1038/mp.2010.109	48	59	62	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90980	10.1371/journal.pone.0090980	http://dx.doi.org/10.1371/journal.pone.0090980			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608543	Green Published, gold, Green Accepted			2022-12-27	WOS:000332485800072
J	Jacobs, GB; Wilkinson, E; Isaacs, S; Spies, G; de Oliveira, T; Seedat, S; Engelbrecht, S				Jacobs, Graeme Brendon; Wilkinson, Eduan; Isaacs, Shahieda; Spies, Georgina; de Oliveira, Tulio; Seedat, Soraya; Engelbrecht, Susan			HIV-1 Subtypes B and C Unique Recombinant Forms (URFs) and Transmitted Drug Resistance Identified in the Western Cape Province, South Africa	PLOS ONE			English	Article							FULL-LENGTH CLONES; PHYLOGENETIC ANALYSIS; MOLECULAR CHARACTERIZATION; MAXIMUM-LIKELIHOOD; SEQUENCE-ANALYSIS; TYPE-1; TOWN; DIVERSITY; RELIABILITY; GENOME	South Africa has the largest worldwide HIV/AIDS population with 5.6 million people infected and at least 2 million people on antiretroviral therapy. The majority of these infections are caused by HIV-1 subtype C. Using genotyping methods we characterized HIV-1 subtypes of the gag p24 and pol PR and RT fragments, from a cohort of female participants in the Western Cape Province, South Africa. These participants were recruited as part of a study to assess the combined brain and behavioural effects of HIV and early childhood trauma. The partial HIV-1 gag and pol fragments of 84 participants were amplified by PCR and sequenced. Different online tools and manual phylogenetic analysis were used for HIV-1 subtyping. Online tools included: REGA HIV Subtyping tool version 3; Recombinant Identification Program (RIP); Context-based Modeling for Expeditious Typing (COMET); jumping profile Hidden Markov Models (jpHMM) webserver; and subtype classification using evolutionary algorithms (SCUEAL). HIV-1 subtype C predominates within the cohort with a prevalence of 93.8%. We also show, for the first time, the presence of circulating BC strains in at least 4.6% of our study cohort. In addition, we detected transmitted resistance associated mutations in 4.6% of analysed sequences. With tourism and migration rates to South Africa currently very high, we are detecting more and more HIV-1 URFs within our study populations. It is stil unclear what role these unique strains will play in terms of long term antiretroviral treatment and what challenges they will pose to vaccine development. Nevertheless, it remains vitally important to monitor the HIV-1 diversity in South Africa and worldwide as the face of the epidemic is continually changing.	[Jacobs, Graeme Brendon; Wilkinson, Eduan; Isaacs, Shahieda; Engelbrecht, Susan] Univ Stellenbosch, Div Med Virol, ZA-7505 Tygerberg, South Africa; [Wilkinson, Eduan; de Oliveira, Tulio] Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Mtubatuba, South Africa; [Spies, Georgina; Seedat, Soraya] Univ Stellenbosch, Dept Psychiat, ZA-7505 Tygerberg, South Africa; [Engelbrecht, Susan] NHLS, Tygerberg Coastal, South Africa	Stellenbosch University; University of Kwazulu Natal; Stellenbosch University	Engelbrecht, S (corresponding author), Univ Stellenbosch, Div Med Virol, ZA-7505 Tygerberg, South Africa.	susanen@sun.ac.za	Engelbrecht, Susan/G-7286-2011	Engelbrecht, Susan/0000-0002-1318-5994; Seedat, Soraya/0000-0002-5118-786X; Jacobs, Graeme/0000-0002-3259-1496	Poliomyelitis Research Foundation (PRF); Medical Research Council (MRC); National Research Foundation (NRF) of South Africa	Poliomyelitis Research Foundation (PRF); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Research Foundation (NRF) of South Africa(National Research Foundation - South Africa)	This study was funded by Poliomyelitis Research Foundation (PRF), the Medical Research Council (MRC) and the National Research Foundation (NRF) of South Africa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bredell H, 2002, AIDS RES HUM RETROV, V18, P681, DOI 10.1089/088922202760019400; Bulla I, 2012, STAT APPL GENET MOL, V11, DOI 10.2202/1544-6115.1680; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; de Oliveira T, 2010, NATURE, V464, P673, DOI 10.1038/464673c; ENGELBRECHT S, 1995, AIDS RES HUM RETROV, V11, P1269, DOI 10.1089/aid.1995.11.1269; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Holguin A, 2008, J CLIN MICROBIOL, V46, P3896, DOI 10.1128/JCM.00515-08; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Iweriebor BC, 2011, AIDS RES HUM RETROV, V27, P911, DOI [10.1089/aid.2010.0286, 10.1089/AID.2010.0286]; Jacobs GB, 2006, J MED VIROL, V78, P1529, DOI 10.1002/jmv.20735; Jacobs GB, 2009, J MED VIROL, V81, P1852, DOI 10.1002/jmv.21609; Jacobs GB, 2008, AIDS RES HUM RETROV, V24, P1009, DOI 10.1089/aid.2008.0028; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lessells RJ, 2012, CURR OPIN VIROL, V2, P636, DOI 10.1016/j.coviro.2012.08.006; Loxton AG, 2005, AIDS RES HUM RETROV, V21, P410, DOI 10.1089/aid.2005.21.410; National Strategic Plan for HIV and AIDS, 2011, NAT STRAT PLAN HIV A; Novitsky VA, 1999, J VIROL, V73, P4427, DOI 10.1128/JVI.73.5.4427-4432.1999; Ntemgwa M, 2008, AIDS RES HUM RETROV, V24, P995, DOI 10.1089/aid.2008.0064; Papathanasopoulos MA, 2002, AIDS RES HUM RETROV, V18, P879, DOI 10.1089/08892220260190362; Papathanasopoulos MA, 2002, INFECT GENET EVOL, V18, P879; Pond SLK, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000581; PRESTON BD, 1988, SCIENCE, V242, P1168, DOI 10.1126/science.2460924; Rodenburg CM, 2001, AIDS RES HUM RETROV, V17, P161, DOI 10.1089/08892220150217247; Santos AF, 2006, AIDS, V20, P2011; Santos AF, 2010, VIRUSES-BASEL, V2, P503, DOI 10.3390/v2020503; Schultz AK, 2009, NUCLEIC ACIDS RES, V37, pW647, DOI 10.1093/nar/gkp371; South African Department of Health/Directorate Health Systems Research, 2012, 2011 NAT ANT SENT HI; Swanson P, 2003, AIDS RES HUM RETROV, V19, P625, DOI 10.1089/088922203322231003; UNAIDS/WHO working group on global HIV/AIDS & STD surveillance, 2012, AIDS EP UPD; van Harmelen J, 2001, AIDS RES HUM RETROV, V17, P1527, DOI 10.1089/08892220152644232; Van Harmelen JH, 1999, AIDS RES HUM RETROV, V15, P395; vanHarmelen J, 1997, AIDS, V11, P81, DOI 10.1097/00002030-199701000-00012; Wilkinson E, 2009, INFECT GENET EVOL, V9, P840, DOI 10.1016/j.meegid.2009.05.001; WILLIAMSON C, 1995, LANCET, V346, P782, DOI 10.1016/S0140-6736(95)91543-5; Zhang M, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-25	38	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90845	10.1371/journal.pone.0090845	http://dx.doi.org/10.1371/journal.pone.0090845			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24609015	gold, Green Published, Green Submitted			2022-12-27	WOS:000332485800060
J	Rowe, JM; Jeanniard, A; Gurnon, JR; Xia, YN; Dunigan, DD; Van Etten, JL; Blanc, G				Rowe, Janet M.; Jeanniard, Adrien; Gurnon, James R.; Xia, Yuannan; Dunigan, David D.; Van Etten, James L.; Blanc, Guillaume			Global Analysis of Chlorella variabilis NC64A mRNA Profiles during the Early Phase of Paramecium bursaria Chlorella Virus-1 Infection	PLOS ONE			English	Article							GREEN-ALGA; GENOME; FEATURES; SUBUNIT; REVEALS; PBCV-1; GENES	The PBCV-1/Chlorella variabilis NC64A system is a model for studies on interactions between viruses and algae. Here we present the first global analyses of algal host transcripts during the early stages of infection, prior to virus replication. During the course of the experiment stretching over 1 hour, about a third of the host genes displayed significant changes in normalized mRNA abundance that either increased or decreased compared to uninfected levels. The population of genes with significant transcriptional changes gradually increased until stabilizing at 40 minutes post infection. Functional categories including cytoplasmic ribosomal proteins, jasmonic acid biosynthesis and anaphase promoting complex/cyclosomes had a significant excess in upregulated genes, whereas spliceosomal snRNP complexes and the shikimate pathway had significantly more down-regulated genes, suggesting that these pathways were activated or shut-down in response to the virus infection. Lastly, we examined the expression of C. varibilis RNA polymerase subunits, as PBCV-1 transcription depends on host RNA polymerases. Two subunits were up-regulated, RPB10 and RPC34, suggesting that they may function to support virus transcription. These results highlight genes and pathways, as well as overall trends, for further refinement of our understanding of the changes that take place during the early stages of viral infection.	[Rowe, Janet M.; Gurnon, James R.; Dunigan, David D.; Van Etten, James L.] Univ Nebraska, Dept Plant Pathol, Lincoln, NE 68583 USA; [Rowe, Janet M.; Jeanniard, Adrien; Gurnon, James R.; Dunigan, David D.; Van Etten, James L.] Univ Nebraska, Nebraska Ctr Virol, Lincoln, NE USA; [Jeanniard, Adrien; Blanc, Guillaume] Aix Marseille Univ, CNRS, UMR7256, Lab Informat Struct & Genom, Marseille, France; [Xia, Yuannan] Univ Nebraska, Ctr Biotechnol, Lincoln, NE USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; University of Nebraska System; University of Nebraska Lincoln	Blanc, G (corresponding author), Aix Marseille Univ, CNRS, UMR7256, Lab Informat Struct & Genom, Marseille, France.	guillaume.blanc@igs.cnrs-mrs.fr	Dunigan, David/AAF-1386-2019; Blanc, Guillaume/T-6958-2017	Blanc, Guillaume/0000-0001-5728-1104; Goins, Janet/0000-0003-1139-6058; Dunigan, David D/0000-0001-9496-5396	NSF-EPSCoR [EPS-1004094]; French Ministry of Research; CNRS; PACA-Bioinfo platform; National Center for Research Resources [P20-RR15635]; National Institute of Allergy and Infectious Diseases [1T32AIO60547];  [DOE-DE-EE0003142]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103509] Funding Source: NIH RePORTER	NSF-EPSCoR(National Science Foundation (NSF)NSF - Office of the Director (OD)); French Ministry of Research(Ministry of Research, FranceEuropean Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); PACA-Bioinfo platform; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by academic funding only. This research was partially supported by NSF-EPSCoR grant EPS-1004094 (JLVE), DOE-DE-EE0003142 (JLVE), French Ministry of Research, CNRS, PACA-Bioinfo platform, and grant P20-RR15635 from the COBRE program of the National Center for Research Resources. JR was supported by a Ruth L. Kirschstein National Research Service Award 1T32AIO60547 from the National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarkova I, 2008, J VIROL, V82, P12181, DOI 10.1128/JVI.01687-08; Agarkova IV, 2006, J VIROL, V80, P8114, DOI 10.1128/JVI.00486-06; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bidle KD, 2007, P NATL ACAD SCI USA, V104, P6049, DOI 10.1073/pnas.0701240104; Blanc G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090989; Blanc G, 2010, PLANT CELL, V22, P2943, DOI 10.1105/tpc.110.076406; Brennan L, 2010, RENEW SUST ENERG REV, V14, P557, DOI 10.1016/j.rser.2009.10.009; Brun I, 1997, EMBO J, V16, P5730, DOI 10.1093/emboj/16.18.5730; Brussaard C.P.D., 2008, PLANT VIRUSES, V2, P1, DOI DOI 10.1016/J.VIROL.2003.10.033; Cerutti H, 2011, EUKARYOT CELL, V10, P1164, DOI 10.1128/EC.05106-11; Christov C, 2001, BIOL PLANTARUM, V44, P367, DOI 10.1023/A:1012490610127; Dillies MA, 2012, BRIEF BIOINFORM; Dunigan DD, 2012, J VIROL, V86, P8821, DOI 10.1128/JVI.00907-12; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Gao ZQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042243; Iyer LA, 2006, VIRUS RES, V117, P156, DOI 10.1016/j.virusres.2006.01.009; Iyer LM, 2001, J VIROL, V75, P11720, DOI 10.1128/JVI.75.23.11720-11734.2001; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; KARAKASHIAN SJ, 1965, EVOLUTION, V19, P368, DOI 10.2307/2406447; Kawasaki T, 2001, Nucleic Acids Res Suppl, P67; Kombrink E, 2012, PLANTA, V236, P1351, DOI 10.1007/s00425-012-1705-z; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Mackinder LCM, 2009, J GEN VIROL, V90, P2306, DOI 10.1099/vir.0.011635-0; Manzur KL, 2003, NAT STRUCT BIOL, V10, P187, DOI 10.1038/nsb898; Mo M, 2012, TRENDS MICROBIOL, V20, P440, DOI 10.1016/j.tim.2012.05.007; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Mujtaba S, 2008, NAT CELL BIOL, V10, P1114, DOI 10.1038/ncb1772; Nagasaki K, 2010, MANUAL AQUATIC VIRAL, V10; Nagasaki K, 2008, J MICROBIOL, V46, P235, DOI 10.1007/s12275-008-0098-y; Pagarete A, 2011, FEMS MICROBIOL ECOL, V78, P555, DOI 10.1111/j.1574-6941.2011.01191.x; Piotrowska-Niczyporuk A, 2012, PLANT PHYSIOL BIOCH, V52, P52, DOI 10.1016/j.plaphy.2011.11.009; Rowe JM, 2013, VIROLOGY, V442, P101, DOI 10.1016/j.virol.2013.04.018; SKRDLA MP, 1984, VIROLOGY, V135, P308, DOI 10.1016/0042-6822(84)90188-0; Thiel G, 2010, PROG BOT, V71, P169, DOI 10.1007/978-3-642-02167-1_7; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Van Etten JL, 2012, TRENDS PLANT SCI, V17, P1, DOI 10.1016/j.tplants.2011.10.005; VANETTEN JL, 1983, SCIENCE, V219, P994, DOI 10.1126/science.219.4587.994; Wilson WH, 2009, CURR TOP MICROBIOL, V328, P1; Wilson WH, 2005, SCIENCE, V309, P1090, DOI 10.1126/science.1113109; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; WOYCHIK NA, 1990, J BIOL CHEM, V265, P17816; Yamada T, 2006, ADV VIRUS RES, V66, P293, DOI 10.1016/S0065-3527(06)66006-5; Yutin N, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-223; Zhang XZ, 2011, P NATL ACAD SCI USA, V108, P14837, DOI 10.1073/pnas.1107847108	44	11	13	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90988	10.1371/journal.pone.0090988	http://dx.doi.org/10.1371/journal.pone.0090988			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608695	Green Published, Green Submitted, gold			2022-12-27	WOS:000332485800074
J	Araujo, EB; Moreira, AA; Furtado, V; Pequeno, THC; Andrade, JS				Araujo, Eduardo B.; Moreira, Andre A.; Furtado, Vasco; Pequeno, Tarcisio H. C.; Andrade, Jose S., Jr.			Collaboration Networks from a Large CV Database: Dynamics, Topology and Bonus Impact	PLOS ONE			English	Article							WEIGHTED NETWORKS; COMPLEX; PROXIMITY; EVOLUTION; GROWTH	Understanding the dynamics of research production and collaboration may reveal better strategies for scientific careers, academic institutions, and funding agencies. Here we propose the use of a large and multidisciplinary database of scientific curricula in Brazil, namely, the Lattes Platform, to study patterns of scientific production and collaboration. Detailed information about publications and researchers is available in this database. Individual curricula are submitted by the researchers themselves so that coauthorship is unambiguous. Researchers can be evaluated by scientific productivity, geographical location and field of expertise. Our results show that the collaboration network is growing exponentially for the last three decades, with a distribution of number of collaborators per researcher that approaches a power-law as the network gets older. Moreover, both the distributions of number of collaborators and production per researcher obey power-law behaviors, regardless of the geographical location or field, suggesting that the same universal mechanism might be responsible for network growth and productivity. We also show that the collaboration network under investigation displays a typical assortative mixing behavior, where teeming researchers (i.e., with high degree) tend to collaborate with others alike.	[Araujo, Eduardo B.; Moreira, Andre A.; Andrade, Jose S., Jr.] Univ Fed Ceara, Dept Fis, Fortaleza, Ceara, Brazil; [Furtado, Vasco; Pequeno, Tarcisio H. C.] Univ Fortaleza, Nucleo Aplicacao Tecnol Informacao, Fortaleza, Ceara, Brazil	Universidade Federal do Ceara; Universidade Fortaleza	Araujo, EB (corresponding author), Univ Fed Ceara, Dept Fis, Fortaleza, Ceara, Brazil.	eduardo.araujo@fisica.ufc.br	Araújo, Eduardo B/P-4044-2014; Moreira, Andre Auto A/C-5290-2013; Furtado, Vasco/C-3748-2013; Furtado, Vasco/AAB-8318-2019; Andrade, José S/C-5451-2013	Araújo, Eduardo B/0000-0003-0807-3178; Moreira, Andre Auto A/0000-0003-1046-5218; Furtado, Vasco/0000-0001-8721-4308; Furtado, Vasco/0000-0001-8721-4308; Andrade, José S/0000-0002-5571-7610	CNPq; CAPES; FUNCAP; FUNCAP/CNPq Pronex grant; National Institute of Science and Technology for Complex Systems in Brazil	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FUNCAP(Fundacao Cearense de Apoio ao Desenvolvimento Cientifico e Tecnologico (FUNCAP)); FUNCAP/CNPq Pronex grant; National Institute of Science and Technology for Complex Systems in Brazil	Project funded by the Brazilian Agencies CNPq (www.cnpq.br), CAPES (www.capes.gov.br), FUNCAP (www.funcap.ce.gov.br), the FUNCAP/CNPq Pronex grant, and the National Institute of Science and Technology for Complex Systems in Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; ALLISON PD, 1980, SOC STUD SCI, V10, P163, DOI 10.1177/030631278001000203; Barabasi AL, 2002, PHYSICA A, V311, P590, DOI 10.1016/S0378-4371(02)00736-7; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Barrat A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066149; Beaver D. deB., 1978, Scientometrics, V1, P65, DOI 10.1007/BF02016840; Bettencourt LMA, 2007, P NATL ACAD SCI USA, V104, P7301, DOI 10.1073/pnas.0610172104; Bozeman B, 2004, RES POLICY, V33, P599, DOI 10.1016/j.respol.2004.01.008; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Dorogovtsev SN, 2002, ARXIVCONDMAT0204102C; FOX MF, 1984, J HIGH EDUC, V55, P347, DOI 10.2307/1981888; FRAME JD, 1979, SOC STUD SCI, V9, P481; Gallos LK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066443; Galvao V, 2010, P NATL ACAD SCI USA, V107, P5750, DOI 10.1073/pnas.0914748107; Goh KI, 2002, P NATL ACAD SCI USA, V99, P12583, DOI 10.1073/pnas.202301299; Hagstrom WO, 1964, SCI COMMUNITY; HEFFNER AG, 1981, SCIENTOMETRICS, V3, P5, DOI 10.1007/BF02021860; KATZ JS, 1994, SCIENTOMETRICS, V31, P31, DOI 10.1007/BF02018100; Katz JS, 1997, RES POLICY, V26, P1, DOI 10.1016/S0048-7333(96)00917-1; Katz JS, 1999, RES POLICY, V28, P501, DOI 10.1016/S0048-7333(99)00010-4; Kraut R., 1988, PATTERNS CONTACT COM; Laudel G, 2002, RES EVALUAT, V11, P3, DOI 10.3152/147154402781776961; LAWANI SM, 1986, SCIENTOMETRICS, V9, P13, DOI 10.1007/BF02016604; Lee S, 2005, SOC STUD SCI, V35, P673, DOI 10.1177/0306312705052359; Li MH, 2005, PHYSICA A, V350, P643, DOI 10.1016/j.physa.2004.11.039; Lind PG, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.036117; Lotka A.J., 1926, J WASH ACAD SCI, V16, P317, DOI DOI 10.1002/ASI.4630280610; LOWRANCE R, 1975, J ACM, V22, P177, DOI 10.1145/321879.321880; Moreira AA, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.065101; Moreira AA, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.018701; Muchnik L, 2013, SCI REP-UK, V3, DOI 10.1038/srep01783; Newman MEJ, 2004, P NATL ACAD SCI USA, V101, P5200, DOI 10.1073/pnas.0307545100; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Newman MEJ, 2002, PHYS REV E, V64; Newman MEJ, 2002, PHYS REV E, V64; NICHOLLS PT, 1986, INFORM PROCESS MANAG, V22, P417, DOI 10.1016/0306-4573(86)90076-2; ONEILL ET, 1993, LIBR RESOUR TECH SER, V37, P59; Pan RK, 2012, SCI REP-UK, V2, DOI 10.1038/srep00902; PAO ML, 1986, J AM SOC INFORM SCI, V37, P26, DOI 10.1002/asi.4630370105; Pareto, 1897, COURS EC POLITIQUE; Pond R, 2007, PAP REG SCI, V86, P423, DOI 10.1111/j.1435-5957.2007.00126.x; PRICE DJD, 1966, AM PSYCHOL, V21, P1011; Ravasz E, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026112; Schlapfer M, 2013, ARXIV12105215V2PHYSI; Schneider CM, 2011, P NATL ACAD SCI USA, V108, P3838, DOI 10.1073/pnas.1009440108; Tang L, 2010, SCIENTOMETRICS, V84, P763, DOI 10.1007/s11192-010-0196-6; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Zhang J, 2012, ARXIV12124914PHYSICS; Zhou T, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.046115	51	14	14	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90537	10.1371/journal.pone.0090537	http://dx.doi.org/10.1371/journal.pone.0090537			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC4ID	24603470	gold, Green Published, Green Submitted			2022-12-27	WOS:000332483600062
J	Kolmus, K; Van Troys, M; Van Wesemael, K; Ampe, C; Haegeman, G; Tavernier, J; Gerlo, S				Kolmus, Krzysztof; Van Troys, Marleen; Van Wesemael, Karlien; Ampe, Christophe; Haegeman, Guy; Tavernier, Jan; Gerlo, Sarah			beta-Agonists Selectively Modulate Proinflammatory Gene Expression in Skeletal Muscle Cells via Non-Canonical Nuclear Crosstalk Mechanisms	PLOS ONE			English	Article							NF-KAPPA-B; HISTONE H3 PHOSPHORYLATION; NECROSIS-FACTOR-ALPHA; BINDING PROTEIN CREB; TNF-ALPHA; TRANSCRIPTIONAL ACTIVITY; IL-6 EXPRESSION; CAMP; ACETYLATION; ACTIVATION	The proinflammatory cytokine Tumour Necrosis Factor (TNF)-alpha is implicated in a variety of skeletal muscle pathologies. Here, we have investigated how in vitro cotreatment of skeletal muscle C2C12 cells with b-agonists modulates the TNF-alpha-induced inflammatory program. We observed that C2C12 myotubes express functional TNF receptor 1 (TNF-R1) and beta 2 adrenoreceptors (beta 2-ARs). TNF-alpha activated the canonical Nuclear Factor-kappa B (NF-kappa B) pathway and Mitogen-Activated Protein Kinases (MAPKs), culminating in potent induction of NF-kappa B-dependent proinflammatory genes. Cotreatment with the beta-agonist isoproterenol potentiated the expression of inflammatory mediators, including Interleukin-6 (IL-6) and several chemokines. The enhanced production of chemotactic factors upon TNF-alpha/isoproterenol cotreatment was also suggested by the results from migrational analysis. Whereas we could not explain our observations by cytoplasmic crosstalk, we found that TNF-R1-and beta 2-AR-induced signalling cascades cooperate in the nucleus. Using the IL-6 promoter as a model, we demonstrated that TNF-alpha/isoproterenol cotreatment provoked phosphorylation of histone H3 at serine 10, concomitant with enhanced promoter accessibility and recruitment of the NF-kappa B p65 subunit, cAMP-response element-binding protein (CREB), CREB-binding protein (CBP) and RNA polymerase II. In summary, we show that b-agonists potentiate TNF-alpha action, via nuclear crosstalk, that promotes chromatin relaxation at selected gene promoters. Our data warrant further study into the mode of action of beta-agonists and urge for caution in their use as therapeutic agents for muscular disorders.	[Kolmus, Krzysztof; Tavernier, Jan; Gerlo, Sarah] Univ Ghent VIB, Dept Med Prot Res, B-9052 Ghent, Belgium; [Kolmus, Krzysztof; Van Troys, Marleen; Ampe, Christophe; Tavernier, Jan; Gerlo, Sarah] Univ Ghent, Fac Med & Hlth Sci, Dept Biochem, B-9000 Ghent, Belgium; [Van Wesemael, Karlien; Haegeman, Guy] Univ Ghent, Fac Sci, Dept Physiol, B-9000 Ghent, Belgium	Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Ghent University	Gerlo, S (corresponding author), Univ Ghent VIB, Dept Med Prot Res, B-9052 Ghent, Belgium.	Sarah.Gerlo@vib-ugent.be	Tavernier, Jan/AAG-3636-2019	Christophe, Ampe/0000-0002-8554-3594; Van Troys, Marleen/0000-0003-4283-8103	Fund For Scientific Research Flanders (FWO) [KaN1.5.223.13N]; GROUP-ID Ghent University Multidisciplinary Research Platform	Fund For Scientific Research Flanders (FWO)(FWO); GROUP-ID Ghent University Multidisciplinary Research Platform	This work is supported by the Fund For Scientific Research Flanders (FWO)(KaN1.5.223.13N, a postdoctoral fellowship to SG and a doctoral fellowship to KK). In addition this work is funded by the GROUP-ID Ghent University Multidisciplinary Research Platform. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avni D, 2010, MOL IMMUNOL, V47, P1396, DOI 10.1016/j.molimm.2010.02.015; Baouz S, 2005, INT IMMUNOL, V17, P1473, DOI 10.1093/intimm/dxh325; Bhatnagar S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013262; BLAU HM, 1983, CELL, V32, P1171, DOI 10.1016/0092-8674(83)90300-8; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; Cha-Molstad H, 2004, P NATL ACAD SCI USA, V101, P13572, DOI 10.1073/pnas.0405587101; Chen LF, 2002, EMBO J, V21, P6539, DOI 10.1093/emboj/cdf660; Cheung P, 2000, MOL CELL, V5, P905, DOI 10.1016/S1097-2765(00)80256-7; Clayton AL, 2003, FEBS LETT, V546, P51, DOI 10.1016/S0014-5793(03)00451-4; Corti S, 2001, EXP CELL RES, V268, P36, DOI 10.1006/excr.2001.5267; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; De Paepe B, 2007, ANN NY ACAD SCI, V1109, P441, DOI 10.1196/annals.1398.050; Dempsey PW, 2003, CYTOKINE GROWTH F R, V14, P193, DOI 10.1016/S1359-6101(03)00021-2; Drobic B, 2010, NUCLEIC ACIDS RES, V38, P3196, DOI 10.1093/nar/gkq030; Farmer P, 2000, AM J PHYSIOL-LUNG C, V279, pL675, DOI 10.1152/ajplung.2000.279.4.L675; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; Frost RA, 2004, AM J PHYSIOL-ENDOC M, V286, pE809, DOI 10.1152/ajpendo.00560.2003; Gavrilyuk V, 2002, J BIOL CHEM, V277, P29662, DOI 10.1074/jbc.M203256200; Guttridge DC, 1999, MOL CELL BIOL, V19, P5785; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Hinkle RT, 2002, MUSCLE NERVE, V25, P729, DOI 10.1002/mus.10092; Holmqvist PH, 2013, TRANSCR-AUSTIN, V4, P18, DOI 10.4161/trns.22601; Kaur M, 2008, AM J PHYSIOL-LUNG C, V295, pL505, DOI 10.1152/ajplung.00046.2008; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Leung TH, 2004, CELL, V118, P453, DOI 10.1016/j.cell.2004.08.007; Li YP, 2001, CURR OPIN RHEUMATOL, V13, P483, DOI 10.1097/00002281-200111000-00005; Lu Q, 2003, J BIOL CHEM, V278, P15727, DOI 10.1074/jbc.M300546200; Lynch GS, 2008, PHYSIOL REV, V88, P729, DOI 10.1152/physrev.00028.2007; Mayr BM, 2001, P NATL ACAD SCI USA, V98, P10936, DOI 10.1073/pnas.191152098; McManus KJ, 2001, BIOCHEM CELL BIOL, V79, P253, DOI 10.1139/bcb-79-3-253; Monroy MA, 2001, J BIOL CHEM, V276, P40721, DOI 10.1074/jbc.M103615200; Mourkioti F, 2008, J MOL MED, V86, P747, DOI 10.1007/s00109-008-0308-4; Nedachi T, 2009, AM J PHYSIOL-ENDOC M, V297, pE866, DOI 10.1152/ajpendo.00104.2009; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; Peterson JM, 2008, INT REV IMMUNOL, V27, P375, DOI 10.1080/08830180802302389; Porter JD, 2003, NEUROMUSCULAR DISORD, V13, P223, DOI 10.1016/S0960-8966(02)00242-0; Riccio A, 2006, MOL CELL, V21, P283, DOI 10.1016/j.molcel.2005.12.006; Ryall JG, 2002, AM J PHYSIOL-REG I, V283, pR1386, DOI 10.1152/ajpregu.00324.2002; Salvador LM, 2001, J BIOL CHEM, V276, P40146, DOI 10.1074/jbc.M106710200; Schreiber SL, 2002, CELL, V111, P771, DOI 10.1016/S0092-8674(02)01196-0; Serrano AL, 2008, CELL METAB, V7, P33, DOI 10.1016/j.cmet.2007.11.011; Shimada M, 2010, J BIOL CHEM, V285, P9390, DOI 10.1074/jbc.M109.057745; Siggers T, 2012, NAT IMMUNOL, V13, P95, DOI 10.1038/ni.2151; Smale ST, 2012, IMMUNOL REV, V246, P193, DOI 10.1111/j.1600-065X.2011.01091.x; Smale ST, 2011, NAT IMMUNOL, V12, P689, DOI 10.1038/ni.2070; Spooren A, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/275892; Spooren A, 2010, CELL SIGNAL, V22, P871, DOI 10.1016/j.cellsig.2010.01.018; Spurlock DM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-320; Steensberg A, 2001, AM J PHYSIOL-CELL PH, V281, pC1001; Sundar IK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031378; Terrillon S, 2004, EMBO REP, V5, P30, DOI 10.1038/sj.embor.7400052; Tie F, 2009, DEVELOPMENT, V136, P3131, DOI 10.1242/dev.037127; Vanden Berghe W, 1998, J BIOL CHEM, V273, P3285, DOI 10.1074/jbc.273.6.3285; Vermeulen L, 2003, EMBO J, V22, P1313, DOI 10.1093/emboj/cdg139; Vermeulen L, 2002, BIOCHEM PHARMACOL, V64, P963, DOI 10.1016/S0006-2952(02)01161-9; Wang YG, 2010, P NATL ACAD SCI USA, V107, P3087, DOI 10.1073/pnas.0914897107; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Warren GL, 2004, AM J PHYSIOL-CELL PH, V286, pC1031, DOI 10.1152/ajpcell.00467.2003; Wertz IE, 2008, CYTOKINE GROWTH F R, V19, P313, DOI 10.1016/j.cytogfr.2008.04.014; Witherow DS, 2004, P NATL ACAD SCI USA, V101, P8603, DOI 10.1073/pnas.0402851101; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Ye RD, 2000, AM J PHYSIOL-LUNG C, V279, pL615, DOI 10.1152/ajplung.2000.279.4.L615; Yoon JH, 2011, J PROTEOME RES, V10, P5315, DOI 10.1021/pr200573b; Zador E, 2001, MUSCLE NERVE, V24, P1058, DOI 10.1002/mus.1110; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0	65	6	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90649	10.1371/journal.pone.0090649	http://dx.doi.org/10.1371/journal.pone.0090649			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603712	gold, Green Published, Green Submitted			2022-12-27	WOS:000332483600071
J	Sengupta, N; Ghosh, S; Vasaikar, SV; Gomes, J; Basu, A				Sengupta, Nabonita; Ghosh, Sourish; Vasaikar, Suhas V.; Gomes, James; Basu, Anirban			Modulation of Neuronal Proteome Profile in Response to Japanese Encephalitis Virus Infection	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; QUANTITATIVE PROTEOMICS; SYSTEMS BIOLOGY; IDENTIFICATION; PROTEINS; RNA; CYTOSCAPE; INTERACTS; VIMENTIN; PLATFORM	In this study we have reported the in vivo proteomic changes during Japanese Encephalitis Virus (JEV) infection in combination with in vitro studies which will help in the comprehensive characterization of the modifications in the host metabolism in response to JEV infection. We performed a 2-DE based quantitative proteomic study of JEV-infected mouse brain as well as mouse neuroblastoma (Neuro2a) cells to analyze the host response to this lethal virus. 56 host proteins were found to be differentially expressed post JEV infection (defined as exhibiting >= 1.5-fold change in protein abundance upon JEV infection). Bioinformatics analyses were used to generate JEV-regulated host response networks which reported that the identified proteins were found to be associated with various cellular processes ranging from intracellular protein transport, cellular metabolism and ER stress associated unfolded protein response. JEV was found to invade the host protein folding machinery to sustain its survival and replication inside the host thereby generating a vigorous unfolded protein response, subsequently triggering a number of pathways responsible for the JEV associated pathologies. The results were also validated using a human cell line to correlate them to the human response to JEV. The present investigation is the first report on JEV-host interactome in in vivo model and will be of potential interest for future antiviral research in this field.	[Sengupta, Nabonita; Ghosh, Sourish; Basu, Anirban] Natl Brain Res Ctr, Manesar, Haryana, India; [Vasaikar, Suhas V.; Gomes, James] Indian Inst Technol Delhi, Kusuma Sch Biol Sci, New Delhi, India	Department of Biotechnology (DBT) India; National Brain Research Centre (NBRC); Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi	Sengupta, N (corresponding author), Natl Brain Res Ctr, Manesar, Haryana, India.	nabonita.s@gmail.com	Vasaikar, Suhas/AAJ-5885-2020; Ghosh, Sourish/AAL-7250-2021	Ghosh, Sourish/0000-0001-8438-9487; Basu, Anirban/0000-0002-5200-2054; Vasaikar, Suhas/0000-0001-9763-3899	Department of Biotechnology; Research Associateship from Indian Council of Medical Research	Department of Biotechnology; Research Associateship from Indian Council of Medical Research	This work was supported by the core grant from the Department of Biotechnology, to the National Brain Research Centre. NS is the recipient of Research Associateship from Indian Council of Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; BLACKSHEAR PJ, 1984, METHOD ENZYMOL, V104, P237; Byun K, 2012, ANAT CELL BIOL, V45, P47, DOI 10.5115/acb.2012.45.1.47; Chiou CT, 2003, J GEN VIROL, V84, P2795, DOI 10.1099/vir.0.19201-0; Coombs KM, 2010, J VIROL, V84, P10888, DOI 10.1128/JVI.00431-10; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; Das S, 2011, VIRUS RES, V160, P404, DOI 10.1016/j.virusres.2011.06.001; Das S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008134; De Mees C, 2006, MOL CELL BIOL, V26, P2012, DOI 10.1128/MCB.26.5.2012-2018.2006; Freudenburg W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052408; Ghoshal A, 2007, GLIA, V55, P483, DOI 10.1002/glia.20474; Glaser V, 2010, NEUROTOXICOLOGY, V31, P454, DOI 10.1016/j.neuro.2010.05.012; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Hauler F, 2012, P NATL ACAD SCI USA, V109, P19733, DOI 10.1073/pnas.1210659109; He B, 2006, CELL DEATH DIFFER, V13, P393, DOI 10.1038/sj.cdd.4401833; Jaag HM, 2011, J VIROL, V85, P243, DOI 10.1128/JVI.01749-10; Jin R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052909; Kalia M, 2013, J VIROL, V87, P148, DOI 10.1128/JVI.01399-12; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Katoh H, 2011, J VIROL, V85, P10976, DOI 10.1128/JVI.00846-11; Kaushik DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032270; Khadka S, 2011, MOL CELL PROTEOMICS, V10, DOI [10.1074/mcp.M111.012187-1, 10.1074/mcp.M111.012187]; Koh WL, 2005, EMERG INFECT DIS, V11, P629, DOI 10.3201/eid1104.041076; Kumar B, 2013, PROTEOMICS, V13, P89, DOI 10.1002/pmic.201200227; KUMAR R, 1990, INDIAN J MED RES-A, V91, P321; Kurihara LJ, 2001, HUM MOL GENET, V10, P1963, DOI 10.1093/hmg/10.18.1963; Lee JW, 2011, J PROTEOME RES, V10, P4522, DOI 10.1021/pr200338d; Liang JJ, 2011, CELL MICROBIOL, V13, P1358, DOI 10.1111/j.1462-5822.2011.01624.x; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Mishra MK, 2009, NEUROCHEM INT, V54, P464, DOI 10.1016/j.neuint.2009.01.022; Mkrtchian S, 1998, EUR J BIOCHEM, V251, P304, DOI 10.1046/j.1432-1327.1998.2510304.x; Munday DC, 2012, PROTEOMICS, V12, P666, DOI 10.1002/pmic.201100488; Navratil V, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-13; Pastorino B, 2009, MOL CELL PROTEOMICS, V8, P1623, DOI 10.1074/mcp.M800565-MCP200; Pattanakitsakul S, 2007, J PROTEOME RES, V6, P4592, DOI 10.1021/pr070366b; Diniz JAP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001733; Russo A, 2011, NUCLEIC ACIDS RES, V39, P7576, DOI 10.1093/nar/gkr461; Samad MA, 2007, FEBS LETT, V581, P3283, DOI 10.1016/j.febslet.2007.06.024; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Sengupta N, INFECT IMMUNITY, V78, P3957; Sengupta N, 2010, INFECT IMMUN, V78, P3957, DOI 10.1128/IAI.00374-10; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Su HL, 2002, J VIROL, V76, P4162, DOI 10.1128/JVI.76.9.4162-4171.2002; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tan SL, 2007, NAT BIOTECHNOL, V25, P1383, DOI 10.1038/nbt1207-1383; Tavender TJ, 2010, EMBO J, V29, P4185, DOI 10.1038/emboj.2010.273; Taylor MP, 2011, NAT REV MICROBIOL, V9, P427, DOI 10.1038/nrmicro2574; Tsuda Y, 2006, MICROBIOL IMMUNOL, V50, P225, DOI 10.1111/j.1348-0421.2006.tb03789.x; Tsukumo Y, 2007, J BIOL CHEM, V282, P29264, DOI 10.1074/jbc.M705038200; Tulsawani R, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-125; Turano C, 2011, CELL MOL BIOL LETT, V16, P539, DOI 10.2478/s11658-011-0022-z; Uchil PD, 2006, J VIROL, V80, P5451, DOI 10.1128/JVI.01982-05; Vasaikar SV, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-3; Wang T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002507; Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008; Yang SH, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-40; Zhang LK, 2013, J PROTEOME RES, V12, P2666, DOI 10.1021/pr400011k; Zhou ST, 2011, SCI CHINA LIFE SCI, V54, P502, DOI 10.1007/s11427-011-4177-7	58	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90211	10.1371/journal.pone.0090211	http://dx.doi.org/10.1371/journal.pone.0090211			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599148	gold, Green Submitted, Green Published			2022-12-27	WOS:000332479400055
J	Zevnik, B; Uyttersprot, NC; Perez, AV; Bothe, GWM; Kern, H; Kauselmann, G				Zevnik, Branko; Uyttersprot, Nathalie C.; Perez, Ana V.; Bothe, Gerald W. M.; Kern, Heidrun; Kauselmann, Gunther			C57BL/6N Albino/Agouti Mutant Mice as Embryo Donors for Efficient Germline Transmission of C57BL/6 ES Cells	PLOS ONE			English	Article							IMPROVED GENERATION; BALB/C BLASTOCYSTS; STEM-CELLS; MOUSE; ESTABLISHMENT; GENE; LINE; TYROSINASE	We generated C57BL/6NTac mice carrying a tyrosinase loss-of function mutation and a reversion of the nonagouti locus to agouti. This strain has a high superovulation response, allows visual detection of chimeric coat color contribution of C57BL/6 ES-cells and provides a simplified breeding format that generates black G1 offspring of pure inbred C57BL/6 background in one step, providing the ideal host for genetically manipulated C57BL/6 ES cells.	[Zevnik, Branko] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany; [Uyttersprot, Nathalie C.; Kern, Heidrun; Kauselmann, Gunther] TaconicArtemis GmbH, Cologne, Germany; [Perez, Ana V.; Bothe, Gerald W. M.] Taconic, Hudson, NY USA	University of Cologne	Zevnik, B (corresponding author), Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany.	branko.zevnik@uk-koeln.de	Zevnik, Branko/AAB-7853-2020	Zevnik, Branko/0000-0001-7845-9522	Taconic (NY, USA)	Taconic (NY, USA)	This work has been funded by Taconic (NY, USA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auerbach W, 2000, BIOTECHNIQUES, V29, P1024, DOI 10.2144/00295st04; BULTMAN SJ, 1994, GENE DEV, V8, P481, DOI 10.1101/gad.8.4.481; BULTMAN SJ, 1992, CELL, V71, P1195, DOI 10.1016/S0092-8674(05)80067-4; Cheng J, 2004, GENESIS, V39, P100, DOI 10.1002/gene.20031; Collins FS, 2007, CELL, V128, P9, DOI 10.1016/j.cell.2006.12.018; Fielder TJ, 2012, TRANSGENIC RES; Gertsenstein M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011260; Kern Heidrun, 2009, V530, P187, DOI 10.1007/978-1-59745-471-1_10; KONTGEN F, 1993, INT IMMUNOL, V5, P957, DOI 10.1093/intimm/5.8.957; KWON BS, 1989, J INVEST DERMATOL, V93, P589, DOI 10.1111/1523-1747.ep12319693; LEDERMANN B, 1991, EXP CELL RES, V197, P254, DOI 10.1016/0014-4827(91)90430-3; Lemckert FA, 1997, NUCLEIC ACIDS RES, V25, P917, DOI 10.1093/nar/25.4.917; Nagy A., 2003, MANIPULATING MOUSE E; Ohta H, 2009, HUM REPROD, V24, P775, DOI 10.1093/humrep/den456; Pacholczyk G, 2008, BIOTECHNIQUES, V44, P413, DOI 10.2144/000112706; Pettitt SJ, 2009, NAT METHODS, V6, P493, DOI 10.1038/nmeth.1342; Ryder E, 2013, GENESIS, V51, P523, DOI 10.1002/dvg.22398; Schaft J, 2001, GENESIS, V31, P6, DOI 10.1002/gene.1076; Schoonjans L, 2003, STEM CELLS, V21, P90, DOI 10.1634/stemcells.21-1-90; Schuster-Gossler K, 2001, BIOTECHNIQUES, V31, P1022, DOI 10.2144/01315st01; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; YOKOYAMA T, 1990, NUCLEIC ACIDS RES, V18, P7293, DOI 10.1093/nar/18.24.7293	22	5	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90570	10.1371/journal.pone.0090570	http://dx.doi.org/10.1371/journal.pone.0090570			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599260	Green Published, Green Submitted, gold			2022-12-27	WOS:000332479400095
J	Kim, JS; Park, HM; Chae, S; Lee, TH; Hwang, DJ; Oh, SD; Park, JS; Song, DG; Pan, CH; Choi, D; Kim, YH; Nahm, BH; Kim, YK				Kim, Joung Sug; Park, Hyang-Mi; Chae, Songhwa; Lee, Tae-Ho; Hwang, Duk-Ju; Oh, Sung-Dug; Park, Jong-Sug; Song, Dae-Geun; Pan, Cheol-Ho; Choi, Doil; Kim, Yul-Ho; Nahm, Baek Hie; Kim, Yeon-Ki			A Pepper MSRB2 Gene Confers Drought Tolerance in Rice through the Protection of Chloroplast-Targeted Genes	PLOS ONE			English	Article							METHIONINE SULFOXIDE REDUCTASES; ARABIDOPSIS-THALIANA; STRESS RESPONSES; OXIDATIVE STRESS; EXPRESSION; PROTEIN; PLANTS; PATHWAYS; NUCLEUS; OXYGEN	ackground: The perturbation of the steady state of reactive oxygen species (ROS) due to biotic and abiotic stresses in a plant could lead to protein denaturation through the modification of amino acid residues, including the oxidation of methionine residues. Methionine sulfoxide reductases (MSRs) catalyze the reduction of methionine sulfoxide back to the methionine residue. To assess the role of this enzyme, we generated transgenic rice using a pepper CaMSRB2 gene under the control of the rice Rab21 (responsive to ABA protein 21) promoter with/without a selection marker, the bar gene. Results: A drought resistance test on transgenic plants showed that CaMSRB2 confers drought tolerance to rice, as evidenced by less oxidative stress symptoms and a strengthened PSII quantum yield under stress conditions, and increased survival rate and chlorophyll index after the re-watering. The results from immunoblotting using a methionine sulfoxide antibody and nano-LC-MS/MS spectrometry suggest that porphobilinogen deaminase (PBGD), which is involved in chlorophyll synthesis, is a putative target of CaMSRB2. The oxidized methionine content of PBGD expressed in E. coli increased in the presence of H2O2, and the Met-95 and Met-227 residues of PBGD were reduced by CaMSRB2 in the presence of dithiothreitol (DTT). An expression profiling analysis of the overexpression lines also suggested that photosystems are less severely affected by drought stress. Conclusions: Our results indicate that CaMSRB2 might play an important functional role in chloroplasts for conferring drought stress tolerance in rice.	[Kim, Joung Sug; Nahm, Baek Hie] Myong Ji Univ, Div Biosci & Bioinformat, Yongin, Kyonggido, South Korea; [Chae, Songhwa; Lee, Tae-Ho; Nahm, Baek Hie; Kim, Yeon-Ki] GreenGene BioTech Inc, Genom Genet Inst, Yongin, Kyonggido, South Korea; [Park, Hyang-Mi; Kim, Yul-Ho] Natl Inst Crop Sci, Rice Res Div, Suwon, South Korea; [Hwang, Duk-Ju; Oh, Sung-Dug; Park, Jong-Sug] Rural Dev Adm, Natl Acad Agr Sci, Suwon, South Korea; [Choi, Doil] Seoul Natl Univ, Coll Agr & Life Sci, Seoul, South Korea; [Choi, Doil] Seoul Natl Univ, Plant Genom & Breeding Inst, Seoul, South Korea; [Song, Dae-Geun; Pan, Cheol-Ho] Korea Inst Sci & Technol, Funct Food Ctr, Kangnung, Gangwon Do, South Korea	Myongji University; Rural Development Administration (RDA), Republic of Korea; National Institute of Crop Science; Rural Development Administration (RDA), Republic of Korea; Seoul National University (SNU); Seoul National University (SNU); Korea Institute of Science & Technology (KIST)	Nahm, BH (corresponding author), Myong Ji Univ, Div Biosci & Bioinformat, Yongin, Kyonggido, South Korea.	bhnahm@gmail.com; kim750a11@gmail.com	Choi, Doil/F-5002-2011		Next-Generation BioGreen 21 Program [PJ008070, PJ009484, PJ008145]; RDA the Republic of Korea; 21st Century Frontier Program, Korean ministry of Education, Science and Technology [2011-0031518]; Korea Institute of Science and Technology Gangneung Institute [2Z03850]; BK21	Next-Generation BioGreen 21 Program(Rural Development Administration (RDA), Republic of Korea); RDA the Republic of Korea; 21st Century Frontier Program, Korean ministry of Education, Science and Technology; Korea Institute of Science and Technology Gangneung Institute(Korea Institute of Science & Technology (KIST)); BK21(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	This work was supported by grants from the Next-Generation BioGreen 21 Program (YKK, grant no. PJ008070 and PJ009484; BHN, grant no. PJ008145), RDA the Republic of Korea and 21st Century Frontier Program, Korean ministry of Education, Science and Technology (BHN, grant no. 2011-0031518) and by grants from the Korea Institute of Science and Technology Gangneung Institute intramural research grant 2Z03850 (DGS and CHP). JSK and BHN were supported by BK21. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn IP, 2008, PLANT PHYSIOL, V146, P213, DOI 10.1104/pp.107.105890; Ankele E, 2007, PLANT CELL, V19, P1964, DOI 10.1105/tpc.106.048744; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Arnoys EJ, 2007, ACTA HISTOCHEM, V109, P89, DOI 10.1016/j.acthis.2006.10.002; Balzergue S, 2001, BIOTECHNIQUES, V30, P496, DOI 10.2144/01303bm06; Beck CF, 2005, PLANTA, V222, P743, DOI 10.1007/s00425-005-0021-2; Bellafiore S, 2005, NATURE, V433, P892, DOI 10.1038/nature03286; BJORKMAN O, 1987, PLANTA, V170, P489, DOI 10.1007/BF00402983; Bonardi V, 2005, NATURE, V437, P1179, DOI 10.1038/nature04016; BOYER JS, 1982, SCIENCE, V218, P443, DOI 10.1126/science.218.4571.443; Chaves MM, 2009, ANN BOT-LONDON, V103, P551, DOI 10.1093/aob/mcn125; Cheng W, 2011, BIOL PLANTARUM, V55, P173, DOI 10.1007/s10535-011-0025-7; Cho HS, 2004, PLANT CELL, V16, P2665, DOI 10.1105/tpc.104.024281; Cho JI, 2009, PLANT PHYSIOL, V149, P745, DOI 10.1104/pp.108.131227; Cooke MS, 2003, FASEB J, V17, P1195, DOI 10.1096/fj.02-0752rev; Davies MJ, 2005, BBA-PROTEINS PROTEOM, V1703, P93, DOI 10.1016/j.bbapap.2004.08.007; de Carvalho MHC, 2008, PLANT SIGNAL BEHAV, V3, P156, DOI 10.4161/psb.3.3.5536; DEBLOCK M, 1987, EMBO J, V6, P2513, DOI 10.1002/j.1460-2075.1987.tb02537.x; Degenkolbe T, 2009, PLANT MOL BIOL, V69, P133, DOI 10.1007/s11103-008-9412-7; Le DT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065637; Ebinuma H, 2004, TRANSGENIC PLANTS ME, P237, DOI [10.1385/1-59259-827-7:237, DOI 10.1385/1-59259-827-7:237]; Ezraty B, 2005, BBA-PROTEINS PROTEOM, V1703, P221, DOI 10.1016/j.bbapap.2004.08.017; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fernandez AP, 2008, CURR OPIN PLANT BIOL, V11, P509, DOI 10.1016/j.pbi.2008.06.002; Foyer CH, 2005, PLANT CELL, V17, P1866, DOI 10.1105/tpc.105.033589; Guo XL, 2009, PLANTA, V230, P227, DOI 10.1007/s00425-009-0934-2; Gustavsson N, 2002, PLANT J, V29, P545, DOI 10.1046/j.1365-313X.2002.029005545.x; Hadiarto T, 2011, PLANT CELL REP, V30, P297, DOI 10.1007/s00299-010-0956-z; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Hirochika H, 1996, P NATL ACAD SCI USA, V93, P7783, DOI 10.1073/pnas.93.15.7783; Huang MS, 2009, MOL PLANT, V2, P773, DOI 10.1093/mp/ssp029; Jang IC, 1999, MOL BREEDING, V5, P453, DOI 10.1023/A:1009665314850; Jang IC, 2003, PLANT PHYSIOL, V131, P516, DOI 10.1104/pp.007237; Jewell MC, 2010, TRANSGENIC CROP PLANTS: VOL 2, P67, DOI 10.1007/978-3-642-04812-8_2; JONES RM, 1994, BIOCHEM J, V299, P895, DOI 10.1042/bj2990895; Jorgensen RB, 1996, TRENDS PLANT SCI, V1, P356; Kim JS, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-19; Kim MJ, 2012, METHODS MOL BIOL, V786, P65, DOI 10.1007/978-1-61779-292-2_4; KROGMANN DW, 1959, PLANT PHYSIOL, V34, P272, DOI 10.1104/pp.34.3.272; Kwon SJ, 2007, PLANT CELL PHYSIOL, V48, P1713, DOI 10.1093/pcp/pcm143; Laugier E, 2010, PLANT J, V61, P271, DOI 10.1111/j.1365-313X.2009.04053.x; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Mandavilli BS, 2002, MUTAT RES-FUND MOL M, V509, P127, DOI 10.1016/S0027-5107(02)00220-8; Miyao A, 2012, PLANT CELL PHYSIOL, V53, P256, DOI 10.1093/pcp/pcr172; MUNDY J, 1988, EMBO J, V7, P2279, DOI 10.1002/j.1460-2075.1988.tb03070.x; Nakamura K, 2006, J BIOL CHEM, V281, P36758, DOI 10.1074/jbc.M606797200; Oh SK, 2010, PLANT PHYSIOL, V154, P245, DOI 10.1104/pp.110.162339; Oien DB, 2009, ARCH BIOCHEM BIOPHYS, V485, P35, DOI 10.1016/j.abb.2009.01.020; op den Camp RGL, 2003, PLANT CELL, V15, P2320, DOI 10.1105/tpc.014662; Qin F, 2011, PLANT CELL PHYSIOL, V52, P1569, DOI 10.1093/pcp/pcr106; Reddy AR, 2004, J PLANT PHYSIOL, V161, P1189, DOI 10.1016/j.jplph.2004.01.013; Rodermel S, 2003, BIOESSAYS, V25, P631, DOI 10.1002/bies.10308; Rouhier N, 2006, PHOTOSYNTH RES, V89, P247, DOI 10.1007/s11120-006-9097-1; SEKHAR BPS, 1982, THEOR APPL GENET, V62, P35, DOI 10.1007/BF00276278; Sohn SooIn, 2006, Korean Journal of Breeding, V38, P173; Strand A, 2003, NATURE, V421, P79, DOI 10.1038/nature01204; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Phung TH, 2011, PLANT PHYSIOL, V157, P1746, DOI 10.1104/pp.111.188276; Vannini C, 2007, PLANT SCI, V173, P231, DOI 10.1016/j.plantsci.2007.05.007; WALLSGROVE RM, 1983, PLANT CELL ENVIRON, V6, P301; Wang FZ, 2005, J PLANT PHYSIOL, V162, P465, DOI 10.1016/j.jplph.2004.09.009; WORKMAN C, 2002, GENOME BIOL, V0003; Xu FQ, 2008, PLANT SCI, V175, P674, DOI 10.1016/j.plantsci.2008.07.002; Yi N, 2010, PLANTA, V232, P743, DOI 10.1007/s00425-010-1212-z	64	15	15	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e90588	10.1371/journal.pone.0090588	http://dx.doi.org/10.1371/journal.pone.0090588			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614245	gold, Green Published, Green Submitted			2022-12-27	WOS:000332839300032
J	Sahadevan, S; Gunawan, A; Tholen, E; Grosse-Brinkhaus, C; Tesfaye, D; Schellander, K; Hofmann-Apitius, M; Cinar, MU; Uddin, MJ				Sahadevan, Sudeep; Gunawan, Asep; Tholen, Ernst; Grosse-Brinkhaus, Christine; Tesfaye, Dawit; Schellander, Karl; Hofmann-Apitius, Martin; Cinar, Mehmet Ulas; Uddin, Muhammad Jasim			Pathway Based Analysis of Genes and Interactions Influencing Porcine Testis Samples from Boars with Divergent Androstenone Content in Back Fat	PLOS ONE			English	Article							REGULATORY PROTEIN EXPRESSION; LEYDIG-CELL STEROIDOGENESIS; GENOME-WIDE ASSOCIATION; QUANTITATIVE TRAIT LOCI; KINASE-C; ADIPOSE-TISSUE; TAINT; PIGS; BIOSYNTHESIS; CERAMIDE	One of the primary factors contributing to boar taint is the level of androstenone in porcine adipose tissues. A majority of the studies performed to identify candidate biomarkers for the synthesis of androstenone in testis tissues follow a reductionist approach, identifying and studying the effect of biomarkers individually. Although these studies provide detailed information on individual biomarkers, a global picture of changes in metabolic pathways that lead to the difference in androstenone synthesis is still missing. The aim of this work was to identify major pathways and interactions influencing steroid hormone synthesis and androstenone biosynthesis using an integrative approach to provide a bird's eye view of the factors causing difference in steroidogenesis and androstenone biosynthesis. For this purpose, we followed an analysis procedure merging together gene expression data from boars with divergent levels of androstenone and pathway mapping and interaction network retrieved from KEGG database. The interaction networks were weighted with Pearson correlation coefficients calculated from gene expression data and significant interactions and enriched pathways were identified based on these networks. The results show that 1,023 interactions were significant for high and low androstenone animals and that a total of 92 pathways were enriched for significant interactions. Although published articles show that a number of these enriched pathways were activated as a result of downstream signaling of steroid hormones, we speculate that the significant interactions in pathways such as glutathione metabolism, sphingolipid metabolism, fatty acid metabolism and significant interactions in cAMP-PKA/PKC signaling might be the key factors determining the difference in steroidogenesis and androstenone biosynthesis between boars with divergent androstenone levels in our study. The results and assumptions presented in this study are from an in-silico analysis done at the gene expression level and further laboratory experiments at genomic, proteomic or metabolomic level are necessary to validate these findings.	[Sahadevan, Sudeep; Gunawan, Asep; Tholen, Ernst; Grosse-Brinkhaus, Christine; Tesfaye, Dawit; Schellander, Karl; Uddin, Muhammad Jasim] Univ Bonn, Inst Anim Sci, Bonn, Germany; [Sahadevan, Sudeep; Hofmann-Apitius, Martin] Fraunhofer Inst Algorithms & Sci Comp SCAI, St Augustin, Germany; [Gunawan, Asep] Bogor Agr Univ, Dept Anim Prod & Technol, Fac Anim Sci, Bogor, Indonesia; [Hofmann-Apitius, Martin] Bonn Aachen Int Ctr Informat Technol B IT, Bonn, Germany; [Cinar, Mehmet Ulas] Erciyes Univ, Dept Anim Sci, Fac Agr, Kayseri, Turkey	University of Bonn; Fraunhofer Gesellschaft; Fraunhofer Institute Center Schloss Birlinghoven; Bogor Agricultural University; Erciyes University	Uddin, MJ (corresponding author), Univ Bonn, Inst Anim Sci, Bonn, Germany.	judd@itw.uni-bonn.de	Uddin, Muhammad Jasim/P-8497-2019; Gunawan, Asep/GON-4264-2022; Große-Brinkhaus, Christine/AAF-6712-2020; Uddin, Muhammad Jasim/N-3866-2013; Hofmann-Apitius, Martin/E-6123-2018	Uddin, Muhammad Jasim/0000-0002-6732-5534; Große-Brinkhaus, Christine/0000-0002-6190-4463; Uddin, Dr. Md. Jashim/0000-0002-3243-3455; Gunawan, Asep/0000-0003-0468-2443; Hofmann-Apitius, Martin/0000-0001-9012-6720	Federal Ministry of Food and Agriculture, Germany (BMEL); Federal Office for Agriculture and Food, Germany (BLE); State of North Rhine Westphalia	Federal Ministry of Food and Agriculture, Germany (BMEL); Federal Office for Agriculture and Food, Germany (BLE); State of North Rhine Westphalia	This work was financially supported by the Federal Ministry of Food and Agriculture, Germany (BMEL), the Federal Office for Agriculture and Food, Germany (BLE) and State of North Rhine Westphalia with the programme USL "Umweltvertragliche und Standortgerechte Landwirtschaft". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelson J.N., 1999, SPHINGOLIPID METABOL; Altamirano F, 2009, J ENDOCRINOL, V202, P299, DOI 10.1677/JOE-09-0044; Babraham Bioinformatics, 2013, FASTQC QUAL CONTR TO; Bartke N, 2009, J LIPID RES, V50, pS91, DOI 10.1194/jlr.R800080-JLR200; Billen MJ, 2009, J STEROID BIOCHEM, V113, P98, DOI 10.1016/j.jsbmb.2008.11.012; BONNEAU M, 1992, LIVEST PROD SCI, V32, P63, DOI 10.1016/S0301-6226(12)80012-1; Boron WF., 2005, MED PHYSL CELLULAR M, V2nd; Chalfant C., 2010, SPHINGOLIPIDS SIGNAL; Chandra R, 2000, Indian J Clin Biochem, V15, P155, DOI 10.1007/BF02883745; Chauhan B. S., 2008, PRINCIPLES BIOCH BIO; Chen H, 2008, ENDOCRINOLOGY, V149, P2612, DOI 10.1210/en.2007-1245; Cheng L, 2011, ESSENTIALS ANATOMIC, p125p; Chuang HY, 2010, ANNU REV CELL DEV BI, V26, P721, DOI 10.1146/annurev-cellbio-100109-104122; Droste P, 2013, CHEM-ING-TECH, V85, P849, DOI 10.1002/cite.201200234; Duijvesteijn N, 2012, J ANIM SCI, V90, P2465, DOI 10.2527/jas.2011-4625; Duijvesteijn N, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-42; Dunshea FR, 2001, J ANIM SCI, V79, P2524; Fishbein JC, 2011, ADV MOL TOXICOLOGY; Fix C, 2004, P NATL ACAD SCI USA, V101, P10919, DOI 10.1073/pnas.0404278101; Fleury A, 2004, J STEROID BIOCHEM, V91, P259, DOI 10.1016/j.jsbmb.2004.04.010; Frey P. A., 2007, ENZYMATIC REACTION M; Frieden L., 2011, Lohmann Information, V46, P21; Gatti DM, 2009, BIOINFORMATICS, V25, P541, DOI 10.1093/bioinformatics/btn655; Gregersen VR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-22; Grindflek E, 2011, J ANIM SCI, V89, P680, DOI 10.2527/jas.2010-3290; Grindflek E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-362; Gunawan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063259; Hacker BM, 1998, GENOMICS, V50, P97, DOI 10.1006/geno.1998.5293; Hanada K, 2003, BBA-MOL CELL BIOL L, V1632, P16, DOI 10.1016/S1388-1981(03)00059-3; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hartley JL, 2000, GENOME RES, V10, P1788, DOI 10.1101/gr.143000; Haugen JE, 2012, MEAT SCI, V90, P9, DOI 10.1016/j.meatsci.2011.07.005; Hu J, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-47; James Squires E, 2010, APPL ANIMAL ENDOCRIN, P103; Jo Y, 2005, BIOL REPROD, V73, P244, DOI 10.1095/biolreprod.104.037721; Kumar TR, 2000, ENDOCRINOLOGY, V141, P4270, DOI 10.1210/en.141.11.4270; Kuuranne T, 2003, DRUG METAB DISPOS, V31, P1117, DOI 10.1124/dmd.31.9.1117; Law CW, 2013, VOON PRECISION WEIGH; Lee GJ, 2005, ANIM GENET, V36, P14, DOI 10.1111/j.1365-2052.2004.01214.x; Lennarz WJ, 2013, ENCY BIOL CHEM; Lervik S, 2013, THERIOGENOLOGY, V79, P986, DOI 10.1016/j.theriogenology.2013.01.023; Leung MCK, 2010, ANIM BIOTECHNOL, V21, P77, DOI 10.1080/10495390903500607; Loscalzo J, 2011, WIRES SYST BIOL MED, V3, P619, DOI 10.1002/wsbm.144; Losel RM, 2003, PHYSIOL REV, V83, P965, DOI 10.1152/physrev.00003.2003; Lucki NC, 2010, STEROIDS, V75, P390, DOI 10.1016/j.steroids.2010.01.020; Mander L., 2010, COMPREHENSIVE NATURA; Manna P. R., 2005, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V5, P93, DOI 10.2174/1568008053174714; Manna PR, 2007, J ENDOCRINOL, V193, P53, DOI 10.1677/JOE-06-0201; Manna PR, 2009, ENDOCRINOLOGY, V150, P3308, DOI 10.1210/en.2008-1668; McQueen CA, 2010, COMPREHENSIVE TOXICOLOGY, VOL 10: GASTROINTESTINAL TOXICOLOGY, 2ND EDITION, P1; Meroni SB, 2000, J STEROID BIOCHEM, V75, P307, DOI 10.1016/S0960-0760(00)00188-6; Merrill AH, 2002, J BIOL CHEM, V277, P25843, DOI 10.1074/jbc.R200009200; Merrill AJ., 2006, SPHINGOLIPID BIOL; Moe M, 2007, J ANIM SCI, V85, P2924, DOI 10.2527/jas.2007-0283; Moe M, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-405; Morlein D, 2012, MEAT SCI, V91, P435, DOI 10.1016/j.meatsci.2012.02.028; Morales V, 2003, ENDOCRINOLOGY, V144, P4763, DOI 10.1210/en.2003-0569; MORI K, 1989, TOXICOL APPL PHARM, V101, P299, DOI 10.1016/0041-008X(89)90278-0; Nasman J, 2002, J NEUROCHEM, V83, P1252, DOI 10.1046/j.1471-4159.2002.01270.x; Payne AH, 2007, LEYDING CELL HLTH DI; PORN MI, 1991, BIOCHIM BIOPHYS ACTA, V1093, P7; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Quintanilla R, 2003, J ANIM SCI, V81, P385; R Development Core Team RDC, 2013, R LANG ENV STAT COMP; Rapaport F, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r95; Ray S, 2013, GENE, V526, P46, DOI 10.1016/j.gene.2013.04.018; Ripley B.D., 1987, STOCHASTIC SIMULATIO; Robic A, 2011, ANIM GENET, V42, P662, DOI 10.1111/j.1365-2052.2011.02195.x; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sakata K, 2000, J UROLOGY, V163, P1333, DOI 10.1016/S0022-5347(05)67773-7; SANTANA P, 1995, ENDOCRINOLOGY, V136, P2345, DOI 10.1210/en.136.5.2345; Sanz E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066179; Schomburg D., 2003, SPRINGER HDB ENZYMES; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sharifi AM, 2012, MED HYPOTHESES, V78, P465, DOI 10.1016/j.mehy.2011.12.021; Sharma R, 2011, PHYTOTHER RES, V25, P563, DOI 10.1002/ptr.3297; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Soneson C, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-91; Spoolder H, 2011, 1 PARM; Stocco DM, 2005, MOL ENDOCRINOL, V19, P2647, DOI 10.1210/me.2004-0532; Suomalainen L, 2003, J CLIN ENDOCR METAB, V88, P5572, DOI 10.1210/jc.2003-030776; Tindall D, 2009, ANDROGEN ACTION IN PROSTATE CANCER, P1, DOI 10.1007/978-0-387-69179-4; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Urs AN, 2006, ENDOCRINOLOGY, V147, P5249, DOI 10.1210/en.2006-0355; West AP, 2011, NAT REV IMMUNOL, V11, P389, DOI 10.1038/nri2975; Zhang X, 2012, GENETICS, V190, P1511, DOI 10.1534/genetics.111.137737	86	7	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91077	10.1371/journal.pone.0091077	http://dx.doi.org/10.1371/journal.pone.0091077			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614349	gold, Green Published, Green Submitted			2022-12-27	WOS:000332839300073
J	Guo, WB; Liu, F; Zhang, J; Zhang, ZK; Yu, LY; Liu, JR; Chen, HF; Xiao, CQ				Guo, Wenbin; Liu, Feng; Zhang, Jian; Zhang, Zhikun; Yu, Liuyu; Liu, Jianrong; Chen, Huafu; Xiao, Changqing			Abnormal Default-Mode Network Homogeneity in First-Episode, Drug-Naive Major Depressive Disorder	PLOS ONE			English	Article							MICROVASCULAR COMPLICATIONS; HBA(1C) VARIABILITY; YOUNG-ADULTS; RISK-FACTORS; TYPE-1; RETINOPATHY; NEPHROPATHY; ADOLESCENTS; CHILDREN; HBA1C	Background: Default mode network (DMN) is one of the most commonly recognized resting-state networks in major depressive disorder (MDD). However, the homogeneity of this network in MDD is poorly understood. As such, this study was conducted to determine whether or not an abnormal network homogeneity (NH) of DMN is observed in patients with first-episode and drug-naive MDD. Methods: Twenty-four first-episode drug-naive patients with MDD and twenty-four healthy control subjects participated in the study. NH and independent component analysis (ICA) methods were used to analyze data. Results: Depressed patients exhibited a significantly increased NH in the left dorsal medial prefrontal cortex (MPFC) and decreased NH in the right inferior temporal gyrus (ITG) compared with the healthy control subjects. Receiver operating characteristic curves (ROC) were analyzed and results revealed that the NH values of MPFC and ITG could be applied as candidate markers with relatively high sensitivity and specificity to distinguish patients from healthy control subjects. No correlation was observed between the NH values of the two regions and clinical variables. Conclusions: Our findings suggested that an abnormal DMN homogeneity could be observed in MDD, which highlight the importance of the DMN in the pathophysiology of MDD.	[Guo, Wenbin; Zhang, Jian; Zhang, Zhikun; Yu, Liuyu; Liu, Jianrong; Xiao, Changqing] Guangxi Med Univ, Affiliated Hosp 1, Mental Hlth Ctr, Nanning, Guangxi, Peoples R China; [Liu, Feng; Chen, Huafu] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Minist Educ, Key Lab NeuroInformat, Chengdu 610054, Sichuan, Peoples R China	Guangxi Medical University; University of Electronic Science & Technology of China	Guo, WB (corresponding author), Guangxi Med Univ, Affiliated Hosp 1, Mental Hlth Ctr, Nanning, Guangxi, Peoples R China.	guowenbin76@163.com	Liu, Feng/W-7572-2019	Liu, Feng/0000-0002-3570-4222	National Natural Science Foundations of China [81260210, 30900483]; Natural Science Foundations of Guangxi [2013GXNSFAA019107]; Ministry of Health of the Peoples' Republic of China [201002003]	National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundations of Guangxi; Ministry of Health of the Peoples' Republic of China	The study was supported by grants from the National Natural Science Foundations of China (grant no. 81260210, and no. 30900483), the Natural Science Foundations of Guangxi (no. 2013GXNSFAA019107), and the special funding by the Ministry of Health of the Peoples' Republic of China (grant no. 201002003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1991, OPHTHALMOLOGY, V98, P786; Dawson AJ, 2013, DIABETIC MED, V30, P1172, DOI 10.1111/dme.12160; Gerstl EM, 2008, EUR J PEDIATR, V167, P447, DOI 10.1007/s00431-007-0586-9; Gonen M, 2005, BIOMETRIKA, V92, P965, DOI 10.1093/biomet/92.4.965; Hammes HP, 2011, DIABETOLOGIA, V54, P1977, DOI 10.1007/s00125-011-2198-1; Hammes HP, 2012, DIABETOLOGIE S2, P103; Hietala K, 2013, DIABETOLOGIA, V56, P737, DOI 10.1007/s00125-012-2816-6; Kilpatrick ES, 2012, DIABETOLOGIA, V55, P2089, DOI 10.1007/s00125-012-2610-5; Kilpatrick ES, 2008, DIABETES CARE, V31, P2198, DOI 10.2337/dc08-0864; Kilpatrick ES, 2006, DIABETES CARE, V29, P1486, DOI 10.2337/dc06-0293; Lachin JM, 2008, DIABETES, V57, P995, DOI 10.2337/db07-1618; Liew Gerald, 2009, Int Ophthalmol Clin, V49, P35, DOI 10.1097/IIO.0b013e31819fd5d7; Luk AOY, 2013, DIABETES-METAB RES, V29, P384, DOI 10.1002/dmrr.2404; Mostafa SA, 2012, DIABETES CARE, V35, P1746, DOI 10.2337/dc11-2079; Penno G, 2013, DIABETES CARE, V36, P2301, DOI 10.2337/dc12-2264; Rodriguez-Segade S, 2012, DIABETIC MED, V29, P1562, DOI 10.1111/j.1464-5491.2012.03767.x; Schwab KO, 2006, DIABETES CARE, V29, P218, DOI 10.2337/diacare.29.02.06.dc05-0724	17	59	61	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91102	10.1371/journal.pone.0091102	http://dx.doi.org/10.1371/journal.pone.0091102			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24609111	Green Published, gold, Green Submitted			2022-12-27	WOS:000332485800101
J	Perez-Gonzalez, A; Pazo, A; Navajas, R; Ciordia, S; Rodriguez-Frandsen, A; Nieto, A				Perez-Gonzalez, Alicia; Pazo, Alejandra; Navajas, Rosana; Ciordia, Sergio; Rodriguez-Frandsen, Ariel; Nieto, Amelia			hCLE/C14orf166 Associates with DDX1-HSPC117-FAM98B in a Novel Transcription-Dependent Shuttling RNA-Transporting Complex	PLOS ONE			English	Article							INFLUENZA-VIRUS POLYMERASE; MENTAL-RETARDATION PROTEIN; MESSENGER-RNA; RIBOSOME BIOGENESIS; MASS-SPECTROMETRY; MAMMALIAN-CELLS; BINDING PROTEIN; GLOBAL ANALYSIS; LOCALIZATION; INTERACTS	hCLE/C14orf166 is a nuclear and cytoplasmic protein that interacts with the RNAP II, modulates nuclear RNA metabolism and is present in cytoplasmic RNA granules involved in localized translation. Here we have studied whether hCLE shares common interactors in the nucleus and the cytosol, which could shed light on its participation in the sequential phases of RNA metabolism. Nuclear and cytoplasmic purified hCLE-associated factors were identified and proteins involved in mRNA metabolism, motor-related proteins, cytoskeletal and translation-related factors were found. Purified hCLE complexes also contain RNAs and as expected some hCLE-interacting proteins (DDX1, HSPC117, FAM98B) were found both in the nucleus and the cytoplasm. Moreover, endogenous hCLE fractionates in protein complexes together with DDX1, HSPC117 and FAM98B and silencing of hCLE down-regulates their nuclear and cytosolic accumulation levels. Using a photoactivatable hCLE-GFP protein, nuclear import and export of hCLE was observed indicating that hCLE is a shuttling protein. Interestingly, hCLE nuclear import required active transcription, as did the import of DDX1, HSPC117 and FAM98B proteins. The data indicate that hCLE probably as a complex with DDX1, HSPC117 and FAM98B shuttles between the nucleus and the cytoplasm transporting RNAs suggesting that this complex has a prominent role on nuclear and cytoplasmic RNA fate.	[Perez-Gonzalez, Alicia; Pazo, Alejandra; Navajas, Rosana; Ciordia, Sergio; Rodriguez-Frandsen, Ariel; Nieto, Amelia] CSIC, Ctr Nacl Biotecnol, Madrid, Spain; [Perez-Gonzalez, Alicia; Pazo, Alejandra; Rodriguez-Frandsen, Ariel; Nieto, Amelia] Ciber Enfermedades Resp, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); CIBER - Centro de Investigacion Biomedica en Red; CIBERES	Nieto, A (corresponding author), CSIC, Ctr Nacl Biotecnol, Darwin 3, Madrid, Spain.	anieto@cnb.csic.es	Rodriguez, Ariel/B-3908-2013; Rodriguez Frandsen, Ariel/HDM-7270-2022	Rodriguez, Ariel/0000-0001-6850-5003; Rodriguez Frandsen, Ariel/0000-0001-6850-5003; Ciordia, Sergio/0000-0002-5726-853X; Navajas, Rosana/0000-0002-4481-0553	Ministerio de Ciencia e Innovacion, Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica [BFU2008-00448, BFU2011-26175]; Instituto de Salud Carlos III (Programa especial de investigacion sobre la gripe pandemica) [GR09/0023, GR09/0040, GR09/0039]; Spanish National Proteomics Institute (ProteoRed-ISC III) [2005X747_3]; Ciber de Enfermedades Respiratorias	Ministerio de Ciencia e Innovacion, Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica(Ministry of Science and Innovation, Spain (MICINN)); Instituto de Salud Carlos III (Programa especial de investigacion sobre la gripe pandemica); Spanish National Proteomics Institute (ProteoRed-ISC III); Ciber de Enfermedades Respiratorias	This work was supported by the Ministerio de Ciencia e Innovacion, Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica (BFU2008-00448 and BFU2011-26175), Instituto de Salud Carlos III (Programa especial de investigacion sobre la gripe pandemica GR09/0023, GR09/0040, GR09/0039), the Spanish National Proteomics Institute (ProteoRed-ISC III) (grant number 2005X747_3) and Ciber de Enfermedades Respiratorias. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonina E, 1998, J BIOL CHEM, V273, P13015, DOI 10.1074/jbc.273.21.13015; Amiel J, 2007, AM J HUM GENET, V80, P988, DOI 10.1086/515582; Bardoni B, 2003, HUM MOL GENET, V12, P1689, DOI 10.1093/hmg/ddg181; Bertolotti A, 1996, EMBO J, V15, P5022, DOI 10.1002/j.1460-2075.1996.tb00882.x; Caceres JF, 1998, GENE DEV, V12, P55, DOI 10.1101/gad.12.1.55; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Chen HC, 2002, J BIOL CHEM, V277, P40403, DOI 10.1074/jbc.M206981200; Cisterna B, 2010, INT REV CEL MOL BIO, V284, P67, DOI 10.1016/S1937-6448(10)84002-X; Delestienne N, 2010, FEBS J, V277, P2496, DOI 10.1111/j.1742-4658.2010.07664.x; Drewett V, 2001, NUCLEIC ACIDS RES, V29, P479, DOI 10.1093/nar/29.2.479; Elvira G, 2006, MOL CELL PROTEOMICS, V5, P635, DOI 10.1074/mcp.M500255-MCP200; Emmott E, 2013, J VIROL, V87, P9486, DOI 10.1128/JVI.00321-13; Fant X, 2009, J CELL SCI, V122, P1134, DOI 10.1242/jcs.035238; Freibaum BD, 2010, J PROTEOME RES, V9, P1104, DOI 10.1021/pr901076y; Fukuda A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072496; Garaigorta U, 2005, J VIROL, V79, P15246, DOI 10.1128/JVI.79.24.15246-15257.2005; Howng SL, 2004, FEBS LETT, V566, P162, DOI 10.1016/j.febslet.2004.04.024; Huarte M, 2001, J VIROL, V75, P8597, DOI 10.1128/JVI.75.18.8597-8604.2001; Iida Y, 2011, J BIOL CHEM, V286, P16929, DOI 10.1074/jbc.M110.215871; Jeronimo C, 2007, MOL CELL, V27, P262, DOI 10.1016/j.molcel.2007.06.027; Jorba N, 2008, PROTEOMICS, V8, P2077, DOI 10.1002/pmic.200700508; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Kim HK, 2005, BIOCHEM BIOPH RES CO, V328, P895, DOI 10.1016/j.bbrc.2005.01.041; Kruger T, 2007, J CELL BIOL, V177, P573, DOI 10.1083/jcb.200612048; Kula A, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-60; Lecuyer E, 2007, CELL, V131, P174, DOI 10.1016/j.cell.2007.08.003; Lee JW, 2011, J PROTEOME RES, V10, P4522, DOI 10.1021/pr200338d; Lin YT, 2006, RNA, V12, P1486, DOI 10.1261/rna.42206; Lloris-Garcera P, 2012, J BIOL CHEM, V287, P26052, DOI 10.1074/jbc.M112.357590; Makise M, 2012, J BIOL CHEM, V287, P38515, DOI 10.1074/jbc.M112.378893; Marko M, 2012, GENE, V506, P331, DOI 10.1016/j.gene.2012.06.088; Miller LC, 2009, MOL CELL NEUROSCI, V40, P485, DOI 10.1016/j.mcn.2009.01.007; ORTIN J, 1980, GENE, V11, P319, DOI 10.1016/0378-1119(80)90072-4; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Perez-Gonzalez A, 2006, J MOL BIOL, V362, P887, DOI 10.1016/j.jmb.2006.07.085; Pinol-Roma Serafin, 1993, Trends in Cell Biology, V3, P151, DOI 10.1016/0962-8924(93)90135-N; Popow J, 2011, SCIENCE, V331, P760, DOI 10.1126/science.1197847; Rappsilber J, 2002, GENOME RES, V12, P1231, DOI 10.1101/gr.473902; Robertson-Anderson RM, 2011, J MOL BIOL, V410, P959, DOI 10.1016/j.jmb.2011.04.026; Rodriguez A, 2007, J VIROL, V81, P5315, DOI 10.1128/JVI.02129-06; Rodriguez A, 2011, J VIROL, V85, P12062, DOI 10.1128/JVI.00684-11; Shevchenko A, 2001, ELECTROPHORESIS, V22, P1194, DOI 10.1002/1522-2683()22:6<1194::AID-ELPS1194>3.0.CO;2-A; Stefani G, 2004, J NEUROSCI, V24, P7272, DOI 10.1523/JNEUROSCI.2306-04.2004; Switala J, 1999, BIOCHEMISTRY-US, V38, P3895, DOI 10.1021/bi982863z; Tan M, 2004, J VIROL, V78, P6233, DOI 10.1128/JVI.78.12.6233-6242.2004; Tokunaga K, 2006, GENES CELLS, V11, P305, DOI 10.1111/j.1365-2443.2006.00936.x; Villace P, 2004, NUCLEIC ACIDS RES, V32, P2411, DOI 10.1093/nar/gkh552; WIGLER M, 1979, P NATL ACAD SCI USA, V76, P1373, DOI 10.1073/pnas.76.3.1373; Ruiz-Loredo AY, 2012, INT REV CEL MOL BIO, V293, P85, DOI 10.1016/B978-0-12-394304-0.00008-7	49	34	39	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90957	10.1371/journal.pone.0090957	http://dx.doi.org/10.1371/journal.pone.0090957			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608264	Green Published, Green Submitted, gold			2022-12-27	WOS:000332485800069
J	Lawton, RJ; de Nys, R; Skinner, S; Paul, NA				Lawton, Rebecca J.; de Nys, Rocky; Skinner, Stephen; Paul, Nicholas A.			Isolation and Identification of Oedogonium Species and Strains for Biomass Applications	PLOS ONE			English	Article							FRESH-WATER ALGAE; SEQUENCES; CLASSIFICATION; TEMPERATURE; RECOVERY; RDNA	Freshwater macroalgae from the genus Oedogonium have recently been targeted for biomass applications; however, strains of Oedogonium for domestication have not yet been identified. Therefore, the objective of this study was to compare the performance of isolates of Oedogonium collected from multiple geographic locations under varying environmental conditions. We collected and identified wild-type isolates of Oedogonium from three geographic locations in Eastern Australia, then measured the growth of these isolates under a range of temperature treatments corresponding to ambient conditions in each geographic location. Our sampling identified 11 isolates of Oedogonium that could be successfully maintained under culture conditions. It was not possible to identify most isolates to species level using DNA barcoding techniques or taxonomic keys. However, there were considerable genetic and morphological differences between isolates, strongly supporting each being an identifiable species. Specific growth rates of species were high (>26% day(-1)) under 7 of the 9 temperature treatments (average tested temperature range: 20.9-27.7 degrees C). However, the variable growth rates of species under lower temperature treatments demonstrated that some were better able to tolerate lower temperatures. There was evidence for local adaptation under lower temperature treatments (winter conditions), but not under higher temperature treatments (summer conditions). The high growth rates we recorded across multiple temperature treatments for the majority of species confirm the suitability of this diverse genus for biomass applications and the domestication of Oedogonium.	[Lawton, Rebecca J.; de Nys, Rocky; Paul, Nicholas A.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [Skinner, Stephen] Molonglo Catchment Grp, Fyshwick, Australia	James Cook University	Lawton, RJ (corresponding author), James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia.	rebecca.lawton@jcu.edu.au	Paul, Nicholas/B-6496-2009; Lawton, Rebecca/E-5711-2014; de Nys, Rocky/D-6741-2012; Lawton, Rebecca/A-6149-2012	Lawton, Rebecca/0000-0001-6296-6415; de Nys, Rocky/0000-0003-3869-4928; Paul, Nicholas/0000-0002-9275-1535	Australian Government through the Australian Renewable Energy Agency; Advanced Manufacturing Cooperative Research Centre (AMCRC); Australian Government's Cooperative Research Centre Scheme	Australian Government through the Australian Renewable Energy Agency(Australian Renewable Energy Agency (ARENA)); Advanced Manufacturing Cooperative Research Centre (AMCRC)(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Australian Government's Cooperative Research Centre Scheme(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	This research is supported by the Australian Government through the Australian Renewable Energy Agency and the Advanced Manufacturing Cooperative Research Centre (AMCRC), funded through the Australian Government's Cooperative Research Centre Scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achten WMJ, 2010, BIOFUELS-UK, V1, P91, DOI 10.4155/BFS.09.4; Anderson MJ, 2008, PERMANCOVA PRIMER GU; BAKKER FT, 1995, J MOL EVOL, V40, P640, DOI 10.1007/BF00160512; Bird MI, 2012, GCB BIOENERGY, V4, P61, DOI 10.1111/j.1757-1707.2011.01109.x; Cole AJ, 2014, GCB BIOENERGY, V6, P637, DOI 10.1111/gcbb.12097; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; DAVISON IR, 1991, J PHYCOL, V27, P2, DOI 10.1111/j.0022-3646.1991.00002.x; Eggert A., 2012, SEAWEED BIOL, P47, DOI [10.1007/978-3-642-28451-9_3, DOI 10.1007/978-3-642-28451-9_3]; Entwisle T.J., 2007, ALGAE AUSTR BATRACHO, P1; Evenson RE, 2003, SCIENCE, V300, P758, DOI 10.1126/science.1078710; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Harper JT, 2001, CAH BIOL MAR, V42, P25; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Kebede-Westhead E, 2006, J APPL PHYCOL, V18, P41, DOI 10.1007/s10811-005-9012-8; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Lawton RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077344; Lawton RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064168; Lobban CS, 2000, SEAWEED ECOLOGY PHYS, P366; Mei H, 2007, PLANT SYST EVOL, V265, P179, DOI 10.1007/s00606-007-0523-4; MINORSKY PV, 1989, PLANT CELL ENVIRON, V12, P119, DOI 10.1111/j.1365-3040.1989.tb01924.x; Mulbry W, 2008, BIORESOURCE TECHNOL, V99, P8137, DOI 10.1016/j.biortech.2008.03.073; Paul NA, 2012, AQUACULTURE: FARMING AQUATIC ANIMALS AND PLANTS, 2ND EDITION, P268; RAVEN JA, 1988, NEW PHYTOL, V110, P441, DOI 10.1111/j.1469-8137.1988.tb00282.x; Ross AB, 2008, BIORESOURCE TECHNOL, V99, P6494, DOI 10.1016/j.biortech.2007.11.036; Saunders RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036470; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Silva PHD, 2008, AQUACULTURE, V284, P74, DOI 10.1016/j.aquaculture.2008.07.035; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Yan J, 2012, GCB BIOENERGY, V4, P49, DOI 10.1111/j.1757-1707.2011.01108.x	32	39	40	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90223	10.1371/journal.pone.0090223	http://dx.doi.org/10.1371/journal.pone.0090223			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603705	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000332483600031
J	Kolby, JE				Kolby, Jonathan E.			Presence of the Amphibian Chytrid Fungus Batrachochytrium dendrobatidis in Native Amphibians Exported from Madagascar	PLOS ONE			English	Article							POPULATION DECLINES; RANA-CATESBEIANA; CHYTRIDIOMYCOSIS; TRADE; EMERGENCE; DISEASE; FROGS; TIME	The emerging infectious disease chytridiomycosis is driven by the spread of amphibian chytrid fungus (Batrachochytrium dendrobatidis, Bd), a highly virulent pathogen threatening global amphibian biodiversity. Although pandemic in distribution, previous intensive field surveys have failed to detect Bd in Madagascar, a biodiversity hotspot home to hundreds of endemic amphibian species. Due to the presence of Bd in nearby continental Africa and the ecological crisis that can be expected following establishment in Madagascar, enhanced surveillance is imperative. I sampled 565 amphibians commercially exported from Madagascar for the presence of Bd upon importation to the USA, both to assist early detection efforts and demonstrate the conservation potential of wildlife trade disease surveillance. Bd was detected in three animals via quantitative PCR: a single Heterixalus alboguttatus, Heterixalus betsileo, and Scaphiophryne spinosa. This is the first time Bd has been confirmed in amphibians from Madagascar and presents an urgent call to action. Our early identification of pathogen presence prior to widespread infection provides the necessary tools and encouragement to catalyze a swift, targeted response to isolate and eradicate Bd from Madagascar. If implemented before establishment occurs, an otherwise likely catastrophic decline in amphibian biodiversity may be prevented.	James Cook Univ, Sch Publ Hlth Trop Med & Rehabil Sci, Hlth Res Grp 1, Townsville, Qld 4811, Australia	James Cook University	Kolby, JE (corresponding author), James Cook Univ, Sch Publ Hlth Trop Med & Rehabil Sci, Hlth Res Grp 1, Townsville, Qld 4811, Australia.	jonathan.kolby@my.jcu.edu.au	Kolby, Jonathan/GWZ-3092-2022; Kolby, Jonathan/GWV-5557-2022		James Cook University Australian Postgraduate Research Scholarship	James Cook University Australian Postgraduate Research Scholarship	Jonathan Kolby was supported by a James Cook University Australian Postgraduate Research Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreone F, 2008, PLOS BIOL, V6, P943, DOI 10.1371/journal.pbio.0060118; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Boyle DG, 2003, DIS AQUAT ORGAN, V56, P59, DOI 10.3354/dao056059; Carey C, 2006, ECOHEALTH, V3, P5, DOI 10.1007/s10393-005-0006-4; Crottini A, 2011, NORTH-WEST J ZOOL, V7, P346; Daszak P, 2004, HERPETOL J, V14, P201; Daszak P, 1999, EMERG INFECT DIS, V5, P735, DOI 10.3201/eid0506.990601; Farrer RA, 2011, P NATL ACAD SCI USA, V108, P18732, DOI 10.1073/pnas.1111915108; Fisher Matthew C., 2007, Fungal Biology Reviews, V21, P2, DOI 10.1016/j.fbr.2007.02.002; Fisher MC, 2009, ANNU REV MICROBIOL, V63, P291, DOI 10.1146/annurev.micro.091208.073435; Garland S, 2010, DIS AQUAT ORGAN, V92, P113, DOI 10.3354/dao02053; Hyatt AD, 2007, DIS AQUAT ORGAN, V73, P175, DOI 10.3354/dao073175; Johnson ML, 2003, EMERG INFECT DIS, V9, P922; Lips KR, 2008, PLOS BIOL, V6, P441, DOI 10.1371/journal.pbio.0060072; Longcore JE, 1999, MYCOLOGIA, V91, P219, DOI 10.2307/3761366; Lotters S., 2011, BIODIVERSITY HOTSPOT, P255; Nichols DK, 2001, J WILDLIFE DIS, V37, P1; Olson DH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056802; Pounds JA, 2006, NATURE, V439, P161, DOI 10.1038/nature04246; Reeder NMM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033567; Richards-Hrdlicka KL, 2013, DIS AQUAT ORGAN, V102, P169, DOI 10.3354/dao02552; Schloegel LM, 2012, MOL ECOL, V21, P5162, DOI 10.1111/j.1365-294X.2012.05710.x; Schloegel LM, 2009, BIOL CONSERV, V142, P1420, DOI 10.1016/j.biocon.2009.02.007; Skerratt LF, 2008, DIS AQUAT ORGAN, V80, P85, DOI 10.3354/dao01923; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Vredenburg VT, 2012, HERPETOLOGY NOTES, V5, P507, DOI DOI 10.1186/1756-0500-5-507; Webb R, 2007, DIS AQUAT ORGAN, V74, P13, DOI 10.3354/dao074013; Weldon C, 2004, EMERG INFECT DIS, V10, P2100, DOI 10.3201/eid1012.030804; Weldon Che, 2008, Museo Regionale di Scienze Naturali Monografie (Turin), V45, P95	31	15	19	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e89660	10.1371/journal.pone.0089660	http://dx.doi.org/10.1371/journal.pone.0089660			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599336	Green Accepted, gold, Green Published			2022-12-27	WOS:000332479400022
J	Luna-Gomes, T; Filardy, AA; Rocha, JDB; Decote-Ricardo, D; LaRocque-de-Freitas, IF; Morrot, A; Bozza, PT; Castro-Faria-Neto, HC; DosReis, GA; Nunes, MP; Freire-de-Lima, CG				Luna-Gomes, Tatiana; Filardy, Alessandra A.; Rocha, Juliana Dutra B.; Decote-Ricardo, Debora; LaRocque-de-Freitas, Isabel Ferreira; Morrot, Alexandre; Bozza, Patricia T.; Castro-Faria-Neto, Hugo C.; DosReis, George A.; Nunes, Marise P.; Freire-de-Lima, Celio G.			Neutrophils Increase or Reduce Parasite Burden in Trypanosoma cruzi-Infected Macrophages, Depending on Host Strain: Role of Neutrophil Elastase	PLOS ONE			English	Article							APOPTOTIC CELLS; LEISHMANIA-MAJOR; MONOCLONAL-ANTIBODY; NITRIC-OXIDE; PHAGOCYTOSIS; MICE; RECOGNITION; GENERATION; DEPLETION; DRIVES	Neutrophils are involved in the initial steps of most responses to pathogens and are essential components of the innate immune response. Due to the ability to produce and release various soluble mediators, neutrophils may participate in the regulation of the inflammatory response. Little is known about the role of neutrophils during protozoan infections including infection by Trypanosoma cruzi. In the present study we investigated the importance of inflammatory neutrophils on macrophage activation and T. cruzi replication in vitro, in cells obtained from BALB/c mice and C57Bl/6 mice. Co-cultures of BALB/c apoptotic or live neutrophils with infected peritoneal macrophages resulted in increased replication of the parasites and in the production of TGF-beta and PGE(2). The treatment with anti-TGF-beta neutralizing antibody and COX inhibitor blocked the parasite replication in vitro. On the other hand, co-cultures of T. cruzi infected macrophages with live neutrophils isolated from C57BL/6 mice resulted in decreased number of trypomastigotes in culture and increased production of TNF-alpha and NO. The addition of anti-TNF-alpha neutralizing antibody or elastase inhibitor resulted in the abolishment of macrophage microbicidal effect and increased parasite replication. Addition of elastase to infected macrophages reduced the replication of the parasites, and on the other hand, addition of a selective inhibitor of iNOS increased parasite growth, suggesting the role of NO in this system. Our findings reveal that neutrophils may regulate T. cruzi experimental infection and determine susceptibility and resistance to infection.	[Luna-Gomes, Tatiana; Filardy, Alessandra A.; Rocha, Juliana Dutra B.; DosReis, George A.; Freire-de-Lima, Celio G.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941 Rio De Janeiro, Brazil; [Decote-Ricardo, Debora; LaRocque-de-Freitas, Isabel Ferreira] Univ Fed Rural Rio de Janeiro, Inst Vet, Rio De Janeiro, Brazil; [Morrot, Alexandre] Univ Fed Rio de Janeiro, Inst Microbiol Paulo Goes, Rio De Janeiro, Brazil; [Bozza, Patricia T.; Castro-Faria-Neto, Hugo C.; Nunes, Marise P.] Fiocruz MS, Inst Oswaldo Cruz, BR-21045900 Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal Rural do Rio de Janeiro (UFRRJ); Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz	Freire-de-Lima, CG (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941 Rio De Janeiro, Brazil.	celio@biof.ufrj.br	de Lima, Celio Geraldo Freire/A-9057-2012; Filardy, Alessandra/AAH-6034-2020; Bozza, Patricia T./AAM-4537-2021; Bozza, Patricia T./AAE-2933-2021; Decote-Ricardo, Debora/O-6480-2019	Filardy, Alessandra/0000-0003-4098-3235; Bozza, Patricia T./0000-0001-8349-9529; DosReis, George/0000-0002-8924-4727	Brazilian National Research Council (CNPq); Rio de Janeiro State Science Foundation (FAPERJ)	Brazilian National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Rio de Janeiro State Science Foundation (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by Brazilian National Research Council (CNPq) and Rio de Janeiro State Science Foundation (FAPERJ). The funders had no the role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A-Gonzalez N, 2009, IMMUNITY, V31, P245, DOI 10.1016/j.immuni.2009.06.018; Abdallah DSA, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00382; Appelberg R, 2007, TRENDS MICROBIOL, V15, P87, DOI 10.1016/j.tim.2006.11.009; Bliss SK, 1999, J IMMUNOL, V163, P2081; Chen L, 2001, EUR J IMMUNOL, V31, P265, DOI 10.1002/1521-4141(200101)31:1<265::AID-IMMU265>3.3.CO;2-C; CONTRERAS VT, 1985, MOL BIOCHEM PARASIT, V16, P315, DOI 10.1016/0166-6851(85)90073-8; D'Avila H, 2011, J INFECT DIS, V204, P951, DOI 10.1093/infdis/jir432; Daley JM, 2008, J LEUKOCYTE BIOL, V83, P64, DOI 10.1189/jlb.0407247; Carmo EVD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013815; Erwig LP, 2008, CELL DEATH DIFFER, V15, P243, DOI 10.1038/sj.cdd.4402184; Fadok VA, 2001, SEMIN IMMUNOL, V13, P365, DOI 10.1006/smim.2001.0333; Faurschou M, 2003, MICROBES INFECT, V5, P1317, DOI 10.1016/j.micinf.2003.09.008; Freire-de-Lima CG, 2006, J BIOL CHEM, V281, P38376, DOI 10.1074/jbc.M605146200; Freire-de-Lima CG, 2000, NATURE, V403, P199, DOI 10.1038/35003208; Fu LM, 2003, INT J TUBERC LUNG D, V7, P1027; GAZZINELLI RT, 1992, J IMMUNOL, V148, P1792; Gregory SH, 2002, J LEUKOCYTE BIOL, V72, P239; HASLETT C, 1994, PHILOS T ROY SOC B, V345, P327, DOI 10.1098/rstb.1994.0113; Henson PM, 2001, CURR BIOL, V11, pR795, DOI 10.1016/S0960-9822(01)00474-2; Hoffmann PR, 2005, J IMMUNOL, V174, P1393, DOI 10.4049/jimmunol.174.3.1393; Huynh MLN, 2002, J CLIN INVEST, V109, P41, DOI 10.1172/JCI200211638; Ji YS, 2013, EXP PARASITOL, V133, P70, DOI 10.1016/j.exppara.2012.10.013; KUDO C, 1993, J IMMUNOL, V150, P3728; KWON NS, 1989, J BIOL CHEM, V264, P20496; Laskay T, 2003, TRENDS MICROBIOL, V11, P210, DOI 10.1016/S0966-842X(03)00075-1; Lopes MF, 2000, IMMUNOL TODAY, V21, P489, DOI 10.1016/S0167-5699(00)01713-8; Meyer-Hoffert U, 2009, FRONT BIOSCI-LANDMRK, V14, P3409, DOI 10.2741/3462; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Nauseef WM, 2007, IMMUNOL REV, V219, P88, DOI 10.1111/j.1600-065X.2007.00550.x; Patel VA, 2012, J BIOL CHEM, V287, P13761, DOI 10.1074/jbc.M112.350843; Peters NC, 2008, SCIENCE, V321, P970, DOI 10.1126/science.1159194; Ribeiro-Gomes FL, 2006, PARASITOLOGY, V132, pS61, DOI 10.1017/S0031182006000862; Ribeiro-Gomes FL, 2004, J IMMUNOL, V172, P4454, DOI 10.4049/jimmunol.172.7.4454; Ribeiro-Gomes FL, 2007, J IMMUNOL, V179, P3988, DOI 10.4049/jimmunol.179.6.3988; Romani L, 1997, J IMMUNOL, V158, P2356; Savill J, 1997, BRIT MED BULL, V53, P491; van Zandbergen G, 2004, J IMMUNOL, V173, P6521, DOI 10.4049/jimmunol.173.11.6521; WEI XQ, 1995, NATURE, V375, P408, DOI 10.1038/375408a0; Zhang Y, 2010, J INTERF CYTOK RES, V30, P113, DOI 10.1089/jir.2010.0004	39	26	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90582	10.1371/journal.pone.0090582	http://dx.doi.org/10.1371/journal.pone.0090582			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599360	Green Submitted, gold, Green Published			2022-12-27	WOS:000332479400098
J	Frocklin, S; de la Torre-Castro, M; Hakansson, E; Carlsson, A; Magnusson, M; Jiddawi, NS				Frocklin, Sara; de la Torre-Castro, Maricela; Hakansson, Elin; Carlsson, Anna; Magnusson, Madeleine; Jiddawi, Narriman S.			Towards Improved Management of Tropical Invertebrate Fisheries: Including Time Series and Gender	PLOS ONE			English	Article							CHWAKA-BAY; MARINE INVERTEBRATE; OVER-EXPLOITATION; ZANZIBAR; ABUNDANCE	Invertebrate harvesting is an important livelihood in tropical settings providing income and food for numerous populations throughout the world. However, the lack of research, policy and management directed towards this livelihood hinders the analysis of time trends to evaluate invertebrate resources status. Another missing aspect is the consideration of gender analysis, i.e., the different roles and interests of men and women engaged in this activity. Based on interviews, catch assessments and inventories this multi-disciplinary study from Chwaka Bay (Zanzibar, Tanzania) shows how unregulated harvesting of invertebrates may result in sharp declines in animal abundance over a relatively short period of time (2005 to 2010), threatening the sustainability of the fishery. Specifically, the results show that catches in general, and prime target species of gastropods and bivalves in particular, had been significantly reduced in number and size. Interviews revealed gender disparities; female harvesters experienced less access to good fishing/ collecting grounds and species of high value, which subsequently resulted in lower individual income. This is tightly linked to women's reproductive roles, which not only leads to limited mobility but also lessen their chances to accumulate livelihood assets (natural, physical, financial, social and human capital) thus impacting livelihood strategies. To protect invertebrate resources from overexploitation, and assure a constant flow of income and food for future generations, this case study illustrates the need for formal monitoring to assess changes in invertebrate resources, and possible ecological consequences, over time. Managers and policy-makers must also address gender to evaluate the contribution of all resource users, their capacity to cope with changing conditions, as well as specific interests.	[Frocklin, Sara; Hakansson, Elin; Carlsson, Anna; Magnusson, Madeleine] Stockholm Univ, Dept Ecol Environm & Plant Sci, S-10691 Stockholm, Sweden; [de la Torre-Castro, Maricela] Stockholm Univ, Dept Phys Geog & Quaternary Geol, S-10691 Stockholm, Sweden; [de la Torre-Castro, Maricela] Stockholm Univ, Stockholm Resilience Ctr, S-10691 Stockholm, Sweden; [Jiddawi, Narriman S.] Univ Dar Salaam, Inst Marine Sci, Zanzibar, Tanzania	Stockholm University; Stockholm University; Stockholm University; University of Dar es Salaam	Frocklin, S (corresponding author), Stockholm Univ, Dept Ecol Environm & Plant Sci, S-10691 Stockholm, Sweden.	sara.frocklin@su.se			Swedish International Development Cooperation Agency, Sida; Swedish Research Council (Vetenskapsradet, VR)	Swedish International Development Cooperation Agency, Sida; Swedish Research Council (Vetenskapsradet, VR)(Swedish Research Council)	SF, AK, MM and EH were financed by the Swedish International Development Cooperation Agency, Sida. MTC was funded by The Swedish Research Council (Vetenskapsradet, VR). VR project: Genus, fattigdom och marina resurser. Project nr. ID (Avtals ID): B0544801; project holder MTC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal B, 2000, CAMB J ECON, V24, P283, DOI 10.1093/cje/24.3.283; Anderson M., 2005, PERMANOVA PERMUTATIO; Anderson SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024368; Andrew NL, 2002, OCEANOGR MAR BIOL, V40, P343; [Anonymous], 2004, CORAL REEF GUIDE RED; [Anonymous], 2002, FIELD GUIDE SEASHORE; Bostrom C, 1997, J SEA RES, V37, P153, DOI 10.1016/S1385-1101(96)00007-X; Bryman A., 2008, SOCIAL RES METHODS, V3rd; Castilla JC, 1998, ECOL APPL, V8, pS124, DOI 10.1890/1051-0761(1998)8[S124:SBFICO]2.0.CO;2; Cederlof U, 1995, AMBIO, V24, P458; Colin PL, 1995, TROPICAL PACIFIC INV; Crawford B, 2010, COAST MANAGE, V38, P195, DOI 10.1080/08920753.2010.483174; de la Torre-Castro M, 2004, OCEAN COAST MANAGE, V47, P361, DOI 10.1016/j.ocecoaman.2004.07.005; de la Torre-Castro M, 2012, PEOPLE NATURE RES CH, DOI DOI 10.1007/s10811-012-9842-0; de la Torre-Castro M, 2012, PEOPLE NATURE RES CH, P279; de la Torre-Castro M, 2006, ECOL SOC, V11; Di Ciommo RC, 2012, OCEAN COAST MANAGE, V62, P15, DOI 10.1016/j.ocecoaman.2012.02.010; EDGAR GJ, 1990, J EXP MAR BIOL ECOL, V137, P215, DOI 10.1016/0022-0981(90)90186-G; Ellis Frank, 2000, RURAL LIVELIHOODS DI; Eriksson BH, 2010, AQUAT LIVING RESOUR, V23, P387, DOI 10.1051/alr/2011002; Eriksson H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035504; Fernandez M, 1997, J SHELLFISH RES, V16, P371; Gossling S, 2004, BIODIVERS CONSERV, V13, P2623, DOI 10.1007/s10531-004-2139-0; Gullstrom M, 2006, ESTUAR COAST SHELF S, V67, P399, DOI 10.1016/j.ecss.2005.11.020; Gullstrom M., 2012, PEOPLE NATURE RES PR, P175; Hakansson E., 2012, PEOPLE NATURE RES CH, P235; Hall SJ, 2012, PNAS; Harding Sandra, 1986, SCI QUESTION FEMINIS; Harper S, 2013, MAR POLICY, V39, P56, DOI 10.1016/j.marpol.2012.10.018; Hobday AJ, 2001, REV FISH BIOL FISHER, V10, P493; IMF, 2013, WOR ECON OUTLOOK, P1; Jackson C, 1994, SOCIAL THEORY ENV; JAMIESON GS, 1993, AM ZOOL, V33, P551; Jiddawi N., 2012, PEOPLE NATURE RES CH, P23; Jiddawi N. S., 2012, PEOPLE NATURE RES CH, P193; Jiddawi NS, 2002, AMBIO, V31, P518, DOI 10.1639/0044-7447(2002)031[0518:MFIT]2.0.CO;2; Kvale S, 1994, INTRO QUALITATIVE RE; Leach M, 2007, DEV CHANGE, V38, P67, DOI 10.1111/j.1467-7660.2007.00403.x; Leiva GE, 2002, REV FISH BIOL FISHER, V11, P283; Lyimo T, 2012, PEOPLE NATURE RES CH, P17; Matthews E, 2012, GENDER PERSPECTIVE S; Medard M., 2002, GLOB S WOM FISH 6 AS, P155; NEWTON LC, 1993, BIOL CONSERV, V63, P241, DOI 10.1016/0006-3207(93)90719-H; Nordlund L, 2010, AQUAT LIVING RESOUR, V23, P399, DOI 10.1051/alr/2011006; Nordlund LM, 2014, AMBIO, V43, P1006, DOI 10.1007/s13280-013-0465-8; Perry RI, 1999, REV FISH BIOL FISHER, V9, P125, DOI 10.1023/A:1008946522213; PHILLIPS BF, 2007, FISHERIES MANAGEMENT, P231; Pinnegar JK, 2008, REV FISH BIOL FISHER, V18, P1, DOI 10.1007/s11160-007-9058-6; Population Census, 2012, POP HOUS CENS UN REP; Prescott J, 2013, MAR FRESHWATER RES, V64, P599, DOI 10.1071/MF12081; Roberts CM, 1999, TRENDS ECOL EVOL, V14, P241, DOI 10.1016/S0169-5347(98)01584-5; Siason IM, 2002, GLOB S WOM FISH 6 AS; Sprague J., 2016, FEMINIST METHODOLOGI; Tobisson E, 1998, AMBIO, V27, P677; Uthicke S, 2001, CORAL REEFS, V19, P271; Weeratunge N, 2010, FISH FISH, V11, P405, DOI 10.1111/j.1467-2979.2010.00368.x; Williams MJ, 2002, GLOB S WOM FISH 6 AS; Williams MJ, 2012, SPC WOMEN FISHERIES, V22; Wynter P, 1997, SAGE, V7, P33	59	48	48	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91161	10.1371/journal.pone.0091161	http://dx.doi.org/10.1371/journal.pone.0091161			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614075	gold, Green Published, Green Submitted			2022-12-27	WOS:000332839300086
J	Hayashi, A; Yamauchi, N; Shibahara, J; Kimura, H; Morikawa, T; Ishikawa, S; Nagae, G; Nishi, A; Sakamoto, Y; Kokudo, N; Aburatani, H; Fukayama, M				Hayashi, Akimasa; Yamauchi, Naoko; Shibahara, Junji; Kimura, Hiroshi; Morikawa, Teppei; Ishikawa, Shumpei; Nagae, Genta; Nishi, Akihiro; Sakamoto, Yoshihiro; Kokudo, Norihiro; Aburatani, Hiroyuki; Fukayama, Masashi			Concurrent Activation of Acetylation and Tri-Methylation of H3K27 in a Subset of Hepatocellular Carcinoma with Aggressive Behavior	PLOS ONE			English	Article							HIGH EXPRESSION; HISTONE MODIFICATIONS; POOR-PROGNOSIS; P53; GENE; EZH2; P300; OVEREXPRESSION; ASSOCIATION; PROTEINS	Analysis of acetylation and tri-methylation of the same residue of histone molecules might identify a subset of hepatocellular carcinoma (HCC) with aggressive behavior. In the present study, we examined acetylation and tri-methylation of lysine 27 on histone H3 (H3K27ac and H3K27me3, respectively) because these two modifications are known to exhibit opposite effects (enhancing and silencing) on gene expression. Neoplastic and non-neoplastic tissues from 198 HCC cases were immunostained with specific monoclonal antibodies against H3K27ac and H3K27me3. The stained tissues were evaluated by an image analyzing program to generate histological scores (H-scores, range 0-300), which were determined by multiplying the percentage of positive-stained cells with the classified immunohistochemical marker intensity (0-3). HCC tissues showed significantly higher H3K27ac (156.7 +/- 86.8) and H3K27me3 H-scores (151.8 +/- 78.1) compared with the background liver (40.3 +/- 33.0 and 64.7 +/- 45.6, respectively) (both P<0.001). The cases with H-scores of high-H3K27ac/high-H3K27me3 (n = 54) showed significant correlation with poor differentiation of morphology (P<0.01) and p53-positive staining (P<0.05), and poor prognosis (P<0.01). Confocal microscopy revealed segregated intranuclear localization of both modifications in the individual cancer cells: H3K27ac localization in central euchromatin regions and H3K27me3 in peripheral heterochromatin regions. Concurrent acetylation and methylation at H3K27 occurs in HCC cells in association with p53 abnormalities. These findings demonstrate that image analyzer-assisted H-scores of H3K27ac and H3K27me3 identified an aggressive subgroup of HCC, and could serve as a prognostic marker for HCC.	[Hayashi, Akimasa; Yamauchi, Naoko; Shibahara, Junji; Morikawa, Teppei; Fukayama, Masashi] Univ Tokyo, Grad Sch Med, Dept Pathol, Tokyo, Japan; [Hayashi, Akimasa; Nagae, Genta; Aburatani, Hiroyuki] Univ Tokyo, Adv Sci & Technol Res Ctr, Genome Sci Div, Tokyo, Japan; [Kimura, Hiroshi] Osaka Univ, Grad Sch Frontier Biosci, Biomol Networks Labs Grp, Suita, Osaka, Japan; [Ishikawa, Shumpei] Tokyo Med & Dent Univ, Med Res Inst, Dept Genom Pathol, Tokyo, Japan; [Sakamoto, Yoshihiro; Kokudo, Norihiro] Univ Tokyo, Grad Sch Med, Dept Surg, Hepatobiliary Pancreat Surg Div, Tokyo, Japan; [Nishi, Akihiro] Yale Inst Network Sci, New Haven, CT USA	University of Tokyo; University of Tokyo; Osaka University; Tokyo Medical & Dental University (TMDU); University of Tokyo	Fukayama, M (corresponding author), Univ Tokyo, Grad Sch Med, Dept Pathol, Tokyo, Japan.	mfukayama-tky@umin.net	Nagae, Genta/AAN-1167-2021; Nagae, Genta/H-6579-2019; Kimura, Hiroshi/B-9524-2015	Nagae, Genta/0000-0002-2929-7990; Kimura, Hiroshi/0000-0003-0854-083X; Nishi, Akihiro/0000-0003-1629-5985	New Energy and Industrial Technology Development Organization (NEDO), Japan [P10005]	New Energy and Industrial Technology Development Organization (NEDO), Japan(New Energy and Industrial Technology Development Organization (NEDO))	This work was supported by the grant, Technology development for drug discovery platform based on the epigenetic mechanism (P10005) from New Energy and Industrial Technology Development Organization (NEDO), Japan (http://www.nedo.go.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai X, 2008, J CANCER RES CLIN, V134, P83, DOI 10.1007/s00432-007-0252-7; Blanche P, 2013, STAT MED, V32, P5381, DOI 10.1002/sim.5958; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; Braun M, 2013, HISTOL HISTOPATHOL, V28, P605, DOI 10.14670/HH-28.605; Cai MY, 2011, MOL MED, V17, P12, DOI 10.2119/molmed.2010.00103; Chen X, 2002, MOL BIOL CELL, V13, P1929, DOI 10.1091/mbc.02-02-0023; Chervona Y, 2012, AM J CANCER RES, V2, P589; Di Agostino S, 2006, CANCER CELL, V10, P191, DOI 10.1016/j.ccr.2006.08.013; European Assoc Study Liver, 2012, EUR J CANCER, V48, P599, DOI 10.1016/j.ejca.2011.12.021; Garraway LA, 2013, CELL, V153, P17, DOI 10.1016/j.cell.2013.03.002; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Guichard C, 2012, NAT GENET, V44, P694, DOI 10.1038/ng.2256; He CC, 2012, HUM PATHOL, V43, P1425, DOI 10.1016/j.humpath.2011.11.003; Heagerty PJ, 2000, BIOMETRICS, V56, P337, DOI 10.1111/j.0006-341X.2000.00337.x; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Ho WH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029179; Hoshida Y, 2009, CANCER RES, V69, P7385, DOI 10.1158/0008-5472.CAN-09-1089; HSU HC, 1993, CANCER RES, V53, P4691; Japan LCSGo, 2003, GEN RUL CLIN PATH ST; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kimura H, 2008, CELL STRUCT FUNCT, V33, P61, DOI 10.1247/csf.07035; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Li M, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-5; LITTAU VC, 1964, P NATL ACAD SCI USA, V52, P93, DOI 10.1073/pnas.52.1.93; MAKUUCHI M, 1993, SEMIN SURG ONCOL, V9, P298, DOI 10.1002/ssu.2980090404; Ong CT, 2011, NAT REV GENET, V12, P283, DOI 10.1038/nrg2957; Quint K, 2011, VIRCHOWS ARCH, V459, P129, DOI 10.1007/s00428-011-1103-0; Research FfPoC, 2011, CANC STAT JAP 2011; Rikimaru T, 2007, ONCOLOGY-BASEL, V72, P69, DOI 10.1159/000111106; Salichs E, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000397; Sasaki M, 2008, LAB INVEST, V88, P873, DOI 10.1038/labinvest.2008.52; Seligson DB, 2009, AM J PATHOL, V174, P1619, DOI 10.2353/ajpath.2009.080874; Selvi BR, 2010, BBA-GENE REGUL MECH, V1799, P810, DOI 10.1016/j.bbagrm.2010.09.005; Shen H, 2013, CELL, V153, P38, DOI 10.1016/j.cell.2013.03.008; Song L, 2013, HISTOPATHOLOGY, V62, P343, DOI 10.1111/j.1365-2559.2012.04362.x; Sudo T, 2005, BRIT J CANCER, V92, P1754, DOI 10.1038/sj.bjc.6602531; Takayasu K, 2006, GASTROENTEROLOGY, V131, P461, DOI 10.1053/j.gastro.2006.05.021; Tamagawa H, 2013, EJSO-EUR J SURG ONC, V39, P655, DOI 10.1016/j.ejso.2013.02.023; Tandon P, 2009, LIVER INT, V29, P502, DOI 10.1111/j.1478-3231.2008.01957.x; Tang XH, 2004, ONCOGENE, V23, P5759, DOI 10.1038/sj.onc.1207706; Torbenson M, 2004, AM J CLIN PATHOL, V122, P377, DOI 10.1309/YH0H3FKYM4RMU1JF; Van Den Broeck A, 2008, CLIN CANCER RES, V14, P7237, DOI 10.1158/1078-0432.CCR-08-0869; Vleugel MM, 2006, HUM PATHOL, V37, P1085, DOI 10.1016/j.humpath.2006.03.015; Yamada A, 2011, INT J ONCOL, V38, P345, DOI 10.3892/ijo.2010.868; Yokomizo C, 2011, CANCER LETT, V310, P140, DOI 10.1016/j.canlet.2011.06.030	45	25	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91330	10.1371/journal.pone.0091330	http://dx.doi.org/10.1371/journal.pone.0091330			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614346	gold, Green Submitted, Green Published			2022-12-27	WOS:000332839300113
J	Jeffrey, M; Martin, S; Chianini, F; Eaton, S; Dagleish, MP; Gonzalez, L				Jeffrey, Martin; Martin, Stuart; Chianini, Francesca; Eaton, Samantha; Dagleish, Mark P.; Gonzalez, Lorenzo			Incidence of Infection in Prnp ARR/ARR Sheep following Experimental Inoculation with or Natural Exposure to Classical Scrapie	PLOS ONE			English	Article							BOVINE SPONGIFORM ENCEPHALOPATHY; DISEASE-ASSOCIATED PRP; PRION PROTEIN; CLINICAL SCRAPIE; SUFFOLK SHEEP; GENOTYPE; ACCUMULATION; BRAIN; AGENT; SUSCEPTIBILITY	The prion protein gene (Prnp) is highly influential in determining risk and susceptibility of sheep exposed to classical scrapie. Sheep homozygous for alanine at codon 136 and arginine at codons 154 and 171 (ARR/ARR) of the Prnp gene are historically considered to be highly resistant to classical scrapie, although they form a significant fraction of cases of atypical scrapie. To date, experimental transmission of prions to ARR/ARR sheep has only been achieved with the BSE agent and mostly by the intracerebral route. We summarise here the results of six separate studies, in which 95 sheep of the ARR/ARR genotype were naturally exposed to (n = 18) or experimentally challenged with (n = 77) natural or experimental sources of classical scrapie by the oral, intra-intestinal, subcutaneous or intracerebral routes and allowed to survive for periods of up to 94 months post-infection. Only the intracerebral route resulted in disease and/or amplification of disease associated PrP (PrP delta), and only in two of 19 sheep that survived for longer than 36 months. Discriminatory immunohistochemistry and Western blot confirmed the scrapie, non-BSE signature of PrP delta in those two sheep. However, the neuropathological phenotype was different from any other scrapie (classical or atypical) or BSE source previously reported in sheep of any Prnp genotype. These studies confirm the widely held view that ARR/ARR sheep are highly resistant to classical scrapie infection, at least within their commercial lifespan. Moreover, within the constraints of the present studies (only two infected sheep), these results do not support the suggestion that atypical scrapie or BSE are generated by adaptation or mutation of classical scrapie in sheep of resistant ARR/ARR genotype.	[Jeffrey, Martin; Martin, Stuart; Gonzalez, Lorenzo] Anim Hlth & Vet Labs Agcy AHVLA Lasswade, Penicuik, Midlothian, Scotland; [Chianini, Francesca; Eaton, Samantha; Dagleish, Mark P.] Moredun Res Inst, Penicuik, Midlothian, Scotland	Moredun Research Institute	Jeffrey, M (corresponding author), Anim Hlth & Vet Labs Agcy AHVLA Lasswade, Pentlands Sci Pk, Penicuik, Midlothian, Scotland.	martin.jeffrey@ahvla.gsi.gov.uk	González, Lorenzo/A-5325-2010; Chianini, Francesca/K-1451-2013; Jeffrey, Martin/D-2251-2009	González, Lorenzo/0000-0003-4199-4526; Chianini, Francesca/0000-0001-9962-446X; 	Defra [SE1851, SE1948, SE1949, SE1951/1955, SE1952, SE1953]	Defra(Department for Environment, Food & Rural Affairs (DEFRA))	The UK government supported these projects through the following Defra approved grants: SE1851, SE1948, SE1949, SE1951/1955, SE1952 and SE1953. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreoletti O, 2006, J GEN VIROL, V87, P1043, DOI 10.1099/vir.0.81318-0; Bencsik A, 2007, J INFECT DIS, V195, P989, DOI 10.1086/512087; Benestad SL, 2003, VET REC, V153, P202, DOI 10.1136/vr.153.7.202; Benestad SL, 2008, VET RES, V39, DOI 10.1051/vetres:2007056; Brun A, 2004, NEUROSCI RES, V48, P75, DOI 10.1016/j.neures.2003.09.004; Chianini F, 2013, VET IMMUNOL IMMUNOP, V152, P348, DOI 10.1016/j.vetimm.2013.01.005; Choi JK, 2006, HYBRIDOMA, V25, P271, DOI 10.1089/hyb.2006.25.271; Eaton SL, 2007, J GEN VIROL, V88, P1384, DOI 10.1099/vir.0.82197-0; Elsen JM, 1999, ARCH VIROL, V144, P431, DOI 10.1007/s007050050516; Goldmann W, 2008, VET RES, V39, DOI 10.1051/vetres:2008010; Gonzalez L, 2006, VET REC, V158, P325, DOI 10.1136/vr.158.10.325; Gonzalez L, 2005, J GEN VIROL, V86, P827, DOI 10.1099/vir.0.80299-0; Gonzalez L, 2013, J COMP PATH IN PRESS, DOI DOI 10.1016/J.JCPA.2013.10.00); Gonzalez L, 2013, J COMP PATH IN PRESS, DOI DOI 10.1016/J.JCPA.2013.06.006); Gonzalez L, 2007, J GEN VIROL, V88, P714, DOI 10.1099/vir.0.82426-0; Gonzalez L, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-55; Gonzalez L, 2012, J GEN VIROL, V93, P203, DOI 10.1099/vir.0.034652-0; Groschup MH, 2007, EMERG INFECT DIS, V13, P1201, DOI 10.3201/eid1308.070077; IKEDA T, 1995, J GEN VIROL, V76, P2577, DOI 10.1099/0022-1317-76-10-2577; Jacobs JG, 2011, J VIROL, V85, P12537, DOI 10.1128/JVI.00448-11; Jeffrey M, 2006, J PATHOL, V209, P4, DOI 10.1002/path.1962; Jeffrey M, 2006, J COMP PATHOL, V134, P17, DOI 10.1016/j.jcpa.2005.06.005; Jeffrey M, 2004, CURR TOP MICROBIOL, V284, P65; Jeffrey M, 2002, J COMP PATHOL, V127, P264, DOI 10.1053/jcpa.2002.0592; Jeffrey M, 2001, J COMP PATHOL, V125, P48, DOI 10.1053/jcpa.2001.0476; McIntyre KM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003994; Ryder SJ, 2009, BMC VET RES, V5, DOI 10.1186/1746-6148-5-9; Siso S, 2012, PRION, V6, P174, DOI 10.4161/pri.18990; Spraker TR, 2002, J VET DIAGN INVEST, V14, P3, DOI 10.1177/104063870201400102; Stack M, 2009, J GEN VIROL, V90, P764, DOI 10.1099/vir.0.005983-0; Thuring CMA, 2005, J COMP PATHOL, V132, P59, DOI 10.1016/j.jcpa.2004.06.004; Tongue SC, 2006, VET REC, V158, P43, DOI 10.1136/vr.158.2.43	32	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91026	10.1371/journal.pone.0091026	http://dx.doi.org/10.1371/journal.pone.0091026			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614120	Green Submitted, Green Published, gold			2022-12-27	WOS:000332839300067
J	Mocevic, E; Svendsen, SW; Jorgensen, KT; Frost, P; Bonde, JP				Mocevic, Emina; Svendsen, Susanne Wulff; Jorgensen, Kristian Tore; Frost, Poul; Bonde, Jens Peter			Occupational Lifting, Fetal Death and Preterm Birth: Findings from the Danish National Birth Cohort Using a Job Exposure Matrix	PLOS ONE			English	Article							WORKING HOURS; PHYSICAL-ACTIVITIES; RISK; PREGNANCY; PREECLAMPSIA; PREMATURITY; DELIVERY; WEIGHT	Objective: We examined the association between occupational lifting during pregnancy and risk of fetal death and preterm birth using a job exposure matrix (JEM). Methods: For 68,086 occupationally active women in the Danish National Birth Cohort, interview information on occupational lifting was collected around gestational week 16. We established a JEM based on information from women, who were still pregnant when interviewed. The JEM provided mean total loads lifted per day within homogeneous exposure groups as informed by job and industry codes. All women were assigned an exposure estimate from the JEM. We used Cox regression models with gestational age as underlying time variable and adjustment for covariates. Results: We observed 2,717 fetal deaths and 3,128 preterm births within the study cohort. No exposure-response relation was observed for fetal death, but for women with a prior fetal death, we found a hazard ratio (HR) of 2.87 (95% CI 1.37, 6.01) for stillbirth (fetal death >= 22 completed gestational weeks) among those who lifted >200 kg/day. For preterm birth, we found an exposure-response relation for primigravid women, reaching a HR of 1.43 (95% CI 1.13, 1.80) for total loads >200 kg per day. These findings correspond to an excess fraction of 11% for stillbirth and 10% for preterm birth. Conclusion: We found an increased risk of stillbirth among women with a prior fetal death, who lifted >200 kg/day, and an exposure-response relationship between occupational lifting and preterm birth among primigravid women. The study adds to a large body of prospective studies on occupational lifting and adverse pregnancy outcomes by refined exposure assessment.	[Mocevic, Emina; Jorgensen, Kristian Tore; Bonde, Jens Peter] Univ Copenhagen, Bispebjerg Hosp, Dept Occupat & Environm Med, Copenhagen, Denmark; [Svendsen, Susanne Wulff] Herning Reg Hosp, Univ Dept Occupat Med, Danish Ramazzini Ctr, Herning, Denmark; [Frost, Poul] Aarhus Univ Hosp, Danish Ramazzini Ctr, Dept Occupat Med, DK-8000 Aarhus, Denmark	Aarhus University; University of Copenhagen; Bispebjerg Hospital; Aarhus University; Aarhus University	Mocevic, E (corresponding author), Univ Copenhagen, Bispebjerg Hosp, Dept Occupat & Environm Med, Copenhagen, Denmark.	emina.mocevic.01@regionh.dk			Danish Working Environment Research Fund [20080016458]	Danish Working Environment Research Fund	This study is part of the Danish collaborative MINERVA project addressing occupational risk to human reproduction, which is supported by a grant from the Danish Working Environment Research Fund (contract 20080016458). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHLBORG G, 1990, INT J EPIDEMIOL, V19, P90, DOI 10.1093/ije/19.1.90; Andersen AMN, 2000, BRIT MED J, V320, P1708, DOI 10.1136/bmj.320.7251.1708; Armstrong BG, 1998, OCCUP ENVIRON MED, V55, P651, DOI 10.1136/oem.55.10.651; Bonde JP, 2013, SCAND J WORK ENV HEA, V39, P325, DOI 10.5271/sjweh.3337; Bonzini M, 2009, OCCUP ENVIRON MED, V66, P685, DOI 10.1136/oem.2008.043935; Bonzini M, 2007, OCCUP ENVIRON MED, V64, P228, DOI 10.1136/oem.2006.026872; Braveman PA, 2005, JAMA-J AM MED ASSOC, V294, P2879, DOI 10.1001/jama.294.22.2879; Burdorf A, 2011, OCCUP ENVIRON MED, V68, P197, DOI 10.1136/oem.2009.046516; Fenster L, 1997, EPIDEMIOLOGY, V8, P66, DOI 10.1097/00001648-199701000-00011; FLORACK EIM, 1993, INT J EPIDEMIOL, V22, P878, DOI 10.1093/ije/22.5.878; Henderson JJ, 2012, J MATERN-FETAL NEO M, V25, P642, DOI 10.3109/14767058.2011.597899; Juhl M, 2013, SCAND J WORK ENV HEA, V39, P335, DOI 10.5271/sjweh.3335; Langhoff-Roos J, 2006, BMJ-BRIT MED J, V332, P937, DOI 10.1136/bmj.38751.524132.2F; Lawson CC, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.08.006; Lohse Sarah Rytter, 2010, Clin Epidemiol, V2, P247, DOI 10.2147/CLEP.S13815; Nugteren JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039263; Olsen J, 2001, SCAND J PUBLIC HEALT, V29, P300, DOI 10.1177/14034948010290040201; Palmer KT, 2013, OCCUP ENVIRON MED, V70, P213, DOI 10.1136/oemed-2012-101032; Runge SB, 2013, OCCUP ENVIRON MED, V70, P782, DOI 10.1136/oemed-2012-101173; Saigal S, 2008, LANCET, V371, P261, DOI 10.1016/S0140-6736(08)60136-1; SAURELCUBIZOLLES MJ, 1991, J EPIDEMIOL COMMUN H, V45, P29, DOI 10.1136/jech.45.1.29; Snijder CA, 2012, OCCUP ENVIRON MED, V69, P543, DOI 10.1136/oemed-2011-100615; Wilcox AJ., 2010, FERTILITY PREGNANCY	23	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e90550	10.1371/journal.pone.0090550	http://dx.doi.org/10.1371/journal.pone.0090550			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614129	Green Published, Green Submitted, gold			2022-12-27	WOS:000332839300029
J	Fan, Z; Jiang, GF; Liu, YX; He, QX; Blanchard, B				Fan, Zhou; Jiang, Guo-Fang; Liu, Yu-Xiang; He, Qi-Xin; Blanchard, Benjamin			Population Explosion in the Yellow-Spined Bamboo Locust Ceracris kiangsu and Inferences for the Impact of Human Activity	PLOS ONE			English	Article							QINGHAI-TIBETAN PLATEAU; MITOCHONDRIAL-DNA; GENETIC-STRUCTURE; MOLECULAR EVIDENCE; COMPARATIVE PHYLOGEOGRAPHY; ENTOMOPATHOGENIC FUNGUS; AFLP; INSECT; POLYMORPHISM; DIVERSITY	Geographic distance and geographical barriers likely play a considerable role in structuring genetic variation in species, although some migratory species may have less phylogeographic structure on a smaller spatial scale. Here, genetic diversity and the phylogenetic structure among geographical populations of the yellow-spined bamboo locust, Ceracris kiangsu, were examined with 16S rDNA and amplified fragment length polymorphisms (AFLPs). In this study, no conspicuous phylogeographical structure was discovered from either Maximum parsimony (MP) and Neighbor-joining (NJ) phylogenetic analyses. The effect of geographical isolation was not conspicuous on a large spatial scale. At smaller spatial scales local diversity of some populations within mountainous areas were detected using Nei's genetic distance and AMOVA. There is a high level of genetic diversity and a low genetic differentiation among populations in the C. kiangsu of South and Southeast China. Our analyses indicate that C. kiangsu is a monophyletic group. Our results also support the hypothesis that the C. kiangsu population is in a primary differentiation stage. Given the mismatch distribution, it is likely that a population expansion in C. kiangsu occurred about 0.242 Ma during the Quaternary interglaciation. Based on historical reports, we conjecture that human activities had significant impacts on the C. kiangsu gene flow.	[Fan, Zhou; Jiang, Guo-Fang; Liu, Yu-Xiang] Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Biodivers & Biotechnol, Nanjing, Jiangsu, Peoples R China; [Jiang, Guo-Fang; He, Qi-Xin; Blanchard, Benjamin] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA	Nanjing Normal University; University of Michigan System; University of Michigan	Jiang, GF (corresponding author), Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Biodivers & Biotechnol, Nanjing, Jiangsu, Peoples R China.	cnjgf1208@163.com	Jiang, Guo-Fang/I-5236-2019	Jiang, Guo-Fang/0000-0003-0164-0950	National Natural Sciences Foundation of China [30670257, 30970339]; Nanjing Normal University Innovative Team Project [0319PM0902]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Nanjing Normal University Innovative Team Project; Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by grants from the National Natural Sciences Foundation of China (Nos. 30670257, 30970339, http://www.nsfc.gov.cn/) to Guo-Fang Jiang, Nanjing Normal University Innovative Team Project (No. 0319PM0902), and A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahern RG, 2009, MOL ECOL, V18, P343, DOI 10.1111/j.1365-294X.2008.04034.x; [Anonymous], 1963, ANIMAL SPECIES EVOLU; Apple LJ, 2010, MOL ECOL, V19, P1365; ArisBrosou S, 1996, MOL BIOL EVOL, V13, P494, DOI 10.1093/oxfordjournals.molbev.a025610; Arrigo N, 2011, MOL PHYLOGENET EVOL, V58, P33, DOI 10.1016/j.ympev.2010.11.009; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Ayoub NA, 2004, MOL ECOL, V13, P3453, DOI 10.1111/j.1365-294X.2004.02335.x; Balint M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031872; Bamboo Research Group Forestry Department of Henan Municipal Agricultural and Forestry Bureau, 1976, CHINESE FOREST SCI, P7; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Behura SK, 2006, MOL ECOL, V15, P3087, DOI 10.1111/j.1365-294X.2006.03014.x; Borer M, 2010, MOL PHYLOGENET EVOL, V57, P703, DOI 10.1016/j.ympev.2010.08.017; Chen B, 2011, HEREDITY, V106, P241, DOI 10.1038/hdy.2010.58; Chen Y, 2007, METALLOGENIC SYSTEM, P1; Comes HP, 2003, TAXON, V52, P451, DOI 10.2307/3647445; COOPER SJB, 1995, MOL ECOL, V4, P49, DOI 10.1111/j.1365-294X.1995.tb00191.x; De Moura PA, 2011, BMC GENET, V12, P1471; Devi UK, 2007, MYCOL RES, V111, P716, DOI 10.1016/j.mycres.2007.03.003; Ehrich D, 2006, MOL ECOL NOTES, V6, P603, DOI 10.1111/j.1471-8286.2006.01380.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fu YX, 1997, GENETICS, V147, P915; Fuentes-Contreras E, 2008, J ECON ENTOMOL, V101, P190, DOI 10.1603/0022-0493(2008)101[190:PGSOCM]2.0.CO;2; Galbreath KE, 2004, MOL ECOL, V13, P135, DOI 10.1046/j.1365-294X.2004.02026.x; Garcia JT, 2011, MOL PHYLOGENET EVOL, V61, P671, DOI 10.1016/j.ympev.2011.07.017; Hartl D.L., 1997, PRINCIPLES POPULATIO, V3rd ed.; Henan Native Fresh Food Company, 1978, J HENAN AGR U, P16; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hollingsworth PM, 2004, HEREDITY, V92, P490, DOI 10.1038/sj.hdy.6800445; Hrbek T, 2005, ANIM CONSERV, V8, P297, DOI 10.1017/S1367943005002210; Manrique-Poyato MI, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059041, 10.1371/journal.pone.0083712]; Inoue MK, 2009, BIODIVERSITY OTTAWA, V10, P2; [姜石生 JIANG Shisheng], 2011, [中南林业科技大学学报, Journal of Central South University of Forestry & Technology], V31, P115; Kambhampati S, 1995, INSECT MOL BIOL, V4, P233, DOI 10.1111/j.1365-2583.1995.tb00028.x; Kingman J.F.C., 1980, CBMS-NSF Regional Conference Series in Applied Mathematics, P1; Knowles LL, 2005, MOL ECOL, V14, P4023, DOI 10.1111/j.1365-294X.2005.02711.x; Knowles LL, 2000, EVOLUTION, V54, P1337, DOI 10.1111/j.0014-3820.2000.tb00566.x; Koblmuller S, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-7; Kosman E, 2005, MOL ECOL, V14, P415, DOI 10.1111/j.1365-294X.2005.02416.x; Kronforst MR, 2008, P ROY SOC B-BIOL SCI, V275, P493, DOI 10.1098/rspb.2007.1378; Lanave C, 2002, NUCLEIC ACIDS RES, V30, P174, DOI 10.1093/nar/30.1.174; Li SH, 2009, MOL ECOL, V18, P622, DOI 10.1111/j.1365-294X.2008.04028.x; Li T, 2011, GENETICA, V139, P511, DOI 10.1007/s10709-011-9573-1; Li XS, 2010, J INSECT CONSERV, V14, P257, DOI 10.1007/s10841-009-9254-x; Liu JW, 2006, ORIENT INSECTS, V40, P153, DOI 10.1080/00305316.2006.10417467; Lohse K, 2010, MOL ECOL, V30, P1365; Lunt DH, 1996, INSECT MOL BIOL, V5, P153, DOI 10.1111/j.1365-2583.1996.tb00049.x; Magri D, 2010, QUATERN INT, V219, P145, DOI 10.1016/j.quaint.2009.10.032; Mendelson TC, 2005, NATURE, V433, P375, DOI 10.1038/433375a; Meng LH, 2007, MOL ECOL, V16, P4128, DOI 10.1111/j.1365-294X.2007.03459.x; Meudt HM, 2007, TRENDS PLANT SCI, V12, P106, DOI 10.1016/j.tplants.2007.02.001; Mopper S, 1996, TRENDS ECOL EVOL, V11, P235, DOI 10.1016/0169-5347(96)10036-7; Morgan K, 2011, MOL ECOL, V20, P4533, DOI 10.1111/j.1365-294X.2011.05268.x; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; NEI M, 1978, GENETICS, V89, P583; Nei M., 2000, MOL EVOLUTION PHYLOG; Ortego J, 2010, MOL ECOL, V19, P472, DOI 10.1111/j.1365-294X.2009.04512.x; Pang JF, 2003, MOL PHYLOGENET EVOL, V27, P398, DOI 10.1016/S1055-7903(03)00019-8; Peterson MA, 1998, AM NAT, V152, P428, DOI 10.1086/286180; Poggio CE, 2002, J PROSTHET DENT, V87, P688, DOI 10.1067/mpr.2002.126421; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Posada D., 2003, CURRENT PROTOCOLS BI; Pritchard JK, 2000, GENETICS, V155, P945; Qu YH, 2009, MOL PHYLOGENET EVOL, V51, P312, DOI 10.1016/j.ympev.2009.01.013; Quek SP, 2010, P NATL ACAD SCI USA, V107, P7365, DOI 10.1073/pnas.0911572107; Rand DM, 1996, CONSERV BIOL, V10, P665, DOI 10.1046/j.1523-1739.1996.10020665.x; Roehrdanz R.L., 1993, Insect Molecular Biology, V2, P89, DOI 10.1111/j.1365-2583.1993.tb00129.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rosetti N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040807; ROZAS J, 2005, DNASP DNA SEQUENCE P; Rudh A, 2007, MOL ECOL, V16, P4284, DOI 10.1111/j.1365-294X.2007.03479.x; Russell AL, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-88; Scheffer SJ, 2007, MOL ECOL, V16, P2627, DOI 10.1111/j.1365-294X.2007.03303.x; Schonswetter P, 2004, J BIOGEOGR, V31, P1673, DOI 10.1111/j.1365-2699.2004.01103.x; Shen K, 2009, J INSECT PHYSIOL, V55, P78, DOI 10.1016/j.jinsphys.2008.10.011; Shen L, 2002, ACTA ECOLOGY SINICA, V22, P1985; Shreve SM, 2011, MOL ECOL, V20, P4433, DOI 10.1111/j.1365-294X.2011.05298.x; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; TAJIMA F, 1993, MECHANISMS OF MOLECULAR EVOLUTION, P37; TAJIMA F, 1989, GENETICS, V123, P597; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Teng ZQ, 2007, INSECT SCI, V14, P193, DOI 10.1111/j.1744-7917.2007.00143.x; Vekemans X, 2002, MOL ECOL, V11, P139, DOI 10.1046/j.0962-1083.2001.01415.x; Arana MV, 2010, MOL PHYLOGENET EVOL, V54, P941, DOI 10.1016/j.ympev.2009.11.007; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wright S, 1943, GENETICS, V28, P114; Xuan WJ, 2009, EUR J ENTOMOL, V106, P663, DOI 10.14411/eje.2009.082; Yeh F.C., 1999, MICROSOFT WINDOWS BA; Yeh WB, 2004, ANN ENTOMOL SOC AM, V97, P613, DOI 10.1603/0013-8746(2004)097[0613:GDOLAC]2.0.CO;2; Yi CL, 2005, QUATERNARY SCI, V25, P611; Yu HP, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.0145; Yu HP, 2011, ENTOMOL EXP APPL, V138, P71, DOI 10.1111/j.1570-7458.2010.01076.x; Yu HP, 2010, PHYSIOL ENTOMOL, V35, P379, DOI 10.1111/j.1365-3032.2010.00755.x; Yu HP, 2010, J INSECT BEHAV, V23, P472, DOI 10.1007/s10905-010-9230-z; Yu XW, 2003, FOREST HUMANKIND, V10, P50; Yu ZD, 2011, WORLD BAMBOO RATTAN, V9, P43; Zamoum T, 2005, HEREDITY, V94, P630, DOI 10.1038/sj.hdy.6800673; Zhan XJ, 2011, MOL ECOL, V20, P3014, DOI 10.1111/j.1365-294X.2011.05144.x; Zhang CS, 2007, MOL BIOTECHNOL, V36, P23, DOI 10.1007/s12033-007-0022-4; Zhang DX, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-144; Zhang DX, 1997, INSECT MOL BIOL, V6, P143, DOI 10.1111/j.1365-2583.1997.tb00082.x; Zhang MW, 2009, MOLECULAR PHYLOGENET, V54, P47; Zhang Q, 2005, MOL ECOL, V14, P3513, DOI 10.1111/j.1365-294X.2005.02677.x; Zhang XM, 2010, WORLD BAMBOO RATTAN, V8, P34; Zheng Z. M., 1998, FAUNA SINICA INSECTA; Zhivotovsky LA, 1999, MOL ECOL, V8, P907, DOI 10.1046/j.1365-294x.1999.00620.x; Zou YG, 2006, J FUJIAN FORESTRY SC, V33, P192	110	9	11	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e89873	10.1371/journal.pone.0089873	http://dx.doi.org/10.1371/journal.pone.0089873			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603526	gold, Green Published			2022-12-27	WOS:000332483600025
J	Lai, MS; Cheng, YS; Chen, PR; Tsai, SJ; Huang, BM				Lai, Meng-Shao; Cheng, Yu-Sheng; Chen, Pei-Rong; Tsai, Shaw-Jenq; Huang, Bu-Miin			Fibroblast Growth Factor 9 Activates Akt and MAPK Pathways to Stimulate Steroidogenesis in Mouse Leydig Cells	PLOS ONE			English	Article							HUMAN GLIOMA-CELLS; REGULATES STEROIDOGENESIS; FACTOR RECEPTORS; KINASE PATHWAYS; LUNG-CANCER; TUMOR-CELLS; EXPRESSION; BOVINE; DIFFERENTIATION; SB202190	Fibroblast growth factor 9 (FGF9) is a multifunctional polypeptide belonging to the FGF family and has functions related to bone formation, lens-fiber differentiation, nerve development, gap-junction formation and sex determination. In a previous study, we demonstrated that FGF9 stimulates the production of testosterone in mouse Leydig cells. In the present study, we used both primary mouse Leydig cells and MA-10 mouse Leydig tumor cells to further investigate the molecular mechanism of FGF9-stimulated steroidogenesis. Results showed that FGF9 significantly activated steroidogenesis in both mouse primary and tumor Leydig cells (p<0.05). Furthermore, FGF9 significantly induced the expression of phospho-Akt at 0.5 and 24 hr, phospho-JNK at 0.25, 0.5, and 24 hr, phospho-p38 at 0.5 hr, and phospho-ERK1/2 from 0.25 to 24 hr in primary Leydig cells (p<0.05). Also, FGF9 significantly up-regulated the expression of phospho-Akt at 3 hr, phospho-JNK at 0.25 hr, and phospho-ERK1/2 at 1 and 3 hr in MA-10 cells (p<0.05). Using specific inhibitors of Akt, JNK, p38, and ERK1/2, we further demonstrated that the inhibitors of Akt and ERK1/2 significantly suppressed the stimulatory effect of FGF9 on steroidogenesis in mouse Leydig cells. In conclusion, FGF9 specifically activated the Akt and ERK1/2 in normal mouse Leydig cells and the Akt, JNK and ERK1/2 in MA-10 mouse Leydig tumor cells to stimulate steroidogenesis.	[Lai, Meng-Shao; Huang, Bu-Miin] Natl Cheng Kung Univ, Coll Med, Inst Basic Med, Tainan 70101, Taiwan; [Lai, Meng-Shao; Chen, Pei-Rong; Huang, Bu-Miin] Natl Cheng Kung Univ, Coll Med, Dept Cell Biol & Anat, Tainan 70101, Taiwan; [Cheng, Yu-Sheng] Natl Cheng Kung Univ Hosp, Douliou Branch, Dept Urol, Yunlin, Taiwan; [Tsai, Shaw-Jenq] Natl Cheng Kung Univ, Coll Med, Dept Physiol, Tainan 70101, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University	Huang, BM (corresponding author), Natl Cheng Kung Univ, Coll Med, Inst Basic Med, Tainan 70101, Taiwan.	bumiin@mail.ncku.edu.tw	Tsai, Shaw-Jenq/AAG-6569-2019	TSAI, SHAW-JENQ/0000-0002-3569-5813	National Science Council Grants of Taiwan, Republic of China [NSC101-2320-B-006-005-MY3]; National Cheng Kung University Hospital Grant [NCKUH-10205009]	National Science Council Grants of Taiwan, Republic of China; National Cheng Kung University Hospital Grant	This work was supported by National Science Council Grants of Taiwan, Republic of China (NSC101-2320-B-006-005-MY3) and National Cheng Kung University Hospital Grant (NCKUH-10205009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SW, 2013, J BIOL CHEM, V288, P15937, DOI 10.1074/jbc.M113.451773; ASCOLI M, 1981, ENDOCRINOLOGY, V108, P88, DOI 10.1210/endo-108-1-88; Ascoli M, 2002, ENDOCR REV, V23, P141, DOI 10.1210/er.23.2.141; Brion L, 2011, ENDOCRINOLOGY, V152, P2665, DOI 10.1210/en.2011-0021; Chung CL, 2013, FERTIL STER IN PRESS; Coffey E, 2013, J HISTOCHEM CYTOCHEM, V61, P671, DOI 10.1369/0022155413497366; Cohen RI, 2000, J NEUROSCI RES, V61, P273, DOI 10.1002/1097-4547(20000801)61:3<273::AID-JNR5>3.0.CO;2-I; Colvin JS, 2001, CELL, V104, P875, DOI 10.1016/S0092-8674(01)00284-7; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Falvella FS, 2009, INT J CANCER, V124, P2880, DOI 10.1002/ijc.24302; Guijarro MV, 2012, ONCOGENE, V31, P4447, DOI 10.1038/onc.2011.619; Hirakawa T, 2002, ENDOCRINOLOGY, V143, P1026, DOI 10.1210/en.143.3.1026; Hiramatsu R, 2010, DEVELOPMENT, V137, P303, DOI 10.1242/dev.040519; Hiramatsu R, 2009, DEVELOPMENT, V136, P129, DOI 10.1242/dev.029587; Hirosawa M, 2009, LEUKEMIA RES, V33, P693, DOI 10.1016/j.leukres.2008.09.028; JOHNSON DE, 1993, ADV CANCER RES, V60, P1; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kim JY, 2010, TOXICOL LETT, V193, P200, DOI 10.1016/j.toxlet.2010.01.011; Lin YM, 2010, INT J ANDROL, V33, P545, DOI 10.1111/j.1365-2605.2009.00966.x; Lovicu FJ, 1998, DEVELOPMENT, V125, P3365; Maillard V, 2011, REPRODUCTION, V141, P467, DOI 10.1530/REP-10-0419; Manna Pulak R, 2011, J Signal Transduct, V2011, P821615, DOI 10.1155/2011/821615; Matsui Y, 2007, CANCER RES, V67, P1212, DOI 10.1158/0008-5472.CAN-06-3283; Menon MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023054; MOHAMMADI M, 1991, MOL CELL BIOL, V11, P5068, DOI 10.1128/MCB.11.10.5068; Muniyappa H, 2008, CELL SIGNAL, V20, P675, DOI 10.1016/j.cellsig.2007.12.003; NARUO K, 1993, J BIOL CHEM, V268, P2857; Niederst MJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004652; Norman M, 2012, J CELL SCI, V125, P59, DOI 10.1242/jcs.085803; Pao HY, 2012, J AGR FOOD CHEM, V60, P4905, DOI 10.1021/jf205091b; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Qiao DH, 2013, MOL CELL BIOL, V33, P4408, DOI 10.1128/MCB.00238-13; Reuss B, 2000, GLIA, V30, P231, DOI 10.1002/(SICI)1098-1136(200005)30:3<231::AID-GLIA3>3.3.CO;2-T; Romero I, 2012, ENDOCRINOLOGY, V153, P1593, DOI 10.1210/en.2011-2123; SAEZ JM, 1994, ENDOCR REV, V15, P574, DOI 10.1210/er.15.5.574; Schreiber NB, 2012, J ENDOCRINOL, V215, P167, DOI 10.1530/JOE-12-0293; Schreiber NB, 2012, ENDOCRINOLOGY, V153, P4491, DOI 10.1210/en.2012-1003; Wang Q, 2013, ENDOCRINOLOGY, V154, P956, DOI 10.1210/en.2012-1836; Yao B, 2011, ASIAN J ANDROL, V13, P438, DOI 10.1038/aja.2010.158	40	38	39	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90243	10.1371/journal.pone.0090243	http://dx.doi.org/10.1371/journal.pone.0090243			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603862	Green Published, gold, Green Submitted			2022-12-27	WOS:000332483600035
J	Lourenco, BH; Cardoso, MA				Lourenco, Barbara H.; Cardoso, Marly A.		ACTION Study Team	C-Reactive Protein Concentration Predicts Change in Body Mass Index during Childhood	PLOS ONE			English	Article							MIDDLE-AGED ADULTS; WEIGHT-GAIN; LIFE-COURSE; INFLAMMATION; HEALTH; NUTRITION; CHILDREN; DISEASE; MARKERS; OBESITY	Objective: Inflammation may constitute an underlying mechanism for increased risk of developing chronic diseases in later years, but few prospective studies have assessed the influence of low-grade inflammation on body weight gain, particularly among children in low-to middle-income settings with lower prevalence of overweight and obesity. We aimed to investigate whether C-reactive protein (CRP), as a biomarker of low-grade inflammation, predicts changes in body mass index-for-age z scores (BAZ) during childhood. Methods: A population-based longitudinal study was conducted in the Brazilian Amazon among children aged <= 10 years in 2007, with follow-up visits in 2009 and 2012. Outcome was annual change in BAZ. As the main exposure of interest, CRP concentrations were divided into four categories, with values <1 mg/L divided in tertiles plus a fourth category with values ranging from 1 to 10 mg/L. Children were simultaneously screened for iron and vitamin A deficiencies, diarrhea, and wheezing. We used mixed-effect linear regression models to measure the effect of CRP concentrations on annual BAZ change and linear regression models to explore CRP predictors at baseline. Results: At baseline, 1007 children had CRP and anthropometric data [ mean (SD) age: 5.3 (2.9) years; 50.9% male, 84.5% mulatto/mixed-race, 14.0% at risk for overweight or obesity, 4.8% stunted]; 737 were successfully followed up. Morbidities and nutritional deficiencies were widespread. Among participants aged >5 years, children in the highest tertile of CRP <1 mg/L at baseline, regarded as an indicator of low-grade inflammation, had a 0.04 z/y higher gain in BAZ (95% CI: 0.01, 0.09 z/y) during follow-up. CRP was positively associated with household poverty and worse nutritional indicators. Conclusions: We found evidence of a role for low-grade inflammation in predicting annual BAZ gain among children aged >5 years.	[Lourenco, Barbara H.] Univ Sao Paulo, Publ Hlth Nutr Program, Sch Publ Hlth, Sao Paulo, Brazil; [Cardoso, Marly A.] Univ Sao Paulo, Dept Nutr, Sch Publ Hlth, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Cardoso, MA (corresponding author), Univ Sao Paulo, Dept Nutr, Sch Publ Hlth, Sao Paulo, Brazil.	marlyac@usp.br	Lourenco, Barbara/H-8291-2012; Cardoso, Marly Augusto/B-8010-2013	Lourenco, Barbara/0000-0002-2006-674X; Cardoso, Marly Augusto/0000-0003-0973-3908	Brazilian National Counsel of Technological and Scientific Development, CNPq [551359/2001-3, 502937/2003-3, 307728/2006-4, 470573/2007-4]; Sao Paulo Research Foundation, FAPESP [2007/53042-1]; FAPESP [2008/57796-3]; Organization of American States [20100656]	Brazilian National Counsel of Technological and Scientific Development, CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Sao Paulo Research Foundation, FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Organization of American States	This study was funded by the Brazilian National Counsel of Technological and Scientific Development, CNPq (Grant nos. 551359/2001-3, 502937/2003-3, 307728/2006-4, and 470573/2007-4) and the Sao Paulo Research Foundation, FAPESP (Grant no. 2007/53042-1). BHL received PhD scholarships from the FAPESP (Grant no. 2008/57796-3) and the Organization of American States (BR Self Grad 2010/11, ID 20100656). The views expressed in this paper are those of the authors and not necessarily those of any funding agencies or others whose support is acknowledged. The funders had no influence on the study design, data collection, analysis or interpretation, decision to publish, or preparation of the manuscript.	Aeberli I, 2006, AM J CLIN NUTR, V84, P748, DOI 10.1093/ajcn/84.4.748; [Anonymous], 2009, WHO GLOBAL DATABASE; Augusto RA, 2013, PUBLIC HEALTH NUTR, V16, P256; Barros FC, 2010, REV SAUDE PUBL, V44, P1, DOI 10.1590/S0034-89102010000100001; Cardoso MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036341; Chen K, 2006, NAT MED, V12, P425, DOI 10.1038/nm1372; Cobayashi F, 2014, PUBLIC HEALTH NUTR, V17, P551, DOI 10.1017/S1368980013000190; Danese A, 2007, P NATL ACAD SCI USA, V104, P1319, DOI 10.1073/pnas.0610362104; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; DeBoer MD, 2012, NUTR REV, V70, P642, DOI 10.1111/j.1753-4887.2012.00543.x; Dewey KG, 2011, MATERN CHILD NUTR, V7, P129, DOI 10.1111/j.1740-8709.2011.00357.x; Duncan BB, 2000, OBES RES, V8, P279, DOI 10.1038/oby.2000.33; Egger G, 2009, OBES REV, V10, P237, DOI 10.1111/j.1467-789X.2008.00542.x; Engstrom G, 2003, DIABETES, V52, P2097, DOI 10.2337/diabetes.52.8.2097; Finch CE, 2004, SCIENCE, V305, P1736, DOI 10.1126/science.1092556; Gomes LF, 2004, ANTIOXID REDOX SIGN, V6, P237, DOI 10.1089/152308604322899305; Holz T, 2010, OBESITY, V18, P2347, DOI 10.1038/oby.2010.73; Howe LD, 2013, J EPIDEMIOL COMMUN H, V67, P358, DOI 10.1136/jech-2012-201892; Kaptoge S, 2012, NEW ENGL J MED, V367, P1310, DOI 10.1056/NEJMoa1107477; Lakshmy R, 2011, INT J EPIDEMIOL, V40, P102, DOI 10.1093/ije/dyq121; Lam QLK, 2007, CELL MOL IMMUNOL, V4, P1; Lohman T. G., 1998, ANTROPOMETRIC STANDA; Lourenco BH, 2015, MATERN CHILD NUTR, V11, P240, DOI 10.1111/mcn.12005; Margolis R, 2010, ADV LIFE COURSE RES, V15, P132, DOI 10.1016/j.alcr.2010.10.001; Maslova E, 2009, FOOD NUTR BULL, V30, P103, DOI 10.1177/156482650903000201; Monteiro CA, 2011, PUBLIC HEALTH NUTR, V14, P5, DOI 10.1017/S1368980010003241; Muniz PT, 2007, CAD SAUDE PUBLICA, V23, P1283, DOI 10.1590/S0102-311X2007000600004; Nazmi A, 2009, AM J HUM BIOL, V21, P192, DOI 10.1002/ajhb.20852; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Procaccini C, 2012, MOL ASPECTS MED, V33, P35, DOI 10.1016/j.mam.2011.10.012; Scagliusi FB, 2011, CAD SAUDE PUBLICA, V27, P2196; Skinner AC, 2010, PEDIATRICS, V125, pE801, DOI 10.1542/peds.2009-2182; Slopen N, 2013, PSYCHONEUROENDOCRINO, V38, P188, DOI 10.1016/j.psyneuen.2012.05.013; STRACK AM, 1995, AM J PHYSIOL-REG I, V268, pR142, DOI 10.1152/ajpregu.1995.268.1.R142; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Tanner J.H., 1962, GROWTH ADOLESCENTS; Tzoulaki I, 2008, EUR HEART J, V29, P1049, DOI 10.1093/eurheartj/ehn105; WHO, 2006, ACTA PAEDIATR, P76, DOI DOI 10.1111/J.1651-2227.2006.TB02378.X; World Health Organization Centers for Disease Control and Prevention, 2007, ASS IR STAT POP; Zhu JH, 2000, AM J CARDIOL, V85, P140, DOI 10.1016/S0002-9149(99)00653-0	40	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90357	10.1371/journal.pone.0090357	http://dx.doi.org/10.1371/journal.pone.0090357			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603645	Green Submitted, gold, Green Published			2022-12-27	WOS:000332483600047
J	Manichaikul, A; Rich, SS; Perry, H; Yeboah, J; Law, M; Davis, M; Parker, M; Ragosta, M; Connelly, JJ; McNamara, CA; Taylor, AM				Manichaikul, Ani; Rich, Stephen S.; Perry, Heather; Yeboah, Joseph; Law, Michelle; Davis, Molly; Parker, Matthew; Ragosta, Michael; Connelly, Jessica J.; McNamara, Coleen A.; Taylor, Angela M.			A Functionally Significant Polymorphism in ID3 Is Associated with Human Coronary Pathology	PLOS ONE			English	Article							BINDING INHIBITOR ID3; T-CELLS; INTRAVASCULAR ULTRASOUND; SJOGRENS-SYNDROME; ARTERY-DISEASE; MOUSE MODEL; ATHEROSCLEROSIS; MICE; 12/15-LIPOXYGENASE; DIFFERENTIATION	Aims: We previously identified association between the ID3 SNP rs11574 and carotid intima-media thickness in the Diabetes Heart Study, a predominantly White diabetic population. The nonsynonymous SNP rs11574 results in an amino acid substitution in the C-terminal region of ID3, attenuating the dominant negative function of ID3 as an inhibitor of basic HLH factor E12-mediated transcription. In the current investigation, we characterize the association between the functionally significant polymorphism in ID3, rs11574, with human coronary pathology. Methods and Results: The Multi-Ethnic Study of Atherosclerosis (MESA) is a longitudinal study of subclinical cardiovascular disease, including non-Hispanic White (n = 2,588), African American (n = 2,560) and Hispanic (n = 2,130) participants with data on coronary artery calcium (CAC). The Coronary Assessment in Virginia cohort (CAVA) included 71 patients aged 30-80 years, undergoing a medically necessary cardiac catheterization and intravascular ultrasound (IVUS) at the University of Virginia. ID3 SNP rs11574 risk allele was associated with the presence of CAC in MESA Whites (P = 0.017). In addition, the risk allele was associated with greater atheroma burden and stenosis in the CAVA cohort (P = 0.003, P = 0.04 respectively). The risk allele remained predictive of atheroma burden in multivariate analysis (Model 1: covariates age, gender, and LDL, regression coefficient = 9.578, SE = 3.657, p = 0.0110; Model 2: covariates Model 1, presence of hypertension, presence of diabetes, regression coefficient = 8.389, SE = 4.788, p = 0.0163). Conclusions: We present additional cohorts that demonstrate association of ID3 SNP rs11574 directly with human coronary artery pathology as measured by CAC and IVUS: one a multiethnic, relatively healthy population with low levels of diabetes and the second a predominantly White population with a higher incidence of T2DM referred for cardiac catheterization.	[Manichaikul, Ani; Rich, Stephen S.] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA USA; [Manichaikul, Ani] Univ Virginia, Dept Publ Hlth Sci, Div Biostat & Epidemiol, Charlottesville, VA USA; [Perry, Heather; Law, Michelle; Davis, Molly; Parker, Matthew; Connelly, Jessica J.; McNamara, Coleen A.; Taylor, Angela M.] Univ Virginia, Cardiovasc Res Ctr, Charlottesville, VA 22903 USA; [Yeboah, Joseph] Wake Forest Univ Hlth Sci, Dept Internal Med Cardiol, Winston Salem, NC USA; [Law, Michelle; Ragosta, Michael; Connelly, Jessica J.; McNamara, Coleen A.; Taylor, Angela M.] Univ Virginia, Dept Med, Div Cardiovasc Med, Charlottesville, VA USA	University of Virginia; University of Virginia; University of Virginia; Wake Forest University; Wake Forest University School of Medicine; University of Virginia	Taylor, AM (corresponding author), Univ Virginia, Cardiovasc Res Ctr, Charlottesville, VA 22903 USA.	amt6b@virginia.edu		Manichaikul, Ani/0000-0002-5998-795X; Taylor, Angela/0000-0003-4927-4320; Rich, Stephen/0000-0003-3872-7793	NIH [P01 HL55798, R01 HL096447, R01 HL107490, K23HL093118-04]; Pfizer Preventive Cardiology Award; National Heart, Lung, and Blood Institute (NHLBI) [N01-HC-95159, N01-HC-95169, RR-024156]; NHLBI [N02-HL-6-4278];  [R01HL071051];  [R01HL071205];  [R01HL071250];  [R01HL071251];  [R01HL071252];  [R01HL071258];  [R01HL071259]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC095159, N01HC095169] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024156] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071259, R01HL071250, R01HL071252, R01HL064278, P01HL055798, R01HL071251, R01HL107490, T32HL007355, R01HL096447, R01HL071051, R01HL136098, K23HL093118, R01HL071258, R01HL071205] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pfizer Preventive Cardiology Award; National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ; ; ; ; ; ; ; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The CAVA study was supported by NIH P01 HL55798 (CAM), NIH R01 HL096447 (CAM), NIH R01 HL107490 (CAM), K23HL093118-04 (AMT), Pfizer Preventive Cardiology Award (AMT). The funders of the CAVA study had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. MESA and the MESA SHARe project are conducted and supported by contracts N01-HC-95159 through N01-HC-95169 and RR-024156 from the National Heart, Lung, and Blood Institute (NHLBI). Funding for MESA SHARe genotyping was provided by NHLBI Contract N02-HL-6-4278. MESA Family is conducted and supported in collaboration with MESA investigators; support is provided by grants and contracts R01HL071051, R01HL071205, R01HL071250, R01HL071251, R01HL071252, R01HL071258, R01HL071259. The funders (NHLBI) had a significant role in design and data collection for the MESA study. The funders had no role in analysis, decision to publish, or preparation of the manuscript.	Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Calvert PA, 2011, JACC-CARDIOVASC IMAG, V4, P894, DOI 10.1016/j.jcmg.2011.05.005; Campbell KA, 2012, CIRC RES, V110, P889, DOI 10.1161/CIRCRESAHA.111.263186; Chan L, 1994, CARDIOL REV, V2, P130, DOI DOI 10.1097/00045415-199405000-00003; Chou MY, 2009, J CLIN INVEST, V119, P1335, DOI 10.1172/JCI36800; Deliri H, 2011, ARTERIOSCL THROM VAS, V31, P110, DOI 10.1161/ATVBAHA.110.212068; Doran AC, 2012, CIRC RES, V110, pE1, DOI 10.1161/CIRCRESAHA.111.256438; Doran AC, 2010, CIRC RES, V106, P1303, DOI 10.1161/CIRCRESAHA.109.210294; Guo ZL, 2011, IMMUNOL LETT, V135, P34, DOI 10.1016/j.imlet.2010.09.009; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Ji Y, 2011, NAT IMMUNOL, V12, P1230, DOI 10.1038/ni.2153; Jones-Mason ME, 2012, IMMUNITY, V36, P348, DOI 10.1016/j.immuni.2012.02.010; KEYS A, 1986, AM J EPIDEMIOL, V124, P903, DOI 10.1093/oxfordjournals.aje.a114480; Lahoute C, 2011, NAT REV CARDIOL, V8, P348, DOI 10.1038/nrcardio.2011.62; Li HM, 2004, IMMUNITY, V21, P551, DOI 10.1016/j.immuni.2004.08.013; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Lipinski MJ, 2012, ARTERIOSCL THROM VAS, V32, P2855, DOI 10.1161/ATVBAHA.112.300352; Lusis MJ, 2004, ANNU REV GENOM HUM G, V5, P189, DOI [10.1146/annurev.genom.5.061903.175930, 10.1016/j.tig.2012.03.001]; Mahlios J, 2011, MOL IMMUNOL, V49, P227, DOI 10.1016/j.molimm.2011.08.012; Maruyama T, 2011, NAT IMMUNOL, V12, P86, DOI 10.1038/ni.1965; Mintz GS, 2001, J AM COLL CARDIOL, V37, P1478, DOI 10.1016/S0735-1097(01)01175-5; Miyazaki M, 2011, NAT IMMUNOL, V12, P992, DOI 10.1038/ni.2086; Morris-Rosenfeld S, 2013, EXPERT REV CLIN IMMU; NICHAMAN MZ, 1975, AM J EPIDEMIOL, V102, P491, DOI 10.1093/oxfordjournals.aje.a112187; Nicholls SJ, 2010, J AM COLL CARDIOL, V55, P2399, DOI 10.1016/j.jacc.2010.02.026; Perry HM, 2013, ARTERIOSCL THROM VAS, V33, P2771, DOI 10.1161/ATVBAHA.113.302571; Ragosta M, 2011, J CARDIOVASC TRANSL, V4, P385, DOI 10.1007/s12265-011-9274-2; Taylor AM, 2005, ARTERIOSCL THROM VAS, V25, P2069, DOI 10.1161/01.ATV.0000178992.40088.f2; Tsimikas S, 2007, J LIPID RES, V48, P425, DOI 10.1194/jlr.M600361-JLR200; Wang Q, 2004, AM J HUM GENET, V74, P262, DOI 10.1086/381560; Welch CL, 2001, P NATL ACAD SCI USA, V98, P7946, DOI 10.1073/pnas.141239098; Yang CY, 2011, NAT IMMUNOL, V12, P1221, DOI 10.1038/ni.2158; Yeboah J, 2012, JAMA-J AM MED ASSOC, V308, P788, DOI 10.1001/jama.2012.9624	34	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90222	10.1371/journal.pone.0090222	http://dx.doi.org/10.1371/journal.pone.0090222			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603695	gold, Green Submitted, Green Published			2022-12-27	WOS:000332483600030
J	Petri, I; Dumbell, R; Scherbarth, F; Steinlechner, S; Barrett, P				Petri, Ines; Dumbell, Rebecca; Scherbarth, Frank; Steinlechner, Stephan; Barrett, Perry			Effect of Exercise on Photoperiod-Regulated Hypothalamic Gene Expression and Peripheral Hormones in the Seasonal Dwarf Hamster Phodopus sungorus	PLOS ONE			English	Article							MELATONIN-RELATED RECEPTOR; GROWTH-FACTOR 21; BODY-WEIGHT; SIBERIAN HAMSTER; DJUNGARIAN HAMSTER; ARCUATE NUCLEUS; FOOD-INTAKE; SKELETAL-MUSCLE; NEUROPEPTIDE-Y; MESSENGER-RNA	The Siberian hamster (Phodopus sungorus) is a seasonal mammal responding to the annual cycle in photoperiod with anticipatory physiological adaptations. This includes a reduction in food intake and body weight during the autumn in anticipation of seasonally reduced food availability. In the laboratory, short-day induction of body weight loss can be reversed or prevented by voluntary exercise undertaken when a running wheel is introduced into the home cage. The mechanism by which exercise prevents or reverses body weight reduction is unknown, but one hypothesis is a reversal of short-day photoperiod induced gene expression changes in the hypothalamus that underpin body weight regulation. Alternatively, we postulate an exercise-related anabolic effect involving the growth hormone axis. To test these hypotheses we established photoperiod-running wheel experiments of 8 to 16 weeks duration assessing body weight, food intake, organ mass, lean and fat mass by magnetic resonance, circulating hormones FGF21 and insulin and hypothalamic gene expression. In response to running wheel activity, short-day housed hamsters increased body weight. Compared to short-day housed sedentary hamsters the body weight increase was accompanied by higher food intake, maintenance of tissue mass of key organs such as the liver, maintenance of lean and fat mass and hormonal profiles indicative of long day housed hamsters but there was no overall reversal of hypothalamic gene expression regulated by photoperiod. Therefore the mechanism by which activity induces body weight gain is likely to act largely independently of photoperiod regulated gene expression in the hypothalamus.	[Petri, Ines; Scherbarth, Frank; Steinlechner, Stephan] Univ Vet Med, Dept Zool, Hannover, Germany; [Dumbell, Rebecca; Barrett, Perry] Univ Aberdeen, Rowett Inst Nutr & Hlth, Aberdeen, Scotland	University of Veterinary Medicine Hannover, Foundation; University of Aberdeen	Barrett, P (corresponding author), Univ Aberdeen, Rowett Inst Nutr & Hlth, Aberdeen, Scotland.	P.Barrett@abdn.ac.uk	Steinlechner, Stephan/AAF-5703-2021; Dumbell, Rebecca/AES-7678-2022	Dumbell, Rebecca/0000-0002-8805-3777; Steinlechner, Stephan/0000-0002-9435-3469; Barrett, Perry/0000-0003-3604-2950	Scottish Government; Deutsche Forschunsgemeinschaft (DFG) [Ste 331/8-1]	Scottish Government; Deutsche Forschunsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by the Scottish Government in the laboratory of PB. Work in the laboratory of SS was supported by a grant from the Deutsche Forschunsgemeinschaft (DFG, Ste 331/8-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam CL, 2000, ENDOCRINOLOGY, V141, P4349, DOI 10.1210/en.141.12.4349; Adams VL, 2006, ENDOCRINOLOGY, V147, P4843, DOI 10.1210/en.2006-0408; Atgie C, 2009, J PHYSIOL BIOCHEM, V65, P377, DOI 10.1007/BF03185933; Barrett P, 2005, ENDOCRINOLOGY, V146, P1930, DOI 10.1210/en.2004-1452; Barrett P, 2009, ENDOCRINOLOGY, V150, P3655, DOI 10.1210/en.2008-1620; Barrett P, 2007, ENDOCRINOLOGY, V148, P3608, DOI 10.1210/en.2007-0316; Barrett P, 2006, J ENDOCRINOL, V191, P687, DOI 10.1677/joe.1.06929; Barrett P, 2012, J PINEAL RES, V52, P376, DOI 10.1111/j.1600-079X.2011.00963.x; Bechtold DA, 2012, CURR BIOL, V22, P70, DOI 10.1016/j.cub.2011.11.043; Bianco AC, 2002, ENDOCR REV, V23, P38, DOI 10.1210/er.23.1.38; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bolborea M, 2011, ENDOCRINOLOGY, V152, P3871, DOI 10.1210/en.2011-1039; BORER KT, 1978, AM J PHYSIOL, V234, pE611, DOI 10.1152/ajpendo.1978.234.6.E611; BORER KT, 1986, ENDOCRINOLOGY, V118, P844, DOI 10.1210/endo-118-2-844; BORER KT, 1983, BIOL REPROD, V29, P38, DOI 10.1095/biolreprod29.1.38; Chen W, 2011, J BIOL CHEM, V286, P34559, DOI 10.1074/jbc.M111.285965; Cuevas-Ramos D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038022; Drew JE, 2001, J NEUROENDOCRINOL, V13, P453, DOI 10.1046/j.1365-2826.2001.00651.x; Ebling FJP, 2008, J NEUROENDOCRINOL, V20, P576, DOI 10.1111/j.1365-2826.2008.01702.x; FIGALA J, 1973, OECOLOGIA, V12, P89, DOI 10.1007/BF00345511; Flores MBS, 2006, DIABETES, V55, P2554, DOI 10.2337/db05-1622; Gattermann R, 2004, PHYSIOL BEHAV, V82, P541, DOI 10.1016/j.physbeh.2004.05.006; GIBBS FP, 1986, PHYSIOL BEHAV, V37, P159, DOI 10.1016/0031-9384(86)90399-9; Hand LE, 2013, ENDOCRINOLOGY, V154, P2081, DOI 10.1210/en.2012-2051; Helwig M, 2013, J NEUROENDOCRINOL, V25, P190, DOI 10.1111/j.1365-2826.2012.02384.x; Henningsen J, 2010, MOL CELL PROTEOMICS, V9, P2482, DOI 10.1074/mcp.M110.002113; Herwig A, 2012, J NEUROENDOCRINOL, V24, P991, DOI 10.1111/j.1365-2826.2012.02324.x; Herwig A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062003; Herwig A, 2009, AM J PHYSIOL-REG I, V296, pR1307, DOI 10.1152/ajpregu.90755.2008; HOFFMANN K, 1973, J COMP PHYSIOL, V85, P267, DOI 10.1007/BF00694233; Hojman P, 2009, DIABETES, V58, P2797, DOI 10.2337/db09-0713; Jethwa PH, 2007, ENDOCRINOLOGY, V148, P4044, DOI 10.1210/en.2007-0038; Keppler D., 1984, METHOD ENZYMAT AN, V6, P11; Klosen P, 2013, FASEB J, V27, P2677, DOI 10.1096/fj.13-229559; LERCHL A, 1993, NEUROENDOCRINOLOGY, V57, P359, DOI 10.1159/000126380; Mercer JG, 2003, EUR J PHARMACOL, V480, P43, DOI 10.1016/j.ejphar.2003.08.091; Mercer JG, 2003, REGUL PEPTIDES, V111, P129, DOI 10.1016/S0167-0115(02)00263-X; Mercer JG, 1997, AM J PHYSIOL-REG I, V273, pR768, DOI 10.1152/ajpregu.1997.273.2.R768; Mercer JG, 2000, AM J PHYSIOL-REG I, V278, pR271, DOI 10.1152/ajpregu.2000.278.1.R271; Mercer JG, 2001, ENDOCRINOLOGY, V142, P4173, DOI 10.1210/en.142.10.4173; Morgan PJ, 1996, ENDOCRINOLOGY, V137, P4018, DOI 10.1210/en.137.9.4018; Murata Y, 2011, J NUTR METAB, V2011, DOI 10.1155/2011/981315; Murphy M, 2013, J NEUROENDOCRINOL, V25, P180, DOI 10.1111/j.1365-2826.2012.02383.x; Murphy M, 2012, ENDOCRINOLOGY, V153, P101, DOI 10.1210/en.2011-1249; Nedachi T, 2008, AM J PHYSIOL-ENDOC M, V295, pE1191, DOI 10.1152/ajpendo.90280.2008; Nilaweera KN, 2009, J NEUROENDOCRINOL, V21, P123, DOI 10.1111/j.1365-2826.2008.01810.x; Nilaweera K, 2011, GLIA, V59, P1695, DOI 10.1002/glia.21216; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; Reddy AB, 1999, EUR J NEUROSCI, V11, P3255, DOI 10.1046/j.1460-9568.1999.00746.x; Rodriguez EM, 2005, INT REV CYTOL, V247, P89, DOI 10.1016/S0074-7696(05)47003-5; Ropelle ER, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000465; Ross AW, 2009, J NEUROENDOCRINOL, V21, P610, DOI 10.1111/j.1365-2826.2009.01878.x; Ross AW, 2005, ENDOCRINOLOGY, V146, P1940, DOI 10.1210/en.2004-1538; Ross AW, 2004, ENDOCRINOLOGY, V145, P13, DOI 10.1210/en.2003-0838; Scherbarth F, 2008, J COMP PHYSIOL B, V178, P607, DOI 10.1007/s00360-007-0251-7; Scherbarth F, 2007, AM J PHYSIOL-REG I, V293, pR1368, DOI 10.1152/ajpregu.00106.2007; SCHLATT S, 1995, BIOL REPROD, V53, P1169, DOI 10.1095/biolreprod53.5.1169; Siegel S., 1988, NONPARAMETRIC STAT B, P213, DOI DOI 10.1177/014662168901300212; THOMAS EM, 1993, AM J PHYSIOL, V265, pR951, DOI 10.1152/ajpregu.1993.265.4.R951; Tups A, 2006, J NEUROENDOCRINOL, V18, P139, DOI 10.1111/j.1365-2826.2005.01394.x; Watanabe M, 2004, ENDOCRINOLOGY, V145, P1546, DOI 10.1210/en.2003-1593; WEBB SM, 1985, HORM METAB RES, V17, P107, DOI 10.1055/s-2007-1013464	62	13	15	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90253	10.1371/journal.pone.0090253	http://dx.doi.org/10.1371/journal.pone.0090253			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603871	Green Published, Green Submitted, gold			2022-12-27	WOS:000332483600036
J	Tang, JZ; Wang, XQ; Ma, FF; Wang, B; Wang, PF; Peng, ZX; Zhou, XY				Tang, Jun-Zhou; Wang, Xiu-Qing; Ma, Fa-Feng; Wang, Bo; Wang, Peng-Fei; Peng, Zhi-Xi; Zhou, Xi-Yuan			Association between Polymorphisms in Lysyl Oxidase-Like 1 and Susceptibility to Pseudoexfoliation Syndrome and Pseudoexfoliation Glaucoma	PLOS ONE			English	Article							COMMON SEQUENCE VARIANTS; SINGLE NUCLEOTIDE POLYMORPHISMS; LOXL1 GENE; RISK-FACTORS; POPULATION; METAANALYSIS	The present knowledge on the association of single nucleotide polymorphisms (SNPs) of lysyl oxidase-like 1 (LOXL1) with pseudoexfoliation syndrome (PEXS) and pseudoexfoliation glaucoma (PEXG) is controversial and inconclusive. This meta-analysis sought to derive a more precise estimation of the effects of LOXL1 SNP loci (rs1048661, rs3825942, and rs2165241) on PEXS/PEXG. Literature searches were conducted on the PubMed, EMBASE, ISI Web of Science, and Cochrane Library databases through October 2013. Twelve studies describing 1810 cases and 1790 controls met the inclusion criteria. The strengths of the associations found through the meta-analysis were assessed with pooled odds ratios and their 95% confidence intervals (CI). A meta-regression analysis was also used to examine the influence of the study and population characteristics. The results indicated that rs1048661 TT carriers had 92.1% and 40.4% less risk of developing PEXS/PEXG than did the controls in the Caucasian and Asian populations, respectively. Carriers of rs3825942 AA or rs2165241 CC also had significantly less PEXS/PEXG susceptibility than did the non-carriers. Meta-regression showed that in Caucasians, the male proportion (slope: 0.272; 95% CI: 0.167-0.376; P = 0.0001) and mean age (slope: 0.796; 95% CI: 0.375-1.217; P = 0.0002) of the PEXS/PEXG subjects correlated positively with the effect of rs3825942 on PEXS/PEXG susceptibility. The meta-analysis suggested that LOXL1 rs1048661 TT, rs3825942 AA, and rs2165241 CC were associated with a reduced risk of developing PEXS/PEXG.	[Tang, Jun-Zhou] Third Mil Med Univ, Ctr Bone Metab & Repair, State Key Lab Trauma Burns & Combined Injury, Ctr Trauma,Res Inst Surg,Daping Hosp, Chongqing, Peoples R China; [Wang, Xiu-Qing; Ma, Fa-Feng; Peng, Zhi-Xi; Zhou, Xi-Yuan] Chongqing Univ Med Sci, Affiliated Hosp 2, Dept Ophthalmol, Chongqing, Peoples R China; [Wang, Bo] Chongqing Med Univ, Affiliated Hosp 2, Dept Endocrinol, Chongqing, Peoples R China; [Wang, Peng-Fei] Chongqing Med Univ, Affiliated Hosp 2, Dept Emergency, Chongqing, Peoples R China	Army Medical University; Chongqing Medical University; Chongqing Medical University; Chongqing Medical University	Zhou, XY (corresponding author), Chongqing Univ Med Sci, Affiliated Hosp 2, Dept Ophthalmol, Chongqing, Peoples R China.	zhouxiyuan2002@aliyun.com			National Natural Science Foundation of China [81170858]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (81170858). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Amero KK, 2010, MOL VIS, V16, P2805; Bengtsson B, 2005, J GLAUCOMA, V14, P135, DOI 10.1097/01.ijg.0000151683.04410.f3; Challa P, 2008, MOL VIS, V14, P146; Challa P, 2009, CURR OPIN OPHTHALMOL, V20, P88, DOI 10.1097/ICU.0b013e328320d86a; Elhawy E, 2012, HUM GENOMICS, V6, DOI 10.1186/1479-7364-6-22; Fan BJ, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-5; Fan BJ, 2008, MOL VIS, V14, P2484; Guadarrama-Vallejo D, 2013, MOL VIS, V19, P1937; Hewitt AW, 2008, HUM MOL GENET, V17, P710, DOI 10.1093/hmg/ddm342; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Jaimes M, 2012, OPHTHALMIC GENET, V33, P12, DOI 10.3109/13816810.2011.615078; Lee KYC, 2009, MOL VIS, V15, P1120; Liu XQ, 2004, NAT GENET, V36, P178, DOI 10.1038/ng1297; Malukiewicz G, 2011, ACTA OPHTHALMOL, V89, pE64, DOI 10.1111/j.1755-3768.2010.02083.x; Metaxaki I, 2013, MOL VIS, V19, P1446; Micheal S, 2012, MOL VIS, V18, P1040; Ozaki M, 2008, INVEST OPHTH VIS SCI, V49, P3976, DOI 10.1167/iovs.08-1805; Park DY, 2013, MOL VIS, V19, P448; Pasutto F, 2008, INVEST OPHTH VIS SCI, V49, P1459, DOI 10.1167/iovs.07-1449; Ramprasad VL, 2008, MOL VIS, V14, P318; Schlotzer-Schrehardt U, 2006, AM J OPHTHALMOL, V141, P921, DOI 10.1016/j.ajo.2006.01.047; Schlotzer-Schrehardt U, 2012, OPHTHALMOLOGY, V119, P1832, DOI 10.1016/j.ophtha.2012.03.015; Schlotzer-Schrehardt U, 2011, MIDDLE EAST AFR J OP, V18, P30, DOI 10.4103/0974-9233.75882; Shakya S, 2008, Nepal Med Coll J, V10, P147; Song FJ, 1998, BRIT MED J, V316, P471; Sowka Joseph, 2004, Optometry, V75, P245, DOI 10.1016/S1529-1839(04)70052-4; Thorleifsson G, 2007, SCIENCE, V317, P1397, DOI 10.1126/science.1146554; Topouzis F, 2011, AM J OPHTHALMOL, V152, P219, DOI 10.1016/j.ajo.2011.01.032; Wagenseil Jessica E., 2007, Birth Defects Research, V81, P229, DOI 10.1002/bdrc.20111; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Zenkel M, 2011, INVEST OPHTH VIS SCI, V52, P8488, DOI 10.1167/iovs.11-8361	32	11	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90331	10.1371/journal.pone.0090331	http://dx.doi.org/10.1371/journal.pone.0090331			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603551	gold, Green Submitted, Green Published			2022-12-27	WOS:000332483600044
J	Zou, MY; Guo, FF; Li, XZ; Zhao, J; Qu, YB				Zou, Mouyong; Guo, Fenfen; Li, Xuezhi; Zhao, Jian; Qu, Yinbo			Enhancing Production of Alkaline Polygalacturonate Lyase from Bacillus subtilis by Fed-Batch Fermentation	PLOS ONE			English	Article							PECTATE LYASE; DEGRADING ENZYMES; PECTIN LYASE; PURIFICATION; INHIBITION; SUBSTRATE; KINETICS; METHANOL; FIBERS; GENE	Alkaline polygalacturonate lyase (PGL, EC 4.2.2.2) is an enzyme used in many industries. We developed a fed-batch fermentation process that combines the enzymatic pretreatment of the carbon source with controlling the pH of the fermentative broth to enhance the PGL production from Bacillus subtilis 7-3-3 to decrease the production cost. Maintaining the fermentation broth at pH 6.5 prior to feeding with ammonia and at pH 6.0 after feeding significantly improved PGL activity (743.5 U mL(-1)) compared with the control (202.5 U mL(-1)). The average PGL productivity reached 19.6 U mL(-1) h(-1) after 38 h of fermentation. The crude PGL was suitable for environmentally friendly ramie enzymatic degumming.	[Zou, Mouyong; Guo, Fenfen; Li, Xuezhi; Zhao, Jian; Qu, Yinbo] Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China	Shandong University	Li, XZ (corresponding author), Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China.	lixz@sdu.edu.cn; zhaojian@sdu.edu.cn			National High Technology Research and Development Program of China [2012AA022203B]; National Natural Sciences Foundation of China [31170107]; Natural Sciences Foundation of Shandong Province [ZR2010CM023]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Sciences Foundation of Shandong Province(Natural Science Foundation of Shandong Province)	This study was supported by grants from the National High Technology Research and Development Program of China (No. 2012AA022203B)(http:// www.863.gov.cn), the National Natural Sciences Foundation of China (31170107)(http://www.nsfc.gov.cn/Portal0/default152.htm), and the Natural Sciences Foundation of Shandong Province (ZR2010CM023)(http://www.sdnsf.gov.cn/portal/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAILEY MJ, 1992, J BIOTECHNOL, V23, P257, DOI 10.1016/0168-1656(92)90074-J; Basu S, 2009, J IND MICROBIOL BIOT, V36, P239, DOI 10.1007/s10295-008-0490-y; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bruhlmann F, 2000, J BIOTECHNOL, V76, P43, DOI 10.1016/S0168-1656(99)00175-3; COOPER RM, 1975, PHYSIOL PLANT PATHOL, V5, P135, DOI 10.1016/0048-4059(75)90017-X; DEAN RA, 1989, PLANT CELL, V1, P275, DOI 10.1105/tpc.1.3.275; FEDER J, 1970, BIOCHEMISTRY-US, V9, P2784, DOI 10.1021/bi00816a005; FUJII M, 1983, J BACTERIOL, V154, P831, DOI 10.1128/JB.154.2.831-837.1983; Gummadi S. N., 2006, American Journal of Food Technology, V1, P19; Guo FF, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/212315; Herron SR, 2000, P NATL ACAD SCI USA, V97, P8762, DOI 10.1073/pnas.97.16.8762; HONG J, 1986, BIOTECHNOL BIOENG, V28, P1421, DOI 10.1002/bit.260280916; Hoondal GS, 2002, APPL MICROBIOL BIOT, V59, P409, DOI 10.1007/s00253-002-1061-1; Hossain MZ, 1996, ENZYME MICROB TECH, V18, P95, DOI 10.1016/0141-0229(95)00071-2; Kapoor M, 2000, PROCESS BIOCHEM, V36, P467, DOI 10.1016/S0032-9592(00)00238-7; Kilonzo PA, 2004, BIOCHEM ENG J, V17, P27, DOI 10.1016/S1369-703X(03)00121-9; Klug-Santner BG, 2006, J BIOTECHNOL, V121, P390, DOI 10.1016/j.jbiotec.2005.07.019; Matsumoto T, 2002, BIOCHEM ENG J, V12, P175, DOI 10.1016/S1369-703X(02)00075-X; MCCONN JD, 1964, J BIOL CHEM, V239, P3706; Moo-Young M, 2011, COMPREHENSIVE BIOTEC, P515; PAZLAROVA J, 1984, APPL MICROBIOL BIOT, V20, P331, DOI 10.1007/BF00270595; Qureshi MS, 2010, J IND MICROBIOL BIOT, V37, P323, DOI 10.1007/s10295-009-0677-x; SAID S, 1991, WORLD J MICROB BIOT, V7, P607, DOI 10.1007/BF00452841; Song JJ, 2010, THESIS SHANDONG U JI; Songpim M., 2010, OPEN BIOL J, V3, P1; TSUYUMU S, 1984, PHYSIOL PLANT PATHOL, V24, P291, DOI 10.1016/0048-4059(84)90003-1; van Niel EWJ, 2003, BIOTECHNOL BIOENG, V81, P255, DOI 10.1002/bit.10463; Wang B, 2007, BOT STUD, V48, P173; Wang Y, 2009, BIORESOURCE TECHNOL, V100, P1343, DOI 10.1016/j.biortech.2008.07.049; Wang ZH, 2010, BIORESOURCE TECHNOL, V101, P1318, DOI 10.1016/j.biortech.2009.09.025; Yadav S, 2009, PROCESS BIOCHEM, V44, P1, DOI 10.1016/j.procbio.2008.09.012; Zhang JJ, 2013, BIORESOURCE TECHNOL, V146, P543, DOI 10.1016/j.biortech.2013.07.129; Zhao Z, 2003, IND MICROBIOLOGY, V2, P003; Zheng LS, 2001, BIORESOURCE TECHNOL, V78, P89, DOI 10.1016/S0960-8524(00)00154-1; ZUCKER M, 1970, J BACTERIOL, V104, P13, DOI 10.1128/JB.104.1.13-18.1970	35	13	15	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90392	10.1371/journal.pone.0090392	http://dx.doi.org/10.1371/journal.pone.0090392			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603713	Green Published, Green Submitted, gold			2022-12-27	WOS:000332483600051
J	de Jong, TR; Beiderbeck, DI; Neumann, ID				de Jong, Trynke R.; Beiderbeck, Daniela I.; Neumann, Inga D.			Measuring Virgin Female Aggression in the Female Intruder Test (FIT): Effects of Oxytocin, Estrous Cycle, and Anxiety	PLOS ONE			English	Article							C-FOS EXPRESSION; SEX-DIFFERENCES; MATERNAL AGGRESSION; GENDER-DIFFERENCES; CONDUCT DISORDER; HYPOTHALAMIC AGGRESSION; ARGININE-VASOPRESSIN; INTERMALE AGGRESSION; SOCIAL AGGRESSION; SEROTONIN 1A	The costs of violence and aggression in our society have stimulated the scientific search for the predictors and causes of aggression. The majority of studies have focused on males, which are considered to be more aggressive than females in most species. However, rates of offensive behavior in girls and young women are considerable and are currently rising in Western society. The extrapolation of scientific results from males to young, non-maternal females is a priori limited, based on the profound sex differences in brain areas and functioning of neurotransmitters involved in aggression. Therefore, we established a paradigm to assess aggressive behavior in young virgin female rats, i.e. the female intruder test (FIT). We found that approximately 40% of un-manipulated adult (10-11 weeks old) female Wistar rats attack an intruder female during the FIT, independent of their estrous phase or that of their intruder. In addition, adolescent (7-8 weeks old) female rats selected for high anxiety behavior (HABs) displayed significantly more aggression than non-selected (NAB) or low-anxiety (LAB) rats. Intracerebroventricular infusion of oxytocin (OXT, 0.1 mu g/5 mu l) inhibited aggressive behavior in adult NAB and LAB, but not HAB females. Adolescent NAB rats that had been aggressive towards their intruder showed increased pERK immunoreactivity (IR) in the hypothalamic attack area and reduced pERK-IR in OXT neurons in the paraventricular hypothalamic nucleus compared to non-aggressive NAB rats. Taken together, aggressive behavior in young virgin female rats is partly dependent on trait anxiety, and appears to be under considerable OXT control.	[de Jong, Trynke R.; Beiderbeck, Daniela I.; Neumann, Inga D.] Univ Regensburg, Dept Behav & Mol Neurobiol, D-93053 Regensburg, Germany	University of Regensburg	de Jong, TR (corresponding author), Univ Regensburg, Dept Behav & Mol Neurobiol, D-93053 Regensburg, Germany.	trynke.de-jong@ur.de	de Jong, Trynke R./D-8989-2013	de Jong, Trynke R./0000-0001-8361-6895	Alexander von Humboldt Foundation Research Fellowship for Postdoctoral Researchers; Deutsche Forschungsgemeinschaft; European Community [602407]	Alexander von Humboldt Foundation Research Fellowship for Postdoctoral Researchers(Alexander von Humboldt Foundation); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Community(European Commission)	TdJ was funded by an Alexander von Humboldt Foundation Research Fellowship for Postdoctoral Researchers (http://www.humboldt-foundation.de). The research leading to these results has received funding from the Deutsche Forschungsgemeinschaft (www.dfg.de) and the European Community's Seventh Framework Programme (FP7/2007-2013) under Grant Agreement no 602407 (FemNAT-CD) (http://ec.europa.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBONETTI ME, 1993, AGGRESSIVE BEHAV, V19, P369, DOI 10.1002/1098-2337(1993)19:5<369::AID-AB2480190506>3.0.CO;2-W; Archer J, 2009, BEHAV BRAIN SCI, V32, P249, DOI 10.1017/S0140525X09990951; Baranyi J, 2005, PHYSIOL BEHAV, V84, P511, DOI 10.1016/j.physbeh.2005.01.005; Bartz JA, 2010, PSYCHOL SCI, V21, P1426, DOI 10.1177/0956797610383439; Baumgartner T, 2008, NEURON, V58, P639, DOI 10.1016/j.neuron.2008.04.009; Beiderbeck DI, 2007, EUR J NEUROSCI, V26, P3597, DOI 10.1111/j.1460-9568.2007.05974.x; Beiderbeck DI, 2012, PSYCHONEUROENDOCRINO, V37, P1969, DOI 10.1016/j.psyneuen.2012.04.011; Berkout OV, 2011, AGGRESS VIOLENT BEH, V16, P503, DOI 10.1016/j.avb.2011.06.001; Blumstein D. T., 2007, QUANTIFYING BEHAV JW; Bosch OJ, 2005, J NEUROSCI, V25, P6807, DOI 10.1523/JNEUROSCI.1342-05.2005; Bosch OJ, 2012, HORM BEHAV, V61, P293, DOI 10.1016/j.yhbeh.2011.11.002; Bosch OJ, 2010, EUR J NEUROSCI, V31, P883, DOI 10.1111/j.1460-9568.2010.07115.x; Calcagnoli F, 2014, BEHAV BRAIN RES, V261, P315, DOI 10.1016/j.bbr.2013.12.050; Calcagnoli F, 2013, PSYCHOPHARMACOLOGY, V229, P639, DOI 10.1007/s00213-013-3124-7; Caldwell HK, 2008, PROG NEUROBIOL, V84, P1, DOI 10.1016/j.pneurobio.2007.10.007; Campbell A, 1999, BEHAV BRAIN SCI, V22, P203, DOI 10.1017/S0140525X99001818; Campbell A, 2013, AGGRESSIVE BEHAV, V39, P316, DOI 10.1002/ab.21478; Collishaw S, 2012, J ABNORM CHILD PSYCH, V40, P119, DOI 10.1007/s10802-011-9543-1; Cordero MI, 2013, PSYCHONEUROENDOCRINO, V38, P2758, DOI 10.1016/j.psyneuen.2013.07.005; Davis ES, 2004, NEUROSCIENCE, V127, P611, DOI 10.1016/j.neuroscience.2004.05.034; de Boer SF, 2003, BEHAV GENET, V33, P485, DOI 10.1023/A:1025766415159; de Vries GJ, 2008, PROG BRAIN RES, V170, P17, DOI 10.1016/S0079-6123(08)00402-0; Fairchild G, 2013, J CHILD PSYCHOL PSYC, V54, P86, DOI 10.1111/j.1469-7610.2012.02617.x; FERRIS CF, 1992, ANN NY ACAD SCI, V652, P456, DOI 10.1111/j.1749-6632.1992.tb34382.x; Ferris CF, 2000, EXP PHYSIOL, V85, p85S, DOI 10.1111/j.1469-445X.2000.tb00011.x; Fontaine N, 2008, ARCH GEN PSYCHIAT, V65, P320, DOI 10.1001/archgenpsychiatry.2007.41; Fuxjager MJ, 2011, ENDOCRINOLOGY, V152, P3422, DOI 10.1210/en.2011-1099; Gammie SC, 2001, BRAIN RES, V898, P232, DOI 10.1016/S0006-8993(01)02189-8; Goodson JL, 2009, BIOL LETTERS, V5, P554, DOI 10.1098/rsbl.2009.0316; Gutzler SJ, 2010, EUR J NEUROSCI, V31, P1655, DOI 10.1111/j.1460-9568.2010.07190.x; Haller J, 2006, NEUROSCI BIOBEHAV R, V30, P292, DOI 10.1016/j.neubiorev.2005.01.005; Haller J, 2006, PHYSIOL BEHAV, V88, P173, DOI 10.1016/j.physbeh.2006.03.030; Harmon AC, 2002, J NEUROENDOCRINOL, V14, P963, DOI 10.1046/j.1365-2826.2002.00863.x; Hasen NS, 2005, PHYSIOL BEHAV, V84, P681, DOI 10.1016/j.physbeh.2005.02.010; Henniger MSH, 2000, BEHAV BRAIN RES, V111, P153, DOI 10.1016/S0166-4328(00)00151-0; Hines M, 2011, ANNU REV NEUROSCI, V34, P69, DOI 10.1146/annurev-neuro-061010-113654; Ho HP, 2001, NEUROPSYCHOPHARMACOL, V24, P502, DOI 10.1016/S0893-133X(00)00219-0; Hodgins S, 2011, J FORENSIC PSYCHI PS, V22, P669, DOI 10.1080/14789949.2011.617539; Hurlemann R, 2010, J NEUROSCI, V30, P4999, DOI 10.1523/JNEUROSCI.5538-09.2010; JOPPA MA, 1995, NEUROSCIENCE, V68, P783, DOI 10.1016/0306-4522(95)00179-M; Joppa MA, 1997, PHARMACOL BIOCHEM BE, V58, P349, DOI 10.1016/S0091-3057(97)00277-3; Jovanovic H, 2008, NEUROIMAGE, V39, P1408, DOI 10.1016/j.neuroimage.2007.10.016; Kalueff AV, 2005, J NEUROSCI METH, V143, P169, DOI 10.1016/j.jneumeth.2004.10.001; Karriker-Jaffe KJ, 2008, J ABNORM CHILD PSYCH, V36, P1227, DOI 10.1007/s10802-008-9245-5; KOLLACKWALKER S, 1995, NEUROSCIENCE, V66, P721, DOI 10.1016/0306-4522(94)00563-K; Koolhaas JM, 2013, JOVE-J VIS EXP, DOI 10.3791/4367; KRUK MR, 1991, NEUROSCI BIOBEHAV R, V15, P527, DOI 10.1016/S0149-7634(05)80144-7; Lanctot N, 2007, CRIMINOLOGY, V45, P131, DOI 10.1111/j.1745-9125.2007.00074.x; Lehto-Salo P, 2009, NORD J PSYCHIAT, V63, P308, DOI 10.1080/08039480902730615; Lin DY, 2011, NATURE, V470, P221, DOI 10.1038/nature09736; Lonstein JS, 2002, NEUROSCI BIOBEHAV R, V26, P869, DOI 10.1016/S0149-7634(02)00087-8; Lukas M, 2013, PSYCHONEUROENDOCRINO, V38, P916, DOI 10.1016/j.psyneuen.2012.09.018; Lukas M, 2011, NEUROPSYCHOPHARMACOL, V36, P2159, DOI 10.1038/npp.2011.95; MARCONDES F. K., 2002, Braz. J. Biol., V62, P609, DOI 10.1590/S1519-69842002000400008; McCarthy MM, 2011, NAT NEUROSCI, V14, P677, DOI 10.1038/nn.2834; Miczek KA, 2007, J NEUROSCI, V27, P11803, DOI 10.1523/JNEUROSCI.3500-07.2007; Morcillo C, 2012, J PSYCHIATR RES, V46, P323, DOI 10.1016/j.jpsychires.2011.10.012; Murgatroyd C, 2004, J NEUROSCI, V24, P7762, DOI 10.1523/JNEUROSCI.1614-04.2004; Naslund J, 2013, PSYCHOPHARMACOLOGY, V230, P29, DOI 10.1007/s00213-013-3133-6; Nelson RJ, 2007, NAT REV NEUROSCI, V8, P536, DOI 10.1038/nrn2174; Nephew BC, 2008, PHARMACOL BIOCHEM BE, V91, P77, DOI 10.1016/j.pbb.2008.06.013; Neumann ID, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00012; Nishizawa S, 1997, P NATL ACAD SCI USA, V94, P5308, DOI 10.1073/pnas.94.10.5308; Odgers CL, 2008, DEV PSYCHOPATHOL, V20, P673, DOI 10.1017/S0954579408000333; Olivier B, 1995, PHARMACOPSYCHIATRY, V28, P80, DOI 10.1055/s-2007-979624; Pajer KA, 1998, AM J PSYCHIAT, V155, P862, DOI 10.1176/ajp.155.7.862; Paxinos G, 1997, RAT BRAIN STEREOTACT; Pedersen CA, 2002, STRESS, V5, P259, DOI 10.1080/1025389021000037586; Polier GG, 2012, EUR CHILD ADOLES PSY, V21, P31, DOI 10.1007/s00787-011-0229-6; Rimmele U, 2009, J NEUROSCI, V29, P38, DOI 10.1523/JNEUROSCI.4260-08.2009; Schwartzer JJ, 2013, AGGRESSIVE BEHAV, V39, P290, DOI 10.1002/ab.21476; Silva AL, 2010, BEHAV BRAIN RES, V208, P528, DOI 10.1016/j.bbr.2009.12.038; Staffend NA, 2012, NEUROSCIENCE, V227, P163, DOI 10.1016/j.neuroscience.2012.09.064; Takahashi A, 2011, PSYCHOPHARMACOLOGY, V213, P183, DOI 10.1007/s00213-010-2000-y; Thornton AJV, 2012, J INTERPERS VIOLENCE, V27, P1399, DOI 10.1177/0886260511425789; Toth M, 2012, BEHAV BRAIN RES, V233, P120, DOI 10.1016/j.bbr.2012.04.025; Toth M, 2010, BEHAV BRAIN RES, V215, P7, DOI 10.1016/j.bbr.2010.05.050; Trainor BC, 2010, NEUROSCIENCE, V165, P325, DOI 10.1016/j.neuroscience.2009.10.050; Trainor BC, 2010, HORM BEHAV, V58, P506, DOI 10.1016/j.yhbeh.2010.04.008; Veenema AH, 2007, BRAIN BEHAV EVOLUT, V70, P274, DOI 10.1159/000105491; Veenema AH, 2007, HORM BEHAV, V51, P11, DOI 10.1016/j.yhbeh.2006.07.004; Veenema AH, 2008, PROG BRAIN RES, V170, P261, DOI 10.1016/S0079-6123(08)00422-6; Veening JG, 2005, EUR J PHARMACOL, V526, P226, DOI 10.1016/j.ejphar.2005.09.041; Wang YF, 2007, J NEUROSCI, V27, P13822, DOI 10.1523/JNEUROSCI.4119-07.2007; Wasserman GA, 2005, AM J PUBLIC HEALTH, V95, P131, DOI 10.2105/AJPH.2003.024737; Yang CF, 2013, CELL, V153, P896, DOI 10.1016/j.cell.2013.04.017; Young LJ, 2004, NAT NEUROSCI, V7, P1048, DOI 10.1038/nn1327	87	34	35	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91701	10.1371/journal.pone.0091701	http://dx.doi.org/10.1371/journal.pone.0091701			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614336	Green Submitted, Green Published, gold			2022-12-27	WOS:000332839300151
J	Ward, AC; Connolly, P; Tucker, NP				Ward, Andrew C.; Connolly, Patricia; Tucker, Nicholas P.			Pseudomonas aeruginosa Can Be Detected in a Polymicrobial Competition Model Using Impedance Spectroscopy with a Novel Biosensor	PLOS ONE			English	Article							ELECTRODE-SOLUTION INTERFACE; DOUBLE-LAYER CAPACITANCE; IMPEDIMETRIC APPROACH; BIOFILM; PYOCYANIN; BACTERIA; ADHESION; SENSOR	Electrochemical Impedance Spectroscopy (EIS) is a powerful technique that can be used to elicit information about an electrode interface. In this article, we highlight six principal processes by which the presence of microorganisms can affect impedance and show how one of these - the production of electroactive metabolites - changes the impedance signature of culture media containing Pseudomonas aeruginosa. EIS, was used in conjunction with a low cost screen printed carbon sensor to detect the presence of P. aeruginosa when grown in isolation or as part of a polymicrobial infection with Staphylococcus aureus. By comparing the electrode to a starting measurement, we were able to identify an impedance signature characteristic of P. aeruginosa. Furthermore, we are able to show that one of the changes in the impedance signature is due to pyocyanin and associated phenazine compounds. The findings of this study indicate that it might be possible to develop a low cost sensor for the detection of P. aeruginosa in important point of care diagnostic applications. In particular, we suggest that a development of the device described here could be used in a polymicrobial clinical sample such as sputum from a CF patient to detect P. aeruginosa.	[Ward, Andrew C.; Connolly, Patricia] Univ Strathclyde, Dept Biomed Engn, Glasgow, Lanark, Scotland; [Tucker, Nicholas P.] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland	University of Strathclyde; University of Strathclyde	Connolly, P (corresponding author), Univ Strathclyde, Dept Biomed Engn, Glasgow, Lanark, Scotland.	patricia.connolly@strath.ac.uk		Tucker, Nicholas/0000-0002-6331-3704	Engineering and Phyiscal Sciences Research Council [EP/F50036X/1]	Engineering and Phyiscal Sciences Research Council	This work has been funded by the Engineering and Phyiscal Sciences Research Council (www.epsrc.ac.uk, grant number: EP/F50036X/1) as part of an Engineering Doctorate. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bard A. J., 2001, ELECTROCHEMICAL METH; Bayoudh S, 2008, COLLOID SURFACE A, V318, P291, DOI 10.1016/j.colsurfa.2008.01.005; Ben-Yoav H, 2011, ELECTROCHIM ACTA, V56, P7780, DOI 10.1016/j.electacta.2010.12.025; Branski LK, 2009, SURG INFECT, V10, P389, DOI 10.1089/sur.2009.024; Cady P, 1975, NEW APPROACHES IDENT, P74; Connolly P., 2010, WO2009136157, Patent No. [2009136157, WO2009136157 (A3)]; Dheilly A, 2008, APPL MICROBIOL BIOT, V79, P157, DOI 10.1007/s00253-008-1404-7; Dietrich LEP, 2006, MOL MICROBIOL, V61, P1308, DOI 10.1111/j.1365-2958.2006.05306.x; Farrow MJ, 2012, BIOSENSORS-BASEL, V2, P171, DOI 10.3390/bios2020171; Firstenberg-Eden R., 1984, IMPEDANCE MICROBIOLO; Harrison F, 2007, MICROBIOL-SGM, V153, P917, DOI 10.1099/mic.0.2006/004077-0; Hassett DJ, 2009, TRENDS MICROBIOL, V17, P130, DOI 10.1016/j.tim.2008.12.003; Hernandez ME, 2001, CELL MOL LIFE SCI, V58, P1562, DOI 10.1007/PL00000796; Jefferies JMC, 2012, J MED MICROBIOL, V61, P1052, DOI 10.1099/jmm.0.044818-0; K'Owino IO, 2005, ELECTROANAL, V17, P2101, DOI 10.1002/elan.200503371; Kim S, 2012, ELECTROCHIM ACTA, V82, P126, DOI 10.1016/j.electacta.2012.05.131; Kim T, 2011, WATER RES, V45, P4615, DOI 10.1016/j.watres.2011.06.010; Kirchner S, 2012, JOVE-J VIS EXP, DOI 10.3791/3857; KITO N, 1974, CHEM LETT, P353, DOI 10.1246/cl.1974.353; Korgaonkar A, 2013, P NATL ACAD SCI USA, V110, P1059, DOI 10.1073/pnas.1214550110; Lau GW, 2004, TRENDS MOL MED, V10, P599, DOI 10.1016/j.molmed.2004.10.002; Liberati NT, 2006, P NATL ACAD SCI USA, V103, P2833, DOI 10.1073/pnas.0511100103; Liu GY, 2009, TRENDS MICROBIOL, V17, P406, DOI 10.1016/j.tim.2009.06.006; Marsili E, 2008, APPL ENVIRON MICROB, V74, P7329, DOI 10.1128/AEM.00177-08; Marsili E, 2008, P NATL ACAD SCI USA, V105, P3968, DOI 10.1073/pnas.0710525105; Mavrodi DV, 2001, J BACTERIOL, V183, P6454, DOI 10.1128/JB.183.21.6454-6465.2001; McColl D., 2009, WOUNDS UK, V5, P94; Moulton SE, 2004, ELECTROCHIM ACTA, V49, P4223, DOI 10.1016/j.electacta.2004.03.034; Munoz-Berbel X, 2008, ELECTROCHIM ACTA, V53, P5739, DOI 10.1016/j.electacta.2008.03.050; Munoz-Berbel X, 2008, BIOSENS BIOELECTRON, V23, P1540, DOI 10.1016/j.bios.2008.01.007; Munoz-Berbel X, 2006, SENSOR ACTUAT B-CHEM, V118, P129, DOI 10.1016/j.snb.2006.04.070; Munoz-Berbel X, 2007, ELECTROCHEM COMMUN, V9, P2654, DOI 10.1016/j.elecom.2007.08.011; Nair D, 2011, J BACTERIOL, V193, P2332, DOI 10.1128/JB.00027-11; Ohfuji K, 2004, BIOSENS BIOELECTRON, V19, P1237, DOI 10.1016/j.bios.2003.11.010; Paredes J, 2013, SENSOR ACTUAT B-CHEM, V178, P663, DOI 10.1016/j.snb.2013.01.027; Paredes J, 2012, BIOSENS BIOELECTRON, V38, P226, DOI 10.1016/j.bios.2012.05.027; Poortinga AT, 2001, BIOPHYS CHEM, V91, P273, DOI 10.1016/S0301-4622(01)00177-6; Price-Whelan A, 2006, NAT CHEM BIOL, V2, P71, DOI 10.1038/nchembio764; Price-Whelan A, 2007, J BACTERIOL, V189, P6372, DOI 10.1128/JB.00505-07; Ratjen F, 2003, LANCET, V361, P681, DOI 10.1016/S0140-6736(03)12567-6; Reguera G, 2005, NATURE, V435, P1098, DOI 10.1038/nature03661; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Stewart L, 2014, PATHOG DIS, V71, P20, DOI 10.1111/2049-632X.12107; Ur A, 1975, NEW APPROACHES IDENT; Wang J, 1996, ANALYST, V121, P345, DOI 10.1039/an9962100345; Wang Y, 2008, ENVIRON SCI TECHNOL, V42, P2380, DOI 10.1021/es702290a; Wang Y, 2010, J BACTERIOL, V192, P365, DOI 10.1128/JB.01188-09; WATSON D, 1986, EUR J BIOCHEM, V159, P309, DOI 10.1111/j.1432-1033.1986.tb09869.x; Winsor GL, 2011, NUCLEIC ACIDS RES, V39, pD596, DOI 10.1093/nar/gkq869; Yang LJ, 2004, BIOSENS BIOELECTRON, V19, P1139, DOI 10.1016/j.bios.2003.10.009; Yang LJ, 2003, BIOSENS BIOELECTRON, V19, P495, DOI 10.1016/S0956-5663(03)00229-X	51	36	38	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91732	10.1371/journal.pone.0091732	http://dx.doi.org/10.1371/journal.pone.0091732			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614411	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000332839300152
J	Huang, SB; Cheng, Y; Lang, DP; Chi, RH; Liu, GF				Huang, Shaobin; Cheng, Yuan; Lang, Dapeng; Chi, Ronghua; Liu, Guofeng			A Formal Algorithm for Verifying the Validity of Clustering Results Based on Model Checking	PLOS ONE			English	Article							TEMPORAL LOGIC; VERIFICATION	The limitations in general methods to evaluate clustering will remain difficult to overcome if verifying the clustering validity continues to be based on clustering results and evaluation index values. This study focuses on a clustering process to analyze crisp clustering validity. First, we define the properties that must be satisfied by valid clustering processes and model clustering processes based on program graphs and transition systems. We then recast the analysis of clustering validity as the problem of verifying whether the model of clustering processes satisfies the specified properties with model checking. That is, we try to build a bridge between clustering and model checking. Experiments on several datasets indicate the effectiveness and suitability of our algorithms. Compared with traditional evaluation indices, our formal method can not only indicate whether the clustering results are valid but, in the case the results are invalid, can also detect the objects that have led to the invalidity.	[Huang, Shaobin; Cheng, Yuan; Lang, Dapeng; Chi, Ronghua; Liu, Guofeng] Harbin Engn Univ, Coll Comp Sci & Technol, Harbin, Peoples R China	Harbin Engineering University	Cheng, Y (corresponding author), Harbin Engn Univ, Coll Comp Sci & Technol, Harbin, Peoples R China.	changuang7@sina.com	Dapeng, Lang/AAA-5429-2022	Dapeng, Lang/0000-0002-7536-9764	National Key Project of Scientific and Technical Supporting Programs [2012BAH08B02]	National Key Project of Scientific and Technical Supporting Programs	Supported by National Key Project of Scientific and Technical Supporting Programs (No. 2012BAH08B02), http://kjzc.jhgl.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtert E, 2012, PROC INT CONF DATA, P1285, DOI 10.1109/ICDE.2012.128; Amigo E, 2009, INFORM RETRIEVAL, V12, P461, DOI 10.1007/s10791-008-9066-8; Ball T, 2003, ACM SIGPLAN NOTICES, V38, P97, DOI 10.1145/640128.604140; Banerjee A, 2004, P 10 ACM SIGKDD INT, P515; Ben-Hur A, 2002, J MACH LEARN RES, V2, P125, DOI 10.1162/15324430260185565; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Cardoso MGMS, 2009, INTELL DATA ANAL, V13, P725, DOI 10.3233/IDA-2009-0390; Clake E, 1994, DECADE CONCURRENCY R, P124; Clarke E, 2001, FORM METHOD SYST DES, V19, P7, DOI 10.1023/A:1011276507260; Clarke E. M., 1981, LECT NOTES COMPUTER, V131, P52, DOI DOI 10.1007/BFB0025774; Clarke EM, 2009, COMMUN ACM, V52, P75, DOI 10.1145/1592761.1592781; Clarke EM, 1999, MODEL CHECKING, P1; CLARKE EM, 1995, FORM METHOD SYST DES, V6, P217, DOI 10.1007/BF01383968; de Souto M. C. P., 2012, 2012 Brazilian Symposium on Neural Networks (SBRN 2012), P49, DOI 10.1109/SBRN.2012.25; EMERSON EA, 1982, SCI COMPUT PROGRAM, V2, P241, DOI 10.1016/0167-6423(83)90017-5; Ester M., 1996, KDD-96 Proceedings. Second International Conference on Knowledge Discovery and Data Mining, P226; Halkidi M, 2002, SIGMOD REC, V31, P19, DOI 10.1145/601858.601862; Halkidi M, 2002, SIGMOD RECORD, V31, P40, DOI 10.1145/565117.565124; Halkidi M, 2001, J INTELL INF SYST, V17, P107, DOI 10.1023/A:1012801612483; Halkidi M, 2001, THIRTEENTH INTERNATIONAL CONFERENCE ON SCIENTIFIC AND STATISTICAL DATABASE MANAGEMENT, PROCEEDINGS, P3, DOI 10.1109/SSDM.2001.938534; Han J., 2006, DATA MINING CONCEPTS, DOI 10.1016/C2009-0-61819-5; Huth M, 2007, LOGIC COMPUTER SCI M, P115; Jegatha Deborah L, 2010, INT J COMPUTER SCI E, V1, P85, DOI [10.5121/ijcses.2010.1207, DOI 10.5121/IJCSES.2010.1207]; Kashyap C, 2013, INT J ENG INNOVATIVE, V2, P210; Kohonen T, 2000, IEEE T NEURAL NETWOR, V11, P574, DOI 10.1109/72.846729; Lamirel Jean-Charles, 2012, New Frontiers in Applied Data Mining. PAKDD 2011 International Workshops. Revised Selected Papers, P209, DOI 10.1007/978-3-642-28320-8_18; Liu Y, 2010, IEEE 10 INT C C DAT, P13; [吕宗磊 Lu Zonglei], 2008, [计算机研究与发展, Journal of Computer Research and Development], V45, P1477; MacQueen J., 1967, P 5 BERKELEY S MATH, VVolume 1, P281, DOI DOI 10.1007/S11665-016-2173-6; Martin A, 2001, ELECT NOTES THEORETI, V52, P21; Raimi R, 1997, INT TEST CONF P, P964; Reichart R., 2009, P CONLL 2009 P 13 C, P165, DOI DOI 10.3115/1596374.1596401; Shtern M, 2009, PROC IEEE INT CONF S, P297, DOI 10.1109/ICSM.2009.5306306; Theodoridis S., 2008, PATTERN RECOGN, V4th ed.; VARDI MY, 1986, J COMPUT SYST SCI, V32, P183, DOI 10.1016/0022-0000(86)90026-7; Vendramin Lucas, 2010, Statistical Analysis and Data Mining, V3, P209, DOI 10.1002/sam.10080; Zahid N, 1999, PATTERN RECOGN, V32, P1089, DOI 10.1016/S0031-3203(98)00157-5; Zalik KR, 2011, PATTERN RECOGN LETT, V32, P221, DOI 10.1016/j.patrec.2010.08.007; Zhang T., 1996, P 1996 ACM SIGMOD IN, DOI [10.1145/235968.233324, DOI 10.1145/235968.233324]	40	1	2	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90109	10.1371/journal.pone.0090109	http://dx.doi.org/10.1371/journal.pone.0090109			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608823	Green Published, gold, Green Submitted			2022-12-27	WOS:000332485800017
J	Nouri, E; Breuillin-Sessoms, F; Feller, U; Reinhardt, D				Nouri, Eva; Breuillin-Sessoms, Florence; Feller, Urs; Reinhardt, Didier			Phosphorus and Nitrogen Regulate Arbuscular Mycorrhizal Symbiosis in Petunia hybrida	PLOS ONE			English	Article							MINERAL ACQUISITION; ROOT-SYSTEM; PHYSIOLOGICAL-RESPONSES; PHOSPHATE TRANSPORTERS; FUNGAL DIVERSITY; NITRATE; PLANTS; SOIL; GENE; EXPRESSION	Phosphorus and nitrogen are essential nutrient elements that are needed by plants in large amounts. The arbuscular mycorrhizal symbiosis between plants and soil fungi improves phosphorus and nitrogen acquisition under limiting conditions. On the other hand, these nutrients influence root colonization by mycorrhizal fungi and symbiotic functioning. This represents a feedback mechanism that allows plants to control the fungal symbiont depending on nutrient requirements and supply. Elevated phosphorus supply has previously been shown to exert strong inhibition of arbuscular mycorrhizal development. Here, we address to what extent inhibition by phosphorus is influenced by other nutritional pathways in the interaction between Petunia hybrida and R. irregularis. We show that phosphorus and nitrogen are the major nutritional determinants of the interaction. Interestingly, the symbiosis-promoting effect of nitrogen starvation dominantly overruled the suppressive effect of high phosphorus nutrition onto arbuscular mycorrhiza, suggesting that plants promote the symbiosis as long as they are limited by one of the two major nutrients. Our results also show that in a given pair of symbiotic partners (Petunia hybrida and R. irregularis), the entire range from mutually symbiotic to parasitic can be observed depending on the nutritional conditions. Taken together, these results reveal complex nutritional feedback mechanisms in the control of root colonization by arbuscular mycorrhizal fungi.	[Nouri, Eva; Breuillin-Sessoms, Florence; Reinhardt, Didier] Univ Fribourg, Dept Biol, CH-1700 Fribourg, Switzerland; [Feller, Urs] Univ Bern, Inst Plant Sci, Bern, Switzerland	University of Fribourg; University of Bern	Reinhardt, D (corresponding author), Univ Fribourg, Dept Biol, CH-1700 Fribourg, Switzerland.	didier.reinhardt@unifr.ch	Feller, Urs/A-1807-2008; Reinhardt, Didier/M-8508-2014	Feller, Urs/0000-0001-7858-5721; Reinhardt, Didier/0000-0003-3495-6783	National Centre of Competence in Research (NCCR)	National Centre of Competence in Research (NCCR)(Swiss National Science Foundation (SNSF))	This work was supported by a grant from the National Centre of Competence in Research (NCCR) "Plant Survival". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT LK, 1984, NEW PHYTOL, V97, P437, DOI 10.1111/j.1469-8137.1984.tb03609.x; Alguacil MM, 2008, ECOL APPL, V18, P527, DOI 10.1890/07-0521.1; Allen JW, 2009, PLANT PHYSIOL, V149, P549, DOI 10.1104/pp.108.129866; AMIJEE F, 1989, NEW PHYTOL, V111, P435, DOI 10.1111/j.1469-8137.1989.tb00706.x; AMIJEE F, 1989, PLANT SOIL, V119, P334, DOI 10.1007/BF02370427; Amtmann A, 2009, NEW PHYTOL, V181, P35, DOI 10.1111/j.1469-8137.2008.02666.x; Angelard C, 2010, CURR BIOL, V20, P1216, DOI 10.1016/j.cub.2010.05.031; [Anonymous], ECOLOGY LETT, V10, P1135; Auge RM, 2001, MYCORRHIZA, V11, P3, DOI 10.1007/s005720100097; BAATH E, 1989, CAN J BOT, V67, P3227, DOI 10.1139/b89-402; Bago B, 1998, NEW PHYTOL, V139, P375, DOI 10.1046/j.1469-8137.1998.00199.x; Balzergue C, 2011, J EXP BOT, V62, P1049, DOI 10.1093/jxb/erq335; Blanke V, 2005, NEW PHYTOL, V166, P981, DOI 10.1111/j.1469-8137.2005.01374.x; BOHLEY P, 1967, H-S Z PHYSIOL CHEM, V348, P100, DOI 10.1515/bchm2.1967.348.1.100; Bouguyon E, 2012, SEMIN CELL DEV BIOL, V23, P648, DOI 10.1016/j.semcdb.2012.01.004; Breuillin F, 2010, PLANT J, V64, P1002, DOI 10.1111/j.1365-313X.2010.04385.x; Brundrett MC, 2002, NEW PHYTOL, V154, P275, DOI 10.1046/j.1469-8137.2002.00397.x; Bucher M, 2007, NEW PHYTOL, V173, P11, DOI 10.1111/j.1469-8137.2006.01935.x; Cai HM, 2012, J BIOSCIENCES, V37, P731, DOI 10.1007/s12038-012-9242-2; Charpentier M, 2013, PLANT PHYSIOL, V163, P496, DOI 10.1104/pp.113.220863; Chen AQ, 2007, NEW PHYTOL, V173, P817, DOI 10.1111/j.1469-8137.2006.01962.x; Clark RB, 1996, SOIL BIOL BIOCHEM, V28, P1495, DOI 10.1016/S0038-0717(96)00163-0; Clark RB, 2000, J PLANT NUTR, V23, P867, DOI 10.1080/01904160009382068; Conrath U, 2006, MOL PLANT MICROBE IN, V19, P1062, DOI 10.1094/MPMI-19-1062; Dechorgnat J, 2011, J EXP BOT, V62, P1349, DOI 10.1093/jxb/erq409; Douds Jr D. D., 2000, ARBUSCULAR MYCORRHIZ, P107, DOI [10.1007/978-94-017-0776-3_6, DOI 10.1007/978-94-017-0776-3_6]; Egerton-Warburton LM, 2001, P ROY SOC B-BIOL SCI, V268, P2479, DOI 10.1098/rspb.2001.1844; Fellbaum CR, 2012, P NATL ACAD SCI USA, V109, P2666, DOI 10.1073/pnas.1118650109; FRIESE CF, 1991, MYCOLOGIA, V83, P409, DOI 10.2307/3760351; Garcion C, 2006, TRENDS PLANT SCI, V11, P320, DOI 10.1016/j.tplants.2006.05.009; George E., 2000, ARBUSCULAR MYCORRHIZ, P307, DOI DOI 10.1007/978-94-017-0776-3_14; Gojon A, 2011, J EXP BOT, V62, P2299, DOI 10.1093/jxb/erq419; Govindarajulu M, 2005, NATURE, V435, P819, DOI 10.1038/nature03610; Guether M, 2009, PLANT PHYSIOL, V150, P73, DOI 10.1104/pp.109.136390; Gusewell S, 2004, NEW PHYTOL, V164, P243, DOI 10.1111/j.1469-8137.2004.01192.x; Hell R, 2001, CURR OPIN BIOTECH, V12, P161, DOI 10.1016/S0958-1669(00)00193-2; HEPPER CM, 1983, NEW PHYTOL, V93, P389, DOI 10.1111/j.1469-8137.1983.tb03439.x; Hermans C, 2006, TRENDS PLANT SCI, V11, P610, DOI 10.1016/j.tplants.2006.10.007; Hodge A, 2010, P NATL ACAD SCI USA, V107, P13754, DOI 10.1073/pnas.1005874107; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; JASPER DA, 1979, SOIL BIOL BIOCHEM, V11, P501, DOI 10.1016/0038-0717(79)90009-9; Javot H, 2007, P NATL ACAD SCI USA, V104, P1720, DOI 10.1073/pnas.0608136104; Javot H, 2007, PLANT CELL ENVIRON, V30, P310, DOI 10.1111/j.1365-3040.2006.01617.x; Johnson NC, 2010, NEW PHYTOL, V185, P631, DOI 10.1111/j.1469-8137.2009.03110.x; Johnson NC, 1997, NEW PHYTOL, V135, P575, DOI 10.1046/j.1469-8137.1997.00729.x; Jung SC, 2012, J CHEM ECOL, V38, P651, DOI 10.1007/s10886-012-0134-6; Karandashov V, 2005, TRENDS PLANT SCI, V10, P22, DOI 10.1016/j.tplants.2004.12.003; Kiba T, 2012, PLANT CELL, V24, P245, DOI 10.1105/tpc.111.092221; Klironomos JN, 2003, ECOLOGY, V84, P2292, DOI 10.1890/02-0413; Lin XG, 2012, ENVIRON SCI TECHNOL, V46, P5764, DOI 10.1021/es3001695; Liu YJ, 2012, NEW PHYTOL, V194, P523, DOI 10.1111/j.1469-8137.2012.04050.x; Lopez-Raez JA, 2008, NEW PHYTOL, V178, P863, DOI 10.1111/j.1469-8137.2008.02406.x; Mader P, 2000, NEW PHYTOL, V146, P155, DOI 10.1046/j.1469-8137.2000.00615.x; Maeda D, 2006, PLANT CELL PHYSIOL, V47, P807, DOI 10.1093/pcp/pcj069; MENGE JA, 1978, NEW PHYTOL, V80, P575, DOI 10.1111/j.1469-8137.1978.tb01589.x; Muchhal US, 1999, P NATL ACAD SCI USA, V96, P5868, DOI 10.1073/pnas.96.10.5868; Muchhal US, 1996, P NATL ACAD SCI USA, V93, P10519, DOI 10.1073/pnas.93.19.10519; Muller A, 2013, PLANT SOIL, V364, P341, DOI 10.1007/s11104-012-1372-7; Nacry P, 2005, PLANT PHYSIOL, V138, P2061, DOI 10.1104/pp.105.060061; Nagajyoti PC, 2010, ENVIRON CHEM LETT, V8, P199, DOI 10.1007/s10311-010-0297-8; Nagy R, 2005, PLANT J, V42, P236, DOI 10.1111/j.1365-313X.2005.02364.x; Nuwaysir EF, 2002, GENOME RES, V12, P1749, DOI 10.1101/gr.362402; Olsson PA, 2010, FEMS MICROBIOL ECOL, V72, P123, DOI 10.1111/j.1574-6941.2009.00833.x; Parniske M, 2008, NAT REV MICROBIOL, V6, P763, DOI 10.1038/nrmicro1987; Remans T, 2006, PLANT PHYSIOL, V140, P909, DOI 10.1104/pp.105.075721; Sawers RJH, 2010, THEOR APPL GENET, V120, P1029, DOI 10.1007/s00122-009-1231-y; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seddas P, 2009, SIGNAL COMMUN PLANTS, P45, DOI 10.1007/978-3-540-89230-4_3; Sekhara RDMR, 2007, PLANT J, V51, P739, DOI 10.1111/j.1365-313X.2007.03175.x; Sieh D, 2013, NEW PHYTOL, V197, P606, DOI 10.1111/nph.12034; Smith FA, 2009, NEW PHYTOL, V182, P347, DOI 10.1111/j.1469-8137.2008.02753.x; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Smith SE, 2011, ANNU REV PLANT BIOL, V62, P227, DOI 10.1146/annurev-arplant-042110-103846; Smith SE, 2004, NEW PHYTOL, V162, P511, DOI 10.1111/j.1469-8137.2004.01039.x; Smith SE, 2003, PLANT PHYSIOL, V133, P16, DOI 10.1104/pp.103.024380; STIEGER PA, 1994, PLANT SOIL, V160, P87, DOI 10.1007/BF00150349; Sugiura M, 2007, PLANT CELL PHYSIOL, V48, P1022, DOI 10.1093/pcp/pcm073; Tawaraya K, 2003, SOIL SCI PLANT NUTR, V49, P655, DOI 10.1080/00380768.2003.10410323; THOMSON BD, 1986, NEW PHYTOL, V103, P751, DOI 10.1111/j.1469-8137.1986.tb00850.x; Tian CJ, 2010, PLANT PHYSIOL, V153, P1175, DOI 10.1104/pp.110.156430; Tsay YF, 2007, FEBS LETT, V581, P2290, DOI 10.1016/j.febslet.2007.04.047; van Diepen LTA, 2007, NEW PHYTOL, V176, P175, DOI 10.1111/j.1469-8137.2007.02150.x; VERWOERD TC, 1989, NUCLEIC ACIDS RES, V17, P2362, DOI 10.1093/nar/17.6.2362; Wang RC, 2009, PLANT PHYSIOL, V151, P472, DOI 10.1104/pp.109.140434; Wegmueller S, 2008, PLANT J, V54, P1115, DOI 10.1111/j.1365-313X.2008.03474.x; Yang SY, 2012, PLANT CELL, V24, P4236, DOI 10.1105/tpc.112.104901; Yoneyama K, 2007, PLANTA, V227, P125, DOI 10.1007/s00425-007-0600-5; Yoneyama K, 2007, PLANTA, V225, P1031, DOI 10.1007/s00425-006-0410-1	88	146	156	4	140	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90841	10.1371/journal.pone.0090841	http://dx.doi.org/10.1371/journal.pone.0090841			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608923	Green Published, Green Submitted, gold			2022-12-27	WOS:000332485800059
J	Scharnowski, F; Rosa, MJ; Golestani, N; Hutton, C; Josephs, O; Weiskopf, N; Rees, G				Scharnowski, Frank; Rosa, Maria Joao; Golestani, Narly; Hutton, Chloe; Josephs, Oliver; Weiskopf, Nikolaus; Rees, Geraint			Connectivity Changes Underlying Neurofeedback Training of Visual Cortex Activity	PLOS ONE			English	Article							DYNAMIC CAUSAL-MODELS; NEURAL ACTIVITY; ACTIVITY FLUCTUATIONS; FMRI NEUROFEEDBACK; DIRECTED ATTENTION; SPATIAL ATTENTION; PARIETAL CORTEX; MECHANISMS; PERCEPTION; ACTIVATION	Neurofeedback based on real-time functional magnetic resonance imaging (fMRI) is a new approach that allows training of voluntary control over regionally specific brain activity. However, the neural basis of successful neurofeedback learning remains poorly understood. Here, we assessed changes in effective brain connectivity associated with neurofeedback training of visual cortex activity. Using dynamic causal modeling (DCM), we found that training participants to increase visual cortex activity was associated with increased effective connectivity between the visual cortex and the superior parietal lobe. Specifically, participants who learned to control activity in their visual cortex showed increased top-down control of the superior parietal lobe over the visual cortex, and at the same time reduced bottom-up processing. These results are consistent with efficient employment of top-down visual attention and imagery, which were the cognitive strategies used by participants to increase their visual cortex activity.	[Scharnowski, Frank; Hutton, Chloe; Josephs, Oliver; Weiskopf, Nikolaus; Rees, Geraint] UCL, Wellcome Trust Ctr Neuroimaging, UCL Inst Neurol, London, England; [Scharnowski, Frank; Golestani, Narly; Rees, Geraint] UCL, UCL Inst Cognit Neurosci, London, England; [Scharnowski, Frank] Ecole Polytech Fed Lausanne, Swiss Inst Technol Lausanne, Inst Bioengn, CH-1015 Lausanne, Switzerland; [Scharnowski, Frank] Univ Geneva, CIBM, Dept Radiol & Med Informat, Geneva, Switzerland; [Rosa, Maria Joao] Kings Coll London, Inst Psychiat, Dept Neurosci, London WC2R 2LS, England; [Golestani, Narly] Univ Geneva, Univ Med Sch, Geneva, Switzerland	University of London; University College London; University of London; University College London; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Geneva; University of London; King's College London; University of Geneva	Scharnowski, F (corresponding author), UCL, Wellcome Trust Ctr Neuroimaging, UCL Inst Neurol, London, England.	frank.scharnowski@epfl.ch	Weiskopf, Nikolaus/B-9357-2008; Rees, Geraint/C-1493-2008; Rosa, Maria J./K-3185-2015; Golestani, Narly/C-4879-2009	Weiskopf, Nikolaus/0000-0001-5239-1881; Rees, Geraint/0000-0002-9623-7007; Rosa, Maria J./0000-0001-9822-3752; Golestani, Narly/0000-0001-7388-4714; Scharnowski, Frank/0000-0002-9973-2521	Swiss National Science Foundation; European Union; Wellcome Trust [091593/Z10/Z]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Union(European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Swiss National Science Foundation, the European Union, and the Wellcome Trust (GR). The Wellcome Trust Centre for Neuroimaging is supported by core funding from the Wellcome Trust 091593/Z10/Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Birbaumer N, 2013, TRENDS COGN SCI, V17, P295, DOI 10.1016/j.tics.2013.04.009; Boly M, 2007, P NATL ACAD SCI USA, V104, P12187, DOI 10.1073/pnas.0611404104; Brefczynski JA, 1999, NAT NEUROSCI, V2, P370, DOI 10.1038/7280; Chiu YC, 2009, J NEUROSCI, V29, P3930, DOI 10.1523/JNEUROSCI.5737-08.2009; Decharms RC, 2007, TRENDS COGN SCI, V11, P473, DOI 10.1016/j.tics.2007.08.014; Deichmann R, 2004, NEUROIMAGE, V21, P757, DOI 10.1016/j.neuroimage.2003.09.062; Desseilles M, 2011, NEUROIMAGE, V54, P1662, DOI 10.1016/j.neuroimage.2010.08.061; Disner SG, 2011, NAT REV NEUROSCI, V12, P467, DOI 10.1038/nrn3027; Drevets WC, 2001, CURR OPIN NEUROBIOL, V11, P240, DOI 10.1016/S0959-4388(00)00203-8; Driver J, 2001, COGNITION, V79, P39, DOI 10.1016/S0010-0277(00)00124-4; Fox MD, 2007, NEURON, V56, P171, DOI 10.1016/j.neuron.2007.08.023; Friston KJ, 2007, NEUROIMAGE, V34, P220, DOI 10.1016/j.neuroimage.2006.08.035; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Gitelman DR, 2003, NEUROIMAGE, V19, P200, DOI 10.1016/S1053-8119(03)00058-2; Greenberg AS, 2010, J NEUROSCI, V30, P14330, DOI 10.1523/JNEUROSCI.4248-09.2010; Hayes JP, 2012, BIOL MOOD ANXIETY DI, V2, DOI 10.1186/2045-5380-2-9; Hesselmann G, 2008, P NATL ACAD SCI USA, V105, P10984, DOI 10.1073/pnas.0712043105; Hesselmann G, 2008, J NEUROSCI, V28, P14481, DOI 10.1523/JNEUROSCI.4398-08.2008; Hoeting JA, 1999, STAT SCI, V14, P382, DOI 10.1214/ss/1009212519; Hopfinger JB, 2000, NAT NEUROSCI, V3, P284, DOI 10.1038/72999; Hutton C, 2011, NEUROIMAGE, V57, P101, DOI 10.1016/j.neuroimage.2011.04.018; Hutton C, 2002, NEUROIMAGE, V16, P217, DOI 10.1006/nimg.2001.1054; James W., 1890, PRINCIPLES PSYCHOL, V2, P283; Kastner S, 1998, SCIENCE, V282, P108, DOI 10.1126/science.282.5386.108; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; Kelley TA, 2008, CEREB CORTEX, V18, P114, DOI 10.1093/cercor/bhm036; Kiebel SJ, 2007, NEUROIMAGE, V34, P1487, DOI 10.1016/j.neuroimage.2006.10.026; Koenigs M, 2009, J NEUROSCI, V29, P14980, DOI 10.1523/JNEUROSCI.3706-09.2009; Kosslyn SM, 2001, NAT REV NEUROSCI, V2, P635, DOI 10.1038/35090055; Koush Y, 2013, NEUROIMAGE, V81, P422, DOI 10.1016/j.neuroimage.2013.05.010; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Lee JH, 2012, NEUROSCI RES, V72, P347, DOI 10.1016/j.neures.2012.01.002; Lee S, 2011, NEUROREHAB NEURAL RE, V25, P259, DOI 10.1177/1545968310385128; Li X, 2008, P NATL ACAD SCI USA, V105, P6202, DOI 10.1073/pnas.0801390105; Mechelli A, 2004, CEREB CORTEX, V14, P1256, DOI 10.1093/cercor/bhh087; Patel R, 2012, NEUROSCI BIOBEHAV R, V36, P2130, DOI 10.1016/j.neubiorev.2012.06.003; Penny WD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000709; Rota G, 2011, BRAIN LANG, V117, P123, DOI 10.1016/j.bandl.2010.07.008; Scharnowski F, 2012, J NEUROSCI, V32, P17830, DOI 10.1523/JNEUROSCI.6334-11.2012; Shibata K, 2011, SCIENCE, V334, P1413, DOI 10.1126/science.1212003; Slotnick SD, 2005, CEREB CORTEX, V15, P1570, DOI 10.1093/cercor/bhi035; Stephan KE, 2010, NEUROIMAGE, V49, P3099, DOI 10.1016/j.neuroimage.2009.11.015; Stephan KE, 2007, J BIOSCIENCES, V32, P129, DOI 10.1007/s12038-007-0012-5; Stephan KE, 2008, NEUROIMAGE, V42, P649, DOI 10.1016/j.neuroimage.2008.04.262; Stephan KE, 2009, NEUROIMAGE, V46, P1004, DOI 10.1016/j.neuroimage.2009.03.025; Stokes M, 2009, J NEUROSCI, V29, P1565, DOI 10.1523/JNEUROSCI.4657-08.2009; Sulzer J, 2013, NEUROIMAGE, V76, P386, DOI 10.1016/j.neuroimage.2013.03.033; Vossel S, 2012, J NEUROSCI, V32, P10637, DOI 10.1523/JNEUROSCI.0414-12.2012; Vuilleumier P, 2008, CURR BIOL, V18, P1525, DOI 10.1016/j.cub.2008.08.072; Weiskopf N, 2004, J PHYSIOL-PARIS, V98, P357, DOI 10.1016/j.jphysparis.2005.09.019; Weiskopf N, 2004, IEEE T BIO-MED ENG, V51, P966, DOI 10.1109/TBME.2004.827063; Wundt W, 1882, PHILOS STUDIEN, V1, P251; Yantis S, 2002, NAT NEUROSCI, V5, P995, DOI 10.1038/nn921; Zotev V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024522	57	20	21	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91090	10.1371/journal.pone.0091090	http://dx.doi.org/10.1371/journal.pone.0091090			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24609065	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000332485800099
J	Vicens, A; Luke, L; Roldan, ERS				Vicens, Alberto; Lueke, Lena; Roldan, Eduardo R. S.			Proteins Involved in Motility and Sperm-Egg Interaction Evolve More Rapidly in Mouse Spermatozoa	PLOS ONE			English	Article							IPG STRIP PREFRACTIONATION; REPRODUCTIVE PROTEINS; ADAPTIVE EVOLUTION; POSITIVE SELECTION; COMPETITION; GENES; ZONADHESIN; IDENTIFICATION; EXPRESSION; PROTEOMICS	Proteomic studies of spermatozoa have identified a large catalog of integral sperm proteins. Rapid evolution of these proteins may underlie adaptive changes of sperm traits involved in different events leading to fertilization, although the selective forces underlying such rapid evolution are not well understood. A variety of selective forces may differentially affect several steps ending in fertilization, thus resulting in a compartmentalized adaptation of sperm proteins. Here we analyzed the evolution of genes associated to various events in the sperm's life, from sperm formation to sperm-egg interaction. Evolutionary analyses were performed on gene sequences from 17 mouse strains whose genomes have been sequenced. Four of these are derived from wild Mus musculus, M. domesticus, M. castaneus and M. spretus. We found a higher proportion of genes exhibiting a signature of positive selection among those related to sperm motility and sperm-egg interaction. Furthermore, sperm proteins involved in sperm-egg interaction exhibited accelerated evolution in comparison to those involved in other events. Thus, we identified a large set of candidate proteins for future comparative analyses of genotype-phenotype associations in spermatozoa of species subjected to different sexual selection pressures. Adaptive evolution of proteins involved in motility could be driven by sperm competition, since this selective force is known to increase the proportion of motile sperm and their swimming velocity. On the other hand, sperm proteins involved in gamete interaction could be coevolving with their egg partners through episodes of sexual selection or sexual conflict resulting in species-specific sperm-egg interactions and barriers preventing interspecies fertilization.	[Vicens, Alberto; Lueke, Lena; Roldan, Eduardo R. S.] CSIC, Museo Nacl Ciencias Nat, Reprod Ecol & Biol Grp, E-28006 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN)	Roldan, ERS (corresponding author), CSIC, Museo Nacl Ciencias Nat, Reprod Ecol & Biol Grp, E-28006 Madrid, Spain.	roldane@mncn.csic.es	Roldan, Eduardo R.S./M-7947-2014; Arévalo, Lena/D-8757-2013; Arévalo, Lena/AAM-5277-2020	Roldan, Eduardo R.S./0000-0002-7545-4248; Arévalo, Lena/0000-0002-0681-0392; Arévalo, Lena/0000-0002-0681-0392	Spanish Ministry of Economy and Competitiveness [CGL2011-26341, BES-2009-029239]; Consejo Superior de Investigaciones Cientificas (JAE-Predoc); European Social Fund	Spanish Ministry of Economy and Competitiveness(Spanish Government); Consejo Superior de Investigaciones Cientificas (JAE-Predoc); European Social Fund(European Social Fund (ESF))	This work was funded by the Spanish Ministry of Economy and Competitiveness (grant CGL2011-26341 to E.R.S.R. and postgraduate scholarship BES-2009-029239 to A.V.), and by a postgraduate scholarship from the Consejo Superior de Investigaciones Cientificas (JAE-Predoc) co-funded by the European Social Fund (to L.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisimova M, 2001, MOL BIOL EVOL, V18, P1585, DOI 10.1093/oxfordjournals.molbev.a003945; Baker MA, 2008, PROTEOMICS, V8, P1720, DOI 10.1002/pmic.200701020; Baker MA, 2008, PROTEOMICS, V8, P2312, DOI 10.1002/pmic.200700876; Beck JA, 2000, NAT GENET, V24, P23, DOI 10.1038/71641; Bielawski JP, 2001, MOL BIOL EVOL, V18, P523, DOI 10.1093/oxfordjournals.molbev.a003831; Birkhead TR, 1998, SPERM COMPETITION SE; BOER PH, 1987, MOL CELL BIOL, V7, P3107, DOI 10.1128/MCB.7.9.3107; Cao WL, 2006, MOL CELL PROTEOMICS, V5, P801, DOI 10.1074/mcp.M500322-MCP200; Chapman T, 2003, TRENDS ECOL EVOL, V18, P41, DOI 10.1016/S0169-5347(02)00004-6; Clark NL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000570; Clark NL, 2006, REPRODUCTION, V131, P11, DOI 10.1530/rep.1.00357; Coyne J.A., 2004, SPECIATION; Dean MD, 2008, MOL BIOL EVOL, V25, P383, DOI 10.1093/molbev/msm265; Dean MD, 2009, MOL BIOL EVOL, V26, P1733, DOI 10.1093/molbev/msp094; Dorus S, 2004, NAT GENET, V36, P1326, DOI 10.1038/ng1471; Dorus S, 2006, NAT GENET, V38, P1440, DOI 10.1038/ng1915; Dorus S, 2012, SYST BIOL REPROD MED, V58, P218, DOI 10.3109/19396368.2012.700442; Dorus S, 2010, MOL BIOL EVOL, V27, P1235, DOI 10.1093/molbev/msq007; Dorus S, 2009, SPERM BIOLOGY: AN EVOLUTIONARY PERSPECTIVE, P435, DOI 10.1016/B978-0-12-372568-4.00011-2; Eberhard W. G., 1996, FEMALE CONTROL SEXUA; Findlay GD, 2010, BIOESSAYS, V32, P26, DOI 10.1002/bies.200900127; Finn S, 2010, J MOL EVOL, V71, P231, DOI 10.1007/s00239-010-9382-7; Fitzpatrick JL, 2009, P NATL ACAD SCI USA, V106, P1128, DOI 10.1073/pnas.0809990106; Florman HM, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P55; Gavrilets S, 2000, NATURE, V403, P886, DOI 10.1038/35002564; Glassey B, 2004, MOL BIOL EVOL, V21, P851, DOI 10.1093/molbev/msh080; Goios A, 2007, GENOME RES, V17, P293, DOI 10.1101/gr.5941007; Gomendio M, 2008, INT J DEV BIOL, V52, P439, DOI 10.1387/ijdb.082595mg; Gomenido Montserrat, 1998, P667, DOI 10.1016/B978-012100543-6/50041-6; Montoto LG, 2011, REPRODUCTION, V142, P819, DOI 10.1530/REP-11-0232; Good JM, 2005, MOL BIOL EVOL, V22, P1044, DOI 10.1093/molbev/msi087; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hamm D, 2007, AM J HUM GENET, V81, P44, DOI 10.1086/518695; Hendriksen PJM, 1997, GENOMICS, V41, P350, DOI 10.1006/geno.1997.4673; Herlyn H, 2005, MOL PHYLOGENET EVOL, V37, P62, DOI 10.1016/j.ympev.2005.04.001; Herlyn H, 2006, J MOL EVOL, V63, P602, DOI 10.1007/s00239-005-0146-8; Hess KC, 2005, DEV CELL, V9, P249, DOI 10.1016/j.devcel.2005.06.007; Howard DJ, 1999, ANNU REV ECOL SYST, V30, P109, DOI 10.1146/annurev.ecolsys.30.1.109; Howard DJ, 1993, HYBRID ZONES EVOLUTI; Karr TL, 2009, SPERM BIOLOGY: AN EVOLUTIONARY PERSPECTIVE, P305, DOI 10.1016/B978-0-12-372568-4.00008-2; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Luke L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029247; Lupold S, 2009, P R SOC B, V276, P1175, DOI 10.1098/rspb.2008.1645; Martin-Coello J, 2009, EVOLUTION, V63, P613, DOI 10.1111/j.1558-5646.2008.00585.x; Martinez-Heredia J, 2008, HUM REPROD, V23, P783, DOI 10.1093/humrep/den024; Miki K, 2004, P NATL ACAD SCI USA, V101, P16501, DOI 10.1073/pnas.0407708101; Miki Kiyoshi, 2007, Soc Reprod Fertil Suppl, V65, P309; Navarro B, 2008, INT J DEV BIOL, V52, P607, DOI 10.1387/ijdb.072554bn; Palumbi SR, 2009, HEREDITY, V102, P66, DOI 10.1038/hdy.2008.104; Siegel C, 1988, NONPARAMETRIC STAT B, P213; Stein KK, 2006, PROTEOMICS, V6, P3533, DOI 10.1002/pmic.200500845; Sutton KA, 2008, P NATL ACAD SCI USA, V105, P8661, DOI 10.1073/pnas.0800603105; Suzuki H, 2004, MOL PHYLOGENET EVOL, V33, P626, DOI 10.1016/j.ympev.2004.08.003; Swanson WJ, 2004, GENETICS, V168, P1457, DOI 10.1534/genetics.104.030478; Swanson WJ, 2002, NAT REV GENET, V3, P137, DOI 10.1038/nrg733; Swanson WJ, 2001, P NATL ACAD SCI USA, V98, P2509, DOI 10.1073/pnas.051605998; Swanson WJ, 2003, MOL BIOL EVOL, V20, P18, DOI 10.1093/oxfordjournals.molbev.a004233; Tardif S, 2011, MOL HUM REPROD, V17, P661, DOI 10.1093/molehr/gar039; Team R. Core, 2012, R LANG ENV STAT COMP; Torgerson DG, 2002, MOL BIOL EVOL, V19, P1973, DOI 10.1093/oxfordjournals.molbev.a004021; Tourmente M, 2013, EVOLUTION, V67, P1838, DOI 10.1111/evo.12079; Tourmente M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-12; Turner LM, 2008, INT J DEV BIOL, V52, P769, DOI 10.1387/ijdb.082577lt; Turner LM, 2008, GENETICS, V179, P2075, DOI 10.1534/genetics.107.085902; Turner RM, 2006, REPROD FERT DEVELOP, V18, P25, DOI 10.1071/RD05120; Wyckoff GJ, 2000, NATURE, V403, P304, DOI 10.1038/35002070; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	68	38	38	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91302	10.1371/journal.pone.0091302	http://dx.doi.org/10.1371/journal.pone.0091302			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608277	Green Submitted, Green Published, gold			2022-12-27	WOS:000332485800126
J	Yun, SH; Choi, CW; Lee, SY; Lee, YG; Kwon, J; Leem, SH; Chung, YH; Kahng, HY; Kim, SJ; Kwon, KK; Kim, SI				Yun, Sung Ho; Choi, Chi-Won; Lee, Sang-Yeop; Lee, Yeol Gyun; Kwon, Joseph; Leem, Sun Hee; Chung, Young Ho; Kahng, Hyung-Yeel; Kim, Sang Jin; Kwon, Kae Kyoung; Kim, Seung Il			Proteomic Characterization of Plasmid pLA1 for Biodegradation of Polycyclic Aromatic Hydrocarbons in the Marine Bacterium, Novosphingobium pentaromativorans US6-1	PLOS ONE			English	Article							MYCOBACTERIUM-VANBAALENII PYR-1; PYRENE DEGRADATION; STRAIN; IDENTIFICATION; DIOXYGENASE; EXPRESSION; PREDICTION; PATHWAYS; SEQUENCE	Novosphingobium pentaromativorans US6-1 is a halophilic marine bacterium able to degrade polycyclic aromatic hydrocarbons (PAHs). Genome sequence analysis revealed that the large plasmid pLA1 present in N. pentaromativorans US6-1 consists of 199 ORFs and possess putative biodegradation genes that may be involved in PAH degradation. 1-DE/LC-MS/MS analysis of N. pentaromativorans US6-1 cultured in the presence of different PAHs and monocyclic aromatic hydrocarbons (MAHs) identified approximately 1,000 and 1,400 proteins, respectively. Up-regulated biodegradation enzymes, including those belonging to pLA1, were quantitatively compared. Among the PAHs, phenanthrene induced the strongest up-regulation of extradiol cleavage pathway enzymes such as ring-hydroxylating dioxygenase, putative biphenyl-2,3-diol 1,2-dioxygenase, and catechol 2,3-dioxygenase in pLA1. These enzymes lead the initial step of the lower catabolic pathway of aromatic hydrocarbons through the extradiol cleavage pathway and participate in the attack of PAH ring cleavage, respectively. However, N. pentaromativorans US6-1 cultured with p-hydroxybenzoate induced activation of another extradiol cleavage pathway, the protocatechuate 4,5-dioxygenase pathway, that originated from chromosomal genes. These results suggest that N. pentaromativorans US6-1 utilizes two different extradiol pathways and plasmid pLA1 might play a key role in the biodegradation of PAH in N. pentaromativorans US6-1.	[Yun, Sung Ho; Choi, Chi-Won; Lee, Sang-Yeop; Lee, Yeol Gyun; Kwon, Joseph; Chung, Young Ho; Kim, Seung Il] Korea Basic Sci Inst, Div Life Sci, Taejon, South Korea; [Leem, Sun Hee] Dong A Univ, Dept Biol, Pusan, South Korea; [Kahng, Hyung-Yeel] Sunchon Natl Univ, Dept Environm Educ, Sunchon, South Korea; [Kim, Sang Jin; Kwon, Kae Kyoung] Korea Inst Ocean Sci & Technol, Ansan, South Korea; [Kim, Seung Il] Univ Sci & Technol, Dept Bioanalyt Sci, Taejon, South Korea	Korea Basic Science Institute (KBSI); Dong A University; Sunchon National University; Korea Institute of Ocean Science & Technology (KIOST)	Kim, SI (corresponding author), Korea Basic Sci Inst, Div Life Sci, Taejon, South Korea.	ksi@kbsi.re.kr		Kahng, Hyung-Yeel/0000-0002-3856-0295; Lee, Sang-Yeop/0000-0002-8257-6112	Marine and Extreme Genome Research Center Program of the Ministry of Land, Transportation and Maritime Affairs, Republic of Korea; Korea Basic Science Institute [T32414]; National Research Foundation of Korea (NRF); Korea government (MEST) [2012-0000481]; KBSI [T33417]	Marine and Extreme Genome Research Center Program of the Ministry of Land, Transportation and Maritime Affairs, Republic of Korea(Ministry of Land, Transport and Maritime Affairs (MLTM), Republic of Korea); Korea Basic Science Institute; National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); KBSI	This work was supported by the Marine and Extreme Genome Research Center Program of the Ministry of Land, Transportation and Maritime Affairs, Republic of Korea and the Korea Basic Science Institute Grant (T32414). SHL was partially supported by a National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (2012-0000481). YHC was partially supported by a KBSI grant (T33417). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aylward FO, 2013, APPL ENVIRON MICROB, V79, P3724, DOI 10.1128/AEM.00518-13; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Choi CW, 2012, DIAGN MICR INFEC DIS, V72, P318, DOI 10.1016/j.diagmicrobio.2011.12.013; Demaneche S, 2004, APPL ENVIRON MICROB, V70, P6714, DOI 10.1128/AEM.70.11.6714-6725.2004; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Jouanneau Y, 2006, APPL ENVIRON MICROB, V72, P4726, DOI 10.1128/AEM.00395-06; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Kasai Y, 2003, APPL ENVIRON MICROB, V69, P6688, DOI 10.1128/AEM.69.11.6688-6697.2003; Kim SJ, 2007, J BACTERIOL, V189, P464, DOI 10.1128/JB.01310-06; Kim SJ, 2009, CURR OPIN MICROBIOL, V12, P301, DOI 10.1016/j.mib.2009.03.006; Kim SI, 2007, OMICS, V11, P280, DOI 10.1089/omi.2007.0019; Kim SJ, 2004, PROTEOMICS, V4, P3899, DOI 10.1002/pmic.200400872; Kim YH, 2006, PROTEOMICS, V6, P1301, DOI 10.1002/pmic.200500329; Kim YH, 2005, APPL MICROBIOL BIOT, V67, P275, DOI 10.1007/s00253-004-1796-y; Kweon O, 2011, J BACTERIOL, V193, P4326, DOI 10.1128/JB.00215-11; Liang Y, 2006, APPL ENVIRON MICROB, V72, P7821, DOI 10.1128/AEM.01274-06; Luo YR, 2012, J BACTERIOL, V194, P907, DOI 10.1128/JB.06476-11; Moon YJ, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.015420; Romine MF, 1999, J BACTERIOL, V181, P1585, DOI 10.1128/JB.181.5.1585-1602.1999; Sarma PM, 2010, BIODEGRADATION, V21, P59, DOI 10.1007/s10532-009-9281-z; Shintani M, 2007, J BACTERIOL, V189, P2007, DOI 10.1128/JB.01486-06; Singleton DR, 2012, APPL ENVIRON MICROB, V78, P3552, DOI 10.1128/AEM.00173-12; Sohn JH, 2004, INT J SYST EVOL MICR, V54, P1483, DOI 10.1099/ijs.0.02945-0; Yu CS, 2006, PROTEINS, V64, P643, DOI 10.1002/prot.21018; Yun SH, 2011, J PROTEOMICS, V74, P620, DOI 10.1016/j.jprot.2011.01.020	25	18	20	3	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90812	10.1371/journal.pone.0090812	http://dx.doi.org/10.1371/journal.pone.0090812			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608660	Green Submitted, Green Published, gold			2022-12-27	WOS:000332485800053
J	Almeida, ST; Nunes, S; Paulo, ACS; Valadares, I; Martins, S; Breia, F; Brito-Avo, A; Morais, A; de Lencastre, H; Sa-Leao, R				Almeida, Sonia T.; Nunes, Sonia; Santos Paulo, Ana Cristina; Valadares, Idalina; Martins, Sara; Breia, Fatima; Brito-Avo, Antonio; Morais, Ana; de Lencastre, Herminia; Sa-Leao, Raquel			Low Prevalence of Pneumococcal Carriage and High Serotype and Genotype Diversity among Adults over 60 Years of Age Living in Portugal	PLOS ONE			English	Article							DAY-CARE-CENTERS; STREPTOCOCCUS-PNEUMONIAE; HAEMOPHILUS-INFLUENZAE; NASOPHARYNGEAL CARRIAGE; RAPID IDENTIFICATION; HIGH-RATES; CHILDREN; COLONIZATION; RESISTANCE; SMOKING	Pneumococcal disease is frequent at the extremes of age. While several studies have looked at colonization among young children, much less is known among the elderly. We aimed to evaluate pneumococcal carriage among elderly adults living in Portugal. Between April 2010 and December 2012, nasopharyngeal and oropharyngeal swabs of adults over 60 years of age, living in an urban area (n = 1,945) or in a rural area (n = 1,416), were obtained. Pneumococci were isolated by culture-based standard procedures, identified by optochin susceptibility, bile solubility and PCR screening for lytA and cpsA, and characterized by antibiotype, serotype, and MLST. Associations between pneumococcal carriage, socio-demographic and clinical characteristics were evaluated by univariate analysis and multiple logistic regression. The global prevalence of carriage was 2.3% (95% CI: 1.8-2.8). In the multiple logistic regression analysis, smoking, being at a retirement home, and living in a rural area increased the odds of being a pneumococcal carrier by 4.4-fold (95% CI: 1.9-9.2), 2.0-fold (95% CI: 1.1-3.6) and 2.0-fold (95% CI: 1.2-3.5), respectively. Among the 77 pneumococcal isolates, 26 serotypes and 40 STs were identified. The most prevalent serotypes were (in decreasing order) 19A, 6C, 22F, 23A, 35F, 11A, and 23B, which accounted, in total, for 60.0% of the isolates. Most isolates (93.5%) had STs previously described in the MLST database. Resistance to macrolides, non-susceptibility to penicillin and multidrug resistance were found in 19.5%, 11.7%, and 15.6% of the isolates, respectively. We conclude that the prevalence of pneumococcal carriage in the elderly, in Portugal, as determined by culture-based methods, is low. Serotype and genotype diversity is high. Living in a rural area, in a retirement home, and being a smoker increased the risk of pneumococcal carriage. This study contributes to the establishment of a baseline that may be used to monitor how novel pneumococcal vaccines impact on colonization among the elderly.	[Almeida, Sonia T.; Nunes, Sonia; Santos Paulo, Ana Cristina; Sa-Leao, Raquel] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Lab Mol Microbiol Human Pathogens, Oeiras, Portugal; [Valadares, Idalina; Martins, Sara; Brito-Avo, Antonio; Morais, Ana] Agrupamento Ctr Saude Oeiras Carnaxide, Oeiras, Portugal; [Breia, Fatima] Agrupamento Ctr Sau Alentejo Cent II, Evora, Portugal; [de Lencastre, Herminia] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Mol Genet Lab, P-2780156 Oeiras, Portugal; [de Lencastre, Herminia] Rockefeller Univ, Lab Microbiol Infect Dis, New York, NY 10021 USA	Universidade Nova de Lisboa; Universidade Nova de Lisboa; Rockefeller University	Sa-Leao, R (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, Lab Mol Microbiol Human Pathogens, Oeiras, Portugal.	rsaleao@itqb.unl.pt	Sá-Leão, Raquel/A-9341-2011	Sá-Leão, Raquel/0000-0001-9804-827X; PAULO, Ana Cristina/0000-0002-9249-2609; /0000-0001-6816-8932; Almeida, Sonia/0000-0002-8143-5254	Pfizer; Fundacao para a Ciencia e Tecnologia (FCT) [PEst-OE/EQB/LA0004/2011]; FCT, Portugal [SFRH/BD/40706/2007]	Pfizer(Pfizer); Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); FCT, Portugal(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was partially supported by an unrestricted research grant from Pfizer (to RSL) and grant PEst-OE/EQB/LA0004/2011 (to the Oeiras Associated Laboratory) from Fundacao para a Ciencia e Tecnologia (FCT). SN was supported by grant SFRH/BD/40706/2007 from FCT, Portugal. The funders had no role in study design, data collection and analysis, preparation of the manuscript or decision to submit the manuscript for publication.	Abdullahi O, 2008, PEDIATR INFECT DIS J, V27, P59, DOI 10.1097/INF.0b013e31814da70c; Aguiar SI, 2010, VACCINE, V28, P5167, DOI 10.1016/j.vaccine.2010.06.008; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P1; [Anonymous], 2000, NEW ENGL J MED, DOI 10.1056/NEJM200003093421002; Carvalho MDG, 2013, PEERJ, V1, DOI 10.7717/peerj.97; Carvalho MD, 2012, J CLIN MICROBIOL, V50, P3146, DOI 10.1128/JCM.01505-12; Chien YW, 2013, PEDIATR INFECT DIS J, V32, P72, DOI 10.1097/INF.0b013e318270d850; de la Campa AG, 2004, EMERG INFECT DIS, V10, P1751, DOI 10.3201/eid1010.040382; Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049; European Commission, 2006, RTD INFO MAGAZINE EU, V49, P11; Ferreira DM, 2013, AM J RESP CRIT CARE, V187, P855, DOI 10.1164/rccm.201212-2277OC; Flamaing J, 2010, J AM GERIATR SOC, V58, P396, DOI 10.1111/j.1532-5415.2009.02700.x; Garcia-Rodriguez JA, 2002, J ANTIMICROB CHEMOTH, V50, P59, DOI 10.1093/jac/dkf506; Greenberg D, 2006, CLIN INFECT DIS, V42, P897, DOI 10.1086/500935; Horacio AN, 2012, VACCINE, V30, P218, DOI 10.1016/j.vaccine.2011.11.022; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Llull D, 2006, J CLIN MICROBIOL, V44, P1250, DOI 10.1128/JCM.44.4.1250-1256.2006; Lo YC, 2009, J MICROBIOL IMMUNOL, V42, P234; Loddenkemper R, 2003, EUROPEAN LUNG WHITE, P16; Ludwig E, 2012, EUR RESPIR REV, V21, P57, DOI 10.1183/09059180.00008911; Mackenzie GA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-304; Murphy TF, 2006, CLIN INFECT DIS, V42, P904, DOI 10.1086/500942; MURRAY PR, 1979, J CLIN MICROBIOL, V9, P290; Nunes S, 2005, J CLIN MICROBIOL, V43, P1285, DOI 10.1128/JCM.43.3.1285-1293.2005; Nuorti JP, 1998, NEW ENGL J MED, V338, P1861, DOI 10.1056/NEJM199806253382601; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; O'Brien KL, 2001, J CLIN MICROBIOL, V39, P1021, DOI 10.1128/JCM.39.3.1021-1024.2001; Ogami M, 2010, EUR J PEDIATR, V169, P1221, DOI 10.1007/s00431-010-1208-5; Pai R, 2006, J CLIN MICROBIOL, V44, P124, DOI 10.1128/JCM.44.1.124-131.2006; Palmu AA, 2012, SCAND J INFECT DIS, V44, P433, DOI 10.3109/00365548.2011.652162; R Development Core Team, 2012, R LANG ENV STAT COMP; Regev-Yochay G, 2004, CLIN INFECT DIS, V38, P632, DOI 10.1086/381547; Rolo D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057047; Sa-Leado R, 2008, J CLIN MICROBIOL, V46, P225, DOI 10.1128/JCM.01551-07; Sa-Leao R, 2009, CLIN MICROBIOL INFEC, V15, P1002, DOI 10.1111/j.1469-0691.2009.02775.x; Sa-Leao R, 2000, J CLIN MICROBIOL, V38, P4137; Scholz CFP, 2012, J CLIN MICROBIOL, V50, P1968, DOI 10.1128/JCM.00365-12; Simell B, 2012, EXPERT REV VACCINES, V11, P841, DOI [10.1586/ERV.12.53, 10.1586/erv.12.53]; Simoes AS, 2011, DIAGN MICR INFEC DIS, V71, P208, DOI 10.1016/j.diagmicrobio.2011.07.009; Simoes AS, 2011, J CLIN MICROBIOL, V49, P2810, DOI 10.1128/JCM.00517-11; Simoes AS, 2010, J CLIN MICROBIOL, V48, P238, DOI 10.1128/JCM.01313-09; SORENSEN UBS, 1993, J CLIN MICROBIOL, V31, P2097; Trzcinski K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060520; Watt JP, 2004, J CLIN MICROBIOL, V42, P4974, DOI 10.1128/JCM.42.11.4974-4976.2004; Wessels E, 2012, J CLIN MICROBIOL, V50, P1171, DOI 10.1128/JCM.06609-11	46	36	37	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90974	10.1371/journal.pone.0090974	http://dx.doi.org/10.1371/journal.pone.0090974			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24604030	gold, Green Submitted, Green Published			2022-12-27	WOS:000332483600118
J	Berg, K; Ericsson, M; Lindgren, M; Gustafsson, H				Berg, Kirsti; Ericsson, Madelene; Lindgren, Mikael; Gustafsson, Hakan			A High Precision Method for Quantitative Measurements of Reactive Oxygen Species in Frozen Biopsies	PLOS ONE			English	Article							OXIDATIVE STRESS; IN-VIVO; INFLAMMATION; SUPEROXIDE; EPR; DOSIMETRY; RADICALS; HYDROXYLAMINE; PEROXYNITRITE; CANCER	Objective: An electron paramagnetic resonance (EPR) technique using the spin probe cyclic hydroxylamine 1-hydroxy-3-methoxycarbonyl-2,2,5,5-tetramethylpyrrolidine (CMH) was introduced as a versatile method for high precision quantification of reactive oxygen species, including the superoxide radical in frozen biological samples such as cell suspensions, blood or biopsies. Materials and Methods: Loss of measurement precision and accuracy due to variations in sample size and shape were minimized by assembling the sample in a well-defined volume. Measurement was carried out at low temperature (150 K) using a nitrogen flow Dewar. The signal intensity was measured from the EPR 1st derivative amplitude, and related to a sample, 3-carboxy-proxyl (CPN) with known spin concentration. Results: The absolute spin concentration could be quantified with a precision and accuracy better than +/- 10 mu M (k = 1). The spin concentration of samples stored at -80 degrees C could be reproduced after 6 months of storage well within the same error estimate. Conclusion: The absolute spin concentration in wet biological samples such as biopsies, water solutions and cell cultures could be quantified with higher precision and accuracy than normally achievable using common techniques such as flat cells, tissue cells and various capillary tubes. In addition; biological samples could be collected and stored for future incubation with spin probe, and also further stored up to at least six months before EPR analysis, without loss of signal intensity. This opens for the possibility to store and transport incubated biological samples with known accuracy of the spin concentration over time.	[Berg, Kirsti; Ericsson, Madelene] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, N-7034 Trondheim, Norway; [Ericsson, Madelene] Umea Univ, Dept Med Biosci, Umea, Sweden; [Lindgren, Mikael] Norwegian Univ Sci & Technol, Dept Phys, N-7034 Trondheim, Norway; [Lindgren, Mikael] Linkoping Univ, Dept Phys Chem & Biol, Linkoping, Sweden; [Gustafsson, Hakan] Linkoping Univ, Dept Med & Hlth Sci, Dept Biomed Engn MTO, Cty Council Ostergotland, Linkoping, Sweden	Norwegian University of Science & Technology (NTNU); Umea University; Norwegian University of Science & Technology (NTNU); Linkoping University; City Council Ostergotland; Linkoping University	Ericsson, M (corresponding author), Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, N-7034 Trondheim, Norway.	madelene.ericsson@medbio.umu.se		Lindgren, Mikael/0000-0001-6649-7871; Ericsson, Madelene/0000-0002-8632-4502	Swedish Research Council [diarienr 2009-5430]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	H. Gustafsson acknowledges The Swedish Research Council (diarienr 2009-5430) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam S, 2010, UROL RES, V38, P179, DOI 10.1007/s00240-010-0256-7; Adolfsson E, 2012, PHYS MED BIOL, V57, P2209, DOI 10.1088/0031-9155/57/8/2209; Anton M, 2006, PHYS MED BIOL, V51, P5419, DOI 10.1088/0031-9155/51/21/003; Berg K, 2013, EUR J CARDIO-THORAC, V43, P1154, DOI 10.1093/ejcts/ezs591; Carl P HP, 2008, QUANTITATIVE EPT TEC, P17; Da Costa LA, 2012, PROG MOL BIOL TRANSL, V108, P179, DOI 10.1016/B978-0-12-398397-8.00008-3; Dikalov S, 1997, BIOCHEM BIOPH RES CO, V230, P54, DOI 10.1006/bbrc.1996.5880; Dikalov S, 2007, HYPERTENSION, V49, P717, DOI 10.1161/01.HYP.0000258594.87211.6b; Dikalov SI, 2007, BIOCHEM PHARMACOL, V73, P972, DOI 10.1016/j.bcp.2006.12.012; Dikalov SI, 2011, FREE RADICAL RES, V45, P417, DOI 10.3109/10715762.2010.540242; Dikalov SI, 2002, ARCH BIOCHEM BIOPHYS, V402, P218, DOI 10.1016/S0003-9861(02)00064-4; Dikalov SI, 2012, METHODS DETECTION MI; Dikalova A, 2005, CIRCULATION, V112, P2668, DOI 10.1161/CIRCULATIONAHA.105.538934; Drummond GR, 2011, NAT REV DRUG DISCOV, V10, P453, DOI 10.1038/nrd3403; Fink B, 2000, FREE RADICAL BIO MED, V28, P121, DOI 10.1016/S0891-5849(99)00228-2; FINKELSTEIN E, 1979, MOL PHARMACOL, V16, P676; FREJAVILLE C, 1995, J MED CHEM, V38, P258, DOI 10.1021/jm00002a007; Gustafsson H, 2008, PHYS MED BIOL, V53, P4667, DOI 10.1088/0031-9155/53/17/014; Halliwell B, 2004, BRIT J PHARMACOL, V142, P231, DOI 10.1038/sj.bjp.0705776; Halliwell Barry GJMC, 2007, FREE RADICALS BIOL M; Hofer Peter CP, 2009, METHOD DETERMINING A; IJsselmuiden AJJ, 2008, NAT CLIN PRACT CARD, V5, P811, DOI 10.1038/ncpcardio1364; Khan N, 2005, J BIOCHEM BIOPH METH, V62, P125, DOI 10.1016/j.jbbm.2004.10.001; Kundu JK, 2012, FREE RADICAL BIO MED, V52, P2013, DOI 10.1016/j.freeradbiomed.2012.02.035; Kuzkaya N, 2005, BIOCHEM PHARMACOL, V70, P343, DOI 10.1016/j.bcp.2005.05.009; Lee R, 2012, CURR MED CHEM, V19, P2504, DOI 10.2174/092986712800493057; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Mrakic-Sposta S, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/973927; NAGY V, 1994, APPL MAGN RESON, V6, P259, DOI 10.1007/BF03162494; Rains JL, 2011, FREE RADICAL BIO MED, V50, P567, DOI 10.1016/j.freeradbiomed.2010.12.006; Ramzan R, 2012, ADV EXP MED BIOL, V748, P265, DOI 10.1007/978-1-4614-3573-0_11; Reuter S, 2010, FREE RADICAL BIO MED, V49, P1603, DOI 10.1016/j.freeradbiomed.2010.09.006; Schaeken B, 2011, RADIOTHER ONCOL, V99, P94, DOI 10.1016/j.radonc.2011.01.026; YORDANOV ND, 1994, APPL MAGN RESON, V6, P241, DOI 10.1007/BF03162493	34	28	28	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90964	10.1371/journal.pone.0090964	http://dx.doi.org/10.1371/journal.pone.0090964			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603936	Green Published, Green Submitted, gold			2022-12-27	WOS:000332483600116
J	Korpela, K; Flint, HJ; Johnstone, AM; Lappi, J; Poutanen, K; Dewulf, E; Delzenne, N; de Vos, WM; Salonen, A				Korpela, Katri; Flint, Harry J.; Johnstone, Alexandra M.; Lappi, Jenni; Poutanen, Kaisa; Dewulf, Evelyne; Delzenne, Nathalie; de Vos, Willem M.; Salonen, Anne			Gut Microbiota Signatures Predict Host and Microbiota Responses to Dietary Interventions in Obese Individuals	PLOS ONE			English	Article							HUMAN INTESTINAL MICROBIOTA; DNA-EXTRACTION METHODS; SPECIES RESPONSE; DOUBLE-BLIND; WEIGHT-LOSS; DIFFERENTIATE; METAGENOME; BACTERIAL; IMPACT	Background: Interactions between the diet and intestinal microbiota play a role in health and disease, including obesity and related metabolic complications. There is great interest to use dietary means to manipulate the microbiota to promote health. Currently, the impact of dietary change on the microbiota and the host metabolism is poorly predictable and highly individual. We propose that the responsiveness of the gut microbiota may depend on its composition, and associate with metabolic changes in the host. Methodology: Our study involved three independent cohorts of obese adults (n = 78) from Belgium, Finland, and Britain, participating in different dietary interventions aiming to improve metabolic health. We used a phylogenetic microarray for comprehensive fecal microbiota analysis at baseline and after the intervention. Blood cholesterol, insulin and inflammation markers were analyzed as indicators of host response. The data were divided into four training set - test set pairs; each intervention acted both as a part of a training set and as an independent test set. We used linear models to predict the responsiveness of the microbiota and the host, and logistic regression to predict responder vs. non-responder status, or increase vs. decrease of the health parameters. Principal Findings: Our models, based on the abundance of several, mainly Firmicute species at baseline, predicted the responsiveness of the microbiota (AUC = 0.77-1; predicted vs. observed correlation = 0.67-0.88). Many of the predictive taxa showed a non-linear relationship with the responsiveness. The microbiota response associated with the change in serum cholesterol levels with an AUC of 0.96, highlighting the involvement of the intestinal microbiota in metabolic health. Conclusion: This proof-of-principle study introduces the first potential microbial biomarkers for dietary responsiveness in obese individuals with impaired metabolic health, and reveals the potential of microbiota signatures for personalized nutrition.	[Korpela, Katri; de Vos, Willem M.; Salonen, Anne] Univ Helsinki, Dept Bacteriol & Immunol, Immunobiol Res Program, Helsinki, Finland; [Flint, Harry J.; Johnstone, Alexandra M.] Univ Aberdeen, Rowett Inst Nutr & Hlth, Aberdeen, Scotland; [Lappi, Jenni; Poutanen, Kaisa] Univ Eastern Finland, Dept Clin Nutr, Kuopio, Finland; [Poutanen, Kaisa] VTT Tech Res Ctr, Espoo, Finland; [Poutanen, Kaisa] VTT Tech Res Ctr, Kuopio, Finland; [Dewulf, Evelyne; Delzenne, Nathalie] Catholic Univ Louvain, Louvain Drug Res Inst, Brussels, Belgium; [de Vos, Willem M.] Univ Helsinki, Dept Vet Biosci, Helsinki, Finland; [de Vos, Willem M.] Wageningen Univ, Microbiol Lab, NL-6700 AP Wageningen, Netherlands	University of Helsinki; University of Aberdeen; University of Eastern Finland; VTT Technical Research Center Finland; VTT Technical Research Center Finland; Universite Catholique Louvain; University of Helsinki; Wageningen University & Research	Salonen, A (corresponding author), Univ Helsinki, Dept Bacteriol & Immunol, Immunobiol Res Program, Helsinki, Finland.	anne.salonen@helsinki.fi	Salonen, Anne/AAW-1858-2020; Delzenne, Nathalie/AAC-4628-2019	Salonen, Anne/0000-0002-6960-7447; Delzenne, Nathalie/0000-0003-2115-6082; Lappi, Jenni/0000-0002-4886-8242; Johnstone, Alexandra/0000-0002-5484-292X	FNRS grant; World Cancer Research Fund; EU 6th Framework Programme in project HEALTHGRAIN; WMdV by Academy of Finland [1141130]; ERC [400795]	FNRS grant(Fonds de la Recherche Scientifique - FNRS); World Cancer Research Fund(World Cancer Research Fund International (WCRF)); EU 6th Framework Programme in project HEALTHGRAIN; WMdV by Academy of Finland(Academy of Finland); ERC(European Research Council (ERC)European Commission)	The study involved samples from previously published studies including the Belgian trial funded the FNRS grant, British study funded by World Cancer Research Fund and the Finnish trials funded by EU 6th Framework Programme in project HEALTHGRAIN. WMdV and AS are funded by the grants to WMdV by Academy of Finland (grant 1141130) http://www.aka.fi/en-GB/A/ and ERC (grant 400795) http://erc.europa.eu/advanced-grants. KK is funded by the Helsinki Biomedical Graduate Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Backhed F, 2012, NUTR REV, V70, pS14, DOI 10.1111/j.1753-4887.2012.00496.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bouhnik Y, 2004, AM J CLIN NUTR, V80, P1658, DOI 10.1093/ajcn/80.6.1658; Cheng J, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-113; Cotillard A, 2013, NATURE, V500, P585, DOI 10.1038/nature12480; Davis LMG, 2010, INT J FOOD MICROBIOL, V144, P285, DOI 10.1016/j.ijfoodmicro.2010.10.007; Delzenne NM, 2011, NAT REV ENDOCRINOL, V7, P639, DOI 10.1038/nrendo.2011.126; Dewulf EM, 2013, GUT, V62, P1112, DOI 10.1136/gutjnl-2012-303304; Everard A, 2013, BEST PRACT RES CL GA, V27, P73, DOI 10.1016/j.bpg.2013.03.007; Faith JJ, 2013, SCIENCE, V341, P44, DOI 10.1126/science.1237439; Flint HJ, 2011, J CLIN GASTROENTEROL, V45, pS128, DOI 10.1097/MCG.0b013e31821f44c4; Haiser HJ, 2012, SCIENCE, V336, P1253, DOI 10.1126/science.1224396; Harmon JP, 2009, SCIENCE, V323, P1347, DOI 10.1126/science.1167396; Holmes E, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004244; Jalanka-Tuovinen J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023035; Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198; Kolida S, 2007, EUR J CLIN NUTR, V61, P1189, DOI 10.1038/sj.ejcn.1602636; Kootte RS, 2012, DIABETES OBES METAB, V14, P112, DOI 10.1111/j.1463-1326.2011.01483.x; Lahti L, 2013, PEERJ, V1, DOI 10.7717/peerj.32; Lampe JW, 2013, P NUTR SOC, V72, P207, DOI 10.1017/S0029665113000025; Lappi J, 2013, J NUTR, V143, P648, DOI 10.3945/jn.112.172668; Lobley GE, 2013, NUTRIENTS, V5, P2144, DOI 10.3390/nu5062144; Louis P, 2004, J BACTERIOL, V186, P2099, DOI 10.1128/JB.186.7.2099-2106.2004; Louis P, 2012, AGRO FOOD IND HI TEC, V23, P26; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Maeda M, 1998, YAKUGAKU ZASSHI, V118, P150, DOI 10.1248/yakushi1947.118.4_150; Martinez I, 2013, ISME J, V7, P269, DOI 10.1038/ismej.2012.104; Martinez I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015046; Maukonen J, 2012, FEMS MICROBIOL ECOL, V79, P697, DOI 10.1111/j.1574-6941.2011.01257.x; McOrist AL, 2011, J NUTR, V141, P883, DOI 10.3945/jn.110.128504; Million M, 2013, CLIN MICROBIOL INFEC, V19, P305, DOI 10.1111/1469-0691.12172; MOORE WEC, 1974, APPL MICROBIOL, V27, P961, DOI 10.1128/AEM.27.5.961-979.1974; Moosavian M, 2008, PAK J MED SCI, V24, P209; Mutch DM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001344; Nakamura N, 2010, ANNU REV FOOD SCI T, V1, P363, DOI 10.1146/annurev.food.102308.124101; Nikkila J, 2010, J CLIN GASTROENTEROL, V44, pS2, DOI 10.1097/MCG.0b013e3181e5018f; Papa E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039242; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rainey FA, 2009, BERGEYS MANUAL SYSTE, P774; Rajilic-Stojanovic M, 2009, ENVIRON MICROBIOL, V11, P1736, DOI 10.1111/j.1462-2920.2009.01900.x; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Rydgren K, 2003, J VEG SCI, V14, P869, DOI 10.1111/j.1654-1103.2003.tb02220.x; Salonen A, 2010, J MICROBIOL METH, V81, P127, DOI 10.1016/j.mimet.2010.02.007; Tims S, 2013, ISME J, V7, P707, DOI 10.1038/ismej.2012.146; Velagapudi VR, 2010, J LIPID RES, V51, P1101, DOI 10.1194/jlr.M002774; Walker AW, 2013, PHARMACOL RES, V69, P75, DOI 10.1016/j.phrs.2012.09.008; Walker AW, 2011, ISME J, V5, P220, DOI 10.1038/ISMEJ.2010.118; Whitford MF, 2001, INT J SYST EVOL MICR, V51, P1977, DOI 10.1099/00207713-51-6-1977; Willems A., 2006, PROKARYOTES; Williams BL, 2012, MBIO, V3, DOI 10.1128/mBio.00261-11; Zeng XQ, 2010, J APPL MICROBIOL, V108, P2059, DOI 10.1111/j.1365-2672.2009.04608.x	53	130	145	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90702	10.1371/journal.pone.0090702	http://dx.doi.org/10.1371/journal.pone.0090702			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603757	Green Published, gold, Green Submitted			2022-12-27	WOS:000332483600073
J	Mertz, D; Kim, TH; Johnstone, J; Lam, PP; Science, M; Kuster, SP; Fadel, SA; Tran, D; Fernandez, E; Bhatnagar, N; Loeb, M				Mertz, Dominik; Kim, Tae Hyong; Johnstone, Jennie; Lam, Po-Po; Science, Michelle; Kuster, Stefan P.; Fadel, Shaza A.; Dat Tran; Fernandez, Eduardo; Bhatnagar, Neera; Loeb, Mark			Populations at Risk for Severe or Complicated Avian Influenza H5N1: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							A H5N1; VIRUS-INFECTION; HUMANS METAANALYSIS; HUMAN-DISEASE; JUNE 2006; INDONESIA; SEROEVIDENCE; THAILAND; FEATURES; A(H5N1)	Background: Little is known about risk factors for severe outcomes in patients infected with H5N1 and no systematic review has been conducted. Understanding risk factors is an important step for prioritizing prophylaxis or treatment in the event of a pandemic. Objectives: To systematically evaluate risk factors for severe outcomes in patients with avian influenza H5N1 infection. Data sources: MEDLINE, EMBASE, CINAHL, GlobalHealth, and CENTRAL through March 2011 Eligibility criteria for selecting studies: Observational studies of any design published in English, French, Spanish, German or Korean that reported on risk factor-outcome combinations of interest in participants with confirmed H5N1 infections. Outcomes considered included death, ventilator support, hospital and ICU admission, pneumonia, and composite outcomes. Study appraisal: Risk of bias was assessed using the Newcastle-Ottawa scale (NOS). Results: We identified 20 studies reporting on 999 patients infected with H5N1. The majority of studies (n = 14, 70%) were at intermediate risk of bias, i.e. 4-6 points on the NOS. Females were at increased risk of death (OR 1.75, 95% CI 1.27-2.44), while young age, in particular <5 years of age (OR 0.44, 95% CI 0.25-0.79 for death), was protective. Data on traditional risk factors was scarce and requires further studies. Another major limitation in the published literature was lack of adjustment for confounders. Interpretation: Females were at increased risk for complications following H5N1 infection while young age protected against severe outcomes. Research on traditional risk factors was limited and is required.	[Mertz, Dominik; Loeb, Mark] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Mertz, Dominik; Kim, Tae Hyong; Johnstone, Jennie; Science, Michelle; Fernandez, Eduardo; Loeb, Mark] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Mertz, Dominik; Loeb, Mark] McMaster Univ, Michael G DeGroote Inst Infect Dis Res, Hamilton, ON, Canada; [Kim, Tae Hyong] Soon Chun Hyang Univ, Seoul Hosp, Dept Internal Med, Div Infect Dis, Seoul, South Korea; [Lam, Po-Po; Kuster, Stefan P.] Mt Sinai Hosp, Dept Microbiol, Toronto, ON M5G 1X5, Canada; [Lam, Po-Po; Fadel, Shaza A.] Univ Toronto, Div Epidemiol, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Science, Michelle; Dat Tran] Univ Toronto, Hosp Sick Children, Dept Pediat, Div Infect Dis, Toronto, ON M5S 1A1, Canada; [Kuster, Stefan P.] Univ Zurich, Univ Zurich Hosp, Div Infect Dis & Hosp Epidemiol, Zurich, Switzerland; [Bhatnagar, Neera] McMaster Univ, Hlth Sci Lib, Hamilton, ON, Canada; [Loeb, Mark] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada	McMaster University; McMaster University; McMaster University; Soonchunhyang University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Zurich; University Zurich Hospital; McMaster University; McMaster University	Loeb, M (corresponding author), McMaster Univ, Dept Med, Hamilton, ON, Canada.	loebm@mcmaster.ca	Kim, Tae Hyong/L-7336-2015; Kuster, Stefan/T-7388-2019	Kim, Tae Hyong/0000-0003-2920-9038; Kuster, Stefan/0000-0002-0525-6529; Fadel, Shaza/0000-0002-2336-6254	World Health Organization (WHO); Swiss National Science Foundation [PASMP3-132571]; Lichtenstein-Stiftung; Research Early Career Award from Hamilton Health Sciences Foundation; Canadian Institutes of Health Research	World Health Organization (WHO)(World Health Organization); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Lichtenstein-Stiftung; Research Early Career Award from Hamilton Health Sciences Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	The World Health Organization (WHO) funded the study. The protocol was reviewed by the WHO and the WHO's suggestions were incorporated into the protocol. DM was partly supported by a research scholarship from the Swiss National Science Foundation (PASMP3-132571) and the Lichtenstein-Stiftung, and is a recipient of a Research Early Career Award from Hamilton Health Sciences Foundation (Jack Hirsh Fellowship); ML holds the Michael G. DeGroote Chair in Infectious Diseases at McMaster University; JJ receives salary support from the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adisasmito W, 2010, J INFECT DIS, V202, P1154, DOI 10.1086/656316; [Anonymous], 2006, Wkly Epidemiol Rec, V81, P249; Areechokchai D, 2006, MMWR MORBIDITY MORTA; Buricchi F, 2013, EUR J IMMUNOL, V43, P641, DOI 10.1002/eji.201242563; Chen JM, 2007, AM J INFECT CONTROL, V35, P467, DOI 10.1016/j.ajic.2006.12.001; Chotpitayasunondh T, 2005, EMERG INFECT DIS, V11, P201, DOI 10.3201/eid1102.041061; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dudley JP, 2009, EURO SURVEILLANCE B, V14; Fasina FO, 2010, EUROSURVEILLANCE, V15, P4; Fiebig L, 2011, EURO SURVEILLANCE B, V16; Giriputro S, 2008, ANN ACAD MED SINGAP, V37, P454; Hien TT, 2004, NEW ENGL J MED, V350, P1179, DOI 10.1056/NEJMoa040419; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Kandun IN, 2008, LANCET, V372, P744, DOI 10.1016/S0140-6736(08)61125-3; Kandun IN, 2006, NEW ENGL J MED, V355, P2186, DOI 10.1056/NEJMoa060930; Mertz D, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5061; Nguyen TL, 2009, CLIN INFECT DIS, V48, P1639, DOI 10.1086/599031; Olsen SJ, 2005, EMERG INFECT DIS, V11, P1601, DOI 10.3201/eid1110.041267; Oner AF, 2006, NEW ENGL J MED, V355, P2179, DOI 10.1056/NEJMoa060601; Peiris JSM, 2004, LANCET, V363, P617, DOI 10.1016/S0140-6736(04)15595-5; Pollack CV, 1998, ANN EMERG MED, V31, P648; Sedyaningsih ER, 2007, J INFECT DIS, V196, P522, DOI 10.1086/519692; Soepandi PZ, 2010, CHEST, V138, P665, DOI 10.1378/chest.09-2644; Tam JS, 2002, VACCINE, V20, pS77, DOI 10.1016/S0264-410X(02)00137-8; The Cochrane Collaboration, 2011, COCHRANE HDB SYSTEMA; Van Kerkhove MD, 2012, SCIENCE, V336, DOI 10.1126/science.1221434; Wang TT, 2012, SCIENCE, V335, P1463, DOI 10.1126/science.1218888; Wells G.A., NEWCASTLE OTTAWA SCA; WHO, 2013, CUM NUMB CONF HUM CA; WHO, 2011, INFL HUM AN INT SUMM; *WHO, 2007, WKLY EPIDEMIOL REC, V82, P41; Yin Jingchuan, 2013, Virologica Sinica, V28, P3, DOI 10.1007/s12250-013-3294-9; Yu HJ, 2007, EMERG INFECT DIS, V13, P1061, DOI 10.3201/eid1307.061557; Yu HJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002985; Yuen KY, 1998, LANCET, V351, P467, DOI 10.1016/S0140-6736(98)01182-9	35	18	20	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e89697	10.1371/journal.pone.0089697	http://dx.doi.org/10.1371/journal.pone.0089697			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603885	Green Published, gold, Green Accepted			2022-12-27	WOS:000332483600018
J	Sor-suwan, S; Jariyapan, N; Roytrakul, S; Paemanee, A; Phumee, A; Phattanawiboon, B; Intakhan, N; Chanmol, W; Bates, PA; Saeung, A; Choochote, W				Sor-suwan, Sriwatapron; Jariyapan, Narissara; Roytrakul, Sittiruk; Paemanee, Atchara; Phumee, Atchara; Phattanawiboon, Benjarat; Intakhan, Nuchpicha; Chanmol, Wetpisit; Bates, Paul A.; Saeung, Atiporn; Choochote, Wej			Identification of Salivary Gland Proteins Depleted after Blood Feeding in the Malaria Vector Anopheles campestris-like Mosquitoes (Diptera: Culicidae)	PLOS ONE			English	Article							IMMUNO-EPIDEMIOLOGIC TOOL; PLATELET-AGGREGATION; FEMALE MOSQUITO; TRANSCRIPTOME; EXPOSURE; PEPTIDE; GAMBIAE; EXPRESSION; EVOLUTION; ABUNDANT	Malaria sporozoites must invade the salivary glands of mosquitoes for maturation before transmission to vertebrate hosts. The duration of the sporogonic cycle within the mosquitoes ranges from 10 to 21 days depending on the parasite species and temperature. During blood feeding salivary gland proteins are injected into the vertebrate host, along with malaria sporozoites in the case of an infected mosquito. To identify salivary gland proteins depleted after blood feeding of female Anopheles campestris-like, a potential malaria vector of Plasmodium vivax in Thailand, two-dimensional gel electrophoresis and nano-liquid chromatography-mass spectrometry techniques were used. Results showed that 19 major proteins were significantly depleted in three to four day-old mosquitoes fed on a first blood meal. For the mosquitoes fed the second blood meal on day 14 after the first blood meal, 14 major proteins were significantly decreased in amount. The significantly depleted proteins in both groups included apyrase, 5'-nucleotidase/apyrase, D7, D7-related 1, short form D7r1, gSG6, antiplatelet protein, serine/threonine-protein kinase rio3, putative sil1, cyclophilin A, hypothetical protein Phum_PHUM512530, AGAP007618-PA, and two non-significant hit proteins. To our knowledge, this study presents for the first time the salivary gland proteins that are involved in the second blood feeding on the day corresponding to the transmission period of the sporozoites to new mammalian hosts. This information serves as a basis for future work concerning the possible role of these proteins in the parasite transmission and the physiological processes that occur during the blood feeding.	[Sor-suwan, Sriwatapron; Jariyapan, Narissara; Phattanawiboon, Benjarat; Intakhan, Nuchpicha; Chanmol, Wetpisit; Saeung, Atiporn; Choochote, Wej] Chiang Mai Univ, Fac Med, Dept Parasitol, Chiang Mai 50000, Thailand; [Roytrakul, Sittiruk; Paemanee, Atchara] Natl Sci & Technol Dev Agcy, Natl Ctr Genet Engn & Biotechnol BIOTEC, Pathum Thani, Thailand; [Phumee, Atchara] Chulalongkorn Univ, Fac Med, Dept Parasitol, Bangkok 10330, Thailand; [Bates, Paul A.] Univ Lancaster, Fac Hlth & Med, Div Biomed & Life Sci, Lancaster, England	Chiang Mai University; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Chulalongkorn University; Lancaster University	Jariyapan, N (corresponding author), Chiang Mai Univ, Fac Med, Dept Parasitol, Chiang Mai 50000, Thailand.	narsuwan@mail.med.cmu.ac.th	Chanmol, Wetpisit/AFV-0649-2022; PHUMEE, ATCHARA/AAG-4881-2020	PHUMEE, ATCHARA/0000-0001-8243-7406; Saeung, Atiporn/0000-0003-3550-5992; Bates, Paul/0000-0001-6861-5421; Paemanee, Atchara/0000-0001-9206-3153	Thailand Research Fund [PHD/0149/2551, RMU5180011]; Faculty of Medicine Endowment Fund, Chiang Mai University	Thailand Research Fund(Thailand Research Fund (TRF)); Faculty of Medicine Endowment Fund, Chiang Mai University	The authors sincerely thank the Thailand Research Fund through the Royal Golden Jubilee Ph.D. program (PHD/0149/2551), the Thailand Research Fund (RMU5180011 to NJ), and the Faculty of Medicine Endowment Fund, Chiang Mai University, for financial support in this research project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arca B, 2002, INSECT MOL BIOL, V11, P47, DOI 10.1046/j.0962-1075.2001.00309.x; Arca B, 2005, J EXP BIOL, V208, P3971, DOI 10.1242/jeb.01849; Arca B, 1999, P NATL ACAD SCI USA, V96, P1516, DOI 10.1073/pnas.96.4.1516; Beier JC, 1998, ANNU REV ENTOMOL, V43, P519, DOI 10.1146/annurev.ento.43.1.519; Boisson B, 2006, FEBS LETT, V580, P1988, DOI 10.1016/j.febslet.2006.02.069; Calvo E, 2006, J BIOL CHEM, V281, P1935, DOI 10.1074/jbc.M510359200; Calvo E, 2004, INSECT MOL BIOL, V13, P73, DOI 10.1111/j.1365-2583.2004.00463.x; Calvo E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-57; Cazares-Raga FE, 2007, INSECT MOL BIOL, V16, P187, DOI 10.1111/j.1365-2583.2006.00712.x; CHOOCHOTE W, 1983, Southeast Asian Journal of Tropical Medicine and Public Health, V14, P204; Choumet V, 2007, PROTEOMICS, V7, P3384, DOI 10.1002/pmic.200700334; Das S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-566; Fontaine A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-614; GOLENDA CF, 1995, J MED ENTOMOL, V32, P300, DOI 10.1093/jmedent/32.3.300; Gross TL, 2009, J MED ENTOMOL, V46, P496, DOI 10.1603/033.046.0313; Isawa H, 2007, INSECT BIOCHEM MOLEC, V37, P466, DOI 10.1016/j.ibmb.2007.02.002; JAMES AA, 1991, MOL BIOCHEM PARASIT, V44, P245, DOI 10.1016/0166-6851(91)90010-4; Jaresitthikunchai J, 2009, P 2 BIOCH MOL BIOL C, P29; Jariyapan N, 2006, J MED ENTOMOL, V43, P867, DOI 10.1603/0022-2585(2006)43[867:AGAGPI]2.0.CO;2; Jariyapan N, 2012, PARASITOL RES, V111, P1239, DOI 10.1007/s00436-012-2958-y; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Kim Se-Joo, 2003, Korean Journal of Entomology, V33, P267; Lanfrancotti A, 2002, FEBS LETT, V517, P67, DOI 10.1016/S0014-5793(02)02578-4; Lombardo F, 2009, INSECT BIOCHEM MOLEC, V39, P457, DOI 10.1016/j.ibmb.2009.04.006; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Phumee A, 2011, ASIAN BIOMED, V5, P353, DOI 10.5372/1905-7415.0502.046; Poinsignon A, 2010, TROP MED INT HEALTH, V15, P1198, DOI 10.1111/j.1365-3156.2010.02611.x; Poinsignon A, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-198; Poinsignon A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002472; Raghavendra K, 2011, PARASITOL RES, V108, P757, DOI 10.1007/s00436-010-2232-0; Ribeiro JMC, 2003, ANNU REV ENTOMOL, V48, P73, DOI 10.1146/annurev.ento.48.060402.102812; RIBEIRO JMC, 1995, INFECT AGENT DIS, V4, P143; Rizzo C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017980; ROSSIGNOL PA, 1984, AM J TROP MED HYG, V33, P17, DOI 10.4269/ajtmh.1984.33.17; Simons FER, 2001, INT ARCH ALLERGY IMM, V124, P403, DOI 10.1159/000053771; Siriyasatien Padet, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P64; Soliman Mohamed A., 1999, Journal of the Egyptian Society of Parasitology, V29, P619; Sor-suwan S, 2013, PARASITOL RES, V112, P1065, DOI 10.1007/s00436-012-3233-y; Sun DF, 2006, PLATELETS, V17, P178, DOI 10.1080/09537100500460234; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Thangamani S, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-34; Thongsahuan S, 2011, MEM I OSWALDO CRUZ, V106, P105, DOI 10.1590/S0074-02762011000100017; Thongsahuan S, 2009, MEM I OSWALDO CRUZ, V104, P558, DOI 10.1590/S0074-02762009000400004; Valenzuela JG, 2003, INSECT BIOCHEM MOLEC, V33, P717, DOI 10.1016/S0965-1748(03)00067-5; Valenzuela JG, 2002, INSECT MOL BIOL, V11, P149, DOI 10.1046/j.1365-2583.2002.00319.x; Wasinpiyamongkol L, 2010, PROTEOMICS, V10, P1906, DOI 10.1002/pmic.200900626; WHO, 2012, WORLD MALARIA REPORT 2012, P1; Yoshida S, 2008, BLOOD, V111, P2007, DOI 10.1182/blood-2007-06-097824	48	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90809	10.1371/journal.pone.0090809	http://dx.doi.org/10.1371/journal.pone.0090809			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599352	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000332479400134
J	Cougnard-Gregoire, A; Delyfer, MN; Korobelnik, JF; Rougier, MB; Le Goff, M; Dartigues, JF; Barberger-Gateau, P; Delcourt, C				Cougnard-Gregoire, Audrey; Delyfer, Marie-Noelle; Korobelnik, Jean-Francois; Rougier, Marie-Benedicte; Le Goff, Melanie; Dartigues, Jean-Francois; Barberger-Gateau, Pascale; Delcourt, Cecile			Elevated High-Density Lipoprotein Cholesterol and Age-Related Macular Degeneration: The Alienor Study	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; 5-YEAR INCIDENCE; APOLIPOPROTEIN-E; STATIN USE; LOWERING MEDICATIONS; VISUAL IMPAIRMENT; LIPID-METABOLISM; MACULOPATHY; PREVALENCE; ASSOCIATION	Background: Lipid metabolism and particularly high-density lipoprotein (HDL) may be involved in the pathogenic mechanism of age-related macular degeneration (AMD). However, conflicting results have been reported in the associations of AMD with plasma HDL and other lipids, which may be confounded by the recently reported associations of AMD with HDL-related genes. We explored the association of AMD with plasma lipid levels and lipid-lowering medication use, taking into account most of HDL-related genes associated with AMD. Methods: The Alienor study is a population-based study on age-related eye diseases performed in 963 elderly residents of Bordeaux (France). AMD was graded from non mydriatic color retinal photographs in three exclusive stages: no AMD (n = 430 subjects, 938 eyes); large soft distinct drusen and/or large soft indistinct drusen and/or reticular drusen and/or pigmentary abnormalities (early AMD, n = 176, 247); late AMD (n = 40, 61). Associations of AMD with plasma lipids (HDL, total cholesterol (TC), Low-density lipoprotein (LDL), and triglycerides (TG)) were estimated using Generalized Estimating Equation logistic regressions. Statistical analyses included 646 subjects with complete data. Results: After multivariate adjustment for age, sex, educational level, smoking, BMI, lipid-lowering medication use, cardiovascular disease and diabetes, and for all relevant genetic polymorphisms (ApoE2, ApoE4, CFH Y402H, ARMS2 A69S, LIPC rs10468017, LIPC rs493258, LPL rs12678919, ABCA1 rs1883025 and CETP rs3764261), higher HDL was significantly associated with an increased risk of early (OR = 2.45, 95% CI: 1.54-3.90; P = 0.0002) and any AMD (OR = 2.29, 95% CI: 1.46-3.59; P = 0.0003). Association with late AMD was far from statistical significance (OR = 1.58, 95% CI: 0.48-5.17; p = 0.45). No associations were found for any stage of AMD with TC, LDL and TG levels, statin or fibrate drug use. Conclusions: This study suggests that elderly patients with high HDL concentration may be at increased risk for AMD and, further, that HDL dysfunction might be implicated in AMD pathogenesis.	[Cougnard-Gregoire, Audrey; Delyfer, Marie-Noelle; Korobelnik, Jean-Francois; Le Goff, Melanie; Dartigues, Jean-Francois; Barberger-Gateau, Pascale; Delcourt, Cecile] Univ Bordeaux, Bordeaux, France; [Cougnard-Gregoire, Audrey; Delyfer, Marie-Noelle; Korobelnik, Jean-Francois; Le Goff, Melanie; Dartigues, Jean-Francois; Barberger-Gateau, Pascale; Delcourt, Cecile] INSERM, ISPED, Ctr INSERM Epidemiol Biostat U897, Bordeaux, France; [Delyfer, Marie-Noelle; Korobelnik, Jean-Francois; Rougier, Marie-Benedicte] Ctr Hosp Univ CHU Bordeaux, Serv Ophtalmol, Bordeaux, France	UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Bordeaux	Cougnard-Gregoire, A (corresponding author), Univ Bordeaux, Bordeaux, France.	Audrey.Cougnard-Gregoire@isped.u-bordeaux2.fr	COUGNARD-GREGOIRE, Audrey/T-4443-2019; KOROBELNIK, Jean-Francois/A-5448-2016; DARTIGUES, Jean François/T-4513-2019; Delcourt, Cecile/I-2627-2013; LE GOFF, Mélanie/A-3541-2016; Delyfer, Marie-Noelle/T-3304-2019	COUGNARD-GREGOIRE, Audrey/0000-0002-1494-5764; Delcourt, Cecile/0000-0002-2099-0481; LE GOFF, Melanie/0000-0003-2848-6287	Laboratoires Thea (Clermont-Ferrand, France), Fondation Voir et Entendre (Paris, France),	Laboratoires Thea (Clermont-Ferrand, France), Fondation Voir et Entendre (Paris, France),	Laboratoires Thea (Clermont-Ferrand, France), Fondation Voir et Entendre (Paris, France), Laboratoires Thea participated in the design of the study, but no sponsor participated in the collection, management, statistical analysis and interpretation of the data, nor in the preparation, review or approval of the present manuscript.	Alperovitch A, 2003, NEUROEPIDEMIOLOGY, V22, P316, DOI 10.1159/000072920; [Anonymous], 1992, Arch Ophthalmol, V110, P1701; Augood CA, 2006, ARCH OPHTHALMOL-CHIC, V124, P529, DOI 10.1001/archopht.124.4.529; Baird PN, 2006, HUM MUTAT, V27, P337, DOI 10.1002/humu.20288; Bindu GH, 2011, CHOLESTEROL, DOI 10.1155/2011/274629; BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X; BLUMENKRANZ MS, 1986, OPHTHALMOLOGY, V93, P552; Bretillon L, 2008, INVEST OPHTH VIS SCI, V49, P1307, DOI 10.1167/iovs.07-0808; Buch H, 2005, ACTA OPHTHALMOL SCAN, V83, P400, DOI [10.1111/j.1600-0420.2005.00474.x, 10.1111/j.1600-0420.2005.thesis.x]; Butt AL, 2011, OPHTHALMOLOGY, V118, P1380, DOI 10.1016/j.ophtha.2010.11.007; Cackett P, 2008, AM J OPHTHALMOL, V146, P960, DOI 10.1016/j.ajo.2008.06.026; Chakravarthy U, 2010, BMC OPHTHALMOL, V10, DOI 10.1186/1471-2415-10-31; Chen W, 2010, P NATL ACAD SCI USA, V107, P7401, DOI 10.1073/pnas.0912702107; Conley YP, 2005, HUM MOL GENET, V14, P1991, DOI 10.1093/hmg/ddi204; Curcio CA, 2011, BRIT J OPHTHALMOL, V95, P1638, DOI 10.1136/bjophthalmol-2011-300344; Curcio CA, 2010, J LIPID RES, V51, P451, DOI 10.1194/jlr.R002238; Davari MH, 2013, J RES HEALTH SCI, V13, P98; Delcourt C, 2001, Ophthalmic Epidemiol, V8, P237, DOI 10.1076/opep.8.4.237.1613; Delcourt C, 2010, J NUTR HEALTH AGING, V14, P854, DOI 10.1007/s12603-010-0131-9; Delcourt C, 2011, INVEST OPHTH VIS SCI, DOI [10.11673443.10-6235, DOI 10.1167/IOVS910-6235]; Drobek-Slowik Monika, 2008, Klin Oczna, V110, P50; Ebrahimi KB, 2011, J LIPIDS, V2011, DOI 10.1155/2011/802059; Eren Esin, 2012, Open Biochem J, V6, P78, DOI 10.2174/1874091X01206010078; Etminan M, 2008, CURR DRUG SAF, V3, P24, DOI 10.2174/157488608783333952; Fisher EA, 2012, ARTERIOSCL THROM VAS, V32, P2813, DOI 10.1161/ATVBAHA.112.300133; Fliesler SJ, 2010, J LIPID RES, V51, P3399, DOI 10.1194/jlr.R010538; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Friedman E, 2005, IOVS, V46, P199; Gehlbach P, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006927.pub3; Hall Nigel F, 2002, Expert Opin Pharmacother, V3, P803; Hogg RE, 2008, OPHTHALMOLOGY, V115, P1046, DOI 10.1016/j.ophtha.2007.07.031; Hyman L, 2000, ARCH OPHTHALMOL-CHIC, V118, P351, DOI 10.1001/archopht.118.3.351; Kaiserman N, 2009, CURR EYE RES, V34, P304, DOI 10.1080/02713680902741670; Kanda A, 2007, P NATL ACAD SCI USA, V104, P16227, DOI 10.1073/pnas.0703933104; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Kishan AU, 2011, SURV OPHTHALMOL, V56, P195, DOI 10.1016/j.survophthal.2010.08.008; Klein R, 2006, OPHTHALMOLOGY, V113, P373, DOI 10.1016/j.ophtha.2005.12.013; Klein R, 2003, ARCH OPHTHALMOL-CHIC, V121, P1151, DOI 10.1001/archopht.121.8.1151; Klein R, 2003, OPHTHALMOLOGY, V110, P25, DOI 10.1016/S0161-6420(02)01565-8; Klein R, 1997, OPHTHALMOLOGY, V104, P1804, DOI 10.1016/S0161-6420(97)30023-2; Klein R, 1999, ARCH OPHTHALMOL-CHIC, V117, P1203; Klein R, 2001, ARCH OPHTHALMOL-CHIC, V119, P1354; KLEIN R, 1993, OPHTHALMOLOGY, V100, P406; Klein R, 2007, AM J OPHTHALMOL, V144, P1, DOI 10.1016/j.ajo.2007.02.047; Klein Ronald, 2003, Ophthalmology, V110, P1273, DOI 10.1016/S0161-6420(03)00599-2; Klein R, 2010, ARCH OPHTHALMOL-CHIC, V128, P750, DOI 10.1001/archophthalmol.2010.92; Lim LS, 2012, LANCET, V379, P1728, DOI 10.1016/S0140-6736(12)60282-7; Loane E, 2010, INVEST OPHTH VIS SCI, V51, P2636, DOI 10.1167/iovs.09-4397; Maguire MG, 2009, OPHTHALMOLOGY, V116, P2381, DOI 10.1016/j.ophtha.2009.06.055; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; McCarty CA, 2001, MED J AUSTRALIA, V175, P340, DOI 10.5694/j.1326-5377.2001.tb143604.x; McGwin G, 2006, ARCH OPHTHALMOL-CHIC, V124, P33, DOI 10.1001/archopht.124.1.33; McGwin G, 2005, OPHTHALMOLOGY, V112, P488, DOI 10.1016/j.ophtha.2004.10.027; McGwin G, 2003, BRIT J OPHTHALMOL, V87, P1121, DOI 10.1136/bjo.87.9.1121; Merle BM, PLOS ONE IN PRESS; Mitchell P, 2002, OPHTHALMOLOGY, V109, P1092, DOI 10.1016/S0161-6420(02)01055-2; Neale BM, 2010, P NATL ACAD SCI USA, V107, P7395, DOI 10.1073/pnas.0912019107; Nowak M, 2005, CLIN EXP MED, V4, P183, DOI 10.1007/s10238-004-0054-z; Peponis V, 2010, CLIN OPHTHALMOL, V4, P865; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Reynolds R, 2010, OPHTHALMOLOGY, V117, P1989, DOI 10.1016/j.ophtha.2010.07.009; SANDERS TAB, 1993, AM J CLIN NUTR, V57, P428, DOI 10.1093/ajcn/57.3.428; Scholl HPN, 2007, MOL VIS, V13, P196; Seddon JM, 2007, JAMA-J AM MED ASSOC, V297, P1793, DOI 10.1001/jama.297.16.1793; Shalev V, 2011, OPHTHAL EPIDEMIOL, V18, P83, DOI 10.3109/09286586.2011.560746; Smeeth L, 2005, BRIT J OPHTHALMOL, V89, P1171, DOI 10.1136/bjo.2004.064477; Smith W, 1998, ARCH OPHTHALMOL-CHIC, V116, P583, DOI 10.1001/archopht.116.5.583; Souied EH, 1998, AM J OPHTHALMOL, V125, P353, DOI 10.1016/S0002-9394(99)80146-9; Tan JSL, 2007, OPHTHALMOLOGY, V114, P1143, DOI 10.1016/j.ophtha.2006.09.033; Tan JSL, 2007, AM J OPHTHALMOL, V143, P685, DOI 10.1016/j.ajo.2006.11.021; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Thakkinstian A, 2006, AM J EPIDEMIOL, V164, P813, DOI 10.1093/aje/kwj279; Tomany SC, 2004, OPHTHALMOLOGY, V111, P1280, DOI 10.1016/j.ophtha.2003.11.010; TSANG NCK, 1992, DOC OPHTHALMOL, V81, P387; Ulas F, 2013, INT OPHTHALMOL, V33, P485, DOI 10.1007/s10792-013-9728-4; van Leeuwen R, 2004, AM J OPHTHALMOL, V137, P750, DOI 10.1016/S0002-9394(03)01089-4; van Leeuwen R, 2003, BRIT MED J, V326, P255, DOI 10.1136/bmj.326.7383.255; VanderBeek BL, 2013, RETINA-J RET VIT DIS, V33, P414, DOI 10.1097/IAE.0b013e318276e0cf; VINGERLING JR, 1995, OPHTHALMOLOGY, V102, P205; Wang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010329; Wilson HL, 2004, AM J OPHTHALMOL, V137, P615, DOI 10.1016/j.ajo.2003.10.025; Yates JRW, 2007, NEW ENGL J MED, V357, P553, DOI 10.1056/NEJMoa072618; Yu Y, 2011, INVEST OPHTH VIS SCI, V52, P4663, DOI 10.1167/iovs.10-7070; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734	84	72	75	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90973	10.1371/journal.pone.0090973	http://dx.doi.org/10.1371/journal.pone.0090973			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608419	Green Published, Green Submitted, gold			2022-12-27	WOS:000332485800071
J	DiTommaso, A; Morris, SH; Parker, JD; Cone, CL; Agrawal, AA				DiTommaso, Antonio; Morris, Scott H.; Parker, John D.; Cone, Caitlin L.; Agrawal, Anurag A.			Deer Browsing Delays Succession by Altering Aboveground Vegetation and Belowground Seed Banks	PLOS ONE			English	Article							WHITE-TAILED DEER; COMMUNITY STRUCTURE; FOREST ECOSYSTEMS; PLANT-COMMUNITIES; COASTAL-PLAIN; DISTURBANCE; DISPERSAL; DIVERSITY; DYNAMICS; REDUCTIONS	Soil seed bank composition is important to the recovery of natural and semi-natural areas from disturbance and serves as a safeguard against environmental catastrophe. White-tailed deer (Odocoileus virginianus) populations have increased dramatically in eastern North America over the past century and can have strong impacts on aboveground vegetation, but their impacts on seed bank dynamics are less known. To document the long-term effects of deer browsing on plant successional dynamics, we studied the impacts of deer on both aboveground vegetation and seed bank composition in plant communities following agricultural abandonment. In 2005, we established six 15615 m fenced enclosures and paired open plots in recently fallowed agricultural fields near Ithaca, NY, USA. In late October of each of six years (2005-2010), we collected soil from each plot and conducted seed germination cycles in a greenhouse to document seed bank composition. These data were compared to measurements of aboveground plant cover (2005-2008) and tree density (2005-2012). The impacts of deer browsing on aboveground vegetation were severe and immediate, resulting in significantly more bare soil, reduced plant biomass, reduced recruitment of woody species, and relatively fewer native species. These impacts persisted throughout the experiment. The impacts of browsing were even stronger on seed bank dynamics. Browsing resulted in significantly decreased overall species richness (but higher diversity), reduced seed bank abundance, relatively more short-lived species (annuals and biennials), and fewer native species. Both seed bank richness and the relative abundance of annuals/biennials were mirrored in the aboveground vegetation. Thus, deer browsing has long-term and potentially reinforcing impacts on secondary succession, slowing succession by selectively consuming native perennials and woody species and favoring the persistence of short-lived, introduced species that continually recruit from an altered seed bank.	[DiTommaso, Antonio; Morris, Scott H.; Cone, Caitlin L.] Cornell Univ, Dept Crop & Soil Sci, Ithaca, NY 14850 USA; [Parker, John D.] Smithsonian Environm Res Ctr, Edgewater, MD 21037 USA; [Agrawal, Anurag A.] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY USA	Cornell University; Smithsonian Institution; Smithsonian Environmental Research Center; Cornell University	DiTommaso, A (corresponding author), Cornell Univ, Dept Crop & Soil Sci, Ithaca, NY 14850 USA.	ad97@cornell.edu	Agrawal, Anurag A/Y-2497-2019; Parker, John D/F-9761-2010	Agrawal, Anurag A/0000-0003-0095-1220; Parker, John D/0000-0002-3632-7625; DiTommaso, Antonio/0000-0001-8215-2777	NSF [DEB-1118783]; United States Department of Agriculture [NYC-183430]	NSF(National Science Foundation (NSF)); United States Department of Agriculture(United States Department of Agriculture (USDA))	This work was funded by NSF DEB-1118783 and federal formula funds from the United States Department of Agriculture (Hatch project NYC-183430) to AAA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVERSON WS, 1988, CONSERV BIOL, V2, P348, DOI 10.1111/j.1523-1739.1988.tb00199.x; Augustine DJ, 1998, J WILDLIFE MANAGE, V62, P1165, DOI 10.2307/3801981; Bakker JP, 1996, ACTA BOT NEERL, V45, P461; Bardgett RD, 2003, ECOLOGY, V84, P2258, DOI 10.1890/02-0274; Baskin CC, 2006, WEED SCI, V54, P549, DOI 10.1614/WS-05-034R.1; Bates D., 2011, IME4 LINEAR MIXED EF; BAZZAZ FA, 1968, ECOLOGY, V49, P924, DOI 10.2307/1936544; Bertiller MB, 1996, ENVIRON MANAGE, V20, P123, DOI 10.1007/PL00006692; Boulanger V, 2011, PLANT ECOL, V212, P307, DOI 10.1007/s11258-010-9823-9; BOWERS MA, 1993, OIKOS, V67, P129, DOI 10.2307/3545103; Bressette JW, 2012, OIKOS, V121, P1749, DOI 10.1111/j.1600-0706.2011.20305.x; Cadenasso ML, 2002, J TORREY BOT SOC, V129, P228, DOI 10.2307/3088773; CHAMBERS JC, 1994, ANNU REV ECOL SYST, V25, P263, DOI 10.1146/annurev.es.25.110194.001403; Cote SD, 2004, ANNU REV ECOL EVOL S, V35, P113, DOI 10.1146/annurev.ecolsys.35.021103.105725; DESSAINT F, 1991, J APPL ECOL, V28, P721, DOI 10.2307/2404578; Diaz-Villa MD, 2003, J VEG SCI, V14, P701, DOI 10.1111/j.1654-1103.2003.tb02202.x; Dolle M, 2009, APPL VEG SCI, V12, P415, DOI 10.1111/j.1654-109X.2009.01036.x; DONELAN M, 1980, BIOL CONSERV, V17, P297, DOI 10.1016/0006-3207(80)90029-4; Eschtruth AK, 2008, ECOL APPL, V18, P360, DOI 10.1890/07-0446.1; Fargione MJ, 1991, HOMES GROUNDS GARDEN; Forrester JA, 2006, AM MIDL NAT, V156, P135, DOI 10.1674/0003-0031(2006)156[135:ITEOWD]2.0.CO;2; Gill RMA, 2001, FORESTRY, V74, P209, DOI 10.1093/forestry/74.3.209; Glen-Lewin DC, 1992, PLANT SUCCESSION THE; Grandin U, 2001, ECOGRAPHY, V24, P731, DOI 10.1034/j.1600-0587.2001.240611.x; Hopfensperger KN, 2007, OIKOS, V116, P1438, DOI [10.1111/j.2007.0030-1299.15818.x, 10.1111/j.0030-1299.2007.15818.x]; Horsley SB, 2003, ECOL APPL, V13, P98, DOI 10.1890/1051-0761(2003)013[0098:WTDIOT]2.0.CO;2; Knight TM, 2009, NAT AREA J, V29, P110, DOI 10.3375/043.029.0202; LAVOREL S, 1991, J VEG SCI, V2, P367, DOI 10.2307/3235929; LEVIN MH, 1966, AM MIDL NAT, V75, P101, DOI 10.2307/2423484; Luzuriaga AL, 2005, ACTA OECOL, V27, P57, DOI 10.1016/j.actao.2004.09.003; McCabe TR, 1992, SCI OVERABUNDANCE DE, P11; Mcnicoll MB, 2010, AM MIDL NAT, V164, P136, DOI 10.1674/0003-0031-164.1.136; Myers JA, 2004, OECOLOGIA, V139, P35, DOI 10.1007/s00442-003-1474-2; OOSTING HENRY J., 1940, BULL TORREY BOT CLUB, V67, P253, DOI 10.2307/2481173; Pakeman RJ, 2013, J VEG SCI, V24, P865, DOI 10.1111/j.1654-1103.2012.01484.x; Parker JD, 2006, SCIENCE, V311, P1459, DOI 10.1126/science.1121407; Perdomo P., 2004, LANDSCAPE PLANTS RAT; Rawinski T.J., 2008, IMPACTS WHITE TAILED; Rooney TP, 2003, FOREST ECOL MANAG, V181, P165, DOI 10.1016/S0378-1127(03)00130-0; Rooney TP, 2001, FORESTRY, V74, P201, DOI 10.1093/forestry/74.3.201; Rossell CR, 2007, NORTHEAST NAT, V14, P61, DOI 10.1656/1092-6194(2007)14[61:EODBON]2.0.CO;2; Royo AA, 2010, BIOL CONSERV, V143, P2425, DOI 10.1016/j.biocon.2010.05.020; Russell FL, 2001, AM MIDL NAT, V146, P1, DOI 10.1674/0003-0031(2001)146[0001:EOWTDO]2.0.CO;2; Spellerberg IF, 2003, GLOBAL ECOL BIOGEOGR, V12, P177, DOI 10.1046/j.1466-822X.2003.00015.x; Stromayer KAK, 1997, WILDLIFE SOC B, V25, P227; Tanentzap AJ, 2011, BIOL CONSERV, V144, P376, DOI 10.1016/j.biocon.2010.09.015; THOMPSON K, 1987, NEW PHYTOL, V106, P23; THOMPSON K, 1979, J ECOL, V67, P893, DOI 10.2307/2259220; WARR SJ, 1993, PROG PHYS GEOG, V17, P329, DOI 10.1177/030913339301700303; Webster CR, 2005, BIOL CONSERV, V125, P297, DOI 10.1016/j.biocon.2005.03.027	50	25	25	3	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91155	10.1371/journal.pone.0091155	http://dx.doi.org/10.1371/journal.pone.0091155			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608258	gold, Green Published			2022-12-27	WOS:000332485800108
J	Han, GX; Xing, QH; Luo, YQ; Rafique, R; Yu, JB; Mikle, N				Han, Guangxuan; Xing, Qinghui; Luo, Yiqi; Rafique, Rashad; Yu, Junbao; Mikle, Nate			Vegetation Types Alter Soil Respiration and Its Temperature Sensitivity at the Field Scale in an Estuary Wetland	PLOS ONE			English	Article							CARBON-DIOXIDE FLUX; CO2 EFFLUX; PHOTOSYNTHESIS CONTROLS; TEMPORAL VARIATION; PLANT; WATER; ECOSYSTEM; PATTERNS; MECHANISMS; DYNAMICS	Vegetation type plays an important role in regulating the temporal and spatial variation of soil respiration. Therefore, vegetation patchiness may cause high uncertainties in the estimates of soil respiration for scaling field measurements to ecosystem level. Few studies provide insights regarding the influence of vegetation types on soil respiration and its temperature sensitivity in an estuary wetland. In order to enhance the understanding of this issue, we focused on the growing season and investigated how the soil respiration and its temperature sensitivity are affected by the different vegetation (Phragmites australis, Suaeda salsa and bare soil) in the Yellow River Estuary. During the growing season, there were significant linear relationships between soil respiration rates and shoot and root biomass, respectively. On the diurnal timescale, daytime soil respiration was more dependent on net photosynthesis. A positive correlation between soil respiration and net photosynthesis at the Phragmites australis site was found. There were exponential correlations between soil respiration and soil temperature, and the fitted Q(10) values varied among different vegetation types (1.81, 2.15 and 3.43 for Phragmites australis, Suaeda salsa and bare soil sites, respectively). During the growing season, the mean soil respiration was consistently higher at the Phragmites australis site (1.11 mu mol CO2 m(-2) s(-1)), followed by the Suaeda salsa site (0.77 mu mol CO2 m(-2) s(-1)) and the bare soil site (0.41 mu mol CO2 m(-2) s(-1)). The mean monthly soil respiration was positively correlated with shoot and root biomass, total C, and total N among the three vegetation patches. Our results suggest that vegetation patchiness at a field scale might have a large impact on ecosystem-scale soil respiration. Therefore, it is necessary to consider the differences in vegetation types when using models to evaluate soil respiration in an estuary wetland.	[Han, Guangxuan; Xing, Qinghui; Yu, Junbao] Chinese Acad Sci, Yantai Inst Coastal Zone Res, Key Lab Coastal Environm Proc & Ecol Remediat, Yantai, Peoples R China; [Han, Guangxuan; Luo, Yiqi; Rafique, Rashad; Mikle, Nate] Univ Oklahoma, Dept Microbiol & Plant Biol, Norman, OK 73019 USA	Chinese Academy of Sciences; Yantai Institute of Coastal Zone Research, CAS; University of Oklahoma System; University of Oklahoma - Norman	Han, GX (corresponding author), Chinese Acad Sci, Yantai Inst Coastal Zone Res, Key Lab Coastal Environm Proc & Ecol Remediat, Yantai, Peoples R China.	gxhan@yic.ac.cn; jbyu@yic.ac.cn		Yu, Junbao/0000-0002-3433-3538	National Natural Science Foundation of China [41301083]; National Science and Technology Support Program of China [2011BAC02B01]; Chinese Academy of Sciences [KZCX2-YW-223]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Support Program of China; Chinese Academy of Sciences(Chinese Academy of Sciences)	This research was funded by the National Natural Science Foundation of China (No. 41301083), the National Science and Technology Support Program of China (No. 2011BAC02B01), and the Chinese Academy of Sciences (No. KZCX2-YW-223). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahn M, 2010, NEW PHYTOL, V186, P292, DOI 10.1111/j.1469-8137.2010.03237.x; Ball BA, 2009, SOIL BIOL BIOCHEM, V41, P1510, DOI 10.1016/j.soilbio.2009.04.011; Barba J, 2013, FOREST ECOL MANAG, V306, P79, DOI 10.1016/j.foreco.2013.06.025; Barron-Gafford GA, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001442; BhupinderpalSingh, 2003, PLANT CELL ENVIRON, V26, P1287, DOI 10.1046/j.1365-3040.2003.01053.x; Boone RD, 1998, NATURE, V396, P570, DOI 10.1038/25119; Bosatta E, 1999, SOIL BIOL BIOCHEM, V31, P1889, DOI 10.1016/S0038-0717(99)00105-4; Cable JM, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2011JG001757; Cable JM, 2009, PLANT SOIL, V320, P153, DOI 10.1007/s11104-008-9880-1; Cardon ZG, 2002, OECOLOGIA, V133, P215, DOI 10.1007/s00442-002-1045-y; Chen QS, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003538; Cui BS, 2010, PLANT ECOL, V209, P279, DOI 10.1007/s11258-010-9723-z; DeForest JL, 2006, INT J BIOMETEOROL, V51, P135, DOI 10.1007/s00484-006-0046-7; Dias ATC, 2010, OECOLOGIA, V163, P805, DOI 10.1007/s00442-010-1569-5; Edwards EJ, 2004, GLOBAL CHANGE BIOL, V10, P209, DOI 10.1111/j.1365-2486.2004.00729.x; Ekblad A, 2005, OECOLOGIA, V143, P136, DOI 10.1007/s00442-004-1776-z; Engels JG, 2010, OIKOS, V119, P679, DOI 10.1111/j.1600-0706.2009.17940.x; Euskirchen ES, 2003, ECOSYSTEMS, V6, P595, DOI 10.1007/s10021-002-0167-8; Fang HL, 1999, THESIS CHINESE ACAD; Gaumont-Guay D, 2008, TREE PHYSIOL, V28, P161, DOI 10.1093/treephys/28.2.161; Geng Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034968; Han GX, 2007, PLANT SOIL, V291, P15, DOI 10.1007/s11104-006-9170-8; Han GX, 2007, SOIL BIOL BIOCHEM, V39, P418, DOI 10.1016/j.soilbio.2006.08.009; Heinemeyer A, 2006, NEW PHYTOL, V171, P159, DOI 10.1111/j.1469-8137.2006.01730.x; Hogberg P, 2001, NATURE, V411, P789, DOI 10.1038/35081058; Hogberg P, 2002, OECOLOGIA, V132, P579, DOI 10.1007/s00442-002-0983-8; Hogberg P, 2006, TRENDS ECOL EVOL, V21, P548, DOI 10.1016/j.tree.2006.06.004; Jassal RS, 2008, GLOBAL CHANGE BIOL, V14, P1305, DOI 10.1111/j.1365-2486.2008.01573.x; Jenkins M, 2010, GLOBAL CHANGE BIOL, V16, P209, DOI 10.1111/j.1365-2486.2009.01954.x; Jenkins ME, 2011, SOIL BIOL BIOCHEM, V43, P1266, DOI 10.1016/j.soilbio.2011.02.017; Jin HM, 2009, ECOL RES, V24, P731, DOI 10.1007/s11284-008-0544-7; Johnson D, 2008, BIOL LETTERS, V4, P345, DOI 10.1098/rsbl.2008.0121; Kuzyakov Y, 2004, PLANT SOIL, V263, P85, DOI 10.1023/B:PLSO.0000047728.61591.fd; Kuzyakov Y, 2001, SOIL BIOL BIOCHEM, V33, P1915, DOI 10.1016/S0038-0717(01)00117-1; Kuzyakov Y, 2010, GLOBAL CHANGE BIOL, V16, P3386, DOI 10.1111/j.1365-2486.2010.02179.x; Li SN, 2009, ECOL ENG, V35, P1719, DOI 10.1016/j.ecoleng.2009.07.009; Luo J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042354; Maestre FT, 2003, APPL SOIL ECOL, V23, P199, DOI 10.1016/S0929-1393(03)00050-7; Metcalfe DB, 2011, BIOGEOSCIENCES, V8, P2047, DOI 10.5194/bg-8-2047-2011; Moyano FE, 2008, AGR FOREST METEOROL, V148, P135, DOI 10.1016/j.agrformet.2007.09.006; Nakano T, 2010, SOIL SCI PLANT NUTR, V56, P773, DOI 10.1111/j.1747-0765.2010.00502.x; Parsons AN, 2004, ECOSYSTEMS, V7, P286, DOI 10.1007/s10021-003-0132-1; RAICH JW, 1995, GLOBAL BIOGEOCHEM CY, V9, P23, DOI 10.1029/94GB02723; RAICH JW, 1992, TELLUS B, V44, P81, DOI 10.1034/j.1600-0889.1992.t01-1-00001.x; Raich JW, 1997, ECOLOGY, V78, P707; Rey A, 2011, SOIL BIOL BIOCHEM, V43, P393, DOI 10.1016/j.soilbio.2010.11.007; SODERSTROM B, 1987, SOIL BIOL BIOCHEM, V19, P231, DOI 10.1016/0038-0717(87)90002-2; Stoyan H, 2000, PLANT SOIL, V222, P203, DOI 10.1023/A:1004757405147; Tang JW, 2005, BIOGEOCHEMISTRY, V73, P183, DOI 10.1007/s10533-004-5889-6; Tang JW, 2005, GLOBAL CHANGE BIOL, V11, P1298, DOI 10.1111/j.1365-2486.2005.00978.x; Tang YS, 2011, SOIL BIOL BIOCHEM, V43, P638, DOI 10.1016/j.soilbio.2010.11.035; Wan SQ, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001971; Wang LX, 2009, CLIMATIC CHANGE, V94, P63, DOI 10.1007/s10584-009-9548-8; Wang XH, 2010, SOIL BIOL BIOCHEM, V42, P1728, DOI 10.1016/j.soilbio.2010.06.008; Xie T, 2011, ECOL MODEL, V222, P241, DOI 10.1016/j.ecolmodel.2010.01.012; Xu M, 2001, GLOBAL CHANGE BIOL, V7, P667, DOI 10.1046/j.1354-1013.2001.00435.x; Yan LM, 2011, GLOBAL CHANGE BIOL, V17, P1990, DOI 10.1111/j.1365-2486.2010.02365.x; Yuste JC, 2007, GLOBAL CHANGE BIOL, V13, P2018, DOI 10.1111/j.1365-2486.2007.01415.x; Yuste JC, 2004, GLOBAL CHANGE BIOL, V10, P161, DOI 10.1111/j.1529-8817.2003.00727.x; Zhang LH, 2010, J ARID ENVIRON, V74, P1200, DOI 10.1016/j.jaridenv.2010.05.031; Zheng ZM, 2009, SOIL BIOL BIOCHEM, V41, P1531, DOI 10.1016/j.soilbio.2009.04.013	61	25	32	7	117	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91182	10.1371/journal.pone.0091182	http://dx.doi.org/10.1371/journal.pone.0091182			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608636	Green Published, gold, Green Submitted			2022-12-27	WOS:000332485800112
J	Li, X; Suo, J; Shao, SJ; Xue, LY; Chen, W; Dong, LJ; Shi, J; Fu, M; Lu, N; Zhan, QM; Tong, T				Li, Xiao; Suo, Jing; Shao, Shujuan; Xue, Liyan; Chen, Wei; Dong, Lijia; Shi, Ji; Fu, Ming; Lu, Ning; Zhan, Qimin; Tong, Tong			Overexpression of OLC1 Promotes Tumorigenesis of Human Esophageal Squamous Cell Carcinoma	PLOS ONE			English	Article							ENDOTHELIAL-GROWTH-FACTOR; CYTOCHROME-C RELEASE; AURORA-A; SACCHAROMYCES-CEREVISIAE; PROGNOSTIC-SIGNIFICANCE; CLINICAL-SIGNIFICANCE; CIGARETTE-SMOKE; PROTEIN SPARTIN; BCL-2 FAMILY; CYCLE ARREST	Purpose: OLC1 was recently identified to be a potential oncogene. However, the role of OLC1 in human esophageal cell carcinoma (ESCC) is unknown. The aim of this study was therefore to evaluate the expression of OLC1 in human ESCC from normal, premalignant, and malignant lesions, and to clarify the mechanisms by which OLC1 contributes to the progression of ESCC. Experimental Design: Two hundred and fourteen paired ESCC specimens, and an independent set from 28 ESCC patients, were used to analyze the correlation between OLC1 expression and the pathological characteristics of tumors using immunohistochemistry. Stable OLC1-overexpressing and OLC1-interfering esophageal cancer cells were established and a series of experimental methods were used to investigate the biological functions and mechanisms of action of OLC1. Results: We showed that OLC1 was overexpressed in 145 of 214 (67.8%) of human ESCC specimens, compared with in only 59 of 214 (27.57%) paired adjacent normal tissues (P<0.001). OLC1 overexpression occurred at a rate of 35% (10/28) at the stage of mild/moderate dysplasia, but was significantly upregulated to 66% (22/33) at the stages of severe dysplasia and in situ carcinoma, while 71% positive staining (22/28) was observed in invasive carcinoma tissues compared with normal tissues (P<0.05). We also provided evidence that OLC1 abnormalities significantly altered the cell proliferation and apoptosis induced by cytotoxic agents. OLC1 overexpression suppressed apoptosis, and was associated with attenuated caspase-3 activation and increased Bcl-2 stability. Conclusion: Our study provides strong evidence suggesting OLC1 abnormalities may contribute to the development of human ESCC and have some important clinical significance.	[Li, Xiao; Chen, Wei; Dong, Lijia; Shi, Ji; Fu, Ming; Zhan, Qimin; Tong, Tong] Chinese Acad Med Sci, Inst Canc, State Key Lab Mol Oncol, Beijing 100021, Peoples R China; [Li, Xiao; Xue, Liyan; Chen, Wei; Dong, Lijia; Shi, Ji; Fu, Ming; Lu, Ning; Zhan, Qimin; Tong, Tong] Chinese Acad Med Sci, Canc Hosp, Beijing 100730, Peoples R China; [Li, Xiao; Xue, Liyan; Chen, Wei; Dong, Lijia; Shi, Ji; Fu, Ming; Lu, Ning; Zhan, Qimin; Tong, Tong] Peking Union Med Coll, Beijing 100021, Peoples R China; [Xue, Liyan; Lu, Ning] Chinese Acad Med Sci, Inst Canc, Dept Pathol, Beijing 100021, Peoples R China; [Li, Xiao] Chinese Acad Sci, Dalian Inst Chem Phys, CAS Key Lab Separat Sci Analyt Chem, Dalian, Liaoning, Peoples R China; [Li, Xiao; Suo, Jing; Shao, Shujuan; Shi, Ji] Dalian Med Univ, Dept Histol & Embryol, Dalian, Liaoning, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS; Dalian Medical University	Zhan, QM (corresponding author), Chinese Acad Med Sci, Inst Canc, State Key Lab Mol Oncol, Beijing 100021, Peoples R China.	qiminzhan@163.com; tongt5@yahoo.com			National Natural Science Foundation of China [31250001]; 973 National Key Fundamental Research Program of China [2009CB521801]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 National Key Fundamental Research Program of China(National Basic Research Program of China)	This work was supported by the grants from the National Natural Science Foundation of China (31250001), and the 973 National Key Fundamental Research Program of China (2009CB521801). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agromayor M, 2009, MOL BIOL CELL, V20, P1374, DOI 10.1091/mbc.E08-05-0474; Bajorek M, 2009, MOL BIOL CELL, V20, P1360, DOI 10.1091/mbc.E08-05-0475; Cao LY, 2009, WORLD J GASTROENTERO, V15, P4183, DOI 10.3748/wjg.15.4183; Chava S, 2012, DIS ESOPHAGUS, V25, P81, DOI 10.1111/j.1442-2050.2011.01213.x; Chung JY, 2006, CANCER EPIDEM BIOMAR, V15, P1403, DOI 10.1158/1055-9965.EPI-05-0651; Cory S, 2003, ONCOGENE, V22, P8590, DOI 10.1038/sj.onc.1207102; Cryns V, 1998, GENE DEV, V12, P1551, DOI 10.1101/gad.12.11.1551; Dimaano C, 2008, MOL BIOL CELL, V19, P465, DOI 10.1091/mbc.E07-08-0747; Entian KD, 1999, MOL GEN GENET, V262, P683, DOI 10.1007/PL00013817; Silveira APF, 2011, ANTICANCER RES, V31, P1685; Hu H, 2002, INT J CANCER, V102, P580, DOI 10.1002/ijc.10739; Huang P, 2011, INT J MOL MED, V28, P579, DOI 10.3892/ijmm.2011.727; Hussain S, 2011, MOL CARCINOGEN, V50, P487, DOI 10.1002/mc.20732; Itami A, 1999, ONCOLOGY-BASEL, V57, P311, DOI 10.1159/000012067; Kimura Y, 2003, ONCOL REP, V10, P1747; Kitamura A, 2001, ONCOLOGY-BASEL, V61, P205, DOI 10.1159/000055376; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Lan CH, 2010, J DIGEST DIS, V11, P43, DOI 10.1111/j.1751-2980.2009.00412.x; Lee S, 2012, MOL BIOL CELL, V23, P4347, DOI 10.1091/mbc.E12-04-0292; Li YF, 2009, J GENE MED, V11, P3, DOI 10.1002/jgm.1270; Lin DC, 2009, DIS ESOPHAGUS, V22, P9, DOI 10.1111/j.1442-2050.2008.00845.x; Ling Q, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-66; Luo KJ, 2011, J SURG ONCOL, V104, P236, DOI 10.1002/jso.21921; Lyronis ID, 2008, PATHOL ONCOL RES, V14, P267, DOI 10.1007/s12253-008-9032-1; Mathew R, 2002, EUR J CANCER, V38, P832, DOI 10.1016/S0959-8049(02)00007-2; Matsuda A, 2003, ONCOGENE, V22, P3307, DOI 10.1038/sj.onc.1206406; Matsumoto M, 2004, ONCOLOGY-BASEL, V67, P143, DOI 10.1159/000081001; Mega S, 2005, DIS ESOPHAGUS, V18, P109, DOI 10.1111/j.1442-2050.2005.00463.x; Osawa H, 2004, ANTICANCER RES, V24, P3703; Puhringer-Oppermann F, 2010, INT J COLORECTAL DIS, V25, P515, DOI 10.1007/s00384-009-0867-z; Renvoise B, 2012, HUM MOL GENET, V21, P3604, DOI 10.1093/hmg/dds191; Renvoise B, 2010, MOL BIOL CELL, V21, P3293, DOI 10.1091/mbc.E09-10-0879; Rue SM, 2008, MOL BIOL CELL, V19, P475, DOI 10.1091/mbc.E07-07-0694; Shi Ji, 2010, Zhonghua Zhong Liu Za Zhi, V32, P748; Shih CH, 2000, CLIN CANCER RES, V6, P1161; Shimada H, 2001, CANCER-AM CANCER SOC, V92, P663, DOI 10.1002/1097-0142(20010801)92:3<663::AID-CNCR1368>3.0.CO;2-L; Song YM, 2008, CARCINOGENESIS, V29, P307, DOI 10.1093/carcin/bgm269; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; Thepot A, 2010, INT J CANCER, V127, P2051, DOI 10.1002/ijc.25221; Tong T, 2005, MOL CELL BIOL, V25, P4488, DOI 10.1128/MCB.25.11.4488-4500.2005; Tong T, 2004, CLIN CANCER RES, V10, P7304, DOI 10.1158/1078-0432.CCR-04-0806; Tung EWY, 2011, REPROD TOXICOL, V32, P255, DOI 10.1016/j.reprotox.2011.05.020; Tyagi A, 2011, CLIN CANCER RES, V17, P5402, DOI 10.1158/1078-0432.CCR-11-1072; Uchikado Y, 2005, CLIN CANCER RES, V11, P1174; Wagner AK, 2011, J CEREBR BLOOD F MET, V31, P1886, DOI 10.1038/jcbfm.2011.31; Wang XX, 2006, CELL RES, V16, P356, DOI 10.1038/sj.cr.7310046; Wang XX, 2009, CANCER BIOL THER, V8, P1852, DOI 10.4161/cbt.8.19.9550; Wu PP, 2011, INT J ONCOL, V38, P1605, DOI 10.3892/ijo.2011.973; Yuan JS, 2008, JNCI-J NATL CANCER I, V100, P1592, DOI 10.1093/jnci/djn379; Zhang JT, 2011, J PROTEOME RES, V10, P2863, DOI 10.1021/pr200141c; Zhang XJ, 2011, BIOCHEM BIOPH RES CO, V407, P753, DOI 10.1016/j.bbrc.2011.03.095	51	4	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90958	10.1371/journal.pone.0090958	http://dx.doi.org/10.1371/journal.pone.0090958			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608342	Green Published, Green Submitted, gold			2022-12-27	WOS:000332485800070
J	Sabo, A; Doni, M; Amati, B				Sabo, Arianna; Doni, Mirko; Amati, Bruno			SUMOylation of Myc-Family Proteins	PLOS ONE			English	Article							HUMAN NEUROBLASTOMA-CELLS; C-MYC; BURKITT-LYMPHOMA; N-MYC; TRANSCRIPTIONAL ACTIVATION; GENE AMPLIFICATION; CODING REGION; DNA-BINDING; UBIQUITIN; MUTATIONS	Myc-family proteins are key controllers of the metabolic and proliferative status of the cell, and are subjected to a complex network of regulatory events that guarantee their efficient and fast modulation by extracellular stimuli. Hence, unbalances in regulatory mechanisms leading to altered Myc levels or activities are often reported in cancer cells. Here we show that c- and N-Myc are conjugated to SUMO proteins at conserved lysines in their C-terminal domain. No obvious effects of SUMOylation were detected on bulk N-Myc stability or activities, including the regulation of transcription, proliferation or apoptosis. N-Myc SUMOylation could be induced by cellular stresses, such as heat shock and proteasome inhibition, and in all instances concerned a small fraction of the N-Myc protein. We surmise that, as shown for other substrates, SUMOylation may be part of a quality-control mechanism acting on misfolded Myc proteins.	[Sabo, Arianna; Amati, Bruno] Fdn Ist Italiano Tecnol IIT, Ctr Genom Sci IIT SEMM, Milan, Italy; [Sabo, Arianna; Doni, Mirko; Amati, Bruno] European Inst Oncol IEO, Dept Expt Oncol, Milan, Italy	Istituto Italiano di Tecnologia - IIT; IRCCS European Institute of Oncology (IEO)	Amati, B (corresponding author), Fdn Ist Italiano Tecnol IIT, Ctr Genom Sci IIT SEMM, Milan, Italy.	bruno.amati@iit.it	Sabò, Arianna/J-9531-2018; Doni, Mirko/AAN-6027-2020; Doni, Mirko/ABA-9174-2021; Amati, Bruno/AAM-3418-2020	Sabò, Arianna/0000-0002-9542-0045; Doni, Mirko/0000-0001-7099-2701; Amati, Bruno/0000-0002-2958-1799	EU-FP7 Program (EuroSystem); European Research Council; Italian health ministry; Italian Association for Cancer Research (AIRC)	EU-FP7 Program (EuroSystem)(European Commission); European Research Council(European Research Council (ERC)European Commission); Italian health ministry(Ministry of Health, Italy); Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro)	Work was supported by grants from the EU-FP7 Program (EuroSystem), the European Research Council, the Italian health ministry and the Italian Association for Cancer Research (AIRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikary S, 2005, CELL, V123, P409, DOI 10.1016/j.cell.2005.08.016; AMATI B, 1992, NATURE, V359, P423, DOI 10.1038/359423a0; Amente S, 2012, AM J CANCER RES, V2, P330; Bahram F, 2000, BLOOD, V95, P2104, DOI 10.1182/blood.V95.6.2104; Bettermann K, 2012, CANCER LETT, V316, P113, DOI 10.1016/j.canlet.2011.10.036; BHATIA K, 1994, BLOOD, V84, P883; BHATIA K, 1993, NAT GENET, V5, P56, DOI 10.1038/ng0993-56; BLACKWELL TK, 1993, MOL CELL BIOL, V13, P5216, DOI 10.1128/MCB.13.9.5216; BLACKWELL TK, 1990, SCIENCE, V250, P1149, DOI 10.1126/science.2251503; Bordow SB, 1998, J CLIN ONCOL, V16, P3286, DOI 10.1200/JCO.1998.16.10.3286; Campaner S, 2010, NAT CELL BIOL, V12, P54, DOI 10.1038/ncb2004; Castoralova M, 2012, BIOCH BIOPHYS ACTA; Chen A, 1998, BIOCHEM MOL BIOL INT, V46, P1161; CLARK HM, 1994, CANCER RES, V54, P3383; Cohn SL, 2009, J CLIN ONCOL, V27, P289, DOI 10.1200/JCO.2008.16.6785; Combaret V, 1996, J CLIN ONCOL, V14, P25, DOI 10.1200/JCO.1996.14.1.25; Cowling VH, 2006, MOL CELL BIOL, V26, P4226, DOI 10.1128/MCB.01959-05; DANI C, 1984, P NATL ACAD SCI-BIOL, V81, P7046, DOI 10.1073/pnas.81.22.7046; Efstratiadis A, 2007, CELL CYCLE, V6, P418, DOI 10.4161/cc.6.4.3838; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Faiola F, 2005, MOL CELL BIOL, V25, P10220, DOI 10.1128/MCB.25.23.10220-10234.2005; Galderisi U, 1999, J CELL BIOCHEM, V73, P97, DOI 10.1002/(SICI)1097-4644(19990401)73:1<97::AID-JCB11>3.0.CO;2-M; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Giulino-Roth L, 2012, BLOOD, V120, P5181, DOI 10.1182/blood-2012-06-437624; Golebiowski F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000282; HANN SR, 1984, MOL CELL BIOL, V4, P2486, DOI 10.1128/MCB.4.11.2486; Hemann MT, 2005, NATURE, V436, P807, DOI 10.1038/nature03845; Henriksen JR, BMC DEV BIOL, V11, P1, DOI [10.1186/1471-11-1, DOI 10.1186/1471-11-1]; Jentsch S, 2013, ANNU REV GENET, V47, P167, DOI 10.1146/annurev-genet-111212-133453; Jiang RC, 2011, BIOCHEM BIOPH RES CO, V410, P364, DOI 10.1016/j.bbrc.2011.06.020; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kamitani T, 1998, J BIOL CHEM, V273, P11349, DOI 10.1074/jbc.273.18.11349; Kang JH, 2006, BIOCHEM BIOPH RES CO, V351, P192, DOI 10.1016/j.bbrc.2006.10.020; Kerscher O, 2007, EMBO REP, V8, P550, DOI 10.1038/sj.embor.7400980; Kessler JD, 2012, SCIENCE, V335, P348, DOI 10.1126/science.1212728; Kuppers R, 2001, ONCOGENE, V20, P5580, DOI 10.1038/sj.onc.1204640; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; Love C, 2012, NAT GENET, V44, P1321, DOI 10.1038/ng.2468; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; Miteva M, 2010, SUBCELL BIOCHEM, V54, P195, DOI 10.1007/978-1-4419-6676-6_16; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; Neyret-Kahn H, 2013, GENOME RES, V23, P1563, DOI 10.1101/gr.154872.113; Otto T, 2009, CANCER CELL, V15, P67, DOI 10.1016/j.ccr.2008.12.005; Patel JH, 2004, MOL CELL BIOL, V24, P10826, DOI 10.1128/MCB.24.24.10826-10834.2004; Popov N, NAT, P765, DOI [10.1038/ncb1601, DOI 10.1038/NCB1601]; Praefcke GJK, 2012, TRENDS BIOCHEM SCI, V37, P23, DOI 10.1016/j.tibs.2011.09.002; RABBITTS TH, 1983, NATURE, V306, P760, DOI 10.1038/306760a0; RAMSAY G, 1984, P NATL ACAD SCI-BIOL, V81, P7742, DOI 10.1073/pnas.81.24.7742; Rubie H, 1997, J CLIN ONCOL, V15, P1171, DOI 10.1200/JCO.1997.15.3.1171; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; Sansom OJ, 2007, NATURE, V446, P676, DOI 10.1038/nature05674; Schmitz R, 2012, NATURE, V490, P116, DOI 10.1038/nature11378; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Sharma VM, 2007, CELL CYCLE, V6, P927, DOI 10.4161/cc.6.8.4134; Sur I, 2013, CANCER RES, V73, P4180, DOI 10.1158/0008-5472.CAN-13-0789; Tatham MH, 2001, J BIOL CHEM, V276, P35368, DOI 10.1074/jbc.M104214200; Tatham MH, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001484; Ulrich HD, 2005, TRENDS CELL BIOL, V15, P525, DOI 10.1016/j.tcb.2005.08.002; Vervoorts J, 2006, J BIOL CHEM, V281, P34725, DOI 10.1074/jbc.R600017200; Wang YG, 2009, J CELL SCI, V122, P4249, DOI 10.1242/jcs.050542; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Wilkinson KA, 2010, BIOCHEM J, V428, P133, DOI 10.1042/BJ20100158; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217; Yu Un-Young, 2008, Cancer Res Treat, V40, P27, DOI 10.4143/crt.2008.40.1.27; Zhang KL, 2005, BIOCHEM BIOPH RES CO, V336, P274, DOI 10.1016/j.bbrc.2005.08.075	65	24	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91072	10.1371/journal.pone.0091072	http://dx.doi.org/10.1371/journal.pone.0091072			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608896	gold, Green Published, Green Submitted			2022-12-27	WOS:000332485800096
J	Ye, Z; Cong, LM; Ding, GQ; Yu, M; Zhang, XW; Hu, RY; Wu, JJ; Fang, L; Wang, H; Zhang, J; He, QF; Su, DT; Zhao, M; Wang, LX; Gong, WW; Xiao, YY; Liang, MB; Pan, J				Ye, Zhen; Cong, Liming; Ding, Gangqiang; Yu, Min; Zhang, Xinwei; Hu, Ruying; Wu, Jianjun; Fang, Le; Wang, Hao; Zhang, Jie; He, Qingfang; Su, Danting; Zhao, Ming; Wang, Lixin; Gong, Weiwei; Xiao, Yuanyuan; Liang, Mingbin; Pan, Jin			Optimal Cut-Off Points for Two-Step Strategy in Screening of Undiagnosed Diabetes: A Population-Based Study in China	PLOS ONE			English	Article							FASTING PLASMA-GLUCOSE; LIFE-STYLE; MELLITUS; DIAGNOSIS; TOLERANCE; IMPROVES	To identify optimal cut-off points of fasting plasma glucose for two-step strategy in screening of undiagnosed diabetes in Chinese people, data were selected from two cross-sectional studies of Metabolic Syndrome in Zhejiang Province of China, Zhejiang Statistical Yearbook (2010), and published literatures. Two-step strategy was used among 17437 subjects sampled from population to screen undiagnosed diabetes. Effectiveness (proportion of cases identified), costs (including medical and non-medical costs), and efficiency (cost per case identified) of these different two-step screening strategies were evaluated. This study found the sensitivities of all the two-step screening strategies with further Oral Glucose Tolerance Test (OGTT) at different Fasting Plasma Glucose (FPG) cut-off points from 5.0 to 7.0 (mmol/L) ranged from 0.66 to 0.91. For the FPG point of 5.0 mmol/L, 91 percent of undiagnosed cases were identified. The total cost of detecting one undiagnosed diabetes case ranged from 547.1 to 1294.5 CNY/case, and the strategy with FPG at cut-off point of 6.1 (mmol/L) resulted in the least cost. Considering both sensitivity and cost of screening diabetes, FPG cut-off point at 5.4 mmol/L was optimized for the two-step strategy. In conclusion, different optimal cut-off points of FPG for two-step strategy in screening of undiagnosed diabetes should be used for different screening purposes.	[Ye, Zhen; Cong, Liming; Ding, Gangqiang; Yu, Min; Zhang, Xinwei; Hu, Ruying; Fang, Le; Wang, Hao; Zhang, Jie; He, Qingfang; Su, Danting; Zhao, Ming; Wang, Lixin; Gong, Weiwei; Xiao, Yuanyuan; Liang, Mingbin; Pan, Jin] Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China; [Wu, Jianjun] Zhejiang Univ, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang Provincial Center for Disease Control & Prevention; Zhejiang University	Yu, M (corresponding author), Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China.	myu@cdc.zj.cn; lef@cdc.zj.cn	ding, gangqiang/AHD-5012-2022; su, dan/GYJ-1940-2022; Wu, Jian/AAU-5221-2020; Wu, Jian/AAU-5221-2020	Wu, Jian/0000-0001-9933-7364; Wu, Jian/0000-0002-3394-1507	Zhejiang Provincial Major Special Project of Science and Technology [2011C13032-1]	Zhejiang Provincial Major Special Project of Science and Technology	This study was supported by Zhejiang Provincial Major Special Project of Science and Technology (2011C13032-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Alqahtani N, 2013, INT J PREVENTIVE MED, V4, P1025; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; [Anonymous], 2011, MATLAB VERS 7 12 COM; Appajigol J, 2011, RECENT RES SCI TECHN, V3; Eborall H, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X630106; Gilmer TP, 2010, DIABETES CARE, V33, P1695, DOI 10.2337/dc10-0855; He YN, 2009, DIABETES CARE, V32, P1972, DOI 10.2337/dc09-0714; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Ma XJ, 2010, CLIN EXP PHARMACOL P, V37, P974, DOI 10.1111/j.1440-1681.2010.05417.x; Nakagami T, 2002, DIABETES RES CLIN PR, V55, P35, DOI 10.1016/S0168-8227(01)00270-4; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; Tai ES, 2000, DIABETIC MED, V17, P771, DOI 10.1046/j.1464-5491.2000.00382.x; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Wang L, 2005, REPORT CHINA NATIONW, P18; Waugh N, 2007, HEALTH TECHNOL ASSES, V11, P1; Zhang P, 2005, DIABETES CARE, V28, P1321, DOI 10.2337/diacare.28.6.1321; Zhang P, 2003, DIABETES CARE, V26, P2536, DOI 10.2337/diacare.26.9.2536	19	7	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e87690	10.1371/journal.pone.0087690	http://dx.doi.org/10.1371/journal.pone.0087690			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24609110	Green Submitted, gold, Green Published			2022-12-27	WOS:000332485800002
J	Agnihotri, S; Sundeep, PVDS; Seelamantula, CS; Balakrishnan, R				Agnihotri, Samira; Sundeep, P. V. D. S.; Seelamantula, Chandra Sekhar; Balakrishnan, Rohini			Quantifying Vocal Mimicry in the Greater Racket-Tailed Drongo: A Comparison of Automated Methods and Human Assessment	PLOS ONE			English	Article							MIMETIC ACCURACY; PASSERINE BIRD; ALARM CALLS; SPEECH; SONG; RECOGNITION; IDENTIFICATION; MECHANISMS; SOUNDS	Objective identification and description of mimicked calls is a primary component of any study on avian vocal mimicry but few studies have adopted a quantitative approach. We used spectral feature representations commonly used in human speech analysis in combination with various distance metrics to distinguish between mimicked and non-mimicked calls of the greater racket-tailed drongo, Dicrurus paradiseus and cross-validated the results with human assessment of spectral similarity. We found that the automated method and human subjects performed similarly in terms of the overall number of correct matches of mimicked calls to putative model calls. However, the two methods also misclassified different subsets of calls and we achieved a maximum accuracy of ninety five per cent only when we combined the results of both the methods. This study is the first to use Mel-frequency Cepstral Coefficients and Relative Spectral Amplitude - filtered Linear Predictive Coding coefficients to quantify vocal mimicry. Our findings also suggest that in spite of several advances in automated methods of song analysis, corresponding cross-validation by humans remains essential.	[Agnihotri, Samira; Balakrishnan, Rohini] Indian Inst Sci, Ctr Ecol Sci, Bangalore 560012, Karnataka, India; [Sundeep, P. V. D. S.; Seelamantula, Chandra Sekhar] Indian Inst Sci, Dept Elect Engn, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore	Balakrishnan, R (corresponding author), Indian Inst Sci, Ctr Ecol Sci, Bangalore 560012, Karnataka, India.	rohini@ces.iisc.ernet.in	Balakrishnan, Rohini/Z-5881-2019	pvds, sundeep/0000-0001-9228-4140	Department of Science and Technology, Government of India; Ministry of Environment and Forests, Government of India	Department of Science and Technology, Government of India(Department of Science & Technology (India)); Ministry of Environment and Forests, Government of India(Ministry of Environment, Forest and Climate Change (MoEFCC), Government of India)	Field work for this study was funded by the Department of Science and Technology, Government of India and the Ministry of Environment and Forests, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S., 1983, HDB BIRDS INDIA PAKI; Charif RA, 2010, RAVEN PRO 1 4 USERS; Cheng JK, 2012, BIOACOUSTICS, V21, P157, DOI 10.1080/09524622.2012.669664; Coleman SW, 2007, BIOL LETTERS, V3, P463, DOI 10.1098/rsbl.2007.0234; Cortopassi Kathryn A., 2000, Bioacoustics, V11, P89; Dalziell AH, 2012, ANIM BEHAV, V83, P1401, DOI 10.1016/j.anbehav.2012.03.009; Deller J. R., 2000, DISCRETE TIME PROCES; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; Flower T, 2011, P ROY SOC B-BIOL SCI, V278, P1548, DOI 10.1098/rspb.2010.1932; Goodale E, 2006, P R SOC B, V273, P875, DOI 10.1098/rspb.2005.3392; Goodale E, 2006, ANIM BEHAV, V72, P471, DOI 10.1016/j.anbehav.2006.02.004; Hamao S, 2004, IBIS, V146, P61, DOI 10.1111/j.1474-919X.2004.00226.x; HERMANSKY H, 1990, J ACOUST SOC AM, V87, P1738, DOI 10.1121/1.399423; Hermansky H, 1994, IEEE T SPEECH AUDI P, V2, P578, DOI 10.1109/89.326616; Igic B, 2013, ANIM BEHAV, V85, P593, DOI 10.1016/j.anbehav.2012.12.022; Juang B-H, 1993, SIGNAL PROCESS SER; Kelley LA, 2010, BIOL LETTERS, V6, P626, DOI 10.1098/rsbl.2010.0093; Knudsen DP, 2010, BRAIN LANG, V115, P59, DOI 10.1016/j.bandl.2009.09.008; Lopes MT, 2011, AUTOMATIC BIRD SPECI, P117; MAKHOUL J, 1975, P IEEE, V63, P561, DOI 10.1109/PROC.1975.9792; Paliwal KK, 1993, IEEE T SPEECH AUDI P, V1, P3, DOI 10.1109/89.221363; Putland DA, 2006, BIOL LETT-UK, V2, P367, DOI 10.1098/rsbl.2006.0502; R Core Team, 2013, LANG ENV STAT COMP; Somervuo P, 2006, IEEE T AUDIO SPEECH, V14, P2252, DOI 10.1109/TASL.2006.872624; Stattner E., 2011, WOWMOM, P1; Tchernichovski O, 2000, ANIM BEHAV, V59, P1167, DOI 10.1006/anbe.1999.1416; Vergin R, 1999, IEEE T SPEECH AUDI P, V7, P525, DOI 10.1109/89.784104; Wilson PL, 2001, ANIM BEHAV, V62, P1197, DOI 10.1006/anbe.2001.1863; Wimmer J, 2013, FUTURE GENER COMP SY, V29, P560, DOI 10.1016/j.future.2012.03.004; Zann R, 2008, ANIM BEHAV, V76, P1043, DOI 10.1016/j.anbehav.2008.05.021	30	8	8	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e89540	10.1371/journal.pone.0089540	http://dx.doi.org/10.1371/journal.pone.0089540			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603717	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000332483600013
J	Amiya, RM; Poudel, KC; Poudel-Tandukar, K; Pandey, BD; Jimba, M				Amiya, Rachel M.; Poudel, Krishna C.; Poudel-Tandukar, Kalpana; Pandey, Basu D.; Jimba, Masamine			Perceived Family Support, Depression, and Suicidal Ideation among People Living with HIV/AIDS: A Cross-Sectional Study in the Kathmandu Valley, Nepal	PLOS ONE			English	Article							SOCIAL SUPPORT; EMOTIONAL DISTRESS; HIV; LIFE; BEHAVIOR; STIGMA; SATISFACTION; PREVALENCE; DISORDERS; SYMPTOMS	Background: Depression and suicidal thinking occur frequently alongside HIV/AIDS, triggering profound detrimental impacts on quality of life, treatment adherence, disease progression, and mortality. Yet the psychosocial factors contributing to these psychiatric comorbidities remain underexplored, particularly in the developing country context. This study thus examined different dimensions of perceived family support in relation to depression and suicidal ideation among people living with HIV/AIDS (PLWHA) in Nepal. Methods: A cross-sectional survey of 322 adult PLWHA residing in the Kathmandu Valley, Nepal was conducted. Data were analyzed using multiple logistic regressions for correlates of Beck Depression Inventory (BDI)-Ia-defined depressive symptoms and suicidal ideation in the past 2 weeks. Perceived family support, measured using the 10-item Nepali Family Support and Difficulty Scale, was entered into separate models, in turn, as a composite score, for each sub-scale (emotional, instrumental, and negative support), and for each individual item. Results: Overall, 25.5% of participants registered BDI-Ia-defined depression, with significantly lower rates among those with perceived family support scores in the highest (AOR = 0.19; 95% CI = 0.07, 0.55) and middle (AOR = 0.38; 95% CI = 0.17, 0.86) tertiles relative to those with lowest-tertile scores. Meanwhile, 14.0% reported suicidal thinking, with significantly lower rates among those in the highest perceived family support tertile relative to the lowest (AOR = 0.25; 95% CI = 0.07, 0.91). Broken down by support sub-scale, only negative support (i.e. family difficulty) was significant in its correlations with both outcomes - a trend similarly reflected in the item-wise analyses. Conclusions: Our findings highlight an important role for family support in determining experiences of depression and suicidality among PLWHA. Incorporating family counseling and support services - with special focus on ameliorating negative interaction and bolstering emotional support - into HIV care and treatment services may help to improve mental health along with overall wellness and treatment outcomes for HIV-positive populations in Nepal and similar settings.	[Amiya, Rachel M.; Jimba, Masamine] Univ Tokyo, Grad Sch Med, Dept Community & Global Hlth, Tokyo, Japan; [Poudel, Krishna C.] Univ Massachusetts, Dept Publ Hlth, Sch Publ Hlth & Hlth Sci, Amherst, MA 01003 USA; [Poudel-Tandukar, Kalpana] Waseda Univ, Waseda Inst Adv Study, Tokyo, Japan; [Pandey, Basu D.] Everest Int Clin & Res Ctr, Kathmandu, Nepal	University of Tokyo; University of Massachusetts System; University of Massachusetts Amherst; Waseda University	Amiya, RM (corresponding author), Univ Tokyo, Grad Sch Med, Dept Community & Global Hlth, Tokyo, Japan.	rachel.amiya@gmail.com	Jimba, Masamine/AAF-5630-2020		University of Tokyo; National Center for Global Health and Medicine [21A-2]; Japan Society for the Promotion of Science through the Ministry of Education, Culture, Sports, Science and Technology, Japan [22790581]	University of Tokyo; National Center for Global Health and Medicine(National Center for Global Health & Medicine - Japan); Japan Society for the Promotion of Science through the Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by funding from the University of Tokyo; by the Grant for Research on Global Health and Medicine (No. 21A-2) from the National Center for Global Health and Medicine; and by the Grant-in-Aid for Young Scientists (B) (22790581) from the Japan Society for the Promotion of Science through the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe JAA, 2004, PERS RELATIONSHIP, V11, P231, DOI 10.1111/j.1475-6811.2004.00080.x; ABRAM HS, 1971, AM J PSYCHIAT, V127, P1199, DOI 10.1176/ajp.127.9.1199; Amiya RM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-677; Baider L, 2003, J PSYCHOSOM RES, V55, P453, DOI 10.1016/S0022-3999(03)00502-6; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Bekele T, 2013, AIDS CARE, V25, P337, DOI 10.1080/09540121.2012.701716; Blashill AJ, 2012, AIDS BEHAV, V16, P2251, DOI 10.1007/s10461-011-0056-2; Center for Substance Abuse Treatment, 2008, SUBST AB SUIC PREV E; Central Bureau of Statistics (CBS), 2011, POP CENS 2011 PREL R; COHEN S, 1985, PSYCHOL BULL, V98, P310, DOI 10.1037/0033-2909.98.2.310; COHEN S, 1988, HEALTH PSYCHOL, V7, P269, DOI 10.1037/0278-6133.7.3.269; Demi A, 1998, J FAM PSYCHOL, V12, P344, DOI 10.1037/0893-3200.12.3.344; Gaynes BN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041699; Gonzalez JS, 2011, JAIDS-J ACQ IMM DEF, V58, P181, DOI [10.1097/QAI.0B013E31822D490A, 10.1097/QAI.0b013e31822d490a]; Ingram KM, 1999, AIDS CARE, V11, P313, DOI 10.1080/09540129947947; Justice AC, 2001, J CLIN EPIDEMIOL, V54, pS77, DOI 10.1016/S0895-4356(01)00449-8; Kaestner F, 2012, Int J STD AIDS, V23, pe14, DOI 10.1258/ijsa.2009.009451; Kaushik S, 2010, J MENTAL HLTH HUM BE, V15, P77; Kim HS, 2008, AM PSYCHOL, V63, P518, DOI 10.1037/0003-066X; Kohrt B.A., 2002, NEPAL J PSYCHIAT, V2, P123; Kohrt BA, 2010, CULT MED PSYCHIAT, V34, P322, DOI 10.1007/s11013-010-9170-2; Kohrt BA, 2009, ANN HUM BIOL, V36, P261, DOI 10.1080/03014460902839194; Li L, 2009, AIDS CARE, V21, P1007, DOI 10.1080/09540120802614358; Lincoln KD, 2000, SOC SERV REV, V74, P231, DOI 10.1086/514478; Mcdowell TL, 2007, AIDS CARE, V19, P1223, DOI 10.1080/09540120701402830; Milner A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051333; National Centre for AIDS and STD Control (NCASC), 2012, NAT EST HIV INF NEP; NCASC, 2007, NAT EST HIV INF; Nepal VP, 2010, INT J SEX HEALTH, V22, P20, DOI 10.1080/19317610903393142; Neupane D, 2012, J Nepal Health Res Counc, V10, P136; Okun MA, 1998, J GERONTOL B-PSYCHOL, V53, pP4, DOI 10.1093/geronb/53B.1.P4; Poudel Krishna C, 2014, J Int Assoc Provid AIDS Care, V13, P277, DOI 10.1177/2325957413500989; Poudel-Tandukar K, 2013, AIDS RES HUM RETROV, V29, P528, DOI [10.1089/aid.2012.0120, 10.1089/AID.2012.0120]; Rabkin Judith G, 2008, Curr HIV/AIDS Rep, V5, P163, DOI 10.1007/s11904-008-0025-1; Reinhardt J. P, 2001, APPL DEV SCI, V5, P66; Ryan K, 2008, AIDS CARE, V20, P331, DOI 10.1080/09540120701660338; Serovich JM, 2001, AIDS CARE, V13, P335, DOI 10.1080/09540120120043982; Sherr L, 2011, PSYCHOL HEALTH MED, V16, P612, DOI 10.1080/13548506.2011.579991; Shirey KG., 2013, SUICIDE HIV MENTAL H, P405; Shor E, 2013, SOC NETWORKS, V35, P626, DOI 10.1016/j.socnet.2013.08.004; Shrestha Sadhana, 2014, J Int Assoc Provid AIDS Care, V13, P214, DOI 10.1177/1545109712456741; Siddiqui J, 2009, CURR MED RES OPIN, V25, P1307, DOI [10.1185/03007990902902119, 10.1185/03007990902902119 ]; Simbayi LC, 2007, SOC SCI MED, V64, P1823, DOI 10.1016/j.socscimed.2007.01.006; Soykan A, 2003, TRANSPLANT P, V35, P1290, DOI 10.1016/S0041-1345(03)00522-0; Suh E, 1998, J PERS SOC PSYCHOL, V74, P482, DOI 10.1037/0022-3514.74.2.482; Tezel A, 2011, J RES MED SCI, V16, P666; United Nations Development Programme (UNDP), 2014, HUM DEV REP 2013 RIS; Wada N, 2013, AM J EPIDEMIOL, V177, P116, DOI 10.1093/aje/kws321; Waraich P, 2004, CAN J PSYCHIAT, V49, P124, DOI 10.1177/070674370404900208; Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6; WHO, 2006, MENT HLTH SYST NEP; World Health Organization (WHO), 2011, SUIC PREV SPEC PROGR	52	49	51	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90959	10.1371/journal.pone.0090959	http://dx.doi.org/10.1371/journal.pone.0090959			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC4ID	24603886	Green Published, gold			2022-12-27	WOS:000332483600114
J	He, R; Aluko, RE; Ju, XR				He, Rong; Aluko, Rotimi E.; Ju, Xing-Rong			Evaluating Molecular Mechanism of Hypotensive Peptides Interactions with Renin and Angiotensin Converting Enzyme	PLOS ONE			English	Article							ACE INHIBITORY PEPTIDE; PROTEIN HYDROLYSATE; EGG-WHITE; IDENTIFICATION; PURIFICATION; CALMODULIN; DISCOVERY; BINDING; DESIGN; DRUGS	Our previous study showed that three rapeseed protein-derived peptides (TF, LY and RALP) inhibited the in vitro activities of angiotensin converting enzyme (ACE) and renin. Oral administration of these peptides to spontaneously hypertensive rats led to reductions in systolic blood pressure. In the present work, we examined the potential molecular mechanisms responsible for the ACE-and renin-inhibitory activities of these peptides. Enzyme inhibition kinetics showed competitive, non-competitive and mixed-type peptide-dependent inhibition of renin and ACE activities. Intrinsic fluorescence intensity data showed that LY and RALP have stronger binding effects on ACE molecule compared to that of TF. LY and RALP showed the highest inhibition of ACE and renin activities, respectively. Circular dichroism data showed that the inhibitory mechanism involved extensive peptide-dependent reductions in alpha-helix and beta-sheet fractions of ACE and renin protein conformations. Molecular docking studies confirmed that the higher renin-inhibitory activity of RALP may be due to formation of several hydrogen bonds (H-bonds) with the enzyme's active site residues. The rapeseed peptides inhibited renin and ACE activities mostly through binding to enzyme active site or non-active sites and forming extensive H-bonds that distorted the normal configuration required for catalysis. Data presented from this work could enhance development of highly potent antihypertensive natural peptides or peptidomimetics.	[He, Rong; Ju, Xing-Rong] Nanjing Univ Finance & Econ, Coll Food Sci & Engn, Nanjing, Jiangsu, Peoples R China; [He, Rong; Ju, Xing-Rong] Jiangnan Univ, Sch Food Sci & Technol, Wuxi, Peoples R China; [He, Rong; Aluko, Rotimi E.] Univ Manitoba, Dept Human Nutr Sci, Winnipeg, MB, Canada; [He, Rong; Aluko, Rotimi E.] Univ Manitoba, Richardson Ctr Funct Foods & Nutraceut, Winnipeg, MB, Canada	Nanjing University of Finance & Economics; Jiangnan University; University of Manitoba; University of Manitoba	Ju, XR (corresponding author), Nanjing Univ Finance & Econ, Coll Food Sci & Engn, Nanjing, Jiangsu, Peoples R China.	xingrongju@163.com	he, rong/V-5127-2019	he, rong/0000-0002-3341-9786	National Natural Science Foundation of China [31271930, 31101338]; Natural Sciences and Engineering Research Council of Canada (NSERC)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding for this work was supported by the National Natural Science Foundation of China (Grant No. 31271930 and 31101338). The research program of Dr. R.E. Aluko is funded by the Natural Sciences and Engineering Research Council of Canada (NSERC) through a Discovery Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn CB, 2012, PROCESS BIOCHEM, V47, P2240, DOI 10.1016/j.procbio.2012.08.019; Bonanni L, 2012, THER ADV CHRONIC DIS, V3, P173, DOI 10.1177/2040622312446244; Brew K, 2003, TRENDS PHARMACOL SCI, V24, P391, DOI 10.1016/S0165-6147(03)00196-2; Connelly KA, 2013, CARDIOVASC THER, V31, P84, DOI 10.1111/j.1755-5922.2011.00292.x; Daien V, 2012, AM J HYPERTENS, V25, P126, DOI 10.1038/ajh.2011.180; Du L, 2013, J FUNCT FOODS, V5, P475, DOI 10.1016/j.jff.2012.12.003; Girgih AT, 2011, J AM OIL CHEM SOC, V88, P1767, DOI 10.1007/s11746-011-1841-9; He R, 2013, J FUNCT FOODS, V5, P781, DOI 10.1016/j.jff.2013.01.024; Jao CL, 2012, BIOMEDICINE-TAIWAN, V2, P130, DOI 10.1016/j.biomed.2012.06.005; Jimsheena VK, 2010, PEPTIDES, V31, P1165, DOI 10.1016/j.peptides.2010.02.022; Katayama K, 2004, J AGR FOOD CHEM, V52, P771, DOI 10.1021/jf0350865; Ko SC, 2012, PROCESS BIOCHEM, V47, P2005, DOI 10.1016/j.procbio.2012.07.015; Kobayashi Y, 2008, J BIOSCI BIOENG, V106, P310, DOI 10.1263/jbb.106.310; Li H, 2006, INT J FOOD SCI NUTR, V57, P178, DOI 10.1080/09637480600659144; Memarpoor-Yazdi M, 2012, INT J PEPT RES THER, V18, P353, DOI 10.1007/s10989-012-9311-2; Natesh R, 2004, BIOCHEMISTRY-US, V43, P8718, DOI 10.1021/bi049480n; Natesh R, 2003, NATURE, V421, P551, DOI 10.1038/nature01370; Oliva RV, 2012, MANAGING KIDNEY HEAR, P59; Omoni AO, 2006, MOL NUTR FOOD RES, V50, P958, DOI 10.1002/mnfr.200600041; Pan DD, 2012, FOOD CHEM, V130, P121, DOI 10.1016/j.foodchem.2011.07.011; Pina AS, 2009, J MOL RECOGNIT, V22, P162, DOI 10.1002/jmr.905; Rahuel J, 2000, CHEM BIOL, V7, P493, DOI 10.1016/S1074-5521(00)00134-4; Schmid FX., 1989, SPECTRAL METHODS CHA, P251; SIELECKI AR, 1989, SCIENCE, V243, P1346, DOI 10.1126/science.2493678; Tanzadehpanah H, 2013, INNOV FOOD SCI EMERG, V18, P212, DOI 10.1016/j.ifset.2013.02.002; Thangapandian S, 2011, EUR J MED CHEM, V46, P2469, DOI 10.1016/j.ejmech.2011.03.035; Valika AA, 2013, HEART FAIL REV, V18, P135, DOI 10.1007/s10741-011-9295-6; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853	28	48	50	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e91051	10.1371/journal.pone.0091051	http://dx.doi.org/10.1371/journal.pone.0091051			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603692	Green Submitted, Green Published, gold			2022-12-27	WOS:000332483600125
J	Hee, L; Liao, DH; Sandager, P; Gregersen, H; Uldbjerg, N				Hee, Lene; Liao, Donghua; Sandager, Puk; Gregersen, Hans; Uldbjerg, Niels			Cervical Stiffness Evaluated In Vivo by Endoflip in Pregnant Women	PLOS ONE			English	Article							LIGHT-INDUCED FLUORESCENCE; MECHANICAL-PROPERTIES; UTERINE CERVIX; DISTENSIBILITY; INSTRUMENT; DELIVERY; INDEX	Objective: To determine the stiffness of the pregnant uterine cervix in vivo. Method: Five women in early pregnancy and six women in late pregnancy were included. The EndoFlip is a 1-m-long probe with a 12-cm-long bag mounted on the tip. The tip of the probe was inserted into the cervical canal. Sensors spaced at 0.5-cm intervals along the probe were used to determine 16 serial cross-sectional areas of the bag. The diameter of the cervical canal could thereby be determined during inflation with up to 50 ml saline solution. Tissue stiffness was calculated from the geometric profiles and the pressure-strain elastic modulus (EP) at each sensor site. Three parts of the cervix were defined: the uterus-near part, the middle and the vaginal part. The EPmax was defined as the highest EP detected along the cervical canal. Results: The EPmax was always found in the middle part of the cervix. The median EPmax was 243 kPa (IQR, 67-422 kPa) for the early pregnant women and 5 kPa (IQR, 4-15 kPa) for those at term. In the early pregnant women the stiffness differed along the cervical length (p<0.05) whereas difference along the cervix was not found for late pregnant women. A positive correlation coefficient (Spearman's rho) was established between the EPs of the uterus-near and the middle part (0.84), between the vaginal and the middle part (0.81), and between the uterus-near and the vaginal part (0.85). Conclusion: This new method can estimate the stiffness along the cervical canal in vivo. This method may be useful in the clinical examination of the biomechanical properties of the uterine cervix.	[Hee, Lene; Sandager, Puk; Uldbjerg, Niels] Aarhus Univ Hosp, Dept Obstet & Gynecol, DK-8000 Aarhus, Denmark; [Hee, Lene; Liao, Donghua; Sandager, Puk; Uldbjerg, Niels] Aarhus Univ, Inst Clin Med, Aarhus, Denmark; [Liao, Donghua] Aalborg Univ Hosp, Dept Gastroenterol & Surg, Mech Sense, Aalborg, Denmark; [Gregersen, Hans] Chongqing Univ, Giome Ctr, Coll Bioengn, Chongqing 630044, Peoples R China; [Gregersen, Hans] GIOME FZE, Giome Inst, Ras Al Khaymah, U Arab Emirates	Aarhus University; Aarhus University; Aalborg University; Aalborg University Hospital; Chongqing University	Hee, L (corresponding author), Aarhus Univ Hosp, Dept Obstet & Gynecol, DK-8000 Aarhus, Denmark.	lenehee@ki.au.dk	Gregersen, Hans/AAH-3723-2021; Uldbjerg, Niels/O-2038-2016	Gregersen, Hans/0000-0002-5792-2845; Uldbjerg, Niels/0000-0002-6449-6426	Aase og Ejnar Danielsens Fond; Brodrene Hartmanns Fond [DKK 100.000. 2]; Direktor Jacob Madsens & Hustru Olga Madsens Fond [DKK 100.000. 3]; Kong Christian den Tiendes Fond [DKK 10.000. 4, DKK 50.000. 5]; Linexfonden (Frede Duelund Nielsens Fond) [DKK 10.000. 6]	Aase og Ejnar Danielsens Fond; Brodrene Hartmanns Fond; Direktor Jacob Madsens & Hustru Olga Madsens Fond; Kong Christian den Tiendes Fond; Linexfonden (Frede Duelund Nielsens Fond)	Funding came from: 1) Aase og Ejnar Danielsens Fond (http://www.danielsensfond.dk/), DKK 100.000. 2) Brodrene Hartmanns Fond (http://www.hartmannfonden.dk/), DKK 100.000. 3) Direktor Jacob Madsens & Hustru Olga Madsens Fond DKK 10.000. 4) Fonden af 17-12-1981 http://www.fondenaf17121981.dk/), DKK 50.000. 5) Kong Christian den Tiendes Fond (http://kongehuset.dk/Menu/Fonde-legater/Kong-Christian-den-Tiendes-Fond/kong-christian-den-tiendesfond), DKK 10.000. 6) Linexfonden (Frede Duelund Nielsens Fond) (http://www.farum.eurojuris.dk/dk/filnavn=/dk/linex_fonden__udfyld_ansoegningen_om_stoette_paa_skaermen_ved_at_downloade_skemaet.asp), DKK 5.000. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTHONY GS, 1982, BRIT J OBSTET GYNAEC, V89, P1046, DOI 10.1111/j.1471-0528.1982.tb04662.x; BAKKE T, 1973, ACTA OBSTET GYN SCAN, V52, P277, DOI 10.3109/00016347309158327; Bauer M, 2007, ANN NY ACAD SCI, V1101, P186, DOI 10.1196/annals.1389.004; Bauer M, 2009, EUR J OBSTET GYN R B, V144, pS77, DOI 10.1016/j.ejogrb.2009.02.025; BISHOP EH, 1964, OBSTET GYNECOL, V24, P266; CABROL D, 1990, GYNECOL OBSTET INVES, V29, P32, DOI 10.1159/000293296; CABROL D, 1991, GYNECOL OBSTET INVES, V32, P28, DOI 10.1159/000292987; CABROL D, 1991, GYNECOL OBSTET INVES, V32, P36, DOI 10.1159/000292989; COLSTRUP H, 1983, J UROLOGY, V130, P507, DOI 10.1016/S0022-5347(17)51276-8; DANFORTH DN, 1954, AM J OBSTET GYNECOL, V68, P1261; DANFORTH DN, 1947, AM J OBSTET GYNECOL, V53, P541, DOI 10.1016/0002-9378(47)90273-1; Feltovich H, 2010, ULTRASONIC IMAGING, V32, P131, DOI 10.1177/016173461003200302; GAMBLE G, 1994, STROKE, V25, P11, DOI 10.1161/01.STR.25.1.11; Garfield RE, 2002, J SOC GYNECOL INVEST, V9, P265, DOI 10.1016/S1071-5576(02)00173-9; Gregersen H, 1988, Clin Phys Physiol Meas, V9 Suppl A, P61, DOI 10.1088/0143-0815/9/4A/011; Gregersen H., 2003, BIOMECHANICS GASTROI, DOI [10.1007/978-1-4471-3742-9_9, 10.1007/978-1-4471-3742-9]; Harris J, 1971, URODYNAMICS, P465; KIWI R, 1988, OBSTET GYNECOL, V71, P568; LOSE G, 1986, MED BIOL ENG COMPUT, V24, P488, DOI 10.1007/BF02443964; Maul H, 2003, AM J OBSTET GYNECOL, V188, P537, DOI 10.1067/mob.2003.94; Molina FS, 2012, ULTRASOUND OBST GYN, V39, P685, DOI 10.1002/uog.11067; Nabhani F., 2012, REDUCTION STRESSES C; PETERSEN LK, 1991, OBSTET GYNECOL, V77, P772; RECHBERGER T, 1988, OBSTET GYNECOL, V71, P563; RORIE DK, 1967, AM J OBSTET GYNECOL, V99, P466; Rust OA, 2005, AM J OBSTET GYNECOL, V192, P1060, DOI 10.1016/j.ajog.2005.01.076; SCHWALM H, 1966, AM J OBSTET GYNECOL, V94, P391, DOI 10.1016/0002-9378(66)90661-2; Volumenie JL, 2004, EUR J OBSTET GYN R B, V117, P33, DOI 10.1016/j.ejogrb.2004.02.029	28	23	24	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e91121	10.1371/journal.pone.0091121	http://dx.doi.org/10.1371/journal.pone.0091121			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603859	gold, Green Published, Green Submitted			2022-12-27	WOS:000332483600132
J	Manninen, O; Laitinen, T; Lehtimaki, KK; Tegelberg, S; Lehesjoki, AE; Grohn, O; Kopra, O				Manninen, Otto; Laitinen, Teemu; Lehtimaki, Kimmo K.; Tegelberg, Saara; Lehesjoki, Anna-Elina; Grohn, Olli; Kopra, Outi			Progressive Volume Loss and White Matter Degeneration in Cstb-Deficient Mice: A Diffusion Tensor and Longitudinal Volumetry MRI Study	PLOS ONE			English	Article							UNVERRICHT-LUNDBORG-DISEASE; CYSTATIN-B DEFICIENCY; MYOCLONUS EPILEPSY; MOUSE-BRAIN; EPM1; EXPRESSION; MUTATION; MODEL; PHENOTYPE; APOPTOSIS	Unverricht-Lundborg type progressive myoclonus epilepsy (EPM1, OMIM 254800) is an autosomal recessive disorder characterized by onset at the age of 6 to 16 years, incapacitating stimulus-sensitive myoclonus and tonic-clonic epileptic seizures. It is caused by mutations in the gene encoding cystatin B. Previously, widespread white matter changes and atrophy has been detected both in adult EPM1 patients and in 6-month-old cystatin B-deficient mice, a mouse model for the EPM1 disease. In order to elucidate the spatiotemporal dynamics of the brain atrophy and white matter changes in EPM1, we conducted longitudinal in vivo magnetic resonance imaging and ex vivo diffusion tensor imaging accompanied with tract-based spatial statistics analysis to compare volumetric changes and fractional anisotropy in the brains of 1 to 6 months of age cystatin B-deficient and control mice. The results reveal progressive but non-uniform volume loss of the cystatin B-deficient mouse brains, indicating that different neuronal populations possess distinct sensitivity to the damage caused by cystatin B deficiency. The diffusion tensor imaging data reveal early and progressive white matter alterations in cystatin B-deficient mice affecting all major tracts. The results also indicate that the white matter damage in the cystatin B-deficient brain is most likely secondary to glial activation and neurodegenerative events rather than a primary result of CSTB deficiency. The data also show that diffusion tensor imaging combined with TBSS analysis provides a feasible approach not only to follow white matter damage in neurodegenerative mouse models but also to detect fractional anisotropy changes related to normal white matter maturation and reorganisation.	[Manninen, Otto; Tegelberg, Saara; Lehesjoki, Anna-Elina; Kopra, Outi] Folkhalsan Inst Genet, Helsinki, Finland; [Manninen, Otto; Tegelberg, Saara; Lehesjoki, Anna-Elina; Kopra, Outi] Univ Helsinki, Dept Med Genet, Helsinki, Finland; [Manninen, Otto; Tegelberg, Saara; Lehesjoki, Anna-Elina; Kopra, Outi] Univ Helsinki, Res Programs Unit, Haartman Inst, Helsinki, Finland; [Manninen, Otto; Tegelberg, Saara; Lehesjoki, Anna-Elina; Kopra, Outi] Univ Helsinki, Neurosci Ctr, Helsinki, Finland; [Laitinen, Teemu; Lehtimaki, Kimmo K.; Grohn, Olli] Univ Eastern Finland, Dept Neurobiol, AI Virtanen Inst Mol Sci, Kuopio, Finland	University of Helsinki; University of Helsinki; University of Helsinki; University of Eastern Finland	Manninen, O (corresponding author), Folkhalsan Inst Genet, Helsinki, Finland.	otto.manninen@helsinki.fi	Lehtimäki, Kimmo K/A-6018-2009	Lehtimäki, Kimmo K/0000-0003-2750-8229	Folkhalsan Research Foundation; Sigrid Juselius Foundation; Academy of Finland [137950]; Finnish Brain Foundation; Finnish Foundation for Epilepsy research; UEF Brain strategic funding from the University of Eastern Finland	Folkhalsan Research Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland); Finnish Brain Foundation; Finnish Foundation for Epilepsy research; UEF Brain strategic funding from the University of Eastern Finland	This study was funded by the Folkhalsan Research Foundation, the Sigrid Juselius Foundation (http://www.sigridjuselius.fi/foundation) and the Academy of Finland (grant # 137950) (http://www.aka.fi/en-GB/A/), the Finnish Brain Foundation (http://www.aivosaatio.fi/), Finnish Foundation for Epilepsy research (http://www.epilepsia.fi/epilepsiatutkimussaatio/), Oskar O " flund Foundation (http://www.oskaroflund.fi/) and UEF Brain strategic funding from the University of Eastern Finland (http://www.uef.fi/en/home). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buzzi A, 2012, NEUROBIOL DIS, V47, P216, DOI 10.1016/j.nbd.2012.04.005; Canafoglia L, 2012, EPILEPSIA, V53, P2120, DOI 10.1111/j.1528-1167.2012.03718.x; Chahboune H, 2007, NMR BIOMED, V20, P375, DOI 10.1002/nbm.1130; Chew NK, 2008, MOVEMENT DISORD, V23, P107, DOI 10.1002/mds.21812; Cohen NR, 2011, ACTA NEUROPATHOL, V121, P421, DOI 10.1007/s00401-010-0738-2; Danner N, 2013, MOVEMENT DISORD, V28, P1860, DOI 10.1002/mds.25615; ELDRIDGE R, 1983, LANCET, V2, P838, DOI 10.1016/s0140-6736(83)90749-3; Erdinc OO, 2010, J NEUROL SCI-TURK, V27, P1; Franceschetti S, 2007, NEUROBIOL DIS, V25, P675, DOI 10.1016/j.nbd.2006.11.006; HALTIA M, 1969, ACTA NEUROL SCAND, V45, P63; Houseweart MK, 2003, J NEUROBIOL, V56, P315, DOI 10.1002/neu.10253; Joensuu T, 2014, PLOS ONE IN PRESS; Joensuu T, 2007, EUR J HUM GENET, V15, P185, DOI 10.1038/sj.ejhg.5201723; Kalviainen R, 2008, EPILEPSIA, V49, P549, DOI 10.1111/j.1528-1167.2008.01546.x; Korja M, 2007, EPILEPSIA, V48, P1768, DOI 10.1111/j.1528-1167.2007.01118.x; Koskenkorva P, 2009, NEUROLOGY, V73, P606, DOI 10.1212/WNL.0b013e3181b3888b; KOSKINIEMI M, 1974, ACTA NEUROL SCAND, V50, P307; Lalioti MD, 1997, NAT GENET, V17, P17, DOI 10.1038/ng0997-17; Larvaron P, 2007, NMR BIOMED, V20, P413, DOI 10.1002/nbm.1082; Lehtinen MK, 2009, J NEUROSCI, V29, P5910, DOI 10.1523/JNEUROSCI.0682-09.2009; Lieuallen K, 2001, HUM MOL GENET, V10, P1867, DOI 10.1093/hmg/10.18.1867; Ma J, 2007, NEUROCHEM RES, V32, P311, DOI 10.1007/s11064-006-9183-y; Manninen O, 2013, RADIOLOGY, V269, P232, DOI 10.1148/radiol.13122458; Mascalchi M, 2002, NEUROLOGY, V58, P1686, DOI 10.1212/WNL.58.11.1686; MERVAALA E, 1986, EPILEPSIA, V27, P542, DOI 10.1111/j.1528-1157.1986.tb03581.x; MERVAALA E, 1984, J NEUROL SCI, V64, P131, DOI 10.1016/0022-510X(84)90031-5; Parmeggiani A, 1997, EPILEPSIA, V38, P637, DOI 10.1111/j.1528-1157.1997.tb01232.x; Paxinos G, 2007, MOUSE BRAIN STEREOTA; Pennacchio LA, 1998, NAT GENET, V20, P251, DOI 10.1038/3059; Pennacchio LA, 1996, GENOME RES, V6, P1103, DOI 10.1101/gr.6.11.1103; Pinto E, 2012, EPILEPSY RES, V99, P187, DOI 10.1016/j.eplepsyres.2011.11.004; Prinz M, 2011, GLIA, V59, P177, DOI 10.1002/glia.21104; Rinne R, 2002, ANN MED, V34, P380, DOI 10.1080/078538902320772124; Santoshkumar B, 2008, PEDIATR NEUROL, V38, P252, DOI 10.1016/j.pediatrneurol.2007.11.006; Shannon P, 2002, J NEUROPATH EXP NEUR, V61, P1085, DOI 10.1093/jnen/61.12.1085; Sierra A, 2011, BRAIN STRUCT FUNCT, V216, P123, DOI 10.1007/s00429-010-0299-0; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Tegelberg S, 2012, J NEUROPATH EXP NEUR, V71, P40, DOI 10.1097/NEN.0b013e31823e68e1; Verma R, 2005, P NATL ACAD SCI USA, V102, P6978, DOI 10.1073/pnas.0407828102	39	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90709	10.1371/journal.pone.0090709	http://dx.doi.org/10.1371/journal.pone.0090709			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603771	Green Published, gold, Green Submitted			2022-12-27	WOS:000332483600074
J	Sutton, JE; Buset, M; Keller, M				Sutton, Jennifer E.; Buset, Melanie; Keller, Mikayla			Navigation Experience and Mental Representations of the Environment: Do Pilots Build Better Cognitive Maps?	PLOS ONE			English	Article							SPATIAL ABILITIES; INDIVIDUAL-DIFFERENCES; TAXI DRIVERS; KNOWLEDGE	A number of careers involve tasks that place demands on spatial cognition, but it is still unclear how and whether skills acquired in such applied experiences transfer to other spatial tasks. The current study investigated the association between pilot training and the ability to form a mental survey representation, or cognitive map, of a novel, ground-based, virtual environment. Undergraduate students who were engaged in general aviation pilot training and controls matched to the pilots on gender and video game usage freely explored a virtual town. Subsequently, participants performed a direction estimation task that tested the accuracy of their cognitive map representation of the town. In addition, participants completed the Object Perspective Test and rated their spatial abilities. Pilots were significantly more accurate than controls at estimating directions but did not differ from controls on the Object Perspective Test. Locations in the town were visited at a similar rate by the two groups, indicating that controls' relatively lower accuracy was not due to failure to fully explore the town. Pilots' superior performance is likely due to better online cognitive processing during exploration, suggesting the spatial updating they engage in during flight transfers to a non-aviation context.	[Sutton, Jennifer E.; Buset, Melanie; Keller, Mikayla] Brescia Univ Coll, Dept Psychol, London, ON, Canada	Western University (University of Western Ontario)	Sutton, JE (corresponding author), Brescia Univ Coll, Dept Psychol, London, ON, Canada.	jennifer.sutton@uwo.ca			Brescia University College	Brescia University College	Funding for this research was provided by a grant from Brescia University College. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen GL, 1996, INTELLIGENCE, V22, P327, DOI 10.1016/S0160-2896(96)90026-4; ARETZ AJ, 1991, HUM FACTORS, V33, P85, DOI 10.1177/001872089103300107; Bennett ATD, 1996, J EXP BIOL, V199, P219; Blade MF, 1955, PSYCHOL MONOGR-GEN A, V69, P1; Carretta TR, 2000, AFRLHEWPTR20000116 D; Casner S.M., 2005, INT J APPL AVIAT STU, V5, P153; Chen XL, 2011, PSYCHON B REV, V18, P985, DOI 10.3758/s13423-011-0134-5; DROR IE, 1993, J APPL PSYCHOL, V78, P763, DOI 10.1037/0021-9010.78.5.763; Golledge RG, 1999, WAYFINDING BEHAVIOR, P5; Hegarty M, 2006, INTELLIGENCE, V34, P151, DOI 10.1016/j.intell.2005.09.005; Hegarty M, 2004, INTELLIGENCE, V32, P175, DOI 10.1016/j.intell.2003.12.001; Hegarty M, 2002, INTELLIGENCE, V30, P425, DOI 10.1016/S0160-2896(02)00116-2; Hegarty M, 2009, LEARN INDIVID DIFFER, V19, P61, DOI 10.1016/j.lindif.2008.04.006; Ishikawa T, 2006, COGNITIVE PSYCHOL, V52, P93, DOI 10.1016/j.cogpsych.2005.08.003; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; Maguire EA, 2006, HIPPOCAMPUS, V16, P1091, DOI 10.1002/hipo.20233; Montello DR, 2004, HUMAN SPATIAL MEMORY: REMEMBERING WHERE, P251; Montello DR, 2005, CAMBRIDGE HDB VISUOS, P257, DOI DOI 10.1017/CBO9780511610448.008; Montello DR, 1998, SPATIAL TEMPORAL REA, P143, DOI DOI 10.1088/1748-6041/6/2/025001; National Transportation Safety Board, 2010, NTSBSS1001; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Siegel A W, 1975, Adv Child Dev Behav, V10, P9, DOI 10.1016/S0065-2407(08)60007-5; Spence I, 2010, REV GEN PSYCHOL, V14, P92, DOI 10.1037/a0019491; TOLMAN EC, 1948, PSYCHOL REV, V55, P189, DOI 10.1037/h0061626; Transport Canada, 2012, CAN AV REG 4; United States Department of Transportation Federal Aviation Administration, 2008, FAAH808325A US DEP T; Uttal DH, 2013, PSYCHOL BULL, V139, P352, DOI 10.1037/a0028446; Wolbers T, 2005, J NEUROSCI, V25, P3333, DOI 10.1523/JNEUROSCI.4705-04.2005; Wolbers T, 2010, TRENDS COGN SCI, V14, P138, DOI 10.1016/j.tics.2010.01.001; Woollett K, 2011, CURR BIOL, V21, P2109, DOI 10.1016/j.cub.2011.11.018; Woollett K, 2010, J ENVIRON PSYCHOL, V30, P565, DOI 10.1016/j.jenvp.2010.03.003	31	10	10	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90058	10.1371/journal.pone.0090058	http://dx.doi.org/10.1371/journal.pone.0090058			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC4ID	24603608	gold, Green Published, Green Submitted			2022-12-27	WOS:000332483600027
J	Yeh, KW; Lee, CM; Chang, CJ; Lin, YJ; Huang, JL				Yeh, Kuo-Wei; Lee, Chi-Ming; Chang, Chee-Jen; Lin, Yu-Jr; Huang, Jing-Long			Lipid Profiles Alter from Pro-Atherogenic into Less Atherogenic and Proinflammatory in Juvenile Idiopathic Arthritis Patients Responding to Anti TNF-alpha Treatment	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; ACTIVE RHEUMATOID-ARTHRITIS; CARDIOVASCULAR-DISEASE; RISK-FACTORS; ETANERCEPT; PLASMA; ASSOCIATION; CHILDREN; THERAPY; SAFETY	Objective: Dyslipidemia with higher inflammatory states, disease activity, and longer disease duration in juvenile idiopathic arthritis (JIA) patients seemed to increase the risks of atherosclerosis. Tumor necrosis factor-alpha (TNF-alpha) receptor blocking agent etanercept has been proven to be effective in JIA. However, data about the correlation of anti-inflammatory treatment on lipid profiles and atherogenic index in JIA patients remains limited. This study aimed to investigate the longitudinal changes on lipid profiles and atherogenic index in JIA patients after etanercept treatment. Methods: Twenty-three patients diagnosed with JIA (polyarticular type n = 7; oligoarticular type, n = 2; systemic type, n = 10, Enthesitis-related arthritis = 4) received treatment with etanercept during the period 2004-012 in a medical center. We measured their serum lipid profiles at baseline and 2, 4, 6, 12 months later, and determined whether there were differences in complete blood counts, inflammatory mediators, lipid levels and atherogenic indices between patients who had inactive disease (responders) and those who were poor responders (non-responders) to etanercept treatment. Results: Analysis of dynamic change in total JIA patients before and after TNF inhibitor therapy showed modest increases in hemoglobin levels (P = 0.02) and decreases in WBC counts, Platelet and CRP levels progressively (p = 0.002, p = 0.006 and p = 0.006, respectively). Twelve of the 23 patients achieved inactive disease status (responders) after 12-months of treatment. In responders, compared to non-responders, total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C) and high-density lipoprotein cholesterol (HDL-C) increased significantly (P = 0.007, P = 0.044, P<0.001), whereas triglyceride and atherogenic index (TC/HDL-C ratio) significantly decreased (P = 0.04, P = 0.01, respectively) after etanercept treatment. Conclusion: Disease severity was associated with triglyceride level, atherogenic index and was inversely associated with total cholesterol, HDL-C, and LDL-C levels and can be improved substantially by using anti TNF-alpha treatment. Such treatment may have a beneficial effect on the cardiovascular risk in patients with JIA.	[Yeh, Kuo-Wei; Lee, Chi-Ming; Huang, Jing-Long] Chang Gung Mem Hosp Linkou, Dept Pediat, Div Allergy Asthma & Rheumatol, Tao Yuan, Taiwan; [Yeh, Kuo-Wei; Lee, Chi-Ming; Huang, Jing-Long] Chang Gung Univ, Tao Yuan, Taiwan; [Chang, Chee-Jen] Chang Gung Univ, Grad Inst Clin Med Sci, Tao Yuan, Taiwan; [Chang, Chee-Jen; Lin, Yu-Jr] Chang Gung Mem Hosp Linkuo, Biostat Ctr Clin Res, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital	Huang, JL (corresponding author), Chang Gung Mem Hosp Linkou, Dept Pediat, Div Allergy Asthma & Rheumatol, Tao Yuan, Taiwan.	long@adm.cgmh.org.tw	Yeh, Kuo-Wei/V-3725-2019	Huang, Jing-Long/0000-0001-9280-920X; Chang, Chee Jen/0000-0002-7725-7555; Huang, Jing-Long/0000-0002-3530-7753	Chang Gung Memorial Hospital	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This study was supported by a research grant from Chang Gung Memorial Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no grant or additional financial support from pharmaceutical accepted to perform the study.	Bakkaloglu A, 1996, CLIN RHEUMATOL, V15, P341, DOI 10.1007/BF02230355; BALLANTYNE CM, 2000, J CLIN ENDOCR METAB, V85, P2089; Beukelman T, 2011, ARTHRIT CARE RES, V63, P465, DOI 10.1002/acr.20460; DELEURAN BW, 1992, ARTHRITIS RHEUM, V35, P1170, DOI 10.1002/art.1780351009; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Garrison L, 1999, ANN RHEUM DIS, V58, P65, DOI 10.1136/ard.58.2008.i65; Goncalves Marcela, 2007, Pediatr Rheumatol Online J, V5, P2, DOI 10.1186/1546-0096-5-2; Hokanson J E, 1996, J Cardiovasc Risk, V3, P213, DOI 10.1097/00043798-199604000-00014; Horneff G, 2009, ANN RHEUM DIS, V68, P519, DOI 10.1136/ard.2007.087593; Huang Jing-Long, 2012, Chang Gung Med J, V35, P1; ILOWITE NT, 1989, J PEDIATR-US, V114, P823, DOI 10.1016/S0022-3476(89)80148-9; Jamnitski A, 2010, ANN RHEUM DIS, V69, P1929, DOI 10.1136/ard.2009.127597; Kaplan MJ, 2009, NAT REV RHEUMATOL, V5, P208, DOI 10.1038/nrrheum.2009.29; Marangoni RG, 2011, CLINICS, V66, P1549, DOI 10.1590/S1807-59322011000900007; Millan J, 2009, VASC HEALTH RISK MAN, V5, P757; Naranjo A, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2383; Otten MH, 2011, JAMA-J AM MED ASSOC, V306, P2340, DOI 10.1001/jama.2011.1671; Petty RE, 2004, J RHEUMATOL, V31, P390; Petty Ross E., 1998, Journal of Rheumatology, V25, P1991; Popa C, 2005, ANN RHEUM DIS, V64, P303, DOI 10.1136/ard.2004.023119; Popa C, 2007, ANN RHEUM DIS, V66, P1503, DOI 10.1136/ard.2006.066191; Prakken B, 2011, LANCET, V377, P2138, DOI 10.1016/S0140-6736(11)60244-4; Rodriguez-Moran M, 2013, DIABETES VASC DIS RE, V10, P17, DOI 10.1177/1479164112440713; Shen CC, 2013, SEMIN ARTHRITIS RHEU, V42, P590, DOI 10.1016/j.semarthrit.2012.10.002; Tselepis AD, 1999, ARTHRITIS RHEUM-US, V42, P373, DOI 10.1002/1529-0131(199902)42:2<373::AID-ANR21>3.0.CO;2-3; Twisk JWR, 2004, EUR J EPIDEMIOL, V19, P769, DOI 10.1023/B:EJEP.0000036572.00663.f2; van Eijk IC, 2009, ARTHRITIS RHEUM-US, V60, P1324, DOI 10.1002/art.24492; Vermont CL, 2005, CRIT CARE MED, V33, P1610, DOI 10.1097/01.CCM.0000171272.50888.AD; Wallace CA, 2004, J RHEUMATOL, V31, P2290; Woo P, 1998, BAILLIERE CLIN RHEUM, V12, P219, DOI 10.1016/S0950-3579(98)80016-2; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	31	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90757	10.1371/journal.pone.0090757	http://dx.doi.org/10.1371/journal.pone.0090757			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603504	Green Published, Green Submitted, gold			2022-12-27	WOS:000332483600082
J	Yeste, M; Estrada, E; del Alamo, MMR; Bonet, S; Rigau, T; Rodriguez-Gil, JE				Yeste, Marc; Estrada, Efren; Rivera del Alamo, Maria-Montserat; Bonet, Sergi; Rigau, Teresa; Rodriguez-Gil, Joan-Enric			The Increase in Phosphorylation Levels of Serine Residues of Protein HSP70 during Holding Time at 17 degrees C Is Concomitant with a Higher Cryotolerance of Boar Spermatozoa	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; THAWING INDUCES ALTERATIONS; SPERM DNA FRAGMENTATION; PLASMA-MEMBRANE; FLOW-CYTOMETRY; HEAT-SHOCK-PROTEIN-70 HSP-70; NUCLEOPROTEIN STRUCTURE; MAMMALIAN SPERMATOZOA; REDUCED GLUTATHIONE; BOVINE SPERMATOZOA	Boar-sperm cryopreservation is not usually performed immediately after semen collection, but rather a holding time (HT) of 4 h-30 h at 17 degrees C is spent before starting this procedure. Taking this into account, the aim of this study was to go further in-depth into the mechanisms underlying the improving effects of HT at 17 degrees C on boar-sperm cryotolerance by evaluating the effects of two different HTs (3 h and 24 h) on overall boar-sperm function and survival before and after cryopreservation. Given that phospho/dephosphorylation mechanisms are of utmost importance in the overall regulation of sperm function, the phosphorylation levels of serine residues (pSer) in 30 different sperm proteins after a 3 h-or 24 h-HT period were also assessed. We found that a HT of 24 h contributed to a higher sperm resistance to freeze-thawing procedures, whereas mini-array protein analyses showed that a HT of 24 h induced a significant (P<0.05) increase in pSer (from 100.0 +/- 1.8 arbitrary units in HT 3 h to 150.2 +/- 5.1 arbitrary units in HT 24 h) of HSP70 and, to a lesser extent, in protein kinases GSK3 and total TRK and in the cell-cycle regulatory protein CDC2/CDK1. In the case of HSP70, this increase was confirmed through immunoprecipation analyses. Principal component and multiple regression analyses indicated that a component explaining a percentage of variance higher than 50% in sperm cryotolerance was significantly correlated with pSer levels in HSP70. In addition, from all the parameters evaluated before freeze-thawing, only pSer levels in HSP70 resulted to be able to predict sperm cryotolerance. In conclusion, our results suggest that boar spermatozoa modulate its function during HT, at least partially, by changes in pSer levels of proteins like HSP70, and this is related to a higher cryotolerance.	[Yeste, Marc; Estrada, Efren; Rivera del Alamo, Maria-Montserat; Rigau, Teresa; Rodriguez-Gil, Joan-Enric] Autonomous Univ Barcelona, Fac Vet Med, Dept Anim Med & Surg, Unit Anim Reprod, Barcelona, Spain; [Bonet, Sergi] Univ Girona, Inst Food & Agr Technol, Dept Biol, TechnoSperm, Girona, Spain	Autonomous University of Barcelona; Universitat de Girona	Yeste, M (corresponding author), Autonomous Univ Barcelona, Fac Vet Med, Dept Anim Med & Surg, Unit Anim Reprod, Barcelona, Spain.	marc.yeste@uab.cat	Bonet, Sergi/AAA-9768-2020; Yeste, Marc/G-5945-2012; Bonet, Sergi/P-5026-2015; Rodriguez-Gil, Joan E./F-8748-2016	Bonet, Sergi/0000-0002-5125-7274; Yeste, Marc/0000-0002-2209-340X; Bonet, Sergi/0000-0002-5125-7274; Rodriguez-Gil, Joan E./0000-0002-1112-9884; Rigau Mas, Teresa/0000-0002-2688-0275	Spanish Ministry of Economy and Competitivity [AGL-2008-01792GAN]; Post-doctoral JdC fellowship [JCI-2010-08620]	Spanish Ministry of Economy and Competitivity(Spanish Government); Post-doctoral JdC fellowship	This research has been supported by Project AGL-2008-01792GAN of the Spanish Ministry of Economy and Competitivity and by Post-doctoral JdC fellowship (JCI-2010-08620) granted to Marc Yeste. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aparicio IM, 2007, REPRODUCTION, V134, P435, DOI 10.1530/REP-06-0388; Aquila S, 2004, J CLIN ENDOCR METAB, V89, P1443, DOI 10.1210/jc.2003-031681; Ball BA, 2001, AM J VET RES, V62, P508, DOI 10.2460/ajvr.2001.62.508; Baumber J, 2003, J ANDROL, V24, P621; Bilodeau JF, 2000, MOL REPROD DEV, V55, P282, DOI 10.1002/(SICI)1098-2795(200003)55:3&lt;282::AID-MRD6&gt;3.0.CO;2-7; Bohring C, 2001, MOL HUM REPROD, V7, P113, DOI 10.1093/molehr/7.2.113; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Breitbart H, 1999, REV REPROD, V4, P151; Casas I, 2010, THERIOGENOLOGY, V74, P940, DOI 10.1016/j.theriogenology.2010.04.021; Casas I, 2009, THERIOGENOLOGY, V72, P930, DOI 10.1016/j.theriogenology.2009.07.001; Cole JA, 2011, J ANDROL, V32, P402, DOI 10.2164/jandrol.110.010702; de Lamirande E, 2002, MOL HUM REPROD, V8, P124, DOI 10.1093/molehr/8.2.124; Dun MD, 2012, HUM REPROD UPDATE, V18, P420, DOI 10.1093/humupd/dms009; Enciso M, 2006, THERIOGENOLOGY, V65, P308, DOI 10.1016/j.theriogenology.2005.05.044; Erata GO, 2008, FERTIL STERIL, V90, P322, DOI 10.1016/j.fertnstert.2007.06.021; Eriksson BM, 2001, THERIOGENOLOGY, V55, P1593, DOI 10.1016/S0093-691X(01)00505-2; Estrada E, 2014, ANDROLOGY-US, V2, P88, DOI 10.1111/j.2047-2927.2013.00144.x; Fernandez-Novell JM, 2011, REPROD FERT DEVELOP, V23, P468, DOI 10.1071/RD10120; Flesch FM, 2000, BBA-REV BIOMEMBRANES, V1469, P197, DOI 10.1016/S0304-4157(00)00018-6; Flores E, 2008, THERIOGENOLOGY, V69, P1083, DOI 10.1016/j.theriogenology.2008.01.022; Flores E, 2011, THERIOGENOLOGY, V76, P1450, DOI 10.1016/j.theriogenology.2011.05.039; Fraser L, 2010, REPROD DOMEST ANIM, V45, pE155, DOI 10.1111/j.1439-0531.2009.01537.x; GARNER DL, 1995, BIOL REPROD, V53, P276, DOI 10.1095/biolreprod53.2.276; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; Grunewald S, 2005, ARCH ANDROLOGY, V51, P449, DOI 10.1080/014850190947813; Guthrie HD, 2006, J ANIM SCI, V84, P2089, DOI 10.2527/jas.2005-766; Guthrie HD, 2005, THERIOGENOLOGY, V63, P396, DOI 10.1016/j.theriogenology.2004.09.020; Harrison RAP, 2004, MOL REPROD DEV, V67, P337, DOI 10.1002/mrd.20028; Harrison RAP, 1996, MOL REPROD DEV, V45, P378, DOI 10.1002/(SICI)1098-2795(199611)45:3&lt;378::AID-MRD16&gt;3.0.CO;2-V; Huang SY, 2000, ANIM REPROD SCI, V63, P231, DOI 10.1016/S0378-4320(00)00175-5; Ibrahim NM, 2000, J ANDROL, V21, P887; Ibrahim NM, 2001, J ANDROL, V22, P863; Jha KN, 2006, MOL HUM REPROD, V12, P781, DOI 10.1093/molehr/gal085; Johnson LA, 2000, ANIM REPROD SCI, V62, P143, DOI 10.1016/S0378-4320(00)00157-3; Jungnickel MK, 2007, DEV BIOL, V304, P116, DOI 10.1016/j.ydbio.2006.12.023; Kadirvel G, 2009, ANIM REPROD SCI, V116, P244, DOI 10.1016/j.anireprosci.2009.02.003; Kim SH, 2010, THERIOGENOLOGY, V73, P282, DOI 10.1016/j.theriogenology.2009.09.011; Kim S, 2011, ANIM REPROD SCI, V124, P118, DOI 10.1016/j.anireprosci.2011.01.014; KotziasBandeira E, 1997, DEUT TIERARZTL WOCH, V104, P302; Lee JA, 2008, CYTOM PART A, V73A, P926, DOI 10.1002/cyto.a.20623; Linke K, 2003, ANTIOXID REDOX SIGN, V5, P425, DOI 10.1089/152308603768295168; Martin G, 2007, HUM REPROD, V22, P380, DOI 10.1093/humrep/del399; Matwee C, 2001, MOL HUM REPROD, V7, P829, DOI 10.1093/molehr/7.9.829; Muino-Blanco T, 2008, REPROD DOMEST ANIM, V43, P18, DOI 10.1111/j.1439-0531.2008.01228.x; Naaby-Hansen S, 2010, J REPROD IMMUNOL, V84, P32, DOI 10.1016/j.jri.2009.09.006; Nagy S, 2003, BIOL REPROD, V68, P1828, DOI 10.1095/biolreprod.102.011445; Naz Rajesh K, 2004, Reprod Biol Endocrinol, V2, P75, DOI 10.1186/1477-7827-2-75; NAZ RK, 1994, MOL REPROD DEV, V39, P397; NAZ RK, 1993, BIOL REPROD, V48, P720, DOI 10.1095/biolreprod48.4.720; Oliva R, 2006, HUM REPROD UPDATE, V12, P417, DOI 10.1093/humupd/dml009; Paasch U, 2004, FERTIL STERIL, V81, P802, DOI 10.1016/j.fertnstert.2003.09.030; Petrunkina AM, 2010, THERIOGENOLOGY, V73, P995, DOI 10.1016/j.theriogenology.2009.12.006; PURSEL VG, 1975, J ANIM SCI, V40, P99, DOI 10.2527/jas1975.40199x; Rath D, 2009, Soc Reprod Fertil Suppl, V66, P51; Silva PFN, 2006, THERIOGENOLOGY, V65, P958, DOI 10.1016/j.theriogenology.2005.09.010; Spinaci M, 2005, MOL REPROD DEV, V72, P534, DOI 10.1002/mrd.20367; Suzuki T, 2010, REPRODUCTION, V139, P847, DOI 10.1530/REP-08-0366; TAMULI MK, 1994, VET REC, V135, P160, DOI 10.1136/vr.135.7.160; Tardif S, 2001, BIOL REPROD, V65, P784, DOI 10.1095/biolreprod65.3.784; Thundathil J, 2002, MOL HUM REPROD, V8, P811, DOI 10.1093/molehr/8.9.811; Travert C, 2009, GYNECOL OBSTET FERTI, V37, P523, DOI 10.1016/j.gyobfe.2009.04.004; Urner F, 2003, REPRODUCTION, V125, P17, DOI 10.1530/rep.0.1250017; Vallorani C, 2010, ANIM REPROD SCI, V122, P58, DOI 10.1016/j.anireprosci.2010.07.007; Vijayaraghavan Srinivasan, 2007, Soc Reprod Fertil Suppl, V63, P111; Visconti PE, 2009, P NATL ACAD SCI USA, V106, P667, DOI 10.1073/pnas.0811895106; Volpe S, 2008, REPROD DOMEST ANIM, V43, P385, DOI 10.1111/j.1439-0531.2007.00918.x; Westendorf P, 1975, Dtsch Tierarztl Wochenschr, V82, P261; Yeste M, 2008, ANIM REPROD SCI, V108, P180, DOI 10.1016/j.anireprosci.2007.08.008; Yeste M, 2013, REPROD FERT DEVELOP, V25, P1036, DOI 10.1071/RD12230; Yeste M, 2013, THERIOGENOLOGY, V79, P929, DOI 10.1016/j.theriogenology.2013.01.008; Yeste M, 2010, ANIM REPROD SCI, V119, P265, DOI 10.1016/j.anireprosci.2010.02.011	71	52	57	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90887	10.1371/journal.pone.0090887	http://dx.doi.org/10.1371/journal.pone.0090887			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603527	Green Published, gold, Green Submitted			2022-12-27	WOS:000332483600101
J	Cotoia, A; Scrima, R; Gefter, JV; Piccoli, C; Cinnella, G; Dambrosio, M; Fink, MP; Capitanio, N				Cotoia, Antonella; Scrima, Rosella; Gefter, Julia V.; Piccoli, Claudia; Cinnella, Gilda; Dambrosio, Michele; Fink, Mitchell P.; Capitanio, Nazzareno			p-Hydroxyphenylpyruvate, an Intermediate of the Phe/Tyr Catabolism, Improves Mitochondrial Oxidative Metabolism under Stressing Conditions and Prolongs Survival in Rats Subjected to Profound Hemorrhagic Shock	PLOS ONE			English	Article							RINGERS ETHYL PYRUVATE; FLUID RESUSCITATION; VOLUME; MODEL; METHYL-2-ACETAMIDOACRYLATE; ACID	The aim of this study was to test the effect of a small volume administration of p-hydroxyphenylpyruvate (pHPP) in a rat model of profound hemorrhagic shock and to assess a possible metabolic mechanism of action of the compound. The results obtained show that hemorrhaged rats treated with 2-4% of the estimated blood volume of pHPP survived significantly longer (p<0.001) than rats treated with vehicle. In vitro analysis on cultured EA.hy 926 cells demonstrated that pHPP improved cell growth rate and promoted cell survival under stressing conditions. Moreover, pHPP stimulated mitochondria-related respiration under ATP-synthesizing conditions and exhibited antioxidant activity toward mitochondria-generated reactive oxygen species. The compound effects reported in the in vitro and in vivo analyses were obtained in the same millimolar concentration range. These data disclose pHPP as an efficient energetic substrates-supplier to the mitochondrial respiratory chain as well as an antioxidant supporting the view that the compound warrants further evaluation as a therapeutic agent.	[Cotoia, Antonella; Cinnella, Gilda; Dambrosio, Michele] Univ Foggia, Dept Med & Surg Sci, Foggia, Italy; [Scrima, Rosella; Piccoli, Claudia; Capitanio, Nazzareno] Univ Foggia, Dept Clin & Expt Med, Foggia, Italy; [Gefter, Julia V.] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA USA; [Fink, Mitchell P.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Surg & Anesthesiol, Los Angeles, CA 90095 USA	University of Foggia; University of Foggia; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Capitanio, N (corresponding author), Univ Foggia, Dept Clin & Expt Med, Foggia, Italy.	nazzareno.capitanio@unifg.it	Cinnella, Gilda/O-2987-2016	Cinnella, Gilda/0000-0001-9864-2893; Cotoia, Antonella/0000-0002-0154-0418	Defense Advanced Research Projects Agency (DARPA), University of Pittsburgh, USA; Departments of Anesthesiology and Clinical and Experimental Medicine, University of Foggia, Italy	Defense Advanced Research Projects Agency (DARPA), University of Pittsburgh, USA; Departments of Anesthesiology and Clinical and Experimental Medicine, University of Foggia, Italy	This study was financed by Defense Advanced Research Projects Agency (DARPA), University of Pittsburgh, USA, and by local grants of the Departments of Anesthesiology and Clinical and Experimental Medicine, University of Foggia, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett-Guerrero E, 2009, J CARDIOTHOR VASC AN, V23, P324, DOI 10.1053/j.jvca.2008.08.005; Cairns C B, 2001, Curr Opin Crit Care, V7, P437, DOI 10.1097/00075198-200112000-00011; Cotton BA, 2011, J TRAUMA, V70, pS30, DOI [10.1097/TA.0b013e31821a55a, 10.1097/TA.0b013e31821a55af]; DICKSON AJ, 1981, FEBS LETT, V127, P28, DOI 10.1016/0014-5793(81)80333-X; Dubick MA, 2003, J TRAUMA, V54, pS43, DOI 10.1097/01.TA.0000064514.42470.3B; Famili A, 2013, MOL VIS, V19, P1304; Fink MP, 2007, CRIT CARE MED, V35, pS461, DOI 10.1097/01.CCM.0000279192.96303.E7; Graham J M, 2001, Curr Protoc Cell Biol, VChapter 3, DOI [10.1002/0471143030.cb0303s04, 10.1002/0471143030.cb0305s06, 10.1002/0471143030.cb0304s04]; Kao KK, 2010, BIOCHEM PHARMACOL, V80, P151, DOI 10.1016/j.bcp.2010.03.007; Kaufman S, 1999, P NATL ACAD SCI USA, V96, P3160, DOI 10.1073/pnas.96.6.3160; Kauvar DS, 2006, J TRAUMA, V60, pS3, DOI 10.1097/01.ta.0000199961.02677.19; Ke N, 2011, METHODS MOL BIOL, V740, P33, DOI 10.1007/978-1-61779-108-6_6; Kim SW, 2011, MOL PHARMACOL, V79, P220, DOI 10.1124/mol.110.067520; Kuznetsov AV, 2011, ANAL BIOANAL CHEM, V400, P2383, DOI 10.1007/s00216-011-4764-2; Lantum HBM, 2003, TOXICOL SCI, V74, P192, DOI 10.1093/toxsci/kfg104; Leelahavanichkul A, 2008, AM J PHYSIOL-RENAL, V295, pF1825, DOI 10.1152/ajprenal.90442.2008; Macias CA, 2005, CRIT CARE MED, V33, pA32, DOI 10.1097/00003246-200512002-00122; Macias CA, 2007, ANN SURG, V245, P305, DOI 10.1097/01.sla.0000236626.57752.8e; McSwain NE, 2011, J TRAUMA, V70, pS2, DOI 10.1097/TA.0b013e31821b201d; Mulier KE, 2005, SHOCK, V23, P248, DOI 10.1097/01.shk.0000153353.58341.ff; OWENS TM, 1995, J TRAUMA, V39, P200, DOI 10.1097/00005373-199508000-00004; PEITZMAN AB, 1995, CURR PROB SURG, V32, P930; Probst RJ, 2006, J AM ASSOC LAB ANIM, V45, P49; Riddez L, 2002, SHOCK, V17, P377, DOI 10.1097/00024382-200205000-00006; Robinson KM, 2006, P NATL ACAD SCI USA, V103, P15038, DOI 10.1073/pnas.0601945103; Sappington PL, 2005, BIOCHEM PHARMACOL, V70, P1579, DOI 10.1016/j.bcp.2005.08.015; Shah KJ, 2002, SHOCK, V18, P242, DOI 10.1097/00024382-200209000-00007; Tawadrous ZS, 2002, SHOCK, V17, P473, DOI 10.1097/00024382-200206000-00006; Taylor JH, 2004, SHOCK, V21, P58, DOI 10.1097/01.shk.0000101674.49265.93; Varma SD, 1998, FREE RADICAL RES, V28, P131, DOI 10.3109/10715769809065799; Yang R, 2002, AM J PHYSIOL-REG I, V283, pR1263, DOI 10.1152/ajpregu.00278.2002	31	9	10	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90917	10.1371/journal.pone.0090917	http://dx.doi.org/10.1371/journal.pone.0090917			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599095	Green Published, Green Accepted, gold			2022-12-27	WOS:000332479400145
J	Tu, XB; Li, ZH; Wang, J; Huang, XB; Yang, JW; Fan, CB; Wu, HH; Wang, QL; Zhang, ZH				Tu, Xiongbing; Li, Zhihong; Wang, Jie; Huang, Xunbing; Yang, Jiwen; Fan, Chunbin; Wu, Huihui; Wang, Qinglei; Zhang, Zehua			Improving the Degree-Day Model for Forecasting Locusta migratoria manilensis (Meyen) (Orthoptera: Acridoidea)	PLOS ONE			English	Article							CALCULATING TEMPERATURE-DEPENDENCE; LONG-TIME PERIODS; GROWTH; COLEOPTERA; SURVIVAL; WEIGHT	The degree-day (DD) model is an important tool for forecasting pest phenology and voltinism. Unfortunately, the DD model is inaccurate, as is the case for the Oriental migratory locust. To improve the existing DD model for this pest, we first studied locust development in seven growth chambers, each of which simulated the complete growing-season climate of a specific region in China (Baiquan, Chengde, Tumotezuoqi, Wenan, Rongan, Qiongzhong, or Qiongshan). In these seven treatments, locusts completed 0.95, 1, 1.1, 2.2, 2.95, 3.95, and 4.95 generations, respectively. Hence, in the Baiquan (700), Rongan (2400), Qiongzhong (3200), and Qiongshan (2400) treatments, the final generation were unable to lay eggs. In a second experiment, we reared locusts for a full generation in growth chambers, at different constant temperatures. This experiment provided two important findings. First, temperatures between 32 and 42 degrees C did not influence locust development rate. Hence, the additional heat provided by temperatures above 32 degrees C did not add to the total heat units acquired by the insects, according to the traditional DD model. Instead, temperatures above 32 degrees C represent overflow heat, and can not be included when calculating total heat acquired during development. We also noted that females raised at constant 21 degrees C failed to oviposit. Hence, temperatures lower than 21 degrees C should be deducted when calculating total heat acquired during adult development. Using our experimental findings, we next micmiked 24-h temperature curve and constructed a new DD model based on a 24-h temperature integral calculation. We then compared our new model with the traditional DD model, results showed the DD deviation was 166 heat units in Langfang during 2011. At last we recalculated the heat by our new DD model, which better predicted the results from our first growth chamber experiment.	[Tu, Xiongbing; Wang, Jie; Huang, Xunbing; Wu, Huihui; Zhang, Zehua] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Tu, Xiongbing; Li, Zhihong] China Agr Univ, Coll Agron & Biotechnol, Dept Entomol, Beijing 100094, Peoples R China; [Yang, Jiwen; Fan, Chunbin] Tianjin Binhai New Area Dagang Agr Serv Ctr, Tianjin, Peoples R China; [Wang, Qinglei] Cangzhou Acad Agr & Forestry Sci Hebei, Cangzhou, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; China Agricultural University	Zhang, ZH (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.	lgbcc@263.net		Zehua, Zhang/0000-0002-0648-8954	earmarked fund for China Agriculture Research System [CARS-35-07]; Special Fund for Agro-scientific Research in the Public Interest [201003079]	earmarked fund for China Agriculture Research System; Special Fund for Agro-scientific Research in the Public Interest	This article was supported by the earmarked fund for China Agriculture Research System (CARS-35-07) and the Special Fund for Agro-scientific Research in the Public Interest, 201003079. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKONOR JB, 1988, INSECT SCI APPL, V9, P625, DOI 10.1017/S1742758400005117; ALLEN JC, 1976, ENVIRON ENTOMOL, V5, P388, DOI 10.1093/ee/5.3.388; [Anonymous], 1991, BIOL MIGRATORY LOCUS; Arnold CY, 1960, AM SOC HORTICULTURAL, V76, P682; BASKERVILLE GL, 1969, ECOLOGY, V50, P514, DOI 10.2307/1933912; BEGON M, 1983, ECOL ENTOMOL, V8, P361, DOI 10.1111/j.1365-2311.1983.tb00516.x; Briere JF, 1998, ENVIRON ENTOMOL, V27, P94, DOI 10.1093/ee/27.1.94; Chappell M.A., 1990, P143; Chen YL, 2007, MAIN LOCUST ECOLOGIC, P82; Chen Yong-Lin, 2000, Entomological Knowledge, V37, P50; Chown S.L., 2004, INSECT PHYSL ECOLOGY, DOI DOI 10.1002/joc.5086; Davidson J., 1942, AUSTRALIAN JOUR EXP BIOL AND MED SCI, V20, P233, DOI 10.1038/icb.1942.39; de Reaumur R, 1735, MEMOIRE ACAD SCI PAR; DUDLEY B., 1964, Transactions of the Royal Entomological Society of London, V116, P115; Eizenberg H, 2005, WEED SCI, V53, P37, DOI 10.1614/WS-04-018R1; Feng CH, 2011, PLANT PROTECTION THE, P68; Frouz J, 2002, J ECON ENTOMOL, V95, P699, DOI 10.1603/0022-0493-95.4.699; Hamilton A. G., 1950, Transactions of the Royal Entomological Society of London, V101, P1; HAMILTON ANDREW G., 1936, TRANS ROY ENT SOC LONDON, V85, P1; Heinrich B., 1993, HOT BLOODED INSECTS; HIGLEY LG, 1986, ENVIRON ENTOMOL, V15, P999, DOI 10.1093/ee/15.5.999; Jong G. de, 2009, Phenotypic plasticity of insects: mechanisms and consequences, P523; Kontodimas DC, 2004, ENVIRON ENTOMOL, V33, P1, DOI 10.1603/0046-225X-33.1.1; LIN YU, 1959, ACTA ENT SINICA, V9, P423; Lischke H, 1997, AGR FOREST METEOROL, V86, P169, DOI 10.1016/S0168-1923(97)00015-4; Lischke H, 1997, ECOL MODEL, V98, P105, DOI 10.1016/S0304-3800(96)01907-2; LUDWIG DANIEL, 1928, PHYSIOL ZOOL, V1, P358; MA S. C., 1958, ACTA ENT SINICA, V8, P1; Ma S.J, 1965, STUDY DISTRIBUTION M; Mohsen M, 2007, EUROPE J ENTOMOLOGY, V104, P631; Mu J. Y., 1987, Acta Phytophylactica Sinica, V14, P169; Nicholas M, 1949, J AM STAT ASSOC, V44, P335; Popov GB, 1959, ECOLOGY, V66, P1084; Pradhan S., 1945, Proceedings of the National Institute of Sciences of India, V11, P74; PRUESS KP, 1983, ENVIRON ENTOMOL, V12, P613, DOI 10.1093/ee/12.3.613; SCHOOLFIELD RM, 1981, J THEOR BIOL, V88, P719, DOI 10.1016/0022-5193(81)90246-0; Shi Pei-Jian, 2011, Chinese Journal of Applied Entomology, V48, P1149; Son Y, 2005, AGR FOREST ENTOMOL, V7, P201, DOI 10.1111/j.1461-9555.2005.00260.x; Stauffer Timothy W., 1997, P231; Tu XB, 2010, THESIS CHINESE ACAD; Tu Xiongbing, 2012, Journal of Orthoptera Research, V21, P133, DOI 10.1665/034.021.0201; UVAROV B. P., 1931, TRANS ENT SOC [LONDON], V79, P1; UVAROV B. P., 1936, Bulletin of Entomological Research, V27, P91, DOI 10.1017/S0007485300058144; Uvarov B. P., 1977, GRASSHOPPERS LOCUSTS, V2; Uvarov BP., 1966, GRASSHOPPERS LOCUSTS, V1; WAGNER TL, 1984, ANN ENTOMOL SOC AM, V77, P208, DOI 10.1093/aesa/77.2.208; WANG JY, 1960, ECOLOGY, V41, P785, DOI 10.2307/1931815; Watanabe N, 1981, DIS INSECT PEST OBSE, V2, P39; [徐兴奎 XU Xing-Kui], 2009, [生态学报, Acta Ecologica Sinica], V29, P6042; YANG V. L., 1959, ACTA ENT SINICA, V9, P137; [昝庆安 Zan Qingan], 2010, [云南农业大学学报, Journal of Yunnan Agricultural University], V25, P476; Zhang XX, 1979, PEST FORECAST PRINCI, P1; Zhang XX, 2002, INSECT ECOLOGY FOREC, P1; Zhou Y, 1980, HIST CHINESE ENTOMOL, P55; Zhu EL, 1999, OCCURRENCE MANAGEMEN, P5	55	9	13	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e89523	10.1371/journal.pone.0089523	http://dx.doi.org/10.1371/journal.pone.0089523			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599091	Green Published, gold, Green Submitted			2022-12-27	WOS:000332479400015
J	Xue, WW; Liu, HX; Yao, XJ				Xue, Weiwei; Liu, Huanxiang; Yao, Xiaojun			Molecular Modeling Study on the Allosteric Inhibition Mechanism of HIV-1 Integrase by LEDGF/p75 Binding Site Inhibitors	PLOS ONE			English	Article							CONFORMATIONAL-CHANGES; DYNAMICS SIMULATIONS; COMBINING DOCKING; RESP METHODOLOGY; FREE-ENERGIES; FORCE-FIELD; PROTEINS; INSIGHTS; DNA; RALTEGRAVIR	HIV-1 integrase (IN) is essential for the integration of viral DNA into the host genome and an attractive therapeutic target for developing antiretroviral inhibitors. LEDGINs are a class of allosteric inhibitors targeting LEDGF/p75 binding site of HIV-1 IN. Yet, the detailed binding mode and allosteric inhibition mechanism of LEDGINs to HIV-1 IN is only partially understood, which hinders the structure-based design of more potent anti-HIV agents. A molecular modeling study combining molecular docking, molecular dynamics simulation, and binding free energy calculation were performed to investigate the interaction details of HIV-1 IN catalytic core domain (CCD) with two recently discovered LEDGINs BI-1001 and CX14442, as well as the LEDGF/p75 protein. Simulation results demonstrated the hydrophobic domain of BI-1001 and CX14442 engages one subunit of HIV-1 IN CCD dimer through hydrophobic interactions, and the hydrophilic group forms hydrogen bonds with HIV-1 IN CCD residues from other subunit. CX14442 has a larger tert-butyl group than the methyl of BI-1001, and forms better interactions with the highly hydrophobic binding pocket of HIV-1 IN CCD dimer interface, which can explain the stronger affinity of CX14442 than BI-1001. Analysis of the binding mode of LEDGF/p75 with HIV-1 IN CCD reveals that the LEDGF/p75 integrase binding domain residues Ile365, Asp366, Phe406 and Val408 have significant contributions to the binding of the LEDGF/p75 to HIV1-IN. Remarkably, we found that binding of BI-1001 and CX14442 to HIV-1 IN CCD induced the structural rearrangements of the 140 s loop and oration displacements of the side chains of the three conserved catalytic residues Asp64, Asp116, and Glu152 located at the active site. These results we obtained will be valuable not only for understanding the allosteric inhibition mechanism of LEDGINs but also for the rational design of allosteric inhibitors of HIV-1 IN targeting LEDGF/p75 binding site.	[Xue, Weiwei; Yao, Xiaojun] Lanzhou Univ, Dept Chem, State Key Lab Appl Organ Chem, Lanzhou 730000, Peoples R China; [Liu, Huanxiang] Lanzhou Univ, Sch Pharm, Lanzhou 730000, Peoples R China; [Yao, Xiaojun] Macau Univ Sci & Technol, Macau Inst Appl Res Med & Hlth, State Key Lab Qual Res Chinese Med, Taipa, Macau, Peoples R China	Lanzhou University; Lanzhou University; Macau University of Science & Technology	Yao, XJ (corresponding author), Lanzhou Univ, Dept Chem, State Key Lab Appl Organ Chem, Lanzhou 730000, Peoples R China.	xjyao@lzu.edu.cn	; Xue, Weiwei/C-7461-2016	Liu, Huanxiang/0000-0002-9284-3667; Xue, Weiwei/0000-0002-3285-0574	National Natural Science Foundation of China [21175063]; Program for Changjiang Scholars and Innovative Research Team in University [PCSIRT: IRT1137]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by the National Natural Science Foundation of China (Grant No 21175063) and the Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT: IRT1137). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mawsawi LQ, 2011, CHEMMEDCHEM, V6, P228, DOI 10.1002/cmdc.201000443; Allingham JS, 1999, J MOL BIOL, V289, P1195, DOI 10.1006/jmbi.1999.2837; Alonso H, 2006, MED RES REV, V26, P531, DOI 10.1002/med.20067; [Anonymous], 2008, AMBER 10; [Anonymous], 2009, PRIM VERS 2 1; [Anonymous], 2009, LIGPREP VERS 2 3; [Anonymous], 2009, GLID VERS 5 5; [Anonymous], 2009, EP VERS 2 0; Asante-Appiah E, 1999, ADV VIRUS RES, V52, P351, DOI 10.1016/S0065-3527(08)60306-1; BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Busschots K, 2009, MOL BIOSYST, V5, P21, DOI 10.1039/b810306b; Cherepanov P, 2005, P NATL ACAD SCI USA, V102, P17308, DOI 10.1073/pnas.0506924102; Cherepanov P, 2005, NAT STRUCT MOL BIOL, V12, P526, DOI 10.1038/nsmb937; Christ F, 2013, VIROLOGY, V435, P102, DOI 10.1016/j.virol.2012.09.033; Christ F, 2012, ANTIMICROB AGENTS CH, V56, P4365, DOI 10.1128/AAC.00717-12; Christ F, 2010, NAT CHEM BIOL, V6, P442, DOI 10.1038/nchembio.370; CIEPLAK P, 1995, J COMPUT CHEM, V16, P1357, DOI 10.1002/jcc.540161106; Cui W, 2010, J CHEM INF MODEL, V50, P380, DOI 10.1021/ci900404p; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; De Luca L, 2012, J CHEM INF MODEL, V52, P3245, DOI 10.1021/ci300361e; DeJesus E, 2006, JAIDS-J ACQ IMM DEF, V43, P1, DOI 10.1097/01.qai.0000233308.82860.2f; Du L, 2008, BIOCHEM BIOPH RES CO, V375, P139, DOI 10.1016/j.bbrc.2008.07.139; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; ENGELMAN A, 1994, J VIROL, V68, P5911, DOI 10.1128/JVI.68.9.5911-5917.1994; Fox T, 1998, J PHYS CHEM B, V102, P8070, DOI 10.1021/jp9717655; Frisch M. J., 2009, GAUSSIAN 16 REVISION; Greenwald J, 1999, BIOCHEMISTRY-US, V38, P8892, DOI 10.1021/bi9907173; Halgren TA, 1999, J COMPUT CHEM, V20, P730, DOI 10.1002/(SICI)1096-987X(199905)20:7<730::AID-JCC8>3.0.CO;2-T; Hare S, 2009, VIRUSES-BASEL, V1, P780, DOI 10.3390/v1030780; Hou TJ, 2008, J MOL BIOL, V376, P1201, DOI 10.1016/j.jmb.2007.12.054; Hu GP, 2012, J MED CHEM, V55, P10108, DOI 10.1021/jm301226a; Hu GP, 2012, J MOL MODEL, V18, P4995, DOI 10.1007/s00894-012-1494-0; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; Kessl JJ, 2012, J BIOL CHEM, V287, P16801, DOI 10.1074/jbc.M112.354373; Kessl JJ, 2009, MOL PHARMACOL, V76, P824, DOI 10.1124/mol.109.058883; Kobayashi M, 2011, ANTIMICROB AGENTS CH, V55, P813, DOI 10.1128/AAC.01209-10; Koelsch KK, 2009, CURR OPIN HIV AIDS, V4, P518, DOI 10.1097/COH.0b013e328331b526; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; KUKOLJ G, 1995, GENE DEV, V9, P2556, DOI 10.1101/gad.9.20.2556; Liu H., 2009, MOL PHARM, V7, P75; Marchand C, 2012, EXPERT OPIN INV DRUG, V21, P901, DOI 10.1517/13543784.2012.685653; Onufriev A, 2004, PROTEINS, V55, P383, DOI 10.1002/prot.20033; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; Quashie PK, 2013, CURR OPIN INFECT DIS, V26, P43, DOI 10.1097/QCO.0b013e32835ba81c; Rocchia W, 2001, J PHYS CHEM B, V105, P6507, DOI 10.1021/jp010454y; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schrijvers R, 2012, 19 INT AIDS C; Schrodinger, 2009, MAESTR VERS 9 0; SCHUPBACH J, 1984, SCIENCE, V224, P503, DOI 10.1126/science.6200937; Shun MC, 2007, GENE DEV, V21, P1767, DOI 10.1101/gad.1565107; SITKOFF D, 1994, J PHYS CHEM-US, V98, P1978, DOI 10.1021/j100058a043; Summa V, 2008, J MED CHEM, V51, P5843, DOI 10.1021/jm800245z; Tintori C, 2010, PROTEINS, V78, P3396, DOI 10.1002/prot.22847; Tsiang M, 2012, J BIOL CHEM, V287, P21189, DOI 10.1074/jbc.M112.347534; U. S. Food and Drug Administration, 2013, FDA APPR NEW DRUG TR; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Xu L, 2012, MOL BIOSYST, V8, P2260, DOI 10.1039/c2mb25146a; Xue WW, 2013, J CHEM INF MODEL, V53, P210, DOI 10.1021/ci300541c; Xue WW, 2012, MOL BIOSYST, V8, P2753, DOI 10.1039/c2mb25157d; Xue WW, 2012, MOL BIOSYST, V8, P2135, DOI 10.1039/c2mb25114k; Xue WW, 2012, J COMPUT CHEM, V33, P527, DOI 10.1002/jcc.22887; Yang Y, 2012, MOL BIOSYST, V8, P2106, DOI 10.1039/c2mb25042j; Yang Y, 2011, J CHEM INF MODEL, V51, P3235, DOI 10.1021/ci200159g; Zhao YX, 2010, J CHEM INF MODEL, V50, P1633, DOI 10.1021/ci1002119	67	15	16	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90799	10.1371/journal.pone.0090799	http://dx.doi.org/10.1371/journal.pone.0090799			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599328	gold, Green Published, Green Submitted			2022-12-27	WOS:000332479400133
J	Geerts, CJ; Jacobsen, L; van de Bospoort, R; Verhage, M; Groffen, AJA				Geerts, Cornelia J.; Jacobsen, Linda; van de Bospoort, Rhea; Verhage, Matthijs; Groffen, Alexander J. A.			Tomosyn Interacts with the SUMO E3 Ligase PIAS gamma	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; SNARE COMPLEX-FORMATION; PROTEIN SUMOYLATION; NEUROTRANSMITTER RELEASE; SYNAPTIC-TRANSMISSION; DEPENDENT ACTIVATION; CONJUGATION; EXOCYTOSIS; RECEPTOR; MOTIF	Protein modification by Small Ubiquitin-like MOdifier (SUMO) entities is involved in a number of neuronal functions, including synaptogenesis and synaptic plasticity. Tomosyn-1 (syntaxin-binding protein 5; STXPB5) binds to t-SNARE (Soluble NSF Attachment Protein Receptor) proteins to regulate neurotransmission and is one of the few neuronal SUMO substrate proteins identified. Here we used yeast two-hybrid screening to show that tomosyn-1 interacts with the SUMO E3 ligase PIAS gamma (Protein Inhibitor of Activated STAT; PIAS4 or ZMIZ6). This novel interaction involved the C-terminus of tomosyn-1 and the N-terminus of PIAS gamma. It was confirmed by two-way immunoprecipitation experiments using the full-length proteins expressed in HEK293T cells. Tomosyn-1 was preferentially modified by the SUMO-2/3 isoform. PIAS gamma-dependent modification of tomosyn-1 with SUMO-2/3 presents a novel mechanism to adapt secretory strength to the dynamic synaptic environment.	[Geerts, Cornelia J.; Jacobsen, Linda; van de Bospoort, Rhea; Verhage, Matthijs; Groffen, Alexander J. A.] Vrije Univ Amsterdam, Ctr Neurogen & Cognit Res, Dept Funct Genom, Amsterdam, Netherlands; [Verhage, Matthijs; Groffen, Alexander J. A.] Vrije Univ Amsterdam Med Ctr, Dept Clin Genet, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Groffen, AJA (corresponding author), Vrije Univ Amsterdam, Ctr Neurogen & Cognit Res, Dept Funct Genom, Neurosci Campus Amsterdam, Amsterdam, Netherlands.	sander.groffen@cncr.vu.nl	Groffen, A.J.A./C-1118-2009	Groffen, A.J.A./0000-0003-0046-4027; verhage, matthijs/0000-0002-6085-7503	Centre for Medical Systems Biology [CMSB2] [3.3.5]	Centre for Medical Systems Biology [CMSB2]	This study was supported by the Centre for Medical Systems Biology [CMSB2 project 3.3.5; http://www.cmsb.nl/research/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba T, 2005, J CELL BIOL, V170, P1113, DOI 10.1083/jcb.200504055; Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; Bohren KM, 2007, PROTEIN EXPRES PURIF, V54, P289, DOI 10.1016/j.pep.2007.03.013; Cai QL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009720; Chamberlain SEL, 2012, NAT NEUROSCI, V15, P845, DOI 10.1038/nn.3089; Chen KY, 2011, P NATL ACAD SCI USA, V108, P18482, DOI 10.1073/pnas.1110184108; Cheviet S, 2006, J CELL SCI, V119, P2912, DOI 10.1242/jcs.03037; Chung CD, 1997, SCIENCE, V278, P1803, DOI 10.1126/science.278.5344.1803; Cimarosti H, 2008, NEUROPHARMACOLOGY, V54, P280, DOI 10.1016/j.neuropharm.2007.09.010; Cimarosti H, 2012, J CEREBR BLOOD F MET, V32, P17, DOI 10.1038/jcbfm.2011.146; Craig TJ, 2012, CURR OPIN NEUROBIOL, V22, P480, DOI 10.1016/j.conb.2011.10.017; Datwyler AL, 2011, J CEREBR BLOOD F MET, V31, P2152, DOI 10.1038/jcbfm.2011.112; Di Filippo M, 2008, NEUROPHARMACOLOGY, V55, P353, DOI 10.1016/j.neuropharm.2008.01.012; Feligioni M, 2009, EUR J NEUROSCI, V29, P1348, DOI 10.1111/j.1460-9568.2009.06692.x; Fujita Y, 1998, NEURON, V20, P905, DOI 10.1016/S0896-6273(00)80472-9; Gietz R Daniel, 2006, Methods Mol Biol, V313, P107; Gill G, 2004, GENE DEV, V18, P2046, DOI 10.1101/gad.1214604; Gladycheva SE, 2007, J BIOL CHEM, V282, P22887, DOI 10.1074/jbc.M701787200; Goehler H, 2004, MOL CELL, V15, P853, DOI 10.1016/j.molcel.2004.09.016; Gracheva EO, 2006, PLOS BIOL, V4, P1426, DOI 10.1371/journal.pbio.0040261; Groffen AJA, 2005, J NEUROCHEM, V92, P554, DOI 10.1111/j.1471-4159.2004.02890.x; Gross M, 2004, ONCOGENE, V23, P3059, DOI 10.1038/sj.onc.1207443; Hatsuzawa K, 2003, J BIOL CHEM, V278, P31159, DOI 10.1074/jbc.M305500200; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hietakangas V, 2006, P NATL ACAD SCI USA, V103, P45, DOI 10.1073/pnas.0503698102; Ihara M, 2005, MOL CELL BIOL, V25, P3506, DOI 10.1128/MCB.25.9.3506-3518.2005; James P, 1996, GENETICS, V144, P1425; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kerscher O, 2007, EMBO REP, V8, P550, DOI 10.1038/sj.embor.7400980; Kraut R, 2001, CURR BIOL, V11, P417, DOI 10.1016/S0960-9822(01)00124-5; Krumova P, 2013, CELL MOL LIFE SCI, V70, P2123, DOI 10.1007/s00018-012-1158-3; Li TW, 2006, J BIOL CHEM, V281, P36221, DOI 10.1074/jbc.M608236200; Liu B, 2001, P NATL ACAD SCI USA, V98, P3203, DOI 10.1073/pnas.051489598; Loriol C, 2013, BIOL CELL, V105, P30, DOI 10.1111/boc.201200016; Lu H, 2009, BIOCHEM BIOPH RES CO, V390, P872, DOI 10.1016/j.bbrc.2009.10.065; Martin S, 2007, NATURE, V447, P321, DOI 10.1038/nature05736; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; McEwen JM, 2006, NEURON, V51, P303, DOI 10.1016/j.neuron.2006.06.025; Nacerddine K, 2005, DEV CELL, V9, P769, DOI 10.1016/j.devcel.2005.10.007; Renner F, 2011, EMBO REP, V12, P129, DOI 10.1038/embor.2010.207; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Rytinki MM, 2009, CELL MOL LIFE SCI, V66, P3029, DOI 10.1007/s00018-009-0061-z; Sachdev S, 2001, GENE DEV, V15, P3088, DOI 10.1101/gad.944801; Sakisaka T, 2004, J CELL BIOL, V166, P17, DOI 10.1083/jcb.200405002; Sakisaka T, 2008, J CELL BIOL, V183, P323, DOI 10.1083/jcb.200805150; Schmidt D, 2002, P NATL ACAD SCI USA, V99, P2872, DOI 10.1073/pnas.052559499; Shilo Y, 2003, P NATL ACAD SCI USA, V100, P13225, DOI 10.1073/pnas.1735528100; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; Sturm S, 2000, J MOL NEUROSCI, V14, P107, DOI 10.1385/JMN:14:1-2:107; Tahk S, 2007, P NATL ACAD SCI USA, V104, P11643, DOI 10.1073/pnas.0701877104; Wilkinson KA, 2008, NEUROSCI LETT, V436, P239, DOI 10.1016/j.neulet.2008.03.029; Wilkinson KA, 2010, BRAIN RES REV, V64, P195, DOI 10.1016/j.brainresrev.2010.04.002; Williams AL, 2011, J BIOL CHEM, V286, P14542, DOI 10.1074/jbc.M110.215624; Wong KA, 2004, MOL CELL BIOL, V24, P5577, DOI 10.1128/MCB.24.12.5577-5586.2004; Yamamoto H, 2003, EMBO J, V22, P2047, DOI 10.1093/emboj/cdg204; Yamamoto Y, 2010, BIOCHEM BIOPH RES CO, V399, P24, DOI 10.1016/j.bbrc.2010.07.026; Yamamoto Y, 2009, J BIOL CHEM, V284, P12480, DOI 10.1074/jbc.M807182200; Yang SH, 2003, CELL CYCLE, V2, P528, DOI 10.4161/cc.2.6.597; Yang W, 2008, J CEREBR BLOOD F MET, V28, P892, DOI 10.1038/sj.jcbfm.9600601; Yang W, 2008, J CEREBR BLOOD F MET, V28, P269, DOI 10.1038/sj.jcbfm.9600523; Yizhar O, 2004, P NATL ACAD SCI USA, V101, P2578, DOI 10.1073/pnas.0308700100; Zhang W, 2006, DIABETES, V55, P574, DOI 10.2337/diabetes.55.03.06.db05-0015; Zhong S, 2000, BLOOD, V95, P2748, DOI 10.1182/blood.V95.9.2748.009k31a_2748_2752	63	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91697	10.1371/journal.pone.0091697	http://dx.doi.org/10.1371/journal.pone.0091697			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614299	Green Submitted, gold, Green Published			2022-12-27	WOS:000332839300150
J	Okello, J; Nakimuli-Mpungu, E; Musisi, S; Broekaert, E; Derluyn, I				Okello, James; Nakimuli-Mpungu, Etheldreda; Musisi, Seggane; Broekaert, Eric; Derluyn, Ilse			The Association between Attachment and Mental Health Symptoms among School-Going Adolescents in Northern Uganda: The Moderating Role of War-Related Trauma	PLOS ONE			English	Article							PEER ATTACHMENT; CHILD SOLDIERS; DEPRESSION; RISK; INVENTORY; EXPOSURE; VIOLENCE; PARENT; AFGHANISTAN; PERSPECTIVE	Background: The association between attachment and mental health symptoms in adolescents in a post-conflict low resource setting has not been documented. Methods: We investigated the relationship between parent and peer attachment and posttraumatic stress, depression and anxiety symptoms in a sample of 551 adolescents aged 13-21 years old. Attachment quality was assessed using the Inventory of Parent and Peer Attachment (IPPA). Post-traumatic stress, depression and anxiety symptoms were assessed using the Impact of Events Scale Revised (IESR) and Hopkins Symptom Checklist for Adolescents (HSCL-37A) respectively. Gender differences in attachment relationships were determined using independent t-tests. Multivariate logistic regression was used to assess whether attachment relationships were independently associated with posttraumatic stress, depression and anxiety symptoms. Hierarchical linear regression analyses were conducted to explore the moderating role of war-related trauma. Results: Our analyses revealed gender differences in attachment to parents, with males reporting stronger attachment than females. Parental attachment was protective against depression and anxiety symptoms but not posttraumatic stress symptoms after adjusting for potential confounders. Alienation by parents was independently associated with an increase in these mental health symptoms while peer attachment was not associated with any of these symptoms. However, in situations of severe trauma, our analyses showed that peer attachment was significantly protective against post-traumatic stress symptoms. Conclusions: Secure parental attachment is associated with better psychosocial adjustment in adolescents affected by war. Further, adolescents with secure peer attachment relationships in situations of severe war trauma may be less likely to develop posttraumatic stress symptoms. Interventions to enhance peer support in this post conflict setting would benefit this vulnerable population.	[Okello, James; Nakimuli-Mpungu, Etheldreda; Musisi, Seggane] Makerere Univ, Coll Hlth Sci, Dept Psychiat, Kampala, Uganda; [Okello, James] Gulu Univ, Dept Psychiat, Gulu, Uganda; [Broekaert, Eric] Univ Ghent, Dept Orthopedag, B-9000 Ghent, Belgium; [Okello, James; Derluyn, Ilse] Univ Ghent, Dept Social Welf Studies, B-9000 Ghent, Belgium; [Okello, James; Derluyn, Ilse] Univ Ghent, Ctr Children Vulnerable Situat, B-9000 Ghent, Belgium	Makerere University; Ghent University; Ghent University; Ghent University	Okello, J (corresponding author), Makerere Univ, Coll Hlth Sci, Dept Psychiat, Kampala, Uganda.	drokellojames@gmail.com		Nakimuli-Mpungu, Etheldreda/0000-0001-6857-8931	Belgian Technical Cooperation	Belgian Technical Cooperation	This study was supported by a doctoral scholarship from the Belgian Technical Cooperation to James Okello. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amone-P'Olak K, 2007, J ADOLESCENCE, V30, P655, DOI 10.1016/j.adolescence.2006.05.004; ARMSDEN GC, 1987, J YOUTH ADOLESCENCE, V16, P427, DOI 10.1007/BF02202939; Bean T, 2007, ADOLESCENCE, V42, P51; Betancourt TS, 2011, J AM ACAD CHILD PSY, V50, P323, DOI 10.1016/j.jaac.2011.01.008; Betancourt TS, 2010, J AM ACAD CHILD PSY, V49, P606, DOI 10.1016/j.jaac.2010.03.008; Bowlby J, 1988, SECURE BASE CLIN APP; Bruffaerts R, 2010, BRIT J PSYCHIAT, V197, P20, DOI 10.1192/bjp.bp.109.074716; Catani C, 2008, J MARITAL FAM THER, V34, P165, DOI 10.1111/j.1752-0606.2008.00062.x; Cohen JA, 2008, J AM ACAD CHILD PSY, V47, P981, DOI 10.1097/CHI.0b013e31817eed8c; Costello EJ, 2002, J TRAUMA STRESS, V15, P99, DOI 10.1023/A:1014851823163; Derluyn I, 2004, LANCET, V363, P861, DOI 10.1016/S0140-6736(04)15734-6; Derluyn I, 2008, EUR CHILD ADOLES PSY, V17, P54, DOI 10.1007/s00787-007-0636-x; Fowler JC, 2013, J AFFECT DISORDERS, V149, P313, DOI 10.1016/j.jad.2013.01.045; Gorrese A, 2012, J YOUTH ADOLESCENCE, V41, P650, DOI 10.1007/s10964-012-9759-6; Gullone E, 2005, CLIN PSYCHOL PSYCHOT, V12, P67, DOI 10.1002/cpp.433; Igreja V, 2003, INF MENTAL HLTH J, V24, P469, DOI 10.1002/imhj.10068; Klasen F, 2010, J TRAUMA STRESS, V23, P573, DOI 10.1002/jts.20557; Kliewer W, 2001, J CONSULT CLIN PSYCH, V69, P971, DOI [10.1037/0022-006X.69.6.971, 10.1037//0022-006X.69.6.971]; Luthar SS, 2000, CHILD DEV, V71, P543, DOI 10.1111/1467-8624.00164; Mels C, 2010, SOC PSYCH PSYCH EPID, V45, P899, DOI 10.1007/s00127-009-0128-z; MIKULINCER M, 1993, J PERS SOC PSYCHOL, V64, P817, DOI 10.1037/0022-3514.64.5.817; Mikulincer M, 2007, INT J GROUP PSYCHOTH, V57, P233, DOI 10.1521/ijgp.2007.57.2.233; Mikulincer M, 2013, J PERS, V81, P606, DOI 10.1111/j.1467-6494.2012.00806.x; Mikulincer M, 2012, WORLD PSYCHIATRY, V11, P11, DOI 10.1016/j.wpsyc.2012.01.003; Moretti Marlene M, 2004, Paediatr Child Health, V9, P551; Okello J, 2007, Afr J Psychiatry (Johannesbg), V10, P225; Okello J, 2013, J AFFECT DISORDERS, V151, P715, DOI 10.1016/j.jad.2013.07.030; Pace CS, 2011, PERS INDIV DIFFER, V51, P83, DOI 10.1016/j.paid.2011.03.006; Panter-Brick C, 2011, J AM ACAD CHILD PSY, V50, P349, DOI 10.1016/j.jaac.2010.12.001; Papini D.R., 1992, J EARLY ADOLESC, V12, P420, DOI [https://doi.org/10.1177/0272431692012004005, DOI 10.1177/0272431692012004005]; Peltonen K, 2010, INT J BEHAV DEV, V34, P554, DOI 10.1177/0165025410368943; Petersen T., 2013, OPEN J EPIDEMIOLOGY, V3, P62, DOI DOI 10.4236/OJEPI.2013.32010; Punamaki RL, 2005, CHILD ABUSE NEGLECT, V29, P351, DOI 10.1016/j.chiabu.2004.10.011; Sund AM, 2002, J AM ACAD CHILD PSY, V41, P1478, DOI 10.1097/00004583-200212000-00020; Waldinger RJ, 2007, AM J PSYCHIAT, V164, P949, DOI 10.1176/appi.ajp.164.6.949; Weiss D.S., 1997, ASSESSING PSYCHOL TR, P399, DOI DOI 10.1037/T12199-000; Whiffen VE, 1999, J INTERPERS VIOLENCE, V14, P940, DOI 10.1177/088626099014009002; Yi JY, 2012, DEPRESS ANXIETY, V29, P789, DOI 10.1002/da.21953	38	25	26	8	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e88494	10.1371/journal.pone.0088494	http://dx.doi.org/10.1371/journal.pone.0088494			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9FH	24614005	Green Published, gold			2022-12-27	WOS:000332839300006
J	Otto, SA; Diekmann, R; Flinkman, J; Kornilovs, G; Mollmann, C				Otto, Saskia A.; Diekmann, Rabea; Flinkman, Juha; Kornilovs, Georgs; Mollmann, Christian			Habitat Heterogeneity Determines Climate Impact on Zooplankton Community Structure and Dynamics	PLOS ONE			English	Article							CENTRAL BALTIC SEA; CALANOID COPEPODS; SPECIES-DIVERSITY; LIFE-CYCLE; POPULATION-DYNAMICS; TEMORA-LONGICORNIS; BORNHOLM BASIN; EGG-PRODUCTION; REGIME SHIFTS; ECOSYSTEM	Understanding and predicting species distribution in space and time and consequently community structure and dynamics is an important issue in ecology, and particularly in climate change research. A crucial factor determining the composition and dynamics of animal populations is habitat heterogeneity, i.e., the number of structural elements in a given locality. In the marine pelagic environment habitat heterogeneity is represented by the distribution of physical oceanographic parameters such as temperature, salinity and oxygen that are closely linked to atmospheric conditions. Little attention has been given, however, to the role of habitat heterogeneity in modulating the response of animal communities to external climate forcing. Here we investigate the long-term dynamics of Acartia spp., Temora longicornis, and Pseudocalanus acuspes, three dominant zooplankton species inhabiting different pelagic habitats in the Central Baltic Sea (CBS). We use the three copepods as indicator species for changes in the CBS zooplankton community and apply non-linear statistical modeling techniques to compare spatial population trends and to identify their drivers. We demonstrate that effects of climate variability and change depend strongly on species-specific habitat utilization, being more direct and pronounced at the upper water layer. We propose that the differential functional response to climate-related drivers in relation to strong habitat segregation is due to alterations of the species' environmental niches. We stress the importance of understanding how anticipated climate change will affect ecological niches and habitats in order to project spatio-temporal changes in species abundance and distribution.	[Otto, Saskia A.] Stockholm Univ, Stockholm Resilience Ctr, S-10691 Stockholm, Sweden; [Otto, Saskia A.; Diekmann, Rabea; Mollmann, Christian] Univ Hamburg, Inst Hydrobiol & Fisheries Sci, Ctr Earth Syst Res & Sustainabil CEN, Hamburg, Germany; [Flinkman, Juha] Finnish Environm Inst SYKE, Ctr Marine Res, Helsinki, Finland; [Kornilovs, Georgs] Inst Food Safety Anim Hlth & Environm, Dept Fish Resources Res, Riga, Latvia	Stockholm University; University of Hamburg; Finnish Environment Institute; Institute of Food Safety, Animal Health & Environment "BIOR"	Otto, SA (corresponding author), Stockholm Univ, Stockholm Resilience Ctr, S-10691 Stockholm, Sweden.	saskia.otto@stockholmresilience.su.se	Möllmann, Christian/C-4788-2011; Möllmann, Christian/M-8006-2019	Möllmann, Christian/0000-0001-9161-6342; 	BONUS project AMBER; Stockholm University's strategic marine environmental research funds through the Baltic Ecosystem Adaptive Management Program	BONUS project AMBER; Stockholm University's strategic marine environmental research funds through the Baltic Ecosystem Adaptive Management Program	This study has been carried out with financial support from the BONUS project AMBER (http://www.io-warnemuende.de/amber.html) and the Stockholm University's strategic marine environmental research funds through the Baltic Ecosystem Adaptive Management Program (http://www.smf.su.se/beam). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, 2 INT S INF THEOR, P267, DOI DOI 10.1007/978-1-4612-1694-0_15; BARTLEIN PJ, 1986, J BIOGEOGR, V13, P35, DOI 10.2307/2844848; BAZZAZ FA, 1975, ECOLOGY, V56, P485, DOI 10.2307/1934981; Beaugrand G, 2002, SCIENCE, V296, P1692, DOI 10.1126/science.1071329; Casini M, 2008, P ROY SOC B-BIOL SCI, V275, P1793, DOI 10.1098/rspb.2007.1752; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Chiba S, 2009, GLOBAL CHANGE BIOL, V15, P1846, DOI 10.1111/j.1365-2486.2009.01890.x; Cottenie K, 2005, ECOL LETT, V8, P1175, DOI 10.1111/j.1461-0248.2005.00820.x; DICKSON RR, 1988, J PLANKTON RES, V10, P151, DOI 10.1093/plankt/10.1.151; Diekmann ABS, 2012, MAR BIOL, V159, P2399, DOI 10.1007/s00227-012-1955-0; Dippner JW, 2000, J MARINE SYST, V25, P23, DOI 10.1016/S0924-7963(00)00006-3; Dutz J, 2010, MAR ECOL PROG SER, V406, P223, DOI 10.3354/meps08545; Dzierzbicka-Glowacka L, 2010, BIOGEOSCIENCES, V7, P2247, DOI 10.5194/bg-7-2247-2010; Eero M, 2007, ICES J MAR SCI, V64, P1257, DOI 10.1093/icesjms/fsm114; Gaedke U, 2010, GLOBAL CHANGE BIOL, V16, P1122, DOI 10.1111/j.1365-2486.2009.02009.x; Gulati RD, 1997, FRESHWATER BIOL, V38, P753, DOI 10.1046/j.1365-2427.1997.00275.x; Hansen FC, 2006, J PLANKTON RES, V28, P39, DOI 10.1093/plankt/fbi097; Hare SR, 2000, PROG OCEANOGR, V47, P103, DOI 10.1016/S0079-6611(00)00033-1; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; HECK KL, 1977, J BIOGEOGR, V4, P135, DOI 10.2307/3038158; Helaouet P, 2009, ECOSYSTEMS, V12, P1235, DOI 10.1007/s10021-009-9261-5; Hickling R, 2006, GLOBAL CHANGE BIOL, V12, P450, DOI 10.1111/j.1365-2486.2006.01116.x; Hirzel AH, 2008, J APPL ECOL, V45, P1372, DOI 10.1111/j.1365-2664.2008.01524.x; Holste L, 2006, MAR BIOL, V148, P1061, DOI 10.1007/s00227-005-0132-0; Holste L, 2009, MAR BIOL, V156, P527, DOI 10.1007/s00227-008-1101-1; HOLT RD, 1985, THEOR POPUL BIOL, V28, P181, DOI 10.1016/0040-5809(85)90027-9; Hsieh CH, 2009, GLOBAL CHANGE BIOL, V15, P2137, DOI 10.1111/j.1365-2486.2009.01875.x; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; ICES, 2011, CM2011ACOM10 ICES WG; Jackson ST, 2000, PALEOBIOLOGY, V26, P194, DOI 10.1666/0094-8373(2000)26[194:ROPPAC]2.0.CO;2; Jackson ST, 1999, P NATL ACAD SCI USA, V96, P13847, DOI 10.1073/pnas.96.24.13847; KLOPFER PH, 1960, AM NAT, V94, P293, DOI 10.1086/282130; Koski M, 1999, J PLANKTON RES, V21, P1779, DOI 10.1093/plankt/21.9.1779; Koster FW, 2005, ICES J MAR SCI, V62, P1408, DOI 10.1016/j.icesjms.2005.05.004; Lehmann A, 2002, TELLUS A, V54, P299, DOI 10.1034/j.1600-0870.2002.00289.x; Lehmann A, 2000, PHYS CHEM EARTH PT B, V25, P183, DOI 10.1016/S1464-1909(99)00140-9; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; MAC ARTHUR ROBERT H., 1967; Mackas DL, 2010, J MARINE SYST, V79, P286, DOI 10.1016/j.jmarsys.2008.11.030; MacKenzie BR, 2004, ECOLOGY, V85, P784, DOI 10.1890/02-0780; MAGUIRE B, 1973, AM NAT, V107, P213, DOI 10.1086/282827; MCGUINNESS KA, 1986, J EXP MAR BIOL ECOL, V104, P97, DOI 10.1016/0022-0981(86)90099-7; MENGE BA, 1976, AM NAT, V110, P351, DOI 10.1086/283073; Mollmann C, 2008, ICES J MAR SCI, V65, P302, DOI 10.1093/icesjms/fsm197; Mollmann C, 2009, GLOBAL CHANGE BIOL, V15, P1377, DOI 10.1111/j.1365-2486.2008.01814.x; Moller KA, 2013, THESIS U HAMBURG HAM; Mollmann C, 2000, J PLANKTON RES, V22, P2015, DOI 10.1093/plankt/22.11.2015; Mollmann C, 2004, J FISH BIOL, V65, P1563, DOI 10.1111/j.0022-1112.2004.00566.x; Mollmann C, 2002, J PLANKTON RES, V24, P959, DOI 10.1093/plankt/24.10.959; Munguia P, 2011, ECOL APPL, V21, P925, DOI 10.1890/09-2398.1; OCONNOR NA, 1991, OECOLOGIA, V85, P504, DOI 10.1007/BF00323762; Ojaveer E, 1998, ICES J MAR SCI, V55, P748, DOI 10.1006/jmsc.1998.0393; Ottersen G, 2010, J MARINE SYST, V79, P343, DOI 10.1016/j.jmarsys.2008.12.013; Otto SA, 2014, MAR ECOL PO IN PRESS; Peters J, 2013, J PLANKTON RES, V35, P595, DOI 10.1093/plankt/fbt004; PIANKA ER, 1969, ECOLOGY, V50, P498, DOI 10.2307/1933908; Planque B, 1998, ICES J MAR SCI, V55, P644, DOI 10.1006/jmsc.1998.0390; Pulliam HR, 2000, ECOL LETT, V3, P349, DOI 10.1046/j.1461-0248.2000.00143.x; R Core Team, 2020, R LANG ENV STAT COMP; Reid PC, 2001, FISH RES, V50, P163, DOI 10.1016/S0165-7836(00)00249-6; Renz J, 2006, MAR BIOL, V148, P567, DOI 10.1007/s00227-005-0103-5; Schmidt JO, 2006, THESIS CHRISTIAN ALB; Schulz J, 2007, J PLANKTON RES, V29, P881, DOI 10.1093/plankt/fbm066; Schulz J, 2012, PROG OCEANOGR, V107, P3, DOI 10.1016/j.pocean.2012.07.002; Soberon J, 2009, P NATL ACAD SCI USA, V106, P19644, DOI 10.1073/pnas.0901637106; Tews J, 2004, J BIOGEOGR, V31, P79, DOI 10.1046/j.0305-0270.2003.00994.x; TILZER MM, 1986, POLAR BIOL, V5, P105, DOI 10.1007/BF00443382; TONN WM, 1982, ECOLOGY, V63, P1149, DOI 10.2307/1937251; VanDerWal J, 2013, NAT CLIM CHANGE, V3, P239, DOI [10.1038/nclimate1688, 10.1038/NCLIMATE1688]; Vuorinen I, 1998, ICES J MAR SCI, V55, P767, DOI 10.1006/jmsc.1998.0398; Walker BK, 2009, J COASTAL RES, V25, P39, DOI [10.2112/S153-005.1, 10.2112/SI53-005.1]; Walther GR, 2010, PHILOS T R SOC B, V365, P2019, DOI 10.1098/rstb.2010.0021; Wasmund N, 2003, ICES J MAR SCI, V60, P177, DOI 10.1016/S1054-3139(02)00280-1; Wasmund N, 2011, J MARINE SYST, V87, P145, DOI 10.1016/j.jmarsys.2011.03.010; Winder M, 2012, HYDROBIOLOGIA, V698, P5, DOI 10.1007/s10750-012-1149-2; Wood S.N., 2017, GEN ADDITIVE MODELS, V2nd ed., DOI [10.1201/9781315370279, DOI 10.1201/9781315370279]; Zuur A.F., 2007, ANAL ECOLOGICAL DATA; Zuur Alain F., 2009, P1	78	21	21	2	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e90875	10.1371/journal.pone.0090875	http://dx.doi.org/10.1371/journal.pone.0090875			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614110	Green Published, Green Submitted, gold			2022-12-27	WOS:000332839300048
J	Hu, LB; Yao, WX; Wang, F; Rong, X; Peng, T				Hu, Longbo; Yao, Wenxia; Wang, Fang; Rong, Xia; Peng, Tao			GP73 Is Upregulated by Hepatitis C Virus (HCV) Infection and Enhances HCV Secretion	PLOS ONE			English	Article							NONSTRUCTURAL PROTEIN 5A; GOLGI PHOSPHOPROTEIN 2; APOLIPOPROTEIN-E; LIVER-CANCER; SERUM MARKER; ASSOCIATION; EXPRESSION; REPLICATION; DISEASE	Hepatitis C virus (HCV) is a major cause of chronic liver disease. However, little is known about the details of its assembly and secretion. Golgi-related proteins have been recently proven to have a key function in HCV secretion. Golgi protein 73 (GP73), a resident Golgi membrane protein, is a potential serum biomarker for the diagnosis of liver diseases and hepatocellular carcinoma. Previous studies have demonstrated the upregulation of GP73 in the liver samples and sera of HCV-infected patients. However, the function and regulatory mechanism of GP73 in HCV infection at the cellular level remain unknown. In this study, we examined the expression level of GP73 in HCV infected cells and its effect on HCV life cycle in cell culture systems. Both the protein expression and mRNA levels of GP73 significantly increased in HCV subgenomic replicon-harboring cells and HCV-infected cells, which imply that GP73 was upregulated by HCV infection. HCV production was significantly enhanced when GP73 was overexpressed, but dramatically inhibited when GP73 was silenced. However, the overexpression and knockdown of GP73 showed no evident effect on the entry, protein translation, RNA replication, and assembly of HCV, which indicates that GP73 enhanced the secretion process. Moreover, the coiled-coil domain of GP73 was required to increase HCV secretion. GP73 increased and interacted with apolipoprotein E, an identified host factor that assists in HCV secretion. These results demonstrate the critical function of GP73 in HCV secretion and provide new insights into the therapeutic design of antiviral strategies.	[Hu, Longbo; Yao, Wenxia; Wang, Fang; Peng, Tao] Chinese Acad Sci, State Key Lab Resp Dis, Guangzhou Inst Biomed & Hlth, Guangzhou, Guangdong, Peoples R China; [Rong, Xia] Guangzhou Blood Ctr, Guangzhou, Guangdong, Peoples R China; [Peng, Tao] South China United Vaccine Insititute, Guangzhou, Guangdong, Peoples R China	Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; State Key Laboratory of Respiratory Disease; Guangzhou Blood Center	Peng, T (corresponding author), Chinese Acad Sci, State Key Lab Resp Dis, Guangzhou Inst Biomed & Hlth, Guangzhou, Guangdong, Peoples R China.	peng_tao@gibh.ac.cn	hu, longbo/S-7060-2018; wang, fang/GYD-4295-2022	hu, longbo/0000-0002-3495-6268; Peng, Tao/0000-0001-5260-7128	National Basic Research Program (973) [2009CB522306, 2010CB530100]; National Science Foundation [309701647]	National Basic Research Program (973)(National Basic Research Program of China); National Science Foundation(National Science Foundation (NSF))	This work was supported by National Basic Research Program (973) (Grant Nos. 2009CB522306 and 2010CB530100) and National Science Foundation (309701647). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulou A, 2012, WORLD J GASTROENTERO, V18, P6060, DOI 10.3748/wjg.v18.i42.6060; Amako Y, 2011, J BIOL CHEM, V286, P11265, DOI 10.1074/jbc.M110.182097; [Anonymous], PSYCHIAT GENET, V20, P190; BARRERA JM, 1995, HEPATOLOGY, V21, P639, DOI 10.1016/0270-9139(95)90511-1; Bartosch B, 2003, J EXP MED, V197, P633, DOI 10.1084/jem.20021756; Benga WJA, 2010, HEPATOLOGY, V51, P43, DOI 10.1002/hep.23278; Bishe B, 2012, VIRUSES-BASEL, V4, P2340, DOI 10.3390/v4102340; Bishe B, 2012, J BIOL CHEM, V287, P27637, DOI 10.1074/jbc.M112.346569; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Chang KS, 2007, J VIROL, V81, P13783, DOI 10.1128/JVI.01091-07; Coller KE, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002466; Cun W, 2010, J VIROL, V84, P11532, DOI 10.1128/JVI.01021-10; Gastaminza P, 2008, J VIROL, V82, P2120, DOI 10.1128/JVI.02053-07; Giannelli G, 2006, DIGEST LIVER DIS, V38, P854, DOI 10.1016/j.dld.2006.05.007; Gomaa AI, 2009, WORLD J GASTROENTERO, V15, P1301, DOI 10.3748/wjg.15.1301; Gu YL, 2009, ANN CLIN BIOCHEM, V46, P38, DOI 10.1258/acb.2008.008088; Hishiki T, 2010, J VIROL, V84, P12048, DOI 10.1128/JVI.01063-10; Hu LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014556; Huang H, 2007, P NATL ACAD SCI USA, V104, P5848, DOI 10.1073/pnas.0700760104; Iftikhar R, 2004, AM J GASTROENTEROL, V99, P1087, DOI 10.1111/j.1572-0241.2004.30572.x; Inkster B, 2012, NEUROBIOL AGING, V33, P457, DOI 10.1016/j.neurobiolaging.2010.04.018; Jiang JY, 2009, J VIROL, V83, P12680, DOI 10.1128/JVI.01476-09; Kato N, 2001, ACTA MED OKAYAMA, V55, P133; Kim HJ, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-31; Kladney RD, 2002, HEPATOLOGY, V35, P1431, DOI 10.1053/jhep.2002.32525; Kladney RD, 2000, GENE, V249, P53, DOI 10.1016/S0378-1119(00)00136-0; Leone N, 2005, Minerva Gastroenterol Dietol, V51, P31; Levrero M, 2006, ONCOGENE, V25, P3834, DOI 10.1038/sj.onc.1209562; Li H, 2008, ARCH NEUROL-CHICAGO, V65, P45, DOI 10.1001/archneurol.2007.3; Li XL, 2014, J VIROL, V88, P612, DOI 10.1128/JVI.02068-13; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Malaguarnera G, 2010, DIGEST DIS SCI, V55, P2744, DOI 10.1007/s10620-010-1184-7; Mao Y, 2010, GUT; Marrero JA, 2005, J HEPATOL, V43, P1007, DOI 10.1016/j.jhep.2005.05.028; Moradpour D, 2004, J VIROL, V78, P7400, DOI 10.1128/JVI.78.14.7400-7409.2004; Nahmias Y, 2008, HEPATOLOGY, V47, P1437, DOI 10.1002/hep.22197; Norton PA, 2008, J CELL BIOCHEM, V104, P136, DOI 10.1002/jcb.21610; Owen DM, 2009, VIROLOGY, V394, P99, DOI 10.1016/j.virol.2009.08.037; Ozkan H, 2011, DIGESTION, V83, P83, DOI 10.1159/000320379; Ploss A, 2012, CURR OPIN VIROL, V2, P14, DOI 10.1016/j.coviro.2011.12.007; Popescu CI, 2010, BIOL CELL, V102, P63, DOI 10.1042/BC20090125; Rice Charles M, 2011, Top Antivir Med, V19, P117; Riener MO, 2009, HEPATOLOGY, V49, P1602, DOI 10.1002/hep.22843; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Sundaram M, 2012, ARTERIOSCL THROM VAS, V32, P1073, DOI 10.1161/ATVBAHA.111.241455; Suzuki T, 2007, J GASTROENTEROL, V42, P411, DOI 10.1007/s00535-007-2030-3; Suzuki T, 2007, ADV DRUG DELIVER REV, V59, P1200, DOI 10.1016/j.addr.2007.04.014; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Yuan Q, 2012, NEUROL SCI, V33, P1021, DOI 10.1007/s10072-011-0881-0; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102; Zhong J, 2006, J VIROL, V80, P11082, DOI 10.1128/JVI.01307-06; Zhou Y, 2011, MOL BIOL REP, V38, P1457, DOI 10.1007/s11033-010-0251-7; Zlokovic BV, 2013, JAMA NEUROL, V70, P440, DOI 10.1001/jamaneurol.2013.2152	54	21	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90553	10.1371/journal.pone.0090553	http://dx.doi.org/10.1371/journal.pone.0090553			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608522	Green Submitted, Green Published, gold			2022-12-27	WOS:000332485800033
J	Kim, HR; Lee, A; Choi, EJ; Hong, MP; Kie, JH; Lim, W; Lee, HK; Moon, BI; Seoh, JY				Kim, Hyung-Ran; Lee, Anbok; Choi, Eun-Jeong; Hong, Min-Pyo; Kie, Jeong-Hae; Lim, Woosung; Lee, Hyeon Kook; Moon, Byung-In; Seoh, Ju-Young			Reactive Oxygen Species Prevent Imiquimod-Induced Psoriatic Dermatitis through Enhancing Regulatory T Cell Function	PLOS ONE			English	Article							DELAYED RADIATION INJURIES; HYPERBARIC-OXYGEN; INDOLEAMINE 2,3-DIOXYGENASE; GLUTATHIONE PEROXIDASE-1; OXIDATIVE DAMAGE; MICE DEFICIENT; DNA-DAMAGE; THERAPY; INFLAMMATION; RESPONSES	Psoriasis is a chronic inflammatory skin disease resulting from immune dysregulation. Regulatory T cells (Tregs) are important in the prevention of psoriasis. Traditionally, reactive oxygen species (ROS) are known to be implicated in the progression of inflammatory diseases, including psoriasis, but many recent studies suggested the protective role of ROS in immune-mediated diseases. In particular, severe cases of psoriasis vulgaris have been reported to be successfully treated by hyperbaric oxygen therapy (HBOT), which raises tissue level of ROS. Also it was reported that Treg function was closely associated with ROS level. However, it has been only investigated in lowered levels of ROS so far. Thus, in this study, to clarify the relationship between ROS level and Treg function, as well as their role in the pathogenesis of psoriasis, we investigated imiquimod-induced psoriatic dermatitis (PD) in association with Treg function both in elevated and lowered levels of ROS by using knockout mice, such as glutathione peroxidase-1(-/-) and neutrophil cytosolic factor-1(-/-) mice, as well as by using HBOT or chemicals, such as 2,3-dimethoxy-1,4-naphthoquinone and N-acetylcysteine. The results consistently showed Tregs were hyperfunctional in elevated levels of ROS, whereas hypofunctional in lowered levels of ROS. In addition, imiquimod-induced PD was attenuated in elevated levels of ROS, whereas aggravated in lowered levels of ROS. For the molecular mechanism that may link ROS level and Treg function, we investigated the expression of an immunoregulatory enzyme, indoleamine 2,3-dioxygenase (IDO) which is induced by ROS, in PD lesions. Taken together, it was implied that appropriately elevated levels of ROS might prevent psoriasis through enhancing IDO expression and Treg function.	[Kim, Hyung-Ran; Choi, Eun-Jeong; Seoh, Ju-Young] Ewha Womans Univ, Grad Sch Med, Dept Microbiol, Seoul, South Korea; [Lee, Anbok; Lim, Woosung; Lee, Hyeon Kook; Moon, Byung-In] Ewha Womans Univ, Grad Sch Med, Dept Surg, Seoul, South Korea; [Hong, Min-Pyo] Boston Coll, Coll Arts & Sci, Chestnut Hill, MA 02167 USA; [Kie, Jeong-Hae] Natl Hlth Insurance Cooperat Ilsan Hosp, Koyang, South Korea	Ewha Womans University; Ewha Womans University; Boston College	Seoh, JY (corresponding author), Ewha Womans Univ, Grad Sch Med, Dept Microbiol, Seoul, South Korea.	jyseoh@ewha.ac.kr		SEOH, JU-YOUNG/0000-0002-1168-5354; Kie, Jeong Hae/0000-0003-1782-5650	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI12C0050]; Ewha Womans University	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea; Ewha Womans University	This study was supported by a grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI12C0050) and RP-Grant 2011 of Ewha Womans University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen S, 2012, SUPPORT CARE CANCER, V20, P2467, DOI 10.1007/s00520-012-1379-x; Banham NDG, 2011, DIVING HYPERB MED, V41, P202; Bovenschen HJ, 2011, J INVEST DERMATOL, V131, P1853, DOI 10.1038/jid.2011.139; Briganti S, 2008, FREE RADICAL BIO MED, V45, P636, DOI 10.1016/j.freeradbiomed.2008.05.006; Buchman AL, 2001, J CLIN GASTROENTEROL, V33, P289, DOI 10.1097/00004836-200110000-00006; Butler Glenn, 2009, J Med Case Rep, V3, P7023, DOI 10.4076/1752-1947-3-7023; Chen AF, 2012, CLIN SCI, V123, P73, DOI 10.1042/CS20110562; Chen SY, 2003, CLIN IMMUNOL, V108, P103, DOI 10.1016/S1521-6616(03)00091-3; de Haan JB, 2006, J LIPID RES, V47, P1157, DOI 10.1194/jlr.M500377-JLR200; De Ravin SS, 2008, J ALLERGY CLIN IMMUN, V122, P1097, DOI 10.1016/j.jaci.2008.07.050; Dennog C, 1996, MUTAGENESIS, V11, P605, DOI 10.1093/mutage/11.6.605; Dennog C, 1999, MUTAT RES-FUND MOL M, V431, P351, DOI 10.1016/S0027-5107(99)00178-5; Efimova O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016013; Esworthy RS, 2001, AM J PHYSIOL-GASTR L, V281, pG848, DOI 10.1152/ajpgi.2001.281.3.G848; Faleo G, 2012, DIABETES, V61, P1769, DOI 10.2337/db11-0516; Fallarino F, 2006, TRANSPL IMMUNOL, V17, P58, DOI 10.1016/j.trim.2006.09.017; Favre D, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000632; Feldmeier JJ, 2012, UNDERSEA HYPERBAR M, V39, P1121; Furuhashi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054895; Guzman JA, 2012, CRIT CARE CLIN, V28, P537, DOI 10.1016/j.ccc.2012.07.007; Hampson NB, 2011, CANCER, V118, P3860; Ho YS, 1997, J BIOL CHEM, V272, P16644, DOI 10.1074/jbc.272.26.16644; Hultqvist M, 2004, P NATL ACAD SCI USA, V101, P12646, DOI 10.1073/pnas.0403831101; Hultqvist M, 2009, TRENDS IMMUNOL, V30, P201, DOI 10.1016/j.it.2009.03.004; Jung YJ, 2009, IMMUNOBIOLOGY, V214, P291, DOI 10.1016/j.imbio.2008.09.004; Kahles T, 2012, CELL MOL LIFE SCI, V69, P2345, DOI 10.1007/s00018-012-1011-8; Kim HR, 2012, RHEUMATOLOGY, V51, P1357, DOI 10.1093/rheumatology/kes058; Korhonen K, 2000, ANN CHIR GYNAECOL, V89, P7; Kudchodkar B, 2008, CLIN IMMUNOL, V128, P435, DOI 10.1016/j.clim.2008.05.004; Kurien BT, 2008, AUTOIMMUN REV, V7, P567, DOI 10.1016/j.autrev.2008.04.019; Lee K, 2011, P NATL ACAD SCI USA, V108, P9548, DOI 10.1073/pnas.1012645108; Lin H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074130; Liu R, 2013, MAYO CLIN PROC, V88, P166, DOI 10.1016/j.mayocp.2012.10.021; Munn DH, 2013, TRENDS IMMUNOL, V34, P137, DOI 10.1016/j.it.2012.10.001; Nagatomo F, 2010, CLIN EXP MED, V10, P7, DOI 10.1007/s10238-009-0064-y; NARKOWICZ CK, 1993, FREE RADICAL RES COM, V19, P71, DOI 10.3109/10715769309056501; Novo E, 2011, J HEPATOL, V54, P964, DOI 10.1016/j.jhep.2010.09.022; Ogasawara N, 2009, J CELL BIOCHEM, V108, P716, DOI 10.1002/jcb.22308; Olivieri AN, 2010, ITAL J PEDIATR, V36, DOI 10.1186/1824-7288-36-72; Olszanski Romuald, 1992, Bulletin of the Institute of Maritime and Tropical Medicine in Gdynia, V43, P79; Ozturk F, 2013, CUTAN OCUL TOXICOL, V32, P72, DOI 10.3109/15569527.2012.705407; Palomares O, 2010, EUR J IMMUNOL, V40, P1232, DOI 10.1002/eji.200940045; Plafki C, 2000, AVIAT SPACE ENVIR MD, V71, P119; Pouplard C, 2013, J EUR ACAD DERMATOL, V27, P36, DOI 10.1111/jdv.12165; Quaglino P, 2011, DERMATOLOGY, V223, P57, DOI 10.1159/000330330; Rachmilewitz D, 1998, GUT, V43, P512, DOI 10.1136/gut.43.4.512; Ralainirina N, 2007, J LEUKOCYTE BIOL, V81, P144, DOI 10.1189/jlb.0606409; Romani L, 2008, NATURE, V451, P211, DOI 10.1038/nature06471; Saito C, 2009, J DERMATOL SCI, V53, P231, DOI 10.1016/j.jdermsci.2008.09.011; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Selman C, 2012, TRENDS ECOL EVOL, V27, P570, DOI 10.1016/j.tree.2012.06.006; Si CL, 2013, FOOD CHEM TOXICOL, V59, P145, DOI 10.1016/j.fct.2013.05.051; Sohal RS, 2012, FREE RADICAL BIO MED, V52, P539, DOI 10.1016/j.freeradbiomed.2011.10.445; Soyland E, 2011, BRIT J DERMATOL, V164, P344, DOI 10.1111/j.1365-2133.2010.10149.x; Sugiyama H, 2005, J IMMUNOL, V174, P164, DOI 10.4049/jimmunol.174.1.164; Takeshima F, 1999, AM J GASTROENTEROL, V94, P3374, DOI 10.1111/j.1572-0241.1999.03374.x; TAYLOR MW, 1991, FASEB J, V5, P2516, DOI 10.1096/fasebj.5.11.1907934; Terness P, 2002, J EXP MED, V196, P447, DOI 10.1084/jem.20020052; Thom SR, 2011, PLAST RECONSTR SURG, V127, p131S, DOI 10.1097/PRS.0b013e3181fbe2bf; Thom SR, 2009, J APPL PHYSIOL, V106, P988, DOI 10.1152/japplphysiol.91004.2008; Thomas SR, 1999, REDOX REP, V4, P199, DOI 10.1179/135100099101534927; van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999; van Horssen J, 2011, BBA-MOL BASIS DIS, V1812, P141, DOI 10.1016/j.bbadis.2010.06.011; Vann RD, 2011, LANCET, V377, P153, DOI 10.1016/S0140-6736(10)61085-9; Weigle N, 2013, AM FAM PHYSICIAN, V87, P626; Won HY, 2013, J IMMUNOL, V191, P4029, DOI 10.4049/jimmunol.1203247; Won Hee Yeon, 2011, Immune Netw, V11, P169, DOI 10.4110/in.2011.11.3.169; Won HY, 2010, ANTIOXID REDOX SIGN, V13, P575, DOI 10.1089/ars.2009.2989; Yan YP, 2010, J IMMUNOL, V185, P5953, DOI 10.4049/jimmunol.1001628; Yildiz S, 2004, AVIAT SPACE ENVIR MD, V75, P992; Zaba LC, 2009, J INVEST DERMATOL, V129, P79, DOI 10.1038/jid.2008.194; Zhang YQ, 2009, J GERONTOL A-BIOL, V64, P1212, DOI 10.1093/gerona/glp132	72	55	56	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91146	10.1371/journal.pone.0091146	http://dx.doi.org/10.1371/journal.pone.0091146			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608112	gold, Green Published, Green Submitted			2022-12-27	WOS:000332485800104
J	Resch, MC; Shrubovych, J; Bartel, D; Szucsich, NU; Timelthaler, G; Bu, Y; Walzl, M; Pass, G				Resch, Monika Carol; Shrubovych, Julia; Bartel, Daniela; Szucsich, Nikolaus U.; Timelthaler, Gerald; Bu, Yun; Walzl, Manfred; Pass, Guenther			Where Taxonomy Based on Subtle Morphological Differences Is Perfectly Mirrored by Huge Genetic Distances: DNA Barcoding in Protura (Hexapoda)	PLOS ONE			English	Article							RIBOSOMAL-RNA; ACERENTOMATA ACERENTOMIDAE; MOLECULAR SYSTEMATICS; SEQUENCE; IDENTIFICATION; COLLEMBOLA; 18S; 28S; VARIABILITY; ARTHROPODS	Background: Protura is a group of tiny, primarily wingless hexapods living in soil habitats. Presently about 800 valid species are known. Diagnostic characters are very inconspicuous and difficult to recognize. Therefore taxonomic work constitutes an extraordinary challenge which requires special skills and experience. Aim of the present pilot project was to examine if DNA barcoding can be a useful additional approach for delimiting and determining proturan species. Methodology and Principal Findings: The study was performed on 103 proturan specimens, collected primarily in Austria, with additional samples from China and Japan. The animals were examined with two markers, the DNA barcoding region of the mitochondrial COI gene and a fragment of the nuclear 285 rDNA (Divergent Domain 2 and 3). Due to the minuteness of Protura a modified non-destructive DNA-extraction method was used which enables subsequent species determination. Both markers separated the examined proturans into highly congruent well supported clusters. Species determination was performed without knowledge of the results of the molecular analyses. The investigated specimens comprise a total of 16 species belonging to 8 genera. Remarkably, morphological determination in all species exactly mirrors molecular clusters. The investigation revealed unusually huge genetic COI distances among the investigated proturans, both maximal intraspecific distances (0-21.3%), as well as maximal congeneric interspecifical distances (up to 44.7%). Conclusions: The study dearly demonstrates that the tricky morphological taxonomy in Protura has a solid biological background and that accurate species delimitation is possible using both markers, COI and 28S rDNA. The fact that both molecular and morphological analyses can be performed on the same individual will be of great importance for the description of new species and offers a valuable new tool for biological and ecological studies, in which proturans have generally remained undetermined at species level.	[Resch, Monika Carol; Bartel, Daniela; Szucsich, Nikolaus U.; Timelthaler, Gerald; Walzl, Manfred; Pass, Guenther] Univ Vienna, Dept Integrat Zool, Vienna, Austria; [Shrubovych, Julia] Polish Acad Sci, Inst Systemat & Evolut Anim, Krakow, Poland; [Bu, Yun] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Shanghai, Peoples R China	University of Vienna; Polish Academy of Sciences; Institute of Systematics & Evolution of Animals of the Polish Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Szucsich, NU (corresponding author), Univ Vienna, Dept Integrat Zool, Vienna, Austria.	nikola.szucsich@univie.ac.at	Szucsich, Nikolaus/O-1776-2017; Shrubovych, Julia/F-9767-2014	Szucsich, Nikolaus/0000-0002-8945-5153; Shrubovych, Julia/0000-0002-8880-0007; Timelthaler, Gerald/0000-0002-0260-089X	FWF [P 23251-B17, P 20497-B17]; Austrian Science Fund (FWF) [P 23251] Funding Source: researchfish	FWF(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	DB and GP are supported by grant number P 23251-B17 of the FWF, and MCR by grant number P 20497-B17 of the FWF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai Y, 2013, ZOOKEYS, P29, DOI 10.3897/zookeys.338.6099; Balkenhol B, 1996, PEDOBIOLOGIA, V40, P212; Barrett RDH, 2005, CAN J ZOOL, V83, P481, DOI 10.1139/Z05-024; Ben Ali A, 1999, NUCLEIC ACIDS RES, V27, P2825; Blaxter M, 2003, NATURE, V421, P122, DOI 10.1038/421122a; Boehm Alexander, 2011, Soil Organisms, V83, P335; Bu Y, 2012, FLA ENTOMOL, V95, P839, DOI 10.1653/024.095.0404; [卜云 Bu Yun], 2012, [生命科学, Chinese Bulletin of Life Sciences], V24, P130; Busse HJ, 1996, J BIOTECHNOL, V47, P3, DOI 10.1016/0168-1656(96)01379-X; Carapelli A, 2000, PEDOBIOLOGIA, V44, P361, DOI 10.1078/S0031-4056(04)70055-4; Chen WJ, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-246; Christian E, 2004, PEDOBIOLOGIA, V48, P445, DOI 10.1016/j.pedobi.2004.05.009; Chu KH, 2006, BIOINFORMATICS, V22, P1690, DOI 10.1093/bioinformatics/btl146; Coulson SJ, 2002, FUNCT ECOL, V16, P353, DOI 10.1046/j.1365-2435.2002.00636.x; Dell'Ampio Emiliano, 2011, Soil Organisms, V83, P347; Dell'Ampio E, 2009, ZOOL SCR, V38, P155, DOI 10.1111/j.1463-6409.2008.00368.x; Dunger W, 2002, PEDOBIOLOGIA, V46, P316, DOI 10.1078/0031-4056-00139; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gao Y, 2008, ZOOL SCI, V25, P1139, DOI 10.2108/zsj.25.1139; Grimaldi DA, 2010, ARTHROPOD STRUCT DEV, V39, P191, DOI 10.1016/j.asd.2009.10.008; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; HILLIS DM, 1991, Q REV BIOL, V66, P411, DOI 10.1086/417338; Imadate G, 1974, PROTURA INSECTA FAUN; Ionesco MA, 1932, PUBLICATIUNILE SOC N, V11, P167; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Jinbo U, 2011, ENTOMOL SCI, V14, P107, DOI 10.1111/j.1479-8298.2011.00449.x; Kaneko Nobuhiro, 2012, Diversity-Basel, V4, P318; Kasapidis P, 2005, MOL PHYLOGENET EVOL, V35, P612, DOI 10.1016/j.ympev.2005.02.005; Kjer KM, 2004, SYST BIOL, V53, P506, DOI 10.1080/10635150490445922; Luan YX, 2005, MOL BIOL EVOL, V22, P1579, DOI 10.1093/molbev/msi148; Mallatt J, 2006, MOL PHYLOGENET EVOL, V40, P772, DOI 10.1016/j.ympev.2006.04.021; Marx MT, 2009, PESQUI AGROPECU BRAS, V44, P1002, DOI 10.1590/S0100-204X2009000800032; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Misof B, 2009, SYST BIOL, V58, P21, DOI 10.1093/sysbio/syp006; Moritz C, 2004, PLOS BIOL, V2, P1529, DOI 10.1371/journal.pbio.0020354; Nosek J, 1973, EUROPEAN PROTURA THE; Pass Guenther, 2011, Soil Organisms, V83, P309; Raupach MJ, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-26; Rimskij-Korsakov M., 1912, Revue Russe d'Entomologie, V11; Roe AD, 2007, MOL PHYLOGENET EVOL, V44, P325, DOI 10.1016/j.ympev.2006.12.005; Rubinoff D, 2005, SYST BIOL, V54, P952, DOI 10.1080/10635150500234674; RUSEK J, 1989, REV ECOL BIOL SOL, V26, P527; Shao HG, 1999, CHINESE SCI BULL, V44, P2031, DOI 10.1007/BF02884915; Shrubovych J, 2012, ANN SOC ENTOMOL FR, V48, P1; Southwood TRE, 2000, ECOLOGICAL METHODS P; Sterzynska M, 2012, ANN ZOOL FENN, V49, P309, DOI 10.5735/086.049.0504; Sturm H., 2001, HDB ZOOLOGY, V4; Szeptycki A, 2000, FOLIA BIOL-KRAKOW, V48, P65; SZEPTYCKI A, 1988, Acta Zoologica Cracoviensia, V31, P297; Szeptycki A., 2000, Annalen des Naturhistorischen Museums in Wien Serie B Botanik und Zoologie, V102B, P83; SZEPTYCKI A, 1991, Acta Zoologica Cracoviensia, V34, P1; Szeptycki Andrzej, 2007, Acta Zoologica Cracoviensia Ser B-Invertebrata, V50B; Szeptycki Andrzej, 1997, Fragmenta Faunistica (Warsaw), V40, P307; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TICHY H, 1988, J EXP ZOOL, V245, P130, DOI 10.1002/jez.1402450203; Tuxen S. L., 1931, Zeitschrift fuer Morphologie und Oekologie der Tiere Berlin, V22, P671, DOI 10.1007/BF00446572; Tuxen SL, 1964, PROTURA REVISION SPE; Vences M, 2005, PHILOS T R SOC B, V360, P1859, DOI 10.1098/rstb.2005.1717; Vences Miguel, 2005, Front Zool, V2, P5, DOI 10.1186/1742-9994-2-5; Villani MG, 1999, ANNU REV ENTOMOL, V44, P233, DOI 10.1146/annurev.ento.44.1.233; Wiemers M, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-8; Wiens JJ, 2002, SYST BIOL, V51, P69, DOI 10.1080/106351502753475880; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Yin W, 1996, P 20 INT C ENT 25 31, P60; Yin W-Y, 1999, ARTHROPODA PROTURA F	70	22	25	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90653	10.1371/journal.pone.0090653	http://dx.doi.org/10.1371/journal.pone.0090653			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24609003	Green Published, gold, Green Submitted			2022-12-27	WOS:000332485800041
J	Xing, DJ; Zhang, HX; Huang, N; Wu, KC; Huang, XF; Huang, F; Tong, Y; Pang, CP; Qu, J; Jin, ZB				Xing, Dong-Jun; Zhang, Hong-Xing; Huang, Na; Wu, Kun-Chao; Huang, Xiu-Feng; Huang, Fang; Tong, Yi; Pang, Chi-Pui; Qu, Jia; Jin, Zi-Bing			Comprehensive Molecular Diagnosis of Bardet-Biedl Syndrome by High-Throughput Targeted Exome Sequencing	PLOS ONE			English	Article							MUTATION	Bardet-Biedl syndrome (BBS) is an autosomal recessive disorder with significant genetic heterogeneity. BBS is linked to mutations in 17 genes, which contain more than 200 coding exons. Currently, BBS is diagnosed by direct DNA sequencing for mutations in these genes, which because of the large genomic screening region is both time-consuming and expensive. In order to develop a practical method for the clinic diagnosis of BBS, we have developed a high-throughput targeted exome sequencing (TES) for genetic diagnosis. Five typical BBS patients were recruited and screened for mutations in a total of 144 known genes responsible for inherited retinal diseases, a hallmark symptom of BBS. The genomic DNA of these patients and their families were subjected to high-throughput DNA re-sequencing. Deep bioinformatics analysis was carried out to filter the massive sequencing data, which were further confirmed through co-segregation analysis. TES successfully revealed mutations in BBS genes in each patient and family member. Six pathological mutations, including five novel mutations, were revealed in the genes BBS2, MKKS, ARL6, MKS1. This study represents the first report of targeted exome sequencing in BBS patients and demonstrates that high-throughput TES is an accurate and rapid method for the genetic diagnosis of BBS.	[Xing, Dong-Jun; Huang, Na; Wu, Kun-Chao; Huang, Xiu-Feng; Huang, Fang; Jin, Zi-Bing] Wenzhou Med Univ, Hosp Eye, Lab Stem Cell & Retinal Regenerat, Div Ophthalm Genet, Wenzhou, Peoples R China; [Xing, Dong-Jun; Huang, Na; Wu, Kun-Chao; Huang, Xiu-Feng; Huang, Fang; Qu, Jia; Jin, Zi-Bing] Minist Hlth PR China, State Key Lab Cultivat Base, Wenzhou, Peoples R China; [Xing, Dong-Jun; Huang, Na; Wu, Kun-Chao; Huang, Xiu-Feng; Huang, Fang; Qu, Jia; Jin, Zi-Bing] Minist Hlth PR China, Key Lab Vis Sci, Wenzhou, Peoples R China; [Zhang, Hong-Xing] Second Peoples Hosp, Jinan Eye Hosp, Jinan, Peoples R China; [Tong, Yi] Fuzhou Southeastern Eye Hosp, Fuzhou, Peoples R China; [Pang, Chi-Pui] Chinese Univ Hong Kong, Dept Ophthalmol & Visual Sci, Hong Kong, Hong Kong, Peoples R China	Wenzhou Medical University; Chinese University of Hong Kong	Qu, J (corresponding author), Minist Hlth PR China, State Key Lab Cultivat Base, Wenzhou, Peoples R China.	jqu@mail.eye.ac.cn; jinzb@mail.eye.ac.cn	Jin, Zi-Bing/AAE-4106-2019; Pang, Chi P/I-5388-2014; Jin, Zi-Bing/J-6810-2014	Jin, Zi-Bing/0000-0003-0515-698X; Jin, Zi-Bing/0000-0003-0515-698X; Huang, Xiu-Feng/0000-0002-7852-6358	National Key Basic Research Program [2013CB967502, 2011CB504600]; National Natural Science Foundation of China [81371059]; MOST Projects [2012YQ12008004]; Qianjiang Scholarship; Qianjiang Talents Project [2012R10072]; Zhejiang Provincial Natural Science Foundation of China [LR13H120001]	National Key Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); MOST Projects; Qianjiang Scholarship; Qianjiang Talents Project; Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	This work was supported by the National Key Basic Research Program (2013CB967502 to ZBJ, 2011CB504600 to JQ), National Natural Science Foundation of China (81371059 to ZBJ), MOST Projects (2012YQ12008004 to ZBJ), and partly funded by a Qianjiang Scholarship (to ZBJ) and Qianjiang Talents Project (2012R10072 to ZBJ), Zhejiang Provincial Natural Science Foundation of China under Grant No. LR13H120001 (to ZBJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Safieh L, 2012, EUR J HUM GENET, V20, P420, DOI 10.1038/ejhg.2011.205; Badano JL, 2003, HUM MOL GENET, V12, P1651, DOI 10.1093/hmg/ddg188; Beales PL, 1999, J MED GENET, V36, P437; Chen XJ, 2013, INVEST OPHTH VIS SCI, V54, P2186, DOI 10.1167/iovs.12-10967; Chou J, 2012, CURR OPIN ALLERGY CL, V12, P623, DOI 10.1097/ACI.0b013e3283588ca6; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; Forsythe E, 2013, EUR J HUM GENET, V21, P8, DOI 10.1038/ejhg.2012.115; GREEN JS, 1989, NEW ENGL J MED, V321, P1002, DOI 10.1056/NEJM198910123211503; He J, 2011, ONCOTARGET, V2, P178; Hou HB, 2010, NUCLEIC ACIDS RES, V38, pW732, DOI 10.1093/nar/gkq302; Huang XF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063832; Janssen S, 2011, HUM GENET, V129, P79, DOI 10.1007/s00439-010-0902-8; Jin ZB, 2008, J MED GENET, V45, P465, DOI 10.1136/jmg.2007.056416; Katsanis N, 2001, SCIENCE, V293, P2256, DOI 10.1126/science.1063525; Kuehn BM, 2008, JAMA-J AM MED ASSOC, V300, P2715, DOI 10.1001/jama.2008.823; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Lieber DS, 2013, NEUROLOGY, V80, P1762, DOI 10.1212/WNL.0b013e3182918c40; M'hamdi O, 2011, J COMMUN GENET, V2, P97, DOI 10.1007/s12687-011-0040-6; Mason JM, 2004, CHEMBIOCHEM, V5, P170, DOI 10.1002/cbic.200300781; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Redin C, 2012, J MED GENET, V49, P502, DOI 10.1136/jmedgenet-2012-100875; Sheffield VC, 2011, NEW ENGL J MED, V364, P1932, DOI 10.1056/NEJMra1012354; Summerer D, 2010, GENOMICS, V95, P241, DOI 10.1016/j.ygeno.2010.01.006; Wu J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002543; Yang ZL, 2008, MOL VIS, V14, P2304	27	23	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90599	10.1371/journal.pone.0090599	http://dx.doi.org/10.1371/journal.pone.0090599			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608809	Green Submitted, Green Published, gold			2022-12-27	WOS:000332485800037
J	Frei, R; Roduit, C; Bieli, C; Loeliger, S; Waser, M; Scheynius, A; van Hage, M; Pershagen, G; Doekes, G; Riedler, J; von Mutius, E; Sennhauser, F; Akdis, CA; Braun-Fahrlander, C; Lauener, RP				Frei, Remo; Roduit, Caroline; Bieli, Christian; Loeliger, Susanne; Waser, Marco; Scheynius, Annika; van Hage, Marianne; Pershagen, Goran; Doekes, Gert; Riedler, Josef; von Mutius, Erika; Sennhauser, Felix; Akdis, Cezmi A.; Braun-Fahrlaender, Charlotte; Lauener, Roger P.		PARSIFAL Study Team	Expression of Genes Related to Anti-Inflammatory Pathways Are Modified Among Farmers' Children	PLOS ONE			English	Article							CLASS-SWITCH RECOMBINATION; SCHOOL-AGE-CHILDREN; RURAL LIFE-STYLE; INNATE IMMUNITY; ATOPIC SENSITIZATION; ALLERGIC DISEASES; HAY-FEVER; T-CELLS; TRANSCRIPTION FACTOR; HYGIENE HYPOTHESIS	Background: The hygiene hypothesis states that children exposed to higher loads of microbes such as farmers' children suffer less from allergies later in life. Several immunological mechanisms underpinning the hygiene hypothesis have been proposed such as a shift in T helper cell balance, T regulatory cell activity, or immune regulatory mechanisms induced by the innate immunity. Objective: To investigate whether the proposed immunological mechanisms for the hygiene hypotheses are found in farmers' children. Methods: We assessed gene expression levels of 64 essential markers of the innate and adaptive immunity by quantitative real-time PCR in white blood cells in 316 Swiss children of the PARSIFAL study to compare farmers' to non-farmers' expressions and to associate them to the prevalence of asthma and rhinoconjunctivitis, total and allergen-specific IgE in serum, and expression of Ce germ-line transcripts. Results: We found enhanced expression of genes of the innate immunity such as IRAK-4 and RIPK1 and enhanced expression of regulatory molecules such as IL-10, TGF-beta, SOCS4, and IRAK-2 in farmers' children. Furthermore, farmers' children expressed less of the T(H)1 associated cytokine IFN-gamma while T(H)2 associated transcription factor GATA3 was enhanced. No significant associations between the assessed immunological markers and allergic diseases or sensitization to allergens were observed. Conclusion: Farmers' children express multiple increased innate immune response and immune regulatory molecules, which may contribute to the mechanisms of action of the hygiene hypothesis.	[Frei, Remo; Akdis, Cezmi A.] Univ Zurich, Swiss Inst Allergy & Asthma Res SIAF, Davos, Switzerland; [Frei, Remo; Roduit, Caroline; Loeliger, Susanne; Akdis, Cezmi A.; Lauener, Roger P.] Christine Kuhne Ctr Allergy Res & Educ, Zurich, Switzerland; [Roduit, Caroline; Bieli, Christian; Loeliger, Susanne; Sennhauser, Felix] Univ Zurich, Childrens Hosp, Zurich, Switzerland; [Waser, Marco; Braun-Fahrlaender, Charlotte] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Waser, Marco; Braun-Fahrlaender, Charlotte] Univ Basel, Basel, Switzerland; [Scheynius, Annika] Karolinska Inst, Translat Immunol Unit, Dept Med Solna, Stockholm, Sweden; [Scheynius, Annika; van Hage, Marianne] Univ Hosp, Stockholm, Sweden; [van Hage, Marianne] Karolinska Inst, Clin Immunol & Allergy Unit, Dept Med Solna, Stockholm, Sweden; [Pershagen, Goran] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden; [Doekes, Gert] Univ Utrecht, Inst Risk Assessment Sci, Utrecht, Netherlands; [Riedler, Josef] Childrens Hosp Schwarzach, Schwarzach, Austria; [von Mutius, Erika] Univ Munich, Dr von Hauner Childrens Hosp, Munich, Germany; [Lauener, Roger P.] Kantonsspital St Gallen, St Gallen, Switzerland	Swiss Institute of Allergy & Asthma Research; University of Zurich; University Children's Hospital Zurich; University of Zurich; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Utrecht University; University of Munich	Frei, R (corresponding author), Univ Zurich, Swiss Inst Allergy & Asthma Res SIAF, Davos, Switzerland.	remo.frei@siaf.uzh.ch	Akdis, Cezmi/AAV-4844-2020; Roduit, Caroline/S-4928-2017; van Hage, Marianne/A-9678-2017; riedler, josef/AAQ-4666-2020; Lauener, Roger P/O-8612-2016; Frei, Remo/AAI-9180-2020; Bieli, Christian/F-7209-2014	Akdis, Cezmi/0000-0001-8020-019X; van Hage, Marianne/0000-0003-3091-1596; Lauener, Roger P/0000-0002-8412-606X; von Mutius, Erika/0000-0002-8893-4515; Pershagen, Goran/0000-0002-9701-1130; Roduit, Caroline/0000-0002-5988-0570; Bieli, Christian/0000-0002-2128-6082	European Union [QLRT 1999-013]; Swiss National Science Foundation [2-100324]; Christine Kuhne - Center for Allergy Research and Education (CK-Care) in Davos	European Union(European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Christine Kuhne - Center for Allergy Research and Education (CK-Care) in Davos	Supported by grants from the European Union QLRT 1999-013, from the Swiss National Science Foundation 2-100324, and by the Christine Kuhne - Center for Allergy Research and Education (CK-Care) in Davos. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdis M, 2004, J EXP MED, V199, P1567, DOI 10.1084/jem.20032058; Akdis M, 2011, J ALLERGY CLIN IMMUN, V127, P701, DOI 10.1016/j.jaci.2010.11.050; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Alfven T, 2006, ALLERGY, V61, P414, DOI 10.1111/j.1398-9995.2005.00939.x; ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bieli C, 2008, ALLERGY, V63, P1633, DOI 10.1111/j.1398-9995.2008.01744.x; Bieli C, 2007, J ALLERGY CLIN IMMUN, V120, P1308, DOI 10.1016/j.jaci.2007.07.034; Braun-Fahrlander C, 1999, CLIN EXP ALLERGY, V29, P28, DOI 10.1046/j.1365-2222.1999.00479.x; Braun-Fahrlander C, 2002, NEW ENGL J MED, V347, P869, DOI 10.1056/NEJMoa020057; Chaudhuri J, 2004, NAT REV IMMUNOL, V4, P541, DOI 10.1038/nri1395; Ege MJ, 2011, NEW ENGL J MED, V364, P701, DOI 10.1056/NEJMoa1007302; Ege MJ, 2007, J ALLERGY CLIN IMMUN, V119, P1140, DOI 10.1016/j.jaci.2007.01.037; Ege MJ, 2006, J ALLERGY CLIN IMMUN, V117, P817, DOI 10.1016/j.jaci.2005.12.1307; Eyerich K, 2013, ALLERGY, V68, P974, DOI 10.1111/all.12184; Felliet H, 2004, CURR OPIN GASTROEN, V20, P560; Filipiak B, 2001, CLIN EXP ALLERGY, V31, P1829, DOI 10.1046/j.1365-2222.2001.01246.x; Flannery S, 2010, BIOCHEM PHARMACOL, V80, P1981, DOI 10.1016/j.bcp.2010.06.020; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Frei R, 2012, ALLERGY, V67, P451, DOI 10.1111/j.1398-9995.2011.02783.x; Frei R, 2013, J ALLERGY CLIN IMMUN, V132, P194, DOI 10.1016/j.jaci.2013.01.013; Jiang H, 2006, NEW ENGL J MED, V354, P1166, DOI 10.1056/NEJMra055446; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kim HY, 2010, NAT IMMUNOL, V11, P577, DOI 10.1038/ni.1892; Kramer U, 1999, LANCET, V353, P450, DOI 10.1016/S0140-6736(98)06329-6; Lauener RP, 2002, LANCET, V360, P465, DOI 10.1016/S0140-6736(02)09641-1; Lee SY, 2012, INT ARCH ALLERGY IMM, V158, P168, DOI 10.1159/000330820; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1038/ni829; Loftus EV, 2004, GASTROENTEROLOGY, V126, P1504, DOI 10.1053/j.gastro.2004.01.063; Loss G, 2012, J ALLERGY CLIN IMMUN, V130, P523, DOI 10.1016/j.jaci.2012.05.049; Loss G, 2011, J ALLERGY CLIN IMMUN, V128, P766, DOI 10.1016/j.jaci.2011.07.048; Macpherson AJ, 2002, NAT IMMUNOL, V3, P798, DOI 10.1038/ni0902-798; Manis JP, 2002, TRENDS IMMUNOL, V23, P31, DOI 10.1016/S1471-4906(01)02111-1; Marshall AL, 2004, DIABETIC MED, V21, P1035, DOI 10.1111/j.1464-5491.2004.01282.x; Matricardi PM, 1997, BRIT MED J, V314, P999, DOI 10.1136/bmj.314.7086.999; Mrabet-Dahbi S, 2010, ALLERGY, V65, P1351, DOI 10.1111/j.1398-9995.2010.02452.x; Ng LG, 2005, MOL IMMUNOL, V42, P763, DOI 10.1016/j.molimm.2004.06.041; Pfefferle PI, 2008, J ALLERGY CLIN IMMUN, V122, P711, DOI 10.1016/j.jaci.2008.06.035; Rebane A, 2012, J ALLERGY CLIN IMMUN, V129, P1297, DOI 10.1016/j.jaci.2012.02.020; Riedler J, 2001, LANCET, V358, P1129, DOI 10.1016/S0140-6736(01)06252-3; Riedler J, 2000, CLIN EXP ALLERGY, V30, P194, DOI 10.1046/j.1365-2222.2000.00799.x; Roduit C, 2011, J ALLERGY CLIN IMMUN, V127, P179, DOI 10.1016/j.jaci.2010.10.010; Rosenlund H, 2009, PEDIATRICS, V123, P771, DOI 10.1542/peds.2008-0013; Sheikh A, 2003, J ALLERGY CLIN IMMUN, V111, P131, DOI 10.1067/mai.2003.8; Soyka MB, 2012, IMMUNOTHERAPY-UK, V4, P389, DOI [10.2217/IMT.12.10, 10.2217/imt.12.10]; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Ublagger E, 2005, CLIN EXP ALLERGY, V35, P1033, DOI 10.1111/j.1365-2222.2005.02308.x; Wickman M, 2002, PEDIATR ALLERGY IMMU, V13, P11, DOI 10.1034/j.1399-3038.13.s.15.10.x; Yu KF, 2003, NAT IMMUNOL, V4, P442, DOI 10.1038/ni919; Zeller S, 2009, J ALLERGY CLIN IMMUN, V124, P278, DOI 10.1016/j.jaci.2009.05.015; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zimmermann M, 2011, J ALLERGY CLIN IMMUN, V127, P200, DOI 10.1016/j.jaci.2010.11.005	56	28	27	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e91097	10.1371/journal.pone.0091097	http://dx.doi.org/10.1371/journal.pone.0091097			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603716	Green Published, gold, Green Accepted			2022-12-27	WOS:000332483600128
J	Komar-Stossel, C; Gross, E; Dery, E; Corchia, N; Meir, K; Fried, I; Abramovitch, R				Komar-Stossel, Chani; Gross, Eitan; Dery, Elia; Corchia, Nathalie; Meir, Karen; Fried, Iris; Abramovitch, Rinat			TL-118 and Gemcitabine Drug Combination Display Therapeutic Efficacy in a MYCN Amplified Orthotopic Neuroblastoma Murine Model - Evaluation by MRI	PLOS ONE			English	Article							RETINOIC ACID; INHIBITS ANGIOGENESIS; TUMOR ANGIOGENESIS; GROWTH; CHEMOTHERAPY; MIGRATION; EXPRESSION; RECEPTORS; HYPEROXIA; CHILDREN	Neuroblastoma (NB) is the most common extra-cranial pediatric solid tumor with up to 50% of NB patients classified as having high-risk disease with poor long-term survival rates. The poor clinical outcome and aggressiveness of high-risk NB strongly correlates with enhanced angiogenesis, suggesting anti-angiogenic agents as attractive additions to the currently insufficient therapeutics. TL-118, a novel drug combination has been recently developed to inhibit tumor angiogenesis. In the current study, we used the SK-N-BE (2) cell line to generate orthotopic NB tumors in order to study the combinational therapeutic potential of TL-118 with either Gemcitabine (40 mg/kg; IP) or Retinoic acid (40 mg/kg; IP). We show that TL-118 treatment (n = 9) significantly inhibited tumor growth, increased cell apoptosis, reduced proliferation and extended mouse survival. Moreover, the reciprocal effect of TL-118 and Gemcitabine treatment (n = 10) demonstrated improved anti-tumor activity. The synergistic effect of these drugs in combination was more effective than either TL or Gemcitabine alone (n = 9), via significantly reduced cell proliferation (p<0.005), increased apoptosis (p<0.05) and significantly prolonged survival (2-fold; p<0.00001). To conclude, we demonstrate that the novel drug combination TL-118 has the ability to suppress the growth of an aggressive NB tumor. The promising results with TL-118 in this aggressive animal model may imply that this drug combination has therapeutic potential in the clinical setting.	[Komar-Stossel, Chani; Dery, Elia; Corchia, Nathalie; Abramovitch, Rinat] Hadassah Hebrew Univ Med Ctr, Goldyne Savad Inst Gene Therapy, Jerusalem, Israel; [Komar-Stossel, Chani; Dery, Elia; Corchia, Nathalie; Abramovitch, Rinat] Hadassah Hebrew Univ Med Ctr, MRI MRS Lab HBRC, Jerusalem, Israel; [Gross, Eitan; Meir, Karen; Fried, Iris] Hadassah Hebrew Univ Med Ctr, Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Abramovitch, R (corresponding author), Hadassah Hebrew Univ Med Ctr, Goldyne Savad Inst Gene Therapy, Jerusalem, Israel.	rinat@hadassah.org.il			Israeli Cancer Association [20130099]; Manferd and Sabine Landau (London)	Israeli Cancer Association; Manferd and Sabine Landau (London)	This research was supported by a grant from the Israeli Cancer Association (20130099) and a financial support from Manferd and Sabine Landau (London). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alique M, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-1; Barash H, 2007, RADIOLOGY, V243, P727, DOI 10.1148/radiol.2433060433; Barasli H, 2008, HEPATOLOGY, V48, P1232, DOI 10.1002/hep.22394; Ben-Sasson SA, 2008, US Patent, Patent No. [7 838 513, 7838513]; Browder T, 2000, CANCER RES, V60, P1878; Canete A, 2000, J CLIN ONCOL, V18, P27, DOI 10.1200/JCO.2000.18.1.27; Choudhury SR, 2012, J ONCOL, V2012, DOI 10.1155/2012/782020; Chung CH, 2009, BRIT J PHARMACOL, V156, P846, DOI 10.1111/j.1476-5381.2008.00095.x; Cohn SL, 2009, J CLIN ONCOL, V27, P289, DOI 10.1200/JCO.2008.16.6785; Edrei Y, 2012, BRIT J CANCER, V107, P658, DOI 10.1038/bjc.2012.322; Edrei Y, 2011, NEOPLASIA, V13, P244, DOI 10.1593/neo.101354; Eggert A, 2000, CLIN CANCER RES, V6, P1900; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Geoerger B, 2011, EUR J CANCER, V47, P230, DOI 10.1016/j.ejca.2010.09.015; Goel S, 2011, PHYSIOL REV, V91, P1071, DOI 10.1152/physrev.00038.2010; Grunewald M, 2006, CELL, V124, P175, DOI 10.1016/j.cell.2005.10.036; Hoffmann S, 2007, MOL CELL ENDOCRINOL, V264, P74, DOI 10.1016/j.mce.2006.10.009; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Kubecova M, 2011, EUR J PHARM SCI, V42, P439, DOI 10.1016/j.ejps.2011.02.004; Laquente B, 2008, MOL CANCER THER, V7, P638, DOI 10.1158/1535-7163.MCT-07-2122; Li B, 2009, MOL CANCER THER, V8, P2635, DOI 10.1158/1535-7163.MCT-09-0162; Lingen MW, 1998, CANCER RES, V58, P5551; Ma J, 2008, MOL CANCER THER, V7, P3670, DOI 10.1158/1535-7163.MCT-08-0715; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; Masia S, 2007, MOL ENDOCRINOL, V21, P2391, DOI 10.1210/me.2007-0062; Matthay KK, 2009, J CLIN ONCOL, V27, P1007, DOI 10.1200/JCO.2007.13.8925; Mayorek N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012715; Megison ML, 2013, CLIN EXP METASTAS, V30, P555, DOI 10.1007/s10585-012-9560-7; Meitar D, 1996, J CLIN ONCOL, V14, P405, DOI 10.1200/JCO.1996.14.2.405; Messi E, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-30; Mora J, 2009, J PEDIAT HEMATOL ONC, V31, P723, DOI 10.1097/MPH.0b013e3181b2598c; Natori T, 2005, BIOMED PHARMACOTHER, V59, P56, DOI 10.1016/j.biopha.2004.05.018; Nevo I, 2008, NEOPLASIA, V10, P817, DOI 10.1593/neo.08402; O'Connor JPB, 2008, LANCET ONCOL, V9, P766, DOI 10.1016/S1470-2045(08)70196-7; Ogawa M, 2005, CLIN CANCER RES, V11, P3485, DOI 10.1158/1078-0432.CCR-04-1781; Park JR, 2010, HEMATOL ONCOL CLIN N, V24, P65, DOI 10.1016/j.hoc.2009.11.011; Pasquier E, 2010, NAT REV CLIN ONCOL, V7, P455, DOI 10.1038/nrclinonc.2010.82; Pili R, 2001, CANCER RES, V61, P1477; Rapkin L, 2012, PEDIATR BLOOD CANCER, V59, P854, DOI 10.1002/pbc.24101; Ribatti D, 2002, INT J CANCER, V102, P351, DOI 10.1002/ijc.10742; Ribattia Domenico, 2005, Cancer Treatment Reviews, V31, P27, DOI 10.1016/j.ctrv.2004.09.006; Rossler J, 2011, INT J CANCER, V128, P2748, DOI 10.1002/ijc.25611; SORBO J, 1994, INT J EXP PATHOL, V75, P43; Warner TD, 2004, FASEB J, V18, P790, DOI 10.1096/fj.03-0645rev; Weber CK, 2000, GASTROENTEROLOGY, V119, P1209, DOI 10.1053/gast.2000.19458; Weiss WA, 1997, EMBO J, V16, P2985, DOI 10.1093/emboj/16.11.2985; Weninger W, 1998, J INVEST DERMATOL, V111, P907, DOI 10.1046/j.1523-1747.1998.00393.x; Yu AL, 2010, NEW ENGL J MED, V363, P1324, DOI 10.1056/NEJMoa0911123; Zage PE, 2010, CANCER-AM CANCER SOC, V116, P2465, DOI 10.1002/cncr.25017	49	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90224	10.1371/journal.pone.0090224	http://dx.doi.org/10.1371/journal.pone.0090224			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603724	gold, Green Published			2022-12-27	WOS:000332483600032
J	Laxminarayan, R; Reif, J; Malani, A				Laxminarayan, Ramanan; Reif, Julian; Malani, Anup			Incentives for Reporting Disease Outbreaks	PLOS ONE			English	Article							MENINGOCOCCAL MENINGITIS; HAJJ PILGRIMS; INFLUENZA; AFRICA	Background: Countries face conflicting incentives to report infectious disease outbreaks. Reports of outbreaks can prompt other countries to impose trade and travel restrictions, which has the potential to discourage reporting. However, reports can also bring medical assistance to contain the outbreak, including access to vaccines. Methods: We compiled data on reports of meningococcal meningitis to the World Health Organization (WHO) from 54 African countries between 1966 and 2002, a period is marked by two events: first, a large outbreak reported from many countries in 1987 associated with the Hajj that resulted in more stringent requirements for meningitis vaccination among pilgrims; and second, another large outbreak in Sub-Saharan Africa in 1996 that led to a new international mechanism to supply vaccines to countries reporting a meningitis outbreak. We used fixed-effects regression modeling to statistically estimate the effect of external forcing events on the number of countries reporting cases of meningitis to WHO. Findings: We find that the Hajj vaccination requirements started in 1988 were associated with reduced reporting, especially among countries with relatively fewer cases reported between 1966 and 1979. After the vaccine provision mechanism was in place in 1996, reporting among countries that had previously not reported meningitis outbreaks increased. Interpretation: These results indicate that countries may respond to changing incentives to report outbreaks when they can do so. In the long term, these incentives are likely to be more important than surveillance assistance in prompt reporting of outbreaks.	[Laxminarayan, Ramanan; Malani, Anup] Ctr Dis Dynam Econ & Policy, Washington, DC 20036 USA; [Laxminarayan, Ramanan] Princeton Univ, Princeton, NJ 08544 USA; [Laxminarayan, Ramanan] Publ Hlth Fdn India, Inst Area, New Delhi, India; [Malani, Anup] Univ Chicago, Sch Law, Chicago, IL 60637 USA; [Malani, Anup] Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA; [Reif, Julian] Univ Illinois, Dept Finance, Champaign, IL USA; [Reif, Julian] Univ Illinois, Inst Govt & Publ Affairs, Champaign, IL USA	Princeton University; Public Health Foundation of India; University of Chicago; University of Chicago; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Laxminarayan, R (corresponding author), Ctr Dis Dynam Econ & Policy, Washington, DC 20036 USA.	Ramanan@cddep.org	Laxminarayan, Ramanan/ABD-5050-2021	Malani, Anup/0000-0002-2594-5778	Health Grand Challenges Program at Princeton University	Health Grand Challenges Program at Princeton University	Ramanan Laxminarayan was supported by the Health Grand Challenges Program at Princeton University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlGahtani YM, 1995, EPIDEMIOL INFECT, V115, P399, DOI 10.1017/S0950268800058556; [Anonymous], 2008, LANCET INFECT DIS, V8, P1; Baker MG, 2006, EMERG INFECT DIS, V12, P1058; Central Intelligence Agency, 2009, WORLD FACTB 2009; El Bashir H, 2007, LANCET, V369, P1343, DOI 10.1016/S0140-6736(07)60625-4; ElBushra HE, 1995, E AFR MED J, V72, P715; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; French Howard W., 1996, NY TIMES; Greenwood B, 1999, T ROY SOC TROP MED H, V93, P341, DOI 10.1016/S0035-9203(99)90106-2; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Malani A, 2011, J HUM RESOUR, V46, P176; Memish ZA, 2002, CLIN INFECT DIS, V34, P84, DOI 10.1086/323403; Normile D, 2010, SCIENCE, V330, P435, DOI 10.1126/science.330.6003.435; NOVELLI VM, 1987, LANCET, V2, P863; Teyssou R, 2007, VACCINE, V25, pA3, DOI 10.1016/j.vaccine.2007.04.032; World Health Organization, 2013, WHO VACC PREV DIS MO	16	5	5	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90290	10.1371/journal.pone.0090290	http://dx.doi.org/10.1371/journal.pone.0090290			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603414	Green Submitted, Green Published, gold			2022-12-27	WOS:000332483600040
J	Starha, P; Hosek, J; Vanco, J; Dvorak, Z; Suchy, P; Popa, I; Prazanova, G; Travnicek, Z				Starha, Pavel; Hosek, Jan; Vanco, Jan; Dvorak, Zdenek; Suchy, Pavel, Jr.; Popa, Igor; Prazanova, Gabriela; Travnicek, Zdenek			Pharmacological and Molecular Effects of Platinum(II) Complexes Involving 7-Azaindole Derivatives	PLOS ONE			English	Article							IN-VITRO CYTOTOXICITY; CISPLATIN RESISTANCE; CRYSTAL-STRUCTURE; CARRIER LIGANDS; ANTICANCER; CELL; OXALIPLATIN; CANCER; AGENTS; DNA	The in vitro antitumour activity studies on a panel of human cancer cell lines (A549, HeLa, G-361, A2780, and A2780R) and the combined in vivo and ex vivo antitumour testing on the L1210 lymphocytic leukaemia model were performed on the cis-[PtCl2(naza)2] complexes (1-3) involving the 7-azaindole derivatives (naza). The platinum(II) complexes showed significantly higher in vitro cytotoxic effects on cell-based models, as compared with cisplatin, and showed the ability to avoid the acquired resistance of the A2780R cell line to cisplatin. The in vivo testing of the complexes (applied at the same dose as cisplatin) revealed their positive effect on the reduction of cancerous tissues volume, even if it is lower than that of cisplatin, however, they also showed less serious adverse effects on the healthy tissues and the health status of the treated mice. The results of ex vivo assays revealed that the complexes 1-3 were able to modulate the levels of active forms of caspases 3 and 8, and the transcription factor p53, and thus activate the intrinsic (mitochondrial) pathway of apoptosis. The pharmacological observations were supported by both the histological and immunohistochemical evaluation of isolated cancerous tissues. The applicability of the prepared complexes and their fate in biological systems, characterized by the hydrolytic stability and the thermodynamic aspects of the interactions with cysteine, reduced glutathione, and human serum albumin were studied by the mass spectrometry and isothermal titration calorimetric experiments.	[Starha, Pavel; Hosek, Jan; Vanco, Jan; Popa, Igor; Travnicek, Zdenek] Palacky Univ, Dept Inorgan Chem, Reg Ctr Adv Technol & Mat, Fac Sci, CR-77147 Olomouc, Czech Republic; [Dvorak, Zdenek] Palacky Univ, Fac Sci, Dept Cell Biol & Genet, Reg Ctr Adv Technol & Mat, CR-77147 Olomouc, Czech Republic; [Suchy, Pavel, Jr.; Prazanova, Gabriela] Univ Vet & Pharmaceut Sci Brno, Fac Pharm, Dept Human Pharmacol & Toxicol, Brno, Czech Republic	Palacky University Olomouc; Palacky University Olomouc; University of Veterinary Sciences Brno	Travnicek, Z (corresponding author), Palacky Univ, Dept Inorgan Chem, Reg Ctr Adv Technol & Mat, Fac Sci, CR-77147 Olomouc, Czech Republic.	zdenek.travnicek@upol.cz	Starha, Pavel/H-3902-2016; Suchy, Pavel/A-6632-2009; Vanco, Jan/H-2705-2013; Hosek, Jan/B-6274-2009	Suchy, Pavel/0000-0002-6277-2749; Vanco, Jan/0000-0003-3351-1192; Hosek, Jan/0000-0003-0975-1671; Starha, Pavel/0000-0003-0422-045X; Travnicek, Zdenek/0000-0002-5890-7874; Dvorak, Zdenek/0000-0002-3938-3585	Czech Science Foundation [GACR P207/11/0841]; Operational Program Research and Development for Innovations - European Regional Development Fund [CZ.1.05/2.1.00/03.0058]; Ministry of Education, Youth and Sports of the Czech Republic [CZ.1.07/2.3.00/20.0017]; Palacky University in Olomouc [PrF_2013_015]; University of Veterinary and Pharmaceutical Sciences Brno [IGA VFU 82/2012/FaF]	Czech Science Foundation(Grant Agency of the Czech Republic); Operational Program Research and Development for Innovations - European Regional Development Fund; Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Palacky University in Olomouc; University of Veterinary and Pharmaceutical Sciences Brno	The authors acknowledge funding from the Czech Science Foundation (GACR P207/11/0841), Operational Program Research and Development for Innovations - European Regional Development Fund (CZ.1.05/2.1.00/03.0058), Operational Program Education for Competitiveness - European Social Fund (CZ.1.07/2.3.00/20.0017) of the Ministry of Education, Youth and Sports of the Czech Republic, Palacky University in Olomouc (PrF_2013_015), and University of Veterinary and Pharmaceutical Sciences Brno (IGA VFU 82/2012/FaF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal ML, 1998, J BIOL CHEM, V273, P1, DOI 10.1074/jbc.273.1.1; AKAZA H, 1992, CANCER CHEMOTH PHARM, V31, P187, DOI 10.1007/BF00685546; [Anonymous], 2010, US Patent, Patent No. [H.J. Dyke, S. Price, K. Williams, 20100216768]; Brown SD, 2012, DALTON T, V41, P11330, DOI 10.1039/c2dt31313h; Carland M, 2010, J INORG BIOCHEM, V104, P815, DOI 10.1016/j.jinorgbio.2010.03.011; Carreira M, 2012, J INORG BIOCHEM, V116, P204, DOI 10.1016/j.jinorgbio.2012.06.017; Chauhan P, 2009, IMMUNOBIOLOGY, V214, P197, DOI 10.1016/j.imbio.2008.07.012; Cheve G, 2012, MEDCHEMCOMM, V3, P788, DOI 10.1039/c2md20104f; de Mier-Vinue J, 2008, J MED CHEM, V51, P424, DOI 10.1021/jm070844u; Esposito BP, 2002, COORDIN CHEM REV, V232, P137, DOI 10.1016/S0010-8545(02)00049-8; Galanski M, 2004, EUR J MED CHEM, V39, P707, DOI 10.1016/j.ejmech.2004.04.003; Gong JG, 1999, NATURE, V399, P806; HARRAP KR, 1985, CANCER TREAT REV, V12, P21, DOI 10.1016/0305-7372(85)90015-5; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Holford J, 1998, ANTI-CANCER DRUG DES, V13, P1; Holford J, 1998, BRIT J CANCER, V77, P366, DOI 10.1038/bjc.1998.59; Hong S, 2012, J MED CHEM, V55, P5337, DOI 10.1021/jm3002982; Hua H, 2011, CELL MOL LIFE SCI, V68, P3853, DOI 10.1007/s00018-011-0763-x; Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167; Kelland LR, 2000, PLATINUM BASED DRUGS; KIDANI Y, 1978, J MED CHEM, V21, P1315, DOI 10.1021/jm00210a029; Komeda S, 2013, METALLOMICS, V5, P461, DOI 10.1039/c3mt00040k; Margiotta N, 2010, J MED CHEM, V53, P5144, DOI 10.1021/jm100429r; McKeage MJ, 2001, EXPERT OPIN INV DRUG, V10, P119, DOI 10.1517/13543784.10.1.119; Muchova T, 2013, J BIOL INORG CHEM, V18, P579, DOI 10.1007/s00775-013-1003-7; Nagle PS, 2012, J MED CHEM, V55, P4397, DOI 10.1021/jm300296f; Pierce LT, 2012, EUR J MED CHEM, V56, P292, DOI 10.1016/j.ejmech.2012.08.002; Pogozhev D, 2013, POLYHEDRON, V52, P1329, DOI 10.1016/j.poly.2012.06.009; Quirante J, 2011, J INORG BIOCHEM, V105, P1720, DOI 10.1016/j.jinorgbio.2011.09.021; REEDIJK J, 1987, PURE APPL CHEM, V59, P181, DOI 10.1351/pac198759020181; Reedijk J, 1999, CHEM REV, V99, P2499, DOI 10.1021/cr980422f; ROSENBERG B, 1969, NATURE, V222, P385, DOI 10.1038/222385a0; ROSENBERG B, 1965, NATURE, V205, P698, DOI 10.1038/205698a0; Ruiz J, 2010, DALTON T, V39, P3290, DOI 10.1039/b920854b; Salemi G, 2009, NEUROL SCI, V30, P361, DOI 10.1007/s10072-009-0090-2; Sharp SY, 2002, EUR J CANCER, V38, P2309, DOI 10.1016/S0959-8049(02)00244-7; Shen DW, 2012, PHARMACOL REV, V64, P706, DOI 10.1124/pr.111.005637; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Spuches AM, 2005, INORG CHEM, V44, P2964, DOI 10.1021/ic048694q; Starha P, 2012, J INORG BIOCHEM, V115, P57, DOI 10.1016/j.jinorgbio.2012.05.006; Starha P, 2012, POLYHEDRON, V33, P404, DOI 10.1016/j.poly.2011.11.059; TALHOUK RS, 1991, DEVELOPMENT, V112, P439; Timerbaev AR, 2006, CHEM REV, V106, P2224, DOI 10.1021/cr040704h; Travnicek Z, 2011, J INORG BIOCHEM, V105, P937, DOI 10.1016/j.jinorgbio.2011.04.002; Tsoureas N, 2011, DALTON T, V40, P951, DOI 10.1039/c0dt01148g; Vrzal R, 2010, J INORG BIOCHEM, V104, P1130, DOI 10.1016/j.jinorgbio.2010.07.002; W.H. Organization, 2009, WORLD HLTH STAT 2009; Wheate NJ, 2010, DALTON T, V39, P8113, DOI 10.1039/c0dt00292e; Xu G, 2011, EUR J MED CHEM, V46, P356, DOI 10.1016/j.ejmech.2010.11.025; Yamori T, 2003, CANCER CHEMOTH PHARM, V52, pS74, DOI 10.1007/s00280-003-0649-1; Zhang BZ, 2008, J AM SOC NEPHROL, V19, P923, DOI 10.1681/ASN.2007090982	51	29	30	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90341	10.1371/journal.pone.0090341	http://dx.doi.org/10.1371/journal.pone.0090341			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603594	Green Published, Green Submitted, gold			2022-12-27	WOS:000332483600045
J	Jia, HG; Wang, N				Jia, Hongge; Wang, Nian			Targeted Genome Editing of Sweet Orange Using Cas9/sgRNA	PLOS ONE			English	Article							XANTHOMONAS-CITRI; TOBACCO PLANTS; MUTAGENESIS; GENE; RNA; ARABIDOPSIS; NUCLEASES; TALEN; EXPRESSION; MULTIPLEX	Genetic modification, including plant breeding, has been widely used to improve crop yield and quality, as well as to increase disease resistance. Targeted genome engineering is expected to contribute significantly to future varietal improvement, and genome editing technologies using zinc finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs), and clustered regularly interspaced short palindromic repeat (CRISPR)/Cas9/single guide RNA ( sgRNA) have already been successfully used to genetically modify plants. However, to date, there has been no reported use of any of the current genome editing approaches in sweet orange, an important fruit crop. In this study, we first developed a novel tool, Xcc-facilitated agroinfiltration, for enhancing transient protein expression in sweet orange leaves. We then successfully employed Xcc-facilitated agroinfiltration to deliver Cas9, along with a synthetic sgRNA targeting the CsPDS gene, into sweet orange. DNA sequencing confirmed that the CsPDS gene was mutated at the target site in treated sweet orange leaves. The mutation rate using the Cas9/sgRNA system was approximately 3.2 to 3.9%. Off-target mutagenesis was not detected for CsPDS-related DNA sequences in our study. This is the first report of targeted genome modification in citrus using the Cas9/sgRNA system-a system that holds significant promise for the study of citrus gene function and for targeted genetic modification.	[Jia, Hongge; Wang, Nian] Univ Florida, Dept Microbiol & Cell Sci, Citrus Res & Educ Ctr, Lake Alfred, FL 33850 USA	State University System of Florida; University of Florida	Wang, N (corresponding author), Univ Florida, Dept Microbiol & Cell Sci, Citrus Res & Educ Ctr, Lake Alfred, FL 33850 USA.	nianwang@ufl.edu	Wang, Nian/HDM-2087-2022	Wang, Nian/0000-0001-7743-0728; Ren, Ning/0000-0001-9776-2471	Citrus Research and Development Foundation	Citrus Research and Development Foundation	This work was supported by the Citrus Research and Development Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belhaj K, 2013, PLANT METHODS, V9, DOI 10.1186/1746-4811-9-39; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Brunings AM, 2003, MOL PLANT PATHOL, V4, P141, DOI 10.1046/j.1364-3703.2003.00163.x; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Chen KL, 2013, J GENET GENOMICS, V40, P271, DOI 10.1016/j.jgg.2013.03.009; Christian M, 2013, TARGETED MUTAGENESIS, pG3; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Curtin SJ, 2013, METHODS MOL BIOL, V1069, P25, DOI 10.1007/978-1-62703-613-9_3; de Pater S, 2013, PLANT BIOTECHNOL J, V11, P510, DOI 10.1111/pbi.12040; DING SW, 1995, J GEN VIROL, V76, P459, DOI 10.1099/0022-1317-76-2-459; Febres V, 2011, CITRUS TRANSFORMATIO, DOI [10.5772/24526, DOI 10.5772/24526]; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Jia HG, 2007, PLANT CELL REP, V26, P1961, DOI 10.1007/s00299-007-0403-y; Jia HG, 2006, TRANSGENIC RES, V15, P375, DOI 10.1007/s11248-006-0011-6; Jiang WZ, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt780; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Li JF, 2013, NAT BIOTECHNOL, V31, P688, DOI 10.1038/nbt.2654; Li T, 2012, NAT BIOTECHNOL, V30, P390, DOI 10.1038/nbt.2199; Liu ZZ, 2003, PLANTA, V216, P824, DOI 10.1007/s00425-002-0934-y; Lloyd A, 2005, P NATL ACAD SCI USA, V102, P2232, DOI 10.1073/pnas.0409339102; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Nekrasov V, 2013, NAT BIOTECHNOL, V31, P691, DOI 10.1038/nbt.2655; Qi Y, 2013, TARGETED DELETION IN, pG3; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; Shukla VK, 2009, NATURE, V459, P437, DOI 10.1038/nature07992; Strauss A, 2013, MOL PLANT, V6, P1384, DOI 10.1093/mp/sst075; Streubel J, 2012, NAT BIOTECHNOL, V30, P593, DOI 10.1038/nbt.2304; Sun Z, 2013, J INTEGR PLANT BIOL; SWARUP S, 1992, MOL PLANT MICROBE IN, V5, P204, DOI 10.1094/MPMI-5-204; Talon Manuel, 2008, Int J Plant Genomics, V2008, P528361, DOI 10.1155/2008/528361; Townsend JA, 2009, NATURE, V459, P442, DOI 10.1038/nature07845; Wendt T, 2013, PLANT MOL BIOL, V83, P279, DOI 10.1007/s11103-013-0078-4; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Xie KB, 2013, MOL PLANT, V6, P1975, DOI 10.1093/mp/sst119; Xu Q, 2013, NAT GENET, V45, P59, DOI 10.1038/ng.2472; Yan Q, 2012, MOL PLANT MICROBE IN, V25, P69, DOI 10.1094/MPMI-05-11-0121; Zhang F, 2011, METHODS MOL BIOL, V701, P167, DOI 10.1007/978-1-61737-957-4_9; Zhang F, 2010, P NATL ACAD SCI USA, V107, P12028, DOI 10.1073/pnas.0914991107; Zhang Y, 2013, PLANT PHYSIOL, V161, P20, DOI 10.1104/pp.112.205179	41	144	182	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93806	10.1371/journal.pone.0093806	http://dx.doi.org/10.1371/journal.pone.0093806			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24603412	gold, Green Published, Green Submitted			2022-12-27	WOS:000334159800053
J	Chien, MH; Guo, HR				Chien, Ming-Hung; Guo, How-Ran			Nutritional Status and Falls in Community-Dwelling Older People: A Longitudinal Study of a Population-Based Random Sample	PLOS ONE			English	Article							MASS INDEX BMI; RISK-FACTORS; ASSESSMENT MNA; ELDERLY-PATIENTS; INJURIOUS FALLS; PREDICTORS; MORTALITY; FUNCTIONALITY; PREVENTION; CARE	Background: Falls are common in older people and may lead to functional decline, disability, and death. Many risk factors have been identified, but studies evaluating effects of nutritional status are limited. To determine whether nutritional status is a predictor of falls in older people living in the community, we analyzed data collected through the Survey of Health and Living Status of the Elderly in Taiwan (SHLSET). Methods: SHLSET include a series of interview surveys conducted by the government on a random sample of people living in community dwellings in the nation. We included participants who received nutritional status assessment using the Mini Nutritional Assessment Taiwan Version 2 (MNA-T2) in the 1999 survey when they were 53 years or older and followed up on the cumulative incidence of falls in the one-year period before the interview in the 2003 survey. Results: At the beginning of follow-up, the 4440 participants had a mean age of 69.5 (standard deviation = 9.1) years, and 467 participants were "not well-nourished," which was defined as having an MNA-T2 score of 23 or less. In the one-year study period, 659 participants reported having at least one fall. After adjusting for other risk factors, we found the associated odds ratio for falls was 1.73 (95% confidence interval, 1.23, 2.42) for "not well-nourished," 1.57 (1.30, 1.90) for female gender, 1.03 (1.02, 1.04) for one-year older, 1.55 (1.22, 1.98) for history of falls, 1.34 (1.05, 1.72) for hospital stay during the past 12 months, 1.66 (1.07, 2.58) for difficulties in activities of daily living, and 1.53 (1.23, 1.91) for difficulties in instrumental activities of daily living. Conclusion: Nutritional status is an independent predictor of falls in older people living in the community. Further studies are warranted to identify nutritional interventions that can help prevent falls in the elderly.	[Chien, Ming-Hung] Chung Hwa Univ Med Technol, Dept Hlth Care Adm, Tainan, Taiwan; [Guo, How-Ran] Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth, Tainan 70101, Taiwan; [Guo, How-Ran] Natl Cheng Kung Univ Hosp, Dept Occupat & Environm Med, Tainan 70428, Taiwan	Chung Hua University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital	Guo, HR (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth, Tainan 70101, Taiwan.	hrguo@mail.ncku.edu.tw	Guo, How-Ran/AAK-9063-2020	Guo, How-Ran/0000-0003-3343-3446				Ahmed T, 2010, CLIN INTERV AGING, V5, P207; Avila-Funes JA, 2008, J AM COLL NUTR, V27, P492, DOI 10.1080/07315724.2008.10719730; Beck AM, 1999, BRIT J NUTR, V81, P31, DOI 10.1017/S0007114599000860; Cairella G, 2005, Ann Ig, V17, P35; CAMPBELL AJ, 1989, J GERONTOL, V44, pM112, DOI 10.1093/geronj/44.4.m112; Cereda E, 2008, CLIN NUTR, V27, P700, DOI 10.1016/j.clnu.2008.06.001; Chan K. M., 1997, SMJ, V38, P427; Chang HH, 2010, ARCH GERONTOL GERIAT, V50, pS30, DOI 10.1016/S0167-4943(10)70009-1; Charlton KE, 2005, PUBLIC HEALTH NUTR, V8, P468, DOI 10.1079/PHN2005783; Chu LW, 2005, ANN ACAD MED SINGAP, V34, P60; Close JCT, 2012, EMERG MED J, V29, P742, DOI 10.1136/emermed-2011-200380; Lantigua MC, 2007, ARCH LATINOAM NUTR, V57, P255; Duh MS, 2008, DRUG AGING, V25, P325, DOI 10.2165/00002512-200825040-00005; Ganz DA, 2007, JAMA-J AM MED ASSOC, V297, P77, DOI 10.1001/jama.297.1.77; Gill T, 2005, GERONTOLOGY, V51, P340, DOI 10.1159/000086372; Graafmans WC, 1996, AM J EPIDEMIOL, V143, P1129; Grundstrom AC, 2012, ARCH GERONTOL GERIAT, V54, P421, DOI 10.1016/j.archger.2011.06.008; Guigoz Y, 1997, Ther Umsch, V54, P345; Guigoz Y, 2006, J NUTR HEALTH AGING, V10, P466; Guigoz Y, 1996, NUTR REV, V54, pS59; Iizaka S, 2008, GERIATR GERONTOL INT, V8, P24, DOI 10.1111/j.1447-0594.2008.00443.x; Johnson C Shanthi, 2003, J Nutr Health Aging, V7, P247; Kannus P, 2005, LANCET, V366, P1885, DOI 10.1016/S0140-6736(05)67604-0; Kearns WD, 2012, J AM MED DIR ASSOC, V13, DOI 10.1016/j.jamda.2012.06.010; Kool B, 2009, INJURY PREV, V15, P341, DOI 10.1136/ip.2008.021303; Koski K, 1998, GERONTOLOGY, V44, P232, DOI 10.1159/000022017; Kwan MMS, 2011, J AM GERIATR SOC, V59, P536, DOI 10.1111/j.1532-5415.2010.03286.x; Lee LC, 2012, ARCH GERONTOL GERIAT, V54, pE405, DOI 10.1016/j.archger.2011.12.006; Lin CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018976; Meijers JMM, 2012, J NUTR HEALTH AGING, V16, P654, DOI 10.1007/s12603-012-0010-7; Muraki S, 2013, BONE, V52, P516, DOI 10.1016/j.bone.2012.10.020; NEVITT MC, 1989, JAMA-J AM MED ASSOC, V261, P2663, DOI 10.1001/jama.261.18.2663; Newton Mel, 2013, Nurs Older People, V25, P16, DOI 10.7748/nop2013.10.25.8.16.e489; Neyens J, 2013, ARCH GERONTOL GERIAT, V56, P265, DOI 10.1016/j.archger.2012.08.005; ROBBINS AS, 1989, ARCH INTERN MED, V149, P1628, DOI 10.1001/archinte.1989.00390070138022; Robertson MC, 2013, JAMA-J AM MED ASSOC, V309, P1406, DOI 10.1001/jama.2013.3130; Rubenstein LZ, 2002, CLIN GERIATR MED, V18, P141, DOI 10.1016/S0749-0690(02)00002-2; RYYNANEN OP, 1991, PUBLIC HEALTH, V105, P373, DOI 10.1016/S0033-3506(05)80597-9; Sai AJ, 2010, J MUSCULOSKEL NEURON, V10, P142; Salvi F, 2008, AGING CLIN EXP RES, V20, P322; Sherrington C, 2008, J AM GERIATR SOC, V56, P2234, DOI 10.1111/j.1532-5415.2008.02014.x; Stevens JA, 2008, J SAFETY RES, V39, P345, DOI 10.1016/j.jsr.2008.05.002; *TAIW PROV I FAM P, 1989, 1 U MICH POP STUD CT; Tinetti ME, 1998, J GERONTOL A-BIOL, V53, pM112, DOI 10.1093/gerona/53A.2.M112; TINETTI ME, 1988, NEW ENGL J MED, V319, P1701, DOI 10.1056/NEJM198812293192604; Tsai AC, 2010, J NUTR HEALTH AGING, V14, P183, DOI 10.1007/s12603-010-0046-5; Tsai AC, 2008, J NUTR HEALTH AGING, V12, P696; Tsai AC, 2008, BRIT J NUTR, V100, P152, DOI 10.1017/S0007114507873600; Tsai AC, 2011, J CLIN NURS, V20, P341, DOI 10.1111/j.1365-2702.2010.03467.x; Tsai AC, 2010, BRIT J NUTR, V104, P93, DOI 10.1017/S0007114510000188; Tsai AC, 2009, INT J NURS STUD, V46, P1431, DOI 10.1016/j.ijnurstu.2009.05.004; Tsai AC, 2009, J CLIN NURS, V18, P82, DOI 10.1111/j.1365-2702.2008.02319.x; Tsai ACH, 2007, ASIA PAC J CLIN NUTR, V16, P656; Tsai ACH, 2012, ARCH GERONTOL GERIAT, V54, P443, DOI 10.1016/j.archger.2011.05.015; Vellas B, 1999, NUTRITION, V15, P116, DOI 10.1016/S0899-9007(98)00171-3; Vellas BJ, 1998, J GERONTOL A-BIOL, V53, pM264, DOI 10.1093/gerona/53A.4.M264; Vivanti A, 2011, J NUTR HEALTH AGING, V15, P388, DOI 10.1007/s12603-010-0302-8; Wikby K, 2008, J CLIN NURS, V17, P1211, DOI 10.1111/j.1365-2702.2007.02012.x	58	34	35	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91044	10.1371/journal.pone.0091044	http://dx.doi.org/10.1371/journal.pone.0091044			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9FH	24614184	Green Published, gold			2022-12-27	WOS:000332839300070
J	Degroote, RL; Hauck, SM; Amann, B; Hirmer, S; Ueffing, M; Deeg, CA				Degroote, Roxane L.; Hauck, Stefanie M.; Amann, Barbara; Hirmer, Sieglinde; Ueffing, Marius; Deeg, Cornelia A.			Unraveling the Equine Lymphocyte Proteome: Differential Septin 7 Expression Associates with Immune Cells in Equine Recurrent Uveitis	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; RETINAL S-ANTIGEN; AUTOIMMUNE UVEITIS; MEMBRANE-PROTEINS; MAMMALIAN SEPTINS; BINDING PROTEIN; T-LYMPHOCYTES; TARGET TISSUE; IDENTIFICATION; AUTOANTIGENS	Equine recurrent uveitis is a spontaneous, lymphocyte-driven autoimmune disease. It affects horses worldwide and presents with painful remitting-relapsing inflammatory attacks of inner eye structures eventually leading to blindness. Since lymphocytes are the key players in equine recurrent uveitis, we were interested in potential changes of their protein repertoire which may be involved in disease pathogenesis. To create a reference for differential proteome analysis, we first unraveled the equine lymphocyte proteome by two-dimensional sodium dodecyl sulfate - polyacrylamide gel electrophoresis and subsequently identified 352 protein spots. Next, we compared lymphocytes from ERU cases and healthy horses with a two-dimensional fluorescence difference in gel electrophoresis approach. With this technique, we identified seven differentially expressed proteins between conditions. One of the significantly lower expressed candidates, septin 7, plays a role in regulation of cell shape, motility and migration. Further analyses revealed T cells as the main cell type with decreased septin 7 abundance in equine recurrent uveitis. These findings point to a possible pathogenetic role of septin 7 in this sight-threatening disease.	[Degroote, Roxane L.; Amann, Barbara; Hirmer, Sieglinde; Deeg, Cornelia A.] Univ Munich, Dept Vet Sci, Inst Anim Physiol, Munich, Germany; [Hauck, Stefanie M.; Ueffing, Marius] German Res Ctr Environm Hlth, Helmholtz Ctr Munich, Res Unit Prot Sci, Neuherberg, Germany; [Ueffing, Marius] Univ Tubingen, Ctr Ophthalmol, Inst Ophthalm Res, Tubingen, Germany	University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Deeg, CA (corresponding author), Univ Munich, Dept Vet Sci, Inst Anim Physiol, Munich, Germany.	deeg@tiph.vetmed.uni-muenchen.de	Deeg, Cornelia A/G-4940-2010; Deeg, Cornelia/U-4216-2019; Hauck, Stefanie/B-3300-2013	Deeg, Cornelia A/0000-0003-0375-3190; Hauck, Stefanie/0000-0002-1630-6827; Degroote, Roxane/0000-0003-2680-7227	Deutsche Forschungsgemeinschaft [DFG SFB 571-3 A5, DE 719/4-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Research was supported by grants of the Deutsche Forschungsgemeinschaft to CD; DFG SFB 571-3 A5 and DE 719/4-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonilha VL, 2007, EXP EYE RES, V84, P613, DOI 10.1016/j.exer.2006.01.011; BYERS B, 1976, J CELL BIOL, V69, P717, DOI 10.1083/jcb.69.3.717; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Caspi R, 2008, IMMUNOL RES, V42, P41, DOI 10.1007/s12026-008-8031-3; Caspi RR, 2006, IMMUNOL REV, V213, P23, DOI 10.1111/j.1600-065X.2006.00439.x; Chae JI, 2012, ANIM REPROD SCI, V134, P164, DOI 10.1016/j.anireprosci.2012.07.008; Deeg CA, 2006, INVEST OPHTH VIS SCI, V47, P652, DOI 10.1167/iovs.05-0789; Deeg CA, 2004, INVEST OPHTH VIS SCI, V45, P2286, DOI 10.1167/iovs.03-1226; Deeg CA, 2002, EXP EYE RES, V75, P127, DOI 10.1006/exer.2002.2011; Deeg CA, 2002, EUR J IMMUNOL, V32, P2598, DOI 10.1002/1521-4141(200209)32:9&lt;2598::AID-IMMU2598&gt;3.0.CO;2-#; Deeg CA, 2001, INVEST OPHTH VIS SCI, V42, P393; Deeg CA, 2008, OPHTHAL RES, V40, P151, DOI 10.1159/000119867; Deeg CA, 2006, MOL CELL PROTEOMICS, V5, P1462, DOI 10.1074/mcp.M500352-MCP200; Deeg CA, 2007, CLIN DEV IMMUNOL, DOI 10.1155/2007/39245; Degroote RL, 2013, J PROTEOME RES; Degroote RL, 2012, J PROTEOMICS, V75, P4536, DOI 10.1016/j.jprot.2012.01.023; DESMET MD, 1993, J AUTOIMMUN, V6, P587, DOI 10.1006/jaut.1993.1048; Engidawork E, 2003, NEUROSCIENCE, V122, P145, DOI 10.1016/S0306-4522(03)00605-5; Eriksen KW, 2010, J INVEST DERMATOL, V130, P1590, DOI 10.1038/jid.2010.6; Finlay DK, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00247; Fischer R, 2006, BIOCHEM CELL BIOL, V84, P303, DOI 10.1139/O06-058; Fruhauf B., 1998, Vet Ophthalmol, V1, P137, DOI 10.1046/j.1463-5224.1998.00030.x; Gerling IC, 2006, MOL CELL PROTEOMICS, V5, P293, DOI 10.1074/mcp.M500197-MCP200; Gilger BC, 2006, INVEST OPHTH VIS SCI, V47, P2596, DOI 10.1167/iovs.05-1540; Gilger BC, 2004, VET CLIN N AM-EQUINE, V20, P417, DOI 10.1016/j.cveq.2004.04.010; Gilger BC, 1999, VET IMMUNOL IMMUNOP, V71, P17, DOI 10.1016/S0165-2427(99)00082-3; HARTWELL LH, 1971, EXP CELL RES, V69, P265, DOI 10.1016/0014-4827(71)90223-0; HASHIZUME S, 1983, BIOCHIM BIOPHYS ACTA, V763, P377, DOI 10.1016/0167-4889(83)90099-X; Hauck SM, 2010, MOL CELL PROTEOMICS, V9, P2292, DOI 10.1074/mcp.M110.001073; Haudek VJ, 2009, J PROTEOME RES, V8, P3834, DOI 10.1021/pr801085g; Jia ZF, 2010, J NEURO-ONCOL, V98, P329, DOI 10.1007/s11060-009-0092-1; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kinoshita M, 2002, DEV CELL, V3, P791, DOI 10.1016/S1534-5807(02)00366-0; Kremer BE, 2005, MOL BIOL CELL, V16, P4648, DOI 10.1091/mbc.E05-03-0267; Kremer BE, 2007, CELL, V130, P837, DOI 10.1016/j.cell.2007.06.053; LeHoang P, 2008, OPHTHAL RES, V40, P181, DOI 10.1159/000119873; Lenchik NI, 2005, PROTEOMICS, V5, P2202, DOI 10.1002/pmic.200401107; Li S, 2012, CELL CYCLE, V11, P3211, DOI 10.4161/cc.21553; Lilley KS, 2004, EXPERT REV PROTEOMIC, V1, P401, DOI 10.1586/14789450.1.4.401; Maldonado EN, 2012, J PHARMACOL EXP THER, V342, P637, DOI 10.1124/jpet.112.192153; Marko AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015425; MAZURIER J, 1989, EUR J BIOCHEM, V179, P481, DOI 10.1111/j.1432-1033.1989.tb14578.x; Nagaraj N, 2008, J PROTEOME RES, V7, P5028, DOI 10.1021/pr800412j; Okunuki Y, 2008, MOL VIS, V14, P1094; Pao LI, 2007, ANNU REV IMMUNOL, V25, P473, DOI 10.1146/annurev.immunol.23.021704.115647; Pore D, 2013, J IMMUNOL; Ramirez-Boo M, 2006, PROTEOMICS, V6, pS215, DOI 10.1002/pmic.200500386; Sampson MJ, 1997, J BIOL CHEM, V272, P18966, DOI 10.1074/jbc.272.30.18966; Santoni V, 2000, ELECTROPHORESIS, V21, P1054, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1054::AID-ELPS1054>3.3.CO;2-#; Santos J, 2009, LEUK RES; Schulz M, 2007, J PROTEOME RES, V6, P3752, DOI 10.1021/pr070285f; SCHWINK KL, 1992, VET CLIN N AM-EQUINE, V8, P557, DOI 10.1016/S0749-0739(17)30441-8; Spiess B M, 2010, Equine Vet J Suppl, P50; Tatton WG, 2000, ADV RES NEURODEGENER, V8, P77; Tooley AJ, 2009, NAT CELL BIOL, V11, P17, DOI 10.1038/ncb1808; Vergara D, 2008, PROTEOMICS, V8, P2045, DOI 10.1002/pmic.200700726; Wasik AA, 2012, MOL BIOL CELL, V23, P3370, DOI 10.1091/mbc.E11-12-1010; Weirich CS, 2008, NAT REV MOL CELL BIO, V9, P478, DOI 10.1038/nrm2407; Wildner G, 2008, OPHTHAL RES, V40, P141, DOI 10.1159/000119865; Zipplies JK, 2010, INVEST OPHTH VIS SCI, V51, P375, DOI 10.1167/iovs.09-4094	60	20	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91684	10.1371/journal.pone.0091684	http://dx.doi.org/10.1371/journal.pone.0091684			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614191	Green Published, gold, Green Submitted			2022-12-27	WOS:000332839300149
J	Jeong, MH; Tran, NKS; Kwak, TH; Park, BK; Lee, CS; Park, TS; Lee, YH; Park, WJ; Yang, DK				Jeong, Moon Hee; Nguyen Khoi Song Tran; Kwak, Tae Hwan; Park, Byung Keon; Lee, Chul Soon; Park, Tae-Sik; Lee, Young-Hoon; Park, Woo Jin; Yang, Dong Kwon			beta-Lapachone Ameliorates Lipotoxic Cardiomyopathy in Acyl CoA Synthase Transgenic Mice	PLOS ONE			English	Article							FATTY-ACID OXIDATION; MITOCHONDRIAL-FUNCTION; RAT-HEART; SIRT1; ACTIVATION; OBESITY; METABOLISM; RESVERATROL; DYSFUNCTION; STRESS	Lipotoxic cardiomyopathy is caused by myocardial lipid accumulation and often occurs in patients with diabetes and obesity. This study investigated the effects of beta-lapachone (beta-lap), a natural compound that activates Sirt1 through elevation of the intracellular NAD(+) level, on acyl CoA synthase (ACS) transgenic (Tg) mice, which have lipotoxic cardiomyopathy. Oral administration of beta-lap to ACS Tg mice significantly attenuated heart failure and inhibited myocardial accumulation of triacylglycerol. Electron microscopy and measurement of mitochondrial complex II protein and mitochondrial DNA revealed that administration of beta-lap restored mitochondrial integrity and biogenesis in ACS Tg hearts. Accordingly, beta-lap administration significantly increased the expression of genes associated with mitochondrial biogenesis and fatty acid metabolism that were down-regulated in ACS Tg hearts. beta-lap also restored the activities of Sirt1 and AMP-activated protein kinase (AMPK), the two key regulators of metabolism, which were suppressed in ACS Tg hearts. In H9C2 cells, beta-lap-mediated elevation of AMPK activity was retarded when the level of Sirt1 was reduced by transfection of siRNA against Sirt1. Taken together, these results indicate that beta-lap exerts cardioprotective effects against cardiac lipotoxicity through the activation of Sirt1 and AMPK. beta-lap may be a novel therapeutic agent for the treatment of lipotoxic cardiomyopathy.	[Jeong, Moon Hee; Park, Woo Jin; Yang, Dong Kwon] Gwangju Inst Sci & Technol, Coll Life Sci, Kwangju, South Korea; [Nguyen Khoi Song Tran; Lee, Chul Soon; Park, Tae-Sik] Gachon Univ, Dept Life Sci, Songnam, South Korea; [Kwak, Tae Hwan] KT&G Life Sci Corp, R&D Ctr, Suwon, South Korea; [Park, Byung Keon; Lee, Young-Hoon] Chonbuk Natl Univ, Dept Oral Anat, Sch Dent, Jeonju, South Korea; [Park, Byung Keon; Lee, Young-Hoon] Chonbuk Natl Univ, Inst Oral Biosci, Jeonju, South Korea	Gwangju Institute of Science & Technology (GIST); Gachon University; Samsung; Jeonbuk National University; Jeonbuk National University	Park, WJ (corresponding author), Gwangju Inst Sci & Technol, Coll Life Sci, Kwangju, South Korea.	woojinpark@me.com; dkyang0502@gmail.com			Global Research Laboratory Program of the Korean Ministry of Education, Science and Technology [M6-0605-00-0001]; Korean Health Technology R&D Project of Korean Ministry of Health, Welfare Family Affairs [A101749]; Systems Biology Infrastructure Establishment Program of GIST; Korean Ministry of Education, Science and Technology [2010-0010754]	Global Research Laboratory Program of the Korean Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korean Health Technology R&D Project of Korean Ministry of Health, Welfare Family Affairs; Systems Biology Infrastructure Establishment Program of GIST; Korean Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	WJP was supported by a grant (M6-0605-00-0001) from the Global Research Laboratory Program of the Korean Ministry of Education, Science and Technology, a grant (A101749) from the Korean Health Technology R&D Project of Korean Ministry of Health, Welfare & Family Affairs, and a grant from the Systems Biology Infrastructure Establishment Program of GIST. DKY was supported by a grant (2010-0010754) from the Basic Science Research Program of the Korean Ministry of Education, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; BISHOP SP, 1970, AM J PHYSIOL, V218, P153, DOI 10.1152/ajplegacy.1970.218.1.153; Boudina S, 2007, DIABETES, V56, P2457, DOI 10.2337/db07-0481; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Chiu HC, 2001, J CLIN INVEST, V107, P813, DOI 10.1172/JCI10947; Choi YH, 2003, J BIOCHEM MOL BIOL, V36, P223; Feige JN, 2008, CELL METAB, V8, P347, DOI 10.1016/j.cmet.2008.08.017; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Goodwin GW, 1998, J BIOL CHEM, V273, P29530, DOI 10.1074/jbc.273.45.29530; Guarente L, 2011, NEW ENGL J MED, V364, P2235, DOI 10.1056/NEJMra1100831; Hwang JH, 2009, DIABETES, V58, P965, DOI 10.2337/db08-1183; Imai S, 2010, TRENDS PHARMACOL SCI, V31, P212, DOI 10.1016/j.tips.2010.02.003; Jaiswal AK, 2000, FREE RADICAL BIO MED, V29, P254, DOI 10.1016/S0891-5849(00)00306-3; KANNEL WB, 1974, AM J CARDIOL, V34, P29, DOI 10.1016/0002-9149(74)90089-7; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Khan RS, 2010, CURR OPIN CLIN NUTR, V13, P145, DOI 10.1097/MCO.0b013e3283357272; Kim SY, 2009, CIRC RES, V104, P842, DOI 10.1161/CIRCRESAHA.108.189837; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lan F, 2008, J BIOL CHEM, V283, P27628, DOI 10.1074/jbc.M805711200; Molavi B, 2006, CURR OPIN CARDIOL, V21, P479, DOI 10.1097/01.hco.0000240586.76344.f5; Pink JJ, 2000, EXP CELL RES, V255, P144, DOI 10.1006/excr.1999.4790; Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Rajamohan SB, 2009, MOL CELL BIOL, V29, P4116, DOI 10.1128/MCB.00121-09; Ritov VB, 2005, DIABETES, V54, P8, DOI 10.2337/diabetes.54.1.8; Rodgers JT, 2007, P NATL ACAD SCI USA, V104, P12861, DOI 10.1073/pnas.0702509104; SCHAFFNERSABBA K, 1984, J MED CHEM, V27, P990, DOI 10.1021/jm00374a010; Sharma S, 2004, FASEB J, V18, P1692, DOI 10.1096/fj.04-2263com; Shin BH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064953; SPURR AR, 1969, J ULTRA MOL STRUCT R, V26, P31, DOI 10.1016/S0022-5320(69)90033-1; Taegtmeyer H, 2004, ANN NY ACAD SCI, V1015, P202, DOI 10.1196/annals.1302.017; Tsutsui H, 2009, CARDIOVASC RES, V81, P449, DOI 10.1093/cvr/cvn280; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Wilson PWF, 2002, ARCH INTERN MED, V162, P1867, DOI 10.1001/archinte.162.16.1867; WITTELS B, 1968, J CLIN INVEST, V47, P1787, DOI 10.1172/JCI105868; Young ME, 2002, DIABETES, V51, P2587, DOI 10.2337/diabetes.51.8.2587; Zhou YT, 2000, P NATL ACAD SCI USA, V97, P1784, DOI 10.1073/pnas.97.4.1784	37	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91039	10.1371/journal.pone.0091039	http://dx.doi.org/10.1371/journal.pone.0091039			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614171	gold, Green Published, Green Submitted			2022-12-27	WOS:000332839300069
J	Jones, CB; Filippi, C; Sachithanantham, S; Rodriguez-Calvo, T; Ehrhardt, K; von Herrath, M				Jones, Carmen Baca; Filippi, Christophe; Sachithanantham, Sowbarnika; Rodriguez-Calvo, Teresa; Ehrhardt, Katrin; von Herrath, Matthias			Direct Infection of Dendritic Cells during Chronic Viral Infection Suppresses Antiviral T Cell Proliferation and Induces IL-10 Expression in CD4 T Cells	PLOS ONE			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; AMINO-ACID CHANGE; CROSS-PRESENTATION; IN-VIVO; TRANSGENIC MICE; PERSISTENCE; ANTIGEN; INTERLEUKIN-10; GLYCOPROTEIN; EXHAUSTION	Elevated levels of systemic IL-10 have been associated with several chronic viral infections, including HCV, EBV, HCMV and LCMV. In the chronic LCMV infection model, both elevated IL-10 and enhanced infection of dendritic cells (DCs) are important for viral persistence. This report highlights the relationship between enhanced viral tropism for DCs and the induction of IL-10 in CD4 T cells, which we identify as the most frequent IL-10-expressing cell type in chronic LCMV infection. Here we report that infected CD8 alpha(neg) DCs express elevated IL-10, induce IL-10 expression in LCMV specific CD4 T cells, and suppress LCMV-specific T cell proliferation. DCs exposed in vivo to persistent LCMV retain the capacity to stimulate CD4 T cell proliferation but induce IL-10 production by both polyclonal and LCMV-specific CD4 T cells. Our study delineates the unique effects of direct infection versus viral exposure on DCs. Collectively these data point to enhanced infection of DCs as a key trigger of the IL-10 induction cascade resulting in maintenance of elevated IL-10 expression in CD4 T cells and inhibition of LCMV-specific CD4 and CD8 T cell proliferation.	[Jones, Carmen Baca; Filippi, Christophe; Sachithanantham, Sowbarnika; Rodriguez-Calvo, Teresa; Ehrhardt, Katrin; von Herrath, Matthias] La Jolla Inst Allergy & Immunol, Type Diabet Ctr 1, La Jolla, CA 92037 USA	La Jolla Institute for Immunology	von Herrath, M (corresponding author), La Jolla Inst Allergy & Immunol, Type Diabet Ctr 1, La Jolla, CA 92037 USA.	matthias@liai.org	Rodriguez-Calvo, Teresa/AAH-2365-2019	Ehrhardt, Katrin/0000-0003-0471-2008	National Institutes of Health [R01AI068818, 3R01AI068818-03S1]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027366] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068818, P01AI089624] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grants R01AI068818 and 3R01AI068818-03S1. This work was supported by National Institutes of Health grants R01AI068818 and 3R01AI068818-03S1. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alatery A, 2010, EUR J IMMUNOL, V40, P2190, DOI 10.1002/eji.200939973; Albert ML, 1998, NATURE, V392, P86, DOI 10.1038/32183; Basta S, 2005, J IMMUNOL, V175, P796, DOI 10.4049/jimmunol.175.2.796; Belz GT, 2005, J IMMUNOL, V175, P196, DOI 10.4049/jimmunol.175.1.196; Blackburn SD, 2007, TRENDS MICROBIOL, V15, P143, DOI 10.1016/j.tim.2007.02.006; Blum JS, 2013, ANNU REV IMMUNOL, V31, P443, DOI 10.1146/annurev-immunol-032712-095910; BORROW P, 1992, J VIROL, V66, P7270, DOI 10.1128/JVI.66.12.7270-7281.1992; Brady MT, 2003, EUR J IMMUNOL, V33, P3448, DOI 10.1002/eji.200324251; Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492; CLERICI M, 1994, J CLIN INVEST, V93, P768, DOI 10.1172/JCI117031; den Haan JMM, 2002, J EXP MED, V196, P817, DOI 10.1084/jem.20020295; Eisen HN, 2012, P NATL ACAD SCI USA, V109, P4580, DOI 10.1073/pnas.1201586109; Ejrnaes M, 2006, J EXP MED, V203, P2461, DOI 10.1084/jem.20061462; Freigang S, 2007, P NATL ACAD SCI USA, V104, P13426, DOI 10.1073/pnas.0704423104; Gallimore A, 1998, J EXP MED, V187, P1383, DOI 10.1084/jem.187.9.1383; Heath WR, 2001, NAT REV IMMUNOL, V1, P126, DOI 10.1038/35100512; Joffre OP, 2012, NAT REV IMMUNOL, V12, P557, DOI 10.1038/nri3254; Kamanaka M, 2006, IMMUNITY, V25, P941, DOI 10.1016/j.immuni.2006.09.013; Kotenko SV, 2000, P NATL ACAD SCI USA, V97, P1695, DOI 10.1073/pnas.97.4.1695; MATLOUBIAN M, 1990, J EXP MED, V172, P1043, DOI 10.1084/jem.172.4.1043; McCausland MM, 2008, J VIROL METHODS, V147, P167, DOI 10.1016/j.jviromet.2007.08.025; Ng CT, 2012, P NATL ACAD SCI USA, V109, P14116, DOI 10.1073/pnas.1211910109; Nopora K, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00348; Oxenius A, 1998, EUR J IMMUNOL, V28, P390, DOI 10.1002/(SICI)1521-4141(199801)28:01<390::AID-IMMU390>3.0.CO;2-O; Pavelic V, 2009, EUR J IMMUNOL, V39, P704, DOI 10.1002/eji.200838901; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; Redpath S, 1999, J IMMUNOL, V162, P6701; Redpath S, 2001, TRENDS MICROBIOL, V9, P86, DOI 10.1016/S0966-842X(00)01919-3; Richter K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003735; SALVATO M, 1988, VIROLOGY, V164, P517, DOI 10.1016/0042-6822(88)90566-1; SALVATO M, 1991, J VIROL, V65, P1863, DOI 10.1128/JVI.65.4.1863-1869.1991; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Sevilla N, 2000, J EXP MED, V192, P1249, DOI 10.1084/jem.192.9.1249; Sevilla N, 2004, J CLIN INVEST, V113, P737, DOI 10.1172/JCI20243; Sullivan BM, 2011, P NATL ACAD SCI USA, V108, P2969, DOI 10.1073/pnas.1019304108; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Wilson EB, 2012, CELL HOST MICROBE, V11, P481, DOI 10.1016/j.chom.2012.03.009; Yewdell JW, 1999, ANNU REV CELL DEV BI, V15, P579, DOI 10.1146/annurev.cellbio.15.1.579; Yewdell JW, 2002, NAT IMMUNOL, V3, P1019, DOI 10.1038/ni1102-1019; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205; ZELLER W, 1988, VIROLOGY, V162, P90, DOI 10.1016/0042-6822(88)90397-2; Zuniga EI, 2008, CELL HOST MICROBE, V4, P374, DOI 10.1016/j.chom.2008.08.016	43	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e90855	10.1371/journal.pone.0090855	http://dx.doi.org/10.1371/journal.pone.0090855			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24613988	Green Published, Green Submitted, gold			2022-12-27	WOS:000332839300045
J	O'Connell, JL; Byrd, KB; Kelly, M				O'Connell, Jessica L.; Byrd, Kristin B.; Kelly, Maggi			Remotely-Sensed Indicators of N-Related Biomass Allocation in Schoenoplectus acutus	PLOS ONE			English	Article							OPTIMAL PARTITIONING THEORY; SAN-JOAQUIN DELTA; NITROGEN CONCENTRATION; CANOPY NITROGEN; CARBON SEQUESTRATION; VEGETATION INDEXES; SALT-MARSH; PATTERNS; LEAF; BAND	Coastal marshes depend on belowground biomass of roots and rhizomes to contribute to peat and soil organic carbon, accrete soil and alleviate flooding as sea level rises. For nutrient-limited plants, eutrophication has either reduced or stimulated belowground biomass depending on plant biomass allocation response to fertilization. Within a freshwater wetland impoundment receiving minimal sediments, we used experimental plots to explore growth models for a common freshwater macrophyte, Schoenoplectus acutus. We used N-addition and control plots (4 each) to test whether remotely sensed vegetation indices could predict leaf N concentration, root: shoot ratios and belowground biomass of S. acutus. Following 5 months of summer growth, we harvested whole plants, measured leaf N and total plant biomass of all above and belowground vegetation. Prior to harvest, we simulated measurement of plant spectral reflectance over 164 hyperspectral Hyperion satellite bands (350-2500 nm) with a portable spectroradiometer. N-addition did not alter whole plant, but reduced belowground biomass 36% and increased aboveground biomass 71%. We correlated leaf N concentration with known N-related spectral regions using all possible normalized difference (ND), simple band ratio (SR) and first order derivative ND (FDN) and SR (FDS) vegetation indices. FDN1235, (549) was most strongly correlated with leaf N concentration and also was related to belowground biomass, the first demonstration of spectral indices and belowground biomass relationships. While S. acutus exhibited balanced growth (reduced root: shoot ratio with respect to nutrient addition), our methods also might relate N-enrichment to biomass point estimates for plants with isometric root growth. For isometric growth, foliar N indices will scale equivalently with above and belowground biomass. Leaf N vegetation indices should aid in scaling-up field estimates of biomass and assist regional monitoring.	[O'Connell, Jessica L.; Kelly, Maggi] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Byrd, Kristin B.] US Geol Survey, Menlo Pk, CA 94025 USA	University of California System; University of California Berkeley; United States Department of the Interior; United States Geological Survey	Kelly, M (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.	maggi@berkeley.edu	O'Connell, Jessica/D-3220-2019	O'Connell, Jessica/0000-0002-2814-0668; Kelly, Nina Maggi/0000-0002-0198-2822; Byrd, Kristin/0000-0002-5725-7486	NASA [NNH10A086I]	NASA(National Aeronautics & Space Administration (NASA))	This research was supported by K. Byrd's NASA New Investigator Program in Earth Sciences Grant Number: NNH10A086I. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Rahman EM, 2013, INT J REMOTE SENS, V34, P712, DOI 10.1080/01431161.2012.713142; Abdel-Rahman EM, 2010, INT J APPL EARTH OBS, V12, pS52, DOI 10.1016/j.jag.2009.11.003; ASD Inc, 2008, VIEWSPEC PROTM US MA; Bedford BL, 1999, ECOLOGY, V80, P2151, DOI 10.1890/0012-9658(1999)080[2151:PINAAP]2.0.CO;2; Belyea LR, 2004, GLOBAL CHANGE BIOL, V10, P1043, DOI 10.1111/j.1529-8817.2003.00783.x; Boyer KE, 2001, WETLANDS, V21, P315, DOI 10.1672/0277-5212(2001)021[0315:SVIASC]2.0.CO;2; Cahoon DR, 2006, ESTUAR COAST, V29, P889, DOI 10.1007/BF02798648; Carnegie Museum of Natural History, 2005, CRAYF LINKS CARN MUS; Cohen RA, 2005, J PHYCOL, V41, P287, DOI 10.1111/j.1529-8817.2005.04022.x; Cohen RA, 2006, ECOL APPL, V16, P1405, DOI 10.1890/1051-0761(2006)016[1405:UOGMAI]2.0.CO;2; CURRAN PJ, 1989, REMOTE SENS ENVIRON, V30, P271, DOI 10.1016/0034-4257(89)90069-2; Darby FA, 2008, ESTUAR COAST, V31, P223, DOI 10.1007/s12237-007-9014-7; Dawson TP, 1998, INT J REMOTE SENS, V19, P2133, DOI 10.1080/014311698214910; Deegan LA, 2012, NATURE, V490, P388, DOI 10.1038/nature11533; DELAUNE RD, 1994, J COASTAL RES, V10, P1021; DEMETRIADESSHAH TH, 1990, REMOTE SENS ENVIRON, V33, P55, DOI 10.1016/0034-4257(90)90055-Q; Deverel SJ, 2010, SAN FRANCISCO ESTUAR, V8; Drexler JZ, 2009, ESTUAR COAST, V32, P871, DOI 10.1007/s12237-009-9202-8; Drexler JZ, 2009, WETLANDS, V29, P372, DOI 10.1672/08-97.1; Environmental Protection Agency, 2002, MID INT ASS MAIA EST; Ernst MD, 2004, STAT SCI, V19, P676, DOI 10.1214/088342304000000396; GAO BC, 1995, REMOTE SENS ENVIRON, V52, P155, DOI 10.1016/0034-4257(95)00039-4; Gorham E, 2012, QUATERNARY SCI REV, V58, P77, DOI 10.1016/j.quascirev.2012.09.018; Guyot G., 1988, J CHEM INF MODEL, P279; Jong SM, 1998, ITC J, P1; Kao JT, 2003, WETLANDS, V23, P979, DOI 10.1672/0277-5212(2003)023[0979:DNAPRB]2.0.CO;2; Kim MS, 1994, USE HIGH SPECTRAL RE, P229; Knyazikhin Y, 2013, P NATL ACAD SCI USA, V110, pE185, DOI 10.1073/pnas.1210196109; Kobe RK, 2010, ECOLOGY, V91, P166, DOI 10.1890/09-0027.1; Kochubey SM, 2012, FRONT EARTH SCI-PRC, V6, P188, DOI 10.1007/s11707-012-0325-z; Kokaly RF, 2009, REMOTE SENS ENVIRON, V113, pS78, DOI 10.1016/j.rse.2008.10.018; Kokaly RF, 1999, REMOTE SENS ENVIRON, V67, P267, DOI 10.1016/S0034-4257(98)00084-4; Larkin DJ, 2012, AQUAT BOT, V100, P62, DOI 10.1016/j.aquabot.2012.03.001; Lu DS, 2006, INT J REMOTE SENS, V27, P1297, DOI 10.1080/01431160500486732; Martin ME, 2008, REMOTE SENS ENVIRON, V112, P3511, DOI 10.1016/j.rse.2008.04.008; McCarthy MC, 2007, FUNCT ECOL, V21, P713, DOI 10.1111/j.1365-2435.2007.01276.x; Merino JH, 2010, WETL ECOL MANAG, V18, P111, DOI 10.1007/s11273-008-9124-4; Miller R. L., 2008, SAN FRANCISCO ESTUAR, V6; Miphokasap P, 2012, REMOTE SENS-BASEL, V4, P1651, DOI 10.3390/rs4061651; Mitsch W.J., 2007, WETLANDS, V4th ed., DOI DOI 10.1017/CBO9781107415324.004; Mokany K, 2006, GLOBAL CHANGE BIOL, V12, P84, DOI 10.1111/j.1365-2486.2005.001043.x; Mokhele TA, 2010, J APPL REMOTE SENS, V4, DOI 10.1117/1.3525241; Moore P. D., 1987, GEOL SOC SPEC PUBL, V32, P7, DOI DOI 10.1144/GSL.SP.1987.032.01.02; Morris JT, 2013, WETLANDS, V33, P975, DOI 10.1007/s13157-013-0480-3; Nungesser MK, 2011, WETL ECOL MANAG, V19, P475, DOI 10.1007/s11273-011-9229-z; NYMAN JA, 1993, MAR ECOL PROG SER, V96, P269, DOI 10.3354/meps096269; Nyman JA, 2006, ESTUAR COAST SHELF S, V69, P370, DOI 10.1016/j.ecss.2006.05.041; Ollinger SV, 2011, NEW PHYTOL, V189, P375, DOI 10.1111/j.1469-8137.2010.03536.x; Poorter H, 2012, NEW PHYTOL, V193, P30, DOI 10.1111/j.1469-8137.2011.03952.x; Prokopovich N.P., 1985, B ASS ENG GEOL, V22, P395; Ramoelo A, 2012, INT J APPL EARTH OBS, V19, P151, DOI 10.1016/j.jag.2012.05.009; Rasse DP, 2005, PLANT SOIL, V269, P341, DOI 10.1007/s11104-004-0907-y; Ryu C, 2009, BIOSYST ENG, V104, P465, DOI 10.1016/j.biosystemseng.2009.09.002; Sartoris JJ, 2000, ECOL ENG, V14, P49; Serrano L, 2002, REMOTE SENS ENVIRON, V81, P355, DOI 10.1016/S0034-4257(02)00011-1; Sheppard JK, 2008, CONT SHELF RES, V28, P2282, DOI 10.1016/j.csr.2008.03.033; Shipley B, 2002, FUNCT ECOL, V16, P326, DOI 10.1046/j.1365-2435.2002.00626.x; Siciliano D, 2008, REMOTE SENS ENVIRON, V112, P4020, DOI 10.1016/j.rse.2008.05.019; Sims NC, 2013, IEEE J-STARS, V6, P320, DOI 10.1109/JSTARS.2013.2251610; Smith ML, 2002, ECOL APPL, V12, P1286; Stralberg D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027388; Stroppiana D, 2012, HYPERSPECTRAL REMOTE SENSING OF VEGETATION, P245; Stroppiana D, 2009, FIELD CROP RES, V111, P119, DOI 10.1016/j.fcr.2008.11.004; Suwandana E, 2012, J COASTAL RES, V28, P956, DOI 10.2112/JCOASTRES-D-11-00222.1; Thenkabail PS, 2012, HYPERSPECTRAL REMOTE SENSING OF VEGETATION, P3; Thenkabail PS, 2013, IEEE J-STARS, V6, P427, DOI 10.1109/JSTARS.2013.2252601; Thenkabail PS, 2004, REMOTE SENS ENVIRON, V91, P354, DOI 10.1016/j.rse.2004.03.013; Thenkabail PS, 2002, PHOTOGRAMM ENG REM S, V68, P607; Tian YC, 2011, FIELD CROP RES, V120, P299, DOI 10.1016/j.fcr.2010.11.002; Titus J. G., 1988, Greenhouse effect, sea level rise and coastal wetlands, P1; Tornqvist TE, 2008, NAT GEOSCI, V1, P173, DOI 10.1038/ngeo129; Townsend PA, 2003, IEEE T GEOSCI REMOTE, V41, P1347, DOI 10.1109/TGRS.2003.813205; Turner RE, 2009, LIMNOL OCEANOGR, V54, P1634, DOI 10.4319/lo.2009.54.5.1634; USDA NRCS, 2010, PLANTS DAT; Wankel SD, 2006, LIMNOL OCEANOGR, V51, P1654, DOI 10.4319/lo.2006.51.4.1654; WESSMAN CA, 1988, NATURE, V335, P154, DOI 10.1038/335154a0; Xue LH, 2004, AGRON J, V96, P135, DOI 10.2134/agronj2004.0135; Yang YH, 2009, J VEG SCI, V20, P177, DOI 10.1111/j.1654-1103.2009.05566.x; Zedler JB, 2005, ANNU REV ENV RESOUR, V30, P39, DOI 10.1146/annurev.energy.30.050504.144248; Zhao GY, 2009, J ENVIRON SCI, V21, P1393, DOI 10.1016/S1001-0742(08)62431-6	80	16	16	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e90870	10.1371/journal.pone.0090870	http://dx.doi.org/10.1371/journal.pone.0090870			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614037	Green Published, Green Submitted, gold			2022-12-27	WOS:000332839300046
J	Rubin-Blum, M; Antler, G; Tsadok, R; Shemesh, E; Austin, JA; Coleman, DF; Goodman-Tchernov, BN; Ben-Avraham, Z; Tchernov, D				Rubin-Blum, Maxim; Antler, Gilad; Tsadok, Rami; Shemesh, Eli; Austin, James A., Jr.; Coleman, Dwight F.; Goodman-Tchernov, Beverly N.; Ben-Avraham, Zvi; Tchernov, Dan			First Evidence for the Presence of Iron Oxidizing Zetaproteobacteria at the Levantine Continental Margins	PLOS ONE			English	Article							HYDROTHERMAL FIELDS; MEDITERRANEAN SEA; MICROBIAL MATS; WATER; FLUX; AVAILABILITY; DIVERSITY; BASIN; BIOGEOCHEMISTRY; METAGENOMICS	During the 2010-2011 E/V Nautilus exploration of the Levantine basin's sediments at the depth of 300-1300 m, densely patched orange-yellow flocculent mats were observed at various locations along the continental margin of Israel. Cores from the mat and the control locations were collected by remotely operated vehicle system (ROV) operated by the E/V Nautilus team. Microscopic observation and phylogenetic analysis of microbial 16S and 23S rRNA gene sequences indicated the presence of zetaproteobacterial stalk forming Mariprofundus spp. - like prokaryotes in the mats. Bacterial tag-encoded FLX amplicon pyrosequencing determined that zetaproteobacterial populations were a dominant fraction of microbial community in the biofilm. We show for the first time that zetaproteobacterial may thrive at the continental margins, regardless of crustal iron supply, indicating significant fluxes of ferrous iron to the sediment-water interface. In light of this discovery, we discuss the potential bioavailability of sediment-water interface iron for organisms in the overlying water column.	[Rubin-Blum, Maxim; Tsadok, Rami; Shemesh, Eli; Goodman-Tchernov, Beverly N.; Ben-Avraham, Zvi; Tchernov, Dan] Univ Haifa, Leon H Charney Sch Marine Sci, IL-31999 Haifa, Israel; [Antler, Gilad] Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England; [Austin, James A., Jr.] Univ Texas Austin, Inst Geophys, Jackson Sch Geosci, Austin, TX USA; [Coleman, Dwight F.] Univ Rhode Isl, Grad Sch Oceanog, Narragansett, RI 02882 USA; [Ben-Avraham, Zvi] Tel Aviv Univ, Fac Exact Sci, Dept Geophys Atmospher & Planetary Sci, Ramat Aviv, Israel	University of Haifa; University of Cambridge; University of Texas System; University of Texas Austin; University of Rhode Island; Tel Aviv University	Rubin-Blum, M (corresponding author), Univ Haifa, Leon H Charney Sch Marine Sci, IL-31999 Haifa, Israel.	mrubin.deepmed@gmail.com	Antler, Gilad/AFO-2996-2022; Tchernov, Dan/AAE-2545-2021; Antler, Gilad/T-5497-2017	Antler, Gilad/0000-0002-6865-5412; Tchernov, Dan/0000-0003-1135-8270; Antler, Gilad/0000-0002-6865-5412; Rubin Blum, Maxim/0000-0003-2953-3161; Goodman Tchernov, Beverly/0000-0003-3660-9240	European Commission [Assemble 227799]; Leon H. Charney School for Marine Sciences	European Commission(European CommissionEuropean Commission Joint Research Centre); Leon H. Charney School for Marine Sciences	Support for this project was provided by European Commission FP7 research infrastructure initiative program "Assemble 227799'' and The Leon H. Charney School for Marine Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achterberg EP, 2001, ANAL CHIM ACTA, V442, P1, DOI 10.1016/S0003-2670(01)01091-1; Azetsu-Scott K, 2004, LIMNOL OCEANOGR, V49, P741, DOI 10.4319/lo.2004.49.3.0741; Bazylinski DA, 2013, INT J SYST EVOL MICR, V63, P1824, DOI 10.1099/ijs.0.044453-0; Berman-Frank I, 2001, LIMNOL OCEANOGR, V46, P1249, DOI 10.4319/lo.2001.46.6.1249; Boyd PW, 2010, NAT GEOSCI, V3, P675, DOI [10.1038/NGEO964, 10.1038/ngeo964]; Breitbarth E, 2010, BIOGEOSCIENCES, V7, P1075, DOI 10.5194/bg-7-1075-2010; BRULAND KW, 1994, GEOCHIM COSMOCHIM AC, V58, P3171, DOI 10.1016/0016-7037(94)90044-2; Capone KA, 2011, J INVEST DERMATOL, V131, P2026, DOI 10.1038/jid.2011.168; Chan CS, 2011, ISME J, V5, P717, DOI 10.1038/ismej.2010.173; Chase Z, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002590; Coleman D, 2011, EOS T AGU, V92; Coleman DF, 2012, OCEANOGRAPHY, V25, P40; Coma R, 2009, P NATL ACAD SCI USA, V106, P6176, DOI 10.1073/pnas.0805801106; Dang HY, 2011, ENVIRON MICROBIOL, V13, P3059, DOI 10.1111/j.1462-2920.2011.02583.x; Danovaro R, 1999, PROG OCEANOGR, V44, P287, DOI 10.1016/S0079-6611(99)00030-0; Danovaro R, 2001, TRENDS ECOL EVOL, V16, P505, DOI 10.1016/S0169-5347(01)02215-7; Danovaro R, 1995, PROG OCEANOGR, V36, P329, DOI 10.1016/0079-6611(96)00002-X; De Rijk S, 2000, MAR MICROPALEONTOL, V40, P151, DOI 10.1016/S0377-8398(00)00037-2; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dowd SF, 2008, FOODBORNE PATHOG DIS, V5, P459, DOI 10.1089/fpd.2008.0107; Elrod VA, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020216; Emerson D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000667; Emerson D, 2010, ANNU REV MICROBIOL, V64, P561, DOI 10.1146/annurev.micro.112408.134208; Emerson D, 2010, OCEANOGRAPHY, V23, P148, DOI 10.5670/oceanog.2010.67; Eren AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026732; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Frank JA, 2008, APPL ENVIRON MICROB, V74, P2461, DOI 10.1128/AEM.02272-07; Gontcharova Viktoria, 2010, Open Microbiol J, V4, P8, DOI 10.2174/1874285801004010008; Guieu C, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014454; Herut B, 2000, OCEANOL ACTA, V23, P771, DOI 10.1016/S0399-1784(00)01118-X; Hodges TW, 2009, APPL ENVIRON MICROB, V75, P1650, DOI 10.1128/AEM.01835-08; Iversen MH, 2010, BIOGEOSCIENCES, V7, P2613, DOI 10.5194/bg-7-2613-2010; Kato S, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00089; Kato S, 2009, ENVIRON MICROBIOL, V11, P3210, DOI 10.1111/j.1462-2920.2009.02031.x; Katz T, 2012, LIMNOL OCEANOGR, V57, P945, DOI 10.4319/lo.2012.57.4.0945; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Konstantinidis KT, 2003, MICROB ECOL, V45, P191, DOI 10.1007/s00248-002-1035-y; Lam PJ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033294; Lam PJ, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002557; Lohan MC, 2008, ENVIRON SCI TECHNOL, V42, P6462, DOI 10.1021/es800144j; McAllister SM, 2011, APPL ENVIRON MICROB, V77, P5445, DOI 10.1128/AEM.00533-11; McBeth JM, 2013, ENV MICROBIOL REP, V5, P453, DOI 10.1111/1758-2229.12033; McBeth JM, 2011, APPL ENVIRON MICROB, V77, P1405, DOI 10.1128/AEM.02095-10; Nei M., 2000, MOL EVOLUTION PHYLOG; Omoregie EO, 2008, APPL ENVIRON MICROB, V74, P3198, DOI 10.1128/AEM.01751-07; Ortega-Osorio A, 2001, CAN MINERAL, V39, P17, DOI 10.2113/gscanmin.39.1.17; Pakhornova SV, 2007, MAR CHEM, V107, P319, DOI 10.1016/j.marchem.2007.06.001; RICH HW, 1990, LIMNOL OCEANOGR, V35, P652, DOI 10.4319/lo.1990.35.3.0652; Sanchez E, 2004, GLOBAL PLANET CHANGE, V44, P163, DOI 10.1016/j.gloplacha.2004.06.010; Sarthou G, 2001, MAR CHEM, V74, P115, DOI 10.1016/S0304-4203(00)00119-5; Severmann S, 2010, GEOCHIM COSMOCHIM AC, V74, P3984, DOI 10.1016/j.gca.2010.04.022; Shaked Y, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00123; Singer E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025386; STOOKEY LL, 1970, ANAL CHEM, V42, P779, DOI 10.1021/ac60289a016; Sundby B, 2006, MAR CHEM, V102, P2, DOI 10.1016/j.marchem.2005.09.016; Swanson KS, 2011, ISME J, V5, P639, DOI 10.1038/ismej.2010.162; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanaka T, 2007, DEEP-SEA RES PT I, V54, P1721, DOI 10.1016/j.dsr.2007.06.008; Theodosi C, 2010, MAR CHEM, V120, P100, DOI 10.1016/j.marchem.2008.05.004; Tolika K, 2013, EGU GEN ASS 2013, P2922; Toner BM, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00118; Viollier E, 2000, APPL GEOCHEM, V15, P785, DOI 10.1016/S0883-2927(99)00097-9; WESTERLUND S, 1991, MAR CHEM, V35, P199, DOI 10.1016/S0304-4203(09)90018-4; Wommack KE, 2008, APPL ENVIRON MICROB, V74, P1453, DOI 10.1128/AEM.02181-07; Wu JF, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001453; Yogev T, 2011, ENVIRON MICROBIOL, V13, P854, DOI 10.1111/j.1462-2920.2010.02402.x; Zhang HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006108	67	23	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91456	10.1371/journal.pone.0091456	http://dx.doi.org/10.1371/journal.pone.0091456			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614177	Green Published, gold, Green Submitted			2022-12-27	WOS:000332839300129
J	Hawker, GA; Croxford, R; Bierman, AS; Harvey, PJ; Ravi, B; Stanaitis, I; Lipscombe, LL				Hawker, Gillian A.; Croxford, Ruth; Bierman, Arlene S.; Harvey, Paula J.; Ravi, Bheeshma; Stanaitis, Ian; Lipscombe, Lorraine L.			All-Cause Mortality and Serious Cardiovascular Events in People with Hip and Knee Osteoarthritis: A Population Based Cohort Study	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; OLDER-ADULTS; PREVALENCE; MANAGEMENT; HEALTH; PAIN; RECOMMENDATIONS; HYPERTENSION; DEPRESSION; ARTHRITIS	Background: Because individuals with osteoarthritis (OA) avoid physical activities that exacerbate symptoms, potentially increasing risk for cardiovascular disease (CVD) and death, we assessed the relationship between OA disability and these outcomes. Methods: In a population cohort aged 55+ years with at least moderately severe symptomatic hip and/or knee OA, OA disability (Western Ontario McMaster Universities (WOMAC) OA scores; Health Assessment Questionnaire (HAQ) walking score; use of walking aids) and other covariates were assessed by questionnaire. Survey data were linked to health administrative data to determine the relationship between baseline OA symptom severity to all-cause mortality and occurrence of a composite CVD outcome (acute myocardial infarction, coronary revascularization, heart failure, stroke or transient ischemic attack) over a median follow-up of 13.2 and 9.2 years, respectively. Results: Of 2156 participants, 1,236 (57.3%) died and 822 (38.1%) experienced a CVD outcome during follow-up. Higher (worse) baseline WOMAC function scores and walking disability were independently associated with a higher all-cause mortality (adjusted hazard ratio, aHR, per 10-point increase in WOMAC function score 1.04, 95% confidence interval, CI 1.01-1.07, p = 0.004; aHR per unit increase in HAQ walking score 1.30, 95% CI 1.22-1.39, p<0.001; and aHR for those using versus not using a walking aid 1.51, 95% CI 1.34-1.70, p<0.001). In survival analysis, censoring on death, risk of our composite CVD outcome was also significantly and independently associated with greater baseline walking disability ((aHR for use of a walking aid = 1.27, 95% CI 1.10-1.47, p = 0.001; aHR per unit increase in HAQ walking score = 1.17, 95% CI 1.08-1.27, p<0.001). Conclusions: Among individuals with hip and/or knee OA, severity of OA disability was associated with a significant increase in all-cause mortality and serious CVD events after controlling for multiple confounders. Research is needed to elucidate modifiable mechanisms.	[Hawker, Gillian A.; Harvey, Paula J.; Stanaitis, Ian; Lipscombe, Lorraine L.] Womens Coll Hosp, Womens Coll Res Inst, Toronto, ON, Canada; [Hawker, Gillian A.; Bierman, Arlene S.; Ravi, Bheeshma; Lipscombe, Lorraine L.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Hawker, Gillian A.; Croxford, Ruth; Bierman, Arlene S.; Lipscombe, Lorraine L.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Hawker, Gillian A.; Bierman, Arlene S.; Harvey, Paula J.; Lipscombe, Lorraine L.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Bierman, Arlene S.] Univ Toronto, Lawrence S Bloomberg Fac Nursing, Toronto, ON, Canada; [Ravi, Bheeshma] Univ Toronto, Dept Surg, Div Orthopaed, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto	Hawker, GA (corresponding author), Womens Coll Hosp, Womens Coll Res Inst, Toronto, ON, Canada.	g.hawker@utoronto.ca		Lipscombe, Lorraine/0000-0001-7412-7993	Canadian Institutes of Health Research [MOP-15468]; Institute for Clinical Evaluative Sciences (ICES); Ontario Ministry of Health and Long-Term Care	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Institute for Clinical Evaluative Sciences (ICES)(University of Toronto); Ontario Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario)	This study was funded by an operating grant from the Canadian Institutes of Health Research, grant # MOP-15468. This study was also supported by the Institute for Clinical Evaluative Sciences (ICES), which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No endorsement by ICES or the Ontario Ministry of Health and Long-Term Care is intended or should be inferred. ICES had no role in the study design, collection, analysis, or interpretation of the data, writing of the report, or in the decision to submit the report for publication.	Alter DA, 2006, ANN INTERN MED, V144, P82, DOI 10.7326/0003-4819-144-2-200601170-00005; BELLAMY N, 1988, J RHEUMATOL, V15, P1833; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P2469, DOI 10.1001/jama.288.19.2469; Butchart A, 2009, CLIN J PAIN, V25, P293, DOI 10.1097/AJP.0b013e31818bf574; Centers for Medicare & Medicaid Services, 2012, CHRONIC CONDITIONS M; Choodari-Oskooei B, 2012, STAT MED, V31, P2627, DOI 10.1002/sim.4242; Freedman VA, 2000, AM J PUBLIC HEALTH, V90, P1755, DOI 10.2105/AJPH.90.11.1755; Friedman B, 2005, J AM GERIATR SOC, V53, P1978, DOI 10.1111/j.1532-5415.2005.00469.x; FRIES JF, 1980, ARTHRITIS RHEUM, V23, P137, DOI 10.1002/art.1780230202; Gulati M, 2005, NEW ENGL J MED, V353, P468, DOI 10.1056/NEJMoa044154; Gunther JP, 2001, BEST PRACT RES CL RH, V15, P627, DOI 10.1053/berh.2001.0178; Hackam DG, 2010, CAN J CARDIOL, V26, P249, DOI 10.1016/S0828-282X(10)70379-2; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Hawker GA, 2001, MED CARE, V39, P206, DOI 10.1097/00005650-200103000-00002; Hawker GA, 2011, ARTHRIT CARE RES, V63, P1382, DOI 10.1002/acr.20298; Hawker GA, 2009, MED CARE, V47, P732, DOI 10.1097/MLR.0b013e3181934553; Hux JE, 2002, DIABETES CARE, V25, P512, DOI 10.2337/diacare.25.3.512; Kodama S, 2009, JAMA-J AM MED ASSOC, V301, P2024, DOI 10.1001/jama.2009.681; Lee DS, 2009, CAN MED ASSOC J, V181, pE55, DOI 10.1503/cmaj.081629; Leffondre K, 2004, J CLIN EPIDEMIOL, V57, P1049, DOI 10.1016/j.jclinepi.2004.02.012; Lipscombe LL, 2007, LANCET, V369, P750, DOI 10.1016/S0140-6736(07)60361-4; Nuesch E, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1165; Paterson MJ, 2006, TOTAL HIP KNEE REPLA; Perruccio AV, 2006, J RHEUMATOL, V33, P1856; Rankin EA, 2004, J BONE JOINT SURG AM, V86A, P1328; Ravi B, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6187; Sale JEM, 2006, ARTHRIT RHEUM-ARTHR, V55, P272, DOI 10.1002/art.21853; Statistics Canada, 2011, HLTH TRENDS; Thompson PD, 2003, CIRCULATION, V107, P3109, DOI 10.1161/01.CIR.0000075572.40158.77; Trelle S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7086; Tu JV, 2009, CAN MED ASSOC J, V180, pE118, DOI 10.1503/cmaj.081197; Tu K, 2008, CAN MED ASSOC J, V178, P1429, DOI 10.1503/cmaj.071283; Tu Karen, 2007, Open Med, V1, pe18; Vinluan CM, 2012, METABOLISM, V61, P302, DOI 10.1016/j.metabol.2011.07.002; Weiner J., 2011, J HOPKINS ACG SYSTEM; World Health Organization, 2012, WORLD HLTH STAT 2012; Zhang W, 2010, OSTEOARTHR CARTILAGE, V18, P476, DOI 10.1016/j.joca.2010.01.013	37	144	152	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91286	10.1371/journal.pone.0091286	http://dx.doi.org/10.1371/journal.pone.0091286			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608134	Green Published, gold			2022-12-27	WOS:000332485800123
J	Kessler, Y; Vandermorris, S; Gopie, N; Daros, A; Winocur, G; Moscovitch, M				Kessler, Yoav; Vandermorris, Susan; Gopie, Nigel; Daros, Alexander; Winocur, Gordon; Moscovitch, Morris			Divided Attention Improves Delayed, but Not Immediate Retrieval of a Consolidated Memory	PLOS ONE			English	Article							LONG-TERM-MEMORY; RECONSOLIDATION; FEAR; RETENTION; DYNAMICS; HUMANS	A well-documented dissociation between memory encoding and retrieval concerns the role of attention in the two processes. The typical finding is that divided attention (DA) during encoding impairs future memory, but retrieval is relatively robust to attentional manipulations. However, memory research in the past 20 years had demonstrated that retrieval is a memory-changing process, in which the strength and availability of information are modified by various characteristics of the retrieval process. Based on this logic, several studies examined the effects of DA during retrieval (Test 1) on a future memory test (Test 2). These studies yielded inconsistent results. The present study examined the role of memory consolidation in accounting for the after-effect of DA during retrieval. Initial learning required a classification of visual stimuli, and hence involved incidental learning. Test 1 was administered 24 hours after initial learning, and therefore required retrieval of consolidated information. Test 2 was administered either immediately following Test 1 or after a 24-hour delay. Our results show that the effect of DA on Test 2 depended on this delay. DA during Test 1 did not affect performance on Test 2 when it was administered immediately, but improved performance when Test 2 was given 24-hours later. The results are consistent with other findings showing long-term benefits of retrieval difficulty. Implications for theories of reconsolidation in human episodic memory are discussed.	Baycrest Ctr Geriatr Care, Rotman Res Inst, Toronto, ON, Canada; Univ Toronto, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Baycrest; University of Toronto	Kessler, Y (corresponding author), Ben Gurion Univ Negev, Dept Psychol, IL-84105 Beer Sheva, Israel.	kesslery@bgu.ac.il	Daros, Alexander/AAG-6135-2020; Kessler, Yoav/F-5530-2012	Kessler, Yoav/0000-0003-0203-7213	Natural Sciences and Engineering Research Council of Canada [A8347]; Alzheimer Society of Canada; Alzheimer Society of British Columbia	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Alzheimer Society of Canada; Alzheimer Society of British Columbia	This work was supported by the Natural Sciences and Engineering Research Council of Canada (A8347) to MM (http://www.nserc-crsng.gc.ca/index_eng. asp) and a postdoctoral fellowship from the Alzheimer Society of Canada (http://www.alzheimer.ca/en) and the Alzheimer Society of British Columbia (http://www.alzheimerbc.org/) to SV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON MC, 1994, J EXP PSYCHOL LEARN, V20, P1063, DOI 10.1037/0278-7393.20.5.1063; BADDELEY A, 1984, J EXP PSYCHOL GEN, V113, P518, DOI 10.1037/0096-3445.113.4.518; Bjork R.A., 1992, LEARNING PROCESSES C, P35; Craik FIM, 1996, J EXP PSYCHOL GEN, V125, P159, DOI 10.1037/0096-3445.125.2.159; Dudai Y, 2012, ANNU REV NEUROSCI, V35, P227, DOI 10.1146/annurev-neuro-062111-150500; Dudukovic NM, 2009, MEM COGNITION, V37, P953, DOI 10.3758/MC.37.7.953; Fernandes MA, 2000, J EXP PSYCHOL GEN, V129, P155, DOI 10.1037/0096-3445.129.2.155; Fernandes MA, 2002, MEM COGNITION, V30, P731, DOI 10.3758/BF03196429; Forcato C, 2007, LEARN MEMORY, V14, P295, DOI 10.1101/lm.486107; Forcato C, 2010, NEUROBIOL LEARN MEM, V93, P77, DOI 10.1016/j.nlm.2009.08.006; Foricato C, 2009, NEUROBIOL LEARN MEM, V91, P50, DOI 10.1016/j.nlm.2008.09.011; Gaspelin N, 2013, MEM COGNITION, V41, P978, DOI 10.3758/s13421-013-0326-5; Gopie N, 2011, PSYCHOL SCI, V22, P634, DOI 10.1177/0956797611403321; Guez J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074447; Hardt O, 2010, ANNU REV PSYCHOL, V61, P141, DOI 10.1146/annurev.psych.093008.100455; Hupbach A, 2008, LEARN MEMORY, V15, P574, DOI 10.1101/lm.1022308; Hupbach A, 2007, LEARN MEMORY, V14, P47, DOI 10.1101/lm.365707; Hupbach A, 2009, MEMORY, V17, P502, DOI 10.1080/09658210902882399; LANDAUER TK, 1978, PRACTICAL ASPECTS ME, P625; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Moscovitch M, 2001, PERSPECTIVES HUMAN M; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Naveh-Benjamin M, 1998, J EXP PSYCHOL LEARN, V24, P1091, DOI 10.1037/0278-7393.24.5.1091; Roediger HL, 2006, PSYCHOL SCI, V17, P249, DOI 10.1111/j.1467-9280.2006.01693.x; Rossion B, 2004, PERCEPTION, V33, P217, DOI 10.1068/p5117; Sara SJ, 2000, LEARN MEMORY, V7, P73, DOI 10.1101/lm.7.2.73; Schiller D, 2010, NATURE, V463, P49, DOI 10.1038/nature08637; SCHMIDT RA, 1992, PSYCHOL SCI, V3, P207, DOI 10.1111/j.1467-9280.1992.tb00029.x; Sevenster D, 2012, NEUROBIOL LEARN MEM, V97, P338, DOI 10.1016/j.nlm.2012.01.009; TULVING E, 1974, AM SCI, V62, P74	30	12	12	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91309	10.1371/journal.pone.0091309	http://dx.doi.org/10.1371/journal.pone.0091309			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC4IY	24608365	Green Submitted, Green Published, gold			2022-12-27	WOS:000332485800127
J	Mukherjee, R; Kim, SW; Choi, MS; Yun, JW				Mukherjee, Rajib; Kim, Sang Woo; Choi, Myung Sook; Yun, Jong Won			Sex-Dependent Expression of Caveolin 1 in Response to Sex Steroid Hormones Is Closely Associated with Development of Obesity in Rats	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; BROWN ADIPOSE-TISSUE; DIET-INDUCED OBESITY; INSULIN SENSITIVITY; ANDROGEN RECEPTOR; SKELETAL-MUSCLE; CAVEOLIN-1-DEFICIENT MICE; PROTEIN EXPRESSION; LIPID-METABOLISM; GENE-EXPRESSION	Caveolin-1 (CAV1) is a conserved group of structural membrane proteins that form special cholesterol and sphingolipid-rich compartments, especially in adipocytes. Recently, it has been reported that CAV1 is an important target protein in sex hormone-dependent regulation of various metabolic pathways, particularly in cancer and diabetes. To clarify distinct roles of CAV1 in sex-dependent obesity development, we investigated the effects of high fat diet (HFD) and sex steroid hormones on CAV1 expression in adipose tissues of male and female rats. Results of animal experiments revealed that estrogen (17-beta-estradiol, E2) and androgen (dihydrotestosterone, DHT) had opposite effects on body weight gain as well as on the regulation of CAV1, hormone sensitive lipase (HSL) and uncoupling protein 1 (UCP1) in adipose tissues. Furthermore, sex hormone receptors and aromatase were differentially expressed in a sex-dependent manner in response to E2 and DHT treatments. In vivo data were confirmed using 3T3-L1 and HIB1B cell lines, where Cav1 knock down stimulated lipogenesis but suppressed sex hormone receptor signaling proteins. Most importantly, co-immunoprecipitation enabled the identification of previously unrecognized CAV1-interacting mitochondrial or lipid oxidative pathway proteins in adipose tissues. Taken together, current data showed that CAV1 may play important preventive role in the development of obesity, with more prominent effects in females, and proved to be an important target protein for the hormonal regulation of adipose tissue metabolism by manipulating sex hormone receptors and mitochondrial oxidative pathways. Therefore, we can report, for the first time, the molecular mechanism underlying the effects of sex steroid hormones in the sex-dimorphic regulation of CAV1.	[Mukherjee, Rajib; Kim, Sang Woo; Yun, Jong Won] Daegu Univ, Dept Biotechnol, Kyungsan, South Korea; [Choi, Myung Sook] Kyungpook Natl Univ, Ctr Food & Nutr Genom Res, Taegu, South Korea; [Choi, Myung Sook] Kyungpook Natl Univ, Dept Food Sci & Nutr, Taegu, South Korea	Daegu University; Kyungpook National University; Kyungpook National University	Yun, JW (corresponding author), Daegu Univ, Dept Biotechnol, Kyungsan, South Korea.	jwyun@daegu.ac.kr	Mukherjee, Rajib/J-9195-2019	Mukherjee, Rajib/0000-0002-3509-4997; Kim, Sang Woo/0000-0002-3144-4822; Yun, Jong Won/0000-0003-2453-2282	Mid-career Researcher Program through NRF [2013R1A2A2A05004195]; SRC Program (Center for Food & Nutritional Genomics) through NRF [2008-0062157]; Ministry of Science, ICT and Future Planning, Korea	Mid-career Researcher Program through NRF; SRC Program (Center for Food & Nutritional Genomics) through NRF; Ministry of Science, ICT and Future Planning, Korea	This work was supported by the Mid-career Researcher Program (2013R1A2A2A05004195) and SRC Program (Center for Food & Nutritional Genomics: grant number 2008-0062157) through NRF grant funded by the Ministry of Science, ICT and Future Planning, Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson LA, 2002, DIABETES OBES METAB, V4, P209, DOI 10.1046/j.1463-1326.2002.00214.x; Asterholm IW, 2012, CELL METAB, V15, P171, DOI 10.1016/j.cmet.2012.01.004; Babaei Parvin, 2010, Menopause Int, V16, P100, DOI 10.1258/mi.2010.010028; Baghaei F, 2003, OBES RES, V11, P578, DOI 10.1038/oby.2003.81; Basu R, 2007, DIABETES CARE, V30, P1972, DOI 10.2337/dc07-0359; Bosch M, 2011, CURR BIOL, V21, P681, DOI 10.1016/j.cub.2011.03.030; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Briand N, 2011, DIABETES, V60, P448, DOI 10.2337/db10-0856; Bryzgalova G, 2008, AM J PHYSIOL-ENDOC M, V295, pE904, DOI 10.1152/ajpendo.90248.2008; Butera PC, 2010, PHYSIOL BEHAV, V99, P142, DOI 10.1016/j.physbeh.2009.10.009; Campbell L, 2001, ADV DRUG DELIVER REV, V49, P325, DOI 10.1016/S0169-409X(01)00145-4; Catalan V, 2008, CLIN ENDOCRINOL, V68, P213, DOI 10.1111/j.1365-2265.2007.03021.x; Choi DK, 2011, CELL PHYSIOL BIOCHEM, V28, P933, DOI 10.1159/000335807; Choi HR, 2012, J MICROBIOL BIOTECHN, V22, P1029, DOI 10.4014/jmb.1112.12059; Choi JW, 2010, PROTEOMICS, V10, P4386, DOI 10.1002/pmic.201000391; Cohen AW, 2004, PHYSIOL REV, V84, P1341, DOI 10.1152/physrev.00046.2003; Cohen AW, 2005, DIABETES, V54, P679, DOI 10.2337/diabetes.54.3.679; Cohen AW, 2004, DIABETES, V53, P1261, DOI 10.2337/diabetes.53.5.1261; Cohen AW, 2003, AM J PHYSIOL-CELL PH, V285, pC222, DOI 10.1152/ajpcell.00006.2003; D'Eon TM, 2005, J BIOL CHEM, V280, P35983, DOI 10.1074/jbc.M507339200; Dieudonne MN, 2004, AM J PHYSIOL-CELL PH, V286, pC655, DOI 10.1152/ajpcell.00321.2003; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Fan WQ, 2005, DIABETES, V54, P1000, DOI 10.2337/diabetes.54.4.1000; Faulds MH, 2012, J ENDOCRINOL, V212, P3, DOI 10.1530/JOE-11-0044; Fernandez MA, 2006, SCIENCE, V313, P1628, DOI 10.1126/science.1130773; Fernandez-Real JM, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-20; Foryst-Ludwig A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000108; Fujioka K, 2012, AM J PHYSIOL-ENDOC M, V302, pE694, DOI 10.1152/ajpendo.00112.2011; Gao H, 2006, MOL ENDOCRINOL, V20, P1287, DOI 10.1210/me.2006-0012; Hajer GR, 2008, EUR HEART J, V29, P2959, DOI 10.1093/eurheartj/ehn387; Haring R, 2009, DIABETES, V58, P2027, DOI 10.2337/db09-0031; Heine PA, 2000, P NATL ACAD SCI USA, V97, P12729, DOI 10.1073/pnas.97.23.12729; Jayachandran M, 2001, AM J PHYSIOL-HEART C, V281, pH1327, DOI 10.1152/ajpheart.2001.281.3.H1327; Jedrzejuk D, 2003, Aging Male, V6, P151, DOI 10.1080/713604785; Jeong S, 2011, ACTA PHARMACOL SIN, V32, P230, DOI 10.1038/aps.2010.198; Jones MEE, 2000, P NATL ACAD SCI USA, V97, P12735, DOI 10.1073/pnas.97.23.12735; Joo JI, 2011, CELL PHYSIOL BIOCHEM, V27, P327, DOI 10.1159/000327959; Joo JI, 2011, PROTEOMICS, V11, P1429, DOI 10.1002/pmic.201000515; Kanaya N, 2013, J STEROID BIOCHEM, V138, P100, DOI 10.1016/j.jsbmb.2013.04.001; Karamanlidis G, 2007, J BIOL CHEM, V282, P24660, DOI 10.1074/jbc.M703101200; Kim DH, 2011, J PROTEOME RES, V10, P1281, DOI 10.1021/pr101048q; Kramarova TV, 2009, METABOLISM, V6, pe49, DOI DOI 10.1016/J.DDMEC.2009.11.001; Le Lay S, 2009, BBA-MOL CELL BIOL L, V1791, P514, DOI 10.1016/j.bbalip.2008.10.008; Li WP, 2001, J CELL SCI, V114, P1397; Liu H, 2012, PROTEOMICS, V12, P269, DOI 10.1002/pmic.201100127; Liu PS, 2002, J BIOL CHEM, V277, P41295, DOI 10.1074/jbc.R200020200; Lu ML, 2001, J BIOL CHEM, V276, P13442, DOI 10.1074/jbc.M006598200; Mahmoudi M, 2003, J PATHOL, V200, P396, DOI 10.1002/path.1368; Mattiasson I, 2002, HORM METAB RES, V34, P583, DOI 10.1055/s-2002-35420; Mattsson CL, 2010, BBA-MOL CELL RES, V1803, P983, DOI 10.1016/j.bbamcr.2010.03.015; McInnes KJ, 2012, DIABETES, V61, P1072, DOI 10.2337/db11-1136; Monjo M, 2003, ENDOCRINOLOGY, V144, P4923, DOI 10.1210/en.2003-0537; Moverare-Skrtic S, 2006, OBESITY, V14, P662, DOI 10.1038/oby.2006.75; Mukherjee R, 2013, MOL BIOL REP, V40, P3783, DOI 10.1007/s11033-012-2455-5; Mukherjee R, 2012, CELL PHYSIOL BIOCHEM, V29, P617, DOI 10.1159/000338515; Nadal A, 2001, NEWS PHYSIOL SCI, V16, P251; Oh TS, 2011, CELL PHYSIOL BIOCHEM, V28, P981, DOI 10.1159/000335811; Oh YS, 2008, DIABETOLOGIA, V51, P1025, DOI 10.1007/s00125-008-0993-0; Oh YS, 2011, MOL MED, V17, P4, DOI 10.2119/molmed.2009.00105; Okamoto T, 1998, J BIOL CHEM, V273, P5419, DOI 10.1074/jbc.273.10.5419; Oliveira PJ, 2012, J LIPIDS, V2012, DOI 10.1155/2012/365798; Palin SL, 2003, METABOLISM, V52, P383, DOI 10.1053/meta.2003.50088; Pedersen SB, 2001, BIOCHEM BIOPH RES CO, V288, P191, DOI 10.1006/bbrc.2001.5763; Pirwany IR, 2002, HUM REPROD, V17, P825, DOI 10.1093/humrep/17.3.825; Quarta C, 2012, J MOL ENDOCRINOL, V49, pR1, DOI 10.1530/JME-12-0043; Razandi M, 2002, MOL ENDOCRINOL, V16, P100, DOI 10.1210/me.16.1.100; Razani B, 2002, J BIOL CHEM, V277, P8635, DOI 10.1074/jbc.M110970200; Razani B, 2001, J CLIN INVEST, V108, P1553, DOI 10.1172/JCI14611; Relling DP, 2006, J HYPERTENS, V24, P549, DOI 10.1097/01.hjh.0000203846.34314.94; Rodriguez AM, 2002, CELL MOL LIFE SCI, V59, P1714, DOI 10.1007/PL00012499; Schlegel A, 1999, J BIOL CHEM, V274, P33551, DOI 10.1074/jbc.274.47.33551; Schwencke C, 2006, CARDIOVASC RES, V70, P42, DOI 10.1016/j.cardiores.2005.11.029; Slocum N, 2013, EXP TOXICOL PATHOL, V65, P549, DOI 10.1016/j.etp.2012.04.001; Sonnino S, 2009, FEBS LETT, V583, P597, DOI 10.1016/j.febslet.2009.01.007; Sud N, 2010, MOL ENDOCRINOL, V24, P1637, DOI 10.1210/me.2010-0043; Wang X, 2012, PROTEOMICS, V12, P284, DOI 10.1002/pmic.201100271; Wang X, 2011, BRIT J NUTR, V106, P612, DOI 10.1017/S0007114511000651; Weigt C, 2013, MOL CELL ENDOCRINOL, V377, P147, DOI 10.1016/j.mce.2013.07.007; YAMADA K, 1990, BIOCHEM BIOPH RES CO, V169, P531, DOI 10.1016/0006-291X(90)90363-R; Yamamoto M, 1998, J BIOL CHEM, V273, P26962, DOI 10.1074/jbc.273.41.26962	81	15	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90918	10.1371/journal.pone.0090918	http://dx.doi.org/10.1371/journal.pone.0090918			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608114	gold, Green Submitted, Green Published			2022-12-27	WOS:000332485800066
J	Pei, ZJ; Lan, XL; Cheng, Z; Qin, CX; Xia, XT; Yuan, H; Ding, ZL; Zhang, YX				Pei, Zhijun; Lan, Xiaoli; Cheng, Zhen; Qin, Chunxia; Xia, Xiaotian; Yuan, Hui; Ding, Zhiling; Zhang, Yongxue			Multimodality Molecular Imaging to Monitor Transplanted Stem Cells for the Treatment of Ischemic Heart Disease	PLOS ONE			English	Article							LEFT-VENTRICULAR FUNCTION; TYPE-1 THYMIDINE KINASE; REPORTER GENE; MYOCARDIAL-INFARCTION; BIOLUMINESCENCE; SURVIVAL; THERAPY; PET; DELIVERY; SIZE	Purpose: Non-invasive techniques to monitor the survival and migration of transplanted stem cells in real-time is crucial for the success of stem cell therapy. The aim of this study was to explore multimodality molecular imaging to monitor transplanted stem cells with a triple-fused reporter gene [TGF; herpes simplex virus type 1 thymidine kinase (HSV1-tk), enhanced green fluorescence protein (eGFP), and firefly luciferase (FLuc)] in acute myocardial infarction rat models. Methods: Rat myocardial infarction was established by ligating the left anterior descending coronary artery. A recombinant adenovirus carrying TGF (Ad5-TGF) was constructed. After transfection with Ad5-TGF, 5x10(6) bone marrow mesenchymal stem cells (BMSCs) were transplanted into the anterior wall of the left ventricle (n = 14). Untransfected BMSCs were as controls (n = 8). MicroPET/CT, fluorescence and bioluminescence imaging were performed. Continuous images were obtained at day 2, 3 and 7 after transplantation with all three imaging modalities and additional images were performed with bioluminescence imaging until day 15 after transplantation. Results: High signals in the heart area were observed using microPET/CT, fluorescence and bioluminescence imaging of infarcted rats injected with Ad5-TGF-transfected BMSCs, whereas no signals were observed in controls. Semi-quantitative analysis showed the gradual decrease of signals in all three imaging modalities with time. Immunohistochemistry assays confirmed the location of the TGF protein expression was the same as the site of stem cell-specific marker expression, suggesting that TGF tracked the stem cells in situ. Conclusions: We demonstrated that TGF could be used as a reporter gene to monitor stem cells in a myocardial infarction model by multimodality molecular imaging.	[Pei, Zhijun; Lan, Xiaoli; Qin, Chunxia; Xia, Xiaotian; Yuan, Hui; Ding, Zhiling; Zhang, Yongxue] Huazhong Univ Sci & Technol, Tongji Med Coll, Hubei Prov Key Lab Mol Imaging, Dept Nucl Med,Union Hosp, Wuhan 430074, Peoples R China; [Pei, Zhijun] Hubei Univ Med, Taihe Hosp, Dept PET Ctr, Shiyan City, Hubei Province, Peoples R China; [Cheng, Zhen] Stanford Univ, Mol Imaging Program, Stanford & Biox Program, Stanford, CA 94305 USA	Huazhong University of Science & Technology; Hubei University of Medicine; Stanford University	Lan, XL (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Hubei Prov Key Lab Mol Imaging, Dept Nucl Med,Union Hosp, Wuhan 430074, Peoples R China.	LXL730724@hotmail.com; zhyx1229@163.com	qin, chunxia/GPG-1369-2022; Xia, Xiaotian/GWK-0088-2022; Cheng, Zhen/K-2843-2012	Cheng, Zhen/0000-0001-8177-9463; Pei, Zhijun/0000-0001-6125-0626; Yuan, Hui/0000-0002-9122-3407	National Natural Science Foundation of China [30830041, 30571816, 30772208, 30970853]; China Postdoctoral Science Foundation [2005037194]; Hubei Province Science Fund for Distinguished Young Scholars [2010CDA094]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Hubei Province Science Fund for Distinguished Young Scholars	This study was supported by the National Natural Science Foundation of China (No. 30830041, 30571816, 30772208, and 30970853) (http://www.nsfc.gov.cn/Portal0/default152.htm), the China Postdoctoral Science Foundation (2005037194) (http://211.166.12.38/V1/Program1/Default.aspx), and Hubei Province Science Fund for Distinguished Young Scholars (2010CDA094) (http://www.hbstd.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao F, 2006, CIRCULATION, V113, P1005, DOI 10.1161/CIRCULATIONAHA.105.588954; Clifford DM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006536.pub3; Contag CH, 2007, ANNU REV PATHOL-MECH, V2, P277, DOI 10.1146/annurev.pathol.2.010506.091930; Copland IB, 2009, STEM CELLS, V27, P467, DOI 10.1634/stemcells.2008-0520; Deuse T, 2009, CIRCULATION, V120, pS247, DOI 10.1161/CIRCULATIONAHA.108.843680; FISHBEIN MC, 1978, AM J PATHOL, V90, P57; Gyongyosi M, 2008, CIRC-CARDIOVASC IMAG, V1, P94, DOI 10.1161/CIRCIMAGING.108.797449; Higuchi T, 2009, J NUCL MED, V50, P1088, DOI 10.2967/jnumed.108.060665; Higuchi T, 2009, J NUCL MED, V50, P1881, DOI 10.2967/jnumed.109.067801; Hu S, 2011, MOL IMAGING, V10, P227, DOI 10.2310/7290.2010.00051; Inubushi M, 2007, EUR J NUCL MED MOL I, V34, pS27, DOI 10.1007/s00259-007-0438-x; Jaffer FA, 2007, CIRCULATION, V116, P1052, DOI 10.1161/CIRCULATIONAHA.106.647164; Jang YY, 2012, MOL IMAGING, V11, P1; JOHNS TNP, 1954, ANN SURG, V140, P675, DOI 10.1097/00000658-195411000-00006; Krause U, 2007, STEM CELLS DEV, V16, P31, DOI 10.1089/scd.2006.0089; Li WZ, 2007, STEM CELLS, V25, P2118, DOI 10.1634/stemcells.2006-0771; Love Z, 2007, J NUCL MED, V48, P2011, DOI 10.2967/jnumed.107.043166; Massoud TF, 2003, GENE DEV, V17, P545, DOI 10.1101/gad.1047403; Min JJ, 2006, ANN NUCL MED, V20, P165, DOI 10.1007/BF03027425; Orlic D, 2003, PEDIATR TRANSPLANT, V7, P86, DOI 10.1034/j.1399-3046.7.s3.13.x; Pei ZJ, 2012, NUCL MED BIOL, V39, P813, DOI 10.1016/j.nucmedbio.2011.12.014; PFEFFER MA, 1979, CIRC RES, V44, P503, DOI 10.1161/01.RES.44.4.503; Picinich SC, 2007, EXPERT OPIN BIOL TH, V7, P965, DOI 10.1517/14712598.7.7.965; Plewka M, 2011, KARDIOL POL, V69, P1234; Price MJ, 2006, INT J CARDIOL, V111, P231, DOI 10.1016/j.ijcard.2005.07.036; Rodriguez-Porcel M., 2008, STEMBOOK; Roelants V, 2008, J NUCL MED, V49, P1836, DOI 10.2967/jnumed.108.052175; Schafer R, 2008, PANMINERVA MED, V50, P31; Sheikh AY, 2007, STEM CELLS, V25, P2677, DOI 10.1634/stemcells.2007-0041; Song SW, 2009, STEM CELLS, V27, P1358, DOI 10.1002/stem.47; Sun LJ, 2007, BIOCHEM BIOPH RES CO, V357, P779, DOI 10.1016/j.bbrc.2007.04.010; Tarnavski O, 2004, PHYSIOL GENOMICS, V16, P349, DOI 10.1152/physiolgenomics.00041.2003; Wang HE, 2006, J NUCL MED, V47, P1161; Weissleder R, 1999, RADIOLOGY, V212, P609, DOI 10.1148/radiology.212.3.r99se18609; Willmann JK, 2009, RADIOLOGY, V252, P117, DOI 10.1148/radiol.2513081616; Wolf D, 2007, J AM SOC ECHOCARDIOG, V20, P512, DOI 10.1016/j.echo.2006.11.008; Wu JC, 2006, PHYSIOL GENOMICS, V25, P29, DOI 10.1152/physiolgenomics.00254.2005; Wu JC, 2003, CIRCULATION, V108, P1302, DOI 10.1161/01.CIR.0000091252.20010.6E; Yaghoubi SS, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2821415; Yaghoubi SS, 2006, J NUCL MED, V47, P706	40	17	17	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90543	10.1371/journal.pone.0090543	http://dx.doi.org/10.1371/journal.pone.0090543			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608323	gold, Green Published, Green Submitted			2022-12-27	WOS:000332485800031
J	Thierfelder, KM; Meimarakis, G; Nikolaou, K; Sommer, WH; Schmitt, P; Kazmierczak, PM; Reiser, MF; Theisen, D				Thierfelder, Kolja M.; Meimarakis, Georgios; Nikolaou, Konstantin; Sommer, Wieland H.; Schmitt, Peter; Kazmierczak, Philipp M.; Reiser, Maximilian F.; Theisen, Daniel			Non-Contrast-Enhanced MR Angiography at 3 Tesla in Patients with Advanced Peripheral Arterial Occlusive Disease	PLOS ONE			English	Article							MAGNETIC-RESONANCE ANGIOGRAPHY; NEPHROGENIC SYSTEMIC FIBROSIS; VASCULAR-DISEASE; METAANALYSIS; EXPERIENCE; ACCURACY; CT	Purpose: The aim of this study was to assess the diagnostic performance of ECG-gated non-contrast-enhanced quiescent interval single-shot (QISS) magnetic resonance angiography at a magnetic field strength of 3 Tesla in patients with advanced peripheral arterial occlusive disease (PAOD). Method and Materials: A total of 21 consecutive patients with advanced PAOD (Fontaine stage IIb and higher) referred for peripheral magnetic resonance angiography (MRA) were included. Imaging was performed on a 3 T whole body MR. Image quality and stenosis diameter were evaluated in comparison to contrast-enhanced continuous table and TWIST MRA (CE-MRA) as standard of reference. QISS images were acquired with a thickness of 1.5 mm each (high-resolution QISS, HR-QISS). Two blinded readers rated the image quality and the degree of stenosis for both HR-QISS and CE-MRA in 26 predefined arterial vessel segments on 5-point Likert scales. Results: With CE-MRA as the reference standard, HR-QISS showed high sensitivity (94.1%), specificity (97.8%), positive (95.1%), and negative predictive value (97.2%) for the detection of significant (>= 50%) stenosis. Interreader agreement for stenosis assessment of both HR-QISS and CE-MRA was excellent (kappa-values of 0.951 and 0.962, respectively). As compared to CR-MRA, image quality of HR-QISS was significantly lower for the distal aorta, the femoral and iliac arteries (each with p<0.01), while no significant difference was found in the popliteal (p = 0.09) and lower leg arteries (p = 0.78). Conclusion: Non-enhanced ECG-gated HR-QISS performs very well in subjects with severe PAOD and is a good alternative for patients with a high risk of nephrogenic systemic fibrosis.	[Thierfelder, Kolja M.; Nikolaou, Konstantin; Sommer, Wieland H.; Kazmierczak, Philipp M.; Reiser, Maximilian F.; Theisen, Daniel] Ludwig Maximilians Univ Hosp, Dept Clin Radiol, Munich, Germany; [Meimarakis, Georgios] Ludwig Maximilians Univ Hosp, Dept Vasc & Endovasc Surg, Munich, Germany; [Schmitt, Peter] Siemens AG, Healthcare Sect, Erlangen, Germany	University of Munich; University of Munich; Siemens AG; Siemens Germany	Thierfelder, KM (corresponding author), Ludwig Maximilians Univ Hosp, Dept Clin Radiol, Munich, Germany.	kolja.thierfelder@med.uni-muenchen.de		Nikolaou, Konstantin/0000-0003-2668-7325				Bongartz G, 2008, EUR J RADIOL, V66, P213, DOI 10.1016/j.ejrad.2008.01.031; Bridges MD, 2009, AM J ROENTGENOL, V192, P1538, DOI 10.2214/AJR.07.3895; COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; Edelman RR, 2013, MAGN RESON MED, V70, P1662, DOI 10.1002/mrm.24596; Edelman RR, 2010, MAGN RESON MED, V63, P951, DOI 10.1002/mrm.22287; FELBLINGER J, 1994, MAGNET RESON MED, V32, P523, DOI 10.1002/mrm.1910320416; FONTAINE R, 1954, Helv Chir Acta, V21, P499; Guerrero A, 2006, NEPHROL DIAL TRANSPL, V21, P3525, DOI 10.1093/ndt/gfl470; Haneder S, 2011, EUR RADIOL, V21, P1452, DOI 10.1007/s00330-011-2063-0; Hodnett PA, 2011, AM J ROENTGENOL, V197, P1466, DOI 10.2214/AJR.10.6091; Hodnett PA, 2011, RADIOLOGY, V260, P282, DOI 10.1148/radiol.11101336; Klasen J, 2011, CLIN RADIOL; Koelemay MJW, 2001, JAMA-J AM MED ASSOC, V285, P1338, DOI 10.1001/jama.285.10.1338; Kuo PH, 2007, RADIOLOGY, V242, P647, DOI 10.1148/radiol.2423061640; Li D, 2011, EUR RADIOL, V21, P1311, DOI 10.1007/s00330-010-2028-8; Lim RP, 2008, J MAGN RESON IMAGING, V28, P181, DOI 10.1002/jmri.21416; MCCAULEY TR, 1994, RADIOLOGY, V192, P351, DOI 10.1148/radiology.192.2.8029396; Menke J, 2010, ANN INTERN MED, V153, P325, DOI 10.7326/0003-4819-153-5-201009070-00007; Merkx MAG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053615; Napoli A, 2011, RADIOLOGY, V261, P976, DOI 10.1148/radiol.11103564; O'Hare A, 2001, J AM SOC NEPHROL, V12, P2838, DOI 10.1681/ASN.V12122838; Offerman EJ, 2013, MAGN RESON MED, V69, P158, DOI 10.1002/mrm.24240; Offerman EJ, 2011, J MAGN RESON IMAGING, V33, P401, DOI 10.1002/jmri.22457; Rapp JH, 2005, RADIOLOGY, V236, P71, DOI 10.1148/radiol.2361040148; Reimer P, 1999, EUR RADIOL, V9, P122, DOI 10.1007/s003300050642; Sandhu GS, 2012, AM J ROENTGENOL, V198, P686, DOI 10.2214/AJR.11.7065; Thom T, 2006, CIRCULATION, V113, pE85, DOI 10.1161/CIRCULATIONAHA.105.171600; Ward EV, 2013, J MAGN RESON IMAGING	28	25	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91078	10.1371/journal.pone.0091078	http://dx.doi.org/10.1371/journal.pone.0091078			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608937	Green Published, Green Submitted, gold			2022-12-27	WOS:000332485800097
J	Wang, T; Green, LA; Gupta, SK; Kim, C; Wang, L; Almodovar, S; Flores, SC; Prudovsky, IA; Jolicoeur, P; Liu, ZY; Clauss, M				Wang, Ting; Green, Linden A.; Gupta, Samir K.; Kim, Chul; Wang, Liang; Almodovar, Sharilyn; Flores, Sonia C.; Prudovsky, Igor A.; Jolicoeur, Paul; Liu, Ziyue; Clauss, Matthias			Transfer of Intracellular HIV Nef to Endothelium Causes Endothelial Dysfunction	PLOS ONE			English	Article							NADPH OXIDASE ACTIVATION; OXIDATIVE STRESS; PULMONARY-HYPERTENSION; INFLAMMATORY PATHWAYS; HEART-DISEASE; VITAMIN-E; T-CELLS; B-CELLS; ATHEROSCLEROSIS; CORONARY	With effective antiretroviral therapy (ART), cardiovascular diseases (CVD) are emerging as a major cause of morbidity and death in the aging HIV-infected population. To address whether HIV-Nef, a viral protein produced in infected cells even when virus production is halted by ART, can lead to endothelial activation and dysfunction, we tested Nef protein transfer to and activity in endothelial cells. We demonstrated that Nef is essential for major endothelial cell activating effects of HIV-infected Jurkat cells when in direct contact with the endothelium. In addition, we found that Nef protein in endothelial cells is sufficient to cause apoptosis, ROS generation and release of monocyte attractant protein-1 (MCP-1). The Nef protein-dependent endothelial activating effects can be best explained by our observation that Nef protein rapidly transfers from either HIV-infected or Nef-transfected Jurkat cells to endothelial cells between these two cell types. These results are of in vivo relevance as we demonstrated that Nef protein induces GFP transfer from T cells to endothelium in CD4.Nef.GFP transgenic mice and Nef is present in chimeric SIV-infected macaques. Analyzing the signal transduction effects of Nef in endothelial cells, we found that Nef-induced apoptosis is mediated through ROS-dependent mechanisms, while MCP-1 production is NF-kB dependent. Together, these data indicate that inhibition of Nef-associated pathways may be promising new therapeutic targets for reducing the risk for cardiovascular disease in the HIV-infected population.	[Wang, Ting; Clauss, Matthias] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; [Wang, Ting; Green, Linden A.; Kim, Chul; Wang, Liang; Clauss, Matthias] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA; [Wang, Ting; Green, Linden A.; Kim, Chul; Wang, Liang; Clauss, Matthias] Indiana Univ Sch Med, Indiana Ctr Vasc Biol & Med, Indianapolis, IN 46202 USA; [Wang, Ting; Green, Linden A.; Wang, Liang; Clauss, Matthias] RL Roudebush VA Med Ctr, Indianapolis, IN USA; [Gupta, Samir K.] Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA; [Almodovar, Sharilyn; Flores, Sonia C.] Univ Colorado, Dept Med Pulm Sci & Crit Care Med, Denver, CO 80202 USA; [Prudovsky, Igor A.] Maine Med Ctr, Res Inst, Ctr Mol Med, Scarborough, ME USA; [Jolicoeur, Paul] Univ Montreal, Inst Rech Clin Montreal, Montreal, PQ, Canada; [Liu, Ziyue] Indiana Univ Sch Med, Dept Biostat, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center; Indiana University System; Indiana University Bloomington; University of Colorado System; University of Colorado Denver; Maine Medical Center; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Indiana University System; Indiana University Bloomington	Clauss, M (corresponding author), Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA.	mclauss@iupui.edu	Almodovar, Sharilyn/ABI-9237-2022; Prudovsky, Igor/GVU-1521-2022; Wang, Ting/H-1075-2015	Almodovar, Sharilyn/0000-0002-4769-1924; Clauss, Matthias/0000-0001-5180-3899; Wang, Liang/0000-0002-4052-1316	NIH-NHLBI; American Heart Association [R01 HL095149, R01-HL083491, T32 HL079995, AHA 13PRE14780025]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001108, UL1TR002529, UL1TR001082] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL079995, R01HL095149, R01HL083491] Funding Source: NIH RePORTER	NIH-NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by the NIH-NHLBI and American Heart Association, contract grant no. R01 HL095149 (MC and SG), R01-HL083491 (SCF), T32 HL079995 (LG) and AHA 13PRE14780025 (TW). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almodovar Sharilyn, 2011, Proc Am Thorac Soc, V8, P308, DOI 10.1513/pats.201006-046WR; Alonso-Villaverde C, 2004, CIRCULATION, V110, P2204, DOI 10.1161/01.CIR.0000143835.95029.7D; Appay V, 2002, AIDS, V16, P161, DOI 10.1097/00002030-200201250-00004; Arts MJTJ, 2004, FOOD CHEM TOXICOL, V42, P45, DOI 10.1016/j.fct.2003.08.004; Astern JM, 2007, AM J PATHOL, V171, P349, DOI 10.2353/ajpath.2007.060831; Baliga RS, 2005, AM J PHYSIOL-HEART C, V289, pH1373, DOI 10.1152/ajpheart.00304.2005; Chen XL, 2004, AM J PHYSIOL-HEART C, V286, pH1001, DOI 10.1152/ajpheart.00716.2003; Clauss M, 2011, J CLIN INVEST, V121, P2470, DOI 10.1172/JCI43881; Csanyi G, 2011, FREE RADICAL BIO MED, V51, P1116, DOI 10.1016/j.freeradbiomed.2011.04.025; Currier Judith S, 2008, Circulation, V118, pe29, DOI 10.1161/CIRCULATIONAHA.107.189624; De Proost I, 2008, AM J RESP CELL MOL, V39, P180, DOI 10.1165/rcmb.2008-0011OC; Duffy P, 2009, J SURG RES; Duffy P, 2009, J SURG RES, V156, P257, DOI 10.1016/j.jss.2009.02.005; Eugenin EA, 2009, CELL IMMUNOL, V254, P142, DOI 10.1016/j.cellimm.2008.08.005; Foster JL, 2011, J NEUROIMMUNE PHARM, V6, P230, DOI 10.1007/s11481-011-9262-y; Foster JL, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-84; Foti M, 1999, J BIOL CHEM, V274, P34765, DOI 10.1074/jbc.274.49.34765; Freiberg MS, 2013, JAMA INTERN MED, V173, P614, DOI 10.1001/jamainternmed.2013.3728; Freiberg MS, 2011, CIRC-CARDIOVASC QUAL, V4, P425, DOI 10.1161/CIRCOUTCOMES.110.957415; Geyer M, 2001, EMBO REP, V2, P580, DOI 10.1093/embo-reports/kve141; Gosling J, 1999, J CLIN INVEST, V103, P773, DOI 10.1172/JCI5624; Green LA, 2012, AIDS RES HUM RETROVI; Green LA, 2012, AM J RESP CELL MOL, V47, P807, DOI 10.1165/rcmb.2012-0132OC; Grunfeld C, 2009, AIDS, V23, P1841, DOI 10.1097/QAD.0b013e32832d3b85; Heitzer T, 2001, CIRCULATION, V104, P2673, DOI 10.1161/hc4601.099485; Heumuller S, 2008, HYPERTENSION, V51, P211, DOI 10.1161/HYPERTENSIONAHA.107.100214; Hodis HN, 2002, CIRCULATION, V106, P1453, DOI 10.1161/01.CIR.0000029092.99946.08; Johnson DK, 2002, ENDOTHELIUM-J ENDOTH, V9, P191, DOI 10.1080/10623320213638; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; Kim C, 2011, ANTIVIR THER, V16, P1335, DOI 10.3851/IMP1891; Kinlay S, 2004, J AM COLL CARDIOL, V43, P629, DOI 10.1016/j.jacc.2003.08.051; Kline ER, 2008, AM J PHYSIOL-HEART C, V294, pH2792, DOI 10.1152/ajpheart.91447.2007; Lenassi M, 2010, TRAFFIC, V11, P110, DOI 10.1111/j.1600-0854.2009.01006.x; Liu XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033497; Mandell CP, 1999, VIROLOGY, V265, P235, DOI 10.1006/viro.1999.0051; Manninen A, 1998, VIROLOGY, V250, P273, DOI 10.1006/viro.1998.9381; Merchant AT, 2005, J NUTR, V135, P1776, DOI 10.1093/jn/135.7.1776; Muratori C, 2009, CELL HOST MICROBE, V6, P218, DOI 10.1016/j.chom.2009.06.009; Obel N, 2007, CLIN INFECT DIS, V44, P1625, DOI 10.1086/518285; Ohman MK, 2010, ARTERIOSCL THROM VAS, V30, P1151, DOI 10.1161/ATVBAHA.110.205914; Olivetta E, 2005, BIOCHEM J, V390, P591, DOI 10.1042/BJ20042139; Qi ML, 2008, VIROLOGY, V373, P287, DOI 10.1016/j.virol.2007.12.001; Qiao XG, 2006, NAT IMMUNOL, V7, P302, DOI 10.1038/ni1302; Rajashekhar G, 2008, STEM CELLS, V26, P2674, DOI 10.1634/stemcells.2008-0277; Riccioni Graziano, 2012, Front Biosci (Elite Ed), V4, P373; Salmen S, 2010, CELL IMMUNOL, V263, P166, DOI 10.1016/j.cellimm.2010.03.012; Schluter T, 2008, CARDIOVASC RES, V80, P271, DOI 10.1093/cvr/cvn185; Sehgal PB, 2009, AM J PHYSIOL-LUNG C, V297, pL729, DOI 10.1152/ajplung.00087.2009; Sowinski S, 2008, NAT CELL BIOL, V10, P211, DOI 10.1038/ncb1682; Stolp B, 2012, P NATL ACAD SCI USA, V109, P18541, DOI 10.1073/pnas.1204322109; Subramanian S, 2012, JAMA-J AM MED ASSOC, V308, P379, DOI 10.1001/jama.2012.6698; Toborek M, 2003, J NEUROCHEM, V84, P169, DOI 10.1046/j.1471-4159.2003.01543.x; Triant VA, 2007, J CLIN ENDOCR METAB, V92, P2506, DOI 10.1210/jc.2006-2190; Ullrich CK, 2000, BLOOD, V96, P1438, DOI 10.1182/blood.V96.4.1438.h8001438_1438_1442; Vilhardt F, 2002, J BIOL CHEM, V277, P42136, DOI 10.1074/jbc.M200862200; Xu WF, 2009, NAT IMMUNOL, V10, P1008, DOI 10.1038/ni.1753; Yang Fan, 2010, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V26, P44	57	45	45	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91063	10.1371/journal.pone.0091063	http://dx.doi.org/10.1371/journal.pone.0091063			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608713	Green Submitted, Green Published, gold			2022-12-27	WOS:000332485800093
J	Yan, L; Gu, YH; Tao, X; Lai, XJ; Zhang, YZ; Tan, XM; Wang, HY				Yan, Lang; Gu, Ying-Hong; Tao, Xiang; Lai, Xian-Jun; Zhang, Yi-Zheng; Tan, Xue-Mei; Wang, Haiyan			Scanning of Transposable Elements and Analyzing Expression of Transposase Genes of Sweet Potato [Ipomoea batatas]	PLOS ONE			English	Article							EVOLUTIONARY DYNAMICS; SINGLE-COPY; ARABIDOPSIS; IDENTIFICATION; DIVERSITY; RESOURCE; SEQUENCE; FAMILY; DNA; ANNOTATION	Background: Transposable elements (TEs) are the most abundant genomic components in eukaryotes and affect the genome by their replications and movements to generate genetic plasticity. Sweet potato performs asexual reproduction generally and the TEs may be an important genetic factor for genome reorganization. Complete identification of TEs is essential for the study of genome evolution. However, the TEs of sweet potato are still poorly understood because of its complex hexaploid genome and difficulty in genome sequencing. The recent availability of the sweet potato transcriptome databases provides an opportunity for discovering and characterizing the expressed TEs. Methodology/Principal Findings: We first established the integrated-transcriptome database by de novo assembling four published sweet potato transcriptome databases from three cultivars in China. Using sequence-similarity search and analysis, a total of 1,405 TEs including 883 retrotransposons and 522 DNA transposons were predicted and categorized. Depending on mapping sets of RNA-Seq raw short reads to the predicted TEs, we compared the quantities, classifications and expression activities of TEs inter-and intra-cultivars. Moreover, the differential expressions of TEs in seven tissues of Xushu 18 cultivar were analyzed by using Illumina digital gene expression (DGE) tag profiling. It was found that 417 TEs were expressed in one or more tissues and 107 in all seven tissues. Furthermore, the copy number of 11 transposase genes was determined to be 1-3 copies in the genome of sweet potato by Real-time PCR-based absolute quantification. Conclusions/Significance: Our result provides a new method for TE searching on species with transcriptome sequences while lacking genome information. The searching, identification and expression analysis of TEs will provide useful TE information in sweet potato, which are valuable for the further studies of TE-mediated gene mutation and optimization in asexual reproduction. It contributes to elucidating the roles of TEs in genome evolution.	[Yan, Lang; Gu, Ying-Hong; Lai, Xian-Jun; Zhang, Yi-Zheng; Tan, Xue-Mei; Wang, Haiyan] Sichuan Univ, Key Lab Bioresources & Ecoenvironm, Sichuan Key Lab Mol Biol & Biotechnol,Minist Educ, Ctr Funct Genom & Bioinformat,Coll Life Sci, Chengdu 610064, Sichuan, Peoples R China; [Tao, Xiang] Chinese Acad Sci, Chengdu Inst Biol, Chengdu, Sichuan, Peoples R China	Sichuan University; Chinese Academy of Sciences; Chengdu Institute of Biology, CAS	Tan, XM (corresponding author), Sichuan Univ, Key Lab Bioresources & Ecoenvironm, Sichuan Key Lab Mol Biol & Biotechnol,Minist Educ, Ctr Funct Genom & Bioinformat,Coll Life Sci, Chengdu 610064, Sichuan, Peoples R China.	txmyyf@scu.edu.cn; hayawang@scu.edu.cn	GU, Yinghong/D-2433-2010	GU, Yinghong/0000-0002-9364-1389	National Science and Technology Pillar Program of China [2007BAD78B03]; "Eleventh-Five" Key Project of Sichuan Province, China [07SG111-003-1]	National Science and Technology Pillar Program of China; "Eleventh-Five" Key Project of Sichuan Province, China	This work was supported by funds from the National Science and Technology Pillar Program of China (No. 2007BAD78B03, http://kjzc.jhgl.org/) and the "Eleventh-Five" Key Project of Sichuan Province, China (No. 07SG111-003-1, http://www.scst.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Beltran J, 2009, IN VITRO CELL DEV-PL, V45, P48, DOI 10.1007/s11627-008-9159-5; Bennetzen JL, 2000, PLANT MOL BIOL, V42, P251, DOI 10.1023/A:1006344508454; Biemont C, 2010, GENETICS, V186, P1085, DOI 10.1534/genetics.110.124180; Bundock P, 2005, NATURE, V436, P282, DOI 10.1038/nature03667; Carpena A. L., 2009, P27, DOI 10.1007/978-1-4020-9475-0_4; Casacuberta E, 2013, MOL ECOL, V22, P1503, DOI 10.1111/mec.12170; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cowley M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003234; de Souza FSJ, 2013, MOL BIOL EVOL, V30, P1239, DOI 10.1093/molbev/mst045; Diao Xian-Min, 2006, Acta Genetica Sinica, V33, P477, DOI 10.1016/S0379-4172(06)60075-9; Dolgin E, 2009, NATURE NEWS, P1098; Du JC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-113; Duarte JM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-61; Firon N., 2009, P13, DOI 10.1007/978-1-4020-9475-0_3; Gaba V., 2009, P65, DOI 10.1007/978-1-4020-9475-0_6; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; He XJ, 2011, J TROPICAL AGR, V31, P10; HERSHBERGER RJ, 1995, GENETICS, V140, P1087; Hillman-Jackson Jennifer, 2012, Curr Protoc Bioinformatics, VChapter 10, DOI 10.1002/0471250953.bi1005s38; Hoen DR, 2006, MOL BIOL EVOL, V23, P1254, DOI 10.1093/molbev/msk015; Holligan D, 2006, GENETICS, V174, P2215, DOI 10.1534/genetics.106.062752; Hollister JD, 2007, MOL BIOL EVOL, V24, P2515, DOI 10.1093/molbev/msm197; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kihara T, 2006, BIOSCI BIOTECH BIOCH, V70, P1780, DOI 10.1271/bbb.50687; Knip M, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-192; Lal SK, 2005, HEREDITY, V95, P421, DOI 10.1038/sj.hdy.6800764; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Le QH, 2000, P NATL ACAD SCI USA, V97, P7376, DOI 10.1073/pnas.97.13.7376; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Lisch D, 2013, NAT REV GENET, V14, P49, DOI 10.1038/nrg3374; Loebenstein G., 2009, P9, DOI 10.1007/978-1-4020-9475-0_2; Luo WL, 2012, J AGR SCI, V2, P135; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Mayer KFX, 2012, NATURE, V491, P711, DOI 10.1038/nature11543; Morgante M, 2006, CURR OPIN BIOTECH, V17, P168, DOI 10.1016/j.copbio.2006.03.001; Nagy Z, 2004, RES MICROBIOL, V155, P387, DOI 10.1016/j.resmic.2004.01.008; Ouyang S, 2004, NUCLEIC ACIDS RES, V32, pD360, DOI 10.1093/nar/gkh099; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rossi M, 2001, GENET MOL BIOL, V24, P147, DOI 10.1590/S1415-47572001000100020; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Shapiro JA, 2010, MOBILE DNA-UK, V1, DOI 10.1186/1759-8753-1-4; Shimatani Z, 2009, MOL GENET GENOMICS, V281, P329, DOI 10.1007/s00438-008-0410-x; Srinivas T., 2009, P235, DOI 10.1007/978-1-4020-9475-0_12; Tao X, 2013, BIOSCI BIOTECH BIOCH, V77, P2169, DOI 10.1271/bbb.130218; Tao X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036234; Thottappilly G., 2009, P3, DOI 10.1007/978-1-4020-9475-0_1; Tollis M, 2012, GENOME DYNAM, V7, P68, DOI 10.1159/000337126; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Wall PK, 2008, NUCLEIC ACIDS RES, V36, pD970, DOI 10.1093/nar/gkm972; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-726; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Wu QY, 2011, HUNAN AGR SCI, V5, P4; Xie FL, 2012, PLANTA, V236, P101, DOI 10.1007/s00425-012-1591-4; Xu ZN, 2005, PLANT CELL, V17, P375, DOI 10.1105/tpc.104.027797; Yi CX, 2008, ANAL BIOCHEM, V375, P150, DOI 10.1016/j.ab.2007.11.022; Yurchenko N.N., 2011, RUSS J GENET APPL RE, V1, P489, DOI [10.1134/S2079059711060141, DOI 10.1134/S2079059711060141]; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	62	6	13	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90895	10.1371/journal.pone.0090895	http://dx.doi.org/10.1371/journal.pone.0090895			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608103	Green Submitted, gold, Green Published			2022-12-27	WOS:000332485800064
J	Baldan, R; Cigana, C; Testa, F; Bianconi, I; De Simone, M; Pellin, D; Di Serio, C; Bragonzi, A; Cirillo, DM				Baldan, Rossella; Cigana, Cristina; Testa, Francesca; Bianconi, Irene; De Simone, Maura; Pellin, Danilo; Di Serio, Clelia; Bragonzi, Alessandra; Cirillo, Daniela M.			Adaptation of Pseudomonas aeruginosa in Cystic Fibrosis Airways Influences Virulence of Staphylococcus aureus In Vitro and Murine Models of Co-Infection	PLOS ONE			English	Article							GENOME SEQUENCE; INFECTIONS; EXPRESSION; GROWTH	Cystic fibrosis (CF) airways disease represents an example of polymicrobial infection whereby different bacterial species can interact and influence each other. In CF patients Staphylococcus aureus is often the initial pathogen colonizing the lungs during childhood, while Pseudomonas aeruginosa is the predominant pathogen isolated in adolescents and adults. During chronic infection, P. aeruginosa undergoes adaptation to cope with antimicrobial therapy, host response and co-infecting pathogens. However, S. aureus and P. aeruginosa often co-exist in the same niche influencing the CF pathogenesis. The goal of this study was to investigate the reciprocal interaction of P. aeruginosa and S. aureus and understand the influence of P. aeruginosa adaptation to the CF lung in order to gain important insight on the interplay occurring between the two main pathogens of CF airways, which is still largely unknown. P. aeruginosa reference strains and eight lineages of clinical strains, including early and late clonal isolates from different patients with CF, were tested for growth inhibition of S. aureus. Next, P. aeruginosa/S. aureus competition was investigated in planktonic co-culture, biofilm, and mouse pneumonia model. P. aeruginosa reference and early strains, isolated at the onset of chronic infection, outcompeted S. aureus in vitro and in vivo models of co-infection. On the contrary, our results indicated a reduced capacity to outcompete S. aureus of P. aeruginosa patho-adaptive strains, isolated after several years of chronic infection and carrying several phenotypic changes temporally associated with CF lung adaptation. Our findings provide relevant information with respect to interspecies interaction and disease progression in CF.	[Baldan, Rossella; Testa, Francesca; Cirillo, Daniela M.] Ist Sci San Raffaele, Emerging Bacterial Pathogens Unit, I-20132 Milan, Italy; [Cigana, Cristina; Bianconi, Irene; De Simone, Maura; Bragonzi, Alessandra] Ist Sci San Raffaele, Infect & Cyst Fibrosis Unit, I-20132 Milan, Italy; [Pellin, Danilo; Di Serio, Clelia] Univ Vita Salute San Raffaele, Univ Ctr Stat Biomed Sci, Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University	Cirillo, DM (corresponding author), Ist Sci San Raffaele, Emerging Bacterial Pathogens Unit, I-20132 Milan, Italy.	cirillo.daniela@hsr.it	Di Serio, Clelia/AAO-5494-2020; Bragonzi, Alessandra/AAC-6751-2022; Cirillo, Daniela Maria/AAB-3646-2019; Cigana, Cristina/D-2883-2016	Cirillo, Daniela Maria/0000-0001-6415-1535; Cigana, Cristina/0000-0003-0436-9721; Baldan, Rossella/0000-0002-4674-4326; Bianconi, Irene/0000-0002-5923-4296; Bragonzi, Alessandra/0000-0002-5808-7669; DI SERIO, Mariaclelia Stefania/0000-0001-6385-6058	Fondazione per la ricerca sulla Fibrosi Cistica (project FFC) [9/2010]	Fondazione per la ricerca sulla Fibrosi Cistica (project FFC)	This study was supported to DMC and AB by Fondazione per la ricerca sulla Fibrosi Cistica (project FFC#9/2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], CYST FIBR FDN PAT RE; Armougom F, 2009, EUR J CLIN MICROBIOL, V28, P1151, DOI 10.1007/s10096-009-0749-x; Baba T, 2008, J BACTERIOL, V190, P300, DOI 10.1128/JB.01000-07; Baldan R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043153; Bianconi I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001270; Biswas L, 2009, APPL ENVIRON MICROB, V75, P6910, DOI 10.1128/AEM.01211-09; Bittar F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002908; Bouchara JP, 2009, J CLIN MICROBIOL, V47, P142, DOI 10.1128/JCM.01668-08; Bragonzi A, 2006, MICROBIOL-SGM, V152, P3261, DOI 10.1099/mic.0.29175-0; Bragonzi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052330; Bragonzi A, 2009, AM J RESP CRIT CARE, V180, P138, DOI 10.1164/rccm.200812-1943OC; Brogden KA, 2005, LANCET, V365, P253, DOI 10.1016/S0140-6736(05)70155-0; Cigana C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008439; Dalton T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027317; Doring G, 1997, PEDIATR PULM, P235; Doring Gerd, 2004, J Cyst Fibros, V3, P67, DOI 10.1016/j.jcf.2004.03.008; Ecker DJ, 2008, NAT REV MICROBIOL, V6, P553, DOI 10.1038/nrmicro1918; Folkesson A, 2012, NAT REV MICROBIOL, V10, P841, DOI 10.1038/nrmicro2907; Goss CH, 2011, J CYST FIBROS, V10, P298, DOI 10.1016/j.jcf.2011.06.002; Harrison F, 2007, MICROBIOL-SGM, V153, P917, DOI 10.1099/mic.0.2006/004077-0; Hibbing ME, 2010, NAT REV MICROBIOL, V8, P15, DOI 10.1038/nrmicro2259; Hoffman LR, 2006, P NATL ACAD SCI USA, V103, P19890, DOI 10.1073/pnas.0606756104; Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011; Horsburgh MJ, 2002, J BACTERIOL, V184, P5457, DOI 10.1128/JB.184.19.5457-5467.2002; Jarry TM, 2006, INFECT IMMUN, V74, P2568, DOI 10.1128/IAI.74.5.2568-2577.2006; Johnson AP, 2011, J ANTIMICROB CHEMOTH, V66, pIV43, DOI 10.1093/jac/dkr076; Liberati NT, 2006, P NATL ACAD SCI USA, V103, P2833, DOI 10.1073/pnas.0511100103; LiPuma JJ, 2010, CLIN MICROBIOL REV, V23, P299, DOI 10.1128/CMR.00068-09; Lore NI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035648; Macho AP, 2007, MOL PLANT PATHOL, V8, P437, DOI 10.1111/J.1364-3703.2007.00404.X; Mann EE, 2012, FEMS MICROBIOL REV, V36, P893, DOI 10.1111/j.1574-6976.2011.00322.x; Maselli JH, 2003, PEDIATR PULM, V35, P257, DOI 10.1002/ppul.10230; Mashburn LM, 2005, J BACTERIOL, V187, P554, DOI 10.1128/JB.187.2.554-566.2005; Montanari S, 2007, MICROBIOL-SGM, V153, P1445, DOI 10.1099/mic.0.2006/003400-0; Nocker A, 2007, MICROB ECOL, V54, P276, DOI 10.1007/s00248-006-9199-5; Pastar I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056846; Peters BM, 2012, CLIN MICROBIOL REV, V25, P193, DOI 10.1128/CMR.00013-11; Qazi S, 2006, INFECT IMMUN, V74, P910, DOI 10.1128/IAI.74.2.910-919.2006; Qin ZQ, 2009, MICROBIOL-SGM, V155, P2148, DOI 10.1099/mic.0.028001-0; Ratjen F, 2012, AM J RESP CRIT CARE, V185, P933, DOI 10.1164/rccm.201202-0306UP; Razvi S, 2009, CHEST, V136, P1554, DOI 10.1378/chest.09-0132; Rogers GB, 2010, TRENDS MICROBIOL, V18, P357, DOI 10.1016/j.tim.2010.04.005; Rogers GB, 2010, EXPERT REV MOL DIAGN, V10, P187, DOI 10.1586/ERM.09.81; Rogers GB, 2009, J MED MICROBIOL, V58, P1401, DOI 10.1099/jmm.0.013334-0; Ryan RP, 2008, MOL MICROBIOL, V68, P75, DOI 10.1111/j.1365-2958.2008.06132.x; Sibley CD, 2006, FUTURE MICROBIOL, V1, P53, DOI 10.2217/17460913.1.1.53; Sibley CD, 2008, P NATL ACAD SCI USA, V105, P15070, DOI 10.1073/pnas.0804326105; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Yang L, 2011, FEMS IMMUNOL MED MIC, V62, P339, DOI 10.1111/j.1574-695X.2011.00820.x	49	100	103	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e89614	10.1371/journal.pone.0089614	http://dx.doi.org/10.1371/journal.pone.0089614			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603807	Green Published, gold, Green Submitted			2022-12-27	WOS:000332483600015
J	Chandrayan, SK; Prakash, S; Ahmed, S; Guptasarma, P				Chandrayan, Sanjeev Kumar; Prakash, Satya; Ahmed, Shubbir; Guptasarma, Purnananda			Hyperthermophile Protein Behavior: Partially-Structured Conformations of Pyrococcus furiosus Rubredoxin Monomers Generated through Forced Cold-Denaturation and Refolding	PLOS ONE			English	Article							HYPERTHERMOSTABILITY; APORUBREDOXINS; TEMPERATURE; STABILITY; NMR	Some years ago, we showed that thermo-chemically denatured, partially-unfolded forms of Pyrococcus furiosus triosephosphateisomerase (PfuTIM) display cold-denaturation upon cooling, and heat-renaturation upon reheating, in proportion with the extent of initial partial unfolding achieved. This was the first time that cold-denaturation was demonstrated for a hyperthermophile protein, following unlocking of surface salt bridges. Here, we describe the behavior of another hyperthermophile protein, the small, monomeric, 53 residues-long rubredoxin from Pyrococcus furiosus (PfRd), which is one of the most thermostable proteins known to man. Like PfuTIM, PfRd too displays cold-denaturation after initial thermo-chemical perturbation, however, with two differences: (i) PfRd requires considerably higher temperatures as well as higher concentrations of guanidium hydrochloride (Gdm. HCl) than PfuTIM; (ii) PfRd's cold-denaturation behavior during cooling after thermo-chemical perturbation is incompletely reversible, unlike PfuTIM's, which was clearly reversible (from each different conformation generated). Differential cold-denaturation treatments allow PfRd to access multiple partially-unfolded states, each of which is clearly highly kinetically-stable. We refer to these as 'Trishanku' unfolding intermediates (or TUIs). Fascinatingly, refolding of TUIs through removal of Gdm. HCl generates multiple partially-refolded, monomeric, kinetically-trapped, non-native 'Trishanku' refolding intermediates (or TRIs), which differ from each other and from native PfRd and TUIs, in structural content and susceptibility to proteolysis. We find that the occurrence of cold denaturation and observations of TUI and TRI states is contingent on the oxidation status of iron, with redox agents managing to modulate the molecule's behavior upon gaining access to PfRd's iron atom. Mass spectrometric examination provides no evidence of the formation of disulfide bonds, but other experiments suggest that the oxidation status of iron (and its extent of burial) together determine whether or not PfRd shows cold denaturation, and also whether redox agents are able to modulate its behavior.	[Prakash, Satya; Guptasarma, Purnananda] Indian Inst Sci Educ & Res IISER Mohali, Dept Biol Sci, Sect 81, Sas Nagar Mohali, Punjab, India; [Chandrayan, Sanjeev Kumar; Prakash, Satya; Ahmed, Shubbir; Guptasarma, Purnananda] Council Sci & Ind Res CSIR, Inst Microbial Technol, Prot Sci & Engn Div, IMTECH, Chandigarh, India	Indian Institute of Science Education & Research (IISER) - Mohali; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Guptasarma, P (corresponding author), Indian Inst Sci Educ & Res IISER Mohali, Dept Biol Sci, Sect 81, Sas Nagar Mohali, Punjab, India.	guptasarma@iisermohali.ac.in	CHANDRAYAN, SANJEEV/M-1662-2016; Guptasarma, Purnananda/C-3976-2009; Ahmed, Shubbir/AAC-4289-2019	CHANDRAYAN, SANJEEV/0000-0003-2219-4654; Guptasarma, Purnananda/0000-0002-4801-3180; Ahmed, Shubbir/0000-0003-1655-6735				BLAKE PR, 1991, BIOCHEMISTRY-US, V30, P10885, DOI 10.1021/bi00109a012; BLAKE PR, 1992, PROTEIN SCI, V1, P1508, DOI 10.1002/pro.5560011112; Bonomi F, 2008, J BIOL INORG CHEM, V13, P981, DOI 10.1007/s00775-008-0385-4; CAVAGNERO S, 1995, BIOCHEMISTRY-US, V34, P9865, DOI 10.1021/bi00031a007; Cavagnero S, 1998, BIOCHEMISTRY-US, V37, P3369, DOI 10.1021/bi9721795; Cavagnero S, 1998, BIOCHEMISTRY-US, V37, P3377, DOI 10.1021/bi9721804; Chandrayan SK, 2008, PROTEINS, V72, P539, DOI 10.1002/prot.22077; CHRISTENSEN HEM, 1994, EUR J BIOCHEM, V224, P97, DOI 10.1111/j.1432-1033.1994.tb19999.x; DAY MW, 1992, PROTEIN SCI, V1, P1494, DOI 10.1002/pro.5560011111; Hansen RE, 2009, P NATL ACAD SCI USA, V106, P422, DOI 10.1073/pnas.0812149106; Hernandez G, 2001, BIOCHEMISTRY-US, V40, P14384, DOI 10.1021/bi0112560; Hernandez G, 2000, P NATL ACAD SCI USA, V97, P3166, DOI 10.1073/pnas.040569697; Mukherjee S, 2005, ANAL BIOCHEM, V347, P49, DOI 10.1016/j.ab.2005.08.028; Scigelova M, 2001, EUR J MASS SPECTROM, V7, P29, DOI 10.1255/ejms.385; Sechi S, 1998, ANAL CHEM, V70, P5150, DOI 10.1021/ac9806005; Strop P, 2000, BIOCHEMISTRY-US, V39, P1251, DOI 10.1021/bi992257j; Vondrasek J, 2007, CHEM-EUR J, V13, P9022, DOI 10.1002/chem.200700428; Zartler ER, 2001, BIOCHEMISTRY-US, V40, P7279, DOI 10.1021/bi0026831	18	6	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e80014	10.1371/journal.pone.0080014	http://dx.doi.org/10.1371/journal.pone.0080014			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603413	Green Published, gold, Green Submitted			2022-12-27	WOS:000332483600001
J	Kooijman, E; Nijboer, CH; van Velthoven, CTJ; Mol, W; Dijkhuizen, RM; Kesecioglu, J; Heijnen, CJ				Kooijman, Elke; Nijboer, Cora H.; van Velthoven, Cindy T. J.; Mol, Wouter; Dijkhuizen, Rick M.; Kesecioglu, Jozef; Heijnen, Cobi J.			Long-Term Functional Consequences and Ongoing Cerebral Inflammation after Subarachnoid Hemorrhage in the Rat	PLOS ONE			English	Article							DIFFERENT BRAIN-REGIONS; NECROSIS-FACTOR-ALPHA; CEREBROSPINAL-FLUID; MOLECULAR-MECHANISMS; LEARNING-DEFICITS; HYPOXIA-ISCHEMIA; NEURONAL DEATH; BLOOD-FLOW; MYELOPEROXIDASE; INJURY	Subarachnoid hemorrhage (SAH) represents a considerable health problem with an incidence of 6-7 per 100.000 individuals per year in Western society. We investigated the long-term consequences of SAH on behavior, neuroinflammation and grayand white-matter damage using an endovascular puncture model in Wistar rats. Rats were divided into a mild or severe SAH group based on their acute neurological score at 24 h post-SAH. The degree of hemorrhage determined in post-mortem brains at 48 h strongly correlated with the acute neurological score. Severe SAH induced increased TNF-alpha, IL-1 beta, IL-10, MCP-1, MIP2, CINC-1 mRNA expression and cortical neutrophil influx at 48 h post-insult. Neuroinflammation after SAH was very long-lasting and still present at day 21 as determined by Iba-1 staining (microglia/macrophages) and GFAP (astrocytes). Long-term neuroinflammation was strongly associated with the degree of severity of SAH. Cerebral damage to gray-and white-matter was visualized by immunohistochemistry for MAP2 and MBP at 21 days after SAH. Severe SAH induced significant gray- and white-matter damage. MAP2 loss at day 21 correlated significantly with the acute neurological score determined at 24 h post-SAH. Sensorimotor behavior, determined by the adhesive removal task and von Frey test, was affected after severe SAH at day 21. In conclusion, we are the first to show that SAH induces ongoing cortical inflammation. Moreover, SAH induces mainly cortical long-term brain damage, which is associated with long-term sensorimotor damage.	[Kooijman, Elke; Kesecioglu, Jozef; Heijnen, Cobi J.] Univ Med Ctr Utrecht, Dept Intens Care Med, Utrecht, Netherlands; [Kooijman, Elke; Nijboer, Cora H.; van Velthoven, Cindy T. J.] Univ Med Ctr Utrecht, Lab Neuroimmunol & Dev Origins Dis, Utrecht, Netherlands; [Mol, Wouter; Dijkhuizen, Rick M.] Univ Med Ctr Utrecht, Image Sci Inst, Utrecht, Netherlands; [Heijnen, Cobi J.] Univ Texas MD Anderson Canc Ctr, Div Internal Med, Dept Symptom Res, Houston, TX 77030 USA	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Texas System; UTMD Anderson Cancer Center	Heijnen, CJ (corresponding author), Univ Med Ctr Utrecht, Dept Intens Care Med, Utrecht, Netherlands.	CJHeijnen@mdanderson.org		Dijkhuizen, Rick/0000-0002-4623-4078; van Velthoven, Cindy/0000-0001-5120-4546	Dirkzwager-Assink foundation; 'Friends of University Medical Center Utrecht' foundation	Dirkzwager-Assink foundation; 'Friends of University Medical Center Utrecht' foundation	This study was funded in part by the Dirkzwager-Assink foundation and by the 'Friends of University Medical Center Utrecht' foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aihara Y, 2001, STROKE, V32, P212, DOI 10.1161/01.STR.32.1.212; Al-Tamimi YZ, 2010, WORLD NEUROSURG, V73, P654, DOI 10.1016/j.wneu.2010.02.005; Anderson C, 2000, STROKE, V31, P1843; Bessis A, 2007, GLIA, V55, P233, DOI 10.1002/glia.20459; Cahill WJ, 2006, J CEREBR BLOOD F MET, V26, P1341, DOI 10.1038/sj.jcbfm.9600283; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chen G, 2013, NEUROSCIENCE, V231, P136, DOI 10.1016/j.neuroscience.2012.11.024; Chou SHY, 2012, J INVEST MED, V60, P1054, DOI 10.2310/JIM.0b013e3182686932; Dietmann A, 2012, CEREBROVASC DIS, V33, P16, DOI 10.1159/000331925; Dziurdzik P, 2004, INFLAMM RES, V53, P338, DOI 10.1007/s00011-004-1265-1; Fleiss B, 2012, LANCET NEUROL, V11, P556, DOI 10.1016/S1474-4422(12)70058-3; Flood C, 2001, J CEREBR BLOOD F MET, V21, P157, DOI 10.1097/00004647-200102000-00007; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Frontera JA, 2005, ACTA NEUROCHIR S, V95, P377; Hendryk S, 2004, NEUROENDOCRINOL LETT, V25, P141; Iseda K, 2007, J NEUROSURG, V107, P128, DOI 10.3171/JNS-07/07/0128; Jeon H, 2010, NEUROSCIENCE, V169, P1805, DOI 10.1016/j.neuroscience.2010.06.039; Kato H, 2009, ANESTH ANALG, V108, P288, DOI 10.1213/ane.0b013e318187bb93; Khalili MA, 2012, J STROKE CEREBROVASC, V21, P445, DOI 10.1016/j.jstrokecerebrovasdis.2010.10.005; Kimball MM, 2011, NEUROCRIT CARE, V15, P336, DOI 10.1007/s12028-011-9600-1; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; Koenig Matthew A, 2012, Continuum (Minneap Minn), V18, P579, DOI 10.1212/01.CON.0000415429.99394.e8; KUBOTA T, 1993, STROKE, V24, P1993, DOI 10.1161/01.STR.24.12.1993; Lad SP, 2012, J STROKE CEREBROVASC, V21, P30, DOI 10.1016/j.jstrokecerebrovasdis.2010.04.004; Lu H, 2009, BRAIN RES, V1262, P73, DOI 10.1016/j.brainres.2009.01.017; Malle E, 2007, BRIT J PHARMACOL, V152, P838, DOI 10.1038/sj.bjp.0707358; Mathiesen T, 1997, J NEUROSURG, V87, P215, DOI 10.3171/jns.1997.87.2.0215; Nijboer CHA, 2008, J NEUROSCI, V28, P3324, DOI 10.1523/JNEUROSCI.4769-07.2008; Nijboer CHA, 2007, J CEREBR BLOOD F MET, V27, P282, DOI 10.1038/sj.jcbfm.9600342; Ostrowski RP, 2006, NEUROL RES, V28, P399, DOI 10.1179/016164106X115008; Prunell GF, 2005, J NEUROSURG, V102, P1046, DOI 10.3171/jns.2005.102.6.1046; Prunell GF, 2005, NEUROSURGERY, V56, P1082, DOI 10.1227/01.NEU.0000157966.76590.39; Prunell GF, 2003, NEUROSURGERY, V52, P165, DOI 10.1097/00006123-200301000-00022; Rothwell NJ, 1999, J PHYSIOL-LONDON, V514, P3, DOI 10.1111/j.1469-7793.1999.003af.x; Schneider T, 1996, J IMMUNOL METHODS, V198, P1, DOI 10.1016/0022-1759(96)00143-3; Segovia KN, 2008, ANN NEUROL, V63, P520, DOI 10.1002/ana.21359; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P459, DOI 10.1038/jcbfm.2009.240; Sherchan P, 2011, J NEUROTRAUM, V28, P2503, DOI 10.1089/neu.2011.1864; Silasi G, 2009, BEHAV BRAIN RES, V198, P380, DOI 10.1016/j.bbr.2008.11.019; Simard JM, 2009, J CEREBR BLOOD F MET, V29, P317, DOI 10.1038/jcbfm.2008.120; Sozen T, 2009, STROKE, V40, P2519, DOI 10.1161/STROKEAHA.109.549592; Sugawara T, 2008, J NEUROSCI METH, V167, P327, DOI 10.1016/j.jneumeth.2007.08.004; Suzuki H, 2010, STROKE, V41, P1783, DOI 10.1161/STROKEAHA.110.586537; Takata K, 2008, EXP NEUROL, V213, P336, DOI 10.1016/j.expneurol.2008.06.009; Takizawa T, 2001, NEUROL RES, V23, P724, DOI 10.1179/016164101101199243; Tiebosch IACW, 2013, NEUROCRIT CARE, V18, P96, DOI 10.1007/s12028-012-9692-2; van der Veen BS, 2009, ANTIOXID REDOX SIGN, V11, P2899, DOI [10.1089/ars.2009.2538, 10.1089/ARS.2009.2538]; van Gijn J, 2007, LANCET, V369, P306, DOI 10.1016/S0140-6736(07)60153-6; Wang Z, 2013, NEUROL SCI, V34, P1331, DOI 10.1007/s10072-012-1240-5; Willemen HLDM, 2010, PAIN, V150, P550, DOI 10.1016/j.pain.2010.06.015; Wu X, 2012, NEUROBIOL AGING, V33, P1364, DOI 10.1016/j.neurobiolaging.2010.11.002	51	63	69	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90584	10.1371/journal.pone.0090584	http://dx.doi.org/10.1371/journal.pone.0090584			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603553	Green Submitted, Green Published, gold			2022-12-27	WOS:000332483600065
J	Bodicoat, DH; Gray, LJ; Henson, J; Webb, D; Guru, A; Misra, A; Gupta, R; Vikram, N; Sattar, N; Davies, MJ; Khunti, K				Bodicoat, Danielle H.; Gray, Laura J.; Henson, Joseph; Webb, David; Guru, Arvind; Misra, Anoop; Gupta, Rajeev; Vikram, Naval; Sattar, Naveed; Davies, Melanie J.; Khunti, Kamlesh			Body Mass Index and Waist Circumference Cut-Points in Multi-Ethnic Populations from the UK and India: The ADDITION-Leicester, Jaipur Heart Watch and New Delhi Cross-Sectional Studies	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; CARDIOVASCULAR-DISEASE; ABDOMINAL ADIPOSITY; REDEFINING OBESITY; ASIAN INDIANS; RISK; PEOPLE; RATIONALE; DIAGNOSIS; BMI	Aims: To derive cut-points for body mass index (BMI) and waist circumference (WC) for minority ethnic groups that are risk equivalent based on endogenous glucose levels to cut-points for white Europeans (BMI 30 kg/m(2); WC men 102 cm; WC women 88 cm). Materials and Methods: Cross-sectional data from participants aged 40-75 years: 4,672 white and 1,348 migrant South Asian participants from ADDITION-Leicester (UK) and 985 indigenous South Asians from Jaipur Heart Watch/New Delhi studies (India). Cut-points were derived using fractional polynomial models with fasting and 2-hour glucose as outcomes, and ethnicity, objectively-measured BMI/WC, their interaction and age as covariates. Results: Based on fasting glucose, obesity cut-points were 25 kg/m(2) (95% Confidence Interval: 24, 26) for migrant South Asian, and 18 kg/m(2) (16, 20) for indigenous South Asian populations. For men, WC cut-points were 90 cm (85, 95) for migrant South Asian, and 87 cm (82, 91) for indigenous South Asian populations. For women, WC cut-points were 77 cm (71, 82) for migrant South Asian, and 54 cm (20, 63) for indigenous South Asian populations. Cut-points based on 2-hour glucose were lower than these. Conclusions: These findings strengthen evidence that health interventions are required at a lower BMI and WC for South Asian individuals. Based on our data and the existing literature, we suggest an obesity threshold of 25 kg/m(2) for South Asian individuals, and a very high WC threshold of 90 cm for South Asian men and 77 cm for South Asian women. Further work is required to determine whether lower cut-points are required for indigenous, than migrant, South Asians.	[Bodicoat, Danielle H.; Henson, Joseph; Webb, David; Davies, Melanie J.; Khunti, Kamlesh] Univ Leicester, Diabet Res Ctr, Leicester, Leics, England; [Gray, Laura J.] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England; [Guru, Arvind] Postgrad Inst Med Educ & Res, Chandigarh 160012, Punjab, India; [Misra, Anoop] Fortis Hosp, Dept Diabet & Metab Dis, Delhi, India; [Gupta, Rajeev] Fortis Escorts Hosp, Dept Internal Med, Jaipur, Rajasthan, India; [Vikram, Naval] All India Inst Med Sci, Dept Med, Delhi, India; [Sattar, Naveed] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland	University of Leicester; University of Leicester; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Fortis Escorts Hospital; All India Institute of Medical Sciences (AIIMS) New Delhi; University of Glasgow	Bodicoat, DH (corresponding author), Univ Leicester, Diabet Res Ctr, Leicester, Leics, England.	dhm6@le.ac.uk	/ABC-9527-2021	Sattar, Naveed/0000-0002-1604-2593; Gray, Laura/0000-0002-9284-9321; Webb, David/0000-0002-3932-3339; Henson, Joseph/0000-0002-3898-7053; Davies, Melanie/0000-0002-9987-9371; Khunti, Kamlesh/0000-0003-2343-7099	National Institute for Health and Care Excellence (NICE), Department of Health; University Hospitals of Leicester Diabetes Research Fund; Diabetes UK	National Institute for Health and Care Excellence (NICE), Department of Health; University Hospitals of Leicester Diabetes Research Fund; Diabetes UK(Diabetes UK)	This work was supported by funding from the National Institute for Health and Care Excellence (NICE), Department of Health, the University Hospitals of Leicester Diabetes Research Fund and Diabetes UK, and was conducted as part of activities supported by the National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care - Leicestershire, Northamptonshire and Rutland (NIHR CLAHRC - LNR), the NIHR Leicester-Loughborough Diet, Lifestyle and Physical Activity Biomedical Research Unit which is a partnership between University Hospitals of Leicester NHS Trust, Loughborough University and the University of Leicester, and by the Leicester Clinical Trials Unit. Analyses of the Addition-Leicester study with regards to BMI and waist circumference cut-points in black and minority ethnicity groups were commissioned by NICE during the development of their guidance on this topic. The researchers were independent from the funders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; BHATNAGAR D, 1995, LANCET, V345, P405; Chiu M, 2011, DIABETES CARE, V34, P1741, DOI 10.2337/dc10-2300; Ford ES, 2010, J AM COLL CARDIOL, V55, P1310, DOI 10.1016/j.jacc.2009.10.060; Gerstein HC, 2007, DIABETES RES CLIN PR, V78, P305, DOI 10.1016/j.diabres.2007.05.004; Gholap N, 2011, PRIM CARE DIABETES, V5, P45, DOI 10.1016/j.pcd.2010.08.002; Gray LJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026464; Gupta Rajeev, 2007, Indian Heart J, V59, P346; Gupta Rajeev, 2002, Indian Heart J, V54, P59; Kumar S, 2011, INT J CLIN PRACT, V65, P378, DOI 10.1111/j.1742-1241.2010.02548.x; LEAN MEJ, 1995, BRIT MED J, V311, P158, DOI 10.1136/bmj.311.6998.158; Low S, 2009, ANN ACAD MED SINGAP, V38, P66; Misra A, 2006, INT J OBESITY, V30, P106, DOI 10.1038/sj.ijo.0803111; Misra A, 2009, J Assoc Physicians India, V57, P163; Mostafa SA, 2010, POSTGRAD MED J, V86, P656, DOI 10.1136/pgmj.2009.091215; National Institute for Health and Clinical Excellence, 2006, OB GUID PREV ID ASS, V43; National Institute for Health and Clinical Excellence, 2009, TYP 2 DIAB MAN TYP 2; NICE, 2013, ASS BOD MASS IND WAI; Office for National Statistics, 2012, 2011 CENS KEY STAT L; Patel JV, 2010, ATHEROSCLEROSIS, V209, P579, DOI 10.1016/j.atherosclerosis.2009.10.010; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; Rahman M, 2010, OBSTET GYNECOL, V115, P982, DOI 10.1097/AOG.0b013e3181da9423; Razak F, 2007, CIRCULATION, V115, P2111, DOI 10.1161/CIRCULATIONAHA.106.635011; WANG J, 1994, AM J CLIN NUTR, V60, P23, DOI 10.1093/ajcn/60.1.23; Wang YF, 2005, AM J CLIN NUTR, V81, P555; Webb DR, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-16; Wen CP, 2009, PUBLIC HEALTH NUTR, V12, P497, DOI 10.1017/S1368980008002802; WHO Consultation, 2000, WHO TECH REP SER, V894, P1; World Health Organization, 1995, PHYS STAT US INT ANT	29	30	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90813	10.1371/journal.pone.0090813	http://dx.doi.org/10.1371/journal.pone.0090813			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599391	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000332479400135
J	Goh, S; Lee, K; Choi, M; Fortin, JY				Goh, Segun; Lee, Keumsook; Choi, MooYoung; Fortin, Jean-Yves			Emergence of Criticality in the Transportation Passenger Flow: Scaling and Renormalization in the Seoul Bus System	PLOS ONE			English	Article							SELF-ORGANIZED CRITICALITY; POWER LAWS; MODEL; TRANSITION; MOBILITY	Social systems have recently attracted much attention, with attempts to understand social behavior with the aid of statistical mechanics applied to complex systems. Collective properties of such systems emerge from couplings between components, for example, individual persons, transportation nodes such as airports or subway stations, and administrative districts. Among various collective properties, criticality is known as a characteristic property of a complex system, which helps the systems to respond flexibly to external perturbations. This work considers the criticality of the urban transportation system entailed in the massive smart card data on the Seoul transportation network. Analyzing the passenger flow on the Seoul bus system during one week, we find explicit power-law correlations in the system, that is, power-law behavior of the strength correlation function of bus stops and verify scale invariance of the strength fluctuations. Such criticality is probed by means of the scaling and renormalization analysis of the modified gravity model applied to the system. Here a group of nearby (bare) bus stops are transformed into a (renormalized) "block stop'' and the scaling relations of the network density turn out to be closely related to the fractal dimensions of the system, revealing the underlying structure. Specifically, the resulting renormalized values of the gravity exponent and of the Hill coefficient give a good description of the Seoul bus system: The former measures the characteristic dimensionality of the network whereas the latter reflects the coupling between distinct transportation modes. It is thus demonstrated that such ideas of physics as scaling and renormalization can be applied successfully to social phenomena exemplified by the passenger flow.	[Goh, Segun; Choi, MooYoung] Seoul Natl Univ, Dept Phys & Astron, Seoul, South Korea; [Goh, Segun; Choi, MooYoung] Seoul Natl Univ, Ctr Theoret Phys, Seoul, South Korea; [Lee, Keumsook] Sungshin Womens Univ, Dept Geog, Seoul, South Korea; [Fortin, Jean-Yves] CNRS, Inst Jean Lamour, Dept Phys Matiere & Mat, UMR 7198, Vandoeuvre Les Nancy, France	Seoul National University (SNU); Seoul National University (SNU); Sungshin Women's University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Lorraine	Lee, K (corresponding author), Sungshin Womens Univ, Dept Geog, Seoul, South Korea.	kslee@sungshin.ac.kr; mychoi@snu.ac.kr	Goh, Segun/E-5471-2018	Goh, Segun/0000-0003-3027-8815; Choi, MooYoung/0000-0001-8070-7716	National Research Foundation of Korea [NRF-2013017764/1, 2012R1A2A4A01004419, 2011-0012331]	National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by the National Research Foundation of Korea (Grant Nos. NRF-2013017764/1, 2012R1A2A4A01004419, and 2011-0012331). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAK P, 1987, PHYS REV LETT, V59, P381, DOI 10.1103/PhysRevLett.59.381; Barthelemy Marc, 2011, Physics Reports, V499, P1, DOI 10.1016/j.physrep.2010.11.002; Batty M, 1999, DISCRETE DYN NAT SOC, V3, P109, DOI 10.1155/S1026022699000151; BINDER K, 1981, Z PHYS B CON MAT, V43, P119, DOI 10.1007/BF01293604; Blagus N, 2012, PHYSICA A, V391, P2794, DOI 10.1016/j.physa.2011.12.055; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; Chen YG, 2008, CHAOS SOLITON FRACT, V35, P85, DOI 10.1016/j.chaos.2006.05.018; Fraiman D, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00307; Goh S, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.026102; Goldenfeld N., 1992, LECT PHASE TRANSITIO, DOI DOI 10.1201/9780429493492; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; GRASSBERGER P, 1983, PHYSICA D, V9, P189, DOI 10.1016/0167-2789(83)90298-1; Guimera R, 2004, EUR PHYS J B, V38, P381, DOI 10.1140/epjb/e2004-00131-0; Haimovici A, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.178101; Jung WS, 2008, EPL-EUROPHYS LETT, V81, DOI 10.1209/0295-5075/81/48005; Kardar M., 2007, STAT PHYS FIELDS; Kim BJ, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.168701; Kitzbichler MG, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000314; Lee K, 2008, PHYSICA A, V387, P6231, DOI 10.1016/j.physa.2008.06.035; Lee K, 2011, J PHYS A-MATH THEOR, V44, DOI 10.1088/1751-8113/44/11/115007; Li DQ, 2011, NAT PHYS, V7, P481, DOI [10.1038/NPHYS1932, 10.1038/nphys1932]; Louf R, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.198702; MA SK, 1976, PHYS REV LETT, V37, P461, DOI 10.1103/PhysRevLett.37.461; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; Newman MEJ, 1999, PHYS LETT A, V263, P341, DOI 10.1016/S0375-9601(99)00757-4; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Official web site for the Seoul traffic system, 2013, TRANSP MOD SHAR; Ohira T, 1998, PHYS REV E, V58, P193, DOI 10.1103/PhysRevE.58.193; Petri G, 2013, SCI REP-UK, V3, DOI 10.1038/srep01798; Radicchi F, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.148701; Rhee I, 2011, IEEE ACM T NETWORK, V19, P630, DOI 10.1109/TNET.2011.2120618; Roth C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015923; Shen GQ, 2002, INT J GEOGR INF SCI, V16, P419, DOI 10.1080/13658810210137013; Shen Y, 2003, CLIN NEUROPHYSIOL, V114, P199, DOI 10.1016/S1388-2457(02)00338-3; Simini F, 2012, NATURE, V484, P96, DOI 10.1038/nature10856; Solow AR, 2005, ECOL LETT, V8, P361, DOI 10.1111/j.1461-0248.2005.00738.x; Song CM, 2005, NATURE, V433, P392, DOI 10.1038/nature03248; Truscott J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002699; Viboud C, 2006, SCIENCE, V312, P447, DOI 10.1126/science.1125237	41	16	16	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e89980	10.1371/journal.pone.0089980	http://dx.doi.org/10.1371/journal.pone.0089980			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599221	Green Published, gold			2022-12-27	WOS:000332479400037
J	Ocheretina, O; Escuyer, VE; Mabou, MM; Royal-Mardi, G; Collins, S; Vilbrun, SC; Pape, JW; Fitzgerald, DW				Ocheretina, Oksana; Escuyer, Vincent E.; Mabou, Marie-Marcelle; Royal-Mardi, Gertrude; Collins, Sean; Vilbrun, Stalz C.; Pape, Jean W.; Fitzgerald, Daniel W.			Correlation between Genotypic and Phenotypic Testing for Resistance to Rifampin in Mycobacterium tuberculosis Clinical Isolates in Haiti: Investigation of Cases with Discrepant Susceptibility Results	PLOS ONE			English	Article							PORT-AU-PRINCE; MULTIDRUG-RESISTANCE; SILENT MUTATION; RNA-POLYMERASE; RPOB GENE; DIAGNOSIS; STRAINS; ASSAY; BREAKPOINTS; PERFORMANCE	The World Health Organization has recommended use of molecular-based tests MTBDRplus and GeneXpert MTB/RIF to diagnose multidrug-resistant tuberculosis in developing and high-burden countries. Both tests are based on detection of mutations in the Rifampin (RIF) Resistance-Determining Region of DNA-dependent RNA Polymerase gene (rpoB). Such mutations are found in 95-98% of Mycobacterium tuberculosis strains determined to be RIF-resistant by the "gold standard" culture-based drug susceptibility testing (DST). We report the phenotypic and genotypic characterization of 153 consecutive clinical Mycobacterium tuberculosis strains diagnosed as RIF-resistant by molecular tests in our laboratory in Port-au-Prince, Haiti. 133 isolates (86.9%) were resistant to both RIF and Isoniazid and 4 isolates (2.6%) were RIF mono-resistant in MGIT SIRE liquid culture-based DST. However the remaining 16 isolates (10.5%) tested RIF-sensitive by the assay. Five strains with discordant genotypic and phenotypic susceptibility results had RIF minimal inhibitory concentration (MIC) close to the cut-off value of 1 mu g/ml used in phenotypic susceptibility assays and were confirmed as resistant by DST on solid media. Nine strains had sub-critical RIF MICs ranging from 0.063 to 0.5 mu g/ml. Finally two strains were pan-susceptible and harbored a silent rpoB mutation. Our data indicate that not only detection of the presence but also identification of the nature of rpoB mutation is needed to accurately diagnose resistance to RIF in Mycobacterium tuberculosis. Observed clinical significance of low-level resistance to RIF supports the re-evaluation of the present critical concentration of the drug used in culture-based DST assays.	[Ocheretina, Oksana; Collins, Sean; Pape, Jean W.; Fitzgerald, Daniel W.] Weill Cornell Med Coll, Ctr Global Hlth, Div Infect Dis, Dept Med, New York, NY 10021 USA; [Ocheretina, Oksana; Mabou, Marie-Marcelle; Royal-Mardi, Gertrude; Vilbrun, Stalz C.; Pape, Jean W.] Ctr GHESKIO, Port Au Prince, Haiti; [Escuyer, Vincent E.] New York State Dept Hlth, Wadsworth Ctr, Lab Mycobacteriol, Albany, NY USA	Cornell University; State University of New York (SUNY) System; Wadsworth Center	Ocheretina, O (corresponding author), Weill Cornell Med Coll, Ctr Global Hlth, Div Infect Dis, Dept Med, New York, NY 10021 USA.	oko2001@med.cornell.edu			Fogarty International Center [AITRP: TW000018-25]; NIAID [K24: AI098627-02]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI069421, K24AI098627] Funding Source: NIH RePORTER	Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding came from the Fogarty International Center - AITRP: TW000018-25;NIAID - K24: AI098627-02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Alonso M, 2011, J CLIN MICROBIOL, V49, P2688, DOI 10.1128/JCM.00659-11; Angr PK, 2012, J CLIN MICROBIOL, V50, P1233, DOI 10.1128/JCM.06479-11; [Anonymous], 2011, GLOB TUB CONTR 2011; Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Campbell EA, 2005, EMBO J, V24, P674, DOI 10.1038/sj.emboj.7600499; Comas I, 2012, NAT GENET, V44, P106, DOI 10.1038/ng.1038; Dalhoff A, 2009, INFECTION, V37, P296, DOI 10.1007/s15010-009-7108-9; Franzblau SG, 1998, J CLIN MICROBIOL, V36, P362, DOI 10.1128/JCM.36.2.362-366.1998; Gumbo T, 2010, ANTIMICROB AGENTS CH, V54, P1484, DOI 10.1128/AAC.01474-09; Huang WL, 2009, J CLIN MICROBIOL, V47, P2520, DOI 10.1128/JCM.02499-08; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; KAPUR V, 1994, J CLIN MICROBIOL, V32, P1095, DOI 10.1128/JCM.32.4.1095-1098.1994; Kent PT, 1985, GUIDE LEVEL 3 LAB; Kim BJ, 1997, J CLIN MICROBIOL, V35, P492, DOI 10.1128/JCM.35.2.492-494.1997; Lawn SD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001067; Ling DI, 2008, EUR RESPIR J, V32, P1165, DOI 10.1183/09031936.00061808; Mani C, 2001, J CLIN MICROBIOL, V39, P2987, DOI 10.1128/JCM.39.8.2987-2990.2001; Marlowe EM, 2011, J CLIN MICROBIOL, V49, P1621, DOI 10.1128/JCM.02214-10; Moure R, 2011, J CLIN MICROBIOL, V49, P3722, DOI 10.1128/JCM.05314-11; National Committee for Clinical Laboratory Standards, 2003, M24A NCCLS; Ocheretina O, 2013, J CLIN MICROBIOL, V51, P2232, DOI 10.1128/JCM.00268-13; Ocheretina O, 2012, REV PANAM SALUD PUBL, V31, P221, DOI 10.1590/S1020-49892012000300006; Ramaswamy S., 1998, Tubercle and Lung Disease, V79, P3, DOI 10.1054/tuld.1998.0002; Scott LE, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001061; TELENTI A, 1993, LANCET, V341, P647, DOI 10.1016/0140-6736(93)90417-F; TENOVER FC, 1993, J CLIN MICROBIOL, V31, P767, DOI 10.1128/JCM.31.4.767-770.1993; Theron G, 2011, AM J RESP CRIT CARE, V184, P132, DOI 10.1164/rccm.201101-0056OC; Traore H, 2000, INT J TUBERC LUNG D, V4, P481; Turnidge J, 2007, CLIN MICROBIOL REV, V20, P391, DOI 10.1128/CMR.00047-06; Van Deun A, 2009, J CLIN MICROBIOL, V47, P3501, DOI 10.1128/JCM.01209-09; Van Rie A, 2012, INT J TUBERC LUNG D, V16, P206, DOI 10.5588/ijtld.11.0395; *WHO, 1994, WHOTB94178; Williamson DA, 2012, INT J TUBERC LUNG D, V16, P216, DOI 10.5588/ijtld.11.0178; Williamson DA, 2011, DIAGN MICROBIOL INFE, V74, P207; World Health Organization, 2008, MOL LIN PROB ASS RAP; World Health Organization, 2011, WHOHTMTB20112; Yang B, 1998, J ANTIMICROB CHEMOTH, V42, P621, DOI 10.1093/jac/42.5.621; Yuan XL, 2012, J CLIN MICROBIOL, V50, P2404, DOI 10.1128/JCM.06860-11	39	80	83	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90569	10.1371/journal.pone.0090569	http://dx.doi.org/10.1371/journal.pone.0090569			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599230	gold, Green Published, Green Submitted			2022-12-27	WOS:000332479400094
J	Heaf, JG; Wehberg, S				Heaf, James G.; Wehberg, Sonja			Relative Survival of Peritoneal Dialysis and Haemodialysis Patients: Effect of Cohort and Mode of Dialysis Initiation	PLOS ONE			English	Article							RESIDUAL RENAL-FUNCTION; MORTALITY-RATES; COMPARING MORTALITY; MEMBRANE-TRANSPORT; HOME HEMODIALYSIS; TECHNIQUE FAILURE; SIMILAR OUTCOMES; ESRD PATIENTS; RISK-FACTORS; MODALITY	Introduction: Epidemiological studies consistently show an initial survival advantage for PD patients compared to HD. It has recently been suggested that this is due to the fact that many HD patients are referred late, and start dialysis on an acute, inpatient basis. The present study was performed to investigate (1) whether, and if so, how, PD and HD prognosis had changed in recent years, (2) whether a potential survival advantage of PD versus HD is constant over dialysis duration, and (3) whether differences in prognosis could be explained by patient age, renal diagnosis of diabetic nephropathy, or mode of dialysis initiation. Patients and Methods: 12095 patients starting dialysis therapy between 1990 and 2010 in Denmark were studied. Prognosis was assessed according to initial dialysis modality on an intention-to-treat basis, censored for transplantation. Results were adjusted for age, sex, renal diagnosis, Charlson Comorbidity Index (CCI), and mode of dialysis initiation. Results: Overall adjusted prognosis improved by 34% (HD 30%, PD 42%). PD prognosis relative to HD improved, and was 16% better at the end of the period. Final PD prognosis improved consistently from 1990-99 to 2000-10 in all subgroups. PD was associated with a significant initial survival advantage, both overall and for all subgroups For the latter cohort, overall PD prognosis was better than HD for the first 4 years, after which it was insignificantly worse. The initial survival advantage was also present in a subgroup analysis of patients with early & routine ESRD initiation. Conclusions: Dialysis survival has increased during the past 20 years. PD survival since 2000 has been better than HD, overall and for all subgroups. The difference in survival is not explained by mode of dialysis initiation.	[Heaf, James G.] Copenhagen Univ Hosp Herlev, Dept Nephrol B, Herlev, Denmark; [Wehberg, Sonja] Odense Univ Hosp, Dept Epidemiol, DK-5000 Odense, Denmark	University of Copenhagen; University of Southern Denmark; Odense University Hospital	Heaf, JG (corresponding author), Copenhagen Univ Hosp Herlev, Dept Nephrol B, Herlev, Denmark.	heaf@dadlnet.dk		Wehberg, Sonja/0000-0003-1503-2649	Baxter; Fresenius	Baxter; Fresenius	The authors have read the journal's policy and have the following conflicts. James Heaf has received travel funding and lecture fees from Baxter and Fresenius, and a research grant from Fresenius. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Andersen TF, 1999, DAN MED BULL, V46, P263; Brimble KS, 2006, J AM SOC NEPHROL, V17, P2591, DOI 10.1681/ASN.2006030194; Burton JO, 2009, CLIN J AM SOC NEPHRO, V4, P914, DOI 10.2215/CJN.03900808; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Churchill DN, 1998, J AM SOC NEPHROL, V9, P1285; Collins AJ, 2002, SEMIN DIALYSIS, V15, P98, DOI 10.1046/j.1525-139X.2002.00032.x; Collins AJ, 2012, AM J KIDNEY DIS, V59, pEVII, DOI 10.1053/j.ajkd.2011.11.015; Davies SJ, 2006, KIDNEY INT, V70, pS76, DOI 10.1038/sj.ki.5001920; Eknoyan G, 2002, NEW ENGL J MED, V347, P2010, DOI 10.1056/NEJMoa021583; Fenton SSA, 1997, AM J KIDNEY DIS, V30, P334, DOI 10.1016/S0272-6386(97)90276-6; Foley RN, 2011, NEW ENGL J MED, V365, P1099, DOI 10.1056/NEJMoa1103313; Frimat L, 2006, PERITON DIALYSIS INT, V26, P231; Ganesh SK, 2003, J AM SOC NEPHROL, V14, P415, DOI 10.1097/01.ASN.0000043140.23422.4F; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Grooteman MPC, 2012, J AM SOC NEPHROL, V23, P1087, DOI 10.1681/ASN.2011121140; Heaf JG, 2002, NEPHROL DIAL TRANSPL, V17, P112, DOI 10.1093/ndt/17.1.112; Heaf JG, 2011, DANISH NEPHROLOGY RE, P1; Huang CC, 2008, PERITON DIALYSIS INT, V28, pS15; Jaar BG, 2005, ANN INTERN MED, V143, P174, DOI 10.7326/0003-4819-143-3-200508020-00003; Jansen MAM, 2002, KIDNEY INT, V62, P1046, DOI 10.1046/j.1523-1755.2002.00505.x; Johnson DW, 2012, NEPHROL DIAL TRANSPL, V27, P4445, DOI 10.1093/ndt/gfs314; Johnson DW, 2012, J AM SOC NEPHROL, V23, P1097, DOI 10.1681/ASN.2011121201; Johnson DW, 2010, NEPHROL DIAL TRANSPL, V25, P1973, DOI 10.1093/ndt/gfp780; Lang SM, 2001, PERITON DIALYSIS INT, V21, P52; Lee CC, 2009, PERITON DIALYSIS INT, V29, P182; Liem YS, 2007, KIDNEY INT, V71, P153, DOI 10.1038/sj.ki.5002014; Locatelli F, 2001, J AM SOC NEPHROL, V12, P2411, DOI 10.1681/ASN.V12112411; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Marshall MR, 2011, AM J KIDNEY DIS, V58, P782, DOI 10.1053/j.ajkd.2011.04.027; McDonald SP, 2009, J AM SOC NEPHROL, V20, P155, DOI 10.1681/ASN.2007111188; Mehrotra R, 2011, ARCH INTERN MED, V171, P110, DOI 10.1001/archinternmed.2010.352; Mircescu G, 2006, PERITON DIALYSIS INT, V26, P266; Moist LM, 2000, J AM SOC NEPHROL, V11, P556, DOI 10.1681/ASN.V113556; Paniagua R, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V1351307; Pauly RP, 2009, NEPHROL DIAL TRANSPL, V24, P2915, DOI 10.1093/ndt/gfp295; Pedersen CB, 2006, DAN MED BULL, V53, P441; Port FK, 2006, CLIN J AM SOC NEPHRO, V1, P246, DOI 10.2215/CJN.01050905; Quinn RR, 2011, J AM SOC NEPHROL, V22, P1534, DOI 10.1681/ASN.2010121232; Sanabria M, 2008, KIDNEY INT, V73, pS165, DOI 10.1038/sj.ki.5002619; Schaubel DE, 1998, PERITON DIALYSIS INT, V18, P478; Sens F, 2011, KIDNEY INT, V80, P970, DOI 10.1038/ki.2011.233; Stack AG, 2003, KIDNEY INT, V64, P1071, DOI 10.1046/j.1523-1755.2003.00165.x; Termorshuizen F, 2003, J AM SOC NEPHROL, V14, P2851, DOI 10.1097/01.ASN.0000091585.45723.9E; van de Luijtgaarden MWM, 2011, NEPHROL DIAL TRANSPL, V26, P2940, DOI 10.1093/ndt/gfq845; Vilar E, 2009, NEPHROL DIAL TRANSPL, V24, P2502, DOI 10.1093/ndt/gfp071; Vonesh EF, 2004, KIDNEY INT, V66, P2389, DOI 10.1111/j.1523-1755.2004.66028.x; Vonesh EF, 1999, J AM SOC NEPHROL, V10, P354; Wehberg S, 2010, DATAGRUNDLAG ANALYSE, P14; Weinhandl ED, 2010, J AM SOC NEPHROL, V21, P499, DOI 10.1681/ASN.2009060635; Winkelmayer WC, 2002, J AM SOC NEPHROL, V13, P2353, DOI 10.1097/01.ASN.0000025785.41314.76; Yang X, 2008, PERITON DIALYSIS INT, V28, P82; Yeates K, 2012, NEPHROL DIAL TRANSPL, V27, P3568, DOI 10.1093/ndt/gfr674	52	61	67	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e90119	10.1371/journal.pone.0090119	http://dx.doi.org/10.1371/journal.pone.0090119			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614569	gold, Green Published, Green Submitted			2022-12-27	WOS:000332839300018
J	Liu, CY; Huang, CJ; Huang, LH; Chen, IJ; Chiu, JP; Hsu, CH				Liu, Chia-Yu; Huang, Chien-Jung; Huang, Lin-Huang; Chen, I-Ju; Chiu, Jung-Peng; Hsu, Chung-Hua			Effects of Green Tea Extract on Insulin Resistance and Glucagon-Like Peptide 1 in Patients with Type 2 Diabetes and Lipid Abnormalities: A Randomized, Double-Blinded, and Placebo-Controlled Trial	PLOS ONE			English	Article							WEIGHT-LOSS; GLUCOSE; IMMUNOASSAYS; INTERVENTION; CHOLESTEROL; MANAGEMENT; HORMONE; DIETARY; SYSTEM; RISK	The aim of this study is to investigate the effect of green tea extract on patients with type 2 diabetes mellitus and lipid abnormalities on glycemic and lipid profiles, and hormone peptides by a double-blinded, randomized and placebo controlled clinical trial. This trial enrolled 92 subjects with type 2 diabetes mellitus and lipid abnormalities randomized into 2 arms, each arm comprising 46 participants. Of the participants, 39 in therapeutic arm took 500 mg green tea extract, three times a day, while 38 in control arm took cellulose with the same dose and frequency to complete the 16-week study. Anthropometrics measurements, glycemic and lipid profiles, safety parameters, and obesity-related hormone peptides were analyzed at screening and after 16-week course. Within-group comparisons showed that green tea extract caused a significant decrease in triglyceride and homeostasis model assessment of insulin resistance index after 16 weeks. Green tea extract also increased significantly high density lipoprotein cholesterol. The HOMA-IR index decreased from 5.4+/-3.9 to 3.5+/-2.0 in therapeutic arm only. Adiponectin, apolipoprotein A1, and apolipoprotein B100 increased significantly in both arms, but only glucagon-like peptide 1 increased in the therapeutic arm. However, only decreasing trend in triglyceride was found in between-group comparison. Our study suggested that green tea extract significantly improved insulin resistance and increased glucagon-like peptide 1 only in within-group comparison. The potential effects of green tea extract on insulin resistance and glucagon-like peptide 1 warrant further investigation.	[Liu, Chia-Yu; Huang, Lin-Huang; Chen, I-Ju; Chiu, Jung-Peng; Hsu, Chung-Hua] Natl Yang Ming Univ, Inst Tradit Med, Sch Med, Taipei 112, Taiwan; [Liu, Chia-Yu; Chen, I-Ju; Chiu, Jung-Peng; Hsu, Chung-Hua] Taipei City Hosp, Dept Chinese Med, Branch Linsen & Chinese Med, Taipei, Taiwan; [Huang, Chien-Jung] Taipei City Hosp, Branch Linsen & Chinese Med, Dept Metab, Taipei, Taiwan	National Yang Ming Chiao Tung University; Taipei City Hospital; Taipei City Hospital	Hsu, CH (corresponding author), Natl Yang Ming Univ, Inst Tradit Med, Sch Med, Taipei 112, Taiwan.	owlherbs@yahoo.com.tw		Huang, Chien-Jung/0000-0003-4233-4677	National Science Council, Taiwan [101-2320-B-010-075]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported financially by the National Science Council, Taiwan, under Grant No. 101-2320-B-010-075. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agin A, 2006, CLIN CHEM LAB MED, V44, P1379, DOI 10.1515/CCLM.2006.257; Badulescu O, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/169420; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Brown AS, 2005, AM J CARDIOL, V96, p26E, DOI 10.1016/j.amjcard.2005.07.001; Cernea Simona, 2011, Rev Diabet Stud, V8, P323, DOI 10.1900/RDS.2011.8.323; Davidson M, 2008, AM J CARDIOL, V102, p19L, DOI 10.1016/j.amjcard.2008.09.071; Deacon CF, 2009, BEST PRACT RES CL EN, V23, P425, DOI 10.1016/j.beem.2009.03.006; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Goto T, 2012, BRIT J NUTR, V107, P769, DOI 10.1017/S0007114511003758; Guyton JR, 1998, AM J CARDIOL, V82, p85U, DOI 10.1016/S0002-9149(98)00956-4; Heijboer AC, 2011, CLIN CHIM ACTA, V412, P1191, DOI 10.1016/j.cca.2011.03.010; Hsu CH, 2008, CLIN NUTR, V27, P363, DOI 10.1016/j.clnu.2008.03.007; Hsu Chung-Hua, 2011, Altern Med Rev, V16, P157; Hursel R, 2011, OBES REV, V12, pE573, DOI 10.1111/j.1467-789X.2011.00862.x; Hursel R, 2009, INT J OBESITY, V33, P956, DOI 10.1038/ijo.2009.135; Ikeda I, 2005, BIOSCI BIOTECH BIOCH, V69, P1049, DOI 10.1271/bbb.69.1049; Imatoh T, 2011, EUR J NUTR, V50, P279, DOI 10.1007/s00394-010-0136-5; Jing YL, 2009, J GEN INTERN MED, V24, P557, DOI 10.1007/s11606-009-0929-5; Kappe C, 2012, J GASTROENTEROL; Khan N, 2007, LIFE SCI, V81, P519, DOI 10.1016/j.lfs.2007.06.011; Kishimoto M, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-115; Kreisberg RA, 1998, AM J CARDIOL, V82, p67U, DOI 10.1016/S0002-9149(98)00848-0; Li L, 2006, J LIPID RES, V47, P67, DOI 10.1194/jlr.M500424-JLR200; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mazzanti G, 2009, EUR J CLIN PHARMACOL, V65, P331, DOI 10.1007/s00228-008-0610-7; Olofsson SO, 2007, VASC HEALTH RISK MAN, V3, P491; Ortsater H, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-11; Pan HJ, 2011, J CHIN MED ASSOC, V74, P169, DOI 10.1016/j.jcma.2011.01.038; Phung OJ, 2010, AM J CLIN NUTR, V91, P73, DOI 10.3945/ajcn.2009.28157; Polonsky KS, 2012, NEW ENGL J MED, V367, P1332, DOI 10.1056/NEJMra1110560; Rask E, 2001, DIABETES CARE, V24, P1640, DOI 10.2337/diacare.24.9.1640; Sone T, 2011, FOOD NUTR RES, V55, DOI 10.3402/fnr.v55i0.8326; STARR JI, 1978, J LAB CLIN MED, V91, P683; Thondam SK, 2012, DIABETIC MED, V29, pE205, DOI 10.1111/j.1464-5491.2012.03675.x; Tian C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053796; van Woudenbergh GJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036910; Vilsboll T, 2001, DIABETES, V50, P609, DOI 10.2337/diabetes.50.3.609; Wu AH, 2012, CANCER PREV RES, V5, P393, DOI 10.1158/1940-6207.CAPR-11-0407; Wu AH, 2011, NUTR CANCER, V63, P549, DOI 10.1080/01635581.2011.551986; Yamaoka-Tojo M, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-17; Yao G, 2002, J FORMOS MED ASSOC, V101, P342	41	65	66	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91163	10.1371/journal.pone.0091163	http://dx.doi.org/10.1371/journal.pone.0091163			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614112	Green Published, gold, Green Submitted			2022-12-27	WOS:000332839300087
J	Mitchell, AL; Macarthur, KDR; Gan, EH; Baggott, LE; Wolff, ASB; Skinningsrud, B; Platt, H; Short, A; Lobell, A; Kampe, O; Bensing, S; Betterle, C; Kasperlik-Zaluska, A; Zurawek, M; Fichna, M; Kockum, I; Eriksson, GN; Ekwall, O; Wahlberg, J; Dahlqvist, P; Hulting, AL; Penna-Martinez, M; Meyer, G; Kahles, H; Badenhoop, K; Hahner, S; Quinkler, M; Falorni, A; Phipps-Green, A; Merriman, TR; Ollier, W; Cordell, HJ; Undlien, D; Czarnocka, B; Husebye, E; Pearce, SHS				Mitchell, Anna L.; Macarthur, Katie D. R.; Gan, Earn H.; Baggott, Lucy E.; Wolff, Anette S. B.; Skinningsrud, Beate; Platt, Hazel; Short, Andrea; Lobell, Anna; Kampe, Olle; Bensing, Sophie; Betterle, Corrado; Kasperlik-Zaluska, Anna; Zurawek, Magdalena; Fichna, Marta; Kockum, Ingrid; Eriksson, Gabriel Nordling; Ekwall, Olov; Wahlberg, Jeanette; Dahlqvist, Per; Hulting, Anna-Lena; Penna-Martinez, Marissa; Meyer, Gesine; Kahles, Heinrich; Badenhoop, Klaus; Hahner, Stephanie; Quinkler, Marcus; Falorni, Alberto; Phipps-Green, Amanda; Merriman, Tony R.; Ollier, William; Cordell, Heather J.; Undlien, Dag; Czarnocka, Barbara; Husebye, Eystein; Pearce, Simon H. S.			Association of Autoimmune Addison's Disease with Alleles of STAT4 and GATA3 in European Cohorts	PLOS ONE			English	Article							GRAVES-DISEASE; HASHIMOTOS-THYROIDITIS; RHEUMATOID-ARTHRITIS; GENE; SUSCEPTIBILITY; POLYMORPHISM; HAPLOTYPE; PREVALENCE; PROMOTER; RISK	Background: Gene variants known to contribute to Autoimmune Addison's disease (AAD) susceptibility include those at the MHC, MICA, CIITA, CTLA4, PTPN22, CYP27B1, NLRP-1 and CD274 loci. The majority of the genetic component to disease susceptibility has yet to be accounted for. Aim: To investigate the role of 19 candidate genes in AAD susceptibility in six European case-control cohorts. Methods: A sequential association study design was employed with genotyping using Sequenom iPlex technology. In phase one, 85 SNPs in 19 genes were genotyped in UK and Norwegian AAD cohorts (691 AAD, 715 controls). In phase two, 21 SNPs in 11 genes were genotyped in German, Swedish, Italian and Polish cohorts (1264 AAD, 1221 controls). In phase three, to explore association of GATA3 polymorphisms with AAD and to determine if this association extended to other autoimmune conditions, 15 SNPs in GATA3 were studied in UK and Norwegian AAD cohorts, 1195 type 1 diabetes patients from Norway, 650 rheumatoid arthritis patients from New Zealand and in 283 UK Graves' disease patients. Meta-analysis was used to compare genotype frequencies between the participating centres, allowing for heterogeneity. Results: We report significant association with alleles of two STAT4 markers in AAD cohorts (rs4274624: P = 0.00016; rs10931481: P = 0.0007). In addition, nominal association of AAD with alleles at GATA3 was found in 3 patient cohorts and supported by meta-analysis. Association of AAD with CYP27B1 alleles was also confirmed, which replicates previous published data. Finally, nominal association was found at SNPs in both the NF-kappa B1 and IL23A genes in the UK and Italian cohorts respectively. Conclusions: Variants in the STAT4 gene, previously associated with other autoimmune conditions, confer susceptibility to AAD. Additionally, we report association of GATA3 variants with AAD: this adds to the recent report of association of GATA3 variants with rheumatoid arthritis.	[Mitchell, Anna L.; Macarthur, Katie D. R.; Gan, Earn H.; Baggott, Lucy E.; Cordell, Heather J.; Pearce, Simon H. S.] Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Wolff, Anette S. B.; Husebye, Eystein] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Skinningsrud, Beate; Undlien, Dag] Oslo Univ Hosp, Dept Med Genet, Oslo, Norway; [Skinningsrud, Beate; Undlien, Dag] Univ Oslo, Oslo, Norway; [Platt, Hazel; Short, Andrea; Ollier, William] Univ Manchester, Inst Populat Hlth, CIGMR, Manchester, Lancs, England; [Lobell, Anna; Kampe, Olle; Bensing, Sophie] Uppsala Univ, Uppsala, Sweden; [Bensing, Sophie; Hulting, Anna-Lena] Karolinska Inst, Stockholm, Sweden; [Betterle, Corrado] Univ Padua, Sch Med, Dept Med, Padua, Italy; [Kasperlik-Zaluska, Anna] Med Ctr Postgrad Educ, Dept Endocrinol, Warsaw, Poland; [Zurawek, Magdalena; Fichna, Marta] Polish Acad Sci, Inst Human Genet, PL-60479 Poznan, Poland; [Kockum, Ingrid] Karolinska Inst, Dept Clin Neurosci, Neuroimmunol Unit, Stockholm, Sweden; [Kockum, Ingrid] Karolinska Inst, Ctr Mol Med, Stockholm, Sweden; [Eriksson, Gabriel Nordling] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Ekwall, Olov] Univ Gothenburg, Sahlgrenska Acad, Gothenburg, Sweden; [Wahlberg, Jeanette] Linkoping Univ, Fac Hlth Sci, Div Endocrinol, Dept Med & Hlth Sci, Linkoping, Sweden; [Dahlqvist, Per] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Penna-Martinez, Marissa; Meyer, Gesine; Kahles, Heinrich; Badenhoop, Klaus] Goethe Univ Frankfurt, Univ Hosp Frankfurt, Dept Med, Div Endocrinol, D-60054 Frankfurt, Germany; [Hahner, Stephanie] Univ Hosp Wuerzburg, Dept Med Endocrinol & Diabetol, Wurzburg, Germany; [Quinkler, Marcus] Charite, Charite Campus Mitte, D-13353 Berlin, Germany; [Falorni, Alberto] Univ Perugia, Dept Internal Med, I-06100 Perugia, Italy; [Phipps-Green, Amanda; Merriman, Tony R.] Univ Otago, Dept Biochem, Otago, New Zealand; [Czarnocka, Barbara] Med Ctr Postgrad Educ, Dept Biochem & Mol Biol, Warsaw, Poland; [Husebye, Eystein] Haukeland Hosp, Dept Med, N-5021 Bergen, Norway	Newcastle University - UK; University of Bergen; University of Oslo; University of Oslo; University of Manchester; Uppsala University; Karolinska Institutet; University of Padua; Centre of Postgraduate Medical Education - Poland; Polish Academy of Sciences; Institute of Human Genetics of the Polish Academy of Sciences; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; University of Gothenburg; Linkoping University; Umea University; Goethe University Frankfurt; Goethe University Frankfurt Hospital; University of Wurzburg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Perugia; University of Otago; Centre of Postgraduate Medical Education - Poland; University of Bergen; Haukeland University Hospital	Mitchell, AL (corresponding author), Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	annamitchell@doctors.org.uk	Wolff, Anette/AAN-5981-2020; Phipps-Green, Mandy/HDN-5829-2022; Meyer, Gesine/ABD-7219-2021; Pearce, Simon/AAB-3692-2019; Kockum, Ingrid/O-8781-2018; Czarnocka, Barbara/V-1048-2019	Phipps-Green, Mandy/0000-0002-1763-9623; Pearce, Simon/0000-0001-8384-8063; Kockum, Ingrid/0000-0002-0867-4726; Czarnocka, Barbara/0000-0001-7701-760X; Gan, Earn/0000-0003-1707-130X; Ekwall, Olov/0000-0002-4506-9955; Hahner, Stefanie/0000-0003-1616-8986; Quinkler, Marcus/0000-0003-4028-1671; Cordell, Heather/0000-0002-1879-5572; Wolff, Anette Susanne Boe/0000-0002-8485-2248; Merriman, Tony/0000-0003-0844-8726; Zurawek, Magdalena/0000-0002-0345-4054; Fichna, Marta/0000-0003-2865-7074; Kampe, Olle/0000-0001-6091-9914	European Union [201167]; Stockholm County Council; Karolinska Institutet; Swedish Society for Medical Research; Swedish Society of Medicine; NovoNordisk Foundation; Ake Wiberg Foundation; MRC [G0100594, G0600237, MR/K002279/1, G0901461, G0900390, G0900753] Funding Source: UKRI; Medical Research Council [MR/K002279/1, G0900753, G0900390, G0100594, G0600237, G0901461] Funding Source: researchfish; National Institute for Health Research [ACF-2007-01-004] Funding Source: researchfish; Novo Nordisk Fonden [NNF14OC0011003, NNF13OC0005975] Funding Source: researchfish	European Union(European Commission); Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet); Swedish Society for Medical Research; Swedish Society of Medicine; NovoNordisk Foundation(Novo Nordisk Foundation); Ake Wiberg Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Novo Nordisk Fonden(Novo Nordisk Foundation)	This study was funded by a European Union Framework 7 grant 201167 to the Euradrenal Consortium. Financial support for the Swedish contribution was also provided through the regional agreement on medical training and clinical research (ALF) between Stockholm County Council and Karolinska Institutet, The Swedish Society for Medical Research, the Swedish Society of Medicine, the NovoNordisk Foundation, Karolinska Institutet, and the Ake Wiberg Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, REV MAN REVMAN COMP; Badenhoop K, 2012, CURR DIABETES REP, V12, P635, DOI 10.1007/s11892-012-0322-3; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Blomhoff A, 2004, J CLIN ENDOCR METAB, V89, P3474, DOI 10.1210/jc.2003-031854; Cooper JD, 2011, DIABETES, V60, P1624, DOI 10.2337/db10-1656; Cross DS, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-51; Dudbridge F, 2008, HUM HERED, V66, P87, DOI 10.1159/000119108; Eyre S, 2012, NAT GENET, V44, P1336, DOI 10.1038/ng.2462; FAIRCHILD RS, 1980, J CLIN ENDOCR METAB, V51, P1074, DOI 10.1210/jcem-51-5-1074; Fichna M, 2010, EXP CLIN ENDOCR DIAB, V118, P544, DOI 10.1055/s-0029-1241206; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gombos Z, 2007, EUR J ENDOCRINOL, V157, P757, DOI 10.1530/EJE-07-0290; HEGGARTY H, 1968, BMJ-BRIT MED J, V1, P559, DOI 10.1136/bmj.1.5591.559; HEWITT PH, 1957, BMJ-BRIT MED J, V2, P1530, DOI 10.1136/bmj.2.5060.1530; Jennings CE, 2005, J MOL ENDOCRINOL, V34, P859, DOI 10.1677/jme.1.01760; Kahles H, 2005, EUR J ENDOCRINOL, V153, P895, DOI 10.1530/eje.1.02035; Korman BD, 2008, GENES IMMUN, V9, P267, DOI 10.1038/gene.2008.1; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Laureti S, 1999, J CLIN ENDOCR METAB, V84, P1762, DOI 10.1210/jc.84.5.1762; Lee HS, 2007, MOL MED, V13, P455, DOI 10.2119/2007-00072.Lee; Lopez ER, 2004, EUR J ENDOCRINOL, V151, P193, DOI 10.1530/eje.0.1510193; Lovas K, 2002, CLIN ENDOCRINOL, V56, P787, DOI 10.1046/j.1365-2265.2002.t01-1-01552.x; MACLAREN NK, 1986, J CLIN ENDOCR METAB, V62, P455, DOI 10.1210/jcem-62-3-455; Myhre AG, 2002, J CLIN ENDOCR METAB, V87, P618, DOI 10.1210/jc.87.2.618; Pani MA, 2002, J CLIN ENDOCR METAB, V87, P2564, DOI 10.1210/jc.87.6.2564; Remmers EF, 2007, NEW ENGL J MED, V357, P977, DOI 10.1056/NEJMoa073003; RUSSELL GAB, 1991, ARCH DIS CHILD, V66, P350, DOI 10.1136/adc.66.3.350; SIMMONDS JP, 1978, POSTGRAD MED J, V54, P552, DOI 10.1136/pgmj.54.634.552; Skinningsrud B, 2011, J CLIN ENDOCR METAB, V96, pE1703, DOI 10.1210/jc.2011-0645; Skinningsrud B, 2010, ANN RHEUM DIS, V69, P1471, DOI 10.1136/ard.2009.114934; SMITH ME, 1963, BRIT MED J, P1316, DOI 10.1136/bmj.2.5368.1316; Tai TS, 2013, J IMMUNOL, V190, P428, DOI 10.4049/jimmunol.1201361; Vaidya B, 2000, J CLIN ENDOCR METAB, V85, P688, DOI 10.1210/jc.85.2.688; Velaga MR, 2004, J CLIN ENDOCR METAB, V89, P5862, DOI 10.1210/jc.2004-1108	34	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e88991	10.1371/journal.pone.0088991	http://dx.doi.org/10.1371/journal.pone.0088991			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614117	Green Published, gold			2022-12-27	WOS:000332839300009
J	Olofsson, B; Porsch, H; Heldin, P				Olofsson, Berit; Porsch, Helena; Heldin, Paraskevi			Knock-Down of CD44 Regulates Endothelial Cell Differentiation via NF kappa B-Mediated Chemokine Production	PLOS ONE			English	Article							MOLECULAR-WEIGHT HYALURONAN; IN-VITRO; ANGIOGENIC OLIGOSACCHARIDES; ADHESION MOLECULES; SIGNALING PATHWAYS; RECEPTORS CD44; UP-REGULATION; CANCER CELLS; ACID; PROLIFERATION	A striking feature of microvascular endothelial cells is their capacity to fuse and differentiate into tubular structures when grown in three-dimensional (3D) extracellular matrices, in collagen or Matrigel, mimicking the in vivo blood vessel formation. In this study we demonstrate that human telomerase-immortalised foreskin microvascular endothelial (TIME) cells express high levels of the hyaluronan receptor CD44 and the hyaluronidase HYAL2. Knock-down of CD44 or HYAL2 resulted in an inability of TIME cells to form a tubular network, suggesting a key regulatory role of hyaluronan in controlling TIME cell tubulogenesis in 3D matrices. Knock-down of CD44 resulted in an upregulation of mRNA expression of the chemokines CXCL9 and CXCL12, as well as their receptors CXCR3 and CXCR4. This was accompanied by a defect maturation of the tubular structure network and increased phosphorylation of the inhibitor of NF kappa B kinase (IKK) complex and thus translocation of NF kappa B into the nucleus and activation of chemokine targed genes. Furthermore, the interaction between CD44 and hyaluronan determines the adhesion of breast cancer cells. In summary, our observations support the notion that the interaction between CD44 and hyaluronan regulates microvascular endothelial cell tubulogenesis by affecting the expression of cytokines and their receptors, as well as breast cancer dissemination.	[Olofsson, Berit; Porsch, Helena; Heldin, Paraskevi] Uppsala Univ, Ludwig Inst Canc Res, Sci Life Lab, Biomed Ctr, Uppsala, Sweden	Ludwig Institute for Cancer Research; Uppsala University	Heldin, P (corresponding author), Uppsala Univ, Ludwig Inst Canc Res, Sci Life Lab, Biomed Ctr, Uppsala, Sweden.	Evi.Heldin@LICR.uu.se			Swedish Cancer Society; Agnes and Mac Rudbergs Foundation; Gurli and Edward Brunnberg Foundation (Uppsala University); Ludwig Cancer Research	Swedish Cancer Society(Swedish Cancer Society); Agnes and Mac Rudbergs Foundation; Gurli and Edward Brunnberg Foundation (Uppsala University); Ludwig Cancer Research	The work was supported by grants from the Swedish Cancer Society (www.cancerfonden.se); Agnes and Mac Rudbergs Foundation Gurli and Edward Brunnberg Foundation (Uppsala University, www.uu.se); Ludwig Cancer Research (www.ludwigcancerresearch.org/location/uppsala-branch/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Maxwell CA, 2008, J CELL SCI, V121, P925, DOI 10.1242/jcs.022038; AUSPRUNK DH, 1986, AM J ANAT, V177, P313, DOI 10.1002/aja.1001770304; Bernert B, 2011, J BIOL CHEM, V286, P42349, DOI 10.1074/jbc.M111.278598; Bourguignon LYW, 2004, J BIOL CHEM, V279, P26991, DOI 10.1074/jbc.M311838200; Bourguignon LYW, 2001, J BIOL CHEM, V276, P7327, DOI 10.1074/jbc.M006498200; Cao GY, 2006, AM J PATHOL, V169, P325, DOI 10.2353/ajpath.2006.060206; Cichy J, 2003, J CELL BIOL, V161, P839, DOI 10.1083/jcb.200302098; Csoka AB, 2001, MATRIX BIOL, V20, P499, DOI 10.1016/S0945-053X(01)00172-X; Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3; Deed R, 1997, INT J CANCER, V71, P251, DOI 10.1002/(SICI)1097-0215(19970410)71:2<251::AID-IJC21>3.0.CO;2-J; Dejana E, 2009, DEV CELL, V16, P209, DOI 10.1016/j.devcel.2009.01.004; Duterme C, 2009, J BIOL CHEM, V284, P33495, DOI 10.1074/jbc.M109.044362; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Foster RR, 2013, AM J PATHOL, V183, P604, DOI 10.1016/j.ajpath.2013.04.019; Fuchs K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.364; Ghatak S, 2002, J BIOL CHEM, V277, P38013, DOI 10.1074/jbc.M202404200; Goodison S, 1999, J CLIN PATHOL-MOL PA, V52, P189; Hamilton SR, 2007, J BIOL CHEM, V282, P16667, DOI 10.1074/jbc.M702078200; Harada H, 2007, J BIOL CHEM, V282, P5597, DOI 10.1074/jbc.M608358200; Heldin P, 2013, GROWTH FACTOR REGULA; KOCH AE, 1992, SCIENCE, V258, P1798, DOI 10.1126/science.1281554; Kozlova I, 2012, CELL SIGNAL, V24, P1856, DOI 10.1016/j.cellsig.2012.05.013; Kukreja P, 2005, CANCER RES, V65, P9891, DOI 10.1158/0008-5472.CAN-05-1293; Kuschert GSV, 1999, BIOCHEMISTRY-US, V38, P12959, DOI 10.1021/bi990711d; Lataillade JJ, 2004, EUR CYTOKINE NETW, V15, P177; Lennon FE, 2011, AM J CARDIOVASC DIS, V1, P200; Lesley Jayne, 1998, Frontiers in Bioscience, V3, pD616; Li LL, 2007, BIOCHEM J, V404, P327, DOI 10.1042/BJ20061757; Li LL, 2006, J BIOL CHEM, V281, P26512, DOI 10.1074/jbc.M605607200; Li Y, 2001, BRIT J CANCER, V85, P600, DOI 10.1054/bjoc.2001.1922; Lokeshwar VB, 1996, J BIOL CHEM, V271, P23853, DOI 10.1074/jbc.271.39.23853; Lokeshwar VB, 2000, J BIOL CHEM, V275, P27641; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; LUSTER AD, 1995, J EXP MED, V182, P219, DOI 10.1084/jem.182.1.219; Maiti A, 1998, SCIENCE, V282, P941, DOI 10.1126/science.282.5390.941; Maxwell PJ, 2007, ONCOGENE, V26, P7333, DOI 10.1038/sj.onc.1210536; Mierke CT, 2008, J BIOPHYS, V2008; Milinkovic M, 2004, BLOOD, V103, P740, DOI 10.1182/blood-2003-05-1500; Mohamadzadeh M, 1998, J CLIN INVEST, V101, P97, DOI 10.1172/JCI1604; Monzon ME, 2008, AM J RESP CELL MOL, V39, P289, DOI 10.1165/rcmb.2007-0361OC; Monzon ME, J BIOL CHEM, V285, P26126; Moore MAS, 2002, J CELL BIOCHEM, P29, DOI 10.1002/jcb.10105; Murphy JF, 2005, FASEB J, V19, P446, DOI 10.1096/fj.03-1376fje; Orian-Rousseau V, 2002, GENE DEV, V16, P3074, DOI 10.1101/gad.242602; Orian-Rousseau V, 2008, ADV CANCER RES, V101, P63, DOI 10.1016/S0065-230X(08)00404-1; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Rahmanian M, 2002, INT J CANCER, V97, P601, DOI 10.1002/ijc.10087; Rahmanian M, 1997, EXP CELL RES, V237, P223, DOI 10.1006/excr.1997.3792; Reitsma S, 2007, PFLUG ARCH EUR J PHY, V454, P345, DOI 10.1007/s00424-007-0212-8; Romagnani P, 2001, J CLIN INVEST, V107, P53, DOI 10.1172/JCI9775; Romagnani P, 2004, TRENDS IMMUNOL, V25, P201, DOI 10.1016/j.it.2004.02.006; ROONEY P, 1995, INT J CANCER, V60, P632, DOI 10.1002/ijc.2910600511; Salcedo R, 2003, MICROCIRCULATION, V10, P359, DOI 10.1038/sj.mn.7800200; Savani RC, 2001, J BIOL CHEM, V276, P36770, DOI 10.1074/jbc.M102273200; SHERMAN L, 1994, CURR OPIN CELL BIOL, V6, P726, DOI 10.1016/0955-0674(94)90100-7; Singh AK, 2013, CYTOKINE GROWTH F R, V24, P41, DOI 10.1016/j.cytogfr.2012.08.007; Singleton PA, 2002, CELL MOTIL CYTOSKEL, V53, P293, DOI 10.1002/cm.10078; Slevin M, 2002, J BIOL CHEM, V277, P41046, DOI 10.1074/jbc.M109443200; Slevin M, 2007, MATRIX BIOL, V26, P58, DOI 10.1016/j.matbio.2006.08.261; Sorriento D, 2012, TRANSL MED UNISA, V4, P73; Stern R, 2006, CHEM REV, V106, P818, DOI 10.1021/cr050247k; Stern R, 2013, MAMMALIAN HYALURONID; Sun XQ, 2010, CANCER METAST REV, V29, P709, DOI 10.1007/s10555-010-9256-x; Takahashi Y, 2005, J BIOL CHEM, V280, P24195, DOI 10.1074/jbc.M411913200; Tammi RH, 2011, FEBS J, V278, P1419, DOI 10.1111/j.1742-4658.2011.08070.x; Tolg C, 2010, J BIOL CHEM, V285, P26461, DOI 10.1074/jbc.M110.121491; Tremmel M, 2009, BLOOD, V114, P5236, DOI 10.1182/blood-2009-04-219204; Trochon V, 1996, INT J CANCER, V66, P664, DOI 10.1002/(SICI)1097-0215(19960529)66:5<664::AID-IJC14>3.0.CO;2-4; TURLEY EA, 1985, J CELL SCI, V78, P133; Turley EA, 2002, J BIOL CHEM, V277, P4589, DOI 10.1074/jbc.R100038200; Venetsanakos E, 2002, EXP CELL RES, V273, P21, DOI 10.1006/excr.2001.5424; Weigel PH, 1997, J BIOL CHEM, V272, P13997, DOI 10.1074/jbc.272.22.13997; WEST DC, 1985, SCIENCE, V228, P1324, DOI 10.1126/science.2408340; WEST DC, 1989, BIOL HYALURONAN, V143, P187; Zhou LP, 2010, BIOCELL, V34, P91; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X	76	34	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e90921	10.1371/journal.pone.0090921	http://dx.doi.org/10.1371/journal.pone.0090921			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614402	Green Published, gold, Green Submitted			2022-12-27	WOS:000332839300056
J	Shet, A; Antony, J; Arumugam, K; Dodderi, SK; Rodrigues, R; DeCosta, A				Shet, Anita; Antony, Jimmy; Arumugam, Karthika; Dodderi, Sunil Kumar; Rodrigues, Rashmi; DeCosta, Ayesha			Influence of Adverse Drug Reactions on Treatment Success: Prospective Cohort Analysis of HIV-Infected Individuals Initiating First-Line Antiretroviral Therapy in India	PLOS ONE			English	Article							VIRUS POSITIVE PATIENTS; HAART REGIMEN; SEX-DIFFERENCES; RISK-FACTORS; DISCONTINUATION; ANEMIA; COMBINATION; EVENTS; PREDICTORS; TOXICITIES	Introduction: Adverse drug reactions related to antiretroviral therapy (ART) remain a challenge in resource-limited settings, often causing significant morbidity and impaired adherence leading to treatment failure. This 2-year prospective study aimed to describe patterns and predictors of adverse reactions to first-line ART and assess the impact of these events on treatment success. Methods: Between 2010-2013, 321 ART-naive eligible adults were enrolled at two clinics in southern India. ART regimens included zidovudine or stavudine plus lamivudine, plus nevirapine or efavirenz. Pill count adherence, immunological and virological monitoring, and laboratory-based adverse drug reactions were measured prospectively and analyzed. Results: Among 321 patients in the study, 289 (90.0%) patients experienced at least 1 adverse reaction, and 85 (26.5%) experienced at least 1 severe reaction. The incidence rate was 52 and 15 per 100 person-years for all reactions and severe reactions respectively. The cumulative incidence of zidovudine-induced anemia was 37.1% over 2 years. At 12 and 24 months, the proportion of patients with optimal adherence, undetectable viral load and CD4 counts >350 cells/mm(3) were similar between patients who experienced or did not experience severe adverse drug reactions. Conclusions: Our results highlight the high frequency of ART-related adverse drug reactions among individuals initiating first-line ART in India, underscoring the importance of detailed counseling and monitoring for maintaining ART durability. Severe drug-induced anemia needs to be addressed urgently with alternative first-line agents, and close laboratory surveillance. High treatment efficacy despite decreased drug safety seen here may be because patients have limited treatment options. Our results support the use of currently recommended safer first-line ART regimens that minimize the risk of severe life-threatening toxicities and provide for a better quality of life.	[Shet, Anita] St Johns Med Coll Hosp, Dept Pediat, Bangalore, Karnataka, India; [Antony, Jimmy] St Johns Res Inst, Div Publ Hlth & Infect, Bangalore, Karnataka, India; [Arumugam, Karthika] St Johns Res Inst, Div Biostat, Bangalore, Karnataka, India; [Dodderi, Sunil Kumar] Govt India, Natl AIDS Control Org, Minist Hlth & Family Welf, New Delhi, India; [Rodrigues, Rashmi] St Johns Med Coll Hosp, Dept Community Med, Bangalore, Karnataka, India; [Shet, Anita; DeCosta, Ayesha] Karolinska Inst, Div Global Hlth, Stockholm, Sweden	St. John's National Academy of Health Sciences; St. John's Medical College; St. John's National Academy of Health Sciences; St. John's Research Institute; St. John's National Academy of Health Sciences; St. John's Research Institute; St. John's National Academy of Health Sciences; St. John's Medical College; Karolinska Institutet	Shet, A (corresponding author), St Johns Med Coll Hosp, Dept Pediat, Bangalore, Karnataka, India.	anitashet@stjohns.in	Rodrigues, Rashmi J/H-1901-2012	Rodrigues, Rashmi J/0000-0002-0656-0178; Shet, Anita/0000-0002-7204-8164	European Union [222946]	European Union(European Commission)	The study was financially supported by a grant under the European Union Framework Program 7 (project no: 222946). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agu Kenneth A, 2013, Perspect Clin Res, V4, P117, DOI 10.4103/2229-3485.111784; [Anonymous], 2007, ANT THER GUID HIV IN; [Anonymous], 2012, NAT AIDS CONTR ORG A; Antinori A, 2001, AIDS, V15, P1579, DOI 10.1097/00002030-200108170-00018; Anuradha S, 2013, J Int Assoc Provid AIDS Care, V12, P195, DOI 10.1177/1545109711431344; Bersoff-Matcha SJ, 2001, CLIN INFECT DIS, V32, P124, DOI 10.1086/317536; Blake M, 2000, CLIN INFECT DIS, V30, pS96, DOI 10.1086/313859; Campbell TB, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001290; Cicconi P, 2010, HIV MED, V11, P104, DOI 10.1111/j.1468-1293.2009.00750.x; De Costa A, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-25; Division of AIDS (DAIDS), 2004, TABL GRAD SEV AD PED; Edwards IR, 2000, LANCET, V356, P1255, DOI 10.1016/S0140-6736(00)02799-9; Eluwa George I, 2012, BMC Clin Pharmacol, V12, P7, DOI 10.1186/1472-6904-12-7; Elzi L, 2010, ARCH INTERN MED, V170, P57, DOI 10.1001/archinternmed.2009.432; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Keiser O, 2007, ANTIVIR THER, V12, P1157; Kesselring AM, 2009, AIDS, V23, P1689, DOI 10.1097/QAD.0b013e32832d3b54; Khalili H, 2009, PHARMACOEPIDEM DR S, V18, P848, DOI 10.1002/pds.1793; Kumarasamy N, 2008, AIDS PATIENT CARE ST, V22, P337, DOI 10.1089/apc.2007.0093; Lichtenstein KA, 2008, JAIDS-J ACQ IMM DEF, V47, P27, DOI 10.1097/QAI.0b013e31815acacc; Lodwick RK, 2008, AIDS, V22, P1039, DOI 10.1097/QAD.0b013e3282fec415; Luma HN, 2012, PAN AFR MED J, V12; Mihanovic MP, 2013, MED SCI MONITOR, V19, P483, DOI 10.12659/MSM.889283; Modayil RR, 2010, PHARMACOEPIDEM DR S, V19, P247, DOI 10.1002/pds.1907; Moh R, 2005, ANTIVIR THER, V10, P615; Monforte AD, 2000, AIDS, V14, P499, DOI 10.1097/00002030-200003310-00005; Murphy RA, 2007, J INFECT DIS, V196, pS449, DOI 10.1086/521112; O'Brien ME, 2003, JAIDS-J ACQ IMM DEF, V34, P407, DOI 10.1097/00126334-200312010-00008; Ofotokun I, 2007, GENDER MED, V4, P106, DOI 10.1016/S1550-8579(07)80025-8; Phe T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060206; Prosperi MCF, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-296; Rajesh Radhakrishnan, 2011, Int J Risk Saf Med, V23, P171, DOI 10.3233/JRS-2011-0531; Robison LS, 2008, AIDS RES HUM RETROV, V24, P1347, DOI 10.1089/aid.2008.0083; Ruud KW, 2012, EUR J CLIN PHARMACOL, V68, P1321, DOI 10.1007/s00228-012-1254-1; Severe P, 2005, NEW ENGL J MED, V353, P2325, DOI 10.1056/NEJMoa051908; Sivadasan Ajith, 2009, J Assoc Physicians India, V57, P384; Srikanth BA, 2012, J ADV PHARM TECHNOL, V3, P62, DOI 10.4103/2231-4040.93557; Ssali F, 2006, ANTIVIR THER, V11, P741; WHO, 2001, IRON DEFICIENCY ANAE; World Health Organization, 1972, WHO TECHN REP SER, V498; Yuan Y, 2006, HIV MED, V7, P156, DOI 10.1111/j.1468-1293.2006.00355.x; Zhou JL, 2012, J INT AIDS SOC, V15, DOI 10.1186/1758-2652-15-5	42	30	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91028	10.1371/journal.pone.0091028	http://dx.doi.org/10.1371/journal.pone.0091028			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614165	gold, Green Published, Green Submitted			2022-12-27	WOS:000332839300068
J	Abedini, A; Daud, AR; Hamid, MAA; Othman, NK				Abedini, Alam; Daud, Abdul Razak; Hamid, Muhammad Azmi Abdul; Othman, Norinsan Kamil			Radiolytic Formation of Fe3O4 Nanoparticles: Influence of Radiation Dose on Structure and Magnetic Properties	PLOS ONE			English	Article							IRON-OXIDE NANOPARTICLES; SPIN DISORDER; SIZE; TEMPERATURE; NANOCLUSTERS; SPECTROSCOPY	Colloidal Fe3O4 nanoparticles were synthesized using a gamma-radiolysis method in an aqueous solution containing iron chloride in presence of polyvinyl alcohol and isopropanol as colloidal stabilizer and hydroxyl radical scavenger, respectively. Gamma irradiation was carried out in a Co-60 gamma source chamber at different absorbed doses. Increasing the radiation dose above a certain critical dose (100 kGy) leads to particle agglomeration enhancement, and this can influence the structure and crystallinity, and consequently the magnetic properties of the resultant particles. The optimal condition for formation of Fe3O4 nanoparticles with a uniform and narrow size distribution occurred at a dose of 100 kGy, as confirmed by X-ray diffractometry and transmission electron microscopy. A vibrating sample magnetometry study showed that, when radiation dose increased, the saturation and remanence magnetization decreased, whereas the coercivity and the remanence ratio increased. This magnetic behavior results from variations in crystallinity, surface effects, and particle size effects, which are all dependent on the radiation dose. In addition, Fourier transform infrared spectroscopy was performed to investigate the nature of the bonds formed between the polymer chains and the metal surface at different radiation doses.	[Abedini, Alam; Daud, Abdul Razak; Hamid, Muhammad Azmi Abdul; Othman, Norinsan Kamil] Univ Kebangsaan Malaysia, Fac Sci & Technol, Sch Appl Phys, Bangi 43600, Selangor, Malaysia	Universiti Kebangsaan Malaysia	Abedini, A (corresponding author), Univ Kebangsaan Malaysia, Fac Sci & Technol, Sch Appl Phys, Bangi 43600, Selangor, Malaysia.	alamabedini@gmail.com	othman, Norinsan kamil/M-3583-2019; Al-Douri, Yarub/W-4147-2017	Al-Douri, Yarub/0000-0002-5175-6372; Othman, Norinsan kamil/0000-0002-6214-4400	Universiti Kebangsaan Malaysia [DIP-2012-14, FRGS/2/2013/SG06/UKM/02/4]	Universiti Kebangsaan Malaysia	This work is supported by Universiti Kebangsaan Malaysia through grants No. DIP-2012-14 and FRGS/2/2013/SG06/UKM/02/4. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Abbas M, 2013, CERAM INT, V39, P7605, DOI 10.1016/j.ceramint.2013.03.015; Abedini A, 2012, RADIAT PHYS CHEM, V81, P1653, DOI 10.1016/j.radphyschem.2012.05.015; Belloni J, 2006, CATAL TODAY, V113, P141, DOI 10.1016/j.cattod.2005.11.082; Billotey C, 2003, MAGN RESON MED, V49, P646, DOI 10.1002/mrm.10418; Chen YZ, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/50/505703; Compean-Jasso ME, 2008, MATER LETT, V62, P4248, DOI 10.1016/j.matlet.2008.06.053; Darbandi M, 2012, J PHYS D APPL PHYS, V45, DOI 10.1088/0022-3727/45/19/195001; Deng YH, 2005, COLLOID SURFACE A, V262, P87, DOI 10.1016/j.colsurfa.2005.04.009; El-Sawy NM, 2010, POLYM-PLAST TECHNOL, V49, P169, DOI 10.1080/03602550903284248; Faraji M, 2010, J IRAN CHEM SOC, V7, P1, DOI 10.1007/BF03245856; Finkelstein G, 2000, SCIENCE, V289, P90, DOI 10.1126/science.289.5476.90; Fortin JP, 2007, J AM CHEM SOC, V129, P2628, DOI 10.1021/ja067457e; Frey NA, 2009, CHEM SOC REV, V38, P2532, DOI 10.1039/b815548h; Gohil JM, 2006, J POLYM RES, V13, P161, DOI 10.1007/s10965-005-9023-9; Gonzales-Weimuller M, 2009, J MAGN MAGN MATER, V321, P1947, DOI 10.1016/j.jmmm.2008.12.017; Gu HW, 2005, CHEM COMMUN, P4270, DOI 10.1039/b507779f; Gubin SP, 2005, USP KHIM+, V74, P539, DOI 10.1070/RC2005V074N06ABEH000897; Hafeli U, 2001, J MAGN MAGN MATER, V225, P73, DOI 10.1016/S0304-8853(00)01230-0; He SL, 2005, CHINESE PHYS, V14, P1055, DOI 10.1088/1009-1963/14/5/036; Hogemann D, 2000, BIOCONJUGATE CHEM, V11, P941, DOI 10.1021/bc000079x; Hou YL, 2003, J MATER CHEM, V13, P1983, DOI 10.1039/b305526d; Issa B, 2013, INT J MOL SCI, V14, P21266, DOI 10.3390/ijms141121266; Johannsen M, 2010, INT J HYPERTHER, V26, P790, DOI 10.3109/02656731003745740; JOLIVET JP, 1992, CLAY CLAY MINER, V40, P531, DOI 10.1346/CCMN.1992.0400506; Kayal S, 2010, MAT SCI ENG C-MATER, V30, P484, DOI 10.1016/j.msec.2010.01.006; Kim SW, 2010, B KOREAN CHEM SOC, V31, P910, DOI 10.5012/bkcs.2010.31.04.910; Kim YI, 2003, PHYSICA B, V337, P42, DOI 10.1016/S0921-4526(03)00322-3; LABIDI N.S., 2008, JMMCE, V07, P147, DOI [10.4236/jmmce.2008.72012, DOI 10.4236/JMMCE.2008.72012]; Lima E, 2006, J APPL PHYS, V99, DOI 10.1063/1.2191471; Lodhia J, 2010, Biomed Imaging Interv J, V6, pe12, DOI 10.2349/biij.6.2.e12; Lu HM, 2007, J PHYS D APPL PHYS, V40, P320, DOI 10.1088/0022-3727/40/2/006; Lu Y, 2002, NANO LETT, V2, P183, DOI 10.1021/nl015681q; Mansur HS, 2008, MAT SCI ENG C-BIO S, V28, P539, DOI 10.1016/j.msec.2007.10.088; Mathew DS, 2007, CHEM ENG J, V129, P51, DOI 10.1016/j.cej.2006.11.001; Naseri MG, 2010, J NANOMATER, V2010, DOI 10.1155/2010/907686; Ni YH, 2002, CHEM MATER, V14, P1048, DOI 10.1021/cm010446u; Nikolic VM, 2007, ELECTROCHEM COMMUN, V9, P2661, DOI 10.1016/j.elecom.2007.08.022; Ozkaya T, 2009, J ALLOY COMPD, V472, P18, DOI 10.1016/j.jallcom.2008.04.101; Pal S, 2007, IEEE T MAGN, V43, P3091, DOI 10.1109/TMAG.2007.894000; Qu YQ, 2006, MATER LETT, V60, P3548, DOI 10.1016/j.matlet.2006.03.055; Rao YN, 2010, RADIAT PHYS CHEM, V79, P1240, DOI 10.1016/j.radphyschem.2010.07.004; Respaud M, 1998, PHYS REV B, V57, P2925, DOI 10.1103/PhysRevB.57.2925; Roca AG, 2006, NANOTECHNOLOGY, V17, P2783, DOI 10.1088/0957-4484/17/11/010; Saeed R, 2008, PHYS CHEM LIQ, V46, P9, DOI 10.1080/00319100601188703; Seino S, 2008, J NANOPART RES, V10, P1071, DOI 10.1007/s11051-007-9334-3; Sohn BH, 1998, J MAGN MAGN MATER, V182, P216, DOI 10.1016/S0304-8853(97)00675-6; Xu CJ, 2004, J AM CHEM SOC, V126, P9938, DOI 10.1021/ja0464802; Yan AG, 2008, J ALLOY COMPD, V458, P487, DOI 10.1016/j.jallcom.2007.04.019; Yang TZ, 2005, J PHYS CHEM B, V109, P23233, DOI 10.1021/jp054291f	49	48	52	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90055	10.1371/journal.pone.0090055	http://dx.doi.org/10.1371/journal.pone.0090055			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608715	Green Published, Green Submitted, gold			2022-12-27	WOS:000332485800015
J	Previlon, M; Pezet, M; Vinet, L; Mercadier, JJ; Rouet-Benzineb, P				Previlon, Miresta; Pezet, Mylene; Vinet, Laurent; Mercadier, Jean-Jacques; Rouet-Benzineb, Patricia			Gender-Specific Potential Inhibitory Role of Ca2+/Calmodulin Dependent Protein Kinase Phosphatase (CaMKP) in Pressure-Overloaded Mouse Heart	PLOS ONE			English	Article							CARDIAC-HYPERTROPHY; HISTONE DEACETYLASE-4; ESTROGEN-RECEPTOR; ACTIN GENE; IN-VIVO; CALCIUM; MICE; TRANSCRIPTION; CALCINEURIN; MYOCYTES	Background: Ca2+/calmodulin-dependent protein kinase phosphatase (CaMKP) has been proposed as a potent regulator of multifunctional Ca2+/calmodulin-dependent protein kinases (i.e., CaMKII). The CaMKII-dependent activation of myocyte enhancer factor 2 (MEF2) disrupts interactions between MEF2-histone deacetylases (HDACs), thereby de-repressing downstream gene transcription. Whether CaMKP modulates the CaMKII-MEF2 pathway in the heart is unknown. Here, we investigated the molecular and functional consequences of left ventricular (LV) pressure overload in the mouse of both genders, and in particular we evaluated the expression levels and localization of CaMKP and its association with CaMKII-MEF2 signaling. Methodology and Principal Findings: Five week-old B6D1/F1 mice of both genders underwent a sham-operation or thoracic aortic constriction (TAC). Thirty days later, TAC was associated with pathological LV hypertrophy characterized by systolic and diastolic dysfunction. Gene expression was assessed by real-time PCR. Fetal gene program re-expression comprised increased RNA levels of brain natriuretic peptide and alpha-skeletal actin. Mouse hearts of both genders expressed both CaMKP transcript and protein. Activation of signalling pathways was studied by Western blot in LV lysates or subcellular fractions (nuclear and cytoplasmic). TAC was associated with increased CaMKP expression in male LVs whereas it tended to be decreased in females. The DNA binding activity of MEF2 was determined by spectrophotometry. CaMKP compartmentalization differed according to gender. In male TAC mice, nuclear CaMKP was associated with inactive CaMKII resulting in less MEF2 activation. In female TAC mice, active CaMKII (phospho-CaMKII) detected in the nuclear fraction, was associated with a strong MEF2 transcription factor-binding activity. Conclusions/Significance: Gender-specific CaMKP compartmentalization is associated with CaMKII-mediated MEF2 activation in pressure-overloaded hearts. Therefore, CaMKP could be considered as an important novel cellular target for the development of new therapeutic strategies for heart diseases.	[Previlon, Miresta; Vinet, Laurent; Rouet-Benzineb, Patricia] Univ Paris Diderot, Sorbonne Paris Cite, INSERM, UMRS 698, Paris, France; [Pezet, Mylene] CEFI Inst Claude Bernard IFR02, Paris, France; [Pezet, Mylene] Inst Albert Bonniot Site Sante, INSERM, U823, F-38042 Grenoble, France; [Vinet, Laurent] Univ Geneva, Sch Med, Dept Cell Physiol & Metab, CH-1211 Geneva, Switzerland; [Mercadier, Jean-Jacques] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France; [Mercadier, Jean-Jacques] Univ Paris 11, INSERM, UMRS 769, IFR141,LabEx LERMIT, Chatenay Malabry, France; [Mercadier, Jean-Jacques] Hop Bichat Claude Bernard, AP HP, F-75877 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Geneva; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite	Rouet-Benzineb, P (corresponding author), Univ Paris Diderot, Sorbonne Paris Cite, INSERM, UMRS 698, Paris, France.	patricia.rouetbenzineb@inserm.fr	Pezet, Mylene/N-1833-2013	Pezet, Mylene/0000-0002-4365-7454	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Diderot (Paris 7); EU [LSHM-CT-2005-018833]; Ministere de l'Enseignement Superieur et de la Recherche	Institut National de la Sante et de la Recherche Medicale (Inserm)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite Paris Diderot (Paris 7); EU(European Commission); Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission)	This study was funded by the Institut National de la Sante et de la Recherche Medicale (Inserm), Universite Paris Diderot (Paris 7), and by EU FP6 grant LSHM-CT-2005-018833, EUGeneHeart. Miresta Previlon was supported by a scholarship of the Ministere de l'Enseignement Superieur et de la Recherche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson ME, 2011, J MOL CELL CARDIOL, V51, P468, DOI 10.1016/j.yjmcc.2011.01.012; [Anonymous], 2008, CHIN J PHYSL, V51, P261; Awad S, 2013, NUCLEIC ACIDS RES, V41, P7656, DOI 10.1093/nar/gkt500; Baba H, 2012, ARCH BIOCHEM BIOPHYS, V526, P9, DOI 10.1016/j.abb.2012.06.005; Backs J, 2008, MOL CELL BIOL, V28, P3437, DOI 10.1128/MCB.01611-07; Backs J, 2006, J CLIN INVEST, V116, P1853, DOI 10.1172/JCI27438; Bers DM, 2005, ANN NY ACAD SCI, V1047, P86, DOI 10.1196/annals.1341.008; Bers DM, 2011, HEART RHYTHM, V8, P1101, DOI 10.1016/j.hrthm.2011.01.030; Domnguez-Rodriguez A, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00452; el Azzouzi H, 2010, EUR J HEART FAIL, V12, P4, DOI 10.1093/eurjhf/hfp165; Erickson JR, 2008, CELL, V133, P462, DOI 10.1016/j.cell.2008.02.048; Erickson JR, 2011, PHYSIOL REV, V91, P889, DOI 10.1152/physrev.00018.2010; Fliegner D, 2010, AM J PHYSIOL-REG I, V298, pR1597, DOI 10.1152/ajpregu.00825.2009; Grimm M, 2010, J MOL CELL CARDIOL, V48, P322, DOI 10.1016/j.yjmcc.2009.10.016; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Hori Y, 2008, CHINESE J PHYSIOL, V51, P146; Houser SR, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.125pe31; Ishida A, 2008, BRIT J PHARMACOL, V154, P729, DOI 10.1038/bjp.2008.127; Ishida A, 2005, ARCH BIOCHEM BIOPHYS, V435, P134, DOI 10.1016/j.abb.2004.11.022; Ishida A, 2003, PHARMACOL THERAPEUT, V100, P291, DOI 10.1016/j.pharmthera.2003.09.003; Ishida A, 1998, J BIOL CHEM, V273, P1904, DOI 10.1074/jbc.273.4.1904; Kameshita I, 2010, ANAL BIOCHEM, V400, P118, DOI 10.1016/j.ab.2009.12.035; Kitani T, 1999, J BIOCHEM-TOKYO, V125, P1022, DOI 10.1093/oxfordjournals.jbchem.a022381; Konhilas JP, 2004, AM J PHYSIOL-HEART C, V287, pH2768, DOI 10.1152/ajpheart.00292.2004; Lemonnier M, 2004, J BIOL CHEM, V279, P55651, DOI 10.1074/jbc.M411082200; Li YH, 2004, ENDOCRINOLOGY, V145, P951, DOI 10.1210/en.2003-0816; Little GH, 2007, J BIOL CHEM, V282, P7219, DOI 10.1074/jbc.M604281200; MacDonnell SM, 2009, CIRC RES, V105, P316, DOI 10.1161/CIRCRESAHA.109.194035; Maier LS, 2012, ADV EXP MED BIOL, V740, P685, DOI 10.1007/978-94-007-2888-2_30; Maier LS, 2009, FRONT BIOSCI-LANDMRK, V14, P486, DOI 10.2741/3257; Montalvo C, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0035635, DOI 10.1371/J0URNAL.P0NE.0035635.EPUB]; Muscat George E. O., 1992, Gene Expression, V2, P111; Nimura T, 2007, ARCH BIOCHEM BIOPHYS, V457, P205, DOI 10.1016/j.abb.2006.09.034; Passier R, 2000, J CLIN INVEST, V105, P1395, DOI 10.1172/JCI8551; Prasad AM, 2011, AM J PHYSIOL-HEART C, V300, pH173, DOI 10.1152/ajpheart.00841.2010; Previlon M, 2011, CAN J PHYSIOL PHARM, V89, P769, DOI 10.1139/Y11-075; Previlon M, 2010, CAN J PHYSIOL PHARM, V88, P1093, DOI [10.1139/Y10-087, 10.1139/y10-087]; Santana LF, 2008, CIRC RES, V103, P681, DOI 10.1161/CIRCRESAHA.108.185090; Sueyoshi N, 2012, ARCH BIOCHEM BIOPHYS, V517, P43, DOI 10.1016/j.abb.2011.10.017; Sueyoshi N, 2009, ARCH BIOCHEM BIOPHYS, V488, P48, DOI 10.1016/j.abb.2009.06.003; Swaminathan PD, 2012, CIRC RES, V110, P1661, DOI 10.1161/CIRCRESAHA.111.243956; Takeuchi M, 2001, J BIOCHEM, V130, P833, DOI 10.1093/oxfordjournals.jbchem.a003055; Tan KML, 2001, J BIOL CHEM, V276, P44193, DOI 10.1074/jbc.M105880200; van Rooij E, 2010, CIRC RES, V106, P155, DOI 10.1161/CIRCRESAHA.109.207084; Vinet L, 2008, AM J PHYSIOL-HEART C, V295, pH352, DOI 10.1152/ajpheart.01101.2007; Vinet L, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0246-8; Wagner S, 2013, ANTIOXID REDOX SIGN, V18, P1063, DOI 10.1089/ars.2012.4818; Wang W, 2004, CIRC RES, V95, P798, DOI 10.1161/01.RES.0000145361.50017.aa; Westphal C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050802; Zarain-Herzberg A, 2011, IUBMB LIFE, V63, P847, DOI 10.1002/iub.545; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9; Zhang T, 2007, J BIOL CHEM, V282, P35078, DOI 10.1074/jbc.M707083200; Zhong X, 2012, CELL BIOL INT, V36, P937, DOI 10.1042/CBI20110594	53	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90822	10.1371/journal.pone.0090822	http://dx.doi.org/10.1371/journal.pone.0090822			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608696	Green Submitted, Green Published, gold			2022-12-27	WOS:000332485800054
J	Savage, AL; Wilm, TP; Khursheed, K; Shatunov, A; Morrison, KE; Shaw, PJ; Shaw, CE; Smith, B; Breen, G; Al-Chalabi, A; Moss, D; Bubb, VJ; Quinn, JP				Savage, Abigail L.; Wilm, Thomas P.; Khursheed, Kejhal; Shatunov, Aleksey; Morrison, Karen E.; Shaw, Pamela J.; Shaw, Christopher E.; Smith, Bradley; Breen, Gerome; Al-Chalabi, Ammar; Moss, Diana; Bubb, Vivien J.; Quinn, John P.			An Evaluation of a SVA Retrotransposon in the FUS Promoter as a Transcriptional Regulator and Its Association to ALS	PLOS ONE			English	Article							SEROTONIN TRANSPORTER GENE; VARIABLE NUMBER; FUNCTIONAL VARIANT; TANDEM REPEATS; EXPRESSION; ENHANCER; MUTATIONS; ELEMENTS; POLYMORPHISMS; DEPRESSION	Genetic mutations of FUS have been linked to many diseases including Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Lobar Degeneration. A primate specific and polymorphic retrotransposon of the SINE-VNTR-Alu (SVA) family is present upstream of the FUS gene. Here we have demonstrated that this retrotransposon can act as a classical transcriptional regulatory domain in the context of a reporter gene construct both in vitro in the human SK-N-AS neuroblastoma cell line and in vivo in a chick embryo model. We have also demonstrated that the SVA is composed of multiple distinct regulatory domains, one of which is a variable number tandem repeat (VNTR). The ability of the SVA and its component parts to direct reporter gene expression supported a hypothesis that this region could direct differential FUS expression in vivo. The SVA may therefore contribute to the modulation of FUS expression exhibited in and associated with neurological disorders including ALS where FUS regulation may be an important parameter in progression of the disease. As VNTRs are often clinical associates for disease progression we determined the extent of polymorphism within the SVA. In total 2 variants of the SVA were identified based within a central VNTR. Preliminary analysis addressed the association of these SVA variants within a small sporadic ALS cohort but did not reach statistical significance, although we did not include other parameters such as SNPs within the SVA or an environmental factor in this analysis. The latter may be particularly important as the transcriptional and epigenetic properties of the SVA are likely to be directed by the environment of the cell.	[Savage, Abigail L.; Wilm, Thomas P.; Khursheed, Kejhal; Bubb, Vivien J.; Quinn, John P.] Univ Liverpool, Inst Translat Med, Dept Mol & Clin Pharmacol, Liverpool L69 3BX, Merseyside, England; [Shatunov, Aleksey; Shaw, Christopher E.; Smith, Bradley; Breen, Gerome; Al-Chalabi, Ammar] Kings Coll London, Inst Psychiat, London, England; [Morrison, Karen E.] Univ Birmingham, Coll Med & Dent, Sch Clin & Expt Med, Birmingham, W Midlands, England; [Morrison, Karen E.] Univ Hosp Birmingham NHS Fdn Trust, Div Neurosci, Birmingham, W Midlands, England; [Shaw, Pamela J.] Univ Sheffield, Acad Unit Neurol, Dept Neurosci, Sheffield Inst Translat Res, Sheffield, S Yorkshire, England; [Breen, Gerome] Kings Coll London, Inst Psychiat, MRC Social Genet & Dev Psychiat Res Ctr, London, England; [Breen, Gerome] Natl Inst Hlth Res Biomed Res, Ctr Mental Hlth, South London, England; [Breen, Gerome] Maudsley NHS Fdn Trust, London, England; [Moss, Diana] Univ Liverpool, Dept Cellular & Mol Physiol, Inst Translat Med, Liverpool L69 3BX, Merseyside, England	University of Liverpool; University of London; King's College London; University of Birmingham; University of Birmingham; University of Sheffield; University of London; King's College London; South London & Maudsley NHS Trust; University of Liverpool	Quinn, JP (corresponding author), Univ Liverpool, Inst Translat Med, Dept Mol & Clin Pharmacol, Liverpool L69 3BX, Merseyside, England.	jquinn@liv.ac.uk	Breen, Gerome/Y-2706-2019; Smith, Bradley/H-6107-2013; Quinn, John P/A-2972-2010; Al-Chalabi, Ammar/E-5361-2010	Breen, Gerome/0000-0003-2053-1792; Quinn, John P/0000-0003-3551-7803; Shaw, Christopher/0000-0003-0251-0146; Smith, Bradley/0000-0002-6980-2453; Morrison, Karen Elaine/0000-0003-0216-5717; Pfaff, Abigail/0000-0002-2231-9800; Shaw, Pamela/0000-0002-8925-2567; Shatunov, Aleksey/0000-0002-2671-8040; Al-Chalabi, Ammar/0000-0002-4924-7712	Motor Neurone Disease Association [Quinn/Mar09/RF/6056]; University of Liverpool; European Community [259867]; National Institute for Health Research (NIHR) Dementia Biomedical Research Unit at South London and Maudsley National Health Service (NHS) Foundation Trust; King's College London; NIHR Biomedical Research Centre for Mental Health at South London and Maudsley NHS Foundation Trust; [Institute of Psychiatry] King's College London; National Institute for Health Research; MRC [MC_G1000733, G0900635, G0600974, G0500289, G1100695, G0900688] Funding Source: UKRI; Medical Research Council [G0500289, G0900688, MC_G1000733, G0500289B, G9817803B, G0600974, G1100695, G0900635, MR/L501529/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10082] Funding Source: researchfish	Motor Neurone Disease Association; University of Liverpool; European Community(European Commission); National Institute for Health Research (NIHR) Dementia Biomedical Research Unit at South London and Maudsley National Health Service (NHS) Foundation Trust; King's College London; NIHR Biomedical Research Centre for Mental Health at South London and Maudsley NHS Foundation Trust; [Institute of Psychiatry] King's College London; National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work is funded by the Motor Neurone Disease Association (Grant Ref: Quinn/Mar09/RF/6056: Prediction and analysis of genetic variation which would affect expression of candidate genes associated with Motor Neurone Disease). ALS is funded by the University of Liverpool Anatomy Demonstratorship program. This work also received funding from the European Community's Health Seventh Framework Programme (FP7/2007-2013) [259867 (to AAC, CES and PJS)]. AAC receives salary support from the National Institute for Health Research (NIHR) Dementia Biomedical Research Unit at South London and Maudsley National Health Service (NHS) Foundation Trust and King's College London. PJS is supported as an NIHR Senior Investigator. Lab work was funded in part by the NIHR Biomedical Research Centre for Mental Health at South London and Maudsley NHS Foundation Trust and [Institute of Psychiatry] King's College London. This article presents independent research in part funded by the National Institute for Health Research. The views expressed are those of the authors and not necessarily those of the National Health Service, the National Institute for Health Research or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel O, 2012, HUM MUTAT, V33, P1345, DOI 10.1002/humu.22157; Alfahad T, 2013, ANTIVIR RES, V99, P180, DOI 10.1016/j.antiviral.2013.05.006; Ali FR, 2010, J NEUROCHEM, V112, P296, DOI 10.1111/j.1471-4159.2009.06453.x; Andrews WD, 2000, J MED VIROL, V61, P527, DOI 10.1002/1096-9071(200008)61:4&lt;527::AID-JMV17&gt;3.0.CO;2-A; Baillie JK, 2011, NATURE, V479, P534, DOI 10.1038/nature10531; Bantysh OB, 2009, BIOCHEMISTRY-MOSCOW+, V74, P1393, DOI 10.1134/S0006297909120153; Brotons O, 2011, MOL PSYCHIATR, V16, P124, DOI 10.1038/mp.2009.6; Chio A, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.05.016; Corrado L, 2010, J MED GENET, V47, P190, DOI 10.1136/jmg.2009.071027; Damert A, 2009, GENOME RES, V19, P1992, DOI 10.1101/gr.093435.109; Davidson S, 2011, NEUROPSYCHOPHARMACOL, V36, P2211, DOI 10.1038/npp.2011.93; Deng HX, 2010, ANN NEUROL, V67, P739, DOI 10.1002/ana.22051; Doolittle WF, 2013, P NATL ACAD SCI US; Douville R, 2011, ANN NEUROL, V69, P141, DOI 10.1002/ana.22149; Faulkner GJ, 2011, FEBS LETT, V585, P1589, DOI 10.1016/j.febslet.2011.03.061; Guindalini C, 2006, P NATL ACAD SCI USA, V103, P4552, DOI 10.1073/pnas.0504789103; Haddley K, 2008, NEUROCHEM RES, V33, P652, DOI 10.1007/s11064-007-9521-8; Haddley K, 2012, CURR TOP BEHAV NEURO; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hancks DC, 2012, CURR OPIN GENET DEV, V22, P191, DOI 10.1016/j.gde.2012.02.006; Hancks DC, 2009, GENOME RES, V19, P1983, DOI 10.1101/gr.093153.109; Hing B, 2012, BIOL PSYCHIAT, V71, P618, DOI 10.1016/j.biopsych.2011.11.030; Kavanagh DH, 2013, MOL PSYCHIAT; Klenova E, 2004, J NEUROSCI, V24, P5966, DOI 10.1523/JNEUROSCI.1150-04.2004; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Lai SL, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2009.12.020; MacKenzie A, 2004, NEUROPEPTIDES, V38, P1, DOI 10.1016/j.npep.2003.09.004; MacKenzie A, 1999, P NATL ACAD SCI USA, V96, P15251, DOI 10.1073/pnas.96.26.15251; Michelhaugh SK, 2001, J NEUROCHEM, V79, P1033, DOI 10.1046/j.1471-4159.2001.00647.x; Mitchell JC, 2013, ACTA NEUROPATHOL, V125, P273, DOI 10.1007/s00401-012-1043-z; Miyajima F, 2008, GENES BRAIN BEHAV, V7, P714, DOI 10.1111/j.1601-183X.2008.00409.x; Paredes UM, 2012, GENES BRAIN BEHAV; Paredes UM, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-46; Roberts J, 2007, J NEUROSCI, V27, P2793, DOI 10.1523/JNEUROSCI.0892-06.2007; Savage AL, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-101; SHAM PC, 1995, ANN HUM GENET, V59, P97, DOI 10.1111/j.1469-1809.1995.tb01608.x; Shanley L, 2010, NEUROSIGNALS, V18, P173, DOI 10.1159/000322010; Sproviero W, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.10.005; Steele AJ, 2005, NEUROLOGY, V64, P454, DOI 10.1212/01.WNL.0000150899.76130.71; Szpakowski S, 2009, GENE, V448, P151, DOI 10.1016/j.gene.2009.08.006; Uchikawa M, 2003, DEV CELL, V4, P509, DOI 10.1016/S1534-5807(03)00088-1; Uchikawa M, 2008, DEV GROWTH DIFFER, V50, P467, DOI [10.1111/j.1440-169x.2008.01028.x, 10.1111/j.1440-169X.2008.01028.x]; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Vasiliou SA, 2012, ADDICT BIOL, V17, P156, DOI 10.1111/j.1369-1600.2010.00288.x; Wang H, 2005, J MOL BIOL, V354, P994, DOI 10.1016/j.jmb.2005.09.085; Wendland JR, 2006, MOL PSYCHIATR, V11, P224, DOI 10.1038/sj.mp.4001789; Wray NR, 2009, BIOL PSYCHIAT, V66, P468, DOI 10.1016/j.biopsych.2009.04.030	47	24	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90833	10.1371/journal.pone.0090833	http://dx.doi.org/10.1371/journal.pone.0090833			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608899	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000332485800058
J	Smulders, K; Esselink, RA; Cools, R; Bloem, BR				Smulders, Katrijn; Esselink, Rianne A.; Cools, Roshan; Bloem, Bastiaan R.			Trait Impulsivity Is Associated with the Risk of Falls in Parkinson's Disease	PLOS ONE			English	Article							RECURRENT FALLERS; PHYSICAL-ACTIVITY; CONTROL DISORDERS; STROKE; TESTS; TRIAL; SCALE	Objective: Impulsivity is a "tendency to act prematurely without foresight." Clinical experience suggests that such impulsive behavior can impact on the fall risk in Parkinson's disease (PD), but this has never been tested. We investigated whether trait impulsivity is related to fall risk in a large cohort of PD patients. We also investigated whether trait impulsivity affects the fall risk differently for patients with more or less postural instability and gait disability (PIGD). Methods: 388 patients with PD (H&Y&LE; 3) completed the Barratt Impulsiveness Scale (BIS-11, higher scores indicating greater impulsivity) to assess trait impulsivity, including three subscales: motor impulsivity (e. g. "I do things without thinking"), attentional impulsivity (e. g. "I concentrate easily") and non-planning (e. g. "I plan tasks carefully"). Falls were registered prospectively for 6 months. Patients classified as non-fallers (0 falls, n = 237) were compared to recurrent PD fallers (>1 fall, n = 78). Results: Total impulsivity scores were higher for recurrent fallers (59.5) compared to non-fallers (56.8; p = .012). This effect was predominantly driven by higher scores on the subscale for attentional impulsivity (p = .003). The difference in attentional impulsivity was independent of gender, disease severity, dopaminergic medication, and cognitive function. Motor and non-planning impulsivity did not differ between recurrent fallers and non-fallers. There was no evidence that impulsivity modulated the association between PIGD and fall risk. Discussion: This is the first evidence that impulsivity, in particular in the attentional domain, is related to fall risk in PD.	[Smulders, Katrijn; Esselink, Rianne A.; Bloem, Bastiaan R.] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Neurol, NL-6525 ED Nijmegen, Netherlands; [Smulders, Katrijn] HAN Univ Appl Sci, Inst Studies Sports & Exercise, Nijmegen, Netherlands; [Cools, Roshan] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Psychiat, NL-6525 ED Nijmegen, Netherlands; [Cools, Roshan] Radboud Univ Nijmegen, Ctr Cognit Neuroimaging, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Smulders, K (corresponding author), Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Neurol, NL-6525 ED Nijmegen, Netherlands.	katrijn.smulders@gmail.com	Bloem, Bastiaan/H-8013-2014; Cools, Roshan/D-1905-2010; Smulders, Katrijn/K-9939-2019; Esselink, R.A.J./L-4298-2015	Bloem, Bastiaan/0000-0002-6371-3337; Smulders, Katrijn/0000-0001-9338-5277; Cools, Roshan/0000-0001-8994-5534	ZonMw; Netherlands Organization for Health Research and Development [75020012]; Michael J. Fox Foundation for Parkinson's Research	ZonMw(Netherlands Organization for Health Research and Development); Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); Michael J. Fox Foundation for Parkinson's Research	This study was supported by ZonMw, the Netherlands Organization for Health Research and Development (75020012 to BRB), and the Michael J. Fox Foundation for Parkinson's Research (to BRB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlskog JE, 2010, NEUROLOGY, V75, P1226, DOI 10.1212/WNL.0b013e3181f5d507; Allcock LM, 2009, PARKINSONISM RELAT D, V15, P110, DOI 10.1016/j.parkreldis.2008.03.010; Anstey KJ, 2009, NEUROPSYCHOLOGY, V23, P500, DOI 10.1037/a0015389; Antonini A, 2011, MOVEMENT DISORD, V26, P464, DOI 10.1002/mds.23501; Barratt ES., 1985, MOTIVATION EMOTION P, P137, DOI DOI 10.1371/JOURNAL.PONE.0129139; Bloem BR, 2004, MOVEMENT DISORD, V19, P359; Bloem BR, 2004, CLIN DISORDERS BALAN, V2, P173; Dalley JW, 2011, NEURON, V69, P680, DOI 10.1016/j.neuron.2011.01.020; Daruna J.H., 1993, IMPULSIVE CLIENT THE, P23, DOI DOI 10.1037/10500-002; Esselink RAJ, 2004, NEUROLOGY, V62, P201, DOI 10.1212/01.WNL.0000103235.12621.C3; Evenden JL, 1999, PSYCHOPHARMACOLOGY, V146, P348, DOI 10.1007/PL00005481; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Goudriaan AE, 2008, PSYCHOL MED, V38, P41, DOI 10.1017/S0033291707000694; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Holtzer R, 2007, NEUROPSYCHOLOGY, V21, P540, DOI 10.1037/0894-4105.21.5.540; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Keilp JG, 2005, PSYCHIAT RES, V135, P191, DOI 10.1016/j.psychres.2005.03.006; Lamb SE, 2003, STROKE, V34, P494, DOI 10.1161/01.STR.0000053444.00582.B7; Mak MKY, 2010, J NEUROL, V257, P1543, DOI 10.1007/s00415-010-5573-9; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Pickering RM, 2007, MOVEMENT DISORD, V22, P1892, DOI 10.1002/mds.21598; RAPPORT LJ, 1993, ARCH PHYS MED REHAB, V74, P621, DOI 10.1016/0003-9993(93)90160-C; ROBBINS TW, 1994, DEMENTIA, V5, P266, DOI 10.1159/000106735; Smulders K, 2012, J NEUROL; Stanford MS, 2009, PERS INDIV DIFFER, V47, P385, DOI 10.1016/j.paid.2009.04.008; Stel VS, 2004, J CLIN EPIDEMIOL, V57, P252, DOI 10.1016/j.jclinepi.2003.07.008; van den Wildenberg WPM, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00222; Van der Elst W, 2006, J INT NEUROPSYCH SOC, V12, P80, DOI 10.1017/S1355617706060115; van der Marck MA, 2011, J AM GERIATR SOC, V59, P340, DOI 10.1111/j.1532-5415.2010.03263.x; van Nimwegen M, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-70; Voon V, 2007, ARCH NEUROL-CHICAGO, V64, P1089, DOI 10.1001/archneur.64.8.1089; Voon V, 2011, BRAIN, V134, P1438, DOI 10.1093/brain/awr080; Weintraub D, 2010, ARCH NEUROL-CHICAGO, V67, P589, DOI 10.1001/archneurol.2010.65; Wylie SA, 2012, J NEUROLOGY NEUROSUR	34	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91190	10.1371/journal.pone.0091190	http://dx.doi.org/10.1371/journal.pone.0091190			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC4IY	24608747	Green Published, Green Submitted, gold			2022-12-27	WOS:000332485800114
J	Zhang, X; Bao, T; Rao, ZM; Yang, TW; Xu, ZH; Yang, ST; Li, HZ				Zhang, Xian; Bao, Teng; Rao, Zhiming; Yang, Taowei; Xu, Zhenghong; Yang, Shangtian; Li, Huazhong			Two-Stage pH Control Strategy Based on the pH Preference of Acetoin Reductase Regulates Acetoin and 2,3-Butanediol Distribution in Bacillus subtilis	PLOS ONE			English	Article							SERRATIA-MARCESCENS H32; STATISTICAL OPTIMIZATION; DEHYDROGENASE; DIACETYL; CITRATE; GENE; METABOLISM; LACTIS	Acetoin reductase/2,3-butanediol dehydrogenase (AR/BDH), which catalyzes the interconversion between acetoin and 2,3-butanediol, plays an important role in distribution of the products pools. This work characterized the Bacillus subtilis AR/BDH for the first time. The enzyme showed very different pH preferences of pH 6.5 for reduction and pH 8.5 for oxidation. Based on these above results, a two-stage pH control strategy was optimized for acetoin production, in which the pH was controlled at 6.5 for quickly converting glucose to acetoin and 2,3-butanediol, and then 8.0 for reversely transforming 2,3-butanediol to acetoin. By over-expression of AR/BDH in the wild-type B. subtilis JNA 3-10 and applying fed-batch fermentation based on the two-stage pH control strategy, acetoin yield of B. subtilis was improved to a new record of 73.6 g/l, with the productivity of 0.77 g/(l? h). The molar yield of acetoin was improved from 57.5% to 83.5% and the ratio of acetoin/2,3-butanediol was switched from 2.7:1 to 18.0:1.	[Zhang, Xian; Bao, Teng; Rao, Zhiming; Yang, Taowei; Li, Huazhong] Jiangnan Univ, Sch Biotechnol, Minist Educ, Key Lab Ind Biotechnol, Wuxi, Jiangsu, Peoples R China; [Xu, Zhenghong] Jiangnan Univ, Sch Med & Pharmaceut, Wuxi, Jiangsu, Peoples R China; [Yang, Shangtian] Ohio State Univ, Dept Chem Engn, Columbus, OH 43210 USA	Jiangnan University; Jiangnan University; University System of Ohio; Ohio State University	Rao, ZM (corresponding author), Jiangnan Univ, Sch Biotechnol, Minist Educ, Key Lab Ind Biotechnol, Wuxi, Jiangsu, Peoples R China.	raozhm@jiangnan.edu.cn; hzhli@jiangnan.edu.cn	Yang, Shang-Tian/A-7892-2009		Program for New Century Excellent Talents in University [NCET-10-0459]; National Basic Research Program of China (973 Program) [2012CB725202]; National Natural Science Foundation of China [21276110]; Research Project of Chinese Ministry of Education [113033A]; Fundamental Research Funds for the Central Universities [JUSRP51306A, JUSRP21121]; 111 Project [111-2-06]; Priority Academic Program Development of Jiangsu Higher Education Institution	Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Project of Chinese Ministry of Education(Ministry of Education, China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); 111 Project(Ministry of Education, China - 111 Project); Priority Academic Program Development of Jiangsu Higher Education Institution	This work was supported by the Program for New Century Excellent Talents in University (NCET-10-0459), the National Basic Research Program of China (973 Program) (2012CB725202), the National Natural Science Foundation of China (21276110), the Research Project of Chinese Ministry of Education (No. 113033A), the Fundamental Research Funds for the Central Universities (JUSRP51306A and JUSRP21121), the 111 Project (111-2-06) and a Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cho S, 2013, APPL BIOCHEM BIOTECH, V170, P1922, DOI 10.1007/s12010-013-0291-2; COGAN TM, 1981, APPL ENVIRON MICROB, V41, P1; CROW VL, 1990, APPL ENVIRON MICROB, V56, P1656, DOI 10.1128/AEM.56.6.1656-1665.1990; Ehsani M, 2009, BIOTECHNOL BIOENG, V104, P381, DOI 10.1002/bit.22391; Gao J, 2013, LETT APPL MICROBIOL, V57, P274, DOI 10.1111/lam.12107; Geckil H, 2004, BIOPROC BIOSYST ENG, V26, P325, DOI 10.1007/s00449-004-0373-1; Gonzalez E, 2000, J BIOL CHEM, V275, P35876, DOI 10.1074/jbc.M003035200; HEIDLAS J, 1990, ARCH MICROBIOL, V154, P267, DOI 10.1007/BF00248966; HOHNBENTZ H, 1978, ARCH MICROBIOL, V116, P197, DOI 10.1007/BF00406037; Ji XJ, 2011, BIOTECHNOL ADV, V29, P351, DOI 10.1016/j.biotechadv.2011.01.007; KAVADZE A V, 1979, Biology Bulletin of the Academy of Sciences of the USSR, V6, P356; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Machielsen R, 2006, APPL ENVIRON MICROB, V72, P233, DOI 10.1128/AEM.72.1.233-238.2006; Nicholson WL, 2008, APPL ENVIRON MICROB, V74, P6832, DOI 10.1128/AEM.00881-08; Passerini D, 2013, INT J FOOD MICROBIOL, V160, P329, DOI 10.1016/j.ijfoodmicro.2012.10.023; ROMANO P, 1993, FEMS MICROBIOL LETT, V108, P23; Schallmey M, 2004, CAN J MICROBIOL, V50, P1, DOI 10.1139/W03-076; Schmitt P, 1997, APPL MICROBIOL BIOT, V47, P715, DOI 10.1007/s002530051000; Siemerink MAJ, 2011, APPL ENVIRON MICROB, V77, P2582, DOI 10.1128/AEM.01616-10; Sun JA, 2012, BIORESOURCE TECHNOL, V119, P94, DOI 10.1016/j.biortech.2012.05.108; Sun JN, 2012, BIOTECHNOL BIOPROC E, V17, P598, DOI 10.1007/s12257-011-0587-4; Wang Z, 2014, APPL MICROBIOL BIOT, V98, P641, DOI 10.1007/s00253-013-4870-5; Xiao ZJ, 2007, APPL MICROBIOL BIOT, V74, P61, DOI 10.1007/s00253-006-0646-5; Xiao ZJ, 2007, CRIT REV MICROBIOL, V33, P127, DOI 10.1080/10408410701364604; Xiao ZJ, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-88; Xiao ZJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008860; Zhang X, 2013, J IND MICROBIOL BIOT; Zhang X, 2011, WORLD J MICROB BIOT, V27, P2785, DOI 10.1007/s11274-011-0754-y; Zhang YJ, 2013, BIORESOURCE TECHNOL, V130, P256, DOI 10.1016/j.biortech.2012.10.036	31	5	8	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91187	10.1371/journal.pone.0091187	http://dx.doi.org/10.1371/journal.pone.0091187			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608678	gold, Green Published, Green Submitted			2022-12-27	WOS:000332485800113
J	Adams, RI; Miletto, M; Lindow, SE; Taylor, JW; Bruns, TD				Adams, Rachel I.; Miletto, Marzia; Lindow, Steven E.; Taylor, John W.; Bruns, Thomas D.			Airborne Bacterial Communities in Residences: Similarities and Differences with Fungi	PLOS ONE			English	Article							OUTDOOR AIR; DIVERSITY; BUILDINGS; DATABASE; DUST	Genetic analysis of indoor air has uncovered a rich microbial presence, but rarely have both the bacterial and fungal components been examined in the same samples. Here we present a study that examined the bacterial component of passively settled microbes from both indoor and outdoor air over a discrete time period and for which the fungal component has already been reported. Dust was allowed to passively settle in five common locations around a home - living room, bedroom, bathroom, kitchen, and balcony - at different dwellings within a university-housing complex for a one-month period at two time points, once in summer and again in winter. We amplified the bacterial 16S rRNA gene in these samples and analyzed them with high-throughput sequencing. Like fungal OTU-richness, bacterial OTU-richness was higher outdoors then indoors and was invariant across different indoor room types. While fungal composition was structured largely by season and residential unit, bacterial composition varied by residential unit and room type. Bacteria from putative outdoor sources, such as Sphingomonas and Deinococcus, comprised a large percentage of the balcony samples, while human-associated taxa comprised a large percentage of the indoor samples. Abundant outdoor bacterial taxa were also observed indoors, but the reverse was not true; this is unlike fungi, in which the taxa abundant indoors were also well-represented outdoors. Moreover, there was a partial association of bacterial composition and geographic distance, such that samples separated by even a few hundred meters tended have greater compositional differences than samples closer together in space, a pattern also observed for fungi. These data show that while the outdoor source for indoor bacteria and fungi varies in both space and time, humans provide a strong and homogenizing effect on indoor bacterial bioaerosols, a pattern not observed in fungi.	[Adams, Rachel I.; Miletto, Marzia; Lindow, Steven E.; Taylor, John W.; Bruns, Thomas D.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Adams, RI (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA.	adamsri@berkeley.edu		Adams, Rachel/0000-0003-4499-5743	Alfred P. Sloan Foundation [2010-10-03]	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation)	This work was funded with a grant from the Alfred P. Sloan Foundation (http://www.sloan.org), grant number 2010-10-03. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarenkov K, 2010, NEW PHYTOL, V186, P281, DOI 10.1111/j.1469-8137.2009.03160.x; Adams RI, 2013, MICROB ECOL, V66, P735, DOI 10.1007/s00248-013-0266-4; Adams RI, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0078866, 10.1371/journal.pone.0067861]; Adams RI, 2013, ISME J, V7, P1262, DOI 10.1038/ismej.2013.28; Amend AS, 2010, P NATL ACAD SCI USA, V107, P13748, DOI 10.1073/pnas.1000454107; Bowers RM, 2011, APPL ENVIRON MICROB, V77, P6350, DOI 10.1128/AEM.05498-11; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dunn RR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064133; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, UPARSE PIPELINE; Edgar RC, PYTHON SCRIPTS; Edgar RC, UCHIME SOFTWARE; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Flannigan B., 2001, MICROORGANISMS HOME, DOI [10.1201/9780203302934, DOI 10.1201/9780203302934]; Flannigan B, 2011, MICROORGANISMS IN HOME AND INDOOR WORK ENVIRONMENTS: DIVERSITY, HEALTH IMPACTS, INVESTIGATION AND CONTROL, 2ND EDITION; Flores GE, 2013, ENVIRON MICROBIOL, V15, P588, DOI 10.1111/1462-2920.12036; Flores GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028132; Fujimura KE, 2010, J ALLERGY CLIN IMMUN, V126, DOI 10.1016/j.jaci.2010.05.042; Hospodsky D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034867; Karvala K, 2010, INT ARCH OCC ENV HEA, V83, P855, DOI 10.1007/s00420-010-0507-5; Kembel SW, 2012, ISME J, V6, P1469, DOI 10.1038/ismej.2011.211; Kuczynski J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-210; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Meadow JF, 2014, INDOOR AIR, V24, P41, DOI 10.1111/ina.12047; Montacutelli R, 2000, AEROBIOLOGIA, V16, P441, DOI 10.1023/A:1026525432412; OKSANEN J, 2012, R PACKAGE VERSION, V2, P1, DOI DOI 10.3856/V0L41-ISSUEL-FULLTEXT-11; Pitkaranta M, 2008, APPL ENVIRON MICROB, V74, P233, DOI 10.1128/AEM.00692-07; Pitkaranta M, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-235; R Development Core Team, 2012, R LANG ENV STAT COMP; Rintala H, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-56; Taubel M, 2009, J ALLERGY CLIN IMMUN, V124, P834, DOI 10.1016/j.jaci.2009.07.045; Thos C, 1887, PHILOS T R SOC B, V178, P61, DOI DOI 10.1098/RSTB.1887.0004; Tsai FC, 2005, INDOOR AIR, V15, P71, DOI 10.1111/j.1600-0668.2005.00346.x	35	102	103	3	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e91283	10.1371/journal.pone.0091283	http://dx.doi.org/10.1371/journal.pone.0091283			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603548	Green Submitted, gold, Green Published			2022-12-27	WOS:000332483600140
J	Dozio, E; Malavazos, AE; Vianello, E; Briganti, S; Dogliotti, G; Bandera, F; Giacomazzi, F; Castelvecchio, S; Menicanti, L; Sigruener, A; Schmitz, G; Romanelli, MMC				Dozio, Elena; Malavazos, Alexis Elias; Vianello, Elena; Briganti, Silvia; Dogliotti, Giada; Bandera, Francesco; Giacomazzi, Francesca; Castelvecchio, Serenella; Menicanti, Lorenzo; Sigrueener, Alexander; Schmitz, Gerd; Romanelli, Massimiliano Marco Corsi			Interleukin-15 and Soluble Interleukin-15 Receptor alpha in Coronary Artery Disease Patients: Association with Epicardial Fat and Indices of Adipose Tissue Distribution	PLOS ONE			English	Article							CARDIAC ABNORMALITIES; IL-15; IL-15R-ALPHA; OBESITY; CHAIN; CELL; EXPRESSION; BIOLOGY; MUSCLE; FORM	Interleukin-15 (IL-15) is a pro-inflammatory cytokine which signals via a specific alpha receptor subunit (IL-15R alpha). Increased IL-15 level has been observed in cardiovascular patients and IL-15 immunoreactivity has been detected at vulnerable atherosclerotic plaques. Due to the association between adipose tissue distribution, inflammation and coronary artery disease (CAD), we quantified IL-15 and IL-15R alpha in CAD patients with different adiposity and adipose tissue distribution and we evaluated whether epicardial adipose tissue (EAT), a visceral fat depot surrounding and infiltrating myocardium, may be a source of both molecules. IL-15 and IL-15R alpha proteins were quantified by enzyme-linked immunosorbent assays. Gene expression of IL-15 and IL-15R alpha in EAT depots was evaluated by one colour microarray platform. EAT thickness was measured by echocardiography. Plasmatic IL-15 and IL-15R alpha levels were higher in CAD than non-CAD patients. After classification according to adipose tissue distribution, IL-15 was higher in CAD patients with increased abdominal adiposity. Increased level of IL-15R alpha was observed both in CAD and non-CAD patients with increased abdominal fat. EAT was a source of IL-15 and IL-15R alpha and their expression was higher in CAD patients with increased EAT thickness. In conclusion, our data suggest that circulating levels of IL-15 and IL-15R alpha seem to reflect visceral distribution of adipose tissue and that EAT may be a potential source of both IL-15 and IL-15R alpha. Future studies on the relationship between IL-15, visceral fat and characteristics of atherosclerotic plaques could help to better understand the complex biology of this cytokine.	[Dozio, Elena; Vianello, Elena; Dogliotti, Giada; Romanelli, Massimiliano Marco Corsi] Univ Milan, Chair Clin Pathol, Dept Biomed Sci Hlth, Milan, Italy; [Malavazos, Alexis Elias; Briganti, Silvia] IRCCS Policlin San Donato, Diabetol & Metab Dis Unit, Milan, Italy; [Bandera, Francesco] IRCCS Policlin San Donato, Cardiol Unit, Milan, Italy; [Giacomazzi, Francesca; Castelvecchio, Serenella; Menicanti, Lorenzo] IRCCS Policlin San Donato, Cardiac Surg Unit, Milan, Italy; [Sigrueener, Alexander; Schmitz, Gerd] Univ Regensburg, Inst Clin Chem & Lab Med, D-93053 Regensburg, Germany; [Romanelli, Massimiliano Marco Corsi] IRCCS Policlin San Donato, Dept Hlth Serv Diag & Treatment Lab Med, Serv Lab Med Clin Pathol 1, Milan, Italy	University of Milan; IRCCS Policlinico San Donato; IRCCS Policlinico San Donato; IRCCS Policlinico San Donato; University of Regensburg; IRCCS Policlinico San Donato	Dozio, E (corresponding author), Univ Milan, Chair Clin Pathol, Dept Biomed Sci Hlth, Milan, Italy.	elena.dozio@unimi.it	Malavazos, Alexis Elias/AAB-2370-2021; , CASTELVECCHIO/J-9091-2016; Bandera, Francesco/K-6532-2016; Bandera, Francesco/HGB-0711-2022; menicanti, lorenzo/K-5649-2018; , ele/ABG-3014-2020; Romanelli, Massimiliano M Corsi/K-9359-2016	Malavazos, Alexis Elias/0000-0002-0852-9625; , CASTELVECCHIO/0000-0001-5365-7063; Bandera, Francesco/0000-0002-5821-7371; menicanti, lorenzo/0000-0001-8530-6284; , ele/0000-0001-5833-0780; Romanelli, Massimiliano M Corsi/0000-0001-7928-7697; VIANELLO, ELENA/0000-0001-6461-654X	Italian Ministry for Health "Ricerca Corrente" I.R.C.C.S. Policlinico San Donato; University of Regensburg; EU Framework/project 'LipidomicNet'	Italian Ministry for Health "Ricerca Corrente" I.R.C.C.S. Policlinico San Donato; University of Regensburg; EU Framework/project 'LipidomicNet'	The study was supported by funds from Italian Ministry for Health "Ricerca Corrente" I.R.C.C.S. Policlinico San Donato, internal funds from University of Regensburg and the EU Framework/project 'LipidomicNet'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Bergamaschi C, 2008, J BIOL CHEM, V283, P4189, DOI 10.1074/jbc.M705725200; Bergamaschi C, 2012, BLOOD, V120, pE1, DOI 10.1182/blood-2011-10-384362; Budagian V, 2006, CYTOKINE GROWTH F R, V17, P259, DOI 10.1016/j.cytogfr.2006.05.001; Despres JP, 2012, CIRCULATION, V126, P1301, DOI 10.1161/CIRCULATIONAHA.111.067264; Djaberi R, 2008, AM J CARDIOL, V102, P1602, DOI 10.1016/j.amjcard.2008.08.010; Dozio E, 2012, INT J IMMUNOPATH PH, V25, P1011, DOI 10.1177/039463201202500418; Dubois S, 1999, J BIOL CHEM, V274, P26978, DOI 10.1074/jbc.274.38.26978; Dubois S, 2002, IMMUNITY, V17, P537, DOI 10.1016/S1074-7613(02)00429-6; Fehniger TA, 2001, BLOOD, V97, P14, DOI 10.1182/blood.V97.1.14; Fox CS, 2007, CIRCULATION, V116, P39, DOI 10.1161/CIRCULATIONAHA.106.675355; GIRI JG, 1994, EMBO J, V13, P2822, DOI 10.1002/j.1460-2075.1994.tb06576.x; Gokkusu C, 2010, CYTOKINE, V49, P58, DOI 10.1016/j.cyto.2009.09.004; Houtkamp MA, 2001, ARTERIOSCL THROM VAS, V21, P1208, DOI 10.1161/hq0701.092162; Iacobellis G, 2003, OBES RES, V11, P304, DOI 10.1038/oby.2003.45; Iacobellis G, 2011, INT J CARDIOL, V146, P452, DOI 10.1016/j.ijcard.2010.10.117; Ikeoka D, 2010, REV ASSOC MED BRAS, V56, P116, DOI 10.1590/S0104-42302010000100026; Kaibe M, 2005, AM J HYPERTENS, V18, P1019, DOI 10.1016/j.amjhyper.2005.02.014; Diaz ACM, 2012, ARTHRITIS, DOI 10.1155/2012/943156; Malavazos AE, 2007, INT J CARDIOL, V121, P132, DOI 10.1016/j.ijcard.2006.08.061; Malavazos AE, 2007, NUTR METAB CARDIOVAS, V17, P294, DOI 10.1016/j.numecd.2006.01.001; Mariner JM, 2001, J IMMUNOL, V166, P2602, DOI 10.4049/jimmunol.166.4.2602; Mazurek T, 2003, CIRCULATION, V108, P2460, DOI 10.1161/01.CIR.0000099542.57313.C5; Mortier E, 2004, J IMMUNOL, V173, P1681, DOI 10.4049/jimmunol.173.3.1681; Neely GG, 2004, J IMMUNOL, V172, P4225, DOI 10.4049/jimmunol.172.7.4225; Pistilli EE, 2008, CYTOKINE, V43, P45, DOI 10.1016/j.cyto.2008.04.008; Qiao Q, 2010, EUR J CLIN NUTR, V64, P23, DOI 10.1038/ejcn.2009.92; Quinn LBS, 2005, CELL BIOL INT, V29, P449, DOI 10.1016/j.cellbi.2005.02.005; Sacks HS, 2011, METAB SYNDR RELAT D, V9, P433, DOI 10.1089/met.2011.0024; Schejbal V, 1989, Pneumologie, V43, P490; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246	32	32	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90960	10.1371/journal.pone.0090960	http://dx.doi.org/10.1371/journal.pone.0090960			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603895	gold, Green Published, Green Submitted			2022-12-27	WOS:000332483600115
J	Dragoni, S; Laforenza, U; Bonetti, E; Reforgiato, M; Poletto, V; Lodola, F; Bottino, C; Guido, D; Rappa, A; Pareek, S; Tomasello, M; Guarrera, MR; Cinelli, MP; Aronica, A; Guerra, G; Barosi, G; Tanzi, F; Rosti, V; Moccia, F				Dragoni, Silvia; Laforenza, Umberto; Bonetti, Elisa; Reforgiato, Marta; Poletto, Valentina; Lodola, Francesco; Bottino, Cinzia; Guido, Daniele; Rappa, Alessandra; Pareek, Sumedha; Tomasello, Mario; Guarrera, Maria Rosa; Cinelli, Maria Pia; Aronica, Adele; Guerra, Germano; Barosi, Giovanni; Tanzi, Franco; Rosti, Vittorio; Moccia, Francesco			Enhanced Expression of Stim, Orai, and TRPC Transcripts and Proteins in Endothelial Progenitor Cells Isolated from Patients with Primary Myelofibrosis	PLOS ONE			English	Article							OPERATED CA2+ ENTRY; CALCIUM-ENTRY; HEMATOPOIETIC PROGENITOR; STORE; CHANNELS; CANCER; PROLIFERATION; TARGETS; IDENTIFICATION; OSCILLATIONS	Background: An increase in the frequency of circulating endothelial colony forming cells (ECFCs), the only subset of endothelial progenitor cells (EPCs) truly belonging to the endothelial phenotype, occurs in patients affected by primary myelofibrosis (PMF). Herein, they might contribute to the enhanced neovascularisation of fibrotic bone marrow and spleen. Store-operated Ca2+ entry (SOCE) activated by the depletion of the inositol-1,4,5-trisphosphate (InsP(3))-sensitive Ca2+ store drives proliferation in ECFCs isolated from both healthy donors (N-ECFCs) and subjects suffering from renal cellular carcinoma (RCC-ECFCs). SOCE is up-regulated in RCC-ECFCs due to the over-expression of its underlying molecular components, namely Stim1, Orai1, and TRPC1. Methodology/Principal Findings: We utilized Ca2+ imaging, real-time polymerase chain reaction, western blot analysis and functional assays to evaluate molecular structure and the functional role of SOCE in ECFCs derived from PMF patients (PMF-ECFCs). SOCE, induced by either pharmacological (i.e. cyclopiazonic acid or CPA) or physiological (i.e. ATP) stimulation, was significantly higher in PMF-ECFCs. ATP-induced SOCE was inhibited upon blockade of the phospholipase C/InsP(3) signalling pathway with U73111 and 2-APB. The higher amplitude of SOCE was associated to the over-expression of the transcripts encoding for Stim2, Orai2-3, and TRPC1. Conversely, immunoblotting revealed that Stim2 levels remained constant as compared to N-ECFCs, while Stim1, Orai1, Orai3, TRPC1 and TRPC4 proteins were over-expressed in PMF-ECFCs. ATP-induced SOCE was inhibited by BTP-2 and low micromolar La3+ and Gd3+, while CPA-elicited SOCE was insensitive to Gd3+. Finally, BTP-2 and La3+ weakly blocked PMF-ECFC proliferation, while Gd3+ was ineffective. Conclusions: Two distinct signalling pathways mediate SOCE in PMF-ECFCs; one is activated by passive store depletion and is Gd3+-resistant, while the other one is regulated by the InsP(3)-sensitive Ca2+ pool and is inhibited by Gd3+. Unlike N- and RCC-ECFCs, the InsP(3)-dependent SOCE does not drive PMF-ECFC proliferation.	[Dragoni, Silvia; Reforgiato, Marta; Lodola, Francesco; Guido, Daniele; Rappa, Alessandra; Pareek, Sumedha; Tomasello, Mario; Guarrera, Maria Rosa; Tanzi, Franco; Moccia, Francesco] Univ Pavia, Lab Gen Physioloy, Dept Biol & Biotechnol Lazzaro Spallanzani, I-27100 Pavia, Italy; [Laforenza, Umberto; Bottino, Cinzia] Univ Pavia, Dept Mol Med, I-27100 Pavia, Italy; [Bonetti, Elisa; Poletto, Valentina; Aronica, Adele; Barosi, Giovanni; Rosti, Vittorio] Fdn IRCCS Policlin San Matteo, Ctr Study Myelofibrosis, Biotechnol Lab, Pavia, Italy; [Cinelli, Maria Pia] Univ Naples Federico II, Dept Publ Hlth, Naples, Italy; [Guerra, Germano] Univ Molise, Dept Hlth Sci, Campobasso, Italy	University of Pavia; University of Pavia; IRCCS Fondazione San Matteo; University of Naples Federico II; University of Molise	Rosti, V (corresponding author), Fdn IRCCS Policlin San Matteo, Ctr Study Myelofibrosis, Biotechnol Lab, Pavia, Italy.	v.rosti@smatteo.pv.it; francesco.moccia@unipv.it	Rosti, Vittorio/K-1743-2018; Bonetti, Elisa/D-4478-2016; Barosi, Giovanni/AAI-1714-2019; Moccia, Francesco/AAX-6447-2020; Lodola, Francesco/J-8129-2018; Rappa, Alessandra/AAB-1778-2021	Rosti, Vittorio/0000-0003-4195-2289; Bonetti, Elisa/0000-0002-8406-5252; Moccia, Francesco/0000-0003-0010-0098; Lodola, Francesco/0000-0002-3506-5619; Laforenza, Umberto/0000-0003-2951-5983; Dragoni, Silvia/0000-0002-9107-6291; Pareek, Sumedha/0000-0001-6492-3849	Associazione Italiana per la Ricerca sul Cancro (AIRC, Milano) Special Program Molecular Clinical Oncology [561000]	Associazione Italiana per la Ricerca sul Cancro (AIRC, Milano) Special Program Molecular Clinical Oncology(Fondazione AIRC per la ricerca sul cancro)	This work was supported by a grant from Associazione Italiana per la Ricerca sul Cancro (AIRC, Milano) Special Program Molecular Clinical Oncology 561000 to AIRC-Gruppo Italiano Malattie Mieloproliferative (AGIMM). A detailed description of the AGIMM project is available at (http://www.progettoagimm.it). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullaev IF, 2008, CIRC RES, V103, P1289, DOI 10.1161/01.RES.0000338496.95579.56; Aytes A, 2012, MOL CARCINOGEN, V51, P746, DOI 10.1002/mc.20843; Badalucco S, 2013, HAEMATOLOGICA, V98, P514, DOI 10.3324/haematol.2012.076752; Barosi G, 2004, BRIT J HAEMATOL, V124, P618, DOI 10.1111/j.1365-2141.2004.04829.x; Barosi G, 2001, BLOOD, V98, P3249, DOI 10.1182/blood.V98.12.3249; Barosi G, 2007, BLOOD, V110, P4030, DOI 10.1182/blood-2007-07-099184; Barritt GJ, 2009, CLIN EXP PHARMACOL P, V36, P77, DOI 10.1111/j.1440-1681.2008.05095.x; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bird GS, 2008, METHODS, V46, P204, DOI 10.1016/j.ymeth.2008.09.009; Boyd RS, 2009, MOL CELL PROTEOMICS, V8, P1501, DOI 10.1074/mcp.M800515-MCP200; Brandman O, 2007, CELL, V131, P1327, DOI 10.1016/j.cell.2007.11.039; Capiod T, 2013, RECENT PAT ANTI-CANC, V8, P4; Case J, 2007, EXP HEMATOL, V35, P1109, DOI 10.1016/j.exphem.2007.04.002; Cheng KT, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001025; Ciarcia R, 2010, J CELL PHYSIOL, V224, P443, DOI 10.1002/jcp.22140; Clemens MJ, 2004, ONCOGENE, V23, P3180, DOI 10.1038/sj.onc.1207544; Courjaret Raphael, 2012, Front Biosci (Elite Ed), V4, P331; Davis FM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036923; Dragoni S, 2013, STEM CELLS DEV, V22, P2561, DOI 10.1089/scd.2013.0032; Dragoni S, 2011, STEM CELLS, V29, P1898, DOI 10.1002/stem.734; El Boustany C, 2008, HEPATOLOGY, V47, P2068, DOI 10.1002/hep.22263; Feske S, 2009, IMMUNOL REV, V231, P189, DOI 10.1111/j.1600-065X.2009.00818.x; Freichel M, 2001, NAT CELL BIOL, V3, P121, DOI 10.1038/35055019; Gusev K, 2003, J GEN PHYSIOL, V122, P81, DOI 10.1085/jgp.200308815; Han S, 2012, HUM IMMUNOL, V73, P316, DOI 10.1016/j.humimm.2011.12.018; He BF, 2012, ONCOL REP, V27, P1548, DOI 10.3892/or.2012.1695; Hollywood MA, 2010, BRIT J PHARMACOL, V160, P1293, DOI 10.1111/j.1476-5381.2010.00795.x; Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396; Jaffe LF, 2005, ADV CANCER RES, V94, P231, DOI 10.1016/S0065-230X(05)94006-2; Jang SS, 2011, AM J PHYSIOL-CELL PH, V301, pC150, DOI 10.1152/ajpcell.00002.2010; Jiang HN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067637; Lehen'kyi V, 2011, AM J PHYSIOL-CELL PH, V301, pC1281, DOI 10.1152/ajpcell.00249.2011; Li J, 2011, CIRC RES, V108, P1190, DOI 10.1161/CIRCRESAHA.111.243352; Liao YY, 2009, P NATL ACAD SCI USA, V106, P3202, DOI 10.1073/pnas.0813346106; Lodola F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042541; Massa M, 2005, BLOOD, V106, p79A; Mesa RA, 2000, BLOOD, V96, P3374; Misquitta CM, 2006, CELL CALCIUM, V40, P329, DOI 10.1016/j.ceca.2006.04.004; Moccia F, 2012, CURR MED CHEM, V19, P5802, DOI 10.2174/092986712804143240; Moccia F, 2014, ANTI-CANCER AGENT ME, V14, P296, DOI 10.2174/18715206113139990315; Moccia F, 2013, BMC SURG, V13, DOI 10.1186/1471-2482-13-S2-S46; Moccia Francesco, 2012, World J Biol Chem, V3, P127, DOI 10.4331/wjbc.v3.i7.127; Moccia F, 2012, CURR SIGNAL TRANSD T, V7, P161, DOI 10.2174/157436212800376672; Monteith GR, 2007, NAT REV CANCER, V7, P519, DOI 10.1038/nrc2171; Monteith GR, 2012, J BIOL CHEM, V287, P31666, DOI 10.1074/jbc.R112.343061; Morita T, 2009, J CELL SCI, V122, P1220, DOI 10.1242/jcs.041640; Motiani RK, 2013, PFLUG ARCH EUR J PHY, V465, P1249, DOI 10.1007/s00424-013-1254-8; Motiani RK, 2010, J BIOL CHEM, V285, P19173, DOI 10.1074/jbc.M110.102582; Ouadid-Ahidouch H, 2013, TRENDS MOL MED, V19, P117, DOI 10.1016/j.molmed.2012.11.004; Papp B, 2004, BIOCHEM BIOPH RES CO, V322, P1223, DOI 10.1016/j.bbrc.2004.08.030; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Piaggio G, 2009, BLOOD, V114, P3127, DOI 10.1182/blood-2008-12-190991; Plant TD, 2005, N-S ARCH PHARMACOL, V371, P266, DOI 10.1007/s00210-005-1055-5; Prevarskaya N, 2010, TRENDS MOL MED, V16, P107, DOI 10.1016/j.molmed.2010.01.005; Ritchie MF, 2011, CELL CALCIUM, V49, P314, DOI 10.1016/j.ceca.2010.10.001; Roderick HL, 2008, NAT REV CANCER, V8, P361, DOI 10.1038/nrc2374; Rosti V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015277; Ruano Y, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-39; Sanchez-Hernandez Y, 2010, STEM CELLS DEV, V19, P1967, DOI 10.1089/scd.2010.0047; Sozer S, 2008, BLOOD CELL MOL DIS, V41, P284, DOI 10.1016/j.bcmd.2008.06.008; Teofili L, 2011, BLOOD, V117, P2700, DOI 10.1182/blood-2010-07-297598; Tiruppathi C, 2002, CIRC RES, V91, P70, DOI 10.1161/01.RES.0000023391.40106.A8; Vanden Abeele F, 2004, J BIOL CHEM, V279, P30326, DOI 10.1074/jbc.M400106200; Yang N, 2013, CANCER LETT, V330, P163, DOI 10.1016/j.canlet.2012.11.040; Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471; Yoder MC, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006692; Zarayskiy V, 2007, CHANNELS, V1, P246, DOI 10.4161/chan.4835; Zeng B, 2013, CURR CANCER DRUG TAR, V13, P103, DOI 10.2174/156800913804486629	68	60	61	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e91099	10.1371/journal.pone.0091099	http://dx.doi.org/10.1371/journal.pone.0091099			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603752	Green Published, gold, Green Submitted			2022-12-27	WOS:000332483600129
J	Sousa, GR; Gomes, JAS; Fares, RCG; Damasio, MPD; Chaves, AT; Ferreira, KS; Nunes, MCP; Medeiros, NI; Valente, VAA; Correa-Oliveira, R; Rocha, MOD				Sousa, Giovane Rodrigo; Silva Gomes, Juliana Assis; Gomes Fares, Rafaelle Christine; de Souza Damasio, Marcos Paulo; Chaves, Ana Thereza; Ferreira, Karine Silvestre; Pereira Nunes, Maria Carmo; Medeiros, Nayara Ingrid; Azevedo Valente, Vanessa Alves; Correa-Oliveira, Rodrigo; da Costa Rocha, Manoel Otavio			Plasma Cytokine Expression Is Associated with Cardiac Morbidity in Chagas Disease	PLOS ONE			English	Article							DIFFERENT CLINICAL FORMS; NECROSIS-FACTOR-ALPHA; REGULATORY T-CELLS; IFN-GAMMA; FUNCTIONAL-CHARACTERISTICS; CARDIOMYOPATHY; INDETERMINATE; MOLECULES; MONOCYTES; DISPLAY	The expression of immune response appears to be associated with morbidity in Chagas disease. However, the studies in this field have usually employed small samples of patients and statistical analyses that do not consider the wide dispersion of cytokine production observed in these patients. The aim of this study was to evaluate the plasma cytokine levels in well-defined clinical polar groups of chagasic patients divided into categories that better reflect the wide cytokine profile and its relationship with morbidity. Patients infected with Trypanosoma cruzi (T. cruzi) were grouped as indeterminate (IND) and cardiac (CARD) forms ranging from 23 to 69 years of age (mean of 45.6 +/- 11.25). The IND group included 82 individuals, ranging from 24 to 66 years of age (mean of 39.6 +/- 10.3). The CARD group included 94 patients ranging from 23 to 69 years of age (mean of 48 +/- 12.52) presenting dilated cardiomyopathy. None of the patients have undergone chemotherapeutic treatment, nor had been previously treated for T. cruzi infection. Healthy non-chagasic individuals, ranging from 29 to 55 years of age (mean of 42.6 +/- 8.8) were included as a control group (NI). IND patients have a higher intensity of interleukin 10 (IL-10) expression when compared with individuals in the other groups. By contrast, inflammatory cytokine expression, such as interferon gamma (IFN-gamma), tumor necrosis factor alpha (TNF-alpha), interleukin 6 (IL-6), and interleukin 1 beta (IL-1 beta), proved to be the highest in the CARD group. Correlation analysis showed that higher IL-10 expression was associated with better cardiac function, as determined by left ventricular ejection fraction and left ventricular diastolic diameter values. Altogether, these findings reinforce the concept that a fine balance between regulatory and inflammatory cytokines represents a key element in the establishment of distinct forms of chronic Chagas disease.	[Sousa, Giovane Rodrigo; Silva Gomes, Juliana Assis; Pereira Nunes, Maria Carmo; da Costa Rocha, Manoel Otavio] Univ Fed Minas Gerais, Fac Med, Programa Posgrad Ciencias Saude Infectol & Med Tr, Belo Horizonte, MG, Brazil; [Silva Gomes, Juliana Assis; de Souza Damasio, Marcos Paulo; Ferreira, Karine Silvestre; Azevedo Valente, Vanessa Alves] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Morfol, Belo Horizonte, MG, Brazil; [Gomes Fares, Rafaelle Christine; Chaves, Ana Thereza; Medeiros, Nayara Ingrid; Correa-Oliveira, Rodrigo] Fundacao Oswaldo Cruz, Lab Imunol Celular & Mol, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil; [Correa-Oliveira, Rodrigo] Inst Nacl Ciencia & Tecnol Doencas Tropicais, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Fundacao Oswaldo Cruz	Correa-Oliveira, R (corresponding author), Fundacao Oswaldo Cruz, Lab Imunol Celular & Mol, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil.	correa@cpqrr.fiocruz.br	Nunes, Maria Carmo/AAV-5185-2020; Damasio, Marcos/AAJ-7196-2021; Medeiros, Nayara I/F-3273-2018; Sousa, Giovane R./H-6102-2016; Gomes, Juliana A. S./M-4083-2017	Medeiros, Nayara I/0000-0002-5791-4802; Sousa, Giovane R./0000-0003-0085-3882; Gomes, Juliana A. S./0000-0002-8332-2907; Correa-Oliveira, Rodrigo/0000-0001-6419-9459; Fares Gusmao, Rafaelle/0000-0002-2186-4145	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [478846/2009-6]; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) [APQ-02601-10]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This study was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, grant number: 478846/2009-6, http://www.cnpq.br) and Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG, grant number: APQ-02601-10, http://www.fapemig.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel LCJ, 2001, J AUTOIMMUN, V17, P99, DOI 10.1006/jaut.2001.0523; Altman DG, 1991, PRACTICAL STAT MED R, P419; Araujo FF, 2007, FRONT BIOSCI-LANDMRK, V12, P2797, DOI 10.2741/2273; Bahia-Oliveira LMG, 1998, BRAZ J MED BIOL RES, V31, P127, DOI 10.1590/S0100-879X1998000100017; Chen R, 1999, CLIN CHEM, V45, P1693; Costa GC, 2009, J INFECT DIS, V199, P451, DOI 10.1086/596061; Crema E, 2006, CLIN IMMUNOL, V119, P213, DOI 10.1016/j.clim.2005.12.011; de Araujo FF, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000992; de Araujo FF, 2011, HUM PATHOL, V42, P299, DOI 10.1016/j.humpath.2010.10.002; Dias J C, 1989, Rev Soc Bras Med Trop, V22, P147, DOI 10.1590/S0037-86821989000300007; Dutra WO, 2000, SCAND J IMMUNOL, V51, P91; Dutra WO, 1997, SCAND J IMMUNOL, V45, P74, DOI 10.1046/j.1365-3083.1997.d01-362.x; Gomes JAS, 2005, INFECT IMMUN, V73, P7960, DOI 10.1128/IAI.73.12.7960-7966.2005; Gomes JAS, 2003, INFECT IMMUN, V71, P1185, DOI 10.1128/IAI.71.3.1185-1193.2003; Menezes CAS, 2004, CLIN EXP IMMUNOL, V137, P129, DOI 10.1111/j.1365-2249.2004.02479.x; Reis MM, 1997, CLIN IMMUNOL IMMUNOP, V83, P165, DOI 10.1006/clin.1997.4335; Rocha MOC, 2003, FRONT BIOSCI-LANDMRK, V8, pE44, DOI 10.2741/926; Rocho MOC, 2007, EXPERT REV ANTI-INFE, V5, P727, DOI 10.1586/14787210.5.4.727; Souza PEA, 2007, INFECT IMMUN, V75, P1886, DOI 10.1128/IAI.01931-06; Souza PEA, 2004, INFECT IMMUN, V72, P5283, DOI 10.1128/IAI.72.9.5283-5291.2004; Talvani A, 2004, CLIN INFECT DIS, V38, P943, DOI 10.1086/381892; Vitelli-Avelar DM, 2008, SCAND J IMMUNOL, V68, P516, DOI 10.1111/j.1365-3083.2008.02167.x	24	69	72	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e87082	10.1371/journal.pone.0087082	http://dx.doi.org/10.1371/journal.pone.0087082			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603474	Green Published, gold, Green Submitted			2022-12-27	WOS:000332483600004
J	Zhou, HT; Ji, XM; Wu, Y; Xuan, J; Qi, ZL; Shen, L; Lan, L; Li, Q; Yin, ZM; Li, ZJ; Zhao, ZH				Zhou, HuiTing; Ji, XueMei; Wu, Yun; Xuan, Ju; Qi, ZhiLin; Shen, Lei; Lan, Lei; Li, Qing; Yin, ZhiMin; Li, ZhongJun; Zhao, ZhiHui			A Dual-Role of Gu-4 in Suppressing HMGB1 Secretion and Blocking HMGB1 Pro-Inflammatory Activity during Inflammation	PLOS ONE			English	Article							MOBILITY GROUP BOX-1; CHROMATIN PROTEIN HMGB1; TUMOR-NECROSIS-FACTOR; DOUBLE-BLIND; SYSTEMIC INFLAMMATION; LACTOSYL DERIVATIVES; MONOCLONAL-ANTIBODY; CYTOKINE ACTIVITY; CELL RECRUITMENT; CONTROLLED-TRIAL	Background: High mobility group box 1(HMGB1) was first recognized as a nuclear protein that increased the chromatin remodeling and regulates transcription of many genes. In recent years, HMGB1 has been identified as a critical "late'' proinflammatory mediator due to its unique secretion pattern and lethal effects in sepsis. Therefore, preventing the active release and inhibiting the pro-inflammatory activity of HMGB1 become promising strategies for the treatment of sepsis. Here, we reported the therapeutic effects of Gu-4, a lactosyl derivative, on sepsis and the underlying molecular mechanisms. Methodology/Principal Findings: In an experimental rat model of sepsis caused by cecal ligation and puncture (CLP), Gu-4 administration prominently attenuated lung injury and improved the survival of the septic animals, which was positively correlated with the decrease of the serum HMGB1 level. Using RAW264.7 macrophage cell line, we further showed that Gu-4 significantly suppressed the lipopolysaccharide (LPS)-induced release and cytoplasmic translocation of HMGB1. Moreover, Gu-4 not only dose-dependently attenuated recombinant human (rhHMGB1)-induced production of TNF-alpha, IL-6, and IL-1 beta in THP-1 cells, but also greatly inhibited the adhesion of rhHMGB1-challenged THP-1 cells to HUVECs. Analyses of flow cytometry demonstrated that Gu-4 could effectively reduce the activation of CD11b elicited by rhHMGB1. Western blot analyses revealed that Gu-4 treatment could partially block the rhHMGB1-induced activation of ERK and NF-kappa B signalings. Meanwhile, CD11b knockdown also obviously attenuated the rhHMGB1-induced phosphorylations of ERK and IKK alpha/beta. Conclusions/Significance: Taken together, our results suggest that Gu-4 possesses a therapeutic potential in the treatment of sepsis probably via inhibiting the LPS-induced release of HMGB1 from macrophages and via suppressing the proinflammatory activity of HMGB1.	[Zhou, HuiTing; Ji, XueMei; Wu, Yun; Xuan, Ju; Qi, ZhiLin; Shen, Lei; Lan, Lei; Yin, ZhiMin; Zhao, ZhiHui] Nanjing Normal Univ, Coll Life Sci, Jiangsu Prov Key Lab Mol & Med Biotechnol, Nanjing, Jiangsu, Peoples R China; [Li, Qing; Li, ZhongJun] Peking Univ, State Key Lab Nat & Biomimet Drugs, Sch Pharmaceut Sci, Beijing 100871, Peoples R China; [Lan, Lei; Yin, ZhiMin; Zhao, ZhiHui] Collaborat Innovat Ctr Biomed Publ Hyg Emergency, Nanjing, Jiangsu, Peoples R China	Nanjing Normal University; Peking University	Zhao, ZH (corresponding author), Nanjing Normal Univ, Coll Life Sci, Jiangsu Prov Key Lab Mol & Med Biotechnol, Nanjing, Jiangsu, Peoples R China.	zhaozhihui_1964@aliyun.com			Natural Science Foundation of China (NSFC) [81273232, 91213301]; Priority Academic Program Development of Jiangsu Higher Education Institutions [164320H106]	Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was financially supported by the Natural Science Foundation of China (NSFC: 81273232 and 91213301), and a project from the Priority Academic Program Development of Jiangsu Higher Education Institutions (No. 164320H106). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM E, 1995, JAMA-J AM MED ASSOC, V273, P934, DOI 10.1001/jama.273.12.934; Abraham E, 1998, LANCET, V351, P929; Andersson U, 2011, ANNU REV IMMUNOL, V29, P139, DOI 10.1146/annurev-immunol-030409-101323; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Bonaldi T, 2003, EMBO J, V22, P5551, DOI 10.1093/emboj/cdg516; Bustin M, 1999, MOL CELL BIOL, V19, P5237; Dave SH, 2009, J LEUKOCYTE BIOL, V86, P633, DOI 10.1189/jlb.1008662; Diener KR, 2013, IMMUNOL CELL BIOL, V91, P443, DOI 10.1038/icb.2013.25; Dumitriu IE, 2005, J IMMUNOL, V174, P7506, DOI 10.4049/jimmunol.174.12.7506; Fan J, 2012, GLYCOCONJUGATE J, V29, P305, DOI 10.1007/s10719-012-9407-0; FISHER CJ, 1994, JAMA-J AM MED ASSOC, V271, P1836, DOI 10.1001/jama.271.23.1836; Fiuza C, 2003, BLOOD, V101, P2652, DOI 10.1182/blood-2002-05-1300; Gao HM, 2011, J NEUROSCI, V31, P1081, DOI 10.1523/JNEUROSCI.3732-10.2011; Gardella S, 2002, EMBO REP, V3, P995, DOI 10.1093/embo-reports/kvf198; Hagiwara S, 2008, CRIT CARE, V12, DOI 10.1186/cc6851; Harris HE, 2006, EMBO REP, V7, P774, DOI 10.1038/sj.embor.7400759; Hubbard WJ, 2005, SHOCK, V24, P52, DOI 10.1097/01.shk.0000191414.94461.7e; Kazama H, 2008, IMMUNITY, V29, P21, DOI 10.1016/j.immuni.2008.05.013; LaRosa S. P., 2011, Clinical Investigation, V1, P195, DOI 10.4155/cli.10.19; Li H, 2000, CARBOHYD RES, V328, P611, DOI 10.1016/S0008-6215(00)00137-3; Li JH, 2004, J IMMUNOL METHODS, V289, P211, DOI 10.1016/j.jim.2004.04.019; Li JH, 2003, MOL MED, V9, P37, DOI 10.1007/BF03402105; Li Q, 2003, CARBOHYD RES, V338, P207, DOI 10.1016/S0008-6215(02)00438-X; Li W, 2007, J IMMUNOL, V178, P3856, DOI 10.4049/jimmunol.178.6.3856; Li W, 2011, BIOCHEM PHARMACOL, V81, P1152, DOI 10.1016/j.bcp.2011.02.015; Liu ZW, 2008, FEBS LETT, V582, P1643, DOI 10.1016/j.febslet.2008.04.016; Orlova VV, 2007, EMBO J, V26, P1129, DOI 10.1038/sj.emboj.7601552; Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200; Park JS, 2003, AM J PHYSIOL-CELL PH, V284, pC870, DOI 10.1152/ajpcell.00322.2002; PRUITT JH, 1995, SHOCK, V3, P235, DOI 10.1097/00024382-199504000-00001; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Soriano FG, 2011, SHOCK, V35, P560, DOI 10.1097/SHK.0b013e31820fe5d5; Ulloa L, 2002, P NATL ACAD SCI USA, V99, P12351, DOI 10.1073/pnas.192222999; Venereau E, 2012, J EXP MED, V209, P1519, DOI 10.1084/jem.20120189; Wang H, 2004, NAT MED, V10, P1216, DOI 10.1038/nm1124; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Yamada S, 2007, CLIN CHIM ACTA, V375, P36, DOI 10.1016/j.cca.2006.07.019; Yan TT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030110; Yang D, 2007, J LEUKOCYTE BIOL, V81, P59, DOI 10.1189/jlb.0306180; Yang H, 2004, P NATL ACAD SCI USA, V101, P296, DOI 10.1073/pnas.2434651100; Yang H, 2012, MOL MED, V18, P250, DOI 10.2119/molmed.2011.00389; Yang HA, 2010, P NATL ACAD SCI USA, V107, P11942, DOI 10.1073/pnas.1003893107; Yang H, 2010, BBA-GENE REGUL MECH, V1799, P149, DOI 10.1016/j.bbagrm.2009.11.019; Yu M, 2006, SHOCK, V26, P174, DOI 10.1097/01.shk.0000225404.51320.82; Zhao ZH, 2009, GLYCOCONJUGATE J, V26, P173, DOI 10.1007/s10719-008-9174-0	45	12	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e89634	10.1371/journal.pone.0089634	http://dx.doi.org/10.1371/journal.pone.0089634			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603876	Green Published, Green Submitted, gold			2022-12-27	WOS:000332483600017
J	Ntie-Kang, F; Onguene, PA; Fotso, GW; Andrae-Marobela, K; Bezabih, M; Ndom, JC; Ngadjui, BT; Ogundaini, AO; Abegaz, BM; Meva'a, LM				Ntie-Kang, Fidele; Onguene, Pascal Amoa; Fotso, Ghislain W.; Andrae-Marobela, Kerstin; Bezabih, Merhatibeb; Ndom, Jean Claude; Ngadjui, Bonaventure T.; Ogundaini, Abiodun O.; Abegaz, Berhanu M.; Meva'a, Luc Mbaze			Virtualizing the p-ANAPL Library: A Step towards Drug Discovery from African Medicinal Plants	PLOS ONE			English	Article							NATURAL-PRODUCTS; ALOE-EMODIN; ANTIINFLAMMATORY ACTIVITY; ANTIPLASMODIAL ACTIVITY; ANTIBACTERIAL ACTIVITY; SCAFFOLD ANALYSIS; ANTICANCER AGENT; IN-VITRO; PIPERINE; CANNABIDIOL	Background: Natural products play a key role in drug discovery programs, both serving as drugs and as templates for the synthesis of drugs, even though the quantities and availabilities of samples for screening are often limitted. Experimental approach: A current collection of physical samples of. 500 compound derived from African medicinal plants aimed at screening for drug discovery has been made by donations from several researchers from across the continent to be directly available for drug discovery programs. A virtual library of 3D structures of compounds has been generated and Lipinski's "Rule of Five" has been used to evaluate likely oral availability of the samples. Results: A majority of the compound samples are made of flavonoids and about two thirds (2/3) are compliant to the "Rule of Five". The pharmacological profiles of thirty six (36) selected compounds in the collection have been discussed. Conclusions and implications: The p-ANAPL library is the largest physical collection of natural products derived from African medicinal plants directly available for screening purposes. The virtual library is also available and could be employed in virtual screening campaigns.	[Ntie-Kang, Fidele] Univ Buea, Dept Chem, Chem & Bioact Informat Ctr, Fac Sci, Buea, Cameroon; [Onguene, Pascal Amoa; Ndom, Jean Claude; Meva'a, Luc Mbaze] Univ Douala, Dept Chem, Fac Sci, Douala, Cameroon; [Fotso, Ghislain W.] Univ Yaounde I, Dept Organ Chem, Yaounde, Cameroon; [Andrae-Marobela, Kerstin] Univ Botswana, Dept Biol Sci, Gaborone, Botswana; [Bezabih, Merhatibeb] Univ Botswana, Dept Chem, Gaborone, Botswana; [Ngadjui, Bonaventure T.] Univ Yaounde I, Fac Med & Biomed Sci, Dept Pharmaceut Sci & Tradit Pharmacopeia, Yaounde, Cameroon; [Ogundaini, Abiodun O.] Obafemi Awolowo Univ, Dept Pharmaceut Chem, Ife, Nigeria; [Abegaz, Berhanu M.] Acad Sci, Nairobi, Kenya	University of Yaounde I; University of Botswana; University of Botswana; University of Yaounde I; Obafemi Awolowo University	Andrae-Marobela, K (corresponding author), Univ Botswana, Dept Biol Sci, Gaborone, Botswana.	Marobelak@mopipi.ub.bw; lmbazze@yahoo.fr	Ntie-Kang, Fidele/B-5877-2013; Wabo, Ghislain Fotso/AAY-7266-2020	Ntie-Kang, Fidele/0000-0003-0795-394X; Ogundaini, Abiodun/0000-0001-9356-497X	Office of Research and Development (ORD) of the University of Botswana; Stellenbosch Institute for Advanced Studies (STIAS), Stellenbosch, South-Africa;  [K047]	Office of Research and Development (ORD) of the University of Botswana; Stellenbosch Institute for Advanced Studies (STIAS), Stellenbosch, South-Africa; 	We are grateful to the Office of Research and Development (ORD) of the University of Botswana which provided a Post-Doctoral position to GWF and a grant to KAM (K047) through which PAO was able to conduct the scientific work for this report. We are also grateful to the Stellenbosch Institute for Advanced Studies (STIAS), Stellenbosch, South-Africa which provided financial means for a stay of BMA in South-Africa during which he was able to write his contribution for this paper. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abegaz BM, 2000, CURR ORG CHEM, V4, P1079, DOI 10.2174/1385272003375905; Abegaz BM, 2002, J NAT PROD, V65, P1117, DOI 10.1021/np0201218; Abegaz BM, 2002, PHYTOCHEMISTRY, V59, P877, DOI 10.1016/S0031-9422(01)00483-6; Andrae-Marobela K, 2013, CURR DRUG METAB, V14, P392, DOI 10.2174/13892002113149990095; Bang JS, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2662; Banzouzi JT, 2002, J ETHNOPHARMACOL, V81, P399, DOI 10.1016/S0378-8741(02)00121-6; Basu S, 2005, PHYTOTHER RES, V19, P888, DOI 10.1002/ptr.1752; Bhardwaj RK, 2002, J PHARMACOL EXP THER, V302, P645, DOI 10.1124/jpet.102.034728; Bisogno T, 2001, BRIT J PHARMACOL, V134, P845, DOI 10.1038/sj.bjp.0704327; Blanco B, 2013, J AM CHEM SOC, V135, P12366, DOI 10.1021/ja405853p; Bringmann G, 1999, PLANTA MED, V65, P757, DOI 10.1055/s-2006-960859; Camarero S, 2008, ENVIRON SCI TECHNOL, V42, P6703, DOI 10.1021/es8008979; Cardenas C, 2006, CELL MOL LIFE SCI, V63, P3083, DOI 10.1007/s00018-006-6399-6; Chemical Computing Group Inc, 2010, MOL OP ENV SOFTW; Chen YY, 2010, INT J ONCOL, V36, P1113; Chibale K., 2012, DRUG DISCOVERY AFRIC, Vfirst; Coopoosamy RM, 2006, AFR J BIOTECHNOL, V5, P1092; DAGNE E, 1984, PHYTOCHEMISTRY, V23, P1729, DOI 10.1016/S0031-9422(00)83479-2; Daniel R, 2005, J VIROL, V79, P2058, DOI 10.1128/JVI.79.4.2058-2065.2005; DAVIS BD, 1951, J BIOL CHEM, V191, P315; Dobson CM, 2004, NATURE, V432, P824, DOI 10.1038/nature03192; Dunkel M, 2006, NUCLEIC ACIDS RES, V34, pD678, DOI 10.1093/nar/gkj132; Efange S. M. N., 2002, Ethnomedicine and drug discovery, P61; Fan GJ, 2001, BIOORG MED CHEM LETT, V11, P2361, DOI 10.1016/S0960-894X(01)00429-2; Feher M, 2003, J CHEM INF COMP SCI, V43, P218, DOI 10.1021/ci0200467; Fullbeck M, 2006, NAT PROD REP, V23, P347, DOI 10.1039/b513504b; García-Sosa Karlina, 2006, J. Mex. Chem. Soc, V50, P76; Gu JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062839; Guimaraes LRC, 2010, PARASITOL RES, V107, P1075, DOI 10.1007/s00436-010-1973-0; Guo MX, 2013, EUR J PHARMACOL, V714, P56, DOI 10.1016/j.ejphar.2013.05.047; Habtemariam S, 2010, FITOTERAPIA, V81, P1013, DOI 10.1016/j.fitote.2010.06.021; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI [10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P, 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X]; Ham A, 2013, BRAIN RES, V1524, P54, DOI 10.1016/j.brainres.2013.05.036; Hampson AJ, 1998, P NATL ACAD SCI USA, V95, P8268, DOI 10.1073/pnas.95.14.8268; Hann MM, 2004, CURR OPIN CHEM BIOL, V8, P255, DOI 10.1016/j.cbpa.2004.04.003; Harvey AL, 2008, DRUG DISCOV TODAY, V13, P894, DOI 10.1016/j.drudis.2008.07.004; Hostettmann K, 2000, CURR ORG CHEM, V4, P973, DOI 10.2174/1385272003375923; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Irwin JJ, 2012, J CHEM INF MODEL, V52, P1757, DOI 10.1021/ci3001277; Jin J, 2011, J MED MICROBIOL, V60, P223, DOI 10.1099/jmm.0.025734-0; JURD L, 1971, PHYTOCHEMISTRY, V10, P2971, DOI 10.1016/S0031-9422(00)97334-5; Kakarala M, 2010, BREAST CANCER RES TR, V122, P777, DOI 10.1007/s10549-009-0612-x; Khanna V, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-30; Kim SJ, 2010, MOLECULES, V15, P6436, DOI 10.3390/molecules15096436; Koehn FE, 2005, NAT REV DRUG DISCOV, V4, P206, DOI 10.1038/nrd1657; Kuete V, 2010, FRONT PHARMACOL, V1, DOI 10.3389/fphar.2010.00123; Kuete V, 2010, PLANTA MED, V76, P1479, DOI 10.1055/s-0030-1250027; Kuo PL, 2002, LIFE SCI, V71, P1879, DOI 10.1016/S0024-3205(02)01900-8; Lai YL, 2006, MOL CELL BIOCHEM, V292, P45, DOI 10.1007/s11010-006-9175-x; Lam KS, 2007, TRENDS MICROBIOL, V15, P279, DOI 10.1016/j.tim.2007.04.001; Lee MS, 2008, BIOL PHARM BULL, V31, P2154, DOI 10.1248/bpb.31.2154; Li JWH, 2009, SCIENCE, V325, P161, DOI 10.1126/science.1168243; Lino CS, 1997, PHYTOTHER RES, V11, P211, DOI 10.1002/(SICI)1099-1573(199705)11:3<211::AID-PTR72>3.3.CO;2-N; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Lipinski CA, 2000, J PHARMACOL TOX MET, V44, P235, DOI 10.1016/S1056-8719(00)00107-6; Lu CC, 2010, MOL NUTR FOOD RES, V54, P967, DOI 10.1002/mnfr.200900265; Magadula JJ, 2009, NAT PROD REP, V26, P1535, DOI 10.1039/b906089h; Malfait AM, 2000, P NATL ACAD SCI USA, V97, P9561, DOI 10.1073/pnas.160105897; Mbaveng AT, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-83; MORALES A, 1987, J UROLOGY, V137, P1168, DOI 10.1016/S0022-5347(17)44436-3; MUJUMDAR AM, 1990, JPN J MED SCI BIOL, V43, P95, DOI 10.7883/yoken1952.43.95; Mutanyatta J, 2005, TETRAHEDRON, V61, P8475, DOI 10.1016/j.tet.2005.06.055; Newman DJ, 2008, J MED CHEM, V51, P2589, DOI 10.1021/jm0704090; Ngameni B, 2007, ARKIVOC, P116, DOI 10.3998/ark.5550190.0008.d14; Ntie-Kang F, 2013, MALAR J UNPUB; Ntie-Kang F, 2014, RSC ADV, V4, P409, DOI 10.1039/c3ra43754j; Ntie-Kang F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078085; Ntie-Kang F, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-147; Ntie-Kang F, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-88; Onguene PA, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-449; Oprea TI, 2002, J COMPUT AID MOL DES, V16, P325, DOI 10.1023/A:1020877402759; Palomo JM, 2002, ENZYME MICROB TECH, V31, P775, DOI 10.1016/S0141-0229(02)00169-2; Pan L, 2013, FRONT BIOSCI, V4, P142, DOI DOI 10.2741/257; Pecere T, 2000, CANCER RES, V60, P2800; Quinn RJ, 2008, J NAT PROD, V71, P464, DOI 10.1021/np070526y; Ramesh B, 2006, J MED FOOD, V9, P562, DOI 10.1089/jmf.2006.9.562; Ramesh B, 2006, LIFE SCI, V79, P306, DOI 10.1016/j.lfs.2006.01.005; Schneider G, 2002, CURR MED CHEM, V9, P2095, DOI 10.2174/0929867023368755; Schwikkard S, 2002, NAT PROD REP, V19, P675, DOI 10.1039/b008980j; Seo EJ, 2012, J PHARMACOL SCI, V118, P245, DOI 10.1254/jphs.11123FP; Sharma S, 2010, J ANTIMICROB CHEMOTH, V65, P1694, DOI 10.1093/jac/dkq186; Silayo A, 1999, PHYTOCHEMISTRY, V52, P947, DOI 10.1016/S0031-9422(99)00267-8; Silvan AM, 1996, J NAT PROD, V59, P1183, DOI 10.1021/np960422f; Singh R, 2010, FOOD CHEM, V120, P825, DOI 10.1016/j.foodchem.2009.11.022; STARKE K, 1975, EUR J PHARMACOL, V34, P385, DOI 10.1016/0014-2999(75)90268-X; Sunila ES, 2004, J ETHNOPHARMACOL, V90, P339, DOI 10.1016/j.jep.2003.10.016; SUSSET JG, 1989, J UROLOGY, V141, P1360, DOI 10.1016/S0022-5347(17)41308-5; Teague SJ, 1999, ANGEW CHEM INT EDIT, V38, P3743, DOI 10.1002/(SICI)1521-3773(19991216)38:24<3743::AID-ANIE3743>3.0.CO;2-U; Titanji VPK, 2008, AFR J TRADIT COMPLEM, V5, P302; Vasisht K., 2004, COMPENDIUM MED AROMA, V1, P23; Vasisht K, 2002, TRADE PRODUCTION HER, P3; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Volak LP, 2008, DRUG METAB DISPOS, V36, P1594, DOI 10.1124/dmd.108.020552; Yang J, 2010, J ASIAN NAT PROD RES, V12, P185, DOI 10.1080/10286020903427336; Yongye AB, 2012, CHEM BIOL DRUG DES, V80, P717, DOI 10.1111/cbdd.12011; Zofou D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079544; Zofou D, 2013, NAT PROD REP, V30, P1098, DOI 10.1039/c3np70030e; Zofou D, 2012, PARASITOL RES, V110, P539, DOI 10.1007/s00436-011-2519-9; Zuardi AW, 2006, BRAZ J MED BIOL RES, V39, P421, DOI 10.1590/S0100-879X2006000400001	99	42	42	5	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90655	10.1371/journal.pone.0090655	http://dx.doi.org/10.1371/journal.pone.0090655			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599120	Green Published, Green Submitted, gold			2022-12-27	WOS:000332479400109
J	Chen, L; Shi, Y; Yuan, J; Han, YL; Qin, R; Wu, Q; Jia, BQ; Wei, B; Wei, LX; Dai, GH; Jiao, SC				Chen, Li; Shi, Yan; Yuan, Jing; Han, Yalin; Qin, Rui; Wu, Qian; Jia, Baoqing; Wei, Bo; Wei, Lixin; Dai, Guanghai; Jiao, Shunchang			HIF-1 Alpha Overexpression Correlates with Poor Overall Survival and Disease-Free Survival in Gastric Cancer Patients Post-Gastrectomy	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTORS; TRANSFORMING GROWTH-FACTOR-BETA-1; TUMOR ANGIOGENESIS; BREAST-CANCER; GROWTH; METASTASIS; HIF-1-ALPHA; INVASION; EXPRESSION; CELLS	Background: Overall, gastric cancer prognosis remains poor. Detailed characterization of molecular markers that govern gastric cancer pathogenesis is warranted to establish innovative therapeutic options. HIF-1 alpha overexpression has been linked to poor gastric cancer prognosis. However, though researched for years, the prognostic role of HIF-1 alpha in gastric cancer is still controversial. Hence, the objective of the present study was to analyze the prognostic values of HIF-1 alpha, TGF-beta, VEGF and pERK1/2 in gastric cancer patients following gastrectomy. Methods: This study included 446 patients with confirmed gastric cancer who underwent gastrectomy in a single Chinese Cancer Center between 2005 and 2006. Clinicopathologic features, as well as immunohistochemical analysis of TGF-beta, HIF-1 alpha, VEGF and pERK1/2 were determined. Long-term survival of these patients was analyzed using univariate and multivariate analyses. Results: HIF-1 alpha overexpression was more frequent in patients with hepatic metastases (71.6% versus 43.0% in those without hepatic metastases, P = 0.000, chi(2) = 23.086) and more frequent in patients with peritoneum cavity metastasis (62.3% versus 43.0% in those without such metastasis, P = 0.000, chi(2) = 13.691). In univariate analysis, patients with HIF-1 alpha overexpression had a shorter disease-free survival (DFS) and overall survival (OS) than patients with weak-expression (DFS: NA VS. 16.8 m, P = 0.000, chi(2) = 74.937; OS: NA VS. 25.5 m, P = 0.000, chi(2) = 90.594). Importantly, HIF-1 alpha overexpression was a promising prognostic marker for poor survival by multivariate analysis (DFS: HR 2.766, 95% CI 2.136-2.583, P = 0.000; OS: HR 3.529, 95% CI 2.663-4.667, P = 0.000). Conclusions: HIF-1 alpha overexpression could be considered a useful independent prognostic biomarker in gastric cancer after gastrectomy, and is correlated to both a poor overall survival and disease-free survival in these patients. HIF-1 alpha expression can be used to stratify patients at higher risk for poor prognosis, and is potentially an important therapeutic target in gastric cancer patients.	[Chen, Li; Shi, Yan; Han, Yalin; Qin, Rui; Wu, Qian; Dai, Guanghai] Chinese Peoples Liberat Army Gen Hosp, Dept Comprehens Treatment Oncol, Beijing, Peoples R China; [Yuan, Jing; Wei, Lixin] Chinese Peoples Liberat Army Gen Hosp, Dept Pathol, Beijing, Peoples R China; [Jia, Baoqing] Chinese Peoples Liberat Army Gen Hosp, Dept Surg Oncol, Beijing, Peoples R China; [Wei, Bo] Chinese Peoples Liberat Army Gen Hosp, Dept Gen Surg, Beijing, Peoples R China; [Jiao, Shunchang] Chinese Peoples Liberat Army Gen Hosp, Dept Med Oncol, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital	Jiao, SC (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Med Oncol, Beijing, Peoples R China.	jiaosc@vip.sina.com		Shi, Yan/0000-0001-9777-8836	Doctor Fund of People's Liberation Army General Hospital [10BCZ04]	Doctor Fund of People's Liberation Army General Hospital	We are grateful to all the subjects who participated in this study. This study was supported by the Doctor Fund of People's Liberation Army General Hospital (10BCZ04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandyopadhyay A, 2006, CANCER RES, V66, P6714, DOI 10.1158/0008-5472.CAN-05-3565; Brown NS, 2001, BREAST CANCER RES, V3, P323, DOI 10.1186/bcr315; Calon A, 2012, CANCER CELL, V22, P571, DOI 10.1016/j.ccr.2012.08.013; Chen J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066524; Comerci JT, 1996, CANCER, V77, P1107, DOI 10.1002/(SICI)1097-0142(19960315)77:6<1107::AID-CNCR16>3.3.CO;2-A; Dornagafa-Kulawik J, 2006, ARCH IMMUNOL THER EX, V54, P143, DOI 10.1007/s00005-006-0016-0; Ehata S, 2007, CANCER SCI, V98, P127, DOI 10.1111/j.1349-7006.2006.00357.x; Folkman J, 2002, SEMIN ONCOL, V29, P15, DOI 10.1053/sonc.2002.37263; FOLKMAN J, 1974, CANCER RES, V34, P2109; Fu H, 2009, ACTA BIOCH BIOPH SIN, V41, P648, DOI 10.1093/abbs/gmp053; Gu JW, 2013, VASC CELL, V5, DOI 10.1186/2045-824X-5-9; Halon Agnieszka, 2012, ScientificWorldJournal, V2012, P941259, DOI 10.1100/2012/941259; IVANOVIC V, 1995, NAT MED, V1, P282, DOI 10.1038/nm0495-282; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Lin EY, 2007, MOL ONCOL, V1, P288, DOI 10.1016/j.molonc.2007.10.003; Lu X, 2010, CLIN CANCER RES, V16, P5928, DOI 10.1158/1078-0432.CCR-10-1360; Ma GF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054249; Maehara Y, 1999, J CLIN ONCOL, V17, P607, DOI 10.1200/JCO.1999.17.2.607; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; Matsuo Y, 2013, J HEPATOBILIARY PANC, V21, P105, DOI [10.1002/jhbp.6, DOI 10.1002/JHBP.6.[]; Miyake S, 2013, INT J ONCOL, V43, P1431, DOI 10.3892/ijo.2013.2068; Nam SY, 2011, BRIT J CANCER, V104, P166, DOI 10.1038/sj.bjc.6606020; Ottaviano AJ, 2006, CANCER RES, V66, P7032, DOI 10.1158/0008-5472.CAN-05-4421; REMMELE W, 1987, PATHOLOGE, V8, P138; Saito H, 2000, ANTICANCER RES, V20, P4489; Saji Hisashi, 2003, Ann Thorac Cardiovasc Surg, V9, P295; Semenza GL, 2012, TRENDS PHARMACOL SCI, V33, P207, DOI 10.1016/j.tips.2012.01.005; Shimomura M, 2013, ANN SURG ONCOL, V20, pS527, DOI 10.1245/s10434-013-2945-2; Stoeltzing O, 2004, JNCI-J NATL CANCER I, V96, P946, DOI 10.1093/jnci/djh168; Tsai YP, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-102; Wang YX, 2010, CANCER BIOL THER, V10, P376, DOI 10.4161/cbt.10.4.12441; Wei H, 2013, EUR REV MED PHARMACO, V17, P436; Yang Shang-You, 2007, Sarcoma, V2007, P95628, DOI 10.1155/2007/95628; Yeo EJ, 2003, J NATL CANCER I, V95, P516, DOI 10.1093/jnci/95.7.516; Yuan XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065659; Zhang Q, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0070961, DOI 10.1371/J0URNAL.P0NE.0070961]; Zhang ZG, 2013, ASIAN PAC J CANCER P, V14, P4195, DOI 10.7314/APJCP.2013.14.7.4195	39	37	40	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e90678	10.1371/journal.pone.0090678	http://dx.doi.org/10.1371/journal.pone.0090678			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614305	gold, Green Published, Green Submitted			2022-12-27	WOS:000332839300033
J	Chen, YZ; Bogema, DR; Barchia, IM; Herron, GA				Chen, Yizhou; Bogema, Daniel R.; Barchia, Idris M.; Herron, Grant A.			Quantification of the Pirimicarb Resistance Allele Frequency in Pooled Cotton Aphid (Aphis gossypii Glover) Samples by TaqMan SNP Genotyping Assay	PLOS ONE			English	Article							REAL-TIME PCR; POLYMERASE-CHAIN-REACTION; SINGLE-NUCLEOTIDE POLYMORPHISMS; CONFERS INSECTICIDE RESISTANCE; HIGH-THROUGHPUT; DNA; VALIDATION; DROSOPHILA; HEMIPTERA; KINETICS	Background: Pesticide resistance monitoring is a crucial part to achieving sustainable integrated pest management (IPM) in agricultural production systems. Monitoring of resistance in arthropod populations is initially performed by bioassay, a method that detects a phenotypic response to pesticides. Molecular diagnostic assays, offering speed and cost improvements, can be developed when the causative mutation for resistance has been identified. However, improvements to throughput are limited as genotyping methods cannot be accurately applied to pooled DNA. Quantifying an allele frequency from pooled DNA would allow faster and cheaper monitoring of pesticide resistance. Methodology/Principal Findings: We demonstrate a new method to quantify a resistance allele frequency (RAF) from pooled insects via TaqMan assay by using raw fluorescence data to calculate the transformed fluorescence ratio k' at the inflexion point based on a four parameter sigmoid curve. Our results show that k' is reproducible and highly correlated with RAF (r>0.99). We also demonstrate that k' has a non-linear relationship with RAF and that five standard points are sufficient to build a prediction model. Additionally, we identified a non-linear relationship between runs for k', allowing the combination of samples across multiple runs in a single analysis. Conclusions/Significance: The transformed fluorescence ratio (k') method can be used to monitor pesticide resistance in IPM and to accurately quantify allele frequency from pooled samples. We have determined that five standards (0.0, 0.2, 0.5, 0.8, and 1.0) are sufficient for accurate prediction and are statistically-equivalent to the 13 standard points used experimentally	[Chen, Yizhou; Bogema, Daniel R.; Barchia, Idris M.; Herron, Grant A.] NSW Dept Primary Ind, Elizabeth Macarthur Agr Inst, Menangle, NSW, Australia	NSW Department of Primary Industries	Chen, YZ (corresponding author), NSW Dept Primary Ind, Elizabeth Macarthur Agr Inst, Menangle, NSW, Australia.	yizhou.chen@dpi.nsw.gov.au	Chen, Yizhou/K-7095-2012; Bogema, Daniel/ABE-8287-2020; Bogema, Daniel/B-4629-2011; Bogema, Daniel/AAE-2935-2020; Herron, Grant Alexander/H-4413-2012	Chen, Yizhou/0000-0002-1273-0348; Bogema, Daniel/0000-0001-7013-7326; Bogema, Daniel/0000-0001-7013-7326; Bogema, Daniel/0000-0001-7013-7326; Herron, Grant Alexander/0000-0002-9104-6535	CRDC [DAN1203]	CRDC(Cotton R&D Corp)	This study is funded by the CRDC (DAN1203). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews MC, 2004, INSECT MOL BIOL, V13, P555, DOI 10.1111/j.0962-1075.2004.00517.x; Bar T, 2012, NUCLEIC ACIDS RES, V40, P1395, DOI 10.1093/nar/gkr778; BARBAGALLO S., 1997, APHIDS PRINCIPAL FRU; Billard A, 2012, APPL ENVIRON MICROB, V78, P1063, DOI 10.1128/AEM.06957-11; Breen G, 2000, BIOTECHNIQUES, V28, P464, DOI 10.2144/00283st03; Busvine J.R., 1971, CRITICAL REV TECHNIQ; Carr AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037640; Chen J, 2002, CANCER EPIDEM BIOMAR, V11, P131; Daborn PJ, 2002, SCIENCE, V297, P2253, DOI 10.1126/science.1074170; FFRENCHCONSTANT RH, 1993, NATURE, V363, P449, DOI 10.1038/363449a0; FFRENCHCONSTANT RH, 1991, PESTICIDE RESISTANCE, P4; Georghiou G. P., 1983, Pest resistance to pesticides, P1; Germer S, 2000, GENOME RES, V10, P258, DOI 10.1101/gr.10.2.258; Herron GA, 2001, AUST J ENTOMOL, V40, P85, DOI 10.1046/j.1440-6055.2001.00200.x; Johnson MP, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh046; Karlen Y, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-131; Liu WH, 2002, BIOCHEM BIOPH RES CO, V294, P347, DOI 10.1016/S0006-291X(02)00478-3; Mass S, 2012, COTTON PEST MANAGEME; McLoon MO, 2009, AUST J ENTOMOL, V48, P65, DOI 10.1111/j.1440-6055.2008.00685.x; Newcomb RD, 1997, P NATL ACAD SCI USA, V94, P7464, DOI 10.1073/pnas.94.14.7464; Oliver DH, 2000, J MOL DIAGN, V2, P202, DOI 10.1016/S1525-1578(10)60638-1; PAYNE RW, 2007, GENSTAT RELEASE 10 R; Psifidi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014560; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Rutledge RG, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh177; Spiess AN, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-221; Swillens S, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh053; Toda S, 2004, INSECT MOL BIOL, V13, P549, DOI 10.1111/j.0962-1075.2004.00513.x; Weill M, 2002, P ROY SOC B-BIOL SCI, V269, P2007, DOI 10.1098/rspb.2002.2122; Yu AR, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-143; Yu S., 2008, TOXICOLOGY BIOCH INS, DOI 10.1201/9781420059762	31	104	104	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91104	10.1371/journal.pone.0091104	http://dx.doi.org/10.1371/journal.pone.0091104			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614533	gold, Green Published, Green Submitted			2022-12-27	WOS:000332839300075
J	Kraaijenbrink, T; van der Gaag, KJ; Zuniga, SB; Xue, YL; Carvalho-Silva, DR; Tyler-Smith, C; Jobling, MA; Parkin, EJ; Su, B; Shi, H; Xiao, CJ; Tang, WR; Kashyap, VK; Trivedi, R; Sitalaximi, T; Banerjee, J; Gaselo, KTO; Tuladhar, NM; Opgenort, JRML; van Driem, GL; Barbujani, G; de Knijff, P				Kraaijenbrink, Thirsa; van der Gaag, Kristiaan J.; Zuniga, Sofia B.; Xue, Yali; Carvalho-Silva, Denise R.; Tyler-Smith, Chris; Jobling, Mark A.; Parkin, Emma J.; Su, Bing; Shi, Hong; Xiao, Chun-Jie; Tang, Wen-Ru; Kashyap, V. K.; Trivedi, R.; Sitalaximi, T.; Banerjee, Jheelam; Gaselo, Karma Tshering Of; Tuladhar, Nirmal M.; Opgenort, Jean-Robert M. L.; van Driem, George L.; Barbujani, Guido; de Knijff, Peter			A Linguistically Informed Autosomal STR Survey of Human Populations Residing in the Greater Himalayan Region	PLOS ONE			English	Article							ALLELE FREQUENCY-DISTRIBUTION; TIBETO-BURMAN POPULATIONS; MULTILOCUS GENOTYPE DATA; GENETIC-STRUCTURE; DIVERSITY; LOCI; INFERENCE; INDIA; SOUTH; SOFTWARE	The greater Himalayan region demarcates two of the most prominent linguistic phyla in Asia: Tibeto-Burman and Indo-European. Previous genetic surveys, mainly using Y-chromosome polymorphisms and/or mitochondrial DNA polymorphisms suggested a substantially reduced geneflow between populations belonging to these two phyla. These studies, however, have mainly focussed on populations residing far to the north and/or south of this mountain range, and have not been able to study geneflow patterns within the greater Himalayan region itself. We now report a detailed, linguistically informed, genetic survey of Tibeto-Burman and Indo-European speakers from the Himalayan countries Nepal and Bhutan based on autosomal microsatellite markers and compare these populations with surrounding regions. The genetic differentiation between populations within the Himalayas seems to be much higher than between populations in the neighbouring countries. We also observe a remarkable genetic differentiation between the Tibeto-Burman speaking populations on the one hand and Indo-European speaking populations on the other, suggesting that language and geography have played an equally large role in defining the genetic composition of present-day populations within the Himalayas.	[Kraaijenbrink, Thirsa; van der Gaag, Kristiaan J.; Zuniga, Sofia B.; de Knijff, Peter] Leiden Univ, Med Ctr, MGC Dept Human & Clin Genet, Leiden, Netherlands; [Xue, Yali; Carvalho-Silva, Denise R.; Tyler-Smith, Chris] Wellcome Trust Sanger Inst, Hinxton, Cambs, England; [Jobling, Mark A.; Parkin, Emma J.] Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; [Su, Bing; Shi, Hong] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Yunnan, Peoples R China; [Su, Bing; Shi, Hong] Chinese Acad Sci, Kunming Primate Res Ctr, Kunming, Yunnan, Peoples R China; [Xiao, Chun-Jie; Tang, Wen-Ru] Yunnan Univ, Ctr Human Genet, Kunming, Yunnan, Peoples R China; [Kashyap, V. K.; Trivedi, R.; Sitalaximi, T.; Banerjee, Jheelam] Cent Forens Sci Lab, Natl DNA Anal Ctr, Kolkata, India; [Gaselo, Karma Tshering Of; Opgenort, Jean-Robert M. L.; van Driem, George L.] Univ Bern, Sprachwissensch Inst, Himalayan Languages Project, Bern, Switzerland; [Tuladhar, Nirmal M.] Tribhuvan Univ, Ctr Nepal & Asian Studies, Kirtipur, Nepal; [Barbujani, Guido] Univ Ferrara, Dept Life Sci & Biotechnol, I-44100 Ferrara, Italy	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Wellcome Trust Sanger Institute; University of Leicester; Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; Yunnan University; University of Bern; Tribhuvan University; University of Ferrara	de Knijff, P (corresponding author), Leiden Univ, Med Ctr, MGC Dept Human & Clin Genet, Leiden, Netherlands.	knijff@lumc.nl	de Knijff, Peter/Y-2519-2018; Barbujani, Guido/ABE-9998-2020	de Knijff, Peter/0000-0002-0899-771X; Barbujani, Guido/0000-0001-7854-6669; Kraaijenbrink, Thirsa/0000-0002-1771-8401; van Driem, George/0000-0002-7185-0657; Carvalho-Silva, Dr D/0000-0001-5662-1840; Jobling, Mark/0000-0002-8061-1308; van der Gaag, Kristiaan/0000-0001-7976-1977	NWO (Netherlands Organisation for Scientific Research) [231-70-001]; Arts and Humanities Research Board of Great Britain [AN/9585/APN15314]; EC Sixth Framework Programme [ERAS-CT-2003-980409]; Wellcome Trust [WT 098051]; MAJ by a Wellcome Trust Senior Fellowship in Basic Biomedical Science [WT 087576]	NWO (Netherlands Organisation for Scientific Research)(Netherlands Organization for Scientific Research (NWO)); Arts and Humanities Research Board of Great Britain; EC Sixth Framework Programme(European CommissionEuropean Commission Joint Research Centre); Wellcome Trust(Wellcome TrustEuropean Commission); MAJ by a Wellcome Trust Senior Fellowship in Basic Biomedical Science	This work, as part of the European Science Foundation EUROCORES Programme OMLL, was supported by funds from NWO (Netherlands Organisation for Scientific Research, grant no. 231-70-001), the Arts and Humanities Research Board of Great Britain (grant no. AN/9585/APN15314) and the EC Sixth Framework Programme (Contract no. ERAS-CT-2003-980409). YX and CTS are supported by The Wellcome Trust (WT 098051), and MAJ by a Wellcome Trust Senior Fellowship in Basic Biomedical Science (WT 087576). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, GRAPHPAD PRISM 6; Bertoni B., 2014, ADMIX95; Bindu GH, 2007, FORENSIC SCI INT, V170, P76, DOI 10.1016/j.forsciint.2006.04.012; Bindu GH, 2005, J FORENSIC SCI, V50, P978; Bonnet E, 2002, J STAT SOFTW, V7, P1, DOI DOI 10.18637/JSS.V007.I10; Bosch E, 2000, EUR J HUM GENET, V8, P360, DOI 10.1038/sj.ejhg.5200464; Cai XY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024282; Cann HM, 2002, SCIENCE, V296, P261; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Cavalli-Sforza LL, 2005, NAT REV GENET, V6, P333, DOI 10.1038/nrg1579; Chatterji SK, 1926, ORGIN DEV BEGALI LAN; Cordaux R, 2004, MOL BIOL EVOL, V21, P1525, DOI 10.1093/molbev/msh151; Corunet JM, 1996, GENETICS; Duchesne P, 2009, MOL ECOL RESOUR, V9, P1333, DOI 10.1111/j.1755-0998.2009.02571.x; Duchesne P, 2012, J HERED, V103, P734, DOI 10.1093/jhered/ess038; Ersts PJ, 2014, GEOGRAPHIC DISTANCE; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Frasier TR, 2008, MOL ECOL RESOUR, V8, P1263, DOI 10.1111/j.1755-0998.2008.02358.x; Friedlaender JS, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040019; Gaikwad S, 2003, FORENSIC SCI INT, V134, P225, DOI 10.1016/S0379-0738(03)00166-X; Gayden T, 2007, AM J HUM GENET, V80, P884, DOI 10.1086/516757; Gayden T, 2009, J HUM GENET, V54, P216, DOI 10.1038/jhg.2009.14; Gordon R. G., 2005, ETHNOLOGUE LANGUAGES, V15th; Greenhill SJ, 2010, P ROY SOC B-BIOL SCI, V277, P2443, DOI 10.1098/rspb.2010.0051; Hoernle August Friedrich Rudolf, 1880, COMP GRAMMAR GAUDIAN; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Hunley KL, 2009, AM J PHYS ANTHROPOL, V139, P35, DOI 10.1002/ajpa.20932; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Joshi DM, 1975, INDIAN LINGUISTICS, V36, P285; Kang LL, 2012, ANN HUM GENET, V76, P92, DOI 10.1111/j.1469-1809.2011.00690.x; Kashyap VK, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-28; Kashyap VK, 2004, J GENET, V83, P49, DOI 10.1007/BF02715829; Kayser M, 2001, AM J HUM GENET, V68, P990, DOI 10.1086/319510; Kraaijenbrink T, 2007, FORENSIC SCI INT, V168, P227, DOI 10.1016/j.forsciint.2006.02.014; Kraaijenbrink T, 2007, FORENSIC SCI INT, V170, P68, DOI 10.1016/j.forsciint.2006.04.006; Kraaijenbrink T, 2009, BECOMING ELOQUENT: ADVANCES IN THE EMERGENCE OF LANGUAGE, HUMAN COGNITION, AND MODERN CULTURES, P181; Kraaijenbrink T, 2008, FORENSIC SCI INT-GEN, V3, pE11, DOI 10.1016/j.fsigen.2008.02.007; Krithika S, 2006, ANN HUM BIOL, V33, P26, DOI 10.1080/03014460500424043; Lee AC, 2004, EUR J HUM GENET, V12, P1077, DOI 10.1038/sj.ejhg.5201271; LI CC, 1993, HUM HERED, V43, P45, DOI 10.1159/000154113; Majumdar PC, 1979, HIST PHONOLOGY ORIYA; Majumder PP, 2008, CURR OPIN GENET DEV, V18, P280, DOI 10.1016/j.gde.2008.07.003; Manni F, 2004, HUM BIOL, V76, P173, DOI 10.1353/hub.2004.0034; Martinez-Cruz B, 2011, EUR J HUM GENET, V19, P216, DOI 10.1038/ejhg.2010.153; Metspalu M, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-26; Neeta S, 2004, J FORENSIC SCI, V49, P184; Number Cruncher Statistical Software, 1997, US GUID 1 NCSS97 STA; Pandit P.B., 1954, INDIAN LINGUISTICS, V14, P36; PANDIT PB, 1961, LANGUAGE, V37, P54, DOI 10.2307/411249; Pandit PB, 1955, INDIAN LINGUISTICS, V17, P165; Park S.D.E., 2001, TRYPANOTOLERANCE W A; Pattanayak DP, 1966, CONTROLLED HIST RECO; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pritchard JK, 2000, GENETICS, V155, P945; Quintana-Murci L, 2001, AM J HUM GENET, V68, P537, DOI 10.1086/318200; Rajkumar R, 2003, AM J FOREN MED PATH, V24, P187, DOI 10.1097/00000433-200306000-00018; Rousset F, 1997, GENETICS, V145, P1219; Shepard EM, 2006, J HUM GENET, V51, P467, DOI 10.1007/s10038-006-0387-4; Shi H, 2005, AM J HUM GENET, V77, P408, DOI 10.1086/444436; Turner R. L., 1921, J ROY ASIATIC SOC, P329; Turner Ralph Lilley, 1931, COMP ETYMOLOGICAL DI; Turner RL, 1914, J ROY ASIATIC SOC, V1914, P1033; Xue YL, 2006, GENETICS, V172, P2431, DOI 10.1534/genetics.105.054270; Zerjal T, 2002, AM J HUM GENET, V71, P466, DOI 10.1086/342096	67	16	16	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91534	10.1371/journal.pone.0091534	http://dx.doi.org/10.1371/journal.pone.0091534			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614536	gold, Green Submitted, Green Published			2022-12-27	WOS:000332839300135
J	Ng, HY; Yisireyili, M; Saito, S; Lee, CT; Adelibieke, Y; Nishijima, F; Niwa, T				Ng, Hwee-Yeong; Yisireyili, Maimaiti; Saito, Shinichi; Lee, Chien-Te; Adelibieke, Yelixiati; Nishijima, Fuyuhiko; Niwa, Toshimitsu			Indoxyl Sulfate Downregulates Expression of Mas Receptor via OAT3/AhR/Stat3 Pathway in Proximal Tubular Cells	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; CONVERTING ENZYME 2; GENE-EXPRESSION; NITRIC-OXIDE; ANGIOTENSIN-II; PROGRESSION; SENESCENCE; KIDNEY; ACE2; DYSFUNCTION	Renin-angiotensin system (RAS) plays a pivotal role in chronic kidney disease (CKD). Angiotensin converting enzyme-related carboxypeptidase 2 (ACE2)/angiotensin (Ang)-(1-7)/Mas receptor axis counteracts the deleterious actions of Ang II. ACE2 exerts its actions by cleaving Ang II into Ang-(1-7) which activates Mas receptor. This study aimed to determine if the expression of Mas receptor is altered in the kidneys of CKD rats, and if indoxyl sulfate (IS), a uremic toxin, affects the expression of Mas receptor in rat kidneys and cultured human proximal tubular cells (HK-2 cells). The expression of Mas receptor was examined in the kidneys of CKD and AST-120-treated CKD rats using immunohistochemistry. Further, the effects of IS on Mas receptor expression in the kidneys of normotensive and hypertensive rats were examined. The effects of IS on the expression of Mas receptor and phosphorylation of endothelial nitric oxide synthase (eNOS) in HK-2 cells were examined using immunoblotting. CKD rats showed reduced renal expression of Mas receptor, while AST-120 restored its expression. Administration of IS downregulated Mas receptor expression in the kidneys of normotensive and hypertensive rats. IS downregulated Mas receptor expression in HK-2 cells in a time-and dose-dependent manner. Knockdown of organic anion transporter 3 (OAT3), aryl hydrocarbon receptor (AhR), and signal transducer and activator of transcription 3 (Stat3) inhibited IS-induced downregulation of Mas receptor and phosphorylated eNOS. N-acetylcysteine, an antioxidant, also inhibited IS-induced downregulation of Mas receptor and phosphorylated eNOS. Ang-(1-7) attenuated IS-induced transforming growth factor-beta 1 (TGF-beta 1) expression. Conclusion: Mas receptor expression is reduced in the kidneys of CKD rats. IS downregulates renal expression of Mas receptor via OAT3/AhR/Stat3 pathway in proximal tubular cells. IS-induced downregulation of Mas receptor might be involved in upregulation of TGF-beta 1 in proximal tubular cells.	[Ng, Hwee-Yeong; Yisireyili, Maimaiti; Saito, Shinichi; Adelibieke, Yelixiati; Niwa, Toshimitsu] Nagoya Univ, Grad Sch Med, Dept Adv Med Uremia, Nagoya, Aichi 4648601, Japan; [Ng, Hwee-Yeong; Lee, Chien-Te] Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Nephrol, Kaohsiung, Taiwan; [Ng, Hwee-Yeong; Lee, Chien-Te] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Nishijima, Fuyuhiko] Kureha Co, Biomed Res Labs, Tokyo, Japan	Nagoya University; Chang Gung Memorial Hospital; Chang Gung University	Niwa, T (corresponding author), Nagoya Univ, Grad Sch Med, Dept Adv Med Uremia, Nagoya, Aichi 4648601, Japan.	tniwa@med.nagoya-u.ac.jp			Aichi Kidney Foundation; Kureha Corporation, Japan	Aichi Kidney Foundation; Kureha Corporation, Japan	This work was supported by the research grant from Aichi Kidney Foundation, and a grant from Kureha Corporation, Japan. The funder provided support in the form of salaries for FN, but did not have additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of these authors are articulated in the 'author contributions' section.	Adijiang A, 2011, J RENAL NUTR, V21, P105, DOI 10.1053/j.jrn.2010.10.020; Bolati D, 2012, J RENAL NUTR, V22, P176, DOI 10.1053/j.jrn.2011.10.015; Pinheiro SVB, 2012, INT J HYPERTENS, V2012, DOI 10.1155/2012/414128; de Godoy MAF, 2012, INT J HYPERTENS, V2012, DOI 10.1155/2012/121740; Enomoto A, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000022017.96399.B2; Esteban V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005406; Gondouin B, 2013, KIDNEY INT, V84, P733, DOI 10.1038/ki.2013.133; Hankinson O, 2005, ARCH BIOCHEM BIOPHYS, V433, P379, DOI 10.1016/j.abb.2004.09.031; Hayashi T, 2006, P NATL ACAD SCI USA, V103, P17018, DOI 10.1073/pnas.0607873103; Ishimura T, 2002, TRANSPLANT INT, V15, P635, DOI 10.1007/s00147-002-0473-2; Soler MJ, 2013, NEPHROL DIAL TRANSPL, V28, P2687, DOI 10.1093/ndt/gft320; Katovich MJ, 2008, CURR HYPERTENS REP, V10, P227, DOI 10.1007/s11906-008-0043-9; Koka V, 2008, AM J PATHOL, V172, P1174, DOI 10.2353/ajpath.2008.070762; Li YW, 2009, HYPERTENS RES, V32, P369, DOI 10.1038/hr.2009.25; Manucha W, 2004, KIDNEY INT, V65, P2091, DOI 10.1111/j.1523-1755.2004.00643.x; Miyazaki T, 2000, NEPHROL DIAL TRANSPL, V15, P1773, DOI 10.1093/ndt/15.11.1773; Nadarajah R, 2012, KIDNEY INT, V82, P292, DOI 10.1038/ki.2012.83; Ng HY, 2011, AM J NEPHROL, V34, P55, DOI 10.1159/000328742; Niwa T, 1997, KIDNEY INT, V52, pS23; NIWA T, 1994, J LAB CLIN MED, V124, P96; Niwa T, 2010, J RENAL NUTR, V20, pS2, DOI 10.1053/j.jrn.2010.05.002; Palm F, 2010, AM J PHYSIOL-RENAL, V299, pF380, DOI 10.1152/ajprenal.00175.2010; Patel RD, 2009, LAB INVEST, V89, P695, DOI 10.1038/labinvest.2009.24; Pinheiro SVB, 2009, KIDNEY INT, V75, P1184, DOI 10.1038/ki.2009.61; Plato CF, 2000, HYPERTENSION, V35, P319, DOI 10.1161/01.HYP.35.1.319; Quintana FJ, 2013, IMMUNOLOGY, V138, P183, DOI 10.1111/imm.12046; RAIJ L, 1995, KIDNEY INT, V48, P20, DOI 10.1038/ki.1995.262; Ruster C, 2006, J AM SOC NEPHROL, V17, P2985, DOI 10.1681/ASN.2006040356; Santos RAS, 2013, J ENDOCRINOL, V216, pR1, DOI 10.1530/JOE-12-0341; Shimizu H, 2013, AM J PHYSIOL-CELL PH, V304, pC685, DOI 10.1152/ajpcell.00236.2012; Shimizu H, 2012, AM J NEPHROL, V36, P184, DOI 10.1159/000341515; Shimizu H, 2010, AM J PHYSIOL-CELL PH, V299, pC1110, DOI 10.1152/ajpcell.00217.2010; Silva ACSE, 2013, BRIT J PHARMACOL, V169, P477, DOI 10.1111/bph.12159; Sun CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034026; Tassone EJ, 2013, CARDIOVASC RES, V99, P129, DOI 10.1093/cvr/cvt065; Velkoska E, 2011, CLIN SCI, V120, P335, DOI 10.1042/CS20100280; Wang H, 2002, HYPERTENSION, V39, P662, DOI 10.1161/hy0202.103470	37	35	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91517	10.1371/journal.pone.0091517	http://dx.doi.org/10.1371/journal.pone.0091517			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614509	gold, Green Published, Green Submitted			2022-12-27	WOS:000332839300134
J	Unates, DR; Guidobaldi, HA; Gatica, LV; Cubilla, MA; Teves, ME; Moreno, A; Giojalas, LC				Rafael Unates, Diego; Alejandro Guidobaldi, Hector; Virginia Gatica, Laura; Angelica Cubilla, Marisa; Eugenia Teves, Maria; Moreno, Ayelen; Cecilia Giojalas, Laura			Versatile Action of Picomolar Gradients of Progesterone on Different Sperm Subpopulations	PLOS ONE			English	Article							CAPACITATED HUMAN SPERMATOZOA; IN-VITRO FERTILIZATION; ACROSOME REACTION; ZONA-PELLUCIDA; MOUSE SPERMATOZOA; CALCIUM-CHANNELS; FOLLICULAR-FLUID; CUMULUS CELLS; OOCYTE; ACTIVATION	High step concentrations of progesterone may stimulate various sperm physiological processes, such as priming and the acrosome reaction. However, approaching the egg, spermatozoa face increasing concentrations of the hormone, as it is secreted by the cumulus cells and then passively diffuses along the cumulus matrix and beyond. In this context, several questions arise: are spermatozoa sensitive to the steroid gradients as they undergo priming and the acrosome reaction? If so, what are the functional gradual concentrations of progesterone? Do spermatozoa in different physiological states respond differentially to steroid gradients? To answer these questions, spermatozoa were confronted with progesterone gradients generated by different hormone concentrations (1 pM to 100 mu M). Brief exposure to a 10 pM progesterone gradient stimulated priming for the acrosome reaction in one sperm subpopulation, and simultaneously induced the acrosome reaction in a different sperm subpopulation. This effect was not observed in non-capacitated cells or when progesterone was homogeneously distributed. The results suggest a versatile role of the gradual distribution of very low doses of progesterone, which selectively stimulate the priming and the acrosome reaction in different sperm subpopulations.	[Cecilia Giojalas, Laura] Ctr Biol Celular & Mol UNC, Cordoba, Argentina; Inst Invest Biol & Tecnol UNC CONICET, Cordoba, Argentina		Giojalas, LC (corresponding author), Ctr Biol Celular & Mol UNC, Cordoba, Argentina.	lcgiojalas@com.uncor.edu	Teves, Maria/AAJ-9523-2020; Guidobaldi, Héctor Alejandro/K-6724-2017	Teves, Maria/0000-0001-7035-2202; Guidobaldi, Héctor Alejandro/0000-0002-5033-2981; Moreno, Ayelen/0000-0001-6810-6475; Giojalas, Laura/0000-0002-1036-1251; Cubilla, Marisa Angelica/0000-0002-9862-8933	Fondo para la Investigacion Cientifica y Tecnologica; Consejo Nacional de Investigaciones Cientificas y Tecnicas from Argentina; Universidad Nacional de Cordoba [38062-2005]	Fondo para la Investigacion Cientifica y Tecnologica; Consejo Nacional de Investigaciones Cientificas y Tecnicas from Argentina; Universidad Nacional de Cordoba	Fondo para la Investigacion Cientifica y Tecnologica, #38062-2005 by Universidad Nacional de Cordoba and Consejo Nacional de Investigaciones Cientificas y Tecnicas from Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Haila A, 2003, HISTOCHEM CELL BIOL, V119, P179, DOI 10.1007/s00418-003-0504-9; Aitken R J, 2007, Soc Reprod Fertil Suppl, V63, P273; Aitken RJ, 2013, MOL HUM REPROD, V19, P785, DOI 10.1093/molehr/gat067; Alasmari W, 2013, J BIOL CHEM, V288, P6248, DOI 10.1074/jbc.M112.439356; Guidobaldi HA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003040; Avella MA, 2013, MOL HUM REPROD, V19, P279, DOI 10.1093/molehr/gat004; BALDI E, 1991, J ANDROL, V12, P323; Baldi E, 2009, MOL CELL ENDOCRINOL, V308, P39, DOI 10.1016/j.mce.2009.02.006; Blengini CS, 2011, ASIAN J ANDROL, V13, P769, DOI 10.1038/aja.2011.27; Bonaccorsi L, 2001, INT J ANDROL, V24, P341, DOI 10.1046/j.1365-2605.2001.00313.x; Bronson RA, 1999, MOL HUM REPROD, V5, P507, DOI 10.1093/molehr/5.6.507; CARDULLO RA, 2002, FERTILIZATION, P57; CarverWard JA, 1996, HUM REPROD, V11, P121; COHENDAYAG A, 1995, P NATL ACAD SCI USA, V92, P11039, DOI 10.1073/pnas.92.24.11039; Costello S, 2009, REPRODUCTION, V138, P425, DOI 10.1530/REP-09-0134; Darszon A, 2011, PHYSIOL REV, V91, P1305, DOI 10.1152/physrev.00028.2010; DASGUPTA S, 1994, HUM REPROD, V9, P2103, DOI 10.1093/oxfordjournals.humrep.a138400; de Lamirande E, 1998, J ANDROL, V19, P215; Eisenbach M, 2006, NAT REV MOL CELL BIO, V7, P276, DOI 10.1038/nrm1893; Eisenbach M, 1999, REV REPROD, V4, P56, DOI 10.1530/revreprod/4.1.56; Emiliozzi C, 1996, INT J ANDROL, V19, P39, DOI 10.1111/j.1365-2605.1996.tb00433.x; Teves ME, 2010, FERTIL STERIL, V93, P2450, DOI 10.1016/j.fertnstert.2009.09.012; Fabro G, 2002, BIOL REPROD, V67, P1565, DOI 10.1095/biolreprod.102.006395; Familiari G, 1996, MOL REPROD DEV, V43, P392, DOI 10.1002/(SICI)1098-2795(199603)43:3<392::AID-MRD14>3.0.CO;2-3; FORESTA C, 1992, ANDROLOGIA, V24, P33; Francavilla F, 2002, INT J ANDROL, V25, P106, DOI 10.1046/j.1365-2605.2002.00333.x; Garcia MA, 1999, J ANDROL, V20, P88; Gatica LV, 2013, MOL HUM REPROD, V19, P559, DOI 10.1093/molehr/gat037; Giojalas LC, 2004, FERTIL STERIL, V82, P247, DOI 10.1016/j.fertnstert.2003.11.046; Harper CV, 2005, HUM REPROD, V20, P2675, DOI 10.1093/humrep/dei158; Harper CV, 2004, J BIOL CHEM, V279, P46315, DOI 10.1074/jbc.M401194200; Inoue N, 2011, P NATL ACAD SCI USA, V108, P20008, DOI 10.1073/pnas.1116965108; Jin M, 2011, P NATL ACAD SCI USA, V108, P4892, DOI 10.1073/pnas.1018202108; KAY VJ, 1994, HUM REPROD, V9, P2318, DOI 10.1093/oxfordjournals.humrep.a138445; Keenan TM, 2008, LAB CHIP, V8, P34, DOI 10.1039/b711887b; Kirkman-Brown JC, 2000, DEV BIOL, V222, P326, DOI 10.1006/dbio.2000.9729; Larson JL, 1999, MOL REPROD DEV, V52, P445, DOI 10.1002/(SICI)1098-2795(199904)52:4&lt;445::AID-MRD14&gt;3.0.CO;2-6; Lishko PV, 2011, NATURE, V471, P387, DOI 10.1038/nature09767; Nishigaki T, 2006, BIOTECHNIQUES, V41, P191, DOI 10.2144/000112220; Oren-Benaroya R, 2007, HUM REPROD, V22, P2947, DOI 10.1093/humrep/dem273; OSMAN RA, 1989, BIOCHEM BIOPH RES CO, V160, P828, DOI 10.1016/0006-291X(89)92508-4; Park KH, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001595; Ren DJ, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002102; ROLDAN ERS, 1994, SCIENCE, V266, P1578, DOI 10.1126/science.7985030; SABEUR K, 1995, J ANDROL, V16, P266; Sabeur K, 1996, BIOL REPROD, V54, P993, DOI 10.1095/biolreprod54.5.993; Sagare-Patil V, 2012, INT J ANDROL, V35, P633, DOI 10.1111/j.1365-2605.2012.01291.x; Schuffner AA, 2002, MOL HUM REPROD, V8, P722, DOI 10.1093/molehr/8.8.722; Strunker T, 2011, NATURE, V471, P382, DOI 10.1038/nature09769; SUELDO CE, 1993, FERTIL STERIL, V60, P137; TESARIK J, 1988, FERTIL STERIL, V50, P133; TESARIK J, 1990, DEVELOPMENT, V110, P391; Tesarik J, 1996, MOL HUM REPROD, V2, P225, DOI 10.1093/molehr/2.4.225; Teves ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008211; Teves ME, 2006, FERTIL STERIL, V86, P745, DOI 10.1016/j.fertnstert.2006.02.080; Thundathil J, 2002, MOL HUM REPROD, V8, P811, DOI 10.1093/molehr/8.9.811; Tsai PS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011204; UHLER ML, 1992, FERTIL STERIL, V58, P1191; VANDERHYDEN BC, 1995, BIOL REPROD, V53, P1243, DOI 10.1095/biolreprod53.6.1243; Wassarman PM, 2008, J BIOL CHEM, V283, P24285, DOI 10.1074/jbc.R800027200; World Health Organization (WHO), 2021, WHO LAB MAN EX PROC, V6th, DOI DOI 10.HTTP://WHQLIBD0C.WH0.INT/PUBLICATI0NS/2010/9789241547789_; Yamashita Y, 2003, BIOL REPROD, V68, P1193, DOI 10.1095/biolreprod.102.010934; Yanagimachi R, 1994, PHYSL REPRODUCTION, V1, P189	63	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91181	10.1371/journal.pone.0091181	http://dx.doi.org/10.1371/journal.pone.0091181			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614230	Green Published, gold, Green Submitted			2022-12-27	WOS:000332839300091
J	Carciofo, R; Du, F; Song, N; Zhang, K				Carciofo, Richard; Du, Feng; Song, Nan; Zhang, Kan			Mind Wandering, Sleep Quality, Affect and Chronotype: An Exploratory Study	PLOS ONE			English	Article							DAYTIME SLEEPINESS; OLDER-ADULTS; CIRCADIAN PREFERENCE; MINDFULNESS; LIFE; CONSEQUENCES; PATTERNS; INSOMNIA; CHINESE; THOUGHT	Poor sleep quality impairs cognition, including executive functions and concentration, but there has been little direct research on the relationships between sleep quality and mind wandering or daydreaming. Evening chronotype is associated with poor sleep quality, more mind wandering and more daydreaming; negative affect is also a mutual correlate. This exploratory study investigated how mind wandering and daydreaming are related to different aspects of sleep quality, and whether sleep quality influences the relationships between mind wandering/daydreaming and negative affect, and mind wandering/daydreaming and chronotype. Three surveys (Ns = 213; 190; 270) were completed with Chinese adults aged 1850, including measures of sleep quality, daytime sleepiness, mind wandering, daydreaming, chronotype and affect (positive and negative). Higher frequencies of mind wandering and daydreaming were associated with poorer sleep quality, in particular with poor subjective sleep quality and increased sleep latency, night-time disturbance, daytime dysfunction and daytime sleepiness. Poor sleep quality was found to partially mediate the relationships between daydreaming and negative affect, and mind wandering and negative affect. Additionally, low positive affect and poor sleep quality, in conjunction, fully mediated the relationships between chronotype and mind wandering, and chronotype and daydreaming. The relationships between mind wandering/daydreaming and positive affect were also moderated by chronotype, being weaker in those with a morning preference. Finally, while daytime sleepiness was positively correlated with daydream frequency, it was negatively correlated with a measure of problem-solving daydreams, indicating that more refined distinctions between different forms of daydreaming or mind wandering are warranted. Overall, the evidence is suggestive of a bi-directional relationship between poor sleep quality and mind wandering/daydreaming, which may be important in attempts to deal with sleep problems and improve sleep quality. These findings and further research on this topic may also have implications for definitions and theories of mind wandering and daydreaming.	[Carciofo, Richard; Du, Feng; Zhang, Kan] Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China; [Carciofo, Richard] Chinese Acad Sci, Grad Univ, Coll Humanities & Social Sci, Beijing, Peoples R China; [Song, Nan] Beijing Foreign Studies Univ, Training Coll, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Beijing Foreign Studies University	Du, F (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China.	duf@psych.ac.cn		Du, Feng/0000-0002-5900-8002	National Natural Science Foundation of China [31200766, 91124003]; Chinese Academy of Sciences [KJZD-EW-L04]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	This study was supported by grants from the National Natural Science Foundation of China (No. 31200766 and 91124003) and the key project of the Chinese Academy of Sciences (KJZD-EW-L04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAN A, 1991, PERS INDIV DIFFER, V12, P241, DOI 10.1016/0191-8869(91)90110-W; Adan A, 2012, CHRONOBIOL INT, V29, P1153, DOI 10.3109/07420528.2012.719971; Akerstedt T, 2007, PHYSIOL BEHAV, V90, P209, DOI 10.1016/j.physbeh.2006.09.007; Alapin I, 2000, J PSYCHOSOM RES, V49, P381, DOI 10.1016/S0022-3999(00)00194-X; Alhola Paula, 2007, Neuropsychiatr Dis Treat, V3, P553; ANTROBUS JS, 1966, PERCEPT MOTOR SKILL, V23, P399, DOI 10.2466/pms.1966.23.2.399; Barclay NL, 2010, CHRONOBIOL INT, V27, P278, DOI 10.3109/07420521003663801; Biss RK, 2012, EMOTION, V12, P437, DOI 10.1037/a0027071; Bixler EO, 2005, J CLIN ENDOCR METAB, V90, P4510, DOI 10.1210/jc.2005-0035; Braboszcz C, 2011, NEUROIMAGE, V54, P3040, DOI 10.1016/j.neuroimage.2010.10.008; Brown KW, 2003, J PERS SOC PSYCHOL, V84, P822, DOI 10.1037/0022-3514.84.4.822; Buysse DJ, 2008, J CLIN SLEEP MED, V4, P563; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Carciofo R, 2014, BIOL RHYTHM RES, V45, P37, DOI 10.1080/09291016.2013.790651; Carciofo R, 2012, SLEEP BIOL RHYTHMS, V10, P310, DOI 10.1111/j.1479-8425.2012.00577.x; Cheng SH, 2012, PSYCHIAT RES, V197, P270, DOI 10.1016/j.psychres.2011.08.011; Chung KF, 2008, SLEEP, V31, P185, DOI 10.1093/sleep/31.2.185; Curcio G, 2006, SLEEP MED REV, V10, P323, DOI 10.1016/j.smrv.2005.11.001; Durmer JS, 2005, SEMIN NEUROL, V25, P117, DOI 10.1055/s-0029-1237117; Fernandez-Mendoza J, 2010, SLEEP BIOL RHYTHMS, V8, P52, DOI 10.1111/j.1479-8425.2010.00430.x; Franklin MS, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00583; GIAMBRA LM, 1974, INT J AGING HUM DEV, V5, P115, DOI 10.2190/7AEJ-T3MA-QLGD-CCF5; GIAMBRA LM, 1978, J CLIN PSYCHOL, V34, P14; GIAMBRA LM, 1989, PSYCHOL AGING, V4, P136, DOI 10.1037/0882-7974.4.2.136; Giannotti F, 2002, J SLEEP RES, V11, P191, DOI 10.1046/j.1365-2869.2002.00302.x; Grossman P, 2011, CONTEMP BUDDHISM, V12, P219, DOI 10.1080/14639947.2011.564841; Harvey AG, 2002, BEHAV RES THER, V40, P267, DOI 10.1016/S0005-7967(01)00012-2; Harvey AG, 2005, CLIN PSYCHOL REV, V25, P593, DOI 10.1016/j.cpr.2005.04.005; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; Howell AJ, 2008, PERS INDIV DIFFER, V45, P773, DOI 10.1016/j.paid.2008.08.005; [黄丽 Huang Li], 2003, [中国心理卫生杂志, Chinese Mental Health Journal], V17, P54; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Johns MW, 2000, J SLEEP RES, V9, P5, DOI 10.1046/j.1365-2869.2000.00177.x; Johnson EO, 2006, J PSYCHIATR RES, V40, P700, DOI 10.1016/j.jpsychires.2006.07.008; Kenney SR, 2012, ADDICT BEHAV, V37, P507, DOI 10.1016/j.addbeh.2012.01.006; Killgore WDS, 2012, NEUROREPORT, V23, P741, DOI 10.1097/WNR.0b013e3283565056; Killingsworth MA, 2010, SCIENCE, V330, P932, DOI 10.1126/science.1192439; Klinger E, 1999, AT PLAY IN THE FIELDS OF CONSCIOUSNESS, P29; Klinger E., 1978, STREAM CONSCIOUSNESS, P225, DOI [10.1007/978-1-4684-2466-9_9, DOI 10.1007/978-1-4684-2466-9_9]; KUNZENDORF R, 1983, PSYCHOL REP, V53, P406, DOI 10.2466/pr0.1983.53.2.406; Levinson DB, 2012, PSYCHOL SCI, V23, P375, DOI 10.1177/0956797611431465; Li SX, 2011, SLEEP BIOL RHYTHMS, V9, P19, DOI 10.1111/j.1479-8425.2010.00480.x; Liu X., 1996, CHIN J PSYCHIAT, V29, P103; Lund HG, 2010, J ADOLESCENT HEALTH, V46, P124, DOI 10.1016/j.jadohealth.2009.06.016; Mallis MM, 2008, NEUROERGONOMICS BRAI, P207; Mar RA, 2012, CONSCIOUS COGN, V21, P401, DOI 10.1016/j.concog.2011.08.001; Marchetti I, 2012, CONSCIOUS COGN, V21, P1517, DOI 10.1016/j.concog.2012.05.013; Mason MF, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00477; McMillan RL, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00626; Mcvay JC, 2010, PSYCHOL BULL, V136, P188, DOI 10.1037/a0018298; McVay JC, 2009, PSYCHON B REV, V16, P857, DOI 10.3758/PBR.16.5.857; MIKULINCER M, 1990, PSYCHOL RES-PSYCH FO, V52, P80, DOI 10.1007/BF00867216; Mooneyham BW, 2013, CAN J EXP PSYCHOL, V67, P11, DOI 10.1037/a0031569; Mrazek MD, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00560; Mrazek MD, 2012, EMOTION, V12, P442, DOI 10.1037/a0026678; Norlander T, 2005, SOC BEHAV PERSONAL, V33, P709, DOI 10.2224/sbp.2005.33.7.709; Ong JC, 2009, EXPLORE-NY, V5, P30, DOI 10.1016/j.explore.2008.10.004; Ottaviani C, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00524; Ottaviani C, 2013, BIOL PSYCHOL, V94, P38, DOI 10.1016/j.biopsycho.2013.05.003; Peng Li-Li, 2011, Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V46, P44; Poerio GL, 2013, CONSCIOUS COGN, V22, P1412, DOI 10.1016/j.concog.2013.09.012; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Pritzl T. J, 2003, EFFECT EXPT ENHANCED; Riemann D, 2010, SLEEP MED REV, V14, P19, DOI 10.1016/j.smrv.2009.04.002; Sayette MA, 2009, PSYCHOL SCI, V20, P747, DOI 10.1111/j.1467-9280.2009.02351.x; Schooler JW, 2011, TRENDS COGN SCI, V15, P319, DOI 10.1016/j.tics.2011.05.006; Selvi Y, 2012, SLEEP BIOL RHYTHMS, V10, P14, DOI 10.1111/j.1479-8425.2011.00511.x; Sheehan, 1972, FUNCTION NATURE IMAG, P175; SINGER J L, 1963, Percept Mot Skills, V17, P187; Singer J.L., 1966, DAYDREAMING INTRO EX; Singer JL, 1978, STREAM CONSCIOUSNESS, P187; Smallwood J, 2007, COGNITION EMOTION, V21, P816, DOI 10.1080/02699930600911531; Smallwood J, 2006, PSYCHOL BULL, V132, P946, DOI 10.1037/0033-2909.132.6.946; Smallwood J, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00441; Smallwood J, 2013, PSYCHOL BULL, V139, P519, DOI 10.1037/a0030010; Smallwood J, 2010, PSYCHOL BULL, V136, P202, DOI 10.1037/a0018673; Smallwood J, 2009, EMOTION, V9, P271, DOI 10.1037/a0014855; Song XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044423; Stawarczyk D, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00363; Suen LKP, 2008, CHRONOBIOL INT, V25, P760, DOI 10.1080/07420520802397186; Sukegawa M, 2009, BIOL RHYTHM RES, V40, P121, DOI 10.1080/09291010701794404; Taillard J, 1999, J SLEEP RES, V8, P291, DOI 10.1046/j.1365-2869.1999.00176.x; Vardar E, 2008, BIOL RHYTHM RES, V39, P493, DOI 10.1080/09291010701736884; Verlander LA, 1999, PERCEPT MOTOR SKILL, V88, P893, DOI 10.2466/pms.1999.88.3.893; Vitiello MV, 2009, CURR DIR PSYCHOL SCI, V18, P316, DOI 10.1111/j.1467-8721.2009.01659.x; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Wittmann M, 2006, CHRONOBIOL INT, V23, P497, DOI 10.1080/07420520500545979; Zoccola PM, 2009, PSYCHOSOM MED, V71, P771, DOI 10.1097/PSY.0b013e3181ae58e8	89	51	51	5	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91285	10.1371/journal.pone.0091285	http://dx.doi.org/10.1371/journal.pone.0091285			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC4IY	24609107	gold, Green Published, Green Submitted			2022-12-27	WOS:000332485800122
J	Chiang, TY; Kuo, MC; Chen, CH; Yang, JY; Kao, CF; Ji, DD; Fang, CT				Chiang, Ting-Yi; Kuo, Ming-Chu; Chen, Chang-Hsun; Yang, Jyh-Yuan; Kao, Cheng-Feng; Ji, Dar-Der; Fang, Chi-Tai			Risk Factors for Acute Toxoplasma gondii Diseases in Taiwan: A Population-Based Case-Control Study	PLOS ONE			English	Article							PREGNANT-WOMEN; INFECTION; SEROPREVALENCE; SEROEPIDEMIOLOGY; TRANSMISSION; ETHIOPIA; CATS	Although human toxoplasmosis is a notifiable disease in Taiwan since 2007, little is known about its risk factors. This study aimed to investigate the risk factors for acute Toxoplasma gondii diseases in Taiwan. We conducted a nationwide population-based case-control study. Cases of acute human toxoplasmosis notified to the Taiwan Centers for Diseases Control (Taipei, Taiwan) during 2008-2013 were compared with controls that were randomly selected from healthy T. gondii-seronegative blood donors who participated in a nationwide T. gondii seroepidemiologic study during 2009-2010. Cases and controls were matched according to age, gender and residency at an 1: 8 ratio. Structured questionnaires were used to gather information regarding risk factors. A total of 30 laboratory-confirmed acute T. gondii disease cases and 224 controls were enrolled. The most common clinical manifestation of the cases was flu-like symptoms (n = 20), followed by central nervous system disease (n = 4), ocular diseases (n = 3), abortion (n = 2), and congenital infection (n = 1). Multivariate conditional logistic regression showed that raw clam consumption (adjusted odds ratio [OR] = 3.7; 95% confidence interval [CI] = 1.4-9.9) and having a cat in the household (adjusted OR = 2.9; 95% CI = 1.1-7.9) were two independent risk factors for acute T. gondii disease. We conclude that raw shellfish consumption and domestic cat exposure were risk factors for acquiring acute T. gondii diseases in Taiwan. This finding may guide future research and control policies.	[Chiang, Ting-Yi; Kuo, Ming-Chu; Yang, Jyh-Yuan; Kao, Cheng-Feng; Ji, Dar-Der] Minist Hlth & Welf, Ctr Dis Control, Ctr Res Diagnost & Vaccine Dev, Taipei, Taiwan; [Chiang, Ting-Yi; Fang, Chi-Tai] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Chen, Chang-Hsun] Minist Hlth & Welf, Ctr Dis Control, Div HIV AIDS & TB, Taipei, Taiwan; [Ji, Dar-Der] Natl Yang Ming Univ, Dept Trop Med, Taipei 112, Taiwan; [Fang, Chi-Tai] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Fang, Chi-Tai] Minist Hlth & Welf, Taipei, Taiwan; [Fang, Chi-Tai] Natl Taiwan Univ, Infect Dis Res & Educ Ctr, Taipei 10764, Taiwan	Centers For Disease Control - Taiwan; National Taiwan University; Centers For Disease Control - Taiwan; National Yang Ming Chiao Tung University; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Ji, DD (corresponding author), Minist Hlth & Welf, Ctr Dis Control, Ctr Res Diagnost & Vaccine Dev, Taipei, Taiwan.	jidarder@cdc.gov.tw; fangct@ntu.edu.tw	Fang, Chi-Tai/P-2908-2016	Fang, Chi-Tai/0000-0002-7380-1699	Centers for Disease Control, Ministry of Health and Welfare, Taiwan	Centers for Disease Control, Ministry of Health and Welfare, Taiwan	This work was supported by the Centers for Disease Control, Ministry of Health and Welfare, Taiwan. The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript, but did have a role in data collection.	Alvarado-Esquivel C, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-75; [Anonymous], 1992, MMWR Recomm Rep, V41, P1; [Anonymous], ANIM HLTH RES REV, V6, P41; Baril L, 1999, SCAND J INFECT DIS, V31, P305, DOI 10.1080/00365549950163626; Bowie WR, 1997, LANCET, V350, P173, DOI 10.1016/S0140-6736(96)11105-3; Buffolano W, 1996, EPIDEMIOL INFECT, V116, P347, DOI 10.1017/S0950268800052675; Centers for Disease Control Department of Health R.O.C., 2010, GUID NOT COMM DIS SU; Chiang TY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048139; Cook AJC, 2000, BRIT MED J, V321, P142, DOI 10.1136/bmj.321.7254.142; Dattoli VCC, 2011, J PARASITOL, V97, P1080, DOI 10.1645/GE-2836.1; Derouin F, 2008, CLIN MICROBIOL INFEC, V14, P1089, DOI 10.1111/j.1469-0691.2008.02091.x; Dubey JP, 2004, VET PARASITOL, V126, P57, DOI 10.1016/j.vetpar.2004.09.005; DUBEY JP, 1972, J PROTOZOOL, V19, P155, DOI 10.1111/j.1550-7408.1972.tb03431.x; Edvinsson B, 2006, CLIN MICROBIOL INFEC, V12, P131, DOI 10.1111/j.1469-0691.2005.01332.x; Fan CK, 2002, J PARASITOL, V88, P411, DOI 10.1645/0022-3395(2002)088[0411:SOTGIA]2.0.CO;2; Fan CK, 1998, JPN J MED SCI BIOL, V51, P35, DOI 10.7883/yoken1952.51.35; FRENKEL JK, 1970, SCIENCE, V167, P893, DOI 10.1126/science.167.3919.893; Havelaar AH, 2007, CLIN INFECT DIS, V44, P1467, DOI 10.1086/517511; Jones JL, 2009, CLIN INFECT DIS, V49, P878, DOI 10.1086/605433; Kolbekova P, 2007, CLIN MICROBIOL INFEC, V13, P1012, DOI 10.1111/j.1469-0691.2007.01771.x; Lin YL, 2008, PARASITOL RES, V103, P67, DOI 10.1007/s00436-008-0928-1; Lopes AP, 2012, EPIDEMIOL INFECT, V140, P872, DOI 10.1017/S0950268811001658; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Pappas G, 2009, INT J PARASITOL, V39, P1385, DOI 10.1016/j.ijpara.2009.04.003; Putignani L, 2011, EXP PARASITOL, V127, P409, DOI 10.1016/j.exppara.2010.09.007; Remington JS, 2001, INFECT DIS FETUS NEW, pXiv; Robert-Gangneux F, 2012, CLIN MICROBIOL REV, V25, P264, DOI 10.1128/CMR.05013-11; SIEGEL SE, 1971, BLOOD-J HEMATOL, V37, P388, DOI 10.1182/blood.V37.4.388.388; Walle F, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-15; Zemene E, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-337	30	32	32	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90880	10.1371/journal.pone.0090880	http://dx.doi.org/10.1371/journal.pone.0090880			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24609112	Green Submitted, gold, Green Published			2022-12-27	WOS:000332485800063
J	Gordoa, A; Carreras, G				Gordoa, Ana; Carreras, Gustavo			Determination of Temporal Spawning Patterns and Hatching Time in Response to Temperature of Atlantic Bluefin Tuna (Thunnus thynnus) in the Western Mediterranean	PLOS ONE			English	Article							PELAGIA-NOCTILUCA CNIDARIA; GULF-OF-MEXICO; POPULATION-STRUCTURE; YELLOWFIN TUNA; BIRTH DATE; EASTERN; L.; SEA; MIGRATION; DIET	This study analysed the temporal pattern of Atlantic bluefin tuna (ABFT) spawning in the Balearic spawning ground and examined its reproductive performance after years in captivity. Furthermore, ABFT hatching time at different on-site temperatures was determined for the first time. Spawning surveys carried out in 4 spawning seasons (2009-2012) aboard tuna transport vessels. Three groups of spawners were monitored: a captive group transported to the spawning region and monitored throughout the four spawning seasons and two wild groups caught in 2009 and 2010 which were transferred to a monitoring transport cage immediately after being caught. Surface plankton samples were collected nightly, beginning immediately after the first purse seine catches were made and concluding after spawning was observe have ended. All groups displayed the same spawning hours, restricted between 2:00-5:00 a.m. The captive group, as they got older, shifted towards the earliest hour, suggesting an age influence on reproductive time. The onset of spawning varied annually from the end of May to the at temperatures around 19 degrees C-20 degrees C ending by weak of July. The peak of spawning was consistently around the um er solstice, June negative effect of unstable oceanographic conditions in the spawning process which productive success of ABFT. The influence of temperature on hatching time was higher species, twice as fast at 26 degrees C (23 h) as at 19.5 degrees C (49 h) Overall his study shows the strength of ABFT that controls spawning traits. Spawning in ABFT is cyclical and highly synchronised on diel and annual scales consider that h timing of spawning rather influenced by day length and its adaptive significance is discussed.	[Gordoa, Ana; Carreras, Gustavo] CSIC, Ctr Estudios Avanzados Blanes, Dept Marine Ecol, Blanes, Gerona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB)	Gordoa, A (corresponding author), CSIC, Ctr Estudios Avanzados Blanes, Dept Marine Ecol, Blanes, Gerona, Spain.	gordoa@ceab.csic.es	Gordoa, Ana/A-1470-2013	Gordoa, Ana/0000-0003-1822-8196	Balfego Group; Spanish Ministry of the Economy and Competitiveness [CTM2011-29525-004-04]	Balfego Group; Spanish Ministry of the Economy and Competitiveness(Spanish Government)	This study was funded by the Balfego Group under a programme of scientific cooperation with the Spanish National Research Council and by the Spanish Ministry of the Economy and Competitiveness (CTM2011-29525-004-04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal FJ, 2004, FISH B-NOAA, V102, P407; Alemany F, 2010, PROG OCEANOGR, V86, P21, DOI 10.1016/j.pocean.2010.04.014; Aranda G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076445; Block BA, 2005, NATURE, V434, P1121, DOI 10.1038/nature03463; Boustany AM, 2008, MAR BIOL, V156, P13, DOI 10.1007/s00227-008-1058-0; Brill Richard W., 2001, Fish Physiology, V19, P79; Butler CM, 2010, FISH B-NOAA, V108, P56; Compte J, 2010, MAR ECOL PROG SER, V402, P147, DOI 10.3354/meps08453; Corriero A, 2003, J FISH BIOL, V63, P108, DOI 10.1046/j.1095-8649.2003.00132.x; Cort J. L., 1991, COL VOL SCI PAP ICCA, V35, P213; CUSHING DH, 1969, J CONSEIL, V33, P81; Cushing DH, 1975, MARINE ECOLOGY FISHE; de la Serna J.M., 1992, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V39, P704; de Metrio G., 2005, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V58, P1337; Desse J, 1994, FISH EXPLOITATION, V274, P69; Dicenta A, 1977, B I ESP OCEANOGR, V234, P109; Duclerc J., 1973, Revue Trav Inst Peches Marit, V37, P163; Ferraris M, 2012, J PLANKTON RES, V34, P874, DOI 10.1093/plankt/fbs049; Galuardi B, 2010, CAN J FISH AQUAT SCI, V67, P966, DOI 10.1139/F10-033; Garcia A, 2005, COLLECTIVE VOLUME SC, V58, P1261; Gordoa A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074721; Gordoa A, 2009, ICES J MAR SCI, V66, P2205, DOI 10.1093/icesjms/fsp211; Hattour A., 2002, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V54, P545; Heinisch G, 2008, MAR BIOL, V154, P623, DOI 10.1007/s00227-008-0955-6; Hendry AP, 2005, MOL ECOL, V14, P901, DOI 10.1111/j.1365-294X.2005.02480.x; Karakulak S, 2004, J APPL ICHTHYOL, V20, P318, DOI 10.1111/j.1439-0426.2004.00561.x; Korsmeyer K.E., 2001, TUNA PHYSL ECOLOGY E, P35, DOI DOI 10.1016/S1546-5098(01)19003-5; LAMBERT TC, 1987, MAR ECOL PROG SER, V39, P209, DOI 10.3354/meps039209; LARSON R J, 1987, Biological Oceanography, V4, P447; Licandro P, 2010, BIOL LETTERS, V6, P688, DOI 10.1098/rsbl.2010.0150; Logan JM, 2011, MAR BIOL, V158, P73, DOI 10.1007/s00227-010-1543-0; Margulies D, 2007, FISH B-NOAA, V105, P249; Masuma Shukei, 2006, Bulletin of Fisheries Research Agency, P157; Mather FJ, 1995, NMFSSEFSC370 NOAA; Medina A, 2002, J FISH BIOL, V60, P203, DOI [10.1111/j.1095-8649.2002.tb02398.x, 10.1006/jfbi.2001.1835]; Miyashita M, 2000, SUISAN ZOSHOKU, V48, P475; MORAND P, 1992, ANN I OCEANOGR PARIS, V68, P151; Mourente G, 2001, FISH PHYSIOL BIOCHEM, V24, P351, DOI 10.1023/A:1015011609017; Muhling BA, 2013, MAR ECOL PROG SER, V486, P257, DOI 10.3354/meps10397; NIKAIDO H, 1991, B NATL RES I FAR SEA, V28, P47; Nishida T., 1998, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V48, P107; Oray IK, 2005, J APPL ICHTHYOL, V21, P236, DOI 10.1111/j.1439-0426.2005.00658.x; PAULY D, 1988, ENVIRON BIOL FISH, V22, P261, DOI 10.1007/BF00004892; Pinot JM, 2001, DEEP-SEA RES PT I, V48, P1651, DOI 10.1016/S0967-0637(00)00095-9; Reglero P, 2012, MAR ECOL PROG SER, V463, P273, DOI 10.3354/meps09800; RODRIGUEZ-RODA JULIO, 1964, INVEST PESQUERA, V25, P33; Rooker JR, 2008, SCIENCE, V322, P742, DOI 10.1126/science.1161473; SARA R, 1973, Bollettino di Pesca Piscicoltura e Idrobiologia, V28, P217; Schaefer KM, 1996, FISH B-NOAA, V94, P98; Schaefer Kurt M., 2001, Fish Physiology, V19, P225; Schick RS, 2009, FISH OCEANOGR, V18, P77, DOI 10.1111/j.1365-2419.2008.00499.x; SCHULTZ ET, 1993, EVOLUTION, V47, P520, DOI 10.1111/j.1558-5646.1993.tb02111.x; Scott D.B.C., 1979, Symposia of the Zoological Society of London, P105; Stokesbury MJW, 2007, HYDROBIOLOGIA, V582, P91, DOI 10.1007/s10750-006-0552-y; Susca V, 2001, J FISH BIOL, V58, P815, DOI 10.1111/j.1095-8649.2001.tb00533.x; Teo SLH, 2007, MAR BIOL, V152, P1105, DOI 10.1007/s00227-007-0758-1; Trippel Edward A., 1997, Fish and Fisheries Series, V21, P31; Ultimatun, 2011, DOC PROD F LOP; Walli A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006151; Wright PJ, 2009, FISH FISH, V10, P283, DOI 10.1111/j.1467-2979.2008.00322.x; Wright PJ, 2005, J ANIM ECOL, V74, P303, DOI 10.1111/j.1365-2656.2005.00924.x	61	22	22	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90691	10.1371/journal.pone.0090691	http://dx.doi.org/10.1371/journal.pone.0090691			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608107	gold, Green Published, Green Submitted			2022-12-27	WOS:000332485800045
J	Isaac, B; White, J; Ierodiaconou, D; Cooke, R				Isaac, Bronwyn; White, John; Ierodiaconou, Daniel; Cooke, Raylene			Simplification of Arboreal Marsupial Assemblages in Response to Increasing Urbanization	PLOS ONE			English	Article							POSSUMS TRICHOSURUS-VULPECULA; OWLS NINOX-STRENUA; HOME-RANGE; SPECIES DISTRIBUTION; DEN-USE; URBAN; FOREST; CONSERVATION; POPULATION; MELBOURNE	Arboreal marsupials play an essential role in ecosystem function including regulating insect and plant populations, facilitating pollen and seed dispersal and acting as a prey source for higher-order carnivores in Australian environments. Primarily, research has focused on their biology, ecology and response to disturbance in forested and urban environments. We used presence-only species distribution modelling to understand the relationship between occurrences of arboreal marsupials and eco-geographical variables, and to infer habitat suitability across an urban gradient. We used post-proportional analysis to determine whether increasing urbanization affected potential habitat for arboreal marsupials. The key eco-geographical variables that influenced disturbance intolerant species and those with moderate tolerance to disturbance were natural features such as tree cover and proximity to rivers and to riparian vegetation, whereas variables for disturbance tolerant species were anthropogenic-based (e. g., road density) but also included some natural characteristics such as proximity to riparian vegetation, elevation and tree cover. Arboreal marsupial diversity was subject to substantial change along the gradient, with potential habitat for disturbance-tolerant marsupials distributed across the complete gradient and potential habitat for less tolerant species being restricted to the natural portion of the gradient. This resulted in highly-urbanized environments being inhabited by a few generalist arboreal marsupial species. Increasing urbanization therefore leads to functional simplification of arboreal marsupial assemblages, thus impacting on the ecosystem services they provide.	[Isaac, Bronwyn; White, John; Cooke, Raylene] Deakin Univ, Sch Life & Environm Sci, Burwood, Vic, Australia; [Ierodiaconou, Daniel] Deakin Univ, Sch Life & Environm Sci, Warrnambool, Vic, Australia	Deakin University; Deakin University	Cooke, R (corresponding author), Deakin Univ, Sch Life & Environm Sci, Burwood, Vic, Australia.	raylene.cooke@deakin.edu.au	White, John/A-4285-2008	White, John/0000-0002-7375-5944; Ierodiaconou, Daniel/0000-0002-7832-4801	Holsworth Wildlife Research Endowment; Parks Victoria Research Partners Scheme	Holsworth Wildlife Research Endowment; Parks Victoria Research Partners Scheme	Funding for this project was supplied by the Holsworth Wildlife Research Endowment and the Parks Victoria Research Partners Scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams PA, 2000, TRENDS ECOL EVOL, V15, P337, DOI 10.1016/S0169-5347(00)01908-X; Banaszak-Cibicka W, 2012, J INSECT CONSERV, V16, P331, DOI 10.1007/s10841-011-9419-2; Beyer GL, 2006, WILDLIFE RES, V33, P161, DOI 10.1071/WR04109; Brenden TO, 2008, ENVIRON MANAGE, V42, P821, DOI 10.1007/s00267-008-9150-2; Broome LS, 2001, AUSTRAL ECOL, V26, P275, DOI 10.1046/j.1442-9993.2001.01114.x; Carthew SM, 1999, WILDLIFE RES, V26, P199, DOI 10.1071/WR98021; Caryl FM, 2013, AUSTRAL ECOL, V38, P609, DOI 10.1111/aec.12006; Chace JF, 2006, LANDSCAPE URBAN PLAN, V74, P46, DOI 10.1016/j.landurbplan.2004.08.007; Chapin FS, 1997, SCIENCE, V277, P500, DOI 10.1126/science.277.5325.500; Comport SS, 1996, WILDLIFE RES, V23, P401, DOI 10.1071/WR9960401; Cooke R, 2006, WILDLIFE RES, V33, P199, DOI 10.1071/WR05058; Department of Environment and Primary Industries (DEPI), 2013, EC VEG CLASS EVC BEN; Duguay S, 2007, LANDSCAPE ECOL, V22, P589, DOI 10.1007/s10980-006-9050-x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Environmental Systems Research Institute, 2010, ARCGIS 10 0; Eyre TJ, 2006, FOREST ECOL MANAG, V235, P270, DOI 10.1016/j.foreco.2006.08.338; Fitzsimons James A., 2010, Australian Field Ornithology, V27, P76; Gibbons P., 2002, TREE HOLLOWS WILDLIF, DOI [10.1071/9780643090033, DOI 10.1071/9780643090033]; Gillies CS, 2008, P NATL ACAD SCI USA, V105, P19774, DOI 10.1073/pnas.0803530105; Goldingay Ross L., 2004, P376; Goldingay Ross L., 2004, P298; Goldingay RL, 2011, AUST J ZOOL, V59, P277, DOI 10.1071/ZO11081; Happold D.C.D., 2008, MAMMALS AUSTR, P589; Harper MJ, 2008, AUSTRAL ECOL, V33, P243, DOI 10.1111/j.1442-9993.2007.01689.x; Harper MJ, 2005, WILDLIFE RES, V32, P681, DOI 10.1071/WR04072; Harris Jamie M., 2008, Mammalian Species, P1, DOI 10.1644/815.1; How RA, 1995, MAMMALS AUSTR, P273; IBM Corp, 2016, IBM SPSS STAT WINDOW; Jimenez-Valverde A, 2012, GLOBAL ECOL BIOGEOGR, V21, P498, DOI 10.1111/j.1466-8238.2011.00683.x; Kark S, 2007, J BIOGEOGR, V34, P638, DOI 10.1111/j.1365-2699.2006.01638.x; Kavanagh Rodney P., 2004, P413; Kerle J. A, 2001, POSSUMS BRUSHTAILS R; Kuhn I, 2006, BIOL CONSERV, V127, P292, DOI 10.1016/j.biocon.2005.06.033; LAVAZANIAN E, 1994, WILDLIFE RES, V21, P643, DOI 10.1071/WR9940643; Lindenmayer D, 2002, GLIDERS AUSTR NATURA; Lindenmayer DB, 2000, FOREST ECOL MANAG, V137, P139, DOI 10.1016/S0378-1127(99)00322-9; Lindenmayer DB, 1997, ECOL APPL, V7, P625, DOI 10.1890/1051-0761(1997)007[0625:DACOTW]2.0.CO;2; Lindenmayer DB, 1996, WILDLIFE WOODCHIPS L; Magle SB, 2012, BIOL CONSERV, V155, P23, DOI 10.1016/j.biocon.2012.06.018; Martin JK, 2006, AUST J ZOOL, V54, P225, DOI 10.1071/ZO06023; McDonnell MJ, 2009, ECOLOGY OF CITIES AND TOWNS: A COMPARATIVE APPROACH, P1, DOI 10.1017/CBO9780511609763; McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005; McKinney ML, 2002, BIOSCIENCE, V52, P883, DOI 10.1641/0006-3568(2002)052[0883:UBAC]2.0.CO;2; Melles S, 2003, CONSERV ECOL, V7; Menkhorst Peter W., 2011, Victorian Naturalist (Blackburn), V128, P233; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; Nelson J.L., 1996, Australian Forestry, V59, P189; Njoroge JB, 2014, URBAN ECOSYST, V17, P61, DOI 10.1007/s11252-013-0296-1; Olden JD, 2006, GLOBAL ECOL BIOGEOGR, V15, P113, DOI 10.1111/j.1466-822x.2006.00214.x; Ordenana MA, 2010, J MAMMAL, V91, P1322, DOI 10.1644/09-MAMM-A-312.1; Pahl L., 1984, POSSUMS GLIDERS, P252; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; PIMM SL, 1984, NATURE, V307, P321, DOI 10.1038/307321a0; Razgour O, 2011, BIOL CONSERV, V144, P2922, DOI 10.1016/j.biocon.2011.08.010; Redon M., 2010, 6 SPAT AN GEOM INT C; Robertson OJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0065299, DOI 10.1371/J0URNAL.P0NE.0065299]; Sewell SR, 1998, WILDLIFE RES, V25, P41, DOI 10.1071/WR96078; Smith A, 1997, KEY FIELD GUIDE AUST; SMITH AP, 1989, AUST WILDLIFE RES, V16, P575; Soderquist TR, 2000, BIOL CONSERV, V93, P281, DOI 10.1016/S0006-3207(99)00153-6; Statham M, 1997, WILDLIFE RES, V24, P715, DOI 10.1071/WR96092; SUCKLING GC, 1984, AUST WILDLIFE RES, V11, P49; Taylor BD, 2009, ECOL SOC, V14; Temby I. D., 2004, P 4 INT S URB WILDL, P26; Threlfall CG, 2012, BIOL CONSERV, V146, P41, DOI 10.1016/j.biocon.2011.11.026; Trollope ST, 2009, LANDSCAPE URBAN PLAN, V93, P142, DOI 10.1016/j.landurbplan.2009.06.013; van der Ree Rodney, 2004, P91; van Rensburg BJ, 2009, LANDSCAPE URBAN PLAN, V92, P233, DOI 10.1016/j.landurbplan.2009.05.002; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; WOODWARD JC, 1994, BRIT GEOMOR, P259; Wormington KR, 2002, FOREST SCI, V48, P217	74	15	15	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91049	10.1371/journal.pone.0091049	http://dx.doi.org/10.1371/journal.pone.0091049			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608165	Green Published, gold, Green Submitted			2022-12-27	WOS:000332485800087
J	Kirenga, BJ; Levin, J; Ayakaka, I; Worodria, W; Reilly, N; Mumbowa, F; Nabanjja, H; Nyakoojo, G; Fennelly, K; Nakubulwa, S; Joloba, M; Okwera, A; Eisenach, KD; McNerney, R; Elliott, AM; Mugerwa, RD; Smith, PG; Ellner, JJ; Jones-Lopez, EC				Kirenga, Bruce J.; Levin, Jonathan; Ayakaka, Irene; Worodria, William; Reilly, Nancy; Mumbowa, Francis; Nabanjja, Helen; Nyakoojo, Grace; Fennelly, Kevin; Nakubulwa, Susan; Joloba, Moses; Okwera, Alphonse; Eisenach, Kathleen D.; McNerney, Ruth; Elliott, Alison M.; Mugerwa, Roy D.; Smith, Peter G.; Ellner, Jerrold J.; Jones-Lopez, Edward C.			Treatment Outcomes of New Tuberculosis Patients Hospitalized in Kampala, Uganda: A Prospective Cohort Study	PLOS ONE			English	Article							HIV-INFECTED ADULTS; SUB-SAHARAN AFRICA; PULMONARY TUBERCULOSIS; RISK-FACTORS; ANTIRETROVIRAL THERAPY; COTRIMOXAZOLE PROPHYLAXIS; ACTIVE TUBERCULOSIS; MORTALITY; IMPACT; DEATH	Background: In most resource limited settings, new tuberculosis (TB) patients are usually treated as outpatients. We sought to investigate the reasons for hospitalisation and the predictors of poor treatment outcomes and mortality in a cohort of hospitalized new TB patients in Kampala, Uganda Methods and findings: Ninety-six new TB patients hospitalised between 2003 and 2006 were enrolled and followed for two years. Thirty two were HIV-uninfected and 64 were HIV-infected. Among the HIV-uninfected, the commonest reasons for hospitalization were low Karnofsky score (47%) and need for diagnostic evaluation (25%). HIV-infected patients were commonly hospitalized due to low Karnofsky score (72%), concurrent illness (16%) and diagnostic evaluation (14%). Eleven HIV uninfected patients died (mortality rate 19.7 per 100 person-years) while 41 deaths occurred among the HIV-infected patients (mortality rate 46.9 per 100 person years). In all patients an unsuccessful treatment outcome (treatment failure, death during the treatment period or an unknown outcome) was associated with duration of TB symptoms, with the odds of an unsuccessful outcome decreasing with increasing duration. Among HIV-infected patients, an unsuccessful treatment outcome was also associated with male sex (P = 0.004) and age (P = 0.034). Low Karnofsky score (aHR = 8.93, 95% CI 1.88 - 42.40, P = 0.001) was the only factor significantly associated with mortality among the HIV-uninfected. Mortality among the HIV-infected was associated with the composite variable of CD4 and ART use, with patients with baseline CD4 below 200 cells/mu L who were not on ART at a greater risk of death than those who were on ART, and low Karnofsky score (aHR = 2.02, 95% CI 1.02 - 4.01, P = 0.045). Conclusion: Poor health status is a common cause of hospitalisation for new TB patients. Mortality in this study was very high and associated with advanced HIV Disease and no use of ART.	[Kirenga, Bruce J.; Worodria, William; Elliott, Alison M.; Mugerwa, Roy D.] Makerere Univ, Dept Med, Coll Hlth Sci, Kampala, Uganda; [Levin, Jonathan; Nakubulwa, Susan; Okwera, Alphonse; Elliott, Alison M.] Uganda Virus Res Inst, MRC, Uganda Res Unit AIDS, Entebbe, Uganda; [Levin, Jonathan] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, Gauteng, South Africa; [Ayakaka, Irene; Nabanjja, Helen; Nyakoojo, Grace; Fennelly, Kevin; Mugerwa, Roy D.; Ellner, Jerrold J.; Jones-Lopez, Edward C.] Makerere Univ, Boston Med Ctr Res Collaborat, Kampala, Uganda; [Reilly, Nancy] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Med, Newark, NJ 07103 USA; [Mumbowa, Francis; Joloba, Moses] Makerere Univ, Dept Microbiol, Coll Hlth Sci, Kampala, Uganda; [Fennelly, Kevin] Univ Florida, Dept Med, Div Mycobacteriol, Southeastern Natl TB Ctr, Gainesville, FL USA; [Okwera, Alphonse] Mulago Hosp, TB Clin, Kampala, Uganda; [Eisenach, Kathleen D.] Univ Arkansas Med Sci, Dept Pathol, Little Rock, AR 72205 USA; [Eisenach, Kathleen D.] Univ Arkansas Med Sci, Dept Microbiol & Immunol, Little Rock, AR 72205 USA; [McNerney, Ruth; Elliott, Alison M.] London Sch Hyg & Trop Med, Dept Clin Res, Fac Infect & Trop Dis, London WC1, England; [Smith, Peter G.] London Sch Hyg & Trop Med, MRC, Trop Epidemiol Grp, London WC1, England; [Ellner, Jerrold J.; Jones-Lopez, Edward C.] Boston Med Ctr, Dept Med, Infect Dis Sect, Boston, MA 02118 USA; [Ellner, Jerrold J.; Jones-Lopez, Edward C.] Boston Univ, Sch Med, Boston, MA 02118 USA	Makerere University; Uganda Virus Research Institute; University of Witwatersrand; Makerere University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Makerere University; State University System of Florida; University of Florida; Mulago National Referral Hospital; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; Boston Medical Center; Boston University	Jones-Lopez, EC (corresponding author), Boston Med Ctr, Dept Med, Infect Dis Sect, Boston, MA 02118 USA.	edward.jones@bmc.org	smith, peter/ABH-9627-2020	smith, peter/0000-0003-0080-7560; Elliott, Alison/0000-0003-2818-9549; Jones Lopez, Edward/0000-0001-6323-286X; Joloba, Moses/0000-0002-0334-9983; Kirenga, Bruce/0000-0002-2023-2840	Wellcome Trust - Burroughs Wellcome Fund Infectious Diseases Initiative [063410/ABC/00/Z]; Medical Research Council [MR/K012126/1] Funding Source: researchfish	Wellcome Trust - Burroughs Wellcome Fund Infectious Diseases Initiative; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was supported by Wellcome Trust - Burroughs Wellcome Fund Infectious Diseases Initiative grant 063410/ABC/00/Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abos-Hernandez R, 2002, INT J TUBERC LUNG D, V6, P470; [Anonymous], 1996, BACT 460 SYST PROD P; [Anonymous], 2010, MANUAL NATL TUBERCUL; [Anonymous], 1999, BACT MGIT 960 SYST U; Blanc FX, 2011, NEW ENGL J MED, V365, P1471, DOI 10.1056/NEJMoa1013911; Burton NT, 2011, T ROY SOC TROP MED H, V105, P675, DOI 10.1016/j.trstmh.2011.07.017; Corbett EL, 2006, LANCET, V367, P926, DOI 10.1016/S0140-6736(06)68383-9; Davis JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009859; Dheda K, 2004, J INFECT DIS, V190, P1670, DOI 10.1086/424676; Duarte EC, 2009, J EPIDEMIOL COMMUN H, V63, P233, DOI 10.1136/jech.2008.078972; Dunlap NE, 2000, AM J RESP CRIT CARE, V161, P1376, DOI 10.1164/ajrccm.161.4.16141; Erhabor G E, 2006, Indian J Chest Dis Allied Sci, V48, P253; Gandhi NR, 2010, AM J RESP CRIT CARE, V181, P80, DOI 10.1164/rccm.200907-0989OC; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Greenaway C, 2002, AM J RESP CRIT CARE, V165, P927, DOI 10.1164/ajrccm.165.7.2107040; Greenland S, 2008, STAT MED, V27, P199, DOI 10.1002/sim.2995; Grimwade K, 2005, AIDS, V19, P163, DOI 10.1097/00002030-200501280-00008; Hansel NN, 2004, CHEST, V126, P1079, DOI 10.1378/chest.126.4.1079; Havlir DV, 2011, NEW ENGL J MED, V365, P1482, DOI 10.1056/NEJMoa1013607; Henegar C, 2012, INT J TUBERC LUNG D, V16, P1199, DOI 10.5588/ijtld.11.0613; Jones-Lopez EC, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000427; Karim SSA, 2011, NEW ENGL J MED, V365, P1492, DOI 10.1056/NEJMoa1014181; Karim SSA, 2010, NEW ENGL J MED, V362, P697, DOI 10.1056/NEJMoa0905848; Lawn SD, 2006, AIDS, V20, P1787, DOI 10.1097/01.aids.0000242831.27990.da; Lopez-Gatell H, 2007, AM J EPIDEMIOL, V165, P1134, DOI 10.1093/aje/kwk116; Lubart E, 2007, ISR MED ASSOC J, V9, P870; Mosimaneotsile B, 2003, LANCET, V362, P1551, DOI 10.1016/S0140-6736(03)14745-9; Muhumuza J, 2006, INT J TUBERC LUNG D, V10, P1262; Naidoo S, 2008, SO AFRICAN J EPIDEMI, V22, P8; Nunn AJ, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a257; PablosMendez A, 1996, JAMA-J AM MED ASSOC, V276, P1223, DOI 10.1001/jama.276.15.1223; Palmieri F, 2002, INFECTION, V30, P68, DOI 10.1007/s15010-002-2062-9; Rao VK, 1998, CHEST, V114, P1244, DOI 10.1378/chest.114.5.1244; Shimazaki T, 2013, INT J TUBERC LUNG D, V17, P1420, DOI 10.5588/ijtld.12.0848; Silva DR, 2010, LUNG, V188, P33, DOI 10.1007/s00408-009-9224-9; Steingart KR, 2014, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009593.pub2, 10.1002/14651858.CD009593.pub3]; Tabarsi P, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-14; Taylor Z, 2000, INT J TUBERC LUNG D, V4, P931; van't Hoog AH, 2012, INT J TUBERC LUNG D, V16, P1649, DOI 10.5588/ijtld.12.0135; Volmink J, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003510.pub2; Waitt CJ, 2011, INT J TUBERC LUNG D, V15, P871, DOI 10.5588/ijtld.10.0352; Whalen CC, 2000, AIDS, V14, P1219, DOI 10.1097/00002030-200006160-00020; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1; WHO, 2009, TREATM TUB GUID; Yen YF, 2012, T ROY SOC TROP MED H, V106, P303, DOI 10.1016/j.trstmh.2012.01.011	45	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90614	10.1371/journal.pone.0090614	http://dx.doi.org/10.1371/journal.pone.0090614			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608875	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000332485800039
J	Kuwajima, M; Kumano, G; Nishida, H				Kuwajima, Mami; Kumano, Gaku; Nishida, Hiroki			Regulation of the Number of Cell Division Rounds by Tissue-Specific Transcription Factors and Cdk Inhibitor during Ascidian Embryogenesis	PLOS ONE			English	Article							CYCLIN-DEPENDENT KINASE; T-BOX GENE; INTRACELLULAR INJECTION; POSTPLASMIC/PEM RNAS; HALOCYNTHIA-RORETZI; CIONA-INTESTINALIS; MESODERMAL TISSUES; LINEAGE ANALYSIS; TRACER ENZYME; EXPRESSION	Mechanisms that regulate the number of cell division rounds during embryogenesis have remained largely elusive. To investigate this issue, we used the ascidian, which develops into a tadpole larva with a small number of cells. The embryonic cells divide 11.45 times on average from fertilization to hatching. The number of cell division rounds varies depending on embryonic lineages. Notochord and muscle consist of large postmitotic cells and stop dividing early in developing embryos. Here we show that conversion of mesenchyme to muscle cell fates by inhibition of inductive FGF signaling or mis-expression of a muscle-specific key transcription factor for muscle differentiation, Tbx6, changed the number of cell divisions in accordance with the altered fate. Tbx6 likely activates a putative mechanism to halt cell division at a specific stage. However, precocious expression of Tbx6 has no effect on progression of the developmental clock itself. Zygotic expression of a cyclin-dependent kinase inhibitor, CKI-b, is initiated in muscle and then in notochord precursors. CKI-b is possibly downstream of tissue-specific key transcription factors of notochord and muscle. In the two distinct muscle lineages, postmitotic muscle cells are generated after 9 and 8 rounds of cell division depending on lineage, but the final cell divisions occur at a similar developmental stage. CKI-b gene expression starts simultaneously in both muscle lineages at the 110-cell stage, suggesting that CKI-b protein accumulation halts cell division at a similar stage. The difference in the number of cell divisions would be due to the cumulative difference in cell cycle length. These results suggest that muscle cells do not count the number of cell division rounds, and that accumulation of CKI-b protein triggered by tissue-specific key transcription factors after cell fate determination might act as a kind of timer that measures elapsed time before cell division termination.	[Kuwajima, Mami; Kumano, Gaku; Nishida, Hiroki] Osaka Univ, Grad Sch Sci, Dept Biol Sci, Toyonaka, Osaka 560, Japan	Osaka University	Nishida, H (corresponding author), Osaka Univ, Grad Sch Sci, Dept Biol Sci, Toyonaka, Osaka 560, Japan.	hnishida@bio.sci.osaka-u.ac.jp	Nishida, Hiroki/B-1851-2008; Kumano, Gaku/AAE-1527-2019	Nishida, Hiroki/0000-0002-7249-1668; 	JSPS; MEXT; Grants-in-Aid for Scientific Research [23570252, 25113518] Funding Source: KAKEN	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants in Aid from JSPS and MEXT to H.N. and G.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Besson A, 2008, DEV CELL, V14, P159, DOI 10.1016/j.devcel.2008.01.013; Clayton JE, 2008, DEV BIOL, V313, P603, DOI 10.1016/j.ydbio.2007.10.051; Deng XB, 2004, J BIOL CHEM, V279, P22498, DOI 10.1074/jbc.M400479200; deNooij JC, 1996, CELL, V87, P1237, DOI 10.1016/S0092-8674(00)81819-X; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Fujikawa T, 2011, DEV BIOL, V355, P313, DOI 10.1016/j.ydbio.2011.04.033; Hirano T, 1997, DEV BIOL, V192, P199, DOI 10.1006/dbio.1997.8772; Kawashima T, 2003, DEV GENES EVOL, V213, P284, DOI 10.1007/s00427-003-0323-y; Kim GJ, 2007, DEVELOPMENT, V134, P1509, DOI 10.1242/dev.02825; Kim GJ, 2000, DEVELOPMENT, V127, P2853; Kim GJ, 2001, DEV GROWTH DIFFER, V43, P521; Kumano G, 2007, DEV DYNAM, V236, P1732, DOI 10.1002/dvdy.21108; Kumano G, 2006, DEV BIOL, V300, P770, DOI 10.1016/j.ydbio.2006.07.033; Lane ME, 1996, CELL, V87, P1225, DOI 10.1016/S0092-8674(00)81818-8; LEMAIRE P, 1995, CELL, V81, P85, DOI 10.1016/0092-8674(95)90373-9; Lim SH, 2013, DEVELOPMENT, V140, P3079, DOI 10.1242/dev.091744; Makabe KW, 2012, WIRES DEV BIOL, V1, P501, DOI 10.1002/wdev.54; Makabe KW, 2001, DEVELOPMENT, V128, P2555; Matsumoto J, 2007, DEV BIOL, V306, P870, DOI 10.1016/j.ydbio.2007.03.034; Mitani Y, 1999, DEV DYNAM, V215, P62, DOI 10.1002/(SICI)1097-0177(199905)215:1<62::AID-DVDY7>3.0.CO;2-X; Mitani Y, 2001, DEVELOPMENT, V128, P3717; Nakatani Y, 1996, DEVELOPMENT, V122, P2023; Negishi T, 2007, CURR BIOL, V17, P1014, DOI 10.1016/j.cub.2007.05.047; NISHIDA H, 1992, ROUX ARCH DEV BIOL, V201, P81, DOI 10.1007/BF00420418; Nishida H, 2005, DEV DYNAM, V233, P1177, DOI 10.1002/dvdy.20469; NISHIDA H, 1987, DEV BIOL, V121, P526, DOI 10.1016/0012-1606(87)90188-6; NISHIDA H, 1983, DEV BIOL, V99, P382, DOI 10.1016/0012-1606(83)90288-9; Prodon F, 2007, DEV DYNAM, V236, P1698, DOI 10.1002/dvdy.21109; Sardet C, 2005, BIOL CELL, V97, P35; Sawada K, 2005, GENE EXPR PATTERNS, V5, P429, DOI 10.1016/j.modgep.2004.09.003; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Slack JMW, 1996, CURR BIOL, V6, P348, DOI 10.1016/S0960-9822(02)00487-6; Takahashi H, 2005, DEV GROWTH DIFFER, V47, P173; Takatori N, 2010, DEV CELL, V19, P589, DOI 10.1016/j.devcel.2010.09.003; Vervoorts J, 2008, CELL MOL LIFE SCI, V65, P3255, DOI 10.1007/s00018-008-8296-7; Yagi K, 2005, DEV BIOL, V282, P535, DOI 10.1016/j.ydbio.2005.03.029; Yamada A, 1999, J EXP ZOOL, V284, P379; Yasuo H, 1996, DEV BIOL, V180, P773, DOI 10.1006/dbio.1996.0345	38	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90188	10.1371/journal.pone.0090188	http://dx.doi.org/10.1371/journal.pone.0090188			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608898	Green Published, Green Submitted, gold			2022-12-27	WOS:000332485800019
J	Liu, P; Pieper, R; Rieger, J; Vahjen, W; Davin, R; Plendl, J; Meyer, W; Zentek, J				Liu, Ping; Pieper, Robert; Rieger, Juliane; Vahjen, Wilfried; Davin, Roger; Plendl, Johanna; Meyer, Wilfried; Zentek, Juergen			Effect of Dietary Zinc Oxide on Morphological Characteristics, Mucin Composition and Gene Expression in the Colon of Weaned Piglets	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-2; FEED PARTICLE-SIZE; LARGE-INTESTINE; INFLAMMATORY CYTOKINES; GASTROINTESTINAL-TRACT; LYMPHOID-TISSUES; EPITHELIAL-CELLS; PROTEIN; COPPER; PIGS	The trace element zinc is often used in the diet of weaned piglets, as high doses have resulted in positive effects on intestinal health. However, the majority of previous studies evaluated zinc supplementations for a short period only and focused on the small intestine. The hypothesis of the present study was that low, medium and high levels of dietary zinc (57, 164 and 2,425 mg Zn/kg from zinc oxide) would affect colonic morphology and innate host defense mechanisms across 4 weeks post-weaning. Histological examinations were conducted regarding the colonic morphology and neutral, acidic, sialylated and sulphated mucins. The mRNA expression levels of mucin (MUC) 1, 2, 13, 20, toll-like receptor (TLR) 2, 4, interleukin (IL)-1 beta, 8, 10, interferon-gamma (IFN-gamma) and transforming growth factor-beta (TGF-beta) were also measured. The colonic crypt area increased in an age-depending manner, and the greatest area was found with medium concentration of dietary zinc. With the high concentration of dietary zinc, the number of goblet cells containing mixed neutral-acidic mucins and total mucins increased. Sialomucin containing goblet cells increased age-dependently. The expression of MUC2 increased with age and reached the highest level at 47 days of age. The expression levels of TLR2 and 4 decreased with age. The mRNA expression of TLR4 and the pro-inflammatory cytokine IL-8 were down-regulated with high dietary zinc treatment, while piglets fed with medium dietary zinc had the highest expression. It is concluded that dietary zinc level had a clear impact on colonic morphology, mucin profiles and immunological traits in piglets after weaning. Those changes might support local defense mechanisms and affect colonic physiology and contribute to the reported reduction of post-weaning diarrhea.	[Liu, Ping; Pieper, Robert; Vahjen, Wilfried; Zentek, Juergen] Free Univ Berlin, Dept Vet Med, Inst Anim Nutr, Berlin, Germany; [Rieger, Juliane; Plendl, Johanna] Free Univ Berlin, Dept Vet Med, Inst Vet Anat, Berlin, Germany; [Davin, Roger] Univ Autonoma Barcelona, Fac Vet, Dept Ciencia Anim & Aliment, Grp Nutr Maneig & Benestar Anim, E-08193 Barcelona, Spain; [Meyer, Wilfried] Univ Vet Med Hannover, Inst Anat, Hannover, Germany	Free University of Berlin; Free University of Berlin; Autonomous University of Barcelona; University of Veterinary Medicine Hannover, Foundation	Zentek, J (corresponding author), Free Univ Berlin, Dept Vet Med, Inst Anim Nutr, Berlin, Germany.	juergen.zentek@fu-berlin.de	Davin, Roger/D-1949-2013; Rieger, Juliane/G-8878-2015	Davin, Roger/0000-0003-2391-4879; Rieger, Juliane/0000-0003-1659-9460; Pieper, Robert/0000-0002-0292-1482	Deutsche Forschungsgemeinschaft (DFG) through a grant of the Collaborative Research Group [SFB 852]	Deutsche Forschungsgemeinschaft (DFG) through a grant of the Collaborative Research Group(German Research Foundation (DFG))	This study has been supported by the Deutsche Forschungsgemeinschaft (DFG) through a grant of the Collaborative Research Group SFB 852/Project C3, "Nutrition and Intestinal Microbiota - Host Interactions in the pig." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anguita M, 2007, LIVEST SCI, V107, P182, DOI 10.1016/j.livsci.2006.09.016; Badia R, 2012, J ANIM SCI, V90, P260, DOI 10.2527/jas.53894; Barnett AM, 2012, FOOD FUNCT, V3, P690, DOI 10.1039/c2fo30017f; Bering SB, 2012, BRIT J NUTR, V108, P672, DOI 10.1017/S0007114511006404; BROWN PJ, 1988, J COMP PATHOL, V98, P313, DOI 10.1016/0021-9975(88)90040-0; Brunsgaard G, 1998, J ANIM SCI, V76, P2787; Carlson D, 2007, LIVEST SCI, V108, P45, DOI 10.1016/j.livsci.2007.01.026; Carlson D, 2004, COMP BIOCHEM PHYS A, V137, P757, DOI 10.1016/j.cbpb.2004.02.011; Castellano R, 2013, ANIM FEED SCI TECH, V180, P101, DOI 10.1016/j.anifeedsci.2013.01.010; Corfield AP, 2001, FRONT BIOSCI-LANDMRK, V6, pD1321, DOI 10.2741/Corfield; Croix JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024447; Davin R, 2012, J ANIM SCI, V90, P248, DOI 10.2527/jas.53999; DOBESH GD, 1987, AM J VET RES, V48, P862; Dreno B, 2001, DERMATOLOGY, V203, P135, DOI 10.1159/000051728; Fairbrother John M., 2005, Animal Health Research Reviews, V6, P17, DOI 10.1079/AHR2005105; Feng Z, 2006, COMP BIOCHEM PHYS A, V145, P328, DOI 10.1016/j.cbpa.2006.07.006; FILIPE MI, 1979, INVEST CELL PATHOL, V2, P195; Geiser J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002766; GENDLER SJ, 1995, ANNU REV PHYSIOL, V57, P607, DOI 10.1146/annurev.ph.57.030195.003135; Glitso LV, 1998, BRIT J NUTR, V80, P457, DOI 10.1017/S0007114598001536; Hedemann MS, 2006, J ANIM SCI, V84, P3310, DOI 10.2527/jas.2005-701; Hedemann MS, 2009, BRIT J NUTR, V102, P117, DOI 10.1017/S0007114508143549; Hedemann MS, 2005, J ANIM SCI, V83, P1554; Hoffmann E, 2002, J LEUKOCYTE BIOL, V72, P847; Hojberg O, 2005, APPL ENVIRON MICROB, V71, P2267, DOI 10.1128/AEM.71.5.2267-2277.2005; Hu CH, 2013, ANIM FEED SCI TECH, V181, P65, DOI 10.1016/j.anifeedsci.2013.02.003; Hu CH, 2013, BRIT J NUTR, V110, P681, DOI 10.1017/S0007114512005508; Jansman AJM, 2012, J ANIM SCI, V90, P161, DOI 10.2527/jas.53848; Ji HY, 2011, MOL BIOL REP, V38, P1593, DOI 10.1007/s11033-010-0268-y; Johansson MEV, 2011, P NATL ACAD SCI USA, V108, P4659, DOI 10.1073/pnas.1006451107; Katouli M, 1999, J APPL MICROBIOL, V87, P564, DOI 10.1046/j.1365-2672.1999.00853.x; Kawashima H, 2012, BIOL PHARM BULL, V35, P1637, DOI 10.1248/bpb.b12-00412; Kelly D, 2005, MOL IMMUNOL, V42, P895, DOI 10.1016/j.molimm.2004.12.003; Kreuzer S., 2013, Proceedings of the Society of Nutrition Physiology, V22, P52; Lalles JP, 2007, P NUTR SOC, V66, P260, DOI 10.1017/S0029665107005484; LAWSON MJ, 1988, BIOL TRACE ELEM RES, V18, P115, DOI 10.1007/BF02917495; Liu Y, 2008, BRIT J NUTR, V100, P552, DOI 10.1017/S0007114508911612; Liu YL, 2012, J NUTR, V142, P2017, DOI 10.3945/jn.112.164947; Martin L, 2013, J NUTR, V143, P1205, DOI 10.3945/jn.113.177881; Martin L, 2013, ARCH ANIM NUTR, V67, P248, DOI 10.1080/1745039X.2013.801138; Martin L, 2012, ANIM FEED SCI TECH, V175, P65, DOI 10.1016/j.anifeedsci.2012.04.002; McKay DM, 1999, GUT, V44, P283, DOI 10.1136/gut.44.2.283; Mentschel J, 2003, METABOLISM, V52, P1400, DOI 10.1016/S0026-0495(03)00318-4; Moncada DM, 2003, TRENDS PARASITOL, V19, P305, DOI 10.1016/S1471-4922(03)00122-3; MOWRY RW, 1963, ANN NY ACAD SCI, V106, P402; MUNCHOW H, 1989, ARCH TIERERNAHR, V39, P893, DOI 10.1080/17450398909432971; National Research Council (NRC), 2012, NUTR REQ SWIN, V11, DOI [10.17226/13298, DOI 10.17226/13298]; Nofrarias M, 2006, J ANIM SCI, V84, P2735, DOI 10.2527/jas.2005-414; Pie S, 2004, J NUTR, V134, P641, DOI 10.1093/jn/134.3.641; Piel C, 2005, J NUTR, V135, P86, DOI 10.1093/jn/135.1.86; Pieper R, 2012, J NUTR, V142, P661, DOI 10.3945/jn.111.156190; POULSEN HD, 1995, ACTA AGR SCAND A-AN, V45, P159, DOI 10.1080/09064709509415847; Prasad AS, 2012, J TRACE ELEM MED BIO, V26, P66, DOI 10.1016/j.jtemb.2012.04.004; Puiman PJ, 2011, J NUTR, V141, P1306, DOI 10.3945/jn.110.135145; Rojas M, 1996, J APPL BACTERIOL, V81, P474; Romeis B., 1989, MIKROSKOPISCHE TECHN; Roos S, 2002, MICROBIOL-SGM, V148, P433, DOI 10.1099/00221287-148-2-433; Roselli M, 2003, J NUTR, V133, P4077, DOI 10.1093/jn/133.12.4077; Sales J, 2013, BIOL TRACE ELEM RES, V152, P343, DOI 10.1007/s12011-013-9638-3; Smith AG, 2011, BRIT J NUTR, V105, P669, DOI 10.1017/S0007114510004277; SOUTHON S, 1985, BRIT J NUTR, V53, P595, DOI 10.1079/BJN19850069; SPICER SS, 1965, J HISTOCHEM CYTOCHEM, V13, P211, DOI 10.1177/13.3.211; Starke IC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056405; Swiech E, 2010, LIVEST SCI, V134, P172, DOI 10.1016/j.livsci.2010.06.129; Tohno M, 2005, BIOCHEM BIOPH RES CO, V330, P547, DOI 10.1016/j.bbrc.2005.03.017; Tohno M, 2006, VET RES, V37, P791, DOI 10.1051/vetres:2006036; Tsukahara T, 2003, J NUTR SCI VITAMINOL, V49, P414, DOI 10.3177/jnsv.49.414; TURCK D, 1993, PEDIATR RES, V33, P564, DOI 10.1203/00006450-199306000-00005; Uddin MJ, 2013, RES VET SCI, V95, P92, DOI 10.1016/j.rvsc.2013.01.027; Vahjen W, 2011, J ANIM SCI, V89, P2430, DOI 10.2527/jas.2010-3270; Vahjen W, 2010, APPL ENVIRON MICROB, V76, P6689, DOI 10.1128/AEM.03075-09; van der Sluis M, 2004, BIOCHEM BIOPH RES CO, V325, P952, DOI 10.1016/j.bbrc.2004.10.108	72	50	55	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91091	10.1371/journal.pone.0091091	http://dx.doi.org/10.1371/journal.pone.0091091			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24609095	gold, Green Published, Green Submitted			2022-12-27	WOS:000332485800100
J	Sajgo, S; Ghinia, MG; Shi, M; Liu, P; Dong, LJ; Parmhans, N; Popescu, O; Badea, TC				Sajgo, Szilard; Ghinia, Miruna Georgiana; Shi, Melody; Liu, Pinghu; Dong, Lijin; Parmhans, Nadia; Popescu, Octavian; Badea, Tudor Constantin			Dre - Cre Sequential Recombination Provides New Tools for Retinal Ganglion Cell Labeling and Manipulation in Mice	PLOS ONE			English	Article							SITE-SPECIFIC RECOMBINATION; TRANSCRIPTION FACTORS BRN3A; TRANSGENIC MOUSE LINE; MEDIATED RECOMBINATION; DNA RECOMBINATION; MAMMALIAN-CELLS; COMBINATORIAL EXPRESSION; SOMATOSENSORY NEURONS; FLUORESCENT PROTEINS; COMPETENCE STATE	Background: Genetic targeting methods have greatly advanced our understanding of many of the 20 Retinal Ganglion Cell (RGC) types conveying visual information from the eyes to the brain. However, the complexity and partial overlap of gene expression patterns in RGCs call for genetic intersectional or sparse labeling strategies. Loci carrying the Cre recombinase in conjunction with conditional knock-out, reporter or other genetic tools can be used for targeted cell type ablation and functional manipulation of specific cell populations. The three members of the Pou4f family of transcription factors, Brn3a, Brn3b and Brn3c, expressed early during RGC development and in combinatorial pattern amongst RGC types are excellent candidates for such gene manipulations. Methods and Findings: We generated conditional Cre knock-in alleles at the Brn3a and Brn3b loci, Brn3a(CKOCre) and Brn3b(CKOCre). When crossed to mice expressing the Dre recombinase, the endogenous Brn3 gene expressed by Brn3a(CKOCre) or Brn3b(CKOCre) is removed and replaced with a Cre recombinase, generating Brn3a(Cre) and Brn3b(Cre) knock-in alleles. Surprisingly both Brn3a(Cre) and Brn3b(Cre) knock-in alleles induce early ubiquitous recombination, consistent with germline expression. However in later stages of development, their expression is limited to the expected endogenous pattern of the Brn3a and Brn3b genes. We use the Brn3a(Cre) and Brn3b(Cre) alleles to target a Cre dependent Adeno Associated Virus (AAV) reporter to RGCs and demonstrate its use in morphological characterization, early postnatal gene delivery and tracing the expression of Brn3 genes in RGCs. Conclusions: Dre recombinase effectively recombines the Brn3a(CKOCre) and Brn3b(CKOCre) alleles containing its roxP target sites. Sequential Dre to Cre recombination reveals Brn3a and Brn3b expression in early mouse development. The generated Brn3a(Cre) and Brn3b(Cre) alleles are useful tools that can target exogenously delivered Cre dependent reagents to RGCs in early postnatal development, opening up a large range of potential applications.	[Sajgo, Szilard; Ghinia, Miruna Georgiana; Shi, Melody; Liu, Pinghu; Dong, Lijin; Parmhans, Nadia; Badea, Tudor Constantin] NEI, NIH, Bethesda, MD 20892 USA; [Sajgo, Szilard; Ghinia, Miruna Georgiana; Popescu, Octavian] Univ Babes Bolyai, Dept Biol, R-3400 Cluj Napoca, Romania; [Popescu, Octavian] Romanian Acad, Inst Biol, Bucharest, Romania	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Babes Bolyai University from Cluj; Romanian Academy of Sciences	Badea, TC (corresponding author), NEI, NIH, Bethesda, MD 20892 USA.	badeatc@mail.nih.gov	Popescu, Octavian/E-4942-2010; Popescu, Octavian/O-2134-2019; Badea, Tudor Constantin/B-1654-2018	Popescu, Octavian/0000-0002-2597-7155; Popescu, Octavian/0000-0002-2597-7155; Badea, Tudor Constantin/0000-0003-3086-6713; Tegla, Miruna G./0000-0001-6898-1886	National Institutes of Health; European Union doctoral fellowship system through POSDRU Program [107/1.5/S/76841]; NATIONAL EYE INSTITUTE [ZIAEY000504, ZICEY000458] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Union doctoral fellowship system through POSDRU Program; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by the National Institutes of Health. Partial funding was provided to M.G.G. by the European Union doctoral fellowship system through POSDRU Program 107/1.5/S/76841. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DJ, 2008, PHYSIOL GENOMICS, V34, P225, DOI 10.1152/physiolgenomics.90242.2008; Anastassiadis K, 2010, METHOD ENZYMOL, V477, P109, DOI 10.1016/S0076-6879(10)77007-5; Anastassiadis K, 2009, DIS MODEL MECH, V2, P508, DOI 10.1242/dmm.003087; Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Auricchio A, 2001, HUM MOL GENET, V10, P3075, DOI 10.1093/hmg/10.26.3075; Badea TC, 2003, J NEUROSCI, V23, P2314; Badea TC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007859; Badea TC, 2009, NEURON, V61, P852, DOI 10.1016/j.neuron.2009.01.020; Badea TC, 2012, J NEUROSCI, V32, P995, DOI 10.1523/JNEUROSCI.4755-11.2012; Badea TC, 2011, VISION RES, V51, P269, DOI 10.1016/j.visres.2010.08.039; Belteki G, 2003, NAT BIOTECHNOL, V21, P321, DOI 10.1038/nbt787; Betley JN, 2011, HUM GENE THER, V22, P669, DOI 10.1089/hum.2010.204; Borghuis BG, 2011, J NEUROSCI, V31, P2855, DOI 10.1523/JNEUROSCI.6064-10.2011; Brzezinski JA, 2012, DEV BIOL, V365, P395, DOI 10.1016/j.ydbio.2012.03.006; Buchholz F, 1996, NUCLEIC ACIDS RES, V24, P4256, DOI 10.1093/nar/24.21.4256; Budhram-Mahadeo V, 2001, INT J BIOCHEM CELL B, V33, P1027, DOI 10.1016/S1357-2725(01)00069-3; Chen SK, 2011, NATURE, V476, P92, DOI 10.1038/nature10206; Davies Jamie A, 2012, Methods Mol Biol, V886, P185, DOI 10.1007/978-1-61779-851-1_17; Dymecki SM, 1996, P NATL ACAD SCI USA, V93, P6191, DOI 10.1073/pnas.93.12.6191; Ecker JL, 2010, NEURON, V67, P49, DOI 10.1016/j.neuron.2010.05.023; Eng SR, 2001, J NEUROSCI, V21, P541, DOI 10.1523/JNEUROSCI.21-02-00541.2001; Erkman L, 1996, NATURE, V381, P603, DOI 10.1038/381603a0; Farago AF, 2006, NEURON, V50, P205, DOI 10.1016/j.neuron.2006.03.014; Fenno L, 2011, ANNU REV NEUROSCI, V34, P389, DOI 10.1146/annurev-neuro-061010-113817; Gan L, 1996, P NATL ACAD SCI USA, V93, P3920, DOI 10.1073/pnas.93.9.3920; Groth AC, 2000, P NATL ACAD SCI USA, V97, P5995, DOI 10.1073/pnas.090527097; Guler AD, 2008, NATURE, V453, P102, DOI 10.1038/nature06829; Harding SD, 2011, DEVELOPMENT, V138, P2845, DOI 10.1242/dev.063594; Harris JA., 2012, CURR PROTOC NEUROSCI, V20, P21, DOI [10.1002/0471142301.ns0120-59, DOI 10.1002/0471142301.NS0120-59, 10.1002/0471142301.ns0120s59, DOI 10.1002/0471142301.NS0120S59]; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Hirsch MR, 2013, GENESIS, V51, P506, DOI 10.1002/dvg.22393; Huang CC, 2013, ELIFE, V2, DOI 10.7554/eLife.00400; Huberman AD, 2008, NEURON, V59, P425, DOI 10.1016/j.neuron.2008.07.018; Ivanova E, 2013, J COMP NEUROL, V521, P2165, DOI 10.1002/cne.23279; Jameson SA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002575; Kim IJ, 2008, NATURE, V452, P478, DOI 10.1038/nature06739; Knopfel T, 2012, NAT REV NEUROSCI, V13, P687, DOI 10.1038/nrn3293; Lebherz C, 2008, J GENE MED, V10, P375, DOI 10.1002/jgm.1126; Lee G, 1998, GENE, V216, P55, DOI 10.1016/S0378-1119(98)00325-4; Liu CY, 2013, METHODS MOL BIOL, V1027, P183, DOI 10.1007/978-1-60327-369-5_8; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Masland RH, 2001, CURR OPIN NEUROBIOL, V11, P431, DOI 10.1016/S0959-4388(00)00230-0; Masland RH, 2012, NEURON, V76, P266, DOI 10.1016/j.neuron.2012.10.002; MCLEOD M, 1986, MOL CELL BIOL, V6, P3357, DOI 10.1128/MCB.6.10.3357; Mu XQ, 2004, DEVELOPMENT, V131, P1197, DOI 10.1242/dev.01010; Munch TA, 2009, NAT NEUROSCI, V12, P1308, DOI 10.1038/nn.2389; Nern A, 2011, P NATL ACAD SCI USA, V108, P14198, DOI 10.1073/pnas.1111704108; Ohinata Y, 2008, REPRODUCTION, V136, P503, DOI 10.1530/REP-08-0053; Pang JJ, 2008, VISION RES, V48, P377, DOI 10.1016/j.visres.2007.08.009; Qiu F, 2008, J NEUROSCI, V28, P3392, DOI 10.1523/JNEUROSCI.0043-08.2008; Quina LA, 2005, J NEUROSCI, V25, P11595, DOI 10.1523/JNEUROSCI.2837-05.2005; Rabinowitz JE, 2002, J VIROL, V76, P791, DOI 10.1128/JVI.76.2.791-801.2002; Raymond CS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000162; Rossant J, 2011, P NATL ACAD SCI USA, V108, P7659, DOI 10.1073/pnas.1104844108; Sauer B, 2004, NUCLEIC ACIDS RES, V32, P6086, DOI 10.1093/nar/gkh941; SAUER B, 1988, P NATL ACAD SCI USA, V85, P5166, DOI 10.1073/pnas.85.14.5166; Schnutgen F, 2003, NAT BIOTECHNOL, V21, P562, DOI 10.1038/nbt811; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Sosa MAG, 2010, BRAIN STRUCT FUNCT, V214, P91, DOI 10.1007/s00429-009-0230-8; Suzuki E, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1280; Szobota S, 2010, ANNU REV BIOPHYS, V39, P329, DOI 10.1146/annurev.biophys.093008.131400; Tasic B, 2011, P NATL ACAD SCI USA, V108, P7902, DOI 10.1073/pnas.1019507108; Troy JB, 2002, PROG RETIN EYE RES, V21, P263, DOI 10.1016/S1350-9462(02)00002-2; Wang SW, 2002, DEVELOPMENT, V129, P467; Wang SW, 2000, MOL CELL NEUROSCI, V16, P141, DOI 10.1006/mcne.2000.0860; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; Watanabe S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054146; Xiang M, 1997, COLD SPRING HARB SYM, V62, P325; Xiang MQ, 1996, P NATL ACAD SCI USA, V93, P11950, DOI 10.1073/pnas.93.21.11950; Xiang MQ, 1998, DEV BIOL, V197, P155, DOI 10.1006/dbio.1998.8868; Xiang MQ, 1997, P NATL ACAD SCI USA, V94, P9445, DOI 10.1073/pnas.94.17.9445; XIANG MQ, 1995, J NEUROSCI, V15, P4762; Yang ZY, 2003, DEV BIOL, V264, P240, DOI 10.1016/j.ydbio.2003.08.005; Yonehara K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001533; Zufferey R, 1999, J VIROL, V73, P2886, DOI 10.1128/JVI.73.4.2886-2892.1999	76	20	21	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91435	10.1371/journal.pone.0091435	http://dx.doi.org/10.1371/journal.pone.0091435			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608965	Green Submitted, Green Published, gold			2022-12-27	WOS:000332485800136
J	Poore, KR; Hollis, LJ; Murray, RJS; Warlow, A; Brewin, A; Fulford, L; Cleal, JK; Lillycrop, KA; Burdge, GC; Hanson, MA; Green, LR				Poore, Kirsten R.; Hollis, Lisa J.; Murray, Robert J. S.; Warlow, Anna; Brewin, Andrew; Fulford, Laurence; Cleal, Jane K.; Lillycrop, Karen A.; Burdge, Graham C.; Hanson, Mark A.; Green, Lucy R.			Differential Pathways to Adult Metabolic Dysfunction following Poor Nutrition at Two Critical Developmental Periods in Sheep	PLOS ONE			English	Article							INTRAUTERINE GROWTH RESTRICTION; INSULIN-RESISTANCE SYNDROME; PITUITARY-ADRENAL AXIS; MATERNAL UNDERNUTRITION; PRENATAL EXPOSURE; FETAL SHEEP; GLUCOSE-TOLERANCE; EARLY GESTATION; PERICONCEPTIONAL UNDERNUTRITION; POSTNATAL NUTRITION	Epidemiological and experimental studies suggest early nutrition has long-term effects on susceptibility to obesity, cardiovascular and metabolic diseases. Small and large animal models confirm the influence of different windows of sensitivity, from fetal to early postnatal life, on offspring phenotype. We showed previously that undernutrition in sheep either during the first month of gestation or immediately after weaning induces differential, sex-specific changes in adult metabolic and cardiovascular systems. The current study aims to determine metabolic and molecular changes that underlie differences in lipid and glucose metabolism induced by undernutrition during specific developmental periods in male and female sheep. Ewes received 100% (C) or 50% nutritional requirements (U) from 1-31 days gestation, and 100% thereafter. From weaning (12 weeks) to 25 weeks, offspring were then fed either ad libitum (CC, UC) or were undernourished (CU, UU) to reduce body weight to 85% of their individual target. From 25 weeks, all offspring were fed ad libitum. A cohort of late gestation fetuses were studied after receiving either 40% nutritional requirements (1-31 days gestation) or 50% nutritional requirements (104-127 days gestation). Post-weaning undernutrition increased in vivo insulin sensitivity, insulin receptor and glucose transporter 4 expression in muscle, and lowered hepatic methylation at the delta-like homolog 1/maternally expressed gene 3 imprinted cluster in adult females, but not males. Early gestational undernutrition induced lower hepatic expression of gluconeogenic factors in fetuses and reduced in vivo adipose tissue insulin sensitivity in adulthood. In males, undernutrition in early gestation increased adipose tissue lipid handling mechanisms (lipoprotein lipase, glucocorticoid receptor expression) and hepatic methylation within the imprinted control region of insulin-like growth factor 2 receptor in adulthood. Therefore, undernutrition during development induces changes in mechanisms of lipid and glucose metabolism which differ between tissues and sexes dependent on the period of nutritional restriction. Such changes may increase later life obesity and dyslipidaemia risk.	[Poore, Kirsten R.; Hollis, Lisa J.; Murray, Robert J. S.; Warlow, Anna; Brewin, Andrew; Fulford, Laurence; Cleal, Jane K.; Lillycrop, Karen A.; Burdge, Graham C.; Hanson, Mark A.; Green, Lucy R.] Univ Southampton, Fac Med, Acad Unit Human Dev & Hlth, Southampton SO9 5NH, Hants, England	University of Southampton	Poore, KR (corresponding author), Univ Southampton, Fac Med, Acad Unit Human Dev & Hlth, Southampton SO9 5NH, Hants, England.	kpoore@soton.ac.uk	Cleal, Jane/AAC-5062-2019; Hanson, Mark/AAE-8236-2019; Poore, Kirsten R/H-3949-2011; Cleal, Jane/AAC-9070-2019; Burdge, Graham/A-2370-2014	Cleal, Jane/0000-0001-7978-4327; Hanson, Mark/0000-0002-6907-613X; Poore, Kirsten R/0000-0002-1455-0615; Burdge, Graham/0000-0002-7665-2967; Lillycrop, Karen/0000-0001-7350-5489; Green, Lucy/0000-0001-7423-9696	Wessex Medical Research Innovation Fund [M13]; Biotechnology and Biosciences project grant [D17858]; Gerald Kerkut Trust; British Heart Foundation; Biotechnology and Biological Sciences Research Council [D17858] Funding Source: researchfish	Wessex Medical Research Innovation Fund; Biotechnology and Biosciences project grant; Gerald Kerkut Trust; British Heart Foundation(British Heart Foundation); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Wessex Medical Research Innovation Fund (M13) (www.wesmed.org.uk), a Biotechnology and Biosciences project grant (D17858) (http://www.bbsrc.ac.uk) and a Gerald Kerkut Trust PhD Studentship (http://www.southampton.ac.uk/similar to gktrust/). Professor Mark Hanson is funded by British Heart Foundation (http://www.bhf.org.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFRC (Agricultural and Food Research Council), 1993, EN PROT REQ RUM ADV, P100; Allender S, 2007, OBES REV, V8, P467, DOI 10.1111/j.1467-789X.2007.00394.x; BARKER DJP, 1989, LANCET, V2, P577; Barker DJP, 2005, NEW ENGL J MED, V353, P1802, DOI 10.1056/NEJMoa044160; Bavdekar A, 1999, DIABETES, V48, P2422, DOI 10.2337/diabetes.48.12.2422; Brameld JM, 2000, J ENDOCRINOL, V167, P429, DOI 10.1677/joe.0.1670429; Brown J, 2009, TRENDS BIOCHEM SCI, V34, P612, DOI 10.1016/j.tibs.2009.07.003; Burdge GC, 2000, BRIT J NUTR, V84, P781; Burdge GC, 2010, ANNU REV NUTR, V30, P315, DOI 10.1146/annurev.nutr.012809.104751; Burrage DM, 2009, J PHYSIOL-LONDON, V587, P611, DOI 10.1113/jphysiol.2008.165944; Cleal JK, 2007, PEDIATR RES, V62, P422, DOI 10.1203/PDR.0b013e31813cbe60; Cleal JK, 2007, P NATL ACAD SCI USA, V104, P9529, DOI 10.1073/pnas.0610373104; Costello PM, 2008, J PHYSIOL-LONDON, V586, P2371, DOI 10.1113/jphysiol.2008.150987; Cottrell EC, 2008, PHYSIOL BEHAV, V94, P17, DOI 10.1016/j.physbeh.2007.11.017; Crowther NJ, 1998, DIABETOLOGIA, V41, P1163, DOI 10.1007/s001250051046; Darp RA, 2010, REPROD FERT DEVELOP, V22, P1188, DOI 10.1071/RD09292; Drake AJ, 2012, CLIN ENDOCRINOL, V77, P808, DOI 10.1111/j.1365-2265.2012.04453.x; Dudley KJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021662; Eriksson JG, 2002, DIABETOLOGIA, V45, P342, DOI 10.1007/s00125-001-0757-6; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Gardner DS, 2005, AM J PHYSIOL-REG I, V289, pR947, DOI 10.1152/ajpregu.00120.2005; George LA, 2012, AM J PHYSIOL-REG I, V302, pR795, DOI 10.1152/ajpregu.00241.2011; Godfrey KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041759; Godfrey KM, 2011, DIABETES, V60, P1528, DOI 10.2337/db10-0979; Gonzalez-Barranco J, 2003, METABOLISM, V52, P1005, DOI 10.1016/S0026-0495(03)00151-3; Haugen G, 2005, CIRC RES, V96, P12, DOI 10.1161/01.RES.0000152391.45273.A2; Hawkins P, 2000, EXP PHYSIOL, V85, P85, DOI 10.1111/j.1469-445X.2000.01914.x; Heijmans BT, 2008, P NATL ACAD SCI USA, V105, P17046, DOI 10.1073/pnas.0806560105; Lan Xianyong, 2013, Frontiers in Genetics, V4, P49, DOI 10.3389/fgene.2013.00049; LAW CM, 1992, J EPIDEMIOL COMMUN H, V46, P184, DOI 10.1136/jech.46.3.184; Lee K, 2003, J CLIN INVEST, V111, P453, DOI 10.1172/JCI15924; Lillycrop KA, 2008, BRIT J NUTR, V100, P278, DOI 10.1017/S0007114507894438; Lillycrop KA, 2007, BRIT J NUTR, V97, P1064, DOI 10.1017/S000711450769196X; Limesand SW, 2007, AM J PHYSIOL-ENDOC M, V293, pE1716, DOI 10.1152/ajpendo.00459.2007; MacLaughlin SM, 2005, J PHYSIOL-LONDON, V565, P111, DOI 10.1113/jphysiol.2005.084996; Mericq V, 2005, DIABETOLOGIA, V48, P2609, DOI 10.1007/s00125-005-0036-z; Micke GC, 2011, MOL CELL ENDOCRINOL, V332, P234, DOI 10.1016/j.mce.2010.10.018; Moon YS, 2002, MOL CELL BIOL, V22, P5585, DOI 10.1128/MCB.22.15.5585-5592.2002; Morris TJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007271; O'Connell J, 2011, J CLIN ENDOCR METAB, V96, pE680, DOI 10.1210/jc.2010-2026; Ong KKL, 2002, PEDIATR RES, V52, P863, DOI 10.1203/00006450-200212000-00009; Ozanne SE, 1996, AM J PHYSIOL-ENDOC M, V271, pE1128, DOI 10.1152/ajpendo.1996.271.6.E1128; Ozanne SE, 1997, AM J PHYSIOL-ENDOC M, V273, pE46, DOI 10.1152/ajpendo.1997.273.1.E46; Ozanne SE, 1996, AM J PHYSIOL-ENDOC M, V270, pE559, DOI 10.1152/ajpendo.1996.270.4.E559; PEDERSEN JF, 1980, BRIT MED J, V281, P1253, DOI 10.1136/bmj.281.6250.1253; Petry CJ, 2001, MOL CELL ENDOCRINOL, V185, P81, DOI 10.1016/S0303-7207(01)00627-X; PHILLIPS DIW, 1994, DIABETOLOGIA, V37, P150, DOI 10.1007/s001250050086; Poore KR, 2010, J PHYSIOL-LONDON, V588, P2219, DOI 10.1113/jphysiol.2010.187682; Poore KR, 2007, AM J PHYSIOL-ENDOC M, V292, P32; Ravelli ACJ, 1998, LANCET, V351, P173, DOI 10.1016/S0140-6736(97)07244-9; Rosa AL, 2005, CHROMOSOME RES, V13, P809, DOI 10.1007/s10577-005-1015-4; Roseboom TJ, 2000, HEART, V84, P595, DOI 10.1136/heart.84.6.595; Roseboom TJ, 2000, AM J CLIN NUTR, V72, P1101; Rumball CWH, 2008, J PHYSIOL-LONDON, V586, P1399, DOI 10.1113/jphysiol.2007.144071; RUSSEL AJF, 1969, J AGR SCI, V72, P451, DOI 10.1017/S0021859600024874; Spencer SJ, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00109; Tchirikov M, 2002, PLACENTA, V23, pS153, DOI 10.1053/plac.2002.0810; Thurston A, 2008, REPRODUCTION, V135, P29, DOI 10.1530/REP-07-0211; Waddell JN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015055; Wajchenberg BL, 2000, ENDOCR REV, V21, P697, DOI 10.1210/er.21.6.697; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Wiedmeier JE, 2011, NUTR REV, V69, P76, DOI 10.1111/j.1753-4887.2010.00370.x; Wylie AA, 2000, GENOME RES, V10, P1711, DOI 10.1101/gr.161600; Young LE, 2003, MECH DEVELOP, V120, P1433, DOI 10.1016/j.mod.2003.09.006; Zhang S, 2010, FASEB J, V24, P2772, DOI 10.1096/fj.09-154294	65	10	10	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90994	10.1371/journal.pone.0090994	http://dx.doi.org/10.1371/journal.pone.0090994			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603546	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000332483600120
J	Shukla, S; Bafna, K; Sundar, D; Thorat, SS				Shukla, Shantanu; Bafna, Khushboo; Sundar, Durai; Thorat, Sunil S.			The Bitter Barricading of Prostaglandin Biosynthesis Pathway: Understanding the Molecular Mechanism of Selective Cyclooxygenase-2 Inhibition by Amarogentin, a Secoiridoid Glycoside from Swertia chirayita	PLOS ONE			English	Article							SKIN CARCINOGENESIS MODEL; ASPIRIN-LIKE DRUGS; NF-KAPPA-B; ANTIHEPATOTOXIC ACTIVITY; INDUCED HEPATOTOXICITY; BINDING AFFINITIES; HIGH-THROUGHPUT; DOWN-REGULATION; LIGAND-BINDING; SOLVENT MODELS	Swertia chirayita, a medicinal herb inhabiting the challenging terrains and high altitudes of the Himalayas, is a rich source of essential phytochemical isolates. Amarogentin, a bitter secoiridoid glycoside from S. chirayita, shows varied activity in several patho-physiological conditions, predominantly in leishmaniasis and carcinogenesis. Experimental analysis has revealed that amarogentin downregulates the cyclooxygenase-2 (COX-2) activity and helps to curtail skin carcinogenesis in mouse models; however, there exists no account on selective inhibition of the inducible cyclooxygenase (COX) isoform by amarogentin. Hence the computer-aided drug discovery methods were used to unravel the COX-2 inhibitory mechanism of amarogentin and to check its selectivity for the inducible isoform over the constitutive one. The generated theoretical models of both isoforms were subjected to molecular docking analysis with amarogentin and twenty-one other Food and Drug Authority (FDA) approved lead molecules. The post-docking binding energy profile of amarogentin was comparable to the binding energy profiles of the FDA approved selective COX-2 inhibitors. Subsequent molecular dynamics simulation analysis delineated the difference in the stability of both complexes, with amarogentin-COX-2 complex being more stable after 40ns simulation. The total binding free energy calculated by MMGBSA for the amarogentin-COX-2 complex was - 52.35 KCal/mol against a binding free energy of -8.57 KCal/mol for amarogentin-COX-1 complex, suggesting a possible selective inhibition of the COX-2 protein by the natural inhibitor. Amarogentin achieves this potential selectivity by small, yet significant, structural differences inherent to the binding cavities of the two isoforms. Hypothetically, it might block the entry of the natural substrates in the hydrophobic binding channel of the COX-2, inhibiting the cyclooxygenation step. To sum up briefly, this work highlights the mechanism of the possible selective COX-2 inhibition by amarogentin and endorses the possibility of obtaining efficient, futuristic and targeted therapeutic agents for relieving inflammation and malignancy from this phytochemical source.	[Shukla, Shantanu; Thorat, Sunil S.] Reg Ctr Inst Bioresources & Sustainable Dev, Bioresource Database & Bioinformat Div, Tadong, Gangtok, India; [Bafna, Khushboo; Sundar, Durai] Indian Inst Technol Delhi, Dept Biochem Engn & Biotechnol, New Delhi, India; [Thorat, Sunil S.] Inst Bioresources & Sustainable Dev, Distributed Informat Sub Ctr, Imphal, Manipur, India	Department of Biotechnology (DBT) India; Institute of Bioresources & Sustainable Development (IBSD); Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi; Department of Biotechnology (DBT) India; Institute of Bioresources & Sustainable Development (IBSD)	Sundar, D (corresponding author), Indian Inst Technol Delhi, Dept Biochem Engn & Biotechnol, New Delhi, India.	sundar@dbeb.iitd.ac.in; sunilsthorat.ibsd@nic.in	Sundar, Durai/F-7671-2012	Shukla, Shantanu/0000-0002-5473-0207; Sundar, Durai/0000-0002-6549-6663; Bafna, Khushboo/0000-0002-1893-1175	Department of Biotechnology, Government of India [102/IFD/SAN/3287/2005-2006]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	The project was funded by the Department of Biotechnology, Government of India grant to Sub-Distributed Information Centre, IBSD, Imphal, SAN No. 102/IFD/SAN/3287/2005-2006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeniyi AA, 2013, MOLECULES, V18, P3760, DOI 10.3390/molecules18043760; Alonso H, 2006, MED RES REV, V26, P531, DOI 10.1002/med.20067; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068; Bashford D, 2000, ANNU REV PHYS CHEM, V51, P129, DOI 10.1146/annurev.physchem.51.1.129; Behrens M, 2009, J AGR FOOD CHEM, V57, P9860, DOI 10.1021/jf9014334; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; Brahmachari G, 2004, CHEM BIODIVERS, V1, P1627, DOI 10.1002/cbdv.200490123; Calixto JB, 2003, PLANTA MED, V69, P973, DOI [10.1055/s-2003-45141, 10.1055/s-2004-815483]; Campanera JM, 2010, MOLECULES, V15, P2730, DOI 10.3390/molecules15042730; Cao Y, 2002, J CELL PHYSIOL, V190, P279, DOI 10.1002/jcp.10068; Chandrasekharan NV, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-241; Claria J, 2003, CURR PHARM DESIGN, V9, P2177, DOI 10.2174/1381612033454054; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Corley DA, 2003, GASTROENTEROLOGY, V124, P47, DOI 10.1053/gast.2003.50008; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Dirsch VM, 2001, BIOCHEM PHARMACOL, V61, P587, DOI 10.1016/S0006-2952(00)00580-3; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; FERREIRA SH, 1971, NATURE-NEW BIOL, V231, P237, DOI 10.1038/newbio231237a0; Gilson MK, 2007, ANNU REV BIOPH BIOM, V36, P21, DOI 10.1146/annurev.biophys.36.040306.132550; Hou TJ, 2011, J CHEM INF MODEL, V51, P69, DOI 10.1021/ci100275a; Karan M, 1999, PHYTOTHER RES, V13, P24, DOI 10.1002/(SICI)1099-1573(199902)13:1&lt;24::AID-PTR378&gt;3.0.CO;2-L; Karan M, 1999, PHYTOTHER RES, V13, P95, DOI 10.1002/(SICI)1099-1573(199903)13:2&lt;95::AID-PTR379&gt;3.0.CO;2-4; Kiefer JR, 2000, NATURE, V405, P97, DOI 10.1038/35011103; Kimura A, 2000, PROSTAG LEUKOTR ESS, V63, P315, DOI 10.1054/plef.2000.0220; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Kuhn B, 2000, J MED CHEM, V43, P3786, DOI 10.1021/jm000241h; KUJUBU DA, 1991, J BIOL CHEM, V266, P12866; Kurumbail RG, 1996, NATURE, V384, P644, DOI 10.1038/384644a0; Kurumbail RG, 2001, CURR OPIN STRUC BIOL, V11, P752, DOI 10.1016/S0959-440X(01)00277-9; LANGENBACH R, 1995, CELL, V83, P483, DOI 10.1016/0092-8674(95)90126-4; Mahdi JG, 2006, CELL PROLIFERAT, V39, P147, DOI 10.1111/j.1365-2184.2006.00377.x; Mahmud S, 2004, BRIT J CANCER, V90, P93, DOI 10.1038/sj.bjc.6601416; Massova I, 2000, PERSPECT DRUG DISCOV, V18, P113, DOI 10.1023/A:1008763014207; Medda S, 1999, J ANTIMICROB CHEMOTH, V44, P791, DOI 10.1093/jac/44.6.791; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Mouihate A, 2002, AM J PHYSIOL-REG I, V283, pR800, DOI 10.1152/ajpregu.00258.2002; Pal D, 2012, CARCINOGENESIS, V33, P2424, DOI 10.1093/carcin/bgs276; Pence HE, 2010, J CHEM EDUC, V87, P1123, DOI 10.1021/ed100697w; Phoboo S, 2013, PHYTOTHER RES, V27, P227, DOI 10.1002/ptr.4714; Price MLP, 2000, J AM CHEM SOC, V122, P9455, DOI 10.1021/ja001018c; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Ray S, 1996, J NAT PROD, V59, P27, DOI 10.1021/np960018g; Riendeau D, 2001, J PHARMACOL EXP THER, V296, P558; Rodriguez LAG, 2001, EPIDEMIOLOGY, V12, P88, DOI 10.1097/00001648-200101000-00015; Saha P, 2004, PHYTOTHER RES, V18, P373, DOI 10.1002/ptr.1436; Saha P, 2006, CANCER LETT, V244, P252, DOI 10.1016/j.canlet.2005.12.036; Saklani A, 2008, DRUG DISCOV TODAY, V13, P161, DOI 10.1016/j.drudis.2007.10.010; Samad TA, 2001, NATURE, V410, P471, DOI 10.1038/35068566; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Sheng HM, 1998, J BIOL CHEM, V273, P22120, DOI 10.1074/jbc.273.34.22120; SITKOFF D, 1994, J PHYS CHEM-US, V98, P1978, DOI 10.1021/j100058a043; SMITH JB, 1971, NATURE-NEW BIOL, V231, P235, DOI 10.1038/newbio231235a0; Subbaramaiah K, 2003, TRENDS PHARMACOL SCI, V24, P96, DOI 10.1016/S0165-6147(02)00043-3; Surh YJ, 2001, MUTAT RES-FUND MOL M, V480, P243, DOI 10.1016/S0027-5107(01)00183-X; Turini ME, 2002, ANNU REV MED, V53, P35, DOI 10.1146/annurev.med.53.082901.103952; VANE JR, 1978, AGENTS ACTIONS, V8, P430, DOI 10.1007/BF01968671; Vane JR, 2003, THROMB RES, V110, P255, DOI 10.1016/S0049-3848(03)00379-7; VANE JR, 1971, NATURE-NEW BIOL, V231, P232, DOI 10.1038/newbio231232a0; Vane JR, 1998, ANNU REV PHARMACOL, V38, P97, DOI 10.1146/annurev.pharmtox.38.1.97; Vlot AC, 2009, ANNU REV PHYTOPATHOL, V47, P177, DOI 10.1146/annurev.phyto.050908.135202; Wang WH, 2003, JNCI-J NATL CANCER I, V95, P1784, DOI 10.1093/jnci/djg106; Warner TD, 1999, P NATL ACAD SCI USA, V96, P7563, DOI 10.1073/pnas.96.13.7563; Weiser J, 1999, J COMPUT CHEM, V20, P217, DOI 10.1002/(SICI)1096-987X(19990130)20:2<217::AID-JCC4>3.0.CO;2-A; XIE WL, 1991, P NATL ACAD SCI USA, V88, P2692, DOI 10.1073/pnas.88.7.2692; Zimmermann KC, 1998, MOL PHARMACOL, V54, P536, DOI 10.1124/mol.54.3.536	67	13	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90637	10.1371/journal.pone.0090637	http://dx.doi.org/10.1371/journal.pone.0090637			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603686	gold, Green Published, Green Submitted			2022-12-27	WOS:000332483600069
J	Fulop, A; Szijarto, A; Harsanyi, L; Budai, A; Pekli, D; Korsos, D; Horvath, I; Kovacs, N; Karlinger, K; Mathe, D; Szigeti, K				Fueloep, Andras; Szijarto, Attila; Harsanyi, Laszlo; Budai, Andras; Pekli, Damjan; Korsos, Diana; Horvath, Ildiko; Kovacs, Noemi; Karlinger, Kinga; Mathe, Domokos; Szigeti, Krisztian			Demonstration of Metabolic and Cellular Effects of Portal Vein Ligation Using Multi-Modal PET/MRI Measurements in Healthy Rat Liver	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; BRANCH LIGATION; HEPATOCELLULAR-CARCINOMA; RADIOFREQUENCY ABLATION; GLUCOSE-UTILIZATION; TISSUE; EMBOLIZATION; REGENERATION; F-18-FDG; GROWTH	Objectives: In the early recognition of portal vein ligation (PVL) induced tumor progression, positron emission tomography and magnetic resonance imaging (PET/MRI) could improve diagnostic accuracy of conventionally used methods. It is unknown how PVL affects metabolic patterns of tumor free hepatic tissues. The aim of this preliminary study is to evaluate the effect of PVL on glucose metabolism, using PET/MRI imaging in healthy rat liver. Materials and Methods: Male Wistar rats (n = 30) underwent PVL. 2/deoxy-2-(F-18)fluoro-D-glucose (FDG) PET/MRI imaging (nanoScan PET/MRI) and morphological/histological examination were performed before (Day 0) and 1, 2, 3, and 7 days after PVL. Dynamic PET data were collected and the standardized uptake values (SUV) for ligated and non-ligated liver lobes were calculated in relation to cardiac left ventricle (SUVVOI/SUVCLV) and mean liver SUV (SUVVOI/SUVLiver). Results: PVL induced atrophy of ligated lobes, while non-ligated liver tissue showed compensatory hypertrophy. Dynamic PET scan revealed altered FDG kinetics in both ligated and non-ligated liver lobes. SUVVOI/SUVCLV significantly increased in both groups of lobes, with a maximal value at the 2nd postoperative day and returned near to the baseline 7 days after the ligation. After PVL, ligated liver lobes showed significantly higher tracer uptake compared to the non-ligated lobes (significantly higher SUVVOI/SUVLiver values were observed at postoperative day 1, 2 and 3). The homogenous tracer biodistribution observed before PVL reappeared by 7th postoperative day. Conclusion: The observed alterations in FDG uptake dynamics should be taken into account during the assessment of PET data until the PVL induced atrophic and regenerative processes are completed.	[Fueloep, Andras; Szijarto, Attila; Harsanyi, Laszlo; Budai, Andras; Pekli, Damjan; Korsos, Diana] Semmelweis Univ, Dept Surg 1, H-1085 Budapest, Hungary; [Horvath, Ildiko; Szigeti, Krisztian] Semmelweis Univ, Dept Biophys & Radiat Biol, H-1085 Budapest, Hungary; [Kovacs, Noemi; Mathe, Domokos] CROmed Translat Res Ctr, Budapest, Hungary; [Karlinger, Kinga] Semmelweis Univ, Dept Radiol & Oncotherapy, H-1085 Budapest, Hungary	Semmelweis University; Semmelweis University; Semmelweis University	Fulop, A (corresponding author), Semmelweis Univ, Dept Surg 1, H-1085 Budapest, Hungary.	fulop.andras2@gmail.com		Mathe, Domokos/0000-0001-7343-0413	European Union [HEALTH-F2-2011-278850]; European Community FP7 Transnational Access grant QNANO	European Union(European Commission); European Community FP7 Transnational Access grant QNANO	The work leading to this invention has received funding from the European Union's Seventh Framework Program (FP7/2007-2013) under grant agreement nu HEALTH-F2-2011-278850 (INMiND). This study was supported in part by the European Community FP7 Transnational Access grant QNANO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No other current funding sources were involved in this study.	Abdalla EK, 2002, ARCH SURG-CHICAGO, V137, P675, DOI 10.1001/archsurg.137.6.675; Abdalla EK, 2001, BRIT J SURG, V88, P165, DOI 10.1046/j.1365-2168.2001.01658.x; Abouzied MM, 2005, J NUCL MED TECHNOL, V33, P145; Alexander B, 2002, PFLUG ARCH EUR J PHY, V444, P291, DOI 10.1007/s00424-002-0815-z; Antoch G, 2005, J NUCL MED, V46, P520; Barbaro B, 2003, ACTA RADIOL, V44, P98, DOI 10.1034/j.1600-0455.2003.00016.x; BENGMARK S, 1988, ANN SURG, V207, P120, DOI 10.1097/00000658-198802000-00002; Bennink RJ, 2004, J NUCL MED, V45, P965; BRINKMANN A, 1978, H-S Z PHYSIOL CHEM, V359, P1561, DOI 10.1515/bchm2.1978.359.2.1561; Broering DC, 2002, J GASTROINTEST SURG, V6, P905, DOI 10.1016/S1091-255X(02)00122-1; Caraco C, 2000, J BIOL CHEM, V275, P18489, DOI 10.1074/jbc.M908096199; Clavien P, 2007, NEW ENGL J MED, V356, P1545, DOI 10.1056/NEJMra065156; de Graaf W, 2011, BRIT J SURG, V98, P825, DOI 10.1002/bjs.7456; de Graaf W, 2009, ANN SURG ONCOL, V16, P423, DOI 10.1245/s10434-008-0222-6; Elias D, 1999, BRIT J SURG, V86, P784, DOI 10.1046/j.1365-2168.1999.01154.x; Gock M, 2011, MICROVASC RES, V81, P274, DOI 10.1016/j.mvr.2011.03.005; Hahn Oszkar, 2013, Magy Seb, V66, P21, DOI 10.1556/MaSeb.66.2013.1.3; Hammerstingl R, 2008, EUR RADIOL, V18, P457, DOI 10.1007/s00330-007-0716-9; Heinrich S, 2006, J HEPATOL, V45, P35, DOI 10.1016/j.jhep.2006.02.020; Ho CL, 2003, J NUCL MED, V44, P213; Hsiao IT, 2010, J HEPATOL, V52, P540, DOI 10.1016/j.jhep.2010.01.005; IKEDA K, 1995, ARCH HISTOL CYTOL, V58, P171, DOI 10.1679/aohc.58.171; Juweid ME, 2006, NEW ENGL J MED, V354, P496, DOI 10.1056/NEJMra050276; KAWASAKI S, 1994, SURGERY, V115, P674; Kokudo N, 2001, HEPATOLOGY, V34, P267, DOI 10.1053/jhep.2001.26513; KUBOTA K, 1991, J NUCL MED, V32, P2118; Mueller L, 2003, J SURG RES, V114, P146, DOI 10.1016/S0022-4804(03)00252-X; Pauwels EKJ, 1998, NUCL MED BIOL, V25, P317, DOI 10.1016/S0969-8051(97)00226-6; Pauwels EKJ, 2000, J CANCER RES CLIN, V126, P549, DOI 10.1007/PL00008465; Rocheleau B, 1999, AM J PHYSIOL-GASTR L, V277, pG1000, DOI 10.1152/ajpgi.1999.277.5.G1000; Rosa JL, 1997, HEPATOLOGY, V25, P324; ROZGA J, 1986, AM J PATHOL, V125, P300; Song SL, 2013, J NUCL MED, V54, P104, DOI 10.2967/jnumed.112.109397; Stewart EE, 2006, RADIOLOGY, V239, P740, DOI 10.1148/radiol.2393041382; SUZUKI S, 1993, TRANSPLANTATION, V55, P1265; Takayama T, 2011, JPN J CLIN ONCOL, V41, P447, DOI 10.1093/jjco/hyr016; Takei T, 2005, J NUCL MED, V46, P794; Vogt FM, 2007, J NUCL MED, V48, P1836, DOI 10.2967/jnumed.107.042846; Willatt JM, 2008, RADIOLOGY, V247, P311, DOI 10.1148/radiol.2472061331; Zakko WF, 1998, AM J PHYSIOL-GASTR L, V275, pG717, DOI 10.1152/ajpgi.1998.275.4.G717	40	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90760	10.1371/journal.pone.0090760	http://dx.doi.org/10.1371/journal.pone.0090760			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599299	Green Published, Green Submitted, gold			2022-12-27	WOS:000332479400131
J	Gupta, MA; Knapp, K				Gupta, Madhulika A.; Knapp, Katie			Cardiovascular and Psychiatric Morbidity in Obstructive Sleep Apnea (OSA) with Insomnia (Sleep Apnea Plus) versus Obstructive Sleep Apnea without Insomnia: A Case-Control Study from a Nationally Representative US Sample	PLOS ONE			English	Article							DAYTIME SLEEPINESS; RISK-FACTORS; PREVALENCE; SYMPTOMS; PATHOPHYSIOLOGY; CONSEQUENCES; DISORDERS; DURATION; AXIS	Purpose: To evaluate cardiovascular and psychiatric morbidity in patient visits with obstructive sleep apnea (OSA) with insomnia (OSA+Insomnia) versus OSA without insomnia (OSA-Insomnia) in a nationally representative US sample. Methods: A retrospective case-control study of epidemiologic databases (National Ambulatory Medical Care Survey and National Hospital Ambulatory Medical Care Survey) representing an estimated +/- standard error (SE) 62,253,910 +/- 5,274,747 (unweighted count = 7234) patient visits with diagnosis of OSA from 1995-2010, was conducted. An estimated 3,994,104 +/- 791,386 (unweighted count = 658) were classified as OSA+Insomnia and an estimated 58,259,80 +/- 64,849,800 (unweighted count = 6576) as OSA-Insomnia. Logistic regression analysis was carried out using OSA+ Insomnia versus OSA-Insomnia as the dependent variable, and age (> 50 years versus <= 50 years), sex, race ('White' versus 'non-White'), essential hypertension, heart failure, ischemic heart disease, cardiac dysrhythmia, cerebrovascular disease, diabetes, obesity, hyperlipidemia, depressive, anxiety, and adjustment disorders (includes PTSD), hypersomnia and all medications used as independent variables. All comorbidities were physician diagnosed using the ICD9-CM. Results: Among patient visits with OSA, an estimated 6.4% +/- 0.9% also had insomnia. Logistic regression analysis revealed that the OSA+ Insomnia group was significantly more likely to have essential hypertension (all ICD9-CM codes 401) (OR = 1.83, 95% CI 1.27-2.65) and provisionally more likely to have cerebrovascular disease (ICD9-CM codes 430-438) (OR = 6.58, 95% CI 1.66-26.08). The significant OR for cerebrovascular disease was considered provisional because the unweighted count was < 30. Conclusions: In a nationally representative sample, OSA+ Insomnia was associated significantly more frequently with essential hypertension than OSA-Insomnia, a finding that has not been previously reported. In contrast to studies that have considered patient self-reports of psychological morbidity, the absence of a significant association with psychiatric disorders in our study may be indicative of the fact that we considered only physician-rated psychiatric syndromes meeting ICD9-CM criteria. Our findings among the OSA+ Insomnia group are therefore most likely conservative.	[Gupta, Madhulika A.; Knapp, Katie] Univ Western Ontario, Dept Psychiat, Schulich Sch Med & Dent, London, ON N6A 3K7, Canada	Western University (University of Western Ontario)	Gupta, MA (corresponding author), Univ Western Ontario, Dept Psychiat, Schulich Sch Med & Dent, London, ON N6A 3K7, Canada.	magupta@uwo.ca		Knapp, Katie/0000-0002-4436-6122	M.A. Gupta Medicine Professional Corporation	M.A. Gupta Medicine Professional Corporation	The study was funded (publication fees) by M.A. Gupta Medicine Professional Corporation. The first author (M. A. G) is the sole shareholder of this corporation. M. A. Gupta Medicine Professional Corporation had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Medical Association, 2003, INT CLASS DIS; Beneto A, 2009, SLEEP MED REV, V13, P287, DOI 10.1016/j.smrv.2008.09.006; Bianchi MT, 2013, J SLEEP RES, V22, P557, DOI 10.1111/jsr.12046; Billings ME, 2013, SLEEP, V36, P221, DOI 10.5665/sleep.2376; Bjornsdottir E, 2012, J SLEEP RES, V21, P131, DOI 10.1111/j.1365-2869.2011.00972.x; Bonnet MH, 2010, SLEEP MED REV, V14, P9, DOI 10.1016/j.smrv.2009.05.002; Brostrom Anders, 2012, Qual Prim Care, V20, P287; Buckley TM, 2005, J CLIN ENDOCR METAB, V90, P3106, DOI 10.1210/jc.2004-1056; Celen YT, 2010, ANATOL J CARDIOL, V10, P168, DOI 10.5152/akd.2010.044; Centers for Disease Control and Prevention, AMB HLTH CAR DAT REL; Centers for Disease Control and Prevention, AMB HLTH CAR DAT; Chokroverty S, 2010, INDIAN J MED RES, V131, P126; Chung KF, 2005, RESPIRATION, V72, P460, DOI 10.1159/000087668; Culebras A, 2013, SLEEP STROKE CARDIOV; Das Aneesa M, 2009, Expert Rev Cardiovasc Ther, V7, P619, DOI 10.1586/erc.09.25; Duran-Cantolla J, 2009, SLEEP MED REV, V13, P323, DOI 10.1016/j.smrv.2008.11.001; Fernandez-Mendoza J, 2012, HYPERTENSION, V60, P929, DOI 10.1161/HYPERTENSIONAHA.112.193268; Fichten CS, 2013, J HEALTH PSYCHOL, V18, P750, DOI 10.1177/1359105312465918; Gillespie CF, 2005, PSYCHOSOM MED, V67, pS26, DOI 10.1097/01.psy.0000163456.22154.d2; Golbidi S, 2012, LUNG, V190, P113, DOI 10.1007/s00408-011-9340-1; Golbin Jason M, 2008, Proc Am Thorac Soc, V5, P200, DOI 10.1513/pats.200708-143MG; Gold AR, 2008, SLEEP MED, V9, P675, DOI 10.1016/j.sleep.2007.08.013; Gold AR, 2011, SLEEP MED REV, V15, P389, DOI 10.1016/j.smrv.2010.11.004; Guilleminault C, 2002, J PSYCHOSOM RES, V53, P617, DOI 10.1016/S0022-3999(02)00463-4; GUILLEMINAULT C, 1973, SCIENCE, V181, P856, DOI 10.1126/science.181.4102.856; Guilleminault C, 2008, SLEEP, V31, P1527, DOI 10.1093/sleep/31.11.1527; Harris M, 2009, SLEEP MED REV, V13, P437, DOI 10.1016/j.smrv.2009.04.001; IBM, 2011, SPSS STAT WIND COMPL; Krakow B, 2001, CHEST, V120, P1923, DOI 10.1378/chest.120.6.1923; Krakow B, 2006, SLEEP BREATH, V10, P16, DOI 10.1007/s11325-005-0037-7; Krakow Barry, 2002, Sleep Breath, V6, P189; Krell Suzanne B, 2005, Sleep Breath, V9, P104, DOI 10.1007/s11325-005-0026-x; Lavie P, 2007, SLEEP MED, V8, pS21, DOI 10.1016/S1389-9457(08)70005-4; LeBlanc M, 2009, SLEEP, V32, P1027, DOI 10.1093/sleep/32.8.1027; Lee MH, 2013, SLEEP BREAT IN PRESS; Lichstein KL, 2013, SLEEP MED, V14, P824, DOI 10.1016/j.sleep.2013.02.008; Mota PC, 2012, REV PORT PNEUMOL, V18, P15, DOI 10.1016/j.rppneu.2011.06.016; Mysliwiec V, 2013, CHEST, V144, P549, DOI 10.1378/chest.13-0088; Namen AM, 2002, CHEST, V121, P1741, DOI 10.1378/chest.121.6.1741; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; Nguyen XL, 2013, EUR RESPIR J, V41, P593, DOI 10.1183/09031936.00080011; Nguyen XL, 2010, SLEEP MED, V11, P777, DOI 10.1016/j.sleep.2010.04.008; Pieh C, 2013, SLEEP BREATH, V17, P99, DOI 10.1007/s11325-012-0655-9; Punjabi NM, 2000, SLEEP, V23, P471, DOI 10.1093/sleep/23.4.471; Richardson GS, 2001, J CLIN PSYCHIAT, V62, P39; Roth T, 2007, SLEEP MED REV, V11, P71, DOI 10.1016/j.smrv.2006.06.002; Roth Thomas, 2003, Clin Cornerstone, V5, P5, DOI 10.1016/S1098-3597(03)90031-7; Sateia MJ, 2009, CHEST, V135, P1370, DOI 10.1378/chest.08-1834; SERIES F, 1994, AM J RESP CRIT CARE, V150, P481, DOI 10.1164/ajrccm.150.2.8049833; Sivertsen B, 2013, J SLEEP RES, V22, P223, DOI 10.1111/j.1365-2869.2012.01055.x; Smith S, 2004, SLEEP MED, V5, P449, DOI 10.1016/j.sleep.2004.03.005; Staner L, 2010, SLEEP MED REV, V14, P35, DOI 10.1016/j.smrv.2009.09.003; Vgontzas AN, 2009, SLEEP, V32, P491, DOI 10.1093/sleep/32.4.491; Vgontzas AN, 2001, J CLIN ENDOCR METAB, V86, P3787, DOI 10.1210/jc.86.8.3787; Vozoris NT, 2012, SLEEP MED, V13, P637, DOI 10.1016/j.sleep.2012.01.004; Wickwire EM, 2010, SLEEP MED, V11, P772, DOI 10.1016/j.sleep.2010.03.012; Yang CM, 2011, J PSYCHOSOM RES, V70, P355, DOI 10.1016/j.jpsychores.2010.12.005	57	30	32	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90021	10.1371/journal.pone.0090021	http://dx.doi.org/10.1371/journal.pone.0090021			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC4GP	24599301	Green Published, gold, Green Submitted			2022-12-27	WOS:000332479400040
J	Selva, N; Berezowska-Cnota, T; Elguero-Claramunt, I				Selva, Nuria; Berezowska-Cnota, Teresa; Elguero-Claramunt, Isabel			Unforeseen Effects of Supplementary Feeding: Ungulate Baiting Sites as Hotspots for Ground-Nest Predation	PLOS ONE			English	Article							BOAR SUS-SCROFA; FOOD SUPPLEMENTATION; BREEDING SUCCESS; RED DEER; CONSERVATION; TOOL; CAPERCAILLIE; PRODUCTIVITY; POPULATION; CARCASSES	Despite the ubiquity and magnitude of food provision to wildlife, our understanding of its ecological effects and conservation implications is very limited. Supplementary feeding of ungulates, still one of the main paradigms of game management in Europe, occurs in natural areas on an enormous scale. We investigated the indirect effects of this practice on nest predation risk in the Polish Eastern Carpathians (Bieszczady Mountains). We hypothesized that the predators attracted to ungulate baiting sites would also forage for alternative prey nearby, increasing the nest predation risk for ground-nesting birds in the vicinity. We conducted a paired experiment by placing artificial nests (N = 120) in feeding and control sites (N = 12) at different distances from the ungulate feeding site. We also documented the use of three ungulate feeding sites by potential nest predators with automatic cameras. The proportion of depredated nests was 30% higher in the vicinity of feeding sites than at control sites (65%+/- 31.5 vs 35%+/- 32.1). The probability of a nest being depredated significantly increased with time and at shorter distances from the feeding site. We predicted that the area within 1-km distance from the feeding site would have a high risk (> 0.5) of nest predation. We recorded 13 species of potential ground-nest predators at ungulate baiting sites. Most frequent were Eurasian jays Garrulus glandarius, mice and voles Muroidea, ravens Corvus corax, brown bears Ursus arctos, and wild boar Sus scrofa. Nest predators made most use of supplementary feeding sites (82% pictures with predators vs 8% with ungulates, the target group). Our study alerts of the impacts of ungulate feeding on alternative prey; this is of special concern when affecting protected species. We urge for a sensible management of ungulate feeding, which considers potential indirect effects on other species and the spatial and temporal components of food provision.	[Selva, Nuria; Berezowska-Cnota, Teresa; Elguero-Claramunt, Isabel] Polish Acad Sci, Inst Nat Conservat, Krakow, Poland	Polish Academy of Sciences	Selva, N (corresponding author), Polish Acad Sci, Inst Nat Conservat, Krakow, Poland.	nuriselva@gmail.com	Selva, Nuria/J-6970-2013	Selva, Nuria/0000-0003-3389-201X; Berezowska-Cnota, Teresa/0000-0002-2566-6672	Polish Ministry of Science and Higher Education [NN304294037]; Institute of Nature Conservation PAS	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Institute of Nature Conservation PAS	This study was supported by the Polish Ministry of Science and Higher Education (project NN304294037) and by the budget of the Institute of Nature Conservation PAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apollonio M., 2010, EUROPEAN UNGULATES T; Barrios-Garcia MN, 2012, BIOL INVASIONS, V14, P2283, DOI 10.1007/s10530-012-0229-6; Bartos Ludek, 2010, P243; Bates D., 2013, LME4 LINEAR MIXED EF; Bonczar Z, 2007, ATLAS ROZMIESZCZENIA, P88; Borgmann KL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065909; Brown RD, 2006, WILDLIFE SOC B, V34, P519, DOI 10.2193/0091-7648(2006)34[519:TNEAEA]2.0.CO;2; Brunnschweiler JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058522; Clout MN, 2002, BIOL CONSERV, V107, P13, DOI 10.1016/S0006-3207(01)00267-1; Cooper SM, 2000, WILDLIFE SOC B, V28, P660; Corcoran MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059235; Cortes-Avizanda A, 2009, ANIM CONSERV, V12, P85, DOI 10.1111/j.1469-1795.2008.00231.x; Cortes-Avizanda A, 2009, BASIC APPL ECOL, V10, P265, DOI 10.1016/j.baae.2008.03.009; Cote SD, 2004, ANNU REV ECOL EVOL S, V35, P113, DOI 10.1146/annurev.ecolsys.35.021103.105725; Darveau M, 1997, ECOL APPL, V7, P572, DOI 10.1890/1051-0761(1997)007[0572:FPATRO]2.0.CO;2; Davies ZG, 2009, BIOL CONSERV, V142, P761, DOI 10.1016/j.biocon.2008.12.016; Dunkley L., 2003, COMPREHENSIVE REV EC; Geisser H, 2005, J ZOOL, V267, P89, DOI 10.1017/S095283690500734X; Hamilton AM, 2002, AM MIDL NAT, V147, P123, DOI 10.1674/0003-0031(2002)147[0123:EODFHA]2.0.CO;2; Harrison TJE, 2010, OECOLOGIA, V164, P311, DOI 10.1007/s00442-010-1645-x; Hulme Philip E., 2007, V25, P56; Inslerman R.A., 2006, WILDLIFE SOC TECHNIC, V06-1; Jerina K, 2012, J MAMMAL, V93, P1139, DOI 10.1644/11-MAMM-A-136.1; Kowalczyk R, 2011, FOREST ECOL MANAG, V261, P821, DOI 10.1016/j.foreco.2010.11.026; Lambert BC, 2001, SOUTHWEST NAT, V46, P118, DOI 10.2307/3672387; Lopez-Bao JV, 2008, BIOL CONSERV, V141, P1857, DOI 10.1016/j.biocon.2008.05.002; Mandema FS, 2013, J COAST CONSERV, V17, P409, DOI 10.1007/s11852-013-0239-2; Margalida A, 2010, EUR J WILDLIFE RES, V56, P673, DOI 10.1007/s10344-010-0366-0; Gonzalez L, 2006, BIOL CONSERV, V129, P477, DOI 10.1016/j.biocon.2005.11.014; MARTIN TE, 1993, AM NAT, V141, P897, DOI 10.1086/285515; Martinson TJ, 2003, WILDLIFE SOC B, V31, P510; Marzec B, 2012, LOWIEC POLSKI, V10, P14; McKinnon L, 2010, SCIENCE, V327, P326, DOI 10.1126/science.1183010; Miller R, 2003, J WILDLIFE DIS, V39, P84, DOI 10.7589/0090-3558-39.1.84; Moore RP, 2004, ECOLOGY, V85, P1562, DOI 10.1890/03-0088; Newey S, 2010, J ZOOL, V282, P214, DOI 10.1111/j.1469-7998.2010.00728.x; Newton I., 1998, POPULATION LIMITATIO; Orams MB, 2002, TOURISM MANAGE, V23, P281, DOI 10.1016/S0261-5177(01)00080-2; Orros ME, 2012, BASIC APPL ECOL, V13, P286, DOI 10.1016/j.baae.2012.03.001; Pedersen AO, 2009, EUR J WILDLIFE RES, V55, P371, DOI 10.1007/s10344-009-0253-8; Piper SE, 2005, P INT C CONS MAN VUL, P41; Plummer KE, 2013, SCI REP-UK, V3, DOI 10.1038/srep02002; Putman RJ, 2004, MAMMAL REV, V34, P285, DOI 10.1111/j.1365-2907.2004.00044.x; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Robb GN, 2008, FRONT ECOL ENVIRON, V6, P476, DOI 10.1890/060152; Roodbergen M, 2012, J ORNITHOL, V153, P53, DOI 10.1007/s10336-011-0733-y; Saniga M, 2002, FOLIA ZOOL, V51, P205; Schoech SJ, 2008, BIOL CONSERV, V141, P162, DOI 10.1016/j.biocon.2007.09.009; Seibold S, 2013, BASIC APPL ECOL, V14, P687, DOI 10.1016/j.baae.2013.09.003; Selva N., 2009, VULTURES FEEDING STA, P452; Sikora A., 2007, ATLAS ROZMIESZCZENIA; Sorensen A, 2013, PREV VET ME IN PRESS; Storch I, 2007, WILDLIFE BIOL, V13, P5, DOI 10.2981/0909-6396(2007)13[5:CSOGWA]2.0.CO;2; Summers RW, 2004, J APPL ECOL, V41, P513, DOI 10.1111/j.0021-8901.2004.00891.x; SWENSON JE, 1994, J AVIAN BIOL, V25, P8, DOI 10.2307/3677289; UNEP, 2007, CARP ENV OUTL, P232; Walpole MJ, 2001, ANIM CONSERV, V4, P67, DOI 10.1017/S136794300100107X; Wawrzyniak Piotr, 2010, P223; Wilmers CC, 2003, ECOL LETT, V6, P996, DOI 10.1046/j.1461-0248.2003.00522.x; Winnicki T., 2009, NATURE BIESZCZADY NA; Zanette L, 2010, J ANIM ECOL, V79, P1172, DOI 10.1111/j.1365-2656.2010.01724.x	61	48	48	2	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90740	10.1371/journal.pone.0090740	http://dx.doi.org/10.1371/journal.pone.0090740			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599216	gold, Green Submitted, Green Published			2022-12-27	WOS:000332479400128
J	Valdes, AL; Mc Laughlin, M; Viani, L; Walshe, P; Smith, J; Zeng, FG; Reilly, RB				Valdes, Alejandro Lopez; Mc Laughlin, Myles; Viani, Laura; Walshe, Peter; Smith, Jaclyn; Zeng, Fan-Gang; Reilly, Richard B.			Objective Assessment of Spectral Ripple Discrimination in Cochlear Implant Listeners Using Cortical Evoked Responses to an Oddball Paradigm	PLOS ONE			English	Article							MISMATCH NEGATIVITY; SPEECH RECOGNITION; NORMAL-HEARING; TRIPOLAR STIMULATION; CHILDREN; PERFORMANCE; POTENTIALS; MATURATION; RESOLUTION; ADULTS	Cochlear implants (CIs) can partially restore functional hearing in deaf individuals. However, multiple factors affect CI listener's speech perception, resulting in large performance differences. Non-speech based tests, such as spectral ripple discrimination, measure acoustic processing capabilities that are highly correlated with speech perception. Currently spectral ripple discrimination is measured using standard psychoacoustic methods, which require attentive listening and active response that can be difficult or even impossible in special patient populations. Here, a completely objective cortical evoked potential based method is developed and validated to assess spectral ripple discrimination in CI listeners. In 19 CI listeners, using an oddball paradigm, cortical evoked potential responses to standard and inverted spectrally rippled stimuli were measured. In the same subjects, psychoacoustic spectral ripple discrimination thresholds were also measured. A neural discrimination threshold was determined by systematically increasing the number of ripples per octave and determining the point at which there was no longer a significant difference between the evoked potential response to the standard and inverted stimuli. A correlation was found between the neural and the psychoacoustic discrimination thresholds (R-2 = 0.60, p < 0.01). This method can objectively assess CI spectral resolution performance, providing a potential tool for the evaluation and follow-up of CI listeners who have difficulty performing psychoacoustic tests, such as pediatric or new users.	[Valdes, Alejandro Lopez; Mc Laughlin, Myles; Reilly, Richard B.] Univ Dublin Trinity Coll, Trinity Ctr Bioengn, Dublin 2, Ireland; [Mc Laughlin, Myles; Zeng, Fan-Gang] Univ Calif Irvine, Hearing & Speech Lab, Irvine, CA USA; [Viani, Laura; Walshe, Peter; Smith, Jaclyn] Beaumont Hosp, Natl Cochlear Implant Programme, Dublin 9, Ireland	Trinity College Dublin; University of California System; University of California Irvine	Valdes, AL (corresponding author), Univ Dublin Trinity Coll, Trinity Ctr Bioengn, Dublin 2, Ireland.	lopezvaa@tcd.ie	Reilly, Richard/N-1080-2019; Reilly, Richard B/F-7034-2011; Mc Laughlin, Myles/G-3497-2015; Valdes, Alejandro Lopez/AAW-6341-2020	Reilly, Richard/0000-0001-8578-1245; Reilly, Richard B/0000-0001-8578-1245; Mc Laughlin, Myles/0000-0001-8574-1841; Valdes, Alejandro Lopez/0000-0002-5568-9808	Higher Education Authority (HEA) Graduate Research Education Program in Engineering (GREP-Eng) scholarship; EU FP7 Marie Curie International Outgoing Fellowship; National Institutes of Health; United States Department of Health and Human Services [P30 DC008369]	Higher Education Authority (HEA) Graduate Research Education Program in Engineering (GREP-Eng) scholarship; EU FP7 Marie Curie International Outgoing Fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Health and Human Services	This work was supported by a Higher Education Authority (HEA) Graduate Research Education Program in Engineering (GREP-Eng) scholarship to Alejandro Lopez Valdes, an EU FP7 Marie Curie International Outgoing Fellowship to Myles Mc Laughlin and the National Institutes of Health, the United States Department of Health and Human Services (P30 DC008369). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBAS PJ, 1988, HEARING RES, V36, P153, DOI 10.1016/0378-5955(88)90057-3; Blamey P, 1996, Audiol Neurootol, V1, P293; Brown CJ, 2008, EAR HEARING, V29, P704, DOI 10.1097/AUD.0b013e31817a98af; Brown CJ, 2000, EAR HEARING, V21, P151, DOI 10.1097/00003446-200004000-00009; BYRNE D, 1994, J ACOUST SOC AM, V96, P2108, DOI 10.1121/1.410152; Cheour M, 1998, INT J PSYCHOPHYSIOL, V29, P217, DOI 10.1016/S0167-8760(98)00017-8; Clark JH, 2012, J AM GERIATR SOC, V60, P1936, DOI 10.1111/j.1532-5415.2012.04150.x; Dimitrijevic A, 2004, EAR HEARING, V25, P68, DOI 10.1097/01.AUD.0000111545.71693.48; Firszt Jill B., 2002, Ear and Hearing, V23, P502, DOI 10.1097/00003446-200212000-00002; Franck KH, 2001, EAR HEARING, V22, P289, DOI 10.1097/00003446-200108000-00004; Friesen LM, 2010, HEARING RES, V259, P95, DOI 10.1016/j.heares.2009.10.012; Friesen LM, 2001, J ACOUST SOC AM, V110, P1150, DOI 10.1121/1.1381538; Fu QJ, 2002, NEUROREPORT, V13, P1635, DOI 10.1097/00001756-200209160-00013; Gilley PM, 2008, BRAIN RES, V1239, P56, DOI 10.1016/j.brainres.2008.08.026; Gilley PM, 2006, CLIN NEUROPHYSIOL, V117, P1772, DOI 10.1016/j.clinph.2006.04.018; He C, 2009, NEUROPSYCHOLOGIA, V47, P218, DOI 10.1016/j.neuropsychologia.2008.07.019; Henry BA, 2005, J ACOUST SOC AM, V118, P1111, DOI 10.1121/1.1944567; Henry BA, 2003, J ACOUST SOC AM, V113, P2861, DOI 10.1121/1.1561900; Hofmann M, 2010, JARO-J ASSOC RES OTO, V11, P267, DOI 10.1007/s10162-009-0201-z; Horn D, 2013, 36 ASS RES OT ANN MI, V36, P289; Hughes ML, 2000, EAR HEARING, V21, P164, DOI 10.1097/00003446-200004000-00010; Jones GL, 2011, J ACOUST SOC AM, V133, P425; Landsberger DM, 2009, HEARING RES, V254, P34, DOI 10.1016/j.heares.2009.04.007; Lazard DS, 2010, ACTA OTO-LARYNGOL, V130, P1267, DOI 10.3109/00016481003769972; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; Litvak LM, 2007, J ACOUST SOC AM, V122, P982, DOI 10.1121/1.2749413; Loizou PC, 1999, IEEE ENG MED BIOL, V18, P32, DOI 10.1109/51.740962; Mc Laughlin M, 2013, HEARING RES, V302, P84, DOI 10.1016/j.heares.2013.05.006; Mc Laughlin M, 2012, IEEE T NEUR SYS REH, V20, P443, DOI 10.1109/TNSRE.2012.2186982; Naatanen R, 2012, CLIN NEUROPHYSIOL, V123, P424, DOI 10.1016/j.clinph.2011.09.020; Pantev C, 2006, CEREB CORTEX, V16, P31, DOI 10.1093/cercor/bhi081; Picton TW, 2000, AUDIOL NEURO-OTOL, V5, P111, DOI 10.1159/000013875; Pisoni DB, 1999, VOLTA REV, V101, P111; Ponton CW, 1997, EVOKED POTENTIAL, V104, P143, DOI 10.1016/S0168-5597(97)96104-9; Ponton CW, 1996, EAR HEARING, V17, P430, DOI 10.1097/00003446-199610000-00009; Ponton CW, 2000, AUDIOL NEURO-OTOL, V5, P167, DOI 10.1159/000013878; Sharma A, 2009, J COMMUN DISORD, V42, P272, DOI 10.1016/j.jcomdis.2009.03.003; Supin AY, 1997, HEARING RES, V108, P17, DOI 10.1016/S0378-5955(97)00035-X; Torppa R, 2012, CLIN NEUROPHYSIOL, V123, P1966, DOI 10.1016/j.clinph.2012.03.008; Trainor L, 2003, INT J PSYCHOPHYSIOL, V51, P5, DOI 10.1016/S0167-8760(03)00148-X; van Dijk JE, 1999, AUDIOLOGY, V38, P109; Viola FC, 2011, PSYCHOPHYSIOLOGY, V48, P1470, DOI 10.1111/j.1469-8986.2011.01224.x; Waltzman SB, 2005, PEDIATRICS, V116, pE487, DOI 10.1542/peds.2005-0282; Won JH, 2007, JARO-J ASSOC RES OTO, V8, P384, DOI 10.1007/s10162-007-0085-8; Won JH, 2011, JARO-J ASSOC RES OTO, V12, P375, DOI 10.1007/s10162-011-0257-4; Wong DDE, 2009, IEEE T BIO-MED ENG, V56, P2851, DOI 10.1109/TBME.2009.2029239; Wu CC, 2013, JARO-J ASSOC RES OTO, V14, P213, DOI 10.1007/s10162-012-0366-8; Zeng Fan-Gang, 2004, Trends Amplif, V8, P1, DOI 10.1177/108471380400800102; Zeng Fan-Gang, 2008, IEEE Rev Biomed Eng, V1, P115, DOI 10.1109/RBME.2008.2008250; Zeng FG, 2002, J ACOUST SOC AM, V111, P377, DOI 10.1121/1.1423926; Zhu ZY, 2012, HEARING RES, V283, P45, DOI 10.1016/j.heares.2011.11.005	51	13	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90044	10.1371/journal.pone.0090044	http://dx.doi.org/10.1371/journal.pone.0090044			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599314	Green Published, gold			2022-12-27	WOS:000332479400041
J	Ciocalteu, A; Saftoiu, A; Cartana, T; Gruionu, LG; Pirici, D; Georgescu, CC; Georgescu, CV; Gheonea, DI; Gruionu, G				Ciocalteu, Adriana; Saftoiu, Adrian; Cartana, Tatiana; Gruionu, Lucian Gheorghe; Pirici, Daniel; Georgescu, Corneliu Cristian; Georgescu, Claudia-Valentina; Gheonea, Dan Ionut; Gruionu, Gabriel			Evaluation of New Morphometric Parameters of Neoangiogenesis in Human Colorectal Cancer Using Confocal Laser Endomicroscopy (CLE) and Targeted Panendothelial Markers	PLOS ONE			English	Article							ANTI-ANGIOGENIC THERAPY; IN-VIVO; VASCULATURE; MICROVASCULATURE; VASCULARIZATION; NORMALIZATION; ARCHITECTURE; TORTUOSITY; TUMORS; MODEL	The tumor microcirculation is characterized by an abnormal vascular network with dilated, tortuous and saccular vessels. Therefore, imaging the tumor vasculature and determining its morphometric characteristics represent a critical goal for optimizing the cancer treatment that targets the blood vessels (i.e. antiangiogenesis therapy). The aim of this study was to evaluate new vascular morphometric parameters in colorectal cancer, difficult to achieve through conventional immunohistochemistry, by using the confocal laser endomicroscopy method. Fresh biopsies from tumor and normal tissue were collected during colonoscopy from five patients with T3 colorectal carcinoma without metastasis and were marked with fluorescently labeled anti-CD31 antibodies. A series of optical slices spanning 250 mm inside the tissue were immediately collected for each sample using a confocal laser endomicroscope. All measurements were expressed as the mean +/- standard error. The mean diameter of tumor vessels was significantly larger than the normal vessels (9.46 +/- 0.4 mu m vs. 7.60 +/- 0.3 mu m, p = 0.0166). The vessel density was also significantly higher in the cancer vs. normal tissue samples (5541.05 +/- 262.81 vs. 3755.79 +/- 194.96 vessels/mm(3), p = 0.0006). These results were confirmed by immunohistochemistry. In addition, the tortuosity index and vessel lengths were not significantly different (1.05 +/- 0.016 and 28.30 +/- 3.27 mu m in normal tissue, vs. 1.07 +/- 0.008 and 26.49 +/- 3.18 mu m in tumor tissue respectively, p = 0.5357 and p = 0.7033). The daughter/mother ratio (ratio of the sum of the squares of daughter vessel radii over the square of the mother vessel radius) was 1.15 +/- 0.09 in normal tissue, and 1.21 +/- 0.08 in tumor tissue (p = 0.6531). The confocal laser endomicroscopy is feasible for measuring more vascular parameters from fresh tumor biopsies than conventional immunohistochemistry alone. Provided new contrast agents will be clinically available, future in vivo use of CLE could lead to identification of novel biomarkers based on the morphometric characteristics of tumor vasculature.	[Ciocalteu, Adriana; Saftoiu, Adrian; Cartana, Tatiana; Gruionu, Lucian Gheorghe; Gheonea, Dan Ionut; Gruionu, Gabriel] Univ Med & Pharm Craiova, Res Ctr Gastroenterol & Hepatol, Craiova, Romania; [Gruionu, Lucian Gheorghe] Univ Craiova, Dept Mech Engn, Craiova, Romania; [Pirici, Daniel] Univ Med & Pharm Craiova, Dept Histol, Craiova, Romania; [Georgescu, Corneliu Cristian] Univ Med & Pharm Craiova, Dept Pharmacol, Craiova, Romania; [Georgescu, Corneliu Cristian] Emergency Cty Hosp, Dept Anesthesiol & Intens Care, Craiova, Romania; [Georgescu, Claudia-Valentina] Emergency Cty Hosp, Dept Pathol, Craiova, Romania; [Gruionu, Gabriel] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Radiat Oncol,Edwin L Steele Lab Tumor Biol, Boston, MA USA	University of Medicine & Pharmacy of Craiova; University of Craiova; University of Medicine & Pharmacy of Craiova; University of Medicine & Pharmacy of Craiova; Harvard University; Harvard Medical School; Massachusetts General Hospital	Saftoiu, A (corresponding author), Univ Med & Pharm Craiova, Res Ctr Gastroenterol & Hepatol, Craiova, Romania.	adrian.saftoiu@umfcv.ro	GRUIONU, Lucian Gheorghe/F-6121-2011; Gruionu, Gabriel/C-5152-2011; Ciocalteu, Adriana/AAF-8592-2021; Gheonea, Dan Ionut/C-3578-2012; Saftoiu, Adrian/C-2792-2011; Pirici, Daniel/C-5760-2012	GRUIONU, Lucian Gheorghe/0000-0002-4526-0864; Saftoiu, Adrian/0000-0001-7993-8269; Pirici, Daniel/0000-0001-9192-7319; Pirici, Daniel/0000-0002-0196-0949; Ciocalteu, Adriana/0000-0002-8668-4946	National Research Council (CNCS), Romania [PN-II-ID-PCE-2011-3-0664, PN-II-CT-ERC-2012-1]	National Research Council (CNCS), Romania	This work was supported from two research grants funded by the National Research Council (CNCS), Romania, entitled "Clinical and Biomathematical Modeling of Vascular Changes Following Anti-Angiogenic Therapy in Advanced Colorectal Carcinoma," contract number PN-II-ID-PCE-2011-3-0664, and "Real-time Evaluation of Treatment Effects in Advanced Colorectal Carcinoma," contract number PN-II-CT-ERC-2012-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baish JW, 2000, CANCER RES, V60, P3683; Bullitt E, 2005, ACAD RADIOL, V12, P1232, DOI 10.1016/j.acra.2005.05.027; Bullitt E, 2003, IEEE T MED IMAGING, V22, P1163, DOI 10.1109/TMI.2003.816964; Cartana T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052815; Cheong LS, 2009, J SIGNAL PROCESS SYS, V55, P217, DOI 10.1007/s11265-008-0204-8; Cheung ATW, 1997, INT J ONCOL, V11, P69; Ehling J, 2013, THROMB HAEMOSTASIS, V109, P375, DOI 10.1160/TH12-10-0721; Ellis LM, 1998, EUR J CANCER, V34, P609, DOI 10.1016/S0959-8049(97)10040-5; Fukumura D, 2010, MICROCIRCULATION, V17, P206, DOI 10.1111/j.1549-8719.2010.00029.x; Gheonea DI, 2011, WORLD J GASTROENTERO, V17, P21, DOI 10.3748/wjg.v17.i1.21; Goel S, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006486; Goel S, 2011, PHYSIOL REV, V91, P1071, DOI 10.1152/physrev.00038.2010; Goetz M, 2008, EUR SURG RES, V41, P290, DOI 10.1159/000148242; Gruionu G, 2005, AM J PHYSIOL-HEART C, V288, pH2047, DOI 10.1152/ajpheart.00496.2004; Jain RK, 2001, NAT MED, V7, P987, DOI 10.1038/nm0901-987; JAIN RK, 1988, CANCER RES, V48, P2641; Kachlik D, 2010, J ANAT, V216, P335, DOI 10.1111/j.1469-7580.2009.01199.x; Konerding MA, 2001, BRIT J CANCER, V84, P1354, DOI 10.1054/bjoc.2001.1809; Lang S, 2012, MICROVASC RES, V84, P314, DOI 10.1016/j.mvr.2012.07.002; Lee CG, 2000, CANCER RES, V60, P5565; Less JR, 1997, MICROCIRCULATION-LON, V4, P25, DOI 10.3109/10739689709148315; Li M, 2013, GUT, V62, P1547, DOI 10.1136/gutjnl-2011-301946; Magnon C, 2007, GENE THER, V14, P108, DOI 10.1038/sj.gt.3302849; Meining A, 2008, GASTROENTEROLOGY, V134, P915, DOI 10.1053/j.gastro.2008.02.049; Mizuno K, 2011, DIGEST DIS SCI, V56, P1811, DOI 10.1007/s10620-010-1519-4; Savai R, 2009, NEOPLASIA, V11, P48, DOI 10.1593/neo.81036; SHERMAN TF, 1981, J GEN PHYSIOL, V78, P431, DOI 10.1085/jgp.78.4.431; Tatum JL, 2000, ACAD RADIOL, V7, P798, DOI 10.1016/S1076-6332(00)80628-5; Tong RT, 2004, CANCER RES, V64, P3731, DOI 10.1158/0008-5472.CAN-04-0074; Yuan F, 1996, P NATL ACAD SCI USA, V93, P14765, DOI 10.1073/pnas.93.25.14765	30	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91084	10.1371/journal.pone.0091084	http://dx.doi.org/10.1371/journal.pone.0091084			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614504	Green Published, gold			2022-12-27	WOS:000332839300074
J	Niedermeyer, THJ; Daily, A; Swiatecka-Hagenbruch, M; Moscow, JA				Niedermeyer, Timo H. J.; Daily, Abigail; Swiatecka-Hagenbruch, Monika; Moscow, Jeffrey A.			Selectivity and Potency of Microcystin Congeners against OATP1B1 and OATP1B3 Expressing Cancer Cells	PLOS ONE			English	Article							ANION-TRANSPORTING POLYPEPTIDES; CYCLIC HEPTAPEPTIDE HEPATOTOXINS; STRUCTURAL-CHARACTERIZATION; CYANOBACTERIAL TOXINS; PROTEIN PHOSPHATASE-1; OSCILLATORIA-AGARDHII; MASS-SPECTROMETRY; GENERAL-METHOD; WATER BLOOM; 1ST REPORT	Microcystins are potent phosphatase inhibitors and cellular toxins. They require active transport by OATP1B1 and OATP1B3 transporters for uptake into human cells, and the high expression of these transporters in the liver accounts for their selective hepatic toxicity. Several human tumors have been shown to have high levels of expression of OATP1B3 but not OATP1B1, the main transporter in liver cells. We hypothesized that microcystin variants could be isolated that are transported preferentially by OATP1B3 relative to OATP1B1 to advance as anticancer agents with clinically tolerable hepatic toxicity. Microcystin variants have been isolated and tested for cytotoxicity in cancer cells stably transfected with OATP1B1 and OATP1B3 transporters. Microcystin variants with cytotoxic OATP1B1/OATP1B3 IC50 ratios that ranged between 0.2 and 32 were found, representing a 150-fold range in transporter selectivity. As microcystin structure has a significant impact on transporter selectivity, it is potentially possible to develop analogs with even more pronounced OATP1B3 selectivity and thus enable their development as anticancer drugs.	[Niedermeyer, Timo H. J.; Swiatecka-Hagenbruch, Monika] Cyano Biotech GmbH, Berlin, Germany; [Niedermeyer, Timo H. J.] Univ Tubingen, Interfac Inst Microbiol & Infect Med, Tubingen, Germany; [Daily, Abigail; Moscow, Jeffrey A.] Univ Kentucky, Dept Pediat, Lexington, KY USA	Eberhard Karls University of Tubingen; University of Kentucky	Niedermeyer, THJ (corresponding author), Cyano Biotech GmbH, Berlin, Germany.	timo.niedermeyer@uni-tuebingen.de		Niedermeyer, Timo/0000-0003-1779-7899	DanceBlue; University of Kentucy; German Federal Ministry of Economics and Technology [KF2766301SB0]; Deutsche Forschungsgemeinschaft; Open Access Publishing Fund of Tuebingen University	DanceBlue; University of Kentucy; German Federal Ministry of Economics and Technology(Federal Ministry for Economic Affairs and Energy (BMWi)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publishing Fund of Tuebingen University	This work was supported in part by DanceBlue, a student-run effort that supports clinical care and research in pediatric oncology at the University of Kentucy, and in part by the German Federal Ministry of Economics and Technology (KF2766301SB0). Open Access publishing is supported by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Tuebingen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AN JS, 1994, TOXICON, V32, P1495, DOI 10.1016/0041-0101(94)90308-5; Andersen R. A., 2005, ALGAL CULTURING TECH; AZEVEDO SMFO, 1994, J APPL PHYCOL, V6, P261, DOI 10.1007/BF02181936; Bagu JR, 1997, J BIOL CHEM, V272, P5087, DOI 10.1074/jbc.272.8.5087; BATEMAN KP, 1995, J CHROMATOGR A, V712, P253, DOI 10.1016/0021-9673(95)00438-S; Beattie KA, 1998, PHYTOCHEMISTRY, V47, P1289, DOI 10.1016/S0031-9422(97)00769-3; Beattie KA, 2000, PHYTOCHEMISTRY, V54, P57, DOI 10.1016/S0031-9422(00)00045-5; Blom JF, 2005, TOXICON, V46, P465, DOI 10.1016/j.toxicon.2005.06.013; Boaru DA, 2006, TOXICOLOGY, V218, P134, DOI 10.1016/j.tox.2005.10.005; BOTES DP, 1985, J CHEM SOC PERK T 1, P2747, DOI 10.1039/p19850002747; BOTES DP, 1984, J CHEM SOC PERK T 1, P2311, DOI 10.1039/p19840002311; Brittain S, 2000, TOXICON, V38, P1759, DOI 10.1016/S0041-0101(00)00105-7; Butler N., 2009, MICROCYSTINS BRIEF O; Buxhofer-Ausch V, 2013, J DRUG DELIV, V2013, P1; Campos A, 2010, INT J MOL SCI, V11, P268, DOI 10.3390/ijms11010268; Chen YM, 2006, TOXICON, V47, P742, DOI 10.1016/j.toxicon.2006.01.026; Christiansen G, 2003, J BACTERIOL, V185, P564, DOI 10.1128/JB.185.2.564-572.2003; Christiansen G, 2008, J NAT PROD, V71, P1881, DOI 10.1021/np800397u; Colby DA, 2006, MINI-REV MED CHEM, V6, P109; CRAIG M, 1993, TOXICON, V31, P1541, DOI 10.1016/0041-0101(93)90338-J; Daily A, 2010, TOXICON, V55, P827, DOI 10.1016/j.toxicon.2009.11.019; Dawson RM, 1998, TOXICON, V36, P953, DOI 10.1016/S0041-0101(97)00102-5; del Campo FF, 2010, ENVIRON POLLUT, V158, P2906, DOI 10.1016/j.envpol.2010.06.018; Diehnelt CW, 2006, ANAL CHEM, V78, P501, DOI 10.1021/ac051556d; Diehnelt CW, 2005, TRAC-TREND ANAL CHEM, V24, P622, DOI 10.1016/j.trac.2005.04.013; Dittmann E, 2006, MOL NUTR FOOD RES, V50, P7, DOI 10.1002/mnfr.200500162; Fischer A, 2010, TOXICOL APPL PHARM, V245, P9, DOI 10.1016/j.taap.2010.02.006; GATHERCOLE PS, 1987, J CHROMATOGR, V408, P435, DOI 10.1016/S0021-9673(01)81837-9; GOLDBERG J, 1995, NATURE, V376, P745, DOI 10.1038/376745a0; Grach-Pogrebinsky O, 2004, J NAT PROD, V67, P337, DOI 10.1021/np034036r; Gulledge BM, 2003, BIOORG MED CHEM LETT, V13, P2907, DOI 10.1016/S0960-894X(03)00588-2; Hagenbuch B, 2008, XENOBIOTICA, V38, P778, DOI [10.1080/00498250801986951, 10.1080/00498250801986951 ]; HARADA K, 1991, CHEM RES TOXICOL, V4, P535, DOI 10.1021/tx00023a008; HARADA K, 1991, TOXICON, V29, P479, DOI 10.1016/0041-0101(91)90022-J; Harada K, 2004, CHEM PHARM BULL, V52, P889, DOI 10.1248/cpb.52.889; HARADA K, 1990, CHEM RES TOXICOL, V3, P473, DOI 10.1021/tx00017a014; Hays A, 2013, PHARM RES-DORDR, V30, P2260, DOI 10.1007/s11095-012-0962-7; Herfindal L, 2011, MOL PHARMACEUT, V8, P360, DOI 10.1021/mp1002224; Hicks LM, 2006, ACS CHEM BIOL, V1, P93, DOI 10.1021/cb500007v; Kalliokoski A, 2009, BRIT J PHARMACOL, V158, P693, DOI 10.1111/j.1476-5381.2009.00430.x; KIVIRANTA J, 1992, TOXICON, V30, P1093, DOI 10.1016/0041-0101(92)90054-9; Konig J, 2006, N-S ARCH PHARMACOL, V372, P432, DOI 10.1007/s00210-006-0040-y; KRISHNAMURTHY T, 1989, P NATL ACAD SCI USA, V86, P770, DOI 10.1073/pnas.86.3.770; KUSUMI T, 1987, TETRAHEDRON LETT, V28, P4695, DOI 10.1016/S0040-4039(00)96600-0; Lee TH, 1998, TOXICON, V36, P247, DOI 10.1016/S0041-0101(97)00128-1; Lee TH, 2000, BOT BULL ACAD SINICA, V41, P197; Lee W, 2008, CANCER RES, V68, P10315, DOI 10.1158/0008-5472.CAN-08-1984; Liu TY, 2014, J DRUG TARGET, V22, P14, DOI 10.3109/1061186X.2013.832767; LUUKKAINEN R, 1994, TOXICON, V32, P133, DOI 10.1016/0041-0101(94)90030-2; LUUKKAINEN R, 1993, APPL ENVIRON MICROB, V59, P2204, DOI 10.1128/AEM.59.7.2204-2209.1993; MACKINTOSH C, 1990, FEBS LETT, V264, P187, DOI 10.1016/0014-5793(90)80245-E; Matthiensen A, 2000, PHYTOCHEMISTRY, V55, P383, DOI 10.1016/S0031-9422(00)00335-6; Mayumi T, 2006, J ANTIBIOT, V59, P710, DOI 10.1038/ja.2006.95; Mazur-Marzec H, 2006, RAPID COMMUN MASS SP, V20, P2023, DOI 10.1002/rcm.2558; McCluskey A, 2002, J MED CHEM, V45, P1151, DOI 10.1021/jm010066k; McConnell JL, 2009, MOL PHARMACOL, V75, P1249, DOI 10.1124/mol.108.053140; MERILUOTO JAO, 1989, TOXICON, V27, P1021, DOI 10.1016/0041-0101(89)90153-0; Monks NR, 2007, MOL CANCER THER, V6, P587, DOI 10.1158/1535-7163.MCT-06-0500; Moscow JA, 1997, INT J CANCER, V72, P184, DOI 10.1002/(SICI)1097-0215(19970703)72:1<184::AID-IJC26>3.0.CO;2-I; MOSCOW JA, 1993, BRIT J CANCER, V68, P732, DOI 10.1038/bjc.1993.419; Muto M, 2007, CANCER SCI, V98, P1570, DOI 10.1111/j.1349-7006.2007.00570.x; NAMIKOSHI M, 1992, CHEM RES TOXICOL, V5, P661, DOI 10.1021/tx00029a011; Namikoshi M, 1998, CHEM RES TOXICOL, V11, P143, DOI 10.1021/tx970120t; NAMIKOSHI M, 1992, J ORG CHEM, V57, P866, DOI 10.1021/jo00029a016; NAMIKOSHI M, 1994, J ORG CHEM, V59, P2349, DOI 10.1021/jo00088a014; NAMIKOSHI M, 1995, J ORG CHEM, V60, P3671, DOI 10.1021/jo00117a017; NAMIKOSHI M, 1992, TOXICON, V30, P1457, DOI 10.1016/0041-0101(92)90521-6; NAMIKOSHI M, 1992, TOXICON, V30, P1473, DOI 10.1016/0041-0101(92)90523-8; Niedermeyer THJ, 2014, NAT PRODUCT IN PRESS; Niedermeyer THJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044913; NISHIWAKIMATSUSHIMA R, 1992, J CANCER RES CLIN, V118, P420, DOI 10.1007/BF01629424; Okello W, 2010, ENVIRON TOXICOL, V25, P367, DOI 10.1002/tox.20522; Oksanen I, 2004, APPL ENVIRON MICROB, V70, P5756, DOI 10.1128/AEM.70.10.5756-5763.2004; Pearson L, 2010, MAR DRUGS, V8, P1650, DOI 10.3390/md8051650; Pegram RA, 2008, ADV EXP MED BIOL, V619, P317, DOI 10.1007/978-0-387-75865-7_15; PIANTINI U, 1982, J AM CHEM SOC, V104, P6800, DOI 10.1021/ja00388a062; RINEHART KL, 1988, J AM CHEM SOC, V110, P8557, DOI 10.1021/ja00233a049; Robillot C, 2000, ENVIRON SCI TECHNOL, V34, P3372, DOI 10.1021/es991294v; Sainis I, 2010, MAR DRUGS, V8, P629, DOI 10.3390/md8030629; Sano T, 2004, PHYTOCHEMISTRY, V65, P2159, DOI 10.1016/j.phytochem.2004.03.034; Sano T, 1998, J NAT PROD, V61, P851, DOI 10.1021/np980047m; SANO T, 1995, TETRAHEDRON LETT, V36, P8603, DOI 10.1016/0040-4039(95)01824-2; Sano T, 1998, TETRAHEDRON, V54, P463, DOI 10.1016/S0040-4020(97)10291-5; SIVONEN K, 1990, APPL ENVIRON MICROB, V56, P2650, DOI 10.1128/AEM.56.9.2650-2657.1990; SIVONEN K, 1992, TOXICON, V30, P1465, DOI 10.1016/0041-0101(92)90522-7; SIVONEN K, 1992, TOXICON, V30, P1481, DOI 10.1016/0041-0101(92)90524-9; SIVONEN K, 1992, CHEM RES TOXICOL, V5, P464, DOI 10.1021/tx00028a003; STONER RD, 1989, TOXICON, V27, P825, DOI 10.1016/0041-0101(89)90051-2; Taylor C, 1996, BIOORG MED CHEM LETT, V6, P2113, DOI 10.1016/0960-894X(96)00378-2; Tillett D, 2000, CHEM BIOL, V7, P753, DOI 10.1016/S1074-5521(00)00021-1; Toivola DM, 1999, TOXICOL IN VITRO, V13, P521, DOI 10.1016/S0887-2333(99)00024-7; Tsakalozou E, 2013, DRUG METAB DISPOS, V41, P1404, DOI 10.1124/dmd.112.050021; van Apeldoorn ME, 2007, MOL NUTR FOOD RES, V51, P7, DOI 10.1002/mnfr.200600185; Watanabe MF, 1995, TOXIC MICROCYSTIS; Zurawell RW, 2005, J TOXICOL ENV HEAL B, V8, P1, DOI 10.1080/10937400590889412	95	47	48	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91476	10.1371/journal.pone.0091476	http://dx.doi.org/10.1371/journal.pone.0091476			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614281	Green Submitted, gold, Green Published			2022-12-27	WOS:000332839300131
J	Aitsi-Selmi, A; Bell, R; Shipley, MJ; Marmot, MG				Aitsi-Selmi, Amina; Bell, Ruth; Shipley, Martin J.; Marmot, Michael G.			Education Modifies the Association of Wealth with Obesity in Women in Middle-Income but Not Low-Income Countries: An Interaction Study Using Seven National Datasets, 2005-2010	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; HEALTH; CHINA; OVERWEIGHT; NUTRITION; TRENDS; RISK	Background: Education and wealth may have different associations with female obesity but this has not been investigated in detail outside high-income countries. This study examines the separate and inter-related associations of education and household wealth in relation to obesity in women in a representative sample of low- and middle-income countries (LMICs). Methods: The seven largest national surveys were selected from a list of Demographic and Health Surveys (DHS) ordered by decreasing sample size and resulted in a range of country income levels. These were nationally representative data of women aged 15-49 years collected in the period 2005-2010. The separate and joint effects, unadjusted and adjusted for age group, parity, and urban/rural residence using a multivariate logistic regression model are presented Results: In the four middle-income countries (Colombia, Peru, Jordan, and Egypt), an interaction was found between education and wealth on obesity (P-value for interaction <0.001). Among women with no/primary education the wealth effect was positive whereas in the group with higher education it was either absent or inverted (negative). In the poorer countries (India, Nigeria, Benin), there was no evidence of an interaction. Instead, the associations between each of education and wealth with obesity were independent and positive. There was a statistically significant difference between the average interaction estimates for the low-income and middle-income countries (P < 0.001). Conclusions: The findings suggest that education may protect against the obesogenic effects of increased household wealth as countries develop. Further research could examine the factors explaining the country differences in education effects.	[Aitsi-Selmi, Amina; Bell, Ruth; Shipley, Martin J.; Marmot, Michael G.] UCL, Dept Epidemiol & Publ Hlth, London, England	University of London; University College London	Aitsi-Selmi, A (corresponding author), UCL, Dept Epidemiol & Publ Hlth, London, England.	a.aitsi-selmi@ucl.ac.uk	Marmot, M G/Y-3920-2019	Marmot, M G/0000-0002-2431-6419	Wellcome Trust [WT088536MA]; British Heart Foundation; MRC; ESRC [ES/F02679X/1] Funding Source: UKRI; MRC [G0902037, G0701830, G0601647, G1000616] Funding Source: UKRI; British Heart Foundation [RG/07/008/23674] Funding Source: researchfish; Economic and Social Research Council [ES/F02679X/1] Funding Source: researchfish; Medical Research Council [G0601647, G1000616, G0902037, G0100222, G8802774, G19/35, G0701830] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); British Heart Foundation(British Heart Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Wellcome Trust for funding through a clinical Research Training Fellowship [Grant no WT088536MA]. Martin Shipley is partly supported by the British Heart Foundation. Michael Marmot is supported by a MRC professorship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitsi-Selmi A, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-769; Aitsi-Selmi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039507; Alleyne G, 2013, LANCET; Austin AM, 2013, MATERN CHILD NUTR, V9, P167, DOI 10.1111/j.1740-8709.2011.00346.x; Bartley M., 2004, HLTH INEQUALITY INTR; Bobak M, 2000, J EPIDEMIOL COMMUN H, V54, P91, DOI 10.1136/jech.54.2.91; Brooks R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010587; Chandola T, 2006, J R STAT SOC A STAT, V169, P337, DOI 10.1111/j.1467-985X.2006.00411.x; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Cutler David M, 2010, J Health Econ, V29, P1, DOI 10.1016/j.jhealeco.2009.10.003; Cutler DM, 2006, ED HLTH EVALUATING T; Dahly DL, 2010, J NUTR, V140, P366, DOI 10.3945/jn.109.114207; Dinsa GD, 2012, OBES REV, V13, P1067, DOI 10.1111/j.1467-789X.2012.01017.x; Du SF, 2004, SOC SCI MED, V59, P1505, DOI 10.1016/j.socscimed.2004.01.021; Eizenberg A, 2012, WORKING PAPER; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Harrell FE, 2001, REGRESSION MODELING; Hou XH, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-389; Howe LD, 2012, INT J EPIDEMIOL, V41, P871, DOI 10.1093/ije/dys037; James P, 2006, NUTR REV, V64, pS1, DOI 10.1301/nr.2006.may.S1-S11; Jones-Smith JC, 2012, INT J OBESITY, V36, P1114, DOI 10.1038/ijo.2011.179; Jones-Smith JC, 2011, AM J EPIDEMIOL, V173, P667, DOI 10.1093/aje/kwq428; Just DR, 2009, ANN BEHAV MED, V38, pS47, DOI 10.1007/s12160-009-9119-2; Labonte R, 2007, GLOBALIZATION HEALTH, V3, DOI 10.1186/1744-8603-3-7; Martorell R, 2000, EUR J CLIN NUTR, V54, P247, DOI 10.1038/sj.ejcn.1600931; McKinsey, 2012, WINN 30 TRILL DEC GO; McLaren L, 2007, EPIDEMIOL REV, V29, P29, DOI 10.1093/epirev/mxm001; Mirowsky J., 2003, ED SOCIAL STATUS HLT; Monteiro C, 2004, INT J OBESITY, V28, P1181, DOI 10.1038/sj.ijo.0802716; Monteiro C. A., 2001, Journal of Nutrition, V131, P881; Neuman M, 2011, AM J CLIN NUTR, V94, P1348, DOI 10.3945/ajcn.111.018127; Poterico JA, 2012, OBESITY, V20, P2283, DOI 10.1038/oby.2011.288; Prentice AM, 2009, NESTLE NUTR WORKS SE, V63, P47, DOI 10.1159/000209972; Puoane T, 2002, OBES RES, V10, P1038, DOI 10.1038/oby.2002.141; Rutstein SO, 2004, DHS WEALTH INDEX, Vix; Saito M, 2003, J PHILOS EDUC, V37, P17, DOI 10.1111/1467-9752.3701002; Smith GD, 1998, J EPIDEMIOL COMMUN H, V52, P153; SOBAL J, 1989, PSYCHOL BULL, V105, P260, DOI 10.1037/0033-2909.105.2.260; Stuckler D, 2012, PLOS MED, V9, DOI [10.1371/journal.pmed.1001235, 10.1371/journal.pmed.1001242]; Subramanian SV, 2013, INT J EPIDEMIOL, V42, P1410, DOI 10.1093/ije/dyt017; Subramanian SV, 2011, AM J CLIN NUTR, V93, P413, DOI 10.3945/ajcn.110.004820; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; USAID, 2012, SAMPL HOUS LIST MAN; Wang Y, 2007, INT J OBESITY, V31, P177, DOI 10.1038/sj.ijo.0803354; Wolfe WS, 1997, INT J OBESITY, V21, P802, DOI 10.1038/sj.ijo.0800478; Xiao YY, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-355; Ziraba AK, 2009, BMC HEALTH SERV RES, V9, DOI [10.1186/1471-2458-9-465, 10.1186/1472-6963-9-46]	47	36	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90403	10.1371/journal.pone.0090403	http://dx.doi.org/10.1371/journal.pone.0090403			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC4IY	24608086	Green Submitted, gold, Green Published			2022-12-27	WOS:000332485800024
J	Khelwatty, SA; Essapen, S; Bagwan, I; Green, M; Seddon, AM; Modjtahedi, H				Khelwatty, Said Abdullah; Essapen, Sharadah; Bagwan, Izhar; Green, Margaret; Seddon, Alan Michael; Modjtahedi, Helmout			Co-Expression of HER Family Members in Patients with Dukes' C and D Colon Cancer and Their Impacts on Patient Prognosis and Survival	PLOS ONE			English	Article							FACTOR RECEPTOR EXPRESSION; COLORECTAL-CANCER; MONOCLONAL-ANTIBODY; EGFR EXPRESSION; MUTATIONAL STATUS; ERBB RECEPTORS; THERAPY; PANITUMUMAB; INHIBITOR; CETUXIMAB	The human epidermal growth factor receptor (EGFR) is an important therapeutic target in patients with metastatic colorectal cancer and anti-EGFR antibodies cetuximab and panitumumab have been approved for the treatment of such patients. Despite these advances, the duration of response in some patients can be limited. Since, EGFR is capable of forming heterodimers with the other members of the HER (Human epidermal receptor) family, it is important to investigate the co-expression and prognostic significance of all members of the HER family in colorectal cancer patients. The expression of the HER family members were determined in tumour specimens from 86 patients with Dukes' C and D (metastatic) colon cancer using immunohistochemistry. Sections were scored by the percentage of positive tumour cells and intensity of staining. Their associations with clinicopathological parameters, and overall survival and disease free survival were evaluated using univariate and multivariate analysis. Overall, 43%, 77%, 52% and 92% of the cases were EGFR, HER-2, HER-3 and HER-4 positive respectively. Interestingly, 35%, 24%, 43%, and 18% of the cases had co-expression of EGFR/HER-2, EGFR/HER-3, EGFR/HER-4 and all four members of the HER family respectively. Of these, only the expression of EGFR and co-expression of EGFR/HER-4 were associated with poorer disease-free survival in both univariate and multivariate analysis. Co-expression of all members of the HER family in colon cancer supports the need for further investigations on their predictive value for response to therapy with anti-EGFR mAbs and whether such sub-population of patients may benefit from therapy with the new generation of pan-HER inhibitors.	[Khelwatty, Said Abdullah; Essapen, Sharadah; Seddon, Alan Michael; Modjtahedi, Helmout] Kingston Univ London, Sch Life Sci, Kingston, England; [Essapen, Sharadah] Royal Surrey Cty Hosp, St Lukes Canc Ctr, Guildford, Surrey, England; [Bagwan, Izhar; Green, Margaret] Royal Surrey Cty Hosp, Dept Histopathol, Guildford, Surrey, England	Kingston University; Royal Surrey County Hospital; Royal Surrey County Hospital	Modjtahedi, H (corresponding author), Kingston Univ London, Sch Life Sci, Kingston, England.	H.Modjtahedi@Kingston.ac.uk		Modjtahedi, Helmout/0000-0002-5509-7415; Khelwatty, Said/0000-0002-9735-7641	BRIGHT cancer charity (UK)	BRIGHT cancer charity (UK)	This work is supported by a grant from BRIGHT cancer charity (UK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arteaga CL, 2002, ONCOLOGIST, V7, P31; Baiocchi G, 2009, INT J COLORECTAL DIS, V24, P1059, DOI 10.1007/s00384-009-0702-6; Britten CD, 2004, MOL CANCER THER, V3, P1335; Chu E, 2012, CLIN COLORECTAL CANC, V11, P1, DOI 10.1016/j.clcc.2011.05.005; Ciardiello F, 2008, NEW ENGL J MED, V358, P1160, DOI 10.1056/NEJMra0707704; Cunningham MP, 2006, CANCER RES, V66, P7708, DOI 10.1158/0008-5472.CAN-06-1000; Cunningham MP, 2006, INT J ONCOL, V28, P329; Dempke WCM, 2010, ANTICANCER RES, V30, P4673; Galizia G, 2006, ANN SURG ONCOL, V13, P823, DOI 10.1245/ASO.2006.05.052; Giusti RM, 2008, CLIN CANCER RES, V14, P1296, DOI 10.1158/1078-0432.CCR-07-1354; Goldstein NS, 2001, CANCER, V92, P1331, DOI 10.1002/1097-0142(20010901)92:5<1331::AID-CNCR1455>3.0.CO;2-M; GrausPorta D, 1997, EMBO J, V16, P1647, DOI 10.1093/emboj/16.7.1647; Hebbar M, 2006, ANTI-CANCER DRUG, V17, P855, DOI 10.1097/01.cad.0000217425.44584.9f; Hecht JR, 2010, CLIN CANCER RES, V16, P2205, DOI 10.1158/1078-0432.CCR-09-2017; Khelwatty SA, 2013, FRONT BIOSCI-LANDMRK, V18, P394, DOI 10.2741/4110; Khelwatty SA, 2011, INT J ONCOL, V39, P483, DOI 10.3892/ijo.2011.1054; Kluftinger A M, 1992, Surg Oncol, V1, P97, DOI 10.1016/0960-7404(92)90062-P; Konigsberg R, 2011, ONCOLOGY-BASEL, V81, P359, DOI 10.1159/000334919; Lee JC, 2002, EUR J CANCER, V38, P1065, DOI 10.1016/S0959-8049(02)00004-7; Leung SP, 2008, AM J SURG, V195, P604, DOI 10.1016/j.amjsurg.2007.12.032; Ljuslinder I, 2009, ANTICANCER RES, V29, P1489; Maurer CA, 1998, HUM PATHOL, V29, P771, DOI 10.1016/S0046-8177(98)90444-0; McIntyre E, 2010, BREAST CANCER RES TR, V122, P105, DOI 10.1007/s10549-009-0536-5; Mendelsohn J, 2003, J CLIN ONCOL, V21, P2787, DOI 10.1200/JCO.2003.01.504; Modjtahedi H, 2012, BRIT MED BULL, V104, P41, DOI 10.1093/bmb/lds032; Modjtahedi H, 2009, ANTI-CANCER DRUG, V20, P851, DOI 10.1097/CAD.0b013e3283330590; Nicholson RI, 2001, EUR J CANCER, V37, pS9, DOI 10.1016/s0959-8049(01)00231-3; Normanno N, 2003, ENDOCR-RELAT CANCER, V10, P1, DOI 10.1677/erc.0.0100001; Ooi A, 2004, MODERN PATHOL, V17, P895, DOI 10.1038/modpathol.3800137; Scartozzi M, 2004, J CLIN ONCOL, V22, P4772, DOI 10.1200/JCO.2004.00.117; Scartozzi M, 2011, ONCOLOGIST, V16, P53, DOI 10.1634/theoncologist.2010-0119; Shih T, 2006, CLIN THER, V28, P1779, DOI 10.1016/j.clinthera.2006.11.015; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Siena S, 2009, JNCI-J NATL CANCER I, V101, P1308, DOI 10.1093/jnci/djp280; Spano JP, 2005, ANN ONCOL, V16, P102, DOI 10.1093/annonc/mdi006; Stintzing S, 2012, ANN ONCOL, V23, P1693, DOI 10.1093/annonc/mdr571; Takemura K, 1991, Nihon Shokakibyo Gakkai Zasshi, V88, P1177; Theodoropoulos GE, 2009, ANTICANCER RES, V29, P785; Wei Q, 2011, ONCOL REP, V25, P3, DOI 10.3892/or_00001035; Wong SF, 2005, CLIN THER, V27, P684, DOI 10.1016/j.clinthera.2005.06.003; Wu M, 2008, CLIN THER, V30, P14, DOI 10.1016/j.clinthera.2008.01.014	41	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91139	10.1371/journal.pone.0091139	http://dx.doi.org/10.1371/journal.pone.0091139			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24609222	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000332485800102
J	Kim, JH; Lee, SM; Lee, JH; Jo, YR; Moon, MH; Shin, J; Kim, BJ; Hwang, KR; Lee, TS; Bai, KB; Jeon, HW				Kim, Jee Hyun; Lee, Seung Mi; Lee, Ji-Hyun; Jo, Yu Ri; Moon, Min Hoan; Shin, Jonghwan; Kim, Byoung Jae; Hwang, Kyu Ri; Lee, Taek Sang; Bai, Kwang Bum; Jeon, Hye Won			Successful Conservative Management of Ruptured Ovarian Cysts with Hemoperitoneum in Healthy Women	PLOS ONE			English	Article							RELATIVE BRADYCARDIA; CORPUS-LUTEUM	Study Objective: To determine the success rate of the "intended conservative management strategy" of ruptured ovarian cysts with hemoperitoneum and the risk factors for surgical interventions in healthy women of reproductive age. Methods: Patients who visited the emergency department with abdominal pain and were diagnosed with a ruptured ovarian cyst with hemoperitoneum between August 2008 and June 2013 were included in this retrospective study. The diagnosis of the ruptured ovarian cysts and hemoperitoneum was based on the clinical symptoms, physical examination and ultrasound and CT imaging. The rate of surgical interventions and the risk factors for surgical intervention were determined. Results: A total of 78 women were diagnosed with a ruptured ovarian cyst with hemoperitoneum. Most patients (80.8%, 63/ 78) were managed conservatively, and 19.2% of the patients (15/78) required a surgical intervention. In the multiple logistic regression analysis, the diastolic blood pressure (dBP) (odds ratio [OR] of 0.921 with 95% confidence interval [CI] of 0.855-0.993) and the depth of the total pelvic fluid collection in CT (DTFC_CT) (OR 1.599 with 95% CI 1.092-2.343) were the significant determining factors of surgical intervention after adjustment. The rate of surgical intervention was 6.5% vs. 15.8% vs. 77.8% in the patients with neither dBP <= 70 mmHg nor DTFC_CT >= 5.6 cm, those with only one of those features, and those with both, respectively. Conclusion: Most cases of ruptured ovarian cysts with hemoperitoneum can be managed conservatively. A low diastolic blood pressure and a large amount of hemoperitoneum suggest the need for surgical intervention.	[Kim, Jee Hyun; Lee, Ji-Hyun] Seoul Natl Univ, Bundang Hosp, Dept Obstet & Gynecol, Songnam, South Korea; [Lee, Seung Mi; Kim, Byoung Jae; Hwang, Kyu Ri; Lee, Taek Sang; Bai, Kwang Bum; Jeon, Hye Won] Seoul Natl Univ, Seoul Metropolitan Govt, Dept Obstet & Gynecol, Boramae Med Ctr, Seoul, South Korea; [Jo, Yu Ri] Seoul Natl Univ Hosp, Dept Obstet & Gynecol, Seoul 110744, South Korea; [Moon, Min Hoan] Seoul Natl Univ, Boramae Med Ctr, Seoul Metropolitan Govt, Dept Diagnost Radiol, Seoul, South Korea; [Shin, Jonghwan] Seoul Natl Univ, Boramae Med Ctr, Seoul Metropolitan Govt, Dept Emergency Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital	Jeon, HW (corresponding author), Seoul Natl Univ, Seoul Metropolitan Govt, Dept Obstet & Gynecol, Boramae Med Ctr, Seoul, South Korea.	jshmom04@gmail.com	Lee, Jae Hyuk/W-5616-2018	Lee, Jae Hyuk/0000-0003-2429-4085				ADAMS S L, 1986, Journal of Emergency Medicine, V4, P383, DOI 10.1016/0736-4679(86)90216-7; Bottomley C, 2009, BEST PRACT RES CL OB, V23, P711, DOI 10.1016/j.bpobgyn.2009.02.001; BYDDER GM, 1980, J COMPUT ASSIST TOMO, V4, P145, DOI 10.1097/00004728-198004000-00002; Choi NJ, 2011, J COMPUT ASSIST TOMO, V35, P454, DOI 10.1097/RCT.0b013e31821f4bd2; Hertzberg BS, 1999, ABDOM IMAGING, V24, P304, DOI 10.1007/s002619900502; Ho WK, 2009, TAIWAN J OBSTET GYNE, V48, P108, DOI 10.1016/S1028-4559(09)60267-9; JANSEN RPS, 1978, AUST NZ J OBSTET GYN, V18, P206, DOI 10.1111/j.1479-828X.1978.tb00051.x; Lucey BC, 2005, CURR PROBL DIAGN RAD, V34, P182, DOI 10.1067/j.cpradiol.2005.06.001; Lucey BC, 2007, EMERG RADIOL, V14, P65, DOI [10.1007/s10140-007-0594-0, 10.1007/s10140-007-0600-6]; MacKenna A, 2000, HUM REPROD, V15, P2567, DOI 10.1093/humrep/15.12.2567; QUEENAN JT, 1980, FERTIL STERIL, V34, P99; RAZIEL A, 1993, EUR J OBSTET GYN R B, V50, P77, DOI 10.1016/0028-2243(93)90168-C; Somers MP, 2004, ANN EMERG MED, V43, P382, DOI 10.1016/j.annemergmed.2003.08.004; TANIGUCHI T, 1951, JAMA-J AM MED ASSOC, V147, P1420, DOI 10.1001/jama.1951.03670320020009; Thorson CM, 2013, AM SURGEON, V79, P398	15	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91171	10.1371/journal.pone.0091171	http://dx.doi.org/10.1371/journal.pone.0091171			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608424	gold, Green Submitted, Green Published			2022-12-27	WOS:000332485800110
J	Konecna, E; Safarova, D; Navratil, M; Hanacek, P; Coyne, C; Flavell, A; Vishnyakova, M; Ambrose, M; Redden, R; Smykal, P				Konecna, Eva; Safarova, Dana; Navratil, Milan; Hanacek, Pavel; Coyne, Clarice; Flavell, Andrew; Vishnyakova, Margarita; Ambrose, Mike; Redden, Robert; Smykal, Petr			Geographical Gradient of the eIF4E Alleles Conferring Resistance to Potyviruses in Pea (Pisum) Germplasm	PLOS ONE			English	Article							TRANSLATION INITIATION-FACTORS; GENETIC DIVERSITY; POPULATION-STRUCTURE; NATURAL VARIATION; VIRUSES; IDENTIFICATION; COEVOLUTION; CROP; RETROTRANSPOSON; SUSCEPTIBILITY	Background: The eukaryotic translation initiation factor 4E was shown to be involved in resistance against several potyviruses in plants, including pea. We combined our knowledge of pea germplasm diversity with that of the eIF4E gene to identify novel genetic diversity. Methodology/Principal findings: Germplasm of 2803 pea accessions was screened for eIF4E intron 3 length polymorphism, resulting in the detection of four eIF4E(A-B-C-S) variants, whose distribution was geographically structured. The eIF4E(A) variant conferring resistance to the P1 PSbMV pathotype was found in 53 accessions (1.9%), of which 15 were landraces from India, Afghanistan, Nepal, and 7 were from Ethiopia. A newly discovered variant, eIF4E(B), was present in 328 accessions (11.7%) from Ethiopia (29%), Afghanistan (23%), India (20%), Israel (25%) and China (39%). The eIF4E(C) variant was detected in 91 accessions (3.2% of total) from India (20%), Afghanistan (33%), the Iberian Peninsula (22%) and the Balkans (9.3%). The eIF4E(S) variant for susceptibility predominated as the wild type. Sequencing of 73 samples, identified 34 alleles at the whole gene, 26 at cDNA and 19 protein variants, respectively. Fifteen alleles were virologically tested and 9 alleles (eIF4E(A-1-2-3-4-5-6-7), eIF4E(B-1), eIF4E(C-2)) conferred resistance to the P1 PSbMV pathotype. Conclusions/Significance: This work identified novel eIF4E alleles within geographically structured pea germplasm and indicated their independent evolution from the susceptible eIF4E(S1) allele. Despite high variation present in wild Pisum accessions, none of them possessed resistance alleles, supporting a hypothesis of distinct mode of evolution of resistance in wild as opposed to crop species. The Highlands of Central Asia, the northern regions of the Indian subcontinent, Eastern Africa and China were identified as important centers of pea diversity that correspond with the diversity of the pathogen. The series of alleles identified in this study provides the basis to study the co-evolution of potyviruses and the pea host.	[Konecna, Eva; Hanacek, Pavel] Mendel Univ Brno, Dept Plant Biol, Brno, Czech Republic; [Safarova, Dana; Navratil, Milan] Palacky Univ, Dept Cell Biol & Genet, CR-77147 Olomouc, Czech Republic; [Konecna, Eva; Hanacek, Pavel] Mendel Univ Brno, CEITEC MENDELU, Brno, Czech Republic; [Coyne, Clarice] USDA, Western Reg Plant Intro Stn, Pullman, WA USA; [Flavell, Andrew] Univ Dundee, James Hutton Inst, Div Plant Sci, Invergowrie, Scotland; [Vishnyakova, Margarita] Vavilov Inst Plant Ind, St Petersburg, Russia; [Ambrose, Mike] John Innes Ctr, Norwich, Norfolk, England; [Redden, Robert] Australian Grains Genebank, Horsham, Vic, Australia; [Smykal, Petr] Palacky Univ, Dept Bot, CR-77147 Olomouc, Czech Republic	Mendel University in Brno; Palacky University Olomouc; Mendel University in Brno; United States Department of Agriculture (USDA); James Hutton Institute; University of Dundee; Vavilov All-Russian Institute of Plant Genetic Resources; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Palacky University Olomouc	Smykal, P (corresponding author), Palacky Univ, Dept Bot, CR-77147 Olomouc, Czech Republic.	petr.smykal@upol.cz	Hanacek, Pavel/E-6683-2012; SMÝKAL, Petr/I-3569-2019; Vishnyakova, Margarita Afanasyevna/S-4164-2016	Hanacek, Pavel/0000-0002-9807-1370; SMÝKAL, Petr/0000-0002-6117-8510; Vishnyakova, Margarita Afanasyevna/0000-0003-2808-7745	Ministry of Agriculture [IQ91A229]; USDA (United States Department of Agriculture) [5348-2100=017-00D]; BBSRC [BBS/E/J/000CA493] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/J/000CA493] Funding Source: researchfish; ARS [ARS-0424494] Funding Source: Federal RePORTER	Ministry of Agriculture(Gida Tarim Ve Hayvancilik Bakanligi); USDA (United States Department of Agriculture)(United States Department of Agriculture (USDA)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was supported by the Ministry of Agriculture IQ91A229 project. CC was supported by USDA (United States Department of Agriculture) project #5348-2100=017-00D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbo S, 2012, CRIT REV PLANT SCI, V31, P241, DOI 10.1080/07352689.2011.645428; ALCONERO R, 1985, ANN APPL BIOL, V106, P357, DOI 10.1111/j.1744-7348.1985.tb03125.x; Ali A, 2001, ARCH VIROL, V146, P1855, DOI 10.1007/s007050170038; Andrade M, 2009, J GEN PLANT PATHOL, V75, P241, DOI 10.1007/s10327-009-0163-3; Ashby JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015873; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bhullar NK, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-88; Bhullar NK, 2009, P NATL ACAD SCI USA, V106, P9519, DOI 10.1073/pnas.0904152106; Bruun-Rasmussen M, 2007, MOL PLANT MICROBE IN, V20, P1075, DOI 10.1094/MPMI-20-9-1075; Cavatorta JR, 2008, J MOL EVOL, V67, P551, DOI 10.1007/s00239-008-9172-7; Charron C, 2008, PLANT J, V54, P56, DOI 10.1111/j.1365-313X.2008.03407.x; Chimwamurombe PM, 2011, BIOLOGY AND BREEDING OF FOOD LEGUMES, P19, DOI 10.1079/9781845937669.0019; Cieslarova J, 2012, CZECH J GENET PLANT, V48, P61, DOI 10.17221/127/2011-CJGPB; De Candolle A., 1882, ORIGIN CULTIVATED PL; Fraile A, 2010, ADV VIRUS RES, V76, P1, DOI 10.1016/S0065-3527(10)76001-2; Gao Z, 2004, THEOR APPL GENET, V109, P488, DOI 10.1007/s00122-004-1652-6; Gibbs AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002523; HAGEDORN DJ, 1973, PHYTOPATHOLOGY, V63, P1130, DOI 10.1094/Phyto-63-1130; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hampton R. O., 1975, CMI AAB DESCRIPTIONS; HAMPTON RO, 1986, PISUM NEWSL, V18, P22; Hjulsager CK, 2006, VIROLOGY, V355, P52, DOI 10.1016/j.virol.2006.07.016; Hjulsager CK, 2002, MOL PLANT MICROBE IN, V15, P169, DOI 10.1094/MPMI.2002.15.2.169; Hofinger BJ, 2011, MOL ECOL, V20, P3653, DOI 10.1111/j.1365-294X.2011.05201.x; Ibiza VP, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-631; Jeong HJ, 2012, MOL BREEDING, V29, P349, DOI 10.1007/s11032-011-9550-5; Jing R, 2012, THEOR APPL GENET, V125, P367, DOI 10.1007/s00122-012-1839-1; Jing RC, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-44; JOHANSEN E, 1991, J GEN VIROL, V72, P2625, DOI 10.1099/0022-1317-72-11-2625; Johansen IE, 2001, J VIROL, V75, P6609, DOI 10.1128/JVI.75.14.6609-6614.2001; Johansen IE, 1996, J GEN VIROL, V77, P1329, DOI 10.1099/0022-1317-77-6-1329; Jones EI, 2009, AM NAT, V174, P780, DOI 10.1086/647971; Kang BC, 2005, PLANT J, V42, P392, DOI 10.1111/j.1365-313X.2005.02381.x; Kwon SJ, 2012, GENES GENOM, V34, P305, DOI 10.1007/s13258-011-0213-z; Latham LJ, 2001, AUST J AGR RES, V52, P771, DOI 10.1071/AR00165; Le Gall O, 2011, RECENT ADVANCES IN PLANT VIROLOGY, P177; Li L, 2013, GENET RESOUR CROP EV, V60, P1801, DOI 10.1007/s10722-013-9955-6; Lovisolo O, 2003, ADV VIRUS RES, V62, P325, DOI 10.1016/S0065-3527(03)62006-3; Maxted N, 2001, CURR PLANT SCI BIOT, V39, P181; MUSIL MILOS, 1966, BIOLOGIA [BRATISLAVA], V21, P133; Nicaise V, 2003, PLANT PHYSIOL, V132, P1272, DOI 10.1104/pp.102.017855; Nieto C, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-34; Olsen BS, 2001, ARCH VIROL, V146, P15, DOI 10.1007/s007050170187; Reeves PA, 2012, THEOR APPL GENET, V124, P1155, DOI 10.1007/s00122-011-1776-4; Rigola D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004761; Robaglia C, 2006, TRENDS PLANT SCI, V11, P40, DOI 10.1016/j.tplants.2005.11.004; Roossinck MJ, 2011, CURR OPIN VIROL, V1, P63, DOI 10.1016/j.coviro.2011.05.022; Rubio M, 2009, J GEN VIROL, V90, P2808, DOI 10.1099/vir.0.013151-0; Ruffel S, 2006, J GEN VIROL, V87, P2089, DOI 10.1099/vir.0.81817-0; Safarova D, 2008, ACTA VIROL, V52, P53; Sato M, 2005, FEBS LETT, V579, P1167, DOI 10.1016/j.febslet.2004.12.086; Smykal P, 2008, THEOR APPL GENET, V117, P413, DOI 10.1007/s00122-008-0785-4; Smykal P, 2013, ELSEV INSIGHT, P41, DOI 10.1016/B978-0-12-397935-3.00003-7; Smykal P, 2012, AGRONOMY-BASEL, V2, P74, DOI 10.3390/agronomy2020074; Smykal P, 2011, PLANT GENET RESOUR-C, V9, P4, DOI 10.1017/S147926211000033X; Smykal P, 2010, MOL BREEDING, V26, P425, DOI 10.1007/s11032-009-9383-7; Stein N, 2005, PLANT J, V42, P912, DOI 10.1111/j.1365-313X.2005.02424.x; Tanksley SD, 1997, SCIENCE, V277, P1063, DOI 10.1126/science.277.5329.1063; Vavilov N. I., 1949, ORIGIN VARIATION IMM, P13; Wang AM, 2012, MOL PLANT PATHOL, V13, P795, DOI 10.1111/j.1364-3703.2012.00791.x; WERLE E, 1994, NUCLEIC ACIDS RES, V22, P4354, DOI 10.1093/nar/22.20.4354; Wylie SJ, 2011, ARCH VIROL, V156, P1287, DOI 10.1007/s00705-011-1002-3; Zohary D., 1993, DOMESTICATION PLANTS; Zong XX, 2009, THEOR APPL GENET, V118, P193, DOI 10.1007/s00122-008-0887-z	64	16	17	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90394	10.1371/journal.pone.0090394	http://dx.doi.org/10.1371/journal.pone.0090394			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24609094	gold, Green Published, Green Submitted			2022-12-27	WOS:000332485800023
J	Gomaa, AI; Hashim, MS; Waked, I				Gomaa, Asmaa Ibrahim; Hashim, Mohamed Saad; Waked, Imam			Comparing Staging Systems for Predicting Prognosis and Survival in Patients with Hepatocellular Carcinoma in Egypt	PLOS ONE			English	Article							CLIP SCORE; TRANSARTERIAL CHEMOEMBOLIZATION; RADIOFREQUENCY ABLATION; LIVER-CANCER; JIS SCORE; VALIDATION; JAPAN; CLASSIFICATION; OKUDA; TNM	Introduction: Several hepatocellular carcinoma (HCC) staging systems are available. Although the European Association for Study of Liver Diseases (EASL) and American Association for the Study of Liver Diseases (AASLD) recommended the use of Barcelona Clinic Liver Cancer (BCLC), many studies in different populations revealed heterogeneous results. The aim of this study was to compare different staging systems for predicting prognosis and survival, and for stratifying HCC patients for treatment at a national referral centre for liver disease in Egypt. Methods: 2000 Patients were included in this study. Baseline demographic, clinical, laboratory, and radiological data were determined at diagnosis. Patients were stratified using the Okuda, BCLC, Cancer of the Liver Italian Program (CLIP), and Japan Integrated Staging (JIS). Patients' survival in different stages within each staging system and the validity of the system in predicting survival were compared. Results: The overall survival was 15 months. The 1-, 2-, 3- and 4-year survival of the entire cohort was 56%, 34%, 25% and 15% respectively. The presence of ascites, multiple focal lesions, large tumour size >5 cm, portal vein thrombosis, extrahepatic spread, AFP >= 200 ng/ml and poor Child score were independent predictors of survival (p<0.001). All staging systems were significant in determining overall survival in univariate and multivariate analyses. BCLC was the most predictive staging system for the whole cohort (p<0.001). Among the subgroup of patients offered potentially curative therapy, BCLC was the most informative system in predicting patient survival (p<0.001). For patients with advanced HCC not amenable for specific therapy, CLIP was the best staging system for predicting prognosis (p<0.001). Conclusion: BCLC staging system provided the best prognostic stratification for HCC patients. However, CLIP score has the highest stratification ability in patients with advanced HCC highlighting the importance of including AFP in best staging system.	[Gomaa, Asmaa Ibrahim; Hashim, Mohamed Saad; Waked, Imam] Menoufiya Univ, Hepatol Dept, Natl Liver Inst, Shibin Al Kawm, Menoufiya, Egypt	Egyptian Knowledge Bank (EKB); Menofia University	Gomaa, AI (corresponding author), Menoufiya Univ, Hepatol Dept, Natl Liver Inst, Shibin Al Kawm, Menoufiya, Egypt.	aibrahim@liver-eg.org	Waked/V-1221-2018	Waked/0000-0002-9857-8972; Gomaa, Asmaa/0000-0001-9376-4461; Hashim, Mohamed/0000-0003-2544-1761	National Grant from Science and Technology development Fund (STDF), Egypt [1519]	National Grant from Science and Technology development Fund (STDF), Egypt	This research was funded by a National Grant from Science and Technology development Fund (STDF), Egypt, project ID: 1519. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, GLOBOCAN 2008 V1 2 C; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Chen CH, 2009, EUR J CANCER, V45, P1630, DOI 10.1016/j.ejca.2008.12.025; Chevret S, 1999, J HEPATOL, V31, P133, DOI 10.1016/S0168-8278(99)80173-1; Cho YK, 2008, CANCER-AM CANCER SOC, V112, P352, DOI 10.1002/cncr.23185; Cillo U, 2006, J HEPATOL, V44, P723, DOI 10.1016/j.jhep.2005.12.015; Cillo U, 2004, J HEPATOL, V40, P124, DOI 10.1016/j.jhep.2003.09.027; Collette S, 2008, ANN ONCOL, V19, P1117, DOI 10.1093/annonc/mdn030; COX DR, 1972, J R STAT SOC B, V34, P187; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; El-Zayadi AR, 2005, WORLD J GASTROENTERO, V11, P5193; Farinati F, 2000, CANCER, V89, P2266, DOI 10.1002/1097-0142(20001201)89:11<2266::AID-CNCR15>3.0.CO;2-0; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Grieco A, 2005, GUT, V54, P411, DOI 10.1136/gut.2004.048124; Grizzi F, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-3; Guglielmi A, 2008, AM J GASTROENTEROL, V103, P597, DOI 10.1111/j.1572-0241.2007.01604.x; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Huang YH, 2005, J GASTROEN HEPATOL, V20, P765, DOI 10.1111/j.1440-1746.2005.03746.x; Huitzil-Melendez FD, 2010, J CLIN ONCOL, V28, P2889, DOI 10.1200/JCO.2009.25.9895; Huo TI, 2006, AM J GASTROENTEROL, V101, P975, DOI 10.1111/j.1572-0241.2006.00462.x; Huo TI, 2005, GUT, V54, P1348, DOI 10.1136/gut.2005.069468; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kee KM, 2007, INT J CANCER, V120, P2650, DOI 10.1002/ijc.22616; Kondo K, 2007, HEPATO-GASTROENTEROL, V54, P1534; Kudo M, 2003, J GASTROENTEROL, V38, P207, DOI 10.1007/s005350300038; Kudo M, 2004, HEPATOLOGY, V40, P1396, DOI 10.1002/hep.20486; Kudo M, 2007, ONCOLOGY-BASEL, V72, P2, DOI 10.1159/000111702; Lee Jung Hyun, 2007, Korean J Gastroenterol, V49, P17; Lei HJ, 2006, J AM COLL SURGEONS, V203, P426, DOI 10.1016/j.jamcollsurg.2006.06.030; Leung TWT, 2002, CANCER, V94, P1760, DOI 10.1002/cncr.10384; Levy I, 2002, GUT, V50, P881, DOI 10.1136/gut.50.6.881; Liem MSL, 2005, WORLD J GASTROENTERO, V11, P4465, DOI 10.3748/wjg.v11.i29.4465; Llovet JM, 1999, SEMIN LIVER DIS, V19, P329, DOI 10.1055/s-2007-1007122; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Manghisi G, 1998, HEPATOLOGY, V28, P751; Marrero JA, 2005, HEPATOLOGY, V41, P707, DOI 10.1002/hep.20636; Marrero JA, 2010, ONCOLOGIST, V15, P23, DOI 10.1634/theoncologist.2010-S4-23; Martins A, 2006, LIVER INT, V26, P680, DOI 10.1111/j.1478-3231.2006.001285.x; Meier V, 2009, DIGEST DIS, V27, P131, DOI 10.1159/000218345; Morimoto M, 2007, WORLD J GASTROENTERO, V13, P1003, DOI 10.3748/wjg.v13.i7.1003; Nanashima A, 2005, EJSO-EUR J SURG ONC, V31, P882, DOI 10.1016/j.ejso.2005.04.016; OKUDA K, 1985, CANCER, V56, P918, DOI 10.1002/1097-0142(19850815)56:4<918::AID-CNCR2820560437>3.0.CO;2-E; op den Winkel M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045066; Park Ui Jun, 2008, Korean J Hepatol, V14, P371, DOI 10.3350/kjhep.2008.14.3.371; Pascual S, 2006, LIVER INT, V26, P673, DOI 10.1111/j.1478-3231.2006.01282.x; Peng SY, 2004, INT J CANCER, V112, P44, DOI 10.1002/ijc.20279; Qin LX, 2002, WORLD J GASTROENTERO, V8, P385, DOI 10.3748/wjg.v8.i3.385; Sakar B, 2004, AM J CLIN ONCOL-CANC, V27, P489, DOI 10.1097/01.coc.0000136019.94333.09; Schoniger-Hekele M, 2001, GUT, V48, P103, DOI 10.1136/gut.48.1.103; Tateishi R, 2005, GUT, V54, P419, DOI 10.1136/gut.2003.035055; Toyoda H, 2005, AM J GASTROENTEROL, V100, P1764, DOI 10.1111/j.1572-0241.2005.41943.x; Ueno S, 2002, HEPATOL RES, V24, P395, DOI 10.1016/S1386-6346(02)00144-4; Ueno S, 2001, HEPATOLOGY, V34, P529, DOI 10.1053/jhep.2001.27219; Wildi S, 2004, BRIT J SURG, V91, P400, DOI 10.1002/bjs.4554; Wu J, 2013, J LIVER, V2, pe104, DOI [10.4172/2167-0889.1000e104, DOI 10.4172/2167-0889.1000E104]; Xu HX, 2005, CLIN RADIOL, V60, P1018, DOI 10.1016/j.crad.2005.04.009; Yen YH, 2009, DIGEST LIVER DIS, V41, P431, DOI 10.1016/j.dld.2008.11.008; Zhang H, 2013, J TUMOR, V18, P20; Zhi Hui, 2007, Zhonghua Zhongliu Zazhi, V29, P112	59	51	55	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90929	10.1371/journal.pone.0090929	http://dx.doi.org/10.1371/journal.pone.0090929			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603710	Green Published, gold, Green Submitted			2022-12-27	WOS:000332483600107
J	Huang, FF; Zhang, L; Wu, DS; Yuan, XY; Chen, FP; Zeng, H; Yu, YH; Zhao, XL				Huang, Fang-Fang; Zhang, Li; Wu, Deng-Shu; Yuan, Xiao-Yu; Chen, Fang-Ping; Zeng, Hui; Yu, Yan-Hui; Zhao, Xie-Lan			PTEN Regulates BCRP/ABCG2 and the Side Population through the PI3K/Akt Pathway in Chronic Myeloid Leukemia	PLOS ONE			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; CANCER RESISTANCE PROTEIN; HEMATOPOIETIC STEM-CELLS; ACUTE LYMPHOBLASTIC-LEUKEMIA; ABCG2 MULTIDRUG TRANSPORTER; ABL TYROSINE KINASE; IMATINIB MESYLATE; BCR-ABL; PHILADELPHIA-CHROMOSOME; IN-VITRO	A small population of cancer stem cells named the "side population'' (SP) has been demonstrated to be responsible for the persistence of many solid tumors. However, the role of the SP in leukemic pathogenesis remains controversial. The resistance of leukemic stem cells to targeted therapies, such as tyrosine kinase inhibitors (TKIs), results in therapeutic failure or refractory/relapsed disease in chronic myeloid leukemia (CML). The drug pump, ATP-binding cassette sub-family G member 2 (ABCG2), is well known as a specific marker of the SP and could be controlled by several pathways, including the PI3K/Akt pathway. Our data demonstrated that compared with wild-type K562 cells, the higher percentage of ABCG2+ cells corresponded to the higher SP fraction in K562/ABCG2 (ABCG2 overexpressing) and K562/IMR (resistance to imatinib) cells, which exhibited enhanced drug resistance along with downregulated phosphatase and tensin homologue deleted on chromosome - 10 (PTEN) and activated phosphorylated-Akt (p-Akt). PTEN and p-Akt downregulation could be abrogated by both the PI3K inhibitor LY294002 and the mTOR inhibitor rapamycin. Moreover, in CML patients in the accelerated phase/blastic phase (AP/BP), increased SP phenotype rather than ABCG2 expression was accompanied by the loss of PTEN protein and the up-regulation of p-Akt expression. These results suggested that the expression of ABCG2 and the SP may be regulated by PTEN through the PI3K/Akt pathway, which would be a potentially effective strategy for targeting CML stem cells.	[Huang, Fang-Fang; Wu, Deng-Shu; Yuan, Xiao-Yu; Chen, Fang-Ping; Zeng, Hui; Yu, Yan-Hui; Zhao, Xie-Lan] Cent S Univ, Xiang Ya Hosp, Dept Hematol, Changsha, Hunan, Peoples R China; [Zhang, Li] Sichuan Univ, Dept Hematol, West China Hosp, Chengdu 610064, Sichuan, Peoples R China	Central South University; Sichuan University	Zeng, H (corresponding author), Cent S Univ, Xiang Ya Hosp, Dept Hematol, Changsha, Hunan, Peoples R China.	androps2011@hotmail.com			National Natural Science Foundation of China [81100328, 81170477]; Doctoral Fund of Ministry of Education of China [20110162120010]; Fundamental Research Funds for the Central Universities [2011QNZT151]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Fund of Ministry of Education of China(Ministry of Education, China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (Grant No. 81100328), the Doctoral Fund of Ministry of Education of China (Grant No. 20110162120010), and the Fundamental Research Funds for the Central Universities (Grant No. 2011QNZT151) to HZ and the National Natural Science Foundation of China (Grant No. 81170477) to F-PC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albano F, 2010, ONCOGENE, V29, P2509, DOI 10.1038/onc.2009.524; Barnes DJ, 2005, ONCOGENE, V24, P6432, DOI 10.1038/sj.onc.1208796; Bhatia R, 2003, BLOOD, V101, P4701, DOI 10.1182/blood-2002-09-2780; Bleau AM, 2009, CELL STEM CELL, V4, P226, DOI 10.1016/j.stem.2009.01.007; Burger H, 2004, BLOOD, V104, P2940, DOI 10.1182/blood-2004-04-1398; Cortes J, 2005, CLIN CANCER RES, V11, P3425, DOI 10.1158/1078-0432.CCR-04-2139; Cortes J, 2004, BLOOD, V104, P2204, DOI 10.1182/blood-2004-04-1335; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; Davies A, 2009, LEUKEMIA, V23, P1999, DOI 10.1038/leu.2009.166; Deininger M, 2005, BLOOD, V105, P2640, DOI 10.1182/blood-2004-08-3097; Doyle LA, 2003, ONCOGENE, V22, P7340, DOI 10.1038/sj.onc.1206938; Doyle LA, 1998, P NATL ACAD SCI USA, V95, P15665, DOI 10.1073/pnas.95.26.15665; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; Goodell MA, 1997, NAT MED, V3, P1337, DOI 10.1038/nm1297-1337; Goodell Margaret A, 2005, Curr Protoc Cytom, VChapter 9, DOI 10.1002/0471142956.cy0918s34; Gronbaek K, 1998, BLOOD, V91, P4388; Hegedus C, 2012, BIOCHEM BIOPH RES CO, V420, P869, DOI 10.1016/j.bbrc.2012.03.090; Holyoake TL, 2001, BLOOD, V97, P720, DOI 10.1182/blood.V97.3.720; Houghton PJ, 2004, CANCER RES, V64, P2333, DOI 10.1158/0008-5472.CAN-03-3344; Huang FF, 2013, CANCER LETT, V336, P96, DOI 10.1016/j.canlet.2013.04.006; Illmer T, 2004, LEUKEMIA, V18, P401, DOI 10.1038/sj.leu.2403257; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jordanides NE, 2006, BLOOD, V108, P1370, DOI 10.1182/blood-2006-02-003145; Kantarjian H, 2006, NEW ENGL J MED, V354, P2542, DOI 10.1056/NEJMoa055104; Kantarjian HM, 2007, BLOOD, V110, P3540, DOI 10.1182/blood-2007-03-080689; Li HX, 2011, CANCER BIOL THER, V11, P950, DOI 10.4161/cbt.11.11.15531; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; LUGO TG, 1990, SCIENCE, V247, P1079, DOI 10.1126/science.2408149; Nakanishi T, 2006, BLOOD, V108, P678, DOI 10.1182/blood-2005-10-4020; NOWELL PC, 1960, JNCI-J NATL CANCER I, V25, P85; Ottmann O, 2007, BLOOD, V110, P2309, DOI 10.1182/blood-2007-02-073528; Ozvegy-Laczka C, 2004, MOL PHARMACOL, V65, P1485, DOI 10.1124/mol.65.6.1485; PEIFFER SL, 1995, CANCER RES, V55, P1922; Peng C, 2010, BLOOD, V115, P626, DOI 10.1182/blood-2009-06-228130; Ross DD, 2010, METHODS MOL BIOL, V596, P251, DOI 10.1007/978-1-60761-416-6_12; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0; Thomas J, 2004, BLOOD, V104, P3739, DOI 10.1182/blood-2003-12-4276; Weisberg E, 2003, DRUG RESIST UPDATE, V6, P231, DOI 10.1016/S1368-7646(03)00062-1; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Zeng H, 2009, STEM CELLS, V27, P2435, DOI 10.1002/stem.192; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	42	39	45	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e88298	10.1371/journal.pone.0088298	http://dx.doi.org/10.1371/journal.pone.0088298			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603487	gold, Green Published, Green Submitted			2022-12-27	WOS:000332483600005
J	Li, Y; Wang, JW; Zhong, XJ; Tian, Z; Wu, PP; Zhao, WB; Jin, CJ				Li, Ying; Wang, JiWen; Zhong, XiaoJing; Tian, Zhen; Wu, Peipei; Zhao, Wenbo; Jin, Chenjin			Refractive Error and Risk of Early or Late Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							5-YEAR INCIDENCE; AXIAL LENGTH; MACULOPATHY; PREVALENCE; ASSOCIATIONS; POPULATION; RIGIDITY; DISEASE; EYES	Objective: To summarize relevant evidence investigating the associations between refractive error and age-related macular degeneration (AMD). Design: Systematic review and meta-analysis. Methods: We searched Medline, Web of Science, and Cochrane databases as well as the reference lists of retrieved articles to identify studies that met the inclusion criteria. Extracted data were combined using a random-effects meta-analysis. Studies that were pertinent to our topic but did not meet the criteria for quantitative analysis were reported in a systematic review instead. Main outcome measures: Pooled odds ratios (ORs) and 95% confidence intervals (CIs) for the associations between refractive error (hyperopia, myopia, per-diopter increase in spherical equivalent [SE] toward hyperopia, per-millimeter increase in axial length [AL]) and AMD (early and late, prevalent and incident). Results: Fourteen studies comprising over 5800 patients were eligible. Significant associations were found between hyperopia, myopia, per-diopter increase in SE, per-millimeter increase in AL, and prevalent early AMD. The pooled ORs and 95% CIs were 1.13 (1.06-1.20), 0.75 (0.56-0.94), 1.10 (1.07-1.14), and 0.79 (0.73-0.85), respectively. The per-diopter increase in SE was also significantly associated with early AMD incidence (OR, 1.06; 95% CI, 1.02-1.10). However, no significant association was found between hyperopia or myopia and early AMD incidence. Furthermore, neither prevalent nor incident late AMD was associated with refractive error. Considerable heterogeneity was found among studies investigating the association between myopia and prevalent early AMD (P = 0.001, I-2 = 72.2%). Geographic location might play a role; the heterogeneity became non-significant after stratifying these studies into Asian and non-Asian subgroups. Conclusion: Refractive error is associated with early AMD but not with late AMD. More large-scale longitudinal studies are needed to further investigate such associations.	[Li, Ying; Zhong, XiaoJing; Tian, Zhen; Wu, Peipei; Zhao, Wenbo; Jin, Chenjin] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China; [Wang, JiWen] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Neurosurg, Guangzhou 510275, Guangdong, Peoples R China; [Wang, JiWen] Sun Yat Sen Univ, Affiliated Hosp 1, Pituitary Tumor Ctr, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Jin, CJ (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China.	jinchj@mail.sysu.edu.cn						Anand R, 2000, OPHTHALMOLOGY, V107, P2224; [Anonymous], 1992, Arch Ophthalmol, V110, P1701; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X; Boker T, 1993, Ger J Ophthalmol, V2, P10; Buch H, 2005, ACTA OPHTHALMOL SCAN, V83, P409, DOI 10.1111/J.1600-0420.2005.00492.x; Chaine G, 1998, BRIT J OPHTHALMOL, V82, P996, DOI 10.1136/bjo.82.9.996; Chakravarthy U, 2010, BMC OPHTHALMOL, V10, DOI 10.1186/1471-2415-10-31; Chen SJ, 2008, INVEST OPHTH VIS SCI, V49, P3126, DOI 10.1167/iovs.08-1803; Cheung CMG, 2012, ARCH OPHTHALMOL-CHIC, V130, P480, DOI 10.1001/archophthalmol.2011.376; Coleman HR, 2008, LANCET, V372, P1835, DOI 10.1016/S0140-6736(08)61759-6; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Erke MG, 2012, OPHTHALMOLOGY, V119, P1737, DOI 10.1016/j.ophtha.2012.03.016; Fine SL, 2000, NEW ENGL J MED, V342, P483, DOI 10.1056/NEJM200002173420707; Francis PJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001197; Fraser-Bell S, 2010, AM J OPHTHALMOL, V149, P735, DOI 10.1016/j.ajo.2009.11.013; FRIEDMAN E, 1989, OPHTHALMOLOGY, V96, P104; Gemmy CC, 2012, AM J OPHTHALMOL; GOLDBERG J, 1988, AM J EPIDEMIOL, V128, P700, DOI 10.1093/oxfordjournals.aje.a115023; Hamling J, 2008, STAT MED, V27, P954, DOI 10.1002/sim.3013; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Higgins JPT, 2009, J R STAT SOC A STAT, V172, P137, DOI 10.1111/j.1467-985X.2008.00552.x; Ikram MK, 2003, INVEST OPHTH VIS SCI, V44, P3778, DOI 10.1167/iovs.03-0120; Jonas JB, 2012, ACTA OPHTHALMOL, V90, pe185, DOI 10.1111/j.1755-3768.2011.02316.x; Jonas JB, 2010, OPHTHALMOLOGY, V117, P2234, DOI 10.1016/j.ophtha.2009.12.006; Klein R, 2006, OPHTHALMOLOGY, V113, P373, DOI 10.1016/j.ophtha.2005.12.013; Klein R, 1998, ARCH OPHTHALMOL-CHIC, V116, P506, DOI 10.1001/archopht.116.4.506; KLEIN R, 1991, OPHTHALMOLOGY, V98, P1128; Lavanya R, 2010, INVEST OPHTH VIS SCI, V51, P6247, DOI 10.1167/iovs.10-5229; McCarty CA, 2001, ARCH OPHTHALMOL-CHIC, V119, P1455; Pallikaris IG, 2006, AM J OPHTHALMOL, V141, P611, DOI 10.1016/j.ajo.2005.11.010; Pan CW, 2013, OPHTHALMOLOGY, V120, P284, DOI 10.1016/j.ophtha.2012.07.065; Pan CW, 2013, OPHTHALMOLOGY; Rudnicka AR, 2012, OPHTHALMOLOGY, V119, P571, DOI 10.1016/j.ophtha.2011.09.027; SANDBERG MA, 1993, OPHTHALMOLOGY, V100, P1009; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Tao Y, 2010, EYE, V24, P648, DOI 10.1038/eye.2009.160; Ulvik SO, 2005, ACTA OPHTHALMOL SCAN, V83, P419, DOI 10.1111/J.1600-0420.2005.00520.x; Wang JJ, 2004, CLIN EXP OPHTHALMOL, V32, P255, DOI 10.1111/j.1442-9071.2004.00813.x; Wang JJ, 1998, INVEST OPHTH VIS SCI, V39, P2167; WANG Q, 1994, INVEST OPHTH VIS SCI, V35, P4344; Wong TY, 2002, INVEST OPHTH VIS SCI, V43, P2869; Xu L, 2006, BRIT J OPHTHALMOL, V90, P1087, DOI 10.1136/bjo.2006.096123; Xu L, 2007, OPHTHALMOLOGY, V114, P121, DOI 10.1016/j.ophtha.2006.05.071; You QS, 2012, OPHTHALMOLOGY, V119, P2519, DOI 10.1016/j.ophtha.2012.06.043	45	9	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90897	10.1371/journal.pone.0090897	http://dx.doi.org/10.1371/journal.pone.0090897			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603619	gold, Green Submitted, Green Published			2022-12-27	WOS:000332483600103
J	Wang, CH; Wachholtz, M; Wang, J; Liao, XL; Lu, GQ				Wang, Chenghui; Wachholtz, Michael; Wang, Jun; Liao, Xiaolin; Lu, Guoqing			Analysis of the Skin Transcriptome in Two Oujiang Color Varieties of Common Carp	PLOS ONE			English	Article							CYPRINUS-CARPIO; GENOME DUPLICATION; RNA-SEQ; EVOLUTION; PIGMENTATION; GENE; PATHWAYS; DATABASE; TOOL	Background: Body color and coloration patterns are important phenotypic traits to maintain survival and reproduction activities. The Oujiang color varieties of common carp (Cyprinus carpio var. color), with a narrow distribution in Zhejiang Province of China and a history of aquaculture for over 1,200 years, consistently exhibit a variety of body color patterns. The molecular mechanism underlying diverse color patterns in these variants is unknown. To the practical end, it is essential to develop molecular markers that can distinguish different phenotypes and assist selective breeding. Methodology/Principal Findings: In this exploratory study, we conducted Roche 454 transcriptome sequencing of two pooled skin tissue samples of Oujiang common carp, which correspond to distinct color patterns, red with big black spots (RB) and whole white (WW), and a total of 737,525 sequence reads were generated. The reads obtained in this study were co-assembled jointly with common carp Roche 454 sequencing reads downloaded from NCBI SRA database, resulting in 43,923 isotigs and 546,676 singletons. Over 31 thousand (31,445; 71.6%) isotigs were found with significant BLAST matches (E<1e-10) to the nr protein database, which corresponds to 12,597 annotated zebrafish genes. A total of 70,947 isotigs and singletons (transcripts) were annotated with Gene Ontology, and 60,221 transcripts were found with corresponding EC numbers. Out of 145 zebrafish pigmentation genes, orthologs for 117 were recovered in Oujiang color carp transcriptome, including 18 found only among singletons. Our transcriptome analysis revealed over 52,902 SNPs in Oujiang common carp, and identified 63 SNP markers that are putatively unique either for RB or WW. Conclusions: The transcriptome of Oujiang color varieties of common carp obtained through this study, along with the pigmentation genes recovered and the color pattern-specific molecular markers developed, will facilitate future research on the molecular mechanism of color patterns and promote aquaculture of Oujiang color varieties of common carp through molecular marker assisted-selective breeding.	[Wang, Chenghui] Shanghai Ocean Univ, Minist Agr, Key Lab Freshwater Fisheries Germplasm Resources, Shanghai, Peoples R China; [Wang, Chenghui; Wachholtz, Michael; Wang, Jun; Liao, Xiaolin; Lu, Guoqing] Univ Nebraska, Dept Biol, Omaha, NE 68182 USA; [Liao, Xiaolin] Minist Water Resources, Key Lab Ecol Impacts Hydraul Projects & Restorat, Inst Hydroecol, Wuhan, Peoples R China; [Liao, Xiaolin] Chinese Acad Sci, Wuhan, Peoples R China	Ministry of Agriculture & Rural Affairs; Shanghai Ocean University; University of Nebraska System; Chinese Academy of Sciences; Ministry of Water Resources; Chinese Academy of Sciences	Wang, CH (corresponding author), Shanghai Ocean Univ, Minist Agr, Key Lab Freshwater Fisheries Germplasm Resources, Shanghai, Peoples R China.	wangch@shou.edu.cn; glu3@unomaha.edu		wang, jun/0000-0002-6591-3316	Special Fund for Agro-Scientific Research in the Public Interest [200903045]; National Natural Science Foundation of China [30972250]; Shanghai University Knowledge Service Platform [ZF1206]	Special Fund for Agro-Scientific Research in the Public Interest; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai University Knowledge Service Platform	Funding was provided by grants from the Special Fund for Agro-Scientific Research in the Public Interest (No. 200903045), National Natural Science Foundation of China (No. 30972250), and by the Shanghai University Knowledge Service Platform (ZF1206). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschmied J, 2002, GENETICS, V161, P259; Attwood TK, 2002, NUCLEIC ACIDS RES, V30, P239, DOI 10.1093/nar/30.1.239; Bagnara JT, 2007, PIGM CELL RES, V20, P14, DOI 10.1111/j.1600-0749.2006.00360.x; Bai XD, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016336, 10.1371/journal.pone.0016368]; BALON EK, 1995, AQUACULTURE, V129, P3, DOI 10.1016/0044-8486(94)00227-F; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Braasch I, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-74; Braasch I, 2009, GENOME BIOL EVOL, V1, P479, DOI 10.1093/gbe/evp050; Braasch I, 2009, PIGM CELL MELANOMA R, V22, P839, DOI 10.1111/j.1755-148X.2009.00614.x; Calduch-Giner JA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-178; Chouvarine P, 2012, PLOS ONE, V7, P168, DOI 10.1371/journal.pone.0029850; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; David L, 2004, AQUACULTURE, V233, P129, DOI 10.1016/j.aquaculture.2003.10.033; David L, 2003, MOL BIOL EVOL, V20, P1425, DOI 10.1093/molbev/msg173; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Hoekstra HE, 2006, SCIENCE, V313, P101, DOI 10.1126/science.1126121; Huan P, 2012, MAR BIOTECHNOL, V14, P69, DOI 10.1007/s10126-011-9389-0; Ji PF, 2012, INT J MOL SCI, V13, P9798, DOI 10.3390/ijms13089798; Ji PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035152; Li C, 2012, FISH SHELLFISH IMMUN, V32, P816, DOI 10.1016/j.fsi.2012.02.004; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li S, 2003, AGR DEV OPPORTUNITIE, V65, P17; Li SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036592; Liao XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062308; Logan DW, 2006, PIGM CELL RES, V19, P206, DOI 10.1111/j.1600-0749.2006.00307.x; Ma KY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039727; Ma YQ, 2011, FISHERIES SCI, V77, P591, DOI 10.1007/s12562-011-0359-2; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mellgren EM, 2002, TRENDS GENET, V18, P128, DOI 10.1016/S0168-9525(01)02614-2; Mu YN, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-506; Ng P, 2005, NAT METHODS, V2, P105, DOI 10.1038/NMETH733; Pereiro P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035369; Protas ME, 2008, ANNU REV CELL DEV BI, V24, P425, DOI 10.1146/annurev.cellbio.24.110707.175302; Renaut S, 2010, MOL ECOL, V19, P115, DOI 10.1111/j.1365-294X.2009.04477.x; Richardson J, 2008, ZEBRAFISH, V5, P289, DOI 10.1089/zeb.2008.0541; Rodgers GM, 2010, ANIM BEHAV, V79, P1025, DOI 10.1016/j.anbehav.2010.01.017; Salem M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036264; Salem M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-564; Samanta MP, 2006, SCIENCE, V314, P960, DOI 10.1126/science.1131898; Shen GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029127; Sigrist CJA, 2010, NUCLEIC ACIDS RES, V38, pD161, DOI 10.1093/nar/gkp885; Steiner CC, 2007, PLOS BIOL, V5, P1880, DOI 10.1371/journal.pbio.0050219; Sugie A, 2004, GENE, V343, P337, DOI 10.1016/j.gene.2004.09.019; Visser WE, 2010, HUM MOL GENET, V19, P4189, DOI 10.1093/hmg/ddq337; Wang CH, 2008, J SHANGHAI FISH UNI, V4, P004; Wang CH, 2010, AQUAC RES, V41, P1339, DOI 10.1111/j.1365-2109.2009.02422.x; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Xu F, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2256; Zhu L, 2013, J SHANGHAI IN PRESS	49	36	45	4	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90074	10.1371/journal.pone.0090074	http://dx.doi.org/10.1371/journal.pone.0090074			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603653	gold, Green Published, Green Submitted			2022-12-27	WOS:000332483600028
J	Yan, XY; Ehnert, S; Culmes, M; Bachmann, A; Seeliger, C; Schyschka, L; Wang, ZY; Rahmanian-Schwarz, A; Stockle, U; De Sousa, PA; Pelisek, J; Nussler, AK				Yan, Xueying; Ehnert, Sabrina; Culmes, Mihaela; Bachmann, Anastasia; Seeliger, Claudine; Schyschka, Lilianna; Wang, Zhiyong; Rahmanian-Schwarz, Afshin; Stoeckle, Ulrich; De Sousa, Paul A.; Pelisek, Jaroslav; Nussler, Andreas K.			5-Azacytidine Improves the Osteogenic Differentiation Potential of Aged Human Adipose-Derived Mesenchymal Stem Cells by DNA Demethylation	PLOS ONE			English	Article							SELF-RENEWAL; OSTEOBLAST DIFFERENTIATION; CLINICAL-APPLICATIONS; LINEAGE; SOX2; MECHANISMS; PROLIFERATION; EXPRESSION; PATHWAYS; 5-HYDROXYMETHYLCYTOSINE	The therapeutic value of adipose-derived mesenchymal stem cells (Ad-MSCs) for bone regeneration is critically discussed. A possible reason for reduced osteogenic potential may be an age-related deterioration of the Ad-MSCs. In long term in vitro culture, epigenomic changes in DNA methylation are known to cause gene silencing, affecting stem cell growth as well as the differentiation potential. In this study, we observed an age-related decline in proliferation of primary human Ad-MSCs. Decreased Nanog, Oct4 and Lin28A and increased Sox2 gene-expression was accompanied by an impaired osteogenic differentiation potential of Ad-MSCs isolated from old donors (>60 a) as compared to Ad-MSCs isolated from younger donors (<45 a). 5-hydroxymethylcytosine (5 hmC) and 5-methylcytonsine (5 mC) distribution as well as TET gene expression were evaluated to assess the evidence of active DNA demethylation. We observed a decrease of 5 hmC in Ad-MSCs from older donors. Incubation of these cells with 5-Azacytidine induced proliferation and improved the osteogenic differentiation potential in these cells. The increase in AP activity and matrix mineralization was associated with an increased presence of 5 hmC as well as with an increased TET2 and TET3 gene expression. Our data show, for the first time, a decrease of DNA hydroxymethylation in Ad-MSCs which correlates with donor-age and that treatment with 5-Azacytidine provides an approach which could be used to rejuvenate Ad-MSCs from aged donors.	[Yan, Xueying; Ehnert, Sabrina; Bachmann, Anastasia; Stoeckle, Ulrich; Nussler, Andreas K.] Univ Tubingen, BG Trauma Ctr, Siegfried Weller Inst Trauma Res, Tubingen, Germany; [Culmes, Mihaela; Pelisek, Jaroslav] Tech Univ Munich, Klinikum Rechts Isar, Clin Vasc & Endovasc Surg, D-80290 Munich, Germany; [Seeliger, Claudine; Schyschka, Lilianna; Wang, Zhiyong] Tech Univ Munich, Klinikum Rechts Isar, Dept Trauma Surg, D-80290 Munich, Germany; [Rahmanian-Schwarz, Afshin] Univ Tubingen, BG Trauma Ctr, Clin Hand Plast Reconstruct & Vasc Surg, Tubingen, Germany; [De Sousa, Paul A.] Univ Edinburgh, Ctr Regenerat Med, Edinburgh, Midlothian, Scotland	Eberhard Karls University of Tubingen; Technical University of Munich; Technical University of Munich; Eberhard Karls University of Tubingen; University of Edinburgh	Nussler, AK (corresponding author), Univ Tubingen, BG Trauma Ctr, Siegfried Weller Inst Trauma Res, Tubingen, Germany.	andreas.nuessler@gmail.com	Nussler, Andreas/H-3557-2019; De Sousa, Paul A/H-7416-2013; Bachmann, Anastasia/F-8419-2014; Ehnert, Sabrina/AAE-8163-2019	Nussler, Andreas/0000-0002-6666-6791; De Sousa, Paul A/0000-0003-0745-2504; Ehnert, Sabrina/0000-0003-4347-1702; Seeliger, Claudine/0000-0002-7631-444X	Bayerische Forschungsstiftung; BG Trauma Center Tubingen; Medical Research Council [G0300484] Funding Source: researchfish; MRC [G0300484] Funding Source: UKRI	Bayerische Forschungsstiftung; BG Trauma Center Tubingen; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The present work was partially supported by the Bayerische Forschungsstiftung (www.forschungsstiftung.de) and by research funds of the BG Trauma Center Tubingen (www.bgu-tuebingen.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berdasco M, 2012, AGING CELL, V11, P181, DOI 10.1111/j.1474-9726.2012.00806.x; Casillas MA, 2003, MOL CELL BIOCHEM, V252, P33, DOI 10.1023/A:1025548623524; Chang YQ, 2009, NAT STRUCT MOL BIOL, V16, P312, DOI 10.1038/nsmb.1560; Cimmino L, 2011, CELL STEM CELL, V9, P193, DOI 10.1016/j.stem.2011.08.007; Ding DF, 2012, INT ORTHOP, V36, P1087, DOI 10.1007/s00264-011-1368-6; Ding JJ, 2012, CELL RES, V22, P155, DOI 10.1038/cr.2011.179; Ehnert S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014073; Feng C, 2012, CELL CYCLE, V11, P2486, DOI 10.4161/cc.20893; Granero-Molto F, 2009, STEM CELLS, V27, P1887, DOI 10.1002/stem.103; He SH, 2009, ANNU REV CELL DEV BI, V25, P377, DOI 10.1146/annurev.cellbio.042308.113248; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Koh KP, 2011, CELL STEM CELL, V8, P200, DOI 10.1016/j.stem.2011.01.008; Kuo TK, 2008, GASTROENTEROLOGY, V134, P2111, DOI 10.1053/j.gastro.2008.03.015; Li ZL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020526; Liao Lian-Ming, 2005, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V13, P158; Liu L, 2011, J CELL BIOL, V193, P257, DOI 10.1083/jcb.201010131; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Marcellini S, 2012, BIOESSAYS, V34, P953, DOI 10.1002/bies.201200061; Marsell R, 2011, INJURY, V42, P551, DOI 10.1016/j.injury.2011.03.031; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; McGee-Lawrence ME, 2011, GENE, V474, P1, DOI 10.1016/j.gene.2010.12.003; Meirelles LD, 2009, FRONT BIOSCI-LANDMRK, V14, P4281, DOI 10.2741/3528; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Park SB, 2012, CELL DEATH DIFFER, V19, P534, DOI 10.1038/cdd.2011.137; Polzer H, 2010, TISSUE ENG PART C-ME, V16, P1277, DOI [10.1089/ten.tec.2009.0745, 10.1089/ten.TEC.2009.0745]; Ruzov A, 2011, CELL RES, V21, P1332, DOI 10.1038/cr.2011.113; Seeliger C, 2013, CELL TRANSPLANT, V22, P119, DOI 10.3727/096368912X638946; Selvaraj V, 2010, TRENDS BIOTECHNOL, V28, P214, DOI 10.1016/j.tibtech.2010.01.002; Seo E, 2013, CELL REP, V3, P2075, DOI 10.1016/j.celrep.2013.05.029; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Smith JO, 2011, TISSUE ENG PART B-RE, V17, P307, DOI [10.1089/ten.teb.2011.0143, 10.1089/ten.TEB.2011.0143]; Stolzing A, 2008, MECH AGEING DEV, V129, P163, DOI 10.1016/j.mad.2007.12.002; Thompson RF, 2010, AGING CELL, V9, P506, DOI 10.1111/j.1474-9726.2010.00577.x; Tollervey J., 2012, EPIGENETICS, V7; Tsai CC, 2012, MOL CELL, V47, P169, DOI 10.1016/j.molcel.2012.06.020; Valinluck V, 2007, CANCER RES, V67, P946, DOI 10.1158/0008-5472.CAN-06-3123; Wang HT, 2012, AGING CELL, V11, P704, DOI 10.1111/j.1474-9726.2012.00838.x; Wang SH, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-19; Williams AR, 2011, CIRC RES, V109, P923, DOI 10.1161/CIRCRESAHA.111.243147; Xu BS, 2009, RNA, V15, P357, DOI 10.1261/rna.1368009; Yoon DS, 2011, CELL PROLIFERAT, V44, P428, DOI 10.1111/j.1365-2184.2011.00770.x; Yoshida CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032364	42	62	65	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90846	10.1371/journal.pone.0090846	http://dx.doi.org/10.1371/journal.pone.0090846			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603866	gold, Green Submitted, Green Published			2022-12-27	WOS:000332483600094
J	Sun, XJ; Fang, B; Zhao, X; Zhang, GW; Ma, H				Sun, Xuejun; Fang, Bo; Zhao, Xi; Zhang, Guangwei; Ma, Hong			Preconditioning of Mesenchymal Stem Cells by Sevoflurane to Improve Their Therapeutic Potential	PLOS ONE			English	Article							BONE-MARROW; STROMAL CELLS; IN-VITRO; MYOCARDIAL-INFARCTION; VOLATILE ANESTHETICS; INDUCED APOPTOSIS; PC12 CELLS; HYPOXIA; EXPRESSION; TRANSPLANTATION	Background: Bone marrow mesenchymal stem cells (MSCs) have been found to produce beneficial effects on ischemia-reperfusion injury. However, most of the MSCs died when transplanted into the ischemic tissue, which severely limit their therapeutic potential. Methods: Using an in vitro model of hypoxia and serum deprivation (H/SD), we investigated the hypothesis that sevoflurane preconditioning could protect MSCs against H/SD-induced apoptosis and improve their migration, proliferation, and therapeutic potential. The H/SD of MSCs and neuron-like PC12 cells were incubated in a serum-free medium and an oxygen concentration below 0.1% for 24 h. Sevoflurane preconditioning was performed through a 2-h incubation of MSCs in an airtight chamber filled with 2 vol% sevoflurane. Apoptosis of MSCs or neuron-like PC12 cells was assessed using Annexin V-FITC/propidium iodide (PI). Furthermore, the mitochondrial membrane potential was assessed using lipophilic cationic probe. The proliferation rate was evaluated through cell cycle analysis. Finally, HIF-1 alpha, HIF-2 alpha, VEGF and p-Akt/Akt levels were measured by western blot. Results: Sevoflurane preconditioning minimized the MSCs apoptosis and loss of mitochondrial membrane potential. Furthermore, it increased the migration and expression of HIF-1 alpha, HIF-2 alpha, VEGF, and p-Akt/Akt, reduced by H/SD. In addition, neuron-like PC12 cells were more resistant to H/SD-induced apoptosis when they were co-cultured with sevoflurane preconditioning MSCs. Conclusion: These findings suggest that sevoflurane preconditioning produces protective effects on survival and migration of MSCs against H/SD, as well as improving the therapeutic potential of MSCs. These beneficial effects might be mediated at least in part by upregulating HIF-1 alpha, HIF-2 alpha, VEGF, and p-Akt/Akt.	[Sun, Xuejun; Fang, Bo; Zhao, Xi; Ma, Hong] China Med Univ, Affiliated Hosp 1, Dept Anesthesiol, Shenyang, Liaoning, Peoples R China; [Zhang, Guangwei] China Med Univ, Affiliated Hosp 1, Dept Cardiac Surg, Shenyang, Liaoning, Peoples R China	China Medical University; China Medical University	Ma, H (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Anesthesiol, Shenyang, Liaoning, Peoples R China.	mahong5466@yahoo.com	sun, xuejun/A-5561-2010; Zhang, Guang-Wei/GRN-9137-2022; f, b/AGL-6241-2022	sun, xuejun/0000-0003-2387-5531; Fang, Bo/0000-0002-4812-6919	Ministry of Education of China [20092104110009]; Science and Technology Plan Project of Liaoning Province, China [2012408002]; Fund for Scientific Research of the First Hospital of China Medical University [2014-07]	Ministry of Education of China(Ministry of Education, China); Science and Technology Plan Project of Liaoning Province, China; Fund for Scientific Research of the First Hospital of China Medical University	The study was supported by Doctoral Fund of Ministry of Education of China, No. 20092104110009; Science and Technology Plan Project of Liaoning Province, China, No. 2012408002; and Fund for Scientific Research of the First Hospital of China Medical University, No. 2014-07. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Deng J, 2010, APOPTOSIS, V15, P463, DOI 10.1007/s10495-009-0434-7; Ding Q, 2009, ANESTH ANALG, V109, P1263, DOI 10.1213/ane.0b013e3181b2214c; Emerling BM, 2013, P NATL ACAD SCI USA, V110, P3483, DOI 10.1073/pnas.1222435110; Fan WW, 2013, STEM CELLS, V31, P203, DOI 10.1002/stem.1265; Fang B, 2013, J VASC SURG, V58, P1043, DOI 10.1016/j.jvs.2012.11.087; Gao Q, 2008, NEUROSCIENCE, V152, P646, DOI 10.1016/j.neuroscience.2007.10.069; Geng YJ, 2003, ANN NY ACAD SCI, V1010, P687, DOI 10.1196/annals.1299.126; Grau Cristina Malagelada, 2012, Methods Mol Biol, V846, P201, DOI 10.1007/978-1-61779-536-7_18; Holzwarth C, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-11; Hung SP, 2012, J ORTHOP RES, V30, P260, DOI 10.1002/jor.21517; Kachooei E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041344; Li DL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073334; Li QF, 2006, ANESTHESIOLOGY, V105, P1211, DOI 10.1097/00000542-200612000-00021; Li QF, 2008, BRAIN RES, V1245, P26, DOI 10.1016/j.brainres.2008.09.069; Li ZW, 2010, J CELL BIOCHEM, V111, P811, DOI 10.1002/jcb.22731; Li ZW, 2010, FEBS J, V277, P3688, DOI 10.1111/j.1742-4658.2010.07770.x; Liu HB, 2010, BIOCHEM BIOPH RES CO, V401, P509, DOI 10.1016/j.bbrc.2010.09.076; Liu XB, 2012, J ZHEJIANG UNIV-SC B, V13, P616, DOI 10.1631/jzus.B1201004; Lucchinetti E, 2009, ANESTH ANALG, V109, P1117, DOI 10.1213/ANE.0b013e3181b5a277; Mo SJ, 2012, NEUROSCI LETT, V522, P92, DOI 10.1016/j.neulet.2012.06.002; Muller-Edenborn B, 2012, ANESTHESIOLOGY, V117, P293, DOI 10.1097/ALN.0b013e3182605df1; Nabiuni M, 2012, FLUIDS BARRIERS CNS, V9, DOI 10.1186/2045-8118-9-8; Noiseux N, 2012, ENDOCRINOLOGY, V153, P5361, DOI 10.1210/en.2012-1402; Popescu Mihaela, 2011, Roum Arch Microbiol Immunol, V70, P109; Saller MM, 2012, BIOCHEM BIOPH RES CO, V423, P379, DOI 10.1016/j.bbrc.2012.05.134; Sarnowska A, 2009, EXP NEUROL, V215, P317, DOI 10.1016/j.expneurol.2008.10.023; Scheibe F, 2012, CELL MOL NEUROBIOL, V32, P567, DOI 10.1007/s10571-012-9798-2; Suzuki Y, 2010, AM J PHYSIOL-HEART C, V299, pH1077, DOI 10.1152/ajpheart.00212.2010; Toma C, 2002, CIRCULATION, V105, P93, DOI 10.1161/hc0102.101442; Wang S, 2010, NEUROSCI BULL, V26, P437, DOI 10.1007/s12264-010-6024-4; Wei L, 2012, NEUROBIOL DIS, V46, P635, DOI 10.1016/j.nbd.2012.03.002; Wexler SA, 2003, BRIT J HAEMATOL, V121, P368, DOI 10.1046/j.1365-2141.2003.04284.x; Williams AR, 2013, CIRCULATION, V127, P213, DOI 10.1161/CIRCULATIONAHA.112.131110; Xie XX, 2012, TOHOKU J EXP MED, V226, P29, DOI 10.1620/tjem.226.29; Xinaris C, 2013, CELL TRANSPLANT, V22, P423, DOI 10.3727/096368912X653246; Zhang J, 2008, J NEUROSCI RES, V86, P1501, DOI 10.1002/jnr.21617; Zhong Q, 2012, STEM CELLS DEV, V21, P2703, DOI 10.1089/scd.2011.0604; Zhu WQ, 2006, STEM CELLS, V24, P416, DOI 10.1634/stemcells.2005-0121; Zitta K, 2010, EUR J PHARMACOL, V645, P39, DOI 10.1016/j.ejphar.2010.07.017	39	29	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90667	10.1371/journal.pone.0090667	http://dx.doi.org/10.1371/journal.pone.0090667			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599264	Green Published, gold, Green Submitted			2022-12-27	WOS:000332479400113
J	Wang, XJ; Yu, H; Cai, ZH; Wang, ZF; Ma, BJ; Zhang, Y; Ye, Z				Wang, Xuejian; Yu, Hao; Cai, Zhenhua; Wang, Zhifeng; Ma, Baojun; Zhang, Yi; Ye, Zi			Anatomical Study on Meckel Cave with Endoscopic Endonasal, Endo-Maxillary Sinus, and Endo-Pterygoid Process Approaches	PLOS ONE			English	Article							INTERNAL CAROTID-ARTERY; PETROCLIVAL MENINGIOMAS; PTERYGOPALATINE FOSSA; TRIGEMINAL NEURINOMAS; SURGICAL-MANAGEMENT; SURGERY; REMOVAL; NEUROMA; NERVE	Objective: To study anatomical structures related to Meckel cave with endonasal endoscopic approach and to provide an anatomical basis for endoscopic surgery in Meckel cave. Methods: Meckel cave of 5 adult skulls (10 sides) were fixed with 10% formalin. The anatomical structures of Meckel cave and the related zones adjacent to Meckel cave were observed and measured with endoscopic endonasal approach. Results: Endoscopic endonasal, endo-maxillary sinus, and endo-pterygoid process approaches were successfully applied in observation of the anatomical structures of meckel cave and the rerated zones adjacent to Meckel cave and in measurement of distances between related anatomical structures for each case of samples. The relevant data were obtained. The distance between the front mouth of palatovaginal canal and vidian canal was 21.4 +/- 7 mm, the distance between opening of sphenoid sinus to the upper margin of the choana was 22.3 +/- 2.8 mm, the distance between the opening of vidian and foramen rotundum was 7.57 +/- 0.7 mm and the length of the pterygoid canal was 13.3 +/- 1.2 mm. Based on these data, the positions of the related important structures can be roughly located during surgical operation and various important structures in Meckel cave and its adjacent zones can be found out in a convenient and safe way. Conclusion: 1) It is feasible to use endonasal endoscopic approach to perform surgical operation in Meckel cave; 2) Use of endonasal endoscopic approach can protect and fully take the advantage of the vidian nerve to locate the position of foramina lacerum of the internal carotid artery during surgical operation; and 3) the observational and experimental data obtained with this approach can provide the rational basis for clinical operation procedures.	[Wang, Xuejian; Yu, Hao; Cai, Zhenhua; Wang, Zhifeng; Ma, Baojun; Zhang, Yi; Ye, Zi] Nantong Univ, Hosp 2, Dept Neurosurg, Nantong, Jiangsu, Peoples R China	Nantong University	Yu, H (corresponding author), Nantong Univ, Hosp 2, Dept Neurosurg, Nantong, Jiangsu, Peoples R China.	6841441@163.com.cn	Wang, Xuejian/K-4868-2019	Wang, Xuejian/0000-0003-0389-5674				Al-Mefty O, 2002, J NEUROSURG, V96, P453, DOI 10.3171/jns.2002.96.3.0453; Aziz KMA, 1999, NEUROSURGERY, V44, P1225; Bai ZQ, 2009, NEUROSCI BULL, V25, P376, DOI 10.1007/s12264-009-0605-0; Bambakidis NC, 2007, NEUROSURGERY, V61, P202, DOI [10.1227/01.NIEU.0000280119.36270.BA, 10.1227/01.neu.0000303218.61230.39]; BRICOLO AP, 1992, NEUROSURGERY, V31, P813, DOI 10.1227/00006123-199211000-00001; CRESPO JV, 1981, ACTA NEUROCHIR, V55, P321; Day JD, 1998, NEUROSURGERY, V42, P233, DOI 10.1097/00006123-199802000-00015; DelGaudio JM, 2003, ARCH OTOLARYNGOL, V129, P441, DOI 10.1001/archotol.129.4.441; Fries G, 1998, NEUROSURGERY, V42, P226, DOI 10.1097/00006123-199802000-00008; Gardner PA, 2010, NEUROSURGERY, V66, DOI 10.1227/NEU.0b013e3181faaa70; Goel A, 2003, NEUROSURGERY, V52, P783, DOI 10.1227/01.NEU.0000053365.05795.03; INOUE T, 1990, NEUROSURGERY, V26, P903, DOI 10.1227/00006123-199006000-00001; Jarrahy R, 2000, OTOLARYNG HEAD NECK, V123, P218, DOI 10.1067/mhn.2000.107451; Kassam AB, 2008, J NEUROSURG, V108, P177, DOI 10.3171/JNS/2008/108/01/0177; Kassam AB, 2009, NEUROSURGERY, V64, pS71, DOI 10.1227/01.NEU.0000335162.36862.54; King WA, 2001, NEUROSURGERY, V49, P108, DOI 10.1097/00006123-200107000-00017; Faleiro LCM, 2006, ARQ NEURO-PSIQUIAT, V64, P650, DOI 10.1590/S0004-282X2006000400025; MILLER CG, 1993, NEUROSURGERY, V33, P461; Muto J, 2010, NEUROSURGERY, V67, P291, DOI 10.1227/01.NEU.0000382967.84940.52; Nakamura M, 2010, EJSO-EUR J SURG ONC, V36, P208, DOI 10.1016/j.ejso.2009.07.004; Osawa S, 2009, NEUROSURGERY, V64, P385, DOI 10.1227/01.NEU.0000338945.54863.D9; Pichierri A, 2010, NEUROSURGERY, V67, P29, DOI 10.1227/01.NEU.0000383131.72001.9E; Pinheiro-Neto CD, 2012, LARYNGOSCOPE, V122, P6, DOI 10.1002/lary.21808; Sabanci PA, 2011, WORLD NEUROSURG, V76, P335, DOI 10.1016/j.wneu.2011.03.037; Samii M, 1997, NEUROSURGERY, V41, P767, DOI 10.1097/00006123-199710000-00003; Samii M, 2000, J NEUROSURG, V92, P235, DOI 10.3171/jns.2000.92.2.0235; Sekhar L N, 1991, Acta Neurochir Suppl (Wien), V53, P183; Seoane E, 1999, NEUROSURGERY, V44, P553, DOI 10.1097/00006123-199903000-00065; TAHA JM, 1995, J NEUROSURG, V82, P719, DOI 10.3171/jns.1995.82.5.0719; Vescan AD, 2007, LARYNGOSCOPE, V117, P1338, DOI 10.1097/MLG.0b013e31806146cd; Yoshida K, 1999, J NEUROSURG, V91, P202, DOI 10.3171/jns.1999.91.2.0202	31	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91444	10.1371/journal.pone.0091444	http://dx.doi.org/10.1371/journal.pone.0091444			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614159	gold, Green Published, Green Submitted			2022-12-27	WOS:000332839300127
J	Yamamoto, K; Yamamoto, H; Yoshida, K; Niwa, K; Nishi, Y; Mizuno, A; Kuwabara, M; Asano, T; Sakoda, K; Niinuma, H; Nakahara, F; Takeda, K; Shindoh, C; Komatsu, Y				Yamamoto, Kyoko; Yamamoto, Hiroyuki; Yoshida, Katsumi; Niwa, Koichiro; Nishi, Yutaro; Mizuno, Atsushi; Kuwabara, Masanari; Asano, Taku; Sakoda, Kunihiro; Niinuma, Hiroyuki; Nakahara, Fumiko; Takeda, Kyoko; Shindoh, Chiyohiko; Komatsu, Yasuhiro			The Total Urine Protein-to-Creatinine Ratio Can Predict the Presence of Microalbuminuria	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; CARDIOVASCULAR MORTALITY; GENERAL-POPULATION; COST-EFFECTIVENESS; ALBUMINURIA; ASSOCIATION; PREVENTION	Background: The Kidney Disease: Improving Global Outcomes chronic kidney disease (CKD) guidelines recommend that CKD be classified based on the etiology, glomerular filtration rate (GFR) and degree of albuminuria. The present study aimed to establish a method that predicts the presence of microalbuminuria by measuring the total urine protein-to-creatinine ratio (TPCR) in patients with cardiovascular disease (CVD) risk factors. Methods and Results: We obtained urine samples from 1,033 patients who visited the cardiovascular clinic at St. Luke's International Hospital from February 2012 to August 2012. We measured the TPCR and the urine albumin-to-creatinine ratio (ACR) from random spot urine samples. We performed correlation, receiver operating characteristic (ROC) curve, sensitivity, and subgroup analyses. There was a strong positive correlation between the TPCR and ACR (R-2 = 0.861, p < 0.001). A ROC curve analysis for the TPCR revealed a sensitivity of 94.4%, a specificity of 86.1%, and an area under the curve of 0.903 for detecting microalbuminuria for a TPCR cut-off value of 84 mg/g of creatinine. The subgroup analysis indicated that the cut-off value could be used for patients with CVD risk factors. Conclusions: These results suggest that the TPCR with an appropriate cut-off value could be used to screen for the presence of microalbuminuria in patients with CVD risk factors. This simple, inexpensive measurement has broader applications, leading to earlier intervention and public benefit.	[Yamamoto, Kyoko; Shindoh, Chiyohiko] Tohoku Univ, Grad Sch Med, Dept Lab Med & Clin Sci, Sendai, Miyagi 980, Japan; [Yamamoto, Kyoko; Yamamoto, Hiroyuki; Komatsu, Yasuhiro] St Lukes Int Hosp, Div Nephrol, Dept Internal Med, Tokyo, Japan; [Yoshida, Katsumi] Tohoku Kosai Hosp, Hlth Med Ctr, Sendai, Miyagi, Japan; [Niwa, Koichiro; Nishi, Yutaro; Mizuno, Atsushi; Kuwabara, Masanari; Asano, Taku; Sakoda, Kunihiro; Niinuma, Hiroyuki] St Lukes Int Hosp, Dept Cardiol, Cardiovasc Ctr, Tokyo, Japan; [Nakahara, Fumiko; Takeda, Kyoko] St Lukes Int Hosp, Clin Lab Dept, Tokyo, Japan	Tohoku University; St. Luke's International Hospital; St. Luke's International Hospital; St. Luke's International Hospital	Yamamoto, H (corresponding author), St Lukes Int Hosp, Div Nephrol, Dept Internal Med, Tokyo, Japan.	yama-h@umin.ac.jp; komayasu@luke.or.jp	Kuwabara, Masanari/O-9844-2017; Asano, Taku/AAU-5875-2021; Komatsu, Yasuhiro/AAW-1969-2020	Kuwabara, Masanari/0000-0002-6601-4347; Yamamoto, Hiroyuki/0000-0003-3337-7595	St. Luke's Life Science Institute	St. Luke's Life Science Institute(St. Luke's Life Science Institute (SLLSI))	This study was supported, in part, by a grant from St. Luke's Life Science Institute. No additional external funding received for this study. http://sllsi.luke.or.jp/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelhafiz AH, 2011, NEPHRON EXP NEPHROL, V119, pE6, DOI 10.1159/000328015; Atkins RC, 2003, NEPHROL DIAL TRANSPL, V18, P2170, DOI 10.1093/ndt/gfg314; Atthobari J, 2006, CLIN THER, V28, P432, DOI 10.1016/j.clinthera.2006.03.012; Barr DB, 2005, ENVIRON HEALTH PERSP, V113, P192, DOI 10.1289/ehp.7337; Boersma C, 2010, CLIN THER, V32, P1103, DOI 10.1016/j.clinthera.2010.06.013; Brenner BM, 2008, BRENNER RECTORS KIDN; Brosius FC, 2006, CIRCULATION, V114, P1083, DOI 10.1161/CIRCULATIONAHA.106.177321; de Jong PE, 2006, J AM SOC NEPHROL, V17, P2120, DOI 10.1681/ASN.2006010097; Estacio RO, 2012, AM J CARDIOL, V109, P1743, DOI 10.1016/j.amjcard.2012.02.020; *KIDN DIS IMP GLOB, KDIGO 2012 CLIN PRAC; Lamb EJ, 2009, ANN CLIN BIOCHEM, V46, P205, DOI 10.1258/acb.2009.009007; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Methven S, 2010, NEPHROL DIAL TRANSPL, V25, P2991, DOI 10.1093/ndt/gfq140; *NAT KIDN FDN, 2007, AM J KIDNEY DIS S, V49, pS1, DOI DOI 10.1053/J.; Panek R, 2011, NEPHROL DIAL TRANSPL, V26, P1385, DOI 10.1093/ndt/gfq503; SHIHABI ZK, 1991, CLIN CHEM, V37, P621; Smith ER, 2012, NEPHROL DIAL TRANSPL, V27, P1534, DOI 10.1093/ndt/gfr708; Weir MR, 2007, CLIN J AM SOC NEPHRO, V2, P581, DOI 10.2215/CJN.03190906; WHO (World Health Organization), 1996, BIOL MON CHEM EXP WO; Yamamoto K, 2011, TOHOKU J EXP MED, V225, P195, DOI 10.1620/tjem.225.195	22	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91067	10.1371/journal.pone.0091067	http://dx.doi.org/10.1371/journal.pone.0091067			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614247	gold, Green Submitted, Green Published			2022-12-27	WOS:000332839300071
J	Freese, C; Reinhardt, S; Hefner, G; Unger, RE; Kirkpatrick, CJ; Endres, K				Freese, Christian; Reinhardt, Sven; Hefner, Gudrun; Unger, Ronald E.; Kirkpatrick, C. James; Endres, Kristina			A Novel Blood-Brain Barrier Co-Culture System for Drug Targeting of Alzheimer's Disease: Establishment by Using Acitretin as a Model Drug	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; IN-VITRO MODEL; MICROVASCULAR ENDOTHELIAL-CELLS; PAIRED HELICAL FILAMENTS; SECRETASE CLEAVAGE; PRIMARY CULTURES; BETA-SECRETASE; P-GLYCOPROTEIN; RETINOIC ACID; UP-REGULATION	In the pathogenesis of Alzheimer's disease (AD) the homeostasis of amyloid precursor protein (APP) processing in the brain is impaired. The expression of the competing proteases ADAM10 (a disintegrin and metalloproteinase 10) and BACE-1 (beta site APP cleaving enzyme 1) is shifted in favor of the A-beta generating enzyme BACE-1. Acitretin-a synthetic retinoid-e. g., has been shown to increase ADAM10 gene expression, resulting in a decreased level of A-beta peptides within the brain of AD model mice and thus is of possible value for AD therapy. A striking challenge in evaluating novel therapeutically applicable drugs is the analysis of their potential to overcome the blood-brain barrier (BBB) for central nervous system targeting. In this study, we established a novel cell-based bio-assay model to test ADAM10-inducing drugs for their ability to cross the BBB. We therefore used primary porcine brain endothelial cells (PBECs) and human neuroblastoma cells (SH-SY5Y) transfected with an ADAM10-promoter luciferase reporter vector in an indirect co-culture system. Acitretin served as a model substance that crosses the BBB and induces ADAM10 expression. We ensured that ADAM10-dependent constitutive APP metabolism in the neuronal cells was unaffected under co-cultivation conditions. Barrier properties established by PBECs were augmented by co-cultivation with SH-SY5Y cells and they remained stable during the treatment with acitretin as demonstrated by electrical resistance measurement and permeability-coefficient determination. As a consequence of transcellular acitretin transport measured by HPLC, the activity of the ADAM10-promoter reporter gene was significantly increased in co-cultured neuronal cells as compared to vehicle-treated controls. In the present study, we provide a new bio-assay system relevant for the study of drug targeting of AD. This bio-assay can easily be adapted to analyze other Alzheimer- or CNS disease-relevant targets in neuronal cells, as their therapeutical potential also depends on the ability to penetrate the BBB.	[Freese, Christian; Unger, Ronald E.; Kirkpatrick, C. James] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Pathol, REPAIR Lab, D-55122 Mainz, Germany; [Freese, Christian; Unger, Ronald E.; Kirkpatrick, C. James] European Inst Excellence Tissue Engn & Regenerat, Mainz, Germany; [Reinhardt, Sven; Hefner, Gudrun; Endres, Kristina] Johannes Gutenberg Univ Mainz, Med Ctr, Dept Psychiat & Psychotherapy, D-55122 Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Freese, C (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Pathol, REPAIR Lab, D-55122 Mainz, Germany.	freesec@uni-mainz.de	Endres, Kristina/K-4960-2015; Freese, Christian/Q-5540-2016	Freese, Christian/0000-0001-8411-1573; Kirkpatrick, Charles James/0000-0002-0088-418X	Federal Ministry of Education and Research (BMBF) [FKZ01GS08130]	Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by Federal Ministry of Education and Research (BMBF) grant (FKZ01GS08130; www.bmbf.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Armstrong JL, 2005, BIOCHEM PHARMACOL, V69, P1299, DOI 10.1016/j.bcp.2005.02.003; Bowman Gene L, 2008, Aging health, V4, P47, DOI 10.2217/1745509X.4.1.47; Caille I, 2004, DEVELOPMENT, V131, P2173, DOI 10.1242/dev.01103; Carl SM, 2010, MOL PHARM; CORDONCARDO C, 1989, P NATL ACAD SCI USA, V86, P695, DOI 10.1073/pnas.86.2.695; Culot M, 2008, TOXICOL IN VITRO, V22, P799, DOI 10.1016/j.tiv.2007.12.016; Cury PR, 2007, J PERIODONTOL, V78, P1309, DOI 10.1902/jop.2007.060225; Dauchy S, 2009, BIOCHEM PHARMACOL, V77, P897, DOI 10.1016/j.bcp.2008.11.001; DEHOUCK MP, 1990, J NEUROCHEM, V54, P1798, DOI 10.1111/j.1471-4159.1990.tb01236.x; Deli MA, 2005, CELL MOL NEUROBIOL, V25, P59, DOI 10.1007/s10571-004-1377-8; EISENHARDT EU, 1994, DRUG METAB DISPOS, V22, P26; Endres K, 2010, FEBS J, V277, P1585, DOI 10.1111/j.1742-4658.2010.07566.x; Forster C, 2008, J PHYSIOL-LONDON, V586, P1937, DOI 10.1113/jphysiol.2007.146852; Franke H, 1999, BRAIN RES, V818, P65, DOI 10.1016/S0006-8993(98)01282-7; Franke H, 2000, BRAIN RES PROTOC, V5, P248, DOI 10.1016/S1385-299X(00)00020-9; Fricker G, 2002, BRIT J PHARMACOL, V135, P1308, DOI 10.1038/sj.bjp.0704557; Gaillard PJ, 2001, EUR J PHARM SCI, V12, P215, DOI 10.1016/S0928-0987(00)00123-8; Gumbleton M, 2001, J PHARM SCI-US, V90, P1681, DOI 10.1002/jps.1119; Hatherell K, 2011, J NEUROSCI METH, V199, P223, DOI 10.1016/j.jneumeth.2011.05.012; Hawkins BT, 2005, PHARMACOL REV, V57, P173, DOI 10.1124/pr.57.2.4; Hendrie HC, 1998, AM J GERIAT PSYCHIAT, V6, pS3, DOI 10.1097/00019442-199821001-00002; Hermanns MI, 2009, J ROYAL SOC INTERFAC; Holthoewer D, 2012, NEURODEGENER DIS, V10, P224, DOI 10.1159/000334300; Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811; Igarashi Y, 1999, BIOCHEM BIOPH RES CO, V261, P108, DOI 10.1006/bbrc.1999.0992; Iqbal K, 2008, J CELL MOL MED, V12, P38, DOI 10.1111/j.1582-4934.2008.00225.x; Ishida A, 1997, NEUROREPORT, V8, P2133, DOI 10.1097/00001756-199707070-00009; ISHIGURO K, 1993, FEBS LETT, V325, P167, DOI 10.1016/0014-5793(93)81066-9; ISHIGURO K, 1992, J BIOL CHEM, V267, P10897; Joshi YB, 2012, J ALZHEIMERS DIS, V31, P167, DOI 10.3233/JAD-2012-120328; Karch A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084405; Kasper J, 2011, PART FIBRE TOXICOL, V8, DOI 10.1186/1743-8977-8-6; Kelleher RJ, 2013, AM J CARDIOVASC DIS, V3, P197; Kido Y, 2004, DRUG METABOLISM PHAR, V17, P34; Kuperstein F, 2002, EUR J NEUROSCI, V16, P44, DOI 10.1046/j.1460-9568.2002.02056.x; Lai CH, 2005, BRAIN RES REV, V50, P258, DOI 10.1016/j.brainresrev.2005.07.004; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Loscher W, 2005, PROG NEUROBIOL, V76, P22, DOI 10.1016/j.pneurobio.2005.04.006; Ly PTT, 2013, J CLIN INVEST, V123, P224, DOI 10.1172/JCI64516; Maruszak A, 2011, PROG NEURO-PSYCHOPH, V35, P320, DOI 10.1016/j.pnpbp.2010.07.004; Mattson MP, 1997, PHYSIOL REV, V77, P1081, DOI 10.1152/physrev.1997.77.4.1081; McCubrey JA, 2006, ANTIOXID REDOX SIGN, V8, P1775, DOI 10.1089/ars.2006.8.1775; Messing L, 2013, NEUROBIOL AGING, V34, P1343, DOI 10.1016/j.neurobiolaging.2012.10.024; Nakagawa S, 2007, CELL MOL NEUROBIOL, V27, P687, DOI 10.1007/s10571-007-9195-4; Patabendige A, 2013, BRAIN RES, V1521, P1, DOI 10.1016/j.brainres.2012.06.057; Perry G, 1999, NEUROREPORT, V10, P2411, DOI 10.1097/00001756-199908020-00035; Poller B, 2010, CELL MOL NEUROBIOL, V30, P63, DOI 10.1007/s10571-009-9431-1; Postina R, 2004, J CLIN INVEST, V113, P1456, DOI 10.1172/JCI200420864; Sathya M, 2012, CLIN CHIM ACTA, V414, P171, DOI 10.1016/j.cca.2012.08.013; Schiera G, 2003, J CELL MOL MED, V7, P165, DOI 10.1111/j.1582-4934.2003.tb00215.x; Sharom FJ, 2011, ESSAYS BIOCHEM, V50, P161, DOI [10.1042/BSE0500161, 10.1042/bse0500161]; Sinha S, 1999, P NATL ACAD SCI USA, V96, P11049, DOI 10.1073/pnas.96.20.11049; Steiner H, 2000, NAT CELL BIOL, V2, P848, DOI 10.1038/35041097; Stins MF, 2001, MICROB PATHOGENESIS, V30, P19, DOI 10.1006/mpat.2000.0406; Thornton E, 2006, BRAIN RES, V1094, P38, DOI 10.1016/j.brainres.2006.03.107; Tippmann F, 2009, FASEB J, V23, P1643, DOI 10.1096/fj.08-121392; TONTSCH U, 1991, BRAIN RES, V539, P247, DOI 10.1016/0006-8993(91)91628-E; Unger RE, 2002, IN VITRO CELL DEV-AN, V38, P273; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vos SJB, 2013, LANCET NEUROL, V12, P957, DOI 10.1016/S1474-4422(13)70194-7; Wan XZ, 2012, J NEUROSCI, V32, P3910, DOI 10.1523/JNEUROSCI.3916-11.2012; Weidenfeller C, 2007, J NEUROCHEM, V101, P555, DOI 10.1111/j.1471-4159.2006.04394.x; Weksler B, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-16; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; Wolfe MS, 2012, ADV PHARMACOL, V64, P127, DOI 10.1016/B978-0-12-394816-8.00004-0; Yamagata K, 2003, NEUROSCIENCE, V116, P649, DOI 10.1016/S0306-4522(02)00715-7; Zhang Y, 2006, DRUG METAB DISPOS, V34, P1935, DOI 10.1124/dmd.105.006437; Zipser BD, 2007, NEUROBIOL AGING, V28, P977, DOI 10.1016/j.neurobiolaging.2006.05.016; Zozulya A, 2008, BRAIN RES, V1189, P1, DOI 10.1016/j.brainres.2007.10.099	70	32	33	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91003	10.1371/journal.pone.0091003	http://dx.doi.org/10.1371/journal.pone.0091003			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608847	Green Published, gold, Green Submitted			2022-12-27	WOS:000332485800077
J	Kessels, MY; Huitema, LFA; Boeren, S; Kranenbarg, S; Schulte-Merker, S; van Leeuwen, JL; de Vries, SC				Kessels, Maurijn Y.; Huitema, Leonie F. A.; Boeren, Sjef; Kranenbarg, Sander; Schulte-Merker, Stefan; van Leeuwen, Johan L.; de Vries, Sacco C.			Proteomics Analysis of the Zebrafish Skeletal Extracellular Matrix	PLOS ONE			English	Article							GENE-EXPRESSION; BONE-DEVELOPMENT; SERINE-PROTEASE; SAMPLE PREPARATION; CARTILAGE; COLLAGEN; REVEALS; GROWTH; DIFFERENTIATION; MINERALIZATION	The extracellular matrix of the immature and mature skeleton is key to the development and function of the skeletal system. Notwithstanding its importance, it has been technically challenging to obtain a comprehensive picture of the changes in skeletal composition throughout the development of bone and cartilage. In this study, we analyzed the extracellular protein composition of the zebrafish skeleton using a mass spectrometry-based approach, resulting in the identification of 262 extracellular proteins, including most of the bone and cartilage specific proteins previously reported in mammalian species. By comparing these extracellular proteins at larval, juvenile, and adult developmental stages, 123 proteins were found that differed significantly in abundance during development. Proteins with a reported function in bone formation increased in abundance during zebrafish development, while analysis of the cartilage matrix revealed major compositional changes during development. The protein list includes ligands and inhibitors of various signaling pathways implicated in skeletogenesis such as the Int/Wingless as well as the insulin-like growth factor signaling pathways. This first proteomic analysis of zebrafish skeletal development reveals that the zebrafish skeleton is comparable with the skeleton of other vertebrate species including mammals. In addition, our study reveals 6 novel proteins that have never been related to vertebrate skeletogenesis and shows a surprisingly large number of differences in the cartilage and bone proteome between the head, axis and caudal fin regions. Our study provides the first systematic assessment of bone and cartilage protein composition in an entire vertebrate at different stages of development.	[Kessels, Maurijn Y.; Boeren, Sjef; de Vries, Sacco C.] Wageningen Univ, Biochem Lab, NL-6700 AP Wageningen, Netherlands; [Kessels, Maurijn Y.; Kranenbarg, Sander; Schulte-Merker, Stefan; van Leeuwen, Johan L.] Wageningen Univ, Expt Zool Grp, NL-6700 AP Wageningen, Netherlands; [Huitema, Leonie F. A.; Schulte-Merker, Stefan] Hubrecht Inst KNAW, Utrecht, Netherlands; [Huitema, Leonie F. A.; Schulte-Merker, Stefan] Univ Med Ctr Utrecht, Utrecht, Netherlands	Wageningen University & Research; Wageningen University & Research; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center	de Vries, SC (corresponding author), Wageningen Univ, Biochem Lab, NL-6700 AP Wageningen, Netherlands.	Sacco.devries@wur.nl	van Leeuwen, Johan L/B-7897-2011; van Leeuwen, Johan/N-3437-2019	van Leeuwen, Johan/0000-0002-4433-880X	Research School VLAG, Wageningen University [6161100538]	Research School VLAG, Wageningen University	This work was supported by Grant no. 6161100538 Research School VLAG, Wageningen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens CH, 2010, NAT REV MOL CELL BIO, V11, P789, DOI 10.1038/nrm2973; Alves RDAM, 2011, J PROTEOME RES, V10, P4725, DOI 10.1021/pr200522n; Anderson L, 1997, ELECTROPHORESIS, V18, P533, DOI 10.1002/elps.1150180333; Andress DL, 2001, AM J PHYSIOL-ENDOC M, V281, pE283, DOI 10.1152/ajpendo.2001.281.2.E283; ASHTON BA, 1976, CALC TISS RES, V22, P27; Balooch G, 2005, P NATL ACAD SCI USA, V102, P18813, DOI 10.1073/pnas.0507417102; Bernardo BC, 2011, J BIOL CHEM, V286, P37758, DOI 10.1074/jbc.M111.248039; Bhatia VN, 2009, ANAL CHEM, V81, P9819, DOI 10.1021/ac901335x; Bikle Daniel D, 2012, Curr Mol Pharmacol, V5, P135; Bird NC, 2003, DEV DYNAM, V228, P337, DOI 10.1002/dvdy.10387; Brellier F, 2012, INT J BIOL SCI, V8, P187, DOI 10.7150/ijbs.8.187; Cerda J, 2002, DEV DYNAM, V224, P200, DOI 10.1002/dvdy.10101; Chatani M, 2011, DEV BIOL, V360, P96, DOI 10.1016/j.ydbio.2011.09.013; Deshpande AS, 2008, CRYST GROWTH DES, V8, P3084, DOI 10.1021/cg800252f; Enomoto-Iwamoto M, 2002, DEV BIOL, V251, P142, DOI 10.1006/dbio.2002.0802; Erlebacher A, 1996, J CELL BIOL, V132, P195, DOI 10.1083/jcb.132.1.195; Fitzgerald J, 2008, J BIOL CHEM, V283, P20170, DOI 10.1074/jbc.M710139200; Flores MV, 2004, GENE EXPR PATTERNS, V4, P573, DOI 10.1016/j.modgep.2004.01.016; Fox AJS, 2009, SPORTS HEALTH, V1, P461, DOI 10.1177/1941738109350438; Graham JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074094; Hegde PS, 2003, CURR OPIN BIOTECH, V14, P647, DOI 10.1016/j.copbio.2003.10.006; Hou J, 2005, J CELL BIOCHEM, V94, P470, DOI 10.1002/jcb.20328; Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111; Huitema LFA, 2012, P NATL ACAD SCI USA, V109, P21372, DOI 10.1073/pnas.1214231110; Inada M, 2004, P NATL ACAD SCI USA, V101, P17192, DOI 10.1073/pnas.0407788101; James CG, 2005, MOL BIOL CELL, V16, P5316, DOI 10.1091/mbc.E05-01-0084; Jiang XG, 2007, J PROTEOME RES, V6, P2287, DOI 10.1021/pr070056t; Karve Tejaswita M, 2011, J Amino Acids, V2011, P207691, DOI 10.4061/2011/207691; Kim T, 2009, J BIOL CHEM, V284, P15308, DOI 10.1074/jbc.M807722200; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Kvist AJ, 2008, MATRIX BIOL, V27, P22, DOI 10.1016/j.matbio.2007.07.007; Lammi MJ, 2006, ELECTROPHORESIS, V27, P2687, DOI 10.1002/elps.200600004; LeClair EE, 2009, DEV DYNAM, V238, P2550, DOI 10.1002/dvdy.22086; Lee C, 2009, FRONT BIOSCI-LANDMRK, V14, P2911, DOI 10.2741/3422; Li N, 2009, DEV DYNAM, V238, P459, DOI 10.1002/dvdy.21838; Lu C, 2013, BONE, V53, P566, DOI 10.1016/j.bone.2012.12.016; Mackay E, 2013, BONEKEY IN PRESS; Mackie EJ, 2008, INT J BIOCHEM CELL B, V40, P46, DOI 10.1016/j.biocel.2007.06.009; Manza LL, 2005, PROTEOMICS, V5, P1742, DOI 10.1002/pmic.200401063; Mohan S., 1995, Progress in Growth Factor Research, V6, P465, DOI 10.1016/0955-2235(95)00027-5; Nagayama M, 2008, J DENT RES, V87, P244, DOI 10.1177/154405910808700309; Nakamura H, 2004, BONE, V34, P48, DOI 10.1016/j.bone.2003.09.001; Nishino J, 2004, EMBO J, V23, P1998, DOI 10.1038/sj.emboj.7600202; Nunez C, 2006, J BACTERIOL, V188, P2792, DOI 10.1128/JB.188.8.2792-2800.2006; Nusse R, 2012, EMBO J, V31, P2670, DOI 10.1038/emboj.2012.146; Onnerfjord P, 2012, J BIOL CHEM, V287, P18913, DOI 10.1074/jbc.M111.298968; Peruzzi B, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1651; Quondamatteo F, 2002, HISTOCHEM J, V34, P369, DOI 10.1023/A:1023675619251; Rotllant J, 2008, MATRIX BIOL, V27, P561, DOI 10.1016/j.matbio.2008.03.001; Rozen S, 2000, Methods Mol Biol, V132, P365; Schreiweis MA, 2007, J CELL BIOCHEM, V101, P466, DOI 10.1002/jcb.21196; Schulte-Merker S., 2002, ZEBRAFISH PRACTICAL, V261, P39; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Singh SK, 2011, J SEP SCI, V34, P225, DOI 10.1002/jssc.201000626; Sintuu C, 2008, J ORTHOP RES, V26, P753, DOI 10.1002/jor.20580; Smith A, 2008, DEV DYNAM, V237, P417, DOI 10.1002/dvdy.21417; Spoorendonk KM, 2010, J APPL ICHTHYOL, V26, P219, DOI 10.1111/j.1439-0426.2010.01409.x; Spoorendonk KM, 2008, DEVELOPMENT, V135, P3765, DOI 10.1242/dev.024034; Sprague J, 2003, NUCLEIC ACIDS RES, V31, P241, DOI 10.1093/nar/gkg027; Stickens D, 2004, DEVELOPMENT, V131, P5883, DOI 10.1242/dev.01461; Tahimic Candice G T, 2013, Front Endocrinol (Lausanne), V4, P6, DOI 10.3389/fendo.2013.00006; TAKAHASHI S, 1994, J BIOL CHEM, V269, P28696; Tiaden AN, 2012, STEM CELLS, V30, P2271, DOI 10.1002/stem.1190; Timpl R, 2003, NAT REV MOL CELL BIO, V4, P479, DOI 10.1038/nrm1130; Tocharus J, 2004, DEV GROWTH DIFFER, V46, P257; Topczewski J, 2001, DEV CELL, V1, P251, DOI 10.1016/S1534-5807(01)00005-3; TRIFFITT JT, 1976, NATURE, V262, P226, DOI 10.1038/262226a0; Tsuchiya A, 2005, BONE, V37, P323, DOI 10.1016/j.bone.2005.03.015; van Gool SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044561; Viguet-Carrin S, 2006, OSTEOPOROSIS INT, V17, P319, DOI 10.1007/s00198-005-2035-9; Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271; Wilson R, 2012, MOL CELLULAR PROTEOM, V11; Wisniewski JR, 2009, NAT METHODS, V6, P785, DOI 10.1038/nmeth1109-785b; Yamada Y, 2003, J HUM GENET, V48, P469, DOI 10.1007/s10038-003-0063-x; Zhang H, 2003, OSTEOARTHR CARTILAGE, V11, P309, DOI 10.1016/S1063-4584(03)00032-3; Zhu WH, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/840518	76	31	31	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90568	10.1371/journal.pone.0090568	http://dx.doi.org/10.1371/journal.pone.0090568			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608635	Green Published, gold, Green Submitted			2022-12-27	WOS:000332485800034
J	Lei, ST; Zeng, B; Yuan, Z; Su, XL				Lei, Shutong; Zeng, Bo; Yuan, Zhi; Su, Xiaolei			Changes in Carbohydrate Content and Membrane Stability of Two Ecotypes of Calamagrostis arundinacea Growing at Different Elevations in the Drawdown Zone of the Three Gorges Reservoir	PLOS ONE			English	Article							LONG-TERM SUBMERGENCE; TOLERANCE; RECOVERY; GROWTH; PHOTOSYNTHESIS; RESPONSES; SURVIVAL; PLANTS; RICE	Background: The Three Gorges project has caused many ecosystem problems. Ecological restoration using readily-available plants is an effective way of mitigating environmental impacts. Two perennial submergence-tolerant ecotypes of Calamagrostis arundinacea were planted in an experimental field in the drawdown zone. Responses of the two plant ecotypes to flooding stress in the drawdown zone were unknown. Methodology/Principal Findings: Carbohydrate content and membrane stability, two key factors for survival of plants under flooding stress, of two ecotypes (designated "dwarf" and "green") of C. arundinacea growing at different elevations of the drawdown zone were investigated. Live stems (LS) and dead stems (DS) of the two plant ecotypes at eight elevations (175, 170, 162, 160, 158, 155, 152 m and 149 m) were sampled. Contents of soluble sugar, starch and malondialdehyde (MDA), as well as plasma membrane permeability of live stems were measured. The lowest elevations for survival of dwarf and green C. arundinacea were 160 m and 158 m, respectively. Soluble sugar content of live stems of both ecotypes decreased with elevation, with amounts from an elevation of 170 m being lower than from an elevation of 175 m. MDA content and plasma membrane permeability in live stems of green C. arundinacea did not increase with the decrease in elevation, while these measures in dwarf C. arundinacea from an elevation of 162 m were significantly higher than from an elevation of 175 m. Conclusions: Carbohydrate content, especially soluble sugar content, in both ecotypes was more sensitive to flooding stress than membrane stability. Green C. arundinacea had a higher tolerance to submergence than dwarf C. arundinacea, and thus green C. arundinacea can be planted at lower elevations than dwarf C. arundinacea.	[Lei, Shutong] Linyi Univ, Managing Off Natl Assets & Lab Equipments, Linyi, Peoples R China; [Lei, Shutong; Zeng, Bo; Yuan, Zhi; Su, Xiaolei] Southwest Univ, Chongqing Key Lab Plant Ecol & Resources Three Go, Key Lab Ecoenviron Three Gorges Reservoir Reg, Minist Educ, Chongqing, Peoples R China	Linyi University; Southwest University - China	Zeng, B (corresponding author), Southwest Univ, Chongqing Key Lab Plant Ecol & Resources Three Go, Key Lab Ecoenviron Three Gorges Reservoir Reg, Minist Educ, Chongqing, Peoples R China.	bzeng@swu.edu.cn			National Natural Science Foundation of China [31070474, 31370443]; National Basic Research Program of China [2012CB723205]; Research Grant for Disciplines Conferring Doctorate in China [20100182110022]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Research Grant for Disciplines Conferring Doctorate in China	This research was supported by grants of National Natural Science Foundation of China Nos. 31070474, 31370443 (http://159.226.244.22/portal/Proj_List.asp), National Basic Research Program of China No. 2012CB723205 (http://www.973.gov.cn/AreaMana.aspx), and Research Grant for Disciplines Conferring Doctorate in China (20100182110022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[罗芳丽 LUO FangLi], 2006, [生态学报, Acta Ecologica Sinica], V26, P3602; Bailey-Serres J, 2008, ANNU REV PLANT BIOL, V59, P313, DOI 10.1146/annurev.arplant.59.032607.092752; Fukao T, 2004, TRENDS PLANT SCI, V9, P449, DOI 10.1016/j.tplants.2004.07.005; HEATH RL, 1965, BIOCHEM BIOPH RES CO, V19, P716, DOI 10.1016/0006-291X(65)90316-5; Hong Ming, 2011, Yingyong Shengtai Xuebao, V22, P2829; Jackson MB, 2009, ANN BOT-LONDON, V103, P137, DOI 10.1093/aob/mcn242; Jie SL, 2012, ACTA ECOL SIN, V32, P723; Lei S, 2012, ACTA ECOL SINICA, V32, P227, DOI DOI 10.1016/J.CHNAES.2012.06.001; Lei ST, 2009, J CHONGQING NORM U N, V26, P30; Li Y., 2008, ACTA ECOL SINICA, V28, P1924; Luo FL, 2011, ANN BOT-LONDON, V107, P49, DOI 10.1093/aob/mcq212; Luo FL, 2009, ANN BOT-LONDON, V104, P1435, DOI 10.1093/aob/mcp257; Pan RC, 2003, PLANT PHYSL; Pena-Fronteras JT, 2009, ANN BOT-LONDON, V103, P295, DOI 10.1093/aob/mcn085; Perata P, 2011, NEW PHYTOL, V190, P269, DOI 10.1111/j.1469-8137.2011.03702.x; Ram PC, 2002, FIELD CROP RES, V76, P131, DOI 10.1016/S0378-4290(02)00035-7; Shen Jian-Hong, 2011, Chinese Journal of Plant Ecology, V35, P237, DOI 10.3724/SP.J.1258.2011.00237; [苏晓磊 Su Xiaolei], 2010, [生态学报, Acta Ecologica Sinica], V30, P2585; Tan S D, 2008, RESOUR ENV YANGTZE B, V17, P101; Tan SD, 2010, ACTA PHYSIOL PLANT, V32, P133, DOI 10.1007/s11738-009-0388-y; Visser EJW, 2003, ANN BOT-LONDON, V91, P107, DOI 10.1093/aob/mcg014; Wang Hai-Feng, 2008, Zhiwu Shengtai Xuebao, V32, P977, DOI 10.3773/j.issn.1005-264x.2008.05.001; [王海锋 WANG HaiFeng], 2008, [生态学报, Acta Ecologica Sinica], V28, P2571; Zhang JianJun, 2012, Scientia Silvae Sinicae, V48, P154; [张艳红 ZHANG Yanhong], 2006, [西南师范大学学报. 自然科学版, Journal of Southwest China Normal University. Natural Science], V31, P153; Zhang ZL, 2003, EXPT GUIDE PLANT PHS; [周永娟 Zhou Yongjuan], 2010, [生态学报, Acta Ecologica Sinica], V30, P6726	27	12	12	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91394	10.1371/journal.pone.0091394	http://dx.doi.org/10.1371/journal.pone.0091394			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608821	Green Published, Green Submitted, gold			2022-12-27	WOS:000332485800133
J	Morel, N; Villain, N; Rauchs, G; Gaubert, M; Piolino, P; Landeau, B; Mezenge, F; Desgranges, B; Eustache, F; Chetelat, G				Morel, Nastassja; Villain, Nicolas; Rauchs, Geraldine; Gaubert, Malo; Piolino, Pascale; Landeau, Brigitte; Mezenge, Florence; Desgranges, Beatrice; Eustache, Francis; Chetelat, Gael			Brain Activity and Functional Coupling Changes Associated with Self-Reference Effect during Both Encoding and Retrieval	PLOS ONE			English	Article							CORTICAL MIDLINE STRUCTURES; EPISODIC MEMORY; DEFAULT-MODE; AUTOBIOGRAPHICAL MEMORY; ALZHEIMERS-DISEASE; PREFRONTAL CORTEX; EMOTIONAL SELF; NETWORK; FMRI; CONNECTIVITY	Information that is processed with reference to oneself, i.e. Self-Referential Processing (SRP), is generally associated with better remembering compared to information processed in a condition not related to oneself. This positive effect of the self on subsequent memory performance is called as Self-Reference Effect (SRE). The neural basis of SRE is still poorly understood. The main goal of the present work was thus to highlight brain changes associated with SRE in terms of activity and functional coupling and during both encoding and retrieval so as to assess the relative contribution of both processes to SRE. For this purpose, we used an fMRI event-related self-referential paradigm in 30 healthy young subjects and measured brain activity during both encoding and retrieval of self-relevant information compared to a semantic control condition. We found that SRE was associated with brain changes during the encoding phase only, including both greater activity in the medial prefrontal cortex and hippocampus, and greater functional coupling between these brain regions and the posterior cingulate cortex. These findings highlight the contribution of brain regions involved in both SRP and episodic memory and the relevance of the communication between these regions during the encoding process as the neural substrates of SRE. This is consistent with the idea that SRE reflects a positive effect of the reactivation of self-related memories on the encoding of new information in episodic memory.	[Morel, Nastassja; Villain, Nicolas; Rauchs, Geraldine; Gaubert, Malo; Landeau, Brigitte; Mezenge, Florence; Desgranges, Beatrice; Eustache, Francis; Chetelat, Gael] INSERM, U1077, Caen, France; [Morel, Nastassja; Villain, Nicolas; Rauchs, Geraldine; Gaubert, Malo; Landeau, Brigitte; Mezenge, Florence; Desgranges, Beatrice; Eustache, Francis; Chetelat, Gael] Univ Caen Basse Normandie, UMR S1077, Caen, France; [Morel, Nastassja; Villain, Nicolas; Rauchs, Geraldine; Gaubert, Malo; Landeau, Brigitte; Mezenge, Florence; Desgranges, Beatrice; Eustache, Francis; Chetelat, Gael] Ecole Prat Hautes Etud, UMR S1077, Caen, France; [Morel, Nastassja; Villain, Nicolas; Rauchs, Geraldine; Gaubert, Malo; Landeau, Brigitte; Mezenge, Florence; Desgranges, Beatrice; Eustache, Francis; Chetelat, Gael] CHU Caen, U1077, F-14000 Caen, France; [Piolino, Pascale] Univ Paris 05, Inst Psychol, Lab Memoire & Cognit, Paris, France; [Piolino, Pascale] INSERM, U894, Ctr Psychiat & Neurosci, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Caen Normandie; CHU de Caen NORMANDIE; Universite de Caen Normandie; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Chetelat, G (corresponding author), INSERM, U1077, Caen, France.	chetelat@cyceron.fr	Villain, Nicolas/E-6475-2012; Piolino, pascale/F-8075-2014; Chetelat, Gael/G-2316-2015; Desgranges, Béatrice/L-7739-2015; RAUCHS, Géraldine/L-7921-2015; Eustache, Francis/J-9465-2015; DESGRANGES, BEATRICE/AAK-4756-2021	Villain, Nicolas/0000-0002-7429-4289; Piolino, pascale/0000-0002-7787-924X; RAUCHS, Géraldine/0000-0001-7128-2189; Eustache, Francis/0000-0003-4460-8686; DESGRANGES, BEATRICE/0000-0002-3657-9996; Gael, Chetelat/0000-0002-4889-7932	Fondation Plan Alzheimer (Alzheimer Plan); Agence Nationale de la Recherche (ANR LONGVIE); Region Basse Normandie; Institut National de la Sante et de la Recherche Medicale (Inserm); Ministere de l'Enseignement Superieur de la Recherche	Fondation Plan Alzheimer (Alzheimer Plan); Agence Nationale de la Recherche (ANR LONGVIE)(French National Research Agency (ANR)); Region Basse Normandie(Region Normandie); Institut National de la Sante et de la Recherche Medicale (Inserm)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Ministere de l'Enseignement Superieur de la Recherche	This work was supported by the Fondation Plan Alzheimer (Alzheimer Plan 2008-2012), Agence Nationale de la Recherche (ANR LONGVIE 2007), Region Basse Normandie, Institut National de la Sante et de la Recherche Medicale (Inserm) and Ministere de l'Enseignement Superieur de la Recherche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benoit RG, 2010, NEUROIMAGE, V50, P1340, DOI 10.1016/j.neuroimage.2009.12.091; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2007, TRENDS COGN SCI, V11, P49, DOI 10.1016/j.tics.2006.11.004; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Cabeza R, 2007, TRENDS COGN SCI, V11, P219, DOI 10.1016/j.tics.2007.02.005; Conway MA, 2005, J MEM LANG, V53, P594, DOI 10.1016/j.jml.2005.08.005; CONWAY MA, 1995, Q J EXP PSYCHOL-A, V48, P125, DOI 10.1080/14640749508401380; Conway MA, 2009, NEUROPSYCHOLOGIA, V47, P2305, DOI 10.1016/j.neuropsychologia.2009.02.003; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; CRAIK FIM, 1975, J EXP PSYCHOL GEN, V104, P268, DOI 10.1037/0096-3445.104.3.268; Craik FIM, 2002, MEMORY, V10, P305, DOI 10.1080/09658210244000135; CRAIK FIM, 1972, J VERB LEARN VERB BE, V11, P671, DOI 10.1016/S0022-5371(72)80001-X; D'Argembeau A, 2008, SOC COGN AFFECT NEUR, V3, P244, DOI 10.1093/scan/nsn020; D'Argembeau A, 2012, CEREB CORTEX, V22, P659, DOI 10.1093/cercor/bhr144; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Deloche G, 1997, TEST DENOMINATION OR; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fossati P, 2004, NEUROIMAGE, V22, P1596, DOI 10.1016/j.neuroimage.2004.03.034; Fossati P, 2003, AM J PSYCHIAT, V160, P1938, DOI 10.1176/appi.ajp.160.11.1938; Fransson P, 2008, NEUROIMAGE, V42, P1178, DOI 10.1016/j.neuroimage.2008.05.059; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Gallese V, 1998, TRENDS COGN SCI, V2, P493, DOI 10.1016/S1364-6613(98)01262-5; Genon S, 2013, CORTEX; Gitelman DR, 2003, NEUROIMAGE, V19, P200, DOI 10.1016/S1053-8119(03)00058-2; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Grezes J, 2001, HUM BRAIN MAPP, V12, P1, DOI 10.1002/1097-0193(200101)12:1<1::AID-HBM10>3.0.CO;2-V; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Gutchess AH, 2010, NEUROPSYCHOLOGIA, V48, P211, DOI 10.1016/j.neuropsychologia.2009.09.006; Haslam C, 2011, BRIT J PSYCHOL, V102, P184, DOI 10.1348/000712610X508091; Herbert C, 2011, NEUROPSYCHOLOGIA, V49, P2947, DOI 10.1016/j.neuropsychologia.2011.06.026; Herwig U, 2010, NEUROIMAGE, V50, P734, DOI 10.1016/j.neuroimage.2009.12.089; Holland AC, 2011, NEUROPSYCHOLOGIA, V49, P3164, DOI 10.1016/j.neuropsychologia.2011.07.015; Johnson SC, 2007, ARCH GEN PSYCHIAT, V64, P1163, DOI 10.1001/archpsyc.64.10.1163; Karusu T.B., 1976, GERIATRIC PSYCHIAT, P77; Kelley WM, 2002, J COGNITIVE NEUROSCI, V14, P785, DOI 10.1162/08989290260138672; Keysers C, 2007, TRENDS COGN SCI, V11, P194, DOI 10.1016/j.tics.2007.02.002; Kim H, 2012, NEUROIMAGE, V61, P966, DOI 10.1016/j.neuroimage.2012.03.025; Klein SB, 2010, WILEY INTERDISCIPLIN; Klein SB, 2012, PERS SOC PSYCHOL REV, V16, P283, DOI 10.1177/1088868311434214; Lalanne J, 2010, PSYCHOL NEUROPSYCHIA, V8, P277, DOI 10.1684/pnv.2010.0231; Macrae CN, 2004, CEREB CORTEX, V14, P647, DOI 10.1093/cercor/bhh025; Maguire EA, 2000, HIPPOCAMPUS, V10, P475; Martinelli P., 2012, HUM BRAIN MAPP; Martinelli P, 2013, HUM BRAIN MAPP, V34, P1515, DOI 10.1002/hbm.22008; Mevel K, 2012, NEUROBIOL AGING; Mitchell JP, 2005, J COGNITIVE NEUROSCI, V17, P1306, DOI 10.1162/0898929055002418; Moran JM, 2009, SOC NEUROSCI-UK, V4, P197, DOI 10.1080/17470910802250519; Northoff G, 2004, TRENDS COGN SCI, V8, P102, DOI 10.1016/j.tics.2004.01.004; Northoff G, 2006, NEUROIMAGE, V31, P440, DOI 10.1016/j.neuroimage.2005.12.002; Philippi CL, 2012, J COGNITIVE NEUROSCI, V24, P475, DOI 10.1162/jocn_a_00138; Qin PM, 2011, NEUROIMAGE, V57, P1221, DOI 10.1016/j.neuroimage.2011.05.028; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Rey A., 1959, MANUEL TEST COPIE FI; ROGERS TB, 1977, J PERS SOC PSYCHOL, V35, P677, DOI 10.1037/0022-3514.35.9.677; Rugg MD, 2013, CURR OPIN NEUROBIOL, V23, P255, DOI 10.1016/j.conb.2012.11.005; Sajonz B, 2010, NEUROIMAGE, V50, P1606, DOI 10.1016/j.neuroimage.2010.01.087; Saxe R, 2006, SOC COGN AFFECT NEUR, V1, P229, DOI 10.1093/scan/nsl034; Schmitz TW, 2004, NEUROIMAGE, V22, P941, DOI 10.1016/j.neuroimage.2004.02.018; Signoret JL, 1991, BATTERIE EFFICIENCE; Spreng RN, 2009, J COGNITIVE NEUROSCI, V21, P489, DOI 10.1162/jocn.2008.21029; Stroop JR, 1935, J EXPT PSYCHOL; Svoboda E, 2006, NEUROPSYCHOLOGIA, V44, P2189, DOI 10.1016/j.neuropsychologia.2006.05.023; Symons CS, 1997, PSYCHOL BULL, V121, P371, DOI 10.1037/0033-2909.121.3.371; Tomasi D, 2011, CEREB CORTEX, V21, P2003, DOI 10.1093/cercor/bhq268; Turk DJ, 2008, CONSCIOUS COGN, V17, P1040, DOI 10.1016/j.concog.2008.02.004; Van der Linden M, 2004, REV NEUROL-FRANCE, V160, pS64; van der Meer L, 2010, NEUROSCI BIOBEHAV R, V34, P935, DOI 10.1016/j.neubiorev.2009.12.004; Vanderwal T, 2008, NEUROIMAGE, V41, P1437, DOI 10.1016/j.neuroimage.2008.03.058; Viard A, 2012, BRAIN COGNITION, V80, P111, DOI 10.1016/j.bandc.2012.05.004; Villain N, 2010, J NEUROIMAGING, V20, P324, DOI 10.1111/j.1552-6569.2010.00470.x; Wager TD, 2003, NEUROIMAGE, V18, P293, DOI 10.1016/S1053-8119(02)00046-0; Yoshimura S, 2009, BRAIN COGNITION, V69, P218, DOI 10.1016/j.bandc.2008.07.010; Zhu L, 2012, HIPPOCAMPUS, V22, P1540, DOI 10.1002/hipo.20994	73	24	26	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90488	10.1371/journal.pone.0090488	http://dx.doi.org/10.1371/journal.pone.0090488			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608131	Green Published, Green Submitted, gold			2022-12-27	WOS:000332485800028
J	Sadhu, S; Manukonda, AR; Yeruva, AR; Patel, SK; Saggurti, N				Sadhu, Santhosh; Manukonda, Archana Rao; Yeruva, Anthony Reddy; Patel, Sangram Kishor; Saggurti, Niranjan			Role of a Community-to-Community Learning Strategy in the Institutionalization of Community Mobilization among Female Sex Workers in India	PLOS ONE			English	Article							ANDHRA-PRADESH; CONDOM USE; HEALTH	Introduction: The institutionalization of community mobilization is not well understood in literature. This paper aims to understand the role of the community-to-community learning strategy in the institutionalization of community mobilization among sex workers communities across eight districts of Andhra Pradesh, India. Materials and Methods: Data collected during baseline (March, 2010) and endline (June, 2012) under an HIV prevention project (SAKSHAM project) was used to investigate the strength (as score) of community mobilization based on two learning strategies: non-government organization (NGO)-to-community-based organization (CBO) strategy, and community-to-CBO strategy. The strength of community mobilization was assessed based on different parameters. The change in scores were computed as a percentage of the improvement to the total potential improvement from baseline to endline on specific indicators and overall. Results: Most of the CBOs considered in the pre-post assessment had been registered during 2004-2008. At baseline, the community ownership and preparedness index scores for the eight CBOs under the community-to-CBO strategy ranged between 21.5 and 27.7 while the scores for the three CBOs under the NGO-to-CBO strategy ranged between 16.3 and 21.5. By endline, the strength of community mobilization among CBOs under the community-to-CBO strategy increased 18 points (equivalent to 23% potential improvement) whereas the strength of community mobilization among CBOs under the NGO-to-CBO strategy increased only 10 points (equivalent to 13% potential improvement). The average percentage difference in improvement between the strategies was 10% (p = 0.102). Further analyses indicate that a greater improvement in community-to-CBO learning strategy was noted around managerial capacities and engagement with stakeholders than other parameters. Conclusion: The community -to- CBO learning strategy presents promising results for HIV prevention with regard to institutionalization of community mobilization among sex workers communities. Findings support the scaling-up of community mobilization initiatives within HIV prevention interventions using well trained community members in India and elsewhere.	[Sadhu, Santhosh; Manukonda, Archana Rao; Yeruva, Anthony Reddy] CARE India, Hyderabad, Andhra Pradesh, India; [Patel, Sangram Kishor; Saggurti, Niranjan] Populat Council, HIV & AIDS Program, New Delhi, India		Sadhu, S (corresponding author), CARE India, Hyderabad, Andhra Pradesh, India.	santhoshsadhu@gmail.com		Saggurti, Niranjan/0000-0002-5267-8425	Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	The study was funded by Bill & Melinda Gates Foundation to CARE-India as part of Avahan, its India AIDS Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This paper was written as part of a mentorship program to the first author, under the Knowledge Network Project of the Population Council, which is a grantee of the Bill & Melinda Gates Foundation through Avahan, its India AIDS Initiative. The views expressed herein are those of the authors and do not necessarily reflect the official policy or position of the Bill & Melinda Gates Foundation and Avahan.	Blankenship KA, 2008, AIDS, V22, pS109, DOI 10.1097/01.aids.0000343769.92949.dd; BRACHT N, 1994, HEALTH EDUC RES, V9, P243, DOI 10.1093/her/9.2.243; CARE India, 2010, LEARN SIT ASS TARG I; CARE India, 2012, COMM COMM LEARN NEW; Chambers R., 1997, WHOSE REALITY COUNTS; Chattopadhyay A, 2004, AIDS PATIENT CARE ST, V18, P159, DOI 10.1089/108729104322994847; Gaikwad SS, 2012, J EPIDEMIOL COMMUN H, V66, pII69, DOI 10.1136/jech-2011-200514; Galavotti C, 2012, J EPIDEMIOL COMMUN H, V66, pII9, DOI 10.1136/jech-2011-200465; Jana S, 2004, AIDS EDUC PREV, V16, P405, DOI 10.1521/aeap.16.5.405.48734; Kothari Cooke, 2001, PARTICIPATION NEW TY; Michau, 2007, GENDER DEV, V15, P95; Mintrom M, 1997, AM J POLIT SCI, V41, P738, DOI 10.2307/2111674; Narayanan P, 2012, J EPIDEMIOL COMMUN H, V66, pII34, DOI 10.1136/jech-2012-201065; Nyonator FK, 2005, HEALTH POLICY PLANN, V20, P25, DOI 10.1093/heapol/czi003; Pinto RM, 2008, WOMEN HEALTH, V47, P83, DOI 10.1300/J013v47n01_05; Praxis, 2009, MEAS COMM MOB PROC M; Saggurti N, 2013, AIDS CARE, V25, pS55, DOI 10.1080/09540121.2012.749334; Sarkar S, 2010, SEX TRANSM INFECT, V86, pI2, DOI 10.1136/sti.2009.039289; Thomas T, 2012, J EPIDEMIOL COMMUN H, V66, pII26, DOI 10.1136/jech-2011-200590; Tripathy P, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-182; UNFPA UNAIDS APNSW, 2012, HIV SEX WORK COLL IN; World Bank, 2012, IND COMM EMP KEY TUR; World Bank, 2007, COMM LED TOT SAN RUR	23	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90592	10.1371/journal.pone.0090592	http://dx.doi.org/10.1371/journal.pone.0090592			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC4IY	24608680	Green Published, gold, Green Submitted			2022-12-27	WOS:000332485800035
J	Bian, LJ; Ji, X				Bian, Liujiao; Ji, Xu			Distribution, Transition and Thermodynamic Stability of Protein Conformations in the Denaturant-Induced Unfolding of Proteins	PLOS ONE			English	Article							MOLTEN GLOBULE; GUANIDINIUM CHLORIDE; ALPHA-LACTALBUMIN; CYTOCHROME-C; FOLDING PATHWAYS; LOW-TEMPERATURE; COMPACT STATE; INTERMEDIATE; BINDING; UREA	Background: Extensive and intensive studies on the unfolding of proteins require appropriate theoretical model and parameter to clearly illustrate the feature and characteristic of the unfolding system. Over the past several decades, four approaches have been proposed to describe the interaction between proteins and denaturants, but some ambiguity and deviations usually occur in the explanation of the experimental data. Methodology/Principal Findings: In this work, a theoretical model was presented to show the dependency of the residual activity ratio of the proteins on the molar denaturant concentration. Through the characteristic unfolding parameters k(i) and Delta m(i) in this model, the distribution, transition and thermodynamic stability of protein conformations during the unfolding process can be quantitatively described. This model was tested with the two-state unfolding of bovine heart cytochrome c and the three-state unfolding of hen egg white lysozyme induced by both guanidine hydrochloride and urea, the four-state unfolding of bovine carbonic anhydrase b induced by guanidine hydrochloride and the unfolding of some other proteins induced by denaturants. The results illustrated that this model could be used accurately to reveal the distribution and transition of protein conformations in the presence of different concentrations of denaturants and to evaluate the unfolding tendency and thermodynamic stability of different conformations. In most denaturant-induced unfolding of proteins, the unfolding became increasingly hard in next transition step and the proteins became more unstable as they attained next successive stable conformation. Conclusions/Significance: This work presents a useful method for people to study the unfolding of proteins and may be used to describe the unfolding and refolding of other biopolymers induced by denaturants, inducers, etc.	[Bian, Liujiao; Ji, Xu] NW Univ Xian, Coll Life Sci, Xian 710069, Shaanxi, Peoples R China	Northwest University Xi'an	Bian, LJ (corresponding author), NW Univ Xian, Coll Life Sci, Xian 710069, Shaanxi, Peoples R China.	bianliujiao@sohu.com			National Natural Science Foundation of China [21075097]; Key Program for Science and Technology Innovative Research Team of Shaanxi Province [2013KCT-24]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Program for Science and Technology Innovative Research Team of Shaanxi Province	This work was supported by a grant from National Natural Science Foundation of China (Grant 21075097) and Key Program for Science and Technology Innovative Research Team of Shaanxi Province (No. 2013KCT-24). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALONSO DOV, 1991, BIOCHEMISTRY-US, V30, P5974, DOI 10.1021/bi00238a023; Bhuyan AK, 2001, J MOL BIOL, V312, P1135, DOI 10.1006/jmbi.2001.4993; Bian LJ, 2011, CHINESE J CHEM, V29, P813, DOI 10.1002/cjoc.201190163; Blancas-Mejia LM, 2009, J MOL BIOL, V386, P1153, DOI 10.1016/j.jmb.2008.12.069; Bose HS, 1999, P NATL ACAD SCI USA, V96, P7250, DOI 10.1073/pnas.96.13.7250; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWNELL PF, 1991, AUST J PLANT PHYSIOL, V18, P589, DOI 10.1071/PP9910589; Chimon S, 2005, J AM CHEM SOC, V127, P13472, DOI 10.1021/ja054039l; D'Onofrio M, 2009, ARCH BIOCHEM BIOPHYS, V481, P21, DOI 10.1016/j.abb.2008.10.017; Darley-Usmar V. M., 1987, MITOCHONDRIA PRACTIC; DeKoster GT, 1997, BIOPHYS CHEM, V64, P59, DOI 10.1016/S0301-4622(96)02219-3; DOLGIKH DA, 1981, FEBS LETT, V136, P311, DOI 10.1016/0014-5793(81)80642-4; DOLGIKH DA, 1985, EUR BIOPHYS J BIOPHY, V13, P109, DOI 10.1007/BF00256531; Domingues MM, 2009, BIOPHYS J, V96, P987, DOI 10.1016/j.bpj.2008.10.044; ELIEZER D, 1993, BIOPHYS J, V65, P912, DOI 10.1016/S0006-3495(93)81124-X; Fang Y, 2003, ACTA CHIM SINICA, V61, P803; Fedor MJ, 2008, J BIOL CHEM, V283, P1209, DOI 10.1074/jbc.R700046200; FINK AL, 1994, BIOCHEMISTRY-US, V33, P12504, DOI 10.1021/bi00207a018; Gorovits BM, 1998, BBA-PROTEIN STRUCT M, V1382, P120, DOI 10.1016/S0167-4838(97)00158-1; GOTO Y, 1990, P NATL ACAD SCI USA, V87, P573, DOI 10.1073/pnas.87.2.573; Grimsrud PA, 2008, J BIOL CHEM, V283, P21837, DOI 10.1074/jbc.R700019200; Hammes GG, 2008, J BIOL CHEM, V283, P22337, DOI 10.1074/jbc.X800005200; Harder ME, 2009, BIOPHYS CHEM, V141, P1, DOI 10.1016/j.bpc.2008.12.001; HINDS DA, 1995, TRENDS BIOTECHNOL, V13, P23, DOI 10.1016/S0167-7799(00)88897-6; Kataoka M, 1997, PROTEIN SCI, V6, P422; Kurganov BI, 2002, BIOCHEMISTRY-MOSCOW+, V67, P409, DOI 10.1023/A:1015277805345; Kuznetsova IM, 2002, BBA-PROTEIN STRUCT M, V1596, P138, DOI 10.1016/S0167-4838(02)00212-1; Muralidhar D, 2005, J BIOL CHEM, V280, P15569, DOI 10.1074/jbc.M414243200; Pace C N, 1986, Methods Enzymol, V131, P266; Ptitsyn OB, 1995, ADV PROTEIN CHEM, V47, P83, DOI 10.1016/S0065-3233(08)60546-X; Rozema D, 1996, BIOCHEMISTRY-US, V35, P15760, DOI 10.1021/bi961638j; SCHELLMAN JA, 1975, BIOPOLYMERS, V14, P999, DOI 10.1002/bip.1975.360140509; SCHELLMAN JA, 1994, BIOPOLYMERS, V34, P1015, DOI 10.1002/bip.360340805; Schellman JA, 1996, BIOPHYS CHEM, V59, P259, DOI 10.1016/0301-4622(95)00130-1; SCHELLMAN JA, 1993, BIOPHYS CHEM, V45, P273, DOI 10.1016/0301-4622(93)80008-7; STANIFORTH RA, 1993, BIOCHEMISTRY-US, V32, P3842, DOI 10.1021/bi00066a003; Tanford C, 1970, Adv Protein Chem, V24, P1, DOI 10.1016/S0065-3233(08)60241-7; Uverskii VN, 1998, BIOFIZIKA+, V43, P416; Uversky VN, 1998, J MOL BIOL, V278, P879, DOI 10.1006/jmbi.1998.1741; UVERSKY VN, 1994, BIOCHEMISTRY-US, V33, P2782, DOI 10.1021/bi00176a006; Uversky VN, 1996, J MOL BIOL, V255, P215, DOI 10.1006/jmbi.1996.0018; Uversky VN, 1997, PROTEIN PEPTIDE LETT, V4, P355; Uversky VN, 1997, FOLD DES, V2, P163, DOI 10.1016/S1359-0278(97)00023-0; Welker E, 2004, J AM CHEM SOC, V126, P3720, DOI 10.1021/ja031658q; WU LC, 1993, BIOCHEMISTRY-US, V32, P10271, DOI 10.1021/bi00089a050	45	5	5	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e91129	10.1371/journal.pone.0091129	http://dx.doi.org/10.1371/journal.pone.0091129			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603868	Green Published, Green Submitted, gold			2022-12-27	WOS:000332483600133
J	Blivet, S; Cobarzan, D; Beauchet, A; El Hajjam, M; Lacombe, P; Chinet, T				Blivet, Sandra; Cobarzan, Daniel; Beauchet, Alain; El Hajjam, Mostafa; Lacombe, Pascal; Chinet, Thierry			Impact of Pulmonary Arteriovenous Malformations on Respiratory-Related Quality of Life in Patients with Hereditary Haemorrhagic Telangiectasia	PLOS ONE			English	Article							HEALTH-STATUS; QUESTIONNAIRE; EMBOLIZATION; EPISTAXIS; DISEASE; HHT	Fifteen to fifty percent of patients with hereditary haemorrhagic telangiectasia have pulmonary arteriovenous malformations. The objective of this study was to measure the effect of the presence of pulmonary arteriovenous malformations and of their embolisation on respiratory-related quality of life (QoL). We prospectively recruited patients with a diagnosis of hereditary haemorrhagic telangiectasia based on the Curacao criteria and/or the identification of a pathogenic mutation. Respiratory-related quality of life was measured using the Saint George's Respiratory Questionnaire (SGRQ). Patients who underwent embolisation of pulmonary arteriovenous malformations completed the questionnaire before and 6-12 mo after the procedure. The 56 participants were divided into three groups: no pulmonary arteriovenous malformation (group A, n = 10), small pulmonary arteriovenous malformations not accessible to embolotherapy (group B, n = 19), and large pulmonary arteriovenous malformations accessible to embolotherapy (group C, n = 27). The SGRQ score was significantly higher in group C compared to the other groups, indicating a worse respiratory-specific QoL. There was no significant difference between groups A and B. Among the 17 patients who underwent an embolisation, the SGRQ score decreased significantly after the procedure, to a value similar to that in patients without pulmonary arteriovenous malformation. Our results indicate that the presence of large but not small pulmonary arteriovenous malformations negatively affects the respiratory-related quality of life and that embolisation of pulmonary arteriovenous malformations normalizes the respiratory-related quality of life.	[Blivet, Sandra; Cobarzan, Daniel; El Hajjam, Mostafa; Lacombe, Pascal; Chinet, Thierry] Univ Versailles St Quentin En Yvelines, Hop Ambroise Pare, AP HP, Boulogne, France; [Beauchet, Alain] Univ Versailles St Quentin En Yvelines, Hop Ambroise Pare, AP HP, Dept Sante Publ, Boulogne, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; UDICE-French Research Universities; Universite Paris Saclay	Chinet, T (corresponding author), Univ Versailles St Quentin En Yvelines, Hop Ambroise Pare, AP HP, Boulogne, France.	Thierry.Chinet@Apr.Aphp.Fr			French HHT patient association, AMRO-France HHT (Association Maladie Rendu-Osler)	French HHT patient association, AMRO-France HHT (Association Maladie Rendu-Osler)	This work received financial support from the French HHT patient association, AMRO-France HHT (Association Maladie Rendu-Osler). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abdalla SA, 2006, J MED GENET, V43, P97, DOI 10.1136/jmg.2005.030833; Al-Shair K, 2013, CHEST, V144, P623, DOI 10.1378/chest.12-0014; Bouchet C, 1996, REV MAL RESPIR, V13, P43; de Gussem EM, 2009, RHINOLOGY, V47, P85; Faughnan ME, 2011, J MED GENET, V48, P73, DOI 10.1136/jmg.2009.069013; Faughnan ME, 2009, EUR RESPIR J, V33, P1186, DOI 10.1183/09031936.00061308; Geirdal AO, 2012, AM J MED GENET A, V158A, P1269, DOI 10.1002/ajmg.a.35309; Geisthoff UW, 2007, OTOLARYNG HEAD NECK, V136, P726, DOI 10.1016/j.otohns.2006.12.019; Gossage JR, 1998, AM J RESP CRIT CARE, V158, P643, DOI 10.1164/ajrccm.158.2.9711041; Gupta S, 2009, CHEST, V136, P849, DOI 10.1378/chest.09-0334; GUTTMACHER AE, 1995, NEW ENGL J MED, V333, P918, DOI 10.1056/NEJM199510053331407; JONES PW, 1992, AM REV RESPIR DIS, V145, P1321, DOI 10.1164/ajrccm/145.6.1321; Jones PW, 2002, EUR RESPIR J, V19, P398, DOI 10.1183/09031936.02.00063702; Karapantzos I, 2005, EUR ARCH OTO-RHINO-L, V262, P830, DOI 10.1007/s00405-004-0911-0; Lacombe P, 2009, CHEST, V135, P1031, DOI 10.1378/chest.08-1794; Lennox PA, 2005, AM J RHINOL, V19, P71, DOI 10.1177/194589240501900112; Moussouttas M, 2000, NEUROLOGY, V55, P959, DOI 10.1212/WNL.55.7.959; Nishiyama O, 2005, RESP MED, V99, P408, DOI 10.1016/j.rmed.2004.09.005; Pasculli G, 2004, QUAL LIFE RES, V13, P1715, DOI 10.1007/s11136-004-7865-y; Pfister M, 2009, ACTA OTO-LARYNGOL, V129, P862, DOI 10.1080/00016480802468138; Rubenfire M, 2009, CHEST, V136, P597, DOI 10.1378/chest.08-1260; Shovlin CL, 2000, AM J MED GENET, V91, P66, DOI 10.1002/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-P; Trerotola SO, 2010, AM J ROENTGENOL, V195, P837, DOI 10.2214/AJR.10.5230; Velthuis S, 2013, CHEST, V144, P542, DOI 10.1378/chest.12-1599	24	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90937	10.1371/journal.pone.0090937	http://dx.doi.org/10.1371/journal.pone.0090937			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603803	Green Submitted, Green Published, gold			2022-12-27	WOS:000332483600110
J	Goh, KM; Gan, HM; Chan, KG; Chan, GF; Shahar, S; Chong, CS; Kahar, UM; Chai, KP				Goh, Kian Mau; Gan, Han Ming; Chan, Kok-Gan; Chan, Giek Far; Shahar, Saleha; Chong, Chun Shiong; Kahar, Ummirul Mukminin; Chai, Kian Piaw			Analysis of Anoxybacillus Genomes from the Aspects of Lifestyle Adaptations, Prophage Diversity, and Carbohydrate Metabolism	PLOS ONE			English	Article							THERMOPHILIC BACTERIUM; BETA-GLUCOSIDASES; ESCHERICHIA-COLI; REVERSE GYRASE; ANNOTATION; STABILITY; PROTEINS; CLONING; GENE; SPORULATION	Species of Anoxybacillus are widespread in geothermal springs, manure, and milk-processing plants. The genus is composed of 22 species and two subspecies, but the relationship between its lifestyle and genome is little understood. In this study, two high-quality draft genomes were generated from Anoxybacillus spp. SK3-4 and DT3-1, isolated from Malaysian hot springs. De novo assembly and annotation were performed, followed by comparative genome analysis with the complete genome of Anoxybacillus flavithermus WK1 and two additional draft genomes, of A. flavithermus TNO-09.006 and A. kamchatkensis G10. The genomes of Anoxybacillus spp. are among the smaller of the family Bacillaceae. Despite having smaller genomes, their essential genes related to lifestyle adaptations at elevated temperature, extreme pH, and protection against ultraviolet are complete. Due to the presence of various competence proteins, Anoxybacillus spp. SK3-4 and DT3-1 are able to take up foreign DNA fragments, and some of these transferred genes are important for the survival of the cells. The analysis of intact putative prophage genomes shows that they are highly diversified. Based on the genome analysis using SEED, many of the annotated sequences are involved in carbohydrate metabolism. The presence of glycosyl hydrolases among the Anoxybacillus spp. was compared, and the potential applications of these unexplored enzymes are suggested here. This is the first study that compares Anoxybacillus genomes from the aspect of lifestyle adaptations, the capacity for horizontal gene transfer, and carbohydrate metabolism.	[Goh, Kian Mau; Shahar, Saleha; Chong, Chun Shiong; Kahar, Ummirul Mukminin; Chai, Kian Piaw] Univ Teknol Malaysia, Fac Biosci & Med Engn, Skudai, Johor, Malaysia; [Gan, Han Ming] Monash Univ Sunway Campus, Monash Sch Sci, Petaling Jaya, Selangor, Malaysia; [Chan, Kok-Gan] Univ Malaya, Fac Sci, Inst Biol Sci, Div Genet & Mol Biol, Kuala Lumpur, Malaysia; [Chan, Giek Far] Temasek Polytech, Sch Appl Sci, Singapore, Singapore	Universiti Teknologi Malaysia; Monash University; Monash University Sunway; Universiti Malaya	Goh, KM (corresponding author), Univ Teknol Malaysia, Fac Biosci & Med Engn, Skudai, Johor, Malaysia.	gohkianmau@utm.my	Goh, Kian Mau/C-7221-2011; Kahar, Ummirul Mukminin/T-3689-2019; Chan, Kok Gan/B-8347-2010; Gan, Han Ming/AAF-9519-2019; Chong, Chun Shiong/F-8053-2013	Goh, Kian Mau/0000-0002-2839-8722; Kahar, Ummirul Mukminin/0000-0003-3041-985X; Chan, Kok Gan/0000-0002-1883-1115; Gan, Han Ming/0000-0001-7987-738X; Chong, Chun Shiong/0000-0003-2165-4030; shahar, saleha/0000-0001-6393-4052	Universiti Teknologi Malaysia GUP [04H00]; University of Malaya-Ministry of Higher Education High Impact Research Grant (UMMOHE HIR) [H-50001-A000027]	Universiti Teknologi Malaysia GUP; University of Malaya-Ministry of Higher Education High Impact Research Grant (UMMOHE HIR)	This study was financially supported by the Universiti Teknologi Malaysia GUP Grant 04H00 and University of Malaya-Ministry of Higher Education High Impact Research Grant (UMMOHE HIR Grant No. H-50001-A000027). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bhatia Y, 2002, CRIT REV BIOTECHNOL, V22, P375, DOI 10.1080/07388550290789568; Birge EA, 2006, BACTERIAL BACTERIOPH, P261; Casjens S, 2003, MOL MICROBIOL, V49, P277, DOI 10.1046/j.1365-2958.2003.03580.x; Caspers MP, 2013, GENOME, V1; Chai YY, 2012, ENVIRON TECHNOL, V33, P1231, DOI 10.1080/09593330.2011.618935; Chai YY, 2012, J IND MICROBIOL BIOT, V39, P731, DOI 10.1007/s10295-011-1074-9; Cihan AC, 2013, INT J SYST IN PRESS; Cihan AC, 2011, J BASIC MICROB, V51, P136, DOI 10.1002/jobm.201000115; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Davis BM, 2002, EMBO J, V21, P4240, DOI 10.1093/emboj/cdf427; Deep K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085493; Fouts DE, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks757; Galperin MY, 2012, ENVIRON MICROBIOL, V14, P2870, DOI 10.1111/j.1462-2920.2012.02841.x; Giaquinto L, 2007, J BACTERIOL, V189, P5738, DOI 10.1128/JB.00395-07; Goh KM, 2013, APPL MICROBIOL BIOT, V97, P1475, DOI 10.1007/s00253-012-4663-2; Goosen N, 2008, DNA REPAIR, V7, P353, DOI 10.1016/j.dnarep.2007.09.002; Heine M, 2009, J MICROBIOL, V47, P229, DOI 10.1007/s12275-009-0019-8; HEINEN W, 1982, A VAN LEEUW J MICROB, V48, P265, DOI 10.1007/BF00400386; HOFFMANN T, 1995, FEMS MICROBIOL LETT, V131, P219, DOI 10.1111/j.1574-6968.1995.tb07780.x; Hosoya R, 2004, J GEN APPL MICROBIOL, V50, P271, DOI 10.2323/jgam.50.271; Hou MH, 2001, NUCLEIC ACIDS RES, V29, P5121, DOI 10.1093/nar/29.24.5121; Iguchi A, 2006, GENE, V372, P199, DOI 10.1016/j.gene.2006.01.005; Iyer LM, 2004, NUCLEIC ACIDS RES, V32, P5260, DOI 10.1093/nar/gkh828; Kahar UM, 2013, INT J MOL SCI, V14, P11302, DOI 10.3390/ijms140611302; Karp PD, 2005, NUCLEIC ACIDS RES, V33, P6083, DOI 10.1093/nar/gki892; Kramer N, 2007, MOL MICROBIOL, V65, P454, DOI 10.1111/j.1365-2958.2007.05799.x; Kumar S, 2000, PROTEIN ENG, V13, P179, DOI 10.1093/protein/13.3.179; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee SJ, 2012, J BACTERIOL, V194, P6684, DOI 10.1128/JB.01877-12; Matsutani M, 2013, GENOME ANNOUNC, V1; Moumen B, 2012, GENET RES INT, V2012, DOI 10.1155/2012/543286; Mukherjee A, 2008, NUCLEIC ACIDS RES, V36, P3956, DOI 10.1093/nar/gkn348; OGAWA KI, 1995, J BACTERIOL, V177, P1409, DOI 10.1128/jb.177.5.1409-1413.1995; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Perugino G, 2009, BIOCHEM SOC T, V37, P69, DOI 10.1042/BST0370069; Phadtare S, 2004, CURR ISSUES MOL BIOL, V6, P125; Piggot PJ, 2004, CURR OPIN MICROBIOL, V7, P579, DOI 10.1016/j.mib.2004.10.001; Pikuta E, 2000, INT J SYST EVOL MICR, V50, P2109, DOI 10.1099/00207713-50-6-2109; Richardson DJ, 2001, CELL MOL LIFE SCI, V58, P165, DOI 10.1007/PL00000845; Saw JH, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-11-r161; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Schirner K, 2009, MICROBIOL-SGM, V155, P3611, DOI 10.1099/mic.0.030692-0; Schomburg I, 2013, NUCLEIC ACIDS RES, V41, pD764, DOI 10.1093/nar/gks1049; Sharon I, 2011, ISME J, V5, P1178, DOI 10.1038/ismej.2011.2; Singhania RR, 2013, BIORESOURCE TECHNOL, V127, P500, DOI 10.1016/j.biortech.2012.09.012; Smeesters PR, 2011, RES MICROBIOL, V162, P446, DOI 10.1016/j.resmic.2011.02.009; Takami H, 2004, NUCLEIC ACIDS RES, V32, P6292, DOI 10.1093/nar/gkh970; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Trivedi Seema, 2005, Journal of Cell and Molecular Biology, V4, P61; Turner P, 2005, J BIOSCI BIOENG, V100, P380, DOI 10.1263/jbb.100.380; Turner P, 2005, PROTEIN EXPRES PURIF, V39, P54, DOI 10.1016/j.pep.2004.09.012; VANHALL CE, 1963, ANAL CHEM, V35, P315, DOI 10.1021/ac60196a014; Yin YB, 2012, NUCLEIC ACIDS RES, V40, pW445, DOI 10.1093/nar/gks479; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhang XQ, 2013, INT J SYST IN PRESS; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485	59	49	50	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90549	10.1371/journal.pone.0090549	http://dx.doi.org/10.1371/journal.pone.0090549			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603481	Green Published, gold, Green Submitted			2022-12-27	WOS:000332483600063
J	Keijsers, JGS; Poortinga, A; Riksen, MJPM; Maroulis, J				Keijsers, Joep G. S.; Poortinga, Ate; Riksen, Michel J. P. M.; Maroulis, Jerry			Spatio-Temporal Variability in Accretion and Erosion of Coastal Foredunes in the Netherlands: Regional Climate and Local Topography	PLOS ONE			English	Article							AEOLIAN SAND TRANSPORT; SEDIMENT TRANSPORT; DUNE EROSION; BEACH; FETCH; SHOREFACE; MORPHODYNAMICS; DYNAMICS; STORMS; RATES	Depending on the amount of aeolian sediment input and dune erosion, dune size and morphology change over time. Since coastal foredunes play an important role in the Dutch coastal defence, it is important to have good insight in the main factors that control these changes. In this paper the temporal variations in foredune erosion and accretion were studied in relation to proxies for aeolian transport potential and storminess using yearly elevation measurements from 1965 to 2012 for six sections of the Dutch coast. Longshore differences in the relative impacts of erosion and accretion were examined in relation to local beach width. The results show that temporal variability in foredune accretion and erosion is highest in narrow beach sections. Here, dune erosion alternates with accretion, with variability displaying strong correlations with yearly values of storminess (maximum sea levels). In wider beach sections, dune erosion is less frequent, with lower temporal variability and stronger correlations with time series of transport potential. In erosion dominated years, eroded volumes decrease from narrow to wider beaches. When accretion dominates, dune-volume changes are relatively constant alongshore. Dune erosion is therefore suggested to control spatial variability in dune-volume changes. On a scale of decades, the volume of foredunes tends to increase more on wider beaches. However, where widths exceed 200 to 300 m, this trend is no longer observed.	[Keijsers, Joep G. S.; Poortinga, Ate; Riksen, Michel J. P. M.; Maroulis, Jerry] Wageningen Univ, Soil Phys & Land Management Grp, NL-6700 AP Wageningen, Netherlands; [Maroulis, Jerry] Univ Sunshine Coast, Sch Sci Educ & Engn, Sippy Downs, Qld 4556, Australia	Wageningen University & Research; University of the Sunshine Coast	Keijsers, JGS (corresponding author), Wageningen Univ, Soil Phys & Land Management Grp, NL-6700 AP Wageningen, Netherlands.	joep.keijsers@wur.nl	Maroulis, Jerry/H-8799-2019; Riksen, Michel/B-3851-2014	Maroulis, Jerry/0000-0002-6039-8693; Riksen, Michel/0000-0002-3695-4362; Poortinga, Ate/0000-0001-9647-2317	Ministry of Infrastructure and the Environment	Ministry of Infrastructure and the Environment	This study was carried out in the framework of the Dutch National Research Programme Knowledge for Climate (www.knowledgeforclimate.org). This research programme is co-financed by the Ministry of Infrastructure and the Environment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard T, 2004, GEOMORPHOLOGY, V60, P205, DOI 10.1016/j.geomorph.2003.08.002; Aagaard T., 2004, GEOGR TIDSSKR-DEN, V104, P5, DOI [10.1080/00167223.2004.10649499, DOI 10.1080/00167223.2004.10649499]; Adriani MJ, 1974, SAND STABILIZATION D, P68; Anthony EJ, 2006, GEOMORPHOLOGY, V81, P316, DOI 10.1016/j.geomorph.2006.04.022; Anthony EJ, 2013, GEOMORPHOLOGY, V199, P8, DOI 10.1016/j.geomorph.2012.06.007; Anthony EJ, 2009, GEOMORPHOLOGY, V105, P95, DOI 10.1016/j.geomorph.2007.12.013; Arens SM, 1996, GEOMORPHOLOGY, V17, P3, DOI 10.1016/0169-555X(95)00089-N; ARENS SM, 1994, J COASTAL RES, V10, P189; Bagnold R.A., 1954, PHYS BLOWN SAND DESE; Bakker MAJ, 2012, J COAST RES; Bakker WT, 1968, SHORE BEACH, V36, P4; Bauer BO, 2003, GEOMORPHOLOGY, V49, P89, DOI 10.1016/S0169-555X(02)00165-4; Bochev-van der Burgh LM, 2011, COAST ENG, V58, P927, DOI 10.1016/j.coastaleng.2011.05.013; Bollweg AE, 1997, EXTRACTIE STRANDPROT; Burroughs SM, 2008, J COASTAL RES, V24, P104, DOI 10.2112/05-0583.1; CHAPMAN DM, 1990, EARTH SURF PROCESSES, V15, P751, DOI 10.1002/esp.3290150808; Cheung KF, 2007, J COASTAL RES, V23, P106, DOI 10.2112/04-0403.1; Cooper JAG, 2004, MAR GEOL, V210, P261, DOI 10.1016/j.margeo.2004.05.012; da Silva GM, 2012, MAR GEOL, V323, P29, DOI 10.1016/j.margeo.2012.07.015; Davidson-Arnott RGD, 1990, SEASONAL PATTERNS CO, P177; Davidson-Arnott RGD, 2008, EARTH SURF PROC LAND, V33, P55, DOI 10.1002/esp.1527; DavidsonArnott RGD, 1996, J COASTAL RES, V12, P654; Davis R. B.  III, 1987, Proceedings of the Thirteenth Annual Northeast Bioengineering Conference (Cat. No.87CH2436-4), P131; De Graaf HJC, 2003, INWINNING DROGE JARK, P43; de Vries S, 2012, COAST ENG, V67, P41, DOI 10.1016/j.coastaleng.2012.04.002; Delgado-Fernandez I, 2011, GEOMORPHOLOGY, V126, P217, DOI 10.1016/j.geomorph.2010.11.005; Delgado-Fernandez I, 2010, AEOLIAN RES, V2, P61, DOI 10.1016/j.aeolia.2010.04.001; Fryberger S., 1979, STUDY GLOBAL SAND SE; Gares PA, 1996, J COASTAL RES, V12, P673; Gillette DA, 1996, EARTH SURF PROCESSES, V21, P641, DOI 10.1002/(SICI)1096-9837(199607)21:7&lt;641::AID-ESP662&gt;3.0.CO;2-9; Guillen J, 1999, EARTH SURF PROC LAND, V24, P517, DOI 10.1002/(SICI)1096-9837(199906)24:6<517::AID-ESP974>3.0.CO;2-A; Hesp P, 2002, GEOMORPHOLOGY, V48, P245, DOI 10.1016/S0169-555X(02)00184-8; Houser C., 2013, TREATISE GEOMORPHOLO, P267; Houser C, 2008, GEOMORPHOLOGY, V100, P223, DOI 10.1016/j.geomorph.2007.12.007; Jackson DWT, 1999, SEDIMENTOLOGY, V46, P517; Jackson NL, 1998, GEOMORPHOLOGY, V22, P151, DOI 10.1016/S0169-555X(97)00065-2; Komar P. D., 1976, SHORE BEACH, V44, P9; KRIEBEL DL, 1985, COAST ENG, V9, P221, DOI 10.1016/0378-3839(85)90009-2; KROON A, 1990, J COASTAL RES, V6, P367; Ministerie van Verkeer en Waterstaat, 1990, KUSTN KUSTV 1990, P65; NICKLING WG, 1984, SEDIMENTOLOGY, V31, P111, DOI 10.1111/j.1365-3091.1984.tb00726.x; NORDSTROM KF, 1992, SEDIMENTOLOGY, V39, P769, DOI 10.1111/j.1365-3091.1992.tb02152.x; Ollerhead J, 2013, EARTH SURF PROC LAND, V38, P284, DOI 10.1002/esp.3327; Oost AP, 2012, OCEAN COAST MANAGE, V68, P18, DOI 10.1016/j.ocecoaman.2012.07.010; Oosterwijk HJM, 1987, AANSLUITING HOOGTE D, P23; Pye K, 2008, GEOMORPHOLOGY, V102, P652, DOI 10.1016/j.geomorph.2008.06.011; Quartel S, 2008, MAR GEOL, V250, P19, DOI 10.1016/j.margeo.2007.11.003; Rijkswaterstaat, 1973, STORMVL 2 3 APR 1973, P10; Rijkswaterstaat, 1990, VERSL CROC STORMVL 2, P67; Ruessink BG, 2002, EARTH SURF PROC LAND, V27, P1043, DOI 10.1002/esp.391; Sallenger AH, 2003, J COASTAL RES, V19, P125; Sallenger AH, 2000, J COASTAL RES, V16, P890; Saye SE, 2005, GEOMORPHOLOGY, V72, P128, DOI 10.1016/j.geomorph.2005.05.007; SHERMAN DJ, 1993, PROG PHYS GEOG, V17, P413, DOI 10.1177/030913339301700402; Stockdon HF, 2006, COAST ENG, V53, P573, DOI 10.1016/j.coastaleng.2005.12.005; van der Wal D, 1998, J ARID ENVIRON, V39, P533, DOI 10.1006/jare.1997.0364; van der Wal D, 2004, J COASTAL RES, V20, P317, DOI 10.2112/1551-5036(2004)20[317:BIINAA]2.0.CO;2; VANDEGRAAFF J, 1986, COAST ENG, V9, P479, DOI 10.1016/0378-3839(86)90009-8; VELLINGA P, 1982, COAST ENG, V6, P361, DOI 10.1016/0378-3839(82)90007-2; VERHAGEN HJ, 1989, COAST ENG, V13, P129, DOI 10.1016/0378-3839(89)90020-3; Vousdoukas MI, 2012, EARTH SURF PROC LAND, V37, P583, DOI 10.1002/esp.2264; Wijnberg K.M., 2012, JUB C P, P35	62	64	64	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e91115	10.1371/journal.pone.0091115	http://dx.doi.org/10.1371/journal.pone.0091115			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603812	Green Published, gold, Green Submitted			2022-12-27	WOS:000332483600131
J	Ross, IL; Bergthorsdottir, R; Levitt, N; Dave, JA; Schatz, D; Marais, D; Johannsson, G				Ross, Ian Louis; Bergthorsdottir, Ragnhildur; Levitt, Naomi; Dave, Joel Alex; Schatz, Desmond; Marais, David; Johannsson, Gudmundur			Cardiovascular Risk Factors in Patients with Addison's Disease: A Comparative Study of South African and Swedish Patients	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; GLUCOCORTICOID REPLACEMENT THERAPY; CORONARY-HEART-DISEASE; ADRENAL INSUFFICIENCY; PLASMA; CHOLESTEROL; MORTALITY; SECRETION; HORMONES; TRENDS	Background: Patients with Addison's disease (AD) in Scandinavia have an increased risk for premature death due to cardiovascular disease (CVD). Serum lipids are important risk factors for CVD and vascular mortality. Replacement doses of hydrocortisone have historically been higher in Sweden than South Africa. The primary aim was to study the lipid profiles in a large group of patients with AD with the hypothesis that the lipid profile in patients in Sweden would be worse than in South Africa. Methods: In a cross-sectional study, 110 patients with AD (55 from South Africa, 55 from Sweden) matched for age, gender, ethnicity and BMI were studied. Anthropometric measures, blood pressure, lipids, highly sensitive C-reactive protein (hs-CRP) and adiponectin were studied. Results: All patients were Caucasian and the majority were women N = 36 (65.5%). Mean (standard deviation; SD) ages of the Swedish and South African patients were 52.9 (13.0) and 52.6 (14.4) years and BMI 25.3 (3.2) and 25.8 (4.1) kg/m(2), respectively. The mean total daily hydrocortisone dose was greater in the Swedish patients than the South African patients, [33.0 (8.1) versus 24.3 (8.0) mg; p<0.0001]. South African patients had higher median (interquartilerange; IQR) triglycerides (TG) [1.59 (1.1-2.46) versus 0.96 (0.74-1.6) mmol/l; p<0.001], total cholesterol (TC) [6.02(1.50) versus 5.13 (0.87) mmol/l; p<0.001], LDL-C [4.43 (1.44) versus 2.75 (0.80) mmol/l; p<0.001] and median hs-CRP [2.15 (0.93-5.45) versus 0.99 (0.57-2.10) mg/L; p<0.003] and lower HDL-C [0.80 (0.40) versus 1.86 (0.46) mmol/l; p<0.001] than the Swedish patients. Approximately 20% of the patients in both cohorts had hypertension and diabetes mellitus. Conclusions: South African patients with AD have worse lipid profiles and higher hs-CRP compared to their matched Swedish patients, despite lower doses of hydrocortisone. It is uncertain at this time whether these are due to genetic or environmental factors.	[Ross, Ian Louis; Levitt, Naomi; Dave, Joel Alex] Univ Cape Town, Dept Med, Div Endocrinol, ZA-7925 Cape Town, South Africa; [Bergthorsdottir, Ragnhildur; Johannsson, Gudmundur] Univ Gothenburg, Sahlgrenska Univ Hosp, Inst Med, Dept Endocrinol, Gothenburg, Sweden; [Schatz, Desmond] Univ Florida, Dept Paediat, Gainesville, FL USA; [Marais, David] Univ Cape Town, Natl Hlth Lab Serv, Div Chem Pathol, ZA-7925 Cape Town, South Africa	University of Cape Town; Sahlgrenska University Hospital; University of Gothenburg; State University System of Florida; University of Florida; University of Cape Town	Ross, IL (corresponding author), Univ Cape Town, Dept Med, Div Endocrinol, ZA-7925 Cape Town, South Africa.	ian.ross@uct.ac.za	Ross, Ian Louis/N-7420-2017	Ross, Ian Louis/0000-0002-5308-7563; Levitt, Naomi/0000-0001-6480-8066; Dave, joel/0000-0003-3084-7408; Johannsson, Gudmundur/0000-0003-3484-8440	Swedish Research Links Grant [65390/2007]	Swedish Research Links Grant	ILR is the recipient of the Swedish Research Links Grant No: 65390/2007. This research has not received funding or any other support from industry. The funders had no role in study design, data collection and analysis, decision to publish, preparation of the manuscript.	BAGDADE JD, 1976, METABOLISM, V25, P533, DOI 10.1016/0026-0495(76)90007-X; Bensing S, 2008, CLIN ENDOCRINOL, V69, P697, DOI 10.1111/j.1365-2265.2008.03340.x; Bergthorsdottir R, 2006, J CLIN ENDOCR METAB, V91, P4849, DOI 10.1210/jc.2006-0076; Bleicken B, 2010, CLIN ENDOCRINOL, V72, P297, DOI 10.1111/j.1365-2265.2009.03596.x; Brotman DJ, 2005, J CLIN ENDOCR METAB, V90, P3202, DOI 10.1210/jc.2004-2379; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Danilowicz K, 2008, PITUITARY, V11, P279, DOI 10.1007/s11102-008-0126-2; Eliasson M, 2006, J INTERN MED, V260, P551, DOI 10.1111/j.1365-2796.2006.01730.x; Erichsen MM, 2009, EUR J ENDOCRINOL, V160, P233, DOI 10.1530/EJE-08-0550; ESTEBAN NV, 1991, J CLIN ENDOCR METAB, V72, P39, DOI 10.1210/jcem-72-1-39; ETTINGER WH, 1988, METABOLISM, V37, P1055, DOI 10.1016/0026-0495(88)90067-4; Evans V, 2002, CARDIOVASC DRUG THER, V16, P283, DOI 10.1023/A:1021721707639; Filipsson H, 2006, J CLIN ENDOCR METAB, V91, P3954, DOI 10.1210/jc.2006-0524; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; GIDEZ LI, 1982, J LIPID RES, V23, P1206; Giordano R, 2009, J ENDOCRINOL INVEST, V32, P917, DOI [10.3275/6437, 10.1007/BF03345773]; Gurnell EM, 2008, J CLIN ENDOCR METAB, V93, P400, DOI 10.1210/jc.2007-1134; Hazra A, 2008, PHARM RES-DORDR, V25, P769, DOI 10.1007/s11095-007-9371-8; Johannsson G, J CLIN ENDOCRINOL ME, V97, P473; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Leelarathna L, 2010, ENDOCRINE, V38, P113, DOI 10.1007/s12020-010-9359-8; LIN RC, 1988, METABOLISM, V37, P745, DOI 10.1016/0026-0495(88)90009-1; Lovas K, 2009, EUR J ENDOCRINOL, V160, P993, DOI 10.1530/EJE-08-0880; Mayosi BM, 2009, LANCET, V374, P934, DOI 10.1016/S0140-6736(09)61087-4; Nazmi A, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-212; Ng N., 2012, GLOB HLTH ACTION, V5; Pedersen TR, 2004, ATHEROSCLEROSIS SUPP, V5, P81, DOI 10.1016/j.atherosclerosissup.2004.08.027; Ragnarsson O, 2012, CLIN ENDOCRINOL, V76, P246, DOI 10.1111/j.1365-2265.2011.04174.x; REAVEN EP, 1974, J LIPID RES, V15, P74; Reddy KS, 1998, CIRCULATION, V97, P596; Rice SPL, 2009, J CLIN ENDOCR METAB, V94, P1966, DOI 10.1210/jc.2008-2636; Ross IL, 2013, HORM METAB RES, V45, P905, DOI 10.1055/s-0033-1351259; Ross I, 2010, CLIN ENDOCRINOL, V73, P291, DOI 10.1111/j.1365-2265.2010.03807.x; Ross IL, 2013, HORM METAB RES; Smelt A H M, 2003, Ned Tijdschr Geneeskd, V147, P157; Steyn K, 2005, CIRCULATION, V112, P3554, DOI 10.1161/CIRCULATIONAHA.105.563452; Trimpou P, 2012, EUR J ENDOCRINOL, V166, P887, DOI 10.1530/EJE-11-0808; Valle D SO., 2001, METABOLIC MOL BASIS, P1909; Walker BR, 2007, EUR J ENDOCRINOL, V157, P545, DOI 10.1530/EJE-07-0455	39	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90768	10.1371/journal.pone.0090768	http://dx.doi.org/10.1371/journal.pone.0090768			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603607	gold, Green Submitted, Green Published			2022-12-27	WOS:000332483600084
J	Sanchez-Dominguez, CN; Reyes-Lopez, MA; Bustamante, A; Cerda-Flores, RM; Villalobos-Torres, MD; Gallardo-Blanco, HL; Rojas-Martinez, A; Martinez-Rodriguez, HG; Barrera-Saldana, HA; Ortiz-Lopez, R				Sanchez-Dominguez, Celia N.; Reyes-Lopez, Miguel A.; Bustamante, Adriana; Cerda-Flores, Ricardo M.; Villalobos-Torres, Maria del C.; Gallardo-Blanco, Hugo L.; Rojas-Martinez, Augusto; Martinez-Rodriguez, Herminia G.; Barrera-Saldana, Hugo A.; Ortiz-Lopez, Rocio			The Tumor Necrosis Factor alpha (-308 A/G) Polymorphism Is Associated with Cystic Fibrosis in Mexican Patients	PLOS ONE			English	Article							MANNOSE-BINDING-LECTIN; ALPHA-1-ANTITRYPSIN DEFICIENCY ALLELES; SYNCYTIAL VIRUS BRONCHIOLITIS; AIRWAY EPITHELIAL-CELLS; LUNG-DISEASE; TNF-ALPHA; ANTITRYPSIN DEFICIENCY; PROMOTER POLYMORPHISM; RHEUMATOID-ARTHRITIS; GENE POLYMORPHISMS	Environmental and genetic factors may modify or contribute to the phenotypic differences observed in multigenic and monogenic diseases, such as cystic fibrosis (CF). An analysis of modifier genes can be helpful for estimating patient prognosis and directing preventive care. The aim of this study is to determine the association between seven genetic variants of four modifier genes and CF by comparing their corresponding allelic and genotypic frequencies in CF patients (n = 81) and control subjects (n = 104). Genetic variants of MBL2 exon 1 (A, B, C and D), the IL-8 promoter (2251 A/T), the TNF alpha promoter (TNF1/TNF2), and SERPINA1 (PI*Z and PI*S) were tested in CF patients and control subjects from northeastern Mexico by PCR-RFLP. Results: The TNF2 allele (P=0.012, OR 3.43, 95% CI 1.25-9.38) was significantly associated with CF under the dominant and additive models but was not associated with CF under the recessive model. This association remained statistically significant after adjusting for multiple tests using the Bonferroni correction (P=0.0482). The other tested variants and genotypes did not show any association with the disease. Conclusion: An analysis of seven genetic variants of four modifier genes showed that one variant, the TNF2 allele, appears to be significantly associated with CF in Mexican patients.	[Sanchez-Dominguez, Celia N.; Villalobos-Torres, Maria del C.; Rojas-Martinez, Augusto; Martinez-Rodriguez, Herminia G.; Barrera-Saldana, Hugo A.; Ortiz-Lopez, Rocio] Univ Autonoma Nuevo Leon, Fac Med, Dept Bioquim & Med Mol, Monterrey, Nuevo Leon, Mexico; [Reyes-Lopez, Miguel A.] Inst Politecn Nacl, Ctr Biotecnol Genom, Lab Med Conservac, Reynosa, Tamaulipas, Mexico; [Bustamante, Adriana] Univ Autonoma Nuevo Leon, Fac Med, Clin Fibrosis Quist, Ctr Prevenc & Rehabil Enfermedades Pulm Cron CEPR, Monterrey, Nuevo Leon, Mexico; [Bustamante, Adriana] Hosp Univ Dr Jose Eleuterio Gonzalez, Monterrey, Nuevo Leon, Mexico; [Cerda-Flores, Ricardo M.] Univ Autonoma Nuevo Leon, Fac Enfermeria, Monterrey, Nuevo Leon, Mexico; [Gallardo-Blanco, Hugo L.] Univ Autonoma Nuevo Leon, Fac Med, Dept Genet, Monterrey, Nuevo Leon, Mexico; [Rojas-Martinez, Augusto; Ortiz-Lopez, Rocio] Univ Autonoma Nuevo Leon, Ctr Invest & Desarrollo Ciencias Salud, Monterrey, Nuevo Leon, Mexico	Universidad Autonoma de Nuevo Leon; Instituto Politecnico Nacional - Mexico; Universidad Autonoma de Nuevo Leon; Universidad Autonoma de Nuevo Leon; University Hospital Autonomous University of Nuevo Leon; Universidad Autonoma de Nuevo Leon; Universidad Autonoma de Nuevo Leon; Universidad Autonoma de Nuevo Leon	Ortiz-Lopez, R (corresponding author), Univ Autonoma Nuevo Leon, Fac Med, Dept Bioquim & Med Mol, Monterrey, Nuevo Leon, Mexico.	rortizlopez@gmail.com	Ortiz-Lopez, Rocio/F-7020-2014; ROJAS-MARTINEZ, AUGUSTO/Z-3585-2019; ROJAS-MARTINEZ, AUGUSTO/D-1710-2011; Gallardo Blanco, Hugo Leonid/GLU-6868-2022; Ortiz-Lopez, Rocio/N-4827-2018; Sanchez-Dominguez, Celia Nohemi/AAJ-8561-2020; Bustamante, Adriana Ester/AAR-2816-2021; Blanco, Hugo L Gallardo/L-4326-2013; Reyes-Lopez, Miguel Angel/D-9308-2011	Ortiz-Lopez, Rocio/0000-0002-7783-026X; ROJAS-MARTINEZ, AUGUSTO/0000-0003-3765-6778; Ortiz-Lopez, Rocio/0000-0002-7783-026X; Sanchez-Dominguez, Celia Nohemi/0000-0002-3444-9565; Bustamante, Adriana Ester/0000-0002-8245-6671; Blanco, Hugo L Gallardo/0000-0002-7816-4967; Reyes-Lopez, Miguel Angel/0000-0001-9939-3032; Barrera Saldana, Hugo A./0000-0003-1587-4571	Consejo Nacional de Ciencia y Tecnologia CONACyT [62291, 48497]; UANL's PAICyT [1648-07]; Fondo Mixto de Fomento a la Investigacion Cientifica y Tecnologica CONACYT - Gobierno del Estado de Tamaulipas [73578]; SIP-IPN [20080682]; CONACyT; PIFI-IPN; Universia Santander for CNSD	Consejo Nacional de Ciencia y Tecnologia CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); UANL's PAICyT; Fondo Mixto de Fomento a la Investigacion Cientifica y Tecnologica CONACYT - Gobierno del Estado de Tamaulipas; SIP-IPN; CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); PIFI-IPN; Universia Santander for CNSD	This work was supported by grants from the Consejo Nacional de Ciencia y Tecnologia CONACyT (62291 and 48497) and UANL's PAICyT (1648-07) for ROL, Fondo Mixto de Fomento a la Investigacion Cientifica y Tecnologica CONACYT - Gobierno del Estado de Tamaulipas (73578) and SIP-IPN (20080682) for MARL. The authors gratefully acknowledge scholarships from CONACyT, PIFI-IPN and Universia Santander for CNSD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alino-Pellicer SF, 2003, FEDERACION ESPANOLA; Alonso MJ, 2007, ANN HUM GENET, V71, P194, DOI 10.1111/j.1469-1809.2006.00310.x; Arinir U, 2005, ELECTROPHORESIS, V26, P2888, DOI 10.1002/elps.200500095; Buranawuti K, 2007, J MED GENET, V44, P209, DOI 10.1136/jmg.2006.046318; Castro-Giner F, 2009, EUR RESPIR J, V33, P1003, DOI 10.1183/09031936.00140608; Chavez-Saldana M, 2010, REV INVEST CLIN, V62, P546; Chen YP, 2006, CHINESE MED J-PEKING, V119, P719, DOI 10.1097/00029330-200605010-00003; Collaco JM, 2008, CURR OPIN PULM MED, V14, P559, DOI 10.1097/MCP.0b013e3283121cdc; Correa PA, 2005, J RHEUMATOL, V32, P219; Correa Paula A, 2004, Biomed., V24, P43; Cowan MJ, 2000, ANN NY ACAD SCI, V923, P193; Davies JC, 2004, EUR RESPIR J, V24, P798, DOI 10.1183/09031936.04.00055404; de Araujo FG, 2005, BRAZ J MED BIOL RES, V38, P11, DOI 10.1590/S0100-879X2005000100003; Eisen DP, 2010, J INNATE IMMUN, V2, P114, DOI 10.1159/000228159; Frangolias DD, 2003, AM J RESP CELL MOL, V29, P390, DOI 10.1165/rcmb.2002-0271OC; Gambari R, 2012, INT IMMUNOPHARMACOL, V13, P308, DOI 10.1016/j.intimp.2012.04.010; Garred P, 2006, GENES IMMUN, V7, P85, DOI 10.1038/sj.gene.6364283; Garred P, 2002, PEDIATR PULM, V33, P201, DOI 10.1002/ppul.10064; Flores-Ramos LG, 2013, GENET MOL RES, V12, P5680, DOI 10.4238/2013.November.18.17; GREBE TA, 1994, AM J HUM GENET, V54, P443; Haerynck F, 2012, HUM IMMUNOL, V73, P1175, DOI 10.1016/j.humimm.2012.08.010; Hajeer AH, 2000, MICROSC RES TECHNIQ, V50, P216, DOI 10.1002/1097-0029(20000801)50:3<216::AID-JEMT5>3.0.CO;2-Q; HARADA A, 1994, J LEUKOCYTE BIOL, V56, P559, DOI 10.1002/jlb.56.5.559; Heinzmann A, 2004, J ALLERGY CLIN IMMUN, V114, P671, DOI 10.1016/j.jaci.2004.06.038; Hillian AD, 2008, GENES IMMUN, V9, P501, DOI 10.1038/gene.2008.42; Hull J, 2000, THORAX, V55, P1023, DOI 10.1136/thorax.55.12.1023; Hull J, 1998, THORAX, V53, P1018, DOI 10.1136/thx.53.12.1018; Jimenez-Morales S, 2009, HUM IMMUNOL, V70, P251, DOI 10.1016/j.humimm.2009.01.027; Kilpatrick DC, 2003, BIOCHEM SOC T, V31, P745, DOI 10.1042/BST0310745; Kim J, 2007, CURR ALLERGY ASTHM R, V7, P151, DOI 10.1007/s11882-007-0013-3; Kok KF, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-22; Lee WP, 2005, CLIN CANCER RES, V11, P6431, DOI 10.1158/1078-0432.CCR-05-0942; Lora JM, 2005, J BIOL CHEM, V280, P36510, DOI 10.1074/jbc.M507977200; Madsen HO, 1998, J IMMUNOL, V161, P3169; Mahadeva R, 1998, THORAX, V53, P1022, DOI 10.1136/thx.53.12.1022; Mahadeva R, 1998, EUR RESPIR J, V11, P873, DOI 10.1183/09031936.98.11040873; Meyer P, 2002, CLIN GENET, V62, P325, DOI 10.1034/j.1399-0004.2002.620413.x; Miravitlles M, 2003, CHEST, V124, P404, DOI 10.1378/chest.124.1.404; Mizunoe S, 2012, J PHARMACOL SCI, V118, P512, DOI 10.1254/jphs.11240FP; Muhlebach MS, 2006, CLIN EXP IMMUNOL, V145, P302, DOI 10.1111/j.1365-2249.2006.03151.x; Nagy A, 2003, J ALLERGY CLIN IMMUN, V112, P729, DOI 10.1016/S0091-6749(03)02010-4; Sanchez-Dominguez CN, 2008, ALLERGY ASTHMA PROC, V29, P406, DOI 10.2500/aap.2008.29.3125; Orozco L, 2000, HUM GENET, V106, P360, DOI 10.1007/s004390051051; Parra-Rojas I, 2006, HEREDITAS, V143, P167, DOI 10.1111/j.2006.0018-0661.01936.x; Puthothu Beena, 2006, Clin Mol Allergy, V4, P2; Rodriguez-Carreon AA, 2005, J AUTOIMMUN, V24, P63, DOI 10.1016/j.jaut.2004.11.002; Rowntree RK, 2003, ANN HUM GENET, V67, P471, DOI 10.1046/j.1469-1809.2003.00028.x; Sandford AJ, 1999, AM J RESP CRIT CARE, V159, P1624, DOI 10.1164/ajrccm.159.5.9711004; Schrijver I, 2005, J MOL DIAGN, V7, P289, DOI 10.1016/S1525-1578(10)60557-0; Shmarina G, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-19; Sugarman EA, 2004, GENET MED, V6, P392, DOI 10.1097/01.GIM.0000139503.22088.66; Summerfield JA, 2003, BIOCHEM SOC T, V31, P770, DOI 10.1042/bst0310770; Tin SK, 2005, J IMMUNOL METHODS, V303, P148, DOI 10.1016/j.jim.2005.06.001; Turner MW, 1996, IMMUNOL TODAY, V17, P532, DOI 10.1016/0167-5699(96)10062-1; Uguz A, 2005, PEDIAT ALLERG IMM-UK, V16, P231, DOI 10.1111/j.1399-3038.2005.00258.x; Vargas-Alarcon G, 2006, HUM IMMUNOL, V67, P826, DOI 10.1016/j.humimm.2006.07.009; Vargas-Alarcon G, 2012, GENET TEST MOL BIOMA, V16, P1246, DOI 10.1089/gtmb.2012.0100; Velazquez A, 2000, REV MEX PEDIAT, V67, P206; VillalobosTorres C, 1997, AM J MED GENET, V69, P380; Wilson AG, 1997, P NATL ACAD SCI USA, V94, P3195, DOI 10.1073/pnas.94.7.3195; Wu H, 2007, ENVIRON HEALTH PERSP, V115, P616, DOI 10.1289/ehp.9740; Yarden J, 2004, J MED GENET, V41, P629, DOI 10.1136/jmg.2003.017947	62	5	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90945	10.1371/journal.pone.0090945	http://dx.doi.org/10.1371/journal.pone.0090945			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603877	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000332483600113
J	Torring, PM; Larsen, MJ; Kjeldsen, AD; Ousager, LB; Tan, QH; Brusgaard, K				Torring, Pernille M.; Larsen, Martin Jakob; Kjeldsen, Anette D.; Ousager, Lilian Bomme; Tan, Qihua; Brusgaard, Klaus			Long Non-Coding RNA Expression Profiles in Hereditary Haemorrhagic Telangiectasia	PLOS ONE			English	Article							PREVALENCE; MUTATIONS; ENDOGLIN	Hereditary Haemorrhagic Telangiectasia (HHT) is an autosomal dominantly inherited vascular disease characterized by the presence of mucocutaneous telangiectasia and arteriovenous malformations in visceral organs. HHT is predominantly caused by mutations in ENG and ACVRL1, which both belong to the TGF-beta signalling pathway. The exact mechanism of how haploinsufficiency of ENG and ACVRL1 leads to HHT manifestations remains to be identified. As long non-coding RNAs (lncRNAs) are increasingly recognized as key regulators of gene expression and constitute a sizable fraction of the human transcriptome, we wanted to assess whether lncRNAs play a role in the molecular pathogenesis of HHT manifestations. By microarray technology, we profiled lncRNA transcripts from HHT nasal telangiectasial and non-telangiectasial tissue using a paired design. The microarray probes were annotated using the GENCODE v. 16 dataset, identifying 4,810 probes mapping to 2,811 lncRNAs. Comparing HHT telangiectasial tissue with HHT non-telangiectasial tissue, we identified 42 lncRNAs that are differentially expressed (q<0.001). Using GREAT, a tool that assumes cis-regulation, we showed that differently expressed lncRNAs are enriched for genomic loci involved in key pathways concerning HHT. Our study identified lncRNAs that are aberrantly expressed in HHT telangiectasia and indicates that lncRNAs may contribute to regulate protein-coding loci in HHT. These results suggest that the lncRNA component of the transcriptome deserves more attention in HHT. A deeper understanding of lncRNAs and their role in telangiectasia formation possesses potential for discovering therapeutic targets in HHT.	[Torring, Pernille M.; Larsen, Martin Jakob; Ousager, Lilian Bomme; Tan, Qihua; Brusgaard, Klaus] Odense Univ Hosp, Dept Clin Genet, DK-5000 Odense, Denmark; [Kjeldsen, Anette D.] Odense Univ Hosp, Dept Otorhinolaryngol, DK-5000 Odense, Denmark; [Torring, Pernille M.; Larsen, Martin Jakob; Kjeldsen, Anette D.; Ousager, Lilian Bomme; Brusgaard, Klaus] Univ Southern Denmark, Inst Clin Res, Odense, Denmark; [Tan, Qihua] Univ Southern Denmark, Inst Publ Hlth, Odense, Denmark	University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; University of Southern Denmark	Torring, PM (corresponding author), Odense Univ Hosp, Dept Clin Genet, DK-5000 Odense, Denmark.	pernille.toerring@rsyd.dk	Ousager, Lilian Bomme/F-7119-2015; Tan, Qihua/F-1349-2015; Tan, Qihua/AAG-2582-2019; Larsen, Martin Jakob/L-5794-2019; Brusgaard, Klaus/AGE-8988-2022	Tan, Qihua/0000-0003-3194-0030; Tan, Qihua/0000-0003-3194-0030; Ousager, Lilian Bomme/0000-0001-9936-2201; Brusgaard, Klaus/0000-0002-2096-4988; Larsen, Martin Jakob/0000-0003-4107-8771; Kjeldsen, Anette Drohse/0000-0003-0593-6302	Region of Southern Denmark, Overlaegeradets (OUH); Hans Skouby Fond; Torben og Alice Frimodts Fond; Fonden til laegevidenskabens fremme; Tomrermester Alfred Andersen og Hustrus Fond; AJ Andersen og Hustrus Fond; Aase og Ejnar Danielsens Fond; Syddansk Universitets Forskningsfond	Region of Southern Denmark, Overlaegeradets (OUH); Hans Skouby Fond; Torben og Alice Frimodts Fond; Fonden til laegevidenskabens fremme; Tomrermester Alfred Andersen og Hustrus Fond; AJ Andersen og Hustrus Fond; Aase og Ejnar Danielsens Fond; Syddansk Universitets Forskningsfond	This work was supported by the Region of Southern Denmark, Overlaegeradets (OUH), Hans Skouby Fond, Torben og Alice Frimodts Fond, Fonden til laegevidenskabens fremme, Tomrermester Alfred Andersen og Hustrus Fond, AJ Andersen og Hustrus Fond, Aase og Ejnar Danielsens Fond and Syddansk Universitets Forskningsfond. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral PP, 2011, NUCLEIC ACIDS RES, V39, pD146, DOI 10.1093/nar/gkq1138; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Attisano L, 2000, CURR OPIN CELL BIOL, V12, P235, DOI 10.1016/S0955-0674(99)00081-2; Brusgaard K, 2004, CLIN GENET, V66, P556, DOI 10.1111/j.1399-0004.2004.00341.x; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Eerola I, 2003, AM J HUM GENET, V73, P1240, DOI 10.1086/379793; Faughnan ME, 2011, J MED GENET, V48, P73, DOI 10.1136/jmg.2009.069013; Fernandez-Lopez A, 2007, HUM MOL GENET, V16, P1515, DOI 10.1093/hmg/ddm069; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; Kjeldsen AD, 2014, ACTA NEUROL SCAND, V129, P192, DOI 10.1111/ane.12167; Kjeldsen AD, 2000, J INTERN MED, V248, P255, DOI 10.1046/j.1365-2796.2000.00725.x; Kjeldsen AD, 1999, J INTERN MED, V245, P31, DOI 10.1046/j.1365-2796.1999.00398.x; Lebrin F, 2004, EMBO J, V23, P4018, DOI 10.1038/sj.emboj.7600386; Lesca G, 2004, HUM MUTAT, V23, P289, DOI 10.1002/humu.20017; Liquori CL, 2003, AM J HUM GENET, V73, P1459, DOI 10.1086/380314; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Ponting CP, 2010, HUM MOL GENET, V19, pR162, DOI 10.1093/hmg/ddq362; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Schulte Claudia, 2005, Hum Mutat, V25, P595, DOI 10.1002/humu.9345; Shovlin CL, 2000, AM J MED GENET, V91, P66, DOI 10.1002/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-P; Thomas B, 2007, EUR J CLIN INVEST, V37, P580, DOI 10.1111/j.1365-2362.2007.01824.x; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Torring PM, 2014, CLIN GENET, V86, P123, DOI 10.1111/cge.12269	23	19	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90272	10.1371/journal.pone.0090272	http://dx.doi.org/10.1371/journal.pone.0090272			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603890	Green Submitted, gold, Green Published			2022-12-27	WOS:000332483600037
J	Zhu, XY; Li, Q; Chang, RM; Yang, D; Song, ZB; Guo, QL; Huang, CS				Zhu, Xiaoyan; Li, Qian; Chang, Ruimin; Yang, Dong; Song, Zongbing; Guo, Qulian; Huang, Changsheng			Curcumin Alleviates Neuropathic Pain by Inhibiting p300/CBP Histone Acetyltransferase Activity-Regulated Expression of BDNF and Cox-2 in a Rat Model	PLOS ONE			English	Article							CHROMATIN REMODELING EVENTS; NEUROTROPHIC FACTOR; NERVE INJURY; SPINAL-CORD; MOUSE MODEL; DORSAL-ROOT; ACETYLATION; TRANSCRIPTION; ACTIVATION; CYCLOOXYGENASE-2	The management of neuropathic pain is still a major challenge because of its unresponsiveness to most common treatments. Curcumin has been reported to play an active role in the treatment of various neurological disorders, such as neuropathic pain. Curcumin has long been recognized as a p300/CREB-binding protein (CBP) inhibitor of histone acetyltransferase (HAT) activity. However, this mechanism has never been investigated for the treatment of neuropathic pain with curcumin. The aim of the present study was to investigate the anti-nociceptive role of curcumin in the chronic constriction injury (CCI) rat model of neuropathic pain. Furthermore, with this model we investigated the effect of curcumin on P300/CBP HAT activity-regulated release of the pro-nociceptive molecules, brain-derived neurotrophic factor (BDNF) and cyclooxygenase-2 (Cox-2). Treatment with 40 and 60 mg/kg body weight curcumin for 7 consecutive days significantly attenuated CCI-induced thermal hyperalgesia and mechanical allodynia, whereas 20 mg/kg curcumin showed no significant analgesic effect. Chromatin immunoprecipitation analysis revealed that curcumin dose-dependently reduced the recruitment of p300/CBP and acetyl-Histone H3/acetyl-Histone H4 to the promoter of BDNF and Cox-2 genes. A similar dose-dependent decrease of BDNF and Cox-2 in the spinal cord was also observed after curcumin treatment. These results indicated that curcumin exerted a therapeutic role in neuropathic pain by down-regulating p300/CBP HAT activity-mediated gene expression of BDNF and Cox-2.	[Zhu, Xiaoyan; Li, Qian; Song, Zongbing; Guo, Qulian; Huang, Changsheng] Cent S Univ, Dept Anesthesiol, Xiangya Hosp, Changsha, Hunan, Peoples R China; [Chang, Ruimin] Cent S Univ, Liver Canc Lab, Xiangya Hosp, Changsha, Hunan, Peoples R China; [Yang, Dong] Huazhong Univ Sci & Technol, Dept Anesthesiol, Union Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China	Central South University; Central South University; Huazhong University of Science & Technology	Huang, CS (corresponding author), Cent S Univ, Dept Anesthesiol, Xiangya Hosp, Changsha, Hunan, Peoples R China.	docthuang2005@hotmail.com	Song, Zongbin/GYD-5863-2022; Chang, Ruiming/GWN-1856-2022; Changsheng, Huang/M-6033-2018; Yang, Dong/GSD-6859-2022	Song, Zongbin/0000-0002-0447-8648; Huang, Changsheng/0000-0003-0535-1865	National Natural Science Foundation of China [81000478, 81171053]; Science and Technology Planning Project of Hunan Province, China [2012WK3019]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Planning Project of Hunan Province, China	This project was supported by National Natural Science Foundation of China (81000478, 81171053) and Science and Technology Planning Project of Hunan Province, China (2012WK3019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Moundhri MS, 2013, J MED TOXICOL, V9, P25, DOI 10.1007/s13181-012-0239-x; Balasubramanyam K, 2004, J BIOL CHEM, V279, P51163, DOI 10.1074/jbc.M409024200; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Bishnoi M, 2008, PHARMACOL BIOCHEM BE, V88, P511, DOI 10.1016/j.pbb.2007.10.009; Brownell JE, 1996, CURR OPIN GENET DEV, V6, P176, DOI 10.1016/S0959-437X(96)80048-7; Caccamo A, 2010, P NATL ACAD SCI USA, V107, P22687, DOI 10.1073/pnas.1012851108; Chan HM, 2001, J CELL SCI, V114, P2363; Constandil L, 2008, BRAIN RES B, V86, P454; Crump NT, 2011, P NATL ACAD SCI USA, V108, P7814, DOI 10.1073/pnas.1100099108; Deng WG, 2004, BLOOD, V103, P2135, DOI 10.1182/blood-2003-09-3131; Di Pierro F, 2013, J PAIN RES, V6, P497, DOI 10.2147/JPR.S48432; Durrenberger PF, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-1; Dworkin RH, 2010, MAYO CLIN PROC, V85, pS3, DOI 10.4065/mcp.2009.0649; Geng SJ, 2010, EXP NEUROL, V222, P256, DOI 10.1016/j.expneurol.2010.01.003; Goodman RH, 2000, GENE DEV, V14, P1553; Guo W, 2006, J NEUROSCI, V26, P126, DOI 10.1523/JNEUROSCI.3686-05.2006; Ha SO, 2001, NEUROSCIENCE, V107, P301, DOI 10.1016/S0306-4522(01)00353-0; Haanpaa M, 2011, PAIN, V152, P14, DOI 10.1016/j.pain.2010.07.031; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Huang CS, 2012, SPINE J, V12, P1154, DOI 10.1016/j.spinee.2012.10.036; IdanpaanHeikkila JJ, 1997, J PHARMACOL EXP THER, V282, P1366; Jean YH, 2009, BRIT J PHARMACOL, V158, P713, DOI 10.1111/j.1476-5381.2009.00323.x; Ji FT, 2013, CHINESE MED J-PEKING, V126, P1125, DOI 10.3760/cma.j.issn.0366-6999.20122095; Joshi RP, 2013, NANOMED-NANOTECHNOL, V9, P776, DOI 10.1016/j.nano.2013.01.001; Kobayashi H, 2008, BRAIN RES, V1206, P13, DOI 10.1016/j.brainres.2007.12.004; Kulkarni SK, 2008, PSYCHOPHARMACOLOGY, V201, P435, DOI 10.1007/s00213-008-1300-y; Li Y, 2013, INT J MED SCI, V10, P377, DOI 10.7150/ijms.5224; Liu X, 2008, NATURE, V451, P846, DOI 10.1038/nature06546; Ma WY, 2002, BRAIN RES, V937, P94, DOI 10.1016/S0006-8993(02)02593-3; Marcu MG, 2006, MED CHEM, V2, P169, DOI 10.2174/157340606776056133; Martin TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034236; Miao F, 2004, J BIOL CHEM, V279, P18091, DOI 10.1074/jbc.M311786200; Min SW, 2010, NEURON, V67, P953, DOI 10.1016/j.neuron.2010.08.044; Mishra S, 2008, ANN INDIAN ACAD NEUR, V11, P13, DOI 10.4103/0972-2327.40220; Mittal N, 2009, PHYTOTHER RES, V23, P507, DOI 10.1002/ptr.2662; Morimoto T, 2008, J CLIN INVEST, V118, P868, DOI 10.1172/JCI33160; Mutskov V, 1998, MOL CELL BIOL, V18, P6293, DOI 10.1128/MCB.18.11.6293; Ohtori S, 2004, J PAIN, V5, P385, DOI 10.1016/j.jpain.2004.06.004; OSSIPOV MH, 1995, NEUROSCI LETT, V199, P83, DOI 10.1016/0304-3940(95)12026-Z; Piller Nicolas, 2013, BMC Res Notes, V6, P266, DOI 10.1186/1756-0500-6-266; Puglia C, 2012, EUR J PHARM BIOPHARM, V81, P288, DOI 10.1016/j.ejpb.2012.03.015; Quintao NLM, 2008, PAIN, V136, P125, DOI 10.1016/j.pain.2007.06.027; Reeta KH, 2010, EUR J PHARMACOL, V644, P106, DOI 10.1016/j.ejphar.2010.07.022; Renthal W, 2009, SEMIN CELL DEV BIOL, V20, P387, DOI 10.1016/j.semcdb.2009.01.005; Schmidt HD, 2012, J NEUROCHEM, V120, P202, DOI 10.1111/j.1471-4159.2011.07571.x; Seybold VS, 2003, PAIN, V105, P47, DOI 10.1016/S0304-3959(03)00254-9; Sharma S, 2006, EUR J PHARMACOL, V536, P256, DOI 10.1016/j.ejphar.2006.03.006; Sharma S, 2007, PHYTOTHER RES, V21, P278, DOI 10.1002/ptr.2070; Shikama N, 1997, TRENDS CELL BIOL, V7, P230, DOI 10.1016/S0962-8924(97)01048-9; Soliman ML, 2013, LIPIDS, V48, P651, DOI 10.1007/s11745-013-3799-x; Tian F, 2009, J NEUROCHEM, V109, P1375, DOI 10.1111/j.1471-4159.2009.06058.x; TIMMUSK T, 1993, NEURON, V10, P475, DOI 10.1016/0896-6273(93)90335-O; Treede RD, 2008, NEUROLOGY, V70, P1630, DOI 10.1212/01.wnl.0000282763.29778.59; Ura K, 1997, EMBO J, V16, P2096, DOI 10.1093/emboj/16.8.2096; Valor LM, 2013, CURR PHARM DESIGN, V19, P5051, DOI 10.2174/13816128113199990382; Vivancos GG, 2004, BRAZ J MED BIOL RES, V37, P391, DOI 10.1590/S0100-879X2004000300017; Wade PA, 1997, TRENDS BIOCHEM SCI, V22, P128, DOI 10.1016/S0968-0004(97)01016-5; Wall PD, 2006, CENTRAL CONSEQUENCES, P947; Wang DQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009853; Wang XD, 2009, J NEUROSCI, V29, P5508, DOI 10.1523/JNEUROSCI.4288-08.2009; Woolf CJ, 2011, PAIN, V152, pS2, DOI 10.1016/j.pain.2010.09.030; Yadav VS, 2005, IMMUNOPHARM IMMUNOT, V27, P485, DOI 10.1080/08923970500242244; Yajima Y, 2005, J NEUROCHEM, V93, P584, DOI 10.1111/j.1471-4159.2005.03045.x; Yeon KY, 2010, J DENT RES, V89, P170, DOI 10.1177/0022034509356169; Yuan H, 2013, AM J PHYSIOL-RENAL, V304, pF601, DOI 10.1152/ajprenal.00523.2012; Zhao FY, 2007, PAIN, V128, P78, DOI 10.1016/j.pain.2006.08.032; Zhao X, 2012, NEUROPHARMACOLOGY, V62, P843, DOI 10.1016/j.neuropharm.2011.08.050; Zhao Z, 2000, NEUROSCIENCE, V97, P743, DOI 10.1016/S0306-4522(00)00052-X; Zhu XY, 2013, CELL MOL NEUROBIOL, V33, P197, DOI 10.1007/s10571-012-9885-4; Zhu XY, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-84	70	73	76	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e91303	10.1371/journal.pone.0091303	http://dx.doi.org/10.1371/journal.pone.0091303			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603592	Green Submitted, Green Published, gold			2022-12-27	WOS:000332483600141
J	Liu, F; Chen, YM; Feng, XG; Teng, ZH; Yuan, Y; Bin, JP				Liu, Feng; Chen, Yanmei; Feng, Xuguang; Teng, Zhonghua; Yuan, Ye; Bin, Jianping			Effects of Beta-Blockers on Heart Failure with Preserved Ejection Fraction: A Meta-Analysis	PLOS ONE			English	Article							MORTALITY; THERAPY; OUTCOMES; CARVEDILOL; SURVIVAL; AGE; REHOSPITALIZATION; DYSFUNCTION; MORBIDITY; NEBIVOLOL	Background: Effects of beta-blockers on the prognosis of the heart failure patients with preserved ejection fraction (HFpEF) remain controversial. The aim of this meta-analysis was to determine the impact of beta-blockers on mortality and hospitalization in the patients with HFpEF. Methods: A search of MEDLINE, EMBASE, and the Cochrane Library databases from 2005 to June 2013 was conducted. Clinical studies reporting outcomes of mortality and/or hospitalization for patients with HFpEF (EF >= 40%), being assigned to beta-blockers treatment and non-beta-blockers control group were included. Results: A total of 12 clinical studies (2 randomized controlled trials and 10 observational studies) involving 21,206 HFpEF patients were included for this meta-analysis. The pooled analysis demonstrated that beta-blocker exposure was associated with a 9% reduction in relative risk for all-cause mortality in patients with HFpEF (95% CI: 0.87 - 0.95; P < 0.001). Whereas, the all-cause hospitalization, HF hospitalization and composite outcomes (mortality and hospitalization) were not affected by this treatment (P = 0.26, P = 0.97, and P = 0.88 respectively). Conclusions: The beta-blockers treatment for the patients with HFpEF was associated with a lower risk of all-cause mortality, but not with a lower risk of hospitalization. These finding were mainly obtained from observational studies, and further investigations are needed to make an assertion.	[Bin, Jianping] Southern Med Univ, Nanfang Hosp, Dept Cardiol, Guangzhou, Guangdong, Peoples R China; Southern Med Univ, Nanfang Hosp, Natl Key Lab Organ Failure Res, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China	Bin, JP (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Cardiol, Guangzhou, Guangdong, Peoples R China.	jianpingbin@126.com			National Basic Research Program of China (973 Program) [2013CB733804]; National Natural Science Foundation of China [81227801, 81271640]; Natural Science Foundation of Guangdong Province, China [S2011030003134]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province)	This work was supported by grants from National Basic Research Program of China (973 Program) (No. 2013CB733804), National Natural Science Foundation of China (No. 81227801 and No. 81271640), and the Team Program of Natural Science Foundation of Guangdong Province, China (S2011030003134) to Jianping Bin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ather S, 2012, J AM COLL CARDIOL, V59, P998, DOI 10.1016/j.jacc.2011.11.040; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Carson P, 1996, J AM COLL CARDIOL, V27, P642, DOI 10.1016/0735-1097(95)00503-X; Chan JD, 2005, AM HEART J, V150, P464, DOI 10.1016/j.ahj.2004.12.022; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dobre D, 2007, EUR J HEART FAIL, V9, P280, DOI 10.1016/j.ejheart.2006.07.008; El-Refai M, 2013, J CARD FAIL, V19, P73, DOI 10.1016/j.cardfail.2012.11.011; Farasat SM, 2010, AM J CARDIOL, V105, P229, DOI 10.1016/j.amjcard.2009.09.008; Fonarow GC, 2007, J AM COLL CARDIOL, V50, P768, DOI 10.1016/j.jacc.2007.04.064; Fukuta H, 2005, CIRCULATION, V112, P357, DOI 10.1161/CIRCULATIONAHA.104.519876; Ghio S, 2006, EUR HEART J, V27, P562, DOI 10.1093/eurheartj/ehi735; Hernandez AF, 2009, J AM COLL CARDIOL, V53, P184, DOI 10.1016/j.jacc.2008.09.031; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Holland DJ, 2011, J AM COLL CARDIOL, V57, P1676, DOI 10.1016/j.jacc.2010.10.057; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Krum H, 2003, JAMA-J AM MED ASSOC, V289, P712, DOI 10.1001/jama.289.6.712; Lam CSP, 2011, EUR J HEART FAIL, V13, P18, DOI 10.1093/eurjhf/hfq121; Masoudi FA, 2003, J AM COLL CARDIOL, V41, P217, DOI 10.1016/S0735-1097(02)02696-7; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Nevzorov R, 2012, EUR J INTERN MED, V23, P374, DOI 10.1016/j.ejim.2012.01.011; Nohria A, 2003, J AM COLL CARDIOL, V41, P1797, DOI 10.1016/S0735-1097(03)00309-7; Packer M, 2001, NEW ENGL J MED, V344, P1651, DOI 10.1056/NEJM200105313442201; Pan A, 2011, JAMA-J AM MED ASSOC, V306, P1241, DOI 10.1001/jama.2011.1282; Paulus WJ, 2010, J AM COLL CARDIOL, V55, P526, DOI 10.1016/j.jacc.2009.06.067; Shah R, 2008, AM J CARDIOL, V101, P217, DOI 10.1016/j.amjcard.2007.08.050; Shamagian LG, 2006, J CARD FAIL, V12, P128, DOI 10.1016/j.cardfail.2005.09.001; Smith GL, 2003, J AM COLL CARDIOL, V41, P1510, DOI 10.1016/S0735-1097(03)00185-2; Spruance SL, 2004, ANTIMICROB AGENTS CH, V48, P2787, DOI 10.1128/AAC.48.8.2787-2792.2004; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Tehrani F, 2009, AM J CARDIOL, V103, P829, DOI 10.1016/j.amjcard.2008.11.047; van Veldhuisen DJ, 2009, J AM COLL CARDIOL, V53, P2150, DOI 10.1016/j.jacc.2009.02.046; Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654; Yamamoto K, 2013, EUR J HEART FAIL, V15, P110, DOI 10.1093/eurjhf/hfs141; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019; Zhou JM, 2010, EUR J HEART FAIL, V12, P181, DOI 10.1093/eurjhf/hfp193	35	61	65	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90555	10.1371/journal.pone.0090555	http://dx.doi.org/10.1371/journal.pone.0090555			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599093	Green Published, gold, Green Submitted			2022-12-27	WOS:000332479400091
J	Mao, XD; Zheng, HC; Liu, ZW; Wu, Y; Na, RS; Wang, CP; Zheng, XL; Gao, J; Wu, LM; Shi, XH; Liu, C; Sheng, HG				Mao, Xudong; Zheng, Hongchao; Liu, Zhiwen; Wu, Yan; Na, Risu; Wang, Chunping; Zheng, Xulei; Gao, Jing; Wu, Liming; Shi, Xiaohong; Liu, Cong; Sheng, Hongguang			Analysis of 25(OH) D Serum Concentrations of Hospitalized Elderly Patients in the Shanghai Area	PLOS ONE			English	Article							VITAMIN-D DEFICIENCY; 25-HYDROXYVITAMIN D; GENE-EXPRESSION; D INSUFFICIENCY; US POPULATION; D-3	Objective: To find an association between basic characteristics, seasons as well as disease types and 25-Hydroxyvitamin D serum concentrations in Chinese patients. Methods: We randomly selected 5470 Chinese patients with various diseases, who were hospitalized between May 2012 and August 2013 in Shanghai and analyzed their serum 25-Hydroxyvitamin D2 (25 (OH) D2) and 25-Hydroxyvitamin D3 (25(OH) D3) concentrations with liquid chromatography-tandem mass spectrometry (LC-MS/MS) as well as their parathyroid hormone (PTH) and serum creatinine blood levels. The resulting data were analyzed by linear regression and variance analyses or multivariate analysis with covariance. Results: The 25(OH) D serum concentrations were lowest in December. Among the subjects with a median age of 83.0 +/- 16.0, the median 25(OH) D2, 25(OH) D3 and total 25(OH) D serum concentrations were 1.00 +/- 1.80 ng/ml, 12.20 +/- 8.50 ng/ml and 14.80 +/- 9.80 respectively, indicating a prevalent 25(OH) D deficiency. According to our multivariate analysis of covariance, the factors affecting 25(OH) D2 and 25(OH) D3 serum concentrations included age, creatinine, PTH, season and type of disease, whereas gender correlated only with 25(OH) D2 and 25(OH) D2 and D3 values correlated negatively with each other. Our results further revealed that 25(OH) D3 levels were low while 25(OH) D2 levels were high among patients with lung diseases, dyskinesia and coronary heart diseases. In addition, participants with diabetes and cerebral infarction had higher 25(OH) D3 serum concentrations compared with lung disease patients. Conclusion: Vitamin D intake particularly during winter and summer seasons is important especially for elderly lung disease, dyskinesia and coronary heart disease patients to improve their quality of life.	[Mao, Xudong; Liu, Zhiwen; Na, Risu; Wang, Chunping; Zheng, Xulei; Wu, Liming; Shi, Xiaohong; Liu, Cong; Sheng, Hongguang] Xuhui Dist Cent Hosp, Dept Endocrinol, Shanghai, Peoples R China; [Zheng, Hongchao] Xuhui Dist Cent Hosp, Dept Cardiol, Shanghai, Peoples R China; [Wu, Yan] Shanghai Mental Hlth Ctr, Dept Psychiat, Shanghai, Peoples R China; [Gao, Jing] Xuhui Dist Cent Hosp, Dept Informat, Shanghai, Peoples R China		Mao, XD (corresponding author), Xuhui Dist Cent Hosp, Dept Endocrinol, Shanghai, Peoples R China.	maoxud@sina.com; zhcmxd@163.com	Wu, liming/AAH-5415-2019		 [81170734]		This work was supported by Research Grants (81170734). Funder's website: http://www.nutrition.ac.cn/PI/PI_lihx.asp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Davies P, 2010, AM J RESP CRIT CARE, V181, P94, DOI 10.1164/ajrccm.181.1.94a; Dawson-Hughes B, 2010, OSTEOPOROSIS INT, V21, P1151, DOI 10.1007/s00198-010-1285-3; Demetriou ETW, 2012, ENDOCR PRACT, V18, P399, DOI 10.4158/EP11268.OR; Dorjgochoo T, 2012, BRIT J NUTR, V108, P449, DOI 10.1017/S0007114511005745; Douglas AS, 1995, J EPIDEMIOL COMMUN H, V49, P575, DOI 10.1136/jech.49.6.575; Du XQ, 2001, AM J CLIN NUTR, V74, P494; Gibney KB, 2008, CLIN INFECT DIS, V46, P443, DOI 10.1086/525268; Ginde AA, 2009, ARCH INTERN MED, V169, P626, DOI 10.1001/archinternmed.2008.604; Holick MF, 2004, AM J CLIN NUTR, V80, p1678S, DOI 10.1093/ajcn/80.6.1678S; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Hong W, 2011, CHIN J OSTEOPOROSIS, V4, P224; Jacques PF, 1997, AM J CLIN NUTR, V66, P929, DOI 10.1093/ajcn/66.4.929; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; MACLAUGHLIN J, 1985, J CLIN INVEST, V76, P1536, DOI 10.1172/JCI112134; Mansoor S, 2010, CLIN BIOCHEM, V43, P1431, DOI 10.1016/j.clinbiochem.2010.09.022; MERKE J, 1989, J CLIN INVEST, V83, P1903, DOI 10.1172/JCI114097; Mithal A, 2009, OSTEOPOROSIS INT, V20, P1807, DOI 10.1007/s00198-009-0954-6; Nibbelink KA, 2007, J STEROID BIOCHEM, V103, P533, DOI 10.1016/j.jsbmb.2006.12.099; Pike JW, 2007, J BONE MINER RES, V22, pV16, DOI [10.1359/jbmr.07s207, 10.1359/JBMR.07S207]; Ralph AP, 2008, TRENDS MICROBIOL, V16, P336, DOI 10.1016/j.tim.2008.04.003; Ralph AR, 2013, LANCET INFECT DIS, V13, P77, DOI 10.1016/S1473-3099(12)70275-X; Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704; Rucker D, 2002, CAN MED ASSOC J, V166, P1517; Sai AJ, 2011, J CLIN ENDOCR METAB, V96, pE436, DOI 10.1210/jc.2010-1886; Scragg R, 2008, AM J EPIDEMIOL, V168, P577, DOI 10.1093/aje/kwn163; Shin SY, 2013, J CLIN LAB ANAL, V27, P284, DOI 10.1002/jcla.21598; VANDERWIELEN RPJ, 1995, LANCET, V346, P207, DOI 10.1016/S0140-6736(95)91266-5; [汪纯 WANG Chun], 2011, [上海医学, Shanghai Medical Journal], V34, P166; Wu-Wong JR, 2006, ATHEROSCLEROSIS, V186, P20, DOI 10.1016/j.atherosclerosis.2005.06.046; Zhu H, 2010, CHIN J OSTEOPROSIS B, V3, P157	31	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90729	10.1371/journal.pone.0090729	http://dx.doi.org/10.1371/journal.pone.0090729			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599155	gold, Green Submitted, Green Published			2022-12-27	WOS:000332479400127
J	Miller, NA; Chen, X; Stillman, JH				Miller, Nathan A.; Chen, Xi; Stillman, Jonathon H.			Metabolic Physiology of the Invasive Clam, Potamocorbula amurensis: The Interactive Role of Temperature, Salinity, and Food Availability	PLOS ONE			English	Article							SAN-FRANCISCO ESTUARY; FRESH-WATER FLOW; CALIFORNIA; ENZYMES; PHYTOPLANKTON; ENERGETICS; RESPONSES; PROTEINS; PATTERNS; STRESS	In biological systems energy serves as the ultimate commodity, often determining species distributions, abundances, and interactions including the potential impact of invasive species on native communities. The Asian clam Potamocorbula amurensis invaded the San Francisco Estuary (SFE) in 1986 and is implicated in the decline of native fish species through resource competition. Using a combined laboratory/field study we examined how energy expenditure in this clam is influenced by salinity, temperature and food availability. Measures of metabolism were made at whole organism (metabolic rate) and biochemical (pyruvate kinase (PK) and citrate synthase (CS) enzyme activities) levels. We found in the field, over the course of a year, the ratio of PK to CS was typically 1.0 suggesting that aerobic and fermentative metabolism were roughly equivalent, except for particular periods characterized by low salinity, higher temperatures, and intermediate food availabilities. In a 30-day laboratory acclimation experiment, however, neither metabolic rate nor PK: CS ratio was consistently influenced by the same variables, though the potential for fermentative pathways did predominate. We conclude that in field collected animals, the addition of biochemical measures of energetic state provide little additional information to the previously measured whole organism metabolic rate. In addition, much of the variation in the laboratory remained unexplained and additional variables, including reproductive stage or body condition may influence laboratory-based results. Further study of adult clams must consider the role of organismal condition, especially reproductive state, in comparisons of laboratory experiments and field observations.	[Miller, Nathan A.; Chen, Xi; Stillman, Jonathon H.] San Francisco State Univ, Romberg Tiburon Ctr, Tiburon, CA USA; [Miller, Nathan A.; Chen, Xi; Stillman, Jonathon H.] San Francisco State Univ, Dept Biol, Tiburon, CA USA; [Stillman, Jonathon H.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	California State University System; San Francisco State University; California State University System; San Francisco State University; University of California System; University of California Berkeley	Miller, NA (corresponding author), San Francisco State Univ, Romberg Tiburon Ctr, Tiburon, CA USA.	natemiller77@gmail.com		Stillman, Jonathon/0000-0002-4783-3830	United States Department of the Interior, Bureau of Reclamation [R10AC-20074]	United States Department of the Interior, Bureau of Reclamation	This research was supported by the United States Department of the Interior, Bureau of Reclamation, Cooperative Agreement Number R10AC-20074. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALPINE AE, 1992, LIMNOL OCEANOGR, V37, P946, DOI 10.4319/lo.1992.37.5.0946; BAYNE B, 1973, Netherlands Journal of Sea Research, V7, P399, DOI 10.1016/0077-7579(73)90061-6; BLACKSTOCK J, 1980, J EXP MAR BIOL ECOL, V46, P197, DOI 10.1016/0022-0981(80)90031-3; CARLTON JT, 1990, MAR ECOL PROG SER, V66, P81, DOI 10.3354/meps066081; Castillo-Duran A, 2013, REV BIOL MAR OCEANOG, V48, P59, DOI 10.4067/S0718-19572013000100006; CHIH CP, 1987, COMP BIOCHEM PHYS B, V86, P541, DOI 10.1016/0305-0491(87)90445-7; Cullen M, 2003, DEEP-SEA RES PT II, V50, P1787, DOI 10.1016/S0967-0645(03)00088-2; Dahlhoff EP, 2004, ANNU REV PHYSIOL, V66, P183, DOI 10.1146/annurev.physiol.66.032102.114509; Dahlhoff EP, 2002, INTEGR COMP BIOL, V42, P862, DOI 10.1093/icb/42.4.862; Feyrer F, 2007, CAN J FISH AQUAT SCI, V64, P723, DOI 10.1139/F07-048; Fly EK, 2013, OECOLOGIA, V172, P35, DOI 10.1007/s00442-012-2486-6; Greene VE, 2011, MAR ECOL PROG SER, V431, P183, DOI 10.3354/meps09099; Hochachka P. W., 2002, BIOCH ADAPTATION MEC, DOI 10.1002/bmb.2002.494030030071; Kearney MR, 2012, J EXP BIOL, V215, P922, DOI 10.1242/jeb.059634; Kilham SS, 1998, HYDROBIOLOGIA, V377, P147, DOI 10.1023/A:1003231628456; Kimmerer WJ, 2009, ESTUAR COAST, V32, P375, DOI 10.1007/s12237-008-9124-x; KIMMERER WJ, 1994, MAR ECOL PROG SER, V113, P81, DOI 10.3354/meps113081; Kimmerer WJ, 2002, MAR ECOL PROG SER, V243, P39, DOI 10.3354/meps243039; Lesser MP, 2004, COMP BIOCHEM PHYS A, V137, P495, DOI 10.1016/j.cbpb.2003.10.022; Lockwood BL, 2011, J EXP MAR BIOL ECOL, V400, P167, DOI 10.1016/j.jembe.2011.02.022; Miller NA, 2013, MAR ECOL PROG SER, V476, P129, DOI 10.3354/meps10149; Moschino V, 2006, COMP BIOCHEM PHYS A, V145, P433, DOI 10.1016/j.cbpa.2006.07.021; Nisbet RM, 2012, J EXP BIOL, V215, P892, DOI 10.1242/jeb.059675; Orsi James J., 1996, P375; Paganini A, 2010, AQUAT BIOL, V11, P139, DOI 10.3354/ab00304; Parchaso Francis, 2002, Pacific Science, V56, P329, DOI 10.1353/psc.2002.0027; R Core Team, 2021, R LANGUAGE ENV STAT; Somero GN, 2012, ANNU REV MAR SCI, V4, P39, DOI 10.1146/annurev-marine-120710-100935; Werner I, 2004, MAR ENVIRON RES, V58, P803, DOI 10.1016/j.marenvres.2004.03.097; WERNER I, 1993, LIMNOL OCEANOGR, V38, P949, DOI 10.4319/lo.1993.38.5.0949; Werner I, 2000, MAR ENVIRON RES, V50, P379, DOI 10.1016/S0141-1136(00)00058-1; Werner I, 1999, BIOMARKERS, V4, P473, DOI 10.1080/135475099230633; Wilkerson FP, 2006, ESTUAR COAST, V29, P401, DOI 10.1007/BF02784989; Zuur Alain F., 2009, P1	34	7	7	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e91064	10.1371/journal.pone.0091064	http://dx.doi.org/10.1371/journal.pone.0091064			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599347	gold, Green Published, Green Submitted			2022-12-27	WOS:000332479400153
J	Sepp, D; Franz, D; Triftshaeuser, N; Ott, I; Esposito-Bauer, L; Feurer, R; Seifert, CL; Thaler, M; Hemmer, B; Poppert, H				Sepp, Dominik; Franz, Daniela; Triftshaeuser, Natalie; Ott, Ilka; Esposito-Bauer, Lorena; Feurer, Regina; Seifert, Christian L.; Thaler, Markus; Hemmer, Bernhard; Poppert, Holger			Mobilization of CD133(+) Progenitor Cells in Patients with Acute Cerebral Infarction	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; CORONARY-ARTERY-DISEASE; ACUTE ISCHEMIC-STROKE; COA REDUCTASE INHIBITORS; ENDOTHELIAL-CELLS; PERIPHERAL-BLOOD; IN-VITRO; INCREASE; CD34; INTERLEUKIN-8	Progenitor cells (PCs) contribute to the endogenous repair mechanism after ischemic events. Interleukin-8 (IL-8) as part of the acute inflammatory reaction may enhance PC mobilization. Also, statins are supposed to alter number and function of circulating PCs. We aimed to investigate PC mobilization after acute ischemic stroke as well as its association with inflammatory markers and statin therapy. Sixty-five patients with ischemic stroke were enrolled in the study. The number of CD133(+) PCs was analyzed by flow cytometry. Blood samples were drawn within 24 hours after symptom onset and after 5 days. The number of CD133(+) PCs increased significantly within 5 days (p < 0.001). We found no correlation between CD133(+) PCs and the serum levels of IL-8, IL-6, or C-reactive protein (CRP). Multivariate analysis revealed that preexisting statin therapy correlated independently with the increase of CD133(+) PCs (p = 0.001). This study showed a mobilization of CD133(+) PCs in patients with acute cerebral infarction within 5 days after symptom onset. The early systemic inflammatory response did not seem to be a decisive factor in the mobilization of PCs. Preexisting statin therapy was associated with the increase in CD133(+) PCs, suggesting a potentially beneficial effect of statin therapy in patients with stroke.	[Sepp, Dominik; Triftshaeuser, Natalie; Esposito-Bauer, Lorena; Feurer, Regina; Seifert, Christian L.; Hemmer, Bernhard; Poppert, Holger] Tech Univ Munich, Klinikum Rechts Isar, Dept Neurol, D-80290 Munich, Germany; [Franz, Daniela] Tech Univ Munich, Klinikum Rechts Isar, Dept Radiol, D-80290 Munich, Germany; [Ott, Ilka] Tech Univ Munich, Deutsch Herzzentrum, Dept Cardiovasc Dis, D-80290 Munich, Germany; [Thaler, Markus] Tech Univ Munich, Klinikum Rechts Isar, Inst Clin Chem & Pathobiochem, D-80290 Munich, Germany	Technical University of Munich; Technical University of Munich; German Heart Center Berlin; German Heart Centre Munich; Technical University of Munich; Technical University of Munich	Sepp, D (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Dept Neurol, D-80290 Munich, Germany.	sepp@lrz.tum.de	Hemmer, Bernhard/GPX-8451-2022; Hemmer, Bernhard/AAT-8388-2021	Hemmer, Bernhard/0000-0001-5985-6784; Poppert, Holger/0000-0003-2189-7681; Junker, Daniela/0000-0002-7598-8485	MerckSerono; Bundesministerium fur Wirtschaft und Technologie; Bayer Schering; Novartis; Biogen Idec; Merck Serono; Teva Pharmaceutical Industries Ltd.; Roche and Genentech, Inc; Bayer Healthcare; Deutsche Stiftung Neurologie	MerckSerono(Merck & Company); Bundesministerium fur Wirtschaft und Technologie(Federal Ministry for Economic Affairs and Energy (BMWi)); Bayer Schering(Bayer AG); Novartis(Novartis); Biogen Idec(Biogen); Merck Serono(Merck & Company); Teva Pharmaceutical Industries Ltd.(Teva Pharmaceutical Industries); Roche and Genentech, Inc; Bayer Healthcare(Bayer AGBayer Healthcare Pharmaceuticals); Deutsche Stiftung Neurologie	D. Sepp received government research support (Bundesministerium fur Wirtschaft und Technologie) and received funding for travel from MerckSerono. R. Feurer received government research support (Bundesministerium fur Wirtschaft und Technologie). C. L. Seifert received government research support (Bundesministerium fur Wirtschaft und Technologie). B. Hemmer has served on scientific advisory boards for Roche, Novartis, Bayer Schering, and Genzyme Corporation; received funding for travel from Bayer Schering, Novartis, Biogen Idec, Merck Serono, Teva Pharmaceutical Industries Ltd., Roche and Genentech, Inc; serves on the international advisory board of Archives of Neurology, Nervenarzt and Experimental Neurology; has received speaker honoraria from Bayer Schering, Novartis, Biogen Idec, Merck Serono, and Teva Pharmaceutical Industries Ltd; serves as consultant to Genentech Inc., Micromet Inc., Roche, Chugai, GlaxoSmithKline and Novartis; and receives research support from Biogen Idec, Bayer Schering, Merck Serono and Novartis. H. Poppert has served on a scientific advisory board for Bayer Healthcare, received speaker honoraria from Bayer Healthcare, Boehringer Ingelheim, Novartis and Roche, received funding for travel from Bayer Healthcare, received government research support (Bundesministerium fur Wirtschaft und Technologie) and received research support from Deutsche Stiftung Neurologie. This does not alter our adherence to all the PLOS ONE policies on sharing data and materials.	Anand N, 2005, CEREBROVASC DIS, V20, P213, DOI 10.1159/000087701; Bogoslovsky T, 2010, NEUROLOGY, V75, P2059, DOI 10.1212/WNL.0b013e318200d741; BROWN J, 1991, INT IMMUNOL, V3, P175, DOI 10.1093/intimm/3.2.175; Deschaseaux F, 2007, EUR J PHARMACOL, V562, P111, DOI 10.1016/j.ejphar.2007.01.045; Dimmeler S, 2001, J CLIN INVEST, V108, P391, DOI 10.1172/JCI13152; Fan YF, 2008, J CEREBR BLOOD F MET, V28, P90, DOI 10.1038/sj.jcbfm.9600509; FINA L, 1990, BLOOD, V75, P2417; Gehling UM, 2000, BLOOD, V95, P3106; George J, 2004, EUR HEART J, V25, P1003, DOI 10.1016/j.ehj.2004.03.026; Grau AJ, 2001, J NEUROL SCI, V192, P41, DOI 10.1016/S0022-510X(01)00590-1; Grundmann F, 2007, CLIN RES CARDIOL, V96, P621, DOI 10.1007/s00392-007-0543-7; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Hristov M, 2007, ATHEROSCLEROSIS, V192, P413, DOI 10.1016/j.atherosclerosis.2006.05.031; Paczkowska E, 2009, STROKE, V40, P1237, DOI 10.1161/STROKEAHA.108.535062; Pruijt J F, 1999, Curr Opin Hematol, V6, P152, DOI 10.1097/00062752-199905000-00005; Ren Guofeng, 2003, Current Drug Targets - Inflammation and Allergy, V2, P242, DOI 10.2174/1568010033484098; Schomig K, 2006, EUR HEART J, V27, P1032, DOI 10.1093/eurheartj/ehi761; Sepp Dominik, 2009, J Angiogenes Res, V1, P10, DOI 10.1186/2040-2384-1-10; Shintani S, 2001, CIRCULATION, V103, P2776, DOI 10.1161/hc2301.092122; Taguchi A, 2004, J CLIN INVEST, V114, P330, DOI 10.1172/jci200420622; Taguchi A, 2004, CIRCULATION, V109, P2972, DOI 10.1161/01.CIR.0000133311.25587.DE; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953; Vasa M, 2001, CIRCULATION, V103, P2885, DOI 10.1161/hc2401.092816; Yip HK, 2008, STROKE, V39, P69, DOI 10.1161/STROKEAHA.107.489401; Zhou WJ, 2009, HYPERTENS RES, V32, P306, DOI 10.1038/hr.2009.16; Zohlnhofer D, 2006, JAMA-J AM MED ASSOC, V295, P1003, DOI 10.1001/jama.295.9.1003	26	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e70796	10.1371/journal.pone.0070796	http://dx.doi.org/10.1371/journal.pone.0070796			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599235	Green Published, Green Submitted, gold			2022-12-27	WOS:000332479400001
J	Spinner, M; Gorb, SN; Balmert, A; Bleckmann, H; Westhoff, G				Spinner, Marlene; Gorb, Stanislav N.; Balmert, Alexander; Bleckmann, Horst; Westhoff, Guido			Non-Contaminating Camouflage: Multifunctional Skin Microornamentation in the West African Gaboon Viper (Bitis rhinoceros)	PLOS ONE			English	Article							CONTACT ANGLES; SURFACE; LOTUS; WETTABILITY; TRANSITION; ROUGHNESS; POLAR; WINGS; WATER	The West African Gaboon viper (Bitis rhinoceros) has an extraordinary coloration of pale brown and velvety black markings. The velvety black appearance is caused by a unique hierarchical surface structures which was not found on the pale brown scales. In the present study we examined the wettability of the vipers scales by measuring contact angles of water droplets. Velvet black scale surfaces had high static contact angles beyond 160 degrees and low roll-off angles below 20 degrees indicating an outstanding superhydrophobicity. Our calculations showed that the Cassie-Baxter model describes well wettability effects for these surfaces. Self-cleaning capabilities were determined by contaminating the scales with particles and fogging them until droplets formed. Black scales were clean after fogging, while pale scales stayed contaminated. Black scales feature multifunctional structures providing not only water-repellent but also self-cleaning properties. The pattern of nanoridges can be used as a model for surface-active technical surfaces.	[Spinner, Marlene; Gorb, Stanislav N.] Univ Kiel, Inst Zool, D-24098 Kiel, Germany; [Balmert, Alexander; Bleckmann, Horst; Westhoff, Guido] Univ Bonn, Inst Zool, Bonn, Germany	University of Kiel; University of Bonn	Spinner, M (corresponding author), Univ Kiel, Inst Zool, D-24098 Kiel, Germany.	mspinner@zoologie.uni-kiel.de			German Science Foundation (DFG Graduiertenkolleg Bionik) [GRK 1572]; Federal Ministry of Education, Science and Technology, Germany (BMBF) [01RB0812]; German Science Foundation (DFG) 'Biomimetic Materials Research: Functionality by Hierarchical Structuring of Materials' [SPP 1420, GO 995/9-3]	German Science Foundation (DFG Graduiertenkolleg Bionik)(German Research Foundation (DFG)); Federal Ministry of Education, Science and Technology, Germany (BMBF)(Federal Ministry of Education & Research (BMBF)); German Science Foundation (DFG) 'Biomimetic Materials Research: Functionality by Hierarchical Structuring of Materials'(German Research Foundation (DFG))	This work was partially supported by the German Science Foundation (DFG Graduiertenkolleg Bionik, GRK 1572) to GW and HB, by the Federal Ministry of Education, Science and Technology, Germany (BMBF project Biona 01RB0812) to GW, and by the SPP 1420 priority programme of German Science Foundation (DFG) 'Biomimetic Materials Research: Functionality by Hierarchical Structuring of Materials' (project GO 995/9-3) to SG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Autumn K, 2006, J COMP PHYSIOL A, V192, P1205, DOI 10.1007/s00359-006-0149-y; Balmert A, 2011, J MORPHOL, V272, P442, DOI 10.1002/jmor.10921; Barbieri L, 2007, LANGMUIR, V23, P1723, DOI 10.1021/la0617964; Barthlott W, 1997, PLANTA, V202, P1, DOI 10.1007/s004250050096; Bhushan B, 2007, ULTRAMICROSCOPY, V107, P1033, DOI 10.1016/j.ultramic.2007.05.002; Bormashenko E, 2007, J COLLOID INTERF SCI, V311, P212, DOI 10.1016/j.jcis.2007.02.049; BURKEN RR, 1985, COMP BIOCHEM PHYS B, V81, P315, DOI 10.1016/0305-0491(85)90319-0; BUSSCHER HJ, 1984, COLLOID SURFACE, V9, P319, DOI 10.1016/0166-6622(84)80175-4; Cassie ABD, 1944, T FARADAY SOC, V40, P0546, DOI 10.1039/tf9444000546; Erbil HY, 1997, LANGMUIR, V13, P5484, DOI 10.1021/la9620521; Extrand CW, 2004, LANGMUIR, V20, P5013, DOI 10.1021/la036481s; Extrand CW, 2002, LANGMUIR, V18, P7991, DOI 10.1021/la025769z; FOWKES FM, 1964, IND ENG CHEM, V56, P40, DOI 10.1021/ie50660a008; Furstner R, 2005, LANGMUIR, V21, P956, DOI 10.1021/la0401011; Goodwyn PP, 2009, NATURWISSENSCHAFTEN, V96, P781, DOI 10.1007/s00114-009-0531-z; Hiller UN, 2009, FUNCTIONAL SURFACES IN BIOLOGY, VOL 1, P47, DOI 10.1007/978-1-4020-6697-9_4; HOLDGATE MW, 1955, J EXP BIOL, V32, P591; KAELBLE DH, 1970, J ADHESION, V2, P66, DOI 10.1080/0021846708544582; Klein MCG, 2012, J R SOC INTERFACE, V9, P3140, DOI 10.1098/rsif.2012.0479; Lafuma A, 2003, NAT MATER, V2, P457, DOI 10.1038/nmat924; Li W, 2008, SOFT MATTER, V4, P462, DOI 10.1039/b715731b; Li W, 2007, ADV COLLOID INTERFAC, V132, P51, DOI 10.1016/j.cis.2007.01.001; MADERSON PFA, 1978, J EXP ZOOL, V204, P11, DOI 10.1002/jez.1402040103; Marmur A, 2004, LANGMUIR, V20, P3517, DOI 10.1021/la036369u; Marmur A, 2006, SOFT MATTER, V2, P12, DOI 10.1039/b514811c; Nosonovsky M, 2007, LANGMUIR, V23, P3157, DOI 10.1021/la062301d; Oner D, 2000, LANGMUIR, V16, P7777, DOI 10.1021/la000598o; OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815; Patankar NA, 2004, LANGMUIR, V20, P8209, DOI 10.1021/la048629t; Patankar NA, 2004, LANGMUIR, V20, P7097, DOI 10.1021/la049329e; Rabel W., 1977, Physikalische Blaetter, V33, P151, DOI 10.1002/phbl.19770330402; SILBERGLIED R, 1980, SCIENCE, V207, P773, DOI 10.1126/science.207.4432.773; Spawls S., 1995, DANGEROUS SNAKES AFR; Spinner M, 2013, SCI REP-UK, V3, DOI 10.1038/srep01846; Sun G, 2009, J BIONIC ENG, V6, P71, DOI 10.1016/S1672-6529(08)60094-3; Toni M, 2007, ZOOLOGY, V110, P41, DOI 10.1016/j.zool.2006.07.001; Voigt D, 2011, ZOOLOGY, V114, P265, DOI 10.1016/j.zool.2011.05.004; Wagner T, 1996, ACTA ZOOL-STOCKHOLM, V77, P213, DOI 10.1111/j.1463-6395.1996.tb01265.x; Wenzel RN, 1936, IND ENG CHEM, V28, P988, DOI 10.1021/ie50320a024; Young T., 1805, PHILOS T R SOC LONDO, V95, P65, DOI [10.1098/rstl.1805.0005, DOI 10.1098/RSTL.1805.0005]; Zenkiewicz M., 2007, J ACHIEV MAT MANUF E, V24, P137	41	21	21	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e91087	10.1371/journal.pone.0091087	http://dx.doi.org/10.1371/journal.pone.0091087			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599379	Green Submitted, gold, Green Published			2022-12-27	WOS:000332479400154
J	Yao, Y; Marchal, K; Van de Peer, Y				Yao, Yao; Marchal, Kathleen; Van de Peer, Yves			Improving the Adaptability of Simulated Evolutionary Swarm Robots in Dynamically Changing Environments	PLOS ONE			English	Article							ARTIFICIAL NEURAL-NETWORKS; ADAPTATION; GENES; LIFE	One of the important challenges in the field of evolutionary robotics is the development of systems that can adapt to a changing environment. However, the ability to adapt to unknown and fluctuating environments is not straightforward. Here, we explore the adaptive potential of simulated swarm robots that contain a genomic encoding of a bio-inspired gene regulatory network (GRN). An artificial genome is combined with a flexible agent-based system, representing the activated part of the regulatory network that transduces environmental cues into phenotypic behaviour. Using an artificial life simulation framework that mimics a dynamically changing environment, we show that separating the static from the conditionally active part of the network contributes to a better adaptive behaviour. Furthermore, in contrast with most hitherto developed ANN-based systems that need to re-optimize their complete controller network from scratch each time they are subjected to novel conditions, our system uses its genome to store GRNs whose performance was optimized under a particular environmental condition for a sufficiently long time. When subjected to a new environment, the previous condition-specific GRN might become inactivated, but remains present. This ability to store 'good behaviour' and to disconnect it from the novel rewiring that is essential under a new condition allows faster re-adaptation if any of the previously observed environmental conditions is reencountered. As we show here, applying these evolutionary-based principles leads to accelerated and improved adaptive evolution in a non-stable environment.	[Yao, Yao; Van de Peer, Yves] Univ Ghent VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium; [Yao, Yao; Marchal, Kathleen; Van de Peer, Yves] Univ Ghent, Dept Plant Biotechnol & Bioinformat, B-9000 Ghent, Belgium; [Yao, Yao; Marchal, Kathleen] Katholieke Univ Leuven, Dept Microbial & Mol Syst, Louvain, Belgium; [Marchal, Kathleen] Univ Ghent, iMinds, Dept Informat Technol, B-9000 Ghent, Belgium; [Van de Peer, Yves] Univ Pretoria, Dept Genet, Genom Res Inst, ZA-0002 Pretoria, South Africa	Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; KU Leuven; Ghent University; IMEC; University of Pretoria	Marchal, K (corresponding author), Univ Ghent, Dept Plant Biotechnol & Bioinformat, B-9000 Ghent, Belgium.	kathleen.marchal@intec.ugent.be; yves.vandepeer@psb.ugent.be	Van de Peer, Yves/D-4388-2009; Marchal, Kathleen/O-7936-2017; Marchal, Kathleen/B-5001-2013; Van de Peer, Yves/AAE-7666-2019	Van de Peer, Yves/0000-0003-4327-3730; Marchal, Kathleen/0000-0002-2169-4588; Marchal, Kathleen/0000-0002-2169-4588; Van de Peer, Yves/0000-0003-4327-3730	European Commission within the Work Program "Future and Emergent Technologies Proactive" [216342 (Symbrion)]; Ghent University; European Research Council under the European Union/ERC [322739 - DOUBLE-UP]; KU Leuven: project NATAR [GOA/08/011]; Agentschap voor Innovatie door Wetenschap en Technologie (IWT): SBONEMOA; Fonds Wetenschappelijk Onderzoek-Vlaanderen (FWO) [IOK-B9725-G.0329.09]	European Commission within the Work Program "Future and Emergent Technologies Proactive"; Ghent University(Ghent University); European Research Council under the European Union/ERC(European Research Council (ERC)); KU Leuven: project NATAR; Agentschap voor Innovatie door Wetenschap en Technologie (IWT): SBONEMOA; Fonds Wetenschappelijk Onderzoek-Vlaanderen (FWO)(FWO)	The authors acknowledge the support of the European Commission within the Work Program "Future and Emergent Technologies Proactive" under the grant agreement no. 216342 (Symbrion) and Ghent University (Multidisciplinary Research Partnership 'Bioinformatics: from nucleotides to networks'. YVdP acknowledges support from the European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013)/ERC Advanced Grant Agreement n. 322739 - DOUBLE-UP. KM acknowledges support from KU Leuven: GOA/08/011, project NATAR; Agentschap voor Innovatie door Wetenschap en Technologie (IWT): SBONEMOA; Fonds Wetenschappelijk Onderzoek-Vlaanderen (FWO) IOK-B9725-G.0329.09. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed E, 2005, MANSOURA J MATH, V32, P6059; Bedau MA, 2003, TRENDS COGN SCI, V7, P505, DOI 10.1016/j.tics.2003.09.012; Bennett MR, 2008, NATURE, V454, P1119, DOI 10.1038/nature07211; Bentley P, 1999, GECCO-99: PROCEEDINGS OF THE GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, P35; Bongard J, 2002, IEEE C EVOL COMPUTAT, P1872, DOI 10.1109/CEC.2002.1004528; Bredeche N, 2010, LECT NOTES COMPUT SC, V5975, P110, DOI 10.1007/978-3-642-14156-0_10; Conrad M, 1995, COMPUTERKULTUR, V2, P261; DOUGLAS HC, 1966, GENETICS, V54, P911; Draghi JA, 2011, NATURE, V474, P45, DOI 10.1038/474045a; Durr P, 2006, LECT NOTES COMPUT SC, V4193, P671; Floreano D, 2001, AUTON ROBOT, V11, P311, DOI 10.1023/A:1012459627968; Floreano D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000292; Floreano D, 2008, EVOL INTELL, V1, P47, DOI 10.1007/s12065-007-0002-4; Grefenstette JJ DR, 1996, SYMPOSIUM, P45; Guo HL, 2009, BIOSYSTEMS, V98, P193, DOI 10.1016/j.biosystems.2009.05.003; Hornby GS, 2002, ARTIF LIFE, V8, P223, DOI 10.1162/106454602320991837; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; James HA, 2004, RES LETT INFORM MATH, V6, P143; Kurakin A, 2009, THEOR BIOL MED MODEL, V6, DOI 10.1186/1742-4682-6-6; Lenski RE, 2003, NATURE, V423, P139, DOI 10.1038/nature01568; Linksvayer TA, 2012, J EXP ZOOL PART B, V318B, P159, DOI 10.1002/jez.b.22001; Lynch M, 2010, MOL BIOL EVOL, V27, P1404, DOI 10.1093/molbev/msq020; Mattiussi C, 2011, J COMPUT SCI-NETH, V2, P165, DOI 10.1016/j.jocs.2011.01.007; Mitchell A, 2009, NATURE, V460, P220, DOI 10.1038/nature08112; Polvichai J BU, 2011, SOFTWARE ENG, P166; Reil T, 1999, LECT NOTES ARTIF INT, V1674, P457; Rosenberg SM, 2001, NAT REV GENET, V2, P504, DOI 10.1038/35080556; Stanley KO, 2003, ARTIF LIFE, V9, P93, DOI 10.1162/106454603322221487; Stanley KO, 2002, EVOL COMPUT, V10, P99, DOI 10.1162/106365602320169811; Subagdja B, 2009, AAMAS 09 P 8 INT C A, V2, P1081; Tanner CJ, 2012, J ANIM ECOL, V81, P260, DOI 10.1111/j.1365-2656.2011.01879.x; Tononi G, 1999, P NATL ACAD SCI USA, V96, P3257, DOI 10.1073/pnas.96.6.3257; Wagner GP, 1996, EVOLUTION, V50, P967, DOI [10.2307/2410639, 10.1111/j.1558-5646.1996.tb02339.x]; Weng JY, 2001, SCIENCE, V291, P599, DOI 10.1126/science.291.5504.599; Yao X, 1998, APPL MATH COMPUT, V91, P83, DOI 10.1016/S0096-3003(97)10005-4; Yu JB, 2008, NEUROCOMPUTING, V71, P1054, DOI 10.1016/j.neucom.2007.10.013	36	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90695	10.1371/journal.pone.0090695	http://dx.doi.org/10.1371/journal.pone.0090695			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599485	Green Published, gold, Green Submitted			2022-12-27	WOS:000332479400118
J	Berg, M; Michalowski, A; Palzer, S; Rupp, S; Sohn, K				Berg, Michael; Michalowski, Annette; Palzer, Silke; Rupp, Steffen; Sohn, Kai			An In Vivo Photo-Cross-Linking Approach Reveals a Homodimerization Domain of Aha1 in S. cerevisiae	PLOS ONE			English	Article							EXPANDED GENETIC-CODE; ESCHERICHIA-COLI; AMINO-ACID; SACCHAROMYCES-CEREVISIAE; COCHAPERONE AHA1; YEAST PROTEOME; PROTEINS; HSP90; CELLS; SITE	Protein-protein interactions play an essential role in almost any biological processes. Therefore, there is a particular need for methods which describe the interactions of a defined target protein in its physiological context. Here we report a method to photo-cross-link interacting proteins in S. cerevisiae by using the non-canonical amino acid p-azido-L-phenylalanine (pAzpa). Based on the expanded genetic code the photoreactive non-canonical amino acid pAzpa was site-specifically incorporated at eight positions into a domain of Aha1 that was previously described to bind Hsp90 in vitro to function as a cochaperone of Hsp90 and activates its ATPase activity. In vivo photo-cross-linking to the cognate binding partner of Aha1 was carried out by irradiation of mutant strains with UV light (365 nm) to induce covalent intermolecular bonds. Surprisingly, an interaction between Aha1 and Hsp90 was not detected, although, we could confirm binding of suppressed pAzpa containing Aha1 to Hsp90 by native co-immunoprecipitation. However, a homodimer consisting of two covalently crosslinked Aha1 monomers was identified by mass spectrometry. This homodimer could also be confirmed using p-benzoyl-L-phenylalanine, another photoreactive non-canonical amino acid. Crosslinking was highly specific as it was dependent on irradiation using UV light, the exact position of the non-canonical amino acid in the protein sequence as well as on the addition of the non-canonical amino acid to the growth medium. Therefore it seems possible that an interaction of Aha1 with Hsp90 takes place at different positions than previously described in vitro highlighting the importance of in vivo techniques to study protein-protein interactions. Accordingly, the expanded genetic code can easily be applied to other S. cerevisiae proteins to study their interaction under physiological relevant conditions in vivo.	[Berg, Michael; Rupp, Steffen; Sohn, Kai] Fraunhofer IGB, Stuttgart, Germany; [Michalowski, Annette] Univ Stuttgart, IBVT, D-70174 Stuttgart, Germany; [Palzer, Silke] Univ Stuttgart, IGVP, D-70174 Stuttgart, Germany	University of Stuttgart; University of Stuttgart	Sohn, K (corresponding author), Fraunhofer IGB, Stuttgart, Germany.	kai.sohn@igb.fraunhofer.de			Fraunhofer grant "MEF Genoprot"	Fraunhofer grant "MEF Genoprot"	This work was supported by a Fraunhofer grant "MEF Genoprot". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agard NJ, 2006, ACS CHEM BIOL, V1, P644, DOI 10.1021/cb6003228; BORKOVICH KA, 1989, MOL CELL BIOL, V9, P3919, DOI 10.1128/MCB.9.9.3919; Chen HT, 2007, NAT STRUCT MOL BIOL, V14, P696, DOI 10.1038/nsmb1272; Chen S, 2007, J MOL BIOL, V371, P112, DOI 10.1016/j.jmb.2007.05.017; Chin JW, 2003, SCIENCE, V301, P964, DOI 10.1126/science.1084772; Chin JW, 2002, P NATL ACAD SCI USA, V99, P11020, DOI 10.1073/pnas.172226299; Chin JW, 2002, J AM CHEM SOC, V124, P9026, DOI 10.1021/ja027007w; Cho H, 2011, P NATL ACAD SCI USA, V108, P9060, DOI 10.1073/pnas.1100387108; Das S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.182931; Dennehey BK, 2013, MOL CELL BIOL, V33, P605, DOI 10.1128/MCB.01053-12; Dorman G, 2000, TRENDS BIOTECHNOL, V18, P64, DOI 10.1016/S0167-7799(99)01402-X; Forne I, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.012088; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Gietz R Daniel, 2006, Methods Mol Biol, V313, P107; Grunbeck A, 2011, BIOCHEMISTRY-US, V50, P3411, DOI 10.1021/bi200214r; Hino N, 2005, NAT METHODS, V2, P201, DOI 10.1038/NMETH739; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Krishnamurthy M, 2011, ACS CHEM BIOL, V6, P1321, DOI 10.1021/cb200308e; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lemke EA, 2007, NAT CHEM BIOL, V3, P769, DOI 10.1038/nchembio.2007.44; Liu CC, 2010, ANNU REV BIOCHEM, V79, P413, DOI 10.1146/annurev.biochem.052308.105824; Majmudar CY, 2009, J AM CHEM SOC, V131, P14240, DOI 10.1021/ja904378z; Meyer P, 2004, EMBO J, V23, P1402, DOI 10.1038/sj.emboj.7600141; Millson SH, 2005, EUKARYOT CELL, V4, P849, DOI 10.1128/EC.4.5.849-860.2005; Mollapour M, 2010, MOL CELL, V37, P333, DOI 10.1016/j.molcel.2010.01.005; Mori H, 2006, P NATL ACAD SCI USA, V103, P16159, DOI 10.1073/pnas.0606390103; Nehring S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031992; Palzer S, 2013, EUKARYOT CELL; Panaretou B, 2002, MOL CELL, V10, P1307, DOI 10.1016/S1097-2765(02)00785-2; Peters FB, 2009, CHEM BIOL, V16, P148, DOI 10.1016/j.chembiol.2009.01.013; Pham ND, 2012, CURR OPIN CHEM BIOL; Retzlaff M, 2010, MOL CELL, V37, P344, DOI 10.1016/j.molcel.2010.01.006; Seok WK, 2004, INORG CHEM, V43, P5205, DOI 10.1021/ic0302985; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Takimoto JK, 2009, MOL BIOSYST, V5, P931, DOI 10.1039/b904228h; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Wandinger SK, 2008, J BIOL CHEM, V283, P18473, DOI 10.1074/jbc.R800007200; Wang L, 2001, SCIENCE, V292, P498, DOI 10.1126/science.1060077; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Wittelsberger A, 2008, CHEM BIOL DRUG DES, V71, P380, DOI 10.1111/j.1747-0285.2008.00646.x; Wu JW, 1999, ACTA BIOCHIM POL, V46, P591, DOI 10.18388/abp.1999_4131; Xie JM, 2006, NAT REV MOL CELL BIO, V7, P775, DOI 10.1038/nrm2005; Young TS, 2009, BIOCHEMISTRY-US, V48, P2643, DOI 10.1021/bi802178k	45	12	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e89436	10.1371/journal.pone.0089436	http://dx.doi.org/10.1371/journal.pone.0089436			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614167	Green Published, Green Submitted, gold			2022-12-27	WOS:000332839300011
J	Sood, R; Flint-Ashtamker, G; Borenstein, D; Barki-Harrington, L				Sood, Rapita; Flint-Ashtamker, Galit; Borenstein, Dafna; Barki-Harrington, Liza			Upregulation of Prostaglandin Receptor EP1 Expression Involves Its Association with Cyclooxygenase-2	PLOS ONE			English	Article							PROSTANOID RECEPTORS; PROTEIN-DEGRADATION; ENDOTHELIAL-CELLS; ARACHIDONIC-ACID; E-2 RECEPTORS; LOCALIZATION; SUBTYPE; PATHWAY; DRUGS; CDNA	While many signals cause upregulation of the pro-inflammatory enzyme cyclooxygenase -2 (COX-2), much less is known about mechanisms that actively downregulate its expression. We have recently shown that the prostaglandin EP1 receptor reduces the expression of COX-2 in a pathway that facilitates its ubiquitination and degradation via the 26S proteasome. Here we show that an elevation of COX-2 intracellular levels causes an increase in the endogenous expression of prostaglandin EP1. The increase in EP1 levels does not occur at the transcriptional level, but is rather associated with complex formation between the receptor and COX-2, which occurs both in vitro and in mammalian tissues. The EP1-COX-2 complex is disrupted following binding of arachidonic acid to COX-2 and accompanied by a parallel reduction in EP1 levels. We propose that a transient interaction between COX-2 and EP1 constitutes a feedback loop whereby an increase in COX-2 expression elevates EP1, which ultimately acts to downregulate COX-2 by expediting its proteasomal degradation. Such a post translational mechanism may serve to control both the ligand-generating system of COX-2 and its reception system.	[Sood, Rapita; Flint-Ashtamker, Galit; Borenstein, Dafna; Barki-Harrington, Liza] Univ Haifa, Dept Human Biol, Fac Nat Sci, IL-31999 Haifa, Israel	University of Haifa	Barki-Harrington, L (corresponding author), Univ Haifa, Dept Human Biol, Fac Nat Sci, IL-31999 Haifa, Israel.	lbarki@psy.haifa.ac.il			United States-Israel Binational Scientific Foundation [2009246]	United States-Israel Binational Scientific Foundation	This study was funded by the United States-Israel Binational Scientific Foundation, project number 2009246. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhattacharya M, 1998, P NATL ACAD SCI USA, V95, P15792, DOI 10.1073/pnas.95.26.15792; Bhattacharya M, 1999, J BIOL CHEM, V274, P15719, DOI 10.1074/jbc.274.22.15719; Breyer RM, 2001, ANNU REV PHARMACOL, V41, P661, DOI 10.1146/annurev.pharmtox.41.1.661; Chen SF, 2013, J BIOL CHEM, V288, P33462, DOI 10.1074/jbc.M113.521799; Chen SF, 2010, J CELL BIOCHEM, V109, P356, DOI 10.1002/jcb.22407; Dannenberg AJ, 2001, LANCET ONCOL, V2, P544, DOI 10.1016/S1470-2045(01)00488-0; Dannenberg AJ, 2003, CANCER CELL, V4, P431, DOI 10.1016/S1535-6108(03)00310-6; Fujino H, 2003, J BIOL CHEM, V278, P12151, DOI 10.1074/jbc.M212665200; Gobeil F, 2002, CIRC RES, V90, P682, DOI 10.1161/01.RES.0000013303.17964.7A; Haddad A, 2012, J BIOL CHEM, V287, P17214, DOI 10.1074/jbc.M111.304220; HAIMOVITZFRIEDMAN A, 1991, CANCER RES, V51, P2552; Han C, 2006, J BIOL CHEM, V281, P24831, DOI 10.1074/jbc.M602201200; HARKER LA, 1986, CIRCULATION, V73, P206, DOI 10.1161/01.CIR.73.2.206; Ichikawa A, 1996, J LIPID MEDIAT CELL, V14, P83, DOI 10.1016/0929-7855(96)00512-3; Kang YJ, 2007, PROG LIPID RES, V46, P108, DOI 10.1016/j.plipres.2007.01.001; KATOH H, 1995, BBA-GEN SUBJECTS, V1244, P41, DOI 10.1016/0304-4165(94)00182-W; RIDKER PM, 1991, ANN INTERN MED, V114, P835, DOI 10.7326/0003-4819-114-10-835; Rouzer CA, 2003, CHEM REV, V103, P2239, DOI 10.1021/cr000068x; Rouzer CA, 2009, J LIPID RES, V50, pS29, DOI 10.1194/jlr.R800042-JLR200; Rowlinson SW, 1999, J BIOL CHEM, V274, P23305, DOI 10.1074/jbc.274.33.23305; Sharma NP, 2010, MOL PHARMACOL, V77, P979, DOI 10.1124/mol.109.063115; Smith T, 2000, J BIOL CHEM, V275, P40407, DOI 10.1074/jbc.M005563200; Smith WL, 2001, J CLIN INVEST, V107, P1491, DOI 10.1172/JCI13271; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Sugimoto Y, 2007, J BIOL CHEM, V282, P11613, DOI 10.1074/jbc.R600038200; WATABE A, 1993, J BIOL CHEM, V268, P20175; Zhang L, 2007, MOL CELL BIOCHEM, V305, P19, DOI 10.1007/s11010-007-9523-5; Zidar N, 2008, J CELL MOL MED	28	8	8	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91018	10.1371/journal.pone.0091018	http://dx.doi.org/10.1371/journal.pone.0091018			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614038	Green Submitted, gold, Green Published			2022-12-27	WOS:000332839300065
J	Duvvuri, VR; Duvvuri, B; Alice, C; Wu, GE; Gubbay, JB; Wu, JH				Duvvuri, Venkata R.; Duvvuri, Bhargavi; Alice, Christilda; Wu, Gillian E.; Gubbay, Jonathan B.; Wu, Jianhong			Preexisting CD4+T-Cell Immunity in Human Population to Avian Influenza H7N9 Virus: Whole Proteome-Wide Immunoinformatics Analyses	PLOS ONE			English	Article							T-CELL RESPONSE; EPITOPE-BASED DIAGNOSTICS; A H7N9; SEASONAL INFLUENZA; VACCINE TARGETS; HUMAN INFECTION; ORIGIN; CHINA; PROTECTION; IMMUNOGENICITY	In 2013, a novel avian influenza H7N9 virus was identified in human in China. The antigenically distinct H7N9 surface glycoproteins raised concerns about lack of cross-protective neutralizing antibodies. Epitope-specific preexisting T-cell immunity was one of the protective mechanisms in pandemic 2009 H1N1 even in the absence of cross-protective antibodies. Hence, the assessment of preexisting CD4+ T-cell immunity to conserved epitopes shared between H7N9 and human influenza A viruses (IAV) is critical. A comparative whole proteome-wide immunoinformatics analysis was performed to predict the CD4+ T-cell epitopes that are commonly conserved within the proteome of H7N9 in reference to IAV subtypes (H1N1, H2N2, and H3N2). The CD4+ T-cell epitopes that are commonly conserved (similar to 556) were further screened against the Immune Epitope Database (IEDB) to validate their immunogenic potential. This analysis revealed that 45.5% (253 of 556) epitopes are experimentally proven to induce CD4+ T-cell memory responses. In addition, we also found that 23.3% of CD4+ T-cell epitopes have >= 90% of sequence homology with experimentally defined CD8+ T-cell epitopes. We also conducted the population coverage analysis across different ethnicities using commonly conserved CD4+ T-cell epitopes and corresponding HLA-DRB1 alleles. Interestingly, the indigenous populations from Canada, United States, Mexico and Australia exhibited low coverage (28.65% to 45.62%) when compared with other ethnicities (57.77% to 94.84%). In summary, the present analysis demonstrate an evidence on the likely presence of preexisting T-cell immunity in human population and also shed light to understand the potential risk of H7N9 virus among indigenous populations, given their high susceptibility during previous pandemic influenza events. This information is crucial for public health policy, in targeting priority groups for immunization programs.	[Duvvuri, Venkata R.; Duvvuri, Bhargavi; Alice, Christilda; Wu, Jianhong] York Inst Hlth Res, Ctr Dis Modelling, Toronto, ON, Canada; [Gubbay, Jonathan B.] Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Wu, Gillian E.; Wu, Jianhong] York Univ, Toronto, ON M3J 2R7, Canada; [Gubbay, Jonathan B.] Publ Hlth Ontario, Toronto, ON, Canada; [Gubbay, Jonathan B.] Univ Toronto, Toronto, ON, Canada; [Gubbay, Jonathan B.] Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada	York University - Canada; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); York University - Canada; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto	Duvvuri, VR (corresponding author), York Inst Hlth Res, Ctr Dis Modelling, Toronto, ON, Canada.	venkata.r.duvvuri@gmail.com	Duvvuri, Bhargavi/H-3443-2019; Wu, Jian/AAU-5221-2020; wu, ge/ABE-3285-2020; Duvvuri, Venkata R/H-2728-2019; Gubbay, Jonathan/Q-8580-2019; Wu, Jian/AAU-5221-2020	Duvvuri, Bhargavi/0000-0002-8717-0584; Wu, Jian/0000-0001-9933-7364; Duvvuri, Venkata R/0000-0001-7356-338X; Gubbay, Jonathan/0000-0003-0026-3786; Wu, Jian/0000-0002-3394-1507	Canada Research Chairs program; Natural Sciences and Engineering Research Council of Canada; International Development Research Centre	Canada Research Chairs program(Canada Research Chairs); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); International Development Research Centre	This work was supported by the Canada Research Chairs program, The Natural Sciences and Engineering Research Council of Canada and International Development Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlers JD, 1997, P NATL ACAD SCI USA, V94, P10856, DOI 10.1073/pnas.94.20.10856; Assarsson E, 2008, J VIROL, V82, P12241, DOI 10.1128/JVI.01563-08; Ayyoub M, 2005, CLIN IMMUNOL, V114, P70, DOI 10.1016/j.clim.2004.08.014; Boggild AK, 2011, CAN J PUBLIC HEALTH, V102, P345, DOI 10.1007/BF03404174; Brooks EG, 2012, J FORENSIC SCI, V57, P1512, DOI 10.1111/j.1556-4029.2012.02163.x; Bui HH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-361; Bui HH, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-153; CARRENO BM, 1992, J IMMUNOL, V148, P894; Cheng VCC, 2012, CLIN MICROBIOL REV, V25, P223, DOI 10.1128/CMR.05012-11; De Groot AS, 2013, HUM VACC IMMUNOTHER, V9, P950, DOI 10.4161/hv.24939; De Groot AS, 2009, VACCINE, V27, P5740, DOI 10.1016/j.vaccine.2009.07.040; Dennis KM, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3693; Duvvuri VR, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-204; Duvvuri VR, 2012, VACCINE, V30, P6054, DOI 10.1016/j.vaccine.2012.07.054; Duvvuri VRSK, 2010, INFLUENZA OTHER RESP, V4, P249, DOI 10.1111/j.1750-2659.2010.00161.x; Galli G, 2009, P NATL ACAD SCI USA, V106, P3877, DOI 10.1073/pnas.0813390106; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Greenbaum JA, 2009, P NATL ACAD SCI USA, V106, P20365, DOI 10.1073/pnas.0911580106; Heiny AT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001190; Hertz T, 2013, P NATL ACAD SCI USA, V110, P13492, DOI 10.1073/pnas.1221555110; Kageyama T, 2013, EUROSURVEILLANCE, V18, P7; Karosiene E, 2013, IMMUNOGENETICS, V65, P711, DOI 10.1007/s00251-013-0720-y; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Khan AM, 2006, CELL IMMUNOL, V244, P141, DOI 10.1016/j.cellimm.2007.02.005; Kumar A, 2009, JAMA-J AM MED ASSOC, V302, P1872, DOI 10.1001/jama.2009.1496; La Ruche G, 2009, EUROSURVEILLANCE, V14, P51; Li Q., 2013, N ENGL J ME IN PRESS; Lin HH, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S12-S22; Lindstrom S, 2012, EMERG INFECT DIS, V18, P834, DOI 10.3201/eid1805.111922; Liu D, 2013, LANCET, V381, P1926, DOI 10.1016/S0140-6736(13)60938-1; Lv HK, 2013, EMERG INFECT DIS, V19, P1885, DOI 10.3201/eid1911.130717; McElhaney JE, 2006, J IMMUNOL, V176, P6333, DOI 10.4049/jimmunol.176.10.6333; MCMICHAEL AJ, 1983, NEW ENGL J MED, V309, P13, DOI 10.1056/NEJM198307073090103; Qi X, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4752; Quinones-Parra S, 2014, P NATL ACAD SCI US; Reed C, 2009, EMERG INFECT DIS, V15, P2004, DOI 10.3201/eid1512.091413; Richards KA, 2010, J IMMUNOL, V185, P4998, DOI 10.4049/jimmunol.1001395; Roti M, 2008, J IMMUNOL, V180, P1758, DOI 10.4049/jimmunol.180.3.1758; Schaffer A, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-869; Trauer JM, 2013, EMERG INFECT DIS, V19, P92, DOI 10.3201/eid1901.111643; TUITE AR, 2009, CMAJ, V182, P131, DOI DOI 10.1503/CMAJ.091807; Uyeki TM, 2013, NEW ENGL J MED, V368, P1862, DOI 10.1056/NEJMp1304661; Vita R, 2010, NUCLEIC ACIDS RES, V38, pD854, DOI 10.1093/nar/gkp1004; Webby RJ, 2003, P NATL ACAD SCI USA, V100, P7235, DOI 10.1073/pnas.1232449100; Weinfurter JT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002381; Wilkinson TM, 2012, NAT MED, V18, P274, DOI 10.1038/nm.2612; World Health Organization, BACKGR SUMM HUM INF; Yang SG, 2014, J INFECT DIS, V209, P265, DOI 10.1093/infdis/jit430; Zarychanski R, 2010, CAN MED ASSOC J, V182, P257, DOI 10.1503/cmaj.091884; Zhu YF, 2013, LANCET, V381, P2134, DOI 10.1016/S0140-6736(13)61135-6; Zwaveling S, 2002, J IMMUNOL, V169, P350, DOI 10.4049/jimmunol.169.1.350	51	10	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91273	10.1371/journal.pone.0091273	http://dx.doi.org/10.1371/journal.pone.0091273			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24609014	Green Published, gold, Green Submitted			2022-12-27	WOS:000332485800120
J	Kamperman, AM; Henrichs, J; Bogaerts, S; Lesaffre, EMEH; Wierdsma, AI; Ghauharali, RRR; Swildens, W; Nijssen, Y; van der Gaag, M; Theunissen, JR; Delespaul, PA; van Weeghel, J; van Busschbach, JT; Kroon, H; Teplin, LA; van de Mheen, D; Mulder, CL				Kamperman, Astrid M.; Henrichs, Jens; Bogaerts, Stefan; Lesaffre, Emmanuel M. E. H.; Wierdsma, Andre I.; Ghauharali, Razia R. R.; Swildens, Wilma; Nijssen, Yolanda; van der Gaag, Mark; Theunissen, Jan R.; Delespaul, Philippe A.; van Weeghel, Jaap; van Busschbach, Jooske T.; Kroon, Hans; Teplin, Linda A.; van de Mheen, Dike; Mulder, Cornelis L.			Criminal Victimisation in People with Severe Mental Illness: A Multi-Site Prevalence and Incidence Survey in the Netherlands	PLOS ONE			English	Article							SUBSTANCE USE DISORDERS; VIOLENT VICTIMIZATION; SEXUAL ASSAULT; WOMEN; HOMELESS; TRAUMA; COMMUNITY; ADULTS; RISK	Background: Although crime victimisation is as prevalent in psychiatric patients as crime perpetration (and possibly more so), few European figures for it are available. We therefore assessed its one-year prevalence and incident rates in Dutch severely mentally ill outpatients, and compared the results with victimisation rates in the general population. Method: This multisite epidemiological survey included a random sample of 956 adult severely mentally ill outpatients. Data on victimisation were obtained using the victimisation scale of the Dutch Crime and Victimisation Survey, which assesses crime victimisation over the preceding 12 months. Comparison data were derived from the nationwide survey on safety and victimisation in the Netherlands. Prevalence and incident rates were weighted for sex, age, ethnicity and socioeconomic status, and compared with a general population sample matched by region (N = 38,227). Results: In the past year, almost half of the severely mentally ill outpatients (47%) had been victim of a crime. After control for demographic differences, prevalence rates of overall and specific victimisation measures were significantly higher in severely mentally ill outpatients than in the general population. The relative rates were especially high for personal crimes such as violent threats (RR = 2.12, 95% CI: 1.72-2.61), physical assaults (RR = 4.85, 95% CI: 3.69-6.39) and sexual harassment and assaults (RR = 3.94, 95% CI: 3.05-5.09). In concordance, severely mentally ill outpatients reported almost 14 times more personal crime incidents than persons from the general population (IRR = 13.68, 95% CI: 12.85-14.56). Conclusion: Crime victimisation is a serious problem in Dutch severely mentally ill outpatients. Mental-healthcare institutions and clinicians should become aware of their patients' victimisation risk, and should implement structural measures to detect and prevent (re-)victimisation.	[Kamperman, Astrid M.; Wierdsma, Andre I.; Mulder, Cornelis L.] Erasmus MC, Dept Psychiat, Epidemiol & Social Psychiat Res Inst, Rotterdam, Netherlands; [Henrichs, Jens; Bogaerts, Stefan] Tilburg Univ, Dept Dev Psychol, NL-5000 LE Tilburg, Netherlands; [Bogaerts, Stefan] FPC Kijvelanden, Karid, Roterdam, Netherlands; [Lesaffre, Emmanuel M. E. H.] Erasmus MC, Dept Biostat, Rotterdam, Netherlands; [Lesaffre, Emmanuel M. E. H.] Catholic Univ Louvain, L Biostat, B-3000 Louvain, Belgium; [Ghauharali, Razia R. R.] Dutch Crime & Victim Survey Desk, The Hague, Netherlands; [Swildens, Wilma] Altrecht Mental Hlth Care, Utrecht, Netherlands; [Nijssen, Yolanda; van Weeghel, Jaap] Dijk en Duin Mental Hlth Ctr, Parnassia Grp, Castricum, Netherlands; [van der Gaag, Mark] Parnassia Psychiat Inst, The Hague, Netherlands; [van der Gaag, Mark] Vrije Univ Amsterdam, Amsterdam, Netherlands; [van der Gaag, Mark] EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Theunissen, Jan R.] GGZinGeest Mental Hlth Care, Amsterdam, Netherlands; [Theunissen, Jan R.] Vrije Univ Amsterdam Med Ctr, Dept Psychiat, Amsterdam, Netherlands; [Delespaul, Philippe A.] Maastricht Univ Med Ctr, Sch Mental Hlth & Neurosci, Dept Psychiat & Psychol, Maastricht, Netherlands; [Delespaul, Philippe A.] Mondriaan Mental Hlth Care, Heerlen, Netherlands; [van Weeghel, Jaap] Tilburg Univ, Tilburg Sch Social & Behav Sci, Dept Tranzo, NL-5000 LE Tilburg, Netherlands; [van Busschbach, Jooske T.] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Groningen, Netherlands; [van Busschbach, Jooske T.] Windesheim Univ Appl Sci, Dept Movement & Educ, Zwolle, Netherlands; [Kroon, Hans] Trimbos Inst, Utrecht, Netherlands; [Teplin, Linda A.] Northwestern Univ, Dept Psychiat & Behav Sci, Feinberg Sch Med, Chicago, IL 60611 USA; [van de Mheen, Dike] IVO Addict Res Inst, Rotterdam, Netherlands; [van de Mheen, Dike] Erasmus MC, Rotterdam, Netherlands; [van de Mheen, Dike] Maastricht Univ, Dept Hlth Promot, Maastricht, Netherlands; [Mulder, Cornelis L.] BavoEuropoort, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Tilburg University; Erasmus University Rotterdam; Erasmus MC; Universite Catholique Louvain; Parnassia Psychiatric Institute; Parnassia Psychiatric Institute; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Maastricht University; Maastricht University Medical Centre (MUMC); Tilburg University; University of Groningen; Trimbos Institute; Northwestern University; Feinberg School of Medicine; Erasmus University Rotterdam; Erasmus MC; Maastricht University	Kamperman, AM (corresponding author), Erasmus MC, Dept Psychiat, Epidemiol & Social Psychiat Res Inst, Rotterdam, Netherlands.	a.kamperman@erasmusmc.nl	Delespaul, Philippe/E-8982-2011; Bogaerts, Stefan/H-2263-2013; Delespaul, Philippe/L-1396-2019; Mulder, Cornelis Lambert/HGU-3446-2022; Kamperman, Astrid/J-8046-2015; van der Gaag, Mark/A-6840-2008; Henrichs, Jens/H-7678-2013; Kroon, Hans/AAM-7959-2020; Kroon, Hans/I-5683-2016	Delespaul, Philippe/0000-0001-7420-0898; Bogaerts, Stefan/0000-0003-3776-3792; Delespaul, Philippe/0000-0001-7420-0898; Kamperman, Astrid/0000-0003-4455-6492; van der Gaag, Mark/0000-0002-3525-6415; Henrichs, Jens/0000-0003-2238-4060; Kroon, Hans/0000-0002-2259-1628; Wierdsma, Andre/0000-0002-0734-4776	NWO, Netherlands Organisation for Scientific Research [432-09-802]	NWO, Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO))	The study was funded by the NWO, Netherlands Organisation for Scientific Research (grant no. 432-09-802). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], SOC PSYCHIAT PSYCHIA, V47, P1581; Arseneault L, 2000, ARCH GEN PSYCHIAT, V57, P979, DOI 10.1001/archpsyc.57.10.979; Bachman R, 1995, VIOLENCE WOMEN ESTIM, P8; Bowling A, 2005, J PUBLIC HEALTH-UK, V27, P281, DOI 10.1093/pubmed/fdi031; BURNAM MA, 1988, J CONSULT CLIN PSYCH, V56, P843, DOI 10.1037/0022-006X.56.6.843; CBS, 2012, INT VEIL 2011; CBS, 2009, INT VEIL 2008; Choe JY, 2008, PSYCHIAT SERV, V59, P153, DOI 10.1176/ps.2008.59.2.153; CORRIGAN PW, 1994, HOSP COMMUNITY PSYCH, V45, P273; de Vries S, 2011, MAANDBLAD GEESTELIJK, V66, P8; Dean K, 2007, ACTA PSYCHIAT SCAND, V116, P345, DOI 10.1111/j.1600-0447.2007.01078.x; Delespaul P H, 2013, Tijdschr Psychiatr, V55, P427; Dieperink C, 2006, MAANDBLAD GEESTELIJK, V61, P228; Fabiano PM, 2003, J AM COLL HEALTH, V52, P105, DOI 10.1080/07448480309595732; Fortugno F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058142; Fujii DE, 2004, SCHIZOPHR RES, V69, P67, DOI 10.1016/S0920-9964(03)00122-1; Gearon JS, 1999, COMMUNITY MENT HLT J, V35, P401, DOI 10.1023/A:1018778310859; Goodman LA, 1997, SCHIZOPHRENIA BULL, V23, P685, DOI 10.1093/schbul/23.4.685; Goodman LA, 2001, J TRAUMA STRESS, V14, P615, DOI 10.1023/A:1013026318450; Goodman LA, 1997, PREVALENCE IMPACT SE; HIDAY VA, 1995, J HEALTH SOC BEHAV, V36, P122, DOI 10.2307/2137220; Hiday VA, 1999, PSYCHIATR SERV, V50, P62, DOI 10.1176/ps.50.1.62; Holmes EP, 1997, PSYCHIATR REHABIL J, V20, P64, DOI 10.1037/h0095361; Huys HWJM, 2012, WODC CRIMINALITEIT R, P57; Kaal H., 2008, SOCIOLOGIE, V4, P371; Keij I., 2000, INDEX, V10, P24; Kushel MB, 2003, ARCH INTERN MED, V163, P2492, DOI 10.1001/archinte.163.20.2492; Lam JA, 1998, PSYCHIATR SERV, V49, P678, DOI 10.1176/ps.49.5.678; Logan TK, 2002, REV GEN PSYCHOL, V6, P325, DOI 10.1037//1089-2680.6.4.325; Lysaker PH, 2001, PSYCHIATR SERV, V52, P1485, DOI 10.1176/appi.ps.52.11.1485; Maniglio R, 2009, ACTA PSYCHIAT SCAND, V119, P180, DOI 10.1111/j.1600-0447.2008.01300.x; Marley JA, 2001, SOC WORK, V46, P115, DOI 10.1093/sw/46.2.115; Mueser KT, 2008, J CONSULT CLIN PSYCH, V76, P259, DOI 10.1037/0022-006X.76.2.259; Mueser KT, 2002, SCHIZOPHR RES, V53, P123, DOI 10.1016/S0920-9964(01)00173-6; Norman SB, 2010, J PSYCHOACTIVE DRUGS, V42, P83, DOI 10.1080/02791072.2010.10399788; Oakes JM, 2003, SOC SCI MED, V56, P769, DOI 10.1016/S0277-9536(02)00073-4; Perese EF., 2007, J AM PSYCHIAT NURSES, V13, P285, DOI [DOI 10.1177/1078390307307830, 10.1177/1078390307307830]; Porter J, 2011, J INTERPERS VIOLENCE, V26, P3210, DOI 10.1177/0886260510393011; Priebe S, 2008, PSYCHIAT SERV, V59, P570, DOI 10.1176/ps.2008.59.5.570; RachBeisel J, 1999, PSYCHIATR SERV, V50, P1427, DOI 10.1176/ps.50.11.1427; Sells DJ, 2003, PSYCHIAT SERV, V54, P1253, DOI 10.1176/appi.ps.54.9.1253; Silver E, 2005, AM J PUBLIC HEALTH, V95, P2015, DOI 10.2105/AJPH.2003.021436; Silver E, 2011, LAW HUMAN BEHAV, V35, P49, DOI 10.1007/s10979-009-9206-8; Sleegers J, 2000, PSYCHIATR SERV, V51, P100, DOI 10.1176/ps.51.1.100; Steadman HJ, 1998, ARCH GEN PSYCHIAT, V55, P393, DOI 10.1001/archpsyc.55.5.393; Struckman-Johnson C, 2006, J INTERPERS VIOLENCE, V21; SWANSON JW, 1990, HOSP COMMUNITY PSYCH, V41, P761; Teplin LA, 2005, ARCH GEN PSYCHIAT, V62, P911, DOI 10.1001/archpsyc.62.8.911; Thomas C., 1995, PSYCHIATRIC B, V19, P600; Thornicroft G., 2006, SHUNNED DISCRIMINATI, DOI 10.1093/med/9780198570981.001.0001; Tiihonen J, 1997, AM J PSYCHIAT, V154, P840; Truman JL, 2012, CRIMINAL VICTIMIZATI, P20; US Bureau of the Census, 1994, TECHN BACKGR RED NAT; van den Berg DPG, 2012, J BEHAV THER EXP PSY, V43, P664, DOI 10.1016/j.jbtep.2011.09.011; Whitbeck LB, 1999, AM J COMMUN PSYCHOL, V27, P273, DOI 10.1023/A:1022891802943	55	60	60	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91029	10.1371/journal.pone.0091029	http://dx.doi.org/10.1371/journal.pone.0091029			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC4IY	24609108	Green Published, gold, Green Submitted			2022-12-27	WOS:000332485800083
J	McCutcheon, S; Langeveld, JPM; Tan, BC; Gill, AC; de Wolf, C; Martin, S; Gonzalez, L; Alibhai, J; Blanco, ARA; Campbell, L; Hunter, N; Houston, EF				McCutcheon, Sandra; Langeveld, Jan P. M.; Tan, Boon Chin; Gill, Andrew C.; de Wolf, Christopher; Martin, Stuart; Gonzalez, Lorenzo; Alibhai, James; Blanco, A. Richard Alejo; Campbell, Lauren; Hunter, Nora; Houston, E. Fiona			Prion Protein-Specific Antibodies that Detect Multiple TSE Agents with High Sensitivity	PLOS ONE			English	Article							BOVINE SPONGIFORM ENCEPHALOPATHY; PRP MONOCLONAL-ANTIBODIES; CELLULAR PRION; IMMUNOFLUOROMETRIC ASSAY; DIFFERENTIAL-DIAGNOSIS; PENTOSAN POLYSULFATE; SHEEP BRAIN; SCRAPIE; DISEASE; EPITOPES	This paper describes the generation, characterisation and potential applications of a panel of novel anti-prion protein monoclonal antibodies (mAbs). The mAbs were generated by immunising PRNP null mice, using a variety of regimes, with a truncated form of recombinant ovine prion protein spanning residues 94-233. Epitopes of specific antibodies were mapped using solid-phase Pepscan analysis and clustered to four distinct regions within the PrP molecule. We have demonstrated the utility of these antibodies by use of Western blotting and immunohistochemistry in tissues from a range of different species affected by transmissible spongiform encephalopathy (TSE). In comparative tests against extensively-used and widely-published, commercially available antibodies, similar or improved results can be obtained using these new mAbs, specifically in terms of sensitivity of detection. Since many of these antibodies recognise native PrP C, they could also be applied to a broad range of immunoassays such as flow cytometry, DELFIA analysis or immunoprecipitation. We are using these reagents to increase our understanding of TSE pathogenesis and for use in potential diagnostic screening assays.	[McCutcheon, Sandra; Tan, Boon Chin; Gill, Andrew C.; de Wolf, Christopher; Alibhai, James; Blanco, A. Richard Alejo; Campbell, Lauren; Hunter, Nora; Houston, E. Fiona] Roslin Inst, Div Neurobiol, Edinburgh, Midlothian, Scotland; [McCutcheon, Sandra; Tan, Boon Chin; Gill, Andrew C.; de Wolf, Christopher; Alibhai, James; Blanco, A. Richard Alejo; Campbell, Lauren; Hunter, Nora; Houston, E. Fiona] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh EH9 1QH, Midlothian, Scotland; [Langeveld, Jan P. M.] Cent Vet Inst Wageningen UR, Lelystad, Netherlands; [Martin, Stuart; Gonzalez, Lorenzo] Anim Hlth & Vet Labs Agcy, Lasswade Lab, Edinburgh, Midlothian, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; Wageningen University & Research	McCutcheon, S (corresponding author), Roslin Inst, Div Neurobiol, Edinburgh, Midlothian, Scotland.	sandra.mccutcheon@roslin.ed.ac.uk	Gill, ANdrew/GRO-1248-2022; González, Lorenzo/A-5325-2010; Gill, Andrew C/A-5219-2009	González, Lorenzo/0000-0003-4199-4526; Gill, Andrew C/0000-0001-5201-9473; Tan, Kyle BC/0000-0001-5901-2418	BBSRC [201/BS3 09722]; British Council; NWO for (UK-Netherlands Partnership Program) [PPS 801]; BBSRC [BBS/E/D/20251968, BBS/E/A/00001658, BBS/E/D/20251967] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/A/00001658, BBS/E/D/20251967, 1026989, BBS/E/D/20251968] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Council(The British Council in India); NWO for (UK-Netherlands Partnership Program); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by grants from BBSRC (201/BS3 09722), British Council and the NWO for (UK-Netherlands Partnership Program, PPS 801). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrievskaia O, 2006, CLIN VACCINE IMMUNOL, V13, P98, DOI 10.1128/CVI.13.1.98-105.2006; Baron T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000137; BARRY RA, 1986, J INFECT DIS, V154, P518, DOI 10.1093/infdis/154.3.518; Benestad SL, 2003, VET REC, V153, P202, DOI 10.1136/vr.153.7.202; Beringue V, 2003, BRAIN, V126, P2065, DOI 10.1093/brain/awg205; Biacabe AG, 2004, EMBO REP, V5, P110, DOI 10.1038/sj.embor.7400054; Biacabe AG, 2007, PRION, V1, P61, DOI 10.4161/pri.1.1.3828; Brown KL, 2013, J GEN VIROLOGY; Campbell L, 2013, BBA-MOL BASIS DIS, V1832, P826, DOI 10.1016/j.bbadis.2013.02.020; Dawson M, 1998, VET REC, V142, P623; de Marco MF, 2010, J PATHOL, V222, P380, DOI 10.1002/path.2767; Esiri MM, 2000, NEUROPATH APPL NEURO, V26, P273, DOI 10.1046/j.1365-2990.2000.00239.x; Farquhar C, 1999, LANCET, V353, P117, DOI 10.1016/S0140-6736(98)05395-1; Feraudet C, 2005, J BIOL CHEM, V280, P11247, DOI 10.1074/jbc.M407006200; GEYSEN HM, 1984, P NATL ACAD SCI-BIOL, V81, P3998, DOI 10.1073/pnas.81.13.3998; Gill AC, 2011, CAB REV, V6; GOLDMANN W, 1994, J GEN VIROL, V75, P989, DOI 10.1099/0022-1317-75-5-989; Gonzalez L, 2005, J GEN VIROL, V86, P827, DOI 10.1099/vir.0.80299-0; Gonzalez L, 2002, J COMP PATHOL, V126, P17, DOI 10.1053/jcpa.2001.0516; Gretzschel A, 2006, J GEN VIROL, V87, P3715, DOI 10.1099/vir.0.81816-0; GROSCHUP MH, 1993, J GEN VIROL, V74, P1451, DOI 10.1099/0022-1317-74-7-1451; Halliday S, 2005, J GEN VIROL, V86, P1571, DOI 10.1099/vir.0.80561-0; Harlow E, 1988, LAB MANUAL, P310; Harmeyer S, 1998, J GEN VIROL, V79, P937, DOI 10.1099/0022-1317-79-4-937; Hilton DA, 2004, J PATHOL, V203, P733, DOI 10.1002/path.1580; Holada K, 2007, TRANSFUSION, V47, P2223, DOI 10.1111/j.1537-2995.2007.01451.x; Holznagel E, 2010, TRANSFUSION, V50, P452, DOI 10.1111/j.1537-2995.2009.02437.x; Horiuchi M, 1999, EMBO J, V18, P3193, DOI 10.1093/emboj/18.12.3193; Horiuchi M, 2009, VIROLOGY, V394, P200, DOI 10.1016/j.virol.2009.08.025; Hunter N, 1997, TRENDS MICROBIOL, V5, P331, DOI 10.1016/S0966-842X(97)01081-0; Jacobs JG, 2011, J VIROL, V85, P12537, DOI 10.1128/JVI.00448-11; Jacobs JG, 2011, J GEN VIROL, V92, P222, DOI 10.1099/vir.0.026153-0; Jeffrey M, 2006, J COMP PATHOL, V134, P17, DOI 10.1016/j.jcpa.2005.06.005; Jeffrey M, 2003, J GEN VIROL, V84, P1033, DOI 10.1099/vir.0.18825-0; Jeffrey M, 2001, J COMP PATHOL, V125, P271, DOI 10.1053/jcpa.2001.0499; Kanyo ZF, 1999, J MOL BIOL, V293, P855, DOI 10.1006/jmbi.1999.3193; Kascsak R, 2010, J BIOL CHEM, V285, pLE5, DOI 10.1074/jbc.L109.088831; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; Kirby L, 2003, J GEN VIROL, V84, P1013, DOI 10.1099/vir.0.18903-0; Kirby L, 2010, BIOCHEMISTRY-US, V49, P1448, DOI 10.1021/bi901855z; Klohn PC, 2012, SCIENCE, V335, P52, DOI 10.1126/science.1215579; Korth C, 1997, NATURE, V390, P74, DOI 10.1038/36337; Kovacs GG, 2002, BRAIN PATHOL, V12, P1; Krasemann S, 1996, J IMMUNOL METHODS, V199, P109, DOI 10.1016/S0022-1759(96)00165-2; Langeveld Jan P M, 2006, BMC Vet Res, V2, P19, DOI 10.1186/1746-6148-2-19; Lee CA, 1998, THROMB HAEMOSTASIS, V80, P909; Lee IY, 1998, GENOME RES, V8, P1022, DOI 10.1101/gr.8.10.1022; Lezmi S, 2004, J VIROL, V78, P3654, DOI 10.1128/JVI.78.7.3654-3662.2004; Li L, 2009, PROTEIN ENG DES SEL, V22, P523, DOI 10.1093/protein/gzp038; Madampage CA, 2013, PRION, V7; MANSON JC, 1994, MOL NEUROBIOL, V8, P121, DOI 10.1007/BF02780662; McCutcheon S, 2005, J IMMUNOL METHODS, V298, P119, DOI 10.1016/j.jim.2005.01.012; McCutcheon S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023169; Moroncini G, 2004, P NATL ACAD SCI USA, V101, P10404, DOI 10.1073/pnas.0403522101; Nakamura N, 2003, HYBRIDOMA HYBRIDOM, V22, P263, DOI 10.1089/153685903322328992; Orru CD, 2011, MBIO, V2, DOI 10.1128/mBio.00078-11; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Pan T, 2004, J NEUROCHEM, V90, P1205, DOI 10.1111/j.1471-4159.2004.02582.x; Panigaj M, 2011, TRANSFUSION, V51, P1012, DOI 10.1111/j.1537-2995.2010.02924.x; Paramithiotis E, 2003, NAT MED, V9, P893, DOI 10.1038/nm883; PICCARDO P, 1995, J NEUROPATH EXP NEUR, V54, P790, DOI 10.1097/00005072-199511000-00006; Pirisinu L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066405; Polymenidou M, 2005, LANCET NEUROL, V4, P805, DOI 10.1016/S1474-4422(05)70225-8; Polymenidou M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003872; Privat N, 2008, MODERN PATHOL, V21, P140, DOI 10.1038/modpathol.3800994; Rhie A, 2003, J BIOL CHEM, V278, P39697, DOI 10.1074/jbc.M305297200; Rodriguez-Martinez AB, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-99; Roettger Y, 2013, NAT REV NEUROL, V9, P98, DOI 10.1038/nrneurol.2012.258; Rubenstein R, 1999, J NEUROVIROL, V5, P401, DOI 10.3109/13550289909029481; Seuberlich T, 2012, EMERG INFECT DIS, V18, P158, DOI 10.3201/eid1801.111225; Shimizu Y, 2010, MICROBIOL IMMUNOL, V54, P112, DOI 10.1111/j.1348-0421.2009.00190.x; Silva CJ, 2012, PRION, V6, P163, DOI 10.4161/pri.18795; Slootstra JW, 1996, MOL DIVERS, V1, P87, DOI 10.1007/BF01721323; Solforosi L, 2004, SCIENCE, V303, P1514, DOI 10.1126/science.1094273; Stack MJ, 2002, ACTA NEUROPATHOL, V104, P279, DOI 10.1007/s00401-002-0556-2; Stanker LH, 2012, HYBRIDOMA, V31, P314, DOI 10.1089/hyb.2012.0022; Tan BC, 2012, J GEN VIROL, V93, P2749, DOI 10.1099/vir.0.039008-0; Tang Y, 2012, J IMMUNOL METHODS, V380, P30, DOI 10.1016/j.jim.2012.03.004; Tang Y, 2010, J IMMUNOL METHODS, V356, P29, DOI 10.1016/j.jim.2010.03.002; Thackray AM, 2006, BIOCHEM J, V400, P349, DOI 10.1042/BJ20060746; Thackray AM, 2005, BIOCHEM J, V390, P563, DOI 10.1042/BJ20050571; Thuring CMA, 2004, J CLIN MICROBIOL, V42, P972, DOI 10.1128/JCM.42.3.972-980.2004; Thuring CMA, 2005, J COMP PATHOL, V132, P59, DOI 10.1016/j.jcpa.2004.06.004; Todd NV, 2005, J INFECTION, V50, P394, DOI 10.1016/j.jinf.2004.07.015; Tveit H, 2005, BIOCHEM BIOPH RES CO, V337, P232, DOI 10.1016/j.bbrc.2005.09.031; vanKeulen LJM, 1996, J CLIN MICROBIOL, V34, P1228, DOI 10.1128/JCM.34.5.1228-1231.1996; Wadsworth JDF, 2001, LANCET, V358, P171, DOI 10.1016/S0140-6736(01)05403-4; Whyte SM, 2003, BIOCHEM J, V373, P485, DOI 10.1042/BJ20021911; Williamson RA, 1998, J VIROL, V72, P9413, DOI 10.1128/JVI.72.11.9413-9418.1998; Wisniewski T, 2010, EXPERT REV VACCINES, V9, P1441, DOI [10.1586/erv.10.131, 10.1586/ERV.10.131]; YOKOYAMA T, 1995, CLIN DIAGN LAB IMMUN, V2, P172, DOI 10.1128/CDLI.2.2.172-176.1995; Yuan FF, 2005, IMMUNOL CELL BIOL, V83, P632, DOI 10.1111/j.1440-1711.2005.01384.x; Zanusso G, 1998, P NATL ACAD SCI USA, V95, P8812, DOI 10.1073/pnas.95.15.8812	93	17	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91143	10.1371/journal.pone.0091143	http://dx.doi.org/10.1371/journal.pone.0091143			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608105	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000332485800103
J	Poveda, C; Fresno, M; Girones, N; Martins, OA; Ramirez, JD; Santi-Rocca, J; Marin-Neto, JA; Morillo, CA; Rosas, F; Guhl, F				Poveda, Cristina; Fresno, Manuel; Girones, Nuria; Martins-Filho, Olindo A.; David Ramirez, Juan; Santi-Rocca, Julien; Marin-Neto, Jose A.; Morillo, Carlos A.; Rosas, Fernando; Guhl, Felipe			Cytokine Profiling in Chagas Disease: Towards Understanding the Association with Infecting Trypanosoma cruzi Discrete Typing Units (A BENEFIT TRIAL Sub-Study)	PLOS ONE			English	Article							HEART-DISEASE; PLASMA-LEVELS; IFN-GAMMA; TNF-ALPHA; T-CELLS; CARDIOMYOPATHY; IDENTIFICATION; IL-10; REACTIVATION; POLYMORPHISM	Background: Chagas disease caused by the protozoan Trypanosoma cruzi is an important public health problem in Latin America. The immunological mechanisms involved in Chagas disease pathogenesis remain incompletely elucidated. The aim of this study was to explore cytokine profiles and their possible association to the infecting DTU and the pathogenesis of Chagas disease. Methods: 109 sero-positive T. cruzi patients and 21 negative controls from Bolivia and Colombia, were included. Flow cytometry assays for 13 cytokines were conducted on human sera. Patients were divided into two groups: in one we compared the quantification of cytokines between patients with and without chronic cardiomyopathy; in second group we compared the levels of cytokines and the genetic variability of T. cruzi. Results: Significant difference in anti-inflammatory and pro-inflammatory cytokines profiles was observed between the two groups cardiac and non-cardiac. Moreover, serum levels of IFN-gamma, IL-12, IL-22 and IL-10 presented an association with the genetic variability of T. cruzi, with significant differences in TcI and mixed infections TcI/TcII. Conclusion: Expression of anti-inflammatory and pro-inflammatory cytokines may play a relevant role in determining the clinical presentation of chronic patients with Chagas disease and suggests the occurrence of specific immune responses, probably associated to different T. cruzi DTUs.	[Poveda, Cristina; David Ramirez, Juan; Guhl, Felipe] Univ Los Andes, Fac Ciencias, Ctr Invest Microbiol & Parasitol, Bogota, Colombia; [Fresno, Manuel; Girones, Nuria; Santi-Rocca, Julien] Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain; [Martins-Filho, Olindo A.] Fundacao Oswaldo Cruz FIOCRUZ, Ctr Pesquisas Rene Rachou, Lab Diagnost & Monitoring Biomarkers, Belo Horizonte, MG, Brazil; [Marin-Neto, Jose A.] Univ Sao Paulo, Med Sch Ribeirao Preto, Dept Internal Med, Div Cardiol, Sao Paulo, Brazil; [Morillo, Carlos A.] McMaster Univ, Dept Med, Div Cardiol, PHRI HHSC, Hamilton, ON, Canada; [Rosas, Fernando] Clin Abood Shaio, Bogota, Colombia	Universidad de los Andes (Colombia); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Fundacao Oswaldo Cruz; Universidade de Sao Paulo; McMaster University; Population Health Research Institute	Guhl, F (corresponding author), Univ Los Andes, Fac Ciencias, Ctr Invest Microbiol & Parasitol, Bogota, Colombia.	fguhl@uniandes.edu.co	Santi-Rocca, Julien/AAD-2448-2020; Gironès, Núria/AAR-7436-2020; Martins-Filho, Olindo Assis/ABE-6278-2021; Poveda, Cristina/AAU-4111-2020; Zaky, Mohammad/I-3187-2017; Marin-Neto, Jose Antonio/F-6099-2012; Girones, Nuria/L-7865-2017; Ramírez, Juan David/F-3524-2016	Santi-Rocca, Julien/0000-0002-9791-3521; Gironès, Núria/0000-0002-8130-2750; Martins-Filho, Olindo Assis/0000-0002-5494-4889; Poveda, Cristina/0000-0003-0361-2232; Zaky, Mohammad/0000-0003-3547-2588; Girones, Nuria/0000-0002-8130-2750; Ramírez, Juan David/0000-0002-1344-9312; Fresno Escudero, Manuel/0000-0002-9223-5477; Guhl, Felipe/0000-0001-7180-7125; Morillo, Carlos/0000-0002-8739-2099; Mursalin, Adi/0000-0002-1867-0868; Girones Pujol, Nuria/0000-0002-0932-5018; Marin-Neto, Jose Antonio/0000-0002-8651-8833	Ministerio de Ciencia e Innovacion of Spain [SAF2010-18733]; Chagas EpiNet from The European Union Seventh Framework Programme [223034]; RED RICET [RD12/0018/0004]; Comunidad de Madrid [S-2010/BMD-2332]; Fundacion Ramon Areces; Fondo de Investigaciones Sanitarias [PS09/00538]; Canadian Institute of Health Research (CIHR); TDR/WHO; faculty of sciences from the Universidad de los Andes; Centre of Molecular Biology "Severo Ochoa" from Universidad Autonoma de Madrid (Spain)	Ministerio de Ciencia e Innovacion of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Chagas EpiNet from The European Union Seventh Framework Programme; RED RICET; Comunidad de Madrid(Comunidad de Madrid); Fundacion Ramon Areces; Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); TDR/WHO(World Health Organization); faculty of sciences from the Universidad de los Andes; Centre of Molecular Biology "Severo Ochoa" from Universidad Autonoma de Madrid (Spain)	This study was supported by grants from Ministerio de Ciencia e Innovacion of Spain (SAF2010-18733), Chagas EpiNet from The European Union Seventh Framework Programme, contract no. 223034, RED RICET RD12/0018/0004 and Comunidad de Madrid S-2010/BMD-2332 to MF, and an institutional grant of Fundacion Ramon Areces and by Fondo de Investigaciones Sanitarias (PS09/00538), the Canadian Institute of Health Research (CIHR) and TDR/WHO. The authors thank the research fund of the faculty of sciences from the Universidad de los Andes and Centre of Molecular Biology "Severo Ochoa" from Universidad Autonoma de Madrid (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anez N, 2004, TROP MED INT HEALTH, V9, P1319, DOI 10.1111/j.1365-3156.2004.01333.x; Armah HB, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-147; Bautista-Lopez NL, 2013, AM HEART J, V165, P558, DOI 10.1016/j.ahj.2013.01.001; Boulware DR, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000384; Burgos JM, 2010, CLIN INFECT DIS, V51, P485, DOI 10.1086/655680; Campos MA, 2001, J IMMUNOL, V167, P416, DOI 10.4049/jimmunol.167.1.416; Correa-Oliveira R, 1999, MEM I OSWALDO CRUZ, V94, P253, DOI 10.1590/S0074-02761999000700042; Costa GC, 2009, J INFECT DIS, V199, P451, DOI 10.1086/596061; Coura JR, 2002, TRENDS PARASITOL, V18, P171, DOI 10.1016/S1471-4922(01)02200-0; Cura CI, 2010, INT J PARASITOL, V40, P1599, DOI 10.1016/j.ijpara.2010.06.006; D'Avila DA, 2009, MEM I OSWALDO CRUZ, V104, P100, DOI 10.1590/S0074-02762009000100015; Ramirez JD, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002041; Ramirez JD, 2012, MOL ECOL, V21, P4216, DOI 10.1111/j.1365-294X.2012.05699.x; Diosque P, 2003, INT J PARASITOL, V33, P997, DOI 10.1016/S0020-7519(03)00139-5; Dutra WO, 2009, MEM I OSWALDO CRUZ, V104, P208, DOI 10.1590/S0074-02762009000900027; Dutra WO, 2005, TRENDS PARASITOL, V21, P581, DOI 10.1016/j.pt.2005.09.007; Erdman LK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017440; Gomes JAS, 2003, INFECT IMMUN, V71, P1185, DOI 10.1128/IAI.71.3.1185-1193.2003; Lopez L, 2006, REV ESP CARDIOL, V59, P50, DOI 10.1157/13083649; Luiza-Silva M, 2011, J INFECT DIS, V204, P873, DOI 10.1093/infdis/jir439; Macedo AM, 2004, MEM I OSWALDO CRUZ, V99, P1, DOI 10.1590/S0074-02762004000100001; Marcili A, 2009, INFECT GENET EVOL, V9, P1265, DOI 10.1016/j.meegid.2009.07.003; Guedes PMM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001630; Miguel BJ, 2008, INT J INFECT DIS, V12, pS11, DOI 10.1016/S1201-9712(08)60027-2; Ong'echa JM, 2011, INFECT IMMUN, V79, P4674, DOI 10.1128/IAI.05161-11; Pissetti CW, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000976; Pissetti CW, 2009, REV SOC BRAS MED TRO, V42, P425, DOI 10.1590/S0037-86822009000400013; Ramirez JD, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000899; Rassi A, 2012, INFECT DIS CLIN N AM, V26, P275, DOI 10.1016/j.idc.2012.03.002; Satthaporn S, 2001, J ROY COLL SURG EDIN, V46, P9; Schmunis GA, 2010, ACTA TROP, V115, P14, DOI 10.1016/j.actatropica.2009.11.003; Tarleton RL, 2007, CURR OPIN IMMUNOL, V19, P430, DOI 10.1016/j.coi.2007.06.003; Torres OA, 2010, INFECT GENET EVOL, V10, P682, DOI 10.1016/j.meegid.2010.03.009; Vitelli-Avelar DM, 2006, CLIN EXP IMMUNOL, V145, P81, DOI 10.1111/j.1365-2249.2006.03123.x; WHO, 2007, WHO GLOB HLTH ATL; Zafra G, 2008, PARASITOL RES, V103, P731, DOI 10.1007/s00436-008-1034-0; Zafra G, 2007, MICROBES INFECT, V9, P1049, DOI 10.1016/j.micinf.2007.04.010; Zingales B, 2009, MEM I OSWALDO CRUZ, V104, P1051, DOI 10.1590/S0074-02762009000700021; Zingales B, 2012, INFECT GENET EVOL, V12, P240, DOI 10.1016/j.meegid.2011.12.009	40	50	50	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91154	10.1371/journal.pone.0091154	http://dx.doi.org/10.1371/journal.pone.0091154			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608170	Green Submitted, Green Published, gold			2022-12-27	WOS:000332485800107
J	Tsang, VWK; Young, D; During, MJ; Birch, NP				Tsang, Vicky W. K.; Young, Deborah; During, Matthew J.; Birch, Nigel P.			AAV-Mediated Overexpression of Neuroserpin in the Hippocampus Decreases PSD-95 Expression but Does Not Affect Hippocampal-Dependent Learning and Memory	PLOS ONE			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; SERINE-PROTEASE INHIBITOR; CENTRAL-NERVOUS-SYSTEM; LONG-TERM POTENTIATION; TRANSGENIC MICE; SYNAPTIC PLASTICITY; RECEPTOR SUBUNIT; GENE-EXPRESSION; NMDA RECEPTOR; RAT-BRAIN	Neuroserpin is a serine protease inhibitor, or serpin, that is expressed in the nervous system and inhibits the protease tissue plasminogen activator (tPA). Neuroserpin has been suggested to play a role in learning and memory but direct evidence for such a role is lacking. Here we have used an adeno-associated virus (AAV) vector expression system to investigate the effect of neuroserpin on hippocampal-dependent learning and memory in the young adult rat. A FLAG-tagged neuroserpin construct was initially characterized by in vitro transcription/translation and transfection into HEK293 cells and shown to interact with tPA and be targeted to the secretory pathway. Targeted injection of a chimeric AAV1/2 vector expressing FLAG-neuroserpin resulted in localized overexpression in the dorsal hippocampus. Neuroserpin overexpression led to the appearance of an unstable neuroserpin: tPA complex in zymographic assays consistent with interaction with endogenous tPA in vivo. Rats overexpressing neuroserpin also showed a significant decrease in the levels of postsynaptic density protein 95, a major postsynaptic scaffolding protein. Three weeks after injection, a range of behavioural tests was performed to measure spatial and associative learning and memory, as well as innate and acquired fear. These tests provided no evidence of a role for neuroserpin in hippocampal-dependent learning and memory. In summary this study does not support a role for neuroserpin in hippocampal-dependent learning and memory in young adult rats but does suggest an involvement of neuroserpin in hippocampal synaptic plasticity.	[Tsang, Vicky W. K.; Birch, Nigel P.] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; [Young, Deborah; During, Matthew J.] Univ Auckland, Dept Mol Med & Pathol, Auckland 1, New Zealand; [Young, Deborah] Univ Auckland, Dept Pharmacol & Clin Pharmacol, Auckland 1, New Zealand; [Tsang, Vicky W. K.; Young, Deborah; During, Matthew J.; Birch, Nigel P.] Univ Auckland, Ctr Brain Res, Auckland 1, New Zealand; [During, Matthew J.] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA	University of Auckland; University of Auckland; University of Auckland; University of Auckland; Ohio State University	Tsang, VWK (corresponding author), Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand.	v.tsang@auckland.ac.nz	During, Matthew/AAC-1388-2020; Birch, Nigel/H-2498-2011	Birch, Nigel/0000-0002-8417-3587; Young, Deborah/0000-0003-1085-2824	Royal Society of New Zealand Marsden Grant; University of Auckland Doctoral Scholarship	Royal Society of New Zealand Marsden Grant(Royal Society of New ZealandMarsden Fund (NZ)); University of Auckland Doctoral Scholarship	This research was funded by a Royal Society of New Zealand Marsden Grant. V. W. K. T. was supported by a University of Auckland Doctoral Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker-Carlson K, 2002, J BIOL CHEM, V277, P46852, DOI 10.1074/jbc.M207740200; Berger P, 1999, MOL CELL NEUROSCI, V14, P455, DOI 10.1006/mcne.1999.0804; Bolivar VJ, 2003, BEHAV NEUROSCI, V117, P1233, DOI 10.1037/0735-7044.117.6.1233; Borges VM, 2010, J NEUROSCI RES, V88, P2610, DOI 10.1002/jnr.22428; Burger C, 2004, MOL THER, V10, P302, DOI 10.1016/j.ymthe.2004.05.024; Calabresi P, 2000, EUR J NEUROSCI, V12, P1002, DOI 10.1046/j.1460-9568.2000.00991.x; Cao L, 2004, NAT GENET, V36, P827, DOI 10.1038/ng1395; Caroni P, 1997, J NEUROSCI METH, V71, P3, DOI 10.1016/S0165-0270(96)00121-5; Carreton O, 2012, EXP NEUROL, V237, P335, DOI 10.1016/j.expneurol.2012.06.033; Chen XB, 2005, P NATL ACAD SCI USA, V102, P11551, DOI 10.1073/pnas.0505359102; Cinelli P, 2001, MOL CELL NEUROSCI, V18, P443, DOI 10.1006/mcne.2001.1028; Conde CA, 1999, PHARMACOL BIOCHEM BE, V63, P63, DOI 10.1016/S0091-3057(98)00251-2; De Roo M, 2008, CEREB CORTEX, V18, P151, DOI 10.1093/cercor/bhm041; Dobo J, 2004, J BIOL CHEM, V279, P9264, DOI 10.1074/jbc.M311731200; During Matthew J, 2003, Methods Mol Med, V76, P221; El-Hussein AE, 2000, SCIENCE, V290, P1364; Fassio A, 2011, SEMIN CELL DEV BIOL, V22, P408, DOI 10.1016/j.semcdb.2011.07.005; Feyissa AM, 2009, PROG NEURO-PSYCHOPH, V33, P70, DOI 10.1016/j.pnpbp.2008.10.005; Frey U, 1996, J NEUROSCI, V16, P2057; Hall C, 1932, U CALIFORNIA PUBLICA; Hall RA, 1997, J BIOL CHEM, V272, P4135, DOI 10.1074/jbc.272.7.4135; Hastings GA, 1997, J BIOL CHEM, V272, P33062, DOI 10.1074/jbc.272.52.33062; Hauck B, 2003, MOL THER, V7, P419, DOI 10.1016/S1525-0016(03)00012-1; Hill RM, 2000, BIOCHEM J, V345, P595, DOI 10.1042/0264-6021:3450595; Huang YY, 1996, P NATL ACAD SCI USA, V93, P8699, DOI 10.1073/pnas.93.16.8699; Huh KH, 1999, J BIOL CHEM, V274, P151, DOI 10.1074/jbc.274.1.151; Ishigami S, 2007, BIOCHEM J, V402, P25, DOI 10.1042/BJ20061170; KAPLITT MG, 1994, NAT GENET, V8, P148, DOI 10.1038/ng1094-148; Karolewicz B, 2009, INT J NEUROPSYCHOPH, V12, P143, DOI 10.1017/S1461145708008985; Kirik D, 2002, J NEUROSCI, V22, P2780, DOI 10.1523/JNEUROSCI.22-07-02780.2002; Kiyota T, 2011, GENE THER, V19; Klugmann M, 2005, MOL CELL NEUROSCI, V28, P347, DOI 10.1016/j.mcn.2004.10.002; Krueger SR, 1997, J NEUROSCI, V17, P8984; Lee TW, 2008, J NEUROSCI RES, V86, P1243, DOI 10.1002/jnr.21592; Li SF, 2006, BRAIN RES, V1122, P1, DOI 10.1016/j.brainres.2006.09.042; Madani R, 2003, MOL CELL NEUROSCI, V23, P473, DOI 10.1016/S1044-7431(03)00077-0; Madani R, 1999, EMBO J, V18, P3007, DOI 10.1093/emboj/18.11.3007; Makarova A, 2003, J BIOL CHEM, V278, P50250, DOI 10.1074/jbc.M309150200; Martin AM, 2008, J BIOL CHEM, V283, P12004, DOI 10.1074/jbc.M707607200; Mastakov MY, 2001, MOL THER, V3, P225, DOI 10.1006/mthe.2001.0246; Mataga N, 2002, P NATL ACAD SCI USA, V99, P7717, DOI 10.1073/pnas.102088899; MEIRI N, 1994, P NATL ACAD SCI USA, V91, P3196, DOI 10.1073/pnas.91.8.3196; Miranda E, 2004, J BIOL CHEM, V279, P28283, DOI 10.1074/jbc.M313166200; Miranda E, 2006, CELL MOL LIFE SCI, V63, P709, DOI 10.1007/s00018-005-5077-4; Miranda E, 2008, HUM MOL GENET, V17, P1527, DOI 10.1093/hmg/ddn041; Mouravlev A, 2006, P NATL ACAD SCI USA, V103, P4705, DOI 10.1073/pnas.0506137103; Okabe S, 2001, J NEUROSCI, V21, P6105, DOI 10.1523/JNEUROSCI.21-16-06105.2001; Olson ST, 2011, PROG MOL BIOL TRANSL, V99, P185, DOI 10.1016/S1877-1173(11)99005-X; Osterwalder T, 1998, J BIOL CHEM, V273, P2312, DOI 10.1074/jbc.273.4.2312; Osterwalder T, 1996, EMBO J, V15, P2944, DOI 10.1002/j.1460-2075.1996.tb00657.x; Pawlak R, 2002, NEUROSCIENCE, V113, P995, DOI 10.1016/S0306-4522(02)00166-5; Ricagno S, 2009, J MOL BIOL, V388, P109, DOI 10.1016/j.jmb.2009.02.056; Teesalu T, 2004, THROMB HAEMOSTASIS, V92, P358; Toro C, 2005, SCHIZOPHR RES, V80, P323, DOI 10.1016/j.schres.2005.07.003; Tye KM, 2011, NATURE, V471, P358, DOI 10.1038/nature09820; VASSALLI JD, 1984, J EXP MED, V159, P1653, DOI 10.1084/jem.159.6.1653; Wang DV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018739; Wannier-Morino P, 2003, EUR J NEUROSCI, V17, P1853, DOI 10.1046/j.1460-9568.2003.02628.x; Watson Paxinos, 1986, RAT BRAIN STEREOTAXI; Woods GF, 2011, J NEUROSCI, V31, P12129, DOI 10.1523/JNEUROSCI.6662-10.2011; Xu R, 2001, GENE THER, V8, P1323, DOI 10.1038/sj.gt.3301529; Xu WF, 2011, CURR OPIN NEUROBIOL, V21, P306, DOI 10.1016/j.conb.2011.03.001; Zhou AW, 2001, J BIOL CHEM, V276, P27541, DOI 10.1074/jbc.M102594200	63	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91050	10.1371/journal.pone.0091050	http://dx.doi.org/10.1371/journal.pone.0091050			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608243	Green Submitted, Green Published, gold			2022-12-27	WOS:000332485800088
J	Wills, ES; Jonkers, DMAE; Savelkoul, PH; Masclee, AA; Pierik, MJ; Penders, J				Wills, Edgar S.; Jonkers, Daisy M. A. E.; Savelkoul, Paul H.; Masclee, Ad A.; Pierik, Marieke J.; Penders, John			Fecal Microbial Composition of Ulcerative Colitis and Crohn's Disease Patients in Remission and Subsequent Exacerbation	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; COLONIC-MUCOSA; DIVERSITY; IBD; 6-MERCAPTOPURINE; AZATHIOPRINE; MICROFLORA; FLORA	Background: Limited studies have examined the intestinal microbiota composition in relation to changes in disease course of IBD over time. We aimed to study prospectively the fecal microbiota in IBD patients developing an exacerbation during follow-up. Design: Fecal samples from 10 Crohn's disease (CD) and 9 ulcerative colitis (UC) patients during remission and subsequent exacerbation were included. Active disease was determined by colonoscopy and/or fecal calprotectine levels. Exclusion criteria were pregnancy, antibiotic use, enema use and/or medication changes between consecutive samples. The microbial composition was assessed by 16S rDNA pyrosequencing. Results: After quality control, 6,194-11,030 sequences per sample were available for analysis. Patient-specific shifts in bacterial composition and diversity were observed during exacerbation compared to remission, but overarching shifts within UC or CD were not observed. Changes in the bacterial community composition between remission and exacerbation as assessed by Bray-Curtis dissimilarity, were significantly larger in CD versus UC patients (0.59 vs. 0.42, respectively; p = 0.025). Thiopurine use was found to be a significant cause of clustering as shown by Principal Coordinate Analysis and was associated with decreases in bacterial richness (Choa1 501.2 vs. 847.6 in non-users; p<0.001) and diversity (Shannon index: 5.13 vs. 6.78, respectively; p<0.01). Conclusion: Shifts in microbial composition in IBD patients with changing disease activity over time seem to be patient-specific, and are more pronounced in CD than in UC patients. Furthermore, thiopurine use was found to be associated with the microbial composition and diversity, and should be considered when studying the intestinal microbiota in relation to disease course.	[Wills, Edgar S.; Jonkers, Daisy M. A. E.; Masclee, Ad A.; Pierik, Marieke J.] Maastricht Univ, Med Ctr, Div Gastroenterol & Hepatol, Sch Nutr Toxicol & Metab NUTRIM, Maastricht, Netherlands; [Wills, Edgar S.; Savelkoul, Paul H.; Penders, John] Maastricht Univ, Med Ctr, Dept Med Microbiol, Sch Nutr Toxicol & Metab NUTRIM, Maastricht, Netherlands; [Penders, John] Maastricht Univ, Dept Epidemiol, Sch Publ Hlth & Primary Care Caphri, Maastricht, Netherlands	Maastricht University; Maastricht University; Maastricht University	Penders, J (corresponding author), Maastricht Univ, Med Ctr, Dept Med Microbiol, Sch Nutr Toxicol & Metab NUTRIM, Maastricht, Netherlands.	j.penders@mumc.nl	Penders, John/A-1280-2011	Penders, John/0000-0001-9146-5919	Academic Foundation of Maastricht University Medical Center+; IBD Research Foundation	Academic Foundation of Maastricht University Medical Center+; IBD Research Foundation	This study was financially supported by grants form the Academic Foundation of Maastricht University Medical Center+ and by the IBD Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	af Bjorkesten CG, 2012, SCAND J GASTROENTERO, V47, P528, DOI 10.3109/00365521.2012.660542; Andoh A, 2011, J GASTROENTEROL, V46, P479, DOI 10.1007/s00535-010-0368-4; Bibiloni R, 2006, J MED MICROBIOL, V55, P1141, DOI 10.1099/jmm.0.46498-0; Blumenstein I, 2008, INFLAMM BOWEL DIS, V14, P53, DOI 10.1002/ibd.20257; Buchanan J, 2011, J CROHNS COLITIS, V5, P301, DOI 10.1016/j.crohns.2011.02.005; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Claesson MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006669; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Gophna U, 2006, J CLIN MICROBIOL, V44, P4136, DOI 10.1128/JCM.01004-06; Greenstein RJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000161; Kaser A, 2010, DIGEST DIS, V28, P395, DOI 10.1159/000320393; Kotlowski R, 2007, GUT, V56, P669, DOI 10.1136/gut.2006.099796; LENNARDJONES JE, 1989, SCAND J GASTROENTERO, V24, P2, DOI 10.3109/00365528909091339; Lladser ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021105; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; Martinez-Medina M, 2006, INFLAMM BOWEL DIS, V12, P1136, DOI 10.1097/01.mib.0000235828.09305.0c; Masclee GMC, 2013, INFLAMM BOWEL DIS, V19, P124, DOI 10.1002/ibd.22976; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Morgan XC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r79; Mylonaki M, 2005, INFLAMM BOWEL DIS, V11, P481, DOI 10.1097/01.MIB.0000159663.62651.4f; Nagalingam NA, 2011, INFLAMM BOWEL DIS; Nam YD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022109; Ohkusa T, 2002, J GASTROEN HEPATOL, V17, P849, DOI 10.1046/j.1440-1746.2002.02834.x; Ott SJ, 2004, GUT, V53, P685, DOI 10.1136/gut.2003.025403; Patrick Sheila, 2012, Mob Genet Elements, V2, P149; Prindiville TP, 2000, EMERG INFECT DIS, V6, P171, DOI 10.3201/eid0602.000210; Rajilic-Stojanovic M, 2013, INFLAMM BOWEL DIS, V19, P481, DOI 10.1097/MIB.0b013e31827fec6d; Regueiro M, 2011, INFLAMM BOWEL DIS, V17, P118, DOI 10.1002/ibd.21355; Rehman A, 2010, J MED MICROBIOL, V59, P1114, DOI 10.1099/jmm.0.021170-0; Robizadeh S, 2007, INFLAMM BOWEL DIS, V13, P1475, DOI 10.1002/ibd.20265; Sandborn WJ, 2001, GUT, V48, P591, DOI 10.1136/gut.48.5.591; Scharl M, 2012, CURR OPIN GASTROEN, V28, P301, DOI 10.1097/MOG.0b013e328353e61e; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Seksik P, 2003, GUT, V52, P237, DOI 10.1136/gut.52.2.237; Sepehri S, 2007, INFLAMM BOWEL DIS, V13, P675, DOI 10.1002/ibd.20101; Shin SJ, 2008, ANTIMICROB AGENTS CH, V52, P418, DOI 10.1128/AAC.00678-07; Sokol H, 2006, INFLAMM BOWEL DIS, V12, P106, DOI 10.1097/01.MIB.0000200323.38139.c6; Sokol H, 2009, INFLAMM BOWEL DIS, V15, P1183, DOI 10.1002/ibd.20903; Sokol H, 2008, INFLAMM BOWEL DIS, V14, P858, DOI 10.1002/ibd.20392; Swidsinski A, 2005, J CLIN MICROBIOL, V43, P3380, DOI 10.1128/JCM.43.7.3380-3389.2005; Swidsinski A, 2008, INFLAMM BOWEL DIS, V14, P147, DOI 10.1002/ibd.20330; Takaishi H, 2008, INT J MED MICROBIOL, V298, P463, DOI 10.1016/j.ijmm.2007.07.016; Talley NJ, 2011, AM J GASTROENTEROL, V106, pS2, DOI 10.1038/ajg.2011.58; van den Bogert B, 2011, APPL ENVIRON MICROB, V77, P2071, DOI 10.1128/AEM.02477-10; van der Valk ME, 2014, GUT; Vaughn BP, 2014, CURR TREAT OPTIONS G; Willing BP, 2010, GASTROENTEROLOGY, V139, P1844, DOI 10.1053/j.gastro.2010.08.049; Young VB, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00144	52	86	89	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90981	10.1371/journal.pone.0090981	http://dx.doi.org/10.1371/journal.pone.0090981			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608638	gold, Green Submitted, Green Published			2022-12-27	WOS:000332485800073
J	Janoir, C; Cohen, R; Levy, C; Bingen, E; Lepoutre, A; Gutmann, L; Varon, E				Janoir, Claire; Cohen, Robert; Levy, Corinne; Bingen, Edouard; Lepoutre, Agnes; Gutmann, Laurent; Varon, Emmanuelle		Observ Regionaux Pneumocoque ORP	Clonal Expansion of the Macrolide Resistant ST386 within Pneumococcal Serotype 6C in France	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE SEROTYPE; ACUTE OTITIS-MEDIA; CONJUGATE VACCINE; INVASIVE DISEASE; NASOPHARYNGEAL CARRIAGE; 6D; 6A; IDENTIFICATION; 13-VALENT; PCR	In France, the use of the 7-valent pneumococcal conjugate vaccine (PCV7) lead to an overall significant decrease in PCV7 invasive pneumococcal disease (IPD) incidence. However, the decrease in vaccine serotype prevalence was partially counterbalanced by the serotype replacement phenomenon. In this study, we analyzed the role of the newly described serotype 6C as one of the replacement serotypes. This work was conducted on a large time scale from the early PCV7 era (2002-2003) to the PCV13 era (2010-2011), both on IPD strains recovered from the whole population and nasopharyngeal colonizing strains isolated in infant less than two years, who are known to be the main reservoir for pneumococci. Serotype 6C took advantage over 6A and 6B serotypes, which both decreased over time. A continuous and significant increase in 6C IPD was observed in adults along the study period; in contrast, in children less than two years, only an increase in 6C nasopharyngeal carriage was found, the prevalence of serotype 6C in IPD remaining very low over time. Among 101 6C invasive and colonizing strains studied by MLST, 24 STs were found to be related to three major clonal complexes, CC395, CC176, and CC315. STs related to CC176 tend to disappear after 2009 and were essentially replaced by ST386 (CC315), which dramatically increased over time. This clonal expansion may be explained by the erythromycin and tetracycline resistances associated with this clone. Finally, the decrease observed in nasopharyngeal 6C carriage since 2010, likely related to the PCV13 introduction in the French immunization schedule, is expected to lead to a decrease in 6C IPD in adults thereafter.	[Janoir, Claire; Gutmann, Laurent; Varon, Emmanuelle] Hop Europeen Georges Pompidou, AP HP, CNRP, Paris, France; [Janoir, Claire] Fac Pharm EA4043, Dept Microbiol, Chatenay Malabry, France; [Cohen, Robert] Ctr Hosp Intercommunal, Dept Microbiol, Creteil, France; [Cohen, Robert; Levy, Corinne] Ctr Hosp Intercommunal, Ctr Rech Clin, Creteil, France; [Cohen, Robert; Levy, Corinne] Assoc Clin Therapeut Infantile Val de Marne ACTIV, St Maur Des Fosses, France; [Cohen, Robert; Levy, Corinne; Bingen, Edouard] GPIP, Paris, France; [Bingen, Edouard] Univ Paris 07, Hop Robert Debre, AP HP, Dept Microbiol, Paris, France; [Lepoutre, Agnes] Inst Veille Sanit, Dept Malad Infect, St Maurice, France; [Gutmann, Laurent; Varon, Emmanuelle] Hop Europeen Georges Pompidou, AP HP, Microbiol Lab, Paris, France; [Gutmann, Laurent] INSERM, U872, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CHI Creteil; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CHI Creteil; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Institute of Public Health Surveillance; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Varon, E (corresponding author), Hop Europeen Georges Pompidou, AP HP, CNRP, Paris, France.	emmanuelle.varon@egp.aphp.fr	Cohen, Robert/AAM-4426-2021; LEVY, Corinne/AAM-3541-2021	Cohen, Robert/0000-0001-6151-0686; LEVY, Corinne/0000-0002-1927-6360; KEMPF, Marie/0000-0002-2943-7500	Public Health Service grant from InVS; Pfizer	Public Health Service grant from InVS; Pfizer(Pfizer)	This work was supported by Public Health Service grant from InVS. Financial support was given by Pfizer for part of the carriage study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaenssens N, 2011, J ANTIMICROB CHEMOTH, V66, P3, DOI 10.1093/jac/dkr453; Bratcher PE, 2011, MICROBIOL-SGM, V157, P189, DOI 10.1099/mic.0.043901-0; Bratcher PE, 2010, MICROBIOL-SGM, V156, P555, DOI 10.1099/mic.0.034116-0; Cai P, 2012, CARBOHYD RES, V351, P98, DOI 10.1016/j.carres.2012.01.017; Campos LC, 2009, DIAGN MICR INFEC DIS, V65, P112, DOI 10.1016/j.diagmicrobio.2009.06.020; Carvalho MD, 2009, J CLIN MICROBIOL, V47, P554, DOI 10.1128/JCM.01919-08; Catalayud L, 2010, J CLIN MICROBIOL, V48, P1310; Cohen R, 2010, VACCINE, V28, P6114, DOI 10.1016/j.vaccine.2009.05.037; Cohen R, 2012, PEDIATR INFECT DIS J, V31, P297, DOI 10.1097/INF.0b013e318247ef84; Cooper D, 2011, VACCINE, V29, P7207, DOI 10.1016/j.vaccine.2011.06.056; Dagan R, 2013, CLIN INFECT DIS, V57, P952, DOI 10.1093/cid/cit428; Elberse K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025018; Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049; Gertz RE, 2010, J INFECT DIS, V201, P770, DOI 10.1086/650496; Hausdorff WP, 2000, CLIN INFECT DIS, V30, P100, DOI 10.1086/313608; Jacobs MR, 2010, J CLIN MICROBIOL, V48, P1456, DOI 10.1128/JCM.01907-09; Jacobs MR, 2009, J CLIN MICROBIOL, V47, P64, DOI 10.1128/JCM.01524-08; Jean-Verdier B, 2011, MED ENFANCE, V31, P187; Jin P, 2009, J INFECT DIS, V200, P1375, DOI 10.1086/606118; Jin P, 2009, J CLIN MICROBIOL, V47, P2470, DOI 10.1128/JCM.00484-09; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Lambertsen L, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-282; LEPOUTRE A, 2008, EURO SURVEILL, V13; Loman NJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064731; Mavroidi A, 2004, J BACTERIOL, V186, P8181, DOI 10.1128/JB.186.24.8181-8192.2004; Millar EV, 2010, CLIN INFECT DIS, V51, P1258, DOI 10.1086/657070; Moschioni M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061003; Nahm MH, 2009, J INFECT DIS, V199, P320, DOI 10.1086/596064; Nunes S, 2009, J CLIN MICROBIOL, V47, P472, DOI 10.1128/JCM.01984-08; Oftadeh S, 2010, J CLIN MICROBIOL, V48, P3378, DOI 10.1128/JCM.00675-10; Park IH, 2008, J INFECT DIS, V198, P1818, DOI 10.1086/593339; Park IH, 2007, INFECT IMMUN, V75, P4482, DOI 10.1128/IAI.00510-07; Park IH, 2007, J CLIN MICROBIOL, V45, P1225, DOI 10.1128/JCM.02199-06; Rolo D, 2011, J ANTIMICROB CHEMOTH, V66, P1712, DOI 10.1093/jac/dkr193; Rolo D, 2011, J CLIN MICROBIOL, V49, P2328, DOI 10.1128/JCM.02545-10; Song JH, 2011, J CLIN MICROBIOL, V49, P1758, DOI 10.1128/JCM.02628-10; Tocheva AS, 2010, EMERG INFECT DIS, V16, P154, DOI 10.3201/eid1601.090650; Varon E, CTR NATL REFERENCE P; Whitney CG, 2006, LANCET, V368, P1495, DOI 10.1016/S0140-6736(06)69637-2; World Health Organization, 2007, WKLY EPIDEMIOL REC, V82, P93; Yildirim I, 2010, VACCINE, V29, P283, DOI 10.1016/j.vaccine.2010.10.032	41	13	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90935	10.1371/journal.pone.0090935	http://dx.doi.org/10.1371/journal.pone.0090935			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603763	Green Submitted, Green Published, gold			2022-12-27	WOS:000332483600109
J	Mueller, A; Davis, A; Carlson, SS; Robinson, FR				Mueller, Adrienne; Davis, Adam; Carlson, Steven S.; Robinson, Farrel R.			N-Acetylgalactosamine Positive Perineuronal Nets in the Saccade-Related-Part of the Cerebellar Fastigial Nucleus Do Not Maintain Saccade Gain	PLOS ONE			English	Article							CHONDROITIN-SULFATE PROTEOGLYCANS; CENTRAL-NERVOUS-SYSTEM; EXTRACELLULAR-MATRIX; ADAPTATION; BRAIN; AGGRECAN; TERM; REGENERATION; DEPRIVATION; DEGRADATION	Perineuronal nets (PNNs) accumulate around neurons near the end of developmental critical periods. PNNs are structures of the extracellular matrix which surround synaptic contacts and contain chondroitin sulfate proteoglycans. Previous studies suggest that the chondroitin sulfate chains of PNNs inhibit synaptic plasticity and thereby help end critical periods. PNNs surround a high proportion of neurons in the cerebellar nuclei. These PNNs form during approximately the same time that movements achieve normal accuracy. It is possible that PNNs in the cerebellar nuclei inhibit plasticity to maintain the synaptic organization that produces those accurate movements. We tested whether or not PNNs in a saccade-related part of the cerebellar nuclei maintain accurate saccade size by digesting a part of them in an adult monkey performing a task that changes saccade size (long term saccade adaptation). We use the enzyme Chondroitinase ABC to digest the glycosaminoglycan side chains of proteoglycans present in the majority of PNNs. We show that this manipulation does not result in faster, larger, or more persistent adaptation. Our result indicates that intact perineuronal nets around saccade-related neurons in the cerebellar nuclei are not important for maintaining long-term saccade gain.	[Mueller, Adrienne; Davis, Adam; Robinson, Farrel R.] Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA; [Carlson, Steven S.] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Mueller, A (corresponding author), Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA.	alm04@uw.edu	Mueller, Adrienne/AAU-3106-2021	Mueller, Adrienne/0000-0001-9161-5323; Robinson, Farrel/0000-0002-3903-8327	National Institutes of Health [EY018585, 3R01EY018585-02S1, 2T32EY007031-36]; NATIONAL EYE INSTITUTE [R01EY018585, P30EY001730, T32EY007031] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD010425] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by National Institutes of Health grants EY018585, 3R01EY018585-02S1 and 2T32EY007031-36. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandtlow CE, 2000, PHYSIOL REV, V80, P1267, DOI 10.1152/physrev.2000.80.4.1267; Bruckner G, 1998, EXP BRAIN RES, V121, P300, DOI 10.1007/s002210050463; Buzunov E, 2013, BRAIN RES, V1503, P33, DOI 10.1016/j.brainres.2013.02.001; Carlson SS, 1996, MATRIX BIOL, V15, P281, DOI 10.1016/S0945-053X(96)90118-3; Carulli D, 2006, J COMP NEUROL, V494, P559, DOI 10.1002/cne.20822; Carulli D, 2010, BRAIN, V133, P2331, DOI 10.1093/brain/awq145; Corvetti L, 2005, J NEUROSCI, V25, P7150, DOI 10.1523/JNEUROSCI.0683-05.2005; Crook JD, 2007, NEUROSCIENCE, V149, P834, DOI 10.1016/j.neuroscience.2007.08.030; Deak A, 2012, NEUROSCI LETT, V513, P1, DOI 10.1016/j.neulet.2012.01.076; Dityatev A, 2007, DEV NEUROBIOL, V67, P570, DOI 10.1002/dneu.20361; Foscarin S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016666; FUCHS AF, 1993, J NEUROPHYSIOL, V70, P1723, DOI 10.1152/jn.1993.70.5.1723; FUCHS AF, 1966, J APPL PHYSIOL, V21, P1068, DOI 10.1152/jappl.1966.21.3.1068; Ghez C, 2000, PRINCIPLES NEURAL SC, P831; Goffart L, 2004, J NEUROPHYSIOL, V92, P3351, DOI 10.1152/jn.01199.2003; Gogolla N, 2009, SCIENCE, V325, P1258, DOI 10.1126/science.1174146; Goldberg ME, 1993, CEREBELLUM BASAL GAN, P203; Hartig W, 1999, BRAIN RES, V842, P15, DOI 10.1016/S0006-8993(99)01784-9; Hensch TK, 2004, ANNU REV NEUROSCI, V27, P549, DOI 10.1146/annurev.neuro.27.070203.144327; HOCKFIELD S, 1990, COLD SPRING HARB SYM, V55, P505; Horn AK, 2003, J COMP NEUROL, V455, P341, DOI 10.1002/cne.10495; Inaba N, 2003, NEUROSCI RES, V46, P359, DOI 10.1016/S0168-0102(03)00098-1; Jager C, 2013, NEUROSCIENCE, V238, P168, DOI 10.1016/j.neuroscience.2013.02.014; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; Kwok JCF, 2012, INT J BIOCHEM CELL B, V44, P582, DOI 10.1016/j.biocel.2012.01.004; Kwok JCF, 2008, RESTOR NEUROL NEUROS, V26, P131; Matthews RT, 2002, J NEUROSCI, V22, P7536; McKay BE, 2004, J COMP NEUROL, V473, P86, DOI 10.1002/cne.20109; MCLAUGHLIN SC, 1967, PERCEPT PSYCHOPHYS, V2, P359, DOI 10.3758/BF03210071; McRae PA, 2007, J NEUROSCI, V27, P5405, DOI 10.1523/JNEUROSCI.5425-06.2007; Moon LDF, 2001, NAT NEUROSCI, V4, P465, DOI 10.1038/87415; Morawski M, 2012, INT J BIOCHEM CELL B, V44, P690, DOI 10.1016/j.biocel.2012.01.010; Mueller AL, 2012, NEUROSCIENCE, V224, P38, DOI 10.1016/j.neuroscience.2012.08.012; NODA H, 1988, J NEUROPHYSIOL, V60, P1036, DOI 10.1152/jn.1988.60.3.1036; OHTSUKA K, 1990, EXP BRAIN RES, V81, P659, DOI 10.1007/BF02423517; OIKE Y, 1980, BIOCHEM J, V191, P193, DOI 10.1042/bj1910193; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Pizzorusso T, 2006, P NATL ACAD SCI USA, V103, P8517, DOI 10.1073/pnas.0602657103; Rhodes KE, 2004, J ANAT, V204, P33, DOI 10.1111/j.1469-7580.2004.00261.x; Robinson FR, 2006, J NEUROPHYSIOL, V96, P1030, DOI 10.1152/jn.01151.2005; ROBINSON FR, 1993, J NEUROPHYSIOL, V70, P1741, DOI 10.1152/jn.1993.70.5.1741; Romberg C, 2013, J NEUROSCI, V33, P7057, DOI 10.1523/JNEUROSCI.6267-11.2013; Sale A, 2007, NAT NEUROSCI, V10, P679, DOI 10.1038/nn1899; Schmalfeldt M, 1998, J BIOL CHEM, V273, P15758, DOI 10.1074/jbc.273.25.15758; Schnell SA, 1999, J HISTOCHEM CYTOCHEM, V47, P719, DOI 10.1177/002215549904700601; SCHUIRMANN DJ, 1987, J PHARMACOKINET BIOP, V15, P657, DOI 10.1007/BF01068419; Seeberger T, 2002, BRAIN RES, V956, P374, DOI 10.1016/S0006-8993(02)03577-1; Silbert JE, 2002, IUBMB LIFE, V54, P177, DOI 10.1080/15216540214923; Straube A, 1997, J NEUROPHYSIOL, V77, P874, DOI 10.1152/jn.1997.77.2.874; Wang DF, 2012, CELL TISSUE RES, V349, P147, DOI 10.1007/s00441-012-1375-y; Yamaguchi Y, 2000, CELL MOL LIFE SCI, V57, P276, DOI 10.1007/PL00000690; Zimmermann DR, 2008, HISTOCHEM CELL BIOL, V130, P635, DOI 10.1007/s00418-008-0485-9	52	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e86154	10.1371/journal.pone.0086154	http://dx.doi.org/10.1371/journal.pone.0086154			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603437	gold, Green Submitted, Green Published			2022-12-27	WOS:000332483600002
J	Patel, N; Vogel, R; Chandra-Kuntal, K; Glasgow, W; Kelavkar, U				Patel, Nima; Vogel, Robert; Chandra-Kuntal, Kumar; Glasgow, Wayne; Kelavkar, Uddhav			A Novel Three Serum Phospholipid Panel Differentiates Normal Individuals from Those with Prostate Cancer	PLOS ONE			English	Article							PLASMA PHOSPHOLIPIDS; MEMBRANE-LIPIDS; FATTY-ACIDS; BIOMARKERS; LIPIDOMICS; LEVEL; RISK	Background: The results of prostate specific antigen (PSA) and digital rectal examination (DRE) screenings lead to both under and over treatment of prostate cancer (PCa). As such, there is an urgent need for the identification and evaluation of new markers for early diagnosis and disease prognosis. Studies have shown a link between PCa, lipids and lipid metabolism. Therefore, the aim of this study was to examine the concentrations and distribution of serum lipids in patients with PCa as compared with serum from controls. Method: Using Electrospray ionization mass spectrometry (ESI-MS/MS) lipid profiling, we analyzed serum phospholipids from age-matched subjects who were either newly diagnosed with PCa or healthy (normal). Results: We found that cholester (CE), dihydrosphingomyelin (DSM), phosphatidylcholine (PC), egg phosphatidylcholine (ePC) and egg phoshphatidylethanolamine (ePE) are the 5 major lipid groups that varied between normal and cancer serums. ePC 38: 5, PC 40: 3, and PC 42: 4 represent the lipids species most prevalent in PCa as compared with normal serum. Further analysis revealed that serum ePC 38: 5 >= 0.015 nmoles, PC 40.3 <= 0.001 nmoles and PC 42: 4 <= 0.0001 nmoles correlated with the absence of PCa at 94% prediction. Conversely, serum ePC 38: 5 <= 0.015 nmoles, PC 40: 3 >= 0.001 nmoles, and PC 42: 4 >= 0.0001 nmoles correlated with the presence of PCa. Conclusion: In summary, we have demonstrated that ePC 38: 5, PC 40: 3, and PC 42: 4 may serve as early predictive serum markers for the presence of PCa.	[Patel, Nima; Chandra-Kuntal, Kumar; Glasgow, Wayne; Kelavkar, Uddhav] Mem Univ, Dept Lab Oncol Res, Med Ctr MUMC, Savannah, GA 31404 USA; [Patel, Nima; Chandra-Kuntal, Kumar; Glasgow, Wayne; Kelavkar, Uddhav] Mercer Univ, Sch Med MUSM, Anderson Canc Inst, Savannah, GA USA; [Vogel, Robert] Georgia So Univ, Statesboro, GA 30460 USA	Mercer University; University System of Georgia; Georgia Southern University	Kelavkar, U (corresponding author), Mem Univ, Dept Lab Oncol Res, Med Ctr MUMC, Savannah, GA 31404 USA.	Kelavkar_U@mercer.edu						Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; [Anonymous], 2007, FOOD NUTR PHYS ACT P; Arab L, 2003, J NUTR, V133, p925S, DOI 10.1093/jn/133.3.925S; Awwad HM, 2012, CLIN BIOCH; Bartz R, 2007, J LIPID RES, V48, P837, DOI 10.1194/jlr.M600413-JLR200; Benjamini Y, 2005, J AM STAT ASSOC, V100, P71, DOI 10.1198/016214504000001907; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brasky TM, AM J EPIDEMIOLOGY, V173, P1429; Brett AS, 2011, NEW ENGL J MED, V365, P1949, DOI 10.1056/NEJMp1112191; Bretz F, 2005, METHOD INFORM MED, V44, P423; Bretz F, 2005, METHOD INFORM MED, V44, P431; Brugger B, 1997, P NATL ACAD SCI USA, V94, P2339, DOI 10.1073/pnas.94.6.2339; Chan JM, 2004, J UROLOGY, V172, pS17; Chan June M, 2004, J Urol, V172, pS13, DOI 10.1097/01.ju.0000142068.66876.53; Clarke Raymond A, 2010, Cancers (Basel), V2, P1125, DOI 10.3390/cancers2021125; Crowe FL, 2008, AM J CLIN NUTR, V88, P1353, DOI 10.3945/ajcn.2008.26369; Cvetkovic B, 2012, MED ONCOL, V29, P809, DOI 10.1007/s12032-011-9914-z; DeMarzo AM, 2003, LANCET, V361, P955, DOI 10.1016/S0140-6736(03)12779-1; Devaiah SP, 2006, PHYTOCHEMISTRY, V67, P1907, DOI 10.1016/j.phytochem.2006.06.005; Epstein MM, 2012, AM J EPIDEMIOL, V176, P240, DOI 10.1093/aje/kwr520; Greene KL, 2009, J UROLOGY, V182, P2232, DOI 10.1016/j.juro.2009.07.093; Gronberg H, 2003, LANCET, V361, P859, DOI 10.1016/S0140-6736(03)12713-4; Heidenreich A, 2010, GUIDELINES PROSTATE; Huang MG, 2012, PROSTATE, V72, P1779, DOI 10.1002/pros.22531; Jump DB, 2004, CRIT REV CL LAB SCI, V41, P41, DOI 10.1080/10408360490278341; Kelavkar UP, 2007, PROSTAG OTH LIPID M, V82, P185, DOI 10.1016/j.prostaglandins.2006.05.015; Kim SY, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-144; Krzanowski WJ, 2009, MONOGR STAT APPL PRO, V111, P1; LEAF DA, 1995, AM J CLIN NUTR, V62, P68, DOI 10.1093/ajcn/62.1.68; Liebisch G, 2004, BBA-MOL CELL BIOL L, V1686, P108, DOI 10.1016/j.bbalip.2004.09.003; Min HK, 2011, ANAL BIOANAL CHEM, V399, P823, DOI 10.1007/s00216-010-4290-7; Norrish AE, 1999, BRIT J CANCER, V81, P1238, DOI 10.1038/sj.bjc.6690835; Pepe MS, 2001, J NATL CANCER I, V93, P1054, DOI 10.1093/jnci/93.14.1054; Pepe MS, 2004, STAT EVALUATION MED; PUNNONEN K, 1989, J CANCER RES CLIN, V115, P575, DOI 10.1007/BF00391361; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Reynolds MA, 2003, CLIN CHEM, V49, P1733, DOI 10.1373/49.10.1733; Sartor MA, 2009, BIOINFORMATICS, V25, P211, DOI 10.1093/bioinformatics/btn592; Steele CB, 2000, AM J PUBLIC HEALTH, V90, P1595, DOI 10.2105/AJPH.90.10.1595; Tewari R, 2012, J ANDROL, V33, P763, DOI 10.2164/jandrol.111.015578; Thompson IM, 2004, NEW ENGL J MED, V350, P2239, DOI 10.1056/NEJMoa031918; Tsai CA, 2003, BIOMETRICS, V59, P1071, DOI 10.1111/j.0006-341X.2003.00123.x; Van AHT, 2012, BIOINFORMATICS, V28, P1766, DOI 10.1093/bioinformatics/bts238; Welti R, 2002, J BIOL CHEM, V277, P31994, DOI 10.1074/jbc.M205375200; Yang YJ, 1999, CLIN BIOCHEM, V32, P405, DOI 10.1016/S0009-9120(99)00036-3; Zhou X, EXPT MOL PATHOLOGY, V92, P105; ZWEIG MH, 1993, CLIN CHEM, V39, P561	47	23	26	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e88841	10.1371/journal.pone.0088841	http://dx.doi.org/10.1371/journal.pone.0088841			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603597	Green Submitted, Green Published, gold			2022-12-27	WOS:000332483600007
J	Tian, JH; Fu, LP; Yin, DY; Zhang, JM; Chen, YM; An, NY; Xu, BX				Tian, Jiahe; Fu, Liping; Yin, Dayi; Zhang, Jinming; Chen, Yingmao; An, Ningyu; Xu, Baixuan			Does the Novel Integrated PET/MRI Offer the Same Diagnostic Performance as PET/CT for Oncological Indications?	PLOS ONE			English	Article							WHOLE-BODY PET/MRI; POSITRON-EMISSION-TOMOGRAPHY; ATTENUATION CORRECTION; HYBRID PET/MRI; MAGNETIC-FIELD; MRI; SCANNER; CANCER; SEGMENTATION; IMPACT	Background: We compared PET/MRI with PET/CT in terms of lesion detection and quantitative measurement to verify the feasibility of the novel integrated imaging modality for oncological applications. Methodology/Principal Findings: In total, 285 patients referred to our PET/CT center for oncological indications voluntarily participated in this same-day PET/CT and PET/MRI comparative study. PET/CT images were acquired and reconstructed following routine protocols, and then PET/MRI was performed at a mean time interval of 28 +/- 11 min (range 15-45 min). PET/MRI covered the body trunk with a sequence combination of transverse T1WI 3D-volumetric interpolated breath-hold, T2WI turbo spin echo with fat saturation, diffusion-weighted imaging with double b values (50 and 800 s/mm(2)), and simultaneous PET acquisition over 45 min/5 bed positions. The maximum standardized uptake value (SUVmax) was assessed by manually drawn regions of interest over fluorodeoxyglucose-positive lesions. Among 285 cases, 57 showed no abnormalities, and 368 lesions (278 malignant, 68 benign and 22 undetermined) were detected in 228 patients. When stand-alone modalities were evaluated, PET revealed 31 and 12 lesions missed by CT and MRI, respectively, and CT and MRI revealed 38 and 61 more lesions, respectively, than PET. Compared to CT, MRI detected 40 more lesions and missed 8. In the integrated mode, PET/CT correctly detected 6 lesions misdiagnosed by PET/MRI, but was false-negative in 30 cases that were detected by PET/MRI. The overall diagnosis did not differ between integrated PET/MRI and PET/CT. SUVmax for lesions were slightly higher from PET/MRI than PET/CT but correlated well (rho = 0.85-0.91). Conclusions/Significance: The novel integrated PET/MRI performed comparatively to PET/CT in lesion detection and quantitative measurements. PET from either scanner modality offered almost the same information despite differences in hardware. Further study is needed to explore features of integrated PET/MRI not addressed in this study.	[Tian, Jiahe; Fu, Liping; Yin, Dayi; Zhang, Jinming; Chen, Yingmao; Xu, Baixuan] Chinese Peoples Liberat Army, Gen Hosp, Dept Nucl Med, Beijing, Peoples R China; [An, Ningyu] Chinese Peoples Liberat Army, Gen Hosp, Dept Radiol, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital	Tian, JH (corresponding author), Chinese Peoples Liberat Army, Gen Hosp, Dept Nucl Med, Beijing, Peoples R China.	tianjh@vip.sina.com			China Postdoctoral Science Foundation [20090461433]; National Research Key Project [2011 YQ03114]	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Research Key Project	This study was supported by the China Postdoctoral Science Foundation, No. 20090461433; and National Research Key Project 2011 YQ03114. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berker Y, 2012, J NUCL MED, V53, P796, DOI 10.2967/jnumed.111.092577; Beyer T, 2000, J NUCL MED, V41, P1369; Beyer T, 2011, INSIGHTS IMAGING, V2, P235, DOI 10.1007/s13244-011-0085-4; Boss A, 2011, EUR RADIOL, V21, P1439, DOI 10.1007/s00330-011-2072-z; Boss A, 2010, J NUCL MED, V51, P1198, DOI 10.2967/jnumed.110.074773; Brix G, 2009, EUR J NUCL MED MOL I, V36, P131, DOI 10.1007/s00259-008-0937-4; Buchbender C, 2013, EUR J RADIOL, V82, P877, DOI 10.1016/j.ejrad.2013.01.019; Buchbender C, 2013, EUR J RADIOL, V82, P380, DOI 10.1016/j.ejrad.2012.11.018; Buchbender C, 2012, J NUCL MED, V53, P1244, DOI 10.2967/jnumed.112.109306; Buchbender C, 2012, J NUCL MED, V53, P928, DOI 10.2967/jnumed.112.105338; Catana C, 2012, J NUCL MED, V53, P1916, DOI 10.2967/jnumed.112.105346; Dikaios N, 2012, EUR RADIOL, V22, P439, DOI 10.1007/s00330-011-2274-4; Heusch P, 2013, EUR J RADIOL, V82, P870, DOI 10.1016/j.ejrad.2013.01.008; Hillner BE, 2008, J CLIN ONCOL, V26, P2155, DOI 10.1200/JCO.2007.14.5631; Hillner BE, 2008, J NUCL MED, V49, P1928, DOI 10.2967/jnumed.108.056713; Hofmann M, 2011, J NUCL MED, V52, P1392, DOI 10.2967/jnumed.110.078949; Hofmann M, 2009, EUR J NUCL MED MOL I, V36, P93, DOI 10.1007/s00259-008-1007-7; IIDA H, 1986, IEEE T NUCL SCI, V33, P597, DOI 10.1109/TNS.1986.4337173; Judenhofer MS, 2013, SEMIN NUCL MED, V43, P19, DOI 10.1053/j.semnuclmed.2012.08.004; Keereman V, 2010, J NUCL MED, V51, P812, DOI 10.2967/jnumed.109.065425; Keller SH, 2013, MAGN RESON MATER PHY, V26, P173, DOI 10.1007/s10334-012-0345-4; Kim JH, 2012, J NUCL MED, V53, P1878, DOI 10.2967/jnumed.112.104109; Kjaer A, 2013, MAGN RESON MATER PHY, V26, P37, DOI 10.1007/s10334-012-0357-0; Ladefoged CN, 2013, EUR J NUCL MED MOL I, V40, P594, DOI 10.1007/s00259-012-2316-4; Loeffelbein DJ, 2012, J ORAL MAXIL SURG, V70, P473, DOI 10.1016/j.joms.2011.02.120; Mansi L, 2012, EUR J NUCL MED MOL I, V39, P1519, DOI 10.1007/s00259-012-2185-x; Martinez-Moller A, 2012, J NUCL MED, V53, P1415, DOI 10.2967/jnumed.112.109348; Nagarajah J, 2011, EUR J NUCL MED MOL I, V38, P1862, DOI 10.1007/s00259-011-1866-1; Ng TSC, 2012, J NUCL MED, V53, P1102, DOI 10.2967/jnumed.111.099861; Nuyts J, 2012, J NUCL MED, V53, P977; Paulus DH, 2012, MED PHYS, V39, P4306, DOI 10.1118/1.4729716; Peng H, 2012, PHYS MED BIOL, V57, DOI 10.1088/0031-9155/57/9/N101; Pfluger T, 2012, EUR J NUCL MED MOL I, V39, P1745, DOI 10.1007/s00259-012-2228-3; Platzek I, 2013, EUR J NUCL MED MOL I, V40, P6, DOI 10.1007/s00259-012-2248-z; Raylman RR, 1996, IEEE T NUCL SCI, V43, P2406, DOI 10.1109/23.531789; Sattler B, 2013, MAGN RESON MATER PHY, V26, P159, DOI 10.1007/s10334-012-0347-2; Sauter AW, 2010, TRENDS MOL MED, V16, P508, DOI 10.1016/j.molmed.2010.08.003; Seemann MD, 2005, TECHNOL CANCER RES T, V4, P577, DOI 10.1177/153303460500400512; Stegger L, 2012, ACTA RADIOL, V53, P1066, DOI 10.1258/ar.2012.120191; Tatsumi M, 2011, INT J CLIN ONCOL, V16, P408, DOI 10.1007/s10147-011-0202-x; Thorwarth D, 2011, INT J RADIAT ONCOL, V81, P277, DOI 10.1016/j.ijrobp.2010.10.078; Wiesmuller M, 2013, EUR J NUCL MED MOL I, V40, P12, DOI 10.1007/s00259-012-2249-y	42	20	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90844	10.1371/journal.pone.0090844	http://dx.doi.org/10.1371/journal.pone.0090844			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603857	gold, Green Published, Green Submitted			2022-12-27	WOS:000332483600093
J	Utami, KH; Hillmer, AM; Aksoy, I; Chew, EGY; Teo, ASM; Zhang, ZS; Lee, CWH; Chen, PJ; Seng, CC; Ariyaratne, PN; Rouam, SL; Soo, LS; Yousoof, S; Prokudin, I; Peters, G; Collins, F; Wilson, M; Kakakios, A; Haddad, G; Menuet, A; Perche, O; Tay, SKH; Sung, KWK; Ruan, XA; Ruan, YJ; Liu, ET; Briault, S; Jamieson, RV; Davila, S; Cacheux, V				Utami, Kagistia H.; Hillmer, Axel M.; Aksoy, Irene; Chew, Elaine G. Y.; Teo, Audrey S. M.; Zhang, Zhenshui; Lee, Charlie W. H.; Chen, Pauline J.; Seng, Chan Chee; Ariyaratne, Pramila N.; Rouam, Sigrid L.; Soo, Lim Seong; Yousoof, Saira; Prokudin, Ivan; Peters, Gregory; Collins, Felicity; Wilson, Meredith; Kakakios, Alyson; Haddad, Georges; Menuet, Arnaud; Perche, Olivier; Tay, Stacey Kiat Hong; Sung, Ken W. K.; Ruan, Xiaoan; Ruan, Yijun; Liu, Edison T.; Briault, Sylvain; Jamieson, Robyn V.; Davila, Sonia; Cacheux, Valere			Detection of Chromosomal Breakpoints in Patients with Developmental Delay and Speech Disorders	PLOS ONE			English	Article							LINKED LYMPHOPROLIFERATIVE SYNDROME; COPY NUMBER VARIATION; HUMAN GENOME; TRANSLOCATION BREAKPOINT; INSITU HYBRIDIZATION; STRUCTURAL VARIATION; MENTAL-RETARDATION; REARRANGEMENTS; GENE; SCHIZOPHRENIA	Delineating candidate genes at the chromosomal breakpoint regions in the apparently balanced chromosome rearrangements (ABCR) has been shown to be more effective with the emergence of next-generation sequencing (NGS) technologies. We employed a large-insert (7-11 kb) paired-end tag sequencing technology (DNA-PET) to systematically analyze genome of four patients harbouring cytogenetically defined ABCR with neurodevelopmental symptoms, including developmental delay (DD) and speech disorders. We characterized structural variants (SVs) specific to each individual, including those matching the chromosomal breakpoints. Refinement of these regions by Sanger sequencing resulted in the identification of five disrupted genes in three individuals: guanine nucleotide binding protein, q polypeptide (GNAQ), RNA-binding protein, fox-1 homolog (RBFOX3), unc-5 homolog D (C. elegans) (UNC5D), transmembrane protein 47 (TMEM47), and X-linked inhibitor of apoptosis (XIAP). Among them, XIAP is the causative gene for the immunodeficiency phenotype seen in the patient. The remaining genes displayed specific expression in the fetal brain and have known biologically relevant functions in brain development, suggesting putative candidate genes for neurodevelopmental phenotypes. This study demonstrates the application of NGS technologies in mapping individual gene disruptions in ABCR as a resource for deciphering candidate genes in human neurodevelopmental disorders (NDDs).	[Utami, Kagistia H.; Hillmer, Axel M.; Aksoy, Irene; Chew, Elaine G. Y.; Teo, Audrey S. M.; Zhang, Zhenshui; Lee, Charlie W. H.; Chen, Pauline J.; Seng, Chan Chee; Ariyaratne, Pramila N.; Rouam, Sigrid L.; Soo, Lim Seong; Sung, Ken W. K.; Ruan, Xiaoan; Ruan, Yijun; Liu, Edison T.; Davila, Sonia; Cacheux, Valere] Genome Inst Singapore, Singapore, Singapore; [Yousoof, Saira; Prokudin, Ivan; Jamieson, Robyn V.] Childrens Hosp Westmead, Childrens Med Res Inst, Sydney, NSW, Australia; [Yousoof, Saira; Prokudin, Ivan; Jamieson, Robyn V.] Save Sight Inst, Sydney, NSW, Australia; [Yousoof, Saira; Prokudin, Ivan] Univ Sydney, Sydney Med Sch, Discipline Paediat & Child Hlth, Sydney, NSW 2006, Australia; [Yousoof, Saira; Prokudin, Ivan] Univ Sydney, Sydney Med Sch, Discipline Genet Med, Sydney, NSW 2006, Australia; [Peters, Gregory] Childrens Hosp Westmead, Dept Cytogenet, Sydney, NSW, Australia; [Collins, Felicity; Wilson, Meredith] Childrens Hosp Westmead, Dept Clin Genet, Sydney, NSW, Australia; [Kakakios, Alyson] Childrens Hosp Westmead, Dept Immunol, Sydney, NSW, Australia; [Haddad, Georges] Ctr Hosp, Unite Genet, Blois, France; [Menuet, Arnaud; Perche, Olivier; Briault, Sylvain] Ctr Hosp Reg Orleans, Serv Genet INEM CNRS Univ UMR7355, Orleans, France; [Utami, Kagistia H.; Tay, Stacey Kiat Hong] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Paediat, Singapore 117595, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Children's Medical Research Institute - Australia; University of Sydney; University of Sydney; University of Sydney; University of Sydney; University of Sydney; University of Sydney; University of Sydney; Centre Hospitalier Regional d'Orleans; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); National University of Singapore	Cacheux, V (corresponding author), Genome Inst Singapore, Singapore, Singapore.	valerecacheux@gmail.com	Aksoy, Irene/O-2238-2013; Utami, Kagistia Hana/AAS-2710-2021; Tay, Stacey/E-7029-2015; Jamieson, Robyn/M-5161-2019; Hillmer, Axel M/B-7485-2015; Hillmer, Axel M/N-2927-2014	Aksoy, Irene/0000-0003-4353-5876; Tay, Stacey/0000-0002-3077-4184; Jamieson, Robyn/0000-0002-7285-0253; Hillmer, Axel M/0000-0002-3381-7266; Hillmer, Axel M/0000-0002-3381-7266; Perche, Olivier/0000-0002-6513-5534; Chew, Elaine/0000-0001-9763-703X; Sung, Wing-Kin/0000-0001-7806-7086	Biomedical Medical Research Council (BMRC) of the Agency for Science, Technology and Research (A*STAR), Singapore; National Health and Medical Research Australia (NHMRC); Singapore International Graduate Award (SINGA) fellowship; Genome Institute of Singapore internal research funds from the BMRC	Biomedical Medical Research Council (BMRC) of the Agency for Science, Technology and Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR)); National Health and Medical Research Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Singapore International Graduate Award (SINGA) fellowship; Genome Institute of Singapore internal research funds from the BMRC	This study is supported by grants from Biomedical Medical Research Council (BMRC) of the Agency for Science, Technology and Research (A*STAR), Singapore. Support is also acknowledged from the National Health and Medical Research Australia (NHMRC). KHU is funded by Singapore International Graduate Award (SINGA) fellowship. Additional support was also provided by the Genome Institute of Singapore internal research funds from the BMRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam MM, 2012, J PHYS CHEM A, V116, P11034, DOI 10.1021/jp3090233; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Ben-Zur T, 2000, DEV BIOL, V217, P107, DOI 10.1006/dbio.1999.9532; Ben-Zur T, 1999, GENOMICS, V58, P102, DOI 10.1006/geno.1999.5798; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; CHELLY J, 1993, NAT GENET, V3, P14, DOI 10.1038/ng0193-14; Chen W, 2010, EUR J HUM GENET, V18, P539, DOI 10.1038/ejhg.2009.211; CHERIF D, 1990, NOUV REV FR HEMATOL, V32, P459; Chiang C, 2012, NAT GENET, V44, P390, DOI 10.1038/ng.2202; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; Corpas M, 2012, CURR PROTOC HUM GENE; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fantes JA, 2008, AM J HUM GENET, V82, P916, DOI 10.1016/j.ajhg.2008.02.007; Girirajan S, 2012, NEW ENGL J MED, V367, P1321, DOI 10.1056/NEJMoa1200395; Hillmer AM, 2011, GENOME RES, V21, P665, DOI 10.1101/gr.113555.110; Hochstenbach R, 2009, EUR J MED GENET, V52, P161, DOI 10.1016/j.ejmg.2009.03.015; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Inaki K, 2011, GENOME RES, V21, P676, DOI 10.1101/gr.113225.110; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Kloosterman WP, 2012, CELL REP, V1, P648, DOI 10.1016/j.celrep.2012.05.009; Kloosterman WP, 2011, HUM MOL GENET, V20, P1916, DOI 10.1093/hmg/ddr073; Kloosterman WP, 2013, CURR OPIN CELL BIOL; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Le Scouarnec S, 2012, HEREDITY, V108, P75, DOI 10.1038/hdy.2011.100; LICHTER P, 1990, SCIENCE, V247, P64, DOI 10.1126/science.2294592; Liu PF, 2011, CELL, V146, P888, DOI 10.1016/j.cell.2011.07.042; MACGREGOR DJ, 1989, J MED GENET, V26, P590, DOI 10.1136/jmg.26.9.590; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; Millar JK, 2000, HUM MOL GENET, V9, P1415, DOI 10.1093/hmg/9.9.1415; Millar JK, 2001, MOL PSYCHIATR, V6, P173, DOI 10.1038/sj.mp.4000784; Miller DT, 2010, AM J HUM GENET, V86, P749, DOI 10.1016/j.ajhg.2010.04.006; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; MUIR WJ, 1995, CYTOGENET CELL GENET, V70, P35, DOI 10.1159/000133986; Nagarajan N, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-r115; Ng KP, 2012, NAT MED; Offermanns S, 1997, P NATL ACAD SCI USA, V94, P14089, DOI 10.1073/pnas.94.25.14089; Rauch A, 2004, J MED GENET, V41, P916, DOI 10.1136/jmg.2004.022855; Rauch A, 2006, AM J MED GENET A, V140A, P2063, DOI 10.1002/ajmg.a.31416; RAY PN, 1985, NATURE, V318, P672, DOI 10.1038/318672a0; Rigaud S, 2006, NATURE, V444, P110, DOI 10.1038/nature05257; Rigaud S, 2007, M S-MED SCI, V23, P235, DOI 10.1051/medsci/2007233235; Savage MS, 2011, CURR OPIN OBSTET GYN, V23, P103, DOI 10.1097/GCO.0b013e32834457c7; Schluth-Bolard C, 2013, J MED GENET, V50, P144, DOI 10.1136/jmedgenet-2012-101351; Shaffer LG, 2005, GENET MED, V7, P650, DOI 10.1097/01.gim.0000186545.83160.1e; Swaminathan GJ, 2012, HUM MOL GENET, V21, pR37, DOI 10.1093/hmg/dds362; Takemoto M, 2011, CEREB CORTEX, V21, P1925, DOI 10.1093/cercor/bhq265; Talkowski ME, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.028; Talkowski ME, 2011, AM J HUM GENET, V88, P469, DOI 10.1016/j.ajhg.2011.03.013; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; van Heesch S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-257; Vandeweyer G, 2009, HUM GENET, V126, P133, DOI 10.1007/s00439-009-0661-6; VERGA V, 1991, AM J HUM GENET, V48, P1133; Wang JC, 2010, AM J MED GENET A, V152A, P209, DOI 10.1002/ajmg.a.33161; WARBURTON D, 1991, AM J HUM GENET, V49, P995; Yao F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046152; Zhu YY, 2013, J CLIN INVEST, V123, P2935, DOI 10.1172/JCI65988	59	27	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90852	10.1371/journal.pone.0090852	http://dx.doi.org/10.1371/journal.pone.0090852			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603971	gold, Green Published, Green Submitted			2022-12-27	WOS:000332483600099
J	Yin, J; Liu, ZP; Li, HX; Sun, JY; Chang, XZ; Liu, J; He, SS; Li, BH				Yin, Jian; Liu, Zhipei; Li, Haixin; Sun, Jingyan; Chang, Xinzhong; Liu, Jing; He, Shanshan; Li, Binghui			Association of PKC zeta Expression with Clinicopathological Characteristics of Breast Cancer	PLOS ONE			English	Article							PROTEIN-KINASE-C; DOWN-REGULATION; INHIBITS MIGRATION; CELL-POLARITY; ACTIVATION; COMPLEX; PAR6; CHEMOTAXIS; INTERACTS; TISSUE	The protein kinase C (PKC) family has been functionally linked to cancer. It has been suggested that atypical PKCs contribute to cell proliferation and cancer progression. With respect to breast cancer, PKC zeta has been found to play a key role in intracellular transduction of mitogenic and apoptotic signals using mammary cell lines. However, little is known about its function in vivo. Here we examined the correlation between PKC zeta protein levels and important clinicopathologic factors in breast cancer using patient samples. To conduct the study, 30 invasive ductal carcinoma cases and their paired normal tissues were used for tissue microarray analysis (TMA) and 16 were used for western blot analysis. In addition, the correlation between PKC zeta expression levels and clinicopathologic characteristics was determined in 176 cases with relevant clinical data. Finally, the correlation between PKC zeta and epithelial growth factor receptor 2 (HER2) expressions was determined using three breast cancer cell lines by western blot analysis. Both TMA and western blot results showed that PKC zeta protein was highly expressed in primary tumors but not in paired normal tissue. The correlation study indicated that high PKC zeta levels were associated with premenopausal patients (p = 0.019) and worse prognostic factors, such as advanced clinical stage, more lymph node involvement and larger tumor size. Both disease-free survival and overall survival rates were lower in the high PKC zeta group than those in the low PKC zeta group. No correlation was observed between PKC zeta levels and age, histological grade, or estrogen or progesterone receptor expression status. A positive correlation between PKC zeta and HER2 levels was observed in both tumor samples and cell lines. Our observations link PKC zeta expression with factors pointing to worse prognosis, higher HER2 levels and a lower survival rate. This suggests that PKC zeta protein levels may serve as a prognostic marker of breast cancer.	[Yin, Jian; Sun, Jingyan; Chang, Xinzhong; Liu, Jing; He, Shanshan] Tianjin Med Univ, Canc Inst & Hosp, Natl Clin Res Ctr Canc, Dept Breast Surg, Tianjin, Peoples R China; [Yin, Jian; Sun, Jingyan; Chang, Xinzhong; Liu, Jing; He, Shanshan] Key Lab Canc Prevent & Therapy, Tianjin, Peoples R China; [Yin, Jian; Sun, Jingyan; Chang, Xinzhong; Liu, Jing; He, Shanshan] Tianjin Med Univ, Minist Educ, Key Lab Breast Canc Prevent & Therapy, Tianjin, Peoples R China; [Liu, Zhipei] Tianjin Binhai Union Gene Technol Co LTD, Prod & R&D Ctr, Tianjin, Peoples R China; [Liu, Zhipei] Union Stem Cell & Gene Engn Co LTD, Gene Bank, Tianjin, Peoples R China; [Li, Haixin] Tianjin Med Univ, Tumor Tissue Banking Facil, Dept Epidemiol & Biostat, Canc Inst & Hosp, Tianjin, Peoples R China; [Li, Binghui] Tianjin Med Univ, Canc Inst & Hosp, Canc Cell Biol Lab, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; Tianjin Medical University	Yin, J (corresponding author), Tianjin Med Univ, Canc Inst & Hosp, Natl Clin Res Ctr Canc, Dept Breast Surg, Tianjin, Peoples R China.	yinjian@tjmuch.com			Chinese National Natural Science Foundation [81202100]	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	The study has been supported by Chinese National Natural Science Foundation (No. 81202100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awadelkarim KD, 2012, INT J CANCER, V131, P2852, DOI 10.1002/ijc.27600; CASTAGNA M, 1982, J BIOL CHEM, V257, P7847; Castoria G, 2004, MOL CELL BIOL, V24, P7643, DOI 10.1128/MCB.24.17.7643-7653.2004; Cheng W, 2012, J BIOL CHEM, V287, P26126, DOI 10.1074/jbc.M112.342170; Dong LQ, 1999, J BIOL CHEM, V274, P8117, DOI 10.1074/jbc.274.12.8117; Etienne-Manneville S, 2003, CURR OPIN CELL BIOL, V15, P67, DOI 10.1016/S0955-0674(02)00005-4; Fields Alan P, 2003, Methods Mol Biol, V233, P519; Guo H, 2009, J LEUKOCYTE BIOL, V85, P911, DOI 10.1189/jlb.0708429; Guo H, 2009, J NEUROCHEM, V109, P203, DOI 10.1111/j.1471-4159.2009.05946.x; Hollstein M, 2010, J PATHOL, V220, P164, DOI 10.1002/path.2637; Iakoubov R, 2011, ENDOCRINOLOGY, V152, P1244, DOI 10.1210/en.2010-1352; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Le Good JA, 1998, SCIENCE, V281, P2042, DOI 10.1126/science.281.5385.2042; Li HY, 2012, ANTI-CANCER DRUG, V23, P691, DOI 10.1097/CAD.0b013e3283514cc1; Lin YM, 2012, CHINESE J PHYSIOL, V55, P55, DOI 10.4077/CJP.2012.AMM118; Liu XF, 2004, MOL CELL BIOL, V24, P6665, DOI 10.1128/mcb.24.15.6665-6675.2004; Liu Y, 2009, MOL CANCER RES, V7, P944, DOI 10.1158/1541-7786.MCR-08-0368; Liu Y, 2009, LUNG CANCER, V63, P210, DOI 10.1016/j.lungcan.2008.05.010; NAKANISHI H, 1993, J BIOL CHEM, V268, P13; Nazarenko I, 2010, MOL CANCER RES, V8, P919, DOI 10.1158/1541-7786.MCR-09-0358; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; PAGE DL, 1991, AM J SURG PATHOL, V15, P334, DOI 10.1097/00000478-199104000-00002; Pu YS, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-39; Sun RH, 2005, CANCER RES, V65, P1433, DOI 10.1158/0008-5472.CAN-04-1163; Valkov A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017507; Valkova C, 2010, MOL CANCER RES, V8, P783, DOI 10.1158/1541-7786.MCR-09-0164; Venkatachalam K, 2010, J NEUROSCI, V30, P11337, DOI 10.1523/JNEUROSCI.2709-10.2010; Wilson MI, 2003, MOL CELL, V12, P39, DOI 10.1016/S1097-2765(03)00246-6; Wu J, 2010, INVEST NEW DRUG, V28, P268, DOI 10.1007/s10637-009-9242-8; Zhang F, 2010, CANCER RES, V70, P9360, DOI 10.1158/0008-5472.CAN-10-0207	30	13	13	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90811	10.1371/journal.pone.0090811	http://dx.doi.org/10.1371/journal.pone.0090811			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603690	gold, Green Published, Green Submitted			2022-12-27	WOS:000332483600087
J	D'Arcangelo, D; Nicodemi, EM; Rossi, S; Giampietri, C; Facchiano, F; Facchiano, A				D'Arcangelo, Daniela; Nicodemi, Ezio M.; Rossi, Stefania; Giampietri, Claudia; Facchiano, Francesco; Facchiano, Antonio			Identification of Serum Regression Signs in Infantile Hemangioma	PLOS ONE			English	Article							CHEMOATTRACTANT PROTEIN-1 MCP-1; GROWTH FACTOR-BB; IN-VITRO; VASCULAR MALFORMATIONS; CLINICAL CHARACTERISTICS; RECEPTOR-ALPHA; CELLS; VIVO; EXPRESSION; MICE	Vessel proliferation underlies a number of serious pathological conditions. Infantile Hemangioma (IH) is a low-aggressive vascular tumor, interesting as an in vivo model of spontaneous tumor regression. Identifying mechanisms underlying IH spontaneous regression may then help to elucidate vessel-growth control, strongly deregulated in other serious conditions such as sarcoma, melanoma, diabetic retinopathy. The present study was aimed at identifying early regression indicators within hematological parameters. Thirty-four blood samples were collected from IH diagnosed babies (20-months median age), spontaneously regressing with age. Nineteen serum standard blood-tests were carried out using diagnostic reagents; in addition, serum-expression of 27 cytokine/chemokines was measured. Samples were divided in three age-groups, namely <= 12, 13 to 24 and >24 months-age, respectively. Red-cells count, Hemoglobin, Hematocrit, Neutrophils, Lymphocytes, MCP-1 and MIP-1beta were significantly different in the three age-groups, according to one-way ANOVA analysis. The same parameters showed a significant Pearson-correlation with age, supporting the direct link of age with IH-regression. ROC analysis showed that red-cells count, Hemoglobin, Hematocrit, MCP-1 and MIP-1beta levels significantly discriminate IH in the proliferating-phase from IH in the regressing-phase. Such data indicate for the first time that standard hematological tests and cytokine serum-expression values may effectively discriminate proliferating-from regressing-IH, unrevealing early regression signs, and demonstrate that standard blood-tests may have novel unsuspected diagnostic/prognostic relevance in altered vessel-growth conditions.	[D'Arcangelo, Daniela; Facchiano, Antonio] IRCCS, IDI, Rome, Italy; [Nicodemi, Ezio M.] IRCCS, IDI, Ctr Anomalie Vasc, Div Chirurg Plast, Rome, Italy; [Rossi, Stefania; Facchiano, Francesco] Ist Super Sanita, Dipartimento Ematol Oncol & Med Mol, I-00161 Rome, Italy; [Giampietri, Claudia] Univ Roma La Sapienza, Dept Anat Histol Forens Med & Orthoped, Sect Histol & Med Embryol, I-00185 Rome, Italy	IRCCS Istituto Dermopatico dell'Immacolata (IDI); IRCCS Istituto Dermopatico dell'Immacolata (IDI); Istituto Superiore di Sanita (ISS); Sapienza University Rome	Facchiano, A (corresponding author), IRCCS, IDI, Rome, Italy.	a.facchiano@idi.it	Rossi, Stefania/J-8328-2016; D'Arcangelo, Daniela/K-6533-2016; Facchiano, Antonio/K-5984-2016; Facchiano, Antonio/J-4744-2012; Facchiano, Francesco/K-8716-2016	Rossi, Stefania/0000-0002-8854-7072; D'Arcangelo, Daniela/0000-0002-7862-3289; Facchiano, Antonio/0000-0002-4243-2392; Facchiano, Antonio/0000-0002-4243-2392; Facchiano, Francesco/0000-0003-4313-0617; Giampietri, Claudia/0000-0002-5025-5365	Italian Ministry of Health [RC12 3.5, RF07ONC-25/3]; Italy-USA Oncoproteomics Program	Italian Ministry of Health(Ministry of Health, Italy); Italy-USA Oncoproteomics Program	This work was funded by the Italian Ministry of Health [grant # RC12 3.5 and grant RF07ONC-25/3) and Italy-USA Oncoproteomics Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi MS, 2011, MOL THER, V19, P266, DOI 10.1038/mt.2010.211; Anghelina M, 2004, STEM CELLS DEV, V13, P665, DOI 10.1089/scd.2004.13.665; Bianchi G, 2000, Dev Immunol, V7, P143, DOI 10.1155/2000/39893; Bruckner AL, 2006, J AM ACAD DERMATOL, V55, P671, DOI 10.1016/j.jaad.2006.05.017; Cappuzzello C, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-28; Carmeliet P, 2011, NAT REV DRUG DISCOV, V10, P417, DOI 10.1038/nrd3455; Carvalho T, 2008, VET IMMUNOL IMMUNOP, V121, P344, DOI 10.1016/j.vetimm.2007.09.020; Chang LC, 2008, PEDIATRICS, V122, P360, DOI 10.1542/peds.2007-2767; Chiller KG, 2002, ARCH DERMATOL, V138, P1567, DOI 10.1001/archderm.138.12.1567; D'Amico G, 1998, BLOOD, V92, P207, DOI 10.1182/blood.V92.1.207.413a02_207_214; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Facchiano F, 2006, MOL ENDOCRINOL, V20, P2806, DOI 10.1210/me.2005-0322; Faraone D, 2006, BLOOD, V107, P1896, DOI 10.1182/blood-2005-04-1524; Faraone D, 2009, NEOPLASIA, V11, P732, DOI 10.1593/neo.09408; FRITZ E, 1986, BLOOD, V68, P514; Gonsalves C, 2010, J IMMUNOL, V185, P6253, DOI 10.4049/jimmunol.1000660; Gordillo GM, 2002, METHOD ENZYMOL, V352, P422; Greenberger S, 2010, ANGIOGENESIS, V13, P327, DOI 10.1007/s10456-010-9189-6; Haemmerling GJ, 2006, CELL CYCLE, V5, P509, DOI 10.4161/cc.5.5.2517; Haggstrom AN, 2006, PEDIATRICS, V118, P882, DOI 10.1542/peds.2006-0413; Holland KE, 2013, DERMATOL CLIN, V31, P289, DOI 10.1016/j.det.2012.12.006; Horuk R, 2001, CYTOKINE GROWTH F R, V12, P313, DOI 10.1016/S1359-6101(01)00014-4; Isik FF, 1996, J SURG RES, V61, P71, DOI 10.1006/jsre.1996.0083; Khan ZA, 2008, J CLIN INVEST, V118, P2592, DOI 10.1172/JCI33493; Kleiman A, 2012, EXP MOL PATHOL, V93, P264, DOI 10.1016/j.yexmp.2012.04.020; Krol A, 2005, ARCH FACIAL PLAST S, V7, P307, DOI 10.1001/archfaci.7.5.307; Landaw S, 1991, HEMATOLOGY BASIC PRI, P274; MULLIKEN JB, 1982, PLAST RECONSTR SURG, V69, P412, DOI 10.1097/00006534-198203000-00002; Nguyen J, 2009, SEMIN OPHTHALMOL, V24, P178, DOI 10.1080/08820530902805602; North PE, 2000, HUM PATHOL, V31, P11, DOI 10.1016/S0046-8177(00)80192-6; North PE, 2001, ARCH DERMATOL, V137, P1607; Panee J, 2012, CYTOKINE, V60, P1, DOI 10.1016/j.cyto.2012.06.018; Pozzetto U, 2008, ANN CLIN BIOCHEM, V45, P213, DOI 10.1258/acb.2007.007155; Quinlivan EP, 2008, AM J CLIN NUTR, V87, P1537, DOI 10.1093/ajcn/87.5.1537; Ritter Matthew R., 2007, Expert Reviews in Molecular Medicine, V9, DOI 10.1017/S146239940700052X; Roach EE, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.58; Rossler J, 2013, PEDIATR RES, V73, P409, DOI 10.1038/pr.2013.16; Russo K, 2002, J BIOL CHEM, V277, P1284, DOI 10.1074/jbc.M108858200; Spring H, 2005, P NATL ACAD SCI USA, V102, P18111, DOI 10.1073/pnas.0507158102; Tan ST, 2004, PLAST RECONSTR SURG, V113, P999, DOI 10.1097/01.PRS.0000105683.10752.A6; Tatara Y, 2009, J MOL CELL CARDIOL, V47, P104, DOI 10.1016/j.yjmcc.2009.03.012; Verdoliva V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057104; Zafra-Stone S, 2007, MOL NUTR FOOD RES, V51, P675, DOI 10.1002/mnfr.200700002	43	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e88545	10.1371/journal.pone.0088545	http://dx.doi.org/10.1371/journal.pone.0088545			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599340	Green Submitted, Green Published, gold			2022-12-27	WOS:000332479400005
J	Kolby, JE; Smith, KM; Berger, L; Karesh, WB; Preston, A; Pessier, AP; Skerratt, LF				Kolby, Jonathan E.; Smith, Kristine M.; Berger, Lee; Karesh, William B.; Preston, Asa; Pessier, Allan P.; Skerratt, Lee F.			First Evidence of Amphibian Chytrid Fungus (Batrachochytrium dendrobatidis) and Ranavirus in Hong Kong Amphibian Trade	PLOS ONE			English	Article							BULLFROGS RANA-CATESBEIANA; LONG-TERM; CHYTRIDIOMYCOSIS; DISEASE; INFECTION; PATHOGEN; ORIGIN; ASSAYS	The emerging infectious amphibian diseases caused by amphibian chytrid fungus (Batrachochytrium dendrobatidis, Bd) and ranaviruses are responsible for global amphibian population declines and extinctions. Although likely to have been spread by a variety of activities, transcontinental dispersal appears closely associated with the international trade in live amphibians. The territory of Hong Kong reports frequent, high volume trade in amphibians, and yet the presence of Bd and ranavirus have not previously been detected in either traded or free-ranging amphibians. In 2012, a prospective surveillance project was conducted to investigate the presence of these pathogens in commercial shipments of live amphibians exported from Hong Kong International Airport. Analysis of skin (Bd) and cloacal (ranavirus) swabs by quantitative PCR detected pathogen presence in 31/265 (11.7%) and in 105/185 (56.8%) of amphibians, respectively. In addition, the water in which animals were transported tested positive for Bd, demonstrating the risk of pathogen pollution by the disposal of untreated wastewater. It is uncertain whether Bd and ranavirus remain contained within Hong Kong's trade sector, or if native amphibians have already been exposed. Rapid response efforts are now urgently needed to determine current pathogen distribution in Hong Kong, evaluate potential trade-associated exposure to free-ranging amphibians, and identify opportunities to prevent disease establishment.	[Kolby, Jonathan E.; Berger, Lee; Skerratt, Lee F.] James Cook Univ, Hlth Res Grp 1, Sch Publ Hlth Trop Med & Rehabil Sci, Townsville, Qld 4811, Australia; [Kolby, Jonathan E.; Berger, Lee; Skerratt, Lee F.] James Cook Univ, Hlth Res Grp 1, Townsville, Qld 4811, Australia; [Kolby, Jonathan E.; Smith, Kristine M.; Karesh, William B.] EcoHlth Alliance, New York, NY USA; [Preston, Asa; Pessier, Allan P.] San Diego Zoo Global, Inst Conservat Res, Amphibian Dis Lab, San Diego, CA USA	James Cook University; James Cook University; EcoHealth Alliance	Kolby, JE (corresponding author), James Cook Univ, Hlth Res Grp 1, Sch Publ Hlth Trop Med & Rehabil Sci, Townsville, Qld 4811, Australia.	jonathan.kolby@my.jcu.edu.au	Kolby, Jonathan/GWV-5557-2022; Karesh, William/AAU-9084-2020; Kolby, Jonathan/GWZ-3092-2022	Karesh, William/0000-0001-6042-2860; Skerratt, Lee/0000-0003-3471-7512; Berger, Lee/0000-0001-9227-5439	EcoHealth Alliance through the New York Community Trust; James Cook University Australian Postgraduate Research Scholarship; Division Of Environmental Biology [0955897] Funding Source: National Science Foundation	EcoHealth Alliance through the New York Community Trust; James Cook University Australian Postgraduate Research Scholarship; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding for this project was provided by EcoHealth Alliance through the New York Community Trust and JEK is supported by a James Cook University Australian Postgraduate Research Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai CM, 2012, DIVERS DISTRIB, V18, P307, DOI 10.1111/j.1472-4642.2011.00878.x; Bai CM, 2010, ECOHEALTH, V7, P127, DOI 10.1007/s10393-010-0307-0; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Daszak P, 2004, HERPETOL J, V14, P201; Farrer RA, 2011, P NATL ACAD SCI USA, V108, P18732, DOI 10.1073/pnas.1111915108; Fisher Matthew C., 2007, Fungal Biology Reviews, V21, P2, DOI 10.1016/j.fbr.2007.02.002; Geng Y, 2011, J COMP PATHOL, V145, P95, DOI 10.1016/j.jcpa.2010.11.012; Gilbert M, 2012, ECOHEALTH, V9, P386, DOI 10.1007/s10393-013-0817-7; Gray MJ, 2012, DIS AQUAT ORGAN, V99, P1, DOI 10.3354/dao02436; Gray MJ, 2009, DIS AQUAT ORGAN, V87, P243, DOI 10.3354/dao02138; Hanselmann R, 2004, BIOL CONSERV, V120, P115, DOI 10.1016/j.biocon.2004.02.013; Hyatt AD, 2007, DIS AQUAT ORGAN, V73, P175, DOI 10.3354/dao073175; Johnson ML, 2003, EMERG INFECT DIS, V9, P922; Johnson ML, 2005, DIS AQUAT ORGAN, V65, P181, DOI 10.3354/dao065181; Kirshtein JD, 2007, DIS AQUAT ORGAN, V77, P11, DOI 10.3354/dao01831; Kolby JE, 2010, DIS AQUAT ORGAN, V92, P245, DOI 10.3354/dao02055; Miller D, 2011, VIRUSES-BASEL, V3, P2351, DOI 10.3390/v3112351; Nazir J, 2012, DIS AQUAT ORGAN, V98, P177, DOI 10.3354/dao02443; Olson DH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056802; Pallister J, 2007, J FISH DIS, V30, P427, DOI 10.1111/j.1365-2761.2007.00828.x; Picco AM, 2008, CONSERV BIOL, V22, P1582, DOI 10.1111/j.1523-1739.2008.01025.x; RISCH JP, 1980, J HERPETOL, V14, P337, DOI 10.2307/1563687; Rowley J, 2010, BIOL LETTERS, V6, P336, DOI 10.1098/rsbl.2009.0793; Rowley JJL, 2007, DIS AQUAT ORGAN, V78, P87, DOI 10.3354/dao01861; Schloegel LM, 2012, MOL ECOL, V21, P5162, DOI 10.1111/j.1365-294X.2012.05710.x; Schloegel LM, 2010, DIS AQUAT ORGAN, V92, P101, DOI 10.3354/dao02140; Schloegel LM, 2009, BIOL CONSERV, V142, P1420, DOI 10.1016/j.biocon.2009.02.007; Skerratt LF, 2008, DIS AQUAT ORGAN, V80, P85, DOI 10.3354/dao01923; Skerratt LF, 2011, J HERPETOL, V45, P444, DOI 10.1670/10-193.1; Skerratt LF, 2010, EXPT RES OBTAIN BETT; Stohr AC, 2013, VET J, V197, P238, DOI 10.1016/j.tvjl.2013.02.014; Swei A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023179; Teacher AGF, 2010, ANIM CONSERV, V13, P514, DOI 10.1111/j.1469-1795.2010.00373.x; Thrusfield M., 2018, VET EPIDEMIOLOGY, DOI [10.1002/9781118280249, DOI 10.1002/9781118280249]; Une Y, 2009, EMERG INFECT DIS, V15, P1146, DOI 10.3201/eid1507.081636; Voros J, 2012, HERPETOL NOTES, V5, P519; Vredenburg VT, 2010, P NATL ACAD SCI USA, V107, P9689, DOI 10.1073/pnas.0914111107; Weldon C, 2004, EMERG INFECT DIS, V10, P2100, DOI 10.3201/eid1012.030804; Xu K, 2010, ECOHEALTH, V7, P18, DOI 10.1007/s10393-010-0289-y	39	61	63	4	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90750	10.1371/journal.pone.0090750	http://dx.doi.org/10.1371/journal.pone.0090750			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599268	Green Published, Green Accepted, gold			2022-12-27	WOS:000332479400130
J	Moreno, B; Lopez, I; Fernandez-Diez, B; Gottlieb, M; Matute, C; Sanchez-Gomez, MV; Domercq, M; Giralt, A; Alberch, J; Collon, KW; Zhang, H; Parent, JM; Teixido, M; Giralt, E; Cena, V; Posadas, I; Martinez-Pinilla, E; Villoslada, P; Franco, R				Moreno, Beatriz; Lopez, Iciar; Fernandez-Diez, Begona; Gottlieb, Miroslav; Matute, Carlos; Sanchez-Gomez, Maria Victoria; Domercq, Maria; Giralt, Albert; Alberch, Jordi; Collon, Kevin W.; Zhang, Helen; Parent, Jack M.; Teixido, Meritxell; Giralt, Ernest; Cena, Valentin; Posadas, Inmaculada; Martinez-Pinilla, Eva; Villoslada, Pablo; Franco, Rafael			Differential Neuroprotective Effects of 5 '-Deoxy-5 '-Methylthioadenosine	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; EXCITOTOXICITY; BRAIN; PARKINSONS; METHYLTHIOADENOSINE; ACTIVATION; KYNURENINE; RECEPTORS; ISCHEMIA; SURVIVAL	Background: 5'-deoxy-5'-methylthioadenosine (MTA) is an endogenous compound produced through the metabolism of polyamines. The therapeutic potential of MTA has been assayed mainly in liver diseases and, more recently, in animal models of multiple sclerosis. The aim of this study was to determine the neuroprotective effect of this molecule in vitro and to assess whether MTA can cross the blood brain barrier (BBB) in order to also analyze its potential neuroprotective efficacy in vivo. Methods: Neuroprotection was assessed in vitro using models of excitotoxicity in primary neurons, mixed astrocyte-neuron and primary oligodendrocyte cultures. The capacity of MTA to cross the BBB was measured in an artificial membrane assay and using an in vitro cell model. Finally, in vivo tests were performed in models of hypoxic brain damage, Parkinson's disease and epilepsy. Results: MTA displays a wide array of neuroprotective activities against different insults in vitro. While the data from the two complementary approaches adopted indicate that MTA is likely to cross the BBB, the in vivo data showed that MTA may provide therapeutic benefits in specific circumstances. Whereas MTA reduced the neuronal cell death in pilocarpine-induced status epilepticus and the size of the lesion in global but not focal ischemic brain damage, it was ineffective in preserving dopaminergic neurons of the substantia nigra in the 1-methyl-4-phenyl-1,2,3,6-tetrahydro-pyridine (MPTP)-mice model. However, in this model of Parkinson's disease the combined administration of MTA and an A(2A) adenosine receptor antagonist did produce significant neuroprotection in this brain region. Conclusion: MTA may potentially offer therapeutic neuroprotection.	[Moreno, Beatriz; Fernandez-Diez, Begona; Villoslada, Pablo] Hosp Clin Barcelona, Ctr Neuroimmunol, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain; [Lopez, Iciar; Martinez-Pinilla, Eva; Franco, Rafael] Univ Navarra, Div Neurosci, CIMA, E-31080 Pamplona, Spain; [Lopez, Iciar; Franco, Rafael] Ctr Biomed Res Rioja CIBIR, Lung Canc Unit, Oncol Area, Logrono, Spain; [Gottlieb, Miroslav; Matute, Carlos; Sanchez-Gomez, Maria Victoria; Domercq, Maria; Franco, Rafael] Univ Basque Country, Dept Neurosci, Achucarro Basque Ctr Neurosci, Leioa, Spain; [Gottlieb, Miroslav; Matute, Carlos; Franco, Rafael] Slovak Acad Sci, Inst Neurobiol, Kosice 04001, Slovakia; [Matute, Carlos; Giralt, Albert; Alberch, Jordi; Franco, Rafael] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain; [Giralt, Albert; Alberch, Jordi; Franco, Rafael] Univ Barcelona, Sch Med, Dept Cellular Biol Immunol & Neurosci, Barcelona, Spain; [Collon, Kevin W.; Zhang, Helen; Parent, Jack M.; Franco, Rafael] Univ Michigan, Med Ctr, Dept Neurol, Ann Arbor, MI 48109 USA; [Teixido, Meritxell; Giralt, Ernest; Franco, Rafael] IRB, Barcelona, Spain; [Cena, Valentin; Posadas, Inmaculada; Franco, Rafael] Univ Castilla La Mancha, Albacete, Spain; [Franco, Rafael] Univ Barcelona, Sch Biol, Dept Biochem & Mol Biol, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Navarra; University of Basque Country; Slovak Academy of Sciences; CIBERNED; University of Barcelona; University of Michigan System; University of Michigan; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Universidad de Castilla-La Mancha; University of Barcelona	Moreno, B (corresponding author), Hosp Clin Barcelona, Ctr Neuroimmunol, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain.	bmoreno@clinic.ub.es	Matute, Carlos/N-5559-2014; Giralt, Albert/AAA-5308-2020; Cena, Valentin/L-1751-2017; Martínez-Pinilla, Eva/C-7907-2013; Franco, Rafael/C-3694-2015; Domercq, Maria/Z-2274-2019; Villoslada, Pablo/AAF-9547-2019; Sánchez-Gómez, M Victoria/AAU-9720-2021; teixido, meritxell/I-3282-2015; Alberch, Jordi/K-5702-2014; Giralt, Albert/M-7672-2015; Posadas, Inmaculada/M-1124-2014	Matute, Carlos/0000-0001-8672-711X; Cena, Valentin/0000-0001-8928-3681; Martínez-Pinilla, Eva/0000-0002-0572-0926; Franco, Rafael/0000-0003-2549-4919; Domercq, Maria/0000-0002-4918-9276; Sánchez-Gómez, M Victoria/0000-0001-5730-8194; teixido, meritxell/0000-0002-7825-3695; Alberch, Jordi/0000-0002-8684-2721; Giralt, Albert/0000-0001-5334-0963; Posadas, Inmaculada/0000-0003-1854-3372	Instituto de Salud Carlos III RETICS program (Red Espanola de Esclerosis Multiple) [RD07/60/001]; FIMA (intramural); Digna Biotech;  [SK-VEGA 02/0092/12]	Instituto de Salud Carlos III RETICS program (Red Espanola de Esclerosis Multiple); FIMA (intramural); Digna Biotech; 	This work was supported by the Instituto de Salud Carlos III RETICS program (Red Espanola de Esclerosis Multiple (RD07/60/001) to PV), and funds from FIMA (intramural) and Digna Biotech. Models of focal and global ischemia in rat were supported by the project SK-VEGA 02/0092/12. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHESON A, 1986, EMBO J, V5, P2799, DOI 10.1002/j.1460-2075.1986.tb04570.x; Alberdi E, 2002, NEUROBIOL DIS, V9, P234, DOI 10.1006/nbdi.2001.0457; Arbeloa J, 2012, NEUROBIOL DIS, V45, P954, DOI 10.1016/j.nbd.2011.12.014; Avila MA, 2004, INT J BIOCHEM CELL B, V36, P2125, DOI 10.1016/j.biocel.2003.11.016; BARRES BA, 1992, J NEUROBIOL, V23, P1221, DOI 10.1002/neu.480230912; Bruno V, 2001, EUR J NEUROSCI, V13, P1469, DOI 10.1046/j.0953-816x.2001.01541.x; di Penta A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054722; Doble A, 1999, PHARMACOL THERAPEUT, V81, P163, DOI 10.1016/S0163-7258(98)00042-4; Doorn KJ, 2012, PROG NEUROBIOL, V98, P222, DOI 10.1016/j.pneurobio.2012.06.005; Greenwood J, 1996, J NEUROIMMUNOL, V71, P51, DOI 10.1016/S0165-5728(96)00130-0; Guillemin GJ, 2007, J NEUROSCI, V27, P12884, DOI 10.1523/JNEUROSCI.4101-07.2007; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Karadottir R, 2007, NEUROSCIENCE, V145, P1426, DOI 10.1016/j.neuroscience.2006.08.070; Klein C, 2013, NEUROPHARMACOLOGY, V70, P254, DOI 10.1016/j.neuropharm.2013.02.006; Kron MM, 2010, J NEUROSCI, V30, P2051, DOI 10.1523/JNEUROSCI.5655-09.2010; Latasa MU, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015690; Linker RA, 2011, BRAIN, V134, P678, DOI 10.1093/brain/awq386; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Moreno B, 2010, MULT SCLER J, V16, P1102, DOI 10.1177/1352458510375968; Moreno B, 2006, ANN NEUROL, V60, P323, DOI 10.1002/ana.20895; Neumann H, 1998, J NEUROPATH EXP NEUR, V57, P1, DOI 10.1097/00005072-199801000-00001; NOZAKI K, 1992, J CEREBR BLOOD F MET, V12, P400, DOI 10.1038/jcbfm.1992.57; OLSON L, 1994, J NEUROL, V242, pS12, DOI 10.1007/BF00939233; Panaro MA, 2012, CURR PHARM DESIGN, V18, P200; PULSINELLI WA, 1979, STROKE, V10, P267, DOI 10.1161/01.STR.10.3.267; Simile MM, 2001, J HEPATOL, V34, P386, DOI 10.1016/S0168-8278(00)00078-7; Stramentinoli G, 1984, U.S. patent, Patent No. 4454122; Vallejo-Illarramendi A, 2005, GLIA, V50, P276, DOI 10.1002/glia.20172; WILLIAMSASHMAN HG, 1982, BIOCHEM PHARMACOL, V31, P277, DOI 10.1016/0006-2952(82)90171-X	29	9	9	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90671	10.1371/journal.pone.0090671	http://dx.doi.org/10.1371/journal.pone.0090671			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599318	gold, Green Published			2022-12-27	WOS:000332479400115
J	Peters, KR; Ray, LB; Fogel, S; Smith, V; Smith, CT				Peters, Kevin R.; Ray, Laura B.; Fogel, Stuart; Smith, Valerie; Smith, Carlyle T.			Age Differences in the Variability and Distribution of Sleep Spindle and Rapid Eye Movement Densities	PLOS ONE			English	Article							ELDERLY HUMAN-SUBJECTS; ALZHEIMERS-DISEASE; FREQUENCY ACTIVITY; OLD-AGE; PARAMETERS; PATTERNS; YOUNG; ORGANIZATION; PROBABILITY; VARIANCES	The present study had two main objectives. The first objective was to compare the sleep architecture of young and older adults, with an emphasis on sleep spindle density and REM density. The second objective was to examine two aspects of age differences that have not been considered in previous studies: age differences in the variability of sleep measures as well as the magnitude of age differences in phasic events across the distribution of values (i.e., at each decile rather than a single measure of location such as the mean or median. A total of 24 young (mean age = 20.75 +/- 1.78 years) and 24 older (mean age = 71.17 +/- 6.15 years) adults underwent in-home polysomnography. Whole-night spindle density was significantly higher in young adults than older adults. The two age groups did not differ significantly in whole-night REM density, although significant increases in REM density across the night were observed in both age groups. These results suggest that spindle density is more affected by age than REM density. Although age differences were observed in the degree of absolute variability (older adults had significantly larger variances than young adults for sleep efficiency and time spent awake after sleep onset), a similar pattern was also observed within the two age groups: the four sleep measures with the lowest degrees of relative variability were the same and included time spent in REM and Stage 2 sleep, total sleep time, and sleep efficiency. The distributional analysis of age differences in sleep spindle density revealed that the largest age differences were initially observed in the middle of the distributions, but as the night progressed, they were seen at the upper end of the distributions. The results reported here have potential implications for the causes and functional implications of age-related changes in sleep architecture.	[Peters, Kevin R.; Ray, Laura B.; Smith, Valerie; Smith, Carlyle T.] Trent Univ, Dept Psychol, Peterborough, ON K9J 7B8, Canada; [Fogel, Stuart] Univ Western Ontario, Brain & Mind Inst, London, ON, Canada; [Fogel, Stuart] Univ Western Ontario, Dept Psychol, London, ON, Canada	Trent University; Western University (University of Western Ontario); Western University (University of Western Ontario)	Peters, KR (corresponding author), Trent Univ, Dept Psychol, Peterborough, ON K9J 7B8, Canada.	kevinpeters@trentu.ca	Fogel, Stuart/F-7179-2017	Fogel, Stuart/0000-0002-3227-5370	Canadian Institutes of Health Research [178403]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This research was funded by an operating grant (#178403) from the Canadian Institutes of Health Research (www.cihr-irsc.gc.ca/e/?). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acion L, 2006, STAT MED, V25, P591, DOI 10.1002/sim.2256; American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DIS; Beck A.T., 1987, BECK DEPRESSION INVE; BLIWISE DL, 2000, PRINCIPLES PRACTICE; Boos DD, 2004, STAT SCI, V19, P571, DOI 10.1214/088342304000000503; Brunner E, 2000, BIOMETRICAL J, V42, P17, DOI 10.1002/(SICI)1521-4036(200001)42:1<17::AID-BIMJ17>3.0.CO;2-U; Crowley K, 2002, CLIN NEUROPHYSIOL, V113, P1615, DOI 10.1016/S1388-2457(02)00237-7; Crowley K, 2011, NEUROPSYCHOL REV, V21, P41, DOI 10.1007/s11065-010-9154-6; Curran-Everett D, 2009, ADV PHYSIOL EDUC, V33, P286, DOI 10.1152/advan.00062.2009; Dang-Vu TT, 2010, CURR BIOL, V20, pR626, DOI 10.1016/j.cub.2010.06.032; Darchia N, 2004, BRAIN RES BULL, V63, P433, DOI 10.1016/j.brainresbull.2003.12.017; Darchia N, 2003, SLEEP, V26, P973, DOI 10.1093/sleep/26.8.973; Dijk DJ, 1995, NEUROSCI LETT, V201, P13, DOI 10.1016/0304-3940(95)12118-N; DOUGLASS AB, 1994, SLEEP, V17, P160, DOI 10.1093/sleep/17.2.160; Dykierek P, 1998, J PSYCHIATR RES, V32, P1, DOI 10.1016/S0022-3956(97)00049-6; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; EHLERS CL, 1989, ELECTROEN CLIN NEURO, V72, P118, DOI 10.1016/0013-4694(89)90172-7; Erceg-Hurn DM, 2008, AM PSYCHOL, V63, P591, DOI 10.1037/0003-066X.63.7.591; FEINBERG I, 1967, J PSYCHIAT RES, V5, P107, DOI 10.1016/0022-3956(67)90027-1; FEINBERG I, 1974, J PSYCHIATR RES, V10, P283, DOI 10.1016/0022-3956(74)90011-9; Ficca G, 1999, NEUROSCI LETT, V275, P219, DOI 10.1016/S0304-3940(99)00765-X; Fogel Stuart, 2012, Front Neurol, V3, P176, DOI 10.3389/fneur.2012.00176; GRISSOM RJ, 1994, J APPL PSYCHOL, V79, P314, DOI 10.1037/0021-9010.79.2.314; GUAZZELLI M, 1986, ELECTROEN CLIN NEURO, V63, P526, DOI 10.1016/0013-4694(86)90140-9; Iber C., 2007, AASM MANUAL SCORING; Kraemer HC, 2006, BIOL PSYCHIAT, V59, P990, DOI 10.1016/j.biopsych.2005.09.014; Landolt HP, 1996, BRAIN RES, V738, P205, DOI 10.1016/S0006-8993(96)00770-6; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; Lim TS, 1996, COMPUT STAT DATA AN, V22, P287, DOI 10.1016/0167-9473(95)00054-2; Martin N, 2013, NEUROBIOL AGING, V34, P468, DOI 10.1016/j.neurobiolaging.2012.05.020; Neikrug AB, 2010, GERONTOLOGY, V56, P181, DOI 10.1159/000236900; Nelson AE, 1992, GERONTOLOGIST, V32, P17; Nicolas A, 2001, CLIN NEUROPHYSIOL, V112, P521, DOI 10.1016/S1388-2457(00)00556-3; Noguchi K, 2012, J STAT SOFTW, V50, P1, DOI 10.18637/jss.v050.i12; Ohayon MM, 2004, SLEEP, V27, P1255, DOI 10.1093/sleep/27.7.1255; R Development Core Team, 2012, R LANG ENV STAT COMP; Rauchs G, 2008, NEUROREPORT, V19, P1159, DOI 10.1097/WNR.0b013e32830867c4; Rechtschaffen A., 1968, BRAIN INFORM SERVICE; Salzarulo P, 1997, ACTA NEUROL BELG, V97, P118; Spiegel R, 1999, BIOL PSYCHIAT, V45, P435, DOI 10.1016/S0006-3223(98)00042-0; STERIADE M, 1994, J PSYCHIATR NEUROSCI, V19, P354; Vegni C, 2001, NEUROSCI LETT, V297, P58, DOI 10.1016/S0304-3940(00)01636-0; WAUQUIER A, 1993, PHYSIOL BEHAV, V54, P803, DOI 10.1016/0031-9384(93)90095-W; Wei HG, 1999, NEUROSCI LETT, V260, P29, DOI 10.1016/S0304-3940(98)00851-9; Wilcox R. R., 2012, INTRO ROBUST ESTIMAT; YAMADORI A, 1971, Kobe Journal of Medical Sciences, V17, P97	47	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e91047	10.1371/journal.pone.0091047	http://dx.doi.org/10.1371/journal.pone.0091047			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC4GP	24599302	Green Submitted, Green Published, gold			2022-12-27	WOS:000332479400151
J	Roque, F; Soares, S; Breitenfeld, L; Gonzalez-Gonzalez, C; Figueiras, A; Herdeiro, MT				Roque, Fatima; Soares, Sara; Breitenfeld, Luiza; Gonzalez-Gonzalez, Cristian; Figueiras, Adolfo; Herdeiro, Maria Teresa			Portuguese Community Pharmacists' Attitudes to and Knowledge of Antibiotic Misuse: Questionnaire Development and Reliability	PLOS ONE			English	Article							INTRACLASS CORRELATION-COEFFICIENT; TEST-RETEST RELIABILITY; SELF-MEDICATION; RESISTANCE; EUROPE; SCALES	Objective: To develop and evaluate the reliability of a self-administered questionnaire designed to assess the attitudes and knowledge of community pharmacists in Portugal about microbial resistance and the antibiotic dispensing process. Methods: This study was divided into the following three stages: (1) design of the questionnaire, which included a literature review and a qualitative study with focus-group sessions; (2) assessment of face and content validity, using a panel of experts and a pre-test of community pharmacists; and, (3) pilot study and reliability analysis, which included a test-retest study covering fifty practising pharmacists based at community pharmacies in five districts situated in Northern Portugal. Questionnaire reproducibility was quantified using the intraclass correlation coefficient (ICC; 95% confidence interval) computed by means of one-way analysis of variance (ANOVA). Internal consistency was evaluated using Cronbach's alpha. Results: The correlation coefficients were fair to good (ICC > 0.4) for all statements (scale-items) regarding knowledge of and attitudes to antibiotic resistance, and ranged from fair to good to excellent for statements about situations in which pharmacists acknowledged that antibiotics were sometimes dispensed without a medical prescription (ICC > 0.8). Cronbach's alpha for this section was 0.716. Conclusions: The questionnaire designed in this study is valid and reliable in terms of content validity, face validity and reproducibility.	[Roque, Fatima; Breitenfeld, Luiza] Univ Beira Interior CICS UBI, Hlth Sci Res Ctr, Covilha, Portugal; [Roque, Fatima; Soares, Sara; Herdeiro, Maria Teresa] Univ Aveiro CBC UA, Ctr Cell Biol, Aveiro, Portugal; [Roque, Fatima] Polytech Inst Guarda UDI IPG, Res Unit Inland Dev, Guarda, Portugal; [Gonzalez-Gonzalez, Cristian; Figueiras, Adolfo] Univ Santiago de Compostela, Dept Prevent Med & Publ Hlth, Santiago De Compostela, Spain; [Figueiras, Adolfo] Univ Santiago de Compostela, Consortium Biomed Res Epidemiol & Publ Hlth CIBER, Santiago De Compostela, Spain; [Herdeiro, Maria Teresa] Ctr Hlth Technol & Informat Syst Res CINTESIS FMU, Oporto, Portugal; [Herdeiro, Maria Teresa] Hlth Technol Res Ctr CITS CESPU, Gandra, Portugal	Universidade da Beira Interior; Universidade de Aveiro; Instituto Politecnico da Guarda; Universidade de Santiago de Compostela; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Universidade de Santiago de Compostela; Universidade do Porto	Herdeiro, MT (corresponding author), Univ Aveiro CBC UA, Ctr Cell Biol, Aveiro, Portugal.	teresaherdeiro@ua.pt	Roque, Fatima Marques/H-1713-2013; Granadeiro, Luiza Breitenfeld/P-1852-2015; Figueiras, Adolfo/K-8563-2015; Soares, Sara/N-6285-2019; Herdeiro, Maria/H-8195-2013	Roque, Fatima Marques/0000-0003-0169-3788; Granadeiro, Luiza Breitenfeld/0000-0001-8550-1645; Figueiras, Adolfo/0000-0002-5766-8672; Herdeiro, Maria/0000-0002-0500-4049; Soares, Sara/0000-0002-7996-0519	Foundation for Science & Technology (Fundacao para a Ciencia e Tecnologia - FCT) from the Portuguese Ministry of Science Education [PTDC/SAU-ESA/105530/2008, Pest-OE/EGE/UI4056/2014]	Foundation for Science & Technology (Fundacao para a Ciencia e Tecnologia - FCT) from the Portuguese Ministry of Science Education	This work was supported by Foundation for Science & Technology (Fundacao para a Ciencia e Tecnologia - FCT) grants [PTDC/SAU-ESA/105530/2008] and [Pest-OE/EGE/UI4056/2014] from the Portuguese Ministry of Science & Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adu A, 1999, J CLIN PHARM THER, V24, P181, DOI 10.1046/j.1365-2710.1999.00216.x; Alumran Arwa, 2012, J Infect Public Health, V5, P221, DOI 10.1016/j.jiph.2012.03.003; Bland JM, 1997, BRIT MED J, V314, P572, DOI 10.1136/bmj.314.7080.572; Bonita R., 2006, BASIC EPIDEMIOLOGY, V2nd ed.; Bronzwaer SLAM, 2002, EMERG INFECT DIS, V8, P278, DOI 10.3201/eid0803.010192; Coenen S, 2004, J ANTIMICROB CHEMOTH, V54, P661, DOI 10.1093/jac/dkh374; COMMENGES D, 1994, BIOMETRICS, V50, P517, DOI 10.2307/2533395; de Melo MN, 2006, PHARM WORLD SCI, V28, P19, DOI 10.1007/s11096-005-2222-y; Pernas SID, 2012, INT J CLIN PHARM-NET, V34, P693, DOI 10.1007/s11096-012-9675-6; Du Toit R, 2002, OPTOMETRY VISION SCI, V79, P313, DOI 10.1097/00006324-200205000-00011; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Grigoryan L, 2010, CURR DRUG SAF, V5, P329, DOI 10.2174/157488610792246046; Gross R, 2001, CLIN INFECT DIS, V33, P289, DOI 10.1086/321880; Herdeiro MT, 2008, DRUG SAFETY, V31, P335, DOI 10.2165/00002018-200831040-00007; Herdeiro MT, 2006, DRUG SAFETY, V29, P331, DOI 10.2165/00002018-200629040-00004; Howard DH, 2005, CLIN INFECT DIS, V41, pS283, DOI 10.1086/430792; Johanson GA, 2010, EDUC PSYCHOL MEAS, V70, P394, DOI 10.1177/0013164409355692; Llor C, 2009, CLIN INFECT DIS, V48, P1345, DOI 10.1086/598183; Martins AP, 2002, PHARMACOEPIDEM DR S, V11, P409, DOI 10.1002/pds.711; Marx RG, 2003, J CLIN EPIDEMIOL, V56, P730, DOI 10.1016/S0895-4356(03)00084-2; Paul-Dauphin A, 1999, AM J EPIDEMIOL, V150, P1117, DOI 10.1093/oxfordjournals.aje.a009937; Plachouras D, 2010, EUROSURVEILLANCE, V15, P12; Roque F, 2013, INT J CLIN PHARM-NET, V35, P417, DOI 10.1007/s11096-013-9753-4; Rosner B., 2006, FUNDAMENTALS BIOSTAT; Saengcharoen W, 2008, J CLIN PHARM THER, V33, P123, DOI 10.1111/j.1365-2710.2007.00890.x; Shen J, 2011, INT J CLIN PHARM-NET, V33, P929, DOI 10.1007/s11096-011-9577-z; Tavakol M, 2011, INT J MED EDUC, V2, P53, DOI 10.5116/ijme.4dfb.8dfd; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; Yaghmaie F., 2003, J MED EDUC, V3, P25, DOI DOI 10.22037/JME.V3I1.870	29	14	14	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90470	10.1371/journal.pone.0090470	http://dx.doi.org/10.1371/journal.pone.0090470			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599387	Green Published, gold, Green Submitted			2022-12-27	WOS:000332479400080
J	Candido, ED; Fernandes, GD; de Alencar, SA; Cardoso, MHES; de Freitas Lima, SM; Miranda, VD; Porto, WF; Nolasco, DO; de Oliveira, NG; Barbosa, AEAD; Pogue, RE; Rezende, TMB; Dias, SC; Franco, OL				Candido, Elizabete de Souza; Fernandes, Gabriel da Rocha; de Alencar, Sergio Amorim; Cardoso, Marlon Henrique e Silva; de Freitas Lima, Stella Maris; Miranda, Vivian de Jesus; Porto, William Farias; Nolasco, Diego Oliveira; de Oliveira, Nelson Gomes; Anjos de Deus Barbosa, Aulus Estevao; Pogue, Robert Edward; Rezende, Taia Maria Berto; Dias, Simoni Campos; Franco, Octavio Luiz			Shedding Some Light over the Floral Metabolism by Arum Lily (Zantedeschia aethiopica) Spathe De Novo Transcriptome Assembly	PLOS ONE			English	Article							LIPID TRANSFER PROTEINS; LYSM RECEPTOR KINASE; PSEUDOMONAS-SYRINGAE; ANTIMICROBIAL PEPTIDES; DISEASE RESISTANCE; ARABIDOPSIS TCH4; BASAL DEFENSE; PLANT; GENE; AUXIN	Zantedeschia aethiopica is an evergreen perennial plant cultivated worldwide and commonly used for ornamental and medicinal purposes including the treatment of bacterial infections. However, the current understanding of molecular and physiological mechanisms in this plant is limited, in comparison to other non-model plants. In order to improve understanding of the biology of this botanical species, RNA-Seq technology was used for transcriptome assembly and characterization. Following Z. aethiopica spathe tissue RNA extraction, high-throughput RNA sequencing was performed with the aim of obtaining both abundant and rare transcript data. Functional profiling based on KEGG Orthology (KO) analysis highlighted contigs that were involved predominantly in genetic information (37%) and metabolism (34%) processes. Predicted proteins involved in the plant circadian system, hormone signal transduction, secondary metabolism and basal immunity are described here. In silico screening of the transcriptome data set for antimicrobial peptide (AMP) - encoding sequences was also carried out and three lipid transfer proteins (LTP) were identified as potential AMPs involved in plant defense. Spathe predicted protein maps were drawn, and suggested that major plant efforts are expended in guaranteeing the maintenance of cell homeostasis, characterized by high investment in carbohydrate, amino acid and energy metabolism as well as in genetic information.	[Candido, Elizabete de Souza; Fernandes, Gabriel da Rocha; de Alencar, Sergio Amorim; de Freitas Lima, Stella Maris; Miranda, Vivian de Jesus; Porto, William Farias; Nolasco, Diego Oliveira; Anjos de Deus Barbosa, Aulus Estevao; Pogue, Robert Edward; Rezende, Taia Maria Berto; Dias, Simoni Campos; Franco, Octavio Luiz] Univ Catolica Brasilia, Programa Pos Graduacao Cienc Genom & Biotecnol, Brasilia, DF, Brazil; [Candido, Elizabete de Souza; Cardoso, Marlon Henrique e Silva; de Freitas Lima, Stella Maris; Miranda, Vivian de Jesus; Porto, William Farias; de Oliveira, Nelson Gomes; Anjos de Deus Barbosa, Aulus Estevao; Rezende, Taia Maria Berto; Dias, Simoni Campos; Franco, Octavio Luiz] Univ Catolica Brasilia, Ctr Anal Proteom & Bioquim, Brasilia, DF, Brazil; [de Oliveira, Nelson Gomes] Univ Brasilia, Programa Pos Graduacao Biol Anim, Brasilia, DF, Brazil; [Nolasco, Diego Oliveira] Univ Catolica Brasilia, Curso Fis, Brasilia, DF, Brazil; [Rezende, Taia Maria Berto] Univ Catolica Brasilia, Curso Odontol, Brasilia, DF, Brazil	Universidade Catolica de Brasilia; Universidade Catolica de Brasilia; Universidade de Brasilia; Universidade Catolica de Brasilia; Universidade Catolica de Brasilia	Franco, OL (corresponding author), Univ Catolica Brasilia, Programa Pos Graduacao Cienc Genom & Biotecnol, Brasilia, DF, Brazil.	ocfranco@gmail.com	Cardoso, Marlon/O-9734-2019; Cardoso, Marlon H/N-6972-2017; da Rocha Fernandes, Gabriel/A-5383-2010; de Alencar, Sérgio A/G-9545-2012; Oliveira-Júnior, Nelson/M-5794-2014; Nolasco, Diego O/O-6743-2014; Pogue, Robert/C-3860-2016; de Freitas Lima, Stella Maris/A-4501-2014; Nolasco, Diego O./D-1241-2017; Franco, Octavio L/T-3020-2017; Rezende, Taia M B/D-3732-2015; Cândido, Elizabete/F-3347-2019	Cardoso, Marlon/0000-0001-6676-5362; Cardoso, Marlon H/0000-0001-6676-5362; da Rocha Fernandes, Gabriel/0000-0002-4897-8521; de Alencar, Sérgio A/0000-0001-8236-6468; Oliveira-Júnior, Nelson/0000-0001-9437-6778; Nolasco, Diego O/0000-0001-7931-5475; Pogue, Robert/0000-0002-8789-3512; de Freitas Lima, Stella Maris/0000-0003-1359-8761; Nolasco, Diego O./0000-0001-7931-5475; Rezende, Taia M B/0000-0002-4148-0659; Cândido, Elizabete/0000-0002-3126-029X; Barbosa, Aulus/0000-0003-2332-5337; Miranda, Vivian/0000-0002-2739-6100; Franco, Octavio/0000-0001-9546-0525	Center for Scientific Computing (NCC/GridUNESP) of the Sao Paulo State University (UNESP)	Center for Scientific Computing (NCC/GridUNESP) of the Sao Paulo State University (UNESP)	This research was granted by CNPq, CAPES, FAPDF and UCB. The authors are thankful to the support provided by the Center for Scientific Computing (NCC/GridUNESP) of the Sao Paulo State University (UNESP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AAIJ C, 1972, BIOCHIM BIOPHYS ACTA, V269, P192, DOI 10.1016/0005-2787(72)90426-1; Ahmed AS, 2012, J ETHNOPHARMACOL, V143, P826, DOI 10.1016/j.jep.2012.08.004; Albrecht C, 2012, P NATL ACAD SCI USA, V109, P303, DOI 10.1073/pnas.1109921108; ANESINI C, 1993, J ETHNOPHARMACOL, V39, P119, DOI 10.1016/0378-8741(93)90027-3; Annadurai RS, 2012, BMC GENOMICS, V13, P1, DOI 10.1186/1471-2164-13-663; Arondel V, 2000, PLANT SCI, V157, P1, DOI 10.1016/S0168-9452(00)00232-6; Avato P, 1997, PLANTA MED, V63, P503, DOI 10.1055/s-2006-957751; Belkhadir Y, 2006, SCIENCE, V314, P1410, DOI 10.1126/science.1134040; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; Besemer J, 2005, NUCLEIC ACIDS RES, V33, pW451, DOI 10.1093/nar/gki487; Bhuvaneshwari L, 2007, ANC SCI LIFE, V26, P24; Burgess A, 2011, IMMUNOL CELL BIOL, V89, P661, DOI 10.1038/icb.2011.30; Chen CM, 2011, PLANT SCI, V181, P439, DOI 10.1016/j.plantsci.2011.07.003; Chou ML, 2013, PLANTA; Curir P, 2003, PHYTOCHEM ANALYSIS, V14, P8, DOI 10.1002/pca.672; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; de Torres M, 2006, PLANT J, V47, P368, DOI 10.1111/j.1365-313X.2006.02798.x; Dhankhar Sandeep, 2012, Recent Pat Antiinfect Drug Discov, V7, P242; Dodd AN, 2005, SCIENCE, V309, P630, DOI 10.1126/science.1115581; Donaldson JG, 2011, NAT REV MOL CELL BIO, V12, P362, DOI 10.1038/nrm3117; Fu J, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00074; Fu J, 2011, PLANT PHYSIOL, V155, P589, DOI 10.1104/pp.110.163774; Garg R, 2011, PLANT PHYSIOL, V156, P1661, DOI 10.1104/pp.111.178616; Ge XC, 2003, J BIOCHEM MOL BIOL, V36, P603; Giang KTN, 2011, J BIOL CHEM, V286, P24275, DOI 10.1074/jbc.M111.229922; Gimenez-Ibanez S, 2009, PLANT SIGNAL BEHAV, V4, P539, DOI 10.4161/psb.4.6.8697; Gimenez-Ibanez S, 2009, CURR BIOL, V19, P423, DOI 10.1016/j.cub.2009.01.054; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hann DR, 2007, PLANT J, V49, P607, DOI 10.1111/j.1365-313X.2006.02981.x; Hanson AD, 2002, CURR OPIN PLANT BIOL, V5, P244, DOI 10.1016/S1369-5266(02)00249-2; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hirano K, 2008, TRENDS PLANT SCI, V13, P192, DOI 10.1016/j.tplants.2008.02.005; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hutchings A., 1996, ZULU MED PLANTS INVE; Iliev EA, 2002, PLANT PHYSIOL, V130, P770, DOI 10.1104/pp.008680; Ishihama N, 2012, CURR OPIN PLANT BIOL, V15, P431, DOI 10.1016/j.pbi.2012.02.003; Jiao YL, 2007, NAT REV GENET, V8, P217, DOI 10.1038/nrg2049; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karlova Rumyana, 2006, Sci STKE, V2006, ppe36, DOI 10.1126/stke.3542006pe36; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee J, 2012, PLANTA; Leyser O, 2006, CURR BIOL, V16, pR424, DOI 10.1016/j.cub.2006.05.014; Li XY, 2005, P NATL ACAD SCI USA, V102, P12990, DOI 10.1073/pnas.0502425102; Lin L, 2009, MOL BIOL REP, V36, P437, DOI 10.1007/s11033-007-9198-8; Liu YB, 2010, PLANT PHYSIOL BIOCH, V48, P836, DOI 10.1016/j.plaphy.2010.07.001; Lohse M, 2012, NUCLEIC ACIDS RES, V40, pW622, DOI 10.1093/nar/gks540; Lomsadze A, 2005, NUCLEIC ACIDS RES, V33, P6494, DOI 10.1093/nar/gki937; LULIN H, 2012, PLOS ONE, V0007; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; Meyer E, 2012, PLANT J, V70, P879, DOI 10.1111/j.1365-313X.2012.04938.x; Miya A, 2007, P NATL ACAD SCI USA, V104, P19613, DOI 10.1073/pnas.0705147104; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Mohammed MJ, 2009, PHYTOMEDICINE, V16, P632, DOI 10.1016/j.phymed.2008.12.026; MOLINA A, 1993, FEBS LETT, V316, P119, DOI 10.1016/0014-5793(93)81198-9; Munoz-Merida A., 2013, DNA RES; NCCLS, 2003, M7A6 NCCLS; Oh MH, 2010, P NATL ACAD SCI USA, V107, P17827, DOI 10.1073/pnas.0915064107; Oh Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057868; Ohta M, 2000, PLANT J, V22, P29, DOI 10.1046/j.1365-313x.2000.00709.x; Park J, 2013, PLANT CELL; Park JE, 2007, J BIOL CHEM, V282, P10036, DOI 10.1074/jbc.M610524200; Pauwels L, 2011, PLANT CELL, V23, P3089, DOI 10.1105/tpc.111.089300; Pieterse C. M. J., 2001, AgBiotechNet, V3, P1; Pirrello J, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-190; Porto WF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051444; Porto WF, 2012, PEPTIDES, V38, P127, DOI 10.1016/j.peptides.2012.07.025; Porto WF, 2010, LECT N BIOINFORMAT, V6268, P59, DOI 10.1007/978-3-642-15060-9_6; Rahnamaeian M, 2011, PLANT SIGNAL BEHAV, V6, P1325, DOI 10.4161/psb.6.9.16319; Roenneberg T, 1999, J BIOL RHYTHM, V14, P449, DOI 10.1177/074873099129001019; Roy A, 2012, NUCLEIC ACIDS RES, V40, pW471, DOI 10.1093/nar/gks372; SEGURA A, 1993, FEBS LETT, V332, P243, DOI 10.1016/0014-5793(93)80641-7; Setzer M. C., 2006, Biologically active natural products for the 21st century, P21; Silverstein KAT, 2007, PLANT J, V51, P262, DOI 10.1111/j.1365-313X.2007.03136.x; Singh KB, 2002, CURR OPIN PLANT BIOL, V5, P430, DOI 10.1016/S1369-5266(02)00289-3; Solano R, 1998, GENE DEV, V12, P3703, DOI 10.1101/gad.12.23.3703; Spoel SH, 2012, NAT REV IMMUNOL, V12, P89, DOI 10.1038/nri3141; Stotz HU, 2009, PLANT MOL BIOL, V71, P131, DOI 10.1007/s11103-009-9512-z; Takai R, 2008, MOL PLANT MICROBE IN, V21, P1635, DOI 10.1094/MPMI-21-12-1635; Takechi K, 1999, PLANT CELL PHYSIOL, V40, P1287, DOI 10.1093/oxfordjournals.pcp.a029517; Tavares LS, 2008, PEPTIDES, V29, P1842, DOI 10.1016/j.peptides.2008.06.003; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Ueguchi-Tanaka M, 2007, ANNU REV PLANT BIOL, V58, P183, DOI 10.1146/annurev.arplant.58.032806.103830; Vanneste S, 2009, CELL, V136, P1005, DOI 10.1016/j.cell.2009.03.001; Verma AK, 2010, INDIAN J PHARM SCI, V72, P655, DOI 10.4103/0250-474X.78541; Wan JR, 2008, PLANT CELL, V20, P471, DOI 10.1105/tpc.107.056754; Wang GF, 2011, PLANT PHYSIOL, V156, P1508, DOI 10.1104/pp.111.176776; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Wei ZZ, 2012, AM J BOT, V99, pE493, DOI 10.3732/ajb.1200228; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Wu ST, 2007, NUCLEIC ACIDS RES, V35, P3375, DOI 10.1093/nar/gkm251; XU W, 1995, PLANT CELL, V7, P1555, DOI 10.1105/tpc.7.10.1555; Yan XH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-26; Yang CQ, 2012, J INTEGR PLANT BIOL, V54, P703, DOI 10.1111/j.1744-7909.2012.01161.x; Yi O, 2007, INT J FOOD SCI NUTR, V58, P178, DOI 10.1080/09637480601121318; Zeng JG, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053409, 10.1371/journal.pone.0082091]; Zhai RR, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-19; Zhang SW, 2009, PLANT PHYSIOL, V151, P1889, DOI 10.1104/pp.109.146803; Zhang XM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042082; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524; Zhang ZQ, 2007, PLANT PHYSIOL, V145, P450, DOI 10.1104/pp.107.106021; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485; Zipfel C, 2008, CURR OPIN IMMUNOL, V20, P10, DOI 10.1016/j.coi.2007.11.003; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037; Zipfel C, 2009, CURR OPIN PLANT BIOL, V12, P414, DOI 10.1016/j.pbi.2009.06.003	108	10	12	4	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e90487	10.1371/journal.pone.0090487	http://dx.doi.org/10.1371/journal.pone.0090487			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614014	Green Published, gold, Green Submitted			2022-12-27	WOS:000332839300026
J	Hwang, KK; Trama, AM; Kozink, DM; Chen, X; Wiehe, K; Cooper, AJ; Xia, SM; Wang, MY; Marshall, DJ; Whitesides, J; Alam, M; Tomaras, GD; Allen, SL; Rai, KR; McKeating, J; Catera, R; Yan, XJ; Chu, CC; Kelsoe, G; Liao, HX; Chiorazzi, N; Haynes, BF				Hwang, Kwan-Ki; Trama, Ashley M.; Kozink, Daniel M.; Chen, Xi; Wiehe, Kevin; Cooper, Abby J.; Xia, Shi-Mao; Wang, Minyue; Marshall, Dawn J.; Whitesides, John; Alam, Munir; Tomaras, Georgia D.; Allen, Steven L.; Rai, Kanti R.; McKeating, Jane; Catera, Rosa; Yan, Xiao-Jie; Chu, Charles C.; Kelsoe, Garnett; Liao, Hua-Xin; Chiorazzi, Nicholas; Haynes, Barton F.			IGHV1-69 B Cell Chronic Lymphocytic Leukemia Antibodies Cross-React with HIV-1 and Hepatitis C Virus Antigens as Well as Intestinal Commensal Bacteria	PLOS ONE			English	Article							HIGH-FREQUENCY; PREFERENTIAL USE; INFLUENZA-VIRUS; GENE; NEUTRALIZATION; SUBSETS; EXPRESSION; LYMPHOMAS; IDIOTYPES; SELECTION	IGHV1-B-cell chronic lymphocytic leukemia (B-CLL) patients expressing unmutated immunoglobulin heavy variable regions (IGHVs) use the IGHV1-69 B cell receptor (BCR) in 25% of cases. Since HIV-1 envelope gp41 antibodies also frequently use IGHV1-69 gene segments, we hypothesized that IGHV1-69 B-CLL precursors may contribute to the gp41 B cell response during HIV-1 infection. To test this hypothesis, we rescued 5 IGHV1-69 unmutated antibodies as heterohybridoma IgM paraproteins and as recombinant IgG(1) antibodies from B-CLL patients, determined their antigenic specificities and analyzed BCR sequences. IGHV1-69 B-CLL antibodies were enriched for reactivity with HIV-1 envelope gp41, influenza, hepatitis C virus E2 protein and intestinal commensal bacteria. These IGHV1-69 B-CLL antibodies preferentially used IGHD3 and IGHJ6 gene segments and had long heavy chain complementary determining region 3s (HCDR3s) (>= 21 aa). IGHV1-69 B-CLL BCRs exhibited a phenylalanine at position 54 (F-54) of the HCDR2 as do rare HIV-1 gp41 and influenza hemagglutinin stem neutralizing antibodies, while IGHV1-69 gp41 antibodies induced by HIV-1 infection predominantly used leucine (L-54) allelic variants. These results demonstrate that the B-CLL cell population is an expansion of members of the innate polyreactive B cell repertoire with reactivity to a number of infectious agent antigens including intestinal commensal bacteria. The B-CLL IGHV1-69 B cell usage of F-54 allelic variants strongly suggests that IGHV1-69 B-CLL gp41 antibodies derive from a restricted B cell pool that also produces rare HIV-1 gp41 and influenza hemagglutinin stem antibodies.	[Hwang, Kwan-Ki; Trama, Ashley M.; Kozink, Daniel M.; Chen, Xi; Wiehe, Kevin; Cooper, Abby J.; Xia, Shi-Mao; Wang, Minyue; Marshall, Dawn J.; Whitesides, John; Alam, Munir; Tomaras, Georgia D.; Liao, Hua-Xin; Haynes, Barton F.] Duke Univ, Med Ctr, Duke Human Vaccine Inst, Durham, NC 27708 USA; [McKeating, Jane] Univ Birmingham, Sch Immun & Infect, Inst Biomed Res, Birmingham, W Midlands, England; [Allen, Steven L.; Rai, Kanti R.; Catera, Rosa; Yan, Xiao-Jie; Chu, Charles C.; Chiorazzi, Nicholas] Feinstein Inst Med Res, Karches Ctr Chron Lymphocyt Leukemia Res, Manhasset, NY USA; [Kelsoe, Garnett] Duke Univ, Sch Med, Dept Immunol, Durham, NC USA	Duke University; University of Birmingham; Northwell Health; Duke University	Haynes, BF (corresponding author), Duke Univ, Med Ctr, Duke Human Vaccine Inst, Durham, NC 27708 USA.	hayne002@mc.duke.edu	Allen, Steven/N-6088-2019; Tomaras, Georgia/J-5041-2016	Allen, Steven/0000-0002-3482-3182; McKeating, Jane/0000-0002-7229-5886	National Institute of Allergy and Infectious Diseases of the National Institutes of Health; Center for HIV/AIDS Vaccine Immunology [U19-AI067854]; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery [UM1-AI100645-01]; National Cancer Institute of the National Institutes of Health [CA81554]; Nash Family Foundation; Karches Foundation; NATIONAL CANCER INSTITUTE [R01CA081554, P30CA014236] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI100645, U19AI067854] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Center for HIV/AIDS Vaccine Immunology; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery; National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Nash Family Foundation; Karches Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research reported in this publication was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health, by the Center for HIV/AIDS Vaccine Immunology, grant number U19-AI067854 and by the Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, grant number UM1-AI100645-01. This work was also supported by an R01 grant from the National Cancer Institute of the National Institutes of Health, grant number CA81554 and by philanthropic grants from the Nash Family Foundation and the Karches Foundation to KRR and NC. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Baumgarth N, 1999, P NATL ACAD SCI USA, V96, P2250, DOI 10.1073/pnas.96.5.2250; Baumgarth N, 2011, NAT REV IMMUNOL, V11, P34, DOI 10.1038/nri2901; Bomsel M, 1998, IMMUNITY, V9, P277, DOI 10.1016/S1074-7613(00)80610-X; Carbonari M, 2005, J IMMUNOL, V174, P6532, DOI 10.4049/jimmunol.174.10.6532; Catera R, 2008, MOL MED, V14, P665, DOI 10.2119/2008-00102.Catera; Chan CH, 2001, BLOOD, V97, P1023, DOI 10.1182/blood.V97.4.1023; Chiorazzi N, 2005, NEW ENGL J MED, V352, P804, DOI 10.1056/NEJMra041720; Chiorazzi N, 2011, BLOOD, V117, P1781, DOI 10.1182/blood-2010-07-155663; Corti D, 2010, J CLIN INVEST, V120, P1663, DOI 10.1172/JCI41902; Darzentas N, 2010, LEUKEMIA, V24, P125, DOI 10.1038/leu.2009.186; Davies J, 1996, IMMUNOTECHNOLOGY, V2, P169, DOI 10.1016/S1380-2933(96)00045-0; Dennison SM, 2011, J VIROL, V85, P1340, DOI 10.1128/JVI.01680-10; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Fais F, 1998, J CLIN INVEST, V102, P1515, DOI 10.1172/JCI3009; Ghiotto F, 2006, MOL MED, V12, P300, DOI 10.2119/2006-00080.Ghiotto; Gorny MK, 2009, MOL IMMUNOL, V46, P917, DOI 10.1016/j.molimm.2008.09.005; Griffin DO, 2011, J EXP MED, V208, P67, DOI 10.1084/jem.20101499; Gustchina E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001182; Herve M, 2005, J CLIN INVEST, V115, P1636, DOI 10.1172/JCI24387; Hwang KK, 2012, BLOOD, V119, pE35, DOI 10.1182/blood-2011-08-371203; Kawatsu K, 2008, J CLIN MICROBIOL, V46, P1226, DOI 10.1128/JCM.02170-07; KIPPS TJ, 1990, J EXP MED, V171, P189, DOI 10.1084/jem.171.1.189; KIPPS TJ, 1991, J CLIN INVEST, V87, P2087, DOI 10.1172/JCI115239; KIPPS TJ, 1988, BLOOD, V72, P422; KIPPS TJ, 1989, P NATL ACAD SCI USA, V86, P5913, DOI 10.1073/pnas.86.15.5913; Liao HX, 2006, VIROLOGY, V353, P268, DOI 10.1016/j.virol.2006.04.043; Liao HX, 2011, J EXP MED, V208, P2237, DOI 10.1084/jem.20110363; Liao HX, 2009, J VIROL METHODS, V158, P171, DOI 10.1016/j.jviromet.2009.02.014; Logvinoff C, 2004, P NATL ACAD SCI USA, V101, P10149, DOI 10.1073/pnas.0403519101; Luftig MA, 2006, NAT STRUCT MOL BIOL, V13, P740, DOI 10.1038/nsmb1127; Ma BJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002200; Messmer BT, 2004, J EXP MED, V200, P519, DOI 10.1084/jem.20040544; Morris L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023532; Mouquet H, 2010, NATURE, V467, P591, DOI 10.1038/nature09385; Murray F, 2008, BLOOD, V111, P1524, DOI 10.1182/blood-2007-07-099564; Myhrinder AL, 2008, BLOOD, V111, P3838, DOI 10.1182/blood-2007-11-125450; Rossio JL, 1998, J VIROL, V72, P7992, DOI 10.1128/JVI.72.10.7992-8001.1998; Sabin C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001195; Sasso EH, 1996, J CLIN INVEST, V97, P2074, DOI 10.1172/JCI118644; SASSO EH, 1993, J CLIN INVEST, V91, P2358, DOI 10.1172/JCI116468; Schelonka RL, 2008, J IMMUNOL, V181, P8409, DOI 10.4049/jimmunol.181.12.8409; SCHROEDER HW, 1987, SCIENCE, V238, P791, DOI 10.1126/science.3118465; Seifert M, 2012, J EXP MED, V209, P2183, DOI 10.1084/jem.20120833; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; Tobin G, 2004, BLOOD, V104, P2879, DOI 10.1182/blood-2004-01-0132; Tomaras GD, 2008, J VIROL, V82, P12449, DOI 10.1128/JVI.01708-08; Weller S, 2004, BLOOD, V104, P3647, DOI 10.1182/blood-2004-01-0346; Widhopf GF, 2004, BLOOD, V104, P2499, DOI 10.1182/blood-2004-03-0818; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352	51	33	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e90725	10.1371/journal.pone.0090725	http://dx.doi.org/10.1371/journal.pone.0090725			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614505	Green Published, gold, Green Submitted			2022-12-27	WOS:000332839300035
J	Hassan, LEA; Ahamed, MBK; Majid, ASA; Iqbal, MA; Al Suede, FSR; Haque, RA; Ismail, Z; Ein, OC; Majid, AMSA				Hassan, Loiy Elsir Ahmed; Ahamed, Mohamed B. Khadeer; Majid, Aman Shah Abdul; Iqbal, Muhammad Adnan; Al Suede, Fouad Saleih R.; Haque, Rosenani A.; Ismail, Zhari; Ein, Oon Chern; Majid, Amin Malik Shah Abdul			Crystal Structure Elucidation and Anticancer Studies of (-)-Pseudosemiglabrin: A Flavanone Isolated from the Aerial Parts of Tephrosia apollinea	PLOS ONE			English	Article							BIS-BENZIMIDAZOLIUM SALTS; CANCER CHEMOPREVENTION; PHYSICAL-PROPERTIES; CARBENE COMPLEXES; NATURAL-PRODUCTS; CELL-LINES; APOPTOSIS; DERIVATIVES; AGENTS; ESTER	Tephrosia apollinea is a perennial shrublet widely distributed in Africa and is known to have medicinal properties. The current study describes the bio-assay (cytotoxicity) guided isolation of (-)-pseudosemiglabrin from the aerial parts of T. apollinea. The structural and stereochemical features have been described using spectral and x-ray crystallographic techniques. The cytotoxicity of isolated compound was evaluated against nine cancer cell lines. In addition, human fibroblast was used as a model cell line for normal cells. The results showed that (-)-pseudosemiglabrin exhibited dose-dependent antiproliferative effect on most of the tested cancer cell lines. Selectively, the compound showed significant inhibitory effect on the proliferation of leukemia, prostate and breast cancer cell lines. Further studies revealed that, the compound exhibited proapoptotic phenomenon of cytotoxicity. Interestingly, the compound did not display toxicity against the normal human fibroblast. It can be concluded that (-)-pseudosemiglabrin is worthy for further investigation as a potential chemotherapeutic agent.	[Hassan, Loiy Elsir Ahmed; Ahamed, Mohamed B. Khadeer; Al Suede, Fouad Saleih R.; Ismail, Zhari; Majid, Amin Malik Shah Abdul] Univ Sains Malaysia, Sch Pharmaceut Sci, EMAN Res & Testing Lab, George Town, Malaysia; [Majid, Aman Shah Abdul] Univ Sains Malaysia, Adv Med & Dent Inst IPPT, George Town, Malaysia; [Iqbal, Muhammad Adnan; Haque, Rosenani A.] Univ Sains Malaysia, Sch Chem Sci, George Town, Malaysia; [Ein, Oon Chern] Univ Sains Malaysia, Inst Res Mol Med INFORMM, George Town, Malaysia	Universiti Sains Malaysia; Universiti Sains Malaysia; Universiti Sains Malaysia; Universiti Sains Malaysia	Majid, AMSA (corresponding author), Univ Sains Malaysia, Sch Pharmaceut Sci, EMAN Res & Testing Lab, George Town, Malaysia.	aminmalikshah@gmail.com	Basheer, Mohamed Khadeer Ahamed/P-1681-2014; Majid, Aman Shah Abdul/I-3809-2012; Oon, Chern E/B-3684-2013; Iqbal, Muhammad Adnan/Q-5408-2016; Alsuede, Fouad Saleih Resq/AAE-6203-2021; Haque, Rosenani/J-2461-2017	Basheer, Mohamed Khadeer Ahamed/0000-0001-9616-1770; Majid, Aman Shah Abdul/0000-0001-9679-122X; Oon, Chern E/0000-0002-4685-6408; Iqbal, Muhammad Adnan/0000-0001-6241-7547; Abdul Majid, Amin Malik Shah/0000-0001-7499-2258; A. Haque, Rosenani/0000-0002-5232-1469	TWAS-USM [3240240313]; USM [304/PKIMIA/6311123]	TWAS-USM; USM(Universiti Sains Malaysia)	The authors wish to acknowledge TWAS-USM (FR number: 3240240313) for the fellowship to LEAH and financial support for this research. RAH is thankful to USM for the research grant No 304/PKIMIA/6311123. The authors state that the funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE H, 1995, MACROMOLECULES, V28, P844, DOI 10.1021/ma00108a007; Abou-Douh AM, 2005, Z NATURFORSCH B, V60, P458; Ahamed MBK, 2012, NUTR CANCER, V64, P89, DOI 10.1080/01635581.2012.630160; Al-Salahi OSA, 2013, MICROVASC RES, V90, P30, DOI 10.1016/j.mvr.2013.07.007; Anadu NO, 2006, J MED CHEM, V49, P3897, DOI 10.1021/jm0602817; Aytemir MD, 2003, TURK J CHEM, V27, P445; BIBBY MC, 1987, BRIT J CANCER, V55, P159, DOI 10.1038/bjc.1987.32; Bold RJ, 1997, SURG ONCOL, V6, P133, DOI 10.1016/S0960-7404(97)00015-7; Brinkmann M, 2000, J AM CHEM SOC, V122, P5147, DOI 10.1021/ja993608k; Castedo M, 2002, J IMMUNOL METHODS, V265, P39, DOI 10.1016/S0022-1759(02)00069-8; Chen YJ, 2001, ANTI-CANCER DRUG, V12, P143, DOI 10.1097/00001813-200102000-00008; Daouda B, 2013, ACTA CRYSTALLOGR E, V69, pO662, DOI 10.1107/S1600536813008702; Du ZY, 2013, ACTA CRYSTALLOGR E, V69, pO624, DOI 10.1107/S1600536813008015; Gulecha V, 2011, ASIAN PAC J TROP MED, V4, P526, DOI 10.1016/S1995-7645(11)60139-9; Haque R., 2013, MED CHEM RES, DOI 10. 1007/s00044-012-0461-8; Haque RA, 2013, APPL ORGANOMET CHEM, V27, P214, DOI 10.1002/aoc.2953; Harvey AL, 2008, DRUG DISCOV TODAY, V13, P894, DOI 10.1016/j.drudis.2008.07.004; Hong WK, 1997, SCIENCE, V278, P1073, DOI 10.1126/science.278.5340.1073; Iqbal MA, 2013, MED CHEM RES, V22, P2455, DOI 10.1007/s00044-012-0240-6; Jayashree BS, 2012, MED CHEM RES, V21, P1991, DOI 10.1007/s00044-011-9725-y; Kajimoto S, 2002, INT J CANCER, V99, P879, DOI 10.1002/ijc.10414; Kalai T, 2004, ARKIVOC, P266, DOI 10.3998/ark.5550190.0005.721; Kelloff GJ, 1999, ANN NY ACAD SCI, V889, P1, DOI 10.1111/j.1749-6632.1999.tb08718.x; Khoo BY, 2010, INT J MOL SCI, V11, P2188, DOI 10.3390/ijms11052188; Kosmider B, 2004, DRUG DEVELOP RES, V63, P200, DOI 10.1002/ddr.10421; Lahtinen M, 2013, ACTA CRYSTALLOGR E, V69, pO681, DOI 10.1107/S1600536813008957; Lehmler HJ, 2013, ACTA CRYSTALLOGR E, V69, pO650, DOI 10.1107/S160053681300826X; Li X, 2006, PHARMAZIE, V61, P474; Li ZJ, 1997, J PHARM SCI, V86, P1073, DOI 10.1021/js970195h; Lim HK, 2009, FOOD CHEM, V114, P1245, DOI 10.1016/j.foodchem.2008.10.088; Lindholm P, 2002, J BIOMOL SCREEN, V7, P333, DOI 10.1177/108705710200700405; Mann J, 2002, NAT REV CANCER, V2, P143, DOI 10.1038/nrc723; MANOHARAN R, 1993, ATHEROSCLEROSIS, V103, P181, DOI 10.1016/0021-9150(93)90261-R; Matysik G, 2005, CHROMATOGRAPHIA, V61, P89, DOI 10.1365/s10337-004-0443-1; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Musharraf SG, 2013, CHEM CENT J, V7, DOI 10.1186/1752-153X-7-77; Nassar ZD, 2012, ONCOL REP, V27, P727, DOI 10.3892/or.2011.1569; Nobili S, 2009, PHARMACOL RES, V59, P365, DOI 10.1016/j.phrs.2009.01.017; Qian Y, 2010, BIOORGAN MED CHEM, V18, P4991, DOI 10.1016/j.bmc.2010.06.003; REILLY M, 1995, TETRAHEDRON LETT, V36, P217, DOI 10.1016/0040-4039(94)02226-2; Ren WY, 2003, MED RES REV, V23, P519, DOI 10.1002/med.10033; Seidel N, 2013, ACTA CRYSTALLOGR E, V69, pO1732, DOI 10.1107/S1600536813028857; Skommer J, 2007, LEUKEMIA RES, V31, P277, DOI 10.1016/j.leukres.2006.06.027; Song XQ, 2005, MOL PHARMACEUT, V2, P157, DOI 10.1021/mp049888e; Sun SY, 2004, JNCI-J NATL CANCER I, V96, P662, DOI 10.1093/jnci/djh123; Touqeer S, 2013, REV PHYTOCHEMISTRY P; Vatkar B. S., 2010, International Journal of ChemTech Research, V2, P504; WATERMAN PG, 1980, PHYTOCHEMISTRY, V19, P909, DOI 10.1016/0031-9422(80)85137-5; Wattenberg LW, 1995, ANN NY ACAD SCI, V768, P73, DOI 10.1111/j.1749-6632.1995.tb12111.x; Xue F, 2009, J SUN YAT SEN U MED, V4, P015; Zhang H, 2013, ACTA CRYSTALLOGR E, V69, pO678, DOI 10.1107/S1600536813008829	51	18	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90806	10.1371/journal.pone.0090806	http://dx.doi.org/10.1371/journal.pone.0090806			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608571	gold, Green Published, Green Submitted			2022-12-27	WOS:000332485800052
J	Oh, TJ; Hyun, SH; Lee, SG; Chun, YJ; Sung, GH; Choi, HK				Oh, Taek-Joo; Hyun, Sun-Hee; Lee, Seul-Gi; Chun, Young-Jin; Sung, Gi-Ho; Choi, Hyung-Kyoon			NMR and GC-MS Based Metabolic Profiling and Free-Radical Scavenging Activities of Cordyceps pruinosa Mycelia Cultivated under Different Media and Light Conditions	PLOS ONE			English	Article							CULTURED MYCELIA; FRUITING BODY; ANTIOXIDANT ACTIVITIES; EDIBLE MUSHROOMS; IN-VITRO; MILITARIS; ASPERGILLUS; SPORULATION; FUNGI; POLYSACCHARIDE	Variation of metabolic profiles in Cordyceps pruinosa mycelia cultivated under various media and light conditions was investigated using 1 H nuclear magnetic resonance (NMR) analysis and gas chromatography mass spectrometry (GC-MS) with multivariate statistical analysis. A total of 71 metabolites were identified (5 alcohols, 21 amino acids, 15 organic acids, 4 purines, 3 pyrimidines, 7 sugars, 11 fatty acids, and 5 other metabolites) by NMR and GC-MS analysis. The mycelia grown in nitrogen media and under dark conditions showed the lowest growth and ergosterol levels, essential to a functional fungal cell membrane; these mycelia, however, had the highest levels of putrescine, which is involved in abiotic stress tolerance. In contrast, mycelia cultivated in sabouraud dextrose agar with yeast extract (SDAY) media and under light conditions contained relatively higher levels of fatty acids, including valeric acid, stearic acid, lignoceric acid, myristic acid, oleic acid, palmitoleic acid, hepadecenoic acid, and linoleic acid. These mycelia also had the highest phenolic content and antioxidant activity, and did not exhibit growth retardation due to enhanced asexual development caused by higher levels of linoleic acid. Therefore, we suggested that a light-enriched environment with SDAY media was more optimal than dark condition for cultivation of C. pruinosa mycelia as biopharmaceutical or nutraceutical resources.	[Oh, Taek-Joo; Hyun, Sun-Hee; Lee, Seul-Gi; Chun, Young-Jin; Choi, Hyung-Kyoon] Chung Ang Univ, Coll Pharm, Seoul 156756, South Korea; [Sung, Gi-Ho] RDA, Natl Inst Hort & Herbal Sci, Dept Herbal Crop Res, Mushroom Res Div, Eumseong, South Korea	Chung Ang University; National Institute of Horticultural & Herbal Science (NIHHS), Republic of Korea; Rural Development Administration (RDA), Republic of Korea	Sung, GH (corresponding author), RDA, Natl Inst Hort & Herbal Sci, Dept Herbal Crop Res, Mushroom Res Div, Eumseong, South Korea.	sung97330@gmail.com; hykychoi@cau.ac.kr			Next-Generation Biogreen 21 Program, Rural Development Administration [PJ008154]; Mid-career Researcher Program through NRF [NRF-2012R1A2A2A02011748]; MSIP, Republic of Korea	Next-Generation Biogreen 21 Program, Rural Development Administration; Mid-career Researcher Program through NRF; MSIP, Republic of Korea	This work was supported by a grant from the Next-Generation Biogreen 21 Program (No. PJ008154), Rural Development Administration, and by Mid-career Researcher Program (NRF-2012R1A2A2A02011748) through NRF grant funded by the MSIP, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Calvo AM, 2001, J BIOL CHEM, V276, P25766, DOI 10.1074/jbc.M100732200; Calvo AM, 1999, APPL ENVIRON MICROB, V65, P3668; Chen SY, 2012, LWT-FOOD SCI TECHNOL, V47, P274, DOI 10.1016/j.lwt.2012.01.019; Dadakova E, 2009, EUR FOOD RES TECHNOL, V230, P163, DOI 10.1007/s00217-009-1148-3; de Oliveira AC, 2009, FOOD CHEM, V115, P469, DOI 10.1016/j.foodchem.2008.12.045; Dong CH, 2008, LWT-FOOD SCI TECHNOL, V41, P669, DOI 10.1016/j.lwt.2007.05.002; Dong JZ, 2012, APPL BIOCHEM BIOTECH, V166, P2030, DOI 10.1007/s12010-012-9628-5; Dyer PS, 2012, FEMS MICROBIOL REV, V36, P165, DOI 10.1111/j.1574-6976.2011.00308.x; Fan DD, 2012, BIOCHEM ENG J, V60, P30, DOI 10.1016/j.bej.2011.09.014; FURUYA T, 1983, PHYTOCHEMISTRY, V22, P2509, DOI 10.1016/0031-9422(83)80150-2; Gill SS, 2010, PLANT SIGNAL BEHAV, V5, P26, DOI 10.4161/psb.5.1.10291; GOLDSTEIN A, 1962, J GEN MICROBIOL, V28, P689; Hao Y, 1999, JUN WU XUE BAO, V18, P307; HILL EP, 1976, J GEN MICROBIOL, V95, P39, DOI 10.1099/00221287-95-1-39; Huang J, 1998, J FUJIAN TEACH U NAT, V14, P82; Johnson L, 2008, MYCOL RES, V112, P170, DOI 10.1016/j.mycres.2007.11.012; Kalogeropoulos N, 2013, FOOD CHEM TOXICOL, V55, P378, DOI 10.1016/j.fct.2013.01.010; Kim HG, 2010, J ETHNOPHARMACOL, V128, P342, DOI 10.1016/j.jep.2010.01.049; Kim KM, 2003, TOXICOL APPL PHARM, V190, P1, DOI 10.1016/S0041-008X(03)00152-2; Kim MY, 2008, J AGR FOOD CHEM, V56, P7265, DOI 10.1021/jf8008553; Kim Soo-Young, 2010, Mycobiology, V38, P133, DOI 10.4489/MYCO.2010.38.2.133; Lee Je-O, 2007, Mycobiology, V35, P230, DOI 10.4489/MYCO.2007.35.4.230; Liang ZQ, 1991, MYCOSYSTEMA, V10, P104; Liu J., 2001, THE J, V17, P189; Liu ZY, 2002, MYCOL RES, V106, P1100, DOI 10.1017/S0953756202006378; Ou ZQ, 2013, J PHARM PHARMACOL, V65, P271, DOI 10.1111/j.2042-7158.2012.01591.x; Palacios I, 2011, FOOD CHEM, V128, P674, DOI 10.1016/j.foodchem.2011.03.085; Park HS, 2012, CURR OPIN MICROBIOL, V15, P669, DOI 10.1016/j.mib.2012.09.006; Prathumpai W, 2007, APPL BIOCHEM BIOTECH, V136, P223, DOI 10.1007/BF03259856; Ramadan Z, 2006, TALANTA, V68, P1683, DOI 10.1016/j.talanta.2005.08.042; Shrestha Bhushan, 2006, Mycobiology, V34, P83, DOI 10.4489/MYCO.2006.34.2.083; Styczynski MP, 2007, ANAL CHEM, V79, P966, DOI 10.1021/ac0614846; Sung Jae-Mo, 2006, Mycobiology, V34, P131, DOI 10.4489/MYCO.2006.34.3.131; Vanegas JM, 2012, BIOPHYS J, V102, P507, DOI 10.1016/j.bpj.2011.12.038; Won SY, 2005, J ETHNOPHARMACOL, V96, P555, DOI 10.1016/j.jep.2004.10.009; Xiao JH, 2004, PROCESS BIOCHEM, V39, P2241, DOI 10.1016/j.procbio.2003.11.026	36	17	18	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90823	10.1371/journal.pone.0090823	http://dx.doi.org/10.1371/journal.pone.0090823			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608751	Green Published, gold, Green Submitted			2022-12-27	WOS:000332485800055
J	Wu, H; Ji, HK				Wu, Hao; Ji, Hongkai			PolyaPeak: Detecting Transcription Factor Binding Sites from ChIP-seq Using Peak Shape Information	PLOS ONE			English	Article							GENOME; IDENTIFICATION; PROFILES	ChIP-seq is a powerful technology for detecting genomic regions where a protein of interest interacts with DNA. ChIP-seq data for mapping transcription factor binding sites (TFBSs) have a characteristic pattern: around each binding site, sequence reads aligned to the forward and reverse strands of the reference genome form two separate peaks shifted away from each other, and the true binding site is located in between these two peaks. While it has been shown previously that the accuracy and resolution of binding site detection can be improved by modeling the pattern, efficient methods are unavailable to fully utilize that information in TFBS detection procedure. We present PolyaPeak, a new method to improve TFBS detection by incorporating the peak shape information. PolyaPeak describes peak shapes using a flexible Polya model. The shapes are automatically learnt from the data using Minorization-Maximization (MM) algorithm, then integrated with the read count information via a hierarchical model to distinguish true binding sites from background noises. Extensive real data analyses show that PolyaPeak is capable of robustly improving TFBS detection compared with existing methods. An R package is freely available.	[Wu, Hao] Emory Univ, Dept Biostat & Bioinformat, Atlanta, GA 30322 USA; [Ji, Hongkai] Johns Hopkins Univ, Dept Biostat, Baltimore, MD 21205 USA	Emory University; Johns Hopkins University	Wu, H (corresponding author), Emory Univ, Dept Biostat & Bioinformat, Atlanta, GA 30322 USA.	hao.wu@emory.edu; hji@jhsph.edu	Wu, Hao/H-3899-2017	Wu, Hao/0000-0003-1269-7354	National Institute of Health [R01HG006282]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006282] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Research by HJ is supported by the National Institute of Health grant: R01HG006282. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Celniker SE, 2009, NATURE, V459, P927, DOI 10.1038/459927a; Chen L, 2011, BIOINFORMATICS, V27, P1447, DOI 10.1093/bioinformatics/btr156; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Fejes AP, 2008, BIOINFORMATICS, V24, P1729, DOI 10.1093/bioinformatics/btn305; Guo YC, 2010, BIOINFORMATICS, V26, P3028, DOI 10.1093/bioinformatics/btq590; Hower V, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-15; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Jothi R, 2008, NUCLEIC ACIDS RES, V36, P5221, DOI 10.1093/nar/gkn488; Kuan PF, 2011, J AM STAT ASSOC, V106, P891, DOI 10.1198/jasa.2011.ap09706; Laajala TD, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-618; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Qin ZHS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-369; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Rozowsky J, 2009, NAT BIOTECHNOL, V27, P66, DOI 10.1038/nbt.1518; Rye MB, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1187; Spyrou C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-299; Thomas DJ, 2007, NUCLEIC ACIDS RES, V35, pD663, DOI 10.1093/nar/gkl1017; Valouev A, 2008, NAT METHODS, V5, P829, DOI 10.1038/NMETH.1246; Wilbanks EG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011471; ZHANG X, 2010, BIOMETRICS; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou H, 2010, J COMPUT GRAPH STAT, V19, P645, DOI 10.1198/jcgs.2010.09014	23	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e89694	10.1371/journal.pone.0089694	http://dx.doi.org/10.1371/journal.pone.0089694			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608116	Green Published, Green Submitted, gold			2022-12-27	WOS:000332485800006
J	Bei, AK; Patel, SD; Volkman, SK; Ahouidi, AD; Ndiaye, D; Mboup, S; Wirth, DF				Bei, Amy K.; Patel, Saurabh D.; Volkman, Sarah K.; Ahouidi, Ambroise D.; Ndiaye, Daouda; Mboup, Souleymane; Wirth, Dyann F.			An Adjustable Gas-Mixing Device to Increase Feasibility of In Vitro Culture of Plasmodium falciparum Parasites in the Field	PLOS ONE			English	Article							MALARIA PARASITES; CULTIVATION; ERYTHROCYTES; INVITRO; CHLOROQUINE; INVASION; OXYGEN; VIVAX; CELLS; ASSAY	A challenge to conducting high-impact and reproducible studies of the mechanisms of P. falciparum drug resistance, invasion, virulence, and immunity is the lack of robust and sustainable in vitro culture in the field. While the technology exists and is routinely utilized in developed countries, various factors-from cost, to supply, to quality-make it hard to implement in malaria endemic countries. Here, we design and rigorously evaluate an adjustable gas-mixing device for the in vitro culture of P. falciparum parasites in the field to circumvent this challenge. The device accurately replicates the gas concentrations needed to culture laboratory isolates, short-term adapted field isolates, cryopreserved previously non-adapted isolates, as well as to adapt ex vivo isolates to in vitro culture in the field. We also show an advantage over existing alternatives both in cost and in supply. Furthermore, the adjustable nature of the device makes it an ideal tool for many applications in which varied gas concentrations could be critical to culture success. This adjustable gas-mixing device will dramatically improve the feasibility of in vitro culture of Plasmodium falciparum parasites in malaria endemic countries given its numerous advantages.	[Bei, Amy K.; Patel, Saurabh D.; Volkman, Sarah K.; Wirth, Dyann F.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Bei, Amy K.; Ahouidi, Ambroise D.; Mboup, Souleymane] Cheikh Anta Diop Univ, Fac Med & Pharm, Lab Bacteriol & Virol, Dakar, Senegal; [Patel, Saurabh D.] Boston Childrens Hosp, Div Gastroenterol Hepatol & Nutr, Boston, MA USA; [Volkman, Sarah K.; Wirth, Dyann F.] Broad Inst MIT & Harvard, Cambridge, MA USA; [Volkman, Sarah K.] Simmons Coll, Sch Nursing & Hlth Sci, Boston, MA 02115 USA; [Ndiaye, Daouda] Cheikh Anta Diop Univ, Lab Parasitol & Mycol, Fac Med & Pharm, Dakar, Senegal	Harvard University; Harvard T.H. Chan School of Public Health; University Cheikh Anta Diop Dakar; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Simmons University; University Cheikh Anta Diop Dakar	Bei, AK (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, 665 Huntington Ave, Boston, MA 02115 USA.	abei@hsph.harvard.edu		Patel, Saurabh/0000-0002-5738-3175	Bill & Melinda Gates Foundation [OPP1053604]; National Institutes of Health [1R01AI099105-01A1]; American Society of Tropical Medicine & Hygiene (ASTMH) Centennial Award; Office of Faculty Development at Boston Children's Hospital; Shore fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI099105] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Society of Tropical Medicine & Hygiene (ASTMH) Centennial Award; Office of Faculty Development at Boston Children's Hospital; Shore fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the Bill & Melinda Gates Foundation (grant OPP1053604) and the National Institutes of Health (grant 1R01AI099105-01A1). AKB is supported by an American Society of Tropical Medicine & Hygiene (ASTMH) Centennial Award. SDP is supported by a grant from the Office of Faculty Development at Boston Children's Hospital, and the Shore fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beeson JG, 1999, J INFECT DIS, V180, P464, DOI 10.1086/314899; Bei AK, 2010, AM J HEMATOL, V85, P234, DOI 10.1002/ajh.21642; BIGGS BA, 1989, P NATL ACAD SCI USA, V86, P2428, DOI 10.1073/pnas.86.7.2428; Bopp SER, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003293; Brackett R G, 1979, Bull World Health Organ, V57 Suppl 1, P33; Briolant S, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-44; Butcher G A, 1979, Bull World Health Organ, V57 Suppl 1, P17; Cortes A, 2008, TRENDS PARASITOL, V24, P517, DOI 10.1016/j.pt.2008.08.005; DIVO AA, 1985, ANTIMICROB AGENTS CH, V27, P21, DOI 10.1128/AAC.27.1.21; Djimde A.A., 2007, Bulletin de la Societe de Pathologie Exotique, V100, P3, DOI 10.3185/pathexo2883; Dvorin JD, 2010, SCIENCE, V328, P910, DOI 10.1126/science.1188191; FAIRLAMB AH, 1985, ANN TROP MED PARASIT, V79, P379, DOI 10.1080/00034983.1985.11811935; Gysin J, 1999, INFECT IMMUN, V67, P6596; He SY, 2000, EXP PARASITOL, V94, P121, DOI 10.1006/expr.1999.4471; JENSEN JB, 1977, J PARASITOL, V63, P883, DOI 10.2307/3279900; JENSEN MD, 1983, J PARASITOL, V69, P1060, DOI 10.2307/3280864; LeRoux M, 2009, TRENDS PARASITOL, V25, P474, DOI 10.1016/j.pt.2009.07.005; Lin Q, 1999, Kansenshogaku Zasshi, V73, P1099; Mueller I, 2009, LANCET INFECT DIS, V9, P555, DOI 10.1016/S1473-3099(09)70177-X; NGUYENDINH P, 1980, SCIENCE, V209, P1249, DOI 10.1126/science.6773146; Noulin F, 2013, TRENDS PARASITOL, V29, P286, DOI 10.1016/j.pt.2013.03.012; Nsobya SL, 2008, J INFECT DIS, V198, P1554, DOI 10.1086/592506; OSISANYA JOS, 1981, ANN TROP MED PARASIT, V75, P107, DOI 10.1080/00034983.1981.11687415; Ribacke U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069781; SOUTHWELL BR, 1989, T ROY SOC TROP MED H, V83, P464, DOI 10.1016/0035-9203(89)90248-4; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; TRAGER W, 1977, B WORLD HEALTH ORGAN, V55, P363; TRAGER W, 1990, T ROY SOC TROP MED H, V84, P466, DOI 10.1016/0035-9203(90)90362-I; TRAGER W, 1982, BRIT MED BULL, V38, P129, DOI 10.1093/oxfordjournals.bmb.a071748; Trager W, 1979, Bull World Health Organ, V57 Suppl 1, P85; TRAGER W, 1979, J PROTOZOOL, V26, P125, DOI 10.1111/j.1550-7408.1979.tb02747.x; UDEINYA IJ, 1983, EXP PARASITOL, V56, P207, DOI 10.1016/0014-4894(83)90064-4	32	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90928	10.1371/journal.pone.0090928	http://dx.doi.org/10.1371/journal.pone.0090928			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603696	Green Published, gold, Green Submitted			2022-12-27	WOS:000332483600106
J	Suzuki, M; Kirimoto, H; Sugawara, K; Oyama, M; Yamada, S; Yamamoto, J; Matsunaga, A; Fukuda, M; Onishi, H				Suzuki, Makoto; Kirimoto, Hikari; Sugawara, Kazuhiro; Oyama, Mineo; Yamada, Sumio; Yamamoto, Jun-ichi; Matsunaga, Atsuhiko; Fukuda, Michinari; Onishi, Hideaki			Motor Cortex-Evoked Activity in Reciprocal Muscles Is Modulated by Reward Probability	PLOS ONE			English	Article							TRANSCRANIAL-MAGNETIC-STIMULATION; LATENCY AFFERENT INHIBITION; SYNAPTIC PLASTICITY; INTRACORTICAL INHIBITION; MOVEMENT REPRESENTATIONS; CORTICAL PLASTICITY; PARKINSONS-DISEASE; PREFRONTAL CORTEX; NUCLEUS-ACCUMBENS; DOPAMINE NEURONS	Horizontal intracortical projections for agonist and antagonist muscles exist in the primary motor cortex (M1), and reward may induce a reinforcement of transmission efficiency of intracortical circuits. We investigated reward-induced change in M1 excitability for agonist and antagonist muscles. Participants were 8 healthy volunteers. Probabilistic reward tasks comprised 3 conditions of 30 trials each: 30 trials contained 10% reward, 30 trials contained 50% reward, and 30 trials contained 90% reward. Each trial began with a cue (red fixation cross), followed by blue circle for 1 s. The subjects were instructed to perform wrist flexion and press a button with the dorsal aspect of middle finger phalanx as quickly as possible in response to disappearance of the blue circle without looking at their hand or the button. Two seconds after the button press, reward/non-reward stimulus was randomly presented for 2-s duration. The reward stimulus was a picture of Japanese 10-yen coin, and each subject received monetary reward at the end of experiment. Subjects were not informed of the reward probabilities. We delivered transcranial magnetic stimulation of the left M1 at the midpoint between center of gravities of agonist flexor carpi radialis (FCR) and antagonist extensor carpi radialis (ECR) muscles at 2 s after the red fixation cross and 1 s after the reward/non-reward stimuli. Relative motor evoked potential (MEP) amplitudes at 2 s after the red fixation cross were significantly higher for 10% reward probability than for 90% reward probability, whereas relative MEP amplitudes at 1 s after reward/non-reward stimuli were significantly higher for 90% reward probability than for 10% and 50% reward probabilities. These results implied that reward could affect the horizontal intracortical projections in M1 for agonist and antagonist muscles, and M1 excitability including the reward-related circuit before and after reward stimulus could be differently altered by reward probability.	[Suzuki, Makoto; Matsunaga, Atsuhiko; Fukuda, Michinari] Kitasato Univ, Grad Sch Med Sci, Sagamihara, Kanagawa, Japan; [Kirimoto, Hikari; Sugawara, Kazuhiro; Oyama, Mineo; Onishi, Hideaki] Niigata Univ Hlth & Welf, Inst Human Movement & Med Sci, Niigata, Japan; [Yamada, Sumio] Nagoya Univ, Grad Sch Med, Nagoya, Aichi 4648601, Japan; [Yamamoto, Jun-ichi] Keio Univ, Grad Sch Human Relat, Tokyo, Japan	Kitasato University; Niigata University; Nagoya University; Keio University	Suzuki, M (corresponding author), Kitasato Univ, Grad Sch Med Sci, Sagamihara, Kanagawa, Japan.	maksuzu@gmail.com	Kirimoto, Hikari/O-6495-2016	Kirimoto, Hikari/0000-0003-3768-5907	Japan Society for the Promotion of Science (JSPS) [25350632]; Niigata University of Health and Welfare	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Niigata University of Health and Welfare	This work was supported by a Grant-in-Aid for Scientific Research (C) 25350632 from the Japan Society for the Promotion of Science (JSPS) and a Grant-in-Aid for Advanced Research from Niigata University of Health and Welfare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abler B, 2006, NEUROIMAGE, V31, P790, DOI 10.1016/j.neuroimage.2006.01.001; Alle H, 2009, J PHYSIOL-LONDON, V587, P5163, DOI 10.1113/jphysiol.2009.179820; Awenowicz PW, 2002, J NEUROPHYSIOL, V88, P3439, DOI 10.1152/jn.00078.2002; Bertolasi L, 1998, J PHYSIOL-LONDON, V511, P947, DOI 10.1111/j.1469-7793.1998.947bg.x; Calabresi P, 2007, TRENDS NEUROSCI, V30, P211, DOI 10.1016/j.tins.2007.03.001; Campos M, 2005, J NEUROPHYSIOL, V94, P1325, DOI 10.1152/jn.00022.2005; Centonze D, 2003, J NEUROSCI, V23, P8506, DOI 10.1523/jneurosci.23-24-08506.2003; Centonze D, 2001, EUR J NEUROSCI, V13, P1071, DOI 10.1046/j.0953-816x.2001.01485.x; Chen R, 1999, EXP BRAIN RES, V129, P77, DOI 10.1007/s002210050938; Davis EJH, 2007, NEUROSCIENCE, V146, P784, DOI 10.1016/j.neuroscience.2007.01.039; Devanne H, 1997, EXP BRAIN RES, V114, P329, DOI 10.1007/PL00005641; Di Lazzaro V, 2007, CLIN NEUROPHYSIOL, V118, P2207, DOI 10.1016/j.clinph.2007.07.005; Di Lazzaro V, 2005, J PHYSIOL-LONDON, V569, P315, DOI 10.1113/jphysiol.2005.092155; Di Lazzaro V, 2005, J PHYSIOL-LONDON, V564, P661, DOI 10.1113/jphysiol.2004.061747; Gao WJ, 2003, J NEUROSCI, V23, P1622; Gerachshenko T, 2007, EXP BRAIN RES, V183, P531, DOI 10.1007/s00221-007-1071-4; Giacobbe V, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-46; Gottlieb GL, 1998, J NEUROPHYSIOL, V80, P1860, DOI 10.1152/jn.1998.80.4.1860; Gottschalk JM, 2000, J APPL BEHAV ANAL, V33, P85, DOI 10.1901/jaba.2000.33-85; Gupta N, 2011, EUR J NEUROSCI, V33, P183, DOI 10.1111/j.1460-9568.2010.07510.x; Haruno M, 2004, J NEUROSCI, V24, P1660, DOI 10.1523/JNEUROSCI.3417-03.2004; Hikosaka O, 2008, CURR OPIN NEUROBIOL, V18, P203, DOI 10.1016/j.conb.2008.07.002; Hortobagyi T, 2006, EXP BRAIN RES, V171, P322, DOI 10.1007/s00221-005-0274-9; Hosp JA, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00145; Hosp JA, 2011, J NEUROSCI, V31, P2481, DOI 10.1523/JNEUROSCI.5411-10.2011; Hulley S. B., 1988, DESIGNING CLIN RES; HUNTLEY GW, 1991, J NEUROPHYSIOL, V66, P390, DOI 10.1152/jn.1991.66.2.390; Ikemoto S, 2007, BRAIN RES REV, V56, P27, DOI 10.1016/j.brainresrev.2007.05.004; Kapogiannis D, 2008, EUR J NEUROSCI, V27, P1836, DOI 10.1111/j.1460-9568.2008.06147.x; Kapogiannis D, 2011, MOVEMENT DISORD, V26, P1451, DOI 10.1002/mds.23701; Kleim JA, 2007, NAT PROTOC, V2, P1675, DOI 10.1038/nprot.2007.206; Klein TA, 2007, SCIENCE, V318, P1642, DOI 10.1126/science.1145044; Koepp MJ, 1998, NATURE, V393, P266, DOI 10.1038/30498; KUJIRAI T, 1993, J PHYSIOL-LONDON, V471, P501, DOI 10.1113/jphysiol.1993.sp019912; Lang N, 2008, BIOL PSYCHIAT, V63, P231, DOI 10.1016/j.biopsych.2007.04.033; Macaluso A, 2002, MUSCLE NERVE, V25, P858, DOI 10.1002/mus.10113; Mang CS, 2011, EXP BRAIN RES, V209, P355, DOI 10.1007/s00221-011-2556-8; Marconi B, 2011, NEUROREHAB NEURAL RE, V25, P48, DOI 10.1177/1545968310376757; Matsuzaka Y, 2007, J NEUROPHYSIOL, V97, P1819, DOI 10.1152/jn.00784.2006; Meesen RLJ, 2011, HUM BRAIN MAPP, V32, P872, DOI 10.1002/hbm.21075; Melgari JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003069; Michael J, 1988, Anal Verbal Behav, V6, P3; Molina-Luna K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007082; Murray EA, 2007, TRENDS COGN SCI, V11, P489, DOI 10.1016/j.tics.2007.08.013; Nudo RJ, 1996, J NEUROSCI, V16, P785; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Ott DVM, 2011, NEUROIMAGE, V57, P617, DOI 10.1016/j.neuroimage.2011.04.038; PASCUALLEONE A, 1995, J NEUROPHYSIOL, V74, P1037, DOI 10.1152/jn.1995.74.3.1037; Pfann KD, 2001, MOVEMENT DISORD, V16, P1048, DOI 10.1002/mds.1220; Rioult-Pedotti MS, 2007, J NEUROPHYSIOL, V98, P3688, DOI 10.1152/jn.00164.2007; Rioult-Pedotti MS, 2000, SCIENCE, V290, P533, DOI 10.1126/science.290.5491.533; Rosenkranz K, 2007, J NEUROSCI, V27, P12058, DOI 10.1523/JNEUROSCI.2663-07.2007; Rosler KM, 2001, NEWS PHYSIOL SCI, V16, P297; Rossini PM, 2010, IEEE ENG MED BIOL, V29, P84, DOI 10.1109/MEMB.2009.935474; Rota S, 2014, J ELECTROMYOGR KINES, V24, P90, DOI 10.1016/j.jelekin.2013.10.007; Sanes JN, 2000, ANNU REV NEUROSCI, V23, P393, DOI 10.1146/annurev.neuro.23.1.393; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Schultz W, 2007, ANNU REV NEUROSCI, V30, P259, DOI 10.1146/annurev.neuro.28.061604.135722; Siebner HR, 2003, EXP BRAIN RES, V148, P1, DOI 10.1007/s00221-002-1234-2; Smyth C, 2010, HUM MOVEMENT SCI, V29, P618, DOI 10.1016/j.humov.2010.02.006; Stowe AM, 2008, J NEUROSCI METH, V170, P317, DOI 10.1016/j.jneumeth.2008.01.031; Suzuki M, 2012, BRAIN RES, V1473, P114, DOI 10.1016/j.brainres.2012.07.043; Thabit MN, 2011, CLIN NEUROPHYSIOL, V122, P1764, DOI 10.1016/j.clinph.2011.02.021; Tokimura H, 2000, J PHYSIOL-LONDON, V523, P503, DOI 10.1111/j.1469-7793.2000.t01-1-00503.x; Ungless MA, 2004, SCIENCE, V303, P2040, DOI 10.1126/science.1093360; Wassermann EM, 1998, EVOKED POTENTIAL, V108, P1, DOI 10.1016/S0168-5597(97)00096-8; Wickens JR, 2003, CURR OPIN NEUROBIOL, V13, P685, DOI 10.1016/j.conb.2003.10.013; Yang HD, 2006, J CLIN NEUROSCI, V13, P245, DOI 10.1016/j.jocn.2004.12.011; Zald DH, 2004, J NEUROSCI, V24, P4105, DOI 10.1523/JNEUROSCI.4643-03.2004; Ziemann U, 1996, J PHYSIOL-LONDON, V496, P873, DOI 10.1113/jphysiol.1996.sp021734	71	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90773	10.1371/journal.pone.0090773	http://dx.doi.org/10.1371/journal.pone.0090773			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603644	gold, Green Submitted, Green Published			2022-12-27	WOS:000332483600085
J	Zhao, GJ; Mu, XM; Strehmel, A; Tian, P				Zhao, Guangju; Mu, Xingmin; Strehmel, Alex; Tian, Peng			Temporal Variation of Streamflow, Sediment Load and Their Relationship in the Yellow River Basin, China	PLOS ONE			English	Article							YANGTZE-RIVER; SOIL-EROSION; RAINFALL SIMULATION; DISCHARGE; IMPACTS; CLIMATE; VEGETATION; REACHES; FLOW	Variation of streamflow and sediment load in the Yellow River basin has received considerable attention due to its drastic reduction during the past several decades. This paper presents a detailed investigation on the changes of streamflow and sediment load from 1952 to 2011 using monthly observations at four gauging stations along the Yellow River. The results show significant decreasing trends for both streamflow and sediment load at all four gauging stations over the past 60 years. The wavelet transform demonstrated discontinuous periodicities from 1969 to 1973 and after 1986 due to the construction of large reservoirs and implementation of numerous soil and water conservations practices. The sediment rating curves with the power-law function was applied to investigate the relationship between discharge and sediment load. The results indicate distinct variations of the relationship between streamflow and sediment and implied significant hydro-morphological changes within different periods. The reducing sediment supply from the source region and the increased erosive power of the river are detected at Lanzhou station, while the decrease of the transport capacity at Toudaoguai is caused by severe siltation. Significant changes in the relationship between streamflow and sediment load are found at Huayuankou and Gaocun stations, which are largely induced by evident sediment income and trapping effects of large reservoirs. It is estimated that numerous reservoirs have strongly altered the regime and magnitude of streamflow and trapped large amount of sediment, leading to severe siltation and evident reduction of their total volumes. A decrease in precipitation, incoming water from the upper reaches, soil and water conservation measures as well as water consumption contribute most to the significant reduction of streamflow. The decrease of sediment load mainly resulted from various soil and water conservation measures and trapping in reservoirs from 1986 to 2011.	[Zhao, Guangju; Mu, Xingmin] Northwest A&F Univ, Inst Soil & Water Conservat, Yangling, Shaanxi Provinc, Peoples R China; [Zhao, Guangju; Mu, Xingmin] Chinese Acad Sci, Inst Soil & Water Conservat, Yangling, Shaanxi Provinc, Peoples R China; [Zhao, Guangju; Mu, Xingmin] Minist Water Resources, Yangling, Shaanxi Provinc, Peoples R China; [Strehmel, Alex] Univ Kiel, Inst Nat Resource Conservat, Dept Hydrol & Water Resources Management, Kiel, Germany; [Tian, Peng] Northwest A&F Univ, Coll Resource & Environm, Yangling, Shaanxi Provinc, Peoples R China	Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Northwest A&F University - China; Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Ministry of Water Resources; University of Kiel; Northwest A&F University - China	Mu, XM (corresponding author), Northwest A&F Univ, Inst Soil & Water Conservat, Yangling, Shaanxi Provinc, Peoples R China.	xmmu@ms.iswc.ac.cn		Zhao, Guangju/0000-0002-4233-9403; Zhao, Guangju/0000-0001-7756-4494	National Natural Sciences Foundation of China [41201266, 41271295]; Key Research Program of the Chinese Academy of Sciences [KZZD-EW-04]; Key Project of the National Science and Technology Ministry [2012BAB02B05]; Program for Excellent Youth Scholars in the Institute of Soil and Water Conservation [A315021394]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Key Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Key Project of the National Science and Technology Ministry; Program for Excellent Youth Scholars in the Institute of Soil and Water Conservation	This work was supported by the National Natural Sciences Foundation of China (Grant Nos.: 41201266, 41271295), the Key Research Program of the Chinese Academy of Sciences (No. KZZD-EW-04), the Key Project of the National Science and Technology Ministry (No. 2012BAB02B05) and the Program for Excellent Youth Scholars in the Institute of Soil and Water Conservation (A315021394). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asselman NEM, 2000, J HYDROL, V234, P228, DOI 10.1016/S0022-1694(00)00253-5; Brown AE, 2013, J HYDROL, V483, P39, DOI 10.1016/j.jhydrol.2012.12.031; Cerda A, 2010, LAND DEGRAD DEV, V21, P71, DOI 10.1002/ldr.968; Cerda A, 1999, SOIL SCI SOC AM J, V63, P362, DOI 10.2136/sssaj1999.03615995006300020014x; Cerda A, 1998, CAN J SOIL SCI, V78, P321, DOI 10.4141/S97-060; Cerda A, 1998, J ARID ENVIRON, V38, P145, DOI 10.1006/jare.1997.0342; Fan X, 2012, LAND DEGRAD DEV, V23, P175, DOI 10.1002/ldr.1071; Gao P, 2011, HYDROL EARTH SYST SC, V15, P1, DOI 10.5194/hess-15-1-2011; Giordano M, 2004, 348 COMPR ASS WAT MA, V3, P48; Grinsted A, 2004, NONLINEAR PROC GEOPH, V11, P561, DOI 10.5194/npg-11-561-2004; Hu BQ, 2011, QUATERN INT, V230, P34, DOI 10.1016/j.quaint.2009.08.018; Li XL, 2013, LAND DEGRAD DEV, V24, P72, DOI 10.1002/ldr.1108; Liu CM, 2004, HYDROL PROCESS, V18, P2337, DOI 10.1002/hyp.5534; Miao CY, 2011, GLOBAL PLANET CHANGE, V76, P196, DOI 10.1016/j.gloplacha.2011.01.008; Milliman JD, 2008, GLOBAL PLANET CHANGE, V62, P187, DOI 10.1016/j.gloplacha.2008.03.001; MILLIMAN JD, 1983, J GEOL, V91, P1, DOI 10.1086/628741; Morgan R. P. C., 1995, SOIL EROSION CONSERV; Mu XM, 2012, CLEAN-SOIL AIR WATER, V40, P303, DOI 10.1002/clen.201000319; PAN XT, 2006, RIVERBED PROCESS LOW; Peng J, 2010, CATENA, V83, P135, DOI 10.1016/j.catena.2010.08.006; Ran DC, 2006, TRAPPING EFFECTS SOI; Syvitski JP, 2000, WATER RESOUR RES, V36, P2747, DOI 10.1029/2000WR900133; Syvitski JPM, 2005, SCIENCE, V308, P376, DOI 10.1126/science.1109454; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Valentin C, 2005, CATENA, V63, P132, DOI 10.1016/j.catena.2005.06.001; Walling DE, 2003, GLOBAL PLANET CHANGE, V39, P111, DOI 10.1016/S0921-8181(03)00020-1; Wang G., 2002, VARIATION STREAMFLOW; Wang HJ, 2010, J HYDROL, V391, P302, DOI 10.1016/j.jhydrol.2010.07.030; Wang SY, 2010, LAND USE POLICY, V27, P313, DOI 10.1016/j.landusepol.2009.04.002; Xu J. H., 1998, J SEDIMENT RES, V4, P36; Xu JX, 2009, QUATERN INT, V208, P85, DOI 10.1016/j.quaint.2008.11.003; Xu JX, 2005, ENVIRON MANAGE, V35, P620, DOI 10.1007/s00267-004-3094-y; Xu KH, 2010, GLOBAL PLANET CHANGE, V73, P219, DOI 10.1016/j.gloplacha.2010.07.002; Yang GF, 2007, GEOMORPHOLOGY, V85, P166, DOI 10.1016/j.geomorph.2006.03.016; Yao W.Y.., 2011, ANAL EVALUATION WATE; YRCC Yellow River Water Conservancy Committee, 2000, B YELL RIV; Zhang Q, 2007, J HYDROL, V333, P265, DOI 10.1016/j.jhydrol.2006.08.010; Zhang X., 2008, WATER RESOURCES RES, V44; Zhao GJ, 2013, HYDROL PROCESS, V27, P3852, DOI 10.1002/hyp.9504; Zhao GJ, 2013, LAND DEGRAD DEV, V24, P499, DOI 10.1002/ldr.2246; Zhao GJ, 2012, QUATERN INT, V282, P5, DOI 10.1016/j.quaint.2011.10.020; Zheng HX, 2009, WATER RESOUR RES, V45, DOI 10.1029/2007WR006665	42	39	41	2	100	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e91048	10.1371/journal.pone.0091048	http://dx.doi.org/10.1371/journal.pone.0091048			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603668	Green Published, gold, Green Submitted			2022-12-27	WOS:000332483600124
J	Grozinger, F; Thein, J; Feldhaar, H; Rodel, MO				Groezinger, Franziska; Thein, Juergen; Feldhaar, Heike; Roedel, Mark-Oliver			Giants, Dwarfs and the Environment - Metamorphic Trait Plasticity in the Common Frog	PLOS ONE			English	Article							PREY GROWTH-RATE; PHENOTYPIC PLASTICITY; RANA-TEMPORARIA; LARVAL DENSITY; PREDATION RISK; DEVELOPMENTAL PLASTICITY; ADAPTIVE PLASTICITY; MODEL SELECTION; LIFE-HISTORY; FOOD LEVEL	In order to understand adaptation processes and population dynamics, it is central to know how environmental parameters influence performance of organisms within populations, including their phenotypes. The impact of single or few particular parameters in concert was often assessed in laboratory and mesocosm experiments. However, under natural conditions, with many biotic and abiotic factors potentially interacting, outcomes on phenotypic changes may be different. To study the potential environmental impact on realized phenotypic plasticity within a natural population, we assessed metamorphic traits (developmental time, size and body mass) in an amphibian species, the European common frog Rana temporaria, since a) larval amphibians are known to exhibit high levels of phenotypic plasticity of these traits in response to habitat parameters and, b) the traits' features may strongly influence individuals' future performance and fitness. In 2007 we studied these metamorphic traits in 18 ponds spread over an area of 28 km 2. A subset of six ponds was reinvestigated in 2009 and 2010. This study revealed locally high variances in metamorphic traits in this presumed generalist species. We detected profound differences between metamorphing froglets (up to factor ten); both between and within ponds, on a very small geographic scale. Parameters such as predation and competition as well as many other pond characteristics, generally expected to have high impact on development, could not be related to the trait differences. We observed high divergence of patterns of mass at metamorphosis between ponds, but no detectable pattern when metamorphic traits were compared between ponds and years. Our results indicate that environment alone, i.e. as experienced by tadpoles sharing the same breeding pond, can only partly explain the variability of metamorphic traits observed. This emphasizes the importance to assess variability of reaction norms on the individual level to explain within-population variability.	[Groezinger, Franziska] Univ Wurzburg, Theodor Boveri Inst, Bioctr, Dept Anim Ecol & Trop Biol Zool 3, D-97070 Wurzburg, Germany; [Groezinger, Franziska; Roedel, Mark-Oliver] Museum Nat Kunde Berlin, Leibniz Inst Res Evolut & Biodivers, Berlin, Germany; [Thein, Juergen] Buro Faunist & Umweltbildung, Hassfurt, Germany; [Feldhaar, Heike] Univ Bayreuth, Bayreuth Ctr Ecol & Environm Res BayCEER, Bayreuth, Germany; [Groezinger, Franziska; Roedel, Mark-Oliver] Berlin Brandenburg Inst Adv Biodivers Res BBIB, Berlin, Germany	University of Wurzburg; Leibniz Institut fur Evolutions und Biodiversitatsforschung; University of Bayreuth	Rodel, MO (corresponding author), Museum Nat Kunde Berlin, Leibniz Inst Res Evolut & Biodivers, Berlin, Germany.	mo.roedel@mfn-berlin.de	Feldhaar, Heike/AAB-8678-2020	Feldhaar, Heike/0000-0001-6797-5126	Cusanuswerk Bischofliche Studienforderung	Cusanuswerk Bischofliche Studienforderung	FG was supported by a scholarship of "Cusanuswerk Bischofliche Studienforderung'' (http://www.cusanuswerk.de/de/startseite/bischoeflichestudienfoerderung/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams PA, 1996, EVOLUTION, V50, P1052, DOI 10.1111/j.1558-5646.1996.tb02346.x; Altwegg R, 2003, OECOLOGIA, V136, P46, DOI 10.1007/s00442-003-1248-x; Altwegg R, 2003, EVOLUTION, V57, P872; Alvarez D, 2002, FUNCT ECOL, V16, P640, DOI 10.1046/j.1365-2435.2002.00658.x; Atkinson D., 1996, Society for Experimental Biology Seminar Series, V59, P183; Barton K., 2013, MUMIN MULTI MODEL IN; Benard MF, 2004, ANNU REV ECOL EVOL S, V35, P651, DOI 10.1146/annurev.ecolsys.35.021004.112426; BERVEN KA, 1988, OECOLOGIA, V75, P67, DOI 10.1007/BF00378815; BERVEN KA, 1990, ECOLOGY, V71, P1599, DOI 10.2307/1938295; Berven KA, 2009, COPEIA, P328, DOI 10.1643/CH-08-052; Biek R, 2002, CONSERV BIOL, V16, P728, DOI 10.1046/j.1523-1739.2002.00433.x; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Borcard D, 2012, ECOLOGY, V93, P1473; Brady LD, 2000, J ZOOL, V252, P61; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Burnham KP, 2003, MODEL SELECTION MULT; COLLINS JP, 1979, ECOLOGY, V60, P738, DOI 10.2307/1936611; Crawley M.J., 2007, R BOOK; Crisci C, 2012, ECOL MODEL, V240, P113, DOI 10.1016/j.ecolmodel.2012.03.001; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; Denver RJ, 1997, AM ZOOL, V37, P172; Fordyce JA, 2006, J EXP BIOL, V209, P2377, DOI 10.1242/jeb.02271; Glos J, 2003, COPEIA, P650; GOTTHARD K, 1995, OIKOS, V74, P3, DOI 10.2307/3545669; Grozinger F, 2012, J ZOOL, V288, P103, DOI 10.1111/j.1469-7998.2012.00929.x; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Hatch AC, 2003, ECOL APPL, V13, P1083, DOI 10.1890/1051-0761(2003)13[1083:CEOURA]2.0.CO;2; Hettyey A, 2011, J EVOLUTION BIOL, V24, P1007, DOI 10.1111/j.1420-9101.2011.02233.x; Hughes AR, 2008, ECOL LETT, V11, P609, DOI 10.1111/j.1461-0248.2008.01179.x; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663; Indermaur L, 2010, ECOGRAPHY, V33, P887, DOI 10.1111/j.1600-0587.2010.06150.x; JOHNALDER HB, 1990, COPEIA, P856, DOI 10.2307/1446453; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; KAPLAN RH, 1984, AM NAT, V123, P393, DOI 10.1086/284211; Laurila A, 2002, EVOLUTION, V56, P617; Laurila A, 1998, OIKOS, V83, P307, DOI 10.2307/3546842; Laurila A, 1999, J ANIM ECOL, V68, P1123, DOI 10.1046/j.1365-2656.1999.00354.x; Laurila A, 2008, ECOLOGY, V89, P1399, DOI 10.1890/07-1521.1; Legendre P., 2012, NUMERICAL ECOLOGY; LEIPS J, 1994, ECOLOGY, V75, P1345, DOI 10.2307/1937459; Loman J, 2006, J APPL ECOL, V43, P690, DOI 10.1111/j.1365-2664.2006.01172.x; Loman J, 2004, ECOLOGY, V85, P1611, DOI 10.1890/03-0179; Loman J, 1999, AMPHIBIA-REPTILIA, V20, P421, DOI 10.1163/156853899X00466; MANTEL N, 1967, CANCER RES, V27, P209; Melvin SD, 2012, OECOLOGIA, V169, P861, DOI 10.1007/s00442-012-2260-9; NEWMAN RA, 1989, ECOLOGY, V70, P1775, DOI 10.2307/1938111; NEWMAN RA, 1992, BIOSCIENCE, V42, P671, DOI 10.2307/1312173; Nicieza AG, 2000, OECOLOGIA, V123, P497, DOI 10.1007/s004420000343; Nussey DH, 2007, J EVOLUTION BIOL, V20, P831, DOI 10.1111/j.1420-9101.2007.01300.x; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Peacor SD, 2002, ECOL LETT, V5, P77, DOI 10.1046/j.1461-0248.2002.00287.x; Pechenik JA, 2006, INTEGR COMP BIOL, V46, P323, DOI 10.1093/icb/icj028; Pierce Banjamin A., 1993, Ecotoxicology, V2, P65, DOI 10.1007/BF00058215; Pigliucci M., 2001, SYN ECO EVO; Pinheiro J, 2020, R PACKAGE VERSION 31; R Core Team, 2021, R LANGUAGE ENV STAT; R?del M.-O., 2009, METHODEN FELDHERPETO, P243; Ramos O, 2012, OECOLOGIA, V169, P535, DOI 10.1007/s00442-011-2208-5; Relyea RA, 2002, AM NAT, V159, P272, DOI 10.1086/338540; Relyea RA, 2003, OECOLOGIA, V134, P596, DOI 10.1007/s00442-002-1161-8; Relyea RA, 2007, OECOLOGIA, V152, P389, DOI 10.1007/s00442-007-0675-5; Richter-Boix A, 2010, MOL ECOL, V19, P716, DOI 10.1111/j.1365-294X.2009.04502.x; Ripley B., 2013, PACKAGE MASS; Rudolf VHW, 2007, EVOL ECOL, V21, P121, DOI 10.1007/s10682-006-0017-9; SCHEINER SM, 1993, ANNU REV ECOL SYST, V24, P35, DOI 10.1146/annurev.es.24.110193.000343; Schlupmann M, 1996, AMPHIBIEN REPTILIEN, P412; Schmitz OJ, 2007, ECOLOGY, V88, P2415, DOI 10.1890/06-0937.1; Scott DE, 2007, OECOLOGIA, V153, P521, DOI 10.1007/s00442-007-0755-6; SCOTT DE, 1990, ECOLOGY, V71, P296, DOI 10.2307/1940269; SCOTT DE, 1994, ECOLOGY, V75, P1383, DOI 10.2307/1937462; SEMLITSCH RD, 1988, ECOLOGY, V69, P184, DOI 10.2307/1943173; Sih A, 1998, TRENDS ECOL EVOL, V13, P350, DOI 10.1016/S0169-5347(98)01437-2; SKELLY DK, 1992, ECOLOGY, V73, P704, DOI 10.2307/1940779; SKELLY DK, 1990, ECOLOGY, V71, P2313, DOI 10.2307/1938642; SMITH DC, 1987, ECOLOGY, V68, P344, DOI 10.2307/1939265; Stamper CE, 2008, HERPETOL J, V18, P187; STEARNS SC, 1986, EVOLUTION, V40, P893, DOI 10.1111/j.1558-5646.1986.tb00560.x; Taylor BE, 1997, HERPETOLOGICA, V53, P132; TRAVIS J, 1980, EVOLUTION, V34, P40, DOI 10.1111/j.1558-5646.1980.tb04787.x; UCHMANSKI J, 1985, PHILOS T ROY SOC B, V310, P1, DOI 10.1098/rstb.1985.0099; Van Allen BG, 2010, OECOLOGIA, V164, P891, DOI 10.1007/s00442-010-1728-8; Van Buskirk J, 2000, ECOLOGY, V81, P2813, DOI 10.1890/0012-9658(2000)081[2813:TCOAID]2.0.CO;2; Van Buskirk J, 2005, ECOLOGY, V86, P1936, DOI 10.1890/04-1237; Van Buskirk J, 2005, J EVOLUTION BIOL, V18, P596, DOI 10.1111/j.1420-9101.2004.00869.x; Van Buskirk J, 1998, OIKOS, V82, P20; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; WESTEBERHARD MJ, 1989, ANNU REV ECOL SYST, V20, P249, DOI 10.1146/annurev.es.20.110189.001341; WILBUR HM, 1973, SCIENCE, V182, P1305, DOI 10.1126/science.182.4119.1305; WILBUR HM, 1977, ECOLOGY, V58, P206, DOI 10.2307/1935124; Winkler JD, 2012, FUNCT ECOL, V26, P513, DOI 10.1111/j.1365-2435.2012.01965.x	90	18	18	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e89982	10.1371/journal.pone.0089982	http://dx.doi.org/10.1371/journal.pone.0089982			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599256	Green Published, Green Submitted, gold			2022-12-27	WOS:000332479400038
J	Hauser, PM; Bernard, T; Greub, G; Jaton, K; Pagni, M; Hafen, GM				Hauser, Philippe M.; Bernard, Thomas; Greub, Gilbert; Jaton, Katia; Pagni, Marco; Hafen, Gaudenz M.			Microbiota Present in Cystic Fibrosis Lungs as Revealed by Whole Genome Sequencing	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; DATABASE; IDENTIFICATION; COMMUNITIES; CULTUROMICS; INFECTIONS; ALIGNMENT; ACCURATE; GENES; FUNGI	Determination of the precise composition and variation of microbiota in cystic fibrosis lungs is crucial since chronic inflammation due to microorganisms leads to lung damage and ultimately, death. However, this constitutes a major technical challenge. Culturing of microorganisms does not provide a complete representation of a microbiota, even when using culturomics (high-throughput culture). So far, only PCR-based metagenomics have been investigated. However, these methods are biased towards certain microbial groups, and suffer from uncertain quantification of the different microbial domains. We have explored whole genome sequencing (WGS) using the Illumina high-throughput technology applied directly to DNA extracted from sputa obtained from two cystic fibrosis patients. To detect all microorganism groups, we used four procedures for DNA extraction, each with a different lysis protocol. We avoided biases due to whole DNA amplification thanks to the high efficiency of current Illumina technology. Phylogenomic classification of the reads by three different methods produced similar results. Our results suggest that WGS provides, in a single analysis, a better qualitative and quantitative assessment of microbiota compositions than cultures and PCRs. WGS identified a high quantity of Haemophilus spp. (patient 1) or Staphylococcus spp. plus Streptococcus spp. (patient 2) together with low amounts of anaerobic (Veillonella, Prevotella, Fusobacterium) and aerobic bacteria (Gemella, Moraxella, Granulicatella). WGS suggested that fungal members represented very low proportions of the microbiota, which were detected by cultures and PCRs because of their selectivity. The future increase of reads' sizes and decrease in cost should ensure the usefulness of WGS for the characterisation of microbiota.	[Hauser, Philippe M.; Greub, Gilbert; Jaton, Katia] CHU Vaudois, Inst Microbiol, CH-1011 Lausanne, Switzerland; [Hauser, Philippe M.; Greub, Gilbert; Jaton, Katia; Hafen, Gaudenz M.] Univ Lausanne, Lausanne, Switzerland; [Bernard, Thomas; Pagni, Marco] SIB, Vital IT Grp, Lausanne, Switzerland; [Hafen, Gaudenz M.] CHU Vaudois, Pulm Unit, Dept Paediat, CH-1011 Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Swiss Institute of Bioinformatics; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Hafen, GM (corresponding author), CHU Vaudois, Pulm Unit, Dept Paediat, CH-1011 Lausanne, Switzerland.	gaudenz.hafen@chuv.ch	Jaton, Katia/A-2828-2016; Greub, Gilbert GG/K-5804-2017	Greub, Gilbert GG/0000-0001-9529-3317; Bernard, Thomas/0000-0003-3736-1507; Pagni, Marco/0000-0001-9292-9463; Hauser, Philippe/0000-0003-2834-7922; Jaton, Katia/0000-0001-8944-7295	Swiss Society for Cystic Fibrosis; Swiss Federal Government through the State Secretariat for Education and Research (SER)	Swiss Society for Cystic Fibrosis; Swiss Federal Government through the State Secretariat for Education and Research (SER)	This work was supported by the Swiss Society for Cystic Fibrosis (http://www.cfch.ch/). The computations were performed at the Vital-IT Center for high-performance computing (http://www.vital-it.ch) of the Swiss Institute of Bioinformatics (SIB). SIB receives financial support from the Swiss Federal Government through the State Secretariat for Education and Research (SER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarenkov K, 2010, NEW PHYTOL, V186, P281, DOI 10.1111/j.1469-8137.2009.03160.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Baquero F, 2012, CLIN MICROBIOL INFEC, V18, P2, DOI 10.1111/j.1469-0691.2012.03916.x; Bellemain E, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-189; Bittar F, 2010, CLIN MICROBIOL INFEC, V16, P809, DOI 10.1111/j.1469-0691.2010.03236.x; Blainey PC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004458; Bouchara JP, 2009, J CLIN MICROBIOL, V47, P142, DOI 10.1128/JCM.01668-08; Burns JL, 2013, J CYST FIBROS, pS1569; Carmody Lisa A, 2013, Ann Am Thorac Soc, V10, P179, DOI 10.1513/AnnalsATS.201211-107OC; Charlson ES, 2011, AM J RESP CRIT CARE, V184, P957, DOI 10.1164/rccm.201104-0655OC; Croxatto A, 2012, FEMS MICROBIOL REV, V36, P380, DOI 10.1111/j.1574-6976.2011.00298.x; Delhaes L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036313; Filkins LM, 2012, J BACTERIOL, V194, P4709, DOI 10.1128/JB.00566-12; Gilchrist FJ, 2011, ARCH DIS CHILD, V96, P215, DOI 10.1136/adc.2009.177618; Greub G, 2012, CLIN MICROBIOL INFEC, V18, P1157, DOI 10.1111/1469-0691.12032; Klepac-Ceraj V, 2010, ENVIRON MICROBIOL, V12, P1293, DOI 10.1111/j.1462-2920.2010.02173.x; Koetschan C, 2012, MOL PHYLOGENET EVOL, V63, P585, DOI 10.1016/j.ympev.2012.01.026; Lagier JC, 2012, CLIN MICROBIOL INFEC, V18, P1185, DOI 10.1111/1469-0691.12023; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Liu B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S2-S4; Lynch SV, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a009738; Madan JC, 2012, MBIO, V3, DOI 10.1128/mBio.00251-12; Meinicke P, 2011, BIOINFORMATICS, V27, P1618, DOI 10.1093/bioinformatics/btr266; Mowat E, 2010, FEMS MICROBIOL LETT, V313, P96, DOI 10.1111/j.1574-6968.2010.02130.x; Parkins MD, 2008, PEDIATR PULM, V43, P490, DOI 10.1002/ppul.20809; Peleg AY, 2010, NAT REV MICROBIOL, V8, P340, DOI 10.1038/nrmicro2313; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rogers GB, 2013, ISME J, V7, P697, DOI 10.1038/ismej.2012.145; Ross MG, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r51; Santamaria M, 2012, BRIEF BIOINFORM, V13, P682, DOI 10.1093/bib/bbs036; Segata N, 2012, NAT METHODS, V9, P811, DOI [10.1038/NMETH.2066, 10.1038/nmeth.2066]; Sibley CD, 2011, CAN J MICROBIOL, V57, P69, DOI [10.1139/W10-105, 10.1139/w10-105]; Wang Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007401; Wat D, 2008, J CYST FIBROS, V7, P320, DOI 10.1016/j.jcf.2007.12.002; Willner D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007370; Wong JK, 2013, PEDIAT PULMONOL, V43, P490; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	38	27	27	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90934	10.1371/journal.pone.0090934	http://dx.doi.org/10.1371/journal.pone.0090934			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599149	Green Published, gold, Green Submitted			2022-12-27	WOS:000332479400146
J	Janczur, MK; Solano, HJL; Ramos, LTS; Reyes, CHM; Cerro, MDO; Berasain, MDM; Manzano, IVR; Manjarrez, J; Benitez, JLV; Czarnoleski, M				Krzysztof Janczur, Mariusz; Leon Solano, Hector Javier; Solache Ramos, Lupita Tzenyatze; Mendoza Reyes, Citlalli Hypatia; Oro Cerro, Maria del Carmen; Mariezcurrena Berasain, Maria Dolores; Rivas Manzano, Irma Victoria; Manjarrez, Javier; Villareal Benitez, Jose Luis; Czarnoleski, Marcin			Chemical and Physical Defense Traits in Two Sexual Forms of Opuntia robusta in Central Eastern Mexico	PLOS ONE			English	Article							REPRODUCTION; HERBIVORY; PLANTS; COSTS; METAANALYSIS; ALLOCATION; PATTERNS; CLADODES; SPINES; GROWTH	Sexually dimorphic plants provide an excellent opportunity for examining the differences in the extent of their defense against herbivores because they exhibit sex-related differences in reproductive investment. Such differences enable comparison of the sex with high reproduction expenses with the sex that expends less. The more costly sex is usually also better defended against herbivores. Generally, females are considered more valuable than hermaphrodites in terms of fitness; however, hermaphrodites are more valuable if they can produce seed by autonomous selfing, provided that the inbreeding depression is low and pollen is limited. We studied a gynodioecious population of Opuntia robusta from Central-Eastern Mexico, which has been reported to be trioecious, dioecious, or hermaphrodite, and addressed the following questions: 1) Is the hermaphrodite's reproductive output higher than the female's, and are hermaphrodites thus better defended? 2) Are plant tissues differentially defended? 3) Do trade-offs exist among different physical defense traits? and 4) among physical and chemical defense traits? We found that 1) hermaphrodites had a higher seed output and more spines per areola than females and that their spines contained less moisture. Non-reproductive hermaphrodite cladodes contained more total phenolic compounds (TPCs) than female ones. In addition, 2) hermaphrodite reproductive cladodes bore more spines than female cladodes, and 3) and 4) we found a negative relationship between spine number per areola and areola number per cladode and a positive relationship between spine number per areola per plant and TPC concentration per plant. Non-reproductive hermaphrodite cladodes contained a higher concentration of TPCs than female cladodes, and parental cladodes contained fewer TPCs than both reproductive and empty cladodes.	[Krzysztof Janczur, Mariusz; Leon Solano, Hector Javier; Solache Ramos, Lupita Tzenyatze; Mendoza Reyes, Citlalli Hypatia; Oro Cerro, Maria del Carmen; Manjarrez, Javier] Autonomous Univ State Mexico, Res Grp Behav Biol & Conservat, Toluca, Estado De Mexic, Mexico; [Rivas Manzano, Irma Victoria] Autonomous Univ State Mexico, Res Grp Flora Composit & Ecol Trop & Template Sys, Toluca, Estado De Mexic, Mexico; [Mariezcurrena Berasain, Maria Dolores] Autonomous Univ State Mexico, Fac Agr Sci, Toluca, Estado De Mexic, Mexico; [Krzysztof Janczur, Mariusz; Czarnoleski, Marcin] Jagiellonian Univ, Inst Environm Sci, Res Grp Life Hist Evolut, Krakow, Poland; [Villareal Benitez, Jose Luis] Univ Nacl Autonoma Mexico, Div Comp Serv Informat & Commun Technol, Mexico City 04510, DF, Mexico	Universidad Autonoma del Estado de Mexico; Universidad Autonoma del Estado de Mexico; Universidad Autonoma del Estado de Mexico; Jagiellonian University; Universidad Nacional Autonoma de Mexico	Janczur, MK (corresponding author), Autonomous Univ State Mexico, Res Grp Behav Biol & Conservat, Carretera Toluca Tlachaloya, Toluca, Estado De Mexic, Mexico.	majmx@interia.pl	Janczur, Mariusz K/A-3964-2012; Manjarrez, Javier/S-3082-2019; Mariezcurrena Berasain, Maria/B-4923-2016; Czarnoleski, Marcin/H-2893-2015	Manjarrez, Javier/0000-0003-3053-3257; Mariezcurrena Berasain, Maria/0000-0003-1569-1783; Czarnoleski, Marcin/0000-0003-2645-0360; Janczur, Mariusz Krzysztof/0000-0002-3886-6710	UAEM project [2823/2009U]; CONACyT [180694/2012]; Secretaria de Investigacion, Autonomous University of the State of Mexico (UAEM); PIFI, Faculty of Agricultural Sciences, UAEM	UAEM project; CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Secretaria de Investigacion, Autonomous University of the State of Mexico (UAEM); PIFI, Faculty of Agricultural Sciences, UAEM	The study was financed by the UAEM project 2823/2009U (partially) and by the CONACyT project 180694/2012 (http://www.conacyt.gob.mx/FondosyApoyos/Sectoriales/InvestigacionBasicaAplicada/SEP/Basica/Documents/Resultados_de_la_Convocatoria_de_Ciencia_Basica_2012.pdf). Article edition charge was financed by Secretaria de Investigacion, Autonomous University of the State of Mexico (UAEM). Article processing charge was financed by PIFI 2014, Faculty of Agricultural Sciences, UAEM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addinsoft, 2011, XLSTAT; Agren J., 1999, GENDER SEXUAL DIMORP, P217, DOI DOI 10.1007/978-3-662-03908-3_8; Alonso C, 2003, OIKOS, V101, P505, DOI 10.1034/j.1600-0706.2003.12115.x; Alonso C, 1996, J ECOL, V84, P495, DOI 10.2307/2261472; [Anonymous], INT J EVOL BIOL; Barton KE, 2010, AM NAT, V175, P481, DOI 10.1086/650722; Brailovsky-Alperowitz HU, 1981, CACTACEAS SUCULENTAS, V26, P86; Cornelissen T, 2005, OIKOS, V111, P488, DOI 10.1111/j.1600-0706.2005.14075.x; del Castillo R.F., 1988, AGROCIENCIA-MEXICO, V71, P185; del Castillo RF, 2009, AM J BOT, V96, P1148, DOI 10.3732/ajb.0800301; del Castillo RF, 1986, SELECCION NATURAL SI; Endara MJ, 2011, FUNCT ECOL, V25, P389, DOI 10.1111/j.1365-2435.2010.01803.x; Gershenzon J, 1994, INSECT PLANT INTERAC, P205; Gindl-Altmutter W, 2012, BIORESOURCES, V7, P1232; Koricheva J, 2004, AM NAT, V163, pE64, DOI 10.1086/382601; Janczur MK, 2009, EVOL ECOL RES, V11, P447; Malainine ME, 2003, CARBOHYD POLYM, V51, P77, DOI 10.1016/S0144-8617(02)00157-1; Marroquin JS, 1964, PUBLICACION ESPECIAL, V2; MAUSETH JD, 1984, AM J BOT, V71, P1283, DOI 10.2307/2443653; McCall AC, 2010, J ECOL, V98, P985, DOI 10.1111/j.1365-2745.2010.01693.x; MCKEY D, 1974, AM NAT, V108, P305, DOI 10.1086/282909; Mutikainen P, 1996, OIKOS, V75, P353, DOI 10.2307/3545874; Mutikainen P., 1999, LIFE HIST EVOLUTION, P195; Nicotra AB, 1999, J ECOL, V87, P138, DOI 10.1046/j.1365-2745.1999.00337.x; Obeso JR, 1997, J ECOL, V85, P159, DOI 10.2307/2960648; Obeso JR, 2002, NEW PHYTOL, V155, P321, DOI 10.1046/j.1469-8137.2002.00477.x; Peer 393, 2013, PEERAGE SCI; Peer 408, 2013, PEERAGE SCI; Pimienta-Barrios E, 2005, ANN BOT-LONDON, V95, P363, DOI 10.1093/aob/mci034; Quinn GP, 2003, EXPT DESIGN DATA ANA; SEMARNAT, 2013, AR NAT PROT DIAGN FI; Shykoff JA, 2003, OECOLOGIA, V135, P1, DOI 10.1007/s00442-002-1133-z; StatSoft, 2013, STATISTICA; Webb C.J., 1999, GENDER SEXUAL DIMORP, P61, DOI DOI 10.1007/978-3-662-03908-3_3	34	12	12	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e89535	10.1371/journal.pone.0089535	http://dx.doi.org/10.1371/journal.pone.0089535			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599143	Green Published, gold			2022-12-27	WOS:000332479400016
J	Lee, SY; Haq, F; Kim, D; Jun, C; Jo, HJ; Ahn, SM; Lee, WS				Lee, Sun Young; Haq, Farhan; Kim, Deokhoon; Jun, Cui; Jo, Hui-Jong; Ahn, Sung-Min; Lee, Won-Suk			Comparative Genomic Analysis of Primary and Synchronous Metastatic Colorectal Cancers	PLOS ONE			English	Article							MICROSATELLITE INSTABILITY; PANCREATIC-CANCER; SOMATIC MUTATION; LIVER METASTASES; GENETIC-VARIANTS; CLONAL ANALYSIS; PRIMARY TUMORS; COLON-CANCER; KDR GENE; ORIGIN	Approximately 50% of patients with primary colorectal carcinoma develop liver metastases. Understanding the genetic differences between primary colon cancer and their metastases to the liver is essential for devising a better therapeutic approach for this disease. We performed whole exome sequencing and copy number analysis for 15 triplets, each comprising normal colorectal tissue, primary colorectal carcinoma, and its synchronous matched liver metastasis. We analyzed the similarities and differences between primary colorectal carcinoma and matched liver metastases in regards to somatic mutations and somatic copy number alterationss. The genomic profiling demonstrated mutations in APC(73%), KRAS (33%), ARID1A and PIK3CA (6.7%) genes between primary colorectal and metastatic liver tumors. TP53 mutation was observed in 47% of the primary samples and 67% in liver metastatic samples. The grouped pairs, in hierarchical clustering showed similar somatic copy number alteration patterns, in contrast to the ungrouped pairs. Many mutations (including those of known key cancer driver genes) were shared in the grouped pairs. The ungrouped pairs exhibited distinct mutation patterns with no shared mutations in key driver genes. Four ungrouped liver metastasis samples had mutations in DNA mismatch repair genes along with hypermutations and a substantial number of copy number alterations. Our results suggest that about half of the metastatic colorectal carcinoma had the same clonal origin with their primary colorectal carcinomas, whereas remaining cases were genetically distinct from their primary carcinomas. These findings underscore the need to evaluate metastatic lesions separately for optimized therapy, rather than to extrapolate from primary tumor data.	[Lee, Sun Young; Haq, Farhan; Jun, Cui; Jo, Hui-Jong; Lee, Won-Suk] Gachon Univ, Lee Gil Ya Canc & Diabet Inst, Inchon, South Korea; [Kim, Deokhoon; Ahn, Sung-Min] Univ Ulsan, Asan Med Ctr, Coll Med, Ctr Canc Genome Discovery,Asan Inst Life Sci, Seoul, South Korea; [Ahn, Sung-Min] Univ Ulsan, Asan Med Ctr, Coll Med, Dept Oncol, Seoul, South Korea; [Ahn, Sung-Min] Univ Ulsan, Asan Med Ctr, Coll Med, Dept Biomed Informat, Seoul, South Korea; [Lee, Won-Suk] Gachon Univ, Dept Surg, Gil Med Ctr, Inchon, South Korea	Gachon University; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; Gachon University	Ahn, SM (corresponding author), Univ Ulsan, Asan Med Ctr, Coll Med, Ctr Canc Genome Discovery,Asan Inst Life Sci, Seoul, South Korea.	smahn@amc.seoul.kr; lws@gilhospital.com	Haq, Farhan/Q-3067-2017	Haq, Farhan/0000-0001-9190-4360; Ahn, Sung-Min/0000-0002-5031-1929	National Research Foundation of Korea (NRF); Ministry of Science, ICT & Future Planning [2012R1A1A1013369]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Science, ICT & Future Planning(Ministry of Science, ICT & Future Planning, Republic of Korea)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (No. 2012R1A1A1013369). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albanese I, 2004, BIOCHEM BIOPH RES CO, V325, P784, DOI 10.1016/j.bbrc.2004.10.111; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Baldus SE, 2010, CLIN CANCER RES, V16, P790, DOI 10.1158/1078-0432.CCR-09-2446; BEUTLER E, 1967, NEW ENGL J MED, V276, P389, DOI 10.1056/NEJM196702162760706; Boland CR, 2010, GASTROENTEROLOGY, V138, P2073, DOI [10.1053/j.gastro.2009.12.064, 10.1053/j.gastro.2010.04.024]; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Camps J, 2006, CARCINOGENESIS, V27, P419, DOI 10.1093/carcin/bgi244; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Cho E, 2004, JNCI-J NATL CANCER I, V96, P1015, DOI 10.1093/jnci/djh185; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; DIX BR, 1995, DIAGN MOL PATHOL, V4, P261, DOI 10.1097/00019606-199512000-00006; Dong GL, 2012, CANCER SCI, V103, P561, DOI 10.1111/j.1349-7006.2011.02194.x; FEARON ER, 1987, SCIENCE, V238, P193, DOI 10.1126/science.2889267; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Goel A, 2003, CANCER RES, V63, P1608; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Halberg RB, 2007, CELL CYCLE, V6, P44, DOI 10.4161/cc.6.1.3651; HSU SH, 1983, SCIENCE, V221, P951, DOI 10.1126/science.6879192; Jasmine F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031968; Jones AM, 2005, ONCOGENE, V24, P118, DOI 10.1038/sj.onc.1208194; Kim MJ, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-347; Klein CA, 2009, NAT REV CANCER, V9, P302, DOI 10.1038/nrc2627; Knijn N, 2011, BRIT J CANCER, V104, P1020, DOI 10.1038/bjc.2011.26; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li LS, 2003, AM J PATHOL, V163, P1429, DOI 10.1016/S0002-9440(10)63500-6; Liu WN, 2009, NAT MED, V15, P559, DOI 10.1038/nm.1944; Manfredi S, 2006, ANN SURG, V244, P254, DOI 10.1097/01.sla.0000217629.94941.cf; MCCUNE CS, 1981, CANCER, V47, P1984, DOI 10.1002/1097-0142(19810415)47:8<1984::AID-CNCR2820470814>3.0.CO;2-J; Nakao K, 2004, CARCINOGENESIS, V25, P1345, DOI 10.1093/carcin/bgh134; Navin NE, 2010, MOL ONCOL, V4, P267, DOI 10.1016/j.molonc.2010.04.010; Norton Larry, 2008, Breast Dis, V29, P27; Palena C, 2011, EXP BIOL MED, V236, P537, DOI 10.1258/ebm.2011.010367; Parsons BL, 2008, MUTAT RES-REV MUTAT, V659, P232, DOI 10.1016/j.mrrev.2008.05.004; Saunders CT, 2012, BIOINFORMATICS, V28, P1811, DOI 10.1093/bioinformatics/bts271; Siegmund KD, 2009, CELL CYCLE, V8, P2187, DOI 10.4161/cc.8.14.9151; Spratlin JL, 2010, J CLIN ONCOL, V28, P780, DOI 10.1200/JCO.2009.23.7537; Sturmer T, 2000, J NATL CANCER I, V92, P1178, DOI 10.1093/jnci/92.14.1178; Talmadge JE, 2010, CANCER RES, V70, P5649, DOI 10.1158/0008-5472.CAN-10-1040; Torres L, 2007, BREAST CANCER RES TR, V102, P143, DOI 10.1007/s10549-006-9317-6; Trautmann K, 2006, CLIN CANCER RES, V12, P6379, DOI 10.1158/1078-0432.CCR-06-1248; Turajlic S, 2012, GENOME RES, V22, P196, DOI 10.1101/gr.125591.111; Van Cutsem E, 2009, ANN ONCOL, V20, P61, DOI 10.1093/annonc/mdp130; Visvader JE, 2011, NATURE, V469, P314, DOI 10.1038/nature09781; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang LH, 2012, GENOME RES, V22, P208, DOI 10.1101/gr.123109.111; Wang Y, 2007, J AM COLL CARDIOL, V50, P760, DOI 10.1016/j.jacc.2007.04.074; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Zhang WL, 2009, STROKE, V40, P2720, DOI 10.1161/STROKEAHA.109.554394	50	59	61	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90459	10.1371/journal.pone.0090459	http://dx.doi.org/10.1371/journal.pone.0090459			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599305	gold, Green Published, Green Submitted			2022-12-27	WOS:000332479400077
J	Phillips, M; Beatty, JD; Cataneo, RN; Huston, J; Kaplan, PD; Lalisang, RI; Lambin, P; Lobbes, MBI; Mundada, M; Pappas, N; Patel, U				Phillips, Michael; Beatty, J. David; Cataneo, Renee N.; Huston, Jan; Kaplan, Peter D.; Lalisang, Roy I.; Lambin, Philippe; Lobbes, Marc B. I.; Mundada, Mayur; Pappas, Nadine; Patel, Urvish			Rapid Point-Of-Care Breath Test for Biomarkers of Breast Cancer and Abnormal Mammograms	PLOS ONE			English	Article							OXIDATIVE STRESS; EXHALED BREATH; VOLATILE BIOMARKERS; PULMONARY TUBERCULOSIS; LUNG; PREDICTION; CLASSIFICATION; MARKERS; IMPACT; WOMEN	Background: Previous studies have reported volatile organic compounds (VOCs) in breath as biomarkers of breast cancer and abnormal mammograms, apparently resulting from increased oxidative stress and cytochrome p450 induction. We evaluated a six-minute point-of-care breath test for VOC biomarkers in women screened for breast cancer at centers in the USA and the Netherlands. Methods: 244 women had a screening mammogram (93/37 normal/abnormal) or a breast biopsy (cancer/no cancer 35/79). A mobile point-of-care system collected and concentrated breath and air VOCs for analysis with gas chromatography and surface acoustic wave detection. Chromatograms were segmented into a time series of alveolar gradients (breath minus room air). Segmental alveolar gradients were ranked as candidate biomarkers by C-statistic value (area under curve [AUC] of receiver operating characteristic [ROC] curve). Multivariate predictive algorithms were constructed employing significant biomarkers identified with multiple Monte Carlo simulations and cross validated with a leave-one-out (LOO) procedure. Results: Performance of breath biomarker algorithms was determined in three groups: breast cancer on biopsy versus normal screening mammograms (81.8% sensitivity, 70.0% specificity, accuracy 79% (73% on LOO) [C-statistic value], negative predictive value 99.9%); normal versus abnormal screening mammograms (86.5% sensitivity, 66.7% specificity, accuracy 83%, 62% on LOO); and cancer versus no cancer on breast biopsy (75.8% sensitivity, 74.0% specificity, accuracy 78%, 67% on LOO). Conclusions: A pilot study of a six-minute point-of-care breath test for volatile biomarkers accurately identified women with breast cancer and with abnormal mammograms. Breath testing could potentially reduce the number of needless mammograms without loss of diagnostic sensitivity.	[Phillips, Michael; Cataneo, Renee N.; Kaplan, Peter D.; Mundada, Mayur; Patel, Urvish] Menssana Res Inc, Breath Res Lab, Newark, NJ 07103 USA; [Phillips, Michael] New York Med Coll, Dept Med, Valhalla, NY 10595 USA; [Beatty, J. David] Swedish Canc Inst, Seattle, WA USA; [Huston, Jan] HackensackUMC Mountainside, Montclair, NJ USA; [Lalisang, Roy I.] Maastricht Univ Med Ctr, GROW Sch Oncol & Dev Biol, Dept Internal Med, Div Med Oncol, Maastricht, Netherlands; [Lambin, Philippe] Maastricht Univ Med Ctr, GROW Sch Oncol & Dev Biol, Dept Radiotherapy MAASTRO, Maastricht, Netherlands; [Lobbes, Marc B. I.] Maastricht Univ Med Ctr, GROW Sch Oncol & Dev Biol, Dept Radiol, Maastricht, Netherlands; [Pappas, Nadine] St Michaels Hosp, Newark, NJ USA	New York Medical College; Swedish Cancer Institute; Swedish Medical Center; Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC)	Phillips, M (corresponding author), Menssana Res Inc, Breath Res Lab, Newark, NJ 07103 USA.	mphillips@menssanaresearch.com		Kaplan, Peter/0000-0002-2292-6862; Lambin, Philippe/0000-0001-7961-0191	National Institutes of Health [1R43RR030689-01]; Dutch Pink Ribbon foundation; CTMM framework (AIRFORCE project) foundation [030-103]; NATIONAL CENTER FOR RESEARCH RESOURCES [R43RR030689] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dutch Pink Ribbon foundation; CTMM framework (AIRFORCE project) foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This project was funded in part by National Institutes of Health grant 1R43RR030689-01. In the Netherlands, this project was funded in part by the Dutch Pink Ribbon foundation and the CTMM framework (AIRFORCE project, grant 030-103) foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerson K, 2009, J ADV NURS, V65, P1130, DOI 10.1111/j.1365-2648.2009.04981.x; Amann A, 2011, EXPERT REV MOL DIAGN, V11, P207, DOI [10.1586/ERM.10.112, 10.1586/erm.10.112]; [Anonymous], BREAST CANC; Blanchard K, 2004, CANCER-AM CANCER SOC, V101, P495, DOI 10.1002/cncr.20392; Brett J, 2005, PSYCHO-ONCOLOGY, V14, P917, DOI 10.1002/pon.904; Bulun SE, 2009, ANN NY ACAD SCI, V1155, P121, DOI 10.1111/j.1749-6632.2009.03705.x; Centers for Disease Control and Prevention, CANC WOM; Consedine NS, 2004, CANCER EPIDEM BIOMAR, V13, P501; Cook NR, 2008, CLIN CHEM, V54, P17, DOI 10.1373/clinchem.2007.096529; D'Amico Arnaldo, 2012, Expert Opin Med Diagn, V6, P175, DOI 10.1517/17530059.2012.665870; Gordon RT, 2008, J ALTERN COMPLEM MED, V14, P61, DOI 10.1089/acm.2006.6408; HIETANEN E, 1994, EUR J CLIN NUTR, V48, P575; Jansen-van der Weide MC, 2010, EUR RADIOL, V20, P2547, DOI 10.1007/s00330-010-1839-y; Jezierska-Drutel A, 2013, ADV CANCER RES, V119, P107, DOI 10.1016/B978-0-12-407190-2.00003-4; Jiang WY, 2007, STAT MED, V26, P5320, DOI 10.1002/sim.2968; Jiang YL, 2007, RADIOLOGY, V243, P360, DOI 10.1148/radiol.2432060253; Jorgensen KJ, 2013, DAN MED J, V60; KNEEPKENS CMF, 1994, FREE RADICAL BIO MED, V17, P127; Ludviksdottir D, 2012, CLIN RESPIR J, V6, P193, DOI 10.1111/crj.12001; Ma SG, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-253; Mangler M, 2012, GINEKOL POL, V83, P730; Mathews JM, 1997, TOXICOL APPL PHARM, V146, P255, DOI 10.1006/taap.1997.8257; McCulloch M, 2006, INTEGR CANCER THER, V5, P30, DOI 10.1177/1534735405285096; Nelson HD, 2009, 1005142EF1 AHRQ; Patterson SG, 2011, AM SURGEON, V77, P747; Peng G, 2010, BRIT J CANCER, V103, P542, DOI 10.1038/sj.bjc.6605810; Phillips M, 2000, J LAB CLIN MED, V136, P243, DOI 10.1067/mlc.2000.108943; Phillips M, 2004, AM J CARDIOL, V94, P1593, DOI 10.1016/j.amjcard.2004.08.052; Phillips M, 2008, CLIN CHIM ACTA, V393, P76, DOI 10.1016/j.cca.2008.02.021; Phillips Michael, 2007, Cancer Biomarkers, V3, P95; Phillips M, 2007, TUBERCULOSIS, V87, P44, DOI 10.1016/j.tube.2006.03.004; Phillips M, 2006, BREAST CANCER RES TR, V99, P19, DOI 10.1007/s10549-006-9176-1; Phillips M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075274; Phillips Michael, 2003, Breast J, V9, P184, DOI 10.1046/j.1524-4741.2003.09309.x; Phillips M, 2013, J BREATH RES, V7, DOI 10.1088/1752-7155/7/3/036002; Phillips M, 2012, TUBERCULOSIS, V92, P314, DOI 10.1016/j.tube.2012.04.002; Phillips M, 2010, J BREATH RES, V4, DOI 10.1088/1752-7155/4/2/026003; Phillips M, 2010, TUBERCULOSIS, V90, P145, DOI 10.1016/j.tube.2010.01.003; Pisano ED, 2005, NEW ENGL J MED, V353, P1773, DOI 10.1056/NEJMoa052911; Schmalfuss F, 2013, BIOMARK INSIGHTS, V8, P9, DOI 10.4137/BMI.S11153; Shuster G, 2011, BREAST CANCER RES TR, V126, P791, DOI 10.1007/s10549-010-1317-x; Stolarek RA, 2010, J CANCER RES CLIN, V136, P923, DOI 10.1007/s00432-009-0734-x; Syhre M, 2009, TUBERCULOSIS, V89, P263, DOI 10.1016/j.tube.2009.04.003; Xu YW, 2013, J BIOMED NANOTECHNOL, V9, P1164, DOI 10.1166/jbn.2013.1651; Yang J, 2006, J ZHEJIANG UNIV-SC B, V7, P603	45	31	33	1	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90226	10.1371/journal.pone.0090226	http://dx.doi.org/10.1371/journal.pone.0090226			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599224	Green Published, Green Submitted, gold			2022-12-27	WOS:000332479400056
J	Schwab, F; Gastmeier, P; Meyer, E				Schwab, Frank; Gastmeier, Petra; Meyer, Elisabeth			The Warmer the Weather, the More Gram-Negative Bacteria - Impact of Temperature on Clinical Isolates in Intensive Care Units	PLOS ONE			English	Article							BLOOD-STREAM INFECTION; SEASONAL-VARIATION; SERRATIA-MARCESCENS; DISEASES; PEAKS	Background: We investigated the relationship between average monthly temperature and the most common clinical pathogens causing infections in intensive care patients. Methods: A prospective unit-based study in 73 German intensive care units located in 41 different hospitals and 31 different cities with total 188,949 pathogen isolates (102,377 Gram-positives and 86,572 Gram-negatives) from 2001 to 2012. We estimated the relationship between the number of clinical pathogens per month and the average temperature in the month of isolation and in the month prior to isolation while adjusting for confounders and long-term trends using time series analysis. Adjusted incidence rate ratios for temperature parameters were estimated based on generalized estimating equation models which account for clustering effects. Results: The incidence density of Gram-negative pathogens was 15% (IRR 1.15, 95% CI 1.10-1.21) higher at temperatures >= 20 degrees C than at temperatures below 5 degrees C. E. cloacae occurred 43% (IRR = 1.43; 95% CI 1.31-1.56) more frequently at high temperatures, A. baumannii 37% (IRR = 1.37; 95% CI 1.11-1.69), S. maltophilia 32% (IRR = 1.32; 95% CI 1.12-1.57), K. pneumoniae 26% (IRR = 1.26; 95% CI 1.13-1.39), Citrobacter spp. 19% (IRR = 1.19; 95% CI 0.99-1.44) and coagulase-negative staphylococci 13% (IRR = 1.13; 95% CI 1.04-1.22). By contrast, S. pneumoniae 35% (IRR = 0.65; 95% CI 0.50-0.84) less frequently isolated at high temperatures. For each 5 degrees C increase, we observed a 3% (IRR = 1.03; 95% CI 1.02-1.04) increase of Gram-negative pathogens. This increase was highest for A. baumannii with 8% (IRR = 1.08; 95% CI 1.05-1.12) followed by K. pneumoniae, Citrobacter spp. and E. cloacae with 7%. Conclusion: Clinical pathogens vary by incidence density with temperature. Significant higher incidence densities of Gram-negative pathogens were observed during summer whereas S. pneumoniae peaked in winter. There is increasing evidence that different seasonality due to physiologic changes underlies host susceptibility to different bacterial pathogens. Even if the underlying mechanisms are not yet clear, the temperature-dependent seasonality of pathogens has implications for infection control and study design.	[Schwab, Frank; Gastmeier, Petra; Meyer, Elisabeth] Charite, Inst Hyg & Environm Med, D-13353 Berlin, Germany; [Schwab, Frank; Gastmeier, Petra; Meyer, Elisabeth] Natl Reference Ctr Surveillance Nosocomial Infect, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Schwab, F (corresponding author), Charite, Inst Hyg & Environm Med, D-13353 Berlin, Germany.	frank.schwab@charite.de		Meyer, Elisabeth/0000-0001-5590-2421; Gastmeier, Petra/0000-0001-5520-4287	Federal Ministry of Education and Research [01Kl 9907]	Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	SARI (Surveillance of Antimicrobial use and antimicrobial Resistance in German Intensive Care Units) was supported until 2006 by a grant from the Federal Ministry of Education and Research (01Kl 9907). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hasan MN, 2011, CLIN MICROBIOL INFEC, V17, P539, DOI 10.1111/j.1469-0691.2010.03277.x; Al-Hasan MN, 2010, MAYO CLIN PROC, V85, P139, DOI 10.4065/mcp.2009.0410; Anderson DJ, 2008, J INFECT DIS, V197, P752, DOI 10.1086/527486; [Anonymous], 1930, LANCET, V216, P302; Chazan B, 2011, CLIN MICROBIOL INFEC, V17, P851, DOI 10.1111/j.1469-0691.2010.03327.x; (DAE) AEMdDAE, 2013, LEITL EMPF SICH GUT; Dowell SF, 2003, EMERG INFECT DIS, V9, P573, DOI 10.3201/eid0905.020556; Dowell SF, 2001, EMERG INFECT DIS, V7, P369; Eber MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025298; Fisman DN, 2007, ANNU REV PUBL HEALTH, V28, P127, DOI 10.1146/annurev.publhealth.28.021406.144128; Freeman JT, 2009, CLIN MICROBIOL INFEC, V15, P951, DOI 10.1111/j.1469-0691.2009.02866.x; Freeman J, 2009, INFECT CONT HOSP EP, V30, P813, DOI 10.1086/597506; Grundmann H, 2005, CRIT CARE MED, V33, P946, DOI 10.1097/01.CCM.0000163223.26234.56; Hejazi A, 1997, J MED MICROBIOL, V46, P903, DOI 10.1099/00222615-46-11-903; Leekha S, 2012, CLIN MICROBIOL INFEC, V18, P927, DOI 10.1111/j.1469-0691.2012.03955.x; McDonald LC, 1999, CLIN INFECT DIS, V29, P1133, DOI 10.1086/313441; Meyer E, 2003, INFECTION, V31, P208, DOI 10.1007/s15010-003-3201-7; Ostro B, 2010, AM J EPIDEMIOL, V172, P1053, DOI 10.1093/aje/kwq231; Paynter S, 2010, LANCET, V376, P1804, DOI 10.1016/S0140-6736(10)62141-1; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Perencevich EN, 2008, INFECT CONT HOSP EP, V29, P1124, DOI 10.1086/592698; Stone L, 2007, NATURE, V446, P533, DOI 10.1038/nature05638; Terletskaia-Ladwig E, 1946, DEUT MED WOCHENSCHR, V136, P69; Walter ND, 2010, CLIN INFECT DIS, V50, P175, DOI 10.1086/649208; Yang AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013728; YU VL, 1979, NEW ENGL J MED, V300, P887, DOI 10.1056/NEJM197904193001604; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734	27	47	47	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e91105	10.1371/journal.pone.0091105	http://dx.doi.org/10.1371/journal.pone.0091105			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599500	Green Published, Green Submitted, gold			2022-12-27	WOS:000332479400155
J	Tapiainen, T; Paalanne, N; Arkkola, T; Renko, M; Pokka, T; Kaijalainen, T; Uhari, M				Tapiainen, Terhi; Paalanne, Niko; Arkkola, Tuula; Renko, Marjo; Pokka, Tytti; Kaijalainen, Tarja; Uhari, Matti			Diet as a Risk Factor for Pneumococcal Carriage and Otitis Media: A Cross-Sectional Study among Children in Day Care Centers	PLOS ONE			English	Article							URINARY-TRACT-INFECTIONS; STREPTOCOCCUS-PNEUMONIAE; DENTAL-CARIES; BEVERAGE CONSUMPTION; RANDOMIZED-TRIAL; NASOPHARYNGEAL; PREVENTION; XYLITOL; BIOFILMS; VACCINE	Background: Pharyngeal bacteria are exposed to different sugar conditions depending on the diet of the child. We hypothesized that dietary factors such as daily intake of carbohydrates could be associated with pneumococcal carriage and the occurrence of otitis media in children. Methods: Our study design was a cross-sectional study among 1006 children attending child day care centers. Parents filled in a food frequency questionnaire. Oropharyngeal swabs were collected from each child. The primary outcome was the occurrence of pneumococcal carriage and the secondary outcome the number of acute otitis media episodes during life. Principal component analysis was used to group dietary intake into nine factors. The models were adjusted for age, gender of the child and educational level of the mother. Results: The dietary factor which included high consumption of sweet pastries and jam was associated with an increased risk of pneumococcal carriage (OR 1.17, 95% CI 1.01 to 1.36, P-value 0.04). The factor including frequent consumption of fruit and berries was associated with a decreased risk of acute otitis (regression coefficient -0.51, 95% CI -0.98 to -0.03, P = 0.04). A high intake of consumption of sweets and snacks (OR 1.36, 95% CI 1.03 to 1.80, P = 0.03) was associated with an increased risk of caries. Conclusions: Diet was associated with a risk of pneumococcal carriage and the occurrence of otitis media. Diet may thus be a modifiable risk factor for the occurrence of acute otitis media.	[Tapiainen, Terhi; Paalanne, Niko; Arkkola, Tuula; Renko, Marjo; Pokka, Tytti; Uhari, Matti] Oulu Univ Hosp, Dept Pediat, Oulu, Finland; [Tapiainen, Terhi; Paalanne, Niko; Renko, Marjo; Pokka, Tytti; Uhari, Matti] Univ Oulu, Dept Pediat, SF-90100 Oulu, Finland; [Kaijalainen, Tarja] Natl Inst Hlth & Welf, Oulu, Finland	University of Oulu; University of Oulu; Finland National Institute for Health & Welfare	Tapiainen, T (corresponding author), Oulu Univ Hosp, Dept Pediat, Oulu, Finland.	terhi.tapiainen@oulu.fi	Renko, Marjo/F-7811-2014	Renko, Marjo/0000-0003-0507-4773	Foundation for Pediatric Research; Juho Vainio Foundation, Finland	Foundation for Pediatric Research; Juho Vainio Foundation, Finland	This work was financially supported by the Foundation for Pediatric Research, and the Juho Vainio Foundation, Finland. No other funding was used. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Duarte S, 2006, FEMS MICROBIOL LETT, V257, P50, DOI 10.1111/j.1574-6968.2006.00147.x; Eskola J, 2001, NEW ENGL J MED, V344, P403, DOI 10.1056/NEJM200102083440602; Garcia-Rodriguez JA, 2002, J ANTIMICROB CHEMOTH, V50, P59, DOI 10.1093/jac/dkf506; Greenberg D, 2004, J CLIN MICROBIOL, V42, P4604, DOI 10.1128/JCM.42.10.4604-4609.2004; Grimes CA, 2013, PEDIATRICS, V131, P14, DOI 10.1542/peds.2012-1628; Kilpi T, 2001, PEDIATR INFECT DIS J, V20, P654, DOI 10.1097/00006454-200107000-00004; Kontiokari T, 2003, AM J CLIN NUTR, V77, P600, DOI 10.1093/ajcn/77.3.600; Kontiokari T, 2001, BMJ-BRIT MED J, V322, P1571, DOI 10.1136/bmj.322.7302.1571; Koo H, 2010, CARIES RES, V44, P116, DOI 10.1159/000296306; Kurola P, 2011, APMIS, V119, P135, DOI 10.1111/j.1600-0463.2010.02703.x; Kyttala P., 2008, DIET FINNISH PRESCHO; Leino T, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-173; Makinen KK, 1995, J DENT RES, V74, P1904, DOI 10.1177/00220345950740121501; Marshall TA, 2003, PEDIATRICS, V112, pE184, DOI 10.1542/peds.112.3.e184; Ministry of Education and Culture Finland, 2010, SUOM VAEST KOUL VAHV; Mosby TT, 2012, ANTICANCER RES, V32, P4171; Niemela M, 2000, PEDIATRICS, V106, P483, DOI 10.1542/peds.106.3.483; O'Brien KL, 2001, J CLIN MICROBIOL, V39, P1021, DOI 10.1128/JCM.39.3.1021-1024.2001; Rueda AM, 2010, J INFECTION, V60, P99, DOI 10.1016/j.jinf.2009.12.003; Salo J, 2012, CLIN INFECT DIS, V54, P340, DOI 10.1093/cid/cir801; SIPILA M, 1988, ACTA OTO-LARYNGOL, V106, P94, DOI 10.3109/00016488809107375; Syrjanen RK, 2001, J INFECT DIS, V184, P451, DOI 10.1086/322048; Touger-Decker R, 2003, AM J CLIN NUTR, V78, p881S, DOI 10.1093/ajcn/78.4.881S; Uhari M, 1996, BRIT MED J, V313, P1180, DOI 10.1136/bmj.313.7066.1180; Uhari M, 1996, CLIN INFECT DIS, V22, P1079, DOI 10.1093/clinids/22.6.1079; Vadeboncoeur C, 1997, FEMS MICROBIOL REV, V19, P187, DOI 10.1016/S0168-6445(96)00029-0; Veenhoven R, 2003, LANCET, V361, P2189, DOI 10.1016/S0140-6736(03)13772-5; Watt JP, 2004, J CLIN MICROBIOL, V42, P4974, DOI 10.1128/JCM.42.11.4974-4976.2004	28	0	0	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90585	10.1371/journal.pone.0090585	http://dx.doi.org/10.1371/journal.pone.0090585			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599395	Green Submitted, Green Published, gold			2022-12-27	WOS:000332479400099
J	Kashyap, RS; Nayak, AR; Gaherwar, HM; Husain, AA; Shekhawat, SD; Jain, RK; Panchbhai, MS; Raje, DV; Purohit, HJ; Taori, GM; Daginawala, HF				Kashyap, Rajpal S.; Nayak, Amit R.; Gaherwar, Hari M.; Husain, Aliabbas A.; Shekhawat, Seema D.; Jain, Ruchika K.; Panchbhai, Milind S.; Raje, Dhananjay V.; Purohit, Hemant J.; Taori, Girdhar M.; Daginawala, Hatim F.			Latent TB Infection Diagnosis in Population Exposed to TB Subjects in Close and Poor Ventilated High TB Endemic Zone in India	PLOS ONE			English	Article							BLOOD INTERFERON-GAMMA; MYCOBACTERIUM-TUBERCULOSIS INFECTION; HEALTH-CARE WORKERS; SKIN-TEST; RELEASE ASSAYS; LARGE-SCALE; MALNUTRITION; TRANSMISSION; RISK	Background: The present study was designed to investigate the utility of Quantiferon TB gold (QFT-G) and Tuberculin skin test (TST) for diagnosis of latent TB infection (LTBI) in high crowding TB endemic zone of Nagpur, India and their comparison with associated risk factors. Methods: Out of 342 eligible participants, QFT-G and TST were performed in 162 participants. Results: The prevalence of LTBI observed according to QFT-G and TST was 48% and 42% respectively, with an agreement of 52.47%. QFT-G positivity was associated with age while TST positivity was associated with body mass index (BMI). Duration of exposure emerged as a key risk factor significantly associated with both the tests. Conclusion: The prevalence of LTBI was quite high in the studied zone as detected by both the evaluated tests and thus, the combination of both the tests will be best predictive for LTBI in such high TB endemic regions.	[Kashyap, Rajpal S.; Nayak, Amit R.; Gaherwar, Hari M.; Husain, Aliabbas A.; Shekhawat, Seema D.; Jain, Ruchika K.; Panchbhai, Milind S.; Taori, Girdhar M.; Daginawala, Hatim F.] Cent India Inst Med Sci, Biochem Res Lab, Nagpur, Maharashtra, India; [Raje, Dhananjay V.] MDS Bioanalyt Pvt Ltd, Nagpur, Maharashtra, India; [Purohit, Hemant J.] Natl Environm Engn Res Inst, Environm Genom Unit, Nagpur 440020, Maharashtra, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Environmental Engineering Research Institute (NEERI)	Kashyap, RS (corresponding author), Cent India Inst Med Sci, Biochem Res Lab, Nagpur, Maharashtra, India.	raj_ciims@rediffmail.com	Panchabhai, Dr. Milind(MishtiZ) Sadashiv/AIB-4720-2022; Kashyap, Rajpal/AAP-8461-2020		Central India Institute of Medical Sciences	Central India Institute of Medical Sciences	Authors would like to thank Central India Institute of Medical Sciences for funding this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batra S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040880; Connell TG, 2006, THORAX, V61, P616, DOI 10.1136/thx.2005.048033; Davidow AL, 2008, INT J TUBERC LUNG D, V12, P152; FEREBEE SH, 1970, BIBL TUBERC MED THOR, V17, P28; Fietta A, 2003, AM J INFECT CONTROL, V31, P347, DOI 10.1016/S0196-6553(02)48240-5; GRZYBOWSKI S, 1975, Bulletin of the International Union Against Tuberculosis, V50, P90; Harada N, 2006, INFECT CONT HOSP EP, V27, P442, DOI 10.1086/504358; Hesseling AC, 2009, THORAX, V64, P840, DOI 10.1136/thx.2007.085340; Hill PC, 2004, CLIN INFECT DIS, V38, P966, DOI 10.1086/382362; Kang YA, 2005, JAMA-J AM MED ASSOC, V293, P2756, DOI 10.1001/jama.293.22.2756; Kashyap RS, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-74; Kashyap RS, 2005, CLIN DIAGN LAB IMMUN, V12, P752, DOI 10.1128/CDLI.12.6.752-758.2005; Lienhardt C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010508; Lucas M, 2010, THORAX, V65, P442, DOI 10.1136/thx.2009.127555; Mahomed H, 2006, INT J TUBERC LUNG D, V10, P310; Mori T, 2004, AM J RESP CRIT CARE, V170, P59, DOI 10.1164/rccm.200402-179OC; Mutsvangwa J, 2010, THORAX, V65, P315, DOI 10.1136/thx.2009.124891; Nakaoka H, 2006, EMERG INFECT DIS, V12, P1383, DOI 10.3201/eid1209.051606; Nienhaus A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002665; Pai M, 2005, JAMA-J AM MED ASSOC, V293, P2746, DOI 10.1001/jama.293.22.2746; Panchbhai M. S., 2011, International Journal of Biology, V3, P122; Pelly TF, 2005, INT J TUBERC LUNG D, V9, P977; ROUILLON A, 1976, TUBERCLE, V57, P275, DOI 10.1016/S0041-3879(76)80006-2; SHAW JB, 1954, AM REV TUBERC PULM, V69, P724; Singh D, 2001, AM J RESP CRIT CARE, V164, P962, DOI 10.1164/ajrccm.164.6.2102076; Van Lettow M, 2004, INT J TUBERC LUNG D, V8, P211; Zwerling A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043014; Zwerling A, 2012, THORAX, V67, P62, DOI 10.1136/thx.2010.143180	28	16	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e89524	10.1371/journal.pone.0089524	http://dx.doi.org/10.1371/journal.pone.0089524			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614179	gold, Green Submitted, Green Published			2022-12-27	WOS:000332839300012
J	Nguyen, MT; Koo, BK; Vu, TTT; Song, JA; Chong, SH; Jeong, B; Ryu, HB; Moh, SH; Choe, H				Minh Tan Nguyen; Koo, Bon-Kyung; Thu Trang Thi Vu; Song, Jung-A; Chong, Seon-Ha; Jeong, Boram; Ryu, Han-Bong; Moh, Sang-Hyun; Choe, Han			Prokaryotic Soluble Overexpression and Purification of Bioactive Human Growth Hormone by Fusion to Thioredoxin, Maltose Binding Protein, and Protein Disulfide Isomerase	PLOS ONE			English	Article							ESCHERICHIA-COLI; EXPRESSION SYSTEM; DNA CLONING; SOLUBILIZATION; REDUCTION; RETENTION; PROLACTIN; DOMAINS; SCALE	Human growth hormone (hGH) is synthesized by somatotroph cells of the anterior pituitary gland and induces cell proliferation and growth. This protein has been approved for the treatment of various conditions, including hGH deficiency, chronic renal failure, and Turner syndrome. Efficient production of hGH in Escherichia coli (E. coli) has proven difficult because the E. coli-expressed hormone tends to aggregate and form inclusion bodies, resulting in poor solubility. In this study, seven N-terminal fusion partners, hexahistidine (His6), thioredoxin (Trx), glutathione S-transferase (GST), maltose-binding protein (MBP), N-utilization substance protein A (NusA), protein disulfide bond isomerase (PDI), and the b'a' domain of PDI (PDIb'a'), were tested for soluble overexpression of codon-optimized hGH in E. coli. We found that MBP and hPDI tags significantly increased the solubility of the hormone. In addition, lowering the expression temperature to 18 degrees C also dramatically increased the solubility of all the fusion proteins. We purified hGH from MBP-, PDIb'a'-, or Trx-tagged hGH expressed at 18 degrees C in E. coli using simple chromatographic techniques and compared the final purity, yield, and activity of hGH to assess the impact of each partner protein. Purified hGH was highly pure on silver-stained gel and contained very low levels of endotoxin. On average, similar to 37 mg, similar to 12 mg, and similar to 7 mg of hGH were obtained from 500 mL-cell cultures of Trx-hGH, MBP-hGH, and PDIb'a'-hGH, respectively. Subsequently, hGH was analyzed using mass spectroscopy to confirm the presence of two intra-molecular disulfide bonds. The bioactivity of purified hGHs was demonstrated using Nb2-11 cell.	[Minh Tan Nguyen; Koo, Bon-Kyung; Thu Trang Thi Vu; Song, Jung-A; Chong, Seon-Ha; Jeong, Boram; Ryu, Han-Bong; Choe, Han] Univ Ulsan, Coll Med, Dept Physiol, Seoul, South Korea; [Minh Tan Nguyen; Koo, Bon-Kyung; Thu Trang Thi Vu; Song, Jung-A; Chong, Seon-Ha; Jeong, Boram; Ryu, Han-Bong; Choe, Han] Univ Ulsan, Coll Med, Biomed Inst Technol, Seoul, South Korea; [Moh, Sang-Hyun] BioFD & C Co Ltd, Inchon, South Korea	University of Ulsan; University of Ulsan	Choe, H (corresponding author), Univ Ulsan, Coll Med, Dept Physiol, Seoul, South Korea.	hchoe@ulsan.ac.kr	Nguyen, Minh Tan/AAH-7865-2019	choe, han/0000-0003-4604-647X	MRC [2008-0062286]; Priority Research Center Program of National Research Foundation [2009-0094054]; Ministry of Education, Science and Technology of Korea	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Priority Research Center Program of National Research Foundation; Ministry of Education, Science and Technology of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by MRC grant (2008-0062286) and Priority Research Center Program (2009-0094054) of National Research Foundation funded by the Ministry of Education, Science and Technology of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apte-Deshpande A, 2009, BIOTECHNOL APPL BIOC, V54, P197, DOI 10.1042/BA20090179; Ayyar Vageesh S, 2011, Indian J Endocrinol Metab, V15 Suppl 3, pS162, DOI 10.4103/2230-8210.84852; Bach H, 2001, J MOL BIOL, V312, P79, DOI 10.1006/jmbi.2001.4914; Baldwin RL, 1996, BIOPHYS J, V71, P2056, DOI 10.1016/S0006-3495(96)79404-3; Baumann GP, 2009, GROWTH HORM IGF RES, V19, P333, DOI 10.1016/j.ghir.2009.04.011; BECKER GW, 1986, FEBS LETT, V204, P145, DOI 10.1016/0014-5793(86)81403-X; Besson A, 2005, J CLIN ENDOCR METAB, V90, P2493, DOI 10.1210/jc.2004-1838; Bolar K, 2008, J CLIN ENDOCR METAB, V93, P344, DOI 10.1210/jc.2007-1723; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Busso D, 2005, ANAL BIOCHEM, V343, P313, DOI 10.1016/j.ab.2005.05.015; Calik P, 2008, BIOTECHNOL PROGR, V24, P221, DOI 10.1021/bp070294t; Catzel D, 2003, PROTEIN EXPRES PURIF, V32, P126, DOI 10.1016/j.pep.2003.07.002; CONNORS MH, 1973, J CLIN ENDOCR METAB, V37, P499, DOI 10.1210/jcem-37-4-499; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; De Palo EF, 2006, CLIN CHIM ACTA, V364, P67, DOI 10.1016/j.cca.2005.06.009; DIXON JS, 1966, SCIENCE, V154, P785, DOI 10.1126/science.154.3750.785; Fahnert B, 2004, ADV BIOCHEM ENG BIOT, V89, P93; Franklin SL, 2009, ENDOCRIN METAB CLIN, V38, P587, DOI 10.1016/j.ecl.2009.06.006; Graslund S, 2008, NAT METHODS, V5, P135, DOI 10.1038/nmeth.f.202; Gu YP, 2001, MOL CELL BIOCHEM, V223, P35, DOI 10.1023/A:1017941625858; Hartley JL, 2000, GENOME RES, V10, P1788, DOI 10.1101/gr.143000; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; Jeay S, 2002, MOL CELL ENDOCRINOL, V188, P1, DOI 10.1016/S0303-7207(02)00014-X; Jung AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083781; Junnila RK, 2013, ENDOKRYNOL POL, V64, P300, DOI 10.5603/EP.2013.0009; Kapust RB, 1999, PROTEIN SCI, V8, P1668, DOI 10.1110/ps.8.8.1668; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Kasimova MR, 2002, J MOL BIOL, V318, P679, DOI 10.1016/S0022-2836(02)00137-7; Kim MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056168; Koo TY, 2007, J MICROBIOL BIOTECHN, V17, P579; Kopchick JJ, 2003, HORM RES, V60, P103, DOI 10.1159/000074510; Lan HL, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/306462; Le Roith D, 2001, ENDOCR REV, V22, P53, DOI 10.1210/er.22.1.53; Lee JW, 2006, NATURE, V440, P363, DOI 10.1038/nature04537; MARTIAL JA, 1979, SCIENCE, V205, P602, DOI 10.1126/science.377496; NILSSON A, 1994, EUR J CLIN NUTR, V48, pS150; Nordberg J, 2001, FREE RADICAL BIO MED, V31, P1287, DOI 10.1016/S0891-5849(01)00724-9; Park C, 2007, J MOL BIOL, V368, P1426, DOI 10.1016/j.jmb.2007.02.091; Patra AK, 2000, PROTEIN EXPRES PURIF, V18, P182, DOI 10.1006/prep.1999.1179; Shin NK, 1998, J BIOTECHNOL, V62, P143, DOI 10.1016/S0168-1656(98)00054-6; Singh SM, 2009, PROTEIN EXPRES PURIF, V68, P54, DOI 10.1016/j.pep.2009.05.014; Sockolosky JT, 2013, PROTEIN EXPRES PURIF, V87, P129, DOI 10.1016/j.pep.2012.11.002; Solomon G, 2006, GROWTH HORM IGF RES, V16, P297, DOI 10.1016/j.ghir.2006.07.002; Song JA, 2013, APPL BIOCHEM BIOTECH, V170, P67, DOI 10.1007/s12010-013-0140-3; Sonoda H, 2008, BIOSCI BIOTECH BIOCH, V72, P2675, DOI 10.1271/bbb.80332; TANAKA T, 1980, J CLIN ENDOCR METAB, V51, P1058, DOI 10.1210/jcem-51-5-1058; Tritos NA, 1998, AM J MED, V105, P44, DOI 10.1016/S0002-9343(98)00135-1; WALSH RJ, 1990, BRAIN RES, V530, P1, DOI 10.1016/0006-8993(90)90651-Q; Wang S, 2013, APPL MICROBIOL BIOT, V97, P2885, DOI 10.1007/s00253-012-4553-7; WATAHIKI M, 1989, J BIOL CHEM, V264, P312; Waugh DS, 2011, PROTEIN EXPRES PURIF, V80, P283, DOI 10.1016/j.pep.2011.08.005; Wilkinson B, 2004, BBA-PROTEINS PROTEOM, V1699, P35, DOI 10.1016/j.bbapap.2004.02.017; Xu J, 2009, VITAM HORM, V80, P125, DOI 10.1016/S0083-6729(08)00606-7; YARASHESKI KE, 1992, AM J PHYSIOL, V262, pE261, DOI 10.1152/ajpendo.1992.262.3.E261	54	49	56	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e89038	10.1371/journal.pone.0089038	http://dx.doi.org/10.1371/journal.pone.0089038			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614134	Green Published, Green Submitted, gold			2022-12-27	WOS:000332839300010
J	Link, J; Ryner, ML; Fink, K; Hermanrud, C; Lima, I; Brynedal, B; Kockum, I; Hillert, J; Fogdell-Hahn, A				Link, Jenny; Ryner, Malin Lundkvist; Fink, Katharina; Hermanrud, Christina; Lima, Izaura; Brynedal, Boel; Kockum, Ingrid; Hillert, Jan; Fogdell-Hahn, Anna			Human Leukocyte Antigen Genes and Interferon Beta Preparations Influence Risk of Developing Neutralizing Anti-Drug Antibodies in Multiple Sclerosis	PLOS ONE			English	Article							BINDING; IMMUNOGENICITY; QUANTITATION; HAPLOTYPE; TITER	A significant proportion of patients with multiple sclerosis who receive interferon beta (IFN beta) therapy develop neutralizing antibodies (NAbs) that reduce drug efficacy. To investigate if HLA class I and II alleles are associated with development of NAbs against IFN beta we analyzed whether NAb status and development of NAb titers high enough to be biologically relevant (>150 tenfold reduction units/ml) correlated with the HLA allele group carriage in a cohort of 903 Swedish patients with multiple sclerosis treated with either intramuscular IFN beta-1a, subcutaneous IFN beta-1a or subcutaneous IFN beta-1b. Carriage of HLA-DRB1*15 was associated with increased risk of developing NAbs and high NAb titers. After stratification based on type of IFNb preparation, HLA-DRB1*15 carriage was observed to increase the risk of developing NAbs as well as high NAb titers against both subcutaneous and intramuscular IFN beta-1a. Furthermore, in patients receiving subcutaneous IFN beta-1a carriage of HLA-DQA1*05 decreased the risk for high NAb titers. In IFN beta-1b treated patients, HLA-DRB1* 04 increased the risk of developing high NAb titers, and in a subgroup analysis of DRB1*04 alleles the risk for NAbs was increased in DRB1*04:01 carriers. In conclusion, there is a preparation-specific genetically determined risk to develop NAbs against IFN beta high enough to be clinically relevant in treatment decisions for patients with multiple sclerosis if confirmed in future studies. However, choice of IFN beta preparation still remains the single most significant determinant for the risk of developing NAbs.	[Link, Jenny; Ryner, Malin Lundkvist; Fink, Katharina; Hermanrud, Christina; Lima, Izaura; Kockum, Ingrid; Hillert, Jan; Fogdell-Hahn, Anna] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Brynedal, Boel] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Ryner, ML (corresponding author), Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden.	malin.ryner@ki.se	; Kockum, Ingrid/O-8781-2018	Lima Bomfim, Izaura/0000-0003-0890-3872; Link, Jenny/0000-0002-6134-9404; Kockum, Ingrid/0000-0002-0867-4726; Fogdell-Hahn, Anna/0000-0002-0311-9184; Brynedal, Boel/0000-0002-7872-2981	Swedish Association for Persons with Neurological Disabilities, Swedish Research Council; Bibbi and Nils Jensens Foundation; European Commission; Innovative Medicines Initiative Joint Undertaking [115303]; European Union's Seventh Framework Program; EFPIA	Swedish Association for Persons with Neurological Disabilities, Swedish Research Council; Bibbi and Nils Jensens Foundation; European Commission(European CommissionEuropean Commission Joint Research Centre); Innovative Medicines Initiative Joint Undertaking; European Union's Seventh Framework Program; EFPIA	This study was supported by an unrestricted research grant from BiogenIdec and research grants from the Swedish Association for Persons with Neurological Disabilities, Swedish Research Council, Bibbi and Nils Jensens Foundation and the European Commission and the Innovative Medicines Initiative Joint Undertaking under grant agreement no [115303], resources of which are composed of financial contribution from the European Union's Seventh Framework Program (FP7/2007-2013) and EFPIA companies' in kind contribution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlers JD, 2010, TRENDS MOL MED, V16, P478, DOI 10.1016/j.molmed.2010.07.007; Barbosa MDFS, 2006, CLIN IMMUNOL, V118, P42, DOI 10.1016/j.clim.2005.08.017; Barnard JG, 2013, J PHARM SCI-US, V102, P915, DOI 10.1002/jps.23415; Bertolotto A, 2007, J IMMUNOL METHODS, V321, P19, DOI 10.1016/j.jim.2006.12.012; Bertolotto A, 2004, J NEUROL, V251, P15, DOI 10.1007/s00415-004-1204-7; Bozhinov A, 2012, J ALLERGY CLIN IMMUN, V129, P855, DOI 10.1016/j.jaci.2011.10.035; Buck D, 2011, ARCH NEUROL-CHICAGO, V68, P480, DOI 10.1001/archneurol.2011.65; Cortes A, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3204; Dengjel J, 2005, J MASS SPECTROM, V40, P100, DOI 10.1002/jms.780; Dilthey A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002877; Dilthey AT, 2011, BIOINFORMATICS, V27, P968, DOI 10.1093/bioinformatics/btr061; DUQUETTE P, 1993, NEUROLOGY, V43, P655, DOI 10.1212/wnl.43.4.655; Engelhard VH, 2006, CURR OPIN IMMUNOL, V18, P92, DOI 10.1016/j.coi.2005.11.015; Farrell RA, 2011, MULT SCLER J, V17, P1333, DOI 10.1177/1352458511412654; Francis G, 2001, NEUROLOGY, V56, P1628; Grossberg SE, 2011, J INTERF CYTOK RES, V31, P337, DOI 10.1089/jir.2010.0038; Hegen H, 2012, MULT SCLER J, V18, P610, DOI 10.1177/1352458511426738; Hesse D, 2009, NEUROLOGY, V73, P372, DOI 10.1212/WNL.0b013e3181b04c98; Hoffmann S, 2008, AM J HUM GENET, V83, P219, DOI 10.1016/j.ajhg.2008.07.006; Jacobs LD, 1996, ANN NEUROL, V39, P285, DOI 10.1002/ana.410390304; Jensen PEH, 2012, EUR J NEUROL, V19, P1311, DOI 10.1111/j.1468-1331.2012.03721.x; Jungedal R, 2012, MULT SCLER J, V18, P1775, DOI 10.1177/1352458512446036; Kappos L, 2005, NEUROLOGY, V65, P40, DOI 10.1212/01.wnl.0000171747.59767.5c; KAWADE Y, 1986, METHOD ENZYMOL, V119, P558; Klareskog L, 2006, ARTHRITIS RHEUM-US, V54, P38, DOI 10.1002/art.21575; Klechevsky E, 2008, IMMUNITY, V29, P497, DOI 10.1016/j.immuni.2008.07.013; Nielsen M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-238; Nielsen M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-296; OLERUP O, 1992, TISSUE ANTIGENS, V39, P225, DOI 10.1111/j.1399-0039.1992.tb01940.x; Paolicelli D, 2013, J NEUROL, V260, P1562, DOI 10.1007/s00415-012-6829-3; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ross C, 2000, ANN NEUROL, V48, P706, DOI 10.1002/1531-8249(200011)48:5<706::AID-ANA3>3.3.CO;2-M; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Schlesselman JJ, 1982, CASE CONTROL STUDIES; Sominanda A, 2008, J NEUROL NEUROSUR PS, V79, P57, DOI 10.1136/jnnp.2007.122549; Sominanda A, 2007, MULT SCLER, V13, P208, DOI 10.1177/1352458506070762; Sorensen PS, 2003, LANCET, V362, P1184, DOI 10.1016/S0140-6736(03)14541-2; Stickler M, 2004, GENES IMMUN, V5, P1, DOI 10.1038/sj.gene.6364027; Weber F, 2012, PHARMACOGENOMICS J, V12, P238, DOI 10.1038/tpj.2011.14	39	30	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90479	10.1371/journal.pone.0090479	http://dx.doi.org/10.1371/journal.pone.0090479			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608124	Green Submitted, Green Published, gold			2022-12-27	WOS:000332485800027
J	Surendran, S; Girijamma, A; Nair, R; Ramegowda, KS; Nair, DH; Thulaseedharan, JV; Lakkappa, RB; Kamalapurkar, G; Kartha, CC				Surendran, Sumi; Girijamma, Athira; Nair, Radhakrishnan; Ramegowda, Kalpana S.; Nair, Divya H.; Thulaseedharan, Jissa V.; Lakkappa, Ravikumar B.; Kamalapurkar, Giridhar; Kartha, Chandrasekharan C.			Forkhead box C2 Promoter Variant c.-512C > T Is Associated with Increased Susceptibility to Chronic Venous Diseases	PLOS ONE			English	Article							VARICOSE-VEINS; LYMPHEDEMA-DISTICHIASIS; TRANSCRIPTION FACTORS; IN-VITRO; FOXC2; EXPRESSION; MUTATIONS; FAILURE; LINKAGE; REGION	Chronic venous disease (CVD) is one of the most prevalent yet underrated disorders worldwide. High heritability estimates of CVD indicate prominent genetic components in its etiology and pathology. Mutations in human forkhead box C2 (Fox(2) gene are strongly associated with valve failure in saphenous and deep veins of lower extremities. We explored the association of genetic variants of FoxC2 as well as FoxC2 mRNA and protein expression levels with CVD of lower limbs. We systematically sequenced the single coding exon, 5' and 3' flanking regions of FoxC2 gene in 754 study subjects which includes 382 patients with CVD and 372 healthy subjects. Four novel and three reported polymorphisms were identified in our cohort. Three variants in 5' flanking region and one in 3' flanking region of FoxC2 gene were significantly associated with CVD risk. FoxC2 mRNA in vein tissues from 22 patients was 4 +/- 1.42 fold increased compared to saphenous veins from 20 normal subjects (p<0.01). FoxC2 protein was also significantly upregulated in varicose veins compared to control samples. The c.-512C>T (rs34221227: C>T) variant which is located in the FoxC2 putative promoter region was further analyzed. Functional analysis of c.-512C>T revealed increased mRNA and protein expression in patients with homozygous TT genotype compared to heterozygous CT and wild CC genotypes. Luciferase assay indicated higher transcriptional activity of mutant compared to wild genotype of this variant. These findings suggested that c.-512C>T variant of FoxC2 was strongly associated with susceptibility to CVD and also that this variant resulted in FoxC2 overexpression. To obtain a mechanistic insight into the role of upregulated FoxC2 in varicosities, we overexpressed FoxC2 in venous endothelial cells and observed elevated expression of arterial markers 0114 and Hey2 and downregulation of venous marker COUP-TFIL Our study indicates altered FoxC2-Notch signaling in saphenous vein wall remodeling in patients with varicose veins.	[Surendran, Sumi; Girijamma, Athira; Kartha, Chandrasekharan C.] Rajiv Gandhi Ctr Biotechnol, Thiruvananthapuram, Kerala, India; [Nair, Radhakrishnan] St Thomas Inst Res Venous Dis, Changanassery, Kerala, India; [Ramegowda, Kalpana S.; Kamalapurkar, Giridhar] Sri Jayadeva Inst Cardiovasc Sci & Res, Bangalore, Karnataka, India; [Nair, Divya H.; Thulaseedharan, Jissa V.] Sree Chitra Tirunal Inst Med Sci & Technol, Achutha Menon Ctr Hlth Sci Studies, Thiruvananthapuram, Kerala, India; [Lakkappa, Ravikumar B.] Kempegowda Inst Med Sci, Bangalore, Karnataka, India	Department of Biotechnology (DBT) India; Rajiv Gandhi Centre for Biotechnology (RGCB); Department of Science & Technology (India); Sree Chitra Tirunal Institute for Medical Sciences Technology (SCTIMST); Kempegowda Institute of Medical Sciences (KIMS)	Kartha, CC (corresponding author), Rajiv Gandhi Ctr Biotechnol, Thiruvananthapuram, Kerala, India.	cckartha@rgcb.res.in		Kartha, CC/0000-0002-6782-4456; S, Sumi/0000-0002-1162-0219	Department of Biotechnology, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported by intramural funds from the authors' institute without any aid from external funding agencies. Sumi S was supported by a post-doctoral fellowship from Department of Biotechnology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bihari I, 2012, PHLEBOLOGY, V27, P77, DOI 10.1258/phleb.2011.010063; Brice G, 2002, J MED GENET, V39, P478, DOI 10.1136/jmg.39.7.478; CORNUTHENARD A, 1994, J DERMATOL SURG ONC, V20, P318, DOI 10.1111/j.1524-4725.1994.tb01631.x; Diez H, 2007, EXP CELL RES, V313, P1, DOI 10.1016/j.yexcr.2006.09.009; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; Eklof B, 2004, J VASC SURG, V40, P1248, DOI 10.1016/j.jvs.2004.09.027; Fiebig A, 2010, HUM GENET, V127, P669, DOI 10.1007/s00439-010-0812-9; Hayashi H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002401; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kume T, 2009, ADV EXP MED BIOL, V665, P63; Labropoulos N, 2005, J VASC SURG, V41, P291, DOI 10.1016/j.jvs.2004.11.014; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Mellor RH, 2007, CIRCULATION, V115, P1912, DOI 10.1161/CIRCULATIONAHA.106.675348; Ng MYM, 2005, J MED GENET, V42, P235, DOI 10.1136/jmg.2004.024075; Petrova TV, 2004, NAT MED, V10, P974, DOI 10.1038/nm1094; PORTER JM, 1995, J VASC SURG, V21, P635, DOI 10.1016/S0741-5214(95)70195-8; Ramachandran S, 2012, PROTEOMICS, V12, P2808, DOI 10.1002/pmic.201100586; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Ridderstrale M, 2002, DIABETES, V51, P3554, DOI 10.2337/diabetes.51.12.3554; Robertson L, 2008, PHLEBOLOGY, V23, P103, DOI 10.1258/phleb.2007.007061; Sakata Y, 2004, ARTERIOSCL THROM VAS, V24, P2069, DOI 10.1161/01.ATV.0000143936.77094.a4; Seo S, 2006, DEV BIOL, V294, P458, DOI 10.1016/j.ydbio.2006.03.035; SISTO T, 1995, EUR J SURG, V161, P405; van Steensel MAM, 2009, HUM MUTAT, V30, pE1002, DOI 10.1002/humu.21127; Wu X, 2011, LYMPHOLOGY, V44, P35	26	15	22	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90682	10.1371/journal.pone.0090682	http://dx.doi.org/10.1371/journal.pone.0090682			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608096	gold, Green Published, Green Submitted			2022-12-27	WOS:000332485800044
J	Bao, GB; Schild, D				Bao, Guobin; Schild, Detlev			Fast and Accurate Fitting and Filtering of Noisy Exponentials in Legendre Space	PLOS ONE			English	Article								The parameters of experimentally obtained exponentials are usually found by least-squares fitting methods. Essentially, this is done by minimizing the mean squares sum of the differences between the data, most often a function of time, and a parameter-defined model function. Here we delineate a novel method where the noisy data are represented and analyzed in the space of Legendre polynomials. This is advantageous in several respects. First, parameter retrieval in the Legendre domain is typically two orders of magnitude faster than direct fitting in the time domain. Second, data fitting in a low-dimensional Legendre space yields estimates for amplitudes and time constants which are, on the average, more precise compared to least-squares-fitting with equal weights in the time domain. Third, the Legendre analysis of two exponentials gives satisfactory estimates in parameter ranges where least-squares-fitting in the time domain typically fails. Finally, filtering exponentials in the domain of Legendre polynomials leads to marked noise removal without the phase shift characteristic for conventional lowpass filters.	[Bao, Guobin; Schild, Detlev] Univ Gottingen, Dept Neurophysiol & Cellular Biophys, D-37073 Gottingen, Germany; [Bao, Guobin; Schild, Detlev] DFG Cluster Excellence 171, Gottingen, Germany	University of Gottingen	Schild, D (corresponding author), Univ Gottingen, Dept Neurophysiol & Cellular Biophys, D-37073 Gottingen, Germany.	dschild@gwdg.de			Cluster of Excellence; DFG Research Center Nanoscale Microscopy and Molecular Physiology of the Brain	Cluster of Excellence; DFG Research Center Nanoscale Microscopy and Molecular Physiology of the Brain(German Research Foundation (DFG))	This work was funded by the Cluster of Excellence and DFG Research Center Nanoscale Microscopy and Molecular Physiology of the Brain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramowitz M., 1965, HDB MATH FUNCTIONS; Bazzicalupi C, 2010, DALTON T, V39, P9838, DOI 10.1039/c0dt00552e; Belousov VV, 2006, NAT METHODS, V3, P281, DOI 10.1038/NMETH866; Courant R., 2008, METHODS MATH PHYS; Halmer D, 2004, REV SCI INSTRUM, V75, P2187, DOI 10.1063/1.1711189; Jerri A., 1992, INTEGRAL DISCRETE TR; Legendre A.M., 1806, NOUVELLES METHODES D; Levenberg K., 1944, Q APPL MATH, V2, P164, DOI [10.1090/qam/10666, DOI 10.1090/QAM/10666]; Marquardt D., 1963, INT J COMPUT VISION, V11, P431, DOI DOI 10.1137/0111030; MendezPerez JMR, 1997, MATH NACHR, V188, P219, DOI 10.1002/mana.19971880113; Papoulis A., 2001, PROBABILITY RANDOM V, V4th ed.; Tranter J, 1950, Q J MATH OXFORD, V2, P1	13	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90500	10.1371/journal.pone.0090500	http://dx.doi.org/10.1371/journal.pone.0090500			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603904	gold, Green Published, Green Submitted			2022-12-27	WOS:000332483600058
J	Gaetano, J; van der Zwan, R; Blair, D; Brooks, A				Gaetano, Justin; van der Zwan, Rick; Blair, Duncan; Brooks, Anna			Hands as Sex Cues: Sensitivity Measures, Male Bias Measures, and Implications for Sex Perception Mechanisms	PLOS ONE			English	Article							BIOLOGICAL MOTION PERCEPTION; FACE GENDER; FEMALE FACES; NEURAL BASIS; ADAPTATION; DISCRIMINATION; CATEGORIZATION; RECOGNITION; ACTIVATION; BRAIN	Sex perceptions, or more particularly, sex discriminations and sex categorisations, are high-value social behaviours. They mediate almost all inter-personal interactions. The two experiments reported here had the aim of exploring some of the basic characteristics of the processes giving rise to sex perceptions. Experiment 1 confirmed that human hands can be used as a cue to an individual's sex even when colour and texture cues are removed and presentations are brief. Experiment 1 also showed that when hands are sexually ambiguous observers tend to classify them as male more often than female. Experiment 2 showed that "male bias" arises not from sensitivity differences but from differences in response biases. Observers are conservative in their judgements of targets as female but liberal in their judgements of targets as male. These data, combined with earlier reports, suggest the existence of a sex-perception space that is cue-invariant.	[Gaetano, Justin; van der Zwan, Rick; Blair, Duncan; Brooks, Anna] So Cross Univ, Cognit Neurosci Res Cluster, Coffs Harbour, Australia	Southern Cross University	Gaetano, J (corresponding author), So Cross Univ, Cognit Neurosci Res Cluster, Coffs Harbour, Australia.	justin.gaetano@scu.edu.au	Blair, Duncan/G-2026-2014; Gaetano, Justin/E-9469-2012	Blair, Duncan/0000-0002-1654-9511; Gaetano, Justin/0000-0002-4200-163X				Agnihotri AK, 2006, INTERNET J FORENSIC, V2, P1; Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; Armann R, 2012, VISION RES, V63, P69, DOI 10.1016/j.visres.2012.05.005; Atkinson AP, 2011, PHILOS T R SOC B, V366, P1726, DOI 10.1098/rstb.2010.0349; Bachorowski JA, 1999, J ACOUST SOC AM, V106, P1054, DOI 10.1121/1.427115; BARCLAY CD, 1978, PERCEPT PSYCHOPHYS, V23, P145, DOI 10.3758/BF03208295; Bidet-Caulet A, 2005, NEUROIMAGE, V28, P132, DOI 10.1016/j.neuroimage.2005.06.018; Bigoni L, 2010, HOMO, V61, P16, DOI 10.1016/j.jchb.2009.09.004; Bonda E, 1996, J NEUROSCI, V16, P3737; Brooks A, 2008, CURR BIOL, V18, pR728, DOI 10.1016/j.cub.2008.06.054; BRUCE V, 1993, PERCEPTION, V22, P131, DOI 10.1068/p220131; BURTON AM, 1993, PERCEPTION, V22, P153, DOI 10.1068/p220153; Canli T, 2002, P NATL ACAD SCI USA, V99, P10789, DOI 10.1073/pnas.162356599; Cellerino A, 2004, BRAIN RES BULL, V63, P443, DOI 10.1016/j.brainresbull.2004.03.010; Chao LL, 1999, NEUROREPORT, V10, P2945, DOI 10.1097/00001756-199909290-00013; DAVIDENKO N, 2006, J VISION, V6, P1068; Davidenko N, 2007, J VISION, V7, DOI 10.1167/7.4.6; Davidenko N, 2008, VIS COGN, V16, P99; DeBruine LM, 2010, VIS COGN, V18, P816, DOI 10.1080/13506281003691357; Dzhelyova MP, 2011, J COGNITIVE NEUROSCI, V23, P2782, DOI 10.1162/jocn.2011.21604; FERRARIO VF, 1993, AM J ORTHOD DENTOFAC, V103, P327, DOI 10.1016/0889-5406(93)70013-E; Freeman JB, 2011, J EXP SOC PSYCHOL, V47, P259, DOI 10.1016/j.jesp.2010.08.018; Freeman JB, 2010, CEREB CORTEX, V20, P1314, DOI 10.1093/cercor/bhp195; Penton LG, 2010, NEURAL REGEN RES, V5, P1076, DOI 10.3969/j.issn.1673-5374.2010.14.007; Ghuman AS, 2010, CURR BIOL, V20, P32, DOI 10.1016/j.cub.2009.10.077; Grezes J, 1999, BRAIN, V122, P1875, DOI 10.1093/brain/122.10.1875; Hacker Graeme, 2013, BMC Psychol, V1, P10, DOI 10.1186/2050-7283-1-10; Hewig J, 2008, J NONVERBAL BEHAV, V32, P67, DOI 10.1007/s10919-007-0043-5; HILDEBRANDT KA, 1977, PERCEPT MOTOR SKILL, V45, P472, DOI 10.2466/pms.1977.45.2.472; Javadi AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046079; Jellema T, 2000, INT J PSYCHOL, V35, P205; Johnson KL, 2012, P ROY SOC B-BIOL SCI, V279, P4982, DOI 10.1098/rspb.2012.2060; Johnson KL, 2005, PSYCHOL SCI, V16, P890, DOI 10.1111/j.1467-9280.2005.01633.x; Jordan H, 2006, NAT NEUROSCI, V9, P738, DOI 10.1038/nn1710; Kovacs G, 2006, CEREB CORTEX, V16, P742, DOI 10.1093/cercor/bhj020; Kovacs G, 2004, NEUROREPORT, V15, P1275, DOI 10.1097/01.wnr.0000130234.51411.0e; KOZLOWSKI LT, 1977, PERCEPT PSYCHOPHYS, V21, P575, DOI 10.3758/BF03198740; LEINBACH MD, 1993, INFANT BEHAV DEV, V16, P317, DOI 10.1016/0163-6383(93)80038-A; Leopold DA, 2001, NAT NEUROSCI, V4, P89, DOI 10.1038/82947; LI XF, 1991, J ACOUST SOC AM, V90, P3036, DOI 10.1121/1.401778; LIPPA R, 1983, J PERS, V51, P667, DOI 10.1111/j.1467-6494.1983.tb00873.x; Little AC, 2005, P ROY SOC B-BIOL SCI, V272, P2283, DOI 10.1098/rspb.2005.3220; Maner JK, 2007, J PERS SOC PSYCHOL, V93, P389, DOI 10.1037/0022-3514.93.3.389; MATHER G, 1994, P ROY SOC B-BIOL SCI, V258, P273, DOI 10.1098/rspb.1994.0173; Millar JA, 1996, J HUM HYPERTENS, V10, P449; Morris JP, 2006, NEUROPSYCHOLOGIA, V44, P1919, DOI 10.1016/j.neuropsychologia.2006.01.035; Nagy E, 2000, PERCEPT MOTOR SKILL, V90, P102, DOI 10.2466/PMS.90.1.102-104; Napier J, 1993, HANDS, P13; Navarrete CD, 2009, PSYCHOL SCI, V20, P155, DOI 10.1111/j.1467-9280.2009.02273.x; Ng M, 2006, P NATL ACAD SCI USA, V103, P19552, DOI 10.1073/pnas.0605358104; Pelphrey KA, 2005, CEREB CORTEX, V15, P1866, DOI 10.1093/cercor/bhi064; Penn DJ, 2007, J R SOC INTERFACE, V4, P331, DOI 10.1098/rsif.2006.0182; Plant EA, 2011, PERS SOC PSYCHOL B, V37, P1274, DOI 10.1177/0146167211408617; Podrebarac SK, 2013, EXP BRAIN RES, V226, P241, DOI 10.1007/s00221-013-3429-0; Puce A, 2003, PHILOS T R SOC B, V358, P435, DOI 10.1098/rstb.2002.1221; Rhodes G, 2011, SCI SOCIAL VISION, P347; Schouten B, 2010, ATTEN PERCEPT PSYCHO, V72, P1256, DOI 10.3758/APP.72.5.1256; STANGOR C, 1992, J PERS SOC PSYCHOL, V62, P207, DOI 10.1037/0022-3514.62.2.207; Stanislaw H, 1999, BEHAV RES METH INS C, V31, P137, DOI 10.3758/BF03207704; Thompson JC, 2007, NEUROIMAGE, V37, P966, DOI 10.1016/j.neuroimage.2007.05.058; Thompson P, 2009, CURR BIOL, V19, pR11, DOI 10.1016/j.cub.2008.10.014; THOMPSON SK, 1971, DEV PSYCHOL, V5, P181, DOI 10.1037/h0031427; Todorov A, 2013, CURR OPIN NEUROBIOL, V23, P373, DOI 10.1016/j.conb.2012.12.010; Todorov A, 2008, TRENDS COGN SCI, V12, P455, DOI 10.1016/j.tics.2008.10.001; Toups MA, 2011, MOL BIOL EVOL, V28, P29, DOI 10.1093/molbev/msq234; Troje NF, 2006, J VISION, V6, P850, DOI 10.1167/6.8.7; Troje NF, 2002, J VISION, V2, P371, DOI 10.1167/2.5.2; VALENTINE T, 1991, Q J EXP PSYCHOL-A, V43, P161, DOI 10.1080/14640749108400966; van der Zwan R, 2009, EXP BRAIN RES, V198, P373, DOI 10.1007/s00221-009-1800-y; Veleminska J, 2012, HOMO, V63, P81, DOI 10.1016/j.jchb.2012.02.002; Walker PL, 2008, AM J PHYS ANTHROPOL, V136, P39, DOI 10.1002/ajpa.20776; Wang LB, 2012, NEUROIMAGE, V61, P931, DOI 10.1016/j.neuroimage.2012.03.080; Webster MA, 2004, NATURE, V428, P557, DOI 10.1038/nature02420; Wild HA, 2000, J EXP CHILD PSYCHOL, V77, P269, DOI 10.1006/jecp.1999.2554; Winer B.J., 1962, STAT PRINCIPLES EXPT; YAMAGUCHI MK, 1995, PERCEPTION, V24, P563, DOI 10.1068/p240563	76	9	9	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e91032	10.1371/journal.pone.0091032	http://dx.doi.org/10.1371/journal.pone.0091032			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC4ID	24603615	Green Submitted, gold, Green Published			2022-12-27	WOS:000332483600122
J	Jung, WJ; Lee, JW; Yoo, JC				Jung, Won-Ju; Lee, Jin-Won; Yoo, Jeong-Chil			"cu-coo'': Can You Recognize My Stepparents? - A Study of Host-Specific Male Call Divergence in the Common Cuckoo	PLOS ONE			English	Article							CUCULUS-CANORUS; EGG APPEARANCE; RACES; EVOLUTION; DISCRIMINATION; COEVOLUTION; VARIANCE; SONG	The presence of multiple host-specific races in the common cuckoo Cuculus canorus has long been recognized as an evolutionary enigma but how this genetic divergence could be maintained is still equivocal. Some recent studies supported biparental genetic contribution in maintaining the host-races, implying the necessity that they should recognize and mate assortatively with those who belong to the same host-race. One potential mechanism to accomplish this is that males may produce distinctive calls according to host-specific lineages. In order to test this hypothesis, we carried out a comparative study for male cuckoo calls recorded from three distant populations, where two populations share a same host species while the other parasitizes a different host species. Populations with similar habitat structures, maintaining comparable distance interval (ca. 150 km) between neighboring ones, were selected so as to minimize any other causes of vocal differentiation except the pattern of host use. By comparing the vocal characteristics of male cuckoos at the level of individual as well as population, we found that individual males indeed produced different calls in terms of spectral and temporal features. However, these differences disappeared when we compared the calls at the population level according to host species and geographic location. In conclusion, it seems unlikely for the cuckoos to identify the stepparent of male cuckoos based solely on the vocal characteristics, although they may be able to use this cue for individual recognition. Future studies including detailed morphological and genetic comparisons will be worthwhile to further elucidate this issue.	[Lee, Jin-Won] Kyung Hee Univ, Korea Inst Ornithol, Seoul, South Korea; Kyung Hee Univ, Dept Biol, Seoul, South Korea	Kyung Hee University; Kyung Hee University	Lee, JW (corresponding author), Kyung Hee Univ, Korea Inst Ornithol, Seoul, South Korea.	jwlee99@khu.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [NRF-2012R1A6A3A04040003]	Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF; www.nrf.re.kr) funded by the Ministry of Education, Science and Technology (NRF-2012R1A6A3A04040003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubin T, 2002, ADV STUD BEHAV, V31, P243, DOI 10.1016/S0065-3454(02)80010-9; Bell AM, 2009, ANIM BEHAV, V77, P771, DOI 10.1016/j.anbehav.2008.12.022; Berlin S, 2004, P NATL ACAD SCI USA, V101, P15967, DOI 10.1073/pnas.0405126101; BROOKE MD, 1988, NATURE, V335, P630; Chance EP., 1940, TRUTH CUCKOO; Davies N.B., 2000, CUCKOOS COWBIRDS OTH; Davies NB, 2006, P ROY SOC B-BIOL SCI, V273, P693, DOI 10.1098/rspb.2005.3324; Davies NB, 1998, OX ORN SER, V9, P59; DAVIES NB, 1989, J ANIM ECOL, V58, P207, DOI 10.2307/4995; DAVIES NB, 1989, J ANIM ECOL, V58, P225, DOI 10.2307/4996; DAWKINS R, 1979, PROC R SOC SER B-BIO, V205, P489, DOI 10.1098/rspb.1979.0081; DHONDT AA, 1992, TRENDS ECOL EVOL, V7, P178, DOI 10.1016/0169-5347(92)90068-M; Dooling RJ, 2000, SPR HDB AUD, V13, P308; Falls JB., 1982, ACOUSTIC COMMUNICATI, P237; Fisher J., 1954, P71; Fossoy F, 2011, P ROY SOC B-BIOL SCI, V278, P1639, DOI 10.1098/rspb.2010.2090; Fuisz TI, 2007, P ROY SOC B-BIOL SCI, V274, P2093, DOI 10.1098/rspb.2007.0487; Gibbs HL, 2000, NATURE, V407, P183, DOI 10.1038/35025058; Honza M, 2002, ANIM BEHAV, V64, P861, DOI 10.1006/anbe.2002.1969; Kang CW, 2009, FIELDGUIDE BOOK BIRD; KROODSMA DE, 1991, ANIM BEHAV, V42, P477, DOI 10.1016/S0003-3472(05)80047-8; Kruger O, 2013, J EVOLUTION BIOL, V26, P2447, DOI 10.1111/jeb.12238; Lambrechts Marcel M., 1995, Current Ornithology, V12, P115; Lee Jin-Won, 2004, Korean Journal of Biological Sciences, V8, P77; Marchetti K, 1998, SCIENCE, V282, P471, DOI 10.1126/science.282.5388.471; MASATAKA N, 1985, DEV PSYCHOBIOL, V18, P107, DOI 10.1002/dev.420180203; Moksnes A, 2008, J AVIAN BIOL, V39, P238, DOI 10.1111/j.2008.0908-8857.04158.x; Mulard H, 2009, BIOL J LINN SOC, V97, P289, DOI 10.1111/j.1095-8312.2009.01198.x; NAKAMURA H, 1990, Japanese Journal of Ornithology, V39, P1, DOI 10.3838/jjo.39.1; Nakamura Hiroshi, 1997, Japanese Journal of Ornithology, V46, P23, DOI 10.3838/jjo.46.23; Nakamura Hiroshi, 2005, Ornithological Science, V4, P31, DOI 10.2326/osj.4.31; Payne RB, 2005, THE CUCKOOS; Peake TM, 1999, ETHOL ECOL EVOL, V11, P123, DOI 10.1080/08927014.1999.9522831; Podos J, 2007, ADV STUD BEHAV, V37, P403, DOI 10.1016/S0065-3454(07)37009-5; Punnett RC, 1933, NATURE, V132, P892, DOI 10.1038/132892b0; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Reby D, 1998, J ZOOL, V245, P79, DOI 10.1017/S0952836998005093; Robson C, 2007, HDB BIRDS WORLD, V12, P292; ROTHSTEIN SI, 1990, ANNU REV ECOL SYST, V21, P481, DOI 10.1146/annurev.es.21.110190.002405; Ruxton GD, 2006, BEHAV ECOL, V17, P688, DOI 10.1093/beheco/ark016; SEEL DC, 1977, IBIS, V119, P309, DOI 10.1111/j.1474-919X.1977.tb08250.x; SHY E, 1985, Amphibia-Reptilia, V6, P343, DOI 10.1163/156853885X00335; Stoddard MC, 2013, ANIM BEHAV, V85, P693, DOI 10.1016/j.anbehav.2013.01.005; Stoddard MC, 2011, EVOLUTION, V65, P2004, DOI 10.1111/j.1558-5646.2011.01262.x; Stokke BG, 2002, EVOLUTION, V56, P199; Tchernichovski O, 2000, ANIM BEHAV, V59, P1167, DOI 10.1006/anbe.1999.1416; Vogl W, 2002, ANIM BEHAV, V64, P843, DOI 10.1006/anbe.2003.1967; Wyllie I., 1981, CUCKOO	48	18	21	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90468	10.1371/journal.pone.0090468	http://dx.doi.org/10.1371/journal.pone.0090468			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603770	Green Published, Green Submitted, gold			2022-12-27	WOS:000332483600054
J	Li, JZ; Chapman, B; Charlebois, P; Hofmann, O; Weiner, B; Porter, AJ; Samuel, R; Vardhanabhuti, S; Zheng, L; Eron, J; Taiwo, B; Zody, MC; Henn, MR; Kuritzkes, DR; Hide, W				Li, Jonathan Z.; Chapman, Brad; Charlebois, Patrick; Hofmann, Oliver; Weiner, Brian; Porter, Alyssa J.; Samuel, Reshmi; Vardhanabhuti, Saran; Zheng, Lu; Eron, Joseph; Taiwo, Babafemi; Zody, Michael C.; Henn, Matthew R.; Kuritzkes, Daniel R.; Hide, Winston		ACTG A5262 Study Team	Comparison of Illumina and 454 Deep Sequencing in Participants Failing Raltegravir-Based Antiretroviral Therapy	PLOS ONE			English	Article							DRUG-RESISTANCE MUTATIONS; INTEGRASE INHIBITORS; HIV-1; FREQUENCY; NAIVE; VARIANTS; FAILURE	Background: The impact of raltegravir-resistant HIV-1 minority variants (MVs) on raltegravir treatment failure is unknown. Illumina sequencing offers greater throughput than 454, but sequence analysis tools for viral sequencing are needed. We evaluated Illumina and 454 for the detection of HIV-1 raltegravir-resistant MVs. Methods: A5262 was a single-arm study of raltegravir and darunavir/ritonavir in treatment-nai " ve patients. Pre-treatment plasma was obtained from 5 participants with raltegravir resistance at the time of virologic failure. A control library was created by pooling integrase clones at predefined proportions. Multiplexed sequencing was performed with Illumina and 454 platforms at comparable costs. Illumina sequence analysis was performed with the novel snp-assess tool and 454 sequencing was analyzed with V-Phaser. Results: Illumina sequencing resulted in significantly higher sequence coverage and a 0.095% limit of detection. Illumina accurately detected all MVs in the control library at >= 0.5% and 7/10 MVs expected at 0.1%. 454 sequencing failed to detect any MVs at 0.1% with 5 false positive calls. For MVs detected in the patient samples by both 454 and Illumina, the correlation in the detected variant frequencies was high (R-2 = 0.92, P<0.001). Illumina sequencing detected 2.4-fold greater nucleotide MVs and 2.9-fold greater amino acid MVs compared to 454. The only raltegravir-resistant MV detected was an E138K mutation in one participant by Illumina sequencing, but not by 454. Conclusions: In participants of A5262 with raltegravir resistance at virologic failure, baseline raltegravir-resistant MVs were rarely detected. At comparable costs to 454 sequencing, Illumina demonstrated greater depth of coverage, increased sensitivity for detecting HIV MVs, and fewer false positive variant calls.	[Li, Jonathan Z.; Samuel, Reshmi; Kuritzkes, Daniel R.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Infect Dis, Boston, MA 02115 USA; [Chapman, Brad; Hofmann, Oliver; Porter, Alyssa J.; Vardhanabhuti, Saran; Zheng, Lu; Hide, Winston] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Charlebois, Patrick; Weiner, Brian; Zody, Michael C.; Henn, Matthew R.] Broad Inst MIT & Harvard, Cambridge, MA USA; [Samuel, Reshmi] Univ KwaZulu Natal, Dept Virol, Natl Hlth Lab Serv, Durban, South Africa; [Eron, Joseph] Univ N Carolina, Div Infect Dis, Chapel Hill, NC USA; [Taiwo, Babafemi] Northwestern Univ, Div Infect Dis, Chicago, IL 60611 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Kwazulu Natal; University of North Carolina; University of North Carolina Chapel Hill; Northwestern University	Li, JZ (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Infect Dis, Boston, MA 02115 USA.	Jli22@partners.org	Hide, Winston Hide/C-7217-2009; Hide, Winston/R-3815-2019; Hide, Winston A/V-2727-2017; zheng, lu/GXH-7035-2022; Hofmann, Oliver/F-1800-2013	Hide, Winston Hide/0000-0002-8621-3271; Hide, Winston/0000-0002-8621-3271; Hide, Winston A/0000-0002-8621-3271; Hofmann, Oliver/0000-0002-7738-1513	National Institutes of Health (NIH) [K08 AI100699]; National Institutes of Health (NIH) (Statistical and Data Management Center of the AIDS Clinical Trials Group) [U01 AI068634]; National Institutes of Health (NIH) (AIDS Clinical Trials Group) [U01 AI068636]; National Institutes of Health (NIH) (ACTG Statistical and Data Management Center) [U01 AI068634]; Harvard Clinical and Translational Science Center [UL1 RR 025758]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI068634, UM1AI069423, UM1AI069412, UM1AI068634, U01AI068636, P30AI050410, UM1AI106701, P30AI060354, K08AI100699, UM1AI069471, UM1AI068636] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health (NIH) (Statistical and Data Management Center of the AIDS Clinical Trials Group); National Institutes of Health (NIH) (AIDS Clinical Trials Group); National Institutes of Health (NIH) (ACTG Statistical and Data Management Center); Harvard Clinical and Translational Science Center; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health (NIH) grants K08 AI100699 (to Dr. Li), U01 AI068634 (Statistical and Data Management Center of the AIDS Clinical Trials Group), U01 AI068636 (AIDS Clinical Trials Group), U01 AI068634 (ACTG Statistical and Data Management Center), and a subcontract from U01 AI068636 to the Harvard Virology Support Laboratory (to Dr. Kuritzkes). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The TopCoder crowdsourcing competition was funded by the Harvard Clinical and Translational Science Center (UL1 RR 025758 and financial contributions from participating institutions).	Archer J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049602; Archer J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-47; Armenia D, 2012, J INFECT DIS, V205, P557, DOI 10.1093/infdis/jir821; Blanco JL, 2011, J INFECT DIS, V203, P1204, DOI 10.1093/infdis/jir025; Boltz VF, 2011, P NATL ACAD SCI USA, V108, P9202, DOI 10.1073/pnas.1105688108; Ceccherini-Silberstein F, 2010, ANTIMICROB AGENTS CH, V54, P3938, DOI 10.1128/AAC.01720-09; Charpentier C, 2010, AIDS, V24, P867, DOI 10.1097/QAD.0b013e3283367796; Church JD, 2006, J MOL DIAGN, V8, P430, DOI 10.2353/jmoldx.2006.050148; Codoner FM, 2010, ANTIVIR RES, V88, P281, DOI 10.1016/j.antiviral.2010.09.016; Henn MR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002529; Jabara CB, 2011, P NATL ACAD SCI USA, V108, P20166, DOI 10.1073/pnas.1110064108; KAROW J, 2010, SURVEY ILLUMINA SOLI; Lakhani KR, 2013, NAT BIOTECHNOL, V31, P108, DOI 10.1038/nbt.2495; LARDER BA, 1993, NATURE, V365, P671, DOI 10.1038/365671a0; Li JZ, 2011, JAMA-J AM MED ASSOC, V305, P1327, DOI 10.1001/jama.2011.375; Liu J, 2011, ANTIMICROB AGENTS CH, V55, P1114, DOI 10.1128/AAC.01492-10; Luo CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030087; Macalalad AR, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002417; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mukherjee R, 2011, AIDS, V25, P1951, DOI 10.1097/QAD.0b013e32834b34de; Panel on Antiretroviral Guidelines for Adults and Adolescents, 2013, GUIDELINES USE ANTIR, P1; Taiwo B, 2011, AIDS, V25, P2113, DOI 10.1097/QAD.0b013e32834bbaa9; Zagordi O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047046	23	17	17	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90485	10.1371/journal.pone.0090485	http://dx.doi.org/10.1371/journal.pone.0090485			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603872	Green Published, gold			2022-12-27	WOS:000332483600056
J	Lopez-Fernandez, H; Arbour, J; Willis, S; Watkins, C; Honeycutt, RL; Winemiller, KO				Lopez-Fernandez, Hernan; Arbour, Jessica; Willis, Stuart; Watkins, Crystal; Honeycutt, Rodney L.; Winemiller, Kirk O.			Morphology and Efficiency of a Specialized Foraging Behavior, Sediment Sifting, in Neotropical Cichlid Fishes	PLOS ONE			English	Article							ECOMORPHOLOGICAL DIVERSIFICATION; FUNCTIONAL-MORPHOLOGY; CENTRARCHID FISHES; FEEDING MECHANISM; PREY CAPTURE; RIVER; ASSEMBLAGES; DIVERSITY; TELEOSTEI; EVOLUTION	Understanding of relationships between morphology and ecological performance can help to reveal how natural selection drives biological diversification. We investigate relationships between feeding behavior, foraging performance and morphology within a diverse group of teleost fishes, and examine the extent to which associations can be explained by evolutionary relatedness. Morphological adaptation associated with sediment sifting was examined using a phylogenetic linear discriminant analysis on a set of ecomorphological traits from 27 species of Neotropical cichlids. For most sifting taxa, feeding behavior could be effectively predicted by a linear discriminant function of ecomorphology across multiple clades of sediment sifters, and this pattern could not be explained by shared evolutionary history alone. Additionally, we tested foraging efficiency in seven Neotropical cichlid species, five of which are specialized benthic feeders with differing head morphology. Efficiency was evaluated based on the degree to which invertebrate prey could be retrieved at different depths of sediment. Feeding performance was compared both with respect to feeding mode and species using a phylogenetic ANCOVA, with substrate depth as a covariate. Benthic foraging performance was constant across sediment depths in non-sifters but declined with depth in sifters. The non-sifting Hypsophrys used sweeping motions of the body and fins to excavate large pits to uncover prey; this tactic was more efficient for consuming deeply buried invertebrates than observed among sediment sifters. Findings indicate that similar feeding performance among sediment-sifting cichlids extracting invertebrate prey from shallow sediment layers reflects constraints associated with functional morphology and, to a lesser extent, phylogeny.	[Lopez-Fernandez, Hernan; Willis, Stuart; Watkins, Crystal; Honeycutt, Rodney L.; Winemiller, Kirk O.] Texas A&M Univ, Program Ecol & Evolutionary Biol, College Stn, TX USA; [Lopez-Fernandez, Hernan; Willis, Stuart; Watkins, Crystal; Honeycutt, Rodney L.; Winemiller, Kirk O.] Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA; [Lopez-Fernandez, Hernan; Arbour, Jessica] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; University of Toronto	Lopez-Fernandez, H (corresponding author), Royal Ontario Museum, Dept Nat Hist, Toronto, ON M5S 2C6, Canada.	hernanl@rom.on.ca		Lopez-Fernandez, Hernan/0000-0003-0270-1671; Higgs, Dennis/0000-0002-0771-4642; Winemiller, Kirk/0000-0003-0236-5129	NSF Undergraduate Mentoring in Environmental Biology Program [0203992]; NSF DEB [0516831]; NSERC	NSF Undergraduate Mentoring in Environmental Biology Program(National Science Foundation (NSF)); NSF DEB(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding for this project was provided by the NSF Undergraduate Mentoring in Environmental Biology Program (grant #0203992), NSF DEB grant #0516831 to KOW, RLH and HLF, and by an NSERC Discovery Grant to HLF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro ME, 2004, EVOLUTION, V58, P495, DOI 10.1111/j.0014-3820.2004.tb01673.x; Arbour JH, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0849; BAREL CDN, 1983, NETH J ZOOL, V33, P357; BARMUTA LA, 1984, HYDROBIOLOGIA, V112, P105, DOI 10.1007/BF00006913; Bastos RF, 2011, NEOTROP ICHTHYOL, V9, P825, DOI 10.1590/S1679-62252011005000049; Carroll AM, 2004, J EXP BIOL, V207, P3873, DOI 10.1242/jeb.01227; Cichocki, 1976, THESIS U MICHIGAN; Cochran-Biederman JL, 2010, ENVIRON BIOL FISH, V88, P143, DOI 10.1007/s10641-010-9624-y; Collar DC, 2006, EVOLUTION, V60, P2575; DRUCKER EG, 1991, J MORPHOL, V210, P267, DOI 10.1002/jmor.1052100306; Ferry-Graham LA, 2002, MAR BIOL, V141, P819, DOI 10.1007/s00227-002-0882-x; GARLAND T, 1993, SYST BIOL, V42, P265, DOI 10.2307/2992464; HEILIGENBERG W, 1965, ANIM BEHAV, V13, P163, DOI 10.1016/0003-3472(65)90087-4; Higham TE, 2007, J EVOLUTION BIOL, V20, P70, DOI 10.1111/j.1420-9101.2006.01227.x; Hulsey CD, 2002, P ROY SOC B-BIOL SCI, V269, P317, DOI 10.1098/rspb.2001.1874; Hulsey CD, 2005, FUNCT ECOL, V19, P487, DOI 10.1111/j.1365-2435.2005.00987.x; Kullander SO, 1986, CICHLID FISHES AMAZO; LAUDER GV, 1982, AM ZOOL, V22, P275; LIEM KF, 1980, AM ZOOL, V20, P295; Lopez-Fernandez H, 2005, ZOOL SCR, V34, P627, DOI 10.1111/j.1463-6409.2005.00209.x; Lopez-Fernandez H, 2013, EVOLUTION, V67, P1321, DOI 10.1111/evo.12038; Lopez-Fernandez H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033997; Lopez-Fernandez H, 2010, MOL PHYLOGENET EVOL, V55, P1070, DOI 10.1016/j.ympev.2010.02.020; Montana CG, 2010, ECOL FRESHW FISH, V19, P216, DOI 10.1111/j.1600-0633.2010.00406.x; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Revell LJ, 2009, EVOLUTION, V63, P3258, DOI 10.1111/j.1558-5646.2009.00804.x; SAZIMA I, 1986, J FISH BIOL, V29, P53, DOI 10.1111/j.1095-8649.1986.tb04926.x; Soria-Barreto M, 2008, ENVIRON BIOL FISH, V83, P459, DOI 10.1007/s10641-008-9368-0; Wainwright PC, 2005, INTEGR COMP BIOL, V45, P256, DOI 10.1093/icb/45.2.256; Wainwright PC, 1996, ECOLOGY, V77, P1336, DOI 10.2307/2265531; Wainwright PC, 2007, ANNU REV ECOL EVOL S, V38, P381, DOI 10.1146/annurev.ecolsys.38.091206.095706; Waltzek TB, 2003, J MORPHOL, V257, P96, DOI 10.1002/jmor.10111; Westneat MW, 2004, INTEGR COMP BIOL, V44, P378, DOI 10.1093/icb/44.5.378; Willis SC, 2005, OECOLOGIA, V142, P284, DOI 10.1007/s00442-004-1723-z; Winemiller KO, 2008, J BIOGEOGR, V35, P1551, DOI 10.1111/j.1365-2699.2008.01917.x; WINEMILLER KO, 1991, ECOL MONOGR, V61, P343, DOI 10.2307/2937046; WINEMILLER KO, 1995, ENVIRON BIOL FISH, V44, P235, DOI 10.1007/BF00005919	37	29	30	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e89832	10.1371/journal.pone.0089832	http://dx.doi.org/10.1371/journal.pone.0089832			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603485	gold, Green Published, Green Submitted			2022-12-27	WOS:000332483600024
J	Madl, T; Franklin, S; Chen, K; Montaldi, D; Trappl, R				Madl, Tamas; Franklin, Stan; Chen, Ke; Montaldi, Daniela; Trappl, Robert			Bayesian Integration of Information in Hippocampal Place Cells	PLOS ONE			English	Article							GRID CELLS; PATH-INTEGRATION; SPATIAL ORIENTATION; SPIKING NEURONS; NETWORKS; CA1; INFERENCE; DIRECTION; PHASE; RATS	Accurate spatial localization requires a mechanism that corrects for errors, which might arise from inaccurate sensory information or neuronal noise. In this paper, we propose that Hippocampal place cells might implement such an error correction mechanism by integrating different sources of information in an approximately Bayes-optimal fashion. We compare the predictions of our model with physiological data from rats. Our results suggest that useful predictions regarding the firing fields of place cells can be made based on a single underlying principle, Bayesian cue integration, and that such predictions are possible using a remarkably small number of model parameters.	[Madl, Tamas; Chen, Ke] Univ Manchester, Sch Comp Sci, Manchester, Lancs, England; [Franklin, Stan] Univ Memphis, Inst Intelligent Syst, Memphis, TN 38152 USA; [Montaldi, Daniela] Univ Manchester, Sch Psychol Sci, Manchester, Lancs, England; [Madl, Tamas; Trappl, Robert] Austrian Res Inst Artificial Intelligence, Vienna, Austria	University of Manchester; University of Memphis; University of Manchester	Madl, T (corresponding author), Univ Manchester, Sch Comp Sci, Manchester, Lancs, England.	tamas.madl@gmail.com	, Ke/ABG-5874-2020; Chen, Ke/C-2560-2008; Franklin, Stan/AAI-5506-2020	Chen, Ke/0000-0001-9457-9364; 	EPSRC [EP/I028099/1]; FWF [P25380-N23]; Austrian Science Fund (FWF) [P 25380] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); FWF(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This research was supported by EPSRC grant EP/I028099/1 (Engineering and Physical Sciences Research Council, http://www.epsrc.ac.uk), and FWF grant P25380-N23 (Austrian Science Fund, http://www.fwf.ac.at/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed OJ, 2009, TRENDS NEUROSCI, V32, P329, DOI 10.1016/j.tins.2009.01.009; AMARAL DG, 1990, PROG BRAIN RES, V83, P1; Azzalini A, 2005, SCAND J STAT, V32, P159, DOI 10.1111/j.1467-9469.2005.00426.x; Barry C, 2006, REV NEUROSCIENCE, V17, P71; Barry Caswell, 2012, Neural Syst Circuits, V2, P6, DOI 10.1186/2042-1001-2-6; Baumann O, 2010, J NEUROSCI, V30, P12897, DOI 10.1523/JNEUROSCI.3077-10.2010; Bird CM, 2008, NAT REV NEUROSCI, V9, P182, DOI 10.1038/nrn2335; Bonnevie T, 2013, NAT NEUROSCI, V16, P309, DOI 10.1038/nn.3311; Brette R, 2007, J COMPUT NEUROSCI, V23, P349, DOI 10.1007/s10827-007-0038-6; Brette R, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002561; Bromiley P. A., 2003, 2003003 U MANCH MED, V3; Brun VH, 2008, HIPPOCAMPUS, V18, P1200, DOI 10.1002/hipo.20504; Buesing L, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002211; Buhl EH, 1996, HIPPOCAMPUS, V6, P294; Burgess N, 2008, ANN NY ACAD SCI, V1124, P77, DOI 10.1196/annals.1440.002; Burgess N, 2007, HIPPOCAMPUS, V17, P801, DOI 10.1002/hipo.20327; Burgess N, 2011, CURR OPIN NEUROBIOL, V21, P734, DOI 10.1016/j.conb.2011.07.002; Burke SN, 2011, HIPPOCAMPUS, V21, P783, DOI 10.1002/hipo.20929; Canto C, 2008, NEURAL PLASTICITY, V2008; Cheng K, 1998, SPATIAL REPRESENTATION IN ANIMALS, P1; Cheng K, 2007, PSYCHOL BULL, V133, P625, DOI 10.1037/0033-2909.133.4.625; Cheung A, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002651; Colombo M, 2012, BRIT J PHILOS SCI, V63, P697, DOI 10.1093/bjps/axr043; Deneve S, 2008, NEURAL COMPUT, V20, P91, DOI 10.1162/neco.2008.20.1.91; Deshmukh SS, 2013, HIPPOCAMPUS, V23, P253, DOI 10.1002/hipo.22101; Dickson CT, 2002, HIPPOCAMPUS, V12, P447, DOI 10.1002/hipo.10013; Dickson CT, 2000, ANN NY ACAD SCI, V911, P127; Doeller CF, 2012, NEUROSCIENTIST, V18, P556, DOI 10.1177/1073858411422115; Durrant-Whyte H, 2006, IEEE ROBOT AUTOM MAG, V13, P99, DOI 10.1109/MRA.2006.1638022; Ekstrom AD, 2003, NATURE, V425, P184, DOI 10.1038/nature01964; Engel TA, 2008, J NEUROPHYSIOL, V100, P1576, DOI 10.1152/jn.01282.2007; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Etienne AS, 1996, J EXP BIOL, V199, P201; Fiser J, 2010, TRENDS COGN SCI, V14, P119, DOI 10.1016/j.tics.2010.01.003; Fox C. W., 2010, IJCNN, P1, DOI DOI 10.1109/IJCNN.2010.5596681; Goodman DFM, 2009, FRONT NEUROSCI-SWITZ, V3, P192, DOI 10.3389/neuro.01.026.2009; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hancock PA., 1985, MOTOR BEHAV PROGRAMM, P153, DOI [DOI 10.1007/978-3-642-69749-4_5, 10.1007/978-3-642-69749-4_5]; Hartley T, 2000, HIPPOCAMPUS, V10, P369, DOI 10.1002/1098-1063(2000)10:4<369::AID-HIPO3>3.0.CO;2-0; Harvey CD, 2009, NATURE, V461, P941, DOI 10.1038/nature08499; Hasselmo ME, 2008, HIPPOCAMPUS, V18, P1213, DOI 10.1002/hipo.20512; Hoppensteadt F. C., 1997, APPL MATH SCI, V126; Hoyer PO, 2003, ADV NEURAL INFORM PR, V15, P293; Jarsky T, 2005, NAT NEUROSCI, V8, P1667, DOI 10.1038/nn1599; Jeffery KJ, 2007, CURR OPIN NEUROBIOL, V17, P684, DOI 10.1016/j.conb.2007.11.008; Joseph D, 2011, FRONTIERS COMPUTATIO, V5; Kajiwara R, 2008, HIPPOCAMPUS, V18, P266, DOI 10.1002/hipo.20385; Katz Y, 2007, PLOS COMPUT BIOL, V3, P2432, DOI 10.1371/journal.pcbi.0030234; Knill DC, 2004, TRENDS NEUROSCI, V27, P712, DOI 10.1016/j.tins.2004.10.007; Koch C, 2000, NAT NEUROSCI, V3, P1171, DOI 10.1038/81444; Kording KP, 2004, J NEUROPHYSIOL, V92, P3161, DOI 10.1152/jn.00275.2004; Lee I, 2004, NATURE, V430, P456, DOI 10.1038/nature02739; Lee SA, 2012, COGNITION, V123, P144, DOI 10.1016/j.cognition.2011.12.015; Lee TS, 2003, J OPT SOC AM A, V20, P1434, DOI 10.1364/JOSAA.20.001434; Lever C, 2009, J NEUROSCI, V29, P9771, DOI 10.1523/JNEUROSCI.1319-09.2009; Lisman J, 2009, PHILOS T R SOC B, V364, P1193, DOI 10.1098/rstb.2008.0316; Ma WJ, 2008, CURR OPIN NEUROBIOL, V18, P217, DOI 10.1016/j.conb.2008.07.004; Ma WJ, 2006, NAT NEUROSCI, V9, P1432, DOI 10.1038/nn1790; MacNeilage PR, 2008, J NEUROPHYSIOL, V100, P2981, DOI 10.1152/jn.90677.2008; Markus E, 2004, HIPPOCAMPUS, V4, P410; Maurer AP, 2005, HIPPOCAMPUS, V15, P841, DOI 10.1002/hipo.20114; McNaughton BL, 1996, J EXP BIOL, V199, P173; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; Mehta MR, 2000, NEURON, V25, P707, DOI 10.1016/S0896-6273(00)81072-7; Montaldi D, 2010, HIPPOCAMPUS, V20, P1291, DOI 10.1002/hipo.20853; Moser EI, 2008, ANNU REV NEUROSCI, V31, P69, DOI 10.1146/annurev.neuro.31.061307.090723; Myung IJ, 1997, PSYCHON B REV, V4, P79, DOI 10.3758/BF03210778; Myung IJ, 2005, HDB COGNITION, P422; Nardini M, 2008, CURR BIOL, V18, P689, DOI 10.1016/j.cub.2008.04.021; Negenborn R., 2003, THESIS UTRECHT U; Nezis P, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/3/034005; O'Keefe J, 2005, HIPPOCAMPUS, V15, P853, DOI 10.1002/hipo.20115; Odobescu R, 2010, THESIS UCL; Okada K, 2011, IEEE IND ELEC; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OKeefe J, 1996, NATURE, V381, P425, DOI 10.1038/381425a0; Pfuhl G, 2011, B MATH BIOL, V73, P951, DOI 10.1007/s11538-010-9547-y; Prusky GT, 2000, VISION RES, V40, P2201, DOI 10.1016/S0042-6989(00)00081-X; QUIRK GJ, 1990, J NEUROSCI, V10, P2008; Rao RPN, 2004, NEURAL COMPUT, V16, P1, DOI 10.1162/08997660460733976; Rapp PR, 1996, P NATL ACAD SCI USA, V93, P9926, DOI 10.1073/pnas.93.18.9926; Regier T, 2003, ENCY COGNITIVE SCI, P611; Rossant C, 2011, J NEUROSCI, V31, P17193, DOI 10.1523/JNEUROSCI.2482-11.2011; Samu D, 2009, BIOL CYBERN, V101, P19, DOI 10.1007/s00422-009-0311-z; Shadlen MN, 1996, J NEUROSCI, V16, P1486; Sheynikhovich D, 2009, PSYCHOL REV, V116, P540, DOI 10.1037/a0016170; Solstad T, 2006, HIPPOCAMPUS, V16, P1026, DOI 10.1002/hipo.20244; Solstad T, 2008, SCIENCE, V322, P1865, DOI 10.1126/science.1166466; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Sreenivasan S, 2011, NAT NEUROSCI, V14, P1330, DOI 10.1038/nn.2901; Stocker AA, 2006, NAT NEUROSCI, V9, P578, DOI 10.1038/nn1669; Takahashi H, 2009, NEURON, V62, P102, DOI 10.1016/j.neuron.2009.03.007; Taube JS, 2007, ANNU REV NEUROSCI, V30, P181, DOI 10.1146/annurev.neuro.29.051605.112854; Witter M, 2011, SCHOLARPEDIA J, V6, P4380, DOI DOI 10.4249/SCHOLARPEDIA.4380; Yang T, 2007, NATURE, V447, P1075, DOI 10.1038/nature05852; Yoshioka J.G., 1929, U CALIFORNIA PUBLICA, V4, P155; YOUNG BJ, 1994, J NEUROSCI, V14, P6553; Zemankovics R, 2010, J PHYSIOL-LONDON, V588, P2109, DOI 10.1113/jphysiol.2009.185975; Zemel RS, 1998, NEURAL COMPUT, V10, P403, DOI 10.1162/089976698300017818; Zilli EA, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00016	101	19	20	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e89762	10.1371/journal.pone.0089762	http://dx.doi.org/10.1371/journal.pone.0089762			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603429	gold, Green Published, Green Submitted			2022-12-27	WOS:000332483600021
J	Monecke, T; Buschmann, J; Neumann, P; Wahle, E; Ficner, R				Monecke, Thomas; Buschmann, Juliane; Neumann, Piotr; Wahle, Elmar; Ficner, Ralf			Crystal Structures of the Novel Cytosolic 5 '-Nucleotidase IIIB Explain Its Preference for m(7)GMP	PLOS ONE			English	Article							PYRIMIDINE 5'-NUCLEOTIDASE; SUBSTRATE-SPECIFICITY; INSIGHTS; PROTEIN; 7-METHYLGUANINE; IDENTIFICATION; RECOGNITION; NUCLEOTIDE; SYSTEM; PYTHON	5'-nucleotidases catalyze the hydrolytic dephosphorylation of nucleoside monophosphates. As catabolic enzymes they contribute significantly to the regulation of cellular nucleotide levels; misregulation of nucleotide metabolism and nucleotidase deficiencies are associated with a number of diseases. The seven human 5'-nucleotidases differ with respect to substrate specificity and cellular localization. Recently, the novel cytosolic 5'-nucleotidase III-like protein, or cN-IIIB, has been characterized in human and Drosophila. cN-IIIB exhibits a strong substrate preference for the modified nucleotide 7-methylguanosine monophosphate but the structural reason for this preference was unknown. Here, we present crystal structures of cN-IIIB from Drosophila melanogaster bound to the reaction products 7-methylguanosine or cytidine. The structural data reveal that the cytosine-and 7-methylguanine moieties of the products are stacked between two aromatic residues in a coplanar but off-centered position. 7-methylguanosine is specifically bound through p-p interactions and distinguished from unmodified guanosine by additional cation-p coulomb interactions between the aromatic side chains and the positively charged 7-methylguanine. Notably, the base is further stabilized by T-shaped edge-to-face stacking of an additional tryptophan packing perpendicularly against the purine ring and forming, together with the other aromates, an aromatic slot. The structural data in combination with site-directed mutagenesis experiments reveal the molecular basis for the broad substrate specificity of cN-IIIB but also explain the substrate preference for 7-methylguanosine monophosphate. Analyzing the substrate specificities of cN-IIIB and the main pyrimidine 59-nucleotidase cN-IIIA by mutagenesis studies, we show that cN-IIIA dephosphorylates the purine m(7)GMP as well, hence redefining its substrate spectrum. Docking calculations with cN-IIIA and m(7)GMP as well as biochemical data reveal that Asn69 does not generally exclude the turnover of purine substrates thus correcting previous suggestions.	[Monecke, Thomas; Neumann, Piotr; Ficner, Ralf] Univ Gottingen, Inst Mikrobiol & Genet, Gottinger Zentrum Mol Biowissensch, Abt Mol Strukturbiol, D-37073 Gottingen, Germany; [Buschmann, Juliane; Wahle, Elmar] Univ Halle Wittenberg, Inst Biochem & Biotechnol, D-06108 Halle, Saale, Germany	University of Gottingen; Martin Luther University Halle Wittenberg	Monecke, T (corresponding author), Univ Gottingen, Inst Mikrobiol & Genet, Gottinger Zentrum Mol Biowissensch, Abt Mol Strukturbiol, D-37073 Gottingen, Germany.	tmoneck@uni-goettingen.de		Wahle, Elmar/0000-0003-2504-0677	Gottingen University; DFG	Gottingen University; DFG(German Research Foundation (DFG))	Synchrotron data collection was supported by the Helmholtz-Zentrum Berlin. The authors acknowledge support by the Open Access Publication Funds of the Gottingen University, and EW acknowledges support by the DFG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Allegrin S, 2001, J BIOL CHEM, V276, P33526, DOI 10.1074/jbc.M104088200; Allegrini S, 2004, EUR J BIOCHEM, V271, P4881, DOI 10.1111/j.1432-1033.2004.04457.x; Amici A, 2005, CELL MOL LIFE SCI, V62, P1613, DOI 10.1007/s00018-005-5135-y; Amici A, 2002, ARCH BIOCHEM BIOPHYS, V397, P184, DOI 10.1006/abbi.2001.2676; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P127, DOI 10.1016/S0968-0004(98)01189-X; Baxter NJ, 2008, J AM CHEM SOC, V130, P3952, DOI 10.1021/ja078000n; Bianchi V, 2003, J BIOL CHEM, V278, P46195, DOI 10.1074/jbc.R300032200; Bitto E, 2006, J BIOL CHEM, V281, P20521, DOI 10.1074/jbc.M602000200; Bosse-Doenecke E, 2008, PROTEIN EXPRES PURIF, V58, P114, DOI 10.1016/j.pep.2007.10.012; Burroughs AM, 2006, J MOL BIOL, V361, P1003, DOI 10.1016/j.jmb.2006.06.049; Buschmann J, 2013, J BIOL CHEM, V288, P2441, DOI 10.1074/jbc.M112.426700; Cliff MJ, 2010, J AM CHEM SOC, V132, P6507, DOI 10.1021/ja100974t; Collet JF, 1998, J BIOL CHEM, V273, P14107, DOI 10.1074/jbc.273.23.14107; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Grobosky CL, 2012, J MOL BIOL, V423, P540, DOI 10.1016/j.jmb.2012.08.014; HENDLER S, 1970, BIOCHEMISTRY-US, V9, P4141, DOI 10.1021/bi00823a017; Heuts DPHM, 2012, CHEMBIOCHEM, V13, P2384, DOI 10.1002/cbic.201200426; Hokari S, 1998, BIOL CHEM, V379, P329, DOI 10.1515/bchm.1998.379.3.329; Hsu PC, 2000, BIOCHEMISTRY-US, V39, P13730, DOI 10.1021/bi000623p; Hunsucker SA, 2005, PHARMACOL THERAPEUT, V107, P1, DOI 10.1016/j.pharmthera.2005.01.003; Jordheim LP, 2013, BIOCHEM PHARMACOL, V85, P497, DOI 10.1016/j.bcp.2012.11.024; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Knapp K, 2012, STRUCTURE, V20, P2161, DOI 10.1016/j.str.2012.10.001; Lahiri SD, 2003, SCIENCE, V299, P2067, DOI 10.1126/science.1082710; Machnicka MA, 2013, NUCLEIC ACIDS RES, V41, pD262, DOI 10.1093/nar/gks1007; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Mueller U, 2012, J SYNCHROTRON RADIAT, V19, P442, DOI 10.1107/S0909049512006395; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rampazzo C, 2010, MUTAT RES-GEN TOX EN, V703, P2, DOI 10.1016/j.mrgentox.2010.06.002; Reaves ML, 2013, NATURE, V500, P237, DOI 10.1038/nature12445; Rees DC, 2003, BRIT J HAEMATOL, V120, P375, DOI 10.1046/j.1365-2141.2003.03980.x; Reichard P, 2010, BIOCHEM BIOPH RES CO, V396, P19, DOI 10.1016/j.bbrc.2010.02.108; Rinaldo-Matthis A, 2002, NAT STRUCT BIOL, V9, P779, DOI 10.1038/nsb846; Ruszczynska K, 2003, BIOPHYS J, V85, P1450, DOI 10.1016/S0006-3495(03)74577-9; Sambrook J., 2001, MOL CLONING; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; Song MG, 2013, RNA, V19, P390, DOI 10.1261/rna.037309.112; Strasser A, 2005, EMBO J, V24, P2235, DOI 10.1038/sj.emboj.7600701; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; VALENTINE WN, 1974, J CLIN INVEST, V54, P866, DOI 10.1172/JCI107826; van Dijk E, 2002, EMBO J, V21, P6915, DOI 10.1093/emboj/cdf678; Wallden K, 2005, STRUCTURE, V13, P1081, DOI 10.1016/j.str.2005.04.023; Wallden K, 2007, BIOCHEMISTRY-US, V46, P13809, DOI 10.1021/bi7014794; Wallden K, 2007, J BIOL CHEM, V282, P17828, DOI 10.1074/jbc.M700917200; Wallden K, 2011, J MOL BIOL, V408, P684, DOI 10.1016/j.jmb.2011.02.059; Wang ZR, 2002, P NATL ACAD SCI USA, V99, P12663, DOI 10.1073/pnas.192445599; Wang ZZ, 2001, CELL, V107, P12; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	50	14	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90915	10.1371/journal.pone.0090915	http://dx.doi.org/10.1371/journal.pone.0090915			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603684	Green Published, gold, Green Submitted			2022-12-27	WOS:000332483600105
J	Syamsunarno, MRAA; Iso, T; Yamaguchi, A; Hanaoka, H; Putri, M; Obokata, M; Sunaga, H; Koitabashi, N; Matsui, H; Maeda, K; Endo, K; Tsushima, Y; Yokoyama, T; Kurabayashi, M				Syamsunarno, Mas Rizky A. A.; Iso, Tatsuya; Yamaguchi, Aiko; Hanaoka, Hirofumi; Putri, Mirasari; Obokata, Masaru; Sunaga, Hiroaki; Koitabashi, Norimichi; Matsui, Hiroki; Maeda, Kazuhisa; Endo, Keigo; Tsushima, Yoshito; Yokoyama, Tomoyuki; Kurabayashi, Masahiko			Fatty Acid Binding Protein 4 and 5 Play a Crucial Role in Thermogenesis under the Conditions of Fasting and Cold Stress	PLOS ONE			English	Article							BROWN ADIPOSE-TISSUE; INSULIN-RESISTANCE; BETA-OXIDATION; ENDOTHELIAL DYSFUNCTION; ENERGY-EXPENDITURE; OBESITY; MICE; EXPOSURE; DOMINANT; HUMANS	Hypothermia is rapidly induced during cold exposure when thermoregulatory mechanisms, including fatty acid (FA) utilization, are disturbed. FA binding protein 4 (FABP4) and FABP5, which are abundantly expressed in adipose tissues and macrophages, have been identified as key molecules in the pathogenesis of overnutrition-related diseases, such as insulin resistance and atherosclerosis. We have recently shown that FABP4/5 are prominently expressed in capillary endothelial cells in the heart and skeletal muscle and play a crucial role in FA utilization in these tissues. However, the role of FABP4/5 in thermogenesis remains to be determined. In this study, we showed that thermogenesis is severely impaired in mice lacking both FABP4 and FABP5 (DKO mice), as manifested shortly after cold exposure during fasting. In DKO mice, the storage of both triacylglycerol in brown adipose tissue (BAT) and glycogen in skeletal muscle (SkM) was nearly depleted after fasting, and a biodistribution analysis using I-125-BMIPP revealed that non-esterified FAs (NEFAs) are not efficiently taken up by BAT despite the robustly elevated levels of serum NEFAs. In addition to the severe hypoglycemia observed in DKO mice during fasting, cold exposure did not induce the uptake of glucose analogue F-18-FDG by BAT. These findings strongly suggest that DKO mice exhibit pronounced hypothermia after fasting due to the depletion of energy storage in BAT and SkM and the reduced supply of energy substrates to these tissues. In conclusion, FABP4/5 play an indispensable role in thermogenesis in BAT and SkM. Our study underscores the importance of FABP4/5 for overcoming life-threatening environments, such as cold and starvation.	[Syamsunarno, Mas Rizky A. A.; Iso, Tatsuya; Putri, Mirasari; Obokata, Masaru; Koitabashi, Norimichi; Kurabayashi, Masahiko] Gunma Univ, Grad Sch Med, Dept Med & Biol Sci, Gunma, Japan; [Iso, Tatsuya; Kurabayashi, Masahiko] Gunma Univ, Grad Sch Med, Educ & Res Support Ctr, Gunma, Japan; [Yamaguchi, Aiko; Endo, Keigo] Gunma Univ, Grad Sch Med, Dept Bioimaging Informat Anal, Gunma, Japan; [Tsushima, Yoshito] Gunma Univ, Grad Sch Med, Dept Diagnost Radiol & Nucl Med, Gunma, Japan; [Putri, Mirasari] Gunma Univ, Grad Sch Med, Dept Publ Hlth, Gunma, Japan; [Sunaga, Hiroaki; Matsui, Hiroki; Yokoyama, Tomoyuki] Gunma Univ, Grad Sch Hlth Sci, Dept Lab Sci, Gunma, Japan; [Hanaoka, Hirofumi] Chiba Univ, Grad Sch Pharmaceut Sci, Dept Mol Imaging & Radiotherapy, Chiba, Japan; [Maeda, Kazuhisa] Osaka Univ Hosp, Grad Sch Med, Dept Complementary & Alternat Med, Osaka 553, Japan	Gunma University; Gunma University; Gunma University; Gunma University; Gunma University; Gunma University; Chiba University; Osaka University	Syamsunarno, MRAA (corresponding author), Gunma Univ, Grad Sch Med, Dept Med & Biol Sci, Gunma, Japan.	isot@gunma-u.ac.jp	Koitabashi, Norimichi/AAM-8788-2020; Hanaoka, Hirofumi/T-6261-2019; Yamaguchi, Aiko/AAJ-1588-2021; Matsui, Hiroki/P-4033-2019; Putri, Mirasari/AAB-5217-2021	Hanaoka, Hirofumi/0000-0003-2421-7397; Matsui, Hiroki/0000-0003-3243-333X; Putri, Mirasari/0000-0003-0520-1373; Yamaguchi, Aiko/0000-0002-7631-3164; Iso, Tatsuya/0000-0001-5045-1676; Obokata, Masaru/0000-0002-5473-0688	Japan Society for the Promotion of Science; Japan Cardiovascular Foundation; Takeda Science Foundation; Therapeutic Research for Metabolic Syndrome; Astra Zeneca; Vehicle Racing Commemorative Foundation; Grants-in-Aid for Scientific Research [25504002] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Cardiovascular Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Therapeutic Research for Metabolic Syndrome; Astra Zeneca(AstraZeneca); Vehicle Racing Commemorative Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (to MK and TI); a grant from the Japan Cardiovascular Foundation (to MK); and grants from the Takeda Science Foundation, Therapeutic Research for Metabolic Syndrome, Astra Zeneca, and the Vehicle Racing Commemorative Foundation (to TI). The listed funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerni-Flessner L, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-63; Baba S, 2007, J NUCL MED, V48, P1715, DOI 10.2967/jnumed.107.041715; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Boucher J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1905; Ellis JM, 2010, CELL METAB, V12, P53, DOI 10.1016/j.cmet.2010.05.012; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Furuhashi M, 2007, NATURE, V447, P959, DOI 10.1038/nature05844; Garcia-Arcos I, 2013, J BIOL CHEM, V288, P14046, DOI 10.1074/jbc.M113.469270; Goto K, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.004861; Guerra C, 1998, J CLIN INVEST, V102, P1724, DOI 10.1172/JCI4532; Hagberg CE, 2012, NATURE, V490, P426, DOI 10.1038/nature11464; Hagberg CE, 2010, NATURE, V464, P917, DOI 10.1038/nature08945; Haman F, 2006, J APPL PHYSIOL, V100, P1702, DOI 10.1152/japplphysiol.01088.2005; Haman F, 2005, J PHYSIOL-LONDON, V566, P247, DOI 10.1113/jphysiol.2005.086272; Hotamisligil GS, 1996, SCIENCE, V274, P1377, DOI 10.1126/science.274.5291.1377; Houten SM, 2010, J INHERIT METAB DIS, V33, P469, DOI 10.1007/s10545-010-9061-2; Iso T, 2013, ARTERIOSCLER THROMB; Kanda T, 2009, J CLIN INVEST, V119, P110, DOI 10.1172/JCI36233; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Klingenspor M, 2003, EXP PHYSIOL, V88, P141, DOI 10.1113/eph8802508; Maeda K, 2005, CELL METAB, V1, P107, DOI 10.1016/j.cmet.2004.12.008; Maeda K, 2003, DIABETES, V52, P300, DOI 10.2337/diabetes.52.2.300; Meigs JB, 2004, JAMA-J AM MED ASSOC, V291, P1978, DOI 10.1001/jama.291.16.1978; Miinalainen IJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000543; Ouellet V, 2012, J CLIN INVEST, V122, P545, DOI 10.1172/JCI60433; Schuler AM, 2005, MOL GENET METAB, V85, P7, DOI 10.1016/j.ymgme.2004.09.006; Schulz TJ, 2013, NATURE, V495, P379, DOI 10.1038/nature11943; Spiekerkoetter U, 2010, J INHERIT METAB DIS, V33, P539, DOI 10.1007/s10545-010-9121-7; Steinberg HO, 1996, J CLIN INVEST, V97, P2601, DOI 10.1172/JCI118709; Syamsunarno MR, 2013, PLOS ONE IN PRESS; Tolwani RJ, 2005, PLOS GENET, V1, P205, DOI 10.1371/journal.pgen.0010023; Vergnes L, 2011, J BIOL CHEM, V286, P380, DOI 10.1074/jbc.M110.184754; Yamamoto T, 2011, BIOTECHNOL LETT, V33, P237, DOI 10.1007/s10529-010-0444-0; Yamashita H, 2008, BIOCHEM BIOPH RES CO, V377, P632, DOI 10.1016/j.bbrc.2008.10.041; Yoneshiro T, 2011, OBESITY, V19, P13, DOI 10.1038/oby.2010.105	35	25	27	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90825	10.1371/journal.pone.0090825	http://dx.doi.org/10.1371/journal.pone.0090825			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603714	Green Submitted, Green Published, gold			2022-12-27	WOS:000332483600089
J	Gorman, KB; Williams, TD; Fraser, WR				Gorman, Kristen B.; Williams, Tony D.; Fraser, William R.			Ecological Sexual Dimorphism and Environmental Variability within a Community of Antarctic Penguins (Genus Pygoscelis)	PLOS ONE			English	Article							STABLE-ISOTOPES; CLIMATE-CHANGE; WINTER DISTRIBUTION; SIZE DIMORPHISM; GENTOO PENGUINS; SEA-ICE; SEGREGATION; SPECIALIZATION; NITROGEN; CARBON	Background: Sexual segregation in vertebrate foraging niche is often associated with sexual size dimorphism (SSD), i.e., ecological sexual dimorphism. Although foraging behavior of male and female seabirds can vary markedly, differences in isotopic (carbon, delta C-13 and nitrogen, delta N-15) foraging niche are generally more pronounced within sexually dimorphic species and during phases when competition for food is greater. We examined ecological sexual dimorphism among sympatric nesting Pygoscelis penguins asking whether environmental variability is associated with differences in male and female pre-breeding foraging niche. We predicted that all Pygoscelis species would forage sex-specifically, and that higher quality winter habitat, i.e., higher or lower sea ice coverage for a given species, would be associated with a more similar foraging niche among the sexes. Results: P2/P8 primers reliably amplified DNA of all species. On average, male Pygoscelis penguins are structurally larger than female conspecifics. However, chinstrap penguins were more sexually dimorphic in culmen and flipper features than Adelie and gentoo penguins. Adelies and gentoos were more sexually dimorphic in body mass than chinstraps. Only male and female chinstraps and gentoos occupied separate delta N-15 foraging niches. Strong year effects in delta N-15 signatures were documented for all three species, however, only for Adelies, did yearly variation in delta N-15 signatures tightly correlate with winter sea ice conditions. There was no evidence that variation in sex-specific foraging niche interacted with yearly winter habitat quality. Conclusion: Chinstraps were most sexually size dimorphic followed by gentoos and Adelies. Pre-breeding sex-specific foraging niche was associated with overall SSD indices across species; male chinstrap and gentoo penguins were enriched in delta N-15 relative to females. Our results highlight previously unknown trophic pathways that link Pygoscelis penguins with variation in Southern Ocean sea ice suggesting that each sex within a species should respond similarly in pre-breeding trophic foraging to changes in future winter habitat.	[Gorman, Kristen B.; Williams, Tony D.] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada; [Gorman, Kristen B.; Fraser, William R.] Polar Oceans Res Grp, Sheridan, MT USA	Simon Fraser University	Gorman, KB (corresponding author), Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada.	kgorman@sfu.ca		Chiaradia, Andre/0000-0002-6178-4211; Gorman, Kristen B./0000-0002-0258-9264	Palmer Station, Antarctica, Long-Term Ecological Research (LTER) program through the National Science Foundation (NSF), Office of Polar Programs (OPP) [0217282, 0823101]; NSF-OPP; SFU Graduate Fellowships; Glen Geen Graduate Scholarship in Marine Biology; Canada Natural Sciences and Engineering Research Council Discovery Grants;  [0741351]; Directorate For Geosciences [1440435] Funding Source: National Science Foundation	Palmer Station, Antarctica, Long-Term Ecological Research (LTER) program through the National Science Foundation (NSF), Office of Polar Programs (OPP); NSF-OPP(National Science Foundation (NSF)); SFU Graduate Fellowships; Glen Geen Graduate Scholarship in Marine Biology; Canada Natural Sciences and Engineering Research Council Discovery Grants; ; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Research was conducted as part of the Palmer Station, Antarctica, Long-Term Ecological Research (LTER) program (http://pal.lternet.edu) supported by grants #0217282 and #0823101 through the National Science Foundation (NSF), Office of Polar Programs (OPP) to WRF. Supplemental funds for this project were received by a separate grant #0741351 to WRF, also funded by NSF-OPP. KBG was partially supported by SFU Graduate Fellowships and the Glen Geen Graduate Scholarship in Marine Biology, in addition to Canada Natural Sciences and Engineering Research Council Discovery Grants to TDW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainley D.G., 2002, ADELIE PENGUIN BELLW, DOI DOI 10.7312/AINL12306; Andersson Malte, 1994; Baker AJ, 2006, P ROY SOC B-BIOL SCI, V273, P11, DOI 10.1098/rspb.2005.3260; Ballard G, 2010, ECOLOGY, V91, P2056, DOI 10.1890/09-0688.1; Bearhop S, 2002, PHYSIOL BIOCHEM ZOOL, V75, P451, DOI 10.1086/342800; Bearhop S, 2006, MAR ECOL PROG SER, V311, P157, DOI 10.3354/meps311157; Bertellotti M, 2002, WATERBIRDS, V25, P479, DOI 10.1675/1524-4695(2002)025[0479:DSOMPU]2.0.CO;2; Bestelmeyer BT, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00216.1; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Bost CA, 2009, BIOL LETTERS, V5, P473, DOI 10.1098/rsbl.2009.0265; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Chapman EW, 2010, DEEP-SEA RES PT II, V57, P543, DOI 10.1016/j.dsr2.2009.10.005; Cherel Y, 2007, J ANIM ECOL, V76, P826, DOI 10.1111/j.1365-2656.2007.01238.x; Clarke J, 2003, MAR ECOL PROG SER, V248, P267, DOI 10.3354/meps248267; Comiso J. C., 1999, BOOTSTRAP SEA ICE CO; Conradt Larissa, 2005, P11; Costantini V, 2008, ANIM REPROD SCI, V106, P162, DOI 10.1016/j.anireprosci.2007.12.013; Crawley M.J., 2007, R BOOK; Dall SRX, 2012, ECOL LETT, V15, P1189, DOI 10.1111/j.1461-0248.2012.01846.x; Darwin C., 1871, P423; Dehnhard N, 2011, POLAR BIOL, V34, P1763, DOI 10.1007/s00300-011-1026-x; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; Ducklow HW, 2007, PHILOS T R SOC B, V362, P67, DOI 10.1098/rstb.2006.1955; Ducklow HW, 2013, OCEANOGRAPHY, V26, P190, DOI 10.5670/oceanog.2013.62; Dunn MJ, 2011, POLAR BIOL, V34, P205, DOI 10.1007/s00300-010-0870-4; Fairbairn DJ, 1997, ANNU REV ECOL SYST, V28, P659, DOI 10.1146/annurev.ecolsys.28.1.659; FAIRBAIRN J, 1993, OIKOS, V68, P139, DOI 10.2307/3545319; Fargallo JA, 2004, POLAR BIOL, V27, P339, DOI 10.1007/s00300-004-0596-2; Forcada J, 2009, GLOBAL CHANGE BIOL, V15, P1618, DOI 10.1111/j.1365-2486.2009.01909.x; Forero MG, 2005, MAR ECOL PROG SER, V296, P107, DOI 10.3354/meps296107; Forero MG, 2002, MAR ECOL PROG SER, V234, P289, DOI 10.3354/meps234289; FRASER WR, 1992, POLAR BIOL, V11, P525; Fridolfsson AK, 1999, J AVIAN BIOL, V30, P116, DOI 10.2307/3677252; Gauthreaux S.A. Jr, 1978, Perspectives in Ethology, V3, P17; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; Hart T, 2009, WATERBIRDS, V32, P437, DOI 10.1675/063.032.0309; HOBSON KA, 1992, CONDOR, V94, P181, DOI 10.2307/1368807; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Inger R, 2008, IBIS, V150, P447, DOI 10.1111/j.1474-919X.2008.00839.x; Jacobs SS, 1997, J CLIMATE, V10, P697, DOI 10.1175/1520-0442(1997)010<0697:CVITAA>2.0.CO;2; Kelly JF, 2000, CAN J ZOOL, V78, P1, DOI 10.1139/cjz-78-1-1; LANDE R, 1980, EVOLUTION, V34, P292, DOI [10.2307/2407393, 10.1111/j.1558-5646.1980.tb04817.x]; Lewis S, 2002, P ROY SOC B-BIOL SCI, V269, P1687, DOI 10.1098/rspb.2002.2083; LOVICH JE, 1992, GROWTH DEVELOP AGING, V56, P269; Lynch HJ, 2012, ECOLOGY, V93, P1367; Moline MA, 2008, ANN NY ACAD SCI, V1134, P267, DOI 10.1196/annals.1439.010; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Phillips RA, 2004, P ROY SOC B-BIOL SCI, V271, P1283, DOI 10.1098/rspb.2004.2718; Phillips RA, 2011, MAR BIOL, V158, P2199, DOI 10.1007/s00227-011-1725-4; Pinet P, 2012, ANIM BEHAV, V83, P979, DOI 10.1016/j.anbehav.2012.01.019; Polito Michael J., 2012, Marine Ornithology, V40, P89; Polito MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026642; Polito MJ, 2011, MAR ECOL PROG SER, V421, P265, DOI 10.3354/meps08863; R Core Team, 2012, R LANG ENV STAT COMP; Reis EC, 2011, GENET MOL RES, V10, P3731, DOI 10.4238/2011.December.5.7; Ruckstuhl K.E., 2005, SEXUAL SEGREGATION V; SHINE R, 1989, Q REV BIOL, V64, P419, DOI 10.1086/416458; SLATKIN M, 1984, EVOLUTION, V38, P622, DOI 10.1111/j.1558-5646.1984.tb00327.x; Smetacek V, 2005, NATURE, V437, P362, DOI 10.1038/nature04161; Smith TB, 1996, ANNU REV ECOL SYST, V27, P111, DOI 10.1146/annurev.ecolsys.27.1.111; Stammerjohn S, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL050874; Stammerjohn SE, 2008, DEEP-SEA RES PT II, V55, P2041, DOI 10.1016/j.dsr2.2008.04.026; Szekely Tamas, 2007, P27; Tanton JL, 2004, POLAR BIOL, V27, P299, DOI 10.1007/s00300-004-0592-6; Thiebot JB, 2012, ECOLOGY, V93, P122, DOI 10.1890/11-0385.1; Thiebot JB, 2011, MAR ECOL PROG SER, V421, P279, DOI 10.3354/meps08907; Trivelpiece WZ, 2007, POLAR BIOL, V30, P1231, DOI 10.1007/s00300-007-0283-1; Trivelpiece WZ, 2011, P NATL ACAD SCI USA, V108, P7625, DOI 10.1073/pnas.1016560108; Vaughan DG, 2003, CLIMATIC CHANGE, V60, P243, DOI 10.1023/A:1026021217991; Weimerskirch H, 2009, OECOLOGIA, V161, P637, DOI 10.1007/s00442-009-1397-7; WILLIAMS TD, 1990, J ZOOL, V222, P247, DOI 10.1111/j.1469-7998.1990.tb05675.x; Williams TD, 1995, PENGUINS SPHENISCIDA	74	23	23	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90081	10.1371/journal.pone.0090081	http://dx.doi.org/10.1371/journal.pone.0090081			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599330	Green Published, Green Submitted, gold			2022-12-27	WOS:000332479400042
J	Singh, S; Yang, GJ; Schluns, KS; Anthony, SM; Sastry, KJ				Singh, Shailbala; Yang, Guojun; Schluns, Kimberly S.; Anthony, Scott M.; Sastry, K. Jagannadha			Sublingual Vaccination Induces Mucosal and Systemic Adaptive Immunity for Protection against Lung Tumor Challenge	PLOS ONE			English	Article							KILLER T-CELLS; ANTIGEN IN-VIVO; ALPHA-GALACTOSYLCERAMIDE; NKT CELL; DENDRITIC CELLS; INTRANASAL; ADJUVANT; IMMUNIZATION; ACTIVATION; RESPONSES	Sublingual route offers a safer and more practical approach for delivering vaccines relative to other systemic and mucosal immunization strategies. Here we present evidence demonstrating protection against ovalbumin expressing B16 (B16-OVA) metastatic melanoma lung tumor formation by sublingual vaccination with the model tumor antigen OVA plus synthetic glycolipid alpha-galactosylceramide (aGalCer) for harnessing the adjuvant potential of natural killer T (NKT) cells, which effectively bridge innate and adaptive arms of the immune system. The protective efficacy of immunization with OVA plus aGalCer was antigen-specific as immunized mice challenged with parental B16 tumors lacking OVA expression were not protected. Multiple sublingual immunizations in the presence, but not in the absence of aGalCer, resulted in repeated activation of NKT cells in the draining lymph nodes, spleens, and lungs of immunized animals concurrent with progressively increasing OVA-specific CD8(+) T cell responses as well as serum IgG and vaginal IgA levels. Furthermore, sublingual administration of the antigen only in the presence of the aGalCer adjuvant effectively boosted the OVA-specific immune responses. These results support potential clinical utility of sublingual route of vaccination with aGalCer-for prevention of pulmonary metastases.	[Singh, Shailbala; Yang, Guojun; Schluns, Kimberly S.; Anthony, Scott M.; Sastry, K. Jagannadha] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Schluns, Kimberly S.; Anthony, Scott M.; Sastry, K. Jagannadha] Univ Texas Houston, Grad Sch Biomed Sci Houston, Grad Program Immunol, Houston, TX USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston	Sastry, KJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA.	jsastry@mdanderson.org	Schluns, Kimberly/R-5635-2019	Sastry, Jagannadha/0000-0002-6987-4422; Anthony, Scott/0000-0002-1590-7401	National Institutes of Health (NIH) [R21 AI078898]; NATIONAL CANCER INSTITUTE [P30CA016672, T32CA009598] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI078898] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) grant R21 AI078898. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostinis F, 2008, ALLERGY, V63, P1637, DOI 10.1111/j.1398-9995.2008.01742.x; Armstrong ME, 2005, J INFECT DIS, V192, P1628, DOI 10.1086/491739; Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608; Chang DH, 2005, J EXP MED, V201, P1503, DOI 10.1084/jem.20042592; Choi JH, 2012, MOL PHARMACEUT, V9, P156, DOI 10.1021/mp200392g; Courtney AN, 2011, EUR J IMMUNOL, V41, P3312, DOI 10.1002/eji.201041359; Courtney AN, 2009, VACCINE, V27, P3335, DOI 10.1016/j.vaccine.2009.01.083; Cuburu N, 2007, VACCINE, V25, P8598, DOI 10.1016/j.vaccine.2007.09.073; Czerkinsky C, 2011, HUM VACCINES, V7, P110, DOI 10.4161/hv.7.1.13739; Fraser CK, 2010, CANCER BIOL THER, V10, P715, DOI 10.4161/cbt.10.7.12926; Fujihashi K, 2002, VACCINE, V20, P2431, DOI 10.1016/S0264-410X(02)00155-X; Fujii S, 2003, J EXP MED, V198, P267, DOI 10.1084/jem.20030324; Gonzalez-Aseguinolaza G, 2002, J EXP MED, V195, P617, DOI 10.1084/jem.20011889; Guillonneau C, 2009, P NATL ACAD SCI USA, V106, P3330, DOI 10.1073/pnas.0813309106; Hermans IF, 2003, J IMMUNOL, V171, P5140, DOI 10.4049/jimmunol.171.10.5140; Hervouet C, 2013, MUCOSAL IMMUNOL; Hervouet C, 2010, VACCINE, V28, P5582, DOI 10.1016/j.vaccine.2010.06.033; Hovav AH, 2013, MUCOSAL IMMUNOL; Kamijuku H, 2008, MUCOSAL IMMUNOL, V1, P208, DOI 10.1038/mi.2008.2; Kunii N, 2009, CANCER SCI, V100, P1092, DOI 10.1111/j.1349-7006.2009.01135.x; Kweon MN, 2011, CYTOKINE, V54, P1, DOI 10.1016/j.cyto.2010.12.014; Lemiale F, 2003, J VIROL, V77, P10078, DOI 10.1128/JVI.77.18.10078-10087.2003; Leong SPL, 2006, CANCER METAST REV, V25, P221, DOI 10.1007/s10555-006-8502-8; Lycke N, 2012, NAT REV IMMUNOL, V12, P592, DOI 10.1038/nri3251; Mascarell L, 2009, CLIN EXP ALLERGY, V39, P1910, DOI 10.1111/j.1365-2222.2009.03337.x; Matsuo K, 2011, J CONTROL RELEASE, V152, P310, DOI 10.1016/j.jconrel.2011.03.009; Moon JH, 2012, LARYNGOSCOPE, V122, P2442, DOI 10.1002/lary.23257; Mutsch M, 2004, NEW ENGL J MED, V350, P896, DOI 10.1056/NEJMoa030595; Naz RK, 2012, J REPROD IMMUNOL, V93, P1, DOI 10.1016/j.jri.2011.09.005; Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Papamichail M, 2004, CANCER IMMUNOL IMMUN, V53, P176, DOI 10.1007/s00262-003-0478-4; Parekh VV, 2005, J CLIN INVEST, V115, P2572, DOI 10.1172/JCI24762; PATEL JK, 1978, AM J SURG, V135, P807, DOI 10.1016/0002-9610(78)90171-X; Pedersen GK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026973; Reilly EC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037991; Sandoval F., 2013, SCI TRANSL MED, V5; Seino K, 2004, FRONT BIOSCI-LANDMRK, V9, P2577, DOI 10.2741/1418; Silk JD, 2004, J CLIN INVEST, V114, P1800, DOI 10.1172/JCI200422046; Song JH, 2008, P NATL ACAD SCI USA, V105, P1644, DOI 10.1073/pnas.0708684105; Song JH, 2009, J IMMUNOL, V182, P6851, DOI 10.4049/jimmunol.0803568; Uldrich AP, 2005, J IMMUNOL, V175, P3092, DOI 10.4049/jimmunol.175.5.3092	42	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90001	10.1371/journal.pone.0090001	http://dx.doi.org/10.1371/journal.pone.0090001			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599269	Green Published, gold, Green Submitted			2022-12-27	WOS:000332479400039
J	Berthet, P; Lansner, A				Berthet, Pierre; Lansner, Anders			Optogenetic Stimulation in a Computational Model of the Basal Ganglia Biases Action Selection and Reward Prediction Error	PLOS ONE			English	Article							DOPAMINE NEURONS; CORTICOSTRIATAL SYNAPSES; DEPENDENT PLASTICITY; SYNAPTIC PLASTICITY; STRIATAL NEURONS; CORTEX; RAT; ORGANIZATION; VALUES; ROLES	Optogenetic stimulation of specific types of medium spiny neurons (MSNs) in the striatum has been shown to bias the selection of mice in a two choices task. This shift is dependent on the localisation and on the intensity of the stimulation but also on the recent reward history. We have implemented a way to simulate this increased activity produced by the optical flash in our computational model of the basal ganglia (BG). This abstract model features the direct and indirect pathways commonly described in biology, and a reward prediction pathway (RP). The framework is similar to Actor-Critic methods and to the ventral/ dorsal distinction in the striatum. We thus investigated the impact on the selection caused by an added stimulation in each of the three pathways. We were able to reproduce in our model the bias in action selection observed in mice. Our results also showed that biasing the reward prediction is sufficient to create a modification in the action selection. However, we had to increase the percentage of trials with stimulation relative to that in experiments in order to impact the selection. We found that increasing only the reward prediction had a different effect if the stimulation in RP was action dependent (only for a specific action) or not. We further looked at the evolution of the change in the weights depending on the stage of learning within a block. A bias in RP impacts the plasticity differently depending on that stage but also on the outcome. It remains to experimentally test how the dopaminergic neurons are affected by specific stimulations of neurons in the striatum and to relate data to predictions of our model.	[Berthet, Pierre; Lansner, Anders] Stockholm Univ, S-10691 Stockholm, Sweden; [Berthet, Pierre; Lansner, Anders] KTH Royal Inst Technol, Sch Comp Sci & Commun, Dept Computat Biol, Stockholm, Sweden; [Berthet, Pierre; Lansner, Anders] Karolinska Inst, Stockholm Brain Inst, Stockholm, Sweden	Stockholm University; Royal Institute of Technology; Karolinska Institutet	Berthet, P (corresponding author), Stockholm Univ, S-10691 Stockholm, Sweden.	berthet@kth.se	Lansner, Anders/E-4824-2016	Lansner, Anders/0000-0002-2358-7815; berthet, pierre/0000-0002-6878-6842	European Union [237955, 269921]; Swedish Research Council	European Union(European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission)	The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007 2013) under grant agreement no. 237955 (https://facets.kip.uni-heidelberg.de/ITN/, FACETS-ITN) and no. 269921 (http://brainscales.kip.uni-heidelberg.de/, BrainScaleS), and from the Swedish Research Council (http://www.vr.se/inenglish.4.12fff4451215cbd83e4800015152.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamantidis AR, 2011, J NEUROSCI, V31, P10829, DOI 10.1523/JNEUROSCI.2246-11.2011; ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Ball KT, 2011, BEHAV BRAIN RES, V222, P390, DOI 10.1016/j.bbr.2011.03.064; Berthet P, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00065; Bromberg-Martin ES, 2010, J NEUROPHYSIOL, V104, P1068, DOI 10.1152/jn.00158.2010; Buesing L, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002211; Charlesworth JD, 2012, NATURE, V486, P251, DOI 10.1038/nature11078; Chaudhury D, 2013, NATURE, V493, P532, DOI 10.1038/nature11713; Cohen MX, 2009, BEHAV BRAIN RES, V199, P141, DOI 10.1016/j.bbr.2008.09.029; Crittenden JR, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00059; Daw ND, 2006, CURR OPIN NEUROBIOL, V16, P199, DOI 10.1016/j.conb.2006.03.006; Deneve S, 2008, NEURAL COMPUT, V20, P91, DOI 10.1162/neco.2008.20.1.91; Doya K, 2002, NEURAL COMPUT, V14, P1347, DOI 10.1162/089976602753712972; Doya K., 2007, BAYESIAN BRAIN; Fujiyama F, 2011, EUR J NEUROSCI, V33, P668, DOI 10.1111/j.1460-9568.2010.07564.x; GRAYBIEL AM, 1994, SCIENCE, V265, P1826, DOI 10.1126/science.8091209; Hollerman JR, 1998, NAT NEUROSCI, V1, P304, DOI 10.1038/1124; Houk J. C., 1995, MODEL BASAL GANGLIA; Hwang EJ, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00121; Izhikevich EM, 2007, CEREB CORTEX, V17, P2443, DOI 10.1093/cercor/bhl152; Kim H, 2009, J NEUROSCI, V29, P14701, DOI 10.1523/JNEUROSCI.2728-09.2009; Kravitz A V, 2012, NAT NEUROSCI, P1; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; Kreitzer AC, 2011, NEUROSCIENCE, V198, P19, DOI 10.1016/j.neuroscience.2011.08.018; Kress GJ, 2013, NAT NEUROSCI, V16, P665, DOI 10.1038/nn.3397; Lau B, 2007, J NEUROSCI, V27, P14502, DOI 10.1523/JNEUROSCI.3060-07.2007; Lenz JD, 2013, BEHAV BRAIN RES, P1; Lerner TN, 2011, CURR OPIN NEUROBIOL, V21, P322, DOI 10.1016/j.conb.2011.01.005; Lobo MK, 2010, SCIENCE, V330, P385, DOI 10.1126/science.1188472; Matsumoto M, 2007, NATURE, V447, P1111, DOI 10.1038/nature05860; MCGEORGE AJ, 1989, NEUROSCIENCE, V29, P503, DOI 10.1016/0306-4522(89)90128-0; McHaffie JG, 2005, TRENDS NEUROSCI, V28, P401, DOI 10.1016/j.tins.2005.06.006; Mengual E, 1999, J CHEM NEUROANAT, V16, P187; Montague PR, 2004, NATURE, V431, P760, DOI 10.1038/nature03015; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; Nambu A, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00026; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; Ostendorf F, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00010; Oyama K, 2010, J NEUROSCI, V30, P11447, DOI 10.1523/JNEUROSCI.1719-10.2010; Pawlak V., 2010, FRONT SYNAPTIC NEURO, V2, P146, DOI DOI 10.3389/FNSYN.2010.00146; Pawlak V, 2008, J NEUROSCI, V28, P2435, DOI 10.1523/JNEUROSCI.4402-07.2008; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Redgrave P, 1999, NEUROSCIENCE, V89, P1009, DOI 10.1016/S0306-4522(98)00319-4; Reynolds JNJ, 2000, NEUROSCIENCE, V99, P199, DOI 10.1016/S0306-4522(00)00273-6; Reynolds JNJ, 2002, NEURAL NETWORKS, V15, P507, DOI 10.1016/S0893-6080(02)00045-X; Samejima K, 2005, SCIENCE, V310, P1337, DOI 10.1126/science.1115270; Sandberg A, 2002, NETWORK-COMP NEURAL, V13, P179, DOI 10.1088/0954-898X/13/2/302; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 2000, ANNU REV NEUROSCI, V23, P473, DOI 10.1146/annurev.neuro.23.1.473; Shen WX, 2008, SCIENCE, V321, P848, DOI 10.1126/science.1160575; Sheth SA, 2011, J NEUROSCI, V31, P4878, DOI 10.1523/JNEUROSCI.3658-10.2011; Smith Y, 1998, NEUROSCIENCE, V86, P353; Steinberg EE, 2013, NAT NEUROSCI, V16, P966, DOI 10.1038/nn.3413; Surmeier DJ, 2007, TRENDS NEUROSCI, V30, P228, DOI 10.1016/j.tins.2007.03.008; Szydlowski SN, 2013, J NEUROSCI, V33, P1678, DOI 10.1523/JNEUROSCI.3572-12.2013; Tai LH, 2012, NAT NEUROSCI, V15, P1281, DOI 10.1038/nn.3188; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; van Zessen R, 2012, NEURON, V73, P1184, DOI 10.1016/j.neuron.2012.02.016; Wang AY, 2013, NAT NEUROSCI, V16, P639, DOI 10.1038/nn.3377; Watabe-Uchida M, 2012, NEURON, V74, P858, DOI 10.1016/j.neuron.2012.03.017; Wickens JR, 1996, NEUROSCIENCE, V70, P1, DOI 10.1016/0306-4522(95)00436-M; Yang T, 2007, NATURE, V447, P1075, DOI 10.1038/nature05852	63	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e90578	10.1371/journal.pone.0090578	http://dx.doi.org/10.1371/journal.pone.0090578			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614169	Green Published, gold, Green Submitted			2022-12-27	WOS:000332839300030
J	Brink, AATP; von Wintersdorff, CJH; van der Donk, CFM; Peeters, AMMW; Beisser, PS; Stobberingh, EE; Wolffs, PFG				Brink, Antoinette A. T. P.; von Wintersdorff, Christian J. H.; van der Donk, Christina F. M.; Peeters, Anne M. M. W.; Beisser, Patrick S.; Stobberingh, Ellen E.; Wolffs, Petra F. G.			Development and Validation of a Single-Tube Multiple-Locus Variable Number Tandem Repeat Analysis for Klebsiella pneumoniae	PLOS ONE			English	Article							BETA-LACTAMASE; STRAIN; ENZYME	Genotyping of Klebsiella pneumoniae is indispensable for management of nosocomial infections, monitoring of emerging strains -including extended-spectrum beta-lactamase (ESBL) producers-, and general epidemiology. Such objectives require a high-resolution genotyping method with a fixed scheme that allows (1) long-term retrospective and prospective assessment, (2) objective result readout and (3) library storage for database development and exchangeable results. We have developed a multiple-locus variable number tandem repeat analysis (MLVA) using a single-tube fluorescently primed multiplex PCR for 8 Variable Number Tandem Repeats (VNTRs) and automated fragment size analysis. The type allocation scheme was optimized using 224 K. pneumoniae clinical isolates, which yielded 101 MLVA types. The method was compared to the gold standard multilocus sequence typing (MLST) using a subset of these clinical isolates (n = 95) and found to be highly concordant, with at least as high a resolution but with considerably less hands-on time. Our results position this MLVA scheme as an appropriate, high-throughput and relatively low-cost tool for K. pneumoniae epidemiology.	[Brink, Antoinette A. T. P.; von Wintersdorff, Christian J. H.; van der Donk, Christina F. M.; Peeters, Anne M. M. W.; Beisser, Patrick S.; Stobberingh, Ellen E.; Wolffs, Petra F. G.] Maastricht Univ, Med Ctr, Dept Med Microbiol, Maastricht, Netherlands; [Stobberingh, Ellen E.; Wolffs, Petra F. G.] Univ Maastricht, Sch Publ Hlth & Primary Care, Maastricht, Netherlands	Maastricht University; Maastricht University	Wolffs, PFG (corresponding author), Maastricht Univ, Med Ctr, Dept Med Microbiol, Maastricht, Netherlands.	p.wolffs@mumc.nl		von Wintersdorff, Christian/0000-0003-4409-4611; Wolffs, Petra/0000-0002-5326-3985				ARLET G, 1994, J CLIN MICROBIOL, V32, P2553, DOI 10.1128/JCM.32.10.2553-2558.1994; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Chaves J, 2001, ANTIMICROB AGENTS CH, V45, P2856, DOI 10.1128/AAC.45.10.2856-2861.2001; COWAN ST, 1960, J GEN MICROBIOL, V23, P601, DOI 10.1099/00221287-23-3-601; Diancourt L, 2005, J CLIN MICROBIOL, V43, P4178, DOI 10.1128/JCM.43.8.4178-4182.2005; Drieux L, 2008, CLIN MICROBIOL INFEC, V14, P90, DOI 10.1111/j.1469-0691.2007.01846.x; Fehlberg LCC, 2012, BRAZ J INFECT DIS, V16, P577, DOI 10.1016/j.bjid.2012.07.001; Fouts DE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000141; Gadberry MD, 2005, BIOINFORMATICS, V21, P1263, DOI 10.1093/bioinformatics/bti134; Krenke BE, 2002, J FORENSIC SCI, V47, P773; Lindstedt BA, 2003, J CLIN MICROBIOL, V41, P1469, DOI 10.1128/JCM.41.4.1469-1479.2003; Lobersli I, 2012, J MICROBIOL METH, V88, P134, DOI 10.1016/j.mimet.2011.11.003; McClelland M, 2006, KLEBSIELLA PNEUMONIA; Pallecchi L, 2004, ANTIMICROB AGENTS CH, V48, P4556, DOI 10.1128/AAC.48.12.4556-4561.2004; Pitout JDD, 2007, CLIN MICROBIOL INFEC, V13, P291, DOI 10.1111/j.1469-0691.2006.01645.x; Potron A, 2011, CLIN MICROBIOL INFEC, V17, pE24, DOI 10.1111/j.1469-0691.2011.03669.x; Rasheed JK, 2000, ANTIMICROB AGENTS CH, V44, P2382, DOI 10.1128/AAC.44.9.2382-2388.2000; Schouls LM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005082; Turton JF, 2010, J MED MICROBIOL, V59, P541, DOI 10.1099/jmm.0.015198-0; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; van Belkum A, 2007, CLIN MICROBIOL INFEC, V13, P1, DOI 10.1111/j.1469-0691.2007.01786.x; van Belkum A, 2007, FEMS IMMUNOL MED MIC, V49, P22, DOI 10.1111/j.1574-695X.2006.00173.x; Wu KM, 2009, J BACTERIOL, V191, P4492, DOI 10.1128/JB.00315-09	23	9	10	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91209	10.1371/journal.pone.0091209	http://dx.doi.org/10.1371/journal.pone.0091209			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614534	Green Submitted, Green Published, gold			2022-12-27	WOS:000332839300095
J	Ueno, T; Funatsu, T				Ueno, Taro; Funatsu, Takashi			Label-Free Quantification of MicroRNAs Using Ligase-Assisted Sandwich Hybridization on a DNA Microarray	PLOS ONE			English	Article							RNA; EXPRESSION; LIGATION; CANCER; PROBES; ACID; PCR	MicroRNAs (miRNAs) can be used as biomarkers for cancer and other human diseases; therefore, high-throughput and reliable miRNA-quantification methods are required to exploit these markers for diagnostic testing. In this report, we describe the construction of a platform for miRNA-quantification using ligase-assisted sandwich hybridization (LASH) without miRNA-labeling. T4 DNA ligase was used to compensate for the low affinity between miRNAs and two short complementary DNA probes, and it improved the hybridization yield,50,000 times. The LASH assay enabled synthesized miR-143 to be quantified at concentrations ranging from 30 fM to 30 pM. The LASH assay could also quantify endogenous miR-143 released from cultured cells as well as some miRNAs in total RNAs derived from blood. Furthermore, multi-color detection enabled us to distinguish between the highly homologous miR-141 and miR-200a. This simple label-free quantification technique is an easy-to-use approach that can be applied to disease diagnosis.	[Ueno, Taro; Funatsu, Takashi] Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo, Japan	University of Tokyo	Funatsu, T (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo, Japan.	funatsu@mail.ecc.u-tokyo.ac.jp	Funatsu, Takashi/Q-1404-2015	Funatsu, Takashi/0000-0002-9656-8308	Japan Society for the Promotion of Science (JSPS)	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported by the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program) from the Japan Society for the Promotion of Science (JSPS). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Arata H, 2012, ANALYST, V137, P3234, DOI 10.1039/c2an16154k; Asslaber D, 2010, J NUCL ACIDS, V1, pe14; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Driskell JD, 2010, CHEM COMMUN, V46, P3298, DOI 10.1039/c002059a; Du CS, 2009, NAT IMMUNOL, V10, P1252, DOI 10.1038/ni.1798; Duan DM, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr774; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Feuillie C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017847; Git A, 2010, RNA, V16, P991, DOI 10.1261/rna.1947110; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hunt EA, 2009, ANAL BIOCHEM, V387, P1, DOI 10.1016/j.ab.2009.01.011; Husale S, 2009, NATURE, V462, P1075, DOI 10.1038/nature08626; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Lee JM, 2010, ANGEW CHEM INT EDIT, V49, P8662, DOI 10.1002/anie.201004000; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Li J, 2009, ANAL CHEM, V81, P5446, DOI 10.1021/ac900598d; Maroney PA, 2008, NAT PROTOC, V3, P279, DOI 10.1038/nprot.2007.530; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Nielsen UB, 2004, J IMMUNOL METHODS, V290, P107, DOI 10.1016/j.jim.2004.04.012; Poehlmann C, 2010, ANAL CHEM, V82, P4434, DOI 10.1021/ac100186p; Rant U, 2007, P NATL ACAD SCI USA, V104, P17364, DOI 10.1073/pnas.0703974104; Repsilber D, 2005, METHOD INFORM MED, V44, P400; Roy S, 2011, LAB CHIP, V11, P1886, DOI 10.1039/c0lc00638f; Sipova H, 2010, ANAL CHEM, V82, P10110, DOI 10.1021/ac102131s; Su X, 2007, ANAL CHEM, V79, P7192, DOI 10.1021/ac0709403; Wach S, 2012, INT J CANCER, V130, P611, DOI 10.1002/ijc.26064; Yang WJ, 2008, ANAL BIOCHEM, V376, P183, DOI 10.1016/j.ab.2008.02.003; Yeh HC, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl787; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030	31	22	25	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e90920	10.1371/journal.pone.0090920	http://dx.doi.org/10.1371/journal.pone.0090920			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614340	Green Published, Green Submitted, gold			2022-12-27	WOS:000332839300055
J	Borand, L; Madec, Y; Laureillard, D; Chou, M; Marcy, O; Pheng, P; Prak, N; Kim, C; Lak, KK; Hak, C; Dim, B; Nerrienet, E; Fontanet, A; Sok, T; Goldfeld, AE; Blanc, FX; Taburet, AM				Borand, Laurence; Madec, Yoann; Laureillard, Didier; Chou, Monidarin; Marcy, Olivier; Pheng, Phearavin; Prak, Narom; Kim, Chindamony; Lak, Khemarin Kim; Hak, Chanroeun; Dim, Bunnet; Nerrienet, Eric; Fontanet, Arnaud; Sok, Thim; Goldfeld, Anne E.; Blanc, Francois-Xavier; Taburet, Anne-Marie			Plasma Concentrations, Efficacy and Safety of Efavirenz in HIV-Infected Adults Treated for Tuberculosis in Cambodia (ANRS 1295-CIPRA KH001 CAMELIA Trial)	PLOS ONE			English	Article							TRANSCRIPTASE INHIBITOR EFAVIRENZ; ANTIRETROVIRAL TREATMENT; PHARMACOKINETIC INTERACTIONS; ADVERSE EVENTS; RIFAMPICIN; NEVIRAPINE; CYP2B6; THERAPY; POLYMORPHISMS; PERFORMANCE	Objective: To assess efavirenz plasma concentrations and their association with treatment efficacy and tolerance of efavirenz 600 mg daily in HIV-tuberculosis co-infected patients. Methods: HIV-infected adults with CD4+ T cell count <= 200/mm(3) received standard 6-month tuberculosis treatment and antiretroviral therapy including a daily-dose of 600 mg of efavirenz, irrespective of their body weight. Mid-dose blood samples were drawn both on tuberculosis treatment (week +2 and week +6 after antiretroviral therapy initiation, and week 22 of follow-up) and off tuberculosis treatment (week 50 of follow-up). Considered therapeutic range was 1,000 to 4,000 ng/mL. Multivariate analysis was performed to evaluate the association between efavirenz concentration below 1,000 ng/mL and virological failure. Linear regression was used to test the association between efavirenz exposure and CD4+ T cell gain. Severe side effects potentially related to efavirenz were described and their association with efavirenz exposure was tested by multivariate analysis. Results: Efavirenz plasma concentrations were available in 540 patients. Median [interquartile range] efavirenz concentrations were 2,674 ng/mL [1,690-4,533], 2,667 ng/mL [1,753-4,494] and 2,799 ng/mL [1,804-4,744] at week +2, week +6, week 22, respectively, and 2,766 ng/mL [1,941-3,976] at week 50. Efavirenz concentrations were lower at week 50 (off rifampicin) compared to week 22 (on rifampicin) (p < 0.001). Late attendance to study visit and low hemoglobinemia were the only factors associated with an increased risk of efavirenz concentration below 1,000 ng/mL. Efavirenz concentration below 1,000 ng/mL was not associated with treatment failure. Efavirenz concentration above 4,000 ng/mL was associated with higher risk of central nervous system side effects (p < 0.001) and of hepatotoxicity (p < 0.001). Conclusion: Body weight and tuberculosis treatment were not associated with low efavirenz concentrations or treatment failure, supporting the 600 mg daily-dose of efavirenz in HIV-tuberculosis co-infected patients. High efavirenz concentrations were related to a higher risk of central nervous system side effects and hepatotoxicity.	[Borand, Laurence; Marcy, Olivier; Pheng, Phearavin] Inst Pasteur Cambodge, Epidemiol & Publ Hlth Unit, Phnom Penh, Cambodia; [Madec, Yoann; Fontanet, Arnaud] Inst Pasteur, Unite Rech & Expertise Epidemiol Malad Emergentes, Paris, France; [Laureillard, Didier] ANRS, Ho Chi Minh City, Vietnam; [Chou, Monidarin] Univ Hlth Sci, Fac Pharm, Phnom Penh, Cambodia; [Prak, Narom] Khmer Soviet Friendship Hosp, Phnom Penh, Cambodia; [Kim, Chindamony] Donkeo Prov Hosp, Takeo, Cambodia; [Kim, Chindamony; Dim, Bunnet] Medecins Sans Frontieres, Phnom Penh, Cambodia; [Lak, Khemarin Kim] Svay Rieng Prov Hosp, Svay Rieng, Cambodia; [Lak, Khemarin Kim; Sok, Thim; Goldfeld, Anne E.] Cambodian Hlth Comm, Phnom Penh, Cambodia; [Hak, Chanroeun] Calmette Hosp, Phnom Penh, Cambodia; [Dim, Bunnet] Siem Reap Referral Hosp, Siem Reap, Cambodia; [Nerrienet, Eric] Inst Pasteur Cambodge, HIV Hepatitis Lab, Phnom Penh, Cambodia; [Fontanet, Arnaud] Conservatoire Natl Arts & Metiers, Paris, France; [Goldfeld, Anne E.] Harvard Univ, Childrens Hosp, Sch Med, Program Cellular & Mol Med, Boston, MA 02115 USA; [Blanc, Francois-Xavier] Hop Univ Paris Sud, Hop Bicetre, AP HP, Dept Pneumol, Le Kremlin Bicetre, France; [Blanc, Francois-Xavier] Univ Nantes, CHU Nantes, DHU2020,Serv Pneumol, UMR INSERM 1087,CNRS UMR 6291,Inst Thorax, F-44035 Nantes, France; [Taburet, Anne-Marie] Hop Univ Paris Sud, Hop Bicetre, AP HP, Dept Clin Pharm, Le Kremlin Bicetre, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Cambodia; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Cambodia; heSam Universite; Conservatoire National Arts & Metiers (CNAM); Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Hopital Universitaire Paul-Brousse - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Hopital Universitaire Paul-Brousse - APHP; UDICE-French Research Universities; Universite Paris Saclay	Taburet, AM (corresponding author), Hop Univ Paris Sud, Hop Bicetre, AP HP, Dept Clin Pharm, Le Kremlin Bicetre, France.	anne-marie.taburet@bct.aphp.fr	Goldfeld, Anne/AAF-1818-2019; Blanc, François-Xavier/D-7425-2015; Marcy, Olivier/T-3299-2019	Blanc, François-Xavier/0000-0001-7644-2188; Marcy, Olivier/0000-0003-3350-112X; Madec, Yoann/0000-0002-6201-1261; Laureillard, Didier/0000-0002-0104-9047; , arnaud/0000-0002-5239-6110	French National Agency for Research on AIDS and Viral Hepatitis (ANRS); U.S. National Institutes of Health Division of AIDS; Merieux Foundation	French National Agency for Research on AIDS and Viral Hepatitis (ANRS)(ANRSFrench National Research Agency (ANR)); U.S. National Institutes of Health Division of AIDS; Merieux Foundation	The French National Agency for Research on AIDS and Viral Hepatitis (ANRS), the U.S. National Institutes of Health Division of AIDS and the Merieux Foundation have supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIDS, 2009, DIV AIDS TABL GRAD S; [Anonymous], AIDS REV, V8, P115; Best BM, 2008, EXPERT OPIN DRUG MET, V4, P965, DOI 10.1517/17425255.4.7.965 ; BHIVA, 2012, BHIVA GUID TREATM HI; Blanc FX, 2011, NEW ENGL J MED, V365, P1471, DOI 10.1056/NEJMoa1013911; BMS, 2013, SUSTIVA PACK INS; Boulle A, 2008, JAMA-J AM MED ASSOC, V300, P530, DOI 10.1001/jama.300.5.530; Brennan-Benson P, 2005, AIDS, V19, P1541, DOI 10.1097/01.aids.0000183519.45137.a6; Burger D, 2006, BRIT J CLIN PHARMACO, V61, P148, DOI 10.1111/j.1365-2125.2005.02536.x; Cassol E, 2005, J INFECT DIS, V191, P324, DOI 10.1086/427337; CDC, 2012, GUIDELINES USE ANTIR; Clifford DB, 2005, ANN INTERN MED, V143, P714, DOI 10.7326/0003-4819-143-10-200511150-00008; FDA, 2012, SUST LAB UPD DOS ADJ; Friedland G, 2006, J ANTIMICROB CHEMOTH, V58, P1299, DOI 10.1093/jac/dkl399; Fumaz CR, 2005, JAIDS-J ACQ IMM DEF, V38, P560, DOI 10.1097/01.qai.0000147523.41993.47; Gandhi M, 2012, J INFECT DIS, V206, P1453, DOI 10.1093/infdis/jis508; Gandhi M, 2009, JAIDS-J ACQ IMM DEF, V50, P482, DOI 10.1097/QAI.0b013e31819c3376; General Assembly of the World Medical Association, 2014, J Am Coll Dent, V81, P14; Gengiah TN, 2012, EUR J CLIN PHARMACOL, V68, P689, DOI 10.1007/s00228-011-1166-5; Gutierrez-Valencia A, 2009, ANN INTERN MED, V151, P149, DOI 10.7326/0003-4819-151-3-200908040-00127; Haas DW, 2004, AIDS, V18, P2391; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Kappelhoff BS, 2005, ANTIVIR THER, V10, P489; Kwara A, 2011, ANTIMICROB AGENTS CH, V55, P3527, DOI 10.1128/AAC.00980-10; Lalloo UG, 2009, CLIN INFECT DIS, V48, P1760, DOI 10.1086/599115; Lopez-Cortes LF, 2002, CLIN PHARMACOKINET, V41, P681, DOI 10.2165/00003088-200241090-00004; Luetkemeyer AF, 2013, CLIN INFECT DIS; Manosuthi W, 2005, AIDS, V19, P1481, DOI 10.1097/01.aids.0000183630.27665.30; Manosuthi W, 2009, CLIN INFECT DIS, V48, P1752, DOI 10.1086/599114; Marzolini C, 2000, J CHROMATOGR B, V740, P43, DOI 10.1016/S0378-4347(99)00573-3; Marzolini C, 2001, AIDS, V15, P71, DOI 10.1097/00002030-200101050-00011; Morlat P., 2013, PRISE CHARGE MED PER; Nunez M, 2001, J ACQ IMMUN DEF SYND, V28, P399; Orrell C, 2011, ANTIVIR THER, V16, P527, DOI 10.3851/IMP1780; Patel A, 2004, JAIDS-J ACQ IMM DEF, V37, P1166, DOI 10.1097/01.qai.0000135956.96166.f0; Pedral-Sampaio Diana B., 2004, Braz J Infect Dis, V8, P211, DOI 10.1590/S1413-86702004000300004; Ramachandran G, 2009, ANTIMICROB AGENTS CH, V53, P863, DOI 10.1128/AAC.00899-08; Ribaudo HJ, 2010, J INFECT DIS, V202, P717, DOI 10.1086/655470; Rotger Margalida, 2005, Pharmacogenet Genomics, V15, P1, DOI 10.1097/01213011-200501000-00001; Shipton LK, 2009, INT J TUBERC LUNG D, V13, P360; Shubber Z, 2013, AIDS; Stohr W, 2008, ANTIVIR THER, V13, P675; Thompson MA, 2012, JAMA-J AM MED ASSOC, V308, P387, DOI 10.1001/jama.2012.7961; Trancart S, 2012, ANTIMICROB AGENTS CH, V56, P1655, DOI 10.1128/AAC.05452-11; Uttayamakul S, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-8; van Luin M, 2009, ANTIVIR THER, V14, P75; Volberding PA, 2004, CLIN INFECT DIS, V38, P1459, DOI 10.1086/383031; Vrouenraets SME, 2007, EXPERT OPIN PHARMACO, V8, P851, DOI 10.1517/14656566.8.6.851; Ward BA, 2003, J PHARMACOL EXP THER, V306, P287, DOI 10.1124/jpet.103.049601; WHO, 2010, ANT THER HIV INF AD	50	19	20	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90350	10.1371/journal.pone.0090350	http://dx.doi.org/10.1371/journal.pone.0090350			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608960	Green Published, Green Submitted, gold			2022-12-27	WOS:000332485800020
J	Munro, KI; Thrippleton, MJ; Williams, ARW; McKillop, G; Walker, J; Horne, AW; Newby, DE; Anderson, RA; Semple, SI; Marshall, I; Lewis, SC; Millar, RP; Bastin, ME; Critchley, HOD				Munro, Kirsty I.; Thrippleton, Michael J.; Williams, Alistair R. W.; McKillop, Graham; Walker, Jane; Horne, Andrew W.; Newby, David E.; Anderson, Richard A.; Semple, Scott I.; Marshall, Ian; Lewis, Steff C.; Millar, Robert P.; Bastin, Mark E.; Critchley, Hilary O. D.			Quantitative Serial MRI of the Treated Fibroid Uterus	PLOS ONE			English	Article							UTERINE LEIOMYOMAS; WHITE WOMEN; PARAMETERS; MANAGEMENT; THERAPY; IMAGES	Objective: There are no long-term medical treatments for uterine fibroids, and non-invasive biomarkers are needed to evaluate novel therapeutic interventions. The aim of this study was to determine whether serial dynamic contrast-enhanced MRI (DCE-MRI) and magnetization transfer MRI (MT-MRI) are able to detect changes that accompany volume reduction in patients administered GnRH analogue drugs, a treatment which is known to reduce fibroid volume and perfusion. Our secondary aim was to determine whether rapid suppression of ovarian activity by combining GnRH agonist and antagonist therapies results in faster volume reduction. Methods: Forty women were assessed for eligibility at gynaecology clinics in the region, of whom thirty premenopausal women scheduled for hysterectomy due to symptomatic fibroids were randomized to three groups, receiving (1) GnRH agonist (Goserelin), (2) GnRH agonist+GnRH antagonist (Goserelin and Cetrorelix) or (3) no treatment. Patients were monitored by serial structural, DCE-MRI and MT-MRI, as well as by ultrasound and serum oestradiol concentration measurements from enrolment to hysterectomy (approximately 3 months). Results: A volumetric treatment effect assessed by structural MRI occurred by day 14 of treatment (9% median reduction versus 9% increase in untreated women; P = 0.022) and persisted throughout. Reduced fibroid perfusion and permeability assessed by DCE-MRI occurred later and was demonstrable by 2-3 months (43% median reduction versus 20% increase respectively; P = 0.0093). There was no apparent treatment effect by MT-MRI. Effective suppression of oestradiol was associated with early volume reduction at days 14 (P = 0.041) and 28 (P = 0.0061). Conclusion: DCE-MRI is sensitive to the vascular changes thought to accompany successful GnRH analogue treatment of uterine fibroids and should be considered for use in future mechanism/efficacy studies of proposed fibroid drug therapies. GnRH antagonist administration does not appear to accelerate volume reduction, though our data do support the role of oestradiol suppression in GnRH analogue treatment of fibroids.	[Munro, Kirsty I.; Thrippleton, Michael J.; Williams, Alistair R. W.; Horne, Andrew W.; Anderson, Richard A.; Millar, Robert P.; Critchley, Hilary O. D.] Univ Edinburgh, MRC Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland; [Thrippleton, Michael J.; Marshall, Ian; Bastin, Mark E.] Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh, Midlothian, Scotland; [Williams, Alistair R. W.; McKillop, Graham; Walker, Jane] Royal Infirm Edinburgh NHS Trust, NHS Lothian, Edinburgh, Midlothian, Scotland; [Newby, David E.; Semple, Scott I.; Marshall, Ian] Univ Edinburgh, Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland; [Semple, Scott I.] Univ Edinburgh, Clin Res Imaging Ctr, Edinburgh, Midlothian, Scotland; [Lewis, Steff C.] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Millar, Robert P.] Univ Pretoria, Mammal Res Inst, ZA-0002 Pretoria, South Africa; [Millar, Robert P.] Univ Cape Town, UCT MRC Receptor Biol Unit, ZA-7925 Cape Town, South Africa; [Millar, Robert P.] Univ Edinburgh, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh; Royal Infirmary of Edinburgh; University of Edinburgh; University of Edinburgh; University of Edinburgh; University of Edinburgh; University of Pretoria; University of Cape Town; University of Edinburgh	Critchley, HOD (corresponding author), Univ Edinburgh, MRC Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland.	hilary.critchley@ed.ac.uk	Newby, David Ernest/AAB-1364-2019; CRITCHLEY, HILARY OD/C-7575-2013	Thrippleton, Michael/0000-0001-7858-9917; Horne, Andrew/0000-0002-9656-493X; Millar, Robert P/0000-0003-3606-2708; Lewis, Steff/0000-0003-1210-2314; CRITCHLEY, HILARY/0000-0003-1913-4044; Bastin, Mark/0000-0002-0490-0845; Williams, Alistair/0000-0002-7085-4525	Translational Medicine Research Collaboration [WHMSB-EU-131]; University of Edinburgh; Medical Research Council [G1002033, G0701127, G1002118] Funding Source: researchfish; MRC [G1002033, G0701127, G1002118] Funding Source: UKRI	Translational Medicine Research Collaboration; University of Edinburgh; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was funded by the Translational Medicine Research Collaboration (WHMSB-EU-131) and The University of Edinburgh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird DD, 2003, AM J OBSTET GYNECOL, V188, P100, DOI 10.1067/mob.2003.99; Bastin ME, 2009, NEUROBIOL AGING, V30, P125, DOI 10.1016/j.neurobiolaging.2007.05.013; Boss A, 2006, J MAGN RESON IMAGING, V24, P1183, DOI 10.1002/jmri.20754; BRIX G, 1991, J COMPUT ASSIST TOMO, V15, P621, DOI 10.1097/00004728-199107000-00018; BUCKLEY DL, 1994, MAGNET RESON MED, V32, P646, DOI 10.1002/mrm.1910320514; BUTTRAM VC, 1981, FERTIL STERIL, V36, P433; Chia Chun-Chieh, 2006, Taiwan J Obstet Gynecol, V45, P124; Englund K, 1998, J CLIN ENDOCR METAB, V83, P4092, DOI 10.1210/jc.83.11.4092; Flynn M, 2006, AM J OBSTET GYNECOL, V195, P955, DOI 10.1016/j.ajog.2006.02.020; Harry VN, 2010, LANCET ONCOL, V11, P92, DOI 10.1016/S1470-2045(09)70190-1; Jha RC, 2000, RADIOLOGY, V217, P228, DOI 10.1148/radiology.217.1.r00se49228; Khan KN, 2010, HUM REPROD, V25, P642, DOI 10.1093/humrep/dep437; Kobayashi S, 1997, RADIOLOGY, V203, P377, DOI 10.1148/radiology.203.2.9114091; Lee DW, 2009, FERTIL STERIL, V91, P566, DOI 10.1016/j.fertnstert.2007.12.004; OKIZUKA H, 1993, J COMPUT ASSIST TOMO, V17, P760, DOI 10.1097/00004728-199309000-00018; Parsanezhad ME, 2010, FERTIL STERIL, V93, P192, DOI 10.1016/j.fertnstert.2008.09.064; Peddada SD, 2008, P NATL ACAD SCI USA, V105, P19887, DOI 10.1073/pnas.0808188105; Rahn DD, 2011, J CLIN EPIDEMIOL, V64, P293, DOI 10.1016/j.jclinepi.2010.03.017; Sankaran S, 2008, BEST PRACT RES CL OB, V22, P655, DOI 10.1016/j.bpobgyn.2008.03.001; Shimada K, 2004, J MAGN RESON IMAGING, V20, P97, DOI 10.1002/jmri.20063; Shimada K, 2004, AM J ROENTGENOL, V182, P1043, DOI 10.2214/ajr.182.4.1821043; Sreenan JJ, 1996, AM J SURG PATHOL, V20, P427, DOI 10.1097/00000478-199604000-00005; Takahashi K, 2002, INT J ONCOL, V20, P279; Takahashi K, 2001, HUM REPROD, V16, P1989, DOI 10.1093/humrep/16.9.1989; Tekay A, 1996, ULTRASOUND OBST GYN, V7, P129, DOI 10.1046/j.1469-0705.1996.07020129.x; Tofts PS, 1999, J MAGN RESON IMAGING, V10, P223, DOI 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S	26	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e89809	10.1371/journal.pone.0089809	http://dx.doi.org/10.1371/journal.pone.0089809			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608161	Green Published, Green Submitted, gold			2022-12-27	WOS:000332485800008
J	Szymanska, S; Lordal, M; Rathnayake, N; Gustafsson, A; Johannsen, A				Szymanska, Sara; Lordal, Mikael; Rathnayake, Nilminie; Gustafsson, Anders; Johannsen, Annsofi			Dental Caries, Prevalence and Risk Factors in Patients with Crohn's Disease	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; ULCERATIVE-COLITIS; HEALTH; TASTE	Objective: The present study tested the hypothesis that patients with Crohn's disease (CD) have a higher prevalence and risk for caries compared to people without CD. Material and Methods: Patients with CD were divided into groups; 71 patients (50.7 +/- 13.9 years) who had gone through resective intestinal surgery and 79 patients (42.0 +/- 14.4 years) who had not. The patients were compared to 75 controls (48.6 +/- 13.4 years) regarding DMF-T and DMF-S, Lactobacilli (LB), Streptococcus mutans (SM), salivary flow and dental plaque. Statistical methods including ANOVA or Chi-square test for calculation of demographic differences between groups, analysis of covariance (ANCOVA) to compare the clinical variable and Post hoc analyses were done with Fischers Least Significant Difference test or Chi-square. Non-parametric Spearman's correlation matrix coefficient was estimated between clinical variables and disease duration. Results: CD patients who had been subjected to resective surgery had a higher DMF-S score (50.7 versus 36.5; p = 0.01) compared to the control group after adjusting for age, gender and smoking. These patients had higher counts of SM (1.5 versus 0.9; p = 0.04) and LB (10000.0 versus 1000.0; p = 0.01), and more dental plaque (53.7 versus 22.6; p = 0.001). CD patients reported a more frequent consumption of sweetened drinks between meals compared to controls (p = 0.001). Conclusions: The present study shows that patients with CD who had undergone resective surgery had a higher DMFs score, and higher salivary counts of Lactobacilli and Streptococcus mutans compared to the control group.	[Szymanska, Sara; Rathnayake, Nilminie; Gustafsson, Anders; Johannsen, Annsofi] Karolinska Inst, Dept Dent Med, Div Periodontol, Huddinge, Sweden; [Lordal, Mikael] Karolinska Inst, Dept Med, Div Gastroenterol & Hepathol, Huddinge, Sweden; [Lordal, Mikael] Sophiahemmet, Stockholm Gastro Ctr, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Johannsen, A (corresponding author), Karolinska Inst, Dept Dent Med, Div Periodontol, Huddinge, Sweden.	annsofi.johannsen@ki.se			Swedish Association of People with Stomach and Bowel Diseases; Swedish Patent Revenue Research Found; Praktikertjanst AB, Sweden; Swedish Society of Gastroenterology; Sophiahemmet Research Funds	Swedish Association of People with Stomach and Bowel Diseases; Swedish Patent Revenue Research Found; Praktikertjanst AB, Sweden; Swedish Society of Gastroenterology; Sophiahemmet Research Funds	This study was supported by the Swedish Association of People with Stomach and Bowel Diseases, Swedish Patent Revenue Research Found, Praktikertjanst AB, Sweden, Swedish Society of Gastroenterology and Sophiahemmet Research Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEVENIUS J, 1988, ORAL SURG ORAL MED O, V65, P304, DOI 10.1016/0030-4220(88)90114-4; Brito F, 2008, J CLIN PERIODONTOL, V35, P555, DOI 10.1111/j.1600-051X.2008.01231.x; Cho JH, 2011, GASTROENTEROLOGY, V140, P1704, DOI 10.1053/j.gastro.2011.02.046; Crohn BB, 1932, J AMER MED ASSOC, V99, P1323, DOI 10.1001/jama.1932.02740680019005; Fatahzadeh M, 2009, ORAL SURG ORAL MED O, V108, pE1, DOI 10.1016/j.tripleo.2009.07.035; Ferrante M, 2012, CURR DRUG TARGETS, V13, P1294, DOI 10.2174/138945012802429679; Gibson PR, 2005, ALIMENT PHARM THER, V21, P1399, DOI 10.1111/j.1365-2036.2005.02506.x; Grossner-Schreiber B, 2006, J CLIN PERIODONTOL, V33, P478, DOI 10.1111/j.1600-051X.2006.00942.x; Habashneh RA, 2012, J PERIODONTAL RES, V47, P293, DOI 10.1111/j.1600-0765.2011.01431.x; Head Kathleen, 2004, Altern Med Rev, V9, P360; Kappelman MD, 2007, CLIN GASTROENTEROL H, V5, P1424, DOI 10.1016/j.cgh.2007.07.012; Katz JA, 2007, J DIGEST DIS, V8, P65, DOI 10.1111/j.1443-9573.2007.00287.x; Keefer L, 2011, BEHAV RES THER, V49, P145, DOI 10.1016/j.brat.2010.12.005; LENNARDJONES JE, 1984, POSTGRAD MED J, V60, P797, DOI 10.1136/pgmj.60.709.797; PENNY WJ, 1983, GUT, V24, P288, DOI 10.1136/gut.24.4.288; Reif S, 1997, GUT, V40, P754, DOI 10.1136/gut.40.6.754; Rikardsson S, 2009, ORAL HLTH PREV DENT, V7, P277; ROONEY TP, 1984, ORAL SURG ORAL MED O, V57, P623, DOI 10.1016/0030-4220(84)90284-6; Schutz T, 2003, DIGEST DIS, V21, P252, DOI 10.1159/000073343; Selwitz RH, 2007, LANCET, V369, P51, DOI 10.1016/S0140-6736(07)60031-2; Singhal S, 2011, DIGEST DIS SCI, V56, P170, DOI 10.1007/s10620-010-1263-9; SOLOMONS NW, 1977, DIGESTION, V16, P87, DOI 10.1159/000198059; Stange EF, 2006, GUT, V55, DOI 10.1136/gut.2005.081950a; SUNDH B, 1993, ORAL SURG ORAL MED O, V76, P564, DOI 10.1016/0030-4220(93)90063-A; Takahashi N, 2011, J DENT RES, V90, P294, DOI 10.1177/0022034510379602; Touger-Decker R, 2003, AM J CLIN NUTR, V78, p881S, DOI 10.1093/ajcn/78.4.881S; TRAGNONE A, 1995, EUR J GASTROEN HEPAT, V7, P47; Vind I, 2006, AM J GASTROENTEROL, V101, P1274, DOI 10.1111/j.1572-0241.2006.00552.x; World Health Organization, 1997, WHO OR HLTH SURV BAS, V4th	29	18	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91059	10.1371/journal.pone.0091059	http://dx.doi.org/10.1371/journal.pone.0091059			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608416	gold, Green Published, Green Submitted			2022-12-27	WOS:000332485800090
J	Chen, YN; Mao, Y; Liu, HL; Yu, FX; Li, SX; Yin, TM				Chen, Yingnan; Mao, Yan; Liu, Hailin; Yu, Faxin; Li, Shuxian; Yin, Tongming			Transcriptome Analysis of Differentially Expressed Genes Relevant to Variegation in Peach Flowers	PLOS ONE			English	Article							CHALCONE SYNTHASE GENE; TRANSPOSABLE ELEMENT; FLAVONOID BIOSYNTHESIS; COLOR; JAPANESE; PETUNIA; GENOME; BIOCHEMISTRY; ANNOTATION; SUPPRESSION	Background: Variegation in flower color is commonly observed in many plant species and also occurs on ornamental peaches (Prunus persica f. versicolor [Sieb.] Voss). Variegated plants are highly valuable in the floricultural market. To gain a global perspective on genes differentially expressed in variegated peach flowers, we performed large-scale transcriptome sequencing of white and red petals separately collected from a variegated peach tree. Results: A total of 1,556,597 high-quality reads were obtained, with an average read length of 445 bp. The ESTs were assembled into 16,530 contigs and 42,050 singletons. The resulting unigenes covered about 60% of total predicted genes in the peach genome. These unigenes were further subjected to functional annotation and biochemical pathway analysis. Digital expression analysis identified a total of 514 genes differentially expressed between red and white flower petals. Since peach flower coloration is determined by the expression and regulation of structural genes relevant to flavonoid biosynthesis, a detailed examination detected four key structural genes, including C4H, CHS, CHI and F3H, expressed at a significantly higher level in red than in white petal. Except for the structural genes, we also detected 11 differentially expressed regulatory genes relating to flavonoid biosynthesis. Using the differentially expressed structural genes as the test objects, we validated the digital expression results by using quantitative real-time PCR, and the differential expression of C4H, CHS and F3H were confirmed. Conclusion: In this study, we generated a large EST collection from flower petals of a variegated peach. By digital expression analysis, we identified an informative list of candidate genes associated with variegation in peach flowers, which offered a unique opportunity to uncover the genetic mechanisms underlying flower color variegation.	[Chen, Yingnan; Mao, Yan; Liu, Hailin; Li, Shuxian; Yin, Tongming] Nanjing Forestry Univ, Southern Modern Forestry Collaborat Innovat Ctr, Nanjing, Jiangsu, Peoples R China; [Yu, Faxin] Jiangxi Acad Sci, Inst Biol & Resources, Nanchang, Jiangxi, Peoples R China	Nanjing Forestry University	Yin, TM (corresponding author), Nanjing Forestry Univ, Southern Modern Forestry Collaborat Innovat Ctr, Nanjing, Jiangsu, Peoples R China.	tmyin@njfu.com.cn			Natural Science Foundation of China [31270711, 31125008]; Jiangsu Natural Science Foundation for Youth [BK20130968]; Program for Innovative Research Team in Universities of Jiangsu Province; Educational Department of China; Priority Academic Program Development of Jiangsu Higher Education Institutions	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Natural Science Foundation for Youth; Program for Innovative Research Team in Universities of Jiangsu Province; Educational Department of China; Priority Academic Program Development of Jiangsu Higher Education Institutions	Funding for this research was provided by the Natural Science Foundation of China (31270711 and 31125008), the Jiangsu Natural Science Foundation for Youth (BK20130968), and the Program for Innovative Research Team in Universities of Jiangsu Province and the Educational Department of China. It was also funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aoki-Kinoshita Kiyoko F., 2007, V396, P71; Bairoch A, 2008, NUCLEIC ACIDS RES, V36, pD190, DOI 10.1093/nar/gkm895; Broun P, 2005, CURR OPIN PLANT BIOL, V8, P272, DOI 10.1016/j.pbi.2005.03.006; Bruce W, 2000, PLANT CELL, V12, P65, DOI 10.1105/tpc.12.1.65; CHAPARRO JX, 1995, J HERED, V86, P186, DOI 10.1093/oxfordjournals.jhered.a111560; Davies KM, 2012, FUNCT PLANT BIOL, V39, P619, DOI 10.1071/FP12195; Davies Kevin M., 2009, P49, DOI 10.1007/978-0-387-77335-3_3; Dixon RA, 1996, GENE, V179, P61, DOI 10.1016/S0378-1119(96)00327-7; Dubois A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-638; FORKMANN G, 1986, Z NATURFORSCH C, V41, P179; GOTO T, 1991, ANGEW CHEM INT EDIT, V30, P17, DOI 10.1002/anie.199100171; Grotewold E, 2006, ANNU REV PLANT BIOL, V57, P761, DOI 10.1146/annurev.arplant.57.032905.105248; Guo SG, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-384; GUTTERSON N, 1995, HORTSCIENCE, V30, P964, DOI 10.21273/HORTSCI.30.5.964; Harborne JB, 2000, PHYTOCHEMISTRY, V55, P481, DOI 10.1016/S0031-9422(00)00235-1; HOLTON TA, 1995, PLANT CELL, V7, P1071, DOI 10.1105/tpc.7.7.1071; HOSHINO A, 1995, MOL GEN GENET, V247, P114, DOI 10.1007/BF00425828; Huang LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038653; Iida S, 1999, ANN NY ACAD SCI, V870, P265, DOI 10.1111/j.1749-6632.1999.tb08887.x; Iida S, 2004, ONCOGENE, V23, P5266, DOI 10.1038/sj.onc.1207623; INAGAKI Y, 1994, PLANT CELL, V6, P375, DOI 10.1105/tpc.6.3.375; KEVAN PG, 1983, ANNU REV ENTOMOL, V28, P407, DOI 10.1146/annurev.en.28.010183.002203; Liu D, 2001, PLANT CELL PHYSIOL, V42, P419, DOI 10.1093/pcp/pce053; Liu JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060181; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mahomed W, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-167; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Mol J, 1998, TRENDS PLANT SCI, V3, P212, DOI 10.1016/S1360-1385(98)01242-4; Morita Y, 2006, PLANT CELL PHYSIOL, V47, P457, DOI 10.1093/pcp/pcj012; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Morohashi K, 2012, PLANT CELL, V24, P2745, DOI 10.1105/tpc.112.098004; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; NAPOLI C, 1990, PLANT CELL, V2, P279, DOI 10.1105/tpc.2.4.279; Parchman TL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-180; Quattrocchio F, 1999, PLANT CELL, V11, P1433, DOI 10.1105/tpc.11.8.1433; Quinlan RJ, 2008, CURR TOP DEV BIOL, V84, P249, DOI 10.1016/S0070-2153(08)00605-4; Ramskold D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000598; Romualdi C, 2003, PHYSIOL GENOMICS, V12, P159, DOI 10.1152/physiolgenomics.00096.2002; RONCHI A, 1995, EMBO J, V14, P5318, DOI 10.1002/j.1460-2075.1995.tb00216.x; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Schwinn K, 2006, PLANT CELL, V18, P831, DOI 10.1105/tpc.105.039255; Stekel DJ, 2000, GENOME RES, V10, P2055, DOI 10.1101/gr.GR-1325RR; Suzuki S, 2007, PLANT CELL REP, V26, P951, DOI 10.1007/s00299-006-0302-7; To KinYing, 2006, Floriculture, ornamental and plant biotechnology, P300; Tong ZG, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-71; van Houwelingen A, 1998, PLANT J, V13, P39, DOI 10.1046/j.1365-313X.1998.00005.x; VANDERKROL AR, 1988, NATURE, V333, P866, DOI 10.1038/333866a0; Verde I, 2013, NAT GENET, V45, P487, DOI 10.1038/ng.2586; Wang L, 2013, PLANT MOL BIOL, V83, P365, DOI 10.1007/s11103-013-0093-5; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485; Wu B, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-15; Yabuya T, 2001, PLANT SCI, V160, P499, DOI 10.1016/S0168-9452(00)00417-9; Yoshida K, 2000, PHYTOCHEMISTRY, V54, P85, DOI 10.1016/S0031-9422(00)00049-2; Zhang X, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-11-r165; Zhang ZP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018379; Zhu ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034335; Zuker A, 2002, MOL BREEDING, V9, P33, DOI 10.1023/A:1019204531262	60	48	53	5	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90842	10.1371/journal.pone.0090842	http://dx.doi.org/10.1371/journal.pone.0090842			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603808	Green Published, gold, Green Submitted			2022-12-27	WOS:000332483600092
J	Gao, YH; Guan, WJ; Xu, G; Tang, Y; Gao, Y; Lin, ZY; Lin, ZM; Zhong, NS; Chen, RC				Gao, Yong-hua; Guan, Wei-jie; Xu, Gang; Tang, Yan; Gao, Yang; Lin, Zhi-ya; Lin, Zhi-min; Zhong, Nan-shan; Chen, Rong-chang			Macrolide Therapy in Adults and Children with Non-Cystic Fibrosis Bronchiectasis: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							RANDOMIZED CONTROLLED-TRIAL; LOW-DOSE ERYTHROMYCIN; LONG-TERM; DOUBLE-BLIND; DIFFUSE PANBRONCHIOLITIS; CLINICAL-TRIALS; UNITED-STATES; AZITHROMYCIN; EXACERBATIONS; DISEASE	Background: A systematic review and meta-analysis was conducted to evaluate the efficacy and safety of macrolide therapy in adults and children with bronchiectasis. Methods: We searched the PUBMED, EMBASE, CENTRAL databases to identify relevant studies. Two reviewers evaluated the studies and extracted data independently. The primary outcome was the number of bronchiectasis exacerbations. Secondary outcomes included exacerbation-related admissions, quality of life (QoL), spirometry, 6-minute walk test (6MWT) and adverse events. Results: Nine eligible trials with 559 participants were included. Six were conducted on adults, and the remaining on children. Macrolide therapy significantly reduced the number of patients experiencing one or more exacerbation in adults [risk ratio (RR) = 0.59; 95% CI, 0.40 to 0.86; P = 0.006; I-2 = 65%] and children [RR = 0.86; 95% CI, 0.75-0.99; P = 0.04; I-2 = 0%], but not the number of patients with admissions for exacerbation. Macrolide therapy was also associated with reduced frequency of exacerbations in adults (RR = 0.42; 95% CI, 0.29 to 0.61; P<0.001; I-2 = 64%) and children (RR = 0.50; 95% CI, 0.35 to 0.71; P<0.001). Pooled analyses suggested that spirometry, including FEV1 and FVC, were significantly improved in adults but not in children. Macrolide therapy improved the QoL (WMD, -6.56; 95% CI, -11.99 to -1.12; P = 0.02; I-2 = 86%) but no significant difference in 6MWT (WMD, 4.15; 95% CI, -11.83 to 20.13; P = 0.61; I-2 = 31%) and the overall adverse events (RR, 0.96; 95% CI, 0.82 to 1.13; P = 0.66; I-2 = 0%) in adults. However, reports of diarrhea and abdominal discomforts were higher with macrolide therapy. Conclusions: Macrolide maintenance therapy, both in adults and children, was effective and safe in reducing bronchiectasis exacerbations, but not the admissions for exacerbations. In addition, macrolide administration in adults was associated with improvement in QoL and spirometry, but not 6WMT. Future studies are warranted to verify the optimal populations and clarify its potential effects on antimicrobial resistance.	[Gao, Yong-hua; Guan, Wei-jie; Xu, Gang; Tang, Yan; Gao, Yang; Lin, Zhi-ya; Lin, Zhi-min; Zhong, Nan-shan; Chen, Rong-chang] Guangzhou Med Univ, State Key Lab Resp Dis, Natl Clin Res Ctr Resp Dis, Guangzhou Inst Resp Dis,Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University; State Key Laboratory of Respiratory Disease	Chen, RC (corresponding author), Guangzhou Med Univ, State Key Lab Resp Dis, Natl Clin Res Ctr Resp Dis, Guangzhou Inst Resp Dis,Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China.	ChenRC@vip.163.com	Guan, Wei-jie/K-8257-2019					Altenburg J, 2013, JAMA-J AM MED ASSOC, V309, P1251, DOI 10.1001/jama.2013.1937; Benden C, 2009, TRANSPLANTATION, V87, P1538, DOI 10.1097/TP.0b013e3181a492b2; Cai Y, 2011, J ANTIMICROB CHEMOTH, V66, P968, DOI 10.1093/jac/dkr040; Chalmers JD, 2012, AM J RESP CRIT CARE, V186, P657, DOI 10.1164/rccm.201203-0487OC; Cymbala Alicia A, 2005, Treat Respir Med, V4, P117, DOI 10.2165/00151829-200504020-00005; de Diego A, 2013, RESPIROLOGY IN PRESS, DOI [10.1111/resp.12130, DOI 10.1111/RESP.12130.(ARTICLE]; De Soyza A, 2013, THORAX, V68, P695, DOI 10.1136/thoraxjnl-2012-202893; Evans DJ, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001392.pub2; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jones Paul W, 2005, COPD, V2, P75; Kanoh S, 2010, CLIN MICROBIOL REV, V23, P590, DOI 10.1128/CMR.00078-09; Knirsch CA, 2012, NEW ENGL J MED, V367, P772, DOI [10.1056/NEJMoa1003833, 10.1056/NEJMc1207269]; Koh YY, 1997, EUR RESPIR J, V10, P994, DOI 10.1183/09031936.97.10050994; Kudoh S, 1998, AM J RESP CRIT CARE, V157, P1829, DOI 10.1164/ajrccm.157.6.9710075; Martinez-Garcia MA, 2007, CHEST, V132, P1565, DOI 10.1378/chest.07-0490; Masekela R, 2013, J ANTIVIR ANTIRETROV, V5, P044; Pasteur MC, 2010, THORAX, V65, pI1, DOI 10.1136/thx.2010.136119; Patel IS, 2004, AM J RESP CRIT CARE, V170, P400, DOI 10.1164/rccm.200305-648OC; Poletti V, 2006, EUR RESPIR J, V28, P862, DOI 10.1183/09031936.06.00131805; Reiter J, 2013, ALLERGY, V68, P1040, DOI 10.1111/all.12199; Ringshausen FC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071109; Saynajakangas O, 1997, RESP MED, V91, P395, DOI 10.1016/S0954-6111(97)90251-1; Schembri S, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1235; Seitz AE, 2012, CHEST, V142, P432, DOI 10.1378/chest.11-2209; Seitz AE, 2010, CHEST, V138, P944, DOI 10.1378/chest.10-0099; Serisier DJ, 2013, LANCET RESP MED, V1, P262, DOI 10.1016/S2213-2600(13)70038-9; Serisier DJ, 2013, JAMA-J AM MED ASSOC, V309, P1260, DOI 10.1001/jama.2013.2290; Spagnolo P, 2013, EUR RESPIR J, V42, P239, DOI 10.1183/09031936.00136712; Tsang KWT, 1999, EUR RESPIR J, V13, P361, DOI 10.1183/09031936.99.13236199; Twiss J, 2005, ARCH DIS CHILD, V90, P737, DOI 10.1136/adc.2004.066472; Valery PC, 2013, LANCET RESP MED, V1, P610, DOI 10.1016/S2213-2600(13)70185-1; Wilson CB, 1997, AM J RESP CRIT CARE, V156, P536, DOI 10.1164/ajrccm.156.2.9607083; Wong C, 2012, LANCET, V380, P660, DOI 10.1016/S0140-6736(12)60953-2; Yao GY, 2013, RESPIRATION, V86, P254, DOI 10.1159/000350828	35	34	43	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90047	10.1371/journal.pone.0090047	http://dx.doi.org/10.1371/journal.pone.0090047			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603554	Green Submitted, Green Published, gold			2022-12-27	WOS:000332483600026
J	Ibrahim, N; Varricchio, DJ; Sereno, PC; Wilson, JA; Dutheil, DB; Martill, DM; Baidder, L; Zouhri, S				Ibrahim, Nizar; Varricchio, David J.; Sereno, Paul C.; Wilson, Jeff A.; Dutheil, Didier B.; Martill, David M.; Baidder, Lahssen; Zouhri, Samir			Dinosaur Footprints and Other Ichnofauna from the Cretaceous Kem Kem Beds of Morocco	PLOS ONE			English	Article							TRACE FOSSILS; MENISCATE BURROWS; ICHNOGENUS; MOUNTAINS; ICHNOLOGY; TRACKWAYS; DEPOSITS; RECORD; BASIN	We describe an extensive ichnofossil assemblage from the likely Cenomanian-age 'lower' and 'upper' units of the 'Kem Kem beds' in southeastern Morocco. In the lower unit, trace fossils include narrow vertical burrows in cross-bedded sandstones and borings in dinosaur bone, with the latter identified as the insect ichnotaxon Cubiculum ornatus. In the upper unit, several horizons preserve abundant footprints from theropod dinosaurs. Sauropod and ornithischian footprints are much rarer, similar to the record for fossil bone and teeth in the Kem Kem assemblage. The upper unit also preserves a variety of invertebrate traces including Conichnus (the resting trace of a sea-anemone), Scolicia (a gastropod trace), Beaconites (a probable annelid burrow), and subvertical burrows likely created by crabs for residence and detrital feeding on a tidal flat. The ichnofossil assemblage from the Upper Cretaceous Kem Kem beds contributes evidence for a transition from predominantly terrestrial to marine deposition. Body fossil and ichnofossil records together provide a detailed view of faunal diversity and local conditions within a fluvial and deltaic depositional setting on the northwestern coast of Africa toward the end of the Cretaceous.	[Ibrahim, Nizar; Sereno, Paul C.] Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA; [Varricchio, David J.] Montana State Univ, Dept Earth Sci, Bozeman, MT 59717 USA; [Wilson, Jeff A.] Univ Michigan, Museum Paleontol, Ann Arbor, MI 48109 USA; [Wilson, Jeff A.] Univ Michigan, Dept Earth & Environm Sci, Ann Arbor, MI 48109 USA; [Martill, David M.] Univ Portsmouth, Sch Earth & Environm Sci, Portsmouth, Hants, England; [Baidder, Lahssen; Zouhri, Samir] Univ Hassan 2, Fac Sci Ain Chock, Lab Geosci, Casablanca, Morocco	University of Chicago; Montana State University System; Montana State University Bozeman; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Portsmouth; Hassan II University of Casablanca	Ibrahim, N (corresponding author), Univ Chicago, Dept Organismal Biol & Anat, 1025 E 57Th St, Chicago, IL 60637 USA.	nibrahim@uchicago.edu	Zouhri, Samir/T-7894-2019	Zouhri, Samir/0000-0002-3811-9977; Martill, David/0000-0002-3208-5702; Dutheil, Didier/0000-0002-4856-0918; BAIDDER, Lahssen/0000-0001-5318-7102	David and Lucile Packard Foundation; National Geographic Society; Eppley Foundation for Research; University College Dublin Ad Astra Research Scholarship	David and Lucile Packard Foundation(The David & Lucile Packard Foundation); National Geographic Society(National Geographic Society); Eppley Foundation for Research; University College Dublin Ad Astra Research Scholarship	This research was supported by The David and Lucile Packard Foundation, the National Geographic Society, the Eppley Foundation for Research (PCS) and a University College Dublin Ad Astra Research Scholarship (NI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambroggi R., 1954, NOTES SERVICE GEOLOG, V10, P43; Amiot Romain, 2004, Revue de Paleobiologie Volume Special, V9, P143; Avanzini M, 2005, ACTA PALAEONTOL POL, V50, P743; Avanzini M, 2012, LETHAIA, V45, P238, DOI 10.1111/j.1502-3931.2011.00276.x; Belvedere M, 2013, PALAEOGEOGR PALAEOCL, V383, P52, DOI 10.1016/j.palaeo.2013.04.026; CARPENTER K, 1984, CAN J EARTH SCI, V21, P1491, DOI 10.1139/e84-154; Cau A, 2012, ACTA PALAEONTOL POL, V57, P661, DOI 10.4202/app.2011.0043; Cau Andrea, 2009, Atti della Societa Italiana di Scienze Naturali e del Museo Civico di Storia Naturale in Milano, V150, P239; Cavin L, 2010, J AFR EARTH SCI, V57, P391, DOI 10.1016/j.jafrearsci.2009.12.007; Chamberlain C.K., 1975, STUDY TRACE FOSSILS, P431; CHRISTY JH, 1982, ANIM BEHAV, V30, P687, DOI 10.1016/S0003-3472(82)80139-5; DALESSANDRO A, 1987, PALAEONTOLOGY, V30, P743; Dalla Vecchia Fabio M., 2000, Gaia (Lisboa), V15, P355; de Broin FD, 2002, CR PALEVOL, V1, P275; de Souza Carvalho Ismar, 2004, Ichnos, V11, P311; Dutheil Didier B., 1999, P553; Eisawi AAM, 2011, J AFR EARTH SCI, V61, P233, DOI 10.1016/j.jafrearsci.2011.07.001; Ettachfini EM, 2004, CRETACEOUS RES, V25, P277, DOI [10.1016/j.cretres.2004.01.001, DOI 10.1016/J.CRETRES.2004.01.001]; Ettachfini M, 2008, STRATA SERIE, V2; Ettachfini M, 2005, GEOBIOS, V38, P57; Ezquerra R, 2007, GEOLOGY, V35, P507, DOI 10.1130/G23452A.1; Frey R. W., 1970, GEOL J, V2, P141; FREY RW, 1984, J PALEONTOL, V58, P511; FREY RW, 1981, J PALEONTOL, V55, P800; Gaffney ES, 2006, B AM MUS NAT HIST, P1; Gangloff Roland A., 2004, Ichnos, V11, P299, DOI 10.1080/10420940490442269; Gatesy SM, 1999, NATURE, V399, P141, DOI 10.1038/20167; Goldring R, 2005, CRETACEOUS RES, V26, P665, DOI 10.1016/j.cretres.2005.03.001; Hantzschel W, 1966, TREATISE INVERTEBRAT, VW, P177; Hasiotis S.T., 1992, Short Courses in Paleontology, P64; HASIOTIS S.T, 2002, SEPM SHORT COURSE NO, V51, P1; Hasiotis ST, 2005, ICHNOS, V2, P315; Hembree DI, 2005, J PALEONTOL, V79, P583, DOI 10.1666/0022-3360(2005)079<0583:TENIAI>2.0.CO;2; Ibrahim N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010875; Kennedy WJ, 2008, BULL INST R SC N B-S, V78, P149; Lavocat R., 1954, C GEOLOGIQUE INT ALG, V15, P65; Lavocat R., 1954, NOTES MEM SERV GEOL, V116, P1; Lee YN, 1997, J PALEONTOL, V71, P1147, DOI 10.1017/S0022336000036088; Li RH, 2008, NATURWISSENSCHAFTEN, V95, P185, DOI 10.1007/s00114-007-0310-7; Lockley Martin G., 2004, Ichnos, V11, P285, DOI 10.1080/10420940490428742; Lockley Martin G., 1994, Ichnos, V3, P213; Lockley Martin G., 1998, Modern Geology, V23, P331; Lockley MG, 1992, ASPECTS NONMARINE CR, P269; LOCKLEY MG, 1994, MESOZOIC SYSTEMS ROC, P95; Mahler L, 2005, J VERTEBR PALEONTOL, V25, P236, DOI 10.1671/0272-4634(2005)025[0236:ROADTF]2.0.CO;2; Martill DM, 2011, CRETACEOUS RES, V32, P433, DOI 10.1016/j.cretres.2011.01.005; Marty D, 2010, HIST BIOL, V22, P109, DOI 10.1080/08912960903503345; Masrour Moussa, 2013, Geogaceta, V53, P33; Mazzetta GV, 2001, ACTA PALAEONTOL POL, V46, P235; MCCARTHY B, 1979, J PALEONTOL, V53, P345; McGowan AJ, 2009, GEOLOGY, V37, P843, DOI 10.1130/G30188A.1; Mezga A, 1999, CRETACEOUS RES, V20, P735, DOI 10.1006/cres.1999.0180; Milan Jesper, 2010, Bulletin of the New Mexico Museum of Natural History and Science, V51, P15; Nicosia Umberto, 2007, Ichnos, V14, P69, DOI 10.1080/10420940601006859; Paczesna J, 2010, ACTA GEOL POL, V60, P93; PEMBERTON SG, 1988, CAN J EARTH SCI, V25, P866, DOI 10.1139/e88-085; PEMBERTON SG, 1988, J PALEONTOL, V62, P495; Perez-Lorente F., 2006, Geogaceta, V40, P159; Radley JD, 1998, CRETACEOUS RES, V19, P471, DOI 10.1006/cres.1997.0107; Roberts EM, 2007, J PALEONTOL, V81, P201, DOI 10.1666/0022-3360(2007)81[201:CIBIDB]2.0.CO;2; Russell Dale A., 1996, Bulletin du Museum National d'Histoire Naturelle Section C Sciences de la Terre Paleontologie Geologie Mineralogie, V18, P349; Sarjeant WAS, 2008, ICHNOS, V6, P183; Savrda Charles E., 2002, Ichnos, V9, P33, DOI 10.1080/10420940190034058; Sereno PC, 2009, ZOOKEYS, P1, DOI 10.3897/zookeys.28.325; Sereno PC, 1996, SCIENCE, V272, P986, DOI 10.1126/science.272.5264.986; Sidor C. A., 1997, Journal of Vertebrate Paleontology, V17, p76A; Smith JJ, 2008, J PALEONTOL, V82, P267, DOI 10.1666/06-023.1; Snow FH, 1887, T KANSAS ACAD SCI, V10, P3; Souto de PRF, 2010, NEW MEXICO MUSEUM NA, V51, P201; SQUIRES RL, 1984, J PALEONTOL, V58, P593; Sternberg CM, 1932, NATL MUSEUM CAN B, V42, P59; Taquet, 1984, ORME DINOSAURI, P165; Thulborn RA, 1990, DINOSAUR TRACES; TREWIN NH, 1994, PALAEONTOLOGY, V37, P811; VOSSLER SM, 1989, PALAEOGEOGR PALAEOCL, V74, P217, DOI 10.1016/0031-0182(89)90062-X; Wellnhofer Peter, 1999, Palaeontologische Zeitschrift, V73, P133; Whyte Martin A., 1994, Gaia, V10, P15; Wilson JA, 2005, PALEOBIOLOGY, V31, P400, DOI 10.1666/0094-8373(2005)031[0400:IIABFR]2.0.CO;2; Wright JL, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P252; Yabumoto Yoshitaka, 2005, Bulletin of the National Science Museum Series C (Geology & Paleontology), V31, P39; Zouhri S, 2008, CONTINENTAL EVOLUTIO, P331, DOI DOI 10.1007/978-3-540-77076-3_7	81	31	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90751	10.1371/journal.pone.0090751	http://dx.doi.org/10.1371/journal.pone.0090751			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603467	Green Published, gold, Green Submitted			2022-12-27	WOS:000332483600080
J	Pallucca, R; Visconti, S; Camoni, L; Cesareni, G; Melino, S; Panni, S; Torreri, P; Aducci, P				Pallucca, Roberta; Visconti, Sabina; Camoni, Lorenzo; Cesareni, Giovanni; Melino, Sonia; Panni, Simona; Torreri, Paola; Aducci, Patrizia			Specificity of epsilon and Non-epsilon Isoforms of Arabidopsis 14-3-3 Proteins Towards the H+-ATPase and Other Targets	PLOS ONE			English	Article							PLANT PLASMA-MEMBRANE; SUCROSE-PHOSPHATE SYNTHASE; CRYSTAL-STRUCTURE; BINDING; PHOSPHORYLATION; 14-3-3-PROTEIN; PEPTIDE; YEAST; ACID; POLYAMINES	14-3-3 proteins are a family of ubiquitous dimeric proteins that modulate many cellular functions in all eukaryotes by interacting with target proteins. 14-3-3s exist as a number of isoforms that in Arabidopsis identifies two major groups named epsilon and non-epsilon. Although isoform specificity has been demonstrated in many systems, the molecular basis for the selection of specific sequence contexts has not been fully clarified. In this study we have investigated isoform specificity by measuring the ability of different Arabidopsis 14-3-3 isoforms to activate the H+-ATPase. We observed that GF14 isoforms of the non-epsilon group were more effective than epsilon group isoforms in the interaction with the H+-ATPase and in the stimulation of its activity. Kinetic and thermodynamic parameters of the binding of GF14 epsilon and GF14 omega isoforms, representative of epsilon and non-epsilon groups respectively, with the H+-ATPase, have been determined by Surface Plasmon Resonance analysis demonstrating that the higher affinity of GF14 omega is mainly due to slower dissociation. The role of the C-terminal region and of a Gly residue located in the loop 8 and conserved in all non-epsilon isoforms has also been studied by deletion and site-specific mutagenesis. The C-terminal domains, despite their high divergence, play an auto-inhibitory role in both isoforms and they, in addition to a specific residue located in the loop 8, contribute to isoform specificity. To investigate the generality of these findings, we have used the SPOT-synthesis technology to array a number of phosphopeptides matching known or predicted 14-3-3 binding sites present in a number of clients. The results of this approach confirmed isoform specificity in the recognition of several target peptides, suggesting that the isoform specificity may have an impact on the modulation of a variety of additional protein activities, as suggested by probing of a phosphopeptide array with members of the two 14-3-3 groups.	[Pallucca, Roberta; Visconti, Sabina; Camoni, Lorenzo; Cesareni, Giovanni; Aducci, Patrizia] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy; [Melino, Sonia] Univ Roma Tor Vergata, Dept Sci & Chem Technol, Rome, Italy; [Panni, Simona] Univ Calabria, Dept DiBEST, I-87036 Arcavacata Di Rende, Italy; [Torreri, Paola] Ist Super Sanita, Dept Cell Biol & Neurosci, I-00161 Rome, Italy; [Cesareni, Giovanni] Res Inst Fdn Santa Lucia, IRCSS, Rome, Italy	University of Rome Tor Vergata; University of Rome Tor Vergata; University of Calabria; Istituto Superiore di Sanita (ISS); IRCCS Santa Lucia	Visconti, S (corresponding author), Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy.	visconti@uniroma2.it	Cesareni, Gianni/AAW-1382-2020; TORRERI, PAOLA/A-6656-2015	TORRERI, PAOLA/0000-0002-0488-956X; panni, simona/0000-0002-7500-4028; MELINO, SONIA/0000-0001-7694-5279	Regione Lazio, Fondo per lo Sviluppo Economico, la Ricerca e l'Innovazione	Regione Lazio, Fondo per lo Sviluppo Economico, la Ricerca e l'Innovazione	This work has been supported by Regione Lazio, Fondo per lo Sviluppo Economico, la Ricerca e l'Innovazione. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Aducci P, 2002, IUBMB LIFE, V53, P49, DOI 10.1080/15216540210813; Alsterfjord M, 2004, PLANT CELL PHYSIOL, V45, P1202, DOI 10.1093/pcp/pch136; Athwal GS, 2002, PLANT J, V29, P119, DOI 10.1046/j.0960-7412.2001.01200.x; Baunsgaard L, 1998, PLANT J, V13, P661, DOI 10.1046/j.1365-313X.1998.00083.x; Bornke F, 2005, J PLANT PHYSIOL, V162, P161, DOI 10.1016/j.jplph.2004.09.006; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bunney TD, 2001, P NATL ACAD SCI USA, V98, P4249, DOI 10.1073/pnas.061437498; Camoni L, 2000, J BIOL CHEM, V275, P9919, DOI 10.1074/jbc.275.14.9919; Camoni L, 1998, FEBS LETT, V430, P381, DOI 10.1016/S0014-5793(98)00696-6; Camoni L, 2001, J BIOL CHEM, V276, P31709, DOI 10.1074/jbc.M104194200; Camoni L, 2013, IUBMB LIFE, V65, P513, DOI 10.1002/iub.1167; Camoni L, 2012, IUBMB LIFE, V64, P710, DOI 10.1002/iub.1058; Chevalier D, 2009, ANNU REV PLANT BIOL, V60, P67, DOI 10.1146/annurev.arplant.59.032607.092844; Coblitz B, 2006, FEBS LETT, V580, P1531, DOI 10.1016/j.febslet.2006.02.014; Denison FC, 2011, SEMIN CELL DEV BIOL, V22, P720, DOI 10.1016/j.semcdb.2011.08.006; Duby G, 2009, PFLUG ARCH EUR J PHY, V457, P645, DOI 10.1007/s00424-008-0457-x; FERL RJ, 1994, GENETICA, V92, P129, DOI 10.1007/BF00163762; Frank R, 2002, J IMMUNOL METHODS, V267, P13, DOI 10.1016/S0022-1759(02)00137-0; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Fuglsang AT, 1999, J BIOL CHEM, V274, P36774, DOI 10.1074/jbc.274.51.36774; Fullone MR, 1998, J BIOL CHEM, V273, P7698, DOI 10.1074/jbc.273.13.7698; Gampala SS, 2007, DEV CELL, V13, P177, DOI 10.1016/j.devcel.2007.06.009; Garnier J, 1996, METHOD ENZYMOL, V266, P540; Garufi A, 2007, PLANT CELL PHYSIOL, V48, P434, DOI 10.1093/pcp/pcm010; Harthill JE, 2006, PLANT J, V47, P211, DOI 10.1111/j.1365-313X.2006.02780.x; Huber SC, 2002, PLANT MOL BIOL, V50, P1053, DOI 10.1023/A:1021284002779; Johnson C, 2010, BIOCHEM J, V427, P69, DOI 10.1042/BJ20091834; Kinoshita T, 2003, PLANT PHYSIOL, V133, P1453, DOI 10.1104/pp.103.029629; Kulma A, 2004, PLANT J, V37, P654, DOI 10.1111/j.1365-313X.2003.01992.x; Lambeck I, 2010, BIOCHEMISTRY-US, V49, P8177, DOI 10.1021/bi1003487; Latz A, 2007, PLANT J, V52, P449, DOI 10.1111/j.1365-313X.2007.03255.x; LIU D, 1995, NATURE, V376, P191, DOI 10.1038/376191a0; LU GH, 1994, PLANT CELL, V6, P501, DOI 10.1105/tpc.6.4.501; LU GH, 1994, PLANT PHYSIOL, V105, P1459, DOI 10.1104/pp.105.4.1459; Manak MS, 2007, BIOCHEMISTRY-US, V46, P1055, DOI 10.1021/bi061366c; Marra M, 2000, PLANT BIOLOGY, V2, P11, DOI 10.1055/s-2000-9458; Moorhead G, 1999, PLANT J, V18, P1, DOI 10.1046/j.1365-313X.1999.00417.x; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Obsil T, 2001, CELL, V105, P257, DOI 10.1016/S0092-8674(01)00316-6; Oecking C, 2009, CURR OPIN PLANT BIOL, V12, P760, DOI 10.1016/j.pbi.2009.08.003; Ottmann C, 2007, MOL CELL, V25, P427, DOI 10.1016/j.molcel.2006.12.017; Panni S, 2011, PROTEOMICS, V11, P128, DOI 10.1002/pmic.201000030; Paul AL, 2005, MOL BIOL CELL, V16, P1735, DOI 10.1091/mbc.E04-09-0839; Paul AL, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00190; Petosa C, 1998, J BIOL CHEM, V273, P16305, DOI 10.1074/jbc.273.26.16305; REGENBERG B, 1995, PLANT CELL, V7, P1655, DOI 10.1105/tpc.7.10.1655; Rienties IM, 2005, PLANTA, V221, P394, DOI 10.1007/s00425-004-1447-7; Rosenquist M, 2000, J MOL EVOL, V51, P446, DOI 10.1007/s002390010107; Rosenquist M, 2001, PLANT PHYSIOL, V127, P142, DOI 10.1104/pp.127.1.142; Sehnke PC, 2006, PLANT PHYSIOL, V140, P647, DOI 10.1104/pp.105.073916; Sehnke PC, 2000, PLANT PHYSIOL, V122, P235, DOI 10.1104/pp.122.1.235; Sehnke PC, 2002, PLANT MOL BIOL, V50, P1011, DOI 10.1023/A:1021289127519; Sehnke PC, 2001, P NATL ACAD SCI USA, V98, P765, DOI 10.1073/pnas.021304198; Shen W, 2003, PLANT J, V34, P473, DOI 10.1046/j.1365-313X.2003.01739.x; Sinnige MP, 2005, PLANT J, V44, P1001, DOI 10.1111/j.1365-313X.2005.02599.x; Sirichandra C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013935; Sullivan S, 2009, FEBS LETT, V583, P2187, DOI 10.1016/j.febslet.2009.06.011; Toroser D, 1998, FEBS LETT, V435, P110, DOI 10.1016/S0014-5793(98)01048-5; Truong AB, 2002, PROTEINS, V49, P321, DOI 10.1002/prot.10210; Tseng TS, 2012, PLANT CELL, V24, P1114, DOI 10.1105/tpc.111.092130; VILLALBA JM, 1992, J BIOL CHEM, V267, P12341; Visconti S, 2003, J BIOL CHEM, V278, P8172, DOI 10.1074/jbc.M211039200; Visconti S, 2008, PLANT CELL PHYSIOL, V49, P1887, DOI 10.1093/pcp/pcn172; Vysotskii DA, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.22672; Wilker EW, 2005, J BIOL CHEM, V280, P18891, DOI 10.1074/jbc.M500982200; Wurtele M, 2003, EMBO J, V22, P987, DOI 10.1093/emboj/cdg104; Xiao Bing, 1995, Nature (London), V376, P188, DOI 10.1038/376188a0; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0	69	38	40	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90764	10.1371/journal.pone.0090764	http://dx.doi.org/10.1371/journal.pone.0090764			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603559	Green Submitted, gold, Green Published			2022-12-27	WOS:000332483600083
J	Seizova-Cajic, T; Taylor, JL				Seizova-Cajic, Tatjana; Taylor, Janet L.			Somatosensory Space Abridged: Rapid Change in Tactile Localization Using a Motion Stimulus	PLOS ONE			English	Article							CUTANEOUS RABBIT; CORTEX; LENGTH	Introduction: Organization of tactile input into somatotopic maps enables us to localize stimuli on the skin. Temporal relationships between stimuli are important in maintaining the maps and influence perceived locations of discrete stimuli. This points to the spatiotemporal stimulation sequences experienced as motion as a potential powerful organizing principle for spatial maps. We ask whether continuity of the motion determines perceived location of areas in the motion path using a novel tactile stimulus designed to 'convince' the brain that a patch of skin does not exist by rapidly skipping over it. Method: Two brushes, fixed 9 cm apart, moved back and forth along the forearm (at 14.5 cm s(-1)), crossing a 10-cm long 'occluder', which prevented skin stimulation in the middle of the motion path. Crucially, only one brush contacted the skin at any one time, and the occluder was traversed almost instantaneously. Participants pointed with the other arm towards the felt location of the brush when it was briefly halted during repetitive motion, and also reported where they felt they had been brushed. Results: Participants did not report the 10-cm gap in stimulation - the motion path was perceptually completed. Pointing results showed that brush path was 'abridged': locations immediately on either side of the occluder, as well as location at the ends of the brush path, were perceived to be >3 cm closer to each other than in the control condition (F(1,9) =7.19; p = .025 and F(1,9) = 6.02, p = .037 respectively). This bias increased with prolonged stimulation. Conclusions: An illusion of completion induced by our Abridging stimulus is accompanied by gross mislocalization, suggesting that motion determines perceived locations. The effect reveals the operation of Gestalt principles in touch and suggests the existence of dynamic maps that quickly adjust to the current input pattern.	[Taylor, Janet L.] Neurosci Res Australia, Sydney, NSW, Australia; [Taylor, Janet L.] Univ New S Wales, Sydney, NSW, Australia; [Seizova-Cajic, Tatjana] Univ Sydney, Fac Hlth Sci, Sydney, NSW 2006, Australia	Neuroscience Research Australia; University of New South Wales Sydney; University of Sydney	Seizova-Cajic, T (corresponding author), Univ Sydney, Fac Hlth Sci, Sydney, NSW 2006, Australia.	tatjana.seizova-cajic@sydney.edu.au	Seizova-Cajic, Tatjana/A-5916-2016; Taylor, Janet L/C-9667-2011	Seizova-Cajic, Tatjana/0000-0002-8319-4095; Taylor, Janet L/0000-0001-8976-5162	Australian Research Council [DP110104691]; National Health and Medical Research Council of Australia	Australian Research Council(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Australian Research Council Discovery grant DP110104691 to TSC. JT holds a Senior Research Fellowship from the National Health and Medical Research Council of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boring E.G., 1950, CENTURY; Braun C, 2000, J NEUROSCI, V20, P446, DOI 10.1523/JNEUROSCI.20-01-00446.2000; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Cholewiak RW, 1999, PERCEPTION, V28, P851, DOI 10.1068/p2873; Cousineau D, 2005, TUTOR QUANT METHODS, V1, P42, DOI 10.20982/tqmp.01.1.p042; Darian-Smith C., 2008, SENSES COMPREHENSIVE, V6, P259, DOI [10.1016/B978-012370880-9.00356-X, DOI 10.1016/B978-012370880-9.00356-X]; Dinse HR, 2002, PERCEPTUAL LEARNING, P19; Flach R, 2006, J EXP PSYCHOL HUMAN, V32, P717, DOI 10.1037/0096-1523.32.3.717; Gallace A, 2011, PSYCHOL BULL, V137, P538, DOI 10.1037/a0022335; GELDARD FA, 1972, SCIENCE, V178, P178, DOI 10.1126/science.178.4057.178; GELDARD FA, 1976, SENS PROCESS, V1, P77; Goldreich D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000333; Goldreich D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00221; Heiko N, 2003, PERCEPTUAL COMPLETIO, P151; Helson H, 1931, J EXP PSYCHOL, V14, P202, DOI 10.1037/h0071164; KILGARD MP, 1995, NATURE, V373, P663, DOI 10.1038/373663a0; KOENDERINK JJ, 1990, PSYCHOL RES-PSYCH FO, V52, P122, DOI 10.1007/BF00877519; KOHONEN T, 1990, P IEEE, V78, P1464, DOI 10.1109/5.58325; Krubitzer L., 2008, SENSES COMPREHENSIVE, V6, P183; Martin R, 2009, ENCY NEUROSCIENCE, P551; Merzenich M M, 1993, J Hand Ther, V6, P89; Pei YC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000305; Penfield W, 1937, BRAIN, V60, P389, DOI 10.1093/brain/60.4.389; Pessoa L, 1998, BEHAV BRAIN SCI, V21, P723; Pessoa L, 2003, PERCEPTUAL COMPLETIO; RAMACHANDRAN VS, 1992, NATURE, V356, P115, DOI 10.1038/356115a0; SUR M, 1995, NATURE, V378, P13, DOI 10.1038/378013a0; Todorovic D, 2011, HUMANA MENTE, P1; Wertheimer M, 1923, READINGS PERCEPTION; WHITSEL BL, 1986, SOMATOSENS MOT RES, V3, P185, DOI 10.3109/07367228609144583; Wiemer J, 2000, BIOL CYBERN, V82, P173, DOI 10.1007/s004220050017	31	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90892	10.1371/journal.pone.0090892	http://dx.doi.org/10.1371/journal.pone.0090892			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603595	Green Published, gold, Green Submitted			2022-12-27	WOS:000332483600102
J	Vadivel, A; Alphonse, RS; Ionescu, L; Machado, DS; O'Reilly, M; Eaton, F; Haromy, A; Michelakis, ED; Thebaud, B				Vadivel, Arul; Alphonse, Rajesh S.; Ionescu, Lavinia; Machado, Desiree S.; O'Reilly, Megan; Eaton, Farah; Haromy, Al; Michelakis, Evangelos D.; Thebaud, Bernard			Exogenous Hydrogen Sulfide (H2S) Protects Alveolar Growth in Experimental O-2-Induced Neonatal Lung Injury	PLOS ONE			English	Article							INHALED NITRIC-OXIDE; BRONCHOPULMONARY DYSPLASIA; PULMONARY-HYPERTENSION; INCREASES SURVIVAL; PRETERM INFANTS; SMOOTH-MUSCLE; HYPEROXIA; DISEASE; DAMAGE; CELLS	Background: Bronchopulmonary dysplasia (BPD), the chronic lung disease of prematurity, remains a major health problem. BPD is characterized by impaired alveolar development and complicated by pulmonary hypertension (PHT). Currently there is no specific treatment for BPD. Hydrogen sulfide (H2S), carbon monoxide and nitric oxide (NO), belong to a class of endogenously synthesized gaseous molecules referred to as gasotransmitters. While inhaled NO is already used for the treatment of neonatal PHT and currently tested for the prevention of BPD, H2S has until recently been regarded exclusively as a toxic gas. Recent evidence suggests that endogenous H2S exerts beneficial biological effects, including cytoprotection and vasodilatation. We hypothesized that H2S preserves normal alveolar development and prevents PHT in experimental BPD. Methods: We took advantage of a recently described slow-releasing H2S donor, GYY4137 (morpholin-4-ium-4-methoxyphenyl(morpholino) phosphinodithioate) to study its lung protective potential in vitro and in vivo. Results: In vitro, GYY4137 promoted capillary-like network formation, viability and reduced reactive oxygen species in hyperoxia-exposed human pulmonary artery endothelial cells. GYY4137 also protected mitochondrial function in alveolar epithelial cells. In vivo, GYY4137 preserved and restored normal alveolar growth in rat pups exposed from birth for 2 weeks to hyperoxia. GYY4137 also attenuated PHT as determined by improved pulmonary arterial acceleration time on echo-Doppler, pulmonary artery remodeling and right ventricular hypertrophy. GYY4137 also prevented pulmonary artery smooth muscle cell proliferation. Conclusions: H2S protects from impaired alveolar growth and PHT in experimental O-2-induced lung injury. H2S warrants further investigation as a new therapeutic target for alveolar damage and PHT.	[Vadivel, Arul; Thebaud, Bernard] Univ Ottawa, Sprott Ctr Stem Cell Res, Ottawa Hosp Res Inst, Regenerat Med Program, Ottawa, ON, Canada; [Vadivel, Arul; Thebaud, Bernard] Univ Ottawa, Childrens Hosp Eastern Ontario, Ottawa, ON, Canada; [Alphonse, Rajesh S.; Ionescu, Lavinia; Machado, Desiree S.; O'Reilly, Megan; Eaton, Farah; Haromy, Al; Michelakis, Evangelos D.] Univ Alberta, Sch Human Dev, Dept Pediat, Women & Childrens Hlth Res Inst,Cardiovasc Res Ct, Edmonton, AB, Canada; [Alphonse, Rajesh S.; Ionescu, Lavinia; Machado, Desiree S.; O'Reilly, Megan; Eaton, Farah; Haromy, Al; Michelakis, Evangelos D.] Univ Alberta, Pulm Res Grp, Edmonton, AB, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Children's Hospital of Eastern Ontario; University of Alberta; University of Alberta	Thebaud, B (corresponding author), Univ Ottawa, Sprott Ctr Stem Cell Res, Ottawa Hosp Res Inst, Regenerat Med Program, Ottawa, ON, Canada.	bthebaud@ohri.ca			Canadian Institutes of Health Research (CIHR); Maternal Fetal Neonatal Health Training Program (MFN); CIHR-IHDCYH; Alberta Innovates Health Solutions (AIHS); CIHR; AIHS; Canada Foundation for Innovation (CFI); Canada Research Chairs Program; Stollery Children's Hospital Foundation	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Maternal Fetal Neonatal Health Training Program (MFN); CIHR-IHDCYH(Canadian Institutes of Health Research (CIHR)); Alberta Innovates Health Solutions (AIHS); CIHR(Canadian Institutes of Health Research (CIHR)); AIHS; Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); Canada Research Chairs Program(Canada Research Chairs); Stollery Children's Hospital Foundation	This work was supported by the Canadian Institutes of Health Research (CIHR). AV and LI were supported by a stipend from the Maternal Fetal Neonatal Health Training Program (MFN) sponsored by CIHR-IHDCYH. RAS was supported by a stipend from Alberta Innovates Health Solutions (AIHS). BT and EDM were supported by CIHR, AIHS, Canada Foundation for Innovation (CFI), and the Canada Research Chairs Program. BT was also supported by the Stollery Children's Hospital Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alphonse RS, 2011, AM J RESP CELL MOL, V44, P146, DOI 10.1165/rcmb.2009-0182OC; Archer SL, 2004, CIRC RES, V95, P308, DOI 10.1161/01.RES.0000137173.42723.fb; Balasubramaniam V, 2006, AM J PHYSIOL-LUNG C, V291, pL119, DOI 10.1152/ajplung.00395.2005; Berkelhamer SK, 2013, SEMIN PERINATOL, V37, P124, DOI 10.1053/j.semperi.2013.01.009; Bland RD, 2005, AM J RESP CRIT CARE, V172, P899, DOI 10.1164/rccm.200503-384OC; Cai WJ, 2007, CARDIOVASC RES, V76, P29, DOI 10.1016/j.cardiores.2007.05.026; Chen YH, 2012, RESP PHYSIOL NEUROBI, V184, P130, DOI 10.1016/j.resp.2012.03.009; Cho HY, 2012, ANTIOXID REDOX SIGN, V17, P1066, DOI 10.1089/ars.2011.4288; Esteve JM, 1999, FASEB J, V13, P1055, DOI 10.1096/fasebj.13.9.1055; Faller S, 2012, MED GAS RES, V2, DOI 10.1186/2045-9912-2-26; Faller S, 2010, ANESTHESIOLOGY, V113, P104, DOI 10.1097/ALN.0b013e3181de7107; Francis RC, 2011, ANESTHESIOLOGY, V115, P1012, DOI 10.1097/ALN.0b013e31823306cf; FREEMAN BA, 1981, J BIOL CHEM, V256, P986; Iams JD, 2008, LANCET, V371, P164, DOI 10.1016/S0140-6736(08)60108-7; Jankov RP, 2006, PEDIATR RES, V60, P245, DOI 10.1203/01.pdr.0000233056.37254.0b; Kinsella JP, 2006, LANCET, V367, P1421, DOI 10.1016/S0140-6736(06)68615-7; Kotecha SJ, 2013, THORAX, V68, P760, DOI 10.1136/thoraxjnl-2012-203079; Ladha F, 2005, AM J RESP CRIT CARE, V172, P750, DOI 10.1164/rccm.200503-510OC; Li L, 2008, CIRCULATION, V117, P2351, DOI 10.1161/CIRCULATIONAHA.107.753467; McCurnin DC, 2005, AM J PHYSIOL-LUNG C, V288, pL450, DOI 10.1152/ajplung.00347.2004; McGrath-Morrow S, 2009, AM J PHYSIOL-LUNG C, V296, pL565, DOI 10.1152/ajplung.90487.2008; Meng QH, 2007, AM J PATHOL, V170, P1406, DOI 10.2353/ajpath.2007.060939; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Mourani PM, 2013, CURR OPIN PEDIATR, V25, P329, DOI 10.1097/MOP.0b013e328360a3f6; Muellner MK, 2009, BIOCHEM J, V420, P277, DOI 10.1042/BJ20082421; Pierro M, 2013, THORAX, V68, P475, DOI 10.1136/thoraxjnl-2012-202323; Rajendrasozhan S, 2008, AM J RESP CRIT CARE, V177, P861, DOI 10.1164/rccm.200708-1269OC; Shah PS, 2012, J PERINATOL, V32, P132, DOI 10.1038/jp.2011.68; Singleton PA, 2009, CIRC RES, V104, P978, DOI 10.1161/CIRCRESAHA.108.193367; Soll RF, 2012, NEONATOLOGY, V102, P251, DOI 10.1159/000338552; Sutendra G., 2010, SCI TRANSL MED, V2; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P917, DOI 10.1038/nrd2425; Tang XQ, 2008, CLIN EXP PHARMACOL P, V35, P180, DOI 10.1111/j.1440-1681.2007.04799.x; Thebaud B, 2005, CIRCULATION, V112, P2477, DOI 10.1161/CIRCULATIONAHA.105.541524; Vadivel A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067225; van Haaften T, 2009, AM J RESP CRIT CARE, V180, P1131, DOI 10.1164/rccm.200902-0179OC; Wang T, 2012, AM J RESP CELL MOL, V47, P491, DOI 10.1165/rcmb.2011-0248OC; Zheng ZZ, 2007, INT J BIOCHEM CELL B, V39, P340, DOI 10.1016/j.biocel.2006.09.001	38	40	40	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90965	10.1371/journal.pone.0090965	http://dx.doi.org/10.1371/journal.pone.0090965			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603989	gold, Green Published, Green Submitted			2022-12-27	WOS:000332483600117
J	Wu, XD; Liang, HY; Tan, Y; Yuan, C; Li, SJ; Li, XW; Li, GP; Shi, YS; Zhang, XM				Wu, Xidong; Liang, Huiyu; Tan, Yan; Yuan, Chao; Li, Shuji; Li, Xiaowen; Li, Guiping; Shi, Yusheng; Zhang, Xingmei			Cell-SELEX Aptamer for Highly Specific Radionuclide Molecular Imaging of Glioblastoma In Vivo	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; EGFRVIII	Glioblastoma (GBM) is the most frequent and aggressive primary adult brain tumor with poor prognosis. Epidermal growth factor receptor variant III (EGFRvIII) is the most common and highly oncogenic EGFR mutant in GBM. With the aim to generate specific molecular probes able to target EGFRvIII with high affinity, we selected four DNA aptamers (U2, U8, U19 and U31) specifically bound to U87-EGFRvIII cells that over expressed EGFRvIII with K-d values in the nanomole range by a cell-based systematic evolution of ligands by exponential enrichment (cell-SELEX) process. U87MG cells were introduced as control cells for counter selection. We further affirmed U2 and U8 identified EGFRvIII on the surface of target cells specifically. Then we radiolabeled U2 with 188Re to serve as a molecular imaging probe and observed 188Re -labeled U2 significantly targeted EGFRvIII over-expressing glioblastoma exnografts in mice. In conclusion, aptamers obtained from whole cell-SELEX strategy have great potential as molecular imaging probes that are probably beneficial to GBM diagnoses.	[Wu, Xidong; Liang, Huiyu; Tan, Yan; Li, Shuji; Li, Xiaowen; Zhang, Xingmei] Southern Med Univ, Sch Basic Med Sci, Dept Neurobiol, Guangzhou, Guangdong, Peoples R China; [Yuan, Chao] Southern Med Univ, Nanfang Hosp, Dept Neurol, Guangzhou, Guangdong, Peoples R China; [Li, Guiping] Southern Med Univ, Nanfang Hosp, Dept Nucl Med, Guangzhou, Guangdong, Peoples R China; [Shi, Yusheng] Southern Med Univ, Nanfang Hosp, Dept Radiat Oncol, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China; Southern Medical University - China; Southern Medical University - China	Shi, YS (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Radiat Oncol, Guangzhou, Guangdong, Peoples R China.	390637670@qq.com; zxmray@hotmail.com		zhang, xingmei/0000-0001-9548-1289	National Science Foundation of China [30973481, 81272509]; Guangdong Natural Science Foundation [9151051501000053, 07005145]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province)	This work was supported by grants from the National Science Foundation of China (No. 30973481 and No. 81272509) and the Guangdong Natural Science Foundation (No. 9151051501000053 and No. 07005145). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argyrou Maria, 2013, Int J Mol Imaging, V2013, P290750, DOI 10.1155/2013/290750; Boockvar JA, 2003, MOL CELL NEUROSCI, V24, P1116, DOI 10.1016/j.mcn.2003.09.011; Cheng Y, 2013, ADV DRUG DELIV REV; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Da Pieve C, 2009, NUCL MED BIOL, V36, P703, DOI 10.1016/j.nucmedbio.2009.04.004; Dunn GP, 2012, GENE DEV, V26, P756, DOI 10.1101/gad.187922.112; Gan HK, 2013, FEBS J, V280, P5350, DOI 10.1111/febs.12393; Gomes SD, 2012, BIOCONJUGATE CHEM, V23, P2192, DOI 10.1021/bc300146c; Hicke BJ, 2006, J NUCL MED, V47, P668; Hosseinimehr SJ, 2012, DRUG DISCOV TODAY, V17, P1224, DOI 10.1016/j.drudis.2012.07.002; Jeong JM, 2008, SEMIN NUCL MED, V38, pS19, DOI 10.1053/j.semnuclmed.2007.10.003; Keefe AD, 2010, NAT REV DRUG DISCOV, V9, P537, DOI 10.1038/nrd3141; Lambert B, 2005, J NUCL MED, V46, P60; Lambert B, 2009, Q J NUCL MED MOL IM, V53, P305; Lepareur Nicolas, 2012, Int J Mol Imaging, V2012, P278306, DOI 10.1155/2012/278306; MANKOFF DA, 2007, J NUCL MED, V48; Mukherjee B, 2009, CANCER RES, V69, P4252, DOI 10.1158/0008-5472.CAN-08-4853; Ramnarain DB, 2006, CANCER RES, V66, P867, DOI 10.1158/0008-5472.CAN-05-2753; Sefah K, 2010, NAT PROTOC, V5, P1169, DOI 10.1038/nprot.2010.66; Shi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070476; Shi H, 2010, CHEM-ASIAN J, V5, P2209, DOI 10.1002/asia.201000242; Tao F, 2010, DRUG DEVELOP RES, V71, P99, DOI 10.1002/ddr.20331; Van Meir EG, 2010, CA-CANCER J CLIN, V60, P166, DOI 10.3322/caac.20069; Varmira K, 2013, J DRUG TARGET; Wykosky Jill, 2011, Chin J Cancer, V30, P5; Zhan Y, 2004, CANCER RES, V64, P8292, DOI 10.1158/0008-5472.CAN-03-3143	26	46	50	3	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90752	10.1371/journal.pone.0090752	http://dx.doi.org/10.1371/journal.pone.0090752			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603483	Green Submitted, Green Published, gold			2022-12-27	WOS:000332483600081
J	Painer, J; Jewgenow, K; Dehnhard, M; Arnemo, JM; Linnell, JDC; Odden, J; Hildebrandt, TB; Goeritz, F				Painer, Johanna; Jewgenow, Katarina; Dehnhard, Martin; Arnemo, Jon M.; Linnell, John D. C.; Odden, John; Hildebrandt, Thomas B.; Goeritz, Frank			Physiologically Persistent Corpora lutea in Eurasian Lynx (Lynx lynx) - Longitudinal Ultrasound and Endocrine Examinations Intra-Vitam	PLOS ONE			English	Article							OVARIAN; CAT; PSEUDOPREGNANCY; MAINTENANCE; MORTALITY; EVOLUTION; PREGNANCY; PHENOLOGY; PATTERNS; RATES	Felids generally follow a poly-estrous reproductive strategy. Eurasian lynx (Lynx lynx) display a different pattern of reproductive cyclicity where physiologically persistent corpora lutea (CLs) induce a mono-estrous condition which results in highly seasonal reproduction. The present study was based around a sono-morphological and endocrine study of captive Eurasian lynx, and a control-study on free-ranging lynx. We verified that CLs persist after pregnancy and pseudo-pregnancy for at least a two-year period. We could show that lynx are able to enter estrus in the following year, while CLs from the previous years persisted in structure and only temporarily reduced their function for the period of estrus onset or birth, which is unique among felids. The almost constant luteal progesterone secretion (average of 5 ng/ml serum) seems to prevent folliculogenesis outside the breeding season and has converted a poly-estrous general felid cycle into a mono-estrous cycle specific for lynx. The hormonal regulation mechanism which causes lynx to have the longest CL lifespan amongst mammals remains unclear. The described non-felid like ovarian physiology appears to be a remarkably non-plastic system. The lynx's reproductive ability to adapt to environmental and anthropogenic changes needs further investigation.	[Painer, Johanna; Jewgenow, Katarina; Dehnhard, Martin; Hildebrandt, Thomas B.; Goeritz, Frank] Forsch Verbund Berlin eV, Leibniz Inst Zoo & Wildlife Res, Dept Reprod Management & Reprod Biol, Berlin, Germany; [Arnemo, Jon M.] Hedmark Univ Coll, Fac Appl Ecol & Agr Sci, Dept Forestry & Wildlife Management, Elverum, Norway; [Arnemo, Jon M.] Swedish Univ Agr Sci, Dept Wildlife Fish & Environm Studies, Fac Forest Sci, S-90183 Umea, Sweden; [Linnell, John D. C.; Odden, John] Norwegian Inst Nat Res, N-7004 Trondheim, Norway	Leibniz Institut fur Zoo und Wildtierforschung; Inland Norway University of Applied Sciences; Swedish University of Agricultural Sciences; Norwegian Institute Nature Research	Painer, J (corresponding author), Forsch Verbund Berlin eV, Leibniz Inst Zoo & Wildlife Res, Dept Reprod Management & Reprod Biol, Berlin, Germany.	painer@izw-berlin.de	Odden, John/F-6088-2019; Linnell, John/V-4177-2019	Odden, John/0000-0002-6275-8648; Linnell, John/0000-0002-8370-5633; Jewgenow, Katarina/0000-0002-6173-840X; Painer - Gigler, Johanna/0000-0003-3929-511X	German ministry of education and research [BMBF 033L046]; Norwegian Research Council; Norwegian Directorate for Nature Management (DN); Nature Protection Division of the County Governor's Office for Troms and Finnmark; Regional Management Board of Region 8	German ministry of education and research(Federal Ministry of Education & Research (BMBF)); Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian Directorate for Nature Management (DN); Nature Protection Division of the County Governor's Office for Troms and Finnmark; Regional Management Board of Region 8	The study on the captive population was funded by the German ministry of education and research (BMBF 033L046). Scandlynx is supported by the Norwegian Research Council, the Norwegian Directorate for Nature Management (DN), the Nature Protection Division of the County Governor's Office for Troms and Finnmark, and the Regional Management Board of Region 8. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andren H, 2006, BIOL CONSERV, V131, P23, DOI 10.1016/j.biocon.2006.01.025; [Anonymous], 2010, R LANG ENV STAT COMP; Apps Clayton D., 2000, P351; Arnemo J. M., 2012, BIOMEDICAL PROTOCOLS; Arnemo JM, 2006, WILDLIFE BIOL, V12, P109, DOI 10.2981/0909-6396(2006)12[109:ROCMIL]2.0.CO;2; BANKS DR, 1983, BIOL REPROD, V28, P923, DOI 10.1095/biolreprod28.4.923; Bischof R, 2012, J APPL ECOL, V49, P824, DOI 10.1111/j.1365-2664.2012.02167.x; Brown JL, 2011, ANIM REPROD SCI, V124, P155, DOI 10.1016/j.anireprosci.2010.08.024; Carnaby K, 2012, REPRODUCTION, V144, P477, DOI 10.1530/REP-12-0166; Crowe D.M., 1977, Proceedings of the Great Plains Wildlife Damage Control Workshop, V3, P40; DAWSON AB, 1946, ANAT REC, V95, P29, DOI 10.1002/ar.1090950105; Dehnhard M, 2010, GEN COMP ENDOCR, V167, P287, DOI 10.1016/j.ygcen.2010.03.023; Drews B, 2008, THERIOGENOLOGY, V69, P1120, DOI 10.1016/j.theriogenology.2008.01.026; Dupre SM, 2011, NEUROENDOCRINOLOGY, V94, P101, DOI 10.1159/000328971; Fanson KV, 2010, GEN COMP ENDOCR, V169, P217, DOI 10.1016/j.ygcen.2010.09.003; Ferguson SH, 2006, OIKOS, V114, P249; Finkenwirth C, 2010, THERIOGENOLOGY, V73, P530, DOI 10.1016/j.theriogenology.2009.10.008; Goeritz F, 2012, REPROD DOMEST ANIM, V47, P156, DOI 10.1111/rda.12026; Goritz F, 2009, REPROD DOMEST ANIM, V44, P87, DOI 10.1111/j.1439-0531.2009.01380.x; Goeritz Frank, 2009, P366; Hayssen V, 1993, ASDELLS PATTERN MAMM; Henriksen HB, 2005, EUR J WILDLIFE RES, V51, P151, DOI 10.1007/s10344-005-0104-1; Hermes R, 2000, ACTA THERIOL, V45, P559, DOI 10.4098/AT.arch.00-54; Jewgenow K, 2012, REPROD DOMEST ANIM, V47, P25, DOI 10.1111/rda.12033; Jewgenow K, REPROD SCI ANIMAL CO; Johnson WE, 2004, J HERED, V95, P19, DOI 10.1093/jhered/esh006; Kaczensky P, 1991, UNTERSUCHUNG RAUMNUT; KVAM T, 1991, Z SAUGETIERKD, V56, P146; Lane JE, 2012, NATURE, V489, P554, DOI 10.1038/nature11335; Linnell John D.C., 2009, P72, DOI 10.1002/9781444312034.ch4; Linnell JDC, 2010, ENVIRON MANAGE, V45, P1142, DOI 10.1007/s00267-010-9455-9; Logan K.A., 2001, DESERT PUMA EVOLUTIO; Lueders I, 2012, P ROY SOC B-BIOL SCI, V279, P3687, DOI 10.1098/rspb.2012.1038; Mattisson J, 2011, BIOL CONSERV, V144, P3009, DOI 10.1016/j.biocon.2011.09.004; Mejlgaard T, 2013, J ZOOL, V289, P222, DOI 10.1111/j.1469-7998.2012.00980.x; Nilsen EB, 2012, ACTA THERIOL, V57, P217, DOI 10.1007/s13364-011-0066-5; Nilsen EB, 2010, OECOLOGIA, V164, P943, DOI 10.1007/s00442-010-1713-2; Painer J., 2012, P63; Pau S, 2011, GLOBAL CHANGE BIOL, V17, P3633, DOI 10.1111/j.1365-2486.2011.02515.x; Pelican Katharine M., 2009, P340; Samelius G, 2012, J ZOOL, V286, P120, DOI 10.1111/j.1469-7998.2011.00857.x; Schadt S, 2002, J APPL ECOL, V39, P189, DOI 10.1046/j.1365-2664.2002.00700.x; SHILLE VM, 1979, BIOL REPROD, V21, P1217, DOI 10.1095/biolreprod21.5.1217; Weems CW, 2006, VET J, V171, P206, DOI 10.1016/j.tvjl.2004.11.014; WILDT DE, 1981, BIOL REPROD, V25, P15, DOI 10.1095/biolreprod25.1.15	45	24	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90469	10.1371/journal.pone.0090469	http://dx.doi.org/10.1371/journal.pone.0090469			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599348	Green Published, gold			2022-12-27	WOS:000332479400079
J	Zhou, QM; Xu, F; Wu, QY; Gong, W; Xie, L; Wang, T; Fang, L; Yang, DY; Melgiri, ND; Xie, P				Zhou, Qinming; Xu, Fan; Wu, Qingyuan; Gong, Wei; Xie, Liang; Wang, Tao; Fang, Liang; Yang, Deyu; Melgiri, Narayan D.; Xie, Peng			The Mutual Influences between Depressed Macaca fascicularis Mothers and Their Infants	PLOS ONE			English	Article							NONHUMAN PRIMATE MODELS; POSTPARTUM-DEPRESSION; MATERNAL DEPRESSION; SOCIAL INTERACTIONS; BEHAVIOR; STRESS; CHILDREN; ANXIETY; PSYCHOPATHOLOGY; PHYSIOLOGY	Objective: To assess the influence of infant rearing on the behavior of depressed adult female Macaca fascicularis and the influence of depressed infant-rearing adult female Macaca fascicularis on their infants in a free enclosure environment. Methods: Here, 20 depressed subjects and then 20 healthy subjects were randomly selected from a total population of 1007 adult female Macaca fascicularis subjects. Four depressed subjects and eight healthy subjects were rearing infants. By focal observation, three trained observers video-recorded the selected subjects over a total observational period of 560 hours. The video footage was analyzed by qualified blinded analysts that coded the raw footage into quantitative behavioral data (i.e., durations of 53 pre-defined behavioral items across 12 behavioral categories) for statistical analysis. Results: Between infant-rearing and non-rearing healthy subjects, ten differential behaviors distributed across five behavioral categories were identified. Between infant-rearing and non-rearing depressed subjects, nine behaviors distributed across five behavioral categories were identified. Between infant-rearing healthy and infant-rearing depressed subjects, fifteen behaviors distributed across six behavioral categories were identified. Conclusion: Infant-rearing depressed adult female Macaca fascicularis subjects may have a worse psychological status as compared to non-rearing depressed counterparts. Infant rearing may negatively influence depressed Macaca fascicularis mothers. Infant-rearing depressed subjects were less adequate at raising infants as compared to infant-rearing healthy subjects. Thus, maternal depression in this macaque species may negatively impact infatile development, which is consistent with previous findings in humans.	[Zhou, Qinming; Xu, Fan; Wu, Qingyuan; Gong, Wei; Xie, Liang; Wang, Tao; Fang, Liang; Melgiri, Narayan D.; Xie, Peng] Chongqing Med Univ, Inst Neurosci, Chongqing, Peoples R China; [Zhou, Qinming; Xu, Fan; Wu, Qingyuan; Gong, Wei; Xie, Liang; Wang, Tao; Fang, Liang; Melgiri, Narayan D.; Xie, Peng] Chongqing Key Lab Neurobiol, Chongqing, Peoples R China; [Zhou, Qinming; Wu, Qingyuan; Wang, Tao; Xie, Peng] Chongqing Med Univ, Dept Neurol, Affiliated Hosp 1, Chongqing, Peoples R China; [Yang, Deyu] Chongqing Med Univ, Yongchuan Hosp, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University; Chongqing Medical University	Xie, P (corresponding author), Chongqing Med Univ, Inst Neurosci, Chongqing, Peoples R China.	xiepeng@cqmu.edu.cn	Zhou, Qinming/GWZ-7229-2022	Zhou, Qinming/0000-0001-6211-0588	National Basic Research Program of China (973 Program) [2009CB918300]; National Natural Science Foundation of China [31271189]; Chongqing Postdoctoral Science Foundation [XM20120010]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chongqing Postdoctoral Science Foundation	This work was supported by the National Basic Research Program of China (973 Program) (Grant No. 2009CB918300), the National Natural Science Foundation of China (Grant No. 31271189), and the Chongqing Postdoctoral Science Foundation (Grant No. XM20120010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aureli F, 1999, J COMP PSYCHOL, V113, P59, DOI 10.1037/0735-7036.113.1.59; Aureli F, 2010, BIOL LETTERS, V6, P27, DOI 10.1098/rsbl.2009.0513; Bardi M, 2002, DEV PSYCHOBIOL, V41, P364, DOI 10.1002/dev.10065; BOCCIA ML, 1989, PHYSIOL BEHAV, V45, P667, DOI 10.1016/0031-9384(89)90089-9; BURKE KC, 1991, ARCH GEN PSYCHIAT, V48, P789; Cabib S, 2000, BEHAV BRAIN RES, V112, P13, DOI 10.1016/S0166-4328(00)00157-1; Chance MRA, 1970, SOCIAL GROUPS MONKEY; Cooper PJ, 1998, BMJ-BRIT MED J, V316, P1884; Dietz PM, 2007, AM J PSYCHIAT, V164, P1515, DOI 10.1176/appi.ajp.2007.06111893; DRI M, 1991, FOLIA PRIMATOL, V57, P121; DUNBAR RIM, 1991, FOLIA PRIMATOL, V57, P121, DOI 10.1159/000156574; Eberhard-Gran M, 2003, SOC PSYCH PSYCH EPID, V38, P551, DOI 10.1007/s00127-003-0679-3; Evans J, 2001, BRIT MED J, V323, P257, DOI 10.1136/bmj.323.7307.257; FAIRBANKS LA, 1989, DEV PSYCHOBIOL, V22, P669, DOI 10.1002/dev.420220703; FAIRBANKS LA, 1988, DEV PSYCHOBIOL, V21, P711, DOI 10.1002/dev.420210708; GOTLIB IH, 1995, J CONSULT CLIN PSYCH, V63, P90, DOI 10.1037/0022-006X.63.1.90; Guangmei Yan GZ, 2011, NATURE BIOTECHNOLOGY, V29; Herodin F, 2005, EUR CYTOKINE NETW, V16, P104; HOPKINS J, 1984, PSYCHOL BULL, V95, P498, DOI 10.1037/0033-2909.95.3.498; Kalin NH, 2003, ANN NY ACAD SCI, V1008, P189, DOI 10.1196/annals.1301.021; KESSLER RC, 1994, J AFFECT DISORDERS, V30, P15, DOI 10.1016/0165-0327(94)90147-3; Li J., 1994, CURRENT PRIMATOLOGY, VII, P185; Liang Bin, 2011, Zoological Research, V32, P91, DOI 10.3724/SP.J.1141.2011.01091; Maestripieri D, 2005, GESTURE, V5, P1; Maestripieri D, 2011, AM J PRIMATOL, V73, P516, DOI 10.1002/ajp.20882; Maestripieri D, 2009, PHYSIOL BEHAV, V96, P613, DOI 10.1016/j.physbeh.2008.12.016; Mbaya Albert Wulari, 2011, Pakistan Journal of Biological Sciences, V14, P709, DOI 10.3923/pjbs.2011.709.714; Michopoulos V, 2012, PSYCHONEUROENDOCRINO, V37, P1071, DOI 10.1016/j.psyneuen.2011.12.004; MingfeiHan DG, 2008, W CHINA MED; MORSE JM, 1992, CAN J PUBLIC HEALTH, V83, P213; MURRAY L, 1993, J CHILD PSYCHOL PSYC, V34, P1083, DOI 10.1111/j.1469-7610.1993.tb01775.x; Natl Acad Natl Res Council & Inst Med, 2009, DEPRESSION IN PARENTS, PARENTING, AND CHILDREN: OPPORTUNITIES TO IMPROVE IDENTIFICATION, TREATMENT, AND PREVENTION, P1; O'Hara M. W., 1988, MOTHERHOOD MENTAL IL, P17; OHARA MW, 1990, J ABNORM PSYCHOL, V99, P3, DOI 10.1037/0021-843X.99.1.3; OHara MW, 1996, INT REV PSYCHIATR, V8, P37, DOI 10.3109/09540269609037816; ORVASCHEL H, 1988, J ABNORM CHILD PSYCH, V16, P17, DOI 10.1007/BF00910497; Poirier E., 1974, AM SOC ZOOLOGISTS, V14, P275; Radford AN, 2012, BIOL LETTERS, V8, P24, DOI 10.1098/rsbl.2011.0559; Rees W D, 1971, J R Coll Gen Pract, V21, P26; RUTTER M, 1990, DEV PSYCHOL, V26, P60, DOI 10.1037/h0092669; Sackett GP, 1973, DEV MONKEYS VARIED E; Schino G, 2001, DEV PSYCHOBIOL, V38, P186, DOI 10.1002/dev.1012; Shively CA, 1997, BIOL PSYCHIAT, V41, P871, DOI 10.1016/S0006-3223(96)00185-0; Shively CA, 2005, BIOL PSYCHOL, V69, P67, DOI 10.1016/j.biopsycho.2004.11.006; Sibal L R, 2001, ILAR J, V42, P74; SILK J B, 1980, Primates, V21, P100, DOI 10.1007/BF02383827; Simpson MJA, 1985, PRIMATES, V26, P57; Speranza AM, 2006, CLIN NEUROPSYCHIATR, V3, P57; SUOMI SJ, 1975, J ABNORM PSYCHOL, V84, P576, DOI 10.1037/h0077066; TETI DM, 1995, DEV PSYCHOL, V31, P364, DOI 10.1037/0012-1649.31.3.364; WEISBARD C, 1976, FOLIA PRIMATOL, V25, P95, DOI 10.1159/000155709; WEISSMAN MM, 1984, J AM ACAD CHILD PSY, V23, P78, DOI 10.1097/00004583-198401000-00011; WHIFFEN VE, 1993, J CONSULT CLIN PSYCH, V61, P485; WHIFFEN VE, 1991, J PSYCHIATR NEUROSCI, V16, P160; Willard SL, 2012, AM J PRIMATOL, V74, P528, DOI 10.1002/ajp.21013; Xia Houjun ZG, 2010, ZOOL RES, V31, P57; Xiaoqiu Li JX, 2002, J CHINESE J PSYCHIAT, V35, P184; Xu F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037486	58	2	3	4	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e89931	10.1371/journal.pone.0089931	http://dx.doi.org/10.1371/journal.pone.0089931			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599092	Green Published, gold, Green Submitted			2022-12-27	WOS:000332479400034
J	Cai, XL; Han, XY; Zhang, SM; Luo, YY; Chen, YL; Ji, LN				Cai, Xiaoling; Han, Xueyao; Zhang, Simin; Luo, Yingying; Chen, Yingli; Ji, Linong			Age at Diagnosis and C-Peptide Level Are Associated with Diabetic Retinopathy in Chinese	PLOS ONE			English	Article							BETA-CELL FUNCTION; SUBCLINICAL HYPOTHYROIDISM; RISK-FACTORS; EARLY-ONSET; FOLLOW-UP; PREVALENCE; COMPLICATIONS; COHORT; EPIDEMIOLOGY; POPULATION	Objective: To find the associations between diabetic retinopathy and age at diagnosis, C-peptide level and thyroid-stimulating hormone (TSH) level in Chinese type 2 diabetes mellitus. Methods: 3100 hospitalized type 2 diabetic patients in Peking University People's Hospital were included in this retrospective study. Their medical history and the laboratory data were collected. All the patients received examination of diabetic retinopathy (DR) by professional ophthalmologist. Results: Comparisons among patients with NDR, NPDR and PDR showed that with the progression of diabetic retinopathy, patients turned to have older age but younger age at diagnosis of diabetes, and have higher SBP, longer duration of diabetes, higher mean HbA1c but lower fasting and 2 hours postprandial C-peptide level. Moreover, with the progression of diabetic retinopathy, patients turned to have higher prevalence of primary hypertension, higher prevalence of peripheral vascular sclerosis, higher proportion with insulin treatment. TSH level was comparable among the three groups of patients. Association analysis showed that after adjusting for age, sex, duration of diabetes, body mass index, HbA1c, blood pressure and albuminurea creatinine ratio and insulin treatment, age at diagnosis (OR 0.888, 95% CI 0.870-0.907, p = 0.00) and postprandial C-peptide (OR 0.920, 95% CI 0.859-0.937, p = 0.00) are the independent associated factors of DR in Chinese type 2 diabetes. Conclusions: According to the results, postprandial C-peptide level and age at diabetes may be two independent associated factors with DR in Chinese type 2 diabetes. The lower level of postprandial C-peptide, the younger age at diagnosis, may indicate the higher prevalence of DR.	[Cai, Xiaoling; Han, Xueyao; Zhang, Simin; Luo, Yingying; Chen, Yingli; Ji, Linong] Peking Univ, Peoples Hosp, Dept Endocrinol & Metab, Beijing 100871, Peoples R China	Peking University	Ji, LN (corresponding author), Peking Univ, Peoples Hosp, Dept Endocrinol & Metab, Beijing 100871, Peoples R China.	prof_jilinong@aliyun.com	Linong, Ji/AAB-6543-2020	Cai, Xiaoling/0000-0002-7881-0543				Bo S, 2012, EUR J ENDOCRINOL, V167, P173, DOI 10.1530/EJE-12-0085; Cai XL, 2006, CHINESE MED J-PEKING, V119, P822, DOI 10.1097/00029330-200605020-00005; Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; Chen HS, 2007, DIABETIC MED, V24, P1336, DOI 10.1111/j.1464-5491.2007.02270.x; Chuang LM, 2006, DIABETES RES CLIN PR, V71, P146, DOI 10.1016/j.diabres.2005.05.007; Fukui T, 2013, ENDOCR J, V60, P715, DOI 10.1507/endocrj.EJ12-0357; Gottsater A, 1999, DIABETIC MED, V16, P49, DOI 10.1046/j.1464-5491.1999.00001.x; Kim BY, 2011, ENDOCR J, V58, P1065, DOI 10.1507/endocrj.EJ11-0199; Kim BY, 2012, ACTA DIABETOL, V49, P9, DOI 10.1007/s00592-010-0249-6; Kim JH, 2011, J KOREAN MED SCI, V26, P1068, DOI 10.3346/jkms.2011.26.8.1068; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; KLEIN R, 1995, DIABETES, V44, P796, DOI 10.2337/diabetes.44.7.796; Kostev K, 2013, DIABETOLOGIA, V56, P109, DOI 10.1007/s00125-012-2742-7; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045264; Mosier M A, 1984, Diabetes Res, V1, P151; Nakanishi K, 2008, J CLIN ENDOCR METAB, V93, P4759, DOI 10.1210/jc.2008-1209; Ramis JN, 2012, DIABETES RES CLIN PR, V97, pE45, DOI 10.1016/j.diabres.2012.05.015; Porta M, 2002, DIABETOLOGIA, V45, P1617, DOI 10.1007/s00125-002-0990-7; Rema M, 2005, INVEST OPHTH VIS SCI, V46, P2328, DOI 10.1167/iovs.05-0019; Sivaprasad S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032182; Song SH, 2011, DIABETES RES CLIN PR, V94, P207, DOI 10.1016/j.diabres.2011.07.030; Steffes MW, 2003, DIABETES CARE, V26, P832, DOI 10.2337/diacare.26.3.832; Tapp RJ, 2003, DIABETES CARE, V26, P1731, DOI 10.2337/diacare.26.6.1731; Thomas RL, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e874; Wilkinson CP, 2003, OPHTHALMOLOGY, V110, P1677, DOI 10.1016/S0161-6420(03)00475-5; Wong TY, 2006, AM J OPHTHALMOL, V141, P446, DOI 10.1016/j.ajo.2005.08.063; Yang JK, 2010, DIABETES CARE, V33, P1018, DOI 10.2337/dc09-1784; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Yau JWY, 2012, DIABETES CARE, V35, P556, DOI 10.2337/dc11-1909; Yokoyama H, 1997, DIABETES CARE, V20, P844, DOI 10.2337/diacare.20.5.844; Yoon HJ, 2012, DIABETES METAB J, V36, P379, DOI 10.4093/dmj.2012.36.5.379; Zheng WW, 2011, DIABETES RES CLIN PR, V92, P244, DOI 10.1016/j.diabres.2011.02.007	32	15	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91174	10.1371/journal.pone.0091174	http://dx.doi.org/10.1371/journal.pone.0091174			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614131	Green Published, gold, Green Submitted			2022-12-27	WOS:000332839300088
J	Deng, B; Xu, H; Zhang, J; Wang, J; Han, LC; Li, LY; Wu, GL; Hou, YN; Guo, GZ; Wang, Q; Sang, HF; Xu, LX				Deng, Bin; Xu, Hao; Zhang, Jin; Wang, Jin; Han, Li-Chun; Li, Li-Ya; Wu, Guang-Li; Hou, Yan-Ning; Guo, Guo-Zhen; Wang, Qiang; Sang, Han-Fei; Xu, Li-Xian			Neuroprotective Effects of Sevoflurane against Electromagnetic Pulse-Induced Brain Injury through Inhibition of Neuronal Oxidative Stress and Apoptosis	PLOS ONE			English	Article							MOBILE PHONE RADIATION; FOCAL CEREBRAL-ISCHEMIA; FLUORO-JADE-C; FREE-RADICALS; MITOCHONDRIAL-FUNCTION; REPERFUSION INJURY; EXPOSURE; RATS; EXPRESSION; PROTEIN	Electromagnetic pulse (EMP) causes central nervous system damage and neurobehavioral disorders, and sevoflurane protects the brain from ischemic injury. We investigated the effects of sevoflurane on EMP-induced brain injury. Rats were exposed to EMP and immediately treated with sevoflurane. The protective effects of sevoflurane were assessed by Nissl staining, Fluoro-Jade C staining and electron microscopy. The neurobehavioral effects were assessed using the open-field test and the Morris water maze. Finally, primary cerebral cortical neurons were exposed to EMP and incubated with different concentration of sevoflurane. The cellular viability, lactate dehydrogenase (LDH) release, superoxide dismutase (SOD) activity and malondialdehyde (MDA) level were assayed. TUNEL staining was performed, and the expression of apoptotic markers was determined. The cerebral cortexes of EMP-exposed rats presented neuronal abnormalities. Sevoflurane alleviated these effects, as well as the learning and memory deficits caused by EMP exposure. In vitro, cell viability was reduced and LDH release was increased after EMP exposure; treatment with sevoflurane ameliorated these effects. Additionally, sevoflurane increased SOD activity, decreased MDA levels and alleviated neuronal apoptosis by regulating the expression of cleaved caspase-3, Bax and Bcl-2. These findings demonstrate that Sevoflurane conferred neuroprotective effects against EMP radiation-induced brain damage by inhibiting neuronal oxidative stress and apoptosis.	[Deng, Bin; Zhang, Jin; Xu, Li-Xian] Fourth Mil Med Univ, State Key Lab Mil Stomatol, Dept Anesthesiol, Sch Stomatol, Xian 710032, Peoples R China; [Xu, Hao] Fourth Mil Med Univ, Dept Anat Histol & Embryol, KK Leung Brain Res Ctr, Xian 710032, Peoples R China; [Hou, Yan-Ning; Sang, Han-Fei] Peoples Liberat Army, Bethune Int Peace Hosp, Dept Clin Pharmacol, Shijiazhuang, Peoples R China; [Wang, Jin; Guo, Guo-Zhen] Fourth Mil Med Univ, Dept Radiat Med, Fac Prevent Med, Xian 710032, Peoples R China; [Han, Li-Chun] Shannxi Tumor Hosp, Dept Anesthesiol, Xian, Peoples R China; [Li, Li-Ya; Wang, Qiang] Fourth Mil Med Univ, Xijing Hosp, Dept Anesthesiol, Xian 710032, Peoples R China; [Wu, Guang-Li] Peoples Liberat Army, Dept Nephrol, Bethune Int Peace Hosp, Shijiazhuang, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Wang, Q (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Anesthesiol, Xian 710032, Peoples R China.	wangqiang@fmmu.edu.cn; hfsang@fmmu.edu.cn; xlx116@fmmu.edu.cn			National Natural Science Foundation of China [30371763, 81071060, 81070997, 31100785, 81171237]; Natural Science Foundation of Shaanxi Province [2006C254, 2011KJXX67, 2013JM4040, 2012KTCG01-02, 2013KTZB03-03]; Fourth Military Medical University Foundation [2013-D03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shaanxi Province(Natural Science Foundation of Shaanxi Province); Fourth Military Medical University Foundation	This work was supported by the National Natural Science Foundation of China (Grants No. 30371763, No. 81071060, No. 81070997, No. 31100785 and No. 81171237), the Natural Science Foundation of Shaanxi Province (Grants No. 2006C254, No. 2011KJXX67 and No. 2013JM4040, 2012KTCG01-02,2013KTZB03-03), and the Fourth Military Medical University Foundation (Grant No. 2013-D03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedirli N, 2012, J NEUROSURG ANESTH, V24, P336, DOI 10.1097/ANA.0b013e318266791e; Bian GL, 2007, BRAIN RES, V1150, P55, DOI 10.1016/j.brainres.2007.02.078; Blancas S, 2011, NEUROCHEM INT, V58, P934, DOI 10.1016/j.neuint.2011.03.017; Blettner M, 2000, ACTA ONCOL, V39, P927; Borah A, 2013, CNS NEUROSCI THER, V19, P847, DOI 10.1111/cns.12175; Bundgaard H, 1998, ACTA ANAESTH SCAND, V42, P621, DOI 10.1111/j.1399-6576.1998.tb05292.x; Challis LJ, 2005, BIOELECTROMAGNETICS, pS98, DOI 10.1002/bem.20119; Chavdoula ED, 2010, MUTAT RES-GEN TOX EN, V700, P51, DOI 10.1016/j.mrgentox.2010.05.008; Chen YB, 2011, INT J RADIAT BIOL, V87, P1147, DOI 10.3109/09553002.2011.584937; Cheng G, 2009, NEUROSCI LETT, V451, P105, DOI 10.1016/j.neulet.2008.12.045; Codaccioni JL, 2009, ANESTHESIOLOGY, V110, P1271, DOI 10.1097/ALN.0b013e3181a1fe68; Deng B, 2013, BIOMATERIALS, V34, P8786, DOI 10.1016/j.biomaterials.2013.07.076; Ding GR, 2010, TOXICOL LETT, V196, P154, DOI 10.1016/j.toxlet.2010.04.011; Ding GR, 2009, BIOMED ENVIRON SCI, V22, P265, DOI 10.1016/S0895-3988(09)60055-6; Dragicevic N, 2011, NEUROSCIENCE, V185, P135, DOI 10.1016/j.neuroscience.2011.04.012; Funk RHW, 2009, PROG HISTOCHEM CYTO, V43, P177, DOI 10.1016/j.proghi.2008.07.001; Grafstrom G, 2008, BRAIN RES BULL, V77, P257, DOI 10.1016/j.brainresbull.2008.08.004; Grigoriev Yu G., 2011, Radiatsionnaya Biologiya Radioekologiya, V51, P721; Head BP, 2007, CURR OPIN ANESTHESIO, V20, P395, DOI 10.1097/ACO.0b013e3282efa69d; Hug K, 2006, SOZ PRAVENTIV MED, V51, P210, DOI 10.1007/s00038-006-5096-4; Irmak MK, 2000, CELL BIOCHEM FUNCT, V20, P279; Istaphanous GK, 2011, ANESTHESIOLOGY, V114, P578, DOI 10.1097/ALN.0b013e3182084a70; Jeon YT, 2013, J NEUROSURG ANESTH, V25, P43, DOI 10.1097/ANA.0b013e31826ca3bc; Jiang DP, 2013, ARCH MED RES, V44, P178, DOI 10.1016/j.arcmed.2013.03.005; Liu HG, 2012, MOL BIOL REP, V39, P10505, DOI 10.1007/s11033-012-1935-y; Lorsomradee S, 2006, J CARDIOTHOR VASC AN, V20, P684, DOI 10.1053/j.jvca.2006.02.035; Muehsam D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061752; Ozgur E, 2010, INT J RADIAT BIOL, V86, P935, DOI 10.3109/09553002.2010.496029; Pape M, 2006, ANESTH ANALG, V103, P173, DOI 10.1213/01.ane.0000222634.51192.a4; Qiu LB, 2010, TOXICOLOGY, V273, P29, DOI 10.1016/j.tox.2010.04.013; Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054; Somosy Z, 2000, MICRON, V31, P165, DOI 10.1016/S0968-4328(99)00083-9; Trosic I, 2011, COLLEGIUM ANTROPOL, V35, P1259; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Wang JK, 2010, BRAIN RES, V1357, P142, DOI 10.1016/j.brainres.2010.08.009; Wang Q, 2011, J SURG RES, V169, P292, DOI 10.1016/j.jss.2009.11.707; Wang Q, 2009, CELL MOL NEUROBIOL, V29, P97, DOI 10.1007/s10571-008-9301-2; Wang R, 2011, BRAIN RES, V1372, P127, DOI 10.1016/j.brainres.2010.11.059; Wilson JX, 2002, J NEUROSURG ANESTH, V14, P66, DOI 10.1097/00008506-200201000-00014; Yang Y, 2012, NEUROSCI LETT, V516, P15, DOI 10.1016/j.neulet.2012.03.022; Ye RD, 2012, CRIT CARE MED, V40, P2685, DOI 10.1097/CCM.0b013e318258fb90; Zeng Y, 2012, BRAIN RES, V1452, P140, DOI 10.1016/j.brainres.2012.02.063; Zhang W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063472; Zhang Y, 2012, MOLECULES, V17, P341, DOI 10.3390/molecules17010341; Zhou JX, 2013, BIOMED ENVIRON SCI, V26, P128, DOI 10.3967/0895-3988.2013.02.007	45	18	27	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91019	10.1371/journal.pone.0091019	http://dx.doi.org/10.1371/journal.pone.0091019			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614080	Green Published, Green Submitted, gold			2022-12-27	WOS:000332839300066
J	Dupuy, AK; David, MS; Li, L; Heider, TN; Peterson, JD; Montano, EA; Dongari-Bagtzoglou, A; Diaz, PI; Strausbaugh, LD				Dupuy, Amanda K.; David, Marika S.; Li, Lu; Heider, Thomas N.; Peterson, Jason D.; Montano, Elizabeth A.; Dongari-Bagtzoglou, Anna; Diaz, Patricia I.; Strausbaugh, Linda D.			Redefining the Human Oral Mycobiome with Improved Practices in Amplicon-based Taxonomy: Discovery of Malassezia as a Prominent Commensal	PLOS ONE			English	Article							FUNGAL; DIVERSITY; COLONIZATION; BIODIVERSITY; NOMENCLATURE; MAGNITUDE; IMPACTS; GALAXY; PLANT	Fungi are a large, complex group, increasingly recognized as emerging threats. Their roles as modifiers of health mandate accurate portrayals of fungal communities in humans. As an entry point into the airways and gastrointestinal tract, fungi in the mouth are relevant to several biocompartments. We have revised current practices in sequence-based taxonomy assignments and employed the improvements to address the question of the fungal genera present in the healthy human mouth. The human oral mycobiome was surveyed using massively parallel, high throughput sequencing of internal transcribed spacer 1 (ITS1) amplicons from saliva following robust extraction methods. Taxonomy was assigned by comparison to a curated reference dataset, followed by filtering with an empirically determined BLAST E-value match statistic (10(-42)). Nomenclature corrections further refined results by conjoining redundant names for a single fungal genus. Following these curation steps, about two-thirds of the initially identified genera were eliminated. In comparison with the one similar metagenomic study and several earlier culture-based ones, our findings change the current conception of the oral mycobiome, especially with the discovery of the high prevalence and abundance of the genus Malassezia. Previously identified as an important pathogen of the skin, and recently reported as the predominant fungal genus at the nostril and backs of the head and ear, this is the first account of Malassezia in the human mouth. Findings from this study were in good agreement with others on the existence of many consensus members of the core mycobiome, and on unique patterns for individual subjects. This research offered a cautionary note about unconditional acceptance of lengthy lists of community members produced by automated assignments, provided a roadmap for enhancing the likely biological relevance of sequence-based fungal surveys, and built the foundation for understanding the role of fungi in health and disease of the oral cavity.	[Dupuy, Amanda K.; David, Marika S.; Li, Lu; Heider, Thomas N.; Peterson, Jason D.; Montano, Elizabeth A.; Strausbaugh, Linda D.] Univ Connecticut, Ctr Appl Genet & Technol, Storrs, CT 06269 USA; [Dupuy, Amanda K.; David, Marika S.; Li, Lu; Heider, Thomas N.; Peterson, Jason D.; Montano, Elizabeth A.; Strausbaugh, Linda D.] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT USA; [Dongari-Bagtzoglou, Anna; Diaz, Patricia I.] Univ Connecticut, Ctr Hlth, Div Periodontol, Dept Oral Hlth & Diagnost Sci,Sch Dent Med, Farmington, CT USA	University of Connecticut; University of Connecticut; University of Connecticut	Strausbaugh, LD (corresponding author), Univ Connecticut, Ctr Appl Genet & Technol, Storrs, CT 06269 USA.	Linda.Strausbaugh@uconn.edu			NIH [RO1 DE021578]; NSF MRI [0821466]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE021578] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF MRI(National Science Foundation (NSF)NSF - Office of the Director (OD)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	NIH RO1 DE021578, The Oral Microbiome during Cancer Chemotherapy and Its Role in Oral Mucositis; and NSF MRI 0821466, MRI: Acquisition of a Genome Sequencer for Research and Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amend AS, 2010, P NATL ACAD SCI USA, V107, P13748, DOI 10.1073/pnas.1000454107; Ashbee HR, 2002, CLIN MICROBIOL REV, V15, P21, DOI 10.1128/CMR.15.1.21-57.2002; Blackwell M, 2011, AM J BOT, V98, P426, DOI 10.3732/ajb.1000298; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Braun U, 2012, IMA FUNGUS, V3, P81, DOI 10.5598/imafungus.2012.03.01.08; Brown GD, 2012, SCIENCE, V336, P647, DOI 10.1126/science.1222236; Buzina W, 2005, J CLIN MICROBIOL, V43, P2009, DOI 10.1128/JCM.43.4.2009-2011.2005; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chang HJ, 1998, NEW ENGL J MED, V338, P706, DOI 10.1056/NEJM199803123381102; Delhaes L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036313; Diaz PI, 2012, MOL ORAL MICROBIOL, V27, P182, DOI 10.1111/j.2041-1014.2012.00642.x; Diaz PI, 2013, CLIN VACCINE IMMUNOL, V20, P920, DOI 10.1128/CVI.00734-12; Diaz PI, 2012, FRONT ORAL BIOL, V15, P17, DOI 10.1159/000329669; Everett JE, 2003, TRANSPL P, V35, P1387, DOI 10.1016/S0041-1345(03)00440-8; Findley K, 2013, NATURE, V498, P367, DOI 10.1038/nature12171; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Ghannoum MA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000713; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Hamad I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040888; Hawksworth DL, 2012, MYCOSPHERE, V3, P143, DOI [10.5943/mycosphere/3/2/4, 10.5598/imafungus.2012.03.01.03]; Hawksworth DL, 2011, IMA FUNGUS, V2, P155, DOI 10.5598/imafungus.2011.02.02.06; Hawksworth DL, 2011, IMA FUNGUS, V2, P105, DOI 10.5598/imafungus.2011.02.01.14; Hawksworth DL, 2001, MYCOL RES, V105, P1422, DOI 10.1017/S0953756201004725; HAWKSWORTH DL, 1991, MYCOL RES, V95, P641, DOI 10.1016/S0953-7562(09)80810-1; HCv Woerden, 2013, BMC INFECT DIS, V13, P1471; Hubka V, 2013, MYCOLOGIA; IOM (Institute of Medicine), 2011, FUNG DIS EM THREAT H; Kalkanci A, 2006, MED MYCOL, V44, P531, DOI 10.1080/13693780500340510; LaTuga MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027858; Lee CK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044224; Nagano Y, 2010, MED MYCOL, V48, P166, DOI 10.3109/13693780903127506; Nilsson RH, 2008, EVOL BIOINFORM, V4, P193; Nonnenmann MW, 2012, J ENVIRON MONITOR, V14, P2038, DOI 10.1039/c2em30229b; Park HK, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032847, 10.1371/journal.pone.0039921]; Saunders CW, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002701; Schmieder R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017288; Shelton BG, 2002, APPL ENVIRON MICROB, V68, P1743, DOI 10.1128/AEM.68.4.1743-1753.2002; Suh SO, 2006, MYCOLOGIA, V98, P1006, DOI 10.3852/mycologia.98.6.1006; Taylor D, 2011, BIOINFORMATICS PIPEL; Taylor JW, 2011, IMA FUNGUS, V2, P113, DOI 10.5598/imafungus.2011.02.02.01; Tedersoo L, 2010, NEW PHYTOL, V188, P291, DOI 10.1111/j.1469-8137.2010.03373.x; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Yoshikawa T, 2008, INT J ORAL MED SCI, V7, P72	45	150	154	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e90899	10.1371/journal.pone.0090899	http://dx.doi.org/10.1371/journal.pone.0090899			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614173	gold, Green Submitted, Green Published			2022-12-27	WOS:000332839300051
J	Higuchi, T; Fujimura, H; Yuyama, I; Harii, S; Agostini, S; Oomori, T				Higuchi, Tomihiko; Fujimura, Hiroyuki; Yuyama, Ikuko; Harii, Saki; Agostini, Sylvain; Oomori, Tamotsu			Biotic Control of Skeletal Growth by Scleractinian Corals in Aragonite-Calcite Seas	PLOS ONE			English	Article							TEMPERATURE; MINERALOGY; EVOLUTION; DRIVEN	Modern scleractinian coral skeletons are commonly composed of aragonite, the orthorhombic form of CaCO3. Under certain conditions, modern corals produce calcite as a secondary precipitate to fill pore space. However, coral construction of primary skeletons from calcite has yet to be demonstrated. We report a calcitic primary skeleton produced by the modern scleractinian coral Acropora tenuis. When uncalcified juveniles were incubated from the larval stage in seawater with low mMg/Ca levels, the juveniles constructed calcitic crystals in parts of the primary skeleton such as the septa; the deposits were observable under Raman microscopy. Using scanning electron microscopy, we observed different crystal morphologies of aragonite and calcite in a single juvenile skeleton. Quantitative analysis using X-ray diffraction showed that the majority of the skeleton was composed of aragonite even though we had exposed the juveniles to manipulated seawater before their initial crystal nucleation and growth processes. Our results indicate that the modern scleractinian coral Acropora mainly produces aragonite skeletons in both aragonite and calcite seas, but also has the ability to use calcite for part of its skeletal growth when incubated in calcite seas.	[Higuchi, Tomihiko; Yuyama, Ikuko] Shizuoka Univ, Grad Sch Sci & Technol, Suruga Ku, Shizuoka, Japan; [Fujimura, Hiroyuki; Oomori, Tamotsu] Univ Ryukyus, Dept Chem Biol & Marine Sci, Nishihara, Okinawa 90301, Japan; [Harii, Saki] Univ Ryukyus, Trop Biosphere Res Ctr, Sesoko Stn, Motobu, Okinawa, Japan; [Agostini, Sylvain] Univ Tsukuba, Shimoda Marine Res Ctr, Shimoda, Shizuoka, Japan	Shizuoka University; University of the Ryukyus; University of the Ryukyus; University of Tsukuba	Higuchi, T (corresponding author), Shizuoka Univ, Grad Sch Sci & Technol, Suruga Ku, Shizuoka, Japan.	dthiguc@ipc.shizuoka.ac.jp; fujimura@sci.u-ryukyu.ac.jp	Higuchi, Tomihiko/AAW-6006-2020; Higuchi, Tomihiko/D-7118-2019; Harii, Saki/AHC-2263-2022	Higuchi, Tomihiko/0000-0001-7324-5752; Higuchi, Tomihiko/0000-0001-7324-5752; Harii, Saki/0000-0003-0440-7169; Agostini, Sylvain/0000-0001-9040-9296	Sasagawa Scientific Research Grant from The Japan Science Society [24-704 M]; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [20121003, 20310014]; Grants-in-Aid for Scientific Research [14J40135] Funding Source: KAKEN	Sasagawa Scientific Research Grant from The Japan Science Society; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Sasagawa Scientific Research Grant from The Japan Science Society (No. 24-704 M), Grant-in-Aid for Scientific Research on Innovative Areas "Coral reef science for symbiosis and coexistence of human and ecosystem under combined stresses" (No. 20121003) and "Response and possible drastic change of coral reef ecosystem in response to global warming and ocean acidification" (No. 20310014) of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison N, 2007, GEOCHIM COSMOCHIM AC, V71, P4693, DOI 10.1016/j.gca.2007.07.026; Belcher AM, 1996, NATURE, V381, P56, DOI 10.1038/381056a0; Berner RA, 2006, GEOCHIM COSMOCHIM AC, V70, P5653, DOI 10.1016/j.gca.2005.11.032; Clode PL, 2011, CORAL REEFS, V30, P1, DOI 10.1007/s00338-010-0673-7; Cohen AL, 2003, REV MINERAL GEOCHEM, V54, P151, DOI 10.2113/0540151; Cowan J. A., 1993, INORGANIC BIOCH INTR; Cuif JP, 1999, COMP BIOCHEM PHYS A, V123, P269, DOI 10.1016/S1095-6433(99)00059-8; Drake JL, 2013, P NATL ACAD SCI USA, V110, P3788, DOI 10.1073/pnas.1301419110; Dubinsky Z, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P1, DOI 10.1007/978-94-007-0114-4; Fine M, 2007, SCIENCE, V315, P1811, DOI 10.1126/science.1137094; Fukuda I, 2003, BIOCHEM BIOPH RES CO, V304, P11, DOI 10.1016/S0006-291X(03)00527-8; Goffredo S, 2012, GEOCHIM COSMOCHIM AC, V85, P187, DOI 10.1016/j.gca.2012.02.014; Goffredo S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022338; GOLDSMITH JR, 1961, AM MINERAL, V46, P453; HOUCK JE, 1975, SCIENCE, V189, P997, DOI 10.1126/science.189.4207.997; Iwao K, 2002, CORAL REEFS, V21, P127, DOI 10.1007/s00338-002-0219-8; Kiessling W, 2008, NAT GEOSCI, V1, P527, DOI 10.1038/ngeo251; Medina M, 2006, P NATL ACAD SCI USA, V103, P9096, DOI 10.1073/pnas.0602444103; Nothdurft LD, 2007, GEOCHIM COSMOCHIM AC, V71, P5423, DOI 10.1016/j.gca.2007.09.025; OHDE S, 1978, GEOCHEM J, V12, P115, DOI 10.2343/geochemj.12.115; OOMORI T, 1987, MAR CHEM, V20, P327, DOI 10.1016/0304-4203(87)90066-1; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; Rahman MA, 2009, CONNECT TISSUE RES, V50, P285, DOI 10.3109/03008200802714933; Ries JB, 2010, BIOGEOSCIENCES, V7, P2795, DOI 10.5194/bg-7-2795-2010; Ries JB, 2006, GEOLOGY, V34, P525, DOI 10.1130/G22600.1; SANDBERG PA, 1983, NATURE, V305, P19, DOI 10.1038/305019a0; Shinzato C, 2011, NATURE, V476, P320, DOI 10.1038/nature10249; Stanley GD, 2003, EARTH-SCI REV, V60, P195, DOI 10.1016/S0012-8252(02)00104-6; Stanley GD, 2001, SCIENCE, V291, P1913, DOI 10.1126/science.1056632; Stanley SM, 2006, PALAEOGEOGR PALAEOCL, V232, P214, DOI 10.1016/j.palaeo.2005.12.010; Stanley SM, 1998, PALAEOGEOGR PALAEOCL, V144, P3, DOI 10.1016/S0031-0182(98)00109-6; Stolarski J, 2007, SCIENCE, V318, P92, DOI 10.1126/science.1149237; Suwa R, 2010, FISHERIES SCI, V76, P93, DOI 10.1007/s12562-009-0189-7; Yamamoto S, 2012, BIOGEOSCIENCES, V9, P1441, DOI 10.5194/bg-9-1441-2012; Yuyama I, 2012, MAR ENVIRON RES, V76, P41, DOI 10.1016/j.marenvres.2011.09.004	35	14	16	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91021	10.1371/journal.pone.0091021	http://dx.doi.org/10.1371/journal.pone.0091021			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24609012	Green Submitted, Green Published, gold			2022-12-27	WOS:000332485800081
J	Wang, PL; Bao, Y; Yee, MC; Barrett, SP; Hogan, GJ; Olsen, MN; Dinneny, JR; Brown, PO; Salzman, J				Wang, Peter L.; Bao, Yun; Yee, Muh-Ching; Barrett, Steven P.; Hogan, Gregory J.; Olsen, Mari N.; Dinneny, Jose R.; Brown, Patrick O.; Salzman, Julia			Circular RNA Is Expressed across the Eukaryotic Tree of Life	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; SCHIZOSACCHAROMYCES-POMBE; INTRON DEFINITION; EXON DEFINITION; MESSENGER-RNA; FISSION YEAST; GENE; TRANSCRIPTS; CIRCLES; REPEATS	An unexpectedly large fraction of genes in metazoans (human, mouse, zebrafish, worm, fruit fly) express high levels of circularized RNAs containing canonical exons. Here we report that circular RNA isoforms are found in diverse species whose most recent common ancestor existed more than one billion years ago: fungi (Schizosaccharomyces pombe and Saccharomyces cerevisiae), a plant (Arabidopsis thaliana), and protists (Plasmodium falciparum and Dictyostelium discoideum). For all species studied to date, including those in this report, only a small fraction of the theoretically possible circular RNA isoforms from a given gene are actually observed. Unlike metazoans, Arabidopsis, D. discoideum, P. falciparum, S. cerevisiae, and S. pombe have very short introns (similar to 100 nucleotides or shorter), yet they still produce circular RNAs. A minority of genes in S. pombe and P. falciparum have documented examples of canonical alternative splicing, making it unlikely that all circular RNAs are by-products of alternative splicing or 'piggyback' on signals used in alternative RNA processing. In S. pombe, the relative abundance of circular to linear transcript isoforms changed in a gene-specific pattern during nitrogen starvation. Circular RNA may be an ancient, conserved feature of eukaryotic gene expression programs.	[Wang, Peter L.; Barrett, Steven P.; Hogan, Gregory J.; Olsen, Mari N.; Brown, Patrick O.; Salzman, Julia] Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA; [Wang, Peter L.; Salzman, Julia] Stanford Univ, Stanford Canc Inst, Sch Med, Stanford, CA 94305 USA; [Bao, Yun; Yee, Muh-Ching; Dinneny, Jose R.] Carnegie Inst Sci, Dept Plant Biol, Stanford, CA 94305 USA; [Bao, Yun; Yee, Muh-Ching; Dinneny, Jose R.] Natl Univ Singapore, Temasek Lifesci Lab, Singapore 117548, Singapore; [Bao, Yun; Yee, Muh-Ching; Dinneny, Jose R.] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Olsen, Mari N.; Brown, Patrick O.] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford Cancer Institute; Stanford University; Carnegie Institution for Science; National University of Singapore; National University of Singapore; Howard Hughes Medical Institute; Stanford University	Salzman, J (corresponding author), Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA.	julia.salzman@stanford.edu	wang, peter/AAD-5851-2020	Dinneny, Jose/0000-0002-3998-724X	Howard Hughes Medical Institute; Canary Foundation; NIH NCI [1K99CA168987-01]; NATIONAL CANCER INSTITUTE [R00CA168987, K99CA168987] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Canary Foundation; NIH NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported mainly by the Howard Hughes Medical Institute. POB is an investigator for the Howard Hughes Medical Institute. PLW was supported by a grant from the Canary Foundation. JS was supported by NIH NCI 1K99CA168987-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awan AR, 2013, P NATL ACAD SCI USA, V110, P12762, DOI 10.1073/pnas.1218353110; Bailleul B, 1996, NUCLEIC ACIDS RES, V24, P1015, DOI 10.1093/nar/24.6.1015; Baum J, 2009, NUCLEIC ACIDS RES, V37, P3788, DOI 10.1093/nar/gkp239; Burd CE, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001233; Caldas C, 1998, GENE, V208, P167, DOI 10.1016/S0378-1119(97)00640-9; COCQUERELLE C, 1993, FASEB J, V7, P155, DOI 10.1096/fasebj.7.1.7678559; Collart M A, 2001, Curr Protoc Mol Biol, VChapter 13, DOI 10.1002/0471142727.mb1312s23; Csuros M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002150; De Conti L, 2013, WIRES RNA, V4, P49, DOI 10.1002/wrna.1140; Drinnenberg IA, 2009, SCIENCE, V326, P544, DOI 10.1126/science.1176945; Dubin RA, 1995, GENE, V167, P245, DOI 10.1016/0378-1119(95)00639-7; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Hansen TB, 2011, EMBO J, V30, P4414, DOI 10.1038/emboj.2011.359; Hossain MA, 2011, NUCLEIC ACIDS RES, V39, P8612, DOI 10.1093/nar/gkr497; Houseley JM, 2006, J HERED, V97, P253, DOI 10.1093/jhered/esj037; HSU MT, 1979, NATURE, V280, P339, DOI 10.1038/280339a0; Irimia M, 2013, TRENDS GENET, V29, P521, DOI 10.1016/j.tig.2013.05.008; Irimia M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000148; Jeck WR, 2013, RNA, V19, P141, DOI 10.1261/rna.035667.112; Lamm AT, 2011, GENOME RES, V21, P265, DOI 10.1101/gr.108845.110; Li YT, 2011, MOL PLANT, V4, P171, DOI 10.1093/mp/ssq052; Marguerat S, 2012, CELL, V151, P671, DOI 10.1016/j.cell.2012.09.019; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Moldon A, 2008, NATURE, V455, P997, DOI 10.1038/nature07325; Nam K, 1997, MOL CELL BIOL, V17, P809, DOI 10.1128/MCB.17.2.809; NIGRO JM, 1991, CELL, V64, P607, DOI 10.1016/0092-8674(91)90244-S; Ram O, 2007, TRENDS GENET, V23, P5, DOI 10.1016/j.tig.2006.10.002; ROBBERSON BL, 1990, MOL CELL BIOL, V10, P84, DOI 10.1128/MCB.10.1.84; Romfo CM, 2000, MOL CELL BIOL, V20, P7955, DOI 10.1128/MCB.20.21.7955-7970.2000; Salzman J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003777; Salzman J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030733; Shao XA, 2006, BIOINFORMATICS, V22, P692, DOI 10.1093/bioinformatics/bti795; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Singh PK, 2012, BBA-GENE REGUL MECH, V1819, P1186, DOI 10.1016/j.bbagrm.2012.08.014; Sorber K, 2011, NUCLEIC ACIDS RES, V39, P3820, DOI 10.1093/nar/gkq1223; Vincent HA, 2006, J BIOL CHEM, V281, P29769, DOI 10.1074/jbc.M606744200; Yanagida M, 2009, TRENDS CELL BIOL, V19, P705, DOI 10.1016/j.tcb.2009.09.006; Zaphiropoulos PG, 1996, P NATL ACAD SCI USA, V93, P6536, DOI 10.1073/pnas.93.13.6536; Zhang XH, 2011, EUKARYOT CELL, V10, P1422, DOI 10.1128/EC.05193-11	40	561	599	7	100	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90859	10.1371/journal.pone.0090859	http://dx.doi.org/10.1371/journal.pone.0090859			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24609083	Green Published, gold, Green Submitted			2022-12-27	WOS:000332485800061
J	Zhu, QC; Jin, ZM; Wu, W; Gao, RY; Guo, BM; Gao, ZG; Yang, YZ; Qin, HL				Zhu, Qingchao; Jin, Zhiming; Wu, Wen; Gao, Renyuan; Guo, Bomin; Gao, Zhiguang; Yang, Yongzhi; Qin, Huanlong			Analysis of the Intestinal Lumen Microbiota in an Animal Model of Colorectal Cancer	PLOS ONE			English	Article							MOLECULAR-PHYLOGENETIC CHARACTERIZATION; GUT MICROBIOTA; FUSOBACTERIUM-NUCLEATUM; RIBOSOMAL-RNA; HOST; IMBALANCES; INFECTION; CELLS	Recent reports have suggested that multiple factors such as host genetics, environment and diet can promote the progression of healthy mucosa towards sporadic colorectal carcinoma. Accumulating evidence has additionally associated intestinal bacteria with disease initiation and progression. In order to examine and analyze the composition of gut microbiota in the absence of confounding influences, we have established an animal model of 1, 2-dimethylhydrazine (DMH)-induced colon cancer. Using this model, we have performed pyrosequencing of the V3 region of the 16S rRNA genes in this study to determine the diversity and breadth of the intestinal microbial species. Our findings indicate that the microbial composition of the intestinal lumen differs significantly between control and tumor groups. The abundance of Firmicutes was elevated whereas the abundance of Bacteroidetes and Spirochetes was reduced in the lumen of CRC rats. Fusobacteria was not detected in any of the healthy rats and there was no significant difference in observed Proteobacteria species when comparing the bacterial communities between our two groups. Interestingly, the abundance of Proteobacteria was higher in CRC rats. At the genus level, Bacteroides exhibited a relatively higher abundance in CRC rats compared to controls (14.92% vs. 9.22%, p<0.001). Meanwhile, Prevotella (55.22% vs. 26.19%), Lactobacillus (3.71% vs. 2.32%) and Treponema (3.04% vs. 2.43%), were found to be significantly more abundant in healthy rats than CRC rats (p<0.001, respectively). We also demonstrate a significant reduction of butyrate-producing bacteria such as Roseburia and Eubacterium in the gut microbiota of CRC rats. Furthermore, a significant increase in Desulfovibrio, Erysipelotrichaceae and Fusobacterium was also observed in the tumor group. A decrease in probiotic species such as Ruminococcus and Lactobacillus was likewise observed in the tumor group. Collectively, we can conclude that a significant difference in intestinal bacterial flora exists between healthy rats and CRC rats.	[Zhu, Qingchao; Jin, Zhiming; Wu, Wen; Gao, Renyuan; Guo, Bomin; Gao, Zhiguang; Yang, Yongzhi; Qin, Huanlong] Shanghai Jiao Tong Univ, Peoples Hosp 6, Dept Surg, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Qin, HL (corresponding author), Shanghai Jiao Tong Univ, Peoples Hosp 6, Dept Surg, Shanghai 200030, Peoples R China.	huanlongqin@yahoo.com	huanlong, Qin/B-3844-2015		National Nature Science Foundation of China [81230057]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Nature Science Foundation of China (No. 81230057). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen-Vercoe E, 2011, GUT MICROBES, V2, P294, DOI 10.4161/gmic.2.5.18603; Antonic V, 2013, J CANCER, V4, P227, DOI 10.7150/jca.5835; Arthur JC, 2011, INFLAMM BOWEL DIS, V17, P396, DOI 10.1002/ibd.21354; Attene-Ramos MS, 2006, MOL CANCER RES, V4, P9, DOI 10.1158/1541-7786.MCR-05-0126; Beeckman DSA, 2010, CURR ISSUES MOL BIOL, V12, P17; Bibiloni R, 2012, GUT MICROBES, V3, P536, DOI 10.4161/gmic.21905; Candela M, 2011, CRIT REV MICROBIOL, V37, P1, DOI 10.3109/1040841X.2010.501760; Castellarin M, 2012, GENOME RES, V22, P299, DOI 10.1101/gr.126516.111; Chen WG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039743; Dejea C, 2013, FUTURE MICROBIOL, V8, P445, DOI [10.2217/fmb.13.17, 10.2217/FMB.13.17]; Dharmani P, 2011, INFECT IMMUN, V79, P2597, DOI 10.1128/IAI.05118-11; Duncan SH, 2007, APPL ENVIRON MICROB, V73, P1073, DOI 10.1128/AEM.02340-06; Forde BM, 2013, BRIEF FUNCT GENOMICS, V12, P440, DOI 10.1093/bfgp/els062; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Kaur N, 2011, GUT MICROBES, V2, P211, DOI 10.4161/gmic.2.4.17863; Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Marchesi JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020447; MOORE WEC, 1995, APPL ENVIRON MICROB, V61, P3202, DOI 10.1128/AEM.61.9.3202-3207.1995; Muyzer G, 2008, NAT REV MICROBIOL, V6, P441, DOI 10.1038/nrmicro1892; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Ott SJ, 2004, GUT, V53, P685, DOI 10.1136/gut.2003.025403; Proctor LM, 2011, CELL HOST MICROBE, V10, P287, DOI 10.1016/j.chom.2011.10.001; ROEDIGER WEW, 1982, GASTROENTEROLOGY, V83, P424; Sasaki Maiko, 2012, J Signal Transduct, V2012, P704953, DOI 10.1155/2012/704953; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sears CL, 2008, CLIN INFECT DIS, V47, P797, DOI 10.1086/591130; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Sengupta S, 2006, J GASTROEN HEPATOL, V21, P209, DOI 10.1111/j.1440-1746.2006.04213.x; Sobhani I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016393; Strauss J, 2008, ANAEROBE, V14, P301, DOI 10.1016/j.anaerobe.2008.12.003; Strauss J, 2011, INFLAMM BOWEL DIS, V17, P1971, DOI 10.1002/ibd.21606; Suau A, 1999, APPL ENVIRON MICROB, V65, P4799; Swidsinski A, 2011, GUT, V60, P34, DOI 10.1136/gut.2009.191320; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Waidmann M, 2003, GASTROENTEROLOGY, V125, P162, DOI 10.1016/S0016-5085(03)00672-3; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang TT, 2012, ISME J, V6, P320, DOI 10.1038/ismej.2011.109; Wei H, 2010, FEMS MICROBIOL ECOL, V73, P577, DOI 10.1111/j.1574-6941.2010.00924.x; Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015; Xenoulis PG, 2008, FEMS MICROBIOL ECOL, V66, P579, DOI 10.1111/j.1574-6941.2008.00556.x; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; zur Hausen H, 2009, VIROLOGY, V392, P1, DOI 10.1016/j.virol.2009.06.001	45	124	136	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90849	10.1371/journal.pone.0090849	http://dx.doi.org/10.1371/journal.pone.0090849			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603888	Green Published, gold, Green Submitted			2022-12-27	WOS:000332483600096
J	Halliday, E; McLellan, SL; Amaral-Zettler, LA; Sogin, ML; Gast, RJ				Halliday, Elizabeth; McLellan, Sandra L.; Amaral-Zettler, Linda A.; Sogin, Mitchell L.; Gast, Rebecca J.			Comparison of Bacterial Communities in Sands and Water at Beaches with Bacterial Water Quality Violations	PLOS ONE			English	Article							MICROBIAL SOURCE TRACKING; FECAL INDICATOR BACTERIA; ESCHERICHIA-COLI; QUANTITATIVE PCR; DIVERSITY; ENTEROCOCCI; POPULATION; ORGANISMS; PATHOGENS; SURVIVAL	Recreational water quality, as measured by culturable fecal indicator bacteria (FIB), may be influenced by persistent populations of these bacteria in local sands or wrack, in addition to varied fecal inputs from human and/or animal sources. In this study, pyrosequencing was used to generate short sequence tags of the 16S hypervariable region ribosomal DNA from shallow water samples and from sand samples collected at the high tide line and at the intertidal water line at sites with and without FIB exceedance events. These data were used to examine the sand and water bacterial communities to assess the similarity between samples, and to determine the impact of water quality exceedance events on the community composition. Sequences belonging to a group of bacteria previously identified as alternative fecal indicators were also analyzed in relationship to water quality violation events. We found that sand and water samples hosted distinctly different overall bacterial communities, and there was greater similarity in the community composition between coastal water samples from two distant sites. The dissimilarity between high tide and intertidal sand bacterial communities, although more similar to each other than to water, corresponded to greater tidal range between the samples. Within the group of alternative fecal indicators greater similarity was observed within sand and water from the same site, likely reflecting the anthropogenic contribution at each beach. This study supports the growing evidence that community-based molecular tools can be leveraged to identify the sources and potential impact of fecal pollution in the environment, and furthermore suggests that a more diverse bacterial community in beach sand and water may reflect a less contaminated site and better water quality.	[Halliday, Elizabeth; Gast, Rebecca J.] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; [McLellan, Sandra L.] Univ Wisconsin, Sch Freshwater Sci, Great Lakes Water Inst, Milwaukee, WI 53201 USA; [Amaral-Zettler, Linda A.; Sogin, Mitchell L.] Marine Biol Lab, Josephine Bay Paul Ctr, Woods Hole, MA 02543 USA; [Amaral-Zettler, Linda A.] Brown Univ, Dept Geosci, Providence, RI 02912 USA	Woods Hole Oceanographic Institution; University of Wisconsin System; University of Wisconsin Milwaukee; Marine Biological Laboratory - Woods Hole; Brown University	Gast, RJ (corresponding author), Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA.	rgast@whoi.edu	Sogin, Mitchell/AAE-7186-2019	McLellan, Sandra/0000-0003-3283-1151; Gast, Rebecca J/0000-0003-3875-3975	National Science Foundation [OCE-0430724]; National Institute of Environmental Health Sciences [P0ES012742]; WHOI Academic Programs; WHOI Ocean Ventures Fund; WHOI Coastal Ocean Institute; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P50ES012742] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); WHOI Academic Programs; WHOI Ocean Ventures Fund; WHOI Coastal Ocean Institute; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Science Foundation grant OCE-0430724, and the National Institute of Environmental Health Sciences grant P0ES012742 to the Woods Hole Center for Ocean and Human Health. E. Halliday was partially supported by WHOI Academic Programs and grants from the WHOI Ocean Ventures Fund and the WHOI Coastal Ocean Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelzaher AM, 2010, APPL ENVIRON MICROB, V76, P724, DOI 10.1128/AEM.02127-09; Alm EW, 2003, WATER RES, V37, P3978, DOI 10.1016/S0043-1354(03)00301-4; Beversdorf LJ, 2007, J APPL MICROBIOL, V102, P1372, DOI 10.1111/j.1365-2672.2006.03177.x; Bibby K, 2010, WATER RES, V44, P4252, DOI 10.1016/j.watres.2010.05.039; Boer SI, 2009, ISME J, V3, P780, DOI 10.1038/ismej.2009.29; Bonilla TD, 2007, MAR POLLUT BULL, V54, P1472, DOI 10.1016/j.marpolbul.2007.04.016; Byappanahalli M, 2004, WATER SCI TECHNOL, V50, P27, DOI 10.2166/wst.2004.0009; Cao YP, 2011, ENVIRON SCI TECHNOL, V45, P7195, DOI 10.1021/es201118r; Cui HL, 2013, APPL ENVIRON MICROB, V79, P3601, DOI 10.1128/AEM.00135-13; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Elmanama AA, 2005, ENVIRON RES, V99, P1, DOI 10.1016/j.envres.2004.12.014; Feng F, 2010, FEMS MICROBIOL ECOL, V74, P214, DOI 10.1111/j.1574-6941.2010.00921.x; FUERST JA, 1995, MICROBIOL-UK, V141, P1493, DOI 10.1099/13500872-141-7-1493; Gast RJ, 2004, APPL ENVIRON MICROB, V70, P2028, DOI 10.1128/AEM.70.4.2028-2037.2004; Ge ZF, 2012, LIMNOL OCEANOGR, V57, P362, DOI 10.4319/lo.2012.57.1.0362; Gobet A, 2012, ISME J, V6, P542, DOI 10.1038/ismej.2011.132; Gobet A, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq545; Goodwin KD, 2012, WATER RES, V46, P4195, DOI 10.1016/j.watres.2012.04.001; Gorley C.K., 2006, GETTING STARTED PRIM; Halliday E, 2011, ENV SCI TECHNOLOGY; Halliday EA, 2012, SANDS ENV CONDITIONS; Halliday E, 2010, LIMNOL OCEANOGR-METH, V8, P146, DOI 10.4319/lom.2010.8.146; Hartz A, 2008, J ENVIRON QUAL, V37, P898, DOI 10.2134/jeq2007.0312; Heaney CD, 2012, EPIDEMIOLOGY, V23, P95, DOI 10.1097/EDE.0b013e31823b504c; Heaney CD, 2009, AM J EPIDEMIOL, V170, P164, DOI 10.1093/aje/kwp152; Hewson I, 2003, MICROB ECOL, V46, P337, DOI 10.1007/s00248-002-1041-0; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Laverock B, 2010, ISME J, V4, P1531, DOI 10.1038/ismej.2010.86; Llobet-Brossa E, 1998, APPL ENVIRON MICROB, V64, P2691; Ludwig W, 2000, SYST APPL MICROBIOL, V23, P556, DOI 10.1016/S0723-2020(00)80030-2; McLellan SL, 2010, ENVIRON MICROBIOL, V12, P378, DOI 10.1111/j.1462-2920.2009.02075.x; Mika KB, 2009, J APPL MICROBIOL, V107, P72, DOI 10.1111/j.1365-2672.2009.04197.x; Newton RJ, 2011, APPL ENVIRON MICROB; Phillips MC, 2011, WATER RES, V45, P6763, DOI 10.1016/j.watres.2011.10.028; Piggot AM, 2012, APPL ENV MICROBIOLOG; Russell T, 2012, ENV SCI TECHNOLOGY; Shanks OC, 2013, APPL ENVIRON MICROB, V79, P2906, DOI 10.1128/AEM.03448-12; Shibata T, 2012, ENV SCI TECHNOLOGY; Simpson JM, 2002, ENVIRON SCI TECHNOL, V36, P5279, DOI 10.1021/es026000b; Tsertova N, 2011, ENV MICROBIOL REP, V3, P270, DOI 10.1111/j.1758-2229.2010.00221.x; U.S. Environmental Protection Agency, 2014, 1600 US EPA; Unno T, 2010, ENV SCI TECHNOLOGY; Wery N, 2010, WATER RES, V44, P1873, DOI 10.1016/j.watres.2009.11.027; Yamahara KM, 2007, ENVIRON SCI TECHNOL, V41, P4515, DOI 10.1021/es062822n; Yamahara KM, 2012, APPL ENVIRON MICROB, V78, P1733, DOI 10.1128/AEM.06185-11; Yamahara KM, 2009, APPL ENVIRON MICROB, V75, P1517, DOI 10.1128/AEM.02278-08; Ye L, 2011, ENV SCI TECHNOLOGY; Zhu X, 2011, WATER RES	51	42	42	3	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90815	10.1371/journal.pone.0090815	http://dx.doi.org/10.1371/journal.pone.0090815			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599478	Green Published, gold			2022-12-27	WOS:000332479400136
J	Castello, NA; Nguyen, MH; Tran, JD; Cheng, D; Green, KN; LaFerla, FM				Castello, Nicholas A.; Nguyen, Michael H.; Tran, Jenny D.; Cheng, David; Green, Kim N.; LaFerla, Frank M.			7,8-Dihydroxyflavone, a Small Molecule TrkB Agonist, Improves Spatial Memory and Increases Thin Spine Density in a Mouse Model of Alzheimer Disease-Like Neuronal Loss	PLOS ONE			English	Article							NEUROTROPHIC FACTOR; DENDRITIC SPINES; ENTORHINAL CORTEX; BRAIN; BDNF; CA1; DEFICITS; HIPPOCAMPUS; PLASTICITY; MICE	Augmenting BDNF/TrkB signaling has been demonstrated to be a promising strategy for reversing cognitive deficits in preclinical models of Alzheimer disease (AD). Although these studies highlight the potential of targeting BDNF/TrkB signaling, this strategy has not yet been tested in a model that develops the disease features that are most closely associated with cognitive decline in AD: severe synaptic and neuronal loss. In the present study, we investigated the impact of 7,8-dihydroxyflavone (DHF), a TrkB agonist, in CaM/Tet-DTA mice, an inducible model of severe neuronal loss in the hippocampus and cortex. Systemic 7,8-DHF treatment significantly improved spatial memory in lesioned mice, as measured by water maze. Analysis of GFP-labeled neurons in CaM/Tet-DTA mice revealed that 7,8-DHF induced a significant and selective increase in the density of thin spines in CA1 of lesioned mice, without affecting mushroom or stubby spines. These findings suggest chronic upregulation of TrkB signaling with 7,8-DHF may be an effective and practical strategy for improving function in AD, even after substantial neuronal loss has occurred.	[Castello, Nicholas A.; Nguyen, Michael H.; Tran, Jenny D.; Cheng, David; Green, Kim N.; LaFerla, Frank M.] Univ Calif Irvine, Inst Memory Impairments & Neurol Disorders, Irvine, CA 92697 USA; [Castello, Nicholas A.; Nguyen, Michael H.; Tran, Jenny D.; Cheng, David; Green, Kim N.; LaFerla, Frank M.] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA USA	University of California System; University of California Irvine; University of California System; University of California Irvine	LaFerla, FM (corresponding author), Univ Calif Irvine, Inst Memory Impairments & Neurol Disorders, Irvine, CA 92697 USA.	laferla@uci.edu			American Health Assistance Foundation (FML) [NIH F31AG034061]; NATIONAL INSTITUTE ON AGING [F31AG034061] Funding Source: NIH RePORTER	American Health Assistance Foundation (FML); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work is supported by a grant from the American Health Assistance Foundation (FML) and NIH F31AG034061 (NAC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aungst S, 2013, J NEUROPHYSIOL, V109, P813, DOI 10.1152/jn.00869.2012; Bartoletti A, 2002, J NEUROSCI, V22, P10072; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; Blurton-Jones M, 2009, P NATL ACAD SCI USA, V106, P13594, DOI 10.1073/pnas.0901402106; Bobinski M, 1998, BRAIN RES, V805, P267, DOI 10.1016/S0006-8993(98)00759-8; Bourne J, 2007, CURR OPIN NEUROBIOL, V17, P381, DOI 10.1016/j.conb.2007.04.009; Brown CE, 2008, STROKE, V39, P1286, DOI 10.1161/STROKEAHA.107.498238; Brown CE, 2007, J NEUROSCI, V27, P4101, DOI 10.1523/JNEUROSCI.4295-06.2007; Chakravarthy S, 2006, P NATL ACAD SCI USA, V103, P1071, DOI 10.1073/pnas.0506305103; COTMAN CW, 1973, P NATL ACAD SCI USA, V70, P3473, DOI 10.1073/pnas.70.12.3473; Devi L, 2012, NEUROPSYCHOPHARMACOL, V37, P434, DOI 10.1038/npp.2011.191; Dinocourt C, 2006, EUR J NEUROSCI, V24, P1857, DOI 10.1111/j.1460-9568.2006.05067.x; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; FUKUTANI Y, 1995, NEUROSCI LETT, V200, P57, DOI 10.1016/0304-3940(95)12083-G; Giannakopoulos P, 2003, NEUROLOGY, V60, P1495, DOI 10.1212/01.WNL.0000063311.58879.01; GomezIsla T, 1996, J NEUROSCI, V16, P4491; Gorski JA, 2003, J NEUROSCI, V23, P6856; HAMORI J, 1990, J EXP BIOL, V153, P251; HARRIS KM, 1992, J NEUROSCI, V12, P2685; Heldt SA, 2007, MOL PSYCHIATR, V12, P656, DOI 10.1038/sj.mp.4001957; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Iwasaki Y, 2012, J NEUROSCI RES, V90, P981, DOI 10.1002/jnr.22830; Jang SW, 2010, P NATL ACAD SCI USA, V107, P2687, DOI 10.1073/pnas.0913572107; Lin AJ, 2013, LASERS SURG MED; Massa SM, 2010, J CLIN INVEST, V120, P1774, DOI 10.1172/JCI41356; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; Monteggia LM, 2004, P NATL ACAD SCI USA, V101, P10827, DOI 10.1073/pnas.0402141101; Monville C, 2006, J NEUROSCI METH, V158, P219, DOI 10.1016/j.jneumeth.2006.06.001; Nagahara AH, 2009, NAT MED, V15, P331, DOI 10.1038/nm.1912; NEARY D, 1986, J NEUROL NEUROSUR PS, V49, P229, DOI 10.1136/jnnp.49.3.229; Noguchi J, 2005, NEURON, V46, P609, DOI 10.1016/j.neuron.2005.03.015; Poduslo JF, 1996, MOL BRAIN RES, V36, P280, DOI 10.1016/0169-328X(95)00250-V; Posmantur RM, 1996, J NEUROPATH EXP NEUR, V55, P68, DOI 10.1097/00005072-199601000-00007; Price JL, 2001, ARCH NEUROL-CHICAGO, V58, P1395, DOI 10.1001/archneur.58.9.1395; Radecki DT, 2005, HIPPOCAMPUS, V15, P246, DOI 10.1002/hipo.20048; Sadan O, 2009, STEM CELLS DEV, V18, P1179, DOI 10.1089/scd.2008.0411; Sasaki M, 2009, J NEUROSCI, V29, P14932, DOI 10.1523/JNEUROSCI.2769-09.2009; Scheff SW, 2005, J NEUROTRAUM, V22, P719, DOI 10.1089/neu.2005.22.719; SCHEFF SW, 1977, BEHAV BIOL, V21, P286, DOI 10.1016/S0091-6773(77)90374-1; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Tyler WJ, 2003, J PHYSIOL-LONDON, V553, P497, DOI 10.1113/jphysiol.2003.052639; Tyler WJ, 2001, J NEUROSCI, V21, P4249, DOI 10.1523/JNEUROSCI.21-12-04249.2001; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; WEST MJ, 1994, LANCET, V344, P769, DOI 10.1016/S0140-6736(94)92338-8; Xie YX, 2010, J NEUROSCI, V30, P14708, DOI 10.1523/JNEUROSCI.1637-10.2010; Yacoubian TA, 2000, NAT NEUROSCI, V3, P342, DOI 10.1038/73911; Yamasaki TR, 2007, J NEUROSCI, V27, P11925, DOI 10.1523/JNEUROSCI.1627-07.2007; Yeung ST, 2014, NEUROSCIENCE, V259, P214, DOI 10.1016/j.neuroscience.2013.11.054; Zeng Y, 2012, J ALZHEIMERS DIS, V31, P765, DOI 10.3233/JAD-2012-120886; Zhang Z, 2013, NEUROPSYCHOPHARMACOL	50	83	89	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91453	10.1371/journal.pone.0091453	http://dx.doi.org/10.1371/journal.pone.0091453			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614170	Green Published, gold			2022-12-27	WOS:000332839300128
J	Chow, PKH; Poon, DYH; Khin, MW; Singh, H; Han, HS; Goh, ASW; Choo, SP; Lai, HK; Lo, RHG; Tay, KH; Lim, TG; Gandhi, M; Tan, SB; Soo, KC				Chow, Pierce K. H.; Poon, Donald Y. H.; Khin, Maung-Win; Singh, Harjit; Han, Ho-Seong; Goh, Anthony S. W.; Choo, Su-Pin; Lai, Hee-Kit; Lo, Richard H. G.; Tay, Kiang-Hiong; Lim, Teong-Guan; Gandhi, Mihir; Tan, Say-Beng; Soo, Khee-Chee		Asia-Pacific Hepatocellular	Multicenter Phase II Study of Sequential Radioembolization-Sorafenib Therapy for Inoperable Hepatocellular Carcinoma	PLOS ONE			English	Article							TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION; RADIATION-THERAPY; Y-90 MICROSPHERES; RADIOTHERAPY; EFFICACY; SURVIVAL; SAFETY	Background: The safety and tolerability of sequential radioembolization-sorafenib therapy is unknown. An open-label, single arm, investigator-initiated Phase II study (NCT0071279) was conducted at four Asia-Pacific centers to evaluate the safety and efficacy of sequential radioembolization-sorafenib in patients with hepatocellular carcinoma (HCC) not amenable to curative therapies. Methods: Sorafenib (400 mg twice-daily) was initiated 14 days post-radioembolization with yttrium-90 (Y-90) resin microspheres given as a single procedure. The primary endpoints were safety and tolerability and best overall response rate (ORR) using RECIST v1.0.Secondary endpoints included: disease control rate (complete [CR] plus partial responses [PR] and stable disease [SD]) and overall survival (OS). Results: Twenty-nine patients with Barcelona Clinic Liver Cancer (BCLC) stage B (38%) or C (62%) HCC received a median of 3.0 GBq (interquartile range, 1.0) Y-90-microspheres followed by sorafenib (median dose/day, 600.0 mg; median duration, 4.1 months). Twenty eight patients experienced >= 1 toxicity; 15 (52%) grade >= 3. Best ORR was 25%, including 2 (7%) CR and 5 (18%) PR, and 15 (54%) SD. Disease control was 100% and 65% in BCLC stage B and C, respectively. Two patients (7%) had sufficient response to enable radical therapy. Median survivals for BCLC stage B and C were 20.3 and 8.6 months, respectively. Conclusions: This study shows the potential efficacy and manageable toxicity of sequential radioembolization-sorafenib.	[Chow, Pierce K. H.; Goh, Anthony S. W.; Lai, Hee-Kit; Lo, Richard H. G.; Tay, Kiang-Hiong; Lim, Teong-Guan; Soo, Khee-Chee] Natl Canc Ctr, Singapore, Singapore; [Chow, Pierce K. H.; Poon, Donald Y. H.; Choo, Su-Pin; Soo, Khee-Chee] Singapore Gen Hosp, Singapore, Singapore; [Chow, Pierce K. H.; Gandhi, Mihir; Tan, Say-Beng; Soo, Khee-Chee] Duke NUS Grad Med Sch, Singapore, Singapore; [Khin, Maung-Win] Yangon Gastrointestinal & Liver Ctr, Yangon, Myanmar; [Singh, Harjit] Selayang Hosp, Selangor, Malaysia; [Han, Ho-Seong] Seoul Natl Univ, Bundang Hosp, Bundang, South Korea; [Gandhi, Mihir; Tan, Say-Beng] Singapore Clin Res Inst, Singapore, Singapore	National Cancer Centre Singapore (NCCS); Singapore General Hospital; National University of Singapore; Seoul National University (SNU); Seoul National University Hospital; Singapore Clinical Research Institute	Chow, PKH (corresponding author), Natl Canc Ctr, Singapore, Singapore.	pierce.chow.k.h@nccs.com.sg	CHOO, Su Pin/ABB-3892-2020	Chow, Pierce/0000-0003-0584-2584; Win, Khin Maung/0000-0003-4126-307X	National Medical Research Council Singapore [NMRC/1161/2008]; Sirtex Medical Limited, Sydney, Australia; Bayer Schering Pharma AG, Berlin, Germany	National Medical Research Council Singapore(National Medical Research Council, SingaporeUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Sirtex Medical Limited, Sydney, Australia; Bayer Schering Pharma AG, Berlin, Germany(Bayer AG)	This study is funded jointly by the National Medical Research Council Singapore grant number NMRC/1161/2008 (http://www.nmrc.gov.sg/); Sirtex Medical Limited, Sydney, Australia; and Bayer Schering Pharma AG, Berlin, Germany, in the form of free therapeutics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A'Hern RP, 2001, STAT MED, V20, P859, DOI 10.1002/sim.721; Bruix J, 2001, J HEPATOL, V35, P421, DOI 10.1016/S0168-8278(01)00130-1; Bruix J, 2012, J HEPATOL, V57, P821, DOI 10.1016/j.jhep.2012.06.014; Cheng AL, 2012, EUR J CANCER, V48, P1452, DOI 10.1016/j.ejca.2011.12.006; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Cheng JCH, 2006, ONCOGENE, V25, P7009, DOI 10.1038/sj.onc.1209706; Chow PK, 2009, J CLIN ONCOL, V27; Chow PKH, 2002, HEPATOLOGY, V36, P1221, DOI 10.1053/jhep.2002.36824; Chung YL, 2006, CLIN CANCER RES, V12, P2706, DOI 10.1158/1078-0432.CCR-05-2721; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; *EMEA, 2013, NEX SOR SUMM PROD CH; Erhardt A, 2011, J HEPATOL, V54, pS35, DOI 10.1016/S0168-8278(11)60081-0; Farrell GC, 2010, J GASTROEN HEPATOL, V25, P657, DOI 10.1111/j.1440-1746.2009.06167.x; Gil-Alzugaray B, 2013, HEPATOLOGY, V57, P1078, DOI 10.1002/hep.26191; Ho S, 1996, EUR J NUCL MED, V23, P947, DOI 10.1007/BF01084369; Hoffman MA, 2008, J VASC INTERV RADIOL, V19, P1099, DOI 10.1016/j.jvir.2008.02.027; Hoffman RT, 2008, MED RADIOL DIAGN IMA, P139, DOI 10.1007/978-3-540-35423-9_14; Hung H, 2005, CURR CANCER DRUG TAR, V5, P131, DOI 10.2174/1568009053202063; Lau WY, 2012, INT J RADIAT ONCOL, V82, P401, DOI 10.1016/j.ijrobp.2010.08.015; Lau WY, 1998, INT J RADIAT ONCOL, V40, P583, DOI 10.1016/S0360-3016(97)00818-3; LEUNG TWT, 1995, INT J RADIAT ONCOL, V33, P919, DOI 10.1016/0360-3016(95)00039-3; Li Baosheng, 2003, Am J Clin Oncol, V26, pe92, DOI 10.1097/00000421-200308000-00030; Liu DM, 2005, J VASC INTERV RADIOL, V16, P911, DOI 10.1097/01.RVI.0000164324.79242.B2; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Mazzaferro V, 2013, HEPATOLOGY, V57, P1826, DOI 10.1002/hep.26014; Memon K, 2013, J HEPATOL, V58, P73, DOI 10.1016/j.jhep.2012.09.003; Pawlik TM, 2011, J CLIN ONCOL, V29, P3960, DOI 10.1200/JCO.2011.37.1021; Plastaras JP, 2007, CANCER RES, V67, P9443, DOI 10.1158/0008-5472.CAN-07-1473; Salem R, 2010, GASTROENTEROLOGY, V138, P52, DOI 10.1053/j.gastro.2009.09.006; Sangro B, 2011, HEPATOLOGY, V54, P868, DOI 10.1002/hep.24451; Sangro B, 2008, CANCER-AM CANCER SOC, V112, P1538, DOI 10.1002/cncr.23339; SHAH RR, 2013, DRUG SAF IN PRESS; Suen AW, 2010, INT J RADIAT ONCOL, V78, P213, DOI 10.1016/j.ijrobp.2010.02.064; Tsuchiya A, 2002, HEALTH ECON, V11, P341, DOI 10.1002/hec.673; Wang JH, 2008, EUR J CANCER, V44, P1000, DOI 10.1016/j.ejca.2008.02.018; Yang CW, 2010, SOUTH MED J, V103, P1264, DOI 10.1097/SMJ.0b013e3181fa5ec7; Zhao JD, 2010, RADIAT ONCOL, V5, DOI 10.1186/1748-717X-5-12; Zhou ZH, 2007, BRIT J RADIOL, V80, P194, DOI 10.1259/bjr/33521596	38	52	55	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e90909	10.1371/journal.pone.0090909	http://dx.doi.org/10.1371/journal.pone.0090909			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614178	Green Published, Green Submitted, gold			2022-12-27	WOS:000332839300052
J	Peddayelachagiri, BV; Paul, S; Makam, SS; Urs, RM; Kingston, JJ; Tuteja, U; Sripathy, MH; Batra, HV				Peddayelachagiri, Bhavani V.; Paul, Soumya; Makam, Shivakiran S.; Urs, Radhika M.; Kingston, Joseph J.; Tuteja, Urmil; Sripathy, Murali H.; Batra, Harsh V.			Functional Characterization and Evaluation of In Vitro Protective Efficacy of Murine Monoclonal Antibodies BURK24 and BURK37 against Burkholderia pseudomallei	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEINS; PSEUDOMONAS-AERUGINOSA; CAPSULAR POLYSACCHARIDE; ESCHERICHIA-COLI; SERUM RESISTANCE; STAPHYLOCOCCUS-EPIDERMIDIS; ANTIBIOTIC SUSCEPTIBILITY; INTRACELLULAR SURVIVAL; NEISSERIA-GONORRHOEAE; FACTOR-H	Burkholderia pseudomallei, the causative agent of melioidosis has been recognized by CDC as a category B select agent. Although substantial efforts have been made for development of vaccine molecules against the pathogen, significant hurdles still remain. With no licensed vaccines available and high relapse rate of the disease, there is a pressing need for development of alternate protection strategies. Antibody-mediated passive protection is promising in this regard and our primary interest was to unravel this frontier of specific mAbs against Burkholderia pseudomallei infections, as functional characterization of antibodies is a pre-requisite to demonstrate them as protective molecules. To achieve this, we designed our study on in vitro-based approach and assessed two mAbs, namely BURK24 and BURK37, reactive with outer membrane proteins and lipopolysaccharide of the pathogen respectively, for their ability to manifest inhibitory effects on the pathogenesis mechanisms of B. pseudomallei including biofilm formation, invasion and induction of apoptosis. The experiments were performed using B. pseudomallei standard strain NCTC 10274 and a clinical isolate, B. pseudomallei 621 recovered from a septicemia patient with diabetic ailment. The growth kinetic studies of the pathogen in presence of various concentrations of each individual mAb revealed their anti-bacterial properties. Minimal inhibitory concentration and minimal bactericidal concentration of both the mAbs were determined by using standards of Clinical and Laboratory Standards Institute (CLSI) and experiments were performed using individual mAbs at their respective bacteriostatic concentration. As an outcome, both mAbs exhibited significant anti-Burkholderia pseudomallei properties. They limited the formation of biofilm by the bacterium and completely crippled its invasion into human alveolar adenocarcinoma epithelial cells. Also, the mAbs were appreciably successful in preventing the bacterium to induce apoptosis in A549 cells. The present study design revealed the protection attributes possessed by BURK24 and BURK37 that has to be further substantiated by additional in vivo studies.	[Peddayelachagiri, Bhavani V.; Paul, Soumya; Makam, Shivakiran S.; Urs, Radhika M.; Kingston, Joseph J.; Sripathy, Murali H.; Batra, Harsh V.] Def Food Res Lab, Div Microbiol, Mysore 570011, Karnataka, India; [Tuteja, Urmil] Def Res & Dev Estab, Div Microbiol, Gwalior 474002, Madhya Pradesh, India	Defence Research & Development Organisation (DRDO); Defence Food Research Laboratory (DFRL); Defence Research & Development Organisation (DRDO); Defence Research & Development Establishment (DRDE)	Batra, HV (corresponding author), Def Food Res Lab, Div Microbiol, Mysore 570011, Karnataka, India.	drharshvardhanbatra@gmail.com	S, Shivakiran M/D-7211-2015	S, Shivakiran M/0000-0003-3844-9770	Department of Science and Technology (DST), India; Council of Scientific and Industrial Research (CSIR), India	Department of Science and Technology (DST), India(Department of Science & Technology (India)); Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India)	The first author is thankful to Department of Science and Technology (DST), India for support through INSPIRE program. The third author is thankful to Council of Scientific and Industrial Research (CSIR), India for support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama M, 2000, MICROBIOL IMMUNOL, V44, P629, DOI 10.1111/j.1348-0421.2000.tb02543.x; Allwood EM, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00170; Anuntagool N, 2006, AM J TROP MED HYG, V74, P348, DOI 10.4269/ajtmh.2006.74.348; AuCoin DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035386; Behera B, 2012, ASIAN PAC J TROP MED, V5, P329, DOI 10.1016/S1995-7645(12)60050-9; Bogino PC, 2013, INT J MOL SCI, V14, P15838, DOI 10.3390/ijms140815838; Bottex C, 2005, IMMUNOPHARM IMMUNOT, V27, P565, DOI 10.1080/08923970500493995; Brekke OH, 2003, NAT REV DRUG DISCOV, V2, P52, DOI 10.1038/nrd984; Brook MD, 1997, J APPL MICROBIOL, V82, P589, DOI 10.1111/j.1365-2672.1997.tb02867.x; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; CHAOWAGUL W, 1993, J INFECT DIS, V168, P1181, DOI 10.1093/infdis/168.5.1181; Chetchotisakd P, 2014, LANCET, V383, P807, DOI 10.1016/S0140-6736(13)61951-0; Clinical and Laboratory Standards Institute, 1999, METHODS DETERMINING; CROSA JH, 1981, INFECT IMMUN, V31, P223, DOI 10.1128/IAI.31.1.223-227.1981; Currie BJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000900; DANCE DAB, 1989, J ANTIMICROB CHEMOTH, V24, P295, DOI 10.1093/jac/24.3.295; DIPADOVA FE, 1993, INFECT IMMUN, V61, P3863, DOI 10.1128/IAI.61.9.3863-3872.1993; Dunne WM, 2002, CLIN MICROBIOL REV, V15, P155, DOI 10.1128/CMR.15.2.155-166.2002; FINKE M, 1991, INFECT IMMUN, V59, P1251, DOI 10.1128/IAI.59.4.1251-1254.1991; FULOP MJ, 1991, J CLIN MICROBIOL, V29, P1407, DOI 10.1128/JCM.29.7.1407-1412.1991; Griep RA, 1998, PHYTOPATHOLOGY, V88, P795, DOI 10.1094/PHYTO.1998.88.8.795; HEESEMANN J, 1987, FEMS MICROBIOL LETT, V40, P37, DOI 10.1016/0378-1097(87)90512-X; Hellwage J, 2001, J BIOL CHEM, V276, P8427, DOI 10.1074/jbc.M007994200; Jenney AWJ, 2001, INT J ANTIMICROB AG, V17, P109, DOI 10.1016/S0924-8579(00)00334-4; Jones AL, 1996, INFECT IMMUN, V64, P782, DOI 10.1128/IAI.64.3.782-790.1996; Jones SM, 2002, J MED MICROBIOL, V51, P1055, DOI 10.1099/0022-1317-51-12-1055; Kespichayawattana W, 2000, INFECT IMMUN, V68, P5377, DOI 10.1128/IAI.68.9.5377-5384.2000; Kim K, 2010, APPL ENVIRON MICROB, V76, P5188, DOI 10.1128/AEM.02498-09; Knobloch JKM, 2002, J ANTIMICROB CHEMOTH, V49, P683, DOI 10.1093/jac/49.4.683; Koebnik R, 2000, MOL MICROBIOL, V37, P239, DOI 10.1046/j.1365-2958.2000.01983.x; Koh SF, 2013, TROP BIOMED, V30, P428; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Kulkarni RD, 2010, INDIAN J MED RES, V131, P584; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEVITZ SM, 1991, J INFECT DIS, V163, P1108, DOI 10.1093/infdis/163.5.1108; Lin J, 2002, MICROBES INFECT, V4, P325, DOI 10.1016/S1286-4579(02)01545-9; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MASUDA N, 1995, ANTIMICROB AGENTS CH, V39, P645, DOI 10.1128/AAC.39.3.645; Mitov I, 2003, FEMS MICROBIOL LETT, V225, P299, DOI 10.1016/S0378-1097(03)00533-0; MORELLO JA, 1989, J INFECT DIS, V160, P1012, DOI 10.1093/infdis/160.6.1012; Nelson M, 2004, J MED MICROBIOL, V53, P1177, DOI 10.1099/jmm.0.45766-0; Phewkliang A, 2010, SE ASIAN J TROP MED, V41, P1164; Pibalpakdee P, 2012, INT J ANTIMICROB AG, V39, P356, DOI 10.1016/j.ijantimicag.2011.12.010; POLLACK M, 1995, INFECT IMMUN, V63, P4481, DOI 10.1128/IAI.63.11.4481-4488.1995; Ram S, 1998, J EXP MED, V188, P671, DOI 10.1084/jem.188.4.671; Sawasdidoln C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009196; Shahin Susan, 2004, DSTOTR1584; Silva EB, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00010; Sun DQ, 2005, CLIN DIAGN LAB IMMUN, V12, P93, DOI 10.1128/CDLI.12.1.93-100.2005; Suparak S, 2005, J BACTERIOL, V187, P6556, DOI 10.1128/JB.187.18.6556-6560.2005; ter Meulen J, 2007, EXPERT OPIN EMERG DR, V12, P525, DOI 10.1517/14728214.12.4.525; Thibault FM, 2004, J ANTIMICROB CHEMOTH, V54, P1134, DOI 10.1093/jac/dkh471; Toropainen M, 2006, INFECT IMMUN, V74, P2803, DOI 10.1128/IAI.74.5.2803-2808.2006; Wayne P.A., 2006, CLSI NCCLS M7 A7, V7th; WEISER JN, 1991, INFECT IMMUN, V59, P2252, DOI 10.1128/IAI.59.7.2252-2258.1991; Westerman RB, 1997, J CLIN MICROBIOL, V35, P679, DOI 10.1128/JCM.35.3.679-684.1997; White NJ, 2003, LANCET, V361, P1715, DOI 10.1016/S0140-6736(03)13374-0	57	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e90930	10.1371/journal.pone.0090930	http://dx.doi.org/10.1371/journal.pone.0090930			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614539	Green Submitted, Green Published, gold			2022-12-27	WOS:000332839300058
J	Ansari, A; Tarique, M; Tuteja, R				Ansari, Abulaish; Tarique, Mohammed; Tuteja, Renu			Genetically Engineered Synthetic Miniaturized Versions of Plasmodium falciparum UvrD Helicase Are Catalytically Active	PLOS ONE			English	Article							ESCHERICHIA-COLI; DNA HELICASES; PROTEIN; BIPOLAR; ENZYME	Helicases catalyze unwinding of double stranded nucleic acids in an energy-dependent manner. We have reported characterization of UvrD helicase from Plasmodium falciparum. We reported that the N-terminal and C-terminal fragments of PfUvrD contain characteristic ATPase and DNA helicase activities. Here we report the generation and characterization of a genetically engineered version of PfUvrD and its derivatives. This synthetic UvrD (sUD) contains all the conserved domains of PfUvrD but only the intervening linker sequences are shortened. sUD (similar to 45 kDa) and one of its smallest derivative sUDN1N2 (similar to 22 kDa) contain ATPase and DNA helicase activities. sUD and sUDN1N2 can utilize hydrolysis of all the NTPs and dNTPs, can also unwind blunt end duplex DNA substrate and unwind DNA duplex in 3 to 5 direction only. Some of the properties of sUD are similar to the PfUvrD helicase. Mutagenesis in the conserved motif Ia indicate that the mutants sUDM and sUDN1N2M lose all the enzyme activities, which further confirms that these activities are intrinsic to the synthesized proteins. These studies show that for helicase activity only the conserved domains are essentially required and intervening sequences have almost no role. These observations will aid in understanding the unwinding mechanism by a helicase.	[Ansari, Abulaish; Tarique, Mohammed; Tuteja, Renu] Int Ctr Genet Engn & Biotechnol, Malaria Grp, New Delhi, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Tuteja, R (corresponding author), Int Ctr Genet Engn & Biotechnol, Malaria Grp, Aruna Asaf Ali Marg, New Delhi, India.	renu@icgeb.res.in			Department of Biotechnology, Government of India; International Centre for Genetic Engineering and Biotechnology	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); International Centre for Genetic Engineering and Biotechnology	This work is partially supported by funds from Department of Biotechnology, Government of India, and was also supported by the International Centre for Genetic Engineering and Biotechnology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049385; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2; Greenfield NJ, 2006, NAT PROTOC, V1, P2527, DOI 10.1038/nprot.2006.204; Greenfield NJ, 2006, NAT PROTOC, V1, P2891, DOI 10.1038/nprot.2006.244; Karpe YA, 2010, J VIROL, V84, P3595, DOI 10.1128/JVI.02130-09; Laskowski RA, 2009, NUCLEIC ACIDS RES, V37, pD355, DOI 10.1093/nar/gkn860; Lee JY, 2006, CELL, V127, P1349, DOI 10.1016/j.cell.2006.10.049; Matson SW, 2006, NUCLEIC ACIDS RES, V34, P4089, DOI 10.1093/nar/gkl450; Matusan AE, 2001, J VIROL, V75, P9633, DOI 10.1128/JVI.75.20.9633-9643.2001; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; MENDONCA VM, 1995, GENETICS, V141, P443; Moolenaar GF, 2000, J BACTERIOL, V182, P5706, DOI 10.1128/JB.182.20.5706-5714.2000; Motre A, 2008, GENE, V420, P17, DOI 10.1016/j.gene.2008.04.017; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pradhan A, 2005, MOL BIOCHEM PARASIT, V144, P133, DOI 10.1016/j.molbiopara.2005.08.006; Pradhan A, 2007, J MOL BIOL, V373, P268, DOI 10.1016/j.jmb.2007.07.056; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Shankar J, 2008, GENE, V410, P223, DOI 10.1016/j.gene.2007.12.015; TUTEJA N, 1993, NUCLEIC ACIDS RES, V21, P2323, DOI 10.1093/nar/21.10.2323; Tuteja N, 2004, EUR J BIOCHEM, V271, P1849, DOI 10.1111/j.1432-1033.2004.04094.x; Tuteja N, 2004, EUR J BIOCHEM, V271, P1835, DOI 10.1111/j.1432-1033.2004.04093.x; Tuteja R, 2013, COMM INT BIOL 1, V1; Tuteja R, 2007, FEBS J, V274, P4699, DOI 10.1111/j.1742-4658.2007.06000.x; Tuteja R, 2010, CELL CYCLE, V9, P104, DOI 10.4161/cc.9.1.10241; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; von Hippel PH, 2001, CELL, V104, P177, DOI 10.1016/S0092-8674(01)00203-3	27	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90951	10.1371/journal.pone.0090951	http://dx.doi.org/10.1371/journal.pone.0090951			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608129	Green Published, gold			2022-12-27	WOS:000332485800067
J	Garbe, J; Sjogren, J; Cosgrave, EFJ; Struwe, WB; Bober, M; Olin, AI; Rudd, PM; Collin, M				Garbe, Julia; Sjogren, Jonathan; Cosgrave, Eoin F. J.; Struwe, Weston B.; Bober, Marta; Olin, Anders I.; Rudd, Pauline M.; Collin, Mattias			EndoE from Enterococcus faecalis Hydrolyzes the Glycans of the Biofilm Inhibiting Protein Lactoferrin and Mediates Growth	PLOS ONE			English	Article							BETA-N-ACETYLGLUCOSAMINIDASE; BACTERIAL MOONLIGHTING PROTEINS; URINARY-TRACT-INFECTION; STREPTOCOCCUS-PYOGENES; ALPHA-ENOLASE; HOST-DEFENSE; IRON; PATHOGENESIS; VIRULENCE; SURFACE	Glycosidases are widespread among bacteria. The opportunistic human pathogen Enterococcus faecalis encodes several putative glycosidases but little is known about their functions. The identified endo-beta-N-acetylglucosaminidase EndoE has activity on the N-linked glycans of the human immunoglobulin G (IgG). In this report we identified the human glycoprotein lactoferrin (hLF) as a new substrate for EndoE. Hydrolysis of the N-glycans from hLF was investigated using lectin blot, UHPLC and mass spectrometry, showing that EndoE releases major glycoforms from this protein. hLF was shown to inhibit biofilm formation of E. faecalis in vitro. Glycans of hLF influence the binding to E. faecalis, and EndoE-hydrolyzed hLF inhibits biofilm formation to lesser extent than intact hLF indicating that EndoE prevents the inhibition of biofilm. In addition, hLF binds to a surface-associated enolase of E. faecalis. Culture experiments showed that the activity of EndoE enables E. faecalis to use the glycans derived from lactoferrin as a carbon source indicating that they could be used as nutrients in vivo when no other preferred carbon source is available. This report adds important information about the enzymatic activity of EndoE from the commensal and opportunist E. faecalis. The activity on the human glycoprotein hLF, and the functional consequences with reduced inhibition of biofilm formation highlights both innate immunity functions of hLF and a bacterial mechanism to evade this innate immunity function. Taken together, our results underline the importance of glycans in the interplay between bacteria and the human host, with possible implications for both commensalism and opportunism.	[Garbe, Julia; Sjogren, Jonathan; Bober, Marta; Olin, Anders I.; Collin, Mattias] Lund Univ, Dept Clin Sci, Div Infect Med, Lund, Sweden; [Cosgrave, Eoin F. J.; Struwe, Weston B.; Rudd, Pauline M.] NIBRT, Dublin Oxford Glycobiol Grp, Blackrock, Dublin, Ireland	Lund University	Garbe, J (corresponding author), Lund Univ, Dept Clin Sci, Div Infect Med, Lund, Sweden.	julia.garbe@med.lu.se	Struwe, Weston/D-6180-2018; Collin, Mattias/C-6398-2009	Struwe, Weston/0000-0003-0594-226X; Collin, Mattias/0000-0002-6166-7410; Sjogren, Jonathan/0000-0003-1371-9623	Swedish governmental funding for clinical research (ALF); Swedish Research Council [2010-57X-20240]; Foundation of Wiberg; Foundation of Kock; Foundation of Bergvall; Foundation of Osterlund; Foundation of Hedberg; Foundation of Hedlund; Foundation of Groschinsky; Foundation of Soderberg; Swedish Society for Medicine; Royal Physiographic Society; King Gustaf V's Memorial Fund; Medical Faculty at Lund University; Hansa Medical AB	Swedish governmental funding for clinical research (ALF); Swedish Research Council(Swedish Research CouncilEuropean Commission); Foundation of Wiberg; Foundation of Kock; Foundation of Bergvall; Foundation of Osterlund; Foundation of Hedberg; Foundation of Hedlund; Foundation of Groschinsky; Foundation of Soderberg; Swedish Society for Medicine; Royal Physiographic Society; King Gustaf V's Memorial Fund; Medical Faculty at Lund University; Hansa Medical AB	MC is supported by Swedish governmental funding for clinical research (ALF), grants from the Swedish Research Council (2010-57X-20240; http://www.vr.se/), the Foundations of Wiberg (http://www.ake-wiberg.com/), Kock (http://www.kockskastiftelsen.se/), Bergvall (http://www.magnbergvallsstiftelse.nu/), Osterlund (http://www.alfredosterlundsstiftelse.se/), Hedberg (http://www.hedbergsstiftelse.se/), Hedlund (http://www.hedlundsstiftelse.se/), Groschinsky (http://www.groschinsky.org/), Soderberg (http://www.torstensoderbergsstiftelse.se/), the Swedish Society for Medicine (http://www.ssmf.se/), the Royal Physiographic Society (http://www.fysiografen.se/), King Gustaf V's Memorial Fund, the Medical Faculty at Lund University (http://www.med.lu.se/english/about_the_faculty), and Hansa Medical AB (http://www.hansamedical.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allhorn M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001413; Allhorn M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-3; ALUGUPALLI KR, 1995, APMIS, V103, P154, DOI 10.1111/j.1699-0463.1995.tb01091.x; Andres MT, 2010, ANTIMICROB AGENTS CH, V54, P4335, DOI 10.1128/AAC.01620-09; Arias CA, 2012, NAT REV MICROBIOL, V10, P266, DOI 10.1038/nrmicro2761; Bergmann S, 2001, MOL MICROBIOL, V40, P1273, DOI 10.1046/j.1365-2958.2001.02448.x; Berlutti F, 2004, BIOMETALS, V17, P271; BROCK JH, 1980, ARCH DIS CHILD, V55, P417, DOI 10.1136/adc.55.6.417; Byers HL, 1999, GLYCOBIOLOGY, V9, P469, DOI 10.1093/glycob/9.5.469; CLARKE VA, 1995, J BIOL CHEM, V270, P8805, DOI 10.1074/jbc.270.15.8805; Collin M, 2004, J BIOL CHEM, V279, P22558, DOI 10.1074/jbc.M402156200; Collin M, 2002, INFECT IMMUN, V70, P6646, DOI 10.1128/IAI.70.12.6646-6651.2002; Collin M, 2001, EMBO J, V20, P3046, DOI 10.1093/emboj/20.12.3046; ELLISON RT, 1988, INFECT IMMUN, V56, P2774, DOI 10.1128/IAI.56.11.2774-2781.1988; Fisher K, 2009, MICROBIOL-SGM, V155, P1749, DOI 10.1099/mic.0.026385-0; Foley I, 1997, J ANTIMICROB CHEMOTH, V40, P667, DOI 10.1093/jac/40.5.667; Frederiksen RF, 2013, MICROBIOL-SGM, V159, P833, DOI 10.1099/mic.0.051839-0; Garbe J, 2012, J INNATE IMMUN, V4, P121, DOI 10.1159/000334775; Ge JP, 2004, INFECT IMMUN, V72, P6748, DOI 10.1128/IAI.72.11.6748-6752.2004; Gonzalez-Chavez SA, 2009, INT J ANTIMICROB AG, V33, DOI 10.1016/j.ijantimicag.2008.07.020; Guile GR, 1996, ANAL BIOCHEM, V240, P210, DOI 10.1006/abio.1996.0351; GUZMAN CA, 1989, INFECT IMMUN, V57, P1834; HALL LMC, 1992, J CLIN MICROBIOL, V30, P1953, DOI 10.1128/JCM.30.8.1953-1957.1992; Harvey DJ, 2009, PROTEOMICS, V9, P3796, DOI 10.1002/pmic.200900096; Henderson B, 2013, CURR TOP MICROBIOL, V358, P155, DOI 10.1007/82_2011_188; Henderson B, 2011, INFECT IMMUN, V79, P3476, DOI 10.1128/IAI.00179-11; Joyanes Providencia, 1999, Clin Microbiol Infect, V5, P382, DOI 10.1111/j.1469-0691.1999.tb00160.x; King SJ, 2010, MOL ORAL MICROBIOL, V25, P15, DOI 10.1111/j.2041-1014.2009.00564.x; Lambert LA, 2005, COMP BIOCHEM PHYS B, V142, P129, DOI 10.1016/j.cbpb.2005.07.007; Legrand D, 2004, BIOMETALS, V17, P225, DOI 10.1023/B:BIOM.0000027696.48707.42; Legrand D, 2008, ADV EXP MED BIOL, V606, P163, DOI 10.1007/978-0-387-74087-4_6; Leitch EC, 1999, J MED MICROBIOL, V48, P867, DOI 10.1099/00222615-48-9-867; MASSON PL, 1971, COMP BIOCHEM PHYSIOL, V39, P119, DOI 10.1016/0305-0491(71)90258-6; Mohamed JA, 2004, INFECT IMMUN, V72, P3658, DOI 10.1128/IAI.72.6.3658-3663.2004; Mohamed JA, 2007, J MED MICROBIOL, V56, P1581, DOI 10.1099/jmm.0.47331-0; MURRAY BE, 1993, J BACTERIOL, V175, P5216, DOI 10.1128/JB.175.16.5216-5223.1993; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; Pancholi V, 1998, J BIOL CHEM, V273, P14503, DOI 10.1074/jbc.273.23.14503; Paulsen IT, 2003, SCIENCE, V299, P2071, DOI 10.1126/science.1080613; Renzi F, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002118; RICE LB, 1991, REV INFECT DIS, V13, P1; Roberts G, 2001, J MED MICROBIOL, V50, P620, DOI 10.1099/0022-1317-50-7-620; Roberts G, 2000, J BACTERIOL, V182, P882, DOI 10.1128/JB.182.4.882-890.2000; Rooijakkers SHM, 2010, J BIOL CHEM, V285, P27609, DOI 10.1074/jbc.M110.154930; Rudd PM, 2001, SCIENCE, V291, P2370, DOI 10.1126/science.291.5512.2370; Sava IG, 2010, CLIN MICROBIOL INFEC, V16, P533, DOI 10.1111/j.1469-0691.2010.03213.x; Shankar N, 2001, INFECT IMMUN, V69, P4366, DOI 10.1128/IAI.69.7.4366-4372.2001; Singh P, 2005, NATURE, V417, P552; Sjogren J, 2013, BIOCHEM J, V455, P107, DOI 10.1042/BJ20130126; Stepanovic S, 2000, J MICROBIOL METH, V40, P175, DOI 10.1016/S0167-7012(00)00122-6; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Valenti P, 2005, CELL MOL LIFE SCI, V62, P2576, DOI 10.1007/s00018-005-5372-0; VANBERKEL PHC, 1995, BIOCHEM J, V312, P107, DOI 10.1042/bj3120107; Wakabayashi H, 2009, ANTIMICROB AGENTS CH, V53, P3308, DOI 10.1128/AAC.01688-08; Ward PP, 2004, BIOMETALS, V17, P203, DOI 10.1023/B:BIOM.0000027693.60932.26; WILLIAMS P, 1992, MED MICROBIOL IMMUN, V181, P301; Yu TA, 2011, GLYCOBIOLOGY, V21, P206, DOI 10.1093/glycob/cwq151	57	23	26	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91035	10.1371/journal.pone.0091035	http://dx.doi.org/10.1371/journal.pone.0091035			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608122	Green Published, Green Submitted, gold			2022-12-27	WOS:000332485800085
J	Haile, D; Belachew, T; Birhanu, G; Setegn, T; Biadgilign, S				Haile, Demewoz; Belachew, Tefera; Birhanu, Getenesh; Setegn, Tesfaye; Biadgilign, Sibhatu			Predictors of Breastfeeding Cessation among HIV Infected Mothers in Southern Ethiopia: A Survival Analysis	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; UNINFECTED CHILDREN; DURATION; BOTSWANA; BORN	Background: Mother-to-child transmission (MTCT) of Human immunodeficiency virus (HIV) through breastfeeding remains the most significant route infection among children. Although the current guideline is recommending continued breastfeeding for HIV exposed infants, significant proportion of infants have been subjected to early weaning to prevent HIV transmission. However the predictors of breastfeeding cessation among HIV positive mothers were not documented in Ethiopia. Therefore the objective of this study was to determine the predictors of breastfeeding cessation among HIV-infected women in Southern Ethiopia. Methods: A facility based cross sectional study was conducted in Southern Ethiopia. The samples were selected by cluster sampling technique. The Kaplan-Meier curve was used to describe the survival time of breastfeeding and a step-wise multivariable Cox-proportional hazards regression model were used to identify the predictors of breastfeeding cessation. Both crude and adjusted hazard ratio were determined and p < 0.05 was considered as statistically significant. Result: The mean duration of breastfeeding among HIV positive mothers was 13.79 [95% CI: (12.97-14.59)] months. The Kaplan-Meier estimate showed that proportions of women who were breastfeeding at 6, 9, 12 and 17 months were 89.3%, 75.3%, 66% and 17%, respectively. Those mothers having a monthly income of <= 500 ETB [AHR = 0.16, 95% CI :(0.03-0.76)], having a family size of three and below [AHR = 0.12, 95% CI: (0.02-0.68), four and above [AHR = 0.07, 95% CI: (0.01-0.35)] and bottle feeding [AHR = 3.95, 95% CI: (1.64-9.51)] were also independent factors associated with breastfeeding cessation. Conclusion: Above one third of HIV positive mothers stopped breastfeeding before 12 months. Monthly income, bottle feeding and family size were the independent predictors of breastfeeding cessations. Strengthening the current counseling and promotion modality on avoidance of bottle feeding and continued breastfeeding is recommended for improved HIV free survival.	[Haile, Demewoz] Madawalabu Univ, Coll Med & Hlth Sci, Dept Publ Hlth, Bale Goba, Ethiopia; [Belachew, Tefera] Jimma Univ, Coll Publ Hlth & Med Sci, Dept Populat & Family Hlth, Jimma, Ethiopia; [Birhanu, Getenesh] Hawassa Univ, Sch Food Sci & Nutr, Dept Appl Human Nutr, Hawassa, Ethiopia; [Setegn, Tesfaye] Bahir Dar Univ, Coll Med & Hlth Sci, Dept Publ Hlth, Bahir Dar, Ethiopia; [Biadgilign, Sibhatu] Independent Publ Hlth Consultants, Addis Ababa, Ethiopia	Jimma University; Hawassa University; Bahir Dar University	Haile, D (corresponding author), Madawalabu Univ, Coll Med & Hlth Sci, Dept Publ Hlth, Bale Goba, Ethiopia.	demewozhaile@yahoo.com	Belachew, Tefera/AAO-5877-2020; Mengistu, Tesfaye S./AAI-4027-2021; Mengistu, Tesfaye Setegn/AFQ-0237-2022	Mengistu, Tesfaye S./0000-0001-8276-5143; Haile, Demewoz/0000-0003-0047-4276; Biadgilign, Sibhatu/0000-0002-7582-5977	HENNA (Higher Education Network for Applied Human Nutrition between Eastern Africa and Europe) project	HENNA (Higher Education Network for Applied Human Nutrition between Eastern Africa and Europe) project	Funding provided by HENNA (Higher Education Network for Applied Human Nutrition between Eastern Africa and Europe) (http://hennaproject.org) project funded this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agboado G, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-3; Arpadi S, 2009, AM J CLIN NUTR, V90, P344, DOI 10.3945/ajcn.2009.27745; Berra S, 2003, ACTA PAEDIATR, V92, P952, DOI 10.1080/08035250310004216; Chaves RG, 2007, J PEDIAT-BRAZIL, V83, P241, DOI 10.2223/JPED.1610; Coovadia HM, 2007, LANCET, V369, P1107, DOI 10.1016/S0140-6736(07)60283-9; Coutsoudis A, 2004, J INFECT DIS, V189, P2154, DOI 10.1086/420834; Creek TL, 2010, JAIDS-J ACQ IMM DEF, V53, P14, DOI 10.1097/QAI.0b013e3181bdf676; Doherty T, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-105; Ethiopia CCSA, 2007, SUMM STAT REP 2007 P; Fadnes LT, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-124; Ghuman MR, 2009, S AFR J CLIN NUTR, V22, P74, DOI 10.1080/16070658.2009.11734222; *HAPCO FMOH, 2007, GUID PREV MOTH TO CH; Hornell A, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.3.e38; Kagaayi J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003877; Kuhn L, 2008, NEW ENGL J MED, V359, P130, DOI 10.1056/NEJMoa073788; Morgan MC, 2010, AIDS CARE, V22, P866, DOI 10.1080/09540120903483000; Onyango-Makumbi C, 2010, J ACQUIR IMMUNE DEFI, V53; Petraro P, 2011, MATERN CHILD NUTR, V7, P273, DOI 10.1111/j.1740-8709.2009.00236.x; Taha TE, 2011, CLIN INFECT DIS, V53, P388, DOI 10.1093/cid/cir413; Thior I, 2006, JAMA-J AM MED ASSOC, V296, P794, DOI 10.1001/jama.296.7.794; WHO U, 2008, IND ASS INF YOUNG CH; WHO/UNAIDS/UNICEF, 2009, UN ACC SCAL HIV PRIO; Young SL, 2011, ADV NUTR, V2, P225, DOI 10.3945/an.110.000224	23	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90067	10.1371/journal.pone.0090067	http://dx.doi.org/10.1371/journal.pone.0090067			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608772	Green Published, Green Submitted, gold			2022-12-27	WOS:000332485800016
J	Konitsiotis, AD; Chang, SC; Jovanovic, B; Ciepla, P; Masumoto, N; Palmer, CP; Tate, EW; Couchman, JR; Magee, AI				Konitsiotis, Antonios D.; Chang, Shu-Chun; Jovanovic, Biljana; Ciepla, Paulina; Masumoto, Naoko; Palmer, Christopher P.; Tate, Edward W.; Couchman, John R.; Magee, Anthony I.			Attenuation of Hedgehog Acyltransferase-Catalyzed Sonic Hedgehog Palmitoylation Causes Reduced Signaling, Proliferation and Invasiveness of Human Carcinoma Cells	PLOS ONE			English	Article							LIPID MODIFICATIONS; PATHWAY; INHIBITION; REQUIREMENT; DIFFERENTIATION; ACTIVATION; INDUCTION; DESERT; GROWTH; MODEL	Overexpression of Hedgehog family proteins contributes to the aetiology of many cancers. To be highly active, Hedgehog proteins must be palmitoylated at their N-terminus by the MBOAT family multispanning membrane enzyme Hedgehog acyltransferase (Hhat). In a pancreatic ductal adenocarcinoma (PDAC) cell line PANC-1 and transfected HEK293a cells Hhat localized to the endoplasmic reticulum. siRNA knockdown showed that Hhat is required for Sonic hedgehog (Shh) palmitoylation, for its assembly into high molecular weight extracellular complexes and for functional activity. Hhat knockdown inhibited Hh autocrine and juxtacrine signaling, and inhibited PDAC cell growth and invasiveness in vitro. In addition, Hhat knockdown in a HEK293a cell line constitutively expressing Shh and A549 human non-small cell lung cancer cells inhibited their ability to signal in a juxtacrine/paracrine fashion to the reporter cell lines C3H10T1/2 and Shh-Light2. Our data identify Hhat as a key player in Hh-dependent signaling and tumour cell transformed behaviour.	[Konitsiotis, Antonios D.; Chang, Shu-Chun; Jovanovic, Biljana; Magee, Anthony I.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Mol Med Sect, London, England; [Ciepla, Paulina; Masumoto, Naoko; Tate, Edward W.] Univ London Imperial Coll Sci Technol & Med, Dept Chem, London SW7 2AY, England; [Ciepla, Paulina; Masumoto, Naoko; Tate, Edward W.; Magee, Anthony I.] Univ London Imperial Coll Sci Technol & Med, Inst Chem Biol, London SW7 2AY, England; [Palmer, Christopher P.] London Metropolitan Univ, Inst Hlth Res & Policy, London, England; [Couchman, John R.] Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark	Imperial College London; Imperial College London; Imperial College London; London Metropolitan University; University of Copenhagen	Magee, AI (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Mol Med Sect, London, England.	t.magee@imperial.ac.uk	Magee, Anthony/V-8345-2019; Masumoto, Naoko/AAH-6687-2021	Tate, Edward/0000-0003-2213-5814; Masumoto, Naoko/0000-0002-1609-5185; Ciepla, Paulina/0000-0002-5139-9635	UK Medical Research Council [G0700771]; Pancreatic Cancer Research Fund; National Heart & Lung Institute Foundation; Imperial College London Institute of Chemical Biology EPSRC Doctoral Training Centre [EP/F500416/1]; Danish National Research Foundation; Fabrikant Vilhelm Pedersen og Hustrus Legat; Novo Nordisk Fonden; Lundbeck Fonden; Danish Cancer Society [DP08019]; BBSRC [BB/D02014X/1]; Biotechnology and Biological Sciences Research Council [978583, BB/D02014X/1] Funding Source: researchfish; Cancer Research UK [16402] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Pancreatic Cancer Research Fund; National Heart & Lung Institute Foundation; Imperial College London Institute of Chemical Biology EPSRC Doctoral Training Centre(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Danish National Research Foundation(Danmarks Grundforskningsfond); Fabrikant Vilhelm Pedersen og Hustrus Legat; Novo Nordisk Fonden(Novo Nordisk Foundation); Lundbeck Fonden(Lundbeckfonden); Danish Cancer Society(Danish Cancer Society); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK)	This work was supported by UK Medical Research Council (www.mrc.ac.uk) grant #G0700771 to AIM and a grant from the Pancreatic Cancer Research Fund (www.pcrf.org.uk) grant to AIM and EWT. BJ was funded by a PhD studentship from the National Heart & Lung Institute Foundation (www.nhlif.info). PC and NM were funded by PhD studentships from the Imperial College London Institute of Chemical Biology EPSRC Doctoral Training Centre (grant EP/F500416/1; www.epsrc.ac.uk). JRC was supported by The Danish National Research Foundation (http://dg.dk/en/), Fabrikant Vilhelm Pedersen og Hustrus Legat (www.vplegat.dk), Novo Nordisk Fonden (www.novonordiskfonden.dk), Lundbeck Fonden (www.lundbeckfoundation.com) and was co-PI of Project DP08019 from the Danish Cancer Society (www.cancer.dk). EWT thanks BBSRC (www.bbsrc.ac.uk) for the award of a David Phillips Fellowship (grant BB/D02014X/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphe C, 2004, DEVELOPMENT, V131, P5009, DOI 10.1242/dev.01367; Barnett BP, 2010, SCIENCE, V330, P1689, DOI 10.1126/science.1196154; Berman DM, 2003, NATURE, V425, P846, DOI 10.1038/nature01972; Buglino JA, 2008, J BIOL CHEM, V283, P22076, DOI 10.1074/jbc.M803901200; Buglino JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011195; Callejo A, 2006, DEVELOPMENT, V133, P471, DOI 10.1242/dev.02217; Chamoun Z, 2001, SCIENCE, V293, P2080, DOI 10.1126/science.1064437; Chang SC, 2011, J BIOL CHEM, V286, P44391, DOI 10.1074/jbc.M111.285361; Chang SC, 2009, MOL MEMBR BIOL, V26, P104, DOI 10.1080/09687680802706432; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Chen MH, 2004, GENE DEV, V18, P641, DOI 10.1101/gad.1185804; Chi SM, 2006, CANCER LETT, V244, P53, DOI 10.1016/j.canlet.2005.11.036; di Magliano MP, 2003, NAT REV CANCER, V3, P903, DOI 10.1038/nrc1229; Dierker T, 2009, J BIOL CHEM, V284, P8013, DOI 10.1074/jbc.M806838200; Farzan SF, 2008, AM J PHYSIOL-GASTR L, V294, pG844, DOI 10.1152/ajpgi.00564.2007; Fokin VV, 2007, ACS CHEM BIOL, V2, P775, DOI 10.1021/cb700254v; Gutierrez JA, 2008, P NATL ACAD SCI USA, V105, P6320, DOI 10.1073/pnas.0800708105; Hatsell S, 2007, J MAMMARY GLAND BIOL, V12, P163, DOI 10.1007/s10911-007-9048-2; Heal WP, 2008, ORG BIOMOL CHEM, V6, P2308, DOI 10.1039/b803258k; Heal WP, 2011, CHEM COMMUN, V47, P4081, DOI 10.1039/c0cc04710d; Jacob L, 2007, SCIENCE, V318, P66, DOI 10.1126/science.1147314; Katano M, 2005, CANCER LETT, V227, P99, DOI 10.1016/j.canlet.2004.11.030; Kohtz JD, 2001, DEVELOPMENT, V128, P2351; Lee JD, 2001, CURR BIOL, V11, P1147, DOI 10.1016/S0960-9822(01)00323-2; Lehnert L, 1999, ANN NY ACAD SCI, V880, P83, DOI 10.1111/j.1749-6632.1999.tb09512.x; Mann RK, 2004, ANNU REV BIOCHEM, V73, P891, DOI 10.1146/annurev.biochem.73.011303.073933; Micchelli CA, 2002, DEVELOPMENT, V129, P843; Nakajima A, 2008, CANCER SCI, V99, P1892, DOI 10.1111/j.1349-7006.2008.00904.x; Nakamura T, 1997, BIOCHEM BIOPH RES CO, V237, P465, DOI 10.1006/bbrc.1997.7156; Nolan-Stevaux O, 2009, GENE DEV, V23, P24, DOI 10.1101/gad.1753809; Ohlig S, 2012, J BIOL CHEM, V287, P43708, DOI 10.1074/jbc.M112.356667; Ohlig S, 2011, DEV CELL, V20, P764, DOI 10.1016/j.devcel.2011.05.010; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Pathi S, 2001, MECH DEVELOP, V106, P107, DOI 10.1016/S0925-4773(01)00427-0; Petrova E, 2013, NAT CHEM BIOL, V9, P247, DOI [10.1038/NCHEMBIO.1184, 10.1038/nchembio.1184]; Proffitt KD, 2013, CANCER RES, V73, P502, DOI 10.1158/0008-5472.CAN-12-2258; Rodriguez-Blanco J, 2013, ONCOGENE, V32, P2335, DOI 10.1038/onc.2012.243; Shindou H, 2009, J BIOL CHEM, V284, P1, DOI 10.1074/jbc.R800046200; Sirivatanauksorn V, 2001, INT J CANCER, V91, P350, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1049>3.3.CO;2-3; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; Tian H, 2009, P NATL ACAD SCI USA, V106, P4254, DOI 10.1073/pnas.0813203106; Turner TT, 2004, J ANDROL, V25, P514; van den Brink GR, 2007, PHYSIOL REV, V87, P1343, DOI 10.1152/physrev.00054.2006; Varjosalo M, 2008, GENE DEV, V22, P2454, DOI 10.1101/gad.1693608; Watkins DN, 2003, NATURE, V422, P313, DOI 10.1038/nature01493; Yang J, 2008, P NATL ACAD SCI USA, V105, P10750, DOI 10.1073/pnas.0805353105; Yauch RL, 2008, NATURE, V455, P406, DOI 10.1038/nature07275; Yauch RL, 2009, SCIENCE, V326, P572, DOI 10.1126/science.1179386; Yuan Z, 2007, ONCOGENE, V26, P1046, DOI 10.1038/sj.onc.1209860; Zhai L, 2004, J BIOL CHEM, V279, P33220, DOI 10.1074/jbc.M403407200	51	29	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e89899	10.1371/journal.pone.0089899	http://dx.doi.org/10.1371/journal.pone.0089899			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608521	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000332485800012
J	Slagt, IKB; IJzermans, JNM; Visser, LJ; Weimar, W; Roodnat, JI; Terkivatan, T				Slagt, Inez K. B.; IJzermans, Jan N. M.; Visser, Laurents J.; Weimar, Willem; Roodnat, Joke I.; Terkivatan, Turkan			Independent Risk Factors for Urological Complications after Deceased Donor Kidney Transplantation	PLOS ONE			English	Article							MULTIPLE RENAL-ARTERIES; HEART-BEATING DONORS; EXTRAVESICAL URETERONEOCYSTOSTOMY; URETERAL COMPLICATIONS; METAANALYSIS; NEPHRECTOMY; EXPERIENCE; SURVIVAL; IMPACT	Urological complications after kidney transplantation are mostly related to the ureteroneocystostomy, often requiring interventions with additional costs, morbidity and mortality. Our aim was to assess risk factors for urological complications in deceased donor kidney transplantation. Between January 2000 and December 2011, 566 kidney transplantations were performed with deceased donor kidneys. Recipients were divided in a group with, and a group without urological complications, defined as the need for a percutaneous nephrostomy catheter or surgical revision of the ureteroneocystostomy. Univariate and multivariate analyses were performed. Univariate analysis showed increased number of male donors (p = 0.041), male recipients (p = 0.002), pre-emptively transplanted recipients (p = 0.007), and arterial reconstructions (p = 0.004) in the group with urological complications. Less urological complications occurred in recipients on hemodialysis (p = 0.005). More overall surgical interventions (p < 0.001), surgical site infections (p = 0.042), urinary tract infections (p < 0.001) and lymphoceles (p < 0.001) occurred in the group with urological complications. Multivariate analysis showed that male recipients (p = 0.010) and arterial reconstructions (p = 0.019) were independent risk factors. No difference was found between both groups in patient or graft survival. In conclusion, recipient male gender and arterial reconstruction are independent risk factors for urological complications after deceased donor kidney transplantation. Nevertheless, graft and recipient survival is not different between both groups.	[Slagt, Inez K. B.; IJzermans, Jan N. M.; Visser, Laurents J.; Terkivatan, Turkan] Erasmus MC, Univ Med Ctr, Div Transplant Surg, Dept Surg, Rotterdam, Netherlands; [Weimar, Willem; Roodnat, Joke I.] Erasmus MC, Univ Med Ctr, Div Nephrol, Dept Internal Med, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Terkivatan, T (corresponding author), Erasmus MC, Univ Med Ctr, Div Transplant Surg, Dept Surg, Rotterdam, Netherlands.	t.terkivatan@erasmusmc.nl	Roodnat, Joke/GLN-4175-2022					Alberts VP, 2012, UROL INT, V88, P333, DOI 10.1159/000335329; Butterworth PC, 1997, BRIT J UROL, V79, P499, DOI 10.1046/j.1464-410X.1997.00117.x; Carter JT, 2005, AM J TRANSPLANT, V5, P1312, DOI 10.1111/j.1600-6143.2005.00859.x; Dinckan A, 2007, TRANSPL INT, V20, P702, DOI 10.1111/j.1432-2277.2007.00500.x; Dols LFC, 2011, TRANSPL P, V43, P1623, DOI 10.1016/j.transproceed.2011.01.186; Dunkin BJ, 2000, J AM COLL SURGEONS, V190, P96, DOI 10.1016/S1072-7515(99)00210-0; GREGOIR W, 1964, Acta Chir Belg, V63, P431; Kayler L, 2010, TRANSPL P, V42, P1413, DOI 10.1016/j.transproceed.2010.04.016; Keizer KM, 2005, TRANSPLANTATION, V79, P1195, DOI 10.1097/01.TP.0000160765.66962.0B; Khairoun M, 2009, TRANSPL INT, V22, P192, DOI 10.1111/j.1432-2277.2008.00756.x; Koffman G, 2003, J NEPHROL, V16, P334; KOOTSTRA G, 1995, TRANSPLANT P, V27, P2893; Krol R, 2006, TRANSPL P, V38, P127, DOI 10.1016/j.transproceed.2005.12.100; Kuo PC, 1998, AM J SURG, V176, P559, DOI 10.1016/S0002-9610(98)00260-8; Laging M, 2012, TRANSPL INT; Mangus RS, 2004, AM J TRANSPLANT, V4, P1889, DOI 10.1111/j.1600-6143.2004.00595.x; Neri F, 2009, TRANSPL P, V41, P1224, DOI 10.1016/j.transproceed.2009.03.044; POLITANO VA, 1958, J UROLOGY, V79, P932, DOI 10.1016/S0022-5347(17)66369-9; Praz V, 2005, UROL INT, V75, P144, DOI 10.1159/000087169; Slagt IKB, 2012, TRANSPLANTATION, V94, P1179, DOI 10.1097/TP.0b013e3182643544; Streeter EH, 2002, BJU INT, V90, P627, DOI 10.1046/j.1464-410X.2002.03004.x; van Roijen JH, 2001, J UROLOGY, V165, P1884, DOI 10.1016/S0022-5347(05)66234-9; Wilson CH, 2005, TRANSPLANTATION, V80, P877, DOI 10.1097/01.tp.0000181197.21706.fa; Zavos G, 2008, TRANSPL P, V40, P1386, DOI 10.1016/j.transproceed.2008.03.103	24	27	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91211	10.1371/journal.pone.0091211	http://dx.doi.org/10.1371/journal.pone.0091211			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608797	Green Published, gold, Green Submitted			2022-12-27	WOS:000332485800115
J	Liu-Helmersson, J; Stenlund, H; Wilder-Smith, A; Rocklov, J				Liu-Helmersson, Jing; Stenlund, Hans; Wilder-Smith, Annelies; Rocklov, Joacim			Vectorial Capacity of Aedes aegypti: Effects of Temperature and Implications for Global Dengue Epidemic Potential	PLOS ONE			English	Article							TRANSMISSION; IMPACT; FEVER; MODEL; FLUCTUATIONS; POPULATION; MOSQUITOS; CULICIDAE; DIPTERA; DISEASE	Dengue is a mosquito-borne viral disease that occurs mainly in the tropics and subtropics but has a high potential to spread to new areas. Dengue infections are climate sensitive, so it is important to better understand how changing climate factors affect the potential for geographic spread and future dengue epidemics. Vectorial capacity (VC) describes a vector's propensity to transmit dengue taking into account human, virus, and vector interactions. VC is highly temperature dependent, but most dengue models only take mean temperature values into account. Recent evidence shows that diurnal temperature range (DTR) plays an important role in influencing the behavior of the primary dengue vector Aedes aegypti. In this study, we used relative VC to estimate dengue epidemic potential (DEP) based on the temperature and DTR dependence of the parameters of A. aegypti. We found a strong temperature dependence of DEP; it peaked at a mean temperature of 29.3 degrees C when DTR was 0 degrees C and at 20 degrees C when DTR was 20 degrees C. Increasing average temperatures up to 29 degrees C led to an increased DEP, but temperatures above 29 degrees C reduced DEP. In tropical areas where the mean temperatures are close to 29 degrees C, a small DTR increased DEP while a large DTR reduced it. In cold to temperate or extremely hot climates where the mean temperatures are far from 29 degrees C, increasing DTR was associated with increasing DEP. Incorporating these findings using historical and predicted temperature and DTR over a two hundred year period (1901-2099), we found an increasing trend of global DEP in temperate regions. Small increases in DEP were observed over the last 100 years and large increases are expected by the end of this century in temperate Northern Hemisphere regions using climate change projections. These findings illustrate the importance of including DTR when mapping DEP based on VC.	[Liu-Helmersson, Jing; Stenlund, Hans; Wilder-Smith, Annelies; Rocklov, Joacim] Umea Univ, Dept Publ Hlth & Clin Med Epidemiol & Global Hlth, Umea, Sweden; [Wilder-Smith, Annelies] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 639798, Singapore	Umea University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Liu-Helmersson, J (corresponding author), Umea Univ, Dept Publ Hlth & Clin Med Epidemiol & Global Hlth, Umea, Sweden.	Jing.Helmersson@umu.se	Wilder-Smith, Annelies/F-8751-2015	Wilder-Smith, Annelies/0000-0003-0362-5375; Helmersson, Jing/0000-0001-9647-1015; Stenlund, Hans/0000-0001-9943-296X; Rocklov, Joacim/0000-0003-4030-0449	European Union [282589]	European Union(European Commission)	This study is part of the DengueTools project [33] funded by the European Union Seventh Framework Programme FP7/2007-2013 under grant agreement no. 282589. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R M, 1991; Astrom C, 2013, ECOHEALTH; Beebe NW, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000429; Bhatt S, 2013, NATURE, V12060; Briere JF, 1999, ENVIRON ENTOMOL, V28, P22, DOI 10.1093/ee/28.1.22; Carrington LB, 2013, J MED ENTOMOL, V50, P43, DOI 10.1603/ME11242; CMIP5, 2013, COUPL MOD INT PROJ P; Descloux E, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001470; European Centre for Disease Prevention and Control, 2012, EP UPD OUTBR DENG MA; European Centre for Disease Prevention and Control (ECDC), 2009, TECH REP DEV AED ALB; FOCKS DA, 1995, AM J TROP MED HYG, V53, P489, DOI 10.4269/ajtmh.1995.53.489; GARRETTJONES C, 1964, NATURE, V204, P1173, DOI 10.1038/2041173a0; Gething PW, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-92; Goosse H, 2013, REPRESENTATIVE CONCE; Gosling S, 2009, INT J BIOMETEOROL, V53, P31, DOI 10.1007/s00484-008-0189-9; Hales S, 2002, LANCET, V360, P830, DOI 10.1016/S0140-6736(02)09964-6; Hempel S, 2013, EARTH SYST DYN DISCU, V4, DOI [DOI 10.5194/ESD-4-219-2013, 10.5194/esd-4-219-2013]; Huang ZJ, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-33; ISI-MIP, 2013, INT SECT IMP MOD INT; Jones P., 2008, CRU TIME SERIES TS H; Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108; Liu-Helmersson J, 2012, THESIS; Mari R, 2012, INTECH; Massad E, 2011, PHYS LIFE REV, V8, P169, DOI 10.1016/j.plrev.2011.01.001; MCLEAN DM, 1974, CAN J MICROBIOL, V20, P255, DOI 10.1139/m74-040; Paaijmans K, 2010, INFLUENCE CLIMATE MA; Patz JA, 1998, ENVIRON HEALTH PERSP, V106, P147, DOI 10.1289/ehp.98106147; Raffel TR, 2013, NAT CLIM CHANGE, V3, P146, DOI [10.1038/nclimate1659, 10.1038/NCLIMATE1659]; Randolph SE, 2010, NAT REV MICROBIOL, V8, P361, DOI 10.1038/nrmicro2336; Reiter P, 2003, EMERG INFECT DIS, V9, P86; Reiter P, 2010, EUROSURVEILLANCE, V15, P11; Scott TW, 2000, J MED ENTOMOL, V37, P89, DOI 10.1603/0022-2585-37.1.89; Sousa CA, 2012, EUROSURVEILLANCE, V17, P15; Tatem AJ, 2006, ADV PARASIT, V62, P293, DOI 10.1016/S0065-308X(05)62009-X; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Warszawski L., 2013, P NATL ACAD SCI; WATTS DM, 1987, AM J TROP MED HYG, V36, P143, DOI 10.4269/ajtmh.1987.36.143; Wilder-Smith A, 2008, MED CLIN N AM, V92, P1377, DOI 10.1016/j.mcna.2008.07.002; Yang HM, 2009, EPIDEMIOL INFECT, V137, P1188, DOI 10.1017/S0950268809002040	39	214	218	4	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e89783	10.1371/journal.pone.0089783	http://dx.doi.org/10.1371/journal.pone.0089783			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603439	gold, Green Published			2022-12-27	WOS:000332483600022
J	Matsushita, H; Sano, A; Wu, H; Jiao, JA; Kasinathan, P; Sullivan, EJ; Wang, ZD; Kuroiwa, Y				Matsushita, Hiroaki; Sano, Akiko; Wu, Hua; Jiao, Jin-an; Kasinathan, Poothappillai; Sullivan, Eddie J.; Wang, Zhongde; Kuroiwa, Yoshimi			Triple Immunoglobulin Gene Knockout Transchromosomic Cattle: Bovine Lambda Cluster Deletion and Its Effect on Fully Human Polyclonal Antibody Production	PLOS ONE			English	Article							INTRAVENOUS IMMUNOGLOBULIN; PLASMA; EXPRESSION	Towards the goal of producing fully human polyclonal antibodies (hpAbs or hIgGs) in transchromosomic (Tc) cattle, we previously reported that Tc cattle carrying a human artificial chromosome (HAC) comprising the entire unrearranged human immunoglobulin (Ig) heavy-chain (hIGH), kappa-chain (hIGK), and lambda-chain (hIGL) germline loci produced physiological levels of hIgGs when both of the bovine immunoglobulin mu heavy-chains, bIGHM and bIGHML1, were homozygously inactivated (bIGHM(-/-), bIGHML1(-/-); double knockouts or DKO). However, because endogenous bovine immunoglobulin light chain loci are still intact, the light chains are produced both from the hIGK and hIGL genomic loci on the HAC and from the endogenous bovine kappa-chain (bIGK) and lambda-chain (bIGL) genomic loci, resulting in the production of fully hIgGs (both Ig heavy-chains and light-chains are of human origin: hIgG/hIgk or hIgG/hIg lambda) and chimeric hIgGs (Ig heavy-chains are of human origin while the Ig light-chains are of bovine origin: hIgG/bIgk or hIgG/bIg lambda). To improve fully hIgG production in Tc cattle, we here report the deletion of the entire bIGL joining (J) and constant (C) gene cluster (bIGLJ1-IGLC1 to bIGLJ5-IGLC5) by employing Cre/loxP mediated site-specific chromosome recombination and the production of triple knockout (bIGHM(-/-), bIGHML1(-/-) and bIGL(-/-); TKO) Tc cattle. We further demonstrate that bIGL cluster deletion greatly improves fully hIgGs production in the sera of TKO Tc cattle, with 51.3% fully hIgGs (hIgG/hIgk plus hIgG/hIg lambda).	[Matsushita, Hiroaki; Wu, Hua; Jiao, Jin-an; Sullivan, Eddie J.] Sanford Appl Biosci LLC, Sioux Falls, SD 57104 USA; [Sano, Akiko; Kuroiwa, Yoshimi] Kyowa Hakko Kirin Co Ltd, Chiyoda Ku, Tokyo, Japan; [Wang, Zhongde] Utah State Univ, Dept Anim Dairy & Vet Sci, Logan, UT 84322 USA; [Kasinathan, Poothappillai] Trans Ova Genet, Sioux Ctr, IA USA; [Matsushita, Hiroaki; Sano, Akiko; Wu, Hua; Jiao, Jin-an; Kasinathan, Poothappillai; Sullivan, Eddie J.; Wang, Zhongde; Kuroiwa, Yoshimi] Hematech Inc, Sioux Falls, SD USA	Kyowa Kirin Ltd; Utah System of Higher Education; Utah State University	Sullivan, EJ (corresponding author), Sanford Appl Biosci LLC, Sioux Falls, SD 57104 USA.	eddie.sullivan@sanfordhealth.org; zonda.wang@usu.edu		Sullivan, Eddie/0000-0001-7468-2006; Wang, Zhongde/0000-0003-2441-4729	Hematech, Inc.	Hematech, Inc.	This work was financed by internal funding of Hematech, Inc., which no longer exists and no longer has financial interest in the work. Hematech has transferred all of its business to Sanford Applied Biosciences, LLC. No current external funding sources for this study. Financial interest in this work is currently owned by Sanford Applied Biosciences, who did have a role in the decision to publish as well as the preparation of the manuscript. While it is considered beneficial to the interests of Sanford Applied Biosciences to publish this work, this consideration played no role in the study design, data collection and analysis and preparation of the manuscript. This is evidenced by the inclusion of now independent authors with no affiliation to Sanford Applied Biosciences.	Arun SS, 1996, J VET MED A, V43, P573, DOI 10.1111/j.1439-0442.1996.tb00489.x; Boothpur R, 2010, AM J KIDNEY DIS, V55, P141, DOI 10.1053/j.ajkd.2009.06.017; Buchacher Andrea, 2006, Biotechnology Journal, V1, P148, DOI 10.1002/biot.200500037; Chen LM, 2008, VET IMMUNOL IMMUNOP, V124, P284, DOI 10.1016/j.vetimm.2008.04.012; Kumar A, 2006, INT ARCH ALLERGY IMM, V140, P185, DOI 10.1159/000093204; Kuroiwa Y, 2004, NAT GENET, V36, P775, DOI 10.1038/ng1373; Kuroiwa Y, 2009, NAT BIOTECHNOL, V27, P173, DOI 10.1038/nbt.1521; Lundquist AL, 2007, LIVER TRANSPLANT, V13, P647, DOI 10.1002/lt.21098; Newcombe C, 2007, J CHROMATOGR B, V848, P2, DOI 10.1016/j.jchromb.2006.07.004; Pasman Y, 2010, VET IMMUNOL IMMUNOP, V135, P306, DOI 10.1016/j.vetimm.2009.12.012; Sellahewa K. H., 1994, Ceylon Medical Journal, V39, P173; Sullivan EJ, 2004, BIOL REPROD, V70, P146, DOI 10.1095/biolreprod.103.021220; Tomizuka K, 2000, P NATL ACAD SCI USA, V97, P722, DOI 10.1073/pnas.97.2.722; Yeh KM, 2005, J ANTIMICROB CHEMOTH, V56, P919, DOI 10.1093/jac/dki346	14	40	45	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90383	10.1371/journal.pone.0090383	http://dx.doi.org/10.1371/journal.pone.0090383			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603704	Green Published, gold			2022-12-27	WOS:000332483600050
J	Padmanabhan, RK; Somasundar, VH; Griffith, SD; Zhu, JL; Samoyedny, D; Tan, KS; Hu, JH; Liao, XJ; Carin, L; Yoon, SS; Flaherty, KT; DiPaola, RS; Heitjan, DF; Lal, P; Feldman, MD; Roysam, B; Lee, WMF				Padmanabhan, Raghav K.; Somasundar, Vinay H.; Griffith, Sandra D.; Zhu, Jianliang; Samoyedny, Drew; Tan, Kay See; Hu, Jiahao; Liao, Xuejun; Carin, Lawrence; Yoon, Sam S.; Flaherty, Keith T.; DiPaola, Robert S.; Heitjan, Daniel F.; Lal, Priti; Feldman, Michael D.; Roysam, Badrinath; Lee, William M. F.			An Active Learning Approach for Rapid Characterization of Endothelial Cells in Human Tumors	PLOS ONE			English	Article							GENE-EXPRESSION DATA; ANGIOGENESIS; QUANTIFICATION; BEVACIZUMAB; RELEVANCE; CANCER	Currently, no available pathological or molecular measures of tumor angiogenesis predict response to antiangiogenic therapies used in clinical practice. Recognizing that tumor endothelial cells (EC) and EC activation and survival signaling are the direct targets of these therapies, we sought to develop an automated platform for quantifying activity of critical signaling pathways and other biological events in EC of patient tumors by histopathology. Computer image analysis of EC in highly heterogeneous human tumors by a statistical classifier trained using examples selected by human experts performed poorly due to subjectivity and selection bias. We hypothesized that the analysis can be optimized by a more active process to aid experts in identifying informative training examples. To test this hypothesis, we incorporated a novel active learning (AL) algorithm into FARSIGHT image analysis software that aids the expert by seeking out informative examples for the operator to label. The resulting FARSIGHT-AL system identified EC with specificity and sensitivity consistently greater than 0.9 and outperformed traditional supervised classification algorithms. The system modeled individual operator preferences and generated reproducible results. Using the results of EC classification, we also quantified proliferation (Ki67) and activity in important signal transduction pathways (MAP kinase, STAT3) in immunostained human clear cell renal cell carcinoma and other tumors. FARSIGHT-AL enables characterization of EC in conventionally preserved human tumors in a more automated process suitable for testing and validating in clinical trials. The results of our study support a unique opportunity for quantifying angiogenesis in a manner that can now be tested for its ability to identify novel predictive and response biomarkers.	[Padmanabhan, Raghav K.; Somasundar, Vinay H.; Roysam, Badrinath] Univ Houston, Dept Elect & Comp Engn, Houston, TX 77004 USA; [Griffith, Sandra D.] Cleveland Clin, Dept Quantitat Hlth Sci, Cleveland, OH 44106 USA; [Zhu, Jianliang; Samoyedny, Drew; Hu, Jiahao; Lee, William M. F.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Tan, Kay See; Heitjan, Daniel F.] Univ Penn, Dept Biostat & Epidemiol, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Liao, Xuejun; Carin, Lawrence] Duke Univ, Dept Elect & Comp Engn, Durham, NC USA; [Yoon, Sam S.] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA; [Flaherty, Keith T.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Flaherty, Keith T.] MGH, Dept Med, Boston, MA USA; [DiPaola, Robert S.] Canc Inst New Jersey, New Brunswick, NJ USA; [DiPaola, Robert S.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, New Brunswick, NJ USA; [Heitjan, Daniel F.; Feldman, Michael D.; Lee, William M. F.] Univ Penn, Perelman Sch Med, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Lal, Priti; Feldman, Michael D.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA USA	University of Houston System; University of Houston; Cleveland Clinic Foundation; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Duke University; Memorial Sloan Kettering Cancer Center; Harvard University; Harvard Medical School; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Padmanabhan, RK (corresponding author), Univ Houston, Dept Elect & Comp Engn, Houston, TX 77004 USA.	raghav.krishna@gmail.com; broysam@central.uh.edu; leemingf@mail.med.upenn.edu		Carin, Lawrence/0000-0001-6277-7948	National Institutes of Health [R01 CA135509, T32 CA093283]; NATIONAL CANCER INSTITUTE [T32CA093283, P30CA016520, R01CA135509] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants R01 CA135509 (W.M.F.L., B.R., D.F.H., P.L., K.T.F) and T32 CA093283 (S.D.G.) from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Kofahi Y, 2011, HISTOPATHOLOGY, V59, P40, DOI 10.1111/j.1365-2559.2011.03878.x; Al-Kofahi Y, 2010, IEEE T BIO-MED ENG, V57, P841, DOI 10.1109/TBME.2009.2035102; [Anonymous], 1908, BIOMETRIKA, V6, P1; Bache Kevin, 2013, UCI MACHINE LEARNING; Bennett K. P., 2003, NATO SCI SERIES, V190, P227; Bjornsson CS, 2008, J NEUROSCI METH, V170, P165, DOI 10.1016/j.jneumeth.2007.12.024; Boykov Y, 2001, IEEE T PATTERN ANAL, V23, P1222, DOI 10.1109/34.969114; Chia SK, 2001, J CLIN ONCOL, V19, P3660, DOI 10.1200/JCO.2001.19.16.3660; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Doyle S, 2009, OPTIMHISE WORKSH MIC; Doyle S, 2010, LECT N BIOINFORMAT, V6282, P313, DOI 10.1007/978-3-642-16001-1_27; Eberhard A, 2000, CANCER RES, V60, P1388; Fedorov VV., 1972, THEORY OPTIMAL EXPT; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Guo YH, 2007, 20TH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE, P823; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Kachites McCallum A., 1998, Machine Learning. Proceedings of the Fifteenth International Conference (ICML'98), P350; Lassoued W, 2010, CANCER BIOL THER, V10, P1326, DOI 10.4161/cbt.10.12.14009; Lee S.-I., 2006, EFFICIENT L1 REGULAR, V1, P401; Li LJ, 2011, HEMATOL ONCOL CLIN N, V25, P667, DOI 10.1016/j.hoc.2011.04.004; Liao XJ, 2009, IEEE T GEOSCI REMOTE, V47, P1454, DOI 10.1109/TGRS.2008.2005268; Lin G, 2007, CYTOM PART A, V71A, P724, DOI 10.1002/cyto.a.20430; Liu Y, 2004, J CHEM INF COMP SCI, V44, P1936, DOI 10.1021/ci049810a; McAllister SS, 2010, J CLIN ONCOL, V28, P4022, DOI 10.1200/JCO.2010.28.4257; Murphy DA, 2006, AM J PATHOL, V169, P1875, DOI 10.2353/ajpath.2006.050711; Muslea I, 2000, SELECTIVE SAMPLING R; Negrier S, 2012, INVEST NEW DRUG, V30, P1791, DOI 10.1007/s10637-011-9677-6; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Sharma S, 2005, HISTOPATHOLOGY, V46, P481, DOI 10.1111/j.1365-2559.2005.02142.x; Thomas MC, 2006, ELEMENTS INFORM THEO; Tong S, 2002, J MACH LEARN RES, V2, P45, DOI 10.1162/153244302760185243; Weis SM, 2011, NAT MED, V17, P1359, DOI 10.1038/nm.2537; Wu XW, 2004, EURASIP J APPL SIG P, V2004, P53, DOI 10.1155/S1110865704309145; Xu ZB, 2007, LECT NOTES COMPUT SC, V4425, P246; Yao X, 2007, CLIN CANCER RES, V13, P161, DOI 10.1158/1078-0432.CCR-06-0774; Zhu X., 2003, ICML WORKSH CONT LAB	38	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90495	10.1371/journal.pone.0090495	http://dx.doi.org/10.1371/journal.pone.0090495			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603893	Green Published, Green Submitted, gold			2022-12-27	WOS:000332483600057
J	Siegenthaler, C; Gunawan, R				Siegenthaler, Caroline; Gunawan, Rudiyanto			Assessment of Network Inference Methods: How to Cope with an Underdetermined Problem	PLOS ONE			English	Article								The inference of biological networks is an active research area in the field of systems biology. The number of network inference algorithms has grown tremendously in the last decade, underlining the importance of a fair assessment and comparison among these methods. Current assessments of the performance of an inference method typically involve the application of the algorithm to benchmark datasets and the comparison of the network predictions against the gold standard or reference networks. While the network inference problem is often deemed underdetermined, implying that the inference problem does not have a (unique) solution, the consequences of such an attribute have not been rigorously taken into consideration. Here, we propose a new procedure for assessing the performance of gene regulatory network (GRN) inference methods. The procedure takes into account the underdetermined nature of the inference problem, in which gene regulatory interactions that are inferable or non-inferable are determined based on causal inference. The assessment relies on a new definition of the confusion matrix, which excludes errors associated with non-inferable gene regulations. For demonstration purposes, the proposed assessment procedure is applied to the DREAM 4 In Silico Network Challenge. The results show a marked change in the ranking of participating methods when taking network inferability into account.	[Siegenthaler, Caroline; Gunawan, Rudiyanto] Swiss Fed Inst Technol, Inst Chem & Bioengn, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Gunawan, R (corresponding author), Swiss Fed Inst Technol, Inst Chem & Bioengn, Zurich, Switzerland.	rudi.gunawan@chem.ethz.ch	Gunawan, Rudiyanto/D-4650-2009	Gunawan, Rudiyanto/0000-0002-6480-7976	Swiss National Science Foundation [200021-137614]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The study was supported by the Swiss National Science Foundation (project number 200021-137614). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aho A. V., 1972, SIAM Journal on Computing, V1, P131, DOI 10.1137/0201008; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Andersson SA, 1997, ANN STAT, V25, P505; Craciun G, 2008, J MATH CHEM, V44, P244, DOI 10.1007/s10910-007-9307-x; De Smet R, 2010, NAT REV MICROBIOL, V8, P717, DOI 10.1038/nrmicro2419; Emmert-Streib Frank, 2012, Frontiers in Genetics, V3, P8, DOI [10.3389/fgene.2012.00313, 10.3389/fgene.2012.00008]; Jaynes E, 1984, INVERSE PROBL, V14, P151; Marbach D., 2009, DRAFT VERSION 03; Marbach D, 2012, NAT METHODS, V9, P796, DOI [10.1038/nmeth.2016, 10.1038/NMETH.2016]; Marbach D, 2010, P NATL ACAD SCI USA, V107, P6286, DOI 10.1073/pnas.0913357107; Marbach D, 2009, ANN NY ACAD SCI, V1158, P234, DOI 10.1111/j.1749-6632.2008.03944.x; Marbach D, 2009, J COMPUT BIOL, V16, P229, DOI 10.1089/cmb.2008.09TT; Narendra V, 2011, GENOMICS, V97, P7, DOI 10.1016/j.ygeno.2010.10.003; Pearl J, 2010, INT J BIOSTAT, V6, DOI 10.2202/1557-4679.1203; Penfold CA, 2011, INTERFACE FOCUS, V1, P857, DOI 10.1098/rsfs.2011.0053; Prill RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009202; Schaffter T, 2011, BIOINFORMATICS, V27, P2263, DOI 10.1093/bioinformatics/btr373; Spirtes P, 2010, J MACH LEARN RES, V11, P1643; Stolovitzky G, 2007, ANN NY ACAD SCI, V1115, P1, DOI 10.1196/annals.1407.021; Stolovitzky G, 2009, ANN NY ACAD SCI, V1158, P159, DOI 10.1111/j.1749-6632.2009.04497.x; Szederkenyi G, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-177; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Wagner A, 2001, BIOINFORMATICS, V17, P1183, DOI 10.1093/bioinformatics/17.12.1183	23	31	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90481	10.1371/journal.pone.0090481	http://dx.doi.org/10.1371/journal.pone.0090481			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603847	Green Published, gold, Green Submitted			2022-12-27	WOS:000332483600055
J	Aasebo, E; Opsahl, JA; Bjorlykke, Y; Myhr, KM; Kroksveen, AC; Berven, FS				Aasebo, Elise; Opsahl, Jill Anette; Bjorlykke, Yngvild; Myhr, Kjell-Morten; Kroksveen, Ann Cathrine; Berven, Frode S.			Effects of Blood Contamination and the Rostro-Caudal Gradient on the Human Cerebrospinal Fluid Proteome	PLOS ONE			English	Article							MASS-SPECTROMETRY; BARRIER FUNCTION; FLOW-RATE; PROTEINS; IDENTIFICATIONS; EXPRESSION; DYNAMICS; VARIABLES; LUMBAR; BRAIN	Over the last years there has been an increased focus on the importance of knowing the effect of pre-analytical influence on the proteomes under study, particularly in the field of biomarker discovery. We present three proteomics studies examining the effect of blood contamination and the rostro-caudal gradient (RCG) on the cerebrospinal fluid (CSF) proteome, in addition to plasma/CSF protein ratios. The studies showed that the central nervous system (CNS) derived proteins appeared to be unaffected by the RCG, while the plasma-derived proteins showed an increase in concentration towards the lumbar area. This implies that the concentration of the plasma-derived proteins in CSF will vary depending on the volume of CSF that is collected. In the CSF samples spiked with blood, 262 of 814 quantified proteins showed an abundance increase of more than 1.5 fold, while 403 proteins had a fold change of less than 1.2 and appeared to be unaffected by blood contamination. Proteins with a high plasma/CSF ratio appeared to give the largest effect on the CSF proteome upon blood contamination. The results give important background information on how factors like blood contamination, RCG and blood-CNS-barrier influences the CSF proteome. This information is particularly important in the field of biomarker discovery, but also for routine clinical measurements. The data from the blood contamination and RCG discovery studies have been deposited to the ProteomeXchange with identifier PXD000401.	[Aasebo, Elise; Opsahl, Jill Anette; Kroksveen, Ann Cathrine; Berven, Frode S.] Univ Bergen, Dept Biomed, Prote Unit PROBE, Bergen, Norway; [Aasebo, Elise; Opsahl, Jill Anette; Myhr, Kjell-Morten; Kroksveen, Ann Cathrine; Berven, Frode S.] Univ Bergen, Dept Clin Med, KG Jebsen Ctr MS Res, Bergen, Norway; [Bjorlykke, Yngvild] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Myhr, Kjell-Morten; Berven, Frode S.] Haukeland Hosp, Dept Neurol, Norwegian Multiple Sclerosis Competence Ctr, N-5021 Bergen, Norway	University of Bergen; University of Bergen; University of Bergen; University of Bergen; Haukeland University Hospital	Berven, FS (corresponding author), Univ Bergen, Dept Biomed, Prote Unit PROBE, Bergen, Norway.	Frode.berven@biomed.uib.no	Myhr, Kjell-Morten/H-1528-2018	Myhr, Kjell-Morten/0000-0002-0980-510X	National Program for Research in Functional Genomics (FUGE); Norwegian Research Council; Western Norway Regional Health Authority; Meltzer Foundation; Kjell Alme's Legacy for Research in Multiple Sclerosis; Kristian Gerhard Jebsen Foundation; PRIDE Team, EBI	National Program for Research in Functional Genomics (FUGE); Norwegian Research Council(Research Council of NorwayEuropean Commission); Western Norway Regional Health Authority; Meltzer Foundation; Kjell Alme's Legacy for Research in Multiple Sclerosis; Kristian Gerhard Jebsen Foundation; PRIDE Team, EBI	The study was supported by the National Program for Research in Functional Genomics (FUGE) funded by the Norwegian Research Council, Western Norway Regional Health Authority, the Meltzer Foundation, Kjell Alme's Legacy for Research in Multiple Sclerosis, and the Kristian Gerhard Jebsen Foundation. The data deposition to the ProteomeXchange Consortium was supported by PRIDE Team, EBI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbatiello SE, 2010, CLIN CHEM, V56, P291, DOI 10.1373/clinchem.2009.138420; ATACK JR, 1990, NEUROCHEM INT, V16, P533, DOI 10.1016/0197-0186(90)90013-J; Aye TT, 2012, ANAL CHEM, V84, P4999, DOI 10.1021/ac300596r; Berven FS, 2007, PROTEOM CLIN APPL, V1, P699, DOI 10.1002/prca.200700126; Brandner S, 2013, EUR NEUROL, V70, P189, DOI 10.1159/000352032; CSERR HF, 1981, AM J PHYSIOL, V240, pF319, DOI 10.1152/ajprenal.1981.240.4.F319; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; FELGENHAUER K, 1974, KLIN WOCHENSCHR, V52, P1158, DOI 10.1007/BF01466734; Fenyo D, 2003, ANAL CHEM, V75, P768, DOI 10.1021/ac0258709; Geer LY, 2004, J PROTEOME RES, V3, P958, DOI 10.1021/pr0499491; Grijalva I, 2006, SPINAL CORD, V44, P280, DOI 10.1038/sj.sc.3101842; HELMAN LJ, 1988, J CLIN INVEST, V82, P686, DOI 10.1172/JCI113648; Jimenez CR, 2007, PROTEOM CLIN APPL, V1, P1385, DOI 10.1002/prca.200700330; Kirkpatrick LL, 2000, J BIOL CHEM, V275, P17786, DOI 10.1074/jbc.M002254200; Kroksveen AC, 2011, J PROTEOMICS, V74, P371, DOI 10.1016/j.jprot.2010.11.010; Kroksveen AC, 2013, J PROTEOMICS, V78, P312, DOI 10.1016/j.jprot.2012.09.037; Kuroda S, 1999, BIOCHEM BIOPH RES CO, V265, P79, DOI 10.1006/bbrc.1999.1638; MAY C, 1990, NEUROLOGY, V40, P500, DOI 10.1212/WNL.40.3_Part_1.500; Petzold A, 2006, NEUROCRIT CARE, V4, P153, DOI 10.1385/NCC:4:2:153; Portelius E, 2010, INT J ALZHEIMERS DIS; Reiber H, 2003, RESTOR NEUROL NEUROS, V21, P79; REIBER H, 1994, J NEUROL SCI, V122, P189, DOI 10.1016/0022-510X(94)90298-4; REIBER H, 1983, J CLIN CHEM CLIN BIO, V21, P199; Reiber H, 2001, CLIN CHIM ACTA, V310, P173, DOI 10.1016/S0009-8981(01)00573-3; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Simonsen AH, 2013, J NEUROSCI METH, V215, P234, DOI 10.1016/j.jneumeth.2013.03.011; Simonsen AH, 2010, J NEUROSCI METH, V191, P244, DOI 10.1016/j.jneumeth.2010.06.017; Tarnaris A, 2011, NEUROCHEM RES, V36, P528, DOI 10.1007/s11064-010-0374-1; Teunissen CE, 2009, NEUROLOGY, V73, P1914, DOI 10.1212/WNL.0b013e3181c47cc2; Vaudel M, 2011, PROTEOMICS, V11, P996, DOI 10.1002/pmic.201000595; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; WEISNER B, 1978, J NEUROL SCI, V37, P205, DOI 10.1016/0022-510X(78)90204-6; You JS, 2005, PROTEOMICS, V5, P290, DOI 10.1002/pmic.200400889	33	42	42	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90429	10.1371/journal.pone.0090429	http://dx.doi.org/10.1371/journal.pone.0090429			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599184	gold, Green Published, Green Submitted			2022-12-27	WOS:000332479400074
J	Clark, JT; Clark, MR; Shelke, NB; Johnson, TJ; Smith, EM; Andreasen, AK; Nebeker, JS; Fabian, J; Friend, DR; Kiser, PF				Clark, Justin T.; Clark, Meredith R.; Shelke, Namdev B.; Johnson, Todd J.; Smith, Eric M.; Andreasen, Andrew K.; Nebeker, Joel S.; Fabian, Judit; Friend, David R.; Kiser, Patrick F.			Engineering a Segmented Dual-Reservoir Polyurethane Intravaginal Ring for Simultaneous Prevention of HIV Transmission and Unwanted Pregnancy	PLOS ONE			English	Article							TENOFOVIR DISOPROXIL FUMARATE; IN-VITRO RELEASE; DRUG-DELIVERY; PREEXPOSURE PROPHYLAXIS; SUSTAINED DELIVERY; VIRUS-INFECTION; DAPIVIRINE; ADHERENCE; WOMEN; CHALLENGES	The HIV/AIDS pandemic and its impact on women prompt the investigation of prevention strategies to interrupt sexual transmission of HIV. Long-acting drug delivery systems that simultaneously protect womenfrom sexual transmission of HIV and unwanted pregnancy could be important tools in combating the pandemic. We describe the design, in silico, in vitro and in vivo evaluation of a dual-reservoir intravaginal ring that delivers the HIV-1 reverse transcriptase inhibitor tenofovir and the contraceptive levonorgestrel for 90 days. Two polyether urethanes with two different hard segment volume fractions were used to make coaxial extruded reservoir segments with a 100 mm thick rate controlling membrane and a diameter of 5.5 mm that contain 1.3 wt% levonorgestrel. A new mechanistic diffusion model accurately described the levonorgestrel burst release in early time points and pseudo-steady state behavior at later time points. As previously described, tenofovir was formulated as a glycerol paste and filled into a hydrophilic polyurethane, hollow tube reservoir that was melt-sealed by induction welding. These tenofovir-eluting segments and 2 cm long coaxially extruded levonorgestrel eluting segments were joined by induction welding to form rings that released an average of 7.5 mg tenofovir and 21 mg levonorgestrel per day in vitro for 90 days. Levonorgestrel segments placed intravaginally in rabbits resulted in sustained, dose-dependent levels of levonorgestrel in plasma and cervical tissue for 90 days. Polyurethane caps placed between segments successfully prevented diffusion of levonorgestrel into the tenofovir-releasing segment during storage. Hydrated rings endured between 152 N and 354 N tensile load before failure during uniaxial extension testing. In summary, this system represents a significant advance in vaginal drug delivery technology, and is the first in a new class of long-acting multipurpose prevention drug delivery systems.	[Clark, Justin T.; Shelke, Namdev B.; Johnson, Todd J.; Smith, Eric M.; Andreasen, Andrew K.; Nebeker, Joel S.; Fabian, Judit; Kiser, Patrick F.] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA; [Clark, Meredith R.; Friend, David R.] Eastern Virginia Med Sch, Dept Obstet & Gynecol, CONRAD, Arlington, VA USA; [Kiser, Patrick F.] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA	Utah System of Higher Education; University of Utah; Eastern Virginia Medical School; Northwestern University	Kiser, PF (corresponding author), Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA.	patrick.kiser@northwestern.edu	Kiser, Patrick F/C-2843-2014	Kiser, Patrick F/0000-0002-3868-7122; Clark, Meredith/0000-0002-4476-8287	United States Agency for International Development (USAID) [GPO-A-00-08-00005-00, AID-OAA-A-10-0006]; Eastern Virginia Medical School [GPO-A-00-08-00005-00, AID-OAA-A-10-0006]	United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); Eastern Virginia Medical School	Funding was provided under cooperative agreement (GPO-A-00-08-00005-00 and AID-OAA-A-10-0006) between the United States Agency for International Development (USAID) and the Eastern Virginia Medical School. This work was supported by a cooperative agreement from The United States Agency for International Development (USAID). USAID had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews C, 2013, 20 C RETR OPP INF AT; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Clark JT, 2012, J CONTROL RELEASE, V163, P240, DOI 10.1016/j.jconrel.2012.08.033; Clark MR, 2011, DRUG DELIV TRANSL RE, V1, P238, DOI 10.1007/s13346-011-0032-4; Clark MR, 2012, J PHARM SCI-US, V101, P576, DOI 10.1002/jps.22781; Connor J, 2004, B WORLD HEALTH ORGAN, V82, P935; Dobard C, 2012, J VIROL, V86, P718, DOI 10.1128/JVI.05842-11; DUSTERBERG B, 1981, CONTRACEPTION, V24, P673, DOI 10.1016/0010-7824(81)90018-4; Elabd YA, 2001, MACROMOLECULES, V34, P6268, DOI 10.1021/ma002107c; Fetherston SM, 2010, THER DELIV, V1, P785, DOI 10.4155/TDE.10.74; Folkers GK, 2010, JAMA-J AM MED ASSOC, V304, P350, DOI 10.1001/jama.2010.957; Friend DR, 2013, ANTIVIR RES, V99, P391, DOI 10.1016/j.antiviral.2013.06.021; Friend DR, 2012, EXPERT OPIN DRUG DEL, V9, P417, DOI 10.1517/17425247.2012.668183; Friend DR, 2011, DRUG DELIV TRANSL RE, V1, P185, DOI 10.1007/s13346-011-0024-4; Gupta KM, 2008, J PHARM SCI-US, V97, P4228, DOI 10.1002/jps.21331; Hankins CA, 2013, CURR OPIN HIV AIDS, V8, P50, DOI 10.1097/COH.0b013e32835b809d; Helbling IM, 2011, J CONTROL RELEASE, V149, P258, DOI 10.1016/j.jconrel.2010.10.018; Heneine W, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007419; Iskedjian M, 2002, CLIN THER, V24, P302, DOI 10.1016/S0149-2918(02)85026-3; Johnson TJ, 2012, ANTIMICROB AGENTS CH, V56, P6272, DOI 10.1128/AAC.01431-12; Johnson TJ, 2012, ANTIMICROB AGENTS CH, V56, P1291, DOI 10.1128/AAC.05721-11; Johnson TJ, 2010, EUR J PHARM SCI, V39, P203, DOI 10.1016/j.ejps.2009.11.007; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Kiser PF, 2012, AIDS REV, V14, P62; Kiser PF, 2013, WO Patent Application, Patent No. [PCT/US2012/047649, 2012047649]; Kruk ME, 2006, CLIN THER, V28, P1989, DOI 10.1016/j.clinthera.2006.12.011; Malcolm K, 2003, J CONTROL RELEASE, V90, P217, DOI 10.1016/S0168-3659(03)00178-0; Malcolm RK, 2013, CONTRACEPTION, V88, P321, DOI 10.1016/j.contraception.2013.06.009; Marrazzo J.M., 2015, C RETR OPP INF ATL M, P509; Mesquita PMM, 2012, J ANTIMICROB CHEMOTH, V67, P1730, DOI 10.1093/jac/dks097; Nel A, 2009, JAIDS-J ACQ IMM DEF, V51, P416, DOI 10.1097/QAI.0b013e3181acb536; Rose S, 2009, ADV DRUG DELIVER REV, V61, P808, DOI 10.1016/j.addr.2009.04.022; ROWE PJ, 1990, CONTRACEPTION, V41, P105, DOI 10.1016/0010-7824(90)90141-H; Saltzman WM, 2001, ENG PRINCIPLES DRUG; Shattock RJ, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007385; Siepmann J, 2008, INT J PHARMACEUT, V364, P328, DOI 10.1016/j.ijpharm.2008.09.004; Siepmann J, 2012, J CONTROL RELEASE, V161, P351, DOI 10.1016/j.jconrel.2011.10.006; Singer R, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003936; Skoler-Karpoff S, 2008, LANCET, V372, P1977, DOI 10.1016/S0140-6736(08)61842-5; Smith JM, 2013, P NATL ACAD SCI USA, V110, P16145, DOI 10.1073/pnas.1311355110; Szycher M, 1985, US patent, Patent No. [4,523,005, 4523005]; van der Straten A, 2012, AIDS, V26, pF13, DOI 10.1097/QAD.0b013e3283522272; van Laarhoven JAH, 2002, INT J PHARM, V232, P163, DOI 10.1016/S0378-5173(01)00900-0; van Laarhoven JAH, 2002, J CONTROL RELEASE, V82, P309, DOI 10.1016/S0168-3659(02)00139-6; Vergnaud J.-M., 1993, CONTROLLED DRUG RELE; Wertheimer AI, 2013, CURR MED CHEM, V20, P1635	46	73	76	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e88509	10.1371/journal.pone.0088509	http://dx.doi.org/10.1371/journal.pone.0088509			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599325	Green Submitted, gold, Green Published			2022-12-27	WOS:000332479400004
J	Chen, J; Liang, L; Zhan, LB; Zhou, Y; Zheng, LP; Sun, XX; Gong, J; Sui, H; Jiang, RJ; Zhang, FL; Zhang, L				Chen, Jing; Liang, Lina; Zhan, Libin; Zhou, Yan; Zheng, Luping; Sun, Xiaoxin; Gong, Jin; Sui, Hua; Jiang, Rujiao; Zhang, Fuliang; Zhang, Lin			ZiBuPiYin Recipe Protects db/db Mice from Diabetes-Associated Cognitive Decline through Improving Multiple Pathological Changes	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; DENDRITIC SPINE; LEPTIN; BRAIN; NEURONS; GSK-3-BETA; DISORDERS; PROTEINS; RATS	Multiple organ systems, including the brain, which undergoes changes that may increase the risk of cognitive decline, are adversely affected by diabetes mellitus (DM). Here, we demonstrate that type 2 diabetes mellitus (T2DM) db/db mice exhibited hippocampus-dependent memory impairment, which might associate with a reduction in dendritic spine density in the pyramidal neurons of brain, A beta(1-42) deposition in the prefrontal cortex (PFC) and hippocampus, and a decreased expression of neurostructural proteins including microtubule-associated protein (MAP2), a marker of dendrites, and postsynaptic density 95 (PSD95), a marker of excitatory synapses. To investigate the effects of the ZiBuPiYin recipe (ZBPYR), a traditional Chinese medicine recipe, on diabetes-related cognitive decline (DACD), db/db mice received daily administration of ZBPYR over an experimental period of 6 weeks. We then confirmed that ZBPYR rescued learning and memory performance impairments, reversed dendritic spine loss, reduced A beta(1-42) deposition and restored the expression levels of MAP2 and PSD95. The present study also revealed that ZBPYR strengthened brain leptin and insulin signaling and inhibited GSK3 beta overactivity, which may be the potential mechanism or underlying targets of ZBPYR. These findings conclude that ZBPYR prevents DACD, most likely by improving dendritic spine density and attenuating brain leptin and insulin signaling pathway injury. Our findings provide further evidence for the effects of ZBPYR on DACD.	[Chen, Jing; Zhan, Libin; Zhou, Yan] Dalian Med Univ, Affiliated Hosp 2, Dalian, Liaoning, Peoples R China; [Liang, Lina; Zhan, Libin; Zheng, Luping; Sun, Xiaoxin; Sui, Hua; Jiang, Rujiao; Zhang, Lin] Dalian Med Univ, Coll Inst Integrat Med, Dalian, Liaoning, Peoples R China; [Gong, Jin] Dalian Med Univ, Dept Anat, Dalian, Liaoning, Peoples R China; [Zhang, Fuliang] Dalian Med Univ, Dept Publ Hlth, Dalian, Liaoning, Peoples R China	Dalian Medical University; Dalian Medical University; Dalian Medical University; Dalian Medical University	Zhan, LB (corresponding author), Dalian Med Univ, Affiliated Hosp 2, Dalian, Liaoning, Peoples R China.	libinzhan@hotmail.com		Chen, Jing/0000-0001-6751-0935	National Natural Science Foundation, China [81230084]; Specialized Research Fund for the Doctoral Program of Higher Education, China [20112105110006]; Program for Professor of Special Appointment in Liaoning Province	National Natural Science Foundation, China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education, China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Program for Professor of Special Appointment in Liaoning Province	This work was financially supported by The Key Project of National Natural Science Foundation, China (No. 81230084), The Specialized Research Fund for the Doctoral Program of Higher Education, China (No. 20112105110006) and The Program for Professor of Special Appointment in Liaoning Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahtiluoto S, 2010, NEUROLOGY, V75, P1195, DOI 10.1212/WNL.0b013e3181f4d7f8; Belfiore A, 2009, ENDOCR REV, V30, P586, DOI 10.1210/er.2008-0047; Bhatt DH, 2009, ANNU REV PHYSIOL, V71, P261, DOI 10.1146/annurev.physiol.010908.163140; Chiu SL, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-7; Clodfelder-Miller B, 2005, J BIOL CHEM, V280, P39723, DOI 10.1074/jbc.M508824200; Dehmelt L, 2005, GENOME BIOL, V6; Dinel AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024325; Gonzalez-Ramirez MM, 2014, NEUROBIOL LEARN MEM, V109, P94, DOI 10.1016/j.nlm.2013.11.017; Guo ZH, 2008, J BIOL CHEM, V283, P1754, DOI 10.1074/jbc.M703753200; Hains AB, 2009, P NATL ACAD SCI USA, V106, P17957, DOI 10.1073/pnas.0908563106; Hamilton GF, 2010, SYNAPSE, V64, P127, DOI 10.1002/syn.20711; Hooper C, 2008, J NEUROCHEM, V104, P1433, DOI 10.1111/j.1471-4159.2007.05194.x; Hur EM, 2010, NAT REV NEUROSCI, V11, P539, DOI 10.1038/nrn2870; Irvine EE, 2011, LEARN MEMORY, V18, P375, DOI 10.1101/lm.2111311; Jones TS, 2012, NEURAL PLAST, V2012, P1; Keith D, 2008, FRONT MOL NEUROSCI, V1, DOI 10.3389/neuro.02.004.2008; Kopf D, 2009, J ALZHEIMERS DIS, V16, P677, DOI 10.3233/JAD-2009-1011; Kulkarni VA, 2012, MOL CELL NEUROSCI, V50, P10, DOI 10.1016/j.mcn.2012.03.005; Lee CC, 2011, NEUROPHARMACOLOGY, V61, P867, DOI 10.1016/j.neuropharm.2011.06.003; Li XL, 2012, EXP THER MED, V4, P125, DOI 10.3892/etm.2012.562; Morrison CD, 2009, BBA-MOL BASIS DIS, V1792, P401, DOI 10.1016/j.bbadis.2008.12.004; Murphy GG, 2013, EPILEPSY CURR, V13, P26, DOI 10.5698/1535-7511-13.1.26; Oomura Yutaka, 2010, Pathophysiology, V17, P119, DOI 10.1016/j.pathophys.2009.04.004; Penzes P, 2011, NAT NEUROSCI, V14, P285, DOI 10.1038/nn.2741; Perez Sylvia E, 2012, Int J Physiol Pathophysiol Pharmacol, V4, P115; Piao Y, 2012, EVID-BASED COMPL ALT, V2012, P1; Profenno LA, 2010, BIOL PSYCHIAT, V67, P505, DOI 10.1016/j.biopsych.2009.02.013; Ronn SG, 2007, DIABETES, V56, P541, DOI 10.2337/db06-1068; Sharma AN, 2010, PHYSIOL BEHAV, V101, P381, DOI 10.1016/j.physbeh.2010.07.002; Shen H, 2012, AM J PHYSIOL-ENDOC M, V302, pE932, DOI 10.1152/ajpendo.00479.2011; Shi X, 2011, DIABETOLOGIA, V54, P1888, DOI 10.1007/s00125-011-2147-z; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Stranahan AM, 2008, NAT NEUROSCI, V11, P309, DOI 10.1038/nn2055; Talbot K, 2012, J CLIN INVEST, V122, P1316, DOI 10.1172/JCI59903; Tello PS, 2011, INT J ALZHEIMERS DIS, V2011, P1; Terry AV, 2009, FRONT NEUROSCI, P267; Tezapsidis N, 2009, J ALZHEIMERS DIS, V16, P731, DOI 10.3233/JAD-2009-1021; Valentinuzzi VS, 2004, J BIOL RHYTHM, V19, P312, DOI 10.1177/0748730404265688; Wen ZN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018278; Yin J, 2009, AM J PHYSIOL-ENDOC M, V296, pE1275, DOI 10.1152/ajpendo.00092.2009; Zhan LB, 2008, CHIN J INTEGR MED, V14, P117, DOI 10.1007/s11655-008-0117-1; Zhan Li-bin, 2009, Zhong Xi Yi Jie He Xue Bao, V7, P242; Zhang J, 2007, AM J PHYSIOL-REG I, V292, pR868, DOI 10.1152/ajpregu.00213.2006; Zhao Q, 2011, J PHARMACOL SCI, V117, P230, DOI 10.1254/jphs.11115FP; Zhou FQ, 2005, SCIENCE, V308, P211, DOI 10.1126/science.1110301	45	35	37	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91680	10.1371/journal.pone.0091680	http://dx.doi.org/10.1371/journal.pone.0091680			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614172	Green Published, Green Submitted, gold			2022-12-27	WOS:000332839300148
J	Chen, RX; Song, HY; Dong, YY; Hu, C; Zheng, QD; Xue, TC; Liu, XH; Zhang, Y; Chen, J; Ren, ZG; Liu, YK; Cui, JF				Chen, Rong-Xin; Song, Hai-Yan; Dong, Yin-Ying; Hu, Chao; Zheng, Qiong-Dan; Xue, Tong-Chun; Liu, Xiao-Hui; Zhang, Yang; Chen, Jie; Ren, Zheng-Gang; Liu, Yin-Kun; Cui, Jie-Feng			Dynamic Expression Patterns of Differential Proteins during Early Invasion of Hepatocellular Carcinoma	PLOS ONE			English	Article							METASTATIC POTENTIALS; CANCER METASTASIS; CELLS; MODELS; IDENTIFICATION; VIMENTIN; CULTURE; GENE	Background: Tumor cell invasion into the surrounding matrix has been well documented as an early event of metastasis occurrence. However, the dynamic expression patterns of proteins during early invasion of hepatocellular carcinoma (HCC) are largely unknown. Using a three-dimensional HCC invasion culture model established previously, we investigated the dynamic expression patterns of identified proteins during early invasion of HCC. Materials and Methods: Highly metastatic MHCC97H cells and a liver tissue fragment were long-term co-cultured in a rotating wall vessel (RWV) bioreactor to simulate different pathological states of HCC invasion. The established spherical co-cultures were collected on days 0, 5, 10, and 15 for dynamic expression pattern analysis. Significantly different proteins among spheroids at different time points were screened and identified using quantitative proteomics of iTRAQ labeling coupled with LC-MS/MS. Dynamic expression patterns of differential proteins were further categorized by K-means clustering. The expression modes of several differentially expressed proteins were confirmed by Western blot and qRT-PCR. Results: Time course analysis of invasion/metastasis gene expressions (MMP2, MMP7, MMP9, CD44, SPP1, CXCR4, CXCL12, and CDH1) showed remarkable, dynamic alterations during the invasion process of HCC. A total of 1,028 proteins were identified in spherical co-cultures collected at different time points by quantitative proteomics. Among these proteins, 529 common differential proteins related to HCC invasion were clustered into 25 types of expression patterns. Some proteins displayed significant dynamic alterations during the early invasion process of HCC, such as upregulation at the early invasion stage and downregulation at the late invasion stage (e. g., MAPRE1, PHB2, cathepsin D, etc.) or continuous upregulation during the entire invasion process (e. g., vitronectin, Met, clusterin, ICAM1, GSN, etc.). Conclusions: Dynamic expression patterns of candidate proteins during the early invasion process of HCC facilitate the discovery of new molecular targets for early intervention to prevent HCC invasion and metastasis.	[Chen, Rong-Xin; Dong, Yin-Ying; Zheng, Qiong-Dan; Xue, Tong-Chun; Chen, Jie; Ren, Zheng-Gang; Liu, Yin-Kun; Cui, Jie-Feng] Fudan Univ, Liver Canc Inst, Zhongshan Hosp, Shanghai 200032, Peoples R China; [Chen, Rong-Xin; Dong, Yin-Ying; Zheng, Qiong-Dan; Xue, Tong-Chun; Chen, Jie; Ren, Zheng-Gang; Liu, Yin-Kun; Cui, Jie-Feng] Minist Educ, Key Lab Carcinogenesis & Canc Invas, Shanghai, Peoples R China; [Song, Hai-Yan] Shanghai Univ Tradit Chinese Med, Inst Digest Dis, Longhua Hosp, Shanghai, Peoples R China; [Hu, Chao] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Shanghai 200030, Peoples R China; [Liu, Xiao-Hui; Zhang, Yang] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China	Fudan University; Shanghai University of Traditional Chinese Medicine; Shanghai Jiao Tong University; Fudan University	Cui, JF (corresponding author), Fudan Univ, Liver Canc Inst, Zhongshan Hosp, Shanghai 200032, Peoples R China.	cui.jiefeng@zs-hospital.sh.cn	Dong, Yinying/HHC-3041-2022	Hu, Chao/0000-0001-5895-6038	National Natural Science Foundation of China [81071902, 81272583, 81272723, 81000909]; Shanghai Science and Technology Program [11JC1402100]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Program	This study was sponsored by grants from the National Natural Science Foundation of China (Nos. 81071902; 81272583; 81272723; and 81000909) and the Shanghai Science and Technology Program (No. 11JC1402100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chakrabarti A, 2012, ANN BIOMED ENG, V40, P2488, DOI 10.1007/s10439-012-0655-8; Chen B, 2013, CELL BIOL INT, V37, P643, DOI 10.1002/cbin.10062; Chen RX, 2012, ANN SURG ONCOL, V19, pS375, DOI 10.1245/s10434-011-1836-7; Cheng J, 2013, MOL CARCINOG; Ding SJ, 2004, PROTEOMICS, V4, P982, DOI 10.1002/pmic.200300653; Feng HX, 2010, J PROTEOMICS, V73, P1421, DOI 10.1016/j.jprot.2009.12.004; Goyal L, 2013, CLIN CANCER RES, V19, P2310, DOI 10.1158/1078-0432.CCR-12-2791; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; He H, 2002, GENE EXPRESSION, V10, P231, DOI 10.3727/000000002783992406; Huang XF, 2000, WORLD J GASTROENTERO, V6, P693; Kim JB, 2005, SEMIN CANCER BIOL, V15, P365, DOI 10.1016/j.semcancer.2005.05.002; Kimlin LC, 2013, MOL CARCINOGEN, V52, P167, DOI 10.1002/mc.21844; Kitamura Y, 2011, ANTICANCER RES, V31, P1289; Lau SH, 2006, ONCOGENE, V25, P1242, DOI 10.1038/sj.onc.1209141; Lee JM, 2013, LAB INVEST, V93, P528, DOI 10.1038/labinvest.2013.41; Li Y, 2004, J CANCER RES CLIN, V130, P460, DOI 10.1007/s00432-004-0564-9; Li Y, 2001, WORLD J GASTROENTERO, V7, P630; Li Y, 2012, NAT REV GASTRO HEPAT, V9, P32, DOI 10.1038/nrgastro.2011.196; Liu SP, 2013, GASTROENTEROLOGY, V144, P1031, DOI 10.1053/j.gastro.2013.01.046; Orimo T, 2008, HEPATOLOGY, V48, P1851, DOI 10.1002/hep.22552; Pan TL, 2012, J PROTEOMICS, V75, P4676, DOI 10.1016/j.jprot.2012.02.017; Schmidt VA, 2008, MOL CELL BIOL, V28, P1489, DOI 10.1128/MCB.01090-07; Song PM, 2009, PROTEOM CLIN APPL, V3, P841, DOI 10.1002/prca.200780131; Tang JH, 2011, TUMOR BIOL, V32, P469, DOI 10.1007/s13277-010-0140-7; Tang ZY, 2004, J CANCER RES CLIN, V130, P187, DOI 10.1007/s00432-003-0511-1; Tonack S, 2009, J PROTEOMICS, V73, P352, DOI 10.1016/j.jprot.2009.07.009; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Wang C, 2012, INT J BIOCHEM CELL B, V44, P2308, DOI 10.1016/j.biocel.2012.09.012; Weeks CA, 2013, BIOTECHNOL BIOENG, V110, P2548, DOI 10.1002/bit.24899; Woo HG, 2011, MOL CARCINOGEN, V50, P235, DOI 10.1002/mc.20691; Wu J, 2013, BIOMED PHARMACOTHER, V67, P313, DOI 10.1016/j.biopha.2013.01.011; Ye QH, 2003, NAT MED, V9, P416, DOI 10.1038/nm843; Yi X, 2008, MOL CELL PROTEOMICS, V7, P315, DOI 10.1074/mcp.M700116-MCP200	34	29	29	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e88543	10.1371/journal.pone.0088543	http://dx.doi.org/10.1371/journal.pone.0088543			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614035	Green Submitted, Green Published, gold			2022-12-27	WOS:000332839300007
J	Kwasiborski, A; Bajji, M; Renaut, J; Delaplace, P; Jijakli, MH				Kwasiborski, Anthony; Bajji, Mohammed; Renaut, Jenny; Delaplace, Pierre; Jijakli, M. Haissam			Identification of Metabolic Pathways Expressed by Pichia anomala Kh6 in the Presence of the Pathogen Botrytis cinerea on Apple: New Possible Targets for Biocontrol Improvement	PLOS ONE			English	Article							BIOLOGICAL-CONTROL; METSCHNIKOWIA-PULCHERRIMA; TRICHODERMA-ATROVIRIDE; POSTHARVEST PATHOGENS; STATIONARY-PHASE; YEAST PROTEINS; STRAIN-K; GROWTH; ANTAGONIST; COMPONENTS	Yeast Pichia anomala strain Kh6 Kurtzman (Saccharomycetales: Endomycetaceae) exhibits biological control properties that provide an alternative to the chemical fungicides currently used by fruit or vegetable producers against main post-harvest pathogens, such as Botrytis cinerea (Helotiales: Sclerotiniaceae). Using an in situ model that takes into account interactions between organisms and a proteomic approach, we aimed to identify P. anomala metabolic pathways influenced by the presence of B. cinerea. A total of 105 and 60 P. anomala proteins were differentially represented in the exponential and stationary growth phases, respectively. In the exponential phase and in the presence of B. cinerea, the pentose phosphate pathway seems to be enhanced and would provide P. anomala with the needed nucleic acids and energy for the wound colonisation. In the stationary phase, P. anomala would use alcoholic fermentation both in the absence and presence of the pathogen. These results would suggest that the competitive colonisation of apple wounds could be implicated in the mode of action of P. anomala against B. cinerea.	[Kwasiborski, Anthony; Bajji, Mohammed; Jijakli, M. Haissam] Gembloux Agrobio Tech Univ Liege, Plant Pathol Unit, Gembloux, Belgium; [Renaut, Jenny] Ctr Rech Publ Gabriel Lippmann, Dept Environm & Agrobiotechnol, Belvaux, Luxembourg; [Delaplace, Pierre] Gembloux Agrobio Tech Univ Liege, Plant Biol Unit, Gembloux, Belgium	Luxembourg Institute of Science & Technology	Kwasiborski, A (corresponding author), Gembloux Agrobio Tech Univ Liege, Plant Pathol Unit, Gembloux, Belgium.	kwasiborski@hotmail.fr	Renaut, Jenny/K-3216-2012	Renaut, Jenny/0000-0002-0450-3866; Delaplace, Pierre/0000-0001-6198-7820	Belgian Fond National de la Recherche Scientifique (FNRS) [FRFC 2.4.574.08.F]	Belgian Fond National de la Recherche Scientifique (FNRS)(Fonds de la Recherche Scientifique - FNRS)	This work was supported by the Belgian Fond National de la Recherche Scientifique (FNRS, FRFC 2.4.574.08.F convention) [URL: http://www.frs-fnrs.be/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abano E.E., 2012, INT J ADV BIOL RES, V2, P1; Andrew EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066242; ANDREWS JH, 1994, CAN J MICROBIOL, V40, P6, DOI 10.1139/m94-002; Bajji M., 2009, IOBC/WPRS Bulletin, V43, P327; BARRETT AJ, 1965, BIOCHEM J, V94, P617, DOI 10.1042/bj0940617; BOGONEZ E, 1985, J GEN MICROBIOL, V131, P1425; BORKOVICH KA, 1989, MOL CELL BIOL, V9, P3919, DOI 10.1128/MCB.9.9.3919; Castoria R, 2001, POSTHARVEST BIOL TEC, V22, P7, DOI 10.1016/S0925-5214(00)00186-1; Delaplace P, 2006, PROTEOMICS, V6, P6494, DOI 10.1002/pmic.200600493; Demianova M, 1996, J BIOL CHEM, V271, P11383, DOI 10.1074/jbc.271.19.11383; Donoso I, 2005, MOL GENET GENOMICS, V274, P155, DOI 10.1007/s00438-005-0005-8; DROBY S, 1989, CAN J MICROBIOL, V35, P794, DOI 10.1139/m89-132; Droby S, 2009, POSTHARVEST BIOL TEC, V52, P137, DOI 10.1016/j.postharvbio.2008.11.009; Dumas R, 2001, ACCOUNTS CHEM RES, V34, P399, DOI 10.1021/ar000082w; Filonow AB, 1998, BIOCONTROL SCI TECHN, V8, P243, DOI 10.1080/09583159830315; Fravel DR, 2005, ANNU REV PHYTOPATHOL, V43, P337, DOI 10.1146/annurev.phyto.43.032904.092924; Fredlund E, 2004, APPL ENVIRON MICROB, V70, P5905, DOI 10.1128/AEM.70.10.5905-5911.2004; Fredlund E, 2004, FEMS MICROBIOL LETT, V238, P133, DOI 10.1016/j.femsle.2004.07.027; Friel D, 2007, MOL PLANT MICROBE IN, V20, P371, DOI 10.1094/MPMI-20-4-0371; FUGE EK, 1994, J BACTERIOL, V176, P5802, DOI 10.1128/JB.176.18.5802-5813.1994; Gorg A, 2005, PROTEOMICS, V5, P826, DOI 10.1002/pmic.200590007; Grevesse C, 2003, PHYTOPATHOLOGY, V93, P1145, DOI 10.1094/PHYTO.2003.93.9.1145; Grinyer J, 2005, CURR GENET, V47, P381, DOI 10.1007/s00294-005-0575-3; Grinyer J, 2004, CURR GENET, V45, P163, DOI 10.1007/s00294-003-0474-4; Haissam JM, 2011, ANTON LEEUW INT J G, V99, P93, DOI 10.1007/s10482-010-9541-2; Janisiewicz WJ, 2002, ANNU REV PHYTOPATHOL, V40, P411, DOI 10.1146/annurev.phyto.40.120401.130158; Jijakli M. H., 1993, Mededelingen Faculteit Landbouwkundige en Toegepaste Biologische Wetenschappen Universiteit Gent, V58, P1349; Jijakli M. H, 1999, BIOTECHNOLOGICAL APP, P31, DOI DOI 10.1007/978-1-4615-4745-7_2; Jijakli MH, 1998, PHYTOPATHOLOGY, V88, P335, DOI 10.1094/PHYTO.1998.88.4.335; Jijakli MH, 1993, IOBC WPRS B, V16, P106; Kwasiborski A, 2012, BIOCONTROL, V57, P837, DOI 10.1007/s10526-012-9460-4; Marra R, 2006, CURR GENET, V50, P307, DOI 10.1007/s00294-006-0091-0; Massart S, 2006, PHYTOPATHOLOGY, V96, P80, DOI 10.1094/PHYTO-96-0080; Matsushika A, 2012, ENZYME MICROB TECH, V51, P16, DOI 10.1016/j.enzmictec.2012.03.008; Nair N, 2007, APPL ENVIRON MICROB, V73, P2001, DOI 10.1128/AEM.02515-06; Norbeck J, 1997, YEAST, V13, P1519, DOI 10.1002/(SICI)1097-0061(199712)13:16<1519::AID-YEA211>3.0.CO;2-U; Piano S, 1997, POSTHARVEST BIOL TEC, V11, P131, DOI 10.1016/S0925-5214(97)00022-7; PRIMERANO DA, 1983, J BACTERIOL, V153, P259, DOI 10.1128/JB.153.1.259-269.1983; Spadaro D, 2004, INT J FOOD MICROBIOL, V91, P185, DOI 10.1016/S0168-1605(03)00380-5; Spadaro D, 2002, POSTHARVEST BIOL TEC, V24, P123, DOI 10.1016/S0925-5214(01)00172-7; ter Schure EG, 2000, FEMS MICROBIOL REV, V24, P67, DOI 10.1016/S0168-6445(99)00030-3; VICTOR J, 1979, J BIOL CHEM, V254, P2647; WISNIEWSKI M, 1989, CAN J BOT, V67, P2317, DOI 10.1139/b89-296; WISNIEWSKI M, 1991, PHYSIOL MOL PLANT P, V39, P245, DOI 10.1016/0885-5765(91)90033-E; Ying WH, 2008, ANTIOXID REDOX SIGN, V10, P179, DOI 10.1089/ars.2007.1672; Zakrajsek T, 2011, J PROTEOMICS, V74, P2837, DOI 10.1016/j.jprot.2011.06.026; Zanelli CF, 2006, BIOCHEM BIOPH RES CO, V348, P1358, DOI 10.1016/j.bbrc.2006.07.195	47	14	16	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91434	10.1371/journal.pone.0091434	http://dx.doi.org/10.1371/journal.pone.0091434			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614090	Green Published, gold, Green Submitted			2022-12-27	WOS:000332839300125
J	Lopez, J; Hurwood, D; Dryden, B; Fuller, S				Lopez, Jobina; Hurwood, David; Dryden, Bart; Fuller, Susan			Feral Pig Populations Are Structured at Fine Spatial Scales in Tropical Queensland, Australia	PLOS ONE			English	Article							SUS-SCROFA; PHYLOGENETIC-RELATIONSHIPS; GENETIC-STRUCTURE; DNA; ERADICATION; DISEASE; ORIGIN; PREVALENCE; MANAGEMENT; SOFTWARE	Feral pigs occur throughout tropical far north Queensland, Australia and are a significant threat to biodiversity and World Heritage values, agriculture and are a vector of infectious diseases. One of the constraints on long-lasting, local eradication of feral pigs is the process of reinvasion into recently controlled areas. This study examined the population genetic structure of feral pigs in far north Queensland to identify the extent of movement and the scale at which demographically independent management units exist. Genetic analysis of 328 feral pigs from the Innisfail to Tully region of tropical Queensland was undertaken. Seven microsatellite loci were screened and Bayesian clustering methods used to infer population clusters. Sequence variation at the mitochondrial DNA control region was examined to identify pig breed. Significant population structure was identified in the study area at a scale of 25 to 35 km, corresponding to three demographically independent management units (MUs). Distinct natural or anthropogenic barriers were not found, but environmental features such as topography and land use appear to influence patterns of gene flow. Despite the strong, overall pattern of structure, some feral pigs clearly exhibited ancestry from a MU outside of that from which they were sampled indicating isolated long distance dispersal or translocation events. Furthermore, our results suggest that gene flow is restricted among pigs of domestic Asian and European origin and non-random mating influences management unit boundaries. We conclude that the three MUs identified in this study should be considered as operational units for feral pig control in far north Queensland. Within a MU, coordinated and simultaneous control is required across farms, rainforest areas and National Park Estates to prevent recolonisation from adjacent localities.	[Lopez, Jobina; Hurwood, David; Fuller, Susan] Queensland Univ Technol, Fac Sci & Engn, Brisbane, Qld 4001, Australia; [Dryden, Bart] Terrain Nat Resource Management Ltd, Innisfail, Qld, Australia	Queensland University of Technology (QUT)	Fuller, S (corresponding author), Queensland Univ Technol, Fac Sci & Engn, Brisbane, Qld 4001, Australia.	s.fuller@qut.edu.au	; Hurwood, David/I-9923-2012	Fuller, Susan/0000-0003-4399-0166; Hurwood, David/0000-0001-9143-360X	TerrainNRM	TerrainNRM	TerrainNRM funded this project and provided tissue samples. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelkrim J, 2005, CONSERV BIOL, V19, P1509, DOI 10.1111/j.1523-1739.2005.00206.x; Alexander LJ, 1996, ANIM GENET, V27, P137, DOI 10.1111/j.1365-2052.1996.tb00941.x; [Anonymous], 1996, MANAGING VERTEBRATE; Caley P, 1997, WILDLIFE RES, V24, P77, DOI 10.1071/WR94075; Caley P, 1993, THESIS U CANBERRA; CAMPBELL NJH, 1995, MOL ECOL, V4, P407, DOI 10.1111/j.1365-294X.1995.tb00234.x; CHOQUENOT D, 1993, WILDLIFE RES, V20, P15, DOI 10.1071/WR9930015; Cowled BD, 2008, CONSERV GENET, V9, P211, DOI 10.1007/s10592-007-9331-1; Cowled BD, 2006, J WILDLIFE MANAGE, V70, P1690, DOI 10.2193/0022-541X(2006)70[1690:MTDAGE]2.0.CO;2; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Giuffra E, 2000, GENETICS, V154, P1785; Giuffra E, 2002, MAMM GENOME, V13, P569, DOI 10.1007/s00335-002-2184-5; Gongora J, 2004, MOL PHYLOGENET EVOL, V33, P339, DOI 10.1016/j.ympev.2004.06.004; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hampton JO, 2004, J APPL ECOL, V41, P735, DOI 10.1111/j.0021-8901.2004.00936.x; Hampton J, 2006, ECOHEALTH, V3, P103, DOI 10.1007/s10393-006-0018-8; HONE J, 1983, AUST WILDLIFE RES, V10, P269; Hone J, 2002, BIOL CONSERV, V105, P231, DOI 10.1016/S0006-3207(01)00185-9; Kim KI, 2002, ANIM GENET, V33, P19, DOI 10.1046/j.1365-2052.2002.00784.x; LETTS G. A., 1962, Australian Veterinary Journal, V38, P282, DOI 10.1111/j.1751-0813.1962.tb04032.x; Luetkemeier ES, 2010, MOL PHYLOGENET EVOL, V54, P680, DOI 10.1016/j.ympev.2009.11.004; Manel S, 2005, TRENDS ECOL EVOL, V20, P136, DOI 10.1016/j.tree.2004.12.004; McInerney J, 1995, AUST VET J, V72, P448, DOI 10.1111/j.1751-0813.1995.tb03486.x; MEYER A, 1990, NATURE, V347, P550, DOI 10.1038/347550a0; MILLER B, 1985, BIOL CONSERV, V34, P55, DOI 10.1016/0006-3207(85)90057-6; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mitchell J, 2009, WILDLIFE RES, V36, P110, DOI 10.1071/WR06066; Mitchell J, 2003, THESIS J COOK U; MITCHELL J, 1993, SYSTEMATIC ASSESSMEN; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; PAVLOV PM, 1992, WILDLIFE RES, V19, P179, DOI 10.1071/WR9920179; PAVLOV PM, 1981, AUST J EXP AGR, V21, P570, DOI 10.1071/EA9810570; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; PECH RP, 1988, J APPL ECOL, V25, P63, DOI 10.2307/2403610; Pritchard JK, 2000, GENETICS, V155, P945; PULLAR E. M., 1950, AUSTRALIAN VET JOUR, V26, P99, DOI 10.1111/j.1751-0813.1950.tb04901.x; Pullar EM, 1953, MEMOIRS NATL MUSEUM; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rekwot PI, 2001, ANIM REPROD SCI, V65, P157, DOI 10.1016/S0378-4320(00)00223-2; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Robertson BC, 2004, J APPL ECOL, V41, P1042, DOI 10.1111/j.0021-8901.2004.00984.x; Spencer P. B. S., 2004, ECOLOGICAL MANAGEMEN, V5, P231, DOI [10.1111/j.1442-8903.2004.209-9.x, DOI 10.1111/J.1442-8903.2004.209-9.X]; Spencer PBS, 2005, J WILDLIFE MANAGE, V69, P377, DOI 10.2193/0022-541X(2005)069&lt;0377:ITAGSO&gt;2.0.CO;2; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON RCA, 1988, AUST VET J, V65, P188, DOI 10.1111/j.1751-0813.1988.tb14298.x; Tisdell C., 1984, Tigerpaper (Bangkok), V11, P13; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Watanabe T, 2001, J MOL EVOL, V52, P281, DOI 10.1007/s002390010156; Watanobe T, 1999, MOL ECOL, V8, P1509, DOI 10.1046/j.1365-294x.1999.00729.x; Wurster CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043538	52	9	9	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91657	10.1371/journal.pone.0091657	http://dx.doi.org/10.1371/journal.pone.0091657			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614160	Green Published, Green Submitted, gold			2022-12-27	WOS:000332839300147
J	Mutinda, M; Chenge, G; Gakuya, F; Otiende, M; Omondi, P; Kasiki, S; Soriguer, RC; Alasaad, S				Mutinda, Matthew; Chenge, Geoffrey; Gakuya, Francis; Otiende, Moses; Omondi, Patrick; Kasiki, Samuel; Soriguer, Ramon C.; Alasaad, Samer			Detusking Fence-Breaker Elephants as an Approach in Human-Elephant Conflict Mitigation	PLOS ONE			English	Article							CROP-RAIDING ELEPHANTS; SELECTION; WILDLIFE; CHOICE	Background: Human-elephant conflict (HEC) is a recurring problem that appears wherever the range of elephants and humans overlap. Different methods including the use of electric fences are used worldwide to mitigate this conflict. Nonetheless, elephants learn quickly that their tusks do not conduct electricity and use them to break down fences (fence-breakers). Methodology/Principal Findings: In Lewa Wildlife Conservancy, Kenya, destructive elephants (Loxodonta africana) were monitored between 2010 and 2013. The fence-breaking rate reached four incidents (fence-breaking) per elephant per 100 days. Ten bull males and 57 females were identified as fence-breakers. The bulls were involved in 85.07% and the females in 14.93% of incidents. The Kenya Wildlife Service approved detusking (partial cutting of tusks) in four of the 10 fence-breakers as a way of preventing them from breaking down fences, thereby mitigating HEC in the Conservancy. The result of the detusking was a drastic six-fold reduction in damage to fences (range: 1.67 to 14.5 times less fence-breaking) by the four worst fence-breaker elephants, because with trimmed tusks elephants lack the tools to break down fences. Detusking could not totally eliminate fence destruction because, despite lacking their tools, elephants can still destroy fences using their heads, bodies and trunks, albeit less effectively. On the other hand, apart from inherent aesthetic considerations, the detusking of elephants may have certain negative effects on factors such as elephants' social hierarchies, breeding, mate selection and their access to essential minerals and food. Conclusions: Elephant detusking seems to be effective in drastically reducing fence-breaking incidents, nonetheless its negative effects on behaviour, access to food and its aesthetical consequences still need to be further studied and investigated.	[Mutinda, Matthew; Gakuya, Francis; Otiende, Moses; Omondi, Patrick; Kasiki, Samuel] Kenya Wildlife Serv, Nairobi, Kenya; [Chenge, Geoffrey] Lewa Wildlife Conservancy, Isiolo, Kenya; [Soriguer, Ramon C.; Alasaad, Samer] CSIC, Estn Biol Donana, E-41080 Seville, Spain; [Alasaad, Samer] Univ Zurich, Inst Evolutionary Biol & Environm Studies IEU, Zurich, Switzerland	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); University of Zurich	Mutinda, M (corresponding author), Kenya Wildlife Serv, Nairobi, Kenya.	mmutinda@kws.go.ke; sameralasaad@hotmail.com	Soriguer, Ramon/J-1494-2014; Angelone, Samer/G-4727-2013	Soriguer, Ramon/0000-0002-9165-7766; Angelone, Samer/0000-0003-0868-7276				ALLEN JL, 1984, J AM VET MED ASSOC, V185, P1447; Allendorf FW, 2009, P NATL ACAD SCI USA, V106, P9987, DOI 10.1073/pnas.0901069106; [Anonymous], 2011, KWS REP; Archie EA, 2012, MOL ECOL, V21, P765, DOI 10.1111/j.1365-294X.2011.05237.x; Athreya V., 2006, CONSERV SOC, V4, P419; Balfour D., 2007, REV OPTIONS MANAGING; Beringer J, 2002, WILDLIFE SOC B, V30, P767; Bouche P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020619; Chiyo PI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031382; Corti P, 2002, CAN J ZOOL, V80, P2108, DOI [10.1139/z02-207, 10.1139/Z02-207]; Dickman AJ, 2010, ANIM CONSERV, V13, P458, DOI 10.1111/j.1469-1795.2010.00368.x; Frynta D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063110; Gakuya F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043342; Graham M., 2009, TRIALS FARM BASED DE; GRAHAM MD, 2009, 1 LAIK EL PROJ; Hedges S, 2010, ORYX, V44, P139, DOI 10.1017/S0030605309990093; Hoare, 1999, STANDARDISED DATA CO; HOARE R, 1995, PACHYDERM, V19, P54; JENKINS PR, 1982, LAIKIPIA ELEPHANT PR; Jones AG, 2009, P NATL ACAD SCI USA, V106, P10001, DOI 10.1073/pnas.0901129106; King LE, 2011, AFR J ECOL, V49, P431, DOI 10.1111/j.1365-2028.2011.01275.x; Kioko J, 2008, S AFR J WILDL RES, V38, P52, DOI 10.3957/0379-4369-38.1.52; Loarie SR, 2009, BIOL CONSERV, V142, P3086, DOI 10.1016/j.biocon.2009.08.008; Mijele D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071179; Moss C, 2013, TRUTH TUSKS; Nelson A., 2003, REV HUMAN ELEPHANT C; NEWMARK WD, 1994, CONSERV BIOL, V8, P249, DOI 10.1046/j.1523-1739.1994.08010249.x; Ngene S, 2009, PACHYDERM, V45, P77; Ngene S, 2010, THESIS U TWENTE NETH; Okech RN, 2010, AFR J CONFL RESOLUT, V10, P65; Osborn FV, 2003, ORYX, V37, P80, DOI 10.1017/S0030605303000152; Osborn FV, 2004, AFR J ECOL, V42, P322, DOI 10.1111/j.1365-2028.2004.00531.x; Parker G. E., 2007, HUMAN ELEPHANT CONFL; Pelletier F, 2004, ANIM BEHAV, V67, P1163, DOI 10.1016/j.anbehav.2003.07.009; POOLE JH, 1989, ANIM BEHAV, V37, P842, DOI 10.1016/0003-3472(89)90068-7; R Core Team, 2018, R LANG ENV STAT COMP; Rode KD, 2006, J TROP ECOL, V22, P441, DOI 10.1017/S0266467406003233; THOULESS CR, 1995, BIOL CONSERV, V72, P99, DOI 10.1016/0006-3207(94)00071-W; Vollrath F, 2002, NATURWISSENSCHAFTEN, V89, P508, DOI 10.1007/s00114-002-0375-2; Wambwa Elizabeth, 2001, Pachyderm, V31, P58; WEIR JS, 1969, J ZOOL, V158, P293	41	23	24	2	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91749	10.1371/journal.pone.0091749	http://dx.doi.org/10.1371/journal.pone.0091749			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614538	Green Published, gold, Green Submitted			2022-12-27	WOS:000332839300154
J	Schmitz, AMT; Oudejans, JJ; Gilhuijs, KGA				Schmitz, Alexander M. Th; Oudejans, Joost J.; Gilhuijs, Kenneth G. A.			Agreement on Indication for Systemic Therapy between Biopsied Tissue and Surgical Excision Specimens in Breast Cancer Patients	PLOS ONE			English	Article							PATHOLOGICAL PROGNOSTIC-FACTORS; CONSERVING THERAPY; CORE BIOPSIES; NODE BIOPSY; TUMOR SIZE; FOLLOW-UP; TRIAL; ULTRASOUND; ABLATION; CARCINOMA	Purpose: In breast cancer therapy, the indication for systemic therapy is typically based on prognostic markers from the surgical excision specimen. If such is unavailable, for instance prior to tumor ablation therapy, the indication for adjuvant systemic therapy may be assessed from pretreatment biopsies. The effect of differences in tumor characteristics between biopsy and excision specimen on agreement in indication for systemic therapy is, however, largely unknown. The aim of this study is to determine the agreement in eligibility for systemic therapy between preoperative and postoperative assessment. Secondly, to identify which patient-, tumor-or lymph node characteristics may influence this agreement. Materials and Methods: In this retrospective study, 300 consecutive female patients with primary invasive breast carcinoma on biopsy were included. Indication for systemic therapy was determined separately from biopsied tissue and from excision specimens using national guidelines based on adjuvant! online. Agreement was assessed, and patient-, tumor-and lymph node characteristics affecting agreement analyzed. Results: Agreement in tumor characteristics between biopsy and excision specimen varied from high (ER-status: 99%), to lower (tumor grade: 62%, tumor size: 59%, and lymph node status: 67%). Without preoperative sentinel node biopsy (SNB), agreement on systemic therapy exists in 77% of patients (kappa = 0,547). Positive pretreatment indication for systemic therapy was highly indicative of the postoperative indication (PPV = 94%). Negative indication was, however, only indicative in 67% of patients. Conversely, with preoperative SNB, agreement on negative indication was raised to 89%. Agreement was especially high for ER-negative status, tumor grade 3, tumor size > 2 cm, lymph node positivity at biopsy and a negative preoperative SNB. Conclusions: A positive indication for systemic therapy from biopsy is highly indicative for a positive indication from the excision specimen. When the indication is negative, additional stratification using preoperative SNB raises the agreement. Still, discordance occurs in 1 out of 10 patients.	[Schmitz, Alexander M. Th; Gilhuijs, Kenneth G. A.] Univ Med Ctr Utrecht, Image Sci Inst, Dept Radiol, Utrecht, Netherlands; [Oudejans, Joost J.] Diakonessen Hosp, Dept Pathol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Diakonessenhuis	Gilhuijs, KGA (corresponding author), Univ Med Ctr Utrecht, Image Sci Inst, Dept Radiol, Utrecht, Netherlands.	k.g.a.gilhuijs@umcutrecht.nl		Oudejans, Joost/0000-0003-3162-5516	Dutch Pink Ribbon Foundation [9684, 2011.WO36]	Dutch Pink Ribbon Foundation	The study was conducted with financial support of The Dutch Pink Ribbon Foundation (www.pinkribbon.nl), grant number 9684, 2011.WO36. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badoual C, 2005, BREAST, V14, P22, DOI 10.1016/j.breast.2004.07.005; Bartelink H, 2007, J CLIN ONCOL, V25, P3259, DOI 10.1200/JCO.2007.11.4991; Bosch AM, 2003, EUR J RADIOL, V48, P285, DOI 10.1016/S0720-048X(03)00081-0; Bueno-de-Mesquita JM, ANN ONCOL, V21, P40; Burge CN, 2006, BREAST, V15, P167, DOI 10.1016/j.breast.2005.06.004; Cahill RA, 2006, ANN SURG ONCOL, V13, P45, DOI 10.1245/ASO.2006.03.047; de Kanter AY, 1999, BRIT J SURG, V86, P1459, DOI 10.1046/j.1365-2168.1999.01243.x; Deurloo EE, 2003, EUR J CANCER, V39, P1068, DOI 10.1016/S0959-8049(02)00748-7; Douglas-Jones AG, 2001, J CLIN PATHOL, V54, P951, DOI 10.1136/jcp.54.12.951; Esteva FJ, 2004, BREAST CANCER RES, V6, P109, DOI 10.1186/bcr777; Fisher B, 2002, NEW ENGL J MED, V347, P1233, DOI 10.1056/NEJMoa022152; Gianfelice D, 2003, RADIOLOGY, V227, P849, DOI 10.1148/radiol.2281012163; Giuliano AE, 2011, JAMA-J AM MED ASSOC, V305, P569, DOI 10.1001/jama.2011.90; Harris GC, 2003, AM J SURG PATHOL, V27, P11, DOI 10.1097/00000478-200301000-00002; Kuenen-Boumeester V, 2003, EUR J CANCER, V39, P170, DOI 10.1016/S0959-8049(02)00501-4; Kuhl C, 2007, RADIOLOGY, V244, P356, DOI 10.1148/radiol.2442051620; Kuhl CK, 2007, RADIOLOGY, V244, P672, DOI 10.1148/radiol.2443051661; Luparia A, 2013, RADIOL MED; Mook S, LANCET ONCOL, V10, P1070; Naik AM, 2004, ANN SURG, V240, P462, DOI 10.1097/01.sla.0000137130.23530.19; Nichols EM, 2010, INT J RADIAT ONCOL, V77, P197, DOI 10.1016/j.ijrobp.2009.04.063; O'Leary R, 2004, J CLIN PATHOL, V57, P193, DOI 10.1136/jcp.2003.12914; Olivotto IA, J CLIN ONCOL, V23, P2716; Onesti JK, 2008, AM J SURG, V196, P844, DOI 10.1016/j.amjsurg.2008.07.028; Palta M, 2012, INT J RADIAT ONCOL, V82, P37, DOI 10.1016/j.ijrobp.2010.09.041; Postma EL, 2013, EUR J PHARM; Rakha EA, J CLIN ONCOL, V26, P3153; Ravdin PM, J CLIN ONCOL, V19, P980; Sabel MS, 2004, ANN SURG ONCOL, V11, P542, DOI 10.1245/ASO.2004.08.003; Schmitz AC, 2008, EUR RADIOL, V18, P1431, DOI 10.1007/s00330-008-0906-0; Sharifi S, 1999, MODERN PATHOL, V12, P941; van den Bosch M, 2008, J MAGN RESON IMAGING, V27, P204, DOI 10.1002/jmri.21190; van Dongen JA, 2000, JNCI-J NATL CANCER I, V92, P1143, DOI 10.1093/jnci/92.14.1143; VERONESI U, 1995, EUR J CANCER, V31A, P1574, DOI 10.1016/0959-8049(95)00271-J; Wishart GC, BR J CANC, V107, P800; Zhao Z, 2010, EJSO-EUR J SURG ONC, V36, P1149, DOI 10.1016/j.ejso.2010.09.012	36	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91439	10.1371/journal.pone.0091439	http://dx.doi.org/10.1371/journal.pone.0091439			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614128	Green Published, gold, Green Submitted			2022-12-27	WOS:000332839300126
J	Franco, FP; Santiago, AC; Henrique-Silva, F; de Castro, PA; Goldman, GH; Moura, DS; Silva-Filho, MC				Franco, Flavia P.; Santiago, Adelita C.; Henrique-Silva, Flavio; de Castro, Patricia Alves; Goldman, Gustavo H.; Moura, Daniel S.; Silva-Filho, Marcio C.			The Sugarcane Defense Protein SUGARWIN2 Causes Cell Death in Colletotrichum falcatum but Not in Non-Pathogenic Fungi	PLOS ONE			English	Article							PATHOGENESIS-RELATED PROTEIN; EUROPEAN CORN-BORER; ASPERGILLUS-NIDULANS; ANTIFUNGAL ACTIVITY; NEUROSPORA-CRASSA; PR-4 PROTEINS; WHEAT; GENE; GROWTH; LEPIDOPTERA	Plants respond to pathogens and insect attacks by inducing and accumulating a large set of defense-related proteins. Two homologues of a barley wound-inducible protein (BARWIN) have been characterized in sugarcane, SUGARWIN1 and SUGARWIN2 (sugarcane wound-inducible proteins). Induction of SUGARWINs occurs in response to Diatraea saccharalis damage but not to pathogen infection. In addition, the protein itself does not show any effect on insect development; instead, it has antimicrobial activities toward Fusarium verticillioides, an opportunistic fungus that usually occurs after D. saccharalis borer attacks on sugarcane. In this study, we sought to evaluate the specificity of SUGARWIN2 to better understand its mechanism of action against phytopathogens and the associations between fungi and insects that affect plants. We used Colletotrichum falcatum, a fungus that causes red rot disease in sugarcane fields infested by D. saccharalis, and Ceratocystis paradoxa, which causes pineapple disease in sugarcane. We also tested whether SUGARWIN2 is able to cause cell death in Aspergillus nidulans, a fungus that does not infect sugarcane, and in the model yeast Saccharomyces cerevisiae, which is used for bioethanol production. Recombinant SUGARWIN2 altered C. falcatum morphology by increasing vacuolization, points of fractures and a leak of intracellular material, leading to germling apoptosis. In C. paradoxa, SUGARWIN2 showed increased vacuolization in hyphae but did not kill the fungi. Neither the non-pathogenic fungus A. nidulans nor the yeast S. cerevisiae was affected by recombinant SUGARWIN2, suggesting that the protein is specific to sugarcane opportunistic fungal pathogens.	[Franco, Flavia P.; Silva-Filho, Marcio C.] Univ Sao Paulo, Dept Genet, Escola Super Agr Luiz de Queiroz, Piracicaba, SP, Brazil; [Santiago, Adelita C.; Henrique-Silva, Flavio] Univ Fed Sao Carlos, Dept Genet & Evolucao, BR-13560 Sao Carlos, SP, Brazil; [de Castro, Patricia Alves; Goldman, Gustavo H.] Univ Sao Paulo, Fac Ciencias Farmaceut, BR-14049 Ribeirao Preto, SP, Brazil; [Goldman, Gustavo H.] Lab Nacl Ciencia & Tecnol Bioetanol CTBE, Campinas, SP, Brazil; [Moura, Daniel S.] Univ Sao Paulo, Escola Super Agr Luiz de Queiroz, Dept Ciencias Biol, Piracicaba, SP, Brazil	Universidade de Sao Paulo; Universidade Federal de Sao Carlos; Universidade de Sao Paulo; Universidade de Sao Paulo	Silva-Filho, MC (corresponding author), Univ Sao Paulo, Dept Genet, Escola Super Agr Luiz de Queiroz, Piracicaba, SP, Brazil.	mdcsilva@usp.br	Henrique-Silva, Flavio/A-1937-2013; Silva-Filho, Marcio/F-2639-2012; Goldman, Gustavo Henrique/F-1848-2013; Santiago, Adelita Carolina/R-9825-2017; Franco, Flávia Pereira/C-5795-2016; Moura, Daniel S/D-6673-2012	Silva-Filho, Marcio/0000-0003-2129-0388; Goldman, Gustavo Henrique/0000-0002-2986-350X; Franco, Flávia Pereira/0000-0003-3739-8625; Moura, Daniel S/0000-0003-2042-1403	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [08/52067-3]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [474542/2010-6]; Instituto Nacional de Ciencia e Tecnologia do Bioetanol [574002/2008-1]; FAPESP [08/57908-6]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Nacional de Ciencia e Tecnologia do Bioetanol; FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) grant 08/52067-3, the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) grant 474542/2010-6, and the Instituto Nacional de Ciencia e Tecnologia do Bioetanol grant 574002/2008-1 and FAPESP 08/57908-6. M. C. Silva-Filho, G. H. Goldman, F. Henrique-Silva and D. S. Moura are also research fellows of CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS TH, 1992, MOL CELL BIOL, V12, P3827, DOI 10.1128/MCB.12.9.3827; Bai SH, 2013, PLANT PHYSIOL BIOCH, V62, P23, DOI 10.1016/j.plaphy.2012.10.016; Banno S, 2005, GENES GENET SYST, V80, P25, DOI 10.1266/ggs.80.25; Bertini L, 2003, PLANT SCI, V164, P1067, DOI 10.1016/S0168-9452(03)00112-2; Bertini L, 2006, BIOL CHEM, V387, P1101, DOI 10.1515/BC.2006.136; Bertini L, 2009, FEBS LETT, V583, P2865, DOI 10.1016/j.febslet.2009.07.045; BOYLAN MT, 1987, MOL CELL BIOL, V7, P3113, DOI 10.1128/MCB.7.9.3113; Bravo JM, 2003, PLANT MOL BIOL, V52, P745, DOI 10.1023/A:1025016416951; Calvo AM, 2002, MICROBIOL MOL BIOL R, V66, P447, DOI 10.1128/MMBR.66.3.447-459.2002; Caporale C, 2004, FEBS LETT, V575, P71, DOI 10.1016/j.febslet.2004.07.091; Caporale C, 2003, J MOL MODEL, V9, P9, DOI 10.1007/s00894-002-0103-z; CARRUTHERS RI, 1986, ANN ENTOMOL SOC AM, V79, P385, DOI 10.1093/aesa/79.3.385; Caruso C, 2001, J PROTEIN CHEM, V20, P327, DOI 10.1023/A:1010905802749; Cui JP, 2002, PLANT PHYSIOL, V129, P551, DOI 10.1104/pp.010815; Ericsson M, 2000, J BACTERIOL, V182, P5551, DOI 10.1128/JB.182.19.5551-5555.2000; Falco MC, 2001, GENET MOL BIOL, V24, P113, DOI 10.1590/S1415-47572001000100016; Gatch EW, 2002, PLANT DIS, V86, P1156, DOI 10.1094/PDIS.2002.86.10.1156; Guest GM, 2004, FUNGAL GENET BIOL, V41, P13, DOI 10.1016/j.fgb.2003.08.006; HEJGAARD J, 1992, FEBS LETT, V307, P389, DOI 10.1016/0014-5793(92)80720-2; Jeong HY, 2003, FUNGAL GENET BIOL, V38, P228, DOI 10.1016/S1087-1845(02)00527-3; Kays AM, 2000, MOL CELL BIOL, V20, P7693, DOI 10.1128/MCB.20.20.7693-7705.2000; Kempel A, 2010, FUNCT ECOL, V24, P293, DOI 10.1111/j.1365-2435.2009.01647.x; LEE BN, 1994, MOL MICROBIOL, V14, P323, DOI 10.1111/j.1365-2958.1994.tb01293.x; Li SJ, 2006, MOL MICROBIOL, V62, P1418, DOI 10.1111/j.1365-2958.2006.05447.x; Li XD, 2010, MOL BIOL REP, V37, P995, DOI 10.1007/s11033-009-9783-0; Lu HC, 2012, PLANT PHYSIOL BIOCH, V56, P1, DOI 10.1016/j.plaphy.2012.04.004; Luchi N, 2012, FOREST PATHOL, V42, P246, DOI 10.1111/j.1439-0329.2011.00750.x; Ludovico P, 2001, MICROBIOL-SGM, V147, P3335, DOI 10.1099/00221287-147-12-3335; Madeo F, 1997, J CELL BIOL, V139, P729, DOI 10.1083/jcb.139.3.729; Madeo F, 1999, J CELL BIOL, V145, P757, DOI 10.1083/jcb.145.4.757; Madigan MT, 2000, BROCK BIOL MICROBIOL; MARHOUL JF, 1995, GENETICS, V139, P537; McFarlane SA, 2009, ANN APPL BIOL, V155, P349, DOI 10.1111/j.1744-7348.2009.00345.x; McKaig N, 1936, J AGRIC RES, V52, P0017; Medeiros AH, 2012, MOL PLANT MICROBE IN, V25, P613, DOI 10.1094/MPMI-09-11-0254; Mello M. L. S., 2007, CELULA; MIAN AA, 1969, CAN J CHEM ENG, V47, P499, DOI 10.1002/cjce.5450470517; MONHEIT JE, 1984, ARCH PATHOL LAB MED, V108, P616; NIDERMAN T, 1995, PLANT PHYSIOL, V108, P17, DOI 10.1104/pp.108.1.17; OGUNWOLU EO, 1991, CROP PROT, V10, P57, DOI 10.1016/0261-2194(91)90027-O; PONSTEIN AS, 1994, PLANT PHYSIOL, V104, P109, DOI 10.1104/pp.104.1.109; SCHLUMBAUM A, 1986, NATURE, V324, P365, DOI 10.1038/324365a0; Shimizu K, 2001, GENETICS, V157, P591; SVENSSON B, 1992, BIOCHEMISTRY-US, V31, P8767, DOI 10.1021/bi00152a012; Talukder M. I., 2007, Journal of Agriculture & Rural Development (Gazipur), V5, P79; Van der Ent S, 2009, PHYTOCHEMISTRY, V70, P1581, DOI 10.1016/j.phytochem.2009.06.009; Van Wees SCM, 2008, CURR OPIN PLANT BIOL, V11, P443, DOI 10.1016/j.pbi.2008.05.005; von Burg S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046333; WESSELS JGH, 1993, NEW PHYTOL, V123, P397, DOI 10.1111/j.1469-8137.1993.tb03751.x; Zhu T, 2006, J PHYTOPATHOL, V154, P378, DOI 10.1111/j.1439-0434.2006.01110.x	50	14	15	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91159	10.1371/journal.pone.0091159	http://dx.doi.org/10.1371/journal.pone.0091159			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608349	gold, Green Published, Green Submitted			2022-12-27	WOS:000332485800109
J	Star, B; Nederbragt, AJ; Hansen, MHS; Skage, M; Gilfillan, GD; Bradbury, IR; Pampoulie, C; Stenseth, NC; Jakobsen, KS; Jentoft, S				Star, Bastiaan; Nederbragt, Alexander J.; Hansen, Marianne H. S.; Skage, Morten; Gilfillan, Gregor D.; Bradbury, Ian R.; Pampoulie, Christophe; Stenseth, Nils Chr; Jakobsen, Kjetill S.; Jentoft, Sissel			Palindromic Sequence Artifacts Generated during Next Generation Sequencing Library Preparation from Historic and Ancient DNA	PLOS ONE			English	Article							GENOME SEQUENCE; NEANDERTHAL; DAMAGE; PATTERNS; REVEALS; SYSTEM	Degradation-specific processes and variation in laboratory protocols can bias the DNA sequence composition from samples of ancient or historic origin. Here, we identify a novel artifact in sequences from historic samples of Atlantic cod (Gadus morhua), which forms interrupted palindromes consisting of reverse complementary sequence at the 5' and 3'-ends of sequencing reads. The palindromic sequences themselves have specific properties - the bases at the 5'-end align well to the reference genome, whereas extensive misalignments exists among the bases at the terminal 3'-end. The terminal 3' bases are artificial extensions likely caused by the occurrence of hairpin loops in single stranded DNA (ssDNA), which can be ligated and amplified in particular library creation protocols. We propose that such hairpin loops allow the inclusion of erroneous nucleotides, specifically at the 3'-end of DNA strands, with the 5'-end of the same strand providing the template. We also find these palindromes in previously published ancient DNA (aDNA) datasets, albeit at varying and substantially lower frequencies. This artifact can negatively affect the yield of endogenous DNA in these types of samples and introduces sequence bias.	[Star, Bastiaan; Nederbragt, Alexander J.; Hansen, Marianne H. S.; Skage, Morten; Stenseth, Nils Chr; Jakobsen, Kjetill S.; Jentoft, Sissel] Univ Oslo, Dept Biosci, CEES, Oslo, Norway; [Gilfillan, Gregor D.] Oslo Univ Hosp, Dept Med Genet, Oslo, Norway; [Bradbury, Ian R.] Fisheries & Oceans Canada, St John, NF, Canada; [Pampoulie, Christophe] Marine Res Inst, IS-121 Reykjavik, Iceland	University of Oslo; University of Oslo; Fisheries & Oceans Canada; Marine & Freshwater Research Institute (MFRI)	Star, B (corresponding author), Univ Oslo, Dept Biosci, CEES, Oslo, Norway.	bastiaan.star@ibv.uio.no	Gilfillan, Gregor Duncan/N-9541-2019; Stenseth, Nils Chr./G-5212-2016	Stenseth, Nils Chr./0000-0002-1591-5399; Jentoft, Sissel/0000-0001-8707-531X; Star, Bastiaan/0000-0003-0235-9810; Nederbragt, Lex/0000-0001-5539-0999; Christophe, Pampoulie/0000-0001-6425-9060; Gilfillan, Gregor/0000-0001-8116-0134	Norwegian Research Council [203850/E40]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	This work was supported by the Norwegian Research Council under the project, "Fisheries induced evolution in Atlantic cod investigated by ancient and historic samples (#203850/E40)". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Briggs AW, 2007, P NATL ACAD SCI USA, V104, P14616, DOI 10.1073/pnas.0704665104; Briggs AW, 2009, SCIENCE, V325, P318, DOI 10.1126/science.1174462; Dabney J, 2012, BIOTECHNIQUES, V52, P87, DOI 10.2144/000113809; Gansauge MT, 2013, NAT PROTOC, V8, P737, DOI 10.1038/nprot.2013.038; Ginolhac A, 2011, BIOINFORMATICS, V27, P2153, DOI 10.1093/bioinformatics/btr347; Green RE, 2008, CELL, V134, P416, DOI 10.1016/j.cell.2008.06.021; Green RE, 2009, EMBO J, V28, P2494, DOI 10.1038/emboj.2009.222; Jonsson H, 2013, BIOINFORMATICS, V29, P1682, DOI 10.1093/bioinformatics/btt193; Kibbe WA, 2007, NUCLEIC ACIDS RES, V35, pW43, DOI 10.1093/nar/gkm234; Krause J, 2010, NATURE, V464, P894, DOI 10.1038/nature08976; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lindgreen Stinus, 2012, BMC Res Notes, V5, P337, DOI 10.1186/1756-0500-5-337; Meyer M., 2010, COLD SPRING HARBOR P, V2010, DOI 10.1101/pdb.prot5448; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Milne I, 2013, BRIEF BIOINFORM, V14, P193, DOI 10.1093/bib/bbs012; Orlando L, 2011, GENOME RES, V21, P1705, DOI 10.1101/gr.122747.111; Overballe-Petersen S, 2012, TRENDS BIOTECHNOL, V30, P364, DOI 10.1016/j.tibtech.2012.03.007; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; Quail MA, 2008, NAT METHODS, V5, P1005, DOI 10.1038/nmeth.1270; Rasmussen M, 2011, SCIENCE, V334, P94, DOI 10.1126/science.1211177; Rasmussen M, 2010, NATURE, V463, P757, DOI 10.1038/nature08835; Schubert M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-178; Seguin-Orlando A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078575; Sinding M-HS, 2012, J ARCHAEOLOGICAL SCI; Star B, 2011, NATURE, V477, P207, DOI 10.1038/nature10342	25	17	17	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e89676	10.1371/journal.pone.0089676	http://dx.doi.org/10.1371/journal.pone.0089676			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608104	Green Published, Green Submitted, gold			2022-12-27	WOS:000332485800005
J	Tamam, OAS				Tamam, Omar A. S.			The Aetiology, Histopathology, and Ultrastructural Features of Perianal Erythema (Red Anus Syndrome) in the European Eel (Anguilla anguilla)	PLOS ONE			English	Article							LIFE-CYCLE; CRASSUS; PREVALENCE; INFECTION; PARASITES; NEMATODE; FISH	The European eel (Anguilla anguilla) is a critically endangered species. Red anus syndrome (RAS) is known to be associated with parasitic infections of the eel, particularly with Anguillicola crassus, but the full range of causative pathogenic organisms has not been systematically investigated. Here we examined the infective organisms and histopathological and ultrastructural features of seventy eels with RAS. In total, nine different pathogens were detected in association with RAS: Pseudomonas aeruginosa were present in twelve specimens (17%), the metacercaria of Euclinostromum heterostomum in three cases (4%), Gastrostome (Bucephalidae family) in seven cases (10%), A. crassus in forty-five cases (64%), Bothriocephalus in seventeen cases (24%), and Proteocephalus in twenty-three cases (32%). Yeast, amoeba, and myxobolus-like pathogens were seen in the anal skin in all cases when examined in combination with electron microscopy. Histopathologically, the lesions appeared as anoproctitis of varying severity from mild anusitis to severe haemorrhagic anoproctitis, with severe perianal oedema, haemorrhage, and proctoptosis. Gut inflammation ranged from mild catarrhal enteritis to severe haemorrhagic enteritis with mucosal sloughing. RAS is associated with a range of parasitic infections, not only A. crassus, some of which we describe here for the first time. Since RAS is not associated with direct invasion by parasites, it is likely that RAS is a secondary phenomenon caused by superadded infection on a background of generalised immunosuppression, or indirect local toxic effects. RAS may be used as a non-invasive indicator of underlying parasitic infection, but further investigations are required to establish the causative organisms for effective fishery management.	Univ Sadat City, Environm Studies & Res Inst, Dept Nat Resources, Sadat City, Egypt	Egyptian Knowledge Bank (EKB); University of Sadat City	Tamam, OAS (corresponding author), Univ Sadat City, Environm Studies & Res Inst, Dept Nat Resources, Sadat City Campus, Sadat City, Egypt.	Otamam2002@hotmail.com						Abdelmonem AA, 2010, PARASITOL RES, V106, P463, DOI 10.1007/s00436-009-1688-2; Banning PV, 1990, EFFECTS SWIMBLADDER, P317; Buller N. B., 2004, Bacteria from fish and other aquatic animals: a practical identification manual, DOI [10.1079/9780851997384.0137, 10.1079/9780851997384.0000]; COPLAND JW, 1982, J FISH DIS, V5, P549, DOI 10.1111/j.1365-2761.1982.tb00516.x; Crean SR, 2003, J FISH BIOL, V62, P482, DOI 10.1046/j.1095-8649.2003.00034.x; Culling CFA, 1974, HDB HISTOPATHOLOGICA, V3rd; Fernando CH, 1972, U WATERLOO SERIES; Fingold S, 1982, BAILEY SCOTTS DIAGNO, P128; Hedrick RP, 2002, AM FISH S S, V29, P45; HOGLUND J, 1992, J FISH DIS, V15, P507, DOI 10.1111/j.1365-2761.1992.tb00682.x; Jhansilakshmibai K, 1997, SYST PARASITOL, V38, P51, DOI 10.1023/A:1005829625739; Kennedy CR, 2007, J FISH DIS, V30, P319, DOI 10.1111/j.1365-2761.2007.00821.x; KENNEDY CR, 1990, J FISH BIOL, V36, P117, DOI 10.1111/j.1095-8649.1990.tb05588.x; Lucky Z., 1977, METHODS DIAGNOSIS FI; MELLERGAARD S, 1987, AQUACULTURE, V67, P139, DOI 10.1016/0044-8486(87)90019-6; MOLNAR K, 1986, Journal of Applied Ichthyology, V2, P42, DOI 10.1111/j.1439-0426.1986.tb00428.x; PILCHER MW, 1993, J FISH BIOL, V43, P339, DOI 10.1006/jfbi.1993.1135; Roberts RJ., 2012, FISH PATHOL, V4, DOI [10.1002/9781118222942, DOI 10.1002/9781118222942]; Rodjuk Galina, 2006, Wiadomosci Parazytologiczne, V52, P121; Scholz T, 1998, FOLIA PARASIT, V45, P27; Thune Ronald L., 1993, Annual Review of Fish Diseases, V3, P37, DOI 10.1016/0959-8030(93)90028-A; TRUST TJ, 1986, ANNU REV MICROBIOL, V40, P479, DOI 10.1146/annurev.mi.40.100186.002403; Wardle RA, 1952, ZOOLOGY TAPEWORMS TA; Woo PTK, 1995, FISH DIS DISORDERS, V1; Wurtz J, 2000, DIS AQUAT ORGAN, V39, P121, DOI 10.3354/dao039121; Wurtz J, 1998, DIS AQUAT ORGAN, V32, P137, DOI 10.3354/dao032137; Yamaguti S., 1971, P1; Yamaguti S, 1971, SYNOPSIS DIGENETIC T, VII	28	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90790	10.1371/journal.pone.0090790	http://dx.doi.org/10.1371/journal.pone.0090790			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608418	Green Submitted, Green Published, gold			2022-12-27	WOS:000332485800051
J	Zhao, YH; Miao, W; Li, CY; Yu, XH; Shan, ZY; Guan, HX; Teng, WP				Zhao, Yuhang; Miao, Wei; Li, Chenyang; Yu, Xiaohui; Shan, Zhongyan; Guan, Haixia; Teng, Weiping			Dynamic Changes in Serum 25-Hydroxyvitamin D during Pregnancy and Lack of Effect on Thyroid Parameters	PLOS ONE			English	Article							VITAMIN-D STATUS; MATERNAL WEIGHT-GAIN; D DEFICIENCY; CALCIUM HOMEOSTASIS; BONE METABOLISM; D INSUFFICIENCY; HIGH PREVALENCE; SEASONAL-CHANGES; SUN EXPOSURE; WOMEN	Background & Aims: To explore vitamin D status and its dynamic changes during pregnancy in women living in Northeast China. The association between 25-hydroxyvitamin D and serum calcium, phosphate and parathyroid hormone was studied. Because vitamin D deficiency or thyroid dysfunction/autoimmunity during pregnancy may lead to similar adverse events, the relationship between 25-hydroxyvitamin D and thyroid parameters was investigated. Methods: Serum samples of 50 women (aged 22 to 36 years) were selected retrospectively. The samples were collected at gestational 8 weeks +/- 3 days, 20 weeks +/- 3 days and 32 weeks +/- 3 days for measurement of 25-hydroxyvitamin D, calcium, phosphate, parathyroid hormone, and thyroid parameters. Results: The median 25-hydroxyvitamin D levels were 28.29, 39.23 and 40.03 nmol/L, respectively, from the first to the third trimester. The 25-hydroxyvitamin D concentration during the first trimester was significantly lower than the next two trimesters (p < 0.01) and was unchanged between the second and the third trimester. Of these women, 96%, 78% and 76% showed 25-hydroxyvitamin D <= 50 nmol/L during each trimester. Season was associated with 25-hydroxyvitamin D during each trimester (p < 0.05), and a significant association was found between calcium and 25-hydroxyvitamin D during the first and the second trimesters. Only triiodothyronine was associated with 25-hydroxyvitamin D in the first trimester (p = 0.024), but statistical significance was only a trend (p = 0.063) after excluding abnormal values. No association was observed between 25-hydroxyvitamin D and phosphate, parathyroid hormone, and other thyroid parameters. Conclusions: Vitamin D deficiency during pregnancy was prevalent in women from Northeast China who did not use supplementation. No significant relationships were observed between 25-hydroxyvitamin D and thyroid parameters during pregnancy.	[Zhao, Yuhang; Miao, Wei; Yu, Xiaohui; Shan, Zhongyan; Guan, Haixia; Teng, Weiping] China Med Univ, Affiliated Hosp 1, Liaoning Prov Key Lab Endocrine Dis, Dept Endocrinol & Metab,Inst Endocrinol, Shenyang, Liaoning Provin, Peoples R China; [Li, Chenyang] Shenyang Womens & Childrens Hosp, Dept Gynecol & Obstet, Shenyang, Liaoning Provin, Peoples R China	China Medical University	Shan, ZY (corresponding author), China Med Univ, Affiliated Hosp 1, Liaoning Prov Key Lab Endocrine Dis, Dept Endocrinol & Metab,Inst Endocrinol, Shenyang, Liaoning Provin, Peoples R China.	shanzhongyan@medmail.com.cn			special project of national 973 Plan [2011CB512112]	special project of national 973 Plan	The present study was supported by grants from the special project of national 973 Plan (project No. 2011CB512112). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS B, 1995, OBSTET GYNECOL, V86, P163, DOI 10.1016/0029-7844(95)00118-B; Aghajafari F, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1169; Alzaim M, 2013, NUTR REV, V71, P158, DOI 10.1111/nure.12018; Andersen R, 2013, EUR J CLIN NUTR, V67, P270, DOI 10.1038/ejcn.2013.3; Andersen S, 2013, BRIT J NUTR, V110, P50, DOI 10.1017/S0007114512004709; BERG JP, 1994, J STEROID BIOCHEM, V50, P145, DOI 10.1016/0960-0760(94)90021-3; Bezerra FF, 2002, J NUTR, V132, P2183, DOI 10.1093/jn/132.8.2183; Bikle D, 2009, J CLIN ENDOCR METAB, V94, P26, DOI 10.1210/jc.2008-1454; Bodnar LM, 2007, J CLIN ENDOCR METAB, V92, P3517, DOI 10.1210/jc.2007-0718; Bodnar LM, 2007, J NUTR, V137, P447, DOI 10.1093/jn/137.2.447; Brembeck Petra, 2013, Br J Nutr, V110, P856, DOI 10.1017/S0007114512005855; Brot C, 2001, BRIT J NUTR, V86, pS97, DOI 10.1079/BJN2001345; Cantorna MT, 2004, AM J CLIN NUTR, V80, p1717S, DOI 10.1093/ajcn/80.6.1717S; Carmichael S, 1997, PAEDIATR PERINAT EP, V11, P392, DOI 10.1046/j.1365-3016.1997.d01-28.x; Chailurkit LO, 2013, THYROID, V23, P25, DOI 10.1089/thy.2012.0001; Charatcharoenwitthaya N, 2013, CLIN ENDOCRINOL, V78, P126, DOI 10.1111/j.1365-2265.2012.04470.x; CROSS NA, 1995, AM J CLIN NUTR, V61, P514, DOI 10.1093/ajcn/61.3.514; Datt S, 2002, BJOG-INT J OBSTET GY, V109, P905, DOI 10.1016/S1470-0328(02)01171-0; Deluca HF, 2001, FASEB J, V15, P2579, DOI 10.1096/fj.01-0433rev; FAO/WHO/UNU, 2004, FAO FOOD NUTR TECH R, V1, P103; GILLETTE ME, 1982, CALCIFIED TISSUE INT, V34, P9, DOI 10.1007/BF02411200; Ginde AA, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.11.036; Glinoer D, 1997, ENDOCR REV, V18, P404, DOI 10.1210/er.18.3.404; Godel JC, 2007, PAED CHILD HEALT-CAN, V12, P583, DOI 10.1093/pch/12.7.583; Goswami R, 2009, BRIT J NUTR, V102, P382, DOI 10.1017/S0007114509220824; Grundmann M, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-146; HASHIZUME K, 1991, BIOCHEM BIOPH RES CO, V177, P388, DOI 10.1016/0006-291X(91)91995-O; Heaney RP, 2005, J STEROID BIOCHEM, V97, P13, DOI 10.1016/j.jsbmb.2005.06.020; Hedlund L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060864; HIRAMATSU K, 1983, J CLIN ENDOCR METAB, V56, P623, DOI 10.1210/jcem-56-3-623; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Institute of Medicine, 2009, WEIGHT GAIN PREGN RE; Institute of Medicine, 2010, DIETARY REFERENCE IN; Karakosta P, 2012, J CLIN ENDOCR METAB, V97, P4464, DOI 10.1210/jc.2012-2540; KENT GN, 1993, OSTEOPOROSIS INT, V3, pS44; Kovacs CS, 1997, ENDOCR REV, V18, P832, DOI 10.1210/er.18.6.832; Krassas GE, 2010, ENDOCR REV, V31, P702, DOI 10.1210/er.2009-0041; Lapillonne A, 2010, MED HYPOTHESES, V74, P71, DOI 10.1016/j.mehy.2009.07.054; Levenson CW, 2008, NUTR REV, V66, P726, DOI 10.1111/j.1753-4887.2008.00122.x; Li Y, 2010, ELECTRICAL CONDUCTIVE ADHESIVES WITH NANOTECHNOLOGIES, P25, DOI 10.1007/978-0-387-88783-8_2; McAree T, 2013, MATERN CHILD NUTR, V9, P23, DOI 10.1111/mcn.12014; Merlino LA, 2004, ARTHRITIS RHEUM-US, V50, P72, DOI 10.1002/art.11434; Miller AE, 1997, NEUROLOGY, V48, P312, DOI 10.1212/WNL.48.2.312; Negro R, 2011, BEST PRACT RES CL EN, V25, P927, DOI 10.1016/j.beem.2011.07.010; NIfHaC, 2009, IMPR HLTH NUTR PREG; Novakovic B, 2009, J BIOL CHEM, V284, P14838, DOI 10.1074/jbc.M809542200; Ojah RCI, 2012, NUTRIENTS, V4, P399, DOI 10.3390/nu4050399; PITKIN RM, 1977, AM J OBSTET GYNECOL, V127, P775, DOI 10.1016/0002-9378(77)90256-3; Prentice A, 2000, ANNU REV NUTR, V20, P249, DOI 10.1146/annurev.nutr.20.1.249; Ritchie LD, 1998, AM J CLIN NUTR, V67, P693, DOI 10.1093/ajcn/67.4.693; Rosen CJ, 2011, NEW ENGL J MED, V364, P248, DOI 10.1056/NEJMcp1009570; Samuel S, 2008, NUTR REV, V66, pS116, DOI 10.1111/j.1753-4887.2008.00094.x; SAR M, 1980, CELL TISSUE RES, V209, P161; SMITH MA, 1989, SURGERY, V106, P987; Smyth PPA, 2005, THYROID, V15, P474, DOI 10.1089/thy.2005.15.474; Tamer G, 2011, THYROID, V21, P891, DOI 10.1089/thy.2009.0200; Thuesen B, 2012, BONE, V50, P605, DOI 10.1016/j.bone.2011.12.016; Tsiaras WG, 2011, ACTA DERM-VENEREOL, V91, P115, DOI 10.2340/00015555-0980; Tsur A, 2011, OSTEOPOROSIS INT, V22, P2895, DOI 10.1007/s00198-010-1492-y; Urrutia RP, 2012, CURR OPIN OBSTET GYN, V24, P57, DOI 10.1097/GCO.0b013e3283505ab3; Van Belle TL, 2011, BEST PRACT RES CL EN, V25, P617, DOI 10.1016/j.beem.2011.04.009; van der Meer IM, 2006, AM J CLIN NUTR, V84, P350; Vandevijvere S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043868; WEISMAN Y, 1979, NATURE, V281, P317, DOI 10.1038/281317a0; Xiang F, 2013, J ENDOCRINOL INVEST, V36, P503, DOI 10.3275/8814; Yamashita H, 2000, SURGERY, V127, P377, DOI 10.1067/msy.2000.104123; Zipitis CS, 2008, ARCH DIS CHILD, V93, P512, DOI 10.1136/adc.2007.128579	67	8	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90161	10.1371/journal.pone.0090161	http://dx.doi.org/10.1371/journal.pone.0090161			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608866	Green Submitted, gold, Green Published			2022-12-27	WOS:000332485800018
J	Dewavrin, F; Zerimech, F; Boyer, A; Maboudou, P; Balduyck, M; Duhamel, A; Nseir, S				Dewavrin, Florent; Zerimech, Farid; Boyer, Alexandre; Maboudou, Patrice; Balduyck, Malika; Duhamel, Alain; Nseir, Saad			Accuracy of Alpha Amylase in Diagnosing Microaspiration in Intubated Critically-Ill Patients	PLOS ONE			English	Article							VENTILATOR-ASSOCIATED PNEUMONIA; INTENSIVE-CARE-UNIT; RISK-FACTORS; ASPIRATION PNEUMONIA; ACQUIRED PNEUMONIA; GASTRIC CONTENTS; TRACHEAL TUBES; CUFF PRESSURE; COLONIZATION; PREVENTION	Objectives: Amylase concentration in respiratory secretions was reported to be a potentially useful marker for aspiration and pneumonia. The aim of this study was to determine accuracy of alpha-amylase in diagnosing microaspiration in critically ill patients. Methods: Retrospective analysis of prospectively collected data collected in a medical ICU. All patients requiring mechanical ventilation for at least 48 h, and included in a previous randomized controlled trial were eligible for this study, provided that at least one tracheal aspirate was available for alpha-amylase measurement. As part of the initial trial, pepsin was quantitatively measured in all tracheal aspirates during a 48-h period. All tracheal aspirates were frozen, allowing subsequent measurement of alpha-amylase for the purpose of the current study. Microaspiration was defined as the presence of at least one positive tracheal aspirate for pepsin (>200 ng.mL(-1)). Abundant microaspiration was defined as the presence of pepsin at significant level in >74% of tracheal aspirates. Results: Amylase was measured in 1055 tracheal aspirates, collected from 109 patients. Using mean alpha-amylase level per patient, accuracy of alpha-amylase in diagnosing microaspiration was moderate (area under the receiver operator curve 0.72 +/- 0.05 [95% CI 0.61-0.83], for an alpha-amylase value of 1685 UI.L-1). However, when alpha-amylase levels, coming from all samples, were taken into account, area under the receiver operator curve was 0.56 +/- 0.05 [0.53-0.60]. Mean alpha-amylase level, and percentage of tracheal aspirates positive for alpha-amylase were significantly higher in patients with microaspiration, and in patients with abundant microaspiration compared with those with no microaspiration; and similar in patients with microaspiration compared with those with abundant microaspiration. alpha-amylase and pepsin were significantly correlated (r(2) = 0.305, p = 0.001). Conclusion: Accuracy of mean alpha-amylase in diagnosing microaspiration is moderate. Further, when all alpha-amylase levels were taken into account, alpha-amylase was inaccurate in diagnosing microaspiration, compared with pepsin.	[Dewavrin, Florent] Valenciennes Hosp, Intens Care Unit, Valenciennes, France; [Zerimech, Farid; Maboudou, Patrice; Balduyck, Malika] Univ Lille 2, Fac Pharm, Biochem & Mol Biol Lab, Lille, France; [Boyer, Alexandre] CHU Bordeaux, Med Intens Care Unit, Bordeaux, France; [Duhamel, Alain] Nord de France Univ, Lille, France; [Nseir, Saad] Univ Hosp Lille, R Salengro Hosp, Crit Care Ctr, Lille, France; [Nseir, Saad] Univ Lille Nord France, EA 2694, Med Assessment Lab, Lille, France	CH de Valenciennes; Universite de Lille - ISITE; Universite de Lille; CHU Bordeaux; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; Universite de Lille	Nseir, S (corresponding author), Univ Hosp Lille, R Salengro Hosp, Crit Care Ctr, Lille, France.	s-nseir@chru-lille.fr	Duhamel, Alain/A-4899-2013; Zerimech, Farid/B-5745-2011	BOYER, Alexandre/0000-0003-4384-8872; Nseir, Saad/0000-0002-7618-0357; Zerimech, Farid/0000-0003-2964-1031				Abou Jaoude P, 2010, EXPERT REV MOL DIAGN, V10, P309, DOI [10.1586/ERM.10.7, 10.1586/erm.10.7]; [Anonymous], AM J RESP CRIT CARE, V188, P220; Beuret P, 2012, ANN INTENSIVE CARE, V2, DOI 10.1186/2110-5820-2-45; Bohman JK, 2013, CHEST, V143, P1407, DOI 10.1378/chest.12-1860; BONTEN MJM, 1994, CHEST, V105, P878, DOI 10.1378/chest.105.3.878; Bosch X, 2012, EUR J INTERN MED, V23, P720, DOI 10.1016/j.ejim.2012.08.006; Cvejic L, 2011, RESPIROLOGY, V16, P269, DOI 10.1111/j.1440-1843.2010.01875.x; Dudeck MA, 2013, AM J INFECT CONTROL, V41, P286, DOI 10.1016/j.ajic.2013.01.002; El-Solh AA, 2011, CURR OPIN INFECT DIS, V24, P148, DOI 10.1097/QCO.0b013e328343b6cc; European Centre for Disease Prevention and Control, 2011, REP 2009 SURV DAT 20; Filloux B, 2013, MINERVA ANESTESIOL, V79, P1003; GarrousteOrgeas M, 1997, AM J RESP CRIT CARE, V156, P1647, DOI 10.1164/ajrccm.156.5.96-04076; Gross RD, 2009, AM J RESP CRIT CARE, V179, P559, DOI 10.1164/rccm.200807-1139OC; Heyland DK, 2001, CRIT CARE MED, V29, P1495, DOI 10.1097/00003246-200108000-00001; Jaillette E, 2013, BMC ANESTHESIOL, V13, DOI 10.1186/1471-2253-13-50; Jaillette E, 2011, CRIT CARE MED, V39, P725, DOI 10.1097/CCM.0b013e318208ec61; LeGall JR, 1996, JAMA-J AM MED ASSOC, V276, P802, DOI 10.1001/jama.276.10.802; Lucangelo U, 2008, CRIT CARE MED, V36, P409, DOI 10.1097/01.CCM.0000297888.82492.31; Marik PE, 2001, NEW ENGL J MED, V344, P665, DOI 10.1056/NEJM200103013440908; Melsen WG, 2013, LANCET INFECT DIS, V13, P665, DOI 10.1016/S1473-3099(13)70081-1; Melsen WG, 2009, CRIT CARE MED, V37, P2709, DOI 10.1097/CCM.0b013e3181ab8655; Metheny NA, 2006, CRIT CARE MED, V34, P1007, DOI 10.1097/01.CCM.0000206106.65220.59; Metheny NA, JPEN J PARENTER ENTE, V28, P79; NIEDERMAN MS, 1989, CHEST, V95, P155, DOI 10.1378/chest.95.1.155; Nseir S, 2003, INFECT DIS CLIN N AM, V17, P707, DOI 10.1016/S0891-5520(03)00075-8; Nseir S, 2011, AM J RESP CRIT CARE, V184, P1041, DOI 10.1164/rccm.201104-0630OC; Nseir Saad, 2011, Infectious Disorders - Drug Targets, V11, P413; Nseir S, 2010, INTENS CARE MED, V36, P1156, DOI 10.1007/s00134-010-1892-7; Rosenthal VD, 2012, CRIT CARE MED, V40, P3121, DOI 10.1097/CCM.0b013e3182657916; Touat L, 2013, INTENS CARE MED, V39, P575, DOI 10.1007/s00134-012-2750-6; Tsai HC, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.12.008; Weiss CH, 2013, CRIT CARE MED, V41, P765, DOI 10.1097/CCM.0b013e31827417bc; Winklmaier U, 2006, DYSPHAGIA, V21, P237, DOI 10.1007/s00455-006-9047-2; Wu YC, 2009, CHEST, V136, P118, DOI 10.1378/chest.08-2668	34	34	36	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90851	10.1371/journal.pone.0090851	http://dx.doi.org/10.1371/journal.pone.0090851			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603906	Green Published, gold, Green Submitted			2022-12-27	WOS:000332483600098
J	Sakurai, T; Woolls, MJ; Jin, SW; Murakami, M; Simons, M				Sakurai, Takashi; Woolls, Melissa J.; Jin, Suk-Won; Murakami, Masahiro; Simons, Michael			Inter-Cellular Exchange of Cellular Components via VE-Cadherin-Dependent Trans-Endocytosis	PLOS ONE			English	Article							VASCULAR ENDOTHELIAL CADHERIN; FLUORESCENT PROTEIN; INDEPENDENT ENDOCYTOSIS; LIGAND ENDOCYTOSIS; LIVING CELLS; BETA-CATENIN; MYOSIN-II; MECHANISM; JUNCTIONS; P120-CATENIN	Cell-cell communications typically involve receptor-mediated signaling initiated by soluble or cell-bound ligands. Here, we report a unique mode of endocytosis: proteins originating from cell-cell junctions and cytosolic cellular components from the neighboring cell are internalized, leading to direct exchange of cellular components between two adjacent endothelial cells. VE-cadherins form transcellular bridges between two endothelial cells that are the basis of adherence junctions. At such adherens junction sites, we observed the movement of the entire VE-cadherin molecule from one endothelial cell into the other with junctional and cytoplasmic components. This phenomenon, here termed trans-endocytosis, requires the establishment of a VE-cadherin homodimer in trans with internalization proceeding in a Rac1-, and actomyosin-dependent manner. Importantly, the trans-endocytosis is not dependent on any known endocytic pathway including clathrin-dependent endocytosis, macropinocytosis or phagocytosis. This novel form of cell-cell communications, leading to a direct exchange of cellular components, was observed in 2D and 3D-cultured endothelial cells as well as in the developing zebrafish vasculature.	[Sakurai, Takashi; Woolls, Melissa J.; Jin, Suk-Won; Murakami, Masahiro; Simons, Michael] Yale Univ, Sch Med, Dept Internal Med, Yale Cardiovasc Res Ctr, New Haven, CT 06510 USA; [Sakurai, Takashi; Woolls, Melissa J.; Jin, Suk-Won; Murakami, Masahiro; Simons, Michael] Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med, New Haven, CT 06510 USA; [Simons, Michael] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA	Yale University; Yale University; Yale University	Sakurai, T (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Yale Cardiovasc Res Ctr, New Haven, CT 06510 USA.	takashi_sakurai@gakushikai.jp	Simons, Michael/G-8553-2014	Simons, Michael/0000-0003-0348-7734	American Heart Association [10SDG4170137]; National Institutes of Health [R01 HL084619]; American Heart Pre-Doctoral Fellowship [11PRE7760026]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084619] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Pre-Doctoral Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work is supported by an American Heart Association Scientist Development Grant 10SDG4170137 (MM) and National Institutes of Health R01 HL084619 (MS). MJW was supported by an American Heart Pre-Doctoral Fellowship, 11PRE7760026. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens T, 2003, J MOL BIOL, V325, P733, DOI 10.1016/S0022-2836(02)01286-X; Allport JR, 2002, J LEUKOCYTE BIOL, V71, P821; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Chi NC, 2008, GENE DEV, V22, P734, DOI 10.1101/gad.1629408; Conway DE, 2013, CURR BIOL, V23, P1024, DOI 10.1016/j.cub.2013.04.049; Domhan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021283; Donaldson JG, 2009, CELL SIGNAL, V21, P1, DOI 10.1016/j.cellsig.2008.06.020; Fisher S, 2006, NAT PROTOC, V1, P1297, DOI 10.1038/nprot.2006.230; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Gautier A, 2008, CHEM BIOL, V15, P128, DOI 10.1016/j.chembiol.2008.01.007; Golachowska MR, 2010, TRENDS CELL BIOL, V20, P618, DOI 10.1016/j.tcb.2010.08.004; Greco V, 2001, CELL, V106, P633, DOI 10.1016/S0092-8674(01)00484-6; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Habuchi S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003944; Haga Y, 2009, EMBO J, V28, P1197, DOI 10.1038/emboj.2009.78; Hansson EM, 2010, J CELL SCI, V123, P2931, DOI 10.1242/jcs.073239; Hatanaka K, 2011, AM J PHYSIOL-HEART C, V300, pH162, DOI 10.1152/ajpheart.00650.2010; Haupts U, 1998, P NATL ACAD SCI USA, V95, P13573, DOI 10.1073/pnas.95.23.13573; Hergenreider E, 2012, NAT CELL BIOL, V14, P249, DOI 10.1038/ncb2441; Herren B, 1998, MOL BIOL CELL, V9, P1589, DOI 10.1091/mbc.9.6.1589; Hosoda T, 2011, CIRCULATION, V123, P1287, DOI 10.1161/CIRCULATIONAHA.110.982918; Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; Huveneers S, 2012, J CELL BIOL, V196, P641, DOI 10.1083/jcb.201108120; IPPENIHLER KA, 1986, ANNU REV GENET, V20, P593, DOI 10.1146/annurev.ge.20.120186.003113; Jamur MC, 2010, METHODS MOL BIOL, V588, P63, DOI 10.1007/978-1-59745-324-0_9; Jerke U, 2013, J BIOL CHEM, V288, P12910, DOI 10.1074/jbc.M112.434613; Jordan K, 2001, J CELL SCI, V114, P763; Katakowski M, 2010, CANCER RES, V70, P8259, DOI 10.1158/0008-5472.CAN-10-0604; Keppler A, 2003, NAT BIOTECHNOL, V21, P86, DOI 10.1038/nbt765; Kim JD, 2012, DEV CELL, V23, P441, DOI 10.1016/j.devcel.2012.07.007; Kogure T, 2011, HEPATOLOGY, V54, P1237, DOI 10.1002/hep.24504; Kowalczyk AP, 2004, CURR OPIN CELL BIOL, V16, P522, DOI 10.1016/j.ceb.2004.07.001; Kumari S, 2008, NAT CELL BIOL, V10, P30, DOI 10.1038/ncb1666; Kusakari S, 2008, J CELL SCI, V121, P1213, DOI 10.1242/jcs.025015; Lanahan AA, 2006, PHYSIOL GENOMICS, V27, P380, DOI 10.1152/physiolgenomics.00145.2006; Larrivee B, 2012, DEV CELL, V22, P489, DOI 10.1016/j.devcel.2012.02.005; Le TL, 1999, J CELL BIOL, V146, P219, DOI 10.1083/jcb.146.1.219; Lecuit T, 2010, NAT CELL BIOL, V12, P522, DOI 10.1038/ncb2066; Legrand P, 2001, J BIOL CHEM, V276, P3581, DOI 10.1074/jbc.M002667200; Limouze J, 2004, J MUSCLE RES CELL M, V25, P337, DOI 10.1007/s10974-004-6060-7; Marston DJ, 2003, NAT CELL BIOL, V5, P879, DOI 10.1038/ncb1044; Matsuda M, 2004, J CELL SCI, V117, P1247, DOI 10.1242/jcs.00972; Maxfield F R, 1987, Adv Exp Med Biol, V225, P189; McKinney MC, 2011, DEV DYNAM, V240, P1391, DOI 10.1002/dvdy.22612; Merzlyak EM, 2007, NAT METHODS, V4, P555, DOI 10.1038/NMETH1062; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; Nichols JT, 2007, J CELL BIOL, V176, P445, DOI 10.1083/jcb.200609014; Nickel BM, 2008, BIOCHEM BIOPH RES CO, V374, P679, DOI 10.1016/j.bbrc.2008.07.108; Niu XL, 2009, J CELL SCI, V122, P600, DOI 10.1242/jcs.031427; Onfelt B, 2004, J IMMUNOL, V173, P1511, DOI 10.4049/jimmunol.173.3.1511; Potter MD, 2005, J BIOL CHEM, V280, P31906, DOI 10.1074/jbc.M505568200; Qureshi OS, 2011, SCIENCE, V332, P600, DOI 10.1126/science.1202947; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133; Schnatwinkel C, 2004, PLOS BIOL, V2, P1363, DOI 10.1371/journal.pbio.0020261; Schulte D, 2011, EMBO J, V30, P4157, DOI 10.1038/emboj.2011.304; Schulz B, 2008, CIRC RES, V102, P1192, DOI 10.1161/CIRCRESAHA.107.169805; Shaner NC, 2008, NAT METHODS, V5, P545, DOI 10.1038/nmeth.1209; Spacek J, 2004, J NEUROSCI, V24, P4233, DOI 10.1523/JNEUROSCI.0287-04.2004; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Stirling L, 2009, MOL BIOL CELL, V20, P2991, DOI 10.1091/mbc.E08-10-1074; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Tamura K, 1998, NEURON, V20, P1153, DOI 10.1016/S0896-6273(00)80496-1; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Tsutsui H, 2005, EMBO REP, V6, P233, DOI 10.1038/sj.embor.7400361; Valiunas V, 2005, J PHYSIOL-LONDON, V568, P459, DOI 10.1113/jphysiol.2005.090985; Vestweber D, 2008, ARTERIOSCL THROM VAS, V28, P223, DOI 10.1161/ATVBAHA.107.158014; Weis WI, 2006, J BIOL CHEM, V281, P35593, DOI 10.1074/jbc.R600027200; Wu YI, 2009, NATURE, V461, P104, DOI 10.1038/nature08241; Xiao KY, 2005, MOL BIOL CELL, V16, P5141, DOI 10.1091/mbc.E05-05-0440	70	6	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90736	10.1371/journal.pone.0090736	http://dx.doi.org/10.1371/journal.pone.0090736			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603875	gold, Green Published, Green Submitted			2022-12-27	WOS:000332483600077
J	Tarimo, EAM; Munseri, P; Aboud, S; Bakari, M; Mhalu, F; Sandstrom, E				Tarimo, Edith A. M.; Munseri, Patricia; Aboud, Said; Bakari, Muhammad; Mhalu, Fred; Sandstrom, Eric			Experiences of Social Harm and Changes in Sexual Practices among Volunteers Who Had Completed a Phase I/II HIV Vaccine Trial Employing HIV-1 DNA Priming and HIV-1 MVA Boosting in Dar es Salaam, Tanzania	PLOS ONE			English	Article							RISK BEHAVIOR; POLICE OFFICERS; EFFICACY TRIAL; ISSUES	Background: Volunteers in phase I/II HIV vaccine trials are assumed to be at low risk of acquiring HIV infection and are expected to have normal lives in the community. However, during participation in the trials, volunteers may encounter social harm and changes in their sexual behaviours. The current study aimed to study persistence of social harm and changes in sexual practices over time among phase I/II HIV vaccine immunogenicity (HIVIS03) trial volunteers in Dar es Salaam, Tanzania. Methods and Results: A descriptive prospective cohort study was conducted among 33 out of 60 volunteers of HIVIS03 trial in Dar es Salaam, Tanzania, who had received three HIV-1 DNA injections boosted with two HIV-1 MVA doses. A structured interview was administered to collect data. Analysis was carried out using SPSS and McNemars' chi-square (chi(2)) was used to test the association within-subjects. Participants reported experiencing negative comments from their colleagues about the trial; but such comments were less severe during the second follow up visits (chi(2) = 8.72; P<0.001). Most of the comments were associated with discrimination (chi(2) = 26.72; P<0.001), stigma (chi(2) = 6.06; P<0.05), and mistrust towards the HIV vaccine trial (chi(2) = 4.9; P<0.05). Having a regular sexual partner other than spouse or cohabitant declined over the two follow-up periods (chi(2) = 4.45; P<0.05). Conclusion: Participants in the phase I/II HIV vaccine trial were likely to face negative comments from relatives and colleagues after the end of the trial, but those comments decreased over time. In this study, the inherent sexual practice of having extra sexual partners other than spouse declined over time. Therefore, prolonged counselling and support appears important to minimize risky sexual behaviour among volunteers after participation in HIV Vaccine trials.	[Tarimo, Edith A. M.] Muhimbili Univ Hlth & Allied Sci, Dept Nursing Management, Dar Es Salaam, Tanzania; [Munseri, Patricia; Bakari, Muhammad] Muhimbili Univ Hlth & Allied Sci, Dept Internal Med, Dar Es Salaam, Tanzania; [Aboud, Said; Mhalu, Fred] Muhimbili Univ Hlth & Allied Sci, Dept Microbiol & Immunol, Dar Es Salaam, Tanzania; [Sandstrom, Eric] Karolinska Inst, Sodersjukhuset, Stockholm, Sweden	Muhimbili University of Health & Allied Sciences; Muhimbili University of Health & Allied Sciences; Muhimbili University of Health & Allied Sciences; Karolinska Institutet; Sodersjukhuset Hospital	Tarimo, EAM (corresponding author), Muhimbili Univ Hlth & Allied Sci, Dept Nursing Management, Dar Es Salaam, Tanzania.	etarimo54@yahoo.co.uk			Swedish International Development Agency (Sida) through a bilateral research capacity building grant; European Union (EU); European and Developing Countries Clinical Trials Partnership (EDCTP)	Swedish International Development Agency (Sida) through a bilateral research capacity building grant; European Union (EU)(CGIAREuropean Commission); European and Developing Countries Clinical Trials Partnership (EDCTP)	The study was funded by the Swedish International Development Agency (Sida) through a bilateral research capacity building grant to the Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania. The European Union (EU) is being thanked for having supported the initial HIVIS03 HIV-1 Vaccine trial from which subjects for this study were drawn. The European and Developing Countries Clinical Trials Partnership (EDCTP) is also acknowledged for having funded the HIV vaccine trial part when a second HIV-1 DNA MVA boost was administered to the vaccinees. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen M, 2001, AIDS RES HUM RETROV, V17, P667, DOI 10.1089/088922201750236942; Bakari M, 2000, AIDS, V14, P313, DOI 10.1097/00002030-200002180-00014; Bakari M, 2011, VACCINE, V29, P8417, DOI 10.1016/j.vaccine.2011.08.001; Bartholow BN, 2005, JAIDS-J ACQ IMM DEF, V39, P90, DOI 10.1097/01.qai.0000143600.41363.78; Belshe RB, 2001, J INFECT DIS, V183, P1343, DOI 10.1086/319863; Fuchs J, 2007, JAIDS-J ACQ IMM DEF, V46, P362, DOI 10.1097/QAI.0b013e3181565dcb; Guest G, 2005, AIDS CARE, V17, P46, DOI 10.1080/09540120412331305124; IAVI, DAT AIDS VACC CAND C; Jenkins RA, 2005, JAIDS-J ACQ IMM DEF, V40, P592, DOI 10.1097/01.qai.0000171725.09812.a5; Lampinen TM, 2005, CAN MED ASSOC J, V172, P479, DOI 10.1503/cmaj.1031785; Maek-A-Nantawat Wirach, 2003, J Med Assoc Thai, V86, P299; Milford C, 2007, AIDS CARE, V19, P1110, DOI 10.1080/09540120701335212; Newman PA, 2008, VACCINE, V26, P1091, DOI 10.1016/j.vaccine.2007.12.016; Pitisuttithum Punnee, 2007, Journal of the Medical Association of Thailand, V90, P2442; Tarimo EAM, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-283; Tarimo EAM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014619; Tarimo EAM, 2009, GLOBAL HEALTH ACTION, V2, DOI 10.3402/gha.v2i0.1953; Tarimo EAM, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-292; Thapinta D, 1999, J ACQ IMMUN DEF SYND, V20, P308, DOI 10.1097/00042560-199903010-00015; van Griensven F, 2004, AIDS, V18, P295, DOI 10.1097/00002030-200401230-00020	20	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90938	10.1371/journal.pone.0090938	http://dx.doi.org/10.1371/journal.pone.0090938			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603848	gold, Green Published			2022-12-27	WOS:000332483600111
J	Viviant, M; Monestiez, P; Guinet, C				Viviant, Morgane; Monestiez, Pascal; Guinet, Christophe			Can We Predict Foraging Success in a Marine Predator from Dive Patterns Only? Validation with Prey Capture Attempt Data	PLOS ONE			English	Article							AREA-RESTRICTED SEARCH; ANTARCTIC FUR SEALS; OCEANOGRAPHIC HABITAT; ARCTOCEPHALUS-GAZELLA; KERGUELEN ISLANDS; DIVING BEHAVIOR; WEDDELL SEALS; ELEPHANT SEAL; TIME; STRATEGIES	Predicting how climatic variations will affect marine predator populations relies on our ability to assess foraging success, but evaluating foraging success in a marine predator at sea is particularly difficult. Dive metrics are commonly available for marine mammals, diving birds and some species of fish. Bottom duration or dive duration are usually used as proxies for foraging success. However, few studies have tried to validate these assumptions and identify the set of behavioral variables that best predict foraging success at a given time scale. The objective of this study was to assess if foraging success in Antarctic fur seals could be accurately predicted from dive parameters only, at different temporal scales. For this study, 11 individuals were equipped with either Hall sensors or accelerometers to record dive profiles and detect mouth-opening events, which were considered prey capture attempts. The number of prey capture attempts was best predicted by descent and ascent rates at the dive scale; bottom duration and descent rates at 30-min, 1-h, and 2-h scales; and ascent rates and maximum dive depths at the all-night scale. Model performances increased with temporal scales, but rank and sign of the factors varied according to the time scale considered, suggesting that behavioral adjustment in response to prey distribution could occur at certain scales only. The models predicted the foraging intensity of new individuals with good accuracy despite high inter-individual differences. Dive metrics that predict foraging success depend on the species and the scale considered, as verified by the literature and this study. The methodology used in our study is easy to implement, enables an assessment of model performance, and could be applied to any other marine predator.	[Viviant, Morgane; Guinet, Christophe] CNRS, Ctr Etud Biol Chize, Villiers En Bois, France; [Monestiez, Pascal] INRA, Unite Biostat & Proc Spatiaux, Avignon, France	Centre National de la Recherche Scientifique (CNRS); INRAE	Guinet, C (corresponding author), CNRS, Ctr Etud Biol Chize, Villiers En Bois, France.	guinet@cebc.cnrs.fr	Guinet, Christophe/AAR-8457-2020	Monestiez, Pascal/0000-0001-5851-2699	French Polar Institute (Institut Paul Emile Victor, IPEV) [109]; Territoire des Terres Australes et Antarctiques Francaises (TAAF); French "Ministere de la Recherche'' through Pierre et Marie Curie University	French Polar Institute (Institut Paul Emile Victor, IPEV); Territoire des Terres Australes et Antarctiques Francaises (TAAF); French "Ministere de la Recherche'' through Pierre et Marie Curie University	This study is part of the national research program (no 109, H. Weimerskirch) supported by the French Polar Institute (Institut Paul Emile Victor, IPEV) and the Territoire des Terres Australes et Antarctiques Francaises (TAAF). MV was supported by a PhD grant from the French "Ministere de la Recherche'' through Pierre et Marie Curie University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin D, 2006, J ANIM ECOL, V75, P408, DOI 10.1111/j.1365-2656.2006.01057.x; Austin D, 2006, ECOLOGY, V87, P3095, DOI 10.1890/0012-9658(2006)87[3095:LMDAHT]2.0.CO;2; Bailey H, 2009, MAR ECOL PROG SER, V378, P279, DOI 10.3354/meps07887; Bailleul F, 2007, PHILOS T R SOC B, V362, P2169, DOI 10.1098/rstb.2007.2109; Bastille-Rousseau G, 2010, J ANIM ECOL, V79, P1157, DOI 10.1111/j.1365-2656.2010.01737.x; Bestley S, 2010, ECOLOGY, V91, P2373, DOI 10.1890/08-2019.1; Bost CA, 2007, DEEP-SEA RES PT II, V54, P248, DOI 10.1016/j.dsr2.2006.11.007; BOYD IL, 1995, ANIM BEHAV, V50, P769, DOI 10.1016/0003-3472(95)80137-5; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Calambokidis J, 2007, MAR TECHNOL SOC J, V41, P19, DOI 10.4031/002533207787441980; Casper RM, 2010, ECOGRAPHY, V33, P748, DOI 10.1111/j.1600-0587.2009.06155.x; Cezilly F, 1996, REV ECOL-TERRE VIE, V51, P43; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Cherel Y, 1997, POLAR BIOL, V17, P87, DOI 10.1007/s003000050109; CROXALL JP, 1985, J ANIM ECOL, V54, P1, DOI 10.2307/4616; Duhamel G, 2000, POLAR BIOL, V23, P106, DOI 10.1007/s003000050015; Fedak MA, 2001, MAR MAMMAL SCI, V17, P94, DOI 10.1111/j.1748-7692.2001.tb00982.x; Fossette S, 2008, J ANIM ECOL, V77, P236, DOI 10.1111/j.1365-2656.2007.01344.x; Gales NJ, 1998, MAR MAMMAL SCI, V14, P355, DOI 10.1111/j.1748-7692.1998.tb00727.x; Goldbogen JA, 2006, J EXP BIOL, V209, P1231, DOI 10.1242/jeb.02135; Hanuise N, 2010, J EXP BIOL, V213, P3874, DOI 10.1242/jeb.044057; HARRELL FE, 1984, STAT MED, V3, P143, DOI 10.1002/sim.4780030207; Hooker SK, 2002, MAR MAMMAL SCI, V18, P680, DOI 10.1111/j.1748-7692.2002.tb01066.x; Horsburgh JM, 2008, MAR MAMMAL SCI, V24, P207, DOI 10.1111/j.1748-7692.2007.00156.x; Jonsen ID, 2007, MAR ECOL PROG SER, V337, P255, DOI 10.3354/meps337255; KNOPPIEN P, 1985, J THEOR BIOL, V114, P273, DOI 10.1016/S0022-5193(85)80107-7; Kuhn CE, 2009, J ANIM ECOL, V78, P513, DOI 10.1111/j.1365-2656.2008.01509.x; Lea MA, 2002, MAR ECOL PROG SER, V245, P281, DOI 10.3354/meps245281; Lea MA, 2002, POLAR BIOL, V25, P269, DOI 10.1007/s00300-001-0339-6; Louzao M, 2006, ECOL APPL, V16, P1683, DOI 10.1890/1051-0761(2006)016[1683:OHOAEM]2.0.CO;2; Louzao M, 2011, J APPL ECOL, V48, P121, DOI 10.1111/j.1365-2664.2010.01910.x; Luque SP, 2007, BEHAVIOUR, V144, P1315, DOI 10.1163/156853907782418213; Marshall GJ, 1998, MAR TECHNOL SOC J, V32, P11; Mori Y, 2005, MAR ECOL PROG SER, V295, P257, DOI 10.3354/meps295257; Mori Y, 1998, J THEOR BIOL, V190, P187, DOI 10.1006/jtbi.1997.0550; Mori Y, 2007, ISR J ECOL EVOL, V53, P347, DOI 10.1560/IJEE.53.3.347; Morris DW, 2009, ANN NY ACAD SCI, V1162, P334, DOI 10.1111/j.1749-6632.2009.04494.x; Paiva VH, 2010, OIKOS, V119, P1423, DOI 10.1111/j.1600-0706.2010.18294.x; Peron C, 2010, MAR ECOL PROG SER, V416, P267, DOI 10.3354/meps08785; R Development Core Team, 2012, R LANG ENV STAT COMP; Robinson PW, 2007, DEEP-SEA RES PT II, V54, P356, DOI 10.1016/j.dsr2.2006.11.020; Ropert-Coudert Y, 2006, MAR BIOL, V149, P139, DOI 10.1007/s00227-005-0188-x; Ropert-Coudert Y, 2001, POLAR BIOL, V24, P467, DOI 10.1007/s003000100235; Shillinger GL, 2011, MAR ECOL PROG SER, V422, P275, DOI 10.3354/meps08884; Simeone A, 2003, MAR BIOL, V143, P825, DOI 10.1007/s00227-003-1114-8; Suryan RM, 2006, DEEP-SEA RES PT II, V53, P370, DOI 10.1016/j.dsr2.2006.01.012; Suzuki I, 2009, POLAR BIOL, V32, P667, DOI 10.1007/s00300-009-0596-3; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Takahashi A., 2004, Marine Ornithology, V32, P47; Thums M, 2008, J EXP MAR BIOL ECOL, V363, P75, DOI 10.1016/j.jembe.2008.06.024; Viviant M, 2010, POLAR BIOL, V33, P713, DOI 10.1007/s00300-009-0750-y; Watanabe Y, 2003, MAR ECOL PROG SER, V252, P283, DOI 10.3354/meps252283; Weimerskirch H, 2007, AM NAT, V170, P734, DOI 10.1086/522059; Wilson RP, 2002, MAR BIOL, V140, P17, DOI 10.1007/s002270100659; WILSON RP, 1992, J EXP BIOL, V167, P267; Wilson RP, 2003, MAR ECOL PROG SER, V249, P305, DOI 10.3354/meps249305; Zuur A.F., 2007, ANAL ECOLOGICAL DATA	58	32	32	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e88503	10.1371/journal.pone.0088503	http://dx.doi.org/10.1371/journal.pone.0088503			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603534	Green Published, gold			2022-12-27	WOS:000332483600006
J	Wang, HS; Fan, XL; Owada, M; Wang, M; Nylin, S				Wang, Houshuai; Fan, Xiaoling; Owada, Mamoru; Wang, Min; Nylin, Soeren			Phylogeny, Systematics and Biogeography of the Genus Panolis (Lepidoptera: Noctuidae) Based on Morphological and Molecular Evidence	PLOS ONE			English	Article							PINE BEAUTY MOTH; OBLIGATE POLLINATION MUTUALISM; HISTORICAL BIOGEOGRAPHY; BUTTERFLIES; INFERENCE; EVOLUTION; FLAMMEA; TREE; DIVERGENCE; RADIATION	The genus Panolis is a small group of noctuid moths with six recognized species distributed from Europe to East Asia, and best known for containing the widespread Palearctic pest species P. flammea, the pine beauty moth. However, a reliable classification and robust phylogenetic framework for this group of potentially economic importance are currently lacking. Here, we use morphological and molecular data (mitochondrial genes cytochrome c oxidase subunit I and 16S ribosomal RNA, nuclear gene elongation factor-1 alpha) to reconstruct the phylogeny of this genus, with a comprehensive systematic revision of all recognized species and a new one, P. ningshan sp. nov. The analysis results of maximum parsimony, maximum likelihood and Bayesian inferring methods for the combined morphological and molecular data sets are highly congruent, resulting in a robust phylogeny and identification of two clear species groups, i.e., the P. flammea species group and the P. exquisita species group. We also estimate the divergence times of Panolis moths using two conventional mutation rates for the arthropod mitochondrial COI gene with a comparison of two molecular clock models, as well as reconstruct their ancestral areas. Our results suggest that 1) Panolis is a young clade, originating from the Oriental region in China in the Late Miocene (6-10Mya), with an ancestral species in the P. flammea group extending northward to the Palearctic region some 3-6 Mya; 2) there is a clear possibility for a representative of the Palearctic clade to become established as an invasive species in the Nearctic taiga.	[Wang, Houshuai; Fan, Xiaoling; Wang, Min] South China Agr Univ, Coll Nat Resources & Environm, Dept Entomol, Guangzhou, Guangdong, Peoples R China; [Wang, Houshuai; Nylin, Soeren] Univ Stockholm, Dept Zool, S-10691 Stockholm, Sweden; [Owada, Mamoru] Natl Museum Nat & Sci, Dept Zool, Tsukuba, Ibaraki, Japan	South China Agricultural University; Stockholm University; National Museum of Nature and Science	Wang, M (corresponding author), South China Agr Univ, Coll Nat Resources & Environm, Dept Entomol, Guangzhou, Guangdong, Peoples R China.	minwang@scau.edu.cn	Nylin, Soren/B-7375-2008	Nylin, Soren/0000-0003-4195-8920	Oversea Study Program of Guangzhou Elite Project [[2012] 59]; Swedish Research Council; National Natural Science Foundation of China [31172136]	Oversea Study Program of Guangzhou Elite Project; Swedish Research Council(Swedish Research CouncilEuropean Commission); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by Oversea Study Program of Guangzhou Elite Project (Sui jiaoke [2012] 59), a grant from the Swedish Research Council to SN (Grant 621-2011-5636) as well as a grant from National Natural Science Foundation of China to XF (31172136). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Beck Herbert, 1996, Neue Entomologische Nachrichten, V36, P3; Brandley MC, 2006, SYST BIOL, V55, P138, DOI 10.1080/10635150500431155; BROWER AVZ, 1994, P NATL ACAD SCI USA, V91, P6491, DOI 10.1073/pnas.91.14.6491; Canfield MR, 2008, MOL PHYLOGENET EVOL, V49, P477, DOI 10.1016/j.ympev.2008.07.003; Carter D. J., 1984, Pest Lepidoptera of Europe with special reference to the British Isles.; Chen Y.X., 1999, FAUNA SINICA INSECTA, V16, P52; CHO SW, 1995, MOL BIOL EVOL, V12, P650; Colston TJ, 2013, MOL PHYLOGENET EVOL, V66, P953, DOI 10.1016/j.ympev.2012.11.027; de Villers CJ, 1789, LINNAEI ENTOMOLOGIA; DeChaine EG, 2005, J BIOGEOGR, V32, P1943, DOI 10.1111/j.1365-2699.2005.01356.x; Denis JNCM, 1775, ANKUNDUNG SYSTEMATIS; Dinca V, 2011, P ROY SOC B-BIOL SCI, V278, P347, DOI 10.1098/rspb.2010.1089; DRAUDT M., 1950, MITTEIL MONCHNER ENT GES, V40, P1; Draudt M, 1935, MACROLEPIDOPTERA WOR, V3, P199; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Fabricius JC, 1787, MANTISSA INSECTORVM, VII; Farrell BD, 2001, MOL PHYLOGENET EVOL, V18, P467, DOI 10.1006/mpev.2000.0888; FARRIS JS, 1994, CLADISTICS, V10, P315, DOI 10.1111/j.1096-0031.1996.tb00196.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Goeze JAE, 1781, ENTOMOLOGISCHE BEYTR, V3; Goloboff P, 1999, NONA TREE SEARCHING; Grant T, 2003, CLADISTICS, V19, P379, DOI 10.1111/j.1096-0031.2003.tb00311.x; Hacker H., 1996, ESPERIANA, V5, P7; Hampson G.F., 1905, CATALOGUE LEPIDOPTER, V5; Hausmann A, 2011, SPIXIANA, V34, P47; Hausmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017134; Hebert PDN, 2010, BIOL LETTERS, V6, P359, DOI 10.1098/rsbl.2009.0848; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hicks BJ, 2001, AGR FOREST ENTOMOL, V3, P161, DOI 10.1046/j.1461-9555.2001.00106.x; Hicks BJ, 2008, AGR FOREST ENTOMOL, V10, P263, DOI 10.1111/j.1461-9563.2008.00382.x; Holder M, 2003, NAT REV GENET, V4, P275, DOI 10.1038/nrg1044; HOLLOWAY J D, 1986, Malayan Nature Journal, V40, P1; Hreblay M, 1997, ACTA ZOOL ACAD SCI H, V43, P21; Hubner J, 1826, VERZEICHNISS BEKANNT; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Inoue H., 1958, P431; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kawakita A, 2009, P R SOC B, V276, P417, DOI 10.1098/rspb.2008.1226; Kononenko V.S., 1989, Nota Lepidopterologica, V12, P29; LEATHER SR, 1995, INT J PEST MANAGE, V41, P123, DOI 10.1080/09670879509371936; Molet T, 2011, CPHST PEST DATASHEET; Nazari V, 2007, INSECT SYST EVOL, V38, P121, DOI 10.1163/187631207788783996; Nixon K.C., 2002, WINCLADA VERSION 1 0; Oliver JC, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002893; Papadopoulou A, 2010, MOL BIOL EVOL, V27, P1659, DOI 10.1093/molbev/msq051; Paykull G, 1786, VETENSKAPS ACAD NYA, V7, P60; Pfeiler Edward, 2012, Psyche (Cambridge), V2012, P1, DOI 10.1155/2012/423756; Poole R.W., 1989, P501; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Quek SP, 2004, EVOLUTION, V58, P554, DOI 10.1111/j.0014-3820.2004.tb01678.x; Rambaut A, 2007, TRACER V 1 5; Randle CP, 2010, CLADISTICS, V26, P550, DOI 10.1111/j.1096-0031.2009.00301.x; Randle CP, 2006, SYST BIOL, V55, P147, DOI 10.1080/10635150500481630; Ronkay Gabor, 2010, Esperiana, V15, P223; Ronkay L, 2001, HADENINAE 2 NOCTUIDA, V5; Ronquist F, 1997, SYST BIOL, V46, P195, DOI 10.2307/2413643; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ronquist F, 2001, DIVA VERSION 1 2 COM; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Simonov EA, 2008, AMUR HEILONG RIVER B; Sinev S.Yu., 2008, CATALOGUE LEPIDOPTER; Smith CI, 2008, EVOLUTION, V62, P2676, DOI 10.1111/j.1558-5646.2008.00500.x; Steel M, 2005, TRENDS GENET, V21, P307, DOI 10.1016/j.tig.2005.04.001; Sugi S, 1992, LEPIDOPTERA TAIWAN, VI, P198; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wahlberg N, 2006, SYST BIOL, V55, P703, DOI 10.1080/10635150600913235; Wang HS, 2010, FLA ENTOMOL, V93, P352, DOI 10.1653/024.093.0305; Wang M, 2011, MOTHS GUANGDONG NALI; Wiemers M, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-300; Wileman A. E., 1914, Entomologist London, V47; Yamamoto M, 1987, LARVAE LARGER MOTHS, P197; Yu Y, 2011, PLANT SYST EVOL, V296, P179, DOI 10.1007/s00606-011-0486-3	75	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90598	10.1371/journal.pone.0090598	http://dx.doi.org/10.1371/journal.pone.0090598			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603596	Green Published, gold, Green Submitted			2022-12-27	WOS:000332483600066
J	Wehrkamp, CJ; Gutwein, AR; Natarajan, SK; Phillippi, MA; Mott, JL				Wehrkamp, Cody J.; Gutwein, Ashley R.; Natarajan, Sathish Kumar; Phillippi, Mary Anne; Mott, Justin L.			XIAP Antagonist Embelin Inhibited Proliferation of Cholangiocarcinoma Cells	PLOS ONE			English	Article							FLUORESCENT-PROBE SUBSTRATE; X-LINKED INHIBITOR; APOPTOSIS PROTEIN; HEPATOCELLULAR-CARCINOMA; MITOCHONDRIAL PATHWAY; STRUCTURAL BASIS; CYTOCHROME-C; G2/M PHASE; CANCER; IAP	Cholangiocarcinoma cells are dependent on antiapoptotic signaling for survival and resistance to death stimuli. Recent mechanistic studies have revealed that increased cellular expression of the E3 ubiquitin-protein ligase X-linked inhibitor of apoptosis (XIAP) impairs TRAIL-and chemotherapy-induced cytotoxicity, promoting survival of cholangiocarcinoma cells. This study was undertaken to determine if pharmacologic antagonism of XIAP protein was sufficient to sensitize cholangiocarcinoma cells to cell death. We employed malignant cholangiocarcinoma cell lines and used embelin to antagonize XIAP protein. Embelin treatment resulted in decreased XIAP protein levels by 8 hours of treatment with maximal effect at 16 hours in KMCH and Mz-ChA-1 cells. Assessment of nuclear morphology demonstrated a concentration-dependent increase in nuclear staining. Interestingly, embelin induced nuclear morphology changes as a single agent, independent of the addition of TNF-related apoptosis inducing ligand (TRAIL). However, caspase activity assays revealed that increasing embelin concentrations resulted in slight inhibition of caspase activity, not activation. In addition, the use of a pan-caspase inhibitor did not prevent nuclear morphology changes. Finally, embelin treatment of cholangiocarcinoma cells did not induce DNA fragmentation or PARP cleavage. Apoptosis does not appear to contribute to the effects of embelin on cholangiocarcinoma cells. Instead, embelin caused inhibition of cell proliferation and cell cycle analysis indicated that embelin increased the number of cells in S and G2/M phase. Our results demonstrate that embelin decreased proliferation in cholangiocarcinoma cell lines. Embelin treatment resulted in decreased XIAP protein expression, but did not induce or enhance apoptosis. Thus, in cholangiocarcinoma cells the mechanism of action of embelin may not be dependent on apoptosis.	[Wehrkamp, Cody J.; Gutwein, Ashley R.; Natarajan, Sathish Kumar; Phillippi, Mary Anne; Mott, Justin L.] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Fred & Pamela Buffett Canc Ctr, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center	Mott, JL (corresponding author), Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Fred & Pamela Buffett Canc Ctr, Omaha, NE 68198 USA.	justin.mott@unmc.edu		Mott, Justin/0000-0002-2927-6962	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) at the National Institutes of Health [R03 DK092263]; Medical Student Summer Research Program; Fred and Pamela Buffett Cancer Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK092263] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Medical Student Summer Research Program; Fred and Pamela Buffett Cancer Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by grant number R03 DK092263 (J.L.M.) from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) at the National Institutes of Health. The contents of this manuscript are solely the responsibility of the authors and do not necessarily represent the official views of NIDDK. Additional support was from the Medical Student Summer Research Program (A.R.G.) and the Fred and Pamela Buffett Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn KS, 2007, MOL PHARMACOL, V71, P209, DOI 10.1124/mol.106.028787; Aird KM, 2008, MOL CANCER THER, V7, P38, DOI 10.1158/1535-7163.MCT-07-0370; BRANDTS JF, 1990, BIOCHEMISTRY-US, V29, P6927, DOI 10.1021/bi00481a024; Che YF, 2012, AM J PATHOL, V180, P1798, DOI 10.1016/j.ajpath.2012.01.016; Clawson KA, 2010, J SURG RES, V163, P244, DOI 10.1016/j.jss.2010.03.067; Cliby WA, 2002, J BIOL CHEM, V277, P1599, DOI 10.1074/jbc.M106287200; Dai Y, 2011, AM J CANCER RES, V1, P128; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Deveraux QL, 1998, EMBO J, V17, P2215, DOI 10.1093/emboj/17.8.2215; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; FRANCIS R, 1995, GENETICS, V139, P579; FUKADA H, 1983, J BIOL CHEM, V258, P3193; GUPTA O P, 1977, Indian Journal of Physiology and Pharmacology, V21, P31; Heo JY, 2011, CANCER LETT, V308, P71, DOI 10.1016/j.canlet.2011.04.015; Hu R, 2011, MED ONCOL, V28, P1584, DOI 10.1007/s12032-010-9601-5; Kim SW, 2013, PROSTATE, V73, P296, DOI 10.1002/pros.22574; KNUTH A, 1985, J HEPATOL, V1, P579, DOI 10.1016/S0168-8278(85)80002-7; KUBISTA M, 1987, BIOCHEMISTRY-US, V26, P4545, DOI 10.1021/bi00388a057; Kurita S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018330; Li Y, 2013, ONCOL LETT, V5, P1005, DOI 10.3892/ol.2012.1084; Liston P, 1996, NATURE, V379, P349, DOI 10.1038/379349a0; Liu ZH, 2000, NATURE, V408, P1004, DOI 10.1038/35050006; Maciejowski J, 2006, DEV BIOL, V292, P142, DOI 10.1016/j.ydbio.2005.12.046; MIYAGIWA M, 1989, IN VITRO CELL DEV B, V25, P503; Molina DM, 2013, SCIENCE, V341, P84, DOI 10.1126/science.1233606; Mori T, 2007, J SURG RES, V142, P281, DOI 10.1016/j.jss.2007.03.068; MUNSHI SR, 1972, INDIAN J MED RES, V60, P1054; MURAKAMI T, 1987, HEPATOLOGY, V7, P551, DOI 10.1002/hep.1840070322; Nikolovska-Coleska Z, 2004, J MED CHEM, V47, P2430, DOI 10.1021/jm030420+; Shiraishi J, 2001, AM J PHYSIOL-HEART C, V281, pH1637, DOI 10.1152/ajpheart.2001.281.4.H1637; SHRAKE A, 1990, J BIOL CHEM, V265, P5055; SHRAKE A, 1992, BIOPOLYMERS, V32, P925, DOI 10.1002/bip.360320804; Siegelin MD, 2009, NEUROCHEM INT, V55, P423, DOI 10.1016/j.neuint.2009.04.011; Sirica AE, 2008, HEPATOLOGY, V47, P1178, DOI 10.1002/hep.22088; Taghiyev A, 2012, EXP THER MED, V4, P649, DOI 10.3892/etm.2012.637; Valle J, 2010, NEW ENGL J MED, V362, P1273, DOI 10.1056/NEJMoa0908721; Wu G, 2000, NATURE, V408, P1008, DOI 10.1038/35050012; Yamagiwa Y, 2004, CANCER RES, V64, P1293, DOI 10.1158/0008-5472.CAN-03-2517; Yasujima T, 2011, J PHARM SCI-US, V100, P4006, DOI 10.1002/jps.22548; Yasujima T, 2010, DRUG METAB DISPOS, V38, P715, DOI 10.1124/dmd.109.030221	40	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90238	10.1371/journal.pone.0090238	http://dx.doi.org/10.1371/journal.pone.0090238			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603802	gold, Green Published			2022-12-27	WOS:000332483600034
J	Li, Y; Wang, NA; Zhang, CQ				Li, Yu; Wang, Nai'ang; Zhang, Chengqi			An Abrupt Centennial-Scale Drought Event and Mid-Holocene Climate Change Patterns in Monsoon Marginal Zones of East Asia	PLOS ONE			English	Article							HOLOCENE ENVIRONMENTAL-CHANGE; HIGH-RESOLUTION; MOISTURE EVOLUTION; TENGGER DESERT; QINGHAI LAKE; RECORD; DRY; SEDIMENTS; CHINA; STALAGMITE	The mid-latitudes of East Asia are characterized by the interaction between the Asian summer monsoon and the westerly winds. Understanding long-term climate change in the marginal regions of the Asian monsoon is critical for understanding the millennial-scale interactions between the Asian monsoon and the westerly winds. Abrupt climate events are always associated with changes in large-scale circulation patterns; therefore, investigations into abrupt climate changes provide clues for responses of circulation patterns to extreme climate events. In this paper, we examined the time scale and mid-Holocene climatic background of an abrupt dry mid-Holocene event in the Shiyang River drainage basin in the northwest margin of the Asian monsoon. Mid-Holocene lacustrine records were collected from the middle reaches and the terminal lake of the basin. Using radiocarbon and OSL ages, a centennial-scale drought event, which is characterized by a sand layer in lacustrine sediments both from the middle and lower reaches of the basin, was absolutely dated between 8.0-7.0 cal kyr BP. Grain size data suggest an abrupt decline in lake level and a dry environment in the middle reaches of the basin during the dry interval. Previous studies have shown mid-Holocene drought events in other places of monsoon marginal zones; however, their chronologies are not strong enough to study the mechanism. According to the absolutely dated records, we proposed a new hypothesis that the mid-Holocene dry interval can be related to the weakening Asian summer monsoon and the relatively arid environment in arid Central Asia. Furthermore, abrupt dry climatic events are directly linked to the basin-wide effective moisture change in semi-arid and arid regions. Effective moisture is affected by basin-wide precipitation, evapotranspiration, lake surface evaporation and other geographical settings. As a result, the time scales of the dry interval could vary according to locations due to different geographical features.	[Li, Yu; Wang, Nai'ang; Zhang, Chengqi] Lanzhou Univ, Coll Earth & Environm Sci, Ctr Hydrol Cycle & Water Resources Arid Reg, Lanzhou 730000, Peoples R China	Lanzhou University	Li, Y (corresponding author), Lanzhou Univ, Coll Earth & Environm Sci, Ctr Hydrol Cycle & Water Resources Arid Reg, Lanzhou 730000, Peoples R China.	liyu@lzu.edu.cn	zhang, chi/GRX-3610-2022	Li, Yu/0000-0003-3381-5372	National Natural Science Foundation of China [41371009, 41001116]; Fundamental Research Fund for the Central Universities [lzujbky-2013-127, lzujbky-2013-129]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Fund for the Central Universities	This research was supported by the National Natural Science Foundation of China (Grant No. 41371009 and 41001116) and the Fundamental Research Fund for the Central Universities (Grant No. lzujbky-2013-127 and lzujbky-2013-129). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens CD, 1985, METEOROLOGY TODAY; Alley RB, 2000, P NATL ACAD SCI USA, V97, P1331, DOI 10.1073/pnas.97.4.1331; An CB, 2006, QUATERNARY SCI REV, V25, P351, DOI 10.1016/j.quascirev.2005.03.013; An CB, 2008, GLOBAL PLANET CHANGE, V63, P283, DOI 10.1016/j.gloplacha.2008.03.007; An ZS, 2000, QUATERNARY SCI REV, V19, P743, DOI 10.1016/S0277-3791(99)00031-1; [Anonymous], 1983, ACTA GEOGRAPHICA SIN, DOI DOI 10.3321/j.issn:0375-5444.1983.01.001; BERGER A, 1991, QUATERNARY SCI REV, V10, P297, DOI 10.1016/0277-3791(91)90033-Q; Cai YJ, 2010, EARTH PLANET SC LETT, V291, P21, DOI 10.1016/j.epsl.2009.12.039; Chen CTA, 2003, PALAEOGEOGR PALAEOCL, V193, P181, DOI 10.1016/S0031-0182(03)00225-6; Chen FH, 2006, HOLOCENE, V16, P675, DOI 10.1191/0959683606hl951rp; Chen FH, 2008, QUATERNARY SCI REV, V27, P351, DOI 10.1016/j.quascirev.2007.10.017; Chen FH, 2003, CHINESE SCI BULL, V48, P1401, DOI 10.1360/03wd0245; Chen L.H., 1992, RATIONAL DEV USE LAN; Clemens SC, 2010, PALEOCEANOGRAPHY, V25, DOI 10.1029/2010PA001926; Cosford J, 2008, EARTH PLANET SC LETT, V275, P296, DOI 10.1016/j.epsl.2008.08.018; Dong JG, 2010, HOLOCENE, V20, P257, DOI 10.1177/0959683609350393; Dykoski CA, 2005, EARTH PLANET SC LETT, V233, P71, DOI 10.1016/j.epsl.2005.01.036; Fleitmann D, 2003, SCIENCE, V300, P1737, DOI 10.1126/science.1083130; Fowell SJ, 2003, QUATERNARY RES, V59, P353, DOI 10.1016/S0033-5894(02)00020-0; GASSE F, 1991, NATURE, V353, P742, DOI 10.1038/353742a0; Guo ZT, 2000, GLOBAL PLANET CHANGE, V26, P97, DOI 10.1016/S0921-8181(00)00037-0; He Y, 2004, QUATERNARY RES, V61, P52, DOI 10.1016/j.yqres.2003.08.004; Herzschuh U, 2006, QUATERNARY SCI REV, V25, P163, DOI 10.1016/j.quascirev.2005.02.006; Hu CY, 2008, EARTH PLANET SC LETT, V266, P221, DOI 10.1016/j.epsl.2007.10.015; Huang DY, 1997, GANSU VEGETATION; Jiang WY, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2007JD009050; Lerman A., 1978, LAKE CHEM GEOLOGY PH; Li JJ, 1990, QUATERNARY SCI, V3, P197; Li Y, 2012, J ASIAN EARTH SCI, V58, P78, DOI 10.1016/j.jseaes.2012.07.001; Li Y, 2010, CLIM DYNAM, V35, P1115, DOI 10.1007/s00382-010-0861-8; Li Y, 2009, BOREAS, V38, P349, DOI 10.1111/j.1502-3885.2008.00063.x; Li Y, 2009, REV PALAEOBOT PALYNO, V154, P54, DOI 10.1016/j.revpalbo.2008.12.005; Lin C, 1993, ATMOSPHERE CLIMATE C; Liu XQ, 2008, QUATERNARY RES, V70, P412, DOI 10.1016/j.yqres.2008.06.005; Liu XQ, 2007, CHINESE SCI BULL, V52, P539, DOI 10.1007/s11434-007-0086-3; Long H, 2010, QUATERNARY RES, V74, P46, DOI 10.1016/j.yqres.2010.03.009; MIDDLETON GV, 1976, J GEOL, V84, P405, DOI 10.1086/628208; Morrill C, 2006, QUATERNARY RES, V65, P232, DOI 10.1016/j.yqres.2005.02.014; PACHUR HJ, 1995, QUATERNARY RES, V44, P171, DOI 10.1006/qres.1995.1061; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; Shen J, 2005, QUATERN INT, V136, P131, DOI 10.1016/j.quaint.2004.11.014; Sun DH, 2002, SEDIMENT GEOL, V152, P263, DOI 10.1016/S0037-0738(02)00082-9; [王可丽 Wang Keli], 2005, [水科学进展, Advances in Water Science], V16, P432; Wang W, 2011, QUATERN INT, V229, P74, DOI 10.1016/j.quaint.2010.06.005; Wang YJ, 2005, SCIENCE, V308, P854, DOI 10.1126/science.1106296; Wang YB, 2010, EARTH-SCI REV, V103, P135, DOI 10.1016/j.earscirev.2010.09.004; Wunnemann B, 2006, PALAEOGEOGR PALAEOCL, V234, P223, DOI 10.1016/j.palaeo.2005.10.016; Wunnemann B, 1998, QUATERNARY DESERTS AND CLIMATIC CHANGE, P381; Zhang HC, 2004, PALAEOGEOGR PALAEOCL, V211, P45, DOI 10.1016/j.palaeo.2004.04.006; Zhang HC, 2000, PALAEOGEOGR PALAEOCL, V162, P389, DOI 10.1016/S0031-0182(00)00139-5; Zhang J., 1992, CLIMATE CHINA; Zhao Y, 2008, J ARID ENVIRON, V72, P2054, DOI 10.1016/j.jaridenv.2008.06.016; Zhou WJ, 2004, QUATERNARY RES, V62, P39, DOI 10.1016/j.yqres.2004.05.004	53	2	2	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90241	10.1371/journal.pone.0090241	http://dx.doi.org/10.1371/journal.pone.0090241			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599259	gold, Green Published, Green Submitted			2022-12-27	WOS:000332479400057
J	Olson, SH; Parmley, J; Soos, C; Gilbert, M; Latorre-Margalef, N; Hall, JS; Hansbro, PM; Leighton, F; Munster, V; Joly, D				Olson, Sarah H.; Parmley, Jane; Soos, Catherine; Gilbert, Martin; Latorre-Margalef, Neus; Hall, Jeffrey S.; Hansbro, Phillip M.; Leighton, Frederick; Munster, Vincent; Joly, Damien			Sampling Strategies and Biodiversity of Influenza A Subtypes in Wild Birds	PLOS ONE			English	Article							PATHOGENIC AVIAN INFLUENZA; MIGRATORY BIRDS; VIRUS; SURVEILLANCE; WATERFOWL; PREVALENCE; PREDICTION; RICHNESS; PATTERNS	Wild aquatic birds are recognized as the natural reservoir of avian influenza A viruses (AIV), but across high and low pathogenic AIV strains, scientists have yet to rigorously identify most competent hosts for the various subtypes. We examined 11,870 GenBank records to provide a baseline inventory and insight into patterns of global AIV subtype diversity and richness. Further, we conducted an extensive literature review and communicated directly with scientists to accumulate data from 50 non-overlapping studies and over 250,000 birds to assess the status of historic sampling effort. We then built virus subtype sample-based accumulation curves to better estimate sample size targets that capture a specific percentage of virus subtype richness at seven sampling locations. Our study identifies a sampling methodology that will detect an estimated 75% of circulating virus subtypes from a targeted bird population and outlines future surveillance and research priorities that are needed to explore the influence of host and virus biodiversity on emergence and transmission.	[Olson, Sarah H.; Gilbert, Martin] Wildlife Conservat Soc, Bronx, NY USA; [Parmley, Jane] Univ Guelph, Dept Pathobiol, Canadian Cooperat Wildlife Hlth Ctr, Guelph, ON N1G 2W1, Canada; [Soos, Catherine] Environm Canada, Sci & Technol Branch, Saskatoon, SK, Canada; [Latorre-Margalef, Neus] Linnaeus Univ, Ctr Ecol & Evolut Microbial Model Syst EEMiS, Kalmar, Sweden; [Latorre-Margalef, Neus] Univ Georgia, Coll Vet Med, Dept Populat Hlth, Southeastern Cooperat Wildlife Dis Study, Athens, GA USA; [Hall, Jeffrey S.] USGS, Natl Wildlife Hlth Ctr, Madison, WI USA; [Hansbro, Phillip M.] Univ Newcastle, Prior Res Ctr Asthma & Resp Dis, Newcastle, NSW 2300, Australia; [Hansbro, Phillip M.] Hunter Med Res Inst, Newcastle, NSW, Australia; [Leighton, Frederick] Univ Saskatchewan, Western Coll Vet Med, Canadian Cooperat Wildlife Hlth Ctr, Saskatoon, SK S7N 0W0, Canada; [Munster, Vincent] NIAID, Virol Lab, Div Intramural Res, NIH, Hamilton, MT USA; [Joly, Damien] Metabiota, Nanaimo, BC, Canada	Wildlife Conservation Society; University of Guelph; Environment & Climate Change Canada; Linnaeus University; University System of Georgia; University of Georgia; United States Department of the Interior; United States Geological Survey; University of Newcastle; Hunter Medical Research Institute; University of Newcastle; University of Saskatchewan; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Joly, D (corresponding author), Metabiota, Nanaimo, BC, Canada.	djoly@metabiota.com	Soos, Catherine/Q-4983-2019; Hansbro, Phil/G-7486-2013; Munster, Vincent/I-7607-2018	Soos, Catherine/0000-0003-4610-3614; Hansbro, Phil/0000-0002-4741-3035; Munster, Vincent/0000-0002-2288-3196; Hall, Jeffrey/0000-0001-5599-2826; Gilbert, Martin/0000-0002-9930-4383	Division of Intramural Research, National Institute of Allergy and Infectious Disease, National Institutes of Health; National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH); Department of Health and Human Services [HHSN266200700007C]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001179] Funding Source: NIH RePORTER	Division of Intramural Research, National Institute of Allergy and Infectious Disease, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Department of Health and Human Services; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was made possible by the generous support of the American people through the United States Agency for International Development (USAID) Emerging Pandemic Threats program, PREDICT project. VJM is supported by the Division of Intramural Research, National Institute of Allergy and Infectious Disease, National Institutes of Health. Additional funding for this work was provided by the National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), and the Department of Health and Human Services under contract HHSN266200700007C. Journal access was provided by in-kind support from the University of Wisconsin-Madison Center for Sustainability and the Global Environment (SAGE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony SJ, 2013, MBIO, V4, DOI 10.1128/mBio.00598-13; BirdLife International, 2013, DAT ZON; Brown JD, 2012, J WILDLIFE DIS, V48, P991, DOI 10.7589/2011-09-280; Brown JD, 2010, J WILDLIFE DIS, V46, P896, DOI 10.7589/0090-3558-46.3.896; Butler D, 2012, NATURE, V483, P520, DOI 10.1038/483520a; Chao A, 2009, ECOLOGY, V90, P1125, DOI 10.1890/07-2147.1; Cheng MC, 2010, AVIAN DIS, V54, P109, DOI 10.1637/8960-061709-Reg.1; Colwell R.K., 2006, ESTIMATES STAT ESTIM; DeLiberto TJ, 2009, INTEGR ZOOL, V4, P426, DOI 10.1111/j.1749-4877.2009.00180.x; Dove ADM, 2006, TRENDS PARASITOL, V22, P568, DOI 10.1016/j.pt.2006.09.008; Dugan VG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000076; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Gilbert M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044097; Gotelli N. J., 2010, BIOL DIVERSITY FRONT, P39, DOI DOI 10.1016/J.BAAE.2011.07.002; Gunnarsson G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035679; Hansbro PM, 2010, EMERG INFECT DIS, V16, P1896, DOI 10.3201/eid1612.100776; Henaux V, 2011, J WILDLIFE DIS, V47, P566, DOI 10.7589/0090-3558-47.3.566; Henriques AM, 2011, AVIAN PATHOL, V40, P597, DOI 10.1080/03079457.2011.618943; Herrick KA, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-42; HINSHAW VS, 1985, B WORLD HEALTH ORGAN, V63, P711; HINSHAW VS, 1982, J VIROL, V42, P865, DOI 10.1128/JVI.42.3.865-872.1982; HOSMER DW, 1980, COMMUN STAT A-THEOR, V9, P1043, DOI 10.1080/03610928008827941; Hoye BJ, 2010, EMERG INFECT DIS, V16, P1827, DOI 10.3201/eid1612.100589; Kageyama T, 2013, EUROSURVEILLANCE, V18, P7; Koehler AV, 2008, MOL ECOL, V17, P4754, DOI 10.1111/j.1365-294X.2008.03953.x; Krauss S, 2007, PLOS PATHOG, V3, P1684, DOI 10.1371/journal.ppat.0030167; Latorre-Margalef N, 2013, PLOS PATHOG, V9, DOI [10.1371/journal.ppat.1003443, DOI 10.1371/J0URNAL.PPAT.1003443]; Latorre-Margalef N, P R SOC B; Latorre-Margalef N, 2009, P ROY SOC B-BIOL SCI, V276, P1029, DOI 10.1098/rspb.2008.1501; Morrison R. L., 2009, PROC OSA TOPICAL M C; Morse SS, 2012, LANCET, V380, P1956, DOI 10.1016/S0140-6736(12)61684-5; Munster VJ, 2007, PLOS PATHOG, V3, P630, DOI 10.1371/journal.ppat.0030061; Munster VJ, 2009, J CLIN MICROBIOL, V47, P666, DOI 10.1128/JCM.01625-08; NCBI, INFL VIR DAT; Nolting Jacqueline, 2012, PLoS Curr, V4, pRRN1290; OIE, 2018, TERR AN HLTH COD; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Parmley JE, 2008, EMERG INFECT DIS, V14, P2005; R Development Core Team, 2012, R LANG ENV STAT COMP; Sivay MV, 2012, AVIAN DIS, V56, P456, DOI 10.1637/9868-080111-Reg.1; Soliman A, 2012, J WILDLIFE DIS, V48, P669, DOI 10.7589/0090-3558-48.3.669; Soos C, 2012, J WILDLIFE DIS, V48, P444, DOI 10.7589/0090-3558-48.2.444; Squires RB, 2012, INFLUENZA OTHER RESP, V6, P404, DOI 10.1111/j.1750-2659.2011.00331.x; Turmelle AS, 2009, ECOHEALTH, V6, P522, DOI 10.1007/s10393-009-0263-8; United States Fish & Wildlife Service, 2012, N AM FLYW DIR 146; USDA, 2006, EARL DET SYST HIGHL; Wahlgren J, 2008, VECTOR-BORNE ZOONOT, V8, P783, DOI 10.1089/vbz.2007.0274; Wallensten A, 2007, EMERG INFECT DIS, V13, P404, DOI 10.3201/eid1303.061130; Wallensten A, 2006, VACCINE, V24, P6734, DOI 10.1016/j.vaccine.2006.05.057; Wille M, 2011, ARCH VIROL, V156, P107, DOI 10.1007/s00705-010-0839-1	50	39	40	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90826	10.1371/journal.pone.0090826	http://dx.doi.org/10.1371/journal.pone.0090826			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599502	Green Published, Green Submitted, gold			2022-12-27	WOS:000332479400137
J	Bartels, M; Calgarotto, AK; Martens, AC; Maso, V; da Silva, SL; Bierings, MB; de Souza Queiroz, ML; Coffer, PJ				Bartels, Marije; Calgarotto, Andrana K.; Martens, Anton C.; Maso, Victor; da Silva, Saulo L.; Bierings, Marc B.; de Souza Queiroz, Mary L.; Coffer, Paul J.			Differential Effects of Nitrostyrene Derivatives on Myelopoiesis Involve Regulation of C/EBP alpha and p38MAPK Activity	PLOS ONE			English	Article							PROTEIN PHOSPHATASE 2A; TRANSCRIPTIONAL REGULATION; P38 MAPK; INHIBITORS; KINASE; HEMATOPOIESIS; GRANULOCYTE; APOPTOSIS; BETA; GRANULOPOIESIS	Bone marrow failure syndromes and MDS represent a heterogenous group of diseases, characterized by ineffective myelopoiesis, the risk of clonal evolution and a generally poor response to chemotherapy-based treatment regimen. Nitrostyrene derivatives have been studied as protein phosphatase inhibitors in various tumor models. Pharmacological studies have identified nitrostyrene as the structural core underlying a pro-apoptotic effect in tumor cells, yet their effects on normal cells, including those of the hematopoietic system, are largely unknown. In this study, utilizing umbilical cord blood-derived myeloid progenitor cells, patient-derived bone marrow cells, and a (BALB/c) mouse model; we investigated the effects of treatment with two nitrostyrene derivatives (NTS1 and NTS2) on myeloid development. We demonstrate that these compounds stimulate the expansion and differentiation of myeloid progenitors in vitro and improve myeloid reconstitution after chemotherapy-induced bone marrow depletion in vitro and in vivo. These effects were accompanied by increased C/EBP alpha expression and activity and inhibition of the p38MAPK signalling pathway. Together, our data suggest that nitrostyrenes improve myelopoiesis and represent potential new treatment strategies for patients suffering from bone marrow failure syndromes, hypocellular myelodysplastic syndrome and chemotherapy-induced aplasia.	[Bartels, Marije; Martens, Anton C.; Coffer, Paul J.] Univ Med Ctr Utrecht, Dept Cell Biol, Utrecht, Netherlands; [Bartels, Marije; Bierings, Marc B.; Coffer, Paul J.] Univ Med Ctr Utrecht, Div Pediat, Utrecht, Netherlands; [Calgarotto, Andrana K.; Maso, Victor; de Souza Queiroz, Mary L.] Univ Estadual Campinas, Dept Farmacol, Campinas, SP, Brazil; [Martens, Anton C.] Univ Med Ctr Utrecht, Dept Immunol, Utrecht, Netherlands; [da Silva, Saulo L.] Univ Fed Sao Joao, Dept Quim, Ouro Branco, MG, Brazil	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Universidade Estadual de Campinas; Utrecht University; Utrecht University Medical Center; Universidade Federal de Sao Joao del-Rei	Bartels, M (corresponding author), Univ Med Ctr Utrecht, Dept Cell Biol, Utrecht, Netherlands.	mbartel2@umcutrecht.nl	Coffer, Paul/AAF-7970-2020; Da Silva, Saulo Luís/AGX-1028-2022	Da Silva, Saulo Luis/0000-0002-7029-2016	Coordenacao de Aperfeicoamento de Pessoal de Nivel (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)	Coordenacao de Aperfeicoamento de Pessoal de Nivel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The work of AKC was supported financially by Coordenacao de Aperfeicoamento de Pessoal de Nivel (CAPES) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarado-Kristensson M, 2005, J BIOL CHEM, V280, P6238, DOI 10.1074/jbc.M409718200; Arthur JSC, 2013, NAT REV IMMUNOL, V13, P679, DOI 10.1038/nri3495; Berliner N, 2008, BLOOD, V111, P5427, DOI 10.1182/blood-2007-10-077396; Cantor AB, 2001, CURR OPIN GENET DEV, V11, P513, DOI 10.1016/S0959-437X(00)00226-4; Dahl R, 2003, NAT IMMUNOL, V4, P1029, DOI 10.1038/ni973; Enver T, 1998, BLOOD, V92, P348, DOI 10.1182/blood.V92.2.348.Con3_348_351; Fathi AR, 2000, BIOORG MED CHEM LETT, V10, P1605, DOI 10.1016/S0960-894X(00)00294-8; FECCHIO D, 1990, INFLAMMATION, V14, P125, DOI 10.1007/BF00914035; Friedman AD, 2003, BLOOD CELL MOL DIS, V31, P338, DOI 10.1016/S1079-9796(03)00135-9; Friedman AD, 2002, INT J HEMATOL, V75, P466, DOI 10.1007/BF02982108; Friedman AD, 2002, ONCOGENE, V21, P3377, DOI 10.1038/sj.onc.1205324; Geest CR, 2009, J LEUKOCYTE BIOL, V86, P237, DOI 10.1189/jlb.0209097; Kaap S, 2003, BIOCHEM PHARMACOL, V65, P603, DOI 10.1016/S0006-2952(02)01618-0; Katsoulidis E, 2005, CANCER RES, V65, P9029, DOI 10.1158/0008-5472.CAN-04-4555; Kim JH, 2003, MOL PHARMACOL, V63, P1117, DOI 10.1124/mol.63.5.1117; Lin SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049605; Metcalf D, 1998, BLOOD, V92, P345, DOI 10.1182/blood.V92.2.345b.Con2_345_347; Navas TA, 2006, BLOOD, V108, P4170, DOI 10.1182/blood-2006-05-023093; Park J, 2004, BIOCHEMISTRY-US, V43, P15014, DOI 10.1021/bi0486233; Peng A, 2010, ONCOGENE, V29, P5977, DOI 10.1038/onc.2010.371; Prickett TD, 2007, MOL CELL BIOL, V27, P4217, DOI 10.1128/MCB.00067-07; RICH IN, 1991, BLOOD, V77, P1164; Ross SE, 2004, MOL CELL BIOL, V24, P675, DOI 10.1128/MCB.24.2.675-686.2004; Schonthal AH, 2001, CANCER LETT, V170, P1, DOI 10.1016/S0304-3835(01)00561-4; Spinelli E, 2012, CLIN CANCER RES, V18, P3079, DOI 10.1158/1078-0432.CCR-11-0686; Verma A, 2002, J BIOL CHEM, V277, P7726, DOI 10.1074/jbc.M106640200; Villar JAFP, 2008, TOXICON, V51, P1467, DOI 10.1016/j.toxicon.2008.03.023; Wang D, 2006, BLOOD, V108, P1223, DOI 10.1182/blood-2005-12-008763; Wang WY, 2007, BIOCHEM PHARMACOL, V74, P601, DOI 10.1016/j.bcp.2007.06.001; Ward AC, 2000, LEUKEMIA, V14, P973, DOI 10.1038/sj.leu.2401808	30	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e90586	10.1371/journal.pone.0090586	http://dx.doi.org/10.1371/journal.pone.0090586			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614182	Green Published, Green Submitted, gold			2022-12-27	WOS:000332839300031
J	Batke, SP; Jocque, M; Kelly, DL				Batke, Sven P.; Jocque, Merlijn; Kelly, Daniel L.			Modelling Hurricane Exposure and Wind Speed on a Mesoclimate Scale: A Case Study from Cusuco NP, Honduras	PLOS ONE			English	Article							LUQUILLO-EXPERIMENTAL-FOREST; PUERTO-RICO; CATASTROPHIC WIND; DAMAGE; RECOVERY; HUGO; VEGETATION; MORTALITY; PROFILES; PATTERNS	High energy weather events are often expected to play a substantial role in biotic community dynamics and large scale diversity patterns but their contribution is hard to prove. Currently, observations are limited to the documentation of accidental records after the passing of such events. A more comprehensive approach is synthesising weather events in a location over a long time period, ideally at a high spatial resolution and on a large geographic scale. We provide a detailed overview on how to generate hurricane exposure data at a meso-climate level for a specific region. As a case study we modelled landscape hurricane exposure in Cusuco National Park (CNP), Honduras with a resolution of 50 mx50 m patches. We calculated actual hurricane exposure vulnerability site scores (EVVS) through the combination of a wind pressure model, an exposure model that can incorporate simple wind dynamics within a 3-dimensional landscape and the integration of historical hurricanes data. The EVSS was calculated as a weighted function of sites exposure, hurricane frequency and maximum wind velocity. Eleven hurricanes were found to have affected CNP between 1995 and 2010. The highest EVSS's were predicted to be on South and South-East facing sites of the park. Ground validation demonstrated that the South-solution (i.e. the South wind inflow direction) explained most of the observed tree damage (90% of the observed tree damage in the field). Incorporating historical data to the model to calculate actual hurricane exposure values, instead of potential exposure values, increased the model fit by 50%.	[Batke, Sven P.; Kelly, Daniel L.] Univ Dublin Trinity Coll, Dept Bot, Dublin 2, Ireland; [Batke, Sven P.; Kelly, Daniel L.] Trinity Coll Dublin, Trinity Ctr Biodivers Res, Dublin, Ireland; [Jocque, Merlijn] Koninklijk Belgisch Inst Natuurwetenschappen, Brussels, Belgium; [Batke, Sven P.; Jocque, Merlijn; Kelly, Daniel L.] Operat Wallacea, Old Bolingbroke, Lincs, England; [Jocque, Merlijn] Rutgers State Univ, Dept Biol Sci, Newark, NJ 07102 USA	Trinity College Dublin; Trinity College Dublin; Rutgers State University Newark; Rutgers State University New Brunswick	Batke, SP (corresponding author), Univ Dublin Trinity Coll, Dept Bot, Dublin 2, Ireland.	batkesp@tcd.ie		Batke, Sven/0000-0002-1938-3625	Trinity College Dublin; Rufford Foundation; Operation Wallacea; Royal Geographic Society London	Trinity College Dublin; Rufford Foundation; Operation Wallacea; Royal Geographic Society London	This project was funded by Trinity College Dublin, the Rufford Foundation, Operation Wallacea and the Royal Geographic Society London (in collaboration with Dr. Merlijn Jocque). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELLINGHAM PJ, 1992, J TROP ECOL, V8, P217, DOI 10.1017/S0266467400006386; Boose ER, 2004, ECOL MONOGR, V74, P335, DOI 10.1890/02-4057; BOOSE ER, 1994, ECOL MONOGR, V64, P369, DOI 10.2307/2937142; Breloer H, 1994, BODY LANGUAGE TREES; BROKAW NVL, 1991, BIOTROPICA, V23, P442, DOI 10.2307/2388264; BW Blanchard, 2005, RADIAL VARIATION TAN, P1; Censky EJ, 1998, NATURE, V395, P556, DOI 10.1038/26886; Chapman L, 2000, METEOROL APPL, V7, P335, DOI 10.1017/S1350482700001729; Emanuel K, 2005, NATURE, V436, P686, DOI 10.1038/nature03906; ESRI, 2011, ARCGIS; Everham EM, 1996, BOT REV, V62, P113, DOI 10.1007/BF02857920; FOSTER DR, 1992, J ECOL, V80, P79, DOI 10.2307/2261065; FRANGI JL, 1991, BIOTROPICA, V23, P324, DOI 10.2307/2388248; Hanewinkel M, 2011, EUR J FOREST RES, V130, P329, DOI 10.1007/s10342-010-0392-1; Harper B., 2002, TROPICAL CYCLONE PAR, V83; Hartshorn G, 1983, TROPICAL RAIN FOREST; HOLLAND GJ, 1980, MON WEATHER REV, V108, P1212, DOI 10.1175/1520-0493(1980)108<1212:AAMOTW>2.0.CO;2; Holland G, 2008, MON WEATHER REV, V136, P3432, DOI 10.1175/2008MWR2395.1; Holland GJ, 2010, MON WEATHER REV, V138, P4393, DOI 10.1175/2010MWR3317.1; IPCC (Intergovernmental Panel on Climate Change), 2013, CLIMATE CHANGE 2013; Lanquaye-Opoku N, 2005, FOREST ECOL MANAG, V216, P134, DOI 10.1016/j.foreco.2005.05.032; Mark D.M., 1975, GEOGR ANN A, V57, P165, DOI [DOI 10.2307/520612, 10.2307/520612]; Microsoft Office Professional Plus, 2010, MICR EXC SPREADSH; Mikita T, 2010, J LANDSCAPE ECOL, V3, P45; NOAA, 1999, HURR BAS; NOAA, 2012, NHC DAT ARCH; Ostertag R, 2005, BIOTROPICA, V37, P16, DOI 10.1111/j.1744-7429.2005.04052.x; Perotto-Baldiviezo HL, 2004, AGR ECOSYST ENVIRON, V103, P165, DOI 10.1016/j.agee.2003.10.011; Peterson CJ, 2000, FOREST ECOL MANAG, V135, P237, DOI 10.1016/S0378-1127(00)00283-8; Philpott SM, 2008, AGR ECOSYST ENVIRON, V128, P12, DOI 10.1016/j.agee.2008.04.016; Pietri L, 2009, MEC IND, V10, P181, DOI 10.1051/meca/2009047; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; REILLY AE, 1991, BIOTROPICA, V23, P414, DOI 10.2307/2388260; Rossi E, 2013, GISCI REMOTE SENS, V50, P385, DOI 10.1080/15481603.2013.820066; Smith J, 1997, ASSESSMENT SOIL WATE; Vickery PJ, 2000, J STRUCT ENG-ASCE, V126, P1203, DOI 10.1061/(ASCE)0733-9445(2000)126:10(1203); WALKER LR, 1991, BIOTROPICA, V23, P379, DOI 10.2307/2388255; Wang Y, 2012, STRUCT SAF, V35, P40, DOI 10.1016/j.strusafe.2011.12.001; WOLF JHD, 1993, ANN MO BOT GARD, V80, P928, DOI 10.2307/2399938; Xi WM, 2008, FORESTRY, V81, P317, DOI 10.1093/forestry/cpn020; YOU CX, 1991, BIOTROPICA, V23, P400, DOI 10.2307/2388258; ZIMMERMAN JK, 1995, FOREST ECOL MANAG, V77, P65, DOI 10.1016/0378-1127(95)03575-U; ZIMMERMAN JK, 1994, J ECOL, V82, P911, DOI 10.2307/2261454	43	13	13	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91306	10.1371/journal.pone.0091306	http://dx.doi.org/10.1371/journal.pone.0091306			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614168	Green Submitted, Green Published, gold			2022-12-27	WOS:000332839300109
J	Fleury, M; Rodrigues, RR; do Couto, HTZ; Galetti, M				Fleury, Marina; Rodrigues, Ricardo R.; do Couto, Hilton T. Z.; Galetti, Mauro			Seasonal Variation in the Fate of Seeds under Contrasting Logging Regimes	PLOS ONE			English	Article							LEAF-CUTTING ANTS; ATLANTIC RAIN-FOREST; RATTUS-EXULANS PEALE; HOME-RANGE USE; TROPICAL FOREST; SMALL MAMMALS; AMAZONIAN FOREST; FRAGMENT SIZE; LONG-TERM; PREDATION	Seed predators and dispersers may drive the speed and structure of forest regeneration in natural ecosystems. Rodents and ants prey upon and disperse seeds, yet empirical studies on the magnitude of these effects are lacking. Here, we examined the role of ants and rodents on seed predation in 4 plant species in a successional gradient on a tropical rainforest island. We found that (1) seeds are mostly consumed rather than dispersed; (2) rates of seed predation vary by habitat, season, and species; (3) seed size, shape, and hardness do not affect the probability of being depredated. Rodents were responsible for 70% of seed predation and were negligible (0.14%) seed dispersers, whereas ants were responsible for only 2% of seed predation and for no dispersal. We detected seasonal and habitat effects on seed loss, with higher seed predation occurring during the wet season and in old-growth forests. In the absence of predators regulating seed-consumer populations, the densities of these resilient animals explode to the detriment of natural regeneration and may reduce diversity and carrying capacity for consumers and eventually lead to ecological meltdown.	[Fleury, Marina; Galetti, Mauro] Univ Estadual Paulista, Dept Ecol, Sao Paulo, Brazil; [Fleury, Marina; Rodrigues, Ricardo R.] Univ Sao Paulo, USP ESALQ, Dept Ciencias Biol, Lab Ecol & Restauracao Florestal, Sao Paulo, Brazil; [do Couto, Hilton T. Z.] USP ESALQ, Dept Ciencias Florestais, Lab Metodos Quantitat, Sao Paulo, Brazil	Universidade Estadual Paulista; Universidade de Sao Paulo; Universidade de Sao Paulo	Fleury, M (corresponding author), Univ Estadual Paulista, Dept Ecol, Sao Paulo, Brazil.	marina.fleury@mac.com	Galetti, Mauro/C-5275-2008; Galetti, Mauro/M-8751-2013; Rodrigues, Ricardo Ribeiro/D-5557-2012	Galetti, Mauro/0000-0002-8187-8696; Galetti, Mauro/0000-0002-8187-8696; Rodrigues, Ricardo Ribeiro/0000-0003-4818-0736	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2004/13230-5, 2005/55093-7]; FAPESP; Conselho Nacional de Pesquisas	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Pesquisas	This work was funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (2004/13230-5 and 2005/55093-7). MF and RSB received fellowships from FAPESP, and MG, RRR and HTZ received fellowships from Conselho Nacional de Pesquisas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aide TM, 1994, RESTOR ECOL, V2, P219, DOI [10.1111/j.1526-100X.1994.tb00054.x, DOI 10.1111/J.1526-100X.1994.TB00054.X]; Aliaga-Rossel E, 2008, J TROP ECOL, V24, P367, DOI 10.1017/S0266467408005129; Asquith NM, 1999, J TROP ECOL, V15, P229, DOI 10.1017/S0266467499000772; Asquith NM, 1997, ECOLOGY, V78, P941, DOI 10.1890/0012-9658(1997)078[0941:DMCCCR]2.0.CO;2; BENCKE CINARA S.C., 2002, Braz. J. Bot., V25, P269, DOI 10.1590/S0100-84042002000300003; Blate GM, 1998, OIKOS, V82, P522, DOI 10.2307/3546373; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Bovendorp RS, 2007, BIOL INVASIONS, V9, P353, DOI 10.1007/s10530-006-9031-7; Bovendorp RS, 2013, MAMMALIA, V77, P51, DOI 10.1515/mammalia-2011-0099; BOWERS MA, 1993, OECOLOGIA, V94, P247, DOI 10.1007/BF00341324; Bowers MA, 1997, J MAMMAL, V78, P999, DOI 10.2307/1383044; Brancalion PHS, 2011, BIOTROPICA, V43, P12, DOI 10.1111/j.1744-7429.2010.00726.x; BUDOWSKI G, 1965, TURRIALBA, V15, P40; BURKEY TV, 1993, BIOL CONSERV, V66, P139, DOI 10.1016/0006-3207(93)90145-Q; Calderon-Miller L, 2008, THESIS UNESP RIO CLA; Campbell DJ, 2002, BIOL CONSERV, V107, P19, DOI 10.1016/S0006-3207(02)00039-3; Campbell DJ, 1999, J ROY SOC NEW ZEAL, V29, P265, DOI 10.1080/03014223.1999.9517597; Carson W., 2008, TROPICAL FOREST COMM, P367; Chazdon RL, 2008, SCIENCE, V320, P1458, DOI 10.1126/science.1155365; Cole RJ, 2009, BIOTROPICA, V41, P319, DOI 10.1111/j.1744-7429.2009.00490.x; CONNELL JH, 1977, AM NAT, V111, P1119, DOI 10.1086/283241; Dalling J. W., 2005, Seed fate: predation, dispersal and seedling establishment, P31, DOI 10.1079/9780851998060.0031; DAVIDSON DW, 1980, BIOSCIENCE, V30, P233, DOI 10.2307/1307877; Dirzo R, 2007, BIOTROPICA, V39, P355, DOI 10.1111/j.1744-7429.2007.00274.x; Donatti CI, 2009, ECOL RES, V24, P1187, DOI 10.1007/s11284-009-0601-x; Duncan RS, 2000, BIOTROPICA, V32, P33, DOI 10.1111/j.1744-7429.2000.tb00445.x; Ecroyd CE, 1996, NEW ZEAL J ECOL, V20, P81; Emsens WJ, 2013, BIOTROPICA, V45, P88, DOI 10.1111/j.1744-7429.2012.00888.x; Fadini RF, 2008, ACTA OECOL, DOI [10.1016/j.actao.2008.10.001, DOI 10.1016/J.ACTA0.2008.10.001]; Farwig N, 2012, BASIC APPL ECOL, V13, P109, DOI 10.1016/j.baae.2012.02.006; Fleury M, 2004, ACTA OECOL, V26, P179, DOI 10.1016/j.actao.2004.04.003; Fleury M, 2006, BIOL CONSERV, V131, P1, DOI 10.1016/j.biocon.2005.10.049; Forget Pierre-Michel, 2005, P379, DOI 10.1079/9780851998060.0000; Forget PM, 1996, J TROP ECOL, V12, P751, DOI 10.1017/S0266467400009998; FOURNIER LA, 1974, TURRIALBA, V24, P422; Galetti M, 2006, BOT J LINN SOC, V151, P141, DOI 10.1111/j.1095-8339.2006.00529.x; Galetti M, 2013, BIOL CONSERV, V163, P1, DOI 10.1016/j.biocon.2013.04.020; Galetti M, 2010, ZOOLOGIA-CURITIBA, V27, P472, DOI 10.1590/S1984-46702010000300022; Genini J, 2009, FLORA, V204, P131, DOI 10.1016/j.flora.2008.01.002; Guariguata MR, 2001, FOREST ECOL MANAG, V148, P185, DOI 10.1016/S0378-1127(00)00535-1; GUILLAUMON J.R., 1989, PLANO MANEJO PARQUE; Guimaraes Paulo R. Jr, 2008, PLoS ONE, V3, pUnpaginated, DOI 10.1371/journal.pone.0001745; Harrington Graham N., 1997, P292; Hill JK, 2004, J APPL ECOL, V41, P744, DOI 10.1111/j.0021-8901.2004.00926.x; Holl KD, 1997, BIOTROPICA, V29, P459, DOI 10.1111/j.1744-7429.1997.tb00040.x; Houghton RA, 2010, TELLUS B, V62, P337, DOI 10.1111/j.1600-0889.2010.00473.x; Howe HF, 1999, ECOLOGY, V80, P1776, DOI 10.1890/0012-9658(1999)080[1776:EOBARO]2.0.CO;2; HOWE HF, 1982, ANNU REV ECOL SYST, V13, P201, DOI 10.1146/annurev.es.13.110182.001221; HULME PE, 1994, J ECOL, V82, P645, DOI 10.2307/2261271; Hulme Philip E., 2005, P9, DOI 10.1079/9780851998060.0009; Jansen PA, 2004, ECOL MONOGR, V74, P569, DOI 10.1890/03-4042; Jansen PA, 2012, P NATL ACAD SCI USA, V109, P12610, DOI 10.1073/pnas.1205184109; Jansen PA, 2010, J TROP ECOL, V26, P473, DOI 10.1017/S0266467410000337; Jones ER, 2008, J TROP ECOL, V24, P259, DOI 10.1017/S026646740800494X; Kasangaki A, 2003, AFR J ECOL, V41, P115, DOI 10.1046/j.1365-2028.2003.00383.x; Krishna A, 2008, OIKOS, V117, P1609, DOI 10.1111/j.1600-0706.2008.16540.x; Legendre P., 2012, NUMERICAL ECOLOGY; LI-COR, 1991, PLANT CAN AN OP MAN; Luize BG, 2007, 2 WORKSH FEN COM FER; MATHER AS, 1992, AREA, V24, P367; McGarigal K., 2000, MULTIVARIATE STAT WI; Meyer ST, 2011, ECOL ENTOMOL, V36, P14, DOI 10.1111/j.1365-2311.2010.01241.x; Morellato LPC, 2000, BIOTROPICA, V32, P786, DOI 10.1111/j.1744-7429.2000.tb00618.x; Morris RJ, 2010, PHILOS T R SOC B, V365, P3709, DOI 10.1098/rstb.2010.0273; Muller-Landau H. C., 2002, Seed dispersal and frugivory: ecology, evolution and conservation. Third International Symposium-Workshop on Frugivores and Seed Dispersal, Sao Pedro, Brazil, 6-11 August 2000, P35, DOI 10.1079/9780851995250.0035; Muller-Landau HC, 2007, BIOTROPICA, V39, P372, DOI 10.1111/j.1744-7429.2007.00290.x; Munro NT, 2011, RESTOR ECOL, V19, P223, DOI 10.1111/j.1526-100X.2010.00703.x; Myster RW, 2004, PLANT ECOL, V172, P199, DOI 10.1023/B:VEGE.0000026338.57498.40; Nepstad DC, 1996, OIKOS, V76, P25, DOI 10.2307/3545745; Nogales M, 2012, NEW PHYTOL, V194, P313, DOI 10.1111/j.1469-8137.2011.04051.x; Notman E, 2001, BIOTROPICA, V33, P621, DOI 10.1111/j.1744-7429.2001.tb00220.x; Notman Evan M., 2005, P55, DOI 10.1079/9780851998060.0055; OSUNKOYA OO, 1994, AUST J ECOL, V19, P52, DOI 10.1111/j.1442-9993.1994.tb01543.x; Palmer M. A., 2006, FDN RESTORATION ECOL, P1; Pardini R, 2005, BIOL CONSERV, V124, P253, DOI 10.1016/j.biocon.2005.01.033; Pardini R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013666; Pena-Claros M, 2002, J TROP ECOL, V18, P261, DOI 10.1017/S0266467402002171; PICKETT STA, 1987, BOT REV, V53, P335, DOI 10.1007/BF02858321; Puttker T, 2008, STUD NEOTROP FAUNA E, V43, P11, DOI 10.1080/01650520701553651; R Core Team, 2021, R LANGUAGE ENV STAT; Rees M, 2001, SCIENCE, V293, P650, DOI 10.1126/science.1062586; Rodrigues RR, 2009, BIOL CONSERV, V142, P1242, DOI 10.1016/j.biocon.2008.12.008; Silvius KM, 2003, BIOTROPICA, V35, P74, DOI 10.1111/j.1744-7429.2003.tb00264.x; Silvius KM, 2002, J TROP ECOL, V18, P707, DOI 10.1017/S0266467402002468; Suntsov VV, 2003, MAMMALIA, V67, P379, DOI 10.1515/mamm.2003.67.3.379; Svenning JC, 2008, J BIOGEOGR, V35, P394, DOI 10.1111/j.1365-2699.2007.01841.x; Terborgh J., 2002, Seed dispersal and frugivory: ecology, evolution and conservation. Third International Symposium-Workshop on Frugivores and Seed Dispersal, Sao Pedro, Brazil, 6-11 August 2000, P1, DOI 10.1079/9780851995250.0001; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397; THOMPSON K, 1993, FUNCT ECOL, V7, P236, DOI 10.2307/2389893; Umetsu F, 2007, LANDSCAPE ECOL, V22, P517, DOI 10.1007/s10980-006-9041-y; Urbas P, 2007, BIOTROPICA, V39, P489, DOI 10.1111/j.1744-7429.2007.00285.x; Vander Wall SB, 2005, ECOLOGY, V86, P801, DOI 10.1890/04-0847; Vander Wall SB, 2004, TRENDS ECOL EVOL, V19, P155, DOI 10.1016/j.tree.2003.12.004; Vander Wall SB., 1990, FOOD HOARDING ANIMAL; Wijdeven SMJ, 2000, RESTOR ECOL, V8, P414, DOI 10.1046/j.1526-100x.2000.80056.x; Wilder SM, 2005, OECOLOGIA, V144, P391, DOI 10.1007/s00442-005-0086-4; Williams PA, 2000, AUSTRAL ECOL, V25, P523, DOI 10.1046/j.1442-9993.2000.01078.x; Wilson DJ, 2007, ECOGRAPHY, V30, P105, DOI [10.1111/j.2006.0906-7590.04771.x, 10.1111/j.0906-7590.2007.04771.x]; Wirth R, 2007, J TROP ECOL, V23, P501, DOI 10.1017/S0266467407004221; Wright SJ, 2010, ANN NY ACAD SCI, V1195, P1, DOI [10.1111/j.1749-6632.2009.05400.x, 10.1111/j.1749-6632.2010.05455.x]; Wright SJ, 2002, OECOLOGIA, V130, P1, DOI 10.1007/s004420100809; Wuethrich B, 2007, SCIENCE, V315, P1070, DOI 10.1126/science.315.5815.1070; Zar JH, 1998, BIOSTATITICAL ANAL	103	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e90060	10.1371/journal.pone.0090060	http://dx.doi.org/10.1371/journal.pone.0090060			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614500	Green Published, gold, Green Submitted			2022-12-27	WOS:000332839300016
J	Krin, E; Cambray, G; Mazel, D				Krin, Evelyne; Cambray, Guillaume; Mazel, Didier			The Superintegron Integrase and the Cassette Promoters Are Co-Regulated in Vibrio cholerae	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE GENES; CYCLIC-AMP; ESCHERICHIA-COLI; PROTEIN COMPLEX; EXPRESSION; TRANSCRIPTION; VIRULENCE; TOXIN; COLONIZATION; ENVIRONMENT	Chromosome 2 of Vibrio cholerae carries a chromosomal superintegron, composed of an integrase, a cassette integration site (attI) and an array of mostly promoterless gene cassettes. We determined the precise location of the promoter, Pc, which drives the transcription of the first cassettes of the V. cholerae superintegron. We found that cassette mRNA starts 65 bp upstream of the attI site, so that the inversely oriented promoters Pc and Pint (integrase promoter) partly overlap, allowing for their potential co-regulation. Pint was previously shown to be induced during the SOS response and is further controlled by the catabolite repression cAMP-CRP complex. We found that cassette expression from Pc was also controlled by the cAMP-CRP complex, but is not part of the SOS regulon. Pint and Pc promoters were both found to be induced in rich medium, at high temperature, high salinity and at the end of exponential growth phase, although at very different levels and independently of sigma factor RpoS. All these results show that expression from the integrase and cassette promoters can take place at the same time, thus leading to coordinated excisions and integrations within the superintegron and potentially coupling cassette shuffling to immediate selective advantage.	[Krin, Evelyne; Cambray, Guillaume; Mazel, Didier] Inst Pasteur, Dept Genomes & Genet, Unite Plasticite Genome Bacterien, Paris, France; [Krin, Evelyne; Mazel, Didier] CNRS, UMR 3525, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Mazel, D (corresponding author), Inst Pasteur, Dept Genomes & Genet, Unite Plasticite Genome Bacterien, Paris, France.	mazel@pasteur.fr	Cambray, Guillaume/A-9476-2015; Mazel, Didier/F-9200-2013	Cambray, Guillaume/0000-0003-0087-2469; Mazel, Didier/0000-0001-6482-6002	Institut Pasteur; Centre National de la Recherche Scientifique [CNRS-UMR3525]; French National Research Agency [ANR-2012-Blanc SVSE3-DynamINT]; French Government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases" [ANR-10-LABX-62-IBEID]; European Union	Institut Pasteur(European Commission); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); French National Research Agency(French National Research Agency (ANR)); French Government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases"(French National Research Agency (ANR)); European Union(European Commission)	This study was funded by the Institut Pasteur, the Centre National de la Recherche Scientifique (CNRS-UMR3525), the French National Research Agency (ANR-2012-Blanc SVSE3-DynamINT), the French Government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases" (grant noANR-10-LABX-62-IBEID) and the European Union Seventh Framework Programme (FP7-HEALTH-2011-single-stage) "Evolution and Transfer of Antibiotic Resistance" (EvoTAR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AYEKYAW, 1990, BIOCHEM MED METAB B, V43, P80, DOI 10.1016/0885-4505(90)90011-O; Baharoglu Z, 2012, J BACTERIOL, V194, P1659, DOI 10.1128/JB.05982-11; Baharoglu Z, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001165; Barnard A, 2004, CURR OPIN MICROBIOL, V7, P102, DOI 10.1016/j.mib.2004.02.011; Biskri L, 2005, J BACTERIOL, V187, P1740, DOI 10.1128/JB.187.5.1740-1750.2005; Biskri L, 2003, ANTIMICROB AGENTS CH, V47, P3326, DOI 10.1128/AAC.47.10.3326-3331.2003; Boucher Y, 2011, MBIO, V2, DOI 10.1128/mBio.00335-10; Butala M, 2008, FEMS MICROBIOL LETT, V283, P104, DOI 10.1111/j.1574-6968.2008.01161.x; Cambray G, 2010, ANNU REV GENET, V44, P141, DOI 10.1146/annurev-genet-102209-163504; COLLIS CM, 1995, ANTIMICROB AGENTS CH, V39, P155, DOI 10.1128/AAC.39.1.155; Collis CM, 2002, J BACTERIOL, V184, P3017, DOI 10.1128/JB.184.11.3017-3026.2002; da Fonseca EL, 2011, J ANTIMICROB CHEMOTH, V66, P797, DOI 10.1093/jac/dkr011; Demarre G, 2005, RES MICROBIOL, V156, P245, DOI 10.1016/j.resmic.2004.09.007; DEPAOLA A, 1987, APPL ENVIRON MICROB, V53, P1181, DOI 10.1128/AEM.53.5.1181-1182.1987; DiRita V.J., 2001, PRINCIPLES BACTERIAL, P457; Erill I, 2003, BIOINFORMATICS, V19, P2225, DOI 10.1093/bioinformatics/btg303; Erill I, 2007, FEMS MICROBIOL REV, V31, P637, DOI 10.1111/j.1574-6976.2007.00082.x; Guerin E, 2011, J BACTERIOL, V193, P5675, DOI 10.1128/JB.05246-11; Guerin E, 2009, SCIENCE, V324, P1034, DOI 10.1126/science.1172914; Guerout AM, 2013, J BACTERIOL, V195, P2270, DOI 10.1128/JB.01389-12; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; Hommais F, 2004, MICROBIOL-SGM, V150, P61, DOI 10.1099/mic.0.26659-0; Jove T, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000793; Krin E, 2010, RES MICROBIOL, V161, P363, DOI 10.1016/j.resmic.2010.04.002; Le Roux F, 2009, ENVIRON MICROBIOL, V11, P1959, DOI 10.1111/j.1462-2920.2009.01918.x; Lee HJ, 2008, J BIOL CHEM, V283, P30438, DOI 10.1074/jbc.M802219200; Lee SH, 1999, CELL, V99, P625, DOI 10.1016/S0092-8674(00)81551-2; LEVESQUE C, 1994, GENE, V142, P49, DOI 10.1016/0378-1119(94)90353-0; Liang W, 2007, MICROBIOL-SGM, V153, P2964, DOI 10.1099/mic.0.2007/006668-0; Mazel D, 1998, SCIENCE, V280, P605, DOI 10.1126/science.280.5363.605; Michael CA, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-82; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Mishra A, 2003, J MED MICROBIOL, V52, P933, DOI 10.1099/jmm.0.05171-0; Nielsen AT, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001102; OGAWA A, 1993, MICROBIOL IMMUNOL, V37, P607, DOI 10.1111/j.1348-0421.1993.tb01683.x; Partridge SR, 2009, FEMS MICROBIOL REV, V33, P757, DOI 10.1111/j.1574-6976.2009.00175.x; Quinones M, 2005, MOL CELL, V17, P291, DOI 10.1016/j.molcel.2004.11.046; Rapa RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058430; Rowe-Magnus DA, 2003, GENOME RES, V13, P428, DOI 10.1101/gr.617103; Rowe-Magnus DA, 1999, RES MICROBIOL, V150, P641, DOI 10.1016/S0923-2508(99)00127-8; Rowe-Magnus DA, 2002, MOL MICROBIOL, V43, P1657, DOI 10.1046/j.1365-2958.2002.02861.x; Rowe-Magnus DA, 2001, P NATL ACAD SCI USA, V98, P652, DOI 10.1073/pnas.98.2.652; SCHAFER DE, 1970, P NATL ACAD SCI USA, V67, P851, DOI 10.1073/pnas.67.2.851; Skorupski K, 1997, P NATL ACAD SCI USA, V94, P265, DOI 10.1073/pnas.94.1.265; Soutourina O, 1999, J BACTERIOL, V181, P7500, DOI 10.1128/JB.181.24.7500-7508.1999; Szekeres S, 2007, MOL MICROBIOL, V63, P1588, DOI 10.1111/j.1365-2958.2007.05613.x; TADDEI F, 1995, P NATL ACAD SCI USA, V92, P11736, DOI 10.1073/pnas.92.25.11736; van Dongen WMAM, 1987, MOL GEN LIFE SCI ADV, V6, P85; Vital M, 2007, MICROBIOL-SGM, V153, P1993, DOI 10.1099/mic.0.2006/005173-0; Yildiz FH, 1998, J BACTERIOL, V180, P773, DOI 10.1128/JB.180.4.773-784.1998	50	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91194	10.1371/journal.pone.0091194	http://dx.doi.org/10.1371/journal.pone.0091194			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614503	Green Published, Green Submitted, gold			2022-12-27	WOS:000332839300094
J	Tang, BZ; Chen, J; Hou, YM; Meng, E				Tang, Baozhen; Chen, Jun; Hou, Youming; Meng, E.			Transcriptome Immune Analysis of the Invasive Beetle Octodonta nipae (Maulik) (Coleoptera: Chrysomelidae) Parasitized by Tetrastichus brontispae Ferriere (Hymenoptera: Eulophidae)	PLOS ONE			English	Article							PLUTELLA-XYLOSTELLA; INTEGRIN BETA-1; INNATE IMMUNITY; MANDUCA-SEXTA; RHO-GTPASES; INSECT; RESPONSES; ENCAPSULATION; STRATEGIES; PROTEINS	The beetle Octodonta nipae (Maulik) (Coleoptera: Chrysomelidae) is a serious invasive insect pest of palm plants in southern China, and the endoparasitoid Tetrastichus brontispae Ferriere (Hymenoptera: Eulophidae) is a natural enemy of this pest that exhibits great ability in the biocontrol of O. nipae. For successful parasitism, endoparasitoids often introduce or secrete various virulence factors to suppress host immunity. To investigate the effects of parasitization by T. brontispae on the O. nipae immune system, the transcriptome of O. nipae pupae was analyzed with a focus on immune-related genes through Illumina sequencing. De novo assembly generated 49,919 unigenes with a mean length of 598 bp. Of these genes, 27,490 unigenes (55.1% of all unigenes) exhibited clear homology to known genes in the NCBI nr database. Parasitization had significant effects on the transcriptome profile of O. nipae pupae, and most of these differentially expressed genes were down-regulated. Importantly, the expression profiles of immune-related genes were significantly regulated after parasitization. Taken together, these transcriptome sequencing efforts shed valuable light on the host (O. nipae) manipulation mechanisms induced by T. brontispae, which will pave the way for the development of novel immune defense-based management strategies of O. nipae, and provide a springboard for further molecular analyses, particularly of O. nipae invasion.	[Tang, Baozhen; Chen, Jun; Hou, Youming; Meng, E.] Fujian Agr & Forestry Univ, Dept Plant Protect, Fujian Prov Key Lab Insect Ecol, Fuzhou, Fujian, Peoples R China; [Tang, Baozhen; Chen, Jun; Hou, Youming; Meng, E.] Minist Agr, Key Lab Integrated Pest Management Crops Fujian T, Fuzhou, Fujian, Peoples R China	Fujian Agriculture & Forestry University; Ministry of Agriculture & Rural Affairs	Hou, YM (corresponding author), Fujian Agr & Forestry Univ, Dept Plant Protect, Fujian Prov Key Lab Insect Ecol, Fuzhou, Fujian, Peoples R China.	ymhou@fafu.edu.cn		Hou, Youming/0000-0001-7984-9688	National Natural Science Foundation of China [31071749, 31272108, 31301727]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by grants from the National Natural Science Foundation of China (31071749, 31272108 and 31301727). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Latief M, 2008, INSECT BIOCHEM MOLEC, V38, P136, DOI 10.1016/j.ibmb.2007.10.001; Asgari S, 2006, ARCH INSECT BIOCHEM, V61, P146, DOI 10.1002/arch.20109; Asgari S, 2012, PARASITOID VIRUSES: SYMBIONTS AND PATHOGENS, P217, DOI 10.1016/B978-0-12-384858-1.00018-7; Asgari S, 2011, ANNU REV ENTOMOL, V56, P313, DOI 10.1146/annurev-ento-120709-144849; Askew R.R., 1986, P225; Barandoc KP, 2010, J MICROBIOL, V48, P117, DOI 10.1007/s12275-009-9261-3; Beck MH, 2007, P NATL ACAD SCI USA, V104, P19267, DOI 10.1073/pnas.0708056104; Beckage NE, 2004, ANNU REV ENTOMOL, V49, P299, DOI 10.1146/annurev.ento.49.061802.123324; Boutros M, 2002, DEV CELL, V3, P711, DOI 10.1016/S1534-5807(02)00325-8; Brown NH, 2002, DEV CELL, V3, P569, DOI 10.1016/S1534-5807(02)00290-3; Bulet P, 1999, DEV COMP IMMUNOL, V23, P329, DOI 10.1016/S0145-305X(99)00015-4; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Cerenius L, 2008, TRENDS IMMUNOL, V29, P263, DOI 10.1016/j.it.2008.02.009; Cho MY, 1999, EUR J BIOCHEM, V262, P737, DOI 10.1046/j.1432-1327.1999.00416.x; Christensen BM, 2005, TRENDS PARASITOL, V21, P192, DOI 10.1016/j.pt.2005.02.007; Christophides GK, 2002, SCIENCE, V298, P159, DOI 10.1126/science.1077136; Colinet D, 2009, DEV COMP IMMUNOL, V33, P681, DOI 10.1016/j.dci.2008.11.013; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Etebari K, 2012, DEV COMP IMMUNOL, V38, P517, DOI 10.1016/j.dci.2012.08.006; Etebari K, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-446; Fang Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026888; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gunaratna RT, 2013, DEV COMP IMMUNOL, V39, P388, DOI 10.1016/j.dci.2012.10.004; Hou YM, 2010, ENVIRON ENTOMOL, V39, P1676, DOI 10.1603/EN10015; Howard F.W., 2001, INSECTS PALMS, V131, DOI [10.1079/9780851993263.0000, DOI 10.1079/9780851993263.0000]; Hu JA, 2010, J INSECT PHYSIOL, V56, P1846, DOI 10.1016/j.jinsphys.2010.08.001; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Kaeslin M, 2010, J INSECT PHYSIOL, V56, P686, DOI 10.1016/j.jinsphys.2009.12.005; Keeling CI, 2012, INSECT BIOCHEM MOLEC, V42, P525, DOI 10.1016/j.ibmb.2012.03.010; Kim T, 2005, J BIOCHEM MOL BIOL, V38, P121; Lavine MD, 2003, INSECT MOL BIOL, V12, P441, DOI 10.1046/j.1365-2583.2003.00428.x; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Levin DM, 2005, INSECT BIOCHEM MOLEC, V35, P369, DOI 10.1016/j.ibmb.2005.01.003; Lu Z, 2008, J BIOL CHEM, V283, P21325, DOI 10.1074/jbc.M801593200; Moon SY, 2003, TRENDS CELL BIOL, V13, P13, DOI 10.1016/S0962-8924(02)00004-1; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; NAPPI AJ, 1993, PIGM CELL RES, V6, P117, DOI 10.1111/j.1600-0749.1993.tb00590.x; Nappi AJ, 2005, INSECT BIOCHEM MOLEC, V35, P443, DOI 10.1016/j.ibmb.2005.01.014; NOBES C, 1994, CURR OPIN GENET DEV, V4, P77, DOI 10.1016/0959-437X(94)90094-9; Pennacchio F, 2006, ANNU REV ENTOMOL, V51, P233, DOI 10.1146/annurev.ento.51.110104.151029; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Schlenke TA, 2007, PLOS PATHOG, V3, P1486, DOI 10.1371/journal.ppat.0030158; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Song KH, 2008, J INSECT PHYSIOL, V54, P1271, DOI 10.1016/j.jinsphys.2008.06.010; Vassiliou VA, 2011, PHYTOPARASITICA, V39, P51, DOI 10.1007/s12600-010-0128-2; Williams MJ, 2006, J CELL SCI, V119, P2015, DOI 10.1242/jcs.02920; Williams MJ, 2005, GENES CELLS, V10, P813, DOI 10.1111/j.1365-2443.2005.00883.x; Xu Li, 2011, Chinese Journal of Applied Entomology, V48, P922; Xu QY, 2012, DEV COMP IMMUNOL, V37, P438, DOI 10.1016/j.dci.2012.02.003; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zheng Y, 2001, TRENDS BIOCHEM SCI, V26, P724, DOI 10.1016/S0968-0004(01)01973-9; Zhu Jia-Ying, 2013, PLoS ONE, V8, pe54411, DOI 10.1371/journal.pone.0054411; ZHU JY, 2012, PLOS ONE, V7; Zhuang S, 2008, DEV COMP IMMUNOL, V32, P365, DOI 10.1016/j.dci.2007.07.007; Zhuang SF, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M700341200; Zou Z, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r177	56	46	50	3	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91482	10.1371/journal.pone.0091482	http://dx.doi.org/10.1371/journal.pone.0091482			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614330	Green Published, Green Submitted, gold			2022-12-27	WOS:000332839300132
J	Tinetti, ME; Han, L; McAvay, GJ; Lee, DSH; Peduzzi, P; Dodson, JA; Gross, CP; Zhou, BQ; Lin, HQ				Tinetti, Mary E.; Han, Ling; McAvay, Gail J.; Lee, David S. H.; Peduzzi, Peter; Dodson, John A.; Gross, Cary P.; Zhou, Bingqing; Lin, Haiqun			Anti-Hypertensive Medications and Cardiovascular Events in Older Adults with Multiple Chronic Conditions	PLOS ONE			English	Article							BLOOD-PRESSURE; BIAS REDUCTION; AGED 85; HYPERTENSION; METAANALYSIS; PEOPLE; DISEASE; TRIAL	Importance: Randomized trials of anti-hypertensive treatment demonstrating reduced risk of cardiovascular events in older adults included participants with less comorbidity than clinical populations. Whether these results generalize to all older adults, most of whom have multiple chronic conditions, is uncertain. Objective: To determine the association between anti-hypertensive medications and CV events and mortality in a nationally representative population of older adults. Design: Competing risk analysis with propensity score adjustment and matching in the Medicare Current Beneficiary Survey cohort over three-year follow-up through 2010. Participants and Setting: 4,961 community-living participants with hypertension. Exposure: Anti-hypertensive medication intensity, based on standardized daily dose for each anti-hypertensive medication class participants used. Main Outcomes and Measures: Cardiovascular events (myocardial infarction, unstable angina, cardiac revascularization, stroke, and hospitalizations for heart failure) and mortality. Results: Of 4,961 participants, 14.1% received no anti-hypertensives; 54.6% received moderate, and 31.3% received high, anti-hypertensive intensity. During follow-up, 1,247 participants (25.1%) experienced cardiovascular events; 837 participants (16.9%) died. Of deaths, 430 (51.4%) occurred in participants who experienced cardiovascular events during follow-up. In the propensity score adjusted cohort, after adjusting for propensity score and other covariates, neither moderate (adjusted hazard ratio, 1.08 [95% CI, 0.89-1.32]) nor high (1.16 [0.94-1.43]) anti-hypertensive intensity was associated with experiencing cardiovascular events. The hazard ratio for death among all participants was 0.79 [0.65-0.97] in the moderate, and 0.72 [0.58-0.91] in the high intensity groups compared with those receiving no anti-hypertensives. Among participants who experienced cardiovascular events, the hazard ratio for death was 0.65 [0.48-0.87] and 0.58 [0.42-0.80] in the moderate and high intensity groups, respectively. Results were similar in the propensity score-matched subcohort. Conclusions and Relevance: In this nationally representative cohort of older adults, anti-hypertensive treatment was associated with reduced mortality but not cardiovascular events. Whether RCT results generalize to older adults with multiple chronic conditions remains uncertain.	[Tinetti, Mary E.; Han, Ling; McAvay, Gail J.; Gross, Cary P.] Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA; [Tinetti, Mary E.; Peduzzi, Peter; Zhou, Bingqing] Yale Univ, Sch Publ Hlth, New Haven, CT USA; [Lee, David S. H.] Oregon Hlth & Sci Univ, Oregon State Univ, Coll Pharm, Portland, OR USA; [Dodson, John A.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA	Yale University; Yale University; Oregon Health & Science University; Oregon State University; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Tinetti, ME (corresponding author), Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA.	mary.tinetti@yale.edu		Lin, Haiqun/0000-0002-3114-9671	National Institute on Aging [R01 AG038528]; Yale Pepper Center from the National Institute on Aging [P30 AG021342]; NATIONAL INSTITUTE ON AGING [R01AG038528, P30AG021342] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Yale Pepper Center from the National Institute on Aging; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was funded by R01 AG038528 from the National Institute on Aging and by the Yale Pepper Center (P30 AG021342) from the National Institute on Aging. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison P. D., 1999, LOGISTIC REGRESSION; Andrade SE, 2012, PHARMACOEPIDEM DR S, V21, P100, DOI 10.1002/pds.2312; Aronow WS, 2011, J AM COLL CARDIOL, V57, P2037, DOI 10.1016/j.jacc.2011.01.008; Austin PC, 2008, STAT MED, V27, P2037, DOI 10.1002/sim.3150; Beckett N, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7541; Beckett NS, 2008, NEW ENGL J MED, V358, P1887, DOI 10.1056/NEJMoa0801369; Bejan-Angoulvant T, 2010, J HYPERTENS, V28, P1366, DOI 10.1097/HJH.0b013e328339f9c5; Biskupiak JE, 2010, J CLIN HYPERTENS, V12, P935, DOI 10.1111/j.1751-7176.2010.00362.x; Chen J, 2010, CIRCULATION, V121, P1322, DOI 10.1161/CIRCULATIONAHA.109.862094; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Danaei G, 2012, AM J EPIDEMIOL, V175, P250, DOI 10.1093/aje/kwr301; Denardo SJ, 2010, AM J MED, V123, P719, DOI 10.1016/j.amjmed.2010.02.014; Dhruva SS, 2008, ARCH INTERN MED, V168, P136, DOI 10.1001/archinternmed.2007.56; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Fang Jing, 2012, Morbidity and Mortality Weekly Report, V61, P379; Faries DE, 2010, ANALYSIS OF OBSERVAT; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Goldstein LB, 2011, STROKE, V42, P517, DOI 10.1161/STR.0b013e3181fcb238; Gu QP, 2012, CIRCULATION, V126, P2105, DOI 10.1161/CIRCULATIONAHA.112.096156; Gueyffier F, 1999, LANCET, V353, P793, DOI 10.1016/S0140-6736(98)08127-6; Hosmer DW, 1999, WILEY PS TX; Jatos Study Grp, 2008, HYPERTENS RES, V31, P2115, DOI 10.1291/hypres.31.2115; Johnson ES, 2013, PHARMACOEPIDEM DR S, V22, P1, DOI 10.1002/pds.3334; Kohl M, 2012, TECHNICAL REPORT 08; Leon AC, 2007, STAT MED, V26, P110, DOI 10.1002/sim.2458; Messerli FH, 2006, ANN INTERN MED, V144, P884, DOI 10.7326/0003-4819-144-12-200606200-00005; Molander L, 2008, J AM GERIATR SOC, V56, P1853, DOI 10.1111/j.1532-5415.2008.01948.x; Musini VM, 2009, COCHRANE DATABASE SY, V7; National Institute for Health and Clinical Excellence, HYPERTENSION; Ogihara T, 2011, GERIATR GERONTOL INT, V11, P414, DOI 10.1111/j.1447-0594.2011.00690.x; Rastas S, 2006, J AM GERIATR SOC, V54, P912, DOI 10.1111/j.1532-5415.2006.00742.x; Smith SC, 2011, CIRCULATION, V124, P2458, DOI 10.1161/CIR.0b013e318235eb4d; Tinetti ME, 2014, JAMA INTERNAL MEDICI; Voko Z, 1999, HYPERTENSION, V34, P1181, DOI 10.1161/01.HYP.34.6.1181; WHO Collaborating Centre for Drug Statistics Methodology, 2013, GUIDELINES FOR ATC C; Woolcott JC, 2009, ARCH INTERN MED, V169, P1952, DOI 10.1001/archinternmed.2009.357; Xu R, 2000, BIOSTATISTICS, V1; Zhou BQ, 2012, BIOSTATISTICS, V13, P371, DOI 10.1093/biostatistics/kxr032	39	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e90733	10.1371/journal.pone.0090733	http://dx.doi.org/10.1371/journal.pone.0090733			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614535	gold, Green Submitted, Green Published			2022-12-27	WOS:000332839300036
J	Hayat, T; Ashraf, MB; Alsulami, HH; Alhuthali, MS				Hayat, Tasawar; Ashraf, Muhammad Bilal; Alsulami, Hamed H.; Alhuthali, Muhammad Shahab			Three-Dimensional Mixed Convection Flow of Viscoelastic Fluid with Thermal Radiation and Convective Conditions	PLOS ONE			English	Article							BOUNDARY-LAYER-FLOW; MASS-TRANSFER; HEAT-TRANSFER; STAGNATION-POINT; CHEMICAL-REACTION; STRETCHING SHEET; MAXWELL FLUID; SLIP-FLOW; MHD FLOW; NANOFLUID	The objective of present research is to examine the thermal radiation effect in three-dimensional mixed convection flow of viscoelastic fluid. The boundary layer analysis has been discussed for flow by an exponentially stretching surface with convective conditions. The resulting partial differential equations are reduced into a system of nonlinear ordinary differential equations using appropriate transformations. The series solutions are developed through a modern technique known as the homotopy analysis method. The convergent expressions of velocity components and temperature are derived. The solutions obtained are dependent on seven sundry parameters including the viscoelastic parameter, mixed convection parameter, ratio parameter, temperature exponent, Prandtl number, Biot number and radiation parameter. A systematic study is performed to analyze the impacts of these influential parameters on the velocity and temperature, the skin friction coefficients and the local Nusselt number. It is observed that mixed convection parameter in momentum and thermal boundary layers has opposite role. Thermal boundary layer is found to decrease when ratio parameter, Prandtl number and temperature exponent are increased. Local Nusselt number is increasing function of viscoelastic parameter and Biot number. Radiation parameter on the Nusselt number has opposite effects when compared with viscoelastic parameter.	[Hayat, Tasawar; Ashraf, Muhammad Bilal] Quaid I Azam Univ, Dept Math, Islamabad, Pakistan; [Hayat, Tasawar; Alsulami, Hamed H.; Alhuthali, Muhammad Shahab] King Abdulaziz Univ, Fac Sci, Nonlinear Anal & Appl Math NAAM Res Grp, Jeddah 21413, Saudi Arabia	Quaid I Azam University; King Abdulaziz University	Ashraf, MB (corresponding author), Quaid I Azam Univ, Dept Math, Islamabad, Pakistan.	bilalashraf_qau@yahoo.com	Hayat, Tasawar/Y-2524-2019; Hayat, Tasawar/E-9449-2015; Hayat, Tasawar/A-3853-2013		Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah [26-130-35 Hi Ci]; DSR	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah; DSR	This paper was funded by the Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah, under grant number 26-130-35 Hi Ci. The authors, therefore, acknowledge with thanks DSR technical and financial support. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasbandy S, 2013, QUAEST MATH, V36, P93, DOI 10.2989/16073606.2013.780336; Abbasbandy S, 2012, UPB SCI B, V74; Al-Odat M. Q., 2006, International Journal of Applied Mechanics and Engineering, V11, P289; Aziz MAE, 2012, MATH PROBL ENG, V2012; Bhattacharyya K., 2010, J MATH MATH SCI, V25, P41; Bhattacharyya K, 2012, INT J HEAT MASS TRAN, V55, P2945, DOI 10.1016/j.ijheatmasstransfer.2012.01.051; Bhattacharyya K, 2011, CHINESE PHYS LETT, V28, DOI 10.1088/0256-307X/28/8/084702; Bhattacharyya K, 2011, INT COMMUN HEAT MASS, V38, P917, DOI 10.1016/j.icheatmasstransfer.2011.04.020; Cortell R, 2007, APPL MATH COMPUT, V184, P864, DOI 10.1016/j.amc.2006.06.077; Deger G, 2011, Z NATURFORSCH A, V66, P321, DOI 10.1515/zna-2011-0508; Elbashbeshy E. M. A., 2001, Archives of Mechanics, V53, P643; Ellahi R, 2013, APPL MATH MODEL, V37, P1451, DOI 10.1016/j.apm.2012.04.004; GUPTA PS, 1977, CAN J CHEM ENG, V55, P744, DOI 10.1002/cjce.5450550619; Hayat T, 2013, J THERMOPHYS HEAT TR, V27, P733, DOI 10.2514/1.T4039; Hayat T, 2013, APPL MATH MECH-ENGL, V34, P823, DOI 10.1007/s10483-013-1710-7; Hayat T, 2013, APPL MATH MECH-ENGL, V34, P153, DOI 10.1007/s10483-013-1660-8; Hayat T, 2011, APPL MATH MECH-ENGL, V32, P1119, DOI 10.1007/s10483-011-1486-6; Hayat T, 2010, INT J HEAT MASS TRAN, V53, P466, DOI 10.1016/j.ijheatmasstransfer.2009.09.010; Hayat T, 2009, NONLINEAR ANAL-REAL, V10, P1514, DOI 10.1016/j.nonrwa.2008.01.019; Jamil M, 2011, COMMUN NONLINEAR SCI, V16, P1378, DOI 10.1016/j.cnsns.2010.07.004; Jamil M, 2010, NONLINEAR ANAL-REAL, V11, P4302, DOI 10.1016/j.nonrwa.2010.05.016; Kandasamy R, 2011, NUCL ENG DES, V241, P2155, DOI 10.1016/j.nucengdes.2011.03.002; Keimanesh M, 2011, COMPUT MATH APPL, V62, P2871, DOI 10.1016/j.camwa.2011.07.054; Liao S., 2003, PERTURBATION INTRO H, DOI 10.1201/9780203491164; Liao S., 2012, HOMOTOPY ANAL METHOD; Liu IC, 2013, CHEM ENG COMMUN, V200, P253, DOI 10.1080/00986445.2012.703148; Liu JG, 2010, NONLINEAR ANAL-REAL, V11, P3066, DOI 10.1016/j.nonrwa.2009.10.026; Liu YP, 2013, J SYMB COMPUT, V55, P72, DOI 10.1016/j.jsc.2013.03.006; Magyari E, 1999, J PHYS D APPL PHYS, V32, P577, DOI 10.1088/0022-3727/32/5/012; Makinde OD, 2005, INT COMMUN HEAT MASS, V32, P1411, DOI 10.1016/j.icheatmasstransfer.2005.07.005; Mukhopadhyay S, 2013, CHINESE PHYS B, V22, DOI 10.1088/1674-1056/22/7/074701; Mukhopadhyay S, 2013, J APPL MECH-T ASME, V80, DOI 10.1115/1.4023618; Mustafaa M, 2013, INT J NUMER METHOD H, V23, P945, DOI 10.1108/HFF-09-2011-0179; Nadeem S, 2012, NANOSCALE RES LETT, V7, P1, DOI 10.1186/1556-276X-7-94; Nazar R., 2009, EUR J SCI RES, V29, P509; Pal D, 2010, APPL MATH COMPUT, V217, P2356, DOI 10.1016/j.amc.2010.07.035; Rashidi MM, 2014, INT J HEAT MASS TRAN, V70, P892, DOI 10.1016/j.ijheatmasstransfer.2013.11.058; Sajid M, 2008, INT COMMUN HEAT MASS, V35, P347, DOI 10.1016/j.icheatmasstransfer.2007.08.006; SAKIADIS BC, 1961, AICHE J, V7, P26, DOI 10.1002/aic.690070108; Sanjayanand E, 2006, INT J THERM SCI, V45, P819, DOI 10.1016/j.ijthermalsci.2005.11.002; Schlichting H, 1964, BOUNDARY LAYER THEOR; Turkyilmazoglu M, 2013, INT J HEAT MASS TRAN, V57, P82, DOI 10.1016/j.ijheatmasstransfer.2012.10.006; Turkyilmazoglu M, 2012, COMMUN NONLINEAR SCI, V17, P4097, DOI 10.1016/j.cnsns.2012.01.030; Turkyilmazoglu M, 2011, INT J THERM SCI, V50, P2264, DOI 10.1016/j.ijthermalsci.2011.05.014; Zheng LC, 2012, MATH COMPUT MODEL, V56, P133, DOI 10.1016/j.mcm.2011.11.080	45	28	28	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90038	10.1371/journal.pone.0090038	http://dx.doi.org/10.1371/journal.pone.0090038			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608594	Green Published, gold, Green Submitted			2022-12-27	WOS:000332485800013
J	Jossart, Q; Wattier, RA; Kastally, C; Aron, S; David, B; De Ridder, C; Rigaud, T				Jossart, Quentin; Wattier, Remi A.; Kastally, Chedly; Aron, Serge; David, Bruno; De Ridder, Chantal; Rigaud, Thierry			Genetic Evidence Confirms Polygamous Mating System in a Crustacean Parasite with Multiple Hosts	PLOS ONE			English	Article							SPERM COMPETITION; CHIONOECETES-OPILIO; LARVAL DEVELOPMENT; PATERNITY; BRACHYURA; PARENTAGE; FERTILIZATION; PINNOTHERIDAE; CONSEQUENCES; EVOLUTION	Mating systems are diverse in animals, notably in crustaceans, but can be inferred from a limited set of parameters. Baeza and Thiel (2007) proposed a model predicting mating systems of symbiotic crustaceans with three host characteristic and risk of predation. These authors proposed five mating systems, ranging from monogamy to polygynandry here pie mating occurs for both enders). Using microsatellite loci, we tested the putatively mating system ectoparasite crab Dissodactylus primitivus We determined the mating frequencies of ales and females, parentage assignment (COLONY & GERUD software) as well as the contents e ale sperrnathecae. Our results are globally consistent with the model of Baeza and Thiel and showed, together with previous aquarium experiments, that his ectoparasite evolved a polygamous mating system where males and females move between hosts for mate search. Parentage analyses vealed that polyandry is frequent and concerns more than 60% of clutches, with clutches being fertilized by up to 6 different fathers. Polygyny is supported by the detection of eight males having sired two different broods. We also detected a significant paternity skew in 92% of the multipaternal broods. Moreover, this skew probably higher than the estimation he brood because additional alleles were detected in most of spermathecae. This h skew could be explained by several factors as sperm competition or cryptic female choice. Our genetic data, combined with previous anatomic analyses provide consistent arguments to suggest sperm precedence in D. prirnitivus.	[Jossart, Quentin; Kastally, Chedly; De Ridder, Chantal] Univ Libre Bruxelles, Dept Biol Organismes, Lab Biol Marine, Brussels, Belgium; [Jossart, Quentin; Wattier, Remi A.; David, Bruno; Rigaud, Thierry] Univ Bourgogne, Biogeosci UMR CNRS 6282, Dijon, France; [Kastally, Chedly; Aron, Serge] Univ Libre Bruxelles, Dept Biol Organismes Behav & Evolutionary Ecol, Brussels, Belgium	Universite Libre de Bruxelles; Universite de Bourgogne; Universite Libre de Bruxelles	Jossart, Q (corresponding author), Univ Libre Bruxelles, Dept Biol Organismes, Lab Biol Marine, Brussels, Belgium.	qjossart@ulb.ac.be	Wattier, Remi/ABC-3410-2021; Rigaud, Thierry/T-4053-2017; Rigaud, Thierry/ABE-2552-2020	Rigaud, Thierry/0000-0002-0163-6639; Rigaud, Thierry/0000-0002-0163-6639; Jossart, Quentin/0000-0002-2280-243X	Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture - FRIA [1.E047.11F]; Conseil regional de Bourgogne [2012-9201AAO050505502]	Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture - FRIA(Fonds de la Recherche Scientifique - FNRS); Conseil regional de Bourgogne(Region Bourgogne-Franche-Comte)	This work was supported by a PhD grant (1.E047.11F) to Q. Jossart (Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture - FRIA) and a grant (2012-9201AAO050505502) from the Conseil regional de Bourgogne (programme PAK. It is a contribution of the Centre Interuniversitaire de Biologie Marine (CIBIM - Departement de Biologie des Organismes) and of the laboratory Biogeosciences (Centre National de la Recherche Scientifique, CNRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CM, 2010, MOL ECOL RESOUR, V10, P576, DOI 10.1111/j.1755-0998.2010.02851.x; Angeloni L, 2003, BEHAV ECOL, V14, P554, DOI 10.1093/beheco/arg033; [Anonymous], 1995, SEA STARS SEA URCHIN; Arnaud Ludovic, 1999, Biotechnologie Agronomie Societe et Environnement, V3, P86; Avise JC, 2011, P NATL ACAD SCI USA, V108, P11512, DOI 10.1073/pnas.1109216108; Baeza JA, 2013, J ZOOL, V289, P172, DOI 10.1111/j.1469-7998.2012.00974.x; Baeza JA, 2008, MAR BIOL, V153, P387, DOI 10.1007/s00227-007-0815-9; Baeza J. Antonio, 2007, P249; Baggio RA, 2011, MAR BIOL RES, V7, P520, DOI 10.1080/17451000.2010.528771; Bailie DA, 2011, MAR ECOL PROG SER, V421, P173, DOI 10.3354/meps08895; Becker C, 2011, J MORPHOL, V272, P12, DOI 10.1002/jmor.10884; BELL JL, 1983, MAR ECOL PROG SER, V13, P141, DOI 10.3354/meps013141; Bretman A, 2004, P ROY SOC B-BIOL SCI, V271, P159, DOI 10.1098/rspb.2003.2563; Caulier G, 2012, ZOOSYMPOSIA, V7, P177, DOI 10.11646/zoosymposia.7.1.17; De Bruyn C, 2010, MAR ECOL PROG SER, V398, P183, DOI 10.3354/meps08315; De Bruyn C, 2009, MAR ECOL PROG SER, V375, P173, DOI 10.3354/meps07733; EBERHARD WG, 1991, BIOL REV, V66, P1, DOI 10.1111/j.1469-185X.1991.tb01133.x; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Guichoux E, 2011, MOL ECOL RESOUR, V11, P591, DOI 10.1111/j.1755-0998.2011.03014.x; Jensen PC, 1996, BIOL BULL, V190, P336, DOI 10.2307/1543026; Jones AG, 2005, MOL ECOL NOTES, V5, P708, DOI 10.1111/j.1471-8286.2005.01029.x; Jones OR, 2010, MOL ECOL RESOUR, V10, P551, DOI 10.1111/j.1755-0998.2009.02787.x; Jossart Q, 2013, MAR ECOL PROG SER, V475, P167, DOI 10.3354/meps10131; Karaket T, 2012, AQUACULTURE, V324, P307, DOI 10.1016/j.aquaculture.2011.10.045; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; McDonald J.H., 2009, HDB BIOL STAT; McKeown NJ, 2008, MAR ECOL PROG SER, V368, P209, DOI 10.3354/meps07634; Moreau J, 2002, ANIM BEHAV, V64, P569, DOI 10.1006/anbe.2002.4000; Neff BD, 2002, J FISH BIOL, V61, P739, DOI 10.1111/j.1095-8649.2002.tb00908.x; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Ocampo EH, 2012, J EXP MAR BIOL ECOL, V429, P36, DOI 10.1016/j.jembe.2012.06.009; Pamilo P, 1996, OIKOS, V75, P533, DOI 10.2307/3545895; PARKER GA, 1970, BIOL REV, V45, P525, DOI 10.1111/j.1469-185X.1970.tb01176.x; Pearcy M, 2009, INSECT SOC, V56, P94, DOI 10.1007/s00040-008-1043-0; POHLE G, 1981, B MAR SCI, V31, P753; Ross DM, 1983, BIOL CRUSTACEA, V7; Sainte-Marie Bernard, 2007, P191; Sainte-Marie G, 2000, CAN J ZOOL, V78, P1902, DOI 10.1139/cjz-78-11-1902; SHUSTER SM, 2003, MG BEH ECOL, pR7; Shuster SM, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0046; Streiff R, 2004, MAR BIOTECHNOL, V6, P60, DOI 10.1007/s10126-003-0015-7; Takami Y, 2007, BEHAV ECOL, V18, P628, DOI 10.1093/beheco/arm022; TELFORD M, 1982, B MAR SCI, V32, P584; Thiel M, 2001, SYMBIOSIS, V30, P163; Urbani N, 1998, CAN J FISH AQUAT SCI, V55, P1104, DOI 10.1139/cjfas-55-5-1104; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vogt G, 2013, BIOL REV, V88, P81, DOI 10.1111/j.1469-185X.2012.00241.x; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Yue GH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012721; Yue GH, 2010, INT J BIOL SCI, V6, P107	51	26	26	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90680	10.1371/journal.pone.0090680	http://dx.doi.org/10.1371/journal.pone.0090680			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24609105	Green Published, gold			2022-12-27	WOS:000332485800043
J	Truong, TK; Guidon, A; Song, AW				Trong-Kha Truong; Guidon, Arnaud; Song, Allen W.			Cortical Depth Dependence of the Diffusion Anisotropy in the Human Cortical Gray Matter In Vivo	PLOS ONE			English	Article							SURFACE-BASED ANALYSIS; INDUCED PHASE ERRORS; CEREBRAL-CORTEX; K-SPACE; RADIAL ORGANIZATION; INHERENT CORRECTION; WATER DIFFUSION; BRAIN; MRI; RECONSTRUCTION	Diffusion tensor imaging (DTI) is typically used to study white matter fiber pathways, but may also be valuable to assess the microstructure of cortical gray matter. Although cortical diffusion anisotropy has previously been observed in vivo, its cortical depth dependence has mostly been examined in high-resolution ex vivo studies. This study thus aims to investigate the cortical depth dependence of the diffusion anisotropy in the human cortex in vivo on a clinical 3 T scanner. Specifically, a novel multishot constant-density spiral DTI technique with inherent correction of motion-induced phase errors was used to achieve a high spatial resolution (0.625x0.625x3 mm) and high spatial fidelity with no scan time penalty. The results show: (i) a diffusion anisotropy in the cortical gray matter, with a primarily radial diffusion orientation, as observed in previous ex vivo and in vivo studies, and (ii) a cortical depth dependence of the fractional anisotropy, with consistently higher values in the middle cortical lamina than in the deep and superficial cortical laminae, as observed in previous ex vivo studies. These results, which are consistent across subjects, demonstrate the feasibility of this technique for investigating the cortical depth dependence of the diffusion anisotropy in the human cortex in vivo.	[Trong-Kha Truong; Guidon, Arnaud; Song, Allen W.] Duke Univ, Brain Imaging & Anal Ctr, Durham, NC 27708 USA	Duke University	Truong, TK (corresponding author), Duke Univ, Brain Imaging & Anal Ctr, Durham, NC 27708 USA.	trongkha.truong@duke.edu	Truong, Trong-Kha/S-3089-2016	Truong, Trong-Kha/0000-0003-2699-1554	National Institutes of Health [R01EB012586, R01EB009483, R01NS075017]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009483, R01EB012586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075017] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health (grants R01EB012586, R01EB009483, and R01NS075017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anwander A., 2010, P INT SOC MAGN RESON, P109; Bock AS, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00149; Budde MD, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00003; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; deIpolyi AR, 2005, NEUROIMAGE, V27, P579, DOI 10.1016/j.neuroimage.2005.04.027; Dyrby TB, 2011, HUM BRAIN MAPP, V32, P544, DOI 10.1002/hbm.21043; Frank LR, 2010, NEUROIMAGE, V49, P1510, DOI 10.1016/j.neuroimage.2009.09.010; Gupta RK, 2005, J NEUROSCI RES, V81, P172, DOI 10.1002/jnr.20547; Heidemann RM, 2012, NEUROIMAGE, V60, P967, DOI 10.1016/j.neuroimage.2011.12.081; Heidemann RM, 2010, MAGN RESON MED, V64, P9, DOI 10.1002/mrm.22480; Jaermann T, 2008, AM J NEURORADIOL, V29, P146, DOI 10.3174/ajnr.A0742; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Kleinnijenhuis M, 2011, P INT SOC MAG RESON, V19, P2085; Kleinnijenhuis M, 2013, CORTEX, V49, P2569, DOI 10.1016/j.cortex.2012.11.015; Kroenke CD, 2007, J NEUROSCI, V27, P12506, DOI 10.1523/JNEUROSCI.3063-07.2007; Leuze C. W., 2011, P INT SOC MAGNETIC R, V19, P2371; Leuze CWU, 2014, CEREB CORTEX, V24, P328, DOI 10.1093/cercor/bhs311; Leuze CW, 2012, P EUR SOC MAGN RESON, V29, P417; Leuze CWU, 2012, P INT SOC MAG RESON, V20, P3594; Liu CL, 2005, MAGN RESON MED, V54, P1412, DOI 10.1002/mrm.20706; Maas LC, 2004, NEUROIMAGE, V22, P1134, DOI 10.1016/j.neuroimage.2004.02.035; McKinstry RC, 2002, CEREB CORTEX, V12, P1237, DOI 10.1093/cercor/12.12.1237; McNab JA, 2013, NEUROIMAGE, V69, P87, DOI 10.1016/j.neuroimage.2012.11.065; Mcnab JA, 2009, NEUROIMAGE, V46, P775, DOI 10.1016/j.neuroimage.2009.01.008; Miller KL, 2011, NEUROIMAGE, V57, P167, DOI 10.1016/j.neuroimage.2011.03.070; Mukherjee P, 2006, NEUROIMAG CLIN N AM, V16, P19, DOI 10.1016/j.nic.2005.11.004; Pruessmann KP, 2001, MAGNET RESON MED, V46, P638, DOI 10.1002/mrm.1241; Ronen I, 2005, MAGN RESON MED, V54, P317, DOI 10.1002/mrm.20542; Sizonenko SPV, 2007, CEREB CORTEX, V17, P2609, DOI 10.1093/cercor/bhl168; Sotiropoulos SN, 2013, NEUROIMAGE, V80, P125, DOI 10.1016/j.neuroimage.2013.05.057; Takahashi E, 2010, NEUROIMAGE, V49, P1231, DOI 10.1016/j.neuroimage.2009.09.002; Thornton JS, 1997, MAGN RESON IMAGING, V15, P433, DOI 10.1016/S0730-725X(96)00378-5; Trivedi R, 2009, NEURORADIOLOGY, V51, P567, DOI 10.1007/s00234-009-0533-8; Truong TK, 2014, MAGN RESON MED, V71, P790, DOI 10.1002/mrm.24709; Truong TK, 2012, MAGN RESON MED, V68, P1255, DOI 10.1002/mrm.24124; Truong TK, 2011, NEUROIMAGE, V57, P1343, DOI 10.1016/j.neuroimage.2011.06.008; Van AT, 2011, IEEE T MED IMAGING, V30, P1933, DOI 10.1109/TMI.2011.2158654	37	26	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91424	10.1371/journal.pone.0091424	http://dx.doi.org/10.1371/journal.pone.0091424			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608869	Green Submitted, Green Published, gold			2022-12-27	WOS:000332485800134
J	Vassena, E; Silvetti, M; Boehler, CN; Achten, E; Fias, W; Verguts, T				Vassena, Eliana; Silvetti, Massimo; Boehler, Carsten N.; Achten, Eric; Fias, Wim; Verguts, Tom			Overlapping Neural Systems Represent Cognitive Effort and Reward Anticipation	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; ACUTE TRYPTOPHAN DEPLETION; MEDIAL PREFRONTAL CORTEX; RAPHE SEROTONIN NEURONS; INDIVIDUAL-DIFFERENCES; DOPAMINERGIC MIDBRAIN; BRAIN ACTIVATION; DECISION-MAKING; MENTAL FATIGUE; FUTURE REWARDS	Anticipating a potential benefit and how difficult it will be to obtain it are valuable skills in a constantly changing environment. In the human brain, the anticipation of reward is encoded by the Anterior Cingulate Cortex (ACC) and Striatum. Naturally, potential rewards have an incentive quality, resulting in a motivational effect improving performance. Recently it has been proposed that an upcoming task requiring effort induces a similar anticipation mechanism as reward, relying on the same cortico-limbic network. However, this overlapping anticipatory activity for reward and effort has only been investigated in a perceptual task. Whether this generalizes to high-level cognitive tasks remains to be investigated. To this end, an fMRI experiment was designed to investigate anticipation of reward and effort in cognitive tasks. A mental arithmetic task was implemented, manipulating effort (difficulty), reward, and delay in reward delivery to control for temporal confounds. The goal was to test for the motivational effect induced by the expectation of bigger reward and higher effort. The results showed that the activation elicited by an upcoming difficult task overlapped with higher reward prospect in the ACC and in the striatum, thus highlighting a pivotal role of this circuit in sustaining motivated behavior.	[Vassena, Eliana; Silvetti, Massimo; Boehler, Carsten N.; Fias, Wim; Verguts, Tom] Univ Ghent, Dept Expt Psychol, B-9000 Ghent, Belgium; [Vassena, Eliana; Silvetti, Massimo; Boehler, Carsten N.; Achten, Eric; Fias, Wim; Verguts, Tom] Ghent Univ Hosp, Ghent Inst Funct & Metab Imaging, Ghent, Belgium	Ghent University; Ghent University; Ghent University Hospital	Vassena, E (corresponding author), Univ Ghent, Dept Expt Psychol, B-9000 Ghent, Belgium.	Eliana.Vassena@UGent.be	Boehler, Carsten/J-8619-2015; Vassena, Eliana/R-4591-2019; Verguts, Tom/A-4792-2008; Fias, Wim/D-6861-2010; Vassena, Eliana/O-9984-2019; Silvetti, Massimo/V-3106-2019	Boehler, Carsten/0000-0001-5963-2780; Verguts, Tom/0000-0002-7783-4754; Fias, Wim/0000-0002-5788-7306; Vassena, Eliana/0000-0002-5761-6813; Silvetti, Massimo/0000-0002-2925-0615	Ghent University GOA [BOF08/GOA/011]	Ghent University GOA(Ghent University)	The authors EV, MS, WF and TV were supported by Ghent University GOA grant BOF08/GOA/011. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aarts E, 2008, J NEUROSCI, V28, P4671, DOI 10.1523/JNEUROSCI.4400-07.2008; Alexander WH, 2011, NAT NEUROSCI, V14, P1338, DOI 10.1038/nn.2921; Amat J, 2005, NAT NEUROSCI, V8, P365, DOI 10.1038/nn1399; Amiez C, 2006, CEREB CORTEX, V16, P1040, DOI 10.1093/cercor/bhj046; Assadi SM, 2009, NEUROSCI BIOBEHAV R, V33, P383, DOI 10.1016/j.neubiorev.2008.10.010; Aston-Jones G, 2005, J COMP NEUROL, V493, P99, DOI 10.1002/cne.20723; Bardgett ME, 2009, BEHAV NEUROSCI, V123, P242, DOI 10.1037/a0014625; Basten U, 2010, P NATL ACAD SCI USA, V107, P21767, DOI 10.1073/pnas.0908104107; Beierholm U, 2013, NEUROPSYCHOPHARMACOL, V38, P1495, DOI 10.1038/npp.2013.48; Berridge KC, 2004, PHYSIOL BEHAV, V81, P179, DOI 10.1016/j.physbeh.2004.02.004; Berridge KC, 2009, CURR OPIN PHARMACOL, V9, P65, DOI 10.1016/j.coph.2008.12.014; Boehler CN, 2011, J NEUROSCI, V31, P4955, DOI 10.1523/JNEUROSCI.4845-10.2011; Boksem MAS, 2008, BRAIN RES REV, V59, P125, DOI 10.1016/j.brainresrev.2008.07.001; Botvinick MM, 2009, COGN AFFECT BEHAV NE, V9, P16, DOI 10.3758/CABN.9.1.16; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Boureau YL, 2011, NEUROPSYCHOPHARMACOL, V36, P74, DOI 10.1038/npp.2010.151; Bromberg-Martin ES, 2010, J NEUROSCI, V30, P6262, DOI 10.1523/JNEUROSCI.0015-10.2010; CARVER CS, 1994, J PERS SOC PSYCHOL, V67, P319, DOI 10.1037/0022-3514.67.2.319; Cools R, 2005, PSYCHOPHARMACOLOGY, V180, P670, DOI 10.1007/s00213-005-2215-5; Cools R, 2008, NEUROPSYCHOPHARMACOL, V33, P2291, DOI 10.1038/sj.npp.1301598; Cools R, 2008, TRENDS COGN SCI, V12, P31, DOI 10.1016/j.tics.2007.10.011; Cools R, 2011, CURR OPIN NEUROBIOL, V21, P402, DOI 10.1016/j.conb.2011.04.002; Cools R, 2011, NEUROPSYCHOPHARMACOL, V36, P98, DOI 10.1038/npp.2010.121; Croxson PL, 2009, J NEUROSCI, V29, P4531, DOI 10.1523/JNEUROSCI.4515-08.2009; D'Ardenne K, 2008, SCIENCE, V319, P1264, DOI 10.1126/science.1150605; Engstrom M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00140; Green L, 2004, PSYCHOL BULL, V130, P769, DOI 10.1037/0033-2909.130.5.769; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Harmer CJ, 2006, BIOL PSYCHIAT, V59, P816, DOI 10.1016/j.biopsych.2005.10.015; Hubner R, 2010, PSYCHON B REV, V17, P821, DOI 10.3758/PBR.17.6.821; Imbo I, 2005, PSYCHOL BELG, V45, P101, DOI 10.5334/pb-45-2-101; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kennerley SW, 2009, J COGNITIVE NEUROSCI, V21, P1162, DOI 10.1162/jocn.2009.21100; Knutson B, 2005, CURR OPIN NEUROL, V18, P411, DOI 10.1097/01.wco.0000173463.24758.f6; Kobayashi S, 2008, J NEUROSCI, V28, P7837, DOI 10.1523/JNEUROSCI.1600-08.2008; Kong H, 2005, COGNITIVE BRAIN RES, V22, P397, DOI 10.1016/j.cogbrainres.2004.09.011; Krebs RM, 2012, CEREB CORTEX, V22, P607, DOI 10.1093/cercor/bhr134; Kurniawan IT, 2010, J NEUROPHYSIOL, V104, P313, DOI 10.1152/jn.00027.2010; Kurniawan IT, 2013, J NEUROSCI, V33, P6160, DOI 10.1523/JNEUROSCI.4777-12.2013; Kurniawan IT, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00081; Lallement JH, 2014, SOC COGN AFFECT NEUR, V9, P342, DOI 10.1093/scan/nss147; Levy DJ, 2011, J NEUROSCI, V31, P14693, DOI 10.1523/JNEUROSCI.2218-11.2011; Liu X, 2011, NEUROSCI BIOBEHAV R, V35, P1219, DOI 10.1016/j.neubiorev.2010.12.012; Lorist MM, 2005, COGNITIVE BRAIN RES, V24, P199, DOI 10.1016/j.cogbrainres.2005.01.018; Luks TL, 2002, NEUROIMAGE, V17, P792, DOI 10.1006/nimg.2002.1210; Luo S, 2009, J NEUROSCI, V29, P14820, DOI 10.1523/JNEUROSCI.4261-09.2009; Malecek NJ, 2013, BEHAV BRAIN SCI, V36, P698, DOI 10.1017/S0140525X13001106; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; McGuire JT, 2010, P NATL ACAD SCI USA, V107, P7922, DOI 10.1073/pnas.0910662107; Miyazaki K, 2011, J NEUROSCI, V31, P469, DOI 10.1523/JNEUROSCI.3714-10.2011; Miyazaki KW, 2012, J NEUROSCI, V32, P10451, DOI 10.1523/JNEUROSCI.0915-12.2012; Moeller SJ, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.110; Naccache L, 2005, NEUROPSYCHOLOGIA, V43, P1318, DOI 10.1016/j.neuropsychologia.2004.11.024; Naidic T, 2009, DUVERNOYS ATLAS HUMA; Nakagawa S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056606; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; Niv Y, 2007, PSYCHOPHARMACOLOGY, V191, P507, DOI 10.1007/s00213-006-0502-4; Oikawa H, 2002, AM J NEURORADIOL, V23, P1747; Park SQ, 2011, J NEUROSCI, V31, P9307, DOI 10.1523/JNEUROSCI.4973-10.2011; Pessiglione M, 2007, SCIENCE, V316, P904, DOI 10.1126/science.1140459; Peters J, 2011, TRENDS COGN SCI, V15, P227, DOI 10.1016/j.tics.2011.03.002; Raizada RDS, 2008, FRONT HUM NEUROSCI, V1, DOI 10.3389/neuro.09.003.2007; Rangel A, 2008, NAT REV NEUROSCI, V9, P545, DOI 10.1038/nrn2357; Robinson OJ, 2012, PSYCHOPHARMACOLOGY, V219, P599, DOI 10.1007/s00213-011-2410-5; Roesch MR, 2006, NEURON, V51, P509, DOI 10.1016/j.neuron.2006.06.027; Salamone JD, 2005, CURR OPIN PHARMACOL, V5, P34, DOI 10.1016/j.coph.2004.09.004; Salamone JD, 2007, PSYCHOPHARMACOLOGY, V191, P389, DOI 10.1007/s00213-006-0623-9; Salamone JD, 2012, NEURON, V76, P470, DOI 10.1016/j.neuron.2012.10.021; Schmidt L, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001266; Schultz W, 2000, ANNU REV NEUROSCI, V23, P473, DOI 10.1146/annurev.neuro.23.1.473; Schweighofer N, 2008, J NEUROSCI, V28, P4528, DOI 10.1523/JNEUROSCI.4982-07.2008; Schweighofer N, 2007, ANN NY ACAD SCI, V1104, P289, DOI 10.1196/annals.1390.011; Schweimer J, 2010, LEARN MEMORY, V13, P777; Shenhav A, 2013, NEURON, V79, P217, DOI 10.1016/j.neuron.2013.07.007; Silvetti M, 2013, CORTEX, V49, P1627, DOI 10.1016/j.cortex.2012.05.008; Silvetti M, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00075; Sohn MH, 2007, P NATL ACAD SCI USA, V104, P10330, DOI 10.1073/pnas.0703225104; Sterling P, 2012, PHYSIOL BEHAV, V106, P5, DOI 10.1016/j.physbeh.2011.06.004; Stoppel CM, 2011, BRAIN RES, V1383, P218, DOI 10.1016/j.brainres.2011.01.095; Tanaka SC, 2004, NAT NEUROSCI, V7, P887, DOI 10.1038/nn1279; Treadway MT, 2012, J NEUROSCI, V32, P6170, DOI 10.1523/JNEUROSCI.6459-11.2012; van der Veen FM, 2007, NEUROPSYCHOPHARMACOL, V32, P216, DOI 10.1038/sj.npp.1301212; Verguts T, 2009, TRENDS COGN SCI, V13, P252, DOI 10.1016/j.tics.2009.02.007; Walton ME, 2006, NEURAL NETWORKS, V19, P1302, DOI 10.1016/j.neunet.2006.03.005; Walton ME, 2008, ANN NY ACAD SCI, V44, P1; Woo CW, 2013, NEUROIMAGE	86	106	107	3	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91008	10.1371/journal.pone.0091008	http://dx.doi.org/10.1371/journal.pone.0091008			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC4IY	24608867	Green Submitted, Green Published, gold			2022-12-27	WOS:000332485800078
J	Zhang, YA; Zhu, JM; Yin, J; Tang, WQ; Guo, YM; Shen, XZ; Liu, TT				Zhang, Yi-An; Zhu, Ji-Min; Yin, Jie; Tang, Wen-Qing; Guo, Yan-Mei; Shen, Xi-Zhong; Liu, Tao-Tao			High Expression of Neuro-Oncological Ventral Antigen 1 Correlates with Poor Prognosis in Hepatocellular Carcinoma	PLOS ONE			English	Article							RNA-BINDING PROTEIN; TRANSLATIONAL REGULATION; IN-VITRO; RECEPTOR; GROWTH; CANCER; ANTIBODY; PATIENT; LIVER	Neuro-oncological ventral antigen 1 (Nova1) is a neuron-specific RNA-binding protein in human paraneoplastic opsoclonus-myoclonus ataxia accompanying with malignant tumors, but its role in hepatocellular carcinoma (HCC) remains elusive. In this study, we found that overexpressed intratumoral Nova1 was associated with poor survival rate and increased recurrence rate of HCC, especially early recurrence, and was an independent prognostic factor for overall survival rate and tumor recurrence. HCC cell lines over-expressing Nova1 exhibited greater potentials in cell proliferation, invasion and migration, while knockdown of Nova1 had the opposite effects. All these findings indicate that Nova1 may act as a prognostic marker for poor outcome and high recurrence in HCC.	[Zhang, Yi-An; Zhu, Ji-Min; Yin, Jie; Tang, Wen-Qing; Shen, Xi-Zhong] Fudan Univ, Zhongshan Hosp, Dept Gastroenterol, Shanghai 200433, Peoples R China; [Guo, Yan-Mei] Tongji Univ, Peoples Hosp 10, Dept Gastroenterol, Shanghai 200092, Peoples R China	Fudan University; Tongji University		liu.taotao@zs-hospital.sh.cn	zhu, jimin/HDN-1451-2022; liu, taotao/GSI-7460-2022	Zhu, Ji-Min/0000-0002-2150-473X	Shanghai Science and Technology Commission [10410709400, 10411950100]; National Nature Science Foundation of China [81000968, 81101540, 81101637, 81172273]; National Clinical Key Special Subject of China; China Postdoctoral Science Foundation	Shanghai Science and Technology Commission(Shanghai Science & Technology CommitteeScience & Technology Commission of Shanghai Municipality (STCSM)); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Clinical Key Special Subject of China; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This study was supported by the Shanghai Science and Technology Commission (10410709400, 10411950100), National Nature Science Foundation of China (81000968, 81101540, 81101637 and 81172273), the National Clinical Key Special Subject of China and China Postdoctoral Science Foundation funded project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brieva-Ruiz L, 2008, CLIN NEUROL NEUROSUR, V110, P1044, DOI 10.1016/j.clineuro.2008.06.016; Buckanovich RJ, 1996, J NEUROSCI, V16, P1114; BUCKANOVICH RJ, 1993, NEURON, V11, P657, DOI 10.1016/0896-6273(93)90077-5; CURTIS D, 1995, CELL, V81, P171, DOI 10.1016/0092-8674(95)90325-9; Darnell RB, 2003, NEW ENGL J MED, V349, P1543, DOI 10.1056/NEJMra023009; EDMONDSON HA, 1954, CANCER-AM CANCER SOC, V7, P462, DOI 10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO;2-E; Esteves CL, 2013, J MOL ENDOCRINOL, V51, P91, DOI 10.1530/JME-13-0029; Ganguly S, 2010, AM J PATHOL, V177, P2701, DOI 10.2353/ajpath.2010.100617; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Johnstone O, 2001, ANNU REV GENET, V35, P365, DOI 10.1146/annurev.genet.35.102401.090756; Kazarian M, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-33; Li Y, 2001, WORLD J GASTROENTERO, V7, P630; LIAW YF, 1986, GASTROENTEROLOGY, V90, P263, DOI 10.1016/0016-5085(86)90919-4; Liu Y, 2008, WORLD J GASTROENTERO, V14, P7175, DOI 10.3748/wjg.14.7175; Liu Z, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-153; Lodewyks C, 2011, CAN J PHYSIOL PHARM, V89, P393, DOI [10.1139/y11-031, 10.1139/Y11-031]; Marrero JA, 2011, HEPATOLOGY, V53, P1060, DOI 10.1002/hep.24033; Qin LX, 2004, J CANCER RES CLIN, V130, P497, DOI 10.1007/s00432-004-0572-9; Rahman J, 2013, EUR J NEUROSCI; Schwarz N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041269; Sobin L, 2009, TNM CLASSIFICATION M; Stich O, 2009, ACTA NEUROL SCAND, V119, P338, DOI 10.1111/j.1600-0404.2008.01102.x; Sun D, 2003, AM J PHYSIOL-GASTR L, V285, pG12, DOI 10.1152/ajpgi.00513.2002; Tamburino AM, 2013, G3-GENES GENOM GENET, V3, P297, DOI 10.1534/g3.112.004390; Tsao CM, 2012, HEPATOLOGY, V56, P2277, DOI 10.1002/hep.25933; Wang T, 2008, LIFE SCI, V82, P536, DOI 10.1016/j.lfs.2007.12.014; Wirtz PW, 2002, J NEUROL, V249, P1710, DOI 10.1007/s00415-002-0913-z	27	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90955	10.1371/journal.pone.0090955	http://dx.doi.org/10.1371/journal.pone.0090955			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608171	Green Published, Green Submitted, gold			2022-12-27	WOS:000332485800068
J	Evans, LJ; Raine, NE				Evans, Lisa J.; Raine, Nigel E.			Changes in Learning and Foraging Behaviour within Developing Bumble Bee (Bombus terrestris) Colonies	PLOS ONE			English	Article							HONEY-BEES; DEFENSIVE BEHAVIOR; WORKER SIZE; FLOWER SIZE; BODY-SIZE; SPEED; HYMENOPTERA; PERFORMANCE; EVOLUTION; AGE	Organisation in eusocial insect colonies emerges from the decisions and actions of its individual members. In turn, these decisions and actions are influenced by the individual's behaviour (or temperament). Although there is variation in the behaviour of individuals within a colony, we know surprisingly little about how (or indeed if) the types of behaviour present in a colony change over time. Here, for the first time, we assessed potential changes in the behavioural type of foragers during colony development. Using an ecologically relevant foraging task, we measured the decision speed and learning ability of bumble bees (Bombus terrestris) at different stages of colony development. We determined whether individuals that forage early in the colony life cycle (the queen and early emerging workers) behaved differently from workers that emerge and forage at the end of colony development. Whilst we found no overall change in the foraging behaviour of workers with colony development, there were strong differences in foraging behaviour between queens and their workers. Queens appeared to forage more cautiously than their workers and were also quicker to learn. These behaviours could allow queens to maximise their nectar collecting efficiency whilst avoiding predation. Because the foundress queen is crucial to the survival and success of a bumble bee colony, more efficient foraging behaviour in queens may have strong adaptive value.	[Evans, Lisa J.; Raine, Nigel E.] Royal Holloway Univ London, Sch Biol Sci, Egham, Surrey, England	University of London; Royal Holloway University London	Evans, LJ (corresponding author), Royal Holloway Univ London, Sch Biol Sci, Egham, Surrey, England.	Lisa.evans.2011@live.rhul.ac.uk	Raine, Nigel/AAK-6425-2020; Evans, Lisa/E-7339-2018	Raine, Nigel/0000-0001-6343-2829; Evans, Lisa/0000-0001-7353-9750	Plant and Food Research Ltd New Zealand; C. Alma Baker Scholarship; Allan and Grace Kay Overseas Scholarship; Queen Elizabeth's Technicians Award	Plant and Food Research Ltd New Zealand; C. Alma Baker Scholarship; Allan and Grace Kay Overseas Scholarship; Queen Elizabeth's Technicians Award	There was no specific funding supporting this work. LJE was funded by Plant and Food Research Ltd New Zealand, a C. Alma Baker Scholarship, an Allan and Grace Kay Overseas Scholarship and a Queen Elizabeth's Technicians Award. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alford DV, 1975, BUMBLEBEES; Anderson C, 2001, BIOL REV, V76, P211, DOI 10.1017/S1464793101005656; ARCHER ME, 1972, J ENTOMOL SER A-GEN, V46, P175; BENNETT PM, 1987, J ZOOL, V213, P327, DOI 10.1111/j.1469-7998.1987.tb03708.x; Bernasconi G, 1999, TRENDS ECOL EVOL, V14, P477, DOI 10.1016/S0169-5347(99)01722-X; Blarer A, 2002, ETHOLOGY, V108, P341, DOI 10.1046/j.1439-0310.2002.00778.x; Blumstein DT, 2006, ANIM BEHAV, V71, P389, DOI 10.1016/j.anbehav.2005.05.010; Breed MD, 2004, ANNU REV ENTOMOL, V49, P271, DOI 10.1146/annurev.ento.49.061802.123155; BRIAN M. V., 1957, INSECTES SOCIAUX, V4, P177, DOI 10.1007/BF02222152; Burns JG, 2008, CURR BIOL, V18, pR953, DOI 10.1016/j.cub.2008.08.028; Burns James G., 2005, Animal Behaviour, V70, pe1, DOI 10.1016/j.anbehav.2005.06.002; CARTAR RV, 1991, CAN ENTOMOL, V123, P283, DOI 10.4039/Ent123283-2; Chapman BB, 2011, ANIM BEHAV, V82, P391, DOI 10.1016/j.anbehav.2011.05.019; Chittka L, 2004, POPUL ECOL, V46, P243, DOI 10.1007/s10144-004-0180-1; Chittka L, 2003, NATURE, V424, P388, DOI 10.1038/424388a; Chittka L, 2006, CURR OPIN PLANT BIOL, V9, P428, DOI 10.1016/j.pbi.2006.05.002; CLARK CW, 1994, AM NAT, V144, P542, DOI 10.1086/285693; COLE AC, 1948, AM MIDL NAT, V39, P641, DOI 10.2307/2421529; COLLINS AM, 1982, SCIENCE, V218, P72, DOI 10.1126/science.218.4567.72; Couvillon MJ, 2010, INSECT SOC, V57, P193, DOI 10.1007/s00040-010-0064-7; CROSLAND MWJ, 1990, J INSECT BEHAV, V3, P359, DOI 10.1007/BF01052114; Dall SRX, 2004, ECOL LETT, V7, P734, DOI 10.1111/j.1461-0248.2004.00618.x; Dornhaus A, 2004, APIDOLOGIE, V35, P183, DOI 10.1051/apido:2004002; Drezner-Levy T, 2009, BEHAV ECOL SOCIOBIOL, V64, P135, DOI 10.1007/s00265-009-0829-z; DUCHATEAU MJ, 1988, BEHAVIOUR, V107, P186, DOI 10.1163/156853988X00340; DUKAS R, 1994, ANIM BEHAV, V48, P1001, DOI 10.1006/anbe.1994.1332; Dukas R, 2003, OIKOS, V101, P157, DOI 10.1034/j.1600-0706.2003.12143.x; Dukas R, 2001, ECOL LETT, V4, P327, DOI 10.1046/j.1461-0248.2001.00228.x; Dyer AG, 2004, J COMP PHYSIOL A, V190, P759, DOI 10.1007/s00359-004-0547-y; Foster DJ, 2011, J EXP BIOL, V214, P1896, DOI 10.1242/jeb.051730; Free JB, 1959, BUMBLEBEES; Gill RJ, 2012, NATURE, V491, P105, DOI 10.1038/nature11585; Giurfa M, 1996, J COMP PHYSIOL A, V178, P699; Goulson D, 2010, BUMBLEBEES BEHAV ECO, V2; Guzman-Novoa E, 2004, APIDOLOGIE, V35, P15, DOI 10.1051/apido:2003061; HERBERS JM, 1981, J THEOR BIOL, V89, P175, DOI 10.1016/0022-5193(81)90184-3; Holldobler B., 1990, pi; Ings TC, 2008, CURR BIOL, V18, P1520, DOI 10.1016/j.cub.2008.07.074; Ings TC, 2009, BEHAV ECOL SOCIOBIOL, V63, P1207, DOI 10.1007/s00265-009-0731-8; Jandt JM, 2014, BIOL REV, V89, P48, DOI 10.1111/brv.12042; Jandt JM, 2009, ANIM BEHAV, V77, P641, DOI 10.1016/j.anbehav.2008.11.019; Jeanson R, 2014, BIOL REV, V89, P671, DOI 10.1111/brv.12074; Jones EI, 2011, BEHAV ECOL SOCIOBIOL, V65, P1505, DOI 10.1007/s00265-011-1160-z; Keller L, 1999, LEVELS SELECTION EVO; Laloi D, 2001, APIDOLOGIE, V32, P231, DOI 10.1051/apido:2001125; Latshaw JS, 2005, BEHAV ECOL SOCIOBIOL, V58, P200, DOI 10.1007/s00265-004-0904-4; Lin H, 2012, THESIS ROYAL HOLLOWA; Lye GC, 2009, BIOL CONSERV, V142, P2023, DOI 10.1016/j.biocon.2009.03.032; Mallon EB, 2001, BEHAV ECOL SOCIOBIOL, V50, P352, DOI 10.1007/s002650100377; MARDEN JH, 1987, J EXP BIOL, V130, P235; Matsuura K, 2002, ANIM BEHAV, V64, P167, DOI 10.1006/anbe.2002.3062; MIRENDA JT, 1981, ANIM BEHAV, V29, P410, DOI 10.1016/S0003-3472(81)80100-5; Molet M, 2009, NATURWISSENSCHAFTEN, V96, P213, DOI 10.1007/s00114-008-0465-x; Muller H, 2008, CURR BIOL, V18, pR961, DOI 10.1016/j.cub.2008.09.001; Muller H, 2010, ANIM BEHAV, V80, P1065, DOI 10.1016/j.anbehav.2010.09.016; Oster G.F., 1978, Monographs in Population Biology, pi; Ottoni EB, 2000, BEHAV RES METH INS C, V32, P446, DOI 10.3758/BF03200814; Pankiw T, 1999, J COMP PHYSIOL A, V185, P207, DOI 10.1007/s003590050379; PLOWRIGHT RC, 1977, CAN ENTOMOL, V109, P967, DOI 10.4039/Ent109967-7; POUVREAU A, 1974, Apidologie, V5, P39, DOI 10.1051/apido:19740103; Pruitt JN, 2011, P ROY SOC B-BIOL SCI, V278, P1209, DOI 10.1098/rspb.2010.1700; QUELLER DC, 1989, P NATL ACAD SCI USA, V86, P3224, DOI 10.1073/pnas.86.9.3224; Raine NE, 2008, P R SOC B, V275, P803, DOI 10.1098/rspb.2007.1652; Raine NE, 2007, ENTOMOL GEN, V30, P191; Raine NE, 2006, ADV STUD BEHAV, V36, P305, DOI 10.1016/S0065-3454(06)36007-X; Raine NE, 2006, ENTOMOL GEN, V28, P241; Raine NE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045096; Ray S, 1997, NEUROREPORT, V8, P789, DOI 10.1097/00001756-199702100-00042; ROBINSON GE, 1990, BEHAV ECOL SOCIOBIOL, V26, P315, DOI 10.1007/BF00171096; Rodriguez-Girones MA, 2012, OIKOS, V121, P1473, DOI 10.1111/j.1600-0706.2011.19473.x; Scharf I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033314; Scheiner R, 1999, J COMP PHYSIOL A, V185, P1, DOI 10.1007/s003590050360; Scheiner R, 2001, NEUROBIOL LEARN MEM, V76, P138, DOI 10.1006/nlme.2000.3996; Sih A, 2004, Q REV BIOL, V79, P241, DOI 10.1086/422893; Spaethe J, 2003, J EXP BIOL, V206, P3447, DOI 10.1242/jeb.00570; Spaethe J, 2001, P NATL ACAD SCI USA, V98, P3898, DOI 10.1073/pnas.071053098; SRINIVASAN MV, 1988, J COMP PHYSIOL A, V162, P159, DOI 10.1007/BF00606081; SUTCLIFFE GH, 1990, CAN J ZOOL, V68, P1120, DOI 10.1139/z90-166; WERNER EE, 1984, ANNU REV ECOL SYST, V15, P393, DOI 10.1146/annurev.es.15.110184.002141; Willmer PG, 2004, ADV STUD BEHAV, V34, P347, DOI 10.1016/S0065-3454(04)34009-X; WITTER MS, 1994, ANIM BEHAV, V48, P201, DOI 10.1006/anbe.1994.1227; WOOD LA, 1981, INSECT SOC, V28, P117, DOI 10.1007/BF02223700; Worden BD, 2005, J EXP BIOL, V208, P2045, DOI 10.1242/jeb.01582; Wray MK, 2011, ANIM BEHAV, V81, P559, DOI 10.1016/j.anbehav.2010.11.027; YDENBERG RC, 1986, ADV STUD BEHAV, V16, P229, DOI 10.1016/S0065-3454(08)60192-8	85	11	11	0	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90556	10.1371/journal.pone.0090556	http://dx.doi.org/10.1371/journal.pone.0090556			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599144	Green Submitted, Green Published, gold			2022-12-27	WOS:000332479400092
J	Rendall, AR; Sutherland, DR; Cooke, R; White, J				Rendall, Anthony R.; Sutherland, Duncan R.; Cooke, Raylene; White, John			Camera Trapping: A Contemporary Approach to Monitoring Invasive Rodents in High Conservation Priority Ecosystems	PLOS ONE			English	Article							RATS RATTUS-RATTUS; FERAL HOUSE MICE; BLACK RATS; POPULATION-DYNAMICS; RELATIVE ABUNDANCE; HABITAT STRUCTURE; ANIMAL DENSITY; SEABIRDS; ISLANDS; PREDATION	Invasive rodent species have established on 80% of the world's islands causing significant damage to island environments. Insular ecosystems support proportionally more biodiversity than comparative mainland areas, highlighting them as critical for global biodiversity conservation. Few techniques currently exist to adequately detect, with high confidence, species that are trap-adverse such as the black rat, Rattus rattus, in high conservation priority areas where multiple non-target species persist. This study investigates the effectiveness of camera trapping for monitoring invasive rodents in high conservation areas, and the influence of habitat features and density of colonial-nesting seabirds on rodent relative activity levels to provide insights into their potential impacts. A total of 276 camera sites were established and left in situ for 8 days. Identified species were recorded in discrete 15 min intervals, referred to as 'events'. In total, 19 804 events were recorded. From these, 31 species were identified comprising 25 native species and six introduced. Two introduced rodent species were detected: the black rat (90% of sites), and house mouse Mus musculus (56% of sites). Rodent activity of both black rats and house mice were positively associated with the structural density of habitats. Density of seabird burrows was not strongly associated with relative activity levels of rodents, yet rodents were still present in these areas. Camera trapping enabled a large number of rodents to be detected with confidence in site-specific absences and high resolution to quantify relative activity levels. This method enables detection of multiple species simultaneously with low impact (for both target and non-target individuals); an ideal strategy for monitoring trap-adverse invasive rodents in high conservation areas.	[Rendall, Anthony R.; Cooke, Raylene; White, John] Deakin Univ, Sch Life & Environm Sci, Ctr Integrat Ecol, Melbourne, Vic, Australia; [Sutherland, Duncan R.] Phillip Isl Nat Pk, Res Dept, Cowes, Vic, Australia	Deakin University	Cooke, R (corresponding author), Deakin Univ, Sch Life & Environm Sci, Ctr Integrat Ecol, Melbourne, Vic, Australia.	raylene.cooke@deakin.edu.au	White, John/A-4285-2008; Sutherland, Duncan/E-7763-2011	Sutherland, Duncan/0000-0003-0893-4425; White, John/0000-0002-7375-5944; Rendall, Anthony/0000-0002-7286-9288	Deakin University	Deakin University	Financial support was provided by Deakin University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amori G., 2003, RATS MICE PEOPLE ROD, V96, P63; Angel A, 2009, BIOL INVASIONS, V11, P1743, DOI 10.1007/s10530-008-9401-4; Arthur AD, 2005, OIKOS, V108, P562, DOI 10.1111/j.0030-1299.2005.13327.x; Arthur AD, 2004, J ANIM ECOL, V73, P867, DOI 10.1111/j.0021-8790.2004.00864.x; Banks PB, 2012, WILDLIFE RES, V39, P78, DOI 10.1071/WR11086; Barton K., 2012, MUMIN MULTIMODEL INF; Booth Andrea M., 1996, Notornis, V43, P147; Brooke M. de L., 2010, Endangered Species Research, V11, P47, DOI 10.3354/esr00249; Brown KP, 1996, NEW ZEAL J ECOL, V20, P271; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Caut S, 2008, J APPL ECOL, V45, P428, DOI 10.1111/j.1365-2664.2007.01438.x; CHOWN SL, 1993, OECOLOGIA, V96, P508, DOI 10.1007/BF00320508; Cox C.B., 2000, BIOGEOGRAPHY ECOLOGI; Cox GW, 1993, CONSERVATION ECOLOGY; Cox MPG, 2000, AUSTRAL ECOL, V25, P375, DOI 10.1111/j.1442-9993.2000.tb00043.x; CRAFFORD JE, 1987, BIOL CONSERV, V40, P255, DOI 10.1016/0006-3207(87)90119-4; De Bondi N, 2010, WILDLIFE RES, V37, P456, DOI 10.1071/WR10046; DICKMAN CR, 1986, OECOLOGIA, V70, P536, DOI 10.1007/BF00379900; DICKMAN CR, 1986, ECOL MONOGR, V56, P221, DOI 10.2307/2937075; Drake DR, 2011, DIRECT IMPACTS SEABI; Draper C, 2013, BIOL CONSERV, V158, P422, DOI 10.1016/j.biocon.2012.10.024; Dumont Y, 2010, NAT RESOUR MODEL, V23, P381, DOI 10.1111/j.1939-7445.2010.00068.x; ESRI, 2011, ARCGIS DESKT REL 10; Foster S, 2011, NEW ZEAL J ZOOL, V38, P285, DOI 10.1080/03014223.2011.599400; GRANT GS, 1981, J FIELD ORNITHOL, V52, P336; Grant-Hoffman MN, 2010, BIOL INVASIONS, V12, P805, DOI 10.1007/s10530-009-9503-7; Harper GA, 2010, BIOL INVASIONS, V12, P1449, DOI 10.1007/s10530-009-9560-y; Harper GA, 2005, NEW ZEAL J ECOL, V29, P251; Hines J., 2006, PRESENCE2 SOFTWARE E; Igual JM, 2007, BIOL CONSERV, V137, P189, DOI 10.1016/j.biocon.2007.02.003; Igual JM, 2006, ANIM CONSERV, V9, P59, DOI 10.1111/j.1469-1795.2005.00005.x; Imber M, 2000, NEW ZEAL J ECOL, V24, P153; Jones H, 2008, POETRY WALES, V43, P22; Jones MGW, 2010, ANTARCT SCI, V22, P39, DOI 10.1017/S0954102009990459; Jouventin P, 2003, POLAR BIOL, V26, P371, DOI 10.1007/s00300-003-0497-9; King W.B., 1985, International Council for Bird Preservation Technical Publication, P3; Martin JL, 2000, CONSERV BIOL, V14, P1452, DOI 10.1046/j.1523-1739.2000.99190.x; McKelvey KS, 2001, CAN J ZOOL, V79, P1754, DOI 10.1139/cjz-79-10-1754; McMahon CR, 2012, BIOL CONSERV, V153, P254, DOI 10.1016/j.biocon.2012.05.004; Mitchell K., 2007, QUANTITATIVE ANAL PO; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Oates A, 2011, SUMMERLAND PENINSULA; Paull DJ, 2012, WILDLIFE RES, V39, P546, DOI 10.1071/WR12034; PUTMAN RJ, 1995, BIODIVERS CONSERV, V4, P903, DOI 10.1007/BF00056197; Quillfeldt P, 2008, POLAR BIOL, V31, P333, DOI 10.1007/s00300-007-0363-2; R Core Team, 2012, R LANG ENV STAT COMP; Rowcliffe JM, 2008, J APPL ECOL, V45, P1228, DOI 10.1111/j.1365-2664.2008.01473.x; Rowcliffe JM, 2013, J WILDLIFE MANAGE, V77, P876, DOI 10.1002/jwmg.533; ROWEROWE DT, 1989, POLAR BIOL, V9, P457, DOI 10.1007/BF00443233; Royle JA, 2004, BIOMETRICS, V60, P108, DOI 10.1111/j.0006-341X.2004.00142.x; Ruffino L, 2009, BIOL INVASIONS, V11, P1631, DOI 10.1007/s10530-008-9394-z; Ruffino L, 2011, POPUL ECOL, V53, P535, DOI 10.1007/s10144-011-0265-6; Ruscoe WA, 2001, WILDLIFE RES, V28, P173, DOI 10.1071/WR00035; Russell JC, 2011, OECOLOGIA, V167, P667, DOI 10.1007/s00442-011-2031-z; Russell JC, 2004, GLOBAL ECOL BIOGEOGR, V13, P497, DOI 10.1111/j.1466-822X.2004.00124.x; Smith JK, 2012, AUST MAMMAL, V34, P196, DOI 10.1071/AM11034; Stokes VL, 2013, AUST MAMMAL, V35, P49, DOI 10.1071/AM12002; Towns DR, 2006, BIOL INVASIONS, V8, P863, DOI 10.1007/s10530-005-0421-z; Venables WN., 2002, MODERN APPL STAT S, V4, DOI 10.1007/978-0-387-21706-2; Wanless RM, 2007, BIOLOGY LETT, V3, P241, DOI 10.1098/rsbl.2007.0120; Wanless RM, 2009, BIOL CONSERV, V142, P1710, DOI 10.1016/j.biocon.2009.03.008; Whisson DA, 2005, WILDLIFE RES, V32, P239, DOI 10.1071/WR03128; Whisson DA, 2007, J MAMMAL, V88, P589, DOI 10.1644/06-MAMM-A-239R1.1; Williamson M. H., 1981, ISLAND POPULATIONS; Wilson D, 2004, EMU, V104, P37, DOI 10.1071/MU01054; Yabe Tatsuo, 2009, Marine Ornithology, V37, P293	66	42	44	0	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e86592	10.1371/journal.pone.0086592	http://dx.doi.org/10.1371/journal.pone.0086592			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599307	Green Published, gold, Green Submitted			2022-12-27	WOS:000332479400003
J	Zhang, ZJ; Ma, CT; Zhao, P; Duan, LT; Chen, WQ; Zhang, FS; Cui, ZZ				Zhang, Zhenjie; Ma, Chengtai; Zhao, Peng; Duan, Luntao; Chen, Wenqing; Zhang, Fushou; Cui, Zhizhong			Construction of Recombinant Marek's Disease Virus (rMDV) Co-Expressing AIV-H9N2-NA and NDV-F Genes under Control of MDV's Own Bi-Directional Promoter	PLOS ONE			English	Article							BACTERIAL ARTIFICIAL CHROMOSOME; KB-MESSENGER-RNA; RETICULOENDOTHELIOSIS VIRUS; NEWCASTLE-DISEASES; AVIAN INFLUENZA; FOWLPOX VIRUS; FIELD STRAIN; VACCINE; PROTECTION; CHICKENS	To qualitatively analyze and evaluate a bi-directional promoter transcriptional function in both transient and transgenic systems, several different plasmids were constructed and recombinant MDV type 1 strain GX0101 was developed to coexpress a Neuraminidase (NA) gene from Avian Influenza Virus H9N2 strain and a Fusion (F) gene from the Newcastle disease virus (NDV). The two foreign genes, NDV-F gene and AIV-NA gene, were inserted in the plasmid driven in each direction by the bi-directional promoter. To test whether the expression of pp38/pp24 heterodimers are the required activators for the expression of the foreign genes, the recombinant plasmid pPpp38-NA/1.8kb-F containing expression cassette for the two foreign genes was co-transfected with a pp38/pp24 expression plasmid, pBud-pp38-pp24, in chicken embryo fibroblast (CEF) cells. Alternatively, plasmid pPpp38-NA/1.8kb-F was transfected in GX0101-infected CEFs where the viral endogenous pp38/pp24 were expressed via virus infection. The expression of both foreign genes was activated by pp38/pp24 dimers either via virus infection, or co-expression. The CEFs transfected with pPpp38-NA/1.8kb-F alone had no expression. We chose to insert the expression cassette of Ppp38-NA/1.8kb-F in the non-essential region of GX0101 Delta Meq US2 gene, and formed a new rMDV named MZC13NA/F through homologous recombination. Indirect fluorescence antibody (IFA) test, ELISA and Western blot analyses indicated that F and NA genes were expressed simultaneously under control of the bi-directional promoter, but in opposite directions. The data also indicated the activity of the promoter in the 1.8-kb mRNA transcript direction was higher than that in the direction for the pp38 gene. The expression of pp38/pp24 dimers either via co-tranfection of the pBud-pp38-pp24 plasmid, or by GX0101 virus infection were critical to activate the bidirectional promoter for expression of two foreign genes in both directions. Therefore, the confirmed function of the bidirectional promoter provides better feasibilities to insert multiple foreign genes in MDV genome based vectors.	[Zhang, Zhenjie; Ma, Chengtai; Zhao, Peng; Duan, Luntao; Chen, Wenqing; Zhang, Fushou; Cui, Zhizhong] Shandong Agr Univ, Coll Vet Med, Tai An, Shandong, Peoples R China; [Zhang, Zhenjie; Ma, Chengtai; Zhao, Peng; Duan, Luntao; Chen, Wenqing; Zhang, Fushou; Cui, Zhizhong] Anim Dis Prevent Technol & Res Ctr Shandong Prov, Tai An, Shandong, Peoples R China	Shandong Agricultural University	Cui, ZZ (corresponding author), Shandong Agr Univ, Coll Vet Med, Tai An, Shandong, Peoples R China.	zzcui@sdau.edu.cn	Zhao, Peng/HDO-7507-2022		National Natural Science Foundation [31072149]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	The study was supported by a grant from National Natural Science Foundation Project (31072149). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baigent SJ, 2006, J GEN VIROL, V87, P769, DOI 10.1099/vir.0.81498-0; Barlic-Maganja D, 2001, J VIROL METHODS, V95, P101, DOI 10.1016/S0166-0934(01)00302-0; BRADLEY G, 1989, J VIROL, V63, P2534, DOI 10.1128/JVI.63.6.2534-2542.1989; BRADLEY G, 1989, J VIROL, V63, P4129, DOI 10.1128/JVI.63.10.4129-4135.1989; Cui HY, 2009, J VIROL METHODS, V156, P66, DOI 10.1016/j.jviromet.2008.10.021; Cui HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053340; Cui Hongyu, 2008, Sheng Wu Gong Cheng Xue Bao, V24, P569, DOI 10.1016/S1872-2075(08)60028-X; Cui Z., 1992, Proceedings 19th World's Poultry Congress Amsterdam 19-24 September 1992: Volume 1., P123; CUI ZZ, 1991, J VIROL, V65, P6509, DOI 10.1128/JVI.65.12.6509-6515.1991; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Ding JB, 2006, VIRUS GENES, V32, P193, DOI 10.1007/s11262-005-6876-2; Ding JB, 2006, SCI CHINA SER C, V49, P53, DOI 10.1007/s11427-004-0119-y; Ding Jia-bo, 2005, Weishengwu Xuebao, V45, P363; Ding J, 2007, VIRUS GENES, V35, P643, DOI 10.1007/s11262-007-0129-5; Gimeno IM, 2005, J VIROL, V79, P4545, DOI 10.1128/JVI.79.7.4545-4549.2005; Jiang Shi-jin, 2005, Virologica Sinica, V20, P404; Lee LF, 2012, VACCINE, V30, P5151, DOI 10.1016/j.vaccine.2012.05.043; Lee LF, 2011, AVIAN DIS, V55, P172, DOI 10.1637/9575-101510-Reg.1; Lee LF, 2010, VACCINE, V28, P1294, DOI 10.1016/j.vaccine.2009.11.022; Li YP, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-2; Li YQ, 2011, VACCINE, V29, P8257, DOI 10.1016/j.vaccine.2011.08.115; Ma MX, 2006, VACCINE, V24, P4304, DOI 10.1016/j.vaccine.2006.03.006; McGeoch DJ, 2000, J VIROL, V74, P10401, DOI 10.1128/JVI.74.22.10401-10406.2000; MORGAN RW, 1990, AVIAN DIS, V34, P345, DOI 10.2307/1591417; MORGAN RW, 1992, AVIAN DIS, V36, P858, DOI 10.2307/1591544; Muyrers JPP, 1999, NUCLEIC ACIDS RES, V27, P1555, DOI 10.1093/nar/27.6.1555; Narayanan K, 1999, GENE THER, V6, P442, DOI 10.1038/sj.gt.3300901; Petherbridge L, 2004, J VIROL, V78, P13376, DOI 10.1128/JVI.78.23.13376-13380.2004; Reddy SM, 2002, P NATL ACAD SCI USA, V99, P7054, DOI 10.1073/pnas.092152699; Sakaguchi M, 1998, VACCINE, V16, P472, DOI 10.1016/S0264-410X(97)80001-1; Schumacher D, 2000, J VIROL, V74, P11088, DOI 10.1128/JVI.74.23.11088-11098.2000; Shigekane H, 1999, ARCH VIROL, V144, P1893, DOI 10.1007/s007050050713; Sonoda K, 2000, J VIROL, V74, P3217, DOI 10.1128/JVI.74.7.3217-3226.2000; Su S, 2013, COMP BIOL CHARACTERI; Su S, 2012, J VIROL, V86, P13818, DOI 10.1128/JVI.02583-12; Su Shuai, 2010, Weishengwu Xuebao, V50, P380; Sun AJ, 2010, VIROLOGY, V397, P270, DOI 10.1016/j.virol.2009.11.017; Sun AJ, 2009, CHINESE SCI BULL, V54, P2641, DOI 10.1007/s11434-009-0364-3; [孙淑红 SUN Shuhong], 2007, [畜牧兽医学报, Acta Veterinaria et Zootechnica Sinica], V38, P741; Swayne DE, 2000, VACCINE, V18, P1088, DOI 10.1016/S0264-410X(99)00369-2; TAYLOR J, 1990, J VIROL, V64, P1441, DOI 10.1128/JVI.64.4.1441-1450.1990; Tsukamoto K, 1999, VIROLOGY, V257, P352, DOI 10.1006/viro.1999.9641; WEBSTER RG, 1991, VACCINE, V9, P303, DOI 10.1016/0264-410X(91)90055-B; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597; Zhang Z, 2005, SCI CHINA SER C, V48, P81, DOI 10.1360/03yc0270; 丁家波, 2008, [中国科学. C辑, 生命科学, Science in China. Series C, Life Sciences], V38, P760	46	5	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90677	10.1371/journal.pone.0090677	http://dx.doi.org/10.1371/journal.pone.0090677			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599338	Green Submitted, Green Published, gold			2022-12-27	WOS:000332479400116
J	Zimnicka, AM; Tang, HY; Guo, Q; Kuhr, FK; Oh, MJ; Wan, J; Chen, JW; Smith, KA; Fraidenburg, DR; Choudhury, MSR; Levitan, I; Machado, RF; Kaplan, JH; Yuan, JXJ				Zimnicka, Adriana M.; Tang, Haiyang; Guo, Qiang; Kuhr, Frank K.; Oh, Myung-Jin; Wan, Jun; Chen, Jiwang; Smith, Kimberly A.; Fraidenburg, Dustin R.; Choudhury, Moumita S. R.; Levitan, Irena; Machado, Roberto F.; Kaplan, Jack H.; Yuan, Jason X. -J.			Upregulated Copper Transporters in Hypoxia-Induced Pulmonary Hypertension	PLOS ONE			English	Article							LYSYL OXIDASE; ENDOTHELIAL DYSFUNCTION; OXIDATIVE STRESS; ATPASE ATP7A; HCTR1; MECHANISMS; STIFFNESS; OXYGEN; CHOLESTEROL; CHAPERONE	Pulmonary vascular remodeling and increased arterial wall stiffness are two major causes for the elevated pulmonary vascular resistance and pulmonary arterial pressure in patients and animals with pulmonary hypertension. Cellular copper (Cu) plays an important role in angiogenesis and extracellular matrix remodeling; increased Cu in vascular smooth muscle cells has been demonstrated to be associated with atherosclerosis and hypertension in animal experiments. In this study, we show that the Cu-uptake transporter 1, CTR1, and the Cu-efflux pump, ATP7A, were both upregulated in the lung tissues and pulmonary arteries of mice with hypoxia-induced pulmonary hypertension. Hypoxia also significantly increased expression and activity of lysyl oxidase (LOX), a Cu-dependent enzyme that causes crosslinks of collagen and elastin in the extracellular matrix. In vitro experiments show that exposure to hypoxia or treatment with cobalt (CoCl2) also increased protein expression of CTR1, ATP7A, and LOX in pulmonary arterial smooth muscle cells (PASMC). In PASMC exposed to hypoxia or treated with CoCl2, we also confirmed that the Cu transport is increased using Cu-64 uptake assays. Furthermore, hypoxia increased both cell migration and proliferation in a Cu-dependent manner. Downregulation of hypoxia-inducible factor 1 alpha (HIF-1 alpha) with siRNA significantly attenuated hypoxia-mediated upregulation of CTR1 mRNA. In summary, the data from this study indicate that increased Cu transportation due to upregulated CTR1 and ATP7A in pulmonary arteries and PASMC contributes to the development of hypoxia-induced pulmonary hypertension. The increased Cu uptake and elevated ATP7A also facilitate the increase in LOX activity and thus the increase in crosslink of extracellular matrix, and eventually leading to the increase in pulmonary arterial stiffness.	[Zimnicka, Adriana M.; Tang, Haiyang; Guo, Qiang; Kuhr, Frank K.; Oh, Myung-Jin; Wan, Jun; Chen, Jiwang; Smith, Kimberly A.; Fraidenburg, Dustin R.; Choudhury, Moumita S. R.; Levitan, Irena; Machado, Roberto F.; Yuan, Jason X. -J.] Univ Illinois, Dept Med, Sect Pulm Crit Care Sleep & Allergy Med, Chicago, IL 60612 USA; [Oh, Myung-Jin; Levitan, Irena; Yuan, Jason X. -J.] Univ Illinois, Dept Pharmacol, Chicago, IL USA; [Kaplan, Jack H.] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL USA; [Yuan, Jason X. -J.] Univ Illinois, Ctr Cardiovasc Res, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Yuan, JXJ (corresponding author), Univ Illinois, Dept Med, Sect Pulm Crit Care Sleep & Allergy Med, Chicago, IL 60612 USA.	jxyuan@uic.edu	TANG, HAIYANG/J-4006-2013	Smith, Kimberly/0000-0002-2621-0052; Kaplan, Jack/0000-0002-7048-6574; Machado, Roberto/0000-0002-3722-5954	National Heart, Lung, and Blood Institute of the National Institutes of Health [HL114014, HL066012, HL098053, HL072742]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083298, T32HL072742, T32HL082547, R01HL066012, R01HL115014, R01HL073965, P01HL098053] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the National Heart, Lung, and Blood Institute of the National Institutes of Health [HL114014 (JXY), HL066012 (JXY), HL098053 (JXY), and HL072742 (AMZ)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcudia JF, 2008, FRONT BIOSCI-LANDMRK, V13, P2721, DOI 10.2741/2879; Ashino T, 2010, CIRC RES, V107, P787, DOI 10.1161/CIRCRESAHA.110.225334; Barnes N, 2009, TRAFFIC, V10, P767, DOI 10.1111/j.1600-0854.2009.00901.x; Benita Y, 2009, NUCLEIC ACIDS RES, V37, P4587, DOI 10.1093/nar/gkp425; Bogaard HJ, 2012, AM J RESP CELL MOL, V46, P582, DOI 10.1165/rcmb.2011-0296OC; Budhiraja R, 2004, CIRCULATION, V109, P159, DOI 10.1161/01.CIR.0000102381.57477.50; Byfield FJ, 2006, J LIPID RES, V47, P715, DOI 10.1194/jlr.M500439-JLR200; Byfield FJ, 2004, BIOPHYS J, V87, P3336, DOI 10.1529/biophysj.104.040634; Cross JB, 2003, APPL ENVIRON MICROB, V69, P2245, DOI 10.1128/AEM.69.4.2245-2252.2003; De Feo CJ, 2009, P NATL ACAD SCI USA, V106, P4237, DOI 10.1073/pnas.0810286106; Durand MJ, 2013, AM J HYPERTENS, V26, P739, DOI 10.1093/ajh/hpt015; Durmowicz A G, 1999, Pediatr Rev, V20, pe91; Eisses JF, 2000, BIOCHEMISTRY-US, V39, P7337, DOI 10.1021/bi000690j; Eisses JF, 2005, J BIOL CHEM, V280, P9635, DOI 10.1074/jbc.M500116200; Eisses JF, 2002, J BIOL CHEM, V277, P29162, DOI 10.1074/jbc.M203652200; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Feng WK, 2009, MOL PHARMACOL, V75, P174, DOI 10.1124/mol.108.051516; Firth AL, 2010, DIS MODEL MECH, V3, P268, DOI 10.1242/dmm.003616; Gabrielli LA, 2011, J CARD FAIL, V17, P1012, DOI 10.1016/j.cardfail.2011.08.008; Gaetke LM, 2003, TOXICOLOGY, V189, P147, DOI 10.1016/S0300-483X(03)00159-8; Hochachka PW, 1996, P NATL ACAD SCI USA, V93, P9493, DOI 10.1073/pnas.93.18.9493; Kaplan JH, 2009, J BIOL CHEM, V284, P25461, DOI 10.1074/jbc.R109.031286; Kim BE, 2008, NAT CHEM BIOL, V4, P176, DOI 10.1038/nchembio.72; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Linz R, 2008, AM J PHYSIOL-RENAL, V294, pF53, DOI 10.1152/ajprenal.00314.2007; Malenfant S, 2013, PULM CIRC, V3, P278, DOI 10.4103/2045-8932.114752; Martin F, 2005, BLOOD, V105, P4613, DOI 10.1182/blood-2004-10-3980; Maryon EB, 2007, J BIOL CHEM, V282, P20376, DOI 10.1074/jbc.M701806200; Maryon EB, 2013, AM J PHYSIOL-CELL PH, V304, pC768, DOI 10.1152/ajpcell.00417.2012; Molloy SA, 2009, J BIOL CHEM, V284, P29704, DOI 10.1074/jbc.M109.000166; Morrell NW, 2009, J AM COLL CARDIOL, V54, pS20, DOI 10.1016/j.jacc.2009.04.018; Oh MJ, 2012, JOVE-J VIS EXP, DOI 10.3791/3886; Pak O, 2007, EUR RESPIR J, V30, P364, DOI 10.1183/09031936.00128706; Patel SA, 2008, CELL DEATH DIFFER, V15, P628, DOI 10.1038/cdd.2008.17; Rae TD, 1999, SCIENCE, V284, P805, DOI 10.1126/science.284.5415.805; Rodriguez C, 2008, CARDIOVASC RES, V79, P7, DOI 10.1093/cvr/cvn102; Rucker RB, 1996, J NUTR, V126, P51, DOI 10.1093/jn/126.1.51; SATO M, 1990, J BIOMECH ENG-T ASME, V112, P263, DOI 10.1115/1.2891183; Schaefer M, 1999, AM J PHYSIOL-GASTR L, V276, pG311, DOI 10.1152/ajpgi.1999.276.2.G311; Schermuly RT, 2005, J CLIN INVEST, V115, P2811, DOI 10.1172/JCI24838; Shentu TP, 2010, AM J PHYSIOL-CELL PH, V299, pC218, DOI 10.1152/ajpcell.00383.2009; Siddikuzzaman, 2011, Inflammopharmacology, V19, P117, DOI 10.1007/s10787-010-0073-1; Song M, 2008, J PHARMACOL EXP THER, V325, P409, DOI 10.1124/jpet.107.131227; Stamm Jason A, 2011, Pulm Circ, V1, P138, DOI 10.4103/2045-8932.83444; Sun M, 2007, J CELL SCI, V120, P2223, DOI 10.1242/jcs.001370; Tian Lian, 2012, Pulm Circ, V2, P505, DOI 10.4103/2045-8932.105040; Turski ML, 2009, J BIOL CHEM, V284, P717, DOI 10.1074/jbc.R800055200; van Suylen RJ, 1998, AM J RESP CRIT CARE, V157, P1423, DOI 10.1164/ajrccm.157.5.9709050; Wang Zhijie, 2011, Pulm Circ, V1, P212, DOI 10.4103/2045-8932.83453; White C, 2009, J BIOL CHEM, V284, P33949, DOI 10.1074/jbc.M109.070201; White C, 2009, J CELL SCI, V122, P1315, DOI 10.1242/jcs.043216; Xie LW, 2011, AM J PHYSIOL-CELL PH, V300, pC1298, DOI 10.1152/ajpcell.00023.2011; Yuan Y, 2003, J BIOL CHEM, V278, P15911, DOI 10.1074/jbc.M300463200; Zhou B, 1997, P NATL ACAD SCI USA, V94, P7481, DOI 10.1073/pnas.94.14.7481	54	33	33	5	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e90544	10.1371/journal.pone.0090544	http://dx.doi.org/10.1371/journal.pone.0090544			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614111	Green Published, gold, Green Submitted			2022-12-27	WOS:000332839300028
J	Proverbio, AM; Calbi, M; Manfredi, M; Zani, A				Proverbio, Alice Mado; Calbi, Marta; Manfredi, Mirella; Zani, Alberto			Comprehending Body Language and Mimics: An ERP and Neuroimaging Study on Italian Actors and Viewers	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; SEMANTIC INTEGRATION; N400 ERPS; BRAIN; MIRROR; FACE; REPRESENTATION; SELECTIVITY; PERCEPTION; MECHANISMS	In this study, the neural mechanism subserving the ability to understand people's emotional and mental states by observing their body language (facial expression, body posture and mimics) was investigated in healthy volunteers. ERPs were recorded in 30 Italian University students while they evaluated 280 pictures of highly ecological displays of emotional body language that were acted out by 8 male and female Italian actors. Pictures were briefly flashed and preceded by short verbal descriptions (e.g., "What a bore!") that were incongruent half of the time (e. g., a picture of a very attentive and concentrated person shown after the previous example verbal description). ERP data and source reconstruction indicated that the first recognition of incongruent body language occurred 300 ms post-stimulus. swLORETA performed on the N400 identified the strongest generators of this effect in the right rectal gyrus (BA11) of the ventromedial orbitofrontal cortex, the bilateral uncus (limbic system) and the cingulate cortex, the cortical areas devoted to face and body processing (STS, FFA EBA) and the premotor cortex (BA6), which is involved in action understanding. These results indicate that face and body mimics undergo a prioritized processing that is mostly represented in the affective brain and is rapidly compared with verbal information. This process is likely able to regulate social interactions by providing on-line information about the sincerity and trustfulness of others.	[Proverbio, Alice Mado; Calbi, Marta; Manfredi, Mirella] Univ Milano Bicocca, Dept Psychol, Milan, Italy; [Calbi, Marta] Univ Parma, Dept Neurosci, I-43100 Parma, Italy; [Manfredi, Mirella] Univ Calif San Diego, Dept Cognit Sci, San Diego, CA 92103 USA; [Zani, Alberto] CNR, Inst Mol Bioimaging & Physiol IBFM, I-20133 Milan, Italy	University of Milano-Bicocca; University of Parma; University of California System; University of California San Diego; Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioimmagini e Fisiologia Molecolare (IBFM-CNR)	Proverbio, AM (corresponding author), Univ Milano Bicocca, Dept Psychol, Milan, Italy.	mado.proverbio@unimib.it	Zani, Alberto/ABI-3498-2020; Zani, Alberto/ABG-8894-2020	Zani, Alberto/0000-0002-3906-7988; manfredi, mirella/0000-0002-6549-1993; Calbi, Marta/0000-0001-7555-0611; Proverbio, Alice Mado/0000-0002-5138-1523	University of Milano-Bicocca	University of Milano-Bicocca	The authors gratefully acknowledge financial support from University of Milano-Bicocca (2011FAR funds). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2003, NAT REV NEUROSCI, V4, P165, DOI 10.1038/nrn1056; Amoruso L, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00057; Amoruso L, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00124; Bach P, 2009, SOC NEUROSCI-UK, V4, P212, DOI 10.1080/17470910802362546; Bekkering H, 2009, TOP COGN SCI, V1, P340, DOI 10.1111/j.1756-8765.2009.01023.x; Carr L, 2003, P NATL ACAD SCI USA, V100, P5497, DOI 10.1073/pnas.0935845100; Chen J, 2011, LEARN MEMORY, V18, P523, DOI 10.1101/lm.2135211; de Gelder B, 2006, NAT REV NEUROSCI, V7, P242, DOI 10.1038/nrn1872; de Gelder B, 2004, P NATL ACAD SCI USA, V101, P16701, DOI 10.1073/pnas.0407042101; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; Duran ND, 2013, FRONT PSYCHOL, V27, P4; Ekman P., 2003, ISHK, VReprint edition; Friedrich M, 2004, J COGNITIVE NEUROSCI, V16, P1465, DOI 10.1162/0898929042304705; Gallese V, 2004, TRENDS COGN SCI, V8, P396, DOI 10.1016/j.tics.2004.07.002; Grezes J, 2007, NEUROIMAGE, V35, P959, DOI 10.1016/j.neuroimage.2006.11.030; Grill-Spector K, 2004, NAT NEUROSCI, V7, P555, DOI 10.1038/nn1224; Gu Y, 2013, PLOS ONE, V8; Gunter TC, 2004, NEUROSCI LETT, V372, P52, DOI 10.1016/j.neulet.2004.09.011; Hadjikhani N, 2003, CURR BIOL, V13, P2201, DOI 10.1016/j.cub.2003.11.049; Hagoort P, 2004, SCIENCE, V304, P438, DOI 10.1126/science.1095455; Hamm JP, 2002, CLIN NEUROPHYSIOL, V113, P1339, DOI 10.1016/S1388-2457(02)00161-X; Hutchison WD, 1999, NAT NEUROSCI, V2, P403, DOI 10.1038/8065; Iacoboni M, 2001, P NATL ACAD SCI USA, V98, P13995, DOI 10.1073/pnas.241474598; Kana RK, 2012, SOC COGN AFFECT NEUR, V7, P446, DOI 10.1093/scan/nsr022; Kaplan Jonas T, 2007, Cogn Process, V8, P103, DOI 10.1007/s10339-007-0165-z; Kounios J, 2002, TRENDS COGN SCI, V6, P272, DOI 10.1016/S1364-6613(02)01929-0; Kravitz DJ, 2011, J NEUROSCI, V31, P7322, DOI 10.1523/JNEUROSCI.4588-10.2011; Kutas M, 2011, ANNU REV PSYCHOL, V62, P621, DOI 10.1146/annurev.psych.093008.131123; Lim VK, 2009, BRAIN COGNITION, V71, P306, DOI 10.1016/j.bandc.2009.07.004; Liu BL, 2011, NEUROSCI LETT, V498, P84, DOI 10.1016/j.neulet.2011.04.068; Molnar-Szakacs I, 2006, NEUROIMAGE, V33, P923, DOI 10.1016/j.neuroimage.2006.07.035; Morrison I, 2004, COGN AFFECT BEHAV NE, V4, P270, DOI 10.3758/CABN.4.2.270; Moser EI, 2008, ANNU REV NEUROSCI, V31, P69, DOI 10.1146/annurev.neuro.31.061307.090723; NEVILLE HJ, 1992, CEREB CORTEX, V2, P244, DOI 10.1093/cercor/2.3.244; Palmero-Soler E, 2007, PHYS MED BIOL, V52, P1783, DOI 10.1088/0031-9155/52/7/002; PASCUALMARQUI RD, 1994, INT J PSYCHOPHYSIOL, V18, P49, DOI 10.1016/0167-8760(84)90014-X; Peelen MV, 2007, SOC COGN AFFECT NEUR, V2, P274, DOI 10.1093/scan/nsm023; Peelen MV, 2005, J NEUROPHYSIOL, V93, P603, DOI 10.1152/jn.00513.2004; Pineda JA, 2009, BIOL PSYCHOL, V80, P306, DOI 10.1016/j.biopsycho.2008.11.003; Proverbio AM, 2012, SCI REP-UK, V2, DOI 10.1038/srep00883; Proverbio AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022026; Proverbio AM, 2010, NEUROPSYCHOLOGIA, V48, P1454, DOI 10.1016/j.neuropsychologia.2010.01.015; Proverbio AM, 2009, NEUROSCI LETT, V459, P142, DOI 10.1016/j.neulet.2009.05.012; Sartori L, 2011, COGNITION, V119, P242, DOI 10.1016/j.cognition.2011.01.014; Schulte-Ruther M, 2008, NEUROIMAGE, V42, P393, DOI 10.1016/j.neuroimage.2008.04.180; Schwarzlose RF, 2005, J NEUROSCI, V25, P11055, DOI 10.1523/JNEUROSCI.2621-05.2005; Shibata H, 2009, NEUROSCI LETT, V452, P189, DOI 10.1016/j.neulet.2009.01.042; Singer T, 2006, NATURE, V439, P466, DOI 10.1038/nature04271; Sinke CBA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038118; Stanislavski C., 1936, ACTOR PREPARES; Urgesi C, 2004, CURR BIOL, V14, P2130, DOI 10.1016/j.cub.2004.11.031; van de Riet WAC, 2009, SOC NEUROSCI-UK, V4, P101, DOI 10.1080/17470910701865367; van Elk M, 2008, J PHYSIOLOGY-PARIS, V102, P95, DOI 10.1016/j.jphysparis.2008.03.011; Van Overwalle F, 2009, NEUROIMAGE, V48, P564, DOI 10.1016/j.neuroimage.2009.06.009; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2; Walker MB, 1989, J LANG SOC PSYCHOL, V8; West WC, 2002, COGNITIVE BRAIN RES, V13, P363, DOI 10.1016/S0926-6410(01)00129-X; Wlotko EW, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00181	58	22	22	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91294	10.1371/journal.pone.0091294	http://dx.doi.org/10.1371/journal.pone.0091294			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608244	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000332485800125
J	Zhang, L; Wang, Y; Xiao, Y; Wang, Y; Dong, JK; Gao, K; Gao, Y; Wang, X; Zhang, W; Xu, YJ; Yan, JQ; Yu, JY				Zhang, Liang; Wang, Yue; Xiao, Yi; Wang, Yu; Dong, JinKai; Gao, Kun; Gao, Yan; Wang, Xi; Zhang, Wei; Xu, YuanJi; Yan, JinQi; Yu, JiYun			Enhancement of Antitumor Immunity Using a DNA-Based Replicon Vaccine Derived from Semliki Forest Virus	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; DENDRITIC CELLS; GENE-THERAPY; TUMOR-CELLS; PLASMID DNA; IN-VITRO; ANTIGEN; CANCER; VECTOR; RESPONSES	A DNA-based replicon vaccine derived from Semliki Forest virus, PSVK-shFcG-GM/B7.1 (Fig. 1a) was designed for tumor immunotherapy as previously constructed. The expression of the fusion tumor antigen (survivin and hCG beta-CTP37) and adjuvant molecular protein (Granulocyte-Macrophage Colony-Stimulating Factor/ GM-CSF/B7.1) genes was confirmed by Immunofluorescence assay in vitro, and immunohistochemistry assay in vivo. In this paper, the immunological effect of this vaccine was determined using immunological assays as well as animal models. The results showed that this DNA vaccine induced both humoral and cellular immune responses in C57BL/ 6 mice after immunization, as evaluated by the ratio of CD4(+)/CD8(+) cells and the release of IFN-gamma. Furthermore, the vaccination of C57BL/ 6 mice with PSVK-shFcG-GM/B7.1 significantly delayed the in vivo growth of tumors in animal models (survivin(+) and hCG beta(+) murine melanoma, B16) when compared to vaccination with the empty vector or the other control constructs (Fig. 1b). These data indicate that this type of replicative DNA vaccine could be developed as a promising approach for tumor immunotherapy. Meanwhile, these results provide a basis for further study in vaccine pharmacodynamics and pharmacology, and lay a solid foundation for clinical application.	[Zhang, Liang; Wang, Yue; Xiao, Yi; Wang, Yu; Dong, JinKai; Gao, Kun; Gao, Yan; Wang, Xi; Zhang, Wei; Xu, YuanJi; Yan, JinQi; Yu, JiYun] Beijing Inst Basic Med Sci, Beijing, Peoples R China; [Wang, Yue] China CDC, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China; [Xiao, Yi] Gen Hosp PLA, Affiliated Hosp 1, Dept Urol, Beijing, Peoples R China	Academy of Military Medical Sciences - China; Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese People's Liberation Army General Hospital	Yu, JY (corresponding author), Beijing Inst Basic Med Sci, Beijing, Peoples R China.	yujyun@126.com			863 High-Tech Projects of the Chinese Government [2007AA02Z451]; National Natural Science Foundation of China [30772002]	863 High-Tech Projects of the Chinese Government; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the 863 High-Tech Projects of the Chinese Government (No. 2007AA02Z451) and the National Natural Science Foundation of China (No. 30772002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RJ, 2007, VACCINE, V25, pB24, DOI 10.1016/j.vaccine.2007.05.030; Asselin-Paturel C, 1999, GENE THER, V6, P606, DOI 10.1038/sj.gt.3300841; Bergman PJ, 2007, VET CLIN N AM-SMALL, V37, P1111, DOI 10.1016/j.cvsm.2007.06.005; Bernstein DI, 2009, VACCINE, V28, P484, DOI 10.1016/j.vaccine.2009.09.135; Boussiotis VA, 1996, IMMUNOL REV, V153, P5, DOI 10.1111/j.1600-065X.1996.tb00918.x; Cirone P, 2006, CURR GENE THER, V6, P181, DOI 10.2174/156652306776359513; Cyster JG, 1999, J EXP MED, V189, P447, DOI 10.1084/jem.189.3.447; DAVIS NL, 1989, VIROLOGY, V171, P189, DOI 10.1016/0042-6822(89)90526-6; Durso RJ, 2007, CLIN CANCER RES, V13, P3999, DOI 10.1158/1078-0432.CCR-06-2202; Everson RG, 2008, EXPERT REV ANTICANC, V8, P717, DOI 10.1586/14737140.8.5.717; Ferrone CR, 2006, CLIN CANCER RES, V12, P5511, DOI 10.1158/1078-0432.CCR-06-0979; FYNAN EF, 1993, P NATL ACAD SCI USA, V90, P11478, DOI 10.1073/pnas.90.24.11478; Gabrilovich DI, 1996, NAT MED, V2, P1096, DOI 10.1038/nm1096-1096; Gabrilovich DI, 1997, CLIN CANCER RES, V3, P483; HAEFFNERCAVAILLON N, 1979, J IMMUNOL, V123, P1905; He LZ, 2004, CLIN CANCER RES, V10, P1920, DOI 10.1158/1078-0432.CCR-03-0264; He Y, 2006, VACCINE, V24, P2575, DOI 10.1016/j.vaccine.2005.12.030; Herold KC, 1997, J IMMUNOL, V159, P4150; Hirohashi Y, 2002, CLIN CANCER RES, V8, P1731; HUANG AYC, 1994, SCIENCE, V264, P961, DOI 10.1126/science.7513904; Ikezawa H, 2002, BIOL PHARM BULL, V25, P409, DOI 10.1248/bpb.25.409; Jefferis R, 1998, IMMUNOL REV, V163, P59, DOI 10.1111/j.1600-065X.1998.tb01188.x; Kass E, 2000, CYTOKINE, V12, P960, DOI 10.1006/cyto.2000.0684; Leslie MC, 2007, GENE THER, V14, P316, DOI 10.1038/sj.gt.3302864; LILJESTROM P, 1991, BIO-TECHNOL, V9, P1356, DOI 10.1038/nbt1291-1356; Loisel-Meyer S, 2008, FRONT BIOSCI, V13, P3202; Lundstrom Kenneth, 2003, Methods Mol Med, V76, P503; Lundstrom Kenneth, 2003, Expert Rev Vaccines, V2, P447; Lundstrom K, 2009, VIRUSES-BASEL, V1, P13, DOI 10.3390/v1010013; Lyons JA, 2007, GENE THER, V14, P503, DOI 10.1038/sj.gt.3302889; Moran TP, 2007, VACCINE, V25, P6604, DOI 10.1016/j.vaccine.2007.06.058; Moulton HM, 2002, CLIN CANCER RES, V8, P2044; Nakazaki Y, 1998, GENE THER, V5, P1355, DOI 10.1038/sj.gt.3300726; Otto K, 2005, VACCINE, V23, P884, DOI 10.1016/j.vaccine.2004.08.007; Polo J M, 2000, Dev Biol (Basel), V104, P181; Qin ZH, 1997, J IMMUNOL, V159, P770; Reap EA, 2007, VACCINE, V25, P7441, DOI 10.1016/j.vaccine.2007.08.016; Reap EA, 2007, CLIN VACCINE IMMUNOL, V14, P748, DOI 10.1128/CVI.00037-07; Rice J, 2008, NAT REV CANCER, V8, P108, DOI 10.1038/nrc2326; Riezebos-Brilman A, 2009, VACCINE, V27, P701, DOI 10.1016/j.vaccine.2008.11.032; Sangiorgio Vanessa, 2004, Ital J Biochem, V53, P98; Schmitz M, 2000, CANCER RES, V60, P4845; STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994; Sun XL, 2002, VACCINE, V20, P1466, DOI 10.1016/S0264-410X(01)00476-5; Terrazzini N, 2004, VACCINE, V22, P2146, DOI 10.1016/j.vaccine.2003.12.002; Xiang R, 2005, CANCER RES, V65, P553; XIONG C, 1989, SCIENCE, V243, P1188, DOI 10.1126/science.2922607; Yu JS, 1997, HUM GENE THER, V8, P1065, DOI 10.1089/hum.1997.8.9-1065; Zaffaroni N, 2005, J CELL MOL MED, V9, P360, DOI 10.1111/j.1582-4934.2005.tb00361.x; Zhang Liang, 2011, Nan Fang Yi Ke Da Xue Xue Bao, V31, P937	50	6	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90551	10.1371/journal.pone.0090551	http://dx.doi.org/10.1371/journal.pone.0090551			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608380	Green Published, gold, Green Submitted			2022-12-27	WOS:000332485800032
J	Romero, MD; Roy, S; Pouillot, K; Feito, M; Esteve, M; Grasa, MD; Fernandez-Lopez, JA; Alemany, M; Remesar, X				del Mar Romero, Maria; Roy, Stephanie; Pouillot, Karl; Feito, Marisol; Esteve, Montserrat; del Mar Grasa, Maria; Fernandez-Lopez, Jose-Antonio; Alemany, Maria; Remesar, Xavier			Treatment of Rats with a Self-Selected Hyperlipidic Diet, Increases the Lipid Content of the Main Adipose Tissue Sites in a Proportion Similar to That of the Lipids in the Rest of Organs and Tissues	PLOS ONE			English	Article							ORAL OLEOYL-ESTRONE; OVERWEIGHT MALE RATS; ZUCKER OBESE RATS; WISTAR RATS; BODY-COMPOSITION; SKELETAL-MUSCLE; CAFETERIA DIET; ADIPOCYTES; FAT; ACCUMULATION	Adipose tissue (AT) is distributed as large differentiated masses, and smaller depots covering vessels, and organs, as well as interspersed within them. The differences between types and size of cells makes AT one of the most disperse and complex organs. Lipid storage is partly shared by other tissues such as muscle and liver. We intended to obtain an approximate estimation of the size of lipid reserves stored outside the main fat depots. Both male and female rats were made overweight by 4-weeks feeding of a cafeteria diet. Total lipid content was analyzed in brain, liver, gastrocnemius muscle, four white AT sites: subcutaneous, perigonadal, retroperitoneal and mesenteric, two brown AT sites (interscapular and perirenal) and in a pool of the rest of organs and tissues (after discarding gut contents). Organ lipid content was estimated and tabulated for each individual rat. Food intake was measured daily. There was a surprisingly high proportion of lipid not accounted for by the main macroscopic AT sites, even when brain, liver and BAT main sites were discounted. Muscle contained about 8% of body lipids, liver 1-1.4%, four white AT sites lipid 28-63% of body lipid, and the rest of the body (including muscle) 38-44%. There was a good correlation between AT lipid and body lipid, but lipid in "other organs" was highly correlated too with body lipid. Brain lipid was not. Irrespective of dietary intake, accumulation of body fat was uniform both for the main lipid storage and handling organs: large masses of AT (but also liver, muscle), as well as in the "rest" of tissues. These storage sites, in specialized (adipose) or not-specialized (liver, muscle) tissues reacted in parallel against a hyperlipidic diet challenge. We postulate that body lipid stores are handled and regulated coordinately, with a more centralized and overall mechanisms than usually assumed.	[del Mar Romero, Maria; Roy, Stephanie; Pouillot, Karl; Feito, Marisol; Esteve, Montserrat; del Mar Grasa, Maria; Fernandez-Lopez, Jose-Antonio; Alemany, Maria; Remesar, Xavier] Univ Barcelona, Fac Biol, Dept Nutr & Food Sci, Barcelona, Spain; [del Mar Romero, Maria; Esteve, Montserrat; del Mar Grasa, Maria; Fernandez-Lopez, Jose-Antonio; Alemany, Maria; Remesar, Xavier] Univ Barcelona, Inst Biomed, Barcelona, Spain; [del Mar Romero, Maria; Esteve, Montserrat; del Mar Grasa, Maria; Fernandez-Lopez, Jose-Antonio; Alemany, Maria; Remesar, Xavier] Inst Hlth Carlos III, CIBER Ctr Invest Biomed Red OBN Obesidad & Nutr, Madrid, Spain	University of Barcelona; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN	Remesar, X (corresponding author), Univ Barcelona, Fac Biol, Dept Nutr & Food Sci, Barcelona, Spain.	xremesar@ub.edu	López, José Antonio Fernández/C-5467-2017; Esteve, Montserrat/AAR-4146-2021; del Mar Romero, Maria/K-9004-2017; Remesar, Xavier/G-5703-2013; Alemany, Marià/H-5224-2011; Remesar, Xavier/L-4555-2019; Grasa Martínez, Maria del Mar/L-8031-2014; Esteve, Montserrat/L-6272-2014	López, José Antonio Fernández/0000-0002-2856-7223; Esteve, Montserrat/0000-0003-2128-7859; del Mar Romero, Maria/0000-0001-6274-5743; Remesar, Xavier/0000-0002-9707-7287; Alemany, Marià/0000-0002-9783-8293; Remesar, Xavier/0000-0002-9707-7287; Grasa Martínez, Maria del Mar/0000-0001-6362-0504; Esteve, Montserrat/0000-0003-2128-7859; Roy, Stephanie/0000-0002-5943-7106	Plan Nacional de Investigacion en Biomedicina [SAF2012-34895]; Plan Nacional de Ciencia y Tecnologia de los Alimentos of the Government of Spain [AGL-2011-23635]; CIBER-OBN (Institute of Health Carlos III, Spain)	Plan Nacional de Investigacion en Biomedicina; Plan Nacional de Ciencia y Tecnologia de los Alimentos of the Government of Spain; CIBER-OBN (Institute of Health Carlos III, Spain)	This study was funded by grants of the Plan Nacional de Investigacion en Biomedicina (SAF2012-34895) and the Plan Nacional de Ciencia y Tecnologia de los Alimentos (AGL-2011-23635) of the Government of Spain. CIBER-OBN (Institute of Health Carlos III, Spain) supported the salary of M.M. Romero. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adiels M, 2006, DIABETOLOGIA, V49, P755, DOI 10.1007/s00125-005-0125-z; Alemany M, 2006, CURR NUTR FOOD SCI, V2, P141, DOI 10.2174/157340106776818817; AROLA L, 1979, REV ESP FISIOL, V35, P215; Boettcher M, 2009, J MAGN RESON IMAGING, V29, P1340, DOI 10.1002/jmri.21754; Cabot C, 2012, J ENDOCRINOL METAB, V2, P21, DOI 10.4021/jem63w; Cinti S, 2001, P NUTR SOC, V60, P319, DOI 10.1079/PNS200192; Coatmellec-Taglioni G, 2003, J PHARMACOL EXP THER, V305, P362, DOI 10.1124/jpet.102.045682; Comizio R, 1998, AM J PHYSIOL-ENDOC M, V274, pE860, DOI 10.1152/ajpendo.1998.274.5.E860; Romero MD, 2009, EUR J NUTR, V48, P291, DOI 10.1007/s00394-009-0013-2; DEMING QB, 1958, J EXP MED, V107, P581, DOI 10.1084/jem.107.4.581; ESTEVE M, 1992, MOL CELL BIOCHEM, V118, P67, DOI 10.1007/BF00249696; Ferrer-Lorente R, 2005, LIFE SCI, V77, P2051, DOI 10.1016/j.lfs.2005.04.008; FIELD CJ, 1990, J BIOL CHEM, V265, P11143; FOLCH J, 1957, J BIOL CHEM, V226, P497; Foster D. O., 1986, BROWN ADIPOSE TISSUE, P31; Frayn KN, 2002, DIABETOLOGIA, V45, P1201, DOI 10.1007/s00125-002-0873-y; Gondret F, 2008, J ANIM SCI, V86, P2115, DOI 10.2527/jas.2007-0750; Goodpaster BH, 2004, PEDIATR DIABETES, V5, P219, DOI 10.1111/j.1399-543X.2004.00071.x; Gorski J, 1999, EUR J APPL PHYSIOL O, V79, P421, DOI 10.1007/s004210050532; Grasa MD, 2001, OBES RES, V9, P202; Grasa MM, 2001, DIABETES OBES METAB, V3, P203, DOI 10.1046/j.1463-1326.2001.00143.x; HIMMSHAGEN J, 1981, AM J PHYSIOL, V241, pE116, DOI 10.1152/ajpendo.1981.241.2.E116; KRIKETOS AD, 1995, AM J PHYSIOL-REG I, V269, pR1154, DOI 10.1152/ajpregu.1995.269.5.R1154; LASZLO J, 1965, SOUTHERN MED J, V58, P1099, DOI 10.1097/00007611-196509000-00007; Llado I, 1997, BIOCHEM MOL BIOL INT, V43, P1129; Malaisse WJ, 2006, NEUROSCI LETT, V409, P75, DOI 10.1016/j.neulet.2006.09.023; Martin S, 2005, SEMIN CELL DEV BIOL, V16, P163, DOI 10.1016/j.semcdb.2005.01.007; Massanes RM, 2003, INT J OBESITY, V27, P428, DOI 10.1038/sj.ijo.0802264; Mohamed-Ali V, 1998, INT J OBESITY, V22, P1145, DOI 10.1038/sj.ijo.0800770; OBRIEN JS, 1965, J LIPID RES, V6, P537; OBrien SN, 1996, ANAL QUANT CYTOL, V18, P137; REES ED, 1966, J LIPID RES, V7, P396; Remesar X, 2002, INT J OBESITY, V26, P1092, DOI 10.1038/sj.ijo.0802056; Roelofsen B, 1982, CHEM ENZYMATIC LOCAL, P1; Romero MM, 2006, INT J OBESITY, V30, P1149, DOI 10.1038/sj.ijo.0803224; SCLAFANI A, 1976, PHYSIOL BEHAV, V17, P461, DOI 10.1016/0031-9384(76)90109-8; van Herpen NA, 2008, PHYSIOL BEHAV, V94, P231, DOI 10.1016/j.physbeh.2007.11.049; van Loon LJC, 2004, P NUTR SOC, V63, P301, DOI 10.1079/PNS2004347; Wang P, 2008, J CELL PHYSIOL, V216, P3, DOI 10.1002/jcp.21386; Wisse BE, 2004, J AM SOC NEPHROL, V15, P2792, DOI 10.1097/01.ASN.0000141966.69934.21	40	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90995	10.1371/journal.pone.0090995	http://dx.doi.org/10.1371/journal.pone.0090995			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603584	Green Published, gold, Green Submitted			2022-12-27	WOS:000332483600121
J	Kim, YR; Kim, CH; Park, JH; Pyo, J; Treasure, J				Kim, Youl-Ri; Kim, Chan-Hyung; Park, Jin Hong; Pyo, Jimin; Treasure, Janet			The Impact of Intranasal Oxytocin on Attention to Social Emotional Stimuli in Patients with Anorexia Nervosa: A Double Blind within-Subject Cross-over Experiment	PLOS ONE			English	Article							FACIAL EXPRESSIONS; EATING-DISORDERS; BODY DISSATISFACTION; PERSONALITY; ANGER; AUTISM; THREAT; WOMEN; PSYCHOPATHOLOGY; MAINTENANCE	Background and aim: Social factors may be of importance causally and act as maintenance factors in patients with anorexia nervosa. Oxytocin is a neuromodulatory hormone involved in social emotional processing associated with attentional processes. This study aimed to examine the impact of oxytocin on attentional processes to social faces representing anger, disgust, and happiness in patients with anorexia nervosa. Method: A double-blind, placebo-controlled within-subject crossover design was used. Intranasal oxytocin or placebo followed by a visual probe detection task with faces depicting anger, disgust, and happiness was administered to 64 female subjects: 31 patients with anorexia nervosa and 33 control students. Results: Attentional bias to the disgust stimuli was observed in both groups under the placebo condition. The attentional bias to disgust was reduced under the oxytocin condition (a moderate effect in the patient group). Avoidance of angry faces was observed in the patient group under the placebo condition and vigilance was observed in the healthy comparison group; both of these information processing responses were moderated by oxytocin producing an increase in vigilance in the patients. Happy/smiling faces did not elicit an attentional response in controls or the patients under either the placebo or oxytocin conditions. Conclusion: Oxytocin attenuated attentional vigilance to disgust in patients with anorexia nervosa and healthy controls. On the other hand, oxytocin changed the response to angry faces from avoidance to vigilance in patients but reduced vigilance to anger in healthy controls. We conclude that patients with anorexia nervosa appear to use different strategies/circuits to emotionally process anger from their healthy counterparts.	[Kim, Youl-Ri; Park, Jin Hong; Pyo, Jimin] Inje Univ, Seoul Paik Hosp, Dept Neuropsychiat, Seoul, South Korea; [Kim, Chan-Hyung] Yonsei Univ, Severance Mental Hosp, Dept Psychiat, Coll Med, Gyeonggi Do, South Korea; [Park, Jin Hong] Carleton Coll, Dept Psychol, Northfield, MN 55057 USA; [Treasure, Janet] Kings Coll London, Dept Psychol Med, Sect Eating Disorders, Inst Psychiat, London WC2R 2LS, England	Inje University; Yonsei University; Yonsei University Health System; Carleton College; University of London; King's College London	Kim, YR (corresponding author), Inje Univ, Seoul Paik Hosp, Dept Neuropsychiat, Seoul, South Korea.	youlri.kim@paik.ac.kr	Kim, Youl-Ri/AAE-5170-2021	Park, Scarlet/0000-0002-1545-6284; Kim, Youl-Ri/0000-0002-5538-7180; Treasure, Janet/0000-0003-0871-4596	National Research Foundation of Korea [2011-0030914]; National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London; National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at Maudsley National Health Service (NHS) Foundation Trust; National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at King's College London	National Research Foundation of Korea(National Research Foundation of Korea); National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London(National Institute for Health Research (NIHR)); National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at Maudsley National Health Service (NHS) Foundation Trust; National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at King's College London	This study was supported under the framework of the international cooperation program managed by the National Research Foundation of Korea (2011-0030914) to Youl-Ri Kim. Janet Treasure is in part funded by the National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London, and Maudsley National Health Service (NHS) Foundation Trust and King's College London. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. In addition the Swiss Anorexia Foundation contributed to this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen KL, 2009, J AM ACAD CHILD PSY, V48, P800, DOI 10.1097/CHI.0b013e3181a8136d; Allison S, 2014, AUST NZ J PSYCHIAT, V48, P116, DOI 10.1177/0004867413502092; Arcelus J, 2013, CLIN PSYCHOL REV, V33, P156, DOI 10.1016/j.cpr.2012.10.009; Aspen V, 2013, COGNITION EMOTION, V27, P820, DOI 10.1080/02699931.2012.749777; Bakermans-Kranenburg MJ, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.34; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Bertsch K, 2013, AM J PSYCHIAT, V170, P1169, DOI 10.1176/appi.ajp.2013.13020263; Bradley BP, 1999, BRIT J CLIN PSYCHOL, V38, P267, DOI 10.1348/014466599162845; Brune M, 2013, HUM PSYCHOPHARM CLIN, V28, P552, DOI 10.1002/hup.2343; Cacioppo JT, 2011, ANN NY ACAD SCI, V1224, P162, DOI 10.1111/j.1749-6632.2010.05858.x; Cardi V, 2013, WORLD J BIOL PSYCHIA, V14, P622, DOI 10.3109/15622975.2012.665479; Chon KK, 1996, KOREAN J REHABILITAT, V3, P53; Claes L, 2012, EUR EAT DISORD REV, V20, P484, DOI 10.1002/erv.2212; Corfield F, ELICITED FACIA UNPUB; Davies H, 2011, INT J EAT DISORDER, V44, P531, DOI 10.1002/eat.20852; DEMITRACK MA, 1990, AM J PSYCHIAT, V147, P882; Domes G, 2013, PSYCHOL MED, V43, P1747, DOI 10.1017/S0033291712002565; Domes G, 2013, PSYCHONEUROENDOCRINO, V38, P1198, DOI 10.1016/j.psyneuen.2012.10.002; EKMAN P, 1992, PHILOS T ROY SOC B, V335, P63, DOI 10.1098/rstb.1992.0008; EKMAN P, 1992, PSYCHOL SCI, V3, P34, DOI 10.1111/j.1467-9280.1992.tb00253.x; EKMAN P, 1990, J PERS SOC PSYCHOL, V58, P342, DOI 10.1037/0022-3514.58.2.342; Ekman P., 2002, FACIAL ACTION CODING; Ellenbogen MA, 2012, PSYCHOPHYSIOLOGY, V49, P128, DOI 10.1111/j.1469-8986.2011.01278.x; Fairburn C. G, 1993, EATING DISORDER EXAM, V12th; FAIRBURN CG, 1994, INT J EAT DISORDER, V16, P363; Fassino S, 2001, J PSYCHOSOM RES, V51, P757, DOI 10.1016/S0022-3999(01)00280-X; First MB, 2002, STRUCTURED CLIN INTE; Geller J, 2000, INT J EAT DISORDER, V28, P8, DOI 10.1002/1098-108X(200007)28:1<8::AID-EAT2>3.0.CO;2-U; Gilboa-Schechtman E, 1999, COGNITION EMOTION, V13, P305, DOI 10.1080/026999399379294; GILLBERG CL, 1992, J CHILD PSYCHOL PSYC, V33, P813, DOI 10.1111/j.1469-7610.1992.tb01959.x; Guastella AJ, 2009, PSYCHONEUROENDOCRINO, V34, P220, DOI 10.1016/j.psyneuen.2008.09.001; Harrison A, 2011, CLIN PSYCHOL PSYCHOT, V18, P445, DOI 10.1002/cpp.726; Heo S, 2004, J KOREAN SOC STUDY O, V13, P42; Kim YR, PSYCHIAT IN IN PRESS; Krug I, 2008, PSYCHIAT RES, V161, P195, DOI 10.1016/j.psychres.2007.10.003; Krug I, 2013, J HEALTH PSYCHOL, V18, P26, DOI 10.1177/1359105311435946; Lawson EA, 2012, J CLIN ENDOCR METAB, V97, pE1898, DOI 10.1210/jc.2012-1702; Lawson EA, 2011, J CLIN PSYCHIAT, V72, P1546, DOI 10.4088/JCP.10m06617; Leknes S, 2013, SOC COGN AFFECT NEUR, V8, P741, DOI 10.1093/scan/nss062; Lischke A, 2012, PSYCHONEUROENDOCRINO, V37, P1431, DOI 10.1016/j.psyneuen.2012.01.011; MacDonald E, 2011, PSYCHONEUROENDOCRINO, V36, P1114, DOI 10.1016/j.psyneuen.2011.02.015; MACLEOD C, 1986, J ABNORM PSYCHOL, V95, P15, DOI 10.1037/0021-843X.95.1.15; Maguire S, 2013, EUR EAT DISORD REV, V21, P475, DOI 10.1002/erv.2252; Mansell W, 1999, COGNITION EMOTION, V13, P673, DOI 10.1080/026999399379032; McKnight R, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3800; Menzel JE, 2010, BODY IMAGE, V7, P261, DOI 10.1016/j.bodyim.2010.05.004; Michopoulos V, 2012, PSYCHONEUROENDOCRINO, V37, P1071, DOI 10.1016/j.psyneuen.2011.12.004; Miotto P, 2008, COMPR PSYCHIAT, V49, P364, DOI 10.1016/j.comppsych.2008.01.004; Mogg K, 1998, BEHAV RES THER, V36, P809, DOI 10.1016/S0005-7967(98)00063-1; Murphy SE, 2009, INT J NEUROPSYCHOPH, V12, P169, DOI 10.1017/S1461145708009164; Ochsner KN, 2008, CURR DIR PSYCHOL SCI, V17, P153, DOI 10.1111/j.1467-8721.2008.00566.x; Oldershaw A, 2011, NEUROSCI BIOBEHAV R, V35, P970, DOI 10.1016/j.neubiorev.2010.11.001; Oldershaw A, 2010, PSYCHOSOM MED, V72, P73, DOI 10.1097/PSY.0b013e3181c6c7ca; Park J.Y., 2011, KOREAN FACIAL EXPRES; Parr LA, 2013, PSYCHONEUROENDOCRINO, V38, P1748, DOI 10.1016/j.psyneuen.2013.02.011; Pergamin-Hight L, 2012, BIOL PSYCHIAT, V71, P373, DOI 10.1016/j.biopsych.2011.10.030; POSNER MI, 1980, J EXP PSYCHOL GEN, V109, P160, DOI 10.1037/0096-3445.109.2.160; Prehn K, 2013, PSYCHOPHYSIOLOGY, V50, P528, DOI 10.1111/psyp.12042; Schmidt U, 2006, BRIT J CLIN PSYCHOL, V45, P343, DOI 10.1348/014466505X53902; Schulte-Ruther M, 2012, J AM ACAD CHILD PSY, V51, P832, DOI 10.1016/j.jaac.2012.06.007; Shahrestani S, 2013, NEUROPSYCHOPHARMACOL, V38, P1929, DOI 10.1038/npp.2013.86; Sharpe H, 2013, INT J EAT DISORDER, V46, P643, DOI 10.1002/eat.22151; Spielberger C., 1991, STATE TRAIT ANGER EX; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Tollenaar MS, 2013, PSYCHONEUROENDOCRINO, V38, P1797, DOI 10.1016/j.psyneuen.2013.02.018; Treasure J, 2012, EUR EAT DISORD REV, V20, P431, DOI 10.1002/erv.2181; Zucker NL, 2007, PSYCHOL BULL, V133, P976, DOI 10.1037/0033-2909.133.6.976	69	36	38	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90721	10.1371/journal.pone.0090721	http://dx.doi.org/10.1371/journal.pone.0090721			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC4ID	24603863	Green Submitted, Green Published, gold			2022-12-27	WOS:000332483600076
J	Schuster, S; Penke, M; Gorski, T; Petzold-Quinque, S; Damm, G; Gebhardt, R; Kiess, W; Garten, A				Schuster, Susanne; Penke, Melanie; Gorski, Theresa; Petzold-Quinque, Stefanie; Damm, Georg; Gebhardt, Rolf; Kiess, Wieland; Garten, Antje			Resveratrol Differentially Regulates NAMPT and SIRT1 in Hepatocarcinoma Cells and Primary Human Hepatocytes	PLOS ONE			English	Article							NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; P53 ACETYLATION; TRANSCRIPTION FACTORS; NAD(+) BIOSYNTHESIS; COLORECTAL-CANCER; TUMOR-GROWTH; DNA-DAMAGE; LIFE-SPAN; APOPTOSIS; INHIBITION	Resveratrol is reported to possess chemotherapeutic properties in several cancers. In this study, we wanted to investigate the molecular mechanisms of resveratrol-induced cell cycle arrest and apoptosis as well as the impact of resveratrol on NAMPT and SIRT1 protein function and asked whether there are differences in hepatocarcinoma cells (HepG2, Hep3B cells) and non-cancerous primary human hepatocytes. We found a lower basal NAMPT mRNA and protein expression in hepatocarcinoma cells compared to primary hepatocytes. In contrast, SIRT1 was significantly higher expressed in hepatocarcinoma cells than in primary hepatocytes. Resveratrol induced cell cycle arrest in the S-and G2/M- phase and apoptosis was mediated by activation of p53 and caspase-3 in HepG2 cells. In contrast to primary hepatocytes, resveratrol treated HepG2 cells showed a reduction of NAMPT enzymatic activity and increased p53 acetylation (K382). Resveratrol induced NAMPT release from HepG2 cells which was associated with increased NAMPT mRNA expression. This effect was absent in primary hepatocytes where resveratrol was shown to function as NAMPT and SIRT1 activator. SIRT1 inhibition by EX527 resembled resveratrol effects on HepG2 cells. Furthermore, a SIRT1 overexpression significantly decreased both p53 hyperacetylation and resveratrol-induced NAMPT release as well as S-phase arrest in HepG2 cells. We could show that NAMPT and SIRT1 are differentially regulated by resveratrol in hepatocarcinoma cells and primary hepatocytes and that resveratrol did not act as a SIRT1 activator in hepatocarcinoma cells.	[Schuster, Susanne; Penke, Melanie; Gorski, Theresa; Petzold-Quinque, Stefanie; Kiess, Wieland; Garten, Antje] Univ Leipzig, Fac Med, Ctr Pediat Res Leipzig, Univ Hosp Children & Adolescents, D-04109 Leipzig, Germany; [Damm, Georg] Charite, Dept Gen Visceral & Transplantat Surg, D-13353 Berlin, Germany; [Gebhardt, Rolf] Univ Leipzig, Fac Med, Inst Biochem, D-04109 Leipzig, Germany	Leipzig University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Leipzig University	Schuster, S (corresponding author), Univ Leipzig, Fac Med, Ctr Pediat Res Leipzig, Univ Hosp Children & Adolescents, D-04109 Leipzig, Germany.	Susanne.Schuster@medizin.uni-leipzig.de	Damm, Georg/ABD-7372-2021	Damm, Georg/0000-0002-2104-8076; Garten, Antje/0000-0002-5354-287X; Gaul, Susanne/0000-0003-4780-1844	German Research Foundation (DFG) [KFO 152]; DDG (Deutsche Diabetes Gesellschaft); LIFE (Leipzig Research Center for Civilization Diseases, University of Leipzig ); European Union; European Regional Development Fund (ERDF); German Federal Ministry of Education and Research; German Research Foundation (DFG); Leipzig University within the program of Open Access Publishing	German Research Foundation (DFG)(German Research Foundation (DFG)); DDG (Deutsche Diabetes Gesellschaft); LIFE (Leipzig Research Center for Civilization Diseases, University of Leipzig ); European Union(European Commission); European Regional Development Fund (ERDF)(European Commission); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Research Foundation (DFG)(German Research Foundation (DFG)); Leipzig University within the program of Open Access Publishing	The work was supported by German Research Foundation (DFG) KFO 152 "Atherobesity" (to WK), DDG (Deutsche Diabetes Gesellschaft) (to SS and AG) and by LIFE (Leipzig Research Center for Civilization Diseases, University of Leipzig ) (to WK and SS). LIFE is funded by means of the European Union, by the European Regional Development Fund (ERDF) and by means of the Free State of Saxony within the framework of the excellence initiative. The "virtual liver" program is funded by the German Federal Ministry of Education and Research. We also acknowledge support from the German Research Foundation (DFG) and Leipzig University within the program of Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2004, ANTICANCER RES, V24, P2783; Baarine M, 2011, GENES NUTR, V6, P161, DOI 10.1007/s12263-011-0232-z; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Beher D, 2009, CHEM BIOL DRUG DES, V74, P619, DOI 10.1111/j.1747-0285.2009.00901.x; Berger F, 2004, TRENDS BIOCHEM SCI, V29, P111, DOI 10.1016/j.tibs.2004.01.007; Bernhard D, 2000, CELL DEATH DIFFER, V7, P834, DOI 10.1038/sj.cdd.4400719; Bi TQ, 2010, CANCER BIOL THER, V10, P119, DOI 10.4161/cbt.10.2.12581; Bishayee A, 2010, CANCER TREAT REV, V36, P43, DOI 10.1016/j.ctrv.2009.10.002; Bjorklund M, 2011, CANCER CHEMOTH PHARM, V68, P1459, DOI 10.1007/s00280-011-1640-x; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Cagnetta A, 2013, BLOOD, V122, P1243, DOI 10.1182/blood-2013-02-483511; Carbo N, 1999, BIOCHEM BIOPH RES CO, V254, P739, DOI 10.1006/bbrc.1998.9916; Chen HC, 2012, ANN SURG ONCOL, V19, P2011, DOI 10.1245/s10434-011-2159-4; Chen J, 2011, CANCER RES, V71, P4138, DOI 10.1158/0008-5472.CAN-10-4274; Chiarugi A, 2012, NAT REV CANCER, V12, P741, DOI 10.1038/nrc3340; Chini CC, 2013, CLIN CANC RES; De L, 2001, INT J ONCOL, V19, P83; Delmas D, 2006, CURR DRUG TARGETS, V7, P423, DOI 10.2174/138945006776359331; Delmas D, 2011, CURR MED CHEM, V18, P1100, DOI 10.2174/092986711795029708; Delmas D, 2000, ONCOL REP, V7, P847; Deng CX, 2009, INT J BIOL SCI, V5, P147, DOI 10.7150/ijbs.5.147; Dixit D, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.10; Drevs J, 2003, ANTICANCER RES, V23, P4853; ELLIOTT GC, 1980, ANAL BIOCHEM, V107, P199, DOI 10.1016/0003-2697(80)90512-6; Flick F, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00029; Folgueira MAAK, 2005, CLIN CANCER RES, V11, P7434; Frazzi R., 2012, INT J CANCER; Fukuhara A, 2005, SCIENCE, V307, P426, DOI 10.1126/science.1097243; Fukuhara A, 2007, SCIENCE, V318, P565, DOI 10.1126/science.318.5850.565b; Garten A, 2010, BIOCHEM BIOPH RES CO, V391, P376, DOI 10.1016/j.bbrc.2009.11.066; Gogada R, 2011, J BIOL CHEM, V286, P28749, DOI 10.1074/jbc.M110.202440; Hasmann M, 2003, CANCER RES, V63, P7436; Ho C, 2009, FEBS LETT, V583, P3081, DOI 10.1016/j.febslet.2009.08.031; Houtkooper RH, 2010, ENDOCR REV, V31, P194, DOI 10.1210/er.2009-0026; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Hu Y, 2011, FREE RADICAL BIO MED, V51, P250, DOI 10.1016/j.freeradbiomed.2011.04.034; Hufton SE, 1999, FEBS LETT, V463, P77, DOI 10.1016/S0014-5793(99)01578-1; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Joe AK, 2002, CLIN CANCER RES, V8, P893; Kaeberlein M, 2005, J BIOL CHEM, V280, P17038, DOI 10.1074/jbc.M500655200; Kai L, 2010, INT J CANCER, V126, P1538, DOI 10.1002/ijc.24928; Kang H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006611; Kover K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058767; Kuo PL, 2002, LIFE SCI, V72, P23, DOI 10.1016/S0024-3205(02)02177-X; Liu T, 2009, CANCER RES, V69, P1702, DOI 10.1158/0008-5472.CAN-08-3365; Mahyar-Roemer M, 2001, INT J CANCER, V94, P615, DOI 10.1002/ijc.1516; Muruganandham M, 2005, CLIN CANCER RES, V11, P3503, DOI 10.1158/1078-0432.CCR-04-1399; NUSSLER AK, 2009, STRATEGIES REGENERAT, P283; Pacholec M, 2010, J BIOL CHEM, V285, P8340, DOI 10.1074/jbc.M109.088682; Peck B, 2010, MOL CANCER THER, V9, P844, DOI 10.1158/1535-7163.MCT-09-0971; Pizarro JG, 2011, NEUROCHEM RES, V36, P187, DOI 10.1007/s11064-010-0296-y; Portmann S, 2013, MOL CANCER THER, V12, P499, DOI 10.1158/1535-7163.MCT-12-0700; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Revollo JR, 2007, CELL METAB, V6, P363, DOI 10.1016/j.cmet.2007.09.003; Revollo JR, 2007, CURR OPIN GASTROEN, V23, P164, DOI 10.1097/MOG.0b013e32801b3c8f; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; SAMAL B, 1994, MOL CELL BIOL, V14, P1431, DOI 10.1128/MCB.14.2.1431; Solomon JM, 2006, MOL CELL BIOL, V26, P28, DOI 10.1128/MCB.26.1.28-38.2006; Tan B, 2013, J BIOL CHEM, V288, P3500, DOI 10.1074/jbc.M112.394510; Thakur BK, 2013, INT J CANCER, V132, P766, DOI 10.1002/ijc.27726; Thakur BK, 2012, BIOCHEM BIOPH RES CO, V424, P371, DOI 10.1016/j.bbrc.2012.06.075; van Beijnum JR, 2002, INT J CANCER, V101, P118, DOI 10.1002/ijc.10584; Vang O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019881; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Venturelli S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073097; Wang HN, 2012, ONCOL REP, V28, P311, DOI 10.3892/or.2012.1788; Wang RH, 2008, MOL CELL, V32, P11, DOI 10.1016/j.molcel.2008.09.011; Whitlock NC, 2012, NUTR CANCER, V64, P493, DOI 10.1080/01635581.2012.667862; Yang Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070627; Zhang C, 2011, CARDIOVASC RES, V90, P538, DOI 10.1093/cvr/cvr022; Zhang Q, 2012, EMBO MOL MED, V4, P298, DOI 10.1002/emmm.201100211; Zhang T, 2009, J BIOL CHEM, V284, P20408, DOI 10.1074/jbc.M109.016469; Zhou R, 2009, BRIT J PHARMACOL, V158, P462, DOI 10.1111/j.1476-5381.2009.00268.x	74	32	34	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e91045	10.1371/journal.pone.0091045	http://dx.doi.org/10.1371/journal.pone.0091045			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603648	Green Published, gold			2022-12-27	WOS:000332483600123
J	Gath, J; Bousset, L; Habenstein, B; Melki, R; Bockmann, A; Meier, BH				Gath, Julia; Bousset, Luc; Habenstein, Birgit; Melki, Ronald; Boeckmann, Anja; Meier, Beat H.			Unlike Twins: An NMR Comparison of Two alpha-Synuclein Polymorphs Featuring Different Toxicity	PLOS ONE			English	Article							SOLID-STATE NMR; BAND DECOUPLING SEQUENCE; AMYLOID FIBRILS; CROSS-POLARIZATION; ADIABATIC-PASSAGE; STRUCTURAL-CHARACTERIZATION; HET-S(218-289) PRION; SECONDARY STRUCTURE; WILD-TYPE; PROTEIN	We structurally compare, using solid-state NMR, two different polymorphs of alpha-synuclein which, as established recently, display contrasting biochemical properties, toxicity, and tropism for cells. We show that both forms, which can each be produced as a pure polymorph, are greatly different in secondary structure. While beta-sheets are the dominating secondary structure elements for both polymorphs, they are markedly divergent in terms of number of elements, as well as their distribution. We demonstrate that all identified beta-sheets feature an in-register parallel stacking for both polymorphs. The two forms show a different molecular arrangement in the unit cell and distinct dynamic features, while sharing a highly flexible C-terminal domain. The use of reproducible, well-identified conditions for sample preparation and the recording of identical NMR experiments allows for a direct comparison of the results.	[Gath, Julia; Meier, Beat H.] ETH, Zurich, Switzerland; [Bousset, Luc; Melki, Ronald] CNRS, UPR 3082, Lab Enzymol & Biochim Struct, Gif Sur Yvette, France; [Habenstein, Birgit; Boeckmann, Anja] Univ Lyon 1, CNRS, UMR 5086, Inst Biol & Chim Prot, F-69365 Lyon, France	Swiss Federal Institutes of Technology Domain; ETH Zurich; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Melki, R (corresponding author), CNRS, UPR 3082, Lab Enzymol & Biochim Struct, Gif Sur Yvette, France.	melki@lebs.cnrs-gif.fr; a.bockmann@ibcp.fr; beme@ethz.ch	Böckmann, Anja/AAW-6276-2021; Habenstein, Birgit/E-4425-2013; Meier, Beat H/K-4066-2016	Böckmann, Anja/0000-0001-8149-7941; Habenstein, Birgit/0000-0003-3723-9552; Meier, Beat H/0000-0002-9107-4464; bousset, luc/0000-0002-0433-4337	Agence Nationale de la Recherche [ANR-09-MNPS-013-01, ANR-11-BSV-8021-01, ANR-12-BS08-0013-01]; Swiss National Science Foundation [200020_146757]; Centre National de la Recherche Scientifique; ETH Zurich; European Union through the Human Frontier Science Program; Seventh Framework Program [Bio-NMR 261863]; "Coup d'E lan a la Recherche Francaise" award from Fondation Bettencourt Schueller	Agence Nationale de la Recherche(French National Research Agency (ANR)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); ETH Zurich(ETH Zurich); European Union through the Human Frontier Science Program; Seventh Framework Program(European Commission); "Coup d'E lan a la Recherche Francaise" award from Fondation Bettencourt Schueller	This work was supported by the Agence Nationale de la Recherche (ANR-09-MNPS-013-01 ANR-11-BSV-8021-01 and ANR-12-BS08-0013-01, http://www.agence-nationale-recherche.fr/), the Swiss National Science Foundation (grant 200020_146757, http://www.snf.ch), the Centre National de la Recherche Scientifique (http://www.cnrs.fr/), the ETH Zurich (http://www.ethz.ch), the European Union through the Human Frontier Science Program (http://www.hfsp.org/) and the Seventh Framework Program (contract Bio-NMR 261863, http://www.bio-nmr.net/). RM acknowledges a "Coup d'E lan a la Recherche Francaise" award from Fondation Bettencourt Schueller (http://www.fondationbs.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldus M, 1996, J MAGN RESON SER A, V118, P140, DOI 10.1006/jmra.1996.0022; Baldus M, 1998, MOL PHYS, V95, P1197, DOI 10.1080/00268979809483251; Baxa U, 2007, BIOCHEMISTRY-US, V46, P13149, DOI 10.1021/bi700826b; Bockmann A, 2003, J BIOMOL NMR, V27, P323, DOI 10.1023/A:1025820611009; BODENHAUSEN G, 1980, CHEM PHYS LETT, V69, P185, DOI 10.1016/0009-2614(80)80041-8; Bodner CR, 2010, BIOCHEMISTRY-US, V49, P862, DOI 10.1021/bi901723p; Bousset L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3575; Brundin P, 2010, NAT REV MOL CELL BIO, V11, P301, DOI 10.1038/nrm2873; Castellani F, 2003, BIOCHEMISTRY-US, V42, P11476, DOI 10.1021/bi034903r; Comellas G, 2011, J MOL BIOL, V411, P881, DOI 10.1016/j.jmb.2011.06.026; Cornilescu G, 1999, J AM CHEM SOC, V121, P2949, DOI 10.1021/ja9902221; De Paepe G, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3541251; Der-Sarkissian A, 2003, J BIOL CHEM, V278, P37530, DOI 10.1074/jbc.M305266200; Fogh Rasmus, 2002, Nature Structural Biology, V9, P416, DOI 10.1038/nsb0602-416; Fung BM, 2000, J MAGN RESON, V142, P97, DOI 10.1006/jmre.1999.1896; Gath J, 2014, BIOMOL NMR ASSIGN, V8, P395, DOI 10.1007/s12104-013-9526-y; Gath J, 2012, BIOMOL NMR ASSIGN, V6, P51, DOI 10.1007/s12104-011-9324-3; Guo JL, 2013, CELL, V154, P103, DOI 10.1016/j.cell.2013.05.057; Habenstein B, 2012, ANGEW CHEM INT EDIT, V51, P7963, DOI 10.1002/anie.201202093; HEDIGER S, 1994, CHEM PHYS LETT, V223, P283, DOI 10.1016/0009-2614(94)00470-6; HEDIGER S, 1995, CHEM PHYS LETT, V240, P449, DOI 10.1016/0009-2614(95)00505-X; Heise H, 2005, P NATL ACAD SCI USA, V102, P15871, DOI 10.1073/pnas.0506109102; Heise H, 2008, J MOL BIOL, V380, P444, DOI 10.1016/j.jmb.2008.05.026; Helmus JJ, 2010, J AM CHEM SOC, V132, P2393, DOI 10.1021/ja909827v; Hoyer W, 2002, J MOL BIOL, V322, P383, DOI 10.1016/S0022-2836(02)00775-1; Irwin DJ, 2013, NAT REV NEUROSCI, V14, P626, DOI 10.1038/nrn3549; Karpinar DP, 2009, EMBO J, V28, P3256, DOI 10.1038/emboj.2009.257; Kloepper KD, 2007, J PHYS CHEM B, V111, P13353, DOI 10.1021/jp077036z; Kloepper KD, 2007, J BIOMOL NMR, V39, P197, DOI 10.1007/s10858-007-9189-z; Kloepper KD, 2006, PROTEIN EXPRES PURIF, V48, P112, DOI 10.1016/j.pep.2006.02.009; Kryndushkin DS, 2011, J MOL BIOL, V409, P263, DOI 10.1016/j.jmb.2011.03.067; Lange A, 2009, CHEMBIOCHEM, V10, P1657, DOI 10.1002/cbic.200900019; Lewandowski JR, 2007, J AM CHEM SOC, V129, P728, DOI 10.1021/ja0650394; Lopez del Amo JM, 2012, ANGEW CHEM INT EDIT, V51, P6136, DOI 10.1002/anie.201200965; Loquet A, 2011, J AM CHEM SOC, V133, P4722, DOI 10.1021/ja200066s; Loquet A, 2009, J MOL BIOL, V394, P108, DOI 10.1016/j.jmb.2009.09.016; Lv GH, 2012, J MOL BIOL, V420, P99, DOI 10.1016/j.jmb.2012.04.009; McDermott A, 2000, J BIOMOL NMR, V16, P209, DOI 10.1023/A:1008391625633; MORRIS GA, 1979, J AM CHEM SOC, V101, P760, DOI 10.1021/ja00497a058; Nielsen JT, 2009, ANGEW CHEM INT EDIT, V48, P2118, DOI 10.1002/anie.200804198; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; Pawar AP, 2005, J MOL BIOL, V350, P379, DOI 10.1016/j.jmb.2005.04.016; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Ritter C, 2005, NATURE, V435, P844, DOI 10.1038/nature03793; Ross C. A., 2004, NAT MED, V10, P10, DOI [10.1038/nm1066, DOI 10.1038/NM1066]; Schneider R, 2011, J MOL BIOL, V412, P121, DOI 10.1016/j.jmb.2011.06.045; Scholz I, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2800319; Schuetz A, 2010, CHEMBIOCHEM, V11, P1543, DOI 10.1002/cbic.201000124; SHAKA AJ, 1983, J MAGN RESON, V53, P313, DOI 10.1016/0022-2364(83)90035-5; Siemer AB, 2006, J AM CHEM SOC, V128, P13224, DOI 10.1021/ja063639x; Sivanandam VN, 2011, J AM CHEM SOC, V133, P4558, DOI 10.1021/ja110715f; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; STEINER JA, 2010, NEUROLOGY, V9, P1128, DOI DOI 10.1016/S1474-4422(10)70213-1; Stevens TJ, 2011, J BIOMOL NMR, V51, P437, DOI 10.1007/s10858-011-9569-2; Takegoshi K, 2001, CHEM PHYS LETT, V344, P631, DOI 10.1016/S0009-2614(01)00791-6; Toyama BH, 2007, NATURE, V449, P233, DOI 10.1038/nature06108; UEDA K, 1993, P NATL ACAD SCI USA, V90, P11282, DOI 10.1073/pnas.90.23.11282; van der Wel PCA, 2010, BIOCHEMISTRY-US, V49, P9457, DOI 10.1021/bi100077x; Van Melckebeke H, 2010, J AM CHEM SOC, V132, P13765, DOI [10.1021/ja104213J, 10.1021/ja104213j]; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wasmer C, 2008, SCIENCE, V319, P1523, DOI 10.1126/science.1151839; WISHART DS, 1994, J BIOMOL NMR, V4, P171	62	81	81	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90659	10.1371/journal.pone.0090659	http://dx.doi.org/10.1371/journal.pone.0090659			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599158	gold, Green Submitted, Green Published			2022-12-27	WOS:000332479400110
J	Wei, XL; Qiu, MZ; Lin, HX; Zhang, Y; Liu, JX; Yu, HM; Liang, WP; Jin, Y; Ren, C; He, MM; Chen, WW; Luo, HY; Wang, ZQ; Zhang, DS; Wang, FH; Li, YH; Xu, RH				Wei, Xiao-li; Qiu, Miao-zhen; Lin, Huan-xin; Zhang, Ying; Liu, Jian-xin; Yu, Hong-mei; Liang, Wei-ping; Jin, Ying; Ren, Chao; He, Ming-ming; Chen, Wei-wei; Luo, Hui-yan; Wang, Zhi-qiang; Zhang, Dong-sheng; Wang, Feng-hua; Li, Yu-hong; Xu, Rui-hua			Patients with Old Age or Proximal Tumors Benefit from Metabolic Syndrome in Early Stage Gastric Cancer	PLOS ONE			English	Article							PRIMARY LIVER-CANCER; BODY-MASS INDEX; RISK-FACTORS; INSULIN-RESISTANCE; BREAST-CANCER; PROSPECTIVE COHORT; PROGNOSTIC-FACTOR; MORTALITY; ADENOCARCINOMA; ASSOCIATION	Background: Metabolic syndrome and/or its components have been demonstrated to be risk factors for several cancers. They are also found to influence survival in breast, colon and prostate cancer, but the prognostic value of metabolic syndrome in gastric cancer has not been investigated. Methods: Clinical data and pre-treatment information of metabolic syndrome of 587 patients diagnosed with early stage gastric cancer were retrospectively collected. The associations of metabolic syndrome and/or its components with clinical characteristics and overall survival in early stage gastric cancer were analyzed. Results: Metabolic syndrome was identified to be associated with a higher tumor cell differentiation (P = 0.036). Metabolic syndrome was also demonstrated to be a significant and independent predictor for better survival in patients aged.50 years old (P = 0.009 in multivariate analysis) or patients with proximal gastric cancer (P = 0.047 in multivariate analysis). No association was found between single metabolic syndrome component and overall survival in early stage gastric cancer. In addition, patients with hypertension might have a trend of better survival through a good control of blood pressure (P = 0.052 in univariate analysis). Conclusions: Metabolic syndrome was associated with a better tumor cell differentiation in patients with early stage gastric cancer. Moreover, metabolic syndrome was a significant and independent predictor for better survival in patients with old age or proximal tumors.	[Wei, Xiao-li; Qiu, Miao-zhen; Jin, Ying; Ren, Chao; He, Ming-ming; Chen, Wei-wei; Luo, Hui-yan; Wang, Zhi-qiang; Zhang, Dong-sheng; Wang, Feng-hua; Li, Yu-hong; Xu, Rui-hua] Sun Yat Sen Univ, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Dept Med Oncol,Canc Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Lin, Huan-xin; Zhang, Ying; Liu, Jian-xin; Yu, Hong-mei; Liang, Wei-ping] Sun Yat Sen Univ, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Dept Prevent Care,Canc Ctr, Guangzhou 510275, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University	Xu, RH (corresponding author), Sun Yat Sen Univ, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Dept Med Oncol,Canc Ctr, Guangzhou 510275, Guangdong, Peoples R China.	xurh@sysucc.org.cn	骆, 卉妍/GWR-3383-2022; xu, rui/GRX-5734-2022; Xu, Rui-Hua/AAW-4766-2021	骆, 卉妍/0000-0001-6312-9299; Xu, Rui-Hua/0000-0001-9771-8534	National High Technology Research and Development Program of China (863 Program), China [2012AA02A506]; National Natural Science Foundation of China [81372570]; Science and Technology Department of Guangdong Province, China [2012B031800088]; Medical Scientific Research Foundation of Guangdong Province, China [C2011019]	National High Technology Research and Development Program of China (863 Program), China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Department of Guangdong Province, China; Medical Scientific Research Foundation of Guangdong Province, China	This work was supported by the National High Technology Research and Development Program of China (863 Program), China (NO. 2012AA02A506), the National Natural Science Foundation of China (No. 81372570), The Science and Technology Department of Guangdong Province, China (No. 2012B031800088), and the Medical Scientific Research Foundation of Guangdong Province, China (No. C2011019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almquist M, 2011, CANCER CAUSE CONTROL, V22, P743, DOI 10.1007/s10552-011-9747-2; Barresi V, 2009, J CLIN PATHOL, V62, P705, DOI 10.1136/jcp.2009.066175; Bertuccio P, 2009, INT J CANCER, V125, P666, DOI 10.1002/ijc.24290; Bickenbach KA, 2013, ANN SURG ONCOL, V20, P780, DOI 10.1245/s10434-012-2653-3; Bjorge T, 2011, INT J EPIDEMIOL, V40, P1667, DOI 10.1093/ije/dyr130; Borena W, 2012, INT J CANCER, V131, P193, DOI 10.1002/ijc.26338; Colonna SV, 2012, BREAST CANCER RES TR, V131, P325, DOI 10.1007/s10549-011-1790-x; Cowey S, 2006, AM J PATHOL, V169, P1505, DOI 10.2353/ajpath.2006.051090; Da Li Q, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-315; Esposito K, 2012, DIABETES CARE, V35, P2402, DOI 10.2337/dc12-0336; Friedenreich CM, 2011, CANCER EPIDEM BIOMAR, V20, P2384, DOI 10.1158/1055-9965.EPI-11-0715; Haggstrom C, 2011, INT J CANCER, V128, P1890, DOI 10.1002/ijc.25521; Healy LA, 2012, COLORECTAL DIS, V14, P157, DOI 10.1111/j.1463-1318.2011.02562.x; Healy LA, 2010, CLIN ONCOL-UK, V22, P281, DOI 10.1016/j.clon.2010.02.001; Jaggers JR, 2009, EUR J CANCER, V45, P1831, DOI 10.1016/j.ejca.2009.01.031; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jinjuvadia R, 2013, J CLIN GASTROENTEROL, V47, P33, DOI 10.1097/MCG.0b013e3182688c15; Konings IRHM, 2010, EUR J CANCER, V46, P3200, DOI 10.1016/j.ejca.2010.07.036; Lee JS, 2010, ANN ONCOL, V21, P640, DOI 10.1093/annonc/mdp344; MacInnis RJ, 2006, INT J CANCER, V118, P2628, DOI 10.1002/ijc.21638; Merry AHH, 2007, GUT, V56, P1503, DOI 10.1136/gut.2006.116665; Nagel G, 2012, BRIT J DERMATOL, V167, P59, DOI 10.1111/j.1365-2133.2012.10974.x; Nagel G, 2012, ANN HEMATOL, V91, P1519, DOI 10.1007/s00277-012-1489-z; Nozoe T, 2012, SURG TODAY, V42, P945, DOI 10.1007/s00595-012-0183-z; O'Doherty MG, 2012, GUT, V61, P1261, DOI 10.1136/gutjnl-2011-300551; Otani K, 2008, GASTRIC CANCER, V11, P86, DOI 10.1007/s10120-008-0459-6; Pasanisi P, 2006, INT J CANCER, V119, P236, DOI 10.1002/ijc.21812; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Reeves KW, 2012, CANCER CAUSE CONTROL, V23, P1241, DOI 10.1007/s10552-012-0002-2; Rosato V, 2011, METABOLISM, V60, P1372, DOI 10.1016/j.metabol.2011.03.005; Shebl FM, 2011, BRIT J CANCER, V105, P1424, DOI 10.1038/bjc.2011.363; Shen ZL, 2010, AM J SURG, V200, P59, DOI 10.1016/j.amjsurg.2009.05.005; Shin E, 2013, J CANCER RES CLIN, V139, P709, DOI 10.1007/s00432-013-1379-3; Stebbing J, 2012, ANN ONCOL, V23, P860, DOI 10.1093/annonc/mdr347; Tamura T, 2012, J GASTROEN HEPATOL, V27, P1635, DOI 10.1111/j.1440-1746.2012.07189.x; Tian T, 2012, EXP CLIN ENDOCR DIAB, V120, P217, DOI 10.1055/s-0031-1297969; Tseng CH, 2011, GUT, V60, P774, DOI 10.1136/gut.2010.226522; Tsukada T, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-107; Ulaganathan V, 2012, ASIAN PAC J CANCER P, V13, P3873, DOI 10.7314/APJCP.2012.13.8.3873; Ulmer H, 2012, GYNECOL ONCOL, V125, P330, DOI 10.1016/j.ygyno.2012.01.052; Welzel TM, 2011, HEPATOLOGY, V54, P463, DOI 10.1002/hep.24397; Wu Q, 2012, DIGESTION, V86, P294, DOI 10.1159/000341397; Xiang YZ, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-9; Yang Y, 2013, CANCER-AM CANCER SOC, V119, P1512, DOI 10.1002/cncr.27923	44	14	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e89965	10.1371/journal.pone.0089965	http://dx.doi.org/10.1371/journal.pone.0089965			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599168	Green Published, gold, Green Submitted			2022-12-27	WOS:000332479400036
J	Galiwango, RM; Lubyayi, L; Musoke, R; Kalibbala, S; Buwembo, M; Kasule, J; Serwadda, D; Gray, RH; Reynolds, SJ; Chang, LW				Galiwango, Ronald M.; Lubyayi, Lawrence; Musoke, Richard; Kalibbala, Sarah; Buwembo, Martin; Kasule, Jjingo; Serwadda, David; Gray, Ronald H.; Reynolds, Steven J.; Chang, Larry W.			Field Evaluation of PIMA Point-of-Care CD4 Testing in Rakai, Uganda	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; SOUTH-AFRICA; ANALYZER; SERVICE; MORTALITY; COUNTS	Objective: To assess the accuracy of PIMA Point-of-Care (POC) CD4 testing in rural Rakai, Uganda. Methods: 903 HIV positive persons attending field clinics provided a venous blood sample assessed on site using PIMA analyzers per manufacturer's specifications. The venous samples were then run on FACSCalibur flow cytometry at a central facility. The Bland-Altman method was used to estimate mean bias and 95% limits of agreement (LOA). Sensitivity, specificity, negative predictive value (NPV), and positive predictive value (PPV) were calculated for a CD4 threshold of <350 and <500 cells/uL for antiretroviral eligibility. Results: There was a high correlation between PIMA and FACSCalibur CD4 counts (r = 0.943, p<0.001). Relative to FACSCalibur, the PIMA POC CD4 had negative mean bias of -34.6 cells/uL (95% LOA: -219.8 to 150.6) overall. The dispersion at CD4<350 cells/uL was 5.1 cells/uL (95% LOA: -126.6 to 136.8). For a threshold of CD4<350 cells/uL, PIMA venous blood had a sensitivity of 88.6% (95% CI 84.8-92.4%), specificity of 87.5% (95% CI 84.9-90.1%), NPV of 94.9% (95% CI 93.1-96.7%), and PPV of 74.4% (95% CI 69.6-79.2%). PIMA sensitivity and PPV significantly increased to 96.1% and 88.3% respectively with increased threshold of 500 cells/uL. Conclusions: Overall, PIMA POC CD4 counts demonstrated negative bias compared to FACSCalibur. PIMA POC sensitivity improved significantly at a higher CD4 threshold of 500 than a 350 cells/uL threshold.	[Galiwango, Ronald M.; Lubyayi, Lawrence; Musoke, Richard; Kalibbala, Sarah; Buwembo, Martin; Kasule, Jjingo] Rakai Hlth Sci Program, Kalisizo, Uganda; [Gray, Ronald H.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Reynolds, Steven J.] NIAID, Immunoregulat Lab, Div Intramural Res, NIH, Bethesda, MD 20892 USA; [Reynolds, Steven J.; Chang, Larry W.] Johns Hopkins Univ, Sch Med, Dept Med, Div Infect Dis, Baltimore, MD 21205 USA; [Serwadda, David] Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Kampala, Uganda	Rakai Health Sciences Program; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Johns Hopkins University; Makerere University	Chang, LW (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Div Infect Dis, Baltimore, MD 21205 USA.	lchang8@jhmi.edu		Musoke, Richard/0000-0002-2566-4191; Reynolds, Steven/0000-0002-5403-2759; Lubyayi, Lawrence/0000-0001-5286-6488	CDC Uganda; PEPFAR Uganda; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000361, ZIAAI001040] Funding Source: NIH RePORTER	CDC Uganda; PEPFAR Uganda; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We acknowledge CDC Uganda for the funding support that availed the PIMAs to our institution and PEPFAR Uganda that supports the treatment program. This work was supported in part (SJR) by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health. The funders had no role in the study design, data collection, analysis, decision to publish or preparation of the manuscript.	*AL WEBS, AL PIM CD4 CUST TRAI; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brinkhof MWG, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000066; DIAW PA, J ACQUIR IMMUNE DEFI, V58, pE103; Glencross DK, 2012, J INT AIDS SOC, V15, DOI 10.1186/1758-2652-15-3; Herbert S, 2012, SEX TRANSM INFECT, V88, P413, DOI 10.1136/sextrans-2012-050507; Jaffar Shabbar, 2008, AIDS Res Ther, V5, P4, DOI 10.1186/1742-6405-5-4; Jani IV, 2011, AIDS, V25, P807, DOI 10.1097/QAD.0b013e328344f424; Kagaayi J, 2007, AIDS, V21, P1208, DOI 10.1097/QAD.0b013e32810c8dce; Kiwanuka N, 2004, JAIDS-J ACQ IMM DEF, V36, P721, DOI 10.1097/00126334-200406010-00009; Lawn SD, 2005, AIDS, V19, P2141, DOI 10.1097/01.aids.0000194802.89540.e1; Lawn SD, 2006, CLIN INFECT DIS, V43, P770, DOI 10.1086/507095; Manabe YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034319; Mnyani CN, 2012, JAIDS-J ACQ IMM DEF, V60, P260, DOI 10.1097/QAI.0b013e318256b651; Mtapuri-Zinyowera S, 2010, JAIDS-J ACQ IMM DEF, V55, P1, DOI 10.1097/QAI.0b013e3181e93071; Mwau M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067612; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; Thakar M, 2012, AIDS RES THER, V9, DOI 10.1186/1742-6405-9-26	18	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e88928	10.1371/journal.pone.0088928	http://dx.doi.org/10.1371/journal.pone.0088928			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614083	Green Submitted, Green Published, gold			2022-12-27	WOS:000332839300008
J	Battle, C; Hutchings, H; Bouamra, O; Evans, PA				Battle, Ceri; Hutchings, Hayley; Bouamra, Omar; Evans, Phillip A.			The Effect of Pre-Injury Anti-Platelet Therapy on the Development of Complications in Isolated Blunt Chest Wall Trauma: A Retrospective Study	PLOS ONE			English	Article							RIB FRACTURES; MORTALITY; RISK; PNEUMONIA; MORBIDITY	Introduction: The difficulties in the management of the blunt chest wall trauma patient in the Emergency Department due to the development of late complications are well recognised in the literature. Pre-injury anti-platelet therapy has been previously investigated as a risk factor for poor outcomes following traumatic head injury, but not in the blunt chest wall trauma patient cohort. The aim of this study was to investigate pre-injury anti-platelet therapy as a risk factor for the development of complications in the recovery phase following blunt chest wall trauma. Methods: A retrospective study was completed in which the medical notes were analysed of all blunt chest wall trauma patients presenting to a large trauma centre in Wales in 2012 and 2013. Using univariate and multivariable logistic regression analysis, pre-injury platelet therapy was investigated as a risk factor for the development of complications following blunt chest wall trauma. Previously identified risk factors were included in the analysis to address the influence of confounding. Results: A total of 1303 isolated blunt chest wall trauma patients presented to the ED in Morriston Hospital in 2012 and 2013 with complications recorded in 144 patients (11%). On multi-variable analysis, pre-injury anti-platelet therapy was found to be a significant risk factor for the development of complications following isolated blunt chest wall trauma (odds ratio: 16.9; 95% confidence intervals: 8.2-35.2). As in previous studies patient age, number of rib fractures, chronic lung disease and pre-injury anti-coagulant use were also found to be significant risk factors. Conclusions: Pre-injury anti-platelet therapy is being increasingly used as a first line treatment for a number of conditions and there is a concurrent increase in trauma in the elderly population. Pre-injury anti-platelet therapy should be considered as a risk factor for the development of complications by clinicians managing blunt chest wall trauma.	[Battle, Ceri; Evans, Phillip A.] Morriston Hosp, NISCHR Haemostasis Biomed Res Unit, Swansea, W Glam, Wales; [Hutchings, Hayley] Swansea Univ, Coll Med, Swansea, W Glam, Wales; [Bouamra, Omar] Univ Manchester, Trauma Audit & Res Network, Manchester, Lancs, England	Morriston Hospital; Swansea University; University of Manchester	Battle, C (corresponding author), Morriston Hosp, NISCHR Haemostasis Biomed Res Unit, Swansea, W Glam, Wales.	ceri.battle@wales.nhs.uk	Battle, Ceri/AAK-5856-2021; Hutchings, Hayley A/C-9944-2013	Battle, Ceri/0000-0002-7503-1931; Hutchings, Hayley Anne/0000-0003-4155-1741; bouamra, omar/0000-0002-3155-4634; Evans, Phillip Adrian/0000-0002-0814-5162				Ahmad MA, 2010, INJURY, V41, P981, DOI 10.1016/j.injury.2010.08.004; Alexander JQ, 2000, AM SURGEON, V66, P855; Barnea Y, 2002, CAN J SURG, V45, P43; Battle CE, 2012, INJURY, V43, P8, DOI 10.1016/j.injury.2011.01.004; Battle CE, 2013, INJURY, V44, P1171, DOI 10.1016/j.injury.2012.05.019; Bergeron E, 2003, J TRAUMA, V54, P478, DOI 10.1097/01.TA.0000037095.83469.4C; Beynon C, 2012, CRIT CARE, V16, DOI 10.1186/cc11292; Blecher GE, 2008, INJURY, V39, P586, DOI 10.1016/j.injury.2007.10.021; Bouwmeester W, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001221; Brasel KJ, 2006, CRIT CARE MED, V34, P1642, DOI 10.1097/01.CCM.0000217926.40975.4B; Bulger EM, 2000, J TRAUMA, V48, P1040, DOI 10.1097/00005373-200006000-00007; Catella-Lawson F, 2001, NEW ENGL J MED, V345, P1809, DOI 10.1056/NEJMoa003199; Demirhan Recep, 2009, Interact Cardiovasc Thorac Surg, V9, P450, DOI 10.1510/icvts.2009.206599; Dubinsky I, 1997, AM J EMERG MED, V15, P240, DOI 10.1016/S0735-6757(97)90004-8; Erlich JM, 2011, CHEST, V139, P289, DOI 10.1378/chest.10-0891; Fabbri A, 2013, CRIT CARE, V17, DOI 10.1186/cc12575; Gilbert EH, 1996, ANN EMERG MED, V27, P305, DOI 10.1016/S0196-0644(96)70264-0; Harr JN, 2013, CRIT CARE MED, V41, P399, DOI 10.1097/CCM.0b013e31826ab38b; McMillian WD, 2009, J TRAUMA, V66, P942, DOI 10.1097/TA.0b013e3181978e7b; Neal MD, 2014, ANN SURG, V00, P1; Peduzzi P, 1995, J CLIN EPIDEMIOL, V48, P1503, DOI 10.1016/0895-4356(95)00048-8; Schror K, 1997, SEMIN THROMB HEMOST, V23, P349, DOI 10.1055/s-2007-996108; Simon BJ, 1998, J TRAUMA, V45, P673, DOI 10.1097/00005373-199810000-00005; Victorino GP, 2003, ARCH SURG-CHICAGO, V138, P1093, DOI 10.1001/archsurg.138.10.1093; Vignesh T, 2004, INDIAN J CRIT CARE M, V8, P73	25	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91284	10.1371/journal.pone.0091284	http://dx.doi.org/10.1371/journal.pone.0091284			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24609084	Green Published, Green Submitted, gold			2022-12-27	WOS:000332485800121
J	Imhof, J; Huber, F; Reichelt, M; Gershenzon, J; Wiegreffe, C; Lachler, K; Binder, S				Imhof, Janet; Huber, Florian; Reichelt, Michael; Gershenzon, Jonathan; Wiegreffe, Christoph; Laechler, Kurt; Binder, Stefan			The Small Subunit 1 of the Arabidopsis Isopropylmalate Isomerase Is Required for Normal Growth and Development and the Early Stages of Glucosinolate Formation	PLOS ONE			English	Article							CHAIN AMINO-ACID; METHYLTHIOALKYLMALATE SYNTHASE; SEED DEVELOPMENT; DIFFERENT ORGANS; GENES; BIOSYNTHESIS; LEUCINE; METABOLISM; THALIANA; TARGET	In Arabidopsis thaliana the evolutionary and functional relationship between Leu biosynthesis and the Met chain elongation pathway, the first part of glucosinolate formation, is well documented. Nevertheless the exact functions of some pathway components are still unclear. Isopropylmalate isomerase (IPMI), an enzyme usually involved in Leu biosynthesis, is a heterodimer consisting of a large and a small subunit. While the large protein is encoded by a single gene (ISOPROPYLMALATE ISOMERASE LARGE SUBUNIT1), three genes encode small subunits (ISOPROPYLMALATE ISOMERASE SMALL SUBUNIT1 to 3). We have now analyzed small subunit 1 (ISOPROPYLMALATE ISOMERASE SMALL SUBUNIT1) employing artificial microRNA for a targeted knockdown of the encoding gene. Strong reduction of corresponding mRNA levels to less than 5% of wild-type levels resulted in a severe phenotype with stunted growth, narrow pale leaf blades with green vasculature and abnormal adaxial-abaxial patterning as well as anomalous flower morphology. Supplementation of the knockdown plants with leucine could only partially compensate for the morphological and developmental abnormalities. Detailed metabolite profiling of the knockdown plants revealed changes in the steady state levels of isopropylmalate and glucosinolates as well as their intermediates demonstrating a function of IPMI SSU1 in both leucine biosynthesis and the first cycle of Met chain elongation. Surprisingly the levels of free leucine slightly increased suggesting an imbalanced distribution of leucine within cells and/or within plant tissues.	[Imhof, Janet; Huber, Florian; Laechler, Kurt; Binder, Stefan] Univ Ulm, Inst Mol Bot, D-89069 Ulm, Germany; [Reichelt, Michael; Gershenzon, Jonathan] Max Planck Inst Chem Okol, Abt Biochem, Jena, Germany; [Wiegreffe, Christoph] Univ Ulm, Inst Mol & Zellulare Anat, D-89069 Ulm, Germany	Ulm University; Max Planck Society; Ulm University	Binder, S (corresponding author), Univ Ulm, Inst Mol Bot, D-89069 Ulm, Germany.	Stefan.binder@uni-ulm.de	Wiegreffe, Christoph/AAZ-2634-2020; Gershenzon, Jonathan/K-1331-2013	Gershenzon, Jonathan/0000-0002-1812-1551	Deutsche Forschungsgemeinschaft [Bi590/9-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grant Bi590/9-2 from the Deutsche Forschungsgemeinschaft (http://www.dfg.de) (http://www.dfg.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo WL, 2011, TRENDS PLANT SCI, V16, P489, DOI 10.1016/j.tplants.2011.05.008; Binder Stefan, 2010, Arabidopsis Book, V8, pe0137, DOI 10.1199/tab.0137; Brown PD, 2003, PHYTOCHEMISTRY, V62, P471, DOI 10.1016/S0031-9422(02)00549-6; Caldana C, 2013, PLANT J, V73, P897, DOI 10.1111/tpj.12080; Caldana C, 2011, PLANT J, V67, P869, DOI 10.1111/j.1365-313X.2011.04640.x; Chen H, 2010, PLANT J, V63, P573, DOI 10.1111/j.1365-313X.2010.04261.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Daschner K, 2001, PLANT PHYSIOL, V126, P601, DOI 10.1104/pp.126.2.601; de Kraker JW, 2007, PLANT PHYSIOL, V143, P970, DOI 10.1104/pp.106.085555; de Kraker JW, 2011, PLANT CELL, V23, P38, DOI 10.1105/tpc.110.079269; DEBLAERE R, 1985, NUCLEIC ACIDS RES, V13, P4777, DOI 10.1093/nar/13.13.4777; Deprost D, 2007, EMBO REP, V8, P864, DOI 10.1038/sj.embor.7401043; Ding G, 2012, PLANT J, V70, P562, DOI 10.1111/j.1365-313X.2011.04893.x; Dobrenel T, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00093; Docimo T, 2012, PLANT MOL BIOL, V78, P599, DOI 10.1007/s11103-012-9886-1; EDWARDS K, 1991, NUCLEIC ACIDS RES, V19, P1349, DOI 10.1093/nar/19.6.1349; Fait A, 2006, PLANT PHYSIOL, V142, P839, DOI 10.1104/pp.106.086694; Forner J, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-28; Gao F, 2009, PLANTA, V230, P611, DOI 10.1007/s00425-009-0973-8; Haas FH, 2008, PLANT PHYSIOL, V148, P1055, DOI 10.1104/pp.108.125237; Halkier BA, 2006, ANNU REV PLANT BIOL, V57, P303, DOI 10.1146/annurev.arplant.57.032905.105228; Hannah MA, 2010, PLANT PHYSIOL, V152, P2120, DOI 10.1104/pp.109.147306; He Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057118; He Y, 2011, J BIOL CHEM, V286, P28794, DOI 10.1074/jbc.M111.262519; He Y, 2011, NEW PHYTOL, V189, P160, DOI 10.1111/j.1469-8137.2010.03460.x; He Y, 2010, PLANT CELL PHYSIOL, V51, P1480, DOI 10.1093/pcp/pcq113; He Y, 2009, PLANT J, V60, P679, DOI 10.1111/j.1365-313X.2009.03990.x; Horiguchi G, 2011, PLANT J, V65, P724, DOI 10.1111/j.1365-313X.2010.04457.x; Hull G A, 1995, Methods Mol Biol, V49, P125; Husbands AY, 2009, GENE DEV, V23, P1986, DOI 10.1101/gad.1819909; Jonietz C, 2011, PLANT PHYSIOL, V157, P1430, DOI 10.1104/pp.111.181552; Kimball SR, 2006, AM J CLIN NUTR, V83, p500S; Kimball SR, 2006, J NUTR, V136, p227S, DOI 10.1093/jn/136.1.227S; Knill T, 2008, PLANT PHYSIOL, V146, P1028, DOI 10.1104/pp.107.111609; Knill T, 2009, PLANT MOL BIOL, V71, P227, DOI 10.1007/s11103-009-9519-5; Koroleva OA, 2010, PLANT J, V64, P456, DOI 10.1111/j.1365-313X.2010.04339.x; Mo XR, 2006, PLANT PHYSIOL, V141, P1425, DOI 10.1104/pp.106.084178; Moschopoulos A, 2012, J EXP BOT, V63, P5233, DOI 10.1093/jxb/ers184; Nour-Eldin HH, 2012, NATURE, V488, P531, DOI 10.1038/nature11285; Peterhansel C., 2010, PLANT BIOLOGY, V8, pe0130, DOI DOI 10.1199/TAB.0130; Pinon V, 2008, DEVELOPMENT, V135, P1315, DOI 10.1242/dev.016469; Porra RJ, 2002, PHOTOSYNTH RES, V73, P149, DOI 10.1023/A:1020470224740; Redovnikovic IR, 2012, PLANT PHYSIOL BIOCH, V53, P77, DOI 10.1016/j.plaphy.2012.01.015; Ren MZ, 2012, PLANT CELL, V24, P4850, DOI 10.1105/tpc.112.107144; Robaglia C, 2012, CURR OPIN PLANT BIOL, V15, P301, DOI 10.1016/j.pbi.2012.01.012; Sambrook J., 2001, MOL CLONING LAB MANU; Sawada Y, 2009, PLANT CELL PHYSIOL, V50, P1181, DOI 10.1093/pcp/pcp079; Schuster J, 2005, PLANT MOL BIOL, V57, P241, DOI 10.1007/s11103-004-7533-1; Schuster J, 2006, PLANT CELL, V18, P2664, DOI 10.1105/tpc.105.039339; Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Sureshkumar S, 2009, SCIENCE, V323, P1060, DOI 10.1126/science.1164014; Textor S, 2004, PLANTA, V218, P1026, DOI 10.1007/s00425-003-1184-3; Textor S, 2007, PLANT PHYSIOL, V144, P60, DOI 10.1104/pp.106.091579; Vadassery J, 2012, PLANT PHYSIOL, V159, P1159, DOI 10.1104/pp.112.198150; Watanabe M, 2013, PLANT PHYSIOL, V162, P1290, DOI 10.1104/pp.113.217380; Weigel D., 2002, ARABIDOPSIS LAB MANU; Xiong Y, 2013, NATURE, V496, P181, DOI 10.1038/nature12030; Yan XF, 2007, PLANTA, V226, P1343, DOI 10.1007/s00425-007-0627-7; Yang Q, 2007, CELL RES, V17, P666, DOI 10.1038/cr.2007.64; Yao Y, 2008, DEVELOPMENT, V135, P1325, DOI 10.1242/dev.017913; Yu HL, 2013, J EXP BOT, V64, P599, DOI 10.1093/jxb/ers352	62	15	15	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91071	10.1371/journal.pone.0091071	http://dx.doi.org/10.1371/journal.pone.0091071			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608865	Green Submitted, gold, Green Published			2022-12-27	WOS:000332485800095
J	Mah, W; Jiang, GQ; Olver, D; Cheung, G; Kim, B; Larjava, H; Hakkinen, L				Mah, Wesley; Jiang, Guoqiao; Olver, Dylan; Cheung, Godwin; Kim, Ben; Larjava, Hannu; Haekkinen, Lari			Human Gingival Fibroblasts Display a Non-Fibrotic Phenotype Distinct from Skin Fibroblasts in Three-Dimensional Cultures	PLOS ONE			English	Article							TRANSFORMING-GROWTH-FACTOR; LEUCINE-RICH PROTEOGLYCANS; TRIPLE-HELIX REPEAT; FACTOR-BETA; MATRIX METALLOPROTEINASES; MOLECULAR-MECHANISMS; ORAL MUCOSAL; EXPRESSION; ACTIVATION; FIBROSIS	Scar formation following skin injury can be a major psychosocial and physiological problem. However, the mechanisms of scar formation are still not completely understood. Previous studies have shown that wound healing in oral mucosa is faster, associates with a reduced inflammatory response and results to significantly reduced scar formation compared with skin wounds. In the present study, we hypothesized that oral mucosal fibroblasts from human gingiva are inherently distinct from fibroblasts from breast and abdominal skin, two areas prone to excessive scar formation, which may contribute to the preferential wound healing outcome in gingiva. To this end, we compared the phenotype of human gingival and skin fibroblasts cultured in in vivo-like three-dimensional (3D) cultures that mimic the cells' natural extracellular matrix (ECM) niche. To establish 3D cultures, five parallel fibroblast lines from human gingiva (GFBLs) and breast skin (SFBLs) were seeded in high density, and cultured for up to 21 days in serum and ascorbic acid containing medium to induce expression of wound-healing transcriptome and ECM deposition. Cell proliferation, morphology, phenotype and expression of wound healing and scar related genes were analyzed by real-time RT-PCR, Western blotting and immunocytochemical methods. The expression of a set of genes was also studied in three parallel lines of human abdominal SFBLs. Findings showed that GFBLs displayed morphologically distinct organization of the 3D cultures and proliferated faster than SFBLs. GFBLs expressed elevated levels of molecules involved in regulation of inflammation and ECM remodeling (MMPs) while SFBLs showed significantly higher expression of TGF-beta signaling, ECM and myofibroblast and cell contractility-related genes. Thus, GFBLs display an inherent phenotype conducive for fast resolution of inflammation and ECM remodeling, characteristic for scar-free wound healing, while SFBLs have a profibrotic, scar-prone phenotype.	[Mah, Wesley; Jiang, Guoqiao; Olver, Dylan; Cheung, Godwin; Kim, Ben; Larjava, Hannu; Haekkinen, Lari] Univ British Columbia, Fac Dent, Dept Oral Biol & Med Sci, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Hakkinen, L (corresponding author), Univ British Columbia, Fac Dent, Dept Oral Biol & Med Sci, Vancouver, BC V5Z 1M9, Canada.	lhakkine@dentistry.ubc.ca	Hakkinen, Lari/B-2228-2016; Larjava, Hannu/GRO-4325-2022		Canadian Institutes of Health Research (CIHR, MOP) [77550]; University of British Columbia CIHR Skin Research Training Centre (SRTC) Award; The Faculty of Dentistry, University of British Columbia	Canadian Institutes of Health Research (CIHR, MOP)(Canadian Institutes of Health Research (CIHR)); University of British Columbia CIHR Skin Research Training Centre (SRTC) Award; The Faculty of Dentistry, University of British Columbia	The study was supported by Canadian Institutes of Health Research (CIHR, MOP 77550), University of British Columbia CIHR Skin Research Training Centre (SRTC) Award, and by The Faculty of Dentistry, University of British Columbia, Undergraduate Student Research Awards. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2009, MOL CELL, V36, P2, DOI 10.1016/j.molcel.2009.09.021; Badri KR, 2013, J CLIN INVEST, V123, P4502, DOI 10.1172/JCI69884; Beacham Dorothy A, 2007, Curr Protoc Cell Biol, VChapter 10, DOI 10.1002/0471143030.cb1009s33; Bhattacharyya S, 2013, J PATHOL, V229, P286, DOI 10.1002/path.4131; Bhide VM, 2005, J BIOL CHEM, V280, P23103, DOI 10.1074/jbc.M410060200; Bond JE, 2011, LAB INVEST, V91, P499, DOI 10.1038/labinvest.2010.181; Braddock M, 2000, IDrugs, V3, P783; Bradshaw AD, 2001, J CLIN INVEST, V107, P1049, DOI 10.1172/JCI12939; Carracedo S, 2010, J BIOL CHEM, V285, P10434, DOI 10.1074/jbc.M109.078766; Chang HY, 2002, P NATL ACAD SCI USA, V99, P12877, DOI 10.1073/pnas.162488599; Chen YG, 2009, CELL RES, V19, P58, DOI 10.1038/cr.2008.315; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Dang CM, 2003, PLAST RECONSTR SURG, V111, P2273, DOI 10.1097/01.PRS.0000060102.57809.DA; Delavary BM, 2012, J PLAST SURG HAND SU, V46, P95, DOI 10.3109/2000656X.2012.669184; Dobaczewski M, 2012, J CARDIOVASC TRANSL, V5, P837, DOI 10.1007/s12265-012-9406-3; Dufour A, 2013, TRENDS PHARMACOL SCI, V34, P233, DOI 10.1016/j.tips.2013.02.004; Durani Piyush, 2008, Int J Low Extrem Wounds, V7, P160, DOI 10.1177/1534734608322983; Eba H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052523; Ebisawa K, 2011, J BIOSCI BIOENG, V111, P255, DOI 10.1016/j.jbiosc.2010.11.014; Ehrlich HP, 2006, CELL BIOCHEM FUNCT, V24, P63, DOI 10.1002/cbf.1188; Fang F, 2013, AM J PATHOL, V183, P1197, DOI 10.1016/j.ajpath.2013.06.016; Fang F, 2011, AM J PATHOL, V178, P2077, DOI 10.1016/j.ajpath.2011.01.035; Fournier BPJ, 2013, STEM CELLS DEV, V22, P3157, DOI 10.1089/scd.2013.0015; Frey H, 2013, FEBS J, V280, P2165, DOI 10.1111/febs.12145; Gangemi EN, 2008, ARCH FACIAL PLAST S, V10, P93, DOI 10.1001/archfaci.10.2.93; Gauglitz GG, 2011, MOL MED, V17, P113, DOI 10.2119/molmed.2009.00153; Glim JE, 2013, WOUND REPAIR REGEN, V21, P648, DOI 10.1111/wrr.12072; Green JA, 2007, ADV DRUG DELIVER REV, V59, P1293, DOI 10.1016/j.addr.2007.08.005; Guo F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019756; HAKKINEN L, 1994, BBA-MOL CELL RES, V1224, P33, DOI 10.1016/0167-4889(94)90110-4; Hakkinen L., 2011, ENDOD TOPICS, V24, P94, DOI [DOI 10.1111/ETP.12008, 10.1111/etp.12008]; Honardoust D, 2008, WOUND REPAIR REGEN, V16, P814, DOI 10.1111/j.1524-475X.2008.00435.x; Honardoust D, 2011, WOUND REPAIR REGEN, V19, P368, DOI 10.1111/j.1524-475X.2011.00677.x; Horiguchi M, 2012, J BIOCHEM, V152, P321, DOI 10.1093/jb/mvs089; Iozzo RV, 2010, FEBS J, V277, P3864, DOI 10.1111/j.1742-4658.2010.07797.x; Iyer VR, 1999, SCIENCE, V283, P83, DOI 10.1126/science.283.5398.83; Johnson A, 2013, FASEB J, V27, P3893, DOI 10.1096/fj.12-214189; Jun JI, 2010, AGING-US, V2, P627, DOI 10.18632/aging.100201; King SJ, 2011, METHODS MOL BIOL, V769, P53, DOI 10.1007/978-1-61779-207-6_5; Kyriakides TR, 2009, J CELL COMMUN SIGNAL, V3, P215, DOI 10.1007/s12079-009-0077-z; Lai YL, 2010, STEM CELLS DEV, V19, P1095, DOI 10.1089/scd.2009.0217; Lam AP, 2011, CURR OPIN RHEUMATOL, V23, P562, DOI 10.1097/BOR.0b013e32834b3309; Lan HY, 2012, SEMIN NEPHROL, V32, P236, DOI 10.1016/j.semnephrol.2012.04.002; LeClair R, 2007, TRENDS CARDIOVAS MED, V17, P202, DOI 10.1016/j.tcm.2007.05.004; Li J, 2011, BRIT J DERMATOL, V164, P1030, DOI 10.1111/j.1365-2133.2011.10215.x; Liakouli V, 2011, AUTOIMMUN REV, V10, P590, DOI 10.1016/j.autrev.2011.04.019; Loffek S, 2011, EUR RESPIR J, V38, P191, DOI 10.1183/09031936.00146510; Mak K, 2009, J DERMATOL SCI, V56, P168, DOI 10.1016/j.jdermsci.2009.09.005; Mann J, 2013, CURR OPIN RHEUMATOL, V25, P101, DOI 10.1097/BOR.0b013e32835b13e1; McKeown STW, 2007, J DENT RES, V86, P457, DOI 10.1177/154405910708600513; Mikesh LM, 2013, J PROTEOMICS, V84, P190, DOI 10.1016/j.jprot.2013.03.019; Mori R, 2008, J EXP MED, V205, P43, DOI 10.1084/jem.20071412; NAGASE H, 1991, BIOMED BIOCHIM ACTA, V50, P749; Nakerakanti Sashidhar, 2012, Open Rheumatol J, V6, P156, DOI 10.2174/1874312901206010156; Oliveira GV, 2009, INT WOUND J, V6, P445, DOI 10.1111/j.1742-481X.2009.00638.x; Penn JW, 2012, INT J BURNS TRAUMA, V2, P18; Pitiyage GN, 2011, J PATHOL, V223, P604, DOI 10.1002/path.2839; Pouyani T, 2012, IN VITRO CELL DEV-AN, V48, P493, DOI 10.1007/s11626-012-9541-9; Quiros RM, 2008, GYNECOL ONCOL, V110, P99, DOI 10.1016/j.ygyno.2008.03.006; Rinn JL, 2008, J INVEST DERMATOL, V128, P776, DOI 10.1038/sj.jid.5700986; Rinn JL, 2006, PLOS GENET, V2, P1084, DOI 10.1371/journal.pgen.0020119; Sarrazy V, 2011, WOUND REPAIR REGEN, V19, pS10, DOI 10.1111/j.1524-475X.2011.00708.x; Schiavinato A, 2012, J BIOL CHEM, V287, P11498, DOI 10.1074/jbc.M111.303578; Schor S L, 1996, Oral Dis, V2, P155; SCIUBBA JJ, 1978, J ORAL PATHOL MED, V7, P214, DOI 10.1111/j.1600-0714.1978.tb01596.x; Soo C, 2000, AM J PATHOL, V157, P423, DOI 10.1016/S0002-9440(10)64555-5; Szpaderska AM, 2003, J DENT RES, V82, P621, DOI 10.1177/154405910308200810; Tocchi A, 2013, FEBS J, V280, P2332, DOI 10.1111/febs.12198; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang JF, 2008, LAB INVEST, V88, P1278, DOI 10.1038/labinvest.2008.101; Wipff PJ, 2008, EUR J CELL BIOL, V87, P601, DOI 10.1016/j.ejcb.2008.01.012; Wong JW, 2009, WOUND REPAIR REGEN, V17, P717, DOI 10.1111/j.1524-475X.2009.00531.x; Xu X, 2013, J DENT RES, V92, P825, DOI 10.1177/0022034513497961; Yang ZW, 2007, J CELL BIOL, V176, P787, DOI 10.1083/jcb.200611044	74	44	45	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90715	10.1371/journal.pone.0090715	http://dx.doi.org/10.1371/journal.pone.0090715			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608113	gold, Green Published, Green Submitted			2022-12-27	WOS:000332485800046
J	Wu, YC; Lee, WC				Wu, Yun-Chun; Lee, Wen-Chung			Alternative Performance Measures for Prediction Models	PLOS ONE			English	Article							ROC CURVE; DIAGNOSTIC-TESTS; RISK-FACTORS; CANCER; DISCHARGE; MARKERS; SCORE; AREA	As a performance measure for a prediction model, the area under the receiver operating characteristic curve (AUC) is insensitive to the addition of strong markers. A number of measures sensitive to performance change have recently been proposed; however, these relative-performance measures may lead to self-contradictory conclusions. This paper examines alternative performance measures for prediction models: the Lorenz curve-based Gini and Pietra indices, and a standardized version of the Brier score, the scaled Brier. Computer simulations are performed in order to study the sensitivity of these measures to performance change when a new marker is added to a baseline model. When the discrimination power of the added marker is concentrated in the gray zone of the baseline model, the AUC and the Gini show minimal performance improvements. The Pietra and the scaled Brier show more significant improvements in the same situation, comparatively. The Pietra and the scaled Brier indices are therefore recommended for prediction model performance measurement, in light of their ease of interpretation, clinical relevance and sensitivity to gray-zone resolving markers.	[Wu, Yun-Chun; Lee, Wen-Chung] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Lee, Wen-Chung] Natl Taiwan Univ, Coll Publ Hlth, Res Ctr Genes Environm & Human Hlth, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University	Lee, WC (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan.	wenchung@ntu.edu.tw		Wu, Yun-Chun/0000-0002-8038-0925; Lee, Wen-Chung/0000-0003-3171-7672	National Science Council, Taiwan [NSC 102-2628-B-002-036-MY3]; National Taiwan University, Taiwan [NTU-CESRP-102R7622-8]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Taiwan University, Taiwan(National Taiwan University)	This paper is partly supported by grants from National Science Council, Taiwan (NSC 102-2628-B-002-036-MY3) and National Taiwan University, Taiwan (NTU-CESRP-102R7622-8). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlHilli MM, 2013, J AM COLL SURGEONS, V217, P507, DOI 10.1016/j.jamcollsurg.2013.04.036; [Anonymous], 1975, METHODS MAT DEMOGRAP; Austin PC, 2013, STAT MED, V32, P661, DOI 10.1002/sim.5598; Beukers W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077657; Braun J, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-24; Brier G. W., 1950, MONTHLY WEATHER REVI, V78, P1, DOI DOI 10.1175/1520-0493(1950)078<0001:VOFEIT>2.0.CO;2; Cohen RJ, 1998, BRIT J UROL, V81, P413; Cook NR, 2008, CLIN CHEM, V54, P17, DOI 10.1373/clinchem.2007.096529; Cook NR, 2010, CURR CARDIOVASC RISK, V4, P112, DOI 10.1007/s12170-010-0084-x; Ekelund RB, 1986, ECONOMICS; GAIL MH, 1989, J NATL CANCER I, V81, P1879, DOI 10.1093/jnci/81.24.1879; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Held U, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-99; Lee WC, 1999, STAT MED, V18, P455, DOI 10.1002/(SICI)1097-0258(19990228)18:4<455::AID-SIM44>3.0.CO;2-A; Lorenz MO, 1905, PUBL AM STAT ASSOC, V9, P209, DOI 10.2307/2276207; Meigs JB, 2008, NEW ENGL J MED, V359, P2208, DOI 10.1056/NEJMoa0804742; Meyfroidt G, 2011, BMC MED INFORM DECIS, V11, DOI 10.1186/1472-6947-11-64; Oates J, 2013, AUST NZ J OBSTET GYN, V53, P51, DOI 10.1111/ajo.12046; Parikh NI, 2008, ANN INTERN MED, V148, P102, DOI 10.7326/0003-4819-148-2-200801150-00005; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2012, AM J EPIDEMIOL, V176, P473, DOI 10.1093/aje/kws207; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; Rutter MK, 2004, CIRCULATION, V110, P380, DOI 10.1161/01.CIR.0000136581.59584.0E; Scott IC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003808; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Zou KH, 2007, CIRCULATION, V115, P654, DOI 10.1161/CIRCULATIONAHA.105.594929	27	24	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91249	10.1371/journal.pone.0091249	http://dx.doi.org/10.1371/journal.pone.0091249			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608868	Green Submitted, Green Published, gold			2022-12-27	WOS:000332485800117
J	Zhang, JF; Shu, ZJ; Xie, CY; Li, Q; Jin, XH; Gu, W; Jiang, FJ; Ling, CQ				Zhang, Jin-feng; Shu, Zhi-jun; Xie, Chun-yi; Li, Qi; Jin, Xi-hong; Gu, Wei; Jiang, Fang-jian; Ling, Chang-quan			Prognosis of Unresectable Hepatocellular Carcinoma: Comparison of Seven Staging Systems (TNM, Okuda, BCLC, CLIP, CUPI, JIS, CIS) in a Chinese Cohort	PLOS ONE			English	Article							PROSPECTIVE VALIDATION; CLINICAL-TRIALS; SCORE; INDEX; JAPAN	Background: Many liver staging systems that include the tumor stage and the extent of liver function have been developed. However, prognosis assessment for hepatocellular carcinoma (HCC) remains controversial. In this study, the performances of 7 staging systems were compared in a cohort of patients with HCC who underwent non-surgical treatment. Methods: A total of 196 consecutive patients with HCC who underwent non-surgical treatment seen between January 1, 2004, and December 31, 2007, were included. Performances of TNM sixth edition, Okuda, Barcelona Clinic Liver Cancer (BCLC), Cancer of the Liver Italian Program (CLIP), Chinese University Prognostic Index (CUPI), Japan Integrated Staging (JIS), and China integrated score (CIS) have been compared and ranked using concordance index (c-index). Predictors of survival were identified using univariate and multivariate Cox model analyses. Results: The median survival time for the cohort was 7.6 months (95% CI 5.6-9.7). The independent predictors of survival were performance status (P < .001), serum sodium (P < .001), alkaline phosphatase (P < .001), tumor diameter greater than 5 cm (P = .001), portal vein invasion (P < .001), lymph node metastasis (P = .025), and distant metastasis (P = .004). CUPI staging system had the best independent predictive power for survival when compared with the other six prognostic systems. Performance status and serum sodium improved the discriminatory ability of CUPI. Conclusion: In our selected patient population whose main etiology is hepatitis B, CUPI was the most suitable staging system in predicting survival in patients with unresectable HCC. BCLC was the second top-ranking staging system. CLIP, JIS, CIS, and TNM sixth edition were not helpful in predicting survival outcome, and their use is not supported by our data.	[Zhang, Jin-feng; Jiang, Fang-jian] Shanghai Hosp Chinese Integrat Med, Dept Tradit Chinese Med, Shanghai, Peoples R China; [Shu, Zhi-jun] Shanghai Hosp Chinese Integrat Med, Dept Surg, Shanghai, Peoples R China; [Xie, Chun-yi] Shanghai Hosp Chinese Integrat Med, Dept Cardiol, Shanghai, Peoples R China; [Li, Qi] Shanghai Univ Tradit Chinese Med, Dept Med Oncol, Shuguang Hosp, Shanghai, Peoples R China; [Jin, Xi-hong] Shanghai Univ Tradit Chinese Med, Yueyang Hosp Integrated Chinese & Western Med, Dept Massage, Shanghai, Peoples R China; [Gu, Wei; Ling, Chang-quan] Second Mil Med Univ, Changhai Hosp, Dept Tradit Chinese Med, Shanghai, Peoples R China	Shanghai University of Traditional Chinese Medicine; Shanghai University of Traditional Chinese Medicine; Naval Medical University	Ling, CQ (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Tradit Chinese Med, Shanghai, Peoples R China.	lingchangquan@hotmail.com	Ling, Changquan/J-2108-2016	Ling, Changquan/0000-0003-3476-6445; Ling, Changquan/0000-0002-0037-4059				Bruix J, 2001, J HEPATOL, V35, P421, DOI 10.1016/S0168-8278(01)00130-1; Cabibbo G, 2012, WORLD J HEPATOL, V4, P256, DOI 10.4254/wjh.v4.i9.256; Chan SL, 2011, J GASTROEN HEPATOL, V26, P340, DOI 10.1111/j.1440-1746.2010.06329.x; Cho YK, 2008, CANCER-AM CANCER SOC, V112, P352, DOI 10.1002/cncr.23185; Cillo U, 2006, J HEPATOL, V44, P723, DOI 10.1016/j.jhep.2005.12.015; Collette S, 2008, ANN ONCOL, V19, P1117, DOI 10.1093/annonc/mdn030; Grieco A, 2005, GUT, V54, P411, DOI 10.1136/gut.2004.048124; Hsu CY, 2010, CANCER, V116, P9; Huitzil-Melendez FD, 2010, J CLIN ONCOL, V28, P2889, DOI 10.1200/JCO.2009.25.9895; Huo TI, 2008, DIGEST LIVER DIS, V40, P8; Kondo K, 2009, J GASTROINTEST SURG, V13, P1078, DOI 10.1007/s11605-009-0854-2; Kudo M, 2003, J GASTROENTEROL, V38, P207, DOI 10.1007/s005350300038; Kudo M, 2004, HEPATOLOGY, V40, P1396, DOI 10.1002/hep.20486; Lee YH, 2012, DIGEST LIVER DIS, V44, P868, DOI 10.1016/j.dld.2012.04.018; Lei HJ, 2006, J AM COLL SURGEONS, V203, P426, DOI 10.1016/j.jamcollsurg.2006.06.030; Leung TWT, 2002, CANCER, V94, P1760, DOI 10.1002/cncr.10384; Llovet JM, 1999, SEMIN LIVER DIS, V19, P329, DOI 10.1055/s-2007-1007122; Llovet JM, 2008, JNCI-J NATL CANCER I, V100, P698, DOI 10.1093/jnci/djn134; Manghisi G, 1998, HEPATOLOGY, V28, P751; Marrero JA, 2005, HEPATOLOGY, V41, P707, DOI 10.1002/hep.20636; OKUDA K, 1985, CANCER, V56, P918, DOI 10.1002/1097-0142(19850815)56:4<918::AID-CNCR2820560437>3.0.CO;2-E; op den Winkel M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045066; Perrone F, 2000, HEPATOLOGY, V31, P840; Shen XH, 2010, WORLD J SURG, V34, P1028, DOI 10.1007/s00268-010-0400-0; Sun HC, 2007, J SURG ONCOL, V96, P37, DOI 10.1002/jso.20772; Toyoda H, 2005, AM J GASTROENTEROL, V100, P1764, DOI 10.1111/j.1572-0241.2005.41943.x; Uka K, 2007, WORLD J GASTROENTERO, V13, P414, DOI 10.3748/wjg.v13.i3.414; Zhang BH, 2010, J CANC RES CLIN ONCO, V136; Zhou L, 2013, HEPATOB PANCREAT DIS, V12, P6873	29	32	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e88182	10.1371/journal.pone.0088182	http://dx.doi.org/10.1371/journal.pone.0088182			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24609114	Green Published, gold, Green Submitted			2022-12-27	WOS:000332485800003
J	Bormann, J; Boenisch, MJ; Bruckner, E; Firat, D; Schafer, W				Bormann, Joerg; Boenisch, Marike Johanne; Brueckner, Elena; Firat, Demet; Schaefer, Wilhelm			The Adenylyl Cyclase Plays a Regulatory Role in the Morphogenetic Switch from Vegetative to Pathogenic Lifestyle of Fusarium graminearum on Wheat	PLOS ONE			English	Article							KINASE-A PATHWAY; APPRESSORIUM FORMATION; RHIZOCTONIA-SOLANI; NEUROSPORA-CRASSA; INFECTION PROCESS; G-ALPHA; GENE; CAMP; DEOXYNIVALENOL; GROWTH	Cyclic 3',5'-adenosine monophosphate (cAMP) is a nucleotide derived from adenosine triphosphate that acts as a second messenger throughout all kingdoms. Intracellular cAMP levels are synthesized by a membrane-bound protein, the adenylyl cyclase. In order to analyze the function of this gene and the importance of cAMP in the life cycle of the cereal pathogen Fusarium graminearum, the adenylyl cyclase gene (FGSG_01234) was deleted by gene replacement (Delta Fgac1). The Delta Fgac1 mutant displayed a drastically reduced growth on agar medium which could be rescued by a cAMP analogon. Furthermore, the Delta Fgac1 mutant was unable to produce perithecia on detached wheat nodes. However, artificial conditions like carrot agar allowed perithecia development. Pathogenicity towards wheat was drastically reduced in Delta Fgac1 compared to the wild type. Point-inoculated spikelets showed only small lesions but no typical head blight disease symptoms. Fluorescence microscopy using dsRed-expressing strains revealed that the Delta Fgac1 strain was unable to develop any complex infection structures like lobate appressoria and infection cushions. Instead, hyphal anastomosis occurs frequently. Scanning electron microscopy demonstrated the lack of fungal penetration. Hence, the formation of compound appressoria seems to be essential for infection of wheat. Hyphae on flower leaves produced huge amounts of new conidia, thereby circumventing the infection cycle. This abundant sporulation on wheat epidermis was not observed in wild type. Intriguingly, the Fgac1 deletion mutant was able to infect maize cobs as wild type, indicating that cAMP signaling is not important for maize infection. The DFgac1 mutant was unable to produce the mycotoxin deoxynivalenol both in vitro and during wheat infection. In this study, we show that cAMP signaling controls important cellular processes such as development of infection structures, pathogenicity, secondary metabolite production and sexual reproduction. For the first time, we show that cAMP regulates the switch from vegetative to pathogenic lifestyle of F. graminearum on wheat.	[Bormann, Joerg; Boenisch, Marike Johanne; Brueckner, Elena; Firat, Demet; Schaefer, Wilhelm] Univ Hamburg, Dept Mol Phytopathol & Genet, Bioctr Klein Flottbek, Hamburg, Germany	University of Hamburg	Bormann, J (corresponding author), Univ Hamburg, Dept Mol Phytopathol & Genet, Bioctr Klein Flottbek, Hamburg, Germany.	bormannj@botanik.uni-hamburg.de	Boenisch, Marike/AAM-2678-2020	Boenisch, Marike/0000-0001-8145-1820; Bormann, Jorg/0000-0002-3493-2450	University Hamburg	University Hamburg	The funding for this project comes from the University Hamburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMENTROUT VN, 1987, PHYTOPATHOLOGY, V77, P619, DOI 10.1094/Phyto-77-619; Ausubel F. M., 2002, SHORT PROTOCOLS MOL; Boenisch MJ, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-110; Choi WB, 1997, PLANT CELL, V9, P1973, DOI 10.1105/tpc.9.11.1973; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; DAHLBERG KR, 1982, ANNU REV PHYTOPATHOL, V20, P281, DOI 10.1146/annurev.py.20.090182.001433; EMMETT RW, 1975, ANNU REV PHYTOPATHOL, V13, P147, DOI 10.1146/annurev.py.13.090175.001051; Gardiner DM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-289; Gardiner DM, 2009, MICROBIOL-SGM, V155, P3149, DOI 10.1099/mic.0.029546-0; Gardiner DM, 2009, FUNGAL GENET BIOL, V46, P604, DOI 10.1016/j.fgb.2009.04.004; Gilbert RD, 1996, PHYSIOL MOL PLANT P, V48, P335, DOI 10.1006/pmpp.1996.0027; Glass NL, 2003, EUKARYOT CELL, V2, P1, DOI 10.1128/EC.2.1.1-8.2003; GREEN CE, 1975, CROP SCI, V15, P417, DOI 10.2135/cropsci1975.0011183X001500030040x; Hanoune J, 2001, ANNU REV PHARMACOL, V41, P145, DOI 10.1146/annurev.pharmtox.41.1.145; Hoffman CS, 2005, BIOCHEM SOC T, V33, P257, DOI 10.1042/BST0330257; Holland KA, 2002, TRANSMEMBRANE SIGNAL, DOI [10.1038/npg.els.0000847, DOI 10.1038/NPG.ELS.0000847]]; Huang L, 2008, J PLANT DIS PROTECT, V115, P9, DOI 10.1007/BF03356233; Ilgen P, 2009, MOL PLANT MICROBE IN, V22, P899, DOI 10.1094/MPMI-22-8-0899; Jansen C, 2005, P NATL ACAD SCI USA, V102, P16892, DOI 10.1073/pnas.0508467102; Jenczmionka NJ, 2005, CURR GENET, V47, P29, DOI 10.1007/s00294-004-0547-z; Kays AM, 2004, GENETICS, V166, P1229, DOI 10.1534/genetics.166.3.1229; Kazan K, 2012, MOL PLANT PATHOL, V13, P399, DOI 10.1111/j.1364-3703.2011.00762.x; Klimpel A, 2002, MOL PLANT PATHOL, V3, P439, DOI 10.1046/j.1364-3703.2002.00137.x; Kronstad J, 1998, ARCH MICROBIOL, V170, P395, DOI 10.1007/s002030050659; Kruger J, 1998, MOL GEN GENET, V260, P193, DOI 10.1007/s004380050885; LEACH J, 1982, J GEN MICROBIOL, V128, P1719; Lee N, 2003, ANNU REV PHYTOPATHOL, V41, P399, DOI 10.1146/annurev.phyto.41.052002.095728; Li GT, 2012, CURR OPIN MICROBIOL, V15, P678, DOI 10.1016/j.mib.2012.09.004; Li L, 2007, ANNU REV MICROBIOL, V61, P423, DOI 10.1146/annurev.micro.61.080706.093432; Maier FJ, 2006, MOL PLANT PATHOL, V7, P449, DOI 10.1111/j.1364-3703.2006.00351.x; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; MATSUURA K, 1986, PHYTOPATHOLOGY, V76, P811, DOI 10.1094/Phyto-76-811; Mendgen K, 1996, ANNU REV PHYTOPATHOL, V34, P367, DOI 10.1146/annurev.phyto.34.1.367; Oeser B, 2002, FUNGAL GENET BIOL, V36, P176, DOI 10.1016/S1087-1845(02)00020-8; Palecek SP, 2002, MICROBIOL-SGM, V148, P893, DOI 10.1099/00221287-148-4-893; Ponts N, 2006, FEMS MICROBIOL LETT, V258, P102, DOI 10.1111/j.1574-6968.2006.00200.x; PROCTOR RH, 1995, MOL PLANT MICROBE IN, V8, P593, DOI 10.1094/MPMI-8-0593; REID LM, 1995, PLANT DIS, V79, P461, DOI 10.1094/PD-79-0461; Roca MG, 2005, FEMS MICROBIOL LETT, V249, P191, DOI 10.1016/j.femsle.2005.06.048; Ryu D, 1999, J FOOD PROTECT, V62, P1451, DOI 10.4315/0362-028X-62.12.1451; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schumacher J, 2008, MOL PLANT MICROBE IN, V21, P1443, DOI 10.1094/MPMI-21-11-1443; STOCKWELL V, 1983, PHYTOPATHOLOGY, V73, P1640, DOI 10.1094/Phyto-73-1640; Studt L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058185; Tamaki H, 2007, J BIOSCI BIOENG, V104, P245, DOI 10.1263/jbb.104.245; TERENZI HF, 1979, ARCH MICROBIOL, V123, P251, DOI 10.1007/BF00406658; Trail F, 2009, PLANT PHYSIOL, V149, P103, DOI 10.1104/pp.108.129684; Tsuyuki R, 2011, J AGR FOOD CHEM, V59, P1760, DOI 10.1021/jf103969d; Tudzynski P., 1995, PATHOGENESIS HOST SP, VII, P161; Van Nguyen T, 2013, MOL PLANT MICROBE IN, V26, P1378, DOI 10.1094/MPMI-04-13-0125-R; Voigt CA, 2007, EUR J PLANT PATHOL, V117, P1, DOI 10.1007/s10658-006-9063-y; Wilson RA, 2009, NAT REV MICROBIOL, V7, P185, DOI 10.1038/nrmicro2032; Yan X, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002385; Yu HY, 2008, MICROBIOL-SGM, V154, P392, DOI 10.1099/mic.0.2007/012260-0; Zhao XH, 2005, PLANT CELL, V17, P1317, DOI 10.1105/tpc.104.029116	55	34	38	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e91135	10.1371/journal.pone.0091135	http://dx.doi.org/10.1371/journal.pone.0091135			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603887	Green Published, gold, Green Submitted			2022-12-27	WOS:000332483600135
J	Dong, Y; Ning, G; Ewing, AG; Heien, ML				Dong, Yan; Ning, Gang; Ewing, Andrew G.; Heien, Michael L.			Pituitary Adenylate Cyclase Activating Polypeptide Modulates Catecholamine Storage and Exocytosis in PC12 Cells	PLOS ONE			English	Article							PROTEIN-KINASE-A; SUBSTANTIA-NIGRA; QUANTAL SIZE; FUSION PORE; PERSISTENT STIMULATION; STRESS TRANSDUCTION; MICROARRAY ANALYSES; PARKINSONS-DISEASE; GENE-EXPRESSION; MESSENGER-RNA	A number of efforts have been made to understand how pituitary adenylate cyclase activating polypeptide (PACAP) functions as a neurotrophic and neuroprotective factor in Parkinson's disease (PD). Recently its effects on neurotransmission and underlying mechanisms have generated interest. In the present study, we investigate the effects of PACAP on catecholamine storage and secretion in PC12 cells with amperometry and transmission electron microscopy (TEM). PACAP increases quantal release induced by high K+ without significantly regulating the frequency of vesicle fusion events. TEM data indicate that the increased volume of the vesicle is mainly the result of enlargement of the fluidic space around the dense core. Moreover, the number of docked vesicles isn't modulated by PACAP. When cells are acutely treated with L-DOPA, the vesicular volume and quantal release both increase dramatically. It is likely that the characteristics of amperometric spikes from L-DOPA treated cells are associated with increased volume of individual vesicles rather than a direct effect on the mechanics of exocytosis. Treatment with PACAP versus L-DOPA results in different profiles of the dynamics of exocytosis. Release via the fusion pore prior to full exocytosis was observed with the same frequency following treatment with PACAP and L-DOPA. However, release events have a shorter duration and higher average current after PACAP treatment compared to L-DOPA. Furthermore, PACAP reduced the proportion of spikes having rapid decay time and shortened the decay time of both fast and slow spikes. In contrast, the distributions of the amperometric spike decay for both fast and slow spikes were shifted to longer time following L-DOPA treatment. Compared to L-DOPA, PACAP may produce multiple favorable effects on dopaminergic neurons, including protecting dopaminergic neurons against neurodegeneration and potentially regulating dopamine storage and release, making it a promising therapeutic agent for the treatment of PD.	[Dong, Yan] Second Mil Med Univ, Changzheng Hosp, Dept Neurosurg, Shanghai, Peoples R China; [Dong, Yan; Ewing, Andrew G.; Heien, Michael L.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA; [Ning, Gang] Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA; [Ewing, Andrew G.] Penn State Univ, Dept Neural & Behav Sci, Coll Med, Hershey, PA USA; [Ewing, Andrew G.] Univ Gothenburg, Dept Chem, Gothenburg, Sweden; [Heien, Michael L.] Univ Arizona, Dept Chem & Biochem, Tucson, AZ USA	Naval Medical University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Gothenburg; University of Arizona	Dong, Y (corresponding author), Second Mil Med Univ, Changzheng Hosp, Dept Neurosurg, Shanghai, Peoples R China.	dongyan2006@yahoo.com; mheien@arizona.edu	Ewing, Andrew G/A-3650-2009; Heien, Michael/A-4731-2009	Heien, Michael/0000-0001-5164-9596	National Institutes of Health; Swedish Science Research Council (VR); Natural Science Foundation from Science and Technology Commission of Shanghai Municipality [11ZR1448700]; Research Foundation for Returned Scholars from Ministry of Education of China; European Union	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Science Research Council (VR)(Swedish Research Council); Natural Science Foundation from Science and Technology Commission of Shanghai Municipality; Research Foundation for Returned Scholars from Ministry of Education of China; European Union(European Commission)	This work was supported by the National Institutes of Health and the Swedish Science Research Council (VR) to AGE, and Natural Science Foundation from Science and Technology Commission of Shanghai Municipality (11ZR1448700), Research Foundation for Returned Scholars from Ministry of Education of China to Y.D. A.G.E. is supported by a Marie Curie Chair from the European Union's 6th Framework. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyagi K, 2001, BIOCHEM BIOPH RES CO, V286, P646, DOI 10.1006/bbrc.2001.5443; Atlasz T, 2010, ANN NY ACAD SCI, V1200, P128, DOI 10.1111/j.1749-6632.2010.05512.x; Barg S, 2002, NEURON, V33, P287, DOI 10.1016/S0896-6273(02)00563-9; Barzilai A, 2001, CELL MOL NEUROBIOL, V21, P215, DOI 10.1023/A:1010991020245; Benoit-Marand M, 2007, ELECTROCHEMICAL METH; Botia B, 2007, PEPTIDES, V28, P1746, DOI 10.1016/j.peptides.2007.04.013; Braas KM, 2007, PEPTIDES, V28, P1856, DOI 10.1016/j.peptides.2007.04.004; Bretou M, 2008, J NEUROSCI, V28, P8470, DOI 10.1523/JNEUROSCI.0860-08.2008; Brown D, 2013, J MOL NEUROSCI, V50, P600, DOI 10.1007/s12031-013-0015-7; Colliver TL, 2000, J NEUROSCI, V20, P5276, DOI 10.1523/JNEUROSCI.20-14-05276.2000; Corbitt J, 2002, NEUROPEPTIDES, V36, P34, DOI 10.1054/npep.2002.0885; Corbitt J, 1998, J NEUROCHEM, V71, P478; Costa L, 2009, HIPPOCAMPUS, V19, P99, DOI 10.1002/hipo.20488; Dawson TM, 2010, NEURON, V66, P646, DOI 10.1016/j.neuron.2010.04.034; Deguil J, 2010, NEUROTOX RES, V17, P142, DOI 10.1007/s12640-009-9091-4; Eiden LE, 2008, ANN NY ACAD SCI, V1144, P6, DOI 10.1196/annals.1418.019; Fahn S, 2004, NEW ENGL J MED, V351, P2498; Fahn S, 1996, NEUROLOGY, V47, pS184, DOI 10.1212/WNL.47.6_Suppl_3.184S; Fahn S, 1997, CNS DRUGS, V8, P376, DOI 10.2165/00023210-199708050-00004; FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283; Ghzili H, 2008, FRONT NEUROENDOCRIN, V29, P128, DOI 10.1016/j.yfrne.2007.10.001; Grumolato L, 2003, ENDOCRINOLOGY, V144, P2368, DOI 10.1210/en.2002-0106; Grumolato L, 2003, EUR J NEUROSCI, V17, P71, DOI 10.1046/j.1460-9568.2003.02426.x; Guillot TS, 2008, NEUROPEPTIDES, V42, P423, DOI 10.1016/j.npep.2008.04.003; Hashimoto H, 1996, J COMP NEUROL, V371, P567; Ishido M, 2004, REGUL PEPTIDES, V123, P15, DOI 10.1016/j.regpep.2004.05.020; Kalia LV, 2013, ANN NEUROL, V73, P155, DOI 10.1002/ana.23746; Kuri BA, 2009, J NEUROCHEM, V110, P1214, DOI 10.1111/j.1471-4159.2009.06206.x; Lynch KL, 2008, MOL BIOL CELL, V19, P5093, DOI 10.1091/mbc.E08-03-0235; Machado JD, 2001, MOL PHARMACOL, V60, P514; MASUO Y, 1992, BRAIN RES, V575, P113, DOI 10.1016/0006-8993(92)90430-H; Michel S, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-15; Mohrmann R, 2013, J NEUROSCI, V33, P14417, DOI 10.1523/JNEUROSCI.1236-13.2013; Mohrmann R, 2010, SCIENCE, V330, P502, DOI 10.1126/science.1193134; Muller T, 2012, TRANSL NEURODEGENER, V1, DOI 10.1186/2047-9158-1-10; Mustafa T, 2007, J BIOL CHEM, V282, P8079, DOI 10.1074/jbc.M609638200; Mustafa T, 2010, CELL SIGNAL, V22, P1420, DOI 10.1016/j.cellsig.2010.05.005; Nanmoku T, 2000, BIOCHEM BIOPH RES CO, V274, P310, DOI 10.1006/bbrc.2000.3137; Olanow CW, 2004, ANNU REV MED, V55, P41, DOI 10.1146/annurev.med.55.091902.104422; Omiatek DM, 2010, ACS CHEM NEUROSCI, V1, P234, DOI 10.1021/cn900040e; Plattner H, 1997, J CELL BIOL, V139, P1709, DOI 10.1083/jcb.139.7.1709; Pothos E, 1996, J NEUROCHEM, V66, P629; Pothos EN, 1998, J NEUROSCI, V18, P4106; Przywara DA, 1996, J BIOL CHEM, V271, P10545, DOI 10.1074/jbc.271.18.10545; Pugh PC, 2006, MOL CELL NEUROSCI, V31, P586, DOI 10.1016/j.mcn.2005.11.012; Rat D, 2011, FASEB J, V25, P3208, DOI 10.1096/fj.10-180133; Reglodi D, 2006, NEUROPEPTIDES, V40, P265, DOI 10.1016/j.npep.2006.06.001; Reglodi D, 2004, REGUL PEPTIDES, V123, P85, DOI 10.1016/j.regpep.2004.05.016; Reglodi D, 2011, CURR PHARM DESIGN, V17, P962, DOI 10.2174/138161211795589355; SCHROEDER TJ, 1992, ANAL CHEM, V64, P3077, DOI 10.1021/ac00048a003; Smith CB, 2012, J MOL NEUROSCI, V48, P403, DOI 10.1007/s12031-012-9749-x; Sombers LA, 2004, J NEUROSCI, V24, P303, DOI 10.1523/JNEUROSCI.1119-03.2004; Sombers LA, 2005, J NEUROCHEM, V93, P1122, DOI 10.1111/j.1471-4159.2005.03087.x; Stroth N, 2013, ENDOCRINOLOGY, V154, P330, DOI 10.1210/en.2012-1829; Sudhof TC, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011353; Takei N, 1998, J NEUROSCI RES, V54, P698, DOI 10.1002/(SICI)1097-4547(19981201)54:5<698::AID-JNR15>3.0.CO;2-5; Taupenot L, 1999, HYPERTENSION, V34, P1152, DOI 10.1161/01.HYP.34.5.1152; Vaudry D, 2009, PHARMACOL REV, V61, P283, DOI 10.1124/pr.109.001370; Wang G, 2005, FEBS LETT, V579, P4005, DOI 10.1016/j.febslet.2005.06.013; Wang G, 2008, NEUROPEPTIDES, V42, P267, DOI 10.1016/j.npep.2008.03.002; Watson MB, 2013, NEUROSCIENCE, V240, P277, DOI 10.1016/j.neuroscience.2013.03.002; Webb IC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076365; Wong DL, 2002, ANN NY ACAD SCI, V971, P19, DOI 10.1111/j.1749-6632.2002.tb04428.x	63	6	6	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e91132	10.1371/journal.pone.0091132	http://dx.doi.org/10.1371/journal.pone.0091132			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603879	Green Submitted, Green Published, gold			2022-12-27	WOS:000332483600134
J	Du, YJ; Lu, Y; Wang, XL; Qi, J; Liu, JY; Hu, Y; Li, F; Wu, JQ; Guo, LH; Liu, JZ; Tao, HY; Sun, WB; Chen, L; Cong, XY; Ren, SF; Shi, JL; Li, J; Wang, JB; Huang, BH; Wan, RZ				Du, Yijun; Lu, Yu; Wang, Xinglong; Qi, Jing; Liu, Jiyu; Hu, Yue; Li, Feng; Wu, Jiaqiang; Guo, Lihui; Liu, Junzhen; Tao, Haiying; Sun, Wenbo; Chen, Lei; Cong, Xiaoyan; Ren, Sufang; Shi, Jianli; Li, Jun; Wang, Jinbao; Huang, Baohua; Wan, Renzhong			Highly Efficient Expression of Interleukin-2 under the Control of Rabbit beta-Globin Intron II Gene Enhances Protective Immune Responses of Porcine Reproductive and Respiratory Syndrome (PRRS) DNA Vaccine in Pigs	PLOS ONE			English	Article							SYNDROME VIRUS PRRSV; UNITED-STATES; GP5; SWINE; CHINA; PROTEINS; STRAIN; IMMUNOGENICITY; EMERGENCE; OUTBREAKS	Highly pathogenic porcine reproductive and respiratory syndrome virus (HP-PRRSV) had caused catastrophic losses in swine industry in China. The current inactivated vaccine provided only limited protection, and the attenuated live vaccine could protect piglets against the HP-PRRSV but there was a possibility that the attenuated virus returned to high virulence. In this study, the eukaryotic expression vector pVAX1 (c) was modified under the control of rabbit beta-globin intron II gene and the modified vector pMVAX1 (c) was constructed. Porcine interleukin-2 (IL-2) and GP3-GP5 fusion protein of HP-PRRSV strain SD-JN were highly expressed by pMVAX1 (c). Mice inoculated with pMVAX1 (c)-GP35 developed significantly higher PRRSV-specific antibody responses and T cell proliferation than those vaccinated with pVAX1 (c)-GP35. pMVAX1 (c)-GP35 was selected as PRRS DNA vaccine candidate and co-administrated with pVAX1 (c)-IL-2 or pMVAX1 (c)-IL-2 in pigs. pMVAX1 (c) -IL-2+pMVAX1 (c)-GP35 could provide enhanced PRRSV-specific antibody responses, T cell proliferation, Th1-type and Th2-type cytokine responses and CTL responses than pMVAX1 (c)-GP35 and pVAX1 (c)-IL-2+pMVAX1 (c)-GP35. Following homologous challenge with HP-PRRSV strain SD-JN, similar with attenuated PRRS vaccine group, pigs inoculated with pMVAX1 (c)-IL-2+pMVAX1 (c)-GP35 showed no clinical signs, almost no lung lesions and no viremia, as compared to those in pMVAX1 (c)-GP35 and pVAX1 (c)-IL-2+pMVAX1 (c)-GP35 groups. It indicated that pMVAX1 (c)-IL-2 effectively increases humoral and cell mediated immune responses of pMVAX1 (c)-GP35. Co-administration of pMVAX1 (c)-IL-2 and pMVAX1 (c)-GP35 might be attractive candidate vaccines for preventing HP-PRRSV infections.	[Du, Yijun; Qi, Jing; Chen, Lei; Cong, Xiaoyan; Wang, Jinbao] Shandong Univ, Sch Life Sci, Jinan 250100, Peoples R China; [Du, Yijun; Qi, Jing; Liu, Jiyu; Wu, Jiaqiang; Guo, Lihui; Liu, Junzhen; Tao, Haiying; Sun, Wenbo; Chen, Lei; Cong, Xiaoyan; Ren, Sufang; Shi, Jianli; Li, Jun; Wang, Jinbao; Huang, Baohua] Shandong Acad Agr Sci, Shandong Key Lab Anim Dis Control & Breeding, Inst Anim Sci & Vet Med, Jinan, Peoples R China; [Lu, Yu] Jiangsu Acad Agr Sci, Natl Res Ctr Vet Biol Engn & Technol, Nanjing, Jiangsu, Peoples R China; [Wang, Xinglong] Northwest A&F Univ, Coll Vet Med, Yangling, Peoples R China; [Hu, Yue; Wang, Jinbao] Shandong Agr Univ, Coll Anim Sci & Vet Med, Tai An, Shandong, Peoples R China; [Li, Feng] S Dakota State Univ, Dept Vet & Biomed Sci, Dept Biol & Microbiol, Brookings, SD 57007 USA	Shandong University; Shandong Academy of Agricultural Sciences; Jiangsu Academy of Agricultural Sciences; Northwest A&F University - China; Shandong Agricultural University; South Dakota State University	Wang, JB (corresponding author), Shandong Univ, Sch Life Sci, Jinan 250100, Peoples R China.	wangjb@saas.ac.cn; jn-hbh@163.com; wrzh63@163.com		Li, Feng/0000-0002-8904-2893	National Natural Science Foundation [31170146, 31100119, 31370189]; Special Fund for Agro-scientific Research in the Public Interest [201303046]; Research Award Fund for Outstanding Young Scientist of Shandong Province [BS2012NY012]; China Postdoctoral Science Foundation [2012M521341]; Shandong Province Postdoctoral Special Fund for Innovative Projects [201203036]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest; Research Award Fund for Outstanding Young Scientist of Shandong Province; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Shandong Province Postdoctoral Special Fund for Innovative Projects	This work was supported by the National Natural Science Foundation (31170146, 31100119 and 31370189), Special Fund for Agro-scientific Research in the Public Interest (201303046), Research Award Fund for Outstanding Young Scientist of Shandong Province (BS2012NY012), a grant from the China Postdoctoral Science Foundation (2012M521341), and Shandong Province Postdoctoral Special Fund for Innovative Projects (201203036). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachmann MF, 2007, EMBO REP, V8, P1142, DOI 10.1038/sj.embor.7401099; Bastos RG, 2004, VACCINE, V22, P467, DOI 10.1016/S0264-410X(03)00572-3; Cavanagh D, 1997, ARCH VIROL, V142, P629; Charerntantanakul W, 2009, VET IMMUNOL IMMUNOP, V129, P1, DOI 10.1016/j.vetimm.2008.12.018; Cho JG, 2006, THERIOGENOLOGY, V66, P655, DOI 10.1016/j.theriogenology.2006.04.024; Chow YH, 1997, J VIROL, V71, P169, DOI 10.1128/JVI.71.1.169-178.1997; de Lima M, 2006, VIROLOGY, V353, P410, DOI 10.1016/j.virol.2006.05.036; DEA S, 1991, J VET DIAGN INVEST, V3, P275, DOI 10.1177/104063879100300401; Du YJ, 2012, VIRUS GENES, V45, P474, DOI 10.1007/s11262-012-0790-1; Firth AE, 2011, J GEN VIROL, V92, P1097, DOI 10.1099/vir.0.029264-0; Guo BQ, 2013, VIROLOGY, V446, P238, DOI 10.1016/j.virol.2013.08.008; HALBUR PG, 1995, VET PATHOL, V32, P200, DOI 10.1177/030098589503200218; Hou YH, 2008, VACCINE, V26, P1438, DOI 10.1016/j.vaccine.2007.12.057; Jiang WM, 2008, VIRUS RES, V136, P50, DOI 10.1016/j.virusres.2008.04.016; Jiang YB, 2006, VACCINE, V24, P2869, DOI 10.1016/j.vaccine.2005.12.049; Jiang YB, 2007, VACCINE, V25, P547, DOI 10.1016/j.vaccine.2006.07.032; Johnson CR, 2011, J GEN VIROL, V92, P1107, DOI 10.1099/vir.0.030213-0; Li JX, 2009, VACCINE, V27, P825, DOI 10.1016/j.vaccine.2008.11.088; Li XM, 1998, J EXP MED, V188, P681, DOI 10.1084/jem.188.4.681; Li YF, 2007, VET J, V174, P577, DOI 10.1016/j.tvjl.2007.07.032; Montiel-Equihua CA, 2012, MOL THER, V20, P1400, DOI 10.1038/mt.2012.50; Neumann EJ, 2005, JAVMA-J AM VET MED A, V227, P385, DOI 10.2460/javma.2005.227.385; NUNBERG JH, 1989, P NATL ACAD SCI USA, V86, P4240, DOI 10.1073/pnas.86.11.4240; Opriessnig T, 2002, J VIROL, V76, P11837, DOI 10.1128/JVI.76.23.11837-11844.2002; Plagemann PGW, 2004, VET IMMUNOL IMMUNOP, V102, P263, DOI 10.1016/j.vetimm.2004.09.011; Rompato G, 2006, VET IMMUNOL IMMUNOP, V109, P151, DOI 10.1016/j.vetimm.2005.08.015; Shen GS, 2007, VACCINE, V25, P4193, DOI 10.1016/j.vaccine.2007.03.010; Tian KG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000526; Tian ZJ, 2009, VET MICROBIOL, V138, P34, DOI 10.1016/j.vetmic.2009.03.003; Tong GZ, 2007, EMERG INFECT DIS, V13, P1434, DOI 10.3201/eid1309.070399; Wang XL, 2009, VIRUS RES, V143, P24, DOI 10.1016/j.virusres.2009.02.017; Wootton S, 2000, ARCH VIROL, V145, P2297, DOI 10.1007/s007050070022; Wu J, 2009, ARCH VIROL, V154, P1589, DOI 10.1007/s00705-009-0478-6; Zhou JY, 2005, MOL IMMUNOL, V42, P589, DOI 10.1016/j.molimm.2004.09.014; Zhou L, 2012, VIROLOGY, V434, P96, DOI 10.1016/j.virol.2012.09.005; Zhou YJ, 2008, TRANSBOUND EMERG DIS, V55, P152, DOI 10.1111/j.1865-1682.2008.01020.x	36	11	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90326	10.1371/journal.pone.0090326	http://dx.doi.org/10.1371/journal.pone.0090326			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603502	Green Published, gold, Green Submitted			2022-12-27	WOS:000332483600043
J	Forster, SE; Cho, RY				Forster, Sarah E.; Cho, Raymond Y.			Context Specificity of Post-Error and Post-Conflict Cognitive Control Adjustments	PLOS ONE			English	Article							MEDIAL FRONTAL-CORTEX; EXECUTIVE CONTROL; SIMON TASK; PARAMETRIC MANIPULATION; SEQUENTIAL MODULATIONS; CONTROL MECHANISMS; ADAPTATION; BEHAVIOR; SUPPRESSION; ACTIVATION	There has been accumulating evidence that cognitive control can be adaptively regulated by monitoring for processing conflict as an index of online control demands. However, it is not yet known whether top-down control mechanisms respond to processing conflict in a manner specific to the operative task context or confer a more generalized benefit. While previous studies have examined the taskset-specificity of conflict adaptation effects, yielding inconsistent results, control-related performance adjustments following errors have been largely overlooked. This gap in the literature underscores recent debate as to whether post-error performance represents a strategic, control-mediated mechanism or a nonstrategic consequence of attentional orienting. In the present study, evidence of generalized control following both high conflict correct trials and errors was explored in a task-switching paradigm. Conflict adaptation effects were not found to generalize across tasksets, despite a shared response set. In contrast, post-error slowing effects were found to extend to the inactive taskset and were predictive of enhanced post-error accuracy. In addition, post-error performance adjustments were found to persist for several trials and across multiple task switches, a finding inconsistent with attentional orienting accounts of post-error slowing. These findings indicate that error-related control adjustments confer a generalized performance benefit and suggest dissociable mechanisms of post-conflict and post-error control.	[Forster, Sarah E.] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN USA; [Cho, Raymond Y.] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA 15260 USA; [Cho, Raymond Y.] Univ Pittsburgh, Dept Psychol, Pittsburgh, PA USA; [Cho, Raymond Y.] Ctr Neural Basis Cognit, Pittsburgh, PA USA	Indiana University System; Indiana University Bloomington; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Cho, RY (corresponding author), Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA 15260 USA.	chory@upmc.edu	Cho, Raymond/P-3028-2014	Cho, Raymond/0000-0003-1331-1409	National Institutes of Health [R03 MH073955, K08 MH080329]; NATIONAL INSTITUTE OF MENTAL HEALTH [K08MH080329, R03MH073955] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The current research was supported by grant funding from the National Institutes of Health (R03 MH073955, PI: Cho; K08 MH080329, PI: Cho). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcay C, 2008, J EXP PSYCHOL HUMAN, V34, P958, DOI 10.1037/0096-1523.34.4.958; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Braem S, 2011, J EXP PSYCHOL HUMAN, V37, P1662, DOI 10.1037/a0024385; BREWER N, 1984, J EXP PSYCHOL GEN, V113, P71, DOI 10.1037/0096-3445.113.1.71; Brown JW, 2007, COGNITIVE PSYCHOL, V55, P37, DOI 10.1016/j.cogpsych.2006.09.005; Burle B, 2002, PSYCHOL RES-PSYCH FO, V66, P324, DOI 10.1007/s00426-002-0105-6; BURNS JT, 1971, J EXP PSYCHOL, V90, P141, DOI 10.1037/h0031335; Cho RY, 2009, J EXP PSYCHOL HUMAN, V35, P1161, DOI 10.1037/a0014491; Danielmeier C, 2011, J NEUROSCI, V31, P1780, DOI 10.1523/JNEUROSCI.4299-10.2011; Debener S, 2005, J NEUROSCI, V25, P11730, DOI 10.1523/JNEUROSCI.3286-05.2005; Dudschig C, 2009, BRAIN RES, V1296, P56, DOI 10.1016/j.brainres.2009.08.009; Durston S, 2003, NEUROIMAGE, V20, P2135, DOI 10.1016/j.neuroimage.2003.08.004; Duthoo W, 2012, Q J EXP PSYCHOL, V65, P1993, DOI 10.1080/17470218.2012.676655; Dutilh G, 2012, ATTEN PERCEPT PSYCHO, V74, P454, DOI 10.3758/s13414-011-0243-2; Egner T, 2007, NEUROIMAGE, V35, P940, DOI 10.1016/j.neuroimage.2006.11.061; Fernandez-Duque D, 2008, J EXP PSYCHOL HUMAN, V34, P340, DOI 10.1037/0096-1523.34.2.340; Fischer R, 2008, J EXP PSYCHOL LEARN, V34, P712, DOI 10.1037/0278-7393.34.3.712; Forster SE, 2011, J COGNITIVE NEUROSCI, V23, P923, DOI 10.1162/jocn.2010.21458; Freitas AL, 2007, PSYCHOL SCI, V18, P1040, DOI 10.1111/j.1467-9280.2007.02022.x; Garavan H, 2002, NEUROIMAGE, V17, P1820, DOI 10.1006/nimg.2002.1326; Gehring WJ, 2001, J NEUROSCI, V21, P9430, DOI 10.1523/JNEUROSCI.21-23-09430.2001; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; GRATTON G, 1992, J EXP PSYCHOL GEN, V121, P480, DOI 10.1037/0096-3445.121.4.480; Hajcak G, 2003, PSYCHOPHYSIOLOGY, V40, P895, DOI 10.1111/1469-8986.00107; Hajcak G, 2008, BRAIN COGNITION, V68, P15, DOI 10.1016/j.bandc.2008.02.118; Ham TE, 2013, CEREB CORTEX, V23, P703, DOI 10.1093/cercor/bhs056; Hester R, 2007, COGN AFFECT BEHAV NE, V7, P317, DOI 10.3758/CABN.7.4.317; Holroyd CB, 2005, J EXP PSYCHOL GEN, V134, P163, DOI 10.1037/0096-3445.134.2.163; Hommel B, 2004, TRENDS COGN SCI, V8, P494, DOI 10.1016/j.tics.2004.08.007; Houtman F, 2013, COGNITION, V128, P228, DOI 10.1016/j.cognition.2013.04.003; Houtman F, 2012, J COGN PSYCHOL, V24, P278, DOI 10.1080/20445911.2011.617301; Jentzsch I, 2006, Q J EXP PSYCHOL, V59, P1329, DOI 10.1080/17470210600674394; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Kiesel A, 2006, PSYCHON B REV, V13, P800, DOI 10.3758/BF03194000; King JA, 2010, J NEUROSCI, V30, P12759, DOI 10.1523/JNEUROSCI.3274-10.2010; Klein TA, 2007, NEUROIMAGE, V34, P1774, DOI 10.1016/j.neuroimage.2006.11.014; Kunde W, 2006, MEM COGNITION, V34, P356, DOI 10.3758/BF03193413; LAMING D, 1979, ACTA PSYCHOL, V43, P199, DOI 10.1016/0001-6918(79)90026-X; Laming DR, 1968, INFORM THEORY CHOICE; Maier ME, 2011, NEUROIMAGE, V56, P2339, DOI 10.1016/j.neuroimage.2011.03.083; Marco-Pallares J, 2008, J COGNITIVE NEUROSCI, V20, P1595, DOI 10.1162/jocn.2008.20117; Mayr U, 2003, NAT NEUROSCI, V6, P450, DOI 10.1038/nn1051; Notebaert W, 2001, PSYCHOL RES-PSYCH FO, V65, P170, DOI 10.1007/s004260000054; Notebaert W, 2008, COGNITION, V106, P1071, DOI 10.1016/j.cognition.2007.04.011; Notebaert W, 2011, ACTA PSYCHOL, V136, P212, DOI 10.1016/j.actpsy.2010.05.006; Notebaert W, 2009, COGNITION, V111, P275, DOI 10.1016/j.cognition.2009.02.002; Nunez Castellar E, 2010, COGN AFFECT BEHAV NE, V10, P270, DOI DOI 10.3758/CABN.10.2.270; Purmann S, 2009, PSYCHON B REV, V16, P350, DOI 10.3758/PBR.16.2.350; RABBITT P, 1977, Q J EXP PSYCHOL, V29, P727, DOI 10.1080/14640747708400645; RABBITT PMA, 1966, J EXP PSYCHOL, V71, P264, DOI 10.1037/h0022853; Ridderinkhof KR, 2002, PSYCHOL RES-PSYCH FO, V66, P312, DOI 10.1007/s00426-002-0104-7; Saunders B, 2012, PSYCHON B REV, V19, P1210, DOI 10.3758/s13423-012-0314-y; Steinborn MB, 2012, Q J EXP PSYCHOL, V65, P624, DOI 10.1080/17470218.2012.660962; Steinhauser M, 2008, MEM COGNITION, V36, P979, DOI 10.3758/MC.36.5.979; Steinhauser M, 2006, J EXP PSYCHOL HUMAN, V32, P517, DOI 10.1037/0096-1523.32.3.517; Strozyk JV, 2012, BRAIN RES, V1460, P41, DOI 10.1016/j.brainres.2012.04.028; Sturmer B, 2005, EUR J COGN PSYCHOL, V17, P590, DOI 10.1080/09541440540000077; Ullsperger M, 2005, COGN AFFECT BEHAV NE, V5, P467, DOI 10.3758/CABN.5.4.467; Verguts T, 2011, PSYCHON B REV, V18, P76, DOI 10.3758/s13423-010-0016-2; Wendt M, 2006, J EXP PSYCHOL HUMAN, V32, P644, DOI 10.1037/0096-1523.32.3.644	60	33	34	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90281	10.1371/journal.pone.0090281	http://dx.doi.org/10.1371/journal.pone.0090281			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC4ID	24603900	gold, Green Published, Green Accepted			2022-12-27	WOS:000332483600038
J	Hao, JJ; Lee, R; Chang, A; Fan, J; Labib, C; Parsa, C; Orlando, R; Andresen, B; Huang, Y				Hao, Jijun; Lee, Rachel; Chang, Andy; Fan, Jeffery; Labib, Chantelle; Parsa, Cyrus; Orlando, Robert; Andresen, Bradley; Huang, Ying			DMH1, a Small Molecule Inhibitor of BMP Type I Receptors, Suppresses Growth and Invasion of Lung Cancer	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEINS; TGF-BETA SUPERFAMILY; PROSTATE-CANCER; TUMOR-GROWTH; CELLS; METASTASIS; CARCINOMAS; EXPRESSION; PATHWAYS	The bone morphogenetic protein (BMP) signaling cascade is aberrantly activated in human non-small cell lung cancer (NSCLC) but not in normal lung epithelial cells, suggesting that blocking BMP signaling may be an effective therapeutic approach for lung cancer. Previous studies demonstrated that some BMP antagonists, which bind to extracellular BMP ligands and prevent their association with BMP receptors, dramatically reduced lung tumor growth. However, clinical application of protein-based BMP antagonists is limited by short half-lives, poor intra-tumor delivery as well as resistance caused by potential gain-of-function mutations in the downstream of the BMP pathway. Small molecule BMP inhibitors which target the intracellular BMP cascades would be ideal for anticancer drug development. In a zebrafish embryo-based structure and activity study, we previously identified a group of highly selective small molecule inhibitors specifically antagonizing the intracellular kinase domain of BMP type I receptors. In the present study, we demonstrated that DMH1, one of such inhibitors, potently reduced lung cell proliferation, promoted cell death, and decreased cell migration and invasion in NSCLC cells by blocking BMP signaling, as indicated by suppression of Smad 1/5/8 phosphorylation and gene expression of Id1, Id2 and Id3. Additionally, DMH1 treatment significantly reduced the tumor growth in human lung cancer xenograft model. In conclusion, our study indicates that small molecule inhibitors of BMP type I receptors may offer a promising novel strategy for lung cancer treatment.	[Hao, Jijun] Western Univ Hlth Sci, Coll Vet Med, Pomona, CA 91766 USA; [Lee, Rachel; Chang, Andy; Fan, Jeffery; Andresen, Bradley; Huang, Ying] Western Univ Hlth Sci, Coll Pharm, Pomona, CA USA; [Labib, Chantelle] Western Univ Hlth Sci, Coll Biomed Sci, Pomona, CA USA; [Parsa, Cyrus; Orlando, Robert] Western Univ Hlth Sci, Coll Osteopath Med, Dept Clin Sci, Pomona, CA USA	Western University of Health Sciences; Western University of Health Sciences; Western University of Health Sciences; Western University of Health Sciences	Hao, JJ (corresponding author), Western Univ Hlth Sci, Coll Vet Med, Pomona, CA 91766 USA.	jhao@westernu.edu; yhuang@westernu.edu		Andresen, Bradley/0000-0002-3948-7456	College of Veterinary Medicine at Western University of Health Sciences; Western University of Health Sciences Faculty Development Fund	College of Veterinary Medicine at Western University of Health Sciences; Western University of Health Sciences Faculty Development Fund	This work was supported by the seed fund of College of Veterinary Medicine at Western University of Health Sciences (J.H), and Western University of Health Sciences Faculty Development Fund (Y.H). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamgeer M, 2013, RESPIROLOGY, V18, P757, DOI 10.1111/resp.12094; Alarmo EL, 2010, ENDOCR-RELAT CANCER, V17, pR123, DOI 10.1677/ERC-09-0273; Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Coppe JP, 2004, CLIN CANCER RES, V10, P2044, DOI 10.1158/1078-0432.CCR-03-0933; Cory G, 2011, METHODS MOL BIOL, V769, P25, DOI 10.1007/978-1-61779-207-6_2; Feeley BT, 2006, J BONE MINER RES, V21, P1571, DOI 10.1359/JBMR.060706; Gupta GP, 2007, P NATL ACAD SCI USA, V104, P19506, DOI 10.1073/pnas.0709185104; Hao J, 2010, ACS CHEM BIOL, V5, P245, DOI 10.1021/cb9002865; Katsuno Y, 2008, ONCOGENE, V27, P6322, DOI 10.1038/onc.2008.232; Kosaka T, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/165214; Langenfeld E, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-129; Langenfeld E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061256; Langenfeld EM, 2006, ONCOGENE, V25, P685, DOI 10.1038/sj.onc.1209110; Langenfeld EM, 2005, ANN THORAC SURG, V80, P1028, DOI 10.1016/j.athoracsur.2005.03.094; Langenfeld EM, 2004, MOL CANCER RES, V2, P141; Langenfeld EM, 2003, CARCINOGENESIS, V24, P1445, DOI 10.1093/carcin/bgg100; Lee KB, 2011, J ORTHOP RES, V29, P1712, DOI 10.1002/jor.21383; Levy L, 2006, CYTOKINE GROWTH F R, V17, P41, DOI 10.1016/j.cytogfr.2005.09.009; Maegdefrau U, 2012, EXP MOL PATHOL, V92, P74, DOI 10.1016/j.yexmp.2011.10.004; Miyazawa K, 2002, GENES CELLS, V7, P1191, DOI 10.1046/j.1365-2443.2002.00599.x; Miyazono K, 2005, CYTOKINE GROWTH F R, V16, P251, DOI 10.1016/j.cytogfr.2005.01.009; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Thawani JP, 2010, NEUROSURGERY, V66, P233, DOI 10.1227/01.NEU.0000363722.42097.C2; Ye L, 2007, HISTOL HISTOPATHOL, V22, P1129, DOI 10.14670/HH-22.1129	24	34	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90748	10.1371/journal.pone.0090748	http://dx.doi.org/10.1371/journal.pone.0090748			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603907	Green Published, gold, Green Submitted			2022-12-27	WOS:000332483600079
J	Kaur, P; Khong, WX; Wee, SY; Tan, EL; Pipper, J; Koay, E; Ng, KY; Yap, JK; Chew, KK; Tan, MT; Leo, YS; Inoue, M; Ng, OT				Kaur, Palvinder; Khong, Wei Xin; Wee, Sue Yuen; Tan, Eng Lee; Pipper, Juergen; Koay, Evelyn; Kah Ying Ng; Yap, Joe Kwan; Chew, Kuan Kiat; Tan, Mei Ting; Leo, Yee Sin; Inoue, Masafumi; Oon Tek Ng			Clinical Evaluation of a Low Cost, In-House Developed Real-Time RT-PCR Human Immunodeficiency Virus Type 1 (HIV-1) Quantitation Assay for HIV-1 Infected Patients	PLOS ONE			English	Article							RESOURCE-LIMITED SETTINGS; ACTIVE ANTIRETROVIRAL THERAPY; VIRAL LOAD BLIPS; RNA; SINGAPORE; QUANTIFICATION; TRANSMISSION; PERFORMANCE; INFECTION; FORMS	Objectives: HIV-1 viral quantitation is essential for treatment monitoring. An in-house assay would decrease financial barriers to access. Materials and Methods: A real-time competitive RT-PCR in house assay (Sing-IH) was developed in Singapore. Using HXB2 as reference, the assay's primers and probes were designed to generate a 183-bp product that overlaps a portion of the LTR region and gag region. A competitive internal control (IC) was included in each assay to monitor false negative results due to inhibition or human error. Clinical evaluation was performed on 249 HIV-1 positive patient samples in comparison with the commercially available Generic HIV Viral Load assay. Correlation and agreement of results were assessed for plasma HIV-1 quantification with both assays. Results: The assay has a lower limit of detection equivalent to 126 copies/mL of HIV-1 RNA and a linear range of detection from 100-1000000 copies/mL. Comparative analysis with reference to the Generic assay demonstrated good agreement between both assays with a mean difference of 0.22 log(10) copies/mL and 98.8% of values within 1 log10 copies/mL range. Furthermore, the Sing-IH assay can quantify HIV-1 group M subtypes A-H and group N isolates adequately, making it highly suitable for our region, where subtype B and CRF01_AE predominate. Conclusions: With a significantly lower running cost compared to commercially available assays, the broadly sensitive Sing-IH assay could help to overcome the cost barriers and serve as a useful addition to the currently limited HIV viral load assay options for resource-limited settings.	[Kaur, Palvinder; Khong, Wei Xin; Kah Ying Ng; Yap, Joe Kwan; Chew, Kuan Kiat; Tan, Mei Ting; Leo, Yee Sin; Oon Tek Ng] Tan Tock Seng Hosp, Inst Infect Dis & Epidemiol, Communicable Dis Ctr, Singapore, Singapore; [Wee, Sue Yuen; Inoue, Masafumi] ASTAR, Ctr Expt Therapeut, Singapore, Singapore; [Tan, Eng Lee] Singapore Polytech, Ctr Biomed & Life Sci, Singapore, Singapore; [Tan, Eng Lee] Natl Univ Singapore Hosp, Dept Paediat, Univ Childrens Med Inst, Singapore 117548, Singapore; [Pipper, Juergen] Inst Bioengn & Nanotechnol, Singapore, Singapore; [Koay, Evelyn] Natl Univ Singapore Hosp, Dept Lab Med, Mol Diag Ctr, Singapore 117548, Singapore; [Koay, Evelyn] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pathol, Singapore 117595, Singapore; [Leo, Yee Sin] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore 117595, Singapore; [Leo, Yee Sin] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 639798, Singapore	Tan Tock Seng Hospital; Agency for Science Technology & Research (A*STAR); A*STAR - Experimental Drug Development Centre (EDDC); Experimental Therapeutics Centre; Singapore Polytechnic; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Bioengineering & Bioimaging (IBB); A*STAR - Institute of Bioengineering & Nanotechnology (IBN); National University of Singapore; National University of Singapore; National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Ng, OT (corresponding author), Tan Tock Seng Hosp, Inst Infect Dis & Epidemiol, Communicable Dis Ctr, Singapore, Singapore.	oon_tek_NG@ttsh.com.sg			National Medical Research Council in Singapore [NMRC/EDG/1053/2011, NMRC/TA/0009/2012]; School of Public Health in National University of Singapore [NUHSRO/2013/144/H7N9/06]	National Medical Research Council in Singapore(National Medical Research Council, Singapore); School of Public Health in National University of Singapore(National University of Singapore)	This work was supported by funding from National Medical Research Council in Singapore (NMRC/EDG/1053/2011, NMRC/TA/0009/2012) and the School of Public Health in National University of Singapore (NUHSRO/2013/144/H7N9/06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, GLOB REP UNAIDS REP; Armas Cayarga A, 2011, BIOTECHNOLOGY RES IN, P1, DOI [10.1001/ jama. 300.5.555, DOI 10.1001/JAMA.300.5.555]; Bland JM, 2012, ANESTHESIOLOGY, V116, P182, DOI 10.1097/ALN.0b013e31823d7784; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Buonaguro L, 2007, J VIROL, V81, P10209, DOI 10.1128/JVI.00872-07; Church D, 2011, J CLIN MICROBIOL, V49, P118, DOI 10.1128/JCM.00685-10; Cohen GM, 2007, AIDS, V21, pS81, DOI 10.1097/01.aids.0000279710.47298.5c; Doyle T, 2012, CLIN INFECT DIS, V54, P724, DOI 10.1093/cid/cir936; Drosten C, 2006, CLIN CHEM, V52, P1258, DOI 10.1373/clinchem.2006.066498; Ford N, 2012, AIDS, V26, P1719, DOI 10.1097/QAD.0b013e3283543e2c; Gandhi RT, 2012, CLIN INFECT DIS, V54, P733, DOI 10.1093/cid/cir933; Garrett NJ, 2012, J CLIN VIROL, V53, P354, DOI 10.1016/j.jcv.2011.12.024; Hammer SM, 2008, JAMA-J AM MED ASSOC, V300, P555, DOI 10.1001/jama.300.5.555; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Kalish ML, 2002, VIROLOGY, V304, P311, DOI 10.1006/viro.2002.1691; Keiser O, 2011, AIDS, V25, P1761, DOI 10.1097/QAD.0b013e328349822f; Kuiken Carla, 2008, 0803719 LAUR LOS AL; Lee CC, 2009, HIV MED, V10, P370, DOI 10.1111/j.1468-1293.2009.00698.x; Lee PK, 2006, J ANTIMICROB CHEMOTH, V57, P803, DOI 10.1093/jac/dkl092; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Menu E, 1996, AIDS RES HUM RETROV, V12, P629, DOI 10.1089/aid.1996.12.629; Motomura K, 2000, AIDS RES HUM RETROV, V16, P1831, DOI 10.1089/08892220050195793; Munderi Paula, 2012, AIDS, V26 Suppl 2, pS97, DOI 10.1097/QAD.0b013e32835bdde6; Ng OT, 2011, AIDS RES HUM RETROV, V27, P1135, DOI [10.1089/aid.2010.0364, 10.1089/AID.2010.0364]; Oyomopito R, 2010, HIV MED, V11, P519, DOI 10.1111/j.1468-1293.2010.00822.x; Panel on Antiretroviral Guidelines for Adults and Adolescents, GUID US ANT AG HIV I; Pas S, 2010, J CLIN MICROBIOL, V48, P1195, DOI 10.1128/JCM.01832-09; Promso Somying, 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P477; Rekhviashvili N, 2007, J VIROL METHODS, V146, P14, DOI 10.1016/j.jviromet.2007.05.024; Rouet F, 2007, JAIDS-J ACQ IMM DEF, V45, P380, DOI 10.1097/QAI.0b013e3180640cf5; Rouet Francois, 2011, Expert Opin Med Diagn, V5, P183, DOI 10.1517/17530059.2011.566860; Rouet F, 2010, J VIROL METHODS, V163, P253, DOI 10.1016/j.jviromet.2009.10.005; Santoro MM, 2013, ISRN MICROBIOL, V2013, DOI DOI 10.1155/2013/481314; Sawe FK, 2009, CLIN INFECT DIS, V49, P463, DOI 10.1086/600397; Steegen K, 2007, J VIROL METHODS, V146, P178, DOI 10.1016/j.jviromet.2007.06.019; Watanaveeradej Veerachai, 2005, J Med Assoc Thai, V88 Suppl 3, pS206; WHO, 2013, GLOB UPD HIV TREATM; Wilson D, 2009, T ROY SOC TROP MED H, V103, P601, DOI 10.1016/j.trstmh.2008.11.007	38	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e89826	10.1371/journal.pone.0089826	http://dx.doi.org/10.1371/journal.pone.0089826			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603460	Green Published, gold			2022-12-27	WOS:000332483600023
J	Pusceddu, A; Gambi, C; Corinaldesi, C; Scopa, M; Danovaro, R				Pusceddu, Antonio; Gambi, Cristina; Corinaldesi, Cinzia; Scopa, Mariaspina; Danovaro, Roberto			Relationships between Meiofaunal Biodiversity and Prokaryotic Heterotrophic Production in Different Tropical Habitats and Oceanic Regions	PLOS ONE			English	Article							SPECIES-DIVERSITY; MARINE BIODIVERSITY; POSIDONIA-OCEANICA; ORGANIC-MATTER; MANGROVE; COMMUNITIES; SEDIMENT; BACTERIA; BED; ASSEMBLAGES	Tropical marine ecosystems are among the most diverse of the world oceans, so that assessing the linkages between biodiversity and ecosystem functions (BEF) is a crucial step to predict consequences of biodiversity loss. Most BEF studies in marine ecosystems have been carried out on macrobenthic diversity, whereas the influence of the meiofauna on ecosystem functioning has received much less attention. We compared meiofaunal and nematode biodiversity and prokaryotic heterotrophic production across seagrass, mangrove and reef sediments in the Caribbean, Celebes and Red Seas. For all variables we report the presence of differences among habitats within the same region, and among regions within the same habitat. In all regions, the richness of meiofaunal taxa in reef and seagrass sediments is higher than in mangrove sediments. The sediments of the Celebes Sea show the highest meiofaunal biodiversity. The composition of meiofaunal assemblages varies significantly among habitats in the same region. The nematode beta diversity among habitats within the same region is higher than the beta diversity among regions. Although one site per habitat was considered in each region, these results suggest that the composition of meiofaunal assemblages varies primarily among biogeographic regions, whereas the composition of nematode assemblages varies more considerably among habitats. Meiofauna and nematode biodiversity and prokaryotic heterotrophic production, even after the removal of covariate effects linked with longitude and the quantity and nutritional quality of organic matter, are positively and linearly linked both across regions and within each habitat type. Our results confirm that meiofauna and nematode biodiversity may influence benthic prokaryotic activity, which, in turn, implies that diversity loss could have negative impacts on ecosystem functioning in these systems.	[Pusceddu, Antonio; Gambi, Cristina; Corinaldesi, Cinzia; Scopa, Mariaspina; Danovaro, Roberto] Univ Politecn Marche, Dipartimento Sci Vita & Ambiente, Ancona, Italy; [Scopa, Mariaspina] Expt Reg Ctr Fishery & Acquacolture, Ist Zooprofilatt Sperimentale Abruzzo & Molise G, Termoli, Italy; [Danovaro, Roberto] Stn Zool Anton Dohrn, Naples, Italy	Marche Polytechnic University; IZS Dell'abruzzo E Del Molise Giuseppe Caporale; Stazione Zoologica Anton Dohrn di Napoli	Pusceddu, A (corresponding author), Univ Politecn Marche, Dipartimento Sci Vita & Ambiente, Ancona, Italy.	a.pusceddu@univpm.it		Gambi, Cristina/0000-0001-6160-6004	Polytechnic University of Marche; MIUR Italy	Polytechnic University of Marche; MIUR Italy(Ministry of Education, Universities and Research (MIUR))	This study was carried out in the framework of the projects Ricerca di Ateneo 2004-2011 financed by the Polytechnic University of Marche. This study is a contribution to the FIRB Project EXPLODIVE financially supported by MIUR Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALONGI DM, 1987, MAR ECOL PROG SER, V40, P103, DOI 10.3354/meps040103; ALONGI DM, 1988, J MAR RES, V46, P349, DOI 10.1357/002224088785113630; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Armenteros M, 2006, ESTUAR COAST, V29, P124, DOI 10.1007/BF02784704; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Barnes N, 2011, BIODIVERS CONSERV, V20, P2075, DOI 10.1007/s10531-011-0076-2; Beck M. W., 2009, SHELLFISH REEFS RISK; Benedetti-Cecchi L, 2012, MARINE BIODIVERSITY AND ECOSYSTEM FUNCTIONING: FRAMEWORKS, METHODOLOGIES, AND INTEGRATION, P73; Bulling MT, 2010, PHILOS T R SOC B, V365, P2107, DOI 10.1098/rstb.2010.0022; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Chinnadurai G, 2007, ESTUAR COAST SHELF S, V72, P329, DOI 10.1016/j.ecss.2006.11.004; Claudet J, 2010, BIOL CONSERV, V143, P2195, DOI 10.1016/j.biocon.2010.06.004; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Crain CM, 2008, ECOL LETT, V11, P1304, DOI 10.1111/j.1461-0248.2008.01253.x; Danovaro R, 2002, MAR BIOL, V141, P667, DOI 10.1007/s00227-002-0857-y; Danovaro R, 2002, MAR ECOL PROG SER, V234, P95, DOI 10.3354/meps234095; Danovaro R, 1996, MAR BIOL, V127, P1, DOI 10.1007/BF00993638; Danovaro R, 2001, MICROB ECOL, V42, P177; Danovaro R, 1995, OLSEN INT S, P115; Danovaro R., 2010, METHODS STUDY DEEP S; Danovaro R, 2008, CURR BIOL, V18, P1, DOI 10.1016/j.cub.2007.11.056; Danovaro R, 2009, NEMATODES AS ENVIRONMENTAL INDICATORS, P146, DOI 10.1079/9781845933852.0146; De Mesel I, 2006, POLAR BIOL, V29, P860, DOI 10.1007/s00300-006-0124-7; De Troch M, 2001, J SEA RES, V45, P45, DOI 10.1016/S1385-1101(00)00055-1; DEMORAIS LT, 1984, MAR BIOL, V82, P209, DOI 10.1007/BF00394104; Duarte CM, 2008, ESTUAR COAST, V31, P233, DOI 10.1007/s12237-008-9038-7; Ehrlich P.R., 1981, EXTINCTION; Feller R.J., 1988, P181; Fry J. C., 1990, METHODS AQUATIC BACT, P27; Gambi C, 2014, GLOBAL ECOL BIOGEOGR, V23, P24, DOI 10.1111/geb.12094; Giere O, 2009, MEIOBENTHOLOGY MICRO, DOI 10.1007/978-3-540-68661-3; Gingold R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066653; Gray JS, 2000, J EXP MAR BIOL ECOL, V250, P23, DOI 10.1016/S0022-0981(00)00178-7; Heemsbergen DA, 2004, SCIENCE, V306, P1019, DOI 10.1126/science.1101865; HEIP C, 1985, OCEANOGR MAR BIOL, V23, P399; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; LAWTON JH, 1994, OIKOS, V71, P367, DOI 10.2307/3545824; Leduc D, 2013, MAR ECOL-EVOL PERSP, V34, P334, DOI 10.1111/maec.12019; Loreau M, 2008, CURR BIOL, V18, pR126, DOI 10.1016/j.cub.2007.11.060; Loreau M, 2010, PHILOS T R SOC B, V365, P49, DOI 10.1098/rstb.2009.0155; LORENZEN CJ, 1967, LIMNOL OCEANOGR, V12, P343, DOI 10.4319/lo.1967.12.2.0343; Max LM, 2013, MAR ECOL PROG SER, V482, P181, DOI 10.3354/meps10259; MONTAGNA PA, 1984, MAR ECOL PROG SER, V18, P119, DOI 10.3354/meps018119; Mora C, 2013, NATURE, V502, P183, DOI 10.1038/nature12540; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000606; NAEEM S, 1994, NATURE, V368, P734, DOI 10.1038/368734a0; Nagelkerken I, 2008, AQUAT BOT, V89, P155, DOI 10.1016/j.aquabot.2007.12.007; Netto SA, 2003, HYDROBIOLOGIA, V505, P159, DOI 10.1023/B:HYDR.0000007304.22992.b2; OLAFSSON E, 1995, HYDROBIOLOGIA, V312, P47, DOI 10.1007/BF00018886; Pielou E. C., 1975, ECOLOGICAL DIVERSITY; Pinto TK, 2013, MAR ECOL-EVOL PERSP, V34, P257, DOI 10.1111/maec.12011; Pusceddu A, 2009, ESTUAR COAST SHELF S, V84, P227, DOI 10.1016/j.ecss.2009.06.019; Pusceddu A, 2009, MAR ECOL PROG SER, V375, P41, DOI 10.3354/meps07735; Quang Ngo Xuan, 2007, Ocean Science Journal, V42, P135; SANDERS HL, 1968, AM NAT, V102, P243, DOI 10.1086/282541; SOETAERT K, 1990, MAR ECOL PROG SER, V59, P305, DOI 10.3354/meps059305; Solan M, 2006, MAR ECOL PROG SER, V311, P175, DOI 10.3354/meps311175; Somerfield PJ, 1998, J MAR BIOL ASSOC UK, V78, P717, DOI 10.1017/S0025315400044738; Stephens MP, 1997, GEOCHIM COSMOCHIM AC, V61, P4605, DOI 10.1016/S0016-7037(97)00358-X; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; Valiela I, 2001, BIOSCIENCE, V51, P807, DOI 10.1641/0006-3568(2001)051[0807:MFOOTW]2.0.CO;2; van Oevelen D, 2006, LIMNOL OCEANOGR, V51, P1302, DOI 10.4319/lo.2006.51.3.1302; VANDUYL FC, 1994, MAR BIOL, V120, P323, DOI 10.1007/BF00349694; Vanreusel A, 2010, MAR ECOL-EVOL PERSP, V31, P6, DOI 10.1111/j.1439-0485.2009.00352.x; WATZIN MC, 1983, OECOLOGIA, V59, P163, DOI 10.1007/BF00378833; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; WIESER W., 1953, ARKIV ZOOL, V4, P439; Wilkinson C, 2008, STATUS CORAL REEFS W; Wilson M, 2009, NEMATODES AS ENVIRONMENTAL INDICATORS, pXI, DOI 10.1079/9781845933852.0000; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294	72	39	40	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e91056	10.1371/journal.pone.0091056	http://dx.doi.org/10.1371/journal.pone.0091056			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603709	gold, Green Published, Green Submitted			2022-12-27	WOS:000332483600127
J	Scalzo, RL; Peltonen, GL; Giordano, GR; Binns, SE; Klochak, AL; Paris, HLR; Schweder, MM; Szallar, SE; Wood, LM; Larson, DG; Luckasen, GJ; Hickey, MS; Bell, C				Scalzo, Rebecca L.; Peltonen, Garrett L.; Giordano, Gregory R.; Binns, Scott E.; Klochak, Anna L.; Paris, Hunter L. R.; Schweder, Melani M.; Szallar, Steve E.; Wood, Lacey M.; Larson, Dennis G.; Luckasen, Gary J.; Hickey, Matthew S.; Bell, Christopher			Regulators of Human White Adipose Browning: Evidence for Sympathetic Control and Sexual Dimorphic Responses to Sprint Interval Training	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; INCREASES INSULIN SENSITIVITY; PGC-1-ALPHA MESSENGER-RNA; SKELETAL-MUSCLE; ADRENERGIC-STIMULATION; THERMOGENIC RESPONSE; NERVE ACTIVITY; PPAR-ALPHA; FAT-CELL; TISSUE	The conversion of white adipose to the highly thermogenic beige adipose tissue has been proposed as a potential strategy to counter the unfavorable consequences of obesity. Three regulators of this conversion have recently emerged but information regarding their control is limited, and contradictory. We present two studies examining the control of these regulators. Study 1: In 10 young men, the plasma concentrations of irisin and fibroblast growth factor 21 (FGF21) were determined prior to and during activation of the sympathetic nervous system via hypoxic gas breathing (FIO2 = 0.11). The measurements were performed twice, once with and once without prior/concurrent sympathetic inhibition via transdermal clonidine administration. FGF21 was unaffected by basal sympathetic inhibition (338 +/- 113 vs. 295 +/- 680 pg/mL; P = 0.43; mean +/- SE), but was increased during hypoxia mediated sympathetic activation (368 +/- 135); this response was abrogated (P = 0.035) with clonidine (269 +/- 693). Irisin was unaffected by sympathetic inhibition and/or hypoxia (P>0.21). Study 2: The plasma concentration of irisin and FGF21, and the skeletal muscle protein content of fibronectin type III domain containing 5 (FNDC5) was determined in 19 young adults prior to and following three weeks of sprint interval training (SIT). SIT decreased FGF21 (338 +/- 78 vs. 251 +/- 36; P = 0.046) but did not affect FNDC5 (P = 0.79). Irisin was decreased in males (127 +/- 18 vs. 90 +/- 23 ng/mL; P = 0.045) and increased in females (139 +/- 14 vs. 170 +/- 18). Collectively, these data suggest a potential regulatory role of acute sympathetic activation pertaining to the browning of white adipose; further, there appears to be a sexual dimorphic response of irisin to SIT.d	[Scalzo, Rebecca L.; Peltonen, Garrett L.; Giordano, Gregory R.; Binns, Scott E.; Klochak, Anna L.; Paris, Hunter L. R.; Schweder, Melani M.; Szallar, Steve E.; Wood, Lacey M.; Hickey, Matthew S.; Bell, Christopher] Colorado State Univ, Dept Hlth & Exercise Sci, Ft Collins, CO 80523 USA; [Larson, Dennis G.; Luckasen, Gary J.] Univ Colorado Hlth, Heart Ctr Rockies, Ft Collins, CO USA	Colorado State University; University of Colorado System; University of Colorado Anschutz Medical Campus	Bell, C (corresponding author), Colorado State Univ, Dept Hlth & Exercise Sci, Ft Collins, CO 80523 USA.	christopher.bell@colostate.edu			Defense Advanced Research Projects Agency (DARPA) [N66001-10-c-2134]	Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	The Defense Advanced Research Projects Agency (DARPA: N66001-10-c-2134) provided support for this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez GE, 2002, CIRCULATION, V106, P2533, DOI 10.1161/01.CIR.0000041244.79165.25; Baar K, 2002, FASEB J, V16, P1879, DOI 10.1096/fj.02-0367com; Bell C, 2011, EXERC SPORT SCI REV, V39, P187, DOI 10.1097/JES.0b013e31822673f0; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Burgomaster KA, 2008, J PHYSIOL-LONDON, V586, P151, DOI 10.1113/jphysiol.2007.142109; Chartoumpekis DV, 2011, MOL MED, V17, P736, DOI 10.2119/molmed.2011.00075; Cuevas-Ramos D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038022; Cypess AM, 2012, P NATL ACAD SCI USA, V109, P10001, DOI 10.1073/pnas.1207911109; Fain JN, 2013, METABOLISM; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Fletcher JA, 2012, APPL PHYSIOL NUTR ME, V37, P1054, DOI [10.1139/H2012-091, 10.1139/h2012-091]; Gibala MJ, 2006, J PHYSIOL-LONDON, V575, P901, DOI 10.1113/jphysiol.2006.112094; GRASSI G, 1995, HYPERTENSION, V25, P560, DOI 10.1161/01.HYP.25.4.560; Grassi G, 1998, CIRCULATION, V97, P2037, DOI 10.1161/01.CIR.97.20.2037; Grassi G, 2001, HYPERTENSION, V38, P1316, DOI 10.1161/hy1201.096117; Hecht R, 2012, PLOS ONE; Hecksteden A, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-235; Hondares E, 2011, J BIOL CHEM, V286, P12983, DOI 10.1074/jbc.M110.215889; Huh JY, 2012, METABOLISM, V61, P1725, DOI 10.1016/j.metabol.2012.09.002; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Jenkins Alicia, 2008, Diabetes Res Clin Pract, V82, pe5, DOI 10.1016/j.diabres.2008.06.019; Jocken JWE, 2008, DIABETOLOGIA, V51, P320, DOI 10.1007/s00125-007-0866-y; Jones PP, 1997, AM J PHYSIOL-ENDOC M, V272, pE976, DOI 10.1152/ajpendo.1997.272.6.E976; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kim KH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063517; Kralisch S, 2013, J ENDOCRINOL, V216, P135, DOI 10.1530/JOE-12-0367; Kurosu H, 2007, J BIOL CHEM, V282, P26687, DOI 10.1074/jbc.M704165200; Kurosu H, 2009, MOL CELL ENDOCRINOL, V299, P72, DOI 10.1016/j.mce.2008.10.052; Lichtenbelt WDV, 2011, AM J PHYSIOL-REG I, V301, pR285, DOI 10.1152/ajpregu.00652.2010; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lundasen T, 2007, BIOCHEM BIOPH RES CO, V360, P437, DOI 10.1016/j.bbrc.2007.06.068; Macpherson REK, 2011, MED SCI SPORT EXER, V43, P115, DOI 10.1249/MSS.0b013e3181e5eacd; Moreno-Navarrete JM, 2013, J CLIN ENDOCR METAB, V98, pE769, DOI 10.1210/jc.2012-2749; Matsumoto T, 1999, INT J OBESITY, V23, P793, DOI 10.1038/sj.ijo.0800928; Matsumoto T, 2001, OBES RES, V9, P78, DOI 10.1038/oby.2001.10; Miura S, 2008, ENDOCRINOLOGY, V149, P4527, DOI 10.1210/en.2008-0466; Miura S, 2007, ENDOCRINOLOGY, V148, P3441, DOI 10.1210/en.2006-1646; Monroe MB, 2001, AM J PHYSIOL-ENDOC M, V280, pE740, DOI 10.1152/ajpendo.2001.280.5.E740; Muise ES, 2008, MOL PHARMACOL, V74, P403, DOI 10.1124/mol.108.044826; Navegantes LCC, 2003, J CLIN ENDOCR METAB, V88, P5515, DOI 10.1210/jc.2003-030445; Newsom SA, 2010, J ENDOCRINOL, V206, P307, DOI 10.1677/JOE-10-0152; Norheim F, 2014, FEBS J, V281, P739, DOI 10.1111/febs.12619; Pekkala S, 2013, J PHYSIOL-LONDON, V591, P5393, DOI 10.1113/jphysiol.2013.263707; Peltonen GL, 2012, J PHYSIOL-LONDON, V590, P2801, DOI 10.1113/jphysiol.2011.227090; Pilegaard H, 2003, J PHYSIOL-LONDON, V546, P851, DOI 10.1113/jphysiol.2002.034850; Richards JC, 2010, J PHYSIOL-LONDON, V588, P2961, DOI 10.1113/jphysiol.2010.189886; Roca-Rivada A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060563; Sanchez J.A.G., 2013, MOL NUTR FOOD RES, P1; Sandvei M, 2012, ARCH PHYSIOL BIOCHEM, V118, P139, DOI 10.3109/13813455.2012.677454; SCHERRER U, 1994, CIRCULATION, V89, P2634, DOI 10.1161/01.CIR.89.6.2634; SCHWARTZ RS, 1990, METABOLISM, V39, P733, DOI 10.1016/0026-0495(90)90109-P; Seale P, 2009, DIABETES, V58, P1482, DOI 10.2337/db09-0622; Soderlund V, 2007, EUR J NUCL MED MOL I, V34, P1018, DOI 10.1007/s00259-006-0318-9; Stengel A, 2013, PEPTIDES, V39, P125, DOI 10.1016/j.peptides.2012.11.014; Stuckey MI, 2012, SCAND J MED SCI SPOR, V22, P756, DOI 10.1111/j.1600-0838.2011.01320.x; Tiraby C, 2003, J BIOL CHEM, V278, P33370, DOI 10.1074/jbc.M305235200; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wang H, 2008, MOL CELL BIOL, V28, P188, DOI 10.1128/MCB.00992-07; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Xu J, 2009, AM J PHYSIOL-ENDOC M, V297, pE1105, DOI 10.1152/ajpendo.00348.2009; Zhang X, 2008, DIABETES, V57, P1246, DOI 10.2337/db07-1476	61	39	42	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90696	10.1371/journal.pone.0090696	http://dx.doi.org/10.1371/journal.pone.0090696			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603718	Green Published, gold			2022-12-27	WOS:000332483600072
J	Gaidenko, TA; Price, CW				Gaidenko, Tatiana A.; Price, Chester W.			Genetic Evidence for a Phosphorylation-Independent Signal Transduction Mechanism within the Bacillus subtilis Stressosome	PLOS ONE			English	Article							TRANSCRIPTION FACTOR SIGMA(B); IN-VIVO PHOSPHORYLATION; LIGHT RECEPTOR YTVA; ENVIRONMENTAL-STRESS; PATHWAY; RSBR; ACTIVATION; COMPLEX; KINASE; OUTPUT	The stressosome is a 1.8 MDa cytoplasmic complex that controls diverse bacterial signaling pathways. Its role is best understood in Bacillus subtilis, where it activates the sigma(B) transcription factor in response to a variety of sharp environmental challenges, including acid, ethanol, heat or salt stress. However, details of the signaling mechanism within the stressosome remain uncertain. The core of the complex comprises one or more members of the RsbR co-antagonist family together with the RsbS antagonist protein, which binds the RsbT kinase in the absence of stress. As part of the response, RsbT first phosphorylates the RsbRA co-antagonist on T171 and then RsbS on S59; this latter event correlates with the stress-induced release of RsbT to activate downstream signaling. Here we examine the in vivo consequence of S59 phosphorylation in a model strain whose stressosome core is formed solely with the RsbRA co-antagonist and RsbS. A phosphorylation-deficient S59A substitution in RsbS blocked response to mild stress but had declining impact as stress increased: with strong ethanol challenge response with S59A was 60% as robust as with wild type RsbS. Genetic analysis narrowed this S59-independent activation to the stressosome and established that significant signaling still occurred in a strain bearing both the T171A and S59A substitutions. We infer that S59 phosphorylation increases signaling efficiency but is not essential, and that a second (or underlying) mechanism of signal transduction prevails in its absence. This interpretation nullifies models in which stressosome signaling is solely mediated by control of RsbT kinase activity toward S59.	[Gaidenko, Tatiana A.; Price, Chester W.] Univ Calif Davis, Dept Microbiol & Mol Genet, Davis, CA 95616 USA	University of California System; University of California Davis	Price, CW (corresponding author), Univ Calif Davis, Dept Microbiol & Mol Genet, Davis, CA 95616 USA.	cwprice@ucdavis.edu	Price, Chester/M-6900-2019		National Institute of General Medical Sciences of the National Institutes of Health [RO1 GM42077]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042077] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research reported in this publication was supported by the National Institute of General Medical Sciences of the National Institutes of Health under Award Number RO1 GM42077. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbar S, 1997, MOL MICROBIOL, V24, P567, DOI 10.1046/j.1365-2958.1997.3631732.x; Akbar S, 2001, J BACTERIOL, V183, P1329, DOI 10.1128/JB.183.4.1329-1338.2001; Avila-Perez M, 2006, J BACTERIOL, V188, P6411, DOI 10.1128/JB.00716-06; Avila-Perez M, 2010, J BACTERIOL, V192, P755, DOI 10.1128/JB.00826-09; Avila-Perez M, 2009, J BIOL CHEM, V284, P24958, DOI 10.1074/jbc.M109.033316; BOYLAN SA, 1992, J BACTERIOL, V174, P3695, DOI 10.1128/JB.174.11.3695-3706.1992; Brigulla M, 2003, J BACTERIOL, V185, P4305, DOI 10.1128/JB.185.15.4305-4314.2003; Chen CC, 2004, J BACTERIOL, V186, P6830, DOI 10.1128/JB.186.20.6830-6836.2004; Chen CC, 2003, MOL MICROBIOL, V49, P1657, DOI 10.1046/j.1365-2958.2003.03663.x; Cybulski RJ, 2009, INFECT IMMUN, V77, P274, DOI 10.1128/IAI.00515-08; Delumeau O, 2004, J BIOL CHEM, V279, P40927, DOI 10.1074/jbc.M405464200; Delumeau O, 2006, J BACTERIOL, V188, P7885, DOI 10.1128/JB.00892-06; Diensthuber RP, 2013, STRUCTURE, V21, P1127, DOI 10.1016/j.str.2013.04.024; DUBNAU D, 1971, J MOL BIOL, V56, P209, DOI 10.1016/0022-2836(71)90460-8; Eymann C, 2011, MOL MICROBIOL, V80, P798, DOI 10.1111/j.1365-2958.2011.07609.x; Gaidenko TA, 1999, J MOL BIOL, V288, P29, DOI 10.1006/jmbi.1999.2665; Gaidenko TA, 2006, J BACTERIOL, V188, P6387, DOI 10.1128/JB.00691-06; Gaidenko TA, 2012, J BACTERIOL, V194, P3913, DOI 10.1128/JB.00583-12; Gaidenko TA, 2011, J BACTERIOL, V193, P3588, DOI 10.1128/JB.00060-11; Hecker M, 2007, ANNU REV MICROBIOL, V61, P215, DOI 10.1146/annurev.micro.61.080706.093445; Hoper D, 2005, J BACTERIOL, V187, P2810, DOI 10.1128/JB.187.8.2810-2826.2005; Jurk M, 2013, BIOCHEM BIOPH RES CO, V432, P499, DOI 10.1016/j.bbrc.2013.02.025; Kang CM, 1996, J BACTERIOL, V178, P3846, DOI 10.1128/jb.178.13.3846-3853.1996; Kim TJ, 2004, J BACTERIOL, V186, P6124, DOI 10.1128/jb.186.18.6124-6132.2004; Kim TJ, 2004, J MOL BIOL, V341, P135, DOI 10.1016/j.jmb.2004.05.043; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Liebal UW, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-3; Losi A, 2002, BIOPHYS J, V82, P2627, DOI 10.1016/S0006-3495(02)75604-X; Macek B, 2007, MOL CELL PROTEOMICS, V6, P697, DOI 10.1074/mcp.M600464-MCP200; Mani R, 2008, P NATL ACAD SCI USA, V105, P3461, DOI 10.1073/pnas.0712255105; Marles-Wright J, 2008, SCIENCE, V322, P92, DOI 10.1126/science.1159572; Moglich A, 2007, J MOL BIOL, V373, P112, DOI 10.1016/j.jmb.2007.07.039; Moglich A, 2009, J MOL BIOL, V385, P1433, DOI 10.1016/j.jmb.2008.12.017; Murray JW, 2005, P NATL ACAD SCI USA, V102, P17320, DOI 10.1073/pnas.0506599102; Pane-Farre J, 2005, J MOL MICROB BIOTECH, V9, P65, DOI 10.1159/000088837; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; PIGGOT PJ, 1973, J BACTERIOL, V114, P1241, DOI 10.1128/JB.114.3.1241-1253.1973; Price CW, 2011, BACTERIAL STRESS RESPONSES, 2ND EDITION, P301; Purcell EB, 2010, BIOCHEMISTRY-US, V49, P6761, DOI 10.1021/bi1006404; Quin MB, 2012, STRUCTURE, V20, P350, DOI 10.1016/j.str.2012.01.003; Reeves A, 2010, MICROBIOL-SGM, V156, P990, DOI 10.1099/mic.0.036095-0; Sambrock J, 1989, MOL CLONING LAB MANU, V1; St Onge RP, 2007, NAT GENET, V39, P199, DOI 10.1038/ng1948; STEINMETZ M, 1994, GENE, V142, P79, DOI 10.1016/0378-1119(94)90358-1; Van der Steen JB, 2012, J BACTERIOL, V194, P1708, DOI 10.1128/JB.06705-11; Vijay K, 2000, MOL MICROBIOL, V35, P180, DOI 10.1046/j.1365-2958.2000.01697.x; Yang XF, 1996, GENE DEV, V10, P2265, DOI 10.1101/gad.10.18.2265; Young JW, 2013, P NATL ACAD SCI USA, V110, P4140, DOI 10.1073/pnas.1213060110	48	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90741	10.1371/journal.pone.0090741	http://dx.doi.org/10.1371/journal.pone.0090741			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599254	Green Published, gold			2022-12-27	WOS:000332479400129
J	Zheng, Z; Lee, KS; Zhang, XL; Nguyen, C; Hsu, CY; Wang, JZ; Rackohn, TM; Enjamuri, DR; Murphy, M; Ting, K; Soo, C				Zheng, Zhong; Lee, Kevin S.; Zhang, Xinli; Nguyen, Calvin; Hsu, Chingyun; Wang, Joyce Z.; Rackohn, Todd Matthew; Enjamuri, Dwarak Reddy; Murphy, Maxwell; Ting, Kang; Soo, Chia			Fibromodulin-Deficiency Alters Temporospatial Expression Patterns of Transforming Growth Factor-beta Ligands and Receptors during Adult Mouse Skin Wound Healing	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; TGF-BETA; EXTRACELLULAR-MATRIX; SCAR FORMATION; COLLAGEN FIBRILLOGENESIS; DIFFERENTIAL EXPRESSION; GENE-EXPRESSION; DECORIN; LUMICAN; GROWTH-FACTOR-BETA-1	Fibromodulin (FMOD) is a small leucine-rich proteoglycan required for scarless fetal cutaneous wound repair. Interestingly, increased FMOD levels have been correlated with decreased transforming growth factor (TGF)-beta 1 expression in multiple fetal and adult rodent models. Our previous studies demonstrated that FMOD-deficiency in adult animals results in delayed wound closure and increased scar size accompanied by loose package collagen fiber networks with increased fibril diameter. In addition, we found that FMOD modulates in vitro expression and activities of TGF-beta ligands in an isoform-specific manner. In this study, temporospatial expression profiles of TGF-beta ligands and receptors in FMOD-null and wild-type (WT) mice were compared by immunohistochemical staining and quantitative reverse transcriptase-polymerase chain reaction using a full-thickness, primary intention wound closure model. During the inflammatory stage, elevated inflammatory infiltration accompanied by increased type I TGF-beta receptor levels in individual inflammatory cells was observed in FMOD-null wounds. This increased inflammation was correlated with accelerated epithelial migration during the proliferative stage. On the other hand, significantly more robust expression of TGF-beta 3 and TGF-beta receptors in FMOD-null wounds during the proliferative stage was associated with delayed dermal cell migration and proliferation, which led to postponed granulation tissue formation and wound closure and increased scar size. Compared with WT controls, expression of TGF-beta ligands and receptors by FMOD-null dermal cells was markedly reduced during the remodeling stage, which may have contributed to the declined collagen synthesis capability and unordinary collagen architecture. Taken together, this study demonstrates that a single missing gene, FMOD, leads to conspicuous alternations in TGF-beta ligand and receptor expression at all stages of wound repair in various cell types. Therefore, FMOD critically coordinates temporospatial distribution of TGF-beta ligands and receptors in vivo, suggesting that FMOD modulates TGF-beta bioactivity in a complex way beyond simple physical binding to promote proper wound healing.	[Zheng, Zhong; Lee, Kevin S.; Zhang, Xinli; Nguyen, Calvin; Hsu, Chingyun; Rackohn, Todd Matthew; Murphy, Maxwell; Ting, Kang] Univ Calif Los Angeles, Sch Dent, Dent & Craniofacial Res Inst, Los Angeles, CA 90024 USA; [Zheng, Zhong; Lee, Kevin S.; Zhang, Xinli; Nguyen, Calvin; Hsu, Chingyun; Rackohn, Todd Matthew; Murphy, Maxwell; Ting, Kang] Univ Calif Los Angeles, Sch Dent, Sect Orthodont, Los Angeles, CA 90024 USA; [Wang, Joyce Z.] SUNY Downstate, Kings Country Hosp Ctr, Dept Emergency Med, New York, NY USA; [Enjamuri, Dwarak Reddy] Univ Calif Los Angeles, Dept Psychobiol, Los Angeles, CA USA; [Soo, Chia] Univ Calif Los Angeles, Los Angeles, CA USA; [Soo, Chia] Univ Calif Los Angeles, Orthopaed Hosp Dept Orthopaed Surg, Los Angeles, CA USA; [Soo, Chia] Univ Calif Los Angeles, Orthopaed Hosp Res Ctr, Los Angeles, CA USA; [Soo, Chia] Univ Calif Los Angeles, Sch Med, Dept Surg, Div Plast & Reconstruct Surg, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Ting, K (corresponding author), Univ Calif Los Angeles, Sch Dent, Dent & Craniofacial Res Inst, Los Angeles, CA 90024 USA.	kting@dentistry.ucla.edu; bsoo@ucla.edu	Liu, Chunji/B-5243-2009; Zheng, Zhi/C-4110-2017; Zheng, Zhong/AAZ-9647-2020; Yan, Guijun/A-9809-2011	Zheng, Zhi/0000-0002-1493-1995; Yan, Guijun/0000-0001-9628-1211; Kilian, Andrzej/0000-0002-2730-7462	Plastic Surgery Research Foundation; NIH-NIAMS (SBIR grant) [1R43-AR064126]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R43AR064126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R44DE024692] Funding Source: NIH RePORTER	Plastic Surgery Research Foundation; NIH-NIAMS (SBIR grant); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was supported by the Plastic Surgery Research Foundation (2013 National Endowment for Plastic Surgery Research Grant Program) and NIH-NIAMS (SBIR grant 1R43-AR064126). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN A, 2002, NOVEL TECHNIQUE COMP; [Anonymous], 2011, JUV FAILS LAT STAG T; Baghy K, 2012, J HISTOCHEM CYTOCHEM, V60, P262, DOI 10.1369/0022155412438104; Bandyopadhyay B, 2006, J CELL BIOL, V172, P1093, DOI 10.1083/jcb.200507111; Beanes Steven R., 2003, Expert Reviews in Molecular Medicine, V5, P1, DOI 10.1017/S1462399403005817; Bi YM, 2007, NAT MED, V13, P1219, DOI 10.1038/nm1630; Bossi F, 2011, MOL IMMUNOL, V48, P1676, DOI 10.1016/j.molimm.2011.06.254; BRANDES ME, 1991, J BIOL CHEM, V266, P19697; BRANDES ME, 1991, J IMMUNOL, V147, P1600; Broughton G, 2006, PLAST RECONSTR SURG, V117, p12S, DOI 10.1097/01.prs.0000225430.42531.c2; Chaudhury A, 2009, IUBMB LIFE, V61, P929, DOI 10.1002/iub.239; Clark R., 1996, Mezhdunarodnyi Sel'skokhozyaistvennyi Zhurnal, P3; Clark R. A. F., 1988, MOL CELLULAR BIOL WO; CUI W, 1995, GENE DEV, V9, P945, DOI 10.1101/gad.9.8.945; DANIELPOUR D, 1990, J BIOL CHEM, V265, P6973; Decline F, 2003, CELL MOTIL CYTOSKEL, V54, P64, DOI 10.1002/cm.10086; Denton CP, 2009, J INVEST DERMATOL, V129, P194, DOI 10.1038/jid.2008.171; Eming SA, 2007, J INVEST DERMATOL, V127, P514, DOI 10.1038/sj.jid.5700701; Ezura Y, 2000, J CELL BIOL, V151, P779, DOI 10.1083/jcb.151.4.779; Frank S, 1996, J BIOL CHEM, V271, P10188, DOI 10.1074/jbc.271.17.10188; Goldberg M, 2006, J HISTOCHEM CYTOCHEM, V54, P525, DOI 10.1369/jhc.5A6650.2005; GRANDE J, 1993, LAB INVEST, V69, P387; GRAYCAR JL, 1989, MOL ENDOCRINOL, V3, P1977, DOI 10.1210/mend-3-12-1977; Han GW, 2012, INT J BIOL SCI, V8, P228, DOI 10.7150/ijbs.8.228; HEBDA PA, 1988, J INVEST DERMATOL, V91, P440, DOI 10.1111/1523-1747.ep12476480; Heegaard AM, 2004, J CELL BIOCHEM, V93, P463, DOI 10.1002/jcb.20189; Henry G, 2003, SURG CLIN N AM, V83, P483, DOI 10.1016/S0039-6109(02)00200-1; HILDEBRAND A, 1994, BIOCHEM J, V302, P527, DOI 10.1042/bj3020527; Honardoust D, 2012, J BURN CARE RES, V33, P218, DOI 10.1097/BCR.0b013e3182335980; Honardoust D, 2011, WOUND REPAIR REGEN, V19, P368, DOI 10.1111/j.1524-475X.2011.00677.x; Ikushima H, 2012, CELL TISSUE RES, V347, P37, DOI 10.1007/s00441-011-1179-5; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Iozzo RV, 2011, BIOL EXTRACELL MATR, P197, DOI 10.1007/978-3-642-16555-9_6; Iozzo RV, 2010, FEBS J, V277, P3864, DOI 10.1111/j.1742-4658.2010.07797.x; Isaka Y, 1996, NAT MED, V2, P418, DOI 10.1038/nm0496-418; Jian J, 2013, BIOCH BIOPHYSICAL RE, V436; Kalamajski S, 2009, J BIOL CHEM, V284, P534, DOI 10.1074/jbc.M805721200; Khorasani H, 2011, AM J PATHOL, V178, P621, DOI 10.1016/j.ajpath.2010.10.019; Kolb M, 2001, AM J PHYSIOL-LUNG C, V280, pL1327, DOI 10.1152/ajplung.2001.280.6.L1327; Lagraoui M, 1997, CELL MOL BIOL, V43, P313; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Levens E, 2005, MOL HUM REPROD, V11, P489, DOI 10.1093/molehr/gah187; LEVINE JH, 1993, AM J PATHOL, V143, P368; Li X, 2006, POULTRY SCI, V85, P326, DOI 10.1093/ps/85.2.326; LIN RY, 1995, ANN SURG, V222, P146, DOI 10.1097/00000658-199508000-00006; LOPEZCASILLAS F, 1991, CELL, V67, P785, DOI 10.1016/0092-8674(91)90073-8; LOPEZCASILLAS F, 1994, J CELL BIOL, V124, P557, DOI 10.1083/jcb.124.4.557; Lorenz HP, 2008, WOUNDS BIOL PATHOLOG; Mariano JM, 1998, INT J DEV BIOL, V42, P1125; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; MASSAGUE J, 1990, ANNU REV CELL BIOL, V6, P597, DOI 10.1146/annurev.cb.06.110190.003121; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Mayr C, 2005, BLOOD, V105, P1566, DOI 10.1182/blood-2004-04-1233; Merline R, 2009, J CELL COMMUN SIGNAL, V3, P323, DOI 10.1007/s12079-009-0066-2; Mikaelsson E, 2005, BLOOD, V105, P4828, DOI 10.1182/blood-2004-10-3941; Murata H, 1997, J INVEST DERMATOL, V108, P258, DOI 10.1111/1523-1747.ep12286451; Niewiarowska J, 2011, THROMB RES, V128, P452, DOI 10.1016/j.thromres.2011.06.011; Occleston NL, 2008, J BIOMAT SCI-POLYM E, V19, P1047, DOI 10.1163/156856208784909345; OKane S, 1997, INT J BIOCHEM CELL B, V29, P63, DOI 10.1016/S1357-2725(96)00120-3; Oldberg A, 2007, P NATL ACAD SCI USA, V104, P13966, DOI 10.1073/pnas.0702014104; PARALKAR VM, 1991, DEV BIOL, V143, P303, DOI 10.1016/0012-1606(91)90081-D; Penn JW, 2012, INT J BURNS TRAUMA, V2, P18; Qian H, 2004, ORAL DIS, V10, P233, DOI 10.1111/j.1601-0825.2004.00996.x; Ranjzad P, 2009, GENE THER, V16, P1154, DOI 10.1038/gt.2009.63; ROBERTS AB, 1996, MOL CELLULAR BIOL WO, P275; Schaefer L, 2010, CELL TISSUE RES, V339, P237, DOI 10.1007/s00441-009-0821-y; SHAH M, 1995, J CELL SCI, V108, P985; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Sinno H, 2013, J DERMATOL TREAT, V24, P141, DOI 10.3109/09546634.2011.631977; Sjoberg A, 2005, J BIOL CHEM, V280, P32301, DOI 10.1074/jbc.M504828200; Soo C, 2003, AM J PATHOL, V163, P2459, DOI 10.1016/S0002-9440(10)63601-2; Soo C, 2000, AM J PATHOL, V157, P423, DOI 10.1016/S0002-9440(10)64555-5; Soo C, 2001, SURG FORUM, V52, P578; Stoff A, 2007, J MOL MED-JMM, V85, P481, DOI 10.1007/s00109-006-0148-z; Sun T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008515; Svensson L, 2000, FEBS LETT, V470, P178, DOI 10.1016/S0014-5793(00)01314-4; Svensson L, 1999, J BIOL CHEM, V274, P9636, DOI 10.1074/jbc.274.14.9636; Viola M, 2007, CONNECT TISSUE RES, V48, P141, DOI 10.1080/03008200701276133; WAHL SM, 1987, P NATL ACAD SCI USA, V84, P5788, DOI 10.1073/pnas.84.16.5788; Wu LC, 1997, ARCH SURG-CHICAGO, V132, P753; Xiao YQ, 2009, INVEST OPHTH VIS SCI, V50, P1698, DOI 10.1167/iovs.08-1675; Yamanaka O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082730; Zhang Z, 2007, BURNS, V33, P634, DOI 10.1016/j.burns.2006.08.018; Zhang Z, 2009, BURNS, V35, P527, DOI 10.1016/j.burns.2008.08.021; Zheng Z, 2012, BIOMATERIALS, V33, P5821, DOI 10.1016/j.biomaterials.2012.04.049; Zheng Z, 2011, J INVEST DERMATOL, V131, P769, DOI 10.1038/jid.2010.381	86	56	61	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90817	10.1371/journal.pone.0090817	http://dx.doi.org/10.1371/journal.pone.0090817			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603701	gold, Green Submitted, Green Published			2022-12-27	WOS:000332483600088
J	Liang, WF; Zhao, YL; Liu, LQ; Wang, YC; Dong, ZL; Li, WJ; Lee, GB; Xiao, XB; Zhang, WJ				Liang, Wenfeng; Zhao, Yuliang; Liu, Lianqing; Wang, Yuechao; Dong, Zaili; Li, Wen Jung; Lee, Gwo-Bin; Xiao, Xiubin; Zhang, Weijing			Rapid and Label-Free Separation of Burkitt's Lymphoma Cells from Red Blood Cells by Optically-Induced Electrokinetics	PLOS ONE			English	Article							MECHANICAL-PROPERTIES; DIELECTROPHORESIS; MANIPULATION; SYSTEM	Early stage detection of lymphoma cells is invaluable for providing reliable prognosis to patients. However, the purity of lymphoma cells in extracted samples from human patients' marrow is typically low. To address this issue, we report here our work on using optically-induced dielectrophoresis (ODEP) force to rapidly purify Raji cells' (a type of Burkitt's lymphoma cell) sample from red blood cells (RBCs) with a label-free process. This method utilizes dynamically moving virtual electrodes to induce negative ODEP force of varying magnitudes on the Raji cells and RBCs in an optically-induced electrokinetics (OEK) chip. Polarization models for the two types of cells that reflect their discriminate electrical properties were established. Then, the cells' differential velocities caused by a specific ODEP force field were obtained by a finite element simulation model, thereby established the theoretical basis that the two types of cells could be separated using an ODEP force field. To ensure that the ODEP force dominated the separation process, a comparison of the ODEP force with other significant electrokinetics forces was conducted using numerical results. Furthermore, the performance of the ODEP-based approach for separating Raji cells from RBCs was experimentally investigated. The results showed that these two types of cells, with different concentration ratios, could be separated rapidly using externally-applied electrical field at a driven frequency of 50 kHz at 20 V-pp. In addition, we have found that in order to facilitate ODEP-based cell separation, Raji cells' adhesion to the OEK chip's substrate should be minimized. This paper also presents our experimental results of finding the appropriate bovine serum albumin concentration in an isotonic solution to reduce cell adhesion, while maintaining suitable medium conductivity for electrokinetics-based cell separation. In short, we have demonstrated that OEK technology could be a promising tool for efficient and effective purification of Raji cells from RBCs.	[Liang, Wenfeng; Liu, Lianqing; Wang, Yuechao; Dong, Zaili; Li, Wen Jung] Chinese Acad Sci, Shenyang Inst Automat, State Key Lab Robot, Shenyang 110016, Peoples R China; [Liang, Wenfeng] Univ Chinese Acad Sci, Beijing, Peoples R China; [Liang, Wenfeng; Zhao, Yuliang; Li, Wen Jung] City Univ Hong Kong, Dept Mech & Biomed Engn, Kowloon, Hong Kong, Peoples R China; [Lee, Gwo-Bin] Natl Tsing Hua Univ, Dept Power Mech Engn, Hsinchu, Taiwan; [Xiao, Xiubin; Zhang, Weijing] Acad Mil Med Sci, Affiliated Hosp, Dept Lymphoma, Beijing, Peoples R China	Chinese Academy of Sciences; Shenyang Institute of Automation, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; City University of Hong Kong; National Tsing Hua University; Academy of Military Medical Sciences - China	Liu, LQ (corresponding author), Chinese Acad Sci, Shenyang Inst Automat, State Key Lab Robot, Shenyang 110016, Peoples R China.	lqliu@sia.cn; wenjli@cityu.edu.hk	Zhang, Weijing/GQA-9455-2022; Lee, Gwo-Bin Vincent/D-3032-2012; Li, Wen Jung/A-6153-2010	Lee, Gwo-Bin Vincent/0000-0001-6910-9133; Li, Wen Jung/0000-0001-9616-6213; Wenhua, Liang/0000-0002-1391-8238; Liang, Wenfeng/0000-0002-6605-2511	National Natural Science Foundation of China [61107043]; CAS-Croucher Joint Lab Scheme [9500011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAS-Croucher Joint Lab Scheme	The work was supported by National Natural Science Foundation of China (Project No. 61107043) http://www.nsfc.gov.cn; CAS-Croucher Joint Lab Scheme (Project No. 9500011) http://www.croucher.org.hk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augustsson P, 2012, ANAL CHEM, V84, P7954, DOI 10.1021/ac301723s; BOYUM A, 1976, SCAND J IMMUNOL, P9, DOI 10.1111/j.1365-3083.1976.tb03851.x; Castellanos A, 2003, J PHYS D APPL PHYS, V36, P2584, DOI 10.1088/0022-3727/36/20/023; Chau LH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051577; Chiou PY, 2005, NATURE, V436, P370, DOI [10.1038/nature03831, 10.1038/nature0383l]; Gao J, 2012, ANALYST, V137, P5215, DOI 10.1039/c2an35707k; Hsu HY, 2010, LAB CHIP, V10, P165, DOI 10.1039/b906593h; Huang CJ, 2011, MICROFLUID NANOFLUID, V10, P37, DOI 10.1007/s10404-010-0644-x; Huang SB, 2013, LAB CHIP, V13, P1371, DOI 10.1039/c3lc41256c; Huang SB, 2012, INT J ELECTROCHEM SC, V7, P12656; Hwang H, 2009, BIOMICROFLUIDICS, V3, DOI 10.1063/1.3086600; Janeway CA, 2001, IMMUNOBIOLOGY; Jones T. B., 1995, ELECTROMECHANICS PAR; KAKUTANI T, 1993, BIOELECTROCH BIOENER, V31, P131, DOI 10.1016/0302-4598(93)80002-C; Lau ANK, 2009, LAB CHIP, V9, P2952, DOI 10.1039/b907840a; Li M, 2012, SCI CHINA LIFE SCI, V55, P968, DOI 10.1007/s11427-012-4399-3; Li M, 2011, BIOCHEM BIOPH RES CO, V404, P689, DOI 10.1016/j.bbrc.2010.12.043; Liang WF, 2012, MICROMACHINES-BASEL, V3, P492, DOI 10.3390/mi3020492; Liang WF, 2013, SENSOR ACTUAT A-PHYS, V193, P103, DOI 10.1016/j.sna.2013.01.020; Lin YH, 2010, SENSOR ACTUAT B-CHEM, V145, P854, DOI 10.1016/j.snb.2010.01.019; Lin YH, 2009, OPT EXPRESS, V17, P15318, DOI 10.1364/OE.17.015318; Mikolajczyk S. D., 2011, J ONCOL, V2011, P1, DOI [DOI 10.1186/1477-7819-4-67, 10.1186/1477-7819-4-67]; Moon HS, 2011, LAB CHIP, V11, P1118, DOI [10.1039/c0lc00345j, 10.1039/c01c00345j]; Morgan H., 2003, AC ELECTROKINETICS C, Vfirst; Ohta AT, 2007, IEEE J SEL TOP QUANT, V13, P235, DOI 10.1109/JSTQE.2007.893558; Ohta AT, 2010, LAB CHIP, V10, P3213, DOI [10.1039/c0lc00072h, 10.1039/C0LC00072H]; Polevaya Y, 1999, BBA-BIOMEMBRANES, V1419, P257, DOI 10.1016/S0005-2736(99)00072-3; Rosenberg R, 2002, CYTOMETRY, V49, P150, DOI 10.1002/cyto.10161; Ryu BY, 2005, P NATL ACAD SCI USA, V102, P14302, DOI 10.1073/pnas.0506970102; Sun JS, 2012, LAB CHIP, V12, P3952, DOI 10.1039/c2lc40679a; Talasaz AH, 2009, P NATL ACAD SCI USA, V106, P3970, DOI 10.1073/pnas.0813188106; Valley JK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010160; VETTORE L, 1980, AM J HEMATOL, V8, P291, DOI 10.1002/ajh.2830080307; Wang S, 2011, MICROMACHINES-BASEL, V2, P431, DOI 10.3390/mi2040431; Yang J, 1999, ANAL CHEM, V71, P911, DOI 10.1021/ac981250p	35	115	117	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90827	10.1371/journal.pone.0090827	http://dx.doi.org/10.1371/journal.pone.0090827			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	25329056	gold, Green Submitted, Green Published			2022-12-27	WOS:000332485800056
J	Burns, DA; Woodruff, LG; Bradley, PM; Cannon, WF				Burns, Douglas A.; Woodruff, Laurel G.; Bradley, Paul M.; Cannon, William F.			Mercury in the Soil of Two Contrasting Watersheds in the Eastern United States	PLOS ONE			English	Article							DISSOLVED ORGANIC-MATTER; ATMOSPHERIC DEPOSITION; METHYL MERCURY; UPLAND FOREST; BULK-DENSITY; PATTERNS; METHYLMERCURY; DYNAMICS; CARBON; SEQUESTRATION	Soil represents the largest store of mercury (Hg) in terrestrial ecosystems, and further study of the factors associated with soil Hg storage is needed to address concerns about the magnitude and persistence of global environmental Hg bioaccumulation. To address this need, we compared total Hg and methyl Hg concentrations and stores in the soil of different landscapes in two watersheds in different geographic settings with similar and relatively high methyl Hg concentrations in surface waters and biota, Fishing Brook, Adirondack Mountains, New York, and McTier Creek, Coastal Plain, South Carolina. Median total Hg concentrations and stores in organic and mineral soil samples were three-fold greater at Fishing Brook than at McTier Creek. Similarly, median methyl Hg concentrations were about two-fold greater in Fishing Brook soil than in McTier Creek soil, but this difference was significant only for mineral soil samples, and methyl Hg stores were not significantly different among these watersheds. In contrast, the methyl Hg/total Hg ratio was significantly greater at McTier Creek suggesting greater climate-driven methylation efficiency in the Coastal Plain soil than that of the Adirondack Mountains. The Adirondack soil had eight-fold greater soil organic matter than that of the Coastal Plain, consistent with greater total Hg stores in the northern soil, but soil organic matter - total Hg relations differed among the sites. A strong linear relation was evident at McTier Creek (r(2) = 0.68; p<0.001), but a linear relation at Fishing Brook was weak (r(2) = 0.13; p<0.001) and highly variable across the soil organic matter content range, suggesting excess Hg binding capacity in the Adirondack soil. These results suggest greater total Hg turnover time in Adirondack soil than that of the Coastal Plain, and that future declines in stream water Hg concentrations driven by declines in atmospheric Hg deposition will be more gradual and prolonged in the Adirondacks.	[Burns, Douglas A.] US Geol Survey, Troy, NY 12180 USA; [Woodruff, Laurel G.] US Geol Survey, Mountain View, CA USA; [Bradley, Paul M.] US Geol Survey, Columbia, SC USA; [Cannon, William F.] US Geol Survey, Reston, VA 22092 USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey	Burns, DA (corresponding author), US Geol Survey, Troy, NY 12180 USA.	daburns@usgs.gov	Burns, Douglas/A-7507-2009; Spencer, Thomas/AAD-6434-2020; Bradley, Paul M./AAC-2451-2020; navakanitworakul, raphatphorn/T-5948-2017	Bradley, Paul M./0000-0001-7522-8606; navakanitworakul, raphatphorn/0000-0001-6408-0079; Spencer, Thomas/0000-0003-2815-766X; Burns, Douglas/0000-0001-6516-2869; Burns, Gregory/0000-0003-0021-4319	United States Environmental Protection Agency; National Water Quality Assessment Program of the United States Geological Survey; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD061580] Funding Source: NIH RePORTER	United States Environmental Protection Agency(United States Environmental Protection Agency); National Water Quality Assessment Program of the United States Geological Survey; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Funding for this work was provided by the United States Environmental Protection Agency and the National Water Quality Assessment Program of the United States Geological Survey. The funders has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS WA, 1973, J SOIL SCI, V24, P10, DOI 10.1111/j.1365-2389.1973.tb00737.x; Aelion CM, 2009, SCI TOTAL ENVIRON, V407, P2216, DOI 10.1016/j.scitotenv.2008.11.033; Akerblom S, 2008, WATER AIR SOIL POLL, V189, P239, DOI 10.1007/s11270-007-9571-1; [Anonymous], WATER AIR SOIL POLLU; Arfstrom C, 2000, WATER AIR SOIL POLL, V121, P133, DOI 10.1023/A:1005214908516; ASHWAL LD, 1982, AM MINERAL, V67, P14; Bradley PM, 2013, ENVIRON POLLUT, V172, P42, DOI 10.1016/j.envpol.2012.08.008; Bradley PM, 2011, ENVIRON SCI TECHNOL, V45, P2048, DOI 10.1021/es103923j; BROADBENT FE, 1953, ADV AGRON, V5, P153, DOI 10.1016/S0065-2113(08)60229-1; Brown Z.A., 2002, ANAL METHODS CHEM AN, P1; Burns DA, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2011JG001812; Burns DA, 2013, BIOGEOCHEMISTRY, V113, P451, DOI 10.1007/s10533-012-9773-5; Burt R, 2003, J ENVIRON QUAL, V32, P2109, DOI 10.2134/jeq2003.2109; Bushey JT, 2008, ATMOS ENVIRON, V42, P6905, DOI 10.1016/j.atmosenv.2008.05.043; Chen X, 2010, ENVIRON POLLUT, V158, P48, DOI 10.1016/j.envpol.2009.08.028; Dahl T.E., 2009, DATA COLLECTION REQU; De Vos B, 2005, SOIL SCI SOC AM J, V69, P500, DOI 10.2136/sssaj2005.0500; Demers JD, 2007, ECOL APPL, V17, P1341, DOI 10.1890/06-1697.1; Demers JD, 2013, J GEOPHYS RES-BIOGEO, V118, P825, DOI 10.1002/jgrg.20066; Desaules A, 2012, ENVIRON MONIT ASSESS, V184, P487, DOI 10.1007/s10661-011-1982-1; DeWild JF, 2004, 5A7 US GEOL SURV; Duffera M, 2007, GEODERMA, V137, P327, DOI 10.1016/j.geoderma.2006.08.018; Evers DC, 2007, BIOSCIENCE, V57, P29, DOI 10.1641/B570107; FEDERER CA, 1993, CAN J FOREST RES, V23, P1026, DOI 10.1139/x93-131; Fu XW, 2010, ENVIRON POLLUT, V158, P2324, DOI 10.1016/j.envpol.2010.01.032; Gabriel MC, 2004, ENVIRON GEOCHEM HLTH, V26, P421, DOI 10.1007/s10653-004-1308-0; Gerbig C., 2012, ENV CHEM TOXICOLOGY, DOI [10.1002/9781118146644.ch8, DOI 10.1002/9781118146644.CH8]; Grigal DF, 2003, J ENVIRON QUAL, V32, P393, DOI 10.2134/jeq2003.0393; Guo YY, 2006, SOIL SCI SOC AM J, V70, P601, DOI 10.2136/sssaj2005.0163; Harrison RB, 2003, SOIL SCI SOC AM J, V67, P1602, DOI 10.2136/sssaj2003.1602; Helsel D. R., 2005, NONDETECTS DATA ANAL; Homer C, 2004, PHOTOGRAMM ENG REM S, V70, P829, DOI 10.14358/PERS.70.7.829; Journey CA, 2012, 20125173 US GEOL SUR; Kiernan BD, 2003, ENVIRON POLLUT, V123, P347, DOI 10.1016/S0269-7491(03)00023-X; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; LaPoint S. D., 2004, WETLANDS EFFECTS DAT; Lindqvist O, 1994, WATER AIR SOIL POLL, V55, P1; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Markewich H. W., 1990, Geomorphology, V3, P417, DOI 10.1016/0169-555X(90)90015-I; McGee GG, 2007, J TORREY BOT SOC, V134, P253, DOI 10.3159/1095-5674(2007)134[253:RAFACA]2.0.CO;2; Mitchell CPJ, 2008, ENVIRON SCI TECHNOL, V42, P1010, DOI 10.1021/es0704986; NATER EA, 1992, NATURE, V358, P139, DOI 10.1038/358139a0; Obrist D, 2011, ENVIRON SCI TECHNOL, V45, P3974, DOI 10.1021/es104384m; Obrist D, 2012, ENVIRON SCI TECHNOL, V46, P5921, DOI 10.1021/es2045579; Park JH, 2005, ENVIRON SCI TECHNOL, V39, P6993, DOI 10.1021/es048301m; Post WM, 2000, GLOBAL CHANGE BIOL, V6, P317, DOI 10.1046/j.1365-2486.2000.00308.x; Ravichandran M, 2004, CHEMOSPHERE, V55, P319, DOI 10.1016/j.chemosphere.2003.11.011; Richardson G. Mark, 2003, Environmental Reviews, V11, P17, DOI 10.1139/a03-004; Richardson JB, 2013, ENVIRON POLLUT, V182, P127, DOI 10.1016/j.envpol.2013.07.011; Riva-Murray K, 2011, ECOTOXICOLOGY, V9, P1; Rogers VA, 1985, SOIL SURVEY AIKEN CO; Schelker J, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001330; Schwesig D, 1999, WATER AIR SOIL POLL, V113, P141, DOI 10.1023/A:1005080922234; Scudder BC, 2009, 20095109 US GEOL SUR; Scudder Eikenberry BC, 2012, 20111318 US GEOL SUR; Selin NE, 2009, ANNU REV ENV RESOUR, V34, P43, DOI 10.1146/annurev.environ.051308.084314; SHANLEY JB, 2002, EOS T, V83, P45, DOI DOI 10.1029/2002E0000031; Silverman M. H., 2006, SOIL SURVEY HAMILTON; Skyllberg U, 2003, BIOGEOCHEMISTRY, V64, P53, DOI 10.1023/A:1024904502633; Smith DB, 2009, APPL GEOCHEM, V24, P1357, DOI 10.1016/j.apgeochem.2009.04.008; Smith-Downey NV, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2009JG001124; Tipping E, 2011, ENVIRON POLLUT, V159, P3721, DOI 10.1016/j.envpol.2011.07.011; Tjerngren I, 2012, BIOGEOCHEMISTRY, V108, P335, DOI 10.1007/s10533-011-9603-1; WANG W, 1995, ENVIRON SCI TECHNOL, V29, P2261, DOI 10.1021/es00009a016; Wiener JG, 2006, ENVIRON SCI TECHNOL, V40, P6261, DOI 10.1021/es060822h; Woodruff LG, 2010, ENVIRON SCI TECHNOL, V44, P5371, DOI 10.1021/es100544d; Woodruff LG, 2009, APPL GEOCHEM, V24, P1369, DOI 10.1016/j.apgeochem.2009.04.009; Woodruff LG, 2010, 516 US GEOL SURV	68	176	184	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e86855	10.1371/journal.pone.0086855	http://dx.doi.org/10.1371/journal.pone.0086855			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24614226	Green Published, gold, Green Submitted			2022-12-27	WOS:000331271500010
J	Ji, X; Xu, H; Zhang, H; Hillery, CA; Gao, HQ; Pritchard, KA				Ji, Xiang; Xu, Hao; Zhang, Hao; Hillery, Cheryl A.; Gao, Hai-qing; Pritchard, Kirkwood A., Jr.			Anion Exchange HPLC Isolation of High-Density Lipoprotein (HDL) and On-Line Estimation of Proinflammatory HDL	PLOS ONE			English	Article							SICKLE-CELL-DISEASE; CHOLESTEROL LEVELS; ANTIINFLAMMATORY PROPERTIES; INHIBITS 3; ATHEROSCLEROSIS; INFLUENZA; TRANSPORT; VASODILATION; LOVASTATIN; PROTEINS	Proinflammatory high-density lipoprotein (p-HDL) is a biomarker of cardiovascular disease. Sickle cell disease (SCD) is characterized by chronic states of oxidative stress that many consider to play a role in forming p-HDL. To measure p-HDL, apolipoprotein (apo) B containing lipoproteins are precipitated. Supernatant HDL is incubated with an oxidant/LDL or an oxidant alone and rates of HDL oxidation monitored with dichlorofluorescein (DCFH). Although apoB precipitation is convenient for isolating HDL, the resulting supernatant matrix likely influences HDL oxidation. To determine effects of supernatants on p-HDL measurements we purified HDL from plasma from SCD subjects by anion exchange (AE) chromatography, determined its rate of oxidation relative to supernatant HDL. SCD decreased total cholesterol but not triglycerides or HDL and increased cell-free (cf) hemoglobin (Hb) and xanthine oxidase (XO). HDL isolated by AE-HPLC had lower p-HDL levels than HDL in supernatants after apoB precipitation. XO+xanthine (X) and cf Hb accelerated purified HDL oxidation. Although the plate and AE-HPLC assays both showed p-HDL directly correlated with cf-Hb in SCD plasma, the plate assay yielded p-HDL data that was influenced more by cf-Hb than AE-HPLC generated p-HDL data. The AE-HPLC p-HDL assay reduces the influence of the supernatants and shows that SCD increases p-HDL.	[Ji, Xiang; Gao, Hai-qing] Shandong Univ, Qilu Hosp, Dept Geriatr, Key Lab Cardiovasc Prote Shandong Prov, Jinan 250100, Shandong, Peoples R China; [Ji, Xiang; Xu, Hao; Zhang, Hao; Gao, Hai-qing; Pritchard, Kirkwood A., Jr.] Med Coll Wisconsin, Dept Surg, Div Pediat Surg, Milwaukee, WI 53226 USA; [Hillery, Cheryl A.] Med Coll Wisconsin, Dept Pediat, Div Hematol, Milwaukee, WI 53226 USA; [Hillery, Cheryl A.] Blood Res Inst, Milwaukee, WI USA; [Xu, Hao; Zhang, Hao; Hillery, Cheryl A.; Pritchard, Kirkwood A., Jr.] Childrens Res Inst, Milwaukee, WI USA; [Xu, Hao; Zhang, Hao; Hillery, Cheryl A.; Pritchard, Kirkwood A., Jr.] Med Coll Wisconsin, Milwaukee, WI 53226 USA	Shandong University; Medical College of Wisconsin; Medical College of Wisconsin; Versiti Blood Center of Wisconsin; Medical College of Wisconsin	Pritchard, KA (corresponding author), Med Coll Wisconsin, Dept Surg, Div Pediat Surg, 8700 W Wisconsin Ave, Milwaukee, WI 53226 USA.	kpritch@mcw.edu	He, Zhen/D-1275-2009	He, Zhen/0000-0001-6302-6556	American Heart Association [11SDG5120015]; National Institutes of Health [HL-102996, HL-102836, U54 HL-090503]; Midwest Athletes Against Childhood Cancer Fund; Chinese Government Graduate Student Overseas Study Program by China Scholarship Council [201206220063]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL090503, R01HL102836, R01HL112270, R21HL102996] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Midwest Athletes Against Childhood Cancer Fund; Chinese Government Graduate Student Overseas Study Program by China Scholarship Council; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by American Heart Association Grant 11SDG5120015 (to HZ); National Institutes of Health Grants HL-102996 (to KAP), HL-102836 (to KAP and CAH), U54 HL-090503 (to CAH) and Midwest Athletes Against Childhood Cancer Fund (to CAH). Chinese Government Graduate Student Overseas Study Program by China Scholarship Council (File No. 201206220063) to XJ and HQG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansell BJ, 2003, CIRCULATION, V108, P2751, DOI 10.1161/01.CIR.0000103624.14436.4B; Aslan M, 2001, P NATL ACAD SCI USA, V98, P15215, DOI 10.1073/pnas.221292098; ASSMANN G, 1993, CIRCULATION, V87, P28; CHUANG PT, 1990, ARTERIOSCLEROSIS, V10, P188, DOI 10.1161/01.ATV.10.2.188; Degoma EM, 2008, J AM COLL CARDIOL, V51, P2199, DOI 10.1016/j.jacc.2008.03.016; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; Frei AC, 2008, BLOOD, V112, P398, DOI 10.1182/blood-2007-12-126714; Gharavi NM, 2007, ARTERIOSCL THROM VAS, V27, P1346, DOI 10.1161/ATVBAHA.107.141283; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; Gurfinkel EP, 2002, CIRCULATION, V105, P2143, DOI 10.1161/01.CIR.0000016182.85461.F4; Hanson MS, 2012, AM J PHYSL HEART CIR; HATEFI Y, 1969, P NATL ACAD SCI USA, V62, P1129, DOI 10.1073/pnas.62.4.1129; Hillery CA, 2000, BRIT J HAEMATOL, V109, P322, DOI 10.1046/j.1365-2141.2000.02040.x; Hirowatari Y, 2003, J LIPID RES, V44, P1404, DOI 10.1194/jlr.D300003-JLR200; ITSKOVITZ HD, 1989, CLIN THER, V11, P862; Khera AV, 2011, NEW ENGL J MED, V364, P127, DOI 10.1056/NEJMoa1001689; Kuvin JT, 2002, AM HEART J, V144, P165, DOI 10.1067/mhj.2002.123145; Mastorikou M, 2006, DIABETES, V55, P3099, DOI 10.2337/db06-0723; Navab M, 2000, J LIPID RES, V41, P1481; Navab M, 2000, J LIPID RES, V41, P1495; NAVAB M, 1995, AM J CARDIOL, V76, pC18, DOI 10.1016/S0002-9149(99)80466-4; Navab M, 2001, J LIPID RES, V42, P1308; Ou JS, 2005, CIRC RES, V97, P1190, DOI 10.1161/01.RES.0000190634.60042.cb; Pritchard KA, 2004, AM J PHYSIOL-LUNG C, V286, pL705, DOI 10.1152/ajplung.00288.2002; REYNOLDS GD, 1985, AM J PATHOL, V121, P200; SADRZADEH SMH, 1984, J BIOL CHEM, V259, P4354; TILLETT HE, 1983, INT J EPIDEMIOL, V12, P344, DOI 10.1093/ije/12.3.344; TOLKACHEVA NV, 1989, VOP MED KHIM, V35, P89; Vaisar T, 2007, J CLIN INVEST, V117, P746, DOI 10.1172/JCI26206; Van Lenten BJ, 2001, CIRCULATION, V103, P2283; VanLenten BJ, 1995, J CLIN INVEST, V96, P2758, DOI 10.1172/JCI118345; VINCENT SH, 1988, ARCH BIOCHEM BIOPHYS, V265, P539, DOI 10.1016/0003-9861(88)90159-2; Weihrauch D, 2007, AM J PHYSIOL-HEART C, V293, pH1432, DOI 10.1152/ajpheart.00038.2007; Woo JMP, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3020; Wood KC, 2008, FREE RADICAL BIO MED, V44, P1506, DOI 10.1016/j.freeradbiomed.2008.01.008; Xu H, 2006, FASEB J, V20, pA198; Yuditskaya S, 2009, BLOOD, V113, P1122, DOI 10.1182/blood-2008-03-142604; Zorn U, 2001, ELECTROPHORESIS, V22, P1143, DOI 10.1002/1522-2683()22:6<1143::AID-ELPS1143>3.0.CO;2-Q	38	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91089	10.1371/journal.pone.0091089	http://dx.doi.org/10.1371/journal.pone.0091089			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	25202990	Green Published, Green Submitted, gold			2022-12-27	WOS:000332485800098
J	Zheng, Z; Kilian, A; Yan, GJ; Liu, CJ				Zheng, Zhi; Kilian, Andrzej; Yan, Guijun; Liu, Chunji			QTL Conferring Fusarium Crown Rot Resistance in the Elite Bread Wheat Variety EGA Wylie	PLOS ONE			English	Article							HEAD BLIGHT RESISTANCE; DISEASE; BARLEY; MAP; IDENTIFICATION; GRAMINEARUM; SEEDLINGS; SEVERITY	Fusarium crown rot (FCR) is one of the most damaging cereal diseases in semi-arid regions worldwide. The genetics of FCR resistance in the bread wheat (Triticum eastivum L.) variety EGA Wylie, the most resistant commercial variety available, was studied by QTL mapping. Three populations of recombinant inbred lines were developed with this elite variety as the resistant parent. Four QTL conferring FCR resistance were detected and resistance alleles of all of them were derived from the resistant parent EGA Wylie. One of these loci was located on the short arm of chromosome 5D (designated as Qcrs.cpi-5D). This QTL explains up to 31.1% of the phenotypic variance with an LOD value of 9.6. The second locus was located on the long arm of chromosome 2D (designated as Qcrs.cpi-2D) and explained up to 20.2% of the phenotypic variance with an LOD value of 4.5. Significant effects of both Qcrs.cpi-5D and Qcrs.cpi-2D were detected in each of the three populations assessed. Another two QTL (designated as Qcrs.cpi-4B. 1 and Qcrs.cpi-4B.2, respectively) were located on the short arm of chromosome 4B. These two QTL explained up to 16.9% and 18.8% of phenotypic variance, respectively. However, significant effects of Qcrs.cpi-4B.1 and Qcrs.cpi-4B.2 were not detected when the effects of plant height was accounted for by covariance analysis. The elite characteristics of this commercial variety should facilitate the incorporation of the resistance loci it contains into breeding programs.	[Zheng, Zhi; Liu, Chunji] Commenwealth Sci & Ind Res Org CSIRO Plant Ind, St Lucia, Qld, Australia; [Zheng, Zhi; Yan, Guijun; Liu, Chunji] Univ Western Australia, Sch Plant Biol, Fac Sci, Perth, WA 6009, Australia; [Zheng, Zhi; Yan, Guijun; Liu, Chunji] Univ Western Australia, UWA Inst Agr, Perth, WA 6009, Australia; [Zheng, Zhi] Hebei Acad Agr & Forestry Sci, Inst Millet Crops, Natl Foxtail Millet Improvement Ctr, Shijiazhuang, Peoples R China; [Kilian, Andrzej] Divers Arrays Technol Pty Ltd, Canberra, ACT, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Western Australia; University of Western Australia; Hebei Academy of Agricultural & Forestry Sciences	Liu, CJ (corresponding author), Commenwealth Sci & Ind Res Org CSIRO Plant Ind, St Lucia, Qld, Australia.	Chunji.liu@csiro.au	Liu, Chunji/B-5243-2009; Zheng, Zhi/C-4110-2017; Zheng, Zhong/AAZ-9647-2020; Yan, Guijun/A-9809-2011	Zheng, Zhi/0000-0002-1493-1995; Yan, Guijun/0000-0001-9628-1211; Kilian, Andrzej/0000-0002-2730-7462	Commonwealth Scientific & Industrial Organisation of Australia (CSIRO); University of Western Australia; China Scholarship Council (CSC); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R43AR064126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R44DE024692] Funding Source: NIH RePORTER	Commonwealth Scientific & Industrial Organisation of Australia (CSIRO)(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); University of Western Australia; China Scholarship Council (CSC)(China Scholarship Council); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Funding for the study was provided by the Commonwealth Scientific & Industrial Organisation of Australia (CSIRO). Z. Zheng is grateful to the University of Western Australia and China Scholarship Council (CSC) for his PhD scholarships. No additional external funding was received or used for this study. CSIRO determines the research priorities of all research that it funds. Publication of research is subject to review by CSIRO officials. Specific study design, data collection, data analysis, and preparation of the manuscript is under the control of the individual researchers.	Akbari M, 2006, THEOR APPL GENET, V113, P1409, DOI 10.1007/s00122-006-0365-4; Akinsanmi OA, 2004, AUST J AGR RES, V55, P97, DOI 10.1071/AR03090; Anderson JA, 1992, THEOR APPL GENET, V83, P1035, DOI 10.1007/BF00232969; [Anonymous], 2013, QUEENSLAND WHEAT VAR; Bovill WD, 2006, PLANT BREEDING, V125, P538, DOI 10.1111/j.1439-0523.2006.01251.x; Bovill WD, 2010, THEOR APPL GENET, V121, P127, DOI 10.1007/s00122-010-1296-7; Buerstmayr H, 2009, PLANT BREEDING, V128, P1, DOI 10.1111/j.1439-0523.2008.01550.x; Chakraborty S, 2006, AUSTRALAS PLANT PATH, V35, P643, DOI 10.1071/AP06068; Chen GD, 2014, BMC PLANT BIOL, V14, DOI [10.1186/1471-2229-14-22, 10.1186/1471-2458-14-754]; Chen GD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058040; Li HB, 2009, THEOR APPL GENET, V118, P903, DOI 10.1007/s00122-008-0948-3; Li HB, 2010, THEOR APPL GENET, V121, P941, DOI 10.1007/s00122-010-1363-0; Li XM, 2008, J PHYTOPATHOL, V156, P751, DOI 10.1111/j.1439-0434.2008.01425.x; Liu CJ, 2011, CZECH J GENET PLANT, V47, pS109, DOI 10.17221/3264-CJGPB; Liu YX, 2010, PHYTOPATHOLOGY, V100, P1276, DOI 10.1094/PHYTO-05-10-0142; Ma J, 2010, THEOR APPL GENET, V120, P1119, DOI 10.1007/s00122-009-1239-3; Mudge AM, 2006, PHYSIOL MOL PLANT P, V69, P73, DOI 10.1016/j.pmpp.2007.01.003; Murray GM, 2009, AUSTRALAS PLANT PATH, V38, P558, DOI 10.1071/AP09053; PATERSON AH, 1988, NATURE, V335, P721, DOI 10.1038/335721a0; Poole GJ, 2012, THEOR APPL GENET, V125, P91, DOI 10.1007/s00122-012-1818-6; PURSS G. S., 1966, Queensland Journal of Agricultural and Animal Sciences, V23, P475; Smiley RW, 2005, PLANT DIS, V89, P595, DOI 10.1094/PD-89-0595; Somers DJ, 2004, THEOR APPL GENET, V109, P1105, DOI 10.1007/s00122-004-1740-7; Van Ooijen JW, 2004, MAPQTL 5; Van Ooijen JW, 2006, JOINTMAP 4; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wallwork H, 2004, AUSTRALAS PLANT PATH, V33, P1, DOI 10.1071/AP03073; WILDERMUTH GB, 1994, PLANT DIS, V78, P949, DOI 10.1094/PD-78-0949; Xie GQ, 2007, AUST J EXP AGR, V47, P603, DOI 10.1071/EA05250; Yan W, 2011, PLANT PATHOL, V60, P506, DOI 10.1111/j.1365-3059.2011.02426.x	30	56	61	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2014	9	4							e96011	10.1371/journal.pone.0096011	http://dx.doi.org/10.1371/journal.pone.0096011			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW4HM	24603701	Green Submitted, gold, Green Published			2022-12-27	WOS:000346241800024
J	Wang, GZ; Huang, XY; Ng, TB; Lin, J; Ye, XY				Wang, Guozeng; Huang, Xiaoyun; Ng, Tzi Bun; Lin, Juan; Ye, Xiu Yun			High Phylogenetic Diversity of Glycosyl Hydrolase Family 10 and 11 Xylanases in the Sediment of Lake Dabusu in China	PLOS ONE			English	Article							BACTERIAL DIVERSITY; SODA LAKE; LONAR LAKE; SP-NOV.; ALKALINE; ENDO-BETA-1,4-XYLANASE; PURIFICATION; EXPRESSION; GENETICS; PROGRAM	Soda lakes are one of the most stable naturally occurring alkaline and saline environments, which harbor abundant microorganisms with diverse functions. In this study, culture-independent molecular methods were used to explore the genetic diversity of glycoside hydrolase (GH) family 10 and GH11 xylanases in Lake Dabusu, a soda lake with a pH value of 10.2 and salinity of 10.1%. A total of 671 xylanase gene fragments were obtained, representing 78 distinct GH10 and 28 GH11 gene fragments respectively, with most of them having low homology with known sequences. Phylogenetic analysis revealed that the GH10 xylanase sequences mainly belonged to Bacteroidetes, Proteobacteria, Actinobacteria, Firmicutes and Verrucomicrobia, while the GH11 sequences mainly consisted of Actinobacteria, Firmicutes and Fungi. A full-length GH10 xylanase gene (xynAS10-66) was directly cloned and expressed in Escherichia coli, and the recombinant enzymes showed high activity at alkaline pH. These results suggest that xylanase gene diversity within Lake Dabusu is high and that most of the identified genes might be novel, indicating great potential for applications in industry and agriculture.	[Wang, Guozeng; Huang, Xiaoyun; Lin, Juan; Ye, Xiu Yun] Fuzhou Univ, Coll Biol Sci & Technol, Fuzhou 350108, Peoples R China; [Wang, Guozeng; Lin, Juan; Ye, Xiu Yun] Natl Engn Lab High Efficiency Enzyme Express, Fuzhou 350002, Peoples R China; [Ng, Tzi Bun] Chinese Univ Hong Kong, Sch Biomed Sci, Fac Med, Shatin, Hong Kong, Peoples R China	Fuzhou University; Chinese University of Hong Kong	Lin, J (corresponding author), Fuzhou Univ, Coll Biol Sci & Technol, Fuzhou 350108, Peoples R China.	ljuan@fzu.edu.cn; xiuyunye@fzu.edu.cn	zhang, qingqing/GXF-2381-2022	Wang, Guozeng/0000-0001-6547-0490	National Natural Science Foundation of China [31301406]; Oceanic Public Welfare Industry Special Research Project of China [201305015]; Priming Scientific Research Foundation of Fuzhou University [XRC-1326]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Oceanic Public Welfare Industry Special Research Project of China; Priming Scientific Research Foundation of Fuzhou University	This research was supported by the National Natural Science Foundation of China (31301406), the Oceanic Public Welfare Industry Special Research Project of China (201305015) and the Priming Scientific Research Foundation of Fuzhou University (XRC-1326). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Zarba SS, 2002, INT J SYST EVOL MICR, V52, P525, DOI [10.1099/ijs.0.01658-0, 10.1099/00207713-52-2-525]; Antony CP, 2013, ISME J, V7, P468, DOI 10.1038/ismej.2012.137; Beg QK, 2001, APPL MICROBIOL BIOT, V56, P326, DOI 10.1007/s002530100704; Biely P, 1997, J BIOTECHNOL, V57, P151, DOI 10.1016/S0168-1656(97)00096-5; Blanco J, 1997, APPL MICROBIOL BIOT, V48, P208, DOI 10.1007/s002530051040; Brady SF, 2007, NAT PROTOC, V2, P1297, DOI 10.1038/nprot.2007.195; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Collins T, 2005, FEMS MICROBIOL REV, V29, P3, DOI 10.1016/j.femsre.2004.06.005; Foti MJ, 2008, EXTREMOPHILES, V12, P133, DOI 10.1007/s00792-007-0117-7; Gessesse A, 1998, APPL ENVIRON MICROB, V64, P3533; Gessesse A, 1998, J IND MICROBIOL BIOT, V20, P210, DOI 10.1038/sj.jim.2900503; Huang H, APPL MICROBIOL BIOTE, V87, P1141; Jeffries TW, 1996, CURR OPIN BIOTECH, V7, P337, DOI 10.1016/S0958-1669(96)80041-3; Jones BE, 1998, EXTREMOPHILES, V2, P191, DOI 10.1007/s007920050060; Joshi AA, 2008, MICROB ECOL, V55, P163, DOI 10.1007/s00248-007-9264-8; Khandeparkar R, 2007, BIORESOURCE TECHNOL, V98, P897, DOI 10.1016/j.biortech.2006.02.037; Kovaleva OL, 2011, FEMS MICROBIOL ECOL, V75, P37, DOI 10.1111/j.1574-6941.2010.00996.x; Kulkarni N, 1999, FEMS MICROBIOL REV, V23, P411, DOI 10.1111/j.1574-6976.1999.tb00407.x; Lanzen A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072577; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lin JL, 2005, APPL ENVIRON MICROB, V71, P6458, DOI 10.1128/AEM.71.10.6458-6462.2005; Ma YH, 2004, EXTREMOPHILES, V8, P45, DOI 10.1007/s00792-003-0358-z; Mamo G, 2006, MOL BIOTECHNOL, V33, P149; Martin-Sampedro R, 2012, BIORESOURCE TECHNOL, V110, P371, DOI 10.1016/j.biortech.2012.01.111; MILLER GL, 1960, ANAL BIOCHEM, V1, P127, DOI 10.1016/0003-2697(60)90004-X; Pagaling E, 2009, APPL ENVIRON MICROB, V75, P5750, DOI 10.1128/AEM.00040-09; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Polizeli MLTM, 2005, APPL MICROBIOL BIOT, V67, P577, DOI 10.1007/s00253-005-1904-7; Rees HC, 2004, EXTREMOPHILES, V8, P63, DOI 10.1007/s00792-003-0361-4; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Shen J, 2001, CHIN J OCEANOL LIMN, V19, P91; Simkhada JR, 2012, APPL BIOCHEM BIOTECH, V168, P2017, DOI 10.1007/s12010-012-9914-2; Solomon V, 2007, ACTA CRYSTALLOGR D, V63, P845, DOI 10.1107/S0907444907024845; Sunna A, 1997, CRIT REV BIOTECHNOL, V17, P39, DOI 10.3109/07388559709146606; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Verma D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052459; Wang GZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043480; Wang GZ, 2010, APPL MICROBIOL BIOT, V87, P1383, DOI 10.1007/s00253-010-2564-9; White JR, 2008, BIOINFORMATICS, V24, P462, DOI 10.1093/bioinformatics/btm632; Zhao BS, 2012, INT J SYST EVOL MICR, V62, P2618, DOI 10.1099/ijs.0.038315-0	41	38	43	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112798	10.1371/journal.pone.0112798	http://dx.doi.org/10.1371/journal.pone.0112798			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	24603699	gold, Green Submitted, Green Published			2022-12-27	WOS:000347709300106
J	Burns, G; Brooks, K; Wildung, M; Navakanitworakul, R; Christenson, LK; Spencer, TE				Burns, Gregory; Brooks, Kelsey; Wildung, Mark; Navakanitworakul, Raphatphorn; Christenson, Lane K.; Spencer, Thomas E.			Extracellular Vesicles in Luminal Fluid of the Ovine Uterus	PLOS ONE			English	Article							GASTRIN-RELEASING-PEPTIDE; ENDOGENOUS RETROVIRUSES; INTERFERON-TAU; EXOSOMES; PREGNANCY; EXPRESSION; MICRORNAS; PROTEIN; GENES; RNA	Microvesicles and exosomes are nanoparticles released from cells and can contain small RNAs, mRNA and proteins that affect cells at distant sites. In sheep, endogenous beta retroviruses (enJSRVs) are expressed in the endometrial epithelia of the uterus and can be transferred to the conceptus trophectoderm. One potential mechanism of enJSRVs transfer from the uterus to the conceptus is via exosomes/microvesicles. Therefore, studies were conducted to evaluate exosomes in the uterine luminal fluid (ULF) of sheep. Exosomes/microvesicles (hereafter referred to as extracellular vesicles) were isolated from the ULF of day 14 cyclic and pregnant ewes using ExoQuick-TC. Transmission electron microscopy and nanoparticle tracking analysis found the isolates contained vesicles that ranged from 50 to 200 nm in diameter. The isolated extracellular vesicles were positive for two common markers of exosomes (CD63 and HSP70) by Western blot analysis. Proteins in the extracellular vesicles were determined by mass spectrometry and Western blot analysis. Extracellular vesicle RNA was analyzed for small RNAs by sequencing and enJSRVs RNA by RT-PCR. The ULF extracellular vesicles contained a large number of small RNAs and miRNAs including 81 conserved mature miRNAs. Cyclic and pregnant ULF extracellular vesicles contained enJSRVs env and gag RNAs that could be delivered to heterologous cells in vitro. These studies support the hypothesis that ULF extracellular vesicles can deliver enJSRVs RNA to the conceptus, which is important as enJSRVs regulate conceptus trophectoderm development. Importantly, these studies support the idea that extracellular vesicles containing select miRNAs, RNAs and proteins are present in the ULF and likely have a biological role in conceptus-endometrial interactions important for the establishment and maintenance of pregnancy.	[Burns, Gregory; Brooks, Kelsey; Spencer, Thomas E.] Washington State Univ, Dept Anim Sci, Pullman, WA 99164 USA; [Wildung, Mark] Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA; [Navakanitworakul, Raphatphorn; Christenson, Lane K.] Univ Kansas, Dept Mol & Integrat Physiol, Sch Med, Kansas City, KS USA	Washington State University; Washington State University; University of Kansas; University of Kansas Medical Center	Spencer, TE (corresponding author), Washington State Univ, Dept Anim Sci, Pullman, WA 99164 USA.	thomas.spencer@wsu.edu	Burns, Douglas/A-7507-2009; Spencer, Thomas/AAD-6434-2020; Bradley, Paul M./AAC-2451-2020; navakanitworakul, raphatphorn/T-5948-2017	Bradley, Paul M./0000-0001-7522-8606; navakanitworakul, raphatphorn/0000-0001-6408-0079; Spencer, Thomas/0000-0003-2815-766X; Burns, Douglas/0000-0001-6516-2869; Burns, Gregory/0000-0003-0021-4319	USDA National Institute of Food and Agriculture [2012-67015-30173]; National Institute of Health [HD061580]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD061580] Funding Source: NIH RePORTER	USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Supported in part by AFRI Competitive Grant 2012-67015-30173 (TES) from the USDA National Institute of Food and Agriculture and HD061580 (LKC) from the National Institute of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliotta JM, 2010, EXP HEMATOL, V38, P233, DOI 10.1016/j.exphem.2010.01.002; Arnaud F, 2007, PLOS PATHOG, V3, P1716, DOI 10.1371/journal.ppat.0030170; Bazer FW, 2010, MOL HUM REPROD, V16, P135, DOI 10.1093/molehr/gap095; BAZER FW, 1975, J ANIM SCI, V41, P1376, DOI 10.2527/jas1975.4151376x; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Black SG, 2010, J VIROL, V84, P9078, DOI 10.1128/JVI.00950-10; Dorniak P, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.097063; Dorniak P, 2011, BIOL REPROD, V84, P1119, DOI 10.1095/biolreprod.110.089979; Dunlap KA, 2006, P NATL ACAD SCI USA, V103, P14390, DOI 10.1073/pnas.0603836103; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Escola JM, 1998, J BIOL CHEM, V273, P20121, DOI 10.1074/jbc.273.32.20121; FLECHON JE, 1986, REPROD NUTR DEV, V26, P1017, DOI 10.1051/rnd:19860609; Forbes K, 2012, PLACENTA, V33, P581, DOI 10.1016/j.placenta.2012.03.006; Forde N, 2010, PHYSIOL GENOMICS, V41, P53, DOI 10.1152/physiolgenomics.00162.2009; Frangsmyr L, 2005, MOL HUM REPROD, V11, P35, DOI 10.1093/molehr/gah129; FRASER M, 1994, ENDOCRINOLOGY, V135, P2440, DOI 10.1210/en.135.6.2440; Gifford CA, 2007, J DAIRY SCI, V90, P274, DOI 10.3168/jds.S0022-0302(07)72628-0; GIRAUD A, 1994, ENDOCRINOLOGY, V135, P2806, DOI 10.1210/en.135.6.2806; Gray CA, 2001, BIOL REPROD, V64, P1608, DOI 10.1095/biolreprod64.6.1608; Gray CA, 2001, BIOL REPROD, V65, P1311, DOI 10.1095/biolreprod65.5.1311; GUILLOMOT M, 1995, J REPROD FERTIL, P39; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hergenreider E, 2012, NAT CELL BIOL, V14, P249, DOI 10.1038/ncb2441; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Katakowski M, 2010, CANCER RES, V70, P8259, DOI 10.1158/0008-5472.CAN-10-0604; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Y, 2012, HUM MOL GENET, V21, pR125, DOI 10.1093/hmg/dds317; Lin J, 2011, CARCINOGENESIS, V32, P1641, DOI 10.1093/carcin/bgr199; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Luo SS, 2009, BIOL REPROD, V81, P717, DOI 10.1095/biolreprod.108.075481; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; Mi S, 2000, NATURE, V403, P785, DOI 10.1038/35001608; Mincheva-Nilsson L, 2010, AM J REPROD IMMUNOL, V63, P520, DOI 10.1111/j.1600-0897.2010.00822.x; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; Ng YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058502; Pan Q, 2008, SEMIN REPROD MED, V26, P479, DOI 10.1055/s-0028-1096128; Racicot K, 2012, AM J REPROD IMMUNOL, V67, P498, DOI 10.1111/j.1600-0897.2012.01109.x; Rana S, 2012, INT J BIOCHEM CELL B, V44, P1574, DOI 10.1016/j.biocel.2012.06.018; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Sabapatha A, 2006, AM J REPROD IMMUNOL, V56, P345, DOI 10.1111/j.1600-0897.2006.00435.x; Simmons RM, 2010, BIOL REPROD, V82, P35, DOI 10.1095/biolreprod.109.079608; Simpson RJ, 2008, PROTEOMICS, V8, P4083, DOI 10.1002/pmic.200800109; Simpson RJ, 2009, EXPERT REV PROTEOMIC, V6, P267, DOI [10.1586/epr.09.17, 10.1586/EPR.09.17]; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Song G, 2007, PLACENTA, V28, P1091, DOI 10.1016/j.placenta.2007.04.004; Song GH, 2005, ENDOCRINOLOGY, V146, P4825, DOI 10.1210/en.2005-0768; Song G, 2008, BIOL REPROD, V79, P376, DOI 10.1095/biolreprod.108.068403; Spencer T E, 2007, Soc Reprod Fertil Suppl, V64, P379; Spencer TE, 2008, REPRODUCTION, V135, P165, DOI 10.1530/REP-07-0327; Spencer TE, 2007, REPROD FERT DEVELOP, V19, P65, DOI 10.1071/RD06102; Spencer TE, 2012, J REPROD DEVELOP, V58, P33, DOI 10.1262/jrd.2011-026; Spencer Thomas E, 2004, Reprod Biol Endocrinol, V2, P49, DOI 10.1186/1477-7827-2-49; Taylor DD, 2006, J IMMUNOL, V176, P1534, DOI 10.4049/jimmunol.176.3.1534; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Tolosa JM, 2012, PLACENTA, V33, P933, DOI 10.1016/j.placenta.2012.08.004; Urnovitz HB, 1996, CLIN MICROBIOL REV, V9, P72, DOI 10.1128/CMR.9.1.72; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Yang M, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-117; Zeng Y, 2003, P NATL ACAD SCI USA, V100, P9779, DOI 10.1073/pnas.1630797100	61	176	184	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e90913	10.1371/journal.pone.0090913	http://dx.doi.org/10.1371/journal.pone.0090913			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614226	Green Submitted, Green Published, gold			2022-12-27	WOS:000332839300053
J	Liu, YQ; Luo, BW; Han, FY; Li, XM; Xiong, J; Jiang, M; Yang, XF; Wu, YZ; Zhang, ZR				Liu, Yuqi; Luo, Bangwei; Han, Fuyu; Li, Xiaoming; Xiong, Jian; Jiang, Man; Yang, Xioafeng; Wu, Yuzhang; Zhang, Zhiren			Erythropoietin-Derived Nonerythropoietic Peptide Ameliorates Experimental Autoimmune Neuritis by Inflammation Suppression and Tissue Protection	PLOS ONE			English	Article							EXPERIMENTAL ALLERGIC NEURITIS; PERIPHERAL NERVOUS-SYSTEM; TERTIARY STRUCTURE; CANCER-PATIENTS; CELLS; NEUROPATHIES; RECEPTOR; ANEMIA; ARA290; TRIAL	Experimental autoimmune neuritis (EAN) is an autoantigen-specific T-cell-mediated disease model for human demyelinating inflammatory disease of the peripheral nervous system. Erythropoietin (EPO) has been known to promote EAN recovery but its haematopoiesis stimulating effects may limit its clinic application. Here we investigated the effects and potential mechanisms of an EPO-derived nonerythropoietic peptide, ARA 290, in EAN. Exogenous ARA 290 intervention greatly improved EAN recovery, improved nerve regeneration and remyelination, and suppressed nerve inflammation. Furthermore, haematopoiesis was not induced by ARA 290 during EAN treatment. ARA 290 intervention suppressed lymphocyte proliferation and altered helper T cell differentiation by inducing increase of Foxp3(+)/CD4(+) regulatory T cells and IL-4(+)/CD4(+) Th2 cells and decrease of IFN-gamma(+)/CD4(+) Th1 cells in EAN. In addition, ARA 290 inhibited inflammatory macrophage activation and promoted its phagocytic activity. In vitro, ARA 290 was shown to promote Schwann cell proliferation and inhibit its inflammatory activation. In summary, our data demonstrated that ARA 290 could effectively suppress EAN by attenuating inflammation and exerting direct cell protection, indicating that ARA 290 could be a potent candidate for treatment of autoimmune neuropathies.	[Liu, Yuqi; Luo, Bangwei; Han, Fuyu; Li, Xiaoming; Xiong, Jian; Jiang, Man; Yang, Xioafeng; Wu, Yuzhang; Zhang, Zhiren] Third Mil Med Univ, Peoples Liberat Army, Inst Immunol, Chongqing, Peoples R China	Army Medical University	Wu, YZ (corresponding author), Third Mil Med Univ, Peoples Liberat Army, Inst Immunol, Chongqing, Peoples R China.	yuzhangwu@yahoo.com.cn; zhangzhiren@yahoo.com	Zhang, Zhiren/O-1012-2019; zhang, zhiren/I-1046-2014	Zhang, Zhiren/0000-0002-5238-2835; zhang, zhiren/0000-0002-5238-2835; Wu, Yuzhang/0000-0002-4049-0214	National Nature Science Foundation of China [31170851]; National Science and Technology Major Projects of New Drugs [2012ZX09103301-035]; SRF for ROCS, SEM	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Projects of New Drugs; SRF for ROCS, SEM(Scientific Research Foundation for the Returned Overseas Chinese Scholars)	This investigation was supported by National Nature Science Foundation of China (http://www.nsfc.gov.cn/Portal0/default166.htm), No: 31170851, the National Science and Technology Major Projects of New Drugs (2012ZX09103301-035) and the SRF for ROCS, SEM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Bohlius J, 2006, NAT CLIN PRACT ONCOL, V3, P152, DOI 10.1038/ncponc0451; Bohr S, 2013, P NATL ACAD SCI USA, V110, P3513, DOI 10.1073/pnas.1214099110; Brines M, 2005, NAT REV NEUROSCI, V6, P484, DOI 10.1038/nrn1687; Brines M, 2004, P NATL ACAD SCI USA, V101, P14907, DOI 10.1073/pnas.0406491101; Brines M, 2008, P NATL ACAD SCI USA, V105, P10925, DOI 10.1073/pnas.0805594105; Chateauvieux S, 2011, BIOCHEM PHARMACOL, V82, P1291, DOI 10.1016/j.bcp.2011.06.045; CRAGGS RI, 1984, ACTA NEUROPATHOL, V62, P316, DOI 10.1007/BF00687614; Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; Enders U, 1998, BRAIN, V121, P1257, DOI 10.1093/brain/121.7.1257; Farrell F, 2004, ONCOLOGIST, V9, P18, DOI 10.1634/theoncologist.9-90005-18; Glaspy JA, 2009, ANNU REV MED, V60, P181, DOI 10.1146/annurev.med.60.050307.110718; Heij L, 2012, MOL MED, V18, P1430, DOI 10.2119/molmed.2012.00332; Henke M, 2003, LANCET, V362, P1255, DOI 10.1016/S0140-6736(03)14567-9; Horste GMZ, 2008, MUSCLE NERVE, V37, P3, DOI 10.1002/mus.20893; Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9; Hughes RAC, 2002, J ANAT, V200, P331, DOI 10.1046/j.1469-7580.2002.00041.x; Kiefer R, 2001, PROG NEUROBIOL, V64, P109, DOI 10.1016/S0301-0082(00)00060-5; Kieseier BC, 2004, MUSCLE NERVE, V30, P131, DOI 10.1002/mus.20076; Maiese K, 2008, PROG NEUROBIOL, V85, P194, DOI 10.1016/j.pneurobio.2008.02.002; Maurer M, 2002, REV NEUROL-FRANCE, V158, pS7; Mausberg AK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026280; Nairz M, 2012, MICROBES INFECT, V14, P238, DOI 10.1016/j.micinf.2011.10.005; Rosenzweig MQ, 2004, J PAIN SYMPTOM MANAG, V27, P185, DOI 10.1016/j.jpainsymman.2003.06.010; SCHABET M, 1991, J NEUROIMMUNOL, V31, P265, DOI 10.1016/0165-5728(91)90048-C; Shin T, 2012, ANAT CELL BIOL, V45, P215, DOI 10.5115/acb.2012.45.4.215; Soliven B, 2012, J PERIPHER NERV SYST, V17, P28, DOI 10.1111/j.1529-8027.2012.00392.x; Swartjes M, 2011, ANESTHESIOLOGY, V115, P1084, DOI 10.1097/ALN.0b013e31822fcefd; van Rijt WG, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-9; Winer JB, 2001, J CLIN PATHOL-MOL PA, V54, P381; Xanthos T, 2011, CURR PHARM DESIGN, V17, P1517, DOI 10.2174/138161211796197115; Zhang G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027067; Zhang Z, 2009, EXP NEUROL, V216, P75, DOI 10.1016/j.expneurol.2008.11.014; ZHANG ZY, 2009, NEUROPATHOL APPL NEU	34	45	52	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90942	10.1371/journal.pone.0090942	http://dx.doi.org/10.1371/journal.pone.0090942			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603865	Green Published, Green Submitted, gold			2022-12-27	WOS:000332483600112
J	Wang, GF; Zhang, QQ; Xu, N; Xu, KF; Wang, J; He, W; Yang, T				Wang, Guofeng; Zhang, Qingqing; Xu, Ning; Xu, Kuanfeng; Wang, Jian; He, Wei; Yang, Tao			Associations between Two Polymorphisms (FokI and BsmI) of Vitamin D Receptor Gene and Type 1 Diabetes Mellitus in Asian Population: A Meta-Analysis	PLOS ONE			English	Article							BONE-MINERAL DENSITY; SUSCEPTIBILITY; ONSET; PATTERN; APAI; TAQI	Background: Vitamin D receptor (VDR) gene polymorphisms are possibly involved in the development of type 1 diabetes mellitus (T1DM). However, the results to date have been inconclusive. We performed a meta-analysis to examine the association between 2 polymorphisms (FokI and BsmI) of the VDR gene and T1DM in the Asian population. Methods: Literature was retrieved from PubMed, Web of Science, CBM, Embase and Chinese databases. Pooled odds ratios (ORs) with 95% confidence intervals (CIs) were calculated using a random or fixed effect model. Results: In total, 20 papers (BsmI: 13 studies; FokI: 13 studies) were included. In contrast to the FokI polymorphism, the BsmI polymorphism was associated with an increased risk of T1DM in the Asian population (OR = 1.47, 95% CI = 1.13-1.91, P = 0.004 for B vs. b). Upon stratification by regional geography, an increased risk of T1DM in association with the BsmI polymorphism was observed in the East Asian population (OR = 1.97, 95% CI = 1.38-2.83, P<0.001 for B vs. b), whereas the FokI polymorphism was associated with an increased risk of T1DM in the West Asian population (OR = 1.45, 95% CI = 1.12-1.88, P = 0.004 for F vs. f). Conclusions: Our meta-analysis suggests that the BsmI polymorphism may be a risk factor for susceptibility to T1DM in the East Asian population, and the FokI polymorphism is associated with an increased risk of T1DM in the West Asian population. However, because the study size was limited, further studies are essential to confirm our results.	[Wang, Guofeng; Xu, Ning] Xuzhou Med Coll, Affiliated Hosp, Lianyungang Peoples Hosp 1, Dept Endocrinol Med, Lianyungang, Peoples R China; [Zhang, Qingqing; Xu, Kuanfeng; Wang, Jian; He, Wei; Yang, Tao] Nanjing Med Univ, Affiliated Hosp 1, Dept Endocrinol Med, Nanjing, Jiangsu, Peoples R China	Xuzhou Medical University; Nanjing Medical University	Yang, T (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Endocrinol Med, Nanjing, Jiangsu, Peoples R China.	yangt@njmu.edu.cn	zhang, qingqing/GXF-2381-2022	Wang, Guozeng/0000-0001-6547-0490				Ban Y, 2001, BMC Med Genet, V2, P7, DOI 10.1186/1471-2350-2-7; Bonakdaran S., 2012, Eastern Mediterranean Health Journal, V18, P614; Chang TJ, 2000, CLIN ENDOCRINOL, V52, P575, DOI 10.1046/j.1365-2265.2000.00985.x; Cheng J., 2010, ZHONG GUO GU ZHI SHU, V16, P9; Du T, 2008, THESIS ZHONGNAN MED, P1; Guo SW, 2006, AM J EPIDEMIOL, V164, P711, DOI 10.1093/aje/kwj278; Israni N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008023; Kocabas A, 2010, J PEDIATR ENDOCR MET, V23, P1289, DOI 10.1515/jpem.2010.203; Lee YH, 2012, MOL BIOL REP, V39, P6471, DOI 10.1007/s11033-012-1466-6; Lemos MC, 2008, HUM IMMUNOL, V69, P134, DOI 10.1016/j.humimm.2008.01.008; Liao L., 2005, THESIS CENTRAL S U, P01, DOI [10.7666/d.y813612, DOI 10.7666/D.Y813612]; Liu JL, 2003, TRADE INFORM, P1; Mohammadnejad Z, 2012, MOL BIOL REP, V39, P831, DOI 10.1007/s11033-011-0805-3; Motohashi Y, 2003, J CLIN ENDOCR METAB, V88, P3137, DOI 10.1210/jc.2002-021881; Ponsonby AL, 2008, AM J EPIDEMIOL, V168, P358, DOI 10.1093/aje/kwn142; Sahin SB, 2012, GENET TEST MOL BIOMA, V16, P1179, DOI 10.1089/gtmb.2012.0173; Shen BS., 2004, THESIS TIANJIN MED U, P01; [盛正妍 SHENG Zheng-yan], 2009, [中国糖尿病杂志, Chinese Journal of Diabetes], V17, P666; Shi YJ., 2007, CHIN J DIABETES, V15, P219; Shimada A, 2008, J AUTOIMMUN, V30, P207, DOI 10.1016/j.jaut.2007.09.002; Xiao Xin-hua, 2006, Chinese Medical Sciences Journal, V21, P95; Xie YT, 2012, THESIS ZHONGNAN MED, P1; Xu MQ, 2010, ATHEROSCLEROSIS, V213, P191, DOI 10.1016/j.atherosclerosis.2010.07.046; Yavuz DG, 2011, ACTA DIABETOL, V48, P329, DOI 10.1007/s00592-011-0284-y; Yokota I, 2002, DIABETES CARE, V25, P1244, DOI 10.2337/diacare.25.7.1244; Zhang J, 2012, MOL CELL ENDOCRINOL, V355, P135, DOI 10.1016/j.mce.2012.02.003; Zhou W, 2006, CANCER EPIDEM BIOMAR, V15, P2239, DOI 10.1158/1055-9965.EPI-06-0023	27	38	43	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e89325	10.1371/journal.pone.0089325	http://dx.doi.org/10.1371/journal.pone.0089325			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603699	gold, Green Submitted, Green Published			2022-12-27	WOS:000332483600011
J	Wang, Y; Yan, HJ; Zhou, SY; Wang, YS; Qi, H; Deng, CY; Li, FR				Wang, Yun; Yan, Hong-Jie; Zhou, Shu-Yan; Wang, Yun-Shuang; Qi, Hui; Deng, Chun-Yan; Li, Fu-Rong			The Immunoregulation Effect of Alpha 1-Antitrypsin Prolong beta-Cell Survival after Transplantation	PLOS ONE			English	Article							ISLET TRANSPLANTATION; REDUCES INFLAMMATION; ALLOGRAFT-REJECTION; ALPHA(1)-ANTITRYPSIN; INHIBITOR	Islet transplantation has considerable potential as a cure for diabetes. However, the difficulties that arise from inflammation and the immunological rejection of transplants must be addressed for islet transplantation to be successful. Alpha 1-antitrypsin (AAT) inhibits the damage on beta cells caused by inflammatory reactions and promotes beta-cell survival and proliferation. This protein also induces specific immune tolerance to transplanted beta cells. However, whether the expression of AAT in beta cells themselves could eliminate or decrease immunological rejection of transplants is not clear. Therefore, we established a beta cell line (NIT-hAAT) that stably expresses human AAT. Interestingly, in a cytotoxic T lymphocyte (CTL)-killing assay, we found that hAAT reduced apoptosis and inflammatory cytokine production in NIT-1 cells and regulated the Th1/Th2 cytokine balance in vitro. In vivo transplantation of NIT-hAAT cells into mice with diabetes showed hAAT inhibited immunological rejection for a short period of time and increased the survival of transplanted beta cells. This study demonstrated that hAAT generated remarkable immunoprotective and immunoregulation effects in a model of beta cell islet transplantation for diabetes model.	[Wang, Yun] Ningxia Med Univ, Gen Hosp, Dept Cardiac Surg, Yinchuan, Peoples R China; [Wang, Yun; Yan, Hong-Jie; Zhou, Shu-Yan; Wang, Yun-Shuang; Qi, Hui; Deng, Chun-Yan; Li, Fu-Rong] Jinan Univ, Shenzhen Peoples Hosp, Clin Med Coll 2, Key Lab Stem Cell & Cellular Therapy, Shenzhen, Peoples R China; [Li, Fu-Rong] Shenzhen Inst Gerontol, Shenzhen, Peoples R China	Ningxia Medical University; Jinan University	Li, FR (corresponding author), Jinan Univ, Shenzhen Peoples Hosp, Clin Med Coll 2, Key Lab Stem Cell & Cellular Therapy, Shenzhen, Peoples R China.	frli62@163.com			National 973 Program of China [2007CB516811]; National Natural Science Foundation of China [30772042, 81270857]; Science and Technology Project of Shenzhen [JCYJ20120618153743791, GJHZ20120618153934353]	National 973 Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Project of Shenzhen	This work was supported by the National 973 Program of China (No. 2007CB516811), The National Natural Science Foundation of China (No. 30772042 and No. 81270857), and The Science and Technology Project of Shenzhen (No. JCYJ20120618153743791, GJHZ20120618153934353). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi R, 2004, J IMMUNOL, V172, P767, DOI 10.4049/jimmunol.172.2.767; Bertuzzi F, 2004, J CLIN ENDOCR METAB, V89, P5724, DOI 10.1210/jc.2004-0659; Boni-Schnetzler M, 2008, J CLIN ENDOCR METAB, V93, P4065, DOI 10.1210/jc.2008-0396; Brantly M, 2002, AM J RESP CELL MOL, V27, P652, DOI 10.1165/rcmb.F250; BRANTLY ML, 1991, CHEST, V100, P703, DOI 10.1378/chest.100.3.703; Churg A, 2001, LAB INVEST, V81, P1119, DOI 10.1038/labinvest.3780324; HAMAGUCHI K, 1991, DIABETES, V40, P842, DOI 10.2337/diabetes.40.7.842; Jie ZJ, 2003, CHINESE MED J-PEKING, V116, P1678; Kalis M, 2010, ISLETS, V2, P185, DOI 10.4161/isl.2.3.11654; Koulmanda M, 2012, P NATL ACAD SCI USA, V109, P15443, DOI 10.1073/pnas.1018366109; Lewis EC, 2005, P NATL ACAD SCI USA, V102, P12153, DOI 10.1073/pnas.0505579102; Lewis EC, 2008, P NATL ACAD SCI USA, V105, P16236, DOI 10.1073/pnas.0807627105; Lu YQ, 2006, HUM GENE THER, V17, P625, DOI 10.1089/hum.2006.17.625; Ludvigsson J, 2010, CURR DIABETES REP, V10, P370, DOI 10.1007/s11892-010-0138-y; Mathis D, 2001, NATURE, V414, P792, DOI 10.1038/414792a; Ottaviani S, 2011, TRANSL RES, V157, P332, DOI 10.1016/j.trsl.2010.12.014; Ozeri E, 2012, J IMMUNOL, V189, P146, DOI 10.4049/jimmunol.1101340; Petrache L, 2006, AM J RESP CRIT CARE, V173, P1222, DOI 10.1164/rccm.200512-1842OC; Pott GB, 2009, J LEUKOCYTE BIOL, V85, P886, DOI 10.1189/jlb.0208145; Robertson RP, 2010, DIABETES, V59, P1285, DOI 10.2337/db09-1846; Shahaf G, 2011, MOL MED, V17, P1000, DOI 10.2119/molmed.2011.00145; Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267; Slobedman B, 2009, J VIROL, V83, P9618, DOI 10.1128/JVI.01098-09; Tawara I, 2012, P NATL ACAD SCI USA, V109, P564, DOI 10.1073/pnas.1117665109; Walters S, 2009, J IMMUNOL, V182, P793, DOI 10.4049/jimmunol.182.2.793; Wei P, 2012, BIOCHEM BIOPH RES CO, V418, P330, DOI 10.1016/j.bbrc.2012.01.021; Weir GC, 2009, CURR DIABETES REP, V9, P100, DOI 10.1007/s11892-009-0018-5; Ye J, 2013, IMMUNOL LETT, V150, P61, DOI 10.1016/j.imlet.2013.01.009; Zhang B, 2007, DIABETES, V56, P1316, DOI 10.2337/db06-1273	29	60	64	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94548	10.1371/journal.pone.0094548	http://dx.doi.org/10.1371/journal.pone.0094548			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722487	Green Published, gold			2022-12-27	WOS:000336909100095
J	Sun, XR; Sun, Z; Zhu, Z; Guan, HX; Zhang, JY; Zhang, YN; Xu, HM; Sun, MJ				Sun, Xuren; Sun, Zhe; Zhu, Zhi; Guan, Haixia; Zhang, Junyan; Zhang, Yining; Xu, Huimian; Sun, Mingjun			Clinicopathological Significance and Prognostic Value of Lactate Dehydrogenase A Expression in Gastric Cancer Patients	PLOS ONE			English	Article							AEROBIC GLYCOLYSIS; GLUCOSE-METABOLISM; LDH-A; CELLS; GROWTH	Introduction: LDH-A, the enzyme responsible for transforming pyruvate into lactate, has been demonstrated to be up-regulated in many types of cancer and to give rise to more aggressive behavior by regulating proliferation and antiapoptosis. However, its expression in gastric cancer (GC) has not been characterized thoroughly. The purpose of this study was to clarify the expression and potential impact of LDH-A in GC. Methods: We examined LDH-A expression by immunohistochemistry on GC tissue microarray (TMA) and using Western blot on fresh GC tissues and cell lines. Prognostic value and correlation with other clinicopathologic factors were evaluated. We transfected siRNA into GC cells against LDH-A. LDH-A was analyzed by Western blotting and real-time RT-PCR. Cell growth was evaluated in vitro and in vivo. Lactate and ATP production by cells were determined. Results: There was significantly higher LDH-A expression in carcinoma than in non-neoplastic mucosa (NNM). There was a positive correlation of LDH-A expression with age, histological type and Lymph node metastases. Survival analysis demonstrated that high expression of LDH-A in GC was associated with lower overall survival (OS). When stratified by Lauren grade and histological classification, significance appeared in diffuse type and undifferentiated type GC. In multivariate analysis, the LDH-A expression in GC was an independent prognostic risk factor for OS (hazard ratio = 1.829, 95% CI 1.375-2.433, P<0.0001). Specific siRNA against LDH-A in GC cell line retarded cell growth both in vitro and in mouse models. LDH-A knockdown also reduced lactate and ATP production in GC cells. Conclusions: Our study indicated the oncogenic role of LDH-A in GC. LDH-A expression is an independent prognostic risk factor in GC patients and up-regulated expression of LDH-A could be predictive of poor outcomes in diffuse type and undifferentiated type GC. Our results suggested that LDH-A might be a potential therapeutic target in gastric cancer.	[Sun, Xuren; Sun, Mingjun] China Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Shenyang, Liaoning Provin, Peoples R China; [Sun, Zhe; Zhu, Zhi; Zhang, Junyan; Xu, Huimian] China Med Univ, Affiliated Hosp 1, Dept Surg Oncol, Shenyang, Liaoning Provin, Peoples R China; [Guan, Haixia] China Med Univ, Affiliated Hosp 1, Dept Endocrinol & Metab, Shenyang, Liaoning Provin, Peoples R China; [Zhang, Yining; Sun, Mingjun] China Med Univ, Affiliated Hosp 1, Dept Gastrointestinal Endoscopy, Shenyang, Liaoning Provin, Peoples R China	China Medical University; China Medical University; China Medical University; China Medical University	Sun, MJ (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Shenyang, Liaoning Provin, Peoples R China.	smjmw@sina.com		Pan, Chen-Wei/0000-0003-3362-4613	Liaoning Province Science and Technology Department [2007225017, 2009225011-2, 2011415052]; Science and Technology projects in Shenyang City [F11-264-1-19]	Liaoning Province Science and Technology Department; Science and Technology projects in Shenyang City	This study was supported by grants from the research projects in Liaoning Province Science and Technology Department (No. 2007225017, No. 2009225011-2 and No. 2011415052) and Science and Technology projects in Shenyang City (No. F11-264-1-19). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brand KA, 1997, FASEB J, V11, P388, DOI 10.1096/fasebj.11.5.9141507; Cai Z, 2010, MOL CELL PROTEOMICS, V9, P2617, DOI 10.1074/mcp.M110.000661; Chen Z, 2007, J BIOENERG BIOMEMBR, V39, P267, DOI 10.1007/s10863-007-9086-x; Dang CV, 1999, TRENDS BIOCHEM SCI, V24, P68, DOI 10.1016/S0968-0004(98)01344-9; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gillies RJ, 2008, J NUCL MED, V49, p24S, DOI 10.2967/jnumed.107.047258; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Lewis BC, 1997, MOL CELL BIOL, V17, P4967, DOI 10.1128/MCB.17.9.4967; Robey IF, 2008, NEOPLASIA, V10, P745, DOI 10.1593/neo.07724; Rong YF, 2013, TUMOR BIOL, V34, P1523, DOI 10.1007/s13277-013-0679-1; Shim H, 1997, P NATL ACAD SCI USA, V94, P6658, DOI 10.1073/pnas.94.13.6658; Vegran F, 2011, CANCER RES, V71, P2550, DOI 10.1158/0008-5472.CAN-10-2828; Wang ZY, 2012, BREAST CANCER RES TR, V131, P791, DOI 10.1007/s10549-011-1466-6; WARBURG O, 1956, SCIENCE, V124, P269; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Yao F, 2013, TUMOR BIOL, V34, P25, DOI 10.1007/s13277-012-0506-0; Zhang YJ, 2012, CANCER LETT, V321, P45, DOI 10.1016/j.canlet.2012.03.013	18	66	69	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91068	10.1371/journal.pone.0091068	http://dx.doi.org/10.1371/journal.pone.0091068			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24788769	gold, Green Published, Green Submitted			2022-12-27	WOS:000332485800094
J	Wang, YW; Shi, DB; Chen, X; Gao, C; Gao, P				Wang, Ya-Wen; Shi, Duan-Bo; Chen, Xu; Gao, Chao; Gao, Peng			Clinicopathological Significance of MicroRNA-214 in Gastric Cancer and Its Effect on Cell Biological Behaviour	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; TUMOR ANGIOGENESIS; TARGETING PTEN; EXPRESSION; PROLIFERATION; GROWTH; INVASIVENESS; PROGRESSION; SURVIVAL; INVASION	Accumulating evidence indicates that numerous microRNAs are involved in the tumorigenesis and progression of gastric cancer, while the clinical significance of microRNA-214 in gastric cancer is poorly understood and the exact role of microRNA-214 in gastric cancer remains obscure. In the present study, expression levels of microRNA-214 in 80 gastric carcinoma tissues, 18 nontumourous gastric tissues, and 4 types of gastric cancer cell lines were quantified by reverse transcription followed by real-time quantitative polymerase chain reaction (RT-qPCR), and the relationship between microRNA-214 expression and cliniopathological characteristics including prognosis was explored. To investigate the potential role of microRNA-214 in gastric cancer cell biological behaviour, we performed cell proliferation, apoptosis, migration and invasion assays in four gastric cancer cell lines and an immortalized gastric cell line in vitro. Our results showed that microRNA-214 was dramatically downregulated in gastric cancer tissues and gastric cancer cell lines, compared with nontumourous gastric tissues. Stepwise downregulation of microRNA-214 expression was observed among nontumourous gastric mucosa, nonmetastasis gastric cancer tissues, and metastasis gastric cancer tissues. The expression of microRNA-214 was significantly inversely correlated with lymph node metastasis and tumour size but had no correlation with the patient's prognosis. Ectopic expression of microRNA-214 could inhibit cell migration and invasion ability in SGC7901 and MKN45 gastric cancer cells. And knockdown of microRNA-214 significantly facilitated cell proliferation, migration and invasion in a cell-specific manner in MKN28, BGC823 and GES-1 cells. Colony stimulating factor 1 (CSF1) was identified as a target gene of microRNA-214. In summary, our data demonstrated that microRNA-214 is a promising novel biomarker for lymph node metastasis in patients with gastric cancer. And we identified that downregulation of microRNA-214 may regulate the proliferation, invasion and migration of gastric cancer cells by directly targeting CSF1.	[Wang, Ya-Wen; Shi, Duan-Bo; Chen, Xu; Gao, Chao; Gao, Peng] Shandong Univ, Sch Med, Dept Pathol, Jinan 250100, Peoples R China	Shandong University	Gao, P (corresponding author), Shandong Univ, Sch Med, Dept Pathol, Jinan 250100, Peoples R China.	gaopeng@sdu.edu.cn			National Natural Science Foundation of China [81172351, 81372856]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 81172351 and 81372856). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aligeti S, 2011, FERTIL STERIL, V95, P2464, DOI 10.1016/j.fertnstert.2011.03.026; BAIOCCHI G, 1991, CANCER, V67, P990, DOI 10.1002/1097-0142(19910215)67:4<990::AID-CNCR2820670422>3.0.CO;2-8; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Dai XZ, 2011, CHINESE SCI BULL, V56, P3301, DOI 10.1007/s11434-011-4717-3; Derfoul A, 2011, CARCINOGENESIS, V32, P1607, DOI 10.1093/carcin/bgr184; Espinosa I, 2011, AM J PATHOL, V179, P2100, DOI 10.1016/j.ajpath.2011.06.021; Gao P, 2013, ONCOGENE, V32, P491, DOI 10.1038/onc.2012.61; Gao P, 2011, J HEPATOL, V54, P1177, DOI 10.1016/j.jhep.2010.09.023; Gill K, 2001, FERTIL STERIL, V76, P1005, DOI 10.1016/S0015-0282(01)02735-2; Iorio MV, 2009, J CLIN ONCOL, V27, P5848, DOI 10.1200/JCO.2009.24.0317; Motoyama K, 2010, INT J ONCOL, V36, P1089, DOI 10.3892/ijo_00000590; Mroczko B, 2007, CLIN CHIM ACTA, V380, P208, DOI 10.1016/j.cca.2007.02.037; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; Okazaki T, 2005, J IMMUNOL, V174, P7531, DOI 10.4049/jimmunol.174.12.7531; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Peng RQ, 2012, J BIOL CHEM, V287, P14301, DOI 10.1074/jbc.M111.337642; Penna E, 2011, EMBO J, V30, P1990, DOI 10.1038/emboj.2011.102; Qiang R, 2011, INT J BIOCHEM CELL B, V43, P632, DOI 10.1016/j.biocel.2011.01.002; Tsukamoto Y, 2010, CANCER RES, V70, P2339, DOI 10.1158/0008-5472.CAN-09-2777; Ueda T, 2010, LANCET ONCOL, V11, P136, DOI 10.1016/S1470-2045(09)70343-2; Wang HJ, 2009, J DIGEST DIS, V10, P258, DOI 10.1111/j.1751-2980.2009.00394.x; Wu WKK, 2010, ONCOGENE, V29, P5761, DOI 10.1038/onc.2010.352; Xing AY, 2013, EXP MOL PATHOL, V95, P91, DOI 10.1016/j.yexmp.2013.05.003; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488; Yang ZZ, 2009, IUBMB LIFE, V61, P1075, DOI 10.1002/iub.252; Zhang BG, 2012, ONCOL REP, V27, P1019, DOI 10.3892/or.2012.1645; Zhang C, 2012, ADV ENG FORUM, V2-3, P7, DOI 10.4028/www.scientific.net/AEF.2-3.7; Zhang ZY, 2008, LAB INVEST, V88, P1358, DOI 10.1038/labinvest.2008.94	28	60	64	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91307	10.1371/journal.pone.0091307	http://dx.doi.org/10.1371/journal.pone.0091307			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24722487	Green Published, gold, Green Submitted			2022-12-27	WOS:000332839300110
